data_5jtm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5jtm _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.63 ' HB2' ' HH ' ' A' ' 101' ' ' TYR . 1.8 t80 . . . . . 0 CA--C 1.538 0.504 0 N-CA-C 109.63 -0.508 . . . . 75.44 109.63 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -147.78 120.35 8.54 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.048 -1.093 . . . . 75.21 108.048 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.2 mt -85.85 120.56 36.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 109.374 -0.602 . . . . 72.23 109.374 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.28 -41.91 19.54 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.463 -0.94 . . . . 73.53 108.463 178.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -169.03 148.91 4.17 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 116.183 -0.462 . . . . 73.42 111.116 -170.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 69.0 mt -137.65 130.35 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 124.61 1.164 . . . . 71.53 108.151 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -167.83 154.52 7.92 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.61 0.719 . . . . 70.31 111.605 -174.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.1 p -83.9 122.35 28.6 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.467 -1.242 . . . . 70.44 109.111 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.408 ' HZ3' ' CD ' ' A' ' 57' ' ' GLU . 42.2 mtpt -94.59 -14.93 24.5 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.161 0.584 . . . . 74.24 110.638 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 18.0 t0 -158.6 139.55 12.97 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.9 -1.148 . . . . 73.3 107.9 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.2 mt -141.16 141.9 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 106.977 -1.49 . . . . 74.21 106.977 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.9 t -157.06 116.48 3.4 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.821 0.343 . . . . 74.32 110.259 177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.566 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 81.6 t80 -110.86 139.82 45.86 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 107.206 -1.405 . . . . 73.21 107.206 170.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 49.1 mt-10 -141.68 109.69 5.82 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 123.321 0.648 . . . . 75.02 109.35 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.05 88.56 1.59 Allowed Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.064 -1.828 . . . . 75.14 106.064 165.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -66.92 -34.05 31.07 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.722 2.281 . . . . 64.31 112.097 -169.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -112.82 26.37 10.58 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 114.959 -1.019 . . . . 74.24 109.311 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.44 ' O ' HG11 ' A' ' 31' ' ' VAL . . . -44.62 -53.91 13.89 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 113.972 1.101 . . . . 72.24 113.972 -169.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.76 -28.47 86.52 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 121.971 1.781 . . . . 73.52 112.824 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.466 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.2 m-70 -89.34 -31.19 17.92 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.439 1.096 . . . . 74.51 110.269 -176.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.529 HG22 ' HA ' ' A' ' 73' ' ' ALA . 3.0 p -73.26 -17.82 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.065 0.546 . . . . 63.42 112.186 -162.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -82.6 -23.71 34.25 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.255 0.622 . . . . 64.44 111.203 -176.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 28.9 pt20 -91.21 -11.86 37.04 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.253 0.621 . . . . 73.11 110.556 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 13.5 mmmm -76.75 168.43 20.1 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.491 0.716 . . . . 73.44 111.842 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.64 117.0 10.69 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.743 -0.836 . . . . 74.51 108.743 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.404 ' CE3' HD21 ' A' ' 68' ' ' LEU . 58.1 t-105 -83.54 85.21 7.29 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.378 0.608 . . . . 75.22 109.766 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -127.82 81.38 70.4 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 107.889 -1.152 . . . . 75.41 107.889 171.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -72.94 108.2 2.53 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.532 2.154 . . . . 75.03 112.514 -174.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -95.43 90.49 5.8 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.911 -1.514 . . . . 74.12 106.911 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 65' ' ' THR . 60.3 t -88.13 113.46 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 CA-C-N 115.021 -0.991 . . . . 73.3 111.044 -171.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.426 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 80.7 tttt -79.82 136.86 36.81 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.346 1.058 . . . . 75.11 110.104 172.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.4 125.37 53.17 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.976 -1.12 . . . . 75.44 107.976 175.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.594 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 22.8 t70 -135.57 126.24 27.17 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.379 -0.6 . . . . 72.13 109.379 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -107.94 133.27 52.52 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.368 0.667 . . . . 75.31 110.278 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.561 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 11.7 t70 -124.18 146.29 48.78 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.382 1.073 . . . . 71.4 108.372 173.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 79.3 m -119.8 139.87 51.66 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.701 0.8 . . . . 74.23 110.073 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.697 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -132.53 131.59 41.73 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.922 0.889 . . . . 53.22 109.286 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.2 m -102.58 151.88 21.82 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.629 0.772 . . . . 64.34 109.946 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.6 t -162.96 127.95 3.12 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.084 -0.709 . . . . 72.0 109.084 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -112.84 119.15 36.99 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.337 -0.986 . . . . 72.21 108.337 171.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.59 HD12 HG22 ' A' ' 83' ' ' ILE . 57.4 mt -96.17 -30.18 13.64 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.216 0.606 . . . . 73.53 111.405 -174.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.22 -175.47 3.98 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.293 0.637 . . . . 60.23 110.469 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.51 117.79 7.24 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.326 -0.852 . . . . 74.41 108.776 171.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 71.93 -5.03 1.8 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.541 1.136 . . . . 62.14 112.93 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.0 t -99.22 106.02 18.3 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 N-CA-C 107.544 -1.28 . . . . 75.24 107.544 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -124.02 125.01 43.81 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.97 -1.122 . . . . 75.0 107.97 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.408 ' CD ' ' HZ3' ' A' ' 19' ' ' LYS . 64.7 tt0 -102.09 114.16 28.05 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.636 -0.876 . . . . 64.33 108.636 176.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.9 m -102.92 136.1 37.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.702 -1.221 . . . . 64.51 107.702 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.697 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 60.7 t -124.93 138.97 52.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 108.751 -0.833 . . . . 74.32 108.751 -174.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -128.19 112.84 14.96 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.593 -0.891 . . . . 63.0 108.593 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.561 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 19.5 ttt180 -93.23 102.44 14.73 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.029 0.932 . . . . 70.23 109.122 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -94.09 127.76 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.49 0.716 . . . . 74.41 109.444 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.594 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 13.9 m -113.31 130.45 56.26 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.836 0.855 . . . . 64.14 109.584 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.7 t -126.65 106.69 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.162 1.385 . . . . 73.02 107.851 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 23.5 m -104.61 134.4 47.85 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 107.762 -1.199 . . . . 75.33 107.762 175.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.52 127.29 55.18 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.835 -1.172 . . . . 64.45 107.835 174.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -126.94 126.33 43.06 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.302 0.641 . . . . 73.52 110.023 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.527 ' HG ' ' HB1' ' A' ' 73' ' ' ALA . 30.9 mt -86.91 78.02 9.11 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.394 1.078 . . . . 63.22 108.363 173.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.58 -84.6 0.87 Allowed Glycine 0 C--N 1.342 0.911 0 CA-C-N 115.229 -0.896 . . . . 74.0 111.443 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -115.27 -28.48 6.89 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.143 0.977 . . . . 71.33 110.621 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -87.94 132.59 34.17 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.289 -0.634 . . . . 74.03 109.289 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.2 m -72.8 123.42 23.31 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.745 0.702 . . . . 71.44 110.307 175.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.529 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -72.21 -57.35 4.31 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.52 -0.764 . . . . 53.32 109.633 174.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.455 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 35.7 p90 -162.58 176.96 9.85 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.612 -1.177 . . . . 74.24 111.093 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 58.6 tp -139.77 142.22 36.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.397 1.479 . . . . 71.55 107.31 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.452 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 76.0 m -145.5 106.96 4.21 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.114 0.965 . . . . 72.01 108.654 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -130.33 122.23 27.52 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.402 0.681 . . . . 73.12 109.492 -174.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.402 HG12 ' HB3' ' A' ' 113' ' ' CYS . 25.0 t -132.14 114.44 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.209 1.004 . . . . 72.21 109.685 -172.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 7.1 tt0 -84.56 90.12 7.59 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.359 -0.978 . . . . 64.33 108.359 173.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.544 ' HG3' HD23 ' A' ' 106' ' ' LEU . 6.8 tp-100 -85.13 104.13 14.74 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.288 -0.634 . . . . 75.32 109.288 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.61 153.39 21.61 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 111.485 -0.646 . . . . 72.22 111.485 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.423 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -155.8 122.0 1.16 Allowed Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 111.262 -0.735 . . . . 63.34 111.262 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.59 HG22 HD12 ' A' ' 51' ' ' LEU . 41.4 mt -83.04 116.15 26.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 N-CA-C 108.962 -0.755 . . . . 64.42 108.962 176.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.584 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 38.0 m-85 -127.19 120.82 29.68 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.267 0.627 . . . . 74.53 109.941 -175.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.8 m -81.1 102.02 9.98 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.434 -0.95 . . . . 74.54 108.434 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.3 pt . . . . . 0 CA--C 1.543 0.704 0 C-N-CA 123.87 0.868 . . . . 73.5 109.991 -175.378 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.945 0.402 . . . . 71.42 110.99 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.488 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 41.6 t-80 -68.79 -24.91 64.47 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.772 0.829 . . . . 74.14 110.584 173.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 69.1 m -75.77 -64.95 0.97 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.565 0.346 . . . . 72.33 110.675 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.518 HD12 ' N ' ' A' ' 99' ' ' GLY . 3.4 pp -71.1 -32.27 68.84 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.149 0.98 . . . . 75.32 112.687 -170.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.518 ' N ' HD12 ' A' ' 98' ' ' LEU . . . -105.54 3.22 39.59 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-O 119.688 -0.506 . . . . 73.03 113.597 -171.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.488 ' HB1' ' O ' ' A' ' 96' ' ' HIS . . . -136.93 -60.5 0.69 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.525 0.663 . . . . 70.42 112.072 -177.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.63 ' HH ' ' HB2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -79.13 -34.82 42.98 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 112.166 0.432 . . . . 73.44 112.166 -174.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 70.9 m -64.55 -43.56 71.43 Favored Pre-proline 0 N--CA 1.491 1.611 0 CA-C-N 115.627 -0.715 . . . . 54.4 112.416 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -48.53 -45.09 28.36 Favored 'Trans proline' 0 C--N 1.391 2.811 0 C-N-CA 122.829 2.353 . . . . 70.31 113.322 163.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -64.52 -21.57 66.72 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.652 0.781 . . . . 72.24 112.03 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.8 mm -74.85 -48.95 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 109.667 -0.494 . . . . 74.24 109.667 174.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.544 HD23 ' HG3' ' A' ' 80' ' ' GLN . 88.4 mt -75.94 -27.05 57.44 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.401 -0.818 . . . . 74.24 112.276 -174.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.509 ' HZ ' HD23 ' A' ' 128' ' ' LEU . 31.7 t80 -63.44 -43.76 79.95 Favored Pre-proline 0 CA--C 1.564 1.504 0 N-CA-C 113.817 1.043 . . . . 71.23 113.817 -169.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.63 -40.11 82.59 Favored 'Trans proline' 0 C--N 1.387 2.578 0 C-N-CA 122.207 1.938 . . . . 75.33 112.887 173.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.468 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 97.9 m-85 -69.69 -40.98 76.02 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.497 0.719 . . . . 74.41 111.415 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.0 -36.04 74.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.425 0.69 . . . . 74.13 110.29 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.589 ' NH1' HD13 ' C' ' 105' ' ' ILE . 37.3 ttm180 -57.8 -55.78 30.44 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.093 0.871 . . . . 74.53 109.6 172.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -63.98 -41.06 97.65 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.024 -0.989 . . . . 75.34 111.73 -173.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.402 ' HB3' HG12 ' A' ' 78' ' ' VAL . 39.0 t -66.45 -30.94 71.41 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.798 0.439 . . . . 72.33 111.167 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 60.7 mt -72.85 -50.99 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.831 0.853 . . . . 62.21 109.857 172.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 63.7 m -57.99 -34.04 69.55 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.667 1.187 . . . . 72.45 111.509 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.8 t -67.35 -46.35 73.64 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 115.439 -0.801 . . . . 73.31 109.8 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.566 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 42.6 mtm -67.49 -36.15 80.53 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.876 0.47 . . . . 74.12 111.483 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.2 t -61.59 -46.85 95.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.369 0.668 . . . . 72.23 110.075 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 41.2 t -67.56 -36.35 80.77 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 115.428 -0.805 . . . . 63.4 111.118 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -72.96 -29.38 63.03 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.686 0.794 . . . . 75.14 109.891 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.55 10.51 61.64 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.869 0.73 . . . . 52.33 112.198 173.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.484 HG23 ' HE ' ' B' ' 15' ' ' ARG . 2.1 t 62.17 20.18 11.49 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.84 2.056 . . . . 72.01 113.266 170.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -84.28 154.89 63.4 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 122.956 0.503 . . . . 73.34 109.65 176.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -53.16 159.63 5.42 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.461 2.774 . . . . 75.15 113.97 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.44 HE21 HG23 ' D' ' 122' ' ' THR . 6.5 tp-100 -62.03 125.53 24.18 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.627 -0.715 . . . . 54.14 111.435 -174.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.455 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 54.9 tp -130.27 113.11 14.0 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.779 1.231 . . . . 74.21 109.407 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -129.22 123.28 31.58 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.364 0.666 . . . . 73.21 109.562 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.509 HD23 ' HZ ' ' A' ' 107' ' ' PHE . 4.2 tt -73.8 127.85 33.92 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 108.333 -0.988 . . . . 74.04 108.333 175.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.51 137.26 96.44 Favored Pre-proline 0 CA--C 1.564 1.49 0 C-N-CA 123.067 0.547 . . . . 75.22 112.051 -174.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.479 ' HG2' ' CE1' ' C' ' 11' ' ' PHE . 36.8 Cg_exo -63.95 127.32 19.17 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.974 3.116 . . . . 74.23 113.429 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.5 t -117.47 114.78 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.04 0.936 . . . . 71.24 108.738 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -83.42 88.31 6.98 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.039 -0.726 . . . . 74.3 109.039 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 . . . . . 0 N--CA 1.478 0.927 0 CA-C-N 115.279 -0.873 . . . . 74.05 110.506 -179.873 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.498 ' SD ' ' N ' ' B' ' 10' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.557 1.216 0 CA-C-O 121.349 0.595 . . . . 74.21 110.777 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 99.9 m -157.87 125.26 5.14 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 106.187 -1.783 . . . . 74.21 106.187 170.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -138.53 125.33 21.0 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.181 -0.674 . . . . 73.41 109.181 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.418 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -148.3 137.7 22.09 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.315 -0.624 . . . . 74.43 109.315 174.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 48.6 mt -85.4 122.6 38.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.608 -0.886 . . . . 74.32 108.608 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . 0.515 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 12.4 mm100 -89.83 -43.51 10.59 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.677 0.791 . . . . 73.32 109.999 -175.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.484 ' HE ' HG23 ' A' ' 122' ' ' THR . 44.2 ttt180 -178.96 130.63 0.11 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.298 -0.631 . . . . 74.13 109.298 -173.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 77.4 mt -116.73 137.08 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 108.31 -0.996 . . . . 75.25 108.31 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -162.99 145.27 10.3 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.455 0.645 . . . . 75.12 111.182 -170.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.3 m -73.68 117.9 16.0 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.471 -1.24 . . . . 63.2 108.091 170.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.466 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 45.1 mtpt -92.78 -25.01 18.36 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.795 0.838 . . . . 73.33 111.354 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -163.45 147.35 10.6 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.528 0.518 . . . . 75.41 109.851 -172.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.511 HD13 ' SG ' ' B' ' 113' ' ' CYS . 28.4 mm -141.81 145.28 24.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 125.35 1.46 . . . . 72.32 108.427 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.456 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 44.2 t -144.01 141.08 29.93 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.727 -1.124 . . . . 72.14 108.387 167.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 81.5 t80 -147.75 126.69 12.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.279 -1.749 . . . . 74.55 106.279 171.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -135.3 116.6 14.55 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.147 -1.057 . . . . 71.24 108.147 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.35 86.48 2.13 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 107.593 -1.262 . . . . 64.54 107.593 174.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.12 -50.35 2.15 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.89 2.393 . . . . 73.03 111.946 -168.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -96.78 15.53 21.74 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.484 0.713 . . . . 75.12 111.191 -175.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -40.36 -65.06 0.48 Allowed Pre-proline 0 N--CA 1.491 1.602 0 C-N-CA 125.242 1.417 . . . . 61.41 114.575 -165.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.17 -25.54 72.68 Favored 'Trans proline' 0 C--N 1.392 2.821 0 C-N-CA 122.262 1.975 . . . . 74.34 113.92 -169.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -94.37 -41.66 9.3 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.138 0.575 . . . . 71.35 111.182 -175.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.89 -12.69 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 123.573 0.749 . . . . 73.53 111.685 -172.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -62.66 -14.3 41.94 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.569 0.748 . . . . 71.03 112.86 174.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.526 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.0 pt20 -60.79 -29.0 69.17 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.663 0.785 . . . . 75.4 110.98 172.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.526 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 96.3 mttt -93.66 108.46 20.19 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.91 1.284 . . . . 74.31 109.959 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -114.97 105.94 13.57 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.074 0.549 . . . . 73.12 110.427 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 21.6 p90 -165.82 -166.04 0.89 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.911 1.284 . . . . 74.43 108.121 169.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 -82.15 103.62 2.46 Favored Pre-proline 0 N--CA 1.477 0.914 0 N-CA-C 108.403 -0.962 . . . . 75.23 108.403 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.69 144.18 87.19 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.769 2.312 . . . . 75.12 113.126 -173.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' B' ' 67' ' ' SER . 5.6 mp0 -55.42 103.36 0.09 Allowed 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.677 1.591 . . . . 70.32 110.311 172.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.421 HG21 HD22 ' B' ' 126' ' ' LEU . 20.3 t -85.62 155.18 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 115.182 -0.917 . . . . 72.42 109.118 -174.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.58 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 50.2 tttm -151.45 101.14 2.79 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.177 -1.786 . . . . 74.22 106.177 166.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 7.8 tt -87.1 144.15 26.99 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.029 -1.471 . . . . 65.23 107.029 172.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.415 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 8.8 t70 -140.28 116.48 10.55 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 106.315 -1.735 . . . . 72.34 106.315 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 15.2 tp -98.13 127.89 44.33 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.182 -1.044 . . . . 73.42 108.182 -173.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -130.18 156.13 45.1 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.013 0.925 . . . . 64.34 109.136 -172.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 49.0 p -106.88 139.02 41.96 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.06 0.544 . . . . 73.14 111.131 -171.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.38 128.46 12.74 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 106.836 -1.542 . . . . 74.2 106.836 172.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.8 m -144.79 163.79 32.99 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.308 0.243 . . . . 71.11 111.16 -173.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 80.8 p -165.76 137.13 3.84 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.006 0.816 . . . . 71.44 110.049 167.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -94.72 108.82 20.82 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.093 -1.077 . . . . 74.41 108.093 171.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 35.3 mt -70.45 -53.49 16.16 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 121.643 0.735 . . . . 74.53 109.789 -175.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.89 -170.31 2.83 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.276 -1.329 . . . . 73.31 108.431 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -86.7 145.58 26.62 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.818 -1.179 . . . . 64.42 107.818 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 67.3 -2.44 1.25 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.815 1.246 . . . . 64.02 112.132 -172.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 45.9 t -126.45 116.75 46.3 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 C-N-CA 124.791 1.237 . . . . 74.4 108.0 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -127.11 139.25 53.11 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.019 -1.104 . . . . 74.02 108.019 175.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -105.51 105.65 15.78 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.628 -1.249 . . . . 74.53 107.628 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 75.1 t -94.94 124.35 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 124.938 1.295 . . . . 75.21 109.8 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.414 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 6.5 t -112.97 146.81 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.251 -1.018 . . . . 74.03 108.251 172.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 20.6 tp -125.4 111.41 15.1 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.258 -1.016 . . . . 73.02 108.258 169.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -87.83 112.23 22.24 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.13 -0.693 . . . . 72.43 109.13 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 60.9 t -104.69 104.02 16.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.7 -1.136 . . . . 73.23 108.049 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 27.0 m -94.92 136.38 35.3 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.114 -1.069 . . . . 74.23 108.114 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 95.0 t -127.85 130.7 70.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 124.096 0.958 . . . . 64.14 109.246 -175.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.58 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 53.5 m -121.53 139.65 53.22 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.899 -1.519 . . . . 65.13 106.899 168.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.05 136.72 30.48 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.668 -1.234 . . . . 63.31 107.668 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.472 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 3.7 m -139.08 145.5 39.59 Favored 'General case' 0 C--O 1.215 -0.726 0 N-CA-C 109.455 -0.572 . . . . 74.21 109.455 -168.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 42.6 mt -113.26 108.48 17.32 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.605 0.716 . . . . 73.34 109.487 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.12 -110.7 3.62 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 114.082 -1.417 . . . . 44.25 113.361 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.72 2.12 35.31 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.268 1.027 . . . . 74.34 110.489 -170.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -133.19 158.23 43.38 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.523 0.729 . . . . 72.1 109.701 -175.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 97.0 m -75.31 137.8 41.39 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.168 0.509 . . . . 72.4 110.081 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.472 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -93.35 -61.33 1.58 Allowed 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.458 1.103 . . . . 73.22 108.281 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -151.99 167.74 27.45 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 114.688 -1.142 . . . . 72.21 110.742 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 70.5 mt -133.87 138.0 45.33 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 106.008 -1.849 . . . . 73.12 106.008 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 47.1 t -138.4 159.17 42.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.869 -1.16 . . . . 75.14 107.869 175.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.456 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 40.5 tt0 -165.77 134.15 3.09 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.985 -0.746 . . . . 73.02 108.985 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.91 145.32 35.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.577 -0.897 . . . . 71.44 108.577 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -121.13 93.99 4.2 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.108 -1.071 . . . . 74.21 108.108 171.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.438 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -87.88 102.44 14.71 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.725 -0.843 . . . . 75.31 108.725 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.466 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.94 156.58 23.02 Favored Glycine 0 N--CA 1.449 -0.492 0 O-C-N 123.965 0.79 . . . . 70.31 111.305 175.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.96 126.35 1.66 Allowed Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 109.99 -1.244 . . . . 73.33 109.99 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 27.1 mt -85.67 130.1 36.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.626 -1.25 . . . . 72.41 107.626 176.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -133.83 134.23 42.55 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.36 -0.978 . . . . 74.3 108.36 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 74.1 m -92.99 110.43 21.9 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.101 -0.703 . . . . 74.03 109.101 172.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' B' ' 10' ' ' THR . 0.2 OUTLIER -124.81 132.71 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.623 1.169 . . . . 74.44 109.122 -178.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.3 172.29 18.75 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.209 0.604 . . . . 71.04 110.741 -172.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.42 -63.6 4.31 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.932 0.77 . . . . 75.11 112.408 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.585 HG23 ' HB3' ' B' ' 94' ' ' MET . 2.5 mm -68.8 157.84 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.474 1.11 . . . . 75.55 112.224 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -160.06 153.5 22.29 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 115.118 -0.947 . . . . 74.21 110.777 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.76 -136.81 13.36 Favored Glycine 0 C--N 1.351 1.413 0 C-N-CA 124.297 0.951 . . . . 61.22 112.933 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 19.5 m -67.14 -27.68 67.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.542 0.737 . . . . 75.24 110.94 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.421 ' HB2' HG22 ' B' ' 89' ' ' ILE . 42.8 mt-30 -63.99 -39.77 94.86 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.689 -1.141 . . . . 74.32 110.965 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.585 ' HB3' HG23 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -88.17 -25.81 22.75 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.565 0.346 . . . . 72.34 110.82 177.379 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.65 -34.2 73.95 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.149 0.58 . . . . 60.44 110.954 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -78.86 -37.57 40.02 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.655 0.782 . . . . 64.02 111.034 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.5 t -62.71 -43.2 99.4 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.201 0.601 . . . . 74.15 111.49 -175.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.406 HD12 HG13 ' B' ' 86' ' ' ILE . 6.6 mp -90.58 -23.33 20.89 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.874 0.47 . . . . 72.34 111.112 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.06 -17.62 66.86 Favored Glycine 0 C--N 1.346 1.104 0 N-CA-C 114.358 0.503 . . . . 75.42 114.358 -174.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.19 -55.56 0.59 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.068 0.547 . . . . 71.33 110.97 -177.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -66.75 -53.31 34.59 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.436 0.902 . . . . 75.43 113.436 -166.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.492 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 76.0 m -60.13 -50.08 87.88 Favored Pre-proline 0 CA--C 1.564 1.504 0 CA-C-O 118.561 -0.733 . . . . 64.21 111.493 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 47.7 Cg_exo -60.33 -29.37 88.7 Favored 'Trans proline' 0 C--N 1.401 3.296 0 C-N-CA 122.4 2.067 . . . . 73.1 113.384 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -71.15 -30.99 67.16 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.578 0.751 . . . . 72.21 110.928 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.424 HG23 ' NH2' ' D' ' 111' ' ' ARG . 53.1 mt -66.87 -37.87 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 109.568 -0.53 . . . . 65.3 109.568 171.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 54.8 mt -84.18 -18.82 35.41 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.026 0.93 . . . . 74.23 112.1 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.42 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 85.7 t80 -57.86 -50.34 88.66 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-O 118.088 -0.958 . . . . 73.52 112.338 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 51.5 Cg_exo -57.89 -38.02 94.01 Favored 'Trans proline' 0 C--N 1.394 2.929 0 C-N-CA 122.401 2.067 . . . . 74.43 113.798 177.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.438 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 38.8 m-85 -68.12 -43.29 78.73 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.281 0.632 . . . . 74.03 110.576 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.445 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -64.8 -40.61 95.51 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.285 0.634 . . . . 74.52 110.427 175.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.489 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 37.9 ttt180 -57.41 -49.57 75.8 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.542 1.537 . . . . 75.11 111.402 -176.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.431 ' HG3' ' NH2' ' C' ' 120' ' ' ARG . 2.1 tm-20 -68.79 -34.6 75.83 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 123.84 0.712 . . . . 55.33 110.033 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.511 ' SG ' HD13 ' B' ' 21' ' ' ILE . 9.3 t -67.27 -33.63 75.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.99 0.516 . . . . 75.11 111.268 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.48 ' O ' HG23 ' B' ' 118' ' ' VAL . 73.7 mt -67.69 -56.04 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 108.91 -0.774 . . . . 73.5 108.91 174.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.1 m -59.84 -26.54 65.89 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 124.336 1.023 . . . . 72.44 111.396 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 29.4 t -64.78 -50.55 66.33 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.273 0.629 . . . . 74.34 109.614 174.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.0 mmt -70.44 -31.21 68.3 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.08 0.552 . . . . 73.52 111.005 -176.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.48 HG23 ' O ' ' B' ' 114' ' ' ILE . 57.7 t -60.57 -47.77 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.487 0.715 . . . . 62.51 109.414 171.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 21.0 t -65.08 -34.62 78.85 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.546 -1.206 . . . . 75.41 111.191 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.41 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 92.6 mtt-85 -70.81 -31.95 68.86 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.986 -1.006 . . . . 75.42 110.384 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.56 5.66 76.96 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.944 0.778 . . . . 52.45 112.656 174.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 80.6 p 54.42 29.95 11.93 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 126.0 1.72 . . . . 75.2 113.015 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -91.02 159.87 38.97 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.264 0.625 . . . . 74.14 111.317 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -48.93 158.11 1.39 Allowed 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 123.732 2.955 . . . . 73.44 114.76 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -57.9 114.6 2.39 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.978 -1.01 . . . . 73.52 111.236 -176.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.421 HD22 HG21 ' B' ' 40' ' ' VAL . 0.3 OUTLIER -121.58 101.87 7.88 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.867 -1.16 . . . . 74.45 107.867 -178.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -119.23 133.99 55.45 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.726 0.811 . . . . 71.43 109.224 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.489 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 6.6 mp -75.42 144.97 41.92 Favored 'General case' 0 C--O 1.242 0.668 0 O-C-N 123.655 0.597 . . . . 73.11 109.956 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.76 134.14 86.18 Favored Pre-proline 0 CA--C 1.549 0.911 0 O-C-N 123.816 0.697 . . . . 70.01 111.093 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -72.47 104.81 1.77 Allowed 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.886 2.391 . . . . 71.42 111.692 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 34.1 m -110.99 139.95 32.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 123.327 0.651 . . . . 74.23 109.63 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -92.08 90.61 7.44 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 106.414 -1.699 . . . . 61.31 106.414 169.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -67.09 -32.0 72.86 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.946 -1.025 . . . . 73.32 111.289 -171.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 . . . . . 0 N--CA 1.471 0.607 0 C-N-CA 123.941 0.896 . . . . 54.42 111.484 175.586 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.656 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.3 t80 . . . . . 0 C--O 1.236 0.356 0 CA-C-O 121.138 0.494 . . . . 72.03 110.406 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -155.31 126.43 7.15 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.839 -1.171 . . . . 74.24 107.839 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 88.4 mt -73.32 120.05 21.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.291 -1.003 . . . . 72.14 108.291 172.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.629 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 23.9 mm-40 -82.54 -42.64 18.11 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.208 -0.905 . . . . 71.11 109.6 -177.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -179.27 134.02 0.12 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.284 0.633 . . . . 75.32 110.345 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.8 mt -117.68 145.95 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.867 0.867 . . . . 74.44 108.855 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -174.65 158.02 2.65 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.276 0.631 . . . . 75.22 110.729 -174.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 63.7 p -83.39 114.69 21.61 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.381 -0.97 . . . . 71.2 108.381 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -77.05 -47.06 21.62 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.736 -0.838 . . . . 74.22 108.736 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.66 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.0 t70 -133.97 137.84 45.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.336 -1.302 . . . . 64.54 109.572 -174.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 71.8 mt -136.81 144.52 32.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.021 -1.474 . . . . 73.12 107.021 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.1 t -161.82 150.66 15.61 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.976 0.417 . . . . 71.11 110.798 174.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -152.36 121.25 6.57 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 114.797 -1.092 . . . . 75.35 108.143 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -122.63 122.27 38.41 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.921 0.888 . . . . 74.11 110.451 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.09 83.01 34.71 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 107.73 -1.211 . . . . 65.4 107.73 168.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.43 -13.61 20.48 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.558 2.172 . . . . 74.55 111.764 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -103.01 14.59 31.58 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.9 1.28 . . . . 74.11 109.862 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.414 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -48.16 -53.52 32.76 Favored Pre-proline 0 C--N 1.37 1.48 0 C-N-CA 124.64 1.176 . . . . 73.01 113.55 -170.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 52.5 Cg_exo -54.59 -50.6 12.82 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 121.871 1.714 . . . . 72.12 112.828 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -68.57 -35.46 77.41 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.911 -1.041 . . . . 71.02 112.173 -172.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.711 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.0 p -78.59 -24.97 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 N-CA-C 113.182 0.808 . . . . 74.0 113.182 -172.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -67.13 -28.36 68.07 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.528 0.566 . . . . 75.14 112.528 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -86.92 5.16 38.44 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.128 0.571 . . . . 73.43 111.773 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.765 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -88.76 150.16 23.09 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.483 0.713 . . . . 74.22 110.369 178.493 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.25 124.07 19.88 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.292 0.637 . . . . 74.1 109.755 167.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -78.71 97.62 5.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.365 0.666 . . . . 74.32 111.211 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -153.6 78.16 5.69 Favored Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 108.605 -0.887 . . . . 75.01 108.605 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -90.45 149.66 4.36 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.013 2.475 . . . . 71.42 113.856 -176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -88.23 102.86 15.24 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 114.028 -1.442 . . . . 75.43 107.365 167.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -81.23 101.71 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.933 -0.576 . . . . 75.13 109.764 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.495 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 11.0 tmtt? -92.38 109.94 21.34 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.23 -1.396 . . . . 72.21 107.23 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 pp -85.14 161.69 19.54 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.585 -0.524 . . . . 73.42 109.585 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.602 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 12.5 t70 -147.19 134.41 20.55 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.674 -1.232 . . . . 71.34 107.674 171.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -128.79 111.24 12.9 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.104 -1.443 . . . . 74.13 107.104 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 21.6 t70 -123.54 152.68 41.55 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.022 0.929 . . . . 71.31 109.124 -177.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 52.5 p -117.92 134.48 54.91 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.519 0.728 . . . . 65.44 111.458 -169.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.53 160.19 42.45 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.377 0.671 . . . . 72.23 110.471 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 72.8 m -160.03 170.93 20.27 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.422 0.689 . . . . 74.52 111.242 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 95.8 p -153.98 140.74 19.06 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.964 0.906 . . . . 71.21 108.934 166.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -86.43 121.43 28.97 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.2 -1.037 . . . . 71.24 108.2 173.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.437 HD13 HD13 ' C' ' 83' ' ' ILE . 53.6 mt -99.22 -30.38 12.29 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.472 0.709 . . . . 73.31 109.923 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.81 -174.39 2.72 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.453 1.101 . . . . 64.52 109.604 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -71.24 125.0 25.79 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.334 -0.987 . . . . 70.43 108.334 171.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 69.37 3.67 4.26 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.876 1.27 . . . . 74.32 113.204 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 96.3 t -117.69 110.64 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 107.892 -1.151 . . . . 74.11 107.892 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -134.34 137.57 44.26 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.537 0.735 . . . . 75.4 109.573 -173.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -86.69 120.93 28.52 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.949 -1.023 . . . . 74.4 109.748 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 55.2 t -96.7 115.39 36.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.818 -1.179 . . . . 74.25 107.818 168.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 64.0 t -112.93 136.26 49.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 N-CA-C 107.603 -1.258 . . . . 73.03 107.603 171.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.686 HD21 ' HB2' ' C' ' 103' ' ' PRO . 11.6 tp -126.73 118.36 24.56 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.619 -0.882 . . . . 70.33 108.619 172.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.469 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 14.2 ttm180 -81.79 115.66 21.11 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.567 -0.742 . . . . 71.44 109.212 176.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 24.9 t -110.5 116.56 52.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.537 -1.283 . . . . 54.44 107.537 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.602 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 17.9 m -128.86 115.52 18.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.424 0.63 . . . . 74.15 109.348 -174.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 84.4 t -108.07 116.04 50.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 124.817 1.247 . . . . 74.14 109.364 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 4.1 m -100.53 145.91 27.74 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.838 -1.171 . . . . 72.23 107.838 171.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.85 119.74 18.48 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.347 -1.353 . . . . 62.45 107.347 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -133.04 125.52 29.85 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.945 0.339 . . . . 73.31 110.361 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.765 HD11 ' HG2' ' C' ' 34' ' ' LYS . 9.0 mt -86.44 41.04 0.92 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.661 1.184 . . . . 74.23 109.776 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.2 -114.2 4.54 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 110.138 -1.185 . . . . 71.22 110.138 -169.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.29 -28.12 21.27 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.346 0.658 . . . . 71.11 109.928 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.94 118.05 9.19 Favored 'General case' 0 C--N 1.345 0.402 0 N-CA-C 108.923 -0.769 . . . . 73.31 108.923 171.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 29.4 m -81.19 121.92 26.75 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 108.06 -1.089 . . . . 74.01 108.06 167.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.711 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.5 -58.14 3.61 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.41 -0.959 . . . . 73.4 108.41 177.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -162.69 170.73 17.95 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 114.95 -1.023 . . . . 74.43 111.708 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -127.6 146.39 50.55 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 106.002 -1.851 . . . . 75.22 106.002 166.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 46.2 t -147.31 130.17 16.19 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.984 -1.117 . . . . 72.2 107.984 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -136.33 117.84 14.82 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.428 -0.582 . . . . 72.34 109.428 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 77.4 t -120.03 122.4 68.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.45 -0.945 . . . . 73.14 108.45 170.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.66 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.3 mt-30 -103.42 94.25 5.39 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 108.023 -1.102 . . . . 70.44 108.023 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -80.07 114.81 19.25 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.963 -1.017 . . . . 65.1 109.655 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.22 146.12 18.14 Favored Glycine 0 C--N 1.34 0.779 0 O-C-N 123.826 0.704 . . . . 73.11 111.423 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.412 ' HA3' HD22 ' C' ' 106' ' ' LEU . . . -154.54 119.66 0.95 Allowed Glycine 0 CA--C 1.503 -0.697 0 N-CA-C 110.554 -1.019 . . . . 75.21 110.554 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.629 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 8.4 mm -85.37 126.74 40.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 108.287 -1.005 . . . . 73.42 108.287 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.656 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 69.7 m-85 -132.23 147.39 52.41 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.365 0.666 . . . . 74.31 109.883 -176.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 45.4 m -87.49 123.66 32.64 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.935 0.894 . . . . 75.43 109.352 171.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.51 HG12 HD21 ' C' ' 98' ' ' LEU . 4.4 mp -121.72 121.03 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 109.675 -0.491 . . . . 74.24 109.675 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.28 167.89 21.29 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.235 1.014 . . . . 54.41 109.903 173.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.67 -60.8 1.2 Allowed Glycine 0 N--CA 1.471 1.026 0 C-N-CA 123.137 0.399 . . . . 74.23 112.661 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 pt -96.06 150.9 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.658 0.783 . . . . 74.4 110.393 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -147.61 146.77 29.49 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.69 0.796 . . . . 75.42 109.555 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.36 -139.18 14.65 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 111.671 -0.571 . . . . 74.45 111.671 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 10.3 p -68.23 -21.35 64.85 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 113.477 0.917 . . . . 64.45 113.477 -174.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.23 -40.72 43.94 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 109.337 -0.616 . . . . 71.35 109.337 177.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.447 ' SD ' HD12 ' C' ' 98' ' ' LEU . 14.3 tmm? -65.48 -36.16 83.04 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.274 -0.876 . . . . 74.21 110.136 172.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.68 -34.72 77.48 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.995 0.918 . . . . 63.13 111.412 176.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -65.65 -40.99 93.08 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.697 -0.683 . . . . 73.01 110.224 173.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.506 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 43.0 t -63.34 -45.25 92.12 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.598 0.561 . . . . 73.53 110.412 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.51 HD21 HG12 ' C' ' 86' ' ' ILE . 75.2 mt -80.98 -51.99 7.92 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.135 0.574 . . . . 72.5 112.397 -175.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.75 11.12 65.17 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 115.081 0.792 . . . . 73.25 115.081 -169.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.35 -61.82 0.14 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.425 0.631 . . . . 64.31 110.813 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.506 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 35.0 t80 -75.2 -37.15 61.3 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 125.502 1.521 . . . . 74.4 113.735 -165.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 91.7 m -77.84 -44.12 2.38 Favored Pre-proline 0 N--CA 1.486 1.344 0 C-N-CA 123.252 0.621 . . . . 73.43 112.033 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.686 ' HB2' HD21 ' C' ' 60' ' ' LEU . 78.6 Cg_endo -75.57 -9.48 19.99 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 121.849 1.699 . . . . 75.24 112.344 172.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -68.08 -37.41 81.21 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.751 -0.833 . . . . 74.04 108.751 168.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.589 HD13 ' NH1' ' A' ' 111' ' ' ARG . 39.8 mm -59.38 -43.41 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 115.455 -0.793 . . . . 74.52 109.366 171.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.412 HD22 ' HA3' ' C' ' 82' ' ' GLY . 82.0 mt -81.92 -16.02 51.96 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.307 1.043 . . . . 75.42 112.913 -173.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -55.03 -53.93 55.88 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-O 118.257 -0.878 . . . . 74.3 112.63 -175.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.13 -30.62 65.36 Favored 'Trans proline' 0 C--N 1.388 2.635 0 C-N-CA 121.951 1.767 . . . . 64.11 113.508 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -67.57 -49.85 61.19 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.297 0.639 . . . . 63.31 110.539 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.18 -42.79 95.76 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.196 -0.911 . . . . 73.2 110.276 176.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -58.81 -52.66 64.76 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.173 1.389 . . . . 71.42 111.359 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -66.84 -37.1 83.83 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.738 0.649 . . . . 72.24 110.052 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 35.2 t -67.7 -32.62 73.39 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.332 0.395 . . . . 63.32 111.59 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 83.9 mt -72.54 -52.99 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.127 0.571 . . . . 70.14 110.23 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 12.3 m -65.01 -29.31 70.22 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.176 0.59 . . . . 75.14 111.321 -175.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 40.6 t -65.72 -49.7 67.52 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.077 -0.712 . . . . 74.15 109.077 173.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.674 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.75 -37.29 78.59 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.157 0.983 . . . . 72.2 112.39 179.257 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 83.0 t -60.74 -48.26 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.226 0.61 . . . . 75.24 110.035 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 26.5 t -72.39 -22.24 61.16 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 115.325 -0.852 . . . . 74.05 111.581 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.431 ' NH2' ' HG3' ' B' ' 112' ' ' GLU . 89.2 mtt-85 -73.93 -35.0 64.54 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.856 0.862 . . . . 73.24 109.705 174.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.05 7.65 70.16 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 115.457 -0.792 . . . . 75.41 112.086 171.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 64.7 p 60.02 26.68 16.01 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.415 1.886 . . . . 72.13 113.412 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -88.65 144.95 34.17 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 108.202 -1.036 . . . . 63.33 108.202 171.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -54.63 154.25 21.01 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 123.121 2.548 . . . . 71.12 113.505 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -54.68 124.33 16.04 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.901 1.28 . . . . 75.12 113.43 -171.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 40.1 tp -127.22 90.47 3.14 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.41 -0.959 . . . . 74.14 108.41 176.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -92.31 131.24 37.67 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.067 0.947 . . . . 63.12 109.545 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.72 134.16 46.07 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.172 0.589 . . . . 73.14 109.512 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.33 151.07 77.75 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 123.291 0.636 . . . . 70.11 110.978 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.468 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 40.9 Cg_endo -68.74 110.67 2.39 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.892 2.395 . . . . 75.24 112.141 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.38 111.61 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.256 0.622 . . . . 73.31 109.595 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -85.41 89.68 7.75 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.716 0.806 . . . . 73.24 110.438 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -59.63 -38.09 80.39 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 109.663 -0.495 . . . . 73.14 109.663 169.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 N--CA 1.472 0.636 0 C-N-CA 125.259 1.424 . . . . 75.2 111.362 179.013 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 65.1 m . . . . . 0 C--O 1.241 0.639 0 N-CA-C 108.071 -1.085 . . . . 73.22 108.071 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.511 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 20.8 t80 -164.79 90.63 0.53 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.673 -1.232 . . . . 63.41 107.673 -177.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -113.05 116.28 29.67 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.13 -1.433 . . . . 74.33 107.13 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.447 HG21 HD11 ' D' ' 16' ' ' ILE . 18.2 mt -68.75 123.26 21.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 109.331 -0.618 . . . . 62.03 109.331 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.532 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 21.0 mm-40 -83.01 -46.46 12.83 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 123.795 0.684 . . . . 73.52 109.687 175.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . 0.41 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 27.7 ttt180 -178.5 141.08 0.21 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 116.603 -0.271 . . . . 75.43 111.706 -164.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.447 HD11 HG21 ' D' ' 13' ' ' ILE . 3.7 mp -122.97 142.0 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.464 -1.31 . . . . 75.41 107.464 172.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.41 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 26.3 p90 -165.46 174.48 9.95 Favored 'General case' 0 C--O 1.238 0.496 0 O-C-N 124.062 0.851 . . . . 74.44 111.187 -175.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 62.3 p -108.71 119.56 39.9 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 114.557 -1.202 . . . . 71.21 109.642 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -92.42 -19.13 22.37 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.378 0.671 . . . . 75.02 110.165 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 15.9 t70 -158.09 133.27 8.68 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.774 -1.103 . . . . 65.2 108.699 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.674 HG21 ' HE1' ' C' ' 117' ' ' MET . 68.8 mt -131.94 147.78 32.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 107.083 -1.451 . . . . 64.23 107.083 173.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -156.24 144.74 20.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 123.741 0.651 . . . . 54.31 110.114 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 87.4 t80 -148.17 122.05 9.36 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 105.346 -2.094 . . . . 72.12 105.346 173.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -133.38 110.8 10.27 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.061 0.544 . . . . 74.21 109.806 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.32 88.13 12.34 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 107.772 -1.195 . . . . 64.31 107.772 175.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -74.2 -39.85 1.47 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.907 2.405 . . . . 70.15 112.06 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -92.34 5.11 51.8 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.749 -1.114 . . . . 72.43 111.021 -176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -30.04 -67.8 0.13 Allowed Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 116.459 2.022 . . . . 63.01 116.459 -164.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.427 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 93.5 Cg_endo -75.07 -23.91 13.22 Favored 'Trans proline' 0 C--N 1.374 1.909 0 CA-C-N 122.831 2.047 . . . . 73.33 113.119 -173.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -73.12 -39.21 65.93 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.932 0.893 . . . . 74.34 109.57 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 p -83.03 -16.11 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-N 115.817 -0.628 . . . . 74.51 110.442 -173.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.427 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.1 m-85 -69.02 -22.82 64.04 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.524 0.33 . . . . 72.41 111.77 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -57.51 -27.04 62.22 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.587 0.755 . . . . 75.45 109.976 172.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.626 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 83.7 mttt -88.43 70.74 9.04 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.818 1.247 . . . . 71.52 109.198 172.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -79.71 87.64 5.22 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.72 -0.673 . . . . 73.4 109.714 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 18.6 p90 -163.29 174.82 11.56 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.337 1.055 . . . . 74.41 109.112 172.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . 0.473 HE21 ' HD2' ' D' ' 38' ' ' PRO . 28.5 tp60 -68.45 115.98 35.37 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.62 0.768 . . . . 74.11 109.565 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.473 ' HD2' HE21 ' D' ' 37' ' ' GLN . 27.0 Cg_exo -63.18 151.87 82.59 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.709 2.273 . . . . 62.43 112.616 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -73.24 113.09 9.92 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.359 -1.349 . . . . 74.55 107.359 172.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.679 HG22 ' HG ' ' D' ' 126' ' ' LEU . 98.8 t -105.93 137.98 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 123.879 0.871 . . . . 73.25 109.739 -172.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -128.32 126.72 41.33 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.616 1.166 . . . . 73.45 108.131 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.478 HD22 HD22 ' D' ' 128' ' ' LEU . 45.2 tp -96.99 144.07 27.24 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.07 -0.715 . . . . 70.12 109.07 176.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 7.5 t70 -144.14 153.82 42.53 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.538 0.735 . . . . 75.32 109.081 176.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.6 mt -133.23 146.41 51.44 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.417 0.687 . . . . 75.11 111.108 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.631 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 5.8 t70 -135.58 155.18 50.88 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.919 1.287 . . . . 75.3 108.215 169.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 97.7 m -101.39 140.48 35.63 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.94 0.896 . . . . 72.41 108.812 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -166.91 142.56 4.29 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.222 -1.029 . . . . 71.54 108.222 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.8 p -176.36 162.44 2.38 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.941 0.496 . . . . 72.4 110.425 -176.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 77.5 p -153.77 150.16 28.2 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.647 0.379 . . . . 75.54 110.936 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -88.14 119.61 28.7 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.72 -0.844 . . . . 73.12 108.72 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.485 HD13 HG22 ' D' ' 83' ' ' ILE . 23.2 mt -94.72 -31.81 13.62 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.793 0.437 . . . . 73.13 111.161 -175.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.554 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -161.27 -175.72 5.0 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.739 0.816 . . . . 75.51 110.602 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.07 109.83 3.16 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.771 -1.104 . . . . 75.44 109.389 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 66.89 6.91 4.93 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.588 1.155 . . . . 74.42 112.677 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 64.1 t -110.91 120.55 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 107.427 -1.323 . . . . 73.25 107.427 175.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -140.85 131.7 25.91 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 122.917 0.487 . . . . 74.41 110.008 -165.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.463 ' HB2' HD11 ' D' ' 51' ' ' LEU . 15.9 tt0 -92.72 135.0 34.49 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.793 0.837 . . . . 73.11 110.5 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 98.0 t -117.5 128.75 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.163 1.385 . . . . 75.24 108.39 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 29.1 t -125.58 130.93 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.408 0.683 . . . . 64.2 109.594 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.491 HD21 HD12 ' D' ' 106' ' ' LEU . 4.6 mm? -117.81 121.09 39.87 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.087 -0.708 . . . . 74.12 109.087 172.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.631 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 41.2 ttm-85 -83.2 96.4 8.43 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.513 -1.291 . . . . 74.33 107.513 172.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 88.3 t -90.34 128.16 42.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.009 -1.108 . . . . 74.34 108.009 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 29.8 m -125.68 139.63 53.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.878 -0.416 . . . . 70.35 109.878 -176.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.607 HG13 HG11 ' D' ' 40' ' ' VAL . 17.8 t -128.61 102.01 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.441 1.096 . . . . 74.51 108.556 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 17.6 m -93.31 112.53 24.48 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.478 -0.934 . . . . 72.34 108.478 173.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.07 141.16 48.49 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.657 0.783 . . . . 71.41 109.186 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.412 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 59.8 p -148.8 127.02 12.12 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 123.52 0.513 . . . . 74.45 111.236 -177.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 28.8 mt -94.16 115.51 27.81 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 124.423 1.089 . . . . 74.43 109.076 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.65 -111.75 3.58 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 111.495 -0.642 . . . . 74.53 111.495 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.97 12.14 10.4 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.702 0.801 . . . . 72.05 110.863 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.626 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 12.0 pt-20 -131.56 165.21 24.13 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.849 0.459 . . . . 73.5 109.965 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -65.63 131.25 45.88 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.762 0.825 . . . . 72.04 111.961 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.412 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -90.97 -68.38 0.79 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.83 -1.174 . . . . 71.15 107.83 171.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -151.17 153.55 35.18 Favored 'General case' 0 C--N 1.353 0.72 0 CA-C-N 115.757 -0.656 . . . . 71.32 111.003 175.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 46.5 mt -118.97 110.56 17.27 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 106.773 -1.566 . . . . 74.12 106.773 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.645 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 45.9 t -126.11 105.93 9.22 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 122.943 0.497 . . . . 61.54 109.972 -170.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -122.73 128.99 51.25 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.442 0.697 . . . . 73.24 109.701 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 25.6 t -126.96 121.19 57.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 123.419 0.688 . . . . 74.42 109.696 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.7 mt-30 -87.35 87.36 7.4 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.149 -1.056 . . . . 62.21 108.149 167.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -81.85 110.6 17.3 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.01 -1.45 . . . . 74.02 108.719 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.79 153.23 17.23 Favored Glycine 0 C--N 1.341 0.859 0 O-C-N 123.545 0.528 . . . . 73.13 111.842 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.8 130.87 2.88 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 111.578 -0.609 . . . . 73.51 111.578 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 22.2 mt -89.4 136.41 23.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 C-N-CA 123.801 0.84 . . . . 75.31 108.949 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -137.85 128.49 26.72 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.351 0.661 . . . . 74.23 110.26 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.1 m -78.78 98.36 6.26 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.638 0.775 . . . . 33.32 109.287 168.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 10.2 pt -115.37 139.66 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.397 1.079 . . . . 72.3 110.302 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.65 167.91 20.56 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.877 0.471 . . . . 73.4 111.048 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.56 17.35 79.98 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.954 -0.566 . . . . 65.02 113.308 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 8.4 mt -110.99 147.05 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.081 0.952 . . . . 74.54 108.832 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.42 165.31 27.13 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.687 0.795 . . . . 73.04 110.127 177.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.99 -142.17 46.62 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.168 0.917 . . . . 54.44 115.073 173.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 20.3 m -76.33 -16.25 59.8 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.93 0.892 . . . . 74.24 111.694 -172.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -68.1 -22.36 64.91 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.617 0.367 . . . . 73.22 110.764 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 92.1 mtp -64.02 -35.68 81.51 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.365 0.666 . . . . 73.31 110.432 172.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.71 -26.36 57.45 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.472 -0.786 . . . . 72.4 110.92 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -74.97 -40.35 60.78 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.812 0.445 . . . . 74.45 110.804 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -56.29 -46.79 79.61 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.422 0.689 . . . . 71.13 110.033 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 47.7 mt -87.23 -20.33 27.07 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.627 -1.169 . . . . 63.41 111.566 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.35 1.89 56.12 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-O 119.489 -0.617 . . . . 53.14 114.04 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.12 -67.82 0.28 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 117.585 0.692 . . . . 72.15 111.713 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -71.51 -38.43 71.12 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.716 0.636 . . . . 75.22 112.716 -170.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.511 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 76.3 m -68.23 -49.66 32.67 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 118.706 -0.664 . . . . 71.31 111.556 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -58.7 -29.44 89.49 Favored 'Trans proline' 0 C--N 1.401 3.308 0 C-N-CA 122.63 2.22 . . . . 74.51 113.139 170.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -63.36 -35.67 81.17 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.681 0.793 . . . . 71.12 110.575 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.8 mm -68.91 -38.09 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.626 0.77 . . . . 74.54 110.351 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.491 HD12 HD21 ' D' ' 60' ' ' LEU . 87.7 mt -81.75 -21.7 37.71 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.534 0.734 . . . . 73.51 112.576 -172.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -62.44 -46.71 89.83 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-O 118.425 -0.798 . . . . 74.14 113.121 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.14 -39.15 93.04 Favored 'Trans proline' 0 C--N 1.391 2.768 0 C-N-CA 122.348 2.032 . . . . 70.23 113.262 174.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -73.97 -36.85 64.62 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.582 0.753 . . . . 74.43 111.707 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.81 -49.25 71.4 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.661 -0.496 . . . . 63.44 109.661 176.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.424 ' NH2' HG23 ' B' ' 105' ' ' ILE . 38.9 ttp180 -58.78 -45.68 89.27 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 124.432 1.082 . . . . 74.13 110.312 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -61.08 -52.73 63.67 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.841 0.713 . . . . 65.23 110.881 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.6 t -56.42 -44.61 80.53 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 123.882 0.738 . . . . 65.42 110.925 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.474 ' O ' HG23 ' D' ' 118' ' ' VAL . 67.8 mt -61.39 -55.67 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.198 0.999 . . . . 71.35 110.69 175.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 92.5 m -58.77 -36.19 73.99 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.141 0.976 . . . . 74.2 111.501 -173.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 40.8 t -67.87 -43.69 78.82 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.375 -0.83 . . . . 74.32 109.794 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.645 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 76.6 mtm -70.02 -27.56 64.77 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.761 0.424 . . . . 71.43 111.841 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.474 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.3 t -64.52 -49.31 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.303 0.641 . . . . 74.34 109.509 174.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.6 p -69.04 -32.51 72.06 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.797 -0.638 . . . . 63.45 110.899 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.4 mtt-85 -68.39 -37.61 80.53 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.924 0.89 . . . . 71.45 110.246 174.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.91 0.97 87.81 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 115.738 -0.664 . . . . 72.35 112.259 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.44 HG23 HE21 ' A' ' 125' ' ' GLN . 30.7 p 63.07 26.79 15.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.7 2.0 . . . . 74.15 113.104 172.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -87.44 152.63 52.57 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 109.239 -0.652 . . . . 74.33 109.239 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.94 124.51 15.68 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.931 2.421 . . . . 74.53 112.341 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -55.42 146.7 19.12 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.633 1.173 . . . . 70.01 112.251 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.679 ' HG ' HG22 ' D' ' 40' ' ' VAL . 3.2 tm? -143.58 117.14 9.17 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.138 -1.06 . . . . 74.42 108.138 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -109.9 118.88 37.65 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.415 -0.958 . . . . 74.1 108.415 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.478 HD22 HD22 ' D' ' 42' ' ' LEU . 6.5 mp -66.73 128.17 35.26 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.781 0.833 . . . . 72.22 110.428 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -67.97 133.74 91.94 Favored Pre-proline 0 CA--C 1.552 1.026 0 O-C-N 123.842 0.714 . . . . 74.11 110.931 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 14.8 Cg_exo -68.83 130.38 20.4 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.902 2.401 . . . . 72.42 112.373 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.479 1.003 0 C-N-CA 123.909 0.884 . . . . 73.43 109.897 177.443 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.723 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 2.9 t80 . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 109.478 -0.564 . . . . 74.44 109.478 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -145.48 114.59 7.01 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.477 -0.935 . . . . 74.14 108.477 176.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.615 HG12 ' HD2' ' A' ' 84' ' ' PHE . 47.7 mt -90.29 129.62 40.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.649 -0.871 . . . . 74.4 108.649 174.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -87.88 -41.79 12.97 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.818 -0.628 . . . . 73.21 110.133 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -175.93 129.46 0.24 Allowed 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.18 0.3 . . . . 75.01 111.197 -170.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.483 HD11 HD11 ' A' ' 13' ' ' ILE . 97.3 mt -121.61 139.9 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 123.653 0.781 . . . . 75.33 108.985 177.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.415 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 35.0 p90 -169.92 177.18 4.46 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.02 0.928 . . . . 74.42 110.597 -169.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.0 p -102.33 121.19 41.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.284 -1.006 . . . . 65.5 108.284 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.415 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 33.8 mtpt -83.15 -44.08 15.48 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.639 -0.875 . . . . 75.04 108.639 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.476 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 21.9 t70 -135.59 134.8 39.72 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.19 -1.368 . . . . 70.12 108.921 -175.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.421 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 80.9 mt -135.14 142.44 39.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.148 -1.427 . . . . 73.25 107.148 178.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -154.17 115.16 4.04 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.095 0.474 . . . . 64.25 110.535 172.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.608 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 75.4 t80 -110.22 138.91 45.95 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 106.838 -1.542 . . . . 65.42 106.838 170.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -138.3 140.62 39.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.227 -1.027 . . . . 74.32 108.227 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.88 78.61 35.44 Favored Pre-proline 0 C--O 1.238 0.48 0 N-CA-C 107.314 -1.365 . . . . 74.42 107.314 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.93 -28.1 36.12 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.968 2.445 . . . . 71.13 112.293 -170.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -114.49 28.8 8.48 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.945 0.898 . . . . 70.11 109.591 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.423 ' O ' HG11 ' A' ' 31' ' ' VAL . . . -47.29 -52.38 35.97 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.03 0.932 . . . . 72.35 113.422 -178.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -63.74 -21.74 69.68 Favored 'Trans proline' 0 C--N 1.39 2.751 0 CA-C-N 121.413 1.541 . . . . 63.5 112.751 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.433 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 4.6 m-70 -94.9 -32.93 13.0 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 124.123 0.969 . . . . 70.3 110.788 -174.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.559 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.5 p -76.32 -16.87 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 112.724 0.639 . . . . 73.45 112.724 -163.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -77.72 -32.58 52.96 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.027 0.531 . . . . 74.15 112.0 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -75.91 -18.62 59.31 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.821 0.449 . . . . 72.13 110.721 174.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 14.5 mmmm -75.29 148.02 39.72 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.61 0.764 . . . . 74.3 111.749 -175.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.06 127.64 32.91 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 124.238 0.961 . . . . 72.34 109.424 171.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -78.98 86.06 4.87 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.529 0.68 . . . . 73.21 110.358 -177.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -136.53 78.59 43.57 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.014 1.325 . . . . 73.24 107.907 176.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -86.45 171.4 7.48 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.448 2.099 . . . . 64.53 113.61 -174.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -115.96 101.08 8.44 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 107.095 -1.446 . . . . 73.5 107.095 170.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -77.59 93.94 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.935 0.874 . . . . 70.14 111.081 -172.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.612 ' HZ1' ' HB3' ' A' ' 41' ' ' LYS . 8.4 mtpm? -82.63 114.28 20.9 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.196 -1.038 . . . . 74.02 108.196 173.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 63' ' ' THR . 0.5 OUTLIER -123.83 107.94 11.94 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.711 0.767 . . . . 74.34 109.847 -174.715 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.484 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.2 m-20 -114.01 136.61 52.72 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.61 -1.177 . . . . 74.13 109.42 -174.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.15 142.17 46.57 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.437 -0.949 . . . . 74.43 108.437 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.666 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 5.9 t70 -147.11 127.6 14.09 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.537 -0.542 . . . . 74.25 109.537 -169.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 64.1 p -105.78 126.96 52.78 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.455 0.702 . . . . 74.25 110.886 -168.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -133.03 141.84 48.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.726 0.81 . . . . 73.43 109.438 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.3 m -132.61 154.98 49.52 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.378 0.671 . . . . 73.01 110.668 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.6 t -153.78 139.59 18.07 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.595 0.758 . . . . 71.24 109.565 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -96.67 120.53 37.17 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.879 -0.785 . . . . 73.31 108.879 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.785 HD12 ' HB2' ' A' ' 57' ' ' GLU . 25.8 mt -107.27 -35.81 6.71 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.553 0.741 . . . . 75.23 110.336 -172.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.54 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -156.71 -176.88 6.22 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.368 1.067 . . . . 71.14 109.687 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -71.75 116.12 11.75 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.68 0.792 . . . . 71.14 109.956 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 70.12 0.22 3.04 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.79 1.236 . . . . 71.04 112.235 -176.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.54 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 58.9 t -111.26 112.43 40.5 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 108.247 -1.02 . . . . 73.34 108.247 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -124.84 173.32 8.68 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.438 1.095 . . . . 71.43 108.972 -173.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.785 ' HB2' HD12 ' A' ' 51' ' ' LEU . 41.3 tt0 -127.17 127.79 45.09 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.195 0.598 . . . . 74.14 109.513 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.426 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 84.3 t -105.44 122.56 58.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.761 -1.2 . . . . 65.2 107.761 170.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 46.1 t -116.78 138.57 46.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 N-CA-C 108.139 -1.06 . . . . 72.31 108.139 174.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.8 tp -127.31 118.08 23.5 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.26 -0.644 . . . . 74.41 109.26 174.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.666 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 16.9 ttm-85 -85.18 102.37 13.25 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.448 -0.945 . . . . 71.24 108.448 173.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.5 t -95.1 108.68 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.559 -0.904 . . . . 72.41 108.559 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 26.8 m -95.46 124.77 39.66 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.623 0.769 . . . . 70.4 108.993 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.9 t -124.74 107.41 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.197 -1.038 . . . . 62.4 108.197 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.561 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 18.3 m -108.12 136.16 48.27 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.515 -0.92 . . . . 72.53 108.515 175.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.12 110.99 20.36 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.29 -1.374 . . . . 72.43 107.29 172.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.9 m -115.31 124.33 51.03 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.598 0.359 . . . . 73.3 110.09 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.4 mt -90.64 84.71 5.93 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.285 -1.006 . . . . 72.14 108.285 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.86 -83.44 0.93 Allowed Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.85 -0.5 . . . . 74.02 111.85 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -125.01 -29.16 3.37 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.861 0.864 . . . . 72.31 109.203 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -77.93 109.94 12.41 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.284 -0.636 . . . . 75.14 109.284 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.8 m -69.53 122.9 19.96 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 110.234 -0.284 . . . . 72.02 110.234 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.559 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -69.03 -61.25 1.87 Allowed 'General case' 0 C--O 1.24 0.596 0 O-C-N 123.843 0.714 . . . . 72.23 110.271 176.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.406 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 26.8 p90 -160.41 172.83 16.58 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.076 -0.965 . . . . 74.32 111.966 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.2 tp -131.41 138.23 49.0 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.984 -1.462 . . . . 75.35 107.497 173.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.428 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 86.1 m -139.12 97.66 3.35 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.28 -1.007 . . . . 73.14 108.28 176.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -120.09 117.23 27.43 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.281 -1.007 . . . . 74.02 108.281 -175.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.0 t -129.31 113.54 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 123.932 0.893 . . . . 52.52 109.867 -170.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.492 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 70.5 mt-30 -84.44 89.01 7.32 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 108.322 -0.992 . . . . 72.41 108.322 170.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.518 ' HG3' HD23 ' A' ' 106' ' ' LEU . 9.5 tp-100 -77.0 103.08 6.73 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.002 -0.999 . . . . 75.53 109.079 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.71 145.83 19.0 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.978 -0.555 . . . . 74.55 111.811 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.406 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.19 123.16 1.46 Allowed Glycine 0 CA--C 1.503 -0.7 0 N-CA-C 110.731 -0.948 . . . . 75.13 110.731 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.527 HG22 HD11 ' A' ' 51' ' ' LEU . 55.5 mt -83.46 121.02 35.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.865 -0.791 . . . . 73.42 108.865 176.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.723 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 23.5 m-85 -134.26 130.13 36.65 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.337 0.655 . . . . 73.34 109.675 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.9 t -99.61 113.93 26.65 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.612 -0.884 . . . . 71.51 108.612 173.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.556 1.176 0 C-N-CA 123.96 0.904 . . . . 71.31 110.787 -175.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 121.166 0.508 . . . . 73.44 110.314 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -68.31 -44.43 75.45 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.219 1.008 . . . . 74.31 110.352 174.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.615 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 83.4 m -64.22 -44.78 90.85 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.369 0.667 . . . . 71.2 111.555 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.59 -50.86 11.67 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.668 0.787 . . . . 65.54 111.735 -173.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.4 5.08 67.42 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-O 119.186 -0.786 . . . . 72.55 114.759 -169.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.72 -51.8 0.15 Allowed 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.582 1.191 . . . . 72.42 113.48 -175.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.615 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 88.0 t80 -75.59 -49.23 19.17 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.826 0.851 . . . . 71.31 112.248 -168.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 99.3 m -69.65 -36.26 6.56 Favored Pre-proline 0 CA--C 1.563 1.478 0 CA-C-O 118.897 -0.573 . . . . 75.3 112.256 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -48.63 -42.43 35.98 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 122.504 2.136 . . . . 73.33 113.839 160.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 101' ' ' TYR . 84.0 m-20 -64.15 -34.44 78.08 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 123.537 0.735 . . . . 74.15 111.553 176.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.6 mm -66.02 -40.39 87.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 N-CA-C 109.587 -0.523 . . . . 74.13 109.587 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.518 HD23 ' HG3' ' A' ' 80' ' ' GLN . 96.5 mt -79.0 -22.44 45.52 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.755 0.822 . . . . 72.55 112.254 -178.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -58.14 -48.83 96.36 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 113.914 1.079 . . . . 63.13 113.914 -172.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -63.1 -39.83 37.11 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 122.111 1.874 . . . . 63.52 112.812 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -69.3 -40.75 77.51 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.298 0.639 . . . . 75.0 111.281 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.23 -40.63 70.97 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.071 0.548 . . . . 44.12 110.367 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.46 HH12 HD13 ' C' ' 105' ' ' ILE . 23.7 ttm180 -49.91 -51.99 36.57 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.01 0.924 . . . . 74.0 110.205 171.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -71.48 -37.54 71.3 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.006 -0.997 . . . . 60.44 111.64 -173.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.8 t -66.06 -32.66 74.25 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 121.061 0.457 . . . . 73.1 110.916 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 93.0 mt -69.18 -54.51 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 115.255 -0.884 . . . . 65.32 109.432 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.456 HG21 ' HE2' ' C' ' 109' ' ' TYR . 95.2 m -51.79 -40.6 60.66 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.994 1.317 . . . . 65.41 112.278 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.9 t -64.12 -47.6 79.36 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 115.249 -0.887 . . . . 73.34 110.656 -177.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.608 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 39.6 mtm -67.84 -36.07 79.69 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.807 0.692 . . . . 74.12 111.373 -178.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.9 -51.47 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 123.677 0.791 . . . . 74.14 110.254 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.5 t -69.46 -29.45 67.13 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.43 -0.804 . . . . 44.12 111.5 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.516 ' HG2' ' HG1' ' B' ' 18' ' ' THR . 42.0 ttm-85 -77.93 -28.82 49.73 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.988 0.915 . . . . 74.44 109.2 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.422 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.96 12.65 59.33 Favored Glycine 0 C--N 1.351 1.411 0 CA-C-N 114.933 -1.03 . . . . 63.23 112.648 170.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.451 HG23 ' HE ' ' B' ' 15' ' ' ARG . 2.0 t 60.66 18.51 8.54 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 126.89 2.076 . . . . 74.11 113.523 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -77.93 158.39 77.79 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 123.938 0.895 . . . . 73.43 110.951 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.46 143.38 77.86 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.831 2.354 . . . . 64.32 112.995 173.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.401 HE21 HG23 ' D' ' 122' ' ' THR . 5.4 tp-100 -53.73 127.74 26.9 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.674 1.19 . . . . 72.13 112.183 -175.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.406 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 43.5 tp -126.92 101.37 6.55 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.048 0.939 . . . . 74.43 109.45 -177.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -123.34 102.11 7.73 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.605 -0.887 . . . . 75.1 108.605 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.62 144.62 56.29 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.985 0.514 . . . . 75.45 109.687 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.41 151.25 97.34 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 123.833 0.853 . . . . 51.23 111.845 -173.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.477 ' HD3' HG13 ' C' ' 13' ' ' ILE . 52.1 Cg_endo -68.97 114.63 3.64 Favored 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 123.094 2.53 . . . . 74.33 113.111 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.1 m -111.61 112.68 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 108.184 -1.043 . . . . 75.22 108.184 165.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -81.61 93.61 6.76 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.63 -1.248 . . . . 73.51 107.63 175.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 . . . . . 0 N--CA 1.481 1.096 0 C-N-CA 124.242 1.017 . . . . 61.12 111.634 -175.415 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 121.225 0.536 . . . . 74.23 110.262 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 61.6 m -133.27 129.35 37.51 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.285 -1.376 . . . . 74.52 107.285 168.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.434 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 42.7 t80 -129.35 126.61 39.3 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.799 -1.185 . . . . 75.04 107.799 175.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.486 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -144.53 126.43 15.36 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.271 -0.64 . . . . 73.34 109.271 178.337 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 27.9 mt -74.8 121.51 26.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.562 -0.903 . . . . 74.3 108.562 172.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -92.06 -50.06 5.88 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.248 -0.649 . . . . 75.11 109.248 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.451 ' HE ' HG23 ' A' ' 122' ' ' THR . 45.8 ttt180 -166.52 131.16 2.14 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.727 -0.67 . . . . 74.44 110.209 -175.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 75.6 mt -114.68 137.18 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 108.029 -1.1 . . . . 73.3 108.029 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -169.87 161.79 9.12 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.442 0.639 . . . . 75.21 111.5 -176.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.516 ' HG1' ' HG2' ' A' ' 120' ' ' ARG . 42.7 m -83.17 130.63 35.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.771 -1.104 . . . . 73.33 109.249 170.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -96.51 -34.22 11.56 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.261 0.625 . . . . 71.11 109.851 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -147.72 145.45 28.86 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.084 0.469 . . . . 73.14 111.177 -173.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.715 HD12 ' SG ' ' B' ' 113' ' ' CYS . 40.3 mm -136.35 146.5 28.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 126.047 1.739 . . . . 72.3 108.708 177.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 36.7 t -150.9 133.32 15.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.558 -1.201 . . . . 71.03 108.324 171.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 74.0 t80 -141.07 135.99 31.54 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.098 -1.445 . . . . 75.34 107.098 172.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -141.51 128.48 20.68 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.218 1.007 . . . . 75.12 108.666 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.17 80.95 69.8 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 107.018 -1.475 . . . . 63.51 107.018 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.82 -26.73 31.96 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.142 2.561 . . . . 72.01 113.152 -171.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.453 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 74.9 m-20 -115.11 18.73 16.13 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.674 0.79 . . . . 73.54 110.047 -177.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.86 -59.17 5.02 Favored Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 125.06 1.344 . . . . 74.52 114.129 -170.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -61.43 -28.49 83.89 Favored 'Trans proline' 0 C--N 1.393 2.89 0 C-N-CA 122.233 1.955 . . . . 74.3 113.346 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.439 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 78.1 m80 -93.96 -38.21 11.29 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.702 -0.681 . . . . 74.32 111.404 -175.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' B' ' 73' ' ' ALA . 4.5 p -67.88 -16.74 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.129 0.572 . . . . 72.24 111.757 -173.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -65.11 -21.03 66.74 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.222 0.823 . . . . 74.23 113.222 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 10.3 pt20 -68.28 -15.27 63.5 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.308 0.643 . . . . 75.01 111.179 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.502 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 89.6 mttt -95.27 105.71 17.68 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.597 1.159 . . . . 75.41 109.791 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -110.72 93.08 4.31 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.09 0.556 . . . . 72.53 109.829 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 39.7 p90 -162.65 179.7 7.52 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.716 1.206 . . . . 75.5 108.411 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -69.05 114.71 25.26 Favored Pre-proline 0 N--CA 1.477 0.915 0 N-CA-C 109.578 -0.527 . . . . 73.53 109.578 177.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.463 ' HB2' ' HB2' ' B' ' 66' ' ' ALA . 43.2 Cg_endo -65.72 139.11 56.4 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 121.901 1.734 . . . . 72.33 111.027 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -66.45 103.68 1.09 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.561 -0.903 . . . . 73.15 108.561 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.568 HG11 HD23 ' B' ' 126' ' ' LEU . 31.2 m -99.83 160.82 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 115.41 -0.813 . . . . 75.01 111.815 -172.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -145.04 133.59 22.01 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.67 -1.15 . . . . 71.33 108.524 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 pp -86.7 164.98 16.44 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 123.038 0.535 . . . . 74.23 110.15 175.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.572 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 17.5 t70 -164.72 126.31 2.15 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.072 -0.967 . . . . 75.13 108.545 175.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.419 HD21 HD21 ' B' ' 60' ' ' LEU . 5.5 mp -123.04 134.15 54.3 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.576 0.75 . . . . 70.21 109.073 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.649 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 10.9 t70 -131.32 133.65 45.55 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.845 0.858 . . . . 63.52 108.758 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 17.9 p -106.37 102.02 11.45 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.244 0.618 . . . . 64.32 109.678 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.473 ' O ' ' HB ' ' B' ' 59' ' ' VAL . . . -119.85 114.21 21.75 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 107.111 -1.44 . . . . 65.22 107.111 174.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 52.6 m -144.77 161.06 40.17 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.385 -0.598 . . . . 73.22 109.385 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 76.1 p -164.73 150.17 9.95 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.906 0.482 . . . . 71.01 110.445 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -82.24 129.5 34.86 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.205 0.602 . . . . 71.25 109.65 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.46 HD12 HG23 ' B' ' 83' ' ' ILE . 20.7 mt -91.07 -49.97 6.11 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.796 0.839 . . . . 74.42 109.971 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.03 -173.49 4.18 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.193 -0.912 . . . . 73.42 110.224 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -65.65 120.73 13.48 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.947 -1.024 . . . . 75.42 109.313 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 68.17 9.2 7.05 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.115 1.366 . . . . 64.11 111.773 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -120.92 109.36 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.048 0.939 . . . . 74.42 109.21 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -119.48 149.04 42.54 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.505 1.122 . . . . 73.52 108.443 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -118.76 122.08 41.58 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.925 0.49 . . . . 73.54 109.78 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 61.9 t -100.93 118.91 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 108.375 -0.972 . . . . 65.41 108.375 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' B' ' 47' ' ' ALA . 21.4 t -118.67 130.82 72.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 107.646 -1.242 . . . . 65.55 107.646 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.419 HD21 HD21 ' B' ' 44' ' ' LEU . 14.2 tp -123.32 124.59 43.31 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 110.128 -0.323 . . . . 74.2 110.128 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.649 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 39.0 ttm180 -87.31 113.5 23.08 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.864 0.865 . . . . 65.51 109.001 173.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 43.1 t -104.88 101.32 12.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.475 -1.306 . . . . 70.03 107.475 173.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.572 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 18.1 m -103.06 132.36 49.38 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.569 0.748 . . . . 75.54 109.065 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 89.6 t -123.24 127.02 74.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 124.773 1.229 . . . . 73.44 108.825 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.1 m -103.98 148.08 26.62 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.822 -0.807 . . . . 70.2 108.822 169.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -148.53 140.14 23.6 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.544 0.738 . . . . 72.32 109.563 176.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.461 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 35.3 p -143.98 137.7 27.91 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 123.635 0.584 . . . . 73.23 110.826 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.459 HD21 ' HA ' ' B' ' 38' ' ' PRO . 67.4 mt -110.52 110.82 21.69 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.043 -1.095 . . . . 72.22 108.043 174.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.55 -129.93 10.29 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 123.245 0.34 . . . . 44.34 113.056 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -96.61 16.44 18.86 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.683 0.793 . . . . 61.0 111.919 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.502 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 12.2 pt-20 -142.06 152.81 43.69 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.699 0.399 . . . . 74.3 110.952 -175.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 58.2 m -64.94 132.65 49.9 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 123.636 0.585 . . . . 65.13 110.136 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.461 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -85.44 -66.64 0.88 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.14 -1.43 . . . . 74.31 107.14 171.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -149.21 159.55 44.15 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 122.01 0.91 . . . . 75.21 112.178 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 71.3 mt -131.45 113.1 13.3 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 105.946 -1.872 . . . . 74.31 105.946 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.567 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 48.3 t -118.9 147.83 43.57 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.739 -0.837 . . . . 74.03 108.739 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 40.0 tt0 -155.9 128.67 7.91 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.92 -0.77 . . . . 72.3 108.92 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 96.1 t -130.36 145.83 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.789 0.836 . . . . 74.04 108.947 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -122.29 101.21 7.38 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.23 -1.026 . . . . 74.13 108.23 172.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -91.25 104.62 17.14 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.079 -0.711 . . . . 74.11 109.079 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.5 142.91 16.27 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.507 -0.769 . . . . 70.44 111.643 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.42 124.0 2.92 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 109.875 -1.29 . . . . 74.43 109.875 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.46 HG23 HD12 ' B' ' 51' ' ' LEU . 53.1 mt -86.26 128.61 39.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.957 -1.127 . . . . 71.44 107.957 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -137.44 134.91 36.38 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.816 0.847 . . . . 74.41 109.001 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 74.3 m -91.11 108.34 19.81 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.597 -0.52 . . . . 72.14 109.597 171.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.653 HD11 HD23 ' B' ' 98' ' ' LEU . 48.4 pt -121.9 143.67 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.41 1.084 . . . . 74.25 110.586 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.8 152.04 22.64 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.185 0.594 . . . . 73.25 110.771 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.95 -69.59 0.23 Allowed Glycine 0 C--N 1.347 1.18 0 O-C-N 123.429 0.455 . . . . 70.03 112.869 170.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 18.5 mt -75.07 152.75 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.394 0.678 . . . . 74.12 110.947 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -155.81 -175.04 5.22 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 124.118 0.967 . . . . 74.1 108.92 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.67 -135.07 26.46 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 123.364 0.507 . . . . 62.11 114.152 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 31.6 m -71.25 -36.51 71.8 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.58 0.752 . . . . 72.41 111.832 -174.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -60.91 -38.22 84.99 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.766 -0.652 . . . . 73.11 110.361 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 42.0 ttp -80.03 -28.07 39.39 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.561 -0.745 . . . . 72.21 110.569 177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.4 -31.89 72.94 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.106 0.562 . . . . 74.25 110.708 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -75.58 -39.01 58.69 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.232 0.613 . . . . 65.11 110.573 173.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.1 t -64.12 -64.52 0.86 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.083 0.553 . . . . 74.15 110.912 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.653 HD23 HD11 ' B' ' 86' ' ' ILE . 65.9 mt -72.47 -30.74 64.82 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.122 0.569 . . . . 74.41 111.968 -176.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.74 -10.44 72.8 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 119.717 -0.491 . . . . 62.53 114.208 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.602 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -142.35 -58.58 0.45 Allowed 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 117.433 0.616 . . . . 71.53 111.948 -175.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -60.51 -49.22 78.43 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.168 0.987 . . . . 63.33 112.385 -176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.434 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 64.1 m -67.65 -50.3 36.02 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-O 118.484 -0.77 . . . . 63.13 112.579 -175.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.406 ' HB2' HD23 ' B' ' 60' ' ' LEU . 74.0 Cg_endo -72.17 -12.62 28.03 Favored 'Trans proline' 0 C--N 1.385 2.473 0 CA-C-N 121.248 1.481 . . . . 73.0 112.84 177.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' B' ' 100' ' ' ALA . 0.2 OUTLIER -73.99 -33.49 63.84 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.071 0.548 . . . . 64.22 109.548 173.619 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 97.7 mt -60.76 -42.24 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 124.031 0.932 . . . . 74.43 109.738 170.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.8 mt -87.34 -14.5 40.61 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.413 -1.267 . . . . 75.02 111.396 -171.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -54.39 -51.82 74.74 Favored Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 124.321 1.048 . . . . 74.24 112.7 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -52.46 -40.15 72.33 Favored 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 122.866 2.378 . . . . 70.23 114.791 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -75.07 -41.31 59.18 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.927 -0.579 . . . . 74.5 110.51 -175.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.86 -40.27 96.16 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.196 0.598 . . . . 71.41 110.43 174.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -57.11 -59.59 4.86 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.468 1.507 . . . . 75.42 110.564 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.82 -37.74 74.35 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 124.124 0.89 . . . . 72.35 110.759 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.715 ' SG ' HD12 ' B' ' 21' ' ' ILE . 19.0 t -68.61 -40.65 80.3 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.336 -0.847 . . . . 63.45 111.593 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.567 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 63.6 mt -62.18 -50.77 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.233 -0.654 . . . . 74.21 109.233 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 4.6 m -61.99 -29.6 70.37 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 124.133 0.896 . . . . 70.53 111.431 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -66.4 -50.42 63.51 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 109.487 -0.56 . . . . 73.31 109.487 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.4 ' SD ' HG22 ' B' ' 21' ' ' ILE . 35.5 mmt -62.44 -41.69 98.91 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 123.699 0.624 . . . . 74.2 110.876 -178.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 70.0 t -61.78 -48.12 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 124.209 1.004 . . . . 63.52 110.857 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 26.0 t -67.48 -30.36 70.04 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.58 -0.736 . . . . 75.44 110.792 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -69.92 -31.31 69.01 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.992 0.517 . . . . 72.21 110.12 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.76 9.66 55.07 Favored Glycine 0 C--N 1.353 1.521 0 O-C-N 123.883 0.739 . . . . 64.21 112.314 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 82.8 p 60.5 22.18 11.88 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 126.825 2.05 . . . . 73.25 113.627 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -84.63 161.93 52.13 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 123.476 0.71 . . . . 75.04 111.062 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -61.9 174.58 2.3 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 123.057 2.505 . . . . 72.22 113.875 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.53 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -62.42 115.13 3.95 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.312 -1.313 . . . . 54.34 111.343 -175.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.568 HD23 HG11 ' B' ' 40' ' ' VAL . 1.6 tm? -131.92 96.08 3.84 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.361 -0.977 . . . . 73.15 108.361 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -123.1 137.01 55.03 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.475 1.11 . . . . 73.13 108.773 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 6.9 mp -70.67 138.01 50.31 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.749 0.655 . . . . 62.15 110.524 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.77 151.26 89.29 Favored Pre-proline 0 CA--C 1.553 1.077 0 O-C-N 124.331 1.019 . . . . 74.31 112.173 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.83 92.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.533 2.822 . . . . 73.41 112.636 173.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 16.1 m -115.09 112.37 39.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 115.673 -0.694 . . . . 73.55 109.194 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -82.57 94.11 7.44 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 107.498 -1.297 . . . . 75.22 107.498 173.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -68.7 -29.9 68.44 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.317 -1.311 . . . . 74.4 110.638 -172.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . 0.602 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 17.5 t70 . . . . . 0 C--N 1.35 0.589 0 C-N-CA 124.048 0.939 . . . . 74.34 110.898 172.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.469 ' CD1' ' HE2' ' C' ' 101' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 121.254 0.55 . . . . 74.23 110.161 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -148.74 126.24 11.65 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.152 -1.425 . . . . 75.22 107.152 173.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.477 HG13 ' HD3' ' A' ' 130' ' ' PRO . 65.2 mt -78.35 123.48 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 109.336 -0.616 . . . . 62.42 109.336 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -86.03 -43.11 13.39 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.331 -0.849 . . . . 74.21 110.315 -177.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -178.79 124.92 0.1 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.554 0.534 . . . . 63.41 110.23 -174.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 97.0 mt -114.03 143.64 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 108.263 -1.014 . . . . 75.53 108.263 175.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.461 ' HH ' HD11 ' C' ' 83' ' ' ILE . 31.3 p90 -174.82 172.7 2.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.34 1.056 . . . . 74.34 109.411 -170.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 66.6 p -96.94 126.06 41.81 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.844 0.458 . . . . 70.42 110.085 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.458 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 27.6 mmtp -76.37 -49.08 17.72 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.196 -1.038 . . . . 74.53 108.196 169.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 11.7 t70 -135.38 147.45 49.05 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 113.858 -1.519 . . . . 73.35 109.473 -170.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.52 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.5 mt -144.09 145.75 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 106.542 -1.651 . . . . 75.33 106.542 172.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -160.16 152.12 20.28 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.294 0.568 . . . . 74.05 110.397 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 70.0 t80 -149.87 136.59 19.3 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.356 -1.35 . . . . 74.41 107.356 175.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -138.96 127.83 23.58 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.346 0.658 . . . . 72.52 109.92 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.77 80.36 5.59 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 107.336 -1.357 . . . . 74.43 107.336 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.44 -35.53 38.84 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.749 2.299 . . . . 72.32 112.094 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -92.29 21.9 4.88 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.547 -1.206 . . . . 75.41 111.217 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.59 -49.44 45.83 Favored Pre-proline 0 CA--C 1.564 1.506 0 N-CA-C 113.849 1.055 . . . . 72.42 113.849 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.41 -44.23 34.54 Favored 'Trans proline' 0 C--N 1.388 2.614 0 CA-C-N 121.584 1.601 . . . . 72.42 112.652 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.401 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 86.4 t60 -69.34 -32.53 71.68 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.072 -0.967 . . . . 75.44 112.56 -175.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.708 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.9 p -78.68 -25.1 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 N-CA-C 112.695 0.628 . . . . 74.22 112.695 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -71.44 -16.02 62.36 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 112.811 0.671 . . . . 72.53 112.811 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 14.0 pt20 -94.9 19.17 10.62 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.282 0.633 . . . . 72.43 110.837 175.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.682 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -109.88 159.66 17.04 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.859 0.864 . . . . 75.15 110.576 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -82.11 131.04 35.24 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.118 0.967 . . . . 65.32 108.982 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -77.05 82.86 3.56 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.261 1.024 . . . . 72.33 112.341 -170.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -126.33 69.84 68.98 Favored Pre-proline 0 N--CA 1.484 1.235 0 C-N-CA 124.087 0.955 . . . . 75.25 109.865 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -88.96 135.06 2.72 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.864 2.376 . . . . 74.32 112.529 -173.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -86.44 115.79 24.17 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 106.902 -1.518 . . . . 74.2 106.902 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.2 t -79.49 100.2 3.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 108.911 -0.774 . . . . 75.42 108.911 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.623 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 4.3 mptp? -90.1 99.63 12.61 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.362 -1.718 . . . . 74.21 106.362 170.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 pp -95.52 145.01 25.52 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.867 -0.79 . . . . 74.44 108.867 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.427 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 23.0 t70 -142.86 145.29 32.99 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.845 -0.798 . . . . 64.13 108.845 -177.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -121.06 113.65 20.35 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.699 0.8 . . . . 73.52 109.312 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -113.59 163.03 15.48 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.267 1.427 . . . . 40.25 107.831 171.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.4 t -144.58 153.83 42.21 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.32 0.581 . . . . 75.01 111.27 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.91 152.17 41.78 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.039 1.336 . . . . 73.41 107.707 172.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.9 p -167.33 167.54 13.92 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 120.996 0.427 . . . . 73.42 111.454 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 69.9 p -161.21 153.61 20.28 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.063 -0.971 . . . . 71.41 109.011 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -88.54 124.11 33.71 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.26 -1.015 . . . . 72.04 108.26 168.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.437 HD13 HD13 ' C' ' 83' ' ' ILE . 64.9 mt -92.74 -38.67 11.68 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.521 0.728 . . . . 71.31 110.755 -176.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.07 178.03 10.82 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.515 0.726 . . . . 75.43 110.7 -178.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -60.65 117.93 5.95 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.401 0.68 . . . . 75.15 109.811 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 70.01 -6.71 1.05 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 125.827 1.651 . . . . 73.01 113.596 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.55 111.67 27.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.932 -1.136 . . . . 65.2 107.932 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -127.78 134.89 49.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.299 -0.63 . . . . 72.41 109.299 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -92.24 126.89 37.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.895 -1.048 . . . . 74.41 109.679 177.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 72.9 t -116.4 116.05 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 107.739 -1.208 . . . . 74.44 107.739 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 38.9 t -116.01 132.57 65.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 108.746 -0.835 . . . . 74.32 108.746 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 54.3 tp -116.72 112.85 21.78 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.504 -0.924 . . . . 75.5 108.504 175.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.565 ' HB2' ' HG2' ' C' ' 79' ' ' GLN . 50.4 ttm-85 -91.62 111.02 22.36 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.882 -0.784 . . . . 73.42 108.882 173.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.537 ' HB ' HD11 ' C' ' 114' ' ' ILE . 20.8 t -99.33 129.16 50.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 N-CA-C 107.785 -1.191 . . . . 73.23 107.785 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 16.5 m -123.05 118.97 28.97 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.114 -0.698 . . . . 72.54 109.114 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 65.4 t -113.55 108.62 25.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-N 114.571 -1.195 . . . . 74.52 108.749 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.623 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 16.5 m -98.25 140.41 32.59 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.873 -1.158 . . . . 72.31 107.873 171.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.48 121.24 28.45 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.169 -1.419 . . . . 72.51 107.169 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 51.0 m -132.43 126.34 32.85 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.941 0.337 . . . . 74.05 110.68 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.655 HD11 ' HG2' ' C' ' 34' ' ' LYS . 10.3 mt -85.49 42.83 0.98 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.562 1.145 . . . . 72.23 109.7 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.03 -113.67 4.51 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 111.108 -0.797 . . . . 70.24 111.108 -172.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.83 -18.6 28.94 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.535 0.734 . . . . 64.43 110.044 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -80.04 120.75 24.63 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.392 1.077 . . . . 74.12 109.145 172.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 99.0 m -78.93 123.01 26.84 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.476 -0.935 . . . . 71.12 108.476 164.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.708 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.16 -56.72 5.51 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.649 0.593 . . . . 70.24 109.614 175.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -158.47 168.94 25.6 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.927 0.87 . . . . 71.44 111.392 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -128.08 141.53 51.47 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 105.859 -1.904 . . . . 72.21 105.859 166.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 37.3 t -145.36 136.85 25.18 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.427 -1.323 . . . . 74.01 107.427 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -156.24 121.14 4.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.532 0.206 . . . . 74.51 110.465 -168.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 84.7 t -132.59 135.56 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.644 0.778 . . . . 74.41 109.671 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.565 ' HG2' ' HB2' ' C' ' 61' ' ' ARG . 20.7 mt-30 -96.89 108.19 20.84 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.657 -0.868 . . . . 64.43 108.657 164.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -90.62 104.24 16.85 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.638 -0.875 . . . . 72.53 108.638 172.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.75 145.55 22.76 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.511 -0.768 . . . . 71.33 111.475 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.2 115.48 0.72 Allowed Glycine 0 CA--C 1.504 -0.656 0 N-CA-C 110.157 -1.177 . . . . 63.24 110.157 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.461 HD11 ' HH ' ' C' ' 17' ' ' TYR . 15.8 mm -83.76 121.74 36.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.886 -1.153 . . . . 73.43 107.886 175.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -129.04 119.35 24.07 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.851 -0.796 . . . . 72.21 108.851 -174.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 57.3 p -77.35 107.71 9.96 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.264 -1.013 . . . . 75.3 108.264 170.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 6.7 tt -116.25 131.91 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.831 1.252 . . . . 75.42 108.997 -177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.02 171.03 20.8 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.913 0.885 . . . . 71.51 110.087 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.73 -58.44 3.71 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 112.228 -0.349 . . . . 65.21 112.228 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 36.2 pt -84.76 158.61 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.276 0.631 . . . . 74.24 110.669 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -149.9 164.71 34.68 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.839 0.855 . . . . 74.35 109.363 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.79 -125.31 30.4 Favored Glycine 0 C--N 1.346 1.094 0 C-N-CA 123.197 0.427 . . . . 72.31 113.69 171.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 45.5 p -56.43 -34.75 67.1 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.841 1.256 . . . . 75.02 112.531 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -73.47 -38.57 65.38 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.763 0.425 . . . . 73.45 111.592 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.433 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 47.3 mtt -62.15 -49.03 77.47 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.496 -0.557 . . . . 74.51 109.496 171.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.66 -35.88 71.14 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.787 0.835 . . . . 74.24 111.286 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -64.41 -46.55 82.79 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.292 1.037 . . . . 64.15 110.739 173.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.539 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 24.2 t -64.06 -42.02 97.16 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.497 -0.774 . . . . 54.44 111.465 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' C' ' 94' ' ' MET . 70.9 mt -85.37 -36.7 20.57 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.567 0.747 . . . . 73.44 111.706 -170.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.95 11.52 58.95 Favored Glycine 0 N--CA 1.474 1.168 0 CA-C-N 116.206 -0.452 . . . . 55.43 114.009 -171.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.43 -60.07 0.14 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.54 0.686 . . . . 75.11 110.616 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.539 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 83.1 t80 -75.79 -35.45 60.07 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 125.138 1.375 . . . . 74.4 113.49 -168.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 91.3 m -79.07 -41.68 1.64 Allowed Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 123.169 0.588 . . . . 75.32 111.49 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.58 -33.37 30.71 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 122.626 2.217 . . . . 75.34 113.705 166.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -66.02 -39.69 90.44 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.633 0.773 . . . . 74.5 111.399 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.46 HD13 HH12 ' A' ' 111' ' ' ARG . 50.6 mm -67.03 -42.64 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.127 0.571 . . . . 63.2 110.062 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 87.8 mt -88.36 -10.21 50.14 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.826 0.851 . . . . 72.21 112.209 -174.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -58.04 -55.29 46.76 Favored Pre-proline 0 N--CA 1.481 1.092 0 CA-C-O 117.892 -1.051 . . . . 72.32 112.493 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.14 -35.56 74.64 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 121.99 1.794 . . . . 74.32 113.158 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . 0.456 ' HE2' HG21 ' A' ' 115' ' ' THR . 91.6 m-85 -64.33 -54.43 33.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.485 0.714 . . . . 75.24 110.659 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.01 -39.13 91.23 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 114.803 -1.09 . . . . 71.21 110.501 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -56.0 -51.43 67.79 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.11 1.364 . . . . 75.4 110.453 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.49 -38.18 77.54 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 123.508 0.505 . . . . 75.24 109.802 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.1 t -64.41 -32.85 74.64 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 122.971 0.508 . . . . 73.22 111.639 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.537 HD11 ' HB ' ' C' ' 62' ' ' VAL . 97.4 mt -73.42 -56.14 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.832 0.853 . . . . 73.02 109.33 175.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 15.0 m -61.88 -27.25 68.67 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.936 0.895 . . . . 73.1 111.688 -175.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 47.6 t -68.03 -47.47 68.33 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.984 0.914 . . . . 74.21 109.71 174.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.647 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.82 -36.77 84.27 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.849 0.86 . . . . 73.44 111.596 178.052 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.5 t -63.35 -39.46 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.377 0.671 . . . . 72.43 110.011 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.6 t -73.06 -29.52 63.03 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.845 0.858 . . . . 75.14 112.061 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' C' ' 116' ' ' SER . 85.4 mtt-85 -71.66 -39.48 70.29 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.014 -0.735 . . . . 75.01 109.014 176.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.18 2.55 60.98 Favored Glycine 0 C--N 1.36 1.874 0 O-C-N 124.103 0.877 . . . . 75.12 112.61 172.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.2 p 61.81 26.35 15.98 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.89 2.076 . . . . 73.33 113.545 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -83.37 146.91 51.81 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 109.066 -0.716 . . . . 71.11 109.066 170.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.489 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 80.1 Cg_exo -49.86 138.21 34.43 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 123.329 2.686 . . . . 75.34 112.688 173.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.544 ' HA ' HE21 ' C' ' 125' ' ' GLN . 0.0 OUTLIER -60.11 111.36 1.48 Allowed 'General case' 0 C--N 1.354 0.761 0 O-C-N 123.955 0.784 . . . . 63.35 110.609 -176.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -105.88 88.05 2.72 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 104.587 -2.375 . . . . 74.03 104.587 174.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -92.34 126.19 37.32 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.261 -0.881 . . . . 71.14 109.046 -171.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.49 136.08 51.0 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 124.128 0.892 . . . . 72.12 109.881 -173.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.06 157.82 83.43 Favored Pre-proline 0 CA--C 1.551 0.996 0 O-C-N 124.148 0.905 . . . . 73.12 111.395 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -54.03 110.33 0.49 Allowed 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 123.03 2.487 . . . . 74.43 113.485 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.23 109.86 30.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.26 -0.644 . . . . 72.42 109.26 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -107.8 91.93 3.86 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 105.866 -1.901 . . . . 63.05 105.866 169.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -53.63 -43.27 68.58 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 124.319 1.012 . . . . 65.13 111.586 -172.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 42.1 t0 . . . . . 0 C--O 1.241 0.647 0 CA-C-N 114.928 -1.033 . . . . 72.4 111.205 -179.232 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 96.1 m . . . . . 0 C--O 1.24 0.605 0 CA-C-O 121.029 0.442 . . . . 74.34 110.047 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.627 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 62.6 t80 -154.66 93.09 1.54 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 107.433 -1.321 . . . . 74.12 107.433 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -120.5 115.34 23.26 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.441 -0.948 . . . . 74.22 108.441 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.512 HG21 HD11 ' D' ' 16' ' ' ILE . 11.2 mt -74.0 134.31 29.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 109.952 -0.388 . . . . 73.02 109.952 -175.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -93.83 -46.42 7.21 Favored 'General case' 0 C--O 1.241 0.656 0 O-C-N 123.426 0.454 . . . . 72.14 110.675 175.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -167.18 142.7 4.13 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.66 0.615 . . . . 75.44 112.66 -165.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.512 HD11 HG21 ' D' ' 13' ' ' ILE . 3.0 mp -122.56 135.94 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.791 1.236 . . . . 75.55 107.725 171.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.416 ' HE1' HG13 ' D' ' 83' ' ' ILE . 25.2 p90 -163.63 157.14 19.0 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.671 0.789 . . . . 72.34 110.737 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.3 p -91.36 114.69 27.29 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.209 -0.905 . . . . 73.35 108.859 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -78.71 -44.88 22.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.354 -0.98 . . . . 74.3 108.354 175.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.569 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 14.1 t70 -135.62 139.38 43.75 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.374 -1.284 . . . . 74.04 109.577 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.647 HG21 ' HE1' ' C' ' 117' ' ' MET . 67.4 mt -138.06 151.23 25.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 124.968 1.307 . . . . 64.43 107.895 174.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -152.23 145.8 24.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.358 1.063 . . . . 75.01 108.986 172.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.52 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 84.9 t80 -152.27 133.41 14.31 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 105.584 -2.006 . . . . 74.12 105.584 173.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -141.79 139.56 32.81 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.353 -0.98 . . . . 72.44 108.353 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.89 89.78 20.31 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 107.646 -1.242 . . . . 71.53 107.646 176.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.2 -32.31 5.26 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 123.022 2.481 . . . . 73.44 113.935 -170.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -103.53 17.32 24.35 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.191 0.596 . . . . 75.41 110.32 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -38.76 -65.81 0.36 Allowed Pre-proline 0 CA--C 1.562 1.416 0 N-CA-C 115.235 1.568 . . . . 73.01 115.235 -159.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.53 -23.87 22.88 Favored 'Trans proline' 0 C--N 1.389 2.688 0 CA-C-N 121.849 1.696 . . . . 74.44 113.337 -173.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.456 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 4.7 t-160 -79.4 -39.01 33.51 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.11 0.964 . . . . 73.4 110.808 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.425 HG21 ' HA ' ' D' ' 73' ' ' ALA . 4.2 p -80.67 -18.68 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 122.537 0.335 . . . . 63.42 110.752 -170.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -62.54 -23.39 66.96 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.346 0.659 . . . . 74.02 112.623 173.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.456 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 55.1 mt-30 -60.33 -23.09 63.96 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.574 0.749 . . . . 72.52 110.603 175.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.535 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 89.1 mttt -92.54 82.14 4.84 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.151 1.381 . . . . 71.11 109.657 176.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.19 84.31 7.72 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.231 0.613 . . . . 74.32 110.353 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.2 p90 -156.82 -178.97 7.76 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.35 0.66 . . . . 74.53 109.343 170.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -66.76 109.84 4.05 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.457 1.103 . . . . 71.25 110.455 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.75 137.68 64.83 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.259 1.973 . . . . 75.53 111.415 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -63.21 108.58 1.31 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.709 -0.849 . . . . 74.42 108.709 172.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.574 HG13 HG13 ' D' ' 64' ' ' VAL . 87.6 t -99.13 148.81 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.034 -1.098 . . . . 72.01 108.034 -175.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.551 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 34.6 ttpt -129.83 138.91 51.26 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.663 -0.866 . . . . 74.34 108.663 169.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 53.7 tp -109.05 112.2 24.26 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.277 -1.008 . . . . 73.34 108.277 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.606 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 71.9 m-20 -111.37 120.95 43.92 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.316 1.046 . . . . 75.32 108.412 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -100.36 128.01 46.53 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.846 -0.428 . . . . 65.33 109.846 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.517 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 9.1 t70 -133.1 157.79 44.41 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 105.75 -1.945 . . . . 74.04 105.75 172.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.3 t -146.96 161.11 41.45 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.144 0.497 . . . . 72.23 111.761 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -163.01 169.41 19.63 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.187 1.395 . . . . 71.51 108.771 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 19.1 p -176.82 -179.75 0.99 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 112.454 0.538 . . . . 65.21 112.454 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 52.2 p -164.77 147.52 8.52 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.624 1.17 . . . . 62.23 109.245 172.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -82.42 119.22 23.9 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.275 -1.009 . . . . 72.04 108.275 171.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.519 HD13 HG22 ' D' ' 83' ' ' ILE . 21.1 mt -89.82 -31.3 17.44 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.779 0.432 . . . . 74.34 110.718 -173.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.73 178.33 8.57 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.22 1.008 . . . . 55.2 109.696 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -73.59 129.36 37.8 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.808 -0.812 . . . . 74.35 108.808 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 69.65 10.59 7.66 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.983 1.313 . . . . 72.41 111.311 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 87.7 t -132.67 118.23 33.65 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 124.034 0.934 . . . . 71.15 108.978 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -140.91 131.25 25.09 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.77 -0.826 . . . . 73.24 108.77 -174.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.423 ' HB2' HD11 ' D' ' 51' ' ' LEU . 31.2 tt0 -91.27 143.57 26.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.669 -1.15 . . . . 75.11 109.941 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.476 HG22 ' HE1' ' D' ' 84' ' ' PHE . 3.9 m -121.49 139.48 48.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 107.887 -1.153 . . . . 75.35 107.887 167.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 23.7 t -127.94 124.51 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 108.328 -0.99 . . . . 65.22 108.328 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.503 HD22 ' HG3' ' D' ' 103' ' ' PRO . 3.9 mm? -118.23 114.07 22.46 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.358 0.663 . . . . 74.45 109.497 -176.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.517 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 22.0 ttm-85 -86.22 99.62 11.68 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.67 0.788 . . . . 73.42 109.609 176.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 85.7 t -91.2 115.04 29.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 108.357 -0.979 . . . . 72.01 108.357 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 9.1 m -115.46 129.09 56.44 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.358 0.599 . . . . 74.44 109.701 -175.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.574 HG13 HG13 ' D' ' 40' ' ' VAL . 24.5 t -118.13 101.56 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.005 1.722 . . . . 75.44 108.693 -177.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 51.5 m -95.57 93.92 7.45 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.467 -0.938 . . . . 75.12 108.467 176.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.38 143.62 27.94 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.373 0.669 . . . . 72.11 110.163 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.404 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 13.7 m -149.3 124.39 10.07 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 123.027 0.531 . . . . 72.03 110.914 -174.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 17.9 mt -94.86 104.76 16.65 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.076 -0.712 . . . . 72.01 109.076 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.24 -120.87 5.26 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.832 -0.622 . . . . 70.44 111.948 -176.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.09 2.28 29.25 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.389 0.676 . . . . 71.35 111.296 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.535 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 13.1 pt-20 -124.11 163.45 21.47 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.315 0.646 . . . . 74.33 109.863 -175.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 16.0 m -68.6 137.42 54.25 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 123.772 0.67 . . . . 73.43 111.503 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.425 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -92.43 -65.41 1.0 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.408 -1.33 . . . . 70.22 107.408 170.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -155.98 143.71 19.56 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 115.787 -0.642 . . . . 74.5 110.619 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 59.6 mt -106.74 109.97 22.02 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.264 -1.013 . . . . 73.01 108.264 173.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.447 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 40.7 t -115.4 143.83 44.7 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.304 -0.998 . . . . 73.35 108.304 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -156.77 127.72 6.8 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.931 0.492 . . . . 75.12 109.895 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -132.41 119.18 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 122.972 0.509 . . . . 65.51 109.879 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.569 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.5 mt-30 -88.79 88.74 7.71 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.848 -0.797 . . . . 71.03 108.848 168.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -80.24 106.44 12.25 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.308 -1.315 . . . . 75.2 108.501 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.32 147.89 16.62 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.408 -0.677 . . . . 64.42 111.408 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.28 136.99 6.57 Favored Glycine 0 C--N 1.331 0.284 0 N-CA-C 111.539 -0.625 . . . . 63.22 111.539 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.519 HG22 HD13 ' D' ' 51' ' ' LEU . 54.1 mt -91.04 126.47 43.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 C-N-CA 123.728 0.811 . . . . 74.1 108.884 174.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . 0.476 ' HE1' HG22 ' D' ' 58' ' ' VAL . 64.9 m-85 -131.79 131.77 43.2 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.765 0.426 . . . . 74.11 110.321 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 15.3 m -84.5 103.96 14.09 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.519 0.727 . . . . 74.21 109.242 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.563 HD13 HD23 ' D' ' 98' ' ' LEU . 37.7 pt -114.13 127.08 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.869 0.867 . . . . 72.35 110.024 -177.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.74 148.92 29.13 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.598 0.359 . . . . 73.14 110.641 -174.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.17 15.99 76.82 Favored Glycine 0 C--N 1.345 1.077 0 O-C-N 123.391 0.432 . . . . 70.34 113.271 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.423 HD13 ' HB ' ' D' ' 86' ' ' ILE . 41.3 mt -97.19 148.65 5.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 109.268 -0.641 . . . . 72.21 109.268 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.631 ' HA ' ' HE2' ' D' ' 94' ' ' MET . 2.3 pt-20 -162.02 178.48 8.8 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.394 1.078 . . . . 71.11 109.963 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.29 -144.43 44.41 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 115.286 -0.87 . . . . 74.53 113.747 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 2.8 p -82.62 -10.64 58.86 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.599 0.76 . . . . 73.21 111.751 176.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -27.63 68.5 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 109.458 -0.571 . . . . 74.41 109.458 174.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.631 ' HE2' ' HA ' ' D' ' 90' ' ' GLU . 40.9 mtt -54.03 -43.42 70.14 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.195 0.598 . . . . 74.53 110.913 171.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.05 -46.18 62.48 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.696 -1.138 . . . . 71.21 110.939 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -64.32 -37.26 86.88 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.996 0.519 . . . . 65.11 111.702 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . 0.405 ' O ' ' SG ' ' D' ' 102' ' ' CYS . 47.9 t -62.03 -48.51 79.97 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.794 0.684 . . . . 60.02 110.553 -174.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.563 HD23 HD13 ' D' ' 86' ' ' ILE . 66.1 mt -98.1 -24.8 15.17 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.359 -0.837 . . . . 63.1 112.163 -169.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.04 -3.75 56.78 Favored Glycine 0 N--CA 1.47 0.925 0 CA-C-O 119.83 -0.428 . . . . 73.52 113.705 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.77 -55.35 0.33 Allowed 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.317 0.558 . . . . 71.02 111.74 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -72.81 -42.77 63.52 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 112.492 0.552 . . . . 74.41 112.492 -168.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.627 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 60.2 m -70.49 -45.66 18.77 Favored Pre-proline 0 CA--C 1.562 1.439 0 CA-C-O 119.07 -0.49 . . . . 71.02 110.881 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.503 ' HG3' HD22 ' D' ' 60' ' ' LEU . 72.7 Cg_exo -53.51 -33.78 69.41 Favored 'Trans proline' 0 C--N 1.394 2.922 0 C-N-CA 122.587 2.191 . . . . 73.5 113.922 168.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -64.98 -40.2 94.61 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.577 0.751 . . . . 74.42 110.078 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.446 HG21 HD12 ' D' ' 13' ' ' ILE . 49.3 mm -60.02 -42.83 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 115.913 -0.585 . . . . 65.11 109.726 173.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.436 HD12 HD23 ' D' ' 60' ' ' LEU . 83.9 mt -80.19 -15.31 57.32 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.004 -0.998 . . . . 61.22 112.558 -172.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -62.7 -48.82 85.05 Favored Pre-proline 0 CA--C 1.563 1.457 0 N-CA-C 113.207 0.817 . . . . 73.2 113.207 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -56.35 -35.56 96.18 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 122.097 1.865 . . . . 72.32 112.955 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -78.61 -29.66 46.12 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.017 0.927 . . . . 74.41 111.978 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.34 -48.03 68.71 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.735 -0.839 . . . . 71.14 108.735 174.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -65.08 -33.54 76.28 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.376 -1.283 . . . . 74.11 110.489 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -54.48 -58.52 7.13 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.067 0.947 . . . . 75.31 110.632 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.15 -45.13 89.84 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.693 -1.14 . . . . 73.04 111.271 -174.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.443 ' O ' HG23 ' D' ' 118' ' ' VAL . 79.8 mt -59.79 -62.06 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.576 0.75 . . . . 72.35 110.87 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.422 HG22 ' HG3' ' D' ' 125' ' ' GLN . 57.9 m -52.82 -38.38 61.22 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.347 1.059 . . . . 74.23 111.97 -175.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.0 t -66.73 -46.6 74.93 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.244 -0.889 . . . . 64.13 110.767 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.447 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 71.5 mtm -67.61 -30.02 69.5 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.782 0.433 . . . . 64.23 111.613 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.443 HG23 ' O ' ' D' ' 114' ' ' ILE . 91.2 t -63.62 -49.99 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 O-C-N 123.786 0.679 . . . . 71.23 109.819 174.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.8 p -69.06 -31.52 70.34 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 116.139 -0.482 . . . . 64.21 110.97 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 77.6 mtt-85 -69.79 -35.51 74.92 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.87 0.868 . . . . 73.54 110.384 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.59 2.62 85.26 Favored Glycine 0 C--N 1.351 1.376 0 O-C-N 123.733 0.646 . . . . 75.41 112.347 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.401 HG23 HE21 ' A' ' 125' ' ' GLN . 22.8 p 57.17 35.76 26.64 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.629 1.971 . . . . 72.42 113.384 176.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -94.7 159.41 33.53 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.267 1.027 . . . . 75.52 110.035 172.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.84 123.2 12.49 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.009 2.473 . . . . 65.32 112.774 170.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.422 ' HG3' HG22 ' D' ' 115' ' ' THR . 34.2 tt0 -53.47 142.73 21.31 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.148 1.379 . . . . 64.34 112.583 -176.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 66.4 tp -125.81 106.27 9.56 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.768 0.827 . . . . 75.42 109.735 -174.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -116.53 95.92 5.27 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.651 0.78 . . . . 73.11 109.517 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 6.2 mp -66.71 116.93 8.17 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.981 -0.748 . . . . 74.31 108.981 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.09 143.86 77.43 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 123.746 0.818 . . . . 71.43 110.626 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.26 107.82 2.53 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.625 2.216 . . . . 62.43 110.524 -174.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.474 0.763 0 C-N-CA 123.254 0.622 . . . . 74.45 110.185 -174.388 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.722 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 4.8 t80 . . . . . 0 C--O 1.238 0.465 0 N-CA-C 108.283 -1.006 . . . . 74.11 108.283 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -152.1 108.44 3.43 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 123.744 0.653 . . . . 72.24 109.501 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.683 HD12 ' HB2' ' C' ' 130' ' ' PRO . 34.5 mt -76.96 125.73 37.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 109.664 -0.495 . . . . 71.51 109.664 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -86.29 -40.32 15.62 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 124.284 0.99 . . . . 73.12 110.113 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -175.38 121.75 0.2 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.489 0.316 . . . . 73.32 110.579 -174.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.6 mt -108.85 135.05 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.79 -0.818 . . . . 72.43 108.79 172.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -164.74 159.4 18.65 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 123.827 0.705 . . . . 74.34 111.784 -172.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.5 p -81.53 115.87 21.04 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.241 -0.89 . . . . 63.31 109.447 173.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -82.19 -25.92 33.83 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.43 -0.581 . . . . 75.45 109.43 174.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.547 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.4 t70 -148.38 142.29 25.8 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.167 -0.924 . . . . 74.54 109.676 176.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 69.1 mt -137.55 142.69 35.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 126.042 1.737 . . . . 72.21 106.617 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.0 t -155.0 135.73 13.58 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.186 0.594 . . . . 64.52 109.465 172.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -135.72 144.68 46.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.252 -1.388 . . . . 73.42 107.252 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -137.18 151.87 49.26 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.803 -0.814 . . . . 74.22 108.803 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.99 79.04 12.17 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 106.937 -1.505 . . . . 74.44 106.937 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.77 -33.93 42.1 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.844 2.363 . . . . 74.31 113.098 -167.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -107.62 24.68 12.52 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.752 0.821 . . . . 74.1 110.281 -176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.549 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -40.88 -62.94 0.86 Allowed Pre-proline 0 CA--C 1.574 1.902 0 CA-C-O 117.547 -1.216 . . . . 65.31 114.245 -167.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.549 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 39.1 Cg_exo -59.09 -29.78 91.48 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 122.4 2.067 . . . . 72.1 114.059 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -78.84 -41.54 29.79 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.692 0.797 . . . . 74.23 110.396 -177.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.594 HG22 ' HA ' ' A' ' 73' ' ' ALA . 4.2 p -77.36 -20.26 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.714 -1.13 . . . . 64.23 111.784 -161.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -70.97 -22.87 62.14 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.557 0.743 . . . . 71.0 110.923 175.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -83.84 -36.41 23.48 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.503 1.121 . . . . 75.04 109.676 175.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.44 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 2.9 tmtp? -67.3 146.98 53.57 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.456 1.502 . . . . 73.41 110.532 -173.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.44 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 7.9 m-20 -58.3 124.99 21.35 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.445 1.098 . . . . 72.01 111.266 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 50.9 t-105 -79.26 82.29 5.43 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.412 0.625 . . . . 74.01 109.733 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -123.24 80.6 52.39 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 108.093 -1.077 . . . . 75.22 108.093 176.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -83.55 124.4 3.58 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.489 2.126 . . . . 60.03 113.718 -168.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -95.9 92.09 6.34 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 106.76 -1.571 . . . . 75.3 106.76 167.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 65' ' ' THR . 16.0 m -79.81 112.41 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 113.911 -1.495 . . . . 64.41 110.965 -172.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.546 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 26.3 ttpp -95.56 112.61 24.3 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.71 -1.219 . . . . 74.45 107.71 171.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mp -98.47 107.4 19.85 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.092 -1.077 . . . . 74.13 108.092 -177.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.755 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 3.3 m-20 -104.02 135.34 45.72 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.691 -0.855 . . . . 63.44 108.691 -174.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 pp -137.3 145.35 43.34 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.35 0.66 . . . . 73.4 110.001 177.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.622 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 33.0 t70 -141.66 155.02 45.72 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 123.287 0.635 . . . . 73.1 109.937 -175.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.7 p -105.54 122.78 46.72 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.401 1.081 . . . . 73.2 110.413 -174.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.449 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -138.87 119.93 14.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.806 0.842 . . . . 72.13 109.032 175.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.9 t -131.91 153.28 50.42 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 122.967 0.507 . . . . 73.03 109.789 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.7 t -160.49 143.68 13.45 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.509 0.724 . . . . 60.23 110.318 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -97.18 117.74 32.06 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.618 -0.882 . . . . 74.35 108.618 173.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.482 HD12 HG22 ' A' ' 83' ' ' ILE . 58.4 mt -85.61 -40.7 15.95 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.066 0.546 . . . . 75.12 109.857 177.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.59 176.44 12.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.285 -0.87 . . . . 72.44 110.379 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -69.05 122.8 19.46 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.505 -0.924 . . . . 60.34 108.505 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 74.92 -2.86 2.74 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.616 1.566 . . . . 72.14 112.115 -174.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.8 t -111.63 105.38 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.092 0.957 . . . . 72.41 108.698 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -124.95 127.61 47.32 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.967 0.907 . . . . 74.04 109.407 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -102.29 120.9 41.24 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.911 0.884 . . . . 75.32 109.958 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.447 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 43.2 t -102.3 129.17 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.038 -1.468 . . . . 72.3 107.038 171.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 54.0 t -122.5 120.05 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 108.55 -0.907 . . . . 73.34 108.55 174.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.444 HD23 HG21 ' A' ' 62' ' ' VAL . 1.0 OUTLIER -104.98 112.94 26.25 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.845 -1.168 . . . . 75.34 107.845 177.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.622 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 68.3 ttt180 -83.07 97.47 8.79 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.061 -1.459 . . . . 73.3 107.061 175.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.444 HG21 HD23 ' A' ' 60' ' ' LEU . 42.7 t -97.81 135.1 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 107.695 -1.224 . . . . 75.42 107.695 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.755 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 30.9 m -137.64 141.5 41.2 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.515 -0.55 . . . . 74.01 109.515 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.7 t -129.31 108.37 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 125.172 1.389 . . . . 75.3 107.337 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 29.3 m -102.25 138.06 39.69 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.999 -1.111 . . . . 75.23 107.999 175.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.5 106.05 10.28 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.661 -1.237 . . . . 71.21 107.661 173.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 59.0 m -111.13 123.31 49.94 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.836 -0.431 . . . . 71.3 109.836 177.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.488 HD13 ' HB1' ' A' ' 73' ' ' ALA . 12.8 mt -90.54 73.71 6.83 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 107.295 -1.372 . . . . 74.42 107.295 176.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.15 -122.83 6.19 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 110.851 -0.9 . . . . 73.05 110.851 -171.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -86.87 -24.98 24.71 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.661 0.785 . . . . 73.45 109.005 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -77.92 132.7 38.02 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.369 1.068 . . . . 73.11 109.772 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 70.1 m -89.25 133.23 34.54 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.238 0.472 . . . . 72.31 110.753 173.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.594 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -75.67 -62.61 1.52 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.803 0.841 . . . . 70.3 109.836 170.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.43 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 37.6 p90 -153.34 173.7 15.28 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.188 -0.914 . . . . 74.23 111.472 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.9 tp -133.59 139.95 46.84 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.731 -1.122 . . . . 65.01 108.479 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 71.4 m -134.69 97.48 3.79 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.917 0.887 . . . . 74.21 110.294 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -113.71 118.8 35.33 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.178 0.591 . . . . 63.5 109.738 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.2 t -128.15 113.64 31.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 124.142 0.977 . . . . 71.44 109.282 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 71.6 mt-30 -84.66 90.05 7.61 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.276 -1.009 . . . . 74.14 108.276 171.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -79.41 102.97 9.01 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.198 -0.91 . . . . 73.21 109.231 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.12 158.47 31.67 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 111.329 -0.708 . . . . 63.01 111.329 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.35 121.14 1.02 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.93 -0.868 . . . . 63.24 110.93 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.482 HG22 HD12 ' A' ' 51' ' ' LEU . 43.9 mt -81.65 120.87 34.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 108.117 -1.068 . . . . 71.14 108.117 171.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.722 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 46.1 m-85 -128.77 119.12 23.97 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.922 -0.77 . . . . 75.21 108.922 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.7 t -84.77 96.22 9.2 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.628 -0.879 . . . . 62.53 108.628 174.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.6 pt . . . . . 0 C--O 1.242 0.669 0 C-N-CA 124.518 1.127 . . . . 71.33 109.425 -177.425 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 120.567 0.223 . . . . 74.54 110.646 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -82.95 -35.04 26.33 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.274 0.63 . . . . 75.42 110.685 172.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 81.7 m -63.51 -47.66 80.79 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.129 0.572 . . . . 72.24 111.322 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.84 -25.06 32.99 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.551 0.741 . . . . 73.33 109.59 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.45 -21.26 45.14 Favored Glycine 0 C--N 1.353 1.502 0 N-CA-C 115.263 0.865 . . . . 73.12 115.263 -170.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.83 -53.85 0.23 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 117.89 0.845 . . . . 73.05 111.837 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -57.7 -60.21 4.03 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 114.352 -1.294 . . . . 72.05 112.509 -171.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.6 m -74.5 -36.28 2.48 Favored Pre-proline 0 CA--C 1.568 1.661 0 N-CA-C 113.144 0.794 . . . . 74.34 113.144 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -50.83 -38.23 56.88 Favored 'Trans proline' 0 C--N 1.397 3.095 0 C-N-CA 122.767 2.311 . . . . 73.51 113.966 164.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -66.03 -38.87 89.51 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.711 0.804 . . . . 75.22 109.983 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.6 mm -58.84 -34.77 53.29 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 C-N-CA 123.784 0.833 . . . . 72.22 111.145 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 88.5 mt -76.27 -28.99 57.27 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.999 0.92 . . . . 73.25 112.665 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.561 ' HZ ' HD23 ' A' ' 128' ' ' LEU . 36.1 t80 -62.35 -44.28 87.61 Favored Pre-proline 0 CA--C 1.569 1.701 0 CA-C-O 117.806 -1.092 . . . . 61.43 113.811 -171.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.56 -31.79 87.47 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.339 2.026 . . . . 61.13 113.52 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.423 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 74.0 m-85 -78.19 -35.34 48.76 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.421 0.688 . . . . 74.23 112.028 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.45 -36.58 71.28 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.641 -0.503 . . . . 71.1 109.641 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.541 HH12 HD13 ' C' ' 105' ' ' ILE . 31.9 ttm180 -60.68 -43.77 97.3 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.557 1.143 . . . . 75.22 110.366 172.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -53.99 -54.31 40.86 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.555 1.142 . . . . 75.3 111.207 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 117' ' ' MET . 48.5 t -66.81 -45.85 77.04 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.586 -1.188 . . . . 73.44 111.297 -174.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.464 ' HA ' ' HE1' ' A' ' 117' ' ' MET . 61.6 mt -60.15 -51.89 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.749 0.82 . . . . 74.22 111.123 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.547 HG21 ' HE2' ' C' ' 109' ' ' TYR . 67.6 m -54.6 -44.19 72.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.884 0.874 . . . . 73.2 111.555 177.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 44.8 t -63.57 -41.5 98.38 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.651 -0.704 . . . . 73.4 111.166 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.468 ' HG3' ' O ' ' A' ' 113' ' ' CYS . 27.0 mtm -69.86 -37.81 76.22 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.94 0.496 . . . . 60.33 111.65 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.92 -50.62 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.38 0.672 . . . . 73.42 109.839 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.1 t -66.22 -31.35 72.13 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 114.801 -1.09 . . . . 74.45 111.192 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.458 ' HG2' ' HG1' ' B' ' 18' ' ' THR . 33.9 ttm-85 -77.5 -31.73 53.74 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.181 0.992 . . . . 64.1 109.404 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.41 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.8 12.15 57.78 Favored Glycine 0 C--N 1.355 1.595 0 CA-C-N 114.804 -1.089 . . . . 71.21 112.508 172.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.2 t 68.47 13.33 8.96 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 126.964 2.106 . . . . 75.43 113.852 169.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -81.76 155.44 70.72 Favored Pre-proline 0 CA--C 1.555 1.147 0 N-CA-C 108.705 -0.85 . . . . 74.11 108.705 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.04 163.76 13.54 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 122.892 2.395 . . . . 74.31 112.928 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -57.3 124.26 18.26 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 123.802 0.689 . . . . 74.25 111.315 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.43 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 66.0 tp -130.06 106.38 8.59 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.695 1.198 . . . . 71.25 109.098 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -119.15 117.34 28.41 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.163 0.985 . . . . 64.15 108.861 176.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.561 HD23 ' HZ ' ' A' ' 107' ' ' PHE . 2.4 tt -70.99 116.61 11.48 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 108.031 -1.1 . . . . 72.11 108.031 178.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.54 145.45 97.29 Favored Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 123.893 0.877 . . . . 73.25 111.021 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.459 ' HD3' HG13 ' C' ' 13' ' ' ILE . 84.6 Cg_endo -75.96 158.69 38.33 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.203 1.935 . . . . 75.44 112.694 -174.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.8 m -128.2 116.16 41.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 114.461 -1.245 . . . . 65.05 108.427 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -72.94 82.69 1.22 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.359 0.664 . . . . 74.11 109.749 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 121.404 0.621 . . . . 73.21 109.528 177.234 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' B' ' 10' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 120.866 0.365 . . . . 73.12 110.813 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.617 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 94.0 m -145.49 114.81 7.11 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.28 -0.888 . . . . 64.25 108.99 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.563 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 51.5 t80 -131.39 132.69 44.59 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 122.957 0.503 . . . . 74.11 110.258 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.414 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -160.21 141.31 12.25 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.159 0.584 . . . . 75.51 110.285 174.28 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.412 HD13 ' HD3' ' D' ' 130' ' ' PRO . 23.2 mt -82.82 123.76 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.792 -0.818 . . . . 74.43 108.792 172.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -89.71 -49.91 6.37 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.438 -0.578 . . . . 71.12 109.438 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -166.23 135.8 3.21 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.816 -0.629 . . . . 75.41 110.021 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.7 mt -115.22 141.47 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 107.547 -1.279 . . . . 73.14 107.547 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -166.36 147.94 6.59 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.935 0.874 . . . . 72.11 112.369 -173.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.458 ' HG1' ' HG2' ' A' ' 120' ' ' ARG . 97.8 m -79.58 122.0 25.96 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.142 -1.39 . . . . 61.32 108.387 172.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -97.33 -19.09 18.75 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.482 0.713 . . . . 73.23 111.138 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -167.71 142.83 3.81 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.831 0.707 . . . . 71.33 110.377 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 38.7 mm -131.63 142.87 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.79 1.236 . . . . 75.32 108.736 172.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 44.3 t -143.78 110.27 5.5 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.414 1.086 . . . . 71.23 108.159 174.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.537 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 92.0 t80 -128.77 109.98 11.77 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.986 -1.116 . . . . 74.33 107.986 172.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -118.75 127.25 53.37 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.893 -0.781 . . . . 73.45 108.893 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.53 86.4 8.32 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 107.769 -1.197 . . . . 64.5 107.769 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -65.94 -43.08 9.94 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.87 2.38 . . . . 71.52 112.648 -168.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -104.26 16.78 25.46 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.098 0.959 . . . . 75.32 110.579 -175.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -38.73 -64.8 0.44 Allowed Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 115.007 1.484 . . . . 75.13 115.007 -162.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.29 -26.05 49.18 Favored 'Trans proline' 0 C--N 1.389 2.682 0 C-N-CA 121.992 1.794 . . . . 63.33 113.451 -170.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -97.5 -23.24 16.13 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.351 0.661 . . . . 60.53 112.736 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.621 HG21 HD13 ' B' ' 68' ' ' LEU . 9.3 p -80.58 -18.87 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 117.869 0.304 . . . . 75.24 111.08 -176.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -61.51 -27.58 68.7 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.792 0.837 . . . . 74.54 113.249 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -57.3 -23.25 47.31 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.452 0.701 . . . . 73.13 112.159 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.441 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 90.7 mttt -89.52 89.0 7.65 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.41 1.084 . . . . 71.4 109.974 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.49 87.65 6.21 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.447 -0.797 . . . . 61.42 110.949 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -163.19 173.23 13.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.343 1.057 . . . . 74.44 108.722 167.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -71.83 117.08 54.62 Favored Pre-proline 0 N--CA 1.474 0.739 0 N-CA-C 109.192 -0.67 . . . . 74.11 109.192 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.407 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 31.3 Cg_endo -63.19 153.82 71.65 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.279 1.986 . . . . 72.11 112.626 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.05 120.42 10.82 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 107.756 -1.201 . . . . 73.5 107.756 170.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 m -116.51 123.03 71.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.435 -0.802 . . . . 75.55 110.219 -167.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.587 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 77.2 tttt -106.98 121.31 44.2 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.66 1.184 . . . . 71.02 107.835 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.756 HD22 HD13 ' B' ' 128' ' ' LEU . 46.5 tp -96.89 137.39 36.04 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.655 -0.869 . . . . 74.03 108.655 169.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -144.01 152.54 41.17 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.22 1.008 . . . . 73.12 109.034 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 27.7 tp -128.7 157.29 41.79 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.688 0.795 . . . . 75.43 109.102 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -145.28 140.4 27.77 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.654 -0.869 . . . . 71.33 108.654 170.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 54.7 p -108.84 113.87 27.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.914 0.886 . . . . 61.23 109.401 -172.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.61 132.05 36.62 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.242 1.017 . . . . 62.41 108.692 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 59.6 p -147.55 178.87 8.1 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.009 0.433 . . . . 75.34 111.464 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.7 p -160.35 137.94 9.6 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.675 1.19 . . . . 75.13 108.91 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -88.63 128.16 35.58 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.209 -0.663 . . . . 75.52 109.209 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.515 HD12 HG22 ' B' ' 83' ' ' ILE . 78.2 mt -91.38 -40.09 11.64 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.106 0.563 . . . . 54.33 110.552 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.55 -172.49 2.93 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.332 0.586 . . . . 64.35 110.801 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.75 128.66 37.31 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.358 -1.292 . . . . 74.55 108.289 172.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . 0.552 ' HB3' ' HB1' ' B' ' 87' ' ' ALA . 9.9 m-20 64.81 3.28 1.98 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.367 1.067 . . . . 75.2 113.31 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 91.6 t -120.45 120.19 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.879 0.872 . . . . 72.25 109.226 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.608 ' HB2' HD11 ' B' ' 86' ' ' ILE . 0.4 OUTLIER -129.21 154.54 46.67 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.931 -0.766 . . . . 73.05 108.931 178.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -125.44 108.1 11.31 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.418 -1.697 . . . . 74.35 106.418 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 31.2 m -109.42 139.43 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 122.964 0.506 . . . . 74.41 110.386 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.497 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 31.7 t -120.86 111.8 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.475 1.11 . . . . 73.24 109.128 -176.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.583 HD11 ' HB3' ' B' ' 103' ' ' PRO . 14.5 tp -94.38 100.07 12.16 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.702 -0.851 . . . . 73.23 108.702 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.489 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 70.2 ttt180 -88.62 106.8 18.55 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.161 0.584 . . . . 74.42 109.867 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.81 106.07 19.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.087 -1.079 . . . . 73.33 108.087 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 27.9 m -109.33 138.41 45.73 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.641 0.776 . . . . 72.34 109.895 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.428 HG23 HD12 ' B' ' 114' ' ' ILE . 88.4 t -134.33 134.18 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.33 1.052 . . . . 75.43 109.502 -175.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.587 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 62.8 m -109.78 149.2 30.15 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.869 0.868 . . . . 72.21 109.56 170.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.18 137.22 38.92 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.777 0.831 . . . . 62.21 109.176 177.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 11.0 m -137.4 124.31 21.36 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.292 0.637 . . . . 74.23 110.898 -175.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.621 HD13 HG21 ' B' ' 31' ' ' VAL . 47.0 mt -104.34 113.85 27.69 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.992 -0.744 . . . . 72.55 108.992 176.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.09 -110.57 3.31 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 114.987 -1.006 . . . . 52.24 111.859 -172.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -117.33 5.33 12.59 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.945 0.898 . . . . 73.14 109.943 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.441 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 24.2 pt-20 -125.52 164.65 20.05 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.884 0.474 . . . . 63.51 110.59 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 62.1 m -79.92 122.91 27.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.652 0.781 . . . . 74.01 110.641 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.528 ' HA ' HG22 ' B' ' 31' ' ' VAL . . . -70.83 -63.63 1.06 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.311 0.645 . . . . 71.3 109.358 172.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -150.7 167.73 26.48 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 115.066 -0.97 . . . . 72.23 111.977 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 65.4 mt -129.98 113.57 14.74 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.141 -1.8 . . . . 72.41 106.141 175.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 30.2 t -123.01 130.45 52.82 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 109.518 -0.549 . . . . 74.22 109.518 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -149.55 131.88 15.58 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.757 -0.831 . . . . 74.31 108.757 -170.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 66.1 t -129.81 144.29 38.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 123.946 0.899 . . . . 74.24 109.005 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.489 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 20.6 mt-30 -118.61 93.61 4.17 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.165 -1.05 . . . . 73.01 108.165 172.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -91.82 100.75 13.38 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.891 -0.595 . . . . 74.12 109.495 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.2 164.06 30.68 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 115.813 -0.63 . . . . 74.21 111.75 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.8 129.48 1.98 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 112.083 -0.407 . . . . 44.4 112.083 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.515 HG22 HD12 ' B' ' 51' ' ' LEU . 38.4 mt -85.42 126.85 40.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 108.214 -1.032 . . . . 74.41 108.214 171.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -133.5 144.22 49.27 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.479 0.712 . . . . 73.14 109.723 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 31.5 m -90.41 113.98 26.01 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.179 0.992 . . . . 73.1 108.837 170.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' B' ' 56' ' ' TYR . 0.2 OUTLIER -128.09 125.1 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.055 0.942 . . . . 71.14 109.024 178.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.617 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.32 172.96 17.58 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.153 0.427 . . . . 72.11 112.153 -175.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.49 -54.68 3.84 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.525 -0.761 . . . . 75.4 112.056 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 32.5 mm -91.25 157.2 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 124.22 1.008 . . . . 72.25 110.601 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.577 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 30.8 tt0 -161.5 153.66 19.75 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.755 0.822 . . . . 73.35 109.619 173.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 102.6 -136.0 12.58 Favored Glycine 0 C--N 1.352 1.453 0 C-N-CA 123.711 0.672 . . . . 73.35 112.917 -175.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 63.5 m -71.95 -43.24 65.55 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 117.421 0.611 . . . . 75.24 111.552 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -58.51 -32.25 68.64 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.508 0.723 . . . . 74.05 110.555 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.577 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 7.2 tpt -72.1 -44.78 62.69 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.246 -0.888 . . . . 75.15 110.426 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.33 -23.18 67.3 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.011 -0.995 . . . . 71.22 111.424 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . 0.502 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 58.1 t-80 -82.82 -20.75 35.08 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.337 1.055 . . . . 64.44 110.874 174.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.566 ' HB3' ' HE2' ' B' ' 94' ' ' MET . 43.7 t -86.11 -67.25 0.82 Allowed 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.993 -0.442 . . . . 63.13 111.314 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.681 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 1.7 pt? -83.94 -14.73 50.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.551 -0.718 . . . . 72.11 111.809 -174.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.83 1.65 55.42 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.376 0.422 . . . . 65.41 113.855 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -143.43 -59.7 0.41 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.438 0.695 . . . . 73.4 109.833 -176.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -71.63 -48.58 46.96 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.215 0.606 . . . . 74.22 112.494 -173.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.681 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 59.2 m -64.35 -43.14 71.4 Favored Pre-proline 0 CA--C 1.56 1.345 0 N-CA-C 112.872 0.693 . . . . 74.13 112.872 -175.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.583 ' HB3' HD11 ' B' ' 60' ' ' LEU . 51.8 Cg_exo -60.12 -30.65 91.88 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 122.191 1.927 . . . . 73.14 113.384 172.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -65.79 -26.89 67.9 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 122.945 0.498 . . . . 63.21 111.641 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 74.2 mt -71.25 -43.71 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.515 0.726 . . . . 74.43 109.49 173.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 99.1 mt -74.13 -23.53 59.3 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.011 -0.995 . . . . 73.14 112.087 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -57.42 -51.9 78.29 Favored Pre-proline 0 CA--C 1.563 1.466 0 CA-C-O 117.696 -1.145 . . . . 73.51 113.42 -173.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.22 -32.04 94.9 Favored 'Trans proline' 0 C--N 1.392 2.854 0 C-N-CA 122.314 2.009 . . . . 75.51 113.7 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -72.57 -40.27 66.76 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.552 0.741 . . . . 63.14 110.229 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.79 -37.87 87.48 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.305 0.642 . . . . 72.21 110.491 173.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.403 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 56.8 ttt-85 -69.4 -50.33 46.89 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.415 1.486 . . . . 72.34 111.223 -171.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.55 -37.4 87.17 Favored 'General case' 0 N--CA 1.484 1.225 0 O-C-N 123.898 0.749 . . . . 74.0 109.286 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.47 ' O ' ' HG2' ' B' ' 117' ' ' MET . 28.8 t -64.07 -40.73 96.9 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.371 0.669 . . . . 64.14 112.003 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.491 ' O ' HG23 ' B' ' 118' ' ' VAL . 70.9 mt -61.05 -56.48 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.692 -0.485 . . . . 75.43 109.692 175.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.8 m -61.77 -26.86 68.35 Favored 'General case' 0 CA--C 1.557 1.216 0 O-C-N 123.752 0.658 . . . . 75.45 111.586 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.45 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.8 t -71.66 -43.25 66.4 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.726 0.81 . . . . 72.43 110.078 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.6 mmt -71.11 -31.92 68.37 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.538 0.335 . . . . 73.44 110.528 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.491 HG23 ' O ' ' B' ' 114' ' ' ILE . 99.1 t -62.7 -43.22 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 124.068 0.947 . . . . 72.24 109.914 170.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 64.0 m -65.89 -36.42 83.37 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.24 -0.891 . . . . 62.53 111.764 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' B' ' 116' ' ' SER . 68.8 mtt-85 -68.53 -38.16 80.62 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.521 -0.763 . . . . 72.54 109.554 176.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.72 -0.29 79.94 Favored Glycine 0 C--N 1.354 1.571 0 O-C-N 124.026 0.829 . . . . 70.14 113.264 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 73.0 p 61.17 16.52 7.28 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 126.343 1.857 . . . . 71.42 113.831 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -77.09 160.06 76.91 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 123.496 0.718 . . . . 64.14 111.493 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -47.14 146.21 6.73 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 123.748 2.965 . . . . 72.31 114.724 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -58.86 122.59 13.98 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.558 1.143 . . . . 74.24 111.095 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 52.8 tp -138.98 99.26 3.72 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.208 0.603 . . . . 73.42 109.851 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -99.12 131.51 45.1 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.739 0.816 . . . . 71.53 108.886 172.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.756 HD13 HD22 ' B' ' 42' ' ' LEU . 25.6 tp -81.99 152.43 26.7 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.23 0.612 . . . . 74.34 112.067 -174.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.54 146.22 83.31 Favored Pre-proline 0 N--CA 1.482 1.126 0 C-N-CA 123.835 0.854 . . . . 63.4 111.644 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -70.82 119.18 6.13 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.158 2.572 . . . . 62.32 111.15 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 26.7 m -107.5 110.88 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.892 0.853 . . . . 74.23 108.912 174.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -110.42 88.8 2.85 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.19 -1.041 . . . . 74.51 108.19 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -61.33 -34.21 74.88 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.636 -0.711 . . . . 73.21 110.73 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . 0.422 ' HA ' ' HB2' ' B' ' 100' ' ' ALA . 17.1 t70 . . . . . 0 N--CA 1.472 0.625 0 C-N-CA 124.563 1.145 . . . . 71.51 111.255 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.55 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 14.7 t80 . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 108.125 -1.065 . . . . 64.11 108.125 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -136.46 119.26 16.19 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.014 -0.736 . . . . 74.03 109.014 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.459 HG13 ' HD3' ' A' ' 130' ' ' PRO . 35.5 mt -73.13 128.02 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.936 -0.764 . . . . 73.0 108.936 175.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -92.65 -48.23 6.7 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.149 -0.685 . . . . 53.53 109.149 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -173.22 134.44 0.54 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.92 -0.77 . . . . 75.33 108.92 -169.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 94.5 mt -126.27 142.23 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 108.017 -1.105 . . . . 63.44 108.017 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.445 ' HB3' HG22 ' D' ' 122' ' ' THR . 26.6 p90 -173.68 167.3 4.51 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 123.942 0.776 . . . . 65.35 110.488 -174.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -86.57 119.07 26.43 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.84 -1.073 . . . . 74.43 109.062 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.564 ' HE3' ' HB2' ' D' ' 28' ' ' ALA . 10.8 mmmm -70.44 -45.8 65.12 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.999 -1.112 . . . . 63.11 107.999 169.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.603 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 5.1 t70 -139.53 147.83 41.77 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 113.776 -1.556 . . . . 75.55 110.258 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.4 mt -137.94 149.08 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.977 1.711 . . . . 60.25 107.24 174.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.4 t -162.04 150.3 14.91 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.427 0.632 . . . . 71.43 110.614 172.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.432 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 91.6 t80 -143.65 146.18 33.04 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 107.029 -1.471 . . . . 71.23 107.029 170.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -149.35 115.87 5.86 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.28 1.032 . . . . 72.34 109.011 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.05 92.01 12.21 Favored Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 105.649 -1.982 . . . . 71.14 105.649 165.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -57.25 -49.93 12.55 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.277 2.652 . . . . 65.23 112.513 -171.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -106.73 39.16 1.9 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.504 0.722 . . . . 71.1 109.488 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.451 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -37.86 -58.56 1.35 Allowed Pre-proline 0 CA--C 1.571 1.75 0 N-CA-C 115.183 1.549 . . . . 73.23 115.183 -171.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.451 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 20.3 Cg_exo -60.56 -43.29 33.93 Favored 'Trans proline' 0 C--N 1.387 2.6 0 CA-C-N 122.198 1.821 . . . . 70.12 112.418 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -69.13 -32.44 71.81 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.14 -0.937 . . . . 75.21 112.258 -175.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.658 HG21 ' HA ' ' C' ' 73' ' ' ALA . 12.4 p -79.38 -27.47 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 122.528 0.331 . . . . 64.31 111.769 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -66.69 -23.08 66.08 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 112.114 0.413 . . . . 75.52 112.114 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -95.55 15.58 19.43 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.392 0.677 . . . . 74.35 111.841 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.784 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -91.52 160.83 15.23 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.369 0.668 . . . . 73.34 110.451 177.239 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -69.01 130.26 42.28 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.833 0.853 . . . . 71.35 108.784 162.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -84.55 102.34 12.79 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.913 0.485 . . . . 75.31 110.607 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -155.37 77.4 4.85 Favored Pre-proline 0 N--CA 1.476 0.83 0 N-CA-C 108.674 -0.861 . . . . 75.22 108.674 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -88.31 148.65 6.52 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.71 2.273 . . . . 71.31 113.819 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -86.52 99.34 11.61 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 107.013 -1.477 . . . . 70.43 107.013 159.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 t -78.54 101.04 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 108.591 -0.892 . . . . 75.45 108.591 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.574 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 62.3 mttm -99.26 105.38 17.4 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.899 -0.778 . . . . 74.43 108.899 -176.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 42.5 tp -83.64 130.02 34.97 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 109.134 -0.691 . . . . 74.34 109.134 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -129.19 139.74 51.77 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.326 1.45 . . . . 73.44 108.284 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.33 147.59 50.25 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.844 0.458 . . . . 74.44 110.702 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 1.5 t70 -130.09 147.49 51.84 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.117 1.367 . . . . 71.35 108.693 173.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 87.9 m -111.51 114.17 27.08 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.709 0.804 . . . . 73.04 109.643 -174.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.5 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -118.36 139.9 50.66 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.29 1.036 . . . . 70.45 108.317 173.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.465 ' HB2' ' OH ' ' C' ' 56' ' ' TYR . 64.8 p -154.26 143.76 21.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.172 -0.33 . . . . 73.53 111.179 -172.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 27.8 p -159.0 128.01 5.4 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 123.923 0.764 . . . . 73.11 109.808 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -80.1 138.27 36.92 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.974 -0.75 . . . . 73.51 108.974 173.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.49 HD13 HD13 ' C' ' 83' ' ' ILE . 49.1 mt -105.48 -38.9 6.3 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.004 0.522 . . . . 75.04 110.712 -176.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.69 -170.55 2.79 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.379 0.672 . . . . 71.31 110.957 -177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -70.39 112.25 6.56 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.261 -0.881 . . . . 71.2 109.785 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 71.24 -1.42 2.74 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 125.396 1.479 . . . . 74.43 112.944 -175.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.438 HG11 ' HB2' ' C' ' 51' ' ' LEU . 66.2 t -102.31 120.02 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.096 -0.705 . . . . 75.01 109.096 175.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . 0.465 ' OH ' ' HB2' ' C' ' 48' ' ' SER . 51.0 t80 -138.62 132.07 30.39 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.104 -1.073 . . . . 70.35 108.104 -174.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -94.48 117.67 30.48 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.384 -0.825 . . . . 71.12 109.045 173.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 35.7 m -96.65 130.14 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.625 -1.25 . . . . 72.23 107.625 168.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 61.9 t -124.02 125.34 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.85 -1.167 . . . . 75.41 107.85 172.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 tp -125.9 116.41 21.47 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.013 -1.106 . . . . 73.24 108.013 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.501 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.7 ttm180 -79.12 122.25 26.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.772 -1.103 . . . . 75.14 109.036 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 11.4 t -100.81 129.06 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.019 -1.474 . . . . 74.41 107.019 171.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 62.8 m -131.95 110.53 10.83 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.089 -1.078 . . . . 75.11 108.089 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.473 HG22 HG21 ' C' ' 114' ' ' ILE . 85.1 t -101.75 112.33 34.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.578 -1.192 . . . . 62.22 108.231 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 20.7 m -97.92 141.15 31.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.014 -1.106 . . . . 73.31 108.014 173.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.33 107.5 6.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 106.233 -1.766 . . . . 72.42 106.233 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 46.2 m -127.16 146.34 50.43 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.611 -0.514 . . . . 73.55 109.611 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.766 HD11 ' HG2' ' C' ' 34' ' ' LYS . 13.1 mt -110.41 35.59 3.39 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.661 1.584 . . . . 75.42 108.2 -173.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.88 -109.68 2.99 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 110.096 -1.202 . . . . 72.52 110.096 -169.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.93 -30.01 18.13 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.869 0.868 . . . . 73.13 110.314 176.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -73.52 103.07 4.02 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.726 0.81 . . . . 74.33 109.77 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 92.6 m -73.26 118.87 16.73 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.544 -0.91 . . . . 75.23 108.544 170.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.658 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -67.68 -57.75 5.85 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 124.464 1.102 . . . . 72.23 109.11 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -156.89 171.65 20.05 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.663 -1.153 . . . . 63.34 111.656 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -139.44 140.02 37.21 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 104.839 -2.282 . . . . 74.44 104.839 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.462 ' SG ' HG22 ' C' ' 114' ' ' ILE . 38.3 t -147.54 112.43 5.42 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.964 -0.754 . . . . 72.21 108.964 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -121.8 116.46 24.5 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.708 0.803 . . . . 75.52 110.147 -171.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 55.5 t -125.06 115.45 44.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.955 0.902 . . . . 74.01 109.357 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.603 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.1 mt-30 -90.96 97.85 11.43 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.807 -0.812 . . . . 73.25 108.807 173.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.57 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 9.1 tp-100 -86.98 117.32 25.62 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.339 0.655 . . . . 73.21 109.766 -177.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.3 146.35 18.23 Favored Glycine 0 C--N 1.342 0.909 0 O-C-N 123.813 0.695 . . . . 71.42 111.831 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.4 116.35 0.99 Allowed Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.754 -0.538 . . . . 61.23 111.754 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.525 HD11 ' HB3' ' D' ' 29' ' ' PRO . 7.7 mm -82.97 122.16 37.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 107.945 -1.131 . . . . 75.32 107.945 174.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -138.26 132.16 31.3 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.426 0.691 . . . . 74.24 109.956 -176.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 21.8 p -95.22 103.97 15.85 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 108.17 -1.048 . . . . 72.14 108.17 169.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.454 HD13 ' H ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -124.15 137.04 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 124.144 0.977 . . . . 74.4 111.459 -171.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.67 173.38 11.96 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.352 1.061 . . . . 74.42 110.934 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 116.89 -49.03 0.88 Allowed Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.941 -0.572 . . . . 74.13 111.74 172.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 30.0 pt -92.31 170.17 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.488 0.715 . . . . 72.45 110.284 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -146.17 148.47 32.58 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.975 0.51 . . . . 73.24 111.226 -168.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.51 -133.32 23.46 Favored Glycine 0 C--N 1.35 1.33 0 O-C-N 123.745 0.653 . . . . 75.45 114.222 172.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.4 p -66.69 -18.55 65.43 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.111 0.964 . . . . 73.21 112.229 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -68.35 -43.22 77.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.196 0.598 . . . . 70.11 110.144 172.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 15.5 ttt -76.72 -31.57 57.25 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.601 -0.727 . . . . 74.53 110.55 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.19 -40.23 90.27 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.373 0.669 . . . . 63.21 110.558 172.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -59.56 -41.75 90.87 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.473 1.109 . . . . 75.22 111.006 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 50.4 t -63.79 -54.27 37.73 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.539 0.524 . . . . 64.33 110.223 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.03 -36.36 83.31 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.332 0.653 . . . . 74.33 112.036 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.6 11.28 66.7 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.497 -0.613 . . . . 73.01 114.304 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.65 -58.02 0.1 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 117.555 0.677 . . . . 62.43 111.999 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -74.51 -48.4 27.37 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.662 0.385 . . . . 63.42 112.002 -172.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.55 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 41.9 m -60.51 -47.2 96.88 Favored Pre-proline 0 CA--C 1.563 1.458 0 C-N-CA 123.97 0.908 . . . . 75.44 112.11 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.87 -12.07 19.87 Favored 'Trans proline' 0 C--N 1.395 3.024 0 C-N-CA 122.026 1.818 . . . . 71.33 113.608 172.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . 0.5 ' HA ' ' CD2' ' C' ' 107' ' ' PHE . 59.7 t30 -71.76 -32.66 67.93 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.434 0.635 . . . . 73.44 109.914 173.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.541 HD13 HH12 ' A' ' 111' ' ' ARG . 30.0 mm -65.54 -30.84 51.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 115.143 -0.935 . . . . 73.35 109.822 170.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 65.5 mt -88.14 -22.64 23.97 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.887 0.875 . . . . 71.14 113.208 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . 0.5 ' CD2' ' HA ' ' C' ' 104' ' ' ASN . 11.8 m-85 -55.38 -48.36 96.48 Favored Pre-proline 0 N--CA 1.49 1.536 0 CA-C-O 117.242 -1.361 . . . . 75.12 113.218 -177.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -54.46 -39.53 87.43 Favored 'Trans proline' 0 C--N 1.39 2.75 0 C-N-CA 122.881 2.387 . . . . 74.52 114.461 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . 0.547 ' HE2' HG21 ' A' ' 115' ' ' THR . 73.9 m-85 -70.04 -49.33 52.34 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.214 0.605 . . . . 72.34 110.901 -176.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.57 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -67.75 -31.97 72.25 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 115.615 -0.72 . . . . 74.43 111.081 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 26.6 ttt-85 -59.21 -54.19 49.76 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.675 1.19 . . . . 71.14 110.328 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -69.33 -29.05 66.79 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.767 0.667 . . . . 71.21 110.425 -177.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 42.7 t -70.22 -38.39 75.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.186 0.594 . . . . 75.02 110.813 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.473 HG21 HG22 ' C' ' 64' ' ' VAL . 87.3 mt -69.54 -49.09 62.24 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.157 0 C-N-CA 123.259 0.624 . . . . 71.3 109.742 174.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 90.5 m -63.25 -33.08 74.72 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.012 0.925 . . . . 75.25 110.977 -175.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 41.8 t -64.62 -46.67 81.6 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 115.349 -0.841 . . . . 74.31 109.092 172.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.537 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.98 -36.43 84.38 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.895 1.278 . . . . 74.34 112.929 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.44 HG23 ' O ' ' C' ' 114' ' ' ILE . 97.4 t -65.56 -44.54 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.093 0.957 . . . . 72.14 108.774 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 30.6 t -66.13 -33.62 76.19 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.162 -1.381 . . . . 74.13 111.496 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' C' ' 116' ' ' SER . 80.1 mtt-85 -70.94 -32.2 69.01 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.648 0.779 . . . . 73.22 109.453 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.3 9.06 76.73 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 123.717 0.636 . . . . 75.03 112.947 174.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.41 HG22 ' HB3' ' D' ' 17' ' ' TYR . 46.0 p 58.19 30.62 19.67 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 126.143 1.777 . . . . 74.15 114.016 174.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -93.02 147.27 33.54 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 108.81 -0.811 . . . . 74.33 108.81 172.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.34 159.76 5.63 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 123.386 2.724 . . . . 74.45 113.742 174.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -47.39 125.59 8.36 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.797 1.239 . . . . 70.34 112.934 -176.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.81 91.25 3.31 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.327 -1.36 . . . . 75.42 107.327 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -116.62 122.18 43.86 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.407 1.083 . . . . 63.12 108.168 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 6.7 mp -69.11 145.94 52.97 Favored 'General case' 0 C--O 1.245 0.832 0 O-C-N 123.406 0.441 . . . . 74.44 110.479 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' C' ' 130' ' ' PRO . . . -72.8 136.22 80.33 Favored Pre-proline 0 CA--C 1.552 1.041 0 O-C-N 124.107 0.879 . . . . 73.01 110.013 177.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.683 ' HB2' HD12 ' A' ' 13' ' ' ILE . 11.1 Cg_exo -69.22 100.7 0.77 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 123.173 2.582 . . . . 64.45 113.725 -170.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.0 t -101.04 108.62 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 108.051 -1.092 . . . . 65.51 108.051 170.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -81.41 92.61 6.46 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 107.091 -1.448 . . . . 75.4 107.091 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -65.43 -35.91 82.33 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.057 0.943 . . . . 71.42 112.642 -161.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.479 1.014 0 C-N-CA 123.516 0.727 . . . . 73.55 111.589 177.899 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 CA--C 1.54 0.571 0 CA-C-O 120.655 0.264 . . . . 75.13 110.579 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.581 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 57.6 t80 -154.14 99.85 2.27 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.703 1.201 . . . . 75.25 107.837 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -117.48 115.43 25.15 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.024 -0.732 . . . . 74.44 109.024 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.432 HG21 HD13 ' D' ' 16' ' ' ILE . 28.5 mt -75.23 121.64 27.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.23 -1.026 . . . . 74.02 108.23 176.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -96.45 -26.94 15.12 Favored 'General case' 0 C--O 1.245 0.819 0 O-C-N 123.417 0.448 . . . . 75.12 111.347 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -171.72 136.04 0.91 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 117.705 0.23 . . . . 74.31 111.364 -168.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.432 HD13 HG21 ' D' ' 13' ' ' ILE . 2.9 mp -120.5 133.4 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 107.107 -1.442 . . . . 71.31 107.107 174.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.41 ' HB3' HG22 ' C' ' 122' ' ' THR . 24.9 p90 -160.6 173.03 16.11 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 122.582 1.182 . . . . 75.42 112.53 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -111.38 120.42 42.14 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 113.613 -1.631 . . . . 70.12 108.136 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -87.93 -24.07 23.72 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.275 0.56 . . . . 74.24 109.552 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.607 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 10.3 t70 -154.57 143.3 20.82 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.124 -1.398 . . . . 70.23 109.138 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.537 HG21 ' HE1' ' C' ' 117' ' ' MET . 47.1 mt -139.96 150.28 21.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 106.539 -1.652 . . . . 75.25 106.539 173.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -157.56 144.84 18.42 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.571 0.701 . . . . 73.5 110.739 169.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.485 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.2 t80 -140.17 128.64 22.76 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 105.872 -1.899 . . . . 72.32 105.872 173.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.7 mt-10 -136.89 123.44 20.93 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.441 -0.948 . . . . 75.43 108.441 -176.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' D' ' 28' ' ' ALA . . . -128.06 86.62 57.64 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 107.605 -1.257 . . . . 75.1 107.605 177.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.67 -36.78 10.41 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 122.676 2.25 . . . . 75.43 112.431 -175.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -96.95 16.76 18.54 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.867 0.867 . . . . 74.54 110.43 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.564 ' HB2' ' HE3' ' C' ' 19' ' ' LYS . . . -43.66 -64.93 0.65 Allowed Pre-proline 0 CA--C 1.561 1.386 0 N-CA-C 115.336 1.606 . . . . 74.14 115.336 -162.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.525 ' HB3' HD11 ' C' ' 83' ' ' ILE . 90.6 Cg_endo -74.69 -12.77 22.24 Favored 'Trans proline' 0 C--N 1.386 2.542 0 CA-C-N 122.626 1.973 . . . . 63.11 113.348 -174.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -84.58 -40.83 17.07 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.119 1.368 . . . . 72.44 110.856 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.437 HG22 HD12 ' D' ' 68' ' ' LEU . 9.9 p -83.72 -17.21 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.123 0 CA-C-N 115.886 -0.597 . . . . 71.23 111.446 -170.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -62.42 -17.62 59.72 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 113.025 0.75 . . . . 74.11 113.025 173.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -65.02 -11.95 44.95 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.369 0.668 . . . . 73.32 110.951 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.682 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 87.2 mttt -109.79 92.13 3.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.303 1.441 . . . . 73.34 109.194 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -90.9 92.5 8.8 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.844 0.457 . . . . 72.34 109.873 177.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 30.7 p90 -162.31 176.87 10.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.69 0.796 . . . . 73.41 109.448 168.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -69.9 114.34 24.3 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 123.689 0.796 . . . . 63.13 110.342 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.519 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 16.4 Cg_exo -68.08 134.98 33.34 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 123.104 2.536 . . . . 73.33 111.096 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.68 122.25 16.83 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.262 0.625 . . . . 73.35 110.033 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 35.8 t -97.87 114.93 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.631 0.773 . . . . 72.3 110.894 -168.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -104.39 152.63 22.06 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.186 -1.413 . . . . 74.53 107.186 166.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 pp -140.34 156.07 46.57 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.025 0.53 . . . . 74.31 110.967 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -150.35 152.61 34.68 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.777 0.831 . . . . 72.35 108.89 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 87.9 mt -126.92 146.92 50.13 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.483 0.713 . . . . 74.34 110.838 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 7.2 t70 -136.84 140.82 42.7 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.738 1.215 . . . . 71.4 108.19 172.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 58.0 m -102.03 142.91 32.57 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.401 0.68 . . . . 60.23 109.655 -173.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.708 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -155.04 155.25 33.78 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.08 0.952 . . . . 62.02 109.032 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 77.3 p -174.62 178.44 1.92 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.007 0.432 . . . . 74.32 111.272 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 73.0 p -168.77 146.58 3.92 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.491 -1.231 . . . . 72.51 108.935 174.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -82.66 128.54 34.44 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.879 -0.786 . . . . 73.24 108.879 171.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.626 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.5 mt -101.28 -34.5 9.62 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.024 0.53 . . . . 74.25 110.18 -175.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.54 -175.89 3.72 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.318 1.047 . . . . 64.43 110.131 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.7 114.51 7.98 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.642 -1.163 . . . . 73.44 109.306 173.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 68.46 18.77 8.95 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.151 1.381 . . . . 73.0 112.461 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 94.7 t -124.16 124.69 69.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 C-N-CA 124.927 1.291 . . . . 75.44 107.609 168.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -144.66 137.72 26.82 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.625 -0.509 . . . . 74.51 109.625 -176.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.626 ' HB2' HD11 ' D' ' 51' ' ' LEU . 27.3 tt0 -91.9 133.53 35.59 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.645 -0.707 . . . . 64.12 109.972 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 78.4 t -111.86 118.28 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.678 -1.23 . . . . 72.15 107.678 172.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.708 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 14.7 t -114.61 131.77 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.21 -1.033 . . . . 62.04 108.21 173.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.405 HD12 ' O ' ' D' ' 45' ' ' ASP . 18.8 tp -130.69 123.5 29.48 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.229 -0.656 . . . . 65.11 109.229 174.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.549 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 14.1 ttm180 -83.53 104.77 13.93 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.702 -0.851 . . . . 72.41 108.702 176.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 70.4 t -89.12 129.39 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 107.979 -1.119 . . . . 73.45 107.979 173.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 20.7 m -121.75 142.6 50.03 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.289 -0.634 . . . . 75.23 109.289 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.505 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 69.5 t -139.44 100.45 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 126.04 1.736 . . . . 75.42 107.307 -174.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 62.5 m -99.69 112.33 24.57 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.757 -0.831 . . . . 73.53 108.757 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.519 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -115.42 141.05 48.57 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.586 0.754 . . . . 64.23 109.972 -173.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.456 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 14.4 p -147.7 128.79 14.59 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 123.526 0.516 . . . . 73.01 111.906 -174.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.437 HD12 HG22 ' D' ' 31' ' ' VAL . 41.2 mt -96.93 114.81 26.46 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 124.758 1.223 . . . . 63.52 108.661 175.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.86 -121.09 8.38 Favored Glycine 0 C--N 1.341 0.858 0 O-C-N 123.737 0.648 . . . . 70.33 112.106 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.07 5.59 22.23 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.177 0.591 . . . . 75.43 111.444 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.682 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 10.9 pt-20 -122.37 162.62 21.24 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.22 0.608 . . . . 65.53 109.727 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 58.8 m -69.65 132.67 46.54 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.457 0.703 . . . . 71.54 111.284 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.456 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -84.95 -68.93 0.69 Allowed 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.414 -1.328 . . . . 65.23 107.414 172.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . 0.424 ' HZ ' HD23 ' D' ' 126' ' ' LEU . 51.5 p90 -149.83 167.28 27.0 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.654 -1.157 . . . . 75.32 110.657 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 77.5 mt -134.49 112.42 10.9 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.794 1.238 . . . . 74.35 108.269 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.505 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 10.6 m -114.81 133.32 56.04 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.189 0.996 . . . . 73.51 108.782 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -152.62 118.42 5.4 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.196 -1.409 . . . . 75.41 107.196 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . 0.519 HG23 HG22 ' D' ' 21' ' ' ILE . 80.0 t -130.09 122.17 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.989 0.916 . . . . 74.32 108.777 -175.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.607 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.9 mt-30 -88.61 87.49 7.28 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.376 -0.972 . . . . 74.41 108.376 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -80.46 110.9 16.36 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.115 -1.402 . . . . 72.13 108.569 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.36 144.55 18.34 Favored Glycine 0 N--CA 1.469 0.887 0 N-CA-C 111.471 -0.651 . . . . 72.21 111.471 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.61 138.3 8.04 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 117.038 0.419 . . . . 71.53 112.199 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.6 mt -88.39 122.86 40.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 108.203 -1.036 . . . . 74.32 108.203 173.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -128.64 156.02 44.07 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.389 0.675 . . . . 74.45 109.253 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 48.8 m -115.36 102.12 9.55 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.424 -0.954 . . . . 72.42 108.424 175.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 3.6 mp -108.05 130.49 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 108.812 -0.81 . . . . 74.13 108.812 -176.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.81 166.9 28.09 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.868 0.867 . . . . 72.13 110.385 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.44 21.71 74.61 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.452 -0.795 . . . . 74.0 114.094 173.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.536 HG23 ' N ' ' D' ' 90' ' ' GLU . 17.5 mt -125.22 157.29 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.458 0.703 . . . . 74.22 110.47 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.536 ' N ' HG23 ' D' ' 89' ' ' ILE . 29.6 mt-10 -135.0 151.84 51.19 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.844 1.257 . . . . 73.51 110.213 172.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.58 -145.79 41.0 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 116.05 1.18 . . . . 72.31 116.05 168.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 4.3 p -74.51 -10.42 59.54 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.208 1.003 . . . . 74.12 111.711 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -30.86 71.56 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.808 0.843 . . . . 72.43 109.426 172.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 56.9 ttm -77.73 -39.04 45.73 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.883 0.473 . . . . 75.24 109.818 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.69 -31.49 68.27 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.238 0.542 . . . . 75.22 111.008 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -70.82 -48.9 51.57 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.471 1.108 . . . . 73.22 110.572 174.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 50.9 t -59.67 -46.29 89.48 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.047 0.539 . . . . 73.34 110.867 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.479 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 7.3 mp -83.89 -18.99 35.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.337 0.655 . . . . 72.04 111.96 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.38 -1.74 60.63 Favored Glycine 0 N--CA 1.476 1.314 0 CA-C-O 119.992 -0.338 . . . . 60.31 113.564 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' D' ' 104' ' ' ASN . . . -140.34 -65.22 0.46 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.887 0.475 . . . . 73.45 110.967 -176.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -73.93 -40.12 63.33 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.828 0.677 . . . . 73.05 112.828 -170.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.581 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 51.5 m -69.45 -45.91 27.05 Favored Pre-proline 0 CA--C 1.559 1.3 0 CA-C-O 118.881 -0.581 . . . . 75.23 112.213 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.52 -18.93 28.94 Favored 'Trans proline' 0 C--N 1.393 2.892 0 C-N-CA 121.66 1.573 . . . . 72.52 112.412 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . 0.462 ' HA ' ' HD2' ' D' ' 107' ' ' PHE . 35.4 t-20 -64.19 -31.12 72.2 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.463 0.705 . . . . 75.12 109.992 175.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.4 mm -68.24 -33.44 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.566 0.746 . . . . 73.51 110.277 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 79.5 mt -81.35 -25.66 36.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.666 0.786 . . . . 73.43 112.664 -173.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . 0.462 ' HD2' ' HA ' ' D' ' 104' ' ' ASN . 41.0 m-85 -64.06 -42.71 71.03 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 114.255 1.206 . . . . 71.13 114.255 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.27 -39.81 85.12 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 122.409 2.073 . . . . 64.54 113.329 172.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -80.59 -32.25 36.55 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.758 0.823 . . . . 73.11 112.045 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.3 -53.03 50.01 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.836 -0.801 . . . . 73.43 108.836 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.41 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 37.4 ttp180 -55.07 -46.9 75.45 Favored 'General case' 0 C--O 1.211 -0.937 0 O-C-N 124.61 1.194 . . . . 72.02 111.313 177.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -64.69 -45.63 85.79 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.217 0.607 . . . . 74.21 111.086 -175.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.405 ' O ' ' HG3' ' D' ' 117' ' ' MET . 44.7 t -57.72 -45.97 85.06 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.413 0.685 . . . . 74.41 110.456 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.483 HG23 ' SG ' ' D' ' 76' ' ' CYS . 93.4 mt -62.79 -52.18 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.755 -1.111 . . . . 74.42 111.101 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 96.8 m -56.13 -41.03 74.69 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.891 1.277 . . . . 72.45 111.119 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 30.6 t -66.72 -43.45 84.23 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.621 -1.172 . . . . 62.24 109.818 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.413 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 74.4 mtm -65.7 -33.03 74.93 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.088 0.555 . . . . 75.44 111.874 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' D' ' 114' ' ' ILE . 76.4 t -64.68 -45.71 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.432 1.093 . . . . 71.34 109.945 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 82.5 p -75.58 -28.36 58.92 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 115.503 -0.771 . . . . 54.45 111.053 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' D' ' 116' ' ' SER . 78.0 mtt-85 -72.63 -29.11 63.19 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.374 0.67 . . . . 72.04 109.805 174.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.63 9.64 75.17 Favored Glycine 0 C--N 1.353 1.494 0 O-C-N 123.849 0.718 . . . . 75.34 112.29 173.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.445 HG22 ' HB3' ' C' ' 17' ' ' TYR . 44.8 p 60.06 20.01 9.19 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 126.533 1.933 . . . . 54.42 114.476 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -82.19 155.24 69.72 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.418 0.687 . . . . 74.45 109.66 171.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.01 132.4 49.27 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.642 2.228 . . . . 71.22 111.221 174.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -49.76 130.47 21.2 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.195 1.398 . . . . 73.53 112.499 -174.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.424 HD23 ' HZ ' ' D' ' 74' ' ' PHE . 17.8 tp -117.51 96.44 5.4 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.908 0.483 . . . . 74.3 109.783 -172.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -99.9 104.45 16.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.579 0.752 . . . . 72.33 109.245 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.41 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 6.6 mp -69.92 115.39 9.09 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.293 0.637 . . . . 72.13 109.813 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.73 126.93 86.37 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 122.898 0.479 . . . . 51.04 110.196 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.412 ' HD3' HD13 ' B' ' 13' ' ' ILE . 51.4 Cg_endo -73.35 133.25 18.93 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.504 2.136 . . . . 63.44 111.855 -171.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 89.3 t . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 108.473 -0.936 . . . . 74.25 108.473 179.349 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.555 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 25.5 t80 . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 109.274 -0.639 . . . . 73.51 109.274 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -144.67 112.9 6.48 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.991 0.916 . . . . 71.44 109.05 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.652 HG12 ' HD2' ' A' ' 84' ' ' PHE . 43.0 mt -77.88 115.06 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 109.702 -0.481 . . . . 73.54 109.702 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -73.39 -27.96 61.75 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 123.801 0.688 . . . . 71.34 111.1 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.2 ttt85 -177.57 149.01 0.6 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 123.265 0.353 . . . . 74.32 111.448 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 91.6 mt -137.23 130.63 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.239 -1.022 . . . . 73.32 108.239 168.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 35.1 p90 -166.14 157.63 13.62 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 124.19 0.931 . . . . 75.12 110.484 -168.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.3 p -83.28 109.82 17.58 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.773 -1.103 . . . . 75.44 108.375 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.492 ' HE3' ' HB1' ' B' ' 28' ' ' ALA . 35.3 mtpt -75.05 -38.3 61.43 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.083 -0.71 . . . . 62.22 109.083 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.523 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 31.4 t70 -140.33 136.48 33.25 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 113.93 -1.486 . . . . 70.15 109.617 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.4 mt -130.23 144.73 37.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 125.406 1.482 . . . . 73.43 107.043 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.488 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 48.3 t -148.82 130.28 14.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.815 -0.809 . . . . 74.24 108.815 174.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.557 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 93.4 t80 -134.72 142.08 46.67 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.375 -1.343 . . . . 74.2 107.375 173.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -141.45 151.16 43.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.446 -0.946 . . . . 74.22 108.446 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.52 81.22 17.66 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 106.905 -1.517 . . . . 74.45 106.905 171.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.16 -46.39 33.91 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.589 2.859 . . . . 73.22 114.303 -166.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.18 37.56 3.97 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.549 -0.908 . . . . 74.53 108.549 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.566 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -40.18 -57.26 2.92 Favored Pre-proline 0 CA--C 1.569 1.686 0 N-CA-C 114.274 1.212 . . . . 74.34 114.274 -172.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 27.9 Cg_exo -62.17 -29.69 81.05 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.042 1.828 . . . . 74.25 114.006 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -83.0 -32.64 26.84 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.689 0.796 . . . . 75.24 111.347 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.638 HG22 ' HA ' ' A' ' 73' ' ' ALA . 3.2 p -77.52 -22.31 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.542 0.737 . . . . 74.43 111.265 -166.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -71.47 -22.38 61.82 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.708 -0.678 . . . . 75.34 110.773 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -80.83 -21.61 40.67 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.284 1.033 . . . . 70.1 110.633 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -82.03 170.8 15.13 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.149 0.98 . . . . 75.51 111.568 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -88.3 131.54 34.75 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.687 0.795 . . . . 75.02 110.044 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.461 ' CE3' HD21 ' A' ' 68' ' ' LEU . 66.4 t-105 -84.47 85.53 7.39 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 121.582 0.706 . . . . 72.32 111.058 -176.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -135.16 80.63 46.76 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 107.225 -1.398 . . . . 71.04 107.225 167.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -82.01 154.24 17.09 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.666 2.244 . . . . 73.12 112.658 -173.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -102.41 85.85 2.7 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.782 -1.562 . . . . 72.34 106.782 170.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 65' ' ' THR . 55.7 t -78.89 97.26 2.33 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 CA-C-N 115.54 -0.755 . . . . 75.52 109.965 -173.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.513 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 56.8 mtpt -79.39 124.18 28.19 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.127 -0.942 . . . . 75.24 109.196 174.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -97.71 108.37 21.07 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 105.922 -1.881 . . . . 73.43 105.922 169.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.755 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 15.0 m-20 -104.5 117.68 34.75 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.628 -0.878 . . . . 60.43 108.628 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -97.53 122.41 40.56 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.892 0.877 . . . . 72.15 109.512 -171.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -136.22 139.36 42.7 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.296 0.638 . . . . 75.05 109.404 172.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.1 p -111.98 136.94 50.66 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.661 0.784 . . . . 74.31 110.239 -175.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.08 110.82 5.64 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 108.341 -0.985 . . . . 62.04 108.341 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 p -132.0 152.04 51.38 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.947 -0.471 . . . . 73.54 109.931 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -152.36 132.38 13.42 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.155 0.582 . . . . 63.24 110.982 -170.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -75.11 126.05 30.21 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 108.936 -0.764 . . . . 75.45 108.936 172.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.568 HD12 HG22 ' A' ' 83' ' ' ILE . 76.1 mt -97.99 -33.24 11.27 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.723 0.409 . . . . 75.22 110.387 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.4 -176.15 5.44 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.178 0.991 . . . . 72.25 110.014 176.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.61 124.2 21.27 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 108.631 -0.877 . . . . 64.22 108.631 169.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 65.04 11.79 7.4 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.465 1.106 . . . . 74.2 112.62 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.06 122.59 65.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 107.938 -1.134 . . . . 75.23 107.938 174.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -140.06 169.01 18.49 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.103 -0.702 . . . . 74.3 109.103 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -129.92 127.31 39.87 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.197 -0.91 . . . . 74.51 108.807 176.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.56 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 91.9 t -102.52 120.91 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.509 -1.293 . . . . 75.13 107.509 168.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.47 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 25.9 t -107.76 131.24 58.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 107.408 -1.331 . . . . 74.53 107.408 168.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 tt -119.24 107.49 13.48 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.627 -0.879 . . . . 70.42 108.627 176.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 31.3 ttt180 -84.47 102.09 12.55 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.373 1.069 . . . . 72.11 109.366 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.4 t -98.41 102.51 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 108.196 -1.038 . . . . 73.2 108.196 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.755 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 33.2 m -94.82 108.02 20.04 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.976 -1.12 . . . . 75.51 107.976 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.3 t -103.22 110.23 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.218 0.607 . . . . 73.24 109.698 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.513 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 11.6 m -100.56 141.18 33.78 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.304 -0.998 . . . . 72.31 108.304 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.89 119.21 20.85 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.239 -1.023 . . . . 64.3 108.239 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.3 m -130.02 126.9 38.82 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.451 0.469 . . . . 72.14 110.724 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.461 HD21 ' CE3' ' A' ' 36' ' ' TRP . 29.6 mt -87.4 80.86 8.01 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 124.722 1.209 . . . . 74.44 109.163 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.5 -84.05 0.87 Allowed Glycine 0 C--N 1.34 0.782 0 CA-C-N 116.168 -0.469 . . . . 71.32 112.038 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -112.63 -27.9 8.02 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.368 0.667 . . . . 74.43 111.403 177.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -95.86 122.47 38.69 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 122.062 -0.399 . . . . 74.22 111.154 -173.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.3 m -65.77 126.8 29.61 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.06 0.457 . . . . 71.41 110.283 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.638 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -78.8 -56.77 4.15 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 114.975 -1.012 . . . . 72.24 109.531 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -159.45 172.71 17.4 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.601 -1.181 . . . . 65.33 111.257 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.9 tp -131.54 139.37 49.23 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 107.5 -1.296 . . . . 75.33 107.5 167.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.458 ' HB3' ' HE1' ' A' ' 117' ' ' MET . 59.3 m -138.31 95.47 3.01 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.827 -0.805 . . . . 75.14 108.827 175.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 33.9 tt0 -105.61 121.16 43.4 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.407 0.683 . . . . 74.21 109.293 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.2 t -129.59 112.47 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.158 0.504 . . . . 72.24 110.008 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 63.8 mt-30 -84.78 88.82 7.41 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.43 -0.952 . . . . 72.42 108.43 172.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -80.01 96.91 6.58 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.452 -0.794 . . . . 74.23 109.407 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.9 151.25 24.8 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 115.944 -0.571 . . . . 73.24 112.085 177.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.77 122.01 1.24 Allowed Glycine 0 CA--C 1.504 -0.631 0 N-CA-C 111.006 -0.837 . . . . 72.43 111.006 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.568 HG22 HD12 ' A' ' 51' ' ' LEU . 46.4 mt -82.1 122.97 37.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 108.188 -1.042 . . . . 74.31 108.188 173.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.652 ' HD2' HG12 ' A' ' 13' ' ' ILE . 22.6 m-85 -124.96 147.98 48.63 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 109.109 -0.7 . . . . 75.03 109.109 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.2 m -113.98 122.77 47.94 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.476 -0.935 . . . . 73.14 108.476 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.549 0.921 0 N-CA-C 108.555 -0.906 . . . . 71.44 108.555 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.804 0.335 . . . . 74.11 110.921 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -67.49 -27.71 67.24 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.918 -0.583 . . . . 74.55 110.732 172.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.509 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 58.3 m -76.78 -63.91 1.24 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 122.71 0.404 . . . . 64.41 110.404 177.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.21 -30.65 71.15 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.978 0.911 . . . . 75.35 112.28 -171.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.42 -1.28 40.75 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-O 119.115 -0.825 . . . . 64.1 114.389 -172.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.86 -59.82 0.23 Allowed 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.985 1.106 . . . . 73.54 113.985 -173.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.509 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 80.1 t80 -74.15 -55.33 6.2 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.167 0.587 . . . . 75.21 111.491 -169.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 79.3 m -65.58 -36.24 14.02 Favored Pre-proline 0 CA--C 1.567 1.632 0 N-CA-C 113.084 0.772 . . . . 74.34 113.084 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.02 -46.65 27.13 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 122.68 2.253 . . . . 70.43 113.735 160.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -69.44 -27.68 65.46 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.546 0.739 . . . . 74.12 110.432 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.62 -38.59 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 C-N-CA 123.382 0.673 . . . . 74.24 110.22 173.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 70.2 mt -76.8 -22.96 52.9 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.616 0.766 . . . . 75.44 112.36 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -61.12 -45.67 95.95 Favored Pre-proline 0 CA--C 1.567 1.607 0 N-CA-C 114.387 1.254 . . . . 73.2 114.387 -171.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -62.6 -34.79 73.55 Favored 'Trans proline' 0 C--N 1.384 2.435 0 CA-C-N 121.676 1.634 . . . . 73.11 113.038 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -70.37 -43.59 69.82 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.229 0.612 . . . . 72.22 111.078 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.11 -36.7 80.19 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.991 -0.55 . . . . 71.03 110.484 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.518 ' NH1' HD13 ' C' ' 105' ' ' ILE . 28.7 ttm180 -54.58 -56.78 15.38 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.859 0.863 . . . . 71.14 109.903 172.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.09 -43.39 95.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.956 0.902 . . . . 75.25 111.768 -174.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 38.2 t -59.51 -42.56 92.49 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.785 0.678 . . . . 73.24 110.613 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.3 mt -68.24 -47.61 77.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 115.497 -0.774 . . . . 72.41 110.328 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 60.2 m -55.49 -41.42 72.99 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.96 0.904 . . . . 72.22 111.527 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.0 t -70.79 -44.61 66.28 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 114.994 -1.003 . . . . 75.5 110.381 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.557 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 21.1 mtp -61.6 -41.47 97.49 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.543 0.737 . . . . 73.02 111.727 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.16 -45.87 97.73 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 123.931 0.892 . . . . 74.54 110.503 175.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 26.0 t -72.28 -30.17 64.57 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.706 -0.679 . . . . 63.44 111.764 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -74.77 -28.62 60.83 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.334 0.653 . . . . 71.31 109.572 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.3 15.83 37.58 Favored Glycine 0 C--N 1.352 1.444 0 O-C-N 123.831 0.707 . . . . 62.15 113.04 172.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.447 HG23 ' HE ' ' B' ' 15' ' ' ARG . 3.0 t 59.94 12.56 3.16 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 127.054 2.142 . . . . 71.33 113.685 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -79.8 147.44 66.61 Favored Pre-proline 0 C--O 1.244 0.781 0 C-N-CA 123.25 0.62 . . . . 73.15 109.502 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.03 141.47 98.34 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.651 2.234 . . . . 60.54 111.748 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -56.28 143.11 35.2 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.029 1.122 . . . . 75.0 114.029 -168.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.1 tp -129.14 113.79 15.53 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.451 1.1 . . . . 74.02 109.195 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -112.75 126.2 55.15 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.381 0.672 . . . . 72.55 109.823 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.13 134.93 46.03 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.389 -0.597 . . . . 75.34 109.389 172.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.62 143.22 84.67 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 122.666 0.386 . . . . 54.34 110.879 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -61.11 126.85 20.49 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.537 2.825 . . . . 71.32 112.558 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.3 m -129.61 113.56 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 123.641 0.777 . . . . 72.34 109.825 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -95.91 89.58 5.29 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.285 0.634 . . . . 73.43 109.597 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 . . . . . 0 N--CA 1.471 0.611 0 CA-C-N 115.349 -0.842 . . . . 73.53 110.362 176.206 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.612 ' HB3' HG12 ' B' ' 89' ' ' ILE . 5.5 ppp? . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 113.614 0.968 . . . . 71.41 113.614 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 93.8 m -134.03 107.1 7.57 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.897 -0.779 . . . . 71.33 108.897 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.52 ' HB2' ' SD ' ' B' ' 9' ' ' MET . 41.4 t80 -123.53 142.95 50.51 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.536 -0.756 . . . . 73.24 110.057 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -160.04 140.79 12.09 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.677 0.611 . . . . 73.21 109.61 174.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.404 HD11 HD11 ' B' ' 16' ' ' ILE . 42.8 mt -79.69 125.99 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 108.693 -0.854 . . . . 74.21 108.693 170.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -98.14 -37.31 9.77 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.394 0.678 . . . . 75.31 109.22 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.447 ' HE ' HG23 ' A' ' 122' ' ' THR . 45.4 ttt180 -174.19 144.32 0.95 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.479 -0.782 . . . . 75.21 109.037 -176.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.404 HD11 HD11 ' B' ' 13' ' ' ILE . 96.5 mt -128.23 142.45 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.55 -1.278 . . . . 74.42 107.55 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -168.63 148.91 4.53 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.664 0.745 . . . . 73.52 112.712 -174.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.572 HG23 HD11 ' B' ' 21' ' ' ILE . 52.5 m -73.72 124.87 26.84 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.147 -1.388 . . . . 74.12 108.945 167.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.433 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 37.6 mtpt -98.41 -21.51 16.54 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.635 0.774 . . . . 74.11 110.863 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -165.56 138.64 4.38 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.761 0.663 . . . . 64.23 110.706 -167.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.572 HD11 HG23 ' B' ' 18' ' ' THR . 48.5 mm -132.96 143.87 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.076 0.951 . . . . 74.21 110.191 174.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.636 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 75.6 m -134.24 136.47 43.66 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 125.911 1.684 . . . . 64.23 107.199 169.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.4 t80 -151.48 114.83 4.8 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.474 -1.306 . . . . 63.31 107.474 165.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -119.31 155.83 31.12 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.379 -0.971 . . . . 63.32 108.379 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.52 86.06 8.27 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 107.766 -1.198 . . . . 64.01 107.766 177.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.24 -45.79 21.43 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.593 2.862 . . . . 74.24 113.86 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -104.0 24.59 11.12 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.186 0.594 . . . . 72.15 110.849 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.492 ' HB1' ' HE3' ' A' ' 19' ' ' LYS . . . -42.24 -62.73 1.09 Allowed Pre-proline 0 N--CA 1.485 1.283 0 N-CA-C 115.202 1.556 . . . . 74.52 115.202 -165.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HB1' ' B' ' 28' ' ' ALA . 51.9 Cg_exo -53.44 -43.23 59.26 Favored 'Trans proline' 0 C--N 1.39 2.751 0 C-N-CA 122.072 1.848 . . . . 72.02 113.878 -168.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -97.12 -22.43 16.77 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.285 0.846 . . . . 74.45 113.285 -171.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.402 HG11 ' O ' ' B' ' 28' ' ' ALA . 9.6 p -68.64 -17.56 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 118.452 0.569 . . . . 64.22 112.06 -173.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -70.48 -15.61 62.82 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 113.305 0.854 . . . . 74.32 113.305 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -61.6 -27.19 68.47 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.152 0.501 . . . . 74.21 109.765 173.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -86.92 80.34 8.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.336 1.054 . . . . 75.43 110.067 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -91.47 90.41 7.64 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.923 -0.581 . . . . 73.0 109.493 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -161.51 -175.64 4.89 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.723 1.209 . . . . 63.5 108.549 172.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -81.32 109.63 14.94 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 122.951 0.501 . . . . 74.51 110.109 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.68 160.22 50.54 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.442 2.095 . . . . 72.42 113.109 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -66.17 112.64 4.03 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.269 0.628 . . . . 74.12 109.63 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 51.5 t -88.86 134.66 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.803 0.841 . . . . 74.4 109.747 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -140.87 118.0 11.26 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 106.532 -1.655 . . . . 73.31 106.532 175.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 pp -114.34 166.58 11.52 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.01 0.433 . . . . 73.33 111.771 -176.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.535 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 14.2 m-20 -147.31 155.87 42.41 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.412 1.085 . . . . 73.41 109.206 174.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -120.98 146.58 46.52 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.31 -0.996 . . . . 62.41 108.31 172.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.594 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 7.4 t70 -137.91 138.19 38.78 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.856 0.862 . . . . 73.14 108.935 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 36.7 p -109.64 127.77 54.77 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.301 0.64 . . . . 72.31 111.166 -175.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.49 142.78 29.53 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.018 0.927 . . . . 75.25 108.622 174.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 35.2 p -144.53 163.62 33.32 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 122.705 0.402 . . . . 73.41 110.855 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 79.6 p -151.1 138.41 19.39 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.875 0.87 . . . . 72.33 109.018 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -96.83 134.06 40.62 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.23 -0.656 . . . . 61.3 109.23 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 46.7 mt -101.12 -39.92 7.44 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.196 0.598 . . . . 70.2 110.64 -175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.73 -173.98 4.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.388 -0.824 . . . . 64.23 110.449 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.12 121.68 19.68 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.009 -0.996 . . . . 71.41 108.864 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 75.51 -7.5 1.77 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 126.246 1.818 . . . . 71.53 112.584 -175.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 96.1 t -110.87 112.28 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.279 -0.637 . . . . 74.04 109.279 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -119.6 -179.77 3.98 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.572 -0.899 . . . . 75.13 108.572 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -144.05 107.01 4.48 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.988 -1.115 . . . . 73.54 107.988 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 74.1 t -96.83 128.55 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.233 1.013 . . . . 73.02 110.212 -175.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.47 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 12.7 t -118.37 126.28 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.86 0.864 . . . . 72.43 109.563 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.683 HD23 ' HB3' ' B' ' 103' ' ' PRO . 52.2 tp -112.85 115.5 28.56 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.482 -0.933 . . . . 74.1 108.482 164.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.594 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 17.2 ttt180 -92.47 118.22 30.74 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.884 -0.784 . . . . 74.13 108.884 175.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.74 121.21 54.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.361 -0.977 . . . . 72.45 108.361 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.535 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 22.6 m -104.82 143.78 32.67 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.881 -0.785 . . . . 75.11 108.881 177.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.457 HG21 HG23 ' B' ' 114' ' ' ILE . 95.0 t -136.29 136.22 49.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 123.785 0.834 . . . . 75.33 108.854 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.8 m -125.86 143.75 50.94 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.609 1.163 . . . . 73.23 108.068 172.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.68 139.2 23.81 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.083 -0.71 . . . . 71.44 109.083 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.497 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 33.2 p -140.37 128.16 21.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.887 -0.597 . . . . 54.51 110.192 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 61.6 mt -96.89 105.42 17.56 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.027 -1.101 . . . . 73.41 108.027 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.26 -111.85 3.52 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 115.663 -0.699 . . . . 75.44 111.644 -173.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -121.76 3.99 10.04 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.781 0.832 . . . . 71.44 110.328 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -113.56 139.02 49.34 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.46 -0.571 . . . . 74.53 109.46 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 94.4 m -67.52 113.41 5.33 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.319 0.581 . . . . 64.42 109.97 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.497 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -70.44 -62.03 1.54 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.258 -1.337 . . . . 75.02 108.331 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -150.22 155.04 39.0 Favored 'General case' 0 C--N 1.347 0.491 0 N-CA-C 112.853 0.686 . . . . 75.32 112.853 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 64.8 mt -123.27 110.94 15.84 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.076 -1.453 . . . . 75.44 107.076 171.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' B' ' 114' ' ' ILE . 37.8 t -118.46 139.23 51.74 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 108.809 -0.811 . . . . 75.41 108.809 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.636 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 39.6 tt0 -156.72 131.9 9.15 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.589 -0.522 . . . . 72.12 109.589 -172.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 98.3 t -128.15 147.91 32.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 123.715 0.806 . . . . 74.41 109.183 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -110.92 103.72 12.25 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.305 -1.368 . . . . 74.35 107.305 165.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.437 ' HB2' ' HB1' ' B' ' 110' ' ' ALA . 7.8 tp-100 -92.96 98.99 11.71 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.387 -1.338 . . . . 73.22 107.387 173.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -96.01 171.31 28.42 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.732 -1.122 . . . . 72.12 110.662 173.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.51 137.11 4.18 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 111.275 -0.73 . . . . 41.23 111.275 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 45.4 mt -84.18 127.14 40.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 107.596 -1.261 . . . . 73.14 107.596 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -136.49 142.69 43.54 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.956 0.902 . . . . 75.31 109.159 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 27.3 m -89.13 113.46 24.63 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.03 -1.1 . . . . 74.31 108.03 168.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.48 HD13 ' SG ' ' B' ' 97' ' ' CYS . 0.4 OUTLIER -130.27 107.83 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.329 1.052 . . . . 74.11 108.322 -176.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' B' ' 9' ' ' MET . . . -156.65 171.89 19.54 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.54 1.136 . . . . 75.41 110.286 -177.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.75 -57.18 1.13 Allowed Glycine 0 C--N 1.346 1.094 0 N-CA-C 112.444 -0.262 . . . . 53.42 112.444 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.612 HG12 ' HB3' ' B' ' 9' ' ' MET . 4.2 mm -83.01 156.31 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.216 0.607 . . . . 74.25 110.394 175.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -152.34 -173.31 4.51 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.195 -0.912 . . . . 74.22 110.665 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.71 -120.46 8.15 Favored Glycine 0 C--N 1.351 1.392 0 CA-C-N 115.607 -0.724 . . . . 73.2 113.289 170.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.8 m -83.48 -37.48 23.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.513 0.673 . . . . 75.15 110.643 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -72.61 -23.17 60.9 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.96 -1.018 . . . . 70.4 111.462 -167.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -71.46 -29.8 65.28 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.028 0.531 . . . . 74.34 111.09 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.64 -37.47 78.78 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.481 0.712 . . . . 73.21 110.692 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -75.15 -30.63 60.81 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.355 -0.839 . . . . 74.2 111.321 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.48 ' SG ' HD13 ' B' ' 86' ' ' ILE . 46.1 t -69.41 -66.7 0.55 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 122.296 0.238 . . . . 73.32 111.544 -174.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.463 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.0 pt? -88.32 -3.59 58.82 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.263 -0.898 . . . . 74.22 111.393 -178.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.79 -4.47 59.0 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-O 119.824 -0.431 . . . . 74.54 114.114 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.643 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -148.46 -50.0 0.16 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 117.576 0.688 . . . . 75.33 111.493 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.499 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 46.3 t80 -67.84 -47.83 67.88 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.148 0.579 . . . . 75.03 111.617 -175.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.479 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 59.2 m -66.46 -48.18 56.52 Favored Pre-proline 0 N--CA 1.488 1.468 0 CA-C-O 119.056 -0.497 . . . . 73.35 112.208 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.683 ' HB3' HD23 ' B' ' 60' ' ' LEU . 72.3 Cg_exo -55.77 -29.98 74.13 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.293 1.996 . . . . 72.4 114.283 170.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -66.68 -37.09 84.03 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.686 0.795 . . . . 75.41 110.618 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.28 -42.76 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 123.544 0.738 . . . . 75.04 110.169 175.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 78.7 mt -78.88 -17.21 55.97 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.298 -1.319 . . . . 72.24 111.728 -174.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.433 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 71.9 t80 -56.92 -53.91 60.01 Favored Pre-proline 0 CA--C 1.563 1.464 0 C-N-CA 124.365 1.066 . . . . 75.04 113.372 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 35.5 Cg_exo -63.27 -32.8 72.89 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 121.796 1.664 . . . . 74.21 113.292 -178.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -70.98 -44.01 66.87 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.441 0.697 . . . . 65.45 110.815 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.437 ' HB1' ' HB2' ' B' ' 80' ' ' GLN . . . -65.97 -36.79 84.29 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.677 0.391 . . . . 73.1 110.344 175.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -55.5 -56.36 21.09 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 124.311 1.007 . . . . 75.33 110.682 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -60.68 -40.24 91.43 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 123.633 0.583 . . . . 61.34 110.501 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.549 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.8 t -66.37 -38.87 88.54 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 123.505 0.503 . . . . 73.05 111.226 -175.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.457 HG23 HG21 ' B' ' 64' ' ' VAL . 97.2 mt -64.71 -52.21 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 123.132 0.573 . . . . 74.05 109.765 174.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 32.3 m -60.72 -32.48 71.74 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.784 0.834 . . . . 70.13 111.493 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.2 m -65.29 -46.58 79.86 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.852 0.461 . . . . 75.33 110.691 175.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.549 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -69.13 -34.4 74.96 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 123.229 0.331 . . . . 73.11 111.099 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.53 -40.91 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.607 0.763 . . . . 72.55 110.437 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -67.32 -37.04 82.68 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 114.95 -1.023 . . . . 72.43 111.561 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.478 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 85.6 mtt-85 -66.99 -36.38 82.03 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.314 -0.857 . . . . 74.3 109.368 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . 0.49 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -83.62 11.65 55.33 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 124.278 0.986 . . . . 74.14 113.496 174.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 50.4 p 56.84 19.58 4.58 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 125.839 1.656 . . . . 65.44 114.648 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -78.9 166.64 40.9 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 123.63 0.772 . . . . 74.44 112.063 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.96 160.14 8.34 Favored 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 123.199 2.599 . . . . 64.33 114.059 171.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.419 HE21 ' ND2' ' B' ' 127' ' ' ASN . 66.7 tp60 -65.37 139.27 58.55 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.527 -0.761 . . . . 62.34 112.443 -173.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 51.5 tp -142.07 119.89 11.92 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.583 0.753 . . . . 75.34 109.667 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . 0.419 ' ND2' HE21 ' B' ' 125' ' ' GLN . 54.2 m-80 -127.51 135.48 50.42 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.117 0.967 . . . . 70.01 108.581 173.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 tt -78.5 124.26 27.94 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 108.743 -0.836 . . . . 74.35 108.743 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.28 141.94 98.23 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.982 0.913 . . . . 71.42 111.993 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -65.67 92.76 0.25 Allowed 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.627 2.218 . . . . 65.44 112.709 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.08 120.4 46.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 108.374 -0.973 . . . . 70.25 108.374 172.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -74.44 85.33 2.01 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 108.176 -1.046 . . . . 73.0 108.176 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -69.15 -34.63 75.29 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.109 -1.405 . . . . 73.01 110.765 -173.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . 0.643 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 19.0 t70 . . . . . 0 CA--C 1.536 0.423 0 CA-C-N 114.118 -1.401 . . . . 74.12 110.785 175.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.418 ' CE1' ' HE2' ' C' ' 101' ' ' TYR . 1.1 t80 . . . . . 0 C--O 1.238 0.471 0 N-CA-C 108.512 -0.921 . . . . 74.43 108.512 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -143.49 128.93 19.01 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 108.886 -0.783 . . . . 75.21 108.886 171.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 37.8 mt -79.5 118.64 27.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.693 -0.855 . . . . 75.22 108.693 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.505 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 18.1 mm-40 -89.99 -33.07 16.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.996 -1.002 . . . . 53.24 109.635 -175.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -177.96 149.47 0.57 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.676 0.79 . . . . 75.42 109.353 -175.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 93.8 mt -137.25 140.25 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 107.965 -1.124 . . . . 75.24 107.965 174.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.407 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 21.1 p90 -171.04 167.37 7.23 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 120.796 0.331 . . . . 75.45 111.342 -171.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.5 p -95.69 127.97 42.17 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 109.456 -0.572 . . . . 74.04 109.456 175.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.407 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 16.7 mmtp -79.24 -50.13 11.42 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 122.597 1.189 . . . . 74.01 108.391 172.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 16.6 t70 -139.15 144.37 38.59 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 112.597 -2.092 . . . . 75.12 108.468 -167.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.458 HG21 ' HE2' ' C' ' 117' ' ' MET . 81.4 mt -138.38 149.35 24.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 106.767 -1.568 . . . . 72.32 106.767 175.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 43.2 t -157.24 150.32 23.67 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.34 0.656 . . . . 65.44 109.412 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -152.31 134.48 15.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.55 -1.278 . . . . 74.33 107.55 173.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . 0.429 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 42.2 mt-10 -133.89 110.85 10.01 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.484 0.713 . . . . 74.31 109.696 -176.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.02 79.11 73.66 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 106.979 -1.489 . . . . 63.14 106.979 163.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.19 -21.52 31.39 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.688 2.259 . . . . 72.44 111.947 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . 0.47 ' ND2' ' HB ' ' C' ' 31' ' ' VAL . 22.9 p-10 -102.38 22.12 13.95 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.586 1.155 . . . . 72.13 110.735 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.59 -58.39 4.51 Favored Pre-proline 0 CA--C 1.562 1.405 0 N-CA-C 114.738 1.385 . . . . 74.31 114.738 -169.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -63.2 -35.64 62.41 Favored 'Trans proline' 0 C--N 1.38 2.236 0 CA-C-N 121.889 1.71 . . . . 75.43 112.169 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -69.82 -37.26 76.17 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.193 0.997 . . . . 73.35 112.247 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.692 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.0 p -80.43 -16.69 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 N-CA-C 113.109 0.781 . . . . 75.15 113.109 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-30 -73.47 -23.14 60.04 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.735 -0.603 . . . . 75.01 111.983 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -90.02 17.93 6.36 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.123 0.569 . . . . 74.54 111.764 175.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.687 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 0.9 OUTLIER -109.45 146.84 33.85 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.922 0.889 . . . . 74.51 110.535 -172.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.51 131.41 49.04 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.679 0.792 . . . . 64.31 110.647 173.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -79.48 89.32 5.04 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.467 0.707 . . . . 70.31 110.421 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -138.42 67.08 45.11 Favored Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 124.062 0.945 . . . . 70.31 109.297 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -90.27 140.4 3.22 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.824 2.349 . . . . 73.51 113.316 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -88.74 101.21 13.79 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.832 -1.173 . . . . 74.43 107.832 166.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.56 97.84 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.779 -0.823 . . . . 71.2 108.779 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.537 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 94.0 mttt -97.97 105.11 17.2 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 114.562 -1.199 . . . . 74.31 108.338 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.504 HD12 HD21 ' C' ' 128' ' ' LEU . 2.8 mm? -85.61 139.68 31.22 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.997 -0.742 . . . . 71.33 108.997 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -141.86 106.69 4.9 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.47 -1.307 . . . . 73.24 107.47 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 8.1 mp -109.02 148.28 31.02 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.256 0.551 . . . . 73.32 110.176 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 14.1 t70 -130.48 145.22 51.8 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.923 1.289 . . . . 74.12 108.896 -174.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 61.7 p -116.71 112.83 21.76 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.984 0.914 . . . . 63.14 110.432 -167.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.26 143.18 39.95 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.102 0.561 . . . . 72.53 110.945 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 22.1 p -160.72 155.61 24.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.245 0.618 . . . . 73.13 110.657 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 90.1 p -143.96 154.07 42.92 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.489 0.715 . . . . 64.52 110.157 -175.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -84.89 123.23 30.25 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.954 0.502 . . . . 73.42 110.29 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.578 HD12 HD13 ' C' ' 83' ' ' ILE . 25.4 mt -100.23 -41.86 6.91 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.946 -0.761 . . . . 75.01 108.946 172.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . 0.401 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -153.35 -172.68 4.31 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.304 1.041 . . . . 74.13 109.611 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.75 117.1 11.83 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.225 -0.898 . . . . 72.24 109.498 173.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 71.95 -5.91 1.6 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.937 1.295 . . . . 73.52 112.78 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 92.2 t -105.9 107.6 23.04 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.396 -0.964 . . . . 74.44 108.396 174.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -127.41 141.3 51.72 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.715 0.806 . . . . 75.34 109.131 -175.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.463 ' HB2' HD12 ' C' ' 51' ' ' LEU . 16.9 tt0 -83.2 111.52 19.01 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.103 -1.408 . . . . 72.23 108.826 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 92.0 t -97.03 119.46 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 108.789 -0.819 . . . . 63.54 108.789 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 33.3 t -123.75 118.21 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.517 0.727 . . . . 74.14 110.477 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 50.0 tp -105.34 110.81 23.31 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.269 -1.011 . . . . 73.12 108.269 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 0.3 OUTLIER -91.91 107.09 18.96 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.417 -0.586 . . . . 75.42 109.417 178.23 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.08 131.63 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.3 -1.0 . . . . 75.23 108.3 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 26.7 m -127.77 117.82 22.6 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.919 -0.771 . . . . 70.51 108.919 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.665 HG23 HG21 ' C' ' 114' ' ' ILE . 61.1 t -102.27 114.58 42.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 115.106 -0.952 . . . . 71.24 109.139 -177.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 27.8 m -98.01 137.11 37.3 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.008 -1.108 . . . . 74.44 108.008 170.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.18 109.5 6.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.235 -1.394 . . . . 64.3 107.235 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 62.6 m -131.38 128.63 40.0 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.013 0.435 . . . . 72.32 110.531 -176.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 10.4 mt -85.51 42.6 0.97 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.303 1.441 . . . . 74.44 110.916 -174.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.48 -89.54 0.54 Allowed Glycine 0 C--N 1.348 1.208 0 N-CA-C 110.898 -0.881 . . . . 72.42 110.898 -173.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.9 -25.58 5.8 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.247 1.019 . . . . 63.34 109.544 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.687 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 6.1 tp10 -76.37 120.98 22.35 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.107 1.363 . . . . 75.11 109.157 169.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 85.1 m -75.4 126.71 31.57 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.761 0.71 . . . . 74.44 109.422 171.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.692 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.31 -58.91 3.23 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.13 -0.692 . . . . 63.0 109.13 173.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . 0.45 ' HZ ' ' HG ' ' C' ' 126' ' ' LEU . 34.8 p90 -159.36 169.86 23.07 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.601 -1.181 . . . . 65.12 111.19 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.0 tm? -130.03 145.99 51.69 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 105.381 -2.081 . . . . 73.11 105.381 169.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 46.2 t -144.74 148.91 34.7 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.929 -1.138 . . . . 61.34 107.929 176.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -158.36 124.76 4.71 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 120.695 0.283 . . . . 72.21 110.628 -173.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 90.0 t -133.97 134.11 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.939 0.896 . . . . 74.32 109.139 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -101.31 93.37 5.39 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.354 -0.98 . . . . 74.34 108.354 170.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -81.53 101.49 9.98 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.393 -0.595 . . . . 72.32 109.393 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.16 169.43 45.93 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 115.797 -0.638 . . . . 63.42 112.472 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.51 126.9 1.08 Allowed Glycine 0 C--O 1.237 0.3 0 N-CA-C 111.452 -0.659 . . . . 64.42 111.452 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.578 HD13 HD12 ' C' ' 51' ' ' LEU . 10.7 mm -85.12 121.28 36.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 108.82 -0.808 . . . . 73.12 108.82 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -131.96 139.91 48.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.371 0.669 . . . . 75.44 109.317 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 16.9 p -92.39 114.51 27.08 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 109.19 -0.67 . . . . 70.53 109.19 170.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.39 104.55 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.405 -0.961 . . . . 72.31 108.405 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.01 165.89 25.94 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.845 0.858 . . . . 54.04 110.197 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.9 -59.72 2.07 Favored Glycine 0 C--N 1.344 1.004 0 O-C-N 123.242 0.339 . . . . 74.52 113.351 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 30.5 pt -81.09 162.65 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 122.923 0.489 . . . . 74.44 110.086 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.632 ' HA ' ' HE1' ' C' ' 94' ' ' MET . 14.0 pt-20 -147.82 174.24 12.03 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.844 0.458 . . . . 72.04 111.191 -175.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.11 -132.41 50.76 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.909 0.756 . . . . 52.5 114.022 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.0 p -64.17 -21.93 66.75 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.788 0.835 . . . . 64.13 112.259 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -65.29 -54.51 28.12 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.507 0.723 . . . . 73.13 110.629 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.632 ' HE1' ' HA ' ' C' ' 90' ' ' GLU . 10.2 ptp -72.17 -28.16 63.05 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 116.208 -0.451 . . . . 74.14 110.746 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.9 -32.83 74.56 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.226 0.611 . . . . 72.03 110.912 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -79.36 -32.08 43.12 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.592 -0.731 . . . . 72.34 110.795 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -59.84 -48.15 82.85 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.393 0.677 . . . . 74.03 111.29 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.24 -20.07 24.6 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.595 0.358 . . . . 75.32 111.633 176.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.49 -29.68 39.18 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 115.064 0.786 . . . . 61.24 115.064 -172.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.88 -39.6 0.3 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.835 0.826 . . . . 70.21 111.265 -172.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.418 ' HE2' ' CE1' ' C' ' 11' ' ' PHE . 67.3 t80 -74.28 -41.03 61.89 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 113.792 -1.549 . . . . 75.34 112.801 -174.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 90.4 m -76.53 -39.45 2.44 Favored Pre-proline 0 N--CA 1.486 1.325 0 CA-C-O 118.959 -0.544 . . . . 75.42 111.938 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -45.55 -35.76 12.92 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.739 2.292 . . . . 75.44 114.652 163.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -66.13 -40.3 90.53 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.237 0.615 . . . . 74.42 110.205 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.518 HD13 ' NH1' ' A' ' 111' ' ' ARG . 45.5 mm -64.81 -40.56 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.142 0.577 . . . . 75.04 110.159 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 91.6 mt -89.06 -8.09 54.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.905 0.882 . . . . 74.43 112.244 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -59.77 -52.21 75.39 Favored Pre-proline 0 N--CA 1.484 1.257 0 C-N-CA 123.883 0.873 . . . . 73.34 113.165 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.41 -30.14 36.84 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 121.614 1.542 . . . . 75.41 112.969 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -70.46 -48.77 54.26 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.184 0.594 . . . . 75.45 110.624 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.25 -41.67 93.7 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.154 -0.93 . . . . 70.11 109.969 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -55.8 -52.22 64.74 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.261 0.976 . . . . 75.42 110.996 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -67.47 -30.12 69.74 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.035 0.534 . . . . 70.4 110.641 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.2 t -74.34 -32.22 62.72 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.071 0.549 . . . . 72.1 111.179 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.665 HG21 HG23 ' C' ' 64' ' ' VAL . 96.1 mt -75.71 -51.64 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.208 0.603 . . . . 75.32 109.995 176.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 12.1 m -63.96 -31.17 72.26 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 123.347 0.659 . . . . 75.4 110.893 -173.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 40.2 t -58.08 -55.25 37.33 Favored 'General case' 0 C--N 1.351 0.63 0 CA-C-N 115.494 -0.775 . . . . 73.2 109.302 169.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.56 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.43 -36.57 76.15 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.746 1.218 . . . . 74.02 113.138 -179.304 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.426 HG23 ' O ' ' C' ' 114' ' ' ILE . 91.4 t -62.9 -49.46 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.312 0.645 . . . . 74.25 109.798 176.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 42.7 t -71.83 -25.75 62.1 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.03 -0.986 . . . . 54.51 111.656 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 -70.24 -40.56 74.39 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.362 0.665 . . . . 74.41 109.463 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.14 8.18 61.47 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.871 0.732 . . . . 75.21 112.915 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 82.7 p 54.9 63.7 2.05 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.975 1.71 . . . . 75.35 113.087 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -120.94 155.86 57.2 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 124.321 1.048 . . . . 75.3 108.41 169.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -55.76 161.63 7.83 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.335 2.69 . . . . 73.43 113.891 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -55.1 113.14 1.25 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.424 -0.807 . . . . 72.34 112.406 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.45 ' HG ' ' HZ ' ' C' ' 74' ' ' PHE . 2.4 tm? -117.75 90.16 3.27 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.534 -1.284 . . . . 72.2 107.534 -175.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -114.38 132.66 56.14 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.719 0.807 . . . . 74.12 108.995 176.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.504 HD21 HD12 ' C' ' 42' ' ' LEU . 96.2 mt -69.75 144.28 52.78 Favored 'General case' 0 C--O 1.246 0.871 0 O-C-N 123.682 0.614 . . . . 75.33 111.113 176.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.79 148.52 98.19 Favored Pre-proline 0 C--N 1.351 0.669 0 O-C-N 124.006 0.816 . . . . 74.35 109.849 172.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.583 ' HB2' HD12 ' A' ' 13' ' ' ILE . 31.1 Cg_exo -61.64 87.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.51 2.14 . . . . 73.4 113.199 177.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 95.0 t -104.41 107.71 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.371 -0.831 . . . . 72.04 108.923 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -83.46 106.55 15.3 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.076 -1.083 . . . . 63.11 108.076 171.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -48.44 -38.54 20.05 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.843 1.34 . . . . 70.2 113.035 -174.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t70 . . . . . 0 N--CA 1.485 1.289 0 C-N-CA 123.587 0.755 . . . . 73.51 111.25 177.541 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 36.2 m . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 107.349 -1.352 . . . . 74.31 107.349 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -162.76 89.51 0.66 Allowed 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.798 -0.815 . . . . 72.33 108.798 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -113.81 114.98 27.04 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.568 -1.271 . . . . 73.34 107.568 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.427 HD12 HG21 ' D' ' 105' ' ' ILE . 26.6 mt -82.11 115.97 25.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 108.347 -0.983 . . . . 74.14 108.347 176.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -75.62 -44.2 44.07 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 123.27 0.356 . . . . 74.44 111.224 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . 0.412 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 22.0 ttt180 -166.87 136.4 2.95 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.072 0.397 . . . . 64.15 112.072 -162.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -115.31 137.5 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 107.92 -1.141 . . . . 73.04 107.92 171.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.412 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 30.6 p90 -159.74 172.24 18.07 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.201 1.001 . . . . 73.14 112.209 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.9 p -113.69 121.91 45.54 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.179 -1.373 . . . . 74.13 108.751 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -90.7 -22.15 21.27 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.048 -0.524 . . . . 74.13 109.75 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -156.85 128.82 7.26 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 114.719 -1.128 . . . . 74.25 108.325 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.56 HG21 ' HE1' ' C' ' 117' ' ' MET . 12.2 mt -128.68 150.47 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 107.866 -1.161 . . . . 73.44 107.866 174.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -154.79 146.16 23.0 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.837 0.827 . . . . 72.34 110.555 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.408 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.4 t80 -146.15 141.32 27.38 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 105.894 -1.891 . . . . 73.2 105.894 171.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.513 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.1 mt-10 -142.11 143.48 33.06 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.355 -0.979 . . . . 72.14 108.355 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.4 88.08 5.85 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 107.912 -1.144 . . . . 71.44 107.912 173.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.86 -17.4 13.9 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.975 2.45 . . . . 75.1 113.37 -176.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -113.84 12.88 18.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.436 1.095 . . . . 72.33 110.941 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -38.18 -67.55 0.25 Allowed Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 126.957 2.103 . . . . 54.43 116.492 -160.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.454 ' HB3' HD11 ' C' ' 83' ' ' ILE . 74.2 Cg_endo -71.86 -26.79 18.54 Favored 'Trans proline' 0 C--N 1.382 2.3 0 CA-C-N 123.22 2.186 . . . . 75.24 114.368 -171.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -86.45 -25.03 25.42 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 117.755 0.252 . . . . 73.42 110.568 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.631 HG22 ' HA ' ' D' ' 73' ' ' ALA . 8.5 p -82.14 -16.0 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 122.78 0.432 . . . . 74.25 111.013 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.431 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.3 m-85 -65.24 -22.83 66.92 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.105 0.409 . . . . 73.51 112.105 177.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -65.14 -15.03 61.96 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.036 0.935 . . . . 64.43 111.385 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.51 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 78.4 mttt -94.9 86.53 4.7 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.057 0.943 . . . . 75.34 110.064 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -87.47 90.86 8.53 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.701 -0.681 . . . . 74.43 109.785 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 42.3 p90 -164.76 175.72 9.43 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.022 0.929 . . . . 73.14 109.197 167.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -73.16 111.56 12.1 Favored Pre-proline 0 N--CA 1.474 0.762 0 N-CA-C 109.178 -0.675 . . . . 73.44 109.178 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -62.77 151.52 83.5 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.574 2.182 . . . . 74.22 111.771 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' D' ' 67' ' ' SER . 56.6 mm-40 -62.77 111.67 2.21 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.018 -1.104 . . . . 65.23 108.018 169.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.737 HG12 HG13 ' D' ' 64' ' ' VAL . 57.8 t -104.68 105.19 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.687 0.795 . . . . 73.44 108.92 -175.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -86.72 129.14 34.99 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.69 -0.856 . . . . 74.4 108.69 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -97.68 110.66 23.18 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.696 -1.224 . . . . 70.4 107.696 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.52 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 10.3 t70 -116.31 130.13 56.62 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.081 -1.451 . . . . 60.31 107.081 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.6 mt -122.29 140.27 52.83 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.142 0.496 . . . . 74.11 111.104 -171.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.544 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 11.7 t70 -136.49 139.48 42.34 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.851 1.26 . . . . 63.51 108.112 174.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 45.4 p -104.03 144.75 31.12 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.361 0.664 . . . . 54.44 110.316 -174.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -160.7 157.32 26.85 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.46 0.704 . . . . 73.14 110.07 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 32.7 p -175.84 167.96 3.06 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.244 0.545 . . . . 71.34 112.178 -178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 62.5 p -156.63 126.65 6.41 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.002 -0.999 . . . . 75.21 108.471 169.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -74.24 121.09 20.73 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.422 -0.584 . . . . 74.04 109.422 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 46.8 mt -90.09 -25.5 20.72 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.273 0.629 . . . . 74.31 110.86 -172.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -172.53 -173.54 1.05 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.028 1.331 . . . . 71.15 109.56 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.87 120.49 12.65 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.886 -0.413 . . . . 73.51 109.886 176.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 69.57 -2.88 1.79 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.964 1.305 . . . . 74.34 112.595 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 97.4 t -110.92 120.06 60.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.432 -1.321 . . . . 74.24 107.432 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -150.36 142.39 23.97 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.385 0.612 . . . . 72.0 109.742 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -88.66 122.69 32.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.166 -1.379 . . . . 73.44 109.3 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 96.0 t -100.48 119.17 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 107.879 -1.156 . . . . 72.45 107.879 173.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 38.7 t -106.84 131.33 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.316 -0.994 . . . . 75.24 108.316 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 15.8 tp -128.58 120.1 26.03 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 109.307 -0.627 . . . . 73.41 109.307 174.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.544 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 28.3 ttm-85 -82.62 99.09 9.35 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.555 -0.906 . . . . 73.11 108.555 177.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 77.1 t -91.25 117.55 34.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.987 -1.116 . . . . 73.21 107.987 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 28.7 m -117.01 135.38 53.74 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.478 -0.564 . . . . 74.13 109.478 -176.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.737 HG13 HG12 ' D' ' 40' ' ' VAL . 41.2 t -128.23 101.21 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.927 1.291 . . . . 74.52 108.684 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 92.8 m -93.04 116.74 29.33 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 107.878 -1.156 . . . . 73.12 107.878 172.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.02 133.96 49.9 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.604 -0.517 . . . . 72.21 109.604 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' D' ' 39' ' ' GLU . 18.2 m -128.22 123.04 33.24 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.534 -0.543 . . . . 74.24 109.534 178.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 31.0 mt -108.9 113.22 25.94 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.693 -1.225 . . . . 73.24 107.693 173.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.78 -133.64 21.22 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 123.467 0.479 . . . . 75.54 112.871 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.76 6.82 39.89 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.718 0.807 . . . . 75.11 111.663 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.51 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 15.7 pt-20 -140.83 174.93 10.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.153 0.502 . . . . 55.45 111.482 -172.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 32.7 m -73.72 135.44 43.64 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.484 1.114 . . . . 73.22 111.322 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.631 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -86.35 -65.27 1.03 Allowed 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.024 -0.732 . . . . 71.21 109.024 168.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -150.36 151.98 33.69 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.593 -1.185 . . . . 75.15 110.894 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.513 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 60.9 mt -110.86 109.84 20.19 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.883 -1.155 . . . . 74.04 107.883 171.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.537 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 48.1 t -116.9 142.14 47.32 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.607 0.763 . . . . 72.4 109.191 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -157.01 142.68 17.61 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.0 0.52 . . . . 75.15 109.793 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 77.7 t -138.89 139.33 40.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 108.173 -1.047 . . . . 73.05 108.173 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -110.58 87.1 2.45 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 107.3 -1.37 . . . . 75.34 107.3 173.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -80.1 99.53 7.77 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.258 -1.337 . . . . 70.44 109.398 -171.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.29 142.78 16.14 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 110.88 -0.888 . . . . 61.43 110.88 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.11 132.71 4.19 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 111.657 -0.577 . . . . 73.54 111.657 -177.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 60.2 mt -87.94 120.39 36.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 109.236 -0.653 . . . . 74.42 109.236 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -121.15 133.14 55.19 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.179 0.591 . . . . 73.1 109.929 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.9 m -111.37 92.99 4.25 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.747 -0.834 . . . . 54.33 108.747 175.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.19 142.71 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.103 0.961 . . . . 75.21 108.622 -176.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.99 160.62 39.52 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 122.967 0.507 . . . . 64.03 111.342 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.62 21.07 52.52 Favored Glycine 0 C--N 1.34 0.759 0 CA-C-N 114.572 -1.195 . . . . 75.44 114.414 171.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 33.2 mt -134.04 127.88 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 117.287 0.543 . . . . 75.34 109.665 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -140.96 171.85 13.49 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.942 0.897 . . . . 62.34 111.097 -171.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.97 -118.77 13.93 Favored Glycine 0 C--N 1.354 1.565 0 CA-C-N 114.944 -1.025 . . . . 63.55 114.861 172.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 20.4 m -86.94 -28.18 22.88 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.343 0.657 . . . . 60.31 111.046 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -68.36 -34.06 75.4 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.78 -0.646 . . . . 64.33 111.025 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -23.3 62.8 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 116.039 -0.528 . . . . 74.12 111.164 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.26 -26.95 68.68 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.86 0.464 . . . . 73.35 110.926 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -78.62 -40.73 33.52 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.843 0.857 . . . . 65.44 111.396 174.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -65.51 -43.97 88.41 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.907 0.483 . . . . 65.2 110.585 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 8.7 mp -67.54 -53.17 30.73 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.365 1.066 . . . . 74.11 109.981 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.81 -3.63 68.5 Favored Glycine 0 C--N 1.342 0.887 0 N-CA-C 115.057 0.783 . . . . 74.41 115.057 -171.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.13 -65.57 0.27 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.046 0.923 . . . . 65.35 112.906 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -61.91 -58.76 6.7 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.955 0.724 . . . . 73.31 112.955 -162.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 75.3 m -63.54 -44.79 82.41 Favored Pre-proline 0 CA--C 1.567 1.626 0 N-CA-C 113.923 1.083 . . . . 74.22 113.923 -175.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.73 -25.49 39.82 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 121.7 1.6 . . . . 73.53 113.132 172.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . 0.573 ' HA ' ' HD2' ' D' ' 107' ' ' PHE . 2.4 t-20 -69.47 -28.7 66.31 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.845 0.458 . . . . 75.12 110.75 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.427 HG21 HD12 ' D' ' 13' ' ' ILE . 51.6 mm -65.07 -35.27 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.402 0.681 . . . . 73.45 110.109 171.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.95 -19.04 48.89 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.587 -0.733 . . . . 74.12 112.619 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . 0.573 ' HD2' ' HA ' ' D' ' 104' ' ' ASN . 27.9 m-85 -60.9 -44.36 94.51 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 113.724 1.009 . . . . 75.31 113.724 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -51.14 -44.99 39.38 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 122.519 2.146 . . . . 73.32 114.329 170.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . 0.401 ' HH ' ' HE2' ' B' ' 107' ' ' PHE . 90.3 m-85 -77.16 -31.66 55.69 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.376 0.67 . . . . 75.23 111.897 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.14 -48.95 71.74 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.075 -0.713 . . . . 75.21 109.075 175.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -54.61 -47.15 73.76 Favored 'General case' 0 C--N 1.352 0.682 0 O-C-N 124.855 1.347 . . . . 75.42 110.937 177.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.35 -46.81 87.0 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.399 0.679 . . . . 72.4 111.311 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 36.4 t -62.05 -42.78 99.54 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.407 0.442 . . . . 74.0 111.238 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.515 HD12 HG22 ' D' ' 64' ' ' VAL . 96.9 mt -61.31 -58.3 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.119 0.967 . . . . 65.3 111.114 175.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 89.4 m -55.92 -40.77 73.56 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.569 1.148 . . . . 63.23 112.068 -173.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 44.7 t -65.04 -42.16 94.54 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.573 -0.739 . . . . 75.54 110.707 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.537 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.1 mtm -68.46 -31.69 71.17 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.811 0.444 . . . . 73.33 111.452 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.41 HG23 ' O ' ' D' ' 114' ' ' ILE . 73.6 t -63.43 -44.65 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 123.525 0.73 . . . . 71.53 110.373 174.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.7 p -77.77 -25.83 49.37 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.056 -0.52 . . . . 74.14 111.572 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -71.64 -36.27 70.67 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.316 0.647 . . . . 73.55 109.6 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.95 0.24 73.13 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.36 -0.837 . . . . 71.02 112.509 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.6 p 61.37 25.29 15.27 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.642 1.977 . . . . 72.22 113.405 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -80.37 164.13 53.53 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.266 1.027 . . . . 71.5 109.717 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.4 129.82 29.64 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.109 1.873 . . . . 72.55 111.423 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -51.32 123.64 10.09 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.402 1.081 . . . . 74.35 111.577 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -116.41 96.73 5.66 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.98 -1.118 . . . . 71.12 107.98 -174.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -98.66 117.89 34.14 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.897 -0.779 . . . . 74.32 108.897 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 6.4 mp -73.97 113.47 11.18 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 109.686 -0.487 . . . . 74.11 109.686 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -54.51 134.62 62.96 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 124.154 0.982 . . . . 74.21 110.953 176.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.499 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 2.8 Cg_exo -72.94 144.64 38.73 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.875 2.383 . . . . 74.4 111.756 -171.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--O 1.24 0.589 0 C-N-CA 123.643 0.777 . . . . 74.11 109.357 -177.358 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.593 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 26.6 t80 . . . . . 0 C--O 1.235 0.338 0 N-CA-C 109.334 -0.617 . . . . 74.13 109.334 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -143.33 119.58 10.84 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.701 0.8 . . . . 71.4 108.859 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.624 HG12 ' HD2' ' A' ' 84' ' ' PHE . 49.5 mt -80.2 124.6 38.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.513 -0.551 . . . . 74.52 109.513 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.23 -42.28 13.92 Favored 'General case' 0 C--O 1.245 0.848 0 O-C-N 123.993 0.808 . . . . 74.03 109.36 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -173.43 122.36 0.36 Allowed 'General case' 0 N--CA 1.483 1.185 0 O-C-N 123.081 0.238 . . . . 73.44 111.477 -168.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.553 HD13 ' HG3' ' C' ' 130' ' ' PRO . 94.8 mt -113.79 138.53 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.99 0.916 . . . . 74.11 109.26 175.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.437 ' HB3' HG21 ' B' ' 122' ' ' THR . 32.3 p90 -167.3 166.69 14.54 Favored 'General case' 0 C--N 1.347 0.496 0 O-C-N 123.902 0.751 . . . . 72.31 111.511 -173.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -89.24 127.29 35.75 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.116 -0.698 . . . . 74.51 109.116 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -96.52 -21.88 17.43 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 120.913 0.387 . . . . 74.34 109.958 176.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.739 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.0 t70 -152.16 141.27 21.29 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 114.7 -1.136 . . . . 75.01 109.588 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.412 HG22 ' SD ' ' A' ' 117' ' ' MET . 82.6 mt -141.51 138.29 32.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 106.556 -1.646 . . . . 74.0 106.556 175.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.5 t -144.66 128.32 17.17 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.55 -0.907 . . . . 72.42 108.55 174.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.666 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 87.4 t80 -138.48 124.84 20.49 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.164 -1.421 . . . . 72.24 107.164 175.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -125.59 142.68 51.38 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.915 -0.772 . . . . 71.53 108.915 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.33 71.53 39.15 Favored Pre-proline 0 C--O 1.243 0.755 0 N-CA-C 105.83 -1.915 . . . . 72.44 105.83 168.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.53 -15.16 34.18 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.39 2.06 . . . . 75.24 112.181 -170.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -117.18 21.6 13.07 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 118.169 -0.92 . . . . 73.0 109.495 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.41 ' O ' HG11 ' A' ' 31' ' ' VAL . . . -45.37 -59.17 4.72 Favored Pre-proline 0 N--CA 1.495 1.804 0 CA-C-O 117.998 -1.001 . . . . 63.32 113.329 -171.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.466 ' HB2' HD23 ' B' ' 51' ' ' LEU . 81.9 Cg_endo -72.16 -9.44 24.46 Favored 'Trans proline' 0 C--N 1.381 2.288 0 CA-C-N 121.629 1.617 . . . . 64.43 112.783 -176.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -90.31 -39.46 12.71 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.858 0.863 . . . . 75.44 110.251 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.713 HG22 ' HA ' ' A' ' 73' ' ' ALA . 6.5 p -79.21 -23.17 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 114.906 -1.043 . . . . 73.31 112.059 -162.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -67.48 -21.12 65.53 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.094 0.558 . . . . 74.22 110.928 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -74.46 -39.23 62.66 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.141 0.976 . . . . 75.32 110.307 173.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 3.3 tmtp? -69.01 143.35 54.37 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.71 1.204 . . . . 74.05 110.374 -169.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.505 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 12.9 m-20 -57.82 121.5 10.62 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.098 0.959 . . . . 74.14 110.843 175.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.414 ' CE3' HD21 ' A' ' 68' ' ' LEU . 70.4 t-105 -77.7 90.66 4.0 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.191 0.597 . . . . 74.22 110.691 -177.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.423 ' H ' HD23 ' A' ' 68' ' ' LEU . 40.6 tt0 -125.81 82.05 64.7 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 107.582 -1.266 . . . . 74.4 107.582 168.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.0 118.86 4.52 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.327 2.018 . . . . 74.43 112.836 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -95.79 94.67 7.8 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.512 -1.292 . . . . 74.22 107.512 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.0 t -67.7 101.21 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 114.622 -1.172 . . . . 75.23 109.594 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.23 115.76 19.96 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.535 1.134 . . . . 74.43 109.221 175.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -96.8 134.99 39.39 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.123 -0.695 . . . . 74.42 109.123 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.619 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 27.5 t70 -145.07 107.53 4.4 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.31 -0.996 . . . . 72.25 108.31 172.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.64 132.3 48.84 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.957 -0.757 . . . . 74.53 108.957 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.646 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 16.2 t70 -129.72 132.54 46.65 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.876 -0.787 . . . . 75.52 108.876 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.4 p -108.01 137.72 45.52 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.815 0.846 . . . . 75.03 110.158 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.57 139.28 18.84 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.745 0.818 . . . . 73.43 110.066 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.7 m -132.53 156.03 47.55 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.844 0.457 . . . . 74.22 110.472 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.3 t -148.8 118.12 6.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.149 0.979 . . . . 74.34 108.739 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 46.5 tt0 -76.93 122.53 25.0 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.95 -0.759 . . . . 72.13 108.95 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 75.7 mt -95.11 -31.72 13.43 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.528 0.731 . . . . 73.33 111.774 -172.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.45 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -155.8 -179.45 8.13 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.454 0.701 . . . . 73.34 110.008 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -65.88 117.7 8.63 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.901 -0.777 . . . . 64.24 108.901 172.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 65.96 18.24 11.01 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.828 1.251 . . . . 71.42 112.083 -178.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.45 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 58.4 t -126.22 121.94 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 108.391 -0.966 . . . . 72.53 108.391 174.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -129.02 172.29 11.53 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.259 0.552 . . . . 72.54 109.584 174.049 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -127.55 132.5 49.87 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.135 -0.938 . . . . 71.23 108.62 176.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.56 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 77.0 t -107.28 119.8 57.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 107.474 -1.306 . . . . 74.04 107.474 173.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.2 t -115.74 129.35 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 108.813 -0.81 . . . . 73.33 108.813 174.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tt -128.21 116.58 20.11 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.582 -0.896 . . . . 71.32 108.582 -176.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.646 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 15.6 ttm180 -84.34 106.06 15.66 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.43 1.092 . . . . 71.33 109.433 176.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.6 t -98.74 101.38 12.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 107.581 -1.266 . . . . 65.02 107.581 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.619 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 21.1 m -98.28 107.08 19.46 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.622 0.769 . . . . 71.53 109.076 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 t -113.38 109.1 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.231 1.012 . . . . 71.12 109.456 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -104.09 130.88 51.82 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 108.044 -1.095 . . . . 74.14 108.044 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.1 109.95 21.79 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.006 -1.479 . . . . 75.44 107.006 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.7 m -114.06 125.13 53.63 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.135 0.493 . . . . 63.21 110.019 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.423 HD23 ' H ' ' A' ' 37' ' ' GLN . 25.9 mt -93.36 76.14 4.51 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 107.896 -1.149 . . . . 71.45 107.896 176.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.38 -84.67 0.95 Allowed Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.414 -0.674 . . . . 64.23 111.414 -175.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -123.46 -25.28 4.42 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.29 1.036 . . . . 74.22 110.124 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -79.05 107.72 12.01 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.511 0.724 . . . . 73.11 109.98 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.5 m -66.14 130.68 44.08 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.113 0.483 . . . . 73.43 110.386 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.713 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -81.89 -58.96 2.75 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.16 -0.927 . . . . 72.14 109.179 175.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -154.99 169.01 25.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 114.396 -1.275 . . . . 75.33 110.945 176.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 23.8 tp -128.13 132.0 48.96 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.857 -1.535 . . . . 73.22 106.857 169.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.424 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 65.3 m -132.96 95.72 3.62 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.606 -0.887 . . . . 70.51 108.606 176.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -111.92 114.63 27.66 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.49 -0.929 . . . . 74.34 108.49 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -124.67 131.98 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 109.435 -0.579 . . . . 71.01 109.435 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.739 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 51.3 mt-30 -103.61 99.09 8.88 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.411 -0.588 . . . . 73.22 109.411 170.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -85.22 114.36 22.27 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.917 -1.038 . . . . 73.04 109.527 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.12 146.71 17.51 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.816 -0.514 . . . . 71.1 111.816 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.568 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -143.29 123.33 2.07 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 112.079 -0.408 . . . . 63.42 112.079 176.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.2 mt -81.98 124.29 38.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.752 -0.833 . . . . 73.12 108.752 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.624 ' HD2' HG12 ' A' ' 13' ' ' ILE . 18.9 m-85 -135.08 135.73 41.45 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.085 -0.709 . . . . 75.03 109.085 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.8 t -99.82 116.02 30.91 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.777 -0.823 . . . . 72.33 108.777 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.95 0 C-N-CA 124.639 1.176 . . . . 74.0 110.155 -173.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.619 0.247 . . . . 71.14 111.227 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -68.98 -31.86 71.02 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 116.044 -0.525 . . . . 73.24 110.634 173.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.406 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 42.0 t -68.65 -55.22 12.21 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.891 0.477 . . . . 54.44 110.742 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 pp -76.39 -16.7 59.66 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.42 0.526 . . . . 71.4 112.42 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.48 -7.24 46.06 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-O 119.465 -0.631 . . . . 64.43 114.57 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.01 -61.96 0.39 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 117.594 0.697 . . . . 75.25 110.891 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.41 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 70.7 t80 -62.08 -66.06 0.6 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.468 1.107 . . . . 65.14 113.581 -169.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.4 m -64.37 -38.24 31.69 Favored Pre-proline 0 CA--C 1.566 1.594 0 N-CA-C 113.741 1.015 . . . . 74.12 113.741 -175.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -65.3 -27.1 55.79 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 121.672 1.581 . . . . 75.2 113.769 167.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -72.41 -28.53 63.04 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 122.952 0.501 . . . . 72.4 109.744 176.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.2 mm -61.92 -40.41 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.457 0.703 . . . . 54.51 109.716 171.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.568 HD22 ' HA3' ' A' ' 82' ' ' GLY . 95.5 mt -77.41 -25.38 50.71 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.386 -0.825 . . . . 71.32 112.239 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -57.2 -45.06 99.96 Favored Pre-proline 0 CA--C 1.57 1.742 0 N-CA-C 113.683 0.994 . . . . 72.41 113.683 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -60.48 -31.63 92.71 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.245 1.963 . . . . 74.43 113.368 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -77.04 -35.63 56.73 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.297 0.639 . . . . 74.51 111.786 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.66 -38.81 84.3 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.478 -0.564 . . . . 74.01 109.478 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.442 ' NH1' HD13 ' C' ' 105' ' ' ILE . 37.7 ttm180 -64.35 -42.3 96.3 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.675 -1.148 . . . . 74.43 110.549 173.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -53.1 -51.68 61.07 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.142 0.977 . . . . 73.31 110.75 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 30.3 t -66.77 -47.82 71.0 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.569 -1.196 . . . . 73.43 111.173 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.84 -54.69 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.426 0.69 . . . . 64.52 111.041 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.0 m -55.91 -38.62 70.49 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.945 0.898 . . . . 62.45 111.723 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.0 t -65.69 -45.54 82.42 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.03 -0.532 . . . . 73.44 110.221 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.666 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 12.6 mtp -63.03 -39.92 96.18 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.009 0.924 . . . . 72.33 111.927 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.7 t -61.9 -45.65 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.935 0.894 . . . . 61.24 110.501 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.9 t -67.24 -37.89 84.3 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.242 -0.89 . . . . 62.02 111.415 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.491 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 83.6 mtt-85 -70.79 -27.72 64.11 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.34 0.656 . . . . 73.33 110.455 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.55 14.18 47.99 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-O 119.227 -0.763 . . . . 72.43 113.278 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.483 HG23 ' HE ' ' B' ' 15' ' ' ARG . 4.4 t 58.31 16.47 4.05 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 127.059 2.144 . . . . 74.41 113.47 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -82.53 150.83 64.1 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.471 0.708 . . . . 73.2 110.363 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -55.39 153.6 27.48 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.248 2.632 . . . . 74.12 113.548 174.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -59.97 132.2 53.21 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.327 1.051 . . . . 73.14 112.552 -171.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.1 tp -131.64 110.42 10.91 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.575 1.15 . . . . 72.42 109.432 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -127.13 114.71 18.08 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 108.401 -0.963 . . . . 73.13 108.401 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.2 mp -67.17 148.85 51.27 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.82 0.448 . . . . 64.12 110.983 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.83 128.66 92.78 Favored Pre-proline 0 CA--C 1.551 0.997 0 O-C-N 123.955 0.785 . . . . 71.51 110.256 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.438 ' HG2' ' CE2' ' C' ' 11' ' ' PHE . 10.4 Cg_exo -74.68 111.9 3.43 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 122.955 2.436 . . . . 71.32 112.178 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.4 m -102.29 116.87 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.314 0.645 . . . . 73.14 109.601 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -76.05 91.07 3.07 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 115.543 -0.753 . . . . 74.04 109.469 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 . . . . . 0 N--CA 1.476 0.854 0 C-N-CA 124.279 1.032 . . . . 71.44 110.673 -179.435 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.511 ' HE2' ' HB2' ' B' ' 11' ' ' PHE . 26.8 ptm . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 115.969 1.841 . . . . 75.31 115.969 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 56.6 m -143.64 123.07 13.13 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 107.232 -1.396 . . . . 75.31 107.232 166.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.511 ' HB2' ' HE2' ' B' ' 9' ' ' MET . 55.1 t80 -131.37 139.36 49.47 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.874 0.87 . . . . 73.42 108.888 -177.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.496 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -155.82 128.98 8.13 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 109.81 -0.441 . . . . 74.34 109.81 174.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.539 HD11 HD12 ' B' ' 105' ' ' ILE . 18.8 mt -77.92 121.5 30.78 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 N-CA-C 108.272 -1.011 . . . . 73.15 108.272 173.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -100.35 -32.77 10.68 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 123.754 0.659 . . . . 70.24 110.056 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.483 ' HE ' HG23 ' A' ' 122' ' ' THR . 49.7 ttt180 -172.37 143.58 1.44 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.959 0.504 . . . . 74.54 109.974 -177.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 84.6 mt -128.34 137.54 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 107.953 -1.128 . . . . 75.41 107.953 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -163.37 160.75 23.95 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-O 121.591 0.71 . . . . 73.51 112.287 -175.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.444 HG21 ' CD1' ' B' ' 21' ' ' ILE . 91.7 m -92.49 126.98 37.81 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.0 -1.0 . . . . 75.44 108.309 168.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -91.83 -25.51 18.95 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.353 0.661 . . . . 72.24 111.002 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -158.94 135.49 9.34 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 120.679 0.276 . . . . 71.2 111.713 -172.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.699 HD12 ' SG ' ' B' ' 113' ' ' CYS . 44.4 mm -125.74 141.4 45.61 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 C-N-CA 124.809 1.244 . . . . 72.24 109.585 173.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.517 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 46.5 t -138.01 141.76 40.4 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 107.686 -1.228 . . . . 64.32 107.686 175.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -159.28 134.55 8.33 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.66 -1.237 . . . . 72.23 107.66 169.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -137.36 157.84 45.72 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.027 0.931 . . . . 73.32 108.644 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.12 82.03 12.22 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 106.917 -1.512 . . . . 73.11 106.917 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.95 -25.32 27.84 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 123.042 2.495 . . . . 63.21 113.53 -169.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -112.75 14.27 19.92 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.663 0.785 . . . . 72.52 110.706 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.471 ' HB1' ' HD3' ' B' ' 29' ' ' PRO . . . -40.78 -62.93 0.85 Allowed Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 115.122 1.527 . . . . 73.23 115.122 -163.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.471 ' HD3' ' HB1' ' B' ' 28' ' ' ALA . 23.1 Cg_exo -61.3 -33.52 89.41 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 122.252 1.968 . . . . 71.12 112.793 -171.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -95.88 -20.5 18.74 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.358 -0.837 . . . . 74.3 112.633 -173.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.43 HG21 ' HA ' ' B' ' 73' ' ' ALA . 5.0 p -82.34 -11.5 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-N 118.459 0.572 . . . . 73.52 110.749 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -70.12 -14.94 62.88 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 112.879 0.696 . . . . 74.14 112.879 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -68.27 -12.54 61.19 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.046 0.538 . . . . 73.54 111.209 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -104.31 105.81 16.08 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.647 1.179 . . . . 73.24 109.29 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -111.01 92.47 4.06 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.743 -0.836 . . . . 61.44 108.743 175.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 8.1 p90 -159.27 -175.69 5.38 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.91 0.884 . . . . 74.15 109.262 170.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -68.4 110.27 5.49 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 123.899 0.88 . . . . 72.54 110.494 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.487 ' HA ' HD21 ' B' ' 68' ' ' LEU . 14.0 Cg_endo -67.62 137.28 41.93 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 121.069 1.179 . . . . 74.42 111.334 177.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.83 110.13 3.18 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 109.09 -0.707 . . . . 75.15 109.09 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 59.3 t -94.5 123.73 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 123.858 0.863 . . . . 74.14 110.692 -174.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -103.45 102.03 11.94 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 106.76 -1.57 . . . . 74.14 106.76 169.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 pp -97.21 148.08 23.45 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.918 -0.583 . . . . 72.1 109.597 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -135.93 154.26 51.17 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.838 1.255 . . . . 71.32 108.056 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 21.1 tp -133.44 126.48 31.28 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.663 -0.865 . . . . 72.4 108.663 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -127.45 147.45 50.3 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.663 1.185 . . . . 75.11 109.972 -172.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 76.0 p -121.9 117.48 26.58 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.056 0.942 . . . . 62.31 110.486 -172.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.13 142.11 44.2 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.906 0.882 . . . . 64.44 108.657 174.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 52.4 p -148.44 176.06 10.61 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.196 0.443 . . . . 73.1 112.196 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 74.9 p -155.79 153.12 29.33 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.299 1.04 . . . . 65.12 109.006 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -102.27 121.52 42.42 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.889 -0.782 . . . . 61.33 108.889 170.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.466 HD23 ' HB2' ' A' ' 29' ' ' PRO . 18.7 mt -85.21 -50.48 7.35 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.747 0.819 . . . . 73.23 109.764 -173.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.78 -176.1 4.64 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.69 -1.141 . . . . 73.05 109.225 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -59.69 110.49 1.15 Allowed 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.025 0.828 . . . . 74.31 109.32 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 64.11 20.21 12.09 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.278 1.031 . . . . 70.22 112.653 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 79.7 t -116.61 112.93 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 106.868 -1.53 . . . . 65.42 106.868 168.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -129.17 137.02 50.92 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.518 -0.919 . . . . 75.21 108.518 -169.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.463 ' HB2' HD13 ' B' ' 51' ' ' LEU . 4.1 tt0 -101.02 124.82 47.33 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.207 -1.035 . . . . 73.33 108.207 174.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 18.5 m -109.26 134.77 50.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.515 -0.92 . . . . 75.51 108.515 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.78 134.32 54.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.529 -0.915 . . . . 72.11 108.529 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' B' ' 103' ' ' PRO . 24.8 tp -115.12 101.18 8.74 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 109.18 -0.674 . . . . 74.24 109.18 174.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -87.48 117.5 26.31 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 123.014 0.526 . . . . 74.1 109.617 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 18.9 t -107.37 122.0 61.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 107.616 -1.253 . . . . 72.04 107.616 171.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.6 m -114.39 138.01 51.09 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.481 -0.562 . . . . 45.31 109.481 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.573 HG22 HG21 ' B' ' 114' ' ' ILE . 71.0 t -129.2 125.2 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.204 1.002 . . . . 73.35 109.81 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 65.3 m -116.04 146.3 42.29 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.299 -1.371 . . . . 63.15 107.299 162.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.55 139.53 35.03 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.285 -1.006 . . . . 73.01 108.285 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.523 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 34.3 p -140.5 136.22 32.71 Favored 'General case' 0 C--O 1.226 -0.183 0 O-C-N 123.413 0.445 . . . . 65.42 110.667 -175.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.487 HD21 ' HA ' ' B' ' 38' ' ' PRO . 92.5 mt -109.51 109.38 20.17 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.799 -1.186 . . . . 73.35 107.799 175.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.23 -137.7 20.17 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.78 -0.645 . . . . 72.02 112.271 -173.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -94.57 14.13 21.89 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.18 0.992 . . . . 73.51 110.818 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -132.17 152.14 51.43 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.345 0.658 . . . . 71.51 110.558 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 64.8 m -75.15 125.65 29.39 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.448 0.699 . . . . 72.23 111.224 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.523 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -78.59 -59.17 2.89 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 114.897 -1.047 . . . . 74.05 108.683 176.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -153.25 160.82 42.84 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 115.179 -0.918 . . . . 65.44 112.483 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 59.5 mt -118.84 154.21 33.26 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.496 1.519 . . . . 72.21 107.812 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.2 t -161.06 157.5 26.23 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.371 0.668 . . . . 72.0 109.23 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 34.8 tt0 -166.02 130.77 2.29 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.044 -0.724 . . . . 74.24 109.044 175.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.404 HG11 ' HA ' ' B' ' 110' ' ' ALA . 96.7 t -123.66 143.65 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 108.707 -0.849 . . . . 75.25 108.707 173.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -124.8 96.33 4.84 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.563 -0.903 . . . . 74.0 108.563 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.403 ' HB2' ' HB1' ' B' ' 110' ' ' ALA . 8.5 tp-100 -85.72 100.07 11.75 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.568 -0.53 . . . . 74.45 109.568 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.15 144.66 17.19 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 111.357 -0.697 . . . . 74.21 111.357 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.49 131.81 4.35 Favored Glycine 0 C--O 1.236 0.274 0 N-CA-C 111.704 -0.558 . . . . 72.21 111.704 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.43 HG22 HD12 ' B' ' 51' ' ' LEU . 69.7 mt -84.63 126.95 40.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 N-CA-C 108.375 -0.972 . . . . 74.05 108.375 172.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -138.62 149.42 45.19 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.199 -0.667 . . . . 74.41 109.199 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 70.4 m -92.38 120.87 33.32 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.783 -0.821 . . . . 75.31 108.783 170.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.43 HD12 ' SG ' ' B' ' 97' ' ' CYS . 3.9 tp -120.71 118.83 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.438 1.095 . . . . 65.15 109.584 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.56 167.08 30.7 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.196 0.598 . . . . 72.23 109.981 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.14 -67.8 3.07 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.36 -0.382 . . . . 71.11 112.83 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mm -82.25 141.78 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.233 0.613 . . . . 75.32 110.813 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.443 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 11.3 pt-20 -153.09 -175.28 5.26 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.114 0.965 . . . . 71.22 109.803 -173.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.87 -133.74 37.43 Favored Glycine 0 C--N 1.354 1.582 0 C-N-CA 123.471 0.557 . . . . 51.04 113.396 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 55.4 m -66.0 -37.52 86.16 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.952 0.901 . . . . 70.45 110.614 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -67.79 -23.22 65.18 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 115.614 -0.721 . . . . 72.22 111.436 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.443 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 22.5 ttp -65.25 -29.49 70.28 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.966 0.906 . . . . 74.33 111.599 175.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.18 -29.99 71.08 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.764 0.826 . . . . 75.41 111.491 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . 0.448 ' O ' ' HB2' ' B' ' 100' ' ' ALA . 45.6 t-80 -69.42 -30.15 68.03 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.444 0.698 . . . . 74.53 111.427 175.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.488 ' SG ' ' HE3' ' B' ' 9' ' ' MET . 44.6 t -79.62 -56.42 4.31 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.458 0.303 . . . . 64.42 111.134 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mp -81.61 -35.6 29.9 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.926 0.491 . . . . 74.23 112.27 -172.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.18 3.87 82.56 Favored Glycine 0 N--CA 1.47 0.961 0 CA-C-O 119.676 -0.514 . . . . 72.52 113.69 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' B' ' 96' ' ' HIS . . . -148.8 -66.88 0.23 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.531 0.567 . . . . 71.52 112.531 -172.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.429 ' HH ' ' HB2' ' D' ' 130' ' ' PRO . 30.4 t80 -60.51 -47.9 84.1 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.272 1.029 . . . . 73.2 111.945 -171.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 67.4 m -70.15 -45.5 21.43 Favored Pre-proline 0 CA--C 1.567 1.631 0 CA-C-O 118.339 -0.839 . . . . 74.1 112.241 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.422 ' HA ' HD23 ' B' ' 60' ' ' LEU . 60.5 Cg_exo -48.07 -40.43 33.81 Favored 'Trans proline' 0 C--N 1.4 3.271 0 C-N-CA 123.137 2.558 . . . . 71.34 114.389 167.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -62.66 -26.06 68.45 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 112.295 0.48 . . . . 71.31 112.295 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.539 HD12 HD11 ' B' ' 13' ' ' ILE . 57.6 mt -84.53 -45.87 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.452 0.701 . . . . 62.54 110.663 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 99.2 mt -82.03 -21.69 36.83 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.329 0.652 . . . . 74.34 112.461 -170.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -57.3 -50.74 86.43 Favored Pre-proline 0 N--CA 1.489 1.497 0 CA-C-O 117.654 -1.165 . . . . 70.22 113.329 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.54 -40.57 83.14 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 122.343 2.029 . . . . 75.34 114.105 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -67.69 -47.98 67.87 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.193 0.597 . . . . 74.44 110.366 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.404 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -63.9 -35.59 81.14 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.466 -0.788 . . . . 73.44 111.292 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -59.05 -58.2 9.72 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.366 1.067 . . . . 74.02 110.399 177.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -62.7 -33.03 74.26 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 123.924 0.765 . . . . 74.33 110.178 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.699 ' SG ' HD12 ' B' ' 21' ' ' ILE . 2.0 t -69.64 -38.59 77.21 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 122.902 0.481 . . . . 65.03 111.735 -176.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.573 HG21 HG22 ' B' ' 64' ' ' VAL . 89.4 mt -65.29 -56.02 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.879 -0.786 . . . . 75.01 108.879 172.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 9.7 m -59.43 -27.74 66.31 Favored 'General case' 0 CA--C 1.554 1.101 0 O-C-N 124.579 1.174 . . . . 74.2 111.619 -174.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.456 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.5 t -65.55 -48.67 71.62 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 123.682 0.793 . . . . 64.51 109.847 175.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.468 ' HE1' HG22 ' B' ' 21' ' ' ILE . 11.2 mmt -70.59 -33.96 71.64 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.236 0.614 . . . . 74.31 110.83 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.434 HG23 ' O ' ' B' ' 114' ' ' ILE . 97.8 t -58.12 -45.23 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 124.046 0.938 . . . . 72.44 109.803 172.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 22.6 t -71.8 -30.14 65.2 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.161 -1.381 . . . . 74.22 111.421 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' B' ' 116' ' ' SER . 82.1 mtt-85 -68.76 -31.97 71.39 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.145 -0.48 . . . . 72.02 109.871 175.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.5 6.85 67.01 Favored Glycine 0 C--N 1.355 1.609 0 O-C-N 123.837 0.71 . . . . 74.3 113.116 173.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.437 HG21 ' HB3' ' A' ' 17' ' ' TYR . 59.6 p 59.83 25.84 14.96 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 126.244 1.818 . . . . 73.03 113.166 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -88.39 160.59 44.89 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 123.805 0.842 . . . . 75.41 111.204 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.49 164.65 5.3 Favored 'Trans proline' 0 C--N 1.39 2.759 0 C-N-CA 123.454 2.77 . . . . 70.44 114.834 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.502 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -64.59 132.15 49.0 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.241 1.016 . . . . 75.45 111.302 -178.76 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 49.6 tp -137.9 114.56 10.51 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.134 0.573 . . . . 74.33 109.825 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -128.82 129.5 45.7 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.65 0.78 . . . . 72.11 109.173 174.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mp -82.41 145.42 29.88 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 123.578 0.751 . . . . 74.42 109.225 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.73 133.25 95.02 Favored Pre-proline 0 CA--C 1.554 1.101 0 O-C-N 123.664 0.603 . . . . 71.42 110.929 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.32 100.23 0.26 Allowed 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.898 2.398 . . . . 62.34 111.859 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 48.8 t -90.42 109.52 20.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 108.58 -0.896 . . . . 74.22 108.58 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -89.86 90.36 8.15 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 107.949 -1.13 . . . . 71.22 107.949 176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -58.55 -35.54 72.49 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.127 -0.942 . . . . 71.34 110.355 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 t70 . . . . . 0 N--CA 1.472 0.634 0 C-N-CA 124.531 1.132 . . . . 63.14 111.097 -174.365 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.438 ' CE2' ' HG2' ' A' ' 130' ' ' PRO . 50.6 t80 . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 108.817 -0.809 . . . . 74.4 108.817 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -150.61 140.1 21.5 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.632 -0.507 . . . . 74.22 109.632 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.415 HG12 ' HE2' ' C' ' 84' ' ' PHE . 43.5 mt -83.38 127.14 40.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.828 -0.804 . . . . 75.12 108.828 173.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.488 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 23.5 mm-40 -92.34 -40.0 11.16 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 123.666 0.604 . . . . 74.14 109.639 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -176.74 124.66 0.16 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.378 0.671 . . . . 75.44 109.812 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.5 mt -110.23 148.22 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 108.454 -0.943 . . . . 74.21 108.454 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -173.61 160.02 3.69 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.046 0.938 . . . . 75.1 109.235 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' THR . . . . . 0.403 HG23 HE22 ' C' ' 80' ' ' GLN . 76.8 p -81.18 107.78 14.27 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.199 -0.667 . . . . 74.44 109.199 176.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt -65.27 -47.72 75.71 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.822 0.82 . . . . 72.4 109.262 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.3 t70 -143.33 144.54 32.13 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.114 -1.403 . . . . 73.41 109.513 -174.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.3 mt -139.13 147.12 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.229 1.411 . . . . 74.54 107.335 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -157.25 150.8 24.12 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.32 0.648 . . . . 74.31 110.008 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -151.91 149.03 28.49 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.713 -1.217 . . . . 73.0 107.713 171.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -147.5 149.55 32.86 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.112 1.365 . . . . 70.04 107.617 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.8 84.72 3.73 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 107.316 -1.364 . . . . 71.34 107.316 169.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.65 -38.3 73.08 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.228 2.619 . . . . 73.41 113.139 -173.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -107.18 19.71 20.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.812 0.845 . . . . 75.1 110.999 -172.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.438 ' O ' HG13 ' C' ' 31' ' ' VAL . . . -45.94 -58.33 6.47 Favored Pre-proline 0 CA--C 1.562 1.426 0 CA-C-O 117.355 -1.307 . . . . 70.34 114.259 -170.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -54.55 -47.46 26.7 Favored 'Trans proline' 0 C--N 1.389 2.694 0 C-N-CA 122.106 1.871 . . . . 71.51 112.255 -177.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.509 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.9 t60 -71.38 -32.9 69.01 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.11 -0.95 . . . . 70.2 112.843 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.659 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.8 p -77.3 -24.02 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 112.541 0.571 . . . . 75.12 112.541 -169.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -63.44 -26.19 68.62 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.085 0.772 . . . . 71.04 113.085 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 10.4 pt20 -87.53 6.6 33.43 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.017 0.527 . . . . 74.14 111.521 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.732 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -88.38 154.89 20.03 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.937 0.895 . . . . 75.35 110.509 179.246 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -66.13 128.2 35.17 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.509 -0.768 . . . . 73.5 109.067 165.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -78.69 90.18 4.59 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.388 0.675 . . . . 75.43 110.796 -174.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -132.96 76.99 69.35 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 124.275 1.03 . . . . 75.4 108.927 174.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -85.83 123.43 2.43 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.521 2.147 . . . . 61.51 112.295 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -83.26 83.68 7.77 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 106.788 -1.56 . . . . 70.43 106.788 167.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 5.6 p -71.83 116.24 13.36 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 CA-C-N 114.081 -1.418 . . . . 72.55 110.787 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -108.24 102.51 11.63 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.298 -1.001 . . . . 75.43 108.298 173.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.65 137.44 32.33 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.305 -0.628 . . . . 70.32 109.305 176.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.426 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 16.0 t70 -119.59 147.72 44.17 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.384 1.074 . . . . 73.52 108.141 -177.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 16.3 tp -130.0 112.5 13.54 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.148 0.499 . . . . 74.2 110.01 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.597 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 13.5 t70 -113.73 154.08 27.93 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.156 1.382 . . . . 75.55 109.153 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 34.0 p -135.32 132.12 37.29 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.489 0.716 . . . . 74.32 110.48 -173.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.46 154.7 48.45 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.918 0.887 . . . . 73.42 109.288 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 48.3 p -160.99 146.68 14.47 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.799 0.333 . . . . 64.04 111.811 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 68.1 p -150.11 133.38 16.37 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.064 0.946 . . . . 74.23 109.154 174.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -76.98 120.82 22.63 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.315 0.646 . . . . 74.01 109.897 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.581 HD12 ' HB2' ' C' ' 57' ' ' GLU . 26.2 mt -94.1 -30.25 14.76 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.154 0.582 . . . . 61.55 110.517 -177.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.33 -178.92 6.99 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.299 1.04 . . . . 72.1 109.882 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.25 113.05 2.95 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.731 -0.668 . . . . 74.14 109.978 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . 0.434 ' HA ' ' HE1' ' C' ' 56' ' ' TYR . 3.6 m-20 63.26 18.63 11.13 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.536 1.134 . . . . 73.22 112.503 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 83.9 t -115.4 114.47 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.131 -1.063 . . . . 74.33 108.131 170.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . 0.434 ' HE1' ' HA ' ' C' ' 54' ' ' ASP . 83.4 m-85 -126.64 134.29 50.78 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.921 0.888 . . . . 64.34 109.018 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.581 ' HB2' HD12 ' C' ' 51' ' ' LEU . 40.2 tt0 -84.58 114.3 21.88 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.082 -1.081 . . . . 74.01 108.082 170.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.9 t -95.93 124.22 48.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 107.693 -1.225 . . . . 74.45 107.693 173.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 94.9 t -117.66 133.27 64.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 107.759 -1.2 . . . . 74.24 107.759 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.447 HD13 ' HB3' ' C' ' 103' ' ' PRO . 23.7 tp -127.8 105.76 8.66 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.691 -0.855 . . . . 74.42 108.691 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.597 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 9.2 ttm180 -82.89 122.61 28.47 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.34 -0.615 . . . . 75.15 109.34 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.465 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.2 t -113.83 127.78 71.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.031 -1.1 . . . . 74.12 108.031 171.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 31.5 m -123.5 110.12 14.68 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.017 0.527 . . . . 73.3 109.607 -177.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.546 HG21 HD12 ' C' ' 114' ' ' ILE . 69.3 t -99.72 108.43 22.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 108.883 -0.784 . . . . 73.41 108.883 -177.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 3.8 m -99.5 126.32 45.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.982 -0.748 . . . . 54.11 108.982 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.38 106.69 13.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.307 -0.997 . . . . 63.32 108.307 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 22.1 m -127.02 129.46 48.1 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.814 -0.81 . . . . 71.33 108.814 175.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.732 HD11 ' HG2' ' C' ' 34' ' ' LYS . 8.1 mt -85.09 32.64 0.54 Allowed 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 125.109 1.364 . . . . 64.52 110.78 -178.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.81 -108.83 2.36 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 110.728 -0.949 . . . . 75.25 110.728 -171.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.71 -23.06 23.06 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.393 0.677 . . . . 73.34 109.943 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.13 115.83 22.07 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 123.993 0.917 . . . . 74.43 109.48 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 79.3 m -84.39 123.84 30.66 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 118.756 0.707 . . . . 74.12 109.164 169.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.659 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -77.38 -57.32 3.89 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.007 -0.997 . . . . 74.31 109.281 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -157.86 172.48 18.39 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 122.103 0.954 . . . . 72.34 111.639 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -135.18 128.36 31.87 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 105.611 -1.996 . . . . 75.03 105.611 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 44.4 t -128.26 143.5 51.03 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.134 -1.061 . . . . 62.41 108.134 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.48 123.29 5.18 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.206 0.316 . . . . 73.34 110.367 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 61.8 t -134.12 125.25 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.457 0.703 . . . . 75.14 109.526 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 25.8 mt-30 -96.02 98.48 10.41 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.926 -1.138 . . . . 72.23 107.926 172.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.403 HE22 HG23 ' C' ' 18' ' ' THR . 10.0 tp-100 -84.25 121.48 27.56 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.053 -0.522 . . . . 62.42 110.153 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.9 147.23 16.7 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 112.168 -0.373 . . . . 75.2 112.168 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.407 ' HA3' HD22 ' C' ' 106' ' ' LEU . . . -148.75 125.14 1.98 Allowed Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.169 -1.173 . . . . 72.4 110.169 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.532 HD13 HD12 ' C' ' 51' ' ' LEU . 13.1 mm -80.63 127.62 39.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 107.554 -1.276 . . . . 74.52 107.554 174.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.415 ' HE2' HG12 ' C' ' 13' ' ' ILE . 64.6 m-85 -134.42 142.28 47.08 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.976 0.417 . . . . 72.31 110.667 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 11.5 p -96.28 107.61 19.99 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 108.246 -1.02 . . . . 73.25 108.246 168.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 69.9 mt -115.36 116.47 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.368 1.067 . . . . 73.45 109.245 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.08 172.38 18.51 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.749 0.82 . . . . 71.42 111.181 -171.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.46 -59.2 0.94 Allowed Glycine 0 C--N 1.349 1.264 0 CA-C-N 116.302 -0.408 . . . . 71.12 113.308 170.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 38.1 pt -94.36 -177.24 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.634 0.774 . . . . 74.22 110.172 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -164.49 155.12 14.78 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 122.974 0.51 . . . . 73.53 110.93 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.04 -130.78 11.69 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 119.25 -0.75 . . . . 65.31 113.845 171.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 21.5 m -55.72 -40.29 72.23 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.5 1.12 . . . . 73.41 111.577 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -56.25 -48.21 77.0 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.404 -1.271 . . . . 73.14 109.817 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.492 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 56.2 ttm -80.33 -27.16 38.41 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 114.822 -1.081 . . . . 73.24 111.234 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.25 81.9 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.53 0.732 . . . . 62.2 111.359 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . 0.515 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 57.8 t-80 -70.75 -28.54 64.77 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.189 -0.914 . . . . 75.03 111.157 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 50.3 t -77.43 -55.33 5.48 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 122.229 -0.294 . . . . 73.24 111.222 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' C' ' 94' ' ' MET . 1.0 OUTLIER -78.09 -22.78 48.45 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 112.968 0.729 . . . . 72.43 112.968 -173.443 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . 0.427 ' N ' HD11 ' C' ' 98' ' ' LEU . . . -97.59 0.62 59.69 Favored Glycine 0 C--N 1.346 1.089 0 O-C-N 123.403 0.44 . . . . 74.35 112.871 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -140.62 -69.18 0.4 Allowed 'General case' 0 C--N 1.347 0.485 0 C-N-CA 123.344 0.658 . . . . 72.14 110.455 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -65.24 -51.85 58.28 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.496 0.924 . . . . 74.52 113.496 -168.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.45 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 19.9 m -61.63 -47.05 93.61 Favored Pre-proline 0 CA--C 1.564 1.506 0 CA-C-O 118.845 -0.598 . . . . 74.3 112.363 -173.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 21.7 Cg_exo -68.91 -26.11 32.0 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 121.997 1.798 . . . . 74.21 112.971 172.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -72.49 -25.43 61.41 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.447 0.699 . . . . 73.24 110.719 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.442 HD13 ' NH1' ' A' ' 111' ' ' ARG . 28.7 mm -66.02 -35.27 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.036 0.534 . . . . 74.21 109.586 169.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.407 HD22 ' HA3' ' C' ' 82' ' ' GLY . 84.3 mt -87.18 -17.68 32.11 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.048 0.939 . . . . 75.22 112.452 -176.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -54.39 -50.77 83.15 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 117.534 -1.222 . . . . 75.53 112.863 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -55.24 -36.75 94.12 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.75 2.3 . . . . 73.13 114.594 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -75.46 -44.16 45.65 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.808 0.443 . . . . 74.31 110.55 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.31 -45.74 90.48 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.453 -0.794 . . . . 73.51 109.662 174.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 41.2 ttt-85 -54.26 -51.49 64.39 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.497 1.519 . . . . 71.53 111.506 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.85 -35.58 74.84 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.319 0.648 . . . . 74.44 110.421 -176.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.6 t -71.75 -31.62 66.85 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.005 0.522 . . . . 74.14 110.901 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.546 HD12 HG21 ' C' ' 64' ' ' VAL . 89.4 mt -70.89 -53.47 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.451 0.7 . . . . 74.42 109.661 174.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.9 m -64.35 -28.79 69.94 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.366 0.667 . . . . 74.43 111.249 -176.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.1 t -65.2 -48.63 72.71 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 109.061 -0.718 . . . . 73.11 109.061 173.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.647 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.86 -36.68 84.08 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.508 1.123 . . . . 72.33 112.354 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.41 HG23 ' O ' ' C' ' 114' ' ' ILE . 97.2 t -67.89 -40.89 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.436 0.694 . . . . 75.55 110.094 176.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 48.4 t -70.18 -29.66 66.59 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.162 -0.926 . . . . 75.35 111.371 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.4 ' HD2' ' SD ' ' C' ' 117' ' ' MET . 86.5 mtt-85 -72.26 -32.18 66.44 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.622 0.769 . . . . 74.32 109.598 176.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.17 5.96 69.67 Favored Glycine 0 C--N 1.354 1.564 0 O-C-N 124.014 0.821 . . . . 65.43 112.91 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.44 HG22 ' HB3' ' D' ' 17' ' ' TYR . 76.7 p 57.73 28.3 15.65 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 126.273 1.829 . . . . 73.42 113.278 178.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -88.16 155.38 52.12 Favored Pre-proline 0 CA--C 1.555 1.153 0 N-CA-C 109.213 -0.662 . . . . 75.3 109.213 171.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.39 142.66 29.19 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 123.166 2.577 . . . . 70.3 113.382 172.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.448 ' HA ' HE21 ' C' ' 125' ' ' GLN . 0.0 OUTLIER -59.98 112.27 1.81 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.694 0.798 . . . . 73.31 111.411 -176.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 48.8 tp -113.38 93.08 4.23 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.469 -0.937 . . . . 75.31 108.469 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -91.48 127.84 37.08 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.364 -0.976 . . . . 74.32 108.364 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 89.0 mt -69.54 134.47 48.88 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 123.375 0.422 . . . . 72.33 110.18 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.09 158.73 76.94 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 123.822 0.849 . . . . 74.52 110.751 -178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.553 ' HG3' HD13 ' A' ' 16' ' ' ILE . 23.5 Cg_endo -56.85 112.0 0.97 Allowed 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.918 2.412 . . . . 73.35 112.666 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 p -96.97 107.49 19.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 107.507 -1.294 . . . . 74.41 107.507 170.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -90.86 82.83 5.65 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.812 -1.085 . . . . 72.05 109.121 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -58.61 -44.83 90.06 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.223 0.535 . . . . 71.54 109.566 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 . . . . . 0 N--CA 1.468 0.457 0 CA-C-N 114.453 -1.249 . . . . 73.43 112.127 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 85.4 m . . . . . 0 C--O 1.241 0.62 0 N-CA-C 108.469 -0.937 . . . . 75.43 108.469 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -154.81 108.25 2.86 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.99 -1.115 . . . . 72.14 107.99 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -122.42 119.78 32.0 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.84 -0.8 . . . . 74.01 108.84 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 65.7 mt -68.09 135.52 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 109.872 -0.418 . . . . 74.1 109.872 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.476 HE22 HG12 ' D' ' 55' ' ' VAL . 51.6 mt-30 -101.41 -39.54 7.51 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.069 0.547 . . . . 74.43 111.405 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 15.4 ttt180 -172.03 135.8 0.83 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.706 0.23 . . . . 71.14 111.374 -169.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.4 mp -120.6 135.51 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 107.59 -1.263 . . . . 73.3 107.59 167.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.44 ' HB3' HG22 ' C' ' 122' ' ' THR . 37.1 p90 -163.53 168.78 19.66 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.941 0.877 . . . . 70.23 111.301 177.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.2 p -99.15 128.33 45.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.316 -1.311 . . . . 74.52 109.082 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -104.66 -15.14 15.36 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.025 0.53 . . . . 72.52 110.384 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.725 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 28.3 t70 -158.62 132.66 7.8 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.484 -1.235 . . . . 72.32 108.157 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.647 HG21 ' HE1' ' C' ' 117' ' ' MET . 57.4 mt -138.8 148.14 24.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.545 -1.279 . . . . 73.51 107.545 176.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 27.2 t -154.13 145.42 22.96 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.416 0.686 . . . . 70.3 109.818 173.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.443 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.1 t80 -149.97 122.02 8.26 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 105.55 -2.018 . . . . 75.31 105.55 172.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 26.6 mt-10 -130.4 111.54 12.42 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.96 -0.756 . . . . 72.43 108.96 -173.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.69 86.22 18.46 Favored Pre-proline 0 C--O 1.241 0.615 0 N-CA-C 108.683 -0.858 . . . . 73.23 108.683 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.77 -39.89 2.24 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.36 2.04 . . . . 73.34 111.727 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -86.72 -3.34 59.03 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.812 1.245 . . . . 74.25 111.31 -176.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -23.74 -67.95 0.05 OUTLIER Pre-proline 0 C--N 1.361 1.096 0 C-N-CA 127.465 2.306 . . . . 75.43 116.737 -165.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.52 ' HB3' HD11 ' C' ' 83' ' ' ILE . 86.2 Cg_endo -73.64 -29.74 10.44 Favored 'Trans proline' 0 C--N 1.375 1.951 0 CA-C-N 123.133 2.155 . . . . 75.54 113.582 -168.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -87.36 -22.52 25.01 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.623 0.249 . . . . 74.1 110.672 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.522 HG23 HD11 ' D' ' 68' ' ' LEU . 10.0 p -81.75 -18.1 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 122.866 0.466 . . . . 74.41 110.482 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -65.62 -18.77 65.57 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 112.562 0.578 . . . . 75.22 112.562 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -64.58 -12.35 44.2 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.131 0.972 . . . . 74.14 111.602 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -102.62 106.83 17.57 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.167 1.387 . . . . 71.44 110.463 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -102.96 83.81 2.28 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.998 0.919 . . . . 74.11 110.158 -176.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -158.28 175.65 13.47 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.698 0.799 . . . . 72.22 109.171 169.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -66.5 111.95 8.12 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 123.412 0.685 . . . . 64.44 110.101 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.408 ' HB2' ' HB3' ' D' ' 66' ' ' ALA . 73.9 Cg_exo -56.12 119.44 6.62 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.004 2.469 . . . . 71.45 111.649 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -60.56 113.74 2.6 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.561 1.145 . . . . 74.44 110.419 -176.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 71.7 t -97.18 126.1 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.339 0.656 . . . . 74.43 111.226 -169.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.614 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 17.0 tppt? -101.72 110.52 22.52 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.312 -1.736 . . . . 74.25 106.312 166.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.52 114.06 25.69 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.287 -1.005 . . . . 74.01 108.287 -172.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.727 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 11.7 m-20 -107.21 150.06 27.04 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.389 1.075 . . . . 73.35 109.451 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 94.4 mt -129.5 151.02 50.58 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.571 0.748 . . . . 70.11 110.476 -176.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.554 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 33.6 t70 -156.88 136.06 11.98 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.795 -1.187 . . . . 72.15 107.795 174.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 41.1 p -107.23 144.43 34.03 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.01 0.524 . . . . 71.43 110.987 -171.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.638 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.44 156.43 41.44 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.931 0.893 . . . . 75.22 109.303 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 10.5 p -172.18 155.78 3.74 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.025 0.53 . . . . 64.43 111.129 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 56.0 p -151.93 123.12 7.68 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.343 -0.844 . . . . 73.34 109.045 175.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -76.64 123.36 26.01 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.956 -0.757 . . . . 71.41 108.956 173.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 35.8 mt -90.01 -31.02 17.38 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.293 0.568 . . . . 75.34 109.997 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.5 171.91 13.99 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.304 1.441 . . . . 72.35 108.397 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -68.08 127.25 32.2 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.299 -0.876 . . . . 74.4 108.978 171.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 75.63 -2.85 2.7 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 125.926 1.69 . . . . 74.42 112.494 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.476 HG12 HE22 ' D' ' 14' ' ' GLN . 64.1 t -117.06 115.7 49.73 Favored 'Isoleucine or valine' 0 C--N 1.354 0.783 0 N-CA-C 108.099 -1.075 . . . . 74.24 108.099 172.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -144.38 169.12 18.54 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.516 -0.549 . . . . 73.21 109.516 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -130.04 132.36 46.18 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.105 -0.952 . . . . 71.44 109.568 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 64.2 t -105.94 124.75 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.464 -1.31 . . . . 75.52 107.464 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 20.9 t -114.84 130.02 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.457 -1.312 . . . . 74.44 107.457 172.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.66 HD23 ' HB3' ' D' ' 103' ' ' PRO . 15.4 tp -125.93 120.55 30.7 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.847 -0.797 . . . . 72.53 108.847 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.554 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 55.3 ttm-85 -83.99 102.78 12.72 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.157 -0.683 . . . . 75.41 109.157 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 71.7 t -91.15 126.86 43.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 107.862 -1.162 . . . . 73.35 107.862 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.727 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 26.8 m -124.14 126.62 46.49 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.486 0.66 . . . . 74.53 110.101 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.415 HG22 HG21 ' D' ' 114' ' ' ILE . 53.4 t -111.36 98.69 7.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 124.853 1.261 . . . . 65.41 107.781 177.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.614 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 31.0 m -95.98 90.04 5.43 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.335 -1.357 . . . . 73.23 107.335 177.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' D' ' 38' ' ' PRO . . . -97.93 148.18 23.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.458 -0.792 . . . . 72.43 110.576 -170.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.482 ' HA ' ' N ' ' D' ' 73' ' ' ALA . 54.8 m -145.34 135.5 23.88 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.259 0.466 . . . . 73.53 112.259 -174.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.522 HD11 HG23 ' D' ' 31' ' ' VAL . 82.0 mt -108.35 105.73 15.54 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.714 0.806 . . . . 75.43 109.151 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.47 -135.68 14.45 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.301 0.376 . . . . 71.24 113.653 175.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.29 5.74 25.6 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.32 0.648 . . . . 74.11 111.616 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -136.93 173.2 11.96 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.243 0.617 . . . . 72.34 110.797 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 37.7 m -66.34 153.08 43.62 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.976 1.31 . . . . 73.23 111.574 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.482 ' N ' ' HA ' ' D' ' 67' ' ' SER . . . -101.67 -65.51 0.97 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.378 -1.341 . . . . 54.13 107.378 168.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -155.21 146.86 23.17 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.478 -1.237 . . . . 74.23 110.246 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.486 HD21 HG21 ' D' ' 65' ' ' THR . 31.7 mt -104.57 111.12 23.69 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.468 -1.308 . . . . 74.12 107.468 172.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.546 ' SG ' HG12 ' D' ' 114' ' ' ILE . 35.0 t -117.26 137.64 52.26 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.621 -0.881 . . . . 75.43 108.621 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -154.86 121.42 5.38 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.646 -0.502 . . . . 74.44 109.646 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 65.4 t -129.47 124.0 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.392 0.677 . . . . 74.11 109.492 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.725 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 22.0 mt-30 -86.95 93.99 9.48 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 107.947 -1.131 . . . . 74.22 107.947 164.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -83.35 105.19 14.1 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.266 -1.013 . . . . 74.43 108.266 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -98.39 150.2 19.32 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-N 116.0 -0.545 . . . . 55.21 112.019 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.49 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -152.78 129.63 2.8 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.76 -0.257 . . . . 41.34 112.511 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.5 mt -91.2 126.89 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 108.211 -1.033 . . . . 64.3 108.211 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -130.68 153.81 48.58 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.639 0.776 . . . . 74.42 110.747 -174.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.3 m -106.71 138.21 43.31 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.504 1.121 . . . . 75.02 108.5 173.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.681 HG12 HD11 ' D' ' 89' ' ' ILE . 8.8 tt -146.4 144.2 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 108.849 -0.797 . . . . 74.11 108.849 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.47 146.62 8.62 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.18 0.592 . . . . 72.04 110.219 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.94 10.4 57.58 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.278 0.361 . . . . 70.32 113.122 -177.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.681 HD11 HG12 ' D' ' 86' ' ' ILE . 3.4 mp -123.65 151.06 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.018 0.927 . . . . 73.54 109.569 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.55 178.36 9.96 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.087 1.355 . . . . 73.23 109.737 174.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.09 -134.0 31.43 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 114.481 0.552 . . . . 64.21 114.481 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 34.6 p -88.88 -12.84 40.66 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.064 0.946 . . . . 74.23 112.419 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -61.7 -40.57 95.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.179 0.592 . . . . 73.31 110.559 177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -75.61 -20.26 58.68 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.624 -0.716 . . . . 62.31 112.2 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.24 -38.57 91.51 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.935 0.494 . . . . 72.42 110.677 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -78.01 -29.44 49.55 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.397 -0.82 . . . . 72.05 111.056 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . 0.414 ' SG ' HD12 ' D' ' 86' ' ' ILE . 44.3 t -68.5 -52.85 27.66 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 122.895 0.122 . . . . 75.14 111.085 -175.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.2 -22.06 42.27 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 110.612 -0.144 . . . . 74.42 110.612 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.29 -3.52 81.9 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-O 119.697 -0.502 . . . . 73.11 114.079 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.39 -58.76 0.13 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 117.479 0.64 . . . . 65.4 111.774 -177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -66.07 -47.96 72.57 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 112.658 0.614 . . . . 71.43 112.658 -170.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 44.6 m -67.85 -44.88 42.78 Favored Pre-proline 0 CA--C 1.565 1.523 0 CA-C-O 118.819 -0.61 . . . . 72.11 112.36 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.66 ' HB3' HD23 ' D' ' 60' ' ' LEU . 50.8 Cg_exo -59.12 -28.81 88.81 Favored 'Trans proline' 0 C--N 1.39 2.75 0 C-N-CA 122.54 2.16 . . . . 72.41 113.618 168.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -69.67 -33.57 72.76 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.507 0.723 . . . . 64.52 110.347 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.9 mm -67.33 -33.27 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-O 121.334 0.588 . . . . 74.34 110.212 174.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.49 HD22 ' HA3' ' D' ' 82' ' ' GLY . 65.4 mt -85.22 -15.97 41.83 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.885 0.874 . . . . 74.24 111.883 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -61.38 -48.51 90.84 Favored Pre-proline 0 CA--C 1.567 1.622 0 CA-C-O 118.002 -0.999 . . . . 71.35 113.262 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -59.92 -31.37 93.61 Favored 'Trans proline' 0 C--N 1.388 2.646 0 C-N-CA 122.093 1.862 . . . . 71.5 112.923 177.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -82.24 -32.04 29.92 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.727 0.811 . . . . 74.24 111.803 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.08 -48.1 72.08 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.847 -0.797 . . . . 75.43 108.847 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.439 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 34.4 ttp180 -55.39 -49.61 71.88 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 124.405 1.066 . . . . 73.44 111.141 176.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -64.68 -50.31 67.51 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 123.898 0.749 . . . . 75.54 111.144 -174.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.404 ' SG ' HD11 ' D' ' 21' ' ' ILE . 44.8 t -57.85 -44.39 86.52 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 124.005 0.816 . . . . 71.14 110.801 -178.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.546 HG12 ' SG ' ' D' ' 76' ' ' CYS . 91.4 mt -63.56 -55.34 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.727 0.811 . . . . 73.43 111.119 175.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 77.1 m -57.37 -39.91 77.04 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.146 0.979 . . . . 73.41 111.217 -174.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 86.5 p -66.7 -41.83 87.38 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.402 -0.817 . . . . 74.41 109.533 -177.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.419 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 65.3 mtm -69.97 -28.89 65.91 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.151 0.58 . . . . 73.32 111.734 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.457 HG23 ' O ' ' D' ' 114' ' ' ILE . 88.3 t -63.23 -49.18 84.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.23 0.612 . . . . 74.43 109.391 172.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.1 p -73.61 -26.1 60.63 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.867 -0.606 . . . . 71.3 111.039 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' D' ' 116' ' ' SER . 74.1 mtt-85 -71.94 -37.79 69.93 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.492 0.717 . . . . 75.43 109.246 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.78 4.86 77.77 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 115.362 -0.835 . . . . 50.12 112.448 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 22.4 p 58.7 30.67 20.26 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 126.683 1.993 . . . . 73.3 113.703 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -84.75 159.62 57.53 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 123.988 0.915 . . . . 74.24 109.883 171.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.35 126.13 21.32 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.693 2.262 . . . . 73.52 112.136 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -64.51 124.72 22.57 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.889 0.876 . . . . 73.42 111.652 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 7.0 tt -124.59 115.08 20.24 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.125 -1.435 . . . . 75.54 107.125 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -99.59 121.62 41.46 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.907 0.883 . . . . 73.12 108.653 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.439 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 7.3 mp -68.77 113.63 6.39 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 109.897 -0.409 . . . . 75.23 109.897 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.7 140.06 97.93 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.017 0.527 . . . . 72.31 110.432 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.429 ' HB2' ' HH ' ' B' ' 101' ' ' TYR . 9.3 Cg_exo -66.53 126.57 15.72 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.106 1.871 . . . . 74.32 110.708 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.484 1.225 0 C-N-CA 123.27 0.628 . . . . 75.42 110.725 -174.356 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.598 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 48.1 t80 . . . . . 0 C--O 1.237 0.406 0 N-CA-C 110.18 -0.304 . . . . 74.5 110.18 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -160.48 129.34 4.82 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.873 0.869 . . . . 73.14 109.372 173.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.44 HG12 ' CD2' ' A' ' 84' ' ' PHE . 58.2 mt -94.14 122.11 45.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.809 -0.811 . . . . 70.1 108.809 172.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -90.98 -31.15 16.44 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.278 0.361 . . . . 74.51 110.759 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.476 ' HB3' HD13 ' A' ' 83' ' ' ILE . 39.8 ttt180 -167.0 122.19 1.09 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 111.99 0.367 . . . . 73.13 111.99 -169.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 73.7 mt -115.02 137.14 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 123.842 0.857 . . . . 74.53 109.24 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -163.01 174.94 11.66 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 123.791 0.836 . . . . 73.11 111.069 -174.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -106.89 118.74 37.49 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.95 -0.759 . . . . 70.23 108.95 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -86.76 -25.75 24.52 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.857 -0.423 . . . . 75.23 109.857 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.697 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 26.3 t70 -145.91 135.39 23.1 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.604 -0.726 . . . . 73.22 109.703 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.7 mt -139.06 140.52 38.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 C-N-CA 125.477 1.511 . . . . 74.21 107.187 176.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -150.35 124.96 9.67 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.235 0.614 . . . . 73.22 109.381 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.435 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 88.1 t80 -124.08 136.6 54.35 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.052 -1.462 . . . . 74.42 107.052 168.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -137.29 135.95 37.58 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.895 0.478 . . . . 64.33 110.069 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.09 74.41 49.7 Favored Pre-proline 0 C--O 1.242 0.696 0 N-CA-C 106.6 -1.63 . . . . 72.55 106.6 167.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.58 -32.09 39.66 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.118 1.878 . . . . 74.51 110.906 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -96.98 19.59 12.53 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.226 -0.897 . . . . 73.14 110.685 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.31 -45.94 83.51 Favored Pre-proline 0 CA--C 1.567 1.614 0 N-CA-C 114.469 1.285 . . . . 64.45 114.469 -172.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -66.37 -19.51 55.56 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 121.767 1.644 . . . . 72.4 113.479 175.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.408 ' HA ' HE21 ' A' ' 33' ' ' GLN . 5.0 m-70 -97.15 -26.07 15.09 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.01 0.924 . . . . 74.44 111.564 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.551 HG22 ' HA ' ' A' ' 73' ' ' ALA . 4.1 p -79.61 -30.26 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 N-CA-C 113.459 0.911 . . . . 74.31 113.459 -158.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -81.75 -23.9 36.4 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.813 0.445 . . . . 73.14 111.189 -171.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.408 HE21 ' HA ' ' A' ' 30' ' ' HIS . 28.9 pt20 -79.91 -11.6 59.79 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.474 0.71 . . . . 74.21 111.038 176.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -81.47 162.3 23.32 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.872 0.469 . . . . 70.5 111.417 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -68.9 126.52 30.04 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.259 -0.882 . . . . 75.34 108.967 173.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 44.3 t-105 -76.4 81.92 3.13 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.762 0.791 . . . . 72.41 109.862 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -130.94 76.19 77.42 Favored Pre-proline 0 C--O 1.246 0.876 0 N-CA-C 107.512 -1.292 . . . . 71.44 107.512 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -85.48 140.22 7.21 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.295 1.997 . . . . 72.23 112.226 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -97.06 101.74 13.37 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.411 -1.329 . . . . 71.12 107.411 169.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 65' ' ' THR . 19.3 t -85.88 93.78 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.846 -0.798 . . . . 74.25 108.846 -176.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -86.12 115.34 23.63 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.531 1.132 . . . . 75.11 109.424 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -97.9 107.81 20.38 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.02 -0.733 . . . . 74.44 109.02 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.543 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 18.1 t70 -106.9 121.75 45.04 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.275 1.03 . . . . 61.24 108.552 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 mp -103.67 145.96 29.29 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.98 -0.378 . . . . 74.11 109.98 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 23.1 t70 -148.76 159.65 43.94 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.067 0.947 . . . . 54.43 108.847 177.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.6 m -135.44 136.85 41.68 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.571 0.749 . . . . 72.14 110.41 -178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.85 144.07 49.95 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.734 1.214 . . . . 74.51 108.279 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.0 p -132.9 167.22 20.62 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.716 0.406 . . . . 72.41 111.478 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.0 t -166.67 122.51 1.19 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.336 -0.847 . . . . 70.01 109.952 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -77.29 110.93 12.41 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 107.871 -1.159 . . . . 65.25 107.871 168.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.445 HD13 ' HB2' ' A' ' 57' ' ' GLU . 31.3 mt -84.94 -36.68 21.25 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.177 0.591 . . . . 71.22 110.75 -173.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.66 -174.47 4.23 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.848 0.859 . . . . 73.33 110.035 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -65.53 119.08 10.44 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.381 -0.6 . . . . 74.12 109.381 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 68.22 2.17 3.14 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.91 1.284 . . . . 74.11 113.015 -177.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.5 t -105.91 111.22 34.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 108.214 -1.032 . . . . 73.23 108.214 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -131.53 137.33 48.45 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.845 -0.798 . . . . 70.25 108.845 -174.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.445 ' HB2' HD13 ' A' ' 51' ' ' LEU . 40.5 tt0 -108.7 118.25 36.3 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.879 -1.055 . . . . 75.13 109.786 -176.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.5 t -103.43 123.74 57.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.043 -1.466 . . . . 74.34 107.043 170.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.8 131.25 70.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 107.817 -1.179 . . . . 73.41 107.817 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 tt -121.8 115.08 22.01 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.179 -1.045 . . . . 72.43 108.179 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.621 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 35.9 ttp180 -85.45 109.49 18.5 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.831 0.852 . . . . 75.34 109.93 175.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.4 t -99.48 102.77 13.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.537 -1.283 . . . . 75.15 107.537 170.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 39.8 m -94.84 108.86 20.89 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.985 0.914 . . . . 75.54 108.907 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.7 t -103.78 110.15 29.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.264 -0.88 . . . . 74.4 109.142 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 21.6 m -102.11 134.74 44.88 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.963 -1.125 . . . . 72.14 107.963 171.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.68 117.22 19.99 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.963 -1.495 . . . . 74.31 106.963 174.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 54.0 m -128.0 132.7 49.14 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.943 0.497 . . . . 71.33 110.97 -175.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.7 mt -90.85 48.01 1.48 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.484 1.114 . . . . 75.45 108.805 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.42 -90.41 0.93 Allowed Glycine 0 C--N 1.351 1.376 0 CA-C-N 114.993 -1.003 . . . . 74.5 112.552 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -87.83 -22.87 24.23 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.785 0.834 . . . . 73.32 111.034 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -118.55 98.82 6.44 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.857 -1.164 . . . . 73.14 107.857 -172.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 93.1 m -59.08 129.19 40.94 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 118.44 0.563 . . . . 71.2 110.597 177.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.551 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -70.18 -60.62 2.17 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.241 -0.891 . . . . 73.11 109.643 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -161.19 164.19 30.65 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 114.863 -1.062 . . . . 73.32 110.99 177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.1 tp -128.62 108.9 10.88 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.502 -0.925 . . . . 73.22 108.502 171.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.403 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 73.9 m -106.48 96.61 6.58 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.59 0.756 . . . . 74.53 109.824 174.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -111.04 115.27 29.18 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.866 -0.79 . . . . 60.11 108.866 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -124.11 132.04 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.048 0.539 . . . . 71.13 109.563 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.697 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.8 mt-30 -98.72 95.59 7.34 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.262 0.625 . . . . 74.01 109.521 168.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -80.41 105.16 11.46 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.807 -1.088 . . . . 70.14 109.03 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.7 150.92 20.59 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.908 -0.587 . . . . 71.2 111.821 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.53 147.49 18.6 Favored Glycine 0 C--O 1.237 0.284 0 N-CA-C 111.529 -0.628 . . . . 53.32 111.529 174.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.476 HD13 ' HB3' ' A' ' 15' ' ' ARG . 64.1 mt -104.13 112.23 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.06 -1.089 . . . . 75.0 108.06 176.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.598 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 5.1 m-85 -123.16 154.83 38.14 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.258 1.023 . . . . 74.34 108.294 -176.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 87.9 p -109.04 116.04 31.22 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.742 -0.836 . . . . 71.24 108.742 172.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 N--CA 1.486 1.365 0 N-CA-C 109.279 -0.637 . . . . 74.51 109.279 178.741 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 120.522 0.201 . . . . 72.32 111.501 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -89.51 -47.49 7.95 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.41 0.684 . . . . 74.34 111.324 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 22.0 p -62.36 -42.86 99.74 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.228 0.537 . . . . 74.0 110.372 -174.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -88.02 -41.4 13.13 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.985 -1.007 . . . . 74.13 109.984 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.94 0.09 89.08 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-O 119.443 -0.643 . . . . 71.42 114.647 -171.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.22 -51.83 0.14 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 117.939 0.869 . . . . 73.43 112.464 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.47 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 85.6 t80 -69.86 -58.64 3.64 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.712 0.634 . . . . 74.12 112.712 -170.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 71.7 m -62.59 -40.49 65.24 Favored Pre-proline 0 CA--C 1.563 1.471 0 N-CA-C 113.651 0.982 . . . . 64.23 113.651 -175.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 34.8 Cg_endo -65.23 -27.84 56.04 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 121.941 1.761 . . . . 71.4 113.166 169.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -75.29 -23.36 57.36 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 122.843 0.457 . . . . 72.34 110.696 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.427 HG21 ' CD1' ' A' ' 13' ' ' ILE . 46.9 mm -62.35 -40.86 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.338 0.655 . . . . 74.14 109.751 170.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 80.1 mt -74.19 -21.56 59.77 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.935 -1.029 . . . . 63.34 111.607 -177.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -60.51 -49.17 91.29 Favored Pre-proline 0 CA--C 1.565 1.536 0 N-CA-C 113.982 1.104 . . . . 72.14 113.982 -172.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.29 -34.17 88.26 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 121.941 1.761 . . . . 75.43 112.829 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -70.13 -41.25 74.17 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.362 0.665 . . . . 74.52 111.455 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.32 -44.02 89.15 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.661 -0.699 . . . . 74.32 109.764 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.505 ' NH1' HD13 ' C' ' 105' ' ' ILE . 30.6 ttm180 -52.6 -48.66 66.15 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.639 1.175 . . . . 74.13 110.64 174.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.07 -49.71 66.69 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.446 0.698 . . . . 75.51 111.33 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 33.1 t -61.54 -26.43 67.93 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.473 0.709 . . . . 73.21 111.495 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 81.1 mt -77.81 -57.3 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 123.84 0.856 . . . . 71.32 110.117 174.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.5 m -55.59 -34.74 65.1 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.823 0.849 . . . . 64.14 111.89 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.0 t -63.73 -49.99 70.88 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.318 -0.856 . . . . 72.24 110.058 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 30.4 mtm -66.5 -37.51 85.23 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.103 0.561 . . . . 71.42 111.229 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.0 t -57.07 -47.98 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 124.02 0.825 . . . . 75.13 110.048 175.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 29.3 t -73.45 -28.89 62.2 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 115.039 -0.982 . . . . 71.43 111.438 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -72.83 -28.64 62.66 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.207 0.603 . . . . 73.22 109.872 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.13 4.67 75.21 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 123.659 0.599 . . . . 64.33 112.918 172.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.528 HG23 HH21 ' B' ' 15' ' ' ARG . 0.6 OUTLIER 65.72 16.33 10.45 Favored 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 126.515 1.926 . . . . 72.11 112.347 177.356 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -79.16 152.93 76.95 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 123.575 0.75 . . . . 63.1 109.666 172.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.98 134.31 63.72 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.474 2.116 . . . . 74.42 111.14 171.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -56.65 158.08 4.85 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.557 0.743 . . . . 72.42 112.416 -173.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.0 tp -135.85 93.73 2.97 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.28 -0.873 . . . . 75.52 109.333 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -98.12 99.14 10.38 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.986 -1.116 . . . . 71.51 107.986 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.405 HD11 ' H ' ' A' ' 129' ' ' ALA . 19.0 tp -59.26 136.7 58.04 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.294 -0.867 . . . . 72.24 110.346 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.405 ' H ' HD11 ' A' ' 128' ' ' LEU . . . -59.04 145.14 81.16 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 124.284 1.033 . . . . 72.43 112.147 -175.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.06 123.34 11.75 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.204 2.603 . . . . 72.41 111.759 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 77.1 t -116.02 115.94 50.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 108.96 -0.755 . . . . 74.3 108.96 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -73.26 74.69 1.32 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.88 0.872 . . . . 71.54 108.654 173.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 24.9 t80 . . . . . 0 N--CA 1.473 0.714 0 C-N-CA 125.037 1.335 . . . . 72.25 111.903 -163.318 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.506 ' HB3' HG13 ' B' ' 89' ' ' ILE . 4.2 ppp? . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 113.218 0.822 . . . . 63.22 113.218 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 93.8 m -133.57 113.59 12.61 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.134 0.574 . . . . 75.41 109.504 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -123.61 143.68 50.08 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.102 0.961 . . . . 75.45 109.342 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -162.88 141.43 8.48 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.38 0.672 . . . . 73.54 110.268 169.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 49.2 mt -68.68 129.39 33.23 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 109.014 -0.735 . . . . 75.12 109.014 171.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -97.95 -42.27 7.61 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.209 0.604 . . . . 72.23 109.537 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.528 HH21 HG23 ' A' ' 122' ' ' THR . 21.7 ttt85 -168.48 144.89 3.77 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.79 -0.641 . . . . 75.01 109.457 -174.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.4 mt -128.73 144.65 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 107.56 -1.274 . . . . 75.44 107.56 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.559 ' HE2' ' HZ3' ' B' ' 19' ' ' LYS . 38.2 p90 -171.12 156.03 4.62 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.182 0.515 . . . . 75.25 111.462 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 95.2 m -85.2 126.28 33.53 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.634 -0.712 . . . . 74.51 109.244 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.559 ' HZ3' ' HE2' ' B' ' 17' ' ' TYR . 33.4 mttp -86.49 -48.36 8.47 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.27 0.628 . . . . 74.44 110.61 172.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -144.96 136.91 25.74 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 110.115 -0.328 . . . . 74.32 110.115 -165.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.435 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 44.7 mm -131.69 142.41 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.389 1.076 . . . . 74.33 109.309 176.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.684 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 69.3 m -138.84 136.67 35.85 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.83 1.252 . . . . 60.21 108.439 177.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' B' ' 75' ' ' LEU . 75.7 t80 -149.91 107.46 3.65 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 107.858 -1.164 . . . . 62.22 107.858 165.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -121.79 112.12 17.97 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.096 0.959 . . . . 74.24 108.945 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.53 87.6 12.0 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.688 1.195 . . . . 73.13 108.231 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.9 -41.93 12.72 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.867 2.378 . . . . 73.44 111.837 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 2.5 m-20 -90.87 3.49 54.36 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.874 -1.057 . . . . 73.23 111.345 -175.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -37.06 -60.51 0.8 Allowed Pre-proline 0 N--CA 1.49 1.552 0 C-N-CA 125.668 1.587 . . . . 71.34 114.973 -164.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.7 -31.63 58.55 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 122.474 2.116 . . . . 73.52 113.278 -173.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -88.62 -38.08 15.12 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.06 0.544 . . . . 71.44 111.103 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.673 HG23 HD13 ' B' ' 68' ' ' LEU . 8.9 p -69.5 -19.15 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 123.339 0.656 . . . . 75.14 111.486 -174.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -58.74 -20.66 51.24 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 113.372 0.879 . . . . 72.31 113.372 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.455 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.1 pt20 -59.82 -31.97 70.21 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.462 0.705 . . . . 72.44 111.33 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.583 ' HZ1' ' HG2' ' B' ' 71' ' ' GLU . 99.8 mttt -87.91 95.95 10.3 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.878 0.871 . . . . 72.11 109.944 -176.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -91.07 87.52 6.61 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.783 -0.644 . . . . 65.21 110.597 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -163.17 -179.22 6.5 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.886 0.874 . . . . 74.23 109.726 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -77.81 108.36 7.18 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.589 0.755 . . . . 75.31 109.812 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.415 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 37.7 Cg_endo -64.77 142.1 74.91 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.433 2.089 . . . . 74.1 113.109 -176.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -68.79 119.95 13.97 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.77 0.828 . . . . 75.3 109.395 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 24.4 m -106.98 161.31 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 123.727 0.811 . . . . 72.13 112.173 -169.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.533 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 55.9 tttm -135.5 109.66 8.31 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.387 1.075 . . . . 72.53 108.794 175.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mp -90.15 138.06 31.83 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.015 -0.735 . . . . 73.21 109.015 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.551 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 7.2 t70 -149.79 158.26 43.99 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 107.838 -1.171 . . . . 71.01 107.838 -176.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -140.52 158.97 43.2 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.034 0.445 . . . . 71.25 110.478 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.439 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 28.9 t70 -146.86 155.58 42.44 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.881 0.872 . . . . 73.3 108.903 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 58.6 m -108.45 137.35 46.57 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.699 0.8 . . . . 72.44 110.854 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.666 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -142.8 146.31 34.09 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.739 -1.208 . . . . 53.44 107.739 166.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.4 p -142.74 168.63 19.27 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.23 0.612 . . . . 72.14 109.935 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' SER . . . . . 0.587 ' HB2' ' HB3' ' B' ' 57' ' ' GLU . 2.3 m -150.65 151.93 33.23 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.149 -1.056 . . . . 74.4 108.149 170.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -115.57 106.59 14.1 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.23 -1.396 . . . . 73.2 107.23 168.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.562 HD12 HG22 ' B' ' 83' ' ' ILE . 21.1 mt -87.53 -38.12 16.3 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.477 0.711 . . . . 70.24 109.771 -173.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.8 -171.24 3.59 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.521 -1.218 . . . . 72.14 109.416 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -69.59 125.59 27.17 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.091 -0.959 . . . . 72.4 108.445 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 68.92 -2.09 1.86 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.771 1.229 . . . . 73.25 112.811 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 88.9 t -107.1 105.25 18.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 108.818 -0.808 . . . . 73.43 108.818 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.462 ' HB2' HD13 ' B' ' 86' ' ' ILE . 1.2 m-85 -116.36 141.65 47.88 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.524 1.129 . . . . 74.31 108.902 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.587 ' HB3' ' HB2' ' B' ' 49' ' ' SER . 6.7 tm-20 -113.8 97.0 6.14 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.39 -1.337 . . . . 74.45 107.39 -176.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 46.4 t -92.32 128.09 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.964 0.905 . . . . 75.42 109.765 -174.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.666 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 17.6 t -120.64 118.18 55.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 C-N-CA 124.105 0.962 . . . . 74.42 108.761 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.413 ' HB2' ' HB3' ' B' ' 103' ' ' PRO . 43.9 tp -102.88 127.63 50.0 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.986 -0.746 . . . . 74.53 108.986 170.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.439 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 12.7 ttm180 -86.25 135.91 33.38 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.876 -0.787 . . . . 71.02 108.876 169.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.531 HG11 HD11 ' B' ' 114' ' ' ILE . 93.9 t -122.32 103.48 13.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 106.958 -1.497 . . . . 71.34 106.958 175.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 52.9 m -95.43 135.99 36.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.918 0.887 . . . . 72.03 108.74 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.413 HG22 HG21 ' B' ' 114' ' ' ILE . 98.3 t -132.44 117.65 32.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.854 -1.165 . . . . 74.43 107.854 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 32.2 m -105.53 149.97 25.77 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.89 -1.152 . . . . 55.42 107.89 170.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.79 145.12 29.81 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.09 -0.707 . . . . 63.42 109.09 176.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.461 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 54.3 p -150.39 128.45 11.88 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 123.865 0.728 . . . . 71.42 110.517 -176.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.673 HD13 HG23 ' B' ' 31' ' ' VAL . 71.1 mt -93.51 98.25 11.06 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 107.281 -1.377 . . . . 74.15 107.281 172.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.97 -129.02 12.41 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 114.91 -1.041 . . . . 74.44 113.568 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -86.72 4.05 42.32 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.469 0.708 . . . . 72.43 112.063 -173.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.583 ' HG2' ' HZ1' ' B' ' 34' ' ' LYS . 13.2 pt-20 -129.63 152.91 48.63 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.927 0.491 . . . . 75.15 110.213 -177.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 85.6 m -72.33 132.87 44.58 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.327 0.651 . . . . 75.23 110.277 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.461 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -86.44 -62.73 1.45 Allowed 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.851 -1.166 . . . . 75.11 107.851 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -156.01 160.73 40.29 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 115.141 -0.936 . . . . 74.24 111.783 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 23.2 mt -124.74 114.75 19.69 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 106.321 -1.733 . . . . 73.44 106.321 174.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.405 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 35.2 t -119.41 146.18 45.59 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.876 -0.787 . . . . 72.41 108.876 175.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.684 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 42.9 tt0 -158.45 134.61 9.22 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.345 -0.613 . . . . 74.34 109.345 -175.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 91.5 t -129.75 142.81 42.92 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 C-N-CA 123.726 0.81 . . . . 71.11 109.107 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -124.28 96.97 5.12 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 107.651 -1.24 . . . . 71.44 107.651 172.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -89.32 107.67 19.19 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.198 -1.038 . . . . 73.55 108.198 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.99 143.56 17.12 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.187 -0.765 . . . . 74.33 111.187 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.8 126.9 2.47 Favored Glycine 0 CA--C 1.51 -0.273 0 N-CA-C 112.04 -0.424 . . . . 60.14 112.04 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.562 HG22 HD12 ' B' ' 51' ' ' LEU . 38.9 mt -85.92 128.19 39.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.37 -0.974 . . . . 74.12 108.37 173.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -137.46 147.94 45.69 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.242 0.617 . . . . 73.32 110.039 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 62.8 m -97.41 125.6 42.14 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.118 -0.697 . . . . 72.22 109.118 170.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' B' ' 56' ' ' TYR . 1.8 pt -138.26 118.13 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 125.049 1.34 . . . . 74.52 108.993 -174.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' B' ' 9' ' ' MET . . . -152.25 168.04 26.65 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.237 0.615 . . . . 73.51 111.055 -173.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.27 -71.0 1.43 Allowed Glycine 0 C--N 1.348 1.225 0 O-C-N 123.496 0.497 . . . . 64.22 112.673 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.67 HG23 ' HB2' ' B' ' 94' ' ' MET . 10.7 mt -75.02 157.61 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.716 0.807 . . . . 74.41 110.651 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.598 ' HG2' ' H ' ' B' ' 91' ' ' GLY . 11.7 tt0 -151.96 -176.48 5.66 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.93 0.892 . . . . 73.21 108.667 173.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.598 ' H ' ' HG2' ' B' ' 90' ' ' GLU . . . 75.51 -136.27 19.81 Favored Glycine 0 C--N 1.345 1.053 0 C-N-CA 123.139 0.399 . . . . 53.41 113.187 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 44.0 m -70.17 -41.64 73.53 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.569 0.748 . . . . 74.2 111.352 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -60.14 -35.53 75.5 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.941 -1.027 . . . . 72.34 111.052 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.67 ' HB2' HG23 ' B' ' 89' ' ' ILE . 9.9 tmm? -85.14 -31.26 23.38 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.129 0.971 . . . . 75.05 111.52 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.61 -27.58 67.86 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.4 0.619 . . . . 72.42 110.324 170.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . 0.42 ' HE2' ' HA ' ' B' ' 134' ' ' ASP . 18.7 t-80 -79.64 -29.33 40.93 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.111 1.365 . . . . 61.25 111.646 173.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -63.22 -51.71 65.16 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.873 0.469 . . . . 65.32 111.746 -175.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 pp -89.62 -13.33 37.37 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 117.853 0.297 . . . . 74.43 110.99 171.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.95 3.12 85.94 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-O 119.479 -0.623 . . . . 73.0 114.099 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.69 -54.92 0.09 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.231 0.612 . . . . 62.34 110.724 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -72.88 -49.72 28.2 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.366 0.876 . . . . 74.5 113.366 -165.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.466 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 62.7 m -59.7 -47.81 96.7 Favored Pre-proline 0 CA--C 1.565 1.526 0 CA-C-O 119.189 -0.434 . . . . 65.5 111.907 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 23.9 Cg_exo -67.14 -24.97 43.95 Favored 'Trans proline' 0 C--N 1.393 2.879 0 C-N-CA 122.263 1.975 . . . . 71.53 113.599 173.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -63.96 -37.5 87.65 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.365 0.666 . . . . 75.35 110.213 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 68.4 mt -65.54 -39.12 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 115.671 -0.695 . . . . 72.55 110.485 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.24 -17.26 52.76 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.24 -0.891 . . . . 75.45 111.735 -175.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -58.99 -49.51 92.98 Favored Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 124.789 1.236 . . . . 74.44 113.556 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -60.79 -39.4 62.92 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 122.262 1.974 . . . . 71.51 113.019 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -64.38 -33.73 76.54 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.487 -0.779 . . . . 71.55 110.491 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.494 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -72.35 -42.16 65.64 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 115.857 -0.611 . . . . 72.1 110.341 174.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -53.36 -55.52 24.21 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.218 1.007 . . . . 71.42 111.527 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.421 ' HG3' ' NH2' ' C' ' 120' ' ' ARG . 2.1 tm-20 -64.03 -34.77 78.76 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.802 0.689 . . . . 70.13 110.106 -177.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.495 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.2 t -73.5 -27.59 61.45 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.734 0.414 . . . . 73.2 111.7 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.531 HD11 HG11 ' B' ' 62' ' ' VAL . 73.0 mt -71.11 -58.62 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 108.578 -0.897 . . . . 74.54 108.578 173.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 4.8 m -65.0 -23.08 67.11 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.906 -1.043 . . . . 73.24 111.441 -173.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.445 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 37.7 t -61.52 -49.87 74.96 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.302 0.641 . . . . 73.42 109.454 171.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.495 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.2 mmt -71.53 -34.14 69.78 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.415 0.686 . . . . 73.32 110.82 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.4 HG21 ' O ' ' B' ' 114' ' ' ILE . 87.5 t -59.76 -46.1 93.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.709 0.804 . . . . 61.43 109.85 172.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -64.56 -36.67 84.98 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.724 -1.125 . . . . 71.23 110.834 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.486 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 93.5 mtt-85 -65.46 -32.84 74.67 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.247 0.619 . . . . 74.51 110.125 177.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.64 8.71 70.97 Favored Glycine 0 C--N 1.353 1.495 0 O-C-N 123.639 0.587 . . . . 71.33 113.146 174.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 75.7 p 57.47 26.92 13.23 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 126.235 1.814 . . . . 63.02 113.5 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -88.08 158.21 50.1 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 123.519 0.728 . . . . 64.35 111.02 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -58.04 157.63 24.32 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 123.403 2.735 . . . . 73.32 114.338 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.552 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -65.33 123.19 18.95 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.482 -1.235 . . . . 64.33 112.186 -177.231 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -138.43 115.3 10.78 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 108.388 -0.967 . . . . 73.41 108.388 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -110.9 136.06 50.49 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.874 0.87 . . . . 74.22 109.819 176.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.423 HD11 ' H ' ' B' ' 129' ' ' ALA . 10.0 tp -86.78 135.52 33.33 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.334 0.653 . . . . 73.21 110.739 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . 0.423 ' H ' HD11 ' B' ' 128' ' ' LEU . . . -68.05 147.0 98.42 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.733 1.213 . . . . 74.23 111.779 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.06 104.16 1.32 Allowed 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.75 2.3 . . . . 72.04 111.994 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 10.8 m -92.84 108.16 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 122.092 0.948 . . . . 74.02 109.601 173.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.54 83.89 3.87 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.949 -1.023 . . . . 75.04 108.423 172.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -52.67 -46.74 67.33 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.608 -0.723 . . . . 71.33 109.633 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . 0.42 ' HA ' ' HE2' ' B' ' 96' ' ' HIS . 9.4 m-20 . . . . . 0 C--N 1.344 0.35 0 CA-C-N 113.411 -1.722 . . . . 74.11 112.458 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.537 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.6 t80 . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 110.276 -0.268 . . . . 64.23 110.276 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -150.85 131.17 13.66 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.536 0.735 . . . . 63.21 109.384 171.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 78.9 mt -74.99 124.06 31.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 108.445 -0.946 . . . . 70.14 108.445 172.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.449 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 81.9 mm-40 -93.74 -39.53 10.71 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.301 0.64 . . . . 71.31 110.915 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -177.19 127.01 0.15 Allowed 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.228 0.33 . . . . 71.35 110.714 -175.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 84.1 mt -114.69 133.42 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.51 0.724 . . . . 74.23 109.473 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.487 ' HE2' ' HD3' ' C' ' 19' ' ' LYS . 23.6 p90 -170.54 172.43 5.95 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-O 121.43 0.633 . . . . 74.21 110.53 -171.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.8 p -97.08 121.65 39.2 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.417 -0.811 . . . . 72.31 109.1 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.487 ' HD3' ' HE2' ' C' ' 17' ' ' TYR . 29.9 mmtp -68.98 -46.69 67.44 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.35 1.072 . . . . 74.05 108.186 167.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -141.76 138.36 32.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 112.989 -1.914 . . . . 72.43 109.041 -167.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.553 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.2 mt -134.38 152.59 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 107.258 -1.386 . . . . 74.25 107.258 174.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -160.4 152.87 20.78 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.395 0.617 . . . . 71.11 110.843 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -149.01 135.43 19.39 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.572 -1.27 . . . . 73.45 107.572 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -140.82 110.38 6.36 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.743 0.817 . . . . 75.44 109.313 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' C' ' 28' ' ' ALA . . . -124.54 85.67 56.04 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 105.371 -2.085 . . . . 64.53 105.371 165.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.82 -17.99 41.75 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 122.866 2.378 . . . . 74.45 112.397 -175.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -112.88 19.27 17.47 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.956 1.302 . . . . 74.25 110.289 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.408 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . . . -44.02 -56.88 6.89 Favored Pre-proline 0 N--CA 1.489 1.475 0 N-CA-C 114.297 1.221 . . . . 73.43 114.297 -170.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.428 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 38.0 Cg_endo -62.02 -35.72 74.95 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.103 1.869 . . . . 75.22 112.582 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -68.34 -50.57 52.35 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.171 0.588 . . . . 74.11 110.972 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.648 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.0 p -69.46 -23.65 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 N-CA-C 112.772 0.656 . . . . 74.2 112.772 -169.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -62.74 -33.16 74.56 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.52 0.563 . . . . 74.04 112.52 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -88.36 15.68 7.43 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.759 0.424 . . . . 71.31 112.099 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.702 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -95.56 158.68 15.35 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.915 0.886 . . . . 72.35 109.993 175.643 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -70.18 129.5 39.56 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 109.047 -0.723 . . . . 75.52 109.047 170.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 55.6 t-105 -78.44 80.41 4.83 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.429 0.692 . . . . 74.33 110.44 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -129.14 74.05 81.34 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 108.279 -1.008 . . . . 75.42 108.279 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -95.92 176.51 0.79 Allowed 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.068 2.512 . . . . 75.04 112.688 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' C' ' 67' ' ' SER . 0.9 OUTLIER -117.82 120.2 37.21 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.417 -1.698 . . . . 75.24 106.417 169.636 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.68 97.42 5.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.257 -1.016 . . . . 75.42 108.257 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.507 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 10.1 tmtt? -91.6 108.67 20.07 Favored 'General case' 0 CA--C 1.527 0.081 0 N-CA-C 106.851 -1.537 . . . . 73.43 106.851 175.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 mp -86.53 136.38 33.1 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.695 -0.854 . . . . 74.51 108.695 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 23.4 t70 -123.04 137.95 54.81 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 124.993 1.317 . . . . 72.23 107.948 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.48 HD22 HD12 ' C' ' 60' ' ' LEU . 6.1 tt -135.48 139.9 44.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.585 -1.265 . . . . 73.4 107.585 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.445 ' N ' HD23 ' C' ' 44' ' ' LEU . 29.9 t70 -143.41 152.64 41.8 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.523 0.729 . . . . 64.53 109.36 170.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 72.4 p -115.48 112.28 22.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.84 0.856 . . . . 75.11 109.486 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.91 157.18 20.96 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.662 -0.866 . . . . 65.14 108.662 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 31.4 p -164.86 169.63 16.36 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.449 0.537 . . . . 74.11 112.449 -170.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 41.9 t -170.12 129.31 0.91 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.232 1.013 . . . . 75.21 109.345 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -77.67 115.5 17.47 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.597 -1.26 . . . . 72.1 107.597 166.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.508 HD13 HD13 ' C' ' 83' ' ' ILE . 62.9 mt -89.48 -36.3 15.48 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.175 0.59 . . . . 74.11 110.805 -175.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.33 -168.68 0.84 Allowed 'General case' 0 CA--C 1.54 0.585 0 O-C-N 124.139 0.9 . . . . 70.31 111.15 -174.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -66.53 114.12 5.26 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.671 1.188 . . . . 74.21 110.084 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 65.82 -3.03 0.79 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 125.234 1.413 . . . . 73.24 113.227 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 78.9 t -98.7 107.17 19.95 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.429 -0.952 . . . . 75.13 108.429 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . 0.436 ' HB3' HD12 ' C' ' 86' ' ' ILE . 49.2 t80 -122.12 137.12 54.94 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.809 -0.632 . . . . 72.23 110.064 -176.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -94.65 119.53 33.44 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.117 0.967 . . . . 75.11 109.735 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.09 117.5 55.17 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.137 -1.06 . . . . 75.14 108.137 174.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.07 136.04 56.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 108.366 -0.976 . . . . 74.01 108.366 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.48 HD12 HD22 ' C' ' 44' ' ' LEU . 16.2 tp -121.58 114.26 20.94 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 109.189 -0.671 . . . . 72.43 109.189 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.421 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 13.3 ttm180 -82.08 108.46 15.57 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.626 -0.879 . . . . 75.25 108.626 172.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.404 HG13 ' CD1' ' C' ' 114' ' ' ILE . 22.2 t -103.93 123.28 57.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.093 -1.447 . . . . 72.45 107.093 172.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 86.0 m -136.92 119.56 16.05 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 123.194 0.598 . . . . 61.22 109.448 -173.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 54.3 t -103.95 113.47 40.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 123.608 0.763 . . . . 64.34 109.135 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 4.9 m -99.4 134.94 41.53 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.674 -1.232 . . . . 74.45 107.674 171.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.01 120.28 25.74 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.791 -1.559 . . . . 71.33 106.791 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 57.0 m -135.52 130.37 34.49 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.081 0.467 . . . . 75.23 110.938 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.702 HD11 ' HG2' ' C' ' 34' ' ' LYS . 8.6 mt -84.67 46.62 1.27 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.93 1.292 . . . . 73.32 109.246 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.41 -119.72 6.48 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 109.46 -1.456 . . . . 62.12 109.46 -165.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -91.17 -19.49 23.01 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.235 0.614 . . . . 74.31 110.198 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -70.62 84.67 0.63 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.747 0.819 . . . . 63.14 108.962 174.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 62.4 m -62.42 121.6 13.65 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 110.291 -0.263 . . . . 74.21 110.291 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.648 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -67.92 -61.76 1.72 Allowed 'General case' 0 C--O 1.235 0.342 0 O-C-N 124.069 0.856 . . . . 62.23 108.739 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -155.06 172.76 17.59 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-O 122.211 1.005 . . . . 72.34 111.196 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -130.74 144.21 51.28 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 105.043 -2.206 . . . . 70.32 105.043 169.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.433 ' SG ' HG21 ' C' ' 114' ' ' ILE . 51.2 t -151.52 135.31 16.4 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.649 -0.871 . . . . 71.15 108.649 177.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -139.66 138.79 36.38 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.081 0.552 . . . . 74.41 109.928 -174.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -141.91 113.46 3.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.959 -1.126 . . . . 74.3 107.959 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -91.07 88.31 6.93 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.235 -1.024 . . . . 72.41 108.235 172.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -78.76 101.15 7.43 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.007 -0.997 . . . . 73.34 108.996 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.25 143.4 17.99 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 111.614 -0.594 . . . . 43.21 111.614 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.56 116.47 0.99 Allowed Glycine 0 CA--C 1.499 -0.949 0 N-CA-C 109.968 -1.253 . . . . 72.23 109.968 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.508 HD13 HD13 ' C' ' 51' ' ' LEU . 12.6 mm -81.63 120.44 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.736 -1.209 . . . . 74.22 107.736 177.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.537 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 54.7 m-85 -130.9 134.74 47.05 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.453 -0.943 . . . . 74.41 108.453 -177.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 49.3 m -80.24 117.42 21.0 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.949 -0.76 . . . . 72.02 108.949 170.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.436 HD12 ' HB3' ' C' ' 56' ' ' TYR . 4.1 mp -115.43 118.07 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.051 -1.092 . . . . 73.23 108.051 173.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.03 162.77 34.42 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.745 0.818 . . . . 74.34 109.86 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.12 -63.24 3.47 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.335 -0.848 . . . . 41.42 112.496 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 28.5 pt -90.03 145.86 6.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-O 120.876 0.37 . . . . 75.22 110.675 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -146.32 150.47 35.8 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.319 -0.855 . . . . 65.22 109.088 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.49 -135.89 13.02 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-O 119.721 -0.488 . . . . 41.31 112.262 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 15.5 m -67.24 -35.11 78.87 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.819 0.848 . . . . 64.51 111.412 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -56.72 -48.66 77.26 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.728 1.211 . . . . 72.04 109.682 176.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.493 ' HE2' HD13 ' C' ' 98' ' ' LEU . 2.7 ttp -66.62 -43.83 83.71 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 113.305 -1.77 . . . . 74.15 110.998 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.21 69.82 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.719 0.808 . . . . 74.44 111.68 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -67.09 -41.89 85.55 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.754 0.822 . . . . 73.2 110.621 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.484 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 30.1 t -63.95 -53.16 54.66 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.832 -0.622 . . . . 72.13 109.86 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.493 HD13 ' HE2' ' C' ' 94' ' ' MET . 80.3 mt -70.14 -28.54 65.44 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.828 0.851 . . . . 72.43 112.695 -175.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.43 12.76 33.29 Favored Glycine 0 N--CA 1.475 1.27 0 N-CA-C 114.322 0.489 . . . . 71.24 114.322 -167.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.486 ' HA ' ' HB2' ' C' ' 133' ' ' PHE . . . -155.89 -60.08 0.1 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.787 0.803 . . . . 64.22 110.8 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.404 ' CE2' ' CE1' ' C' ' 11' ' ' PHE . 53.5 t80 -75.28 -38.2 60.54 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-N 113.607 -1.633 . . . . 75.54 112.324 -170.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.484 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 79.0 m -83.14 -43.8 0.86 Allowed Pre-proline 0 CA--C 1.565 1.528 0 C-N-CA 123.883 0.873 . . . . 73.22 112.699 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -64.86 -20.94 64.7 Favored 'Trans proline' 0 C--N 1.394 2.938 0 C-N-CA 122.325 2.016 . . . . 74.11 112.312 173.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -67.5 -33.83 75.89 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.661 0.784 . . . . 75.01 110.512 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.505 HD13 ' NH1' ' A' ' 111' ' ' ARG . 44.0 mm -65.19 -35.56 75.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-N 115.67 -0.696 . . . . 71.31 109.752 174.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 82.7 mt -89.62 -22.35 22.36 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.201 1.001 . . . . 64.13 112.449 -174.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -54.92 -51.13 81.94 Favored Pre-proline 0 CA--C 1.559 1.297 0 N-CA-C 113.299 0.852 . . . . 74.43 113.299 -174.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -64.23 -34.45 56.28 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.083 1.855 . . . . 73.52 112.871 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -66.32 -44.81 82.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.185 0.594 . . . . 72.4 110.854 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.17 -38.6 88.46 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.527 -0.761 . . . . 73.34 110.661 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -57.64 -53.82 53.84 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.454 1.101 . . . . 75.51 110.594 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.27 -32.58 74.08 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.59 0.556 . . . . 74.43 110.463 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.0 t -73.1 -33.12 65.39 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 122.939 0.495 . . . . 74.43 111.257 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.433 HG21 ' SG ' ' C' ' 76' ' ' CYS . 57.3 mt -71.57 -52.88 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.039 0.536 . . . . 75.1 109.758 174.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.4 m -65.98 -27.05 67.85 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.424 0.689 . . . . 75.31 111.009 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 38.1 t -62.6 -49.4 75.36 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 109.279 -0.637 . . . . 71.51 109.279 169.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.709 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.8 -36.4 81.01 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.208 1.003 . . . . 74.13 112.546 178.222 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.1 -44.35 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.407 0.683 . . . . 72.12 109.343 173.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.441 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 22.7 t -73.27 -25.06 60.54 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.121 -0.945 . . . . 65.3 111.565 -177.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.421 ' NH2' ' HG3' ' B' ' 112' ' ' GLU . 78.3 mtt-85 -75.02 -41.66 58.87 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.567 0.747 . . . . 71.34 108.995 176.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.12 1.6 68.93 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 124.254 0.971 . . . . 61.2 112.364 172.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 22.3 p 60.96 29.84 19.26 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.632 1.973 . . . . 64.13 113.523 170.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -83.65 148.44 54.83 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 123.457 0.703 . . . . 63.12 110.193 173.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -52.83 139.35 59.72 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.351 2.701 . . . . 73.22 113.341 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -56.88 112.95 1.47 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.615 1.166 . . . . 61.35 112.353 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.38 100.9 7.58 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.291 -1.744 . . . . 75.25 106.291 174.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -99.09 131.4 45.16 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.284 0.634 . . . . 65.32 110.318 -172.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.94 142.04 38.62 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.542 0.737 . . . . 73.22 110.041 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.46 162.05 74.15 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.055 0.942 . . . . 72.2 111.58 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.33 109.34 0.97 Allowed 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.385 2.057 . . . . 74.11 111.972 173.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.24 106.85 19.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 108.006 -1.109 . . . . 74.44 108.006 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -101.81 91.6 4.46 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.725 -1.583 . . . . 72.44 106.725 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . 0.486 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 45.8 m-85 -58.09 -37.79 75.18 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.597 0.713 . . . . 75.12 109.534 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 2.6 t70 . . . . . 0 C--N 1.347 0.486 0 CA-C-N 113.789 -1.55 . . . . 73.05 111.059 -177.575 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 55.7 m . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 109.926 -0.398 . . . . 73.13 109.926 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -159.04 113.88 2.47 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.203 -1.036 . . . . 74.02 108.203 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . 0.469 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 49.3 mt-30 -133.33 135.91 45.07 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.865 0.866 . . . . 73.11 108.895 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 16.6 mt -92.47 120.21 41.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 109.48 -0.563 . . . . 73.12 109.48 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -91.61 -47.21 7.52 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.284 0.365 . . . . 75.13 111.404 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -166.6 123.41 1.27 Allowed 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 111.434 0.161 . . . . 74.21 111.434 -168.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.73 137.54 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 108.462 -0.94 . . . . 75.51 108.462 170.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.459 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 22.7 p90 -162.05 168.76 22.15 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 124.16 0.912 . . . . 72.14 110.861 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.1 p -96.98 122.66 40.21 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.405 -0.961 . . . . 74.11 108.405 171.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.459 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 34.4 mtpt -85.13 -40.17 17.06 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.986 -0.746 . . . . 75.01 108.986 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.8 t70 -140.62 141.26 35.13 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 113.978 -1.464 . . . . 71.04 108.99 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.709 HG21 ' HE1' ' C' ' 117' ' ' MET . 94.0 mt -135.44 147.75 28.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.695 1.198 . . . . 75.11 107.922 174.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -147.32 143.4 28.02 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.416 1.086 . . . . 74.42 108.523 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.553 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.9 t80 -149.47 132.24 15.99 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.577 -1.638 . . . . 70.13 106.577 171.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 46.5 mt-10 -135.68 151.16 49.92 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.716 -1.216 . . . . 62.42 107.716 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.66 91.59 5.27 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 108.332 -0.988 . . . . 71.13 108.332 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.78 -50.9 3.52 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.398 2.732 . . . . 61.41 113.551 -171.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.483 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 18.6 m-20 -99.86 14.1 31.54 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.832 0.853 . . . . 71.42 110.071 -171.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -28.48 -68.72 0.1 OUTLIER Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 126.826 2.05 . . . . 63.02 115.82 -163.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.401 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 93.6 Cg_endo -74.29 -19.67 19.47 Favored 'Trans proline' 0 C--N 1.382 2.322 0 CA-C-N 123.162 2.165 . . . . 74.02 114.05 -173.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -79.11 -43.01 24.94 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.848 0.859 . . . . 74.5 109.944 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.523 HG21 ' HA ' ' D' ' 73' ' ' ALA . 10.0 p -75.01 -15.33 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-N 115.613 -0.721 . . . . 71.12 110.744 -172.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -70.56 -17.71 62.92 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 112.281 0.474 . . . . 72.13 112.281 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -64.36 -11.21 30.23 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.372 0.669 . . . . 74.3 110.879 173.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -105.55 97.17 7.04 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.014 1.726 . . . . 74.25 109.438 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -104.91 89.72 3.24 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.547 0.739 . . . . 71.34 109.329 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -162.43 171.88 16.43 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.141 0.976 . . . . 71.43 109.124 171.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 28.7 tp60 -63.56 110.75 4.03 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 123.26 0.624 . . . . 75.25 109.634 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -64.73 143.92 82.16 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.629 2.219 . . . . 70.24 112.325 -176.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -71.48 116.02 11.33 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.442 0.697 . . . . 73.31 109.166 173.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.595 HG11 HG13 ' D' ' 64' ' ' VAL . 78.5 t -115.45 130.28 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.611 0.764 . . . . 74.41 110.963 -169.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.562 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 16.6 tptm -106.11 134.74 48.76 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.656 1.183 . . . . 75.21 108.579 173.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -110.17 114.81 28.6 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.611 0.764 . . . . 73.35 109.741 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.503 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 3.7 m-20 -108.87 113.64 26.72 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.993 0.917 . . . . 72.44 108.532 174.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 8.7 mp -101.29 132.05 47.01 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.182 -0.673 . . . . 74.35 109.182 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.6 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 25.0 t70 -132.48 150.11 52.21 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.027 0.931 . . . . 74.23 108.749 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 52.2 m -105.83 144.04 33.13 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.07 0.948 . . . . 71.31 110.955 -171.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -156.65 161.38 39.89 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.86 1.264 . . . . 73.22 108.994 171.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.3 p -175.71 166.63 3.16 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.127 0.571 . . . . 73.34 111.349 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 80.3 p -161.96 143.3 10.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.528 0.731 . . . . 72.42 110.044 172.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -78.91 121.47 24.91 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.628 -0.878 . . . . 73.24 108.628 171.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.466 HD13 HG22 ' D' ' 83' ' ' ILE . 76.3 mt -99.84 -29.03 12.83 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.809 0.444 . . . . 71.42 111.318 -175.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.26 -175.43 4.84 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.483 0.659 . . . . 74.5 111.135 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -62.62 122.49 15.97 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.1 -1.409 . . . . 54.51 109.479 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 60.09 16.29 5.82 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.786 0.834 . . . . 73.11 112.592 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 81.8 t -119.6 125.74 74.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 C-N-CA 123.806 0.843 . . . . 74.31 108.756 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -135.09 130.85 36.18 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.874 -0.603 . . . . 64.14 109.598 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -91.23 139.81 30.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.317 -0.856 . . . . 74.14 109.579 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 62.5 t -120.8 126.12 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 107.777 -1.194 . . . . 72.54 107.777 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.07 129.28 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.463 0.705 . . . . 75.54 109.363 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -121.7 120.58 35.1 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.031 0.532 . . . . 72.24 110.218 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.6 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 32.9 ttm-85 -87.93 102.98 15.24 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.152 -0.931 . . . . 75.14 108.978 172.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.6 t -91.6 126.3 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 107.72 -1.215 . . . . 75.11 107.72 169.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 8.5 m -121.02 131.76 54.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.474 -0.565 . . . . 71.43 109.474 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.595 HG13 HG11 ' D' ' 40' ' ' VAL . 35.3 t -116.4 102.35 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 124.73 1.212 . . . . 71.5 108.856 -173.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.562 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 9.4 m -94.04 91.68 6.97 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.947 -1.131 . . . . 75.21 107.947 173.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.87 150.0 20.91 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.59 -0.732 . . . . 64.04 109.405 -175.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 67.9 m -149.35 128.95 13.13 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.222 0.534 . . . . 73.54 112.294 -173.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 34.9 mt -110.73 134.55 52.38 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.048 1.339 . . . . 74.42 109.184 174.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.03 -111.85 3.68 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 112.203 -0.359 . . . . 74.45 112.203 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.81 4.47 8.79 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.733 0.813 . . . . 74.52 110.174 178.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -125.22 173.76 8.56 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.688 0.795 . . . . 51.42 110.065 -174.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 82.3 m -72.7 139.58 47.32 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.208 0.528 . . . . 72.13 110.558 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.523 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.7 -67.85 0.8 Allowed 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.012 0.925 . . . . 72.51 108.57 173.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -152.38 160.9 43.24 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.857 -0.611 . . . . 75.4 110.653 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.405 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 68.5 mt -122.84 110.95 16.08 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.739 -1.208 . . . . 74.34 107.739 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.625 ' SG ' ' HE3' ' D' ' 117' ' ' MET . 46.0 t -123.73 115.09 20.83 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.124 0.57 . . . . 71.11 109.906 -173.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -130.83 122.83 27.79 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.534 0.734 . . . . 74.51 109.855 -171.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.14 119.21 48.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 C-N-CA 123.259 0.624 . . . . 74.23 109.676 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.513 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.4 mt-30 -89.65 87.8 7.16 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.214 -0.662 . . . . 75.33 109.214 170.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.21 109.89 15.1 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.742 -1.117 . . . . 74.23 108.826 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.3 143.83 16.92 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 111.524 -0.63 . . . . 72.55 111.524 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.92 134.41 6.57 Favored Glycine 0 CA--C 1.509 -0.287 0 N-CA-C 110.933 -0.867 . . . . 63.13 110.933 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.466 HG22 HD13 ' D' ' 51' ' ' LEU . 48.3 mt -89.0 121.96 39.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 108.251 -1.018 . . . . 74.44 108.251 176.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -131.13 127.8 38.83 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.202 0.314 . . . . 73.51 110.366 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 21.2 m -75.96 104.82 6.68 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.064 -0.717 . . . . 71.24 109.064 170.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.489 HD13 HD12 ' D' ' 89' ' ' ILE . 16.4 tt -126.6 133.23 69.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-O 121.38 0.609 . . . . 74.42 111.077 -174.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.49 168.38 26.34 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.244 1.017 . . . . 72.43 109.601 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.07 13.37 81.12 Favored Glycine 0 N--CA 1.473 1.114 0 N-CA-C 114.289 0.476 . . . . 74.33 114.289 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.489 HD12 HD13 ' D' ' 86' ' ' ILE . 37.1 mt -113.49 139.34 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.433 1.093 . . . . 74.41 109.175 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.672 ' HA ' ' HE2' ' D' ' 94' ' ' MET . 8.7 pt-20 -153.77 158.22 40.61 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.51 0.506 . . . . 73.24 112.205 -171.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.56 -137.34 23.37 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.097 -0.956 . . . . 42.25 112.445 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 40.9 p -69.68 -20.6 63.56 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.581 0.753 . . . . 71.34 111.342 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.403 ' NE2' HG12 ' D' ' 89' ' ' ILE . 46.1 tt0 -60.11 -32.53 71.08 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.953 0.901 . . . . 74.11 111.262 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.672 ' HE2' ' HA ' ' D' ' 90' ' ' GLU . 54.4 mtt -62.49 -47.61 83.22 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.38 0.672 . . . . 74.42 110.717 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.51 94.04 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.039 -0.982 . . . . 55.33 110.471 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -66.81 -43.71 83.12 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.214 0.606 . . . . 72.41 111.785 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 39.5 t -63.13 -51.04 68.08 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.326 0.584 . . . . 65.11 110.463 -172.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 73.9 mt -85.91 -21.24 28.06 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.23 -0.895 . . . . 75.21 111.448 -175.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.39 8.62 55.31 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 119.628 -0.54 . . . . 75.2 114.03 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.92 -54.29 0.09 Allowed 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 117.28 0.54 . . . . 74.45 111.586 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -70.13 -51.1 34.12 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.662 0.385 . . . . 74.1 111.871 -173.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 30.6 m -67.15 -42.16 38.73 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 123.175 0.59 . . . . 74.14 111.904 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -53.72 -35.35 78.04 Favored 'Trans proline' 0 C--N 1.393 2.888 0 C-N-CA 122.667 2.244 . . . . 75.42 113.346 166.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -68.8 -32.92 72.99 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.514 0.726 . . . . 73.3 110.319 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 50.2 mm -67.5 -40.23 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 121.394 0.616 . . . . 75.11 110.146 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 95.6 mt -84.05 -15.52 47.19 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.274 -0.875 . . . . 74.15 112.064 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -61.68 -50.08 83.61 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 124.437 1.095 . . . . 74.32 112.945 -175.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -59.72 -34.6 96.05 Favored 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 122.144 1.896 . . . . 52.33 112.945 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -78.34 -37.22 45.0 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.562 0.745 . . . . 65.3 112.211 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.0 -46.35 78.29 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.426 -0.583 . . . . 75.5 109.426 176.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -57.37 -47.74 80.86 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 124.41 1.068 . . . . 74.44 110.921 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -60.42 -49.88 75.8 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.808 0.843 . . . . 64.33 111.185 -177.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -56.2 -41.8 76.18 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 123.882 0.739 . . . . 73.33 111.101 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.47 ' O ' HG23 ' D' ' 118' ' ' VAL . 98.0 mt -63.46 -56.44 17.06 Favored 'Isoleucine or valine' 0 C--N 1.349 0.568 0 CA-C-N 115.17 -0.923 . . . . 73.3 110.202 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -55.14 -36.82 66.18 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.438 1.095 . . . . 74.22 111.739 -173.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.418 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 37.2 t -66.97 -43.94 81.76 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.403 -0.817 . . . . 73.51 110.553 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.625 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 78.2 mtm -70.64 -25.88 63.22 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.74 0.416 . . . . 72.1 111.956 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.47 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.2 t -65.73 -43.79 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.274 0.63 . . . . 72.04 109.638 174.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.7 p -77.03 -27.44 54.49 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.998 -0.546 . . . . 74.5 111.142 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' D' ' 116' ' ' SER . 89.9 mtt-85 -73.02 -35.83 66.85 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.416 0.686 . . . . 72.13 109.866 174.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.4 -2.34 89.32 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.547 -0.751 . . . . 74.25 112.024 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.7 p 65.9 20.44 11.36 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 127.054 2.142 . . . . 63.54 113.657 172.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -79.16 155.0 77.38 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.418 0.687 . . . . 71.45 110.129 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.58 133.71 54.91 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.078 2.519 . . . . 64.32 112.548 172.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -54.41 140.75 32.9 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.416 1.086 . . . . 73.23 112.644 -172.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 62.4 tp -121.2 110.07 15.73 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.165 0.986 . . . . 72.44 109.141 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -111.21 104.96 13.51 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.812 -0.81 . . . . 71.23 108.812 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 tt -70.53 114.21 8.41 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 107.609 -1.256 . . . . 73.01 107.609 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.65 138.32 88.37 Favored Pre-proline 0 N--CA 1.475 0.823 0 CA-C-O 119.609 -0.234 . . . . 65.34 110.408 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -73.62 141.15 30.63 Favored 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 122.457 2.105 . . . . 75.53 111.693 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.241 0.635 0 C-N-CA 123.88 0.872 . . . . 74.24 108.961 -177.836 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.3 t80 . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 109.172 -0.677 . . . . 63.44 109.172 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -153.29 130.96 11.53 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.47 -1.308 . . . . 73.15 107.47 169.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' C' ' 130' ' ' PRO . 14.5 mt -80.71 114.76 22.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.778 -0.823 . . . . 74.05 108.778 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -72.55 -39.34 67.55 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 123.891 0.745 . . . . 72.22 110.055 -177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -177.52 120.93 0.11 Allowed 'General case' 0 C--N 1.366 1.309 0 N-CA-C 111.74 0.274 . . . . 73.3 111.74 -172.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 78.6 mt -106.32 135.0 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.023 -0.732 . . . . 75.34 109.023 173.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.429 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 20.0 p90 -162.52 147.61 12.29 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 124.11 0.881 . . . . 74.23 109.968 -176.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.0 p -75.59 119.15 19.25 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.242 -0.651 . . . . 70.54 109.242 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.2 mtpt -83.22 -32.11 26.67 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.418 -0.586 . . . . 73.53 109.418 176.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 25.0 t70 -144.23 139.54 28.74 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.207 -0.906 . . . . 65.45 110.354 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.6 mt -133.22 145.61 33.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.941 1.296 . . . . 74.15 108.182 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.565 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 48.1 t -149.73 124.83 10.04 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.458 -0.792 . . . . 72.23 109.295 173.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 86.4 t80 -129.49 111.28 12.6 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 106.62 -1.622 . . . . 71.23 106.62 169.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -121.51 110.41 16.0 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.513 -0.551 . . . . 73.51 109.513 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.32 84.26 0.87 Allowed Pre-proline 0 C--O 1.241 0.654 0 N-CA-C 107.156 -1.424 . . . . 70.2 107.156 168.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.34 -19.3 29.17 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.161 1.908 . . . . 73.24 112.589 -168.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -120.26 22.76 11.24 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.933 0.893 . . . . 74.22 109.77 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.453 ' O ' HG11 ' A' ' 31' ' ' VAL . . . -45.38 -55.04 12.78 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 113.969 1.1 . . . . 72.14 113.969 -170.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.98 -16.95 57.93 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 121.989 1.792 . . . . 74.13 114.119 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -100.94 -26.01 13.88 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.305 1.042 . . . . 73.31 110.933 -176.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.674 HG22 ' HA ' ' A' ' 73' ' ' ALA . 4.5 p -80.78 -25.18 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 115.839 -0.619 . . . . 72.44 112.584 -166.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -71.08 -26.76 63.2 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.882 0.473 . . . . 72.32 110.779 -175.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -85.28 -13.77 48.7 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.534 0.733 . . . . 75.11 111.527 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.496 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 2.0 tmtp? -81.63 132.84 35.31 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.387 -0.968 . . . . 72.31 108.387 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.496 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 12.5 m-20 -52.51 132.35 35.05 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.663 1.185 . . . . 52.43 112.314 178.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.41 ' CE3' HD21 ' A' ' 68' ' ' LEU . 55.3 t-105 -78.57 89.17 4.5 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.374 0.607 . . . . 73.02 110.334 -175.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.459 ' H ' HD23 ' A' ' 68' ' ' LEU . 35.9 tt0 -120.21 78.49 26.18 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.905 1.282 . . . . 74.52 108.465 171.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.6 111.7 2.84 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.307 2.005 . . . . 71.23 113.239 -171.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -95.86 99.11 10.95 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 107.5 -1.296 . . . . 74.1 107.5 173.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.434 HG11 HG13 ' A' ' 64' ' ' VAL . 57.7 t -90.64 100.21 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 123.57 0.748 . . . . 73.31 110.5 -169.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -84.53 114.77 22.2 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.621 0.768 . . . . 74.1 109.754 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mp -104.67 108.35 19.76 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.918 -0.771 . . . . 73.32 108.918 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.54 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 10.7 t70 -102.35 124.49 48.02 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.949 1.3 . . . . 63.32 108.04 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.426 HD22 HD21 ' A' ' 60' ' ' LEU . 6.8 mp -111.77 125.81 54.4 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.901 0.382 . . . . 75.03 110.533 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.452 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 4.2 t70 -119.32 136.17 54.37 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.577 1.151 . . . . 71.04 108.716 175.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 46.9 p -107.75 136.44 47.48 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.243 0.617 . . . . 71.05 110.43 -174.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.617 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . . . -139.13 137.09 35.81 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.575 0.75 . . . . 63.24 109.454 177.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.4 p -133.62 152.8 51.97 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.516 0.726 . . . . 74.45 110.381 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.9 t -161.07 127.38 3.93 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.049 0.54 . . . . 65.32 110.014 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -88.13 105.27 17.4 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.25 -1.019 . . . . 75.42 108.25 171.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.4 mt -79.33 -36.41 39.53 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.039 0.535 . . . . 73.51 111.541 -171.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.05 -174.13 3.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.475 0.71 . . . . 70.13 110.297 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -67.55 118.84 11.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.109 0.564 . . . . 74.31 109.534 171.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 67.69 13.16 9.17 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.819 1.248 . . . . 64.03 111.825 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.25 109.48 24.37 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 N-CA-C 107.864 -1.162 . . . . 72.34 107.864 175.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -129.58 155.49 45.72 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.272 -1.01 . . . . 74.43 108.272 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -129.6 124.59 34.15 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.089 0.556 . . . . 72.45 110.864 -174.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.415 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 85.3 t -109.07 113.42 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.317 -1.364 . . . . 74.21 107.317 166.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.617 ' HB ' ' HB2' ' A' ' 47' ' ' ALA . 40.3 t -103.55 135.05 42.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.554 -0.906 . . . . 74.54 108.554 171.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.426 HD21 HD22 ' A' ' 44' ' ' LEU . 2.6 tt -129.0 119.12 23.72 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.385 -0.598 . . . . 74.21 109.385 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.452 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 12.1 ttm180 -84.84 110.33 18.75 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.251 1.02 . . . . 74.55 109.63 175.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.8 t -100.47 101.33 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 107.719 -1.215 . . . . 65.31 107.719 170.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 20.9 m -99.46 104.23 16.05 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.686 0.794 . . . . 75.45 109.029 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.589 HG12 HD23 ' A' ' 126' ' ' LEU . 14.1 t -104.9 119.63 54.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 123.754 0.822 . . . . 72.13 109.966 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.5 m -112.29 123.88 51.24 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.586 -0.894 . . . . 73.33 108.586 177.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.51 110.5 22.46 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 106.603 -1.629 . . . . 74.31 106.603 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.8 m -109.87 124.9 52.15 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.195 -0.669 . . . . 63.2 109.195 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.459 HD23 ' H ' ' A' ' 37' ' ' GLN . 40.2 mt -88.99 75.76 7.94 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.193 -1.41 . . . . 72.12 107.193 176.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.49 -88.75 0.72 Allowed Glycine 0 C--N 1.345 1.043 0 CA-C-N 114.949 -1.023 . . . . 60.13 110.991 -173.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -120.85 -4.93 9.65 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.501 0.721 . . . . 72.24 111.499 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -101.9 103.6 14.28 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.652 -0.499 . . . . 74.13 109.652 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.0 m -60.52 121.15 11.41 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.139 0.495 . . . . 75.42 110.976 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.674 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -69.55 -58.29 4.13 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.959 -1.019 . . . . 53.0 109.999 175.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -158.65 174.6 14.8 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.353 -1.294 . . . . 72.42 111.16 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.9 tp -132.11 142.6 49.56 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 113.778 -1.556 . . . . 72.24 107.636 173.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 75.1 m -142.7 94.96 2.71 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.293 0.637 . . . . 73.24 109.546 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 39.0 tt0 -115.07 115.62 27.11 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.549 -0.908 . . . . 74.33 108.549 -175.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.73 109.12 18.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.781 -0.822 . . . . 74.44 108.781 -175.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.425 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 76.0 mt-30 -85.58 84.09 7.71 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.117 -1.068 . . . . 73.13 108.117 173.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.409 ' HG3' HD23 ' A' ' 106' ' ' LEU . 7.2 tp-100 -76.48 99.4 4.9 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.508 -1.224 . . . . 75.33 108.949 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.99 144.82 22.11 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 110.298 -1.121 . . . . 75.35 110.298 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.465 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -144.78 120.92 1.47 Allowed Glycine 0 CA--C 1.5 -0.865 0 N-CA-C 110.382 -1.087 . . . . 63.43 110.382 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.0 mt -88.84 123.24 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 108.529 -0.915 . . . . 75.3 108.529 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.415 ' HE1' ' HB ' ' A' ' 58' ' ' VAL . 90.1 m-85 -121.44 119.87 33.32 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.49 -1.3 . . . . 73.15 107.49 -177.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.7 m -84.78 88.5 7.39 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.199 0.6 . . . . 64.44 109.504 173.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.119 0 CA-C-N 115.581 -0.736 . . . . 73.31 110.04 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 121.046 0.451 . . . . 70.2 111.308 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -72.24 -36.58 69.13 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.234 1.014 . . . . 70.12 110.704 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 81.9 m -66.39 -60.99 2.24 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.768 -0.456 . . . . 72.22 109.768 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 69.5 mt -60.24 -40.32 89.84 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.241 1.016 . . . . 65.12 112.061 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.66 -28.13 30.32 Favored Glycine 0 C--N 1.342 0.866 0 O-C-N 123.753 0.658 . . . . 71.42 114.128 -172.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.71 -59.71 1.2 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.982 0.734 . . . . 73.32 112.982 -171.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -73.55 -56.83 4.51 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.597 0.359 . . . . 73.55 111.86 -166.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 66.6 m -55.33 -41.09 88.92 Favored Pre-proline 0 CA--C 1.571 1.785 0 CA-C-O 118.308 -0.853 . . . . 73.33 112.855 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -49.33 -51.39 10.76 Favored 'Trans proline' 0 C--N 1.399 3.224 0 C-N-CA 122.728 2.286 . . . . 73.01 113.207 164.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.441 HD22 ' N ' ' A' ' 133' ' ' PHE . 95.0 m-20 -71.98 -15.4 62.06 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.748 0.819 . . . . 74.43 112.445 -177.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.447 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 30.3 mm -80.72 -45.1 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.259 0.623 . . . . 75.23 109.494 172.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.465 HD21 ' HA3' ' A' ' 82' ' ' GLY . 90.0 mt -74.66 -22.98 58.59 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.06 -0.518 . . . . 74.02 111.053 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -61.96 -46.0 91.96 Favored Pre-proline 0 CA--C 1.559 1.319 0 CA-C-O 117.499 -1.238 . . . . 73.52 113.002 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.447 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 34.5 Cg_exo -60.35 -35.37 91.48 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 121.837 1.692 . . . . 71.34 113.926 174.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.439 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 88.3 m-85 -78.34 -35.82 47.07 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 122.899 0.479 . . . . 71.12 111.093 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.57 -37.91 68.07 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.2 0.6 . . . . 74.04 109.76 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.474 ' NH1' HG23 ' C' ' 105' ' ' ILE . 26.3 ttm180 -63.51 -39.95 95.77 Favored 'General case' 0 C--O 1.209 -1.05 0 C-N-CA 124.061 0.945 . . . . 73.42 109.309 173.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -63.39 -48.3 78.42 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.992 0.917 . . . . 73.11 111.038 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 32.9 t -60.58 -41.32 94.44 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 124.385 1.053 . . . . 74.43 110.04 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 69.1 mt -65.25 -46.77 89.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 123.579 0.752 . . . . 75.03 110.83 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 55.3 m -59.44 -39.22 82.86 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.449 1.1 . . . . 75.41 110.424 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.8 t -75.03 -47.19 30.23 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.893 -1.049 . . . . 74.4 110.476 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.458 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 13.7 mtp -57.44 -45.15 85.02 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.606 0.763 . . . . 75.45 111.948 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.2 t -63.61 -43.66 98.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 124.468 1.107 . . . . 74.43 110.878 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.0 t -70.83 -31.65 68.44 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.215 0.606 . . . . 72.52 111.463 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -73.8 -30.14 62.56 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.287 0.635 . . . . 74.24 109.726 176.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.38 -0.52 78.68 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.286 -0.87 . . . . 63.33 113.41 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.465 HG22 HH21 ' B' ' 15' ' ' ARG . 17.2 m 73.42 15.59 4.2 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-O 122.574 1.178 . . . . 71.4 111.425 173.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -86.27 154.82 57.4 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-N 115.588 -0.733 . . . . 71.0 110.221 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.25 129.7 34.79 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.772 2.315 . . . . 75.12 111.851 171.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -51.76 129.56 26.62 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 124.289 0.993 . . . . 75.53 112.268 -172.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.589 HD23 HG12 ' A' ' 64' ' ' VAL . 56.1 tp -109.47 97.99 7.46 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.229 -0.896 . . . . 55.14 110.177 -174.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -103.28 112.28 25.07 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.432 0.693 . . . . 72.43 109.401 174.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.0 mp -72.43 117.73 14.45 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.103 -1.073 . . . . 72.15 108.103 172.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.24 145.02 94.36 Favored Pre-proline 0 CA--C 1.56 1.354 0 CA-C-N 117.925 0.33 . . . . 73.1 110.716 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.514 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 13.7 Cg_exo -69.44 110.67 2.54 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.743 2.296 . . . . 73.54 112.084 -170.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.2 m -99.49 115.25 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 108.676 -0.861 . . . . 64.34 108.676 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -90.75 98.81 12.0 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.643 -0.873 . . . . 71.11 108.643 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.441 ' N ' HD22 ' A' ' 104' ' ' ASN . 72.7 m-85 . . . . . 0 CA--C 1.542 0.651 0 O-C-N 123.445 0.465 . . . . 74.53 110.278 170.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.418 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 26.2 ttt . . . . . 0 CA--C 1.561 1.398 0 CA-C-O 121.517 0.675 . . . . 74.11 111.942 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m -143.35 133.57 24.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.446 -1.316 . . . . 75.11 107.446 166.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -141.22 137.67 32.75 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.396 -0.594 . . . . 74.44 109.396 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.465 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -158.75 129.0 5.92 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.026 0.93 . . . . 75.41 108.753 173.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.459 HD11 HD12 ' B' ' 105' ' ' ILE . 15.8 mt -75.05 119.06 21.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.629 0 N-CA-C 108.001 -1.111 . . . . 75.33 108.001 169.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -96.3 -42.58 8.09 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 123.537 0.523 . . . . 64.03 110.199 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.465 HH21 HG22 ' A' ' 122' ' ' THR . 23.0 ttt85 -165.64 133.13 2.91 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.9 -0.591 . . . . 74.02 109.739 -175.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 71.8 mt -116.66 143.05 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 107.622 -1.251 . . . . 74.3 107.622 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -166.91 155.68 10.28 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.528 0.68 . . . . 75.35 112.129 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 89.1 m -84.27 120.46 26.26 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.771 -1.104 . . . . 52.41 108.361 170.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.516 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 33.1 mtpt -87.83 -33.74 18.48 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.031 0.532 . . . . 74.11 110.383 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 19.7 t70 -157.62 144.49 18.11 Favored 'General case' 0 C--N 1.347 0.48 0 N-CA-C 112.707 0.632 . . . . 73.4 112.707 -170.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.697 HD12 ' SG ' ' B' ' 113' ' ' CYS . 45.3 mm -137.51 142.14 37.55 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 C-N-CA 125.648 1.579 . . . . 73.11 108.472 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.3 t -147.21 127.22 13.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.924 -1.139 . . . . 63.44 107.924 173.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 90.7 t80 -139.57 110.91 7.02 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.435 -0.95 . . . . 75.32 108.435 175.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -118.04 115.44 24.87 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.351 1.061 . . . . 73.54 108.534 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.7 87.91 3.13 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.032 -1.099 . . . . 54.02 108.032 174.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.54 -44.52 4.41 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.649 2.232 . . . . 65.42 112.562 -170.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -97.29 16.48 19.83 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.936 0.894 . . . . 74.34 110.666 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -38.31 -59.92 1.15 Allowed Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 115.303 1.594 . . . . 75.24 115.303 -168.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -66.61 -26.44 46.45 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 122.039 1.826 . . . . 72.32 112.89 -170.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -93.96 -41.21 9.71 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 115.022 -0.99 . . . . 72.41 111.176 -172.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.491 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.6 p -71.18 -12.47 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.344 0.658 . . . . 61.01 111.837 -170.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -66.25 -12.56 57.01 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.584 0.754 . . . . 73.32 112.716 174.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -65.21 -16.41 63.5 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.321 0.648 . . . . 73.01 111.427 174.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.604 ' HZ1' ' HG2' ' B' ' 71' ' ' GLU . 95.0 mttt -107.53 111.62 23.98 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.023 1.329 . . . . 72.0 111.09 -176.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -107.53 95.16 5.5 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.309 0.644 . . . . 72.34 110.935 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 39.3 p90 -169.27 175.45 5.61 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.7 1.2 . . . . 70.11 108.78 167.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -73.79 107.89 4.11 Favored Pre-proline 0 CA--C 1.555 1.142 0 N-CA-C 109.891 -0.411 . . . . 74.31 109.891 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.494 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 30.5 Cg_endo -64.71 149.73 89.27 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.663 2.242 . . . . 74.41 113.565 -173.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -63.09 114.87 3.99 Favored 'General case' 0 C--N 1.359 1.006 0 O-C-N 124.087 0.867 . . . . 75.3 110.052 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.42 HG23 HD22 ' B' ' 126' ' ' LEU . 88.3 t -92.57 144.09 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 123.983 0.913 . . . . 72.21 111.29 -172.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.504 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 23.6 ttpp -128.82 116.43 19.44 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.845 -1.539 . . . . 74.31 106.845 168.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.484 ' H ' HD23 ' B' ' 42' ' ' LEU . 1.6 pt? -84.11 149.07 26.45 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.146 -0.687 . . . . 75.25 109.146 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.753 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 6.9 m-20 -139.52 110.0 6.62 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.16 -1.422 . . . . 74.21 107.16 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 84.0 mt -104.46 127.12 52.09 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.502 -0.925 . . . . 74.54 108.502 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 14.5 t70 -133.11 143.92 49.61 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.801 0.84 . . . . 64.2 109.409 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 81.3 p -109.98 126.17 53.65 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.755 0.822 . . . . 74.4 110.246 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.06 148.91 52.2 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.837 0.855 . . . . 73.33 109.355 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.9 p -144.48 164.39 31.0 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.703 0.631 . . . . 75.3 112.703 -174.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 69.7 p -155.13 146.74 23.17 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.152 -0.931 . . . . 73.51 109.552 166.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -97.62 128.89 44.67 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.95 -0.759 . . . . 74.53 108.95 174.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.429 HD12 HG22 ' B' ' 83' ' ' ILE . 41.9 mt -97.58 -54.15 3.21 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.315 0.578 . . . . 74.2 110.238 -177.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.38 -168.15 2.98 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.065 -0.971 . . . . 72.32 110.051 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -67.43 103.23 1.26 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.651 -1.158 . . . . 74.44 110.602 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 67.12 15.23 10.03 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.136 1.375 . . . . 64.33 112.414 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.449 HG22 ' HG ' ' B' ' 85' ' ' SER . 68.0 t -105.74 105.71 19.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 107.52 -1.289 . . . . 73.24 107.52 172.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.565 ' HB2' HD12 ' B' ' 86' ' ' ILE . 6.1 t80 -110.53 165.87 11.46 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.339 -0.846 . . . . 72.32 109.003 -172.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -136.23 114.08 11.21 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.966 -1.124 . . . . 72.03 107.966 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 95.8 t -104.09 118.43 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.829 1.252 . . . . 75.53 110.443 -171.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 13.3 t -109.76 122.55 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 109.496 -0.557 . . . . 75.43 109.496 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.523 HD22 ' HB2' ' B' ' 103' ' ' PRO . 51.8 tp -106.3 110.28 22.46 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.76 -0.83 . . . . 74.11 108.76 170.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.511 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 22.1 ttm-85 -85.94 109.38 18.71 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.223 -0.658 . . . . 74.15 109.223 173.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 30.7 t -106.26 101.86 13.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 108.143 -1.058 . . . . 75.31 108.143 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.753 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 10.4 m -102.32 128.76 48.74 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.747 -0.834 . . . . 62.04 108.747 175.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 61.3 t -119.91 108.16 22.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 123.85 0.86 . . . . 74.34 109.289 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 96.4 m -82.34 144.66 30.42 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.409 -0.96 . . . . 74.1 108.409 169.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.15 144.56 29.08 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 122.952 0.501 . . . . 73.04 109.928 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 36.1 p -147.65 127.13 13.19 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.501 0.501 . . . . 74.32 111.127 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 72.7 mt -94.66 110.16 22.02 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.234 -1.025 . . . . 70.23 108.234 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.41 -112.86 3.67 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 115.477 -0.783 . . . . 62.45 111.771 -176.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -120.96 9.46 10.61 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.435 0.694 . . . . 74.3 110.421 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.604 ' HG2' ' HZ1' ' B' ' 34' ' ' LYS . 11.9 pt-20 -123.19 155.15 37.65 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.47 0.708 . . . . 63.42 109.66 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 29.6 m -68.98 133.71 48.53 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.961 0.41 . . . . 63.45 109.984 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -87.98 -63.58 1.28 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.713 -1.217 . . . . 73.24 107.713 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -150.8 161.31 42.91 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.439 -1.255 . . . . 72.43 110.857 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 85.7 mt -125.73 113.28 17.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.564 -2.013 . . . . 75.33 105.564 172.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.8 t -116.66 151.37 36.45 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.5 -0.926 . . . . 72.3 108.5 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.401 ' HB2' HG22 ' B' ' 63' ' ' THR . 42.8 tt0 -161.14 133.18 5.82 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.055 0.455 . . . . 70.34 109.812 -175.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.49 HG11 ' HA ' ' B' ' 110' ' ' ALA . 93.3 t -134.12 149.0 29.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 124.697 1.199 . . . . 75.11 108.261 176.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.413 HE21 ' HB3' ' B' ' 20' ' ' ASP . 25.6 mt-30 -125.25 107.01 10.3 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.121 -1.066 . . . . 74.33 108.121 169.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -96.5 101.22 12.81 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.656 -0.868 . . . . 74.11 108.656 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.516 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -95.09 144.39 17.17 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.366 -0.834 . . . . 63.52 111.275 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.59 126.84 3.13 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.427 -0.669 . . . . 74.13 111.427 -176.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.429 HG22 HD12 ' B' ' 51' ' ' LEU . 70.2 mt -83.96 127.43 39.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.795 -0.817 . . . . 74.21 108.795 174.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -137.85 135.77 36.51 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.936 -0.764 . . . . 75.14 108.936 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.449 ' HG ' HG22 ' B' ' 55' ' ' VAL . 66.8 m -89.24 98.32 11.7 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.693 -0.855 . . . . 72.3 108.693 172.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.565 HD12 ' HB2' ' B' ' 56' ' ' TYR . 1.7 pp -111.48 129.53 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.93 0.892 . . . . 71.21 110.702 -175.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.65 167.31 22.86 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.153 0.581 . . . . 73.41 109.815 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 88.28 -59.42 4.14 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 114.017 0.367 . . . . 42.42 114.017 172.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 15.4 mm -78.85 138.21 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 123.632 0.773 . . . . 74.12 110.067 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -157.24 174.65 15.14 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 115.846 -0.615 . . . . 65.13 111.928 -163.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.11 -127.83 44.82 Favored Glycine 0 C--N 1.354 1.562 0 C-N-CA 123.418 0.532 . . . . 34.42 113.78 -177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 51.8 m -66.29 -30.87 71.37 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.983 0.913 . . . . 74.03 110.94 175.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -65.79 -45.3 82.94 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.707 -0.679 . . . . 71.13 110.544 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -71.17 -24.83 62.32 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.534 0.334 . . . . 73.33 111.425 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.82 -45.15 95.08 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 123.664 0.603 . . . . 55.32 109.875 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -64.66 -40.77 96.0 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.233 0.613 . . . . 73.14 111.307 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.4 t -62.14 -44.57 96.32 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.766 0.427 . . . . 71.15 111.648 -176.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 9.2 mp -92.75 -16.86 24.91 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.046 0.539 . . . . 73.34 111.708 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.11 2.87 47.61 Favored Glycine 0 N--CA 1.474 1.211 0 CA-C-O 120.052 -0.304 . . . . 64.32 113.643 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.07 -57.36 0.34 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.22 0.608 . . . . 74.01 110.57 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -74.02 -51.81 14.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.997 0.519 . . . . 75.44 112.293 -171.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 72.0 m -60.8 -49.23 90.35 Favored Pre-proline 0 CA--C 1.565 1.536 0 CA-C-O 118.59 -0.719 . . . . 73.14 112.44 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.523 ' HB2' HD22 ' B' ' 60' ' ' LEU . 71.5 Cg_endo -71.56 -16.7 30.41 Favored 'Trans proline' 0 C--N 1.393 2.87 0 C-N-CA 122.08 1.853 . . . . 75.22 113.319 176.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -65.64 -41.21 92.89 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 123.469 0.708 . . . . 63.22 109.594 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.459 HD12 HD11 ' B' ' 13' ' ' ILE . 73.7 mt -60.54 -45.36 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.538 1.135 . . . . 74.53 110.741 175.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 49.5 mt -84.01 -13.22 53.81 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.224 -1.353 . . . . 74.34 111.612 -170.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -57.24 -55.74 41.13 Favored Pre-proline 0 CA--C 1.561 1.366 0 CA-C-O 117.946 -1.026 . . . . 72.31 113.549 -176.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -64.85 -27.1 59.26 Favored 'Trans proline' 0 C--N 1.383 2.368 0 CA-C-N 121.338 1.514 . . . . 73.42 113.186 -174.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -68.69 -48.45 63.85 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.839 0.456 . . . . 74.52 109.888 176.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.49 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -60.09 -40.59 90.12 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.449 -0.796 . . . . 65.31 110.745 176.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 45.2 ttt-85 -62.45 -49.03 77.04 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.757 1.223 . . . . 72.32 111.376 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -65.88 -36.85 84.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 123.711 0.632 . . . . 75.54 109.791 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.697 ' SG ' HD12 ' B' ' 21' ' ' ILE . 5.5 t -70.96 -33.8 70.82 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.892 -0.595 . . . . 63.5 111.369 -178.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.479 ' O ' HG23 ' B' ' 118' ' ' VAL . 55.6 mt -64.48 -54.64 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 109.17 -0.678 . . . . 73.51 109.17 173.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 4.3 m -63.72 -23.41 67.36 Favored 'General case' 0 CA--C 1.555 1.168 0 O-C-N 123.85 0.719 . . . . 72.34 111.353 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.0 t -67.25 -49.02 66.0 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 123.075 0.55 . . . . 73.23 109.812 172.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.4 mmt -68.68 -31.83 71.22 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.804 0.442 . . . . 73.22 111.042 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.479 HG23 ' O ' ' B' ' 114' ' ' ILE . 90.9 t -64.17 -42.67 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.837 0.855 . . . . 72.35 109.962 172.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.6 t -67.18 -31.39 71.75 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.924 -1.034 . . . . 72.41 111.336 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' B' ' 116' ' ' SER . 81.7 mtt-85 -73.45 -38.11 65.6 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.26 0.624 . . . . 63.43 110.061 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.95 -3.94 75.98 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 123.729 0.643 . . . . 75.13 112.609 169.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 34.3 p 63.46 24.08 13.96 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 126.426 1.89 . . . . 72.24 113.129 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -77.77 160.58 74.05 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 124.533 1.133 . . . . 75.14 111.36 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -51.95 162.29 1.92 Allowed 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 123.677 2.918 . . . . 74.44 115.049 173.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.606 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 56.3 tp60 -60.24 128.81 38.6 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.287 1.035 . . . . 75.03 111.574 -173.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.42 HD22 HG23 ' B' ' 40' ' ' VAL . 1.4 tm? -146.4 99.79 3.27 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.647 -0.871 . . . . 74.34 108.647 -174.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -131.53 132.2 43.98 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.722 0.809 . . . . 72.35 109.505 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.98 150.41 45.69 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.332 0.653 . . . . 74.34 112.383 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.0 153.19 69.47 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 124.114 0.966 . . . . 71.33 111.702 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.416 ' HB2' HD13 ' D' ' 13' ' ' ILE . 57.8 Cg_endo -68.03 116.72 4.47 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.112 2.541 . . . . 74.14 112.406 176.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 72.3 t -127.79 111.44 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.89 -0.781 . . . . 73.55 108.89 173.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -80.27 94.27 6.06 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 107.688 -1.227 . . . . 74.42 107.688 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -56.69 -41.55 77.53 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.136 0.974 . . . . 63.31 111.487 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 . . . . . 0 C--O 1.239 0.504 0 C-N-CA 124.324 1.049 . . . . 74.03 112.034 -176.56 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.447 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 42.0 t80 . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 109.691 -0.485 . . . . 75.42 109.691 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -159.72 134.31 7.77 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.082 0.953 . . . . 75.22 108.581 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.46 HG13 ' HD3' ' A' ' 130' ' ' PRO . 74.9 mt -72.8 120.46 21.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.492 -0.929 . . . . 74.22 108.492 168.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -89.86 -45.48 9.22 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.698 -0.683 . . . . 75.11 109.36 175.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -176.47 141.31 0.4 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.005 -0.998 . . . . 73.11 108.481 -168.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.475 HG21 ' CD1' ' C' ' 109' ' ' TYR . 56.0 mt -137.01 144.96 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 108.993 -0.743 . . . . 74.44 108.993 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.463 ' HH ' HD11 ' C' ' 83' ' ' ILE . 22.3 p90 -174.89 159.94 2.79 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.576 0.703 . . . . 74.33 110.077 -173.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -78.91 119.36 21.97 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.911 -1.04 . . . . 74.41 108.988 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.409 ' HZ3' ' CD ' ' C' ' 57' ' ' GLU . 19.6 mmtp -69.44 -46.43 66.77 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 107.133 -1.432 . . . . 70.22 107.133 168.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.575 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.2 t70 -135.04 143.05 46.52 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 113.016 -1.902 . . . . 53.12 109.748 -171.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 70.4 mt -136.8 150.44 26.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 105.928 -1.878 . . . . 73.4 105.928 170.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -163.86 151.16 12.24 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.333 0.587 . . . . 72.03 110.012 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -146.21 124.45 12.23 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.183 -1.414 . . . . 72.31 107.183 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -126.98 110.43 12.97 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.086 -0.709 . . . . 72.43 109.086 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.38 84.65 29.39 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 107.292 -1.373 . . . . 74.41 107.292 167.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.41 -37.03 24.73 Favored 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 122.331 2.02 . . . . 72.24 111.011 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -95.83 22.69 7.03 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.044 -0.98 . . . . 71.03 110.64 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.416 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -48.71 -54.45 27.1 Favored Pre-proline 0 CA--C 1.564 1.518 0 N-CA-C 114.127 1.158 . . . . 64.51 114.127 -172.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.54 -40.48 47.04 Favored 'Trans proline' 0 C--N 1.39 2.726 0 CA-C-N 121.797 1.677 . . . . 63.1 111.961 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -70.69 -31.83 68.86 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.659 -1.155 . . . . 74.4 112.563 -175.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.632 HG21 ' HA ' ' C' ' 73' ' ' ALA . 11.7 p -81.46 -26.0 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 112.756 0.65 . . . . 73.21 112.756 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -67.6 -24.58 65.51 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 120.793 0.33 . . . . 74.15 111.71 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -90.49 25.5 2.26 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.789 0.836 . . . . 73.42 110.95 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.704 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -121.32 157.83 29.54 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.603 0.761 . . . . 72.22 110.485 178.547 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -70.19 131.91 44.96 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.956 0.902 . . . . 72.21 110.134 170.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -84.5 88.13 7.29 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.344 0.658 . . . . 74.55 110.779 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -132.48 78.97 66.36 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 108.021 -1.103 . . . . 74.31 108.021 171.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -78.54 126.71 7.64 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.574 2.183 . . . . 75.42 113.919 -172.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -85.05 91.6 8.14 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 106.249 -1.76 . . . . 74.22 106.249 160.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 28.6 m -80.15 142.69 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 114.345 -1.298 . . . . 63.25 111.262 -173.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.537 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 45.5 mmtm -124.52 103.1 7.97 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.597 -0.89 . . . . 63.23 108.597 172.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 pp -86.83 151.5 23.29 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.158 -0.682 . . . . 73.34 109.158 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -144.73 138.75 27.43 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.021 -0.733 . . . . 70.34 109.021 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 mp -125.35 114.97 19.59 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.254 -1.017 . . . . 75.33 108.254 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 11.3 t70 -111.98 144.5 41.23 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.945 0.898 . . . . 74.31 109.045 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -113.28 113.07 24.77 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.489 -0.778 . . . . 74.11 110.613 -169.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.77 141.56 50.37 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.833 0.853 . . . . 70.15 109.362 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 35.2 p -165.84 158.62 15.2 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.626 0.37 . . . . 75.24 111.832 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -161.46 148.93 14.88 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.646 0.779 . . . . 64.11 110.464 -174.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -92.23 126.7 37.42 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.35 -0.611 . . . . 74.32 109.35 172.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.548 HD13 HD13 ' C' ' 83' ' ' ILE . 74.9 mt -89.21 -54.0 4.31 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.563 0.745 . . . . 73.23 111.137 -176.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.91 -166.88 2.46 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.738 -0.665 . . . . 73.14 110.564 -174.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -57.35 103.57 0.13 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.476 1.111 . . . . 71.24 110.401 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 64.14 7.05 3.21 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.05 1.34 . . . . 74.13 113.033 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 88.1 t -97.12 113.92 32.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 107.665 -1.235 . . . . 74.05 107.665 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -118.44 159.85 22.75 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.343 -0.844 . . . . 74.05 109.119 -175.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.409 ' CD ' ' HZ3' ' C' ' 19' ' ' LYS . 29.0 tt0 -126.28 122.68 36.19 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.048 0.939 . . . . 75.13 109.156 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 87.4 t -109.59 125.33 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 107.738 -1.208 . . . . 75.3 107.738 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 66.2 t -124.05 125.67 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 109.083 -0.71 . . . . 71.22 109.083 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' C' ' 103' ' ' PRO . 33.4 tp -112.69 116.58 30.36 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 109.229 -0.656 . . . . 75.45 109.229 175.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 16.7 ttm-85 -82.09 109.31 16.3 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.446 -0.797 . . . . 73.22 109.005 174.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 36.4 t -103.56 119.17 51.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.033 -1.099 . . . . 62.41 108.033 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 27.3 m -125.41 121.49 34.02 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.228 -0.656 . . . . 51.32 109.228 -175.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.519 HG23 HG21 ' C' ' 114' ' ' ILE . 68.4 t -105.82 115.51 47.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 123.767 0.827 . . . . 63.34 109.019 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.543 HG21 HD23 ' C' ' 75' ' ' LEU . 3.7 m -98.48 139.45 34.2 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.359 -1.349 . . . . 61.45 107.359 169.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.94 122.96 31.33 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.072 -1.085 . . . . 55.33 108.072 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 54.1 m -132.54 156.28 47.12 Favored 'General case' 0 C--O 1.213 -0.851 0 C-N-CA 123.393 0.677 . . . . 64.53 109.181 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.569 HD11 ' HG2' ' C' ' 34' ' ' LYS . 39.0 mt -119.07 38.76 3.73 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.439 -1.319 . . . . 75.43 107.439 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.82 -99.59 1.65 Allowed Glycine 0 C--N 1.347 1.178 0 CA-C-N 114.606 -1.179 . . . . 73.35 110.469 -170.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -90.33 -30.8 17.23 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.343 0.657 . . . . 72.41 110.438 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -73.22 116.1 13.36 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.87 0.868 . . . . 74.52 110.654 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.1 m -76.85 118.35 19.36 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.376 -0.972 . . . . 73.5 108.376 168.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.632 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.88 -53.02 9.82 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.953 0.783 . . . . 70.42 109.02 176.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -165.96 173.39 10.5 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-N 115.509 -0.769 . . . . 74.2 112.392 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.543 HD23 HG21 ' C' ' 65' ' ' THR . 2.4 tm? -140.94 102.45 4.27 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 105.836 -1.913 . . . . 74.01 105.836 172.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.474 ' SG ' HG22 ' C' ' 114' ' ' ILE . 46.4 t -109.97 112.0 23.74 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.194 -0.669 . . . . 74.54 109.194 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -118.23 127.57 53.87 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.064 0.546 . . . . 74.42 110.162 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 73.2 t -124.33 138.49 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 108.714 -0.847 . . . . 72.24 108.714 170.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.575 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 47.9 mt-30 -113.1 95.17 5.25 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.714 -0.847 . . . . 64.52 108.714 172.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -81.8 106.93 14.12 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.385 -0.825 . . . . 73.42 109.405 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.52 149.13 20.4 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.539 -0.625 . . . . 75.05 111.539 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.18 117.05 0.92 Allowed Glycine 0 CA--C 1.506 -0.482 0 N-CA-C 111.012 -0.835 . . . . 72.34 111.012 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.548 HD13 HD13 ' C' ' 51' ' ' LEU . 12.5 mm -81.92 125.99 39.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 108.395 -0.965 . . . . 75.34 108.395 175.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -138.77 142.02 38.8 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.277 -0.638 . . . . 74.33 109.277 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 85' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 60.7 m -70.76 115.56 10.05 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.354 -1.35 . . . . 64.25 107.354 164.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 69.8 mt -133.64 110.99 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 109.122 -0.696 . . . . 73.35 109.122 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.55 167.52 19.26 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.91 0.884 . . . . 73.44 110.591 177.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.43 -40.44 2.54 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 116.349 -0.387 . . . . 72.31 113.299 171.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 23.6 pt -101.78 174.77 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.237 0.615 . . . . 73.3 111.038 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.483 ' HA ' ' HE2' ' C' ' 94' ' ' MET . 8.1 tp10 -150.31 153.69 36.55 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 111.999 0.37 . . . . 75.2 111.999 -175.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.54 -115.92 8.59 Favored Glycine 0 C--N 1.353 1.486 0 N-CA-C 114.844 0.698 . . . . 54.54 114.844 169.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 75.5 p -74.49 -29.53 61.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.331 0.652 . . . . 74.1 110.986 -175.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -60.43 -48.26 82.53 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.695 -0.854 . . . . 74.34 108.695 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.483 ' HE2' ' HA ' ' C' ' 90' ' ' GLU . 51.8 ttm -69.71 -33.81 73.02 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.868 -1.514 . . . . 70.42 110.9 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.26 88.15 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.388 0.675 . . . . 72.4 111.66 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -71.2 -32.57 69.01 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.222 -0.445 . . . . 63.35 110.454 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.9 t -67.96 -61.57 1.8 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 122.628 0.371 . . . . 64.43 111.056 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' C' ' 94' ' ' MET . 2.5 pp -70.24 -25.61 63.46 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.069 0.396 . . . . 75.2 112.069 -178.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.95 -17.22 44.76 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 114.584 0.593 . . . . 70.14 114.584 -172.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.73 -53.19 0.87 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 117.466 0.633 . . . . 72.15 111.231 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.514 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 77.2 t80 -72.6 -46.65 53.13 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.615 0.766 . . . . 74.03 112.622 -168.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.447 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 33.7 m -73.35 -46.94 7.74 Favored Pre-proline 0 CA--C 1.569 1.683 0 N-CA-C 113.123 0.786 . . . . 74.12 113.123 -175.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.518 ' HB2' HD23 ' C' ' 60' ' ' LEU . 87.7 Cg_endo -75.87 -10.37 19.81 Favored 'Trans proline' 0 C--N 1.387 2.557 0 C-N-CA 122.094 1.863 . . . . 74.14 112.762 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.66 -32.73 74.53 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.487 0.715 . . . . 64.31 110.314 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.474 HG23 ' NH1' ' A' ' 111' ' ' ARG . 14.6 mm -70.74 -36.5 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.208 -0.905 . . . . 73.44 110.067 177.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 43.8 mt -85.86 -22.52 27.5 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.719 -1.128 . . . . 73.33 111.677 -172.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -58.72 -52.94 71.18 Favored Pre-proline 0 CA--C 1.56 1.352 0 CA-C-O 118.198 -0.906 . . . . 75.22 112.795 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -65.65 -32.02 48.54 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 121.54 1.493 . . . . 75.31 112.382 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . 0.475 ' CD1' HG21 ' C' ' 16' ' ' ILE . 2.6 m-30 -67.23 -45.47 76.68 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.859 0.863 . . . . 72.12 110.025 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.7 -37.87 87.64 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.236 1.014 . . . . 65.35 110.735 176.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -60.8 -49.08 78.91 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.6 1.16 . . . . 72.5 110.794 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -69.98 -34.07 72.89 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.119 0.568 . . . . 73.5 110.058 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 21.4 t -69.26 -31.29 69.73 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.936 0.494 . . . . 52.15 111.502 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.519 HG21 HG23 ' C' ' 64' ' ' VAL . 86.3 mt -73.53 -55.31 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.081 0.553 . . . . 74.03 109.662 173.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 17.1 m -63.87 -27.6 69.27 Favored 'General case' 0 CA--C 1.553 1.074 0 O-C-N 123.653 0.596 . . . . 71.3 111.374 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 36.6 t -62.02 -50.86 70.36 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.232 -0.655 . . . . 71.13 109.232 171.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.613 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.64 -36.07 79.72 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.318 1.047 . . . . 75.42 112.409 178.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.73 -45.23 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.38 0.672 . . . . 72.55 109.821 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 31.0 t -70.6 -25.35 63.01 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 114.907 -1.042 . . . . 72.35 111.809 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' C' ' 116' ' ' SER . 87.2 mtt-85 -74.18 -40.65 62.37 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.35 0.66 . . . . 74.33 109.417 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.72 -0.12 62.88 Favored Glycine 0 C--N 1.354 1.553 0 CA-C-N 115.617 -0.72 . . . . 60.04 112.575 169.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 25.3 p 62.64 30.89 16.97 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 126.787 2.035 . . . . 74.24 113.378 170.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -83.92 148.91 55.19 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 109.044 -0.725 . . . . 74.3 109.044 170.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.606 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 86.3 Cg_exo -51.41 146.91 23.59 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 123.422 2.748 . . . . 75.23 114.2 176.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -58.81 112.11 1.52 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.985 -1.007 . . . . 75.34 112.358 -173.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 42.8 tp -112.83 86.3 2.34 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.373 -0.973 . . . . 75.33 108.373 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -94.2 106.44 18.41 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.224 -0.898 . . . . 74.4 108.816 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 56.9 tp -65.47 144.98 56.69 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.133 0.573 . . . . 74.25 111.525 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.07 143.94 92.09 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 124.03 0.932 . . . . 70.11 110.882 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.517 ' HB2' HD12 ' A' ' 13' ' ' ILE . 5.6 Cg_exo -71.4 127.42 13.29 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.77 2.314 . . . . 73.32 112.237 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -119.18 111.8 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.722 0.809 . . . . 74.44 109.401 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -80.69 97.52 7.3 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.481 0.712 . . . . 75.01 110.448 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -65.07 -41.8 94.75 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.241 -0.652 . . . . 75.45 109.241 170.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 20.4 t70 . . . . . 0 CA--C 1.538 0.494 0 CA-C-N 114.163 -1.381 . . . . 71.32 112.112 177.18 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 30.8 m . . . . . 0 C--O 1.241 0.636 0 N-CA-C 108.542 -0.911 . . . . 63.44 108.542 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -157.66 114.63 2.96 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.858 -0.793 . . . . 72.33 108.858 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -134.06 126.18 29.59 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.038 -1.097 . . . . 75.42 108.038 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.554 HG21 HD11 ' D' ' 16' ' ' ILE . 10.4 mt -78.23 127.76 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.165 -0.68 . . . . 71.44 109.165 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -87.37 -41.61 13.48 Favored 'General case' 0 C--O 1.24 0.583 0 O-C-N 123.704 0.627 . . . . 71.44 110.001 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 -175.17 142.83 0.65 Allowed 'General case' 0 N--CA 1.484 1.273 0 O-C-N 123.173 0.296 . . . . 74.22 111.676 -172.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.554 HD11 HG21 ' D' ' 13' ' ' ILE . 3.4 mp -117.14 136.45 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.303 -1.369 . . . . 74.55 107.303 168.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.45 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 24.5 p90 -163.87 147.39 9.94 Favored 'General case' 0 C--O 1.242 0.659 0 O-C-N 123.871 0.732 . . . . 74.5 110.236 176.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 78.4 p -77.97 106.75 10.04 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.351 -0.84 . . . . 74.51 108.887 173.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.45 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 37.6 mtpt -73.19 -30.57 63.62 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.466 0.65 . . . . 74.44 109.994 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.409 ' HB3' ' HB3' ' D' ' 79' ' ' GLN . 10.6 t70 -152.42 141.46 21.26 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.012 -1.449 . . . . 75.12 108.934 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.613 HG21 ' HE1' ' C' ' 117' ' ' MET . 79.7 mt -141.71 147.76 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.598 -1.26 . . . . 75.35 107.598 175.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 41.5 t -149.46 128.49 12.69 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 123.799 0.839 . . . . 71.42 109.149 170.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.526 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.6 t80 -128.34 135.58 49.77 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.129 -1.804 . . . . 74.12 106.129 169.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 44.0 mt-10 -141.78 150.15 41.35 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 124.288 1.035 . . . . 63.45 108.432 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.96 87.22 5.47 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 107.699 -1.223 . . . . 55.2 107.699 173.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.74 -27.93 17.57 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.701 2.267 . . . . 72.22 112.823 -173.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -107.82 7.21 28.1 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.001 0.921 . . . . 72.22 110.53 -176.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -29.95 -64.64 0.19 Allowed Pre-proline 0 CA--C 1.559 1.312 0 N-CA-C 116.74 2.126 . . . . 72.33 116.74 -165.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 88.7 Cg_endo -76.14 -26.4 9.2 Favored 'Trans proline' 0 C--N 1.381 2.239 0 CA-C-N 122.897 2.07 . . . . 74.23 113.382 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -70.92 -36.14 72.54 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.839 1.256 . . . . 73.41 109.75 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' D' ' 73' ' ' ALA . 9.7 p -84.86 -12.63 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 CA-C-N 115.708 -0.678 . . . . 75.13 111.741 -176.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.425 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.8 m-85 -72.37 -12.22 61.03 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 112.445 0.535 . . . . 72.13 112.445 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -58.13 -23.48 55.21 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.673 0.749 . . . . 74.41 110.066 169.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.684 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 79.3 mttt -104.37 102.61 12.28 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.664 1.586 . . . . 75.41 108.987 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -111.82 90.72 3.42 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.482 0.313 . . . . 74.14 110.442 -175.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 38.3 p90 -164.36 174.35 11.16 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.65 1.18 . . . . 72.42 108.763 172.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . 0.408 HE21 ' HB2' ' D' ' 124' ' ' PRO . 2.2 mp0 -59.08 110.47 2.69 Favored Pre-proline 0 N--CA 1.486 1.328 0 CA-C-O 119.079 -0.486 . . . . 73.44 109.831 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.515 ' HG2' ' HE2' ' D' ' 74' ' ' PHE . 24.5 Cg_exo -63.17 136.74 57.54 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.368 2.045 . . . . 73.04 110.706 -177.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -62.05 107.77 0.93 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.356 -0.979 . . . . 72.03 108.356 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 6.9 m -103.56 121.29 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-N 115.165 -0.925 . . . . 74.33 110.092 -171.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -101.44 119.45 38.78 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 106.313 -1.736 . . . . 75.34 106.313 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 pp -94.66 143.1 26.71 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.193 -0.669 . . . . 75.24 109.193 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.522 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 17.0 t70 -139.38 146.82 40.67 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.411 -0.959 . . . . 72.45 108.411 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -116.33 143.56 45.39 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.126 0.57 . . . . 72.35 110.841 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.556 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.6 t70 -139.05 134.37 32.89 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.354 -1.293 . . . . 42.43 107.731 169.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 22.4 p -103.7 148.27 26.25 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.203 0.601 . . . . 54.14 110.407 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.43 160.9 41.88 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.394 1.078 . . . . 75.23 109.115 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 46.4 p -174.62 167.88 3.78 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.013 0.525 . . . . 61.23 111.275 -175.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.9 p -166.51 147.56 6.27 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.394 -0.821 . . . . 74.22 110.375 174.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -89.23 118.27 28.8 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.602 -0.888 . . . . 74.52 108.602 170.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.524 HD13 HG22 ' D' ' 83' ' ' ILE . 44.1 mt -98.69 -27.28 14.05 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.176 0.59 . . . . 73.41 110.878 -173.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.434 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -158.8 -178.53 7.32 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.021 0.928 . . . . 73.15 110.121 174.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.09 111.31 2.85 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.102 -0.954 . . . . 65.31 109.844 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 65.72 9.06 5.67 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.763 1.225 . . . . 65.15 113.252 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.434 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 83.2 t -108.07 114.15 45.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 107.468 -1.308 . . . . 73.23 107.468 172.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -134.72 131.3 37.47 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.871 -1.059 . . . . 74.11 109.497 -165.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -93.28 129.22 39.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.157 -0.929 . . . . 72.55 110.12 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 78.3 t -109.36 118.96 57.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.209 -1.034 . . . . 71.03 108.209 172.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.462 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 35.7 t -113.78 133.09 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 108.523 -0.918 . . . . 64.42 108.523 177.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 26.4 tp -129.56 120.33 25.14 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.921 -0.4 . . . . 72.04 109.921 171.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.556 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 19.5 ttm-85 -84.54 111.82 19.85 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.952 0.901 . . . . 74.53 109.849 175.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.606 HG23 ' HB1' ' D' ' 110' ' ' ALA . 40.6 t -91.78 122.32 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 108.262 -1.014 . . . . 75.24 108.262 173.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 46.4 m -112.45 143.59 43.32 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.451 -0.574 . . . . 75.01 109.451 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 88.5 t -132.29 101.94 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.663 1.185 . . . . 74.02 108.34 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 19.8 m -93.58 94.92 8.9 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.154 -1.424 . . . . 50.4 107.154 169.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.08 147.47 24.0 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.063 0.545 . . . . 73.43 110.338 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.432 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 63.8 p -150.15 133.72 16.62 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-O 121.068 0.461 . . . . 71.45 111.621 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.7 mt -106.86 114.48 28.59 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.447 -1.316 . . . . 74.13 107.447 171.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.33 -140.96 31.68 Favored Glycine 0 C--N 1.343 0.939 0 O-C-N 123.373 0.42 . . . . 73.32 112.562 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -83.13 3.45 30.66 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.19 0.596 . . . . 73.22 112.302 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.684 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 12.2 pt-20 -131.04 166.0 21.99 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.879 0.472 . . . . 74.44 110.75 -174.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.7 m -72.73 136.93 45.63 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.386 -0.824 . . . . 71.34 110.963 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.502 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -87.68 -69.55 0.68 Allowed 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.588 -1.264 . . . . 73.33 107.588 174.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . 0.515 ' HE2' ' HG2' ' D' ' 38' ' ' PRO . 52.1 p90 -149.58 150.26 31.97 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-N 115.313 -0.858 . . . . 70.32 110.685 177.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.447 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 45.4 mt -106.44 107.2 18.09 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.458 -1.312 . . . . 73.04 107.458 170.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.627 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 36.8 t -116.54 140.03 49.83 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.905 0.882 . . . . 72.34 108.967 -176.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -157.98 141.64 15.51 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.995 0.518 . . . . 72.02 109.948 -174.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -140.82 116.29 6.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.138 -1.06 . . . . 71.22 108.138 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.546 ' HA ' ' HA ' ' D' ' 61' ' ' ARG . 5.9 tt0 -87.41 81.06 7.95 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.37 -1.344 . . . . 70.55 107.37 171.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -80.09 105.18 11.18 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.353 -1.294 . . . . 73.21 108.761 -173.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -104.3 148.32 16.76 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.72 -0.673 . . . . 73.42 111.661 -178.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.421 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -144.93 131.43 4.28 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.057 -0.817 . . . . 72.42 111.057 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.524 HG22 HD13 ' D' ' 51' ' ' LEU . 45.1 mt -88.86 133.3 31.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 108.239 -1.022 . . . . 73.55 108.239 174.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -130.87 159.24 37.97 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.943 0.497 . . . . 70.42 109.87 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 3.9 t -115.27 101.09 8.62 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.248 -1.019 . . . . 53.22 108.248 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.92 109.84 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 109.25 -0.648 . . . . 74.51 109.25 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.34 154.34 45.09 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.398 0.679 . . . . 72.51 109.798 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.92 21.35 65.96 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-O 119.811 -0.439 . . . . 64.41 113.941 175.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.474 HG23 ' N ' ' D' ' 90' ' ' GLU . 10.9 mt -131.97 158.35 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 117.384 0.592 . . . . 75.32 110.255 178.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.622 ' HA ' ' HE3' ' D' ' 94' ' ' MET . 2.9 pp20? -159.44 -175.97 5.51 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.265 1.026 . . . . 70.51 110.056 171.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.46 -141.07 46.67 Favored Glycine 0 N--CA 1.473 1.132 0 N-CA-C 114.839 0.696 . . . . 73.45 114.839 174.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 41.5 p -78.81 -13.98 59.51 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.083 0.953 . . . . 65.44 112.037 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -47.01 70.79 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.556 0.742 . . . . 62.13 109.685 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.622 ' HE3' ' HA ' ' D' ' 90' ' ' GLU . 13.5 ptp -68.78 -34.62 75.86 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 110.271 -0.27 . . . . 71.42 110.271 176.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.45 -26.93 68.77 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.975 0.51 . . . . 61.23 111.461 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -73.03 -51.81 16.77 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.079 0.552 . . . . 74.51 110.579 171.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.7 t -56.64 -43.78 80.62 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 124.074 0.859 . . . . 54.31 111.411 -174.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 16.3 mt -78.3 -30.21 48.25 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.734 -1.121 . . . . 72.4 110.737 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.79 14.58 64.98 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 116.002 -0.545 . . . . 72.3 113.19 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.02 -79.27 0.1 Allowed 'General case' 0 C--N 1.353 0.742 0 C-N-CA 122.929 0.492 . . . . 74.12 111.235 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -65.41 -41.15 93.9 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.101 0.778 . . . . 74.2 113.101 -166.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 81.5 m -64.56 -48.96 73.18 Favored Pre-proline 0 CA--C 1.564 1.494 0 CA-C-O 118.726 -0.654 . . . . 73.53 112.595 -175.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.14 -22.73 34.52 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 121.717 1.611 . . . . 74.01 112.754 170.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.75 -25.88 66.71 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 122.539 0.336 . . . . 75.33 111.237 175.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.482 HG21 HD12 ' D' ' 13' ' ' ILE . 43.3 mm -67.99 -39.55 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.346 0.658 . . . . 72.45 109.983 170.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.421 HD22 ' HA3' ' D' ' 82' ' ' GLY . 79.4 mt -79.5 -17.68 53.58 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 115.155 -0.929 . . . . 72.43 111.941 -171.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -64.69 -45.07 75.61 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 114.214 1.19 . . . . 71.14 114.214 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -54.11 -43.88 54.37 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.065 1.843 . . . . 64.4 112.902 173.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -73.52 -34.01 65.03 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.239 -0.892 . . . . 71.41 111.911 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . 0.606 ' HB1' HG23 ' D' ' 62' ' ' VAL . . . -65.02 -49.61 69.49 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.458 -0.571 . . . . 73.34 109.458 177.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.423 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.8 ttp180 -54.54 -53.43 54.55 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 124.827 1.33 . . . . 75.33 110.801 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -60.16 -46.29 90.17 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.421 1.075 . . . . 70.22 111.378 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 39.6 t -62.12 -41.66 98.46 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.724 0.64 . . . . 73.44 110.935 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.435 ' O ' HG23 ' D' ' 118' ' ' VAL . 82.3 mt -60.48 -58.05 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.674 0.79 . . . . 75.12 110.508 173.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 40.6 m -54.7 -39.23 67.96 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.148 1.379 . . . . 75.45 111.537 -173.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 24.7 t -68.23 -43.45 77.91 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.953 -1.022 . . . . 74.33 110.506 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.627 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.8 mtm -68.6 -32.98 73.26 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 122.646 0.378 . . . . 74.42 111.715 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.435 HG23 ' O ' ' D' ' 114' ' ' ILE . 90.6 t -63.57 -45.48 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.548 0.739 . . . . 73.4 109.859 176.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.6 p -74.52 -29.91 61.59 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.877 -0.602 . . . . 74.32 111.281 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -72.24 -27.85 62.77 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.2 0.6 . . . . 74.03 110.138 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.26 8.29 74.74 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 123.621 0.575 . . . . 72.55 112.587 172.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 80.7 p 55.3 22.64 4.96 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 126.669 1.988 . . . . 74.05 114.105 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -82.96 151.18 63.33 Favored Pre-proline 0 CA--C 1.552 1.04 0 N-CA-C 108.717 -0.846 . . . . 74.14 108.717 168.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.5 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 17.7 Cg_endo -57.74 138.99 88.8 Favored 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.737 2.292 . . . . 75.31 112.872 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -53.03 134.33 38.14 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.58 1.152 . . . . 74.44 112.375 -175.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.83 104.76 9.8 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.526 -1.287 . . . . 74.44 107.526 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -99.58 109.4 21.91 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.605 0.762 . . . . 74.15 109.211 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.423 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 6.5 mp -70.38 119.06 14.0 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.135 0.574 . . . . 75.54 109.548 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.98 137.19 95.43 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.05 0.54 . . . . 74.24 110.774 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.72 130.77 6.92 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.269 1.979 . . . . 74.2 112.108 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.478 0.931 0 C-N-CA 122.879 0.472 . . . . 63.54 110.902 177.066 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.697 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.5 t80 . . . . . 0 C--O 1.238 0.476 0 N-CA-C 109.289 -0.634 . . . . 75.42 109.289 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.482 ' HG3' ' NE2' ' A' ' 14' ' ' GLN . 26.7 tp60 -155.65 97.41 1.85 Allowed 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.29 -1.004 . . . . 74.2 108.29 177.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.449 HG12 ' HD2' ' A' ' 84' ' ' PHE . 29.5 mt -68.21 120.47 15.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 108.729 -0.841 . . . . 74.34 108.729 176.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.482 ' NE2' ' HG3' ' A' ' 12' ' ' GLN . 27.8 mm-40 -81.8 -40.19 22.94 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 123.832 0.707 . . . . 73.23 109.994 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -175.66 122.67 0.2 Allowed 'General case' 0 C--N 1.359 0.994 0 O-C-N 123.426 0.454 . . . . 74.45 111.352 -171.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.513 HD13 ' HG3' ' C' ' 130' ' ' PRO . 88.8 mt -106.96 136.16 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.603 -0.888 . . . . 63.11 108.603 169.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.408 ' HB3' HG23 ' B' ' 122' ' ' THR . 24.0 p90 -164.13 166.19 21.49 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.189 0.996 . . . . 72.11 110.597 -174.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.5 p -96.61 119.12 34.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.534 -0.757 . . . . 73.24 109.012 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -87.09 -30.14 21.35 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.166 -0.679 . . . . 72.25 109.166 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 16.7 t70 -144.83 137.13 26.13 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.189 -0.914 . . . . 75.35 109.276 177.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.9 mt -133.69 142.97 40.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 106.384 -1.71 . . . . 75.23 106.384 174.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.6 t -150.26 135.36 17.83 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.624 -0.51 . . . . 63.22 109.624 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.557 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 87.9 t80 -136.79 137.67 40.05 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.421 -1.696 . . . . 75.13 106.421 172.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -137.75 141.45 40.97 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 108.521 -0.918 . . . . 74.53 108.521 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.68 75.27 31.77 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 106.549 -1.649 . . . . 74.44 106.549 171.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.36 -42.84 31.74 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.284 2.656 . . . . 75.31 112.76 -171.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.457 ' ND2' ' HG3' ' A' ' 71' ' ' GLU . 11.2 m-20 -101.64 22.76 12.25 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 118.35 -0.834 . . . . 63.51 109.913 -178.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.448 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -42.61 -58.31 3.87 Favored Pre-proline 0 N--CA 1.497 1.906 0 N-CA-C 113.867 1.062 . . . . 74.52 113.867 -170.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.448 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 14.4 Cg_exo -65.66 -24.76 54.92 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 121.7 1.6 . . . . 74.31 112.778 -174.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -81.26 -43.33 19.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.114 -0.948 . . . . 72.43 109.91 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.619 HG22 ' HA ' ' A' ' 73' ' ' ALA . 5.2 p -76.32 -14.01 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 115.039 -0.982 . . . . 71.31 112.505 -162.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -69.62 -12.14 61.4 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.871 0.468 . . . . 73.42 111.68 173.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -83.34 -25.59 31.31 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.389 1.076 . . . . 71.51 110.823 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HZ1' ' HB3' ' A' ' 71' ' ' GLU . 23.3 mmtp -68.14 149.61 49.37 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.658 0.783 . . . . 74.44 111.808 -177.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -71.13 131.96 44.35 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.301 -1.0 . . . . 70.33 108.301 171.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -77.77 82.01 4.18 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.798 0.809 . . . . 73.22 110.608 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -128.8 81.23 71.21 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 106.938 -1.504 . . . . 74.04 106.938 168.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -82.98 145.59 12.53 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.65 2.233 . . . . 74.25 112.318 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -97.83 89.83 4.73 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 105.823 -1.917 . . . . 74.31 105.823 168.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.572 HG11 HG11 ' A' ' 64' ' ' VAL . 96.6 t -72.16 92.42 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.425 -0.954 . . . . 75.41 108.425 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.493 ' HB2' ' HZ2' ' A' ' 41' ' ' LYS . 5.0 ttmp? -87.58 115.47 25.03 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.591 -1.186 . . . . 72.52 108.285 174.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.7 pp -95.41 130.59 42.16 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.788 -1.19 . . . . 65.32 107.788 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.604 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.1 m-20 -120.21 105.71 11.23 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 107.796 -1.187 . . . . 75.35 107.796 176.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.7 mp -98.22 146.7 25.36 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.789 -0.819 . . . . 74.12 108.789 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.584 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 24.9 t70 -145.81 148.27 32.74 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 109.491 -0.559 . . . . 74.24 109.491 177.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 49.1 p -106.44 125.99 51.69 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.556 -0.747 . . . . 63.11 110.247 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.512 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -132.91 133.37 43.16 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.035 0.934 . . . . 75.31 108.733 176.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.9 m -133.66 159.26 41.05 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.235 0.614 . . . . 72.34 110.96 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.3 t -158.22 147.77 19.65 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.856 0.863 . . . . 72.12 109.184 174.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -106.81 119.09 38.4 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.118 -1.067 . . . . 63.02 108.118 172.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.486 HD12 HG22 ' A' ' 83' ' ' ILE . 50.3 mt -93.09 -37.72 11.99 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.163 0.585 . . . . 72.52 111.087 -173.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.79 -171.98 3.31 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.718 0.807 . . . . 75.33 110.3 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -63.59 119.45 9.87 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.553 0.741 . . . . 75.13 109.633 170.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 70.74 -7.19 1.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.773 1.229 . . . . 64.32 112.598 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.62 110.72 28.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 N-CA-C 107.965 -1.124 . . . . 75.12 107.965 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -134.1 128.48 34.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.363 -0.835 . . . . 74.53 109.28 -170.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -96.12 127.58 42.25 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.853 0.861 . . . . 74.13 110.921 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.452 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 68.0 t -107.44 124.58 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 107.106 -1.442 . . . . 74.41 107.106 168.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 44.0 t -119.62 124.57 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.367 -0.975 . . . . 70.34 108.367 172.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.8 tt -115.85 115.47 26.31 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.774 -1.195 . . . . 74.14 107.774 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.584 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 49.2 ttt180 -84.11 99.72 10.66 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.897 -1.149 . . . . 72.51 107.897 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 49.9 t -97.96 101.67 12.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.027 -1.101 . . . . 71.21 108.027 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.604 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 21.9 m -102.6 143.7 31.95 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.891 -0.781 . . . . 74.41 108.891 175.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.599 HG13 HD23 ' A' ' 126' ' ' LEU . 24.7 t -136.87 137.55 46.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 125.445 1.498 . . . . 72.22 107.201 173.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.4 m -132.29 127.15 35.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.719 -0.845 . . . . 71.54 108.719 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.62 104.26 14.28 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 107.949 -1.13 . . . . 72.41 107.949 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 50.5 m -108.0 126.86 53.21 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.572 0.349 . . . . 73.12 110.464 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.487 HD13 ' HB1' ' A' ' 73' ' ' ALA . 12.2 mt -103.94 83.11 2.06 Favored 'General case' 0 C--O 1.249 1.065 0 C-N-CA 124.052 0.941 . . . . 74.13 108.535 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.13 -84.79 1.13 Allowed Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.282 -0.872 . . . . 75.53 111.715 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.38 -26.2 3.36 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.925 0.89 . . . . 63.35 110.045 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.457 ' HG3' ' ND2' ' A' ' 27' ' ' ASN . 45.5 tt0 -94.17 112.65 24.47 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.784 0.834 . . . . 75.4 109.643 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 94.0 m -73.25 135.37 44.49 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.018 0.437 . . . . 55.1 110.441 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.619 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -72.61 -61.99 1.61 Allowed 'General case' 0 C--O 1.243 0.75 0 CA-C-N 114.679 -1.146 . . . . 72.02 110.078 176.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -156.23 174.85 14.78 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 114.806 -1.088 . . . . 74.43 112.124 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.3 tp -133.67 135.46 44.12 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.778 1.631 . . . . 73.32 107.647 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 79.2 m -134.96 105.41 6.37 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.042 0.937 . . . . 71.05 109.632 178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -126.54 115.91 20.26 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.257 1.023 . . . . 71.33 109.141 -174.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.4 t -129.74 114.52 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.277 0.631 . . . . 71.31 109.487 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.57 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 75.6 mt-30 -85.0 88.14 7.43 Favored 'General case' 0 C--O 1.249 1.048 0 N-CA-C 108.334 -0.987 . . . . 62.44 108.334 170.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.414 ' HG3' HD23 ' A' ' 106' ' ' LEU . 8.4 tp-100 -77.34 104.96 8.15 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 114.849 -1.069 . . . . 72.41 109.16 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.98 147.35 20.94 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 111.325 -0.71 . . . . 62.14 111.325 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.516 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -152.05 120.77 1.11 Allowed Glycine 0 CA--C 1.499 -0.93 0 N-CA-C 110.78 -0.928 . . . . 74.52 110.78 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.486 HG22 HD12 ' A' ' 51' ' ' LEU . 39.1 mt -83.61 121.49 36.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 108.308 -0.997 . . . . 74.12 108.308 173.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.697 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 33.0 m-85 -129.67 137.49 50.65 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.66 -0.867 . . . . 74.22 108.66 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.1 t -103.69 98.33 8.22 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.995 -0.743 . . . . 73.31 108.995 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.478 0.928 0 C-N-CA 124.626 1.17 . . . . 75.23 109.315 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 121.088 0.471 . . . . 62.25 110.934 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -68.53 -39.47 81.16 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.033 0.933 . . . . 73.12 109.888 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.541 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 43.7 t -69.34 -52.92 22.55 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 123.732 0.645 . . . . 65.01 111.429 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 pp -77.5 -20.96 53.48 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.893 0.477 . . . . 72.13 111.782 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.57 -16.11 23.13 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 115.223 0.849 . . . . 63.33 115.223 -170.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.02 -43.83 0.14 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.616 0.708 . . . . 75.1 112.727 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.541 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 67.9 t80 -67.9 -68.97 0.35 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.815 0.846 . . . . 75.1 111.301 -170.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 76.0 m -65.56 -35.85 12.93 Favored Pre-proline 0 CA--C 1.568 1.641 0 C-N-CA 123.573 0.749 . . . . 64.11 112.781 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -47.56 -48.56 15.25 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 122.774 2.316 . . . . 74.21 114.383 162.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.425 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 29.7 t-20 -69.72 -24.35 63.55 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.089 0.555 . . . . 72.25 110.516 -177.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 38.8 mm -63.39 -39.46 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.218 0.532 . . . . 72.23 110.567 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.516 HD21 ' HA3' ' A' ' 82' ' ' GLY . 91.2 mt -78.63 -24.94 44.99 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.617 0.767 . . . . 75.34 112.056 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -60.65 -47.38 96.18 Favored Pre-proline 0 CA--C 1.565 1.557 0 N-CA-C 114.256 1.206 . . . . 75.21 114.256 -171.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 104' ' ' ASN . 37.0 Cg_exo -62.61 -32.48 79.27 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.034 1.823 . . . . 73.24 113.121 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.463 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 80.7 m-85 -77.37 -38.29 50.41 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.685 0.794 . . . . 74.22 111.002 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.11 -37.25 75.32 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.146 0.578 . . . . 75.31 110.046 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.46 ' NH1' HD13 ' C' ' 105' ' ' ILE . 24.1 ttm180 -60.63 -50.64 72.71 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.215 1.006 . . . . 74.22 109.732 174.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.1 -42.86 88.71 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.81 0.693 . . . . 72.03 110.646 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 43.5 t -62.65 -32.76 73.86 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.813 0.445 . . . . 74.41 110.666 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.3 mt -67.55 -55.76 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 123.518 0.727 . . . . 74.3 109.932 170.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.52 HG21 ' HE2' ' C' ' 109' ' ' TYR . 87.8 m -55.22 -38.38 68.36 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.016 1.326 . . . . 75.2 111.894 -175.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 47.5 t -63.29 -50.03 71.71 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.479 -0.782 . . . . 74.21 110.07 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.557 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 50.9 mtm -63.67 -38.25 90.4 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.373 0.669 . . . . 71.33 111.578 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.9 t -64.18 -53.17 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.807 0.843 . . . . 75.14 110.62 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.2 t -67.52 -31.41 71.51 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.613 -0.722 . . . . 73.04 110.839 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 116' ' ' SER . 24.9 ttm-85 -72.13 -32.77 67.24 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.489 1.116 . . . . 75.53 108.46 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.411 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.82 14.25 53.11 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-N 114.561 -1.2 . . . . 60.05 113.47 173.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.472 HG23 ' HE ' ' B' ' 15' ' ' ARG . 1.3 t 63.38 12.28 6.15 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 126.471 1.908 . . . . 73.23 114.178 172.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -83.16 148.51 56.48 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 108.562 -0.903 . . . . 72.0 108.562 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.15 163.11 10.42 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.215 2.61 . . . . 73.54 113.205 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -57.04 122.46 12.39 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.32 -0.855 . . . . 71.41 112.367 -171.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.599 HD23 HG13 ' A' ' 64' ' ' VAL . 52.0 tp -121.95 106.77 11.53 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.588 1.155 . . . . 71.41 109.022 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -130.14 121.09 25.63 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.996 0.918 . . . . 74.32 108.945 176.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.5 mt -68.25 143.72 55.16 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.797 0.439 . . . . 73.41 109.895 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.41 136.86 91.0 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.123 0.569 . . . . 72.22 110.384 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.585 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 2.7 Cg_endo -79.29 92.12 1.15 Allowed 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.84 2.36 . . . . 74.2 110.609 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.2 t -101.64 113.39 37.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.338 -0.986 . . . . 75.34 108.338 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -69.73 100.05 1.44 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.804 -0.813 . . . . 71.11 108.804 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 . . . . . 0 N--CA 1.485 1.286 0 C-N-CA 123.968 0.907 . . . . 73.11 111.017 -178.24 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 57.6 ttm . . . . . 0 CA--C 1.561 1.396 0 CA-C-O 121.962 0.887 . . . . 75.03 111.336 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 96.6 m -150.1 118.34 6.39 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 106.163 -1.791 . . . . 75.45 106.163 171.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -127.17 144.59 51.0 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.342 -0.614 . . . . 72.24 109.342 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.476 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -155.52 136.44 13.64 Favored 'General case' 0 C--O 1.243 0.715 0 O-C-N 123.671 0.607 . . . . 72.14 110.064 173.011 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.521 HD12 HD11 ' B' ' 16' ' ' ILE . 58.4 mt -76.75 125.4 36.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.492 0 N-CA-C 108.456 -0.942 . . . . 75.43 108.456 169.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -92.17 -49.86 5.97 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.833 -0.803 . . . . 72.53 108.833 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.472 ' HE ' HG23 ' A' ' 122' ' ' THR . 42.9 ttt180 -164.5 134.04 3.81 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.685 -0.689 . . . . 72.15 110.217 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.521 HD11 HD12 ' B' ' 13' ' ' ILE . 76.1 mt -115.24 140.42 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 124.042 0.937 . . . . 74.11 108.603 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -169.18 152.1 4.91 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 112.707 0.632 . . . . 75.15 112.707 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 82.5 m -76.76 125.45 29.3 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.968 -1.015 . . . . 72.23 109.008 169.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -97.87 -31.83 12.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.099 0.56 . . . . 73.0 111.482 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 10.9 t70 -155.66 136.62 13.65 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.275 -0.421 . . . . 72.22 109.992 -168.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.494 HD13 ' SG ' ' B' ' 113' ' ' CYS . 46.7 mm -135.15 142.36 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.69 1.196 . . . . 75.11 108.68 177.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.8 t -149.34 108.17 3.86 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.803 -1.184 . . . . 65.43 107.803 173.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -122.56 118.89 29.29 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 107.644 -1.243 . . . . 64.44 107.644 172.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -118.91 153.03 35.23 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.13 0.972 . . . . 75.42 108.697 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.37 80.32 14.86 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 106.32 -1.733 . . . . 65.44 106.32 173.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.49 -31.0 42.93 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.059 2.506 . . . . 74.33 113.095 -168.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -108.94 14.78 23.91 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.188 0.595 . . . . 71.14 110.828 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.51 -64.34 0.73 Allowed Pre-proline 0 N--CA 1.492 1.661 0 N-CA-C 114.959 1.466 . . . . 62.31 114.959 -166.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.3 -30.62 73.69 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.215 1.943 . . . . 73.4 113.702 -168.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -94.24 -28.68 15.48 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.744 0.418 . . . . 72.25 111.401 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.581 HG21 HD13 ' B' ' 68' ' ' LEU . 2.8 p -73.04 -20.12 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 122.594 0.357 . . . . 75.2 110.464 -176.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -65.43 -14.78 61.68 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.903 0.881 . . . . 75.11 113.104 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -68.05 -19.21 64.87 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.818 0.447 . . . . 74.35 110.701 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -90.6 106.34 18.44 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.451 1.101 . . . . 75.12 109.932 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -93.93 83.87 4.44 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.313 0.645 . . . . 64.35 110.626 -174.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -169.03 173.52 6.84 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.231 1.013 . . . . 75.33 109.854 170.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -85.16 121.54 73.99 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 109.14 -0.689 . . . . 75.44 109.14 176.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.12 165.53 31.07 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.772 2.315 . . . . 75.24 113.863 -175.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 10.1 tp10 -69.76 126.33 29.41 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.388 -0.824 . . . . 75.14 109.483 176.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.7 140.54 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.394 0.616 . . . . 74.03 111.16 -171.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.625 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 63.2 mttp -126.91 143.73 51.19 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.432 1.093 . . . . 72.55 109.696 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -114.07 132.5 56.0 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.924 0.89 . . . . 74.33 108.634 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -151.2 109.29 3.72 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 108.23 -1.026 . . . . 72.31 108.23 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.407 ' HG ' ' HA ' ' B' ' 62' ' ' VAL . 9.9 mp -102.41 157.03 17.2 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.471 -0.566 . . . . 73.43 109.471 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -139.28 153.9 47.86 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 108.445 -0.946 . . . . 75.53 108.445 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 74.3 p -107.66 118.39 36.61 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.362 -0.835 . . . . 74.25 108.929 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -126.87 136.37 52.24 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.552 -1.277 . . . . 54.21 107.552 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 59.7 p -143.25 163.04 34.05 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-O 120.628 0.251 . . . . 75.24 111.132 -174.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 74.9 p -153.28 137.03 16.09 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.739 0.816 . . . . 74.03 109.499 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -94.62 111.47 23.23 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.529 -1.286 . . . . 74.31 107.529 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.586 HD12 HG22 ' B' ' 83' ' ' ILE . 41.5 mt -81.15 -53.55 6.28 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.041 0.448 . . . . 74.24 110.809 -176.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.01 -177.09 5.36 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.123 -0.944 . . . . 75.14 109.517 -175.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.43 109.74 1.45 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.349 0.66 . . . . 71.52 110.011 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 69.15 4.88 4.79 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 125.011 1.324 . . . . 73.24 113.347 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.4 t -104.77 117.54 50.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.615 -1.254 . . . . 72.52 107.615 172.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -123.16 177.26 5.63 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 121.352 0.596 . . . . 75.41 109.822 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -142.66 102.64 4.09 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.446 -1.316 . . . . 74.14 107.446 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 65.5 t -89.43 121.25 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.626 1.171 . . . . 75.03 109.739 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.493 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.6 t -109.2 109.57 28.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 C-N-CA 123.529 0.732 . . . . 75.2 109.26 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 35.6 tp -93.31 109.42 20.96 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.306 -0.627 . . . . 74.41 109.306 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -86.83 117.99 25.92 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 108.614 -0.884 . . . . 74.22 108.614 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.407 ' HA ' ' HG ' ' B' ' 44' ' ' LEU . 14.3 t -112.19 116.82 53.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 108.392 -0.966 . . . . 72.53 108.392 172.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.8 m -112.36 138.45 49.06 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.827 0.822 . . . . 75.12 109.404 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.594 HG22 HG21 ' B' ' 114' ' ' ILE . 54.4 t -127.19 131.41 70.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 125.644 1.578 . . . . 70.34 108.284 -174.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 89.2 m -117.95 146.19 44.16 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.31 -0.626 . . . . 73.44 109.31 173.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.94 139.34 23.62 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.602 0.761 . . . . 71.32 110.085 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.537 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 17.7 p -147.49 127.21 13.4 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.486 0.492 . . . . 61.35 111.619 -176.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.581 HD13 HG21 ' B' ' 31' ' ' VAL . 54.7 mt -98.32 107.39 19.84 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 107.812 -1.181 . . . . 75.41 107.812 174.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.98 -131.53 12.54 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 120.024 -0.32 . . . . 74.01 112.572 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -99.01 17.47 19.62 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.592 0.757 . . . . 73.02 111.687 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -138.84 154.24 48.42 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.424 0.689 . . . . 74.52 109.9 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 49.5 m -77.94 123.32 26.65 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.908 0.385 . . . . 72.23 111.061 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.537 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -74.4 -60.77 2.12 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.322 -0.992 . . . . 63.3 108.322 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -155.85 156.92 35.53 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 115.252 -0.885 . . . . 74.52 112.328 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 79.7 mt -125.68 119.87 29.17 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 125.74 1.616 . . . . 73.53 106.973 175.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.415 ' SG ' HG22 ' B' ' 114' ' ' ILE . 49.3 t -118.28 150.39 39.54 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.709 -0.848 . . . . 72.34 108.709 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -159.88 126.43 4.38 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.419 -0.956 . . . . 74.31 108.419 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 86.9 t -122.69 145.94 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.325 -0.852 . . . . 74.14 109.146 176.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.445 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 18.1 mt-30 -120.65 97.1 5.4 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.271 -1.011 . . . . 74.24 108.271 169.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -87.07 101.53 13.55 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.8 -0.815 . . . . 63.55 108.8 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.08 164.08 33.55 Favored Glycine 0 C--O 1.246 0.848 0 O-C-N 123.903 0.752 . . . . 61.22 111.862 177.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.39 126.07 1.44 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.867 -0.493 . . . . 73.42 111.867 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.586 HG22 HD12 ' B' ' 51' ' ' LEU . 59.9 mt -84.61 130.02 36.71 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 108.31 -0.996 . . . . 75.44 108.31 172.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -139.22 156.5 47.05 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.147 0.579 . . . . 71.0 109.473 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 69.1 m -121.27 133.07 55.13 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.999 0.92 . . . . 71.25 109.126 175.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 12.4 tt -130.56 148.96 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.526 0.73 . . . . 74.43 110.576 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.25 175.07 14.48 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.909 0.884 . . . . 73.43 109.621 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.51 -56.29 4.72 Favored Glycine 0 N--CA 1.473 1.128 0 C-N-CA 123.128 0.394 . . . . 72.53 112.586 175.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.559 HG23 ' HB3' ' B' ' 94' ' ' MET . 7.4 mm -90.9 153.02 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.04 0.936 . . . . 75.0 110.93 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -147.21 -178.6 6.31 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.757 1.223 . . . . 70.25 109.104 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.31 -134.42 22.86 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 115.548 -0.751 . . . . 61.3 113.973 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 54.1 m -75.38 -33.64 61.03 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.559 0.744 . . . . 72.5 111.944 -177.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -60.78 -33.04 72.37 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.369 0.668 . . . . 72.03 111.854 -175.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.559 ' HB3' HG23 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -86.12 -24.62 26.16 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.695 0.398 . . . . 72.15 111.816 176.215 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.75 -32.26 73.71 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.033 0.533 . . . . 70.1 110.817 172.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -76.42 -36.08 58.19 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.554 -0.748 . . . . 71.52 110.966 172.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.0 t -60.67 -52.4 65.28 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.016 0.527 . . . . 73.32 111.354 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.523 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 0.5 OUTLIER -80.52 -13.53 59.01 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.251 0.463 . . . . 74.55 112.251 175.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.23 1.44 62.63 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-O 119.608 -0.551 . . . . 63.42 113.784 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.47 -53.38 0.11 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 117.482 0.641 . . . . 75.35 110.957 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -70.73 -50.33 37.32 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.174 0.59 . . . . 73.23 112.559 -172.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.523 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 61.2 m -60.79 -47.26 96.29 Favored Pre-proline 0 CA--C 1.563 1.452 0 CA-C-O 118.811 -0.614 . . . . 72.51 111.626 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 48.4 Cg_exo -60.8 -32.7 93.14 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 122.432 2.088 . . . . 71.11 114.106 171.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -61.01 -38.09 84.86 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.828 0.851 . . . . 64.33 110.202 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.47 -40.79 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 114.976 -1.011 . . . . 72.03 110.606 174.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 56.3 mt -86.4 -13.12 47.27 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.975 -1.011 . . . . 75.33 111.765 -171.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -55.31 -52.29 72.73 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 124.019 0.928 . . . . 75.11 112.915 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -59.76 -37.0 89.75 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.324 2.016 . . . . 72.33 114.088 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -67.83 -44.57 76.89 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.03 0.532 . . . . 75.14 110.635 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.98 -36.42 83.26 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.726 -0.67 . . . . 65.43 110.822 176.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -61.96 -50.5 71.86 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.967 1.307 . . . . 71.52 110.256 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -68.73 -33.61 74.22 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 115.309 -0.86 . . . . 74.43 109.704 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.494 ' SG ' HD13 ' B' ' 21' ' ' ILE . 13.5 t -66.55 -44.47 82.26 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.934 0.494 . . . . 72.31 111.77 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.594 HG21 HG22 ' B' ' 64' ' ' VAL . 95.2 mt -60.05 -53.5 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 108.894 -0.78 . . . . 75.14 108.894 175.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 38.5 m -57.02 -36.05 69.98 Favored 'General case' 0 CA--C 1.553 1.064 0 O-C-N 124.371 1.045 . . . . 73.13 111.602 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.2 t -62.74 -47.21 84.56 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 123.526 0.73 . . . . 53.54 109.749 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 9.7 mmt -70.38 -35.8 73.73 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.006 0.523 . . . . 74.14 111.172 -176.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.472 HG21 ' O ' ' B' ' 114' ' ' ILE . 97.0 t -60.24 -43.92 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.763 0.825 . . . . 65.45 109.801 172.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.2 t -65.34 -33.0 74.94 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.646 -1.161 . . . . 71.43 111.355 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' B' ' 116' ' ' SER . 83.0 mtt-85 -71.04 -36.21 72.27 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.536 -0.756 . . . . 73.43 110.187 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.95 -3.65 81.21 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 123.752 0.658 . . . . 72.11 112.316 172.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.408 HG23 ' HB3' ' A' ' 17' ' ' TYR . 23.6 p 62.82 35.01 14.01 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.446 1.899 . . . . 64.24 112.428 173.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -93.69 164.45 20.83 Favored Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 124.103 0.961 . . . . 74.22 110.67 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.04 166.15 1.04 Allowed 'Trans proline' 0 C--N 1.393 2.869 0 C-N-CA 123.663 2.909 . . . . 73.52 115.524 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -63.54 121.4 13.77 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 115.375 -0.83 . . . . 71.24 111.127 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 18.6 tp -129.2 98.43 4.9 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.046 -0.524 . . . . 75.54 109.922 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -124.38 121.26 34.45 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.863 0.865 . . . . 75.43 109.591 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mp -64.88 149.25 49.89 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.949 0.5 . . . . 72.55 111.117 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.9 150.99 73.05 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.452 0.701 . . . . 61.31 110.023 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -67.64 129.45 19.99 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 123.031 2.487 . . . . 73.03 112.395 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 26.0 m -131.95 128.4 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.46 0.704 . . . . 72.24 109.257 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -109.13 102.13 11.12 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 107.252 -1.388 . . . . 73.23 107.252 173.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -60.93 -47.73 85.09 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.17 0.918 . . . . 73.43 110.102 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 C--O 1.221 -0.445 0 CA-C-N 114.283 -1.326 . . . . 62.12 112.014 -174.215 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.595 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 33.8 t80 . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 108.093 -1.077 . . . . 73.01 108.093 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -155.16 136.55 14.1 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.887 -0.412 . . . . 72.42 109.887 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.491 HG12 ' HE2' ' C' ' 84' ' ' PHE . 56.4 mt -79.2 128.54 38.47 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 N-CA-C 109.036 -0.728 . . . . 74.35 109.036 171.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -101.0 -34.99 9.53 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.598 0.759 . . . . 65.21 110.073 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -176.63 139.29 0.31 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.167 0.587 . . . . 73.2 109.74 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.0 mt -129.89 142.58 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 108.187 -1.042 . . . . 74.5 108.187 175.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.426 ' HE1' HG12 ' C' ' 83' ' ' ILE . 32.9 p90 -172.47 167.02 5.66 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.162 0.985 . . . . 72.4 109.334 -169.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -91.76 114.2 26.68 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 122.893 0.477 . . . . 73.54 109.912 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.66 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 21.8 mmtp -65.44 -42.58 92.26 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 109.362 -0.607 . . . . 64.45 109.362 168.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.7 t70 -145.53 146.8 31.57 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.932 -1.031 . . . . 73.35 110.391 -174.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.533 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.1 mt -141.72 147.48 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.819 1.648 . . . . 74.33 106.813 174.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.0 t -160.46 151.47 18.95 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.225 0.61 . . . . 72.24 110.174 176.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 77.7 t80 -155.52 112.21 3.2 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 124.384 1.074 . . . . 74.12 108.104 174.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -122.77 132.15 54.1 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.407 0.683 . . . . 72.41 110.477 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.61 86.35 4.67 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 107.634 -1.247 . . . . 74.43 107.634 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.43 -40.81 29.26 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.088 2.525 . . . . 75.44 112.03 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -91.53 18.16 7.72 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 113.902 -1.499 . . . . 73.14 111.625 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.403 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -42.99 -56.32 6.42 Favored Pre-proline 0 N--CA 1.486 1.354 0 N-CA-C 114.029 1.122 . . . . 63.43 114.029 -171.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -60.99 -40.35 53.0 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 121.76 1.64 . . . . 72.14 112.415 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -68.75 -38.03 79.83 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.16 0.984 . . . . 75.33 112.493 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.609 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.6 p -79.04 -13.98 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 C-N-CA 123.329 0.652 . . . . 62.43 111.903 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -75.3 -17.67 60.22 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 112.521 0.563 . . . . 73.43 112.521 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -103.22 36.23 2.31 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.16 0.505 . . . . 72.42 110.208 175.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.626 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 1.0 OUTLIER -119.35 149.45 41.8 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.005 0.522 . . . . 72.42 111.358 -174.536 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -59.17 101.97 0.11 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.237 1.015 . . . . 72.21 109.802 176.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -79.07 101.76 8.03 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.153 0.502 . . . . 75.34 111.528 -171.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -163.04 76.65 1.86 Allowed Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 107.876 -1.157 . . . . 75.5 107.876 167.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -88.0 153.41 7.11 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.776 2.317 . . . . 62.32 113.316 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -87.6 109.04 19.36 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.079 -0.964 . . . . 75.13 108.927 167.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.442 HG21 HG13 ' C' ' 64' ' ' VAL . 2.7 p -72.02 100.35 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-O 121.85 0.833 . . . . 74.03 109.825 173.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -92.28 98.83 11.75 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.835 -1.172 . . . . 72.35 107.835 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 pp -103.19 154.12 19.65 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.661 0.384 . . . . 73.32 110.145 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -143.88 140.44 29.77 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.355 -0.609 . . . . 72.55 109.355 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -118.85 111.96 19.07 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.0 -0.741 . . . . 73.31 109.0 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.49 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 5.8 t70 -112.24 150.85 30.33 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.732 1.213 . . . . 75.03 108.513 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 76.8 p -116.48 138.07 51.67 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.506 0.723 . . . . 63.45 111.259 -170.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.34 150.19 38.81 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.253 1.021 . . . . 74.14 109.105 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 11.7 p -165.49 158.16 15.55 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.425 0.528 . . . . 75.25 112.425 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 67.7 p -160.2 143.93 14.05 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.277 1.031 . . . . 70.24 109.559 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -80.95 131.13 35.31 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.166 -0.679 . . . . 64.45 109.166 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.698 HD12 ' HB2' ' C' ' 57' ' ' GLU . 29.1 mt -107.57 -32.98 7.46 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.259 0.624 . . . . 73.03 110.846 -176.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.17 -174.53 4.76 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.459 0.704 . . . . 64.22 110.68 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -66.15 130.31 42.8 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.943 -1.026 . . . . 74.45 109.166 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 64.86 -6.89 0.29 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.836 1.255 . . . . 74.32 113.274 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 71.0 t -108.87 119.6 58.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 C-N-CA 123.259 0.623 . . . . 73.11 110.432 -167.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . 0.522 ' HB2' HD11 ' C' ' 86' ' ' ILE . 13.6 m-85 -119.99 143.58 47.97 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.72 -1.127 . . . . 74.52 108.864 171.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.698 ' HB2' HD12 ' C' ' 51' ' ' LEU . 24.2 tt0 -83.56 110.24 18.07 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.396 -1.729 . . . . 75.41 107.862 167.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 78.6 t -96.9 112.17 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.033 -1.469 . . . . 73.52 107.033 172.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.446 HG22 ' HG2' ' C' ' 57' ' ' GLU . 90.3 t -113.04 134.05 56.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 107.983 -1.117 . . . . 74.21 107.983 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.452 HD23 ' HB2' ' C' ' 103' ' ' PRO . 26.8 tp -127.61 119.96 27.08 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.037 -0.727 . . . . 74.43 109.037 175.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.49 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.7 ttm180 -81.21 123.68 28.66 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 124.211 0.945 . . . . 72.22 109.45 173.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.1 114.94 48.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.699 -1.222 . . . . 63.1 107.699 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 36.0 m -114.63 142.82 45.96 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.426 -0.953 . . . . 74.12 108.426 -175.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.497 HG22 HG21 ' C' ' 114' ' ' ILE . 53.5 t -136.25 110.0 9.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.717 1.207 . . . . 62.11 107.894 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.491 HG23 HD22 ' C' ' 75' ' ' LEU . 3.7 m -107.0 107.2 18.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.059 -1.46 . . . . 73.31 107.059 172.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.88 122.34 40.88 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.989 -1.485 . . . . 71.32 106.989 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 44.5 m -132.87 127.35 34.24 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.889 0.376 . . . . 71.22 111.115 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.442 HD11 ' HG2' ' C' ' 34' ' ' LYS . 10.2 mt -86.02 43.76 1.07 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.385 1.474 . . . . 74.55 109.787 174.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.49 -113.51 4.61 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 109.748 -1.341 . . . . 74.41 109.748 -171.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -90.01 -28.83 18.82 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.192 0.597 . . . . 74.33 110.2 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.626 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 6.4 tp10 -72.38 102.29 3.12 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.714 -0.847 . . . . 73.31 108.714 175.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 30.1 m -68.99 123.85 22.13 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.294 -0.632 . . . . 71.43 109.294 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.609 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -66.08 -64.46 0.85 Allowed 'General case' 0 C--O 1.239 0.51 0 O-C-N 123.99 0.806 . . . . 74.52 108.908 177.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -154.61 171.85 18.8 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.47 -0.786 . . . . 73.32 110.632 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.491 HD22 HG23 ' C' ' 65' ' ' THR . 2.6 tm? -127.53 144.36 51.07 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.372 -1.714 . . . . 73.14 106.372 172.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.443 ' SG ' HG22 ' C' ' 114' ' ' ILE . 38.3 t -152.73 145.4 24.26 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.309 -0.997 . . . . 74.41 108.309 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -159.24 126.28 4.7 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.383 0.273 . . . . 74.3 110.531 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' C' ' 110' ' ' ALA . 54.9 t -133.93 113.26 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.296 1.039 . . . . 72.42 109.154 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.514 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 27.8 mt-30 -90.55 95.92 10.4 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.611 -0.885 . . . . 72.12 108.611 172.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.545 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 9.0 tp-100 -79.61 108.39 13.12 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.32 -0.854 . . . . 71.23 109.58 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.09 145.39 21.43 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.711 -0.677 . . . . 71.33 111.681 175.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.87 114.81 0.71 Allowed Glycine 0 CA--C 1.507 -0.467 0 N-CA-C 110.279 -1.128 . . . . 71.15 110.279 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.426 HG12 ' HE1' ' C' ' 17' ' ' TYR . 19.0 mm -82.66 123.32 38.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 N-CA-C 108.259 -1.015 . . . . 74.22 108.259 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.491 ' HE2' HG12 ' C' ' 13' ' ' ILE . 58.4 m-85 -132.64 138.8 47.48 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.164 0.586 . . . . 75.34 109.842 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 41.2 p -94.05 100.98 13.0 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.128 -1.064 . . . . 74.31 108.128 167.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.522 HD11 ' HB2' ' C' ' 56' ' ' TYR . 0.2 OUTLIER -116.83 128.79 74.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 C-N-CA 123.752 0.821 . . . . 71.11 109.766 -178.133 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.73 165.98 29.53 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.418 -0.81 . . . . 74.24 110.641 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.08 -59.97 0.36 Allowed Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.85 -0.614 . . . . 71.31 112.838 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 23.7 pt -90.91 172.71 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.634 0.774 . . . . 75.43 111.813 -170.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.545 ' HA ' ' HE3' ' C' ' 94' ' ' MET . 11.4 tp10 -157.4 151.23 24.32 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.204 0.602 . . . . 75.23 111.012 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.29 -132.34 11.06 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.915 -0.584 . . . . 54.1 112.529 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 42.6 p -65.76 -27.05 68.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.744 0.818 . . . . 72.51 111.495 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -58.91 -52.37 66.04 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.972 0.909 . . . . 74.23 109.629 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.545 ' HE3' ' HA ' ' C' ' 90' ' ' GLU . 50.8 ttm -67.88 -39.63 83.67 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 114.655 -1.157 . . . . 74.32 110.109 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.86 88.88 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.109 0.963 . . . . 72.31 111.856 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -70.16 -43.46 70.8 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.977 -0.556 . . . . 75.23 110.793 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.59 -41.87 95.59 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.233 0.613 . . . . 73.31 111.013 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 64.4 mt -84.15 -37.48 21.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.641 0.777 . . . . 74.51 111.457 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.35 10.11 75.39 Favored Glycine 0 N--CA 1.476 1.335 0 N-CA-C 114.212 0.445 . . . . 62.11 114.212 -172.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' C' ' 104' ' ' ASN . . . -153.62 -59.6 0.13 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.083 0.553 . . . . 75.41 110.513 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.585 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 53.7 t80 -72.77 -42.3 64.13 Favored 'General case' 0 CA--C 1.556 1.188 0 N-CA-C 113.013 0.746 . . . . 74.24 113.013 -166.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.595 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 60.3 m -67.25 -49.91 41.96 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 123.112 0.565 . . . . 61.55 111.944 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.452 ' HB2' HD23 ' C' ' 60' ' ' LEU . 70.1 Cg_endo -71.73 -23.71 22.38 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 121.722 1.615 . . . . 72.53 112.799 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . 0.506 ' HA ' ' HD2' ' C' ' 107' ' ' PHE . 46.6 t-20 -56.22 -39.98 73.36 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 123.952 0.901 . . . . 74.1 110.153 176.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.46 HD13 ' NH1' ' A' ' 111' ' ' ARG . 34.8 mm -60.16 -41.1 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 114.382 -1.281 . . . . 75.25 111.12 175.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 68.1 mt -87.07 -19.62 28.33 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.444 0.698 . . . . 74.2 112.689 -168.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . 0.506 ' HD2' ' HA ' ' C' ' 104' ' ' ASN . 28.1 m-85 -55.47 -53.23 64.54 Favored Pre-proline 0 N--CA 1.489 1.509 0 CA-C-O 118.081 -0.961 . . . . 75.33 112.832 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -54.76 -40.19 85.94 Favored 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 122.857 2.372 . . . . 75.12 114.658 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . 0.52 ' HE2' HG21 ' A' ' 115' ' ' THR . 39.7 m-85 -66.62 -50.1 64.1 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.56 0.744 . . . . 74.23 110.77 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.545 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -64.75 -35.33 80.74 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.016 -0.993 . . . . 74.33 111.041 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -61.27 -48.28 82.15 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.159 1.384 . . . . 75.51 110.638 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.73 -35.94 77.77 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 123.515 0.51 . . . . 63.34 109.73 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.4 t -67.99 -33.2 74.18 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.376 0.67 . . . . 73.54 111.151 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.497 HG21 HG22 ' C' ' 64' ' ' VAL . 78.1 mt -72.53 -54.35 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 109.545 -0.539 . . . . 74.42 109.545 174.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 22.6 m -62.37 -28.38 69.73 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 122.909 0.484 . . . . 73.44 111.25 -175.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.6 t -65.27 -49.03 71.11 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.996 -0.742 . . . . 71.34 108.996 171.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.736 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.03 -38.16 85.13 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.602 1.161 . . . . 64.52 112.264 178.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.453 HG23 ' O ' ' C' ' 114' ' ' ILE . 68.0 t -59.39 -47.19 91.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 108.765 -0.828 . . . . 74.23 108.765 175.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 37.9 t -74.64 -23.29 58.65 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.572 -1.195 . . . . 74.31 112.272 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.417 ' HD2' ' SD ' ' C' ' 117' ' ' MET . 90.2 mtt-85 -74.43 -39.06 62.83 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.015 -0.735 . . . . 73.34 109.015 175.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.11 0.96 82.19 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 124.168 0.917 . . . . 64.53 112.172 170.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.9 p 60.87 30.7 19.81 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.687 1.995 . . . . 61.15 113.602 171.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -83.29 143.8 45.63 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 108.242 -1.022 . . . . 71.33 108.242 170.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -51.27 152.16 11.75 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.211 2.608 . . . . 64.24 113.45 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -54.17 125.98 21.15 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.575 0.954 . . . . 74.04 113.575 -170.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 21.7 tp -122.84 86.09 2.53 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 107.682 -1.229 . . . . 73.11 107.682 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -95.7 115.9 28.1 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.387 -0.824 . . . . 72.5 108.994 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.11 129.01 37.12 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.334 0.654 . . . . 75.01 110.155 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.58 145.14 74.83 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 122.633 0.373 . . . . 65.34 110.932 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.513 ' HG3' HD13 ' A' ' 16' ' ' ILE . 71.4 Cg_endo -72.92 144.76 39.04 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.272 2.648 . . . . 73.41 113.369 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 18.5 m -137.91 134.76 45.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.213 1.005 . . . . 73.33 108.65 171.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . 0.523 HD22 ' HE1' ' A' ' 11' ' ' PHE . 3.4 m-20 -81.71 90.24 6.33 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 118.694 -0.669 . . . . 73.33 109.644 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -54.64 -44.66 73.4 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 118.363 0.529 . . . . 60.14 112.084 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 N--CA 1.478 0.929 0 C-N-CA 124.366 1.066 . . . . 73.21 111.582 178.797 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 86.6 m . . . . . 0 C--O 1.241 0.611 0 N-CA-C 108.528 -0.916 . . . . 74.42 108.528 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -163.16 105.4 1.01 Allowed 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.524 -0.917 . . . . 73.1 108.524 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -128.37 127.63 42.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.069 -1.086 . . . . 74.41 108.069 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.523 HG21 HD11 ' D' ' 16' ' ' ILE . 10.8 mt -86.82 131.42 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 109.001 -0.74 . . . . 74.22 109.001 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.414 ' NE2' HG12 ' D' ' 55' ' ' VAL . 47.9 mt-30 -98.48 -35.28 10.31 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.325 0.65 . . . . 71.14 110.931 175.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -167.21 142.03 3.94 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.857 0.688 . . . . 74.43 112.857 -171.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.523 HD11 HG21 ' D' ' 13' ' ' ILE . 3.4 mp -119.65 134.87 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 106.798 -1.556 . . . . 74.42 106.798 170.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.435 ' HE1' HG13 ' D' ' 83' ' ' ILE . 31.9 p90 -164.97 165.49 20.15 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.77 0.795 . . . . 74.33 110.744 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.2 p -102.68 124.11 47.62 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.461 -1.245 . . . . 74.33 108.636 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -89.78 -42.51 11.25 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.75 -0.833 . . . . 74.41 108.75 175.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.409 ' HA ' ' O ' ' C' ' 23' ' ' PHE . 13.5 m-20 -130.9 138.13 49.65 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.433 -0.803 . . . . 75.02 109.354 177.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.736 HG21 ' HE1' ' C' ' 117' ' ' MET . 61.0 mt -138.1 151.45 25.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 107.259 -1.385 . . . . 72.24 107.259 172.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 22' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 46.9 t -157.89 146.04 18.85 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.466 1.106 . . . . 71.11 108.734 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.533 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.0 t80 -149.45 133.44 17.11 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 105.771 -1.937 . . . . 75.23 105.771 169.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.8 mt-10 -132.6 149.64 52.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.487 -0.931 . . . . 73.35 108.487 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.64 77.36 12.47 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 107.355 -1.35 . . . . 63.51 107.355 175.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -67.16 -39.54 13.2 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.709 2.273 . . . . 65.44 112.464 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -98.31 5.8 47.95 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 118.526 -0.749 . . . . 75.34 110.817 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.438 ' O ' HG11 ' D' ' 31' ' ' VAL . . . -29.22 -63.2 0.2 Allowed Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 117.091 2.256 . . . . 72.1 117.091 -166.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.66 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 42.5 Cg_endo -82.36 -15.0 9.08 Favored 'Trans proline' 0 C--N 1.379 2.175 0 CA-C-N 122.827 2.045 . . . . 74.32 113.838 -174.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -77.07 -41.68 41.34 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.493 1.117 . . . . 75.01 109.332 173.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' D' ' 73' ' ' ALA . 9.8 p -83.64 -11.03 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 C-N-CA 124.294 1.038 . . . . 74.4 111.173 -175.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.431 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 12.0 m-85 -69.77 -19.06 63.53 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 112.112 0.412 . . . . 74.11 112.112 174.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -59.67 -25.74 64.97 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.408 0.623 . . . . 74.11 110.229 169.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.649 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 80.6 mttt -100.08 90.78 4.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.966 1.306 . . . . 73.4 109.355 178.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -105.34 93.01 4.45 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.371 -0.603 . . . . 74.24 109.371 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -156.43 175.06 14.52 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.074 0.949 . . . . 74.51 108.74 169.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -67.25 106.98 1.39 Allowed Pre-proline 0 CA--C 1.554 1.099 0 CA-C-O 118.855 -0.593 . . . . 71.44 109.408 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.513 ' HB3' ' HG ' ' D' ' 68' ' ' LEU . 30.5 Cg_endo -69.16 148.7 69.55 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.169 1.913 . . . . 72.41 112.716 -172.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -69.62 113.31 6.78 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 108.443 -0.947 . . . . 74.5 108.443 172.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.401 HG11 HG13 ' D' ' 64' ' ' VAL . 88.3 t -104.52 122.76 57.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 123.184 0.594 . . . . 71.2 109.632 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -94.36 128.47 40.9 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.803 -1.184 . . . . 74.53 107.803 170.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 pp -95.87 146.76 24.31 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.816 0.846 . . . . 75.13 109.468 -171.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.561 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 12.5 t70 -149.66 131.49 15.1 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.272 -1.01 . . . . 62.25 108.272 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -124.82 138.84 54.25 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.847 0.459 . . . . 74.31 109.94 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -133.03 155.8 48.52 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.723 1.209 . . . . 74.42 108.48 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 3.1 m -106.07 152.04 23.9 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.097 0.559 . . . . 71.11 111.62 -167.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.772 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -155.12 142.51 19.54 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.783 -0.821 . . . . 63.0 108.783 169.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.4 p -165.47 152.32 10.25 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 123.193 0.597 . . . . 75.11 109.682 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.2 p -158.91 143.62 15.82 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.112 0.565 . . . . 71.34 109.836 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -77.04 121.73 23.94 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.264 -0.643 . . . . 74.43 109.264 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.3 mt -94.91 -26.42 16.15 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.171 0.588 . . . . 72.23 109.812 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.499 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -170.35 -179.73 3.14 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.712 1.605 . . . . 74.34 109.082 175.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -76.0 123.95 26.58 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.014 -1.106 . . . . 72.51 108.014 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 73.79 -3.12 2.58 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 125.597 1.559 . . . . 65.22 112.269 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 78.3 t -117.53 118.04 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 108.302 -0.999 . . . . 73.24 108.302 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -135.03 172.26 13.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.041 0.448 . . . . 60.43 109.904 -174.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.577 ' HB2' HD11 ' D' ' 51' ' ' LEU . 24.7 tt0 -125.1 126.29 45.09 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.113 0.965 . . . . 74.35 108.714 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.83 115.88 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 107.569 -1.271 . . . . 62.32 107.569 175.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.772 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 26.2 t -117.96 134.68 60.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 123.866 0.866 . . . . 55.3 108.944 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 7.8 mp -121.5 130.73 53.73 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.968 0.413 . . . . 74.23 110.1 171.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -85.47 106.18 16.63 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.809 -1.087 . . . . 75.45 109.071 173.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 94.9 t -91.46 116.19 32.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 108.248 -1.019 . . . . 72.2 108.248 171.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 72.5 m -114.64 142.16 46.83 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 108.816 -0.809 . . . . 74.32 108.816 -176.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.401 HG13 HG11 ' D' ' 40' ' ' VAL . 58.7 t -132.16 102.93 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 125.099 1.36 . . . . 74.33 108.333 -173.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 42.2 m -95.83 91.51 6.08 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.571 -1.27 . . . . 74.42 107.571 168.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.2 143.47 26.59 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.898 -0.779 . . . . 73.22 108.898 -175.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.435 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 41.1 m -143.17 127.36 17.57 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.481 0.488 . . . . 73.52 111.175 -176.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.513 ' HG ' ' HB3' ' D' ' 38' ' ' PRO . 21.7 mt -97.12 105.57 17.75 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.029 -1.101 . . . . 71.05 108.029 173.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.64 -114.12 4.95 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.377 -0.829 . . . . 64.44 111.973 -177.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.48 4.7 30.85 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 112.957 0.725 . . . . 74.24 112.957 -172.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.649 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 13.0 pt-20 -136.24 161.7 35.02 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.496 0.319 . . . . 73.14 110.469 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 70.9 m -62.74 125.17 23.04 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 124.208 0.942 . . . . 71.23 111.45 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.465 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -78.56 -70.84 0.47 Allowed 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.788 -1.096 . . . . 74.22 108.188 170.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -149.34 146.78 27.69 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.493 -0.776 . . . . 75.0 110.382 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.458 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 72.4 mt -111.69 108.24 17.62 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.96 -1.126 . . . . 74.35 107.96 174.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.522 ' SG ' ' HE3' ' D' ' 117' ' ' MET . 43.7 t -116.97 146.7 42.85 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.253 -0.647 . . . . 74.45 109.253 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 19.8 tt0 -153.55 133.13 12.95 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.449 0.699 . . . . 74.14 109.66 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 45.3 t -138.82 116.95 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.081 -0.711 . . . . 72.15 109.081 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -87.83 88.63 7.71 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 108.07 -1.085 . . . . 72.32 108.07 169.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -80.86 114.51 19.79 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.413 -1.267 . . . . 75.32 108.471 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.29 144.5 18.09 Favored Glycine 0 C--N 1.337 0.594 0 O-C-N 123.465 0.478 . . . . 72.53 112.441 -176.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.68 137.83 9.47 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 111.221 -0.752 . . . . 74.41 111.221 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.435 HG13 ' HE1' ' D' ' 17' ' ' TYR . 72.8 mt -88.71 120.45 37.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.66 -1.237 . . . . 74.45 107.66 173.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -128.72 122.07 29.87 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.863 0.865 . . . . 71.44 109.244 -175.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 31.9 m -85.04 93.99 8.73 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.206 -1.035 . . . . 75.44 108.206 169.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 11.7 tt -123.31 131.55 72.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 123.91 0.884 . . . . 73.23 109.161 -173.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.7 166.63 32.83 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.371 0.668 . . . . 64.34 110.902 -173.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.35 17.09 76.94 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.619 -0.718 . . . . 63.33 113.683 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 6.7 mt -125.61 154.13 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.059 0.543 . . . . 74.23 109.861 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.555 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 0.0 OUTLIER -159.51 -174.06 4.47 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 123.934 0.893 . . . . 75.51 110.184 174.268 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.61 -142.29 45.28 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.492 0.495 . . . . 62.33 113.425 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 51.6 m -76.84 -28.31 55.45 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.606 0.762 . . . . 73.4 111.692 -176.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -60.11 -44.17 95.07 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.84 0.456 . . . . 75.23 111.298 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.555 ' SD ' ' HA ' ' D' ' 90' ' ' GLU . 25.6 ptt? -72.38 -30.63 64.85 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 123.111 0.257 . . . . 72.43 111.477 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.76 -36.14 82.72 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.316 0.579 . . . . 73.43 110.24 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -85.86 -18.2 33.47 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.774 -0.648 . . . . 74.4 110.653 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 47.3 t -70.52 -51.07 31.33 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.536 0.684 . . . . 70.15 109.487 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 30.0 mt -77.32 -18.95 57.04 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.87 -1.059 . . . . 74.1 110.545 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.06 15.46 51.33 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 115.764 -0.653 . . . . 74.42 113.815 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.47 -65.8 0.08 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 117.235 0.517 . . . . 74.32 111.911 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -64.21 -53.47 48.74 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.68 0.792 . . . . 75.51 112.681 -169.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 21.7 m -63.67 -43.83 78.52 Favored Pre-proline 0 CA--C 1.565 1.541 0 C-N-CA 123.819 0.847 . . . . 73.34 111.798 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -52.76 -39.05 78.16 Favored 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 122.759 2.306 . . . . 74.45 113.996 166.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -64.54 -28.58 69.75 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.525 0.73 . . . . 73.24 111.682 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.2 mm -69.78 -42.17 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-O 121.491 0.662 . . . . 71.32 109.761 173.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 93.8 mt -82.62 -12.65 57.52 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.819 -1.082 . . . . 65.22 111.887 -177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . 0.409 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 83.7 t80 -60.83 -52.73 70.34 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.489 1.116 . . . . 73.41 113.184 -176.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . 0.409 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 39.6 Cg_exo -61.47 -35.48 82.38 Favored 'Trans proline' 0 C--N 1.385 2.482 0 C-N-CA 121.863 1.708 . . . . 63.44 112.384 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -71.29 -43.98 66.09 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.311 1.045 . . . . 72.43 111.991 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.72 -42.17 86.75 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.416 0.686 . . . . 71.33 110.127 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -57.34 -54.61 44.88 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 124.199 0.937 . . . . 73.14 110.08 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -59.04 -46.03 89.26 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.199 0.937 . . . . 73.52 111.198 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.7 t -58.05 -43.31 86.82 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 123.749 0.656 . . . . 74.35 111.041 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.484 HG22 ' SG ' ' D' ' 76' ' ' CYS . 74.1 mt -65.21 -55.45 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 123.565 0.541 . . . . 72.31 109.994 175.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 62.8 m -51.17 -44.0 61.4 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.927 1.291 . . . . 72.42 111.736 -173.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 35.9 t -65.67 -43.11 90.31 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 114.683 -1.144 . . . . 73.31 109.958 -178.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.522 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 79.3 mtm -67.86 -32.94 73.8 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.116 0.566 . . . . 70.15 111.866 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.439 HG22 ' O ' ' D' ' 114' ' ' ILE . 85.5 t -65.13 -44.19 95.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.469 0.708 . . . . 74.12 109.744 176.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 80.9 p -74.6 -28.46 60.91 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.952 -0.567 . . . . 71.45 111.153 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' D' ' 116' ' ' SER . 82.5 mtt-85 -70.88 -32.89 70.01 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.663 0.785 . . . . 75.2 109.973 174.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.73 5.69 77.46 Favored Glycine 0 C--N 1.353 1.49 0 O-C-N 123.902 0.751 . . . . 42.53 112.068 171.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.2 p 55.78 24.05 6.96 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 127.27 2.228 . . . . 73.24 113.982 176.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -79.59 155.17 76.23 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.571 0.748 . . . . 73.02 109.663 170.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -48.57 126.32 14.07 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.531 2.82 . . . . 74.44 112.327 172.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -51.92 132.39 32.06 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.617 1.167 . . . . 73.21 112.223 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 5.8 tt -108.07 101.77 10.98 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.611 -1.255 . . . . 75.43 107.611 -177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -100.95 102.89 14.0 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.299 -1.001 . . . . 74.52 108.299 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 tt -69.16 115.21 8.18 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 107.794 -1.187 . . . . 72.3 107.794 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.76 139.31 97.1 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 123.201 0.6 . . . . 62.14 110.756 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -58.72 106.26 0.27 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.007 2.471 . . . . 70.54 111.682 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 17.4 m . . . . . 0 C--O 1.241 0.64 0 CA-C-N 115.203 -0.908 . . . . 74.23 109.678 -177.002 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.634 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 16.4 t80 . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 108.491 -0.929 . . . . 74.42 108.491 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -137.7 121.85 18.0 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.552 -0.907 . . . . 75.22 108.552 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.67 HG12 ' HD2' ' A' ' 84' ' ' PHE . 58.8 mt -93.94 123.01 45.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.416 -0.957 . . . . 71.12 108.416 174.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -84.32 -40.85 17.44 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 123.493 0.496 . . . . 74.01 110.158 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -169.61 134.98 1.47 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 116.389 -0.369 . . . . 73.22 110.692 -168.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.498 HD13 ' HG3' ' C' ' 130' ' ' PRO . 85.8 mt -125.39 129.85 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 123.708 0.803 . . . . 71.53 109.218 175.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -162.24 148.06 13.01 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 124.222 0.951 . . . . 75.23 110.715 -167.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.7 p -75.05 129.04 36.93 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 109.407 -0.59 . . . . 61.33 109.407 173.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -97.99 -27.82 14.07 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.6 0.36 . . . . 75.22 110.399 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.523 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 13.6 t70 -141.98 138.47 31.92 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.382 -0.599 . . . . 61.34 109.382 171.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 60.4 mt -130.5 140.64 48.3 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 N-CA-C 107.087 -1.449 . . . . 72.12 107.087 172.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.0 t -150.58 128.2 11.55 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.036 0.534 . . . . 71.1 110.19 175.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.405 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 75.9 t80 -130.48 142.46 50.49 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.416 -1.327 . . . . 71.3 107.416 171.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -141.92 139.36 32.52 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.495 -0.928 . . . . 70.4 108.495 171.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.09 86.49 26.36 Favored Pre-proline 0 C--O 1.241 0.615 0 N-CA-C 106.118 -1.808 . . . . 71.23 106.118 169.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -53.41 -42.69 63.59 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.578 2.852 . . . . 72.53 113.774 -168.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.32 37.46 4.25 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.22 -0.659 . . . . 72.11 109.22 -177.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.489 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -41.75 -60.89 1.68 Allowed Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 113.74 1.015 . . . . 72.13 113.74 -169.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 23.4 Cg_exo -63.19 -27.07 72.52 Favored 'Trans proline' 0 C--N 1.385 2.496 0 CA-C-N 121.786 1.673 . . . . 74.42 112.776 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -84.69 -32.15 23.73 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.225 1.01 . . . . 74.1 111.311 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.685 HG22 ' HA ' ' A' ' 73' ' ' ALA . 4.8 p -79.08 -23.66 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.595 -0.729 . . . . 73.24 111.642 -168.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -72.39 -12.04 60.95 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.171 0.588 . . . . 72.5 111.51 176.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -81.63 -29.79 33.1 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.123 0.969 . . . . 72.35 110.156 173.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -74.46 153.83 38.99 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.178 0.991 . . . . 75.13 111.288 -174.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.78 136.81 45.52 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.594 -0.73 . . . . 75.23 109.259 170.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.407 ' CE3' HD21 ' A' ' 68' ' ' LEU . 62.1 t-105 -80.21 85.09 5.79 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.365 0.666 . . . . 75.24 110.45 -175.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -125.24 79.21 66.45 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.209 1.004 . . . . 71.53 108.5 170.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -89.97 140.79 3.5 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.694 2.263 . . . . 74.13 113.364 -173.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -99.43 90.75 4.63 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 107.805 -1.183 . . . . 72.34 107.805 167.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -70.52 92.36 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 122.477 1.132 . . . . 74.04 109.609 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -79.66 147.68 31.9 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 113.971 -1.468 . . . . 75.12 109.224 172.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 pp -133.64 131.77 39.97 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.535 0.734 . . . . 75.42 110.219 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.603 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 32.8 m-20 -115.89 135.76 53.69 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.294 -1.002 . . . . 70.52 108.294 175.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.8 mp -104.58 121.92 44.51 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.92 0.888 . . . . 74.43 109.176 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -141.99 144.59 33.76 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.884 -0.784 . . . . 65.03 108.884 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.449 ' HG1' ' HG ' ' A' ' 60' ' ' LEU . 23.7 m -146.69 140.26 25.81 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.066 0.547 . . . . 75.44 110.14 -177.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.25 152.38 51.37 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.987 1.315 . . . . 63.52 108.603 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.6 p -132.01 160.61 35.35 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.15 0.58 . . . . 63.44 109.867 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -149.78 119.41 6.99 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.946 -0.761 . . . . 62.22 108.946 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -84.91 111.5 19.72 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.486 -0.561 . . . . 70.14 109.486 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.452 HD12 HG22 ' A' ' 83' ' ' ILE . 56.3 mt -85.36 -29.95 24.05 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.555 0.742 . . . . 73.41 111.25 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.464 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -164.61 -171.58 2.37 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.254 1.022 . . . . 65.2 110.142 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.14 100.75 0.63 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.31 0.644 . . . . 64.11 109.545 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 70.05 8.08 6.51 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.002 1.321 . . . . 73.44 112.613 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.464 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 57.2 t -100.27 118.37 46.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 106.303 -1.739 . . . . 74.41 106.303 166.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -142.46 173.58 11.41 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.321 0.581 . . . . 70.35 110.283 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -127.65 131.68 49.82 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.262 -1.335 . . . . 74.32 108.878 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.491 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 84.5 t -106.01 135.8 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.731 -1.211 . . . . 75.25 107.731 166.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.41 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 39.8 t -123.95 129.67 74.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.863 -1.532 . . . . 75.34 106.863 174.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.449 ' HG ' ' HG1' ' A' ' 46' ' ' THR . 2.7 tt -124.98 117.91 25.08 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.051 -0.722 . . . . 75.44 109.051 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.585 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 21.3 ttp180 -89.59 111.04 21.86 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.884 -1.053 . . . . 74.34 109.661 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.414 HG13 HD12 ' A' ' 128' ' ' LEU . 43.9 t -100.36 110.87 28.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.979 -1.119 . . . . 74.34 107.979 172.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.603 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 26.3 m -97.75 108.92 21.73 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.677 -0.49 . . . . 73.34 109.677 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.4 t -103.68 108.38 24.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.405 1.082 . . . . 75.53 109.065 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.5 m -102.86 137.05 41.58 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.929 -1.137 . . . . 74.54 107.929 171.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.51 118.91 25.87 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 107.457 -1.312 . . . . 61.45 107.457 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -130.87 132.04 44.92 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.746 0.654 . . . . 73.41 111.092 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.407 HD21 ' CE3' ' A' ' 36' ' ' TRP . 15.6 mt -87.92 75.09 8.87 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.613 -1.254 . . . . 73.12 107.613 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.0 -115.69 4.07 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 114.953 -1.021 . . . . 62.2 110.737 -170.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -90.37 -19.63 23.76 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.722 0.809 . . . . 75.24 111.355 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -94.37 119.0 32.46 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.073 0.549 . . . . 74.51 109.993 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.8 m -72.58 121.89 20.45 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.311 0.382 . . . . 74.35 110.859 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.685 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -68.67 -56.27 8.71 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.763 -0.653 . . . . 75.21 109.697 176.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.467 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 42.7 p90 -156.26 175.55 13.84 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.018 -0.992 . . . . 73.45 111.371 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.6 tp -138.52 140.47 39.14 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.056 -1.429 . . . . 64.42 107.268 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 90.1 m -144.26 95.87 2.79 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.834 0.854 . . . . 65.34 108.819 -177.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -116.07 115.27 25.79 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.499 -0.926 . . . . 73.31 108.499 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.4 t -127.91 118.03 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.398 0.679 . . . . 74.24 110.244 -175.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.585 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 78.2 mt-30 -86.31 92.3 8.76 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 108.825 -0.805 . . . . 72.33 108.825 169.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -82.67 112.5 19.59 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.979 -0.748 . . . . 70.43 108.979 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -102.66 166.49 16.96 Favored Glycine 0 C--N 1.335 0.519 0 O-C-N 123.206 0.316 . . . . 64.24 112.855 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.58 131.7 2.3 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.793 -0.523 . . . . 75.42 111.793 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.452 HG22 HD12 ' A' ' 51' ' ' LEU . 57.1 mt -81.33 124.58 39.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 123.316 0.646 . . . . 75.52 109.369 174.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.67 ' HD2' HG12 ' A' ' 13' ' ' ILE . 10.0 m-85 -130.58 118.39 20.96 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.296 -1.001 . . . . 74.43 108.296 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.9 p -96.89 93.33 6.58 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.634 -0.876 . . . . 71.22 108.634 173.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.559 ' HB ' ' HD2' ' A' ' 11' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.475 0.792 0 C-N-CA 124.033 0.933 . . . . 64.34 109.79 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.902 0 CA-C-O 121.202 0.525 . . . . 75.24 111.068 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -68.3 -30.24 69.19 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.426 1.09 . . . . 74.53 111.156 176.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.438 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 48.7 t -68.76 -57.78 5.14 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.202 0.525 . . . . 72.34 110.21 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 pp -76.04 -19.91 58.22 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.566 -0.743 . . . . 75.5 112.093 -177.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.17 -4.49 53.71 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-O 119.519 -0.601 . . . . 70.22 114.225 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.34 -61.37 0.22 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 117.709 0.755 . . . . 74.4 112.155 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.486 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 91.2 t80 -59.92 -61.96 2.22 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 113.21 0.819 . . . . 74.3 113.21 -168.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 73.7 m -64.3 -38.16 31.54 Favored Pre-proline 0 CA--C 1.565 1.543 0 N-CA-C 112.829 0.677 . . . . 72.24 112.829 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.24 -46.12 23.85 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.528 2.152 . . . . 73.31 113.529 161.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.641 HD22 ' HB2' ' A' ' 133' ' ' PHE . 87.7 m-20 -75.88 -12.91 60.25 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.873 0.869 . . . . 71.53 112.224 -177.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.0 mm -70.59 -41.07 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 109.199 -0.667 . . . . 75.44 109.199 169.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 83.7 mt -82.33 -22.62 35.51 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.147 0.979 . . . . 74.15 111.919 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -57.49 -48.91 96.47 Favored Pre-proline 0 CA--C 1.569 1.702 0 N-CA-C 114.245 1.202 . . . . 71.4 114.245 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -63.79 -36.03 53.5 Favored 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 122.001 1.8 . . . . 73.01 112.582 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.469 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 96.0 m-85 -69.18 -42.73 75.45 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.526 0.73 . . . . 71.44 111.383 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.88 -37.68 82.08 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.355 0.662 . . . . 73.24 109.995 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.464 ' NH1' HG23 ' C' ' 105' ' ' ILE . 28.0 ttm180 -54.02 -55.18 29.73 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.804 0.842 . . . . 71.13 110.279 171.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -67.49 -40.36 85.23 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.175 0.99 . . . . 74.43 111.736 -172.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.6 t -63.4 -36.6 84.25 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.366 0.416 . . . . 74.14 110.69 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.448 ' HA ' ' HE1' ' A' ' 117' ' ' MET . 60.0 mt -68.6 -49.58 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 115.461 -0.79 . . . . 75.2 110.039 174.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.6 m -56.32 -37.47 69.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.289 1.035 . . . . 73.42 111.496 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.9 t -62.23 -48.8 78.35 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 115.647 -0.706 . . . . 70.44 110.261 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.448 ' HE1' ' HA ' ' A' ' 114' ' ' ILE . 36.2 mtm -67.48 -36.27 80.8 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.158 0.583 . . . . 73.52 111.569 -176.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.5 t -62.88 -53.72 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 O-C-N 123.739 0.649 . . . . 63.21 110.278 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 38.7 t -66.51 -30.17 70.44 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.339 -0.846 . . . . 73.41 110.812 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.461 ' HG2' ' HG1' ' B' ' 18' ' ' THR . 52.4 ttm-85 -77.43 -28.78 52.69 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.475 1.11 . . . . 74.21 109.343 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.72 9.6 67.84 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 115.283 -0.871 . . . . 74.34 112.23 171.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.5 HG23 ' HE ' ' B' ' 15' ' ' ARG . 1.1 t 67.83 13.5 9.21 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 127.166 2.186 . . . . 73.44 113.568 170.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -81.47 148.56 62.85 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 108.23 -1.026 . . . . 75.44 108.23 172.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -59.31 164.29 10.97 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.922 2.415 . . . . 61.2 113.371 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -54.51 120.25 6.39 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.009 0.923 . . . . 71.02 112.189 -173.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.467 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 62.2 tp -115.19 103.32 10.73 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.378 1.071 . . . . 71.31 108.563 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -99.12 111.16 23.62 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 107.537 -1.283 . . . . 74.04 107.537 177.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.414 HD12 HG13 ' A' ' 62' ' ' VAL . 2.2 tt -64.96 121.51 14.84 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.396 -0.964 . . . . 71.35 108.396 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.45 139.14 97.65 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 122.722 0.409 . . . . 75.33 111.363 -175.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.21 132.58 10.39 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 123.044 2.496 . . . . 72.35 112.199 -175.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.7 t -112.1 114.73 47.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.605 -1.258 . . . . 73.13 107.605 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -82.25 65.93 7.61 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 123.599 0.562 . . . . 75.53 110.345 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.641 ' HB2' HD22 ' A' ' 104' ' ' ASN . 80.4 m-85 . . . . . 0 C--N 1.366 1.301 0 C-N-CA 123.865 0.866 . . . . 72.41 110.789 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.667 ' HB2' ' HB ' ' B' ' 89' ' ' ILE . 12.6 ttt . . . . . 0 CA--C 1.555 1.16 0 CA-C-O 121.646 0.736 . . . . 73.32 111.592 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 87.5 m -139.79 136.18 33.8 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.138 -1.06 . . . . 71.42 108.138 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.576 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 86.0 t80 -126.31 145.16 50.54 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.858 0.863 . . . . 71.34 109.254 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.414 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -157.32 139.29 14.31 Favored 'General case' 0 C--N 1.346 0.441 0 O-C-N 123.501 0.5 . . . . 74.43 109.806 170.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.481 HD11 HD12 ' B' ' 105' ' ' ILE . 26.2 mt -79.8 126.32 39.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.846 -0.798 . . . . 71.34 108.846 172.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -94.45 -51.09 4.92 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.763 -0.458 . . . . 73.11 109.763 175.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.5 ' HE ' HG23 ' A' ' 122' ' ' THR . 33.7 ttt180 -162.67 139.87 7.94 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.547 -0.297 . . . . 74.01 110.758 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.413 HD11 HD12 ' B' ' 13' ' ' ILE . 98.1 mt -120.56 134.68 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 107.672 -1.233 . . . . 75.51 107.672 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -168.47 158.0 9.28 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.302 0.572 . . . . 75.32 111.949 -171.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.461 ' HG1' ' HG2' ' A' ' 120' ' ' ARG . 85.3 m -89.41 129.6 35.9 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.14 -0.936 . . . . 72.41 109.559 173.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -100.37 -20.33 15.88 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.558 0.743 . . . . 75.42 111.412 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -167.52 144.22 4.31 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.52 0.513 . . . . 62.23 111.583 -173.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.763 HD12 ' SG ' ' B' ' 113' ' ' CYS . 43.0 mm -138.42 147.09 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.996 1.319 . . . . 74.35 109.468 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.556 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.2 t -146.01 136.14 23.71 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.638 1.175 . . . . 72.44 108.467 170.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.4 t80 -150.51 108.14 3.66 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 107.749 -1.204 . . . . 72.32 107.749 170.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -120.18 113.94 21.19 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.154 0.982 . . . . 75.24 109.013 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.55 87.94 3.06 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 108.269 -1.011 . . . . 71.25 108.269 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -66.57 -45.25 5.07 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.182 2.588 . . . . 72.35 113.043 -168.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -103.36 23.56 12.32 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.661 0.785 . . . . 75.33 110.494 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -40.86 -62.15 1.07 Allowed Pre-proline 0 N--CA 1.49 1.548 0 C-N-CA 124.749 1.219 . . . . 70.12 113.981 -168.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.55 -23.64 76.84 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.468 2.112 . . . . 44.52 113.5 -173.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -94.28 -39.86 10.28 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.386 0.674 . . . . 72.24 111.954 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' B' ' 73' ' ' ALA . 8.7 p -69.71 -15.89 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 122.996 0.518 . . . . 65.33 112.072 -171.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -68.3 -11.98 60.32 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.561 0.744 . . . . 74.21 112.766 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.572 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.9 pt20 -58.16 -28.82 65.07 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.401 0.62 . . . . 74.54 109.962 172.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.572 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 88.7 mttt -95.94 92.91 6.72 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.253 1.421 . . . . 73.55 109.504 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -95.09 87.92 5.05 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.31 -0.405 . . . . 72.51 110.084 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -165.71 178.18 6.78 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.126 0.97 . . . . 74.42 108.994 170.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -70.9 112.12 12.2 Favored Pre-proline 0 CA--C 1.562 1.412 0 C-N-CA 123.277 0.631 . . . . 73.25 111.302 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.559 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 18.1 Cg_endo -62.66 143.76 92.97 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.278 1.985 . . . . 73.32 112.421 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.84 108.71 4.08 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.985 -0.746 . . . . 73.24 108.985 176.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 30.8 m -93.93 147.53 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.231 -0.895 . . . . 73.34 112.592 -172.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.474 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 61.7 mtpt -125.51 100.94 6.7 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.003 1.321 . . . . 73.44 108.29 174.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pp -96.58 155.6 16.7 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.626 -0.715 . . . . 75.43 111.443 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -150.28 150.92 32.17 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.326 1.05 . . . . 74.34 109.205 -175.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 90.5 mt -125.48 127.29 46.25 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.191 0.996 . . . . 75.4 108.615 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 25.1 t70 -124.21 146.26 48.82 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.016 0.526 . . . . 70.32 110.455 -171.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 90.7 m -110.41 122.76 48.49 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.944 -1.026 . . . . 72.31 110.983 -176.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.36 122.58 11.52 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 107.061 -1.459 . . . . 63.33 107.061 169.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 36.1 p -145.82 163.16 35.89 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.795 0.27 . . . . 62.41 110.804 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 52.5 p -151.99 141.53 21.69 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.83 0.852 . . . . 71.5 109.35 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -84.22 129.82 34.86 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.196 -0.668 . . . . 74.52 109.196 175.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.534 HD12 HG22 ' B' ' 83' ' ' ILE . 50.9 mt -92.22 -44.37 8.81 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.03 0.532 . . . . 74.23 110.312 -176.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.85 -171.86 3.58 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.052 0.941 . . . . 41.54 109.569 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -68.3 129.32 39.58 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.455 -0.793 . . . . 73.15 109.157 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 68.57 -4.67 1.09 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.489 1.515 . . . . 74.44 113.085 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 82.4 t -113.76 117.61 55.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 108.642 -0.873 . . . . 65.44 108.642 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -135.12 140.84 45.77 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.155 -0.683 . . . . 74.54 109.155 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -114.07 114.31 25.93 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.204 -1.035 . . . . 71.25 108.204 -174.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 34.3 m -108.22 136.73 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.616 0.766 . . . . 71.24 110.431 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 19.5 t -120.92 121.65 65.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 108.393 -0.966 . . . . 72.52 108.393 177.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.33 108.86 20.61 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 106.84 -1.541 . . . . 74.43 106.84 170.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.621 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 26.9 ttp180 -86.9 118.73 26.48 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.036 -0.728 . . . . 72.31 109.036 173.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 16.6 t -103.92 121.16 55.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.71 -1.218 . . . . 74.35 107.71 174.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 23.8 m -120.26 124.96 46.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.111 -0.7 . . . . 65.24 109.111 -178.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 97.9 t -123.9 113.53 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 124.216 1.006 . . . . 75.23 109.101 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 67.3 m -84.84 149.38 25.74 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.354 -0.98 . . . . 74.42 108.354 166.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.43 140.77 30.57 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.334 0.653 . . . . 64.5 109.663 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.487 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 21.0 p -145.71 130.05 17.69 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.17 0.51 . . . . 63.52 111.383 -176.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.559 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 28.6 mt -104.59 128.09 52.5 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.323 1.049 . . . . 75.24 109.004 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.99 -111.37 4.09 Favored Glycine 0 C--N 1.344 0.981 0 O-C-N 123.733 0.646 . . . . 72.52 112.196 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -118.46 10.79 12.78 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.575 0.75 . . . . 73.23 111.55 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.464 ' HG2' ' HZ3' ' B' ' 34' ' ' LYS . 13.4 pt-20 -129.7 159.31 36.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.732 0.413 . . . . 71.25 110.759 -175.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.1 m -73.19 121.19 19.89 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 116.043 -0.526 . . . . 60.11 110.317 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.514 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -76.48 -61.68 1.88 Allowed 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.049 -1.093 . . . . 63.35 108.049 177.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -157.52 165.11 36.5 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.953 -1.022 . . . . 74.43 111.9 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 46.1 mt -125.6 112.0 15.65 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 106.043 -1.836 . . . . 62.55 106.043 175.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.42 ' SG ' HG21 ' B' ' 114' ' ' ILE . 34.8 t -117.15 148.93 41.15 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.665 -0.865 . . . . 75.13 108.665 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.556 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 41.9 tt0 -163.88 132.42 3.7 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.167 0.587 . . . . 73.22 109.531 -173.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' B' ' 110' ' ' ALA . 98.8 t -132.86 147.04 31.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 123.757 0.823 . . . . 74.43 109.186 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.621 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 19.1 mt-30 -118.41 103.96 10.27 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.601 -0.889 . . . . 74.15 108.601 169.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -94.62 100.52 12.45 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.195 -1.039 . . . . 61.45 108.195 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.12 153.42 22.9 Favored Glycine 0 C--O 1.242 0.606 0 CA-C-N 114.998 -1.001 . . . . 72.45 111.159 175.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.8 126.25 1.85 Allowed Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 111.316 -0.714 . . . . 72.34 111.316 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.534 HG22 HD12 ' B' ' 51' ' ' LEU . 48.3 mt -85.49 128.21 39.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 107.546 -1.279 . . . . 72.32 107.546 170.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -138.61 149.95 45.77 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.129 -0.693 . . . . 71.03 109.129 176.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 69.8 m -94.52 100.33 12.33 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.464 -0.939 . . . . 73.34 108.464 170.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 1.8 pp -116.1 110.77 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.358 -0.979 . . . . 73.24 108.358 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.32 170.13 21.71 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.33 0.652 . . . . 74.41 110.886 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.84 -65.63 0.25 Allowed Glycine 0 C--N 1.346 1.138 0 CA-C-O 119.672 -0.516 . . . . 74.34 113.151 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.667 ' HB ' ' HB2' ' B' ' 9' ' ' MET . 3.4 tt -82.55 170.07 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 117.597 0.698 . . . . 74.54 110.037 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -152.62 160.74 43.17 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.028 0.931 . . . . 75.33 109.172 -167.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.83 -134.47 11.7 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 110.947 -0.861 . . . . 74.13 110.947 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.4 m -93.47 -18.32 22.45 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 117.247 0.523 . . . . 73.43 110.575 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.39 -26.04 60.82 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.695 -0.628 . . . . 74.3 111.108 -174.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -64.84 -31.76 73.15 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 119.485 -0.293 . . . . 74.53 110.439 171.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.81 -38.73 82.77 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.665 0.786 . . . . 72.51 111.135 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -65.34 -39.21 92.1 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.404 -0.817 . . . . 74.11 111.359 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 40.2 t -66.56 -41.46 88.58 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.626 0.602 . . . . 72.15 112.626 -173.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.571 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.0 pt? -101.35 -14.31 17.66 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 117.862 0.301 . . . . 73.1 111.664 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.32 -21.43 24.81 Favored Glycine 0 C--N 1.352 1.425 0 N-CA-C 114.3 0.48 . . . . 73.23 114.3 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.23 -54.12 1.7 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.487 0.715 . . . . 73.13 110.159 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -69.69 -52.74 23.0 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.299 0.64 . . . . 73.41 112.288 -171.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.576 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 69.0 m -59.11 -49.02 95.29 Favored Pre-proline 0 CA--C 1.565 1.555 0 CA-C-O 119.04 -0.505 . . . . 74.21 112.143 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 39.1 Cg_exo -63.54 -27.73 69.95 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 122.217 1.944 . . . . 75.22 113.835 173.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -63.54 -37.68 88.25 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.032 0.533 . . . . 63.34 109.771 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.481 HD12 HD11 ' B' ' 13' ' ' ILE . 72.1 mt -65.48 -42.43 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.781 0.832 . . . . 72.22 110.2 175.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 91.9 mt -76.96 -20.36 56.21 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.949 -1.023 . . . . 75.42 111.833 -175.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -54.03 -55.79 32.57 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 124.136 0.974 . . . . 75.12 113.151 -176.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -59.34 -31.38 94.88 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.085 1.857 . . . . 74.41 113.737 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -69.73 -46.31 66.2 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.395 0.678 . . . . 75.33 110.503 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.417 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -66.2 -38.66 88.5 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.582 0.753 . . . . 65.24 110.992 177.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -61.88 -53.37 56.79 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.092 1.357 . . . . 74.04 110.778 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.01 -33.38 75.92 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.524 -0.762 . . . . 74.33 109.716 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.763 ' SG ' HD12 ' B' ' 21' ' ' ILE . 38.0 t -64.6 -44.52 90.37 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 123.51 0.506 . . . . 74.0 111.715 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.491 ' O ' HG23 ' B' ' 118' ' ' VAL . 72.9 mt -59.59 -55.01 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 109.12 -0.696 . . . . 71.54 109.12 175.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.1 m -62.26 -28.1 69.48 Favored 'General case' 0 CA--C 1.552 1.044 0 O-C-N 123.633 0.583 . . . . 71.15 112.122 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.484 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.7 t -64.5 -48.04 76.66 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.258 -0.645 . . . . 70.42 109.258 175.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.481 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.8 mmt -70.75 -33.86 71.26 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.053 0.541 . . . . 73.1 110.663 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.491 HG23 ' O ' ' B' ' 114' ' ' ILE . 97.2 t -61.51 -43.4 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.536 0.734 . . . . 73.21 110.067 173.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.8 t -64.56 -37.59 88.08 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.058 -0.974 . . . . 72.23 110.806 178.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' B' ' 116' ' ' SER . 89.7 mtt-85 -66.58 -32.87 74.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.601 -0.727 . . . . 72.24 110.411 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.6 12.21 59.68 Favored Glycine 0 C--N 1.349 1.29 0 O-C-N 123.933 0.771 . . . . 64.41 113.013 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 76.4 p 53.08 27.95 6.31 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 126.161 1.784 . . . . 73.43 113.324 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -86.69 155.37 56.21 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.417 0.687 . . . . 75.44 110.292 177.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.0 176.45 2.47 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.112 2.541 . . . . 65.02 113.784 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.598 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 0.0 OUTLIER -62.93 124.71 21.77 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.878 -1.056 . . . . 73.3 111.8 -173.091 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -144.05 102.92 3.95 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.218 -1.031 . . . . 73.3 108.218 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -119.05 135.08 54.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.02 0.928 . . . . 72.33 108.987 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.39 145.32 52.97 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.127 0.571 . . . . 63.21 110.589 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.3 150.92 65.12 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 122.94 0.496 . . . . 73.4 110.992 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.432 ' CG ' HD11 ' D' ' 16' ' ' ILE . 33.0 Cg_exo -61.54 108.35 0.6 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.149 2.566 . . . . 74.54 111.893 175.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 66.1 t -112.33 111.04 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.573 -0.899 . . . . 74.45 108.573 176.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -96.88 93.04 6.42 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.258 -1.016 . . . . 71.45 108.258 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -61.48 -40.63 95.23 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.89 0.876 . . . . 74.41 110.301 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 . . . . . 0 N--CA 1.47 0.567 0 C-N-CA 124.914 1.286 . . . . 75.21 111.677 -178.836 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.673 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 4.2 t80 . . . . . 0 C--O 1.236 0.385 0 CA-C-O 120.922 0.392 . . . . 75.54 110.383 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -148.19 121.8 9.19 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.86 -1.163 . . . . 61.4 107.86 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 69.2 mt -73.15 124.43 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 109.491 -0.559 . . . . 71.5 109.491 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.434 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 19.1 mm-40 -88.8 -47.87 7.9 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.102 -0.954 . . . . 74.04 109.636 -175.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -170.04 133.6 1.18 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.797 0.439 . . . . 74.4 110.529 -173.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 83.8 mt -116.11 146.28 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 108.007 -1.109 . . . . 74.02 108.007 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -174.9 169.19 3.48 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.366 0.666 . . . . 72.15 110.08 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 66.7 p -92.09 115.77 28.36 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.347 0.659 . . . . 71.54 109.364 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.617 ' HE2' ' HB2' ' D' ' 28' ' ' ALA . 23.1 mmtp -66.22 -47.62 73.24 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.615 0.721 . . . . 75.43 109.705 172.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.434 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 14.1 t70 -144.41 148.79 35.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.132 -1.394 . . . . 73.11 110.147 -175.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.7 mt -142.28 145.57 23.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.121 -1.437 . . . . 74.5 107.121 176.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 42.8 t -157.46 151.7 24.79 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.26 0.624 . . . . 64.21 110.676 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -148.5 146.12 28.21 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.674 -1.232 . . . . 63.54 107.674 170.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -145.71 132.04 19.58 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.815 0.846 . . . . 72.32 109.763 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.41 77.9 4.73 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 106.192 -1.781 . . . . 62.4 106.192 172.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -62.97 -37.65 52.16 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.902 2.402 . . . . 73.44 111.877 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -95.62 21.4 8.36 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.371 -1.286 . . . . 75.31 111.154 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.81 -53.67 9.66 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 113.744 1.016 . . . . 74.01 113.744 -173.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.68 -41.55 38.29 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 121.844 1.696 . . . . 71.53 112.4 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -69.52 -32.88 71.98 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.544 0.738 . . . . 75.13 112.197 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.722 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.1 p -78.14 -27.78 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 N-CA-C 112.359 0.503 . . . . 72.33 112.359 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -64.24 -28.31 69.65 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.466 0.543 . . . . 74.31 112.466 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -87.69 17.67 4.55 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.019 0.528 . . . . 73.52 111.409 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.628 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -109.8 158.25 18.34 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.944 0.898 . . . . 72.34 109.85 178.569 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -65.4 128.09 34.45 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.551 -0.537 . . . . 75.42 109.551 169.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -81.0 89.35 5.92 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.69 -0.686 . . . . 71.12 110.292 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -142.07 79.58 16.08 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.598 0.759 . . . . 65.31 109.131 171.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -89.21 178.23 2.64 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 122.553 2.169 . . . . 72.15 112.704 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -109.84 117.46 33.9 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.416 -1.327 . . . . 74.35 107.416 166.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.5 t -80.29 96.45 2.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 107.613 -1.254 . . . . 73.43 107.613 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.42 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 3.1 tppp? -105.66 100.2 9.77 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.284 -1.006 . . . . 75.32 108.284 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.402 HD23 HD22 ' C' ' 128' ' ' LEU . 1.0 OUTLIER -91.36 158.55 16.47 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.107 -0.952 . . . . 72.11 110.069 -177.392 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.452 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 27.7 t70 -152.95 148.27 26.92 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.609 0.764 . . . . 74.31 109.012 -177.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 9.7 tt -128.5 147.19 50.67 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.839 -0.8 . . . . 54.43 108.839 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.473 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 25.6 t0 -146.36 147.11 30.97 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.592 -1.262 . . . . 74.22 107.592 173.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 18.5 p -114.84 112.3 22.54 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.459 0.704 . . . . 74.4 109.931 -173.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.22 151.75 27.89 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.463 1.105 . . . . 72.53 108.87 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 69.9 m -162.13 158.1 24.21 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.763 0.425 . . . . 72.25 111.787 -174.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 88.1 p -157.29 144.43 18.51 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.08 0.952 . . . . 64.44 109.121 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -87.83 126.19 34.88 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.767 -0.457 . . . . 75.54 109.767 176.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.52 HD13 HD13 ' C' ' 83' ' ' ILE . 71.6 mt -96.75 -43.92 7.31 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.548 -0.751 . . . . 75.53 110.109 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . 0.505 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -156.35 -171.51 3.73 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.593 -0.73 . . . . 65.3 110.91 -176.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -66.64 108.22 2.39 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.115 -0.948 . . . . 71.42 110.038 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 70.94 -6.45 1.28 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.92 1.288 . . . . 75.15 112.772 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.505 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 42.2 t -92.2 97.06 6.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 107.011 -1.477 . . . . 71.32 107.011 173.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -120.93 124.92 46.11 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.244 -1.343 . . . . 75.42 107.985 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -83.5 125.42 31.73 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.169 -0.923 . . . . 74.11 109.778 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 6.0 m -112.09 127.09 69.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 108.026 -1.102 . . . . 72.44 108.026 171.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.523 HG11 ' HG2' ' C' ' 79' ' ' GLN . 21.9 t -121.29 134.97 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.799 -1.186 . . . . 72.42 107.799 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 13.1 tp -116.07 108.33 16.06 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.604 -0.517 . . . . 72.4 109.604 -175.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.473 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 7.3 tmm_? -84.39 105.84 15.54 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.882 -0.784 . . . . 74.44 108.882 177.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.474 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.6 t -100.32 136.31 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.585 -0.894 . . . . 74.4 108.585 175.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 51.4 m -122.94 141.67 51.66 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.239 -1.022 . . . . 73.02 108.239 173.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.454 HG22 HG23 ' C' ' 114' ' ' ILE . 75.4 t -132.85 110.05 15.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 107.75 -1.204 . . . . 73.21 107.75 176.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 4.5 m -99.01 144.21 28.42 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.146 -1.057 . . . . 71.53 108.146 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.71 119.41 17.16 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.443 -0.947 . . . . 41.3 108.443 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 51.6 m -136.91 132.8 34.97 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.696 0.622 . . . . 72.24 110.251 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.614 HD11 ' HG2' ' C' ' 34' ' ' LYS . 11.3 mt -85.22 47.96 1.5 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.133 1.373 . . . . 75.44 109.224 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.93 -109.56 3.53 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 110.256 -1.138 . . . . 73.14 110.256 -171.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -89.94 -32.15 16.95 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.988 0.515 . . . . 73.14 109.729 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -66.01 111.75 3.51 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.284 0.634 . . . . 70.03 109.374 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 26.4 m -79.66 125.65 29.91 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.306 -0.628 . . . . 75.42 109.306 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.722 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -81.98 -55.18 4.75 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.408 0.683 . . . . 74.31 109.837 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -157.59 166.81 31.89 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.704 0.764 . . . . 72.03 111.988 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.409 HD23 HG21 ' C' ' 65' ' ' THR . 1.4 tm? -135.47 122.49 21.37 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 105.866 -1.901 . . . . 74.15 105.866 170.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.421 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 46.2 t -127.48 134.58 49.81 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.121 -1.066 . . . . 73.34 108.121 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -148.6 125.17 11.04 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.258 0.348 . . . . 70.35 110.644 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.6 t -131.51 134.4 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 124.107 0.963 . . . . 73.12 108.927 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.523 ' HG2' HG11 ' C' ' 59' ' ' VAL . 5.4 tt0 -112.52 90.82 3.45 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.606 -1.627 . . . . 74.44 106.606 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -83.19 111.86 19.32 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.061 0.544 . . . . 75.42 110.437 -171.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.41 146.57 18.24 Favored Glycine 0 C--N 1.337 0.63 0 O-C-N 123.491 0.494 . . . . 74.2 112.492 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.99 118.07 0.92 Allowed Glycine 0 C--O 1.243 0.697 0 N-CA-C 110.987 -0.845 . . . . 74.45 110.987 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.52 HD13 HD13 ' C' ' 51' ' ' LEU . 12.9 mm -81.98 116.93 27.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 108.556 -0.905 . . . . 74.33 108.556 174.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.673 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 54.8 m-85 -130.92 144.27 51.35 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.955 -0.757 . . . . 73.13 108.955 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 13.1 p -91.16 118.76 30.71 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 108.915 -0.772 . . . . 71.31 108.915 170.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.465 HG22 HD21 ' C' ' 98' ' ' LEU . 4.4 mp -113.68 101.37 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.944 0.898 . . . . 74.23 108.621 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.19 170.45 16.7 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.109 0.963 . . . . 73.04 110.037 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.76 -49.35 2.55 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 116.341 -0.39 . . . . 71.14 112.141 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 33.8 pt -118.67 159.73 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.707 0.803 . . . . 71.11 110.252 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -147.67 -178.15 6.1 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.776 0.83 . . . . 74.1 109.907 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.98 -142.9 45.68 Favored Glycine 0 C--N 1.351 1.373 0 O-C-N 123.222 0.326 . . . . 71.15 112.94 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 1.2 m -68.82 -23.78 64.31 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.983 0.513 . . . . 74.41 110.699 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -57.74 -57.15 14.03 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 124.118 0.967 . . . . 75.33 109.891 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.459 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 22.3 ptt? -69.8 -30.27 67.77 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.146 -0.479 . . . . 73.14 110.766 178.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.04 -30.65 69.33 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.133 0.573 . . . . 72.53 111.181 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . 0.47 ' NE2' ' HB2' ' C' ' 134' ' ' ASP . 32.3 t-80 -62.5 -46.02 90.33 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.263 -0.88 . . . . 74.52 110.862 170.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.551 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 31.4 t -69.21 -64.57 0.85 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.05 0.219 . . . . 74.34 111.072 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.465 HD21 HG22 ' C' ' 86' ' ' ILE . 3.7 pp -67.6 -31.47 71.54 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 113.146 0.795 . . . . 74.24 113.146 -173.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . 0.42 ' N ' HD11 ' C' ' 98' ' ' LEU . . . -102.8 6.99 52.56 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 114.63 0.612 . . . . 52.11 114.63 -171.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.12 -60.83 0.18 Allowed 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.365 0.603 . . . . 75.45 110.824 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.551 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 5.0 t80 -74.81 -34.3 62.34 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 125.011 1.324 . . . . 74.51 112.757 -171.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.491 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 80.1 m -78.39 -43.81 2.07 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 123.356 0.662 . . . . 75.31 111.057 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -60.92 -27.14 84.34 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 121.943 1.762 . . . . 71.14 112.403 166.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -64.92 -34.93 79.58 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 123.313 0.645 . . . . 71.42 110.696 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.464 HG23 ' NH1' ' A' ' 111' ' ' ARG . 45.6 mm -60.46 -38.33 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 121.326 0.584 . . . . 70.12 109.49 172.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 79.5 mt -89.12 -13.71 37.9 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.549 1.14 . . . . 63.32 112.655 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -57.43 -49.83 91.61 Favored Pre-proline 0 N--CA 1.485 1.281 0 CA-C-O 118.126 -0.94 . . . . 73.11 112.87 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.96 -35.18 78.64 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.179 1.919 . . . . 71.24 113.07 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -66.02 -50.75 63.13 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.517 0.727 . . . . 70.43 111.367 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.4 ' O ' HG13 ' C' ' 114' ' ' ILE . . . -62.63 -42.83 99.82 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.747 -0.66 . . . . 71.34 109.901 178.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -54.85 -53.22 58.23 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.124 1.37 . . . . 75.54 111.052 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -69.09 -36.56 77.72 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.945 0.778 . . . . 74.2 110.283 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.0 t -68.78 -34.54 75.73 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.929 0.491 . . . . 71.35 111.049 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.474 HD11 ' HB ' ' C' ' 62' ' ' VAL . 87.5 mt -69.62 -53.61 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.349 0.66 . . . . 73.13 109.611 175.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 16.8 m -64.56 -29.16 70.18 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.269 0.628 . . . . 75.42 111.28 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.402 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 35.3 t -64.29 -49.94 69.83 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.063 -0.717 . . . . 63.23 109.063 174.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.747 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.54 -37.92 82.79 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.325 1.05 . . . . 74.2 112.179 178.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 69.9 t -66.84 -40.41 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 123.274 0.63 . . . . 73.14 110.137 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 20.9 t -74.09 -23.25 59.3 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.714 0.805 . . . . 74.05 111.576 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' C' ' 116' ' ' SER . 86.3 mtt-85 -76.2 -38.88 55.94 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.706 0.803 . . . . 75.15 108.86 174.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.02 -1.18 67.39 Favored Glycine 0 C--N 1.355 1.627 0 O-C-N 123.974 0.797 . . . . 34.2 112.256 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.7 p 64.64 23.41 12.8 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.926 2.09 . . . . 73.1 113.14 171.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -81.75 143.28 50.21 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 108.209 -1.034 . . . . 62.54 108.209 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.598 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 66.6 Cg_exo -45.23 145.21 3.69 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 123.645 2.896 . . . . 72.33 114.826 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -53.96 114.38 1.56 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.592 1.157 . . . . 75.05 112.593 -175.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 36.8 tp -109.52 94.09 4.85 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.139 -0.937 . . . . 74.53 109.224 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -94.45 115.54 27.73 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.213 0.605 . . . . 73.43 109.709 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.442 HD13 ' H ' ' C' ' 129' ' ' ALA . 0.2 OUTLIER -72.13 149.03 45.12 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.644 0.778 . . . . 75.54 109.781 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . 0.442 ' H ' HD13 ' C' ' 128' ' ' LEU . . . -80.54 156.32 73.33 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.471 0.709 . . . . 73.54 111.194 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.498 ' HG3' HD13 ' A' ' 16' ' ' ILE . 28.7 Cg_endo -61.69 137.39 68.34 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 123.117 2.544 . . . . 73.31 112.274 172.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 15.7 t -128.75 110.27 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 108.948 -0.76 . . . . 63.0 108.948 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -100.17 91.43 4.75 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.771 0.828 . . . . 73.13 109.336 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -65.84 -40.56 91.86 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.163 -0.68 . . . . 74.44 109.163 171.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.47 ' HB2' ' NE2' ' C' ' 96' ' ' HIS . 7.0 p-10 . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 125.538 1.535 . . . . 70.4 112.35 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 24.3 m . . . . . 0 C--O 1.24 0.555 0 N-CA-C 109.171 -0.677 . . . . 72.34 109.171 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -158.73 97.88 1.47 Allowed 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.625 -1.25 . . . . 73.43 107.625 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -117.02 120.56 38.74 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.367 0.667 . . . . 75.52 109.263 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.43 HD11 HD12 ' D' ' 105' ' ' ILE . 19.4 mt -78.0 115.16 19.58 Favored 'Isoleucine or valine' 0 C--N 1.345 0.412 0 N-CA-C 108.968 -0.753 . . . . 74.44 108.968 177.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -90.7 -44.61 9.38 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 122.857 0.463 . . . . 73.22 111.721 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . 0.436 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 40.8 ttt180 -173.85 126.11 0.37 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 112.049 0.388 . . . . 75.44 112.049 -171.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.432 HD11 ' CG ' ' B' ' 130' ' ' PRO . 2.2 mp -104.17 141.57 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.421 -0.955 . . . . 74.52 108.421 170.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.436 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 22.4 p90 -162.72 151.4 14.66 Favored 'General case' 0 C--O 1.238 0.487 0 O-C-N 124.221 0.95 . . . . 74.22 110.571 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.7 p -83.88 120.32 25.93 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.281 -0.872 . . . . 73.35 108.856 172.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.41 ' HZ2' ' CD ' ' D' ' 57' ' ' GLU . 45.1 mtpt -91.33 -17.34 26.05 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.7 0.4 . . . . 72.32 110.525 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.716 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 17.5 t70 -162.7 134.98 5.46 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.641 -0.874 . . . . 73.44 108.641 -174.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.747 HG21 ' HE1' ' C' ' 117' ' ' MET . 88.1 mt -139.28 151.77 23.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 C-N-CA 124.337 1.055 . . . . 73.12 108.321 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 26.6 t -152.02 145.44 24.81 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 124.402 1.081 . . . . 73.21 109.628 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.491 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.7 t80 -151.55 122.46 7.58 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 105.703 -1.962 . . . . 75.44 105.703 169.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -136.51 111.43 8.86 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.821 -0.807 . . . . 74.23 108.821 -176.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.85 91.21 4.09 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.249 -1.019 . . . . 74.41 108.249 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.09 -34.5 10.18 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.968 2.445 . . . . 72.54 113.003 -169.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -112.22 10.81 20.16 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 118.556 -0.735 . . . . 73.13 110.711 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.617 ' HB2' ' HE2' ' C' ' 19' ' ' LYS . . . -18.4 -72.77 0.02 OUTLIER Pre-proline 0 CA--C 1.565 1.556 0 N-CA-C 116.455 2.02 . . . . 72.0 116.455 -168.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.447 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 44.1 Cg_endo -80.29 -13.48 12.4 Favored 'Trans proline' 0 C--N 1.377 2.072 0 CA-C-N 123.903 2.43 . . . . 75.12 114.041 -172.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -77.51 -39.79 45.02 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.573 1.149 . . . . 72.04 109.136 172.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.542 HG23 ' HA ' ' D' ' 73' ' ' ALA . 4.8 p -84.12 -20.53 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.461 -0.791 . . . . 73.31 111.647 -175.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.447 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 21.1 m-85 -66.04 -25.16 66.92 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 120.669 0.271 . . . . 74.41 111.455 177.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -60.07 -26.34 66.09 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.25 -0.886 . . . . 73.01 110.183 175.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.462 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 95.5 mttt -90.94 76.54 6.24 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.972 1.309 . . . . 72.34 109.647 174.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -85.35 92.11 8.37 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.947 -0.569 . . . . 75.31 111.132 -176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -155.25 177.84 10.89 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.881 0.873 . . . . 74.2 108.979 166.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -66.43 110.5 4.89 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.8 0.84 . . . . 73.52 109.272 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -59.48 120.51 8.38 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.954 2.436 . . . . 70.54 111.631 -175.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -69.58 115.03 8.36 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.763 0.664 . . . . 71.52 109.489 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -105.91 137.48 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.003 0.921 . . . . 74.21 111.105 -169.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -109.04 142.08 40.24 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.358 -1.349 . . . . 73.13 107.358 166.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -103.28 148.86 25.32 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.283 -0.636 . . . . 75.22 109.283 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -149.56 130.11 13.96 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.111 -1.07 . . . . 75.23 108.111 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.462 HD21 HD13 ' D' ' 60' ' ' LEU . 5.4 mp -119.51 146.85 45.08 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.251 0.548 . . . . 73.1 110.325 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.602 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 16.2 t70 -132.42 144.17 50.31 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.388 1.075 . . . . 75.32 108.236 175.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 57.2 m -104.21 143.15 33.33 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.864 0.866 . . . . 73.15 109.689 -175.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.656 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.51 142.08 17.68 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.98 0.912 . . . . 70.02 108.983 178.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 25.4 p -162.73 158.41 22.93 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 122.911 0.484 . . . . 73.11 110.132 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 81.4 p -151.82 144.28 24.14 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.799 -0.815 . . . . 71.03 108.799 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -87.3 117.8 26.3 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.096 -0.705 . . . . 73.44 109.096 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.535 HD11 ' HB2' ' D' ' 57' ' ' GLU . 26.1 mt -91.09 -24.3 20.05 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.721 -0.672 . . . . 75.1 110.204 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -172.79 178.55 2.59 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.529 1.131 . . . . 73.12 109.284 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -75.3 135.44 40.91 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.484 -0.932 . . . . 74.24 108.484 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 69.05 2.18 3.49 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.65 1.18 . . . . 73.34 113.024 -171.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 68.9 t -124.13 131.24 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.251 0.621 . . . . 73.05 109.817 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -134.66 153.97 51.74 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 123.189 0.595 . . . . 75.52 110.922 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.535 ' HB2' HD11 ' D' ' 51' ' ' LEU . 14.3 tt0 -110.83 120.3 41.95 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.3 -1.318 . . . . 72.54 107.851 165.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.493 HG23 HD13 ' D' ' 106' ' ' LEU . 33.2 m -106.89 132.45 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 108.485 -0.931 . . . . 74.21 108.485 173.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.656 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 38.7 t -125.89 125.49 68.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 N-CA-C 108.934 -0.765 . . . . 60.32 108.934 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.597 HD21 ' HB3' ' D' ' 103' ' ' PRO . 52.0 tp -115.91 117.49 30.33 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.2 -0.667 . . . . 74.13 109.2 177.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.602 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 46.4 ttm-85 -87.34 101.52 13.64 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.948 -0.76 . . . . 74.13 108.948 176.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 99.4 t -91.53 121.31 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.975 -0.75 . . . . 74.24 108.975 174.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.6 m -120.11 142.78 48.59 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.454 0.645 . . . . 74.11 109.789 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 25.4 t -130.59 102.37 6.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 126.134 1.774 . . . . 71.31 107.606 -171.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 21.2 m -95.2 97.61 10.02 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.487 -0.931 . . . . 74.13 108.487 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.4 147.02 27.23 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.114 -0.948 . . . . 71.23 108.994 -172.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.424 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.0 p -149.75 138.06 20.59 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 123.535 0.522 . . . . 75.33 111.6 -177.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 26.1 mt -115.8 111.66 20.83 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.444 -1.253 . . . . 74.12 107.619 171.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.3 -134.72 21.56 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 116.477 -0.328 . . . . 71.44 113.084 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -86.15 2.89 45.09 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.344 0.658 . . . . 75.0 112.571 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.462 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 10.8 pt-20 -131.57 160.55 34.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.875 0.47 . . . . 72.41 110.064 -171.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 62.5 m -69.39 136.07 51.16 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.265 -0.879 . . . . 74.1 110.492 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.542 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -84.08 -65.8 0.97 Allowed 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.664 -1.235 . . . . 71.5 107.664 174.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -152.43 158.96 43.37 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.154 -0.93 . . . . 75.25 110.458 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 69.5 mt -122.82 108.26 12.81 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.621 -1.622 . . . . 72.13 106.621 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.554 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 52.8 t -117.48 138.16 52.05 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.924 -0.769 . . . . 61.14 108.924 -175.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -152.98 133.73 13.88 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.785 -0.45 . . . . 74.13 109.785 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 54.0 t -139.96 119.3 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.395 0.678 . . . . 75.34 109.678 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.716 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 14.5 mt-30 -86.58 89.94 8.08 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 108.366 -0.975 . . . . 73.13 108.366 165.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . 0.431 ' O ' HD11 ' D' ' 106' ' ' LEU . 7.7 tp-100 -83.01 104.91 13.57 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.937 -1.134 . . . . 75.42 107.937 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -103.92 162.09 15.55 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 111.934 -0.466 . . . . 75.23 111.934 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.0 133.75 3.51 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 112.117 -0.393 . . . . 74.12 112.117 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.406 HG23 HD13 ' D' ' 51' ' ' LEU . 39.0 mt -88.79 128.12 41.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 108.558 -0.905 . . . . 62.23 108.558 174.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . 0.434 ' HB2' HD13 ' D' ' 86' ' ' ILE . 79.8 m-85 -133.97 157.07 46.98 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.888 1.275 . . . . 73.54 108.624 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.8 m -114.63 99.15 7.31 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.802 0.841 . . . . 71.13 108.913 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.434 HD13 ' HB2' ' D' ' 84' ' ' PHE . 2.8 mp -109.66 126.73 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.463 0.705 . . . . 74.44 109.637 -173.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.24 165.04 33.1 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.932 0.893 . . . . 72.13 109.702 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.93 20.97 79.2 Favored Glycine 0 C--N 1.346 1.115 0 N-CA-C 114.413 0.525 . . . . 71.15 114.413 173.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.438 HG23 ' N ' ' D' ' 90' ' ' GLU . 7.3 mt -129.21 157.26 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.32 0.648 . . . . 74.41 109.443 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.438 ' N ' HG23 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -150.81 -174.5 4.8 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.481 0.712 . . . . 70.31 111.01 175.13 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.98 -141.45 39.8 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.26 -0.882 . . . . 60.1 114.274 173.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 15.6 m -90.22 -13.56 35.22 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.234 0.613 . . . . 73.32 110.095 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.413 HE21 HG22 ' D' ' 89' ' ' ILE . 29.7 tt0 -63.0 -37.69 88.21 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.953 0.901 . . . . 73.43 110.806 177.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -73.04 -33.13 65.51 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.879 0.472 . . . . 73.22 111.614 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.97 -33.67 74.08 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.778 0.431 . . . . 74.42 110.364 174.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -74.18 -32.45 63.08 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.557 0.743 . . . . 72.33 110.612 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.1 t -63.18 -50.66 69.47 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.395 0.617 . . . . 75.11 110.242 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.409 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 47.5 mt -83.04 -21.08 33.91 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.893 -1.048 . . . . 74.32 111.26 -176.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.32 -16.95 59.72 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.612 0.57 . . . . 61.52 114.289 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.2 -64.09 0.7 Allowed 'General case' 0 C--O 1.239 0.515 0 C-N-CA 122.685 0.394 . . . . 74.11 111.799 -172.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -63.53 -44.58 93.81 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 112.485 0.55 . . . . 75.55 112.485 -172.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.485 ' HB3' HG22 ' D' ' 58' ' ' VAL . 56.7 m -66.91 -47.3 53.98 Favored Pre-proline 0 CA--C 1.57 1.723 0 CA-C-O 118.943 -0.551 . . . . 70.24 112.105 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.597 ' HB3' HD21 ' D' ' 60' ' ' LEU . 72.2 Cg_exo -56.8 -29.66 81.89 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 122.427 2.084 . . . . 71.32 113.932 168.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -68.59 -26.0 65.16 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.109 0.564 . . . . 75.55 111.81 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.43 HD12 HD11 ' D' ' 13' ' ' ILE . 30.3 mm -71.91 -39.22 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 121.243 0.544 . . . . 73.03 109.648 171.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.493 HD13 HG23 ' D' ' 58' ' ' VAL . 79.1 mt -80.08 -25.57 40.0 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.216 -0.902 . . . . 64.45 111.938 -175.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -59.5 -48.33 95.91 Favored Pre-proline 0 CA--C 1.562 1.409 0 N-CA-C 113.517 0.932 . . . . 75.32 113.517 -174.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.57 -40.05 83.5 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.079 1.853 . . . . 73.14 112.956 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -71.56 -38.63 70.94 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.837 0.855 . . . . 75.25 111.803 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.15 -47.27 74.6 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.281 0.632 . . . . 73.44 109.953 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -58.07 -46.93 84.62 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.154 0.909 . . . . 72.44 110.409 176.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -59.84 -49.67 76.81 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 123.923 0.764 . . . . 71.15 110.364 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.4 t -57.55 -45.33 85.26 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.74 0.65 . . . . 72.55 111.097 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.478 ' O ' HG23 ' D' ' 118' ' ' VAL . 94.4 mt -59.59 -58.09 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.688 0.795 . . . . 65.12 110.17 175.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 90.0 m -55.59 -39.59 70.93 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.254 1.022 . . . . 74.21 111.88 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 37.8 t -66.32 -41.7 89.27 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.321 -0.854 . . . . 64.44 109.754 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.554 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 75.0 mtm -71.45 -28.37 63.92 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.937 0.495 . . . . 75.34 111.65 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' D' ' 114' ' ' ILE . 97.3 t -63.45 -48.69 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.277 -0.638 . . . . 74.43 109.277 173.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 83.1 p -71.91 -28.62 63.61 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.791 -0.641 . . . . 65.31 110.985 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' D' ' 116' ' ' SER . 91.3 mtt-85 -69.97 -36.47 75.23 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.798 0.839 . . . . 73.41 109.948 173.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.9 2.15 87.88 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.923 0.764 . . . . 52.22 112.138 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.1 p 61.17 29.0 18.56 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.836 2.054 . . . . 65.13 114.0 173.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -86.36 154.62 57.04 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.776 -0.824 . . . . 73.21 108.776 168.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -53.0 136.84 61.68 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.838 2.358 . . . . 72.41 112.693 175.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -52.85 128.98 28.71 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 124.289 0.993 . . . . 73.41 112.249 -174.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 56.9 tp -109.51 99.64 8.82 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.363 -0.835 . . . . 75.33 109.142 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -99.96 97.34 8.23 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.596 -0.89 . . . . 75.43 108.596 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.6 tt -67.97 116.43 8.6 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.199 -1.038 . . . . 75.41 108.199 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -57.14 133.51 80.68 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 123.372 0.669 . . . . 52.22 110.025 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 23.7 Cg_exo -62.4 115.38 2.84 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.623 2.216 . . . . 74.52 111.97 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 108.715 -0.846 . . . . 73.05 108.715 -179.174 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.694 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 9.4 t80 . . . . . 0 C--O 1.235 0.294 0 N-CA-C 109.668 -0.493 . . . . 75.2 109.668 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -139.27 111.01 7.17 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.36 -0.978 . . . . 75.42 108.36 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.638 HG12 ' HD2' ' A' ' 84' ' ' PHE . 57.2 mt -82.74 120.44 34.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.421 -0.955 . . . . 71.34 108.421 173.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.43 -41.25 20.1 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 124.146 0.904 . . . . 75.42 109.011 -177.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -173.83 124.09 0.35 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 121.938 0.095 . . . . 75.42 111.061 -169.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.502 HD13 ' HB3' ' C' ' 130' ' ' PRO . 92.2 mt -116.87 138.54 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 C-N-CA 123.924 0.89 . . . . 71.41 109.571 175.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.462 ' HB3' HG21 ' B' ' 122' ' ' THR . 35.3 p90 -169.61 176.26 5.03 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.227 0.955 . . . . 74.32 111.217 -170.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -102.26 119.43 38.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.94 -1.027 . . . . 72.53 108.533 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -83.04 -42.65 17.23 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.957 -0.757 . . . . 72.4 108.957 176.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.624 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 16.2 t70 -134.4 136.62 43.45 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.485 -1.234 . . . . 61.2 109.602 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.8 mt -136.13 143.16 36.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 C-N-CA 125.345 1.458 . . . . 72.42 107.118 174.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.0 t -155.09 119.37 4.68 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-O 121.166 0.507 . . . . 73.44 110.476 171.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.498 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 87.8 t80 -111.34 136.53 50.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.797 -1.557 . . . . 72.44 106.797 169.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -133.53 138.23 45.97 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.638 -0.504 . . . . 74.11 109.638 175.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.85 70.83 16.97 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 106.516 -1.661 . . . . 73.4 106.516 170.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.75 -28.14 30.86 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.539 2.159 . . . . 75.31 111.448 -175.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -101.62 20.42 16.2 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 114.896 -1.047 . . . . 73.4 109.541 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.523 ' HB2' ' HE3' ' B' ' 19' ' ' LYS . . . -48.32 -52.54 41.78 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 114.006 1.113 . . . . 75.1 114.006 -171.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 15.9 Cg_exo -67.16 -18.54 51.04 Favored 'Trans proline' 0 C--N 1.385 2.481 0 CA-C-N 121.748 1.66 . . . . 75.55 113.02 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -90.18 -28.19 19.06 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.407 1.083 . . . . 75.3 110.599 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.494 HG22 ' HA ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -80.55 -21.14 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 115.672 -0.694 . . . . 65.14 111.722 -166.352 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -86.05 -23.99 26.53 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.373 0.669 . . . . 71.44 111.653 -176.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -78.83 -24.26 44.53 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 110.027 -0.36 . . . . 63.12 110.027 174.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -72.48 146.87 46.56 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.794 0.837 . . . . 73.14 110.719 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -67.34 128.91 38.18 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.606 -0.724 . . . . 71.1 109.455 174.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 59.5 t-105 -79.12 89.5 4.83 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.469 0.707 . . . . 74.21 110.426 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -125.11 82.8 61.36 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 108.007 -1.109 . . . . 74.34 108.007 169.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.0 127.93 11.86 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.336 2.024 . . . . 64.54 112.395 -172.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -96.9 93.12 6.46 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 106.354 -1.721 . . . . 70.12 106.354 170.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.8 t -72.67 91.46 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.88 -0.785 . . . . 72.44 108.88 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -98.32 112.46 24.45 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.342 -1.355 . . . . 73.21 107.342 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 pp -123.2 135.02 54.11 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.229 0.538 . . . . 75.22 110.885 -171.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -115.94 145.38 42.97 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.698 -1.223 . . . . 71.32 107.698 172.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.12 123.52 23.28 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.95 -0.759 . . . . 74.33 108.95 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.602 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 24.5 t70 -118.7 139.41 51.59 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.178 0.991 . . . . 75.42 109.246 -174.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.8 p -116.59 121.65 42.35 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.946 0.898 . . . . 71.0 110.476 -170.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.77 131.85 17.29 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.774 0.829 . . . . 72.44 110.636 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.9 m -131.58 157.68 43.0 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.172 0.589 . . . . 73.24 110.482 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.3 t -148.74 123.51 9.9 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.54 0.736 . . . . 65.24 109.359 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -75.41 121.29 22.06 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.284 0.633 . . . . 75.22 110.693 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.581 HD12 HG22 ' A' ' 83' ' ' ILE . 52.9 mt -94.16 -39.37 10.6 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.775 0.83 . . . . 75.1 110.724 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.01 -177.56 5.8 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.878 0.871 . . . . 64.22 109.839 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -63.67 115.36 4.67 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.398 -0.593 . . . . 74.51 109.398 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 70.35 4.07 4.74 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 125.137 1.375 . . . . 73.3 112.929 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.8 t -109.77 114.84 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.115 -1.068 . . . . 72.24 108.115 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -138.63 140.9 39.08 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.568 -0.901 . . . . 72.11 108.568 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -89.79 129.92 36.12 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.753 -0.658 . . . . 72.52 109.435 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.416 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 72.8 t -100.48 126.1 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 107.663 -1.236 . . . . 74.14 107.663 172.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.6 t -120.7 125.56 74.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.662 -0.866 . . . . 73.53 108.662 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -115.25 108.01 16.02 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.153 -1.425 . . . . 61.24 107.153 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.602 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 48.3 ttt180 -83.61 99.94 10.51 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.886 -0.783 . . . . 64.15 108.886 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.9 101.77 12.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.615 -0.721 . . . . 63.24 109.199 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.0 m -97.54 113.46 25.17 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.503 0.721 . . . . 72.13 109.252 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.2 t -116.86 107.64 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.005 0.922 . . . . 72.23 109.097 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.9 m -109.49 129.2 55.57 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.315 -0.994 . . . . 70.4 108.315 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.81 132.71 49.81 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.115 -1.439 . . . . 72.0 107.115 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.0 m -121.32 165.76 15.03 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.199 0.6 . . . . 63.54 110.362 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.9 mt -131.1 43.26 3.12 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.94 -1.133 . . . . 73.24 107.94 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.68 -93.07 1.84 Allowed Glycine 0 C--N 1.339 0.709 0 CA-C-N 114.84 -1.073 . . . . 75.43 111.481 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -95.09 -26.88 15.85 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.194 0.598 . . . . 75.31 111.919 -174.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -105.75 132.63 51.64 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.196 -0.668 . . . . 62.31 109.196 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.4 m -73.44 134.99 44.1 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.732 -0.47 . . . . 71.21 109.732 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.494 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -75.86 -60.91 2.11 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.455 -0.793 . . . . 72.21 109.926 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.422 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 33.4 p90 -160.17 174.29 14.48 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.349 -0.841 . . . . 73.13 111.696 176.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.5 tp -127.79 142.99 51.15 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.445 -1.252 . . . . 74.33 108.482 170.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 80.5 m -143.0 97.39 3.09 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.819 1.248 . . . . 73.25 108.235 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -121.51 115.71 23.35 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.922 -0.77 . . . . 75.23 108.922 -173.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.5 t -129.51 110.63 20.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 123.805 0.842 . . . . 63.31 109.592 -173.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.624 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 28.6 mt-30 -83.69 88.17 7.06 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.14 -1.059 . . . . 73.11 108.14 169.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.485 ' HG3' HD21 ' A' ' 106' ' ' LEU . 9.4 tp-100 -78.48 102.48 7.86 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.692 -1.14 . . . . 74.22 108.691 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.7 145.01 17.43 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.443 -0.663 . . . . 65.4 111.443 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.402 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -151.0 124.5 1.71 Allowed Glycine 0 CA--C 1.508 -0.405 0 N-CA-C 110.78 -0.928 . . . . 50.21 110.78 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.581 HG22 HD12 ' A' ' 51' ' ' LEU . 46.9 mt -81.69 115.68 24.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.864 -0.791 . . . . 73.55 108.864 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.694 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 38.7 m-85 -124.06 120.27 31.91 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.927 -0.768 . . . . 74.12 108.927 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.1 t -95.43 101.84 13.6 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.225 -1.028 . . . . 72.42 108.225 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.4 pt . . . . . 0 N--CA 1.478 0.966 0 C-N-CA 122.594 0.357 . . . . 73.3 110.312 178.907 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.483 0.183 . . . . 74.33 111.208 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -70.63 -47.4 60.26 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.251 0.62 . . . . 72.31 110.818 172.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.599 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 27.4 p -71.67 -43.95 65.13 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.138 0.494 . . . . 74.03 110.949 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.59 -45.35 83.57 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.545 1.138 . . . . 75.11 110.765 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.55 -16.19 47.03 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 114.745 0.658 . . . . 60.21 114.745 -170.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.93 -61.94 0.87 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 117.922 0.861 . . . . 74.52 112.18 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.599 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 88.8 t80 -69.23 -62.28 1.44 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.371 0.878 . . . . 75.22 113.371 -164.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 73.7 m -63.29 -39.3 48.9 Favored Pre-proline 0 CA--C 1.563 1.472 0 N-CA-C 113.697 0.999 . . . . 74.45 113.697 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.21 -32.8 82.55 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 121.854 1.703 . . . . 74.54 113.115 166.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -74.99 -17.98 60.44 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.028 0.531 . . . . 64.15 110.849 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -67.41 -37.46 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 109.186 -0.672 . . . . 71.13 109.186 170.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.485 HD21 ' HG3' ' A' ' 80' ' ' GLN . 77.4 mt -81.23 -17.93 47.8 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.034 0.934 . . . . 73.13 112.191 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -62.81 -47.01 88.16 Favored Pre-proline 0 CA--C 1.572 1.809 0 CA-C-O 118.158 -0.925 . . . . 73.23 113.279 -174.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.61 -37.57 46.36 Favored 'Trans proline' 0 C--N 1.393 2.883 0 C-N-CA 122.35 2.033 . . . . 75.05 112.781 176.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.453 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 95.8 m-85 -66.34 -44.75 82.41 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.466 0.706 . . . . 73.0 111.559 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.22 -41.74 76.65 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.992 -0.549 . . . . 75.35 110.48 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.504 ' NH1' HD13 ' C' ' 105' ' ' ILE . 27.6 ttm180 -52.0 -47.64 64.82 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.969 0.908 . . . . 75.24 110.765 171.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -68.05 -43.96 77.5 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.044 -0.98 . . . . 75.05 111.337 -175.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 39.1 t -65.6 -30.3 71.0 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.189 0.596 . . . . 72.24 111.056 -178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.8 mt -68.69 -58.83 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.888 0.875 . . . . 73.34 109.654 172.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 50.6 m -53.15 -36.51 60.93 Favored 'General case' 0 C--N 1.361 1.094 0 C-N-CA 124.246 1.018 . . . . 65.1 112.097 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -65.24 -51.22 62.27 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.56 -0.745 . . . . 73.41 110.687 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.498 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 61.0 mtm -64.28 -37.87 89.03 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.903 0.481 . . . . 55.31 111.483 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.12 -45.05 99.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.197 0.999 . . . . 73.5 110.335 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.6 t -70.2 -35.5 73.95 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.563 -0.744 . . . . 74.12 110.76 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -69.35 -33.51 73.2 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.543 0.737 . . . . 75.25 109.739 175.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.38 14.34 51.08 Favored Glycine 0 C--N 1.351 1.371 0 CA-C-N 115.344 -0.844 . . . . 63.52 112.879 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.437 HG23 ' HE ' ' B' ' 15' ' ' ARG . 2.5 t 61.4 18.58 9.45 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 126.541 1.936 . . . . 73.22 114.078 170.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -87.46 153.01 53.04 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 123.033 0.533 . . . . 72.54 109.595 176.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -55.16 165.54 2.86 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.521 2.814 . . . . 62.33 114.301 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -59.54 121.95 12.82 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.366 -0.834 . . . . 73.52 111.512 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.422 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 60.4 tp -123.67 94.5 4.26 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.223 1.009 . . . . 74.24 109.362 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -107.79 125.84 51.91 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 107.999 -1.111 . . . . 74.54 107.999 171.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mp -72.8 139.52 47.09 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.708 -0.849 . . . . 75.22 108.708 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.5 146.21 98.19 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.213 0.605 . . . . 74.25 111.242 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.09 116.21 3.58 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.717 2.278 . . . . 73.41 111.751 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.3 t -101.22 113.21 36.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.782 -1.192 . . . . 71.25 107.782 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -86.26 72.32 10.37 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.515 -0.92 . . . . 63.42 108.515 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 N--CA 1.482 1.157 0 C-N-CA 123.491 0.716 . . . . 72.44 110.943 -178.479 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.56 ' HE3' ' SG ' ' B' ' 97' ' ' CYS . 9.6 tpt . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 121.851 0.834 . . . . 74.3 112.889 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 22.7 m -136.73 123.57 21.29 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 106.37 -1.715 . . . . 73.42 106.37 165.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -151.74 129.16 11.34 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.793 -0.817 . . . . 74.23 108.793 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.464 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -155.07 131.14 10.19 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.419 -0.586 . . . . 74.02 109.419 175.273 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.459 HG13 ' HD3' ' D' ' 130' ' ' PRO . 25.2 mt -75.59 121.54 27.57 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 108.746 -0.835 . . . . 73.1 108.746 173.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -93.05 -37.92 11.91 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.53 -0.759 . . . . 72.54 109.234 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.437 ' HE ' HG23 ' A' ' 122' ' ' THR . 46.5 ttt180 -177.39 132.42 0.17 Allowed 'General case' 0 C--N 1.356 0.856 0 CA-C-N 115.608 -0.723 . . . . 74.21 109.64 -174.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.431 HD11 HD11 ' B' ' 13' ' ' ILE . 94.6 mt -115.21 140.05 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 108.008 -1.108 . . . . 74.32 108.008 176.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -171.17 155.78 4.49 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.805 0.812 . . . . 74.11 112.483 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.9 m -75.69 125.03 28.25 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.546 -1.206 . . . . 74.12 109.191 168.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.523 ' HE3' ' HB2' ' A' ' 28' ' ' ALA . 43.9 mtpt -96.79 -31.86 12.41 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.535 0.734 . . . . 74.44 111.065 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -153.54 140.1 18.82 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.47 -0.332 . . . . 74.15 110.557 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.463 HD12 ' SG ' ' B' ' 113' ' ' CYS . 35.4 mm -135.59 143.61 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.972 1.309 . . . . 75.13 108.577 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -150.28 109.52 3.95 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.07 -1.085 . . . . 64.22 108.07 174.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 89.4 t80 -124.48 108.81 12.52 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 108.002 -1.111 . . . . 75.22 108.002 173.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -124.16 123.56 40.56 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.458 0.703 . . . . 74.34 110.29 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.41 87.1 13.22 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.776 1.23 . . . . 62.45 107.932 178.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.21 -29.98 25.61 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.691 2.261 . . . . 70.4 113.224 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -108.56 18.53 20.8 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.57 0.748 . . . . 75.1 110.821 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.09 -59.26 3.26 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 114.938 1.458 . . . . 73.04 114.938 -164.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -62.25 -28.73 79.42 Favored 'Trans proline' 0 C--N 1.395 3.006 0 C-N-CA 122.388 2.059 . . . . 74.2 112.464 -172.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -96.23 -32.76 12.29 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.167 -0.924 . . . . 74.14 112.22 -172.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.44 HG21 HD11 ' B' ' 68' ' ' LEU . 6.0 p -74.17 -6.29 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 122.998 0.519 . . . . 64.3 111.675 -171.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -72.83 -14.05 61.42 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.218 0.607 . . . . 74.42 112.437 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -61.49 -18.17 57.88 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.31 0.644 . . . . 73.22 111.076 172.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -95.54 88.84 5.18 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.296 1.439 . . . . 75.45 109.112 -178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -98.29 78.38 2.45 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.604 0.716 . . . . 71.4 111.19 -176.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -159.31 172.33 18.18 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.327 -1.306 . . . . 74.42 108.582 170.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -68.58 112.73 12.09 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 109.14 -0.689 . . . . 72.45 109.14 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.491 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 20.8 Cg_endo -61.53 163.82 17.11 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.06 2.506 . . . . 71.4 114.41 -173.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -72.73 102.34 3.32 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 107.519 -1.289 . . . . 75.45 107.519 171.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -93.86 146.2 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 114.545 -1.207 . . . . 72.5 110.179 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.782 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 56.1 mtpt -121.82 142.74 49.92 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.771 0.828 . . . . 74.03 109.49 172.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 pp -92.74 134.61 34.88 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 114.33 -1.304 . . . . 74.43 107.781 168.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.671 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 18.5 m-20 -143.74 132.78 22.88 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.143 -1.058 . . . . 61.41 108.143 177.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 86.7 mt -127.92 132.38 49.29 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.485 0.714 . . . . 55.3 109.706 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 7.5 t70 -123.16 138.59 54.62 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.891 1.277 . . . . 74.03 107.587 172.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 43.6 m -108.88 116.19 31.51 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 122.979 0.511 . . . . 72.14 110.083 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.29 135.84 53.54 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.218 1.007 . . . . 64.12 108.42 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.9 m -142.5 161.39 38.19 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 109.527 -0.546 . . . . 72.01 109.527 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 88.6 p -160.63 136.31 8.17 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 123.627 0.579 . . . . 75.51 109.518 174.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -95.08 102.12 13.91 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.119 -1.067 . . . . 74.41 108.119 167.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.468 HD12 HG22 ' B' ' 83' ' ' ILE . 54.3 mt -65.83 -35.95 82.1 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.103 -0.953 . . . . 73.32 111.041 -175.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.49 -179.49 6.02 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.291 1.036 . . . . 70.13 109.443 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.86 122.7 16.06 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.034 -0.984 . . . . 70.42 108.726 173.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 73.95 -4.77 2.19 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 125.371 1.468 . . . . 74.11 113.155 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 56.3 t -113.6 120.7 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 108.978 -0.749 . . . . 70.44 108.978 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -129.19 169.64 14.55 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.214 -0.661 . . . . 72.53 109.214 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -140.87 125.55 17.95 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.475 0.71 . . . . 64.0 109.131 174.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 87.0 t -102.39 119.48 50.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.478 1.111 . . . . 75.02 109.073 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 34.0 t -123.83 111.49 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.732 -0.84 . . . . 75.32 108.732 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 32.3 tp -106.39 119.32 38.96 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 109.059 -0.719 . . . . 72.54 109.059 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 57.7 ttm-85 -86.3 111.76 20.76 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.688 -0.856 . . . . 75.04 108.688 174.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 46.4 t -103.26 102.39 13.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 107.353 -1.351 . . . . 73.32 107.353 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.671 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 17.6 m -101.48 132.15 47.25 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.874 -1.057 . . . . 74.52 109.024 177.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 78.1 t -125.4 112.62 31.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 124.121 0.968 . . . . 75.32 109.153 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.782 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 98.4 m -87.95 149.46 24.03 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.206 -0.906 . . . . 74.43 109.14 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.68 138.4 30.59 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.137 0.575 . . . . 73.04 109.556 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.452 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 45.0 p -146.55 131.29 17.96 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.494 -0.558 . . . . 75.05 109.494 -178.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.491 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 26.0 mt -113.34 113.13 24.82 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.287 1.035 . . . . 74.32 108.962 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.79 -111.32 3.41 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.05 -0.523 . . . . 71.44 112.203 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -113.59 4.87 16.32 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.558 0.743 . . . . 74.43 111.598 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -130.48 151.79 50.58 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.165 0.586 . . . . 74.15 110.699 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 73.9 m -74.24 123.39 24.44 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 122.698 0.399 . . . . 73.15 110.174 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.452 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -76.16 -59.9 2.56 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.14 -0.936 . . . . 74.31 109.085 177.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -149.62 161.75 41.56 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 121.933 0.873 . . . . 75.11 111.468 174.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 78.0 mt -125.49 114.23 18.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 105.127 -2.175 . . . . 73.12 105.127 168.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.4 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 36.3 t -115.72 142.77 46.3 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.343 -1.354 . . . . 74.45 107.343 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -160.9 125.51 3.6 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.937 -0.394 . . . . 71.22 109.937 -169.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 62.0 t -128.67 148.94 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.911 0.884 . . . . 73.14 109.805 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -117.63 111.5 19.26 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.724 -1.213 . . . . 74.42 107.724 163.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -96.95 100.78 12.28 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.797 -1.186 . . . . 71.43 107.797 171.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.02 142.12 15.9 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-N 115.232 -0.894 . . . . 74.44 110.87 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.62 125.99 3.02 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 109.786 -1.326 . . . . 61.41 109.786 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.468 HG22 HD12 ' B' ' 51' ' ' LEU . 57.9 mt -84.69 126.03 40.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 107.788 -1.19 . . . . 74.34 107.788 175.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -131.88 133.37 44.53 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.03 -0.73 . . . . 74.34 109.03 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 67.2 m -89.07 110.69 21.38 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.276 -1.009 . . . . 72.2 108.276 172.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' B' ' 10' ' ' THR . 2.5 pp -124.33 140.76 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.176 0.99 . . . . 72.53 110.213 -172.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.75 171.17 19.31 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.318 0.488 . . . . 72.34 112.318 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.5 -65.7 4.07 Favored Glycine 0 C--N 1.354 1.549 0 CA-C-N 115.148 -0.933 . . . . 73.51 112.946 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.56 ' HB ' ' SD ' ' B' ' 9' ' ' MET . 9.7 mm -68.55 148.86 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.94 1.296 . . . . 75.32 111.026 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -152.38 179.37 8.61 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.641 0.776 . . . . 71.55 111.257 -170.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.02 -127.81 36.18 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 115.968 -0.56 . . . . 63.53 113.374 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 16.3 m -89.28 -18.55 26.77 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.266 0.627 . . . . 64.23 110.787 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -56.34 -41.7 76.53 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 109.338 -0.615 . . . . 74.3 109.338 171.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 17.4 ptt? -81.37 -33.53 32.3 Favored 'General case' 0 C--N 1.358 0.97 0 CA-C-N 115.669 -0.696 . . . . 64.22 111.194 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.4 -36.16 66.12 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.618 0.723 . . . . 71.45 110.894 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . 0.406 ' O ' ' HB2' ' B' ' 100' ' ' ALA . 43.5 t-80 -69.45 -46.14 67.4 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.295 -1.32 . . . . 73.23 111.137 175.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.56 ' SG ' ' HE3' ' B' ' 9' ' ' MET . 51.6 t -73.14 -31.67 64.43 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.202 0.445 . . . . 74.43 112.202 -173.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.492 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 15.5 mt -95.3 -42.8 8.34 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.859 0.864 . . . . 74.32 111.242 -172.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.61 -24.61 45.66 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.832 -0.622 . . . . 63.54 113.576 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.431 ' HB1' ' N ' ' B' ' 134' ' ' ASP . . . -117.09 -49.69 2.6 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.855 0.462 . . . . 60.15 111.741 -171.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -81.97 -41.86 20.19 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.022 0.379 . . . . 74.14 112.022 -174.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.492 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 85.1 m -61.6 -48.67 89.56 Favored Pre-proline 0 CA--C 1.559 1.292 0 CA-C-O 118.425 -0.798 . . . . 72.51 111.916 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 38.0 Cg_exo -64.5 -22.93 64.97 Favored 'Trans proline' 0 C--N 1.396 3.072 0 C-N-CA 122.167 1.912 . . . . 75.35 112.887 173.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -65.46 -35.97 82.5 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.168 0.587 . . . . 74.53 110.45 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 93.3 mt -63.51 -40.77 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.437 1.095 . . . . 75.41 110.017 171.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 59.8 mt -90.26 -13.01 36.24 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 114.677 -1.147 . . . . 74.2 112.337 -170.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -60.36 -48.28 94.29 Favored Pre-proline 0 N--CA 1.488 1.437 0 CA-C-O 117.911 -1.042 . . . . 75.51 113.473 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.78 -37.99 94.51 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 121.881 1.721 . . . . 74.12 113.173 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -67.64 -47.92 68.19 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.443 0.697 . . . . 73.42 110.508 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.68 -42.35 99.58 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.472 0.709 . . . . 75.2 111.123 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -59.92 -51.44 69.69 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.192 0.997 . . . . 74.14 110.777 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -65.21 -31.32 72.43 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.821 0.701 . . . . 73.11 110.03 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.48 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.0 t -74.04 -34.58 64.14 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.016 0.526 . . . . 63.1 111.204 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.426 ' O ' HG23 ' B' ' 118' ' ' VAL . 57.0 mt -66.66 -57.33 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 109.114 -0.698 . . . . 74.24 109.114 173.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.3 m -62.1 -24.61 67.23 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.637 0.775 . . . . 74.34 111.788 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.1 t -64.32 -52.23 59.51 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 109.379 -0.601 . . . . 73.21 109.379 173.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.5 mmt -69.94 -32.2 70.33 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.11 0.564 . . . . 75.31 111.369 -175.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.426 HG23 ' O ' ' B' ' 114' ' ' ILE . 79.3 t -62.72 -46.19 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.858 0.863 . . . . 73.31 110.184 174.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.0 t -65.72 -35.87 81.97 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.994 -1.003 . . . . 72.04 110.829 177.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.477 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 92.5 mtt-85 -67.12 -33.02 74.56 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.687 -0.688 . . . . 74.54 110.322 178.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.98 7.37 75.18 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 123.837 0.711 . . . . 70.23 112.962 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 17' ' ' TYR . 81.5 p 59.68 23.89 12.73 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 126.291 1.837 . . . . 64.54 113.596 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -86.65 159.22 52.88 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 123.739 0.816 . . . . 75.41 111.409 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -54.69 158.78 9.96 Favored 'Trans proline' 0 C--N 1.393 2.882 0 C-N-CA 123.837 3.025 . . . . 75.31 115.39 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -65.01 133.84 52.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.358 1.063 . . . . 74.44 111.703 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 58.0 tp -140.21 120.66 14.09 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.451 0.7 . . . . 75.02 109.615 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -132.13 117.44 18.31 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.341 1.056 . . . . 75.14 108.917 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 7.1 mp -83.53 150.37 26.01 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.259 0.624 . . . . 74.35 110.653 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.5 156.42 90.27 Favored Pre-proline 0 CA--C 1.557 1.246 0 CA-C-N 115.063 -0.971 . . . . 74.24 110.463 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -66.34 111.24 2.0 Allowed 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 122.679 2.253 . . . . 64.43 110.667 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 36.9 t -89.75 107.24 17.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.003 -1.11 . . . . 74.43 108.003 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -104.13 88.67 3.06 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.869 -1.06 . . . . 73.11 109.155 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -63.91 -37.61 88.02 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.982 -0.748 . . . . 75.11 108.982 170.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . 0.431 ' N ' ' HB1' ' B' ' 100' ' ' ALA . 6.9 p-10 . . . . . 0 C--O 1.24 0.59 0 C-N-CA 124.745 1.218 . . . . 74.11 111.632 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.656 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.6 t80 . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 109.672 -0.492 . . . . 71.12 109.672 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -152.41 129.58 11.18 Favored 'General case' 0 C--O 1.242 0.667 0 O-C-N 124.072 0.857 . . . . 74.34 109.219 173.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 86.9 mt -73.36 130.51 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 108.43 -0.952 . . . . 74.52 108.43 172.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -97.05 -42.13 8.03 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.401 0.68 . . . . 73.14 110.283 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -176.19 124.97 0.19 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.701 0.4 . . . . 73.32 110.219 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.9 mt -111.26 146.39 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 109.058 -0.719 . . . . 63.43 109.058 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -172.6 166.5 5.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.12 0.968 . . . . 73.34 109.394 -175.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 63.1 p -85.06 115.43 22.87 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.267 -0.642 . . . . 74.45 109.267 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.638 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 16.3 mmtp -64.67 -44.58 89.91 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.998 -0.741 . . . . 71.03 108.998 171.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 22.6 t70 -147.25 145.55 29.47 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 114.407 -1.27 . . . . 74.11 110.609 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.424 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.8 mt -133.55 145.13 34.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 125.891 1.676 . . . . 71.05 106.712 171.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.1 t -158.37 150.53 21.76 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.414 0.626 . . . . 72.21 109.707 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 72.1 t80 -147.07 137.6 23.58 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.307 -1.368 . . . . 71.01 107.307 173.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -141.11 135.38 30.88 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.632 -0.877 . . . . 73.41 108.632 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.03 83.42 4.68 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 107.701 -1.222 . . . . 73.35 107.701 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.52 -37.39 59.15 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.816 2.344 . . . . 75.43 112.581 -173.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -101.22 21.1 14.53 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.913 -1.04 . . . . 73.03 110.806 -173.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.46 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -48.58 -57.26 11.39 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 114.661 1.356 . . . . 73.51 114.661 -167.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.43 -42.5 54.72 Favored 'Trans proline' 0 C--N 1.386 2.516 0 CA-C-N 122.141 1.801 . . . . 55.44 112.248 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.457 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.3 t60 -70.8 -30.97 67.57 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.823 0.849 . . . . 75.31 112.695 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.607 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.5 p -79.68 -21.31 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 112.501 0.556 . . . . 74.32 112.501 -171.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -72.48 -22.94 60.98 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.489 0.552 . . . . 71.21 112.489 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 20.0 pt20 -85.41 8.5 18.7 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.447 0.299 . . . . 73.35 110.88 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.707 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -97.84 157.31 16.15 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.127 0.971 . . . . 64.32 110.281 175.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.0 132.39 40.14 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.708 0.803 . . . . 70.43 109.504 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 35.1 t-105 -70.36 91.55 0.75 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.842 0.857 . . . . 75.14 110.701 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . 0.547 ' HA ' HE21 ' C' ' 37' ' ' GLN . 0.0 OUTLIER -132.21 71.56 79.56 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.263 1.025 . . . . 74.31 109.112 174.673 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -88.5 158.04 6.54 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.744 2.296 . . . . 73.02 112.842 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -89.06 99.93 12.82 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.013 -1.477 . . . . 71.11 107.013 172.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 15.0 m -66.04 98.36 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-O 122.18 0.99 . . . . 64.22 109.508 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -129.16 103.63 7.08 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.606 -1.179 . . . . 70.44 108.617 -170.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -94.68 148.37 22.34 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.626 -0.879 . . . . 75.45 108.626 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.634 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 11.8 t70 -135.48 123.45 22.72 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.2 -1.037 . . . . 73.55 108.2 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.17 111.78 21.52 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.457 -0.942 . . . . 71.24 108.457 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 16.7 t70 -114.45 137.38 51.91 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.121 0.968 . . . . 73.02 108.472 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 81.7 p -113.17 123.66 50.75 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.743 0.417 . . . . 71.42 111.464 -164.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.62 135.83 42.44 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.807 0.843 . . . . 71.12 109.181 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 51.7 m -161.7 149.19 14.62 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.874 0.47 . . . . 64.22 111.472 -172.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 52.9 p -160.26 140.77 11.77 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.688 0.795 . . . . 75.4 110.156 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . 0.438 ' HA ' ' HA ' ' C' ' 56' ' ' TYR . 60.4 tt0 -74.8 123.46 25.03 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.781 -0.822 . . . . 63.12 108.781 170.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.512 HD13 HD13 ' C' ' 83' ' ' ILE . 87.9 mt -84.23 -49.82 8.44 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.169 0.587 . . . . 72.44 110.622 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.78 -169.74 3.47 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.32 0.648 . . . . 74.52 110.873 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.05 106.52 0.27 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.454 1.102 . . . . 72.42 111.06 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 70.32 -5.32 1.37 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 126.004 1.721 . . . . 62.35 112.68 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 73.8 t -96.53 118.13 42.28 Favored 'Isoleucine or valine' 0 C--N 1.347 0.483 0 C-N-CA 124.572 1.149 . . . . 74.24 108.425 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . 0.486 ' CE1' HG12 ' C' ' 86' ' ' ILE . 37.1 p90 -127.96 168.78 14.79 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.046 0.939 . . . . 70.44 108.955 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -126.07 130.53 51.29 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.14 0.576 . . . . 73.43 110.427 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 76.3 t -106.61 115.77 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 107.933 -1.136 . . . . 75.32 107.933 167.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 98.2 t -109.3 131.75 59.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 107.718 -1.215 . . . . 71.52 107.718 165.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 35.5 tp -129.19 119.96 24.97 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.083 -0.71 . . . . 74.43 109.083 174.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.519 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.3 ttm180 -80.08 111.98 16.94 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.745 -1.116 . . . . 75.44 109.398 175.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 15.5 t -101.32 110.69 28.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.481 -1.303 . . . . 71.54 107.481 171.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.634 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 90.7 m -118.98 118.08 30.54 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.725 -0.843 . . . . 75.54 108.725 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.574 HG23 HG21 ' C' ' 114' ' ' ILE . 94.4 t -101.72 112.85 36.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 108.388 -0.968 . . . . 72.01 108.388 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -98.87 131.85 44.66 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.359 -0.978 . . . . 74.4 108.359 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.57 101.86 4.93 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.416 -1.328 . . . . 75.24 107.416 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 47.9 m -128.62 130.12 46.85 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.957 0.503 . . . . 75.25 109.994 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.556 HD11 ' HG2' ' C' ' 34' ' ' LYS . 12.5 mt -85.75 42.7 0.98 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 124.941 1.297 . . . . 73.53 109.774 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.87 -118.96 6.05 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 109.798 -1.321 . . . . 74.34 109.798 -167.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -89.21 -18.32 27.32 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.397 0.679 . . . . 60.33 110.072 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.433 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 7.4 tp10 -74.76 91.16 2.38 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.579 1.152 . . . . 73.44 109.656 173.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 76.9 m -71.47 119.82 16.17 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 109.516 -0.55 . . . . 74.45 109.516 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.607 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -76.57 -54.68 6.35 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.745 -1.116 . . . . 43.22 109.154 -178.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -157.15 170.38 22.63 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-O 122.349 1.071 . . . . 75.22 112.452 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -142.7 113.55 7.53 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 105.196 -2.15 . . . . 74.22 105.196 175.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.47 ' SG ' HG22 ' C' ' 114' ' ' ILE . 47.9 t -121.92 112.49 18.37 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.162 -0.681 . . . . 70.11 109.162 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -119.28 121.2 39.09 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.724 0.81 . . . . 74.15 110.056 -172.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 43.7 t -125.84 112.58 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.747 -0.834 . . . . 73.22 108.747 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.611 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.3 mt-30 -91.15 95.98 10.35 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.003 -1.11 . . . . 71.43 108.003 173.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -83.13 117.51 22.94 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.771 0.428 . . . . 72.01 109.871 -175.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.21 145.85 17.89 Favored Glycine 0 C--N 1.342 0.913 0 O-C-N 123.863 0.727 . . . . 70.32 111.643 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.98 116.92 0.83 Allowed Glycine 0 C--O 1.238 0.361 0 N-CA-C 111.164 -0.775 . . . . 72.53 111.164 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.512 HD13 HD13 ' C' ' 51' ' ' LEU . 10.3 mm -84.44 116.59 28.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.856 -1.164 . . . . 74.12 107.856 176.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.656 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 46.9 m-85 -128.1 146.57 50.65 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.064 -1.087 . . . . 75.13 108.064 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 85' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 70.7 p -113.1 122.06 46.41 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.311 -0.626 . . . . 64.53 109.311 170.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.486 HG12 ' CE1' ' C' ' 56' ' ' TYR . 17.7 pt -130.35 143.93 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 122.957 0.503 . . . . 74.42 109.904 170.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.7 143.33 18.45 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.035 0.934 . . . . 61.54 108.745 171.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 130.99 -52.29 0.83 Allowed Glycine 0 C--N 1.346 1.128 0 O-C-N 123.208 0.317 . . . . 65.13 113.018 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 33.0 pt -94.48 170.38 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-N 117.325 0.563 . . . . 71.43 111.831 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -156.89 162.3 39.66 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.626 0.77 . . . . 71.4 110.716 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.11 -132.75 15.58 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.034 -0.53 . . . . 74.11 112.686 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 20.4 p -69.36 -24.36 63.87 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.526 0.73 . . . . 64.44 111.769 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -65.15 -51.58 60.32 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 121.243 0.544 . . . . 73.53 110.039 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 46.3 ttp -64.88 -45.09 87.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.763 -1.108 . . . . 71.33 110.153 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.71 -26.03 68.47 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.062 0.945 . . . . 74.41 111.822 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -73.12 -42.72 62.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.036 0.534 . . . . 74.13 110.577 175.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 40.6 t -62.84 -60.7 3.12 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.709 0.63 . . . . 52.43 110.024 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.3 -29.67 65.32 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 112.151 0.426 . . . . 75.42 112.151 -177.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.56 11.42 56.52 Favored Glycine 0 N--CA 1.48 1.584 0 N-CA-C 115.157 0.823 . . . . 72.53 115.157 -167.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.79 -51.99 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 118.21 1.005 . . . . 74.43 110.335 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.426 ' HE2' ' CE1' ' C' ' 11' ' ' PHE . 27.3 t80 -75.93 -38.28 57.82 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 113.652 -1.613 . . . . 74.35 112.793 -169.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 83.4 m -79.28 -42.35 1.62 Allowed Pre-proline 0 CA--C 1.563 1.451 0 CA-C-O 118.553 -0.737 . . . . 51.11 112.196 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.85 -23.01 68.92 Favored 'Trans proline' 0 C--N 1.397 3.106 0 C-N-CA 122.139 1.893 . . . . 74.34 112.702 171.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -63.84 -32.37 73.86 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.793 0.837 . . . . 74.44 111.019 174.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.504 HD13 ' NH1' ' A' ' 111' ' ' ARG . 47.1 mm -67.63 -35.87 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 123.365 0.666 . . . . 75.35 110.303 175.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.0 -25.16 21.0 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.177 0.991 . . . . 73.14 112.923 -170.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . 0.416 ' N ' ' HD2' ' C' ' 108' ' ' PRO . 0.1 OUTLIER -63.55 -40.34 57.01 Favored Pre-proline 0 CA--C 1.557 1.24 0 CA-C-O 117.729 -1.129 . . . . 75.12 113.905 -171.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' C' ' 107' ' ' PHE . 30.0 Cg_endo -61.16 -36.82 79.0 Favored 'Trans proline' 0 C--N 1.388 2.645 0 CA-C-N 121.685 1.638 . . . . 72.4 112.314 174.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -64.29 -49.29 72.41 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.522 0.729 . . . . 74.31 110.729 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.78 -41.05 96.14 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.365 -0.834 . . . . 74.23 110.888 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -53.2 -56.15 18.73 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.659 1.183 . . . . 74.2 111.39 175.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . 0.444 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.8 tm-20 -66.14 -34.34 77.83 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 123.568 0.542 . . . . 75.33 110.286 -176.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.413 ' SG ' HG12 ' C' ' 21' ' ' ILE . 12.9 t -70.6 -27.45 64.11 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.072 0.549 . . . . 75.22 111.321 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.574 HG21 HG23 ' C' ' 64' ' ' VAL . 82.0 mt -77.66 -55.47 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.228 0.611 . . . . 75.4 110.288 173.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 18.8 m -62.49 -27.76 69.36 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.534 0.734 . . . . 72.43 110.96 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 42.6 t -62.06 -51.77 66.61 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 123.786 0.834 . . . . 73.23 109.38 169.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.665 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.03 -35.54 77.17 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.687 1.195 . . . . 64.42 112.668 178.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.405 HG23 ' O ' ' C' ' 114' ' ' ILE . 63.7 t -63.57 -46.7 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.71 0.804 . . . . 72.33 109.238 174.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 30.7 t -68.31 -28.55 67.27 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.859 -1.064 . . . . 73.41 111.851 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -72.77 -40.48 65.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.625 0.77 . . . . 72.52 109.316 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.34 -2.54 79.75 Favored Glycine 0 C--N 1.355 1.591 0 CA-C-N 115.42 -0.809 . . . . 71.05 112.267 171.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.452 HG21 ' HB3' ' D' ' 17' ' ' TYR . 24.8 p 65.44 27.66 11.74 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.783 2.033 . . . . 73.35 113.193 170.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -84.14 152.26 61.46 Favored Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 109.042 -0.725 . . . . 75.12 109.042 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -54.36 160.82 6.19 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 123.447 2.765 . . . . 74.23 114.106 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -55.38 111.16 0.81 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.715 0.806 . . . . 70.25 111.461 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 26.6 tp -116.38 86.28 2.46 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 106.116 -1.809 . . . . 74.13 106.116 167.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -104.56 125.9 51.15 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.862 -1.063 . . . . 71.31 109.587 -167.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.36 127.35 32.44 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.489 0.715 . . . . 74.21 110.238 -173.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.6 156.05 68.32 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 123.99 0.916 . . . . 74.4 111.531 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.502 ' HB3' HD13 ' A' ' 16' ' ' ILE . 19.7 Cg_endo -61.22 102.34 0.21 Allowed 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.784 2.323 . . . . 72.41 112.975 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 60.3 t -118.86 110.08 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 108.742 -0.836 . . . . 71.45 108.742 173.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -96.1 106.39 18.56 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.057 -1.09 . . . . 73.23 108.057 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -53.87 -41.9 68.02 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.348 0.659 . . . . 74.24 112.494 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 10.6 t70 . . . . . 0 CA--C 1.547 0.845 0 C-N-CA 124.093 0.957 . . . . 74.44 111.229 176.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 C--O 1.238 0.489 0 CA-C-O 120.996 0.427 . . . . 73.45 110.603 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' D' ' 85' ' ' SER . 29.6 t80 -147.27 119.06 8.06 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.83 -1.174 . . . . 71.21 107.83 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . 0.405 ' HB2' ' HB3' ' D' ' 85' ' ' SER . 44.6 mt-30 -132.08 133.69 44.64 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.438 -0.949 . . . . 65.41 108.438 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.536 HD11 HG22 ' D' ' 105' ' ' ILE . 21.8 mt -84.68 129.31 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 108.51 -0.922 . . . . 75.41 108.51 173.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.626 HE21 ' HB2' ' D' ' 85' ' ' SER . 80.1 mt-30 -97.36 -46.18 6.19 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 122.586 0.354 . . . . 75.1 111.226 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -170.15 128.87 0.89 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.6 0.593 . . . . 71.12 112.6 -173.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.488 HD11 HG22 ' D' ' 13' ' ' ILE . 2.0 mp -107.57 137.92 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.445 -1.317 . . . . 52.11 107.445 174.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.452 ' HB3' HG21 ' C' ' 122' ' ' THR . 30.0 p90 -163.46 163.73 24.73 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 122.277 1.037 . . . . 74.11 110.956 178.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -93.8 120.89 34.66 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.629 -1.623 . . . . 74.41 108.419 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -85.3 -42.59 14.48 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.869 -1.16 . . . . 75.11 107.869 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.588 ' HB2' ' HB2' ' D' ' 79' ' ' GLN . 20.0 m-20 -136.21 144.79 45.08 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 114.755 -1.111 . . . . 74.23 110.217 176.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.665 HG21 ' HE1' ' C' ' 117' ' ' MET . 56.6 mt -140.73 149.65 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.355 1.462 . . . . 74.31 107.367 174.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.1 t -156.49 142.45 18.0 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.021 0.439 . . . . 74.25 110.849 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.1 t80 -147.63 111.59 5.11 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 106.176 -1.787 . . . . 72.15 106.176 173.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.537 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 23.8 mt-10 -123.04 108.23 12.68 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.011 -0.737 . . . . 73.14 109.011 -173.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.577 ' HB3' ' HB3' ' D' ' 28' ' ' ALA . . . -106.44 89.06 3.72 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 123.594 0.758 . . . . 74.23 109.076 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -80.0 -28.13 3.38 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.766 2.311 . . . . 73.11 113.209 -169.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -110.05 6.29 22.84 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.466 0.706 . . . . 62.52 110.627 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.625 ' HB2' ' HE2' ' C' ' 19' ' ' LYS . . . -29.58 -66.89 0.14 Allowed Pre-proline 0 CA--C 1.566 1.588 0 N-CA-C 116.904 2.187 . . . . 63.31 116.904 -165.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.638 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 64.6 Cg_endo -74.64 -14.57 22.04 Favored 'Trans proline' 0 C--N 1.383 2.381 0 CA-C-N 123.38 2.243 . . . . 65.23 112.847 -172.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -84.4 -39.3 19.19 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.048 1.339 . . . . 73.51 110.318 172.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.643 HG22 HD11 ' D' ' 68' ' ' LEU . 5.6 p -82.48 -22.9 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-N 116.436 -0.347 . . . . 73.41 110.98 -170.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -61.67 -24.05 66.48 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.036 0.534 . . . . 75.23 112.251 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -57.6 -30.09 65.02 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.434 1.094 . . . . 75.14 110.861 175.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.676 ' HZ1' ' HG2' ' D' ' 71' ' ' GLU . 96.1 mttt -84.33 71.98 10.61 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.514 -1.221 . . . . 70.42 109.502 174.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.72 81.55 5.97 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.215 -0.902 . . . . 60.44 110.67 -173.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 21.6 p90 -155.75 179.18 9.44 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.833 0.853 . . . . 72.0 109.485 172.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . 0.526 HE21 ' HD2' ' D' ' 38' ' ' PRO . 25.1 tp60 -68.84 116.26 39.43 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.868 0.867 . . . . 73.14 110.609 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.526 ' HD2' HE21 ' D' ' 37' ' ' GLN . 50.9 Cg_exo -56.79 131.97 48.86 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.652 2.235 . . . . 75.22 112.379 176.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.29 111.15 3.84 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.755 -1.202 . . . . 75.24 107.755 172.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 27.7 m -108.19 137.68 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.42 0.629 . . . . 73.03 110.609 -172.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -123.76 128.21 49.23 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.115 -1.439 . . . . 72.52 107.115 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' D' ' 63' ' ' THR . 7.8 mp -96.84 138.5 34.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.195 0.521 . . . . 72.31 110.653 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -128.01 115.87 19.16 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.331 -1.359 . . . . 75.52 107.331 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 mp -104.47 138.2 41.21 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.356 0.662 . . . . 71.34 110.28 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.61 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.9 t70 -133.7 145.05 49.54 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.089 -1.078 . . . . 73.34 108.089 177.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.5 t -105.97 158.13 17.01 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.859 0.464 . . . . 75.02 111.298 -175.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -167.66 153.11 7.2 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.935 1.294 . . . . 74.43 108.847 173.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 76.9 p -154.0 156.71 37.9 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.555 0.742 . . . . 63.41 109.813 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 15.3 m -147.6 123.92 10.92 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.357 -0.979 . . . . 74.13 108.357 -174.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -78.46 115.39 18.13 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.789 -1.189 . . . . 73.55 107.789 167.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.525 HD13 HG23 ' D' ' 83' ' ' ILE . 26.3 mt -95.44 -27.89 15.19 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.064 -0.717 . . . . 71.13 109.064 177.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.16 -178.64 6.12 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.042 0.937 . . . . 64.21 110.132 172.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -65.67 123.7 20.43 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.549 -0.75 . . . . 72.33 109.816 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 60.45 20.37 10.06 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.25 1.02 . . . . 73.1 112.475 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.3 t -125.08 118.11 52.0 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 C-N-CA 124.205 1.002 . . . . 72.42 108.511 174.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -134.69 131.26 37.48 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.466 0.707 . . . . 75.13 109.849 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.418 ' HB2' HD11 ' D' ' 51' ' ' LEU . 31.5 tt0 -87.38 128.57 35.2 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.812 -1.086 . . . . 63.42 108.274 166.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 43.2 t -110.0 125.42 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 107.789 -1.189 . . . . 73.11 107.789 173.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 16.5 t -118.69 125.67 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.883 -0.784 . . . . 71.2 108.883 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 6.9 mp -121.8 127.46 50.62 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.545 -0.909 . . . . 72.4 108.545 171.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.61 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 18.9 ttm-85 -83.94 103.66 13.38 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.601 1.16 . . . . 74.53 108.903 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 87.0 t -90.94 115.49 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 108.501 -0.925 . . . . 73.41 108.501 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' D' ' 42' ' ' LEU . 18.7 m -125.82 128.29 47.43 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.064 0.459 . . . . 75.13 109.778 -172.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 42.7 t -118.76 101.01 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 125.541 1.537 . . . . 73.21 108.475 -175.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 32.2 m -92.46 95.23 9.53 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.023 -1.103 . . . . 74.41 108.023 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.66 138.64 39.29 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 115.459 -0.791 . . . . 72.21 111.113 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 47.6 m -146.78 134.4 21.01 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 122.786 0.434 . . . . 71.45 110.989 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.643 HD11 HG22 ' D' ' 31' ' ' VAL . 66.2 mt -94.89 102.24 14.08 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.883 -1.154 . . . . 75.2 107.883 171.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.6 -113.82 3.83 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 116.12 -0.491 . . . . 63.1 112.363 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.73 3.66 11.11 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.108 0.563 . . . . 73.04 110.24 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.676 ' HG2' ' HZ1' ' D' ' 34' ' ' LYS . 9.7 pt-20 -116.0 155.08 28.72 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.685 -0.857 . . . . 64.43 108.685 177.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 35.0 m -70.01 136.43 50.39 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 123.395 0.435 . . . . 73.23 111.293 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.464 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -89.29 -62.77 1.4 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.705 -1.22 . . . . 73.23 107.705 172.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . 0.412 ' HE2' ' HG2' ' D' ' 38' ' ' PRO . 52.6 p90 -158.44 154.85 27.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.558 -1.201 . . . . 73.54 110.311 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 91.5 mt -120.56 112.75 19.31 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.58 1.152 . . . . 63.45 108.002 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.49 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 2.5 m -114.25 140.14 48.83 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.299 1.039 . . . . 73.12 108.918 -174.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -153.92 119.36 5.17 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.295 -1.002 . . . . 74.35 108.295 174.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . 0.438 HG23 HG22 ' D' ' 21' ' ' ILE . 60.3 t -124.5 115.13 43.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.487 -0.931 . . . . 73.41 108.487 174.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.588 ' HB2' ' HB2' ' D' ' 20' ' ' ASP . 51.1 mt-30 -88.13 85.37 6.94 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.92 -1.141 . . . . 74.12 107.92 171.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -80.66 104.03 10.91 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 114.132 -1.394 . . . . 72.22 108.467 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.64 141.74 15.42 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.421 -0.672 . . . . 72.14 111.421 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.487 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -137.11 131.93 5.78 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 111.472 -0.651 . . . . 64.03 111.472 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.525 HG23 HD13 ' D' ' 51' ' ' LEU . 50.8 mt -88.02 124.17 41.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.228 -1.027 . . . . 70.13 108.228 175.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -129.59 157.88 40.83 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.684 0.794 . . . . 73.02 110.071 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.626 ' HB2' HE21 ' D' ' 14' ' ' GLN . 43.4 t -115.56 98.88 6.97 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.986 1.314 . . . . 73.24 107.779 -178.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.9 111.55 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.532 0.733 . . . . 73.44 109.443 -176.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -131.87 149.76 52.35 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.932 0.493 . . . . 74.25 110.457 177.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.52 19.75 63.41 Favored Glycine 0 C--N 1.346 1.104 0 O-C-N 123.788 0.68 . . . . 64.11 114.426 172.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.525 HG23 ' N ' ' D' ' 90' ' ' GLU . 10.2 mt -112.65 154.16 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 117.226 0.513 . . . . 75.13 109.996 175.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.525 ' N ' HG23 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -147.82 -174.35 4.53 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 125.085 1.354 . . . . 74.14 110.7 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.01 -138.03 39.01 Favored Glycine 0 C--N 1.353 1.485 0 CA-C-N 115.948 -0.569 . . . . 52.44 113.622 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 28.1 p -90.05 -13.74 35.33 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.793 0.837 . . . . 74.1 111.017 174.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -31.0 72.03 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.351 1.06 . . . . 75.0 110.09 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.416 ' SD ' ' HA ' ' D' ' 90' ' ' GLU . 8.0 ptm -74.52 -21.18 59.67 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.389 0.676 . . . . 74.21 112.124 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.83 -36.13 50.46 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.704 -0.48 . . . . 71.23 109.704 169.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -64.52 -37.28 87.02 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.306 0.642 . . . . 72.4 111.31 175.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 35.9 t -59.97 -49.57 77.17 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.011 -0.54 . . . . 73.5 110.491 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 43.7 mt -85.96 -21.7 27.75 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.246 -0.888 . . . . 75.2 111.557 -175.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.23 5.09 45.04 Favored Glycine 0 N--CA 1.476 1.363 0 N-CA-C 114.551 0.58 . . . . 61.43 114.551 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.05 -68.14 0.2 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.534 0.334 . . . . 74.33 110.855 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -65.13 -52.29 56.13 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 112.654 0.613 . . . . 73.45 112.654 -170.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 71.8 m -61.36 -50.17 84.47 Favored Pre-proline 0 CA--C 1.563 1.444 0 CA-C-O 118.76 -0.638 . . . . 71.21 112.218 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.29 -21.44 35.69 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 121.825 1.684 . . . . 74.34 113.421 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -68.74 -27.38 65.87 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 122.911 0.484 . . . . 73.03 110.528 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.536 HG22 HD11 ' D' ' 13' ' ' ILE . 58.5 mt -72.16 -28.43 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 C-N-CA 124.082 0.953 . . . . 75.44 110.441 171.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.487 HD22 ' HA3' ' D' ' 82' ' ' GLY . 94.2 mt -86.28 -22.94 26.53 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.702 0.801 . . . . 73.21 112.563 -176.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -66.9 -35.28 8.86 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.346 1.239 . . . . 75.32 114.346 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.91 -45.28 37.02 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 121.995 1.797 . . . . 75.53 112.939 166.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -74.51 -33.77 62.87 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.748 0.819 . . . . 73.44 111.884 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.41 -53.04 58.51 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.157 0.583 . . . . 63.52 109.889 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -53.77 -51.63 62.81 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-N 114.328 -1.305 . . . . 75.11 110.829 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -62.2 -44.81 95.75 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.274 0.984 . . . . 74.1 111.53 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.534 ' SG ' HD11 ' D' ' 21' ' ' ILE . 36.8 t -58.58 -40.63 83.72 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 123.814 0.696 . . . . 73.34 110.651 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.473 ' O ' HG22 ' D' ' 118' ' ' VAL . 76.7 mt -68.06 -48.79 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.809 0.843 . . . . 72.42 110.381 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 56.5 m -58.2 -42.45 86.18 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.438 1.095 . . . . 74.33 111.519 -175.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 32.8 t -66.5 -42.81 86.82 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.089 -0.96 . . . . 74.05 110.168 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.8 mtm -64.75 -37.57 88.05 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.946 0.498 . . . . 74.52 111.767 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.473 HG22 ' O ' ' D' ' 114' ' ' ILE . 78.1 t -65.96 -41.7 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.063 0.945 . . . . 73.43 110.842 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.8 p -73.31 -31.36 63.96 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 116.009 -0.541 . . . . 73.3 110.952 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' D' ' 116' ' ' SER . 72.9 mtt-85 -70.19 -33.15 71.36 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.436 0.694 . . . . 73.34 110.176 175.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.48 7.63 78.2 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-N 115.919 -0.582 . . . . 65.33 112.516 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.0 p 59.58 24.12 12.87 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 126.683 1.993 . . . . 65.12 114.073 173.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.468 ' HB2' HG13 ' D' ' 118' ' ' VAL . 97.0 m-85 -83.95 156.37 64.06 Favored Pre-proline 0 N--CA 1.479 0.983 0 N-CA-C 108.908 -0.775 . . . . 72.14 108.908 167.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.474 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 18.5 Cg_endo -60.83 139.69 86.54 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.166 1.911 . . . . 74.34 111.771 176.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -55.28 142.48 31.57 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.755 1.222 . . . . 75.11 112.469 -174.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 45.9 tp -127.91 98.65 5.23 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.658 0.783 . . . . 73.13 109.352 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.23 107.4 18.21 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.442 0.697 . . . . 72.01 109.333 175.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 7.4 mp -63.79 117.95 7.64 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.086 0.954 . . . . 71.32 109.789 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.79 145.05 98.95 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.478 0.711 . . . . 65.02 111.115 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.459 ' HD3' HG13 ' B' ' 13' ' ' ILE . 73.9 Cg_exo -54.53 129.23 33.77 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.824 3.016 . . . . 70.52 113.4 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.474 0.754 0 C-N-CA 123.467 0.707 . . . . 74.24 110.069 177.738 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.679 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 4.3 t80 . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 109.841 -0.429 . . . . 74.22 109.841 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.5 tp60 -150.16 127.33 11.29 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.812 -1.181 . . . . 74.42 107.812 172.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.58 HG12 ' HD2' ' A' ' 84' ' ' PHE . 48.6 mt -94.32 126.37 46.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.827 -0.805 . . . . 73.52 108.827 176.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -77.38 -39.75 46.15 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.675 -0.491 . . . . 73.0 109.675 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -169.16 145.55 3.42 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 116.365 -0.38 . . . . 73.4 110.332 -168.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.447 HD11 HD11 ' A' ' 13' ' ' ILE . 78.1 mt -137.46 136.91 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.021 -1.103 . . . . 62.14 108.021 170.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -167.84 176.49 6.24 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.808 0.843 . . . . 72.31 110.973 -172.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.9 p -102.74 126.78 49.98 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.307 -0.86 . . . . 75.33 108.984 177.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -90.71 -40.37 11.89 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.885 0.474 . . . . 74.24 110.122 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -141.2 139.2 33.79 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.224 -1.028 . . . . 62.44 108.224 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 63.8 mt -134.52 140.32 46.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.786 -1.19 . . . . 72.24 107.786 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.521 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 42.7 t -144.43 125.83 14.85 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.363 1.065 . . . . 72.31 108.134 177.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.49 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 85.7 t80 -135.99 115.04 12.3 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 106.667 -1.605 . . . . 65.54 106.667 170.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -120.09 126.05 49.8 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.777 -0.823 . . . . 74.52 108.777 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.47 81.61 4.21 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 107.162 -1.421 . . . . 64.1 107.162 172.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.15 -41.02 46.16 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.988 2.458 . . . . 74.42 113.415 -164.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -114.87 33.07 5.6 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 109.243 -0.651 . . . . 74.21 109.243 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.5 -49.33 34.78 Favored Pre-proline 0 N--CA 1.5 2.059 0 N-CA-C 114.464 1.283 . . . . 51.14 114.464 -177.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -64.12 -20.89 67.86 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.197 1.931 . . . . 75.35 114.088 177.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -101.37 -23.46 14.36 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.728 1.211 . . . . 74.22 111.634 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.533 HG22 ' HA ' ' A' ' 73' ' ' ALA . 2.4 p -78.74 -24.27 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.342 0.657 . . . . 73.14 112.363 -165.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -79.69 -18.63 50.86 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.549 0.74 . . . . 71.4 112.474 -172.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -88.24 -11.63 46.04 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.473 0.709 . . . . 72.42 111.0 173.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -82.21 161.85 22.59 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.644 0.778 . . . . 74.34 111.823 -174.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -72.75 120.49 18.45 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.221 -0.9 . . . . 74.24 109.755 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -76.34 86.03 3.12 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.378 0.608 . . . . 73.24 109.925 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -128.66 73.35 80.94 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 124.559 1.144 . . . . 74.25 107.996 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -86.84 138.44 5.1 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.849 2.366 . . . . 73.41 113.628 -170.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -102.03 86.2 2.83 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 106.988 -1.486 . . . . 75.52 106.988 169.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.1 m -72.8 90.73 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 123.062 1.41 . . . . 75.02 109.611 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -91.97 116.3 28.81 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 112.87 -1.968 . . . . 74.52 108.206 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.495 HD13 HG12 ' A' ' 62' ' ' VAL . 52.2 tp -104.87 129.52 53.2 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.475 0.71 . . . . 75.21 111.444 -170.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -120.73 126.33 49.9 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.348 1.059 . . . . 73.41 108.925 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.1 mt -114.67 133.87 55.52 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.739 0.816 . . . . 71.24 110.306 -173.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.59 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 18.5 t70 -127.05 138.97 53.31 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.819 0.848 . . . . 75.24 110.338 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.3 p -107.78 121.57 44.99 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.752 0.821 . . . . 73.04 110.222 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.97 128.91 25.05 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.696 0.798 . . . . 74.24 109.466 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.3 p -131.94 164.82 25.3 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.56 0.618 . . . . 72.04 110.432 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -156.96 138.96 14.44 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.616 0.766 . . . . 71.1 109.754 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -93.41 118.76 31.71 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.045 -1.094 . . . . 74.24 108.045 169.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.459 HD12 HG22 ' A' ' 83' ' ' ILE . 43.7 mt -90.95 -38.88 12.58 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.945 0.498 . . . . 73.15 110.528 -176.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.16 -176.77 6.1 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.88 0.872 . . . . 62.11 109.951 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -69.2 115.39 8.43 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.166 0.586 . . . . 73.35 109.669 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 75.94 -6.05 2.06 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 125.734 1.613 . . . . 73.15 112.469 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.9 t -100.51 112.96 34.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 108.127 -1.064 . . . . 71.43 108.127 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -136.17 127.52 28.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.367 -0.605 . . . . 73.01 109.367 -174.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.428 ' HB2' HD13 ' A' ' 51' ' ' LEU . 36.3 tt0 -97.76 142.42 29.57 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.242 1.017 . . . . 74.51 111.159 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.423 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 56.0 t -125.59 132.47 70.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 106.767 -1.568 . . . . 70.55 106.767 173.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 62.0 t -128.11 129.48 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.32 1.048 . . . . 74.34 108.936 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -119.66 110.48 16.88 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.924 -1.139 . . . . 74.14 107.924 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.59 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 8.4 tmm_? -87.56 104.43 16.49 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.638 -0.875 . . . . 72.42 108.638 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.495 HG12 HD13 ' A' ' 42' ' ' LEU . 59.2 t -100.04 108.54 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.753 1.221 . . . . 75.11 109.195 -177.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.3 m -104.04 110.78 23.07 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.611 0.764 . . . . 64.32 110.539 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.3 t -105.08 108.89 26.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 124.157 0.983 . . . . 73.52 109.659 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.3 m -103.83 127.63 51.32 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.909 -0.774 . . . . 62.43 108.909 171.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.53 115.33 29.96 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.04 -1.096 . . . . 64.35 108.04 175.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.6 m -118.44 126.35 51.88 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.084 0.469 . . . . 72.53 110.811 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.7 mt -89.51 76.64 7.39 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 107.832 -1.173 . . . . 74.41 107.832 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.34 -83.65 0.98 Allowed Glycine 0 C--N 1.351 1.368 0 N-CA-C 111.145 -0.782 . . . . 70.03 111.145 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -119.53 -26.58 5.73 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.695 0.798 . . . . 74.15 111.161 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -88.96 110.76 21.39 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.963 0.505 . . . . 74.03 110.277 -174.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.9 m -64.23 122.59 17.0 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.917 0.389 . . . . 72.53 110.667 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.533 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -70.89 -59.86 2.56 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.028 -0.987 . . . . 65.44 110.157 175.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -153.17 174.03 14.76 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.185 -0.916 . . . . 72.13 111.658 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 64.2 tp -133.69 141.13 47.44 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.134 -1.432 . . . . 73.03 107.134 173.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 73.9 m -137.86 93.89 2.83 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.542 -0.91 . . . . 61.3 108.542 172.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 45.3 tt0 -113.1 116.26 29.59 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.696 -0.853 . . . . 73.22 108.696 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 t -135.39 115.92 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.459 0.703 . . . . 74.32 110.205 -170.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -81.98 94.2 7.1 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.071 -1.085 . . . . 71.51 108.071 169.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.414 ' HG3' HD23 ' A' ' 106' ' ' LEU . 9.6 tp-100 -82.17 99.45 9.26 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.69 -0.856 . . . . 74.04 108.69 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.19 146.26 20.21 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 111.192 -0.763 . . . . 53.43 111.192 176.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.22 120.81 1.14 Allowed Glycine 0 CA--C 1.5 -0.845 0 N-CA-C 110.247 -1.141 . . . . 74.24 110.247 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.459 HG22 HD12 ' A' ' 51' ' ' LEU . 21.7 mt -85.36 114.47 25.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.03 -0.73 . . . . 73.21 109.03 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.679 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 23.3 m-85 -119.37 119.57 34.35 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.401 -0.963 . . . . 63.33 108.401 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.4 p -86.03 101.45 12.94 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.775 -0.824 . . . . 64.11 108.775 174.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 C-N-CA 123.392 0.677 . . . . 73.51 110.627 -174.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.811 0.338 . . . . 64.05 111.106 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -67.39 -42.37 83.47 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.693 -0.685 . . . . 75.34 110.091 172.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.625 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 81.6 m -62.71 -55.71 24.24 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 123.918 0.761 . . . . 72.15 111.379 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -73.09 -36.36 66.78 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.338 0.655 . . . . 74.54 111.316 -174.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.69 -16.62 58.1 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 114.764 0.665 . . . . 61.44 114.764 -168.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.74 -54.83 0.19 Allowed 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 117.655 0.728 . . . . 74.52 112.834 -171.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.625 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 79.3 t80 -63.64 -53.19 55.26 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.319 1.047 . . . . 74.43 112.896 -169.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.5 m -72.1 -37.41 4.85 Favored Pre-proline 0 CA--C 1.563 1.453 0 C-N-CA 123.591 0.757 . . . . 74.33 112.678 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.79 -40.48 47.88 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 122.441 2.094 . . . . 71.31 113.588 160.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -70.81 -24.1 62.49 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.87 0.868 . . . . 74.11 111.527 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 51.0 mm -69.6 -36.94 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 109.387 -0.598 . . . . 72.34 109.387 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.414 HD23 ' HG3' ' A' ' 80' ' ' GLN . 83.3 mt -79.58 -23.68 42.57 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.752 0.821 . . . . 75.53 112.445 -177.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -58.72 -49.23 94.54 Favored Pre-proline 0 CA--C 1.571 1.764 0 N-CA-C 113.651 0.982 . . . . 72.45 113.651 -176.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -63.68 -35.74 56.37 Favored 'Trans proline' 0 C--N 1.389 2.672 0 C-N-CA 122.159 1.906 . . . . 73.51 113.484 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.45 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 96.4 m-85 -75.56 -35.67 60.6 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.579 0.752 . . . . 73.14 111.937 -178.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.8 -44.83 65.79 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.376 -0.602 . . . . 70.44 109.376 175.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.424 ' NH1' HG22 ' C' ' 105' ' ' ILE . 17.9 ttm180 -59.5 -33.97 72.02 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.146 0.904 . . . . 75.4 110.165 173.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -66.3 -50.53 63.34 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.864 0.866 . . . . 54.55 110.836 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 36.8 t -61.45 -37.02 82.04 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.744 0.653 . . . . 75.3 110.552 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 118' ' ' VAL . 93.5 mt -62.22 -57.28 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.774 0.83 . . . . 72.35 110.021 172.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.8 m -52.28 -39.66 60.74 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.253 1.421 . . . . 74.12 111.908 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -69.98 -51.42 32.66 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.884 -1.053 . . . . 74.21 110.392 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.417 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 36.7 mtm -64.64 -36.69 85.06 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.93 0.492 . . . . 72.22 111.918 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 114' ' ' ILE . 79.2 t -61.1 -44.94 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.506 0.722 . . . . 72.13 110.227 176.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.9 t -70.47 -34.67 72.66 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.477 -0.783 . . . . 64.52 111.454 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.529 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 93.7 mtt-85 -70.58 -32.56 69.99 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.889 0.876 . . . . 73.03 109.695 176.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.95 1.64 83.66 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-O 119.065 -0.853 . . . . 63.53 112.992 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 122' ' ' THR . 22.5 m 73.71 12.53 4.48 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 122.446 1.117 . . . . 71.44 111.866 173.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.445 ' HB2' HG13 ' A' ' 118' ' ' VAL . 97.9 m-85 -84.13 148.2 52.73 Favored Pre-proline 0 CA--C 1.544 0.736 0 O-C-N 121.369 -0.832 . . . . 71.24 109.591 172.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.1 142.21 96.85 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.533 2.155 . . . . 64.15 110.91 172.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -57.27 145.2 32.74 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 124.281 0.988 . . . . 72.24 113.016 -168.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.5 tp -127.99 114.91 17.73 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.871 0.868 . . . . 73.34 109.41 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -119.69 117.65 28.83 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.534 -0.913 . . . . 74.12 108.534 175.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.9 mp -72.49 146.07 47.11 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.147 0.579 . . . . 74.1 110.232 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.34 136.37 95.65 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.874 0.87 . . . . 72.22 112.15 -174.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -67.83 89.45 0.36 Allowed 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.941 2.427 . . . . 71.5 112.265 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 87.1 t -107.31 112.03 38.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.595 -0.891 . . . . 73.53 108.595 176.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -85.32 96.75 9.63 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 107.688 -1.227 . . . . 72.42 107.688 170.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 . . . . . 0 N--CA 1.479 0.993 0 O-C-N 124.059 0.85 . . . . 74.35 111.002 -179.493 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.413 ' HE3' ' SG ' ' B' ' 97' ' ' CYS . 19.6 ptm . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 113.63 0.974 . . . . 70.03 113.63 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 99.9 m -134.79 140.05 45.59 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.831 1.252 . . . . 73.4 107.84 174.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.452 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 46.0 t80 -142.22 132.89 25.44 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.053 -0.721 . . . . 71.43 109.053 172.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.473 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -153.44 121.11 5.96 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.45 -0.945 . . . . 72.44 108.45 174.086 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 54.7 mt -68.75 120.07 15.62 Favored 'Isoleucine or valine' 0 C--N 1.348 0.528 0 N-CA-C 108.186 -1.042 . . . . 73.53 108.186 170.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -89.07 -49.84 6.52 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.711 -0.848 . . . . 75.11 108.711 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.464 ' HE ' HG21 ' A' ' 122' ' ' THR . 34.2 ttt85 -168.74 137.03 2.1 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.55 -0.75 . . . . 74.14 109.636 -175.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 87.1 mt -115.36 142.19 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 108.341 -0.985 . . . . 73.3 108.341 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -168.13 148.98 5.01 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 112.622 0.601 . . . . 75.11 112.622 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.541 HG21 HD13 ' B' ' 21' ' ' ILE . 39.5 m -79.69 114.14 18.39 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.268 -0.878 . . . . 74.02 108.912 172.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -84.09 -25.89 29.41 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.099 0.56 . . . . 74.44 111.375 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 16.2 t70 -163.43 149.06 11.41 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.367 0.603 . . . . 72.14 112.052 -175.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.541 HD13 HG21 ' B' ' 18' ' ' THR . 46.4 mm -137.15 142.85 36.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 126.018 1.727 . . . . 70.4 107.742 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 42.5 t -146.17 137.15 24.43 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.249 -1.019 . . . . 74.15 108.249 168.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.419 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 91.2 t80 -141.15 131.86 25.69 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.301 -1.37 . . . . 72.02 107.301 172.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 34.4 mt-10 -131.66 126.84 35.65 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.798 -1.186 . . . . 73.11 107.798 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.462 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -127.98 81.19 70.84 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 107.146 -1.428 . . . . 61.54 107.146 170.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.46 -30.53 35.94 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.884 2.389 . . . . 65.11 111.33 -177.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -103.96 2.58 32.55 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.281 -1.327 . . . . 74.45 110.86 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.482 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -32.05 -66.76 0.19 Allowed Pre-proline 0 N--CA 1.499 1.997 0 C-N-CA 126.032 1.733 . . . . 73.14 115.096 -172.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 21.7 Cg_exo -62.55 -31.05 80.12 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.899 2.399 . . . . 61.33 113.669 -164.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -96.22 -41.51 8.65 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.426 -0.807 . . . . 72.32 111.158 -174.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.17 -12.71 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 113.074 0.768 . . . . 72.02 113.074 -170.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -62.89 -18.24 62.73 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.485 0.714 . . . . 73.31 112.641 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.479 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 10.6 pt20 -55.15 -29.92 58.76 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.453 1.101 . . . . 55.44 111.499 173.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.479 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 96.5 mttt -92.38 95.31 9.59 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.7 1.2 . . . . 75.51 109.202 177.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -97.95 76.65 2.43 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 122.009 0.909 . . . . 73.24 111.494 -172.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 43.0 p90 -157.51 161.13 38.82 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.61 -0.885 . . . . 72.44 108.61 171.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -68.16 116.42 38.98 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 109.062 -0.718 . . . . 74.45 109.062 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.97 159.33 54.37 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.162 1.908 . . . . 75.43 112.656 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -64.63 113.13 3.53 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 109.195 -0.669 . . . . 73.4 109.195 174.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.23 121.64 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.881 0.848 . . . . 74.54 109.79 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.523 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 37.6 ttpt -107.04 100.55 10.03 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.578 -1.638 . . . . 73.31 106.578 175.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 pp -110.24 140.58 44.24 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.735 0.814 . . . . 72.25 110.174 -169.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -136.06 129.93 32.68 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.173 0.989 . . . . 63.32 108.915 -174.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -100.78 127.39 47.23 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.802 -1.184 . . . . 62.45 107.802 170.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.483 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 24.1 t70 -126.92 155.11 43.58 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.197 0.999 . . . . 72.22 108.731 -175.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 79.2 p -107.63 120.11 41.29 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.706 -0.679 . . . . 74.54 110.685 -172.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.79 131.18 44.52 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 107.174 -1.417 . . . . 71.52 107.174 172.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 10.7 p -145.91 168.29 21.19 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.699 0.681 . . . . 73.0 111.457 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p -152.19 138.33 18.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.115 0.966 . . . . 75.4 108.521 171.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -93.82 114.0 26.16 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.133 -0.691 . . . . 74.12 109.133 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 51.6 mt -77.58 -43.2 32.51 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.867 0.467 . . . . 63.24 110.157 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.7 -179.24 7.69 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.579 0.752 . . . . 61.1 110.501 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.11 124.38 21.97 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.301 -1.318 . . . . 72.13 109.02 172.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 70.85 6.77 5.98 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.889 1.276 . . . . 74.22 112.282 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.484 HG21 ' HG ' ' B' ' 85' ' ' SER . 78.0 t -119.85 111.54 33.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.7 0 N-CA-C 107.698 -1.223 . . . . 73.13 107.698 170.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -122.13 139.84 53.26 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.54 -0.541 . . . . 70.21 109.54 -177.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.43 ' HG2' HG12 ' B' ' 83' ' ' ILE . 6.6 tm-20 -111.35 101.13 9.61 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 107.489 -1.3 . . . . 74.13 107.489 -176.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 63.4 t -96.5 119.6 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.491 1.117 . . . . 70.23 109.601 -173.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.479 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 10.6 t -114.05 123.93 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.826 0.85 . . . . 75.42 108.711 178.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.445 HD21 ' HB3' ' B' ' 103' ' ' PRO . 15.6 tp -103.93 116.26 31.94 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.094 -0.706 . . . . 65.22 109.094 171.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.483 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 41.2 ttm180 -86.04 109.73 19.01 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.438 -0.949 . . . . 73.24 108.438 174.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 46.9 t -101.6 101.26 11.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.34 -1.355 . . . . 64.34 107.34 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.6 m -97.99 128.55 44.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.505 -0.77 . . . . 70.43 109.094 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.611 HG22 HG21 ' B' ' 114' ' ' ILE . 67.5 t -121.57 131.68 72.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 124.578 1.151 . . . . 74.41 108.184 -174.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 60.3 m -120.88 145.46 47.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.873 -1.158 . . . . 74.25 107.873 171.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.52 126.34 12.68 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.643 -0.873 . . . . 74.23 108.643 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 30.8 p -133.63 128.39 35.02 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.966 0.506 . . . . 72.41 110.114 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.461 HD11 ' HB1' ' B' ' 73' ' ' ALA . 70.4 mt -100.79 107.06 18.52 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.014 0.926 . . . . 72.44 108.804 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.16 -129.9 10.0 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 115.877 -0.601 . . . . 70.33 112.497 -176.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -92.4 1.21 57.37 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.647 0.779 . . . . 64.21 110.766 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.43 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 13.4 pt-20 -121.63 162.25 21.02 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.298 0.639 . . . . 75.02 110.444 -175.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 25.9 m -71.2 145.46 49.65 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.654 0.596 . . . . 75.31 109.787 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.461 ' HB1' HD11 ' B' ' 68' ' ' LEU . . . -101.8 -60.2 1.57 Allowed 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.296 -1.002 . . . . 71.34 108.296 168.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -153.04 164.52 37.85 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.001 0.905 . . . . 74.3 111.255 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 31.3 mt -134.48 142.8 47.18 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 105.427 -2.064 . . . . 70.04 105.427 178.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.3 t -154.8 116.42 4.11 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.601 0.637 . . . . 74.14 109.888 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -121.33 122.86 40.79 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 107.883 -1.155 . . . . 73.54 107.883 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.2 141.76 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.73 0.812 . . . . 74.3 108.959 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.41 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.5 mt-30 -118.63 94.54 4.5 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.697 -1.223 . . . . 73.51 107.697 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -90.31 103.93 16.56 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.988 -0.745 . . . . 75.32 108.988 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.46 161.98 29.04 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 123.798 0.686 . . . . 72.1 112.101 177.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.05 125.03 1.34 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.835 -1.306 . . . . 70.24 109.835 177.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.43 HG12 ' HG2' ' B' ' 57' ' ' GLU . 28.3 mt -85.05 130.22 36.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 107.854 -1.165 . . . . 74.04 107.854 175.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -136.6 133.6 36.49 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.037 -1.098 . . . . 74.41 108.037 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.484 ' HG ' HG21 ' B' ' 55' ' ' VAL . 40.3 m -87.25 92.36 9.04 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.452 -0.944 . . . . 71.14 108.452 170.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -107.43 130.3 59.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-N 114.907 -1.042 . . . . 73.23 108.492 176.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.66 168.73 18.16 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.622 0.769 . . . . 75.35 109.997 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.66 -63.44 4.28 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.079 -0.964 . . . . 73.54 112.903 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.478 HG23 ' HB2' ' B' ' 93' ' ' GLN . 43.4 mm -58.83 149.1 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 N-CA-C 114.757 1.392 . . . . 74.4 114.757 -165.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -159.99 -175.76 5.29 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 125.348 1.459 . . . . 71.23 109.548 171.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.01 -111.59 3.93 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 115.423 0.929 . . . . 71.02 115.423 166.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 51.2 m -81.54 -39.03 25.27 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.706 0.802 . . . . 74.44 111.125 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.478 ' HB2' HG23 ' B' ' 89' ' ' ILE . 51.0 mt-30 -66.4 -25.19 66.66 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.306 0.642 . . . . 71.3 112.219 -169.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.576 ' HE1' HD13 ' B' ' 98' ' ' LEU . 22.3 ptm -67.61 -27.54 66.99 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.223 0.609 . . . . 72.44 112.107 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.64 -33.18 69.78 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.796 0.838 . . . . 71.45 110.73 175.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -84.33 -49.24 8.91 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.295 -0.866 . . . . 72.24 109.811 171.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.413 ' SG ' ' HE3' ' B' ' 9' ' ' MET . 43.8 t -58.51 -65.91 0.58 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.974 0.731 . . . . 70.24 112.974 -167.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.576 HD13 ' HE1' ' B' ' 94' ' ' MET . 0.6 OUTLIER -103.8 -2.32 26.53 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 111.727 0.269 . . . . 65.33 111.727 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.04 -17.39 37.74 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 123.197 0.311 . . . . 53.3 113.527 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.59 -55.07 0.89 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.579 0.752 . . . . 74.3 110.574 -176.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -73.51 -53.07 11.48 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.359 1.064 . . . . 71.21 112.244 -166.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.452 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 64.3 m -63.77 -46.72 82.32 Favored Pre-proline 0 CA--C 1.56 1.35 0 CA-C-O 118.864 -0.589 . . . . 55.2 111.626 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.445 ' HB3' HD21 ' B' ' 60' ' ' LEU . 31.2 Cg_exo -64.23 -28.33 64.23 Favored 'Trans proline' 0 C--N 1.39 2.762 0 C-N-CA 122.003 1.802 . . . . 74.44 114.124 173.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.611 ' HA ' ' HD2' ' B' ' 107' ' ' PHE . 47.3 t-20 -57.94 -41.23 82.34 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 123.606 0.762 . . . . 71.13 110.412 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.42 HG22 ' NH2' ' D' ' 111' ' ' ARG . 96.8 mt -60.17 -42.49 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 114.415 -1.266 . . . . 71.32 110.888 175.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 56.7 mt -85.05 -15.43 44.08 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 115.21 -0.905 . . . . 70.11 112.277 -170.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.611 ' HD2' ' HA ' ' B' ' 104' ' ' ASN . 5.1 m-85 -54.46 -53.02 64.44 Favored Pre-proline 0 N--CA 1.495 1.776 0 C-N-CA 124.139 0.976 . . . . 73.15 113.592 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.16 -30.26 46.71 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 122.292 1.995 . . . . 74.41 113.849 -177.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -70.96 -44.45 66.02 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.832 0.453 . . . . 75.4 110.243 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.22 -41.24 98.21 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.963 -0.562 . . . . 62.51 110.248 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -59.59 -54.25 48.69 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.792 0.837 . . . . 74.22 110.164 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -61.73 -33.63 74.38 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 123.714 0.634 . . . . 75.34 110.289 -174.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.529 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 4.0 t -74.55 -48.23 28.07 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 116.062 -0.517 . . . . 71.32 111.452 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.611 HG21 HG22 ' B' ' 64' ' ' VAL . 98.6 mt -57.39 -56.07 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 C-N-CA 123.39 0.676 . . . . 74.21 109.867 174.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 33.0 m -59.25 -30.96 68.66 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 124.417 1.073 . . . . 75.23 111.06 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.4 t -63.64 -47.37 81.61 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 109.288 -0.634 . . . . 71.14 109.288 171.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.527 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.0 mmt -67.05 -30.79 70.96 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.089 0.556 . . . . 74.32 111.13 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.494 HG23 ' O ' ' B' ' 114' ' ' ILE . 84.8 t -65.97 -47.31 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.152 0.981 . . . . 74.32 109.171 173.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 71.2 m -66.31 -31.33 72.06 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 114.429 -1.26 . . . . 73.13 111.517 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.511 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 90.5 mtt-85 -73.95 -32.61 63.56 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 124.014 0.926 . . . . 74.5 109.655 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.47 6.33 69.31 Favored Glycine 0 C--N 1.353 1.491 0 O-C-N 124.196 0.935 . . . . 63.44 112.506 174.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 80.5 p 54.92 36.09 25.94 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 125.898 1.679 . . . . 73.13 112.653 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -95.6 157.78 35.54 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.138 0.975 . . . . 73.01 110.544 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -52.99 158.9 5.89 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.607 2.871 . . . . 73.24 115.036 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -64.03 115.07 4.57 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.705 -1.134 . . . . 73.15 111.77 -172.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 55.5 tp -125.35 112.14 15.98 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.366 0.666 . . . . 75.3 109.778 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -132.55 135.54 46.01 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.914 0.886 . . . . 73.44 108.89 176.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 8.0 mp -85.71 142.82 28.73 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.112 0.565 . . . . 73.54 111.622 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.99 132.91 49.43 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.064 0.946 . . . . 73.32 110.646 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.37 108.86 2.78 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 123.02 2.48 . . . . 74.52 112.754 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 98.3 t -93.62 111.6 25.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.639 -1.245 . . . . 75.31 107.639 167.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -74.36 91.33 2.2 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.458 0.703 . . . . 72.43 109.214 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -64.21 -41.12 97.19 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.417 -0.81 . . . . 74.51 110.726 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 N--CA 1.475 0.787 0 C-N-CA 124.205 1.002 . . . . 72.2 111.526 178.876 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.472 ' HD1' ' HH ' ' C' ' 101' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.473 0.688 0 CA-C-O 120.622 0.249 . . . . 70.41 110.332 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -150.93 132.77 15.04 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.949 0.899 . . . . 74.14 108.912 168.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 90.4 mt -73.25 127.35 35.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.399 -0.963 . . . . 75.34 108.399 170.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -95.14 -44.08 7.81 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.626 0.77 . . . . 73.44 109.58 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -176.29 134.35 0.25 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.635 0.774 . . . . 73.1 109.464 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.437 HG21 ' CD1' ' C' ' 109' ' ' TYR . 59.4 mt -127.25 151.88 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 118.636 0.653 . . . . 74.42 109.335 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.436 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 21.0 p90 -176.3 168.72 2.79 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.717 0.77 . . . . 74.11 110.978 -172.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 68.8 p -87.69 115.95 25.49 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.571 -1.195 . . . . 71.42 109.489 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.436 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 26.0 mmtp -65.54 -46.91 77.72 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.252 -1.018 . . . . 75.42 108.252 167.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.442 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 18.4 t70 -134.92 142.56 46.57 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 114.207 -1.36 . . . . 62.3 109.667 -174.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.532 HG12 ' SG ' ' C' ' 113' ' ' CYS . 89.0 mt -135.78 141.17 42.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 106.466 -1.679 . . . . 75.23 106.466 167.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.5 t -159.09 150.88 20.7 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.964 -0.384 . . . . 74.44 109.964 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -155.33 106.84 2.6 Favored 'General case' 0 C--O 1.226 -0.16 0 N-CA-C 107.913 -1.143 . . . . 74.33 107.913 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -117.93 111.4 18.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.524 0.73 . . . . 63.24 109.876 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.2 92.15 10.74 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 107.157 -1.423 . . . . 73.12 107.157 170.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.46 -35.58 38.49 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.657 2.238 . . . . 74.15 112.306 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -101.92 24.73 9.56 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.455 -0.793 . . . . 75.34 110.35 -175.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.96 -62.4 1.67 Allowed Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 114.714 1.376 . . . . 72.25 114.714 -167.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.53 -32.73 48.33 Favored 'Trans proline' 0 C--N 1.383 2.387 0 CA-C-N 121.834 1.691 . . . . 72.24 112.306 -174.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.568 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 72.7 t60 -70.84 -40.45 72.37 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.53 0.732 . . . . 74.41 112.012 177.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.736 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.2 p -77.8 -21.44 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 112.081 0.4 . . . . 64.31 112.081 -170.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -63.66 -29.7 70.9 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.44 0.904 . . . . 74.23 113.44 177.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 21.1 pt20 -84.78 5.76 27.21 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 122.727 0.411 . . . . 74.43 111.114 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.711 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -95.21 156.63 16.24 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.427 1.091 . . . . 74.21 110.408 -177.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -67.86 128.78 37.77 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.155 0.982 . . . . 73.14 110.061 169.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -86.07 100.62 12.3 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.331 0.652 . . . . 74.41 111.3 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -156.69 77.35 4.18 Favored Pre-proline 0 N--CA 1.474 0.773 0 N-CA-C 107.82 -1.178 . . . . 72.03 107.82 168.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -86.65 150.03 8.71 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.377 2.051 . . . . 75.42 113.294 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -82.83 81.49 8.53 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 105.953 -1.869 . . . . 72.43 105.953 168.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -69.33 99.51 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-N 114.367 -1.288 . . . . 73.51 109.444 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -96.14 112.14 23.96 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 113.787 -1.551 . . . . 73.21 109.026 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.59 141.99 28.6 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.604 -0.517 . . . . 74.22 109.604 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.452 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 24.1 t70 -135.66 147.09 48.44 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.575 1.15 . . . . 72.15 108.367 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.61 157.13 44.48 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.082 0.553 . . . . 74.42 111.145 -173.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.593 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 17.1 t70 -140.74 144.97 35.83 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.958 0.903 . . . . 72.33 109.029 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -112.78 112.51 24.05 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.19 -0.67 . . . . 64.15 109.19 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.48 150.35 44.0 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.035 0.934 . . . . 75.43 108.787 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 37.7 p -165.99 157.63 13.94 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.363 0.265 . . . . 73.51 111.658 -174.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 23.4 p -166.1 127.73 1.86 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.82 0.848 . . . . 71.41 109.681 173.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -72.12 130.82 41.79 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 108.917 -0.771 . . . . 73.1 108.917 168.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.528 HD13 HD13 ' C' ' 83' ' ' ILE . 60.0 mt -97.64 -37.0 10.09 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.274 0.63 . . . . 74.35 111.264 -175.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.27 -171.39 2.38 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.003 0.521 . . . . 64.44 111.746 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -57.94 109.12 0.68 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.921 1.288 . . . . 74.12 110.081 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 69.67 -7.15 0.92 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 125.224 1.41 . . . . 74.53 112.668 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.7 t -94.0 112.32 26.65 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 N-CA-C 108.061 -1.089 . . . . 73.31 108.061 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -120.17 159.75 24.27 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.128 -0.942 . . . . 72.13 108.492 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -126.66 123.62 37.98 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.237 0.615 . . . . 65.34 110.244 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.488 HG11 ' HD3' ' C' ' 103' ' ' PRO . 89.6 t -104.66 128.19 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 107.974 -1.121 . . . . 64.42 107.974 171.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -121.23 130.98 74.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.071 -1.085 . . . . 74.34 108.071 170.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 29.4 tp -126.17 117.7 23.66 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.187 -1.412 . . . . 75.21 107.187 170.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.593 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 6.9 tmm_? -90.95 128.64 36.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.515 -0.766 . . . . 73.1 109.611 178.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.48 140.56 19.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.971 -1.122 . . . . 73.4 107.971 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 53.8 m -133.93 122.04 22.54 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.882 -0.785 . . . . 65.14 108.882 173.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.562 HG22 HG21 ' C' ' 114' ' ' ILE . 89.4 t -101.55 109.46 25.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 107.979 -1.119 . . . . 71.34 107.979 176.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.411 HG23 HD22 ' C' ' 75' ' ' LEU . 4.2 m -99.57 107.14 19.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.852 -1.166 . . . . 74.22 107.852 175.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.02 108.37 19.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.719 -1.586 . . . . 64.51 106.719 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.4 m -132.23 127.95 36.84 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.149 -0.686 . . . . 73.0 109.149 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.711 HD11 ' HG2' ' C' ' 34' ' ' LYS . 8.2 mt -85.13 48.99 1.65 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.907 1.283 . . . . 72.44 109.56 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.15 -113.63 4.49 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 109.747 -1.341 . . . . 71.41 109.747 -168.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.69 -19.96 17.91 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.411 0.684 . . . . 63.03 110.526 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -67.24 120.66 14.16 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.866 0.867 . . . . 72.32 108.756 169.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.7 m -84.29 125.61 32.41 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 118.764 0.711 . . . . 74.43 109.295 173.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.736 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.79 -63.54 1.28 Allowed 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.364 -0.976 . . . . 74.03 108.364 173.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -155.77 173.09 17.24 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.274 -0.875 . . . . 74.51 110.663 174.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.411 HD22 HG23 ' C' ' 65' ' ' THR . 2.3 tm? -131.03 141.17 50.19 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 105.089 -2.189 . . . . 73.43 105.089 169.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.521 ' SG ' HG22 ' C' ' 114' ' ' ILE . 47.2 t -142.99 136.94 28.96 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.559 -1.274 . . . . 62.12 107.559 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . 0.521 ' HG3' ' HD3' ' C' ' 61' ' ' ARG . 24.4 tt0 -146.4 120.38 9.38 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.658 0.383 . . . . 73.12 110.396 -173.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 54.6 t -129.72 115.9 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.135 0.974 . . . . 73.3 109.231 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.499 ' HG2' ' HB2' ' C' ' 61' ' ' ARG . 22.6 mt-30 -89.56 99.4 12.41 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.747 -1.205 . . . . 74.2 107.747 170.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.515 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 9.0 tp-100 -87.88 109.76 20.02 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.825 -0.806 . . . . 73.2 108.825 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.33 145.45 17.6 Favored Glycine 0 C--N 1.341 0.819 0 O-C-N 123.6 0.562 . . . . 74.01 111.88 176.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.82 126.14 2.67 Favored Glycine 0 CA--C 1.506 -0.487 0 N-CA-C 110.921 -0.872 . . . . 71.2 110.921 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.528 HD13 HD13 ' C' ' 51' ' ' LEU . 9.6 mm -87.27 117.83 32.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 108.383 -0.969 . . . . 64.35 108.383 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.416 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 41.7 m-85 -129.17 120.99 26.78 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.227 1.011 . . . . 74.34 109.256 -173.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 57.3 p -79.4 109.11 13.45 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.633 -0.877 . . . . 74.11 108.633 172.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 70.5 mt -119.86 130.43 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.283 1.033 . . . . 72.14 108.855 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.63 158.52 26.24 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.741 0.816 . . . . 74.42 110.189 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.1 -57.87 1.05 Allowed Glycine 0 C--N 1.345 1.035 0 O-C-N 123.296 0.372 . . . . 71.25 113.217 174.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 37.9 pt -85.41 161.28 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 122.909 0.483 . . . . 74.04 111.398 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.469 ' HA ' ' HE1' ' C' ' 94' ' ' MET . 10.9 pt-20 -152.73 -178.56 6.96 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.92 0.888 . . . . 74.14 110.465 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.85 -139.39 42.91 Favored Glycine 0 C--N 1.349 1.263 0 O-C-N 123.379 0.425 . . . . 73.0 112.845 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.9 p -64.34 -19.86 65.73 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.54 0.736 . . . . 73.21 111.753 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -64.76 -55.92 16.78 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.496 0.718 . . . . 75.03 110.243 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.469 ' HE1' ' HA ' ' C' ' 90' ' ' GLU . 10.6 ptp -71.97 -29.82 64.64 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 116.579 -0.282 . . . . 74.53 110.479 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.47 -32.68 74.19 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.205 0.602 . . . . 72.5 111.51 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -77.43 -37.2 52.18 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.407 0.683 . . . . 72.32 110.069 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.556 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 28.8 t -59.61 -40.08 86.34 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.862 0.726 . . . . 72.33 110.613 175.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' C' ' 94' ' ' MET . 67.7 mt -81.49 -40.22 23.56 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.025 0.93 . . . . 75.23 111.54 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.01 -13.68 82.94 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.414 -0.812 . . . . 72.43 114.843 -168.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.571 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -157.97 -54.71 0.07 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 117.237 0.519 . . . . 72.21 112.388 -173.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.556 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 82.4 t80 -57.5 -40.59 79.01 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.711 1.204 . . . . 71.14 113.736 -172.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 89.3 m -82.08 -44.87 1.02 Allowed Pre-proline 0 CA--C 1.561 1.388 0 CA-C-O 118.784 -0.627 . . . . 73.43 112.361 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.488 ' HD3' HG11 ' C' ' 58' ' ' VAL . 37.1 Cg_endo -68.3 -7.79 21.09 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 121.624 1.549 . . . . 74.14 114.287 170.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . 0.547 HD22 ' HB3' ' C' ' 133' ' ' PHE . 0.9 OUTLIER -68.13 -30.97 70.24 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 123.396 0.678 . . . . 75.11 110.741 168.023 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.424 HG22 ' NH1' ' A' ' 111' ' ' ARG . 41.8 mm -68.33 -40.46 82.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-N 115.416 -0.811 . . . . 71.11 109.519 173.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 61.2 mt -83.08 -26.76 30.78 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.323 -1.308 . . . . 74.12 112.166 -168.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . 0.417 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 89.7 t80 -56.14 -53.93 58.13 Favored Pre-proline 0 CA--C 1.562 1.438 0 CA-C-O 118.07 -0.967 . . . . 70.44 112.754 -176.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . 0.417 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 36.1 Cg_exo -59.42 -36.68 93.21 Favored 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 122.319 2.012 . . . . 72.54 113.221 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . 0.437 ' CD1' HG21 ' C' ' 16' ' ' ILE . 4.4 m-30 -63.73 -50.76 67.86 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.156 0.982 . . . . 72.42 111.059 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.515 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -71.21 -29.89 65.7 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.331 -0.849 . . . . 74.41 111.215 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -61.79 -47.82 83.43 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.598 1.159 . . . . 71.25 110.647 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -71.02 -33.71 70.63 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.891 0.476 . . . . 73.42 110.025 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.532 ' SG ' HG12 ' C' ' 21' ' ' ILE . 44.6 t -64.44 -37.1 86.35 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.12 0.568 . . . . 61.43 111.282 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.562 HG21 HG22 ' C' ' 64' ' ' VAL . 97.0 mt -71.7 -51.77 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.155 0.582 . . . . 73.12 110.352 174.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.0 m -62.4 -28.4 69.75 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.124 0.57 . . . . 73.11 111.426 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.416 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 42.5 t -64.07 -49.94 70.3 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.141 -0.688 . . . . 62.14 109.141 170.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.556 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.45 -33.57 75.85 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.286 1.035 . . . . 73.31 112.662 179.658 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.446 HG23 ' O ' ' C' ' 114' ' ' ILE . 58.3 t -62.83 -44.6 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 109.085 -0.709 . . . . 73.54 109.085 175.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 39.9 t -70.8 -31.0 67.61 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.801 -1.09 . . . . 75.03 111.93 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' C' ' 116' ' ' SER . 90.8 mtt-85 -68.97 -37.49 78.83 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.33 0.652 . . . . 74.33 109.342 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.85 6.87 79.62 Favored Glycine 0 C--N 1.353 1.521 0 O-C-N 123.967 0.792 . . . . 73.1 112.639 174.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 50.7 p 57.34 28.56 15.47 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.278 1.831 . . . . 75.23 114.294 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -83.95 144.63 45.03 Favored Pre-proline 0 N--CA 1.472 0.628 0 N-CA-C 109.059 -0.719 . . . . 73.41 109.059 172.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.81 153.31 37.68 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.67 2.247 . . . . 74.21 112.4 175.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -53.85 129.35 33.37 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.042 0.937 . . . . 72.0 113.487 -170.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 31.3 tp -131.72 84.65 2.18 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 107.054 -1.461 . . . . 72.41 107.054 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -98.16 106.1 18.35 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.462 -1.245 . . . . 72.55 108.425 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.38 138.39 58.51 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.31 0.644 . . . . 75.53 111.213 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.74 133.88 90.4 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 124.088 0.868 . . . . 73.4 110.711 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.45 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 32.2 Cg_endo -65.15 107.74 1.01 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.53 2.153 . . . . 61.54 112.492 176.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 23.7 m -100.33 131.3 48.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 108.941 -0.762 . . . . 75.51 108.941 170.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . 0.427 HD22 ' HE1' ' A' ' 11' ' ' PHE . 3.3 m-20 -72.01 84.89 0.99 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.016 -0.538 . . . . 75.35 109.567 177.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . 0.547 ' HB3' HD22 ' C' ' 104' ' ' ASN . 39.1 t80 -65.07 -31.67 72.99 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.227 -0.897 . . . . 73.53 111.32 -172.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.571 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 32.0 t70 . . . . . 0 N--CA 1.481 1.123 0 C-N-CA 122.747 0.419 . . . . 74.53 111.584 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 67.4 m . . . . . 0 C--O 1.242 0.668 0 N-CA-C 109.479 -0.564 . . . . 75.01 109.479 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -137.56 119.14 14.93 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.042 -1.095 . . . . 71.3 108.042 -175.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -130.88 129.84 42.79 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.315 -0.994 . . . . 63.11 108.315 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.485 HG21 HD13 ' D' ' 16' ' ' ILE . 56.1 mt -79.05 129.53 37.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.985 -0.746 . . . . 72.04 108.985 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -105.14 -28.39 11.02 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 119.037 -0.506 . . . . 74.24 111.74 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -176.82 140.41 0.33 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 118.157 0.435 . . . . 74.42 111.52 -173.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.485 HD13 HG21 ' D' ' 13' ' ' ILE . 3.0 mp -123.53 136.31 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.566 -1.272 . . . . 74.14 107.566 171.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.423 ' HE1' HG13 ' D' ' 83' ' ' ILE . 28.6 p90 -162.81 175.07 11.64 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-O 122.078 0.942 . . . . 75.33 112.231 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -109.71 122.51 47.65 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.049 -1.432 . . . . 71.42 108.814 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -93.17 -31.81 14.63 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.3 -0.63 . . . . 74.42 109.3 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.419 ' HB2' ' HB2' ' D' ' 79' ' ' GLN . 6.5 m-20 -142.36 131.57 23.39 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 108.315 -0.994 . . . . 63.51 108.315 177.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.556 HG23 ' HE1' ' C' ' 117' ' ' MET . 89.0 mt -128.6 150.29 34.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.505 -1.294 . . . . 75.42 107.505 172.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 22' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 47.3 t -151.69 139.39 19.76 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.258 1.023 . . . . 75.44 108.923 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 84.1 t80 -152.86 127.66 9.53 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.464 -2.05 . . . . 73.31 105.464 169.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -135.96 134.59 38.79 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.876 -1.157 . . . . 75.43 107.876 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.88 90.53 46.81 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 108.032 -1.099 . . . . 63.42 108.032 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.44 -41.07 12.68 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.802 2.335 . . . . 75.24 112.688 -172.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.48 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 27.7 m-20 -106.03 9.81 32.38 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.658 0.783 . . . . 72.02 110.737 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -19.44 -70.26 0.03 OUTLIER Pre-proline 0 CA--C 1.563 1.458 0 N-CA-C 117.396 2.369 . . . . 61.52 117.396 -165.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.05 -24.03 13.15 Favored 'Trans proline' 0 C--N 1.382 2.321 0 CA-C-N 123.647 2.338 . . . . 74.4 113.969 -174.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -75.1 -41.07 59.39 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.265 1.026 . . . . 72.15 110.522 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.599 HG21 ' HA ' ' D' ' 73' ' ' ALA . 12.3 p -75.82 -20.22 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 115.856 -0.611 . . . . 75.2 111.243 -173.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -66.64 -20.04 65.9 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 112.699 0.629 . . . . 73.12 112.699 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -59.1 -26.17 64.44 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.769 0.828 . . . . 73.24 110.627 176.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.484 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 99.3 mttt -91.46 108.72 20.09 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.894 1.278 . . . . 74.25 110.17 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -105.84 88.77 2.89 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.948 0.899 . . . . 74.41 110.978 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 45.5 p90 -161.14 177.26 10.43 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.382 1.073 . . . . 75.3 108.339 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -72.85 115.52 40.91 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 108.845 -0.798 . . . . 75.44 108.845 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -60.82 130.47 33.17 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.33 2.02 . . . . 70.04 111.212 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -63.54 114.44 3.92 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.454 -0.943 . . . . 73.21 108.454 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.494 HG13 HD22 ' D' ' 126' ' ' LEU . 31.1 m -106.91 112.05 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-O 121.526 0.679 . . . . 75.13 110.094 -174.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.423 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 12.0 tmtt? -84.49 119.15 24.83 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 106.467 -1.679 . . . . 75.03 106.467 174.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 pp -95.6 150.38 20.41 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.135 0.493 . . . . 75.31 110.187 -173.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.526 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 13.0 t70 -151.29 119.66 6.4 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.023 -0.99 . . . . 74.44 108.741 -176.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.52 133.84 52.6 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.764 -0.458 . . . . 74.24 109.764 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 31.4 t70 -132.99 157.55 44.92 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.094 -1.076 . . . . 75.4 108.094 176.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -119.93 153.88 35.26 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.395 0.617 . . . . 62.45 112.106 -173.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.653 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.72 152.86 33.31 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.215 1.406 . . . . 63.13 107.885 172.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 21.1 p -164.63 152.37 11.86 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.69 0.223 . . . . 65.51 110.967 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 60.3 p -164.23 135.02 4.3 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.485 0.714 . . . . 72.42 109.756 177.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -77.71 136.47 38.18 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.851 -0.796 . . . . 71.43 108.851 172.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' D' ' 57' ' ' GLU . 40.2 mt -103.24 -35.05 8.59 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.88 0.472 . . . . 75.42 110.375 -177.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.53 -174.0 3.55 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.746 0.818 . . . . 61.45 109.954 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.23 114.92 3.73 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.232 -0.895 . . . . 72.24 110.238 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 63.87 12.2 6.58 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.788 1.235 . . . . 75.4 112.761 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 76.4 t -109.03 122.67 64.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 106.936 -1.505 . . . . 70.34 106.936 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.623 ' HB3' HD11 ' D' ' 86' ' ' ILE . 16.5 t80 -143.06 131.04 21.68 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.769 -0.456 . . . . 74.41 109.769 -173.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.408 ' HB2' HD11 ' D' ' 51' ' ' LEU . 8.1 tt0 -99.7 130.97 45.97 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.052 0.941 . . . . 73.41 109.747 177.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.1 t -119.63 127.13 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.275 -1.009 . . . . 72.34 108.275 174.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.653 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 11.5 t -112.81 135.69 51.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 124.086 0.954 . . . . 72.54 108.725 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' D' ' 103' ' ' PRO . 11.5 tp -125.47 116.87 22.5 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.631 -0.507 . . . . 75.54 109.631 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.446 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 17.9 ttm-85 -83.86 103.14 12.89 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.74 0.816 . . . . 72.34 109.383 175.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 62.1 t -93.27 120.24 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.279 -1.008 . . . . 74.4 108.279 170.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 12.2 m -120.66 146.94 45.9 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 122.963 0.505 . . . . 74.15 109.755 -175.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.418 HG13 ' HB ' ' D' ' 40' ' ' VAL . 53.7 t -137.48 103.88 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 125.383 1.473 . . . . 75.32 109.033 -175.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 48.1 m -94.12 96.96 9.97 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.567 -0.901 . . . . 74.24 108.567 169.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.471 ' HB1' HG12 ' D' ' 40' ' ' VAL . . . -97.96 153.07 18.61 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.694 -0.685 . . . . 70.31 109.802 -171.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.411 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.9 p -155.54 128.61 8.14 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 123.559 0.537 . . . . 52.13 112.11 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.545 HD11 HG23 ' D' ' 31' ' ' VAL . 45.7 mt -96.66 96.18 8.45 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.832 -1.173 . . . . 74.55 107.832 169.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -136.14 17.72 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.808 -0.633 . . . . 74.44 112.719 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -84.41 3.15 37.39 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.547 0.739 . . . . 65.31 111.742 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.484 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 12.7 pt-20 -125.01 147.84 48.75 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.998 -0.371 . . . . 70.0 109.998 -178.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 61.8 m -65.02 135.38 55.54 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 123.825 0.703 . . . . 72.24 111.32 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.599 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -85.61 -65.36 1.02 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.387 -0.968 . . . . 71.53 108.387 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -155.14 144.11 20.83 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.605 -0.725 . . . . 72.24 110.691 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 66.3 mt -106.83 107.67 18.81 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.727 -1.212 . . . . 74.33 107.727 172.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.49 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 45.9 t -121.52 141.41 51.07 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.764 0.826 . . . . 71.01 109.527 -174.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . 0.432 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 21.8 tt0 -154.8 136.68 14.54 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.138 0.575 . . . . 71.41 109.487 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 82.0 t -136.76 114.88 14.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.956 -0.757 . . . . 73.42 108.956 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.419 ' HB2' ' HB2' ' D' ' 20' ' ' ASP . 69.6 mt-30 -87.88 86.93 7.21 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 107.592 -1.262 . . . . 64.54 107.592 170.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -79.89 104.02 10.18 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 114.31 -1.313 . . . . 65.34 108.116 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -107.09 143.09 15.8 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 111.557 -0.617 . . . . 71.14 111.557 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.14 138.34 9.27 Favored Glycine 0 CA--C 1.506 -0.497 0 N-CA-C 111.643 -0.583 . . . . 74.21 111.643 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.423 HG13 ' HE1' ' D' ' 17' ' ' TYR . 74.2 mt -86.58 121.4 37.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.199 -1.408 . . . . 75.3 107.199 172.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -125.33 165.8 17.7 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.288 0.635 . . . . 72.04 109.406 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 4.6 t -112.55 105.41 13.62 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.794 -1.188 . . . . 73.45 107.794 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.623 HD11 ' HB3' ' D' ' 56' ' ' TYR . 3.3 mp -107.95 105.76 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 108.328 -0.99 . . . . 73.04 108.328 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.72 147.04 49.98 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.328 0.651 . . . . 73.22 110.44 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.11 13.62 76.76 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-O 119.193 -0.781 . . . . 74.53 114.91 172.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.497 HG23 ' N ' ' D' ' 90' ' ' GLU . 7.6 mt -97.57 157.88 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 118.334 1.067 . . . . 74.32 110.477 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.497 ' N ' HG23 ' D' ' 89' ' ' ILE . 1.1 pp20? -153.11 -177.81 6.54 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.446 1.098 . . . . 72.02 108.979 163.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.44 -141.96 47.94 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.532 0.587 . . . . 71.21 113.694 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 7.4 m -89.96 -9.92 46.99 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.556 1.142 . . . . 71.04 111.379 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.74 -28.45 68.7 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.045 0.538 . . . . 74.12 111.043 -176.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 18.1 ptt? -70.98 -32.35 69.17 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 119.462 -0.304 . . . . 74.13 111.42 176.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.42 84.0 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 120.775 0.322 . . . . 72.45 110.146 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -65.56 -43.82 88.69 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.601 -0.727 . . . . 71.54 110.949 171.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.4 t -61.5 -49.96 74.63 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.886 0.474 . . . . 74.41 110.656 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 19.4 mt -83.19 -20.51 34.51 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.054 0.942 . . . . 74.45 111.518 -173.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.83 5.93 34.98 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 114.131 0.413 . . . . 63.14 114.131 -174.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.44 -66.45 0.29 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.557 0.343 . . . . 72.41 110.855 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -70.25 -52.05 25.98 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.565 0.58 . . . . 74.14 112.565 -170.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.481 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 56.8 m -58.38 -47.63 98.44 Favored Pre-proline 0 CA--C 1.562 1.42 0 C-N-CA 123.53 0.732 . . . . 73.33 111.388 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.628 ' HB3' HD21 ' D' ' 60' ' ' LEU . 51.7 Cg_exo -59.4 -39.7 74.22 Favored 'Trans proline' 0 C--N 1.397 3.115 0 C-N-CA 122.231 1.954 . . . . 62.05 113.277 169.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -59.31 -36.17 75.12 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.9 0.88 . . . . 74.43 110.697 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.419 HG23 HD11 ' D' ' 13' ' ' ILE . 46.2 mm -63.5 -36.92 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.514 0.726 . . . . 64.01 110.597 174.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 73.6 mt -84.43 -13.82 51.04 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 115.221 -0.9 . . . . 74.52 112.371 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -56.68 -50.36 88.4 Favored Pre-proline 0 N--CA 1.5 2.048 0 C-N-CA 124.072 0.949 . . . . 74.34 113.46 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.38 -41.12 81.29 Favored 'Trans proline' 0 C--N 1.392 2.826 0 C-N-CA 122.181 1.921 . . . . 71.12 112.948 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -75.88 -37.98 58.33 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.329 1.052 . . . . 73.14 112.484 -175.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.94 -43.52 71.44 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.08 0.552 . . . . 74.21 110.346 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.42 ' NH2' HG22 ' B' ' 105' ' ' ILE . 46.6 ttp180 -62.28 -47.78 82.81 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.595 -0.729 . . . . 73.1 110.438 176.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -61.28 -45.76 93.13 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.416 0.686 . . . . 74.15 110.757 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.2 t -59.46 -44.5 92.97 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.657 0.598 . . . . 73.31 111.159 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.437 ' O ' HG22 ' D' ' 118' ' ' VAL . 65.5 mt -60.05 -57.64 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.323 0.649 . . . . 73.51 110.326 174.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.9 m -53.43 -41.87 66.49 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.668 1.187 . . . . 74.03 112.673 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 45.6 t -67.19 -41.74 85.34 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.214 -0.903 . . . . 75.33 110.222 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.49 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 73.4 mtm -68.77 -32.49 72.26 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.903 0.481 . . . . 74.41 111.428 178.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.437 HG22 ' O ' ' D' ' 114' ' ' ILE . 78.0 t -65.76 -43.52 93.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.644 0.777 . . . . 73.02 110.264 176.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.3 p -74.17 -30.36 62.21 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.589 0.356 . . . . 75.53 111.176 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 74.5 mtt-85 -71.75 -27.95 63.32 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.695 0.798 . . . . 74.44 110.373 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.93 7.89 78.42 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-N 115.8 -0.636 . . . . 74.25 112.072 171.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 62.3 p 59.5 15.89 4.85 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 127.015 2.126 . . . . 73.41 113.792 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -78.77 157.98 76.08 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.794 0.838 . . . . 71.11 110.462 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.63 127.34 25.52 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.085 2.523 . . . . 75.12 113.069 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -52.97 136.93 33.96 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.264 1.026 . . . . 74.23 112.048 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.494 HD22 HG13 ' D' ' 40' ' ' VAL . 57.3 tp -118.16 108.77 15.58 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.796 0.838 . . . . 73.54 109.395 -177.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -106.73 99.06 8.66 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.008 -0.738 . . . . 74.1 109.008 175.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.86 130.2 41.05 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.193 -0.669 . . . . 74.32 109.193 173.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.02 137.81 97.16 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.338 0.655 . . . . 63.52 110.427 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -69.44 111.02 2.63 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.644 2.229 . . . . 72.44 110.905 -177.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 109.226 -0.657 . . . . 75.34 109.226 -177.103 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.691 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 22.0 t80 . . . . . 0 C--O 1.238 0.494 0 N-CA-C 109.048 -0.723 . . . . 75.44 109.048 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -149.71 112.75 4.87 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.369 0.668 . . . . 74.53 109.299 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.642 HG12 ' HD2' ' A' ' 84' ' ' PHE . 27.5 mt -83.05 116.15 26.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.555 -0.905 . . . . 71.01 108.555 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.454 ' HB3' HG21 ' A' ' 83' ' ' ILE . 35.2 tt0 -79.28 -36.41 39.79 Favored 'General case' 0 C--O 1.242 0.702 0 O-C-N 123.895 0.747 . . . . 72.15 110.258 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -171.9 142.74 1.53 Allowed 'General case' 0 C--N 1.355 0.844 0 CA-C-N 116.374 -0.375 . . . . 70.43 110.457 -170.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.543 HD13 ' HB3' ' C' ' 130' ' ' PRO . 76.8 mt -133.66 141.31 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 124.243 1.017 . . . . 74.53 109.083 172.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.511 ' HB3' HG23 ' B' ' 122' ' ' THR . 21.1 p90 -165.56 171.9 12.63 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 124.356 1.035 . . . . 73.42 110.499 -172.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.4 p -94.61 119.46 33.31 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.484 -0.932 . . . . 63.42 108.484 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.466 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 35.2 mtpt -83.01 -36.16 25.23 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.019 0.438 . . . . 75.15 109.828 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 16.2 t70 -145.72 126.02 13.93 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.114 -0.948 . . . . 75.22 109.1 -178.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.548 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 77.4 mt -118.78 142.32 34.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.864 -1.161 . . . . 72.44 107.864 172.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.0 t -150.53 125.82 10.06 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.784 -0.821 . . . . 73.42 108.784 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.632 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 75.3 t80 -127.48 121.97 32.16 Favored 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 106.867 -1.531 . . . . 75.41 106.867 174.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -124.09 118.29 26.6 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.18 -0.674 . . . . 74.15 109.18 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.48 79.64 4.22 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 106.867 -1.531 . . . . 74.03 106.867 168.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.49 -24.58 26.19 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.539 2.159 . . . . 71.14 112.915 -166.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -114.04 23.21 13.16 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 118.16 -0.924 . . . . 74.11 109.504 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.416 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -40.96 -58.14 2.88 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 114.192 1.182 . . . . 73.34 114.192 -166.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.416 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 18.0 Cg_exo -65.72 -24.65 54.61 Favored 'Trans proline' 0 C--N 1.389 2.675 0 CA-C-N 121.83 1.689 . . . . 73.11 113.245 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -83.48 -37.57 22.95 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.3 1.04 . . . . 73.22 110.833 -176.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.646 HG22 ' HA ' ' A' ' 73' ' ' ALA . 8.0 p -76.94 -23.82 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-N 115.589 -0.732 . . . . 74.52 111.348 -168.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -68.91 -25.18 64.46 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.884 0.474 . . . . 73.1 110.877 174.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -75.5 -33.02 60.73 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.027 0.931 . . . . 74.33 110.027 175.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -70.94 168.2 17.46 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.43 1.092 . . . . 75.41 111.469 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.87 145.76 27.64 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.828 -0.623 . . . . 75.53 110.025 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.411 ' CE3' HD21 ' A' ' 68' ' ' LEU . 75.1 t-105 -93.86 88.84 5.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.265 0.626 . . . . 75.41 109.583 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -135.2 79.97 48.35 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 107.113 -1.44 . . . . 73.01 107.113 170.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -91.82 165.33 3.3 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.269 2.646 . . . . 74.42 114.889 -170.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.71 126.77 39.05 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.954 -1.021 . . . . 74.01 108.7 164.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.545 HG12 HG13 ' A' ' 64' ' ' VAL . 59.8 t -86.82 105.1 14.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.259 -0.645 . . . . 74.25 109.259 174.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -80.89 123.27 28.15 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.604 -1.18 . . . . 74.11 108.488 171.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -96.39 109.32 21.87 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.374 0.669 . . . . 74.42 109.394 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.696 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 15.5 m-20 -110.14 119.82 40.48 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.532 -0.914 . . . . 73.53 108.532 172.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.739 HD23 HD21 ' A' ' 60' ' ' LEU . 6.3 mp -120.84 136.8 54.82 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.056 0.455 . . . . 75.42 111.103 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -134.72 121.27 20.54 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.36 -1.348 . . . . 71.21 107.36 174.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.465 HG21 ' HG ' ' A' ' 60' ' ' LEU . 43.8 p -107.74 136.51 47.37 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.261 0.624 . . . . 75.34 110.47 -172.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.89 145.56 51.04 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.048 0.939 . . . . 75.31 109.464 -178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.5 m -131.7 152.92 50.53 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.844 0.857 . . . . 53.23 109.569 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.496 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 46.7 t -150.1 142.86 24.67 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.632 0.773 . . . . 72.54 109.678 -175.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -101.56 104.32 15.2 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.029 -1.1 . . . . 70.34 108.029 172.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.761 HD12 ' HB2' ' A' ' 57' ' ' GLU . 59.4 mt -81.52 -41.5 21.59 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.921 -0.581 . . . . 73.4 110.295 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.88 -174.53 4.89 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.448 -0.796 . . . . 65.11 110.474 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.8 118.24 7.45 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.693 0.797 . . . . 61.23 110.057 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.28 -6.04 0.83 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.959 1.304 . . . . 71.21 112.74 -177.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.0 t -104.34 113.24 40.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 N-CA-C 108.191 -1.04 . . . . 71.42 108.191 -175.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -120.66 167.26 12.64 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.796 0.838 . . . . 75.53 109.429 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.761 ' HB2' HD12 ' A' ' 51' ' ' LEU . 36.3 tt0 -129.93 128.21 41.68 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.275 1.03 . . . . 73.35 108.789 174.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.428 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 53.4 t -109.89 122.79 65.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.076 -1.083 . . . . 63.2 108.076 169.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.5 t -110.14 136.38 46.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.14 -1.059 . . . . 75.32 108.14 171.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.739 HD21 HD23 ' A' ' 44' ' ' LEU . 3.3 tt -129.98 122.1 27.82 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.575 -0.898 . . . . 73.51 108.575 175.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.5 ttm-85 -85.66 103.03 14.1 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.518 1.127 . . . . 63.21 109.471 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.7 t -94.8 102.36 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 107.532 -1.284 . . . . 72.43 107.532 171.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.696 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 23.9 m -102.1 107.86 19.09 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.888 -0.782 . . . . 72.15 108.888 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.545 HG13 HG12 ' A' ' 40' ' ' VAL . 19.2 t -104.47 112.91 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 124.976 1.31 . . . . 72.11 109.121 -176.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 3.2 m -112.56 124.91 53.58 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 108.839 -0.8 . . . . 61.4 108.839 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.0 113.26 26.58 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.577 -1.268 . . . . 72.45 107.577 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.5 m -113.95 122.49 47.11 Favored 'General case' 0 C--N 1.351 0.637 0 CA-C-N 118.478 0.581 . . . . 74.25 110.903 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.42 HD13 ' HB1' ' A' ' 73' ' ' ALA . 17.5 mt -92.91 79.88 4.64 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 125.582 1.553 . . . . 75.11 107.677 173.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.46 -101.99 1.44 Allowed Glycine 0 C--N 1.34 0.801 0 CA-C-N 115.398 -0.819 . . . . 61.02 111.433 -175.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -106.64 -1.37 22.9 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.726 0.81 . . . . 73.42 111.292 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -107.33 136.69 46.71 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.956 0.903 . . . . 73.31 110.101 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.1 m -87.45 124.39 33.38 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 118.095 0.407 . . . . 61.21 110.002 167.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.646 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -73.77 -55.1 6.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.433 1.093 . . . . 74.24 109.695 174.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -152.24 164.91 36.41 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 114.45 -1.25 . . . . 74.51 111.687 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 36.0 tp -134.36 105.83 6.79 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.205 -1.361 . . . . 70.2 107.64 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.503 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 61.7 m -108.14 98.8 8.3 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.844 0.858 . . . . 75.2 109.813 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -105.4 125.44 50.99 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.384 0.674 . . . . 72.34 109.424 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.8 t -131.0 112.61 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.252 0.621 . . . . 74.15 109.545 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.521 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 78.3 mt-30 -84.33 87.9 7.23 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.324 1.05 . . . . 64.45 108.471 171.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.471 ' HG3' HD23 ' A' ' 106' ' ' LEU . 8.3 tp-100 -79.53 109.76 14.21 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.869 -1.059 . . . . 73.14 109.416 -177.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.56 146.02 18.09 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 111.481 -0.648 . . . . 74.34 111.481 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.2 124.9 2.04 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 111.387 -0.685 . . . . 61.1 111.387 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.454 HG21 ' HB3' ' A' ' 14' ' ' GLN . 49.0 mt -82.94 110.23 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.347 0.659 . . . . 73.43 109.519 176.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.691 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 36.3 m-85 -121.94 120.33 34.12 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.838 0.855 . . . . 75.34 108.747 -177.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.8 m -89.95 101.32 14.02 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.756 -0.831 . . . . 74.22 108.756 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.2 pt . . . . . 0 N--CA 1.484 1.248 0 C-N-CA 123.145 0.578 . . . . 74.41 110.753 -176.214 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.652 0.263 . . . . 42.21 111.707 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -76.03 -38.29 57.39 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.635 -0.711 . . . . 73.32 109.722 172.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.3 t -70.82 -32.81 69.99 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.261 0.624 . . . . 74.53 111.989 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 pp -101.17 -20.02 15.48 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.065 0.546 . . . . 73.34 111.833 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.04 -16.03 29.16 Favored Glycine 0 N--CA 1.478 1.492 0 N-CA-C 113.694 0.238 . . . . 72.12 113.694 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.54 -62.75 1.23 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.789 0.836 . . . . 74.41 109.64 179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.494 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 86.4 t80 -64.47 -60.79 2.74 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.463 1.105 . . . . 74.04 113.957 -167.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 84.7 m -65.71 -37.94 21.75 Favored Pre-proline 0 CA--C 1.566 1.593 0 N-CA-C 113.656 0.984 . . . . 72.43 113.656 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.91 -27.03 43.64 Favored 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 121.729 1.619 . . . . 75.52 112.783 167.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -77.68 -17.45 57.67 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.379 0.672 . . . . 72.31 110.473 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.401 HG22 HD11 ' A' ' 13' ' ' ILE . 43.1 mm -67.84 -41.53 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.89 -0.781 . . . . 72.34 108.89 169.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.471 HD23 ' HG3' ' A' ' 80' ' ' GLN . 90.4 mt -77.06 -21.32 54.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.149 0.979 . . . . 71.31 111.938 -178.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -59.9 -47.53 97.0 Favored Pre-proline 0 CA--C 1.574 1.878 0 C-N-CA 124.293 1.037 . . . . 74.14 113.578 -174.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.92 -40.6 33.95 Favored 'Trans proline' 0 C--N 1.393 2.888 0 C-N-CA 122.051 1.834 . . . . 73.45 112.97 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.461 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 97.5 m-85 -65.42 -44.04 88.64 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.812 0.695 . . . . 75.53 111.314 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.35 -31.81 64.17 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.519 0.728 . . . . 71.43 110.926 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.404 HH12 HD11 ' C' ' 105' ' ' ILE . 32.2 ttm180 -62.11 -50.4 72.07 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 109.321 -0.622 . . . . 73.21 109.321 170.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -66.85 -42.94 84.88 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.269 1.028 . . . . 74.34 112.202 -171.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.3 t -60.42 -42.92 97.01 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 123.786 0.679 . . . . 73.23 109.872 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.438 ' O ' HG23 ' A' ' 118' ' ' VAL . 57.9 mt -64.96 -46.07 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 114.811 -1.086 . . . . 74.02 110.686 175.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.3 m -57.66 -40.82 80.2 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.956 0.902 . . . . 73.54 111.304 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.1 t -66.41 -44.08 83.96 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 115.258 -0.883 . . . . 71.14 110.497 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.632 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 15.9 mtp -64.02 -36.84 85.3 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.895 0.878 . . . . 74.03 111.748 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 114' ' ' ILE . 51.5 t -63.09 -52.34 60.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 124.37 1.068 . . . . 71.24 110.005 176.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.6 t -65.52 -31.31 72.31 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.677 0.791 . . . . 73.52 111.578 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.441 ' HG2' ' HG1' ' B' ' 18' ' ' THR . 44.3 ttm-85 -75.23 -32.53 61.16 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.093 0.957 . . . . 75.25 109.467 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.97 17.04 38.92 Favored Glycine 0 C--N 1.355 1.607 0 CA-C-N 114.97 -1.014 . . . . 62.44 113.254 171.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.492 HG23 ' HE ' ' B' ' 15' ' ' ARG . 1.5 t 62.45 12.65 5.51 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 126.944 2.098 . . . . 74.34 113.838 174.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -79.96 146.5 63.8 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 123.409 0.684 . . . . 74.32 109.474 174.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.54 162.75 35.43 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.61 2.207 . . . . 75.32 113.095 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -54.81 129.2 36.29 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.318 1.447 . . . . 74.13 113.461 -168.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.461 HD12 HG23 ' A' ' 40' ' ' VAL . 59.5 tp -130.4 110.6 11.61 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.392 1.077 . . . . 73.31 109.67 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -125.73 117.19 22.93 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.275 1.03 . . . . 55.24 108.641 175.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.1 mp -66.83 140.75 57.83 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.493 0.717 . . . . 61.14 110.24 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -63.33 130.13 94.03 Favored Pre-proline 0 CA--C 1.552 1.034 0 O-C-N 123.778 0.673 . . . . 60.14 110.417 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 36.8 Cg_exo -64.6 113.63 2.39 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 123.168 2.579 . . . . 71.14 111.893 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.7 t -99.95 114.24 37.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.612 -1.255 . . . . 73.12 107.612 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -74.72 81.42 2.06 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.571 0.748 . . . . 64.23 109.806 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 . . . . . 0 N--CA 1.478 0.949 0 CA-C-N 115.545 -0.752 . . . . 72.44 110.169 179.731 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.559 ' HE1' ' SG ' ' B' ' 97' ' ' CYS . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 112.346 0.499 . . . . 75.43 112.346 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.499 ' N ' ' SD ' ' B' ' 9' ' ' MET . 94.0 m -149.64 109.18 4.0 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.866 1.266 . . . . 73.43 108.597 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' B' ' 85' ' ' SER . 35.5 t80 -130.76 138.23 49.84 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.914 0.486 . . . . 73.22 110.326 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -154.53 140.41 18.2 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.039 0.536 . . . . 74.02 110.479 175.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 17.9 mt -76.33 108.61 9.17 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 C-N-CA 123.7 0.8 . . . . 74.12 108.956 173.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -82.86 -43.64 16.36 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.349 -0.611 . . . . 75.13 109.349 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.492 ' HE ' HG23 ' A' ' 122' ' ' THR . 45.6 ttt180 -167.78 140.45 3.21 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.985 0.514 . . . . 74.52 110.612 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 62.9 mt -118.31 141.46 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 107.752 -1.203 . . . . 75.13 107.752 173.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.446 ' HE1' HG13 ' B' ' 83' ' ' ILE . 20.7 p90 -170.2 150.89 3.74 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.024 0.44 . . . . 70.33 111.721 -173.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.441 ' HG1' ' HG2' ' A' ' 120' ' ' ARG . 86.8 m -78.99 124.65 28.46 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.982 -0.747 . . . . 53.12 108.982 171.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -94.45 -27.72 15.86 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.419 0.688 . . . . 71.54 111.449 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -164.58 149.82 9.99 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.382 0.426 . . . . 72.01 111.777 -175.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.796 HD12 ' SG ' ' B' ' 113' ' ' CYS . 47.0 mm -140.26 142.81 30.73 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 C-N-CA 125.808 1.643 . . . . 75.41 109.344 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.555 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 46.5 t -139.17 131.92 29.08 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.261 -1.385 . . . . 73.33 107.261 171.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.548 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.7 t80 -144.46 122.52 12.11 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.1 -1.444 . . . . 64.22 107.1 170.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.411 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 40.4 mt-10 -130.61 119.73 22.92 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.148 0.979 . . . . 72.54 108.696 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.518 ' HB1' ' CB ' ' B' ' 28' ' ' ALA . . . -113.25 87.18 10.63 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 107.303 -1.369 . . . . 74.14 107.303 174.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.25 -44.86 0.72 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.6 2.2 . . . . 71.34 112.448 -174.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -92.76 5.72 50.14 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.419 1.088 . . . . 74.52 110.526 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.518 ' CB ' ' HB1' ' B' ' 25' ' ' ALA . . . -32.28 -63.24 0.26 Allowed Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 126.002 1.721 . . . . 70.15 115.406 -171.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.79 -48.44 21.24 Favored 'Trans proline' 0 C--N 1.402 3.364 0 C-N-CA 122.465 2.11 . . . . 71.21 113.27 -167.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -97.67 -18.02 19.12 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.361 0.874 . . . . 71.31 113.361 -171.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.541 HG21 HD13 ' B' ' 68' ' ' LEU . 7.6 p -74.15 -16.19 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 118.875 0.761 . . . . 74.34 110.639 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -58.17 -23.48 55.53 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.26 1.024 . . . . 75.32 113.569 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -61.19 -23.21 65.42 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.038 0.535 . . . . 72.33 111.407 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.463 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 91.2 mttt -91.47 99.47 12.4 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.066 0.947 . . . . 73.44 110.211 -177.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -100.42 80.05 2.19 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.501 -0.772 . . . . 73.22 110.363 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 42.7 p90 -155.02 171.16 20.2 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.443 1.097 . . . . 70.44 108.681 170.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -67.72 112.57 10.8 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 108.916 -0.772 . . . . 73.24 108.916 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.55 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 37.8 Cg_endo -65.74 144.08 76.48 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 121.715 1.61 . . . . 74.51 112.315 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -59.71 113.69 2.38 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.499 1.12 . . . . 73.02 109.83 177.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.647 HG13 HG11 ' B' ' 64' ' ' VAL . 81.6 t -92.23 127.26 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.645 0.778 . . . . 74.2 111.262 -173.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.46 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 38.4 tttp -104.62 107.54 18.54 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.017 -1.475 . . . . 73.43 107.017 173.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 pp -85.97 145.59 27.06 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 109.153 -0.684 . . . . 74.24 109.153 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.535 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 5.8 m-20 -142.07 110.9 6.21 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 106.992 -1.485 . . . . 74.55 106.992 171.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -98.85 135.31 40.49 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.336 -1.357 . . . . 74.32 107.336 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -144.99 156.28 43.86 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.989 -1.115 . . . . 73.33 107.989 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 6.1 t -137.14 142.76 42.25 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.457 0.646 . . . . 62.44 110.507 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.43 145.36 35.2 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.27 -1.382 . . . . 75.33 107.27 174.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.8 p -146.39 166.45 26.32 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.853 0.297 . . . . 73.14 111.143 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.5 p -151.41 137.74 18.49 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.189 0.996 . . . . 75.23 109.103 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -92.86 110.74 22.19 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.026 -0.731 . . . . 75.34 109.026 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.481 HD12 HG22 ' B' ' 83' ' ' ILE . 22.9 mt -75.59 -46.68 30.4 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.683 0.754 . . . . 65.11 109.635 -178.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.51 179.45 7.8 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 114.572 -1.195 . . . . 74.14 109.774 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -74.92 128.9 36.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.658 -1.155 . . . . 75.23 108.179 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 73.69 -4.77 2.16 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 125.798 1.639 . . . . 71.15 112.83 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 62.2 t -114.18 113.75 44.7 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 N-CA-C 108.253 -1.017 . . . . 75.22 108.253 172.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.627 ' HB3' HD11 ' B' ' 86' ' ' ILE . 23.1 t80 -125.44 138.25 54.01 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.663 -0.865 . . . . 74.34 108.663 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -113.76 119.75 38.45 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.388 -1.338 . . . . 74.12 107.388 -175.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.438 HG21 ' HB3' ' B' ' 102' ' ' CYS . 33.0 m -116.05 148.93 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.136 0.574 . . . . 74.13 110.37 -177.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 19.3 t -129.59 124.16 58.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 C-N-CA 123.652 0.781 . . . . 74.33 109.11 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 20.0 tp -101.83 108.95 20.6 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 109.318 -0.623 . . . . 64.42 109.318 171.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -88.36 118.47 27.99 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.386 0.674 . . . . 73.21 109.994 175.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.1 t -114.12 103.4 15.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 108.242 -1.022 . . . . 72.03 108.242 176.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.535 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 4.7 m -99.62 130.3 45.84 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.267 0.627 . . . . 74.12 109.383 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.647 HG11 HG13 ' B' ' 40' ' ' VAL . 54.3 t -128.43 102.28 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 124.271 1.029 . . . . 75.04 110.564 -176.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.46 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 31.9 m -83.71 150.01 26.11 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.279 -1.008 . . . . 71.41 108.279 165.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.89 147.91 42.96 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.04 0.536 . . . . 74.41 110.033 177.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 36.2 p -138.92 125.31 20.4 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.121 0.568 . . . . 72.25 110.374 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.55 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 53.2 mt -94.23 100.61 12.64 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.022 -1.473 . . . . 74.52 107.022 173.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.36 -114.27 3.95 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 115.006 -0.997 . . . . 63.2 110.833 -170.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.83 6.32 9.9 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.018 0.927 . . . . 73.14 110.676 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.463 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 11.4 pt-20 -114.39 152.32 31.7 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.389 0.676 . . . . 65.23 109.22 175.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.8 m -64.56 137.99 58.15 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 123.648 0.592 . . . . 74.04 111.15 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.468 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -93.19 -63.62 1.19 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.579 -1.267 . . . . 74.12 107.579 170.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -145.56 167.76 22.26 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 114.244 -1.343 . . . . 74.41 110.601 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.411 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 61.0 mt -130.78 140.89 50.33 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.491 -2.04 . . . . 75.32 105.491 172.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.9 t -146.92 158.54 43.95 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.639 -0.874 . . . . 73.12 108.639 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 41.7 tt0 -165.04 132.24 3.01 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.512 -0.922 . . . . 73.04 108.512 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.0 t -128.23 144.54 37.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 123.479 0.712 . . . . 73.51 109.184 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -120.57 101.05 7.49 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.951 -1.129 . . . . 71.51 107.951 169.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.479 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.5 tp-100 -90.71 102.53 15.28 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.147 -1.057 . . . . 74.54 108.147 175.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.5 158.93 27.95 Favored Glycine 0 C--O 1.245 0.79 0 CA-C-N 115.283 -0.871 . . . . 72.02 110.946 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.98 125.87 1.62 Allowed Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 111.02 -0.832 . . . . 64.22 111.02 -178.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.481 HG22 HD12 ' B' ' 51' ' ' LEU . 50.9 mt -85.0 125.28 40.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 106.902 -1.518 . . . . 74.11 106.902 172.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -134.38 154.75 51.19 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.047 -0.724 . . . . 64.42 109.047 176.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 74.0 m -91.7 104.3 16.78 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.674 -0.861 . . . . 75.42 108.674 169.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.627 HD11 ' HB3' ' B' ' 56' ' ' TYR . 3.7 mp -101.37 107.86 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 106.602 -1.629 . . . . 75.31 106.602 173.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.21 171.32 15.11 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.153 0.581 . . . . 61.34 110.632 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.11 -72.54 2.83 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.364 -0.834 . . . . 63.14 111.89 -177.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.543 ' HB ' ' HG2' ' B' ' 9' ' ' MET . 1.4 mm -87.16 144.35 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.029 0.932 . . . . 65.52 111.103 -176.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.483 ' HG2' ' H ' ' B' ' 91' ' ' GLY . 14.9 tt0 -154.69 175.35 13.8 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.177 -1.374 . . . . 74.21 107.611 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.483 ' H ' ' HG2' ' B' ' 90' ' ' GLU . . . 80.24 -113.89 3.74 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-O 120.03 -0.317 . . . . 52.25 112.364 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 8.9 m -73.96 -53.52 9.9 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.259 0.624 . . . . 71.23 111.718 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -70.98 -26.54 63.19 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.252 -0.886 . . . . 71.11 112.292 -165.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 21.0 ptt? -69.46 -25.08 63.92 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 122.977 0.173 . . . . 75.22 111.115 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.66 -38.72 78.76 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.491 0.716 . . . . 51.34 110.944 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -77.95 -37.4 47.68 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.949 -1.023 . . . . 72.14 110.507 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.559 ' SG ' ' HE1' ' B' ' 9' ' ' MET . 46.5 t -67.74 -25.73 65.79 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.414 0.686 . . . . 65.2 112.12 -177.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 84.3 mt -93.15 -43.92 8.61 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.184 0.594 . . . . 74.3 110.59 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.72 -18.42 73.06 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 115.152 0.821 . . . . 64.45 115.152 -170.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.05 -43.68 1.95 Allowed 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 117.589 0.694 . . . . 63.34 111.799 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.451 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 27.3 t80 -76.77 -52.5 9.45 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.801 -0.636 . . . . 75.05 111.427 -168.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.438 ' HB3' HG21 ' B' ' 58' ' ' VAL . 70.2 m -62.28 -44.4 88.29 Favored Pre-proline 0 CA--C 1.571 1.781 0 CA-C-O 118.269 -0.872 . . . . 75.43 112.959 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -51.68 -43.46 50.79 Favored 'Trans proline' 0 C--N 1.405 3.502 0 C-N-CA 122.832 2.355 . . . . 72.33 113.324 172.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -55.95 -33.3 64.64 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.152 0.981 . . . . 74.41 112.083 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 52.3 mt -77.57 -48.32 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.749 0.82 . . . . 73.11 110.868 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 79.2 mt -87.48 -19.89 27.33 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.661 0.784 . . . . 70.12 112.806 -167.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -64.15 -44.26 76.61 Favored Pre-proline 0 CA--C 1.563 1.479 0 CA-C-O 117.676 -1.154 . . . . 75.1 112.527 -174.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -53.14 -38.46 80.97 Favored 'Trans proline' 0 C--N 1.392 2.862 0 C-N-CA 122.553 2.169 . . . . 71.04 113.83 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.479 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 72.7 m-85 -70.81 -40.69 72.34 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.583 -0.735 . . . . 74.2 110.51 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.8 -37.03 83.75 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.741 0.416 . . . . 73.51 110.673 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -60.85 -55.76 29.19 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.156 1.383 . . . . 75.4 110.717 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -58.86 -37.97 77.7 Favored 'General case' 0 C--N 1.358 0.945 0 O-C-N 124.009 0.818 . . . . 74.43 110.555 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.796 ' SG ' HD12 ' B' ' 21' ' ' ILE . 16.8 t -67.41 -42.61 82.97 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-N 115.374 -0.83 . . . . 75.33 111.293 -175.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.97 -52.68 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 123.741 0.651 . . . . 74.32 109.541 176.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 10.7 m -60.97 -27.29 68.16 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 124.129 0.893 . . . . 74.22 111.689 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -68.52 -52.04 36.4 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 123.187 0.595 . . . . 64.53 109.67 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 33.7 mmt -59.56 -38.7 81.82 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.162 0.585 . . . . 73.31 111.063 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 71.1 t -66.24 -45.63 89.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.789 1.236 . . . . 71.24 111.034 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.7 t -67.63 -29.12 68.35 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.265 0.626 . . . . 64.43 111.107 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -73.34 -38.58 65.7 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.786 0.835 . . . . 74.44 110.042 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.58 -2.5 69.29 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 124.028 0.83 . . . . 65.54 112.5 171.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.511 HG23 ' HB3' ' A' ' 17' ' ' TYR . 20.1 p 63.22 28.87 15.97 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.804 2.042 . . . . 64.5 112.839 174.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -86.93 154.42 55.3 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.886 0.874 . . . . 75.34 110.483 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -48.24 153.37 3.02 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 124.095 3.197 . . . . 74.44 115.567 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.432 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -60.63 126.71 28.42 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.557 1.543 . . . . 74.42 111.797 -175.501 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 38.9 tp -127.8 113.89 16.54 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.822 -0.626 . . . . 73.35 110.386 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -121.36 112.65 18.83 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.295 -1.002 . . . . 72.11 108.295 171.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 9.2 tt -78.31 135.23 37.47 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.497 0.719 . . . . 75.31 109.667 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.93 137.34 87.44 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.487 1.115 . . . . 73.22 112.202 -173.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.458 ' HG3' HD11 ' D' ' 16' ' ' ILE . 38.1 Cg_endo -63.8 100.07 0.28 Allowed 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 123.188 2.592 . . . . 72.32 112.647 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 p -91.22 111.2 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-N 115.509 -0.769 . . . . 71.53 109.003 173.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -80.14 100.87 8.46 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.607 0.763 . . . . 75.3 109.113 -177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -66.38 -41.6 89.15 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.41 0.684 . . . . 74.02 110.932 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 26.2 t70 . . . . . 0 N--CA 1.474 0.745 0 C-N-CA 124.452 1.101 . . . . 62.42 111.941 -174.5 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.592 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.6 t80 . . . . . 0 C--O 1.239 0.532 0 N-CA-C 109.738 -0.467 . . . . 75.33 109.738 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -140.96 123.61 16.07 Favored 'General case' 0 C--O 1.245 0.824 0 N-CA-C 107.611 -1.255 . . . . 72.33 107.611 175.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 70.3 mt -71.4 122.43 23.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.213 -1.032 . . . . 75.34 108.213 171.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.556 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 20.7 mm-40 -85.11 -50.51 7.36 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 124.122 0.889 . . . . 75.33 109.018 -178.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -172.41 124.19 0.48 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.951 -0.568 . . . . 73.43 110.214 -172.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 77.1 mt -112.28 143.74 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.55 -0.908 . . . . 73.32 108.55 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.403 ' HB3' HG21 ' D' ' 122' ' ' THR . 28.0 p90 -174.94 166.03 3.56 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.674 0.79 . . . . 74.11 109.369 -171.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.8 p -89.64 126.0 35.46 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.278 -0.638 . . . . 73.4 109.278 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -74.99 -50.2 17.37 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 122.668 1.223 . . . . 72.34 107.857 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 10.3 t70 -136.0 136.86 40.65 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 112.651 -2.068 . . . . 72.4 108.969 -166.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 75.2 mt -136.28 142.15 39.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.044 -1.465 . . . . 73.34 107.044 172.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -158.46 151.35 22.44 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.312 0.577 . . . . 71.55 110.328 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -150.32 134.42 17.0 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 107.919 -1.141 . . . . 72.45 107.919 174.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -134.35 137.55 44.23 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.465 0.706 . . . . 71.25 109.659 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.36 80.96 8.24 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 106.125 -1.805 . . . . 63.2 106.125 172.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.65 -8.89 24.07 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.9 2.4 . . . . 55.41 112.878 -171.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . 0.463 ' ND2' ' HB ' ' C' ' 31' ' ' VAL . 20.2 p-10 -124.48 20.95 8.67 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.053 1.341 . . . . 74.15 110.277 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.433 ' HA ' HG13 ' C' ' 31' ' ' VAL . . . -43.85 -51.14 17.91 Favored Pre-proline 0 CA--C 1.564 1.511 0 N-CA-C 114.569 1.322 . . . . 72.11 114.569 -168.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.58 -51.13 9.82 Favored 'Trans proline' 0 C--N 1.392 2.845 0 CA-C-N 121.622 1.615 . . . . 70.24 112.169 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.421 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 84.1 t60 -68.38 -29.99 68.82 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.744 0.818 . . . . 72.31 112.28 -174.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.726 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.8 p -77.43 -26.52 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 N-CA-C 112.626 0.602 . . . . 73.22 112.626 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -68.98 -17.98 64.0 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.379 0.881 . . . . 73.35 113.379 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 19.4 pt20 -94.6 8.04 43.66 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.789 0.436 . . . . 72.2 111.181 177.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.751 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -89.78 168.84 11.77 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.005 0.922 . . . . 74.21 110.372 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . 0.448 ' N ' ' HG3' ' C' ' 34' ' ' LYS . 31.6 t70 -74.13 130.56 40.02 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.2 0.6 . . . . 75.03 109.66 165.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -80.7 88.93 5.74 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.059 0.544 . . . . 74.11 109.873 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -143.13 77.85 15.58 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 107.971 -1.122 . . . . 74.24 107.971 172.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . 0.52 ' HB2' HG11 ' C' ' 40' ' ' VAL . 9.2 Cg_endo -88.11 127.09 2.1 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.968 2.445 . . . . 74.33 112.37 -173.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -82.46 86.5 6.75 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.522 -1.658 . . . . 75.01 106.522 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.52 HG11 ' HB2' ' C' ' 38' ' ' PRO . 3.1 m -82.81 111.29 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 113.18 -1.827 . . . . 73.34 111.006 -173.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -106.31 115.97 31.14 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.838 0.855 . . . . 74.54 109.84 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 8.0 mp -85.66 131.18 34.39 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.302 -0.999 . . . . 74.43 108.302 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.51 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 38.6 t70 -123.63 105.7 9.94 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.814 1.246 . . . . 70.21 107.903 -170.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 32.7 tp -95.66 140.57 30.29 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.728 -0.669 . . . . 74.44 110.006 -173.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.614 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 25.9 t70 -147.14 158.06 43.81 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.853 -1.166 . . . . 71.44 107.853 173.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 73.0 p -122.53 132.25 54.23 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.159 0.584 . . . . 64.55 110.59 -174.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.25 147.43 50.22 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.072 -1.085 . . . . 72.23 108.072 173.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 72.3 p -165.55 159.09 16.33 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.597 0.237 . . . . 62.11 111.609 -174.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 65.2 p -164.15 134.79 4.28 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.536 0.734 . . . . 71.4 110.013 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -77.04 120.6 22.36 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.766 -0.827 . . . . 71.44 108.766 171.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.524 HD12 ' HB2' ' C' ' 57' ' ' GLU . 43.6 mt -94.14 -39.84 10.36 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.638 0.775 . . . . 71.41 110.155 -176.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.41 -179.19 6.77 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.852 0.861 . . . . 65.42 110.146 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -57.23 110.39 0.83 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.629 0.772 . . . . 65.12 109.419 173.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 65.02 1.4 1.47 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.317 1.447 . . . . 73.44 114.35 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.1 t -93.18 110.73 23.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 106.914 -1.513 . . . . 73.31 106.914 173.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -125.1 136.25 53.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.911 -0.586 . . . . 75.43 110.137 -171.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.524 ' HB2' HD12 ' C' ' 51' ' ' LEU . 29.6 tt0 -94.05 119.71 33.29 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.222 -0.899 . . . . 53.22 109.234 175.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 61.7 t -104.76 114.04 43.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.419 -1.326 . . . . 73.45 107.419 168.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 63.1 t -105.54 133.24 50.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 107.674 -1.232 . . . . 75.13 107.674 169.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 13.9 tp -116.4 108.62 16.26 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.794 -0.817 . . . . 72.54 108.794 174.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.614 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 0.4 OUTLIER -83.64 114.13 21.33 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.365 -0.976 . . . . 64.31 108.365 179.366 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 12.2 t -110.81 130.13 64.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.076 -1.083 . . . . 74.32 108.076 174.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 31.1 m -124.86 118.52 26.5 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.586 -0.894 . . . . 75.3 108.586 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.547 HG23 HG21 ' C' ' 114' ' ' ILE . 98.9 t -98.77 110.41 26.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.462 -0.94 . . . . 75.31 108.462 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 11.2 m -96.32 137.7 35.01 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.123 -1.436 . . . . 74.24 107.123 174.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.45 118.38 19.25 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.526 -1.287 . . . . 73.52 107.526 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 60.1 m -138.47 127.78 24.43 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 109.253 -0.647 . . . . 63.44 109.253 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.751 HD11 ' HG2' ' C' ' 34' ' ' LYS . 2.9 mt -83.37 15.6 2.93 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.954 1.302 . . . . 72.12 111.291 -175.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.09 -104.49 0.59 Allowed Glycine 0 C--N 1.344 1.013 0 N-CA-C 109.346 -1.502 . . . . 74.13 109.346 -173.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -88.45 -20.79 24.73 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.348 0.659 . . . . 74.22 110.073 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -89.37 122.54 32.7 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.196 0.998 . . . . 74.53 110.156 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 89.1 m -75.97 125.12 28.5 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.998 -0.742 . . . . 73.01 108.998 166.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.726 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.33 -54.12 7.61 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.173 -0.677 . . . . 74.34 109.173 173.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -164.52 166.26 20.54 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 115.56 -0.745 . . . . 74.32 111.856 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -131.6 104.41 6.93 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 106.762 -1.57 . . . . 60.13 106.762 172.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.515 ' SG ' HG22 ' C' ' 114' ' ' ILE . 48.8 t -110.19 146.15 36.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.842 0.857 . . . . 75.44 108.999 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -150.58 133.98 16.36 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.003 0.521 . . . . 53.03 109.877 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.5 t -132.54 132.79 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.507 -0.923 . . . . 74.1 108.507 168.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.47 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 61.0 mt-30 -105.56 98.49 8.18 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.701 -1.222 . . . . 75.42 107.701 173.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -82.57 106.98 14.87 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.888 -0.596 . . . . 74.41 110.43 -174.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.65 145.66 21.98 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.902 -0.59 . . . . 74.23 111.69 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.11 117.2 0.8 Allowed Glycine 0 CA--C 1.509 -0.282 0 N-CA-C 110.477 -1.049 . . . . 71.31 110.477 177.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 13.1 mm -83.87 118.9 32.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.145 -1.057 . . . . 64.32 108.145 177.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.592 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 50.6 m-85 -129.17 128.36 43.23 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.146 0.978 . . . . 72.13 108.71 -176.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.1 p -83.33 115.62 22.08 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.864 -0.791 . . . . 70.21 108.864 172.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 4.4 mp -114.65 100.3 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 107.134 -1.432 . . . . 75.14 107.134 173.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -124.25 152.66 42.72 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.159 0.984 . . . . 75.25 109.034 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.41 -58.25 0.74 Allowed Glycine 0 C--N 1.345 1.04 0 CA-C-O 120.272 -0.182 . . . . 65.12 113.189 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' C' ' 94' ' ' MET . 29.9 pt -81.89 167.44 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 121.111 0.481 . . . . 64.11 111.413 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.61 ' HA ' ' HE1' ' C' ' 94' ' ' MET . 11.2 pt-20 -150.08 -177.24 5.81 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.292 1.037 . . . . 75.52 110.019 177.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.71 -139.07 48.74 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 124.266 0.979 . . . . 70.23 114.618 171.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 68.0 p -70.58 -18.75 62.9 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.853 0.861 . . . . 74.42 111.953 -175.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -74.91 -39.14 61.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.274 0.63 . . . . 74.22 109.951 174.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.61 ' HE1' ' HA ' ' C' ' 90' ' ' GLU . 46.5 ttm -60.81 -49.09 78.89 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.177 0.591 . . . . 73.24 109.815 172.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.22 -29.98 70.83 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.792 0.837 . . . . 71.13 112.072 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -67.15 -40.92 86.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.215 0.606 . . . . 74.45 110.327 174.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.567 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 15.2 t -64.78 -43.72 92.32 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.529 0.518 . . . . 74.43 110.799 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 86.1 mt -74.73 -36.79 62.65 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.413 0.685 . . . . 75.45 112.19 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.92 -23.89 31.49 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 114.651 0.62 . . . . 73.33 114.651 -165.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.471 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -135.99 -47.03 0.65 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.446 0.641 . . . . 73.31 111.875 -172.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.567 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 82.4 t80 -74.23 -40.78 62.18 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 125.485 1.514 . . . . 74.45 112.604 -170.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 94.5 m -76.71 -43.23 3.04 Favored Pre-proline 0 N--CA 1.487 1.382 0 CA-C-O 118.568 -0.73 . . . . 74.04 111.194 176.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -47.34 -40.06 28.13 Favored 'Trans proline' 0 C--N 1.395 3.009 0 C-N-CA 122.84 2.36 . . . . 70.44 113.376 165.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -59.02 -38.49 79.38 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 123.668 0.605 . . . . 65.44 111.276 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.404 HD11 HH12 ' A' ' 111' ' ' ARG . 36.8 mm -65.27 -44.47 94.97 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 122.822 0.449 . . . . 75.52 109.842 174.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 94.9 mt -83.82 -15.22 49.13 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.816 1.043 . . . . 75.21 113.816 -169.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -58.72 -53.43 66.43 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-O 117.614 -1.184 . . . . 74.44 112.946 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.75 -32.11 78.3 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 121.702 1.601 . . . . 71.11 112.949 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -66.71 -53.69 30.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.371 0.668 . . . . 74.53 110.626 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.49 83.81 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.703 0.801 . . . . 75.12 110.465 177.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -57.77 -57.11 14.19 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.298 1.439 . . . . 71.32 111.287 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -38.0 83.19 Favored 'General case' 0 C--N 1.366 1.296 0 O-C-N 123.716 0.635 . . . . 75.54 109.713 -177.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.8 t -66.3 -30.52 70.95 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 122.833 0.453 . . . . 62.3 111.761 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.547 HG21 HG23 ' C' ' 64' ' ' VAL . 91.9 mt -74.46 -55.39 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.209 0.604 . . . . 71.33 109.534 173.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 21.8 m -59.99 -27.4 66.83 Favored 'General case' 0 CA--C 1.558 1.27 0 O-C-N 123.787 0.679 . . . . 75.04 111.204 -175.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 46.7 t -63.68 -48.62 76.44 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 124.429 1.092 . . . . 62.11 109.82 174.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.67 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -66.45 -36.26 82.34 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.115 0.966 . . . . 74.5 111.686 179.129 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 76.1 t -61.75 -41.12 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.561 0.744 . . . . 75.44 109.507 172.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.0 t -74.82 -28.86 60.88 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.95 -1.023 . . . . 73.14 111.763 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' C' ' 116' ' ' SER . 80.5 mtt-85 -73.0 -38.62 66.53 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.815 -0.809 . . . . 74.44 108.815 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.27 -4.92 70.22 Favored Glycine 0 C--N 1.356 1.691 0 CA-C-N 115.375 -0.829 . . . . 61.22 112.777 171.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 19.6 p 64.91 27.67 12.75 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.673 1.989 . . . . 75.41 113.157 171.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -83.99 142.25 41.49 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 108.263 -1.014 . . . . 75.32 108.263 170.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.54 163.44 1.16 Allowed 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.65 2.9 . . . . 71.33 114.711 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -54.33 134.08 45.21 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.326 1.05 . . . . 73.12 113.112 -171.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 27.5 tp -134.93 85.96 2.22 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.51 -1.293 . . . . 74.34 107.51 174.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -96.21 115.54 27.59 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.845 -1.07 . . . . 65.13 109.067 -175.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.24 121.61 14.11 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.747 0.819 . . . . 72.43 109.069 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.61 137.9 74.06 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 123.065 0.546 . . . . 71.21 111.286 -177.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.543 ' HB3' HD13 ' A' ' 16' ' ' ILE . 9.6 Cg_endo -52.47 109.51 0.35 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.139 2.559 . . . . 63.22 114.383 175.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 10.1 m -121.19 112.02 33.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 107.784 -1.191 . . . . 74.4 107.784 165.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -74.49 94.04 2.55 Favored 'General case' 0 C--N 1.354 0.774 0 N-CA-C 108.759 -0.83 . . . . 74.32 108.759 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -54.91 -34.18 62.86 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.943 1.697 . . . . 75.15 111.902 -173.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.471 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 9.7 t70 . . . . . 0 CA--C 1.54 0.592 0 C-N-CA 124.42 1.088 . . . . 73.42 111.178 -177.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 64.5 m . . . . . 0 C--O 1.242 0.701 0 N-CA-C 108.718 -0.845 . . . . 75.32 108.718 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' D' ' 85' ' ' SER . 25.0 t80 -158.58 119.85 3.43 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.757 -0.831 . . . . 74.34 108.757 177.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -138.86 145.24 39.73 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.759 1.224 . . . . 73.33 108.118 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 52.4 mt -91.77 127.62 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.24 -0.652 . . . . 73.11 109.24 176.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.408 HE22 HG12 ' D' ' 55' ' ' VAL . 51.1 mt-30 -97.53 -46.63 5.97 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 122.531 0.333 . . . . 75.15 111.061 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -167.77 127.53 1.34 Allowed 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 117.816 0.28 . . . . 75.31 111.527 -170.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.458 HD11 ' HG3' ' B' ' 130' ' ' PRO . 2.4 mp -103.82 138.05 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.358 -1.349 . . . . 74.43 107.358 167.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -163.94 149.4 10.79 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 123.813 0.695 . . . . 73.2 110.658 176.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.1 p -83.36 116.85 22.66 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.419 -0.81 . . . . 74.41 109.212 174.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -84.74 -35.87 22.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.635 -0.876 . . . . 71.01 108.635 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.618 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 12.7 t70 -143.25 129.23 19.57 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.283 -1.326 . . . . 74.31 109.129 -174.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.67 HG21 ' HE1' ' C' ' 117' ' ' MET . 62.1 mt -135.56 148.45 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.643 1.177 . . . . 71.14 108.612 174.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.6 t -147.17 142.87 27.77 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.027 0.931 . . . . 70.01 109.536 171.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 83.1 t80 -146.63 119.93 8.96 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 105.252 -2.129 . . . . 74.25 105.252 172.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.505 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.8 mt-10 -134.98 109.94 8.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.311 0.645 . . . . 74.24 109.386 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.24 90.95 5.11 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 107.734 -1.21 . . . . 73.14 107.734 175.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -73.5 -33.36 6.92 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.726 2.284 . . . . 72.4 112.554 -169.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -110.4 18.53 19.73 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.143 0.977 . . . . 74.12 109.897 -175.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -34.22 -61.01 0.45 Allowed Pre-proline 0 CA--C 1.569 1.685 0 N-CA-C 116.309 1.966 . . . . 75.3 116.309 -161.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.431 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 93.1 Cg_endo -76.36 -26.88 8.39 Favored 'Trans proline' 0 C--N 1.385 2.481 0 CA-C-N 122.996 2.106 . . . . 71.34 113.202 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -66.38 -44.36 83.31 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.507 1.123 . . . . 73.01 109.624 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.545 HG22 ' HA ' ' D' ' 73' ' ' ALA . 12.0 p -82.46 -16.42 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-N 115.202 -0.908 . . . . 73.15 111.446 -172.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.431 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 16.7 m-85 -64.75 -26.2 68.26 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.102 0.408 . . . . 72.33 112.102 177.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -58.27 -21.92 50.48 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.842 0.857 . . . . 74.41 111.198 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.655 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 88.3 mttt -93.73 97.5 10.49 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.931 1.292 . . . . 73.04 109.09 173.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -104.9 85.29 2.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.718 0.771 . . . . 74.42 109.324 177.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 19.1 p90 -149.25 -173.16 4.31 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.688 -1.142 . . . . 75.33 108.075 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -77.14 113.13 28.01 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.147 0.579 . . . . 64.44 110.237 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.23 130.37 39.04 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.664 2.243 . . . . 75.54 112.696 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.56 112.18 3.05 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.795 -0.817 . . . . 63.42 108.795 172.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 13.9 m -101.81 125.37 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.745 0.818 . . . . 74.31 110.91 -171.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.626 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 0.1 OUTLIER -104.82 111.92 24.84 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.68 1.192 . . . . 74.43 108.096 179.032 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 50.2 tp -98.45 126.22 43.91 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 122.759 0.423 . . . . 73.22 110.004 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -141.25 125.72 17.7 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.78 0.832 . . . . 75.32 109.019 174.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.95 146.67 27.53 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.519 0.728 . . . . 74.31 110.418 -176.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -134.53 156.04 49.34 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.842 1.257 . . . . 71.55 108.159 171.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 5.9 t -127.8 151.4 49.08 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.48 0.657 . . . . 65.31 110.937 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.81 152.62 36.82 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.302 -1.37 . . . . 60.34 107.302 168.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 77.6 p -172.75 153.41 2.71 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.831 0.452 . . . . 70.11 110.752 -175.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 37.2 p -169.48 159.11 8.32 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.069 0.948 . . . . 75.42 109.772 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -90.47 134.77 34.13 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.386 -0.598 . . . . 74.13 109.386 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.45 ' HB2' HG13 ' D' ' 55' ' ' VAL . 63.9 mt -99.68 -42.31 6.93 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.035 0.534 . . . . 74.32 110.7 -177.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.42 -168.94 2.73 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.334 0.653 . . . . 71.31 110.388 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.04 118.36 9.7 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.539 -0.541 . . . . 52.03 109.539 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 64.4 4.65 2.28 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.016 1.327 . . . . 74.4 112.779 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.45 HG13 ' HB2' ' D' ' 51' ' ' LEU . 79.3 t -110.67 129.27 66.12 Favored 'Isoleucine or valine' 0 C--N 1.351 0.638 0 C-N-CA 124.624 1.17 . . . . 71.31 108.6 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -145.37 172.9 12.51 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.691 -0.855 . . . . 65.13 108.691 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -132.29 145.48 51.31 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.097 -0.956 . . . . 75.12 110.12 174.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.422 HG21 ' HB3' ' D' ' 102' ' ' CYS . 15.1 m -129.32 142.12 44.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.204 1.002 . . . . 73.34 108.678 167.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 39.4 t -128.44 117.23 44.59 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 C-N-CA 124.322 1.049 . . . . 74.53 108.223 -175.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.548 HD21 ' HB2' ' D' ' 103' ' ' PRO . 60.9 tp -103.61 119.13 38.28 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.714 -0.476 . . . . 65.42 109.714 174.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -88.17 108.09 19.1 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.047 -0.723 . . . . 74.12 109.047 170.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 41.1 t -91.89 128.41 43.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.356 -1.35 . . . . 73.31 107.356 166.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.4 m -125.17 125.2 43.3 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.582 0.706 . . . . 54.14 110.807 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 48.2 t -115.59 100.76 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.034 1.734 . . . . 74.45 108.242 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.626 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 91.8 m -96.35 102.5 14.29 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.062 -1.088 . . . . 65.25 108.062 172.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.16 139.67 39.48 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.371 -0.831 . . . . 71.23 109.441 -170.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 61.3 p -147.53 126.32 12.66 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.054 0.454 . . . . 73.41 111.52 -173.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.484 HD11 HG21 ' D' ' 31' ' ' VAL . 51.4 mt -98.54 113.91 26.13 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.269 1.028 . . . . 75.02 108.479 175.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.73 -128.32 9.1 Favored Glycine 0 C--N 1.343 0.935 0 O-C-N 123.383 0.427 . . . . 72.42 113.04 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.03 18.95 20.98 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.043 0.537 . . . . 73.05 110.879 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.655 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 11.7 pt-20 -140.32 167.41 22.2 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.261 0.624 . . . . 73.23 110.07 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 77.0 m -74.35 139.5 44.16 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.461 0.704 . . . . 71.33 110.551 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.545 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -87.94 -64.77 1.1 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 107.717 -1.216 . . . . 73.13 107.717 171.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -156.8 162.97 39.72 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 114.497 -1.229 . . . . 74.01 110.176 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.505 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 84.8 mt -121.44 112.27 18.33 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 124.728 1.211 . . . . 74.33 107.921 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.488 ' HG ' ' HE2' ' D' ' 117' ' ' MET . 1.3 m -114.05 133.82 55.27 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.208 -1.034 . . . . 75.24 108.208 -178.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -156.6 120.56 4.36 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.186 -0.672 . . . . 65.32 109.186 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 80.8 t -130.61 114.32 27.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.643 -0.873 . . . . 72.43 108.643 -176.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.618 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 37.5 mt-30 -88.94 87.71 7.32 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 108.489 -0.93 . . . . 74.24 108.489 170.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -80.03 104.51 10.64 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 113.745 -1.571 . . . . 74.42 108.167 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.98 150.98 18.38 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 111.236 -0.746 . . . . 54.34 111.236 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.31 131.13 3.94 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.738 -0.545 . . . . 63.42 111.738 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.9 mt -88.38 123.18 40.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 107.572 -1.27 . . . . 74.13 107.572 171.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -131.51 169.35 16.21 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.254 1.021 . . . . 61.43 108.942 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 25.5 m -112.65 136.03 52.68 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.058 0.943 . . . . 73.12 108.862 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.569 HG12 HD11 ' D' ' 89' ' ' ILE . 12.1 tt -145.79 137.57 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.352 -0.981 . . . . 74.14 108.352 176.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.09 127.4 1.83 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.502 0.321 . . . . 74.44 111.073 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.1 4.81 55.21 Favored Glycine 0 C--N 1.346 1.129 0 O-C-N 123.613 0.57 . . . . 74.03 113.228 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.569 HD11 HG12 ' D' ' 86' ' ' ILE . 3.3 mp -115.56 150.21 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.385 0.674 . . . . 74.24 110.208 -175.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.24 176.06 6.99 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.567 1.547 . . . . 72.33 109.004 173.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . 0.469 ' N ' ' HE2' ' D' ' 94' ' ' MET . . . 60.89 -129.32 46.39 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 114.58 0.592 . . . . 75.34 114.58 175.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.8 m -71.56 -33.49 69.14 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.535 1.134 . . . . 74.42 112.225 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -64.21 -30.37 71.44 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.823 0.849 . . . . 75.03 111.566 -177.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.469 ' HE2' ' N ' ' D' ' 91' ' ' GLY . 48.0 mtm -62.18 -39.33 92.34 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.919 0.488 . . . . 73.12 111.473 174.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.99 -36.98 83.13 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.857 0.463 . . . . 75.4 112.08 -173.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . 0.449 ' O ' ' HB2' ' D' ' 100' ' ' ALA . 54.5 t-80 -81.21 -29.27 34.57 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.339 0.256 . . . . 74.53 111.576 177.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 34.5 t -70.75 -49.91 41.73 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.286 0.565 . . . . 75.11 110.832 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 29.4 mt -93.8 -45.0 7.85 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 124.464 1.105 . . . . 72.03 110.973 -166.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.33 -1.25 88.17 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-O 119.825 -0.431 . . . . 73.23 113.534 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' D' ' 96' ' ' HIS . . . -133.01 -68.46 0.59 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.475 0.637 . . . . 74.23 111.317 -178.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -70.82 -42.9 69.63 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 112.896 0.702 . . . . 74.33 112.896 -167.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.422 ' HB3' HG21 ' D' ' 58' ' ' VAL . 66.6 m -62.04 -50.29 81.29 Favored Pre-proline 0 CA--C 1.568 1.664 0 N-CA-C 112.881 0.697 . . . . 72.41 112.881 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.548 ' HB2' HD21 ' D' ' 60' ' ' LEU . 98.2 Cg_endo -77.52 -7.58 16.86 Favored 'Trans proline' 0 C--N 1.39 2.715 0 C-N-CA 122.267 1.978 . . . . 74.23 112.711 175.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -77.51 -30.57 52.99 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.765 -0.828 . . . . 61.43 108.765 171.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.1 mm -70.51 -38.22 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.518 0.727 . . . . 54.42 109.638 169.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.98 -11.35 59.58 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.488 0.715 . . . . 71.11 111.771 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . 0.433 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 86.5 t80 -65.97 -51.63 45.64 Favored Pre-proline 0 CA--C 1.567 1.634 0 C-N-CA 124.2 1.0 . . . . 73.12 112.605 -177.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 34.3 Cg_exo -60.64 -32.32 93.15 Favored 'Trans proline' 0 C--N 1.395 2.979 0 C-N-CA 122.128 1.885 . . . . 74.04 112.814 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -80.76 -32.07 35.67 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.865 0.866 . . . . 74.14 112.177 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.1 -46.37 81.35 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.804 -0.813 . . . . 71.13 108.804 173.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -62.23 -41.24 98.23 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 124.228 0.955 . . . . 71.42 110.839 177.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -51.68 -53.64 36.83 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.428 1.091 . . . . 74.22 111.131 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.1 t -67.74 -46.75 71.25 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.191 -0.913 . . . . 63.5 111.485 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.464 ' O ' HG23 ' D' ' 118' ' ' VAL . 84.7 mt -62.2 -57.58 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.474 0.71 . . . . 73.22 110.841 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 90.9 m -49.95 -45.75 51.61 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.32 1.013 . . . . 62.42 111.734 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.5 t -64.97 -43.31 93.05 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.083 -0.962 . . . . 73.22 110.955 -175.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.488 ' HE2' ' HG ' ' D' ' 76' ' ' CYS . 73.3 mtm -65.05 -36.35 84.07 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.79 0.436 . . . . 73.53 111.559 179.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.464 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.7 t -62.53 -44.67 99.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.789 0.835 . . . . 73.22 110.366 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.2 p -76.86 -26.25 54.03 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 116.08 -0.509 . . . . 73.02 111.38 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -72.98 -34.24 66.32 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.434 0.694 . . . . 72.3 109.892 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.35 3.17 79.12 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 115.582 -0.736 . . . . 64.24 112.393 171.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.403 HG21 ' HB3' ' C' ' 17' ' ' TYR . 31.0 p 60.39 24.38 13.92 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 126.866 2.067 . . . . 65.14 113.669 175.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -82.43 158.89 65.55 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 124.095 0.958 . . . . 75.41 109.585 169.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -49.64 127.49 18.73 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 123.369 2.713 . . . . 74.12 113.31 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -52.08 131.24 31.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.288 1.035 . . . . 75.11 111.27 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 45.8 tp -124.08 97.86 5.53 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.243 0.617 . . . . 74.32 110.15 -172.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -101.87 121.41 42.06 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.805 0.842 . . . . 75.11 109.664 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 tt -74.3 115.88 14.32 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 108.463 -0.94 . . . . 71.53 108.463 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.47 143.86 98.56 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.684 0.794 . . . . 64.21 111.644 -176.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.451 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 6.8 Cg_exo -70.48 121.88 8.39 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.696 2.264 . . . . 64.3 111.535 -177.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 N--CA 1.482 1.165 0 C-N-CA 124.008 0.923 . . . . 74.35 110.743 -178.747 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.543 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 41.2 t80 . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.287 0.089 . . . . 74.15 110.808 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -158.43 116.39 2.96 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.697 0.623 . . . . 74.32 109.872 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.592 HG12 ' HD2' ' A' ' 84' ' ' PHE . 57.7 mt -72.6 114.71 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 109.416 -0.587 . . . . 73.34 109.416 177.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -82.76 -34.58 27.07 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.003 -0.998 . . . . 72.02 109.921 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -173.18 149.34 1.79 Allowed 'General case' 0 C--N 1.36 1.031 0 O-C-N 123.714 0.634 . . . . 75.31 110.679 -171.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.515 HD13 ' HG3' ' C' ' 130' ' ' PRO . 75.0 mt -141.52 134.6 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 124.23 1.012 . . . . 74.51 108.332 174.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -167.32 176.85 6.42 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.983 0.897 . . . . 74.52 110.97 -173.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.1 p -101.54 116.86 33.72 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.737 -1.209 . . . . 71.22 107.737 174.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 42.8 mtpt -75.78 -41.95 51.52 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.733 0.777 . . . . 74.15 109.002 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 15.9 t70 -135.73 143.35 45.29 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 113.731 -1.577 . . . . 64.24 109.72 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.474 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 92.6 mt -138.62 143.66 31.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 125.743 1.617 . . . . 73.34 106.962 176.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -153.46 138.57 17.36 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.477 -0.564 . . . . 71.13 109.477 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 93.9 t80 -143.29 120.57 11.56 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 106.852 -1.536 . . . . 74.44 106.852 176.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -120.53 148.78 43.39 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.241 -0.652 . . . . 74.11 109.241 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.87 80.27 14.02 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 106.359 -1.719 . . . . 72.41 106.359 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.3 -50.26 12.61 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 123.364 2.709 . . . . 72.34 112.841 -169.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.77 33.84 3.58 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 114.867 -1.06 . . . . 61.23 108.614 -176.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.43 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -47.65 -53.09 33.24 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 113.467 0.914 . . . . 73.42 113.467 -176.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.48 -15.41 45.15 Favored 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 121.536 1.491 . . . . 73.33 112.847 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -97.93 -31.14 12.34 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.259 1.023 . . . . 63.15 110.413 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.828 HG22 ' HA ' ' A' ' 73' ' ' ALA . 4.5 p -77.42 -16.78 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.351 0.66 . . . . 62.33 112.27 -164.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -77.76 1.1 21.17 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 122.901 0.48 . . . . 74.15 111.27 174.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -89.9 -24.66 21.29 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.665 1.186 . . . . 73.34 110.568 168.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 71' ' ' GLU . 30.8 mmmt -66.85 165.5 15.18 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.422 1.089 . . . . 74.4 112.513 -176.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -84.49 138.14 32.95 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 108.011 -1.107 . . . . 64.24 108.011 167.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 26.8 t-105 -72.62 89.37 1.31 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.902 -1.147 . . . . 74.51 107.902 173.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.409 ' H ' HD23 ' A' ' 68' ' ' LEU . 35.3 tt0 -131.1 65.35 76.46 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 125.539 1.536 . . . . 74.02 107.115 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.12 120.82 4.24 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.363 2.042 . . . . 71.55 111.996 -168.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -96.11 99.58 11.31 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.4 -1.333 . . . . 64.3 107.4 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.1 m -74.81 120.9 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-N 114.793 -1.094 . . . . 70.32 111.219 -172.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.534 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 39.7 ttmt -118.24 114.13 22.54 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.032 -1.099 . . . . 74.5 108.032 173.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -114.81 131.96 56.64 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.796 -0.816 . . . . 75.23 108.796 173.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -126.37 135.07 51.0 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.33 1.052 . . . . 74.33 108.418 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -113.38 122.75 48.31 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.284 -0.636 . . . . 75.1 109.284 -175.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.61 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 16.6 t70 -119.65 124.17 45.65 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.313 1.045 . . . . 61.01 108.221 177.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.1 p -106.74 125.96 51.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.254 0.621 . . . . 73.14 110.041 -174.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.46 152.42 50.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.03 0.932 . . . . 72.42 109.514 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.9 p -131.37 165.05 24.32 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.383 0.673 . . . . 75.33 110.359 -177.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.7 t -163.51 121.33 1.89 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.805 -0.634 . . . . 63.45 109.653 175.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -82.33 120.03 24.89 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.413 -1.328 . . . . 74.55 107.413 166.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.665 HD12 ' HB2' ' A' ' 57' ' ' GLU . 24.4 mt -93.13 -40.19 10.63 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.754 -0.832 . . . . 73.44 108.754 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.86 -175.66 4.52 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.813 1.245 . . . . 73.35 109.574 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.1 123.12 20.21 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.061 -0.718 . . . . 75.22 109.061 173.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 69.88 -4.71 1.4 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.943 1.297 . . . . 73.44 112.696 -176.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.4 t -109.68 108.93 26.6 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 N-CA-C 108.05 -1.092 . . . . 74.13 108.05 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -130.07 157.63 41.84 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.352 -0.61 . . . . 73.11 109.352 -173.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.665 ' HB2' HD12 ' A' ' 51' ' ' LEU . 38.9 tt0 -130.59 135.54 47.99 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.067 0.947 . . . . 74.24 108.898 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.6 m -121.85 136.16 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 108.041 -1.096 . . . . 71.21 108.041 165.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.4 t -122.71 127.54 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.05 0.94 . . . . 74.34 109.238 -174.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 tt -117.25 107.41 14.39 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.603 -0.888 . . . . 73.24 108.603 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.61 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 10.9 ttm180 -84.88 104.39 14.79 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.284 1.034 . . . . 73.41 109.715 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 37.3 t -96.01 103.28 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 108.598 -0.89 . . . . 75.54 108.598 174.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.9 m -97.04 108.47 21.21 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.62 0.768 . . . . 74.01 109.852 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.588 HG12 HD23 ' A' ' 126' ' ' LEU . 42.1 t -103.04 139.11 24.85 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 C-N-CA 123.974 0.909 . . . . 71.15 110.588 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 25.5 m -132.14 141.05 48.99 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.898 0.879 . . . . 74.52 108.693 175.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.04 109.66 14.37 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.861 -0.792 . . . . 75.43 108.861 174.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.9 m -108.87 127.37 53.98 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.407 0.683 . . . . 75.45 109.282 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.564 HD13 ' HB1' ' A' ' 73' ' ' ALA . 15.8 mt -99.7 78.37 2.14 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.874 -1.158 . . . . 74.13 107.874 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.69 -83.39 1.14 Allowed Glycine 0 C--N 1.349 1.264 0 N-CA-C 111.502 -0.639 . . . . 72.54 111.502 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -119.98 -28.96 5.05 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.737 0.815 . . . . 72.32 111.315 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.412 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 35.7 tt0 -99.95 128.79 46.0 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.633 -0.667 . . . . 73.33 110.589 -174.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.0 m -69.66 131.36 44.48 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.85 0.86 . . . . 72.44 110.902 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.828 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -74.22 -63.2 1.28 Allowed 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.514 -0.921 . . . . 73.33 108.514 168.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -155.47 163.14 40.43 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.402 -1.272 . . . . 74.23 111.322 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.2 tp -119.02 146.0 45.4 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 113.824 -1.534 . . . . 75.54 107.522 167.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.9 m -138.89 134.37 33.16 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.836 -1.172 . . . . 62.0 107.836 178.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -148.16 116.39 6.51 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.171 -0.678 . . . . 64.22 109.171 174.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.8 t -124.74 126.34 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 123.733 0.813 . . . . 74.41 109.051 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.407 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 64.0 mt-30 -101.48 89.05 3.6 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.227 -1.027 . . . . 73.24 108.227 172.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.41 ' HG3' HD21 ' A' ' 106' ' ' LEU . 9.3 tp-100 -76.81 98.25 4.77 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.615 -1.175 . . . . 72.03 108.48 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.51 142.95 16.36 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 111.338 -0.705 . . . . 75.52 111.338 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.42 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -140.85 126.21 3.05 Favored Glycine 0 CA--C 1.502 -0.733 0 N-CA-C 110.815 -0.914 . . . . 72.34 110.815 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.2 mt -82.47 119.01 31.18 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 108.321 -0.992 . . . . 65.23 108.321 173.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.592 ' HD2' HG12 ' A' ' 13' ' ' ILE . 24.2 m-85 -131.04 130.22 43.0 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.533 -0.914 . . . . 74.43 108.533 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 43.9 t -76.2 108.03 8.85 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.513 -0.921 . . . . 70.03 108.513 172.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.7 mt . . . . . 0 N--CA 1.481 1.095 0 C-N-CA 123.287 0.635 . . . . 73.23 110.332 -173.603 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.443 ' HA ' ' HG ' ' A' ' 98' ' ' LEU . . . . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 120.591 0.234 . . . . 62.35 111.246 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.422 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 22.3 t-80 -68.4 -35.15 77.25 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.573 0.749 . . . . 74.54 110.674 172.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.3 t -74.96 -52.11 11.99 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.244 -0.285 . . . . 74.42 110.735 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.443 ' HG ' ' HA ' ' A' ' 95' ' ' ALA . 4.6 pp -76.34 -20.6 57.08 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.353 0.501 . . . . 73.3 112.353 -175.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.46 2.99 20.24 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 114.971 0.749 . . . . 75.22 114.971 -173.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 96' ' ' HIS . . . -142.24 -52.96 0.41 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 118.031 0.915 . . . . 64.23 111.946 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.515 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 79.4 t80 -78.36 -68.18 0.67 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 122.895 0.478 . . . . 53.53 111.776 -172.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.454 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 76.8 m -63.94 -34.09 11.27 Favored Pre-proline 0 CA--C 1.567 1.632 0 N-CA-C 114.534 1.309 . . . . 75.42 114.534 -173.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 22.6 Cg_endo -62.25 -33.31 81.38 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 121.834 1.689 . . . . 73.51 112.902 167.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.479 ' ND2' ' HA ' ' A' ' 132' ' ' ASN . 15.7 t-20 -80.18 -17.59 52.0 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.635 0.374 . . . . 73.55 110.921 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.7 mm -65.82 -39.38 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 108.92 -0.77 . . . . 75.04 108.92 168.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.42 HD22 ' HA3' ' A' ' 82' ' ' GLY . 91.6 mt -77.15 -19.97 56.14 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.704 0.802 . . . . 63.43 112.205 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -61.24 -49.31 88.65 Favored Pre-proline 0 CA--C 1.571 1.781 0 N-CA-C 113.954 1.094 . . . . 75.11 113.954 -172.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -63.76 -38.42 39.87 Favored 'Trans proline' 0 C--N 1.391 2.81 0 C-N-CA 122.071 1.847 . . . . 74.43 112.654 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -68.48 -35.56 77.7 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.782 -0.645 . . . . 75.45 110.876 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.88 -42.98 76.25 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.238 0.615 . . . . 72.24 110.489 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.54 ' NH1' HD13 ' C' ' 105' ' ' ILE . 37.6 ttm180 -54.6 -53.82 49.59 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 124.164 0.915 . . . . 74.24 109.936 174.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -66.68 -39.38 88.1 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.366 1.042 . . . . 75.2 111.821 -171.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.79 -42.04 92.53 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.539 0.524 . . . . 72.24 110.287 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.09 -47.5 81.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 115.281 -0.872 . . . . 74.03 110.165 175.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.9 m -56.06 -41.74 75.55 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.742 0.817 . . . . 75.23 111.358 -177.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.2 t -69.6 -45.01 69.57 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.198 -0.91 . . . . 74.22 110.766 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.471 ' SD ' HG22 ' A' ' 21' ' ' ILE . 9.2 mtp -58.51 -44.62 89.53 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.636 0.774 . . . . 75.43 111.238 177.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -64.32 -42.89 96.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 114.774 -1.103 . . . . 74.34 110.766 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.3 t -72.22 -32.87 67.14 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.855 -0.612 . . . . 73.43 111.071 -176.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.444 HH12 ' HG3' ' B' ' 112' ' ' GLU . 81.4 mtt-85 -72.57 -29.42 63.52 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.534 0.734 . . . . 74.41 109.322 175.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.38 10.0 60.03 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-N 115.307 -0.861 . . . . 74.41 113.222 173.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.511 HG23 ' HE ' ' B' ' 15' ' ' ARG . 1.5 t 64.09 12.7 7.2 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 126.928 2.091 . . . . 72.41 113.628 173.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -84.72 150.98 57.51 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 109.119 -0.697 . . . . 74.3 109.119 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.53 141.58 41.89 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.211 2.607 . . . . 62.32 112.855 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -53.93 132.31 41.83 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 124.035 0.834 . . . . 74.5 112.162 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.588 HD23 HG12 ' A' ' 64' ' ' VAL . 60.2 tp -123.79 102.43 7.81 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.781 -1.1 . . . . 73.02 110.176 -171.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -111.01 126.35 54.7 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.111 0.965 . . . . 74.22 109.145 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.401 HD21 ' N ' ' A' ' 129' ' ' ALA . 3.5 tt -67.55 143.52 56.08 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 108.155 -1.054 . . . . 75.01 108.155 172.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.401 ' N ' HD21 ' A' ' 128' ' ' LEU . . . -56.81 140.42 76.04 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 123.678 0.791 . . . . 71.12 111.407 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.413 ' HA ' HH22 ' A' ' 111' ' ' ARG . 37.0 Cg_endo -65.12 95.35 0.25 Allowed 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.824 2.349 . . . . 73.22 113.015 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.31 112.49 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.156 -0.929 . . . . 74.21 109.318 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.479 ' HA ' ' ND2' ' A' ' 104' ' ' ASN . 27.5 t-20 -100.97 100.27 10.86 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.556 -1.276 . . . . 74.3 107.556 170.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 . . . . . 0 N--CA 1.483 1.205 0 C-N-CA 123.613 0.765 . . . . 64.23 110.917 -175.492 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.472 ' HE2' ' SG ' ' B' ' 97' ' ' CYS . 1.6 tmt? . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 111.644 0.239 . . . . 72.15 111.644 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 92.7 m -162.34 138.48 7.6 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.334 1.053 . . . . 72.43 108.895 172.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' B' ' 85' ' ' SER . 0.2 OUTLIER -136.35 154.67 50.77 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.45 0.643 . . . . 74.23 109.598 157.283 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -127.71 140.86 51.8 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 114.687 -1.142 . . . . 74.44 108.239 169.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.563 HD11 HD12 ' B' ' 105' ' ' ILE . 46.7 mt -72.13 119.76 19.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 O-C-N 124.143 0.902 . . . . 74.14 108.739 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -88.54 -49.87 6.64 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.637 0.775 . . . . 71.02 109.302 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.511 ' HE ' HG23 ' A' ' 122' ' ' THR . 48.2 ttt180 -163.38 132.8 4.1 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.952 -0.567 . . . . 75.12 110.488 -176.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 94.6 mt -114.23 136.04 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 107.595 -1.261 . . . . 64.24 107.595 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -164.62 146.21 8.21 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.553 0.692 . . . . 75.14 112.432 -175.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 35.3 m -73.45 121.4 20.48 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.16 -1.382 . . . . 73.14 109.27 171.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.425 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 41.2 mtpt -98.32 -27.73 13.99 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.953 0.901 . . . . 74.55 111.393 -176.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 34.9 t70 -158.39 138.03 11.95 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.458 0.473 . . . . 75.4 110.531 -168.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.496 HD13 ' SG ' ' B' ' 113' ' ' CYS . 45.3 mm -142.07 143.16 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.919 1.288 . . . . 74.04 108.976 -177.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 10.2 m -144.57 128.44 17.37 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.313 1.445 . . . . 73.53 107.665 170.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.2 t80 -133.9 109.56 9.13 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.373 -1.714 . . . . 73.13 106.373 166.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -122.39 110.66 15.91 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.807 -0.812 . . . . 71.15 108.807 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.484 ' HB1' ' HB3' ' B' ' 28' ' ' ALA . . . -107.55 87.28 3.32 Favored Pre-proline 0 C--O 1.241 0.624 0 N-CA-C 107.575 -1.268 . . . . 74.21 107.575 174.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -64.97 -34.67 46.86 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.719 2.279 . . . . 74.34 112.216 -170.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -102.25 6.04 40.37 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 117.645 -1.169 . . . . 71.13 112.06 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.484 ' HB3' ' HB1' ' B' ' 25' ' ' ALA . . . -28.66 -66.71 0.12 Allowed Pre-proline 0 N--CA 1.511 2.618 0 N-CA-C 114.785 1.402 . . . . 75.32 114.785 -168.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 28.2 Cg_endo -63.53 -29.77 70.86 Favored 'Trans proline' 0 C--N 1.398 3.134 0 C-N-CA 122.098 1.865 . . . . 73.24 112.879 -172.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.435 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 63.1 m80 -86.78 -36.31 18.65 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.464 -0.789 . . . . 72.1 112.02 -176.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.663 HG23 HD13 ' B' ' 68' ' ' LEU . 8.5 p -74.77 -16.59 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 C-N-CA 122.903 0.481 . . . . 74.34 111.883 -171.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -62.22 -21.2 64.95 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.422 0.689 . . . . 73.24 112.712 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.444 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.7 pt20 -56.53 -32.0 64.67 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.491 0.716 . . . . 73.21 110.919 174.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.444 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 99.2 mttt -91.28 69.44 6.04 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.476 1.11 . . . . 72.34 109.159 177.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -83.0 89.02 6.85 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.244 0.545 . . . . 72.15 110.95 -174.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 28.2 p90 -156.06 175.44 13.96 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.211 1.004 . . . . 74.4 108.406 169.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -71.87 109.05 4.85 Favored Pre-proline 0 CA--C 1.554 1.106 0 N-CA-C 109.601 -0.518 . . . . 62.25 109.601 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.62 149.12 79.23 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.6 2.2 . . . . 74.53 113.143 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.71 106.59 1.53 Allowed 'General case' 0 C--N 1.352 0.701 0 N-CA-C 108.367 -0.975 . . . . 74.43 108.367 174.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -96.52 137.71 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-O 121.742 0.782 . . . . 73.43 111.362 -175.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.472 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 79.0 tttt -109.03 145.81 34.96 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.015 1.326 . . . . 75.33 108.139 168.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 pp -127.83 163.14 25.05 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.844 0.458 . . . . 75.52 110.21 170.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.539 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 32.2 t70 -157.14 154.79 29.92 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.606 0.762 . . . . 72.12 109.247 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -130.94 129.28 41.97 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.251 0.62 . . . . 74.33 109.595 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -124.81 155.69 38.99 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.702 -0.851 . . . . 75.01 108.702 173.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 60.4 p -120.49 133.87 55.35 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.253 0.549 . . . . 72.21 111.497 -170.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.11 161.28 40.54 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.528 1.131 . . . . 72.35 108.764 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 54.5 m -143.13 -175.71 4.63 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.653 0.381 . . . . 74.32 111.048 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.3 p -164.87 137.84 4.68 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.954 0.902 . . . . 65.14 109.58 169.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -89.03 133.25 34.41 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 120.732 0.301 . . . . 71.33 110.704 177.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 40.6 mt -102.03 -44.31 5.51 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.846 0.858 . . . . 64.42 110.457 174.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.34 -169.65 2.54 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.197 -0.91 . . . . 62.34 109.884 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.89 117.65 8.57 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.631 -1.168 . . . . 72.3 108.818 171.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 69.07 5.29 4.99 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.374 1.07 . . . . 65.44 112.486 173.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 56.0 t -112.48 106.44 20.76 Favored 'Isoleucine or valine' 0 C--O 1.246 0.887 0 N-CA-C 107.204 -1.406 . . . . 64.03 107.204 171.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -129.28 153.9 47.36 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.178 -0.675 . . . . 61.52 109.178 -176.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -116.01 122.47 45.31 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.623 -1.251 . . . . 74.33 107.623 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 43.1 t -112.39 123.63 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.667 0.787 . . . . 75.32 109.851 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 18.9 t -103.09 125.75 57.48 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 124.306 1.042 . . . . 74.54 109.978 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.603 HD22 HD13 ' B' ' 106' ' ' LEU . 3.3 mm? -107.4 110.95 23.05 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.996 -0.742 . . . . 72.24 108.996 167.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -85.39 114.25 22.3 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.699 0.8 . . . . 73.55 109.062 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.515 HG11 HD11 ' B' ' 114' ' ' ILE . 96.9 t -103.34 109.45 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.569 1.148 . . . . 74.42 108.547 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 87.2 m -94.45 142.19 27.72 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.392 1.077 . . . . 73.13 108.722 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 98.7 t -136.2 131.97 49.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 124.704 1.202 . . . . 73.41 108.197 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 54.3 m -126.01 148.06 49.39 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.736 -1.209 . . . . 73.44 107.736 172.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.92 143.51 27.41 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.532 -0.544 . . . . 72.34 109.532 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.472 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 23.1 p -148.82 130.2 14.73 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 123.768 0.667 . . . . 70.22 111.07 -175.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.663 HD13 HG23 ' B' ' 31' ' ' VAL . 48.3 mt -103.04 111.2 23.43 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.721 -1.215 . . . . 75.34 107.721 173.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.55 -110.75 3.11 Favored Glycine 0 C--N 1.345 1.054 0 O-C-N 123.39 0.431 . . . . 75.24 112.046 -176.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.24 5.34 9.15 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.096 0.558 . . . . 65.54 111.028 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.84 150.04 34.15 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.426 -0.583 . . . . 74.43 109.426 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 68.2 m -70.1 119.55 14.47 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 123.507 0.505 . . . . 74.41 110.348 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.563 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -70.77 -60.71 2.09 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.244 -1.021 . . . . 60.13 108.244 174.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -157.1 166.0 34.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.39 -1.277 . . . . 72.54 111.164 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 72.7 mt -125.78 137.34 53.79 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 105.791 -1.929 . . . . 74.11 105.791 170.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 44.9 t -138.71 150.64 46.38 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.245 -1.02 . . . . 73.11 108.245 173.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -160.15 131.4 5.84 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.12 -0.696 . . . . 73.45 109.12 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 85.4 t -124.22 149.49 28.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.007 -0.997 . . . . 75.45 108.859 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.425 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 16.7 mt-30 -120.56 97.64 5.66 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.903 -1.147 . . . . 74.42 107.903 167.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -88.54 100.61 13.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.34 -1.356 . . . . 73.53 107.34 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.425 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -97.67 147.26 18.56 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.612 -0.995 . . . . 72.21 110.612 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.44 130.15 4.14 Favored Glycine 0 CA--C 1.507 -0.417 0 N-CA-C 110.852 -0.899 . . . . 70.45 110.852 -177.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 57.4 mt -86.06 126.48 40.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.563 -0.903 . . . . 75.05 108.563 173.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -134.87 131.14 37.0 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 107.504 -1.295 . . . . 70.2 107.504 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 70.9 m -95.06 88.59 5.28 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.34 -0.615 . . . . 70.32 109.34 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 12.4 tt -107.86 129.81 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.922 0.889 . . . . 74.02 111.724 -170.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.43 163.61 33.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.78 0.832 . . . . 75.33 110.899 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.39 -70.19 0.29 Allowed Glycine 0 C--N 1.344 0.993 0 CA-C-N 115.681 -0.691 . . . . 72.32 113.336 172.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.513 HG23 ' HB3' ' B' ' 94' ' ' MET . 11.3 mt -89.65 158.23 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.046 0.938 . . . . 74.02 111.523 -175.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -154.02 158.69 40.95 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.838 1.255 . . . . 73.51 109.173 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.94 -134.79 12.34 Favored Glycine 0 C--N 1.347 1.188 0 C-N-CA 123.352 0.501 . . . . 74.01 113.733 173.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 59.4 m -70.16 -33.18 71.45 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.276 0.63 . . . . 70.4 111.423 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -66.82 -36.14 81.69 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.54 -0.755 . . . . 65.24 111.242 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.513 ' HB3' HG23 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -81.1 -22.36 39.2 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 116.307 -0.406 . . . . 64.45 110.686 176.447 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.54 -24.92 64.09 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.106 0.479 . . . . 72.44 111.168 173.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . 0.443 ' CD2' ' HB2' ' B' ' 134' ' ' ASP . 54.9 t-80 -77.78 -30.01 51.14 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.511 0.724 . . . . 74.5 110.661 171.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.472 ' SG ' ' HE2' ' B' ' 9' ' ' MET . 43.8 t -80.14 -68.39 0.68 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.748 0.819 . . . . 71.42 112.488 -175.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.587 ' H ' HD23 ' B' ' 98' ' ' LEU . 1.9 pt? -102.5 -7.28 22.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.853 -0.529 . . . . 74.12 111.759 -174.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.02 0.75 57.54 Favored Glycine 0 C--N 1.344 1.003 0 O-C-N 123.292 0.37 . . . . 74.4 112.452 173.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.19 -60.07 0.22 Allowed 'General case' 0 C--N 1.358 0.977 0 C-N-CA 122.77 0.428 . . . . 72.44 111.98 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -70.52 -36.82 73.95 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 112.233 0.457 . . . . 74.31 112.233 -175.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.525 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 70.9 m -68.76 -44.39 31.19 Favored Pre-proline 0 N--CA 1.482 1.145 0 CA-C-O 118.545 -0.74 . . . . 74.41 110.818 177.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -45.97 -40.07 20.14 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 122.536 2.157 . . . . 74.4 113.766 162.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -68.49 -33.47 74.21 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.143 0.577 . . . . 74.42 112.504 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.563 HD12 HD11 ' B' ' 13' ' ' ILE . 67.1 mt -69.26 -46.09 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.19 0.596 . . . . 75.5 109.9 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.603 HD13 HD22 ' B' ' 60' ' ' LEU . 60.1 mt -84.03 -11.44 56.75 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.677 -1.147 . . . . 74.24 110.763 -172.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.404 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 81.4 t80 -57.65 -54.47 54.87 Favored Pre-proline 0 CA--C 1.557 1.221 0 CA-C-O 117.971 -1.014 . . . . 73.2 112.993 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 36.5 Cg_exo -62.03 -35.85 74.15 Favored 'Trans proline' 0 C--N 1.39 2.745 0 C-N-CA 121.761 1.641 . . . . 74.32 113.029 -177.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -69.02 -44.69 72.23 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.854 0.462 . . . . 74.32 110.61 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.413 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -65.47 -43.66 89.59 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.903 0.481 . . . . 63.34 110.306 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -54.64 -53.13 58.76 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.523 1.129 . . . . 74.5 110.582 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.444 ' HG3' HH12 ' A' ' 120' ' ' ARG . 13.6 tp10 -62.35 -34.36 76.5 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.872 0.869 . . . . 74.33 111.05 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.51 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.9 t -71.23 -37.82 71.99 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.27 0.228 . . . . 71.22 110.862 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.515 HD11 HG11 ' B' ' 62' ' ' VAL . 84.5 mt -67.39 -56.95 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.445 0.698 . . . . 64.22 109.182 176.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 9.9 m -62.64 -24.01 67.38 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 124.288 0.992 . . . . 73.33 111.364 -173.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 39.7 t -67.19 -49.79 63.34 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 122.968 0.507 . . . . 75.54 109.913 170.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.51 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 33.9 mmt -62.02 -39.46 92.37 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 122.877 0.471 . . . . 75.23 110.644 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 114' ' ' ILE . 84.3 t -59.52 -49.5 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.585 1.154 . . . . 73.21 110.077 176.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.8 t -63.68 -37.34 86.97 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.585 -1.189 . . . . 74.43 111.156 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -69.47 -33.47 72.95 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.476 -0.784 . . . . 71.13 110.335 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.74 5.55 74.3 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.872 0.732 . . . . 73.15 112.835 173.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 74.6 p 54.9 55.82 7.34 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 126.012 1.725 . . . . 72.44 111.99 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -117.76 156.98 49.18 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 124.34 1.056 . . . . 73.52 110.509 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.83 161.86 2.91 Favored 'Trans proline' 0 C--N 1.392 2.829 0 C-N-CA 123.938 3.092 . . . . 71.32 116.139 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.517 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -65.13 121.85 15.7 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 113.911 -1.495 . . . . 75.4 111.6 -178.609 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -138.63 109.55 6.74 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 108.342 -0.984 . . . . 74.33 108.342 177.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -124.49 135.1 52.93 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.935 0.894 . . . . 74.42 109.32 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 5.9 mp -87.8 139.27 30.7 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.819 0.848 . . . . 73.3 110.102 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.48 164.72 56.41 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 124.222 1.009 . . . . 65.12 111.067 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -53.88 103.79 0.1 OUTLIER 'Trans proline' 0 C--N 1.39 2.735 0 C-N-CA 122.824 2.349 . . . . 71.14 112.892 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 37.6 t -90.72 108.62 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.32 -0.993 . . . . 73.45 108.32 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.64 79.95 8.12 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.322 -0.621 . . . . 71.43 109.322 177.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -51.14 -45.36 61.62 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.516 0.726 . . . . 73.3 110.119 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . 0.443 ' HB2' ' CD2' ' B' ' 96' ' ' HIS . 7.6 p-10 . . . . . 0 C--O 1.222 -0.348 0 CA-C-N 113.444 -1.707 . . . . 71.43 112.531 -176.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.584 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.8 t80 . . . . . 0 C--O 1.236 0.362 0 CA-C-O 120.852 0.358 . . . . 73.42 110.565 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -145.53 124.88 13.04 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.095 -1.076 . . . . 72.24 108.095 171.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 51.6 mt -73.95 102.08 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 107.774 -1.195 . . . . 74.55 107.774 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -75.59 -50.92 14.12 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.582 -0.735 . . . . 73.24 110.616 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -167.3 123.88 1.16 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 110.294 -0.261 . . . . 74.22 110.294 -176.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 63.0 mt -108.76 144.46 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 108.002 -1.11 . . . . 71.43 108.002 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.547 ' HB3' HG21 ' D' ' 122' ' ' THR . 21.8 p90 -176.36 172.38 2.27 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.383 0.673 . . . . 74.44 110.11 -174.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.9 p -98.02 122.42 41.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.742 -0.663 . . . . 70.33 109.363 175.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.416 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 18.3 mmtp -70.04 -46.77 64.34 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 107.765 -1.198 . . . . 72.44 107.765 168.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 17.5 t70 -134.51 141.18 46.64 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 113.438 -1.71 . . . . 60.32 109.743 -171.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 87.5 mt -135.81 146.13 30.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 106.082 -1.822 . . . . 71.22 106.082 169.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 22' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' C' ' 77' ' ' GLU . 35.8 t -160.79 151.18 18.01 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.535 0.683 . . . . 74.53 109.859 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 86.9 t80 -144.62 136.43 25.82 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.529 -1.656 . . . . 72.03 106.529 169.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -134.24 129.29 35.46 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.2 -0.667 . . . . 74.52 109.2 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.51 81.01 11.44 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 106.858 -1.534 . . . . 65.32 106.858 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -69.53 -21.54 34.41 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.955 2.437 . . . . 70.1 112.423 -174.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -118.51 25.91 9.95 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.479 1.111 . . . . 64.11 110.147 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.73 -52.9 22.36 Favored Pre-proline 0 CA--C 1.56 1.361 0 CA-C-O 117.818 -1.087 . . . . 71.31 113.683 -173.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.72 -43.76 47.11 Favored 'Trans proline' 0 C--N 1.399 3.212 0 C-N-CA 121.834 1.689 . . . . 75.22 112.434 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.444 ' O ' ' HG3' ' C' ' 33' ' ' GLN . 86.6 t60 -69.45 -43.68 72.78 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.275 -0.875 . . . . 75.23 112.441 -175.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.665 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.2 p -69.82 -18.45 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.324 0 N-CA-C 113.43 0.9 . . . . 75.13 113.43 -174.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -70.19 -20.71 63.1 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 113.099 0.777 . . . . 75.1 113.099 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' C' ' 30' ' ' HIS . 4.9 pp0? -92.67 8.91 37.13 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 111.992 0.367 . . . . 75.24 111.992 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.8 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -91.89 156.59 17.37 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.143 0.577 . . . . 73.44 110.685 179.204 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.35 125.14 22.89 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.171 0.988 . . . . 65.2 109.452 164.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -81.12 88.67 5.98 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.252 0.548 . . . . 74.42 110.49 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -140.28 77.91 23.84 Favored Pre-proline 0 C--O 1.243 0.738 0 N-CA-C 108.234 -1.025 . . . . 61.53 108.234 171.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -84.12 129.84 4.65 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.294 1.996 . . . . 74.11 111.551 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.75 96.49 8.19 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 104.689 -2.338 . . . . 73.32 104.689 166.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 20.8 m -88.8 121.31 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 114.643 -1.162 . . . . 72.54 111.595 -168.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.451 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 35.8 ttpt -97.26 106.48 18.82 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.832 -0.803 . . . . 74.22 108.832 174.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -87.42 121.68 30.17 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.536 -1.283 . . . . 70.52 107.536 175.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -118.5 140.07 50.45 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.086 1.354 . . . . 63.31 108.397 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.618 HD21 HD12 ' C' ' 60' ' ' LEU . 0.0 OUTLIER -137.49 132.53 33.42 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.562 0.345 . . . . 74.23 110.125 172.721 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 15.1 t70 -113.2 148.3 35.73 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.905 0.882 . . . . 74.33 108.906 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 77.0 p -112.76 112.46 23.98 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.449 0.7 . . . . 74.22 109.33 -174.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.2 139.01 48.18 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.568 0.747 . . . . 73.42 109.34 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 55.6 m -157.8 155.62 30.09 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.32 0.648 . . . . 64.41 110.846 -175.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 47.2 t -160.93 130.65 4.92 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.526 -0.761 . . . . 71.44 109.842 -174.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -76.54 122.02 24.0 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.811 -0.44 . . . . 75.32 109.811 174.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.539 HD13 HD13 ' C' ' 83' ' ' ILE . 66.7 mt -86.45 -52.66 5.45 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.539 -0.755 . . . . 74.14 110.119 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.51 -172.04 3.99 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.05 0.54 . . . . 55.44 111.723 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -56.93 103.46 0.11 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.075 1.35 . . . . 63.32 110.875 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 69.51 -1.96 2.07 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 125.907 1.683 . . . . 73.14 113.054 -177.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 75.7 t -93.35 113.7 28.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 108.33 -0.989 . . . . 74.21 108.33 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . 0.557 ' HB3' HD12 ' C' ' 86' ' ' ILE . 50.6 t80 -131.28 126.1 34.52 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.44 -0.8 . . . . 74.13 109.199 -171.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -85.72 124.91 32.76 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.177 0.991 . . . . 63.5 110.223 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 62.9 t -111.94 115.87 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 107.958 -1.127 . . . . 74.3 107.958 171.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.9 t -113.63 129.55 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.493 0.717 . . . . 64.25 109.32 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.618 HD12 HD21 ' C' ' 44' ' ' LEU . 40.9 tp -116.42 113.34 22.73 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.804 -0.814 . . . . 72.43 108.804 173.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.558 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 22.4 ttt180 -81.49 105.74 12.89 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 108.381 -0.97 . . . . 74.31 108.381 176.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 37.3 t -99.0 119.28 46.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 107.7 -1.222 . . . . 70.4 107.7 176.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 60.5 m -130.67 119.74 22.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.757 -0.831 . . . . 73.03 108.757 -174.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.61 HG21 HD12 ' C' ' 114' ' ' ILE . 97.6 t -100.17 114.66 39.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.348 -0.982 . . . . 74.53 108.348 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.506 HG21 HD23 ' C' ' 75' ' ' LEU . 5.2 m -97.69 135.78 38.99 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.104 -1.443 . . . . 75.45 107.104 171.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.12 114.82 16.2 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.308 -1.368 . . . . 74.03 107.308 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 20.1 m -136.15 126.61 26.82 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.113 -0.699 . . . . 75.25 109.113 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.721 HD11 ' HG2' ' C' ' 34' ' ' LYS . 14.2 mt -85.59 13.97 6.28 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.694 1.198 . . . . 73.44 111.588 -176.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.0 -98.77 0.4 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 110.103 -1.199 . . . . 65.23 110.103 -175.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -90.81 -32.85 15.93 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.299 0.64 . . . . 72.25 109.365 171.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -71.8 120.21 17.06 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 114.641 -1.163 . . . . 73.11 109.666 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 62.8 m -76.18 126.13 30.43 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.562 -0.903 . . . . 74.13 108.562 167.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.665 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.87 -58.27 3.39 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.163 -1.051 . . . . 74.25 108.163 170.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -166.22 176.59 7.47 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.623 0.725 . . . . 74.43 111.941 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.506 HD23 HG21 ' C' ' 65' ' ' THR . 2.6 tm? -141.71 104.82 4.6 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 106.983 -1.488 . . . . 73.15 106.983 173.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.488 ' SG ' HG22 ' C' ' 114' ' ' ILE . 49.7 t -109.45 125.76 52.78 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.216 0.606 . . . . 75.04 109.378 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' C' ' 22' ' ' SER . 40.7 tt0 -124.48 139.73 53.62 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.494 0.718 . . . . 73.4 109.527 -177.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' C' ' 110' ' ' ALA . 27.4 t -144.08 114.08 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 108.147 -1.057 . . . . 65.21 108.147 174.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.501 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 77.9 mt-30 -90.69 97.5 11.22 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.545 -0.909 . . . . 72.14 108.545 171.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.544 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 9.0 tp-100 -82.03 105.23 12.96 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.616 -0.513 . . . . 73.52 109.616 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.49 144.73 21.61 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 111.386 -0.686 . . . . 71.42 111.386 175.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.29 116.46 0.84 Allowed Glycine 0 CA--C 1.503 -0.675 0 N-CA-C 110.376 -1.09 . . . . 74.24 110.376 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.539 HD13 HD13 ' C' ' 51' ' ' LEU . 14.6 mm -85.24 118.22 31.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 107.81 -1.182 . . . . 73.52 107.81 177.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.584 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 46.7 m-85 -132.2 142.88 49.59 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.637 0.775 . . . . 75.04 108.975 -174.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -84.54 116.74 23.29 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.671 0.388 . . . . 72.21 109.988 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.557 HD12 ' HB3' ' C' ' 56' ' ' TYR . 3.4 mp -115.09 109.07 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 108.406 -0.961 . . . . 72.31 108.406 172.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.01 161.99 39.69 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.66 1.184 . . . . 73.15 108.916 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.21 -51.14 3.96 Favored Glycine 0 N--CA 1.472 1.064 0 O-C-N 123.136 0.272 . . . . 63.42 112.796 175.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 30.6 pt -91.87 158.22 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.826 0.85 . . . . 73.22 111.48 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.662 ' HA ' ' HE1' ' C' ' 94' ' ' MET . 41.8 tt0 -152.12 162.01 41.75 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.112 0.965 . . . . 72.42 109.589 173.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.67 -117.55 5.8 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.024 -0.535 . . . . 75.21 112.814 172.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 57.3 p -65.1 -37.51 87.73 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.048 0.939 . . . . 74.52 111.497 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -71.8 -42.79 66.63 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.287 0.635 . . . . 64.22 111.6 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.662 ' HE1' ' HA ' ' C' ' 90' ' ' GLU . 9.1 ptp -73.09 -33.33 65.54 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 120.99 -0.284 . . . . 74.52 110.574 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.33 -28.64 69.45 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.004 0.522 . . . . 55.44 110.706 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -70.36 -44.74 67.48 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.449 -0.796 . . . . 74.14 110.206 172.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.582 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 42.3 t -65.54 -40.74 93.24 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 123.292 0.37 . . . . 63.23 110.512 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' C' ' 94' ' ' MET . 86.9 mt -77.27 -49.9 14.03 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.22 0.608 . . . . 72.14 111.781 -175.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.96 12.38 64.03 Favored Glycine 0 N--CA 1.474 1.228 0 N-CA-C 114.898 0.719 . . . . 71.11 114.898 -166.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.707 ' HB2' ' HB2' ' C' ' 134' ' ' ASP . . . -154.67 -62.54 0.13 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 117.624 0.712 . . . . 72.13 110.974 -172.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.582 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 73.9 t80 -76.14 -39.57 54.73 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.139 1.376 . . . . 74.3 113.105 -167.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 96.7 m -77.44 -39.84 2.09 Favored Pre-proline 0 N--CA 1.486 1.328 0 CA-C-O 118.687 -0.673 . . . . 71.02 111.716 176.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -48.5 -35.15 27.99 Favored 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 122.741 2.294 . . . . 75.52 113.683 164.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -38.51 91.2 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.762 0.425 . . . . 74.13 111.022 175.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.54 HD13 ' NH1' ' A' ' 111' ' ' ARG . 33.4 mm -66.99 -46.36 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 109.795 -0.446 . . . . 72.42 109.795 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.13 -20.97 29.48 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 113.547 0.943 . . . . 72.34 113.547 -168.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -58.7 -52.74 72.56 Favored Pre-proline 0 N--CA 1.488 1.449 0 CA-C-O 117.951 -1.023 . . . . 75.33 113.126 -175.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.14 -32.23 83.11 Favored 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 121.647 1.565 . . . . 74.14 113.0 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -64.91 -53.78 41.09 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.253 0.621 . . . . 64.21 110.377 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.544 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -65.96 -33.43 75.79 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.03 -0.986 . . . . 73.44 111.179 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -60.14 -53.85 52.82 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.394 1.078 . . . . 75.0 110.243 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.28 -35.85 78.48 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 110.016 -0.364 . . . . 73.13 110.016 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.413 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 10.2 t -67.06 -27.92 67.78 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.148 0.579 . . . . 73.34 111.323 -178.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.61 HD12 HG21 ' C' ' 64' ' ' VAL . 83.0 mt -76.58 -55.65 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 115.882 -0.599 . . . . 71.4 109.973 171.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 17.1 m -61.15 -27.81 68.66 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 123.389 0.676 . . . . 73.23 111.502 -173.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 41.4 t -62.42 -52.77 62.23 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 124.457 1.103 . . . . 65.44 109.093 170.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.668 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.15 -34.74 75.5 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.46 1.104 . . . . 71.34 112.381 178.352 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 88.8 t -63.38 -44.31 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 109.209 -0.663 . . . . 73.44 109.209 174.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 22.8 t -74.68 -24.04 58.73 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.988 -1.006 . . . . 74.33 111.71 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' C' ' 116' ' ' SER . 87.5 mtt-85 -74.02 -40.7 62.71 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.876 -0.787 . . . . 75.45 108.876 174.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.69 -4.35 70.42 Favored Glycine 0 C--N 1.357 1.719 0 O-C-N 123.951 0.782 . . . . 61.35 112.431 171.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 29.3 p 65.26 28.44 11.97 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.679 1.992 . . . . 73.35 112.934 170.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -83.33 145.96 49.73 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 123.364 0.666 . . . . 74.34 109.323 172.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.81 146.03 29.61 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.137 2.558 . . . . 75.42 113.139 176.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -52.62 111.1 0.59 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.396 1.078 . . . . 74.52 112.254 -172.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 47.3 tp -114.21 88.95 2.97 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.079 -1.452 . . . . 63.24 107.079 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -97.83 126.1 43.02 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.337 -0.847 . . . . 74.44 109.062 -171.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.05 126.48 31.12 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 122.888 0.475 . . . . 74.15 110.218 -172.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.11 152.81 95.66 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 124.29 1.036 . . . . 64.21 111.347 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.515 ' HG3' HD13 ' A' ' 16' ' ' ILE . 38.4 Cg_exo -57.65 117.61 4.34 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.773 2.315 . . . . 62.23 113.104 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -104.06 109.52 27.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 122.397 1.094 . . . . 75.13 108.534 169.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -101.32 76.46 1.71 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.933 -1.031 . . . . 72.45 108.566 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -51.11 -45.78 61.67 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.271 0.628 . . . . 65.34 112.311 -173.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.707 ' HB2' ' HB2' ' C' ' 100' ' ' ALA . 18.4 t0 . . . . . 0 N--CA 1.482 1.155 0 O-C-N 124.01 0.818 . . . . 64.41 110.958 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 109.41 -0.589 . . . . 75.11 109.41 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.439 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 55.1 t80 -158.09 100.82 1.73 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.791 -1.188 . . . . 75.32 107.791 -175.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -127.65 116.76 20.79 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.47 -0.937 . . . . 75.3 108.47 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 7.4 mt -81.8 124.03 38.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.693 -0.484 . . . . 74.52 109.693 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -90.8 -39.24 12.48 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.649 0.78 . . . . 73.22 111.478 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -174.97 123.9 0.25 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 117.805 0.275 . . . . 73.34 111.665 -166.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -103.97 137.1 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 107.986 -1.116 . . . . 73.42 107.986 167.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -160.8 148.57 15.85 Favored 'General case' 0 C--O 1.239 0.533 0 O-C-N 124.142 0.902 . . . . 70.4 109.883 177.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 77.8 p -79.61 114.05 18.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.136 -0.938 . . . . 75.32 108.979 174.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -82.4 -28.59 31.33 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.935 -0.575 . . . . 73.53 110.439 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 30.2 t70 -156.61 140.12 15.86 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.855 -1.066 . . . . 65.3 108.24 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.668 HG21 ' HE1' ' C' ' 117' ' ' MET . 84.6 mt -139.16 150.3 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.203 1.001 . . . . 75.33 108.374 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 22' ' ' SER . . . . . 0.445 ' HB2' ' HB3' ' D' ' 77' ' ' GLU . 71.7 m -147.62 140.57 24.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.689 1.196 . . . . 55.33 109.318 172.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 83.7 t80 -141.23 123.49 15.68 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 105.233 -2.136 . . . . 70.42 105.233 165.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.6 mt-10 -139.7 108.62 6.0 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.187 -0.672 . . . . 74.33 109.187 -170.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.36 94.17 9.35 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 108.422 -0.955 . . . . 65.02 108.422 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.86 -44.36 2.84 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.696 2.264 . . . . 74.23 112.607 -170.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.466 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 36.0 m-20 -96.5 11.75 33.94 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.849 0.86 . . . . 72.21 111.057 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -23.88 -68.38 0.05 OUTLIER Pre-proline 0 CA--C 1.56 1.346 0 N-CA-C 116.941 2.2 . . . . 74.11 116.941 -160.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.21 -27.23 11.82 Favored 'Trans proline' 0 C--N 1.382 2.307 0 CA-C-N 123.334 2.226 . . . . 75.22 113.509 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -66.35 -45.55 79.81 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.758 0.823 . . . . 73.23 110.376 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.642 HG21 ' HA ' ' D' ' 73' ' ' ALA . 11.7 p -76.41 -15.39 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 CA-C-N 115.355 -0.839 . . . . 65.42 112.125 -171.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -69.11 -17.99 63.91 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 112.544 0.572 . . . . 72.22 112.544 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -61.46 -20.95 63.71 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.128 0.571 . . . . 75.2 110.982 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.435 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 98.0 mttt -99.69 90.73 4.57 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.857 1.263 . . . . 74.5 109.477 178.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -96.93 93.08 6.42 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.874 -0.603 . . . . 71.15 109.485 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.442 ' O ' ' HG2' ' D' ' 124' ' ' PRO . 33.1 p90 -160.88 175.86 12.07 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.61 1.164 . . . . 75.15 107.866 167.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -69.62 112.0 10.73 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 122.938 0.495 . . . . 74.21 109.687 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.92 134.55 60.91 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.15 2.567 . . . . 73.24 111.541 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.11 114.27 10.03 Favored 'General case' 0 C--N 1.348 0.524 0 N-CA-C 108.235 -1.024 . . . . 71.04 108.235 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 16.1 m -103.65 108.56 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-O 122.119 0.961 . . . . 71.14 110.997 -166.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.494 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 73.7 mmtt -87.93 128.37 35.37 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.743 -1.117 . . . . 73.35 108.337 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.422 HD21 ' H ' ' D' ' 42' ' ' LEU . 1.0 OUTLIER -96.3 118.89 33.77 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.711 0.767 . . . . 75.43 110.03 -174.393 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.695 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.9 m-20 -110.33 125.69 53.44 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.539 -1.282 . . . . 73.53 107.539 174.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 93.3 mt -122.79 130.77 53.3 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.112 0.565 . . . . 74.25 109.692 -175.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 11.4 t70 -131.73 146.5 52.2 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.154 0.982 . . . . 74.12 108.368 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 42.8 p -119.67 143.73 47.57 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.507 0.723 . . . . 74.11 110.622 -171.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.75 155.68 33.52 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.331 0.653 . . . . 72.11 109.793 175.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 17.7 p -150.2 160.22 43.85 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.901 0.48 . . . . 52.34 110.576 -175.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 2.9 m -152.07 119.65 6.06 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.92 -0.77 . . . . 63.44 108.92 175.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -66.95 116.51 7.87 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.737 -1.209 . . . . 64.2 107.737 163.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.472 HD11 HG23 ' D' ' 83' ' ' ILE . 29.8 mt -95.04 -35.12 12.07 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.296 -0.631 . . . . 73.42 109.296 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.56 -173.12 4.24 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.217 -0.901 . . . . 70.5 110.208 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -68.33 123.57 21.12 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.875 -1.057 . . . . 73.53 110.225 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . 0.512 ' HB3' ' HB3' ' D' ' 87' ' ' ALA . 65.1 m-20 62.25 17.75 9.57 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.699 1.2 . . . . 74.51 112.194 -175.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.6 t -119.44 119.67 61.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.813 -0.81 . . . . 74.24 108.813 174.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.541 ' HD2' ' HB ' ' D' ' 86' ' ' ILE . 78.3 m-85 -134.52 129.06 34.53 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.521 -0.918 . . . . 74.12 108.521 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -92.98 127.53 38.53 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.97 0.908 . . . . 74.44 109.335 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 73.8 t -103.54 112.44 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.856 -1.165 . . . . 71.12 107.856 173.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.411 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 47.5 t -103.68 132.2 50.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 108.094 -1.076 . . . . 74.13 108.094 174.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 53.6 tp -128.54 121.78 29.58 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.722 0.296 . . . . 75.11 110.208 175.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.575 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 20.6 ttm-85 -84.82 98.72 10.45 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.056 0.942 . . . . 74.44 109.404 173.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 93.6 t -90.79 114.49 28.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.31 -0.996 . . . . 54.14 108.31 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.695 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 28.6 m -122.65 133.33 54.52 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.45 0.643 . . . . 72.03 109.666 -174.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.456 HG22 HD12 ' D' ' 114' ' ' ILE . 21.7 t -119.63 101.87 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.863 1.665 . . . . 72.41 108.787 -178.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 59.1 m -92.4 99.79 12.48 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.271 -0.877 . . . . 71.33 108.801 175.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.31 142.21 36.36 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.135 -0.939 . . . . 71.33 109.7 -169.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 70.1 m -142.93 137.45 29.46 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.222 0.534 . . . . 63.43 111.673 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.572 HD11 HG23 ' D' ' 31' ' ' VAL . 55.8 mt -105.53 104.59 14.34 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.629 1.172 . . . . 72.25 108.536 172.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.22 -123.94 6.35 Favored Glycine 0 C--N 1.342 0.896 0 CA-C-N 115.797 -0.638 . . . . 74.52 112.514 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.61 5.87 34.06 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.168 0.587 . . . . 73.55 111.081 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.435 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 13.1 pt-20 -120.49 157.01 30.31 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.327 0.651 . . . . 74.45 109.81 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 63.7 m -71.34 136.45 47.84 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.628 0.58 . . . . 71.53 110.731 178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.642 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -84.45 -64.08 1.22 Allowed 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.329 -0.989 . . . . 71.43 108.329 174.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -157.09 167.5 30.24 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.685 -1.143 . . . . 72.41 110.162 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 83.3 mt -126.42 110.92 13.86 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 106.435 -1.691 . . . . 74.24 106.435 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.545 ' SG ' HG12 ' D' ' 114' ' ' ILE . 42.4 t -114.26 138.1 50.93 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.575 -1.269 . . . . 71.42 107.575 -178.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' D' ' 22' ' ' SER . 43.6 tt0 -155.36 122.58 5.51 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 110.033 -0.358 . . . . 74.22 110.033 -175.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 50.8 t -129.73 114.69 31.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 123.24 0.616 . . . . 75.31 109.368 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.432 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 5.0 mt-30 -86.51 83.65 7.59 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.096 -1.075 . . . . 73.13 108.096 168.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -79.88 98.21 7.02 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 113.346 -1.752 . . . . 74.33 108.145 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -93.71 144.12 16.91 Favored Glycine 0 C--N 1.341 0.85 0 N-CA-C 111.4 -0.68 . . . . 74.12 111.4 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.6 131.33 5.45 Favored Glycine 0 C--N 1.331 0.259 0 N-CA-C 111.162 -0.775 . . . . 75.52 111.162 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.472 HG23 HD11 ' D' ' 51' ' ' LEU . 61.3 mt -88.04 120.23 36.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 107.923 -1.14 . . . . 70.23 107.923 175.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -128.54 126.22 39.93 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.676 0.791 . . . . 75.24 108.97 -175.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.1 m -79.37 99.53 7.19 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.599 -0.889 . . . . 75.44 108.599 172.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.541 ' HB ' ' HD2' ' D' ' 56' ' ' TYR . 17.9 mm -108.98 111.58 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.705 0.802 . . . . 73.33 109.571 -174.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' D' ' 54' ' ' ASP . . . -138.04 147.72 44.39 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.955 0.502 . . . . 73.32 110.705 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.56 10.34 84.68 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 114.724 0.65 . . . . 71.11 114.724 171.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.474 HD13 HG22 ' D' ' 86' ' ' ILE . 8.9 mt -106.46 128.02 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 117.433 0.617 . . . . 64.53 109.744 -175.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -148.51 159.69 43.81 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.562 1.145 . . . . 72.53 109.957 -169.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . 0.461 ' O ' ' HG2' ' D' ' 94' ' ' MET . . . 68.1 -132.24 28.23 Favored Glycine 0 C--N 1.349 1.292 0 O-C-N 124.08 0.863 . . . . 52.54 113.428 173.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 18.7 m -61.75 -37.38 84.05 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.654 0.782 . . . . 71.31 111.098 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -65.77 -34.11 77.41 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.033 -0.985 . . . . 70.14 110.701 -174.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' D' ' 91' ' ' GLY . 10.6 ptm -75.21 -36.0 61.43 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.168 0.587 . . . . 74.42 111.424 -174.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.65 -31.37 63.46 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.484 -0.78 . . . . 70.32 110.362 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -80.0 -31.73 39.69 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.372 -0.831 . . . . 73.5 111.076 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.0 t -69.59 -53.16 20.19 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.664 0.386 . . . . 54.4 110.702 -175.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 10.3 mp -86.82 -22.61 25.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.414 0.286 . . . . 73.44 111.198 -178.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.29 -24.82 56.29 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-O 119.729 -0.484 . . . . 74.43 113.904 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.17 -50.97 0.65 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.494 0.553 . . . . 70.2 112.494 -171.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -73.86 -43.73 57.69 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.834 0.679 . . . . 73.44 112.834 -169.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.439 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 69.0 m -72.76 -44.2 8.81 Favored Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 123.462 0.705 . . . . 73.41 111.822 -176.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.32 -25.14 64.34 Favored 'Trans proline' 0 C--N 1.395 3.017 0 C-N-CA 121.76 1.64 . . . . 71.42 112.681 170.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . 0.524 ' HA ' ' HD2' ' D' ' 107' ' ' PHE . 45.7 t-20 -62.43 -39.89 94.77 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.424 0.689 . . . . 71.23 110.094 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.85 -38.41 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.62 0.768 . . . . 65.32 110.564 174.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 86.4 mt -83.14 -19.73 36.11 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.114 -0.948 . . . . 72.11 112.442 -170.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . 0.524 ' HD2' ' HA ' ' D' ' 104' ' ' ASN . 27.5 m-85 -63.05 -43.79 82.82 Favored Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 114.086 1.143 . . . . 75.43 114.086 -177.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -52.18 -46.14 34.62 Favored 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 122.328 2.019 . . . . 74.55 113.393 172.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -72.86 -36.44 67.42 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.456 -0.793 . . . . 74.23 111.686 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.14 78.67 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.589 0.555 . . . . 71.12 109.639 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -55.58 -50.21 70.69 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 124.953 1.408 . . . . 74.31 110.634 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -65.01 -46.67 80.44 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.728 0.642 . . . . 73.5 111.608 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -57.7 -41.8 82.44 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.578 0.549 . . . . 74.24 110.53 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.545 HG12 ' SG ' ' D' ' 76' ' ' CYS . 81.5 mt -60.93 -56.78 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 115.046 -0.979 . . . . 64.13 110.478 172.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 47.6 m -54.4 -40.77 68.53 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.677 1.191 . . . . 74.23 111.753 -172.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.416 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 32.3 t -67.09 -45.32 77.6 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.034 -0.985 . . . . 70.25 110.567 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.5 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.8 mtm -67.31 -34.5 77.51 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.852 0.461 . . . . 74.44 111.734 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.441 HG23 ' O ' ' D' ' 114' ' ' ILE . 77.3 t -62.08 -45.01 99.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.586 0.754 . . . . 74.44 109.903 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.5 p -75.71 -26.58 57.66 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.901 -0.59 . . . . 73.54 111.401 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' D' ' 116' ' ' SER . 84.3 mtt-85 -72.46 -31.22 65.25 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.374 0.669 . . . . 74.44 110.132 175.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.49 10.75 68.25 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 123.739 0.65 . . . . 34.54 112.139 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.547 HG21 ' HB3' ' C' ' 17' ' ' TYR . 24.3 p 58.63 22.3 9.7 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 126.877 2.071 . . . . 74.11 114.09 174.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -83.96 157.22 63.48 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.846 0.858 . . . . 71.35 110.04 171.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.442 ' HG2' ' O ' ' D' ' 36' ' ' TRP . 77.9 Cg_exo -54.96 134.0 61.12 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.347 2.698 . . . . 73.12 113.835 176.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -55.95 132.1 48.93 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.801 1.241 . . . . 73.53 112.071 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 61.4 tp -110.27 101.88 10.59 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.571 0.748 . . . . 72.51 110.09 -177.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -103.89 104.02 13.96 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.582 -0.896 . . . . 72.41 108.582 175.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 tt -70.9 125.68 27.5 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 108.483 -0.932 . . . . 73.43 108.483 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.91 157.07 81.76 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.173 0.989 . . . . 63.23 112.09 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.51 ' HD3' HG13 ' B' ' 13' ' ' ILE . 54.3 Cg_exo -56.52 103.52 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.046 2.498 . . . . 73.15 112.785 174.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 124.052 0.941 . . . . 73.22 109.84 -179.428 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.512 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 24.6 t80 . . . . . 0 C--O 1.236 0.389 0 N-CA-C 108.433 -0.951 . . . . 72.3 108.433 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -155.14 102.11 2.28 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.193 -0.669 . . . . 74.41 109.193 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.688 HG12 ' HD2' ' A' ' 84' ' ' PHE . 27.5 mt -72.52 120.39 20.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 109.134 -0.691 . . . . 63.13 109.134 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -85.58 -40.87 15.8 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 123.741 0.651 . . . . 72.35 110.001 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.432 ' HB3' HD13 ' A' ' 83' ' ' ILE . 19.9 ttt180 -173.44 120.89 0.34 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.387 -0.37 . . . . 65.05 110.402 -166.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.512 HD13 ' HG3' ' C' ' 130' ' ' PRO . 62.9 mt -114.0 134.47 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 108.78 -0.822 . . . . 74.22 108.78 173.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.431 ' HB3' HG21 ' B' ' 122' ' ' THR . 31.0 p90 -166.32 165.74 17.1 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 124.216 0.947 . . . . 74.32 110.848 -173.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.7 p -89.13 116.94 27.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.978 -1.01 . . . . 75.24 109.088 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -85.58 -32.56 22.04 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.939 0.4 . . . . 71.32 109.996 178.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.655 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 9.9 t70 -142.85 136.41 28.7 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.018 -0.992 . . . . 73.33 109.289 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.0 mt -137.3 146.54 27.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 107.393 -1.336 . . . . 74.13 107.393 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.9 t -155.44 131.7 10.24 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.235 0.614 . . . . 74.5 109.829 172.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.524 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.3 t80 -130.44 141.84 50.52 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.181 -1.414 . . . . 74.22 107.181 171.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -139.48 139.99 37.14 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.021 0.929 . . . . 75.31 108.506 175.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.09 82.81 56.28 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 106.256 -1.757 . . . . 75.14 106.256 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.54 -42.01 29.14 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 123.058 2.505 . . . . 74.45 112.706 -166.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -111.41 25.14 12.0 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 118.13 -0.938 . . . . 72.54 109.654 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.451 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -37.03 -62.8 0.52 Allowed Pre-proline 0 N--CA 1.497 1.924 0 C-N-CA 124.433 1.093 . . . . 75.24 113.915 -166.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.451 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 12.7 Cg_exo -67.87 -24.53 39.98 Favored 'Trans proline' 0 C--N 1.394 2.935 0 C-N-CA 122.175 1.917 . . . . 75.34 112.712 -173.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -78.03 -47.21 18.93 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.88 0.872 . . . . 74.21 109.784 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.607 HG23 ' HA ' ' A' ' 73' ' ' ALA . 4.2 p -79.8 -12.15 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-N 114.645 -1.162 . . . . 63.35 112.654 -163.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -66.81 -27.39 67.52 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.047 0.451 . . . . 71.22 110.623 171.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -78.33 -18.04 55.72 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.284 1.034 . . . . 74.45 111.276 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -80.06 151.08 30.1 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.642 0.777 . . . . 74.54 111.01 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.05 138.82 58.64 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.268 -0.878 . . . . 74.43 110.142 174.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -79.88 83.65 5.77 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.395 0.617 . . . . 74.12 109.837 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -131.62 73.74 78.9 Favored Pre-proline 0 C--O 1.244 0.801 0 N-CA-C 108.039 -1.097 . . . . 72.43 108.039 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -84.4 159.26 12.83 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.269 1.979 . . . . 63.04 111.87 -176.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -111.16 106.4 15.41 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.375 -1.713 . . . . 74.15 106.375 166.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.7 t -66.48 92.25 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 108.557 -0.905 . . . . 65.01 108.557 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -100.32 112.49 24.83 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.612 -1.625 . . . . 72.24 106.612 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.05 150.53 52.13 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.326 0.584 . . . . 71.02 112.318 -174.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -136.06 113.08 10.39 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.483 -1.235 . . . . 75.21 108.262 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 mp -98.08 124.18 42.48 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 108.697 -0.853 . . . . 72.42 108.697 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 11.3 t70 -121.76 149.47 43.24 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.778 1.231 . . . . 74.14 109.953 -171.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.4 m -110.54 132.83 53.85 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.926 0.89 . . . . 73.22 109.917 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.656 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -134.52 151.96 51.47 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.723 1.209 . . . . 71.02 108.46 174.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 p -135.55 173.29 11.88 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.911 0.708 . . . . 61.1 112.911 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.402 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 37.7 t -168.58 143.9 3.47 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.456 1.502 . . . . 74.22 108.218 174.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -113.23 109.15 18.29 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.176 -1.046 . . . . 74.41 108.176 170.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.512 HD12 HG22 ' A' ' 83' ' ' ILE . 53.5 mt -80.81 -39.1 27.24 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.069 -0.514 . . . . 74.1 110.735 -176.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.48 -175.92 5.68 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.431 0.693 . . . . 54.21 110.636 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.65 119.74 12.26 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.984 -0.747 . . . . 73.41 108.984 172.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 71.2 -1.68 2.64 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.723 1.209 . . . . 73.25 112.545 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.7 t -107.36 114.17 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.463 -0.94 . . . . 74.13 108.463 177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -122.3 159.61 27.04 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.58 0.752 . . . . 75.43 109.286 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 12.6 tt0 -130.29 124.84 33.31 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.384 -1.339 . . . . 75.31 107.384 170.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.6 m -119.91 138.22 51.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.486 -0.931 . . . . 70.33 108.486 174.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.656 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 59.5 t -118.83 136.97 54.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.488 1.115 . . . . 70.52 109.117 -175.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tt -114.59 106.81 14.69 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.623 -1.251 . . . . 75.25 107.623 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.718 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 36.9 ttp180 -87.22 102.07 14.12 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.563 -0.532 . . . . 75.25 109.563 176.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.71 107.24 19.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 107.864 -1.162 . . . . 70.2 107.864 172.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.4 m -94.62 143.22 26.61 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 107.789 -1.189 . . . . 73.01 107.789 173.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.9 t -141.07 138.97 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.138 1.375 . . . . 73.41 108.405 -173.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.2 m -138.65 138.92 38.27 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.859 -0.793 . . . . 75.31 108.859 175.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.01 104.5 14.19 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 107.143 -1.429 . . . . 64.23 107.143 169.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -108.91 127.8 54.37 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.762 -0.459 . . . . 75.51 109.762 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.448 HD13 ' HB1' ' A' ' 73' ' ' ALA . 6.3 mt -99.06 75.8 2.06 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 106.86 -1.533 . . . . 71.24 106.86 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.95 -83.43 1.17 Allowed Glycine 0 C--N 1.346 1.105 0 N-CA-C 111.942 -0.463 . . . . 72.31 111.942 -175.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -119.03 -29.97 5.13 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.019 0.528 . . . . 70.33 110.883 175.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -88.68 113.68 24.51 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.107 0.563 . . . . 74.43 109.83 -173.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.3 m -73.37 133.23 43.74 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-O 121.06 0.457 . . . . 74.12 110.884 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.607 ' HA ' HG23 ' A' ' 31' ' ' VAL . . . -77.27 -58.97 2.98 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.915 1.286 . . . . 72.43 109.479 176.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.43 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 35.3 p90 -148.24 164.52 33.73 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.959 -1.019 . . . . 73.51 111.185 174.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.9 tp -123.52 142.11 51.34 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.336 1.454 . . . . 74.22 108.186 173.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.3 m -138.07 138.28 38.6 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 124.42 1.088 . . . . 64.11 108.781 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -148.93 120.12 7.79 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.069 -0.715 . . . . 72.12 109.069 173.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 85.9 t -128.51 128.01 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 123.411 0.684 . . . . 64.31 109.611 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.718 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 47.0 mt-30 -95.56 95.01 8.09 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.695 -0.854 . . . . 72.43 108.695 165.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.432 ' HG3' HD23 ' A' ' 106' ' ' LEU . 9.3 tp-100 -78.51 99.74 6.61 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.927 -0.768 . . . . 74.54 108.927 176.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.62 154.25 29.46 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.764 -0.653 . . . . 71.34 111.557 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.89 124.98 1.44 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.232 -0.747 . . . . 55.3 111.232 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.512 HG22 HD12 ' A' ' 51' ' ' LEU . 48.8 mt -85.69 119.6 34.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.553 -0.906 . . . . 74.34 108.553 174.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.688 ' HD2' HG12 ' A' ' 13' ' ' ILE . 17.4 m-85 -129.9 120.26 24.61 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.386 -1.338 . . . . 75.01 107.386 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.7 t -75.44 96.37 3.43 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.848 -1.167 . . . . 71.23 107.848 174.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 CA--C 1.542 0.649 0 C-N-CA 123.95 0.9 . . . . 73.54 109.292 -178.622 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 111.912 0.338 . . . . 51.3 111.912 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -79.57 -36.03 38.84 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.519 0.327 . . . . 70.25 111.086 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 101' ' ' TYR . 44.7 t -69.14 -50.42 48.02 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.394 0.616 . . . . 63.34 111.069 -177.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -83.27 -39.31 21.03 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.089 0.955 . . . . 71.31 110.667 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.45 -14.17 57.44 Favored Glycine 0 N--CA 1.473 1.114 0 N-CA-C 114.73 0.652 . . . . 71.03 114.73 -171.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.56 -53.53 1.79 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 117.928 0.864 . . . . 54.4 111.207 -176.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.512 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 68.8 t80 -70.94 -50.55 33.39 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-N 115.231 -0.895 . . . . 74.34 111.98 -176.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.421 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 92.1 m -72.05 -32.57 2.08 Favored Pre-proline 0 CA--C 1.576 1.973 0 N-CA-C 115.69 1.737 . . . . 75.51 115.69 -174.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 29.9 Cg_endo -64.43 -32.55 60.06 Favored 'Trans proline' 0 C--N 1.392 2.818 0 CA-C-N 122.343 1.872 . . . . 74.03 112.039 169.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -65.95 -24.26 66.77 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.565 0.746 . . . . 61.41 110.763 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.4 mm -70.53 -50.79 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.479 0.712 . . . . 75.13 110.304 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.432 HD23 ' HG3' ' A' ' 80' ' ' GLN . 84.5 mt -74.1 -23.77 59.37 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.007 0.743 . . . . 74.14 113.007 -176.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -58.94 -49.91 90.8 Favored Pre-proline 0 CA--C 1.573 1.86 0 N-CA-C 113.883 1.068 . . . . 74.13 113.883 -173.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.86 -32.94 54.61 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 122.176 1.917 . . . . 75.24 113.202 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -67.06 -42.52 84.59 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.938 0.495 . . . . 63.05 110.816 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.43 -42.01 98.68 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.401 -0.818 . . . . 73.54 110.343 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.429 ' NH1' HG23 ' C' ' 105' ' ' ILE . 39.3 ttm180 -56.46 -52.09 65.99 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 124.267 0.98 . . . . 75.54 110.183 175.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -63.93 -44.93 91.37 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.766 0.826 . . . . 65.11 111.073 -174.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -59.51 -34.79 73.06 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.553 0.533 . . . . 64.04 111.182 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.4 ' O ' HG23 ' A' ' 118' ' ' VAL . 98.5 mt -72.74 -51.44 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 115.541 -0.754 . . . . 74.53 110.145 174.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 49.6 m -59.03 -34.48 71.94 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.218 1.007 . . . . 74.25 111.558 -174.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 34.6 t -68.45 -47.19 67.79 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.54 -0.754 . . . . 75.13 110.242 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.524 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 54.6 mtm -61.06 -40.69 94.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 123.676 0.61 . . . . 74.0 111.163 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 114' ' ' ILE . 79.1 t -62.13 -52.82 55.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 124.283 0.989 . . . . 74.5 110.753 178.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.9 t -67.72 -29.42 68.66 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.412 0.685 . . . . 52.24 111.007 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.472 ' HG2' ' HG1' ' B' ' 18' ' ' THR . 20.7 ttm-85 -76.79 -30.87 56.65 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.804 1.242 . . . . 72.11 108.632 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.411 ' O ' HG22 ' A' ' 122' ' ' THR . . . -86.37 13.6 57.28 Favored Glycine 0 C--N 1.355 1.634 0 CA-C-N 114.739 -1.119 . . . . 63.21 112.545 171.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.45 HG23 ' HE ' ' B' ' 15' ' ' ARG . 2.0 t 63.79 15.28 8.92 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 126.969 2.108 . . . . 53.42 114.267 171.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -81.99 149.86 63.92 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 109.478 -0.564 . . . . 74.53 109.478 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.64 165.91 4.19 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.413 2.742 . . . . 71.31 114.497 -176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.571 ' HG2' ' HG3' ' C' ' 15' ' ' ARG . 6.7 tp-100 -57.91 123.48 15.97 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.097 -0.956 . . . . 75.44 111.86 -175.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.43 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 60.5 tp -120.56 106.89 12.21 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.455 1.102 . . . . 74.04 108.817 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.407 HD22 ' HA ' ' C' ' 15' ' ' ARG . 18.3 m-80 -100.65 115.12 29.46 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.822 -0.807 . . . . 73.44 108.822 175.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.51 137.73 44.62 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 108.161 -1.052 . . . . 71.14 108.161 174.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.94 146.8 57.67 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 123.864 0.866 . . . . 72.41 112.791 -174.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.455 ' HG3' HG13 ' C' ' 13' ' ' ILE . 14.1 Cg_exo -71.45 127.66 13.55 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.649 2.233 . . . . 74.25 111.541 172.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.5 p -142.93 125.49 13.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-O 121.376 0.607 . . . . 74.24 109.734 170.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -103.4 101.31 11.21 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.083 -1.08 . . . . 71.13 108.083 174.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 . . . . . 0 CA--C 1.544 0.722 0 O-C-N 123.743 0.652 . . . . 73.14 110.258 -179.378 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.616 ' HB3' HG12 ' B' ' 89' ' ' ILE . 18.0 ptm . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 113.522 0.934 . . . . 74.12 113.522 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 26.9 m -155.73 135.71 12.84 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.603 -0.726 . . . . 75.14 109.593 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -151.43 156.51 40.79 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.344 -0.613 . . . . 74.42 109.344 157.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.523 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -125.7 134.26 51.87 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 107.423 -1.325 . . . . 74.42 107.423 172.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.481 HD11 ' HG3' ' D' ' 130' ' ' PRO . 36.4 mt -70.59 116.91 12.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.553 0 N-CA-C 107.948 -1.13 . . . . 65.14 107.948 173.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -89.46 -44.63 10.02 Favored 'General case' 0 C--O 1.243 0.746 0 O-C-N 123.822 0.701 . . . . 73.54 109.49 -176.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.45 ' HE ' HG23 ' A' ' 122' ' ' THR . 40.5 ttt180 -165.4 131.05 2.59 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 116.117 -0.492 . . . . 72.41 110.981 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.4 mt -113.9 139.34 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 107.433 -1.321 . . . . 75.11 107.433 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.406 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 33.7 p90 -167.79 158.5 10.94 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.426 0.631 . . . . 74.23 111.788 -176.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.472 ' HG1' ' HG2' ' A' ' 120' ' ' ARG . 90.0 m -80.69 129.94 34.81 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.859 -1.064 . . . . 73.11 109.284 168.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.406 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 29.9 mtpt -97.47 -32.17 11.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.864 0.866 . . . . 73.23 110.084 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -152.82 138.52 17.87 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.642 -0.708 . . . . 75.13 111.037 -169.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.768 HD12 ' SG ' ' B' ' 113' ' ' CYS . 31.9 mm -134.01 146.57 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.253 1.421 . . . . 75.4 109.63 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 98.0 p -147.87 152.43 37.59 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.371 -1.286 . . . . 74.41 109.283 163.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 85.5 t80 -154.91 109.8 3.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.375 -1.343 . . . . 71.43 107.375 167.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.23 122.2 42.37 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.909 -0.775 . . . . 61.33 108.909 -175.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.454 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -118.32 82.98 19.51 Favored Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 108.807 -0.812 . . . . 74.33 108.807 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.88 -30.13 7.71 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.965 2.443 . . . . 73.4 113.008 -172.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -107.69 10.51 28.93 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 118.799 -0.619 . . . . 73.21 110.9 176.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.454 ' HB1' ' CB ' ' B' ' 25' ' ' ALA . . . -40.6 -61.31 1.25 Allowed Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 115.028 1.492 . . . . 52.52 115.028 -168.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -61.53 -30.05 85.64 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 122.392 2.061 . . . . 74.3 112.811 -169.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -97.74 -32.04 11.94 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.606 0.762 . . . . 74.1 112.394 -175.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.403 HG21 ' HA ' ' B' ' 73' ' ' ALA . 4.3 p -72.04 -20.73 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.22 0.608 . . . . 72.12 111.365 -169.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -60.07 -22.93 63.34 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.763 0.825 . . . . 74.1 113.202 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -67.17 -16.28 64.21 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.207 0.603 . . . . 75.54 111.441 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.434 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 92.6 mttt -87.89 102.26 14.53 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.296 1.038 . . . . 74.52 109.685 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -86.8 78.32 9.1 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.732 0.813 . . . . 64.42 111.358 -174.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -161.68 161.82 29.6 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.777 -0.823 . . . . 75.13 108.777 166.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -70.92 114.86 30.49 Favored Pre-proline 0 C--O 1.246 0.904 0 N-CA-C 107.445 -1.317 . . . . 75.3 107.445 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.523 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 10.3 Cg_endo -53.47 151.19 24.6 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 123.007 2.471 . . . . 73.3 112.712 -173.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.06 104.02 0.67 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.598 -1.26 . . . . 72.14 107.598 172.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.447 HG21 HD21 ' B' ' 126' ' ' LEU . 19.7 m -100.87 155.36 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.244 -0.889 . . . . 74.01 110.449 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -136.2 131.0 34.03 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.263 1.025 . . . . 73.12 108.616 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.9 140.64 29.42 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 107.993 -1.114 . . . . 70.32 107.993 171.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -151.3 112.08 4.24 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.745 -1.206 . . . . 74.14 107.745 172.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -101.74 156.55 17.43 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 122.635 0.374 . . . . 75.44 110.076 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.4 t70 -139.02 151.92 47.2 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.261 0.624 . . . . 73.32 110.48 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 38.9 p -109.88 126.35 53.76 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.669 1.188 . . . . 72.03 110.108 -174.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.69 144.77 20.7 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.784 0.434 . . . . 74.54 110.141 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 47.5 p -145.43 174.09 11.44 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.78 0.432 . . . . 75.11 111.012 176.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 53.8 p -154.05 138.9 17.13 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.426 -0.806 . . . . 75.11 109.538 171.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -84.74 126.02 33.04 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.048 0.539 . . . . 73.43 110.956 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 62.2 mt -93.68 -40.92 9.98 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.759 0.823 . . . . 75.12 109.63 174.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.51 175.92 13.39 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.718 -1.128 . . . . 75.44 109.338 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.03 125.21 23.25 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.766 -0.828 . . . . 74.32 108.766 172.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 73.53 -5.48 1.98 Allowed 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 125.345 1.458 . . . . 74.35 112.831 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 72.8 t -108.05 111.97 38.21 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 N-CA-C 108.936 -0.765 . . . . 72.33 108.936 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -126.02 150.55 48.02 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.859 0.838 . . . . 73.04 110.206 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -108.12 103.94 13.25 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 113.811 -1.54 . . . . 74.54 106.915 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 74.1 t -88.53 117.28 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.885 1.274 . . . . 73.12 110.638 -173.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 18.5 t -107.31 113.64 44.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 108.507 -0.923 . . . . 74.41 108.507 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.775 HD23 ' HB3' ' B' ' 103' ' ' PRO . 43.1 tp -103.61 115.74 31.06 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.036 -1.098 . . . . 75.4 108.036 169.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.564 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 10.3 ttm180 -86.61 131.64 34.11 Favored 'General case' 0 CA--C 1.526 0.025 0 N-CA-C 108.956 -0.757 . . . . 75.11 108.956 174.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.66 103.34 14.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.781 -1.192 . . . . 73.21 107.781 171.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 9.3 m -99.69 133.58 43.83 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.816 -0.809 . . . . 72.32 108.816 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.553 HG23 HD12 ' B' ' 114' ' ' ILE . 86.8 t -123.25 127.65 74.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 124.075 0.95 . . . . 63.1 108.916 175.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 80.1 m -101.54 148.87 24.7 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.296 -1.001 . . . . 64.13 108.296 169.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.8 134.82 23.91 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.13 0.572 . . . . 74.22 109.819 177.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.552 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 33.7 p -142.1 127.93 19.36 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.748 -0.66 . . . . 73.25 110.707 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.523 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 22.1 mt -95.93 105.06 17.03 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.373 -0.973 . . . . 75.0 108.373 173.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.12 -118.05 8.42 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.804 -1.089 . . . . 44.24 112.913 -173.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -107.89 18.4 21.33 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.809 0.844 . . . . 73.44 110.696 -173.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.434 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 12.3 pt-20 -138.64 143.51 39.29 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.496 -0.753 . . . . 73.12 109.992 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.1 m -67.21 114.71 6.16 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.172 0.589 . . . . 62.01 110.555 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.552 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -69.85 -59.24 3.05 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.101 -1.074 . . . . 72.01 108.101 178.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -156.05 167.07 31.57 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.658 -1.156 . . . . 72.13 111.527 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 99.2 mt -128.83 146.99 50.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 113.622 -1.626 . . . . 73.51 106.635 172.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 44.9 t -150.66 135.22 17.23 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.994 -1.113 . . . . 65.23 107.994 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -143.27 124.87 14.87 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 107.959 -1.126 . . . . 64.2 107.959 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 96.9 t -122.91 146.74 27.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.914 -1.143 . . . . 72.35 107.914 178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.493 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 21.7 mt-30 -126.65 102.89 7.28 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.943 -1.132 . . . . 74.14 107.943 172.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -89.0 99.77 12.69 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.099 -1.074 . . . . 73.4 108.099 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.55 143.09 16.3 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 110.698 -0.961 . . . . 71.42 110.698 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.91 126.97 2.48 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 110.054 -1.218 . . . . 72.32 110.054 -173.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 59.2 mt -86.7 127.59 40.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 109.263 -0.643 . . . . 71.43 109.263 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -134.28 133.36 40.69 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.11 -1.07 . . . . 74.33 108.11 175.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.5 m -99.1 89.4 4.24 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.15 0.58 . . . . 75.14 109.499 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.493 HG23 HD12 ' B' ' 98' ' ' LEU . 7.1 tt -98.17 126.75 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.704 0.802 . . . . 74.25 111.92 -168.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.22 163.18 37.78 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.641 0.776 . . . . 74.11 111.061 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.12 -53.37 0.6 Allowed Glycine 0 C--N 1.35 1.321 0 CA-C-N 115.493 -0.776 . . . . 63.11 112.818 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.616 HG12 ' HB3' ' B' ' 9' ' ' MET . 9.7 mm -90.48 162.08 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 124.089 0.956 . . . . 73.12 112.607 -170.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -150.3 162.92 39.58 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.654 0.782 . . . . 73.21 109.855 173.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.81 -135.13 12.83 Favored Glycine 0 C--N 1.348 1.247 0 C-N-CA 123.206 0.431 . . . . 65.43 113.32 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m -89.16 -17.11 29.82 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 117.073 0.436 . . . . 61.25 110.705 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -61.88 -33.6 74.49 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.315 0.646 . . . . 73.12 111.277 175.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.456 ' HB3' HG23 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -80.21 -25.85 39.44 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.462 0.305 . . . . 71.02 110.824 175.701 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.16 -31.06 71.69 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.113 0.565 . . . . 44.23 110.042 171.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -75.92 -39.61 55.9 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.03 0.932 . . . . 70.24 110.613 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 40.6 t -66.52 -52.56 44.52 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.947 0.403 . . . . 74.42 111.389 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.493 HD12 HG23 ' B' ' 86' ' ' ILE . 85.0 mt -89.06 -12.47 41.19 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.358 0.663 . . . . 72.41 111.861 -175.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.98 -6.27 34.59 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-O 119.729 -0.484 . . . . 73.41 113.978 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.36 -65.1 0.62 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 117.24 0.52 . . . . 62.23 110.462 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.473 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 55.2 t80 -59.36 -52.45 65.57 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.78 0.832 . . . . 72.54 112.954 -172.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.468 ' SG ' HD22 ' B' ' 98' ' ' LEU . 61.9 m -67.61 -45.27 46.05 Favored Pre-proline 0 CA--C 1.562 1.411 0 CA-C-N 115.624 -0.716 . . . . 75.4 111.565 -177.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.775 ' HB3' HD23 ' B' ' 60' ' ' LEU . 69.9 Cg_exo -51.88 -38.77 68.84 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.633 2.222 . . . . 64.24 115.161 167.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -60.64 -30.94 70.18 Favored 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 123.123 0.569 . . . . 74.11 111.94 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.433 HD12 HD11 ' B' ' 13' ' ' ILE . 75.2 mt -69.12 -40.19 80.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.909 0.884 . . . . 73.53 110.297 177.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.7 mt -87.34 -21.33 25.76 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.187 -0.915 . . . . 75.33 111.717 -170.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -53.87 -51.09 79.91 Favored Pre-proline 0 CA--C 1.562 1.435 0 C-N-CA 124.141 0.976 . . . . 75.1 113.182 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -54.25 -40.73 81.12 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 122.339 2.026 . . . . 74.31 114.208 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -70.21 -44.99 67.5 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.293 0.637 . . . . 74.12 110.82 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.57 -39.65 91.91 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.483 0.713 . . . . 75.11 111.032 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttt-85 -60.07 -56.22 24.32 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.374 1.07 . . . . 75.45 110.445 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -57.57 -34.69 69.48 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.074 0.95 . . . . 73.35 110.883 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.768 ' SG ' HD12 ' B' ' 21' ' ' ILE . 8.5 t -67.89 -45.85 73.28 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 122.674 0.39 . . . . 73.11 111.187 -178.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.553 HD12 HG23 ' B' ' 64' ' ' VAL . 84.4 mt -63.4 -53.65 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.526 0.73 . . . . 73.54 109.888 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 34.2 m -57.7 -33.32 68.27 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.024 0.929 . . . . 72.34 111.817 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 41.1 t -61.83 -51.1 69.61 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 123.233 0.613 . . . . 75.22 109.795 174.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.483 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -67.16 -37.15 83.25 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.059 0.543 . . . . 74.33 111.407 -175.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.443 HG23 ' O ' ' B' ' 114' ' ' ILE . 95.0 t -59.48 -45.37 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.569 0.748 . . . . 75.52 110.116 174.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.6 t -67.42 -33.66 75.62 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.363 -1.29 . . . . 72.35 111.135 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' B' ' 116' ' ' SER . 93.2 mtt-85 -66.83 -31.61 72.34 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.449 -0.796 . . . . 74.3 110.495 177.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.21 9.36 73.12 Favored Glycine 0 C--N 1.353 1.475 0 CA-C-O 119.036 -0.869 . . . . 63.25 113.343 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.431 HG21 ' HB3' ' A' ' 17' ' ' TYR . 81.6 p 55.73 26.13 9.07 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.624 1.57 . . . . 72.53 113.274 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.428 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 56.3 m-85 -84.76 157.32 60.82 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 123.608 0.763 . . . . 74.35 110.171 176.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -54.74 158.76 10.12 Favored 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 123.274 2.649 . . . . 74.04 113.28 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.427 HE21 ' ND2' ' B' ' 127' ' ' ASN . 66.7 tp60 -64.73 134.17 53.62 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.102 0.961 . . . . 72.14 111.36 -171.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.447 HD21 HG21 ' B' ' 40' ' ' VAL . 2.3 tm? -136.65 120.74 17.75 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.415 -0.957 . . . . 75.2 108.415 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . 0.427 ' ND2' HE21 ' B' ' 125' ' ' GLN . 45.3 m-80 -122.29 136.26 54.87 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.033 0.933 . . . . 65.34 109.292 173.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 5.9 mp -78.92 137.77 37.79 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.785 0.834 . . . . 74.01 109.219 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.64 147.6 78.52 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.517 0.727 . . . . 61.34 110.794 -177.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.529 ' HG3' HD11 ' D' ' 16' ' ' ILE . 89.8 Cg_endo -77.12 114.66 3.83 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.887 2.392 . . . . 75.04 112.389 -175.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 m -121.86 111.36 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.341 0.656 . . . . 73.4 109.956 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -86.41 103.54 15.07 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 108.163 -1.051 . . . . 75.01 108.163 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -60.51 -38.01 82.99 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 124.12 0.888 . . . . 73.31 111.267 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 123.831 0.852 . . . . 74.34 111.298 -178.592 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.553 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.5 t80 . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 121.235 0.54 . . . . 74.14 109.693 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -144.21 133.78 23.48 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.278 1.031 . . . . 72.51 108.88 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.559 HD12 HG22 ' C' ' 105' ' ' ILE . 41.7 mt -81.39 128.77 38.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 108.561 -0.903 . . . . 74.13 108.561 173.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.618 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.5 mm-40 -89.84 -42.61 11.16 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.875 0.87 . . . . 72.22 110.381 -176.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.571 ' HG3' ' HG2' ' A' ' 125' ' ' GLN . 33.4 ttt180 -173.98 123.2 0.33 Allowed 'General case' 0 C--N 1.355 0.823 0 O-C-N 123.522 0.514 . . . . 73.31 110.351 -171.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 98.8 mt -110.1 139.7 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 108.818 -0.808 . . . . 74.51 108.818 174.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -170.6 154.06 4.4 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.988 0.915 . . . . 73.54 109.2 -171.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.7 p -80.84 110.14 16.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.322 -0.992 . . . . 55.44 108.322 172.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.597 ' HE2' HG21 ' C' ' 59' ' ' VAL . 6.0 mmmt -67.94 -48.33 66.22 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.141 -1.059 . . . . 75.31 108.141 175.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.69 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 20.4 t70 -135.87 143.37 45.01 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.334 -1.303 . . . . 74.4 110.153 -177.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.7 mt -135.93 149.94 28.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 125.593 1.557 . . . . 75.42 107.005 175.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 37.6 t -158.95 150.6 20.71 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.331 0.653 . . . . 74.53 109.719 173.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -145.85 138.88 25.94 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 106.534 -1.654 . . . . 74.4 106.534 171.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -143.68 113.77 7.3 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.062 -0.718 . . . . 72.31 109.062 -174.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.84 85.1 61.56 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 107.021 -1.474 . . . . 74.25 107.021 169.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.14 -33.13 19.64 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.567 2.178 . . . . 61.53 111.176 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -95.59 11.3 33.65 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 114.625 -1.17 . . . . 74.54 110.348 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.424 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -44.98 -59.19 4.48 Favored Pre-proline 0 C--N 1.377 1.775 0 C-N-CA 124.703 1.201 . . . . 74.24 113.55 -167.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.451 ' HG3' ' HG2' ' D' ' 57' ' ' GLU . 25.1 Cg_exo -58.35 -45.74 28.96 Favored 'Trans proline' 0 C--N 1.399 3.213 0 C-N-CA 121.633 1.555 . . . . 74.22 111.869 -175.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.417 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 83.8 t60 -69.97 -36.16 75.0 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.975 -1.466 . . . . 71.04 112.322 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.604 HG21 ' HA ' ' C' ' 73' ' ' ALA . 3.4 p -78.22 -19.02 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 111.914 0.338 . . . . 65.22 111.914 -168.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -69.74 -28.96 66.23 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.008 0.523 . . . . 75.41 112.028 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 19.5 pt20 -86.39 5.68 33.75 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 122.905 0.482 . . . . 73.4 111.707 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.802 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -84.93 154.34 22.26 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.328 0.651 . . . . 75.21 110.322 177.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -59.96 110.77 1.26 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.032 0.533 . . . . 72.42 109.763 166.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -71.17 90.84 0.9 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.863 0.865 . . . . 72.34 110.401 -177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -142.3 74.45 20.57 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 107.553 -1.277 . . . . 74.01 107.553 172.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -90.61 143.28 3.56 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.476 2.117 . . . . 74.01 112.446 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -88.96 106.48 18.44 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.544 1.138 . . . . 75.13 108.114 172.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 43.1 t -72.22 97.37 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 108.503 -0.925 . . . . 72.33 108.503 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.58 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 87.8 tttt -93.31 129.89 39.24 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.454 -0.793 . . . . 73.45 109.002 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 16.0 mt -89.23 149.74 22.96 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 124.358 1.063 . . . . 75.32 110.085 -172.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.508 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 31.1 t70 -160.52 118.67 2.55 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.743 0.652 . . . . 74.25 109.532 173.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -118.78 137.58 53.28 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.928 0.891 . . . . 73.4 108.713 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.513 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 18.1 t70 -130.5 153.59 48.66 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.263 -1.014 . . . . 74.54 108.263 174.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 71.7 p -114.24 118.36 33.73 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.507 0.723 . . . . 74.51 109.67 -173.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.39 135.63 54.23 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 107.904 -1.147 . . . . 51.0 107.904 172.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.6 p -167.36 158.91 12.09 Favored 'General case' 0 C--O 1.243 0.73 0 O-C-N 123.469 0.48 . . . . 73.02 111.303 -174.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 50.8 p -166.69 138.73 3.55 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.09 0.869 . . . . 71.32 109.682 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -72.89 121.1 19.46 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.467 -0.938 . . . . 72.2 108.467 170.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.497 HD13 HD13 ' C' ' 83' ' ' ILE . 78.8 mt -85.74 -36.6 20.06 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.91 0.484 . . . . 74.03 111.187 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . 0.476 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -160.7 -176.15 5.38 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.934 0.893 . . . . 73.25 109.957 -173.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -62.46 108.0 1.04 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.62 0.768 . . . . 73.1 109.799 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 66.91 2.02 2.51 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 125.169 1.388 . . . . 60.11 113.017 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 97.9 t -94.4 118.18 39.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.398 -1.334 . . . . 65.23 107.398 173.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -133.46 139.03 46.46 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.679 -0.489 . . . . 71.03 109.679 -172.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -102.1 128.15 48.7 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.555 0.742 . . . . 75.31 109.994 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.466 HG11 ' HD3' ' C' ' 103' ' ' PRO . 91.1 t -112.33 124.05 68.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 107.73 -1.211 . . . . 75.52 107.73 171.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.597 HG21 ' HE2' ' C' ' 19' ' ' LYS . 34.9 t -127.99 116.85 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.387 0.675 . . . . 74.34 109.223 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.516 HD21 ' HB3' ' C' ' 103' ' ' PRO . 42.0 tp -103.99 114.16 28.21 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.403 -0.962 . . . . 70.31 108.403 -176.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.513 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 20.5 ttm-85 -82.0 105.81 13.41 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.95 -1.13 . . . . 74.43 107.95 174.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 10.3 t -100.64 117.25 45.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.736 -1.209 . . . . 73.22 107.736 175.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 34.6 m -121.87 117.99 27.85 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.775 -1.195 . . . . 73.44 107.775 -176.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.479 HG21 HG21 ' C' ' 114' ' ' ILE . 42.1 t -99.24 136.94 28.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.222 -1.354 . . . . 72.04 107.978 174.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.58 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 5.1 m -123.78 140.17 53.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.841 -1.17 . . . . 64.03 107.841 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.54 117.77 19.22 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.588 -1.634 . . . . 70.12 106.588 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.3 m -138.11 126.86 23.75 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.097 0.475 . . . . 63.14 110.965 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.802 HD11 ' HG2' ' C' ' 34' ' ' LYS . 4.3 mt -85.4 53.85 2.9 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.225 1.81 . . . . 70.42 108.427 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.78 -107.76 3.16 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 109.064 -1.614 . . . . 74.11 109.064 -166.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -104.02 -25.14 13.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.61 0.764 . . . . 64.05 110.675 172.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.561 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 5.6 tp10 -62.98 104.07 0.52 Allowed 'General case' 0 C--N 1.353 0.718 0 C-N-CA 123.645 0.778 . . . . 75.44 109.214 175.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 36.7 m -73.99 121.57 21.25 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.402 -0.592 . . . . 74.41 109.402 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.604 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -69.88 -62.45 1.38 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.449 -1.25 . . . . 65.11 108.362 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -153.88 173.02 16.48 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 121.784 0.802 . . . . 72.43 111.043 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.404 HD23 HG21 ' C' ' 65' ' ' THR . 1.7 tm? -137.36 128.3 27.41 Favored 'General case' 0 C--O 1.22 -0.494 0 N-CA-C 105.577 -2.009 . . . . 72.13 105.577 173.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.462 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.1 t -131.15 139.1 49.73 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.98 -1.118 . . . . 75.45 107.98 176.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -145.07 127.14 15.6 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.292 0.637 . . . . 74.3 109.434 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -132.03 114.37 24.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.422 -0.955 . . . . 73.34 108.422 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.69 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 48.1 mt-30 -89.27 87.23 7.05 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.416 -1.327 . . . . 74.03 107.416 171.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -79.34 110.58 14.76 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 114.143 -1.39 . . . . 74.24 109.396 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.36 151.97 20.06 Favored Glycine 0 C--N 1.337 0.626 0 O-C-N 123.673 0.608 . . . . 71.11 112.446 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.96 127.24 2.09 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 109.947 -1.261 . . . . 73.05 109.947 176.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.618 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 14.4 mm -88.45 124.55 41.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 107.648 -1.241 . . . . 72.3 107.648 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.553 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 66.9 m-85 -131.48 123.52 28.24 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.49 0.716 . . . . 72.32 110.001 -174.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 51.1 m -75.12 109.76 8.86 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.859 -0.793 . . . . 72.34 108.859 170.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 67.2 mt -114.13 100.72 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.978 -1.119 . . . . 52.33 107.978 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.33 141.31 29.66 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.09 0.956 . . . . 54.51 109.384 -176.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.07 -19.95 24.47 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-O 119.758 -0.468 . . . . 73.45 112.944 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 36.6 pt -121.86 164.46 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.175 0.59 . . . . 73.13 110.856 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -152.49 164.08 38.29 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.188 0.995 . . . . 74.01 109.736 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.04 -133.22 18.26 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.485 0.491 . . . . 74.33 113.045 171.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 45.8 p -63.5 -31.78 73.04 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.014 0.926 . . . . 75.52 111.428 -178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -61.26 -51.12 70.27 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.061 0.945 . . . . 74.53 110.434 176.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.424 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 56.5 ttm -66.78 -39.84 87.97 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 115.222 -0.899 . . . . 73.13 110.393 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.07 -37.14 76.38 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.253 1.021 . . . . 71.23 111.615 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -71.51 -41.04 69.75 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.443 -0.798 . . . . 72.43 110.804 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.576 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 41.4 t -58.14 -60.89 3.04 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 124.179 0.924 . . . . 73.24 111.036 -177.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.6 pp -69.79 -30.08 67.54 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.988 -0.551 . . . . 73.25 111.766 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . 0.406 ' N ' HD11 ' C' ' 98' ' ' LEU . . . -78.51 -29.94 50.91 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-O 118.896 -0.946 . . . . 74.41 114.672 -168.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.48 -35.87 0.1 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.101 0.95 . . . . 74.4 112.357 -170.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.576 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 18.6 t80 -71.73 -35.57 70.21 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.986 1.315 . . . . 74.44 112.637 -175.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 84.9 m -82.82 -41.55 0.88 Allowed Pre-proline 0 CA--C 1.562 1.434 0 C-N-CA 123.159 0.584 . . . . 72.21 111.001 177.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.516 ' HB3' HD21 ' C' ' 60' ' ' LEU . 52.2 Cg_exo -54.72 -26.77 48.64 Favored 'Trans proline' 0 C--N 1.396 3.068 0 C-N-CA 122.713 2.275 . . . . 54.21 113.779 166.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' C' ' 101' ' ' TYR . 23.4 t-20 -55.75 -44.17 77.37 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 124.194 0.998 . . . . 75.35 110.765 172.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.559 HG22 HD12 ' C' ' 13' ' ' ILE . 45.0 mm -61.97 -40.07 85.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.39 -0.823 . . . . 74.31 110.063 177.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 85.7 mt -86.54 -14.38 43.15 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.161 0.984 . . . . 75.55 112.643 -171.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . 0.439 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 88.7 t80 -55.47 -53.69 59.49 Favored Pre-proline 0 CA--C 1.564 1.486 0 C-N-CA 123.809 0.844 . . . . 75.11 112.481 -177.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . 0.439 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 35.7 Cg_exo -63.23 -34.16 69.06 Favored 'Trans proline' 0 C--N 1.388 2.627 0 C-N-CA 122.243 1.962 . . . . 74.04 113.476 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -64.93 -49.95 68.36 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.583 0.753 . . . . 75.21 111.06 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.37 99.16 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.477 -0.783 . . . . 75.34 110.194 177.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -55.86 -51.8 66.29 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.419 1.488 . . . . 74.04 111.326 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -71.18 -32.26 68.65 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.352 0.661 . . . . 62.02 110.338 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.7 t -70.62 -32.48 69.82 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.953 0.501 . . . . 72.32 111.193 -178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.481 ' O ' HG23 ' C' ' 118' ' ' VAL . 90.0 mt -71.02 -56.38 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 109.072 -0.714 . . . . 72.42 109.072 173.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 23.9 m -60.98 -28.99 69.4 Favored 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 123.574 0.75 . . . . 75.45 111.978 -175.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 43.6 t -64.4 -51.04 65.23 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.671 0.788 . . . . 74.11 109.023 171.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.582 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.37 -35.85 78.61 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.262 1.025 . . . . 75.24 112.781 178.536 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.481 HG23 ' O ' ' C' ' 114' ' ' ILE . 59.5 t -63.45 -43.61 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.332 0.653 . . . . 72.42 109.449 176.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 31.5 t -68.16 -33.37 74.34 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.25 1.02 . . . . 74.33 111.985 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' C' ' 116' ' ' SER . 88.3 mtt-85 -67.59 -36.26 80.55 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.293 0.637 . . . . 74.11 109.786 176.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.22 11.48 60.65 Favored Glycine 0 C--N 1.355 1.616 0 O-C-N 124.059 0.849 . . . . 75.34 112.656 174.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 69.4 p 57.28 23.46 8.82 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.591 1.956 . . . . 73.52 114.746 174.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -82.74 146.07 51.96 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 107.964 -1.124 . . . . 73.55 107.964 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.32 178.75 1.87 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.709 2.273 . . . . 63.01 113.096 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 16.7 mm-40 -56.21 113.02 1.38 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.703 -1.135 . . . . 74.5 113.428 -173.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 39.7 tp -109.41 87.76 2.58 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.852 -1.067 . . . . 73.13 108.241 167.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -91.66 103.89 16.43 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.966 -0.753 . . . . 72.43 108.966 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 6.9 mp -66.14 137.85 57.31 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.224 0.609 . . . . 74.42 109.573 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.83 163.09 55.24 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.249 0.62 . . . . 65.33 110.404 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.512 ' HG3' HD13 ' A' ' 16' ' ' ILE . 43.2 Cg_exo -58.61 138.06 83.64 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.878 2.385 . . . . 75.24 113.42 174.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 15.7 t -130.13 115.0 31.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.884 -0.784 . . . . 73.01 108.884 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -96.63 77.79 2.91 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.795 0.838 . . . . 74.45 108.9 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -62.13 -46.0 90.97 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.626 0.727 . . . . 74.14 109.999 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 . . . . . 0 C--O 1.237 0.406 0 CA-C-N 113.819 -1.537 . . . . 70.01 111.566 -176.483 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 44.8 m . . . . . 0 C--O 1.243 0.743 0 N-CA-C 108.764 -0.828 . . . . 74.52 108.764 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -151.79 103.16 2.9 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.915 -1.143 . . . . 75.11 107.915 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -121.53 142.66 49.85 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.052 -1.092 . . . . 71.42 108.052 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 15.6 mt -90.85 127.66 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 108.265 -1.013 . . . . 72.23 108.265 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -86.77 -37.25 18.04 Favored 'General case' 0 C--O 1.242 0.673 0 O-C-N 123.371 0.419 . . . . 75.21 109.912 175.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -169.22 139.91 2.29 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.436 0.46 . . . . 75.23 111.188 -171.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.529 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.6 mp -117.79 134.04 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 106.986 -1.487 . . . . 71.15 106.986 171.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.401 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 33.9 p90 -164.57 156.54 16.07 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.474 0.654 . . . . 74.3 112.269 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.0 p -81.82 117.35 22.04 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.452 -1.249 . . . . 73.23 109.03 172.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.401 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 42.0 mtpt -88.83 -23.84 22.72 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.444 0.698 . . . . 73.34 110.005 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 18.9 t70 -158.31 143.75 16.7 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 114.616 -1.175 . . . . 74.43 109.01 176.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.582 HG21 ' HE1' ' C' ' 117' ' ' MET . 70.9 mt -142.27 148.21 20.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 106.909 -1.515 . . . . 74.22 106.909 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 30.7 t -155.95 146.25 21.65 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.659 0.784 . . . . 73.32 109.013 170.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.497 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 84.6 t80 -146.4 117.61 7.85 Favored 'General case' 0 C--O 1.213 -0.837 0 N-CA-C 105.411 -2.07 . . . . 74.43 105.411 175.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -127.06 110.16 12.64 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 109.134 -0.691 . . . . 72.41 109.134 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.41 85.91 2.44 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.405 -0.961 . . . . 73.2 108.405 174.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.87 -30.53 5.89 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.084 2.523 . . . . 75.34 113.246 -169.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -103.27 6.67 38.24 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.732 0.813 . . . . 72.43 110.179 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.403 ' HB2' ' HD3' ' D' ' 29' ' ' PRO . . . -29.55 -67.96 0.12 Allowed Pre-proline 0 CA--C 1.562 1.422 0 C-N-CA 126.476 1.91 . . . . 65.33 116.111 -161.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' D' ' 28' ' ' ALA . 54.2 Cg_endo -78.37 -13.69 15.02 Favored 'Trans proline' 0 C--N 1.378 2.122 0 CA-C-N 122.775 2.027 . . . . 72.42 113.782 -172.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -80.34 -40.54 26.5 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.656 0.783 . . . . 72.33 109.589 171.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 5.5 p -81.51 -20.02 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 116.107 -0.497 . . . . 74.01 110.938 -172.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -65.88 -20.21 66.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.215 0.606 . . . . 74.31 112.341 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -61.79 -23.3 66.12 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.639 0.776 . . . . 74.54 110.276 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.468 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 96.7 mttt -93.26 87.15 5.55 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.27 1.428 . . . . 72.35 109.979 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.05 86.81 7.0 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.459 0.704 . . . . 75.4 110.577 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -155.11 173.19 16.94 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.452 -0.944 . . . . 73.54 108.452 167.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -69.41 115.87 36.89 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 108.993 -0.743 . . . . 74.23 108.993 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.23 145.38 78.1 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.676 2.25 . . . . 65.41 111.69 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 37.7 mt-10 -61.59 111.86 1.99 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.662 -0.866 . . . . 74.34 108.662 169.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.714 HG12 HG13 ' D' ' 64' ' ' VAL . 91.9 t -99.48 113.67 35.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.447 -0.946 . . . . 72.34 108.447 -178.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.603 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 10.9 tmtt? -92.53 119.42 31.99 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 106.255 -1.757 . . . . 73.12 106.255 173.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 mp -96.12 137.9 34.51 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.423 -0.954 . . . . 72.34 108.423 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.515 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 8.0 t70 -142.35 148.16 37.47 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.683 -0.858 . . . . 65.13 108.683 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -127.51 147.32 50.32 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.763 0.825 . . . . 74.54 110.358 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.431 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 10.1 t70 -144.18 145.2 31.93 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 107.681 -1.229 . . . . 72.34 107.681 172.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 57.9 p -113.17 144.16 43.14 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.195 0.598 . . . . 72.44 110.336 -175.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.59 151.93 31.22 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.79 0.836 . . . . 75.35 109.284 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 79.4 p -155.88 157.14 35.85 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 120.784 0.326 . . . . 72.11 110.916 -178.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 25.4 p -152.64 119.27 5.67 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.401 1.08 . . . . 71.4 108.917 175.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -79.81 121.05 24.9 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.183 -0.673 . . . . 74.4 109.183 176.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 30.0 mt -91.26 -35.8 14.27 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.054 0.542 . . . . 73.34 109.878 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.75 176.54 12.6 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.987 -1.006 . . . . 74.15 109.707 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -65.56 123.44 19.69 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.558 -0.905 . . . . 75.25 108.558 177.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . 0.594 ' HB3' ' O ' ' D' ' 86' ' ' ILE . 3.8 m-20 71.94 2.95 4.5 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.212 1.005 . . . . 53.52 112.654 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.4 t -114.76 119.05 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.713 0.805 . . . . 74.25 109.255 176.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -133.02 128.43 36.29 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.297 0.639 . . . . 64.22 110.503 -173.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.624 ' HB2' HG12 ' D' ' 83' ' ' ILE . 4.6 tp10 -99.69 110.49 22.9 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 106.759 -1.571 . . . . 75.32 106.759 168.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.505 HG12 HD21 ' D' ' 98' ' ' LEU . 32.7 m -120.56 147.78 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 123.696 0.798 . . . . 73.41 109.111 -174.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 12.8 t -125.48 133.47 69.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 C-N-CA 123.69 0.796 . . . . 74.53 109.898 -169.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.492 HD21 ' HB2' ' D' ' 103' ' ' PRO . 56.3 tp -109.48 110.57 21.72 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.927 -1.138 . . . . 71.3 107.927 165.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.431 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.2 ttm180 -84.72 105.05 15.22 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.539 -0.912 . . . . 74.33 108.539 173.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 79.2 t -91.08 128.97 42.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.932 -1.136 . . . . 73.41 107.932 170.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 27.0 m -125.27 138.06 54.09 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.121 0.568 . . . . 73.35 109.522 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.714 HG13 HG12 ' D' ' 40' ' ' VAL . 24.4 t -129.16 101.04 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 124.945 1.298 . . . . 71.54 108.436 -174.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 36.8 m -95.49 93.86 7.44 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.377 -0.971 . . . . 73.02 108.377 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -95.99 144.19 26.5 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.263 0.625 . . . . 75.52 110.15 -174.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.433 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 64.7 p -145.82 129.29 16.93 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 123.683 0.614 . . . . 73.11 112.145 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 22.5 mt -99.1 112.9 24.92 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.871 0.868 . . . . 73.51 108.852 173.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.84 -111.01 3.18 Favored Glycine 0 C--N 1.345 1.074 0 N-CA-C 111.842 -0.503 . . . . 61.23 111.842 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.25 6.19 9.12 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.975 0.91 . . . . 73.12 110.526 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.468 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 13.1 pt-20 -121.15 165.9 14.71 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.466 0.706 . . . . 74.42 109.788 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.6 m -70.62 129.94 40.5 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.59 0.756 . . . . 74.51 111.924 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.433 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -84.36 -69.4 0.65 Allowed 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.817 -1.179 . . . . 52.25 107.817 170.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -151.07 158.75 44.47 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.74 -0.664 . . . . 72.23 110.803 175.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 74.3 mt -121.46 108.19 13.35 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.372 -1.344 . . . . 73.15 107.372 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.589 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 42.6 t -123.9 107.9 11.86 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.225 0.61 . . . . 74.0 109.506 -169.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -131.15 123.44 28.56 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.756 0.822 . . . . 75.21 109.072 -173.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.41 119.8 51.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 123.578 0.751 . . . . 72.34 109.012 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.532 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.0 mt-30 -87.18 85.7 7.22 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.876 -1.157 . . . . 74.54 107.876 170.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -81.91 110.86 17.58 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.341 -1.299 . . . . 73.45 108.907 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.61 167.58 14.13 Favored Glycine 0 C--N 1.341 0.826 0 O-C-N 123.557 0.536 . . . . 75.32 112.549 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.38 129.18 1.97 Allowed Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.35 -0.7 . . . . 64.32 111.35 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.624 HG12 ' HB2' ' D' ' 57' ' ' GLU . 61.8 mt -89.0 133.41 31.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.884 -1.154 . . . . 71.02 107.884 177.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -132.74 133.99 44.18 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 122.917 0.487 . . . . 71.4 110.879 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.1 m -81.21 104.85 11.96 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.089 0.956 . . . . 64.42 109.095 165.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.594 ' O ' ' HB3' ' D' ' 54' ' ' ASP . 67.3 mt -107.17 145.04 15.1 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 C-N-CA 124.158 0.983 . . . . 72.22 108.577 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.28 157.26 15.16 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 118.325 0.511 . . . . 75.12 110.05 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.96 11.35 74.17 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.568 0.543 . . . . 62.04 114.201 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.488 HG23 ' HB3' ' D' ' 93' ' ' GLN . 11.1 mt -97.57 134.92 33.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 C-N-CA 123.25 0.62 . . . . 75.31 110.696 -175.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -157.41 172.25 18.92 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.498 1.119 . . . . 75.25 109.148 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.89 -133.46 29.34 Favored Glycine 0 CA--C 1.527 0.825 0 O-C-N 123.465 0.478 . . . . 53.13 113.208 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 57.8 p -66.73 -33.19 75.08 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.944 0.898 . . . . 73.42 111.754 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.488 ' HB3' HG23 ' D' ' 89' ' ' ILE . 8.4 tt0 -67.71 -22.33 65.26 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.087 -0.506 . . . . 74.34 112.178 -172.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 91.0 mtp -55.26 -54.18 46.68 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.022 -0.733 . . . . 71.35 109.022 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.36 -47.72 54.61 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.935 -1.03 . . . . 65.11 111.263 -178.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -76.28 -24.53 54.43 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.15 0.98 . . . . 73.44 112.685 -168.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -63.21 -51.67 65.34 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.935 -0.394 . . . . 74.2 109.935 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.505 HD21 HG12 ' D' ' 58' ' ' VAL . 4.5 mp -84.34 -25.78 28.94 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 122.761 0.424 . . . . 74.43 110.341 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.59 -5.05 72.27 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.62 -0.544 . . . . 75.34 113.925 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.65 -57.71 0.11 Allowed 'General case' 0 C--N 1.358 0.955 0 N-CA-C 112.6 0.593 . . . . 70.24 112.6 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -72.31 -50.57 26.02 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 112.792 0.664 . . . . 74.13 112.792 -166.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 35.2 m -61.64 -47.14 93.36 Favored Pre-proline 0 CA--C 1.564 1.507 0 C-N-CA 123.993 0.917 . . . . 75.44 112.974 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.492 ' HB2' HD21 ' D' ' 60' ' ' LEU . 65.8 Cg_endo -70.39 -20.48 31.81 Favored 'Trans proline' 0 C--N 1.392 2.852 0 C-N-CA 122.176 1.917 . . . . 70.03 112.659 175.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -73.65 -26.96 61.01 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.285 0.634 . . . . 75.13 110.539 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mm -65.77 -37.44 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-O 121.525 0.679 . . . . 74.13 109.876 169.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 50.9 mt -84.57 -13.13 52.63 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 114.832 -1.076 . . . . 74.34 111.423 -176.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . 0.416 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 85.1 t80 -61.61 -53.11 64.45 Favored Pre-proline 0 CA--C 1.567 1.605 0 C-N-CA 124.422 1.089 . . . . 75.02 113.025 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 24.5 Cg_exo -65.05 -31.44 55.17 Favored 'Trans proline' 0 C--N 1.393 2.872 0 C-N-CA 122.14 1.893 . . . . 63.35 112.923 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -76.18 -33.99 59.32 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.773 0.829 . . . . 62.24 111.772 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.46 -48.89 73.58 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.238 -0.653 . . . . 64.02 109.238 172.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -55.58 -47.18 76.88 Favored 'General case' 0 C--N 1.358 0.953 0 O-C-N 124.445 1.09 . . . . 64.34 110.454 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.76 -53.26 58.37 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.066 0.546 . . . . 74.54 110.945 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.8 t -55.64 -44.86 77.56 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 123.825 0.703 . . . . 74.15 111.24 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.481 HG22 ' SG ' ' D' ' 76' ' ' CYS . 59.3 mt -60.45 -59.9 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.987 0.915 . . . . 73.25 110.659 175.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 47.7 m -54.11 -38.61 65.58 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.694 1.198 . . . . 71.2 111.796 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.4 t -65.47 -45.61 82.99 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.236 -0.893 . . . . 74.3 110.1 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.589 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 69.7 mtm -70.63 -28.12 64.58 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.861 0.465 . . . . 65.12 111.889 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.458 HG23 ' O ' ' D' ' 114' ' ' ILE . 99.5 t -66.09 -45.76 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.27 0.628 . . . . 73.32 109.585 174.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.0 p -72.13 -31.06 65.65 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.843 -0.617 . . . . 75.41 110.826 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -69.27 -36.32 76.97 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.974 0.909 . . . . 72.51 109.954 175.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.76 1.2 88.68 Favored Glycine 0 C--N 1.351 1.398 0 O-C-N 123.805 0.69 . . . . 74.32 112.012 174.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.0 p 61.97 23.11 13.57 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 126.832 2.053 . . . . 71.34 113.573 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -81.66 160.04 65.14 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.849 0.86 . . . . 75.42 110.003 170.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.64 132.51 51.9 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.973 2.449 . . . . 62.13 112.737 174.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -56.34 134.86 53.87 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.163 0.985 . . . . 75.13 111.792 -175.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 53.9 tp -111.95 103.38 11.6 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.389 -0.823 . . . . 70.53 109.219 -177.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . 0.429 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 86.3 m-20 -100.54 96.75 7.59 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.487 -0.931 . . . . 75.24 108.487 177.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 31.7 tp -67.3 120.75 14.34 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-N 115.4 -0.818 . . . . 73.11 109.885 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.8 137.44 83.05 Favored Pre-proline 0 C--N 1.354 0.792 0 O-C-N 124.348 1.03 . . . . 73.54 111.43 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.481 ' HG3' HD11 ' B' ' 13' ' ' ILE . 1.8 Cg_endo -76.58 103.38 1.74 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.902 2.401 . . . . 74.4 110.891 -172.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 CA--C 1.539 0.523 0 CA-C-N 115.923 -0.58 . . . . 72.2 109.561 179.742 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.657 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 15.6 t80 . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 109.89 -0.411 . . . . 75.43 109.89 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -138.19 117.28 12.56 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.753 0.821 . . . . 75.41 108.943 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.64 HG12 ' HD2' ' A' ' 84' ' ' PHE . 53.8 mt -89.92 125.08 42.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 108.871 -0.788 . . . . 75.24 108.871 176.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -85.94 -41.16 15.15 Favored 'General case' 0 C--O 1.242 0.66 0 O-C-N 123.847 0.717 . . . . 71.45 110.159 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -167.9 136.7 2.47 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.874 -0.417 . . . . 63.14 109.874 -167.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.443 HD11 HD11 ' A' ' 13' ' ' ILE . 94.4 mt -130.01 129.34 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.061 -1.089 . . . . 75.15 108.061 172.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -161.52 176.77 10.7 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 124.216 0.948 . . . . 70.42 111.252 -167.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -107.28 116.22 31.56 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 114.944 -1.025 . . . . 72.22 108.836 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.527 ' HE3' ' HB2' ' B' ' 28' ' ' ALA . 34.5 mtpt -82.11 -26.44 33.58 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 110.012 -0.366 . . . . 75.21 110.012 177.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 18.3 t70 -152.78 136.65 16.24 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.218 -0.901 . . . . 73.22 109.72 174.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.447 HG22 ' SD ' ' A' ' 117' ' ' MET . 83.6 mt -129.18 137.48 56.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 106.285 -1.746 . . . . 73.55 106.285 172.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.6 t -152.03 110.63 3.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.419 0.628 . . . . 75.25 110.226 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.508 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 92.3 t80 -110.38 137.34 48.22 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 107.313 -1.366 . . . . 74.34 107.313 173.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -135.16 140.92 45.76 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.701 -1.222 . . . . 74.12 107.701 171.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.9 80.78 50.01 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 105.891 -1.892 . . . . 74.42 105.891 168.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.2 -31.42 89.9 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.076 2.517 . . . . 74.2 112.746 -167.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -118.44 31.69 6.54 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 118.597 -0.716 . . . . 73.23 109.66 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.598 ' HB2' ' HZ3' ' B' ' 19' ' ' LYS . . . -42.41 -54.47 7.91 Favored Pre-proline 0 CA--C 1.573 1.84 0 N-CA-C 114.84 1.422 . . . . 74.41 114.84 -170.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.43 ' HG3' ' HZ1' ' B' ' 19' ' ' LYS . 14.1 Cg_exo -64.13 -31.4 64.89 Favored 'Trans proline' 0 C--N 1.395 3.004 0 CA-C-N 121.652 1.626 . . . . 75.14 112.572 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -80.17 -39.16 29.86 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.863 -1.062 . . . . 75.31 110.51 -175.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.603 HG22 ' HA ' ' A' ' 73' ' ' ALA . 5.2 p -78.52 -22.23 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 CA-C-N 114.821 -1.081 . . . . 73.53 112.714 -161.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -70.91 -21.1 62.41 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.906 0.482 . . . . 72.44 110.754 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -86.46 -18.34 31.94 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.517 1.127 . . . . 71.04 110.519 176.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.4 tmtp? -78.13 146.67 34.99 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.142 0.977 . . . . 71.23 109.734 -175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.07 138.88 58.67 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.816 0.846 . . . . 71.23 110.524 173.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -93.01 82.99 4.64 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.868 0.842 . . . . 74.45 110.6 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -130.87 83.44 61.3 Favored Pre-proline 0 C--O 1.239 0.539 0 N-CA-C 107.017 -1.475 . . . . 60.03 107.017 165.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -85.97 156.6 10.02 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 122.214 1.943 . . . . 73.23 111.959 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -109.66 93.72 4.65 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 105.036 -2.209 . . . . 75.31 105.036 165.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 65' ' ' THR . 48.1 t -78.5 92.04 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 122.072 0.939 . . . . 74.44 108.695 -177.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.436 ' HE2' ' HB2' ' A' ' 67' ' ' SER . 62.3 mttm -82.98 113.3 20.47 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.596 -1.638 . . . . 74.12 108.98 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 pp -105.73 128.36 53.64 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.008 0.523 . . . . 74.45 110.625 -174.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.547 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.6 m-20 -114.28 139.2 49.61 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.405 1.082 . . . . 70.32 109.029 177.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.1 mt -124.61 119.54 29.34 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.601 0.76 . . . . 74.22 109.513 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 21.8 t70 -120.24 130.31 54.45 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.617 -0.882 . . . . 71.31 108.617 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.3 p -106.98 132.21 53.18 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.878 0.871 . . . . 73.5 110.254 -173.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.18 129.52 10.56 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.049 0.54 . . . . 74.44 110.308 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.2 m -130.82 152.92 49.64 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.223 0.609 . . . . 72.43 110.324 174.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.6 t -149.96 126.71 11.02 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.578 0.751 . . . . 75.33 109.084 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -78.47 132.55 37.31 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.857 0.463 . . . . 75.35 110.927 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.3 mt -101.32 -31.01 11.17 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.441 1.096 . . . . 65.14 111.059 -174.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.63 173.76 12.56 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.489 1.116 . . . . 72.34 109.712 -175.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -56.67 116.47 3.15 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.023 0.529 . . . . 72.12 110.204 171.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 70.49 -10.6 0.68 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 126.215 1.806 . . . . 75.41 113.259 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.7 117.68 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.075 -1.083 . . . . 62.34 108.075 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -142.35 170.33 15.9 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.14 -0.689 . . . . 72.54 109.14 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -120.08 132.99 55.64 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 123.521 0.729 . . . . 73.4 110.021 -175.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.456 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 93.7 t -104.39 126.82 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.008 -1.108 . . . . 73.51 108.008 169.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.99 125.81 74.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 108.269 -1.012 . . . . 74.3 108.269 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.19 110.88 18.11 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.722 -1.214 . . . . 74.5 107.722 176.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.569 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 36.8 ttm180 -81.95 100.26 9.57 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.572 -1.27 . . . . 74.54 107.572 174.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.9 t -98.86 102.46 13.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.679 -1.23 . . . . 71.24 107.679 176.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.547 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 26.5 m -96.91 135.88 38.27 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.444 -0.576 . . . . 73.53 109.444 178.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.53 HG12 HD23 ' A' ' 126' ' ' LEU . 17.9 t -126.73 107.68 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.628 1.171 . . . . 64.41 108.392 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 25.9 m -102.94 134.33 46.54 Favored 'General case' 0 C--O 1.208 -1.083 0 N-CA-C 107.707 -1.22 . . . . 73.31 107.707 173.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.71 105.28 12.56 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 107.699 -1.223 . . . . 75.5 107.699 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 50.2 m -108.72 124.29 50.33 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.304 0.574 . . . . 74.04 110.952 -177.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.454 HD13 ' HB1' ' A' ' 73' ' ' ALA . 20.1 mt -91.04 54.82 2.72 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.889 1.276 . . . . 73.32 108.399 178.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.47 -114.56 4.73 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 110.36 -1.096 . . . . 72.11 110.36 -166.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -91.93 -26.68 18.32 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.007 0.523 . . . . 70.2 110.864 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -86.73 108.8 18.84 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.206 0.602 . . . . 75.11 109.595 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 53.9 m -72.63 124.87 26.16 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.688 0.395 . . . . 73.03 110.625 176.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.603 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -62.26 -58.09 9.0 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.49 1.116 . . . . 71.44 111.183 174.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -155.83 164.54 38.4 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.816 -1.083 . . . . 74.1 111.779 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.5 tp -123.46 138.51 54.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.605 1.162 . . . . 74.21 108.158 173.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.421 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 76.6 m -142.51 96.57 2.97 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.838 0.855 . . . . 72.11 109.555 -178.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -108.29 130.43 55.18 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.788 -0.819 . . . . 74.15 108.788 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.1 t -132.15 112.43 19.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 109.238 -0.653 . . . . 72.35 109.238 173.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.48 ' NE2' HH21 ' A' ' 61' ' ' ARG . 69.6 mt-30 -84.55 84.83 7.53 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.048 -1.093 . . . . 64.43 108.048 172.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.52 ' HG3' HD23 ' A' ' 106' ' ' LEU . 8.4 tp-100 -76.85 102.97 6.55 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.183 -0.917 . . . . 72.12 108.795 -177.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.21 144.92 17.42 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.041 -0.823 . . . . 73.35 111.041 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.427 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -150.86 123.13 1.47 Allowed Glycine 0 CA--C 1.504 -0.615 0 N-CA-C 110.779 -0.928 . . . . 74.43 110.779 -176.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.5 mt -81.22 122.24 36.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 108.973 -0.751 . . . . 75.21 108.973 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.657 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 25.1 m-85 -134.12 137.53 44.61 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.859 -0.793 . . . . 74.41 108.859 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.3 m -102.44 96.79 7.16 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.006 -0.738 . . . . 64.21 109.006 173.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.587 HD13 ' SG ' ' A' ' 102' ' ' CYS . 62.8 mt . . . . . 0 C--O 1.241 0.648 0 N-CA-C 108.355 -0.98 . . . . 74.23 108.355 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.454 0.645 . . . . 74.31 111.545 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -67.83 -39.67 83.84 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.559 1.144 . . . . 73.5 110.582 175.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.421 ' SG ' HD11 ' A' ' 86' ' ' ILE . 18.7 t -72.58 -35.64 67.97 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 116.383 -0.371 . . . . 61.12 111.8 -175.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 pp -83.49 -29.95 27.56 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.932 0.493 . . . . 74.2 111.409 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.25 3.98 37.9 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 114.6 0.6 . . . . 73.35 114.6 -168.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.62 -53.41 0.24 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.832 0.316 . . . . 72.15 111.674 -176.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.434 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 66.4 t80 -73.09 -65.92 0.74 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 123.445 0.465 . . . . 73.1 112.084 -171.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.587 ' SG ' HD13 ' A' ' 86' ' ' ILE . 92.3 m -68.13 -32.91 4.37 Favored Pre-proline 0 CA--C 1.566 1.56 0 N-CA-C 115.135 1.532 . . . . 74.54 115.135 -172.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 25.9 Cg_endo -63.24 -32.04 73.73 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 121.824 1.683 . . . . 75.04 112.554 166.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.444 HD21 ' HD2' ' A' ' 133' ' ' PHE . 29.3 t-20 -76.5 -21.44 55.79 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.997 0.519 . . . . 75.43 110.715 176.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 42.1 mm -67.46 -36.38 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 109.501 -0.555 . . . . 74.54 109.501 170.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.52 HD23 ' HG3' ' A' ' 80' ' ' GLN . 94.7 mt -79.77 -17.52 53.22 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.426 0.69 . . . . 64.3 112.211 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -61.43 -48.79 89.88 Favored Pre-proline 0 CA--C 1.57 1.715 0 CA-C-O 117.933 -1.032 . . . . 75.3 113.546 -175.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.31 -34.1 45.82 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 121.954 1.769 . . . . 73.5 112.909 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -72.67 -40.15 66.54 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.312 0.645 . . . . 72.43 111.382 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.62 -39.45 70.42 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.994 0.518 . . . . 74.24 110.449 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.485 ' NH1' HG23 ' C' ' 105' ' ' ILE . 30.6 ttm180 -54.35 -51.69 63.98 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 124.173 0.921 . . . . 75.11 109.829 173.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -65.75 -42.06 91.37 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.38 1.05 . . . . 73.35 111.558 -175.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 46.2 t -61.51 -42.85 99.43 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.837 0.711 . . . . 72.21 110.329 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.06 -48.1 87.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 O-C-N 124.108 0.88 . . . . 73.23 110.407 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 35.8 m -56.65 -38.55 72.31 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.913 0.885 . . . . 74.23 111.377 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.1 t -68.69 -46.22 69.63 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.435 -0.802 . . . . 65.53 110.353 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.447 ' SD ' HG22 ' A' ' 21' ' ' ILE . 27.1 mtp -59.0 -42.57 90.37 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.884 0.874 . . . . 72.31 111.406 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.473 HG23 HD21 ' A' ' 126' ' ' LEU . 68.9 t -65.72 -44.05 93.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 124.652 1.181 . . . . 74.11 110.71 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 37.5 t -71.43 -31.13 66.85 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.239 0.616 . . . . 65.23 110.935 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.447 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 90.8 mtt-85 -73.98 -32.14 63.3 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.758 0.823 . . . . 72.5 109.512 175.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.417 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.74 12.15 57.55 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 115.453 -0.794 . . . . 63.25 112.823 172.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.417 HG22 ' O ' ' A' ' 121' ' ' GLY . 2.8 t 60.94 15.02 5.7 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 127.234 2.214 . . . . 74.22 114.385 171.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -78.57 155.08 78.82 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 109.019 -0.734 . . . . 74.31 109.019 175.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.68 174.43 2.25 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.636 2.224 . . . . 74.0 113.488 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.1 116.34 1.96 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.2 1.4 . . . . 75.31 111.853 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.53 HD23 HG12 ' A' ' 64' ' ' VAL . 56.9 tp -127.94 106.08 8.85 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.549 0.74 . . . . 72.41 109.152 176.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -130.7 128.33 40.65 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.729 1.212 . . . . 75.14 109.042 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.66 144.92 55.27 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 123.429 0.455 . . . . 75.23 110.079 174.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.17 157.12 78.64 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 124.303 1.041 . . . . 72.3 111.491 -178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.611 ' HD3' HG13 ' C' ' 13' ' ' ILE . 64.7 Cg_endo -70.37 99.33 0.8 Allowed 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.547 2.165 . . . . 73.22 111.981 176.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.4 t -103.97 112.94 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.793 -0.817 . . . . 73.52 108.793 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -95.27 84.12 3.99 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 108.686 -0.857 . . . . 74.31 108.686 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.444 ' HD2' HD21 ' A' ' 104' ' ' ASN . 92.5 m-85 . . . . . 0 N--CA 1.483 1.213 0 O-C-N 123.333 0.396 . . . . 74.41 110.006 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.541 ' SD ' ' N ' ' B' ' 10' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 110.339 -0.245 . . . . 73.44 110.339 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.541 ' N ' ' SD ' ' B' ' 9' ' ' MET . 54.6 m -167.08 130.66 1.85 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.801 0.84 . . . . 73.44 109.685 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' B' ' 85' ' ' SER 0.283 0.5 OUTLIER -155.25 155.85 34.54 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.561 0.696 . . . . 71.14 111.204 143.406 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.741 HE22 ' HB1' ' D' ' 129' ' ' ALA . 25.4 tp60 -127.03 128.38 46.24 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 106.424 -1.695 . . . . 75.35 106.424 172.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.508 HD11 HD12 ' B' ' 105' ' ' ILE . 27.8 mt -68.52 121.34 17.61 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 N-CA-C 108.784 -0.821 . . . . 72.12 108.784 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -90.29 -40.62 12.03 Favored 'General case' 0 C--O 1.243 0.761 0 O-C-N 124.233 0.958 . . . . 74.02 109.583 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.492 ' HA ' ' ND2' ' D' ' 127' ' ' ASN . 28.3 ttt180 -167.56 133.77 2.12 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 116.396 -0.366 . . . . 74.5 111.022 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 86.1 mt -115.56 135.97 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 107.48 -1.304 . . . . 75.04 107.48 173.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -168.73 170.69 9.18 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.98 0.895 . . . . 73.15 113.052 -177.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 86.9 m -96.42 118.03 32.1 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.828 -1.533 . . . . 65.14 108.743 174.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.598 ' HZ3' ' HB2' ' A' ' 28' ' ' ALA . 24.8 mtpp -79.8 -28.99 40.19 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.985 0.514 . . . . 73.32 110.543 176.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -162.7 149.93 13.37 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.218 0.533 . . . . 73.24 112.045 -171.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.622 HD12 ' SG ' ' B' ' 113' ' ' CYS . 28.3 mm -137.89 144.88 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 126.216 1.806 . . . . 75.23 108.612 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 46.2 t -147.64 126.66 12.83 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.965 -1.016 . . . . 75.02 108.786 169.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 85.3 t80 -138.81 109.82 6.8 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 107.529 -1.286 . . . . 74.05 107.529 171.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -119.09 115.47 24.34 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.922 0.889 . . . . 74.52 108.724 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.95 86.35 1.91 Allowed Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 107.091 -1.448 . . . . 55.12 107.091 169.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.88 -45.23 8.6 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.567 2.178 . . . . 73.4 112.131 -169.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 49.4 m-20 -100.59 18.05 20.2 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.674 0.79 . . . . 73.21 110.748 -176.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.527 ' HB2' ' HE3' ' A' ' 19' ' ' LYS . . . -31.12 -68.67 0.13 Allowed Pre-proline 0 N--CA 1.504 2.242 0 N-CA-C 115.419 1.637 . . . . 73.43 115.419 -166.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.37 -13.48 33.19 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 122.336 2.024 . . . . 71.34 113.078 -171.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -92.2 -45.7 8.12 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.544 0.738 . . . . 73.31 110.258 177.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.59 HG21 HD13 ' B' ' 68' ' ' LEU . 9.0 p -69.57 -17.62 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 112.295 0.48 . . . . 73.23 112.295 -171.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -62.92 -18.8 63.55 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.013 0.525 . . . . 63.1 112.383 173.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -65.98 -20.96 66.37 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.609 0.764 . . . . 75.22 110.817 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.505 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 95.4 mttt -103.99 71.27 1.03 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.835 1.254 . . . . 73.15 108.743 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -82.75 91.95 7.12 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.178 -0.919 . . . . 74.31 111.727 -173.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -158.64 -175.18 5.16 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.136 0.974 . . . . 73.2 109.52 170.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -72.74 111.59 11.84 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 123.663 0.785 . . . . 75.15 110.145 176.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.46 153.77 75.67 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.336 2.024 . . . . 72.44 112.216 178.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -69.31 113.93 7.09 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.56 -0.745 . . . . 71.51 109.16 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 12.8 t -86.46 121.35 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 122.991 0.517 . . . . 65.11 109.899 -173.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -115.86 128.63 55.96 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 107.244 -1.391 . . . . 71.42 107.244 172.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.581 HD13 HD22 ' B' ' 128' ' ' LEU . 0.2 OUTLIER -131.19 148.76 52.75 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.134 0.573 . . . . 74.32 109.763 174.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -153.2 129.82 10.77 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.066 0.946 . . . . 72.12 108.713 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 85.7 mt -99.47 150.91 21.71 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.691 0.797 . . . . 73.45 110.04 -176.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.543 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.0 t70 -137.14 139.68 41.35 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.777 -0.823 . . . . 64.31 108.777 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.8 p -109.8 124.23 50.93 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.392 0.677 . . . . 73.52 110.808 -175.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.94 135.36 46.54 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.42 1.088 . . . . 74.33 108.965 176.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 16.2 m -144.35 161.77 38.15 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.76 0.424 . . . . 75.22 111.385 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 53.9 p -160.55 143.39 13.17 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.328 -0.851 . . . . 72.01 109.769 174.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -80.29 107.08 12.8 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 107.821 -1.178 . . . . 72.4 107.821 172.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.602 HD12 ' HB2' ' B' ' 57' ' ' GLU . 40.2 mt -77.09 -42.08 39.6 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.275 0.559 . . . . 74.53 110.295 -174.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.22 -166.06 1.85 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.248 1.019 . . . . 75.43 109.827 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -69.96 131.39 44.33 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.251 0.62 . . . . 62.4 109.764 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 64.75 -10.4 0.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 125.727 1.611 . . . . 72.42 112.343 -171.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.406 HG13 ' HB2' ' B' ' 51' ' ' LEU . 91.1 t -110.7 121.82 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 O-C-N 121.502 -0.749 . . . . 74.44 109.468 -165.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -133.58 -176.48 4.17 Favored 'General case' 0 C--O 1.247 0.973 0 N-CA-C 107.796 -1.187 . . . . 70.4 107.796 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.602 ' HB2' HD12 ' B' ' 51' ' ' LEU . 35.4 tt0 -139.19 129.24 25.15 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.391 0.276 . . . . 72.52 110.608 -177.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 82.8 t -97.11 117.99 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.433 -0.951 . . . . 72.24 108.433 170.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 41.2 t -116.79 110.58 31.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.963 -1.125 . . . . 73.34 107.963 174.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 30.3 tp -107.28 107.85 18.98 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.337 -0.986 . . . . 73.15 108.337 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.543 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 45.9 ttt180 -84.74 114.44 22.05 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.52 -0.918 . . . . 73.43 108.52 176.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.6 t -102.69 105.07 17.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.968 -1.123 . . . . 73.03 107.968 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 33.1 m -95.45 138.37 33.23 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.511 -0.922 . . . . 74.53 108.511 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.55 133.26 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.563 0.745 . . . . 73.42 109.612 177.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.2 m -119.39 145.3 46.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.396 1.078 . . . . 74.34 108.421 169.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.57 129.34 26.49 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.849 -0.797 . . . . 74.54 108.849 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 30.9 p -123.11 127.83 49.25 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.587 0.755 . . . . 73.11 110.638 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.59 HD13 HG21 ' B' ' 31' ' ' VAL . 44.6 mt -102.63 109.39 20.99 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.061 0.944 . . . . 75.11 109.176 172.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.81 -110.56 3.55 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 114.958 -1.019 . . . . 62.11 113.398 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -105.08 4.02 31.04 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.007 0.923 . . . . 74.24 111.708 -174.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.505 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 12.6 pt-20 -139.53 164.79 28.97 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.743 0.417 . . . . 70.35 110.863 -176.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 63.3 m -79.07 125.6 29.61 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.479 0.712 . . . . 73.3 110.719 -177.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.536 ' HA ' HG22 ' B' ' 31' ' ' VAL . . . -70.55 -63.2 1.14 Allowed 'General case' 0 C--O 1.24 0.559 0 O-C-N 123.966 0.792 . . . . 71.45 109.16 171.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -155.08 164.54 38.72 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.462 -1.245 . . . . 74.22 111.724 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 55.4 mt -126.13 111.36 14.56 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 105.545 -2.02 . . . . 74.02 105.545 173.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.494 ' SG ' HG21 ' B' ' 114' ' ' ILE . 31.5 t -119.12 140.18 50.56 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.733 -0.84 . . . . 74.41 108.733 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -160.02 136.2 8.74 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.101 0.477 . . . . 70.34 110.045 -170.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 88.7 t -132.94 151.6 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.746 1.219 . . . . 75.35 108.248 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.54 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 17.3 mt-30 -124.52 98.85 5.91 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.795 -1.187 . . . . 73.23 107.795 170.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.436 ' HB2' ' HB1' ' B' ' 110' ' ' ALA . 7.8 tp-100 -88.76 99.86 12.69 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.645 -0.872 . . . . 74.3 108.645 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.84 141.51 15.62 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.303 -1.119 . . . . 64.4 110.303 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.12 127.08 3.13 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 110.673 -0.971 . . . . 75.45 110.673 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 55.3 mt -89.78 127.41 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.788 0.835 . . . . 71.24 109.084 176.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -135.56 135.06 40.02 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.129 -1.434 . . . . 75.2 107.129 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 67.6 m -99.45 89.92 4.34 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.403 0.547 . . . . 72.23 110.864 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' B' ' 10' ' ' THR . 12.7 tt -95.54 141.43 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.221 1.008 . . . . 72.22 111.607 -172.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.16 166.73 32.42 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.604 0.761 . . . . 71.21 110.436 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.96 -51.55 1.3 Allowed Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.742 -0.663 . . . . 71.11 112.54 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 17.4 mm -90.71 152.82 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.483 0.713 . . . . 75.13 112.315 -174.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.663 ' HA ' ' HE2' ' B' ' 94' ' ' MET . 40.1 tt0 -157.07 157.52 34.74 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 114.628 -1.169 . . . . 74.54 110.056 176.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.11 -135.0 12.59 Favored Glycine 0 C--N 1.353 1.503 0 C-N-CA 123.264 0.459 . . . . 64.33 113.191 170.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m -82.97 -18.32 40.35 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.212 0.605 . . . . 71.45 110.587 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -57.06 -38.74 73.71 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.887 0.875 . . . . 74.15 111.203 173.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.663 ' HE2' ' HA ' ' B' ' 90' ' ' GLU . 17.1 ptp -78.57 -25.37 45.31 Favored 'General case' 0 C--O 1.208 -1.107 0 CA-C-O 119.112 -0.471 . . . . 73.21 111.412 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.63 -34.67 67.5 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 122.963 0.505 . . . . 72.45 111.967 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -75.27 -47.3 28.62 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.815 0.846 . . . . 75.12 111.184 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.401 ' SG ' ' HE3' ' B' ' 9' ' ' MET . 43.2 t -64.11 -49.62 71.47 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.248 0.619 . . . . 64.43 111.415 -175.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 60.4 mt -72.51 -27.99 62.6 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.27 -0.877 . . . . 75.12 111.321 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.7 -0.26 64.56 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-O 119.688 -0.507 . . . . 70.24 113.88 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.5 -62.73 0.46 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 117.384 0.592 . . . . 65.11 111.643 -176.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.444 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 33.7 t80 -64.6 -46.36 82.98 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.986 0.914 . . . . 72.45 111.646 -171.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 39.9 m -73.58 -46.66 7.33 Favored Pre-proline 0 CA--C 1.567 1.624 0 N-CA-C 113.128 0.788 . . . . 64.04 113.128 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -69.12 -21.64 36.16 Favored 'Trans proline' 0 C--N 1.395 2.994 0 C-N-CA 122.022 1.815 . . . . 73.13 113.264 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -57.62 -36.34 71.67 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 124.112 0.965 . . . . 73.51 111.118 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.508 HD12 HD11 ' B' ' 13' ' ' ILE . 68.9 mt -68.74 -43.14 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.666 1.186 . . . . 75.22 110.945 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 78.4 mt -82.94 -22.39 33.82 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.858 -1.065 . . . . 61.14 111.923 -172.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -55.54 -51.34 80.88 Favored Pre-proline 0 CA--C 1.562 1.433 0 CA-C-O 117.655 -1.164 . . . . 73.12 113.062 -175.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.14 -38.47 94.84 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 122.257 1.972 . . . . 75.54 113.744 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -69.41 -48.88 59.68 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.183 0.593 . . . . 74.32 110.747 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.436 ' HB1' ' HB2' ' B' ' 80' ' ' GLN . . . -62.93 -39.87 95.91 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.066 0.546 . . . . 64.43 111.194 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -59.38 -53.97 52.13 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.064 1.346 . . . . 73.23 111.146 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -68.19 -31.63 71.29 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.533 0.733 . . . . 73.12 110.032 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.622 ' SG ' HD12 ' B' ' 21' ' ' ILE . 12.6 t -68.16 -33.67 74.9 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.984 0.514 . . . . 74.31 111.188 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.494 HG21 ' SG ' ' B' ' 76' ' ' CYS . 78.9 mt -68.14 -52.23 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.162 0.585 . . . . 63.34 109.764 172.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.4 m -59.19 -30.44 68.21 Favored 'General case' 0 CA--C 1.553 1.074 0 O-C-N 123.971 0.794 . . . . 74.3 111.666 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 37.3 t -64.38 -50.77 66.37 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 123.498 0.719 . . . . 75.44 109.976 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.483 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.4 mmt -69.27 -32.48 71.69 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 123.615 0.572 . . . . 74.45 111.223 -174.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 114' ' ' ILE . 89.4 t -61.95 -47.44 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.653 0.781 . . . . 75.51 110.307 173.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 34.6 t -62.14 -37.3 84.65 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.81 -1.087 . . . . 74.32 110.799 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.417 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 93.1 mtt-85 -67.68 -32.3 72.87 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 115.435 -0.802 . . . . 74.11 110.612 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.76 4.7 84.36 Favored Glycine 0 C--N 1.349 1.302 0 O-C-N 123.717 0.636 . . . . 50.14 112.905 174.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 68.2 p 57.96 33.97 23.77 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 126.113 1.765 . . . . 74.32 113.204 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -93.99 163.8 22.55 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 123.99 0.916 . . . . 74.3 110.726 177.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.09 170.4 1.12 Allowed 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.537 2.825 . . . . 65.43 115.198 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -64.05 114.36 4.1 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.41 1.084 . . . . 72.14 110.903 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.94 84.72 2.24 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.157 -1.053 . . . . 72.45 108.157 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -108.81 118.53 37.02 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.629 0.772 . . . . 74.33 109.073 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.581 HD22 HD13 ' B' ' 42' ' ' LEU . 0.3 OUTLIER -70.85 133.03 46.14 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.505 0.722 . . . . 72.44 109.23 -177.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -66.76 144.04 98.38 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.428 0.691 . . . . 73.41 111.773 -176.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 12.3 Cg_exo -71.18 92.58 0.65 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.9 2.4 . . . . 74.23 112.686 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 48.3 t -98.13 110.11 25.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.434 -0.95 . . . . 74.43 108.434 172.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -89.87 114.09 25.8 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.026 -0.731 . . . . 73.03 109.026 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -60.88 -43.16 98.82 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.521 0.728 . . . . 74.52 111.0 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 N--CA 1.478 0.956 0 CA-C-N 114.837 -1.074 . . . . 65.24 112.734 -173.472 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.472 0.673 0 CA-C-O 121.313 0.578 . . . . 75.43 109.5 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -134.74 128.28 32.61 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 107.84 -1.17 . . . . 75.01 107.84 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.611 HG13 ' HD3' ' A' ' 130' ' ' PRO . 63.0 mt -65.75 118.27 8.17 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 N-CA-C 107.987 -1.116 . . . . 73.2 107.987 173.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.503 ' HA ' HE21 ' C' ' 14' ' ' GLN . 0.0 OUTLIER -93.82 -36.82 12.07 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 123.981 0.801 . . . . 75.01 108.959 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -178.51 123.28 0.1 Allowed 'General case' 0 C--N 1.361 1.075 0 O-C-N 123.68 0.612 . . . . 75.22 110.766 -172.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.2 mt -109.85 137.91 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.838 1.255 . . . . 71.11 108.923 172.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.483 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 21.1 p90 -174.34 166.77 4.04 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.862 0.865 . . . . 74.31 109.972 -172.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.2 p -91.72 126.33 36.77 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.174 0.589 . . . . 72.14 109.532 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.483 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 14.9 mmtp -74.5 -50.07 19.68 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 107.759 -1.2 . . . . 74.13 107.759 168.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 19.8 t70 -136.08 141.98 44.28 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 113.627 -1.624 . . . . 74.3 109.883 -168.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 88.7 mt -138.37 145.51 28.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 106.604 -1.628 . . . . 75.33 106.604 175.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 22' ' ' SER . . . . . 0.424 ' HB3' ' HB3' ' C' ' 77' ' ' GLU . 42.2 t -154.9 150.11 27.09 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.763 0.825 . . . . 74.15 109.295 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 88.9 t80 -156.86 117.03 3.54 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 107.568 -1.271 . . . . 75.41 107.568 173.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -120.53 111.66 17.96 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.127 0.571 . . . . 73.42 110.146 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.97 82.96 43.68 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.379 1.072 . . . . 72.41 108.274 168.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -69.39 -31.39 22.26 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.588 2.192 . . . . 75.33 110.687 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -96.11 13.82 25.93 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.156 -1.384 . . . . 74.54 110.583 -175.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.99 -56.67 14.26 Favored Pre-proline 0 CA--C 1.566 1.59 0 N-CA-C 113.97 1.1 . . . . 73.54 113.97 -170.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -60.35 -41.41 50.13 Favored 'Trans proline' 0 C--N 1.395 3.014 0 C-N-CA 122.002 1.801 . . . . 71.22 112.075 -177.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -70.24 -38.1 75.1 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.447 -1.251 . . . . 73.43 112.298 -175.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.691 HG21 ' HA ' ' C' ' 73' ' ' ALA . 12.4 p -77.91 -23.02 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 112.471 0.545 . . . . 74.54 112.471 -173.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -64.77 -22.89 67.08 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.081 0.4 . . . . 73.41 112.081 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -103.98 29.51 5.83 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.952 0.901 . . . . 74.53 110.808 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.632 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -114.11 163.35 15.3 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.787 0.835 . . . . 73.23 109.533 173.412 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.52 120.87 11.36 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.621 0.768 . . . . 73.44 109.937 168.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -85.97 90.44 8.09 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.877 0.471 . . . . 75.54 111.133 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -150.25 76.97 8.39 Favored Pre-proline 0 N--CA 1.483 1.208 0 C-N-CA 124.913 1.285 . . . . 74.54 108.216 169.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -84.04 160.57 13.64 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.27 1.98 . . . . 74.53 112.609 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -87.1 119.47 27.35 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 106.207 -1.775 . . . . 74.33 106.207 168.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.548 HG12 HD13 ' C' ' 126' ' ' LEU . 34.9 m -91.36 97.19 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 122.469 1.128 . . . . 65.22 109.47 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.561 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 3.7 ttmp? -96.78 100.32 11.86 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 114.541 -1.208 . . . . 74.03 107.988 177.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 pp -87.93 149.53 24.01 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 109.358 -0.608 . . . . 74.11 109.358 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.476 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 33.6 t70 -149.0 114.17 5.49 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.276 0.63 . . . . 71.21 109.951 -173.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 9.1 mp -105.26 147.83 27.65 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.226 0.536 . . . . 73.32 110.519 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 5.7 t70 -136.36 151.06 49.15 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.334 1.454 . . . . 64.4 107.821 175.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 30.4 p -113.48 112.23 23.26 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.601 -0.518 . . . . 73.41 109.601 -177.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.11 151.62 37.19 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.349 1.06 . . . . 65.52 109.074 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.0 p -166.11 173.59 10.14 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.167 0.432 . . . . 73.32 112.167 -173.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 45.3 t -166.7 146.65 5.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.276 1.031 . . . . 73.51 109.286 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -88.38 118.61 28.12 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.891 -0.781 . . . . 65.03 108.891 170.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.448 HD13 HD13 ' C' ' 83' ' ' ILE . 65.4 mt -89.09 -38.98 13.95 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.352 0.661 . . . . 75.04 110.55 -177.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.53 -174.85 4.18 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.117 -0.947 . . . . 72.51 110.746 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -61.4 104.66 0.43 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 114.317 -1.311 . . . . 75.12 110.001 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 70.9 -2.71 2.22 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 125.894 1.677 . . . . 74.53 113.79 -175.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 71.2 t -93.71 115.61 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 107.748 -1.204 . . . . 70.13 107.748 175.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -133.35 136.99 45.7 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.718 0.771 . . . . 70.35 110.191 -170.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -86.98 113.13 22.48 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.664 1.586 . . . . 74.33 109.211 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 91.2 t -104.47 113.83 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 108.007 -1.109 . . . . 72.12 108.007 174.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -121.57 136.18 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 109.233 -0.655 . . . . 72.33 109.233 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.401 HD22 ' HB3' ' C' ' 103' ' ' PRO . 34.5 tp -120.44 115.96 24.52 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.596 -0.89 . . . . 75.11 108.596 175.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.488 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 15.3 ttm-85 -81.77 130.09 34.95 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.398 -0.964 . . . . 73.44 108.398 173.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.459 ' HB ' HD11 ' C' ' 114' ' ' ILE . 4.2 t -119.02 132.23 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 106.839 -1.541 . . . . 74.15 106.839 171.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 16.1 m -133.36 116.75 16.47 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.014 -0.736 . . . . 74.41 109.014 -177.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.681 HG23 HG21 ' C' ' 114' ' ' ILE . 62.7 t -105.31 114.71 45.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 123.835 0.854 . . . . 74.21 109.464 -175.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 18.5 m -101.79 139.11 37.87 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.559 -0.904 . . . . 75.42 108.559 172.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.46 114.58 13.03 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.887 -1.153 . . . . 74.34 107.887 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 31.4 m -137.0 130.42 31.41 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.104 0.478 . . . . 61.44 111.295 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.632 HD11 ' HG2' ' C' ' 34' ' ' LYS . 11.6 mt -86.32 46.88 1.39 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.795 1.238 . . . . 74.4 109.72 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.88 -109.67 3.56 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 110.699 -0.96 . . . . 75.14 110.699 -174.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -89.6 -23.93 21.82 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.467 0.707 . . . . 54.02 110.241 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -72.54 122.64 21.67 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 123.798 0.839 . . . . 73.54 110.005 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.0 m -82.94 128.04 34.09 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.976 -0.75 . . . . 74.04 108.976 168.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.691 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -80.52 -55.27 4.98 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 123.789 0.68 . . . . 73.3 109.525 172.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -162.6 175.65 11.18 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.116 0.96 . . . . 75.02 111.575 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -137.53 147.36 45.11 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 105.997 -1.853 . . . . 71.21 105.997 171.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 41.9 t -147.78 153.26 38.99 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.588 -0.893 . . . . 71.34 108.588 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' C' ' 22' ' ' SER . 34.6 tt0 -158.1 133.25 8.66 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 122.847 0.459 . . . . 75.21 110.243 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' C' ' 110' ' ' ALA . 49.1 t -137.52 114.43 12.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.481 1.112 . . . . 75.0 108.547 177.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.482 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 58.4 mt-30 -95.85 94.17 7.49 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.693 -0.854 . . . . 75.15 108.693 174.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.467 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 9.5 tp-100 -82.27 111.01 17.96 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.454 -0.794 . . . . 74.52 109.693 -176.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.46 148.08 18.86 Favored Glycine 0 C--N 1.335 0.522 0 O-C-N 123.827 0.705 . . . . 63.25 112.079 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.05 118.57 0.97 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.096 -1.201 . . . . 72.31 110.096 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.448 HD13 HD13 ' C' ' 51' ' ' LEU . 15.0 mm -84.42 128.13 39.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.617 -0.883 . . . . 65.03 108.617 176.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.433 ' HB2' HD11 ' C' ' 86' ' ' ILE . 26.5 m-85 -136.42 149.13 48.12 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.883 -1.154 . . . . 74.25 107.883 176.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 19.4 p -102.61 109.75 21.46 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 108.949 -0.759 . . . . 64.33 108.949 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.433 HD11 ' HB2' ' C' ' 84' ' ' PHE . 4.4 mp -108.58 122.08 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.107 0.563 . . . . 75.04 109.95 -167.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.56 167.58 27.62 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 114.538 -1.21 . . . . 60.53 109.651 175.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.46 -60.67 0.36 Allowed Glycine 0 C--N 1.344 0.973 0 CA-C-N 116.104 -0.498 . . . . 71.45 113.088 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 41.0 pt -113.33 167.55 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.202 0.525 . . . . 75.2 111.294 -176.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -149.18 -177.49 5.85 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.975 -1.011 . . . . 71.34 110.106 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.36 -139.99 42.56 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.68 -0.691 . . . . 44.04 114.077 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 39.4 p -68.99 -27.52 65.78 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.91 0.884 . . . . 64.34 111.33 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -61.48 -45.28 94.9 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.302 0.641 . . . . 74.15 110.157 175.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.649 ' HE1' HD12 ' C' ' 98' ' ' LEU . 9.8 ptm -77.32 -21.8 52.9 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-O 119.221 -0.419 . . . . 63.53 111.068 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.32 -36.72 82.05 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.193 0.52 . . . . 73.22 109.947 172.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . 0.441 ' O ' ' HB2' ' C' ' 100' ' ' ALA . 46.3 t-80 -60.9 -33.26 72.86 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.783 0.833 . . . . 73.43 110.744 173.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -77.79 -57.87 3.57 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.039 -0.528 . . . . 73.03 110.704 176.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.649 HD12 ' HE1' ' C' ' 94' ' ' MET . 96.0 mt -71.18 -37.84 72.15 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.101 0.96 . . . . 63.22 113.386 -165.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.2 -11.15 34.69 Favored Glycine 0 N--CA 1.471 0.993 0 CA-C-O 120.007 -0.329 . . . . 71.34 113.871 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' C' ' 96' ' ' HIS . . . -116.82 -57.61 2.16 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 117.161 0.481 . . . . 74.41 110.742 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -76.74 -47.72 20.92 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.467 0.707 . . . . 75.53 112.506 -174.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.41 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 58.6 m -65.11 -46.57 73.25 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 123.886 0.875 . . . . 54.44 112.722 -173.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.401 ' HB3' HD22 ' C' ' 60' ' ' LEU . 14.1 Cg_exo -72.1 -15.83 28.83 Favored 'Trans proline' 0 C--N 1.392 2.858 0 C-N-CA 122.148 1.899 . . . . 75.54 112.352 176.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -74.48 -33.26 62.81 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.465 0.706 . . . . 75.35 110.083 175.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.485 HG23 ' NH1' ' A' ' 111' ' ' ARG . 48.0 mm -61.34 -40.74 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 115.607 -0.724 . . . . 73.42 109.279 170.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 81.4 mt -87.25 -18.9 29.17 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.852 -1.067 . . . . 73.11 112.923 -173.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -57.72 -51.6 80.55 Favored Pre-proline 0 CA--C 1.559 1.316 0 CA-C-O 117.755 -1.117 . . . . 71.12 113.5 -174.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.17 -30.73 91.97 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 122.032 1.821 . . . . 72.41 113.399 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -68.77 -49.48 58.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.248 0.619 . . . . 72.02 110.643 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.511 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -65.16 -35.85 82.39 Favored 'General case' 0 C--N 1.355 0.843 0 CA-C-N 115.759 -0.655 . . . . 74.12 110.684 177.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -58.82 -51.08 71.51 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.381 1.073 . . . . 72.34 110.746 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.74 -37.57 79.52 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.789 -0.448 . . . . 75.12 109.789 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.9 t -66.06 -31.83 72.94 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.042 0.537 . . . . 71.1 111.51 -176.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.681 HG21 HG23 ' C' ' 64' ' ' VAL . 96.7 mt -72.63 -54.98 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.358 -0.608 . . . . 74.41 109.358 173.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.9 m -60.31 -28.25 67.97 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.935 0.772 . . . . 75.31 111.278 -175.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 30.6 t -66.7 -49.83 64.8 Favored 'General case' 0 C--O 1.213 -0.844 0 N-CA-C 108.734 -0.839 . . . . 64.41 108.734 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.527 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.4 -37.31 83.0 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.454 1.102 . . . . 75.51 112.401 178.17 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.407 HG23 ' O ' ' C' ' 114' ' ' ILE . 76.4 t -63.24 -45.29 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.718 0.807 . . . . 75.31 109.044 174.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 44.5 t -70.55 -26.26 63.47 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.561 -1.2 . . . . 71.21 112.113 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -75.83 -40.56 54.66 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.632 0.773 . . . . 75.4 108.949 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.27 -0.39 61.56 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 123.903 0.752 . . . . 74.13 112.348 168.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.461 HG21 ' HB3' ' D' ' 17' ' ' TYR . 31.0 p 62.75 28.4 16.49 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.692 1.997 . . . . 74.5 113.415 170.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -83.57 141.24 41.72 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 107.997 -1.112 . . . . 73.2 107.997 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -50.98 156.46 4.82 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 123.682 2.922 . . . . 64.34 114.232 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -50.62 111.83 0.6 Allowed 'General case' 0 N--CA 1.481 1.094 0 O-C-N 124.473 1.108 . . . . 74.21 112.695 -171.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.548 HD13 HG12 ' C' ' 40' ' ' VAL . 31.2 tp -112.73 87.51 2.6 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.217 -1.401 . . . . 75.02 107.217 171.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -107.69 107.67 18.57 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.149 -1.056 . . . . 72.1 108.149 -172.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 30.7 tp -65.99 142.59 57.79 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.519 0.512 . . . . 75.54 111.157 -174.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.29 152.92 95.65 Favored Pre-proline 0 CA--C 1.555 1.141 0 O-C-N 124.072 0.858 . . . . 72.41 110.888 178.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.77 143.84 68.58 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.965 2.443 . . . . 75.13 113.559 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.0 p -128.6 110.35 21.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-O 122.665 1.221 . . . . 74.22 109.595 173.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -92.06 84.39 5.29 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.63 -1.989 . . . . 64.13 105.63 169.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -47.15 -44.29 21.7 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.765 0.826 . . . . 74.53 111.883 -171.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.428 ' HB2' ' HB1' ' C' ' 100' ' ' ALA . 16.1 t70 . . . . . 0 N--CA 1.476 0.841 0 CA-C-N 114.628 -1.169 . . . . 64.11 112.468 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 59.8 m . . . . . 0 C--O 1.242 0.693 0 N-CA-C 108.307 -0.997 . . . . 75.24 108.307 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -157.38 118.74 3.66 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.486 -1.302 . . . . 74.45 107.486 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -123.87 115.29 21.07 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.255 -1.017 . . . . 72.41 108.255 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.481 HG21 HD13 ' D' ' 16' ' ' ILE . 56.7 mt -75.72 123.95 32.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.586 -0.894 . . . . 72.43 108.586 173.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -89.81 -40.14 12.65 Favored 'General case' 0 C--O 1.245 0.836 0 O-C-N 123.473 0.483 . . . . 73.32 111.239 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -175.9 128.74 0.24 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 119.645 -0.217 . . . . 75.05 110.929 -163.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.481 HD13 HG21 ' D' ' 13' ' ' ILE . 3.4 mp -112.05 140.89 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.924 -1.139 . . . . 75.23 107.924 166.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.468 ' HE1' HG13 ' D' ' 83' ' ' ILE . 26.0 p90 -161.91 168.43 22.95 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 124.257 0.973 . . . . 72.24 110.41 -177.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -99.46 120.74 40.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.595 -1.184 . . . . 73.23 109.251 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -90.29 -18.32 25.81 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.92 -0.582 . . . . 72.43 109.56 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.1 t70 -160.99 141.05 10.98 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 114.691 -1.141 . . . . 71.22 109.686 177.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.527 HG23 ' HE1' ' C' ' 117' ' ' MET . 67.0 mt -139.14 140.55 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.978 1.311 . . . . 75.23 107.475 174.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.7 t -142.49 140.04 31.73 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.089 0.955 . . . . 54.41 108.927 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.577 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 94.3 t80 -152.19 119.02 5.76 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 106.527 -1.657 . . . . 73.53 106.527 173.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 28.9 mt-10 -134.58 108.64 8.18 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.834 -0.802 . . . . 70.3 108.834 -173.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.4 92.03 9.26 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 109.007 -0.738 . . . . 74.44 109.007 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.74 -52.72 0.39 Allowed 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.044 2.496 . . . . 73.35 112.342 -172.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -94.23 13.25 23.99 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-N 114.943 -1.026 . . . . 73.33 110.32 -174.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -28.7 -61.97 0.21 Allowed Pre-proline 0 CA--C 1.566 1.591 0 N-CA-C 115.984 1.846 . . . . 74.14 115.984 -165.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.414 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 91.2 Cg_endo -78.04 -22.97 9.57 Favored 'Trans proline' 0 C--N 1.384 2.401 0 CA-C-N 122.782 2.029 . . . . 74.52 113.905 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -71.08 -41.3 70.85 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.592 1.157 . . . . 75.43 109.359 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.484 HG23 ' HA ' ' D' ' 73' ' ' ALA . 9.9 p -83.52 -20.69 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.614 -0.721 . . . . 75.2 111.617 -171.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.414 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.4 m-85 -61.85 -28.37 69.44 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.002 0.429 . . . . 75.12 111.71 176.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -59.4 -25.62 64.44 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.79 -1.095 . . . . 54.42 110.341 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.729 ' HZ1' ' HG2' ' D' ' 71' ' ' GLU . 99.4 mttt -86.28 87.01 7.35 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.538 1.135 . . . . 74.42 109.834 170.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -84.04 93.07 8.01 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.003 -0.999 . . . . 72.42 110.944 -177.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 36.9 p90 -164.36 171.27 15.0 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.21 1.004 . . . . 72.21 109.428 167.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . 0.539 HE21 ' HD2' ' D' ' 38' ' ' PRO . 27.7 tp60 -60.76 113.37 7.5 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 123.792 0.837 . . . . 72.33 109.051 176.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.725 ' HD3' ' HG2' ' D' ' 124' ' ' PRO . 62.7 Cg_exo -52.93 124.03 14.52 Favored 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 122.77 2.313 . . . . 74.23 111.693 -177.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -68.02 111.63 4.54 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 124.38 1.05 . . . . 75.55 108.186 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.448 HG13 ' O ' ' D' ' 38' ' ' PRO . 16.6 m -99.86 144.66 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.973 0.892 . . . . 74.12 112.507 -165.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.493 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 17.7 tppt? -113.93 113.46 24.88 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.622 -1.621 . . . . 73.43 106.622 171.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 pp -94.87 141.06 29.08 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 108.069 -1.086 . . . . 74.52 108.069 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.601 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 32.8 t70 -145.68 138.13 25.67 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.487 0.715 . . . . 72.22 109.081 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -116.21 134.96 54.34 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.901 -0.777 . . . . 72.53 108.901 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 35.4 t70 -136.67 157.76 46.03 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 106.832 -1.544 . . . . 64.31 106.832 170.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.9 t -137.09 154.09 50.4 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.256 0.55 . . . . 75.54 111.328 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.38 165.77 32.08 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.906 1.283 . . . . 71.24 108.838 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 32.0 p -172.55 153.89 2.96 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.047 0.539 . . . . 75.32 111.649 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 33.7 p -157.2 120.33 4.06 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 114.722 -1.127 . . . . 42.54 108.554 173.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' D' ' 56' ' ' TYR . 61.7 tt0 -65.59 129.16 38.77 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.353 -0.61 . . . . 74.23 109.353 173.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 76.9 mt -94.96 -38.16 10.81 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.073 0.549 . . . . 71.13 110.971 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.89 -170.3 2.68 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.128 0.49 . . . . 74.23 111.294 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.44 118.13 7.67 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.839 -1.073 . . . . 74.1 109.739 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 67.83 -1.29 1.73 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.833 1.253 . . . . 64.24 112.794 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.56 123.91 65.83 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 N-CA-C 108.954 -0.758 . . . . 73.21 108.954 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' D' ' 50' ' ' GLN . 0.1 OUTLIER -136.13 150.05 48.92 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.959 -0.756 . . . . 73.32 108.959 177.002 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -110.55 134.38 52.44 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.504 -1.295 . . . . 71.22 107.504 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 76.9 t -127.28 131.16 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.617 1.167 . . . . 75.3 108.814 -172.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.479 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 21.7 t -121.56 131.94 71.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 123.446 0.699 . . . . 74.53 109.67 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.494 HD21 HD11 ' D' ' 106' ' ' LEU . 3.9 mm? -117.87 107.97 14.76 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.447 -0.946 . . . . 74.23 108.447 168.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.552 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 15.8 ttm-85 -82.24 101.9 10.81 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.876 0.87 . . . . 75.45 109.08 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 84.7 t -94.09 129.99 43.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.725 -0.843 . . . . 74.42 108.725 174.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 21.7 m -125.03 133.33 53.0 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.804 0.442 . . . . 73.55 110.194 -176.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 42.2 t -124.81 101.07 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.667 1.187 . . . . 64.22 108.703 175.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 93.4 m -92.99 106.45 18.41 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.881 -1.155 . . . . 74.14 107.881 170.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.61 142.37 42.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.893 -0.594 . . . . 70.35 110.011 -171.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.4 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 19.8 m -145.15 137.01 25.59 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.122 -0.49 . . . . 75.33 110.57 -175.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 21.2 mt -105.14 110.82 23.34 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.071 -1.085 . . . . 74.34 108.071 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.54 -130.01 17.48 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 116.229 -0.441 . . . . 43.11 113.242 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -89.6 4.19 50.18 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.348 0.659 . . . . 74.14 111.92 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.729 ' HG2' ' HZ1' ' D' ' 34' ' ' LYS . 12.1 pt-20 -131.8 158.78 40.35 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.695 0.398 . . . . 74.23 110.518 -173.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.3 m -71.29 138.01 49.0 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.355 -0.839 . . . . 74.22 111.103 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.484 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -89.48 -62.24 1.52 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.946 -1.131 . . . . 70.42 107.946 173.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -156.61 159.53 38.56 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.583 -1.19 . . . . 74.34 110.556 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 85.7 mt -121.97 108.84 13.87 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.48 -1.304 . . . . 74.41 107.48 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.608 ' SG ' HG12 ' D' ' 114' ' ' ILE . 45.9 t -117.14 135.27 53.88 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.749 0.82 . . . . 75.32 109.272 -173.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -155.43 126.18 6.96 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.78 0.432 . . . . 63.42 110.033 175.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.43 118.74 46.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 123.819 0.848 . . . . 70.3 109.527 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.4 mt-30 -87.71 88.45 7.67 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.272 -1.01 . . . . 73.14 108.272 170.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -80.85 98.38 7.81 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 115.092 -0.958 . . . . 72.54 109.102 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.32 169.55 33.26 Favored Glycine 0 C--O 1.244 0.772 0 CA-C-N 115.74 -0.663 . . . . 74.23 112.33 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.63 133.33 2.86 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 112.058 -0.417 . . . . 70.14 112.058 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.468 HG13 ' HE1' ' D' ' 17' ' ' TYR . 57.7 mt -88.41 123.84 41.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 107.847 -1.168 . . . . 73.41 107.847 173.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -131.61 157.12 44.52 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.123 0.969 . . . . 74.42 109.718 -175.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 43.2 m -117.21 136.23 53.21 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.029 0.932 . . . . 73.44 110.2 175.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.77 141.71 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.554 1.141 . . . . 75.2 109.956 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.13 161.07 10.18 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.158 0.983 . . . . 72.03 108.639 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.44 21.04 79.93 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 121.426 -0.416 . . . . 75.42 113.382 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.408 HG22 ' HG2' ' D' ' 93' ' ' GLN . 12.7 mt -118.86 152.56 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.464 0.705 . . . . 73.53 109.933 -172.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.578 ' HA ' ' HE1' ' D' ' 94' ' ' MET . 42.1 mt-10 -157.4 148.12 21.28 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.945 1.298 . . . . 71.12 110.557 175.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.57 -125.53 28.79 Favored Glycine 0 C--N 1.353 1.492 0 O-C-N 124.085 0.866 . . . . 71.22 114.9 169.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.2 m -72.0 -24.9 61.65 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.763 0.825 . . . . 75.35 111.803 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.408 ' HG2' HG22 ' D' ' 89' ' ' ILE . 25.6 tt0 -61.78 -29.9 70.45 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.328 0.651 . . . . 75.3 109.976 175.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.578 ' HE1' ' HA ' ' D' ' 90' ' ' GLU . 49.5 mtt -70.8 -44.09 67.33 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.918 0.887 . . . . 72.3 110.692 173.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.85 -36.83 82.36 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.379 0.672 . . . . 73.2 111.34 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -78.85 -29.97 44.91 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.116 0.566 . . . . 75.54 110.696 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 41.1 t -60.38 -51.09 70.99 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.413 0.685 . . . . 54.24 112.311 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.15 -17.07 14.43 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 115.492 -0.776 . . . . 72.31 112.258 -174.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.89 -25.62 29.02 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-O 120.119 -0.267 . . . . 72.54 112.867 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.14 -63.37 1.45 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.009 0.524 . . . . 73.3 110.935 -178.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -62.38 -53.99 46.83 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 112.744 0.646 . . . . 75.01 112.744 -169.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 59.1 m -59.04 -45.43 99.52 Favored Pre-proline 0 N--CA 1.494 1.753 0 CA-C-O 118.612 -0.709 . . . . 75.44 112.563 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -51.71 -46.64 30.68 Favored 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.639 2.226 . . . . 71.24 113.665 165.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -67.64 -15.54 63.7 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 123.376 0.67 . . . . 70.03 112.202 -178.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 35.9 mm -86.61 -49.43 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.285 0.634 . . . . 75.52 109.863 173.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.494 HD11 HD21 ' D' ' 60' ' ' LEU . 91.4 mt -79.52 -30.53 41.92 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.352 0.871 . . . . 74.44 113.352 -168.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -65.6 -39.25 31.23 Favored Pre-proline 0 N--CA 1.49 1.572 0 CA-C-O 118.174 -0.917 . . . . 74.14 113.264 -177.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -49.55 -45.97 28.78 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 122.62 2.213 . . . . 74.23 114.626 166.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -74.57 -36.16 63.06 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.063 0.545 . . . . 64.43 111.581 -177.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.16 -46.59 86.42 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.641 -0.503 . . . . 70.45 109.641 174.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -54.49 -49.59 69.77 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 124.706 1.254 . . . . 65.42 110.606 177.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -62.56 -43.63 98.34 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.797 0.686 . . . . 64.34 111.093 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.9 t -61.76 -44.0 97.76 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 123.761 0.663 . . . . 75.34 110.859 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.608 HG12 ' SG ' ' D' ' 76' ' ' CYS . 97.2 mt -60.61 -59.1 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.14 0.976 . . . . 73.21 110.217 175.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 37.0 m -52.98 -38.95 62.66 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.461 1.504 . . . . 64.22 111.551 -176.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.0 t -66.76 -47.06 73.4 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 114.889 -1.05 . . . . 64.15 110.344 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.8 mtm -67.17 -32.28 73.26 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.787 0.435 . . . . 73.12 111.763 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.5 t -61.9 -46.66 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.776 0.83 . . . . 63.34 109.887 174.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.1 p -76.89 -24.99 52.53 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.809 -0.632 . . . . 75.33 111.51 -177.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -74.02 -37.31 64.4 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.389 0.676 . . . . 74.45 109.52 175.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.8 4.39 65.6 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 115.561 -0.745 . . . . 62.44 112.27 170.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 47.8 p 59.12 23.09 11.3 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 126.947 2.099 . . . . 53.23 114.012 174.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -78.02 149.79 77.11 Favored Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 108.643 -0.873 . . . . 74.35 108.643 169.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.725 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 4.8 Cg_endo -53.42 133.82 54.8 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.675 2.25 . . . . 73.3 112.295 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -50.98 135.76 24.14 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.833 1.333 . . . . 73.13 112.654 -171.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 64.6 tp -114.77 103.06 10.59 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.881 0.872 . . . . 73.4 109.006 -177.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . 0.492 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 86.2 m-20 -99.51 101.29 12.48 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.829 -0.804 . . . . 74.5 108.829 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 tt -66.78 115.98 7.17 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 108.172 -1.047 . . . . 73.22 108.172 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . 0.741 ' HB1' HE22 ' B' ' 12' ' ' GLN . . . -65.15 140.54 97.99 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 123.515 0.726 . . . . 75.5 110.72 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.444 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 5.6 Cg_exo -72.18 151.25 54.83 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.81 2.34 . . . . 72.24 111.981 -171.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 123.637 0.775 . . . . 75.12 110.182 -178.796 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.661 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 35.7 t80 . . . . . 0 C--O 1.239 0.525 0 N-CA-C 109.908 -0.404 . . . . 65.33 109.908 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -152.92 132.96 13.38 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.201 1.0 . . . . 62.11 108.818 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.67 HG12 ' HD2' ' A' ' 84' ' ' PHE . 57.6 mt -93.49 121.25 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.104 -0.702 . . . . 75.25 109.104 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -85.3 -33.98 21.99 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.591 0.756 . . . . 71.31 110.328 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -171.06 142.47 1.82 Allowed 'General case' 0 C--N 1.352 0.717 0 O-C-N 123.411 0.445 . . . . 73.32 110.65 -174.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.425 HD13 ' HG3' ' C' ' 130' ' ' PRO . 78.6 mt -131.75 134.02 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 107.962 -1.125 . . . . 75.45 107.962 170.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.522 ' HB3' HG23 ' B' ' 122' ' ' THR . 37.1 p90 -163.06 176.94 9.57 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 124.168 0.917 . . . . 65.14 110.838 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.4 p -100.06 121.52 41.52 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.178 -0.919 . . . . 73.33 109.035 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -84.28 -37.36 21.78 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.975 0.417 . . . . 74.43 109.935 178.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 24.4 t70 -143.28 135.28 26.84 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.122 -0.944 . . . . 74.53 109.288 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.476 HD11 ' SD ' ' B' ' 117' ' ' MET . 77.5 mt -128.74 140.02 50.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.217 -1.401 . . . . 73.43 107.217 175.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.9 t -151.31 110.98 4.02 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.071 0.462 . . . . 74.4 110.1 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -110.4 132.76 53.89 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.306 -1.368 . . . . 75.44 107.306 169.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -130.57 140.35 50.46 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.878 -1.156 . . . . 73.31 107.878 173.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.38 76.4 56.25 Favored Pre-proline 0 C--O 1.241 0.644 0 N-CA-C 106.208 -1.775 . . . . 75.24 106.208 169.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -62.5 -34.49 75.5 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.985 2.457 . . . . 65.15 112.794 -168.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 -109.1 22.79 15.43 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.467 -0.778 . . . . 72.31 110.224 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.555 ' HB2' ' HE3' ' B' ' 19' ' ' LYS . . . -42.46 -53.84 8.74 Favored Pre-proline 0 N--CA 1.499 1.998 0 N-CA-C 114.097 1.147 . . . . 75.51 114.097 -170.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -65.17 -29.24 55.92 Favored 'Trans proline' 0 C--N 1.387 2.581 0 CA-C-N 121.174 1.455 . . . . 73.15 112.641 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -82.56 -35.21 27.4 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.485 1.114 . . . . 65.25 110.843 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.643 HG22 ' HA ' ' A' ' 73' ' ' ALA . 4.3 p -78.68 -20.95 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 115.125 -0.943 . . . . 73.23 112.54 -161.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -71.85 -19.13 62.01 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-O 120.972 0.415 . . . . 75.31 111.002 176.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -77.88 -25.31 48.48 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.464 1.105 . . . . 64.23 110.695 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -76.58 149.49 36.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.805 0.842 . . . . 74.23 110.863 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.2 138.1 58.43 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 124.007 0.817 . . . . 74.42 109.303 170.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -84.01 92.0 7.75 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.713 -0.477 . . . . 73.23 109.713 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -127.53 82.89 67.42 Favored Pre-proline 0 C--O 1.243 0.755 0 N-CA-C 107.962 -1.125 . . . . 71.42 107.962 170.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.95 125.13 7.81 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.48 2.12 . . . . 75.42 112.677 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -98.87 96.62 7.99 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 106.76 -1.57 . . . . 74.32 106.76 165.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.7 t -75.55 94.51 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 115.948 -0.569 . . . . 74.33 109.662 -175.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.469 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 14.2 mptt -78.68 111.74 15.08 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 107.641 -1.244 . . . . 73.51 107.641 170.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.98 138.52 47.28 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.707 0.803 . . . . 73.34 108.925 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.532 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 21.2 t70 -141.64 140.75 33.35 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.784 1.234 . . . . 73.45 108.483 -172.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.4 mt -123.16 136.95 54.99 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.13 0.572 . . . . 74.22 110.453 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 18.0 t70 -134.25 147.14 50.62 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 114.781 -1.099 . . . . 71.5 108.428 175.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.1 m -106.57 131.65 53.48 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.958 0.903 . . . . 73.11 110.258 -173.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.735 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -131.53 105.41 7.54 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.795 -1.187 . . . . 72.1 107.795 169.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 24.5 m -95.93 152.01 18.9 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.246 -1.02 . . . . 53.0 108.246 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.532 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 31.2 t -159.25 142.59 14.59 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.121 0.568 . . . . 72.1 109.961 -176.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -112.72 130.28 56.11 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.016 -1.105 . . . . 72.11 108.016 168.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.0 mt -104.26 -38.1 7.01 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.215 0.606 . . . . 75.24 110.524 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.05 -170.46 3.4 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.241 0.617 . . . . 73.1 110.381 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.82 113.89 3.7 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.509 1.124 . . . . 52.54 110.023 173.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 85' ' ' SER . 32.1 m-20 69.71 -2.56 1.93 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.369 1.468 . . . . 65.33 112.906 -176.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.3 t -95.75 113.29 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 107.574 -1.269 . . . . 73.3 107.574 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -127.29 125.87 41.64 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.943 -0.762 . . . . 72.21 108.943 -176.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 40.5 tt0 -92.94 116.83 29.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.304 -0.862 . . . . 72.34 108.947 175.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.421 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 54.1 t -100.2 118.61 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 106.368 -1.716 . . . . 72.53 106.368 174.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.735 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 29.5 t -118.46 121.19 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.732 -0.84 . . . . 62.45 108.732 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.35 113.52 26.24 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.476 -0.935 . . . . 74.43 108.476 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 50.1 ttt180 -83.01 101.75 11.3 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.326 -0.991 . . . . 74.0 108.326 174.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.07 102.46 13.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.96 -1.126 . . . . 73.23 107.96 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 28.5 m -97.34 126.03 42.32 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.036 -0.727 . . . . 73.14 109.036 178.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.553 HG13 HD23 ' A' ' 126' ' ' LEU . 75.1 t -122.54 139.92 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.345 1.058 . . . . 74.01 108.265 176.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 17.5 m -136.03 141.69 44.35 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.375 -0.972 . . . . 75.24 108.375 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.61 117.2 32.86 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.619 -1.252 . . . . 71.44 107.619 171.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.6 m -113.06 126.36 55.39 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.878 0.471 . . . . 75.42 109.905 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.471 HD13 ' HB1' ' A' ' 73' ' ' ALA . 13.8 mt -98.92 83.25 2.88 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.42 1.088 . . . . 72.42 108.326 176.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.43 -83.84 1.09 Allowed Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.902 -0.59 . . . . 72.41 112.003 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.73 -25.07 3.72 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.113 0.965 . . . . 73.24 110.188 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -95.85 133.79 39.58 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.688 0.795 . . . . 74.55 109.945 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.5 m -74.34 139.48 44.18 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 122.852 0.461 . . . . 63.12 110.545 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.643 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -82.11 -61.31 1.94 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.696 0.798 . . . . 73.42 109.067 172.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -154.63 168.5 26.58 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.597 -1.183 . . . . 72.24 111.413 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 64' ' ' VAL . 54.5 tp -122.61 139.53 53.83 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.948 1.299 . . . . 75.11 108.376 172.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 79.2 m -140.81 98.18 3.34 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.48 1.112 . . . . 70.22 110.098 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -115.94 127.99 55.4 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.556 0.742 . . . . 73.04 109.25 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.2 t -133.03 113.47 19.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 C-N-CA 123.267 0.627 . . . . 74.41 109.668 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -85.59 89.0 7.6 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.07 -0.968 . . . . 72.42 108.845 173.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.465 ' HG3' HD23 ' A' ' 106' ' ' LEU . 7.9 tp-100 -80.83 107.5 13.7 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.331 -0.849 . . . . 74.21 109.298 -177.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.41 144.44 17.24 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 111.537 -0.625 . . . . 73.45 111.537 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.29 125.56 2.48 Favored Glycine 0 C--N 1.33 0.197 0 N-CA-C 111.54 -0.624 . . . . 62.2 111.54 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.1 mt -81.49 120.48 33.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.663 -0.866 . . . . 75.35 108.663 173.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.67 ' HD2' HG12 ' A' ' 13' ' ' ILE . 21.5 m-85 -136.23 120.44 17.83 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.553 -0.906 . . . . 75.11 108.553 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 66.7 m -89.84 113.27 24.83 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.456 -0.572 . . . . 71.41 109.456 171.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.477 0.909 0 C-N-CA 123.546 0.739 . . . . 75.13 109.996 -179.799 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.599 0.238 . . . . 72.32 111.228 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -67.42 -35.61 79.61 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.858 -0.61 . . . . 71.4 110.582 171.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.649 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 71.5 m -71.08 -66.07 0.66 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.179 0.192 . . . . 74.13 111.215 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.63 -25.4 67.35 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.455 0.702 . . . . 72.0 112.751 -175.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.81 -24.81 22.15 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-O 119.909 -0.384 . . . . 63.3 113.752 -176.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.46 -64.66 0.88 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 117.206 0.503 . . . . 74.55 111.301 -175.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.649 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 83.3 t80 -69.29 -60.47 2.32 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.303 1.041 . . . . 73.14 112.967 -164.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.7 m -62.29 -39.01 52.77 Favored Pre-proline 0 CA--C 1.569 1.701 0 N-CA-C 114.024 1.12 . . . . 53.03 114.024 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -66.49 -28.61 45.64 Favored 'Trans proline' 0 C--N 1.389 2.679 0 CA-C-N 121.366 1.524 . . . . 74.3 112.853 166.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -79.96 -14.64 58.44 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.358 0.663 . . . . 73.22 110.477 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 35.1 mm -68.2 -39.75 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 108.472 -0.936 . . . . 73.21 108.472 168.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.465 HD23 ' HG3' ' A' ' 80' ' ' GLN . 77.2 mt -78.29 -23.66 47.1 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.135 -0.939 . . . . 73.23 112.129 -177.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -59.45 -47.41 97.99 Favored Pre-proline 0 CA--C 1.571 1.759 0 CA-C-O 117.862 -1.066 . . . . 75.54 113.502 -174.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -63.15 -37.13 53.81 Favored 'Trans proline' 0 C--N 1.392 2.857 0 C-N-CA 121.988 1.792 . . . . 71.45 113.224 176.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -72.14 -38.02 69.32 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.131 0.572 . . . . 74.24 111.097 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.52 -42.06 71.76 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.242 0.617 . . . . 53.23 110.207 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.419 ' NH1' HG22 ' C' ' 105' ' ' ILE . 25.7 ttm180 -60.58 -44.82 95.79 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.171 0.919 . . . . 74.51 109.597 175.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -65.24 -43.58 90.92 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.136 0.974 . . . . 75.24 111.687 -176.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.5 t -61.7 -43.49 98.76 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.959 0.787 . . . . 73.31 109.816 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 67.4 mt -61.69 -47.81 91.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 124.436 1.094 . . . . 64.12 110.756 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.3 m -59.52 -39.23 83.22 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.376 1.07 . . . . 75.44 110.816 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 42.9 t -67.64 -46.71 71.67 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 115.184 -0.916 . . . . 74.41 110.605 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 18.2 mtp -59.21 -41.59 88.95 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.969 0.908 . . . . 65.23 111.504 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.412 HG23 HD21 ' A' ' 126' ' ' LEU . 74.0 t -65.8 -51.28 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.237 1.015 . . . . 73.34 110.631 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.4 t -66.11 -27.78 68.31 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.597 -0.728 . . . . 73.23 111.091 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.546 ' HG2' ' HG1' ' B' ' 18' ' ' THR . 30.2 ttm-85 -77.59 -31.61 53.14 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.302 1.041 . . . . 74.23 109.334 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.42 11.27 61.63 Favored Glycine 0 C--N 1.356 1.657 0 CA-C-N 114.673 -1.148 . . . . 55.14 112.811 170.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.43 HG23 ' HE ' ' B' ' 15' ' ' ARG . 1.3 t 64.23 15.59 9.49 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 127.045 2.138 . . . . 72.2 113.925 172.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -80.61 153.12 73.25 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.06 0.544 . . . . 75.1 109.91 178.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.8 155.14 23.49 Favored 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 123.252 2.635 . . . . 62.04 113.569 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -56.41 120.21 7.3 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.383 1.073 . . . . 64.41 112.645 -170.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.553 HD23 HG13 ' A' ' 64' ' ' VAL . 64.0 tp -121.86 106.13 10.99 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.417 1.087 . . . . 64.21 109.894 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -127.09 126.15 42.49 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.947 0.899 . . . . 73.33 108.853 169.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.8 mp -72.15 142.11 49.1 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.215 -0.661 . . . . 71.41 109.215 174.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.58 150.13 94.33 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 122.82 0.448 . . . . 72.13 110.171 176.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.696 ' HG3' ' HD2' ' C' ' 11' ' ' PHE . 44.7 Cg_endo -61.33 154.14 60.62 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.718 2.279 . . . . 74.33 112.779 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.1 m -119.17 116.25 50.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 109.079 -0.712 . . . . 73.42 109.079 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -94.09 64.85 3.35 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.333 0.587 . . . . 74.41 109.581 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 . . . . . 0 N--CA 1.474 0.751 0 CA-C-N 115.336 -0.847 . . . . 73.04 109.855 176.292 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.614 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 14.6 ptm . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 114.65 1.352 . . . . 71.32 114.65 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 40.5 m -133.34 144.85 49.89 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.459 1.103 . . . . 75.34 108.491 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.658 ' CZ ' HG13 ' B' ' 13' ' ' ILE . 0.3 OUTLIER -130.53 149.88 51.99 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 106.916 -1.513 . . . . 74.02 106.916 178.206 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.462 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -156.29 101.11 2.03 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 123.339 0.399 . . . . 71.42 111.605 164.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.658 HG13 ' CZ ' ' B' ' 11' ' ' PHE . 44.6 mt -51.99 123.1 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.855 -0.794 . . . . 75.43 108.855 162.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -100.33 -45.07 5.71 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.048 0.842 . . . . 73.35 109.607 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.43 ' HE ' HG23 ' A' ' 122' ' ' THR . 47.9 ttt180 -162.92 135.58 5.54 Favored 'General case' 0 C--N 1.349 0.565 0 N-CA-C 109.259 -0.645 . . . . 75.45 109.259 -177.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.5 mt -114.89 137.17 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 107.896 -1.149 . . . . 74.24 107.896 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -167.29 158.32 11.73 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.11 0.481 . . . . 73.14 111.632 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.546 ' HG1' ' HG2' ' A' ' 120' ' ' ARG . 87.1 m -85.29 131.13 34.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.708 -0.678 . . . . 74.42 109.184 171.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.555 ' HE3' ' HB2' ' A' ' 28' ' ' ALA . 45.9 mtpt -97.76 -32.63 11.63 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.212 0.605 . . . . 72.31 110.665 177.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -151.13 138.21 19.19 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.613 0.244 . . . . 70.04 111.627 -175.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.736 HD12 ' SG ' ' B' ' 113' ' ' CYS . 45.6 mm -129.52 141.99 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.129 1.371 . . . . 73.03 108.914 173.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.612 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.1 t -144.46 137.43 26.94 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.052 -1.092 . . . . 44.31 108.052 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.2 t80 -154.35 121.47 5.65 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.844 -1.169 . . . . 65.21 107.844 174.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -127.81 122.09 31.83 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.7 0.8 . . . . 75.41 109.572 176.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.477 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -115.72 87.26 17.47 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.986 -1.116 . . . . 74.54 107.986 169.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -71.39 -40.44 3.06 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.431 2.088 . . . . 72.12 111.706 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.475 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 3.4 m-20 -93.98 3.21 55.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.259 1.024 . . . . 74.3 110.244 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.477 ' HB1' ' CB ' ' B' ' 25' ' ' ALA . . . -31.07 -65.84 0.19 Allowed Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 125.825 1.65 . . . . 63.12 114.653 -178.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 37.9 Cg_exo -55.23 -39.21 92.2 Favored 'Trans proline' 0 C--N 1.398 3.138 0 C-N-CA 122.975 2.45 . . . . 73.31 113.564 -162.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -95.51 -41.15 9.09 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 114.689 -1.141 . . . . 71.12 111.848 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.401 HG21 HD13 ' B' ' 68' ' ' LEU . 4.0 p -60.4 -19.22 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.48 0 C-N-CA 123.076 0.55 . . . . 72.13 112.4 -166.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -56.27 -28.89 60.17 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.56 1.144 . . . . 74.41 113.036 175.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -63.63 -21.93 66.63 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.923 0.889 . . . . 64.33 111.67 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -81.48 90.81 6.25 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.354 0.662 . . . . 74.21 109.664 172.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -83.94 89.08 7.17 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.402 -0.817 . . . . 63.21 110.844 -174.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 30.6 p90 -165.37 170.27 14.8 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.401 1.08 . . . . 74.13 109.713 167.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -75.52 111.34 13.75 Favored Pre-proline 0 N--CA 1.48 1.039 0 N-CA-C 109.038 -0.727 . . . . 74.41 109.038 173.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.98 165.69 13.87 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.015 2.476 . . . . 71.53 114.207 -172.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -73.58 103.91 4.35 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.478 -1.237 . . . . 74.32 108.974 175.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.418 HG23 HD11 ' B' ' 126' ' ' LEU . 61.7 t -102.46 123.08 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 115.333 -0.849 . . . . 74.43 111.08 -170.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -107.54 123.26 48.19 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.41 1.084 . . . . 73.43 108.688 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.84 126.1 51.57 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.768 -0.827 . . . . 73.21 108.768 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -122.95 128.47 50.29 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.582 1.153 . . . . 73.21 108.671 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -100.09 164.04 12.15 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.84 -0.8 . . . . 71.53 108.84 172.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.616 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.0 t70 -156.03 152.06 27.63 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.293 -0.867 . . . . 71.53 109.3 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 91.3 m -107.57 115.9 30.97 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.32 -1.309 . . . . 74.2 108.893 -171.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.463 ' HB2' ' HB ' ' B' ' 59' ' ' VAL . . . -137.03 119.32 15.66 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 109.045 -0.724 . . . . 62.54 109.045 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.5 p -142.97 161.83 37.09 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.939 0.496 . . . . 65.4 110.399 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -152.22 142.64 22.58 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.583 0.753 . . . . 74.24 109.836 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -94.87 112.45 24.17 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.466 -0.568 . . . . 72.41 109.466 175.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 77.8 mt -80.69 -45.46 17.11 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.488 0.661 . . . . 72.14 109.314 175.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.38 -177.46 6.61 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.387 -1.278 . . . . 54.45 109.018 176.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.79 123.55 25.81 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.946 -1.025 . . . . 73.42 108.328 173.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 67.53 23.52 8.92 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.121 1.368 . . . . 74.25 111.26 -175.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.529 HG21 ' HG ' ' B' ' 85' ' ' SER . 92.2 t -139.51 103.49 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 107.912 -1.144 . . . . 72.35 107.912 168.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -125.96 138.12 53.74 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.833 -0.803 . . . . 71.04 108.833 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -107.9 103.5 12.76 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.459 -1.312 . . . . 73.32 107.459 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.538 HG22 ' HB2' ' B' ' 98' ' ' LEU . 95.1 t -101.06 118.87 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.65 1.18 . . . . 75.13 109.426 -173.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.564 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 15.3 t -104.34 141.22 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.315 1.046 . . . . 75.14 109.427 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 18.5 tp -118.87 112.7 20.0 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 108.676 -0.861 . . . . 64.43 108.676 172.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.616 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 20.0 ttm-85 -88.47 113.28 23.89 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.581 -0.525 . . . . 74.13 109.581 175.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.469 HG11 HD11 ' B' ' 114' ' ' ILE . 39.8 t -108.19 101.24 12.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 107.356 -1.35 . . . . 74.25 107.356 171.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 16.0 m -97.09 139.97 32.29 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.634 -0.876 . . . . 73.41 108.634 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.524 HG22 HG21 ' B' ' 114' ' ' ILE . 89.7 t -128.16 136.45 60.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 124.339 1.056 . . . . 74.04 109.295 -174.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 95.5 m -124.81 148.31 48.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.121 -1.066 . . . . 74.21 108.121 172.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.71 139.15 31.0 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.92 -0.77 . . . . 74.41 108.92 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.454 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 36.1 p -140.35 128.1 21.78 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 123.716 0.635 . . . . 70.2 110.331 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.401 HD13 HG21 ' B' ' 31' ' ' VAL . 45.0 mt -99.61 103.56 15.27 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.476 -1.305 . . . . 73.44 107.476 173.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.86 -113.96 4.01 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.202 -0.759 . . . . 74.0 111.202 -174.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -121.88 6.05 9.89 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.864 0.466 . . . . 63.22 109.815 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.475 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 4.0 pm0 -113.48 150.89 32.2 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.161 0.584 . . . . 72.15 109.892 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 45.4 m -67.97 118.73 11.55 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.245 1.018 . . . . 73.23 111.095 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.454 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -73.14 -63.92 1.08 Allowed 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.622 -0.881 . . . . 74.4 108.622 173.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -147.77 167.76 23.86 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 114.726 -1.124 . . . . 74.21 110.958 175.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.2 mt -129.13 141.34 51.21 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.278 -1.749 . . . . 74.32 106.278 173.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.0 t -147.44 158.88 44.16 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.346 -0.983 . . . . 72.22 108.346 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.612 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 42.8 tt0 -165.95 133.27 2.79 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.577 -0.897 . . . . 73.2 108.577 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.436 HG11 ' HA ' ' B' ' 110' ' ' ALA . 91.4 t -128.05 142.15 44.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.131 -1.063 . . . . 70.32 108.131 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -124.51 87.87 2.8 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.568 -1.271 . . . . 73.22 107.568 174.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -81.09 102.13 10.05 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.068 -0.969 . . . . 71.21 108.666 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.43 171.71 38.59 Favored Glycine 0 C--O 1.245 0.83 0 CA-C-N 116.017 -0.538 . . . . 62.41 111.935 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.46 132.12 2.31 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 111.083 -0.807 . . . . 72.01 111.083 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 50.2 mt -84.17 125.01 40.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.491 -1.299 . . . . 70.12 107.491 171.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -130.61 129.09 42.27 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.39 -0.966 . . . . 73.32 108.39 174.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.529 ' HG ' HG21 ' B' ' 55' ' ' VAL . 69.2 m -93.52 88.75 6.02 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.522 0.729 . . . . 63.12 109.34 170.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 37.2 pt -103.34 146.28 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 N-CA-C 107.73 -1.211 . . . . 71.24 107.73 176.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.11 164.62 34.17 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 112.722 0.638 . . . . 64.04 112.722 -169.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.29 -71.35 1.19 Allowed Glycine 0 C--N 1.348 1.246 0 CA-C-N 114.822 -1.081 . . . . 72.5 114.579 167.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.614 ' HB ' ' HB3' ' B' ' 9' ' ' MET . 0.4 OUTLIER -89.39 171.7 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 123.876 0.87 . . . . 72.21 111.602 -166.17 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -150.82 158.53 44.26 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.059 0.544 . . . . 62.0 111.865 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.53 -135.81 12.77 Favored Glycine 0 C--N 1.355 1.617 0 C-N-CA 124.789 1.185 . . . . 74.22 112.875 172.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 11.2 m -69.15 -26.59 64.95 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.57 0.7 . . . . 71.34 110.389 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.436 ' NE2' HG12 ' B' ' 89' ' ' ILE . 23.1 mt-30 -62.47 -44.07 97.29 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.539 -1.209 . . . . 75.44 111.315 177.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.482 ' SD ' HD22 ' B' ' 98' ' ' LEU . 0.0 OUTLIER -80.11 -26.88 39.29 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 110.363 -0.236 . . . . 74.52 110.363 178.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.09 -13.98 60.98 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.554 0.742 . . . . 64.13 111.55 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . 0.432 ' HE2' ' HB3' ' B' ' 134' ' ' ASP . 52.5 t-80 -77.38 -34.67 54.9 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.806 0.443 . . . . 70.55 110.672 169.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.626 ' HG ' ' HD2' ' B' ' 11' ' ' PHE . 49.2 t -76.33 -67.58 0.67 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 119.161 -0.447 . . . . 74.32 111.356 -175.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.538 ' HB2' HG22 ' B' ' 58' ' ' VAL . 2.3 pt? -91.88 -12.37 33.78 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 118.255 0.48 . . . . 73.43 111.809 -175.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.76 -24.24 12.34 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-O 119.837 -0.424 . . . . 71.24 113.489 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.2 -55.83 2.03 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.994 0.518 . . . . 71.31 111.197 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.481 ' O ' HG13 ' B' ' 105' ' ' ILE . 56.5 t80 -83.39 -37.06 23.79 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.558 0.577 . . . . 74.35 112.558 -169.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.502 ' HG ' ' HE2' ' B' ' 11' ' ' PHE . 86.9 m -64.47 -43.58 72.06 Favored Pre-proline 0 N--CA 1.482 1.149 0 CA-C-O 118.338 -0.839 . . . . 74.22 110.364 177.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.49 -41.83 43.2 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 122.531 2.154 . . . . 53.34 113.622 163.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -66.27 -33.8 76.55 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 124.119 0.968 . . . . 74.35 111.187 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.652 HG21 HD11 ' B' ' 13' ' ' ILE . 73.5 mt -71.91 -46.1 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.682 0.793 . . . . 73.51 110.082 177.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 93.6 mt -77.39 -19.53 56.05 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 114.727 -1.124 . . . . 75.23 111.173 -175.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -59.91 -52.05 76.36 Favored Pre-proline 0 N--CA 1.483 1.205 0 CA-C-O 117.585 -1.198 . . . . 73.21 113.41 -173.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.02 -27.41 42.51 Favored 'Trans proline' 0 C--N 1.385 2.489 0 CA-C-N 121.546 1.588 . . . . 73.15 112.516 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -70.62 -43.17 69.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.856 0.463 . . . . 73.23 110.302 175.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.436 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -64.73 -43.66 92.66 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.553 -0.749 . . . . 75.31 110.327 176.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -60.98 -49.44 77.42 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.717 1.207 . . . . 75.13 110.506 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -63.17 -32.94 74.45 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 123.903 0.752 . . . . 74.24 109.427 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.736 ' SG ' HD12 ' B' ' 21' ' ' ILE . 17.1 t -72.79 -41.77 64.64 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 123.406 0.442 . . . . 74.22 112.128 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.524 HG21 HG22 ' B' ' 64' ' ' VAL . 84.7 mt -60.6 -57.0 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 108.792 -0.818 . . . . 72.25 108.792 176.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.2 m -61.43 -25.79 67.44 Favored 'General case' 0 CA--C 1.554 1.111 0 O-C-N 124.776 1.297 . . . . 75.41 111.053 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 43.0 t -65.95 -51.36 59.26 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 123.186 0.594 . . . . 51.43 109.641 170.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.487 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.1 mmt -68.16 -30.17 69.23 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.188 0.595 . . . . 73.32 111.613 -177.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.444 HG23 ' O ' ' B' ' 114' ' ' ILE . 95.5 t -66.79 -44.3 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.31 1.044 . . . . 74.12 109.08 173.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.0 t -69.07 -29.38 67.48 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.924 -1.035 . . . . 73.2 111.48 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' B' ' 116' ' ' SER . 89.2 mtt-85 -74.85 -37.44 62.23 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.517 0.727 . . . . 71.43 109.637 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.26 -5.74 77.79 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 123.84 0.713 . . . . 74.32 112.236 170.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.522 HG23 ' HB3' ' A' ' 17' ' ' TYR . 33.8 p 63.55 25.96 14.57 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.608 1.963 . . . . 72.51 112.953 174.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -81.09 159.78 67.34 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 124.511 1.124 . . . . 75.32 110.495 174.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.58 165.09 6.49 Favored 'Trans proline' 0 C--N 1.39 2.714 0 C-N-CA 123.5 2.8 . . . . 75.5 114.273 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.4 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 65.5 tp60 -61.07 136.71 58.16 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.388 -1.278 . . . . 65.23 112.135 -173.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.418 HD11 HG23 ' B' ' 40' ' ' VAL . 43.0 tp -136.25 121.78 19.52 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.887 0.875 . . . . 73.34 109.443 -178.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -132.83 129.07 38.02 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.873 0.869 . . . . 62.34 109.098 175.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.21 149.9 30.3 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.576 0.75 . . . . 72.21 110.261 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.04 129.08 86.87 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 123.429 0.692 . . . . 72.35 111.919 -172.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.86 98.23 0.36 Allowed 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.274 2.649 . . . . 72.04 113.216 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 21.1 m -109.83 135.96 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 109.018 -0.734 . . . . 75.24 109.018 171.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -90.55 100.98 13.72 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.006 -1.109 . . . . 75.24 108.006 177.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -60.78 -43.04 98.58 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.79 0.836 . . . . 75.03 110.816 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . 0.432 ' HB3' ' HE2' ' B' ' 96' ' ' HIS . 6.9 m-20 . . . . . 0 CA--C 1.539 0.524 0 CA-C-N 114.851 -1.068 . . . . 64.12 111.339 -176.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.696 ' HD2' ' HG3' ' A' ' 130' ' ' PRO . 71.0 t80 . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 108.674 -0.861 . . . . 72.44 108.674 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . 0.552 ' HB3' ' HB2' ' C' ' 85' ' ' SER . 38.9 tt0 -142.84 144.21 32.42 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.541 0.736 . . . . 74.44 109.403 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mt -92.72 131.17 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 109.253 -0.647 . . . . 71.24 109.253 173.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.428 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.4 mm-40 -98.96 -43.21 6.79 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.954 0.902 . . . . 74.15 109.84 176.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -172.54 137.18 0.81 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.628 -0.879 . . . . 74.13 108.628 -168.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 85.5 mt -129.64 138.17 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.236 -1.024 . . . . 75.12 108.236 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -170.4 166.64 8.5 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.672 0.749 . . . . 73.44 111.43 -173.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -84.77 109.81 18.34 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.922 -1.035 . . . . 74.24 109.045 174.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -64.33 -44.32 91.88 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 121.994 0.902 . . . . 72.25 108.844 174.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.547 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.0 t70 -147.97 149.89 33.0 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 113.392 -1.731 . . . . 74.15 109.254 -175.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 79.5 mt -140.3 145.43 26.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 125.798 1.639 . . . . 72.53 106.725 177.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.5 t -155.72 150.21 25.97 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.609 0.719 . . . . 74.11 110.057 176.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -148.49 147.94 29.68 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.323 -1.362 . . . . 63.52 107.323 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -144.08 133.52 23.34 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.562 1.145 . . . . 74.52 108.804 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.01 78.68 4.27 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 107.117 -1.438 . . . . 73.4 107.117 171.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.44 -11.2 22.55 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.948 2.432 . . . . 73.33 112.333 -174.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -126.08 26.39 6.53 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.09 1.356 . . . . 72.41 109.791 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.83 -58.5 5.34 Favored Pre-proline 0 CA--C 1.57 1.724 0 CA-C-O 117.831 -1.08 . . . . 72.23 113.574 -172.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -59.95 -38.69 77.13 Favored 'Trans proline' 0 C--N 1.401 3.314 0 C-N-CA 122.162 1.908 . . . . 74.34 112.255 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -70.72 -39.79 73.17 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.331 -0.85 . . . . 71.34 111.831 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.58 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.5 p -78.78 -17.29 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.428 0 N-CA-C 112.224 0.453 . . . . 72.0 112.224 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -66.2 -37.21 85.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.194 -0.316 . . . . 74.53 111.538 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -85.19 13.49 6.29 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.493 0.717 . . . . 74.42 111.709 -176.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.62 169.29 9.61 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.545 1.138 . . . . 72.45 110.308 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -74.7 122.94 24.02 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.402 -0.592 . . . . 71.42 109.402 171.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -84.1 92.26 7.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.511 0.724 . . . . 73.33 110.49 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -146.95 80.96 9.26 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 106.928 -1.508 . . . . 71.54 106.928 168.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -88.22 155.35 6.86 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.597 2.198 . . . . 72.22 112.843 -176.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -86.02 99.49 11.5 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 106.548 -1.649 . . . . 71.12 106.548 166.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 43.9 t -74.77 96.55 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 107.826 -1.175 . . . . 75.45 107.826 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.582 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 88.4 mttt -93.81 100.74 12.88 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.209 -1.404 . . . . 74.0 107.209 178.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 pp -88.71 149.7 23.35 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.187 0.518 . . . . 73.01 109.794 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.627 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 26.1 t70 -144.36 144.84 31.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.306 -0.861 . . . . 51.23 108.964 -176.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.66 142.39 41.15 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.387 0.675 . . . . 74.55 109.782 174.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 25.8 t70 -137.66 146.54 43.98 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.363 1.065 . . . . 74.21 108.605 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 47.3 p -115.53 120.52 39.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.94 0.496 . . . . 75.15 111.283 -170.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.31 160.12 35.9 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.183 0.993 . . . . 74.11 109.447 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 35.4 p -164.55 166.46 20.3 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.908 0.385 . . . . 72.42 112.006 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 83.9 p -151.92 152.81 33.02 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.346 1.058 . . . . 75.22 108.993 171.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -102.22 124.08 47.18 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.498 -0.927 . . . . 74.22 108.498 172.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.434 HD13 HD13 ' C' ' 83' ' ' ILE . 51.2 mt -101.97 -32.27 10.27 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.251 0.62 . . . . 71.31 111.12 -174.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.52 -166.04 1.28 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.351 0.66 . . . . 74.21 110.686 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -63.36 115.62 4.76 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 124.005 0.816 . . . . 64.03 109.42 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 67.49 -5.25 0.79 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 125.017 1.327 . . . . 75.04 113.113 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 67.4 t -92.64 106.7 18.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.54 -1.281 . . . . 75.44 107.54 -177.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -124.64 128.65 49.19 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.521 -1.289 . . . . 74.24 107.521 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -81.36 119.31 23.52 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.001 -1.0 . . . . 72.34 108.547 172.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 65.5 t -96.45 120.44 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.339 -1.356 . . . . 72.42 107.339 171.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 55.7 t -115.09 132.76 63.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 108.671 -0.863 . . . . 71.23 108.671 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 29.9 tp -124.18 117.2 24.07 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.304 -0.999 . . . . 74.23 108.304 170.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 33.3 ttm180 -81.74 135.76 35.48 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.098 0.959 . . . . 72.2 108.955 172.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.509 ' HB ' HD11 ' C' ' 114' ' ' ILE . 14.9 t -122.89 130.06 74.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.258 -1.386 . . . . 63.21 107.258 169.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.627 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 18.0 m -129.65 116.62 19.11 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.534 -0.913 . . . . 74.24 108.534 -177.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.67 HG23 HG21 ' C' ' 114' ' ' ILE . 59.5 t -108.53 113.3 43.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 124.202 1.001 . . . . 71.2 108.978 -173.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 2.5 m -101.62 131.1 48.01 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.936 -0.764 . . . . 73.3 108.936 175.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.2 109.62 16.06 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.434 -1.691 . . . . 64.43 106.434 174.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 24.7 m -131.47 125.46 32.55 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 117.791 0.269 . . . . 71.42 110.358 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.7 mt -85.76 49.59 1.8 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.497 1.119 . . . . 73.42 108.96 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.62 -114.64 4.96 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 110.096 -1.202 . . . . 74.41 110.096 -169.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -91.97 -24.08 19.36 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.36 0.664 . . . . 70.55 110.17 172.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -67.72 101.91 1.12 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.19 -0.67 . . . . 65.13 109.19 176.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 90.3 m -70.78 122.62 20.2 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.617 -0.512 . . . . 73.04 109.617 175.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.58 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.47 -56.92 4.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.291 -1.003 . . . . 71.3 108.291 171.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -159.48 163.32 35.41 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.29 -0.868 . . . . 65.43 111.352 177.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -127.57 131.68 49.96 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 105.966 -1.864 . . . . 75.14 105.966 164.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.442 ' SG ' HG22 ' C' ' 114' ' ' ILE . 42.6 t -137.73 111.19 8.02 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.111 -0.7 . . . . 72.23 109.111 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . 0.406 ' HB2' HG22 ' C' ' 63' ' ' THR . 33.0 tt0 -119.51 116.59 26.39 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.31 0.644 . . . . 74.4 109.841 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -117.11 132.59 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 108.531 -0.914 . . . . 75.23 108.531 172.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.547 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 44.3 mt-30 -105.24 100.46 10.05 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.19 -1.041 . . . . 75.1 108.19 172.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -87.71 121.33 30.0 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.609 -0.723 . . . . 75.31 109.584 -177.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.88 146.92 18.87 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 112.042 -0.423 . . . . 65.42 112.042 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.476 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -143.12 124.58 2.36 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.435 -1.066 . . . . 75.33 110.435 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.511 HD11 ' HB3' ' D' ' 29' ' ' PRO . 16.6 mm -81.04 123.55 37.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.984 -1.117 . . . . 62.14 107.984 176.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -132.47 135.56 46.11 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.738 0.415 . . . . 75.33 110.646 -174.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 85' ' ' SER . . . . . 0.552 ' HB2' ' HB3' ' C' ' 12' ' ' GLN . 43.3 m -83.96 99.91 10.69 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 107.667 -1.235 . . . . 62.15 107.667 167.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 3.6 tt -120.0 117.76 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.519 1.128 . . . . 74.54 110.592 -172.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.24 169.89 16.99 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.458 1.103 . . . . 75.35 109.715 177.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 122.63 -60.5 0.57 Allowed Glycine 0 N--CA 1.472 1.094 0 N-CA-C 112.5 -0.24 . . . . 71.33 112.5 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 23.5 pt -96.4 173.44 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.113 0.565 . . . . 74.11 111.015 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.486 ' HA ' ' HE2' ' C' ' 94' ' ' MET . 12.0 tp10 -153.47 160.39 42.54 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.833 0.853 . . . . 73.34 110.539 -172.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.04 -145.87 30.16 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.762 -0.654 . . . . 62.14 111.646 175.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 46.6 p -63.88 -17.38 63.12 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.082 0.553 . . . . 74.13 112.011 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -67.3 -51.01 57.83 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 123.403 0.681 . . . . 75.32 110.458 173.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.502 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 7.0 ptp -70.24 -37.14 74.9 Favored 'General case' 0 C--N 1.362 1.14 0 N-CA-C 109.839 -0.43 . . . . 75.42 109.839 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.67 -35.88 66.48 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.525 0.73 . . . . 75.14 110.988 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -71.35 -39.64 71.18 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.397 1.079 . . . . 74.21 111.518 173.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -71.28 -62.0 1.56 Allowed 'General case' 0 N--CA 1.481 1.106 0 O-C-N 122.094 -0.379 . . . . 62.4 111.613 -175.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.507 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 1.2 pp -71.14 -21.94 62.12 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.99 0.516 . . . . 74.15 112.34 -178.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.44 4.97 62.36 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 119.594 -0.559 . . . . 52.25 113.466 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.98 -60.14 0.2 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 117.917 0.859 . . . . 75.01 112.348 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -66.7 -51.56 54.6 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.672 0.789 . . . . 75.21 112.087 -175.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.507 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 19.9 m -63.87 -44.77 80.14 Favored Pre-proline 0 CA--C 1.57 1.719 0 C-N-CA 123.738 0.815 . . . . 72.32 112.805 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -68.1 -22.82 40.57 Favored 'Trans proline' 0 C--N 1.397 3.08 0 C-N-CA 122.298 1.999 . . . . 74.12 113.347 171.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -71.16 -32.12 68.53 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 122.974 0.51 . . . . 75.11 110.673 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.419 HG22 ' NH1' ' A' ' 111' ' ' ARG . 37.7 mm -59.33 -42.01 85.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.725 0.81 . . . . 73.34 109.884 171.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.476 HD21 ' HA3' ' C' ' 82' ' ' GLY . 93.8 mt -80.22 -21.22 43.09 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.732 -1.122 . . . . 74.14 112.595 -172.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -53.79 -50.84 81.44 Favored Pre-proline 0 CA--C 1.567 1.618 0 CA-C-O 117.555 -1.212 . . . . 74.4 113.377 -175.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.77 -33.19 96.52 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 122.145 1.897 . . . . 74.22 114.134 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -73.07 -44.46 60.57 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.077 0.551 . . . . 74.54 110.03 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.22 -40.01 88.63 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.242 -0.89 . . . . 64.3 110.261 173.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -59.09 -53.8 54.25 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.962 1.305 . . . . 75.43 110.765 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.79 -36.79 78.72 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 123.358 0.411 . . . . 72.43 109.903 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 20.3 t -65.73 -32.37 73.88 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.978 0.511 . . . . 74.32 111.495 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.67 HG21 HG23 ' C' ' 64' ' ' VAL . 81.5 mt -74.1 -55.8 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.187 0.595 . . . . 75.22 109.859 173.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.8 m -61.37 -27.44 68.52 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.452 0.701 . . . . 54.21 110.964 -174.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.7 t -65.65 -50.17 65.96 Favored 'General case' 0 C--O 1.214 -0.77 0 C-N-CA 123.782 0.833 . . . . 53.01 109.034 171.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.512 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.7 -33.06 74.33 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.218 1.007 . . . . 73.44 112.364 178.286 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 66.4 t -67.85 -41.48 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 123.493 0.717 . . . . 73.53 109.066 174.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 39.9 t -74.07 -23.46 59.37 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.528 1.131 . . . . 75.43 111.986 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -78.12 -39.6 40.74 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.719 -0.845 . . . . 73.45 108.719 176.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.38 -0.65 62.7 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.549 -0.751 . . . . 71.24 112.347 167.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 31.4 p 62.24 29.73 17.46 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.695 1.998 . . . . 74.23 113.653 169.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -81.84 156.29 70.12 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 123.627 0.771 . . . . 72.33 108.947 169.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 25.3 Cg_endo -62.12 168.07 9.78 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.54 2.16 . . . . 62.54 112.485 173.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -59.79 110.47 1.17 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.279 -0.873 . . . . 73.12 112.17 -173.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.41 86.38 2.28 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 105.893 -1.891 . . . . 71.45 105.893 171.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -107.93 108.42 19.56 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.565 -0.902 . . . . 71.11 108.565 -173.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.41 HD23 ' N ' ' C' ' 129' ' ' ALA . 3.5 tt -73.03 144.75 47.03 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.485 0.714 . . . . 74.42 109.796 -174.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . 0.41 ' N ' HD23 ' C' ' 128' ' ' LEU . . . -60.47 157.92 33.01 Favored Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 124.706 1.202 . . . . 73.32 112.417 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.425 ' HG3' HD13 ' A' ' 16' ' ' ILE . 43.6 Cg_exo -57.65 110.53 0.63 Allowed 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 122.735 2.29 . . . . 73.02 112.285 173.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 20.4 t -98.73 108.41 22.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.769 -0.826 . . . . 75.35 108.769 177.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -107.13 90.8 3.41 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 107.836 -1.172 . . . . 74.34 107.836 173.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -55.55 -41.39 73.16 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.044 0.84 . . . . 75.43 110.578 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 t70 . . . . . 0 C--O 1.242 0.67 0 CA-C-N 114.328 -1.305 . . . . 73.44 111.458 -173.179 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 57.0 m . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 109.449 -0.574 . . . . 70.22 109.449 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -157.73 96.72 1.52 Allowed 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.721 -1.214 . . . . 75.13 107.721 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -113.86 115.7 28.15 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.477 -0.935 . . . . 71.54 108.477 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.504 HG21 HD11 ' D' ' 16' ' ' ILE . 46.8 mt -71.32 123.06 24.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.913 -0.773 . . . . 65.32 108.913 177.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.43 HE22 HG12 ' D' ' 55' ' ' VAL . 51.7 mt-30 -93.41 -34.05 13.6 Favored 'General case' 0 C--O 1.246 0.881 0 O-C-N 123.59 0.557 . . . . 74.25 110.664 178.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -173.55 144.52 1.13 Allowed 'General case' 0 C--N 1.364 1.224 0 N-CA-C 112.303 0.483 . . . . 75.22 112.303 -170.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.504 HD11 HG21 ' D' ' 13' ' ' ILE . 3.6 mp -123.34 136.92 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 107.243 -1.391 . . . . 73.2 107.243 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.407 ' HE1' HG13 ' D' ' 83' ' ' ILE . 24.6 p90 -164.61 152.31 11.86 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.64 0.733 . . . . 73.42 110.649 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 56.7 p -84.2 117.47 23.52 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.532 -1.213 . . . . 73.14 108.525 174.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -85.53 -18.02 34.66 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.785 0.326 . . . . 73.2 110.21 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -166.24 140.49 4.33 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.429 1.092 . . . . 70.24 108.283 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.512 HG23 ' HE1' ' C' ' 117' ' ' MET . 77.5 mt -137.18 150.14 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 108.12 -1.067 . . . . 75.54 108.12 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.9 t -156.8 103.43 2.07 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.299 1.04 . . . . 75.23 109.298 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.521 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 80.8 t80 -109.09 122.1 46.56 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 106.366 -1.716 . . . . 74.54 106.366 171.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -130.48 110.47 11.48 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.502 -0.555 . . . . 73.35 109.502 -172.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.4 89.45 4.89 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 108.234 -1.025 . . . . 63.42 108.234 173.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.22 -38.15 3.97 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.555 2.17 . . . . 73.5 112.289 -172.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.458 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 58.2 m-20 -101.7 11.24 39.15 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.899 0.88 . . . . 72.53 110.072 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -20.63 -68.03 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 116.151 1.908 . . . . 73.05 116.151 -168.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.511 ' HB3' HD11 ' C' ' 83' ' ' ILE . 43.6 Cg_endo -79.94 -18.24 10.33 Favored 'Trans proline' 0 C--N 1.379 2.167 0 CA-C-N 122.844 2.052 . . . . 74.24 114.029 -173.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.433 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 7.7 t-160 -76.68 -39.79 50.95 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.511 1.124 . . . . 64.31 109.576 176.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.706 HG22 HD11 ' D' ' 68' ' ' LEU . 11.3 p -82.79 -18.01 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 CA-C-N 115.799 -0.637 . . . . 74.32 111.296 -172.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.402 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 21.2 m-85 -65.86 -22.51 66.53 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 112.094 0.405 . . . . 75.44 112.094 177.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.433 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 58.8 mt-30 -60.31 -20.23 58.42 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.1 0.96 . . . . 73.22 111.26 177.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.57 ' HZ3' ' HG2' ' D' ' 71' ' ' GLU . 93.1 mttt -95.92 102.14 13.9 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.659 1.183 . . . . 75.13 109.816 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -101.16 87.23 3.2 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.759 0.424 . . . . 74.23 110.151 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -158.66 179.79 8.78 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.176 0.991 . . . . 74.4 108.599 167.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -67.19 112.34 9.69 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 123.622 0.769 . . . . 74.42 110.441 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -56.39 141.62 89.26 Favored 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 122.736 2.291 . . . . 62.35 112.016 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 42.6 mt-10 -57.84 118.41 5.3 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.59 1.181 . . . . 73.13 111.291 -177.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 25.6 t -93.58 107.18 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 107.568 -1.271 . . . . 73.41 107.568 -172.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' D' ' 39' ' ' GLU . 31.1 mmtp -125.98 118.92 26.4 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.555 -1.276 . . . . 75.04 107.555 -177.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.91 115.55 27.62 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.203 0.601 . . . . 74.22 109.725 -174.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.599 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.3 m-20 -107.85 119.25 38.93 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.425 1.09 . . . . 75.43 108.066 172.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.58 152.88 27.08 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.754 0.421 . . . . 75.22 110.537 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -157.01 152.82 27.05 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.881 -1.155 . . . . 73.1 107.881 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 57.9 p -118.78 149.21 41.88 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.871 0.468 . . . . 71.23 111.611 -170.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.401 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -152.54 164.03 38.42 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.426 1.09 . . . . 74.21 109.038 172.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 50.8 p -176.95 177.5 1.28 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.702 0.801 . . . . 75.25 110.03 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 50.8 p -173.02 143.83 1.2 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.164 0.986 . . . . 62.41 109.889 169.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -76.3 116.71 17.25 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.794 -1.187 . . . . 75.42 107.794 167.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' D' ' 57' ' ' GLU . 61.3 mt -88.94 -26.66 21.42 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.997 0.519 . . . . 72.43 110.054 -175.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -174.06 -172.98 0.76 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.692 1.197 . . . . 72.43 109.777 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -68.88 126.75 30.74 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.477 -0.783 . . . . 71.43 109.131 174.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 69.08 -2.36 1.82 Allowed 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 124.956 1.302 . . . . 73.44 113.059 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.43 HG12 HE22 ' D' ' 14' ' ' GLN . 94.6 t -110.47 124.55 67.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.029 -1.1 . . . . 74.52 108.029 176.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.62 ' HB3' HD11 ' D' ' 86' ' ' ILE . 66.4 t80 -146.57 137.43 24.1 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.371 0.605 . . . . 73.33 110.142 -177.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.5 ' HB2' HD11 ' D' ' 51' ' ' LEU . 21.9 tt0 -104.13 137.61 41.83 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.964 1.306 . . . . 71.13 110.029 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.88 126.19 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 108.058 -1.09 . . . . 63.24 108.058 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.434 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 25.9 t -124.12 131.82 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.448 0.699 . . . . 74.31 109.388 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.415 HD22 HD12 ' D' ' 106' ' ' LEU . 3.9 mm? -123.81 122.14 37.24 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.518 -0.549 . . . . 73.21 109.518 173.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' D' ' 79' ' ' GLN . 12.5 ttm180 -83.54 106.39 15.24 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.387 -0.968 . . . . 74.34 108.387 170.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -92.02 125.95 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 107.601 -1.259 . . . . 74.41 107.601 169.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 22.1 m -123.83 133.34 53.81 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.041 -0.725 . . . . 72.52 109.041 177.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 73.1 t -114.19 101.36 12.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 107.85 -1.167 . . . . 74.4 107.85 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 78.6 m -90.58 92.43 8.85 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.568 -1.271 . . . . 72.31 107.568 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.572 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -100.98 135.93 41.64 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 114.831 -1.077 . . . . 75.24 109.964 -175.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.408 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 70.1 m -143.21 133.6 24.74 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.005 0.522 . . . . 73.13 110.699 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.706 HD11 HG22 ' D' ' 31' ' ' VAL . 77.2 mt -101.0 110.04 22.02 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.867 -1.16 . . . . 75.01 107.867 172.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.19 -114.02 3.75 Favored Glycine 0 C--N 1.344 0.981 0 O-C-N 123.237 0.336 . . . . 53.54 113.038 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.67 4.46 12.32 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.607 0.763 . . . . 74.12 110.576 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.57 ' HG2' ' HZ3' ' D' ' 34' ' ' LYS . 12.7 pt-20 -120.68 156.11 32.44 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.567 0.747 . . . . 75.43 109.229 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 43.8 m -70.26 135.32 48.86 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 123.676 0.61 . . . . 61.3 110.545 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.476 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -85.91 -65.53 1.0 Allowed 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.062 -1.459 . . . . 65.11 107.062 172.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -157.43 148.57 21.63 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.606 -1.179 . . . . 75.1 110.342 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 60.1 mt -111.86 107.77 16.92 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 105.908 -1.886 . . . . 73.04 105.908 171.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.666 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 46.3 t -116.38 105.53 12.62 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.305 -0.998 . . . . 73.3 108.305 -171.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . 0.465 ' HB2' HG23 ' D' ' 63' ' ' THR . 41.8 tt0 -130.12 131.57 45.76 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.137 0.975 . . . . 64.13 108.994 -165.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.4 t -140.0 119.21 12.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 108.359 -0.978 . . . . 75.34 108.359 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' D' ' 61' ' ' ARG . 71.1 mt-30 -86.93 80.89 8.3 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 107.365 -1.346 . . . . 75.4 107.365 171.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -81.76 106.55 13.79 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 113.527 -1.669 . . . . 72.44 108.901 -172.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -110.36 158.46 14.42 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 115.844 -0.616 . . . . 74.11 112.442 -176.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.93 132.18 3.9 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.828 -0.509 . . . . 74.35 111.828 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.407 HG13 ' HE1' ' D' ' 17' ' ' TYR . 74.5 mt -89.4 130.8 38.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.229 -1.026 . . . . 74.53 108.229 174.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -133.36 166.84 21.58 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 123.512 0.508 . . . . 73.32 110.466 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.0 m -114.69 107.06 14.96 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.036 0.934 . . . . 75.44 108.526 175.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.62 HD11 ' HB3' ' D' ' 56' ' ' TYR . 4.2 mp -109.23 118.13 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 C-N-CA 123.402 0.681 . . . . 74.14 109.223 -176.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.7 139.65 16.33 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.707 0.803 . . . . 75.24 110.326 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.45 21.92 49.5 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-O 120.221 -0.21 . . . . 70.24 113.099 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.411 HG23 ' N ' ' D' ' 90' ' ' GLU . 3.6 mp -116.34 146.72 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.681 0.792 . . . . 73.23 109.035 176.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.411 ' N ' HG23 ' D' ' 89' ' ' ILE . 50.9 mt-10 -149.69 153.85 37.62 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.411 1.084 . . . . 73.44 110.411 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' D' ' 94' ' ' MET . . . 76.98 -133.81 13.97 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 114.835 0.694 . . . . 55.41 114.835 167.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.8 m -85.68 -11.66 53.19 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.259 1.024 . . . . 75.31 110.955 -178.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -57.11 -40.32 76.8 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.314 1.046 . . . . 74.24 110.618 176.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.413 ' HG2' ' O ' ' D' ' 91' ' ' GLY . 23.5 ptt? -74.45 -27.07 60.43 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.572 -0.74 . . . . 74.13 111.72 177.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.11 -34.88 77.22 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.523 0.329 . . . . 75.13 110.608 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -79.7 -32.0 41.3 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.988 -0.551 . . . . 64.42 110.621 174.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.7 t -63.1 -51.12 67.84 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.176 0.512 . . . . 73.44 110.705 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 57.8 mt -82.03 -28.52 32.45 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.096 -0.956 . . . . 71.11 111.252 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.6 11.36 72.29 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-O 119.61 -0.55 . . . . 53.45 113.519 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.82 -65.3 0.11 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 117.728 0.764 . . . . 60.02 111.84 -177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -73.82 -42.26 61.15 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 112.664 0.616 . . . . 74.2 112.664 -168.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.433 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 62.3 m -64.13 -46.48 79.92 Favored Pre-proline 0 CA--C 1.566 1.562 0 CA-C-O 118.55 -0.738 . . . . 74.41 111.904 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.433 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 31.3 Cg_exo -62.42 -28.64 78.34 Favored 'Trans proline' 0 C--N 1.4 3.263 0 C-N-CA 122.423 2.082 . . . . 75.11 113.078 169.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -69.33 -30.3 68.31 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.579 0.751 . . . . 74.54 111.063 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.5 mm -69.12 -36.47 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 121.42 0.628 . . . . 73.12 109.84 172.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.415 HD12 HD22 ' D' ' 60' ' ' LEU . 68.6 mt -86.16 -10.61 54.46 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.27 -0.877 . . . . 74.43 111.819 -176.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -66.0 -49.89 55.0 Favored Pre-proline 0 CA--C 1.565 1.558 0 CA-C-O 117.935 -1.031 . . . . 75.32 112.667 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -60.61 -32.13 93.0 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 122.272 1.981 . . . . 70.53 112.932 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -81.02 -35.24 32.14 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.382 -0.826 . . . . 73.01 112.206 -176.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.17 -52.0 61.09 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.003 -1.11 . . . . 64.21 108.003 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -49.28 -50.01 40.99 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.923 1.389 . . . . 72.13 111.84 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -67.05 -50.38 62.1 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.718 0.636 . . . . 65.33 111.254 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -58.19 -44.17 87.95 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 124.178 0.924 . . . . 71.22 110.611 -177.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.526 ' HA ' ' SG ' ' D' ' 76' ' ' CYS . 91.0 mt -58.53 -63.06 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 124.463 1.105 . . . . 74.31 110.862 173.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 92.0 m -55.04 -38.33 67.84 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.225 1.01 . . . . 71.43 112.287 -173.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 42.0 t -67.89 -42.81 80.63 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.409 -0.814 . . . . 72.1 110.172 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.666 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 73.2 mtm -69.11 -29.9 68.07 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.67 0.388 . . . . 75.24 111.645 177.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.426 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.4 t -62.45 -50.04 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 O-C-N 123.797 0.686 . . . . 74.13 109.457 174.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 81.9 p -71.12 -30.35 66.39 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.942 -0.572 . . . . 73.12 110.855 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 71.8 mtt-85 -70.16 -32.19 70.04 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.369 0.668 . . . . 73.32 109.961 174.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.84 10.72 71.42 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.825 -0.625 . . . . 60.02 112.502 174.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 45.5 p 56.12 30.8 17.03 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 126.444 1.898 . . . . 75.11 114.144 175.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -93.47 159.44 35.07 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 123.813 0.845 . . . . 62.31 110.188 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -51.75 125.03 15.81 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.502 2.801 . . . . 74.22 113.501 171.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -57.59 136.2 56.75 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.844 1.258 . . . . 74.33 111.664 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 59.0 tp -128.53 97.38 4.69 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.454 0.702 . . . . 73.03 109.573 -175.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -100.57 110.07 22.2 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.568 0.747 . . . . 74.42 110.058 -176.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 89.1 mt -71.0 115.24 9.9 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.919 0.488 . . . . 73.04 110.264 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.31 157.28 88.33 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 122.967 0.507 . . . . 64.14 110.568 176.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -51.0 110.06 0.37 Allowed 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.419 2.746 . . . . 74.23 112.959 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 C--O 1.244 0.809 0 N-CA-C 108.639 -0.874 . . . . 75.14 108.639 172.128 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.591 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 19.4 t80 . . . . . 0 C--O 1.235 0.335 0 N-CA-C 108.678 -0.86 . . . . 75.15 108.678 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.7 tp60 -138.92 127.61 23.35 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.329 -0.989 . . . . 72.45 108.329 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.684 HG12 ' HD2' ' A' ' 84' ' ' PHE . 42.6 mt -95.06 112.97 28.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.639 -0.874 . . . . 74.22 108.639 172.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -86.09 -24.33 26.32 Favored 'General case' 0 C--O 1.243 0.722 0 O-C-N 123.386 0.429 . . . . 74.32 111.064 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -173.42 146.42 1.37 Allowed 'General case' 0 N--CA 1.48 1.068 0 O-C-N 123.213 0.321 . . . . 73.05 110.373 -173.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.534 HD13 ' HG3' ' C' ' 130' ' ' PRO . 80.9 mt -138.47 134.9 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 124.021 0.929 . . . . 75.21 108.634 171.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.436 ' HB3' HG21 ' B' ' 122' ' ' THR . 27.6 p90 -167.98 176.19 6.3 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 124.42 1.075 . . . . 73.24 111.58 -168.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.6 p -99.64 120.6 39.95 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.433 -0.951 . . . . 74.43 108.433 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.44 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 43.9 mtpt -87.64 -27.4 22.5 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.069 -0.345 . . . . 75.44 110.069 174.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.629 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.7 t70 -149.14 139.59 22.45 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.649 -0.705 . . . . 74.15 109.989 177.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.4 mt -136.62 146.12 29.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 C-N-CA 125.3 1.44 . . . . 74.45 107.242 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -153.73 136.51 15.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 123.495 0.497 . . . . 65.33 110.064 170.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.579 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 86.3 t80 -133.47 143.45 48.83 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.416 -1.328 . . . . 72.35 107.416 171.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -140.38 144.32 36.17 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 108.949 -0.76 . . . . 63.44 108.949 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.61 74.03 11.49 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 106.151 -1.796 . . . . 52.23 106.151 171.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -64.57 -34.78 51.16 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.39 2.06 . . . . 73.04 111.956 -170.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -101.42 20.52 15.79 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.982 0.913 . . . . 75.14 109.896 -175.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.422 ' O ' HG11 ' A' ' 31' ' ' VAL . . . -45.73 -52.01 26.61 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-O 118.009 -0.996 . . . . 73.32 113.627 -171.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.456 ' HG3' ' HG3' ' B' ' 57' ' ' GLU . 48.4 Cg_exo -57.89 -33.7 97.39 Favored 'Trans proline' 0 C--N 1.39 2.723 0 C-N-CA 121.882 1.721 . . . . 65.41 113.564 176.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -82.1 -30.88 30.98 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.055 0.942 . . . . 72.4 110.687 -177.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.657 HG22 ' HA ' ' A' ' 73' ' ' ALA . 1.3 p -78.96 -22.38 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 C-N-CA 123.169 0.588 . . . . 73.41 112.518 -163.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -77.84 -25.85 49.02 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.697 0.799 . . . . 75.51 112.67 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -83.39 -12.81 56.08 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.407 0.683 . . . . 75.02 111.012 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -82.77 167.88 17.72 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.962 0.905 . . . . 74.43 111.96 -175.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.68 126.54 31.03 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.986 -1.006 . . . . 74.24 109.324 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.41 ' CE3' HD21 ' A' ' 68' ' ' LEU . 54.1 t-105 -75.47 85.5 2.57 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.326 0.584 . . . . 72.0 110.094 175.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.432 ' H ' HD23 ' A' ' 68' ' ' LEU . 35.4 tt0 -122.88 75.2 48.01 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.689 1.196 . . . . 75.25 108.258 173.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -83.9 135.75 6.78 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.866 2.378 . . . . 74.33 112.994 -171.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -104.9 106.47 16.98 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 106.97 -1.493 . . . . 72.04 106.97 170.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 65' ' ' THR . 15.2 m -75.78 91.49 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-O 122.031 0.92 . . . . 74.21 110.652 -175.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.7 tptt -80.52 111.81 17.28 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 107.118 -1.438 . . . . 72.33 107.118 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 pp -127.53 141.92 51.52 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.046 0.539 . . . . 71.45 110.549 -168.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -146.19 134.16 21.41 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.758 -0.83 . . . . 73.22 108.758 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -103.69 118.61 37.12 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.917 -0.771 . . . . 74.14 108.917 177.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 33.0 t70 -119.55 143.9 47.36 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.758 -0.83 . . . . 73.41 108.758 177.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.1 p -106.94 147.86 29.33 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.195 0.598 . . . . 70.13 110.047 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.674 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -147.76 144.05 27.97 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.153 0.981 . . . . 73.23 108.667 176.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 64.2 m -136.54 162.39 33.24 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 118.162 0.437 . . . . 75.1 111.799 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.9 t -149.92 121.86 8.2 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.843 0.857 . . . . 74.21 109.439 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -81.24 125.8 30.75 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.632 -0.507 . . . . 63.13 109.632 175.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.461 HD12 HG22 ' A' ' 83' ' ' ILE . 27.4 mt -107.8 -26.61 10.7 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.915 0.886 . . . . 72.33 110.264 -177.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.38 179.01 6.44 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.252 -1.34 . . . . 74.12 108.672 174.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -67.12 113.02 4.75 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.977 -0.749 . . . . 71.01 108.977 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 76.07 0.32 3.27 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 125.245 1.418 . . . . 74.34 112.401 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.52 109.46 24.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.896 0 N-CA-C 106.744 -1.576 . . . . 74.13 106.744 168.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -133.72 123.38 24.85 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.974 -1.121 . . . . 71.11 107.974 -170.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -86.31 128.3 34.9 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.595 -0.891 . . . . 72.14 108.595 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.457 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 56.5 t -101.93 125.97 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.767 -1.197 . . . . 75.45 107.767 176.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.674 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 36.8 t -116.13 143.18 26.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 108.229 -1.026 . . . . 75.02 108.229 173.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tt -128.9 117.62 21.31 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.765 -0.828 . . . . 73.24 108.765 174.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.569 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 28.1 ttm105 -81.95 101.56 10.35 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 108.025 -1.102 . . . . 74.02 108.025 170.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.83 101.16 12.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 N-CA-C 107.132 -1.432 . . . . 71.54 107.132 171.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -96.47 126.45 41.67 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.906 -0.776 . . . . 75.11 108.906 176.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 67.4 t -128.06 139.76 51.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 125.189 1.396 . . . . 75.23 107.356 176.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 6.4 m -131.24 149.82 52.41 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.702 -1.222 . . . . 70.31 107.702 174.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.19 113.57 22.42 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.203 -1.406 . . . . 74.15 107.203 170.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.0 m -113.85 124.38 52.07 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.157 0.503 . . . . 74.14 110.064 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 37' ' ' GLN . 66.0 mt -90.09 65.52 6.5 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.771 1.228 . . . . 75.13 109.001 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.34 -90.79 0.73 Allowed Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.838 -0.619 . . . . 71.2 111.828 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -102.17 -27.16 13.05 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.291 0.636 . . . . 73.33 111.644 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -100.19 128.5 46.26 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 109.585 -0.524 . . . . 74.34 109.585 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.9 m -71.49 135.91 47.34 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 118.175 0.443 . . . . 62.35 109.92 172.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.657 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -80.61 -63.1 1.48 Allowed 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.448 -0.796 . . . . 70.14 109.729 173.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -156.04 174.88 14.71 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.915 -1.038 . . . . 74.25 111.635 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.6 tp -134.87 137.62 43.41 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.171 1.388 . . . . 73.44 107.853 174.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 82.5 m -136.51 102.92 5.09 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.96 1.304 . . . . 74.22 109.589 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -122.05 117.17 25.69 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.77 -0.826 . . . . 63.45 108.77 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.7 t -128.96 112.08 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.552 0.741 . . . . 75.31 109.976 -174.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.629 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.8 mt-30 -85.76 91.2 8.25 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.873 -0.788 . . . . 74.51 108.873 168.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -80.75 107.87 13.93 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.969 -1.014 . . . . 73.23 108.995 178.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.59 145.28 17.43 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.033 -0.427 . . . . 74.11 112.033 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.06 128.45 3.07 Favored Glycine 0 CA--C 1.507 -0.445 0 N-CA-C 110.942 -0.863 . . . . 74.21 110.942 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.461 HG22 HD12 ' A' ' 51' ' ' LEU . 62.0 mt -79.54 122.38 34.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.867 -0.79 . . . . 75.23 108.867 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.684 ' HD2' HG12 ' A' ' 13' ' ' ILE . 12.6 m-85 -137.54 151.69 48.66 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.744 -0.836 . . . . 75.15 108.744 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 44.3 m -121.01 106.64 11.78 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.325 0.65 . . . . 65.44 109.348 170.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 108.692 -0.855 . . . . 72.31 108.692 178.592 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 111.718 0.266 . . . . 73.44 111.718 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -72.64 -39.28 67.31 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.965 0.506 . . . . 70.12 110.608 171.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.544 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 58.4 m -64.36 -56.21 15.9 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.224 0.61 . . . . 61.11 110.972 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 pp -71.62 -29.37 64.59 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.196 0.599 . . . . 65.33 111.332 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.61 -20.69 57.86 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-O 119.575 -0.569 . . . . 61.11 114.273 -173.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.08 -54.67 0.21 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.063 0.764 . . . . 74.51 113.063 -172.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.544 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 87.5 t80 -60.89 -63.48 1.28 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.524 0.73 . . . . 74.43 112.844 -171.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 78.2 m -65.63 -35.22 10.92 Favored Pre-proline 0 CA--C 1.57 1.732 0 C-N-CA 123.779 0.831 . . . . 75.55 113.073 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.2 -45.73 32.1 Favored 'Trans proline' 0 C--N 1.393 2.914 0 C-N-CA 122.777 2.318 . . . . 64.41 113.374 161.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -70.64 -17.69 62.87 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.401 0.681 . . . . 73.13 112.075 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 46.2 mm -69.71 -43.81 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 N-CA-C 109.209 -0.663 . . . . 72.13 109.209 171.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 89.1 mt -81.89 -23.48 36.27 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.012 0.925 . . . . 73.23 112.549 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -56.22 -47.21 99.3 Favored Pre-proline 0 CA--C 1.572 1.792 0 C-N-CA 124.956 1.303 . . . . 75.13 113.953 -172.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.67 -32.76 14.25 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.119 1.879 . . . . 70.04 112.939 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -68.26 -40.68 81.83 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.058 0.543 . . . . 75.41 110.912 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.73 -39.92 80.13 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.766 -0.652 . . . . 65.22 110.507 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.4 ttm105 -54.67 -47.81 73.13 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.849 0.86 . . . . 75.22 110.912 173.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -68.94 -43.27 75.41 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.709 0.803 . . . . 70.04 111.408 -175.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 43.8 t -63.88 -29.65 70.81 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 123.607 0.567 . . . . 72.33 110.823 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 70.8 mt -68.2 -56.06 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 123.862 0.865 . . . . 73.25 110.011 169.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.2 m -56.28 -35.74 67.83 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.842 1.257 . . . . 72.34 112.339 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.4 t -64.38 -49.61 70.94 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 123.409 0.683 . . . . 51.01 110.647 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.579 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 57.9 mtm -65.9 -37.48 86.21 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.725 0.64 . . . . 72.34 111.25 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.0 t -60.07 -53.19 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.499 1.12 . . . . 72.02 110.403 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 40.2 t -69.78 -29.46 66.79 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.933 0.893 . . . . 61.22 111.49 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.497 ' HG2' ' HG1' ' B' ' 18' ' ' THR . 52.0 ttm-85 -75.75 -28.92 58.68 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.256 1.023 . . . . 74.33 109.362 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.411 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.66 15.56 46.07 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 114.741 -1.118 . . . . 75.15 112.607 172.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.435 HG23 ' HE ' ' B' ' 15' ' ' ARG . 2.8 t 60.81 14.46 5.16 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 127.214 2.205 . . . . 74.45 113.77 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -80.08 155.07 75.1 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 123.681 0.792 . . . . 75.1 110.223 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.68 170.13 10.39 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.853 2.369 . . . . 74.44 113.15 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -63.68 127.69 32.5 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.193 -0.912 . . . . 74.45 111.55 -173.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.6 tp -121.88 103.96 9.21 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.651 1.18 . . . . 73.52 108.306 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -97.22 126.65 42.56 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.713 0.805 . . . . 72.53 108.867 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 tt -72.51 130.78 41.43 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.948 -1.13 . . . . 75.2 107.948 171.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.05 133.22 83.91 Favored Pre-proline 0 CA--C 1.548 0.893 0 O-C-N 123.575 0.547 . . . . 75.52 110.743 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -70.59 95.83 0.64 Allowed 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 122.343 2.028 . . . . 72.53 111.593 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.7 t -102.24 111.45 32.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 108.911 -0.774 . . . . 72.31 108.911 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -86.67 82.9 7.72 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.122 -1.066 . . . . 64.34 108.122 172.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 . . . . . 0 N--CA 1.489 1.488 0 C-N-CA 124.498 1.119 . . . . 74.12 111.785 -176.966 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.584 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 25.3 ptm . . . . . 0 N--CA 1.486 1.351 0 N-CA-C 115.473 1.657 . . . . 72.03 115.473 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 90.2 m -134.78 132.35 38.6 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 106.559 -1.645 . . . . 73.55 106.559 162.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.425 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 37.9 t80 -124.13 137.65 54.53 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.738 -0.838 . . . . 75.44 108.738 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.28 132.94 13.05 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.399 -0.593 . . . . 72.31 109.399 176.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.409 HD12 HD11 ' B' ' 16' ' ' ILE . 32.5 mt -83.32 120.39 34.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 108.438 -0.949 . . . . 72.34 108.438 173.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -88.28 -46.1 9.5 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.539 -0.541 . . . . 71.33 109.539 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.435 ' HE ' HG23 ' A' ' 122' ' ' THR . 49.2 ttt180 -167.67 137.74 2.77 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.704 0.402 . . . . 73.21 110.167 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.409 HD11 HD12 ' B' ' 13' ' ' ILE . 74.1 mt -114.79 142.32 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.407 -0.961 . . . . 75.2 108.407 175.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -169.77 158.53 7.52 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-O 121.682 0.753 . . . . 74.4 112.499 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.497 ' HG1' ' HG2' ' A' ' 120' ' ' ARG . 88.4 m -86.71 129.58 34.81 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.007 -0.997 . . . . 70.12 109.188 170.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.431 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 41.1 mtpt -97.72 -29.22 13.51 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.796 0.838 . . . . 73.12 110.343 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -159.97 141.12 12.43 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.56 0.219 . . . . 73.13 111.334 -170.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.702 HD12 ' SG ' ' B' ' 113' ' ' CYS . 45.7 mm -135.53 146.13 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.291 1.437 . . . . 75.42 109.07 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.593 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 42.4 t -148.21 138.31 22.58 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.851 1.261 . . . . 71.33 107.965 173.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.1 t80 -153.57 109.38 3.27 Favored 'General case' 0 C--O 1.215 -0.755 0 N-CA-C 106.783 -1.562 . . . . 72.31 106.783 170.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -118.53 113.48 21.36 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.33 -1.359 . . . . 73.3 107.33 176.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.14 86.64 1.64 Allowed Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 106.975 -1.491 . . . . 53.34 106.975 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.37 -37.5 13.45 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.902 2.401 . . . . 73.41 112.502 -166.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -108.45 21.84 16.76 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.598 0.759 . . . . 73.0 110.069 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.36 -62.25 0.84 Allowed Pre-proline 0 N--CA 1.497 1.908 0 N-CA-C 114.792 1.404 . . . . 74.1 114.792 -166.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.44 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 46.8 Cg_endo -67.89 -27.54 36.93 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 121.823 1.682 . . . . 73.23 112.631 -174.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.407 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 26.3 m80 -75.38 -48.45 22.87 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 115.36 -0.837 . . . . 75.04 110.896 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.06 -0.49 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.365 0 C-N-CA 123.868 0.867 . . . . 64.41 112.353 -167.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -75.7 -13.38 60.31 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.985 -0.447 . . . . 73.43 112.155 173.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 10.2 pt20 -63.36 -16.97 62.03 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.756 0.822 . . . . 73.53 111.183 171.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -93.72 89.87 6.36 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.058 1.343 . . . . 75.34 110.148 -176.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -89.17 84.5 6.53 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.988 0.515 . . . . 62.44 111.08 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 46.7 p90 -168.11 173.05 8.24 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.332 1.053 . . . . 75.35 109.497 169.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -65.17 116.77 33.37 Favored Pre-proline 0 N--CA 1.478 0.937 0 N-CA-C 108.602 -0.888 . . . . 74.01 108.602 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -60.06 154.15 53.19 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 121.995 1.797 . . . . 74.22 111.881 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 30.3 tt0 -57.23 104.5 0.17 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.014 -0.736 . . . . 70.13 109.014 175.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.2 m -85.2 139.08 17.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-N 114.924 -1.035 . . . . 72.45 110.565 -172.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.473 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 34.3 ttmt -150.5 107.13 3.51 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.723 -0.843 . . . . 74.23 108.723 -175.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.43 141.14 30.17 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 107.672 -1.233 . . . . 70.22 107.672 176.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -143.51 142.04 30.99 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.459 1.103 . . . . 73.22 108.417 174.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.413 HD21 HD12 ' B' ' 60' ' ' LEU . 5.4 mp -123.92 167.31 14.3 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.539 0.685 . . . . 74.32 110.991 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.582 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.0 t70 -149.65 148.55 29.43 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 113.879 -1.51 . . . . 74.44 109.002 175.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 3.4 t -108.27 127.02 53.49 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.236 1.015 . . . . 74.4 108.938 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -158.4 136.85 10.97 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.202 0.601 . . . . 72.3 110.216 -175.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.4 p -146.57 -179.63 6.9 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.264 0.625 . . . . 71.14 111.155 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 65.1 p -152.51 136.38 16.3 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.174 -1.047 . . . . 63.5 108.174 164.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -89.94 118.68 29.69 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.18 -0.674 . . . . 64.25 109.18 175.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.42 HD12 HG22 ' B' ' 83' ' ' ILE . 17.8 mt -84.19 -48.59 9.65 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.596 -0.891 . . . . 75.41 108.596 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.43 179.29 8.26 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.317 -1.31 . . . . 74.01 109.793 175.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.71 130.71 43.11 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.506 -1.224 . . . . 63.11 107.933 172.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 71.12 -5.37 1.55 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 125.145 1.378 . . . . 72.41 112.843 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 86.6 t -119.29 102.52 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.933 0.893 . . . . 72.44 108.714 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -121.68 139.76 53.15 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.447 0.699 . . . . 73.54 109.616 -173.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.456 ' HG3' ' HG3' ' A' ' 29' ' ' PRO . 8.9 tm-20 -106.5 107.48 18.52 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 107.645 -1.243 . . . . 73.43 107.645 -178.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 85.6 t -94.53 126.21 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.163 1.385 . . . . 74.14 110.295 -175.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.442 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 13.6 t -112.9 145.88 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.755 -0.831 . . . . 74.41 108.755 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.413 HD12 HD21 ' B' ' 44' ' ' LEU . 41.9 tp -129.44 112.02 13.37 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 108.026 -1.101 . . . . 72.53 108.026 168.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.582 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 11.4 ttm180 -88.56 110.4 20.86 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.923 -0.769 . . . . 72.21 108.923 173.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 24.9 t -105.36 102.77 14.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 107.189 -1.412 . . . . 72.51 107.189 177.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 25.4 m -99.54 134.0 43.05 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.939 -0.763 . . . . 72.43 108.939 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.463 HG21 HD12 ' B' ' 114' ' ' ILE . 40.6 t -120.28 126.16 74.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 123.53 0.732 . . . . 64.42 109.734 174.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.473 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 78.6 m -103.54 143.56 32.57 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.964 0.906 . . . . 74.35 109.476 171.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -146.82 135.94 22.55 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.703 0.801 . . . . 73.11 109.648 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.511 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 38.0 p -141.81 134.28 28.17 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 123.373 0.669 . . . . 75.55 110.16 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 26.2 mt -108.85 100.87 10.03 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 123.78 0.832 . . . . 71.21 109.647 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.83 -119.58 6.97 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.505 -0.77 . . . . 74.21 113.385 176.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -95.21 18.12 12.93 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.394 0.677 . . . . 74.53 112.21 -173.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -152.74 155.16 36.67 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.928 0.491 . . . . 73.0 110.562 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 96.7 m -73.12 132.38 43.22 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 116.05 -0.523 . . . . 71.44 110.045 174.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.511 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -82.83 -62.23 1.66 Allowed 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.29 -1.004 . . . . 64.25 108.29 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -158.61 160.31 36.41 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 114.882 -1.053 . . . . 72.11 111.658 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 79.6 mt -128.59 113.06 14.97 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.577 -1.638 . . . . 71.22 106.577 173.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.1 t -115.63 153.37 31.4 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.47 -0.937 . . . . 74.35 108.47 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.593 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.8 tt0 -162.03 126.77 3.34 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.286 -0.635 . . . . 74.24 109.286 -175.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.435 HG11 ' HA ' ' B' ' 110' ' ' ALA . 95.9 t -126.3 145.52 33.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 124.095 0.958 . . . . 74.52 108.773 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -123.47 98.75 5.99 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.199 -1.037 . . . . 74.43 108.199 173.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.448 ' HB2' ' HB1' ' B' ' 110' ' ' ALA . 8.1 tp-100 -91.82 101.09 13.68 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.29 -1.004 . . . . 74.41 108.29 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.74 162.7 30.42 Favored Glycine 0 C--O 1.242 0.61 0 N-CA-C 110.9 -0.88 . . . . 73.2 110.9 174.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.74 126.31 1.51 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.821 -0.911 . . . . 63.31 110.821 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.42 HG22 HD12 ' B' ' 51' ' ' LEU . 61.0 mt -84.16 129.46 37.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 107.757 -1.201 . . . . 74.15 107.757 174.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -133.04 168.97 17.53 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.498 0.719 . . . . 75.05 109.244 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 73.7 m -126.64 109.53 12.2 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.574 0.75 . . . . 73.45 109.207 170.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -118.74 126.16 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.7 1.2 . . . . 75.33 108.306 -175.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.47 142.97 17.25 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.718 0.407 . . . . 74.53 111.219 -174.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 107.27 -34.44 5.68 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.274 0.359 . . . . 73.12 113.145 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.584 ' HB ' ' HB3' ' B' ' 9' ' ' MET . 0.6 OUTLIER -94.08 160.48 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.751 0.82 . . . . 71.11 110.121 172.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -161.26 160.8 30.32 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.065 0.546 . . . . 74.11 111.207 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.73 -128.68 9.14 Favored Glycine 0 C--N 1.353 1.505 0 C-N-CA 123.818 0.723 . . . . 72.43 112.641 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 35.9 m -65.34 -31.2 72.2 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.654 0.782 . . . . 74.22 110.636 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -69.91 -37.92 76.12 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.259 -0.882 . . . . 75.42 111.01 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -28.8 38.0 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.952 -0.388 . . . . 61.24 109.952 177.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.6 -31.86 73.16 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.775 0.83 . . . . 61.45 110.546 172.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -81.92 -37.93 26.06 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.662 1.185 . . . . 75.53 110.466 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.434 ' SG ' ' HE1' ' B' ' 9' ' ' MET . 51.8 t -64.73 -46.64 81.41 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.861 0.464 . . . . 53.24 110.918 -175.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 5.5 mp -96.26 -9.51 30.13 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.72 0.408 . . . . 71.31 111.281 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.98 -15.36 33.7 Favored Glycine 0 N--CA 1.476 1.313 0 N-CA-C 114.008 0.363 . . . . 73.33 114.008 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.56 -61.71 0.89 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.467 0.707 . . . . 74.42 109.856 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -67.03 -55.11 15.77 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.409 0.684 . . . . 74.33 112.59 -168.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.467 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 83.1 m -61.46 -49.95 85.09 Favored Pre-proline 0 CA--C 1.559 1.307 0 CA-C-O 118.362 -0.828 . . . . 72.03 111.78 -177.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.467 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 37.7 Cg_exo -61.9 -25.89 78.51 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 122.318 2.012 . . . . 74.32 113.442 174.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -77.02 -25.61 52.82 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.499 0.72 . . . . 75.43 110.927 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 65.2 mt -68.74 -42.86 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.635 0.774 . . . . 64.4 109.529 169.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' B' ' 102' ' ' CYS . 53.6 mt -82.03 -18.76 42.13 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.412 -1.267 . . . . 74.14 111.311 -174.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -57.64 -52.01 77.48 Favored Pre-proline 0 CA--C 1.559 1.306 0 CA-C-O 117.121 -1.419 . . . . 74.41 112.708 -177.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -53.61 -37.86 83.59 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 122.727 2.285 . . . . 70.41 114.477 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -70.34 -44.38 68.28 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.072 0.549 . . . . 73.33 109.871 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' B' ' 80' ' ' GLN . . . -67.18 -32.43 73.51 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 115.351 -0.84 . . . . 63.34 111.591 177.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.412 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 45.3 ttt-85 -70.3 -51.11 32.78 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.985 1.314 . . . . 75.03 109.967 -176.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -35.79 78.52 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 124.324 1.015 . . . . 65.02 108.957 176.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.702 ' SG ' HD12 ' B' ' 21' ' ' ILE . 19.1 t -65.31 -47.71 75.6 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 123.687 0.617 . . . . 74.44 112.432 -177.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.504 ' O ' HG23 ' B' ' 118' ' ' VAL . 75.5 mt -60.33 -54.72 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 108.924 -0.769 . . . . 74.03 108.924 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 45.2 m -58.27 -30.04 66.27 Favored 'General case' 0 CA--C 1.555 1.146 0 O-C-N 124.583 1.177 . . . . 50.31 111.661 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 48.0 t -69.66 -46.15 66.78 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 123.431 0.693 . . . . 73.44 109.194 176.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.565 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 9.4 mmt -70.13 -32.92 71.17 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 123.482 0.489 . . . . 75.54 110.886 -177.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 114' ' ' ILE . 99.4 t -59.96 -47.5 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 124.302 1.041 . . . . 74.51 109.317 171.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.0 t -70.47 -29.73 66.36 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 113.755 -1.566 . . . . 74.23 111.672 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.565 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 92.3 mtt-85 -70.05 -37.01 75.42 Favored 'General case' 0 C--O 1.214 -0.774 0 C-N-CA 123.346 0.658 . . . . 74.41 109.339 176.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.93 8.82 55.85 Favored Glycine 0 C--N 1.353 1.5 0 O-C-N 124.167 0.917 . . . . 71.12 112.863 173.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.436 HG21 ' HB3' ' A' ' 17' ' ' TYR . 76.9 p 55.38 25.32 7.49 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 126.395 1.878 . . . . 74.53 113.62 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -78.39 155.03 79.31 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 123.888 0.875 . . . . 75.34 111.118 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -46.88 143.96 8.77 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.873 3.049 . . . . 74.02 113.707 176.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -58.6 116.19 3.52 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.174 0.99 . . . . 75.14 111.679 -172.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 41.8 tp -121.25 105.08 10.23 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.328 0.651 . . . . 75.21 110.19 -176.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -105.17 126.37 52.01 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 108.913 -0.773 . . . . 73.11 108.913 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.412 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 49.3 mt -74.33 137.85 43.11 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 109.508 -0.552 . . . . 72.53 109.508 175.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.78 136.83 36.29 Favored Pre-proline 0 N--CA 1.479 1.013 0 CA-C-O 119.282 -0.39 . . . . 75.14 110.077 176.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.562 ' HG3' HD13 ' D' ' 16' ' ' ILE . 69.9 Cg_endo -73.94 141.42 30.01 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.334 2.023 . . . . 71.23 111.978 178.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 27.5 m -128.75 131.38 68.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.567 -0.901 . . . . 73.1 108.567 172.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -73.67 95.86 2.4 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.469 -0.567 . . . . 74.33 109.469 174.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -61.93 -43.59 98.54 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.671 -0.863 . . . . 71.0 108.671 171.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 . . . . . 0 CA--C 1.537 0.462 0 CA-C-N 113.603 -1.635 . . . . 64.42 111.704 -179.619 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.479 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.7 t80 . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 121.311 0.577 . . . . 72.13 109.907 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -152.58 137.35 17.03 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.077 -1.453 . . . . 72.43 107.077 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.504 HD12 HG22 ' C' ' 105' ' ' ILE . 64.7 mt -79.81 116.42 23.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 108.332 -0.988 . . . . 75.11 108.332 173.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.467 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 22.2 mm-40 -80.35 -39.0 29.38 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.214 -0.903 . . . . 73.14 109.72 -173.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -179.8 124.33 0.08 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.983 0.513 . . . . 73.21 109.968 -172.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 91.8 mt -109.61 141.21 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 108.848 -0.797 . . . . 71.31 108.848 173.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.434 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 23.5 p90 -174.79 163.97 3.47 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 123.91 0.756 . . . . 74.34 110.236 -173.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.3 p -90.06 125.74 35.52 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.383 0.673 . . . . 70.01 109.369 173.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.434 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 25.8 mmtp -71.07 -49.45 44.43 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 107.887 -1.153 . . . . 74.4 107.887 168.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.719 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 7.9 t70 -139.44 140.77 37.41 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 113.124 -1.853 . . . . 74.22 109.711 -165.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 73.8 mt -139.18 147.03 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.899 -1.519 . . . . 75.41 106.899 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.9 t -158.95 151.76 21.99 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.418 0.687 . . . . 73.44 109.871 176.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -153.93 110.68 3.36 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 107.813 -1.18 . . . . 72.23 107.813 173.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -120.61 110.27 16.23 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.516 0.726 . . . . 64.52 109.557 -173.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.24 87.09 22.73 Favored Pre-proline 0 C--O 1.24 0.6 0 N-CA-C 107.253 -1.388 . . . . 62.03 107.253 170.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.05 -37.2 26.79 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.509 2.139 . . . . 71.22 111.992 -176.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -103.97 28.76 6.41 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.512 0.725 . . . . 75.14 109.999 -175.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.94 -53.8 29.32 Favored Pre-proline 0 CA--C 1.561 1.372 0 N-CA-C 114.322 1.23 . . . . 75.14 114.322 -169.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.78 -49.61 14.1 Favored 'Trans proline' 0 C--N 1.389 2.702 0 CA-C-N 121.747 1.66 . . . . 74.04 112.788 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.451 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 83.2 t60 -69.82 -28.18 65.48 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.859 -0.609 . . . . 70.14 112.087 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.553 HG22 ' HA ' ' C' ' 73' ' ' ALA . 3.7 p -80.93 -13.8 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 O-C-N 121.27 -0.894 . . . . 75.1 112.123 -177.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -81.75 -14.97 55.76 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 112.694 0.627 . . . . 71.41 112.694 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 18.9 pt20 -92.11 9.25 34.25 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.658 0.383 . . . . 74.5 110.559 171.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.494 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 0.0 OUTLIER -101.07 145.72 28.38 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.517 0.727 . . . . 73.03 110.439 -174.394 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -71.21 129.94 40.18 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.2 -0.667 . . . . 72.04 109.2 174.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -76.82 84.92 3.41 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.509 0.724 . . . . 73.41 110.292 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -134.14 63.36 61.37 Favored Pre-proline 0 N--CA 1.478 0.967 0 C-N-CA 124.014 0.926 . . . . 71.25 109.351 173.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . 0.427 ' HG2' HG12 ' C' ' 40' ' ' VAL . 92.5 Cg_endo -88.49 159.72 6.6 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.196 1.93 . . . . 74.14 112.855 -172.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -86.44 86.69 7.34 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.011 -1.477 . . . . 74.03 107.011 161.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.427 HG12 ' HG2' ' C' ' 38' ' ' PRO . 15.9 m -65.99 115.03 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 114.411 -1.268 . . . . 74.32 108.593 172.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -127.43 112.35 14.88 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.613 0.765 . . . . 75.21 109.117 -174.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.53 127.68 34.91 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.846 -0.798 . . . . 74.14 108.846 174.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -120.16 135.47 54.96 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.976 1.31 . . . . 74.22 107.91 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.42 ' H ' HD23 ' C' ' 44' ' ' LEU . 1.8 pt? -122.05 125.81 47.07 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.561 0.696 . . . . 74.13 110.627 -177.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 2.0 t70 -113.78 143.13 45.15 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.575 -1.268 . . . . 73.02 107.575 171.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 62.1 p -112.4 122.38 47.55 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.325 0.65 . . . . 74.15 109.673 -172.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.591 ' HB2' ' HB ' ' C' ' 59' ' ' VAL . . . -115.02 139.85 49.52 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.696 -0.853 . . . . 73.44 108.696 173.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 15.8 m -141.44 143.18 33.75 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.492 0.717 . . . . 72.31 109.677 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 48.3 t -165.8 128.67 2.08 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.082 0.553 . . . . 73.31 109.775 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -82.3 115.67 21.46 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.064 -1.458 . . . . 74.4 107.064 168.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.559 HD12 ' HB2' ' C' ' 57' ' ' GLU . 31.4 mt -84.94 -33.85 22.59 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.554 0.741 . . . . 73.34 110.438 -173.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.96 -175.73 5.52 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.45 -1.25 . . . . 75.3 109.681 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -65.98 121.45 15.14 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.927 -1.033 . . . . 73.44 108.968 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 69.75 -5.64 1.18 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.348 1.459 . . . . 72.31 113.288 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 93.1 t -110.8 100.48 10.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 123.652 0.781 . . . . 73.13 109.028 -175.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -105.26 166.25 10.54 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.335 -0.848 . . . . 73.44 109.373 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.559 ' HB2' HD12 ' C' ' 51' ' ' LEU . 37.5 tt0 -127.3 129.66 48.09 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 114.673 -1.149 . . . . 73.43 108.986 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 m -120.56 114.81 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.372 -0.973 . . . . 74.34 108.372 168.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' C' ' 47' ' ' ALA . 57.6 t -111.23 130.92 63.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 123.823 0.849 . . . . 75.41 108.717 176.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mp -112.79 116.59 30.31 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.114 -0.698 . . . . 71.15 109.114 176.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.601 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 19.1 ttm-85 -82.18 106.91 14.46 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.164 -1.05 . . . . 72.44 108.164 171.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 26.4 t -99.12 111.37 28.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.548 -1.279 . . . . 72.54 107.548 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 25.9 m -120.45 121.61 38.9 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.917 -0.772 . . . . 73.12 108.917 -172.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.534 HG23 HG21 ' C' ' 114' ' ' ILE . 74.5 t -98.87 114.58 37.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.905 -0.776 . . . . 73.03 108.905 176.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.5 m -101.1 110.25 22.25 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.586 -0.894 . . . . 73.21 108.586 165.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.01 110.56 21.87 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 105.951 -1.87 . . . . 75.24 105.951 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -132.23 126.62 33.93 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.162 0.506 . . . . 73.15 110.782 -177.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 14.1 mt -86.55 40.44 0.89 Allowed 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 125.741 1.616 . . . . 74.24 110.341 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.24 -101.37 2.14 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 111.467 -0.653 . . . . 63.42 111.467 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -88.33 -30.84 19.28 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.186 0.594 . . . . 65.44 109.847 175.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.494 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 4.7 tp10 -79.37 121.28 24.94 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.704 0.802 . . . . 61.31 109.585 176.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.3 m -82.48 126.7 32.54 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.488 -0.93 . . . . 70.41 108.488 167.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.553 ' HA ' HG22 ' C' ' 31' ' ' VAL . . . -69.58 -64.4 0.89 Allowed 'General case' 0 C--O 1.238 0.499 0 O-C-N 124.136 0.897 . . . . 75.32 108.792 175.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -155.35 163.13 40.53 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.804 0.811 . . . . 75.4 111.111 173.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -124.16 102.82 7.91 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 105.719 -1.956 . . . . 75.11 105.719 171.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.42 ' SG ' HG22 ' C' ' 114' ' ' ILE . 49.1 t -106.76 151.11 25.58 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 107.742 -1.207 . . . . 60.42 107.742 178.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -158.06 135.89 10.6 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 120.608 0.242 . . . . 72.23 110.489 -173.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' C' ' 110' ' ' ALA . 42.6 t -142.25 114.51 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.52 1.128 . . . . 63.14 108.579 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.719 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 47.1 mt-30 -89.22 91.95 8.98 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.473 -0.936 . . . . 71.51 108.473 169.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.416 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 10.2 tp-100 -80.87 114.61 19.87 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.49 -0.777 . . . . 75.31 109.422 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.86 144.43 16.05 Favored Glycine 0 C--N 1.336 0.538 0 O-C-N 123.808 0.692 . . . . 64.24 111.499 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.76 123.02 2.14 Favored Glycine 0 CA--C 1.5 -0.848 0 N-CA-C 109.657 -1.377 . . . . 74.33 109.657 175.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.467 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 14.1 mm -85.81 123.67 39.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.436 -0.949 . . . . 74.34 108.436 176.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.479 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 59.7 m-85 -130.69 134.15 46.69 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.905 -0.776 . . . . 74.43 108.905 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 20.6 p -89.81 140.71 29.33 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 109.528 -0.545 . . . . 74.12 109.528 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 18.1 tt -137.79 139.08 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.815 0.846 . . . . 74.5 109.14 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.25 164.25 22.51 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.387 0.675 . . . . 42.43 109.374 171.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.92 -59.71 2.79 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-N 116.188 -0.46 . . . . 75.34 112.646 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 35.4 pt -91.49 156.26 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.078 0.551 . . . . 73.44 111.204 -173.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -148.78 -176.68 5.43 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.124 0.97 . . . . 72.23 109.385 -177.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.13 -126.42 40.49 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 114.369 0.508 . . . . 72.24 114.369 176.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 38.6 p -79.12 -19.34 51.36 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.617 0.767 . . . . 73.55 111.635 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -62.27 -49.28 76.3 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.784 0.834 . . . . 74.54 109.593 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.417 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 24.3 ptt? -76.15 -28.19 57.31 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 114.665 -1.152 . . . . 74.52 111.006 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.75 -34.17 74.04 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.284 0.633 . . . . 75.21 111.104 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -63.09 -45.1 93.66 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.242 -0.89 . . . . 75.44 110.865 171.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.565 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 47.6 t -66.96 -62.67 1.32 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.763 -0.653 . . . . 65.55 111.084 -174.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' C' ' 94' ' ' MET . 4.2 pp -71.71 -21.57 61.75 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.234 0.614 . . . . 64.13 112.647 -174.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.05 6.67 43.46 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-O 119.445 -0.642 . . . . 73.12 114.312 -173.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -160.37 -59.4 0.06 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.027 0.913 . . . . 73.52 111.686 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.565 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 15.9 t80 -70.89 -36.25 72.66 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 125.385 1.474 . . . . 74.24 113.0 -167.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.52 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 85.3 m -83.31 -44.06 0.84 Allowed Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 123.249 0.62 . . . . 71.22 111.527 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -53.57 -29.99 52.75 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 122.304 2.003 . . . . 74.43 113.34 165.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -60.07 -36.16 76.74 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.5 1.12 . . . . 71.22 111.1 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.504 HG22 HD12 ' C' ' 13' ' ' ILE . 35.1 mm -62.92 -36.18 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 CA-C-N 115.257 -0.883 . . . . 70.1 110.245 175.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 81.1 mt -89.73 -21.24 22.78 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.286 1.217 . . . . 75.11 114.286 -166.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -55.77 -48.16 97.17 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 113.989 1.107 . . . . 71.31 113.989 -176.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.31 -35.39 84.57 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 122.231 1.954 . . . . 73.52 113.272 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -66.78 -48.78 67.96 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.576 0.751 . . . . 74.42 110.79 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.471 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -66.51 -39.92 88.92 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-N 115.898 -0.592 . . . . 73.03 110.859 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -56.73 -52.36 65.3 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.369 1.043 . . . . 71.31 110.42 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -67.95 -35.52 78.54 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.706 0.629 . . . . 74.54 110.141 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.5 t -70.31 -27.52 64.45 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.955 0.502 . . . . 73.32 111.097 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.534 HG21 HG23 ' C' ' 64' ' ' VAL . 85.6 mt -75.64 -55.41 11.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 109.6 -0.518 . . . . 71.33 109.6 172.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.2 m -66.57 -27.78 68.0 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.955 0.902 . . . . 74.5 111.335 -170.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 46.1 t -63.33 -49.43 73.97 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.655 0.782 . . . . 75.21 109.243 169.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.536 ' HG3' HD12 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.86 -34.74 78.61 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.255 1.022 . . . . 74.52 112.214 178.588 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.412 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.8 t -62.55 -46.41 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.556 0.743 . . . . 73.41 109.114 175.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 30.9 t -66.03 -34.72 78.73 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.194 -1.366 . . . . 64.24 111.6 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -68.2 -31.71 71.43 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.503 0.721 . . . . 75.25 110.054 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.55 10.42 74.63 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.694 0.621 . . . . 73.43 112.839 173.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 62.6 p 56.71 29.27 15.54 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 126.016 1.726 . . . . 75.55 113.941 175.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -88.17 151.73 49.44 Favored Pre-proline 0 N--CA 1.483 1.181 0 C-N-CA 123.357 0.663 . . . . 64.32 109.475 173.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.56 162.98 11.44 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 123.283 2.655 . . . . 75.41 113.98 175.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -52.73 137.53 31.11 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.836 1.254 . . . . 70.34 113.236 -175.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 35.9 tp -150.43 101.53 2.97 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.122 -0.945 . . . . 71.25 109.094 173.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -108.35 133.22 52.85 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.015 0.926 . . . . 74.03 110.142 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.39 138.66 58.6 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.037 0.935 . . . . 73.04 111.705 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.75 147.03 94.15 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.091 0.956 . . . . 53.11 110.559 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.534 ' HG3' HD13 ' A' ' 16' ' ' ILE . 10.8 Cg_exo -68.26 93.79 0.41 Allowed 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.468 2.112 . . . . 74.45 111.762 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 p -98.56 110.12 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-O 121.304 0.574 . . . . 74.42 109.649 176.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -113.96 104.03 11.75 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 106.879 -1.526 . . . . 73.51 106.879 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -55.41 -44.35 76.11 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.106 0.879 . . . . 72.12 112.575 -167.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 N--CA 1.479 0.998 0 O-C-N 123.241 0.338 . . . . 72.53 111.352 -176.578 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 29.9 m . . . . . 0 C--O 1.242 0.683 0 CA-C-O 120.967 0.413 . . . . 72.45 110.204 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -155.85 98.85 1.94 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.608 -1.256 . . . . 75.23 107.608 -177.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . 0.524 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 49.6 mt-30 -113.46 118.85 35.65 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.74 -0.837 . . . . 75.2 108.74 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.498 HG22 ' HG2' ' B' ' 130' ' ' PRO . 38.0 mt -67.7 123.82 21.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 122.673 0.389 . . . . 75.12 110.14 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -96.92 -45.43 6.62 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 123.467 0.479 . . . . 71.51 110.358 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -167.55 131.36 1.77 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 119.417 -0.325 . . . . 74.14 110.908 -169.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.562 HD13 ' HG3' ' B' ' 130' ' ' PRO . 3.1 mp -115.28 138.28 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 107.7 -1.222 . . . . 74.01 107.7 169.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.418 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 41.8 p90 -165.79 176.27 8.08 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 124.293 0.995 . . . . 72.42 111.142 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -106.71 122.95 47.38 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.573 -1.194 . . . . 74.21 109.356 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.418 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 32.8 mtpt -94.23 -24.41 17.48 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.675 -0.693 . . . . 73.3 109.753 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.515 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.6 t70 -152.52 133.28 13.98 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 114.527 -1.215 . . . . 74.32 108.632 176.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.536 HD12 ' HG3' ' C' ' 117' ' ' MET . 80.6 mt -131.07 147.59 33.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.155 -1.424 . . . . 73.3 107.155 172.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 22' ' ' SER . . . . . 0.53 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 34.6 t -150.49 140.36 21.87 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.789 1.236 . . . . 74.1 107.936 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.504 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.5 t80 -152.84 125.92 8.53 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 105.706 -1.961 . . . . 73.32 105.706 171.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 37.0 mt-10 -137.34 111.63 8.52 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.129 0.572 . . . . 70.13 109.644 -175.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.25 85.38 10.43 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 108.396 -0.965 . . . . 71.15 108.396 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.09 -21.12 12.38 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 122.844 2.362 . . . . 75.15 112.697 -173.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -102.64 0.84 33.83 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.786 0.834 . . . . 75.34 110.675 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -28.66 -64.88 0.16 Allowed Pre-proline 0 CA--C 1.565 1.529 0 N-CA-C 116.392 1.997 . . . . 71.32 116.392 -158.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.46 -22.41 10.83 Favored 'Trans proline' 0 C--N 1.383 2.391 0 CA-C-N 123.091 2.14 . . . . 72.43 113.907 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -69.05 -42.67 75.97 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.266 1.027 . . . . 72.31 109.75 174.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.57 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.2 p -83.17 -19.88 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 CA-C-N 115.829 -0.623 . . . . 71.43 111.404 -172.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -63.36 -26.49 68.78 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 112.454 0.539 . . . . 75.21 112.454 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -58.69 -20.59 49.86 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.627 0.771 . . . . 72.23 110.784 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.677 ' HZ2' ' HB3' ' D' ' 71' ' ' GLU . 92.2 mttt -90.52 87.39 6.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.277 1.031 . . . . 73.11 108.63 166.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -97.17 82.13 3.14 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.383 0.611 . . . . 74.14 110.15 -173.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 38.9 p90 -156.94 -174.21 4.82 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.736 1.214 . . . . 75.42 108.691 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.13 114.46 23.63 Favored Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 123.976 0.91 . . . . 72.33 111.108 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.59 127.99 18.25 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.553 2.169 . . . . 74.52 111.847 171.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -75.66 134.99 40.45 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.304 -0.628 . . . . 74.33 109.304 177.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.528 HG11 HG13 ' D' ' 64' ' ' VAL . 74.1 t -102.23 132.81 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.889 0.876 . . . . 72.13 111.306 -174.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.443 ' HB2' ' OG1' ' D' ' 65' ' ' THR . 74.6 mmtt -98.2 130.38 44.94 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.915 -1.143 . . . . 72.53 107.915 168.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -96.69 126.08 41.6 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.544 0.738 . . . . 74.3 109.403 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.789 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 22.4 m-20 -127.66 142.85 51.23 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.136 0.974 . . . . 72.21 108.402 171.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 89.9 mt -129.69 143.26 50.74 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.588 0.755 . . . . 64.5 109.998 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 9.9 t70 -141.36 144.76 34.72 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.209 1.004 . . . . 60.13 108.53 175.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 35.9 p -104.26 143.53 32.83 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.532 0.733 . . . . 52.45 111.327 -173.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.681 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.92 141.74 22.83 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.898 0.879 . . . . 70.11 108.771 171.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.1 p -166.42 154.27 10.07 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.92 0.488 . . . . 73.33 109.795 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 60.2 p -164.04 142.56 7.45 Favored 'General case' 0 C--O 1.24 0.558 0 O-C-N 123.877 0.736 . . . . 64.43 110.224 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -76.36 126.02 30.24 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.104 -0.702 . . . . 75.13 109.104 168.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.536 HD11 HG22 ' D' ' 83' ' ' ILE . 73.9 mt -97.45 -30.73 12.74 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.25 0.62 . . . . 72.52 110.55 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.23 -175.06 2.81 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.693 0.797 . . . . 75.44 110.53 177.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -61.9 116.44 4.87 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.821 -1.081 . . . . 73.22 110.087 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 64.41 9.86 5.29 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.926 1.29 . . . . 73.5 112.48 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.7 t -109.73 114.98 48.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 108.157 -1.053 . . . . 73.34 108.157 173.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.465 ' HB2' HD12 ' D' ' 86' ' ' ILE . 72.7 m-85 -134.69 133.08 39.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.509 -0.923 . . . . 73.53 108.509 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -104.55 136.86 43.31 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.844 0.858 . . . . 73.42 109.322 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 38.2 t -121.69 129.21 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 107.737 -1.209 . . . . 64.13 107.737 174.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.681 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 20.4 t -121.56 132.07 71.59 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 C-N-CA 124.221 1.008 . . . . 71.04 108.674 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.563 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 3.9 mm? -119.09 120.2 36.47 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.305 0.642 . . . . 75.32 109.767 176.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.564 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 18.9 ttm-85 -88.67 101.25 13.8 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.404 -0.816 . . . . 72.12 108.82 173.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 55.1 t -90.99 126.37 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 107.574 -1.269 . . . . 63.32 107.574 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.789 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 9.3 m -122.57 125.7 46.23 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.761 0.791 . . . . 75.43 109.983 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.528 HG13 HG11 ' D' ' 40' ' ' VAL . 25.3 t -111.09 99.43 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.959 1.704 . . . . 72.44 108.137 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.463 HG22 HD21 ' D' ' 75' ' ' LEU . 1.8 p -99.64 94.98 6.66 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 107.887 -1.153 . . . . 73.31 107.887 174.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.23 155.62 16.66 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.935 -1.03 . . . . 61.33 111.141 -170.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.451 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.5 p -153.58 132.45 12.41 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.713 -0.676 . . . . 64.11 111.932 -176.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.551 HD11 HG23 ' D' ' 31' ' ' VAL . 24.9 mt -93.74 99.18 11.63 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 124.893 1.277 . . . . 75.43 108.856 172.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.37 -119.86 7.4 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.129 -0.941 . . . . 74.25 112.015 -174.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.77 5.4 49.22 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.428 1.091 . . . . 72.1 111.241 -177.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.677 ' HB3' ' HZ2' ' D' ' 34' ' ' LYS . 5.5 tp10 -129.08 139.72 51.88 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.063 0.945 . . . . 63.41 109.513 -169.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.4 m -61.55 128.59 37.02 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.809 0.843 . . . . 75.12 111.471 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.57 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -83.95 -70.42 0.57 Allowed 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.838 -1.171 . . . . 73.24 107.838 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -146.33 166.74 25.41 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.623 -1.171 . . . . 75.14 109.025 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.463 HD21 HG22 ' D' ' 65' ' ' THR . 48.2 mt -116.24 151.17 36.3 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 105.842 -1.91 . . . . 74.53 105.842 171.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.46 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 50.3 t -157.1 140.23 15.44 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.247 -1.02 . . . . 74.44 108.247 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 36.7 tt0 -156.75 131.11 8.61 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 122.853 0.461 . . . . 72.52 109.839 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -136.81 118.55 19.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 123.337 0.655 . . . . 72.14 109.742 -177.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.2 mt-30 -86.41 87.13 7.37 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.811 -1.181 . . . . 74.23 107.811 166.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . 0.413 ' O ' HD11 ' D' ' 106' ' ' LEU . 8.5 tp-100 -79.9 105.2 11.01 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.279 -1.328 . . . . 70.23 107.698 176.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -110.45 143.69 16.96 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.854 -0.498 . . . . 74.22 111.854 -177.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.49 131.43 5.51 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 111.371 -0.691 . . . . 63.32 111.371 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.536 HG22 HD11 ' D' ' 51' ' ' LEU . 60.4 mt -89.32 128.42 41.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 C-N-CA 124.497 1.119 . . . . 74.32 107.985 175.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -136.79 145.66 44.8 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.883 0.373 . . . . 74.43 110.876 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 16.6 m -78.04 99.47 6.11 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.274 -1.009 . . . . 72.1 108.274 166.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.465 HD12 ' HB2' ' D' ' 56' ' ' TYR . 66.1 mt -107.22 108.6 25.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 123.867 0.867 . . . . 72.05 108.845 -175.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.52 163.77 34.67 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.545 1.138 . . . . 73.2 109.786 -175.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.71 20.82 79.82 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.693 -0.685 . . . . 74.35 114.373 173.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.521 HG23 ' N ' ' D' ' 90' ' ' GLU . 6.0 mt -104.6 156.88 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 117.374 0.587 . . . . 75.31 110.386 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.521 ' N ' HG23 ' D' ' 89' ' ' ILE . 6.8 pt-20 -140.22 147.62 40.3 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.431 1.092 . . . . 70.42 111.118 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.84 -136.11 48.93 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 115.216 0.847 . . . . 51.32 115.216 169.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 16.0 m -85.67 -9.17 57.63 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.911 0.885 . . . . 71.54 111.554 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.504 ' NE2' HG22 ' D' ' 89' ' ' ILE . 0.1 OUTLIER -53.05 -31.1 39.62 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.673 -0.862 . . . . 53.05 108.673 166.147 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 51.9 mtt -57.32 -55.24 37.31 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.975 0.91 . . . . 73.34 111.357 172.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.3 -29.66 70.94 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.417 0.687 . . . . 65.15 111.516 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -72.4 -40.71 66.98 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.06 0.944 . . . . 64.41 111.139 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.0 t -64.18 -49.56 71.57 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.364 0.666 . . . . 72.44 109.916 -176.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 34.0 mt -75.53 -26.94 58.46 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.275 -1.329 . . . . 74.32 110.914 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.01 -2.5 58.2 Favored Glycine 0 C--N 1.352 1.461 0 CA-C-O 119.368 -0.685 . . . . 74.24 114.399 -176.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.71 -58.98 0.57 Allowed 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 117.905 0.853 . . . . 74.25 111.338 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -71.11 -38.22 72.34 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 111.841 0.311 . . . . 70.4 111.841 -170.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 62.2 m -72.8 -47.98 8.61 Favored Pre-proline 0 CA--C 1.559 1.316 0 CA-C-O 118.576 -0.726 . . . . 75.12 111.776 -177.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.563 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 17.1 Cg_endo -61.5 -22.59 74.88 Favored 'Trans proline' 0 C--N 1.401 3.31 0 C-N-CA 122.27 1.98 . . . . 74.42 112.875 170.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -66.96 -37.46 84.31 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.223 0.609 . . . . 73.25 110.266 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 48.9 mm -71.08 -39.14 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.501 0.72 . . . . 65.11 110.333 175.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.413 HD11 ' O ' ' D' ' 80' ' ' GLN . 86.7 mt -79.28 -18.64 52.29 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.33 -0.85 . . . . 73.51 111.876 -177.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -61.21 -50.1 85.4 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-O 117.87 -1.062 . . . . 72.22 113.487 -175.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.78 -38.99 93.74 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 122.116 1.877 . . . . 71.35 112.667 178.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -78.17 -36.96 46.9 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.087 0.955 . . . . 62.13 112.26 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.79 73.84 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.046 0.539 . . . . 75.35 109.952 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.581 HH12 ' HG3' ' D' ' 130' ' ' PRO . 40.1 ttp180 -57.27 -51.48 69.17 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 124.164 0.915 . . . . 75.13 110.097 174.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -62.54 -43.82 97.87 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.719 0.807 . . . . 74.01 111.729 -174.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.8 t -58.78 -45.51 89.67 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.809 0.693 . . . . 74.51 110.779 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.455 ' O ' HG23 ' D' ' 118' ' ' VAL . 97.5 mt -62.55 -55.14 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.883 -1.053 . . . . 73.1 110.586 174.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 43.5 m -53.24 -40.06 64.29 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.849 1.26 . . . . 71.1 111.449 -174.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.0 t -66.36 -45.15 81.09 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.729 -1.123 . . . . 74.22 110.439 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.451 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 76.1 mtm -70.01 -28.54 65.58 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.781 0.432 . . . . 71.45 112.08 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.455 HG23 ' O ' ' D' ' 114' ' ' ILE . 96.0 t -64.85 -44.86 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.395 0.678 . . . . 74.55 109.633 174.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.8 p -77.3 -25.42 51.26 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 115.444 -0.798 . . . . 73.44 111.007 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' D' ' 116' ' ' SER . 91.0 mtt-85 -72.69 -35.22 67.59 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.438 0.695 . . . . 73.12 109.538 173.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.48 -0.14 86.42 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 115.644 -0.707 . . . . 64.42 112.122 171.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 42.6 p 62.97 22.02 13.22 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.938 2.095 . . . . 62.12 113.972 174.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -82.23 152.07 67.26 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 123.545 0.738 . . . . 75.42 109.286 169.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -49.59 132.2 29.91 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.372 2.715 . . . . 74.24 113.934 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -51.43 141.02 16.4 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.651 1.58 . . . . 73.34 113.002 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 62.5 tp -114.48 109.58 18.51 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.224 1.01 . . . . 74.5 109.577 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -113.62 97.14 6.25 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.645 -0.872 . . . . 75.41 108.645 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 20.1 tp -70.85 126.59 29.99 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 110.008 -0.367 . . . . 74.33 110.008 177.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -62.09 130.26 92.67 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.079 0.952 . . . . 72.11 110.676 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.581 ' HG3' HH12 ' D' ' 111' ' ' ARG . 2.4 Cg_endo -79.74 106.02 1.91 Allowed 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.657 2.238 . . . . 71.43 110.181 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 109.281 -0.637 . . . . 73.1 109.281 -178.783 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.686 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 8.4 t80 . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 120.26 0.076 . . . . 70.34 110.917 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -147.16 108.84 4.35 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.788 0.835 . . . . 73.15 109.412 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.611 HG12 ' HD2' ' A' ' 84' ' ' PHE . 66.7 mt -78.61 124.04 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 109.494 -0.558 . . . . 74.44 109.494 176.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -84.69 -40.05 17.83 Favored 'General case' 0 C--O 1.241 0.639 0 O-C-N 124.192 0.933 . . . . 74.03 110.667 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.411 ' HB3' HD13 ' A' ' 83' ' ' ILE . 23.7 ttt180 -173.35 137.41 0.66 Allowed 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.526 0.516 . . . . 73.13 110.179 -172.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 83.5 mt -126.2 138.81 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.321 -0.992 . . . . 75.32 108.321 174.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.497 ' HB3' HG23 ' B' ' 122' ' ' THR . 21.1 p90 -168.25 168.85 11.26 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.627 0.727 . . . . 73.04 111.599 -173.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -94.52 120.37 34.64 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.104 -0.953 . . . . 74.31 109.143 176.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.473 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 38.2 mtpt -91.34 -30.24 16.67 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.891 0.376 . . . . 74.35 110.635 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 18.8 t70 -148.34 134.39 19.23 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.229 -0.896 . . . . 73.24 109.141 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.464 HG22 ' SD ' ' A' ' 117' ' ' MET . 60.0 mt -132.17 139.31 50.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.061 -1.459 . . . . 60.33 107.061 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.1 t -146.49 122.15 10.49 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.693 -0.854 . . . . 74.53 108.693 173.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.598 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 93.5 t80 -126.0 129.56 49.45 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.699 -1.593 . . . . 75.4 106.699 171.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -139.74 119.31 13.12 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.676 -0.861 . . . . 74.33 108.676 -178.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.38 83.53 8.58 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 106.987 -1.486 . . . . 74.43 106.987 173.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.93 -30.24 67.22 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.916 2.41 . . . . 75.12 112.637 -167.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -117.47 26.45 9.72 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 124.145 0.978 . . . . 72.13 109.45 -174.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.55 ' HB2' ' HE3' ' B' ' 19' ' ' LYS . . . -45.62 -56.34 10.14 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 114.116 1.154 . . . . 74.34 114.116 -169.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 22.3 Cg_exo -64.16 -19.9 66.57 Favored 'Trans proline' 0 C--N 1.385 2.486 0 CA-C-N 121.62 1.614 . . . . 65.53 113.392 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -90.15 -38.19 13.67 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.235 1.014 . . . . 72.44 110.551 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.594 HG22 ' HA ' ' A' ' 73' ' ' ALA . 4.1 p -77.13 -21.19 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 115.246 -0.888 . . . . 70.45 112.185 -159.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -71.45 -24.62 62.05 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.013 -0.54 . . . . 74.34 110.841 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -76.0 -27.53 57.44 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.108 0.963 . . . . 74.13 110.297 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -71.18 148.9 46.86 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.081 0.952 . . . . 75.33 110.866 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.15 124.55 23.4 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.117 0.967 . . . . 71.53 109.333 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -82.04 79.4 8.56 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.704 0.764 . . . . 74.23 110.826 -176.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -132.53 77.15 70.43 Favored Pre-proline 0 C--O 1.245 0.846 0 N-CA-C 106.584 -1.635 . . . . 73.13 106.584 169.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -85.41 154.57 10.67 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 121.986 1.79 . . . . 60.11 112.848 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -94.99 83.79 4.01 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 105.355 -2.091 . . . . 75.44 105.355 161.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.574 HG21 HD11 ' A' ' 126' ' ' LEU . 2.8 p -76.48 92.17 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-O 122.575 1.179 . . . . 74.04 108.15 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -87.01 115.33 24.32 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.214 -1.357 . . . . 72.34 109.363 -175.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.579 HD23 HD23 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -95.45 151.75 19.02 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.44 0.638 . . . . 74.24 110.282 177.24 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.599 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 13.4 t70 -145.38 150.57 36.8 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.603 -1.258 . . . . 73.42 107.603 -177.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.477 ' HB2' HD21 ' A' ' 60' ' ' LEU . 2.4 pt? -136.96 130.63 31.83 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.091 0.472 . . . . 73.14 110.44 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 13.7 t70 -122.94 151.08 42.14 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.46 1.104 . . . . 72.13 109.71 -178.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.0 p -106.71 127.71 53.6 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.379 -0.828 . . . . 74.34 110.923 -172.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.677 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -134.97 137.48 43.09 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.817 0.847 . . . . 64.2 109.019 172.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.0 p -132.12 163.08 29.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.941 0.496 . . . . 73.33 110.756 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.546 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 35.4 t -161.44 153.11 19.15 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.971 0.908 . . . . 64.32 109.82 176.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -113.58 120.18 40.04 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.433 -0.951 . . . . 75.31 108.433 167.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.489 HD12 HG22 ' A' ' 83' ' ' ILE . 52.8 mt -94.35 -32.15 13.72 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.988 0.515 . . . . 72.31 110.265 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.459 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -164.45 -177.11 4.69 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.372 1.069 . . . . 54.33 109.344 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -71.94 130.53 41.21 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.224 -0.658 . . . . 74.42 109.224 174.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 85' ' ' SER . 35.7 m-20 66.15 -2.08 1.04 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.495 1.118 . . . . 73.11 112.657 -174.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.459 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 65.5 t -116.45 107.61 22.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.637 0 N-CA-C 108.53 -0.915 . . . . 72.44 108.53 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -126.31 155.89 41.28 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.871 -0.789 . . . . 74.13 108.871 -174.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 35.5 tt0 -117.93 122.75 44.09 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 123.255 0.622 . . . . 74.14 109.424 175.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.2 t -105.48 122.35 58.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 107.017 -1.475 . . . . 74.14 107.017 170.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.677 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 47.5 t -114.98 129.44 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.453 -0.943 . . . . 62.53 108.453 176.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.477 HD21 ' HB2' ' A' ' 44' ' ' LEU . 1.4 tt -119.8 112.44 19.24 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.978 -0.749 . . . . 73.33 108.978 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.576 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 18.8 ttt180 -86.94 100.64 12.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.18 0.992 . . . . 71.34 109.354 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.8 t -95.46 104.74 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 109.117 -0.697 . . . . 74.44 109.117 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 25.5 m -96.08 106.79 19.01 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.6 0.76 . . . . 64.14 109.515 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.8 t -105.19 108.54 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.876 0.871 . . . . 64.34 109.818 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.2 m -102.23 142.96 32.64 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.827 -1.175 . . . . 71.53 107.827 174.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.01 120.64 35.99 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.334 -1.358 . . . . 62.02 107.334 170.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.2 m -117.64 124.36 48.4 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.736 -0.468 . . . . 72.13 109.736 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.521 ' HG ' ' HB1' ' A' ' 73' ' ' ALA . 94.0 mt -88.67 85.53 6.82 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.118 -1.067 . . . . 71.53 108.118 173.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.1 -93.87 1.44 Allowed Glycine 0 C--N 1.343 0.951 0 CA-C-N 114.845 -1.071 . . . . 74.21 111.276 -175.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -119.24 -20.54 7.91 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.503 0.721 . . . . 74.53 110.795 176.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.91 134.15 35.09 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.473 0.709 . . . . 73.15 109.364 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.1 m -73.41 126.62 30.6 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.298 0.499 . . . . 74.41 110.269 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.594 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -75.35 -58.77 3.08 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.628 0.771 . . . . 70.23 109.543 172.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.436 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 26.2 p90 -158.79 176.08 12.8 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.76 -1.109 . . . . 72.22 111.064 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.1 tp -138.06 142.44 40.29 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.904 1.282 . . . . 74.23 108.144 173.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.467 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 59.6 m -142.43 95.44 2.79 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.001 -1.111 . . . . 74.35 108.001 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -112.41 115.95 29.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.64 0.776 . . . . 75.53 108.937 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.5 t -126.96 117.4 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.637 0.775 . . . . 75.14 110.068 -176.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.425 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 75.5 mt-30 -84.61 96.1 9.08 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.246 -1.02 . . . . 73.15 108.246 168.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.407 ' HG3' HD23 ' A' ' 106' ' ' LEU . 9.5 tp-100 -82.79 103.6 12.4 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.009 -0.737 . . . . 75.32 109.009 177.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.81 146.08 20.4 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.33 -0.708 . . . . 64.52 111.33 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.439 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.23 121.02 1.16 Allowed Glycine 0 CA--C 1.505 -0.59 0 N-CA-C 111.031 -0.827 . . . . 42.42 111.031 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.489 HG22 HD12 ' A' ' 51' ' ' LEU . 34.7 mt -83.03 120.43 34.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 108.814 -0.809 . . . . 73.31 108.814 173.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.686 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 26.6 m-85 -130.1 124.29 32.42 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 109.358 -0.608 . . . . 74.12 109.358 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 73.9 m -86.6 98.34 11.04 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.535 -0.542 . . . . 72.13 109.535 168.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 28.6 pt . . . . . 0 N--CA 1.473 0.687 0 CA-C-N 115.187 -0.915 . . . . 74.4 109.286 177.911 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.865 0.364 . . . . 61.55 111.105 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -69.11 -35.36 76.35 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.471 -0.786 . . . . 75.54 110.975 174.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 78.8 m -69.37 -63.51 1.05 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 122.865 0.466 . . . . 64.23 111.201 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 pp -73.94 -14.05 60.99 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.03 0.532 . . . . 75.34 112.429 -177.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.45 -12.85 29.84 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-O 119.528 -0.595 . . . . 74.41 114.193 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.43 -57.9 0.49 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 117.773 0.786 . . . . 71.33 112.044 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -63.59 -58.74 6.0 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.294 1.038 . . . . 72.13 112.191 -169.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.2 m -70.86 -35.79 4.65 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 113.189 0.811 . . . . 75.12 113.189 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.87 -41.72 54.4 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 122.447 2.098 . . . . 74.53 113.497 162.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -71.48 -23.54 61.83 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.895 0.878 . . . . 73.13 110.5 -176.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -67.03 -39.77 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 123.094 0.558 . . . . 74.52 110.027 173.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.439 HD21 ' HA3' ' A' ' 82' ' ' GLY . 93.9 mt -76.48 -26.71 55.64 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.663 0.785 . . . . 72.14 112.507 -175.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -63.89 -44.12 77.95 Favored Pre-proline 0 CA--C 1.564 1.483 0 N-CA-C 114.003 1.112 . . . . 73.51 114.003 -171.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.33 -33.85 79.08 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 121.88 1.72 . . . . 75.12 113.205 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.507 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 77.5 m-85 -75.66 -37.92 59.23 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.463 0.705 . . . . 75.51 111.929 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.58 -39.19 70.72 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.842 -0.429 . . . . 55.34 109.842 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.662 ' NH1' HD13 ' C' ' 105' ' ' ILE . 33.4 ttm180 -61.96 -38.28 87.91 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 124.06 0.85 . . . . 74.12 109.62 172.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.519 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 2.9 tm-20 -65.95 -48.34 71.65 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.854 0.862 . . . . 72.33 111.071 -177.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 34.4 t -60.31 -44.77 95.12 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 124.273 0.983 . . . . 71.34 110.231 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 82.9 mt -66.47 -43.5 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.909 0.883 . . . . 73.43 111.149 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.1 m -59.81 -40.37 88.19 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.816 0.846 . . . . 60.14 110.606 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.7 t -72.22 -43.69 64.04 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.219 -0.901 . . . . 71.52 110.696 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.598 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 18.8 mtp -60.35 -40.28 90.19 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.466 0.706 . . . . 73.31 111.661 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.46 HG11 ' HB2' ' A' ' 123' ' ' PHE . 48.6 t -66.99 -45.07 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.98 0.912 . . . . 73.21 110.848 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.6 p -71.7 -30.81 66.08 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 120.73 0.3 . . . . 61.32 111.003 -176.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -70.05 -33.73 72.32 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.655 0.782 . . . . 75.35 109.591 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.7 11.97 43.72 Favored Glycine 0 C--N 1.356 1.653 0 O-C-N 123.88 0.738 . . . . 75.41 113.053 173.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.509 HG23 ' HE ' ' B' ' 15' ' ' ARG . 3.4 t 61.56 18.18 9.24 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 127.348 2.259 . . . . 74.32 113.819 172.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.46 ' HB2' HG11 ' A' ' 118' ' ' VAL . 90.3 m-85 -84.84 147.44 48.53 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 107.296 -1.372 . . . . 75.54 107.296 170.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.47 171.85 7.51 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.236 1.957 . . . . 75.15 112.156 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.545 ' HG2' ' H ' ' C' ' 16' ' ' ILE . 9.0 tp-100 -53.31 124.45 14.71 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.035 0.934 . . . . 75.23 112.065 -172.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.574 HD11 HG21 ' A' ' 40' ' ' VAL . 57.4 tp -116.9 118.3 32.09 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.39 -0.823 . . . . 72.1 108.945 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.501 ' ND2' HD13 ' C' ' 16' ' ' ILE . 15.4 m120 -123.65 115.77 21.99 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.755 0.822 . . . . 75.53 111.182 -174.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.579 HD23 HD23 ' A' ' 42' ' ' LEU . 71.1 mt -74.4 121.98 22.26 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.789 -0.819 . . . . 75.04 108.789 167.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.17 130.21 94.28 Favored Pre-proline 0 CA--C 1.555 1.159 0 N-CA-C 110.106 -0.331 . . . . 71.31 110.106 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.511 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 40.0 Cg_endo -67.56 119.35 6.36 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.785 2.324 . . . . 70.05 111.872 -174.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.2 p -101.97 125.24 56.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 114.97 -1.013 . . . . 63.42 109.982 -176.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -102.66 98.09 8.18 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.616 -0.883 . . . . 75.32 108.616 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 123.309 0.644 . . . . 73.4 110.366 178.4 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.56 ' HE2' ' HB2' ' B' ' 11' ' ' PHE . 26.0 ttt . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 122.029 0.919 . . . . 73.22 111.962 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 86.0 m -141.94 126.79 18.17 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 105.921 -1.881 . . . . 64.54 105.921 167.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.56 ' HB2' ' HE2' ' B' ' 9' ' ' MET . 60.6 t80 -143.28 140.47 30.63 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.202 0.456 . . . . 74.3 110.337 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.478 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -150.39 139.53 21.15 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.552 0.741 . . . . 74.33 109.401 173.059 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 25.7 mt -82.8 124.81 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.194 -1.039 . . . . 75.02 108.194 169.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -93.81 -38.12 11.41 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.074 -0.713 . . . . 75.14 109.074 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.509 ' HE ' HG23 ' A' ' 122' ' ' THR . 32.4 ttt180 -169.9 151.64 4.19 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.252 0.621 . . . . 73.31 110.218 -177.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.7 mt -132.95 140.97 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.364 -1.347 . . . . 72.51 107.364 174.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.407 ' HE1' HG13 ' B' ' 83' ' ' ILE . 31.1 p90 -169.72 157.23 6.84 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.61 0.719 . . . . 74.53 112.515 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 87.6 m -82.08 127.5 33.18 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.682 -1.144 . . . . 73.32 108.561 170.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.55 ' HE3' ' HB2' ' A' ' 28' ' ' ALA . 40.4 mtpt -98.39 -35.77 10.19 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.452 0.701 . . . . 72.11 110.39 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 13.1 t70 -150.81 137.72 19.1 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.72 -0.673 . . . . 71.53 110.954 -167.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.476 HD13 ' SG ' ' B' ' 113' ' ' CYS . 46.5 mm -137.92 143.83 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.088 1.355 . . . . 70.23 108.461 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 44.2 t -149.44 114.99 5.57 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.525 -1.287 . . . . 70.13 107.525 174.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 87.5 t80 -132.38 110.81 10.82 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.235 -1.024 . . . . 72.55 108.235 173.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -117.48 137.51 52.49 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.527 0.731 . . . . 64.41 109.363 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.24 84.3 17.23 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 106.489 -1.671 . . . . 72.31 106.489 177.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -63.83 -48.35 5.51 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.829 2.352 . . . . 72.23 112.275 -167.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -104.62 20.13 19.16 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.392 -0.822 . . . . 75.21 110.828 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.78 -59.51 3.46 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 115.56 1.689 . . . . 73.22 115.56 -168.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.75 -31.04 94.23 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 122.657 2.238 . . . . 63.22 113.121 -170.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -96.8 -37.19 10.37 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.173 -0.921 . . . . 74.31 111.6 -176.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.431 HG21 ' HA ' ' B' ' 73' ' ' ALA . 4.0 p -65.45 -20.3 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 123.214 0.606 . . . . 73.11 111.352 -172.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -61.94 -18.47 60.45 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.102 0.961 . . . . 73.52 113.421 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -62.82 -30.78 71.75 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.261 0.553 . . . . 61.42 110.205 176.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -87.71 80.77 7.83 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.45 1.1 . . . . 73.04 109.709 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -84.38 90.42 7.58 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.186 0.517 . . . . 72.11 110.143 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 27.5 p90 -158.73 172.38 18.36 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.711 1.204 . . . . 74.4 108.298 167.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -75.59 110.45 10.63 Favored Pre-proline 0 N--CA 1.477 0.895 0 N-CA-C 109.263 -0.643 . . . . 74.11 109.263 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.14 159.7 51.96 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.23 1.953 . . . . 72.21 112.653 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.44 112.19 3.01 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.685 0.615 . . . . 70.33 109.353 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 48.0 t -85.94 119.95 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.587 -0.894 . . . . 64.15 108.587 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.508 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 24.3 mtpp -119.45 98.56 6.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.332 -1.358 . . . . 71.24 107.332 177.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 pp -94.3 158.07 15.75 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.808 -0.633 . . . . 74.02 110.457 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -162.8 119.44 1.91 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.468 -0.567 . . . . 61.31 109.468 -175.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.593 HD23 HD13 ' B' ' 60' ' ' LEU . 5.2 mp -100.61 143.83 30.31 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.766 0.426 . . . . 74.45 110.1 -178.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -125.2 151.21 46.15 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.128 0.971 . . . . 74.23 109.409 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.1 p -109.02 133.78 52.54 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.338 0.655 . . . . 63.31 110.919 -170.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.624 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -148.65 148.83 30.54 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.617 0.767 . . . . 54.42 109.243 170.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.8 m -146.76 177.21 9.27 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.455 0.702 . . . . 74.23 109.951 172.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 1.4 m -151.55 138.63 19.16 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.681 0.792 . . . . 74.23 108.934 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -92.33 108.99 20.37 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.381 -1.34 . . . . 75.23 107.381 165.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 21.7 mt -83.77 -56.08 3.9 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.131 0.491 . . . . 74.04 109.797 -176.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' B' ' 55' ' ' VAL . . . -138.09 -170.22 2.74 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.197 -0.91 . . . . 71.41 109.257 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.45 109.94 4.47 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 114.75 -1.114 . . . . 55.34 109.542 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 70.45 2.63 4.14 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 125.081 1.352 . . . . 71.41 113.232 -177.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.402 ' HB ' ' HB1' ' B' ' 52' ' ' ALA . 78.3 t -105.74 123.08 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 108.435 -0.95 . . . . 73.21 108.435 173.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.43 ' HE2' ' HB3' ' B' ' 98' ' ' LEU . 4.9 p90 -133.37 175.35 9.49 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.142 0.977 . . . . 71.14 108.739 -176.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -145.4 116.0 7.66 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.806 -0.813 . . . . 71.32 108.806 -175.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 60.2 t -97.91 132.3 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.188 0.595 . . . . 73.51 109.989 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.624 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 20.7 t -115.96 119.06 60.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 124.339 1.056 . . . . 75.3 108.931 176.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.593 HD13 HD23 ' B' ' 44' ' ' LEU . 50.5 tp -106.49 112.44 25.44 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.428 -0.582 . . . . 63.03 109.428 170.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.533 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 31.2 ttm180 -85.52 132.43 34.2 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.708 -0.849 . . . . 73.44 108.708 170.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 17.5 t -126.22 120.96 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 107.819 -1.178 . . . . 72.45 107.819 172.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 9.0 m -114.08 152.54 30.91 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.702 0.801 . . . . 70.4 109.265 -176.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.533 HG22 HG21 ' B' ' 114' ' ' ILE . 97.2 t -139.6 103.62 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.682 1.193 . . . . 53.41 108.559 -175.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.508 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 97.4 m -83.08 140.24 32.77 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.29 -1.004 . . . . 73.11 108.29 162.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.03 137.49 23.57 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.092 -0.707 . . . . 74.23 109.092 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.461 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 36.8 p -144.06 128.73 18.2 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 123.614 0.571 . . . . 70.43 111.584 -174.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.405 HD13 HG23 ' B' ' 31' ' ' VAL . 61.2 mt -95.91 101.41 13.09 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.97 -1.122 . . . . 65.34 107.97 174.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.0 -112.69 3.5 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 116.049 -0.523 . . . . 64.12 112.546 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.71 21.47 11.48 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.034 0.934 . . . . 63.32 111.285 -176.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -137.96 151.63 48.13 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.05 0.54 . . . . 74.24 110.007 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 86.9 m -72.11 118.11 14.58 Favored 'General case' 0 C--O 1.241 0.629 0 O-C-N 123.391 0.432 . . . . 75.1 110.777 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.461 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -71.59 -62.25 1.48 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.228 -0.896 . . . . 75.11 108.738 172.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -152.08 164.73 36.66 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.079 0.942 . . . . 75.35 112.214 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 91.0 mt -132.69 114.02 13.68 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 106.043 -1.836 . . . . 75.42 106.043 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.7 t -116.36 151.28 36.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.568 -0.901 . . . . 72.34 108.568 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -163.42 126.84 2.73 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.42 -0.585 . . . . 75.24 109.42 -175.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 64.4 t -123.63 153.84 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 123.698 0.799 . . . . 74.13 109.117 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.551 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 20.9 mt-30 -127.91 103.54 7.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.235 -1.024 . . . . 65.21 108.235 166.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -91.21 102.29 15.01 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.979 -0.748 . . . . 73.25 108.979 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.412 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.19 164.39 28.39 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.522 -0.763 . . . . 75.53 111.666 174.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.77 127.75 1.72 Allowed Glycine 0 CA--C 1.504 -0.638 0 N-CA-C 111.413 -0.675 . . . . 75.31 111.413 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.407 HG13 ' HE1' ' B' ' 17' ' ' TYR . 66.4 mt -84.21 127.93 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.056 -1.09 . . . . 74.13 108.056 176.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -134.29 164.12 28.11 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.404 1.082 . . . . 75.34 109.136 -176.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.6 m -132.26 133.32 43.97 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.624 0.769 . . . . 63.42 109.454 175.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' B' ' 10' ' ' THR . 9.5 tt -135.53 146.36 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.837 0.855 . . . . 75.42 109.045 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.99 152.45 33.55 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.319 0.248 . . . . 73.12 110.433 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.91 -32.9 5.53 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.581 -0.736 . . . . 71.13 112.563 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.41 HG23 ' N ' ' B' ' 90' ' ' GLU . 46.6 mm -92.89 153.34 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.183 0.993 . . . . 74.44 111.756 -175.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.663 ' HA ' ' HE1' ' B' ' 94' ' ' MET . 0.0 OUTLIER -161.06 -172.0 3.28 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.664 1.186 . . . . 75.44 110.342 177.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.21 -133.44 52.35 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 114.935 0.734 . . . . 73.23 114.935 175.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.6 m -65.66 -37.75 87.39 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.545 0.738 . . . . 70.21 111.231 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -75.46 -20.82 58.58 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.513 -0.767 . . . . 75.2 110.741 -172.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.663 ' HE1' ' HA ' ' B' ' 90' ' ' GLU . 57.3 ttm -64.87 -45.11 87.37 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.425 -0.583 . . . . 75.5 109.425 168.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.02 -30.67 71.67 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.958 0.903 . . . . 62.11 111.168 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -69.94 -35.84 74.83 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.827 0.851 . . . . 75.55 110.995 176.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.419 ' SG ' HD11 ' B' ' 86' ' ' ILE . 42.0 t -69.11 -66.52 0.57 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.024 0.53 . . . . 70.1 110.952 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.43 ' HB3' ' HE2' ' B' ' 56' ' ' TYR . 1.2 pp -76.67 -5.88 49.77 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 112.731 0.641 . . . . 71.41 112.731 -176.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.97 -36.9 8.1 Favored Glycine 0 C--N 1.336 0.535 0 O-C-N 123.452 0.47 . . . . 72.02 113.391 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.84 -52.45 1.33 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.898 0.479 . . . . 73.21 111.569 -169.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -64.46 -46.52 82.74 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.307 1.043 . . . . 73.45 111.66 -174.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.422 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 84.2 m -75.36 -46.55 4.44 Favored Pre-proline 0 CA--C 1.563 1.467 0 N-CA-C 112.74 0.644 . . . . 72.53 112.74 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.486 ' HB3' HD22 ' B' ' 60' ' ' LEU . 53.8 Cg_exo -59.72 -25.29 78.66 Favored 'Trans proline' 0 C--N 1.388 2.612 0 C-N-CA 122.294 1.996 . . . . 75.44 113.887 171.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -62.17 -40.73 97.02 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.442 0.697 . . . . 70.52 110.397 174.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.423 ' HA ' ' NH2' ' D' ' 111' ' ' ARG . 73.9 mt -63.59 -43.67 98.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 CA-C-N 114.795 -1.093 . . . . 74.52 110.253 177.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 78.9 mt -81.98 -19.93 39.56 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.303 -1.317 . . . . 74.12 112.332 -171.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -54.13 -53.25 60.76 Favored Pre-proline 0 CA--C 1.563 1.447 0 N-CA-C 113.945 1.091 . . . . 74.33 113.945 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.98 -33.5 95.55 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.164 1.91 . . . . 73.45 113.711 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -71.74 -45.92 60.19 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.889 -0.596 . . . . 74.2 110.428 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.91 91.0 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.034 0.534 . . . . 75.1 110.563 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.0 ttt-85 -62.28 -51.67 66.76 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.24 1.416 . . . . 71.55 110.872 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.5 -32.72 72.9 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.356 0.663 . . . . 75.42 109.878 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.507 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.3 t -69.93 -35.93 74.93 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 122.653 0.381 . . . . 72.32 111.291 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.533 HG21 HG22 ' B' ' 64' ' ' VAL . 71.6 mt -64.25 -55.25 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 108.66 -0.867 . . . . 74.5 108.66 172.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 37.9 m -57.83 -31.51 66.7 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 124.374 1.047 . . . . 72.02 111.367 -175.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.1 t -62.65 -53.66 51.18 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 123.318 0.647 . . . . 72.52 109.533 175.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.3 mmt -65.92 -35.38 80.48 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.375 0.67 . . . . 75.44 111.582 -174.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.402 HG21 ' O ' ' B' ' 114' ' ' ILE . 85.2 t -64.23 -43.23 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.665 0.786 . . . . 74.23 110.154 175.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 39.7 t -70.08 -28.38 65.38 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.227 -0.897 . . . . 74.15 111.334 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.497 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 89.0 mtt-85 -71.06 -39.19 72.38 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.644 0.777 . . . . 74.44 110.205 176.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.98 -0.88 71.12 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.852 0.72 . . . . 72.43 112.643 172.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.497 HG23 ' HB3' ' A' ' 17' ' ' TYR . 19.0 p 63.76 31.88 13.96 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.561 1.945 . . . . 71.02 112.363 173.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -90.64 160.49 38.69 Favored Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 124.545 1.138 . . . . 74.34 110.407 176.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -50.77 159.64 2.22 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 123.969 3.113 . . . . 74.03 115.874 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -64.08 112.55 3.04 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.868 -1.06 . . . . 73.3 111.42 -173.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 50.6 tp -111.1 122.46 47.94 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.524 0.73 . . . . 74.12 109.271 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -132.8 122.5 24.58 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.303 -0.999 . . . . 73.3 108.303 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 93.3 mt -68.86 145.49 53.66 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.578 0.351 . . . . 75.3 110.816 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.18 142.13 40.79 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.225 0.61 . . . . 74.32 110.463 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.31 116.12 3.42 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.356 2.704 . . . . 75.41 111.844 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 35.2 m -124.55 140.34 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.179 0.592 . . . . 70.2 109.688 175.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -111.52 98.2 7.28 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.942 -0.762 . . . . 75.44 108.942 174.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -56.76 -34.99 68.12 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.87 0.868 . . . . 75.35 110.545 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 t70 . . . . . 0 CA--C 1.536 0.442 0 CA-C-N 113.67 -1.604 . . . . 72.14 111.764 -172.207 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.473 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 23.3 t80 . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 108.828 -0.804 . . . . 70.44 108.828 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -152.55 132.81 13.6 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.883 -0.784 . . . . 75.12 108.883 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 16.7 mt -87.65 131.58 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.83 -0.804 . . . . 74.01 108.83 174.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -92.94 -48.61 6.44 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.558 0.743 . . . . 71.12 110.325 177.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -173.92 130.42 0.4 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 115.963 -0.562 . . . . 75.35 109.778 -168.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.545 ' H ' ' HG2' ' A' ' 125' ' ' GLN . 61.3 mt -123.2 147.76 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.962 -0.755 . . . . 74.22 108.962 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.423 ' HH ' HD11 ' C' ' 83' ' ' ILE . 20.5 p90 -175.33 157.39 2.18 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.515 0.674 . . . . 74.33 110.076 -173.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.0 p -77.99 123.9 27.37 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.767 -1.106 . . . . 73.2 108.712 172.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -70.35 -49.19 51.85 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 107.479 -1.304 . . . . 74.11 107.479 167.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 11.4 t70 -136.68 136.92 39.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 112.874 -1.966 . . . . 55.21 109.203 -166.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.442 HG12 ' SG ' ' C' ' 113' ' ' CYS . 75.3 mt -134.63 142.59 40.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.663 -1.606 . . . . 74.43 106.663 171.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.4 t -156.2 150.47 25.51 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.89 -0.411 . . . . 73.3 109.89 175.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -152.26 116.69 5.01 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.446 1.098 . . . . 74.31 108.043 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -120.72 129.44 53.65 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.642 0.777 . . . . 74.21 109.757 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.38 82.7 33.79 Favored Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 107.25 -1.389 . . . . 74.22 107.25 170.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.92 -14.01 23.96 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.953 2.435 . . . . 72.24 112.06 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -110.79 17.21 20.82 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.138 0.975 . . . . 73.35 109.881 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.446 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -49.28 -56.53 15.57 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 114.514 1.302 . . . . 65.13 114.514 -167.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 35.1 Cg_exo -61.84 -38.9 55.95 Favored 'Trans proline' 0 C--N 1.385 2.474 0 CA-C-N 121.824 1.687 . . . . 73.53 112.39 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -69.5 -34.92 75.0 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.684 -1.144 . . . . 73.41 112.308 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.684 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.4 p -82.75 -16.68 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 N-CA-C 112.724 0.639 . . . . 73.24 112.724 -176.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -78.37 -16.9 57.19 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.257 0.466 . . . . 55.31 112.257 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -94.07 36.77 1.11 Allowed 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.344 0.592 . . . . 74.11 109.906 172.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.472 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 0.2 OUTLIER -126.79 167.21 16.09 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.27 1.028 . . . . 74.25 110.663 -178.55 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -89.97 132.19 35.47 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.804 0.842 . . . . 75.25 109.95 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 50.9 t-105 -81.97 90.51 6.49 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.192 0.52 . . . . 74.32 112.053 -173.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -143.55 77.95 14.9 Favored Pre-proline 0 CA--C 1.559 1.296 0 C-N-CA 124.496 1.119 . . . . 74.4 108.744 171.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -92.74 145.93 2.56 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.967 2.445 . . . . 53.53 114.623 -176.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.75 97.71 10.76 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 107.496 -1.298 . . . . 73.53 107.496 166.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' C' ' 65' ' ' THR . 9.6 m -83.85 100.29 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.745 0.783 . . . . 64.3 111.135 -176.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -92.57 109.09 20.49 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.628 0.771 . . . . 74.44 109.552 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 pp -86.0 163.02 18.22 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.781 -0.645 . . . . 72.41 111.196 -177.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.545 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 31.2 t70 -150.48 112.57 4.59 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.918 -0.771 . . . . 60.33 108.918 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' C' ' 61' ' ' ARG . 5.7 mp -113.51 112.87 24.31 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.035 -0.728 . . . . 74.35 109.035 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -116.87 152.63 34.08 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.098 0.959 . . . . 74.33 109.369 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 33.7 p -112.42 126.93 55.83 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.329 0.652 . . . . 75.02 111.028 -169.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.47 141.31 39.44 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.434 1.094 . . . . 73.42 108.534 174.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 36.0 p -165.73 164.96 18.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.337 0.255 . . . . 73.23 111.258 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 67.8 p -167.07 138.0 3.14 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.856 0.862 . . . . 73.15 109.511 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . 0.461 ' HA ' ' HA ' ' C' ' 56' ' ' TYR . 51.8 tt0 -78.7 117.76 20.15 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.742 -0.836 . . . . 75.31 108.742 174.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.557 HD12 ' HB2' ' C' ' 57' ' ' GLU . 33.3 mt -84.75 -39.91 17.9 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.981 0.912 . . . . 73.0 110.982 -171.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.88 -170.49 3.64 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.654 -0.703 . . . . 74.01 110.943 -175.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -59.05 107.51 0.55 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.315 1.046 . . . . 71.12 110.716 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 63.12 6.82 2.46 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.288 1.035 . . . . 52.02 112.677 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 91.9 t -103.68 113.19 39.85 Favored 'Isoleucine or valine' 0 C--N 1.345 0.38 0 N-CA-C 107.584 -1.265 . . . . 74.11 107.584 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' C' ' 50' ' ' GLN . 50.9 t80 -131.39 135.09 46.91 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.062 0.945 . . . . 74.41 108.8 -173.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.557 ' HB2' HD12 ' C' ' 51' ' ' LEU . 39.3 tt0 -92.43 136.95 32.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.785 -1.098 . . . . 72.22 110.377 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 86.3 t -119.35 115.36 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.312 -1.366 . . . . 75.32 107.312 173.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.3 122.1 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 109.208 -0.664 . . . . 75.41 109.208 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 tp -116.55 125.57 52.07 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.656 -0.868 . . . . 73.13 108.656 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 29.8 ttm180 -79.06 130.96 36.07 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.749 -1.204 . . . . 72.33 107.749 172.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.4 HG13 ' CD1' ' C' ' 114' ' ' ILE . 23.5 t -124.02 111.37 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.13 -1.433 . . . . 75.41 107.13 172.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 63.9 m -121.43 139.89 52.87 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.446 -0.946 . . . . 61.21 108.446 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 85.6 t -131.42 111.6 19.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 108.184 -1.043 . . . . 73.12 108.184 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' C' ' 40' ' ' VAL . 3.2 m -98.5 132.81 43.63 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 107.567 -1.271 . . . . 72.24 107.567 173.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.76 121.47 37.33 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.47 -0.937 . . . . 73.21 108.47 -177.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 47.1 m -136.17 126.08 25.86 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.04 0.447 . . . . 65.13 111.061 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 14.1 mt -86.06 57.92 4.76 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.135 1.374 . . . . 75.23 109.076 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.08 -92.64 1.07 Allowed Glycine 0 C--N 1.343 0.938 0 N-CA-C 110.245 -1.142 . . . . 60.53 110.245 -175.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -126.6 2.01 6.84 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.895 0.878 . . . . 73.35 110.064 172.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.472 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 11.9 tp10 -82.02 114.26 20.46 Favored 'General case' 0 C--N 1.347 0.481 0 N-CA-C 108.151 -1.055 . . . . 71.42 108.151 169.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.2 m -79.02 120.49 23.67 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 119.281 0.946 . . . . 73.15 109.146 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.684 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -79.81 -58.71 3.04 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.885 -1.052 . . . . 71.1 109.006 178.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -159.09 174.85 14.27 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 122.017 0.913 . . . . 72.43 112.321 -178.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.455 HD23 HG21 ' C' ' 65' ' ' THR . 2.4 tm? -138.61 142.57 39.13 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 105.37 -2.085 . . . . 63.24 105.37 170.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.47 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 48.1 t -150.29 112.84 4.71 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.586 -0.524 . . . . 74.22 109.586 176.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -118.01 130.9 56.46 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.568 0.747 . . . . 74.44 109.545 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 55.6 t -131.19 113.23 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.195 0.998 . . . . 75.54 108.542 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -91.03 95.17 9.97 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.885 -1.154 . . . . 74.31 107.885 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.515 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 7.3 tp-100 -86.08 115.42 23.66 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.158 0.583 . . . . 63.31 110.098 -176.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.69 146.88 18.07 Favored Glycine 0 C--N 1.338 0.652 0 O-C-N 123.489 0.493 . . . . 70.32 112.344 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.51 119.18 1.23 Allowed Glycine 0 C--O 1.237 0.308 0 N-CA-C 110.698 -0.961 . . . . 72.11 110.698 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.524 HD13 HD12 ' C' ' 51' ' ' LEU . 16.4 mm -83.86 123.75 39.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.595 -0.891 . . . . 71.1 108.595 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -132.31 123.85 27.67 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.98 0.512 . . . . 71.51 110.851 -173.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 58.7 m -80.19 105.27 11.33 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.394 -0.965 . . . . 72.34 108.394 166.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.4 ' H ' HD11 ' C' ' 86' ' ' ILE . 0.2 OUTLIER -116.0 139.2 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.052 -0.721 . . . . 72.31 109.052 -179.563 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.63 170.2 16.01 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.351 0.661 . . . . 71.45 110.247 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.81 -30.02 7.94 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-O 119.625 -0.542 . . . . 54.33 113.823 172.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 47.4 pt -123.7 151.31 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 118.001 0.901 . . . . 73.34 110.333 176.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.505 ' HA ' ' HE1' ' C' ' 94' ' ' MET . 41.5 tt0 -147.75 157.9 43.76 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.921 0.889 . . . . 73.54 109.774 178.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.58 -148.19 21.77 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 119.167 -0.796 . . . . 74.54 111.878 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 9.8 t -56.77 -26.56 57.81 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.394 0.677 . . . . 75.43 111.681 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -55.33 -59.12 5.24 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.225 1.41 . . . . 63.1 110.423 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.505 ' HE1' ' HA ' ' C' ' 90' ' ' GLU . 32.9 ttp -77.78 -22.47 50.11 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.358 -0.837 . . . . 74.43 111.425 -177.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.92 -35.08 79.49 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.261 0.624 . . . . 74.02 110.706 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -73.82 -31.67 63.34 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.396 -0.82 . . . . 73.02 110.617 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -66.47 -60.93 2.29 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.314 0.246 . . . . 71.55 110.716 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 pp -66.5 -29.96 70.18 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.192 0.597 . . . . 74.03 111.585 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.92 12.4 59.12 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-O 119.251 -0.749 . . . . 74.32 114.475 -173.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.41 -55.38 0.06 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.269 1.035 . . . . 72.33 112.045 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.511 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 56.1 t80 -71.23 -35.67 71.55 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.76 0.824 . . . . 71.23 111.555 -172.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.473 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 60.7 m -76.19 -50.91 2.83 Favored Pre-proline 0 CA--C 1.564 1.5 0 C-N-CA 123.603 0.761 . . . . 73.1 112.249 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.58 -13.54 35.27 Favored 'Trans proline' 0 C--N 1.398 3.138 0 C-N-CA 122.03 1.82 . . . . 75.41 112.959 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -60.89 -37.41 82.12 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.999 0.919 . . . . 75.14 110.154 171.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.662 HD13 ' NH1' ' A' ' 111' ' ' ARG . 37.9 mm -70.02 -36.06 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.229 -0.896 . . . . 74.34 111.19 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 53.6 mt -91.94 -24.59 19.22 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.862 -1.063 . . . . 72.32 111.985 -166.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -57.25 -52.64 72.71 Favored Pre-proline 0 CA--C 1.557 1.241 0 CA-C-O 117.99 -1.005 . . . . 75.33 112.733 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . 0.519 ' HB2' ' HG3' ' A' ' 112' ' ' GLU . 42.0 Cg_endo -63.45 -27.3 70.58 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 121.683 1.589 . . . . 75.32 112.788 -177.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . 0.523 ' CD1' HG21 ' C' ' 16' ' ' ILE . 3.2 m-30 -71.17 -50.4 33.67 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.801 0.84 . . . . 70.34 110.435 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.515 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -63.56 -35.34 80.17 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.303 -0.862 . . . . 73.43 110.914 176.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -60.02 -50.71 72.66 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.349 1.459 . . . . 74.51 111.587 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.7 -37.94 87.86 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 123.552 0.533 . . . . 75.24 109.696 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.442 ' SG ' HG12 ' C' ' 21' ' ' ILE . 42.4 t -63.9 -34.84 78.85 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.338 0.655 . . . . 70.23 111.766 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.47 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 68.0 mt -71.04 -52.19 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.127 0.571 . . . . 73.33 110.414 174.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 35.1 m -62.74 -30.02 71.12 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.25 0.62 . . . . 72.23 111.438 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.1 t -65.97 -48.71 70.36 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.899 -0.778 . . . . 73.14 108.899 174.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.655 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.11 -37.83 81.18 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.673 1.189 . . . . 71.31 112.32 178.496 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.4 HG23 ' O ' ' C' ' 114' ' ' ILE . 93.8 t -65.68 -42.94 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.365 0.666 . . . . 63.22 110.1 177.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.0 t -70.16 -29.1 65.92 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.38 -0.827 . . . . 74.04 111.714 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -69.92 -34.61 73.7 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.324 0.65 . . . . 73.53 109.3 175.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.46 11.27 64.08 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.713 0.633 . . . . 65.52 113.108 174.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 73.0 p 56.23 24.33 8.02 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 126.276 1.83 . . . . 74.23 114.23 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -84.77 140.53 37.85 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.057 -1.09 . . . . 63.23 108.057 169.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.48 168.84 2.67 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 123.028 2.485 . . . . 71.35 114.273 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -50.69 118.71 3.27 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.79 1.236 . . . . 74.53 113.594 -171.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.04 86.57 2.45 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 106.947 -1.501 . . . . 71.34 106.947 174.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -106.08 118.82 37.61 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.642 -0.873 . . . . 73.14 108.642 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.93 133.19 47.87 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.502 0.721 . . . . 70.12 109.459 -177.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.09 152.25 96.25 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 123.355 0.662 . . . . 73.33 112.486 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.507 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 19.3 Cg_endo -61.63 106.28 0.42 Allowed 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.076 2.518 . . . . 73.14 112.712 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.12 109.73 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 108.568 -0.901 . . . . 72.54 108.568 171.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -81.71 110.83 17.41 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.837 1.255 . . . . 73.42 109.996 175.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -49.83 -45.06 49.77 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.428 0.691 . . . . 73.23 111.345 174.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 N--CA 1.477 0.888 0 C-N-CA 124.743 1.217 . . . . 73.31 112.051 178.112 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 49.3 m . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 108.468 -0.938 . . . . 75.13 108.468 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -150.35 108.7 3.78 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.976 -1.12 . . . . 74.14 107.976 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . 0.605 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 43.5 mt-30 -126.46 118.51 25.1 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.194 -1.039 . . . . 75.21 108.194 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 19.8 mt -86.76 125.98 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 109.26 -0.644 . . . . 75.53 109.26 177.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -98.23 -29.06 13.42 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.411 0.684 . . . . 71.12 111.41 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -173.05 131.49 0.5 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 111.934 0.346 . . . . 74.34 111.934 -167.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.74 136.02 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 107.366 -1.346 . . . . 74.32 107.366 167.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.43 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 40.5 p90 -164.64 175.84 9.42 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.779 0.8 . . . . 73.44 112.234 178.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.4 p -110.64 127.69 55.37 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.703 -1.135 . . . . 74.34 109.408 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.43 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 37.9 mtpt -100.38 -18.1 16.91 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.611 0.764 . . . . 73.01 110.134 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.648 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 11.4 t70 -159.27 133.51 7.68 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.575 1.15 . . . . 75.21 108.207 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.655 HG21 ' HE1' ' C' ' 117' ' ' MET . 69.5 mt -136.27 146.52 28.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 106.704 -1.591 . . . . 74.44 106.704 173.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 22' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 23.0 t -152.61 143.82 23.19 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.142 0.577 . . . . 73.32 109.767 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.3 t80 -151.41 125.87 9.46 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 105.806 -1.924 . . . . 74.23 105.806 175.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -140.65 111.48 6.99 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.243 0.617 . . . . 71.42 109.807 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.56 92.0 9.43 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 108.508 -0.923 . . . . 64.13 108.508 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.82 -30.77 2.73 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.921 2.414 . . . . 71.31 113.559 -171.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -102.62 9.07 39.56 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.092 0.957 . . . . 64.01 111.081 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.414 ' O ' HG11 ' D' ' 31' ' ' VAL . . . -30.63 -65.59 0.19 Allowed Pre-proline 0 CA--C 1.556 1.211 0 N-CA-C 117.272 2.323 . . . . 75.32 117.272 -160.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.492 ' HB3' HD11 ' C' ' 83' ' ' ILE . 87.7 Cg_endo -75.09 -29.05 8.49 Favored 'Trans proline' 0 C--N 1.378 2.102 0 CA-C-N 123.173 2.169 . . . . 72.14 113.751 -171.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -85.72 -21.63 28.19 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.598 0.237 . . . . 71.15 110.508 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.414 HG11 ' O ' ' D' ' 28' ' ' ALA . 9.7 p -82.7 -15.72 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 116.037 -0.528 . . . . 72.33 110.827 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -69.69 -22.18 63.44 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 112.5 0.556 . . . . 70.44 112.5 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -57.81 -29.28 64.78 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.637 0.732 . . . . 54.12 109.6 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.535 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 90.4 mttt -88.11 71.13 9.32 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.073 -1.421 . . . . 72.24 109.328 173.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -88.65 84.54 6.73 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.293 0.568 . . . . 61.02 109.753 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.474 ' O ' ' HG2' ' D' ' 124' ' ' PRO . 8.9 p90 -147.49 178.48 8.4 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.379 1.071 . . . . 75.51 108.578 171.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -61.12 111.94 5.01 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 123.098 0.559 . . . . 73.45 109.903 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.11 127.63 24.83 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 121.914 1.743 . . . . 73.02 111.139 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.72 112.71 2.97 Favored 'General case' 0 C--N 1.347 0.469 0 N-CA-C 108.57 -0.9 . . . . 74.23 108.57 173.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 4.5 m -108.56 143.07 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 114.751 -1.113 . . . . 73.34 110.704 -169.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.54 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 13.9 tmtt? -125.46 122.33 36.34 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.224 -1.398 . . . . 74.32 107.224 177.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 pp -95.75 146.48 24.5 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 121.267 0.556 . . . . 74.2 110.037 -177.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.464 ' HB2' ' HZ2' ' D' ' 41' ' ' LYS . 25.9 t70 -147.41 132.02 17.81 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.139 -1.059 . . . . 75.02 108.139 175.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -110.29 144.11 39.49 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.066 -0.716 . . . . 75.4 109.066 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.485 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.3 t70 -132.11 146.37 52.0 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.146 -1.057 . . . . 73.43 108.146 174.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 94.5 m -105.52 144.23 32.57 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.436 0.694 . . . . 73.42 111.158 -173.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.717 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.72 154.58 35.52 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.823 0.849 . . . . 75.21 109.373 170.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 21.6 p -168.59 159.99 10.51 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.699 0.8 . . . . 61.41 109.503 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 51.9 p -160.73 140.53 10.96 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.402 0.681 . . . . 72.44 109.847 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -87.76 124.79 33.97 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.807 -0.442 . . . . 75.32 109.807 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.417 HD11 ' HB2' ' D' ' 57' ' ' GLU . 35.9 mt -95.58 -36.45 11.26 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.015 0.526 . . . . 71.2 110.165 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.85 178.7 9.81 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.303 1.041 . . . . 51.05 109.489 174.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -64.69 119.01 9.75 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.816 -0.809 . . . . 72.43 108.816 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 72.19 9.08 5.94 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 124.316 1.046 . . . . 75.12 111.723 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 90.1 t -118.45 115.1 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.21 -1.034 . . . . 73.52 108.21 171.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.46 ' HB2' HD13 ' D' ' 86' ' ' ILE . 69.8 m-85 -133.47 130.02 38.01 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.349 -0.612 . . . . 70.33 109.349 -175.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.417 ' HB2' HD11 ' D' ' 51' ' ' LEU . 12.8 tm-20 -92.58 124.7 36.8 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.619 -1.252 . . . . 75.33 107.619 174.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 84.6 t -119.98 132.49 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.336 1.054 . . . . 73.24 108.529 -169.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.717 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 14.7 t -125.0 136.73 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.263 0.625 . . . . 72.23 109.886 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 57.2 tp -125.72 118.79 26.35 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.408 -0.96 . . . . 70.54 108.408 167.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.485 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 16.9 ttm-85 -85.88 111.96 20.7 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.619 0.768 . . . . 73.22 109.497 176.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 45.8 t -91.85 128.65 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.521 -0.918 . . . . 74.21 108.521 170.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 9.9 m -122.67 134.82 54.47 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.337 -0.616 . . . . 74.4 109.337 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 57.3 t -127.18 101.53 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 125.86 1.664 . . . . 74.45 107.978 -173.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 21.4 m -92.25 94.34 9.12 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.744 -0.836 . . . . 75.32 108.744 176.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.5 141.39 30.63 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.99 -0.55 . . . . 73.44 110.377 -175.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 66.0 p -147.73 128.88 14.64 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.0 -0.546 . . . . 75.43 110.296 -178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 43.5 mt -93.46 108.83 20.45 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.965 -1.124 . . . . 72.33 107.965 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.91 -115.88 4.33 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.381 -0.827 . . . . 73.41 111.193 -171.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.29 6.15 10.71 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.731 0.812 . . . . 65.35 110.511 -174.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.535 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 11.6 pt-20 -121.59 152.83 38.83 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.905 0.882 . . . . 75.42 109.343 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 35.1 m -64.33 132.13 49.27 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.161 0.505 . . . . 73.21 111.512 -176.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.36 -60.44 1.95 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.492 -1.299 . . . . 73.04 107.492 174.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -157.19 159.38 37.67 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.332 -1.304 . . . . 74.25 110.135 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 86.8 mt -124.31 114.26 19.32 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 107.506 -1.294 . . . . 74.34 107.506 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.482 ' HG ' ' HE2' ' D' ' 117' ' ' MET . 1.2 m -114.12 135.47 53.99 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.061 -1.089 . . . . 72.11 108.061 -175.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 37.5 tt0 -156.18 121.05 4.66 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.624 -0.51 . . . . 75.4 109.624 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.5 t -135.12 116.93 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.025 0.53 . . . . 75.23 109.578 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.648 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 13.9 mt-30 -85.43 91.15 8.13 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.001 -1.111 . . . . 75.14 108.001 166.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -81.61 109.43 16.04 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.103 -1.073 . . . . 70.53 108.103 174.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.94 166.43 14.09 Favored Glycine 0 C--O 1.244 0.745 0 O-C-N 123.72 0.638 . . . . 62.12 111.993 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.89 136.49 4.2 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 112.054 -0.418 . . . . 64.4 112.054 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.8 mt -89.68 122.21 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.536 0.734 . . . . 75.54 109.102 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -130.87 125.48 33.67 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.727 0.811 . . . . 74.23 109.421 -175.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.605 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 45.5 m -89.91 96.74 10.82 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.828 0.851 . . . . 64.24 109.264 173.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.593 ' HB ' HD11 ' D' ' 89' ' ' ILE . 0.2 OUTLIER -110.79 114.92 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 123.588 0.755 . . . . 74.44 110.712 -178.118 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.41 162.47 25.5 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.783 0.833 . . . . 63.51 109.552 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.04 20.34 78.9 Favored Glycine 0 C--N 1.347 1.151 0 C-N-CA 121.783 -0.246 . . . . 71.54 112.74 178.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.593 HD11 ' HB ' ' D' ' 86' ' ' ILE . 55.8 mt -116.36 136.62 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.776 0.83 . . . . 73.23 109.137 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -151.05 152.36 33.34 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.433 0.693 . . . . 75.22 110.935 -170.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.92 -138.9 33.76 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 115.409 -0.814 . . . . 72.32 115.006 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 32.1 m -62.74 -25.58 68.26 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.118 0.967 . . . . 74.12 111.557 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.423 HE21 HG23 ' D' ' 89' ' ' ILE . 21.5 tt0 -62.11 -26.61 68.39 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.53 0.732 . . . . 64.54 111.073 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 69.5 mtm -68.7 -46.56 68.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.804 0.841 . . . . 74.34 111.227 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.04 -30.13 68.43 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.31 -0.859 . . . . 75.0 110.69 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -77.42 -27.15 52.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.414 0.685 . . . . 73.3 110.98 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.8 t -72.1 -52.95 14.36 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.398 0.618 . . . . 73.24 110.278 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 24.2 mt -86.47 -19.36 29.68 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 114.62 -1.173 . . . . 73.05 110.704 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.91 3.4 57.21 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-O 119.35 -0.694 . . . . 63.14 114.16 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.75 -65.9 0.34 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.105 0.952 . . . . 70.44 111.566 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -69.9 -45.95 66.48 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 112.373 0.508 . . . . 70.02 112.373 -173.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 84.0 m -62.94 -45.35 87.01 Favored Pre-proline 0 CA--C 1.569 1.686 0 CA-C-O 118.782 -0.627 . . . . 75.44 112.218 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -59.03 -27.66 85.65 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 122.786 2.324 . . . . 54.25 114.201 169.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -70.87 -26.51 63.29 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 122.854 0.462 . . . . 60.41 111.419 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 43.8 mm -72.02 -35.61 54.42 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-O 121.415 0.626 . . . . 73.14 109.465 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 86.0 mt -84.3 -23.3 30.36 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.058 -0.974 . . . . 63.43 112.114 -175.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 94.0 t80 -58.99 -49.1 95.16 Favored Pre-proline 0 CA--C 1.562 1.407 0 N-CA-C 113.662 0.986 . . . . 74.25 113.662 -174.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.06 -37.48 95.64 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 121.851 1.701 . . . . 75.22 113.116 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -75.9 -37.66 58.56 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.499 -0.773 . . . . 73.41 111.529 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.62 -41.39 96.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.081 0.552 . . . . 74.33 110.086 177.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.423 ' NH2' ' HA ' ' B' ' 105' ' ' ILE . 36.9 ttp180 -58.44 -53.42 58.53 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 124.214 0.946 . . . . 74.33 110.394 174.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.24 -43.26 96.25 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.187 0.929 . . . . 74.15 111.46 -174.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.8 t -59.58 -45.73 91.01 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.637 0.586 . . . . 64.33 111.081 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.43 ' O ' HG23 ' D' ' 118' ' ' VAL . 91.7 mt -64.35 -55.72 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 115.741 -0.663 . . . . 74.13 110.415 177.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 57.6 m -52.79 -40.36 63.14 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.693 1.197 . . . . 73.41 111.753 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.5 t -69.42 -42.39 75.08 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.33 -0.85 . . . . 63.54 110.075 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.482 ' HE2' ' HG ' ' D' ' 76' ' ' CYS . 75.8 mtm -64.85 -34.34 78.14 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.906 0.482 . . . . 62.41 111.482 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.43 HG23 ' O ' ' D' ' 114' ' ' ILE . 93.6 t -63.68 -47.8 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.538 0.735 . . . . 70.51 110.002 176.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.2 p -71.78 -27.33 62.88 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.918 -0.583 . . . . 61.22 110.93 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 74.7 mtt-85 -73.67 -29.29 62.22 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.462 0.705 . . . . 74.44 109.834 173.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.85 3.78 85.88 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 119.523 -0.598 . . . . 32.05 112.723 174.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 44.7 p 60.19 24.98 14.33 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 126.401 1.88 . . . . 73.22 113.733 177.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -89.09 156.43 49.03 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.282 0.633 . . . . 73.43 109.764 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.474 ' HG2' ' O ' ' D' ' 36' ' ' TRP . 71.5 Cg_exo -49.23 123.54 10.27 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.368 2.712 . . . . 73.04 113.338 171.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -53.87 141.17 28.2 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.749 1.22 . . . . 73.35 112.205 -177.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -121.3 116.97 25.85 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.493 -1.299 . . . . 71.42 107.493 -177.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -112.25 103.5 11.64 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.389 0.676 . . . . 73.41 109.513 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.1 116.22 10.2 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.049 0.539 . . . . 73.25 110.558 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.49 143.46 97.86 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.232 0.613 . . . . 62.42 110.28 175.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.72 123.17 13.17 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.082 2.521 . . . . 74.31 112.832 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 98.6 t . . . . . 0 N--CA 1.465 0.316 0 C-N-CA 123.634 0.774 . . . . 73.35 108.941 -176.371 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.59 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 20.5 t80 . . . . . 0 C--O 1.237 0.396 0 N-CA-C 109.296 -0.631 . . . . 70.41 109.296 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -146.72 115.02 6.66 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.912 -0.773 . . . . 74.33 108.912 176.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.688 HG12 ' HD2' ' A' ' 84' ' ' PHE . 32.8 mt -84.38 115.33 26.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.79 -0.818 . . . . 73.33 108.79 176.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -75.77 -33.56 60.2 Favored 'General case' 0 C--O 1.242 0.684 0 O-C-N 123.687 0.617 . . . . 71.05 110.816 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -171.51 148.04 2.46 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.329 0.393 . . . . 74.51 110.912 -170.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.458 HD13 ' HB3' ' C' ' 130' ' ' PRO . 87.6 mt -138.68 133.84 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 107.983 -1.117 . . . . 71.5 107.983 172.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -164.32 157.38 17.57 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.147 0.979 . . . . 75.44 110.701 -171.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -84.42 113.18 20.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.888 -1.051 . . . . 62.44 108.636 177.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 32.7 mtpt -82.27 -31.86 29.88 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.844 0.354 . . . . 74.03 110.287 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.8 t70 -137.45 137.94 39.26 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.392 -0.822 . . . . 74.13 109.634 171.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 64.5 mt -127.23 139.98 50.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 C-N-CA 124.973 1.309 . . . . 75.02 107.535 171.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.9 t -150.45 128.17 11.64 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 123.822 0.701 . . . . 63.05 109.56 173.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 83.2 t80 -129.89 121.85 27.49 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 106.849 -1.537 . . . . 74.1 106.849 172.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 47.2 mt-10 -127.05 112.78 15.61 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.929 0.492 . . . . 62.3 110.0 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.5 81.77 4.33 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 107.287 -1.375 . . . . 72.22 107.287 169.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.43 -16.38 19.31 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.728 2.285 . . . . 65.12 112.599 -171.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -113.01 12.84 19.35 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.381 1.072 . . . . 71.22 110.567 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.35 -59.33 2.37 Favored Pre-proline 0 C--N 1.37 1.468 0 CA-C-O 117.337 -1.316 . . . . 73.32 114.38 -165.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -53.72 -45.23 42.59 Favored 'Trans proline' 0 C--N 1.39 2.737 0 C-N-CA 121.934 1.756 . . . . 75.44 113.881 -174.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -97.75 -14.12 21.02 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.105 0.78 . . . . 72.43 113.105 -170.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.613 HG22 ' HA ' ' A' ' 73' ' ' ALA . 8.0 p -75.46 -22.21 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-N 118.288 0.495 . . . . 74.43 111.341 -175.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -65.85 -22.24 66.52 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.23 0.612 . . . . 73.52 111.124 173.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -80.68 -19.53 44.98 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.143 0.977 . . . . 75.54 111.079 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.429 ' NZ ' ' HB2' ' A' ' 71' ' ' GLU . 31.8 mmtp -81.62 155.02 25.85 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.707 0.803 . . . . 70.45 111.453 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.59 132.37 49.61 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.094 0.958 . . . . 63.32 110.296 174.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -81.59 85.68 6.5 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.012 0.525 . . . . 75.13 110.196 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -121.82 82.25 42.23 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 107.509 -1.293 . . . . 73.43 107.509 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -75.14 115.18 4.19 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 122.435 2.09 . . . . 72.24 111.948 -172.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -91.95 96.53 10.43 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.091 -1.818 . . . . 71.4 106.091 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 m -66.5 90.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.615 0 CA-C-O 122.69 1.233 . . . . 74.55 110.3 -175.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.527 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 54.2 tptt -96.85 110.69 23.13 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.541 -1.651 . . . . 74.54 106.541 175.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.493 HD21 ' H ' ' A' ' 42' ' ' LEU . 2.0 pt? -110.37 147.14 34.56 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.875 -0.417 . . . . 71.13 109.875 -172.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.561 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 13.5 t70 -130.91 129.11 41.81 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.295 -1.372 . . . . 74.44 107.295 177.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -126.57 129.52 48.73 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.108 0.563 . . . . 72.02 109.564 -174.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -152.33 163.06 40.24 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.184 0.994 . . . . 74.12 108.852 -177.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.2 m -147.39 144.11 28.46 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.429 0.692 . . . . 71.22 110.804 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.52 122.22 25.77 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.171 -1.418 . . . . 74.4 107.171 173.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.5 p -131.52 153.5 49.75 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.727 0.299 . . . . 65.31 110.851 -173.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.8 t -155.74 146.83 22.43 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.744 0.818 . . . . 72.52 109.966 -173.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -76.53 141.26 41.27 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.905 -0.776 . . . . 74.35 108.905 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.463 HD13 ' HB2' ' A' ' 57' ' ' GLU . 69.0 mt -113.73 -39.54 4.0 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.095 0.958 . . . . 75.34 109.605 176.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.96 -170.48 3.41 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.242 0.617 . . . . 75.35 110.296 -177.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -60.9 108.33 0.85 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.564 0.746 . . . . 73.34 110.059 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 65.01 7.13 3.82 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.69 1.196 . . . . 73.01 112.79 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.3 t -98.93 116.32 41.66 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 N-CA-C 107.239 -1.393 . . . . 73.25 107.239 178.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -131.81 128.67 39.22 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.173 0.989 . . . . 75.1 109.391 -172.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.463 ' HB2' HD13 ' A' ' 51' ' ' LEU . 38.3 tt0 -87.33 131.42 34.27 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.588 0.755 . . . . 73.4 109.743 172.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.464 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 98.3 t -118.77 116.18 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.156 -1.053 . . . . 60.43 108.156 171.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.543 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 35.6 t -101.31 117.76 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 109.044 -0.724 . . . . 63.42 109.044 175.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.39 113.77 26.68 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.252 -0.647 . . . . 75.12 109.252 -176.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -82.6 101.99 11.14 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.668 -0.864 . . . . 75.52 108.668 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.6 t -100.14 102.6 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 107.404 -1.332 . . . . 74.11 107.404 170.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 37.2 m -106.59 135.92 47.27 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.935 0.894 . . . . 54.12 109.715 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.553 HG12 HD23 ' A' ' 126' ' ' LEU . 40.5 t -130.98 126.6 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.765 1.226 . . . . 75.23 108.753 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 10.8 m -112.44 135.33 53.27 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.545 -0.909 . . . . 74.43 108.545 174.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.92 105.63 14.87 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.364 -1.346 . . . . 65.11 107.364 170.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.7 m -107.1 133.81 51.15 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.903 -1.147 . . . . 74.3 107.903 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.513 HD13 ' HB1' ' A' ' 73' ' ' ALA . 52.7 mt -103.48 47.87 0.87 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.413 -0.958 . . . . 72.52 108.413 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.18 -84.44 1.35 Allowed Glycine 0 C--N 1.342 0.881 0 N-CA-C 110.848 -0.901 . . . . 74.12 110.848 -170.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -90.69 -31.41 16.6 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.615 0.766 . . . . 73.41 111.588 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.429 ' HB2' ' NZ ' ' A' ' 34' ' ' LYS . 3.8 tp10 -115.9 112.69 22.27 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 116.282 -0.417 . . . . 63.11 110.294 -162.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.2 m -70.73 119.57 15.08 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.881 -0.414 . . . . 74.25 109.881 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.613 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -70.01 -58.56 3.69 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 114.951 -1.022 . . . . 75.33 109.52 175.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -155.68 171.57 19.77 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.141 -0.936 . . . . 72.1 112.528 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 28.0 tp -141.31 107.63 5.26 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 113.701 -1.59 . . . . 73.33 107.754 175.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.0 m -106.39 101.68 11.14 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.373 1.069 . . . . 52.44 110.556 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -116.43 117.3 29.55 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.918 0.887 . . . . 73.23 109.292 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.0 t -131.07 110.45 18.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 123.818 0.847 . . . . 75.25 109.326 -174.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 69.9 mt-30 -85.92 88.52 7.58 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.811 -0.811 . . . . 63.35 108.811 171.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -80.46 100.47 8.53 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.347 -0.842 . . . . 64.51 109.537 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.29 144.94 19.45 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 111.678 -0.569 . . . . 64.42 111.678 176.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.98 127.48 2.8 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.408 -0.677 . . . . 53.31 111.408 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.3 mt -85.2 124.75 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.629 0.772 . . . . 75.32 108.946 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.688 ' HD2' HG12 ' A' ' 13' ' ' ILE . 12.5 m-85 -133.41 159.87 39.04 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.111 0.564 . . . . 73.02 109.557 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.0 p -111.24 114.18 27.19 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.063 -0.718 . . . . 62.52 109.063 170.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.6 HG12 HD21 ' A' ' 98' ' ' LEU . 4.1 mp . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 107.754 -1.202 . . . . 73.43 107.754 175.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.909 0.385 . . . . 75.54 110.682 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.423 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 58.9 t-80 -83.76 -37.16 22.98 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.774 -0.648 . . . . 74.41 111.071 176.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 74.3 m -77.75 -64.29 1.19 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 122.724 0.41 . . . . 52.2 111.104 -177.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.6 HD21 HG12 ' A' ' 86' ' ' ILE . 3.2 tm? -72.92 -39.75 66.05 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.883 0.873 . . . . 71.35 110.867 -175.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.82 0.44 76.56 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-O 119.378 -0.679 . . . . 74.31 114.672 -171.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 96' ' ' HIS . . . -146.55 -50.61 0.21 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.113 0.957 . . . . 71.21 112.43 -172.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.476 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 65.1 t80 -76.21 -49.99 15.71 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.556 0.743 . . . . 74.4 111.994 -174.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.2 m -68.47 -34.27 5.49 Favored Pre-proline 0 CA--C 1.568 1.667 0 N-CA-C 113.435 0.902 . . . . 73.32 113.435 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -50.93 -44.36 42.3 Favored 'Trans proline' 0 C--N 1.396 3.065 0 C-N-CA 122.68 2.254 . . . . 72.53 112.954 162.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -70.2 -22.41 62.93 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 114.846 -1.07 . . . . 73.42 111.614 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.1 mm -70.31 -43.93 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 123.299 0.64 . . . . 74.42 110.714 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 88.9 mt -76.31 -19.31 58.38 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.804 -0.634 . . . . 75.31 111.596 -176.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -64.33 -48.33 76.08 Favored Pre-proline 0 CA--C 1.568 1.657 0 N-CA-C 114.153 1.168 . . . . 74.41 114.153 -172.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.28 -34.48 67.29 Favored 'Trans proline' 0 C--N 1.388 2.649 0 CA-C-N 122.035 1.763 . . . . 71.41 112.754 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.444 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 86.4 m-85 -69.2 -45.17 70.56 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.607 0.763 . . . . 73.32 111.435 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.2 -37.83 78.29 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.963 -0.562 . . . . 74.24 110.716 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -60.68 -45.6 93.55 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 124.004 0.815 . . . . 75.04 109.641 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -66.14 -44.56 83.82 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.651 0.78 . . . . 75.54 111.5 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -60.21 -42.21 94.65 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.532 0.52 . . . . 74.41 110.107 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 59.0 mt -59.53 -52.56 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 124.082 0.953 . . . . 74.23 110.5 172.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.407 HG22 ' HE2' ' C' ' 109' ' ' TYR . 94.9 m -54.58 -46.7 73.78 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.472 1.109 . . . . 75.33 111.969 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 44.3 t -70.41 -34.53 72.63 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.331 -0.849 . . . . 71.14 111.22 -176.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.404 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 9.3 mtp -67.44 -40.53 85.44 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.318 0.647 . . . . 75.31 110.863 175.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 51.4 t -62.92 -51.1 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.695 1.198 . . . . 75.45 110.799 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.4 p -68.35 -29.24 67.92 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.356 0.662 . . . . 73.42 111.373 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.602 ' HG2' ' HG1' ' B' ' 18' ' ' THR . 18.5 ttm-85 -74.31 -30.28 61.99 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.207 1.003 . . . . 74.41 110.042 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.441 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.93 11.6 59.6 Favored Glycine 0 C--N 1.353 1.522 0 CA-C-N 115.23 -0.895 . . . . 73.41 112.603 172.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.441 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.0 OUTLIER 66.17 11.59 7.95 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 127.025 2.13 . . . . 72.41 113.148 175.532 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -78.64 148.99 74.07 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 123.263 0.625 . . . . 75.03 109.722 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.02 158.81 41.56 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.622 2.215 . . . . 73.32 112.34 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.403 ' OE1' HG23 ' A' ' 115' ' ' THR . 6.1 tp-100 -58.77 132.56 54.25 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.546 1.138 . . . . 61.21 112.829 -167.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.553 HD23 HG12 ' A' ' 64' ' ' VAL . 51.9 tp -129.31 110.74 12.19 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.986 1.314 . . . . 65.43 109.726 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -129.8 121.16 26.25 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.65 0.78 . . . . 71.03 108.957 172.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.441 HD13 HG22 ' A' ' 64' ' ' VAL . 6.4 mp -71.83 147.0 47.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.615 0.366 . . . . 73.31 110.649 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.76 140.47 96.33 Favored Pre-proline 0 CA--C 1.554 1.124 0 O-C-N 123.771 0.669 . . . . 71.3 110.86 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.31 133.21 42.21 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 123.265 2.643 . . . . 52.53 112.125 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 m -127.1 113.95 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 121.666 0.746 . . . . 65.33 110.391 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -87.88 96.89 10.65 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.242 -1.022 . . . . 75.11 108.242 168.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 . . . . . 0 N--CA 1.475 0.809 0 O-C-N 123.879 0.737 . . . . 72.42 110.474 178.703 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.546 ' HE1' HG21 ' B' ' 86' ' ' ILE . 1.9 tmt? . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 120.907 0.384 . . . . 74.05 111.766 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 87.6 m -169.03 139.58 2.32 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 125.078 1.351 . . . . 75.23 107.936 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.35 157.37 45.65 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.413 0.625 . . . . 75.32 110.105 157.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.475 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -124.56 131.45 53.48 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 107.185 -1.413 . . . . 74.03 107.185 175.558 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 59.7 mt -67.87 117.32 9.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.215 -1.032 . . . . 74.4 108.215 174.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . 0.438 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 11.5 mm-40 -86.9 -37.89 17.24 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 124.038 0.836 . . . . 74.25 108.745 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.421 ' HE ' HG23 ' A' ' 122' ' ' THR . 42.4 ttt180 -175.27 137.61 0.4 Allowed 'General case' 0 C--N 1.355 0.828 0 CA-C-N 115.4 -0.818 . . . . 74.33 109.606 -176.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 94.2 mt -115.49 141.51 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 107.273 -1.38 . . . . 63.53 107.273 173.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.407 ' HE2' ' HZ3' ' B' ' 19' ' ' LYS . 31.2 p90 -165.88 146.41 6.66 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.989 0.423 . . . . 75.54 111.484 -174.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.658 HG21 HD13 ' B' ' 21' ' ' ILE . 96.2 m -75.97 123.48 25.81 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.382 -0.826 . . . . 71.24 109.049 169.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.468 ' HD2' HG23 ' B' ' 59' ' ' VAL . 23.0 mtpp -89.17 -38.84 13.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.817 -0.629 . . . . 74.32 109.965 178.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 14.6 t70 -153.21 142.44 21.49 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.174 0.435 . . . . 75.12 112.174 -169.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.658 HD13 HG21 ' B' ' 18' ' ' THR . 38.2 mm -134.79 146.34 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.029 1.332 . . . . 74.22 108.775 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.512 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 47.7 t -147.9 140.51 24.59 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.905 -1.146 . . . . 55.24 107.905 175.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.1 t80 -157.65 114.15 2.9 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.893 -1.151 . . . . 64.34 107.893 173.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -121.98 112.45 18.29 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.298 -0.63 . . . . 73.52 109.298 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.474 ' HB1' ' CB ' ' B' ' 28' ' ' ALA . . . -108.6 86.81 3.82 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 107.429 -1.323 . . . . 74.4 107.429 172.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.37 -40.79 2.83 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.331 2.021 . . . . 65.21 112.013 -176.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -92.44 9.29 34.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.805 0.842 . . . . 73.32 111.367 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.474 ' CB ' ' HB1' ' B' ' 25' ' ' ALA . . . -40.4 -66.04 0.4 Allowed Pre-proline 0 CA--C 1.57 1.722 0 C-N-CA 125.225 1.41 . . . . 74.0 114.58 -170.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.05 -34.99 94.12 Favored 'Trans proline' 0 C--N 1.399 3.202 0 C-N-CA 122.915 2.41 . . . . 73.33 113.536 -167.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -95.25 -28.85 14.81 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.545 -0.752 . . . . 73.35 111.972 -174.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 p -74.81 -12.44 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-N 118.271 0.487 . . . . 74.3 111.351 -176.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -68.82 -14.51 63.08 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.294 0.85 . . . . 73.22 113.294 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -64.49 -27.07 68.72 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.096 0.474 . . . . 74.44 110.148 172.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.503 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 99.1 mttt -87.75 84.01 7.1 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.647 1.179 . . . . 64.42 110.134 -177.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -93.27 87.56 5.69 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.377 -0.829 . . . . 73.15 109.873 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -160.23 177.03 11.06 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.298 1.039 . . . . 74.12 108.739 171.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -69.83 111.77 10.14 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 109.502 -0.555 . . . . 72.32 109.502 176.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -67.04 157.46 61.61 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.317 2.012 . . . . 74.24 111.89 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 24.9 tt0 -66.23 103.54 1.01 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.16 -1.052 . . . . 71.23 108.16 169.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -86.94 141.59 14.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.579 -0.896 . . . . 71.01 108.579 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -147.05 99.43 3.17 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 108.27 -1.011 . . . . 63.05 108.27 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.19 165.66 12.29 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.213 0.53 . . . . 71.22 111.097 -177.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -159.79 136.61 9.27 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.534 1.133 . . . . 65.22 108.206 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 95.5 mt -99.85 158.26 15.93 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.631 -0.507 . . . . 73.54 109.631 175.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.486 ' HB3' ' HD3' ' B' ' 61' ' ' ARG . 23.0 t70 -145.74 151.85 38.63 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 124.427 1.091 . . . . 72.34 108.163 170.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 46.1 p -107.59 106.26 16.54 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.473 0.709 . . . . 73.23 109.554 -174.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.39 135.81 53.54 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.726 -1.213 . . . . 62.12 107.726 176.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.3 p -148.13 167.54 24.76 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.321 0.581 . . . . 74.22 112.33 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.5 p -153.89 155.66 36.12 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.277 -1.329 . . . . 64.25 108.378 167.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -121.16 119.76 33.28 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.002 -0.74 . . . . 74.33 109.002 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 61.8 mt -84.18 -34.82 23.9 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.335 0.654 . . . . 74.12 111.341 -173.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.51 -175.73 4.35 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.49 -0.777 . . . . 42.34 110.119 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -76.03 119.12 19.54 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.539 -0.755 . . . . 64.54 109.207 178.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 71.45 13.5 6.49 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.099 1.76 . . . . 64.33 111.292 -176.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 99.0 t -122.41 113.19 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 108.114 -1.069 . . . . 65.22 108.114 170.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -118.75 171.52 8.15 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.255 -0.646 . . . . 74.31 109.255 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -141.68 102.79 4.25 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 107.306 -1.368 . . . . 63.15 107.306 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 92.9 t -95.23 135.67 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.219 1.007 . . . . 74.45 110.302 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.468 HG23 ' HD2' ' B' ' 19' ' ' LYS . 22.2 t -128.94 116.39 40.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 124.027 0.931 . . . . 73.54 109.38 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.425 HD22 ' HB3' ' B' ' 103' ' ' PRO . 43.5 tp -95.44 109.41 21.6 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.9 -0.778 . . . . 74.52 108.9 172.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.63 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 59.5 ttt180 -92.34 108.55 20.04 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.465 0.706 . . . . 73.45 109.43 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 38.5 t -106.24 102.49 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.316 1.046 . . . . 72.21 108.99 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 7.9 m -98.2 135.93 39.13 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.436 0.694 . . . . 74.45 109.353 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' B' ' 76' ' ' CYS . 85.8 t -126.9 139.25 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.181 0.993 . . . . 75.15 110.414 -175.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.6 m -124.78 149.44 47.36 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.524 1.13 . . . . 74.14 108.093 172.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.79 142.09 26.24 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 122.927 0.491 . . . . 64.32 110.249 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.503 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 75.8 p -141.06 128.62 21.38 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 123.477 0.485 . . . . 75.04 111.03 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 29.7 mt -100.21 118.85 37.38 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.152 0.981 . . . . 73.2 109.052 175.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.6 -112.34 4.82 Favored Glycine 0 CA--C 1.526 0.726 0 O-C-N 123.932 0.77 . . . . 75.4 112.296 -175.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -115.37 3.05 14.09 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.273 0.629 . . . . 61.35 111.192 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.503 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 13.3 pt-20 -120.4 159.24 25.49 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.952 0.501 . . . . 75.05 110.69 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 58.6 m -68.94 120.78 15.36 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.618 0.767 . . . . 71.12 110.129 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.503 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -77.61 -61.17 2.08 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.259 -1.015 . . . . 63.12 108.259 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -156.34 164.57 38.14 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.628 -1.169 . . . . 75.44 111.427 177.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 45.5 mt -122.49 153.53 39.04 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 106.093 -1.818 . . . . 74.54 106.093 173.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.429 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 49.5 t -157.92 159.67 36.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.393 -0.595 . . . . 74.33 109.393 -179.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.8 tt0 -165.39 135.32 3.59 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.147 -1.056 . . . . 53.45 108.147 174.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 44.9 t -132.92 145.7 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 108.536 -0.912 . . . . 75.21 108.536 174.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.63 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 14.8 mt-30 -126.06 100.34 6.3 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.601 -0.888 . . . . 73.21 108.601 177.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -90.43 114.83 27.06 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.18 -0.674 . . . . 75.24 109.18 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.432 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -104.93 167.9 15.48 Favored Glycine 0 C--O 1.242 0.641 0 O-C-N 123.851 0.719 . . . . 65.41 111.652 177.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.29 134.41 3.14 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.992 -0.843 . . . . 73.21 110.992 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.438 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 45.0 mt -86.43 126.19 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 108.549 -0.908 . . . . 75.15 108.549 173.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -135.96 139.34 43.15 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 106.883 -1.525 . . . . 72.45 106.883 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 67.8 m -108.73 91.17 3.53 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.499 0.59 . . . . 62.5 111.531 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.546 HG21 ' HE1' ' B' ' 9' ' ' MET . 2.8 mp -97.6 130.92 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.772 0.829 . . . . 73.5 110.509 -171.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.79 165.57 27.13 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.737 0.815 . . . . 73.01 110.304 173.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.04 -56.9 0.65 Allowed Glycine 0 C--N 1.347 1.192 0 CA-C-N 116.161 -0.472 . . . . 41.54 112.133 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.408 HG23 ' N ' ' B' ' 90' ' ' GLU . 30.8 mm -87.93 161.83 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.774 0.83 . . . . 75.11 109.798 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.408 ' N ' HG23 ' B' ' 89' ' ' ILE . 40.4 tt0 -167.89 149.72 5.46 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.859 0.864 . . . . 75.5 110.339 166.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.47 -136.83 12.95 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.907 0.765 . . . . 74.31 112.625 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.2 m -81.86 -23.02 36.61 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 117.256 0.528 . . . . 72.44 111.253 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -68.1 -28.22 67.16 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.934 0.493 . . . . 74.44 109.885 169.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 12.4 ttm -79.16 -28.77 42.78 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.215 0.606 . . . . 63.25 111.081 175.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.61 -26.76 64.02 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.15 0.58 . . . . 75.21 111.093 174.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -71.42 -51.33 24.53 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.331 1.053 . . . . 73.43 110.606 172.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 39.2 t -59.66 -45.83 90.86 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.375 0.67 . . . . 63.51 112.418 -175.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 72.9 mt -87.5 -17.63 31.69 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.388 0.675 . . . . 74.22 111.551 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.7 3.88 32.38 Favored Glycine 0 C--N 1.35 1.325 0 O-C-N 123.244 0.34 . . . . 70.25 113.79 -175.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.53 -58.22 0.53 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.019 0.527 . . . . 74.03 110.4 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -73.64 -48.66 30.81 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.772 0.67 . . . . 74.21 112.378 -169.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.406 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 84.2 m -66.04 -46.92 63.81 Favored Pre-proline 0 CA--C 1.566 1.595 0 CA-C-O 118.699 -0.667 . . . . 63.12 111.322 177.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.425 ' HB3' HD22 ' B' ' 60' ' ' LEU . 85.5 Cg_exo -55.21 -33.1 83.26 Favored 'Trans proline' 0 C--N 1.402 3.356 0 C-N-CA 122.819 2.346 . . . . 74.51 114.094 168.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -63.13 -40.25 97.05 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.943 0.897 . . . . 64.13 110.25 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 84.2 mt -68.52 -47.53 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 115.121 -0.945 . . . . 75.23 110.45 175.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.08 -4.44 50.28 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.358 -0.837 . . . . 65.22 111.968 -173.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.07 -61.73 7.34 Favored Pre-proline 0 N--CA 1.478 0.958 0 CA-C-O 117.914 -1.041 . . . . 75.54 112.617 -177.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.77 -25.81 68.17 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 121.842 1.694 . . . . 74.53 112.976 -172.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -71.4 -49.59 40.39 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.812 0.845 . . . . 74.23 110.709 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.74 -42.18 97.91 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.47 0.708 . . . . 64.52 110.866 175.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.407 ' NH2' ' HB3' ' B' ' 127' ' ' ASN . 75.2 ttt-85 -59.17 -59.89 4.73 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.93 1.692 . . . . 74.14 111.512 -176.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -64.01 -25.29 68.06 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.147 0.979 . . . . 72.05 110.845 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.557 ' SG ' HD12 ' B' ' 21' ' ' ILE . 17.5 t -70.38 -46.87 63.19 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 122.293 -0.254 . . . . 71.11 111.604 178.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.414 HG22 HG22 ' B' ' 64' ' ' VAL . 97.8 mt -59.61 -49.98 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.491 0.716 . . . . 74.34 110.004 173.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 14.2 m -60.32 -28.54 68.21 Favored 'General case' 0 CA--C 1.556 1.198 0 O-C-N 123.853 0.721 . . . . 75.44 111.796 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -66.78 -46.86 73.96 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.497 0.719 . . . . 73.13 110.319 173.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.533 ' HE1' HG22 ' B' ' 21' ' ' ILE . 11.9 mmt -71.44 -30.28 65.85 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.979 0.512 . . . . 74.1 111.26 -175.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.5 t -61.23 -47.31 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.537 1.135 . . . . 75.52 109.761 170.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 40.8 t -65.35 -36.79 85.09 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.011 -0.995 . . . . 70.12 111.59 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -71.75 -32.44 67.71 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.694 0.798 . . . . 75.51 110.513 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.19 5.89 81.45 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 123.942 0.776 . . . . 65.43 112.665 174.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 54.7 p 56.7 55.79 6.05 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 125.766 1.626 . . . . 74.41 112.658 176.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -119.95 158.39 50.24 Favored Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 124.585 1.154 . . . . 74.54 110.873 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.93 164.83 5.66 Favored 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 123.845 3.03 . . . . 75.24 115.527 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.475 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -65.19 129.84 41.16 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.653 1.181 . . . . 74.51 112.056 -176.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -139.01 119.21 13.56 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.914 -0.773 . . . . 73.2 108.914 174.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . 0.407 ' HB3' ' NH2' ' B' ' 111' ' ' ARG . 31.8 m-80 -116.45 135.33 53.93 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.233 1.013 . . . . 74.44 109.416 173.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 54.5 tp -78.78 149.18 32.7 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.274 0.63 . . . . 75.31 109.861 175.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.35 148.75 86.28 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 123.192 0.597 . . . . 73.33 110.857 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.528 ' HG3' HD11 ' D' ' 16' ' ' ILE . 72.7 Cg_endo -71.15 88.6 0.7 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.118 2.545 . . . . 72.11 111.391 176.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.58 110.45 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 109.416 -0.587 . . . . 71.03 109.416 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -101.58 93.14 5.21 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 107.529 -1.286 . . . . 64.04 107.529 176.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -62.17 -35.95 80.38 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.461 0.476 . . . . 75.51 110.687 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 . . . . . 0 N--CA 1.481 1.103 0 C-N-CA 123.652 0.781 . . . . 71.31 110.335 179.192 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.417 ' CD1' ' HE2' ' C' ' 101' ' ' TYR . 1.1 t80 . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 108.58 -0.896 . . . . 74.54 108.58 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -137.68 120.89 16.84 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.83 -0.804 . . . . 75.23 108.83 173.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 32.9 mt -69.59 123.76 23.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.68 -0.859 . . . . 73.43 108.68 172.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -87.57 -49.18 7.35 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.518 -0.764 . . . . 72.25 109.564 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -174.41 125.76 0.32 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.754 -0.657 . . . . 75.35 109.728 -169.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 77.2 mt -116.12 138.42 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.315 -0.995 . . . . 73.4 108.315 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.476 ' HH ' HD11 ' C' ' 83' ' ' ILE . 26.5 p90 -175.28 165.45 3.32 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-O 121.484 0.659 . . . . 75.23 110.864 -172.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -86.25 125.07 33.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.501 -0.772 . . . . 75.53 109.389 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.442 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 20.6 mmtp -74.02 -48.47 29.86 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 106.895 -1.52 . . . . 74.12 106.895 167.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 24.4 t70 -134.99 146.56 49.18 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 113.64 -1.618 . . . . 62.33 110.403 -172.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 78.1 mt -140.64 146.04 24.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.088 -1.819 . . . . 75.04 106.088 175.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 31.2 t -160.54 150.32 17.65 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.18 0.514 . . . . 73.43 110.403 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 82.4 t80 -157.18 118.8 3.73 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.042 -1.096 . . . . 71.31 108.042 174.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' D' ' 19' ' ' LYS . 34.1 mt-10 -126.66 130.35 50.25 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.816 0.446 . . . . 74.41 110.204 169.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.57 92.99 12.96 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 107.263 -1.384 . . . . 63.21 107.263 172.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -59.4 -36.18 94.61 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.621 2.881 . . . . 71.42 114.11 -171.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -114.96 29.93 7.7 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.375 0.67 . . . . 63.45 110.245 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.79 -63.79 0.96 Allowed Pre-proline 0 CA--C 1.567 1.597 0 N-CA-C 114.51 1.3 . . . . 74.01 114.51 -164.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -62.67 -40.52 36.72 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 121.918 1.746 . . . . 65.41 112.708 -175.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -69.49 -33.11 72.38 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.075 0.95 . . . . 72.42 112.213 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.513 HG21 ' HA ' ' C' ' 73' ' ' ALA . 3.9 p -81.59 -23.1 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 122.761 0.424 . . . . 74.23 111.857 -177.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -65.45 -28.75 69.44 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.181 0.438 . . . . 74.41 112.181 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -90.23 32.13 0.95 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.696 0.798 . . . . 73.34 110.839 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.487 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 0.5 OUTLIER -125.7 162.63 24.6 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.248 0.619 . . . . 74.52 111.21 -173.494 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.19 129.56 38.31 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.302 1.041 . . . . 75.43 110.89 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 49.2 t-105 -87.4 85.11 7.11 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.698 0.799 . . . . 75.22 111.943 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -138.28 76.42 37.9 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 123.976 0.911 . . . . 74.34 108.804 166.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -81.69 156.76 18.59 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.606 2.204 . . . . 74.43 112.533 -176.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . 0.546 ' HB3' ' HE2' ' C' ' 41' ' ' LYS . 2.6 mp0 -85.36 93.61 8.76 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 106.255 -1.758 . . . . 75.53 106.255 164.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 13.7 m -67.28 95.56 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-O 122.184 0.993 . . . . 74.23 109.302 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.762 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 75.3 mmtt -95.54 100.74 12.44 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.259 -1.015 . . . . 74.14 108.259 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 pp -88.11 137.28 32.47 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.624 -1.171 . . . . 72.43 108.57 -178.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -146.79 107.71 4.17 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.78 -0.822 . . . . 73.03 108.78 -175.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.511 ' H ' HD23 ' C' ' 44' ' ' LEU . 2.0 pt? -119.99 122.86 42.1 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.761 0.791 . . . . 74.3 109.417 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.755 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 22.2 t70 -113.17 157.3 21.85 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 125.168 1.387 . . . . 62.24 109.208 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 74.9 p -113.64 122.27 46.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.2 1.0 . . . . 71.22 109.909 -174.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.59 136.44 41.06 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.578 -0.897 . . . . 75.43 108.578 175.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 25.8 p -164.09 151.65 12.29 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.779 0.431 . . . . 73.52 110.227 -175.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 73.1 p -153.75 154.14 33.49 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.507 0.723 . . . . 75.42 109.713 -175.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -89.3 128.93 35.92 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.529 -0.545 . . . . 73.31 109.529 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.507 HD13 HD13 ' C' ' 83' ' ' ILE . 65.1 mt -96.33 -42.87 7.94 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.638 0.775 . . . . 75.35 111.008 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.86 -166.03 1.51 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.181 -0.918 . . . . 73.2 110.449 -176.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.89 103.77 1.54 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.185 0.994 . . . . 73.2 109.758 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 71.13 -1.67 2.63 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.638 1.575 . . . . 71.13 113.162 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.3 t -91.64 96.3 6.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 106.917 -1.512 . . . . 63.23 106.917 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -110.1 126.69 54.3 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.11 -0.95 . . . . 75.41 110.58 -173.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -83.66 127.79 34.04 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.058 0.943 . . . . 75.01 109.521 175.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 99.1 t -119.28 115.87 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 107.696 -1.224 . . . . 75.2 107.696 170.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 77.5 t -116.38 122.35 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.481 0.712 . . . . 75.14 109.571 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 49.8 tp -106.06 106.8 17.48 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.07 -0.715 . . . . 71.43 109.07 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.755 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 3.1 tmt_? -82.79 108.23 15.99 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.884 -1.154 . . . . 75.51 107.884 177.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.442 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.7 t -106.89 133.64 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.27 -1.011 . . . . 74.31 108.27 176.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 17.7 m -134.19 118.24 17.41 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.033 -0.729 . . . . 73.31 109.033 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 88.7 t -109.75 120.93 61.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.881 -1.054 . . . . 63.41 108.743 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.762 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 6.9 m -107.85 144.3 35.24 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.981 -0.748 . . . . 73.43 108.981 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.9 112.98 10.41 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.499 -0.926 . . . . 71.4 108.499 176.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 51.3 m -133.16 127.39 33.74 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.281 -0.637 . . . . 65.2 109.281 174.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 36.2 mt -84.78 54.98 3.25 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.766 1.226 . . . . 73.22 108.75 176.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.66 -115.8 5.36 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 109.541 -1.424 . . . . 63.25 109.541 -170.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -92.12 -25.7 18.61 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.023 0.929 . . . . 74.43 109.663 170.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.487 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 13.9 tp10 -63.48 94.89 0.09 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.178 1.391 . . . . 72.21 110.101 177.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 30.7 m -75.37 121.48 22.32 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 120.869 0.366 . . . . 75.04 110.56 -174.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.513 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.93 -58.4 3.31 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.999 -1.0 . . . . 70.3 108.604 173.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -163.63 175.58 10.48 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.349 1.071 . . . . 75.22 112.65 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -141.8 141.02 33.15 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 105.046 -2.205 . . . . 75.11 105.046 170.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.48 ' SG ' HG21 ' C' ' 114' ' ' ILE . 49.4 t -147.8 134.74 20.21 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.85 -0.796 . . . . 72.05 108.85 -176.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -142.3 117.35 10.01 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.651 0.38 . . . . 64.43 110.499 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 83.3 t -119.1 122.32 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.828 -0.804 . . . . 74.41 108.828 171.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.468 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 57.4 mt-30 -98.46 89.78 4.55 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 107.782 -1.192 . . . . 75.41 107.782 177.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -78.82 108.95 12.64 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.08 -0.964 . . . . 73.41 110.051 -175.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.35 154.66 25.38 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-O 121.51 0.505 . . . . 71.41 111.855 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.482 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -153.42 117.58 0.81 Allowed Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 109.56 -1.416 . . . . 71.11 109.56 176.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.507 HD13 HD13 ' C' ' 51' ' ' LEU . 16.4 mm -85.61 118.51 32.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.018 -1.104 . . . . 75.04 108.018 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -130.61 129.77 43.14 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.924 0.889 . . . . 72.34 109.256 -171.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 68.6 m -84.31 118.13 24.01 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 109.141 -0.689 . . . . 74.54 109.141 170.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 3.8 mp -114.57 114.01 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 107.656 -1.238 . . . . 70.54 107.656 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.85 162.06 40.03 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.626 0.77 . . . . 70.13 110.259 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.36 -25.61 14.55 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.694 -0.684 . . . . 34.54 113.723 175.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.442 HG13 ' HB3' ' C' ' 94' ' ' MET . 46.3 pt -120.46 162.18 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.675 0.79 . . . . 72.41 110.039 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -147.44 -177.21 5.57 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.768 0.827 . . . . 73.13 109.634 -177.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.0 -136.38 42.05 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 114.569 0.588 . . . . 71.25 114.569 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 34.8 p -65.18 -22.25 66.88 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.535 1.134 . . . . 75.51 112.802 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -60.59 -55.99 26.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.414 0.685 . . . . 74.14 110.045 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.442 ' HB3' HG13 ' C' ' 89' ' ' ILE . 27.7 ptt? -80.79 -20.92 41.51 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.93 -0.577 . . . . 73.21 111.663 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.5 -35.1 79.85 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.315 0.579 . . . . 72.05 110.742 171.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -74.35 -37.11 63.62 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.324 -0.853 . . . . 72.34 110.386 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.478 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 41.6 t -58.35 -55.97 28.13 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.079 0.862 . . . . 64.03 110.552 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 pp -70.46 -28.3 64.9 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.94 0.496 . . . . 65.15 111.852 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.79 -30.04 60.25 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 114.428 0.531 . . . . 75.54 114.428 -171.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.59 -43.2 0.22 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 117.121 0.461 . . . . 72.01 111.878 -173.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.45 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 70.0 t80 -73.85 -35.73 64.81 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 124.822 1.249 . . . . 72.22 113.095 -170.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.478 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 85.8 m -82.09 -43.7 1.02 Allowed Pre-proline 0 N--CA 1.486 1.333 0 CA-C-O 118.759 -0.639 . . . . 74.24 112.477 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.1 -22.94 61.25 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 121.796 1.664 . . . . 71.03 112.115 171.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . 0.498 ' HA ' ' HD2' ' C' ' 107' ' ' PHE . 25.0 t-20 -56.36 -41.28 75.91 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.906 0.883 . . . . 71.2 111.002 175.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 44.0 mm -59.88 -42.08 88.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 115.156 -0.929 . . . . 73.2 109.802 175.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.482 HD21 ' HA3' ' C' ' 82' ' ' GLY . 96.6 mt -82.34 -20.61 36.97 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.077 -0.965 . . . . 73.03 113.484 -169.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . 0.498 ' HD2' ' HA ' ' C' ' 104' ' ' ASN . 16.5 m-85 -55.56 -49.25 93.71 Favored Pre-proline 0 N--CA 1.496 1.837 0 CA-C-O 118.008 -0.996 . . . . 75.01 113.43 -177.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -58.0 -39.81 82.97 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 122.274 1.983 . . . . 74.32 113.999 178.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . 0.407 ' HE2' HG22 ' A' ' 115' ' ' THR . 68.5 m-85 -68.11 -48.32 65.77 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.411 0.685 . . . . 72.42 110.757 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.61 -42.06 91.76 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.128 -0.942 . . . . 74.32 110.466 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -54.59 -57.98 9.3 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.405 1.065 . . . . 72.34 110.819 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -68.02 -30.94 70.29 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.48 0.488 . . . . 75.54 111.09 -173.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 12.5 t -72.31 -32.9 66.96 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.661 0.384 . . . . 72.3 111.289 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.48 HG21 ' SG ' ' C' ' 76' ' ' CYS . 96.9 mt -73.03 -48.1 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.565 0.746 . . . . 72.14 109.706 173.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 27.1 m -67.55 -30.22 69.81 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.409 0.684 . . . . 70.12 111.413 -174.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 43.5 t -66.0 -44.82 83.69 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.708 -0.849 . . . . 74.1 108.708 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.763 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.06 -38.32 90.71 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.383 1.073 . . . . 75.44 112.474 177.763 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.52 -39.92 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.718 0.807 . . . . 71.31 109.983 174.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.5 t -72.11 -30.99 65.62 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.143 -0.935 . . . . 73.23 111.282 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 73.2 mtt-85 -71.79 -34.1 69.13 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.826 0.851 . . . . 74.53 109.181 175.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.33 6.4 72.49 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 123.985 0.803 . . . . 63.12 112.958 173.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.2 p 61.11 26.81 16.68 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.425 1.89 . . . . 72.03 114.393 171.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -88.15 150.44 47.28 Favored Pre-proline 0 N--CA 1.474 0.765 0 N-CA-C 109.619 -0.511 . . . . 74.44 109.619 173.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.64 143.11 22.85 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.471 2.781 . . . . 61.15 113.762 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -58.08 114.97 2.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.41 1.084 . . . . 75.0 112.262 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 53.9 tp -117.08 103.83 10.63 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.025 0.93 . . . . 73.34 108.915 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -95.35 130.36 42.16 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.838 0.855 . . . . 72.23 109.18 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 tt -74.57 128.21 35.0 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 108.302 -0.999 . . . . 72.21 108.302 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.11 147.3 93.49 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.556 0.742 . . . . 74.3 111.72 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.458 ' HB3' HD13 ' A' ' 16' ' ' ILE . 11.6 Cg_endo -57.89 95.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.821 2.347 . . . . 75.55 112.981 171.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 47.4 t -101.59 108.8 24.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.778 -1.194 . . . . 73.12 107.778 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -90.7 88.01 6.92 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.588 -0.893 . . . . 73.44 108.588 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -54.71 -44.71 73.69 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.663 0.785 . . . . 71.54 111.757 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.5 t70 . . . . . 0 CA--C 1.549 0.915 0 O-C-N 124.954 1.408 . . . . 71.33 110.131 -177.628 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 89.5 m . . . . . 0 N--CA 1.467 0.384 0 N-CA-C 109.314 -0.625 . . . . 74.33 109.314 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -153.88 91.52 1.47 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.896 -1.52 . . . . 71.22 106.896 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -119.11 116.36 26.19 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.94 -0.763 . . . . 72.15 108.94 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.532 HD11 HG21 ' D' ' 105' ' ' ILE . 8.7 mt -74.32 116.43 16.85 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 N-CA-C 108.898 -0.779 . . . . 73.43 108.898 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.617 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 11.7 mm100 -81.68 -44.94 16.44 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.555 0.742 . . . . 74.31 110.492 -176.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -171.26 143.67 1.91 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.425 -0.352 . . . . 75.11 111.373 -170.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.528 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.4 mp -117.8 132.66 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 107.223 -1.399 . . . . 74.42 107.223 173.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -161.39 141.49 10.69 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.43 0.633 . . . . 74.45 111.056 177.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 77.0 p -77.36 110.96 12.53 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.004 -0.998 . . . . 73.12 109.265 175.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' C' ' 24' ' ' GLU . 36.9 mtpt -85.53 -23.46 27.69 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.565 -0.289 . . . . 75.41 110.481 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.791 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 4.5 t70 -143.19 139.72 30.43 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.333 1.053 . . . . 64.53 108.84 173.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.763 HG21 ' HE1' ' C' ' 117' ' ' MET . 94.4 mt -139.0 146.88 25.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 106.909 -1.515 . . . . 75.55 106.909 169.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.0 t -159.87 110.26 1.89 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.347 0.659 . . . . 44.54 110.062 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.449 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 94.0 t80 -109.54 131.41 55.09 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 106.106 -1.812 . . . . 75.12 106.106 168.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 39.0 mt-10 -138.61 119.77 14.6 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.97 0.508 . . . . 73.34 109.974 -172.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.36 83.71 37.11 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 108.833 -0.803 . . . . 71.15 108.833 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.75 -33.74 7.76 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.834 2.356 . . . . 73.11 112.237 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -89.22 -3.09 58.68 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.422 1.089 . . . . 74.4 111.89 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -32.39 -61.99 0.31 Allowed Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 116.795 2.146 . . . . 74.44 116.795 -164.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.34 -27.54 7.83 Favored 'Trans proline' 0 C--N 1.376 2.023 0 CA-C-N 122.708 2.003 . . . . 72.24 114.262 -172.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -86.86 -21.4 26.4 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 117.931 0.332 . . . . 71.22 110.838 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.58 -16.19 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 122.794 0.437 . . . . 64.04 110.041 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -68.04 -20.11 64.96 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.46 0.304 . . . . 71.44 111.648 175.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -56.01 -32.12 63.68 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.276 0.56 . . . . 73.13 110.057 171.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.652 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 97.3 mttt -85.99 85.57 7.37 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.831 1.252 . . . . 74.31 109.32 174.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -93.74 78.21 4.25 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.416 0.626 . . . . 74.05 110.418 -176.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -149.73 -178.03 6.22 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.49 -0.777 . . . . 65.15 109.612 170.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -76.42 110.96 12.91 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.65 0.78 . . . . 72.45 109.627 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.551 ' HB3' ' HG ' ' D' ' 68' ' ' LEU . 18.5 Cg_endo -63.22 147.44 93.94 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.472 2.114 . . . . 73.25 112.408 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -64.55 119.34 10.27 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.979 0.799 . . . . 75.0 108.954 172.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.639 HG12 HG13 ' D' ' 64' ' ' VAL . 99.5 t -96.54 131.04 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.856 -0.794 . . . . 72.34 108.856 -176.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.659 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 43.4 mtpt -106.33 157.36 17.67 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.807 0.843 . . . . 75.54 109.31 169.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.46 113.43 16.82 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 106.664 -1.606 . . . . 75.51 106.664 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.716 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 7.5 m-20 -117.71 144.22 45.47 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.992 -1.004 . . . . 64.44 108.912 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.33 154.72 33.11 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.023 0.529 . . . . 74.3 110.18 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.524 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 30.1 t70 -153.11 140.29 19.42 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.819 -1.178 . . . . 71.05 107.819 167.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 87.7 m -104.54 143.82 32.52 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.674 0.79 . . . . 74.2 110.454 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.449 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -154.14 152.76 30.78 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.014 0.925 . . . . 61.35 109.377 171.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 67.0 p -169.04 154.21 5.98 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.441 0.696 . . . . 74.33 110.256 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 82.9 p -156.02 156.06 33.78 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.291 0.637 . . . . 75.44 109.524 171.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -96.13 118.2 32.24 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.185 -1.043 . . . . 75.44 108.185 173.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.577 HD13 HG22 ' D' ' 83' ' ' ILE . 32.1 mt -92.85 -27.43 17.14 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.933 0.493 . . . . 74.32 110.757 -174.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.478 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -163.87 -178.68 5.82 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.264 1.025 . . . . 65.11 110.157 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.95 107.88 4.92 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.24 -0.891 . . . . 74.53 110.038 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 68.51 21.55 8.08 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.424 1.49 . . . . 75.34 111.367 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 42.3 t -124.11 115.31 44.5 Favored 'Isoleucine or valine' 0 C--N 1.35 0.599 0 N-CA-C 107.535 -1.283 . . . . 72.23 107.535 170.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -124.38 170.41 10.86 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.338 0.655 . . . . 73.3 109.489 -171.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.533 ' HB2' HD11 ' D' ' 51' ' ' LEU . 26.4 tt0 -130.31 117.99 20.61 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.649 -0.705 . . . . 75.34 109.397 178.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 88.0 t -100.99 117.38 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.424 1.09 . . . . 75.25 108.291 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.449 ' HB ' ' HB1' ' D' ' 47' ' ' ALA . 24.4 t -119.14 117.45 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.552 -0.907 . . . . 75.33 108.552 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.01 122.24 44.62 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.885 -0.783 . . . . 73.31 108.885 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.524 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 49.6 ttm-85 -87.26 101.87 13.94 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.226 -0.657 . . . . 74.22 109.226 175.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 83.2 t -90.72 114.73 28.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.203 -1.036 . . . . 75.14 108.203 174.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.716 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 28.0 m -116.02 139.62 50.09 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.277 0.561 . . . . 64.11 109.543 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.639 HG13 HG12 ' D' ' 40' ' ' VAL . 7.7 t -125.25 100.26 6.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 124.381 1.072 . . . . 73.41 108.136 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.659 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 58.2 m -93.39 93.75 8.33 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.185 -1.042 . . . . 73.13 108.185 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.72 141.2 29.48 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.026 -0.988 . . . . 64.53 109.487 -176.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.485 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 55.7 m -143.76 126.12 15.73 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.656 0.597 . . . . 75.14 111.105 -177.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.551 ' HG ' ' HB3' ' D' ' 38' ' ' PRO . 26.0 mt -93.75 115.6 28.03 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.348 1.059 . . . . 65.23 108.392 172.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.84 -137.73 32.46 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.402 -0.679 . . . . 71.5 111.402 -171.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -90.88 4.35 52.08 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.212 0.605 . . . . 70.21 111.84 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.652 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 13.6 pt-20 -118.72 160.2 22.29 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.61 0.364 . . . . 75.43 110.279 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 48.7 m -68.34 133.18 48.33 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 123.753 0.658 . . . . 74.23 111.312 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.485 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.51 -68.13 0.78 Allowed 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.519 -1.289 . . . . 75.42 107.519 171.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -151.24 159.51 44.33 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 115.641 -0.709 . . . . 72.32 110.874 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 31.6 mt -117.7 110.12 17.47 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 105.778 -1.934 . . . . 74.04 105.778 173.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.677 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 14.8 t -119.69 112.17 18.95 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.818 -0.808 . . . . 63.35 108.818 -172.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -139.91 141.1 36.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.574 0.75 . . . . 75.03 109.891 -162.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 91.6 t -147.45 121.44 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.126 0.97 . . . . 74.53 109.228 -177.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.791 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 15.4 mt-30 -86.56 91.19 8.49 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 107.802 -1.184 . . . . 64.45 107.802 161.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -80.38 98.63 7.57 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.392 -1.336 . . . . 75.4 107.392 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.16 147.43 18.59 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.628 -0.989 . . . . 72.03 110.628 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.7 133.71 4.81 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.0 -0.84 . . . . 60.41 111.0 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.617 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 25.6 mt -89.17 131.2 37.07 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 108.053 -1.092 . . . . 74.51 108.053 174.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -134.74 124.12 24.72 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.407 -0.59 . . . . 71.03 109.407 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 37.8 m -82.86 97.39 8.63 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.683 -0.858 . . . . 73.33 108.683 169.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.52 143.51 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.599 -0.519 . . . . 73.3 109.599 -177.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.82 142.33 9.03 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.954 0.502 . . . . 72.33 110.437 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.56 -22.72 14.57 Favored Glycine 0 C--N 1.345 1.035 0 O-C-N 123.658 0.599 . . . . 74.54 113.175 174.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 63.7 mt -100.07 146.91 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 117.414 0.607 . . . . 75.1 110.16 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -160.3 176.15 12.03 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.576 1.151 . . . . 75.53 110.041 -178.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.61 -130.74 12.2 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 115.366 -0.834 . . . . 74.21 113.743 174.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 72.8 p -79.57 -24.59 41.99 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.15 0.58 . . . . 73.14 111.027 -177.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -70.06 -38.39 75.75 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.948 -0.569 . . . . 73.13 109.938 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -72.33 -27.25 62.3 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 116.49 -0.323 . . . . 73.4 110.682 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.9 -40.95 90.52 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 120.964 0.411 . . . . 75.15 111.293 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -78.66 -37.28 42.3 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.526 0.73 . . . . 75.43 111.206 175.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 50.0 t -61.29 -41.05 96.31 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.233 0.539 . . . . 75.12 111.275 -176.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 23.6 mt -92.47 -31.92 15.08 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.238 -0.892 . . . . 75.42 110.707 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.15 4.83 81.28 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.719 -0.673 . . . . 71.13 113.823 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -156.81 -57.47 0.09 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 117.867 0.834 . . . . 73.22 112.384 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -66.36 -37.06 84.46 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 112.796 0.665 . . . . 73.43 112.796 -169.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 73.5 m -74.84 -48.2 4.8 Favored Pre-proline 0 CA--C 1.566 1.574 0 CA-C-O 118.689 -0.672 . . . . 54.21 111.824 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.42 -13.76 38.35 Favored 'Trans proline' 0 C--N 1.4 3.274 0 C-N-CA 121.766 1.644 . . . . 74.21 113.404 170.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -65.86 -39.35 90.67 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.601 0.76 . . . . 73.24 109.914 173.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.532 HG21 HD11 ' D' ' 13' ' ' ILE . 49.3 mm -66.02 -39.18 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 115.361 -0.836 . . . . 72.01 110.45 175.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 87.7 mt -80.49 -10.47 59.74 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 115.068 -0.969 . . . . 72.1 111.761 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -65.25 -47.57 70.7 Favored Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 124.403 1.081 . . . . 73.44 113.103 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.88 -45.46 40.86 Favored 'Trans proline' 0 C--N 1.39 2.758 0 C-N-CA 122.378 2.052 . . . . 74.22 113.378 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -69.68 -36.43 75.99 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.481 -0.781 . . . . 73.14 111.855 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.16 -47.35 80.18 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.891 0.476 . . . . 60.12 109.819 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -59.09 -49.48 77.73 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 114.59 -1.186 . . . . 73.53 111.146 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -64.64 -45.57 86.24 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 123.671 0.607 . . . . 74.13 111.277 -175.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.7 t -59.58 -42.17 91.91 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 123.662 0.601 . . . . 62.53 110.666 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.453 ' O ' HG23 ' D' ' 118' ' ' VAL . 69.9 mt -59.99 -57.96 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.856 0.863 . . . . 71.24 110.779 172.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.423 HG23 ' HG3' ' D' ' 125' ' ' GLN . 97.4 m -53.54 -41.97 66.98 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 124.765 1.226 . . . . 71.12 111.841 -174.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 45.2 t -66.94 -42.54 85.12 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.76 -1.109 . . . . 73.51 110.268 -177.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.677 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 73.6 mtm -68.14 -31.71 71.47 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.909 0.484 . . . . 73.25 111.716 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.453 HG23 ' O ' ' D' ' 114' ' ' ILE . 84.8 t -62.0 -47.11 94.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.327 0.651 . . . . 71.34 109.835 174.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.7 p -74.41 -24.98 59.19 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.642 -0.708 . . . . 70.11 111.235 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' D' ' 116' ' ' SER . 91.0 mtt-85 -70.54 -34.69 72.54 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.635 0.774 . . . . 75.31 109.896 174.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.46 9.44 73.37 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 123.889 0.743 . . . . 71.41 112.592 175.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.429 HG22 ' HB3' ' C' ' 17' ' ' TYR . 64.0 p 59.27 19.62 7.75 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 126.383 1.873 . . . . 75.12 113.883 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -84.16 154.38 63.49 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.429 0.692 . . . . 73.45 109.443 171.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -56.32 131.51 46.21 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.195 2.596 . . . . 73.34 112.513 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.423 ' HG3' HG23 ' D' ' 115' ' ' THR . 32.9 tt0 -50.75 137.55 20.06 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.747 1.219 . . . . 72.2 111.827 -177.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -128.96 101.7 6.18 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.724 -0.843 . . . . 73.05 108.724 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -100.65 121.04 40.97 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.775 0.83 . . . . 74.4 108.984 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 6.7 mp -73.65 119.26 17.63 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 109.198 -0.667 . . . . 72.51 109.198 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.44 148.58 79.95 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 123.771 0.829 . . . . 74.14 112.012 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -68.94 98.77 0.62 Allowed 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.871 2.381 . . . . 74.32 111.462 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.48 1.062 0 C-N-CA 123.398 0.679 . . . . 71.35 111.027 -177.698 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.724 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 33.4 t80 . . . . . 0 C--O 1.235 0.317 0 N-CA-C 109.637 -0.505 . . . . 74.22 109.637 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -148.5 127.71 12.93 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.21 -1.033 . . . . 74.24 108.21 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.649 HG12 ' HD2' ' A' ' 84' ' ' PHE . 53.7 mt -85.36 122.9 38.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 108.575 -0.898 . . . . 71.45 108.575 174.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -85.02 -41.47 15.77 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.899 -0.778 . . . . 72.44 108.899 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -173.34 128.83 0.44 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 111.453 0.168 . . . . 73.24 111.453 -167.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.436 HD13 ' CG ' ' C' ' 130' ' ' PRO . 91.8 mt -123.17 132.9 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 124.141 0.976 . . . . 64.24 109.219 176.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.402 ' HB3' HG21 ' B' ' 122' ' ' THR . 30.0 p90 -167.12 154.2 8.74 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.853 0.861 . . . . 73.53 111.119 -169.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.4 p -75.28 126.08 30.28 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.713 -0.676 . . . . 73.31 109.466 170.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -93.48 -21.21 19.61 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.75 -0.463 . . . . 65.34 109.75 173.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 25.0 t70 -153.3 138.49 17.41 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.051 -0.977 . . . . 74.1 110.045 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.419 HG22 ' SD ' ' A' ' 117' ' ' MET . 74.2 mt -133.28 144.29 36.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 C-N-CA 124.989 1.316 . . . . 74.03 108.09 176.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.594 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 42.8 t -147.64 126.37 12.61 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.889 -0.782 . . . . 74.33 108.889 170.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 84.9 t80 -131.3 117.44 18.95 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 106.289 -1.745 . . . . 75.24 106.289 170.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -125.5 120.02 29.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.134 0.425 . . . . 74.42 109.93 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.1 80.65 15.43 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 106.93 -1.507 . . . . 74.32 106.93 171.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.35 -35.54 39.62 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 122.578 2.185 . . . . 73.13 111.488 -174.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -106.01 25.51 10.85 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.922 -1.035 . . . . 73.32 109.457 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.459 ' O ' HG11 ' A' ' 31' ' ' VAL . . . -49.11 -50.83 61.04 Favored Pre-proline 0 CA--C 1.561 1.393 0 N-CA-C 113.471 0.915 . . . . 74.24 113.471 -177.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.22 -21.35 67.4 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 121.647 1.565 . . . . 75.52 113.441 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -91.53 -35.11 14.48 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.105 0.962 . . . . 72.22 110.657 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.542 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.8 p -75.35 -25.03 17.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.564 -0.743 . . . . 64.54 112.569 -163.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -73.35 -17.69 61.26 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.325 0.65 . . . . 74.03 110.874 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -85.65 -32.1 22.18 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.483 1.113 . . . . 75.45 110.134 174.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -68.92 157.88 35.74 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.75 0.82 . . . . 73.1 111.349 -175.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -70.87 131.67 44.12 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.385 0.674 . . . . 73.44 109.386 171.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -84.11 88.3 7.18 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.487 0.661 . . . . 74.33 110.189 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -120.98 81.17 34.92 Favored Pre-proline 0 C--O 1.245 0.829 0 N-CA-C 107.977 -1.12 . . . . 71.34 107.977 169.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.59 112.11 3.39 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 121.972 1.781 . . . . 73.34 112.015 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -94.58 88.84 5.57 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 105.826 -1.916 . . . . 75.1 105.826 167.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.4 m -77.55 114.85 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 113.985 -1.461 . . . . 74.03 111.228 -172.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.439 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 87.0 tttt -87.29 130.98 34.39 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.286 -0.87 . . . . 72.31 109.085 173.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 pp -103.35 148.84 25.38 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.992 -0.744 . . . . 73.42 108.992 173.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.489 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 21.3 t70 -147.56 133.54 19.19 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.134 -0.691 . . . . 75.12 109.134 172.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.6 mt -126.38 128.87 47.72 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.033 0.933 . . . . 75.43 109.805 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -140.15 156.98 46.31 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.253 -0.647 . . . . 74.22 109.253 171.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.3 p -115.36 152.96 31.86 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.467 0.707 . . . . 73.41 110.804 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.409 ' HB1' ' HB ' ' A' ' 59' ' ' VAL . . . -145.57 111.85 5.73 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.179 -1.045 . . . . 74.34 108.179 173.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -89.85 152.47 21.25 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.109 0.563 . . . . 75.2 109.7 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.2 t -157.54 142.12 16.48 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.557 0.743 . . . . 74.41 109.851 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -112.76 134.66 54.17 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.706 -0.85 . . . . 75.43 108.706 171.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.747 HD12 ' HB2' ' A' ' 57' ' ' GLU . 27.0 mt -112.59 -28.86 7.67 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.303 0.641 . . . . 74.33 110.528 -174.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.63 179.64 8.4 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.163 0.985 . . . . 70.35 109.058 175.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.49 120.84 13.59 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.898 -0.778 . . . . 75.24 108.898 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 72.59 -1.88 2.83 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.92 1.288 . . . . 62.15 112.272 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.8 t -101.16 112.0 32.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 107.9 -1.148 . . . . 74.25 107.9 176.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -115.84 156.37 26.22 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 123.653 0.781 . . . . 75.22 108.996 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.747 ' HB2' HD12 ' A' ' 51' ' ' LEU . 48.3 tt0 -128.18 120.72 27.85 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.387 -0.968 . . . . 73.32 108.387 177.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.1 t -99.45 112.68 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.583 -1.636 . . . . 63.13 106.583 174.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.409 ' HB ' ' HB1' ' A' ' 47' ' ' ALA . 49.2 t -102.55 127.37 56.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 107.633 -1.247 . . . . 61.54 107.633 170.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.24 117.03 28.44 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.289 -1.004 . . . . 73.51 108.289 177.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.517 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 57.6 mtt180 -84.92 100.95 11.96 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.064 0.945 . . . . 73.13 108.81 176.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.8 t -103.43 103.29 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.613 -0.884 . . . . 75.15 108.613 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 26.0 m -109.3 109.32 20.19 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.224 0.61 . . . . 73.14 109.78 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.43 HG12 HD23 ' A' ' 126' ' ' LEU . 2.6 t -105.97 133.36 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.944 1.298 . . . . 73.3 109.537 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.439 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 41.7 m -120.47 143.14 48.68 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.538 -0.912 . . . . 72.45 108.538 173.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.14 109.58 18.64 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.612 -1.255 . . . . 74.14 107.612 168.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 50.2 m -111.79 127.39 55.79 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.773 -0.825 . . . . 74.21 108.773 175.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.6 mt -89.63 49.21 1.7 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.265 1.026 . . . . 73.13 109.314 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.28 -92.0 1.37 Allowed Glycine 0 CA--C 1.529 0.906 0 N-CA-C 111.766 -0.534 . . . . 72.02 111.766 -173.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -88.68 -30.53 19.06 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.027 0.531 . . . . 73.45 112.011 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -113.36 126.78 55.74 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 109.779 -0.452 . . . . 75.34 109.779 -175.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 68.4 m -71.12 126.06 28.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.839 0.456 . . . . 75.45 109.81 173.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.542 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -71.87 -57.44 4.33 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.677 0.791 . . . . 72.53 109.923 176.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -157.33 174.94 14.67 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.599 -1.182 . . . . 72.12 111.249 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 tp -132.42 143.55 49.88 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 113.878 -1.51 . . . . 75.14 108.123 175.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 76.1 m -137.65 129.21 28.26 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.968 1.307 . . . . 75.21 107.878 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.594 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 39.7 tt0 -147.73 116.33 6.68 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.489 -0.93 . . . . 72.42 108.489 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.4 t -133.08 110.8 15.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 123.364 0.665 . . . . 75.31 109.743 -173.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.517 ' HG2' ' HG2' ' A' ' 61' ' ' ARG . 18.6 mt-30 -86.4 85.94 7.33 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.092 -1.077 . . . . 72.41 108.092 172.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.44 ' HG3' HD23 ' A' ' 106' ' ' LEU . 9.1 tp-100 -77.61 101.02 6.36 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.27 -0.877 . . . . 75.14 108.907 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.98 146.26 20.35 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.694 -0.962 . . . . 71.43 110.694 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.489 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -149.88 122.51 1.43 Allowed Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 111.399 -0.68 . . . . 74.53 111.399 -176.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 24.6 mt -82.84 116.88 27.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 109.079 -0.711 . . . . 75.32 109.079 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.724 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 14.6 m-85 -133.14 120.56 21.38 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.507 -1.294 . . . . 74.13 107.507 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.0 m -85.17 99.47 11.1 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.854 -0.795 . . . . 60.2 108.854 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.5 pt . . . . . 0 CA--C 1.547 0.862 0 C-N-CA 123.909 0.884 . . . . 74.54 110.67 -172.372 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 111.532 0.197 . . . . 73.12 111.532 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -63.24 -37.87 88.92 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.036 0.534 . . . . 74.44 110.749 174.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 22.2 t -74.66 -54.55 7.2 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.442 0.297 . . . . 74.02 111.09 -175.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 pp -75.42 -30.64 60.11 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.352 0.661 . . . . 75.31 112.347 -172.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.92 3.94 25.75 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.368 -0.684 . . . . 64.33 114.386 -170.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.73 -51.9 0.19 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 118.089 0.945 . . . . 73.24 112.612 -175.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.519 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 91.4 t80 -78.74 -61.7 1.93 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.509 0.723 . . . . 72.35 112.327 -170.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.409 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 71.2 m -65.12 -36.78 16.85 Favored Pre-proline 0 CA--C 1.564 1.495 0 N-CA-C 113.627 0.973 . . . . 61.4 113.627 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 18.0 Cg_endo -61.3 -32.36 89.82 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 121.905 1.737 . . . . 73.14 113.603 165.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -74.31 -21.85 59.53 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 122.988 0.515 . . . . 75.05 110.563 177.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 23.2 mm -65.63 -38.86 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.215 0.606 . . . . 73.24 109.411 170.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.489 HD21 ' HA3' ' A' ' 82' ' ' GLY . 86.4 mt -74.33 -23.55 59.07 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.901 0.881 . . . . 74.45 112.438 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.444 ' HE2' ' HA ' ' A' ' 130' ' ' PRO . 54.7 t80 -61.17 -47.59 94.28 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-O 118.209 -0.9 . . . . 71.33 113.268 -174.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -60.76 -34.86 91.14 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.225 1.95 . . . . 75.3 113.479 174.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.408 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 93.6 m-85 -75.41 -37.51 60.44 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.365 0.666 . . . . 74.44 112.03 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.28 -35.95 63.76 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.813 0.445 . . . . 55.4 109.909 177.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.492 ' NH1' HG23 ' C' ' 105' ' ' ILE . 27.3 ttm105 -63.73 -39.99 95.65 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 108.67 -0.863 . . . . 75.51 108.67 172.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.437 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 3.3 tm-20 -64.52 -48.16 76.16 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.131 0.972 . . . . 75.13 111.461 -177.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 36.0 t -60.68 -43.2 98.0 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 123.906 0.754 . . . . 74.14 110.16 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 72.4 mt -65.08 -44.31 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.353 0.661 . . . . 73.41 110.511 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.9 m -57.83 -41.75 82.94 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.564 1.145 . . . . 75.42 110.793 -177.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.3 t -77.71 -42.84 33.03 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.209 -0.905 . . . . 71.32 111.056 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.419 ' SD ' HG22 ' A' ' 21' ' ' ILE . 9.8 mtp -56.91 -46.85 81.7 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 123.84 0.856 . . . . 71.33 111.621 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.6 t -64.06 -41.9 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.567 1.147 . . . . 75.53 110.949 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.68 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 38.2 t -67.33 -35.11 78.75 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.769 -0.65 . . . . 52.44 111.165 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -74.46 -28.31 60.97 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.814 0.846 . . . . 74.51 110.141 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.9 6.79 64.94 Favored Glycine 0 C--N 1.354 1.53 0 O-C-N 123.899 0.75 . . . . 41.23 112.508 171.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.459 HG23 ' HE ' ' B' ' 15' ' ' ARG . 1.7 t 62.64 19.49 11.37 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 127.108 2.163 . . . . 61.22 113.299 172.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -81.95 161.78 59.52 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 109.174 -0.676 . . . . 74.33 109.174 175.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -53.53 115.13 2.11 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.343 2.029 . . . . 72.1 110.286 169.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.68 ' HG3' ' HB2' ' A' ' 119' ' ' SER . 4.0 tt0 -55.37 131.54 46.01 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 124.289 0.993 . . . . 73.45 111.24 -166.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.43 HD23 HG12 ' A' ' 64' ' ' VAL . 55.7 tp -107.08 106.73 17.38 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.425 -0.807 . . . . 74.02 110.605 -162.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -121.64 107.66 12.64 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.556 1.142 . . . . 74.52 108.582 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.431 ' O ' HD12 ' C' ' 13' ' ' ILE . 7.5 mp -72.75 145.88 46.78 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.826 0.45 . . . . 74.25 110.52 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.49 149.18 92.57 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 123.975 0.91 . . . . 61.42 111.145 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.609 ' HD3' HG13 ' C' ' 13' ' ' ILE . 44.0 Cg_endo -66.16 131.07 25.75 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 123.014 2.476 . . . . 72.22 112.194 -178.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.2 t -113.32 112.98 42.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.735 -1.209 . . . . 74.25 107.735 173.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -81.1 86.69 6.12 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.036 -0.727 . . . . 61.1 109.036 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 . . . . . 0 N--CA 1.475 0.793 0 CA-C-N 115.9 -0.591 . . . . 70.3 109.925 177.941 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.563 ' HB2' ' HB ' ' B' ' 89' ' ' ILE . 16.8 ttt . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.384 0.611 . . . . 64.33 112.415 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 85.3 m -159.24 143.35 15.16 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 124.171 0.988 . . . . 65.24 108.573 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -145.97 156.86 43.79 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.652 0.739 . . . . 72.41 110.448 158.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -125.26 130.59 52.35 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 106.257 -1.757 . . . . 75.42 106.257 172.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.535 HD11 HD12 ' B' ' 105' ' ' ILE . 34.0 mt -67.09 112.68 2.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 108.567 -0.901 . . . . 72.52 108.567 176.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . 0.445 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 16.9 mm-40 -80.15 -49.65 11.39 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.015 -0.993 . . . . 75.4 109.179 -178.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.459 ' HE ' HG23 ' A' ' 122' ' ' THR . 42.6 ttt180 -167.07 139.54 3.44 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.67 -0.695 . . . . 74.25 110.244 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.5 mt -114.86 141.56 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 107.424 -1.325 . . . . 74.04 107.424 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -167.78 153.43 7.26 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.689 0.757 . . . . 64.42 112.362 -176.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.6 m -80.54 122.93 27.65 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.822 -1.081 . . . . 73.45 108.707 168.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.435 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 38.0 mtpt -91.4 -41.89 10.62 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.015 0.526 . . . . 74.4 109.669 176.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 24.5 t70 -142.59 139.03 31.19 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.845 -0.616 . . . . 75.32 111.18 -168.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.55 HD13 ' SG ' ' B' ' 113' ' ' CYS . 48.8 mm -133.15 137.97 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.198 1.399 . . . . 70.43 108.174 173.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.53 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 42.8 t -144.75 117.46 8.68 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.338 -1.356 . . . . 74.51 107.338 -177.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 84.3 t80 -140.07 116.54 10.71 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.76 -1.2 . . . . 74.14 107.76 176.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -124.46 113.84 18.66 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.667 0.787 . . . . 74.1 109.34 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.485 ' HB3' ' HB3' ' B' ' 28' ' ' ALA . . . -108.24 85.45 2.74 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 107.989 -1.115 . . . . 53.43 107.989 170.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -73.38 -23.34 17.66 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.776 2.318 . . . . 72.54 112.667 -171.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -114.99 5.46 15.02 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.169 0.988 . . . . 74.31 110.936 -173.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.485 ' HB3' ' HB3' ' B' ' 25' ' ' ALA . . . -43.71 -61.63 1.84 Allowed Pre-proline 0 N--CA 1.492 1.643 0 C-N-CA 125.638 1.575 . . . . 73.21 114.382 -167.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.86 -24.99 77.84 Favored 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 122.56 2.174 . . . . 75.12 113.245 -171.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -96.04 -33.08 12.25 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.652 0.781 . . . . 74.34 111.496 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 p -74.44 -16.03 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 122.601 0.361 . . . . 71.22 110.571 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -67.88 -7.98 32.64 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.63 0.772 . . . . 72.31 112.838 176.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -67.54 -13.29 61.92 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 122.444 0.297 . . . . 75.54 110.902 171.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -105.55 110.42 22.74 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.445 1.498 . . . . 71.15 109.346 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -107.53 79.71 1.32 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.452 0.701 . . . . 71.01 110.93 -170.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 43.0 p90 -156.93 175.75 13.67 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.584 0.754 . . . . 73.54 109.217 171.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -77.37 113.13 28.64 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.197 -1.038 . . . . 75.55 108.197 173.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.28 148.53 88.6 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.171 1.914 . . . . 74.51 111.925 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -66.53 122.43 17.55 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.727 -0.842 . . . . 75.34 108.727 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.451 HG11 HG12 ' B' ' 64' ' ' VAL . 57.7 t -111.23 131.35 62.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 124.042 0.937 . . . . 70.11 111.021 -171.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -106.02 135.23 47.85 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.942 -1.133 . . . . 72.12 107.942 169.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 pp -109.24 154.83 21.86 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.06 0.944 . . . . 74.55 109.542 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -159.81 150.45 19.05 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.566 0.746 . . . . 74.34 109.273 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.454 HD13 HD13 ' B' ' 60' ' ' LEU . 62.4 mt -123.94 152.27 42.65 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.388 0.675 . . . . 75.33 110.197 175.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 11.4 t70 -138.5 142.6 39.35 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.635 1.174 . . . . 75.22 107.925 173.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 39.4 p -109.94 111.92 23.62 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.428 0.691 . . . . 73.32 109.959 -176.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.452 ' HB2' ' HB ' ' B' ' 59' ' ' VAL . . . -116.71 149.08 40.43 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.179 0.992 . . . . 75.11 108.379 176.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 46.5 p -145.45 162.14 38.05 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.292 0.479 . . . . 73.45 112.292 -174.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.8 p -153.55 136.2 15.22 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 114.691 -1.14 . . . . 70.44 108.532 164.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -93.86 110.18 21.85 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.157 -1.053 . . . . 65.03 108.157 173.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.449 HD12 HG22 ' B' ' 83' ' ' ILE . 63.6 mt -78.01 -39.81 41.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.189 0.596 . . . . 72.04 111.2 -174.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.47 -167.5 1.6 Allowed 'General case' 0 C--O 1.242 0.705 0 CA-C-N 115.184 -0.916 . . . . 60.42 110.167 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -71.71 120.22 16.99 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.985 -1.007 . . . . 71.05 109.083 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 70.35 -4.77 1.5 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.989 1.316 . . . . 74.55 112.362 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 85.3 t -104.88 115.29 46.48 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 N-CA-C 107.504 -1.295 . . . . 74.52 107.504 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -129.46 154.94 46.48 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.587 -0.894 . . . . 72.22 108.587 -175.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -126.25 111.36 14.48 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.341 -0.985 . . . . 74.23 108.341 -174.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 88.0 t -100.81 119.26 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.215 1.406 . . . . 74.14 110.134 -173.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' B' ' 47' ' ' ALA . 20.1 t -109.43 114.21 46.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 109.01 -0.737 . . . . 73.31 109.01 178.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.454 HD13 HD13 ' B' ' 44' ' ' LEU . 35.3 tp -99.51 111.38 23.74 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.804 -0.813 . . . . 74.3 108.804 169.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 33.7 ttm180 -86.09 127.21 34.64 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.824 -0.806 . . . . 72.41 108.824 170.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 36.2 t -113.98 103.92 16.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.579 -1.267 . . . . 74.03 107.579 172.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 9.6 m -98.1 136.27 38.57 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.166 0.586 . . . . 65.2 109.644 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.507 HG23 HD12 ' B' ' 114' ' ' ILE . 69.4 t -125.57 135.89 62.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.862 1.265 . . . . 75.55 109.584 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 95.5 m -117.5 148.86 41.46 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.934 -1.135 . . . . 72.05 107.934 167.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.37 147.0 29.84 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.036 0.534 . . . . 65.12 109.96 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.457 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 15.6 p -147.98 128.13 13.76 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.64 -0.709 . . . . 63.41 111.055 -175.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 53.1 mt -92.55 100.46 12.99 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 106.904 -1.517 . . . . 73.11 106.904 173.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.36 -139.01 26.06 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 111.345 -0.702 . . . . 44.11 111.345 -172.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -92.89 23.01 4.43 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.356 0.662 . . . . 64.25 110.138 175.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -118.93 138.95 52.42 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.276 1.03 . . . . 74.43 108.963 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 55.5 m -69.62 119.74 14.32 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.75 -0.463 . . . . 75.24 109.75 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.457 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -78.16 -62.61 1.62 Allowed 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.246 -1.02 . . . . 63.33 108.246 176.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -157.79 163.04 38.46 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.851 -1.068 . . . . 74.44 111.282 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 23.9 mt -123.34 127.37 48.41 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 105.977 -1.86 . . . . 74.13 105.977 172.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -128.74 155.35 45.24 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.323 -0.621 . . . . 73.13 109.323 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 37.2 tt0 -166.06 129.98 2.16 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.194 -0.669 . . . . 73.05 109.194 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.416 HG21 HD12 ' B' ' 21' ' ' ILE . 99.0 t -128.1 151.33 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.925 0.89 . . . . 71.22 108.708 177.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -125.37 108.93 12.17 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.681 -0.859 . . . . 61.45 108.681 168.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.409 ' HB2' ' HB1' ' B' ' 110' ' ' ALA . 7.5 tp-100 -92.81 100.41 12.9 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.43 -0.952 . . . . 73.53 108.43 174.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.435 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.09 145.32 17.62 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.895 -0.882 . . . . 73.43 110.895 176.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.13 127.7 2.48 Favored Glycine 0 CA--C 1.506 -0.518 0 N-CA-C 110.55 -1.02 . . . . 55.43 110.55 -174.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.449 HG22 HD12 ' B' ' 51' ' ' LEU . 27.8 mt -85.0 119.48 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 108.238 -1.023 . . . . 74.44 108.238 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -126.39 132.18 51.59 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 107.133 -1.432 . . . . 73.32 107.133 175.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 70.1 m -88.98 87.76 7.34 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.344 0.52 . . . . 63.25 109.861 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.437 HG12 HD21 ' B' ' 98' ' ' LEU . 2.6 pp -96.67 131.24 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.092 0.957 . . . . 65.55 109.959 -171.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.21 160.5 37.23 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.737 0.415 . . . . 75.05 111.359 173.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.47 -69.31 0.21 Allowed Glycine 0 C--N 1.343 0.949 0 CA-C-N 115.537 -0.756 . . . . 74.1 112.802 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' B' ' 9' ' ' MET . 0.1 OUTLIER -78.82 154.58 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.248 0.619 . . . . 74.41 110.759 -173.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -154.41 -175.1 5.24 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.706 -0.679 . . . . 72.04 111.717 -164.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.62 -113.52 5.94 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 115.127 -0.942 . . . . 74.43 112.53 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 77.7 m -88.21 -31.33 19.14 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.535 0.734 . . . . 60.24 110.773 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -65.96 -30.98 71.63 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 116.165 -0.47 . . . . 63.22 111.338 -171.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -68.42 -33.38 74.12 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.091 0.472 . . . . 74.55 110.686 174.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.02 -25.79 61.09 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.864 0.866 . . . . 74.13 110.927 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -77.97 -40.18 40.11 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.698 0.799 . . . . 73.33 110.786 174.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.1 t -68.22 -57.62 5.72 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.848 0.356 . . . . 74.3 110.599 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.437 HD21 HG12 ' B' ' 86' ' ' ILE . 6.3 mp -81.43 -8.34 59.72 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 116.384 -0.371 . . . . 72.15 111.638 -177.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.97 4.06 31.88 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 119.763 -0.465 . . . . 74.35 114.037 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.424 ' HB1' ' N ' ' B' ' 134' ' ' ASP . . . -151.91 -49.07 0.11 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 117.157 0.479 . . . . 64.4 111.937 -175.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.418 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 54.0 t80 -78.58 -50.86 10.8 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.942 -0.572 . . . . 73.22 111.148 -173.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 70.3 m -64.24 -46.3 79.14 Favored Pre-proline 0 CA--C 1.568 1.657 0 C-N-CA 123.434 0.694 . . . . 74.12 111.307 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -49.94 -36.93 45.38 Favored 'Trans proline' 0 C--N 1.404 3.473 0 C-N-CA 123.163 2.575 . . . . 72.14 114.996 168.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -63.62 -40.12 96.1 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 122.883 0.473 . . . . 74.44 110.381 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.535 HD12 HD11 ' B' ' 13' ' ' ILE . 64.7 mt -66.11 -42.66 91.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.515 0.726 . . . . 73.14 110.595 178.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 85.2 mt -82.68 -19.2 38.57 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.498 -0.774 . . . . 73.14 112.166 -174.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -57.85 -53.86 61.41 Favored Pre-proline 0 CA--C 1.561 1.367 0 CA-C-O 117.877 -1.058 . . . . 73.22 112.974 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -58.39 -33.42 97.81 Favored 'Trans proline' 0 C--N 1.392 2.854 0 C-N-CA 122.43 2.087 . . . . 74.31 114.209 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -71.02 -51.33 26.02 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.984 0.514 . . . . 74.43 110.46 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' B' ' 80' ' ' GLN . . . -58.07 -37.74 75.04 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.442 -0.799 . . . . 64.33 110.932 176.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -59.73 -57.02 14.73 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.747 1.619 . . . . 74.45 110.696 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -64.83 -29.8 70.78 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.706 0.803 . . . . 74.41 110.413 -178.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.55 ' SG ' HD13 ' B' ' 21' ' ' ILE . 4.2 t -70.3 -43.38 70.52 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 122.957 0.503 . . . . 74.01 110.909 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.507 HD12 HG23 ' B' ' 64' ' ' VAL . 83.6 mt -60.88 -53.15 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.287 -0.634 . . . . 75.31 109.287 175.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.4 m -55.12 -34.87 64.09 Favored 'General case' 0 CA--C 1.551 0.996 0 O-C-N 124.563 1.164 . . . . 74.11 111.744 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 42.7 t -65.85 -51.23 60.57 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 115.39 -0.823 . . . . 71.33 110.197 175.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.594 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 15.1 mmt -67.82 -30.5 69.92 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.355 0.662 . . . . 75.45 111.797 -174.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.94 -44.73 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.392 1.077 . . . . 75.04 109.969 174.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 27.7 t -70.1 -25.49 63.53 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.224 -0.898 . . . . 73.22 110.543 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.594 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 89.8 mtt-85 -70.38 -30.48 67.4 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.804 -0.443 . . . . 75.32 109.804 174.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.46 12.65 54.95 Favored Glycine 0 C--N 1.355 1.62 0 O-C-N 123.549 0.531 . . . . 73.4 112.644 170.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.402 HG21 ' HB3' ' A' ' 17' ' ' TYR . 38.1 p 54.15 24.68 5.05 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 126.464 1.906 . . . . 72.23 113.992 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -83.86 156.76 64.23 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 123.318 0.647 . . . . 73.42 110.673 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -64.41 178.28 1.72 Allowed 'Trans proline' 0 C--N 1.389 2.668 0 C-N-CA 123.429 2.753 . . . . 73.22 114.072 -177.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.627 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 23.2 tp60 -65.16 125.9 26.42 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.443 -1.253 . . . . 64.1 112.27 -169.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -135.52 114.41 12.05 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 108.89 -0.781 . . . . 75.32 108.89 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -130.46 135.04 47.56 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.319 1.047 . . . . 75.32 108.209 171.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 tt -87.78 142.52 27.76 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.787 0.835 . . . . 73.32 109.143 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.24 152.47 94.44 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 123.327 0.651 . . . . 51.11 110.995 176.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.52 139.79 60.27 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.89 2.393 . . . . 73.02 111.372 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.56 110.34 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.786 0.803 . . . . 74.32 109.56 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -92.0 83.97 5.25 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.249 -0.887 . . . . 73.12 109.27 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -58.79 -42.41 88.99 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.766 -0.827 . . . . 73.4 108.766 172.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . 0.424 ' N ' ' HB1' ' B' ' 100' ' ' ALA . 6.4 p-10 . . . . . 0 CA--C 1.538 0.511 0 CA-C-N 113.909 -1.496 . . . . 75.13 112.264 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.456 ' CD1' ' HE2' ' C' ' 101' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 108.83 -0.804 . . . . 73.31 108.83 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -138.31 118.08 13.19 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.248 -1.019 . . . . 73.34 108.248 174.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.609 HG13 ' HD3' ' A' ' 130' ' ' PRO . 75.8 mt -67.95 122.4 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.844 -0.798 . . . . 74.23 108.844 173.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -86.13 -45.63 11.18 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 124.079 0.862 . . . . 72.11 109.481 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -179.4 124.79 0.08 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.293 -0.867 . . . . 74.42 109.414 -170.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.456 HG21 ' CD1' ' C' ' 109' ' ' TYR . 30.1 mt -116.28 150.55 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 108.06 -1.089 . . . . 73.2 108.06 173.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.43 ' HE2' ' HD2' ' C' ' 19' ' ' LYS . 22.8 p90 -174.49 171.54 3.32 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.057 0.943 . . . . 75.23 109.765 -173.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -90.85 118.31 30.16 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.612 -0.884 . . . . 75.23 108.612 174.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.486 ' HE3' ' HB2' ' D' ' 28' ' ' ALA . 10.0 mmmm -69.64 -45.78 67.68 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 122.102 0.953 . . . . 74.22 108.469 171.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.663 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 12.0 t70 -146.0 147.16 31.37 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 113.71 -1.587 . . . . 73.21 109.771 -169.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 63.5 mt -142.9 150.48 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.459 1.503 . . . . 71.25 107.456 177.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -160.57 151.91 19.29 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.389 0.614 . . . . 75.32 110.428 175.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -153.78 109.18 3.19 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.975 -1.12 . . . . 73.1 107.975 171.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -117.09 110.42 18.18 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.214 0.605 . . . . 73.1 110.028 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . 0.509 ' HB1' ' HB3' ' C' ' 28' ' ' ALA . . . -117.56 87.39 25.62 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 106.619 -1.623 . . . . 65.03 106.619 167.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.42 -29.92 19.97 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.37 2.046 . . . . 74.03 111.531 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -91.93 12.57 21.25 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.568 1.147 . . . . 64.55 111.112 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.509 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . . . -53.54 -58.59 12.28 Favored Pre-proline 0 CA--C 1.562 1.442 0 N-CA-C 114.031 1.123 . . . . 74.2 114.031 -166.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -57.85 -39.9 83.08 Favored 'Trans proline' 0 C--N 1.397 3.09 0 C-N-CA 122.182 1.921 . . . . 72.55 112.414 -174.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -69.38 -45.75 68.58 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.449 -1.25 . . . . 74.51 111.688 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.9 p -73.72 -20.89 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 N-CA-C 113.131 0.789 . . . . 75.52 113.131 -165.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -62.15 -25.61 67.85 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 113.99 1.107 . . . . 73.44 113.99 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -98.07 16.89 19.76 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.508 0.723 . . . . 62.22 111.259 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.799 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -94.59 157.13 16.12 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.94 0.896 . . . . 75.3 109.461 173.104 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -67.13 123.24 19.71 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.295 0.638 . . . . 72.41 109.508 166.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -79.14 99.02 6.79 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.765 0.826 . . . . 73.53 110.434 -175.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -151.69 71.31 8.12 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 108.468 -0.938 . . . . 74.24 108.468 176.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -87.41 153.46 7.88 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.916 2.411 . . . . 70.12 112.21 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -89.94 112.33 23.68 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.551 -1.278 . . . . 74.12 107.551 168.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 40.2 t -72.74 102.3 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 109.147 -0.686 . . . . 74.32 109.147 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.498 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 54.0 mmtt -93.24 113.11 25.23 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.193 0.997 . . . . 74.53 109.33 175.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 mp -96.43 123.96 40.27 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.07 -1.085 . . . . 72.24 108.07 176.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -131.87 106.87 8.35 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.971 0.909 . . . . 73.21 109.004 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.35 123.17 48.4 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.258 -0.645 . . . . 74.04 109.258 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 15.5 t70 -112.58 147.79 35.9 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.132 1.373 . . . . 75.43 107.941 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 57.5 p -114.45 126.32 54.83 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.099 0.56 . . . . 75.32 110.904 -170.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.33 151.95 51.9 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.424 1.089 . . . . 71.44 108.494 175.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 6.4 p -163.29 163.43 25.3 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.73 0.412 . . . . 71.45 110.015 -176.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 25.8 t -165.55 133.66 3.08 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.996 0.518 . . . . 71.25 110.25 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -82.24 139.02 34.48 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.038 0.535 . . . . 74.15 109.563 173.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.468 HD13 HD13 ' C' ' 83' ' ' ILE . 84.1 mt -110.46 -41.8 4.26 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.486 0.714 . . . . 72.45 110.039 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.4 -174.36 4.91 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.56 -0.746 . . . . 71.12 110.642 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -68.93 126.22 29.11 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.747 -1.115 . . . . 73.53 108.488 172.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 67.28 6.52 4.89 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.737 1.215 . . . . 73.33 112.561 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 80.9 t -122.5 115.3 45.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 108.171 -1.048 . . . . 71.54 108.171 177.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -137.25 130.13 30.46 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.515 -0.766 . . . . 73.44 109.282 -173.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -92.35 127.26 37.77 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.214 -0.903 . . . . 74.51 109.605 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.449 HG21 HD13 ' C' ' 106' ' ' LEU . 26.9 m -111.87 136.99 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 108.141 -1.059 . . . . 75.33 108.141 166.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -126.66 121.23 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.436 1.094 . . . . 71.33 108.928 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.434 HD22 ' HB3' ' C' ' 103' ' ' PRO . 47.9 tp -111.95 113.8 26.33 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.4 -0.592 . . . . 74.44 109.4 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.444 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 34.5 ttm180 -82.92 107.69 15.71 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 108.856 -0.794 . . . . 72.53 108.856 173.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.472 ' HB ' HD11 ' C' ' 114' ' ' ILE . 6.6 t -99.5 121.34 50.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.053 -1.092 . . . . 71.23 108.053 171.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 72.0 m -112.7 128.21 56.34 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.404 -1.332 . . . . 62.22 107.404 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.514 HG21 HD12 ' C' ' 114' ' ' ILE . 99.5 t -116.03 115.18 48.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.626 -0.879 . . . . 75.22 108.626 172.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 4.4 m -100.78 139.27 36.7 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.73 -0.841 . . . . 74.14 108.73 175.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.33 113.1 15.18 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.577 -1.268 . . . . 75.43 107.577 176.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -136.18 131.44 34.64 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.032 -0.729 . . . . 75.02 109.032 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.799 HD11 ' HG2' ' C' ' 34' ' ' LYS . 3.5 mt -87.13 35.93 0.72 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.575 1.55 . . . . 73.14 110.037 -177.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.02 -117.31 4.9 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 109.682 -1.367 . . . . 74.32 109.682 -164.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -89.93 -20.43 23.36 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.611 0.764 . . . . 72.04 111.221 176.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -78.5 103.2 8.29 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.788 -0.819 . . . . 75.3 108.788 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 37.2 m -72.76 123.49 23.43 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.485 -0.561 . . . . 61.14 109.485 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.64 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.43 -56.03 5.1 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.422 -0.808 . . . . 72.4 109.017 174.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -159.66 168.18 26.63 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 122.223 1.011 . . . . 74.55 112.146 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.453 HD23 HG21 ' C' ' 65' ' ' THR . 1.7 tm? -130.01 130.75 45.37 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 105.386 -2.079 . . . . 74.33 105.386 167.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.428 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 44.6 t -128.75 138.23 52.0 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.228 -1.397 . . . . 65.41 107.228 174.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.16 118.77 5.29 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.979 -0.378 . . . . 73.52 109.979 -172.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' C' ' 61' ' ' ARG . 95.6 t -128.74 136.85 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.564 0.746 . . . . 75.53 109.105 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.663 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 26.4 mt-30 -109.33 97.17 6.81 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.55 -0.908 . . . . 73.12 108.55 169.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -84.85 116.91 23.57 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.351 -0.84 . . . . 72.21 109.136 178.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.6 145.79 16.87 Favored Glycine 0 C--N 1.343 0.921 0 N-CA-C 111.742 -0.543 . . . . 72.32 111.742 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.39 121.3 1.75 Allowed Glycine 0 CA--C 1.507 -0.433 0 N-CA-C 111.751 -0.54 . . . . 72.31 111.751 -176.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.503 HD11 ' HB3' ' D' ' 29' ' ' PRO . 9.5 mm -82.55 118.94 31.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 108.054 -1.091 . . . . 72.4 108.054 174.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -133.71 123.79 25.56 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.393 0.677 . . . . 64.31 109.987 -172.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 70.2 m -71.17 108.17 4.55 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.787 -0.82 . . . . 71.03 108.787 167.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 78.2 mt -117.7 119.74 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.462 1.105 . . . . 73.14 108.412 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.15 168.28 26.46 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.53 0.732 . . . . 61.31 110.442 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.72 -33.78 5.97 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 116.26 -0.427 . . . . 74.44 113.936 170.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 40.2 pt -117.67 163.4 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.493 0.717 . . . . 65.12 110.957 -176.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -146.15 158.04 43.86 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.511 0.724 . . . . 75.15 110.696 -175.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.08 -129.72 15.64 Favored Glycine 0 C--N 1.349 1.258 0 CA-C-N 115.784 -0.644 . . . . 73.33 113.48 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 75.5 p -66.02 -26.79 67.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.685 0.794 . . . . 74.11 111.534 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -62.49 -54.12 44.7 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.959 0.504 . . . . 75.42 110.028 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.496 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 7.6 ptt? -76.79 -23.79 52.86 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.896 -0.593 . . . . 64.45 111.099 -176.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.48 -37.18 77.14 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.377 0.608 . . . . 60.22 110.364 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -67.78 -33.21 74.39 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.643 -1.162 . . . . 72.54 110.442 173.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.529 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 43.9 t -68.86 -60.59 2.27 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.802 -0.635 . . . . 64.53 110.682 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.7 pp -69.42 -28.3 66.03 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.44 0.696 . . . . 73.32 112.411 -174.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . 0.408 ' N ' HD11 ' C' ' 98' ' ' LEU . . . -94.57 -3.9 62.5 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-O 119.558 -0.579 . . . . 64.34 114.21 -172.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.58 -62.15 0.13 Allowed 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 117.496 0.648 . . . . 74.11 112.639 -172.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.529 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 54.7 t80 -66.41 -37.92 86.3 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 124.391 1.076 . . . . 70.1 113.106 -170.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.427 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 29.7 m -80.72 -42.64 1.26 Allowed Pre-proline 0 CA--C 1.564 1.511 0 C-N-CA 123.561 0.745 . . . . 64.4 111.034 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.434 ' HB3' HD22 ' C' ' 60' ' ' LEU . 89.0 Cg_exo -54.13 -24.21 32.36 Favored 'Trans proline' 0 C--N 1.398 3.151 0 C-N-CA 122.995 2.464 . . . . 72.55 114.617 166.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -67.77 -24.72 65.37 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.399 0.68 . . . . 73.21 111.792 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.492 HG23 ' NH1' ' A' ' 111' ' ' ARG . 31.7 mm -77.3 -35.17 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 109.24 -0.652 . . . . 75.45 109.24 173.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.449 HD13 HG21 ' C' ' 58' ' ' VAL . 82.0 mt -79.41 -24.9 42.24 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.671 -1.15 . . . . 73.11 111.818 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -57.11 -55.27 45.81 Favored Pre-proline 0 CA--C 1.557 1.226 0 CA-C-O 118.198 -0.906 . . . . 75.13 113.09 -173.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . 0.437 ' HB2' ' HG3' ' A' ' 112' ' ' GLU . 57.5 Cg_endo -66.57 -23.33 49.93 Favored 'Trans proline' 0 C--N 1.387 2.6 0 CA-C-N 121.174 1.455 . . . . 63.1 112.342 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . 0.456 ' CD1' HG21 ' C' ' 16' ' ' ILE . 2.3 m-30 -75.51 -49.31 19.11 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.13 0.972 . . . . 74.42 110.15 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.68 -38.24 84.29 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.149 0.98 . . . . 64.31 110.07 174.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -58.48 -53.07 62.42 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.253 1.421 . . . . 73.2 110.753 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.47 -32.61 73.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 123.694 0.622 . . . . 73.42 110.278 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.6 t -68.8 -34.41 75.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.001 0.52 . . . . 75.02 111.006 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.514 HD12 HG21 ' C' ' 64' ' ' VAL . 95.5 mt -73.33 -51.93 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.666 0.786 . . . . 74.32 109.84 175.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.0 m -64.56 -28.9 69.96 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.844 0.858 . . . . 71.32 111.426 -175.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.3 t -67.77 -48.62 65.85 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.238 -0.653 . . . . 64.41 109.238 172.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.655 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.1 -38.66 87.09 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.512 1.125 . . . . 74.44 112.836 -179.838 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 82.2 t -62.12 -45.38 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.769 0.828 . . . . 72.4 109.668 175.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 44.8 t -68.2 -32.47 72.71 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.239 -0.891 . . . . 74.43 111.947 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -68.88 -31.61 70.66 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.537 0.735 . . . . 75.13 109.703 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.82 10.79 73.83 Favored Glycine 0 C--N 1.355 1.607 0 O-C-N 123.969 0.793 . . . . 73.22 112.998 173.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.448 HG22 ' HB3' ' D' ' 17' ' ' TYR . 43.2 p 60.19 29.48 19.04 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 126.151 1.78 . . . . 61.44 114.257 173.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -96.03 147.0 32.31 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.494 -0.928 . . . . 75.21 108.494 171.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.627 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 80.6 Cg_exo -49.44 141.06 26.33 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.712 2.941 . . . . 75.51 114.421 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.494 ' HA ' HE21 ' C' ' 125' ' ' GLN . 0.0 OUTLIER -55.49 113.81 1.58 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.175 0.99 . . . . 73.23 111.354 -177.805 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 41.6 tp -107.78 92.81 4.22 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.601 -0.889 . . . . 73.53 108.601 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -93.03 114.71 27.33 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.197 -0.911 . . . . 45.05 108.976 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 tt -73.09 135.89 44.84 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.922 0.889 . . . . 75.4 110.252 -171.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.41 148.76 90.95 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 123.666 0.786 . . . . 70.12 111.997 -175.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.436 ' CG ' HD13 ' A' ' 16' ' ' ILE . 6.6 Cg_exo -70.86 116.57 4.73 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.145 2.563 . . . . 72.11 112.49 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 90.5 t -126.96 110.58 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.784 -0.821 . . . . 75.15 108.784 173.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -71.97 104.69 3.61 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.281 1.032 . . . . 71.24 109.726 174.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -62.75 -44.63 95.71 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.283 0.563 . . . . 74.24 110.052 172.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 . . . . . 0 CA--C 1.54 0.577 0 CA-C-N 114.372 -1.285 . . . . 74.11 111.184 -174.476 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 87.8 m . . . . . 0 C--O 1.237 0.438 0 CA-C-O 120.613 0.244 . . . . 74.3 110.929 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.407 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 31.3 t80 -159.12 89.13 0.91 Allowed 'General case' 0 C--O 1.238 0.45 0 N-CA-C 107.051 -1.463 . . . . 73.41 107.051 171.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -113.96 116.38 29.14 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.018 -1.104 . . . . 74.15 108.018 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.494 HG21 HD13 ' D' ' 16' ' ' ILE . 54.3 mt -72.09 122.95 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 109.588 -0.523 . . . . 70.04 109.588 -178.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -85.61 -42.91 13.92 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.994 0.809 . . . . 72.43 111.189 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -170.97 135.12 1.0 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 111.81 0.3 . . . . 74.35 111.81 -163.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.494 HD13 HG21 ' D' ' 13' ' ' ILE . 2.7 mp -115.76 134.58 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.609 -1.256 . . . . 73.01 107.609 170.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.448 ' HB3' HG22 ' C' ' 122' ' ' THR . 32.9 p90 -166.42 169.57 13.81 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 122.18 0.991 . . . . 71.21 111.394 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.5 p -103.03 120.33 40.46 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 113.567 -1.651 . . . . 72.52 108.534 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -89.96 -31.02 17.43 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.088 -0.708 . . . . 74.42 109.088 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -140.4 134.73 31.24 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 114.385 -1.28 . . . . 61.11 108.343 173.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.655 HG21 ' HE1' ' C' ' 117' ' ' MET . 63.7 mt -128.18 145.08 35.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.021 -1.474 . . . . 74.25 107.021 168.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 30.9 t -147.25 140.89 25.61 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.9 0.88 . . . . 70.3 108.834 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.513 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.1 t80 -146.48 136.22 23.21 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 105.89 -1.892 . . . . 64.01 105.89 168.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 43.8 mt-10 -138.52 152.37 48.18 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.338 -1.356 . . . . 74.14 107.338 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.77 84.33 7.05 Favored Pre-proline 0 C--O 1.239 0.535 0 N-CA-C 107.307 -1.368 . . . . 72.3 107.307 172.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -66.57 -36.91 23.96 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.0 2.467 . . . . 70.13 113.025 -170.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.458 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 52.6 m-20 -101.35 6.84 42.85 Favored 'General case' 0 C--O 1.211 -0.973 0 CA-C-O 118.542 -0.742 . . . . 71.42 110.747 -177.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.486 ' HB2' ' HE3' ' C' ' 19' ' ' LYS . . . -26.08 -65.09 0.11 Allowed Pre-proline 0 N--CA 1.496 1.85 0 N-CA-C 116.621 2.082 . . . . 73.43 116.621 -162.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.503 ' HB3' HD11 ' C' ' 83' ' ' ILE . 67.1 Cg_endo -78.85 -21.97 9.23 Favored 'Trans proline' 0 C--N 1.382 2.314 0 CA-C-N 122.878 2.063 . . . . 72.53 113.842 -177.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -73.74 -37.16 65.16 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.88 1.272 . . . . 75.51 110.37 175.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.583 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.5 p -84.13 -18.93 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.066 0.546 . . . . 74.11 111.531 -174.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -65.45 -15.83 63.02 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 112.529 0.566 . . . . 73.12 112.529 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -58.65 -33.43 70.07 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.55 0.69 . . . . 72.23 110.03 173.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.605 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 97.6 mttt -89.28 93.39 9.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.126 -1.397 . . . . 74.23 109.373 178.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -102.43 91.64 4.34 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.17 0.509 . . . . 64.04 109.981 -177.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 35.6 p90 -158.28 174.0 15.82 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.949 1.3 . . . . 72.4 108.009 169.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -65.43 112.91 9.6 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-O 118.938 -0.553 . . . . 72.1 109.565 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -59.07 141.24 97.99 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.582 2.188 . . . . 74.41 112.713 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -59.42 118.19 5.71 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.607 0.763 . . . . 74.43 109.959 172.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.495 HG11 HG13 ' D' ' 64' ' ' VAL . 59.0 t -97.21 106.94 19.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 123.219 0.608 . . . . 74.53 109.426 -175.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -95.69 127.92 42.12 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.097 -0.956 . . . . 71.12 108.648 173.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -97.51 146.08 25.59 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.139 0.576 . . . . 72.42 109.602 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -149.54 116.76 6.05 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.226 -1.027 . . . . 63.41 108.226 177.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.05 140.12 41.69 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.722 0.409 . . . . 75.42 110.926 -173.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.59 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.2 t70 -136.88 151.82 49.52 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.56 1.144 . . . . 73.15 108.595 173.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.0 t -116.85 150.3 38.64 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.149 0.579 . . . . 74.1 110.839 -172.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.659 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.05 155.09 28.67 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.991 0.917 . . . . 74.54 109.229 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 13.4 p -167.09 162.12 15.16 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.697 0.399 . . . . 73.23 111.323 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 3.0 m -153.38 144.8 23.2 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.243 1.017 . . . . 71.14 108.669 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -97.92 116.49 30.23 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.152 -1.055 . . . . 74.15 108.152 165.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 24.6 mt -95.51 -40.58 9.38 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.044 0.538 . . . . 72.4 110.455 -172.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.546 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -146.11 -176.56 5.2 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.077 -0.965 . . . . 72.34 109.908 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -68.4 105.92 2.34 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.387 0.675 . . . . 73.51 109.652 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 62.85 18.55 10.85 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.759 1.224 . . . . 74.41 112.128 -177.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 57.3 t -109.23 104.83 17.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 107.353 -1.351 . . . . 63.23 107.353 171.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -119.6 131.33 55.46 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.96 -1.473 . . . . 74.43 109.686 -164.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -98.58 132.23 44.15 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.947 -0.57 . . . . 75.15 109.868 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 75.4 t -115.46 118.86 60.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 107.582 -1.266 . . . . 74.51 107.582 175.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 24.9 t -117.96 129.53 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.574 0.75 . . . . 71.12 109.276 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.423 HD21 ' HG3' ' D' ' 103' ' ' PRO . 2.5 mm? -122.74 129.47 51.8 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 110.328 -0.249 . . . . 74.11 110.328 176.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.59 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 14.3 ttm-85 -86.44 100.05 12.07 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.82 -0.807 . . . . 75.11 108.82 172.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 99.1 t -90.41 116.84 32.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.048 -1.093 . . . . 70.21 108.048 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 17.6 m -123.34 126.29 46.57 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.339 0.59 . . . . 71.43 109.671 -172.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.495 HG13 HG11 ' D' ' 40' ' ' VAL . 40.6 t -117.33 100.36 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.742 1.617 . . . . 75.35 107.977 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 60.7 m -93.53 94.26 8.55 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.832 -1.076 . . . . 71.0 108.157 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.16 143.77 28.33 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.712 -0.677 . . . . 65.22 110.456 -174.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.43 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 54.2 p -144.6 135.35 24.78 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 115.735 -0.666 . . . . 74.43 110.429 -177.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.484 HD11 HG23 ' D' ' 31' ' ' VAL . 39.0 mt -98.24 100.0 11.26 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.642 0.777 . . . . 74.44 109.052 172.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.01 -115.06 4.53 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.025 -0.989 . . . . 71.22 112.487 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -102.69 5.64 39.12 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.715 0.806 . . . . 74.2 112.15 -176.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.605 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 13.1 pt-20 -131.7 155.79 47.03 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.81 -0.441 . . . . 73.41 109.81 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 71.8 m -65.67 136.17 55.95 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 123.784 0.677 . . . . 73.51 110.977 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.583 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.6 -64.07 1.19 Allowed 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.577 -1.268 . . . . 74.41 107.577 174.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -155.94 152.14 27.86 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.382 -1.281 . . . . 73.34 110.194 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 78.3 mt -118.5 111.91 19.24 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.319 -0.993 . . . . 72.12 108.319 177.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.522 ' SG ' HG12 ' D' ' 114' ' ' ILE . 44.8 t -116.06 138.79 50.92 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.765 -0.828 . . . . 73.2 108.765 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -155.31 122.32 5.45 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.579 0.352 . . . . 73.3 110.258 -178.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.17 123.89 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.153 0.581 . . . . 72.32 109.957 -175.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -87.3 88.41 7.68 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.17 -1.048 . . . . 74.23 108.17 165.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -80.41 99.76 8.13 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.646 -1.242 . . . . 74.21 107.646 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.63 142.38 15.8 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.448 -0.661 . . . . 40.32 111.448 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.426 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -136.7 131.96 5.85 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.19 -0.764 . . . . 74.25 111.19 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 43.8 mt -90.77 124.78 43.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 108.088 -1.079 . . . . 72.01 108.088 176.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -132.99 123.65 26.27 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.762 0.825 . . . . 74.43 109.483 -174.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.9 m -84.25 97.76 9.59 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.97 -0.752 . . . . 64.31 108.97 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.564 HG13 ' SG ' ' D' ' 97' ' ' CYS . 0.0 OUTLIER -120.66 130.81 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.771 0.828 . . . . 75.23 109.724 -174.073 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.26 164.91 36.44 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.785 0.834 . . . . 73.45 110.76 -176.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.67 -10.55 71.67 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.725 -0.671 . . . . 53.24 114.15 173.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.553 HD13 HD13 ' D' ' 86' ' ' ILE . 34.4 mt -94.5 145.08 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.63 0.772 . . . . 74.34 109.81 -174.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.74 ' HA ' ' HE1' ' D' ' 94' ' ' MET . 0.0 OUTLIER -132.7 166.48 22.1 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.666 0.786 . . . . 70.01 110.62 178.728 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.65 -136.6 41.71 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 114.951 -1.022 . . . . 74.14 114.902 169.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 16.4 m -77.47 -18.33 57.23 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.361 1.065 . . . . 72.11 111.565 -173.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -66.16 -24.84 66.73 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.826 0.45 . . . . 73.21 110.723 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.74 ' HE1' ' HA ' ' D' ' 90' ' ' GLU . 63.3 mtt -60.02 -43.91 94.97 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.967 0.507 . . . . 71.43 110.167 173.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.55 -26.41 67.12 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.399 -0.819 . . . . 73.24 111.53 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -85.26 -34.52 21.94 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.251 0.62 . . . . 71.21 111.111 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . 0.564 ' SG ' HG13 ' D' ' 86' ' ' ILE . 42.6 t -72.43 -52.44 15.92 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.265 0.555 . . . . 70.23 109.747 -175.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 26.2 mt -80.95 -29.57 35.4 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.523 -1.217 . . . . 73.41 110.24 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.4 -17.89 40.89 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 114.968 0.747 . . . . 61.22 114.968 -171.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.65 -50.22 0.91 Allowed 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 117.788 0.794 . . . . 73.53 111.602 -174.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -73.94 -42.24 60.85 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 122.809 0.444 . . . . 74.2 112.043 -174.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.458 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 69.4 m -67.77 -47.31 44.28 Favored Pre-proline 0 CA--C 1.567 1.609 0 C-N-CA 123.161 0.585 . . . . 61.34 111.76 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 51.4 Cg_exo -59.75 -28.57 87.6 Favored 'Trans proline' 0 C--N 1.401 3.327 0 C-N-CA 122.597 2.198 . . . . 64.4 113.385 170.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -64.25 -40.93 97.02 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.95 0.9 . . . . 74.45 110.05 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 48.0 mm -61.73 -42.19 93.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 123.447 0.699 . . . . 74.33 110.193 173.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.426 HD22 ' HA3' ' D' ' 82' ' ' GLY . 96.1 mt -82.99 -13.37 56.09 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.975 -1.011 . . . . 61.41 112.49 -172.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -64.65 -48.15 74.35 Favored Pre-proline 0 N--CA 1.49 1.546 0 C-N-CA 123.929 0.892 . . . . 74.33 112.775 -176.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.52 -36.89 96.82 Favored 'Trans proline' 0 C--N 1.391 2.791 0 C-N-CA 122.201 1.934 . . . . 72.33 113.164 175.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -73.98 -36.08 64.53 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.893 0.877 . . . . 73.14 112.135 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.47 -49.65 72.79 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.209 -0.664 . . . . 64.51 109.209 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -55.1 -48.53 73.46 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 124.933 1.396 . . . . 74.24 110.781 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -61.81 -50.97 70.17 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 123.794 0.684 . . . . 73.11 111.365 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 38.9 t -55.43 -45.58 76.78 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 123.944 0.777 . . . . 75.33 111.039 -177.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.522 HG12 ' SG ' ' D' ' 76' ' ' CYS . 98.8 mt -59.31 -58.2 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.366 1.066 . . . . 71.1 110.817 174.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 60.7 m -54.19 -43.24 70.53 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.596 1.158 . . . . 64.21 112.16 -173.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -66.75 -40.32 88.25 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.026 -0.988 . . . . 71.44 110.045 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.1 mtm -70.28 -29.79 66.64 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.947 0.499 . . . . 74.33 111.616 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.451 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.0 t -64.99 -45.42 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.503 0.721 . . . . 75.13 110.178 175.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -74.33 -30.14 61.91 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.838 -0.619 . . . . 72.15 111.067 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 59.0 mtt-85 -69.83 -34.11 73.22 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.529 0.731 . . . . 75.44 109.867 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.12 -0.82 90.04 Favored Glycine 0 C--N 1.355 1.628 0 O-C-N 123.65 0.594 . . . . 70.44 112.388 173.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.42 HG21 ' HB3' ' C' ' 17' ' ' TYR . 31.1 p 64.21 23.18 13.06 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 126.952 2.101 . . . . 64.32 113.698 174.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -85.27 155.41 60.18 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.537 0.735 . . . . 74.22 110.055 171.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -53.2 125.63 19.0 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.182 2.588 . . . . 65.43 112.643 173.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -50.93 142.77 11.24 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.38 1.472 . . . . 75.43 112.864 -174.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.402 HD12 HG23 ' D' ' 40' ' ' VAL . 43.4 tp -114.35 125.07 53.45 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.613 0.765 . . . . 73.11 109.183 177.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -119.88 100.22 7.1 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.519 -0.919 . . . . 74.22 108.519 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 76.4 mt -61.55 114.84 3.48 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.289 -0.634 . . . . 73.41 109.289 174.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.02 145.22 65.92 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 124.19 0.996 . . . . 72.42 111.979 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.418 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 39.3 Cg_endo -72.33 97.2 0.84 Allowed 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 122.131 1.887 . . . . 62.45 110.343 177.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.47 0.569 0 CA-C-N 114.567 -1.197 . . . . 75.52 109.513 -175.934 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 119.335 -0.364 . . . . 75.31 111.923 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.0 m 53.02 66.92 1.09 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.195 0.998 . . . . 75.14 111.108 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.579 ' HG3' ' HG3' ' A' ' 4' ' ' GLN . 9.6 pt-20 -74.21 -32.2 62.94 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.633 -1.167 . . . . 71.22 111.48 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.579 ' HG3' ' HG3' ' A' ' 3' ' ' GLU . 40.2 mt-30 -96.48 144.88 26.17 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.672 0.789 . . . . 75.51 109.851 -176.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -67.85 130.93 44.49 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.289 -1.004 . . . . 74.14 108.289 173.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.568 ' HA ' ' HG3' ' C' ' 143' ' ' GLN . 28.6 t-20 -172.13 -42.81 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.605 0.565 . . . . 73.04 110.101 -176.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 m 69.12 72.06 0.26 Allowed 'General case' 0 CA--C 1.546 0.789 0 O-C-N 124.48 1.112 . . . . 72.21 109.023 -171.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -75.2 -50.75 15.21 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.715 -1.13 . . . . 72.3 109.639 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.4 ' SD ' ' N ' ' A' ' 10' ' ' THR . 0.1 OUTLIER -68.3 144.98 54.63 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.034 -0.985 . . . . 73.5 109.105 176.55 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.4 ' N ' ' SD ' ' A' ' 9' ' ' MET . 76.5 m -138.75 143.41 39.01 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.218 0.532 . . . . 75.04 110.776 -170.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.63 ' HB2' ' HH ' ' A' ' 101' ' ' TYR . 1.8 t80 -131.81 137.98 48.34 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.875 -1.057 . . . . 75.44 109.63 -172.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -147.78 120.35 8.54 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.048 -1.093 . . . . 75.21 108.048 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.2 mt -85.85 120.56 36.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 109.374 -0.602 . . . . 72.23 109.374 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.28 -41.91 19.54 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.463 -0.94 . . . . 73.53 108.463 178.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -169.03 148.91 4.17 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 116.183 -0.462 . . . . 73.42 111.116 -170.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 69.0 mt -137.65 130.35 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 124.61 1.164 . . . . 71.53 108.151 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -167.83 154.52 7.92 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.61 0.719 . . . . 70.31 111.605 -174.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.1 p -83.9 122.35 28.6 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.467 -1.242 . . . . 70.44 109.111 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.408 ' HZ3' ' CD ' ' A' ' 57' ' ' GLU . 42.2 mtpt -94.59 -14.93 24.5 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.161 0.584 . . . . 74.24 110.638 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 18.0 t0 -158.6 139.55 12.97 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.9 -1.148 . . . . 73.3 107.9 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.2 mt -141.16 141.9 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 106.977 -1.49 . . . . 74.21 106.977 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.9 t -157.06 116.48 3.4 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.821 0.343 . . . . 74.32 110.259 177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.566 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 81.6 t80 -110.86 139.82 45.86 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 107.206 -1.405 . . . . 73.21 107.206 170.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 49.1 mt-10 -141.68 109.69 5.82 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 123.321 0.648 . . . . 75.02 109.35 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.05 88.56 1.59 Allowed Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.064 -1.828 . . . . 75.14 106.064 165.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -66.92 -34.05 31.07 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.722 2.281 . . . . 64.31 112.097 -169.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -112.82 26.37 10.58 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 114.959 -1.019 . . . . 74.24 109.311 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.44 ' O ' HG11 ' A' ' 31' ' ' VAL . . . -44.62 -53.91 13.89 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 113.972 1.101 . . . . 72.24 113.972 -169.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.76 -28.47 86.52 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 121.971 1.781 . . . . 73.52 112.824 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.466 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.2 m-70 -89.34 -31.19 17.92 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.439 1.096 . . . . 74.51 110.269 -176.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.529 HG22 ' HA ' ' A' ' 73' ' ' ALA . 3.0 p -73.26 -17.82 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.065 0.546 . . . . 63.42 112.186 -162.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -82.6 -23.71 34.25 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.255 0.622 . . . . 64.44 111.203 -176.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 28.9 pt20 -91.21 -11.86 37.04 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.253 0.621 . . . . 73.11 110.556 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 13.5 mmmm -76.75 168.43 20.1 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.491 0.716 . . . . 73.44 111.842 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.64 117.0 10.69 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.743 -0.836 . . . . 74.51 108.743 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.404 ' CE3' HD21 ' A' ' 68' ' ' LEU . 58.1 t-105 -83.54 85.21 7.29 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.378 0.608 . . . . 75.22 109.766 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -127.82 81.38 70.4 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 107.889 -1.152 . . . . 75.41 107.889 171.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -72.94 108.2 2.53 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.532 2.154 . . . . 75.03 112.514 -174.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -95.43 90.49 5.8 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.911 -1.514 . . . . 74.12 106.911 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 65' ' ' THR . 60.3 t -88.13 113.46 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 CA-C-N 115.021 -0.991 . . . . 73.3 111.044 -171.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.426 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 80.7 tttt -79.82 136.86 36.81 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.346 1.058 . . . . 75.11 110.104 172.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.457 HD23 HG12 ' E' ' 6' ' ' ILE . 0.6 OUTLIER -110.4 125.37 53.17 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.976 -1.12 . . . . 75.44 107.976 175.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.594 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 22.8 t70 -135.57 126.24 27.17 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.379 -0.6 . . . . 72.13 109.379 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.602 HD21 HD22 ' E' ' 8' ' ' LEU . 2.5 mm? -107.94 133.27 52.52 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.368 0.667 . . . . 75.31 110.278 -177.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.561 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 11.7 t70 -124.18 146.29 48.78 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.382 1.073 . . . . 71.4 108.372 173.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 79.3 m -119.8 139.87 51.66 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.701 0.8 . . . . 74.23 110.073 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.697 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -132.53 131.59 41.73 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.922 0.889 . . . . 53.22 109.286 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.2 m -102.58 151.88 21.82 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.629 0.772 . . . . 64.34 109.946 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.6 t -162.96 127.95 3.12 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.084 -0.709 . . . . 72.0 109.084 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -112.84 119.15 36.99 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.337 -0.986 . . . . 72.21 108.337 171.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.59 HD12 HG22 ' A' ' 83' ' ' ILE . 57.4 mt -96.17 -30.18 13.64 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.216 0.606 . . . . 73.53 111.405 -174.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.22 -175.47 3.98 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.293 0.637 . . . . 60.23 110.469 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.51 117.79 7.24 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.326 -0.852 . . . . 74.41 108.776 171.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 71.93 -5.03 1.8 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.541 1.136 . . . . 62.14 112.93 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.0 t -99.22 106.02 18.3 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 N-CA-C 107.544 -1.28 . . . . 75.24 107.544 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -124.02 125.01 43.81 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.97 -1.122 . . . . 75.0 107.97 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.408 ' CD ' ' HZ3' ' A' ' 19' ' ' LYS . 64.7 tt0 -102.09 114.16 28.05 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.636 -0.876 . . . . 64.33 108.636 176.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.9 m -102.92 136.1 37.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.702 -1.221 . . . . 64.51 107.702 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.697 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 60.7 t -124.93 138.97 52.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 108.751 -0.833 . . . . 74.32 108.751 -174.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -128.19 112.84 14.96 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.593 -0.891 . . . . 63.0 108.593 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.561 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 19.5 ttt180 -93.23 102.44 14.73 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.029 0.932 . . . . 70.23 109.122 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -94.09 127.76 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.49 0.716 . . . . 74.41 109.444 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.594 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 13.9 m -113.31 130.45 56.26 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.836 0.855 . . . . 64.14 109.584 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.7 t -126.65 106.69 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.162 1.385 . . . . 73.02 107.851 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 23.5 m -104.61 134.4 47.85 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 107.762 -1.199 . . . . 75.33 107.762 175.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.52 127.29 55.18 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.835 -1.172 . . . . 64.45 107.835 174.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -126.94 126.33 43.06 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.302 0.641 . . . . 73.52 110.023 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.527 ' HG ' ' HB1' ' A' ' 73' ' ' ALA . 30.9 mt -86.91 78.02 9.11 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.394 1.078 . . . . 63.22 108.363 173.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.58 -84.6 0.87 Allowed Glycine 0 C--N 1.342 0.911 0 CA-C-N 115.229 -0.896 . . . . 74.0 111.443 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -115.27 -28.48 6.89 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.143 0.977 . . . . 71.33 110.621 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -87.94 132.59 34.17 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.289 -0.634 . . . . 74.03 109.289 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.2 m -72.8 123.42 23.31 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.745 0.702 . . . . 71.44 110.307 175.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.529 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -72.21 -57.35 4.31 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.52 -0.764 . . . . 53.32 109.633 174.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.455 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 35.7 p90 -162.58 176.96 9.85 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.612 -1.177 . . . . 74.24 111.093 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 58.6 tp -139.77 142.22 36.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.397 1.479 . . . . 71.55 107.31 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.452 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 76.0 m -145.5 106.96 4.21 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.114 0.965 . . . . 72.01 108.654 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -130.33 122.23 27.52 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.402 0.681 . . . . 73.12 109.492 -174.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.402 HG12 ' HB3' ' A' ' 113' ' ' CYS . 25.0 t -132.14 114.44 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.209 1.004 . . . . 72.21 109.685 -172.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 7.1 tt0 -84.56 90.12 7.59 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.359 -0.978 . . . . 64.33 108.359 173.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.544 ' HG3' HD23 ' A' ' 106' ' ' LEU . 6.8 tp-100 -85.13 104.13 14.74 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.288 -0.634 . . . . 75.32 109.288 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.61 153.39 21.61 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 111.485 -0.646 . . . . 72.22 111.485 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.423 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -155.8 122.0 1.16 Allowed Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 111.262 -0.735 . . . . 63.34 111.262 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.59 HG22 HD12 ' A' ' 51' ' ' LEU . 41.4 mt -83.04 116.15 26.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 N-CA-C 108.962 -0.755 . . . . 64.42 108.962 176.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.584 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 38.0 m-85 -127.19 120.82 29.68 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.267 0.627 . . . . 74.53 109.941 -175.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.8 m -81.1 102.02 9.98 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.434 -0.95 . . . . 74.54 108.434 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.3 pt -126.23 121.38 59.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.87 0.868 . . . . 73.5 109.991 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.46 169.3 8.98 Favored 'General case' 0 C--O 1.247 0.927 0 C-N-CA 124.654 1.181 . . . . 51.32 109.42 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.35 97.13 0.35 Allowed Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.383 -1.087 . . . . 71.45 110.383 -172.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.7 mm 88.05 108.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.185 1.394 . . . . 75.22 109.996 170.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -105.26 -163.6 0.96 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.976 1.311 . . . . 75.52 111.031 -166.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.82 -148.87 40.57 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 116.004 -0.544 . . . . 60.11 112.949 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.415 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 17.8 p -62.22 -25.29 67.73 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.268 1.027 . . . . 74.03 111.963 177.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -61.73 -53.93 49.36 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.28 1.032 . . . . 74.31 109.428 176.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.476 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 46.3 ttp -71.82 -27.71 63.1 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.321 -0.854 . . . . 74.33 111.228 175.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.415 ' HB1' ' HA ' ' A' ' 92' ' ' THR . . . -66.67 -34.21 77.35 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.868 0.467 . . . . 71.42 110.99 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.488 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 41.6 t-80 -68.79 -24.91 64.47 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.772 0.829 . . . . 74.14 110.584 173.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 69.1 m -75.77 -64.95 0.97 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.565 0.346 . . . . 72.33 110.675 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.518 HD12 ' N ' ' A' ' 99' ' ' GLY . 3.4 pp -71.1 -32.27 68.84 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.149 0.98 . . . . 75.32 112.687 -170.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.518 ' N ' HD12 ' A' ' 98' ' ' LEU . . . -105.54 3.22 39.59 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-O 119.688 -0.506 . . . . 73.03 113.597 -171.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.566 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -136.93 -60.5 0.69 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.525 0.663 . . . . 70.42 112.072 -177.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.63 ' HH ' ' HB2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -79.13 -34.82 42.98 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 112.166 0.432 . . . . 73.44 112.166 -174.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 70.9 m -64.55 -43.56 71.43 Favored Pre-proline 0 N--CA 1.491 1.611 0 CA-C-N 115.627 -0.715 . . . . 54.4 112.416 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -48.53 -45.09 28.36 Favored 'Trans proline' 0 C--N 1.391 2.811 0 C-N-CA 122.829 2.353 . . . . 70.31 113.322 163.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -64.52 -21.57 66.72 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.652 0.781 . . . . 72.24 112.03 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.8 mm -74.85 -48.95 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 109.667 -0.494 . . . . 74.24 109.667 174.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.544 HD23 ' HG3' ' A' ' 80' ' ' GLN . 88.4 mt -75.94 -27.05 57.44 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.401 -0.818 . . . . 74.24 112.276 -174.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.509 ' HZ ' HD23 ' A' ' 128' ' ' LEU . 31.7 t80 -63.44 -43.76 79.95 Favored Pre-proline 0 CA--C 1.564 1.504 0 N-CA-C 113.817 1.043 . . . . 71.23 113.817 -169.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.63 -40.11 82.59 Favored 'Trans proline' 0 C--N 1.387 2.578 0 C-N-CA 122.207 1.938 . . . . 75.33 112.887 173.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.468 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 97.9 m-85 -69.69 -40.98 76.02 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.497 0.719 . . . . 74.41 111.415 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.0 -36.04 74.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.425 0.69 . . . . 74.13 110.29 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.589 ' NH1' HD13 ' C' ' 105' ' ' ILE . 37.3 ttm180 -57.8 -55.78 30.44 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.093 0.871 . . . . 74.53 109.6 172.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -63.98 -41.06 97.65 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.024 -0.989 . . . . 75.34 111.73 -173.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.402 ' HB3' HG12 ' A' ' 78' ' ' VAL . 39.0 t -66.45 -30.94 71.41 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.798 0.439 . . . . 72.33 111.167 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 60.7 mt -72.85 -50.99 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.831 0.853 . . . . 62.21 109.857 172.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 63.7 m -57.99 -34.04 69.55 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.667 1.187 . . . . 72.45 111.509 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.8 t -67.35 -46.35 73.64 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 115.439 -0.801 . . . . 73.31 109.8 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.566 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 42.6 mtm -67.49 -36.15 80.53 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.876 0.47 . . . . 74.12 111.483 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.2 t -61.59 -46.85 95.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.369 0.668 . . . . 72.23 110.075 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 41.2 t -67.56 -36.35 80.77 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 115.428 -0.805 . . . . 63.4 111.118 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -72.96 -29.38 63.03 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.686 0.794 . . . . 75.14 109.891 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.55 10.51 61.64 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.869 0.73 . . . . 52.33 112.198 173.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.484 HG23 ' HE ' ' B' ' 15' ' ' ARG . 2.1 t 62.17 20.18 11.49 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.84 2.056 . . . . 72.01 113.266 170.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -84.28 154.89 63.4 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 122.956 0.503 . . . . 73.34 109.65 176.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -53.16 159.63 5.42 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.461 2.774 . . . . 75.15 113.97 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.44 HE21 HG23 ' D' ' 122' ' ' THR . 6.5 tp-100 -62.03 125.53 24.18 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.627 -0.715 . . . . 54.14 111.435 -174.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.455 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 54.9 tp -130.27 113.11 14.0 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.779 1.231 . . . . 74.21 109.407 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -129.22 123.28 31.58 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.364 0.666 . . . . 73.21 109.562 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.509 HD23 ' HZ ' ' A' ' 107' ' ' PHE . 4.2 tt -73.8 127.85 33.92 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 108.333 -0.988 . . . . 74.04 108.333 175.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' E' ' 7' ' ' ALA . . . -65.51 137.26 96.44 Favored Pre-proline 0 CA--C 1.564 1.49 0 C-N-CA 123.067 0.547 . . . . 75.22 112.051 -174.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.479 ' HG2' ' CE1' ' C' ' 11' ' ' PHE . 36.8 Cg_exo -63.95 127.32 19.17 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.974 3.116 . . . . 74.23 113.429 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.5 t -117.47 114.78 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.04 0.936 . . . . 71.24 108.738 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -83.42 88.31 6.98 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.039 -0.726 . . . . 74.3 109.039 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -63.09 -44.22 96.33 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.279 -0.873 . . . . 74.05 110.506 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.566 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 18.6 p-10 -58.09 -41.82 84.31 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.165 1.386 . . . . 70.23 113.201 -170.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.12 96.61 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.246 0.618 . . . . 64.31 111.15 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.49 ' HB2' HD22 ' E' ' 10' ' ' LEU . 87.7 mt -76.38 -15.18 60.01 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.744 -0.662 . . . . 73.41 111.64 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -84.41 -26.52 28.26 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.63 0.372 . . . . 74.14 110.781 169.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 99.4 mmm -69.87 -28.75 65.91 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 110.019 -0.363 . . . . 73.22 110.019 170.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -59.18 -34.62 72.34 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.835 1.254 . . . . 75.34 110.576 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -94.29 -29.07 15.24 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.602 0.761 . . . . 75.1 111.89 177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 40.2 tp -63.54 -49.4 73.64 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.405 0.282 . . . . 74.0 110.675 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -164.5 27.1 0.07 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.521 0.729 . . . . 73.31 111.289 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 67.83 164.52 0.22 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.82 1.248 . . . . 73.43 112.483 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -100.2 101.6 12.67 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.44 0.696 . . . . 65.2 110.201 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.01 169.81 14.23 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.168 0.987 . . . . 75.41 109.498 173.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 100.63 60.71 0.81 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.16 -0.776 . . . . 70.03 111.16 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -75.85 100.64 4.85 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.196 -0.668 . . . . 73.25 109.196 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -90.11 146.0 18.46 Favored Glycine 0 C--N 1.338 0.662 0 N-CA-C 110.921 -0.872 . . . . 74.0 110.921 172.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.5 p -151.38 66.97 0.89 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.06 0.944 . . . . 74.32 108.681 174.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -78.08 87.34 4.21 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.949 -1.13 . . . . 74.24 107.949 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -92.36 157.76 16.45 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.236 1.015 . . . . 73.34 111.122 -170.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -147.0 90.27 1.88 Allowed 'General case' 0 C--O 1.241 0.605 0 C-N-CA 124.276 1.03 . . . . 74.43 108.482 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -75.42 101.84 4.95 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.48 -0.933 . . . . 74.14 108.48 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -174.51 153.88 1.96 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.389 1.076 . . . . 74.1 109.079 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 C-N-CA 124.024 0.93 . . . . 74.54 108.657 177.22 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 110.855 -0.054 . . . . 71.22 110.855 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.5 p -162.86 85.83 0.54 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.535 0.734 . . . . 75.44 109.578 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.65 132.91 35.31 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 108.199 -1.038 . . . . 73.41 108.199 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -74.77 77.69 2.08 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.191 0.596 . . . . 72.14 110.596 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -158.09 159.19 36.01 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.631 -1.248 . . . . 61.11 107.631 -175.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -66.5 89.28 0.14 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.036 0.534 . . . . 71.4 110.159 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -73.49 126.04 29.3 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.286 -0.87 . . . . 75.44 110.693 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 61.47 -84.13 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.22 1.408 . . . . 72.44 111.773 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.498 ' SD ' ' N ' ' B' ' 10' ' ' THR . 0.0 OUTLIER 63.49 166.84 0.14 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 125.603 1.561 . . . . 74.21 110.777 -173.329 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 99.9 m -157.87 125.26 5.14 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 106.187 -1.783 . . . . 74.21 106.187 170.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -138.53 125.33 21.0 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.181 -0.674 . . . . 73.41 109.181 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.418 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -148.3 137.7 22.09 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.315 -0.624 . . . . 74.43 109.315 174.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 48.6 mt -85.4 122.6 38.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.608 -0.886 . . . . 74.32 108.608 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . 0.515 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 12.4 mm100 -89.83 -43.51 10.59 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.677 0.791 . . . . 73.32 109.999 -175.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.484 ' HE ' HG23 ' A' ' 122' ' ' THR . 44.2 ttt180 -178.96 130.63 0.11 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.298 -0.631 . . . . 74.13 109.298 -173.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 77.4 mt -116.73 137.08 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 108.31 -0.996 . . . . 75.25 108.31 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -162.99 145.27 10.3 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.455 0.645 . . . . 75.12 111.182 -170.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.3 m -73.68 117.9 16.0 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.471 -1.24 . . . . 63.2 108.091 170.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.466 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 45.1 mtpt -92.78 -25.01 18.36 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.795 0.838 . . . . 73.33 111.354 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -163.45 147.35 10.6 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.528 0.518 . . . . 75.41 109.851 -172.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.511 HD13 ' SG ' ' B' ' 113' ' ' CYS . 28.4 mm -141.81 145.28 24.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 125.35 1.46 . . . . 72.32 108.427 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.456 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 44.2 t -144.01 141.08 29.93 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.727 -1.124 . . . . 72.14 108.387 167.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 81.5 t80 -147.75 126.69 12.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.279 -1.749 . . . . 74.55 106.279 171.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -135.3 116.6 14.55 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.147 -1.057 . . . . 71.24 108.147 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.35 86.48 2.13 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 107.593 -1.262 . . . . 64.54 107.593 174.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.12 -50.35 2.15 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.89 2.393 . . . . 73.03 111.946 -168.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -96.78 15.53 21.74 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.484 0.713 . . . . 75.12 111.191 -175.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -40.36 -65.06 0.48 Allowed Pre-proline 0 N--CA 1.491 1.602 0 C-N-CA 125.242 1.417 . . . . 61.41 114.575 -165.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.17 -25.54 72.68 Favored 'Trans proline' 0 C--N 1.392 2.821 0 C-N-CA 122.262 1.975 . . . . 74.34 113.92 -169.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -94.37 -41.66 9.3 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.138 0.575 . . . . 71.35 111.182 -175.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.89 -12.69 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 123.573 0.749 . . . . 73.53 111.685 -172.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -62.66 -14.3 41.94 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.569 0.748 . . . . 71.03 112.86 174.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.526 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.0 pt20 -60.79 -29.0 69.17 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.663 0.785 . . . . 75.4 110.98 172.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.526 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 96.3 mttt -93.66 108.46 20.19 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.91 1.284 . . . . 74.31 109.959 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -114.97 105.94 13.57 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.074 0.549 . . . . 73.12 110.427 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 21.6 p90 -165.82 -166.04 0.89 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.911 1.284 . . . . 74.43 108.121 169.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 -82.15 103.62 2.46 Favored Pre-proline 0 N--CA 1.477 0.914 0 N-CA-C 108.403 -0.962 . . . . 75.23 108.403 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.69 144.18 87.19 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.769 2.312 . . . . 75.12 113.126 -173.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.527 ' HB3' ' HA ' ' F' ' 3' ' ' GLN . 5.6 mp0 -55.42 103.36 0.09 Allowed 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.677 1.591 . . . . 70.32 110.311 172.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.421 HG21 HD22 ' B' ' 126' ' ' LEU . 20.3 t -85.62 155.18 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 115.182 -0.917 . . . . 72.42 109.118 -174.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.58 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 50.2 tttm -151.45 101.14 2.79 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.177 -1.786 . . . . 74.22 106.177 166.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 7.8 tt -87.1 144.15 26.99 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.029 -1.471 . . . . 65.23 107.029 172.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.415 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 8.8 t70 -140.28 116.48 10.55 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 106.315 -1.735 . . . . 72.34 106.315 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 15.2 tp -98.13 127.89 44.33 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.182 -1.044 . . . . 73.42 108.182 -173.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -130.18 156.13 45.1 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.013 0.925 . . . . 64.34 109.136 -172.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 49.0 p -106.88 139.02 41.96 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.06 0.544 . . . . 73.14 111.131 -171.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.38 128.46 12.74 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 106.836 -1.542 . . . . 74.2 106.836 172.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.8 m -144.79 163.79 32.99 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.308 0.243 . . . . 71.11 111.16 -173.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 80.8 p -165.76 137.13 3.84 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.006 0.816 . . . . 71.44 110.049 167.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -94.72 108.82 20.82 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.093 -1.077 . . . . 74.41 108.093 171.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 35.3 mt -70.45 -53.49 16.16 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 121.643 0.735 . . . . 74.53 109.789 -175.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.89 -170.31 2.83 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.276 -1.329 . . . . 73.31 108.431 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -86.7 145.58 26.62 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.818 -1.179 . . . . 64.42 107.818 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 67.3 -2.44 1.25 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.815 1.246 . . . . 64.02 112.132 -172.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 45.9 t -126.45 116.75 46.3 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 C-N-CA 124.791 1.237 . . . . 74.4 108.0 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -127.11 139.25 53.11 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.019 -1.104 . . . . 74.02 108.019 175.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -105.51 105.65 15.78 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.628 -1.249 . . . . 74.53 107.628 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 75.1 t -94.94 124.35 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 124.938 1.295 . . . . 75.21 109.8 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.414 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 6.5 t -112.97 146.81 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.251 -1.018 . . . . 74.03 108.251 172.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 20.6 tp -125.4 111.41 15.1 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.258 -1.016 . . . . 73.02 108.258 169.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -87.83 112.23 22.24 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.13 -0.693 . . . . 72.43 109.13 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 60.9 t -104.69 104.02 16.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.7 -1.136 . . . . 73.23 108.049 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 27.0 m -94.92 136.38 35.3 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.114 -1.069 . . . . 74.23 108.114 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 95.0 t -127.85 130.7 70.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 124.096 0.958 . . . . 64.14 109.246 -175.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.58 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 53.5 m -121.53 139.65 53.22 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.899 -1.519 . . . . 65.13 106.899 168.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.05 136.72 30.48 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.668 -1.234 . . . . 63.31 107.668 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.472 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 3.7 m -139.08 145.5 39.59 Favored 'General case' 0 C--O 1.215 -0.726 0 N-CA-C 109.455 -0.572 . . . . 74.21 109.455 -168.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 42.6 mt -113.26 108.48 17.32 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.605 0.716 . . . . 73.34 109.487 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.12 -110.7 3.62 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 114.082 -1.417 . . . . 44.25 113.361 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.72 2.12 35.31 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.268 1.027 . . . . 74.34 110.489 -170.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -133.19 158.23 43.38 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.523 0.729 . . . . 72.1 109.701 -175.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 97.0 m -75.31 137.8 41.39 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.168 0.509 . . . . 72.4 110.081 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.472 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -93.35 -61.33 1.58 Allowed 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.458 1.103 . . . . 73.22 108.281 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -151.99 167.74 27.45 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 114.688 -1.142 . . . . 72.21 110.742 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 70.5 mt -133.87 138.0 45.33 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 106.008 -1.849 . . . . 73.12 106.008 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 47.1 t -138.4 159.17 42.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.869 -1.16 . . . . 75.14 107.869 175.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.456 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 40.5 tt0 -165.77 134.15 3.09 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.985 -0.746 . . . . 73.02 108.985 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.91 145.32 35.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.577 -0.897 . . . . 71.44 108.577 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -121.13 93.99 4.2 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.108 -1.071 . . . . 74.21 108.108 171.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.438 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -87.88 102.44 14.71 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.725 -0.843 . . . . 75.31 108.725 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.466 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.94 156.58 23.02 Favored Glycine 0 N--CA 1.449 -0.492 0 O-C-N 123.965 0.79 . . . . 70.31 111.305 175.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.96 126.35 1.66 Allowed Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 109.99 -1.244 . . . . 73.33 109.99 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 27.1 mt -85.67 130.1 36.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.626 -1.25 . . . . 72.41 107.626 176.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -133.83 134.23 42.55 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.36 -0.978 . . . . 74.3 108.36 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 74.1 m -92.99 110.43 21.9 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.101 -0.703 . . . . 74.03 109.101 172.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' B' ' 10' ' ' THR . 0.2 OUTLIER -124.81 132.71 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.623 1.169 . . . . 74.44 109.122 -178.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.3 172.29 18.75 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.209 0.604 . . . . 71.04 110.741 -172.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.42 -63.6 4.31 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.932 0.77 . . . . 75.11 112.408 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.585 HG23 ' HB3' ' B' ' 94' ' ' MET . 2.5 mm -68.8 157.84 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.474 1.11 . . . . 75.55 112.224 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.508 ' HB3' HH21 ' F' ' 22' ' ' ARG . 17.2 tp10 -160.06 153.5 22.29 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 115.118 -0.947 . . . . 74.21 110.777 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.76 -136.81 13.36 Favored Glycine 0 C--N 1.351 1.413 0 C-N-CA 124.297 0.951 . . . . 61.22 112.933 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 19.5 m -67.14 -27.68 67.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.542 0.737 . . . . 75.24 110.94 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.421 ' HB2' HG22 ' B' ' 89' ' ' ILE . 42.8 mt-30 -63.99 -39.77 94.86 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.689 -1.141 . . . . 74.32 110.965 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.585 ' HB3' HG23 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -88.17 -25.81 22.75 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.565 0.346 . . . . 72.34 110.82 177.379 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.65 -34.2 73.95 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.149 0.58 . . . . 60.44 110.954 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -78.86 -37.57 40.02 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.655 0.782 . . . . 64.02 111.034 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.5 t -62.71 -43.2 99.4 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.201 0.601 . . . . 74.15 111.49 -175.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.406 HD12 HG13 ' B' ' 86' ' ' ILE . 6.6 mp -90.58 -23.33 20.89 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.874 0.47 . . . . 72.34 111.112 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.06 -17.62 66.86 Favored Glycine 0 C--N 1.346 1.104 0 N-CA-C 114.358 0.503 . . . . 75.42 114.358 -174.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.19 -55.56 0.59 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.068 0.547 . . . . 71.33 110.97 -177.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.406 ' HH ' ' HE3' ' D' ' 1' ' ' MET . 49.1 t80 -66.75 -53.31 34.59 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.436 0.902 . . . . 75.43 113.436 -166.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.492 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 76.0 m -60.13 -50.08 87.88 Favored Pre-proline 0 CA--C 1.564 1.504 0 CA-C-O 118.561 -0.733 . . . . 64.21 111.493 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 47.7 Cg_exo -60.33 -29.37 88.7 Favored 'Trans proline' 0 C--N 1.401 3.296 0 C-N-CA 122.4 2.067 . . . . 73.1 113.384 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -71.15 -30.99 67.16 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.578 0.751 . . . . 72.21 110.928 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.424 HG23 ' NH2' ' D' ' 111' ' ' ARG . 53.1 mt -66.87 -37.87 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 109.568 -0.53 . . . . 65.3 109.568 171.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 54.8 mt -84.18 -18.82 35.41 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.026 0.93 . . . . 74.23 112.1 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.42 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 85.7 t80 -57.86 -50.34 88.66 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-O 118.088 -0.958 . . . . 73.52 112.338 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 51.5 Cg_exo -57.89 -38.02 94.01 Favored 'Trans proline' 0 C--N 1.394 2.929 0 C-N-CA 122.401 2.067 . . . . 74.43 113.798 177.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.438 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 38.8 m-85 -68.12 -43.29 78.73 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.281 0.632 . . . . 74.03 110.576 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.445 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -64.8 -40.61 95.51 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.285 0.634 . . . . 74.52 110.427 175.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.489 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 37.9 ttt180 -57.41 -49.57 75.8 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.542 1.537 . . . . 75.11 111.402 -176.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.431 ' HG3' ' NH2' ' C' ' 120' ' ' ARG . 2.1 tm-20 -68.79 -34.6 75.83 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 123.84 0.712 . . . . 55.33 110.033 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.511 ' SG ' HD13 ' B' ' 21' ' ' ILE . 9.3 t -67.27 -33.63 75.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.99 0.516 . . . . 75.11 111.268 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.48 ' O ' HG23 ' B' ' 118' ' ' VAL . 73.7 mt -67.69 -56.04 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 108.91 -0.774 . . . . 73.5 108.91 174.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.1 m -59.84 -26.54 65.89 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 124.336 1.023 . . . . 72.44 111.396 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 29.4 t -64.78 -50.55 66.33 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.273 0.629 . . . . 74.34 109.614 174.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.0 mmt -70.44 -31.21 68.3 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.08 0.552 . . . . 73.52 111.005 -176.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.48 HG23 ' O ' ' B' ' 114' ' ' ILE . 57.7 t -60.57 -47.77 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.487 0.715 . . . . 62.51 109.414 171.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 21.0 t -65.08 -34.62 78.85 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.546 -1.206 . . . . 75.41 111.191 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.41 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 92.6 mtt-85 -70.81 -31.95 68.86 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.986 -1.006 . . . . 75.42 110.384 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.56 5.66 76.96 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.944 0.778 . . . . 52.45 112.656 174.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 80.6 p 54.42 29.95 11.93 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 126.0 1.72 . . . . 75.2 113.015 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -91.02 159.87 38.97 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.264 0.625 . . . . 74.14 111.317 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -48.93 158.11 1.39 Allowed 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 123.732 2.955 . . . . 73.44 114.76 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -57.9 114.6 2.39 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.978 -1.01 . . . . 73.52 111.236 -176.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.421 HD22 HG21 ' B' ' 40' ' ' VAL . 0.3 OUTLIER -121.58 101.87 7.88 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.867 -1.16 . . . . 74.45 107.867 -178.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -119.23 133.99 55.45 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.726 0.811 . . . . 71.43 109.224 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.494 ' HA ' HD13 ' F' ' 6' ' ' ILE . 6.6 mp -75.42 144.97 41.92 Favored 'General case' 0 C--O 1.242 0.668 0 O-C-N 123.655 0.597 . . . . 73.11 109.956 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.76 134.14 86.18 Favored Pre-proline 0 CA--C 1.549 0.911 0 O-C-N 123.816 0.697 . . . . 70.01 111.093 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -72.47 104.81 1.77 Allowed 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.886 2.391 . . . . 71.42 111.692 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.508 HG21 ' HG ' ' F' ' 8' ' ' LEU . 34.1 m -110.99 139.95 32.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 123.327 0.651 . . . . 74.23 109.63 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -92.08 90.61 7.44 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 106.414 -1.699 . . . . 61.31 106.414 169.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -67.09 -32.0 72.86 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.946 -1.025 . . . . 73.32 111.289 -171.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -65.72 -37.76 87.3 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.941 0.896 . . . . 54.42 111.484 175.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.474 ' HA ' ' HB3' ' B' ' 138' ' ' MET . . . -63.48 -32.34 73.76 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.587 0.755 . . . . 71.52 111.668 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.422 ' HB3' HD13 ' F' ' 10' ' ' LEU . 89.5 mt -60.33 -35.2 75.09 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.779 0.832 . . . . 75.12 111.587 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -83.87 -39.07 20.34 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.362 0.665 . . . . 74.11 110.638 174.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.474 ' HB3' ' HA ' ' B' ' 135' ' ' ALA . 1.8 tmt? -62.12 -36.27 81.26 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.243 1.017 . . . . 75.4 111.968 -174.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.2 -24.31 59.34 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.267 0.627 . . . . 74.5 110.502 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -75.68 -35.42 60.36 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 122.681 0.392 . . . . 73.53 110.031 175.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 83.4 mt -87.51 -3.57 58.99 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 112.594 0.59 . . . . 74.12 112.594 -172.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . 0.471 HE22 ' HB3' ' D' ' 5' ' ' ASN . 57.3 tt0 -116.12 137.71 51.89 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.668 0.387 . . . . 74.32 110.609 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -73.1 118.14 15.68 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.457 -0.942 . . . . 71.21 108.457 167.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -74.76 124.53 26.96 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 122.897 0.479 . . . . 75.25 109.733 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -148.36 145.79 28.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.551 0.74 . . . . 74.4 109.533 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -141.89 -164.86 10.22 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.682 -0.567 . . . . 60.14 111.682 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.48 -167.98 1.91 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.527 0.731 . . . . 73.2 109.633 176.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.53 145.86 12.59 Favored Glycine 0 C--N 1.342 0.877 0 C-N-CA 121.727 -0.273 . . . . 75.31 112.523 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 21.2 m -67.87 136.22 53.73 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.384 0.674 . . . . 73.31 110.071 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -120.92 140.6 51.62 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.017 0.927 . . . . 71.42 110.035 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -142.8 172.27 12.92 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.701 0.8 . . . . 74.24 110.614 -176.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -154.43 140.41 18.3 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.648 0.779 . . . . 72.41 109.097 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -154.72 129.72 9.5 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.796 0.839 . . . . 70.32 109.017 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -126.26 110.54 13.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.199 0.999 . . . . 73.53 108.818 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 C-N-CA 123.551 0.74 . . . . 65.15 109.557 176.846 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tmm? . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 108.359 -0.978 . . . . 72.01 108.359 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 20.2 p -171.47 9.14 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.892 1.677 . . . . 72.3 109.69 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -80.61 149.89 29.7 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 124.349 1.059 . . . . 71.1 109.906 -169.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -89.24 -68.74 0.75 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.057 0.943 . . . . 70.14 108.467 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 63.4 t30 64.1 143.98 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.514 1.526 . . . . 75.11 113.05 173.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -81.69 159.48 23.92 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.849 0.459 . . . . 62.3 109.777 175.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 29.0 m -97.02 -72.34 0.64 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.786 -0.82 . . . . 72.41 108.786 173.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 49.28 -93.03 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.882 1.273 . . . . 74.53 110.87 -171.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.575 ' HE2' ' SG ' ' C' ' 97' ' ' CYS . 15.6 tpt 33.28 111.03 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 126.991 2.116 . . . . 74.12 115.141 174.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.597 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 19.9 m -86.24 92.91 8.92 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.975 -1.12 . . . . 75.51 107.975 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.656 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.3 t80 -121.31 135.66 55.07 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.959 -1.018 . . . . 72.03 110.406 -173.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -155.31 126.43 7.15 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.839 -1.171 . . . . 74.24 107.839 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 88.4 mt -73.32 120.05 21.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.291 -1.003 . . . . 72.14 108.291 172.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.629 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 23.9 mm-40 -82.54 -42.64 18.11 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.208 -0.905 . . . . 71.11 109.6 -177.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -179.27 134.02 0.12 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.284 0.633 . . . . 75.32 110.345 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.8 mt -117.68 145.95 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.867 0.867 . . . . 74.44 108.855 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -174.65 158.02 2.65 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.276 0.631 . . . . 75.22 110.729 -174.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 63.7 p -83.39 114.69 21.61 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.381 -0.97 . . . . 71.2 108.381 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -77.05 -47.06 21.62 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.736 -0.838 . . . . 74.22 108.736 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.66 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.0 t70 -133.97 137.84 45.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.336 -1.302 . . . . 64.54 109.572 -174.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 71.8 mt -136.81 144.52 32.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.021 -1.474 . . . . 73.12 107.021 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.1 t -161.82 150.66 15.61 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.976 0.417 . . . . 71.11 110.798 174.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -152.36 121.25 6.57 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 114.797 -1.092 . . . . 75.35 108.143 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -122.63 122.27 38.41 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.921 0.888 . . . . 74.11 110.451 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.09 83.01 34.71 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 107.73 -1.211 . . . . 65.4 107.73 168.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.43 -13.61 20.48 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.558 2.172 . . . . 74.55 111.764 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -103.01 14.59 31.58 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.9 1.28 . . . . 74.11 109.862 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.414 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -48.16 -53.52 32.76 Favored Pre-proline 0 C--N 1.37 1.48 0 C-N-CA 124.64 1.176 . . . . 73.01 113.55 -170.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 52.5 Cg_exo -54.59 -50.6 12.82 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 121.871 1.714 . . . . 72.12 112.828 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -68.57 -35.46 77.41 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.911 -1.041 . . . . 71.02 112.173 -172.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.711 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.0 p -78.59 -24.97 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 N-CA-C 113.182 0.808 . . . . 74.0 113.182 -172.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -67.13 -28.36 68.07 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.528 0.566 . . . . 75.14 112.528 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -86.92 5.16 38.44 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.128 0.571 . . . . 73.43 111.773 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.765 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -88.76 150.16 23.09 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.483 0.713 . . . . 74.22 110.369 178.493 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.25 124.07 19.88 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.292 0.637 . . . . 74.1 109.755 167.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -78.71 97.62 5.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.365 0.666 . . . . 74.32 111.211 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -153.6 78.16 5.69 Favored Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 108.605 -0.887 . . . . 75.01 108.605 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -90.45 149.66 4.36 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.013 2.475 . . . . 71.42 113.856 -176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -88.23 102.86 15.24 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 114.028 -1.442 . . . . 75.43 107.365 167.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -81.23 101.71 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.933 -0.576 . . . . 75.13 109.764 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.495 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 11.0 tmtt? -92.38 109.94 21.34 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.23 -1.396 . . . . 72.21 107.23 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.566 HD21 ' HB ' ' G' ' 6' ' ' ILE . 4.1 pp -85.14 161.69 19.54 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.585 -0.524 . . . . 73.42 109.585 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.602 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 12.5 t70 -147.19 134.41 20.55 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.674 -1.232 . . . . 71.34 107.674 171.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.541 HD11 HD23 ' G' ' 11' ' ' LEU . 1.7 tm? -128.79 111.24 12.9 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.104 -1.443 . . . . 74.13 107.104 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 21.6 t70 -123.54 152.68 41.55 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.022 0.929 . . . . 71.31 109.124 -177.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' THR . . . . . 0.5 ' HB ' ' CD1' ' G' ' 15' ' ' PHE . 52.5 p -117.92 134.48 54.91 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.519 0.728 . . . . 65.44 111.458 -169.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.53 160.19 42.45 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.377 0.671 . . . . 72.23 110.471 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 72.8 m -160.03 170.93 20.27 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.422 0.689 . . . . 74.52 111.242 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 95.8 p -153.98 140.74 19.06 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.964 0.906 . . . . 71.21 108.934 166.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -86.43 121.43 28.97 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.2 -1.037 . . . . 71.24 108.2 173.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.437 HD13 HD13 ' C' ' 83' ' ' ILE . 53.6 mt -99.22 -30.38 12.29 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.472 0.709 . . . . 73.31 109.923 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.81 -174.39 2.72 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.453 1.101 . . . . 64.52 109.604 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -71.24 125.0 25.79 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.334 -0.987 . . . . 70.43 108.334 171.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 69.37 3.67 4.26 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.876 1.27 . . . . 74.32 113.204 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 96.3 t -117.69 110.64 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 107.892 -1.151 . . . . 74.11 107.892 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -134.34 137.57 44.26 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.537 0.735 . . . . 75.4 109.573 -173.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -86.69 120.93 28.52 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.949 -1.023 . . . . 74.4 109.748 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 55.2 t -96.7 115.39 36.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.818 -1.179 . . . . 74.25 107.818 168.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 64.0 t -112.93 136.26 49.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 N-CA-C 107.603 -1.258 . . . . 73.03 107.603 171.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.686 HD21 ' HB2' ' C' ' 103' ' ' PRO . 11.6 tp -126.73 118.36 24.56 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.619 -0.882 . . . . 70.33 108.619 172.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.469 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 14.2 ttm180 -81.79 115.66 21.11 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.567 -0.742 . . . . 71.44 109.212 176.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 24.9 t -110.5 116.56 52.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.537 -1.283 . . . . 54.44 107.537 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.602 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 17.9 m -128.86 115.52 18.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.424 0.63 . . . . 74.15 109.348 -174.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 84.4 t -108.07 116.04 50.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 124.817 1.247 . . . . 74.14 109.364 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 4.1 m -100.53 145.91 27.74 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.838 -1.171 . . . . 72.23 107.838 171.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.85 119.74 18.48 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.347 -1.353 . . . . 62.45 107.347 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -133.04 125.52 29.85 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.945 0.339 . . . . 73.31 110.361 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.765 HD11 ' HG2' ' C' ' 34' ' ' LYS . 9.0 mt -86.44 41.04 0.92 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.661 1.184 . . . . 74.23 109.776 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.2 -114.2 4.54 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 110.138 -1.185 . . . . 71.22 110.138 -169.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.29 -28.12 21.27 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.346 0.658 . . . . 71.11 109.928 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.94 118.05 9.19 Favored 'General case' 0 C--N 1.345 0.402 0 N-CA-C 108.923 -0.769 . . . . 73.31 108.923 171.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 29.4 m -81.19 121.92 26.75 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 108.06 -1.089 . . . . 74.01 108.06 167.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.711 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.5 -58.14 3.61 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.41 -0.959 . . . . 73.4 108.41 177.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -162.69 170.73 17.95 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 114.95 -1.023 . . . . 74.43 111.708 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -127.6 146.39 50.55 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 106.002 -1.851 . . . . 75.22 106.002 166.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 46.2 t -147.31 130.17 16.19 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.984 -1.117 . . . . 72.2 107.984 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -136.33 117.84 14.82 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.428 -0.582 . . . . 72.34 109.428 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 77.4 t -120.03 122.4 68.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.45 -0.945 . . . . 73.14 108.45 170.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.66 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.3 mt-30 -103.42 94.25 5.39 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 108.023 -1.102 . . . . 70.44 108.023 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -80.07 114.81 19.25 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.963 -1.017 . . . . 65.1 109.655 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.22 146.12 18.14 Favored Glycine 0 C--N 1.34 0.779 0 O-C-N 123.826 0.704 . . . . 73.11 111.423 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.412 ' HA3' HD22 ' C' ' 106' ' ' LEU . . . -154.54 119.66 0.95 Allowed Glycine 0 CA--C 1.503 -0.697 0 N-CA-C 110.554 -1.019 . . . . 75.21 110.554 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.629 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 8.4 mm -85.37 126.74 40.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 108.287 -1.005 . . . . 73.42 108.287 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.656 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 69.7 m-85 -132.23 147.39 52.41 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.365 0.666 . . . . 74.31 109.883 -176.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 45.4 m -87.49 123.66 32.64 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.935 0.894 . . . . 75.43 109.352 171.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.51 HG12 HD21 ' C' ' 98' ' ' LEU . 4.4 mp -121.72 121.03 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 109.675 -0.491 . . . . 74.24 109.675 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.597 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -163.28 167.89 21.29 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.235 1.014 . . . . 54.41 109.903 173.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.67 -60.8 1.2 Allowed Glycine 0 N--CA 1.471 1.026 0 C-N-CA 123.137 0.399 . . . . 74.23 112.661 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 pt -96.06 150.9 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.658 0.783 . . . . 74.4 110.393 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -147.61 146.77 29.49 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.69 0.796 . . . . 75.42 109.555 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.36 -139.18 14.65 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 111.671 -0.571 . . . . 74.45 111.671 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 10.3 p -68.23 -21.35 64.85 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 113.477 0.917 . . . . 64.45 113.477 -174.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.23 -40.72 43.94 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 109.337 -0.616 . . . . 71.35 109.337 177.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.447 ' SD ' HD12 ' C' ' 98' ' ' LEU . 14.3 tmm? -65.48 -36.16 83.04 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.274 -0.876 . . . . 74.21 110.136 172.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.68 -34.72 77.48 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.995 0.918 . . . . 63.13 111.412 176.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -65.65 -40.99 93.08 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.697 -0.683 . . . . 73.01 110.224 173.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.575 ' SG ' ' HE2' ' C' ' 9' ' ' MET . 43.0 t -63.34 -45.25 92.12 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.598 0.561 . . . . 73.53 110.412 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.681 HD11 ' HD2' ' G' ' 17' ' ' PRO . 75.2 mt -80.98 -51.99 7.92 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.135 0.574 . . . . 72.5 112.397 -175.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.75 11.12 65.17 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 115.081 0.792 . . . . 73.25 115.081 -169.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.35 -61.82 0.14 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.425 0.631 . . . . 64.31 110.813 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.506 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 35.0 t80 -75.2 -37.15 61.3 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 125.502 1.521 . . . . 74.4 113.735 -165.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 91.7 m -77.84 -44.12 2.38 Favored Pre-proline 0 N--CA 1.486 1.344 0 C-N-CA 123.252 0.621 . . . . 73.43 112.033 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.686 ' HB2' HD21 ' C' ' 60' ' ' LEU . 78.6 Cg_endo -75.57 -9.48 19.99 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 121.849 1.699 . . . . 75.24 112.344 172.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -68.08 -37.41 81.21 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.751 -0.833 . . . . 74.04 108.751 168.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.589 HD13 ' NH1' ' A' ' 111' ' ' ARG . 39.8 mm -59.38 -43.41 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 115.455 -0.793 . . . . 74.52 109.366 171.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.412 HD22 ' HA3' ' C' ' 82' ' ' GLY . 82.0 mt -81.92 -16.02 51.96 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.307 1.043 . . . . 75.42 112.913 -173.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -55.03 -53.93 55.88 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-O 118.257 -0.878 . . . . 74.3 112.63 -175.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.13 -30.62 65.36 Favored 'Trans proline' 0 C--N 1.388 2.635 0 C-N-CA 121.951 1.767 . . . . 64.11 113.508 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -67.57 -49.85 61.19 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.297 0.639 . . . . 63.31 110.539 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.18 -42.79 95.76 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.196 -0.911 . . . . 73.2 110.276 176.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -58.81 -52.66 64.76 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.173 1.389 . . . . 71.42 111.359 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -66.84 -37.1 83.83 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.738 0.649 . . . . 72.24 110.052 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 35.2 t -67.7 -32.62 73.39 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.332 0.395 . . . . 63.32 111.59 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 83.9 mt -72.54 -52.99 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.127 0.571 . . . . 70.14 110.23 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 12.3 m -65.01 -29.31 70.22 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.176 0.59 . . . . 75.14 111.321 -175.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 40.6 t -65.72 -49.7 67.52 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.077 -0.712 . . . . 74.15 109.077 173.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.674 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.75 -37.29 78.59 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.157 0.983 . . . . 72.2 112.39 179.257 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 83.0 t -60.74 -48.26 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.226 0.61 . . . . 75.24 110.035 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 26.5 t -72.39 -22.24 61.16 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 115.325 -0.852 . . . . 74.05 111.581 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.431 ' NH2' ' HG3' ' B' ' 112' ' ' GLU . 89.2 mtt-85 -73.93 -35.0 64.54 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.856 0.862 . . . . 73.24 109.705 174.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.05 7.65 70.16 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 115.457 -0.792 . . . . 75.41 112.086 171.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 64.7 p 60.02 26.68 16.01 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.415 1.886 . . . . 72.13 113.412 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -88.65 144.95 34.17 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 108.202 -1.036 . . . . 63.33 108.202 171.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -54.63 154.25 21.01 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 123.121 2.548 . . . . 71.12 113.505 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -54.68 124.33 16.04 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.901 1.28 . . . . 75.12 113.43 -171.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 40.1 tp -127.22 90.47 3.14 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.41 -0.959 . . . . 74.14 108.41 176.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -92.31 131.24 37.67 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.067 0.947 . . . . 63.12 109.545 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.72 134.16 46.07 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.172 0.589 . . . . 73.14 109.512 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.33 151.07 77.75 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 123.291 0.636 . . . . 70.11 110.978 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.468 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 40.9 Cg_endo -68.74 110.67 2.39 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.892 2.395 . . . . 75.24 112.141 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.588 HG13 ' HB2' ' G' ' 8' ' ' LEU . 39.6 t -105.38 111.61 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.256 0.622 . . . . 73.31 109.595 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -85.41 89.68 7.75 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.716 0.806 . . . . 73.24 110.438 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -59.63 -38.09 80.39 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 109.663 -0.495 . . . . 73.14 109.663 169.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.09 -51.21 67.09 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.259 1.424 . . . . 75.2 111.362 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.55 -30.84 67.68 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.869 0.868 . . . . 64.51 111.237 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.405 ' HA ' ' ND2' ' C' ' 139' ' ' ASN . 96.0 mt -67.65 -32.89 73.89 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.628 -0.715 . . . . 75.01 111.538 173.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -78.07 -25.38 47.65 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.996 0.518 . . . . 74.43 110.944 173.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 66.9 mtt -67.32 -27.95 67.59 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.755 0.422 . . . . 71.42 110.353 172.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . 0.405 ' ND2' ' HA ' ' C' ' 136' ' ' LEU . 95.0 m-20 -59.62 -44.59 93.4 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 123.448 0.699 . . . . 74.33 112.279 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -72.29 -165.74 0.21 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 119.154 0.888 . . . . 71.23 110.498 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 37.5 tp 64.53 -17.43 0.08 Allowed 'General case' 0 CA--C 1.577 1.986 0 C-N-CA 124.615 1.166 . . . . 71.15 114.004 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -156.53 -174.41 4.92 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.891 0.876 . . . . 73.24 110.44 -167.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . 0.568 ' HG3' ' HA ' ' A' ' 6' ' ' ASN . 10.5 pt20 -90.86 147.46 23.15 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.51 0.724 . . . . 74.55 109.681 174.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -122.82 112.79 18.31 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.809 -0.811 . . . . 74.53 108.809 -176.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -116.56 -176.05 2.89 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.781 0.832 . . . . 72.31 108.857 173.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -167.31 121.83 1.0 Allowed Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.668 -0.573 . . . . 72.11 111.668 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -76.78 151.41 35.99 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.072 0.949 . . . . 73.44 110.115 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -95.05 166.84 26.18 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 116.455 -0.339 . . . . 70.52 112.48 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 4.5 t -66.89 114.99 6.16 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.432 0.693 . . . . 73.45 110.051 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -79.41 -27.42 41.8 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.279 1.031 . . . . 74.24 111.689 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 60.21 84.47 0.12 Allowed 'General case' 0 C--N 1.357 0.91 0 C-N-CA 124.225 1.01 . . . . 73.2 110.707 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -139.62 115.89 10.5 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 120.941 0.401 . . . . 75.23 111.38 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -131.61 135.35 46.89 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.539 1.136 . . . . 75.35 108.589 166.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -142.37 159.09 42.91 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.949 0.9 . . . . 64.0 109.438 175.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.883 0 N-CA-C 108.974 -0.75 . . . . 61.5 108.974 -177.016 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.406 ' HE3' ' HH ' ' B' ' 101' ' ' TYR . 1.7 mpt? . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 119.88 -0.105 . . . . 75.24 111.018 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 36.9 m -144.04 170.68 15.47 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.897 0.479 . . . . 71.31 110.348 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -161.96 -174.64 4.24 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.418 1.087 . . . . 65.41 109.938 172.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -70.59 85.41 0.63 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.111 0.964 . . . . 73.41 110.688 -174.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . 0.471 ' HB3' HE22 ' B' ' 142' ' ' GLN . 52.2 t30 -85.56 85.46 7.42 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.508 -0.769 . . . . 73.51 109.046 175.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -128.23 23.19 6.03 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.238 1.015 . . . . 75.14 109.693 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 10.9 t -143.16 -170.97 3.38 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.281 1.032 . . . . 73.43 108.611 -174.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -83.12 24.84 0.75 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.571 0.749 . . . . 65.54 111.763 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 14.4 tpt -30.28 123.59 0.18 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.996 1.718 . . . . 75.11 113.331 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 65.1 m -123.95 142.26 51.31 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.071 -1.085 . . . . 73.22 108.071 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.511 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 20.8 t80 -164.79 90.63 0.53 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.673 -1.232 . . . . 63.41 107.673 -177.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -113.05 116.28 29.67 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.13 -1.433 . . . . 74.33 107.13 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.447 HG21 HD11 ' D' ' 16' ' ' ILE . 18.2 mt -68.75 123.26 21.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 109.331 -0.618 . . . . 62.03 109.331 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.532 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 21.0 mm-40 -83.01 -46.46 12.83 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 123.795 0.684 . . . . 73.52 109.687 175.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.41 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 27.7 ttt180 -178.5 141.08 0.21 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 116.603 -0.271 . . . . 75.43 111.706 -164.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.447 HD11 HG21 ' D' ' 13' ' ' ILE . 3.7 mp -122.97 142.0 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.464 -1.31 . . . . 75.41 107.464 172.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.41 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 26.3 p90 -165.46 174.48 9.95 Favored 'General case' 0 C--O 1.238 0.496 0 O-C-N 124.062 0.851 . . . . 74.44 111.187 -175.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 62.3 p -108.71 119.56 39.9 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 114.557 -1.202 . . . . 71.21 109.642 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -92.42 -19.13 22.37 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.378 0.671 . . . . 75.02 110.165 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 15.9 t70 -158.09 133.27 8.68 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.774 -1.103 . . . . 65.2 108.699 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.674 HG21 ' HE1' ' C' ' 117' ' ' MET . 68.8 mt -131.94 147.78 32.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 107.083 -1.451 . . . . 64.23 107.083 173.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -156.24 144.74 20.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 123.741 0.651 . . . . 54.31 110.114 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 87.4 t80 -148.17 122.05 9.36 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 105.346 -2.094 . . . . 72.12 105.346 173.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -133.38 110.8 10.27 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.061 0.544 . . . . 74.21 109.806 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.32 88.13 12.34 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 107.772 -1.195 . . . . 64.31 107.772 175.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -74.2 -39.85 1.47 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.907 2.405 . . . . 70.15 112.06 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -92.34 5.11 51.8 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.749 -1.114 . . . . 72.43 111.021 -176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -30.04 -67.8 0.13 Allowed Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 116.459 2.022 . . . . 63.01 116.459 -164.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.427 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 93.5 Cg_endo -75.07 -23.91 13.22 Favored 'Trans proline' 0 C--N 1.374 1.909 0 CA-C-N 122.831 2.047 . . . . 73.33 113.119 -173.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -73.12 -39.21 65.93 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.932 0.893 . . . . 74.34 109.57 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 p -83.03 -16.11 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-N 115.817 -0.628 . . . . 74.51 110.442 -173.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.427 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.1 m-85 -69.02 -22.82 64.04 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.524 0.33 . . . . 72.41 111.77 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -57.51 -27.04 62.22 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.587 0.755 . . . . 75.45 109.976 172.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.626 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 83.7 mttt -88.43 70.74 9.04 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.818 1.247 . . . . 71.52 109.198 172.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -79.71 87.64 5.22 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.72 -0.673 . . . . 73.4 109.714 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 18.6 p90 -163.29 174.82 11.56 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.337 1.055 . . . . 74.41 109.112 172.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.473 HE21 ' HD2' ' D' ' 38' ' ' PRO . 28.5 tp60 -68.45 115.98 35.37 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.62 0.768 . . . . 74.11 109.565 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.473 ' HD2' HE21 ' D' ' 37' ' ' GLN . 27.0 Cg_exo -63.18 151.87 82.59 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.709 2.273 . . . . 62.43 112.616 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -73.24 113.09 9.92 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.359 -1.349 . . . . 74.55 107.359 172.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.679 HG22 ' HG ' ' D' ' 126' ' ' LEU . 98.8 t -105.93 137.98 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 123.879 0.871 . . . . 73.25 109.739 -172.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -128.32 126.72 41.33 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.616 1.166 . . . . 73.45 108.131 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.478 HD22 HD22 ' D' ' 128' ' ' LEU . 45.2 tp -96.99 144.07 27.24 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.07 -0.715 . . . . 70.12 109.07 176.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 7.5 t70 -144.14 153.82 42.53 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.538 0.735 . . . . 75.32 109.081 176.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.6 mt -133.23 146.41 51.44 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.417 0.687 . . . . 75.11 111.108 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.631 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 5.8 t70 -135.58 155.18 50.88 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.919 1.287 . . . . 75.3 108.215 169.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' THR . . . . . 0.423 HG23 ' CD1' ' H' ' 15' ' ' PHE . 97.7 m -101.39 140.48 35.63 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.94 0.896 . . . . 72.41 108.812 -176.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' D' ' 152' ' ' HIS . . . -166.91 142.56 4.29 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.222 -1.029 . . . . 71.54 108.222 175.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.8 p -176.36 162.44 2.38 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.941 0.496 . . . . 72.4 110.425 -176.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 77.5 p -153.77 150.16 28.2 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.647 0.379 . . . . 75.54 110.936 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -88.14 119.61 28.7 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.72 -0.844 . . . . 73.12 108.72 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.485 HD13 HG22 ' D' ' 83' ' ' ILE . 23.2 mt -94.72 -31.81 13.62 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.793 0.437 . . . . 73.13 111.161 -175.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.554 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -161.27 -175.72 5.0 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.739 0.816 . . . . 75.51 110.602 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.07 109.83 3.16 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.771 -1.104 . . . . 75.44 109.389 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 66.89 6.91 4.93 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.588 1.155 . . . . 74.42 112.677 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 64.1 t -110.91 120.55 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 107.427 -1.323 . . . . 73.25 107.427 175.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -140.85 131.7 25.91 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 122.917 0.487 . . . . 74.41 110.008 -165.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.463 ' HB2' HD11 ' D' ' 51' ' ' LEU . 15.9 tt0 -92.72 135.0 34.49 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.793 0.837 . . . . 73.11 110.5 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 98.0 t -117.5 128.75 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.163 1.385 . . . . 75.24 108.39 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 29.1 t -125.58 130.93 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.408 0.683 . . . . 64.2 109.594 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.491 HD21 HD12 ' D' ' 106' ' ' LEU . 4.6 mm? -117.81 121.09 39.87 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.087 -0.708 . . . . 74.12 109.087 172.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.631 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 41.2 ttm-85 -83.2 96.4 8.43 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.513 -1.291 . . . . 74.33 107.513 172.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 88.3 t -90.34 128.16 42.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.009 -1.108 . . . . 74.34 108.009 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 29.8 m -125.68 139.63 53.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.878 -0.416 . . . . 70.35 109.878 -176.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.607 HG13 HG11 ' D' ' 40' ' ' VAL . 17.8 t -128.61 102.01 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.441 1.096 . . . . 74.51 108.556 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 17.6 m -93.31 112.53 24.48 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.478 -0.934 . . . . 72.34 108.478 173.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.07 141.16 48.49 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.657 0.783 . . . . 71.41 109.186 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.412 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 59.8 p -148.8 127.02 12.12 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 123.52 0.513 . . . . 74.45 111.236 -177.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 28.8 mt -94.16 115.51 27.81 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 124.423 1.089 . . . . 74.43 109.076 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.65 -111.75 3.58 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 111.495 -0.642 . . . . 74.53 111.495 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.97 12.14 10.4 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.702 0.801 . . . . 72.05 110.863 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.626 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 12.0 pt-20 -131.56 165.21 24.13 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.849 0.459 . . . . 73.5 109.965 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -65.63 131.25 45.88 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.762 0.825 . . . . 72.04 111.961 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.412 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -90.97 -68.38 0.79 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.83 -1.174 . . . . 71.15 107.83 171.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -151.17 153.55 35.18 Favored 'General case' 0 C--N 1.353 0.72 0 CA-C-N 115.757 -0.656 . . . . 71.32 111.003 175.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 46.5 mt -118.97 110.56 17.27 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 106.773 -1.566 . . . . 74.12 106.773 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.645 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 45.9 t -126.11 105.93 9.22 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 122.943 0.497 . . . . 61.54 109.972 -170.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -122.73 128.99 51.25 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.442 0.697 . . . . 73.24 109.701 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 25.6 t -126.96 121.19 57.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 123.419 0.688 . . . . 74.42 109.696 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.7 mt-30 -87.35 87.36 7.4 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.149 -1.056 . . . . 62.21 108.149 167.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -81.85 110.6 17.3 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.01 -1.45 . . . . 74.02 108.719 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.79 153.23 17.23 Favored Glycine 0 C--N 1.341 0.859 0 O-C-N 123.545 0.528 . . . . 73.13 111.842 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.8 130.87 2.88 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 111.578 -0.609 . . . . 73.51 111.578 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 22.2 mt -89.4 136.41 23.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 C-N-CA 123.801 0.84 . . . . 75.31 108.949 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -137.85 128.49 26.72 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.351 0.661 . . . . 74.23 110.26 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.1 m -78.78 98.36 6.26 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.638 0.775 . . . . 33.32 109.287 168.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 10.2 pt -115.37 139.66 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.397 1.079 . . . . 72.3 110.302 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.65 167.91 20.56 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.877 0.471 . . . . 73.4 111.048 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.56 17.35 79.98 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.954 -0.566 . . . . 65.02 113.308 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 8.4 mt -110.99 147.05 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.081 0.952 . . . . 74.54 108.832 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.42 165.31 27.13 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.687 0.795 . . . . 73.04 110.127 177.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.99 -142.17 46.62 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.168 0.917 . . . . 54.44 115.073 173.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 20.3 m -76.33 -16.25 59.8 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.93 0.892 . . . . 74.24 111.694 -172.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -68.1 -22.36 64.91 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.617 0.367 . . . . 73.22 110.764 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 92.1 mtp -64.02 -35.68 81.51 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.365 0.666 . . . . 73.31 110.432 172.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.71 -26.36 57.45 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.472 -0.786 . . . . 72.4 110.92 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -74.97 -40.35 60.78 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.812 0.445 . . . . 74.45 110.804 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -56.29 -46.79 79.61 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.422 0.689 . . . . 71.13 110.033 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 47.7 mt -87.23 -20.33 27.07 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.627 -1.169 . . . . 63.41 111.566 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.35 1.89 56.12 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-O 119.489 -0.617 . . . . 53.14 114.04 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.472 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -146.12 -67.82 0.28 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 117.585 0.692 . . . . 72.15 111.713 -178.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -71.51 -38.43 71.12 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.716 0.636 . . . . 75.22 112.716 -170.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.511 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 76.3 m -68.23 -49.66 32.67 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 118.706 -0.664 . . . . 71.31 111.556 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -58.7 -29.44 89.49 Favored 'Trans proline' 0 C--N 1.401 3.308 0 C-N-CA 122.63 2.22 . . . . 74.51 113.139 170.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -63.36 -35.67 81.17 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.681 0.793 . . . . 71.12 110.575 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.8 mm -68.91 -38.09 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.626 0.77 . . . . 74.54 110.351 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.491 HD12 HD21 ' D' ' 60' ' ' LEU . 87.7 mt -81.75 -21.7 37.71 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.534 0.734 . . . . 73.51 112.576 -172.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -62.44 -46.71 89.83 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-O 118.425 -0.798 . . . . 74.14 113.121 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.14 -39.15 93.04 Favored 'Trans proline' 0 C--N 1.391 2.768 0 C-N-CA 122.348 2.032 . . . . 70.23 113.262 174.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -73.97 -36.85 64.62 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.582 0.753 . . . . 74.43 111.707 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.81 -49.25 71.4 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.661 -0.496 . . . . 63.44 109.661 176.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.424 ' NH2' HG23 ' B' ' 105' ' ' ILE . 38.9 ttp180 -58.78 -45.68 89.27 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 124.432 1.082 . . . . 74.13 110.312 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -61.08 -52.73 63.67 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.841 0.713 . . . . 65.23 110.881 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.6 t -56.42 -44.61 80.53 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 123.882 0.738 . . . . 65.42 110.925 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.474 ' O ' HG23 ' D' ' 118' ' ' VAL . 67.8 mt -61.39 -55.67 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.198 0.999 . . . . 71.35 110.69 175.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 92.5 m -58.77 -36.19 73.99 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.141 0.976 . . . . 74.2 111.501 -173.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 40.8 t -67.87 -43.69 78.82 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.375 -0.83 . . . . 74.32 109.794 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.645 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 76.6 mtm -70.02 -27.56 64.77 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.761 0.424 . . . . 71.43 111.841 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.474 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.3 t -64.52 -49.31 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.303 0.641 . . . . 74.34 109.509 174.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.6 p -69.04 -32.51 72.06 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.797 -0.638 . . . . 63.45 110.899 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.4 mtt-85 -68.39 -37.61 80.53 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.924 0.89 . . . . 71.45 110.246 174.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.91 0.97 87.81 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 115.738 -0.664 . . . . 72.35 112.259 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.44 HG23 HE21 ' A' ' 125' ' ' GLN . 30.7 p 63.07 26.79 15.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.7 2.0 . . . . 74.15 113.104 172.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -87.44 152.63 52.57 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 109.239 -0.652 . . . . 74.33 109.239 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.94 124.51 15.68 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.931 2.421 . . . . 74.53 112.341 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -55.42 146.7 19.12 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.633 1.173 . . . . 70.01 112.251 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.679 ' HG ' HG22 ' D' ' 40' ' ' VAL . 3.2 tm? -143.58 117.14 9.17 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.138 -1.06 . . . . 74.42 108.138 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -109.9 118.88 37.65 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.415 -0.958 . . . . 74.1 108.415 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.541 ' HA ' HD12 ' H' ' 6' ' ' ILE . 6.5 mp -66.73 128.17 35.26 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.781 0.833 . . . . 72.22 110.428 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -67.97 133.74 91.94 Favored Pre-proline 0 CA--C 1.552 1.026 0 O-C-N 123.842 0.714 . . . . 74.11 110.931 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 14.8 Cg_exo -68.83 130.38 20.4 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.902 2.401 . . . . 72.42 112.373 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 29.4 m -116.25 142.0 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.909 0.884 . . . . 73.43 109.897 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -92.97 72.34 4.73 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 122.11 0.957 . . . . 75.34 108.597 173.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -73.31 -23.48 60.27 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.353 -1.294 . . . . 73.02 110.645 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.472 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 2.8 m-20 -48.42 -51.29 27.44 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.724 1.209 . . . . 75.34 111.046 174.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.22 -46.61 86.18 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.279 0.987 . . . . 75.51 111.248 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 49.3 tp -57.9 -40.29 79.96 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.17 0.918 . . . . 75.13 111.156 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.486 ' O ' HD12 ' D' ' 141' ' ' LEU . 14.2 m-85 -60.29 -47.94 83.85 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 115.554 -0.748 . . . . 74.52 110.826 173.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.472 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 41.6 mtt -58.55 -48.65 80.18 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 123.272 0.358 . . . . 74.42 110.748 -175.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -54.15 -40.48 67.47 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 124.308 1.005 . . . . 73.44 111.558 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -76.75 -43.66 36.23 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.972 -0.558 . . . . 74.31 111.162 -177.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.486 HD12 ' O ' ' D' ' 137' ' ' PHE . 5.2 mp -65.18 -42.51 93.55 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.33 1.052 . . . . 72.12 111.688 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -75.44 -1.57 24.67 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.759 -0.655 . . . . 70.51 111.864 -172.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -128.94 43.62 3.11 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 123.481 0.713 . . . . 73.11 109.485 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -177.0 153.46 1.0 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.109 0.964 . . . . 64.34 110.513 171.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.74 8.35 45.05 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.366 0.667 . . . . 73.33 110.506 171.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.3 79.16 0.79 Allowed Glycine 0 C--N 1.353 1.481 0 C-N-CA 123.489 0.566 . . . . 61.42 112.642 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -88.9 85.05 6.65 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.153 0.981 . . . . 72.35 108.439 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -93.85 162.49 25.27 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.519 -0.764 . . . . 62.43 111.945 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 9.5 t -164.58 153.26 12.76 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.576 0.75 . . . . 74.31 110.433 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -113.18 143.15 44.88 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.097 0.559 . . . . 74.22 109.495 174.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -92.52 99.25 12.01 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 106.643 -1.614 . . . . 73.44 106.643 173.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . 0.433 ' O ' ' HA ' ' D' ' 47' ' ' ALA . 58.1 t-80 -146.15 114.75 6.8 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.375 -0.972 . . . . 65.25 108.375 -175.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -130.2 21.02 5.29 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.138 0.575 . . . . 73.43 111.733 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.19 88.47 0.62 Allowed 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 109.291 -0.633 . . . . 74.3 109.291 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.503 0 C-N-CA 124.645 1.178 . . . . 74.14 109.397 -177.606 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 110.062 -0.348 . . . . 72.33 110.062 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -141.79 154.41 45.2 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.752 0.821 . . . . 72.34 110.11 173.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -134.12 177.79 7.47 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.124 0.97 . . . . 72.01 109.447 173.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 41.9 p -143.83 136.73 27.4 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.127 0.571 . . . . 74.34 109.94 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 92.0 m -75.28 152.92 38.19 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.541 0.736 . . . . 74.2 109.536 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.457 HG12 HD23 ' A' ' 42' ' ' LEU . 11.7 tt -52.14 132.99 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 C-N-CA 125.374 1.47 . . . . 73.21 112.766 -176.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 7' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . . . -147.97 162.5 39.21 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.016 0.926 . . . . 74.21 110.522 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . 0.602 HD22 HD21 ' A' ' 44' ' ' LEU . 76.6 mt -81.61 -179.72 7.49 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.599 0.76 . . . . 75.32 110.848 174.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -135.84 175.1 9.9 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.333 1.053 . . . . 74.13 108.758 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . 0.49 HD22 ' HB2' ' A' ' 136' ' ' LEU . 90.0 mt -56.11 129.93 42.02 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.193 0.597 . . . . 73.4 110.639 177.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' E' ' 12' ' ' PRO . 72.4 mt -62.71 109.1 2.05 Favored Pre-proline 0 CA--C 1.549 0.937 0 O-C-N 124.335 1.022 . . . . 74.34 109.303 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 12' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' E' ' 11' ' ' LEU . 6.0 Cg_exo -77.96 68.03 7.89 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 123.786 2.991 . . . . 72.14 111.85 -172.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 6.3 tt -175.91 -49.69 0.01 OUTLIER 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.421 -1.326 . . . . 65.24 107.421 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 61.6 tp 60.03 89.38 0.07 Allowed 'General case' 0 C--N 1.36 1.062 0 O-C-N 124.622 1.201 . . . . 74.44 109.042 -170.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -68.59 136.35 52.9 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.924 -0.58 . . . . 75.22 110.582 -172.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 16' ' ' THR . . . . . 0.459 HG21 HD13 ' A' ' 98' ' ' LEU . 7.5 p -132.86 81.77 57.31 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.176 0.991 . . . . 75.43 109.266 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 17' ' ' PRO . . . . . 0.492 ' HD2' HD11 ' A' ' 98' ' ' LEU . 84.1 Cg_endo -78.87 -23.84 7.63 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.946 2.431 . . . . 71.53 112.999 -176.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 65.4 t -82.8 143.94 11.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 123.64 0.776 . . . . 71.31 109.319 -176.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 35.0 p -68.21 151.54 46.81 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.867 0.867 . . . . 73.35 110.577 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? 68.13 16.14 9.43 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.707 1.203 . . . . 74.13 112.714 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.9 51.29 1.94 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.187 0.595 . . . . 62.1 110.083 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -60.37 128.49 36.95 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.195 0.998 . . . . 73.4 110.59 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 24.4 p -116.44 82.83 12.54 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.14 0.576 . . . . 74.41 110.359 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.92 105.16 2.03 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.579 2.186 . . . . 60.04 111.612 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 . . . . . 0 C--O 1.251 1.163 0 C-N-CA 123.682 0.793 . . . . 64.24 109.368 176.312 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 58.1 mtm . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 109.801 -0.444 . . . . 71.24 109.801 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.37 -56.52 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.635 -0.876 . . . . 72.41 108.635 176.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 3' ' ' GLN . . . . . 0.527 ' HA ' ' HB3' ' B' ' 39' ' ' GLU . 34.9 tt0 81.07 106.61 0.07 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.7 1.6 . . . . 74.11 110.745 -172.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 32.3 t -166.43 -175.03 3.06 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.917 1.287 . . . . 73.2 108.227 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 25.1 m -139.9 107.55 5.62 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.686 -0.857 . . . . 70.42 108.686 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . 0.565 HG22 ' H ' ' F' ' 7' ' ' ALA . 7.3 mm 57.48 -149.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 124.829 1.251 . . . . 75.4 108.5 -176.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 7' ' ' ALA . . . . . 0.565 ' H ' HG22 ' F' ' 6' ' ' ILE . . . -169.4 -92.0 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.63 1.105 . . . . 71.53 109.685 174.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . 0.508 ' HG ' HG21 ' B' ' 131' ' ' VAL . 4.1 mm? 57.02 108.67 0.01 OUTLIER 'General case' 0 C--N 1.363 1.183 0 C-N-CA 124.974 1.309 . . . . 73.32 112.425 -174.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.82 142.41 50.69 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.983 0.913 . . . . 64.14 108.757 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 10' ' ' LEU . . . . . 0.422 HD13 ' HB3' ' B' ' 136' ' ' LEU . 6.3 mp -61.65 117.05 5.29 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.832 -1.173 . . . . 71.41 107.832 174.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 8.6 mp -47.07 108.84 0.93 Allowed Pre-proline 0 CA--C 1.557 1.226 0 O-C-N 125.002 1.439 . . . . 72.2 111.461 -172.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.4 -28.72 26.65 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 122.806 2.337 . . . . 73.54 112.028 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 7.3 mp -82.15 -8.05 59.64 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.993 0.917 . . . . 75.0 109.966 173.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 94.5 mt 61.61 -168.58 0.18 Allowed 'General case' 0 C--N 1.359 0.99 0 C-N-CA 124.77 1.228 . . . . 63.21 110.177 -168.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -112.28 139.84 47.49 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.335 -0.987 . . . . 73.44 108.335 174.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 25.7 p -66.63 108.62 2.5 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.524 0.73 . . . . 64.43 109.092 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 17' ' ' PRO . . . . . 0.5 ' HB2' ' SD ' ' B' ' 94' ' ' MET . 33.4 Cg_endo -86.14 -169.92 0.62 Allowed 'Trans proline' 0 C--N 1.364 1.381 0 C-N-CA 122.84 2.36 . . . . 73.43 112.309 -170.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.04 135.96 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.44 -0.578 . . . . 74.21 109.44 177.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 35.4 m -79.22 104.2 9.68 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.125 -1.065 . . . . 71.23 108.125 170.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 93.7 mttt 56.07 79.68 0.16 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.363 1.065 . . . . 74.52 111.359 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.71 52.85 2.0 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.697 0.799 . . . . 73.14 110.485 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . 0.508 HH21 ' HB3' ' B' ' 90' ' ' GLU . 97.9 mtt180 -143.41 -59.45 0.41 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.945 0.898 . . . . 75.0 109.777 -176.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 52.6 p -117.36 113.24 38.96 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.167 0.587 . . . . 74.42 110.55 -173.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.72 82.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 122.969 2.446 . . . . 71.32 111.909 165.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 . . . . . 0 C--O 1.254 1.314 0 C-N-CA 123.853 0.861 . . . . 74.1 108.74 -176.748 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' G' G ' 1' ' ' MET . . . . . 0.427 ' SD ' ' N ' ' G' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 109.951 -0.389 . . . . 72.53 109.951 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -128.13 117.76 22.17 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.175 -0.676 . . . . 75.43 109.175 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -88.74 61.86 6.19 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 122.015 0.912 . . . . 74.21 108.859 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 52.0 m -152.0 157.15 41.31 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.335 -0.848 . . . . 72.11 109.559 -175.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 25.5 m -63.08 111.23 2.1 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.946 0.779 . . . . 75.34 109.812 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . 0.566 ' HB ' HD21 ' C' ' 42' ' ' LEU 0.278 38.8 pt 51.91 -73.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 127.087 2.155 . . . . 75.03 114.309 178.124 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 7' ' ' ALA . . . . . 0.51 ' H ' HG13 ' G' ' 6' ' ' ILE . . . 67.72 123.63 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.219 1.408 . . . . 55.41 112.657 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 8' ' ' LEU . . . . . 0.588 ' HB2' HG13 ' C' ' 131' ' ' VAL . 29.3 mt -71.99 174.83 6.5 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.213 1.005 . . . . 73.13 110.803 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.52 169.65 11.67 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.822 0.849 . . . . 70.13 110.14 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 45.0 mt -68.78 162.67 25.81 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.624 0.726 . . . . 64.43 111.091 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 11' ' ' LEU . . . . . 0.541 HD23 HD11 ' C' ' 44' ' ' LEU . 34.8 mt -97.35 137.31 21.14 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 114.359 -1.291 . . . . 74.33 109.38 -175.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.86 -46.77 24.17 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 123.258 2.638 . . . . 75.14 111.485 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mp -96.88 142.15 29.21 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 106.906 -1.516 . . . . 73.52 106.906 168.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 mp -75.06 8.82 2.3 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.977 0.732 . . . . 71.13 112.977 -171.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . 0.5 ' CD1' ' HB ' ' C' ' 46' ' ' THR . 93.8 t80 58.62 92.0 0.04 OUTLIER 'General case' 0 C--N 1.36 1.065 0 C-N-CA 124.559 1.144 . . . . 75.31 110.511 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 16' ' ' THR . . . . . 0.596 HG21 ' HB2' ' G' ' 21' ' ' ALA . 7.3 p -141.42 87.36 10.48 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 122.562 0.345 . . . . 75.11 111.54 -175.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 17' ' ' PRO . . . . . 0.681 ' HD2' HD11 ' C' ' 98' ' ' LEU . 57.1 Cg_endo -71.74 -20.85 25.88 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.742 2.294 . . . . 71.5 113.208 172.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 18' ' ' VAL . . . . . . . . . . . . . 93.6 t -65.4 -64.41 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.067 0.547 . . . . 74.11 110.727 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 31.7 p -122.48 -98.12 0.44 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.953 -1.129 . . . . 74.32 107.953 171.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 82.3 tttt 176.5 84.73 0.01 OUTLIER 'General case' 0 C--N 1.352 0.687 0 N-CA-C 107.647 -1.242 . . . . 73.21 107.647 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . 0.596 ' HB2' HG21 ' G' ' 16' ' ' THR . . . -91.57 119.27 31.34 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 122.925 0.49 . . . . 62.14 110.051 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 22' ' ' ARG . . . . . 0.419 ' HG2' ' N ' ' G' ' 23' ' ' THR . 66.7 ttt-85 -172.28 173.9 4.08 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.427 1.491 . . . . 75.21 107.503 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 23' ' ' THR . . . . . 0.419 ' N ' ' HG2' ' G' ' 22' ' ' ARG . 39.2 p -70.71 144.73 91.37 Favored Pre-proline 0 CA--C 1.556 1.182 0 N-CA-C 109.091 -0.707 . . . . 64.21 109.091 164.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.8 -0.63 8.68 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.755 2.303 . . . . 72.0 113.215 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 CA--C 1.555 1.147 0 C-N-CA 124.62 1.168 . . . . 71.33 108.675 -178.984 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 74.0 mtp . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 121.212 0.53 . . . . 71.34 110.298 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -127.68 69.11 1.31 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 106.141 -1.8 . . . . 65.15 106.141 167.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -57.54 -38.22 74.36 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 114.038 -1.437 . . . . 71.3 111.58 -170.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 16.1 m 61.69 -163.38 0.26 Allowed 'General case' 0 C--N 1.353 0.721 0 CA-C-N 114.793 -1.094 . . . . 73.13 110.342 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 98.5 m -63.76 -58.26 7.39 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 109.591 -0.522 . . . . 70.32 109.591 168.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' D' ' 128' ' ' LEU . 6.8 pt -149.03 84.69 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 124.293 1.037 . . . . 72.54 109.814 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -154.86 141.73 19.13 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.188 0.595 . . . . 74.14 110.668 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 8' ' ' LEU . . . . . 0.436 HD23 HD23 ' D' ' 42' ' ' LEU . 57.8 mt -75.65 -57.72 3.71 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.05 -0.722 . . . . 71.31 109.05 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . 64.74 -74.19 0.05 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.645 1.578 . . . . 64.22 112.525 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tt -152.69 134.61 14.76 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.63 -1.248 . . . . 72.31 107.63 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.24 152.78 95.76 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 124.083 0.953 . . . . 75.24 111.204 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.71 -28.02 86.33 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.187 2.591 . . . . 74.33 112.852 -176.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 13' ' ' LEU . . . . . 0.431 HD11 ' N ' ' H' ' 14' ' ' LEU . 2.6 tm? -152.17 150.47 29.88 Favored 'General case' 0 C--O 1.245 0.867 0 N-CA-C 106.293 -1.743 . . . . 75.51 106.293 176.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . 0.431 ' N ' HD11 ' H' ' 13' ' ' LEU . 94.9 mt -54.29 120.29 6.34 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.331 -0.618 . . . . 75.21 109.331 176.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . 0.423 ' CD1' HG23 ' D' ' 46' ' ' THR . 32.9 t80 -49.03 -89.23 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.156 0 O-C-N 125.133 1.52 . . . . 63.04 112.314 -164.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 21.3 p -156.89 155.03 27.81 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 124.281 1.032 . . . . 73.32 109.194 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 17' ' ' PRO . . . . . 0.436 ' O ' ' HB1' ' H' ' 21' ' ' ALA . 53.1 Cg_endo -90.49 168.1 4.12 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 122.881 2.387 . . . . 75.12 109.733 163.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 t -81.09 -9.31 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 121.84 -0.537 . . . . 74.25 109.825 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -56.69 -68.64 0.2 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.543 1.537 . . . . 54.44 112.152 -170.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -122.49 -64.6 1.18 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.033 -1.099 . . . . 74.45 108.033 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . 0.436 ' HB1' ' O ' ' H' ' 17' ' ' PRO . . . 64.96 14.92 9.65 Favored 'General case' 0 C--N 1.362 1.111 0 CA-C-N 114.338 -1.301 . . . . 72.34 112.76 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -163.89 159.94 21.55 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 123.972 0.909 . . . . 75.43 109.366 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 64.0 p -62.9 128.77 92.53 Favored Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 108.873 -0.788 . . . . 74.42 108.873 165.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.2 -3.26 7.05 Favored 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 123.407 2.738 . . . . 74.32 115.671 -165.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 CA--C 1.55 0.943 0 C-N-CA 123.709 0.804 . . . . 72.44 109.7 -177.761 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 mmt . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 110.134 -0.321 . . . . 73.53 110.134 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 m 63.79 -77.69 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.792 1.237 . . . . 64.01 109.507 -168.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -86.83 166.12 15.44 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.197 0.999 . . . . 75.22 111.174 173.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.453 HE22 ' HB3' ' A' ' 142' ' ' GLN . 28.5 pt20 -147.91 -3.93 0.5 Allowed 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 114.505 -1.225 . . . . 71.14 109.875 171.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -114.55 160.87 18.77 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.963 1.305 . . . . 75.42 109.32 -175.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -125.86 -85.75 0.62 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.377 0.671 . . . . 72.54 110.163 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.8 m -158.56 109.08 2.08 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.175 0.59 . . . . 74.31 110.319 -173.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.476 ' HG3' HD13 ' A' ' 89' ' ' ILE . 53.7 mm-40 -137.57 163.13 31.95 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.639 1.175 . . . . 73.05 109.578 175.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.7 ttm 69.95 172.67 0.3 Allowed 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.803 1.241 . . . . 72.51 110.666 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.7 m -136.59 113.45 10.36 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.013 -1.106 . . . . 75.44 108.013 175.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.723 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 2.9 t80 -96.45 134.89 39.07 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.969 -1.014 . . . . 74.44 109.478 -174.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -145.48 114.59 7.01 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.477 -0.935 . . . . 74.14 108.477 176.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.615 HG12 ' HD2' ' A' ' 84' ' ' PHE . 47.7 mt -90.29 129.62 40.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.649 -0.871 . . . . 74.4 108.649 174.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -87.88 -41.79 12.97 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.818 -0.628 . . . . 73.21 110.133 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -175.93 129.46 0.24 Allowed 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.18 0.3 . . . . 75.01 111.197 -170.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.483 HD11 HD11 ' A' ' 13' ' ' ILE . 97.3 mt -121.61 139.9 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 123.653 0.781 . . . . 75.33 108.985 177.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.415 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 35.0 p90 -169.92 177.18 4.46 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.02 0.928 . . . . 74.42 110.597 -169.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.0 p -102.33 121.19 41.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.284 -1.006 . . . . 65.5 108.284 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.415 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 33.8 mtpt -83.15 -44.08 15.48 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.639 -0.875 . . . . 75.04 108.639 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.476 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 21.9 t70 -135.59 134.8 39.72 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.19 -1.368 . . . . 70.12 108.921 -175.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.421 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 80.9 mt -135.14 142.44 39.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.148 -1.427 . . . . 73.25 107.148 178.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -154.17 115.16 4.04 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.095 0.474 . . . . 64.25 110.535 172.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.608 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 75.4 t80 -110.22 138.91 45.95 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 106.838 -1.542 . . . . 65.42 106.838 170.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -138.3 140.62 39.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.227 -1.027 . . . . 74.32 108.227 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.88 78.61 35.44 Favored Pre-proline 0 C--O 1.238 0.48 0 N-CA-C 107.314 -1.365 . . . . 74.42 107.314 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.93 -28.1 36.12 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.968 2.445 . . . . 71.13 112.293 -170.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -114.49 28.8 8.48 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.945 0.898 . . . . 70.11 109.591 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.423 ' O ' HG11 ' A' ' 31' ' ' VAL . . . -47.29 -52.38 35.97 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.03 0.932 . . . . 72.35 113.422 -178.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -63.74 -21.74 69.68 Favored 'Trans proline' 0 C--N 1.39 2.751 0 CA-C-N 121.413 1.541 . . . . 63.5 112.751 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.433 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 4.6 m-70 -94.9 -32.93 13.0 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 124.123 0.969 . . . . 70.3 110.788 -174.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.559 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.5 p -76.32 -16.87 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 112.724 0.639 . . . . 73.45 112.724 -163.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -77.72 -32.58 52.96 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.027 0.531 . . . . 74.15 112.0 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -75.91 -18.62 59.31 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.821 0.449 . . . . 72.13 110.721 174.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 14.5 mmmm -75.29 148.02 39.72 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.61 0.764 . . . . 74.3 111.749 -175.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.06 127.64 32.91 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 124.238 0.961 . . . . 72.34 109.424 171.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -78.98 86.06 4.87 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.529 0.68 . . . . 73.21 110.358 -177.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -136.53 78.59 43.57 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.014 1.325 . . . . 73.24 107.907 176.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -86.45 171.4 7.48 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.448 2.099 . . . . 64.53 113.61 -174.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -115.96 101.08 8.44 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 107.095 -1.446 . . . . 73.5 107.095 170.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -77.59 93.94 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.935 0.874 . . . . 70.14 111.081 -172.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.612 ' HZ1' ' HB3' ' A' ' 41' ' ' LYS . 8.4 mtpm? -82.63 114.28 20.9 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.196 -1.038 . . . . 74.02 108.196 173.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.498 HD12 ' H ' ' E' ' 9' ' ' ALA . 0.5 OUTLIER -123.83 107.94 11.94 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.711 0.767 . . . . 74.34 109.847 -174.715 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.484 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.2 m-20 -114.01 136.61 52.72 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.61 -1.177 . . . . 74.13 109.42 -174.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.15 142.17 46.57 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.437 -0.949 . . . . 74.43 108.437 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.666 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 5.9 t70 -147.11 127.6 14.09 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.537 -0.542 . . . . 74.25 109.537 -169.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 64.1 p -105.78 126.96 52.78 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.455 0.702 . . . . 74.25 110.886 -168.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -133.03 141.84 48.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.726 0.81 . . . . 73.43 109.438 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.3 m -132.61 154.98 49.52 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.378 0.671 . . . . 73.01 110.668 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.6 t -153.78 139.59 18.07 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.595 0.758 . . . . 71.24 109.565 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -96.67 120.53 37.17 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.879 -0.785 . . . . 73.31 108.879 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.785 HD12 ' HB2' ' A' ' 57' ' ' GLU . 25.8 mt -107.27 -35.81 6.71 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.553 0.741 . . . . 75.23 110.336 -172.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.54 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -156.71 -176.88 6.22 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.368 1.067 . . . . 71.14 109.687 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -71.75 116.12 11.75 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.68 0.792 . . . . 71.14 109.956 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 70.12 0.22 3.04 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.79 1.236 . . . . 71.04 112.235 -176.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.54 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 58.9 t -111.26 112.43 40.5 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 108.247 -1.02 . . . . 73.34 108.247 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -124.84 173.32 8.68 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.438 1.095 . . . . 71.43 108.972 -173.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.785 ' HB2' HD12 ' A' ' 51' ' ' LEU . 41.3 tt0 -127.17 127.79 45.09 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.195 0.598 . . . . 74.14 109.513 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.426 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 84.3 t -105.44 122.56 58.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.761 -1.2 . . . . 65.2 107.761 170.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 46.1 t -116.78 138.57 46.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 N-CA-C 108.139 -1.06 . . . . 72.31 108.139 174.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.8 tp -127.31 118.08 23.5 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.26 -0.644 . . . . 74.41 109.26 174.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.666 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 16.9 ttm-85 -85.18 102.37 13.25 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.448 -0.945 . . . . 71.24 108.448 173.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.5 t -95.1 108.68 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.559 -0.904 . . . . 72.41 108.559 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 26.8 m -95.46 124.77 39.66 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.623 0.769 . . . . 70.4 108.993 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.9 t -124.74 107.41 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.197 -1.038 . . . . 62.4 108.197 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.561 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 18.3 m -108.12 136.16 48.27 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.515 -0.92 . . . . 72.53 108.515 175.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.12 110.99 20.36 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.29 -1.374 . . . . 72.43 107.29 172.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.9 m -115.31 124.33 51.03 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.598 0.359 . . . . 73.3 110.09 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.4 mt -90.64 84.71 5.93 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.285 -1.006 . . . . 72.14 108.285 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.86 -83.44 0.93 Allowed Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.85 -0.5 . . . . 74.02 111.85 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -125.01 -29.16 3.37 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.861 0.864 . . . . 72.31 109.203 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -77.93 109.94 12.41 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.284 -0.636 . . . . 75.14 109.284 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.8 m -69.53 122.9 19.96 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 110.234 -0.284 . . . . 72.02 110.234 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.559 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -69.03 -61.25 1.87 Allowed 'General case' 0 C--O 1.24 0.596 0 O-C-N 123.843 0.714 . . . . 72.23 110.271 176.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.406 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 26.8 p90 -160.41 172.83 16.58 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.076 -0.965 . . . . 74.32 111.966 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.2 tp -131.41 138.23 49.0 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.984 -1.462 . . . . 75.35 107.497 173.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.428 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 86.1 m -139.12 97.66 3.35 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.28 -1.007 . . . . 73.14 108.28 176.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -120.09 117.23 27.43 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.281 -1.007 . . . . 74.02 108.281 -175.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.0 t -129.31 113.54 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 123.932 0.893 . . . . 52.52 109.867 -170.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.492 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 70.5 mt-30 -84.44 89.01 7.32 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 108.322 -0.992 . . . . 72.41 108.322 170.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.518 ' HG3' HD23 ' A' ' 106' ' ' LEU . 9.5 tp-100 -77.0 103.08 6.73 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.002 -0.999 . . . . 75.53 109.079 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.71 145.83 19.0 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.978 -0.555 . . . . 74.55 111.811 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.406 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.19 123.16 1.46 Allowed Glycine 0 CA--C 1.503 -0.7 0 N-CA-C 110.731 -0.948 . . . . 75.13 110.731 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.527 HG22 HD11 ' A' ' 51' ' ' LEU . 55.5 mt -83.46 121.02 35.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.865 -0.791 . . . . 73.42 108.865 176.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.723 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 23.5 m-85 -134.26 130.13 36.65 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.337 0.655 . . . . 73.34 109.675 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.9 t -99.61 113.93 26.65 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.612 -0.884 . . . . 71.51 108.612 173.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -139.21 120.36 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 C-N-CA 123.96 0.904 . . . . 71.31 110.787 -175.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.54 160.11 10.7 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.202 1.001 . . . . 64.1 110.301 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 145.17 -85.04 0.18 Allowed Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.467 -0.788 . . . . 54.13 112.407 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.476 HD13 ' HG3' ' A' ' 8' ' ' GLU . 9.0 tt -80.98 -40.49 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 112.514 0.561 . . . . 72.12 112.514 -168.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 67.58 -166.68 0.2 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.078 0.951 . . . . 73.51 110.946 -172.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.34 -135.77 22.78 Favored Glycine 0 C--N 1.353 1.477 0 C-N-CA 122.915 0.293 . . . . 72.01 113.694 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.5 p -68.76 -37.56 79.44 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.172 0.989 . . . . 62.31 111.759 -174.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -63.19 -42.7 99.39 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.82 0.848 . . . . 74.22 111.534 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 18.6 ttt -77.18 -34.78 56.27 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 116.6 -0.273 . . . . 74.24 110.522 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.47 -35.13 79.42 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.156 0.582 . . . . 73.44 110.314 172.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.547 ' NE2' ' HB2' ' A' ' 134' ' ' ASP . 26.9 t-80 -68.31 -44.43 75.45 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.219 1.008 . . . . 74.31 110.352 174.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.615 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 83.4 m -64.22 -44.78 90.85 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.369 0.667 . . . . 71.2 111.555 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.59 -50.86 11.67 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.668 0.787 . . . . 65.54 111.735 -173.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.4 5.08 67.42 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-O 119.186 -0.786 . . . . 72.55 114.759 -169.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -149.72 -51.8 0.15 Allowed 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.582 1.191 . . . . 72.42 113.48 -175.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.615 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 88.0 t80 -75.59 -49.23 19.17 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.826 0.851 . . . . 71.31 112.248 -168.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 99.3 m -69.65 -36.26 6.56 Favored Pre-proline 0 CA--C 1.563 1.478 0 CA-C-O 118.897 -0.573 . . . . 75.3 112.256 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -48.63 -42.43 35.98 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 122.504 2.136 . . . . 73.33 113.839 160.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.505 HD22 ' H ' ' A' ' 134' ' ' ASP . 84.0 m-20 -64.15 -34.44 78.08 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 123.537 0.735 . . . . 74.15 111.553 176.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.6 mm -66.02 -40.39 87.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 N-CA-C 109.587 -0.523 . . . . 74.13 109.587 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.518 HD23 ' HG3' ' A' ' 80' ' ' GLN . 96.5 mt -79.0 -22.44 45.52 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.755 0.822 . . . . 72.55 112.254 -178.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -58.14 -48.83 96.36 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 113.914 1.079 . . . . 63.13 113.914 -172.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -63.1 -39.83 37.11 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 122.111 1.874 . . . . 63.52 112.812 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -69.3 -40.75 77.51 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.298 0.639 . . . . 75.0 111.281 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.23 -40.63 70.97 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.071 0.548 . . . . 44.12 110.367 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.46 HH12 HD13 ' C' ' 105' ' ' ILE . 23.7 ttm180 -49.91 -51.99 36.57 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.01 0.924 . . . . 74.0 110.205 171.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -71.48 -37.54 71.3 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.006 -0.997 . . . . 60.44 111.64 -173.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.8 t -66.06 -32.66 74.25 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 121.061 0.457 . . . . 73.1 110.916 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 93.0 mt -69.18 -54.51 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 115.255 -0.884 . . . . 65.32 109.432 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.456 HG21 ' HE2' ' C' ' 109' ' ' TYR . 95.2 m -51.79 -40.6 60.66 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.994 1.317 . . . . 65.41 112.278 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.9 t -64.12 -47.6 79.36 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 115.249 -0.887 . . . . 73.34 110.656 -177.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.608 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 39.6 mtm -67.84 -36.07 79.69 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.807 0.692 . . . . 74.12 111.373 -178.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.9 -51.47 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 123.677 0.791 . . . . 74.14 110.254 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.5 t -69.46 -29.45 67.13 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.43 -0.804 . . . . 44.12 111.5 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.516 ' HG2' ' HG1' ' B' ' 18' ' ' THR . 42.0 ttm-85 -77.93 -28.82 49.73 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.988 0.915 . . . . 74.44 109.2 -179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.422 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.96 12.65 59.33 Favored Glycine 0 C--N 1.351 1.411 0 CA-C-N 114.933 -1.03 . . . . 63.23 112.648 170.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.451 HG23 ' HE ' ' B' ' 15' ' ' ARG . 2.0 t 60.66 18.51 8.54 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 126.89 2.076 . . . . 74.11 113.523 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -77.93 158.39 77.79 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 123.938 0.895 . . . . 73.43 110.951 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.46 143.38 77.86 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.831 2.354 . . . . 64.32 112.995 173.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.401 HE21 HG23 ' D' ' 122' ' ' THR . 5.4 tp-100 -53.73 127.74 26.9 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.674 1.19 . . . . 72.13 112.183 -175.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.413 HD12 HG21 ' E' ' 6' ' ' ILE . 43.5 tp -126.92 101.37 6.55 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.048 0.939 . . . . 74.43 109.45 -177.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -123.34 102.11 7.73 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.605 -0.887 . . . . 75.1 108.605 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.62 144.62 56.29 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.985 0.514 . . . . 75.45 109.687 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.502 ' HB3' ' HA ' ' E' ' 7' ' ' ALA . . . -68.41 151.25 97.34 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 123.833 0.853 . . . . 51.23 111.845 -173.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.477 ' HD3' HG13 ' C' ' 13' ' ' ILE . 52.1 Cg_endo -68.97 114.63 3.64 Favored 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 123.094 2.53 . . . . 74.33 113.111 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.1 m -111.61 112.68 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 108.184 -1.043 . . . . 75.22 108.184 165.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -81.61 93.61 6.76 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.63 -1.248 . . . . 73.51 107.63 175.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.433 ' O ' ' HB2' ' A' ' 137' ' ' PHE . 79.9 m-85 -49.52 -37.72 27.83 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.242 1.017 . . . . 61.12 111.634 -175.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.547 ' HB2' ' NE2' ' A' ' 96' ' ' HIS . 5.4 p-10 -75.49 -39.54 58.43 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.784 0.834 . . . . 74.2 111.855 -172.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.27 -42.06 93.58 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.523 0.729 . . . . 63.11 111.008 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.21 -26.17 47.35 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.322 -0.854 . . . . 62.2 110.565 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.433 ' HB2' ' O ' ' A' ' 133' ' ' PHE . 9.5 t80 -75.06 -38.5 61.35 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.165 0.586 . . . . 75.01 109.565 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.552 ' HB3' ' HB3' ' A' ' 144' ' ' GLN . 34.6 mmt -76.12 -27.23 57.01 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.397 0.679 . . . . 75.33 110.272 177.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -63.78 -44.98 91.78 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.832 0.853 . . . . 73.54 109.053 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -65.15 -37.7 88.23 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.356 0.662 . . . . 75.12 110.757 172.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 138' ' ' MET . 0.2 OUTLIER -64.8 -50.68 65.77 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.105 0.962 . . . . 73.52 110.465 -171.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.453 ' HB3' HE22 ' A' ' 4' ' ' GLN . 6.2 tp-100 -166.39 28.65 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.791 -0.641 . . . . 71.32 110.391 -170.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 56.5 33.29 22.3 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.155 0.982 . . . . 74.14 111.73 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.552 ' HB3' ' HB3' ' A' ' 138' ' ' MET . 0.6 OUTLIER -80.62 91.09 5.78 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.283 -1.377 . . . . 73.44 107.283 173.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -175.38 168.34 3.29 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.758 1.223 . . . . 60.44 109.62 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 109.82 128.28 5.51 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 116.11 -0.495 . . . . 71.53 112.077 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -118.74 175.73 5.6 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.304 1.041 . . . . 75.11 109.03 171.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 152.4 76.81 0.02 OUTLIER Glycine 0 C--N 1.345 1.071 0 C-N-CA 121.757 -0.259 . . . . 64.02 113.088 174.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 65.4 p -105.3 116.7 32.39 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.937 -0.764 . . . . 73.33 108.937 170.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -100.39 103.54 14.93 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.097 0.959 . . . . 75.32 108.497 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -122.03 116.41 24.23 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.727 0.811 . . . . 73.31 109.721 -175.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -128.43 120.4 26.83 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.903 0.881 . . . . 75.51 109.431 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.454 ' HG3' ' HD2' ' G' ' 24' ' ' PRO . 16.6 mm100 -126.67 98.83 5.54 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.6 -1.259 . . . . 72.3 107.6 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -63.14 121.8 14.53 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.455 0.702 . . . . 74.41 110.864 -175.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 O-C-N 124.112 0.882 . . . . 64.45 110.468 178.616 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.433 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.912 0.387 . . . . 75.23 110.353 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 41.0 t -131.03 127.19 37.76 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.43 1.092 . . . . 71.01 109.216 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -117.78 28.62 8.31 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.788 0.835 . . . . 75.44 109.736 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -59.28 132.83 55.19 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.553 0.741 . . . . 73.34 110.121 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -58.7 100.35 0.06 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.746 0.818 . . . . 71.43 110.864 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -69.19 146.65 52.23 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.495 -0.775 . . . . 75.45 109.692 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.7 t -105.2 175.5 5.47 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.149 0.98 . . . . 75.03 110.323 -176.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 74.97 -61.41 0.49 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 126.118 1.767 . . . . 73.2 112.033 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 25.2 ttt 66.18 175.79 0.23 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.396 1.078 . . . . 74.23 110.262 -174.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 61.6 m -133.27 129.35 37.51 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.285 -1.376 . . . . 74.52 107.285 168.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.434 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 42.7 t80 -129.35 126.61 39.3 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.799 -1.185 . . . . 75.04 107.799 175.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.486 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -144.53 126.43 15.36 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.271 -0.64 . . . . 73.34 109.271 178.337 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 27.9 mt -74.8 121.51 26.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.562 -0.903 . . . . 74.3 108.562 172.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -92.06 -50.06 5.88 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.248 -0.649 . . . . 75.11 109.248 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.451 ' HE ' HG23 ' A' ' 122' ' ' THR . 45.8 ttt180 -166.52 131.16 2.14 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.727 -0.67 . . . . 74.44 110.209 -175.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 75.6 mt -114.68 137.18 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 108.029 -1.1 . . . . 73.3 108.029 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -169.87 161.79 9.12 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.442 0.639 . . . . 75.21 111.5 -176.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.516 ' HG1' ' HG2' ' A' ' 120' ' ' ARG . 42.7 m -83.17 130.63 35.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.771 -1.104 . . . . 73.33 109.249 170.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -96.51 -34.22 11.56 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.261 0.625 . . . . 71.11 109.851 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -147.72 145.45 28.86 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.084 0.469 . . . . 73.14 111.177 -173.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.715 HD12 ' SG ' ' B' ' 113' ' ' CYS . 40.3 mm -136.35 146.5 28.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 126.047 1.739 . . . . 72.3 108.708 177.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 36.7 t -150.9 133.32 15.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.558 -1.201 . . . . 71.03 108.324 171.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 74.0 t80 -141.07 135.99 31.54 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.098 -1.445 . . . . 75.34 107.098 172.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -141.51 128.48 20.68 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.218 1.007 . . . . 75.12 108.666 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.17 80.95 69.8 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 107.018 -1.475 . . . . 63.51 107.018 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.82 -26.73 31.96 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.142 2.561 . . . . 72.01 113.152 -171.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.453 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 74.9 m-20 -115.11 18.73 16.13 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.674 0.79 . . . . 73.54 110.047 -177.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.86 -59.17 5.02 Favored Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 125.06 1.344 . . . . 74.52 114.129 -170.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -61.43 -28.49 83.89 Favored 'Trans proline' 0 C--N 1.393 2.89 0 C-N-CA 122.233 1.955 . . . . 74.3 113.346 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.439 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 78.1 m80 -93.96 -38.21 11.29 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.702 -0.681 . . . . 74.32 111.404 -175.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' B' ' 73' ' ' ALA . 4.5 p -67.88 -16.74 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.129 0.572 . . . . 72.24 111.757 -173.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -65.11 -21.03 66.74 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.222 0.823 . . . . 74.23 113.222 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 10.3 pt20 -68.28 -15.27 63.5 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.308 0.643 . . . . 75.01 111.179 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.502 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 89.6 mttt -95.27 105.71 17.68 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.597 1.159 . . . . 75.41 109.791 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -110.72 93.08 4.31 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.09 0.556 . . . . 72.53 109.829 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 39.7 p90 -162.65 179.7 7.52 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.716 1.206 . . . . 75.5 108.411 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -69.05 114.71 25.26 Favored Pre-proline 0 N--CA 1.477 0.915 0 N-CA-C 109.578 -0.527 . . . . 73.53 109.578 177.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.463 ' HB2' ' HB2' ' B' ' 66' ' ' ALA . 43.2 Cg_endo -65.72 139.11 56.4 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 121.901 1.734 . . . . 72.33 111.027 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -66.45 103.68 1.09 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.561 -0.903 . . . . 73.15 108.561 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.568 HG11 HD23 ' B' ' 126' ' ' LEU . 31.2 m -99.83 160.82 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 115.41 -0.813 . . . . 75.01 111.815 -172.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -145.04 133.59 22.01 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.67 -1.15 . . . . 71.33 108.524 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 pp -86.7 164.98 16.44 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 123.038 0.535 . . . . 74.23 110.15 175.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.572 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 17.5 t70 -164.72 126.31 2.15 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.072 -0.967 . . . . 75.13 108.545 175.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.419 HD21 HD21 ' B' ' 60' ' ' LEU . 5.5 mp -123.04 134.15 54.3 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.576 0.75 . . . . 70.21 109.073 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.649 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 10.9 t70 -131.32 133.65 45.55 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.845 0.858 . . . . 63.52 108.758 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.49 ' HB ' ' HD2' ' F' ' 15' ' ' PHE . 17.9 p -106.37 102.02 11.45 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.244 0.618 . . . . 64.32 109.678 -175.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.473 ' O ' ' HB ' ' B' ' 59' ' ' VAL . . . -119.85 114.21 21.75 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 107.111 -1.44 . . . . 65.22 107.111 174.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 52.6 m -144.77 161.06 40.17 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.385 -0.598 . . . . 73.22 109.385 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 76.1 p -164.73 150.17 9.95 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.906 0.482 . . . . 71.01 110.445 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -82.24 129.5 34.86 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.205 0.602 . . . . 71.25 109.65 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.46 HD12 HG23 ' B' ' 83' ' ' ILE . 20.7 mt -91.07 -49.97 6.11 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.796 0.839 . . . . 74.42 109.971 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.03 -173.49 4.18 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.193 -0.912 . . . . 73.42 110.224 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -65.65 120.73 13.48 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.947 -1.024 . . . . 75.42 109.313 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 68.17 9.2 7.05 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.115 1.366 . . . . 64.11 111.773 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -120.92 109.36 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.048 0.939 . . . . 74.42 109.21 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -119.48 149.04 42.54 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.505 1.122 . . . . 73.52 108.443 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -118.76 122.08 41.58 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.925 0.49 . . . . 73.54 109.78 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 61.9 t -100.93 118.91 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 108.375 -0.972 . . . . 65.41 108.375 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' B' ' 47' ' ' ALA . 21.4 t -118.67 130.82 72.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 107.646 -1.242 . . . . 65.55 107.646 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.419 HD21 HD21 ' B' ' 44' ' ' LEU . 14.2 tp -123.32 124.59 43.31 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 110.128 -0.323 . . . . 74.2 110.128 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.649 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 39.0 ttm180 -87.31 113.5 23.08 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.864 0.865 . . . . 65.51 109.001 173.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 43.1 t -104.88 101.32 12.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.475 -1.306 . . . . 70.03 107.475 173.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.572 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 18.1 m -103.06 132.36 49.38 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.569 0.748 . . . . 75.54 109.065 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 89.6 t -123.24 127.02 74.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 124.773 1.229 . . . . 73.44 108.825 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.1 m -103.98 148.08 26.62 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.822 -0.807 . . . . 70.2 108.822 169.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -148.53 140.14 23.6 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.544 0.738 . . . . 72.32 109.563 176.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.461 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 35.3 p -143.98 137.7 27.91 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 123.635 0.584 . . . . 73.23 110.826 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.459 HD21 ' HA ' ' B' ' 38' ' ' PRO . 67.4 mt -110.52 110.82 21.69 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.043 -1.095 . . . . 72.22 108.043 174.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.55 -129.93 10.29 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 123.245 0.34 . . . . 44.34 113.056 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -96.61 16.44 18.86 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.683 0.793 . . . . 61.0 111.919 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.502 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 12.2 pt-20 -142.06 152.81 43.69 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.699 0.399 . . . . 74.3 110.952 -175.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 58.2 m -64.94 132.65 49.9 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 123.636 0.585 . . . . 65.13 110.136 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.461 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -85.44 -66.64 0.88 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.14 -1.43 . . . . 74.31 107.14 171.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -149.21 159.55 44.15 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 122.01 0.91 . . . . 75.21 112.178 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 71.3 mt -131.45 113.1 13.3 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 105.946 -1.872 . . . . 74.31 105.946 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.567 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 48.3 t -118.9 147.83 43.57 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.739 -0.837 . . . . 74.03 108.739 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 40.0 tt0 -155.9 128.67 7.91 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.92 -0.77 . . . . 72.3 108.92 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 96.1 t -130.36 145.83 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.789 0.836 . . . . 74.04 108.947 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -122.29 101.21 7.38 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.23 -1.026 . . . . 74.13 108.23 172.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -91.25 104.62 17.14 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.079 -0.711 . . . . 74.11 109.079 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.5 142.91 16.27 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.507 -0.769 . . . . 70.44 111.643 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.42 124.0 2.92 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 109.875 -1.29 . . . . 74.43 109.875 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.46 HG23 HD12 ' B' ' 51' ' ' LEU . 53.1 mt -86.26 128.61 39.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.957 -1.127 . . . . 71.44 107.957 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -137.44 134.91 36.38 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.816 0.847 . . . . 74.41 109.001 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 74.3 m -91.11 108.34 19.81 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.597 -0.52 . . . . 72.14 109.597 171.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.653 HD11 HD23 ' B' ' 98' ' ' LEU . 48.4 pt -121.9 143.67 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.41 1.084 . . . . 74.25 110.586 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.8 152.04 22.64 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.185 0.594 . . . . 73.25 110.771 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.95 -69.59 0.23 Allowed Glycine 0 C--N 1.347 1.18 0 O-C-N 123.429 0.455 . . . . 70.03 112.869 170.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 18.5 mt -75.07 152.75 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.394 0.678 . . . . 74.12 110.947 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -155.81 -175.04 5.22 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 124.118 0.967 . . . . 74.1 108.92 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.67 -135.07 26.46 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 123.364 0.507 . . . . 62.11 114.152 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 31.6 m -71.25 -36.51 71.8 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.58 0.752 . . . . 72.41 111.832 -174.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -60.91 -38.22 84.99 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.766 -0.652 . . . . 73.11 110.361 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 42.0 ttp -80.03 -28.07 39.39 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.561 -0.745 . . . . 72.21 110.569 177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.4 -31.89 72.94 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.106 0.562 . . . . 74.25 110.708 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -75.58 -39.01 58.69 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.232 0.613 . . . . 65.11 110.573 173.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.1 t -64.12 -64.52 0.86 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.083 0.553 . . . . 74.15 110.912 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.653 HD23 HD11 ' B' ' 86' ' ' ILE . 65.9 mt -72.47 -30.74 64.82 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.122 0.569 . . . . 74.41 111.968 -176.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.74 -10.44 72.8 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 119.717 -0.491 . . . . 62.53 114.208 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.602 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -142.35 -58.58 0.45 Allowed 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 117.433 0.616 . . . . 71.53 111.948 -175.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -60.51 -49.22 78.43 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.168 0.987 . . . . 63.33 112.385 -176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.434 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 64.1 m -67.65 -50.3 36.02 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-O 118.484 -0.77 . . . . 63.13 112.579 -175.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.406 ' HB2' HD23 ' B' ' 60' ' ' LEU . 74.0 Cg_endo -72.17 -12.62 28.03 Favored 'Trans proline' 0 C--N 1.385 2.473 0 CA-C-N 121.248 1.481 . . . . 73.0 112.84 177.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' B' ' 100' ' ' ALA . 0.2 OUTLIER -73.99 -33.49 63.84 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.071 0.548 . . . . 64.22 109.548 173.619 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 97.7 mt -60.76 -42.24 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 124.031 0.932 . . . . 74.43 109.738 170.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.8 mt -87.34 -14.5 40.61 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.413 -1.267 . . . . 75.02 111.396 -171.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -54.39 -51.82 74.74 Favored Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 124.321 1.048 . . . . 74.24 112.7 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -52.46 -40.15 72.33 Favored 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 122.866 2.378 . . . . 70.23 114.791 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -75.07 -41.31 59.18 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.927 -0.579 . . . . 74.5 110.51 -175.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.86 -40.27 96.16 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.196 0.598 . . . . 71.41 110.43 174.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -57.11 -59.59 4.86 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.468 1.507 . . . . 75.42 110.564 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.82 -37.74 74.35 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 124.124 0.89 . . . . 72.35 110.759 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.715 ' SG ' HD12 ' B' ' 21' ' ' ILE . 19.0 t -68.61 -40.65 80.3 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.336 -0.847 . . . . 63.45 111.593 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.567 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 63.6 mt -62.18 -50.77 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.233 -0.654 . . . . 74.21 109.233 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 4.6 m -61.99 -29.6 70.37 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 124.133 0.896 . . . . 70.53 111.431 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -66.4 -50.42 63.51 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 109.487 -0.56 . . . . 73.31 109.487 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.4 ' SD ' HG22 ' B' ' 21' ' ' ILE . 35.5 mmt -62.44 -41.69 98.91 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 123.699 0.624 . . . . 74.2 110.876 -178.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 70.0 t -61.78 -48.12 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 124.209 1.004 . . . . 63.52 110.857 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 26.0 t -67.48 -30.36 70.04 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.58 -0.736 . . . . 75.44 110.792 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -69.92 -31.31 69.01 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.992 0.517 . . . . 72.21 110.12 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.76 9.66 55.07 Favored Glycine 0 C--N 1.353 1.521 0 O-C-N 123.883 0.739 . . . . 64.21 112.314 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 82.8 p 60.5 22.18 11.88 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 126.825 2.05 . . . . 73.25 113.627 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -84.63 161.93 52.13 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 123.476 0.71 . . . . 75.04 111.062 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -61.9 174.58 2.3 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 123.057 2.505 . . . . 72.22 113.875 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.53 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -62.42 115.13 3.95 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.312 -1.313 . . . . 54.34 111.343 -175.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.568 HD23 HG11 ' B' ' 40' ' ' VAL . 1.6 tm? -131.92 96.08 3.84 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.361 -0.977 . . . . 73.15 108.361 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -123.1 137.01 55.03 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.475 1.11 . . . . 73.13 108.773 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 6.9 mp -70.67 138.01 50.31 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.749 0.655 . . . . 62.15 110.524 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.77 151.26 89.29 Favored Pre-proline 0 CA--C 1.553 1.077 0 O-C-N 124.331 1.019 . . . . 74.31 112.173 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.83 92.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.533 2.822 . . . . 73.41 112.636 173.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 16.1 m -115.09 112.37 39.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 115.673 -0.694 . . . . 73.55 109.194 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . 0.522 ' ND2' ' HB3' ' B' ' 135' ' ' ALA . 49.2 t30 -82.57 94.11 7.44 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 107.498 -1.297 . . . . 75.22 107.498 173.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -68.7 -29.9 68.44 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.317 -1.311 . . . . 74.4 110.638 -172.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.602 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 17.5 t70 -58.34 -45.34 88.34 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.048 0.939 . . . . 74.34 110.898 172.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.522 ' HB3' ' ND2' ' B' ' 132' ' ' ASN . . . -66.51 -32.31 73.59 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.885 0.741 . . . . 70.22 111.481 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 48.6 tp -58.88 -37.06 75.7 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.468 0.707 . . . . 75.41 110.836 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.417 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 38.5 m-85 -91.06 -27.51 18.56 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.641 -0.709 . . . . 75.22 111.57 175.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.446 ' HB3' ' HA ' ' B' ' 135' ' ' ALA . 1.5 tmt? -68.15 -35.74 78.57 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.195 0.598 . . . . 75.03 111.247 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.457 ' HA ' ' NE2' ' B' ' 142' ' ' GLN . 64.3 m-80 -74.68 -16.26 60.77 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.65 0.38 . . . . 74.0 111.184 178.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -77.13 -33.3 56.78 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.623 0.369 . . . . 72.22 110.353 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 67.2 mt -77.88 -6.2 53.48 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.8 0.667 . . . . 74.31 112.8 -172.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . 0.457 ' NE2' ' HA ' ' B' ' 139' ' ' ASN . 3.2 pp0? -152.38 176.21 11.88 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.115 0.566 . . . . 73.3 110.705 177.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -131.78 161.34 33.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.237 1.015 . . . . 64.54 108.755 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -66.32 140.49 58.11 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.186 0.595 . . . . 75.12 111.101 -176.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.16 169.04 25.43 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.152 0.981 . . . . 75.32 110.215 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.77 110.27 0.34 Allowed Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.53 -0.628 . . . . 64.1 111.53 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.81 -21.89 34.35 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.587 0.755 . . . . 64.33 111.034 173.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.83 -179.79 44.38 Favored Glycine 0 C--N 1.351 1.362 0 N-CA-C 113.987 0.355 . . . . 63.4 113.987 170.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 11.7 t -156.79 35.37 0.3 Allowed 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.028 0.931 . . . . 74.43 109.991 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -77.83 151.27 34.02 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 115.463 -0.79 . . . . 71.41 110.291 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.47 172.23 7.1 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.219 0.608 . . . . 74.41 110.972 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -147.49 61.53 1.15 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.286 1.034 . . . . 74.45 108.214 170.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -74.08 148.26 42.04 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.324 -0.853 . . . . 72.51 110.209 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -70.39 96.41 1.14 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.76 0.791 . . . . 75.14 109.315 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 CA-C-N 115.016 -0.993 . . . . 73.42 110.053 -176.917 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 48.8 tpp . . . . . 0 N--CA 1.473 0.675 0 N-CA-C 109.699 -0.482 . . . . 73.25 109.699 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 32.5 t -159.85 154.02 23.47 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.517 0.727 . . . . 71.25 109.728 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -159.72 117.11 2.63 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.985 -0.746 . . . . 73.51 108.985 170.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -146.09 -71.03 0.25 Allowed 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.201 -1.407 . . . . 51.31 107.201 166.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 60.43 178.08 0.1 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.253 1.021 . . . . 75.3 110.725 -176.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 40.5 t30 66.32 154.25 0.08 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.788 0.835 . . . . 74.33 110.758 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 5.6 m 56.43 32.74 21.23 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-O 122.076 0.941 . . . . 75.32 109.982 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -81.87 46.34 0.98 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.474 1.11 . . . . 75.33 110.933 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.653 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 0.0 OUTLIER 63.13 112.87 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.068 1.747 . . . . 75.41 110.731 -172.567 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 72.6 m -87.6 93.19 9.36 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.924 -1.139 . . . . 52.33 107.924 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.653 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 0.9 OUTLIER -123.02 129.55 51.65 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.643 -0.708 . . . . 74.23 110.161 -173.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -148.74 126.24 11.65 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.152 -1.425 . . . . 75.22 107.152 173.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.477 HG13 ' HD3' ' A' ' 130' ' ' PRO . 65.2 mt -78.35 123.48 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 109.336 -0.616 . . . . 62.42 109.336 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -86.03 -43.11 13.39 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.331 -0.849 . . . . 74.21 110.315 -177.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -178.79 124.92 0.1 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.554 0.534 . . . . 63.41 110.23 -174.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 97.0 mt -114.03 143.64 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 108.263 -1.014 . . . . 75.53 108.263 175.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.461 ' HH ' HD11 ' C' ' 83' ' ' ILE . 31.3 p90 -174.82 172.7 2.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.34 1.056 . . . . 74.34 109.411 -170.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 66.6 p -96.94 126.06 41.81 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.844 0.458 . . . . 70.42 110.085 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.458 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 27.6 mmtp -76.37 -49.08 17.72 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.196 -1.038 . . . . 74.53 108.196 169.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 11.7 t70 -135.38 147.45 49.05 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 113.858 -1.519 . . . . 73.35 109.473 -170.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.52 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.5 mt -144.09 145.75 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 106.542 -1.651 . . . . 75.33 106.542 172.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -160.16 152.12 20.28 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.294 0.568 . . . . 74.05 110.397 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 70.0 t80 -149.87 136.59 19.3 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.356 -1.35 . . . . 74.41 107.356 175.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -138.96 127.83 23.58 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.346 0.658 . . . . 72.52 109.92 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.77 80.36 5.59 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 107.336 -1.357 . . . . 74.43 107.336 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.44 -35.53 38.84 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.749 2.299 . . . . 72.32 112.094 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -92.29 21.9 4.88 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.547 -1.206 . . . . 75.41 111.217 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.59 -49.44 45.83 Favored Pre-proline 0 CA--C 1.564 1.506 0 N-CA-C 113.849 1.055 . . . . 72.42 113.849 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.41 -44.23 34.54 Favored 'Trans proline' 0 C--N 1.388 2.614 0 CA-C-N 121.584 1.601 . . . . 72.42 112.652 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.401 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 86.4 t60 -69.34 -32.53 71.68 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.072 -0.967 . . . . 75.44 112.56 -175.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.708 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.9 p -78.68 -25.1 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 N-CA-C 112.695 0.628 . . . . 74.22 112.695 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -71.44 -16.02 62.36 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 112.811 0.671 . . . . 72.53 112.811 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 14.0 pt20 -94.9 19.17 10.62 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.282 0.633 . . . . 72.43 110.837 175.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.682 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -109.88 159.66 17.04 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.859 0.864 . . . . 75.15 110.576 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -82.11 131.04 35.24 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.118 0.967 . . . . 65.32 108.982 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -77.05 82.86 3.56 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.261 1.024 . . . . 72.33 112.341 -170.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -126.33 69.84 68.98 Favored Pre-proline 0 N--CA 1.484 1.235 0 C-N-CA 124.087 0.955 . . . . 75.25 109.865 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -88.96 135.06 2.72 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.864 2.376 . . . . 74.32 112.529 -173.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -86.44 115.79 24.17 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 106.902 -1.518 . . . . 74.2 106.902 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.2 t -79.49 100.2 3.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 108.911 -0.774 . . . . 75.42 108.911 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.623 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 4.3 mptp? -90.1 99.63 12.61 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.362 -1.718 . . . . 74.21 106.362 170.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 pp -95.52 145.01 25.52 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.867 -0.79 . . . . 74.44 108.867 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.427 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 23.0 t70 -142.86 145.29 32.99 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.845 -0.798 . . . . 64.13 108.845 -177.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.561 HD11 HD11 ' G' ' 8' ' ' LEU . 3.1 mm? -121.06 113.65 20.35 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.699 0.8 . . . . 73.52 109.312 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -113.59 163.03 15.48 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.267 1.427 . . . . 40.25 107.831 171.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.4 t -144.58 153.83 42.21 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.32 0.581 . . . . 75.01 111.27 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.91 152.17 41.78 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.039 1.336 . . . . 73.41 107.707 172.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.9 p -167.33 167.54 13.92 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 120.996 0.427 . . . . 73.42 111.454 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 69.9 p -161.21 153.61 20.28 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.063 -0.971 . . . . 71.41 109.011 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -88.54 124.11 33.71 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.26 -1.015 . . . . 72.04 108.26 168.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.437 HD13 HD13 ' C' ' 83' ' ' ILE . 64.9 mt -92.74 -38.67 11.68 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.521 0.728 . . . . 71.31 110.755 -176.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.07 178.03 10.82 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.515 0.726 . . . . 75.43 110.7 -178.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -60.65 117.93 5.95 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.401 0.68 . . . . 75.15 109.811 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 70.01 -6.71 1.05 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 125.827 1.651 . . . . 73.01 113.596 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.55 111.67 27.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.932 -1.136 . . . . 65.2 107.932 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -127.78 134.89 49.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.299 -0.63 . . . . 72.41 109.299 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -92.24 126.89 37.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.895 -1.048 . . . . 74.41 109.679 177.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 72.9 t -116.4 116.05 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 107.739 -1.208 . . . . 74.44 107.739 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 38.9 t -116.01 132.57 65.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 108.746 -0.835 . . . . 74.32 108.746 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 54.3 tp -116.72 112.85 21.78 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.504 -0.924 . . . . 75.5 108.504 175.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.565 ' HB2' ' HG2' ' C' ' 79' ' ' GLN . 50.4 ttm-85 -91.62 111.02 22.36 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.882 -0.784 . . . . 73.42 108.882 173.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.537 ' HB ' HD11 ' C' ' 114' ' ' ILE . 20.8 t -99.33 129.16 50.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 N-CA-C 107.785 -1.191 . . . . 73.23 107.785 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 16.5 m -123.05 118.97 28.97 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.114 -0.698 . . . . 72.54 109.114 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 65.4 t -113.55 108.62 25.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-N 114.571 -1.195 . . . . 74.52 108.749 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.623 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 16.5 m -98.25 140.41 32.59 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.873 -1.158 . . . . 72.31 107.873 171.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.48 121.24 28.45 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.169 -1.419 . . . . 72.51 107.169 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 51.0 m -132.43 126.34 32.85 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.941 0.337 . . . . 74.05 110.68 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.655 HD11 ' HG2' ' C' ' 34' ' ' LYS . 10.3 mt -85.49 42.83 0.98 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.562 1.145 . . . . 72.23 109.7 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.03 -113.67 4.51 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 111.108 -0.797 . . . . 70.24 111.108 -172.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.83 -18.6 28.94 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.535 0.734 . . . . 64.43 110.044 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -80.04 120.75 24.63 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.392 1.077 . . . . 74.12 109.145 172.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 99.0 m -78.93 123.01 26.84 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.476 -0.935 . . . . 71.12 108.476 164.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.708 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.16 -56.72 5.51 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.649 0.593 . . . . 70.24 109.614 175.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -158.47 168.94 25.6 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.927 0.87 . . . . 71.44 111.392 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -128.08 141.53 51.47 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 105.859 -1.904 . . . . 72.21 105.859 166.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 37.3 t -145.36 136.85 25.18 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.427 -1.323 . . . . 74.01 107.427 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -156.24 121.14 4.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.532 0.206 . . . . 74.51 110.465 -168.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 84.7 t -132.59 135.56 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.644 0.778 . . . . 74.41 109.671 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.565 ' HG2' ' HB2' ' C' ' 61' ' ' ARG . 20.7 mt-30 -96.89 108.19 20.84 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.657 -0.868 . . . . 64.43 108.657 164.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -90.62 104.24 16.85 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.638 -0.875 . . . . 72.53 108.638 172.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.75 145.55 22.76 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.511 -0.768 . . . . 71.33 111.475 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.2 115.48 0.72 Allowed Glycine 0 CA--C 1.504 -0.656 0 N-CA-C 110.157 -1.177 . . . . 63.24 110.157 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.461 HD11 ' HH ' ' C' ' 17' ' ' TYR . 15.8 mm -83.76 121.74 36.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.886 -1.153 . . . . 73.43 107.886 175.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -129.04 119.35 24.07 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.851 -0.796 . . . . 72.21 108.851 -174.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 57.3 p -77.35 107.71 9.96 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.264 -1.013 . . . . 75.3 108.264 170.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.512 HD11 HG23 ' G' ' 18' ' ' VAL . 6.7 tt -116.25 131.91 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.831 1.252 . . . . 75.42 108.997 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.02 171.03 20.8 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.913 0.885 . . . . 71.51 110.087 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.73 -58.44 3.71 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 112.228 -0.349 . . . . 65.21 112.228 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.623 HD12 ' HG2' ' C' ' 9' ' ' MET . 36.2 pt -84.76 158.61 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.276 0.631 . . . . 74.24 110.669 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -149.9 164.71 34.68 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.839 0.855 . . . . 74.35 109.363 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' G' ' 21' ' ' ALA . . . 64.79 -125.31 30.4 Favored Glycine 0 C--N 1.346 1.094 0 C-N-CA 123.197 0.427 . . . . 72.31 113.69 171.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 45.5 p -56.43 -34.75 67.1 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.841 1.256 . . . . 75.02 112.531 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -73.47 -38.57 65.38 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.763 0.425 . . . . 73.45 111.592 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.547 ' SD ' ' HB ' ' G' ' 18' ' ' VAL . 47.3 mtt -62.15 -49.03 77.47 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.496 -0.557 . . . . 74.51 109.496 171.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.66 -35.88 71.14 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.787 0.835 . . . . 74.24 111.286 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -64.41 -46.55 82.79 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.292 1.037 . . . . 64.15 110.739 173.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.539 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 24.2 t -64.06 -42.02 97.16 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.497 -0.774 . . . . 54.44 111.465 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.678 HD13 HG21 ' G' ' 18' ' ' VAL . 70.9 mt -85.37 -36.7 20.57 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.567 0.747 . . . . 73.44 111.706 -170.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.95 11.52 58.95 Favored Glycine 0 N--CA 1.474 1.168 0 CA-C-N 116.206 -0.452 . . . . 55.43 114.009 -171.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.43 -60.07 0.14 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.54 0.686 . . . . 75.11 110.616 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.539 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 83.1 t80 -75.79 -35.45 60.07 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 125.138 1.375 . . . . 74.4 113.49 -168.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 91.3 m -79.07 -41.68 1.64 Allowed Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 123.169 0.588 . . . . 75.32 111.49 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.58 -33.37 30.71 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 122.626 2.217 . . . . 75.34 113.705 166.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -66.02 -39.69 90.44 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.633 0.773 . . . . 74.5 111.399 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.46 HD13 HH12 ' A' ' 111' ' ' ARG . 50.6 mm -67.03 -42.64 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.127 0.571 . . . . 63.2 110.062 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 87.8 mt -88.36 -10.21 50.14 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.826 0.851 . . . . 72.21 112.209 -174.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -58.04 -55.29 46.76 Favored Pre-proline 0 N--CA 1.481 1.092 0 CA-C-O 117.892 -1.051 . . . . 72.32 112.493 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.14 -35.56 74.64 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 121.99 1.794 . . . . 74.32 113.158 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . 0.456 ' HE2' HG21 ' A' ' 115' ' ' THR . 91.6 m-85 -64.33 -54.43 33.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.485 0.714 . . . . 75.24 110.659 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.01 -39.13 91.23 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 114.803 -1.09 . . . . 71.21 110.501 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -56.0 -51.43 67.79 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.11 1.364 . . . . 75.4 110.453 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.49 -38.18 77.54 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 123.508 0.505 . . . . 75.24 109.802 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.1 t -64.41 -32.85 74.64 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 122.971 0.508 . . . . 73.22 111.639 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.537 HD11 ' HB ' ' C' ' 62' ' ' VAL . 97.4 mt -73.42 -56.14 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.832 0.853 . . . . 73.02 109.33 175.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 15.0 m -61.88 -27.25 68.67 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.936 0.895 . . . . 73.1 111.688 -175.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 47.6 t -68.03 -47.47 68.33 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.984 0.914 . . . . 74.21 109.71 174.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.647 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.82 -36.77 84.27 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.849 0.86 . . . . 73.44 111.596 178.052 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.5 t -63.35 -39.46 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.377 0.671 . . . . 72.43 110.011 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.6 t -73.06 -29.52 63.03 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.845 0.858 . . . . 75.14 112.061 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' C' ' 116' ' ' SER . 85.4 mtt-85 -71.66 -39.48 70.29 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.014 -0.735 . . . . 75.01 109.014 176.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.18 2.55 60.98 Favored Glycine 0 C--N 1.36 1.874 0 O-C-N 124.103 0.877 . . . . 75.12 112.61 172.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.2 p 61.81 26.35 15.98 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.89 2.076 . . . . 73.33 113.545 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -83.37 146.91 51.81 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 109.066 -0.716 . . . . 71.11 109.066 170.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.489 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 80.1 Cg_exo -49.86 138.21 34.43 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 123.329 2.686 . . . . 75.34 112.688 173.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.544 ' HA ' HE21 ' C' ' 125' ' ' GLN . 0.0 OUTLIER -60.11 111.36 1.48 Allowed 'General case' 0 C--N 1.354 0.761 0 O-C-N 123.955 0.784 . . . . 63.35 110.609 -176.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -105.88 88.05 2.72 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 104.587 -2.375 . . . . 74.03 104.587 174.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -92.34 126.19 37.32 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.261 -0.881 . . . . 71.14 109.046 -171.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.49 136.08 51.0 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 124.128 0.892 . . . . 72.12 109.881 -173.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.06 157.82 83.43 Favored Pre-proline 0 CA--C 1.551 0.996 0 O-C-N 124.148 0.905 . . . . 73.12 111.395 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -54.03 110.33 0.49 Allowed 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 123.03 2.487 . . . . 74.43 113.485 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.586 HG13 ' HB2' ' G' ' 8' ' ' LEU . 40.9 t -112.23 109.86 30.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.26 -0.644 . . . . 72.42 109.26 175.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -107.8 91.93 3.86 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 105.866 -1.901 . . . . 63.05 105.866 169.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -53.63 -43.27 68.58 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 124.319 1.012 . . . . 65.13 111.586 -172.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -60.75 -47.2 87.38 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 114.928 -1.033 . . . . 72.4 111.205 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.19 -22.19 63.91 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.119 -0.946 . . . . 75.12 111.74 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.83 -38.36 90.72 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.902 0.481 . . . . 74.01 110.849 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -66.88 -39.75 87.58 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 116.043 -0.526 . . . . 75.12 110.519 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 61.4 mtt -73.43 -30.98 63.57 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.947 0.899 . . . . 73.55 111.848 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -73.63 -38.0 65.17 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.598 0.759 . . . . 74.11 111.026 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -57.76 -86.28 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.133 0 O-C-N 124.344 1.027 . . . . 74.34 112.511 -170.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 9.2 mp 61.99 -74.35 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.519 1.127 . . . . 72.22 110.86 -171.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -158.68 -74.9 0.08 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.566 -0.902 . . . . 73.23 108.566 174.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -171.07 171.22 5.88 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.419 1.088 . . . . 72.44 108.491 -175.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 73.07 119.23 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.131 1.372 . . . . 63.35 111.355 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -153.31 -52.52 0.1 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.312 0.645 . . . . 71.52 110.0 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 110.53 -166.39 12.38 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.945 -0.57 . . . . 73.12 112.408 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.09 -154.26 0.54 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.565 1.146 . . . . 74.54 109.771 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.96 37.57 2.35 Favored Glycine 0 C--N 1.354 1.578 0 N-CA-C 114.922 0.729 . . . . 73.12 114.922 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 17.4 m 61.47 79.37 0.25 Allowed 'General case' 0 C--N 1.362 1.15 0 C-N-CA 125.108 1.363 . . . . 71.41 111.005 171.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 68.37 -75.63 0.06 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.814 1.246 . . . . 74.31 109.269 -171.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -178.71 -104.89 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.205 1.402 . . . . 73.13 107.692 172.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -162.1 -68.82 0.05 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.227 1.411 . . . . 75.41 108.223 -174.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 70.88 -4.29 1.77 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.624 1.57 . . . . 74.24 113.047 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -90.01 154.92 19.45 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.231 0.612 . . . . 73.41 110.461 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.182 0 C-N-CA 124.89 1.276 . . . . 71.42 108.296 172.769 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 108.94 -0.763 . . . . 74.21 108.94 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 55.5 p -162.8 75.66 0.42 Allowed 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.75 0.786 . . . . 64.13 109.982 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -88.5 67.65 8.59 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.08 0.943 . . . . 73.15 108.974 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -160.66 134.57 7.02 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 106.677 -1.601 . . . . 64.45 106.677 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 64.57 -164.14 0.25 Allowed 'General case' 0 CA--C 1.566 1.576 0 O-C-N 123.909 0.756 . . . . 64.22 109.472 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -57.39 106.44 0.33 Allowed 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 118.918 0.781 . . . . 72.41 110.113 170.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 39.8 p -71.25 -9.16 57.65 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.252 1.021 . . . . 75.32 111.984 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.66 -25.23 68.12 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.287 1.035 . . . . 53.24 111.169 173.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.479 ' HB2' HG12 ' D' ' 89' ' ' ILE . 14.6 ptm -30.42 140.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 125.38 1.472 . . . . 73.45 114.053 173.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 96.1 m -105.92 143.01 34.67 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.475 1.11 . . . . 74.34 110.047 -175.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.627 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 62.6 t80 -154.66 93.09 1.54 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 107.433 -1.321 . . . . 74.12 107.433 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -120.5 115.34 23.26 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.441 -0.948 . . . . 74.22 108.441 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.512 HG21 HD11 ' D' ' 16' ' ' ILE . 11.2 mt -74.0 134.31 29.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 109.952 -0.388 . . . . 73.02 109.952 -175.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -93.83 -46.42 7.21 Favored 'General case' 0 C--O 1.241 0.656 0 O-C-N 123.426 0.454 . . . . 72.14 110.675 175.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -167.18 142.7 4.13 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.66 0.615 . . . . 75.44 112.66 -165.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.512 HD11 HG21 ' D' ' 13' ' ' ILE . 3.0 mp -122.56 135.94 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.791 1.236 . . . . 75.55 107.725 171.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.416 ' HE1' HG13 ' D' ' 83' ' ' ILE . 25.2 p90 -163.63 157.14 19.0 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.671 0.789 . . . . 72.34 110.737 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.3 p -91.36 114.69 27.29 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.209 -0.905 . . . . 73.35 108.859 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -78.71 -44.88 22.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.354 -0.98 . . . . 74.3 108.354 175.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.569 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 14.1 t70 -135.62 139.38 43.75 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.374 -1.284 . . . . 74.04 109.577 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.647 HG21 ' HE1' ' C' ' 117' ' ' MET . 67.4 mt -138.06 151.23 25.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 124.968 1.307 . . . . 64.43 107.895 174.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -152.23 145.8 24.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.358 1.063 . . . . 75.01 108.986 172.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.52 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 84.9 t80 -152.27 133.41 14.31 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 105.584 -2.006 . . . . 74.12 105.584 173.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -141.79 139.56 32.81 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.353 -0.98 . . . . 72.44 108.353 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.89 89.78 20.31 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 107.646 -1.242 . . . . 71.53 107.646 176.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.2 -32.31 5.26 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 123.022 2.481 . . . . 73.44 113.935 -170.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -103.53 17.32 24.35 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.191 0.596 . . . . 75.41 110.32 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -38.76 -65.81 0.36 Allowed Pre-proline 0 CA--C 1.562 1.416 0 N-CA-C 115.235 1.568 . . . . 73.01 115.235 -159.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.53 -23.87 22.88 Favored 'Trans proline' 0 C--N 1.389 2.688 0 CA-C-N 121.849 1.696 . . . . 74.44 113.337 -173.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.456 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 4.7 t-160 -79.4 -39.01 33.51 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.11 0.964 . . . . 73.4 110.808 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.425 HG21 ' HA ' ' D' ' 73' ' ' ALA . 4.2 p -80.67 -18.68 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 122.537 0.335 . . . . 63.42 110.752 -170.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -62.54 -23.39 66.96 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.346 0.659 . . . . 74.02 112.623 173.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.456 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 55.1 mt-30 -60.33 -23.09 63.96 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.574 0.749 . . . . 72.52 110.603 175.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.535 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 89.1 mttt -92.54 82.14 4.84 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.151 1.381 . . . . 71.11 109.657 176.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.19 84.31 7.72 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.231 0.613 . . . . 74.32 110.353 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.2 p90 -156.82 -178.97 7.76 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.35 0.66 . . . . 74.53 109.343 170.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -66.76 109.84 4.05 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.457 1.103 . . . . 71.25 110.455 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.75 137.68 64.83 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.259 1.973 . . . . 75.53 111.415 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -63.21 108.58 1.31 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.709 -0.849 . . . . 74.42 108.709 172.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.574 HG13 HG13 ' D' ' 64' ' ' VAL . 87.6 t -99.13 148.81 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.034 -1.098 . . . . 72.01 108.034 -175.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.551 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 34.6 ttpt -129.83 138.91 51.26 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.663 -0.866 . . . . 74.34 108.663 169.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.657 HD22 HD22 ' H' ' 8' ' ' LEU . 53.7 tp -109.05 112.2 24.26 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.277 -1.008 . . . . 73.34 108.277 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.606 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 71.9 m-20 -111.37 120.95 43.92 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.316 1.046 . . . . 75.32 108.412 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -100.36 128.01 46.53 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.846 -0.428 . . . . 65.33 109.846 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.517 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 9.1 t70 -133.1 157.79 44.41 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 105.75 -1.945 . . . . 74.04 105.75 172.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.3 t -146.96 161.11 41.45 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.144 0.497 . . . . 72.23 111.761 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -163.01 169.41 19.63 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.187 1.395 . . . . 71.51 108.771 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 19.1 p -176.82 -179.75 0.99 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 112.454 0.538 . . . . 65.21 112.454 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 52.2 p -164.77 147.52 8.52 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.624 1.17 . . . . 62.23 109.245 172.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -82.42 119.22 23.9 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.275 -1.009 . . . . 72.04 108.275 171.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.519 HD13 HG22 ' D' ' 83' ' ' ILE . 21.1 mt -89.82 -31.3 17.44 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.779 0.432 . . . . 74.34 110.718 -173.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.73 178.33 8.57 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.22 1.008 . . . . 55.2 109.696 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -73.59 129.36 37.8 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.808 -0.812 . . . . 74.35 108.808 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 69.65 10.59 7.66 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.983 1.313 . . . . 72.41 111.311 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 87.7 t -132.67 118.23 33.65 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 124.034 0.934 . . . . 71.15 108.978 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -140.91 131.25 25.09 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.77 -0.826 . . . . 73.24 108.77 -174.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.423 ' HB2' HD11 ' D' ' 51' ' ' LEU . 31.2 tt0 -91.27 143.57 26.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.669 -1.15 . . . . 75.11 109.941 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.476 HG22 ' HE1' ' D' ' 84' ' ' PHE . 3.9 m -121.49 139.48 48.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 107.887 -1.153 . . . . 75.35 107.887 167.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 23.7 t -127.94 124.51 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 108.328 -0.99 . . . . 65.22 108.328 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.503 HD22 ' HG3' ' D' ' 103' ' ' PRO . 3.9 mm? -118.23 114.07 22.46 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.358 0.663 . . . . 74.45 109.497 -176.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.517 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 22.0 ttm-85 -86.22 99.62 11.68 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.67 0.788 . . . . 73.42 109.609 176.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 85.7 t -91.2 115.04 29.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 108.357 -0.979 . . . . 72.01 108.357 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 9.1 m -115.46 129.09 56.44 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.358 0.599 . . . . 74.44 109.701 -175.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.574 HG13 HG13 ' D' ' 40' ' ' VAL . 24.5 t -118.13 101.56 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.005 1.722 . . . . 75.44 108.693 -177.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 51.5 m -95.57 93.92 7.45 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.467 -0.938 . . . . 75.12 108.467 176.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.38 143.62 27.94 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.373 0.669 . . . . 72.11 110.163 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.404 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 13.7 m -149.3 124.39 10.07 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 123.027 0.531 . . . . 72.03 110.914 -174.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 17.9 mt -94.86 104.76 16.65 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.076 -0.712 . . . . 72.01 109.076 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.24 -120.87 5.26 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.832 -0.622 . . . . 70.44 111.948 -176.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.09 2.28 29.25 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.389 0.676 . . . . 71.35 111.296 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.535 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 13.1 pt-20 -124.11 163.45 21.47 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.315 0.646 . . . . 74.33 109.863 -175.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 16.0 m -68.6 137.42 54.25 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 123.772 0.67 . . . . 73.43 111.503 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.425 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -92.43 -65.41 1.0 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.408 -1.33 . . . . 70.22 107.408 170.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -155.98 143.71 19.56 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 115.787 -0.642 . . . . 74.5 110.619 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 59.6 mt -106.74 109.97 22.02 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.264 -1.013 . . . . 73.01 108.264 173.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.447 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 40.7 t -115.4 143.83 44.7 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.304 -0.998 . . . . 73.35 108.304 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -156.77 127.72 6.8 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.931 0.492 . . . . 75.12 109.895 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -132.41 119.18 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 122.972 0.509 . . . . 65.51 109.879 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.569 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.5 mt-30 -88.79 88.74 7.71 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.848 -0.797 . . . . 71.03 108.848 168.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -80.24 106.44 12.25 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.308 -1.315 . . . . 75.2 108.501 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.32 147.89 16.62 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.408 -0.677 . . . . 64.42 111.408 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.28 136.99 6.57 Favored Glycine 0 C--N 1.331 0.284 0 N-CA-C 111.539 -0.625 . . . . 63.22 111.539 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.519 HG22 HD13 ' D' ' 51' ' ' LEU . 54.1 mt -91.04 126.47 43.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 C-N-CA 123.728 0.811 . . . . 74.1 108.884 174.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . 0.476 ' HE1' HG22 ' D' ' 58' ' ' VAL . 64.9 m-85 -131.79 131.77 43.2 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.765 0.426 . . . . 74.11 110.321 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 15.3 m -84.5 103.96 14.09 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.519 0.727 . . . . 74.21 109.242 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.563 HD13 HD23 ' D' ' 98' ' ' LEU . 37.7 pt -114.13 127.08 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.869 0.867 . . . . 72.35 110.024 -177.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.74 148.92 29.13 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.598 0.359 . . . . 73.14 110.641 -174.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.17 15.99 76.82 Favored Glycine 0 C--N 1.345 1.077 0 O-C-N 123.391 0.432 . . . . 70.34 113.271 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.479 HG12 ' HB2' ' D' ' 9' ' ' MET . 41.3 mt -97.19 148.65 5.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 109.268 -0.641 . . . . 72.21 109.268 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.631 ' HA ' ' HE2' ' D' ' 94' ' ' MET . 2.3 pt-20 -162.02 178.48 8.8 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.394 1.078 . . . . 71.11 109.963 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.29 -144.43 44.41 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 115.286 -0.87 . . . . 74.53 113.747 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 2.8 p -82.62 -10.64 58.86 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.599 0.76 . . . . 73.21 111.751 176.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -27.63 68.5 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 109.458 -0.571 . . . . 74.41 109.458 174.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.631 ' HE2' ' HA ' ' D' ' 90' ' ' GLU . 40.9 mtt -54.03 -43.42 70.14 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.195 0.598 . . . . 74.53 110.913 171.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.05 -46.18 62.48 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.696 -1.138 . . . . 71.21 110.939 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -64.32 -37.26 86.88 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.996 0.519 . . . . 65.11 111.702 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . 0.405 ' O ' ' SG ' ' D' ' 102' ' ' CYS . 47.9 t -62.03 -48.51 79.97 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.794 0.684 . . . . 60.02 110.553 -174.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.563 HD23 HD13 ' D' ' 86' ' ' ILE . 66.1 mt -98.1 -24.8 15.17 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.359 -0.837 . . . . 63.1 112.163 -169.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.04 -3.75 56.78 Favored Glycine 0 N--CA 1.47 0.925 0 CA-C-O 119.83 -0.428 . . . . 73.52 113.705 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.77 -55.35 0.33 Allowed 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.317 0.558 . . . . 71.02 111.74 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -72.81 -42.77 63.52 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 112.492 0.552 . . . . 74.41 112.492 -168.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.627 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 60.2 m -70.49 -45.66 18.77 Favored Pre-proline 0 CA--C 1.562 1.439 0 CA-C-O 119.07 -0.49 . . . . 71.02 110.881 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.503 ' HG3' HD22 ' D' ' 60' ' ' LEU . 72.7 Cg_exo -53.51 -33.78 69.41 Favored 'Trans proline' 0 C--N 1.394 2.922 0 C-N-CA 122.587 2.191 . . . . 73.5 113.922 168.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -64.98 -40.2 94.61 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.577 0.751 . . . . 74.42 110.078 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.446 HG21 HD12 ' D' ' 13' ' ' ILE . 49.3 mm -60.02 -42.83 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 115.913 -0.585 . . . . 65.11 109.726 173.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.436 HD12 HD23 ' D' ' 60' ' ' LEU . 83.9 mt -80.19 -15.31 57.32 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.004 -0.998 . . . . 61.22 112.558 -172.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -62.7 -48.82 85.05 Favored Pre-proline 0 CA--C 1.563 1.457 0 N-CA-C 113.207 0.817 . . . . 73.2 113.207 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -56.35 -35.56 96.18 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 122.097 1.865 . . . . 72.32 112.955 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -78.61 -29.66 46.12 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.017 0.927 . . . . 74.41 111.978 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.34 -48.03 68.71 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.735 -0.839 . . . . 71.14 108.735 174.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -65.08 -33.54 76.28 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.376 -1.283 . . . . 74.11 110.489 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -54.48 -58.52 7.13 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.067 0.947 . . . . 75.31 110.632 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.15 -45.13 89.84 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.693 -1.14 . . . . 73.04 111.271 -174.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.443 ' O ' HG23 ' D' ' 118' ' ' VAL . 79.8 mt -59.79 -62.06 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.576 0.75 . . . . 72.35 110.87 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.422 HG22 ' HG3' ' D' ' 125' ' ' GLN . 57.9 m -52.82 -38.38 61.22 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.347 1.059 . . . . 74.23 111.97 -175.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.0 t -66.73 -46.6 74.93 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.244 -0.889 . . . . 64.13 110.767 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.447 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 71.5 mtm -67.61 -30.02 69.5 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.782 0.433 . . . . 64.23 111.613 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.443 HG23 ' O ' ' D' ' 114' ' ' ILE . 91.2 t -63.62 -49.99 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 O-C-N 123.786 0.679 . . . . 71.23 109.819 174.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.8 p -69.06 -31.52 70.34 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 116.139 -0.482 . . . . 64.21 110.97 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 77.6 mtt-85 -69.79 -35.51 74.92 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.87 0.868 . . . . 73.54 110.384 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.59 2.62 85.26 Favored Glycine 0 C--N 1.351 1.376 0 O-C-N 123.733 0.646 . . . . 75.41 112.347 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.401 HG23 HE21 ' A' ' 125' ' ' GLN . 22.8 p 57.17 35.76 26.64 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.629 1.971 . . . . 72.42 113.384 176.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -94.7 159.41 33.53 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.267 1.027 . . . . 75.52 110.035 172.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.84 123.2 12.49 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.009 2.473 . . . . 65.32 112.774 170.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.422 ' HG3' HG22 ' D' ' 115' ' ' THR . 34.2 tt0 -53.47 142.73 21.31 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.148 1.379 . . . . 64.34 112.583 -176.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 66.4 tp -125.81 106.27 9.56 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.768 0.827 . . . . 75.42 109.735 -174.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -116.53 95.92 5.27 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.651 0.78 . . . . 73.11 109.517 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.429 ' HA ' HD12 ' H' ' 6' ' ' ILE . 6.2 mp -66.71 116.93 8.17 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.981 -0.748 . . . . 74.31 108.981 175.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.09 143.86 77.43 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 123.746 0.818 . . . . 71.43 110.626 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.26 107.82 2.53 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.625 2.216 . . . . 62.43 110.524 -174.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' H' ' 7' ' ' ALA . 27.7 m -107.47 140.3 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.254 0.622 . . . . 74.45 110.185 -174.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -83.99 79.42 9.5 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.865 0.84 . . . . 74.55 109.116 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -76.17 -18.74 58.96 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.785 -1.098 . . . . 75.23 110.962 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' D' ' 138' ' ' MET . 1.7 m-20 -50.77 -47.73 59.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.519 1.128 . . . . 72.01 111.412 171.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.67 -44.12 97.56 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.802 0.841 . . . . 71.14 111.82 -176.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 53.6 tp -63.26 -36.21 82.91 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.538 -0.755 . . . . 74.12 110.715 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.424 ' O ' HD12 ' D' ' 141' ' ' LEU . 38.4 t80 -72.73 -32.29 65.59 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.294 -0.866 . . . . 71.53 110.278 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.463 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 39.9 mtt -67.45 -29.45 68.91 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.578 0.751 . . . . 73.32 110.701 176.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -59.04 -29.59 67.4 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.604 0.761 . . . . 72.25 110.824 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -86.31 -32.65 20.92 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.743 0.817 . . . . 74.53 110.302 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.424 HD12 ' O ' ' D' ' 137' ' ' PHE . 7.7 mp -83.54 -25.97 30.54 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.651 1.18 . . . . 73.32 113.594 -175.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -65.98 2.84 0.96 Allowed 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 114.913 1.449 . . . . 74.53 114.913 -167.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.23 40.74 2.78 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.057 -0.72 . . . . 73.54 109.057 -174.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 174.51 146.12 0.06 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-N 113.464 -1.698 . . . . 70.43 107.663 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -142.56 -77.38 0.25 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.189 -1.412 . . . . 72.25 107.189 172.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 72.38 56.63 6.06 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 116.094 -0.503 . . . . 75.54 113.158 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -67.83 120.87 14.85 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.678 -0.49 . . . . 72.43 109.678 173.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.81 88.95 0.46 Allowed Glycine 0 C--N 1.345 1.051 0 N-CA-C 110.547 -1.021 . . . . 73.1 110.547 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 41.4 p -73.98 74.87 1.69 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.813 0.845 . . . . 73.23 110.532 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.81 137.99 31.87 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 114.919 -1.037 . . . . 64.24 108.304 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.48 134.53 53.6 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 107.964 -1.124 . . . . 75.33 107.964 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -57.82 -32.7 67.84 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.859 0.864 . . . . 73.2 112.686 -171.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 53.53 73.42 0.37 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.73 1.212 . . . . 72.42 110.809 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -81.22 153.86 26.94 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.248 -0.887 . . . . 74.31 110.213 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.235 0 C-N-CA 123.618 0.767 . . . . 70.54 108.933 -176.677 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 61.9 mtt . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 109.7 -0.481 . . . . 75.53 109.7 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -167.69 150.26 5.83 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.972 0.909 . . . . 71.51 109.247 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.64 101.08 5.16 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.007 -1.108 . . . . 75.11 108.007 177.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 42.8 t -69.9 95.55 0.93 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 109.316 -0.624 . . . . 71.24 109.316 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 11.6 t -71.55 -17.24 62.32 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.046 -0.979 . . . . 61.34 111.56 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.413 HG21 HD12 ' A' ' 126' ' ' LEU . 10.1 pt -89.96 90.55 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 123.939 0.896 . . . . 74.35 110.922 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 7' ' ' ALA . . . . . 0.502 ' HA ' ' HB3' ' A' ' 129' ' ' ALA . . . -110.4 -39.8 4.84 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.058 0.943 . . . . 75.32 109.95 176.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 tt 77.0 130.65 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.982 1.713 . . . . 71.31 110.591 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 9' ' ' ALA . . . . . 0.498 ' H ' HD12 ' A' ' 42' ' ' LEU . . . -84.14 159.13 21.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.724 0.81 . . . . 74.23 111.112 -175.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 8.7 mp -71.8 172.16 10.34 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.64 0.376 . . . . 73.32 110.163 172.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 78.7 mt -54.57 112.23 3.76 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.437 0.695 . . . . 72.34 110.799 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.76 -19.14 18.76 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.999 2.466 . . . . 74.1 111.602 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 4.2 mp -114.8 159.12 20.99 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.249 1.02 . . . . 75.15 109.491 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 95.7 mt -82.11 141.03 33.47 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.98 0.512 . . . . 73.11 109.871 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -80.8 134.37 35.78 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.557 -0.534 . . . . 71.24 109.557 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 12.4 p -64.7 114.71 15.61 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 123.959 0.903 . . . . 75.52 110.126 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 17' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.91 -179.27 5.24 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.714 2.276 . . . . 75.35 112.788 -171.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 55.8 t -86.94 141.87 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 123.51 0.724 . . . . 61.33 109.185 173.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 38.4 p -70.75 75.7 0.61 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.006 0.922 . . . . 53.1 109.691 173.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? 176.93 -47.19 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.142 1.377 . . . . 74.44 108.177 -171.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.55 115.64 5.38 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 114.921 -1.036 . . . . 72.11 111.276 -175.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -76.6 164.2 26.15 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.627 -0.508 . . . . 74.42 109.627 169.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 81.8 p -63.36 151.12 88.1 Favored Pre-proline 0 CA--C 1.553 1.081 0 CA-C-N 115.405 -0.816 . . . . 71.24 111.757 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -61.36 93.88 0.11 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.635 2.223 . . . . 74.03 112.363 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 C--O 1.25 1.126 0 C-N-CA 124.589 1.155 . . . . 71.3 107.969 174.966 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 18.4 ptt? . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 110.369 -0.234 . . . . 70.21 110.369 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -74.46 106.45 6.07 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.562 0.745 . . . . 75.21 109.839 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -158.74 158.63 34.01 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.972 0.909 . . . . 75.04 109.962 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 34.0 m -103.52 11.07 36.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.808 0.843 . . . . 64.23 110.006 169.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 32.8 m 63.83 -78.13 0.03 OUTLIER 'General case' 0 C--N 1.36 1.061 0 C-N-CA 125.307 1.443 . . . . 75.24 109.945 -170.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 8.2 tt -175.67 -54.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 125.393 1.477 . . . . 72.43 108.826 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . 62.89 -167.46 0.21 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.003 1.321 . . . . 72.42 111.959 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 69.4 mt -123.89 -179.44 4.4 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.965 0.906 . . . . 71.52 109.337 169.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.4 177.05 9.77 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.245 1.018 . . . . 74.02 109.318 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 83.7 mt -62.08 156.71 20.74 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.894 0.478 . . . . 73.24 110.925 175.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.91 89.29 52.43 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 123.939 0.896 . . . . 74.42 109.406 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.58 44.86 1.77 Allowed 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 123.853 3.036 . . . . 73.2 112.557 -176.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.09 -50.9 2.94 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 108.539 -0.912 . . . . 73.01 108.539 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 85.1 mt 66.42 -175.36 0.19 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.326 1.451 . . . . 74.52 111.832 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . 0.49 ' HD2' ' HB ' ' B' ' 46' ' ' THR . 2.8 p90 -146.97 -178.76 6.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.756 0.822 . . . . 62.32 110.286 -173.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 53.6 p -68.4 130.89 91.95 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 123.931 0.892 . . . . 73.42 112.33 -173.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.72 136.88 76.77 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.737 2.291 . . . . 72.22 111.46 169.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 13.8 t -76.84 116.91 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 109.622 -0.511 . . . . 74.45 109.622 -172.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 38.9 m -63.07 -47.1 84.38 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.007 0.923 . . . . 74.22 111.022 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -103.04 60.12 0.77 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 122.104 0.954 . . . . 74.32 109.877 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.16 -21.59 1.84 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.531 -1.213 . . . . 74.54 108.964 166.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -55.08 137.39 46.65 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 125.057 1.343 . . . . 74.51 110.221 171.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 23' ' ' THR . . . . . 0.432 ' HA ' ' HD3' ' F' ' 24' ' ' PRO . 6.7 t -65.21 120.25 65.84 Favored Pre-proline 0 CA--C 1.554 1.097 0 N-CA-C 109.366 -0.605 . . . . 75.22 109.366 173.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 24' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' F' ' 23' ' ' THR . 3.8 Cg_exo -79.29 9.26 3.46 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.686 2.258 . . . . 75.01 112.902 -174.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 C--O 1.251 1.161 0 C-N-CA 125.014 1.326 . . . . 71.13 111.43 179.208 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' G' G ' 1' ' ' MET . . . . . 0.499 ' N ' ' SD ' ' G' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 121.801 0.81 . . . . 71.22 111.2 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -116.21 76.76 1.04 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 107.99 -1.115 . . . . 71.3 107.99 170.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -138.47 25.27 2.65 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.342 1.057 . . . . 73.42 109.055 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 77.4 p -65.45 148.71 51.25 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.057 0.543 . . . . 75.4 109.9 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 7.5 m -59.49 122.86 15.07 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.76 0.824 . . . . 65.24 111.045 -173.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . . . . . . . . . 2.9 pp -67.44 140.26 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.304 0.642 . . . . 71.5 111.082 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 7' ' ' ALA . . . . . 0.408 ' HB1' HG22 ' C' ' 131' ' ' VAL . . . -156.23 152.85 28.29 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.642 0.777 . . . . 61.3 109.529 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 8' ' ' LEU . . . . . 0.586 ' HB2' HG13 ' C' ' 131' ' ' VAL . 48.2 mt -62.16 135.51 57.53 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.497 0.719 . . . . 74.5 109.905 177.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.21 -175.38 4.12 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.457 0.703 . . . . 73.31 111.71 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.86 158.97 29.25 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.548 0.739 . . . . 64.11 109.042 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 88.9 mt -106.26 97.83 17.4 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 123.027 0.531 . . . . 63.25 110.9 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.01 -13.77 13.93 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 122.58 2.187 . . . . 73.44 111.499 168.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.94 -36.87 83.21 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.0 0.92 . . . . 61.14 109.623 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 86.9 mt 63.53 -159.01 0.31 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.888 1.275 . . . . 74.14 111.248 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -146.34 153.6 40.71 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-O 120.899 0.381 . . . . 71.21 110.317 -174.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 22.0 p -66.33 164.85 27.2 Favored Pre-proline 0 CA--C 1.563 1.449 0 C-N-CA 126.173 1.789 . . . . 61.23 112.423 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 17' ' ' PRO . . . . . 0.678 ' HA ' ' HB2' ' G' ' 21' ' ' ALA . 67.3 Cg_endo -82.55 150.82 14.95 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.537 2.158 . . . . 72.51 114.607 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 18' ' ' VAL . . . . . 0.678 HG21 HD13 ' C' ' 98' ' ' LEU . 55.0 t -76.53 -44.85 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 108.427 -0.953 . . . . 73.14 108.427 164.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 28.8 m -132.41 -67.06 0.67 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.06 -0.973 . . . . 73.54 109.746 174.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 20' ' ' LYS . . . . . 0.559 ' HA ' ' HE3' ' G' ' 20' ' ' LYS . 0.3 OUTLIER -138.32 23.57 2.75 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.151 0.581 . . . . 73.03 110.716 -171.454 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . 0.678 ' HB2' ' HA ' ' G' ' 17' ' ' PRO . . . -60.6 -29.67 69.36 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.726 0.81 . . . . 64.53 113.051 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 22' ' ' ARG . . . . . 0.481 ' H ' ' HB3' ' G' ' 17' ' ' PRO . 0.1 OUTLIER -92.51 60.82 3.63 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.486 -0.931 . . . . 74.31 108.486 -179.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 70.1 m -54.17 101.58 0.27 Allowed Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 126.012 1.725 . . . . 71.42 112.093 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 24' ' ' PRO . . . . . 0.454 ' HD2' ' HG3' ' A' ' 153' ' ' GLN . 78.2 Cg_endo -75.43 160.24 38.94 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.632 2.222 . . . . 71.23 112.318 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 C--O 1.251 1.183 0 C-N-CA 123.968 0.907 . . . . 60.23 109.292 179.727 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' H' H ' 1' ' ' MET . . . . . 0.473 ' N ' ' SD ' ' H' ' 1' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.254 0 N-CA-C 108.773 -0.825 . . . . 71.44 108.773 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -171.22 131.09 0.76 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.864 0.865 . . . . 74.51 109.924 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -37.32 72.37 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.058 0.543 . . . . 75.41 111.662 -177.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 48.7 p -93.84 96.51 9.79 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 108.258 -1.016 . . . . 74.51 108.258 170.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 76.0 p -68.61 -29.12 67.56 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.521 1.128 . . . . 74.05 113.031 -170.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' D' ' 128' ' ' LEU . 29.0 mm -85.31 72.26 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 109.41 -0.589 . . . . 74.22 109.41 -177.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 7' ' ' ALA . . . . . 0.635 ' HA ' HG23 ' D' ' 131' ' ' VAL . . . -176.01 116.18 0.13 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.987 0.915 . . . . 62.55 110.191 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 8' ' ' LEU . . . . . 0.657 HD22 HD22 ' D' ' 42' ' ' LEU . 81.7 mt -75.73 74.27 2.7 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 109.193 -0.669 . . . . 65.32 109.193 171.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.5 100.41 11.88 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.177 0.591 . . . . 72.53 110.8 -173.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 82.2 mt 65.86 174.32 0.23 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.871 1.268 . . . . 75.03 111.917 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -154.29 149.86 21.22 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 109.008 -0.738 . . . . 72.25 109.008 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -45.34 126.39 8.23 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 124.253 3.302 . . . . 75.1 114.698 -174.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 49.3 tp 63.25 -91.95 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.352 1.461 . . . . 71.2 110.668 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -167.05 28.43 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 106.632 -1.618 . . . . 73.12 106.632 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 67.9 t80 58.41 -98.86 0.09 Allowed 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 114.819 -1.082 . . . . 74.45 109.694 -170.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 87.5 m -174.59 122.77 0.37 Allowed Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 126.055 1.742 . . . . 74.43 106.947 -175.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.26 169.07 19.1 Favored 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 122.487 2.125 . . . . 74.43 112.048 172.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . 0.49 HG21 HD11 ' D' ' 86' ' ' ILE . 44.7 t -62.3 -45.33 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 108.78 -0.822 . . . . 72.42 108.78 173.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 23.6 m 65.48 -71.96 0.08 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.974 1.71 . . . . 71.05 112.186 174.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -147.93 16.43 1.09 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.069 0.547 . . . . 74.32 110.611 -176.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.4 75.27 1.4 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.853 0.861 . . . . 64.45 111.219 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . 0.534 ' HG3' HG21 ' H' ' 23' ' ' THR . 20.3 ptt85 -174.95 -34.15 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.513 1.125 . . . . 74.1 110.267 -175.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 23' ' ' THR . . . . . 0.534 HG21 ' HG3' ' H' ' 22' ' ' ARG . 41.4 p -110.51 126.83 28.05 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.78 0.832 . . . . 73.35 109.519 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.71 135.06 61.44 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.438 2.759 . . . . 75.4 112.73 -171.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 . . . . . 0 CA--C 1.56 1.333 0 C-N-CA 123.579 0.751 . . . . 71.03 111.083 -177.607 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 111.774 0.287 . . . . 71.51 111.774 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.712 ' HA ' ' HB2' ' A' ' 151' ' ' GLU . 32.3 p -137.59 74.23 1.47 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.827 0.822 . . . . 60.44 109.901 -175.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -102.07 74.37 1.44 Allowed 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.261 -0.881 . . . . 71.42 109.776 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -83.43 129.53 34.99 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.519 -0.764 . . . . 72.43 109.413 174.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -71.62 -59.68 2.63 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.741 -0.837 . . . . 73.34 108.741 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -178.51 149.48 0.5 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.373 1.469 . . . . 43.45 108.241 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.2 p -86.46 126.47 34.43 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 109.292 -0.633 . . . . 73.43 109.292 172.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -71.4 149.76 45.65 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.581 -0.896 . . . . 74.34 108.581 169.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.6 tmt? 74.46 155.08 0.16 Allowed 'General case' 0 N--CA 1.485 1.316 0 O-C-N 124.407 1.067 . . . . 74.23 109.587 -174.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.4 m -138.28 120.62 15.91 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.595 -0.69 . . . . 73.41 110.089 -177.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.722 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 4.8 t80 -115.55 133.59 55.89 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.732 1.213 . . . . 74.11 108.283 177.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -152.1 108.44 3.43 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 123.744 0.653 . . . . 72.24 109.501 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.683 HD12 ' HB2' ' C' ' 130' ' ' PRO . 34.5 mt -76.96 125.73 37.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 109.664 -0.495 . . . . 71.51 109.664 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -86.29 -40.32 15.62 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 124.284 0.99 . . . . 73.12 110.113 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -175.38 121.75 0.2 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.489 0.316 . . . . 73.32 110.579 -174.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.6 mt -108.85 135.05 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.79 -0.818 . . . . 72.43 108.79 172.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -164.74 159.4 18.65 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 123.827 0.705 . . . . 74.34 111.784 -172.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.5 p -81.53 115.87 21.04 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.241 -0.89 . . . . 63.31 109.447 173.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -82.19 -25.92 33.83 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.43 -0.581 . . . . 75.45 109.43 174.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.547 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.4 t70 -148.38 142.29 25.8 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.167 -0.924 . . . . 74.54 109.676 176.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 69.1 mt -137.55 142.69 35.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 126.042 1.737 . . . . 72.21 106.617 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.0 t -155.0 135.73 13.58 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.186 0.594 . . . . 64.52 109.465 172.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -135.72 144.68 46.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.252 -1.388 . . . . 73.42 107.252 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -137.18 151.87 49.26 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.803 -0.814 . . . . 74.22 108.803 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.99 79.04 12.17 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 106.937 -1.505 . . . . 74.44 106.937 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.77 -33.93 42.1 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.844 2.363 . . . . 74.31 113.098 -167.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -107.62 24.68 12.52 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.752 0.821 . . . . 74.1 110.281 -176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.549 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -40.88 -62.94 0.86 Allowed Pre-proline 0 CA--C 1.574 1.902 0 CA-C-O 117.547 -1.216 . . . . 65.31 114.245 -167.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.549 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 39.1 Cg_exo -59.09 -29.78 91.48 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 122.4 2.067 . . . . 72.1 114.059 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -78.84 -41.54 29.79 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.692 0.797 . . . . 74.23 110.396 -177.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.594 HG22 ' HA ' ' A' ' 73' ' ' ALA . 4.2 p -77.36 -20.26 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.714 -1.13 . . . . 64.23 111.784 -161.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -70.97 -22.87 62.14 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.557 0.743 . . . . 71.0 110.923 175.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -83.84 -36.41 23.48 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.503 1.121 . . . . 75.04 109.676 175.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.44 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 2.9 tmtp? -67.3 146.98 53.57 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.456 1.502 . . . . 73.41 110.532 -173.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.44 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 7.9 m-20 -58.3 124.99 21.35 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.445 1.098 . . . . 72.01 111.266 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 50.9 t-105 -79.26 82.29 5.43 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.412 0.625 . . . . 74.01 109.733 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -123.24 80.6 52.39 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 108.093 -1.077 . . . . 75.22 108.093 176.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -83.55 124.4 3.58 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.489 2.126 . . . . 60.03 113.718 -168.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -95.9 92.09 6.34 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 106.76 -1.571 . . . . 75.3 106.76 167.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.658 HG22 HG23 ' E' ' 6' ' ' ILE . 16.0 m -79.81 112.41 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 113.911 -1.495 . . . . 64.41 110.965 -172.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.546 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 26.3 ttpp -95.56 112.61 24.3 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.71 -1.219 . . . . 74.45 107.71 171.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mp -98.47 107.4 19.85 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.092 -1.077 . . . . 74.13 108.092 -177.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.755 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 3.3 m-20 -104.02 135.34 45.72 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.691 -0.855 . . . . 63.44 108.691 -174.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.408 HD22 HD23 ' E' ' 8' ' ' LEU . 1.2 pp -137.3 145.35 43.34 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.35 0.66 . . . . 73.4 110.001 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.622 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 33.0 t70 -141.66 155.02 45.72 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 123.287 0.635 . . . . 73.1 109.937 -175.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.7 p -105.54 122.78 46.72 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.401 1.081 . . . . 73.2 110.413 -174.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.449 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -138.87 119.93 14.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.806 0.842 . . . . 72.13 109.032 175.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.9 t -131.91 153.28 50.42 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 122.967 0.507 . . . . 73.03 109.789 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' E' ' 22' ' ' ARG . 31.7 t -160.49 143.68 13.45 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.509 0.724 . . . . 60.23 110.318 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' E' ' 20' ' ' LYS . 54.5 tt0 -97.18 117.74 32.06 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.618 -0.882 . . . . 74.35 108.618 173.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.482 HD12 HG22 ' A' ' 83' ' ' ILE . 58.4 mt -85.61 -40.7 15.95 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.066 0.546 . . . . 75.12 109.857 177.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.59 176.44 12.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.285 -0.87 . . . . 72.44 110.379 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -69.05 122.8 19.46 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.505 -0.924 . . . . 60.34 108.505 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 74.92 -2.86 2.74 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.616 1.566 . . . . 72.14 112.115 -174.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.8 t -111.63 105.38 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.092 0.957 . . . . 72.41 108.698 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -124.95 127.61 47.32 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.967 0.907 . . . . 74.04 109.407 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -102.29 120.9 41.24 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.911 0.884 . . . . 75.32 109.958 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.447 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 43.2 t -102.3 129.17 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.038 -1.468 . . . . 72.3 107.038 171.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 54.0 t -122.5 120.05 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 108.55 -0.907 . . . . 73.34 108.55 174.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.444 HD23 HG21 ' A' ' 62' ' ' VAL . 1.0 OUTLIER -104.98 112.94 26.25 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.845 -1.168 . . . . 75.34 107.845 177.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.622 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 68.3 ttt180 -83.07 97.47 8.79 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.061 -1.459 . . . . 73.3 107.061 175.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.444 HG21 HD23 ' A' ' 60' ' ' LEU . 42.7 t -97.81 135.1 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 107.695 -1.224 . . . . 75.42 107.695 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.755 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 30.9 m -137.64 141.5 41.2 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.515 -0.55 . . . . 74.01 109.515 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.7 t -129.31 108.37 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 125.172 1.389 . . . . 75.3 107.337 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 29.3 m -102.25 138.06 39.69 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.999 -1.111 . . . . 75.23 107.999 175.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.5 106.05 10.28 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.661 -1.237 . . . . 71.21 107.661 173.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 59.0 m -111.13 123.31 49.94 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.836 -0.431 . . . . 71.3 109.836 177.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.488 HD13 ' HB1' ' A' ' 73' ' ' ALA . 12.8 mt -90.54 73.71 6.83 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 107.295 -1.372 . . . . 74.42 107.295 176.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.15 -122.83 6.19 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 110.851 -0.9 . . . . 73.05 110.851 -171.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -86.87 -24.98 24.71 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.661 0.785 . . . . 73.45 109.005 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -77.92 132.7 38.02 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.369 1.068 . . . . 73.11 109.772 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 70.1 m -89.25 133.23 34.54 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.238 0.472 . . . . 72.31 110.753 173.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.594 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -75.67 -62.61 1.52 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.803 0.841 . . . . 70.3 109.836 170.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.43 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 37.6 p90 -153.34 173.7 15.28 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.188 -0.914 . . . . 74.23 111.472 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.9 tp -133.59 139.95 46.84 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.731 -1.122 . . . . 65.01 108.479 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 71.4 m -134.69 97.48 3.79 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.917 0.887 . . . . 74.21 110.294 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -113.71 118.8 35.33 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.178 0.591 . . . . 63.5 109.738 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.2 t -128.15 113.64 31.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 124.142 0.977 . . . . 71.44 109.282 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 71.6 mt-30 -84.66 90.05 7.61 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.276 -1.009 . . . . 74.14 108.276 171.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -79.41 102.97 9.01 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.198 -0.91 . . . . 73.21 109.231 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.12 158.47 31.67 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 111.329 -0.708 . . . . 63.01 111.329 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.35 121.14 1.02 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.93 -0.868 . . . . 63.24 110.93 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.482 HG22 HD12 ' A' ' 51' ' ' LEU . 43.9 mt -81.65 120.87 34.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 108.117 -1.068 . . . . 71.14 108.117 171.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.722 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 46.1 m-85 -128.77 119.12 23.97 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.922 -0.77 . . . . 75.21 108.922 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.7 t -84.77 96.22 9.2 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.628 -0.879 . . . . 62.53 108.628 174.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.6 pt -112.58 135.66 51.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 124.518 1.127 . . . . 71.33 109.425 -177.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.34 165.64 34.25 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.444 0.697 . . . . 71.05 110.798 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.26 41.43 79.12 Favored Glycine 0 C--N 1.347 1.178 0 O-C-N 123.965 0.79 . . . . 73.41 111.908 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.508 HD12 HG21 ' E' ' 18' ' ' VAL . 14.9 pt -139.18 131.32 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 124.501 1.12 . . . . 73.4 110.165 -174.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -142.38 159.0 43.1 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.931 0.892 . . . . 72.45 110.209 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.2 -125.28 39.15 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 115.447 0.939 . . . . 64.23 115.447 170.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -78.73 -25.39 44.57 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.013 0.925 . . . . 73.02 111.001 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.24 -42.29 93.51 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.174 0.99 . . . . 74.52 109.216 178.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -78.63 -28.72 45.62 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 116.069 -0.514 . . . . 64.02 111.175 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.92 -25.04 65.28 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.225 0.61 . . . . 74.54 110.646 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -82.95 -35.04 26.33 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.274 0.63 . . . . 75.42 110.685 172.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 81.7 m -63.51 -47.66 80.79 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.129 0.572 . . . . 72.24 111.322 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.426 HD23 HG23 ' E' ' 18' ' ' VAL . 0.2 OUTLIER -82.84 -25.06 32.99 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.551 0.741 . . . . 73.33 109.59 177.647 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.45 -21.26 45.14 Favored Glycine 0 C--N 1.353 1.502 0 N-CA-C 115.263 0.865 . . . . 73.12 115.263 -170.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.83 -53.85 0.23 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 117.89 0.845 . . . . 73.05 111.837 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -57.7 -60.21 4.03 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 114.352 -1.294 . . . . 72.05 112.509 -171.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.6 m -74.5 -36.28 2.48 Favored Pre-proline 0 CA--C 1.568 1.661 0 N-CA-C 113.144 0.794 . . . . 74.34 113.144 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -50.83 -38.23 56.88 Favored 'Trans proline' 0 C--N 1.397 3.095 0 C-N-CA 122.767 2.311 . . . . 73.51 113.966 164.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -66.03 -38.87 89.51 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.711 0.804 . . . . 75.22 109.983 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.6 mm -58.84 -34.77 53.29 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 C-N-CA 123.784 0.833 . . . . 72.22 111.145 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 88.5 mt -76.27 -28.99 57.27 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.999 0.92 . . . . 73.25 112.665 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.561 ' HZ ' HD23 ' A' ' 128' ' ' LEU . 36.1 t80 -62.35 -44.28 87.61 Favored Pre-proline 0 CA--C 1.569 1.701 0 CA-C-O 117.806 -1.092 . . . . 61.43 113.811 -171.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.56 -31.79 87.47 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.339 2.026 . . . . 61.13 113.52 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.423 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 74.0 m-85 -78.19 -35.34 48.76 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.421 0.688 . . . . 74.23 112.028 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.45 -36.58 71.28 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.641 -0.503 . . . . 71.1 109.641 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.541 HH12 HD13 ' C' ' 105' ' ' ILE . 31.9 ttm180 -60.68 -43.77 97.3 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.557 1.143 . . . . 75.22 110.366 172.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -53.99 -54.31 40.86 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.555 1.142 . . . . 75.3 111.207 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 117' ' ' MET . 48.5 t -66.81 -45.85 77.04 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.586 -1.188 . . . . 73.44 111.297 -174.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.464 ' HA ' ' HE1' ' A' ' 117' ' ' MET . 61.6 mt -60.15 -51.89 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.749 0.82 . . . . 74.22 111.123 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.547 HG21 ' HE2' ' C' ' 109' ' ' TYR . 67.6 m -54.6 -44.19 72.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.884 0.874 . . . . 73.2 111.555 177.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 44.8 t -63.57 -41.5 98.38 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.651 -0.704 . . . . 73.4 111.166 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.468 ' HG3' ' O ' ' A' ' 113' ' ' CYS . 27.0 mtm -69.86 -37.81 76.22 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.94 0.496 . . . . 60.33 111.65 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.92 -50.62 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.38 0.672 . . . . 73.42 109.839 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.1 t -66.22 -31.35 72.13 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 114.801 -1.09 . . . . 74.45 111.192 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.458 ' HG2' ' HG1' ' B' ' 18' ' ' THR . 33.9 ttm-85 -77.5 -31.73 53.74 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.181 0.992 . . . . 64.1 109.404 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.41 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.8 12.15 57.78 Favored Glycine 0 C--N 1.355 1.595 0 CA-C-N 114.804 -1.089 . . . . 71.21 112.508 172.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.2 t 68.47 13.33 8.96 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 126.964 2.106 . . . . 75.43 113.852 169.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -81.76 155.44 70.72 Favored Pre-proline 0 CA--C 1.555 1.147 0 N-CA-C 108.705 -0.85 . . . . 74.11 108.705 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.04 163.76 13.54 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 122.892 2.395 . . . . 74.31 112.928 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -57.3 124.26 18.26 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 123.802 0.689 . . . . 74.25 111.315 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.43 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 66.0 tp -130.06 106.38 8.59 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.695 1.198 . . . . 71.25 109.098 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -119.15 117.34 28.41 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.163 0.985 . . . . 64.15 108.861 176.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.561 HD23 ' HZ ' ' A' ' 107' ' ' PHE . 2.4 tt -70.99 116.61 11.48 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 108.031 -1.1 . . . . 72.11 108.031 178.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.54 145.45 97.29 Favored Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 123.893 0.877 . . . . 73.25 111.021 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.459 ' HD3' HG13 ' C' ' 13' ' ' ILE . 84.6 Cg_endo -75.96 158.69 38.33 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.203 1.935 . . . . 75.44 112.694 -174.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' E' ' 7' ' ' ALA . 1.8 m -128.2 116.16 41.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 114.461 -1.245 . . . . 65.05 108.427 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.448 ' HB3' ' HB2' ' A' ' 135' ' ' ALA . 75.6 m-20 -72.94 82.69 1.22 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.359 0.664 . . . . 74.11 109.749 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -62.0 -53.33 57.03 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.404 0.621 . . . . 73.21 109.528 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.61 -42.92 81.61 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 113.661 -1.609 . . . . 74.44 111.005 -169.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 132' ' ' ASN . . . -63.2 -46.03 88.94 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 123.894 0.746 . . . . 72.3 110.634 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.4 HD22 ' HG ' ' E' ' 10' ' ' LEU . 6.4 tt -62.49 -41.32 98.72 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.738 0.815 . . . . 65.41 109.896 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -63.19 -37.03 85.62 Favored 'General case' 0 C--O 1.211 -0.941 0 O-C-N 123.733 0.646 . . . . 74.44 111.269 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.1 mmt -72.47 -39.47 67.7 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 118.013 0.37 . . . . 73.14 111.22 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -69.29 -19.22 63.9 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 122.885 0.474 . . . . 73.32 111.328 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -90.99 -46.62 8.04 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.064 0.459 . . . . 75.45 110.351 176.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.7 tp -69.67 -43.88 71.62 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.621 1.168 . . . . 73.1 112.468 -170.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -158.45 39.14 0.24 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.238 -0.437 . . . . 71.13 110.36 -163.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -42.92 77.83 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 124.586 1.154 . . . . 75.43 113.31 170.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -174.37 117.63 0.22 Allowed 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.891 1.276 . . . . 73.41 108.18 -173.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -126.48 129.68 49.14 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.801 0.84 . . . . 75.35 109.831 -177.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.44 -42.5 14.32 Favored Glycine 0 C--N 1.344 0.989 0 N-CA-C 110.539 -1.024 . . . . 43.14 110.539 169.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -155.59 172.59 18.02 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.384 0.674 . . . . 75.14 110.984 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -146.28 18.1 1.71 Allowed Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.643 -0.708 . . . . 54.41 112.526 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.47 110.96 10.28 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 123.217 0.607 . . . . 74.35 110.864 177.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.18 148.45 28.46 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.313 1.045 . . . . 72.44 110.213 176.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.712 ' HB2' ' HA ' ' A' ' 2' ' ' SER . 8.5 pt-20 -87.1 74.88 9.54 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 121.884 0.85 . . . . 74.42 110.23 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -67.29 116.02 7.61 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.167 -0.924 . . . . 73.34 110.417 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -86.86 169.44 12.54 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.723 0.809 . . . . 75.04 110.945 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -143.92 153.14 41.99 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.633 -1.247 . . . . 72.31 107.633 170.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.951 0 N-CA-C 109.11 -0.7 . . . . 73.14 109.11 178.866 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.494 ' HB3' ' NE2' ' B' ' 4' ' ' GLN . 54.7 mtt . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 121.22 0.533 . . . . 73.4 109.939 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 54.9 p -105.13 -4.68 21.56 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.834 0.854 . . . . 72.21 110.959 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.67 114.88 17.91 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.678 1.191 . . . . 75.22 107.789 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.494 ' NE2' ' HB3' ' B' ' 1' ' ' MET . 84.8 mm-40 -122.86 130.61 53.08 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.207 0.603 . . . . 64.34 110.592 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -88.22 -176.18 5.3 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.219 1.008 . . . . 73.22 109.564 170.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -151.4 138.49 19.18 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.737 -0.838 . . . . 74.25 108.737 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -142.21 16.86 2.07 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 122.903 0.481 . . . . 72.54 111.294 -173.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -147.97 60.95 1.12 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.522 0.729 . . . . 74.02 110.634 -173.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' B' ' 10' ' ' THR . 0.9 OUTLIER 66.01 165.92 0.19 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 125.067 1.347 . . . . 73.12 110.813 -174.309 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.617 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 94.0 m -145.49 114.81 7.11 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.28 -0.888 . . . . 64.25 108.99 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.563 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 51.5 t80 -131.39 132.69 44.59 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 122.957 0.503 . . . . 74.11 110.258 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.414 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -160.21 141.31 12.25 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.159 0.584 . . . . 75.51 110.285 174.28 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.412 HD13 ' HD3' ' D' ' 130' ' ' PRO . 23.2 mt -82.82 123.76 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.792 -0.818 . . . . 74.43 108.792 172.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -89.71 -49.91 6.37 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.438 -0.578 . . . . 71.12 109.438 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -166.23 135.8 3.21 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.816 -0.629 . . . . 75.41 110.021 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.7 mt -115.22 141.47 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 107.547 -1.279 . . . . 73.14 107.547 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -166.36 147.94 6.59 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.935 0.874 . . . . 72.11 112.369 -173.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.458 ' HG1' ' HG2' ' A' ' 120' ' ' ARG . 97.8 m -79.58 122.0 25.96 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.142 -1.39 . . . . 61.32 108.387 172.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -97.33 -19.09 18.75 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.482 0.713 . . . . 73.23 111.138 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -167.71 142.83 3.81 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.831 0.707 . . . . 71.33 110.377 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 38.7 mm -131.63 142.87 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.79 1.236 . . . . 75.32 108.736 172.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 44.3 t -143.78 110.27 5.5 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.414 1.086 . . . . 71.23 108.159 174.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.537 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 92.0 t80 -128.77 109.98 11.77 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.986 -1.116 . . . . 74.33 107.986 172.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -118.75 127.25 53.37 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.893 -0.781 . . . . 73.45 108.893 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.53 86.4 8.32 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 107.769 -1.197 . . . . 64.5 107.769 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -65.94 -43.08 9.94 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.87 2.38 . . . . 71.52 112.648 -168.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -104.26 16.78 25.46 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.098 0.959 . . . . 75.32 110.579 -175.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -38.73 -64.8 0.44 Allowed Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 115.007 1.484 . . . . 75.13 115.007 -162.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.29 -26.05 49.18 Favored 'Trans proline' 0 C--N 1.389 2.682 0 C-N-CA 121.992 1.794 . . . . 63.33 113.451 -170.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -97.5 -23.24 16.13 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.351 0.661 . . . . 60.53 112.736 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.621 HG21 HD13 ' B' ' 68' ' ' LEU . 9.3 p -80.58 -18.87 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 117.869 0.304 . . . . 75.24 111.08 -176.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -61.51 -27.58 68.7 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.792 0.837 . . . . 74.54 113.249 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -57.3 -23.25 47.31 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.452 0.701 . . . . 73.13 112.159 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.441 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 90.7 mttt -89.52 89.0 7.65 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.41 1.084 . . . . 71.4 109.974 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.49 87.65 6.21 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.447 -0.797 . . . . 61.42 110.949 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -163.19 173.23 13.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.343 1.057 . . . . 74.44 108.722 167.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -71.83 117.08 54.62 Favored Pre-proline 0 N--CA 1.474 0.739 0 N-CA-C 109.192 -0.67 . . . . 74.11 109.192 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.407 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 31.3 Cg_endo -63.19 153.82 71.65 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.279 1.986 . . . . 72.11 112.626 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.05 120.42 10.82 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 107.756 -1.201 . . . . 73.5 107.756 170.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 m -116.51 123.03 71.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.435 -0.802 . . . . 75.55 110.219 -167.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.587 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 77.2 tttt -106.98 121.31 44.2 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.66 1.184 . . . . 71.02 107.835 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.756 HD22 HD13 ' B' ' 128' ' ' LEU . 46.5 tp -96.89 137.39 36.04 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.655 -0.869 . . . . 74.03 108.655 169.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -144.01 152.54 41.17 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.22 1.008 . . . . 73.12 109.034 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.603 HD23 HD11 ' F' ' 8' ' ' LEU . 27.7 tp -128.7 157.29 41.79 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.688 0.795 . . . . 75.43 109.102 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -145.28 140.4 27.77 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.654 -0.869 . . . . 71.33 108.654 170.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 54.7 p -108.84 113.87 27.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.914 0.886 . . . . 61.23 109.401 -172.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.61 132.05 36.62 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.242 1.017 . . . . 62.41 108.692 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.515 ' HB3' ' HE2' ' F' ' 15' ' ' PHE . 59.6 p -147.55 178.87 8.1 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.009 0.433 . . . . 75.34 111.464 174.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.7 p -160.35 137.94 9.6 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.675 1.19 . . . . 75.13 108.91 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -88.63 128.16 35.58 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.209 -0.663 . . . . 75.52 109.209 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.515 HD12 HG22 ' B' ' 83' ' ' ILE . 78.2 mt -91.38 -40.09 11.64 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.106 0.563 . . . . 54.33 110.552 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.55 -172.49 2.93 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.332 0.586 . . . . 64.35 110.801 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.75 128.66 37.31 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.358 -1.292 . . . . 74.55 108.289 172.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.552 ' HB3' ' HB1' ' B' ' 87' ' ' ALA . 9.9 m-20 64.81 3.28 1.98 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.367 1.067 . . . . 75.2 113.31 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 91.6 t -120.45 120.19 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.879 0.872 . . . . 72.25 109.226 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.608 ' HB2' HD11 ' B' ' 86' ' ' ILE . 0.4 OUTLIER -129.21 154.54 46.67 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.931 -0.766 . . . . 73.05 108.931 178.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -125.44 108.1 11.31 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.418 -1.697 . . . . 74.35 106.418 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 31.2 m -109.42 139.43 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 122.964 0.506 . . . . 74.41 110.386 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.497 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 31.7 t -120.86 111.8 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.475 1.11 . . . . 73.24 109.128 -176.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.583 HD11 ' HB3' ' B' ' 103' ' ' PRO . 14.5 tp -94.38 100.07 12.16 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.702 -0.851 . . . . 73.23 108.702 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.489 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 70.2 ttt180 -88.62 106.8 18.55 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.161 0.584 . . . . 74.42 109.867 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.81 106.07 19.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.087 -1.079 . . . . 73.33 108.087 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 27.9 m -109.33 138.41 45.73 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.641 0.776 . . . . 72.34 109.895 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.428 HG23 HD12 ' B' ' 114' ' ' ILE . 88.4 t -134.33 134.18 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.33 1.052 . . . . 75.43 109.502 -175.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.587 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 62.8 m -109.78 149.2 30.15 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.869 0.868 . . . . 72.21 109.56 170.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.18 137.22 38.92 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.777 0.831 . . . . 62.21 109.176 177.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 11.0 m -137.4 124.31 21.36 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.292 0.637 . . . . 74.23 110.898 -175.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.621 HD13 HG21 ' B' ' 31' ' ' VAL . 47.0 mt -104.34 113.85 27.69 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.992 -0.744 . . . . 72.55 108.992 176.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.09 -110.57 3.31 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 114.987 -1.006 . . . . 52.24 111.859 -172.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -117.33 5.33 12.59 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.945 0.898 . . . . 73.14 109.943 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.441 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 24.2 pt-20 -125.52 164.65 20.05 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.884 0.474 . . . . 63.51 110.59 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 62.1 m -79.92 122.91 27.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.652 0.781 . . . . 74.01 110.641 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.528 ' HA ' HG22 ' B' ' 31' ' ' VAL . . . -70.83 -63.63 1.06 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.311 0.645 . . . . 71.3 109.358 172.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -150.7 167.73 26.48 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 115.066 -0.97 . . . . 72.23 111.977 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 65.4 mt -129.98 113.57 14.74 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.141 -1.8 . . . . 72.41 106.141 175.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 30.2 t -123.01 130.45 52.82 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 109.518 -0.549 . . . . 74.22 109.518 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -149.55 131.88 15.58 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.757 -0.831 . . . . 74.31 108.757 -170.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 66.1 t -129.81 144.29 38.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 123.946 0.899 . . . . 74.24 109.005 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.489 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 20.6 mt-30 -118.61 93.61 4.17 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.165 -1.05 . . . . 73.01 108.165 172.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -91.82 100.75 13.38 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.891 -0.595 . . . . 74.12 109.495 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.2 164.06 30.68 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 115.813 -0.63 . . . . 74.21 111.75 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.8 129.48 1.98 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 112.083 -0.407 . . . . 44.4 112.083 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.515 HG22 HD12 ' B' ' 51' ' ' LEU . 38.4 mt -85.42 126.85 40.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 108.214 -1.032 . . . . 74.41 108.214 171.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -133.5 144.22 49.27 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.479 0.712 . . . . 73.14 109.723 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 31.5 m -90.41 113.98 26.01 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.179 0.992 . . . . 73.1 108.837 170.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' B' ' 56' ' ' TYR . 0.2 OUTLIER -128.09 125.1 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.055 0.942 . . . . 71.14 109.024 178.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.617 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.32 172.96 17.58 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.153 0.427 . . . . 72.11 112.153 -175.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.49 -54.68 3.84 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.525 -0.761 . . . . 75.4 112.056 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 32.5 mm -91.25 157.2 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 124.22 1.008 . . . . 72.25 110.601 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.577 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 30.8 tt0 -161.5 153.66 19.75 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.755 0.822 . . . . 73.35 109.619 173.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 102.6 -136.0 12.58 Favored Glycine 0 C--N 1.352 1.453 0 C-N-CA 123.711 0.672 . . . . 73.35 112.917 -175.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 63.5 m -71.95 -43.24 65.55 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 117.421 0.611 . . . . 75.24 111.552 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -58.51 -32.25 68.64 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.508 0.723 . . . . 74.05 110.555 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.577 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 7.2 tpt -72.1 -44.78 62.69 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.246 -0.888 . . . . 75.15 110.426 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . 0.624 ' HB2' ' HB3' ' F' ' 14' ' ' LEU . . . -63.33 -23.18 67.3 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.011 -0.995 . . . . 71.22 111.424 176.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . 0.502 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 58.1 t-80 -82.82 -20.75 35.08 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.337 1.055 . . . . 64.44 110.874 174.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.566 ' HB3' ' HE2' ' B' ' 94' ' ' MET . 43.7 t -86.11 -67.25 0.82 Allowed 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.993 -0.442 . . . . 63.13 111.314 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.681 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 1.7 pt? -83.94 -14.73 50.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.551 -0.718 . . . . 72.11 111.809 -174.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.83 1.65 55.42 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.376 0.422 . . . . 65.41 113.855 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -143.43 -59.7 0.41 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.438 0.695 . . . . 73.4 109.833 -176.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -71.63 -48.58 46.96 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.215 0.606 . . . . 74.22 112.494 -173.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.681 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 59.2 m -64.35 -43.14 71.4 Favored Pre-proline 0 CA--C 1.56 1.345 0 N-CA-C 112.872 0.693 . . . . 74.13 112.872 -175.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.583 ' HB3' HD11 ' B' ' 60' ' ' LEU . 51.8 Cg_exo -60.12 -30.65 91.88 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 122.191 1.927 . . . . 73.14 113.384 172.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -65.79 -26.89 67.9 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 122.945 0.498 . . . . 63.21 111.641 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 74.2 mt -71.25 -43.71 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.515 0.726 . . . . 74.43 109.49 173.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 99.1 mt -74.13 -23.53 59.3 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.011 -0.995 . . . . 73.14 112.087 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -57.42 -51.9 78.29 Favored Pre-proline 0 CA--C 1.563 1.466 0 CA-C-O 117.696 -1.145 . . . . 73.51 113.42 -173.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.22 -32.04 94.9 Favored 'Trans proline' 0 C--N 1.392 2.854 0 C-N-CA 122.314 2.009 . . . . 75.51 113.7 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -72.57 -40.27 66.76 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.552 0.741 . . . . 63.14 110.229 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.79 -37.87 87.48 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.305 0.642 . . . . 72.21 110.491 173.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.403 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 56.8 ttt-85 -69.4 -50.33 46.89 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.415 1.486 . . . . 72.34 111.223 -171.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.55 -37.4 87.17 Favored 'General case' 0 N--CA 1.484 1.225 0 O-C-N 123.898 0.749 . . . . 74.0 109.286 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.47 ' O ' ' HG2' ' B' ' 117' ' ' MET . 28.8 t -64.07 -40.73 96.9 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.371 0.669 . . . . 64.14 112.003 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.491 ' O ' HG23 ' B' ' 118' ' ' VAL . 70.9 mt -61.05 -56.48 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.692 -0.485 . . . . 75.43 109.692 175.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.8 m -61.77 -26.86 68.35 Favored 'General case' 0 CA--C 1.557 1.216 0 O-C-N 123.752 0.658 . . . . 75.45 111.586 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.45 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.8 t -71.66 -43.25 66.4 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.726 0.81 . . . . 72.43 110.078 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.6 mmt -71.11 -31.92 68.37 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.538 0.335 . . . . 73.44 110.528 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.491 HG23 ' O ' ' B' ' 114' ' ' ILE . 99.1 t -62.7 -43.22 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 124.068 0.947 . . . . 72.24 109.914 170.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 64.0 m -65.89 -36.42 83.37 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.24 -0.891 . . . . 62.53 111.764 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' B' ' 116' ' ' SER . 68.8 mtt-85 -68.53 -38.16 80.62 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.521 -0.763 . . . . 72.54 109.554 176.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.72 -0.29 79.94 Favored Glycine 0 C--N 1.354 1.571 0 O-C-N 124.026 0.829 . . . . 70.14 113.264 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 73.0 p 61.17 16.52 7.28 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 126.343 1.857 . . . . 71.42 113.831 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -77.09 160.06 76.91 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 123.496 0.718 . . . . 64.14 111.493 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -47.14 146.21 6.73 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 123.748 2.965 . . . . 72.31 114.724 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -58.86 122.59 13.98 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.558 1.143 . . . . 74.24 111.095 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 52.8 tp -138.98 99.26 3.72 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.208 0.603 . . . . 73.42 109.851 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -99.12 131.51 45.1 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.739 0.816 . . . . 71.53 108.886 172.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.756 HD13 HD22 ' B' ' 42' ' ' LEU . 25.6 tp -81.99 152.43 26.7 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.23 0.612 . . . . 74.34 112.067 -174.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.54 146.22 83.31 Favored Pre-proline 0 N--CA 1.482 1.126 0 C-N-CA 123.835 0.854 . . . . 63.4 111.644 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -70.82 119.18 6.13 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.158 2.572 . . . . 62.32 111.15 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.61 HG21 HD12 ' F' ' 8' ' ' LEU . 26.7 m -107.5 110.88 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.892 0.853 . . . . 74.23 108.912 174.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -110.42 88.8 2.85 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.19 -1.041 . . . . 74.51 108.19 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -61.33 -34.21 74.88 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.636 -0.711 . . . . 73.21 110.73 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.422 ' HA ' ' HB2' ' B' ' 100' ' ' ALA . 17.1 t70 -61.74 -54.11 46.97 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.563 1.145 . . . . 71.51 111.255 -177.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.95 -22.65 65.93 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.367 -0.833 . . . . 73.2 111.541 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.51 -53.68 13.06 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 109.125 -0.695 . . . . 75.34 109.125 175.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -69.37 -15.85 63.4 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.108 0.563 . . . . 74.03 111.869 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -63.19 -29.54 70.86 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.105 0.962 . . . . 74.15 111.028 174.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -72.88 -24.8 60.9 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.162 0.585 . . . . 63.14 110.908 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -70.47 -29.2 65.69 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.19 0.596 . . . . 75.43 110.017 173.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 59.0 mt -107.09 19.6 20.2 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.09 0.956 . . . . 74.32 111.039 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -70.28 138.56 51.68 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.523 0.729 . . . . 75.43 111.749 -174.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -115.01 -178.48 3.37 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.521 1.128 . . . . 71.53 111.38 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -105.84 134.85 48.3 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.011 0.924 . . . . 73.3 109.518 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -169.26 -146.21 0.06 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.273 1.429 . . . . 75.3 108.01 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . 0.4 ' HA2' ' H ' ' D' ' 3' ' ' GLU . . . 73.85 37.33 51.16 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-N 117.926 0.33 . . . . 72.52 113.923 171.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -81.03 96.22 7.06 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.258 -1.016 . . . . 74.21 108.258 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -107.47 142.64 15.83 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 116.364 -0.38 . . . . 64.34 112.18 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 22.6 p -132.26 139.56 48.3 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.916 0.886 . . . . 70.0 110.236 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.83 -175.14 2.66 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.632 0.773 . . . . 74.13 110.573 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -144.67 157.94 43.99 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.61 0.764 . . . . 74.21 109.446 172.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -128.68 29.29 5.28 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.515 1.126 . . . . 73.22 108.87 -173.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -60.44 114.25 2.85 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.869 0.867 . . . . 72.13 110.826 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -146.97 89.15 1.79 Allowed 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.666 -0.864 . . . . 71.33 108.666 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.168 0 CA-C-N 115.565 -0.743 . . . . 74.11 109.792 178.181 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.645 0 N-CA-C 106.777 -1.564 . . . . 73.41 106.777 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 44.9 m -71.97 -76.12 0.12 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.066 0.854 . . . . 74.41 111.208 -173.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -172.87 -75.56 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.453 -0.573 . . . . 70.4 109.453 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -139.22 150.08 45.1 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.28 1.032 . . . . 71.42 108.429 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -70.89 95.26 1.14 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.071 0.548 . . . . 74.43 109.933 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -75.66 140.35 42.49 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.027 -1.101 . . . . 72.3 108.027 172.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 19.5 p -62.38 97.39 0.09 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.757 0.823 . . . . 74.54 111.491 -176.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 68.9 104.95 0.06 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.864 1.666 . . . . 73.14 110.825 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.53 ' HE1' ' SG ' ' C' ' 97' ' ' CYS . 0.0 OUTLIER 66.62 114.03 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 126.017 1.727 . . . . 72.14 111.869 179.076 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 42.6 m -98.28 97.53 8.91 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.034 0.934 . . . . 73.55 109.165 173.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.55 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 14.7 t80 -106.98 125.34 50.88 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.125 -1.065 . . . . 64.11 108.125 176.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -136.46 119.26 16.19 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.014 -0.736 . . . . 74.03 109.014 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.459 HG13 ' HD3' ' A' ' 130' ' ' PRO . 35.5 mt -73.13 128.02 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.936 -0.764 . . . . 73.0 108.936 175.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -92.65 -48.23 6.7 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.149 -0.685 . . . . 53.53 109.149 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -173.22 134.44 0.54 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.92 -0.77 . . . . 75.33 108.92 -169.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 94.5 mt -126.27 142.23 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 108.017 -1.105 . . . . 63.44 108.017 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.445 ' HB3' HG22 ' D' ' 122' ' ' THR . 26.6 p90 -173.68 167.3 4.51 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 123.942 0.776 . . . . 65.35 110.488 -174.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -86.57 119.07 26.43 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.84 -1.073 . . . . 74.43 109.062 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.564 ' HE3' ' HB2' ' D' ' 28' ' ' ALA . 10.8 mmmm -70.44 -45.8 65.12 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.999 -1.112 . . . . 63.11 107.999 169.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.603 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 5.1 t70 -139.53 147.83 41.77 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 113.776 -1.556 . . . . 75.55 110.258 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.4 mt -137.94 149.08 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.977 1.711 . . . . 60.25 107.24 174.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.4 t -162.04 150.3 14.91 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.427 0.632 . . . . 71.43 110.614 172.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.432 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 91.6 t80 -143.65 146.18 33.04 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 107.029 -1.471 . . . . 71.23 107.029 170.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -149.35 115.87 5.86 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.28 1.032 . . . . 72.34 109.011 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.05 92.01 12.21 Favored Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 105.649 -1.982 . . . . 71.14 105.649 165.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -57.25 -49.93 12.55 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.277 2.652 . . . . 65.23 112.513 -171.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -106.73 39.16 1.9 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.504 0.722 . . . . 71.1 109.488 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.451 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -37.86 -58.56 1.35 Allowed Pre-proline 0 CA--C 1.571 1.75 0 N-CA-C 115.183 1.549 . . . . 73.23 115.183 -171.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.451 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 20.3 Cg_exo -60.56 -43.29 33.93 Favored 'Trans proline' 0 C--N 1.387 2.6 0 CA-C-N 122.198 1.821 . . . . 70.12 112.418 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -69.13 -32.44 71.81 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.14 -0.937 . . . . 75.21 112.258 -175.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.658 HG21 ' HA ' ' C' ' 73' ' ' ALA . 12.4 p -79.38 -27.47 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 122.528 0.331 . . . . 64.31 111.769 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -66.69 -23.08 66.08 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 112.114 0.413 . . . . 75.52 112.114 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -95.55 15.58 19.43 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.392 0.677 . . . . 74.35 111.841 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.784 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -91.52 160.83 15.23 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.369 0.668 . . . . 73.34 110.451 177.239 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -69.01 130.26 42.28 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.833 0.853 . . . . 71.35 108.784 162.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -84.55 102.34 12.79 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.913 0.485 . . . . 75.31 110.607 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -155.37 77.4 4.85 Favored Pre-proline 0 N--CA 1.476 0.83 0 N-CA-C 108.674 -0.861 . . . . 75.22 108.674 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -88.31 148.65 6.52 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.71 2.273 . . . . 71.31 113.819 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -86.52 99.34 11.61 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 107.013 -1.477 . . . . 70.43 107.013 159.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.522 ' HB ' HG23 ' G' ' 6' ' ' ILE . 35.3 t -78.54 101.04 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 108.591 -0.892 . . . . 75.45 108.591 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.574 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 62.3 mttm -99.26 105.38 17.4 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.899 -0.778 . . . . 74.43 108.899 -176.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 42.5 tp -83.64 130.02 34.97 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 109.134 -0.691 . . . . 74.34 109.134 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -129.19 139.74 51.77 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.326 1.45 . . . . 73.44 108.284 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.33 147.59 50.25 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.844 0.458 . . . . 74.44 110.702 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 1.5 t70 -130.09 147.49 51.84 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.117 1.367 . . . . 71.35 108.693 173.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 87.9 m -111.51 114.17 27.08 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.709 0.804 . . . . 73.04 109.643 -174.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.5 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -118.36 139.9 50.66 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.29 1.036 . . . . 70.45 108.317 173.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.465 ' HB2' ' OH ' ' C' ' 56' ' ' TYR . 64.8 p -154.26 143.76 21.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.172 -0.33 . . . . 73.53 111.179 -172.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 27.8 p -159.0 128.01 5.4 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 123.923 0.764 . . . . 73.11 109.808 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -80.1 138.27 36.92 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.974 -0.75 . . . . 73.51 108.974 173.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.49 HD13 HD13 ' C' ' 83' ' ' ILE . 49.1 mt -105.48 -38.9 6.3 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.004 0.522 . . . . 75.04 110.712 -176.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.69 -170.55 2.79 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.379 0.672 . . . . 71.31 110.957 -177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -70.39 112.25 6.56 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.261 -0.881 . . . . 71.2 109.785 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 71.24 -1.42 2.74 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 125.396 1.479 . . . . 74.43 112.944 -175.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.575 HG23 ' HA ' ' E' ' 1' ' ' MET . 66.2 t -102.31 120.02 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.096 -0.705 . . . . 75.01 109.096 175.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.465 ' OH ' ' HB2' ' C' ' 48' ' ' SER . 51.0 t80 -138.62 132.07 30.39 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.104 -1.073 . . . . 70.35 108.104 -174.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -94.48 117.67 30.48 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.384 -0.825 . . . . 71.12 109.045 173.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 35.7 m -96.65 130.14 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.625 -1.25 . . . . 72.23 107.625 168.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 61.9 t -124.02 125.34 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.85 -1.167 . . . . 75.41 107.85 172.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 tp -125.9 116.41 21.47 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.013 -1.106 . . . . 73.24 108.013 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.501 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.7 ttm180 -79.12 122.25 26.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.772 -1.103 . . . . 75.14 109.036 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 11.4 t -100.81 129.06 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.019 -1.474 . . . . 74.41 107.019 171.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 62.8 m -131.95 110.53 10.83 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.089 -1.078 . . . . 75.11 108.089 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.473 HG22 HG21 ' C' ' 114' ' ' ILE . 85.1 t -101.75 112.33 34.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.578 -1.192 . . . . 62.22 108.231 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 20.7 m -97.92 141.15 31.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.014 -1.106 . . . . 73.31 108.014 173.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.33 107.5 6.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 106.233 -1.766 . . . . 72.42 106.233 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 46.2 m -127.16 146.34 50.43 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.611 -0.514 . . . . 73.55 109.611 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.766 HD11 ' HG2' ' C' ' 34' ' ' LYS . 13.1 mt -110.41 35.59 3.39 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.661 1.584 . . . . 75.42 108.2 -173.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.88 -109.68 2.99 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 110.096 -1.202 . . . . 72.52 110.096 -169.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.93 -30.01 18.13 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.869 0.868 . . . . 73.13 110.314 176.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -73.52 103.07 4.02 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.726 0.81 . . . . 74.33 109.77 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 92.6 m -73.26 118.87 16.73 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.544 -0.91 . . . . 75.23 108.544 170.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.658 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -67.68 -57.75 5.85 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 124.464 1.102 . . . . 72.23 109.11 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -156.89 171.65 20.05 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.663 -1.153 . . . . 63.34 111.656 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -139.44 140.02 37.21 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 104.839 -2.282 . . . . 74.44 104.839 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.462 ' SG ' HG22 ' C' ' 114' ' ' ILE . 38.3 t -147.54 112.43 5.42 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.964 -0.754 . . . . 72.21 108.964 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -121.8 116.46 24.5 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.708 0.803 . . . . 75.52 110.147 -171.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 55.5 t -125.06 115.45 44.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.955 0.902 . . . . 74.01 109.357 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.603 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.1 mt-30 -90.96 97.85 11.43 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.807 -0.812 . . . . 73.25 108.807 173.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.57 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 9.1 tp-100 -86.98 117.32 25.62 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.339 0.655 . . . . 73.21 109.766 -177.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.3 146.35 18.23 Favored Glycine 0 C--N 1.342 0.909 0 O-C-N 123.813 0.695 . . . . 71.42 111.831 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.4 116.35 0.99 Allowed Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.754 -0.538 . . . . 61.23 111.754 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.525 HD11 ' HB3' ' D' ' 29' ' ' PRO . 7.7 mm -82.97 122.16 37.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 107.945 -1.131 . . . . 75.32 107.945 174.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -138.26 132.16 31.3 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.426 0.691 . . . . 74.24 109.956 -176.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 21.8 p -95.22 103.97 15.85 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 108.17 -1.048 . . . . 72.14 108.17 169.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.454 HD13 ' H ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -124.15 137.04 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 124.144 0.977 . . . . 74.4 111.459 -171.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.67 173.38 11.96 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.352 1.061 . . . . 74.42 110.934 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 116.89 -49.03 0.88 Allowed Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.941 -0.572 . . . . 74.13 111.74 172.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 30.0 pt -92.31 170.17 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.488 0.715 . . . . 72.45 110.284 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -146.17 148.47 32.58 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.975 0.51 . . . . 73.24 111.226 -168.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.51 -133.32 23.46 Favored Glycine 0 C--N 1.35 1.33 0 O-C-N 123.745 0.653 . . . . 75.45 114.222 172.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.4 p -66.69 -18.55 65.43 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.111 0.964 . . . . 73.21 112.229 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -68.35 -43.22 77.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.196 0.598 . . . . 70.11 110.144 172.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 15.5 ttt -76.72 -31.57 57.25 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.601 -0.727 . . . . 74.53 110.55 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.19 -40.23 90.27 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.373 0.669 . . . . 63.21 110.558 172.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -59.56 -41.75 90.87 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.473 1.109 . . . . 75.22 111.006 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.53 ' SG ' ' HE1' ' C' ' 9' ' ' MET . 50.4 t -63.79 -54.27 37.73 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.539 0.524 . . . . 64.33 110.223 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.52 HD12 HG23 ' G' ' 18' ' ' VAL . 90.0 mt -63.03 -36.36 83.31 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.332 0.653 . . . . 74.33 112.036 -177.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.6 11.28 66.7 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.497 -0.613 . . . . 73.01 114.304 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.65 -58.02 0.1 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 117.555 0.677 . . . . 62.43 111.999 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -74.51 -48.4 27.37 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.662 0.385 . . . . 63.42 112.002 -172.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.55 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 41.9 m -60.51 -47.2 96.88 Favored Pre-proline 0 CA--C 1.563 1.458 0 C-N-CA 123.97 0.908 . . . . 75.44 112.11 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.87 -12.07 19.87 Favored 'Trans proline' 0 C--N 1.395 3.024 0 C-N-CA 122.026 1.818 . . . . 71.33 113.608 172.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . 0.5 ' HA ' ' CD2' ' C' ' 107' ' ' PHE . 59.7 t30 -71.76 -32.66 67.93 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.434 0.635 . . . . 73.44 109.914 173.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.541 HD13 HH12 ' A' ' 111' ' ' ARG . 30.0 mm -65.54 -30.84 51.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 115.143 -0.935 . . . . 73.35 109.822 170.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 65.5 mt -88.14 -22.64 23.97 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.887 0.875 . . . . 71.14 113.208 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . 0.5 ' CD2' ' HA ' ' C' ' 104' ' ' ASN . 11.8 m-85 -55.38 -48.36 96.48 Favored Pre-proline 0 N--CA 1.49 1.536 0 CA-C-O 117.242 -1.361 . . . . 75.12 113.218 -177.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -54.46 -39.53 87.43 Favored 'Trans proline' 0 C--N 1.39 2.75 0 C-N-CA 122.881 2.387 . . . . 74.52 114.461 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . 0.547 ' HE2' HG21 ' A' ' 115' ' ' THR . 73.9 m-85 -70.04 -49.33 52.34 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.214 0.605 . . . . 72.34 110.901 -176.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.57 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -67.75 -31.97 72.25 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 115.615 -0.72 . . . . 74.43 111.081 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 26.6 ttt-85 -59.21 -54.19 49.76 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.675 1.19 . . . . 71.14 110.328 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -69.33 -29.05 66.79 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.767 0.667 . . . . 71.21 110.425 -177.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 42.7 t -70.22 -38.39 75.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.186 0.594 . . . . 75.02 110.813 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.473 HG21 HG22 ' C' ' 64' ' ' VAL . 87.3 mt -69.54 -49.09 62.24 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.157 0 C-N-CA 123.259 0.624 . . . . 71.3 109.742 174.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 90.5 m -63.25 -33.08 74.72 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.012 0.925 . . . . 75.25 110.977 -175.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 41.8 t -64.62 -46.67 81.6 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 115.349 -0.841 . . . . 74.31 109.092 172.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.537 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.98 -36.43 84.38 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.895 1.278 . . . . 74.34 112.929 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.44 HG23 ' O ' ' C' ' 114' ' ' ILE . 97.4 t -65.56 -44.54 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.093 0.957 . . . . 72.14 108.774 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 30.6 t -66.13 -33.62 76.19 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.162 -1.381 . . . . 74.13 111.496 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' C' ' 116' ' ' SER . 80.1 mtt-85 -70.94 -32.2 69.01 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.648 0.779 . . . . 73.22 109.453 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.3 9.06 76.73 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 123.717 0.636 . . . . 75.03 112.947 174.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.41 HG22 ' HB3' ' D' ' 17' ' ' TYR . 46.0 p 58.19 30.62 19.67 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 126.143 1.777 . . . . 74.15 114.016 174.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -93.02 147.27 33.54 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 108.81 -0.811 . . . . 74.33 108.81 172.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.34 159.76 5.63 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 123.386 2.724 . . . . 74.45 113.742 174.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -47.39 125.59 8.36 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.797 1.239 . . . . 70.34 112.934 -176.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.81 91.25 3.31 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.327 -1.36 . . . . 75.42 107.327 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -116.62 122.18 43.86 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.407 1.083 . . . . 63.12 108.168 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 6.7 mp -69.11 145.94 52.97 Favored 'General case' 0 C--O 1.245 0.832 0 O-C-N 123.406 0.441 . . . . 74.44 110.479 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' C' ' 130' ' ' PRO . . . -72.8 136.22 80.33 Favored Pre-proline 0 CA--C 1.552 1.041 0 O-C-N 124.107 0.879 . . . . 73.01 110.013 177.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.683 ' HB2' HD12 ' A' ' 13' ' ' ILE . 11.1 Cg_exo -69.22 100.7 0.77 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 123.173 2.582 . . . . 64.45 113.725 -170.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.0 t -101.04 108.62 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 108.051 -1.092 . . . . 65.51 108.051 170.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -81.41 92.61 6.46 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 107.091 -1.448 . . . . 75.4 107.091 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -65.43 -35.91 82.33 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.057 0.943 . . . . 71.42 112.642 -161.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -70.1 -41.1 74.46 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.516 0.727 . . . . 73.55 111.589 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.66 -33.36 74.9 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.883 0.739 . . . . 75.35 111.181 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 7.7 tt -54.14 -47.45 71.9 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.957 0.903 . . . . 73.32 110.477 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -80.8 -26.25 37.28 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.438 0.695 . . . . 74.15 111.816 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -77.38 -36.59 53.36 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.719 0.808 . . . . 65.31 111.414 -175.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -55.14 -35.52 64.79 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.053 0.941 . . . . 73.22 111.685 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -59.65 -86.14 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.367 0 O-C-N 123.891 0.745 . . . . 73.44 110.349 172.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 50.7 tp 57.64 -81.5 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.216 1.406 . . . . 70.35 112.759 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -163.28 -172.93 3.16 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.408 1.083 . . . . 64.54 109.914 -172.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -94.39 -27.05 16.26 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.592 0.757 . . . . 73.33 111.746 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -55.41 116.9 3.12 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 124.543 1.137 . . . . 64.42 112.165 -170.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.41 150.71 30.76 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.29 1.036 . . . . 75.14 109.825 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.5 174.05 37.56 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 111.188 -0.765 . . . . 74.42 111.188 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -103.12 156.88 17.39 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.572 0.749 . . . . 74.42 111.452 -172.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -163.49 78.36 0.15 Allowed Glycine 0 C--N 1.342 0.872 0 N-CA-C 110.791 -0.924 . . . . 74.04 110.791 -175.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 8.8 t -156.74 134.82 11.16 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.34 0.656 . . . . 71.33 110.111 -177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -166.8 113.58 0.81 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.395 1.078 . . . . 73.52 108.365 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -147.34 160.78 42.14 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.489 0.716 . . . . 74.11 110.651 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -158.43 -81.29 0.06 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.141 0.976 . . . . 74.35 108.424 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 173.36 127.79 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.799 1.64 . . . . 74.11 107.082 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.67 -51.93 65.29 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.995 0.518 . . . . 73.21 109.711 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 1.398 0 C-N-CA 124.667 1.187 . . . . 64.43 110.962 179.768 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.427 ' HA ' ' HA ' ' D' ' 142' ' ' GLN . 15.4 ptt? . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.517 -0.549 . . . . 73.22 109.517 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 20.9 p 173.33 102.6 0.01 OUTLIER 'General case' 0 C--N 1.363 1.159 0 C-N-CA 124.629 1.172 . . . . 74.25 110.063 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . 0.468 ' HB2' ' SD ' ' D' ' 138' ' ' MET . 1.2 pm0 -148.53 -179.36 6.9 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.914 0.885 . . . . 70.21 110.913 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -66.42 147.66 52.98 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 112.457 0.54 . . . . 74.3 112.457 -174.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -153.81 153.85 32.91 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.466 1.106 . . . . 71.02 109.369 -175.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -63.64 97.68 0.16 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.462 0.705 . . . . 75.44 109.494 173.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 34.2 m -142.35 160.95 39.25 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.966 0.906 . . . . 74.0 109.842 -174.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.49 -4.72 6.27 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.992 1.317 . . . . 73.2 112.963 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.497 ' HE1' ' HB2' ' D' ' 11' ' ' PHE . 1.1 tmt? -28.58 125.36 0.1 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 126.585 1.954 . . . . 72.11 113.27 170.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 28.7 m -112.81 146.71 38.37 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.642 0.777 . . . . 75.13 110.579 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.581 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 57.6 t80 -154.14 99.85 2.27 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.703 1.201 . . . . 75.25 107.837 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -117.48 115.43 25.15 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.024 -0.732 . . . . 74.44 109.024 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.432 HG21 HD13 ' D' ' 16' ' ' ILE . 28.5 mt -75.23 121.64 27.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.23 -1.026 . . . . 74.02 108.23 176.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -96.45 -26.94 15.12 Favored 'General case' 0 C--O 1.245 0.819 0 O-C-N 123.417 0.448 . . . . 75.12 111.347 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -171.72 136.04 0.91 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 117.705 0.23 . . . . 74.31 111.364 -168.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.432 HD13 HG21 ' D' ' 13' ' ' ILE . 2.9 mp -120.5 133.4 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 107.107 -1.442 . . . . 71.31 107.107 174.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.41 ' HB3' HG22 ' C' ' 122' ' ' THR . 24.9 p90 -160.6 173.03 16.11 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 122.582 1.182 . . . . 75.42 112.53 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -111.38 120.42 42.14 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 113.613 -1.631 . . . . 70.12 108.136 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -87.93 -24.07 23.72 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.275 0.56 . . . . 74.24 109.552 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.607 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 10.3 t70 -154.57 143.3 20.82 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.124 -1.398 . . . . 70.23 109.138 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.537 HG21 ' HE1' ' C' ' 117' ' ' MET . 47.1 mt -139.96 150.28 21.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 106.539 -1.652 . . . . 75.25 106.539 173.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -157.56 144.84 18.42 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.571 0.701 . . . . 73.5 110.739 169.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.485 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.2 t80 -140.17 128.64 22.76 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 105.872 -1.899 . . . . 72.32 105.872 173.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.7 mt-10 -136.89 123.44 20.93 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.441 -0.948 . . . . 75.43 108.441 -176.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' D' ' 28' ' ' ALA . . . -128.06 86.62 57.64 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 107.605 -1.257 . . . . 75.1 107.605 177.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.67 -36.78 10.41 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 122.676 2.25 . . . . 75.43 112.431 -175.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -96.95 16.76 18.54 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.867 0.867 . . . . 74.54 110.43 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.564 ' HB2' ' HE3' ' C' ' 19' ' ' LYS . . . -43.66 -64.93 0.65 Allowed Pre-proline 0 CA--C 1.561 1.386 0 N-CA-C 115.336 1.606 . . . . 74.14 115.336 -162.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.525 ' HB3' HD11 ' C' ' 83' ' ' ILE . 90.6 Cg_endo -74.69 -12.77 22.24 Favored 'Trans proline' 0 C--N 1.386 2.542 0 CA-C-N 122.626 1.973 . . . . 63.11 113.348 -174.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -84.58 -40.83 17.07 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.119 1.368 . . . . 72.44 110.856 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.437 HG22 HD12 ' D' ' 68' ' ' LEU . 9.9 p -83.72 -17.21 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.123 0 CA-C-N 115.886 -0.597 . . . . 71.23 111.446 -170.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -62.42 -17.62 59.72 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 113.025 0.75 . . . . 74.11 113.025 173.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -65.02 -11.95 44.95 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.369 0.668 . . . . 73.32 110.951 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.682 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 87.2 mttt -109.79 92.13 3.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.303 1.441 . . . . 73.34 109.194 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -90.9 92.5 8.8 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.844 0.457 . . . . 72.34 109.873 177.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 30.7 p90 -162.31 176.87 10.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.69 0.796 . . . . 73.41 109.448 168.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -69.9 114.34 24.3 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 123.689 0.796 . . . . 63.13 110.342 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.519 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 16.4 Cg_exo -68.08 134.98 33.34 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 123.104 2.536 . . . . 73.33 111.096 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.68 122.25 16.83 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.262 0.625 . . . . 73.35 110.033 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 35.8 t -97.87 114.93 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.631 0.773 . . . . 72.3 110.894 -168.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -104.39 152.63 22.06 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.186 -1.413 . . . . 74.53 107.186 166.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 pp -140.34 156.07 46.57 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.025 0.53 . . . . 74.31 110.967 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -150.35 152.61 34.68 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.777 0.831 . . . . 72.35 108.89 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 87.9 mt -126.92 146.92 50.13 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.483 0.713 . . . . 74.34 110.838 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 7.2 t70 -136.84 140.82 42.7 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.738 1.215 . . . . 71.4 108.19 172.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 58.0 m -102.03 142.91 32.57 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.401 0.68 . . . . 60.23 109.655 -173.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.708 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -155.04 155.25 33.78 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.08 0.952 . . . . 62.02 109.032 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 77.3 p -174.62 178.44 1.92 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.007 0.432 . . . . 74.32 111.272 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 73.0 p -168.77 146.58 3.92 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.491 -1.231 . . . . 72.51 108.935 174.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -82.66 128.54 34.44 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.879 -0.786 . . . . 73.24 108.879 171.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.626 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.5 mt -101.28 -34.5 9.62 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.024 0.53 . . . . 74.25 110.18 -175.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.54 -175.89 3.72 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.318 1.047 . . . . 64.43 110.131 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.7 114.51 7.98 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.642 -1.163 . . . . 73.44 109.306 173.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 68.46 18.77 8.95 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.151 1.381 . . . . 73.0 112.461 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 94.7 t -124.16 124.69 69.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 C-N-CA 124.927 1.291 . . . . 75.44 107.609 168.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.658 ' HB2' HG11 ' H' ' 18' ' ' VAL . 21.3 t80 -144.66 137.72 26.82 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.625 -0.509 . . . . 74.51 109.625 -176.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.626 ' HB2' HD11 ' D' ' 51' ' ' LEU . 27.3 tt0 -91.9 133.53 35.59 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.645 -0.707 . . . . 64.12 109.972 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 78.4 t -111.86 118.28 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.678 -1.23 . . . . 72.15 107.678 172.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.708 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 14.7 t -114.61 131.77 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.21 -1.033 . . . . 62.04 108.21 173.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.405 HD12 ' O ' ' D' ' 45' ' ' ASP . 18.8 tp -130.69 123.5 29.48 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.229 -0.656 . . . . 65.11 109.229 174.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.549 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 14.1 ttm180 -83.53 104.77 13.93 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.702 -0.851 . . . . 72.41 108.702 176.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 70.4 t -89.12 129.39 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 107.979 -1.119 . . . . 73.45 107.979 173.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 20.7 m -121.75 142.6 50.03 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.289 -0.634 . . . . 75.23 109.289 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.505 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 69.5 t -139.44 100.45 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 126.04 1.736 . . . . 75.42 107.307 -174.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 62.5 m -99.69 112.33 24.57 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.757 -0.831 . . . . 73.53 108.757 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.519 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -115.42 141.05 48.57 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.586 0.754 . . . . 64.23 109.972 -173.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.456 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 14.4 p -147.7 128.79 14.59 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 123.526 0.516 . . . . 73.01 111.906 -174.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.437 HD12 HG22 ' D' ' 31' ' ' VAL . 41.2 mt -96.93 114.81 26.46 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 124.758 1.223 . . . . 63.52 108.661 175.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.86 -121.09 8.38 Favored Glycine 0 C--N 1.341 0.858 0 O-C-N 123.737 0.648 . . . . 70.33 112.106 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.07 5.59 22.23 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.177 0.591 . . . . 75.43 111.444 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.682 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 10.9 pt-20 -122.37 162.62 21.24 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.22 0.608 . . . . 65.53 109.727 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 58.8 m -69.65 132.67 46.54 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.457 0.703 . . . . 71.54 111.284 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.456 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -84.95 -68.93 0.69 Allowed 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.414 -1.328 . . . . 65.23 107.414 172.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . 0.424 ' HZ ' HD23 ' D' ' 126' ' ' LEU . 51.5 p90 -149.83 167.28 27.0 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.654 -1.157 . . . . 75.32 110.657 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 77.5 mt -134.49 112.42 10.9 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.794 1.238 . . . . 74.35 108.269 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.505 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 10.6 m -114.81 133.32 56.04 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.189 0.996 . . . . 73.51 108.782 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -152.62 118.42 5.4 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.196 -1.409 . . . . 75.41 107.196 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . 0.519 HG23 HG22 ' D' ' 21' ' ' ILE . 80.0 t -130.09 122.17 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.989 0.916 . . . . 74.32 108.777 -175.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.607 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.9 mt-30 -88.61 87.49 7.28 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.376 -0.972 . . . . 74.41 108.376 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -80.46 110.9 16.36 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.115 -1.402 . . . . 72.13 108.569 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.36 144.55 18.34 Favored Glycine 0 N--CA 1.469 0.887 0 N-CA-C 111.471 -0.651 . . . . 72.21 111.471 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.61 138.3 8.04 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 117.038 0.419 . . . . 71.53 112.199 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.6 mt -88.39 122.86 40.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 108.203 -1.036 . . . . 74.32 108.203 173.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -128.64 156.02 44.07 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.389 0.675 . . . . 74.45 109.253 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 48.8 m -115.36 102.12 9.55 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.424 -0.954 . . . . 72.42 108.424 175.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.724 ' HB ' HG22 ' H' ' 18' ' ' VAL . 3.6 mp -108.05 130.49 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 108.812 -0.81 . . . . 74.13 108.812 -176.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.81 166.9 28.09 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.868 0.867 . . . . 72.13 110.385 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.44 21.71 74.61 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.452 -0.795 . . . . 74.0 114.094 173.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.536 HG23 ' N ' ' D' ' 90' ' ' GLU . 17.5 mt -125.22 157.29 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.458 0.703 . . . . 74.22 110.47 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.536 ' N ' HG23 ' D' ' 89' ' ' ILE . 29.6 mt-10 -135.0 151.84 51.19 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.844 1.257 . . . . 73.51 110.213 172.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . 0.41 ' O ' ' HB1' ' H' ' 21' ' ' ALA . . . 70.58 -145.79 41.0 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 116.05 1.18 . . . . 72.31 116.05 168.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 4.3 p -74.51 -10.42 59.54 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.208 1.003 . . . . 74.12 111.711 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -30.86 71.56 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.808 0.843 . . . . 72.43 109.426 172.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.484 ' SD ' ' HB3' ' H' ' 21' ' ' ALA . 56.9 ttm -77.73 -39.04 45.73 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.883 0.473 . . . . 75.24 109.818 174.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . 0.463 ' HB1' ' HB3' ' H' ' 14' ' ' LEU . . . -58.69 -31.49 68.27 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.238 0.542 . . . . 75.22 111.008 171.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -70.82 -48.9 51.57 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.471 1.108 . . . . 73.22 110.572 174.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 50.9 t -59.67 -46.29 89.48 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.047 0.539 . . . . 73.34 110.867 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.479 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 7.3 mp -83.89 -18.99 35.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.337 0.655 . . . . 72.04 111.96 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.38 -1.74 60.63 Favored Glycine 0 N--CA 1.476 1.314 0 CA-C-O 119.992 -0.338 . . . . 60.31 113.564 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.535 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -140.34 -65.22 0.46 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.887 0.475 . . . . 73.45 110.967 -176.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -73.93 -40.12 63.33 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.828 0.677 . . . . 73.05 112.828 -170.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.581 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 51.5 m -69.45 -45.91 27.05 Favored Pre-proline 0 CA--C 1.559 1.3 0 CA-C-O 118.881 -0.581 . . . . 75.23 112.213 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.52 -18.93 28.94 Favored 'Trans proline' 0 C--N 1.393 2.892 0 C-N-CA 121.66 1.573 . . . . 72.52 112.412 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . 0.462 ' HA ' ' HD2' ' D' ' 107' ' ' PHE . 35.4 t-20 -64.19 -31.12 72.2 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.463 0.705 . . . . 75.12 109.992 175.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.4 mm -68.24 -33.44 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.566 0.746 . . . . 73.51 110.277 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 79.5 mt -81.35 -25.66 36.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.666 0.786 . . . . 73.43 112.664 -173.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . 0.462 ' HD2' ' HA ' ' D' ' 104' ' ' ASN . 41.0 m-85 -64.06 -42.71 71.03 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 114.255 1.206 . . . . 71.13 114.255 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.27 -39.81 85.12 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 122.409 2.073 . . . . 64.54 113.329 172.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -80.59 -32.25 36.55 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.758 0.823 . . . . 73.11 112.045 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.3 -53.03 50.01 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.836 -0.801 . . . . 73.43 108.836 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.41 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 37.4 ttp180 -55.07 -46.9 75.45 Favored 'General case' 0 C--O 1.211 -0.937 0 O-C-N 124.61 1.194 . . . . 72.02 111.313 177.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -64.69 -45.63 85.79 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.217 0.607 . . . . 74.21 111.086 -175.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.405 ' O ' ' HG3' ' D' ' 117' ' ' MET . 44.7 t -57.72 -45.97 85.06 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.413 0.685 . . . . 74.41 110.456 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.483 HG23 ' SG ' ' D' ' 76' ' ' CYS . 93.4 mt -62.79 -52.18 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.755 -1.111 . . . . 74.42 111.101 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 96.8 m -56.13 -41.03 74.69 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.891 1.277 . . . . 72.45 111.119 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 30.6 t -66.72 -43.45 84.23 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.621 -1.172 . . . . 62.24 109.818 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.413 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 74.4 mtm -65.7 -33.03 74.93 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.088 0.555 . . . . 75.44 111.874 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' D' ' 114' ' ' ILE . 76.4 t -64.68 -45.71 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.432 1.093 . . . . 71.34 109.945 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 82.5 p -75.58 -28.36 58.92 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 115.503 -0.771 . . . . 54.45 111.053 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' D' ' 116' ' ' SER . 78.0 mtt-85 -72.63 -29.11 63.19 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.374 0.67 . . . . 72.04 109.805 174.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.63 9.64 75.17 Favored Glycine 0 C--N 1.353 1.494 0 O-C-N 123.849 0.718 . . . . 75.34 112.29 173.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.445 HG22 ' HB3' ' C' ' 17' ' ' TYR . 44.8 p 60.06 20.01 9.19 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 126.533 1.933 . . . . 54.42 114.476 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -82.19 155.24 69.72 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.418 0.687 . . . . 74.45 109.66 171.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.01 132.4 49.27 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.642 2.228 . . . . 71.22 111.221 174.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -49.76 130.47 21.2 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.195 1.398 . . . . 73.53 112.499 -174.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.424 HD23 ' HZ ' ' D' ' 74' ' ' PHE . 17.8 tp -117.51 96.44 5.4 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.908 0.483 . . . . 74.3 109.783 -172.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -99.9 104.45 16.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.579 0.752 . . . . 72.33 109.245 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.41 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 6.6 mp -69.92 115.39 9.09 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.293 0.637 . . . . 72.13 109.813 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.73 126.93 86.37 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 122.898 0.479 . . . . 51.04 110.196 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.412 ' HD3' HD13 ' B' ' 13' ' ' ILE . 51.4 Cg_endo -73.35 133.25 18.93 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.504 2.136 . . . . 63.44 111.855 -171.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 89.3 t -108.9 136.14 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.473 -0.936 . . . . 74.25 108.473 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -77.91 87.69 4.1 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.252 -0.647 . . . . 73.15 109.252 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -58.84 -30.52 67.74 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.088 -0.96 . . . . 75.35 112.272 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.535 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 2.2 t70 -60.4 -46.17 90.97 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.261 0.976 . . . . 63.23 110.203 -174.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.24 -48.27 71.05 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.599 0.76 . . . . 74.41 111.954 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 10.0 mp -66.25 -35.22 79.85 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.755 -0.657 . . . . 74.41 111.519 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.467 ' O ' HD12 ' D' ' 141' ' ' LEU . 12.8 t80 -74.44 -43.86 54.33 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.254 0.622 . . . . 71.23 109.53 -177.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.468 ' SD ' ' HB2' ' D' ' 3' ' ' GLU . 74.3 mtm -57.71 -40.58 79.88 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.668 0.387 . . . . 74.54 110.292 175.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -59.07 -35.02 72.66 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 123.918 0.761 . . . . 74.24 111.621 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -71.0 -49.99 39.06 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.118 0.567 . . . . 73.22 110.755 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.467 HD12 ' O ' ' D' ' 137' ' ' PHE . 10.5 mp -66.83 -33.73 76.25 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.857 0.863 . . . . 74.21 112.438 -172.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' D' ' 1' ' ' MET . 10.3 pt20 -76.09 9.75 2.32 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.309 0.643 . . . . 73.24 112.25 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -118.28 89.26 3.09 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.419 -0.956 . . . . 74.35 108.419 176.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -163.69 148.95 10.91 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.376 1.07 . . . . 65.25 109.087 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.29 135.4 8.91 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.756 0.822 . . . . 73.42 109.227 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.23 -60.89 4.77 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 110.854 -0.898 . . . . 64.01 110.854 -174.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.71 127.88 34.39 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.213 1.005 . . . . 74.35 110.554 171.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -98.74 -110.54 3.03 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 109.825 -1.31 . . . . 72.12 109.825 172.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 4.9 t -166.91 118.88 0.94 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.075 0.95 . . . . 74.23 108.887 175.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . 0.66 ' HB2' ' HG3' ' H' ' 24' ' ' PRO . 6.6 mm-40 -63.06 132.73 52.9 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.696 1.198 . . . . 74.22 113.183 -173.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -142.67 116.06 9.04 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.104 -1.073 . . . . 74.44 108.104 167.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -124.92 46.91 2.23 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.142 -1.058 . . . . 73.14 108.142 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -70.42 -38.32 74.58 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 113.457 -1.701 . . . . 75.51 110.811 -176.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -75.53 -29.48 59.47 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.512 -0.767 . . . . 73.52 110.388 176.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.36 0 C-N-CA 124.83 1.252 . . . . 74.44 111.34 179.044 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 1' ' ' MET . . . . . 0.575 ' HA ' HG23 ' C' ' 55' ' ' VAL . 67.1 mtm . . . . . 0 N--CA 1.477 0.908 0 CA-C-O 120.704 0.287 . . . . 75.35 110.303 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 2' ' ' LYS . . . . . 0.538 ' HB2' ' HZ2' ' E' ' 2' ' ' LYS . 0.0 OUTLIER -88.82 93.82 9.71 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.812 -0.81 . . . . 72.44 108.812 172.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -88.8 -26.76 21.53 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 116.148 -0.478 . . . . 55.33 110.689 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 44.9 m 62.44 91.09 0.07 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.105 0.962 . . . . 51.41 111.021 -173.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 62.0 p -111.95 176.35 5.05 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.879 0.472 . . . . 63.33 110.353 174.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.658 HG23 HG22 ' A' ' 40' ' ' VAL . 41.9 pt -102.73 135.56 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 123.496 0.718 . . . . 74.13 111.219 -169.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 7' ' ' ALA . . . . . 0.409 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -127.17 162.88 25.1 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.79 0.836 . . . . 61.4 109.773 178.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . 0.408 HD23 HD22 ' A' ' 44' ' ' LEU . 93.3 mt -67.9 -90.69 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 122.691 0.397 . . . . 75.12 110.437 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . 166.3 -170.93 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.129 1.772 . . . . 64.25 108.331 -173.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . 0.4 ' HG ' HD22 ' A' ' 136' ' ' LEU . 3.3 tm? -96.38 135.56 38.07 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.304 -1.369 . . . . 62.35 107.304 167.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt -71.51 111.09 9.02 Favored Pre-proline 0 N--CA 1.483 1.218 0 C-N-CA 123.128 0.571 . . . . 64.32 110.368 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.99 -12.58 17.68 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 122.904 2.403 . . . . 62.23 111.869 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 70.6 mt -117.83 140.27 49.93 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.647 1.179 . . . . 75.42 108.494 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 97.9 mt -73.66 157.07 37.27 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.762 0.425 . . . . 73.25 110.116 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -91.38 27.48 1.94 Allowed 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.756 0.822 . . . . 74.11 109.826 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 36.7 m 68.15 123.65 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.45 0 C-N-CA 125.254 1.422 . . . . 75.55 110.597 -170.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 17' ' ' PRO . . . . . 0.436 ' HB2' HG23 ' E' ' 19' ' ' THR . 24.2 Cg_exo -65.54 177.62 2.63 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.877 2.384 . . . . 74.24 113.309 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 18' ' ' VAL . . . . . 0.508 HG21 HD12 ' A' ' 89' ' ' ILE . 22.2 t -81.64 13.29 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 123.845 0.858 . . . . 75.22 111.032 -175.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 19' ' ' THR . . . . . 0.436 HG23 ' HB2' ' E' ' 17' ' ' PRO . 4.6 t -74.43 78.92 1.9 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.69 0.796 . . . . 74.11 109.815 172.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 20' ' ' LYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 96.4 mttt 70.6 -59.24 0.53 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.813 1.645 . . . . 74.12 111.578 -173.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 69.95 -4.22 1.54 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.204 1.002 . . . . 73.31 113.134 172.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 22' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 49' ' ' SER . 45.5 ttt180 -82.83 80.83 8.79 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 107.913 -1.143 . . . . 73.24 107.913 177.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 9.5 t -159.13 135.73 6.57 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-N 115.395 -0.821 . . . . 74.45 110.956 -173.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -66.12 -34.46 37.08 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.691 2.26 . . . . 72.03 112.233 169.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 . . . . . 0 C--O 1.249 1.066 0 N-CA-C 108.215 -1.032 . . . . 72.54 108.215 176.958 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 109.962 -0.384 . . . . 61.45 109.962 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -116.56 177.15 4.8 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 107.981 -1.118 . . . . 73.43 107.981 173.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -77.1 157.34 31.1 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 108.631 -0.877 . . . . 63.04 108.631 162.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 81.1 p -54.7 -41.37 70.18 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.802 0.841 . . . . 64.25 112.066 -173.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 30.5 m -151.6 125.99 9.41 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.137 0.975 . . . . 71.03 108.486 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . 0.502 HD13 ' HB2' ' B' ' 42' ' ' LEU . 33.9 pt -78.12 137.56 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 122.775 0.43 . . . . 65.32 111.18 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -152.69 150.4 29.41 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.595 0.758 . . . . 74.33 110.381 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . 0.61 HD12 HG21 ' B' ' 131' ' ' VAL . 94.4 mt -68.6 143.78 54.74 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.064 0.946 . . . . 71.21 110.199 174.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.67 -74.11 0.18 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.797 0.839 . . . . 65.14 111.666 -172.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 8.5 tt -179.2 149.52 0.41 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.154 -1.054 . . . . 73.12 108.154 -170.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . 0.456 HD23 HD22 ' B' ' 44' ' ' LEU . 91.1 mt -104.83 91.18 4.05 Favored Pre-proline 0 N--CA 1.486 1.344 0 C-N-CA 123.61 0.764 . . . . 75.41 110.476 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.34 -17.47 18.79 Favored 'Trans proline' 0 C--N 1.388 2.615 0 C-N-CA 122.43 2.087 . . . . 74.24 111.596 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 55.9 mt -68.73 -19.32 64.34 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 124.236 1.015 . . . . 60.55 110.621 170.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . 0.624 ' HB3' ' HB2' ' B' ' 95' ' ' ALA . 84.7 mt 61.53 30.47 18.75 Favored 'General case' 0 C--N 1.367 1.35 0 C-N-CA 124.484 1.114 . . . . 75.15 109.97 -173.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . 0.515 ' HE2' ' HB3' ' B' ' 48' ' ' SER . 26.2 t80 59.66 -87.27 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 125.609 1.564 . . . . 71.44 109.728 -174.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 6.6 p -154.3 113.15 2.46 Favored Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 125.0 1.32 . . . . 75.12 108.537 173.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.57 141.53 46.29 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 121.938 1.759 . . . . 73.15 110.552 168.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . 0.559 HG21 HD12 ' B' ' 98' ' ' LEU . 8.2 t -68.92 138.73 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 110.007 -0.368 . . . . 75.23 110.007 -175.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 6.3 m -65.28 -34.3 78.01 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.482 0.713 . . . . 75.43 110.488 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 20' ' ' LYS . . . . . 0.537 ' H ' HG12 ' F' ' 18' ' ' VAL . 0.1 OUTLIER -156.52 102.72 2.08 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.916 1.286 . . . . 74.23 110.326 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . -124.97 40.43 3.75 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 122.129 0.966 . . . . 73.13 109.011 174.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -163.97 164.73 23.1 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-N 114.512 -1.222 . . . . 74.31 109.028 175.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 49.6 p -61.6 147.73 87.96 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.876 0.871 . . . . 75.45 110.739 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.78 -27.77 73.13 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.165 2.576 . . . . 74.02 112.179 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 124.52 1.128 . . . . 72.11 109.214 171.082 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' G' G ' 1' ' ' MET . . . . . 0.454 ' SD ' ' N ' ' G' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 110.197 -0.297 . . . . 75.14 110.197 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -162.47 -39.73 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.435 1.094 . . . . 74.52 109.253 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 52.82 13.37 0.34 Allowed 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 125.822 1.649 . . . . 74.33 115.227 166.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 4' ' ' SER . . . . . 0.464 ' HB2' ' HB3' ' G' ' 7' ' ' ALA . 15.6 m -80.94 154.39 27.02 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.199 0.6 . . . . 72.21 109.986 -177.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 5.2 t -54.91 -33.01 61.66 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.122 0.889 . . . . 73.14 111.399 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . 0.522 HG23 ' HB ' ' C' ' 40' ' ' VAL . 21.3 pt -130.3 -47.15 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.477 0.711 . . . . 74.2 111.089 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 7' ' ' ALA . . . . . 0.464 ' HB3' ' HB2' ' G' ' 4' ' ' SER . . . 59.9 -160.18 0.29 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.239 1.016 . . . . 70.4 112.454 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.0 135.58 54.55 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 107.74 -1.207 . . . . 75.32 107.74 171.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.29 139.47 32.29 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.481 0.712 . . . . 74.21 110.308 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 89.8 mt -61.82 126.04 25.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.702 0.801 . . . . 75.12 110.822 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 95.2 mt -67.9 133.45 92.11 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 123.293 0.637 . . . . 64.41 111.064 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.72 -23.88 25.89 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.967 2.445 . . . . 75.45 112.552 174.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 52.5 tp -150.48 137.69 19.45 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.14 0.976 . . . . 74.43 108.718 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 73.2 mt -95.16 -178.53 4.5 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.516 0.726 . . . . 64.22 110.16 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.0 152.58 43.43 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.299 0.639 . . . . 74.45 110.498 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 59.9 p -73.7 138.89 77.06 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 123.329 0.651 . . . . 62.11 110.867 -174.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 17' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -52.53 134.5 52.87 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.751 2.967 . . . . 73.22 114.553 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 18' ' ' VAL . . . . . 0.52 HG23 HD12 ' C' ' 98' ' ' LEU . 22.1 t -66.03 128.92 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.521 0.728 . . . . 74.32 110.291 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 94.2 m 68.34 -72.0 0.1 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.813 1.245 . . . . 74.23 111.32 176.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 20' ' ' LYS . . . . . 0.53 ' HZ3' ' HB2' ' G' ' 20' ' ' LYS . 4.1 ttmp? -169.63 37.73 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 108.306 -0.998 . . . . 74.24 108.306 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.95 75.53 0.21 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 122.126 0.965 . . . . 73.24 111.379 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -164.56 -71.03 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.331 -1.359 . . . . 74.12 107.331 -169.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -168.33 139.8 2.26 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 125.067 1.347 . . . . 62.23 108.6 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -60.97 141.72 95.34 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.743 2.296 . . . . 73.41 112.31 172.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 25' ' ' GLU . . . . . 0.481 ' HG2' ' HD3' ' G' ' 20' ' ' LYS . 6.7 pt-20 . . . . . 0 CA--C 1.554 1.122 0 C-N-CA 124.376 1.071 . . . . 73.31 109.13 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 49.0 ttm . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 109.901 -0.407 . . . . 74.42 109.901 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.56 82.25 7.39 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.324 0.65 . . . . 75.22 110.55 -171.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.43 28.34 0.24 Allowed 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 114.654 -1.157 . . . . 72.4 108.342 171.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 26.2 m -89.46 123.12 33.3 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.71 0.804 . . . . 74.03 109.69 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 16.4 m -60.34 -32.02 70.86 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.955 0.902 . . . . 73.54 111.081 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . . . . . . . . . 14.2 tt -138.95 129.11 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 123.946 0.898 . . . . 73.22 109.209 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -168.44 -156.15 0.17 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.199 1.0 . . . . 73.11 109.408 -175.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 78.9 mt -136.97 142.47 42.6 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.867 1.267 . . . . 73.23 108.848 173.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -99.9 144.55 28.82 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.395 0.678 . . . . 74.42 111.069 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 35.7 tp -69.11 155.42 40.4 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.716 0.806 . . . . 74.32 111.461 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 mp -86.19 128.13 58.83 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 123.385 0.674 . . . . 75.32 109.228 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.67 -31.71 8.33 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.623 2.216 . . . . 64.3 113.316 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -97.91 135.68 39.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.884 0.873 . . . . 74.41 109.241 -173.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . 0.467 ' HA ' ' HZ ' ' D' ' 137' ' ' PHE . 8.2 mp -76.64 125.46 29.29 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.431 0.692 . . . . 75.25 109.861 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -65.45 146.2 55.18 Favored 'General case' 0 CA--C 1.551 1.018 0 O-C-N 124.159 0.912 . . . . 73.14 110.774 -171.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 19.5 p -62.43 147.47 91.88 Favored Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 124.808 1.243 . . . . 73.32 112.233 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 17' ' ' PRO . . . . . 0.694 ' HB3' ' HB2' ' H' ' 21' ' ' ALA . 55.9 Cg_endo -67.04 169.12 15.64 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.256 2.637 . . . . 74.23 113.815 -177.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . 0.724 HG22 ' HB ' ' D' ' 86' ' ' ILE . 45.6 t -81.06 -74.76 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.002 0.921 . . . . 72.24 110.121 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 46.1 m -111.92 -58.82 2.07 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.432 -0.951 . . . . 75.13 108.432 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -141.63 123.52 15.32 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 115.436 -0.802 . . . . 75.24 109.697 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . 0.694 ' HB2' ' HB3' ' H' ' 17' ' ' PRO . . . -163.08 138.72 6.83 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.526 1.13 . . . . 73.2 108.092 171.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . 0.56 ' HD2' ' H ' ' H' ' 22' ' ' ARG . 0.1 OUTLIER -69.5 87.22 0.46 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.97 0.908 . . . . 75.21 108.558 177.159 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 90.9 m -151.01 93.36 3.68 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 124.376 1.07 . . . . 72.01 108.459 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 24' ' ' PRO . . . . . 0.66 ' HG3' ' HB2' ' D' ' 150' ' ' GLU . 32.6 Cg_endo -87.68 166.59 7.45 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 123.109 2.539 . . . . 74.03 111.814 174.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 C--O 1.253 1.278 0 N-CA-C 108.643 -0.873 . . . . 73.53 108.643 176.95 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 mtt . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 121.533 0.682 . . . . 74.2 109.411 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.4 p -90.77 -57.79 2.7 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.122 -0.945 . . . . 72.33 109.795 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -129.59 47.17 2.53 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 107.887 -1.153 . . . . 71.35 107.887 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 68.61 133.74 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 113.404 -1.726 . . . . 75.45 112.39 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -76.38 79.56 3.12 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.45 -0.944 . . . . 73.55 108.45 172.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -90.89 123.96 34.82 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.932 -0.766 . . . . 71.0 108.932 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.9 p -75.84 75.05 2.78 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.897 0.879 . . . . 74.22 110.388 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -85.64 -59.27 2.36 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.922 0.889 . . . . 74.34 109.793 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -155.88 142.19 18.44 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.204 -1.036 . . . . 75.41 108.204 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.0 m -140.44 143.72 35.72 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.468 0.707 . . . . 74.45 110.253 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.555 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 25.5 t80 -136.52 124.33 22.58 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.004 0.922 . . . . 73.51 109.274 177.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -144.67 112.9 6.48 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.991 0.916 . . . . 71.44 109.05 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.652 HG12 ' HD2' ' A' ' 84' ' ' PHE . 43.0 mt -77.88 115.06 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 109.702 -0.481 . . . . 73.54 109.702 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -73.39 -27.96 61.75 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 123.801 0.688 . . . . 71.34 111.1 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.2 ttt85 -177.57 149.01 0.6 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 123.265 0.353 . . . . 74.32 111.448 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 91.6 mt -137.23 130.63 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.239 -1.022 . . . . 73.32 108.239 168.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 35.1 p90 -166.14 157.63 13.62 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 124.19 0.931 . . . . 75.12 110.484 -168.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.3 p -83.28 109.82 17.58 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.773 -1.103 . . . . 75.44 108.375 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.492 ' HE3' ' HB1' ' B' ' 28' ' ' ALA . 35.3 mtpt -75.05 -38.3 61.43 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.083 -0.71 . . . . 62.22 109.083 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.523 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 31.4 t70 -140.33 136.48 33.25 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 113.93 -1.486 . . . . 70.15 109.617 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.4 mt -130.23 144.73 37.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 125.406 1.482 . . . . 73.43 107.043 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.488 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 48.3 t -148.82 130.28 14.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.815 -0.809 . . . . 74.24 108.815 174.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.557 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 93.4 t80 -134.72 142.08 46.67 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.375 -1.343 . . . . 74.2 107.375 173.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -141.45 151.16 43.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.446 -0.946 . . . . 74.22 108.446 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.52 81.22 17.66 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 106.905 -1.517 . . . . 74.45 106.905 171.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.16 -46.39 33.91 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.589 2.859 . . . . 73.22 114.303 -166.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.18 37.56 3.97 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.549 -0.908 . . . . 74.53 108.549 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.566 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -40.18 -57.26 2.92 Favored Pre-proline 0 CA--C 1.569 1.686 0 N-CA-C 114.274 1.212 . . . . 74.34 114.274 -172.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 27.9 Cg_exo -62.17 -29.69 81.05 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.042 1.828 . . . . 74.25 114.006 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -83.0 -32.64 26.84 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.689 0.796 . . . . 75.24 111.347 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.638 HG22 ' HA ' ' A' ' 73' ' ' ALA . 3.2 p -77.52 -22.31 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.542 0.737 . . . . 74.43 111.265 -166.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -71.47 -22.38 61.82 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.708 -0.678 . . . . 75.34 110.773 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -80.83 -21.61 40.67 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.284 1.033 . . . . 70.1 110.633 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -82.03 170.8 15.13 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.149 0.98 . . . . 75.51 111.568 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -88.3 131.54 34.75 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.687 0.795 . . . . 75.02 110.044 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.461 ' CE3' HD21 ' A' ' 68' ' ' LEU . 66.4 t-105 -84.47 85.53 7.39 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 121.582 0.706 . . . . 72.32 111.058 -176.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -135.16 80.63 46.76 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 107.225 -1.398 . . . . 71.04 107.225 167.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -82.01 154.24 17.09 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.666 2.244 . . . . 73.12 112.658 -173.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -102.41 85.85 2.7 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.782 -1.562 . . . . 72.34 106.782 170.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.633 ' HB ' HG23 ' E' ' 6' ' ' ILE . 55.7 t -78.89 97.26 2.33 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 CA-C-N 115.54 -0.755 . . . . 75.52 109.965 -173.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.513 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 56.8 mtpt -79.39 124.18 28.19 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.127 -0.942 . . . . 75.24 109.196 174.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.748 HD21 ' HB ' ' E' ' 6' ' ' ILE . 1.9 mm? -97.71 108.37 21.07 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 105.922 -1.881 . . . . 73.43 105.922 169.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.755 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 15.0 m-20 -104.5 117.68 34.75 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.628 -0.878 . . . . 60.43 108.628 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -97.53 122.41 40.56 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.892 0.877 . . . . 72.15 109.512 -171.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -136.22 139.36 42.7 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.296 0.638 . . . . 75.05 109.404 172.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.1 p -111.98 136.94 50.66 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.661 0.784 . . . . 74.31 110.239 -175.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.08 110.82 5.64 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 108.341 -0.985 . . . . 62.04 108.341 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 p -132.0 152.04 51.38 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.947 -0.471 . . . . 73.54 109.931 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -152.36 132.38 13.42 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.155 0.582 . . . . 63.24 110.982 -170.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -75.11 126.05 30.21 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 108.936 -0.764 . . . . 75.45 108.936 172.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.568 HD12 HG22 ' A' ' 83' ' ' ILE . 76.1 mt -97.99 -33.24 11.27 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.723 0.409 . . . . 75.22 110.387 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.4 -176.15 5.44 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.178 0.991 . . . . 72.25 110.014 176.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.61 124.2 21.27 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 108.631 -0.877 . . . . 64.22 108.631 169.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 65.04 11.79 7.4 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.465 1.106 . . . . 74.2 112.62 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.06 122.59 65.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 107.938 -1.134 . . . . 75.23 107.938 174.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -140.06 169.01 18.49 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.103 -0.702 . . . . 74.3 109.103 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -129.92 127.31 39.87 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.197 -0.91 . . . . 74.51 108.807 176.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.56 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 91.9 t -102.52 120.91 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.509 -1.293 . . . . 75.13 107.509 168.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.47 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 25.9 t -107.76 131.24 58.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 107.408 -1.331 . . . . 74.53 107.408 168.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 tt -119.24 107.49 13.48 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.627 -0.879 . . . . 70.42 108.627 176.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 31.3 ttt180 -84.47 102.09 12.55 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.373 1.069 . . . . 72.11 109.366 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.4 t -98.41 102.51 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 108.196 -1.038 . . . . 73.2 108.196 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.755 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 33.2 m -94.82 108.02 20.04 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.976 -1.12 . . . . 75.51 107.976 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.3 t -103.22 110.23 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.218 0.607 . . . . 73.24 109.698 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.513 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 11.6 m -100.56 141.18 33.78 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.304 -0.998 . . . . 72.31 108.304 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.89 119.21 20.85 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.239 -1.023 . . . . 64.3 108.239 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.3 m -130.02 126.9 38.82 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.451 0.469 . . . . 72.14 110.724 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.461 HD21 ' CE3' ' A' ' 36' ' ' TRP . 29.6 mt -87.4 80.86 8.01 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 124.722 1.209 . . . . 74.44 109.163 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.5 -84.05 0.87 Allowed Glycine 0 C--N 1.34 0.782 0 CA-C-N 116.168 -0.469 . . . . 71.32 112.038 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -112.63 -27.9 8.02 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.368 0.667 . . . . 74.43 111.403 177.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -95.86 122.47 38.69 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 122.062 -0.399 . . . . 74.22 111.154 -173.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.3 m -65.77 126.8 29.61 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.06 0.457 . . . . 71.41 110.283 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.638 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -78.8 -56.77 4.15 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 114.975 -1.012 . . . . 72.24 109.531 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -159.45 172.71 17.4 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.601 -1.181 . . . . 65.33 111.257 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.9 tp -131.54 139.37 49.23 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 107.5 -1.296 . . . . 75.33 107.5 167.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.458 ' HB3' ' HE1' ' A' ' 117' ' ' MET . 59.3 m -138.31 95.47 3.01 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.827 -0.805 . . . . 75.14 108.827 175.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 33.9 tt0 -105.61 121.16 43.4 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.407 0.683 . . . . 74.21 109.293 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.2 t -129.59 112.47 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.158 0.504 . . . . 72.24 110.008 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 63.8 mt-30 -84.78 88.82 7.41 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.43 -0.952 . . . . 72.42 108.43 172.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -80.01 96.91 6.58 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.452 -0.794 . . . . 74.23 109.407 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.9 151.25 24.8 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 115.944 -0.571 . . . . 73.24 112.085 177.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.77 122.01 1.24 Allowed Glycine 0 CA--C 1.504 -0.631 0 N-CA-C 111.006 -0.837 . . . . 72.43 111.006 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.568 HG22 HD12 ' A' ' 51' ' ' LEU . 46.4 mt -82.1 122.97 37.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 108.188 -1.042 . . . . 74.31 108.188 173.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.652 ' HD2' HG12 ' A' ' 13' ' ' ILE . 22.6 m-85 -124.96 147.98 48.63 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 109.109 -0.7 . . . . 75.03 109.109 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.2 m -113.98 122.77 47.94 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.476 -0.935 . . . . 73.14 108.476 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.8 125.97 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 N-CA-C 108.555 -0.906 . . . . 71.44 108.555 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.72 135.74 22.48 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.474 0.71 . . . . 72.31 110.347 -176.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.95 -62.29 0.34 Allowed Glycine 0 C--N 1.352 1.444 0 N-CA-C 114.038 0.375 . . . . 72.12 114.038 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 48.7 mm -120.88 -40.69 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 112.144 0.424 . . . . 74.21 112.144 -167.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 64.54 -163.7 0.26 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.227 1.011 . . . . 72.22 111.229 -166.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.37 -137.82 26.77 Favored Glycine 0 C--N 1.356 1.681 0 CA-C-O 119.672 -0.515 . . . . 44.25 113.393 175.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.486 HG21 ' HD2' ' E' ' 24' ' ' PRO . 27.8 p -72.42 -26.48 61.87 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.8 0.84 . . . . 62.45 111.727 -177.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -59.64 -52.44 65.52 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.782 0.833 . . . . 73.21 110.159 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 14.0 ptt? -83.29 -16.05 47.77 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.84 -0.618 . . . . 74.11 111.508 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.57 -32.48 73.27 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 118.093 0.406 . . . . 74.11 110.921 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.45 ' NE2' ' HB2' ' A' ' 134' ' ' ASP . 45.3 t-80 -67.49 -27.71 67.24 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.918 -0.583 . . . . 74.55 110.732 172.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.509 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 58.3 m -76.78 -63.91 1.24 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 122.71 0.404 . . . . 64.41 110.404 177.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.21 -30.65 71.15 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.978 0.911 . . . . 75.35 112.28 -171.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.42 -1.28 40.75 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-O 119.115 -0.825 . . . . 64.1 114.389 -172.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.427 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -148.86 -59.82 0.23 Allowed 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.985 1.106 . . . . 73.54 113.985 -173.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.509 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 80.1 t80 -74.15 -55.33 6.2 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.167 0.587 . . . . 75.21 111.491 -169.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 79.3 m -65.58 -36.24 14.02 Favored Pre-proline 0 CA--C 1.567 1.632 0 N-CA-C 113.084 0.772 . . . . 74.34 113.084 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.02 -46.65 27.13 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 122.68 2.253 . . . . 70.43 113.735 160.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -69.44 -27.68 65.46 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.546 0.739 . . . . 74.12 110.432 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.62 -38.59 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 C-N-CA 123.382 0.673 . . . . 74.24 110.22 173.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 70.2 mt -76.8 -22.96 52.9 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.616 0.766 . . . . 75.44 112.36 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -61.12 -45.67 95.95 Favored Pre-proline 0 CA--C 1.567 1.607 0 N-CA-C 114.387 1.254 . . . . 73.2 114.387 -171.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -62.6 -34.79 73.55 Favored 'Trans proline' 0 C--N 1.384 2.435 0 CA-C-N 121.676 1.634 . . . . 73.11 113.038 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -70.37 -43.59 69.82 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.229 0.612 . . . . 72.22 111.078 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.11 -36.7 80.19 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.991 -0.55 . . . . 71.03 110.484 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.518 ' NH1' HD13 ' C' ' 105' ' ' ILE . 28.7 ttm180 -54.58 -56.78 15.38 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.859 0.863 . . . . 71.14 109.903 172.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.09 -43.39 95.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.956 0.902 . . . . 75.25 111.768 -174.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 38.2 t -59.51 -42.56 92.49 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.785 0.678 . . . . 73.24 110.613 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.3 mt -68.24 -47.61 77.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 115.497 -0.774 . . . . 72.41 110.328 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 60.2 m -55.49 -41.42 72.99 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.96 0.904 . . . . 72.22 111.527 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.0 t -70.79 -44.61 66.28 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 114.994 -1.003 . . . . 75.5 110.381 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.557 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 21.1 mtp -61.6 -41.47 97.49 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.543 0.737 . . . . 73.02 111.727 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.16 -45.87 97.73 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 123.931 0.892 . . . . 74.54 110.503 175.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 26.0 t -72.28 -30.17 64.57 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.706 -0.679 . . . . 63.44 111.764 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -74.77 -28.62 60.83 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.334 0.653 . . . . 71.31 109.572 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.3 15.83 37.58 Favored Glycine 0 C--N 1.352 1.444 0 O-C-N 123.831 0.707 . . . . 62.15 113.04 172.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.447 HG23 ' HE ' ' B' ' 15' ' ' ARG . 3.0 t 59.94 12.56 3.16 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 127.054 2.142 . . . . 71.33 113.685 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -79.8 147.44 66.61 Favored Pre-proline 0 C--O 1.244 0.781 0 C-N-CA 123.25 0.62 . . . . 73.15 109.502 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.03 141.47 98.34 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.651 2.234 . . . . 60.54 111.748 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -56.28 143.11 35.2 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.029 1.122 . . . . 75.0 114.029 -168.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.1 tp -129.14 113.79 15.53 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.451 1.1 . . . . 74.02 109.195 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -112.75 126.2 55.15 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.381 0.672 . . . . 72.55 109.823 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.13 134.93 46.03 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.389 -0.597 . . . . 75.34 109.389 172.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.62 143.22 84.67 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 122.666 0.386 . . . . 54.34 110.879 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -61.11 126.85 20.49 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.537 2.825 . . . . 71.32 112.558 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.3 m -129.61 113.56 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 123.641 0.777 . . . . 72.34 109.825 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -95.91 89.58 5.29 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.285 0.634 . . . . 73.43 109.597 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -63.48 -36.11 82.69 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.349 -0.842 . . . . 73.53 110.362 176.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.45 ' HB2' ' NE2' ' A' ' 96' ' ' HIS . 8.6 p-10 -56.82 -42.7 80.05 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.654 1.182 . . . . 75.31 112.139 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.72 -42.3 97.94 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.569 0.543 . . . . 74.02 110.965 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 75.1 mt -65.28 -44.5 87.8 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.323 -0.853 . . . . 75.01 110.955 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -65.23 -30.89 71.82 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.337 0.655 . . . . 75.22 112.024 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.462 ' HE2' ' HA ' ' A' ' 138' ' ' MET . 30.1 mmt -70.18 -33.96 72.39 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.391 0.276 . . . . 73.34 110.969 176.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.517 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 87.5 m-20 -68.62 -20.92 64.5 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.677 0.791 . . . . 72.32 111.529 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -95.55 -38.37 10.45 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.124 0.57 . . . . 72.42 111.733 175.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 57.2 tp -68.87 -46.47 68.38 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.233 0.613 . . . . 74.54 112.017 -174.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -147.07 0.21 0.72 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.767 0.427 . . . . 70.35 110.581 -172.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.517 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 1.8 mp0 63.63 164.74 0.13 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.628 1.171 . . . . 63.14 110.929 -171.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -73.36 93.9 1.99 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.604 0.716 . . . . 75.43 109.361 174.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.95 163.6 32.98 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 114.489 -1.232 . . . . 64.13 109.084 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 150.25 158.39 8.19 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.993 -0.548 . . . . 74.22 112.04 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -134.74 -73.78 0.47 Allowed 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.526 -0.916 . . . . 72.35 108.526 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 62.44 66.38 2.63 Favored Glycine 0 C--N 1.351 1.386 0 O-C-N 123.542 0.527 . . . . 71.05 113.299 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.2 p -106.01 -73.25 0.69 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.27 0.628 . . . . 62.24 109.826 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 55.83 23.09 6.11 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.083 0.953 . . . . 73.33 111.532 -175.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -92.98 149.02 21.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.032 1.333 . . . . 74.02 108.026 -173.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 83.2 t60 70.35 97.28 0.07 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.446 1.098 . . . . 64.32 109.919 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -141.29 92.22 2.46 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.683 -1.228 . . . . 74.24 107.683 177.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -133.95 173.1 11.93 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.599 0.76 . . . . 74.34 110.509 -167.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 C-N-CA 123.739 0.815 . . . . 74.53 109.201 179.422 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.42 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 109.848 -0.427 . . . . 74.11 109.848 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 17.6 m -97.68 -77.07 0.51 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.741 -0.836 . . . . 75.42 108.741 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -174.15 134.25 0.43 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.6 0.76 . . . . 72.52 109.311 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -87.01 24.12 1.6 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.813 0.845 . . . . 74.12 112.07 -177.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -70.59 124.91 25.37 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.349 1.06 . . . . 74.21 110.48 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 64.7 t30 68.67 144.44 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 125.939 1.696 . . . . 74.43 111.395 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t -134.03 120.24 19.99 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.421 0.629 . . . . 74.44 111.343 -173.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -142.95 -45.61 0.3 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.763 1.225 . . . . 74.3 108.046 168.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.612 ' HB3' HG12 ' B' ' 89' ' ' ILE . 5.5 ppp? 51.58 -171.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 126.485 1.914 . . . . 71.41 113.614 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 93.8 m -134.03 107.1 7.57 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.897 -0.779 . . . . 71.33 108.897 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.52 ' HB2' ' SD ' ' B' ' 9' ' ' MET . 41.4 t80 -123.53 142.95 50.51 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.536 -0.756 . . . . 73.24 110.057 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -160.04 140.79 12.09 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.677 0.611 . . . . 73.21 109.61 174.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.404 HD11 HD11 ' B' ' 16' ' ' ILE . 42.8 mt -79.69 125.99 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 108.693 -0.854 . . . . 74.21 108.693 170.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -98.14 -37.31 9.77 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.394 0.678 . . . . 75.31 109.22 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.447 ' HE ' HG23 ' A' ' 122' ' ' THR . 45.4 ttt180 -174.19 144.32 0.95 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.479 -0.782 . . . . 75.21 109.037 -176.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.404 HD11 HD11 ' B' ' 13' ' ' ILE . 96.5 mt -128.23 142.45 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.55 -1.278 . . . . 74.42 107.55 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -168.63 148.91 4.53 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.664 0.745 . . . . 73.52 112.712 -174.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.572 HG23 HD11 ' B' ' 21' ' ' ILE . 52.5 m -73.72 124.87 26.84 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.147 -1.388 . . . . 74.12 108.945 167.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.433 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 37.6 mtpt -98.41 -21.51 16.54 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.635 0.774 . . . . 74.11 110.863 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -165.56 138.64 4.38 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.761 0.663 . . . . 64.23 110.706 -167.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.572 HD11 HG23 ' B' ' 18' ' ' THR . 48.5 mm -132.96 143.87 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.076 0.951 . . . . 74.21 110.191 174.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.636 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 75.6 m -134.24 136.47 43.66 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 125.911 1.684 . . . . 64.23 107.199 169.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.4 t80 -151.48 114.83 4.8 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.474 -1.306 . . . . 63.31 107.474 165.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -119.31 155.83 31.12 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.379 -0.971 . . . . 63.32 108.379 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.52 86.06 8.27 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 107.766 -1.198 . . . . 64.01 107.766 177.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.24 -45.79 21.43 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.593 2.862 . . . . 74.24 113.86 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -104.0 24.59 11.12 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.186 0.594 . . . . 72.15 110.849 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.492 ' HB1' ' HE3' ' A' ' 19' ' ' LYS . . . -42.24 -62.73 1.09 Allowed Pre-proline 0 N--CA 1.485 1.283 0 N-CA-C 115.202 1.556 . . . . 74.52 115.202 -165.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HB1' ' B' ' 28' ' ' ALA . 51.9 Cg_exo -53.44 -43.23 59.26 Favored 'Trans proline' 0 C--N 1.39 2.751 0 C-N-CA 122.072 1.848 . . . . 72.02 113.878 -168.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -97.12 -22.43 16.77 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.285 0.846 . . . . 74.45 113.285 -171.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.402 HG11 ' O ' ' B' ' 28' ' ' ALA . 9.6 p -68.64 -17.56 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 118.452 0.569 . . . . 64.22 112.06 -173.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -70.48 -15.61 62.82 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 113.305 0.854 . . . . 74.32 113.305 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -61.6 -27.19 68.47 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.152 0.501 . . . . 74.21 109.765 173.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -86.92 80.34 8.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.336 1.054 . . . . 75.43 110.067 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -91.47 90.41 7.64 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.923 -0.581 . . . . 73.0 109.493 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -161.51 -175.64 4.89 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.723 1.209 . . . . 63.5 108.549 172.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -81.32 109.63 14.94 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 122.951 0.501 . . . . 74.51 110.109 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.68 160.22 50.54 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.442 2.095 . . . . 72.42 113.109 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -66.17 112.64 4.03 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.269 0.628 . . . . 74.12 109.63 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 51.5 t -88.86 134.66 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.803 0.841 . . . . 74.4 109.747 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -140.87 118.0 11.26 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 106.532 -1.655 . . . . 73.31 106.532 175.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 pp -114.34 166.58 11.52 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.01 0.433 . . . . 73.33 111.771 -176.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.535 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 14.2 m-20 -147.31 155.87 42.41 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.412 1.085 . . . . 73.41 109.206 174.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -120.98 146.58 46.52 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.31 -0.996 . . . . 62.41 108.31 172.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.594 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 7.4 t70 -137.91 138.19 38.78 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.856 0.862 . . . . 73.14 108.935 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 36.7 p -109.64 127.77 54.77 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.301 0.64 . . . . 72.31 111.166 -175.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.49 142.78 29.53 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.018 0.927 . . . . 75.25 108.622 174.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 35.2 p -144.53 163.62 33.32 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 122.705 0.402 . . . . 73.41 110.855 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 79.6 p -151.1 138.41 19.39 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.875 0.87 . . . . 72.33 109.018 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -96.83 134.06 40.62 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.23 -0.656 . . . . 61.3 109.23 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 46.7 mt -101.12 -39.92 7.44 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.196 0.598 . . . . 70.2 110.64 -175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.73 -173.98 4.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.388 -0.824 . . . . 64.23 110.449 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.12 121.68 19.68 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.009 -0.996 . . . . 71.41 108.864 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 75.51 -7.5 1.77 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 126.246 1.818 . . . . 71.53 112.584 -175.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 96.1 t -110.87 112.28 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.279 -0.637 . . . . 74.04 109.279 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -119.6 -179.77 3.98 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.572 -0.899 . . . . 75.13 108.572 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -144.05 107.01 4.48 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.988 -1.115 . . . . 73.54 107.988 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 74.1 t -96.83 128.55 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.233 1.013 . . . . 73.02 110.212 -175.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.47 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 12.7 t -118.37 126.28 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.86 0.864 . . . . 72.43 109.563 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.683 HD23 ' HB3' ' B' ' 103' ' ' PRO . 52.2 tp -112.85 115.5 28.56 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.482 -0.933 . . . . 74.1 108.482 164.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.594 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 17.2 ttt180 -92.47 118.22 30.74 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.884 -0.784 . . . . 74.13 108.884 175.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.74 121.21 54.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.361 -0.977 . . . . 72.45 108.361 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.535 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 22.6 m -104.82 143.78 32.67 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.881 -0.785 . . . . 75.11 108.881 177.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.457 HG21 HG23 ' B' ' 114' ' ' ILE . 95.0 t -136.29 136.22 49.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 123.785 0.834 . . . . 75.33 108.854 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.8 m -125.86 143.75 50.94 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.609 1.163 . . . . 73.23 108.068 172.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.68 139.2 23.81 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.083 -0.71 . . . . 71.44 109.083 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.497 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 33.2 p -140.37 128.16 21.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.887 -0.597 . . . . 54.51 110.192 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 61.6 mt -96.89 105.42 17.56 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.027 -1.101 . . . . 73.41 108.027 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.26 -111.85 3.52 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 115.663 -0.699 . . . . 75.44 111.644 -173.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -121.76 3.99 10.04 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.781 0.832 . . . . 71.44 110.328 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -113.56 139.02 49.34 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.46 -0.571 . . . . 74.53 109.46 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 94.4 m -67.52 113.41 5.33 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.319 0.581 . . . . 64.42 109.97 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.497 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -70.44 -62.03 1.54 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.258 -1.337 . . . . 75.02 108.331 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -150.22 155.04 39.0 Favored 'General case' 0 C--N 1.347 0.491 0 N-CA-C 112.853 0.686 . . . . 75.32 112.853 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 64.8 mt -123.27 110.94 15.84 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.076 -1.453 . . . . 75.44 107.076 171.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' B' ' 114' ' ' ILE . 37.8 t -118.46 139.23 51.74 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 108.809 -0.811 . . . . 75.41 108.809 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.636 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 39.6 tt0 -156.72 131.9 9.15 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.589 -0.522 . . . . 72.12 109.589 -172.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 98.3 t -128.15 147.91 32.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 123.715 0.806 . . . . 74.41 109.183 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -110.92 103.72 12.25 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.305 -1.368 . . . . 74.35 107.305 165.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.437 ' HB2' ' HB1' ' B' ' 110' ' ' ALA . 7.8 tp-100 -92.96 98.99 11.71 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.387 -1.338 . . . . 73.22 107.387 173.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -96.01 171.31 28.42 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.732 -1.122 . . . . 72.12 110.662 173.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.51 137.11 4.18 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 111.275 -0.73 . . . . 41.23 111.275 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 45.4 mt -84.18 127.14 40.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 107.596 -1.261 . . . . 73.14 107.596 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -136.49 142.69 43.54 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.956 0.902 . . . . 75.31 109.159 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 27.3 m -89.13 113.46 24.63 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.03 -1.1 . . . . 74.31 108.03 168.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.48 HD13 ' SG ' ' B' ' 97' ' ' CYS . 0.4 OUTLIER -130.27 107.83 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.329 1.052 . . . . 74.11 108.322 -176.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' B' ' 9' ' ' MET . . . -156.65 171.89 19.54 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.54 1.136 . . . . 75.41 110.286 -177.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.75 -57.18 1.13 Allowed Glycine 0 C--N 1.346 1.094 0 N-CA-C 112.444 -0.262 . . . . 53.42 112.444 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.612 HG12 ' HB3' ' B' ' 9' ' ' MET . 4.2 mm -83.01 156.31 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.216 0.607 . . . . 74.25 110.394 175.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -152.34 -173.31 4.51 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.195 -0.912 . . . . 74.22 110.665 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.71 -120.46 8.15 Favored Glycine 0 C--N 1.351 1.392 0 CA-C-N 115.607 -0.724 . . . . 73.2 113.289 170.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.8 m -83.48 -37.48 23.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.513 0.673 . . . . 75.15 110.643 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -72.61 -23.17 60.9 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.96 -1.018 . . . . 70.4 111.462 -167.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -71.46 -29.8 65.28 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.028 0.531 . . . . 74.34 111.09 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.64 -37.47 78.78 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.481 0.712 . . . . 73.21 110.692 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -75.15 -30.63 60.81 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.355 -0.839 . . . . 74.2 111.321 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.48 ' SG ' HD13 ' B' ' 86' ' ' ILE . 46.1 t -69.41 -66.7 0.55 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 122.296 0.238 . . . . 73.32 111.544 -174.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.552 HD11 ' HD2' ' F' ' 17' ' ' PRO . 2.0 pt? -88.32 -3.59 58.82 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.263 -0.898 . . . . 74.22 111.393 -178.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.79 -4.47 59.0 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-O 119.824 -0.431 . . . . 74.54 114.114 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.643 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -148.46 -50.0 0.16 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 117.576 0.688 . . . . 75.33 111.493 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.499 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 46.3 t80 -67.84 -47.83 67.88 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.148 0.579 . . . . 75.03 111.617 -175.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.479 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 59.2 m -66.46 -48.18 56.52 Favored Pre-proline 0 N--CA 1.488 1.468 0 CA-C-O 119.056 -0.497 . . . . 73.35 112.208 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.683 ' HB3' HD23 ' B' ' 60' ' ' LEU . 72.3 Cg_exo -55.77 -29.98 74.13 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.293 1.996 . . . . 72.4 114.283 170.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -66.68 -37.09 84.03 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.686 0.795 . . . . 75.41 110.618 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.28 -42.76 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 123.544 0.738 . . . . 75.04 110.169 175.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 78.7 mt -78.88 -17.21 55.97 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.298 -1.319 . . . . 72.24 111.728 -174.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.433 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 71.9 t80 -56.92 -53.91 60.01 Favored Pre-proline 0 CA--C 1.563 1.464 0 C-N-CA 124.365 1.066 . . . . 75.04 113.372 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 35.5 Cg_exo -63.27 -32.8 72.89 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 121.796 1.664 . . . . 74.21 113.292 -178.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -70.98 -44.01 66.87 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.441 0.697 . . . . 65.45 110.815 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.437 ' HB1' ' HB2' ' B' ' 80' ' ' GLN . . . -65.97 -36.79 84.29 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.677 0.391 . . . . 73.1 110.344 175.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -55.5 -56.36 21.09 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 124.311 1.007 . . . . 75.33 110.682 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -60.68 -40.24 91.43 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 123.633 0.583 . . . . 61.34 110.501 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.549 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.8 t -66.37 -38.87 88.54 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 123.505 0.503 . . . . 73.05 111.226 -175.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.457 HG23 HG21 ' B' ' 64' ' ' VAL . 97.2 mt -64.71 -52.21 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 123.132 0.573 . . . . 74.05 109.765 174.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 32.3 m -60.72 -32.48 71.74 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.784 0.834 . . . . 70.13 111.493 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.2 m -65.29 -46.58 79.86 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.852 0.461 . . . . 75.33 110.691 175.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.549 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -69.13 -34.4 74.96 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 123.229 0.331 . . . . 73.11 111.099 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.53 -40.91 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.607 0.763 . . . . 72.55 110.437 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -67.32 -37.04 82.68 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 114.95 -1.023 . . . . 72.43 111.561 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.478 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 85.6 mtt-85 -66.99 -36.38 82.03 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.314 -0.857 . . . . 74.3 109.368 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.49 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -83.62 11.65 55.33 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 124.278 0.986 . . . . 74.14 113.496 174.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 50.4 p 56.84 19.58 4.58 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 125.839 1.656 . . . . 65.44 114.648 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -78.9 166.64 40.9 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 123.63 0.772 . . . . 74.44 112.063 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.96 160.14 8.34 Favored 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 123.199 2.599 . . . . 64.33 114.059 171.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.419 HE21 ' ND2' ' B' ' 127' ' ' ASN . 66.7 tp60 -65.37 139.27 58.55 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.527 -0.761 . . . . 62.34 112.443 -173.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 51.5 tp -142.07 119.89 11.92 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.583 0.753 . . . . 75.34 109.667 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . 0.419 ' ND2' HE21 ' B' ' 125' ' ' GLN . 54.2 m-80 -127.51 135.48 50.42 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.117 0.967 . . . . 70.01 108.581 173.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.605 ' HA ' HD11 ' F' ' 6' ' ' ILE . 1.3 tt -78.5 124.26 27.94 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 108.743 -0.836 . . . . 74.35 108.743 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.28 141.94 98.23 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.982 0.913 . . . . 71.42 111.993 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -65.67 92.76 0.25 Allowed 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.627 2.218 . . . . 65.44 112.709 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.416 HG21 ' HA ' ' F' ' 7' ' ' ALA . 60.6 t -97.08 120.4 46.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 108.374 -0.973 . . . . 70.25 108.374 172.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -74.44 85.33 2.01 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 108.176 -1.046 . . . . 73.0 108.176 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.434 ' HZ ' ' HG ' ' F' ' 11' ' ' LEU . 12.9 t80 -69.15 -34.63 75.29 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.109 -1.405 . . . . 73.01 110.765 -173.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.643 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 19.0 t70 -58.94 -49.18 78.79 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.118 -1.401 . . . . 74.12 110.785 175.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.82 -38.29 86.16 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.497 0.719 . . . . 75.11 111.898 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.3 tt -62.63 -50.64 70.4 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.688 0.795 . . . . 74.51 109.663 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -71.26 -33.91 70.24 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.106 -0.952 . . . . 74.12 111.113 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 13.9 tmm? -64.46 -37.04 86.16 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.494 0.718 . . . . 72.2 110.188 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -74.13 -24.89 59.5 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.791 -1.095 . . . . 72.43 110.926 -171.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -62.46 -35.92 80.84 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.743 -0.662 . . . . 65.44 111.041 176.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 pp -120.75 18.96 11.88 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.545 0.738 . . . . 71.51 111.965 -173.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -71.59 -29.45 64.71 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 112.628 0.603 . . . . 73.43 112.628 -173.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -55.57 103.0 0.08 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.488 0.715 . . . . 74.51 111.87 -174.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -135.78 144.71 45.93 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.909 0.884 . . . . 74.22 109.873 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -111.52 144.99 39.86 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.878 0.871 . . . . 72.1 111.029 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.57 120.97 6.45 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 111.045 -0.822 . . . . 75.42 111.045 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -90.76 -173.99 3.91 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.586 0.754 . . . . 65.23 111.951 -174.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.91 -178.3 29.97 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.443 -0.799 . . . . 73.1 111.776 173.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 96.7 m -133.03 127.36 33.91 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.046 0.938 . . . . 74.44 109.545 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -91.88 127.79 37.48 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.9 -0.778 . . . . 74.23 108.9 171.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -99.46 171.6 7.85 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.899 0.879 . . . . 75.22 109.95 174.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -144.69 163.03 35.22 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.363 0.665 . . . . 64.45 110.154 -176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -72.17 157.43 37.76 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 120.883 0.373 . . . . 54.34 111.316 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -161.14 124.16 3.22 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.471 0.708 . . . . 75.34 109.314 177.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.077 0 C-N-CA 123.679 0.791 . . . . 74.21 110.392 178.151 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 109.342 -0.614 . . . . 73.22 109.342 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 41.1 t -84.96 63.61 8.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.904 0.882 . . . . 73.0 108.774 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -173.61 146.87 1.36 Allowed 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.532 1.133 . . . . 63.43 109.32 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . 0.405 HE22 HE22 ' C' ' 12' ' ' GLN . 35.5 tt0 -170.84 -47.75 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.229 1.012 . . . . 65.03 108.702 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 9.8 t30 66.79 98.26 0.05 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.067 1.347 . . . . 74.42 111.726 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -123.66 116.68 23.48 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.994 0.918 . . . . 74.32 108.78 174.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 40.0 p -110.09 112.39 24.34 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.675 0.79 . . . . 71.31 109.365 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 68.95 129.74 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.356 1.462 . . . . 73.51 110.646 -172.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.614 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 0.0 OUTLIER 64.74 113.08 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.883 1.273 . . . . 73.43 110.596 -174.835 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 93.4 m -97.55 102.41 14.17 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.789 -0.819 . . . . 74.4 108.789 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.614 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 1.1 t80 -112.87 128.71 56.53 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.512 -0.921 . . . . 74.43 108.512 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.405 HE22 HE22 ' C' ' 4' ' ' GLN . 7.5 tp-100 -143.49 128.93 19.01 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 108.886 -0.783 . . . . 75.21 108.886 171.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 37.8 mt -79.5 118.64 27.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.693 -0.855 . . . . 75.22 108.693 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.505 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 18.1 mm-40 -89.99 -33.07 16.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.996 -1.002 . . . . 53.24 109.635 -175.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -177.96 149.47 0.57 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.676 0.79 . . . . 75.42 109.353 -175.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 93.8 mt -137.25 140.25 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 107.965 -1.124 . . . . 75.24 107.965 174.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.407 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 21.1 p90 -171.04 167.37 7.23 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 120.796 0.331 . . . . 75.45 111.342 -171.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.5 p -95.69 127.97 42.17 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 109.456 -0.572 . . . . 74.04 109.456 175.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.407 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 16.7 mmtp -79.24 -50.13 11.42 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 122.597 1.189 . . . . 74.01 108.391 172.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 16.6 t70 -139.15 144.37 38.59 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 112.597 -2.092 . . . . 75.12 108.468 -167.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.458 HG21 ' HE2' ' C' ' 117' ' ' MET . 81.4 mt -138.38 149.35 24.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 106.767 -1.568 . . . . 72.32 106.767 175.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 43.2 t -157.24 150.32 23.67 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.34 0.656 . . . . 65.44 109.412 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -152.31 134.48 15.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.55 -1.278 . . . . 74.33 107.55 173.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . 0.429 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 42.2 mt-10 -133.89 110.85 10.01 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.484 0.713 . . . . 74.31 109.696 -176.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.02 79.11 73.66 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 106.979 -1.489 . . . . 63.14 106.979 163.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.19 -21.52 31.39 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.688 2.259 . . . . 72.44 111.947 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . 0.47 ' ND2' ' HB ' ' C' ' 31' ' ' VAL . 22.9 p-10 -102.38 22.12 13.95 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.586 1.155 . . . . 72.13 110.735 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.59 -58.39 4.51 Favored Pre-proline 0 CA--C 1.562 1.405 0 N-CA-C 114.738 1.385 . . . . 74.31 114.738 -169.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -63.2 -35.64 62.41 Favored 'Trans proline' 0 C--N 1.38 2.236 0 CA-C-N 121.889 1.71 . . . . 75.43 112.169 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -69.82 -37.26 76.17 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.193 0.997 . . . . 73.35 112.247 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.692 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.0 p -80.43 -16.69 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 N-CA-C 113.109 0.781 . . . . 75.15 113.109 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-30 -73.47 -23.14 60.04 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.735 -0.603 . . . . 75.01 111.983 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -90.02 17.93 6.36 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.123 0.569 . . . . 74.54 111.764 175.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.687 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 0.9 OUTLIER -109.45 146.84 33.85 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.922 0.889 . . . . 74.51 110.535 -172.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.51 131.41 49.04 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.679 0.792 . . . . 64.31 110.647 173.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -79.48 89.32 5.04 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.467 0.707 . . . . 70.31 110.421 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -138.42 67.08 45.11 Favored Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 124.062 0.945 . . . . 70.31 109.297 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -90.27 140.4 3.22 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.824 2.349 . . . . 73.51 113.316 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -88.74 101.21 13.79 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.832 -1.173 . . . . 74.43 107.832 166.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.48 HG13 HD13 ' G' ' 6' ' ' ILE . 38.6 t -78.56 97.84 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.779 -0.823 . . . . 71.2 108.779 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.537 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 94.0 mttt -97.97 105.11 17.2 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 114.562 -1.199 . . . . 74.31 108.338 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.504 HD12 HD21 ' C' ' 128' ' ' LEU . 2.8 mm? -85.61 139.68 31.22 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.997 -0.742 . . . . 71.33 108.997 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -141.86 106.69 4.9 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.47 -1.307 . . . . 73.24 107.47 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 8.1 mp -109.02 148.28 31.02 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.256 0.551 . . . . 73.32 110.176 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 14.1 t70 -130.48 145.22 51.8 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.923 1.289 . . . . 74.12 108.896 -174.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 61.7 p -116.71 112.83 21.76 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.984 0.914 . . . . 63.14 110.432 -167.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.26 143.18 39.95 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.102 0.561 . . . . 72.53 110.945 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 22.1 p -160.72 155.61 24.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.245 0.618 . . . . 73.13 110.657 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 90.1 p -143.96 154.07 42.92 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.489 0.715 . . . . 64.52 110.157 -175.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -84.89 123.23 30.25 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.954 0.502 . . . . 73.42 110.29 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.578 HD12 HD13 ' C' ' 83' ' ' ILE . 25.4 mt -100.23 -41.86 6.91 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.946 -0.761 . . . . 75.01 108.946 172.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . 0.401 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -153.35 -172.68 4.31 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.304 1.041 . . . . 74.13 109.611 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.75 117.1 11.83 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.225 -0.898 . . . . 72.24 109.498 173.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 71.95 -5.91 1.6 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.937 1.295 . . . . 73.52 112.78 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 92.2 t -105.9 107.6 23.04 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.396 -0.964 . . . . 74.44 108.396 174.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.478 ' CD1' HG22 ' G' ' 18' ' ' VAL . 7.4 m-85 -127.41 141.3 51.72 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.715 0.806 . . . . 75.34 109.131 -175.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.463 ' HB2' HD12 ' C' ' 51' ' ' LEU . 16.9 tt0 -83.2 111.52 19.01 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.103 -1.408 . . . . 72.23 108.826 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 92.0 t -97.03 119.46 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 108.789 -0.819 . . . . 63.54 108.789 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 33.3 t -123.75 118.21 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.517 0.727 . . . . 74.14 110.477 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 50.0 tp -105.34 110.81 23.31 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.269 -1.011 . . . . 73.12 108.269 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 0.3 OUTLIER -91.91 107.09 18.96 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.417 -0.586 . . . . 75.42 109.417 178.23 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.08 131.63 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.3 -1.0 . . . . 75.23 108.3 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 26.7 m -127.77 117.82 22.6 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.919 -0.771 . . . . 70.51 108.919 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.665 HG23 HG21 ' C' ' 114' ' ' ILE . 61.1 t -102.27 114.58 42.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 115.106 -0.952 . . . . 71.24 109.139 -177.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 27.8 m -98.01 137.11 37.3 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.008 -1.108 . . . . 74.44 108.008 170.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.18 109.5 6.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.235 -1.394 . . . . 64.3 107.235 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 62.6 m -131.38 128.63 40.0 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.013 0.435 . . . . 72.32 110.531 -176.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 10.4 mt -85.51 42.6 0.97 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.303 1.441 . . . . 74.44 110.916 -174.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.48 -89.54 0.54 Allowed Glycine 0 C--N 1.348 1.208 0 N-CA-C 110.898 -0.881 . . . . 72.42 110.898 -173.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.9 -25.58 5.8 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.247 1.019 . . . . 63.34 109.544 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.687 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 6.1 tp10 -76.37 120.98 22.35 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.107 1.363 . . . . 75.11 109.157 169.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 85.1 m -75.4 126.71 31.57 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.761 0.71 . . . . 74.44 109.422 171.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.692 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.31 -58.91 3.23 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.13 -0.692 . . . . 63.0 109.13 173.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . 0.45 ' HZ ' ' HG ' ' C' ' 126' ' ' LEU . 34.8 p90 -159.36 169.86 23.07 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.601 -1.181 . . . . 65.12 111.19 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.0 tm? -130.03 145.99 51.69 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 105.381 -2.081 . . . . 73.11 105.381 169.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 46.2 t -144.74 148.91 34.7 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.929 -1.138 . . . . 61.34 107.929 176.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -158.36 124.76 4.71 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 120.695 0.283 . . . . 72.21 110.628 -173.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 90.0 t -133.97 134.11 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.939 0.896 . . . . 74.32 109.139 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -101.31 93.37 5.39 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.354 -0.98 . . . . 74.34 108.354 170.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -81.53 101.49 9.98 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.393 -0.595 . . . . 72.32 109.393 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.16 169.43 45.93 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 115.797 -0.638 . . . . 63.42 112.472 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.51 126.9 1.08 Allowed Glycine 0 C--O 1.237 0.3 0 N-CA-C 111.452 -0.659 . . . . 64.42 111.452 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.578 HD13 HD12 ' C' ' 51' ' ' LEU . 10.7 mm -85.12 121.28 36.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 108.82 -0.808 . . . . 73.12 108.82 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -131.96 139.91 48.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.371 0.669 . . . . 75.44 109.317 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 16.9 p -92.39 114.51 27.08 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 109.19 -0.67 . . . . 70.53 109.19 170.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.39 104.55 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.405 -0.961 . . . . 72.31 108.405 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.01 165.89 25.94 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.845 0.858 . . . . 54.04 110.197 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.9 -59.72 2.07 Favored Glycine 0 C--N 1.344 1.004 0 O-C-N 123.242 0.339 . . . . 74.52 113.351 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 30.5 pt -81.09 162.65 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 122.923 0.489 . . . . 74.44 110.086 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.632 ' HA ' ' HE1' ' C' ' 94' ' ' MET . 14.0 pt-20 -147.82 174.24 12.03 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.844 0.458 . . . . 72.04 111.191 -175.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.11 -132.41 50.76 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.909 0.756 . . . . 52.5 114.022 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.0 p -64.17 -21.93 66.75 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.788 0.835 . . . . 64.13 112.259 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -65.29 -54.51 28.12 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.507 0.723 . . . . 73.13 110.629 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.632 ' HE1' ' HA ' ' C' ' 90' ' ' GLU . 10.2 ptp -72.17 -28.16 63.05 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 116.208 -0.451 . . . . 74.14 110.746 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' G' ' 21' ' ' ALA . . . -65.9 -32.83 74.56 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.226 0.611 . . . . 72.03 110.912 173.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -79.36 -32.08 43.12 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.592 -0.731 . . . . 72.34 110.795 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -59.84 -48.15 82.85 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.393 0.677 . . . . 74.03 111.29 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.558 HD12 ' HB2' ' G' ' 15' ' ' PHE . 1.0 OUTLIER -89.24 -20.07 24.6 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.595 0.358 . . . . 75.32 111.633 176.126 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.49 -29.68 39.18 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 115.064 0.786 . . . . 61.24 115.064 -172.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.88 -39.6 0.3 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.835 0.826 . . . . 70.21 111.265 -172.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.418 ' HE2' ' CE1' ' C' ' 11' ' ' PHE . 67.3 t80 -74.28 -41.03 61.89 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 113.792 -1.549 . . . . 75.34 112.801 -174.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 90.4 m -76.53 -39.45 2.44 Favored Pre-proline 0 N--CA 1.486 1.325 0 CA-C-O 118.959 -0.544 . . . . 75.42 111.938 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -45.55 -35.76 12.92 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.739 2.292 . . . . 75.44 114.652 163.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -66.13 -40.3 90.53 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.237 0.615 . . . . 74.42 110.205 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.518 HD13 ' NH1' ' A' ' 111' ' ' ARG . 45.5 mm -64.81 -40.56 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.142 0.577 . . . . 75.04 110.159 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 91.6 mt -89.06 -8.09 54.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.905 0.882 . . . . 74.43 112.244 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -59.77 -52.21 75.39 Favored Pre-proline 0 N--CA 1.484 1.257 0 C-N-CA 123.883 0.873 . . . . 73.34 113.165 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.41 -30.14 36.84 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 121.614 1.542 . . . . 75.41 112.969 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -70.46 -48.77 54.26 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.184 0.594 . . . . 75.45 110.624 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.25 -41.67 93.7 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.154 -0.93 . . . . 70.11 109.969 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -55.8 -52.22 64.74 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.261 0.976 . . . . 75.42 110.996 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -67.47 -30.12 69.74 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.035 0.534 . . . . 70.4 110.641 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.2 t -74.34 -32.22 62.72 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.071 0.549 . . . . 72.1 111.179 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.665 HG21 HG23 ' C' ' 64' ' ' VAL . 96.1 mt -75.71 -51.64 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.208 0.603 . . . . 75.32 109.995 176.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 12.1 m -63.96 -31.17 72.26 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 123.347 0.659 . . . . 75.4 110.893 -173.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 40.2 t -58.08 -55.25 37.33 Favored 'General case' 0 C--N 1.351 0.63 0 CA-C-N 115.494 -0.775 . . . . 73.2 109.302 169.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.56 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.43 -36.57 76.15 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.746 1.218 . . . . 74.02 113.138 -179.304 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.426 HG23 ' O ' ' C' ' 114' ' ' ILE . 91.4 t -62.9 -49.46 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.312 0.645 . . . . 74.25 109.798 176.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 42.7 t -71.83 -25.75 62.1 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.03 -0.986 . . . . 54.51 111.656 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 -70.24 -40.56 74.39 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.362 0.665 . . . . 74.41 109.463 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.14 8.18 61.47 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.871 0.732 . . . . 75.21 112.915 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 82.7 p 54.9 63.7 2.05 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.975 1.71 . . . . 75.35 113.087 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -120.94 155.86 57.2 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 124.321 1.048 . . . . 75.3 108.41 169.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' C' ' 155' ' ' ALA . 66.6 Cg_exo -55.76 161.63 7.83 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.335 2.69 . . . . 73.43 113.891 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -55.1 113.14 1.25 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.424 -0.807 . . . . 72.34 112.406 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.45 ' HG ' ' HZ ' ' C' ' 74' ' ' PHE . 2.4 tm? -117.75 90.16 3.27 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.534 -1.284 . . . . 72.2 107.534 -175.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -114.38 132.66 56.14 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.719 0.807 . . . . 74.12 108.995 176.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.504 HD21 HD12 ' C' ' 42' ' ' LEU . 96.2 mt -69.75 144.28 52.78 Favored 'General case' 0 C--O 1.246 0.871 0 O-C-N 123.682 0.614 . . . . 75.33 111.113 176.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.79 148.52 98.19 Favored Pre-proline 0 C--N 1.351 0.669 0 O-C-N 124.006 0.816 . . . . 74.35 109.849 172.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.583 ' HB2' HD12 ' A' ' 13' ' ' ILE . 31.1 Cg_exo -61.64 87.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.51 2.14 . . . . 73.4 113.199 177.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 95.0 t -104.41 107.71 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.371 -0.831 . . . . 72.04 108.923 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -83.46 106.55 15.3 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.076 -1.083 . . . . 63.11 108.076 171.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -48.44 -38.54 20.05 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.843 1.34 . . . . 70.2 113.035 -174.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.04 -59.22 4.01 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.587 0.755 . . . . 73.51 111.25 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.63 -23.59 67.44 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.867 -0.606 . . . . 74.34 112.077 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 55.0 tp -63.41 -34.15 77.1 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.907 0.883 . . . . 74.54 110.766 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -64.1 -40.16 95.61 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.776 0.43 . . . . 75.43 111.053 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 84.9 mtp -77.49 -43.34 32.51 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.519 0.728 . . . . 74.53 111.367 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -64.18 -36.04 82.76 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.088 0.955 . . . . 73.51 111.078 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -67.65 -84.85 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 108.039 -1.097 . . . . 72.23 108.039 172.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 1.2 tm? 14.77 -79.91 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 127.851 2.46 . . . . 64.33 114.639 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.63 -56.02 5.27 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.931 0.892 . . . . 73.43 110.34 -171.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -145.32 125.61 13.87 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.754 0.821 . . . . 71.22 109.557 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -116.85 162.12 18.23 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.034 0.534 . . . . 71.11 111.748 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 178.73 170.75 0.83 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.724 1.61 . . . . 75.43 108.465 171.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -151.15 -90.76 0.08 OUTLIER Glycine 0 C--N 1.345 1.066 0 CA-C-O 119.961 -0.355 . . . . 44.2 112.782 -176.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 62.39 -179.86 0.13 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.639 1.176 . . . . 74.34 112.177 -174.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.62 -130.24 5.45 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-O 119.605 -0.553 . . . . 75.01 113.422 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 53.2 m 72.38 93.52 0.08 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.402 1.481 . . . . 71.13 110.907 -172.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -80.31 137.22 36.56 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.478 -0.783 . . . . 74.54 109.068 168.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -73.86 -57.32 4.06 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.7 0.8 . . . . 62.33 110.06 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 33.5 m170 70.56 -59.23 0.53 Allowed 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 125.515 1.526 . . . . 75.25 113.112 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -136.67 165.75 25.17 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.009 0.924 . . . . 72.24 109.543 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -60.16 -62.69 1.68 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.227 1.011 . . . . 74.52 111.135 174.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' C' ' 124' ' ' PRO . . . . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 107.665 -1.235 . . . . 64.15 107.665 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.504 ' SD ' ' N ' ' D' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 121.47 0.652 . . . . 74.22 109.703 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 19.7 m -76.14 169.18 18.69 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.719 0.808 . . . . 75.32 112.691 -173.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -158.03 134.26 9.43 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.297 1.039 . . . . 73.24 108.695 172.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . 0.525 HE22 ' HB2' ' D' ' 90' ' ' GLU . 0.6 OUTLIER -147.75 139.6 24.05 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.161 0.505 . . . . 74.1 111.862 -172.358 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -98.4 23.61 8.25 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 122.156 0.979 . . . . 75.42 108.463 167.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -70.27 143.01 52.23 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.621 1.169 . . . . 70.22 111.016 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -79.4 22.44 0.44 Allowed 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 123.243 0.617 . . . . 72.31 112.564 -172.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -66.6 -17.65 64.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.394 0.677 . . . . 73.42 111.229 165.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.406 ' HE1' ' HA ' ' D' ' 9' ' ' MET . 3.8 tpt -30.94 123.67 0.21 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.839 1.656 . . . . 74.23 113.811 172.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 36.2 m -144.45 150.45 37.66 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.349 -1.352 . . . . 74.31 107.349 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -162.76 89.51 0.66 Allowed 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.798 -0.815 . . . . 72.33 108.798 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -113.81 114.98 27.04 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.568 -1.271 . . . . 73.34 107.568 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.427 HD12 HG21 ' D' ' 105' ' ' ILE . 26.6 mt -82.11 115.97 25.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 108.347 -0.983 . . . . 74.14 108.347 176.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -75.62 -44.2 44.07 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 123.27 0.356 . . . . 74.44 111.224 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.412 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 22.0 ttt180 -166.87 136.4 2.95 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.072 0.397 . . . . 64.15 112.072 -162.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -115.31 137.5 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 107.92 -1.141 . . . . 73.04 107.92 171.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.412 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 30.6 p90 -159.74 172.24 18.07 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.201 1.001 . . . . 73.14 112.209 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.9 p -113.69 121.91 45.54 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.179 -1.373 . . . . 74.13 108.751 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -90.7 -22.15 21.27 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.048 -0.524 . . . . 74.13 109.75 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -156.85 128.82 7.26 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 114.719 -1.128 . . . . 74.25 108.325 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.56 HG21 ' HE1' ' C' ' 117' ' ' MET . 12.2 mt -128.68 150.47 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 107.866 -1.161 . . . . 73.44 107.866 174.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -154.79 146.16 23.0 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.837 0.827 . . . . 72.34 110.555 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.408 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.4 t80 -146.15 141.32 27.38 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 105.894 -1.891 . . . . 73.2 105.894 171.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.513 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.1 mt-10 -142.11 143.48 33.06 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.355 -0.979 . . . . 72.14 108.355 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.4 88.08 5.85 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 107.912 -1.144 . . . . 71.44 107.912 173.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.86 -17.4 13.9 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.975 2.45 . . . . 75.1 113.37 -176.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -113.84 12.88 18.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.436 1.095 . . . . 72.33 110.941 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -38.18 -67.55 0.25 Allowed Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 126.957 2.103 . . . . 54.43 116.492 -160.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.454 ' HB3' HD11 ' C' ' 83' ' ' ILE . 74.2 Cg_endo -71.86 -26.79 18.54 Favored 'Trans proline' 0 C--N 1.382 2.3 0 CA-C-N 123.22 2.186 . . . . 75.24 114.368 -171.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -86.45 -25.03 25.42 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 117.755 0.252 . . . . 73.42 110.568 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.631 HG22 ' HA ' ' D' ' 73' ' ' ALA . 8.5 p -82.14 -16.0 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 122.78 0.432 . . . . 74.25 111.013 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.431 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.3 m-85 -65.24 -22.83 66.92 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.105 0.409 . . . . 73.51 112.105 177.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -65.14 -15.03 61.96 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.036 0.935 . . . . 64.43 111.385 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.51 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 78.4 mttt -94.9 86.53 4.7 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.057 0.943 . . . . 75.34 110.064 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -87.47 90.86 8.53 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.701 -0.681 . . . . 74.43 109.785 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 42.3 p90 -164.76 175.72 9.43 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.022 0.929 . . . . 73.14 109.197 167.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -73.16 111.56 12.1 Favored Pre-proline 0 N--CA 1.474 0.762 0 N-CA-C 109.178 -0.675 . . . . 73.44 109.178 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -62.77 151.52 83.5 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.574 2.182 . . . . 74.22 111.771 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' D' ' 67' ' ' SER . 56.6 mm-40 -62.77 111.67 2.21 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.018 -1.104 . . . . 65.23 108.018 169.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.737 HG12 HG13 ' D' ' 64' ' ' VAL . 57.8 t -104.68 105.19 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.687 0.795 . . . . 73.44 108.92 -175.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -86.72 129.14 34.99 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.69 -0.856 . . . . 74.4 108.69 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -97.68 110.66 23.18 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.696 -1.224 . . . . 70.4 107.696 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.52 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 10.3 t70 -116.31 130.13 56.62 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.081 -1.451 . . . . 60.31 107.081 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.6 mt -122.29 140.27 52.83 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.142 0.496 . . . . 74.11 111.104 -171.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.544 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 11.7 t70 -136.49 139.48 42.34 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.851 1.26 . . . . 63.51 108.112 174.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 45.4 p -104.03 144.75 31.12 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.361 0.664 . . . . 54.44 110.316 -174.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -160.7 157.32 26.85 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.46 0.704 . . . . 73.14 110.07 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 32.7 p -175.84 167.96 3.06 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.244 0.545 . . . . 71.34 112.178 -178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 62.5 p -156.63 126.65 6.41 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.002 -0.999 . . . . 75.21 108.471 169.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -74.24 121.09 20.73 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.422 -0.584 . . . . 74.04 109.422 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 46.8 mt -90.09 -25.5 20.72 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.273 0.629 . . . . 74.31 110.86 -172.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -172.53 -173.54 1.05 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.028 1.331 . . . . 71.15 109.56 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.87 120.49 12.65 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.886 -0.413 . . . . 73.51 109.886 176.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 69.57 -2.88 1.79 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.964 1.305 . . . . 74.34 112.595 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 97.4 t -110.92 120.06 60.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.432 -1.321 . . . . 74.24 107.432 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -150.36 142.39 23.97 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.385 0.612 . . . . 72.0 109.742 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -88.66 122.69 32.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.166 -1.379 . . . . 73.44 109.3 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 96.0 t -100.48 119.17 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 107.879 -1.156 . . . . 72.45 107.879 173.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 38.7 t -106.84 131.33 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.316 -0.994 . . . . 75.24 108.316 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.42 HD13 ' HZ ' ' H' ' 15' ' ' PHE . 15.8 tp -128.58 120.1 26.03 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 109.307 -0.627 . . . . 73.41 109.307 174.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.544 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 28.3 ttm-85 -82.62 99.09 9.35 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.555 -0.906 . . . . 73.11 108.555 177.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 77.1 t -91.25 117.55 34.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.987 -1.116 . . . . 73.21 107.987 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 28.7 m -117.01 135.38 53.74 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.478 -0.564 . . . . 74.13 109.478 -176.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.737 HG13 HG12 ' D' ' 40' ' ' VAL . 41.2 t -128.23 101.21 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.927 1.291 . . . . 74.52 108.684 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 92.8 m -93.04 116.74 29.33 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 107.878 -1.156 . . . . 73.12 107.878 172.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.02 133.96 49.9 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.604 -0.517 . . . . 72.21 109.604 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' D' ' 39' ' ' GLU . 18.2 m -128.22 123.04 33.24 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.534 -0.543 . . . . 74.24 109.534 178.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 31.0 mt -108.9 113.22 25.94 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.693 -1.225 . . . . 73.24 107.693 173.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.78 -133.64 21.22 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 123.467 0.479 . . . . 75.54 112.871 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.76 6.82 39.89 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.718 0.807 . . . . 75.11 111.663 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.51 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 15.7 pt-20 -140.83 174.93 10.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.153 0.502 . . . . 55.45 111.482 -172.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 32.7 m -73.72 135.44 43.64 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.484 1.114 . . . . 73.22 111.322 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.631 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -86.35 -65.27 1.03 Allowed 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.024 -0.732 . . . . 71.21 109.024 168.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -150.36 151.98 33.69 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.593 -1.185 . . . . 75.15 110.894 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.513 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 60.9 mt -110.86 109.84 20.19 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.883 -1.155 . . . . 74.04 107.883 171.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.537 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 48.1 t -116.9 142.14 47.32 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.607 0.763 . . . . 72.4 109.191 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -157.01 142.68 17.61 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.0 0.52 . . . . 75.15 109.793 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 77.7 t -138.89 139.33 40.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 108.173 -1.047 . . . . 73.05 108.173 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -110.58 87.1 2.45 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 107.3 -1.37 . . . . 75.34 107.3 173.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -80.1 99.53 7.77 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.258 -1.337 . . . . 70.44 109.398 -171.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.29 142.78 16.14 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 110.88 -0.888 . . . . 61.43 110.88 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.11 132.71 4.19 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 111.657 -0.577 . . . . 73.54 111.657 -177.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 60.2 mt -87.94 120.39 36.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 109.236 -0.653 . . . . 74.42 109.236 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -121.15 133.14 55.19 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.179 0.591 . . . . 73.1 109.929 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.9 m -111.37 92.99 4.25 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.747 -0.834 . . . . 54.33 108.747 175.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.767 HG22 HG23 ' H' ' 18' ' ' VAL . 0.0 OUTLIER -123.19 142.71 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.103 0.961 . . . . 75.21 108.622 -176.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.99 160.62 39.52 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 122.967 0.507 . . . . 64.03 111.342 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.62 21.07 52.52 Favored Glycine 0 C--N 1.34 0.759 0 CA-C-N 114.572 -1.195 . . . . 75.44 114.414 171.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 33.2 mt -134.04 127.88 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 117.287 0.543 . . . . 75.34 109.665 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.525 ' HB2' HE22 ' D' ' 4' ' ' GLN . 38.1 mt-10 -140.96 171.85 13.49 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.942 0.897 . . . . 62.34 111.097 -171.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.97 -118.77 13.93 Favored Glycine 0 C--N 1.354 1.565 0 CA-C-N 114.944 -1.025 . . . . 63.55 114.861 172.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 20.4 m -86.94 -28.18 22.88 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.343 0.657 . . . . 60.31 111.046 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -68.36 -34.06 75.4 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.78 -0.646 . . . . 64.33 111.025 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.583 ' HG2' ' HB2' ' H' ' 21' ' ' ALA . 0.0 OUTLIER -70.33 -23.3 62.8 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 116.039 -0.528 . . . . 74.12 111.164 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.26 -26.95 68.68 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.86 0.464 . . . . 73.35 110.926 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -78.62 -40.73 33.52 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.843 0.857 . . . . 65.44 111.396 174.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -65.51 -43.97 88.41 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.907 0.483 . . . . 65.2 110.585 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' H' ' 17' ' ' PRO . 8.7 mp -67.54 -53.17 30.73 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.365 1.066 . . . . 74.11 109.981 173.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.81 -3.63 68.5 Favored Glycine 0 C--N 1.342 0.887 0 N-CA-C 115.057 0.783 . . . . 74.41 115.057 -171.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.602 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -147.13 -65.57 0.27 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.046 0.923 . . . . 65.35 112.906 -177.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -61.91 -58.76 6.7 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.955 0.724 . . . . 73.31 112.955 -162.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 75.3 m -63.54 -44.79 82.41 Favored Pre-proline 0 CA--C 1.567 1.626 0 N-CA-C 113.923 1.083 . . . . 74.22 113.923 -175.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.73 -25.49 39.82 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 121.7 1.6 . . . . 73.53 113.132 172.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . 0.573 ' HA ' ' HD2' ' D' ' 107' ' ' PHE . 2.4 t-20 -69.47 -28.7 66.31 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.845 0.458 . . . . 75.12 110.75 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.427 HG21 HD12 ' D' ' 13' ' ' ILE . 51.6 mm -65.07 -35.27 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.402 0.681 . . . . 73.45 110.109 171.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.95 -19.04 48.89 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.587 -0.733 . . . . 74.12 112.619 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . 0.573 ' HD2' ' HA ' ' D' ' 104' ' ' ASN . 27.9 m-85 -60.9 -44.36 94.51 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 113.724 1.009 . . . . 75.31 113.724 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -51.14 -44.99 39.38 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 122.519 2.146 . . . . 73.32 114.329 170.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . 0.401 ' HH ' ' HE2' ' B' ' 107' ' ' PHE . 90.3 m-85 -77.16 -31.66 55.69 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.376 0.67 . . . . 75.23 111.897 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.14 -48.95 71.74 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.075 -0.713 . . . . 75.21 109.075 175.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -54.61 -47.15 73.76 Favored 'General case' 0 C--N 1.352 0.682 0 O-C-N 124.855 1.347 . . . . 75.42 110.937 177.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.35 -46.81 87.0 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.399 0.679 . . . . 72.4 111.311 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 36.4 t -62.05 -42.78 99.54 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.407 0.442 . . . . 74.0 111.238 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.515 HD12 HG22 ' D' ' 64' ' ' VAL . 96.9 mt -61.31 -58.3 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.119 0.967 . . . . 65.3 111.114 175.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 89.4 m -55.92 -40.77 73.56 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.569 1.148 . . . . 63.23 112.068 -173.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 44.7 t -65.04 -42.16 94.54 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.573 -0.739 . . . . 75.54 110.707 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.537 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.1 mtm -68.46 -31.69 71.17 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.811 0.444 . . . . 73.33 111.452 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.41 HG23 ' O ' ' D' ' 114' ' ' ILE . 73.6 t -63.43 -44.65 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 123.525 0.73 . . . . 71.53 110.373 174.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.7 p -77.77 -25.83 49.37 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.056 -0.52 . . . . 74.14 111.572 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -71.64 -36.27 70.67 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.316 0.647 . . . . 73.55 109.6 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.95 0.24 73.13 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.36 -0.837 . . . . 71.02 112.509 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.6 p 61.37 25.29 15.27 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.642 1.977 . . . . 72.22 113.405 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -80.37 164.13 53.53 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.266 1.027 . . . . 71.5 109.717 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.4 129.82 29.64 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.109 1.873 . . . . 72.55 111.423 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -51.32 123.64 10.09 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.402 1.081 . . . . 74.35 111.577 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -116.41 96.73 5.66 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.98 -1.118 . . . . 71.12 107.98 -174.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -98.66 117.89 34.14 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.897 -0.779 . . . . 74.32 108.897 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.523 ' HA ' HD11 ' H' ' 6' ' ' ILE . 6.4 mp -73.97 113.47 11.18 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 109.686 -0.487 . . . . 74.11 109.686 176.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.461 ' H ' HD11 ' H' ' 6' ' ' ILE . . . -54.51 134.62 62.96 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 124.154 0.982 . . . . 74.21 110.953 176.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.499 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 2.8 Cg_exo -72.94 144.64 38.73 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.875 2.383 . . . . 74.4 111.756 -171.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.55 131.95 54.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 123.643 0.777 . . . . 74.11 109.357 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -81.54 82.68 7.24 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.076 -1.083 . . . . 74.42 108.076 174.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -71.03 -21.37 62.28 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.414 -1.266 . . . . 74.01 110.732 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.602 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 15.5 t70 -54.58 -52.72 61.26 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.567 1.147 . . . . 72.15 110.841 172.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.486 ' HA ' ' SD ' ' D' ' 138' ' ' MET . . . -65.26 -37.06 86.04 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.663 0.785 . . . . 74.23 112.37 -179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.92 -42.43 98.12 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.229 0.612 . . . . 64.34 112.075 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -75.17 -26.87 59.41 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.632 -0.713 . . . . 72.42 111.211 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.486 ' SD ' ' HA ' ' D' ' 135' ' ' ALA . 61.5 mtt -54.56 -33.77 60.73 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.199 0.6 . . . . 72.4 111.67 176.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -64.98 -28.54 69.58 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.781 0.833 . . . . 71.41 111.977 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -66.46 -38.07 86.53 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.45 0.7 . . . . 73.3 110.408 172.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.4 -27.6 62.46 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.028 0.531 . . . . 65.34 110.935 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -74.99 -0.79 19.96 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.901 0.48 . . . . 72.0 111.303 173.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -129.35 44.16 3.02 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.206 -1.035 . . . . 74.53 108.206 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -173.97 114.62 0.21 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.173 0.989 . . . . 75.11 108.8 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -153.25 -177.1 6.11 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.445 0.698 . . . . 74.24 110.697 -176.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 58.49 -136.32 51.16 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-N 115.583 -0.735 . . . . 71.02 112.972 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -86.85 73.59 9.94 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.383 0.673 . . . . 74.41 109.405 175.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -106.23 59.15 0.41 Allowed Glycine 0 C--N 1.351 1.408 0 N-CA-C 109.947 -1.261 . . . . 52.42 109.947 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 6.1 m -73.61 82.54 1.53 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.719 0.807 . . . . 71.12 110.279 -177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -100.87 93.42 5.52 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.665 0.745 . . . . 73.22 109.282 174.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -102.89 -164.49 1.09 Allowed 'General case' 0 C--O 1.244 0.766 0 CA-C-N 114.351 -1.295 . . . . 74.3 109.215 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -71.97 86.5 1.01 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.008 0.432 . . . . 64.44 110.151 173.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -64.54 111.05 2.53 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.271 -0.64 . . . . 75.2 109.271 172.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -85.42 80.73 9.01 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.367 0.603 . . . . 72.25 110.361 -171.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.268 0 N-CA-C 107.915 -1.143 . . . . 71.05 107.915 175.288 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 1' ' ' MET . . . . . 0.407 ' SD ' ' N ' ' E' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 109.83 -0.433 . . . . 53.34 109.83 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -105.86 172.68 6.67 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.998 0.919 . . . . 75.1 110.404 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -158.11 149.0 20.8 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.343 0.657 . . . . 75.34 109.759 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 40.7 m -144.11 103.74 4.04 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.195 0.998 . . . . 62.12 108.569 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 28.8 m -65.33 -76.61 0.07 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.212 0.605 . . . . 74.02 109.946 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.748 ' HB ' HD21 ' A' ' 42' ' ' LEU . 1.6 pp -157.78 156.03 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.28 1.032 . . . . 73.41 109.119 171.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -161.25 172.24 17.01 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.135 0.574 . . . . 71.3 110.527 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . 0.504 ' H ' HD21 ' E' ' 8' ' ' LEU . 1.3 pt? -122.96 152.38 40.91 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.133 0.973 . . . . 65.3 109.855 -175.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.78 -174.98 4.2 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.761 0.824 . . . . 71.43 112.046 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 30.0 tp -77.72 17.93 0.51 Allowed 'General case' 0 CA--C 1.568 1.648 0 C-N-CA 124.442 1.097 . . . . 75.51 112.037 -173.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 7.3 mp 70.45 142.18 0.09 OUTLIER Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 125.295 1.438 . . . . 74.22 111.229 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.39 -20.53 20.85 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.242 1.961 . . . . 74.25 112.096 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 pp -154.22 170.36 21.43 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.202 1.001 . . . . 75.33 110.229 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 84.4 mt -104.37 179.64 4.21 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.155 0.582 . . . . 71.45 111.101 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -86.99 154.28 20.9 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.359 1.064 . . . . 65.11 109.038 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 64.2 p -65.87 146.65 98.99 Favored Pre-proline 0 CA--C 1.557 1.216 0 C-N-CA 123.471 0.708 . . . . 74.34 110.917 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 17' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -51.08 150.69 13.24 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.644 2.896 . . . . 74.03 114.483 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 99.2 t -54.79 -41.92 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 124.137 0.975 . . . . 73.43 110.907 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 5.8 t -155.32 -39.73 0.09 Allowed 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.998 -1.001 . . . . 73.15 110.678 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 20' ' ' LYS . . . . . 0.446 ' HB3' ' HZ2' ' E' ' 20' ' ' LYS . 7.5 ttpm? -150.12 -59.93 0.2 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.895 0.478 . . . . 75.25 110.424 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 57.23 69.73 0.72 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.514 1.126 . . . . 73.13 111.248 -174.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -70.42 107.85 4.0 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.449 -0.945 . . . . 74.52 108.449 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 33.0 m -54.58 116.1 10.15 Favored Pre-proline 0 CA--C 1.552 1.05 0 O-C-N 124.509 1.131 . . . . 75.52 110.399 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 24' ' ' PRO . . . . . 0.486 ' HD2' HG21 ' A' ' 92' ' ' THR . 95.1 Cg_endo -86.73 -151.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.708 2.272 . . . . 65.4 110.671 174.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.12 0 N-CA-C 106.338 -1.727 . . . . 71.34 106.338 172.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 70.6 mtp . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.555 0.217 . . . . 64.21 110.662 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -101.14 -156.78 0.57 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.766 1.226 . . . . 73.44 107.911 168.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -62.9 -52.78 61.76 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.265 0.555 . . . . 75.14 109.523 173.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 37.9 m -110.28 110.64 21.54 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.295 1.038 . . . . 62.04 109.691 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 59.5 m -148.02 -40.63 0.17 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.272 0.629 . . . . 70.05 110.185 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . 0.605 HD11 ' HA ' ' B' ' 128' ' ' LEU . 14.7 tt -139.84 90.93 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-O 122.26 1.029 . . . . 74.4 110.164 -176.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 7' ' ' ALA . . . . . 0.416 ' HA ' HG21 ' B' ' 131' ' ' VAL . . . -157.34 143.51 17.8 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.943 -1.026 . . . . 73.44 110.04 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 20.8 mt -76.59 87.86 3.29 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 109.726 -0.472 . . . . 74.13 109.726 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.52 77.14 10.08 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.15 0.58 . . . . 63.12 110.363 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 97.4 mt 60.4 -170.32 0.15 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.349 1.06 . . . . 75.52 112.678 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . 0.434 ' HG ' ' HZ ' ' B' ' 133' ' ' PHE . 98.8 mt -113.95 151.37 44.75 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.16 0.984 . . . . 74.22 109.683 177.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -59.34 -49.41 10.79 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 122.964 2.443 . . . . 75.24 111.636 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.7 153.91 23.61 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.764 0.826 . . . . 74.23 108.865 172.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -69.73 109.34 4.33 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 107.349 -1.352 . . . . 75.1 107.349 175.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -78.56 79.25 4.99 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.696 0.76 . . . . 73.44 109.41 -172.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 7.3 t -134.56 68.33 72.26 Favored Pre-proline 0 CA--C 1.556 1.183 0 CA-C-N 114.668 -1.151 . . . . 74.44 109.157 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 17' ' ' PRO . . . . . 0.552 ' HD2' HD11 ' B' ' 98' ' ' LEU . 32.8 Cg_exo -62.35 -38.68 51.95 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.369 2.046 . . . . 73.23 111.809 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -49.77 -23.96 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 125.218 1.407 . . . . 71.24 113.12 -172.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 24.2 m -49.52 -48.25 48.32 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.514 1.126 . . . . 72.35 112.237 175.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -115.06 -20.17 10.58 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.454 0.702 . . . . 75.31 110.884 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.4 87.5 0.45 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.46 0.704 . . . . 74.13 111.372 -172.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -158.69 97.49 1.45 Allowed 'General case' 0 C--O 1.237 0.413 0 N-CA-C 106.791 -1.559 . . . . 74.33 106.791 167.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 9.3 t -64.55 141.84 98.33 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 115.958 -0.564 . . . . 72.11 110.793 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.63 165.45 11.53 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.333 2.022 . . . . 75.21 112.155 169.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 CA--C 1.562 1.416 0 C-N-CA 123.492 0.717 . . . . 71.1 111.282 175.952 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' G' G ' 1' ' ' MET . . . . . 0.42 ' SD ' ' N ' ' G' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 110.032 -0.358 . . . . 75.34 110.032 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -139.63 118.72 12.65 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.738 -1.208 . . . . 75.22 107.738 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -140.07 138.79 35.63 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.67 0.788 . . . . 75.21 109.603 -174.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 34.7 m -65.21 -37.36 87.04 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.694 0.797 . . . . 74.41 110.987 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -79.91 152.52 29.55 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.03 -0.986 . . . . 73.41 109.748 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . 0.48 HD13 HG13 ' C' ' 40' ' ' VAL . 27.3 pt -63.73 131.42 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.028 0.931 . . . . 75.31 112.011 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.84 -179.03 5.17 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.153 0.581 . . . . 74.15 111.993 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 tt -136.56 137.56 40.35 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 107.442 -1.318 . . . . 72.32 107.442 176.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.11 -179.84 5.22 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.779 0.832 . . . . 73.25 112.47 -177.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 59.1 mt -75.43 164.29 26.54 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.489 0.716 . . . . 74.34 110.708 175.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 89.4 mt -86.97 129.93 50.28 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 109.023 -0.732 . . . . 75.22 109.023 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.86 -45.47 10.62 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.885 2.39 . . . . 62.13 112.25 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 95.6 mt -134.99 175.89 9.16 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.633 1.173 . . . . 75.35 108.79 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 83.6 mt -103.13 -178.04 3.55 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.106 0.562 . . . . 74.25 109.667 173.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . 0.558 ' HB2' HD12 ' C' ' 98' ' ' LEU . 2.2 m-85 -78.11 171.37 15.12 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.463 0.705 . . . . 73.24 110.774 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 12.4 m -66.81 128.41 93.85 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-O 118.511 -0.757 . . . . 74.52 109.387 174.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 17' ' ' PRO . . . . . 0.457 ' HB3' ' HB3' ' G' ' 21' ' ' ALA . 41.6 Cg_exo -43.69 142.32 3.4 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.962 3.108 . . . . 74.53 114.587 174.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 18' ' ' VAL . . . . . 0.527 HG11 ' H ' ' G' ' 19' ' ' THR . 2.2 p -74.17 -91.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 CA-C-O 119.083 -0.484 . . . . 74.55 109.926 176.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 19' ' ' THR . . . . . 0.623 ' HB ' ' HE3' ' C' ' 94' ' ' MET . 8.4 m -86.58 -52.5 5.52 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.603 1.092 . . . . 74.32 110.486 -174.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -162.83 105.85 1.06 Allowed 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 116.084 -0.507 . . . . 64.12 110.248 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' G' ' 17' ' ' PRO . . . -140.15 16.08 2.43 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.526 0.73 . . . . 74.02 110.751 176.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -83.32 160.94 21.57 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.541 0.736 . . . . 74.42 110.333 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 86.5 m 56.98 81.93 0.25 Allowed Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 124.106 0.962 . . . . 74.14 111.35 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -64.73 -67.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 121.759 1.639 . . . . 72.42 109.501 167.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.338 1.455 . . . . 74.53 107.95 166.481 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 12.3 tpt . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 109.275 -0.639 . . . . 63.42 109.275 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -85.68 -174.25 5.05 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.582 0.753 . . . . 74.14 109.89 172.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -82.09 64.2 6.66 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.639 1.209 . . . . 74.24 109.486 169.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 50.2 m -83.17 62.26 6.54 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 114.489 -1.232 . . . . 74.31 109.451 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 43.6 m -163.8 99.22 0.88 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 106.004 -1.85 . . . . 73.45 106.004 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' D' ' 128' ' ' LEU . 3.1 mp 62.17 98.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 124.3 1.04 . . . . 74.31 110.119 -174.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.35 96.1 3.41 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.629 0.772 . . . . 75.33 110.185 -174.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.41 121.12 42.14 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.211 1.004 . . . . 74.2 109.51 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.75 29.17 6.63 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.91 0.884 . . . . 75.34 110.273 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 9.7 mp 66.09 176.08 0.22 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 125.114 1.366 . . . . 71.34 111.174 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.37 123.45 39.54 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 123.256 0.622 . . . . 75.31 110.593 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.26 129.55 18.33 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.796 2.331 . . . . 71.3 110.636 168.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 64.21 179.88 0.17 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.715 1.206 . . . . 73.34 111.448 -172.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 88.3 mt -122.64 173.09 7.93 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.242 1.017 . . . . 73.35 109.701 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . 0.42 ' HZ ' HD13 ' D' ' 60' ' ' LEU . 76.6 m-85 -89.45 -168.83 2.27 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.333 0.653 . . . . 71.02 109.734 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 21.4 p -68.62 131.17 91.52 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.047 0.539 . . . . 73.13 110.411 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 17' ' ' PRO . . . . . 0.427 ' HA ' HD23 ' D' ' 98' ' ' LEU . 53.4 Cg_endo -65.59 146.45 84.57 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 123.061 2.507 . . . . 75.3 113.461 -171.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . 0.767 HG23 HG22 ' D' ' 86' ' ' ILE . 8.3 p -110.4 151.65 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.438 0.695 . . . . 73.43 110.267 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 3.4 m 58.07 29.8 18.34 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.326 1.05 . . . . 73.21 110.226 -176.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 72.16 -48.97 0.69 Allowed 'General case' 0 C--N 1.369 1.435 0 C-N-CA 126.04 1.736 . . . . 72.42 111.439 -175.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . 0.583 ' HB2' ' HG2' ' D' ' 94' ' ' MET . . . 75.07 -75.94 0.07 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.854 1.262 . . . . 75.41 113.299 163.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -41.1 80.91 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.178 0.591 . . . . 75.33 109.469 -178.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 31.6 p -108.57 92.46 10.17 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.667 1.187 . . . . 75.32 109.204 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.29 -177.76 0.71 Allowed 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.853 2.369 . . . . 74.24 113.607 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 . . . . . 0 C--O 1.256 1.406 0 C-N-CA 124.143 0.977 . . . . 75.33 110.888 -179.217 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 ppp? . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 110.431 -0.211 . . . . 72.34 110.431 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -138.58 143.69 39.49 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.232 0.613 . . . . 70.41 111.289 -170.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -83.15 98.02 9.12 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.314 0.646 . . . . 64.35 109.303 170.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -78.96 68.04 4.81 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.981 0.512 . . . . 63.24 110.474 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -133.0 112.02 11.49 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.048 -0.723 . . . . 75.23 109.048 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.411 ' HB2' HG22 ' A' ' 89' ' ' ILE . 15.2 m120 -71.71 173.96 7.44 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.59 -0.732 . . . . 73.22 110.217 173.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.532 ' HB ' ' HA2' ' A' ' 88' ' ' GLY . 81.7 m -73.69 156.2 38.18 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.601 -0.727 . . . . 72.24 110.029 176.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.29 130.99 46.0 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.583 -0.525 . . . . 75.43 109.583 172.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.471 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -64.58 138.75 58.58 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.603 0.564 . . . . 74.42 109.662 -176.118 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.9 m -137.91 130.79 29.97 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 108.529 -0.915 . . . . 52.45 108.529 -170.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.593 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 26.6 t80 -136.4 124.28 22.68 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.422 0.689 . . . . 74.13 109.334 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -143.33 119.58 10.84 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.701 0.8 . . . . 71.4 108.859 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.624 HG12 ' HD2' ' A' ' 84' ' ' PHE . 49.5 mt -80.2 124.6 38.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.513 -0.551 . . . . 74.52 109.513 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.23 -42.28 13.92 Favored 'General case' 0 C--O 1.245 0.848 0 O-C-N 123.993 0.808 . . . . 74.03 109.36 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -173.43 122.36 0.36 Allowed 'General case' 0 N--CA 1.483 1.185 0 O-C-N 123.081 0.238 . . . . 73.44 111.477 -168.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.553 HD13 ' HG3' ' C' ' 130' ' ' PRO . 94.8 mt -113.79 138.53 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.99 0.916 . . . . 74.11 109.26 175.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.437 ' HB3' HG21 ' B' ' 122' ' ' THR . 32.3 p90 -167.3 166.69 14.54 Favored 'General case' 0 C--N 1.347 0.496 0 O-C-N 123.902 0.751 . . . . 72.31 111.511 -173.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -89.24 127.29 35.75 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.116 -0.698 . . . . 74.51 109.116 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -96.52 -21.88 17.43 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 120.913 0.387 . . . . 74.34 109.958 176.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.739 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.0 t70 -152.16 141.27 21.29 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 114.7 -1.136 . . . . 75.01 109.588 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.412 HG22 ' SD ' ' A' ' 117' ' ' MET . 82.6 mt -141.51 138.29 32.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 106.556 -1.646 . . . . 74.0 106.556 175.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.5 t -144.66 128.32 17.17 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.55 -0.907 . . . . 72.42 108.55 174.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.666 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 87.4 t80 -138.48 124.84 20.49 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.164 -1.421 . . . . 72.24 107.164 175.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -125.59 142.68 51.38 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.915 -0.772 . . . . 71.53 108.915 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.33 71.53 39.15 Favored Pre-proline 0 C--O 1.243 0.755 0 N-CA-C 105.83 -1.915 . . . . 72.44 105.83 168.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.53 -15.16 34.18 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.39 2.06 . . . . 75.24 112.181 -170.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -117.18 21.6 13.07 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 118.169 -0.92 . . . . 73.0 109.495 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.41 ' O ' HG11 ' A' ' 31' ' ' VAL . . . -45.37 -59.17 4.72 Favored Pre-proline 0 N--CA 1.495 1.804 0 CA-C-O 117.998 -1.001 . . . . 63.32 113.329 -171.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.466 ' HB2' HD23 ' B' ' 51' ' ' LEU . 81.9 Cg_endo -72.16 -9.44 24.46 Favored 'Trans proline' 0 C--N 1.381 2.288 0 CA-C-N 121.629 1.617 . . . . 64.43 112.783 -176.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -90.31 -39.46 12.71 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.858 0.863 . . . . 75.44 110.251 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.713 HG22 ' HA ' ' A' ' 73' ' ' ALA . 6.5 p -79.21 -23.17 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 114.906 -1.043 . . . . 73.31 112.059 -162.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -67.48 -21.12 65.53 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.094 0.558 . . . . 74.22 110.928 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -74.46 -39.23 62.66 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.141 0.976 . . . . 75.32 110.307 173.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 3.3 tmtp? -69.01 143.35 54.37 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.71 1.204 . . . . 74.05 110.374 -169.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.505 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 12.9 m-20 -57.82 121.5 10.62 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.098 0.959 . . . . 74.14 110.843 175.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.414 ' CE3' HD21 ' A' ' 68' ' ' LEU . 70.4 t-105 -77.7 90.66 4.0 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.191 0.597 . . . . 74.22 110.691 -177.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.423 ' H ' HD23 ' A' ' 68' ' ' LEU . 40.6 tt0 -125.81 82.05 64.7 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 107.582 -1.266 . . . . 74.4 107.582 168.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.0 118.86 4.52 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.327 2.018 . . . . 74.43 112.836 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -95.79 94.67 7.8 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.512 -1.292 . . . . 74.22 107.512 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.0 t -67.7 101.21 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 114.622 -1.172 . . . . 75.23 109.594 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.23 115.76 19.96 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.535 1.134 . . . . 74.43 109.221 175.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -96.8 134.99 39.39 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.123 -0.695 . . . . 74.42 109.123 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.619 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 27.5 t70 -145.07 107.53 4.4 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.31 -0.996 . . . . 72.25 108.31 172.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.64 132.3 48.84 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.957 -0.757 . . . . 74.53 108.957 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.646 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 16.2 t70 -129.72 132.54 46.65 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.876 -0.787 . . . . 75.52 108.876 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.4 p -108.01 137.72 45.52 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.815 0.846 . . . . 75.03 110.158 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.57 139.28 18.84 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.745 0.818 . . . . 73.43 110.066 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.68 ' HB2' HG22 ' E' ' 16' ' ' THR . 56.7 m -132.53 156.03 47.55 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.844 0.457 . . . . 74.22 110.472 173.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.3 t -148.8 118.12 6.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.149 0.979 . . . . 74.34 108.739 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 46.5 tt0 -76.93 122.53 25.0 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.95 -0.759 . . . . 72.13 108.95 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 75.7 mt -95.11 -31.72 13.43 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.528 0.731 . . . . 73.33 111.774 -172.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.45 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -155.8 -179.45 8.13 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.454 0.701 . . . . 73.34 110.008 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -65.88 117.7 8.63 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.901 -0.777 . . . . 64.24 108.901 172.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 65.96 18.24 11.01 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.828 1.251 . . . . 71.42 112.083 -178.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.45 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 58.4 t -126.22 121.94 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 108.391 -0.966 . . . . 72.53 108.391 174.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -129.02 172.29 11.53 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.259 0.552 . . . . 72.54 109.584 174.049 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -127.55 132.5 49.87 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.135 -0.938 . . . . 71.23 108.62 176.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.56 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 77.0 t -107.28 119.8 57.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 107.474 -1.306 . . . . 74.04 107.474 173.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.2 t -115.74 129.35 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 108.813 -0.81 . . . . 73.33 108.813 174.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tt -128.21 116.58 20.11 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.582 -0.896 . . . . 71.32 108.582 -176.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.646 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 15.6 ttm180 -84.34 106.06 15.66 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.43 1.092 . . . . 71.33 109.433 176.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.6 t -98.74 101.38 12.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 107.581 -1.266 . . . . 65.02 107.581 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.619 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 21.1 m -98.28 107.08 19.46 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.622 0.769 . . . . 71.53 109.076 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 t -113.38 109.1 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.231 1.012 . . . . 71.12 109.456 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -104.09 130.88 51.82 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 108.044 -1.095 . . . . 74.14 108.044 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.1 109.95 21.79 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.006 -1.479 . . . . 75.44 107.006 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.7 m -114.06 125.13 53.63 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.135 0.493 . . . . 63.21 110.019 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.423 HD23 ' H ' ' A' ' 37' ' ' GLN . 25.9 mt -93.36 76.14 4.51 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 107.896 -1.149 . . . . 71.45 107.896 176.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.38 -84.67 0.95 Allowed Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.414 -0.674 . . . . 64.23 111.414 -175.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -123.46 -25.28 4.42 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.29 1.036 . . . . 74.22 110.124 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -79.05 107.72 12.01 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.511 0.724 . . . . 73.11 109.98 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.5 m -66.14 130.68 44.08 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.113 0.483 . . . . 73.43 110.386 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.713 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -81.89 -58.96 2.75 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.16 -0.927 . . . . 72.14 109.179 175.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -154.99 169.01 25.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 114.396 -1.275 . . . . 75.33 110.945 176.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 23.8 tp -128.13 132.0 48.96 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.857 -1.535 . . . . 73.22 106.857 169.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.424 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 65.3 m -132.96 95.72 3.62 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.606 -0.887 . . . . 70.51 108.606 176.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -111.92 114.63 27.66 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.49 -0.929 . . . . 74.34 108.49 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -124.67 131.98 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 109.435 -0.579 . . . . 71.01 109.435 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.739 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 51.3 mt-30 -103.61 99.09 8.88 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.411 -0.588 . . . . 73.22 109.411 170.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -85.22 114.36 22.27 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.917 -1.038 . . . . 73.04 109.527 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.12 146.71 17.51 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.816 -0.514 . . . . 71.1 111.816 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.568 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -143.29 123.33 2.07 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 112.079 -0.408 . . . . 63.42 112.079 176.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.2 mt -81.98 124.29 38.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.752 -0.833 . . . . 73.12 108.752 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.624 ' HD2' HG12 ' A' ' 13' ' ' ILE . 18.9 m-85 -135.08 135.73 41.45 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.085 -0.709 . . . . 75.03 109.085 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.8 t -99.82 116.02 30.91 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.777 -0.823 . . . . 72.33 108.777 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.594 HD12 HG21 ' E' ' 18' ' ' VAL . 0.1 OUTLIER -130.48 150.66 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.639 1.176 . . . . 74.0 110.155 -173.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -177.47 -178.08 0.73 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.025 0.93 . . . . 72.33 110.083 173.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.532 ' HA2' ' HB ' ' A' ' 7' ' ' THR . . . 117.41 -83.96 0.36 Allowed Glycine 0 C--N 1.339 0.721 0 O-C-N 123.73 0.644 . . . . 73.3 112.117 175.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 94' ' ' MET . 26.6 pt -120.01 139.61 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.952 0.901 . . . . 72.1 108.998 -175.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -115.38 -165.24 1.01 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.725 0.81 . . . . 71.41 111.101 -171.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.619 ' HA3' HG23 ' E' ' 23' ' ' THR . . . 72.5 -140.59 29.6 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-O 119.577 -0.569 . . . . 73.11 112.712 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -62.62 -26.5 68.65 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.724 0.81 . . . . 74.11 112.031 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -68.63 -47.47 66.53 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.924 0.89 . . . . 74.42 110.724 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 89' ' ' ILE . 55.8 ttm -80.38 -24.35 39.81 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.86 0.464 . . . . 74.41 111.145 176.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.42 -32.24 73.5 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.034 0.534 . . . . 71.14 111.227 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -68.98 -31.86 71.02 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 116.044 -0.525 . . . . 73.24 110.634 173.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.406 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 42.0 t -68.65 -55.22 12.21 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.891 0.477 . . . . 54.44 110.742 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 pp -76.39 -16.7 59.66 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.42 0.526 . . . . 71.4 112.42 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.48 -7.24 46.06 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-O 119.465 -0.631 . . . . 64.43 114.57 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.01 -61.96 0.39 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 117.594 0.697 . . . . 75.25 110.891 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.41 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 70.7 t80 -62.08 -66.06 0.6 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.468 1.107 . . . . 65.14 113.581 -169.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.4 m -64.37 -38.24 31.69 Favored Pre-proline 0 CA--C 1.566 1.594 0 N-CA-C 113.741 1.015 . . . . 74.12 113.741 -175.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -65.3 -27.1 55.79 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 121.672 1.581 . . . . 75.2 113.769 167.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -72.41 -28.53 63.04 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 122.952 0.501 . . . . 72.4 109.744 176.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.2 mm -61.92 -40.41 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.457 0.703 . . . . 54.51 109.716 171.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.568 HD22 ' HA3' ' A' ' 82' ' ' GLY . 95.5 mt -77.41 -25.38 50.71 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.386 -0.825 . . . . 71.32 112.239 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -57.2 -45.06 99.96 Favored Pre-proline 0 CA--C 1.57 1.742 0 N-CA-C 113.683 0.994 . . . . 72.41 113.683 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -60.48 -31.63 92.71 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.245 1.963 . . . . 74.43 113.368 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -77.04 -35.63 56.73 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.297 0.639 . . . . 74.51 111.786 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.66 -38.81 84.3 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.478 -0.564 . . . . 74.01 109.478 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.442 ' NH1' HD13 ' C' ' 105' ' ' ILE . 37.7 ttm180 -64.35 -42.3 96.3 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.675 -1.148 . . . . 74.43 110.549 173.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -53.1 -51.68 61.07 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.142 0.977 . . . . 73.31 110.75 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 30.3 t -66.77 -47.82 71.0 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.569 -1.196 . . . . 73.43 111.173 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.84 -54.69 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.426 0.69 . . . . 64.52 111.041 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.0 m -55.91 -38.62 70.49 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.945 0.898 . . . . 62.45 111.723 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.0 t -65.69 -45.54 82.42 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.03 -0.532 . . . . 73.44 110.221 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.666 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 12.6 mtp -63.03 -39.92 96.18 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.009 0.924 . . . . 72.33 111.927 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.7 t -61.9 -45.65 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.935 0.894 . . . . 61.24 110.501 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.9 t -67.24 -37.89 84.3 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.242 -0.89 . . . . 62.02 111.415 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.491 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 83.6 mtt-85 -70.79 -27.72 64.11 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.34 0.656 . . . . 73.33 110.455 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.55 14.18 47.99 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-O 119.227 -0.763 . . . . 72.43 113.278 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.483 HG23 ' HE ' ' B' ' 15' ' ' ARG . 4.4 t 58.31 16.47 4.05 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 127.059 2.144 . . . . 74.41 113.47 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -82.53 150.83 64.1 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.471 0.708 . . . . 73.2 110.363 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -55.39 153.6 27.48 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.248 2.632 . . . . 74.12 113.548 174.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -59.97 132.2 53.21 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.327 1.051 . . . . 73.14 112.552 -171.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.1 tp -131.64 110.42 10.91 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.575 1.15 . . . . 72.42 109.432 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -127.13 114.71 18.08 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 108.401 -0.963 . . . . 73.13 108.401 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.4 ' HA ' HG21 ' E' ' 6' ' ' ILE . 8.2 mp -67.17 148.85 51.27 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.82 0.448 . . . . 64.12 110.983 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.83 128.66 92.78 Favored Pre-proline 0 CA--C 1.551 0.997 0 O-C-N 123.955 0.785 . . . . 71.51 110.256 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.438 ' HG2' ' CE2' ' C' ' 11' ' ' PHE . 10.4 Cg_exo -74.68 111.9 3.43 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 122.955 2.436 . . . . 71.32 112.178 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.4 m -102.29 116.87 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.314 0.645 . . . . 73.14 109.601 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -76.05 91.07 3.07 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 115.543 -0.753 . . . . 74.04 109.469 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -53.59 -47.78 69.82 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.279 1.032 . . . . 71.44 110.673 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -51.31 -52.06 48.7 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.285 -1.325 . . . . 72.21 112.442 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.51 97.04 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.365 1.041 . . . . 43.34 111.445 -177.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.4 tt -66.92 -43.79 82.38 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 124.137 0.898 . . . . 74.35 110.398 -174.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -66.44 -36.35 82.57 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.884 0.474 . . . . 71.13 111.438 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.414 ' HA ' ' HB3' ' A' ' 141' ' ' LEU . 78.1 mtp -74.11 -20.02 60.4 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.472 0.545 . . . . 75.53 112.472 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.633 ' HA ' ' HB2' ' A' ' 143' ' ' GLN . 94.1 m-20 -60.13 -46.38 89.82 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.989 0.515 . . . . 74.2 110.447 172.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -74.15 -29.74 61.94 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.58 0.352 . . . . 73.1 111.15 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.414 ' HB3' ' HA ' ' A' ' 138' ' ' MET . 58.8 tp -64.39 -47.94 77.32 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.549 0.74 . . . . 73.15 111.457 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -163.08 -15.51 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 114.364 1.246 . . . . 71.32 114.364 -174.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.633 ' HB2' ' HA ' ' A' ' 139' ' ' ASN . 36.9 mt-30 -86.46 151.07 23.82 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 119.126 0.875 . . . . 74.23 111.102 -174.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -162.96 -71.74 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.673 0.389 . . . . 75.54 110.074 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.05 73.58 9.08 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.357 0.663 . . . . 64.32 109.451 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.2 78.4 1.73 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.08 -0.964 . . . . 71.31 111.167 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.89 147.52 29.68 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.864 -0.791 . . . . 73.53 108.864 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -174.51 145.15 7.86 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.616 -0.594 . . . . 62.43 111.616 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.2 p -142.25 168.58 19.41 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.249 1.02 . . . . 74.41 109.76 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -154.38 141.15 19.08 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 122.486 0.315 . . . . 74.24 111.568 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -80.92 87.41 5.96 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.188 -1.041 . . . . 73.53 108.188 171.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.516 ' HB2' ' HA ' ' G' ' 20' ' ' LYS . 15.1 p-80 -78.94 102.42 8.27 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 114.487 -1.233 . . . . 74.04 111.541 -174.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -135.69 92.72 2.86 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.288 -1.005 . . . . 74.55 108.288 171.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -79.12 160.25 27.12 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.543 -0.753 . . . . 73.0 110.209 -176.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 C-N-CA 123.901 0.881 . . . . 75.13 109.609 -175.749 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mmt . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.613 -0.514 . . . . 75.01 109.613 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 42.7 m -142.53 96.24 2.91 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.61 -1.256 . . . . 75.11 107.61 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -109.42 144.0 38.24 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.194 0.598 . . . . 75.25 111.078 -168.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -129.95 12.71 5.72 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.708 0.803 . . . . 71.5 112.587 -173.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 43.5 p30 -68.4 -16.68 64.0 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 113.276 0.843 . . . . 74.33 113.276 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -58.99 121.2 10.63 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.068 0.547 . . . . 61.33 110.064 177.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 10.3 t -71.12 131.82 44.14 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.022 0.826 . . . . 72.14 110.942 -172.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -102.8 -87.52 0.41 Allowed 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 107.552 -1.277 . . . . 73.32 107.552 169.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.511 ' HE2' ' HB2' ' B' ' 11' ' ' PHE . 26.8 ptm 40.9 -171.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 126.448 1.899 . . . . 75.31 115.969 176.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 56.6 m -143.64 123.07 13.13 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 107.232 -1.396 . . . . 75.31 107.232 166.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.511 ' HB2' ' HE2' ' B' ' 9' ' ' MET . 55.1 t80 -131.37 139.36 49.47 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.874 0.87 . . . . 73.42 108.888 -177.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.496 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -155.82 128.98 8.13 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 109.81 -0.441 . . . . 74.34 109.81 174.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.539 HD11 HD12 ' B' ' 105' ' ' ILE . 18.8 mt -77.92 121.5 30.78 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 N-CA-C 108.272 -1.011 . . . . 73.15 108.272 173.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -100.35 -32.77 10.68 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 123.754 0.659 . . . . 70.24 110.056 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.483 ' HE ' HG23 ' A' ' 122' ' ' THR . 49.7 ttt180 -172.37 143.58 1.44 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.959 0.504 . . . . 74.54 109.974 -177.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 84.6 mt -128.34 137.54 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 107.953 -1.128 . . . . 75.41 107.953 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -163.37 160.75 23.95 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-O 121.591 0.71 . . . . 73.51 112.287 -175.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.444 HG21 ' CD1' ' B' ' 21' ' ' ILE . 91.7 m -92.49 126.98 37.81 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.0 -1.0 . . . . 75.44 108.309 168.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -91.83 -25.51 18.95 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.353 0.661 . . . . 72.24 111.002 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -158.94 135.49 9.34 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 120.679 0.276 . . . . 71.2 111.713 -172.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.699 HD12 ' SG ' ' B' ' 113' ' ' CYS . 44.4 mm -125.74 141.4 45.61 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 C-N-CA 124.809 1.244 . . . . 72.24 109.585 173.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.517 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 46.5 t -138.01 141.76 40.4 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 107.686 -1.228 . . . . 64.32 107.686 175.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -159.28 134.55 8.33 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.66 -1.237 . . . . 72.23 107.66 169.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -137.36 157.84 45.72 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.027 0.931 . . . . 73.32 108.644 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.12 82.03 12.22 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 106.917 -1.512 . . . . 73.11 106.917 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.95 -25.32 27.84 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 123.042 2.495 . . . . 63.21 113.53 -169.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -112.75 14.27 19.92 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.663 0.785 . . . . 72.52 110.706 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.471 ' HB1' ' HD3' ' B' ' 29' ' ' PRO . . . -40.78 -62.93 0.85 Allowed Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 115.122 1.527 . . . . 73.23 115.122 -163.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.471 ' HD3' ' HB1' ' B' ' 28' ' ' ALA . 23.1 Cg_exo -61.3 -33.52 89.41 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 122.252 1.968 . . . . 71.12 112.793 -171.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -95.88 -20.5 18.74 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.358 -0.837 . . . . 74.3 112.633 -173.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.43 HG21 ' HA ' ' B' ' 73' ' ' ALA . 5.0 p -82.34 -11.5 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-N 118.459 0.572 . . . . 73.52 110.749 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -70.12 -14.94 62.88 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 112.879 0.696 . . . . 74.14 112.879 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -68.27 -12.54 61.19 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.046 0.538 . . . . 73.54 111.209 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -104.31 105.81 16.08 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.647 1.179 . . . . 73.24 109.29 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -111.01 92.47 4.06 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.743 -0.836 . . . . 61.44 108.743 175.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 8.1 p90 -159.27 -175.69 5.38 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.91 0.884 . . . . 74.15 109.262 170.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -68.4 110.27 5.49 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 123.899 0.88 . . . . 72.54 110.494 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.487 ' HA ' HD21 ' B' ' 68' ' ' LEU . 14.0 Cg_endo -67.62 137.28 41.93 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 121.069 1.179 . . . . 74.42 111.334 177.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.83 110.13 3.18 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 109.09 -0.707 . . . . 75.15 109.09 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.423 ' HB ' HG22 ' F' ' 6' ' ' ILE . 59.3 t -94.5 123.73 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 123.858 0.863 . . . . 74.14 110.692 -174.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -103.45 102.03 11.94 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 106.76 -1.57 . . . . 74.14 106.76 169.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 pp -97.21 148.08 23.45 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.918 -0.583 . . . . 72.1 109.597 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -135.93 154.26 51.17 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.838 1.255 . . . . 71.32 108.056 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 21.1 tp -133.44 126.48 31.28 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.663 -0.865 . . . . 72.4 108.663 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -127.45 147.45 50.3 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.663 1.185 . . . . 75.11 109.972 -172.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 76.0 p -121.9 117.48 26.58 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.056 0.942 . . . . 62.31 110.486 -172.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.13 142.11 44.2 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.906 0.882 . . . . 64.44 108.657 174.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 52.4 p -148.44 176.06 10.61 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.196 0.443 . . . . 73.1 112.196 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 74.9 p -155.79 153.12 29.33 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.299 1.04 . . . . 65.12 109.006 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -102.27 121.52 42.42 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.889 -0.782 . . . . 61.33 108.889 170.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.466 HD23 ' HB2' ' A' ' 29' ' ' PRO . 18.7 mt -85.21 -50.48 7.35 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.747 0.819 . . . . 73.23 109.764 -173.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.78 -176.1 4.64 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.69 -1.141 . . . . 73.05 109.225 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -59.69 110.49 1.15 Allowed 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.025 0.828 . . . . 74.31 109.32 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 64.11 20.21 12.09 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.278 1.031 . . . . 70.22 112.653 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 79.7 t -116.61 112.93 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 106.868 -1.53 . . . . 65.42 106.868 168.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -129.17 137.02 50.92 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.518 -0.919 . . . . 75.21 108.518 -169.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.463 ' HB2' HD13 ' B' ' 51' ' ' LEU . 4.1 tt0 -101.02 124.82 47.33 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.207 -1.035 . . . . 73.33 108.207 174.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 18.5 m -109.26 134.77 50.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.515 -0.92 . . . . 75.51 108.515 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.78 134.32 54.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.529 -0.915 . . . . 72.11 108.529 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' B' ' 103' ' ' PRO . 24.8 tp -115.12 101.18 8.74 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 109.18 -0.674 . . . . 74.24 109.18 174.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -87.48 117.5 26.31 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 123.014 0.526 . . . . 74.1 109.617 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.507 HG11 HD22 ' F' ' 8' ' ' LEU . 18.9 t -107.37 122.0 61.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 107.616 -1.253 . . . . 72.04 107.616 171.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.6 m -114.39 138.01 51.09 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.481 -0.562 . . . . 45.31 109.481 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.573 HG22 HG21 ' B' ' 114' ' ' ILE . 71.0 t -129.2 125.2 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.204 1.002 . . . . 73.35 109.81 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 65.3 m -116.04 146.3 42.29 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.299 -1.371 . . . . 63.15 107.299 162.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.55 139.53 35.03 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.285 -1.006 . . . . 73.01 108.285 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.523 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 34.3 p -140.5 136.22 32.71 Favored 'General case' 0 C--O 1.226 -0.183 0 O-C-N 123.413 0.445 . . . . 65.42 110.667 -175.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.487 HD21 ' HA ' ' B' ' 38' ' ' PRO . 92.5 mt -109.51 109.38 20.17 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.799 -1.186 . . . . 73.35 107.799 175.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.23 -137.7 20.17 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.78 -0.645 . . . . 72.02 112.271 -173.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -94.57 14.13 21.89 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.18 0.992 . . . . 73.51 110.818 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -132.17 152.14 51.43 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.345 0.658 . . . . 71.51 110.558 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 64.8 m -75.15 125.65 29.39 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.448 0.699 . . . . 72.23 111.224 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.523 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -78.59 -59.17 2.89 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 114.897 -1.047 . . . . 74.05 108.683 176.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -153.25 160.82 42.84 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 115.179 -0.918 . . . . 65.44 112.483 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 59.5 mt -118.84 154.21 33.26 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.496 1.519 . . . . 72.21 107.812 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.2 t -161.06 157.5 26.23 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.371 0.668 . . . . 72.0 109.23 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 34.8 tt0 -166.02 130.77 2.29 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.044 -0.724 . . . . 74.24 109.044 175.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.404 HG11 ' HA ' ' B' ' 110' ' ' ALA . 96.7 t -123.66 143.65 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 108.707 -0.849 . . . . 75.25 108.707 173.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -124.8 96.33 4.84 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.563 -0.903 . . . . 74.0 108.563 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.403 ' HB2' ' HB1' ' B' ' 110' ' ' ALA . 8.5 tp-100 -85.72 100.07 11.75 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.568 -0.53 . . . . 74.45 109.568 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.15 144.66 17.19 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 111.357 -0.697 . . . . 74.21 111.357 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.49 131.81 4.35 Favored Glycine 0 C--O 1.236 0.274 0 N-CA-C 111.704 -0.558 . . . . 72.21 111.704 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.43 HG22 HD12 ' B' ' 51' ' ' LEU . 69.7 mt -84.63 126.95 40.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 N-CA-C 108.375 -0.972 . . . . 74.05 108.375 172.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -138.62 149.42 45.19 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.199 -0.667 . . . . 74.41 109.199 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 70.4 m -92.38 120.87 33.32 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.783 -0.821 . . . . 75.31 108.783 170.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.515 HG12 HG23 ' F' ' 18' ' ' VAL . 3.9 tp -120.71 118.83 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.438 1.095 . . . . 65.15 109.584 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.56 167.08 30.7 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.196 0.598 . . . . 72.23 109.981 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.14 -67.8 3.07 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.36 -0.382 . . . . 71.11 112.83 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mm -82.25 141.78 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.233 0.613 . . . . 75.32 110.813 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.443 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 11.3 pt-20 -153.09 -175.28 5.26 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.114 0.965 . . . . 71.22 109.803 -173.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.87 -133.74 37.43 Favored Glycine 0 C--N 1.354 1.582 0 C-N-CA 123.471 0.557 . . . . 51.04 113.396 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 55.4 m -66.0 -37.52 86.16 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.952 0.901 . . . . 70.45 110.614 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -67.79 -23.22 65.18 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 115.614 -0.721 . . . . 72.22 111.436 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.443 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 22.5 ttp -65.25 -29.49 70.28 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.966 0.906 . . . . 74.33 111.599 175.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . 0.6 ' HB2' ' HB3' ' F' ' 14' ' ' LEU . . . -64.18 -29.99 71.08 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.764 0.826 . . . . 75.41 111.491 175.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . 0.448 ' O ' ' HB2' ' B' ' 100' ' ' ALA . 45.6 t-80 -69.42 -30.15 68.03 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.444 0.698 . . . . 74.53 111.427 175.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.488 ' SG ' ' HE3' ' B' ' 9' ' ' MET . 44.6 t -79.62 -56.42 4.31 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.458 0.303 . . . . 64.42 111.134 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mp -81.61 -35.6 29.9 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.926 0.491 . . . . 74.23 112.27 -172.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.18 3.87 82.56 Favored Glycine 0 N--CA 1.47 0.961 0 CA-C-O 119.676 -0.514 . . . . 72.52 113.69 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' B' ' 96' ' ' HIS . . . -148.8 -66.88 0.23 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.531 0.567 . . . . 71.52 112.531 -172.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.429 ' HH ' ' HB2' ' D' ' 130' ' ' PRO . 30.4 t80 -60.51 -47.9 84.1 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.272 1.029 . . . . 73.2 111.945 -171.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 67.4 m -70.15 -45.5 21.43 Favored Pre-proline 0 CA--C 1.567 1.631 0 CA-C-O 118.339 -0.839 . . . . 74.1 112.241 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.422 ' HA ' HD23 ' B' ' 60' ' ' LEU . 60.5 Cg_exo -48.07 -40.43 33.81 Favored 'Trans proline' 0 C--N 1.4 3.271 0 C-N-CA 123.137 2.558 . . . . 71.34 114.389 167.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -62.66 -26.06 68.45 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 112.295 0.48 . . . . 71.31 112.295 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.539 HD12 HD11 ' B' ' 13' ' ' ILE . 57.6 mt -84.53 -45.87 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.452 0.701 . . . . 62.54 110.663 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 99.2 mt -82.03 -21.69 36.83 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.329 0.652 . . . . 74.34 112.461 -170.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -57.3 -50.74 86.43 Favored Pre-proline 0 N--CA 1.489 1.497 0 CA-C-O 117.654 -1.165 . . . . 70.22 113.329 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.54 -40.57 83.14 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 122.343 2.029 . . . . 75.34 114.105 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -67.69 -47.98 67.87 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.193 0.597 . . . . 74.44 110.366 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.404 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -63.9 -35.59 81.14 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.466 -0.788 . . . . 73.44 111.292 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -59.05 -58.2 9.72 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.366 1.067 . . . . 74.02 110.399 177.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -62.7 -33.03 74.26 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 123.924 0.765 . . . . 74.33 110.178 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.699 ' SG ' HD12 ' B' ' 21' ' ' ILE . 2.0 t -69.64 -38.59 77.21 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 122.902 0.481 . . . . 65.03 111.735 -176.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.573 HG21 HG22 ' B' ' 64' ' ' VAL . 89.4 mt -65.29 -56.02 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.879 -0.786 . . . . 75.01 108.879 172.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 9.7 m -59.43 -27.74 66.31 Favored 'General case' 0 CA--C 1.554 1.101 0 O-C-N 124.579 1.174 . . . . 74.2 111.619 -174.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.456 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.5 t -65.55 -48.67 71.62 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 123.682 0.793 . . . . 64.51 109.847 175.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.468 ' HE1' HG22 ' B' ' 21' ' ' ILE . 11.2 mmt -70.59 -33.96 71.64 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.236 0.614 . . . . 74.31 110.83 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.434 HG23 ' O ' ' B' ' 114' ' ' ILE . 97.8 t -58.12 -45.23 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 124.046 0.938 . . . . 72.44 109.803 172.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 22.6 t -71.8 -30.14 65.2 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.161 -1.381 . . . . 74.22 111.421 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' B' ' 116' ' ' SER . 82.1 mtt-85 -68.76 -31.97 71.39 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.145 -0.48 . . . . 72.02 109.871 175.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.5 6.85 67.01 Favored Glycine 0 C--N 1.355 1.609 0 O-C-N 123.837 0.71 . . . . 74.3 113.116 173.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.437 HG21 ' HB3' ' A' ' 17' ' ' TYR . 59.6 p 59.83 25.84 14.96 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 126.244 1.818 . . . . 73.03 113.166 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -88.39 160.59 44.89 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 123.805 0.842 . . . . 75.41 111.204 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.49 164.65 5.3 Favored 'Trans proline' 0 C--N 1.39 2.759 0 C-N-CA 123.454 2.77 . . . . 70.44 114.834 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.502 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -64.59 132.15 49.0 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.241 1.016 . . . . 75.45 111.302 -178.76 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 49.6 tp -137.9 114.56 10.51 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.134 0.573 . . . . 74.33 109.825 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -128.82 129.5 45.7 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.65 0.78 . . . . 72.11 109.173 174.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mp -82.41 145.42 29.88 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 123.578 0.751 . . . . 74.42 109.225 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.408 ' HB1' ' HB1' ' F' ' 7' ' ' ALA . . . -65.73 133.25 95.02 Favored Pre-proline 0 CA--C 1.554 1.101 0 O-C-N 123.664 0.603 . . . . 71.42 110.929 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.32 100.23 0.26 Allowed 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.898 2.398 . . . . 62.34 111.859 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 48.8 t -90.42 109.52 20.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 108.58 -0.896 . . . . 74.22 108.58 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -89.86 90.36 8.15 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 107.949 -1.13 . . . . 71.22 107.949 176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -58.55 -35.54 72.49 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.127 -0.942 . . . . 71.34 110.355 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -66.97 -42.21 85.52 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.531 1.132 . . . . 63.14 111.097 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.62 -38.34 90.68 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.978 0.799 . . . . 64.52 111.076 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -66.02 -50.49 64.03 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 123.746 0.654 . . . . 73.4 109.529 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -61.12 -40.23 92.97 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 123.588 0.555 . . . . 74.41 111.06 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 38.2 mtt -63.56 -40.2 96.38 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 123.386 0.429 . . . . 74.42 111.093 177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -84.01 -25.92 29.55 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 120.931 0.396 . . . . 72.43 110.82 -171.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -70.93 -35.56 72.28 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.729 -0.669 . . . . 74.55 109.851 176.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 66.0 mt -93.84 -5.71 47.48 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.638 -0.71 . . . . 74.05 111.097 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . 0.761 ' HG3' ' HB3' ' D' ' 6' ' ' ASN . 0.0 OUTLIER -147.05 98.78 3.08 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.818 0.818 . . . . 65.3 110.511 -176.272 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -141.13 149.28 41.33 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 125.052 1.341 . . . . 72.35 107.81 174.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -154.07 128.39 9.12 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.585 -0.524 . . . . 73.3 109.585 -176.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.31 121.19 19.02 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 124.108 0.88 . . . . 75.23 110.983 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -151.8 -157.84 8.11 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.922 -0.581 . . . . 73.54 111.88 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . 0.527 ' HB3' HG21 ' B' ' 149' ' ' THR . 4.9 mp0 -71.3 115.2 10.17 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.526 0.73 . . . . 63.32 111.513 -173.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -79.79 69.47 3.05 Favored Glycine 0 C--N 1.347 1.17 0 N-CA-C 110.889 -0.884 . . . . 42.42 110.889 170.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' THR . . . . . 0.527 HG21 ' HB3' ' B' ' 147' ' ' GLU . 10.8 p -82.95 67.38 9.01 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.808 0.843 . . . . 74.43 111.313 -174.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -85.14 18.23 2.66 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.883 0.873 . . . . 71.04 110.655 173.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.02 156.29 25.13 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 124.526 1.13 . . . . 73.43 110.052 171.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -134.46 93.64 3.09 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.51 -0.922 . . . . 63.12 108.51 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -78.75 65.78 4.08 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 122.517 1.151 . . . . 62.42 109.727 172.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.3 176.83 7.05 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.515 -1.22 . . . . 72.4 110.997 -174.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 C-N-CA 123.664 0.785 . . . . 74.33 109.176 -179.513 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.478 ' N ' ' SD ' ' C' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.924 0.393 . . . . 75.24 110.449 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m -131.86 148.18 52.53 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.974 0.91 . . . . 72.1 108.904 174.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -71.66 139.37 49.23 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.127 0.489 . . . . 61.42 110.461 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . 0.438 ' HG2' ' HA ' ' A' ' 143' ' ' GLN . 71.6 mt-30 -102.69 98.7 8.69 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.418 1.087 . . . . 74.31 109.715 -168.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -78.07 151.3 33.5 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.828 0.851 . . . . 71.42 110.725 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . 0.459 ' HB3' ' NE2' ' C' ' 93' ' ' GLN . 45.4 t-20 -73.63 93.45 2.06 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.865 -0.791 . . . . 71.23 108.865 174.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 14.8 t -105.93 21.44 17.31 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 114.677 -1.147 . . . . 75.42 110.136 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -57.44 -74.23 0.06 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.088 0.955 . . . . 74.12 108.969 -178.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.657 ' HE1' ' SG ' ' C' ' 97' ' ' CYS . 0.0 OUTLIER 63.36 115.26 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 124.872 1.269 . . . . 72.53 113.124 167.348 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 45.0 m -98.32 98.48 9.72 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.683 0.793 . . . . 75.32 109.285 171.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.652 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 50.6 t80 -121.53 130.77 53.74 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.817 -0.809 . . . . 74.4 108.817 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -150.61 140.1 21.5 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.632 -0.507 . . . . 74.22 109.632 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.415 HG12 ' HE2' ' C' ' 84' ' ' PHE . 43.5 mt -83.38 127.14 40.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.828 -0.804 . . . . 75.12 108.828 173.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.488 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 23.5 mm-40 -92.34 -40.0 11.16 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 123.666 0.604 . . . . 74.14 109.639 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -176.74 124.66 0.16 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.378 0.671 . . . . 75.44 109.812 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.5 mt -110.23 148.22 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 108.454 -0.943 . . . . 74.21 108.454 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -173.61 160.02 3.69 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.046 0.938 . . . . 75.1 109.235 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' THR . . . . . 0.403 HG23 HE22 ' C' ' 80' ' ' GLN . 76.8 p -81.18 107.78 14.27 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.199 -0.667 . . . . 74.44 109.199 176.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt -65.27 -47.72 75.71 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.822 0.82 . . . . 72.4 109.262 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.3 t70 -143.33 144.54 32.13 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.114 -1.403 . . . . 73.41 109.513 -174.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.3 mt -139.13 147.12 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.229 1.411 . . . . 74.54 107.335 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -157.25 150.8 24.12 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.32 0.648 . . . . 74.31 110.008 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -151.91 149.03 28.49 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.713 -1.217 . . . . 73.0 107.713 171.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -147.5 149.55 32.86 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.112 1.365 . . . . 70.04 107.617 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.8 84.72 3.73 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 107.316 -1.364 . . . . 71.34 107.316 169.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.65 -38.3 73.08 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.228 2.619 . . . . 73.41 113.139 -173.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -107.18 19.71 20.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.812 0.845 . . . . 75.1 110.999 -172.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.438 ' O ' HG13 ' C' ' 31' ' ' VAL . . . -45.94 -58.33 6.47 Favored Pre-proline 0 CA--C 1.562 1.426 0 CA-C-O 117.355 -1.307 . . . . 70.34 114.259 -170.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -54.55 -47.46 26.7 Favored 'Trans proline' 0 C--N 1.389 2.694 0 C-N-CA 122.106 1.871 . . . . 71.51 112.255 -177.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.509 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.9 t60 -71.38 -32.9 69.01 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.11 -0.95 . . . . 70.2 112.843 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.659 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.8 p -77.3 -24.02 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 112.541 0.571 . . . . 75.12 112.541 -169.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -63.44 -26.19 68.62 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.085 0.772 . . . . 71.04 113.085 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 10.4 pt20 -87.53 6.6 33.43 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.017 0.527 . . . . 74.14 111.521 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.732 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -88.38 154.89 20.03 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.937 0.895 . . . . 75.35 110.509 179.246 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -66.13 128.2 35.17 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.509 -0.768 . . . . 73.5 109.067 165.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -78.69 90.18 4.59 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.388 0.675 . . . . 75.43 110.796 -174.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -132.96 76.99 69.35 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 124.275 1.03 . . . . 75.4 108.927 174.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -85.83 123.43 2.43 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.521 2.147 . . . . 61.51 112.295 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -83.26 83.68 7.77 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 106.788 -1.56 . . . . 70.43 106.788 167.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 5.6 p -71.83 116.24 13.36 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 CA-C-N 114.081 -1.418 . . . . 72.55 110.787 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -108.24 102.51 11.63 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.298 -1.001 . . . . 75.43 108.298 173.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.65 137.44 32.33 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.305 -0.628 . . . . 70.32 109.305 176.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.426 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 16.0 t70 -119.59 147.72 44.17 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.384 1.074 . . . . 73.52 108.141 -177.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.471 HD11 HD13 ' G' ' 8' ' ' LEU . 16.3 tp -130.0 112.5 13.54 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.148 0.499 . . . . 74.2 110.01 -177.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.597 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 13.5 t70 -113.73 154.08 27.93 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.156 1.382 . . . . 75.55 109.153 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 34.0 p -135.32 132.12 37.29 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.489 0.716 . . . . 74.32 110.48 -173.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.46 154.7 48.45 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.918 0.887 . . . . 73.42 109.288 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 48.3 p -160.99 146.68 14.47 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.799 0.333 . . . . 64.04 111.811 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 68.1 p -150.11 133.38 16.37 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.064 0.946 . . . . 74.23 109.154 174.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -76.98 120.82 22.63 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.315 0.646 . . . . 74.01 109.897 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.581 HD12 ' HB2' ' C' ' 57' ' ' GLU . 26.2 mt -94.1 -30.25 14.76 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.154 0.582 . . . . 61.55 110.517 -177.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.33 -178.92 6.99 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.299 1.04 . . . . 72.1 109.882 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.25 113.05 2.95 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.731 -0.668 . . . . 74.14 109.978 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . 0.434 ' HA ' ' HE1' ' C' ' 56' ' ' TYR . 3.6 m-20 63.26 18.63 11.13 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.536 1.134 . . . . 73.22 112.503 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 83.9 t -115.4 114.47 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.131 -1.063 . . . . 74.33 108.131 170.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.434 ' HE1' ' HA ' ' C' ' 54' ' ' ASP . 83.4 m-85 -126.64 134.29 50.78 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.921 0.888 . . . . 64.34 109.018 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.581 ' HB2' HD12 ' C' ' 51' ' ' LEU . 40.2 tt0 -84.58 114.3 21.88 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.082 -1.081 . . . . 74.01 108.082 170.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.469 HG12 ' HE2' ' G' ' 15' ' ' PHE . 98.9 t -95.93 124.22 48.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 107.693 -1.225 . . . . 74.45 107.693 173.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 94.9 t -117.66 133.27 64.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 107.759 -1.2 . . . . 74.24 107.759 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.447 HD13 ' HB3' ' C' ' 103' ' ' PRO . 23.7 tp -127.8 105.76 8.66 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.691 -0.855 . . . . 74.42 108.691 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.597 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 9.2 ttm180 -82.89 122.61 28.47 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.34 -0.615 . . . . 75.15 109.34 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.465 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.2 t -113.83 127.78 71.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.031 -1.1 . . . . 74.12 108.031 171.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 31.5 m -123.5 110.12 14.68 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.017 0.527 . . . . 73.3 109.607 -177.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.546 HG21 HD12 ' C' ' 114' ' ' ILE . 69.3 t -99.72 108.43 22.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 108.883 -0.784 . . . . 73.41 108.883 -177.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 3.8 m -99.5 126.32 45.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.982 -0.748 . . . . 54.11 108.982 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.38 106.69 13.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.307 -0.997 . . . . 63.32 108.307 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 22.1 m -127.02 129.46 48.1 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.814 -0.81 . . . . 71.33 108.814 175.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.732 HD11 ' HG2' ' C' ' 34' ' ' LYS . 8.1 mt -85.09 32.64 0.54 Allowed 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 125.109 1.364 . . . . 64.52 110.78 -178.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.81 -108.83 2.36 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 110.728 -0.949 . . . . 75.25 110.728 -171.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.71 -23.06 23.06 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.393 0.677 . . . . 73.34 109.943 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.13 115.83 22.07 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 123.993 0.917 . . . . 74.43 109.48 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 79.3 m -84.39 123.84 30.66 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 118.756 0.707 . . . . 74.12 109.164 169.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.659 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -77.38 -57.32 3.89 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.007 -0.997 . . . . 74.31 109.281 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -157.86 172.48 18.39 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 122.103 0.954 . . . . 72.34 111.639 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -135.18 128.36 31.87 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 105.611 -1.996 . . . . 75.03 105.611 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 44.4 t -128.26 143.5 51.03 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.134 -1.061 . . . . 62.41 108.134 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.48 123.29 5.18 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.206 0.316 . . . . 73.34 110.367 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 61.8 t -134.12 125.25 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.457 0.703 . . . . 75.14 109.526 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 25.8 mt-30 -96.02 98.48 10.41 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.926 -1.138 . . . . 72.23 107.926 172.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.403 HE22 HG23 ' C' ' 18' ' ' THR . 10.0 tp-100 -84.25 121.48 27.56 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.053 -0.522 . . . . 62.42 110.153 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.9 147.23 16.7 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 112.168 -0.373 . . . . 75.2 112.168 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.407 ' HA3' HD22 ' C' ' 106' ' ' LEU . . . -148.75 125.14 1.98 Allowed Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.169 -1.173 . . . . 72.4 110.169 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.532 HD13 HD12 ' C' ' 51' ' ' LEU . 13.1 mm -80.63 127.62 39.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 107.554 -1.276 . . . . 74.52 107.554 174.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.415 ' HE2' HG12 ' C' ' 13' ' ' ILE . 64.6 m-85 -134.42 142.28 47.08 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.976 0.417 . . . . 72.31 110.667 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 11.5 p -96.28 107.61 19.99 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 108.246 -1.02 . . . . 73.25 108.246 168.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 69.9 mt -115.36 116.47 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.368 1.067 . . . . 73.45 109.245 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.08 172.38 18.51 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.749 0.82 . . . . 71.42 111.181 -171.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.46 -59.2 0.94 Allowed Glycine 0 C--N 1.349 1.264 0 CA-C-N 116.302 -0.408 . . . . 71.12 113.308 170.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.4 ' CD1' ' HG2' ' C' ' 9' ' ' MET . 38.1 pt -94.36 -177.24 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.634 0.774 . . . . 74.22 110.172 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -164.49 155.12 14.78 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 122.974 0.51 . . . . 73.53 110.93 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.435 ' H ' ' HA ' ' G' ' 21' ' ' ALA . . . 75.04 -130.78 11.69 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 119.25 -0.75 . . . . 65.31 113.845 171.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 21.5 m -55.72 -40.29 72.23 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.5 1.12 . . . . 73.41 111.577 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.459 ' NE2' ' HB3' ' C' ' 6' ' ' ASN . 14.0 mt-30 -56.25 -48.21 77.0 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.404 -1.271 . . . . 73.14 109.817 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.532 ' SD ' ' HB3' ' G' ' 21' ' ' ALA . 56.2 ttm -80.33 -27.16 38.41 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 114.822 -1.081 . . . . 73.24 111.234 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.25 81.9 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.53 0.732 . . . . 62.2 111.359 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.515 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 57.8 t-80 -70.75 -28.54 64.77 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.189 -0.914 . . . . 75.03 111.157 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.657 ' SG ' ' HE1' ' C' ' 9' ' ' MET . 50.3 t -77.43 -55.33 5.48 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 122.229 -0.294 . . . . 73.24 111.222 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' C' ' 94' ' ' MET . 1.0 OUTLIER -78.09 -22.78 48.45 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 112.968 0.729 . . . . 72.43 112.968 -173.443 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . 0.427 ' N ' HD11 ' C' ' 98' ' ' LEU . . . -97.59 0.62 59.69 Favored Glycine 0 C--N 1.346 1.089 0 O-C-N 123.403 0.44 . . . . 74.35 112.871 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -140.62 -69.18 0.4 Allowed 'General case' 0 C--N 1.347 0.485 0 C-N-CA 123.344 0.658 . . . . 72.14 110.455 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -65.24 -51.85 58.28 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.496 0.924 . . . . 74.52 113.496 -168.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.45 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 19.9 m -61.63 -47.05 93.61 Favored Pre-proline 0 CA--C 1.564 1.506 0 CA-C-O 118.845 -0.598 . . . . 74.3 112.363 -173.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 21.7 Cg_exo -68.91 -26.11 32.0 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 121.997 1.798 . . . . 74.21 112.971 172.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -72.49 -25.43 61.41 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.447 0.699 . . . . 73.24 110.719 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.442 HD13 ' NH1' ' A' ' 111' ' ' ARG . 28.7 mm -66.02 -35.27 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.036 0.534 . . . . 74.21 109.586 169.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.407 HD22 ' HA3' ' C' ' 82' ' ' GLY . 84.3 mt -87.18 -17.68 32.11 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.048 0.939 . . . . 75.22 112.452 -176.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -54.39 -50.77 83.15 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 117.534 -1.222 . . . . 75.53 112.863 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -55.24 -36.75 94.12 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.75 2.3 . . . . 73.13 114.594 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -75.46 -44.16 45.65 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.808 0.443 . . . . 74.31 110.55 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.31 -45.74 90.48 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.453 -0.794 . . . . 73.51 109.662 174.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 41.2 ttt-85 -54.26 -51.49 64.39 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.497 1.519 . . . . 71.53 111.506 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.85 -35.58 74.84 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.319 0.648 . . . . 74.44 110.421 -176.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.6 t -71.75 -31.62 66.85 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.005 0.522 . . . . 74.14 110.901 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.546 HD12 HG21 ' C' ' 64' ' ' VAL . 89.4 mt -70.89 -53.47 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.451 0.7 . . . . 74.42 109.661 174.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.9 m -64.35 -28.79 69.94 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.366 0.667 . . . . 74.43 111.249 -176.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.1 t -65.2 -48.63 72.71 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 109.061 -0.718 . . . . 73.11 109.061 173.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.647 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.86 -36.68 84.08 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.508 1.123 . . . . 72.33 112.354 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.41 HG23 ' O ' ' C' ' 114' ' ' ILE . 97.2 t -67.89 -40.89 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.436 0.694 . . . . 75.55 110.094 176.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 48.4 t -70.18 -29.66 66.59 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.162 -0.926 . . . . 75.35 111.371 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.4 ' HD2' ' SD ' ' C' ' 117' ' ' MET . 86.5 mtt-85 -72.26 -32.18 66.44 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.622 0.769 . . . . 74.32 109.598 176.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.17 5.96 69.67 Favored Glycine 0 C--N 1.354 1.564 0 O-C-N 124.014 0.821 . . . . 65.43 112.91 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.44 HG22 ' HB3' ' D' ' 17' ' ' TYR . 76.7 p 57.73 28.3 15.65 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 126.273 1.829 . . . . 73.42 113.278 178.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -88.16 155.38 52.12 Favored Pre-proline 0 CA--C 1.555 1.153 0 N-CA-C 109.213 -0.662 . . . . 75.3 109.213 171.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.39 142.66 29.19 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 123.166 2.577 . . . . 70.3 113.382 172.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.448 ' HA ' HE21 ' C' ' 125' ' ' GLN . 0.0 OUTLIER -59.98 112.27 1.81 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.694 0.798 . . . . 73.31 111.411 -176.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 48.8 tp -113.38 93.08 4.23 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.469 -0.937 . . . . 75.31 108.469 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -91.48 127.84 37.08 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.364 -0.976 . . . . 74.32 108.364 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 89.0 mt -69.54 134.47 48.88 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 123.375 0.422 . . . . 72.33 110.18 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' G' ' 6' ' ' ILE . . . -78.09 158.73 76.94 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 123.822 0.849 . . . . 74.52 110.751 -178.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.553 ' HG3' HD13 ' A' ' 16' ' ' ILE . 23.5 Cg_endo -56.85 112.0 0.97 Allowed 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.918 2.412 . . . . 73.35 112.666 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 p -96.97 107.49 19.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 107.507 -1.294 . . . . 74.41 107.507 170.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -90.86 82.83 5.65 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.812 -1.085 . . . . 72.05 109.121 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -58.61 -44.83 90.06 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.223 0.535 . . . . 71.54 109.566 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -58.23 -46.86 85.16 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.453 -1.249 . . . . 73.43 112.127 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.75 -41.34 87.94 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.885 0.74 . . . . 65.13 111.406 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.408 HD13 HD22 ' G' ' 10' ' ' LEU . 95.4 mt -68.78 -45.05 72.33 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.559 0.344 . . . . 74.12 110.777 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -68.05 -21.63 65.0 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.8 0.44 . . . . 74.24 111.855 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 49.2 ttm -70.44 -35.33 73.3 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.873 0.869 . . . . 73.24 110.633 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -69.31 -43.65 73.33 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.821 0.449 . . . . 72.34 110.089 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.401 ' HB3' ' H ' ' C' ' 141' ' ' LEU . 56.0 m-85 -72.07 -154.6 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.728 0.811 . . . . 75.5 112.077 175.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.401 ' H ' ' HB3' ' C' ' 140' ' ' TYR . 20.6 tp 71.23 -70.6 0.15 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.431 1.492 . . . . 71.03 110.961 176.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -120.23 89.19 3.08 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.541 -0.911 . . . . 75.25 108.541 166.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -71.76 -18.71 62.1 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.565 0.746 . . . . 75.24 110.567 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -66.62 -26.2 66.96 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.315 0.646 . . . . 74.12 110.615 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 68.9 -177.34 0.21 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.764 1.226 . . . . 72.03 111.295 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -173.44 55.82 0.15 Allowed Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.445 -0.662 . . . . 73.11 111.445 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -74.76 -90.66 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.879 0.872 . . . . 72.32 109.628 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 51.93 20.34 6.2 Favored Glycine 0 C--N 1.361 1.941 0 N-CA-C 115.446 0.938 . . . . 74.33 115.446 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 88.8 m -123.16 102.17 7.81 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.823 0.849 . . . . 72.13 110.35 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -163.24 124.45 2.4 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.115 -1.439 . . . . 71.11 107.115 172.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -153.17 91.27 1.5 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.926 -0.768 . . . . 75.42 108.926 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -137.52 109.28 7.07 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.089 0.956 . . . . 74.52 108.572 173.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -94.12 -76.23 0.49 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.82 0.848 . . . . 74.23 109.888 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -179.42 -65.04 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.9 1.28 . . . . 73.21 108.894 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.904 0 N-CA-C 108.307 -0.997 . . . . 73.13 108.307 -175.228 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 76.3 mtp . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 121.128 0.49 . . . . 73.22 109.997 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 40.7 p -163.54 85.39 0.49 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.239 -1.393 . . . . 65.5 107.239 -172.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -142.65 82.86 1.79 Allowed 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.874 0.845 . . . . 73.2 109.156 -177.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -127.73 154.95 44.75 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.092 0.957 . . . . 75.33 110.142 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -145.84 107.37 4.24 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.583 0.753 . . . . 65.23 109.598 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . 0.761 ' HB3' ' HG3' ' B' ' 142' ' ' GLN . 2.8 p30 -144.95 93.16 2.36 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.959 0.903 . . . . 70.21 109.931 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 7' ' ' THR . . . . . 0.509 HG23 ' HB3' ' D' ' 9' ' ' MET . 2.1 t -164.54 168.45 18.28 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.961 -1.018 . . . . 72.02 110.01 -173.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -68.36 -27.47 66.28 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.735 1.214 . . . . 73.32 110.614 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.712 ' HG3' HD13 ' D' ' 89' ' ' ILE . 16.9 ttt -24.12 125.69 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 127.11 2.164 . . . . 73.0 116.196 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 85.4 m -104.81 142.63 34.39 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.469 -0.937 . . . . 75.43 108.469 168.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -154.81 108.25 2.86 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.99 -1.115 . . . . 72.14 107.99 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -122.42 119.78 32.0 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.84 -0.8 . . . . 74.01 108.84 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 65.7 mt -68.09 135.52 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 109.872 -0.418 . . . . 74.1 109.872 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.476 HE22 HG12 ' D' ' 55' ' ' VAL . 51.6 mt-30 -101.41 -39.54 7.51 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.069 0.547 . . . . 74.43 111.405 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 15.4 ttt180 -172.03 135.8 0.83 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.706 0.23 . . . . 71.14 111.374 -169.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.4 mp -120.6 135.51 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 107.59 -1.263 . . . . 73.3 107.59 167.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.44 ' HB3' HG22 ' C' ' 122' ' ' THR . 37.1 p90 -163.53 168.78 19.66 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.941 0.877 . . . . 70.23 111.301 177.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.2 p -99.15 128.33 45.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.316 -1.311 . . . . 74.52 109.082 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -104.66 -15.14 15.36 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.025 0.53 . . . . 72.52 110.384 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.725 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 28.3 t70 -158.62 132.66 7.8 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.484 -1.235 . . . . 72.32 108.157 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.647 HG21 ' HE1' ' C' ' 117' ' ' MET . 57.4 mt -138.8 148.14 24.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.545 -1.279 . . . . 73.51 107.545 176.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 27.2 t -154.13 145.42 22.96 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.416 0.686 . . . . 70.3 109.818 173.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.443 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.1 t80 -149.97 122.02 8.26 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 105.55 -2.018 . . . . 75.31 105.55 172.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 26.6 mt-10 -130.4 111.54 12.42 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.96 -0.756 . . . . 72.43 108.96 -173.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.69 86.22 18.46 Favored Pre-proline 0 C--O 1.241 0.615 0 N-CA-C 108.683 -0.858 . . . . 73.23 108.683 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.77 -39.89 2.24 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.36 2.04 . . . . 73.34 111.727 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -86.72 -3.34 59.03 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.812 1.245 . . . . 74.25 111.31 -176.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -23.74 -67.95 0.05 OUTLIER Pre-proline 0 C--N 1.361 1.096 0 C-N-CA 127.465 2.306 . . . . 75.43 116.737 -165.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.52 ' HB3' HD11 ' C' ' 83' ' ' ILE . 86.2 Cg_endo -73.64 -29.74 10.44 Favored 'Trans proline' 0 C--N 1.375 1.951 0 CA-C-N 123.133 2.155 . . . . 75.54 113.582 -168.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -87.36 -22.52 25.01 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.623 0.249 . . . . 74.1 110.672 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.522 HG23 HD11 ' D' ' 68' ' ' LEU . 10.0 p -81.75 -18.1 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 122.866 0.466 . . . . 74.41 110.482 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -65.62 -18.77 65.57 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 112.562 0.578 . . . . 75.22 112.562 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -64.58 -12.35 44.2 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.131 0.972 . . . . 74.14 111.602 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -102.62 106.83 17.57 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.167 1.387 . . . . 71.44 110.463 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -102.96 83.81 2.28 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.998 0.919 . . . . 74.11 110.158 -176.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -158.28 175.65 13.47 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.698 0.799 . . . . 72.22 109.171 169.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -66.5 111.95 8.12 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 123.412 0.685 . . . . 64.44 110.101 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.408 ' HB2' ' HB3' ' D' ' 66' ' ' ALA . 73.9 Cg_exo -56.12 119.44 6.62 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.004 2.469 . . . . 71.45 111.649 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -60.56 113.74 2.6 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.561 1.145 . . . . 74.44 110.419 -176.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 71.7 t -97.18 126.1 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.339 0.656 . . . . 74.43 111.226 -169.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.614 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 17.0 tppt? -101.72 110.52 22.52 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.312 -1.736 . . . . 74.25 106.312 166.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.52 114.06 25.69 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.287 -1.005 . . . . 74.01 108.287 -172.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.727 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 11.7 m-20 -107.21 150.06 27.04 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.389 1.075 . . . . 73.35 109.451 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.401 HD21 HD21 ' H' ' 8' ' ' LEU . 94.4 mt -129.5 151.02 50.58 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.571 0.748 . . . . 70.11 110.476 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.554 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 33.6 t70 -156.88 136.06 11.98 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.795 -1.187 . . . . 72.15 107.795 174.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 41.1 p -107.23 144.43 34.03 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.01 0.524 . . . . 71.43 110.987 -171.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.638 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.44 156.43 41.44 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.931 0.893 . . . . 75.22 109.303 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.482 ' HB3' ' HE2' ' H' ' 15' ' ' PHE . 10.5 p -172.18 155.78 3.74 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.025 0.53 . . . . 64.43 111.129 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 56.0 p -151.93 123.12 7.68 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.343 -0.844 . . . . 73.34 109.045 175.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -76.64 123.36 26.01 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.956 -0.757 . . . . 71.41 108.956 173.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 35.8 mt -90.01 -31.02 17.38 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.293 0.568 . . . . 75.34 109.997 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.5 171.91 13.99 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.304 1.441 . . . . 72.35 108.397 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -68.08 127.25 32.2 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.299 -0.876 . . . . 74.4 108.978 171.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 75.63 -2.85 2.7 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 125.926 1.69 . . . . 74.42 112.494 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.476 HG12 HE22 ' D' ' 14' ' ' GLN . 64.1 t -117.06 115.7 49.73 Favored 'Isoleucine or valine' 0 C--N 1.354 0.783 0 N-CA-C 108.099 -1.075 . . . . 74.24 108.099 172.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -144.38 169.12 18.54 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.516 -0.549 . . . . 73.21 109.516 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -130.04 132.36 46.18 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.105 -0.952 . . . . 71.44 109.568 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 64.2 t -105.94 124.75 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.464 -1.31 . . . . 75.52 107.464 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 20.9 t -114.84 130.02 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.457 -1.312 . . . . 74.44 107.457 172.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.66 HD23 ' HB3' ' D' ' 103' ' ' PRO . 15.4 tp -125.93 120.55 30.7 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.847 -0.797 . . . . 72.53 108.847 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.554 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 55.3 ttm-85 -83.99 102.78 12.72 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.157 -0.683 . . . . 75.41 109.157 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 71.7 t -91.15 126.86 43.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 107.862 -1.162 . . . . 73.35 107.862 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.727 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 26.8 m -124.14 126.62 46.49 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.486 0.66 . . . . 74.53 110.101 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.415 HG22 HG21 ' D' ' 114' ' ' ILE . 53.4 t -111.36 98.69 7.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 124.853 1.261 . . . . 65.41 107.781 177.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.614 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 31.0 m -95.98 90.04 5.43 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.335 -1.357 . . . . 73.23 107.335 177.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' D' ' 38' ' ' PRO . . . -97.93 148.18 23.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.458 -0.792 . . . . 72.43 110.576 -170.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.482 ' HA ' ' N ' ' D' ' 73' ' ' ALA . 54.8 m -145.34 135.5 23.88 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.259 0.466 . . . . 73.53 112.259 -174.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.522 HD11 HG23 ' D' ' 31' ' ' VAL . 82.0 mt -108.35 105.73 15.54 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.714 0.806 . . . . 75.43 109.151 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.47 -135.68 14.45 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.301 0.376 . . . . 71.24 113.653 175.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.29 5.74 25.6 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.32 0.648 . . . . 74.11 111.616 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -136.93 173.2 11.96 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.243 0.617 . . . . 72.34 110.797 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 37.7 m -66.34 153.08 43.62 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.976 1.31 . . . . 73.23 111.574 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.482 ' N ' ' HA ' ' D' ' 67' ' ' SER . . . -101.67 -65.51 0.97 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.378 -1.341 . . . . 54.13 107.378 168.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -155.21 146.86 23.17 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.478 -1.237 . . . . 74.23 110.246 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.486 HD21 HG21 ' D' ' 65' ' ' THR . 31.7 mt -104.57 111.12 23.69 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.468 -1.308 . . . . 74.12 107.468 172.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.546 ' SG ' HG12 ' D' ' 114' ' ' ILE . 35.0 t -117.26 137.64 52.26 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.621 -0.881 . . . . 75.43 108.621 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -154.86 121.42 5.38 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.646 -0.502 . . . . 74.44 109.646 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 65.4 t -129.47 124.0 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.392 0.677 . . . . 74.11 109.492 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.725 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 22.0 mt-30 -86.95 93.99 9.48 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 107.947 -1.131 . . . . 74.22 107.947 164.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -83.35 105.19 14.1 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.266 -1.013 . . . . 74.43 108.266 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -98.39 150.2 19.32 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-N 116.0 -0.545 . . . . 55.21 112.019 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.49 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -152.78 129.63 2.8 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.76 -0.257 . . . . 41.34 112.511 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.5 mt -91.2 126.89 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 108.211 -1.033 . . . . 64.3 108.211 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -130.68 153.81 48.58 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.639 0.776 . . . . 74.42 110.747 -174.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.3 m -106.71 138.21 43.31 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.504 1.121 . . . . 75.02 108.5 173.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.681 HG12 HD11 ' D' ' 89' ' ' ILE . 8.8 tt -146.4 144.2 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 108.849 -0.797 . . . . 74.11 108.849 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.47 146.62 8.62 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.18 0.592 . . . . 72.04 110.219 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.94 10.4 57.58 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.278 0.361 . . . . 70.32 113.122 -177.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.712 HD13 ' HG3' ' D' ' 9' ' ' MET . 3.4 mp -123.65 151.06 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.018 0.927 . . . . 73.54 109.569 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.55 178.36 9.96 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.087 1.355 . . . . 73.23 109.737 174.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.09 -134.0 31.43 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 114.481 0.552 . . . . 64.21 114.481 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 34.6 p -88.88 -12.84 40.66 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.064 0.946 . . . . 74.23 112.419 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -61.7 -40.57 95.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.179 0.592 . . . . 73.31 110.559 177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.592 ' HB2' HG22 ' H' ' 18' ' ' VAL . 26.4 ptt? -75.61 -20.26 58.68 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.624 -0.716 . . . . 62.31 112.2 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.24 -38.57 91.51 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.935 0.494 . . . . 72.42 110.677 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -78.01 -29.44 49.55 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.397 -0.82 . . . . 72.05 111.056 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . 0.414 ' SG ' HD12 ' D' ' 86' ' ' ILE . 44.3 t -68.5 -52.85 27.66 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 122.895 0.122 . . . . 75.14 111.085 -175.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.2 -22.06 42.27 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 110.612 -0.144 . . . . 74.42 110.612 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.29 -3.52 81.9 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-O 119.697 -0.502 . . . . 73.11 114.079 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.39 -58.76 0.13 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 117.479 0.64 . . . . 65.4 111.774 -177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -66.07 -47.96 72.57 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 112.658 0.614 . . . . 71.43 112.658 -170.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 44.6 m -67.85 -44.88 42.78 Favored Pre-proline 0 CA--C 1.565 1.523 0 CA-C-O 118.819 -0.61 . . . . 72.11 112.36 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.66 ' HB3' HD23 ' D' ' 60' ' ' LEU . 50.8 Cg_exo -59.12 -28.81 88.81 Favored 'Trans proline' 0 C--N 1.39 2.75 0 C-N-CA 122.54 2.16 . . . . 72.41 113.618 168.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -69.67 -33.57 72.76 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.507 0.723 . . . . 64.52 110.347 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.9 mm -67.33 -33.27 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-O 121.334 0.588 . . . . 74.34 110.212 174.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.49 HD22 ' HA3' ' D' ' 82' ' ' GLY . 65.4 mt -85.22 -15.97 41.83 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.885 0.874 . . . . 74.24 111.883 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -61.38 -48.51 90.84 Favored Pre-proline 0 CA--C 1.567 1.622 0 CA-C-O 118.002 -0.999 . . . . 71.35 113.262 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -59.92 -31.37 93.61 Favored 'Trans proline' 0 C--N 1.388 2.646 0 C-N-CA 122.093 1.862 . . . . 71.5 112.923 177.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -82.24 -32.04 29.92 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.727 0.811 . . . . 74.24 111.803 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.08 -48.1 72.08 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.847 -0.797 . . . . 75.43 108.847 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.439 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 34.4 ttp180 -55.39 -49.61 71.88 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 124.405 1.066 . . . . 73.44 111.141 176.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -64.68 -50.31 67.51 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 123.898 0.749 . . . . 75.54 111.144 -174.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.404 ' SG ' HD11 ' D' ' 21' ' ' ILE . 44.8 t -57.85 -44.39 86.52 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 124.005 0.816 . . . . 71.14 110.801 -178.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.546 HG12 ' SG ' ' D' ' 76' ' ' CYS . 91.4 mt -63.56 -55.34 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.727 0.811 . . . . 73.43 111.119 175.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 77.1 m -57.37 -39.91 77.04 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.146 0.979 . . . . 73.41 111.217 -174.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 86.5 p -66.7 -41.83 87.38 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.402 -0.817 . . . . 74.41 109.533 -177.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.419 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 65.3 mtm -69.97 -28.89 65.91 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.151 0.58 . . . . 73.32 111.734 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.457 HG23 ' O ' ' D' ' 114' ' ' ILE . 88.3 t -63.23 -49.18 84.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.23 0.612 . . . . 74.43 109.391 172.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.1 p -73.61 -26.1 60.63 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.867 -0.606 . . . . 71.3 111.039 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' D' ' 116' ' ' SER . 74.1 mtt-85 -71.94 -37.79 69.93 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.492 0.717 . . . . 75.43 109.246 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.78 4.86 77.77 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 115.362 -0.835 . . . . 50.12 112.448 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 22.4 p 58.7 30.67 20.26 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 126.683 1.993 . . . . 73.3 113.703 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -84.75 159.62 57.53 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 123.988 0.915 . . . . 74.24 109.883 171.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.35 126.13 21.32 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.693 2.262 . . . . 73.52 112.136 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -64.51 124.72 22.57 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.889 0.876 . . . . 73.42 111.652 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 7.0 tt -124.59 115.08 20.24 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.125 -1.435 . . . . 75.54 107.125 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -99.59 121.62 41.46 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.907 0.883 . . . . 73.12 108.653 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.675 ' HA ' HD11 ' H' ' 6' ' ' ILE . 7.3 mp -68.77 113.63 6.39 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 109.897 -0.409 . . . . 75.23 109.897 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.7 140.06 97.93 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.017 0.527 . . . . 72.31 110.432 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.429 ' HB2' ' HH ' ' B' ' 101' ' ' TYR . 9.3 Cg_exo -66.53 126.57 15.72 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.106 1.871 . . . . 74.32 110.708 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.6 m -107.85 146.71 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 C-N-CA 123.27 0.628 . . . . 75.42 110.725 -174.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -97.33 68.7 2.21 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.916 0.865 . . . . 64.11 109.207 -176.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -87.91 -26.6 22.64 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.191 -0.913 . . . . 52.4 111.485 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.69 -44.4 66.23 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.292 0.637 . . . . 71.14 110.779 169.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.07 -43.94 97.76 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 124.222 0.951 . . . . 75.22 111.772 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.84 -45.16 93.91 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.572 0.749 . . . . 73.22 111.161 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -69.32 -30.78 68.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.671 0.788 . . . . 64.21 111.695 175.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 21.1 ttm -68.72 -42.92 76.99 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.41 0.684 . . . . 73.23 109.617 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -70.13 -24.92 63.26 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.165 -0.925 . . . . 73.21 111.2 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . 0.552 ' HA ' HE21 ' D' ' 143' ' ' GLN . 71.2 t80 -68.27 -50.03 56.55 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.981 0.513 . . . . 73.31 110.736 178.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.0 mp -63.56 -32.26 73.67 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.612 0.765 . . . . 72.12 112.6 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -89.99 31.77 0.95 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.075 0.55 . . . . 75.12 112.389 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . 0.552 HE21 ' HA ' ' D' ' 140' ' ' TYR . 48.3 mt-30 -119.77 58.4 0.89 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.727 -0.842 . . . . 71.01 108.727 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -142.49 143.81 32.72 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.087 0.955 . . . . 73.42 108.879 -176.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.7 157.06 35.48 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.661 0.384 . . . . 73.4 110.386 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.63 50.59 4.27 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 112.149 -0.38 . . . . 73.13 112.149 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -150.16 141.84 23.61 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.537 1.135 . . . . 74.25 108.627 -176.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.81 71.36 2.88 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 111.673 -0.571 . . . . 72.03 111.673 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 47.4 p -58.13 142.25 47.75 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.188 0.995 . . . . 74.45 110.656 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -60.78 98.53 0.07 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.187 0.595 . . . . 72.32 110.536 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -72.49 123.77 23.83 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.372 -0.973 . . . . 74.4 108.372 173.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 -78.89 117.51 20.04 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.315 0.579 . . . . 73.2 110.984 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -88.02 66.76 8.74 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.01 0.924 . . . . 74.23 108.783 173.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -75.33 159.13 31.82 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.861 -1.063 . . . . 75.04 110.933 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.965 0 N-CA-C 108.942 -0.762 . . . . 65.1 108.942 178.959 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptp . . . . . 0 N--CA 1.478 0.963 0 CA-C-O 121.616 0.722 . . . . 74.42 110.013 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -154.01 108.15 3.02 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.901 -0.778 . . . . 75.14 108.901 174.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -92.35 103.47 15.91 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.695 -0.854 . . . . 71.43 108.695 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 23.0 t -134.59 93.86 3.11 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.753 -0.832 . . . . 74.24 108.753 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 48.6 p -113.99 144.28 43.35 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.112 0.965 . . . . 75.45 109.327 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.4 HG21 ' HA ' ' A' ' 128' ' ' LEU . 79.9 mt 69.99 133.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 124.784 1.233 . . . . 72.42 111.433 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.47 141.01 29.28 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.492 0.717 . . . . 72.33 109.803 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 16.2 mt -157.06 160.68 39.16 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.41 1.084 . . . . 72.4 108.954 173.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -158.01 -77.91 0.08 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.376 0.67 . . . . 73.15 109.796 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 96.6 mt -136.96 175.92 9.18 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.779 0.831 . . . . 65.42 110.864 -174.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 86.9 mt -86.8 145.87 39.82 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 115.016 -0.993 . . . . 70.34 109.63 174.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -61.98 -46.43 13.28 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.507 2.138 . . . . 75.11 111.341 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -121.97 154.97 36.49 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.883 0.873 . . . . 75.45 108.718 172.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 82.5 mt -89.09 35.67 0.8 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.474 0.709 . . . . 73.42 110.338 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 60.64 -166.58 0.2 Allowed 'General case' 0 C--N 1.359 0.991 0 C-N-CA 124.231 1.012 . . . . 72.14 111.227 -174.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 16' ' ' THR . . . . . 0.68 HG22 ' HB2' ' A' ' 48' ' ' SER . 6.8 t -106.85 145.65 31.51 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 109.368 -0.605 . . . . 74.2 109.368 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 17' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.8 135.43 67.69 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.547 2.165 . . . . 73.22 112.664 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 18' ' ' VAL . . . . . 0.594 HG21 HD12 ' A' ' 86' ' ' ILE . 5.2 p -66.51 -44.84 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.437 0.695 . . . . 70.34 111.177 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 23.2 p -138.0 49.76 1.94 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.211 1.005 . . . . 73.21 110.097 -174.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 59.7 tttm 62.86 25.75 15.23 Favored 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 123.799 0.839 . . . . 74.35 110.147 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.98 87.55 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.785 1.234 . . . . 75.42 112.755 -172.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -147.34 125.4 12.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.019 1.328 . . . . 75.15 108.619 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 23' ' ' THR . . . . . 0.619 HG23 ' HA3' ' A' ' 91' ' ' GLY . 3.5 p -97.28 142.32 24.37 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 123.274 0.63 . . . . 74.1 110.329 175.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -48.59 111.74 0.51 Allowed 'Trans proline' 0 C--N 1.39 2.763 0 C-N-CA 123.587 2.858 . . . . 72.41 113.27 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--O 1.253 1.244 0 C-N-CA 124.269 1.028 . . . . 63.22 111.549 -175.718 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' F' F ' 1' ' ' MET . . . . . 0.419 ' SD ' ' N ' ' F' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 110.259 -0.274 . . . . 74.21 110.259 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -81.21 152.92 27.45 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.266 0.627 . . . . 74.34 110.375 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -77.86 167.42 21.54 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.181 0.593 . . . . 72.21 110.105 168.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 26.7 m 59.15 36.58 24.02 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.813 0.845 . . . . 53.52 111.323 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 22.2 m -53.59 -58.42 7.22 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.843 1.257 . . . . 63.12 112.166 -175.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . 0.423 HG22 ' HB ' ' B' ' 40' ' ' VAL . 1.9 pp -137.23 135.5 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.22 1.008 . . . . 75.12 109.069 176.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 7' ' ' ALA . . . . . 0.408 ' HB1' ' HB1' ' B' ' 129' ' ' ALA . . . -166.81 149.09 6.36 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.393 1.077 . . . . 70.33 109.097 -176.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . 0.507 HD22 HG11 ' B' ' 62' ' ' VAL . 92.4 mt -65.28 129.02 38.22 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.672 0.389 . . . . 73.12 111.122 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.99 147.93 52.56 Favored 'General case' 0 C--O 1.243 0.731 0 O-C-N 123.756 0.66 . . . . 75.23 110.849 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 6.9 tt -60.92 133.24 55.9 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.884 0.874 . . . . 75.22 108.667 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 86.8 mt -66.02 106.53 1.12 Allowed Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.492 0.717 . . . . 74.43 111.589 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.26 -17.27 10.47 Favored 'Trans proline' 0 C--N 1.383 2.35 0 C-N-CA 122.377 2.051 . . . . 75.12 111.589 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 73.0 mt -78.41 -24.74 46.06 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 124.539 1.136 . . . . 75.23 110.379 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . 0.6 ' HB3' ' HB2' ' B' ' 95' ' ' ALA . 90.3 mt 64.82 16.8 10.68 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.95 1.3 . . . . 75.45 111.653 -174.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 21.1 t80 68.94 145.54 0.05 Allowed 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 125.965 1.706 . . . . 74.25 111.369 -177.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 8.2 p -62.66 119.1 47.76 Favored Pre-proline 0 CA--C 1.559 1.296 0 C-N-CA 123.706 0.802 . . . . 74.05 110.976 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.03 165.69 30.76 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.201 2.601 . . . . 73.22 114.1 -167.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . 0.515 HG23 HG12 ' B' ' 86' ' ' ILE . 39.6 t -77.62 140.27 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.607 0.763 . . . . 72.13 109.267 176.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 38.3 m -62.43 -34.77 77.42 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.115 0.566 . . . . 74.21 111.057 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 20' ' ' LYS . . . . . 0.411 ' H ' HG12 ' F' ' 18' ' ' VAL . 99.4 mttt -114.05 -81.66 0.6 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.905 0.482 . . . . 73.4 110.426 175.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . 0.507 ' HB3' ' HB ' ' F' ' 18' ' ' VAL . . . 65.69 30.25 10.4 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 122.093 0.949 . . . . 71.21 110.479 -170.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 22.9 ptt85 -162.96 108.49 1.14 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.73 1.612 . . . . 75.51 108.412 -176.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 15.5 p -63.77 153.07 85.08 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.471 0.708 . . . . 74.0 111.79 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.6 -13.84 32.14 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.058 2.506 . . . . 74.43 112.715 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 CA--C 1.561 1.366 0 C-N-CA 125.523 1.529 . . . . 71.05 108.922 178.582 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ptt? . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 110.175 -0.306 . . . . 73.21 110.175 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -111.78 133.7 53.83 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.051 0.94 . . . . 74.32 109.367 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 55.41 70.47 0.63 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.328 1.051 . . . . 70.33 110.656 -170.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 22.8 p -112.17 -78.54 0.58 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.735 0.814 . . . . 61.13 110.224 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 7.6 m -108.3 163.11 13.48 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.622 0.769 . . . . 75.43 109.635 -175.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . 0.416 ' O ' ' HB3' ' C' ' 129' ' ' ALA . 49.2 pt -64.64 141.82 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.537 0.735 . . . . 74.12 111.571 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -163.33 156.74 19.29 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.584 0.753 . . . . 75.12 109.617 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 8' ' ' LEU . . . . . 0.471 HD13 HD11 ' C' ' 44' ' ' LEU . 83.7 mt -72.23 152.4 42.23 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.478 0.711 . . . . 74.05 111.056 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.74 144.38 37.28 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.027 -0.533 . . . . 45.14 110.361 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 10' ' ' LEU . . . . . 0.408 HD22 HD13 ' C' ' 136' ' ' LEU . 96.5 mt -62.05 134.49 56.68 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.289 0.636 . . . . 65.31 109.816 173.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.9 101.73 0.29 Allowed Pre-proline 0 CA--C 1.558 1.261 0 O-C-N 124.298 0.999 . . . . 71.53 110.776 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.25 -36.02 7.71 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.094 2.529 . . . . 73.04 112.292 -169.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 5.4 mp -73.21 -12.13 60.76 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.194 0.998 . . . . 70.23 111.174 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 84.6 mt 63.12 81.56 0.2 Allowed 'General case' 0 C--N 1.36 1.046 0 C-N-CA 124.77 1.228 . . . . 74.32 109.651 -174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . 0.469 ' HE2' HG12 ' C' ' 58' ' ' VAL . 28.9 t80 -59.17 104.08 0.22 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.781 -0.645 . . . . 74.23 110.217 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 16' ' ' THR . . . . . 0.409 ' HA ' HD13 ' C' ' 98' ' ' LEU . 36.4 m -113.23 87.02 10.32 Favored Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 124.403 1.081 . . . . 73.44 109.796 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 17' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.36 -35.77 13.16 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 123.296 2.664 . . . . 74.04 113.035 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 18' ' ' VAL . . . . . 0.486 HG12 ' SD ' ' C' ' 94' ' ' MET . 61.5 t -84.72 135.82 24.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 115.782 -0.644 . . . . 64.44 110.695 -172.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 80.4 p -67.52 142.68 56.49 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 123.978 0.799 . . . . 72.02 110.375 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 20' ' ' LYS . . . . . 0.664 ' HZ3' ' HB2' ' G' ' 20' ' ' LYS . 9.4 mtmp? 77.55 -8.77 1.62 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.982 1.713 . . . . 70.4 113.232 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . 0.532 ' HB3' ' SD ' ' C' ' 94' ' ' MET . . . -80.18 2.01 25.96 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.145 0.578 . . . . 72.44 111.849 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -62.88 124.14 20.29 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 123.695 0.798 . . . . 72.42 110.704 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -120.61 149.8 51.03 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.64 1.176 . . . . 74.14 109.084 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.65 141.4 90.88 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.248 1.965 . . . . 73.35 111.744 171.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 CA--C 1.553 1.093 0 C-N-CA 123.328 0.651 . . . . 72.45 109.446 175.365 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' H' H ' 1' ' ' MET . . . . . 0.507 ' SD ' ' HG2' ' H' ' 3' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 120.529 0.204 . . . . 75.43 110.556 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -154.0 98.73 2.19 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.541 -1.281 . . . . 75.41 107.541 172.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 3' ' ' GLN . . . . . 0.569 ' HA ' HE21 ' H' ' 3' ' ' GLN . 0.0 OUTLIER -80.81 88.31 5.83 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.435 0.694 . . . . 73.22 110.04 -177.712 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 19.9 m -64.62 92.71 0.09 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.16 0.984 . . . . 75.42 110.551 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 9.9 t -140.28 142.96 35.68 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.366 0.666 . . . . 63.41 110.129 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . 0.675 HD11 ' HA ' ' D' ' 128' ' ' LEU . 9.4 tp -160.53 127.97 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.814 -0.63 . . . . 74.3 109.379 173.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . 58.89 -100.15 0.11 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.575 1.15 . . . . 65.05 112.604 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 8' ' ' LEU . . . . . 0.401 HD21 HD21 ' D' ' 44' ' ' LEU . 2.4 pp -157.28 173.88 16.29 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 122.054 -0.404 . . . . 72.51 111.388 -171.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.91 -71.47 0.27 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.707 0.803 . . . . 62.4 109.15 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 6.4 mp -127.66 146.04 50.68 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.654 0.782 . . . . 74.24 109.522 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.07 140.52 31.58 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.065 0.946 . . . . 74.11 109.429 177.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.36 172.54 16.13 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 122.816 2.344 . . . . 72.14 112.919 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tm? 67.27 -74.78 0.07 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.729 1.612 . . . . 75.31 109.08 -173.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 16.2 tp 69.28 160.85 0.2 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.13 1.372 . . . . 73.02 111.721 174.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . 0.482 ' HE2' ' HB3' ' D' ' 48' ' ' SER . 22.1 m-85 -77.49 153.34 33.57 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.317 0.647 . . . . 74.11 110.081 176.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 28.9 m -137.88 -56.78 0.02 OUTLIER Pre-proline 0 CA--C 1.572 1.801 0 N-CA-C 113.208 0.818 . . . . 74.35 113.208 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -95.18 169.34 1.47 Allowed 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 122.327 2.018 . . . . 74.54 114.49 -175.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . 0.592 HG22 ' HB2' ' D' ' 94' ' ' MET . 11.8 t -106.61 -57.36 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.437 1.095 . . . . 75.13 108.324 166.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 8.4 t -75.7 128.34 34.99 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.175 -0.921 . . . . 73.25 109.578 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt 61.38 27.92 17.45 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.38 1.472 . . . . 71.52 111.189 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.57 120.1 14.83 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.943 0.897 . . . . 65.43 111.157 -175.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 70.02 -75.12 0.08 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.846 1.659 . . . . 75.02 110.29 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 5.4 m 58.26 72.41 0.87 Allowed Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 124.724 1.21 . . . . 74.41 109.978 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.86 103.46 0.72 Allowed 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 123.073 2.515 . . . . 70.31 112.009 -172.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.553 1.07 0 N-CA-C 108.027 -1.101 . . . . 73.3 108.027 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.2 ttp . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.265 0.079 . . . . 63.13 110.927 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 m -70.64 84.56 0.63 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.728 0.775 . . . . 64.14 111.672 -172.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -104.98 87.17 2.58 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.252 1.021 . . . . 75.52 108.932 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.14 -178.45 4.32 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.639 0.776 . . . . 74.23 111.177 -172.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.6 t30 65.98 -74.12 0.06 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.667 1.587 . . . . 64.2 112.42 170.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -117.62 87.81 2.78 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.398 1.479 . . . . 75.44 109.37 -176.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.6 p -98.79 -54.63 2.95 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.51 0.724 . . . . 74.12 110.153 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -84.37 88.21 7.25 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 123.354 0.661 . . . . 75.34 109.483 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.573 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.9 OUTLIER 70.86 157.9 0.18 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.764 1.226 . . . . 74.53 110.894 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.442 ' N ' ' SD ' ' A' ' 9' ' ' MET . 5.7 t -145.78 134.49 22.27 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 123.054 0.542 . . . . 71.33 110.329 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.598 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 48.1 t80 -137.27 135.68 37.38 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.728 -0.669 . . . . 74.5 110.18 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -160.48 129.34 4.82 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.873 0.869 . . . . 73.14 109.372 173.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.44 HG12 ' CD2' ' A' ' 84' ' ' PHE . 58.2 mt -94.14 122.11 45.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.809 -0.811 . . . . 70.1 108.809 172.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -90.98 -31.15 16.44 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.278 0.361 . . . . 74.51 110.759 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.476 ' HB3' HD13 ' A' ' 83' ' ' ILE . 39.8 ttt180 -167.0 122.19 1.09 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 111.99 0.367 . . . . 73.13 111.99 -169.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 73.7 mt -115.02 137.14 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 123.842 0.857 . . . . 74.53 109.24 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -163.01 174.94 11.66 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 123.791 0.836 . . . . 73.11 111.069 -174.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -106.89 118.74 37.49 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.95 -0.759 . . . . 70.23 108.95 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -86.76 -25.75 24.52 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.857 -0.423 . . . . 75.23 109.857 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.697 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 26.3 t70 -145.91 135.39 23.1 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.604 -0.726 . . . . 73.22 109.703 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.7 mt -139.06 140.52 38.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 C-N-CA 125.477 1.511 . . . . 74.21 107.187 176.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -150.35 124.96 9.67 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.235 0.614 . . . . 73.22 109.381 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.435 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 88.1 t80 -124.08 136.6 54.35 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.052 -1.462 . . . . 74.42 107.052 168.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -137.29 135.95 37.58 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.895 0.478 . . . . 64.33 110.069 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.09 74.41 49.7 Favored Pre-proline 0 C--O 1.242 0.696 0 N-CA-C 106.6 -1.63 . . . . 72.55 106.6 167.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.58 -32.09 39.66 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.118 1.878 . . . . 74.51 110.906 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -96.98 19.59 12.53 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.226 -0.897 . . . . 73.14 110.685 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.31 -45.94 83.51 Favored Pre-proline 0 CA--C 1.567 1.614 0 N-CA-C 114.469 1.285 . . . . 64.45 114.469 -172.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -66.37 -19.51 55.56 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 121.767 1.644 . . . . 72.4 113.479 175.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.408 ' HA ' HE21 ' A' ' 33' ' ' GLN . 5.0 m-70 -97.15 -26.07 15.09 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.01 0.924 . . . . 74.44 111.564 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.551 HG22 ' HA ' ' A' ' 73' ' ' ALA . 4.1 p -79.61 -30.26 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 N-CA-C 113.459 0.911 . . . . 74.31 113.459 -158.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -81.75 -23.9 36.4 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.813 0.445 . . . . 73.14 111.189 -171.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.408 HE21 ' HA ' ' A' ' 30' ' ' HIS . 28.9 pt20 -79.91 -11.6 59.79 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.474 0.71 . . . . 74.21 111.038 176.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -81.47 162.3 23.32 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.872 0.469 . . . . 70.5 111.417 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -68.9 126.52 30.04 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.259 -0.882 . . . . 75.34 108.967 173.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 44.3 t-105 -76.4 81.92 3.13 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.762 0.791 . . . . 72.41 109.862 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -130.94 76.19 77.42 Favored Pre-proline 0 C--O 1.246 0.876 0 N-CA-C 107.512 -1.292 . . . . 71.44 107.512 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -85.48 140.22 7.21 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.295 1.997 . . . . 72.23 112.226 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -97.06 101.74 13.37 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.411 -1.329 . . . . 71.12 107.411 169.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 65' ' ' THR . 19.3 t -85.88 93.78 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.846 -0.798 . . . . 74.25 108.846 -176.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -86.12 115.34 23.63 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.531 1.132 . . . . 75.11 109.424 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -97.9 107.81 20.38 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.02 -0.733 . . . . 74.44 109.02 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.543 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 18.1 t70 -106.9 121.75 45.04 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.275 1.03 . . . . 61.24 108.552 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.456 HD21 HD21 ' E' ' 8' ' ' LEU . 6.5 mp -103.67 145.96 29.29 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.98 -0.378 . . . . 74.11 109.98 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 23.1 t70 -148.76 159.65 43.94 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.067 0.947 . . . . 54.43 108.847 177.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.6 m -135.44 136.85 41.68 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.571 0.749 . . . . 72.14 110.41 -178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.85 144.07 49.95 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.734 1.214 . . . . 74.51 108.279 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.0 p -132.9 167.22 20.62 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.716 0.406 . . . . 72.41 111.478 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.0 t -166.67 122.51 1.19 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.336 -0.847 . . . . 70.01 109.952 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -77.29 110.93 12.41 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 107.871 -1.159 . . . . 65.25 107.871 168.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.445 HD13 ' HB2' ' A' ' 57' ' ' GLU . 31.3 mt -84.94 -36.68 21.25 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.177 0.591 . . . . 71.22 110.75 -173.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.66 -174.47 4.23 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.848 0.859 . . . . 73.33 110.035 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -65.53 119.08 10.44 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.381 -0.6 . . . . 74.12 109.381 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 68.22 2.17 3.14 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.91 1.284 . . . . 74.11 113.015 -177.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.5 t -105.91 111.22 34.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 108.214 -1.032 . . . . 73.23 108.214 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -131.53 137.33 48.45 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.845 -0.798 . . . . 70.25 108.845 -174.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.445 ' HB2' HD13 ' A' ' 51' ' ' LEU . 40.5 tt0 -108.7 118.25 36.3 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.879 -1.055 . . . . 75.13 109.786 -176.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.5 t -103.43 123.74 57.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.043 -1.466 . . . . 74.34 107.043 170.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.8 131.25 70.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 107.817 -1.179 . . . . 73.41 107.817 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 tt -121.8 115.08 22.01 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.179 -1.045 . . . . 72.43 108.179 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.621 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 35.9 ttp180 -85.45 109.49 18.5 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.831 0.852 . . . . 75.34 109.93 175.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.4 t -99.48 102.77 13.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.537 -1.283 . . . . 75.15 107.537 170.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 39.8 m -94.84 108.86 20.89 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.985 0.914 . . . . 75.54 108.907 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.7 t -103.78 110.15 29.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.264 -0.88 . . . . 74.4 109.142 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 21.6 m -102.11 134.74 44.88 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.963 -1.125 . . . . 72.14 107.963 171.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.68 117.22 19.99 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.963 -1.495 . . . . 74.31 106.963 174.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 54.0 m -128.0 132.7 49.14 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.943 0.497 . . . . 71.33 110.97 -175.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.7 mt -90.85 48.01 1.48 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.484 1.114 . . . . 75.45 108.805 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.42 -90.41 0.93 Allowed Glycine 0 C--N 1.351 1.376 0 CA-C-N 114.993 -1.003 . . . . 74.5 112.552 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -87.83 -22.87 24.23 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.785 0.834 . . . . 73.32 111.034 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -118.55 98.82 6.44 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.857 -1.164 . . . . 73.14 107.857 -172.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 93.1 m -59.08 129.19 40.94 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 118.44 0.563 . . . . 71.2 110.597 177.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.551 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -70.18 -60.62 2.17 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.241 -0.891 . . . . 73.11 109.643 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -161.19 164.19 30.65 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 114.863 -1.062 . . . . 73.32 110.99 177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.1 tp -128.62 108.9 10.88 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.502 -0.925 . . . . 73.22 108.502 171.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.403 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 73.9 m -106.48 96.61 6.58 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.59 0.756 . . . . 74.53 109.824 174.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -111.04 115.27 29.18 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.866 -0.79 . . . . 60.11 108.866 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -124.11 132.04 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.048 0.539 . . . . 71.13 109.563 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.697 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.8 mt-30 -98.72 95.59 7.34 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.262 0.625 . . . . 74.01 109.521 168.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -80.41 105.16 11.46 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.807 -1.088 . . . . 70.14 109.03 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.7 150.92 20.59 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.908 -0.587 . . . . 71.2 111.821 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.53 147.49 18.6 Favored Glycine 0 C--O 1.237 0.284 0 N-CA-C 111.529 -0.628 . . . . 53.32 111.529 174.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.476 HD13 ' HB3' ' A' ' 15' ' ' ARG . 64.1 mt -104.13 112.23 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.06 -1.089 . . . . 75.0 108.06 176.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.598 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 5.1 m-85 -123.16 154.83 38.14 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.258 1.023 . . . . 74.34 108.294 -176.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 87.9 p -109.04 116.04 31.22 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.742 -0.836 . . . . 71.24 108.742 172.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.47 122.0 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 109.279 -0.637 . . . . 74.51 109.279 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.96 166.47 7.52 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.315 1.046 . . . . 73.14 110.005 173.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 122.07 -81.01 0.34 Allowed Glycine 0 C--N 1.34 0.78 0 O-C-N 123.657 0.598 . . . . 73.34 111.623 174.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.9 mm -117.18 132.88 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.262 -0.644 . . . . 75.23 109.262 -173.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.404 ' HG2' ' HD3' ' E' ' 20' ' ' LYS . 2.0 mp0 -94.57 -144.91 0.25 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.832 0.853 . . . . 75.41 109.519 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.609 ' HA2' ' HB2' ' E' ' 22' ' ' ARG . . . 72.48 -148.86 42.78 Favored Glycine 0 C--N 1.354 1.561 0 N-CA-C 112.24 -0.344 . . . . 75.31 112.24 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.5 p -71.14 -18.19 62.52 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.732 0.813 . . . . 73.2 111.653 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -72.33 -55.27 7.4 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 123.142 0.577 . . . . 75.02 110.485 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.643 ' HA ' ' SG ' ' A' ' 97' ' ' CYS . 58.0 ttm -65.62 -31.7 72.87 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.801 0.273 . . . . 72.35 110.705 176.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.96 -26.96 67.08 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.152 0.581 . . . . 72.32 111.501 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -89.51 -47.49 7.95 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.41 0.684 . . . . 74.34 111.324 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.643 ' SG ' ' HA ' ' A' ' 94' ' ' MET . 22.0 p -62.36 -42.86 99.74 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.228 0.537 . . . . 74.0 110.372 -174.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.526 ' HG ' HG22 ' E' ' 18' ' ' VAL . 3.2 tm? -88.02 -41.4 13.13 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.985 -1.007 . . . . 74.13 109.984 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.94 0.09 89.08 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-O 119.443 -0.643 . . . . 71.42 114.647 -171.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.22 -51.83 0.14 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 117.939 0.869 . . . . 73.43 112.464 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.47 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 85.6 t80 -69.86 -58.64 3.64 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.712 0.634 . . . . 74.12 112.712 -170.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 71.7 m -62.59 -40.49 65.24 Favored Pre-proline 0 CA--C 1.563 1.471 0 N-CA-C 113.651 0.982 . . . . 64.23 113.651 -175.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 34.8 Cg_endo -65.23 -27.84 56.04 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 121.941 1.761 . . . . 71.4 113.166 169.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -75.29 -23.36 57.36 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 122.843 0.457 . . . . 72.34 110.696 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.427 HG21 ' CD1' ' A' ' 13' ' ' ILE . 46.9 mm -62.35 -40.86 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.338 0.655 . . . . 74.14 109.751 170.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 80.1 mt -74.19 -21.56 59.77 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.935 -1.029 . . . . 63.34 111.607 -177.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -60.51 -49.17 91.29 Favored Pre-proline 0 CA--C 1.565 1.536 0 N-CA-C 113.982 1.104 . . . . 72.14 113.982 -172.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.29 -34.17 88.26 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 121.941 1.761 . . . . 75.43 112.829 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -70.13 -41.25 74.17 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.362 0.665 . . . . 74.52 111.455 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.32 -44.02 89.15 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.661 -0.699 . . . . 74.32 109.764 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.505 ' NH1' HD13 ' C' ' 105' ' ' ILE . 30.6 ttm180 -52.6 -48.66 66.15 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.639 1.175 . . . . 74.13 110.64 174.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.07 -49.71 66.69 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.446 0.698 . . . . 75.51 111.33 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 33.1 t -61.54 -26.43 67.93 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.473 0.709 . . . . 73.21 111.495 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 81.1 mt -77.81 -57.3 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 123.84 0.856 . . . . 71.32 110.117 174.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.5 m -55.59 -34.74 65.1 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.823 0.849 . . . . 64.14 111.89 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.0 t -63.73 -49.99 70.88 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.318 -0.856 . . . . 72.24 110.058 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 30.4 mtm -66.5 -37.51 85.23 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.103 0.561 . . . . 71.42 111.229 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.0 t -57.07 -47.98 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 124.02 0.825 . . . . 75.13 110.048 175.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 29.3 t -73.45 -28.89 62.2 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 115.039 -0.982 . . . . 71.43 111.438 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -72.83 -28.64 62.66 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.207 0.603 . . . . 73.22 109.872 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.13 4.67 75.21 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 123.659 0.599 . . . . 64.33 112.918 172.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.528 HG23 HH21 ' B' ' 15' ' ' ARG . 0.6 OUTLIER 65.72 16.33 10.45 Favored 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 126.515 1.926 . . . . 72.11 112.347 177.356 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -79.16 152.93 76.95 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 123.575 0.75 . . . . 63.1 109.666 172.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.98 134.31 63.72 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.474 2.116 . . . . 74.42 111.14 171.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -56.65 158.08 4.85 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.557 0.743 . . . . 72.42 112.416 -173.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.0 tp -135.85 93.73 2.97 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.28 -0.873 . . . . 75.52 109.333 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -98.12 99.14 10.38 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.986 -1.116 . . . . 71.51 107.986 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.645 HD13 HG22 ' E' ' 6' ' ' ILE . 19.0 tp -59.26 136.7 58.04 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.294 -0.867 . . . . 72.24 110.346 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.405 ' H ' HD11 ' A' ' 128' ' ' LEU . . . -59.04 145.14 81.16 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 124.284 1.033 . . . . 72.43 112.147 -175.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.06 123.34 11.75 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.204 2.603 . . . . 72.41 111.759 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 77.1 t -116.02 115.94 50.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 108.96 -0.755 . . . . 74.3 108.96 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.464 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 2.8 m-20 -73.26 74.69 1.32 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.88 0.872 . . . . 71.54 108.654 173.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -58.69 -52.02 67.47 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.037 1.335 . . . . 72.25 111.903 -163.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -69.95 -32.63 70.98 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.98 -1.009 . . . . 75.41 111.29 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 138' ' ' MET . . . -67.65 -33.76 75.6 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.086 0.954 . . . . 74.33 111.935 -175.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 132' ' ' ASN . 77.5 mt -64.35 -38.69 91.92 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.362 0.665 . . . . 74.33 110.272 177.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -75.12 -33.56 61.6 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.409 -0.814 . . . . 64.54 110.597 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.458 ' HB2' ' HA ' ' A' ' 135' ' ' ALA . 7.6 mmt -66.83 -25.9 66.66 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.164 0.986 . . . . 75.3 112.008 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -64.49 -27.74 69.18 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.422 0.689 . . . . 74.55 111.303 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -95.06 -34.87 12.15 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.831 0.452 . . . . 75.21 110.359 172.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.445 HD21 ' SD ' ' A' ' 138' ' ' MET . 11.7 tp -64.91 -46.23 82.58 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.189 0.996 . . . . 73.32 110.948 -170.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.86 -0.28 0.82 Allowed 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.1 -0.5 . . . . 75.33 111.356 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 64.73 100.51 0.04 OUTLIER 'General case' 0 C--N 1.36 1.025 0 C-N-CA 124.541 1.136 . . . . 72.32 111.531 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -75.23 129.21 37.08 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 110.072 -0.344 . . . . 75.23 110.072 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.2 -17.96 38.18 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.364 0.666 . . . . 74.54 110.771 172.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 84.24 176.93 51.26 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 115.497 -0.774 . . . . 74.35 112.094 -173.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -155.68 96.38 1.75 Allowed 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.232 -1.025 . . . . 75.04 108.232 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -178.06 163.37 31.5 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.17 -0.923 . . . . 73.1 112.98 -176.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.5 p -93.08 165.36 12.88 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.933 0.893 . . . . 65.14 109.962 175.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.435 ' O ' ' HA2' ' C' ' 88' ' ' GLY . 33.0 tt0 -81.17 -59.48 2.63 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.275 -0.639 . . . . 71.53 109.275 172.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 54.5 170.03 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.217 1.407 . . . . 63.44 114.426 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -149.58 100.71 3.02 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 113.623 -1.626 . . . . 74.4 106.675 171.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -83.64 66.7 9.13 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.778 0.431 . . . . 73.24 110.274 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -71.73 78.92 0.84 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.751 -0.833 . . . . 74.21 108.751 174.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.966 0 C-N-CA 124.173 0.989 . . . . 74.11 108.613 -177.026 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.737 0.303 . . . . 63.22 110.786 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 28.6 p -104.03 121.24 42.77 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.759 0.824 . . . . 54.44 109.357 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.43 -169.48 1.85 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.761 0.824 . . . . 71.34 110.727 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -72.49 115.17 11.43 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.469 0.708 . . . . 74.0 110.94 -176.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 10.9 t30 174.07 121.18 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.974 1.709 . . . . 75.45 108.444 168.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -154.26 134.52 13.29 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.255 0.622 . . . . 71.23 109.819 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 13.1 t -61.63 172.79 1.13 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.429 1.092 . . . . 72.45 112.18 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' B' ' 9' ' ' MET . 42.4 tt0 79.6 -59.66 0.35 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.686 1.594 . . . . 73.34 110.437 -174.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.506 ' HB3' HG13 ' B' ' 89' ' ' ILE . 4.2 ppp? 57.5 178.97 0.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 126.293 1.837 . . . . 63.22 113.218 176.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 93.8 m -133.57 113.59 12.61 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.134 0.574 . . . . 75.41 109.504 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -123.61 143.68 50.08 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.102 0.961 . . . . 75.45 109.342 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -162.88 141.43 8.48 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.38 0.672 . . . . 73.54 110.268 169.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 49.2 mt -68.68 129.39 33.23 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 109.014 -0.735 . . . . 75.12 109.014 171.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -97.95 -42.27 7.61 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.209 0.604 . . . . 72.23 109.537 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.528 HH21 HG23 ' A' ' 122' ' ' THR . 21.7 ttt85 -168.48 144.89 3.77 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.79 -0.641 . . . . 75.01 109.457 -174.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.4 mt -128.73 144.65 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 107.56 -1.274 . . . . 75.44 107.56 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.559 ' HE2' ' HZ3' ' B' ' 19' ' ' LYS . 38.2 p90 -171.12 156.03 4.62 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.182 0.515 . . . . 75.25 111.462 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 95.2 m -85.2 126.28 33.53 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.634 -0.712 . . . . 74.51 109.244 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.559 ' HZ3' ' HE2' ' B' ' 17' ' ' TYR . 33.4 mttp -86.49 -48.36 8.47 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.27 0.628 . . . . 74.44 110.61 172.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -144.96 136.91 25.74 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 110.115 -0.328 . . . . 74.32 110.115 -165.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.435 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 44.7 mm -131.69 142.41 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.389 1.076 . . . . 74.33 109.309 176.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.684 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 69.3 m -138.84 136.67 35.85 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.83 1.252 . . . . 60.21 108.439 177.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' B' ' 75' ' ' LEU . 75.7 t80 -149.91 107.46 3.65 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 107.858 -1.164 . . . . 62.22 107.858 165.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -121.79 112.12 17.97 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.096 0.959 . . . . 74.24 108.945 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.53 87.6 12.0 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.688 1.195 . . . . 73.13 108.231 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.9 -41.93 12.72 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.867 2.378 . . . . 73.44 111.837 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 2.5 m-20 -90.87 3.49 54.36 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.874 -1.057 . . . . 73.23 111.345 -175.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -37.06 -60.51 0.8 Allowed Pre-proline 0 N--CA 1.49 1.552 0 C-N-CA 125.668 1.587 . . . . 71.34 114.973 -164.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.7 -31.63 58.55 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 122.474 2.116 . . . . 73.52 113.278 -173.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -88.62 -38.08 15.12 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.06 0.544 . . . . 71.44 111.103 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.673 HG23 HD13 ' B' ' 68' ' ' LEU . 8.9 p -69.5 -19.15 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 123.339 0.656 . . . . 75.14 111.486 -174.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -58.74 -20.66 51.24 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 113.372 0.879 . . . . 72.31 113.372 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.455 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.1 pt20 -59.82 -31.97 70.21 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.462 0.705 . . . . 72.44 111.33 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.583 ' HZ1' ' HG2' ' B' ' 71' ' ' GLU . 99.8 mttt -87.91 95.95 10.3 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.878 0.871 . . . . 72.11 109.944 -176.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -91.07 87.52 6.61 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.783 -0.644 . . . . 65.21 110.597 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -163.17 -179.22 6.5 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.886 0.874 . . . . 74.23 109.726 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -77.81 108.36 7.18 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.589 0.755 . . . . 75.31 109.812 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.415 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 37.7 Cg_endo -64.77 142.1 74.91 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.433 2.089 . . . . 74.1 113.109 -176.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -68.79 119.95 13.97 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.77 0.828 . . . . 75.3 109.395 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.471 HG22 HG12 ' F' ' 6' ' ' ILE . 24.4 m -106.98 161.31 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 123.727 0.811 . . . . 72.13 112.173 -169.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.533 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 55.9 tttm -135.5 109.66 8.31 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.387 1.075 . . . . 72.53 108.794 175.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.409 HD21 HD12 ' F' ' 6' ' ' ILE . 5.3 mp -90.15 138.06 31.83 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.015 -0.735 . . . . 73.21 109.015 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.551 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 7.2 t70 -149.79 158.26 43.99 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 107.838 -1.171 . . . . 71.01 107.838 -176.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -140.52 158.97 43.2 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.034 0.445 . . . . 71.25 110.478 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.439 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 28.9 t70 -146.86 155.58 42.44 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.881 0.872 . . . . 73.3 108.903 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 58.6 m -108.45 137.35 46.57 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.699 0.8 . . . . 72.44 110.854 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.666 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -142.8 146.31 34.09 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.739 -1.208 . . . . 53.44 107.739 166.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.4 p -142.74 168.63 19.27 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.23 0.612 . . . . 72.14 109.935 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' SER . . . . . 0.587 ' HB2' ' HB3' ' B' ' 57' ' ' GLU . 2.3 m -150.65 151.93 33.23 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.149 -1.056 . . . . 74.4 108.149 170.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -115.57 106.59 14.1 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.23 -1.396 . . . . 73.2 107.23 168.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.562 HD12 HG22 ' B' ' 83' ' ' ILE . 21.1 mt -87.53 -38.12 16.3 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.477 0.711 . . . . 70.24 109.771 -173.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.8 -171.24 3.59 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.521 -1.218 . . . . 72.14 109.416 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -69.59 125.59 27.17 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.091 -0.959 . . . . 72.4 108.445 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 68.92 -2.09 1.86 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.771 1.229 . . . . 73.25 112.811 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 88.9 t -107.1 105.25 18.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 108.818 -0.808 . . . . 73.43 108.818 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.462 ' HB2' HD13 ' B' ' 86' ' ' ILE . 1.2 m-85 -116.36 141.65 47.88 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.524 1.129 . . . . 74.31 108.902 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.587 ' HB3' ' HB2' ' B' ' 49' ' ' SER . 6.7 tm-20 -113.8 97.0 6.14 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.39 -1.337 . . . . 74.45 107.39 -176.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 46.4 t -92.32 128.09 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.964 0.905 . . . . 75.42 109.765 -174.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.666 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 17.6 t -120.64 118.18 55.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 C-N-CA 124.105 0.962 . . . . 74.42 108.761 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.413 ' HB2' ' HB3' ' B' ' 103' ' ' PRO . 43.9 tp -102.88 127.63 50.0 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.986 -0.746 . . . . 74.53 108.986 170.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.439 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 12.7 ttm180 -86.25 135.91 33.38 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.876 -0.787 . . . . 71.02 108.876 169.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.531 HG11 HD11 ' B' ' 114' ' ' ILE . 93.9 t -122.32 103.48 13.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 106.958 -1.497 . . . . 71.34 106.958 175.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 52.9 m -95.43 135.99 36.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.918 0.887 . . . . 72.03 108.74 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.413 HG22 HG21 ' B' ' 114' ' ' ILE . 98.3 t -132.44 117.65 32.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.854 -1.165 . . . . 74.43 107.854 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 32.2 m -105.53 149.97 25.77 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.89 -1.152 . . . . 55.42 107.89 170.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.79 145.12 29.81 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.09 -0.707 . . . . 63.42 109.09 176.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.461 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 54.3 p -150.39 128.45 11.88 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 123.865 0.728 . . . . 71.42 110.517 -176.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.673 HD13 HG23 ' B' ' 31' ' ' VAL . 71.1 mt -93.51 98.25 11.06 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 107.281 -1.377 . . . . 74.15 107.281 172.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.97 -129.02 12.41 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 114.91 -1.041 . . . . 74.44 113.568 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -86.72 4.05 42.32 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.469 0.708 . . . . 72.43 112.063 -173.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.583 ' HG2' ' HZ1' ' B' ' 34' ' ' LYS . 13.2 pt-20 -129.63 152.91 48.63 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.927 0.491 . . . . 75.15 110.213 -177.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 85.6 m -72.33 132.87 44.58 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.327 0.651 . . . . 75.23 110.277 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.461 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -86.44 -62.73 1.45 Allowed 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.851 -1.166 . . . . 75.11 107.851 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -156.01 160.73 40.29 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 115.141 -0.936 . . . . 74.24 111.783 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 23.2 mt -124.74 114.75 19.69 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 106.321 -1.733 . . . . 73.44 106.321 174.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.405 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 35.2 t -119.41 146.18 45.59 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.876 -0.787 . . . . 72.41 108.876 175.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.684 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 42.9 tt0 -158.45 134.61 9.22 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.345 -0.613 . . . . 74.34 109.345 -175.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 91.5 t -129.75 142.81 42.92 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 C-N-CA 123.726 0.81 . . . . 71.11 109.107 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -124.28 96.97 5.12 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 107.651 -1.24 . . . . 71.44 107.651 172.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -89.32 107.67 19.19 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.198 -1.038 . . . . 73.55 108.198 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.99 143.56 17.12 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.187 -0.765 . . . . 74.33 111.187 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.8 126.9 2.47 Favored Glycine 0 CA--C 1.51 -0.273 0 N-CA-C 112.04 -0.424 . . . . 60.14 112.04 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.562 HG22 HD12 ' B' ' 51' ' ' LEU . 38.9 mt -85.92 128.19 39.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.37 -0.974 . . . . 74.12 108.37 173.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -137.46 147.94 45.69 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.242 0.617 . . . . 73.32 110.039 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 62.8 m -97.41 125.6 42.14 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.118 -0.697 . . . . 72.22 109.118 170.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' B' ' 56' ' ' TYR . 1.8 pt -138.26 118.13 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 125.049 1.34 . . . . 74.52 108.993 -174.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' B' ' 9' ' ' MET . . . -152.25 168.04 26.65 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.237 0.615 . . . . 73.51 111.055 -173.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.27 -71.0 1.43 Allowed Glycine 0 C--N 1.348 1.225 0 O-C-N 123.496 0.497 . . . . 64.22 112.673 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.67 HG23 ' HB2' ' B' ' 94' ' ' MET . 10.7 mt -75.02 157.61 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.716 0.807 . . . . 74.41 110.651 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.598 ' HG2' ' H ' ' B' ' 91' ' ' GLY . 11.7 tt0 -151.96 -176.48 5.66 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.93 0.892 . . . . 73.21 108.667 173.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.598 ' H ' ' HG2' ' B' ' 90' ' ' GLU . . . 75.51 -136.27 19.81 Favored Glycine 0 C--N 1.345 1.053 0 C-N-CA 123.139 0.399 . . . . 53.41 113.187 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 44.0 m -70.17 -41.64 73.53 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.569 0.748 . . . . 74.2 111.352 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -60.14 -35.53 75.5 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.941 -1.027 . . . . 72.34 111.052 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.67 ' HB2' HG23 ' B' ' 89' ' ' ILE . 9.9 tmm? -85.14 -31.26 23.38 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.129 0.971 . . . . 75.05 111.52 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.61 -27.58 67.86 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.4 0.619 . . . . 72.42 110.324 170.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . 0.451 ' HA ' HD22 ' F' ' 14' ' ' LEU . 18.7 t-80 -79.64 -29.33 40.93 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.111 1.365 . . . . 61.25 111.646 173.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -63.22 -51.71 65.16 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.873 0.469 . . . . 65.32 111.746 -175.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.445 HD23 HG23 ' F' ' 18' ' ' VAL . 1.6 pp -89.62 -13.33 37.37 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 117.853 0.297 . . . . 74.43 110.99 171.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.95 3.12 85.94 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-O 119.479 -0.623 . . . . 73.0 114.099 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.69 -54.92 0.09 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.231 0.612 . . . . 62.34 110.724 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -72.88 -49.72 28.2 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.366 0.876 . . . . 74.5 113.366 -165.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.466 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 62.7 m -59.7 -47.81 96.7 Favored Pre-proline 0 CA--C 1.565 1.526 0 CA-C-O 119.189 -0.434 . . . . 65.5 111.907 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 23.9 Cg_exo -67.14 -24.97 43.95 Favored 'Trans proline' 0 C--N 1.393 2.879 0 C-N-CA 122.263 1.975 . . . . 71.53 113.599 173.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -63.96 -37.5 87.65 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.365 0.666 . . . . 75.35 110.213 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 68.4 mt -65.54 -39.12 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 115.671 -0.695 . . . . 72.55 110.485 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.24 -17.26 52.76 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.24 -0.891 . . . . 75.45 111.735 -175.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -58.99 -49.51 92.98 Favored Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 124.789 1.236 . . . . 74.44 113.556 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -60.79 -39.4 62.92 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 122.262 1.974 . . . . 71.51 113.019 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -64.38 -33.73 76.54 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.487 -0.779 . . . . 71.55 110.491 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.494 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -72.35 -42.16 65.64 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 115.857 -0.611 . . . . 72.1 110.341 174.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -53.36 -55.52 24.21 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.218 1.007 . . . . 71.42 111.527 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.421 ' HG3' ' NH2' ' C' ' 120' ' ' ARG . 2.1 tm-20 -64.03 -34.77 78.76 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.802 0.689 . . . . 70.13 110.106 -177.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.495 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.2 t -73.5 -27.59 61.45 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.734 0.414 . . . . 73.2 111.7 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.531 HD11 HG11 ' B' ' 62' ' ' VAL . 73.0 mt -71.11 -58.62 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 108.578 -0.897 . . . . 74.54 108.578 173.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 4.8 m -65.0 -23.08 67.11 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.906 -1.043 . . . . 73.24 111.441 -173.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.445 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 37.7 t -61.52 -49.87 74.96 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.302 0.641 . . . . 73.42 109.454 171.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.495 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.2 mmt -71.53 -34.14 69.78 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.415 0.686 . . . . 73.32 110.82 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.4 HG21 ' O ' ' B' ' 114' ' ' ILE . 87.5 t -59.76 -46.1 93.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.709 0.804 . . . . 61.43 109.85 172.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -64.56 -36.67 84.98 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.724 -1.125 . . . . 71.23 110.834 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.486 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 93.5 mtt-85 -65.46 -32.84 74.67 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.247 0.619 . . . . 74.51 110.125 177.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.64 8.71 70.97 Favored Glycine 0 C--N 1.353 1.495 0 O-C-N 123.639 0.587 . . . . 71.33 113.146 174.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 75.7 p 57.47 26.92 13.23 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 126.235 1.814 . . . . 63.02 113.5 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -88.08 158.21 50.1 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 123.519 0.728 . . . . 64.35 111.02 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -58.04 157.63 24.32 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 123.403 2.735 . . . . 73.32 114.338 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.552 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -65.33 123.19 18.95 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.482 -1.235 . . . . 64.33 112.186 -177.231 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.499 HD13 HD11 ' F' ' 6' ' ' ILE . 2.3 tm? -138.43 115.3 10.78 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 108.388 -0.967 . . . . 73.41 108.388 176.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -110.9 136.06 50.49 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.874 0.87 . . . . 74.22 109.819 176.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.423 HD11 ' H ' ' B' ' 129' ' ' ALA . 10.0 tp -86.78 135.52 33.33 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.334 0.653 . . . . 73.21 110.739 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.423 ' H ' HD11 ' B' ' 128' ' ' LEU . . . -68.05 147.0 98.42 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.733 1.213 . . . . 74.23 111.779 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.06 104.16 1.32 Allowed 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.75 2.3 . . . . 72.04 111.994 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 10.8 m -92.84 108.16 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 122.092 0.948 . . . . 74.02 109.601 173.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.54 83.89 3.87 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.949 -1.023 . . . . 75.04 108.423 172.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -52.67 -46.74 67.33 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.608 -0.723 . . . . 71.33 109.633 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.42 ' HA ' ' HE2' ' B' ' 96' ' ' HIS . 9.4 m-20 -55.11 -41.87 72.2 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 113.411 -1.722 . . . . 74.11 112.458 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.1 -42.58 84.33 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 123.665 0.603 . . . . 73.54 110.755 -171.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.411 ' HB2' HD22 ' F' ' 10' ' ' LEU . 9.4 mp -74.31 -24.67 59.26 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.572 0.349 . . . . 74.32 111.38 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -69.56 -37.6 77.07 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 110.006 -0.368 . . . . 75.2 110.006 170.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 95.8 mmm -69.19 -35.9 76.73 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.314 0.645 . . . . 73.41 110.708 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -76.4 -21.52 55.92 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 116.127 -0.488 . . . . 74.11 110.999 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -69.07 -26.42 64.94 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.24 0.543 . . . . 75.14 109.718 172.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 51.4 mt -94.54 34.77 1.27 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.906 0.883 . . . . 74.11 110.101 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.42 133.69 55.39 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.686 0.795 . . . . 74.12 110.506 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -116.25 144.52 44.11 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.027 0.931 . . . . 61.53 110.021 -176.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -76.86 146.31 37.8 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.213 1.005 . . . . 73.2 111.185 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.85 139.0 32.21 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.077 0.551 . . . . 74.12 110.596 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.61 75.22 0.36 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 111.866 -0.494 . . . . 65.14 111.866 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -101.88 141.26 35.0 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.568 0.747 . . . . 63.0 110.196 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -158.84 140.07 6.66 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 116.293 -0.412 . . . . 53.13 112.24 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 11.5 t -156.86 148.46 22.47 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.371 0.669 . . . . 72.14 110.054 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -121.66 121.82 38.2 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.471 0.708 . . . . 72.22 110.506 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -110.19 122.91 48.75 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.267 1.027 . . . . 71.45 108.363 168.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -149.63 116.45 5.92 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.734 0.414 . . . . 64.22 110.771 -175.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -112.92 142.08 46.0 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.243 -1.021 . . . . 75.23 108.243 169.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -106.17 162.88 13.25 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.152 0.581 . . . . 71.11 110.16 176.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 C-N-CA 124.132 0.973 . . . . 62.44 108.759 178.378 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tpt . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 110.441 -0.207 . . . . 64.21 110.441 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 49.8 m 57.84 -153.31 0.38 Allowed 'General case' 0 N--CA 1.483 1.192 0 O-C-N 124.002 0.814 . . . . 73.32 110.641 -174.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . 0.479 ' HG2' ' H ' ' C' ' 4' ' ' GLN . 19.5 tt0 61.97 -146.12 0.41 Allowed 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 118.444 -0.789 . . . . 74.25 108.953 175.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . 0.479 ' H ' ' HG2' ' C' ' 3' ' ' GLU . 0.0 OUTLIER 72.24 -65.91 0.33 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.897 1.279 . . . . 73.0 111.702 171.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -75.5 89.92 2.71 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.689 0.757 . . . . 65.14 110.397 176.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -109.16 4.0 22.46 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 114.81 -1.086 . . . . 74.15 108.527 166.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 31.8 m -73.52 -59.41 2.73 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 124.088 0.955 . . . . 75.53 111.031 -171.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.06 117.88 6.66 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.844 -0.799 . . . . 70.34 108.844 -176.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.401 ' SD ' ' N ' ' C' ' 10' ' ' THR . 0.0 OUTLIER 64.49 142.6 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 125.331 1.452 . . . . 75.42 112.26 177.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.731 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 40.5 m -129.1 109.88 11.56 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.991 -0.744 . . . . 72.3 108.991 174.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.537 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.6 t80 -124.58 134.03 53.09 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.412 0.685 . . . . 64.23 110.276 -176.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -150.85 131.17 13.66 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.536 0.735 . . . . 63.21 109.384 171.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 78.9 mt -74.99 124.06 31.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 108.445 -0.946 . . . . 70.14 108.445 172.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.449 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 81.9 mm-40 -93.74 -39.53 10.71 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.301 0.64 . . . . 71.31 110.915 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -177.19 127.01 0.15 Allowed 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.228 0.33 . . . . 71.35 110.714 -175.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 84.1 mt -114.69 133.42 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.51 0.724 . . . . 74.23 109.473 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.487 ' HE2' ' HD3' ' C' ' 19' ' ' LYS . 23.6 p90 -170.54 172.43 5.95 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-O 121.43 0.633 . . . . 74.21 110.53 -171.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.8 p -97.08 121.65 39.2 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.417 -0.811 . . . . 72.31 109.1 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.487 ' HD3' ' HE2' ' C' ' 17' ' ' TYR . 29.9 mmtp -68.98 -46.69 67.44 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.35 1.072 . . . . 74.05 108.186 167.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -141.76 138.36 32.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 112.989 -1.914 . . . . 72.43 109.041 -167.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.553 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.2 mt -134.38 152.59 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 107.258 -1.386 . . . . 74.25 107.258 174.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -160.4 152.87 20.78 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.395 0.617 . . . . 71.11 110.843 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -149.01 135.43 19.39 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.572 -1.27 . . . . 73.45 107.572 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -140.82 110.38 6.36 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.743 0.817 . . . . 75.44 109.313 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' C' ' 28' ' ' ALA . . . -124.54 85.67 56.04 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 105.371 -2.085 . . . . 64.53 105.371 165.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.82 -17.99 41.75 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 122.866 2.378 . . . . 74.45 112.397 -175.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -112.88 19.27 17.47 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.956 1.302 . . . . 74.25 110.289 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.408 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . . . -44.02 -56.88 6.89 Favored Pre-proline 0 N--CA 1.489 1.475 0 N-CA-C 114.297 1.221 . . . . 73.43 114.297 -170.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.428 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 38.0 Cg_endo -62.02 -35.72 74.95 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.103 1.869 . . . . 75.22 112.582 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -68.34 -50.57 52.35 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.171 0.588 . . . . 74.11 110.972 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.648 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.0 p -69.46 -23.65 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 N-CA-C 112.772 0.656 . . . . 74.2 112.772 -169.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -62.74 -33.16 74.56 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.52 0.563 . . . . 74.04 112.52 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -88.36 15.68 7.43 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.759 0.424 . . . . 71.31 112.099 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.702 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -95.56 158.68 15.35 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.915 0.886 . . . . 72.35 109.993 175.643 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -70.18 129.5 39.56 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 109.047 -0.723 . . . . 75.52 109.047 170.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 55.6 t-105 -78.44 80.41 4.83 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.429 0.692 . . . . 74.33 110.44 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -129.14 74.05 81.34 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 108.279 -1.008 . . . . 75.42 108.279 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -95.92 176.51 0.79 Allowed 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.068 2.512 . . . . 75.04 112.688 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' C' ' 67' ' ' SER . 0.9 OUTLIER -117.82 120.2 37.21 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.417 -1.698 . . . . 75.24 106.417 169.636 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.68 97.42 5.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.257 -1.016 . . . . 75.42 108.257 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.507 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 10.1 tmtt? -91.6 108.67 20.07 Favored 'General case' 0 CA--C 1.527 0.081 0 N-CA-C 106.851 -1.537 . . . . 73.43 106.851 175.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.439 HD12 ' HB ' ' G' ' 6' ' ' ILE . 4.4 mp -86.53 136.38 33.1 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.695 -0.854 . . . . 74.51 108.695 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 23.4 t70 -123.04 137.95 54.81 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 124.993 1.317 . . . . 72.23 107.948 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.48 HD22 HD12 ' C' ' 60' ' ' LEU . 6.1 tt -135.48 139.9 44.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.585 -1.265 . . . . 73.4 107.585 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.445 ' N ' HD23 ' C' ' 44' ' ' LEU . 29.9 t70 -143.41 152.64 41.8 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.523 0.729 . . . . 64.53 109.36 170.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 72.4 p -115.48 112.28 22.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.84 0.856 . . . . 75.11 109.486 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.91 157.18 20.96 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.662 -0.866 . . . . 65.14 108.662 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 31.4 p -164.86 169.63 16.36 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.449 0.537 . . . . 74.11 112.449 -170.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 41.9 t -170.12 129.31 0.91 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.232 1.013 . . . . 75.21 109.345 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -77.67 115.5 17.47 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.597 -1.26 . . . . 72.1 107.597 166.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.508 HD13 HD13 ' C' ' 83' ' ' ILE . 62.9 mt -89.48 -36.3 15.48 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.175 0.59 . . . . 74.11 110.805 -175.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.33 -168.68 0.84 Allowed 'General case' 0 CA--C 1.54 0.585 0 O-C-N 124.139 0.9 . . . . 70.31 111.15 -174.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -66.53 114.12 5.26 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.671 1.188 . . . . 74.21 110.084 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 65.82 -3.03 0.79 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 125.234 1.413 . . . . 73.24 113.227 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 78.9 t -98.7 107.17 19.95 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.429 -0.952 . . . . 75.13 108.429 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.436 ' HB3' HD12 ' C' ' 86' ' ' ILE . 49.2 t80 -122.12 137.12 54.94 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.809 -0.632 . . . . 72.23 110.064 -176.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -94.65 119.53 33.44 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.117 0.967 . . . . 75.11 109.735 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.09 117.5 55.17 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.137 -1.06 . . . . 75.14 108.137 174.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.07 136.04 56.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 108.366 -0.976 . . . . 74.01 108.366 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.48 HD12 HD22 ' C' ' 44' ' ' LEU . 16.2 tp -121.58 114.26 20.94 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 109.189 -0.671 . . . . 72.43 109.189 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.421 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 13.3 ttm180 -82.08 108.46 15.57 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.626 -0.879 . . . . 75.25 108.626 172.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.404 HG13 ' CD1' ' C' ' 114' ' ' ILE . 22.2 t -103.93 123.28 57.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.093 -1.447 . . . . 72.45 107.093 172.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 86.0 m -136.92 119.56 16.05 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 123.194 0.598 . . . . 61.22 109.448 -173.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 54.3 t -103.95 113.47 40.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 123.608 0.763 . . . . 64.34 109.135 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 4.9 m -99.4 134.94 41.53 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.674 -1.232 . . . . 74.45 107.674 171.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.01 120.28 25.74 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.791 -1.559 . . . . 71.33 106.791 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 57.0 m -135.52 130.37 34.49 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.081 0.467 . . . . 75.23 110.938 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.702 HD11 ' HG2' ' C' ' 34' ' ' LYS . 8.6 mt -84.67 46.62 1.27 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.93 1.292 . . . . 73.32 109.246 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.41 -119.72 6.48 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 109.46 -1.456 . . . . 62.12 109.46 -165.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -91.17 -19.49 23.01 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.235 0.614 . . . . 74.31 110.198 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -70.62 84.67 0.63 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.747 0.819 . . . . 63.14 108.962 174.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 62.4 m -62.42 121.6 13.65 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 110.291 -0.263 . . . . 74.21 110.291 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.648 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -67.92 -61.76 1.72 Allowed 'General case' 0 C--O 1.235 0.342 0 O-C-N 124.069 0.856 . . . . 62.23 108.739 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -155.06 172.76 17.59 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-O 122.211 1.005 . . . . 72.34 111.196 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -130.74 144.21 51.28 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 105.043 -2.206 . . . . 70.32 105.043 169.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.433 ' SG ' HG21 ' C' ' 114' ' ' ILE . 51.2 t -151.52 135.31 16.4 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.649 -0.871 . . . . 71.15 108.649 177.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -139.66 138.79 36.38 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.081 0.552 . . . . 74.41 109.928 -174.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -141.91 113.46 3.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.959 -1.126 . . . . 74.3 107.959 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -91.07 88.31 6.93 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.235 -1.024 . . . . 72.41 108.235 172.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -78.76 101.15 7.43 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.007 -0.997 . . . . 73.34 108.996 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.25 143.4 17.99 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 111.614 -0.594 . . . . 43.21 111.614 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.56 116.47 0.99 Allowed Glycine 0 CA--C 1.499 -0.949 0 N-CA-C 109.968 -1.253 . . . . 72.23 109.968 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.508 HD13 HD13 ' C' ' 51' ' ' LEU . 12.6 mm -81.63 120.44 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.736 -1.209 . . . . 74.22 107.736 177.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.537 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 54.7 m-85 -130.9 134.74 47.05 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.453 -0.943 . . . . 74.41 108.453 -177.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 49.3 m -80.24 117.42 21.0 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.949 -0.76 . . . . 72.02 108.949 170.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.436 HD12 ' HB3' ' C' ' 56' ' ' TYR . 4.1 mp -115.43 118.07 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.051 -1.092 . . . . 73.23 108.051 173.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.731 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -140.03 162.77 34.42 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.745 0.818 . . . . 74.34 109.86 176.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 150' ' ' GLU . . . 89.12 -63.24 3.47 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.335 -0.848 . . . . 41.42 112.496 176.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 28.5 pt -90.03 145.86 6.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-O 120.876 0.37 . . . . 75.22 110.675 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -146.32 150.47 35.8 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.319 -0.855 . . . . 65.22 109.088 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.49 -135.89 13.02 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-O 119.721 -0.488 . . . . 41.31 112.262 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 15.5 m -67.24 -35.11 78.87 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.819 0.848 . . . . 64.51 111.412 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -56.72 -48.66 77.26 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.728 1.211 . . . . 72.04 109.682 176.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.645 ' HE1' ' HA ' ' G' ' 17' ' ' PRO . 2.7 ttp -66.62 -43.83 83.71 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 113.305 -1.77 . . . . 74.15 110.998 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.21 69.82 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.719 0.808 . . . . 74.44 111.68 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -67.09 -41.89 85.55 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.754 0.822 . . . . 73.2 110.621 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.484 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 30.1 t -63.95 -53.16 54.66 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.832 -0.622 . . . . 72.13 109.86 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.722 HD11 HG23 ' G' ' 18' ' ' VAL . 80.3 mt -70.14 -28.54 65.44 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.828 0.851 . . . . 72.43 112.695 -175.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.43 12.76 33.29 Favored Glycine 0 N--CA 1.475 1.27 0 N-CA-C 114.322 0.489 . . . . 71.24 114.322 -167.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.486 ' HA ' ' HB2' ' C' ' 133' ' ' PHE . . . -155.89 -60.08 0.1 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.787 0.803 . . . . 64.22 110.8 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.404 ' CE2' ' CE1' ' C' ' 11' ' ' PHE . 53.5 t80 -75.28 -38.2 60.54 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-N 113.607 -1.633 . . . . 75.54 112.324 -170.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.484 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 79.0 m -83.14 -43.8 0.86 Allowed Pre-proline 0 CA--C 1.565 1.528 0 C-N-CA 123.883 0.873 . . . . 73.22 112.699 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -64.86 -20.94 64.7 Favored 'Trans proline' 0 C--N 1.394 2.938 0 C-N-CA 122.325 2.016 . . . . 74.11 112.312 173.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -67.5 -33.83 75.89 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.661 0.784 . . . . 75.01 110.512 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.505 HD13 ' NH1' ' A' ' 111' ' ' ARG . 44.0 mm -65.19 -35.56 75.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-N 115.67 -0.696 . . . . 71.31 109.752 174.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 82.7 mt -89.62 -22.35 22.36 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.201 1.001 . . . . 64.13 112.449 -174.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -54.92 -51.13 81.94 Favored Pre-proline 0 CA--C 1.559 1.297 0 N-CA-C 113.299 0.852 . . . . 74.43 113.299 -174.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -64.23 -34.45 56.28 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.083 1.855 . . . . 73.52 112.871 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -66.32 -44.81 82.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.185 0.594 . . . . 72.4 110.854 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.17 -38.6 88.46 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.527 -0.761 . . . . 73.34 110.661 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -57.64 -53.82 53.84 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.454 1.101 . . . . 75.51 110.594 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.27 -32.58 74.08 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.59 0.556 . . . . 74.43 110.463 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.0 t -73.1 -33.12 65.39 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 122.939 0.495 . . . . 74.43 111.257 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.433 HG21 ' SG ' ' C' ' 76' ' ' CYS . 57.3 mt -71.57 -52.88 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.039 0.536 . . . . 75.1 109.758 174.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.4 m -65.98 -27.05 67.85 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.424 0.689 . . . . 75.31 111.009 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 38.1 t -62.6 -49.4 75.36 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 109.279 -0.637 . . . . 71.51 109.279 169.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.709 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.8 -36.4 81.01 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.208 1.003 . . . . 74.13 112.546 178.222 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.1 -44.35 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.407 0.683 . . . . 72.12 109.343 173.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.441 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 22.7 t -73.27 -25.06 60.54 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.121 -0.945 . . . . 65.3 111.565 -177.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.421 ' NH2' ' HG3' ' B' ' 112' ' ' GLU . 78.3 mtt-85 -75.02 -41.66 58.87 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.567 0.747 . . . . 71.34 108.995 176.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.12 1.6 68.93 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 124.254 0.971 . . . . 61.2 112.364 172.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 22.3 p 60.96 29.84 19.26 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.632 1.973 . . . . 64.13 113.523 170.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -83.65 148.44 54.83 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 123.457 0.703 . . . . 63.12 110.193 173.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -52.83 139.35 59.72 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.351 2.701 . . . . 73.22 113.341 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -56.88 112.95 1.47 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.615 1.166 . . . . 61.35 112.353 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.38 100.9 7.58 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.291 -1.744 . . . . 75.25 106.291 174.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -99.09 131.4 45.16 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.284 0.634 . . . . 65.32 110.318 -172.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.94 142.04 38.62 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.542 0.737 . . . . 73.22 110.041 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.697 ' HB2' ' HB ' ' G' ' 5' ' ' THR . . . -75.46 162.05 74.15 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.055 0.942 . . . . 72.2 111.58 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.33 109.34 0.97 Allowed 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.385 2.057 . . . . 74.11 111.972 173.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.643 HG13 ' HB2' ' G' ' 8' ' ' LEU . 21.6 t -98.24 106.85 19.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 108.006 -1.109 . . . . 74.44 108.006 174.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -101.81 91.6 4.46 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.725 -1.583 . . . . 72.44 106.725 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.486 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 45.8 m-85 -58.09 -37.79 75.18 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.597 0.713 . . . . 75.12 109.534 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -67.01 -30.76 70.95 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 113.789 -1.55 . . . . 73.05 111.059 -177.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.68 -23.23 64.37 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.369 0.667 . . . . 61.23 111.459 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 8.5 mp -80.22 -26.66 39.01 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.999 0.52 . . . . 64.43 110.37 173.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -78.52 -28.05 46.12 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.754 0.422 . . . . 73.23 110.523 172.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 67.1 mtt -77.01 -30.34 55.83 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.827 0.851 . . . . 75.23 110.04 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -66.71 -38.53 86.91 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.139 0.976 . . . . 63.3 109.665 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -68.2 -84.11 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 115.16 -0.927 . . . . 75.42 108.765 172.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 19.5 tp 63.89 -175.07 0.16 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.227 1.011 . . . . 72.5 110.844 172.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -94.3 144.7 25.31 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 107.582 -1.266 . . . . 74.45 107.582 169.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.39 -53.44 44.87 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.221 1.008 . . . . 71.34 111.373 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -74.74 95.27 2.85 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 109.407 -0.59 . . . . 73.42 109.407 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.27 131.25 6.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.583 1.153 . . . . 61.31 109.006 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.7 137.75 4.74 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 111.971 -0.452 . . . . 53.55 111.971 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . 0.428 ' HG2' ' HE3' ' A' ' 138' ' ' MET . 27.9 mt-10 -92.28 124.11 36.1 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.946 0.898 . . . . 75.35 110.261 -177.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -163.58 128.77 1.89 Allowed Glycine 0 C--N 1.345 1.034 0 N-CA-C 111.29 -0.724 . . . . 62.34 111.29 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 2.5 m -139.13 97.45 3.3 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.211 0.505 . . . . 71.34 109.74 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -86.96 -4.27 59.16 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.199 0.6 . . . . 73.14 110.662 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -82.17 133.16 35.25 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.824 -0.806 . . . . 72.35 108.824 168.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . 0.402 ' CE1' ' HG2' ' E' ' 24' ' ' PRO . 91.3 m-70 -137.54 149.09 46.47 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.826 0.45 . . . . 74.14 111.391 -171.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -155.8 126.35 6.8 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.109 0.964 . . . . 74.3 109.227 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -115.41 108.18 16.17 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.0 -0.741 . . . . 74.12 109.0 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 C-N-CA 123.702 0.801 . . . . 74.21 108.924 179.464 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 109.213 -0.662 . . . . 65.34 109.213 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 49.6 p 46.19 45.3 12.79 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.195 1.398 . . . . 74.35 111.412 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -70.93 132.53 45.35 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 114.522 -1.217 . . . . 74.34 111.822 -171.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . 0.586 ' HG3' ' HG3' ' D' ' 93' ' ' GLN . 42.4 tt0 -137.74 135.34 36.29 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.846 1.258 . . . . 73.11 108.848 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -79.88 74.8 6.61 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 107.848 -1.167 . . . . 74.54 107.848 174.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -88.44 70.51 9.02 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.97 0.89 . . . . 63.01 110.089 -172.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 13.1 t -162.41 166.96 24.4 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 113.904 -1.498 . . . . 71.15 108.769 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 59.04 -96.26 0.06 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 117.771 -1.109 . . . . 74.2 110.435 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.417 ' HE1' ' HB2' ' D' ' 11' ' ' PHE . 5.2 ppp? 22.16 171.96 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 118.766 2.876 . . . . 74.14 118.766 -174.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 55.7 m -140.73 142.06 34.84 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 120.91 -1.119 . . . . 73.13 109.926 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.417 ' HB2' ' HE1' ' D' ' 9' ' ' MET . 40.5 t80 -159.04 113.88 2.47 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.203 -1.036 . . . . 74.02 108.203 177.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . 0.469 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 49.3 mt-30 -133.33 135.91 45.07 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.865 0.866 . . . . 73.11 108.895 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 16.6 mt -92.47 120.21 41.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 109.48 -0.563 . . . . 73.12 109.48 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -91.61 -47.21 7.52 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.284 0.365 . . . . 75.13 111.404 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -166.6 123.41 1.27 Allowed 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 111.434 0.161 . . . . 74.21 111.434 -168.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.73 137.54 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 108.462 -0.94 . . . . 75.51 108.462 170.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.459 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 22.7 p90 -162.05 168.76 22.15 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 124.16 0.912 . . . . 72.14 110.861 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.1 p -96.98 122.66 40.21 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.405 -0.961 . . . . 74.11 108.405 171.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.459 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 34.4 mtpt -85.13 -40.17 17.06 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.986 -0.746 . . . . 75.01 108.986 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.8 t70 -140.62 141.26 35.13 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 113.978 -1.464 . . . . 71.04 108.99 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.709 HG21 ' HE1' ' C' ' 117' ' ' MET . 94.0 mt -135.44 147.75 28.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.695 1.198 . . . . 75.11 107.922 174.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -147.32 143.4 28.02 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.416 1.086 . . . . 74.42 108.523 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.553 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.9 t80 -149.47 132.24 15.99 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.577 -1.638 . . . . 70.13 106.577 171.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 46.5 mt-10 -135.68 151.16 49.92 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.716 -1.216 . . . . 62.42 107.716 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.66 91.59 5.27 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 108.332 -0.988 . . . . 71.13 108.332 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.78 -50.9 3.52 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.398 2.732 . . . . 61.41 113.551 -171.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.483 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 18.6 m-20 -99.86 14.1 31.54 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.832 0.853 . . . . 71.42 110.071 -171.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -28.48 -68.72 0.1 OUTLIER Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 126.826 2.05 . . . . 63.02 115.82 -163.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.401 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 93.6 Cg_endo -74.29 -19.67 19.47 Favored 'Trans proline' 0 C--N 1.382 2.322 0 CA-C-N 123.162 2.165 . . . . 74.02 114.05 -173.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -79.11 -43.01 24.94 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.848 0.859 . . . . 74.5 109.944 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.523 HG21 ' HA ' ' D' ' 73' ' ' ALA . 10.0 p -75.01 -15.33 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-N 115.613 -0.721 . . . . 71.12 110.744 -172.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -70.56 -17.71 62.92 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 112.281 0.474 . . . . 72.13 112.281 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -64.36 -11.21 30.23 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.372 0.669 . . . . 74.3 110.879 173.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -105.55 97.17 7.04 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.014 1.726 . . . . 74.25 109.438 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -104.91 89.72 3.24 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.547 0.739 . . . . 71.34 109.329 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -162.43 171.88 16.43 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.141 0.976 . . . . 71.43 109.124 171.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 28.7 tp60 -63.56 110.75 4.03 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 123.26 0.624 . . . . 75.25 109.634 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -64.73 143.92 82.16 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.629 2.219 . . . . 70.24 112.325 -176.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -71.48 116.02 11.33 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.442 0.697 . . . . 73.31 109.166 173.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.595 HG11 HG13 ' D' ' 64' ' ' VAL . 78.5 t -115.45 130.28 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.611 0.764 . . . . 74.41 110.963 -169.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.562 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 16.6 tptm -106.11 134.74 48.76 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.656 1.183 . . . . 75.21 108.579 173.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -110.17 114.81 28.6 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.611 0.764 . . . . 73.35 109.741 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.503 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 3.7 m-20 -108.87 113.64 26.72 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.993 0.917 . . . . 72.44 108.532 174.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.577 HD11 ' H ' ' H' ' 9' ' ' ALA . 8.7 mp -101.29 132.05 47.01 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.182 -0.673 . . . . 74.35 109.182 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.6 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 25.0 t70 -132.48 150.11 52.21 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.027 0.931 . . . . 74.23 108.749 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 52.2 m -105.83 144.04 33.13 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.07 0.948 . . . . 71.31 110.955 -171.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -156.65 161.38 39.89 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.86 1.264 . . . . 73.22 108.994 171.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.3 p -175.71 166.63 3.16 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.127 0.571 . . . . 73.34 111.349 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 80.3 p -161.96 143.3 10.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.528 0.731 . . . . 72.42 110.044 172.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -78.91 121.47 24.91 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.628 -0.878 . . . . 73.24 108.628 171.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.466 HD13 HG22 ' D' ' 83' ' ' ILE . 76.3 mt -99.84 -29.03 12.83 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.809 0.444 . . . . 71.42 111.318 -175.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.26 -175.43 4.84 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.483 0.659 . . . . 74.5 111.135 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -62.62 122.49 15.97 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.1 -1.409 . . . . 54.51 109.479 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 60.09 16.29 5.82 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.786 0.834 . . . . 73.11 112.592 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 81.8 t -119.6 125.74 74.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 C-N-CA 123.806 0.843 . . . . 74.31 108.756 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -135.09 130.85 36.18 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.874 -0.603 . . . . 64.14 109.598 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -91.23 139.81 30.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.317 -0.856 . . . . 74.14 109.579 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 62.5 t -120.8 126.12 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 107.777 -1.194 . . . . 72.54 107.777 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.07 129.28 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.463 0.705 . . . . 75.54 109.363 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -121.7 120.58 35.1 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.031 0.532 . . . . 72.24 110.218 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.6 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 32.9 ttm-85 -87.93 102.98 15.24 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.152 -0.931 . . . . 75.14 108.978 172.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.6 t -91.6 126.3 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 107.72 -1.215 . . . . 75.11 107.72 169.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 8.5 m -121.02 131.76 54.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.474 -0.565 . . . . 71.43 109.474 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.595 HG13 HG11 ' D' ' 40' ' ' VAL . 35.3 t -116.4 102.35 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 124.73 1.212 . . . . 71.5 108.856 -173.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.562 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 9.4 m -94.04 91.68 6.97 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.947 -1.131 . . . . 75.21 107.947 173.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.87 150.0 20.91 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.59 -0.732 . . . . 64.04 109.405 -175.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 67.9 m -149.35 128.95 13.13 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.222 0.534 . . . . 73.54 112.294 -173.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 34.9 mt -110.73 134.55 52.38 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.048 1.339 . . . . 74.42 109.184 174.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.03 -111.85 3.68 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 112.203 -0.359 . . . . 74.45 112.203 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.81 4.47 8.79 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.733 0.813 . . . . 74.52 110.174 178.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -125.22 173.76 8.56 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.688 0.795 . . . . 51.42 110.065 -174.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 82.3 m -72.7 139.58 47.32 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.208 0.528 . . . . 72.13 110.558 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.523 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.7 -67.85 0.8 Allowed 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.012 0.925 . . . . 72.51 108.57 173.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -152.38 160.9 43.24 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.857 -0.611 . . . . 75.4 110.653 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.405 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 68.5 mt -122.84 110.95 16.08 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.739 -1.208 . . . . 74.34 107.739 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.625 ' SG ' ' HE3' ' D' ' 117' ' ' MET . 46.0 t -123.73 115.09 20.83 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.124 0.57 . . . . 71.11 109.906 -173.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -130.83 122.83 27.79 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.534 0.734 . . . . 74.51 109.855 -171.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.14 119.21 48.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 C-N-CA 123.259 0.624 . . . . 74.23 109.676 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.513 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.4 mt-30 -89.65 87.8 7.16 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.214 -0.662 . . . . 75.33 109.214 170.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.21 109.89 15.1 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.742 -1.117 . . . . 74.23 108.826 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.3 143.83 16.92 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 111.524 -0.63 . . . . 72.55 111.524 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.92 134.41 6.57 Favored Glycine 0 CA--C 1.509 -0.287 0 N-CA-C 110.933 -0.867 . . . . 63.13 110.933 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.466 HG22 HD13 ' D' ' 51' ' ' LEU . 48.3 mt -89.0 121.96 39.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 108.251 -1.018 . . . . 74.44 108.251 176.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -131.13 127.8 38.83 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.202 0.314 . . . . 73.51 110.366 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 21.2 m -75.96 104.82 6.68 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.064 -0.717 . . . . 71.24 109.064 170.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.489 HD13 HD12 ' D' ' 89' ' ' ILE . 16.4 tt -126.6 133.23 69.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-O 121.38 0.609 . . . . 74.42 111.077 -174.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.49 168.38 26.34 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.244 1.017 . . . . 72.43 109.601 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.07 13.37 81.12 Favored Glycine 0 N--CA 1.473 1.114 0 N-CA-C 114.289 0.476 . . . . 74.33 114.289 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.489 HD12 HD13 ' D' ' 86' ' ' ILE . 37.1 mt -113.49 139.34 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.433 1.093 . . . . 74.41 109.175 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.672 ' HA ' ' HE2' ' D' ' 94' ' ' MET . 8.7 pt-20 -153.77 158.22 40.61 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.51 0.506 . . . . 73.24 112.205 -171.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.56 -137.34 23.37 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.097 -0.956 . . . . 42.25 112.445 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 92' ' ' THR . . . . . 0.444 ' HB ' HD23 ' D' ' 141' ' ' LEU . 40.9 p -69.68 -20.6 63.56 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.581 0.753 . . . . 71.34 111.342 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.586 ' HG3' ' HG3' ' D' ' 4' ' ' GLN . 46.1 tt0 -60.11 -32.53 71.08 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.953 0.901 . . . . 74.11 111.262 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.672 ' HE2' ' HA ' ' D' ' 90' ' ' GLU . 54.4 mtt -62.49 -47.61 83.22 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.38 0.672 . . . . 74.42 110.717 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.51 94.04 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.039 -0.982 . . . . 55.33 110.471 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -66.81 -43.71 83.12 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.214 0.606 . . . . 72.41 111.785 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 39.5 t -63.13 -51.04 68.08 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.326 0.584 . . . . 65.11 110.463 -172.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.583 HD11 HG21 ' H' ' 18' ' ' VAL . 73.9 mt -85.91 -21.24 28.06 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.23 -0.895 . . . . 75.21 111.448 -175.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.39 8.62 55.31 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 119.628 -0.54 . . . . 75.2 114.03 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.477 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -154.92 -54.29 0.09 Allowed 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 117.28 0.54 . . . . 74.45 111.586 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -70.13 -51.1 34.12 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.662 0.385 . . . . 74.1 111.871 -173.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 30.6 m -67.15 -42.16 38.73 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 123.175 0.59 . . . . 74.14 111.904 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -53.72 -35.35 78.04 Favored 'Trans proline' 0 C--N 1.393 2.888 0 C-N-CA 122.667 2.244 . . . . 75.42 113.346 166.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -68.8 -32.92 72.99 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.514 0.726 . . . . 73.3 110.319 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 50.2 mm -67.5 -40.23 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 121.394 0.616 . . . . 75.11 110.146 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 95.6 mt -84.05 -15.52 47.19 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.274 -0.875 . . . . 74.15 112.064 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -61.68 -50.08 83.61 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 124.437 1.095 . . . . 74.32 112.945 -175.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -59.72 -34.6 96.05 Favored 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 122.144 1.896 . . . . 52.33 112.945 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -78.34 -37.22 45.0 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.562 0.745 . . . . 65.3 112.211 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.0 -46.35 78.29 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.426 -0.583 . . . . 75.5 109.426 176.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -57.37 -47.74 80.86 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 124.41 1.068 . . . . 74.44 110.921 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -60.42 -49.88 75.8 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.808 0.843 . . . . 64.33 111.185 -177.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -56.2 -41.8 76.18 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 123.882 0.739 . . . . 73.33 111.101 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.47 ' O ' HG23 ' D' ' 118' ' ' VAL . 98.0 mt -63.46 -56.44 17.06 Favored 'Isoleucine or valine' 0 C--N 1.349 0.568 0 CA-C-N 115.17 -0.923 . . . . 73.3 110.202 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -55.14 -36.82 66.18 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.438 1.095 . . . . 74.22 111.739 -173.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.418 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 37.2 t -66.97 -43.94 81.76 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.403 -0.817 . . . . 73.51 110.553 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.625 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 78.2 mtm -70.64 -25.88 63.22 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.74 0.416 . . . . 72.1 111.956 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.47 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.2 t -65.73 -43.79 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.274 0.63 . . . . 72.04 109.638 174.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.7 p -77.03 -27.44 54.49 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.998 -0.546 . . . . 74.5 111.142 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' D' ' 116' ' ' SER . 89.9 mtt-85 -73.02 -35.83 66.85 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.416 0.686 . . . . 72.13 109.866 174.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.4 -2.34 89.32 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.547 -0.751 . . . . 74.25 112.024 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.7 p 65.9 20.44 11.36 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 127.054 2.142 . . . . 63.54 113.657 172.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -79.16 155.0 77.38 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.418 0.687 . . . . 71.45 110.129 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.58 133.71 54.91 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.078 2.519 . . . . 64.32 112.548 172.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -54.41 140.75 32.9 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.416 1.086 . . . . 73.23 112.644 -172.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 62.4 tp -121.2 110.07 15.73 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.165 0.986 . . . . 72.44 109.141 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -111.21 104.96 13.51 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.812 -0.81 . . . . 71.23 108.812 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 tt -70.53 114.21 8.41 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 107.609 -1.256 . . . . 73.01 107.609 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.65 138.32 88.37 Favored Pre-proline 0 N--CA 1.475 0.823 0 CA-C-O 119.609 -0.234 . . . . 65.34 110.408 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -73.62 141.15 30.63 Favored 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 122.457 2.105 . . . . 75.53 111.693 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.74 147.73 24.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 C-N-CA 123.88 0.872 . . . . 74.24 108.961 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . 0.473 ' ND2' ' HB3' ' D' ' 135' ' ' ALA . 60.0 t30 -75.42 82.54 2.5 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.657 -0.868 . . . . 71.01 108.657 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -71.41 -25.86 62.52 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.586 -1.188 . . . . 74.24 110.106 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.477 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 3.8 m-20 -54.55 -43.53 72.09 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 114.818 -1.083 . . . . 74.24 111.146 172.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.473 ' HB3' ' ND2' ' D' ' 132' ' ' ASN . . . -61.66 -45.68 93.01 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.842 0.857 . . . . 73.22 111.303 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 7.6 tt -63.02 -42.48 99.8 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.014 -0.993 . . . . 74.2 110.048 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -72.89 -44.51 61.21 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.566 -0.743 . . . . 65.24 110.941 -174.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 70.2 mtm -64.17 -24.83 67.83 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.162 0.585 . . . . 61.22 111.934 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -60.42 -39.76 88.6 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.769 0.668 . . . . 75.34 110.711 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -64.94 -43.14 93.72 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.295 0.638 . . . . 74.24 110.663 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.444 HD23 ' HB ' ' D' ' 92' ' ' THR . 9.0 mp -66.48 -29.27 69.35 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.312 -0.858 . . . . 74.22 111.992 -175.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -89.93 18.44 5.73 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.088 0.403 . . . . 74.04 112.088 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -121.06 77.07 1.27 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.285 0.564 . . . . 70.14 110.001 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.54 116.37 1.74 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.627 -1.249 . . . . 75.23 107.627 171.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.09 83.25 3.59 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.131 0.491 . . . . 61.13 109.693 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.5 -176.08 38.53 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 115.462 -0.79 . . . . 63.54 112.373 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.69 156.89 46.1 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.895 0.878 . . . . 75.54 109.732 -176.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 85.03 -30.74 3.86 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 116.229 -0.441 . . . . 41.34 113.453 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 63.9 p 51.72 -159.44 0.1 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.622 1.569 . . . . 73.32 111.797 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -162.94 135.22 5.36 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 110.013 -0.366 . . . . 75.23 110.013 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -86.93 64.6 8.57 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 108.136 -1.061 . . . . 75.13 108.136 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -70.67 104.24 2.78 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.61 -0.723 . . . . 62.41 110.491 -171.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -98.34 154.24 17.97 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.202 1.001 . . . . 64.53 110.247 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -145.97 19.65 1.44 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.274 -0.875 . . . . 75.35 109.06 169.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 C-N-CA 124.756 1.222 . . . . 65.31 108.606 176.481 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 58.6 mtt . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.228 -0.656 . . . . 73.34 109.228 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -129.53 105.62 8.2 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.631 0.772 . . . . 73.44 110.747 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -105.51 101.79 11.29 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.177 -1.416 . . . . 73.14 107.177 168.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 37.2 t -68.03 147.92 51.72 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.698 0.761 . . . . 64.04 112.675 -171.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 5' ' ' THR . . . . . 0.454 ' H ' HD11 ' E' ' 6' ' ' ILE . 7.0 t -130.55 8.0 4.93 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 114.197 -1.365 . . . . 74.23 109.442 176.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.645 HG22 HD13 ' A' ' 128' ' ' LEU . 2.7 mp -114.14 119.0 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.76 0.824 . . . . 75.1 108.983 -173.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.51 159.73 37.51 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.126 0.57 . . . . 72.42 111.31 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . 0.456 HD21 HD21 ' A' ' 44' ' ' LEU . 64.7 mt -73.37 151.0 41.37 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.944 0.498 . . . . 74.45 111.066 175.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.76 126.21 41.76 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.443 -0.947 . . . . 61.13 108.443 171.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 mp -63.73 127.42 31.28 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.582 0.753 . . . . 72.15 110.15 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 7.8 mp -76.9 126.66 85.38 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.011 0.524 . . . . 63.35 109.876 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.31 -21.77 30.46 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.717 2.278 . . . . 74.23 112.246 176.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 90.2 mt -114.9 157.95 22.64 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.99 0.916 . . . . 71.53 109.677 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 93.1 mt -90.82 175.13 7.11 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.143 0.577 . . . . 73.15 110.337 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -80.26 160.09 25.66 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.61 0.764 . . . . 74.25 110.265 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 16' ' ' THR . . . . . 0.415 ' O ' HD12 ' A' ' 98' ' ' LEU . 34.1 p -66.62 126.01 91.53 Favored Pre-proline 0 CA--C 1.557 1.216 0 C-N-CA 123.842 0.857 . . . . 60.34 112.159 -171.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 17' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.71 163.53 21.32 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 123.816 3.011 . . . . 73.42 114.156 -171.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 18' ' ' VAL . . . . . 0.526 HG22 ' HG ' ' A' ' 98' ' ' LEU . 58.2 t -102.6 -80.48 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 114.9 -1.045 . . . . 75.23 110.883 -175.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 2.6 m -82.5 -45.48 14.66 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 115.585 -0.734 . . . . 63.43 109.058 -174.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 20' ' ' LYS . . . . . 0.404 ' HD3' ' HG2' ' A' ' 90' ' ' GLU . 76.5 tttt -164.31 -70.9 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.494 -1.23 . . . . 73.5 109.327 -175.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 63.56 159.78 0.09 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.557 1.143 . . . . 71.24 112.134 -171.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 22' ' ' ARG . . . . . 0.609 ' HB2' ' HA2' ' A' ' 91' ' ' GLY . 2.7 mmp_? -134.09 111.1 10.07 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.214 -0.662 . . . . 75.34 109.214 174.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 4.4 t -130.93 100.22 17.54 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.398 1.079 . . . . 73.24 108.32 173.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 24' ' ' PRO . . . . . 0.402 ' HG2' ' CE1' ' C' ' 152' ' ' HIS . 52.9 Cg_exo -59.93 -22.35 68.41 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 123.074 2.516 . . . . 71.41 112.318 172.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.256 1.427 0 C-N-CA 124.505 1.122 . . . . 74.33 109.076 174.351 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.969 -0.382 . . . . 75.14 109.969 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -161.91 -44.62 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.292 1.037 . . . . 75.42 109.501 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 52.14 82.53 0.07 Allowed 'General case' 0 C--N 1.356 0.879 0 C-N-CA 124.958 1.303 . . . . 72.22 111.248 -173.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 31.5 p -65.82 94.49 0.22 Allowed 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.873 -0.788 . . . . 62.41 108.873 173.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 20.5 m -64.96 97.5 0.24 Allowed 'General case' 0 C--N 1.349 0.576 0 CA-C-N 115.304 -0.862 . . . . 74.43 110.188 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . 0.499 HD11 HD13 ' B' ' 126' ' ' LEU . 2.4 pp -72.37 156.72 6.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 CA-C-N 114.743 -1.117 . . . . 75.24 111.348 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -154.75 177.9 10.73 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.342 -0.845 . . . . 53.33 109.571 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 98.7 mt -90.29 163.2 14.85 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.983 0.513 . . . . 74.21 109.763 173.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.77 173.49 8.13 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.548 0.739 . . . . 74.43 111.367 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 10' ' ' LEU . . . . . 0.411 HD22 ' HB2' ' B' ' 136' ' ' LEU . 0.4 OUTLIER -84.5 12.96 6.03 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.985 0.514 . . . . 74.02 110.446 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 82.1 mt 61.42 90.08 0.1 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.118 0.967 . . . . 75.32 110.039 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -65.67 -9.34 22.35 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.844 2.362 . . . . 74.45 113.244 -174.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.7 143.36 23.63 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.355 -0.98 . . . . 62.44 108.355 175.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' B' ' 96' ' ' HIS . 88.6 mt -69.76 159.09 34.2 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.349 0.659 . . . . 74.12 110.31 173.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -75.96 -86.63 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.01 0.524 . . . . 73.04 112.065 -168.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 21.9 p -145.05 149.29 41.64 Favored Pre-proline 0 N--CA 1.486 1.359 0 C-N-CA 123.086 0.554 . . . . 73.21 110.994 -172.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 17' ' ' PRO . . . . . 0.547 ' HB2' HG23 ' F' ' 19' ' ' THR . 88.2 Cg_endo -82.76 114.89 2.38 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.69 2.26 . . . . 73.5 113.2 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . 0.445 HG23 HD23 ' B' ' 98' ' ' LEU . 88.3 t -48.07 -32.43 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 125.626 1.571 . . . . 74.53 113.387 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 19' ' ' THR . . . . . 0.547 HG23 ' HB2' ' F' ' 17' ' ' PRO . 13.5 t -49.79 -35.86 24.16 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 124.306 1.043 . . . . 73.02 112.136 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -174.49 79.54 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.73 1.212 . . . . 74.22 107.989 177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.07 -71.7 0.7 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.455 0.702 . . . . 75.44 110.225 -175.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . 0.433 ' HG2' ' HA ' ' B' ' 49' ' ' SER . 3.3 tpm_? -69.67 -45.24 68.79 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 115.781 -0.645 . . . . 71.33 110.565 -176.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 21.1 m 65.46 106.38 0.03 OUTLIER Pre-proline 0 CA--C 1.56 1.34 0 O-C-N 124.752 1.283 . . . . 74.43 110.295 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.14 83.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.332 2.688 . . . . 75.04 113.638 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 CA--C 1.55 0.961 0 C-N-CA 124.146 0.979 . . . . 75.53 108.96 177.722 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' G' G ' 1' ' ' MET . . . . . 0.455 ' N ' ' SD ' ' G' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 109.33 -0.618 . . . . 73.11 109.33 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -88.89 -85.22 0.2 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.525 -0.546 . . . . 71.52 109.525 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -90.75 89.86 7.69 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.096 -0.705 . . . . 74.21 109.096 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 15.0 m -69.75 139.86 53.38 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.942 -0.572 . . . . 54.41 109.954 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 5' ' ' THR . . . . . 0.697 ' HB ' ' HB2' ' C' ' 129' ' ' ALA . 8.9 p -66.95 109.38 2.93 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.196 0.599 . . . . 74.31 110.353 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . 0.439 ' HB ' HD12 ' C' ' 42' ' ' LEU . 0.2 OUTLIER -60.92 145.78 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.475 1.51 . . . . 73.15 112.772 -173.053 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.85 154.4 46.17 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.167 0.587 . . . . 61.15 110.785 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 8' ' ' LEU . . . . . 0.643 ' HB2' HG13 ' C' ' 131' ' ' VAL . 56.2 mt -75.0 157.85 34.22 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.396 1.079 . . . . 73.14 110.345 177.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.99 159.34 26.29 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.542 0.737 . . . . 74.14 111.165 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 40.8 tp -73.55 147.4 43.97 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.071 0.549 . . . . 72.22 109.838 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 90.4 mt -86.17 110.76 33.57 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.729 0.812 . . . . 72.22 110.399 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.04 -34.94 27.26 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 123.127 2.551 . . . . 72.34 112.661 -175.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 35.4 tp -90.28 -5.41 56.33 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.707 -0.679 . . . . 65.32 110.525 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 7.7 mp 65.71 -77.02 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.734 1.213 . . . . 70.55 109.239 -169.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -166.33 168.47 15.02 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.253 0.621 . . . . 72.01 109.417 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 35.1 p -71.44 155.01 93.22 Favored Pre-proline 0 CA--C 1.561 1.393 0 C-N-CA 124.379 1.071 . . . . 74.4 111.418 176.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 17' ' ' PRO . . . . . 0.645 ' HA ' ' HE1' ' C' ' 94' ' ' MET . 45.6 Cg_endo -65.67 150.52 86.23 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 123.375 2.717 . . . . 73.42 114.098 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 18' ' ' VAL . . . . . 0.722 HG23 HD11 ' C' ' 98' ' ' LEU . 46.2 t -77.22 -55.57 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 109.207 -0.664 . . . . 64.11 109.207 169.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 19' ' ' THR . . . . . 0.501 HG21 ' HG3' ' G' ' 20' ' ' LYS . 21.7 m -137.01 -62.94 0.62 Allowed 'General case' 0 CA--C 1.553 1.074 0 O-C-N 123.211 0.319 . . . . 63.4 111.434 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 20' ' ' LYS . . . . . 0.501 ' HG3' HG21 ' G' ' 19' ' ' THR . 91.1 mttt -125.94 20.6 7.64 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.6 0.76 . . . . 71.22 112.298 -167.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . 0.625 ' HB3' ' HB3' ' G' ' 17' ' ' PRO . . . -65.47 103.74 0.88 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 120.806 0.336 . . . . 62.12 111.613 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -155.66 162.39 40.6 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 115.215 -0.902 . . . . 74.35 109.718 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 32.1 p -116.53 83.79 14.03 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 108.47 -0.937 . . . . 71.44 108.47 172.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -93.29 179.96 0.98 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.49 2.793 . . . . 73.11 113.628 -172.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 . . . . . 0 CA--C 1.551 1.002 0 C-N-CA 123.496 0.718 . . . . 71.2 109.945 176.962 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptm . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.148 -0.315 . . . . 72.32 110.148 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' H' H ' 2' ' ' LYS . . . . . 0.636 ' HE3' ' HA ' ' H' ' 5' ' ' THR . 58.0 tptt -73.93 94.33 2.31 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.121 0.569 . . . . 73.53 110.443 -176.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -113.94 -35.81 4.99 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.047 0.939 . . . . 75.42 109.518 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 16.6 m -82.27 69.07 8.93 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.429 0.692 . . . . 65.21 109.563 175.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 5' ' ' THR . . . . . 0.636 ' HA ' ' HE3' ' H' ' 2' ' ' LYS . 9.9 m -83.31 -23.27 32.65 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.463 -0.79 . . . . 75.32 110.094 176.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . . . . . . . . . 10.7 tp -152.19 137.56 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.018 -1.104 . . . . 74.3 108.018 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.84 144.2 18.91 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.439 0.296 . . . . 62.54 110.817 -176.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -89.85 170.1 10.69 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.272 0.629 . . . . 71.3 110.58 175.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 9' ' ' ALA . . . . . 0.577 ' H ' HD11 ' D' ' 44' ' ' LEU . . . -111.17 148.39 32.86 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.871 -1.059 . . . . 65.44 108.549 170.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 2.3 tt -66.87 147.5 53.16 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.162 -1.051 . . . . 70.41 108.162 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 75.7 mt -65.64 137.1 96.22 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-O 119.425 -0.321 . . . . 73.02 110.402 175.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.99 103.17 0.28 Allowed 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.785 2.324 . . . . 73.24 111.371 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 91.7 mt 67.99 -179.19 0.22 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.064 1.346 . . . . 74.51 111.503 -173.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.88 148.48 48.96 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.472 0.309 . . . . 75.32 110.426 174.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -72.61 149.41 43.96 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 109.049 -0.723 . . . . 74.12 109.049 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 40.7 p -57.54 116.71 14.85 Favored Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 124.755 1.222 . . . . 63.13 111.1 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -62.53 164.85 16.93 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.565 2.843 . . . . 72.12 115.095 -172.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . 0.583 HG21 HD11 ' D' ' 98' ' ' LEU . 12.1 t -81.23 1.75 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.63 0 C-N-CA 124.131 0.972 . . . . 73.43 110.669 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 6.6 m -54.48 -44.42 72.62 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.267 1.027 . . . . 71.43 113.517 -168.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -97.2 -19.31 18.7 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.621 0.368 . . . . 73.54 111.505 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.17 97.13 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.261 0.624 . . . . 75.44 109.703 176.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.08 107.13 8.09 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.361 -1.291 . . . . 74.11 107.763 176.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 23' ' ' THR . . . . . 0.415 ' HA ' ' HD3' ' H' ' 24' ' ' PRO . 5.7 t -157.86 140.52 10.61 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 123.064 0.545 . . . . 74.42 110.079 -174.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 24' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' H' ' 23' ' ' THR . 15.1 Cg_exo -71.48 -18.88 29.14 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 123.218 2.612 . . . . 61.23 113.36 176.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 CA--C 1.553 1.082 0 C-N-CA 124.543 1.137 . . . . 72.13 109.532 -172.075 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 110.384 -0.228 . . . . 73.53 110.384 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m -68.75 102.51 1.54 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.3 0.64 . . . . 74.01 111.443 -176.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -129.04 110.49 12.09 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.097 -1.075 . . . . 74.33 108.097 171.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -67.71 -22.33 65.26 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.814 0.846 . . . . 73.3 111.937 -176.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -65.11 102.06 0.59 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.882 0.473 . . . . 73.1 110.478 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -94.46 105.62 17.59 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.253 -1.017 . . . . 72.45 108.253 173.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.5 t -100.52 -13.96 18.43 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.201 0.6 . . . . 74.4 110.624 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -104.76 122.99 46.87 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.034 -0.728 . . . . 72.34 109.034 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.53 173.39 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 125.065 1.346 . . . . 71.42 112.29 178.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 49.7 p -137.3 108.5 6.81 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 106.481 -1.674 . . . . 74.33 106.481 171.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -131.48 123.76 28.75 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.172 -0.677 . . . . 63.44 109.172 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -153.29 130.96 11.53 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.47 -1.308 . . . . 73.15 107.47 169.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' C' ' 130' ' ' PRO . 14.5 mt -80.71 114.76 22.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.778 -0.823 . . . . 74.05 108.778 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -72.55 -39.34 67.55 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 123.891 0.745 . . . . 72.22 110.055 -177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -177.52 120.93 0.11 Allowed 'General case' 0 C--N 1.366 1.309 0 N-CA-C 111.74 0.274 . . . . 73.3 111.74 -172.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 78.6 mt -106.32 135.0 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.023 -0.732 . . . . 75.34 109.023 173.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.429 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 20.0 p90 -162.52 147.61 12.29 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 124.11 0.881 . . . . 74.23 109.968 -176.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.0 p -75.59 119.15 19.25 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.242 -0.651 . . . . 70.54 109.242 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.2 mtpt -83.22 -32.11 26.67 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.418 -0.586 . . . . 73.53 109.418 176.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 25.0 t70 -144.23 139.54 28.74 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.207 -0.906 . . . . 65.45 110.354 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.6 mt -133.22 145.61 33.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.941 1.296 . . . . 74.15 108.182 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.565 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 48.1 t -149.73 124.83 10.04 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.458 -0.792 . . . . 72.23 109.295 173.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 86.4 t80 -129.49 111.28 12.6 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 106.62 -1.622 . . . . 71.23 106.62 169.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -121.51 110.41 16.0 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.513 -0.551 . . . . 73.51 109.513 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.32 84.26 0.87 Allowed Pre-proline 0 C--O 1.241 0.654 0 N-CA-C 107.156 -1.424 . . . . 70.2 107.156 168.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.34 -19.3 29.17 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.161 1.908 . . . . 73.24 112.589 -168.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -120.26 22.76 11.24 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.933 0.893 . . . . 74.22 109.77 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.453 ' O ' HG11 ' A' ' 31' ' ' VAL . . . -45.38 -55.04 12.78 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 113.969 1.1 . . . . 72.14 113.969 -170.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.98 -16.95 57.93 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 121.989 1.792 . . . . 74.13 114.119 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -100.94 -26.01 13.88 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.305 1.042 . . . . 73.31 110.933 -176.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.674 HG22 ' HA ' ' A' ' 73' ' ' ALA . 4.5 p -80.78 -25.18 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 115.839 -0.619 . . . . 72.44 112.584 -166.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -71.08 -26.76 63.2 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.882 0.473 . . . . 72.32 110.779 -175.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -85.28 -13.77 48.7 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.534 0.733 . . . . 75.11 111.527 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.496 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 2.0 tmtp? -81.63 132.84 35.31 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.387 -0.968 . . . . 72.31 108.387 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.496 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 12.5 m-20 -52.51 132.35 35.05 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.663 1.185 . . . . 52.43 112.314 178.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.41 ' CE3' HD21 ' A' ' 68' ' ' LEU . 55.3 t-105 -78.57 89.17 4.5 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.374 0.607 . . . . 73.02 110.334 -175.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.459 ' H ' HD23 ' A' ' 68' ' ' LEU . 35.9 tt0 -120.21 78.49 26.18 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.905 1.282 . . . . 74.52 108.465 171.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.6 111.7 2.84 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.307 2.005 . . . . 71.23 113.239 -171.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -95.86 99.11 10.95 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 107.5 -1.296 . . . . 74.1 107.5 173.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.434 HG11 HG13 ' A' ' 64' ' ' VAL . 57.7 t -90.64 100.21 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 123.57 0.748 . . . . 73.31 110.5 -169.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -84.53 114.77 22.2 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.621 0.768 . . . . 74.1 109.754 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mp -104.67 108.35 19.76 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.918 -0.771 . . . . 73.32 108.918 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.54 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 10.7 t70 -102.35 124.49 48.02 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.949 1.3 . . . . 63.32 108.04 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.788 HD21 HD11 ' E' ' 8' ' ' LEU . 6.8 mp -111.77 125.81 54.4 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.901 0.382 . . . . 75.03 110.533 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.452 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 4.2 t70 -119.32 136.17 54.37 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.577 1.151 . . . . 71.04 108.716 175.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 46.9 p -107.75 136.44 47.48 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.243 0.617 . . . . 71.05 110.43 -174.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.617 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . . . -139.13 137.09 35.81 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.575 0.75 . . . . 63.24 109.454 177.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.4 p -133.62 152.8 51.97 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.516 0.726 . . . . 74.45 110.381 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.9 t -161.07 127.38 3.93 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.049 0.54 . . . . 65.32 110.014 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -88.13 105.27 17.4 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.25 -1.019 . . . . 75.42 108.25 171.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.4 mt -79.33 -36.41 39.53 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.039 0.535 . . . . 73.51 111.541 -171.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.05 -174.13 3.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.475 0.71 . . . . 70.13 110.297 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -67.55 118.84 11.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.109 0.564 . . . . 74.31 109.534 171.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 67.69 13.16 9.17 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.819 1.248 . . . . 64.03 111.825 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.25 109.48 24.37 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 N-CA-C 107.864 -1.162 . . . . 72.34 107.864 175.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -129.58 155.49 45.72 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.272 -1.01 . . . . 74.43 108.272 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -129.6 124.59 34.15 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.089 0.556 . . . . 72.45 110.864 -174.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.415 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 85.3 t -109.07 113.42 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.317 -1.364 . . . . 74.21 107.317 166.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.617 ' HB ' ' HB2' ' A' ' 47' ' ' ALA . 40.3 t -103.55 135.05 42.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.554 -0.906 . . . . 74.54 108.554 171.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.426 HD21 HD22 ' A' ' 44' ' ' LEU . 2.6 tt -129.0 119.12 23.72 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.385 -0.598 . . . . 74.21 109.385 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.452 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 12.1 ttm180 -84.84 110.33 18.75 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.251 1.02 . . . . 74.55 109.63 175.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.8 t -100.47 101.33 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 107.719 -1.215 . . . . 65.31 107.719 170.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 20.9 m -99.46 104.23 16.05 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.686 0.794 . . . . 75.45 109.029 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.589 HG12 HD23 ' A' ' 126' ' ' LEU . 14.1 t -104.9 119.63 54.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 123.754 0.822 . . . . 72.13 109.966 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.5 m -112.29 123.88 51.24 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.586 -0.894 . . . . 73.33 108.586 177.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.51 110.5 22.46 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 106.603 -1.629 . . . . 74.31 106.603 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.8 m -109.87 124.9 52.15 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.195 -0.669 . . . . 63.2 109.195 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.459 HD23 ' H ' ' A' ' 37' ' ' GLN . 40.2 mt -88.99 75.76 7.94 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.193 -1.41 . . . . 72.12 107.193 176.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.49 -88.75 0.72 Allowed Glycine 0 C--N 1.345 1.043 0 CA-C-N 114.949 -1.023 . . . . 60.13 110.991 -173.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -120.85 -4.93 9.65 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.501 0.721 . . . . 72.24 111.499 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -101.9 103.6 14.28 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.652 -0.499 . . . . 74.13 109.652 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.0 m -60.52 121.15 11.41 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.139 0.495 . . . . 75.42 110.976 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.674 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -69.55 -58.29 4.13 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.959 -1.019 . . . . 53.0 109.999 175.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -158.65 174.6 14.8 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.353 -1.294 . . . . 72.42 111.16 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.9 tp -132.11 142.6 49.56 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 113.778 -1.556 . . . . 72.24 107.636 173.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 75.1 m -142.7 94.96 2.71 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.293 0.637 . . . . 73.24 109.546 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 39.0 tt0 -115.07 115.62 27.11 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.549 -0.908 . . . . 74.33 108.549 -175.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.73 109.12 18.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.781 -0.822 . . . . 74.44 108.781 -175.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.425 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 76.0 mt-30 -85.58 84.09 7.71 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.117 -1.068 . . . . 73.13 108.117 173.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.409 ' HG3' HD23 ' A' ' 106' ' ' LEU . 7.2 tp-100 -76.48 99.4 4.9 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.508 -1.224 . . . . 75.33 108.949 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.99 144.82 22.11 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 110.298 -1.121 . . . . 75.35 110.298 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.465 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -144.78 120.92 1.47 Allowed Glycine 0 CA--C 1.5 -0.865 0 N-CA-C 110.382 -1.087 . . . . 63.43 110.382 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.0 mt -88.84 123.24 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 108.529 -0.915 . . . . 75.3 108.529 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.415 ' HE1' ' HB ' ' A' ' 58' ' ' VAL . 90.1 m-85 -121.44 119.87 33.32 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.49 -1.3 . . . . 73.15 107.49 -177.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.7 m -84.78 88.5 7.39 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.199 0.6 . . . . 64.44 109.504 173.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.18 141.4 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 115.581 -0.736 . . . . 73.31 110.04 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.23 23.81 0.07 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.554 0.742 . . . . 70.33 110.663 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.77 -71.34 0.93 Allowed Glycine 0 C--N 1.348 1.228 0 CA-C-N 116.193 -0.458 . . . . 74.2 112.262 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.441 ' O ' ' HE2' ' A' ' 94' ' ' MET . 1.5 pp -158.94 173.4 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.501 1.12 . . . . 70.44 111.02 -177.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.448 ' HG3' ' H ' ' A' ' 91' ' ' GLY . 6.3 tp10 -114.66 -159.14 0.69 Allowed 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 125.982 1.713 . . . . 65.34 106.74 -175.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.448 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . 75.68 -141.96 28.2 Favored Glycine 0 N--CA 1.468 0.831 0 CA-C-O 119.575 -0.569 . . . . 72.13 112.697 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.9 p -58.35 -42.9 87.95 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.525 0.73 . . . . 74.43 112.761 -174.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -73.1 -43.84 61.2 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 118.887 -0.577 . . . . 75.14 112.383 -172.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.566 ' SD ' ' HB ' ' E' ' 18' ' ' VAL . 58.0 ttm -67.13 -38.82 86.21 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 118.899 0.772 . . . . 75.15 110.809 174.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.42 -31.08 72.14 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 122.853 0.461 . . . . 70.2 111.308 175.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -72.24 -36.58 69.13 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.234 1.014 . . . . 70.12 110.704 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 81.9 m -66.39 -60.99 2.24 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.768 -0.456 . . . . 72.22 109.768 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.668 HD13 HG21 ' E' ' 18' ' ' VAL . 69.5 mt -60.24 -40.32 89.84 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.241 1.016 . . . . 65.12 112.061 -177.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.66 -28.13 30.32 Favored Glycine 0 C--N 1.342 0.866 0 O-C-N 123.753 0.658 . . . . 71.42 114.128 -172.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.71 -59.71 1.2 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.982 0.734 . . . . 73.32 112.982 -171.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -73.55 -56.83 4.51 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.597 0.359 . . . . 73.55 111.86 -166.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 66.6 m -55.33 -41.09 88.92 Favored Pre-proline 0 CA--C 1.571 1.785 0 CA-C-O 118.308 -0.853 . . . . 73.33 112.855 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -49.33 -51.39 10.76 Favored 'Trans proline' 0 C--N 1.399 3.224 0 C-N-CA 122.728 2.286 . . . . 73.01 113.207 164.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.441 HD22 ' N ' ' A' ' 133' ' ' PHE . 95.0 m-20 -71.98 -15.4 62.06 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.748 0.819 . . . . 74.43 112.445 -177.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.447 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 30.3 mm -80.72 -45.1 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.259 0.623 . . . . 75.23 109.494 172.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.465 HD21 ' HA3' ' A' ' 82' ' ' GLY . 90.0 mt -74.66 -22.98 58.59 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.06 -0.518 . . . . 74.02 111.053 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -61.96 -46.0 91.96 Favored Pre-proline 0 CA--C 1.559 1.319 0 CA-C-O 117.499 -1.238 . . . . 73.52 113.002 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.447 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 34.5 Cg_exo -60.35 -35.37 91.48 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 121.837 1.692 . . . . 71.34 113.926 174.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.439 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 88.3 m-85 -78.34 -35.82 47.07 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 122.899 0.479 . . . . 71.12 111.093 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.57 -37.91 68.07 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.2 0.6 . . . . 74.04 109.76 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.474 ' NH1' HG23 ' C' ' 105' ' ' ILE . 26.3 ttm180 -63.51 -39.95 95.77 Favored 'General case' 0 C--O 1.209 -1.05 0 C-N-CA 124.061 0.945 . . . . 73.42 109.309 173.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -63.39 -48.3 78.42 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.992 0.917 . . . . 73.11 111.038 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 32.9 t -60.58 -41.32 94.44 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 124.385 1.053 . . . . 74.43 110.04 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 69.1 mt -65.25 -46.77 89.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 123.579 0.752 . . . . 75.03 110.83 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 55.3 m -59.44 -39.22 82.86 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.449 1.1 . . . . 75.41 110.424 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.8 t -75.03 -47.19 30.23 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.893 -1.049 . . . . 74.4 110.476 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.458 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 13.7 mtp -57.44 -45.15 85.02 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.606 0.763 . . . . 75.45 111.948 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.2 t -63.61 -43.66 98.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 124.468 1.107 . . . . 74.43 110.878 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.0 t -70.83 -31.65 68.44 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.215 0.606 . . . . 72.52 111.463 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -73.8 -30.14 62.56 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.287 0.635 . . . . 74.24 109.726 176.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.38 -0.52 78.68 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.286 -0.87 . . . . 63.33 113.41 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.465 HG22 HH21 ' B' ' 15' ' ' ARG . 17.2 m 73.42 15.59 4.2 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-O 122.574 1.178 . . . . 71.4 111.425 173.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -86.27 154.82 57.4 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-N 115.588 -0.733 . . . . 71.0 110.221 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.25 129.7 34.79 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.772 2.315 . . . . 75.12 111.851 171.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -51.76 129.56 26.62 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 124.289 0.993 . . . . 75.53 112.268 -172.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.589 HD23 HG12 ' A' ' 64' ' ' VAL . 56.1 tp -109.47 97.99 7.46 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.229 -0.896 . . . . 55.14 110.177 -174.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -103.28 112.28 25.07 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.432 0.693 . . . . 72.43 109.401 174.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.0 mp -72.43 117.73 14.45 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.103 -1.073 . . . . 72.15 108.103 172.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.511 ' HB3' ' HB2' ' E' ' 7' ' ' ALA . . . -62.24 145.02 94.36 Favored Pre-proline 0 CA--C 1.56 1.354 0 CA-C-N 117.925 0.33 . . . . 73.1 110.716 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.514 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 13.7 Cg_exo -69.44 110.67 2.54 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.743 2.296 . . . . 73.54 112.084 -170.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' E' ' 8' ' ' LEU . 15.2 m -99.49 115.25 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 108.676 -0.861 . . . . 64.34 108.676 175.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -90.75 98.81 12.0 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.643 -0.873 . . . . 71.11 108.643 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.441 ' N ' HD22 ' A' ' 104' ' ' ASN . 72.7 m-85 -55.58 -34.56 64.92 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 123.445 0.465 . . . . 74.53 110.278 170.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.36 -51.55 19.24 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.864 0.866 . . . . 73.31 111.957 170.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.51 -50.08 74.22 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.315 0.646 . . . . 70.01 111.768 -173.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.08 -40.95 74.7 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.798 0.439 . . . . 72.31 110.932 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -74.96 -27.64 60.26 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.128 0.571 . . . . 74.44 111.533 -174.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.406 ' HE1' ' HA ' ' A' ' 138' ' ' MET . 30.1 mmt -79.91 -37.03 35.53 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.542 0.337 . . . . 73.05 110.186 177.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -59.92 -41.69 92.31 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 123.713 0.633 . . . . 73.25 110.356 173.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -65.15 -47.12 78.16 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.722 -0.672 . . . . 74.32 110.926 173.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.425 HD21 ' HG3' ' C' ' 144' ' ' GLN . 26.3 tp -58.04 -43.2 86.68 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.001 0.813 . . . . 75.13 111.566 -170.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.63 ' HB3' HE22 ' C' ' 144' ' ' GLN . 33.0 tt0 -173.93 -17.72 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 O-C-N 123.859 0.724 . . . . 75.1 111.304 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 14.5 tm0? 67.15 122.42 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.956 1.702 . . . . 74.04 110.554 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -106.63 138.54 42.61 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.226 0.61 . . . . 73.43 110.009 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -148.22 133.83 18.79 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.381 0.672 . . . . 74.1 109.794 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.93 -163.34 9.69 Favored Glycine 0 C--N 1.349 1.266 0 O-C-N 123.445 0.466 . . . . 72.04 112.226 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -71.24 141.17 50.6 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.738 0.415 . . . . 73.03 111.292 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -96.75 -174.19 35.05 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.369 -0.693 . . . . 72.31 111.369 171.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.718 HG22 ' HA3' ' C' ' 91' ' ' GLY . 6.1 m -99.81 127.55 45.96 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.681 -0.488 . . . . 71.3 109.681 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -97.58 149.83 21.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.936 0.494 . . . . 74.54 110.261 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.573 ' HG2' HG22 ' G' ' 23' ' ' THR . 0.3 OUTLIER -138.45 168.74 19.12 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 107.738 -1.208 . . . . 74.53 107.738 176.066 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.401 ' HE1' ' HG2' ' G' ' 24' ' ' PRO . 54.1 m80 -62.5 89.65 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.845 0.858 . . . . 72.42 109.658 172.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -90.62 136.73 32.87 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.188 0.995 . . . . 73.31 109.776 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -98.37 143.98 28.25 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.391 -0.596 . . . . 74.4 109.391 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 C-N-CA 123.895 0.878 . . . . 75.25 109.109 -178.647 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.896 0.379 . . . . 75.34 110.936 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 27.1 p -111.06 128.15 55.78 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.391 -0.966 . . . . 73.3 108.391 169.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -74.45 91.59 2.27 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.58 0.705 . . . . 74.41 110.129 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -90.28 109.7 20.78 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.785 -1.098 . . . . 73.21 109.774 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -68.47 -39.13 81.51 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.423 0.63 . . . . 75.51 109.328 170.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -127.08 120.96 30.19 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.92 -1.511 . . . . 74.12 106.92 169.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 58.0 p -78.35 -29.0 47.27 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.546 0.738 . . . . 73.41 111.494 -174.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 69.07 -2.31 1.83 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.989 1.316 . . . . 73.23 112.984 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.418 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 26.2 ttt 64.07 168.18 0.16 Allowed 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 125.25 1.42 . . . . 74.11 111.942 -170.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m -143.35 133.57 24.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.446 -1.316 . . . . 75.11 107.446 166.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -141.22 137.67 32.75 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.396 -0.594 . . . . 74.44 109.396 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.465 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -158.75 129.0 5.92 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.026 0.93 . . . . 75.41 108.753 173.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.459 HD11 HD12 ' B' ' 105' ' ' ILE . 15.8 mt -75.05 119.06 21.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.629 0 N-CA-C 108.001 -1.111 . . . . 75.33 108.001 169.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -96.3 -42.58 8.09 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 123.537 0.523 . . . . 64.03 110.199 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.465 HH21 HG22 ' A' ' 122' ' ' THR . 23.0 ttt85 -165.64 133.13 2.91 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.9 -0.591 . . . . 74.02 109.739 -175.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 71.8 mt -116.66 143.05 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 107.622 -1.251 . . . . 74.3 107.622 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -166.91 155.68 10.28 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.528 0.68 . . . . 75.35 112.129 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 89.1 m -84.27 120.46 26.26 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.771 -1.104 . . . . 52.41 108.361 170.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.516 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 33.1 mtpt -87.83 -33.74 18.48 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.031 0.532 . . . . 74.11 110.383 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 19.7 t70 -157.62 144.49 18.11 Favored 'General case' 0 C--N 1.347 0.48 0 N-CA-C 112.707 0.632 . . . . 73.4 112.707 -170.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.697 HD12 ' SG ' ' B' ' 113' ' ' CYS . 45.3 mm -137.51 142.14 37.55 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 C-N-CA 125.648 1.579 . . . . 73.11 108.472 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.3 t -147.21 127.22 13.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.924 -1.139 . . . . 63.44 107.924 173.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 90.7 t80 -139.57 110.91 7.02 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.435 -0.95 . . . . 75.32 108.435 175.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -118.04 115.44 24.87 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.351 1.061 . . . . 73.54 108.534 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.7 87.91 3.13 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.032 -1.099 . . . . 54.02 108.032 174.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.54 -44.52 4.41 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.649 2.232 . . . . 65.42 112.562 -170.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -97.29 16.48 19.83 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.936 0.894 . . . . 74.34 110.666 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -38.31 -59.92 1.15 Allowed Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 115.303 1.594 . . . . 75.24 115.303 -168.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -66.61 -26.44 46.45 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 122.039 1.826 . . . . 72.32 112.89 -170.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -93.96 -41.21 9.71 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 115.022 -0.99 . . . . 72.41 111.176 -172.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.491 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.6 p -71.18 -12.47 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.344 0.658 . . . . 61.01 111.837 -170.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -66.25 -12.56 57.01 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.584 0.754 . . . . 73.32 112.716 174.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -65.21 -16.41 63.5 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.321 0.648 . . . . 73.01 111.427 174.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.604 ' HZ1' ' HG2' ' B' ' 71' ' ' GLU . 95.0 mttt -107.53 111.62 23.98 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.023 1.329 . . . . 72.0 111.09 -176.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -107.53 95.16 5.5 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.309 0.644 . . . . 72.34 110.935 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 39.3 p90 -169.27 175.45 5.61 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.7 1.2 . . . . 70.11 108.78 167.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -73.79 107.89 4.11 Favored Pre-proline 0 CA--C 1.555 1.142 0 N-CA-C 109.891 -0.411 . . . . 74.31 109.891 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.494 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 30.5 Cg_endo -64.71 149.73 89.27 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.663 2.242 . . . . 74.41 113.565 -173.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.624 ' HA ' HG22 ' F' ' 5' ' ' THR . 32.7 tt0 -63.09 114.87 3.99 Favored 'General case' 0 C--N 1.359 1.006 0 O-C-N 124.087 0.867 . . . . 75.3 110.052 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.42 HG23 HD22 ' B' ' 126' ' ' LEU . 88.3 t -92.57 144.09 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 123.983 0.913 . . . . 72.21 111.29 -172.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.504 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 23.6 ttpp -128.82 116.43 19.44 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.845 -1.539 . . . . 74.31 106.845 168.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.615 HD11 ' HA ' ' F' ' 8' ' ' LEU . 1.6 pt? -84.11 149.07 26.45 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.146 -0.687 . . . . 75.25 109.146 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.753 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 6.9 m-20 -139.52 110.0 6.62 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.16 -1.422 . . . . 74.21 107.16 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 84.0 mt -104.46 127.12 52.09 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.502 -0.925 . . . . 74.54 108.502 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 14.5 t70 -133.11 143.92 49.61 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.801 0.84 . . . . 64.2 109.409 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 81.3 p -109.98 126.17 53.65 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.755 0.822 . . . . 74.4 110.246 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.06 148.91 52.2 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.837 0.855 . . . . 73.33 109.355 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.9 p -144.48 164.39 31.0 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.703 0.631 . . . . 75.3 112.703 -174.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 69.7 p -155.13 146.74 23.17 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.152 -0.931 . . . . 73.51 109.552 166.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -97.62 128.89 44.67 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.95 -0.759 . . . . 74.53 108.95 174.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.429 HD12 HG22 ' B' ' 83' ' ' ILE . 41.9 mt -97.58 -54.15 3.21 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.315 0.578 . . . . 74.2 110.238 -177.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.38 -168.15 2.98 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.065 -0.971 . . . . 72.32 110.051 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -67.43 103.23 1.26 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.651 -1.158 . . . . 74.44 110.602 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 67.12 15.23 10.03 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.136 1.375 . . . . 64.33 112.414 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.449 HG22 ' HG ' ' B' ' 85' ' ' SER . 68.0 t -105.74 105.71 19.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 107.52 -1.289 . . . . 73.24 107.52 172.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.565 ' HB2' HD12 ' B' ' 86' ' ' ILE . 6.1 t80 -110.53 165.87 11.46 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.339 -0.846 . . . . 72.32 109.003 -172.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -136.23 114.08 11.21 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.966 -1.124 . . . . 72.03 107.966 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 95.8 t -104.09 118.43 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.829 1.252 . . . . 75.53 110.443 -171.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 13.3 t -109.76 122.55 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 109.496 -0.557 . . . . 75.43 109.496 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.523 HD22 ' HB2' ' B' ' 103' ' ' PRO . 51.8 tp -106.3 110.28 22.46 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.76 -0.83 . . . . 74.11 108.76 170.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.511 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 22.1 ttm-85 -85.94 109.38 18.71 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.223 -0.658 . . . . 74.15 109.223 173.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 30.7 t -106.26 101.86 13.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 108.143 -1.058 . . . . 75.31 108.143 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.753 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 10.4 m -102.32 128.76 48.74 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.747 -0.834 . . . . 62.04 108.747 175.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 61.3 t -119.91 108.16 22.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 123.85 0.86 . . . . 74.34 109.289 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 96.4 m -82.34 144.66 30.42 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.409 -0.96 . . . . 74.1 108.409 169.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.15 144.56 29.08 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 122.952 0.501 . . . . 73.04 109.928 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 36.1 p -147.65 127.13 13.19 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.501 0.501 . . . . 74.32 111.127 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 72.7 mt -94.66 110.16 22.02 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.234 -1.025 . . . . 70.23 108.234 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.41 -112.86 3.67 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 115.477 -0.783 . . . . 62.45 111.771 -176.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -120.96 9.46 10.61 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.435 0.694 . . . . 74.3 110.421 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.604 ' HG2' ' HZ1' ' B' ' 34' ' ' LYS . 11.9 pt-20 -123.19 155.15 37.65 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.47 0.708 . . . . 63.42 109.66 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 29.6 m -68.98 133.71 48.53 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.961 0.41 . . . . 63.45 109.984 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -87.98 -63.58 1.28 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.713 -1.217 . . . . 73.24 107.713 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -150.8 161.31 42.91 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.439 -1.255 . . . . 72.43 110.857 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 85.7 mt -125.73 113.28 17.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.564 -2.013 . . . . 75.33 105.564 172.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.8 t -116.66 151.37 36.45 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.5 -0.926 . . . . 72.3 108.5 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.401 ' HB2' HG22 ' B' ' 63' ' ' THR . 42.8 tt0 -161.14 133.18 5.82 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.055 0.455 . . . . 70.34 109.812 -175.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.49 HG11 ' HA ' ' B' ' 110' ' ' ALA . 93.3 t -134.12 149.0 29.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 124.697 1.199 . . . . 75.11 108.261 176.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.413 HE21 ' HB3' ' B' ' 20' ' ' ASP . 25.6 mt-30 -125.25 107.01 10.3 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.121 -1.066 . . . . 74.33 108.121 169.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -96.5 101.22 12.81 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.656 -0.868 . . . . 74.11 108.656 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.516 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -95.09 144.39 17.17 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.366 -0.834 . . . . 63.52 111.275 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.59 126.84 3.13 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.427 -0.669 . . . . 74.13 111.427 -176.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.429 HG22 HD12 ' B' ' 51' ' ' LEU . 70.2 mt -83.96 127.43 39.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.795 -0.817 . . . . 74.21 108.795 174.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -137.85 135.77 36.51 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.936 -0.764 . . . . 75.14 108.936 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.449 ' HG ' HG22 ' B' ' 55' ' ' VAL . 66.8 m -89.24 98.32 11.7 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.693 -0.855 . . . . 72.3 108.693 172.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.565 HD12 ' HB2' ' B' ' 56' ' ' TYR . 1.7 pp -111.48 129.53 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.93 0.892 . . . . 71.21 110.702 -175.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.65 167.31 22.86 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.153 0.581 . . . . 73.41 109.815 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 88.28 -59.42 4.14 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 114.017 0.367 . . . . 42.42 114.017 172.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 15.4 mm -78.85 138.21 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 123.632 0.773 . . . . 74.12 110.067 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -157.24 174.65 15.14 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 115.846 -0.615 . . . . 65.13 111.928 -163.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.11 -127.83 44.82 Favored Glycine 0 C--N 1.354 1.562 0 C-N-CA 123.418 0.532 . . . . 34.42 113.78 -177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 51.8 m -66.29 -30.87 71.37 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.983 0.913 . . . . 74.03 110.94 175.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -65.79 -45.3 82.94 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.707 -0.679 . . . . 71.13 110.544 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.426 ' HE1' ' HB3' ' F' ' 17' ' ' PRO . 22.5 ptt? -71.17 -24.83 62.32 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.534 0.334 . . . . 73.33 111.425 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.82 -45.15 95.08 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 123.664 0.603 . . . . 55.32 109.875 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -64.66 -40.77 96.0 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.233 0.613 . . . . 73.14 111.307 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.4 t -62.14 -44.57 96.32 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.766 0.427 . . . . 71.15 111.648 -176.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.422 ' HB3' ' CD2' ' F' ' 15' ' ' PHE . 9.2 mp -92.75 -16.86 24.91 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.046 0.539 . . . . 73.34 111.708 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.11 2.87 47.61 Favored Glycine 0 N--CA 1.474 1.211 0 CA-C-O 120.052 -0.304 . . . . 64.32 113.643 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.07 -57.36 0.34 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.22 0.608 . . . . 74.01 110.57 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -74.02 -51.81 14.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.997 0.519 . . . . 75.44 112.293 -171.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 72.0 m -60.8 -49.23 90.35 Favored Pre-proline 0 CA--C 1.565 1.536 0 CA-C-O 118.59 -0.719 . . . . 73.14 112.44 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.523 ' HB2' HD22 ' B' ' 60' ' ' LEU . 71.5 Cg_endo -71.56 -16.7 30.41 Favored 'Trans proline' 0 C--N 1.393 2.87 0 C-N-CA 122.08 1.853 . . . . 75.22 113.319 176.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -65.64 -41.21 92.89 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 123.469 0.708 . . . . 63.22 109.594 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.459 HD12 HD11 ' B' ' 13' ' ' ILE . 73.7 mt -60.54 -45.36 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.538 1.135 . . . . 74.53 110.741 175.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 49.5 mt -84.01 -13.22 53.81 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.224 -1.353 . . . . 74.34 111.612 -170.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -57.24 -55.74 41.13 Favored Pre-proline 0 CA--C 1.561 1.366 0 CA-C-O 117.946 -1.026 . . . . 72.31 113.549 -176.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -64.85 -27.1 59.26 Favored 'Trans proline' 0 C--N 1.383 2.368 0 CA-C-N 121.338 1.514 . . . . 73.42 113.186 -174.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -68.69 -48.45 63.85 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.839 0.456 . . . . 74.52 109.888 176.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.49 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -60.09 -40.59 90.12 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.449 -0.796 . . . . 65.31 110.745 176.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 45.2 ttt-85 -62.45 -49.03 77.04 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.757 1.223 . . . . 72.32 111.376 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -65.88 -36.85 84.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 123.711 0.632 . . . . 75.54 109.791 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.697 ' SG ' HD12 ' B' ' 21' ' ' ILE . 5.5 t -70.96 -33.8 70.82 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.892 -0.595 . . . . 63.5 111.369 -178.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.479 ' O ' HG23 ' B' ' 118' ' ' VAL . 55.6 mt -64.48 -54.64 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 109.17 -0.678 . . . . 73.51 109.17 173.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 4.3 m -63.72 -23.41 67.36 Favored 'General case' 0 CA--C 1.555 1.168 0 O-C-N 123.85 0.719 . . . . 72.34 111.353 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.0 t -67.25 -49.02 66.0 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 123.075 0.55 . . . . 73.23 109.812 172.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.4 mmt -68.68 -31.83 71.22 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.804 0.442 . . . . 73.22 111.042 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.479 HG23 ' O ' ' B' ' 114' ' ' ILE . 90.9 t -64.17 -42.67 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.837 0.855 . . . . 72.35 109.962 172.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.6 t -67.18 -31.39 71.75 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.924 -1.034 . . . . 72.41 111.336 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' B' ' 116' ' ' SER . 81.7 mtt-85 -73.45 -38.11 65.6 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.26 0.624 . . . . 63.43 110.061 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.95 -3.94 75.98 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 123.729 0.643 . . . . 75.13 112.609 169.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 34.3 p 63.46 24.08 13.96 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 126.426 1.89 . . . . 72.24 113.129 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -77.77 160.58 74.05 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 124.533 1.133 . . . . 75.14 111.36 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -51.95 162.29 1.92 Allowed 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 123.677 2.918 . . . . 74.44 115.049 173.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.606 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 56.3 tp60 -60.24 128.81 38.6 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.287 1.035 . . . . 75.03 111.574 -173.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.42 HD22 HG23 ' B' ' 40' ' ' VAL . 1.4 tm? -146.4 99.79 3.27 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.647 -0.871 . . . . 74.34 108.647 -174.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -131.53 132.2 43.98 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.722 0.809 . . . . 72.35 109.505 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.591 HD22 HD11 ' F' ' 6' ' ' ILE . 96.1 mt -70.98 150.41 45.69 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.332 0.653 . . . . 74.34 112.383 -175.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.0 153.19 69.47 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 124.114 0.966 . . . . 71.33 111.702 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.416 ' HB2' HD13 ' D' ' 13' ' ' ILE . 57.8 Cg_endo -68.03 116.72 4.47 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.112 2.541 . . . . 74.14 112.406 176.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.601 HG21 ' HB2' ' F' ' 8' ' ' LEU . 72.3 t -127.79 111.44 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.89 -0.781 . . . . 73.55 108.89 173.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -80.27 94.27 6.06 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 107.688 -1.227 . . . . 74.42 107.688 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -56.69 -41.55 77.53 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.136 0.974 . . . . 63.31 111.487 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -64.09 -46.13 85.62 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.324 1.049 . . . . 74.03 112.034 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.68 -27.22 67.48 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.805 0.69 . . . . 62.12 112.2 -175.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 88.2 mt -60.44 -46.51 89.77 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.246 0.618 . . . . 71.2 110.636 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -80.47 -27.39 37.87 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.367 -0.833 . . . . 74.54 111.077 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 25.9 ttt -70.8 -39.47 73.08 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.085 0.554 . . . . 74.23 111.206 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -75.49 -17.25 60.17 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.937 0.495 . . . . 54.41 110.874 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -72.39 -40.08 67.51 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.769 -0.456 . . . . 74.41 109.769 172.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 51.2 mt -86.42 -8.1 57.9 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.799 -0.637 . . . . 73.31 111.275 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -109.11 147.41 32.48 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.787 0.835 . . . . 75.04 109.68 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -142.4 147.52 36.33 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.847 0.859 . . . . 74.24 109.554 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -170.8 152.85 3.79 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.025 0.93 . . . . 73.21 109.844 174.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -164.18 -164.87 0.9 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.325 1.05 . . . . 70.42 109.314 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 126.44 129.05 3.24 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 112.328 -0.309 . . . . 42.23 112.328 173.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -150.35 100.54 2.89 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 107.792 -1.188 . . . . 75.42 107.792 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -69.48 82.15 0.28 Allowed Glycine 0 C--N 1.348 1.22 0 N-CA-C 111.0 -0.84 . . . . 75.05 111.0 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 16.0 p -65.76 88.2 0.1 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.921 0.888 . . . . 71.03 110.738 -177.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.01 137.97 39.31 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.504 -1.225 . . . . 74.43 110.352 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -131.08 146.64 52.44 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.434 -0.95 . . . . 75.4 108.434 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -134.81 118.87 17.48 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.057 -0.519 . . . . 73.14 109.991 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -144.52 134.5 23.95 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.013 0.925 . . . . 73.35 109.111 175.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -165.54 153.32 10.92 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.741 0.816 . . . . 70.54 109.317 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.777 0 N-CA-C 108.583 -0.895 . . . . 63.3 108.583 175.02 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.435 ' SD ' ' N ' ' C' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 108.667 -0.864 . . . . 74.21 108.667 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 31.0 m 66.83 169.4 0.24 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.06 1.344 . . . . 73.14 112.189 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -80.13 -43.42 21.69 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.988 -0.745 . . . . 74.14 108.988 170.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -76.83 91.34 3.52 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.296 -0.865 . . . . 71.45 109.49 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -71.16 -54.36 11.28 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.184 -1.043 . . . . 74.02 108.184 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -170.58 133.78 1.04 Allowed 'General case' 0 C--N 1.351 0.659 0 CA-C-N 115.114 -0.948 . . . . 75.41 109.637 167.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 44.1 m -88.79 -52.39 5.15 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 107.351 -1.352 . . . . 73.45 107.351 167.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -137.4 147.22 45.28 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.446 -1.252 . . . . 73.54 108.288 167.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.595 ' HE2' HG22 ' C' ' 86' ' ' ILE . 13.4 tpt 65.61 122.97 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.149 1.38 . . . . 71.12 113.064 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 20.2 m -111.51 99.68 8.4 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.237 -1.023 . . . . 72.11 108.237 173.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.447 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 42.0 t80 -111.62 140.04 46.56 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.011 0.524 . . . . 75.42 109.691 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -159.72 134.31 7.77 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.082 0.953 . . . . 75.22 108.581 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.46 HG13 ' HD3' ' A' ' 130' ' ' PRO . 74.9 mt -72.8 120.46 21.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.492 -0.929 . . . . 74.22 108.492 168.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -89.86 -45.48 9.22 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.698 -0.683 . . . . 75.11 109.36 175.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -176.47 141.31 0.4 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.005 -0.998 . . . . 73.11 108.481 -168.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.475 HG21 ' CD1' ' C' ' 109' ' ' TYR . 56.0 mt -137.01 144.96 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 108.993 -0.743 . . . . 74.44 108.993 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.463 ' HH ' HD11 ' C' ' 83' ' ' ILE . 22.3 p90 -174.89 159.94 2.79 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.576 0.703 . . . . 74.33 110.077 -173.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -78.91 119.36 21.97 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.911 -1.04 . . . . 74.41 108.988 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.409 ' HZ3' ' CD ' ' C' ' 57' ' ' GLU . 19.6 mmtp -69.44 -46.43 66.77 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 107.133 -1.432 . . . . 70.22 107.133 168.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.575 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.2 t70 -135.04 143.05 46.52 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 113.016 -1.902 . . . . 53.12 109.748 -171.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 70.4 mt -136.8 150.44 26.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 105.928 -1.878 . . . . 73.4 105.928 170.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -163.86 151.16 12.24 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.333 0.587 . . . . 72.03 110.012 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -146.21 124.45 12.23 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.183 -1.414 . . . . 72.31 107.183 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -126.98 110.43 12.97 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.086 -0.709 . . . . 72.43 109.086 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.38 84.65 29.39 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 107.292 -1.373 . . . . 74.41 107.292 167.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.41 -37.03 24.73 Favored 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 122.331 2.02 . . . . 72.24 111.011 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -95.83 22.69 7.03 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.044 -0.98 . . . . 71.03 110.64 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.416 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -48.71 -54.45 27.1 Favored Pre-proline 0 CA--C 1.564 1.518 0 N-CA-C 114.127 1.158 . . . . 64.51 114.127 -172.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.54 -40.48 47.04 Favored 'Trans proline' 0 C--N 1.39 2.726 0 CA-C-N 121.797 1.677 . . . . 63.1 111.961 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -70.69 -31.83 68.86 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.659 -1.155 . . . . 74.4 112.563 -175.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.632 HG21 ' HA ' ' C' ' 73' ' ' ALA . 11.7 p -81.46 -26.0 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 112.756 0.65 . . . . 73.21 112.756 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -67.6 -24.58 65.51 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 120.793 0.33 . . . . 74.15 111.71 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -90.49 25.5 2.26 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.789 0.836 . . . . 73.42 110.95 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.704 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -121.32 157.83 29.54 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.603 0.761 . . . . 72.22 110.485 178.547 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -70.19 131.91 44.96 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.956 0.902 . . . . 72.21 110.134 170.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -84.5 88.13 7.29 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.344 0.658 . . . . 74.55 110.779 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -132.48 78.97 66.36 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 108.021 -1.103 . . . . 74.31 108.021 171.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -78.54 126.71 7.64 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.574 2.183 . . . . 75.42 113.919 -172.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -85.05 91.6 8.14 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 106.249 -1.76 . . . . 74.22 106.249 160.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 28.6 m -80.15 142.69 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 114.345 -1.298 . . . . 63.25 111.262 -173.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.537 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 45.5 mmtm -124.52 103.1 7.97 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.597 -0.89 . . . . 63.23 108.597 172.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.464 HD21 HD22 ' G' ' 8' ' ' LEU . 2.2 pp -86.83 151.5 23.29 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.158 -0.682 . . . . 73.34 109.158 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -144.73 138.75 27.43 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.021 -0.733 . . . . 70.34 109.021 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.462 HD13 HD23 ' G' ' 8' ' ' LEU . 2.4 mp -125.35 114.97 19.59 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.254 -1.017 . . . . 75.33 108.254 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 11.3 t70 -111.98 144.5 41.23 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.945 0.898 . . . . 74.31 109.045 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -113.28 113.07 24.77 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.489 -0.778 . . . . 74.11 110.613 -169.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.77 141.56 50.37 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.833 0.853 . . . . 70.15 109.362 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 35.2 p -165.84 158.62 15.2 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.626 0.37 . . . . 75.24 111.832 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -161.46 148.93 14.88 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.646 0.779 . . . . 64.11 110.464 -174.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -92.23 126.7 37.42 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.35 -0.611 . . . . 74.32 109.35 172.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.548 HD13 HD13 ' C' ' 83' ' ' ILE . 74.9 mt -89.21 -54.0 4.31 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.563 0.745 . . . . 73.23 111.137 -176.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.91 -166.88 2.46 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.738 -0.665 . . . . 73.14 110.564 -174.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -57.35 103.57 0.13 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.476 1.111 . . . . 71.24 110.401 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 64.14 7.05 3.21 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.05 1.34 . . . . 74.13 113.033 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 88.1 t -97.12 113.92 32.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 107.665 -1.235 . . . . 74.05 107.665 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -118.44 159.85 22.75 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.343 -0.844 . . . . 74.05 109.119 -175.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.409 ' CD ' ' HZ3' ' C' ' 19' ' ' LYS . 29.0 tt0 -126.28 122.68 36.19 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.048 0.939 . . . . 75.13 109.156 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 87.4 t -109.59 125.33 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 107.738 -1.208 . . . . 75.3 107.738 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 66.2 t -124.05 125.67 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 109.083 -0.71 . . . . 71.22 109.083 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' C' ' 103' ' ' PRO . 33.4 tp -112.69 116.58 30.36 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 109.229 -0.656 . . . . 75.45 109.229 175.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 16.7 ttm-85 -82.09 109.31 16.3 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.446 -0.797 . . . . 73.22 109.005 174.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 36.4 t -103.56 119.17 51.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.033 -1.099 . . . . 62.41 108.033 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 27.3 m -125.41 121.49 34.02 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.228 -0.656 . . . . 51.32 109.228 -175.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.519 HG23 HG21 ' C' ' 114' ' ' ILE . 68.4 t -105.82 115.51 47.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 123.767 0.827 . . . . 63.34 109.019 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.543 HG21 HD23 ' C' ' 75' ' ' LEU . 3.7 m -98.48 139.45 34.2 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.359 -1.349 . . . . 61.45 107.359 169.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.94 122.96 31.33 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.072 -1.085 . . . . 55.33 108.072 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 54.1 m -132.54 156.28 47.12 Favored 'General case' 0 C--O 1.213 -0.851 0 C-N-CA 123.393 0.677 . . . . 64.53 109.181 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.569 HD11 ' HG2' ' C' ' 34' ' ' LYS . 39.0 mt -119.07 38.76 3.73 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.439 -1.319 . . . . 75.43 107.439 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.82 -99.59 1.65 Allowed Glycine 0 C--N 1.347 1.178 0 CA-C-N 114.606 -1.179 . . . . 73.35 110.469 -170.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -90.33 -30.8 17.23 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.343 0.657 . . . . 72.41 110.438 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -73.22 116.1 13.36 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.87 0.868 . . . . 74.52 110.654 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.1 m -76.85 118.35 19.36 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.376 -0.972 . . . . 73.5 108.376 168.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.632 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.88 -53.02 9.82 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.953 0.783 . . . . 70.42 109.02 176.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -165.96 173.39 10.5 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-N 115.509 -0.769 . . . . 74.2 112.392 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.543 HD23 HG21 ' C' ' 65' ' ' THR . 2.4 tm? -140.94 102.45 4.27 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 105.836 -1.913 . . . . 74.01 105.836 172.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.474 ' SG ' HG22 ' C' ' 114' ' ' ILE . 46.4 t -109.97 112.0 23.74 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.194 -0.669 . . . . 74.54 109.194 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -118.23 127.57 53.87 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.064 0.546 . . . . 74.42 110.162 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 73.2 t -124.33 138.49 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 108.714 -0.847 . . . . 72.24 108.714 170.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.575 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 47.9 mt-30 -113.1 95.17 5.25 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.714 -0.847 . . . . 64.52 108.714 172.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -81.8 106.93 14.12 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.385 -0.825 . . . . 73.42 109.405 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.52 149.13 20.4 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.539 -0.625 . . . . 75.05 111.539 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.18 117.05 0.92 Allowed Glycine 0 CA--C 1.506 -0.482 0 N-CA-C 111.012 -0.835 . . . . 72.34 111.012 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.548 HD13 HD13 ' C' ' 51' ' ' LEU . 12.5 mm -81.92 125.99 39.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 108.395 -0.965 . . . . 75.34 108.395 175.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -138.77 142.02 38.8 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.277 -0.638 . . . . 74.33 109.277 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 85' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 60.7 m -70.76 115.56 10.05 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.354 -1.35 . . . . 64.25 107.354 164.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.595 HG22 ' HE2' ' C' ' 9' ' ' MET . 69.8 mt -133.64 110.99 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 109.122 -0.696 . . . . 73.35 109.122 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.55 167.52 19.26 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.91 0.884 . . . . 73.44 110.591 177.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.43 -40.44 2.54 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 116.349 -0.387 . . . . 72.31 113.299 171.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 23.6 pt -101.78 174.77 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.237 0.615 . . . . 73.3 111.038 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.483 ' HA ' ' HE2' ' C' ' 94' ' ' MET . 8.1 tp10 -150.31 153.69 36.55 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 111.999 0.37 . . . . 75.2 111.999 -175.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.718 ' HA3' HG22 ' A' ' 149' ' ' THR . . . 63.54 -115.92 8.59 Favored Glycine 0 C--N 1.353 1.486 0 N-CA-C 114.844 0.698 . . . . 54.54 114.844 169.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 75.5 p -74.49 -29.53 61.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.331 0.652 . . . . 74.1 110.986 -175.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -60.43 -48.26 82.53 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.695 -0.854 . . . . 74.34 108.695 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.594 ' SD ' ' HB1' ' G' ' 21' ' ' ALA . 51.8 ttm -69.71 -33.81 73.02 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.868 -1.514 . . . . 70.42 110.9 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.26 88.15 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.388 0.675 . . . . 72.4 111.66 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -71.2 -32.57 69.01 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.222 -0.445 . . . . 63.35 110.454 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.508 ' SG ' ' HE1' ' C' ' 9' ' ' MET . 53.9 t -67.96 -61.57 1.8 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 122.628 0.371 . . . . 64.43 111.056 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.538 HD22 HG22 ' G' ' 18' ' ' VAL . 2.5 pp -70.24 -25.61 63.46 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.069 0.396 . . . . 75.2 112.069 -178.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.95 -17.22 44.76 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 114.584 0.593 . . . . 70.14 114.584 -172.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.73 -53.19 0.87 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 117.466 0.633 . . . . 72.15 111.231 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.514 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 77.2 t80 -72.6 -46.65 53.13 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.615 0.766 . . . . 74.03 112.622 -168.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.447 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 33.7 m -73.35 -46.94 7.74 Favored Pre-proline 0 CA--C 1.569 1.683 0 N-CA-C 113.123 0.786 . . . . 74.12 113.123 -175.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.518 ' HB2' HD23 ' C' ' 60' ' ' LEU . 87.7 Cg_endo -75.87 -10.37 19.81 Favored 'Trans proline' 0 C--N 1.387 2.557 0 C-N-CA 122.094 1.863 . . . . 74.14 112.762 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.66 -32.73 74.53 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.487 0.715 . . . . 64.31 110.314 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.474 HG23 ' NH1' ' A' ' 111' ' ' ARG . 14.6 mm -70.74 -36.5 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.208 -0.905 . . . . 73.44 110.067 177.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 43.8 mt -85.86 -22.52 27.5 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.719 -1.128 . . . . 73.33 111.677 -172.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -58.72 -52.94 71.18 Favored Pre-proline 0 CA--C 1.56 1.352 0 CA-C-O 118.198 -0.906 . . . . 75.22 112.795 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -65.65 -32.02 48.54 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 121.54 1.493 . . . . 75.31 112.382 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . 0.475 ' CD1' HG21 ' C' ' 16' ' ' ILE . 2.6 m-30 -67.23 -45.47 76.68 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.859 0.863 . . . . 72.12 110.025 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.7 -37.87 87.64 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.236 1.014 . . . . 65.35 110.735 176.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -60.8 -49.08 78.91 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.6 1.16 . . . . 72.5 110.794 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -69.98 -34.07 72.89 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.119 0.568 . . . . 73.5 110.058 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 21.4 t -69.26 -31.29 69.73 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.936 0.494 . . . . 52.15 111.502 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.519 HG21 HG23 ' C' ' 64' ' ' VAL . 86.3 mt -73.53 -55.31 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.081 0.553 . . . . 74.03 109.662 173.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 17.1 m -63.87 -27.6 69.27 Favored 'General case' 0 CA--C 1.553 1.074 0 O-C-N 123.653 0.596 . . . . 71.3 111.374 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 36.6 t -62.02 -50.86 70.36 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.232 -0.655 . . . . 71.13 109.232 171.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.613 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.64 -36.07 79.72 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.318 1.047 . . . . 75.42 112.409 178.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.73 -45.23 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.38 0.672 . . . . 72.55 109.821 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 31.0 t -70.6 -25.35 63.01 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 114.907 -1.042 . . . . 72.35 111.809 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' C' ' 116' ' ' SER . 87.2 mtt-85 -74.18 -40.65 62.37 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.35 0.66 . . . . 74.33 109.417 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.72 -0.12 62.88 Favored Glycine 0 C--N 1.354 1.553 0 CA-C-N 115.617 -0.72 . . . . 60.04 112.575 169.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 25.3 p 62.64 30.89 16.97 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 126.787 2.035 . . . . 74.24 113.378 170.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -83.92 148.91 55.19 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 109.044 -0.725 . . . . 74.3 109.044 170.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.606 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 86.3 Cg_exo -51.41 146.91 23.59 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 123.422 2.748 . . . . 75.23 114.2 176.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -58.81 112.11 1.52 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.985 -1.007 . . . . 75.34 112.358 -173.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 42.8 tp -112.83 86.3 2.34 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.373 -0.973 . . . . 75.33 108.373 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -94.2 106.44 18.41 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.224 -0.898 . . . . 74.4 108.816 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 56.9 tp -65.47 144.98 56.69 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.133 0.573 . . . . 74.25 111.525 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.07 143.94 92.09 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 124.03 0.932 . . . . 70.11 110.882 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.517 ' HB2' HD12 ' A' ' 13' ' ' ILE . 5.6 Cg_exo -71.4 127.42 13.29 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.77 2.314 . . . . 73.32 112.237 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.709 HG23 ' H ' ' G' ' 8' ' ' LEU . 61.6 t -119.18 111.8 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.722 0.809 . . . . 74.44 109.401 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -80.69 97.52 7.3 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.481 0.712 . . . . 75.01 110.448 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -65.07 -41.8 94.75 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.241 -0.652 . . . . 75.45 109.241 170.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -53.34 -52.38 59.4 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.163 -1.381 . . . . 71.32 112.112 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.84 -31.0 68.1 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 123.854 0.722 . . . . 74.14 112.563 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 89.7 mt -70.05 -41.64 73.92 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.513 0.725 . . . . 71.14 110.658 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -80.79 -15.69 55.74 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.184 0.594 . . . . 75.34 111.795 175.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.403 ' O ' ' HB3' ' C' ' 142' ' ' GLN . 24.4 ttt -78.48 -44.82 23.56 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.805 0.842 . . . . 73.43 111.059 -175.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -60.4 -33.41 72.44 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 120.819 0.343 . . . . 72.04 110.296 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -61.89 -83.53 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.884 0.874 . . . . 73.53 111.642 170.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 84.8 mt -92.37 49.62 1.52 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.529 0.732 . . . . 75.35 112.441 -168.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.403 ' HB3' ' O ' ' C' ' 138' ' ' MET . 0.9 OUTLIER -158.21 129.83 6.71 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 109.041 -0.726 . . . . 74.31 109.041 171.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -146.92 86.94 1.66 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.498 -1.297 . . . . 70.45 107.498 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . 0.63 HE22 ' HB3' ' A' ' 142' ' ' GLN . 22.1 tp60 -135.45 -24.52 1.37 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.173 0.589 . . . . 75.23 111.245 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.63 86.9 0.21 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 120.994 0.426 . . . . 64.13 110.44 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.92 87.01 0.07 OUTLIER Glycine 0 C--N 1.343 0.928 0 CA-C-N 115.484 -0.78 . . . . 73.21 111.814 -175.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -151.76 -98.8 0.06 Allowed 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 107.151 -1.426 . . . . 75.21 107.151 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 82.52 43.14 8.03 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 116.414 1.325 . . . . 71.03 116.414 166.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 17.4 p -78.52 -49.43 13.38 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.479 -0.934 . . . . 72.31 108.479 163.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . 0.492 ' HA ' ' HB3' ' E' ' 24' ' ' PRO . 30.3 tt0 52.33 90.7 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.671 1.588 . . . . 72.22 112.876 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . 0.545 ' HG3' ' H ' ' C' ' 152' ' ' HIS . 5.5 pt-20 -69.74 -67.94 0.45 Allowed 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 123.822 0.849 . . . . 71.4 112.26 -178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . 0.545 ' H ' ' HG3' ' C' ' 151' ' ' GLU . 15.9 t60 179.24 146.8 0.19 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.436 1.094 . . . . 73.4 108.812 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' E' ' 22' ' ' ARG . 0.0 OUTLIER -79.72 108.31 13.18 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 109.036 -0.727 . . . . 63.25 109.036 174.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -125.8 152.17 45.79 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.113 0.565 . . . . 75.3 110.242 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.184 0 C-N-CA 124.073 0.949 . . . . 72.45 108.974 175.089 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.43 ' HB2' ' HA3' ' D' ' 146' ' ' GLY . 1.8 mpt? . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.741 0.305 . . . . 75.11 110.485 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 63.8 p -82.21 175.06 10.61 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.034 0.534 . . . . 64.54 110.186 169.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -81.91 -34.12 30.09 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.784 0.434 . . . . 74.32 110.713 176.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . 0.414 ' HA ' ' HA2' ' D' ' 148' ' ' GLY . 35.3 tt0 -163.94 -79.85 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.123 0.969 . . . . 73.15 108.644 170.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 55.35 37.83 29.46 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.051 0.94 . . . . 74.33 112.464 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -78.76 80.64 5.11 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.446 -0.946 . . . . 63.42 108.446 169.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 29.0 m -149.59 142.89 25.18 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.005 -1.452 . . . . 62.4 107.633 -177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -75.73 87.69 2.78 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.526 0.33 . . . . 61.33 110.121 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.566 ' HG3' HD11 ' D' ' 89' ' ' ILE . 23.1 ttt -31.79 125.73 0.25 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 125.089 1.356 . . . . 65.32 113.686 170.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 30.8 m -107.66 137.9 44.86 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.542 -0.911 . . . . 63.44 108.542 169.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -157.66 114.63 2.96 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.858 -0.793 . . . . 72.33 108.858 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -134.06 126.18 29.59 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.038 -1.097 . . . . 75.42 108.038 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.554 HG21 HD11 ' D' ' 16' ' ' ILE . 10.4 mt -78.23 127.76 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.165 -0.68 . . . . 71.44 109.165 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -87.37 -41.61 13.48 Favored 'General case' 0 C--O 1.24 0.583 0 O-C-N 123.704 0.627 . . . . 71.44 110.001 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 -175.17 142.83 0.65 Allowed 'General case' 0 N--CA 1.484 1.273 0 O-C-N 123.173 0.296 . . . . 74.22 111.676 -172.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.554 HD11 HG21 ' D' ' 13' ' ' ILE . 3.4 mp -117.14 136.45 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.303 -1.369 . . . . 74.55 107.303 168.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.45 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 24.5 p90 -163.87 147.39 9.94 Favored 'General case' 0 C--O 1.242 0.659 0 O-C-N 123.871 0.732 . . . . 74.5 110.236 176.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 78.4 p -77.97 106.75 10.04 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.351 -0.84 . . . . 74.51 108.887 173.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.45 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 37.6 mtpt -73.19 -30.57 63.62 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.466 0.65 . . . . 74.44 109.994 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.409 ' HB3' ' HB3' ' D' ' 79' ' ' GLN . 10.6 t70 -152.42 141.46 21.26 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.012 -1.449 . . . . 75.12 108.934 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.613 HG21 ' HE1' ' C' ' 117' ' ' MET . 79.7 mt -141.71 147.76 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.598 -1.26 . . . . 75.35 107.598 175.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 41.5 t -149.46 128.49 12.69 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 123.799 0.839 . . . . 71.42 109.149 170.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.526 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.6 t80 -128.34 135.58 49.77 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.129 -1.804 . . . . 74.12 106.129 169.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 44.0 mt-10 -141.78 150.15 41.35 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 124.288 1.035 . . . . 63.45 108.432 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.96 87.22 5.47 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 107.699 -1.223 . . . . 55.2 107.699 173.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.74 -27.93 17.57 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.701 2.267 . . . . 72.22 112.823 -173.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -107.82 7.21 28.1 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.001 0.921 . . . . 72.22 110.53 -176.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -29.95 -64.64 0.19 Allowed Pre-proline 0 CA--C 1.559 1.312 0 N-CA-C 116.74 2.126 . . . . 72.33 116.74 -165.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 88.7 Cg_endo -76.14 -26.4 9.2 Favored 'Trans proline' 0 C--N 1.381 2.239 0 CA-C-N 122.897 2.07 . . . . 74.23 113.382 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -70.92 -36.14 72.54 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.839 1.256 . . . . 73.41 109.75 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' D' ' 73' ' ' ALA . 9.7 p -84.86 -12.63 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 CA-C-N 115.708 -0.678 . . . . 75.13 111.741 -176.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.425 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.8 m-85 -72.37 -12.22 61.03 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 112.445 0.535 . . . . 72.13 112.445 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -58.13 -23.48 55.21 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.673 0.749 . . . . 74.41 110.066 169.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.684 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 79.3 mttt -104.37 102.61 12.28 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.664 1.586 . . . . 75.41 108.987 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -111.82 90.72 3.42 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.482 0.313 . . . . 74.14 110.442 -175.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 38.3 p90 -164.36 174.35 11.16 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.65 1.18 . . . . 72.42 108.763 172.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.408 HE21 ' HB2' ' D' ' 124' ' ' PRO . 2.2 mp0 -59.08 110.47 2.69 Favored Pre-proline 0 N--CA 1.486 1.328 0 CA-C-O 119.079 -0.486 . . . . 73.44 109.831 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.515 ' HG2' ' HE2' ' D' ' 74' ' ' PHE . 24.5 Cg_exo -63.17 136.74 57.54 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.368 2.045 . . . . 73.04 110.706 -177.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -62.05 107.77 0.93 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.356 -0.979 . . . . 72.03 108.356 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 6.9 m -103.56 121.29 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-N 115.165 -0.925 . . . . 74.33 110.092 -171.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -101.44 119.45 38.78 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 106.313 -1.736 . . . . 75.34 106.313 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.601 HD21 HG13 ' H' ' 6' ' ' ILE . 4.4 pp -94.66 143.1 26.71 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.193 -0.669 . . . . 75.24 109.193 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.522 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 17.0 t70 -139.38 146.82 40.67 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.411 -0.959 . . . . 72.45 108.411 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -116.33 143.56 45.39 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.126 0.57 . . . . 72.35 110.841 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.556 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.6 t70 -139.05 134.37 32.89 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.354 -1.293 . . . . 42.43 107.731 169.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 22.4 p -103.7 148.27 26.25 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.203 0.601 . . . . 54.14 110.407 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.43 160.9 41.88 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.394 1.078 . . . . 75.23 109.115 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 46.4 p -174.62 167.88 3.78 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.013 0.525 . . . . 61.23 111.275 -175.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.9 p -166.51 147.56 6.27 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.394 -0.821 . . . . 74.22 110.375 174.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -89.23 118.27 28.8 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.602 -0.888 . . . . 74.52 108.602 170.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.524 HD13 HG22 ' D' ' 83' ' ' ILE . 44.1 mt -98.69 -27.28 14.05 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.176 0.59 . . . . 73.41 110.878 -173.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.434 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -158.8 -178.53 7.32 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.021 0.928 . . . . 73.15 110.121 174.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.09 111.31 2.85 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.102 -0.954 . . . . 65.31 109.844 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 65.72 9.06 5.67 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.763 1.225 . . . . 65.15 113.252 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.434 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 83.2 t -108.07 114.15 45.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 107.468 -1.308 . . . . 73.23 107.468 172.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.534 ' HB2' HG11 ' H' ' 18' ' ' VAL . 36.0 t80 -134.72 131.3 37.47 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.871 -1.059 . . . . 74.11 109.497 -165.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -93.28 129.22 39.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.157 -0.929 . . . . 72.55 110.12 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 78.3 t -109.36 118.96 57.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.209 -1.034 . . . . 71.03 108.209 172.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.462 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 35.7 t -113.78 133.09 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 108.523 -0.918 . . . . 64.42 108.523 177.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 26.4 tp -129.56 120.33 25.14 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.921 -0.4 . . . . 72.04 109.921 171.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.556 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 19.5 ttm-85 -84.54 111.82 19.85 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.952 0.901 . . . . 74.53 109.849 175.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.606 HG23 ' HB1' ' D' ' 110' ' ' ALA . 40.6 t -91.78 122.32 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 108.262 -1.014 . . . . 75.24 108.262 173.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 46.4 m -112.45 143.59 43.32 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.451 -0.574 . . . . 75.01 109.451 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 88.5 t -132.29 101.94 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.663 1.185 . . . . 74.02 108.34 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 19.8 m -93.58 94.92 8.9 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.154 -1.424 . . . . 50.4 107.154 169.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.08 147.47 24.0 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.063 0.545 . . . . 73.43 110.338 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.432 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 63.8 p -150.15 133.72 16.62 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-O 121.068 0.461 . . . . 71.45 111.621 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.7 mt -106.86 114.48 28.59 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.447 -1.316 . . . . 74.13 107.447 171.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.33 -140.96 31.68 Favored Glycine 0 C--N 1.343 0.939 0 O-C-N 123.373 0.42 . . . . 73.32 112.562 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -83.13 3.45 30.66 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.19 0.596 . . . . 73.22 112.302 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.684 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 12.2 pt-20 -131.04 166.0 21.99 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.879 0.472 . . . . 74.44 110.75 -174.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.7 m -72.73 136.93 45.63 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.386 -0.824 . . . . 71.34 110.963 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.502 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -87.68 -69.55 0.68 Allowed 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.588 -1.264 . . . . 73.33 107.588 174.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . 0.515 ' HE2' ' HG2' ' D' ' 38' ' ' PRO . 52.1 p90 -149.58 150.26 31.97 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-N 115.313 -0.858 . . . . 70.32 110.685 177.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.447 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 45.4 mt -106.44 107.2 18.09 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.458 -1.312 . . . . 73.04 107.458 170.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.627 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 36.8 t -116.54 140.03 49.83 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.905 0.882 . . . . 72.34 108.967 -176.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -157.98 141.64 15.51 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.995 0.518 . . . . 72.02 109.948 -174.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -140.82 116.29 6.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.138 -1.06 . . . . 71.22 108.138 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.546 ' HA ' ' HA ' ' D' ' 61' ' ' ARG . 5.9 tt0 -87.41 81.06 7.95 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.37 -1.344 . . . . 70.55 107.37 171.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -80.09 105.18 11.18 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.353 -1.294 . . . . 73.21 108.761 -173.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -104.3 148.32 16.76 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.72 -0.673 . . . . 73.42 111.661 -178.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.421 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -144.93 131.43 4.28 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.057 -0.817 . . . . 72.42 111.057 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.524 HG22 HD13 ' D' ' 51' ' ' LEU . 45.1 mt -88.86 133.3 31.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 108.239 -1.022 . . . . 73.55 108.239 174.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -130.87 159.24 37.97 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.943 0.497 . . . . 70.42 109.87 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 3.9 t -115.27 101.09 8.62 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.248 -1.019 . . . . 53.22 108.248 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.92 109.84 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 109.25 -0.648 . . . . 74.51 109.25 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.34 154.34 45.09 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.398 0.679 . . . . 72.51 109.798 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.92 21.35 65.96 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-O 119.811 -0.439 . . . . 64.41 113.941 175.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.566 HD11 ' HG3' ' D' ' 9' ' ' MET . 10.9 mt -131.97 158.35 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 117.384 0.592 . . . . 75.32 110.255 178.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.622 ' HA ' ' HE3' ' D' ' 94' ' ' MET . 2.9 pp20? -159.44 -175.97 5.51 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.265 1.026 . . . . 70.51 110.056 171.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.46 -141.07 46.67 Favored Glycine 0 N--CA 1.473 1.132 0 N-CA-C 114.839 0.696 . . . . 73.45 114.839 174.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 41.5 p -78.81 -13.98 59.51 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.083 0.953 . . . . 65.44 112.037 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -47.01 70.79 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.556 0.742 . . . . 62.13 109.685 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.622 ' HE3' ' HA ' ' D' ' 90' ' ' GLU . 13.5 ptp -68.78 -34.62 75.86 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 110.271 -0.27 . . . . 71.42 110.271 176.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.45 -26.93 68.77 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.975 0.51 . . . . 61.23 111.461 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -73.03 -51.81 16.77 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.079 0.552 . . . . 74.51 110.579 171.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.7 t -56.64 -43.78 80.62 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 124.074 0.859 . . . . 54.31 111.411 -174.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.691 HD11 HG21 ' H' ' 18' ' ' VAL . 16.3 mt -78.3 -30.21 48.25 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.734 -1.121 . . . . 72.4 110.737 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.79 14.58 64.98 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 116.002 -0.545 . . . . 72.3 113.19 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.55 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -153.02 -79.27 0.1 Allowed 'General case' 0 C--N 1.353 0.742 0 C-N-CA 122.929 0.492 . . . . 74.12 111.235 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -65.41 -41.15 93.9 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.101 0.778 . . . . 74.2 113.101 -166.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 81.5 m -64.56 -48.96 73.18 Favored Pre-proline 0 CA--C 1.564 1.494 0 CA-C-O 118.726 -0.654 . . . . 73.53 112.595 -175.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.14 -22.73 34.52 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 121.717 1.611 . . . . 74.01 112.754 170.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . 0.433 HD22 ' HB3' ' D' ' 133' ' ' PHE . 0.9 OUTLIER -66.75 -25.88 66.71 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 122.539 0.336 . . . . 75.33 111.237 175.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.482 HG21 HD12 ' D' ' 13' ' ' ILE . 43.3 mm -67.99 -39.55 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.346 0.658 . . . . 72.45 109.983 170.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.421 HD22 ' HA3' ' D' ' 82' ' ' GLY . 79.4 mt -79.5 -17.68 53.58 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 115.155 -0.929 . . . . 72.43 111.941 -171.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -64.69 -45.07 75.61 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 114.214 1.19 . . . . 71.14 114.214 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -54.11 -43.88 54.37 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.065 1.843 . . . . 64.4 112.902 173.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -73.52 -34.01 65.03 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.239 -0.892 . . . . 71.41 111.911 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . 0.606 ' HB1' HG23 ' D' ' 62' ' ' VAL . . . -65.02 -49.61 69.49 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.458 -0.571 . . . . 73.34 109.458 177.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.423 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.8 ttp180 -54.54 -53.43 54.55 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 124.827 1.33 . . . . 75.33 110.801 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -60.16 -46.29 90.17 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.421 1.075 . . . . 70.22 111.378 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 39.6 t -62.12 -41.66 98.46 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.724 0.64 . . . . 73.44 110.935 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.435 ' O ' HG23 ' D' ' 118' ' ' VAL . 82.3 mt -60.48 -58.05 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.674 0.79 . . . . 75.12 110.508 173.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 40.6 m -54.7 -39.23 67.96 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.148 1.379 . . . . 75.45 111.537 -173.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 24.7 t -68.23 -43.45 77.91 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.953 -1.022 . . . . 74.33 110.506 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.627 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.8 mtm -68.6 -32.98 73.26 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 122.646 0.378 . . . . 74.42 111.715 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.435 HG23 ' O ' ' D' ' 114' ' ' ILE . 90.6 t -63.57 -45.48 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.548 0.739 . . . . 73.4 109.859 176.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.6 p -74.52 -29.91 61.59 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.877 -0.602 . . . . 74.32 111.281 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -72.24 -27.85 62.77 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.2 0.6 . . . . 74.03 110.138 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.26 8.29 74.74 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 123.621 0.575 . . . . 72.55 112.587 172.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 80.7 p 55.3 22.64 4.96 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 126.669 1.988 . . . . 74.05 114.105 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -82.96 151.18 63.33 Favored Pre-proline 0 CA--C 1.552 1.04 0 N-CA-C 108.717 -0.846 . . . . 74.14 108.717 168.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.5 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 17.7 Cg_endo -57.74 138.99 88.8 Favored 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.737 2.292 . . . . 75.31 112.872 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -53.03 134.33 38.14 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.58 1.152 . . . . 74.44 112.375 -175.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.83 104.76 9.8 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.526 -1.287 . . . . 74.44 107.526 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -99.58 109.4 21.91 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.605 0.762 . . . . 74.15 109.211 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.701 ' HA ' HG21 ' H' ' 6' ' ' ILE . 6.5 mp -70.38 119.06 14.0 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.135 0.574 . . . . 75.54 109.548 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.98 137.19 95.43 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.05 0.54 . . . . 74.24 110.774 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.72 130.77 6.92 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.269 1.979 . . . . 74.2 112.108 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 17.6 m -117.43 136.35 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 122.879 0.472 . . . . 63.54 110.902 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -86.92 77.32 9.25 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 107.023 -1.473 . . . . 63.11 107.023 163.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.433 ' HB3' HD22 ' D' ' 104' ' ' ASN . 44.8 t80 -68.34 -26.18 65.47 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 115.026 -0.988 . . . . 74.25 109.925 -176.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.55 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 14.4 t70 -55.98 -43.08 77.24 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 124.154 0.909 . . . . 71.31 111.548 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.578 ' HA ' ' HE2' ' D' ' 138' ' ' MET . . . -70.59 -45.78 64.68 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.809 0.444 . . . . 71.54 111.696 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.4 tt -58.87 -35.46 73.01 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.511 0.724 . . . . 71.12 110.112 176.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -80.74 -29.57 36.27 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.982 0.913 . . . . 75.41 110.92 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.578 ' HE2' ' HA ' ' D' ' 135' ' ' ALA . 59.4 mtm -60.54 -42.19 96.01 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 119.109 -0.472 . . . . 71.24 110.295 174.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -47.91 -49.05 31.22 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 124.414 1.071 . . . . 75.05 111.442 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -56.14 -45.67 79.52 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.008 0.923 . . . . 73.15 111.863 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mp -68.61 -29.98 68.62 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.215 0.606 . . . . 75.24 111.988 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' D' ' 138' ' ' MET . 13.4 mt-30 -83.8 2.06 39.95 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.526 0.73 . . . . 75.51 111.28 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -121.35 48.48 1.66 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.509 1.123 . . . . 74.41 108.132 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -142.53 -174.16 4.06 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.448 1.099 . . . . 73.14 109.78 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.62 165.54 12.47 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.318 0.647 . . . . 73.21 109.533 167.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . 0.43 ' HA3' ' HB2' ' D' ' 1' ' ' MET . . . 135.56 176.65 14.47 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 111.9 -0.48 . . . . 70.54 111.9 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -160.62 -173.02 3.75 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.225 0.61 . . . . 74.33 110.731 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' D' ' 4' ' ' GLN . . . -176.0 79.1 0.07 OUTLIER Glycine 0 C--N 1.338 0.641 0 N-CA-C 110.352 -1.099 . . . . 51.54 110.352 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 5.9 t -65.38 91.41 0.11 Allowed 'General case' 0 CA--C 1.551 1.013 0 CA-C-O 121.976 0.893 . . . . 71.05 110.357 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.44 100.32 2.67 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-N 114.549 -1.205 . . . . 73.24 108.215 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . 0.467 ' HB3' HE22 ' D' ' 153' ' ' GLN . 42.7 mt-10 -115.03 163.24 15.88 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.121 -0.945 . . . . 74.11 109.446 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 36.7 p-80 -166.05 79.36 0.27 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.751 0.821 . . . . 74.23 109.537 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . 0.467 HE22 ' HB3' ' D' ' 151' ' ' GLU . 24.8 mp0 -70.3 162.31 28.75 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 115.631 -0.713 . . . . 74.12 109.8 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -135.65 75.78 1.58 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 109.735 -0.468 . . . . 65.23 109.735 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.017 0 C-N-CA 123.62 0.768 . . . . 72.44 109.883 -178.79 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 110.135 -0.32 . . . . 74.44 110.135 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 95.7 mttt 62.81 93.46 0.05 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.545 1.138 . . . . 74.02 112.177 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -119.26 89.67 3.18 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.416 -1.328 . . . . 75.24 107.416 168.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 50.9 m -145.38 106.1 4.12 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.195 0.998 . . . . 72.32 109.439 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 21.4 m -90.09 160.83 16.1 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.705 0.802 . . . . 64.54 109.783 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.35 160.24 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-O 121.14 0.495 . . . . 75.13 111.129 170.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 7' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . . . -152.65 -62.26 0.16 Allowed 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.674 -0.694 . . . . 73.42 110.023 -171.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . 0.788 HD11 HD21 ' A' ' 44' ' ' LEU . 3.3 tt 170.69 148.07 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.067 1.747 . . . . 73.12 106.349 -176.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 9' ' ' ALA . . . . . 0.42 ' N ' HD21 ' E' ' 8' ' ' LEU . . . -77.73 -83.59 0.08 Allowed 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 109.862 -0.421 . . . . 61.54 109.862 175.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 6.9 mt -172.45 -176.57 1.58 Allowed 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 125.058 1.343 . . . . 75.31 109.727 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 81.9 mt -112.91 133.07 22.05 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 124.178 0.991 . . . . 74.32 109.433 172.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.2 -5.67 17.31 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.582 2.188 . . . . 75.33 113.297 176.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -146.82 171.43 15.19 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.699 0.8 . . . . 74.0 109.792 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . 0.568 HD11 ' HB ' ' E' ' 23' ' ' THR . 75.1 mt -75.68 -84.15 0.06 Allowed 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 109.65 -0.5 . . . . 73.34 109.65 173.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 35.3 t80 177.63 161.18 0.51 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.713 1.205 . . . . 75.35 108.147 -176.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 17.7 p -73.47 128.41 87.29 Favored Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 123.061 0.545 . . . . 64.33 111.23 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 17' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.96 155.28 71.51 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.602 2.868 . . . . 70.03 113.927 -173.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 18' ' ' VAL . . . . . 0.668 HG21 HD13 ' A' ' 98' ' ' LEU . 43.9 t -77.16 -71.98 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.945 0 N-CA-C 109.058 -0.719 . . . . 53.54 109.058 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 33.8 m -76.45 -74.94 0.21 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.618 0.767 . . . . 73.41 111.193 -169.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -164.84 25.59 0.06 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.515 0.931 . . . . 73.54 113.515 -171.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.77 172.34 9.98 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 117.998 0.363 . . . . 70.34 110.426 168.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 22' ' ' ARG . . . . . 0.422 ' O ' ' HB2' ' C' ' 153' ' ' GLN . 0.1 OUTLIER -119.15 -17.22 8.99 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 108.881 -0.785 . . . . 74.43 108.881 173.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 23' ' ' THR . . . . . 0.568 ' HB ' HD11 ' E' ' 14' ' ' LEU . 60.1 p 60.89 121.96 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.622 0 C-N-CA 126.744 2.018 . . . . 71.35 112.69 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 24' ' ' PRO . . . . . 0.492 ' HB3' ' HA ' ' C' ' 150' ' ' GLU . 73.7 Cg_endo -77.81 93.73 1.08 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.381 2.054 . . . . 70.32 111.94 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 CA--C 1.562 1.415 0 C-N-CA 125.015 1.326 . . . . 74.0 110.437 -178.97 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' F' F ' 1' ' ' MET . . . . . 0.487 ' SD ' ' N ' ' F' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 108.882 -0.784 . . . . 71.44 108.882 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 2' ' ' LYS . . . . . 0.402 ' N ' ' HE3' ' F' ' 2' ' ' LYS . 0.0 OUTLIER 63.03 103.33 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.958 1.303 . . . . 74.32 110.903 -173.029 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -60.88 -27.8 68.41 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.44 0.696 . . . . 74.21 111.225 174.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 42.4 m -118.27 50.87 1.12 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.895 0.878 . . . . 74.12 109.612 174.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 5' ' ' THR . . . . . 0.624 HG22 ' HA ' ' B' ' 39' ' ' GLU . 24.4 m -48.25 -48.04 35.58 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.531 0.732 . . . . 63.53 110.532 171.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . 0.591 HD11 HD22 ' B' ' 128' ' ' LEU . 11.8 tt -120.83 125.56 74.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 114.655 -1.157 . . . . 74.35 108.925 174.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -160.46 166.22 29.6 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.026 0.93 . . . . 53.24 109.247 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . 0.615 ' HA ' HD11 ' B' ' 42' ' ' LEU . 91.9 mt -121.58 146.39 47.01 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.214 0.606 . . . . 70.31 110.006 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -118.29 178.19 4.53 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.13 0.972 . . . . 51.1 109.509 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 8.0 mp -71.35 151.54 44.04 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 108.877 -0.786 . . . . 72.24 108.877 172.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 7.5 mp -69.22 117.16 49.46 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 122.923 0.489 . . . . 75.34 109.967 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.62 -37.21 95.5 Favored 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 123.486 2.791 . . . . 74.24 112.546 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 61.0 tp -112.78 121.87 45.98 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.153 -1.054 . . . . 73.53 108.153 166.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . 0.416 HD13 ' N ' ' F' ' 15' ' ' PHE . 2.2 tm? -69.72 142.24 53.34 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 108.051 -1.092 . . . . 71.21 108.051 172.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . 0.422 ' CD2' ' HB3' ' B' ' 98' ' ' LEU . 45.9 t80 -58.26 152.0 18.25 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.788 0.835 . . . . 74.25 112.089 -174.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 40.8 p -62.18 128.83 91.56 Favored Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 124.16 0.984 . . . . 73.11 111.909 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 17' ' ' PRO . . . . . 0.426 ' HB3' ' HE1' ' B' ' 94' ' ' MET . 32.2 Cg_exo -59.71 164.34 11.73 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 123.052 2.502 . . . . 74.55 113.205 175.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . 0.521 HG13 ' H ' ' F' ' 20' ' ' LYS . 16.2 t -76.51 149.83 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 122.683 0.393 . . . . 65.3 110.298 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 20.1 m -57.81 -34.89 70.13 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.952 0.901 . . . . 73.55 111.58 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 20' ' ' LYS . . . . . 0.583 ' HA ' ' HE3' ' F' ' 20' ' ' LYS . 0.5 OUTLIER -144.32 -79.15 0.2 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 122.913 0.485 . . . . 74.35 111.096 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . 0.474 ' HB3' HG11 ' F' ' 18' ' ' VAL . . . 55.38 57.0 5.76 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.386 1.075 . . . . 73.0 111.46 -173.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -161.44 -88.72 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.329 -0.85 . . . . 75.04 109.938 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 22.0 p -145.67 87.28 6.95 Favored Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 123.871 0.869 . . . . 72.42 108.734 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -78.76 112.8 3.18 Favored 'Trans proline' 0 CA--C 1.555 1.545 0 C-N-CA 122.96 2.44 . . . . 72.34 111.735 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.489 1.489 0 C-N-CA 124.964 1.306 . . . . 64.24 110.771 -173.731 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.473 0.719 0 N-CA-C 109.131 -0.692 . . . . 75.0 109.131 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -77.7 106.9 9.82 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.411 -0.959 . . . . 74.14 108.411 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -146.8 138.39 24.38 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.969 -1.014 . . . . 74.23 108.683 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 45.4 t 178.78 150.4 0.27 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.562 1.145 . . . . 74.11 109.047 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 5' ' ' THR . . . . . 0.482 HG22 HD12 ' G' ' 6' ' ' ILE . 5.2 m -79.58 -86.6 0.07 Allowed 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 108.664 -0.865 . . . . 72.44 108.664 173.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . 0.482 HD12 HG22 ' G' ' 5' ' ' THR . 3.8 mp -124.38 132.09 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 106.586 -1.635 . . . . 73.4 106.586 166.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -122.43 157.5 31.77 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.133 0.573 . . . . 70.02 112.296 -172.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 8' ' ' LEU . . . . . 0.709 ' H ' HG23 ' C' ' 131' ' ' VAL . 30.8 mt -88.21 150.01 23.54 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.942 1.297 . . . . 64.34 109.919 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.29 157.07 25.24 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.243 0.617 . . . . 55.4 109.998 173.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 17.3 mt -62.4 172.32 1.58 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.383 0.611 . . . . 74.23 111.841 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 mt -118.33 85.81 26.21 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 115.517 -0.765 . . . . 62.04 109.432 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 12' ' ' PRO . . . . . 0.418 ' HD2' HD13 ' G' ' 13' ' ' LEU . 2.8 Cg_exo -76.98 -13.82 17.25 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.83 2.353 . . . . 73.3 112.267 174.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . 0.418 HD13 ' HD2' ' G' ' 12' ' ' PRO . 5.4 mp -71.38 -47.24 57.48 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.248 0.619 . . . . 74.52 110.522 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 59.55 172.61 0.08 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.73 1.212 . . . . 74.43 111.818 -169.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . 0.489 ' HB2' HD12 ' C' ' 98' ' ' LEU . 28.5 m-85 -91.02 164.32 14.0 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 109.129 -0.693 . . . . 72.22 109.129 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 73.3 p -63.84 151.88 88.13 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 123.462 0.705 . . . . 70.34 111.014 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 17' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.14 128.88 30.41 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.643 2.229 . . . . 75.31 112.788 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 18' ' ' VAL . . . . . 0.577 ' HB ' ' SD ' ' C' ' 94' ' ' MET . 61.8 t -69.52 -34.43 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.061 0.545 . . . . 63.44 109.919 174.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 19' ' ' THR . . . . . 0.454 HG22 ' HG3' ' G' ' 20' ' ' LYS . 20.5 m -133.16 -77.8 0.49 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.544 -0.753 . . . . 74.24 109.732 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 20' ' ' LYS . . . . . 0.454 ' HG3' HG22 ' G' ' 19' ' ' THR . 42.7 mtpt -137.62 20.46 2.9 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.891 0.476 . . . . 73.24 110.302 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . 0.594 ' HB1' ' SD ' ' C' ' 94' ' ' MET . . . -62.75 87.95 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.674 0.79 . . . . 64.13 111.45 -175.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -159.78 -58.94 0.06 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.336 -1.302 . . . . 75.04 107.661 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 23' ' ' THR . . . . . 0.573 HG22 ' HG2' ' A' ' 151' ' ' GLU . 66.2 p 49.9 93.97 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 125.494 1.518 . . . . 70.05 112.454 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 24' ' ' PRO . . . . . 0.401 ' HG2' ' HE1' ' A' ' 152' ' ' HIS . 19.5 Cg_endo -59.29 -32.8 97.43 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.533 2.155 . . . . 75.53 111.764 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 CA--C 1.552 1.032 0 C-N-CA 123.769 0.827 . . . . 75.43 109.009 173.769 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 109.452 -0.573 . . . . 74.3 109.452 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' H' H ' 2' ' ' LYS . . . . . 0.438 ' HE3' ' HA ' ' H' ' 9' ' ' ALA . 13.2 tmtt? -162.78 85.81 0.55 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.092 -1.077 . . . . 75.51 108.092 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -104.41 17.29 24.4 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.915 0.886 . . . . 74.52 109.511 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 6.2 m -63.88 111.55 2.52 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.727 0.811 . . . . 73.41 109.921 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 9.6 m -50.88 -53.67 30.52 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.274 1.43 . . . . 74.31 112.648 -170.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . 0.701 HG21 ' HA ' ' D' ' 128' ' ' LEU . 4.4 tt -145.98 101.14 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.202 0.601 . . . . 71.52 109.584 172.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -177.39 93.43 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.805 1.242 . . . . 75.0 109.295 174.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 82.4 mt 57.81 -165.15 0.17 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.281 1.032 . . . . 71.15 112.535 175.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 9' ' ' ALA . . . . . 0.438 ' HA ' ' HE3' ' H' ' 2' ' ' LYS . . . -150.21 -62.61 0.2 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.326 -1.361 . . . . 71.03 107.326 161.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.89 124.75 6.04 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 107.987 -1.116 . . . . 74.14 107.987 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 67.8 mt -68.05 156.94 88.57 Favored Pre-proline 0 N--CA 1.487 1.392 0 C-N-CA 123.675 0.79 . . . . 74.1 110.958 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -47.59 -51.98 8.8 Favored 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 123.612 2.875 . . . . 73.42 112.608 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 19.7 tp -170.63 -84.46 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.696 0.798 . . . . 74.33 108.881 166.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 92.1 mt -109.9 -161.95 0.78 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.96 0.904 . . . . 75.34 110.232 -173.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -141.27 158.95 43.21 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.204 -1.035 . . . . 73.33 108.204 172.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 24.6 p -56.88 131.4 79.21 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 124.435 1.094 . . . . 75.54 112.095 -175.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.87 152.22 77.46 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.125 2.55 . . . . 60.15 113.616 -173.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . 0.691 HG21 HD11 ' D' ' 98' ' ' LEU . 88.9 t -63.28 -56.52 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.035 0.934 . . . . 64.05 110.448 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 19' ' ' THR . . . . . 0.514 HG21 HG12 ' H' ' 18' ' ' VAL . 12.4 p -144.0 -149.79 0.29 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 113.954 -1.475 . . . . 72.21 108.658 -172.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -62.69 99.12 0.14 Allowed 'General case' 0 C--N 1.36 1.056 0 CA-C-O 121.102 0.477 . . . . 74.2 111.054 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . 0.571 ' HB1' ' SD ' ' D' ' 94' ' ' MET . . . -110.4 128.38 55.55 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.86 0.864 . . . . 75.21 109.243 175.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -69.8 88.94 0.55 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.868 0.842 . . . . 72.23 110.432 174.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 9.6 t -153.56 142.58 14.63 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-N 113.98 -1.464 . . . . 72.22 108.384 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.9 89.84 0.43 Allowed 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.524 2.149 . . . . 74.53 112.344 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 CA--C 1.551 1.008 0 C-N-CA 123.742 0.817 . . . . 75.02 110.525 177.609 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.486 1.345 0 N-CA-C 109.606 -0.516 . . . . 55.32 109.606 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 p -60.44 96.29 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.153 0.981 . . . . 71.15 111.6 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -90.14 -52.74 4.8 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.804 0.842 . . . . 72.11 109.066 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -134.18 35.59 3.26 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 122.275 1.036 . . . . 75.44 109.071 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.15 80.43 9.06 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.572 0.701 . . . . 63.34 109.427 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -76.27 -49.28 17.45 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.777 -1.101 . . . . 63.11 110.418 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.9 p -70.11 -14.7 62.78 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.429 -0.805 . . . . 74.23 112.069 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -63.91 -37.09 86.12 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.465 0.706 . . . . 62.21 109.898 172.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.437 ' SD ' ' N ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -73.46 148.23 43.41 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.645 -0.872 . . . . 75.14 108.645 174.108 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.437 ' N ' ' SD ' ' A' ' 9' ' ' MET . 87.9 m -138.13 124.47 20.56 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.481 0.713 . . . . 74.23 109.308 -173.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.697 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.5 t80 -136.79 136.36 38.79 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 124.046 0.842 . . . . 75.42 109.289 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.482 ' HG3' ' NE2' ' A' ' 14' ' ' GLN . 26.7 tp60 -155.65 97.41 1.85 Allowed 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.29 -1.004 . . . . 74.2 108.29 177.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.449 HG12 ' HD2' ' A' ' 84' ' ' PHE . 29.5 mt -68.21 120.47 15.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 108.729 -0.841 . . . . 74.34 108.729 176.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.482 ' NE2' ' HG3' ' A' ' 12' ' ' GLN . 27.8 mm-40 -81.8 -40.19 22.94 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 123.832 0.707 . . . . 73.23 109.994 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -175.66 122.67 0.2 Allowed 'General case' 0 C--N 1.359 0.994 0 O-C-N 123.426 0.454 . . . . 74.45 111.352 -171.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.513 HD13 ' HG3' ' C' ' 130' ' ' PRO . 88.8 mt -106.96 136.16 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.603 -0.888 . . . . 63.11 108.603 169.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.408 ' HB3' HG23 ' B' ' 122' ' ' THR . 24.0 p90 -164.13 166.19 21.49 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.189 0.996 . . . . 72.11 110.597 -174.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.5 p -96.61 119.12 34.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.534 -0.757 . . . . 73.24 109.012 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -87.09 -30.14 21.35 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.166 -0.679 . . . . 72.25 109.166 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 16.7 t70 -144.83 137.13 26.13 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.189 -0.914 . . . . 75.35 109.276 177.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.9 mt -133.69 142.97 40.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 106.384 -1.71 . . . . 75.23 106.384 174.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.6 t -150.26 135.36 17.83 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.624 -0.51 . . . . 63.22 109.624 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.557 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 87.9 t80 -136.79 137.67 40.05 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.421 -1.696 . . . . 75.13 106.421 172.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -137.75 141.45 40.97 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 108.521 -0.918 . . . . 74.53 108.521 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.68 75.27 31.77 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 106.549 -1.649 . . . . 74.44 106.549 171.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.36 -42.84 31.74 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.284 2.656 . . . . 75.31 112.76 -171.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.457 ' ND2' ' HG3' ' A' ' 71' ' ' GLU . 11.2 m-20 -101.64 22.76 12.25 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 118.35 -0.834 . . . . 63.51 109.913 -178.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.448 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -42.61 -58.31 3.87 Favored Pre-proline 0 N--CA 1.497 1.906 0 N-CA-C 113.867 1.062 . . . . 74.52 113.867 -170.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.448 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 14.4 Cg_exo -65.66 -24.76 54.92 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 121.7 1.6 . . . . 74.31 112.778 -174.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -81.26 -43.33 19.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.114 -0.948 . . . . 72.43 109.91 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.619 HG22 ' HA ' ' A' ' 73' ' ' ALA . 5.2 p -76.32 -14.01 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 115.039 -0.982 . . . . 71.31 112.505 -162.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -69.62 -12.14 61.4 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.871 0.468 . . . . 73.42 111.68 173.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -83.34 -25.59 31.31 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.389 1.076 . . . . 71.51 110.823 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HZ1' ' HB3' ' A' ' 71' ' ' GLU . 23.3 mmtp -68.14 149.61 49.37 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.658 0.783 . . . . 74.44 111.808 -177.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -71.13 131.96 44.35 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.301 -1.0 . . . . 70.33 108.301 171.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -77.77 82.01 4.18 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.798 0.809 . . . . 73.22 110.608 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -128.8 81.23 71.21 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 106.938 -1.504 . . . . 74.04 106.938 168.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -82.98 145.59 12.53 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.65 2.233 . . . . 74.25 112.318 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -97.83 89.83 4.73 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 105.823 -1.917 . . . . 74.31 105.823 168.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.572 HG11 HG11 ' A' ' 64' ' ' VAL . 96.6 t -72.16 92.42 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.425 -0.954 . . . . 75.41 108.425 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.493 ' HB2' ' HZ2' ' A' ' 41' ' ' LYS . 5.0 ttmp? -87.58 115.47 25.03 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.591 -1.186 . . . . 72.52 108.285 174.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.7 pp -95.41 130.59 42.16 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.788 -1.19 . . . . 65.32 107.788 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.604 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.1 m-20 -120.21 105.71 11.23 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 107.796 -1.187 . . . . 75.35 107.796 176.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.7 mp -98.22 146.7 25.36 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.789 -0.819 . . . . 74.12 108.789 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.584 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 24.9 t70 -145.81 148.27 32.74 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 109.491 -0.559 . . . . 74.24 109.491 177.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 49.1 p -106.44 125.99 51.69 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.556 -0.747 . . . . 63.11 110.247 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.512 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -132.91 133.37 43.16 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.035 0.934 . . . . 75.31 108.733 176.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.9 m -133.66 159.26 41.05 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.235 0.614 . . . . 72.34 110.96 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.3 t -158.22 147.77 19.65 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.856 0.863 . . . . 72.12 109.184 174.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -106.81 119.09 38.4 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.118 -1.067 . . . . 63.02 108.118 172.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.486 HD12 HG22 ' A' ' 83' ' ' ILE . 50.3 mt -93.09 -37.72 11.99 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.163 0.585 . . . . 72.52 111.087 -173.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.79 -171.98 3.31 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.718 0.807 . . . . 75.33 110.3 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -63.59 119.45 9.87 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.553 0.741 . . . . 75.13 109.633 170.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 70.74 -7.19 1.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.773 1.229 . . . . 64.32 112.598 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.62 110.72 28.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 N-CA-C 107.965 -1.124 . . . . 75.12 107.965 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -134.1 128.48 34.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.363 -0.835 . . . . 74.53 109.28 -170.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -96.12 127.58 42.25 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.853 0.861 . . . . 74.13 110.921 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.452 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 68.0 t -107.44 124.58 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 107.106 -1.442 . . . . 74.41 107.106 168.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 44.0 t -119.62 124.57 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.367 -0.975 . . . . 70.34 108.367 172.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.8 tt -115.85 115.47 26.31 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.774 -1.195 . . . . 74.14 107.774 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.584 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 49.2 ttt180 -84.11 99.72 10.66 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.897 -1.149 . . . . 72.51 107.897 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 49.9 t -97.96 101.67 12.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.027 -1.101 . . . . 71.21 108.027 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.604 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 21.9 m -102.6 143.7 31.95 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.891 -0.781 . . . . 74.41 108.891 175.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.599 HG13 HD23 ' A' ' 126' ' ' LEU . 24.7 t -136.87 137.55 46.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 125.445 1.498 . . . . 72.22 107.201 173.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.4 m -132.29 127.15 35.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.719 -0.845 . . . . 71.54 108.719 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.62 104.26 14.28 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 107.949 -1.13 . . . . 72.41 107.949 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 50.5 m -108.0 126.86 53.21 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.572 0.349 . . . . 73.12 110.464 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.487 HD13 ' HB1' ' A' ' 73' ' ' ALA . 12.2 mt -103.94 83.11 2.06 Favored 'General case' 0 C--O 1.249 1.065 0 C-N-CA 124.052 0.941 . . . . 74.13 108.535 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.13 -84.79 1.13 Allowed Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.282 -0.872 . . . . 75.53 111.715 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.38 -26.2 3.36 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.925 0.89 . . . . 63.35 110.045 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.457 ' HG3' ' ND2' ' A' ' 27' ' ' ASN . 45.5 tt0 -94.17 112.65 24.47 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.784 0.834 . . . . 75.4 109.643 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 94.0 m -73.25 135.37 44.49 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.018 0.437 . . . . 55.1 110.441 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.619 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -72.61 -61.99 1.61 Allowed 'General case' 0 C--O 1.243 0.75 0 CA-C-N 114.679 -1.146 . . . . 72.02 110.078 176.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -156.23 174.85 14.78 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 114.806 -1.088 . . . . 74.43 112.124 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.3 tp -133.67 135.46 44.12 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.778 1.631 . . . . 73.32 107.647 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 79.2 m -134.96 105.41 6.37 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.042 0.937 . . . . 71.05 109.632 178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -126.54 115.91 20.26 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.257 1.023 . . . . 71.33 109.141 -174.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.4 t -129.74 114.52 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.277 0.631 . . . . 71.31 109.487 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.57 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 75.6 mt-30 -85.0 88.14 7.43 Favored 'General case' 0 C--O 1.249 1.048 0 N-CA-C 108.334 -0.987 . . . . 62.44 108.334 170.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.414 ' HG3' HD23 ' A' ' 106' ' ' LEU . 8.4 tp-100 -77.34 104.96 8.15 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 114.849 -1.069 . . . . 72.41 109.16 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.98 147.35 20.94 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 111.325 -0.71 . . . . 62.14 111.325 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.516 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -152.05 120.77 1.11 Allowed Glycine 0 CA--C 1.499 -0.93 0 N-CA-C 110.78 -0.928 . . . . 74.52 110.78 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.486 HG22 HD12 ' A' ' 51' ' ' LEU . 39.1 mt -83.61 121.49 36.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 108.308 -0.997 . . . . 74.12 108.308 173.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.697 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 33.0 m-85 -129.67 137.49 50.65 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.66 -0.867 . . . . 74.22 108.66 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.1 t -103.69 98.33 8.22 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.995 -0.743 . . . . 73.31 108.995 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.447 HG12 HG23 ' E' ' 18' ' ' VAL . 0.2 OUTLIER -136.11 153.45 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.626 1.17 . . . . 75.23 109.315 179.172 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.31 -32.39 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.552 -0.749 . . . . 73.24 111.127 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.0 64.52 3.91 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.229 -0.441 . . . . 72.24 112.998 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' A' ' 94' ' ' MET . 4.0 pt -147.58 123.39 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.636 1.174 . . . . 74.45 108.836 -175.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -137.38 167.02 22.45 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.934 0.893 . . . . 72.5 110.299 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.02 -136.78 29.12 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.406 0.441 . . . . 75.02 112.599 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.0 t -80.32 -15.27 57.29 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.008 0.523 . . . . 71.44 110.598 174.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -67.65 -34.78 77.62 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.613 0.765 . . . . 74.32 111.011 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.483 ' HA ' ' HB ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -66.77 -41.29 87.96 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 109.845 -0.428 . . . . 74.24 109.845 176.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.86 -29.38 66.6 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.948 0.899 . . . . 62.25 110.934 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -68.53 -39.47 81.16 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.033 0.933 . . . . 73.12 109.888 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.541 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 43.7 t -69.34 -52.92 22.55 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 123.732 0.645 . . . . 65.01 111.429 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.569 HD23 HG11 ' E' ' 18' ' ' VAL . 3.7 pp -77.5 -20.96 53.48 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.893 0.477 . . . . 72.13 111.782 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.563 ' HA3' HD22 ' E' ' 14' ' ' LEU . . . -102.57 -16.11 23.13 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 115.223 0.849 . . . . 63.33 115.223 -170.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.02 -43.83 0.14 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.616 0.708 . . . . 75.1 112.727 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.541 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 67.9 t80 -67.9 -68.97 0.35 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.815 0.846 . . . . 75.1 111.301 -170.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 76.0 m -65.56 -35.85 12.93 Favored Pre-proline 0 CA--C 1.568 1.641 0 C-N-CA 123.573 0.749 . . . . 64.11 112.781 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -47.56 -48.56 15.25 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 122.774 2.316 . . . . 74.21 114.383 162.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.425 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 29.7 t-20 -69.72 -24.35 63.55 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.089 0.555 . . . . 72.25 110.516 -177.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 38.8 mm -63.39 -39.46 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.218 0.532 . . . . 72.23 110.567 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.516 HD21 ' HA3' ' A' ' 82' ' ' GLY . 91.2 mt -78.63 -24.94 44.99 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.617 0.767 . . . . 75.34 112.056 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -60.65 -47.38 96.18 Favored Pre-proline 0 CA--C 1.565 1.557 0 N-CA-C 114.256 1.206 . . . . 75.21 114.256 -171.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 104' ' ' ASN . 37.0 Cg_exo -62.61 -32.48 79.27 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.034 1.823 . . . . 73.24 113.121 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.463 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 80.7 m-85 -77.37 -38.29 50.41 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.685 0.794 . . . . 74.22 111.002 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.11 -37.25 75.32 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.146 0.578 . . . . 75.31 110.046 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.46 ' NH1' HD13 ' C' ' 105' ' ' ILE . 24.1 ttm180 -60.63 -50.64 72.71 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.215 1.006 . . . . 74.22 109.732 174.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.1 -42.86 88.71 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.81 0.693 . . . . 72.03 110.646 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 43.5 t -62.65 -32.76 73.86 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.813 0.445 . . . . 74.41 110.666 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.3 mt -67.55 -55.76 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 123.518 0.727 . . . . 74.3 109.932 170.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.52 HG21 ' HE2' ' C' ' 109' ' ' TYR . 87.8 m -55.22 -38.38 68.36 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.016 1.326 . . . . 75.2 111.894 -175.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 47.5 t -63.29 -50.03 71.71 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.479 -0.782 . . . . 74.21 110.07 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.557 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 50.9 mtm -63.67 -38.25 90.4 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.373 0.669 . . . . 71.33 111.578 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.9 t -64.18 -53.17 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.807 0.843 . . . . 75.14 110.62 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.2 t -67.52 -31.41 71.51 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.613 -0.722 . . . . 73.04 110.839 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 116' ' ' SER . 24.9 ttm-85 -72.13 -32.77 67.24 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.489 1.116 . . . . 75.53 108.46 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.411 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.82 14.25 53.11 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-N 114.561 -1.2 . . . . 60.05 113.47 173.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.472 HG23 ' HE ' ' B' ' 15' ' ' ARG . 1.3 t 63.38 12.28 6.15 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 126.471 1.908 . . . . 73.23 114.178 172.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -83.16 148.51 56.48 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 108.562 -0.903 . . . . 72.0 108.562 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.15 163.11 10.42 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.215 2.61 . . . . 73.54 113.205 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -57.04 122.46 12.39 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.32 -0.855 . . . . 71.41 112.367 -171.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.599 HD23 HG13 ' A' ' 64' ' ' VAL . 52.0 tp -121.95 106.77 11.53 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.588 1.155 . . . . 71.41 109.022 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -130.14 121.09 25.63 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.996 0.918 . . . . 74.32 108.945 176.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.631 HD22 HD12 ' E' ' 6' ' ' ILE . 96.5 mt -68.25 143.72 55.16 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.797 0.439 . . . . 73.41 109.895 173.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.471 ' HB1' ' HA ' ' E' ' 7' ' ' ALA . . . -68.41 136.86 91.0 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.123 0.569 . . . . 72.22 110.384 178.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.585 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 2.7 Cg_endo -79.29 92.12 1.15 Allowed 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.84 2.36 . . . . 74.2 110.609 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.2 t -101.64 113.39 37.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.338 -0.986 . . . . 75.34 108.338 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -69.73 100.05 1.44 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.804 -0.813 . . . . 71.11 108.804 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -50.71 -44.76 58.19 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.968 0.907 . . . . 73.11 111.017 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -66.09 -36.91 84.44 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.171 -1.377 . . . . 45.55 112.644 -176.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.64 -40.25 96.4 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 123.623 0.577 . . . . 73.43 110.408 176.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.7 mp -71.42 -32.24 68.16 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 116.025 -0.534 . . . . 75.12 110.723 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -68.4 -28.12 66.81 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.876 0.47 . . . . 73.13 110.602 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 22.5 mmt -69.7 -33.3 72.33 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.449 0.7 . . . . 74.21 110.491 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 143' ' ' GLN . 0.9 OUTLIER -59.16 -35.57 73.77 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 123.679 0.612 . . . . 73.33 111.052 174.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -85.45 -29.69 24.12 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.726 0.811 . . . . 75.33 111.389 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.2 tp -66.04 -48.8 69.87 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.086 0.555 . . . . 72.25 110.408 -174.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -169.72 -15.45 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.785 0.661 . . . . 73.41 112.785 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' A' ' 139' ' ' ASN . 63.8 mm-40 -99.47 70.84 1.72 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.135 0.574 . . . . 71.54 110.388 -170.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -66.09 88.08 0.11 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.214 0.606 . . . . 73.2 110.586 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.629 ' HA ' HG21 ' C' ' 7' ' ' THR . . . 61.42 -163.97 0.25 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.345 1.058 . . . . 74.32 112.209 175.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 97.53 103.75 2.25 Favored Glycine 0 C--N 1.344 1.027 0 N-CA-C 111.267 -0.733 . . . . 75.04 111.267 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -165.36 140.3 5.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.04 0.936 . . . . 63.45 109.15 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -77.92 169.43 54.6 Favored Glycine 0 C--N 1.35 1.347 0 O-C-N 123.636 0.585 . . . . 50.32 111.829 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.622 ' HA ' ' HA2' ' C' ' 88' ' ' GLY . 12.7 p -135.84 148.61 48.74 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.694 0.798 . . . . 74.31 109.33 176.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.69 105.63 3.46 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 107.564 -1.273 . . . . 71.44 107.564 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.64 -27.48 68.41 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.912 0.885 . . . . 74.33 111.71 -174.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 80.0 t60 66.86 115.76 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.095 1.358 . . . . 64.44 112.94 171.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -131.05 1.1 4.24 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.923 0.489 . . . . 74.15 111.283 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -76.29 94.71 3.62 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.286 0.565 . . . . 74.03 110.536 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 N-CA-C 108.494 -0.928 . . . . 73.02 108.494 177.191 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 C--O 1.244 0.804 0 N-CA-C 110.004 -0.369 . . . . 64.02 110.004 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 67.9 m -137.67 122.34 18.63 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.177 0.991 . . . . 64.33 109.023 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -137.9 111.62 8.23 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.85 0.86 . . . . 65.22 109.114 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -148.28 115.29 6.11 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.087 -0.709 . . . . 64.5 109.087 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -85.77 162.49 18.67 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.347 0.659 . . . . 73.25 110.46 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -114.89 88.33 2.85 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.899 -1.148 . . . . 74.54 107.899 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 32.3 m -137.37 103.67 5.15 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.485 0.714 . . . . 75.41 109.191 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.23 -175.24 5.23 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 124.251 1.02 . . . . 74.52 108.788 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 57.6 ttm 66.17 166.21 0.2 Allowed 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 125.003 1.321 . . . . 75.03 111.336 -174.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 96.6 m -150.1 118.34 6.39 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 106.163 -1.791 . . . . 75.45 106.163 171.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -127.17 144.59 51.0 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.342 -0.614 . . . . 72.24 109.342 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.476 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -155.52 136.44 13.64 Favored 'General case' 0 C--O 1.243 0.715 0 O-C-N 123.671 0.607 . . . . 72.14 110.064 173.011 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.521 HD12 HD11 ' B' ' 16' ' ' ILE . 58.4 mt -76.75 125.4 36.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.492 0 N-CA-C 108.456 -0.942 . . . . 75.43 108.456 169.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -92.17 -49.86 5.97 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.833 -0.803 . . . . 72.53 108.833 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.472 ' HE ' HG23 ' A' ' 122' ' ' THR . 42.9 ttt180 -164.5 134.04 3.81 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.685 -0.689 . . . . 72.15 110.217 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.521 HD11 HD12 ' B' ' 13' ' ' ILE . 76.1 mt -115.24 140.42 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 124.042 0.937 . . . . 74.11 108.603 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -169.18 152.1 4.91 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 112.707 0.632 . . . . 75.15 112.707 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 82.5 m -76.76 125.45 29.3 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.968 -1.015 . . . . 72.23 109.008 169.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -97.87 -31.83 12.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.099 0.56 . . . . 73.0 111.482 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 10.9 t70 -155.66 136.62 13.65 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.275 -0.421 . . . . 72.22 109.992 -168.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.494 HD13 ' SG ' ' B' ' 113' ' ' CYS . 46.7 mm -135.15 142.36 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.69 1.196 . . . . 75.11 108.68 177.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.8 t -149.34 108.17 3.86 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.803 -1.184 . . . . 65.43 107.803 173.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -122.56 118.89 29.29 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 107.644 -1.243 . . . . 64.44 107.644 172.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -118.91 153.03 35.23 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.13 0.972 . . . . 75.42 108.697 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.37 80.32 14.86 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 106.32 -1.733 . . . . 65.44 106.32 173.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.49 -31.0 42.93 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.059 2.506 . . . . 74.33 113.095 -168.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -108.94 14.78 23.91 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.188 0.595 . . . . 71.14 110.828 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.51 -64.34 0.73 Allowed Pre-proline 0 N--CA 1.492 1.661 0 N-CA-C 114.959 1.466 . . . . 62.31 114.959 -166.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.3 -30.62 73.69 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.215 1.943 . . . . 73.4 113.702 -168.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -94.24 -28.68 15.48 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.744 0.418 . . . . 72.25 111.401 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.581 HG21 HD13 ' B' ' 68' ' ' LEU . 2.8 p -73.04 -20.12 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 122.594 0.357 . . . . 75.2 110.464 -176.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -65.43 -14.78 61.68 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.903 0.881 . . . . 75.11 113.104 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -68.05 -19.21 64.87 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.818 0.447 . . . . 74.35 110.701 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -90.6 106.34 18.44 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.451 1.101 . . . . 75.12 109.932 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -93.93 83.87 4.44 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.313 0.645 . . . . 64.35 110.626 -174.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -169.03 173.52 6.84 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.231 1.013 . . . . 75.33 109.854 170.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -85.16 121.54 73.99 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 109.14 -0.689 . . . . 75.44 109.14 176.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.12 165.53 31.07 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.772 2.315 . . . . 75.24 113.863 -175.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 10.1 tp10 -69.76 126.33 29.41 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.388 -0.824 . . . . 75.14 109.483 176.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.7 140.54 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.394 0.616 . . . . 74.03 111.16 -171.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.625 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 63.2 mttp -126.91 143.73 51.19 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.432 1.093 . . . . 72.55 109.696 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.663 HD22 HG13 ' F' ' 6' ' ' ILE . 3.4 mm? -114.07 132.5 56.0 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.924 0.89 . . . . 74.33 108.634 175.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -151.2 109.29 3.72 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 108.23 -1.026 . . . . 72.31 108.23 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.458 HD22 HD13 ' F' ' 8' ' ' LEU . 9.9 mp -102.41 157.03 17.2 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.471 -0.566 . . . . 73.43 109.471 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -139.28 153.9 47.86 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 108.445 -0.946 . . . . 75.53 108.445 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 74.3 p -107.66 118.39 36.61 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.362 -0.835 . . . . 74.25 108.929 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -126.87 136.37 52.24 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.552 -1.277 . . . . 54.21 107.552 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 59.7 p -143.25 163.04 34.05 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-O 120.628 0.251 . . . . 75.24 111.132 -174.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' SER . . . . . 0.487 ' HA ' ' HB3' ' F' ' 22' ' ' ARG . 74.9 p -153.28 137.03 16.09 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.739 0.816 . . . . 74.03 109.499 173.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -94.62 111.47 23.23 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.529 -1.286 . . . . 74.31 107.529 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.586 HD12 HG22 ' B' ' 83' ' ' ILE . 41.5 mt -81.15 -53.55 6.28 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.041 0.448 . . . . 74.24 110.809 -176.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.01 -177.09 5.36 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.123 -0.944 . . . . 75.14 109.517 -175.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.43 109.74 1.45 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.349 0.66 . . . . 71.52 110.011 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 69.15 4.88 4.79 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 125.011 1.324 . . . . 73.24 113.347 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.4 t -104.77 117.54 50.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.615 -1.254 . . . . 72.52 107.615 172.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -123.16 177.26 5.63 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 121.352 0.596 . . . . 75.41 109.822 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -142.66 102.64 4.09 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.446 -1.316 . . . . 74.14 107.446 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 65.5 t -89.43 121.25 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.626 1.171 . . . . 75.03 109.739 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.493 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.6 t -109.2 109.57 28.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 C-N-CA 123.529 0.732 . . . . 75.2 109.26 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 35.6 tp -93.31 109.42 20.96 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.306 -0.627 . . . . 74.41 109.306 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -86.83 117.99 25.92 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 108.614 -0.884 . . . . 74.22 108.614 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.407 ' HA ' ' HG ' ' B' ' 44' ' ' LEU . 14.3 t -112.19 116.82 53.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 108.392 -0.966 . . . . 72.53 108.392 172.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.8 m -112.36 138.45 49.06 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.827 0.822 . . . . 75.12 109.404 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.594 HG22 HG21 ' B' ' 114' ' ' ILE . 54.4 t -127.19 131.41 70.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 125.644 1.578 . . . . 70.34 108.284 -174.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 89.2 m -117.95 146.19 44.16 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.31 -0.626 . . . . 73.44 109.31 173.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.94 139.34 23.62 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.602 0.761 . . . . 71.32 110.085 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.537 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 17.7 p -147.49 127.21 13.4 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.486 0.492 . . . . 61.35 111.619 -176.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.581 HD13 HG21 ' B' ' 31' ' ' VAL . 54.7 mt -98.32 107.39 19.84 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 107.812 -1.181 . . . . 75.41 107.812 174.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.98 -131.53 12.54 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 120.024 -0.32 . . . . 74.01 112.572 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -99.01 17.47 19.62 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.592 0.757 . . . . 73.02 111.687 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -138.84 154.24 48.42 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.424 0.689 . . . . 74.52 109.9 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 49.5 m -77.94 123.32 26.65 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.908 0.385 . . . . 72.23 111.061 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.537 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -74.4 -60.77 2.12 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.322 -0.992 . . . . 63.3 108.322 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -155.85 156.92 35.53 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 115.252 -0.885 . . . . 74.52 112.328 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 79.7 mt -125.68 119.87 29.17 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 125.74 1.616 . . . . 73.53 106.973 175.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.415 ' SG ' HG22 ' B' ' 114' ' ' ILE . 49.3 t -118.28 150.39 39.54 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.709 -0.848 . . . . 72.34 108.709 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -159.88 126.43 4.38 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.419 -0.956 . . . . 74.31 108.419 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 86.9 t -122.69 145.94 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.325 -0.852 . . . . 74.14 109.146 176.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.445 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 18.1 mt-30 -120.65 97.1 5.4 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.271 -1.011 . . . . 74.24 108.271 169.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -87.07 101.53 13.55 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.8 -0.815 . . . . 63.55 108.8 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.08 164.08 33.55 Favored Glycine 0 C--O 1.246 0.848 0 O-C-N 123.903 0.752 . . . . 61.22 111.862 177.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.39 126.07 1.44 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.867 -0.493 . . . . 73.42 111.867 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.586 HG22 HD12 ' B' ' 51' ' ' LEU . 59.9 mt -84.61 130.02 36.71 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 108.31 -0.996 . . . . 75.44 108.31 172.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -139.22 156.5 47.05 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.147 0.579 . . . . 71.0 109.473 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 69.1 m -121.27 133.07 55.13 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.999 0.92 . . . . 71.25 109.126 175.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.429 HG23 HG22 ' F' ' 18' ' ' VAL . 12.4 tt -130.56 148.96 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.526 0.73 . . . . 74.43 110.576 -177.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.25 175.07 14.48 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.909 0.884 . . . . 73.43 109.621 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.51 -56.29 4.72 Favored Glycine 0 N--CA 1.473 1.128 0 C-N-CA 123.128 0.394 . . . . 72.53 112.586 175.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.559 HG23 ' HB3' ' B' ' 94' ' ' MET . 7.4 mm -90.9 153.02 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.04 0.936 . . . . 75.0 110.93 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -147.21 -178.6 6.31 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.757 1.223 . . . . 70.25 109.104 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.31 -134.42 22.86 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 115.548 -0.751 . . . . 61.3 113.973 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 54.1 m -75.38 -33.64 61.03 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.559 0.744 . . . . 72.5 111.944 -177.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -60.78 -33.04 72.37 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.369 0.668 . . . . 72.03 111.854 -175.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.559 ' HB3' HG23 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -86.12 -24.62 26.16 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.695 0.398 . . . . 72.15 111.816 176.215 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.75 -32.26 73.71 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.033 0.533 . . . . 70.1 110.817 172.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -76.42 -36.08 58.19 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.554 -0.748 . . . . 71.52 110.966 172.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.0 t -60.67 -52.4 65.28 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.016 0.527 . . . . 73.32 111.354 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.523 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 0.5 OUTLIER -80.52 -13.53 59.01 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.251 0.463 . . . . 74.55 112.251 175.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.23 1.44 62.63 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-O 119.608 -0.551 . . . . 63.42 113.784 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.47 -53.38 0.11 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 117.482 0.641 . . . . 75.35 110.957 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -70.73 -50.33 37.32 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.174 0.59 . . . . 73.23 112.559 -172.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.523 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 61.2 m -60.79 -47.26 96.29 Favored Pre-proline 0 CA--C 1.563 1.452 0 CA-C-O 118.811 -0.614 . . . . 72.51 111.626 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 48.4 Cg_exo -60.8 -32.7 93.14 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 122.432 2.088 . . . . 71.11 114.106 171.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -61.01 -38.09 84.86 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.828 0.851 . . . . 64.33 110.202 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.47 -40.79 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 114.976 -1.011 . . . . 72.03 110.606 174.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 56.3 mt -86.4 -13.12 47.27 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.975 -1.011 . . . . 75.33 111.765 -171.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -55.31 -52.29 72.73 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 124.019 0.928 . . . . 75.11 112.915 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -59.76 -37.0 89.75 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.324 2.016 . . . . 72.33 114.088 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -67.83 -44.57 76.89 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.03 0.532 . . . . 75.14 110.635 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.98 -36.42 83.26 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.726 -0.67 . . . . 65.43 110.822 176.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -61.96 -50.5 71.86 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.967 1.307 . . . . 71.52 110.256 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -68.73 -33.61 74.22 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 115.309 -0.86 . . . . 74.43 109.704 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.494 ' SG ' HD13 ' B' ' 21' ' ' ILE . 13.5 t -66.55 -44.47 82.26 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.934 0.494 . . . . 72.31 111.77 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.594 HG21 HG22 ' B' ' 64' ' ' VAL . 95.2 mt -60.05 -53.5 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 108.894 -0.78 . . . . 75.14 108.894 175.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 38.5 m -57.02 -36.05 69.98 Favored 'General case' 0 CA--C 1.553 1.064 0 O-C-N 124.371 1.045 . . . . 73.13 111.602 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.2 t -62.74 -47.21 84.56 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 123.526 0.73 . . . . 53.54 109.749 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 9.7 mmt -70.38 -35.8 73.73 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.006 0.523 . . . . 74.14 111.172 -176.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.472 HG21 ' O ' ' B' ' 114' ' ' ILE . 97.0 t -60.24 -43.92 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.763 0.825 . . . . 65.45 109.801 172.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.2 t -65.34 -33.0 74.94 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.646 -1.161 . . . . 71.43 111.355 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' B' ' 116' ' ' SER . 83.0 mtt-85 -71.04 -36.21 72.27 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.536 -0.756 . . . . 73.43 110.187 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.95 -3.65 81.21 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 123.752 0.658 . . . . 72.11 112.316 172.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.408 HG23 ' HB3' ' A' ' 17' ' ' TYR . 23.6 p 62.82 35.01 14.01 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.446 1.899 . . . . 64.24 112.428 173.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -93.69 164.45 20.83 Favored Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 124.103 0.961 . . . . 74.22 110.67 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.04 166.15 1.04 Allowed 'Trans proline' 0 C--N 1.393 2.869 0 C-N-CA 123.663 2.909 . . . . 73.52 115.524 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -63.54 121.4 13.77 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 115.375 -0.83 . . . . 71.24 111.127 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 18.6 tp -129.2 98.43 4.9 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.046 -0.524 . . . . 75.54 109.922 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -124.38 121.26 34.45 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.863 0.865 . . . . 75.43 109.591 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mp -64.88 149.25 49.89 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.949 0.5 . . . . 72.55 111.117 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.9 150.99 73.05 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.452 0.701 . . . . 61.31 110.023 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -67.64 129.45 19.99 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 123.031 2.487 . . . . 73.03 112.395 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 26.0 m -131.95 128.4 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.46 0.704 . . . . 72.24 109.257 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -109.13 102.13 11.12 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 107.252 -1.388 . . . . 73.23 107.252 173.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -60.93 -47.73 85.09 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.17 0.918 . . . . 73.43 110.102 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -60.85 -40.73 93.99 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 114.283 -1.326 . . . . 62.12 112.014 -174.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.98 -40.13 79.89 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 123.906 0.754 . . . . 65.05 111.927 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.681 HD11 HD22 ' F' ' 10' ' ' LEU . 62.9 mt -76.67 -44.25 34.54 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.576 -0.738 . . . . 74.32 111.219 -176.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -70.98 -27.43 63.71 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.055 0.542 . . . . 75.2 111.756 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 10.7 tmm? -68.42 -35.0 76.99 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.509 0.724 . . . . 73.13 109.293 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -75.33 -5.82 46.71 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.763 -1.108 . . . . 73.03 111.856 -172.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -82.31 -26.83 32.7 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 122.791 0.436 . . . . 71.31 110.028 171.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 63.5 mt -104.43 13.69 31.45 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.244 1.018 . . . . 74.1 111.35 -176.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -65.98 129.58 40.27 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.05 0.54 . . . . 70.14 110.384 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -163.2 129.49 3.31 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.148 -0.686 . . . . 73.4 109.148 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -150.35 153.27 35.76 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.392 0.677 . . . . 73.5 110.137 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.18 98.7 1.31 Allowed 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.377 1.071 . . . . 53.51 108.547 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.5 156.95 15.26 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.698 -0.561 . . . . 73.35 111.698 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.91 142.12 37.04 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 108.805 -0.813 . . . . 54.24 108.805 178.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -139.03 103.39 0.39 Allowed Glycine 0 C--N 1.345 1.065 0 N-CA-C 111.488 -0.645 . . . . 64.21 111.488 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 14.7 t -138.57 162.08 35.46 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.657 0.783 . . . . 72.22 110.399 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -150.59 169.3 21.87 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.991 0.916 . . . . 74.32 109.639 171.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -157.84 136.47 11.28 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.553 0.741 . . . . 73.15 110.047 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -164.75 96.3 0.73 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.268 1.027 . . . . 74.53 109.171 174.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -81.23 160.83 24.19 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.386 0.675 . . . . 73.32 110.709 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -147.92 95.91 2.57 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.713 0.805 . . . . 65.1 108.875 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.19 0 C-N-CA 123.812 0.845 . . . . 50.31 109.234 -175.543 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.597 ' HE1' ' HB2' ' C' ' 5' ' ' ASN . 53.8 ttp . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.442 -0.577 . . . . 74.14 109.442 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 43.8 p -71.8 96.62 1.66 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.213 0.605 . . . . 74.43 110.256 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 65.17 -148.78 0.25 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.282 1.033 . . . . 75.21 111.88 169.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -77.38 174.81 10.39 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.013 0.925 . . . . 71.4 112.443 -170.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . 0.597 ' HB2' ' HE1' ' C' ' 1' ' ' MET . 3.4 t-20 -129.55 -43.11 1.28 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.192 0.997 . . . . 73.32 110.159 -176.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -84.07 57.27 4.1 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 122.115 0.959 . . . . 74.5 109.669 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' THR . . . . . 0.629 HG21 ' HA ' ' A' ' 145' ' ' ALA . 11.8 p -142.5 83.09 1.8 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.764 1.225 . . . . 71.01 108.966 -172.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 62.59 86.47 0.11 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.579 1.151 . . . . 72.52 112.112 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 12.6 tpt 65.8 151.85 0.06 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.196 1.398 . . . . 75.03 113.367 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 53.4 m -117.46 92.76 3.93 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.884 -0.784 . . . . 73.11 108.884 170.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.595 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 33.8 t80 -113.21 136.31 52.87 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.093 -1.077 . . . . 73.01 108.093 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -155.16 136.55 14.1 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.887 -0.412 . . . . 72.42 109.887 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.491 HG12 ' HE2' ' C' ' 84' ' ' PHE . 56.4 mt -79.2 128.54 38.47 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 N-CA-C 109.036 -0.728 . . . . 74.35 109.036 171.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -101.0 -34.99 9.53 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.598 0.759 . . . . 65.21 110.073 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -176.63 139.29 0.31 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.167 0.587 . . . . 73.2 109.74 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.0 mt -129.89 142.58 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 108.187 -1.042 . . . . 74.5 108.187 175.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.426 ' HE1' HG12 ' C' ' 83' ' ' ILE . 32.9 p90 -172.47 167.02 5.66 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.162 0.985 . . . . 72.4 109.334 -169.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -91.76 114.2 26.68 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 122.893 0.477 . . . . 73.54 109.912 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.66 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 21.8 mmtp -65.44 -42.58 92.26 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 109.362 -0.607 . . . . 64.45 109.362 168.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.7 t70 -145.53 146.8 31.57 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.932 -1.031 . . . . 73.35 110.391 -174.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.533 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.1 mt -141.72 147.48 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.819 1.648 . . . . 74.33 106.813 174.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.0 t -160.46 151.47 18.95 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.225 0.61 . . . . 72.24 110.174 176.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 77.7 t80 -155.52 112.21 3.2 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 124.384 1.074 . . . . 74.12 108.104 174.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -122.77 132.15 54.1 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.407 0.683 . . . . 72.41 110.477 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.61 86.35 4.67 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 107.634 -1.247 . . . . 74.43 107.634 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.43 -40.81 29.26 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.088 2.525 . . . . 75.44 112.03 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -91.53 18.16 7.72 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 113.902 -1.499 . . . . 73.14 111.625 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.403 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -42.99 -56.32 6.42 Favored Pre-proline 0 N--CA 1.486 1.354 0 N-CA-C 114.029 1.122 . . . . 63.43 114.029 -171.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -60.99 -40.35 53.0 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 121.76 1.64 . . . . 72.14 112.415 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -68.75 -38.03 79.83 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.16 0.984 . . . . 75.33 112.493 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.609 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.6 p -79.04 -13.98 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 C-N-CA 123.329 0.652 . . . . 62.43 111.903 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -75.3 -17.67 60.22 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 112.521 0.563 . . . . 73.43 112.521 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -103.22 36.23 2.31 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.16 0.505 . . . . 72.42 110.208 175.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.626 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 1.0 OUTLIER -119.35 149.45 41.8 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.005 0.522 . . . . 72.42 111.358 -174.536 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -59.17 101.97 0.11 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.237 1.015 . . . . 72.21 109.802 176.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.601 ' HD1' ' HB3' ' C' ' 154' ' ' ASP . 75.9 t-105 -79.07 101.76 8.03 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.153 0.502 . . . . 75.34 111.528 -171.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . 0.459 ' HB2' ' HG2' ' C' ' 153' ' ' GLN . 62.4 tt0 -163.04 76.65 1.86 Allowed Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 107.876 -1.157 . . . . 75.5 107.876 167.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -88.0 153.41 7.11 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.776 2.317 . . . . 62.32 113.316 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -87.6 109.04 19.36 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.079 -0.964 . . . . 75.13 108.927 167.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.442 HG21 HG13 ' C' ' 64' ' ' VAL . 2.7 p -72.02 100.35 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-O 121.85 0.833 . . . . 74.03 109.825 173.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -92.28 98.83 11.75 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.835 -1.172 . . . . 72.35 107.835 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 pp -103.19 154.12 19.65 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.661 0.384 . . . . 73.32 110.145 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -143.88 140.44 29.77 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.355 -0.609 . . . . 72.55 109.355 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -118.85 111.96 19.07 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.0 -0.741 . . . . 73.31 109.0 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.49 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 5.8 t70 -112.24 150.85 30.33 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.732 1.213 . . . . 75.03 108.513 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' THR . . . . . 0.589 ' HB ' ' HD2' ' G' ' 15' ' ' PHE . 76.8 p -116.48 138.07 51.67 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.506 0.723 . . . . 63.45 111.259 -170.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.34 150.19 38.81 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.253 1.021 . . . . 74.14 109.105 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 11.7 p -165.49 158.16 15.55 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.425 0.528 . . . . 75.25 112.425 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 67.7 p -160.2 143.93 14.05 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.277 1.031 . . . . 70.24 109.559 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -80.95 131.13 35.31 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.166 -0.679 . . . . 64.45 109.166 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.698 HD12 ' HB2' ' C' ' 57' ' ' GLU . 29.1 mt -107.57 -32.98 7.46 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.259 0.624 . . . . 73.03 110.846 -176.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.17 -174.53 4.76 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.459 0.704 . . . . 64.22 110.68 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -66.15 130.31 42.8 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.943 -1.026 . . . . 74.45 109.166 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 64.86 -6.89 0.29 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.836 1.255 . . . . 74.32 113.274 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 71.0 t -108.87 119.6 58.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 C-N-CA 123.259 0.623 . . . . 73.11 110.432 -167.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.522 ' HB2' HD11 ' C' ' 86' ' ' ILE . 13.6 m-85 -119.99 143.58 47.97 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.72 -1.127 . . . . 74.52 108.864 171.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.698 ' HB2' HD12 ' C' ' 51' ' ' LEU . 24.2 tt0 -83.56 110.24 18.07 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.396 -1.729 . . . . 75.41 107.862 167.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 78.6 t -96.9 112.17 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.033 -1.469 . . . . 73.52 107.033 172.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.446 HG22 ' HG2' ' C' ' 57' ' ' GLU . 90.3 t -113.04 134.05 56.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 107.983 -1.117 . . . . 74.21 107.983 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.452 HD23 ' HB2' ' C' ' 103' ' ' PRO . 26.8 tp -127.61 119.96 27.08 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.037 -0.727 . . . . 74.43 109.037 175.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.49 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.7 ttm180 -81.21 123.68 28.66 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 124.211 0.945 . . . . 72.22 109.45 173.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.1 114.94 48.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.699 -1.222 . . . . 63.1 107.699 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 36.0 m -114.63 142.82 45.96 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.426 -0.953 . . . . 74.12 108.426 -175.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.497 HG22 HG21 ' C' ' 114' ' ' ILE . 53.5 t -136.25 110.0 9.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.717 1.207 . . . . 62.11 107.894 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.491 HG23 HD22 ' C' ' 75' ' ' LEU . 3.7 m -107.0 107.2 18.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.059 -1.46 . . . . 73.31 107.059 172.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.88 122.34 40.88 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.989 -1.485 . . . . 71.32 106.989 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 44.5 m -132.87 127.35 34.24 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.889 0.376 . . . . 71.22 111.115 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.442 HD11 ' HG2' ' C' ' 34' ' ' LYS . 10.2 mt -86.02 43.76 1.07 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.385 1.474 . . . . 74.55 109.787 174.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.49 -113.51 4.61 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 109.748 -1.341 . . . . 74.41 109.748 -171.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -90.01 -28.83 18.82 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.192 0.597 . . . . 74.33 110.2 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.626 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 6.4 tp10 -72.38 102.29 3.12 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.714 -0.847 . . . . 73.31 108.714 175.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 30.1 m -68.99 123.85 22.13 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.294 -0.632 . . . . 71.43 109.294 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.609 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -66.08 -64.46 0.85 Allowed 'General case' 0 C--O 1.239 0.51 0 O-C-N 123.99 0.806 . . . . 74.52 108.908 177.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -154.61 171.85 18.8 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.47 -0.786 . . . . 73.32 110.632 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.491 HD22 HG23 ' C' ' 65' ' ' THR . 2.6 tm? -127.53 144.36 51.07 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.372 -1.714 . . . . 73.14 106.372 172.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.443 ' SG ' HG22 ' C' ' 114' ' ' ILE . 38.3 t -152.73 145.4 24.26 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.309 -0.997 . . . . 74.41 108.309 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -159.24 126.28 4.7 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.383 0.273 . . . . 74.3 110.531 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' C' ' 110' ' ' ALA . 54.9 t -133.93 113.26 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.296 1.039 . . . . 72.42 109.154 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.514 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 27.8 mt-30 -90.55 95.92 10.4 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.611 -0.885 . . . . 72.12 108.611 172.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.545 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 9.0 tp-100 -79.61 108.39 13.12 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.32 -0.854 . . . . 71.23 109.58 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.09 145.39 21.43 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.711 -0.677 . . . . 71.33 111.681 175.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.87 114.81 0.71 Allowed Glycine 0 CA--C 1.507 -0.467 0 N-CA-C 110.279 -1.128 . . . . 71.15 110.279 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.426 HG12 ' HE1' ' C' ' 17' ' ' TYR . 19.0 mm -82.66 123.32 38.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 N-CA-C 108.259 -1.015 . . . . 74.22 108.259 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.491 ' HE2' HG12 ' C' ' 13' ' ' ILE . 58.4 m-85 -132.64 138.8 47.48 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.164 0.586 . . . . 75.34 109.842 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 41.2 p -94.05 100.98 13.0 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.128 -1.064 . . . . 74.31 108.128 167.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.522 HD11 ' HB2' ' C' ' 56' ' ' TYR . 0.2 OUTLIER -116.83 128.79 74.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 C-N-CA 123.752 0.821 . . . . 71.11 109.766 -178.133 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.73 165.98 29.53 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.418 -0.81 . . . . 74.24 110.641 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . 0.622 ' HA2' ' HA ' ' A' ' 149' ' ' THR . . . 113.08 -59.97 0.36 Allowed Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.85 -0.614 . . . . 71.31 112.838 173.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 23.7 pt -90.91 172.71 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.634 0.774 . . . . 75.43 111.813 -170.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.545 ' HA ' ' HE3' ' C' ' 94' ' ' MET . 11.4 tp10 -157.4 151.23 24.32 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.204 0.602 . . . . 75.23 111.012 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.29 -132.34 11.06 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.915 -0.584 . . . . 54.1 112.529 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 42.6 p -65.76 -27.05 68.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.744 0.818 . . . . 72.51 111.495 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -58.91 -52.37 66.04 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.972 0.909 . . . . 74.23 109.629 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.545 ' HE3' ' HA ' ' C' ' 90' ' ' GLU . 50.8 ttm -67.88 -39.63 83.67 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 114.655 -1.157 . . . . 74.32 110.109 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.86 88.88 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.109 0.963 . . . . 72.31 111.856 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -70.16 -43.46 70.8 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.977 -0.556 . . . . 75.23 110.793 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.59 -41.87 95.59 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.233 0.613 . . . . 73.31 111.013 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.565 HD13 ' HD2' ' G' ' 17' ' ' PRO . 64.4 mt -84.15 -37.48 21.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.641 0.777 . . . . 74.51 111.457 -177.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.35 10.11 75.39 Favored Glycine 0 N--CA 1.476 1.335 0 N-CA-C 114.212 0.445 . . . . 62.11 114.212 -172.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' C' ' 104' ' ' ASN . . . -153.62 -59.6 0.13 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.083 0.553 . . . . 75.41 110.513 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.585 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 53.7 t80 -72.77 -42.3 64.13 Favored 'General case' 0 CA--C 1.556 1.188 0 N-CA-C 113.013 0.746 . . . . 74.24 113.013 -166.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.595 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 60.3 m -67.25 -49.91 41.96 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 123.112 0.565 . . . . 61.55 111.944 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.452 ' HB2' HD23 ' C' ' 60' ' ' LEU . 70.1 Cg_endo -71.73 -23.71 22.38 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 121.722 1.615 . . . . 72.53 112.799 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . 0.506 ' HA ' ' HD2' ' C' ' 107' ' ' PHE . 46.6 t-20 -56.22 -39.98 73.36 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 123.952 0.901 . . . . 74.1 110.153 176.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.46 HD13 ' NH1' ' A' ' 111' ' ' ARG . 34.8 mm -60.16 -41.1 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 114.382 -1.281 . . . . 75.25 111.12 175.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 68.1 mt -87.07 -19.62 28.33 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.444 0.698 . . . . 74.2 112.689 -168.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . 0.506 ' HD2' ' HA ' ' C' ' 104' ' ' ASN . 28.1 m-85 -55.47 -53.23 64.54 Favored Pre-proline 0 N--CA 1.489 1.509 0 CA-C-O 118.081 -0.961 . . . . 75.33 112.832 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -54.76 -40.19 85.94 Favored 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 122.857 2.372 . . . . 75.12 114.658 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . 0.52 ' HE2' HG21 ' A' ' 115' ' ' THR . 39.7 m-85 -66.62 -50.1 64.1 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.56 0.744 . . . . 74.23 110.77 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.545 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -64.75 -35.33 80.74 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.016 -0.993 . . . . 74.33 111.041 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -61.27 -48.28 82.15 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.159 1.384 . . . . 75.51 110.638 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.73 -35.94 77.77 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 123.515 0.51 . . . . 63.34 109.73 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.4 t -67.99 -33.2 74.18 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.376 0.67 . . . . 73.54 111.151 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.497 HG21 HG22 ' C' ' 64' ' ' VAL . 78.1 mt -72.53 -54.35 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 109.545 -0.539 . . . . 74.42 109.545 174.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 22.6 m -62.37 -28.38 69.73 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 122.909 0.484 . . . . 73.44 111.25 -175.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.6 t -65.27 -49.03 71.11 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.996 -0.742 . . . . 71.34 108.996 171.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.736 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.03 -38.16 85.13 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.602 1.161 . . . . 64.52 112.264 178.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.453 HG23 ' O ' ' C' ' 114' ' ' ILE . 68.0 t -59.39 -47.19 91.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 108.765 -0.828 . . . . 74.23 108.765 175.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 37.9 t -74.64 -23.29 58.65 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.572 -1.195 . . . . 74.31 112.272 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.417 ' HD2' ' SD ' ' C' ' 117' ' ' MET . 90.2 mtt-85 -74.43 -39.06 62.83 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.015 -0.735 . . . . 73.34 109.015 175.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.11 0.96 82.19 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 124.168 0.917 . . . . 64.53 112.172 170.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.9 p 60.87 30.7 19.81 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.687 1.995 . . . . 61.15 113.602 171.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -83.29 143.8 45.63 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 108.242 -1.022 . . . . 71.33 108.242 170.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -51.27 152.16 11.75 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.211 2.608 . . . . 64.24 113.45 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -54.17 125.98 21.15 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.575 0.954 . . . . 74.04 113.575 -170.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 21.7 tp -122.84 86.09 2.53 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 107.682 -1.229 . . . . 73.11 107.682 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -95.7 115.9 28.1 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.387 -0.824 . . . . 72.5 108.994 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.51 ' HG ' HD13 ' G' ' 6' ' ' ILE . 6.1 mp -73.11 129.01 37.12 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.334 0.654 . . . . 75.01 110.155 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.58 145.14 74.83 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 122.633 0.373 . . . . 65.34 110.932 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.513 ' HG3' HD13 ' A' ' 16' ' ' ILE . 71.4 Cg_endo -72.92 144.76 39.04 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.272 2.648 . . . . 73.41 113.369 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.747 ' HB ' HD12 ' C' ' 136' ' ' LEU . 18.5 m -137.91 134.76 45.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.213 1.005 . . . . 73.33 108.65 171.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.523 HD22 ' HE1' ' A' ' 11' ' ' PHE . 3.4 m-20 -81.71 90.24 6.33 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 118.694 -0.669 . . . . 73.33 109.644 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -54.64 -44.66 73.4 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 118.363 0.529 . . . . 60.14 112.084 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -56.35 -38.55 71.55 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.366 1.066 . . . . 73.21 111.582 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.32 -28.89 21.98 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.683 0.793 . . . . 73.33 111.7 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.747 HD12 ' HB ' ' C' ' 131' ' ' VAL . 50.4 mt -62.97 -45.91 90.21 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.451 0.701 . . . . 64.34 111.362 -175.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -60.98 -29.18 69.53 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.561 0.538 . . . . 73.4 111.61 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 64.9 mtt -78.08 -59.99 2.55 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.868 0.867 . . . . 74.24 110.855 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -58.75 -35.67 73.12 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.296 1.439 . . . . 75.43 112.058 -175.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -54.99 -84.89 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.576 1.15 . . . . 60.34 109.591 175.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 55.2 tp 61.75 -78.83 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.237 1.015 . . . . 74.22 110.705 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -138.93 2.64 2.16 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 123.5 0.72 . . . . 73.24 111.164 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -118.73 149.33 41.63 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.182 0.593 . . . . 73.43 110.796 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -167.67 102.93 0.49 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 106.604 -1.628 . . . . 73.01 106.604 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.88 157.36 33.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.633 0.773 . . . . 62.14 110.37 -177.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 176.68 176.39 44.8 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.78 -0.645 . . . . 64.03 111.769 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -88.84 54.85 3.15 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.846 0.858 . . . . 75.03 109.916 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.35 81.5 0.48 Allowed Glycine 0 C--N 1.351 1.373 0 CA-C-N 114.87 -1.059 . . . . 62.23 112.89 -177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 5.8 t -158.67 127.5 5.44 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.696 1.198 . . . . 72.32 108.231 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . 0.562 ' HG3' ' HG1' ' G' ' 5' ' ' THR . 0.6 OUTLIER -161.54 143.17 11.49 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.588 -0.523 . . . . 64.14 109.588 -175.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -98.62 -90.9 0.28 Allowed 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.827 0.851 . . . . 65.15 110.72 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 27.3 m80 43.29 79.05 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.688 1.195 . . . . 74.02 112.802 -168.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . 0.459 ' HG2' ' HB2' ' C' ' 37' ' ' GLN . 15.8 tm0? -95.31 134.3 38.24 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 107.687 -1.227 . . . . 74.43 107.687 171.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . 0.601 ' HB3' ' HD1' ' C' ' 36' ' ' TRP . 34.8 t70 -120.55 158.46 27.27 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.995 0.918 . . . . 72.41 109.961 -176.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.089 0 C-N-CA 124.1 0.96 . . . . 62.23 111.624 -176.782 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.755 0.312 . . . . 73.52 111.056 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m -63.5 110.67 2.04 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.876 0.87 . . . . 72.2 111.231 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -101.16 177.54 4.91 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.397 0.617 . . . . 74.22 110.758 173.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -128.18 166.6 18.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.54 1.136 . . . . 73.22 109.683 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -100.98 161.92 13.26 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.126 0.571 . . . . 74.43 109.877 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -128.99 108.75 10.65 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.356 0.662 . . . . 70.21 109.327 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -88.84 12.13 16.0 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.051 0.941 . . . . 74.3 111.859 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -96.58 -60.26 1.64 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.253 0.621 . . . . 74.4 110.38 -176.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.518 ' HE2' HD11 ' D' ' 89' ' ' ILE . 27.9 ptm 24.17 169.52 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 119.154 3.02 . . . . 65.4 119.154 -170.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 86.6 m -129.46 143.24 50.75 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 113.805 -1.543 . . . . 74.42 108.528 170.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -163.16 105.4 1.01 Allowed 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.524 -0.917 . . . . 73.1 108.524 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -128.37 127.63 42.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.069 -1.086 . . . . 74.41 108.069 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.523 HG21 HD11 ' D' ' 16' ' ' ILE . 10.8 mt -86.82 131.42 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 109.001 -0.74 . . . . 74.22 109.001 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.414 ' NE2' HG12 ' D' ' 55' ' ' VAL . 47.9 mt-30 -98.48 -35.28 10.31 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.325 0.65 . . . . 71.14 110.931 175.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -167.21 142.03 3.94 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.857 0.688 . . . . 74.43 112.857 -171.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.523 HD11 HG21 ' D' ' 13' ' ' ILE . 3.4 mp -119.65 134.87 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 106.798 -1.556 . . . . 74.42 106.798 170.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.435 ' HE1' HG13 ' D' ' 83' ' ' ILE . 31.9 p90 -164.97 165.49 20.15 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.77 0.795 . . . . 74.33 110.744 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.2 p -102.68 124.11 47.62 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.461 -1.245 . . . . 74.33 108.636 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -89.78 -42.51 11.25 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.75 -0.833 . . . . 74.41 108.75 175.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.409 ' HA ' ' O ' ' C' ' 23' ' ' PHE . 13.5 m-20 -130.9 138.13 49.65 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.433 -0.803 . . . . 75.02 109.354 177.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.736 HG21 ' HE1' ' C' ' 117' ' ' MET . 61.0 mt -138.1 151.45 25.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 107.259 -1.385 . . . . 72.24 107.259 172.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 22' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 46.9 t -157.89 146.04 18.85 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.466 1.106 . . . . 71.11 108.734 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.533 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.0 t80 -149.45 133.44 17.11 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 105.771 -1.937 . . . . 75.23 105.771 169.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.8 mt-10 -132.6 149.64 52.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.487 -0.931 . . . . 73.35 108.487 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.64 77.36 12.47 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 107.355 -1.35 . . . . 63.51 107.355 175.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -67.16 -39.54 13.2 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.709 2.273 . . . . 65.44 112.464 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -98.31 5.8 47.95 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 118.526 -0.749 . . . . 75.34 110.817 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.438 ' O ' HG11 ' D' ' 31' ' ' VAL . . . -29.22 -63.2 0.2 Allowed Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 117.091 2.256 . . . . 72.1 117.091 -166.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.66 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 42.5 Cg_endo -82.36 -15.0 9.08 Favored 'Trans proline' 0 C--N 1.379 2.175 0 CA-C-N 122.827 2.045 . . . . 74.32 113.838 -174.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -77.07 -41.68 41.34 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.493 1.117 . . . . 75.01 109.332 173.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' D' ' 73' ' ' ALA . 9.8 p -83.64 -11.03 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 C-N-CA 124.294 1.038 . . . . 74.4 111.173 -175.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.431 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 12.0 m-85 -69.77 -19.06 63.53 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 112.112 0.412 . . . . 74.11 112.112 174.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -59.67 -25.74 64.97 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.408 0.623 . . . . 74.11 110.229 169.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.649 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 80.6 mttt -100.08 90.78 4.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.966 1.306 . . . . 73.4 109.355 178.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -105.34 93.01 4.45 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.371 -0.603 . . . . 74.24 109.371 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -156.43 175.06 14.52 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.074 0.949 . . . . 74.51 108.74 169.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -67.25 106.98 1.39 Allowed Pre-proline 0 CA--C 1.554 1.099 0 CA-C-O 118.855 -0.593 . . . . 71.44 109.408 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.513 ' HB3' ' HG ' ' D' ' 68' ' ' LEU . 30.5 Cg_endo -69.16 148.7 69.55 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.169 1.913 . . . . 72.41 112.716 -172.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -69.62 113.31 6.78 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 108.443 -0.947 . . . . 74.5 108.443 172.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.401 HG11 HG13 ' D' ' 64' ' ' VAL . 88.3 t -104.52 122.76 57.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 123.184 0.594 . . . . 71.2 109.632 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -94.36 128.47 40.9 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.803 -1.184 . . . . 74.53 107.803 170.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 pp -95.87 146.76 24.31 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.816 0.846 . . . . 75.13 109.468 -171.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.561 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 12.5 t70 -149.66 131.49 15.1 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.272 -1.01 . . . . 62.25 108.272 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -124.82 138.84 54.25 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.847 0.459 . . . . 74.31 109.94 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -133.03 155.8 48.52 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.723 1.209 . . . . 74.42 108.48 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 3.1 m -106.07 152.04 23.9 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.097 0.559 . . . . 71.11 111.62 -167.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.772 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -155.12 142.51 19.54 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.783 -0.821 . . . . 63.0 108.783 169.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.4 p -165.47 152.32 10.25 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 123.193 0.597 . . . . 75.11 109.682 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.2 p -158.91 143.62 15.82 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.112 0.565 . . . . 71.34 109.836 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -77.04 121.73 23.94 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.264 -0.643 . . . . 74.43 109.264 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.3 mt -94.91 -26.42 16.15 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.171 0.588 . . . . 72.23 109.812 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.499 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -170.35 -179.73 3.14 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.712 1.605 . . . . 74.34 109.082 175.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -76.0 123.95 26.58 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.014 -1.106 . . . . 72.51 108.014 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 73.79 -3.12 2.58 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 125.597 1.559 . . . . 65.22 112.269 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 78.3 t -117.53 118.04 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 108.302 -0.999 . . . . 73.24 108.302 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -135.03 172.26 13.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.041 0.448 . . . . 60.43 109.904 -174.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.577 ' HB2' HD11 ' D' ' 51' ' ' LEU . 24.7 tt0 -125.1 126.29 45.09 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.113 0.965 . . . . 74.35 108.714 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.83 115.88 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 107.569 -1.271 . . . . 62.32 107.569 175.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.772 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 26.2 t -117.96 134.68 60.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 123.866 0.866 . . . . 55.3 108.944 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 7.8 mp -121.5 130.73 53.73 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.968 0.413 . . . . 74.23 110.1 171.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -85.47 106.18 16.63 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.809 -1.087 . . . . 75.45 109.071 173.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 94.9 t -91.46 116.19 32.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 108.248 -1.019 . . . . 72.2 108.248 171.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 72.5 m -114.64 142.16 46.83 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 108.816 -0.809 . . . . 74.32 108.816 -176.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.401 HG13 HG11 ' D' ' 40' ' ' VAL . 58.7 t -132.16 102.93 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 125.099 1.36 . . . . 74.33 108.333 -173.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 42.2 m -95.83 91.51 6.08 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.571 -1.27 . . . . 74.42 107.571 168.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.2 143.47 26.59 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.898 -0.779 . . . . 73.22 108.898 -175.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.435 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 41.1 m -143.17 127.36 17.57 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.481 0.488 . . . . 73.52 111.175 -176.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.513 ' HG ' ' HB3' ' D' ' 38' ' ' PRO . 21.7 mt -97.12 105.57 17.75 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.029 -1.101 . . . . 71.05 108.029 173.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.64 -114.12 4.95 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.377 -0.829 . . . . 64.44 111.973 -177.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.48 4.7 30.85 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 112.957 0.725 . . . . 74.24 112.957 -172.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.649 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 13.0 pt-20 -136.24 161.7 35.02 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.496 0.319 . . . . 73.14 110.469 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 70.9 m -62.74 125.17 23.04 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 124.208 0.942 . . . . 71.23 111.45 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.465 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -78.56 -70.84 0.47 Allowed 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.788 -1.096 . . . . 74.22 108.188 170.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -149.34 146.78 27.69 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.493 -0.776 . . . . 75.0 110.382 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.458 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 72.4 mt -111.69 108.24 17.62 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.96 -1.126 . . . . 74.35 107.96 174.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.522 ' SG ' ' HE3' ' D' ' 117' ' ' MET . 43.7 t -116.97 146.7 42.85 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.253 -0.647 . . . . 74.45 109.253 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 19.8 tt0 -153.55 133.13 12.95 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.449 0.699 . . . . 74.14 109.66 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 45.3 t -138.82 116.95 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.081 -0.711 . . . . 72.15 109.081 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -87.83 88.63 7.71 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 108.07 -1.085 . . . . 72.32 108.07 169.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -80.86 114.51 19.79 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.413 -1.267 . . . . 75.32 108.471 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.29 144.5 18.09 Favored Glycine 0 C--N 1.337 0.594 0 O-C-N 123.465 0.478 . . . . 72.53 112.441 -176.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.68 137.83 9.47 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 111.221 -0.752 . . . . 74.41 111.221 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.435 HG13 ' HE1' ' D' ' 17' ' ' TYR . 72.8 mt -88.71 120.45 37.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.66 -1.237 . . . . 74.45 107.66 173.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -128.72 122.07 29.87 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.863 0.865 . . . . 71.44 109.244 -175.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 31.9 m -85.04 93.99 8.73 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.206 -1.035 . . . . 75.44 108.206 169.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 11.7 tt -123.31 131.55 72.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 123.91 0.884 . . . . 73.23 109.161 -173.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.7 166.63 32.83 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.371 0.668 . . . . 64.34 110.902 -173.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.35 17.09 76.94 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.619 -0.718 . . . . 63.33 113.683 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.518 HD11 ' HE2' ' D' ' 9' ' ' MET . 6.7 mt -125.61 154.13 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.059 0.543 . . . . 74.23 109.861 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.555 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 0.0 OUTLIER -159.51 -174.06 4.47 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 123.934 0.893 . . . . 75.51 110.184 174.268 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.61 -142.29 45.28 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.492 0.495 . . . . 62.33 113.425 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 51.6 m -76.84 -28.31 55.45 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.606 0.762 . . . . 73.4 111.692 -176.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -60.11 -44.17 95.07 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.84 0.456 . . . . 75.23 111.298 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.555 ' SD ' ' HA ' ' D' ' 90' ' ' GLU . 25.6 ptt? -72.38 -30.63 64.85 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 123.111 0.257 . . . . 72.43 111.477 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.76 -36.14 82.72 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.316 0.579 . . . . 73.43 110.24 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -85.86 -18.2 33.47 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.774 -0.648 . . . . 74.4 110.653 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 47.3 t -70.52 -51.07 31.33 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.536 0.684 . . . . 70.15 109.487 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.478 HD11 HG21 ' H' ' 18' ' ' VAL . 30.0 mt -77.32 -18.95 57.04 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.87 -1.059 . . . . 74.1 110.545 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.06 15.46 51.33 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 115.764 -0.653 . . . . 74.42 113.815 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.486 ' HA ' ' HD2' ' D' ' 133' ' ' PHE . . . -159.47 -65.8 0.08 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 117.235 0.517 . . . . 74.32 111.911 176.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -64.21 -53.47 48.74 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.68 0.792 . . . . 75.51 112.681 -169.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 21.7 m -63.67 -43.83 78.52 Favored Pre-proline 0 CA--C 1.565 1.541 0 C-N-CA 123.819 0.847 . . . . 73.34 111.798 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -52.76 -39.05 78.16 Favored 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 122.759 2.306 . . . . 74.45 113.996 166.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -64.54 -28.58 69.75 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.525 0.73 . . . . 73.24 111.682 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.2 mm -69.78 -42.17 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-O 121.491 0.662 . . . . 71.32 109.761 173.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 93.8 mt -82.62 -12.65 57.52 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.819 -1.082 . . . . 65.22 111.887 -177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . 0.409 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 83.7 t80 -60.83 -52.73 70.34 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.489 1.116 . . . . 73.41 113.184 -176.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . 0.409 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 39.6 Cg_exo -61.47 -35.48 82.38 Favored 'Trans proline' 0 C--N 1.385 2.482 0 C-N-CA 121.863 1.708 . . . . 63.44 112.384 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -71.29 -43.98 66.09 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.311 1.045 . . . . 72.43 111.991 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.72 -42.17 86.75 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.416 0.686 . . . . 71.33 110.127 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -57.34 -54.61 44.88 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 124.199 0.937 . . . . 73.14 110.08 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -59.04 -46.03 89.26 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.199 0.937 . . . . 73.52 111.198 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.7 t -58.05 -43.31 86.82 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 123.749 0.656 . . . . 74.35 111.041 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.484 HG22 ' SG ' ' D' ' 76' ' ' CYS . 74.1 mt -65.21 -55.45 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 123.565 0.541 . . . . 72.31 109.994 175.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 62.8 m -51.17 -44.0 61.4 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.927 1.291 . . . . 72.42 111.736 -173.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 35.9 t -65.67 -43.11 90.31 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 114.683 -1.144 . . . . 73.31 109.958 -178.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.522 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 79.3 mtm -67.86 -32.94 73.8 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.116 0.566 . . . . 70.15 111.866 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.439 HG22 ' O ' ' D' ' 114' ' ' ILE . 85.5 t -65.13 -44.19 95.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.469 0.708 . . . . 74.12 109.744 176.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 80.9 p -74.6 -28.46 60.91 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.952 -0.567 . . . . 71.45 111.153 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' D' ' 116' ' ' SER . 82.5 mtt-85 -70.88 -32.89 70.01 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.663 0.785 . . . . 75.2 109.973 174.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.73 5.69 77.46 Favored Glycine 0 C--N 1.353 1.49 0 O-C-N 123.902 0.751 . . . . 42.53 112.068 171.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.2 p 55.78 24.05 6.96 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 127.27 2.228 . . . . 73.24 113.982 176.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -79.59 155.17 76.23 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.571 0.748 . . . . 73.02 109.663 170.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -48.57 126.32 14.07 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.531 2.82 . . . . 74.44 112.327 172.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -51.92 132.39 32.06 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.617 1.167 . . . . 73.21 112.223 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.445 HD23 HD11 ' H' ' 6' ' ' ILE . 5.8 tt -108.07 101.77 10.98 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.611 -1.255 . . . . 75.43 107.611 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -100.95 102.89 14.0 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.299 -1.001 . . . . 74.52 108.299 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.423 ' HG ' HG12 ' H' ' 6' ' ' ILE . 1.5 tt -69.16 115.21 8.18 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 107.794 -1.187 . . . . 72.3 107.794 176.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.76 139.31 97.1 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 123.201 0.6 . . . . 62.14 110.756 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -58.72 106.26 0.27 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.007 2.471 . . . . 70.54 111.682 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 17.4 m -109.14 138.48 36.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 115.203 -0.908 . . . . 74.23 109.678 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -79.78 96.78 6.38 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.384 -0.969 . . . . 71.52 108.384 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.486 ' HD2' ' HA ' ' D' ' 100' ' ' ALA . 7.9 t80 -64.47 -23.67 67.36 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.854 0.862 . . . . 74.24 110.964 -177.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.58 -54.03 51.22 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 124.066 0.946 . . . . 73.12 110.601 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.77 -50.25 73.1 Favored 'General case' 0 C--O 1.22 -0.469 0 O-C-N 124.202 0.939 . . . . 72.13 110.065 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 94.2 mt -49.49 -43.57 45.41 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.952 0.901 . . . . 74.4 112.212 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.49 ' HA ' HD13 ' H' ' 10' ' ' LEU . 48.7 t80 -59.79 -55.19 37.32 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.137 -0.938 . . . . 73.42 110.711 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.439 ' O ' ' HA3' ' D' ' 148' ' ' GLY . 21.7 ptp -73.72 -20.43 60.53 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.819 0.448 . . . . 71.25 111.302 -177.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.99 -30.41 62.47 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.19 0.596 . . . . 72.41 111.112 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . 0.403 ' HB2' HD11 ' H' ' 10' ' ' LEU . 92.9 t80 -60.38 -45.47 93.42 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.276 0.63 . . . . 74.54 111.906 -177.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.27 -38.41 91.05 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.67 0.388 . . . . 72.21 110.518 -175.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.406 ' HB3' ' H ' ' D' ' 148' ' ' GLY . 10.0 pt20 -84.95 4.85 31.67 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.772 -0.649 . . . . 75.42 112.561 -174.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . 0.446 ' NE2' ' HG2' ' D' ' 144' ' ' GLN . 1.0 OUTLIER -133.21 41.1 3.14 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.005 0.431 . . . . 64.42 110.344 168.427 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . 0.446 ' HG2' ' NE2' ' D' ' 143' ' ' GLN . 14.6 mm100 -152.23 -70.2 0.16 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.461 1.104 . . . . 73.32 109.341 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.33 117.91 3.54 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.56 -0.904 . . . . 74.22 108.56 -174.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 78.69 -154.96 40.58 Favored Glycine 0 C--N 1.341 0.85 0 O-C-N 123.544 0.527 . . . . 62.43 112.245 -176.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -127.78 160.52 31.48 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.512 0.725 . . . . 72.2 110.96 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' D' ' 138' ' ' MET . . . -82.96 134.29 12.73 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.626 -0.715 . . . . 72.12 112.532 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 25.7 m -80.88 108.65 14.73 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.245 0.618 . . . . 61.21 110.041 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.88 110.88 15.41 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.827 -1.175 . . . . 75.31 107.827 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -93.78 160.54 14.71 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.499 0.666 . . . . 74.44 111.779 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -84.39 61.43 6.61 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 114.44 -1.255 . . . . 73.15 110.621 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -61.49 -35.96 79.13 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.361 0.664 . . . . 75.5 110.595 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 29.2 t70 74.9 -64.41 0.38 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.681 1.593 . . . . 75.22 111.049 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.354 0 C-N-CA 124.294 1.038 . . . . 73.24 108.811 172.101 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 110.332 -0.248 . . . . 74.21 110.332 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -67.85 136.08 53.53 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.885 0.474 . . . . 75.22 111.144 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -160.12 169.55 23.08 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.853 0.861 . . . . 75.32 109.503 174.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 16.8 p -96.0 137.97 34.31 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.028 0.531 . . . . 54.1 110.431 175.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 76.8 m -66.36 -52.87 42.44 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.637 0.775 . . . . 74.41 109.979 173.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.631 HD12 HD22 ' A' ' 128' ' ' LEU . 28.0 pt -127.52 163.29 31.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 CA-C-N 115.599 -0.728 . . . . 74.22 109.675 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 7' ' ' ALA . . . . . 0.471 ' HA ' ' HB1' ' A' ' 129' ' ' ALA . . . -151.53 -151.1 0.37 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.931 0.893 . . . . 62.03 108.669 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 90.7 mt -126.51 161.87 26.96 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.775 0.83 . . . . 73.32 111.039 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.37 131.28 44.79 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.627 -0.879 . . . . 72.3 108.627 171.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 6.6 mp -63.35 163.51 10.52 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.328 0.651 . . . . 63.45 110.251 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 75.6 mt -113.3 86.54 9.89 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 123.13 0.572 . . . . 73.41 109.493 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.61 -10.95 14.36 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.396 2.064 . . . . 74.04 111.677 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 tt -81.14 -41.6 22.19 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.824 0.849 . . . . 64.22 108.815 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . 0.563 HD22 ' HA3' ' A' ' 99' ' ' GLY . 47.7 mt 66.48 175.36 0.24 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.005 1.322 . . . . 71.12 111.3 -175.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -91.41 167.69 12.09 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.74 -0.467 . . . . 74.21 109.74 170.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 45.3 p -68.13 154.61 93.68 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-O 119.092 -0.48 . . . . 73.21 110.965 -174.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 17' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -54.8 102.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.042 2.495 . . . . 70.43 112.58 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 18' ' ' VAL . . . . . 0.569 HG11 HD23 ' A' ' 98' ' ' LEU . 1.9 p -58.14 121.32 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.629 1.171 . . . . 73.54 112.077 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 12.8 t 42.26 40.38 1.75 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.888 1.675 . . . . 72.34 112.176 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 93.9 mttt 66.8 65.69 0.45 Allowed 'General case' 0 C--N 1.366 1.32 0 CA-C-N 113.951 -1.477 . . . . 63.43 110.375 -172.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.49 107.79 3.51 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.142 -0.935 . . . . 72.43 109.92 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 66.44 87.42 0.12 Allowed 'General case' 0 CA--C 1.543 0.692 0 O-C-N 124.515 1.134 . . . . 72.13 111.263 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 4.8 p -110.22 151.44 42.58 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 123.83 0.852 . . . . 74.13 110.687 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.74 -25.48 53.7 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.77 2.313 . . . . 75.3 112.237 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 C--O 1.252 1.197 0 N-CA-C 107.568 -1.271 . . . . 54.42 107.568 179.195 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' F' F ' 1' ' ' MET . . . . . 0.641 ' HE2' ' HB2' ' F' ' 3' ' ' GLN . 15.4 tpt . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 109.018 -0.734 . . . . 72.45 109.018 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -67.38 -32.97 74.24 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.595 0.758 . . . . 74.55 112.218 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 3' ' ' GLN . . . . . 0.641 ' HB2' ' HE2' ' F' ' 1' ' ' MET . 77.7 mt-30 -73.73 -29.85 62.49 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.849 0.46 . . . . 70.14 111.205 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -84.92 69.1 10.74 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 122.012 0.91 . . . . 75.2 110.07 175.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 64.8 m -119.95 154.73 34.03 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-N 114.536 -1.211 . . . . 74.25 107.869 173.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . 0.663 HG13 HD22 ' B' ' 42' ' ' LEU . 10.3 tt -59.01 100.42 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.215 0 CA-C-O 121.688 0.756 . . . . 74.22 110.865 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -125.93 158.93 33.93 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.403 1.081 . . . . 72.21 109.478 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . 0.458 HD13 HD22 ' B' ' 44' ' ' LEU . 1.6 tt -100.25 127.96 46.42 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 109.14 -0.689 . . . . 74.21 109.14 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.2 45.11 1.1 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.619 0.767 . . . . 74.24 110.805 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 10' ' ' LEU . . . . . 0.681 HD22 HD11 ' B' ' 136' ' ' LEU . 94.0 mt 65.55 178.47 0.2 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.382 1.073 . . . . 73.1 112.593 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 73.4 mt -79.81 143.67 58.61 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.327 -0.851 . . . . 74.43 109.717 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -59.67 -31.64 94.59 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.1 2.534 . . . . 72.1 112.22 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 28.3 tp -165.66 164.39 19.06 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.48 1.112 . . . . 74.15 108.528 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 79.6 mt -67.38 161.9 24.17 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.335 -0.616 . . . . 71.1 109.335 170.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -70.46 -93.33 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.997 0.519 . . . . 74.51 111.11 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 2.3 p -165.38 133.55 2.47 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 124.564 1.146 . . . . 73.33 108.028 -172.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 17' ' ' PRO . . . . . 0.404 ' HB2' ' HE3' ' B' ' 94' ' ' MET . 37.7 Cg_endo -60.02 150.71 77.06 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 122.789 2.326 . . . . 74.54 112.365 -174.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . 0.429 HG22 HG23 ' B' ' 86' ' ' ILE . 58.4 t -54.99 -30.48 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 C-N-CA 124.501 1.121 . . . . 73.22 113.108 -174.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 9.4 t -57.0 -30.42 64.16 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.571 0.748 . . . . 74.34 111.54 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -158.44 74.16 0.68 Allowed 'General case' 0 C--O 1.244 0.805 0 N-CA-C 107.925 -1.139 . . . . 74.25 107.925 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.57 57.0 4.08 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.63 0.729 . . . . 72.54 110.673 -177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . 0.487 ' HB3' ' HA ' ' B' ' 49' ' ' SER . 0.0 OUTLIER -162.78 123.17 2.37 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.6 1.16 . . . . 74.31 109.289 178.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 48.5 m -167.03 -50.66 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.353 0 C-N-CA 125.707 1.603 . . . . 74.53 109.129 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.55 133.01 11.4 Favored 'Trans proline' 0 C--N 1.399 3.19 0 C-N-CA 121.697 1.598 . . . . 75.31 112.168 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 . . . . . 0 CA--C 1.55 0.972 0 C-N-CA 124.421 1.088 . . . . 75.01 108.279 -178.426 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 109.29 -0.633 . . . . 75.32 109.29 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' G' G ' 2' ' ' LYS . . . . . 0.527 ' HA ' ' HG2' ' C' ' 150' ' ' GLU . 9.8 mtmp? 74.21 82.01 0.11 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.319 1.447 . . . . 73.54 111.538 175.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -162.59 154.56 18.55 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.07 -0.968 . . . . 73.41 109.396 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 24.4 m 64.82 25.3 12.87 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.565 1.146 . . . . 75.24 112.303 174.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 5' ' ' THR . . . . . 0.562 ' HG1' ' HG3' ' C' ' 150' ' ' GLU . 2.2 m -58.2 -53.38 58.97 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.406 1.082 . . . . 73.33 110.915 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . 0.51 HD13 ' HG ' ' C' ' 128' ' ' LEU . 10.5 tt -150.28 130.97 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 113.974 -1.466 . . . . 73.3 108.352 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -167.24 154.95 9.13 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.252 0.621 . . . . 62.01 110.601 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 8' ' ' LEU . . . . . . . . . . . . . 40.9 mt -68.61 131.25 44.9 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.908 0.883 . . . . 74.31 110.602 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.96 151.67 28.39 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.104 0.562 . . . . 53.35 110.075 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 10' ' ' LEU . . . . . 0.421 HD11 HD13 ' C' ' 136' ' ' LEU . 6.6 mp -65.65 153.95 40.21 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.128 0.571 . . . . 63.14 109.665 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.95 108.99 5.21 Favored Pre-proline 0 CA--C 1.548 0.867 0 CA-C-O 118.884 -0.579 . . . . 74.51 110.056 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.42 -33.91 21.96 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 122.236 1.958 . . . . 75.11 110.572 177.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 7.4 mp -101.33 106.57 17.76 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.245 -1.391 . . . . 65.11 107.245 169.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.95 113.62 9.18 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.31 -0.626 . . . . 72.13 109.31 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . 0.589 ' HD2' ' HB ' ' C' ' 46' ' ' THR . 55.9 t80 -62.0 112.86 2.51 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 124.153 0.908 . . . . 73.35 109.347 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 9.5 t -159.22 62.32 2.04 Favored Pre-proline 0 CA--C 1.561 1.39 0 CA-C-O 121.445 0.64 . . . . 63.32 111.227 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 17' ' ' PRO . . . . . 0.565 ' HD2' HD13 ' C' ' 98' ' ' LEU . 23.8 Cg_endo -90.01 -6.89 4.65 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.11 2.54 . . . . 73.42 114.395 -172.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 18' ' ' VAL . . . . . 0.467 ' HB ' ' SD ' ' C' ' 94' ' ' MET . 89.0 t -73.89 123.38 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 110.09 -0.337 . . . . 70.13 110.09 -174.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 1.9 m 63.93 -104.18 0.12 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.914 1.285 . . . . 72.44 109.728 -176.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -150.48 38.7 0.71 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 106.688 -1.597 . . . . 74.21 106.688 176.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . 0.474 ' HB3' ' SD ' ' C' ' 94' ' ' MET . . . -61.28 87.81 0.02 OUTLIER 'General case' 0 C--N 1.362 1.128 0 C-N-CA 124.153 0.981 . . . . 73.31 111.181 -174.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -145.07 -0.67 0.88 Allowed 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 114.155 -1.384 . . . . 74.41 108.353 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 23' ' ' THR . . . . . 0.455 ' HA ' ' HD3' ' G' ' 24' ' ' PRO . 37.6 p -69.58 128.72 91.97 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.408 1.083 . . . . 72.0 110.454 -177.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 24' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' G' ' 23' ' ' THR . 16.4 Cg_exo -69.11 179.87 3.06 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 123.353 2.702 . . . . 73.32 112.904 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 C--O 1.248 1.008 0 N-CA-C 108.135 -1.061 . . . . 70.15 108.135 178.254 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 110.23 -0.285 . . . . 72.53 110.23 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -147.73 137.53 22.7 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 107.195 -1.409 . . . . 73.22 107.195 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -67.0 87.79 0.15 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.633 0.773 . . . . 72.33 110.266 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 32.0 t -167.94 170.44 10.57 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-N 114.487 -1.233 . . . . 70.42 108.658 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 27.4 m -79.65 158.41 27.03 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 108.653 -0.869 . . . . 72.24 108.653 173.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . 0.445 HD11 HD23 ' D' ' 126' ' ' LEU . 14.7 tt -56.48 95.29 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 CA-C-O 122.417 1.103 . . . . 72.43 111.98 -177.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.45 13.51 4.55 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 113.937 -1.483 . . . . 74.31 109.888 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 81.0 mt 66.15 175.16 0.23 Allowed 'General case' 0 C--N 1.357 0.904 0 C-N-CA 125.015 1.326 . . . . 71.33 112.368 -176.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -163.79 -163.06 0.76 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.765 1.226 . . . . 71.42 107.953 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 10' ' ' LEU . . . . . 0.49 HD13 ' HA ' ' D' ' 137' ' ' PHE . 7.3 mp -92.71 168.12 11.43 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.821 0.819 . . . . 74.13 110.946 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.21 137.16 20.91 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-N 114.164 -1.38 . . . . 75.43 109.293 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.31 -44.74 6.3 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.623 2.882 . . . . 72.51 113.157 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 tt -73.02 119.53 17.4 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.2 -1.037 . . . . 72.42 108.2 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.47 118.02 20.22 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 107.578 -1.268 . . . . 63.44 107.578 176.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -58.13 171.86 0.5 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.676 1.19 . . . . 75.25 112.715 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 16' ' ' THR . . . . . 0.403 ' HB ' ' HA ' ' H' ' 21' ' ' ALA . 41.7 p -83.99 131.18 52.19 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-N 114.729 -1.123 . . . . 74.24 110.61 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.98 145.12 31.12 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.593 2.862 . . . . 71.12 113.352 -173.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . 0.478 HG21 HD11 ' D' ' 98' ' ' LEU . 77.2 t -52.03 -28.82 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 C-N-CA 124.551 1.141 . . . . 71.51 113.519 -173.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 6.6 p -50.84 -44.99 59.48 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.221 0.608 . . . . 70.51 111.901 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -116.77 -62.18 1.62 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.922 0.889 . . . . 75.52 108.952 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . 0.403 ' HA ' ' HB ' ' H' ' 16' ' ' THR . . . 60.75 26.9 16.68 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.308 1.443 . . . . 73.14 111.919 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -112.85 149.26 33.36 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 113.958 -1.474 . . . . 74.54 108.314 174.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 26.8 p -95.65 101.09 7.2 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 123.979 0.912 . . . . 74.32 109.913 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -71.91 -28.62 16.21 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.272 1.981 . . . . 74.43 111.605 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 CA--C 1.548 0.867 0 N-CA-C 106.262 -1.755 . . . . 75.52 106.262 175.342 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.471 ' HE2' ' HA ' ' A' ' 1' ' ' MET . 7.3 mmt . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.61 0.243 . . . . 74.13 111.009 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 m -138.91 33.09 2.18 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.906 0.483 . . . . 73.11 111.251 -164.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.501 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -125.17 78.91 1.75 Allowed 'General case' 0 CA--C 1.555 1.156 0 CA-C-O 122.019 0.914 . . . . 70.35 110.899 -171.265 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -148.49 66.04 1.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.47 1.108 . . . . 71.15 109.547 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 65.61 -73.93 0.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.647 1.179 . . . . 72.15 111.709 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -78.63 76.98 5.12 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 108.61 -0.885 . . . . 74.52 108.61 174.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.501 HG22 ' HA ' ' A' ' 3' ' ' GLU . 50.5 p -88.78 -168.85 2.32 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 114.323 -1.308 . . . . 74.31 111.169 -170.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -75.84 118.17 18.35 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 107.824 -1.176 . . . . 73.05 107.824 161.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.599 ' HB2' ' HB ' ' C' ' 149' ' ' THR . 22.5 mmt -75.23 126.16 30.44 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.078 -0.712 . . . . 72.44 109.078 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t 174.78 147.15 0.07 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.935 0.894 . . . . 75.1 109.329 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.634 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 16.4 t80 -96.03 120.71 36.8 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.491 -0.929 . . . . 74.42 108.491 164.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -137.7 121.85 18.0 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.552 -0.907 . . . . 75.22 108.552 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.67 HG12 ' HD2' ' A' ' 84' ' ' PHE . 58.8 mt -93.94 123.01 45.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.416 -0.957 . . . . 71.12 108.416 174.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -84.32 -40.85 17.44 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 123.493 0.496 . . . . 74.01 110.158 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -169.61 134.98 1.47 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 116.389 -0.369 . . . . 73.22 110.692 -168.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.498 HD13 ' HG3' ' C' ' 130' ' ' PRO . 85.8 mt -125.39 129.85 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 123.708 0.803 . . . . 71.53 109.218 175.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -162.24 148.06 13.01 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 124.222 0.951 . . . . 75.23 110.715 -167.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.7 p -75.05 129.04 36.93 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 109.407 -0.59 . . . . 61.33 109.407 173.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -97.99 -27.82 14.07 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.6 0.36 . . . . 75.22 110.399 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.523 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 13.6 t70 -141.98 138.47 31.92 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.382 -0.599 . . . . 61.34 109.382 171.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 60.4 mt -130.5 140.64 48.3 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 N-CA-C 107.087 -1.449 . . . . 72.12 107.087 172.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.0 t -150.58 128.2 11.55 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.036 0.534 . . . . 71.1 110.19 175.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.405 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 75.9 t80 -130.48 142.46 50.49 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.416 -1.327 . . . . 71.3 107.416 171.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -141.92 139.36 32.52 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.495 -0.928 . . . . 70.4 108.495 171.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.09 86.49 26.36 Favored Pre-proline 0 C--O 1.241 0.615 0 N-CA-C 106.118 -1.808 . . . . 71.23 106.118 169.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -53.41 -42.69 63.59 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.578 2.852 . . . . 72.53 113.774 -168.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.32 37.46 4.25 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.22 -0.659 . . . . 72.11 109.22 -177.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.489 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -41.75 -60.89 1.68 Allowed Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 113.74 1.015 . . . . 72.13 113.74 -169.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 23.4 Cg_exo -63.19 -27.07 72.52 Favored 'Trans proline' 0 C--N 1.385 2.496 0 CA-C-N 121.786 1.673 . . . . 74.42 112.776 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -84.69 -32.15 23.73 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.225 1.01 . . . . 74.1 111.311 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.685 HG22 ' HA ' ' A' ' 73' ' ' ALA . 4.8 p -79.08 -23.66 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.595 -0.729 . . . . 73.24 111.642 -168.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -72.39 -12.04 60.95 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.171 0.588 . . . . 72.5 111.51 176.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -81.63 -29.79 33.1 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.123 0.969 . . . . 72.35 110.156 173.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -74.46 153.83 38.99 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.178 0.991 . . . . 75.13 111.288 -174.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.78 136.81 45.52 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.594 -0.73 . . . . 75.23 109.259 170.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.407 ' CE3' HD21 ' A' ' 68' ' ' LEU . 62.1 t-105 -80.21 85.09 5.79 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.365 0.666 . . . . 75.24 110.45 -175.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -125.24 79.21 66.45 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.209 1.004 . . . . 71.53 108.5 170.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -89.97 140.79 3.5 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.694 2.263 . . . . 74.13 113.364 -173.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -99.43 90.75 4.63 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 107.805 -1.183 . . . . 72.34 107.805 167.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -70.52 92.36 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 122.477 1.132 . . . . 74.04 109.609 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -79.66 147.68 31.9 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 113.971 -1.468 . . . . 75.12 109.224 172.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.416 HD22 HD11 ' E' ' 6' ' ' ILE . 2.2 pp -133.64 131.77 39.97 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.535 0.734 . . . . 75.42 110.219 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.603 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 32.8 m-20 -115.89 135.76 53.69 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.294 -1.002 . . . . 70.52 108.294 175.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.408 HD21 ' HB3' ' E' ' 8' ' ' LEU . 4.8 mp -104.58 121.92 44.51 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.92 0.888 . . . . 74.43 109.176 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -141.99 144.59 33.76 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.884 -0.784 . . . . 65.03 108.884 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.449 ' HG1' ' HG ' ' A' ' 60' ' ' LEU . 23.7 m -146.69 140.26 25.81 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.066 0.547 . . . . 75.44 110.14 -177.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.25 152.38 51.37 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.987 1.315 . . . . 63.52 108.603 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.6 p -132.01 160.61 35.35 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.15 0.58 . . . . 63.44 109.867 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -149.78 119.41 6.99 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.946 -0.761 . . . . 62.22 108.946 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -84.91 111.5 19.72 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.486 -0.561 . . . . 70.14 109.486 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.452 HD12 HG22 ' A' ' 83' ' ' ILE . 56.3 mt -85.36 -29.95 24.05 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.555 0.742 . . . . 73.41 111.25 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.464 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -164.61 -171.58 2.37 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.254 1.022 . . . . 65.2 110.142 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.14 100.75 0.63 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.31 0.644 . . . . 64.11 109.545 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 70.05 8.08 6.51 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.002 1.321 . . . . 73.44 112.613 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.464 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 57.2 t -100.27 118.37 46.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 106.303 -1.739 . . . . 74.41 106.303 166.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -142.46 173.58 11.41 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.321 0.581 . . . . 70.35 110.283 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -127.65 131.68 49.82 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.262 -1.335 . . . . 74.32 108.878 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.491 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 84.5 t -106.01 135.8 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.731 -1.211 . . . . 75.25 107.731 166.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.41 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 39.8 t -123.95 129.67 74.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.863 -1.532 . . . . 75.34 106.863 174.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.449 ' HG ' ' HG1' ' A' ' 46' ' ' THR . 2.7 tt -124.98 117.91 25.08 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.051 -0.722 . . . . 75.44 109.051 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.585 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 21.3 ttp180 -89.59 111.04 21.86 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.884 -1.053 . . . . 74.34 109.661 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.414 HG13 HD12 ' A' ' 128' ' ' LEU . 43.9 t -100.36 110.87 28.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.979 -1.119 . . . . 74.34 107.979 172.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.603 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 26.3 m -97.75 108.92 21.73 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.677 -0.49 . . . . 73.34 109.677 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.4 t -103.68 108.38 24.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.405 1.082 . . . . 75.53 109.065 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.5 m -102.86 137.05 41.58 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.929 -1.137 . . . . 74.54 107.929 171.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.51 118.91 25.87 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 107.457 -1.312 . . . . 61.45 107.457 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -130.87 132.04 44.92 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.746 0.654 . . . . 73.41 111.092 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.407 HD21 ' CE3' ' A' ' 36' ' ' TRP . 15.6 mt -87.92 75.09 8.87 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.613 -1.254 . . . . 73.12 107.613 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.0 -115.69 4.07 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 114.953 -1.021 . . . . 62.2 110.737 -170.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -90.37 -19.63 23.76 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.722 0.809 . . . . 75.24 111.355 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -94.37 119.0 32.46 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.073 0.549 . . . . 74.51 109.993 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.8 m -72.58 121.89 20.45 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.311 0.382 . . . . 74.35 110.859 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.685 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -68.67 -56.27 8.71 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.763 -0.653 . . . . 75.21 109.697 176.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.467 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 42.7 p90 -156.26 175.55 13.84 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.018 -0.992 . . . . 73.45 111.371 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.6 tp -138.52 140.47 39.14 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.056 -1.429 . . . . 64.42 107.268 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 90.1 m -144.26 95.87 2.79 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.834 0.854 . . . . 65.34 108.819 -177.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -116.07 115.27 25.79 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.499 -0.926 . . . . 73.31 108.499 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.4 t -127.91 118.03 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.398 0.679 . . . . 74.24 110.244 -175.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.585 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 78.2 mt-30 -86.31 92.3 8.76 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 108.825 -0.805 . . . . 72.33 108.825 169.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -82.67 112.5 19.59 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.979 -0.748 . . . . 70.43 108.979 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -102.66 166.49 16.96 Favored Glycine 0 C--N 1.335 0.519 0 O-C-N 123.206 0.316 . . . . 64.24 112.855 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.58 131.7 2.3 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.793 -0.523 . . . . 75.42 111.793 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.452 HG22 HD12 ' A' ' 51' ' ' LEU . 57.1 mt -81.33 124.58 39.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 123.316 0.646 . . . . 75.52 109.369 174.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.67 ' HD2' HG12 ' A' ' 13' ' ' ILE . 10.0 m-85 -130.58 118.39 20.96 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.296 -1.001 . . . . 74.43 108.296 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.9 p -96.89 93.33 6.58 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.634 -0.876 . . . . 71.22 108.634 173.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.559 ' HB ' ' HD2' ' A' ' 11' ' ' PHE . 1.0 OUTLIER -139.53 122.67 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.033 0.933 . . . . 64.34 109.79 -175.443 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.503 ' HA ' HG23 ' E' ' 18' ' ' VAL . . . -129.13 -13.22 4.53 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.737 1.215 . . . . 74.1 109.983 169.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.448 ' H ' HD12 ' A' ' 86' ' ' ILE . . . -88.64 70.09 2.63 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.701 -0.681 . . . . 73.51 114.315 -170.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.586 HD11 ' HB2' ' A' ' 97' ' ' CYS . 19.3 tt -166.09 144.85 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 108.641 -0.874 . . . . 72.03 108.641 175.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.51 170.31 16.23 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.392 0.677 . . . . 73.43 110.224 -166.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.502 ' O ' ' HG3' ' A' ' 94' ' ' MET . . . 69.0 -147.29 46.06 Favored Glycine 0 C--N 1.352 1.462 0 CA-C-N 115.463 -0.79 . . . . 53.45 113.575 174.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.9 p -68.79 -20.84 64.35 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.231 0.613 . . . . 73.44 111.026 173.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -67.78 -35.37 78.55 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 123.664 0.785 . . . . 64.0 112.169 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.502 ' HG3' ' O ' ' A' ' 91' ' ' GLY . 4.0 ppp? -64.79 -40.61 95.51 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 118.128 0.422 . . . . 65.25 110.199 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.632 ' HB1' HD12 ' E' ' 14' ' ' LEU . . . -69.36 -36.21 76.63 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.817 0.847 . . . . 75.24 111.068 176.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -68.3 -30.24 69.19 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.426 1.09 . . . . 74.53 111.156 176.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.586 ' HB2' HD11 ' A' ' 89' ' ' ILE . 48.7 t -68.76 -57.78 5.14 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.202 0.525 . . . . 72.34 110.21 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' E' ' 16' ' ' THR . 4.0 pp -76.04 -19.91 58.22 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.566 -0.743 . . . . 75.5 112.093 -177.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.17 -4.49 53.71 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-O 119.519 -0.601 . . . . 70.22 114.225 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.34 -61.37 0.22 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 117.709 0.755 . . . . 74.4 112.155 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.486 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 91.2 t80 -59.92 -61.96 2.22 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 113.21 0.819 . . . . 74.3 113.21 -168.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 73.7 m -64.3 -38.16 31.54 Favored Pre-proline 0 CA--C 1.565 1.543 0 N-CA-C 112.829 0.677 . . . . 72.24 112.829 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.24 -46.12 23.85 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.528 2.152 . . . . 73.31 113.529 161.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.641 HD22 ' HB2' ' A' ' 133' ' ' PHE . 87.7 m-20 -75.88 -12.91 60.25 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.873 0.869 . . . . 71.53 112.224 -177.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.0 mm -70.59 -41.07 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 109.199 -0.667 . . . . 75.44 109.199 169.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 83.7 mt -82.33 -22.62 35.51 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.147 0.979 . . . . 74.15 111.919 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -57.49 -48.91 96.47 Favored Pre-proline 0 CA--C 1.569 1.702 0 N-CA-C 114.245 1.202 . . . . 71.4 114.245 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -63.79 -36.03 53.5 Favored 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 122.001 1.8 . . . . 73.01 112.582 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.469 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 96.0 m-85 -69.18 -42.73 75.45 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.526 0.73 . . . . 71.44 111.383 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.88 -37.68 82.08 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.355 0.662 . . . . 73.24 109.995 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.464 ' NH1' HG23 ' C' ' 105' ' ' ILE . 28.0 ttm180 -54.02 -55.18 29.73 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.804 0.842 . . . . 71.13 110.279 171.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -67.49 -40.36 85.23 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.175 0.99 . . . . 74.43 111.736 -172.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.6 t -63.4 -36.6 84.25 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.366 0.416 . . . . 74.14 110.69 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.448 ' HA ' ' HE1' ' A' ' 117' ' ' MET . 60.0 mt -68.6 -49.58 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 115.461 -0.79 . . . . 75.2 110.039 174.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.6 m -56.32 -37.47 69.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.289 1.035 . . . . 73.42 111.496 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.9 t -62.23 -48.8 78.35 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 115.647 -0.706 . . . . 70.44 110.261 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.448 ' HE1' ' HA ' ' A' ' 114' ' ' ILE . 36.2 mtm -67.48 -36.27 80.8 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.158 0.583 . . . . 73.52 111.569 -176.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.5 t -62.88 -53.72 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 O-C-N 123.739 0.649 . . . . 63.21 110.278 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 38.7 t -66.51 -30.17 70.44 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.339 -0.846 . . . . 73.41 110.812 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.461 ' HG2' ' HG1' ' B' ' 18' ' ' THR . 52.4 ttm-85 -77.43 -28.78 52.69 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.475 1.11 . . . . 74.21 109.343 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.72 9.6 67.84 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 115.283 -0.871 . . . . 74.34 112.23 171.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.5 HG23 ' HE ' ' B' ' 15' ' ' ARG . 1.1 t 67.83 13.5 9.21 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 127.166 2.186 . . . . 73.44 113.568 170.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -81.47 148.56 62.85 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 108.23 -1.026 . . . . 75.44 108.23 172.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -59.31 164.29 10.97 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.922 2.415 . . . . 61.2 113.371 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -54.51 120.25 6.39 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.009 0.923 . . . . 71.02 112.189 -173.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.467 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 62.2 tp -115.19 103.32 10.73 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.378 1.071 . . . . 71.31 108.563 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -99.12 111.16 23.62 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 107.537 -1.283 . . . . 74.04 107.537 177.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.414 HD12 HG13 ' A' ' 62' ' ' VAL . 2.2 tt -64.96 121.51 14.84 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.396 -0.964 . . . . 71.35 108.396 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' E' ' 6' ' ' ILE . . . -64.45 139.14 97.65 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 122.722 0.409 . . . . 75.33 111.363 -175.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.21 132.58 10.39 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 123.044 2.496 . . . . 72.35 112.199 -175.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.7 t -112.1 114.73 47.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.605 -1.258 . . . . 73.13 107.605 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -82.25 65.93 7.61 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 123.599 0.562 . . . . 75.53 110.345 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.641 ' HB2' HD22 ' A' ' 104' ' ' ASN . 80.4 m-85 -52.6 -41.95 64.11 Favored 'General case' 0 C--N 1.366 1.301 0 C-N-CA 123.865 0.866 . . . . 72.41 110.789 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -55.35 -50.92 68.42 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 124.448 1.092 . . . . 70.21 111.187 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.46 -43.95 95.88 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.657 0.598 . . . . 64.24 111.12 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.2 mt -60.5 -48.72 80.51 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.913 0.885 . . . . 74.44 111.662 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -71.4 -35.62 71.08 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.126 0.57 . . . . 74.55 111.499 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 85.7 mtp -72.12 -22.77 61.28 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 119.079 -0.486 . . . . 73.25 111.651 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -58.75 -29.19 66.55 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 122.924 0.489 . . . . 71.03 111.259 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -84.51 -29.69 25.77 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.242 0.617 . . . . 73.21 110.738 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.2 tp -67.69 -54.97 15.18 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.462 0.705 . . . . 72.34 110.945 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 172.34 15.09 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 125.039 1.336 . . . . 63.3 110.394 -175.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 59.1 -74.18 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.672 1.189 . . . . 74.43 110.468 -163.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 70.17 137.76 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.459 1.503 . . . . 75.21 112.118 174.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -141.01 -174.62 4.05 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.987 0.915 . . . . 74.34 109.751 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -173.43 108.18 0.27 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.611 -0.995 . . . . 74.44 110.611 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -113.72 86.01 2.32 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.645 0.778 . . . . 73.04 110.875 -174.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -96.31 121.68 7.07 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 110.014 -1.235 . . . . 64.12 110.014 171.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' G' ' 24' ' ' PRO . 45.3 p -131.44 134.08 45.83 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.29 0.636 . . . . 72.22 110.386 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.631 ' HB3' ' HG3' ' G' ' 25' ' ' GLU . 9.0 tp10 -160.91 140.44 10.66 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.032 0.933 . . . . 54.21 109.995 172.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -80.33 77.9 7.05 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.445 -0.946 . . . . 74.44 108.445 171.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -106.42 104.51 14.22 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.177 -0.92 . . . . 74.32 108.694 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -89.37 135.38 33.62 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.475 -0.565 . . . . 73.24 109.475 175.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -132.04 140.67 48.97 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 107.896 -1.15 . . . . 61.4 107.896 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 N-CA-C 109.473 -0.566 . . . . 73.2 109.473 -178.105 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttm . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 109.023 -0.732 . . . . 71.4 109.023 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m -79.88 75.18 6.6 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.679 0.792 . . . . 72.12 110.432 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -88.55 96.81 10.77 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.476 -0.784 . . . . 71.24 109.285 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -155.02 133.34 11.79 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.879 0.871 . . . . 72.41 109.034 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -151.11 94.71 2.08 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 107.763 -1.199 . . . . 72.12 107.763 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -125.51 82.24 2.05 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.206 0.527 . . . . 75.54 110.808 -173.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 23.9 p -141.25 18.48 2.25 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.634 1.173 . . . . 71.45 108.458 169.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.568 ' HG2' ' H ' ' B' ' 9' ' ' MET . 12.1 tt0 -82.44 -166.97 1.41 Allowed 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 114.767 -1.106 . . . . 73.44 111.131 -166.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.667 ' HB2' ' HB ' ' B' ' 89' ' ' ILE . 12.6 ttt 67.26 168.32 0.24 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 125.71 1.604 . . . . 73.32 111.592 -176.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 87.5 m -139.79 136.18 33.8 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.138 -1.06 . . . . 71.42 108.138 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.576 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 86.0 t80 -126.31 145.16 50.54 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.858 0.863 . . . . 71.34 109.254 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.414 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -157.32 139.29 14.31 Favored 'General case' 0 C--N 1.346 0.441 0 O-C-N 123.501 0.5 . . . . 74.43 109.806 170.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.481 HD11 HD12 ' B' ' 105' ' ' ILE . 26.2 mt -79.8 126.32 39.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.846 -0.798 . . . . 71.34 108.846 172.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -94.45 -51.09 4.92 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.763 -0.458 . . . . 73.11 109.763 175.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.5 ' HE ' HG23 ' A' ' 122' ' ' THR . 33.7 ttt180 -162.67 139.87 7.94 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.547 -0.297 . . . . 74.01 110.758 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.413 HD11 HD12 ' B' ' 13' ' ' ILE . 98.1 mt -120.56 134.68 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 107.672 -1.233 . . . . 75.51 107.672 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -168.47 158.0 9.28 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.302 0.572 . . . . 75.32 111.949 -171.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.461 ' HG1' ' HG2' ' A' ' 120' ' ' ARG . 85.3 m -89.41 129.6 35.9 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.14 -0.936 . . . . 72.41 109.559 173.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -100.37 -20.33 15.88 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.558 0.743 . . . . 75.42 111.412 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -167.52 144.22 4.31 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.52 0.513 . . . . 62.23 111.583 -173.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.763 HD12 ' SG ' ' B' ' 113' ' ' CYS . 43.0 mm -138.42 147.09 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.996 1.319 . . . . 74.35 109.468 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.556 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.2 t -146.01 136.14 23.71 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.638 1.175 . . . . 72.44 108.467 170.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.4 t80 -150.51 108.14 3.66 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 107.749 -1.204 . . . . 72.32 107.749 170.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -120.18 113.94 21.19 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.154 0.982 . . . . 75.24 109.013 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.55 87.94 3.06 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 108.269 -1.011 . . . . 71.25 108.269 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -66.57 -45.25 5.07 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.182 2.588 . . . . 72.35 113.043 -168.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -103.36 23.56 12.32 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.661 0.785 . . . . 75.33 110.494 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -40.86 -62.15 1.07 Allowed Pre-proline 0 N--CA 1.49 1.548 0 C-N-CA 124.749 1.219 . . . . 70.12 113.981 -168.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.55 -23.64 76.84 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.468 2.112 . . . . 44.52 113.5 -173.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -94.28 -39.86 10.28 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.386 0.674 . . . . 72.24 111.954 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' B' ' 73' ' ' ALA . 8.7 p -69.71 -15.89 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 122.996 0.518 . . . . 65.33 112.072 -171.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -68.3 -11.98 60.32 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.561 0.744 . . . . 74.21 112.766 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.572 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.9 pt20 -58.16 -28.82 65.07 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.401 0.62 . . . . 74.54 109.962 172.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.572 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 88.7 mttt -95.94 92.91 6.72 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.253 1.421 . . . . 73.55 109.504 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -95.09 87.92 5.05 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.31 -0.405 . . . . 72.51 110.084 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -165.71 178.18 6.78 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.126 0.97 . . . . 74.42 108.994 170.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -70.9 112.12 12.2 Favored Pre-proline 0 CA--C 1.562 1.412 0 C-N-CA 123.277 0.631 . . . . 73.25 111.302 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.559 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 18.1 Cg_endo -62.66 143.76 92.97 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.278 1.985 . . . . 73.32 112.421 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.84 108.71 4.08 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.985 -0.746 . . . . 73.24 108.985 176.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 30.8 m -93.93 147.53 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.231 -0.895 . . . . 73.34 112.592 -172.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.474 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 61.7 mtpt -125.51 100.94 6.7 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.003 1.321 . . . . 73.44 108.29 174.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.502 HD21 HD21 ' F' ' 8' ' ' LEU . 1.1 pp -96.58 155.6 16.7 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.626 -0.715 . . . . 75.43 111.443 -174.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -150.28 150.92 32.17 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.326 1.05 . . . . 74.34 109.205 -175.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.45 HD22 HD11 ' F' ' 8' ' ' LEU . 90.5 mt -125.48 127.29 46.25 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.191 0.996 . . . . 75.4 108.615 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 25.1 t70 -124.21 146.26 48.82 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.016 0.526 . . . . 70.32 110.455 -171.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.702 HG23 ' H ' ' F' ' 16' ' ' THR . 90.7 m -110.41 122.76 48.49 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.944 -1.026 . . . . 72.31 110.983 -176.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.36 122.58 11.52 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 107.061 -1.459 . . . . 63.33 107.061 169.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 36.1 p -145.82 163.16 35.89 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.795 0.27 . . . . 62.41 110.804 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 52.5 p -151.99 141.53 21.69 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.83 0.852 . . . . 71.5 109.35 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -84.22 129.82 34.86 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.196 -0.668 . . . . 74.52 109.196 175.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.534 HD12 HG22 ' B' ' 83' ' ' ILE . 50.9 mt -92.22 -44.37 8.81 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.03 0.532 . . . . 74.23 110.312 -176.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.85 -171.86 3.58 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.052 0.941 . . . . 41.54 109.569 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -68.3 129.32 39.58 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.455 -0.793 . . . . 73.15 109.157 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 68.57 -4.67 1.09 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.489 1.515 . . . . 74.44 113.085 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 82.4 t -113.76 117.61 55.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 108.642 -0.873 . . . . 65.44 108.642 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -135.12 140.84 45.77 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.155 -0.683 . . . . 74.54 109.155 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -114.07 114.31 25.93 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.204 -1.035 . . . . 71.25 108.204 -174.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.466 ' HB ' ' HZ ' ' F' ' 15' ' ' PHE . 34.3 m -108.22 136.73 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.616 0.766 . . . . 71.24 110.431 -178.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 19.5 t -120.92 121.65 65.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 108.393 -0.966 . . . . 72.52 108.393 177.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.33 108.86 20.61 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 106.84 -1.541 . . . . 74.43 106.84 170.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.621 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 26.9 ttp180 -86.9 118.73 26.48 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.036 -0.728 . . . . 72.31 109.036 173.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 16.6 t -103.92 121.16 55.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.71 -1.218 . . . . 74.35 107.71 174.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 23.8 m -120.26 124.96 46.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.111 -0.7 . . . . 65.24 109.111 -178.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 97.9 t -123.9 113.53 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 124.216 1.006 . . . . 75.23 109.101 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 67.3 m -84.84 149.38 25.74 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.354 -0.98 . . . . 74.42 108.354 166.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.43 140.77 30.57 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.334 0.653 . . . . 64.5 109.663 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.487 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 21.0 p -145.71 130.05 17.69 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.17 0.51 . . . . 63.52 111.383 -176.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.559 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 28.6 mt -104.59 128.09 52.5 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.323 1.049 . . . . 75.24 109.004 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.99 -111.37 4.09 Favored Glycine 0 C--N 1.344 0.981 0 O-C-N 123.733 0.646 . . . . 72.52 112.196 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -118.46 10.79 12.78 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.575 0.75 . . . . 73.23 111.55 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.464 ' HG2' ' HZ3' ' B' ' 34' ' ' LYS . 13.4 pt-20 -129.7 159.31 36.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.732 0.413 . . . . 71.25 110.759 -175.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.1 m -73.19 121.19 19.89 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 116.043 -0.526 . . . . 60.11 110.317 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.514 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -76.48 -61.68 1.88 Allowed 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.049 -1.093 . . . . 63.35 108.049 177.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -157.52 165.11 36.5 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.953 -1.022 . . . . 74.43 111.9 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 46.1 mt -125.6 112.0 15.65 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 106.043 -1.836 . . . . 62.55 106.043 175.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.42 ' SG ' HG21 ' B' ' 114' ' ' ILE . 34.8 t -117.15 148.93 41.15 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.665 -0.865 . . . . 75.13 108.665 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.556 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 41.9 tt0 -163.88 132.42 3.7 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.167 0.587 . . . . 73.22 109.531 -173.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' B' ' 110' ' ' ALA . 98.8 t -132.86 147.04 31.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 123.757 0.823 . . . . 74.43 109.186 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.621 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 19.1 mt-30 -118.41 103.96 10.27 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.601 -0.889 . . . . 74.15 108.601 169.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -94.62 100.52 12.45 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.195 -1.039 . . . . 61.45 108.195 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.12 153.42 22.9 Favored Glycine 0 C--O 1.242 0.606 0 CA-C-N 114.998 -1.001 . . . . 72.45 111.159 175.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.8 126.25 1.85 Allowed Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 111.316 -0.714 . . . . 72.34 111.316 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.534 HG22 HD12 ' B' ' 51' ' ' LEU . 48.3 mt -85.49 128.21 39.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 107.546 -1.279 . . . . 72.32 107.546 170.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -138.61 149.95 45.77 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.129 -0.693 . . . . 71.03 109.129 176.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 69.8 m -94.52 100.33 12.33 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.464 -0.939 . . . . 73.34 108.464 170.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.441 ' O ' ' HB1' ' F' ' 21' ' ' ALA . 1.8 pp -116.1 110.77 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.358 -0.979 . . . . 73.24 108.358 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.32 170.13 21.71 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.33 0.652 . . . . 74.41 110.886 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.84 -65.63 0.25 Allowed Glycine 0 C--N 1.346 1.138 0 CA-C-O 119.672 -0.516 . . . . 74.34 113.151 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.667 ' HB ' ' HB2' ' B' ' 9' ' ' MET . 3.4 tt -82.55 170.07 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 117.597 0.698 . . . . 74.54 110.037 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -152.62 160.74 43.17 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.028 0.931 . . . . 75.33 109.172 -167.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.83 -134.47 11.7 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 110.947 -0.861 . . . . 74.13 110.947 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.4 m -93.47 -18.32 22.45 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 117.247 0.523 . . . . 73.43 110.575 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.39 -26.04 60.82 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.695 -0.628 . . . . 74.3 111.108 -174.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -64.84 -31.76 73.15 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 119.485 -0.293 . . . . 74.53 110.439 171.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.81 -38.73 82.77 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.665 0.786 . . . . 72.51 111.135 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -65.34 -39.21 92.1 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.404 -0.817 . . . . 74.11 111.359 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 40.2 t -66.56 -41.46 88.58 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.626 0.602 . . . . 72.15 112.626 -173.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.571 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.0 pt? -101.35 -14.31 17.66 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 117.862 0.301 . . . . 73.1 111.664 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.32 -21.43 24.81 Favored Glycine 0 C--N 1.352 1.425 0 N-CA-C 114.3 0.48 . . . . 73.23 114.3 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.23 -54.12 1.7 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.487 0.715 . . . . 73.13 110.159 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -69.69 -52.74 23.0 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.299 0.64 . . . . 73.41 112.288 -171.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.576 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 69.0 m -59.11 -49.02 95.29 Favored Pre-proline 0 CA--C 1.565 1.555 0 CA-C-O 119.04 -0.505 . . . . 74.21 112.143 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 39.1 Cg_exo -63.54 -27.73 69.95 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 122.217 1.944 . . . . 75.22 113.835 173.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -63.54 -37.68 88.25 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.032 0.533 . . . . 63.34 109.771 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.481 HD12 HD11 ' B' ' 13' ' ' ILE . 72.1 mt -65.48 -42.43 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.781 0.832 . . . . 72.22 110.2 175.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 91.9 mt -76.96 -20.36 56.21 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.949 -1.023 . . . . 75.42 111.833 -175.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -54.03 -55.79 32.57 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 124.136 0.974 . . . . 75.12 113.151 -176.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -59.34 -31.38 94.88 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.085 1.857 . . . . 74.41 113.737 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -69.73 -46.31 66.2 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.395 0.678 . . . . 75.33 110.503 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.417 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -66.2 -38.66 88.5 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.582 0.753 . . . . 65.24 110.992 177.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -61.88 -53.37 56.79 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.092 1.357 . . . . 74.04 110.778 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.01 -33.38 75.92 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.524 -0.762 . . . . 74.33 109.716 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.763 ' SG ' HD12 ' B' ' 21' ' ' ILE . 38.0 t -64.6 -44.52 90.37 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 123.51 0.506 . . . . 74.0 111.715 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.491 ' O ' HG23 ' B' ' 118' ' ' VAL . 72.9 mt -59.59 -55.01 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 109.12 -0.696 . . . . 71.54 109.12 175.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.1 m -62.26 -28.1 69.48 Favored 'General case' 0 CA--C 1.552 1.044 0 O-C-N 123.633 0.583 . . . . 71.15 112.122 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.484 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.7 t -64.5 -48.04 76.66 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.258 -0.645 . . . . 70.42 109.258 175.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.481 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.8 mmt -70.75 -33.86 71.26 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.053 0.541 . . . . 73.1 110.663 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.491 HG23 ' O ' ' B' ' 114' ' ' ILE . 97.2 t -61.51 -43.4 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.536 0.734 . . . . 73.21 110.067 173.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.8 t -64.56 -37.59 88.08 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.058 -0.974 . . . . 72.23 110.806 178.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' B' ' 116' ' ' SER . 89.7 mtt-85 -66.58 -32.87 74.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.601 -0.727 . . . . 72.24 110.411 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.6 12.21 59.68 Favored Glycine 0 C--N 1.349 1.29 0 O-C-N 123.933 0.771 . . . . 64.41 113.013 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 76.4 p 53.08 27.95 6.31 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 126.161 1.784 . . . . 73.43 113.324 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -86.69 155.37 56.21 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.417 0.687 . . . . 75.44 110.292 177.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.0 176.45 2.47 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.112 2.541 . . . . 65.02 113.784 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.598 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 0.0 OUTLIER -62.93 124.71 21.77 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.878 -1.056 . . . . 73.3 111.8 -173.091 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -144.05 102.92 3.95 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.218 -1.031 . . . . 73.3 108.218 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -119.05 135.08 54.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.02 0.928 . . . . 72.33 108.987 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.48 HD23 HD11 ' F' ' 6' ' ' ILE . 91.8 mt -69.39 145.32 52.97 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.127 0.571 . . . . 63.21 110.589 174.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.3 150.92 65.12 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 122.94 0.496 . . . . 73.4 110.992 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.432 ' CG ' HD11 ' D' ' 16' ' ' ILE . 33.0 Cg_exo -61.54 108.35 0.6 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.149 2.566 . . . . 74.54 111.893 175.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.541 HG23 ' HB2' ' F' ' 8' ' ' LEU . 66.1 t -112.33 111.04 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.573 -0.899 . . . . 74.45 108.573 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -96.88 93.04 6.42 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.258 -1.016 . . . . 71.45 108.258 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.523 ' HD1' HD13 ' F' ' 10' ' ' LEU . 63.8 m-85 -61.48 -40.63 95.23 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.89 0.876 . . . . 74.41 110.301 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -57.61 -43.64 84.86 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.914 1.286 . . . . 75.21 111.677 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.53 -40.13 95.03 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.623 0.769 . . . . 71.0 111.072 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.459 HD21 HD21 ' F' ' 10' ' ' LEU . 4.1 tt -66.4 -42.81 87.31 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.026 0.53 . . . . 74.5 109.66 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -66.03 -30.97 71.6 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.143 0.577 . . . . 74.32 111.404 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -67.9 -37.48 81.78 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.975 0.51 . . . . 73.23 110.723 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -73.67 -23.03 59.78 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 122.656 0.382 . . . . 74.12 110.472 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -70.4 -36.62 74.17 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.905 0.482 . . . . 74.12 110.472 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 71.7 mt -89.52 4.53 48.93 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.537 0.735 . . . . 73.25 111.847 -176.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -73.26 101.09 3.29 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.01 0.524 . . . . 64.42 110.384 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -134.3 108.01 7.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.803 0.841 . . . . 74.04 108.954 176.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -170.49 110.11 0.37 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.097 -1.446 . . . . 74.2 107.097 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.56 131.44 44.78 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.173 0.589 . . . . 71.22 110.624 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.64 117.55 5.22 Favored Glycine 0 C--N 1.348 1.239 0 O-C-N 123.659 0.6 . . . . 73.12 111.658 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -111.65 140.68 46.07 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.467 0.707 . . . . 65.45 110.484 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 140.02 152.86 5.91 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.726 -0.55 . . . . 74.31 111.726 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 15.3 t -163.74 170.76 16.52 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.288 0.635 . . . . 75.11 110.718 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -143.22 163.1 33.87 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.77 0.828 . . . . 74.25 110.042 173.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -166.75 119.74 1.01 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.153 0.981 . . . . 70.31 108.739 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -129.62 101.79 6.07 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.698 0.799 . . . . 74.21 109.939 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -84.89 84.01 7.85 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 108.809 -0.811 . . . . 75.54 108.809 171.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -89.96 151.57 21.63 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.843 0.857 . . . . 72.41 110.44 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 C-N-CA 124.068 0.947 . . . . 63.51 108.988 178.844 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 58.6 ttp . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.986 -0.375 . . . . 75.02 109.986 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 49.3 m -75.03 80.87 2.21 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.291 0.636 . . . . 75.31 109.855 173.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -77.11 -75.06 0.22 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.864 -0.791 . . . . 72.32 108.864 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -104.52 89.9 3.35 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 108.322 -0.992 . . . . 72.51 108.322 171.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -142.02 147.45 36.9 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 108.093 -1.077 . . . . 75.22 108.093 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -56.14 -48.04 77.01 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.065 0.853 . . . . 71.31 109.366 174.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 17.7 m 65.51 146.39 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 O-C-N 125.083 1.489 . . . . 75.22 111.757 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -112.14 120.67 42.6 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 106.599 -1.63 . . . . 72.54 106.599 174.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.668 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 0.0 OUTLIER 65.08 120.77 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.304 0 O-C-N 124.605 1.191 . . . . 72.53 111.456 178.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.468 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 28.0 m -86.57 85.29 7.3 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.282 -1.007 . . . . 65.54 108.282 175.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.673 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 4.2 t80 -121.08 126.79 50.72 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 114.83 -1.077 . . . . 75.54 110.383 -171.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -148.19 121.8 9.19 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.86 -1.163 . . . . 61.4 107.86 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 69.2 mt -73.15 124.43 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 109.491 -0.559 . . . . 71.5 109.491 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.434 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 19.1 mm-40 -88.8 -47.87 7.9 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.102 -0.954 . . . . 74.04 109.636 -175.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -170.04 133.6 1.18 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.797 0.439 . . . . 74.4 110.529 -173.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 83.8 mt -116.11 146.28 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 108.007 -1.109 . . . . 74.02 108.007 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -174.9 169.19 3.48 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.366 0.666 . . . . 72.15 110.08 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 66.7 p -92.09 115.77 28.36 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.347 0.659 . . . . 71.54 109.364 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.617 ' HE2' ' HB2' ' D' ' 28' ' ' ALA . 23.1 mmtp -66.22 -47.62 73.24 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.615 0.721 . . . . 75.43 109.705 172.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.434 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 14.1 t70 -144.41 148.79 35.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.132 -1.394 . . . . 73.11 110.147 -175.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.7 mt -142.28 145.57 23.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.121 -1.437 . . . . 74.5 107.121 176.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 42.8 t -157.46 151.7 24.79 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.26 0.624 . . . . 64.21 110.676 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -148.5 146.12 28.21 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.674 -1.232 . . . . 63.54 107.674 170.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -145.71 132.04 19.58 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.815 0.846 . . . . 72.32 109.763 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.41 77.9 4.73 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 106.192 -1.781 . . . . 62.4 106.192 172.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -62.97 -37.65 52.16 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.902 2.402 . . . . 73.44 111.877 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -95.62 21.4 8.36 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.371 -1.286 . . . . 75.31 111.154 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.81 -53.67 9.66 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 113.744 1.016 . . . . 74.01 113.744 -173.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.68 -41.55 38.29 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 121.844 1.696 . . . . 71.53 112.4 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -69.52 -32.88 71.98 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.544 0.738 . . . . 75.13 112.197 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.722 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.1 p -78.14 -27.78 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 N-CA-C 112.359 0.503 . . . . 72.33 112.359 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -64.24 -28.31 69.65 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.466 0.543 . . . . 74.31 112.466 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -87.69 17.67 4.55 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.019 0.528 . . . . 73.52 111.409 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.628 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -109.8 158.25 18.34 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.944 0.898 . . . . 72.34 109.85 178.569 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -65.4 128.09 34.45 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.551 -0.537 . . . . 75.42 109.551 169.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -81.0 89.35 5.92 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.69 -0.686 . . . . 71.12 110.292 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -142.07 79.58 16.08 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.598 0.759 . . . . 65.31 109.131 171.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -89.21 178.23 2.64 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 122.553 2.169 . . . . 72.15 112.704 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -109.84 117.46 33.9 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.416 -1.327 . . . . 74.35 107.416 166.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.407 HG11 HD12 ' G' ' 6' ' ' ILE . 46.5 t -80.29 96.45 2.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 107.613 -1.254 . . . . 73.43 107.613 174.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.42 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 3.1 tppp? -105.66 100.2 9.77 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.284 -1.006 . . . . 75.32 108.284 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' G' ' 8' ' ' LEU . 1.0 OUTLIER -91.36 158.55 16.47 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.107 -0.952 . . . . 72.11 110.069 -177.392 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.452 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 27.7 t70 -152.95 148.27 26.92 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.609 0.764 . . . . 74.31 109.012 -177.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.455 HD13 HD21 ' G' ' 11' ' ' LEU . 9.7 tt -128.5 147.19 50.67 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.839 -0.8 . . . . 54.43 108.839 -176.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.473 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 25.6 t0 -146.36 147.11 30.97 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.592 -1.262 . . . . 74.22 107.592 173.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 18.5 p -114.84 112.3 22.54 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.459 0.704 . . . . 74.4 109.931 -173.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.22 151.75 27.89 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.463 1.105 . . . . 72.53 108.87 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 69.9 m -162.13 158.1 24.21 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.763 0.425 . . . . 72.25 111.787 -174.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 88.1 p -157.29 144.43 18.51 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.08 0.952 . . . . 64.44 109.121 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -87.83 126.19 34.88 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.767 -0.457 . . . . 75.54 109.767 176.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.52 HD13 HD13 ' C' ' 83' ' ' ILE . 71.6 mt -96.75 -43.92 7.31 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.548 -0.751 . . . . 75.53 110.109 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . 0.505 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -156.35 -171.51 3.73 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.593 -0.73 . . . . 65.3 110.91 -176.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -66.64 108.22 2.39 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.115 -0.948 . . . . 71.42 110.038 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 70.94 -6.45 1.28 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.92 1.288 . . . . 75.15 112.772 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.505 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 42.2 t -92.2 97.06 6.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 107.011 -1.477 . . . . 71.32 107.011 173.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -120.93 124.92 46.11 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.244 -1.343 . . . . 75.42 107.985 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -83.5 125.42 31.73 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.169 -0.923 . . . . 74.11 109.778 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 6.0 m -112.09 127.09 69.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 108.026 -1.102 . . . . 72.44 108.026 171.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.523 HG11 ' HG2' ' C' ' 79' ' ' GLN . 21.9 t -121.29 134.97 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.799 -1.186 . . . . 72.42 107.799 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 13.1 tp -116.07 108.33 16.06 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.604 -0.517 . . . . 72.4 109.604 -175.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.473 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 7.3 tmm_? -84.39 105.84 15.54 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.882 -0.784 . . . . 74.44 108.882 177.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.474 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.6 t -100.32 136.31 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.585 -0.894 . . . . 74.4 108.585 175.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 51.4 m -122.94 141.67 51.66 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.239 -1.022 . . . . 73.02 108.239 173.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.454 HG22 HG23 ' C' ' 114' ' ' ILE . 75.4 t -132.85 110.05 15.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 107.75 -1.204 . . . . 73.21 107.75 176.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 4.5 m -99.01 144.21 28.42 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.146 -1.057 . . . . 71.53 108.146 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.71 119.41 17.16 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.443 -0.947 . . . . 41.3 108.443 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 51.6 m -136.91 132.8 34.97 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.696 0.622 . . . . 72.24 110.251 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.614 HD11 ' HG2' ' C' ' 34' ' ' LYS . 11.3 mt -85.22 47.96 1.5 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.133 1.373 . . . . 75.44 109.224 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.93 -109.56 3.53 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 110.256 -1.138 . . . . 73.14 110.256 -171.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -89.94 -32.15 16.95 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.988 0.515 . . . . 73.14 109.729 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -66.01 111.75 3.51 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.284 0.634 . . . . 70.03 109.374 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 26.4 m -79.66 125.65 29.91 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.306 -0.628 . . . . 75.42 109.306 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.722 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -81.98 -55.18 4.75 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.408 0.683 . . . . 74.31 109.837 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -157.59 166.81 31.89 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.704 0.764 . . . . 72.03 111.988 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.409 HD23 HG21 ' C' ' 65' ' ' THR . 1.4 tm? -135.47 122.49 21.37 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 105.866 -1.901 . . . . 74.15 105.866 170.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.421 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 46.2 t -127.48 134.58 49.81 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.121 -1.066 . . . . 73.34 108.121 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -148.6 125.17 11.04 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.258 0.348 . . . . 70.35 110.644 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.6 t -131.51 134.4 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 124.107 0.963 . . . . 73.12 108.927 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.523 ' HG2' HG11 ' C' ' 59' ' ' VAL . 5.4 tt0 -112.52 90.82 3.45 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.606 -1.627 . . . . 74.44 106.606 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -83.19 111.86 19.32 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.061 0.544 . . . . 75.42 110.437 -171.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.41 146.57 18.24 Favored Glycine 0 C--N 1.337 0.63 0 O-C-N 123.491 0.494 . . . . 74.2 112.492 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.99 118.07 0.92 Allowed Glycine 0 C--O 1.243 0.697 0 N-CA-C 110.987 -0.845 . . . . 74.45 110.987 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.52 HD13 HD13 ' C' ' 51' ' ' LEU . 12.9 mm -81.98 116.93 27.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 108.556 -0.905 . . . . 74.33 108.556 174.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.673 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 54.8 m-85 -130.92 144.27 51.35 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.955 -0.757 . . . . 73.13 108.955 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 13.1 p -91.16 118.76 30.71 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 108.915 -0.772 . . . . 71.31 108.915 170.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.601 ' HA ' ' HE3' ' C' ' 9' ' ' MET . 4.4 mp -113.68 101.37 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.944 0.898 . . . . 74.23 108.621 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.468 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -146.19 170.45 16.7 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.109 0.963 . . . . 73.04 110.037 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.76 -49.35 2.55 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 116.341 -0.39 . . . . 71.14 112.141 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 33.8 pt -118.67 159.73 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.707 0.803 . . . . 71.11 110.252 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -147.67 -178.15 6.1 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.776 0.83 . . . . 74.1 109.907 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.98 -142.9 45.68 Favored Glycine 0 C--N 1.351 1.373 0 O-C-N 123.222 0.326 . . . . 71.15 112.94 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 1.2 m -68.82 -23.78 64.31 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.983 0.513 . . . . 74.41 110.699 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -57.74 -57.15 14.03 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 124.118 0.967 . . . . 75.33 109.891 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.513 ' HE1' ' HB2' ' G' ' 17' ' ' PRO . 22.3 ptt? -69.8 -30.27 67.77 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.146 -0.479 . . . . 73.14 110.766 178.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.04 -30.65 69.33 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.133 0.573 . . . . 72.53 111.181 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.47 ' NE2' ' HB2' ' C' ' 134' ' ' ASP . 32.3 t-80 -62.5 -46.02 90.33 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.263 -0.88 . . . . 74.52 110.862 170.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.579 ' SG ' ' HE1' ' C' ' 9' ' ' MET . 31.4 t -69.21 -64.57 0.85 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.05 0.219 . . . . 74.34 111.072 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.495 HD22 HG21 ' G' ' 18' ' ' VAL . 3.7 pp -67.6 -31.47 71.54 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 113.146 0.795 . . . . 74.24 113.146 -173.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . 0.42 ' N ' HD11 ' C' ' 98' ' ' LEU . . . -102.8 6.99 52.56 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 114.63 0.612 . . . . 52.11 114.63 -171.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.12 -60.83 0.18 Allowed 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.365 0.603 . . . . 75.45 110.824 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.551 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 5.0 t80 -74.81 -34.3 62.34 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 125.011 1.324 . . . . 74.51 112.757 -171.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.491 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 80.1 m -78.39 -43.81 2.07 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 123.356 0.662 . . . . 75.31 111.057 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -60.92 -27.14 84.34 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 121.943 1.762 . . . . 71.14 112.403 166.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -64.92 -34.93 79.58 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 123.313 0.645 . . . . 71.42 110.696 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.464 HG23 ' NH1' ' A' ' 111' ' ' ARG . 45.6 mm -60.46 -38.33 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 121.326 0.584 . . . . 70.12 109.49 172.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 79.5 mt -89.12 -13.71 37.9 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.549 1.14 . . . . 63.32 112.655 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -57.43 -49.83 91.61 Favored Pre-proline 0 N--CA 1.485 1.281 0 CA-C-O 118.126 -0.94 . . . . 73.11 112.87 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.96 -35.18 78.64 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.179 1.919 . . . . 71.24 113.07 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -66.02 -50.75 63.13 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.517 0.727 . . . . 70.43 111.367 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.4 ' O ' HG13 ' C' ' 114' ' ' ILE . . . -62.63 -42.83 99.82 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.747 -0.66 . . . . 71.34 109.901 178.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -54.85 -53.22 58.23 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.124 1.37 . . . . 75.54 111.052 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -69.09 -36.56 77.72 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.945 0.778 . . . . 74.2 110.283 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.0 t -68.78 -34.54 75.73 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.929 0.491 . . . . 71.35 111.049 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.474 HD11 ' HB ' ' C' ' 62' ' ' VAL . 87.5 mt -69.62 -53.61 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.349 0.66 . . . . 73.13 109.611 175.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 16.8 m -64.56 -29.16 70.18 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.269 0.628 . . . . 75.42 111.28 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.402 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 35.3 t -64.29 -49.94 69.83 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.063 -0.717 . . . . 63.23 109.063 174.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.747 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.54 -37.92 82.79 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.325 1.05 . . . . 74.2 112.179 178.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 69.9 t -66.84 -40.41 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 123.274 0.63 . . . . 73.14 110.137 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 20.9 t -74.09 -23.25 59.3 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.714 0.805 . . . . 74.05 111.576 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' C' ' 116' ' ' SER . 86.3 mtt-85 -76.2 -38.88 55.94 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.706 0.803 . . . . 75.15 108.86 174.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.02 -1.18 67.39 Favored Glycine 0 C--N 1.355 1.627 0 O-C-N 123.974 0.797 . . . . 34.2 112.256 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.7 p 64.64 23.41 12.8 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.926 2.09 . . . . 73.1 113.14 171.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -81.75 143.28 50.21 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 108.209 -1.034 . . . . 62.54 108.209 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.598 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 66.6 Cg_exo -45.23 145.21 3.69 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 123.645 2.896 . . . . 72.33 114.826 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -53.96 114.38 1.56 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.592 1.157 . . . . 75.05 112.593 -175.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 36.8 tp -109.52 94.09 4.85 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.139 -0.937 . . . . 74.53 109.224 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -94.45 115.54 27.73 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.213 0.605 . . . . 73.43 109.709 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.442 HD13 ' H ' ' C' ' 129' ' ' ALA . 0.2 OUTLIER -72.13 149.03 45.12 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.644 0.778 . . . . 75.54 109.781 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.442 ' H ' HD13 ' C' ' 128' ' ' LEU . . . -80.54 156.32 73.33 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.471 0.709 . . . . 73.54 111.194 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.498 ' HG3' HD13 ' A' ' 16' ' ' ILE . 28.7 Cg_endo -61.69 137.39 68.34 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 123.117 2.544 . . . . 73.31 112.274 172.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.427 HG21 ' H ' ' G' ' 8' ' ' LEU . 15.7 t -128.75 110.27 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 108.948 -0.76 . . . . 63.0 108.948 176.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' C' ' 136' ' ' LEU . 12.8 m120 -100.17 91.43 4.75 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.771 0.828 . . . . 73.13 109.336 175.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -65.84 -40.56 91.86 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.163 -0.68 . . . . 74.44 109.163 171.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.47 ' HB2' ' NE2' ' C' ' 96' ' ' HIS . 7.0 p-10 -55.01 -42.14 72.16 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.538 1.535 . . . . 70.4 112.35 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.46 -32.11 24.2 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.046 0.938 . . . . 71.14 110.959 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' C' ' 132' ' ' ASN . 1.5 tm? -59.73 -44.5 93.73 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.833 0.853 . . . . 75.05 110.791 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -62.95 -31.73 72.89 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.14 0.576 . . . . 73.1 111.299 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 62.7 mtt -73.16 -38.55 66.17 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.977 0.511 . . . . 72.01 110.981 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -70.75 -44.1 67.45 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.561 0.745 . . . . 74.34 110.489 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -72.2 -87.1 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.898 0.879 . . . . 74.43 110.321 175.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 46.3 tp 63.95 -72.39 0.06 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 125.108 1.363 . . . . 71.43 111.884 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -76.96 -65.07 0.99 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.836 -0.801 . . . . 64.24 108.836 172.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -179.72 161.21 0.98 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.507 1.123 . . . . 74.33 108.528 -174.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -71.06 82.19 0.69 Allowed 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.727 0.811 . . . . 63.3 110.569 174.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.15 -35.46 77.15 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.814 0.846 . . . . 74.32 111.316 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.42 71.03 1.02 Allowed Glycine 0 C--N 1.348 1.234 0 CA-C-N 115.693 -0.685 . . . . 74.43 112.271 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -72.38 144.64 48.15 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.365 0.666 . . . . 74.53 111.151 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -73.13 69.82 1.29 Allowed Glycine 0 C--N 1.345 1.038 0 N-CA-C 111.379 -0.689 . . . . 64.04 111.379 169.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 149' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 9' ' ' MET . 41.3 p -70.16 -25.8 63.63 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.609 1.163 . . . . 64.44 112.123 -172.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.69 122.15 30.18 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.299 0.639 . . . . 74.52 110.453 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -99.39 -33.75 10.57 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.192 -0.67 . . . . 63.45 109.192 167.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 56.38 82.79 0.11 Allowed 'General case' 0 C--N 1.358 0.941 0 C-N-CA 125.084 1.354 . . . . 74.33 111.53 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -75.0 132.38 41.32 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.146 -1.057 . . . . 75.42 108.146 170.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -144.33 -67.99 0.32 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.037 0.535 . . . . 70.22 110.353 -168.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.522 -0.751 . . . . 70.32 109.026 -179.891 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.972 -0.381 . . . . 73.35 109.972 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 25.7 p -69.98 85.17 0.51 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.917 0.887 . . . . 62.52 110.102 175.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -132.06 168.45 17.93 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.636 1.174 . . . . 75.41 107.833 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -53.2 104.77 0.1 Allowed 'General case' 0 C--N 1.353 0.735 0 N-CA-C 108.864 -0.791 . . . . 72.13 108.864 171.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -74.43 74.57 1.91 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 122.207 1.003 . . . . 74.22 111.822 -172.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -124.32 83.19 2.12 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 106.807 -1.553 . . . . 75.53 106.807 174.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 10.7 t -164.5 168.4 18.39 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.913 -1.04 . . . . 73.32 109.273 -175.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -104.31 85.7 2.41 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.55 -0.907 . . . . 75.23 108.55 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.498 ' HE2' HD11 ' D' ' 89' ' ' ILE . 17.9 ptm -31.33 141.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.407 1.483 . . . . 73.35 114.451 175.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 24.3 m -106.38 143.53 34.36 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 109.171 -0.677 . . . . 72.34 109.171 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -158.73 97.88 1.47 Allowed 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.625 -1.25 . . . . 73.43 107.625 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -117.02 120.56 38.74 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.367 0.667 . . . . 75.52 109.263 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.43 HD11 HD12 ' D' ' 105' ' ' ILE . 19.4 mt -78.0 115.16 19.58 Favored 'Isoleucine or valine' 0 C--N 1.345 0.412 0 N-CA-C 108.968 -0.753 . . . . 74.44 108.968 177.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -90.7 -44.61 9.38 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 122.857 0.463 . . . . 73.22 111.721 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.436 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 40.8 ttt180 -173.85 126.11 0.37 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 112.049 0.388 . . . . 75.44 112.049 -171.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.432 HD11 ' CG ' ' B' ' 130' ' ' PRO . 2.2 mp -104.17 141.57 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.421 -0.955 . . . . 74.52 108.421 170.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.436 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 22.4 p90 -162.72 151.4 14.66 Favored 'General case' 0 C--O 1.238 0.487 0 O-C-N 124.221 0.95 . . . . 74.22 110.571 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.7 p -83.88 120.32 25.93 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.281 -0.872 . . . . 73.35 108.856 172.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.41 ' HZ2' ' CD ' ' D' ' 57' ' ' GLU . 45.1 mtpt -91.33 -17.34 26.05 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.7 0.4 . . . . 72.32 110.525 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.716 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 17.5 t70 -162.7 134.98 5.46 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.641 -0.874 . . . . 73.44 108.641 -174.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.747 HG21 ' HE1' ' C' ' 117' ' ' MET . 88.1 mt -139.28 151.77 23.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 C-N-CA 124.337 1.055 . . . . 73.12 108.321 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 26.6 t -152.02 145.44 24.81 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 124.402 1.081 . . . . 73.21 109.628 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.491 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.7 t80 -151.55 122.46 7.58 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 105.703 -1.962 . . . . 75.44 105.703 169.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -136.51 111.43 8.86 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.821 -0.807 . . . . 74.23 108.821 -176.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.85 91.21 4.09 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.249 -1.019 . . . . 74.41 108.249 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.09 -34.5 10.18 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.968 2.445 . . . . 72.54 113.003 -169.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -112.22 10.81 20.16 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 118.556 -0.735 . . . . 73.13 110.711 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.617 ' HB2' ' HE2' ' C' ' 19' ' ' LYS . . . -18.4 -72.77 0.02 OUTLIER Pre-proline 0 CA--C 1.565 1.556 0 N-CA-C 116.455 2.02 . . . . 72.0 116.455 -168.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.447 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 44.1 Cg_endo -80.29 -13.48 12.4 Favored 'Trans proline' 0 C--N 1.377 2.072 0 CA-C-N 123.903 2.43 . . . . 75.12 114.041 -172.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -77.51 -39.79 45.02 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.573 1.149 . . . . 72.04 109.136 172.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.542 HG23 ' HA ' ' D' ' 73' ' ' ALA . 4.8 p -84.12 -20.53 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.461 -0.791 . . . . 73.31 111.647 -175.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.447 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 21.1 m-85 -66.04 -25.16 66.92 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 120.669 0.271 . . . . 74.41 111.455 177.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -60.07 -26.34 66.09 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.25 -0.886 . . . . 73.01 110.183 175.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.462 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 95.5 mttt -90.94 76.54 6.24 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.972 1.309 . . . . 72.34 109.647 174.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -85.35 92.11 8.37 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.947 -0.569 . . . . 75.31 111.132 -176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -155.25 177.84 10.89 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.881 0.873 . . . . 74.2 108.979 166.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -66.43 110.5 4.89 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.8 0.84 . . . . 73.52 109.272 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -59.48 120.51 8.38 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.954 2.436 . . . . 70.54 111.631 -175.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -69.58 115.03 8.36 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.763 0.664 . . . . 71.52 109.489 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -105.91 137.48 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.003 0.921 . . . . 74.21 111.105 -169.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -109.04 142.08 40.24 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.358 -1.349 . . . . 73.13 107.358 166.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.582 HD21 HD11 ' H' ' 6' ' ' ILE . 3.4 mm? -103.28 148.86 25.32 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.283 -0.636 . . . . 75.22 109.283 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -149.56 130.11 13.96 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.111 -1.07 . . . . 75.23 108.111 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.499 HD23 HD21 ' H' ' 8' ' ' LEU . 5.4 mp -119.51 146.85 45.08 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.251 0.548 . . . . 73.1 110.325 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.602 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 16.2 t70 -132.42 144.17 50.31 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.388 1.075 . . . . 75.32 108.236 175.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 57.2 m -104.21 143.15 33.33 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.864 0.866 . . . . 73.15 109.689 -175.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.656 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.51 142.08 17.68 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.98 0.912 . . . . 70.02 108.983 178.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.427 ' HB3' ' HE2' ' H' ' 15' ' ' PHE . 25.4 p -162.73 158.41 22.93 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 122.911 0.484 . . . . 73.11 110.132 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 81.4 p -151.82 144.28 24.14 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.799 -0.815 . . . . 71.03 108.799 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -87.3 117.8 26.3 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.096 -0.705 . . . . 73.44 109.096 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.535 HD11 ' HB2' ' D' ' 57' ' ' GLU . 26.1 mt -91.09 -24.3 20.05 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.721 -0.672 . . . . 75.1 110.204 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -172.79 178.55 2.59 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.529 1.131 . . . . 73.12 109.284 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -75.3 135.44 40.91 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.484 -0.932 . . . . 74.24 108.484 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 69.05 2.18 3.49 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.65 1.18 . . . . 73.34 113.024 -171.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 68.9 t -124.13 131.24 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.251 0.621 . . . . 73.05 109.817 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -134.66 153.97 51.74 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 123.189 0.595 . . . . 75.52 110.922 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.535 ' HB2' HD11 ' D' ' 51' ' ' LEU . 14.3 tt0 -110.83 120.3 41.95 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.3 -1.318 . . . . 72.54 107.851 165.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.493 HG23 HD13 ' D' ' 106' ' ' LEU . 33.2 m -106.89 132.45 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 108.485 -0.931 . . . . 74.21 108.485 173.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.656 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 38.7 t -125.89 125.49 68.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 N-CA-C 108.934 -0.765 . . . . 60.32 108.934 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.597 HD21 ' HB3' ' D' ' 103' ' ' PRO . 52.0 tp -115.91 117.49 30.33 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.2 -0.667 . . . . 74.13 109.2 177.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.602 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 46.4 ttm-85 -87.34 101.52 13.64 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.948 -0.76 . . . . 74.13 108.948 176.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 99.4 t -91.53 121.31 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.975 -0.75 . . . . 74.24 108.975 174.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.6 m -120.11 142.78 48.59 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.454 0.645 . . . . 74.11 109.789 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 25.4 t -130.59 102.37 6.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 126.134 1.774 . . . . 71.31 107.606 -171.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 21.2 m -95.2 97.61 10.02 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.487 -0.931 . . . . 74.13 108.487 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.4 147.02 27.23 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.114 -0.948 . . . . 71.23 108.994 -172.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.424 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.0 p -149.75 138.06 20.59 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 123.535 0.522 . . . . 75.33 111.6 -177.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 26.1 mt -115.8 111.66 20.83 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.444 -1.253 . . . . 74.12 107.619 171.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.3 -134.72 21.56 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 116.477 -0.328 . . . . 71.44 113.084 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -86.15 2.89 45.09 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.344 0.658 . . . . 75.0 112.571 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.462 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 10.8 pt-20 -131.57 160.55 34.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.875 0.47 . . . . 72.41 110.064 -171.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 62.5 m -69.39 136.07 51.16 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.265 -0.879 . . . . 74.1 110.492 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.542 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -84.08 -65.8 0.97 Allowed 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.664 -1.235 . . . . 71.5 107.664 174.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -152.43 158.96 43.37 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.154 -0.93 . . . . 75.25 110.458 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 69.5 mt -122.82 108.26 12.81 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.621 -1.622 . . . . 72.13 106.621 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.554 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 52.8 t -117.48 138.16 52.05 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.924 -0.769 . . . . 61.14 108.924 -175.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -152.98 133.73 13.88 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.785 -0.45 . . . . 74.13 109.785 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 54.0 t -139.96 119.3 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.395 0.678 . . . . 75.34 109.678 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.716 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 14.5 mt-30 -86.58 89.94 8.08 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 108.366 -0.975 . . . . 73.13 108.366 165.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . 0.431 ' O ' HD11 ' D' ' 106' ' ' LEU . 7.7 tp-100 -83.01 104.91 13.57 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.937 -1.134 . . . . 75.42 107.937 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -103.92 162.09 15.55 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 111.934 -0.466 . . . . 75.23 111.934 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.0 133.75 3.51 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 112.117 -0.393 . . . . 74.12 112.117 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.406 HG23 HD13 ' D' ' 51' ' ' LEU . 39.0 mt -88.79 128.12 41.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 108.558 -0.905 . . . . 62.23 108.558 174.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . 0.434 ' HB2' HD13 ' D' ' 86' ' ' ILE . 79.8 m-85 -133.97 157.07 46.98 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.888 1.275 . . . . 73.54 108.624 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.8 m -114.63 99.15 7.31 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.802 0.841 . . . . 71.13 108.913 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.434 HD13 ' HB2' ' D' ' 84' ' ' PHE . 2.8 mp -109.66 126.73 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.463 0.705 . . . . 74.44 109.637 -173.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.24 165.04 33.1 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.932 0.893 . . . . 72.13 109.702 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.93 20.97 79.2 Favored Glycine 0 C--N 1.346 1.115 0 N-CA-C 114.413 0.525 . . . . 71.15 114.413 173.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.498 HD11 ' HE2' ' D' ' 9' ' ' MET . 7.3 mt -129.21 157.26 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.32 0.648 . . . . 74.41 109.443 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.438 ' N ' HG23 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -150.81 -174.5 4.8 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.481 0.712 . . . . 70.31 111.01 175.13 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.98 -141.45 39.8 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.26 -0.882 . . . . 60.1 114.274 173.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 15.6 m -90.22 -13.56 35.22 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.234 0.613 . . . . 73.32 110.095 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.413 HE21 HG22 ' D' ' 89' ' ' ILE . 29.7 tt0 -63.0 -37.69 88.21 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.953 0.901 . . . . 73.43 110.806 177.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.614 ' HB2' HG21 ' H' ' 18' ' ' VAL . 25.5 ptt? -73.04 -33.13 65.51 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.879 0.472 . . . . 73.22 111.614 177.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.97 -33.67 74.08 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.778 0.431 . . . . 74.42 110.364 174.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -74.18 -32.45 63.08 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.557 0.743 . . . . 72.33 110.612 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.1 t -63.18 -50.66 69.47 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.395 0.617 . . . . 75.11 110.242 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.409 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 47.5 mt -83.04 -21.08 33.91 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.893 -1.048 . . . . 74.32 111.26 -176.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . 0.698 ' HA2' ' HB2' ' H' ' 15' ' ' PHE . . . -87.32 -16.95 59.72 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.612 0.57 . . . . 61.52 114.289 -178.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.2 -64.09 0.7 Allowed 'General case' 0 C--O 1.239 0.515 0 C-N-CA 122.685 0.394 . . . . 74.11 111.799 -172.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -63.53 -44.58 93.81 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 112.485 0.55 . . . . 75.55 112.485 -172.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.485 ' HB3' HG22 ' D' ' 58' ' ' VAL . 56.7 m -66.91 -47.3 53.98 Favored Pre-proline 0 CA--C 1.57 1.723 0 CA-C-O 118.943 -0.551 . . . . 70.24 112.105 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.597 ' HB3' HD21 ' D' ' 60' ' ' LEU . 72.2 Cg_exo -56.8 -29.66 81.89 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 122.427 2.084 . . . . 71.32 113.932 168.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -68.59 -26.0 65.16 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.109 0.564 . . . . 75.55 111.81 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.43 HD12 HD11 ' D' ' 13' ' ' ILE . 30.3 mm -71.91 -39.22 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 121.243 0.544 . . . . 73.03 109.648 171.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.493 HD13 HG23 ' D' ' 58' ' ' VAL . 79.1 mt -80.08 -25.57 40.0 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.216 -0.902 . . . . 64.45 111.938 -175.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -59.5 -48.33 95.91 Favored Pre-proline 0 CA--C 1.562 1.409 0 N-CA-C 113.517 0.932 . . . . 75.32 113.517 -174.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.57 -40.05 83.5 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.079 1.853 . . . . 73.14 112.956 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -71.56 -38.63 70.94 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.837 0.855 . . . . 75.25 111.803 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.15 -47.27 74.6 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.281 0.632 . . . . 73.44 109.953 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -58.07 -46.93 84.62 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.154 0.909 . . . . 72.44 110.409 176.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -59.84 -49.67 76.81 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 123.923 0.764 . . . . 71.15 110.364 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.4 t -57.55 -45.33 85.26 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.74 0.65 . . . . 72.55 111.097 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.478 ' O ' HG23 ' D' ' 118' ' ' VAL . 94.4 mt -59.59 -58.09 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.688 0.795 . . . . 65.12 110.17 175.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 90.0 m -55.59 -39.59 70.93 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.254 1.022 . . . . 74.21 111.88 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 37.8 t -66.32 -41.7 89.27 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.321 -0.854 . . . . 64.44 109.754 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.554 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 75.0 mtm -71.45 -28.37 63.92 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.937 0.495 . . . . 75.34 111.65 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' D' ' 114' ' ' ILE . 97.3 t -63.45 -48.69 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.277 -0.638 . . . . 74.43 109.277 173.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 83.1 p -71.91 -28.62 63.61 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.791 -0.641 . . . . 65.31 110.985 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' D' ' 116' ' ' SER . 91.3 mtt-85 -69.97 -36.47 75.23 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.798 0.839 . . . . 73.41 109.948 173.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.9 2.15 87.88 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.923 0.764 . . . . 52.22 112.138 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.1 p 61.17 29.0 18.56 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.836 2.054 . . . . 65.13 114.0 173.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -86.36 154.62 57.04 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.776 -0.824 . . . . 73.21 108.776 168.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -53.0 136.84 61.68 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.838 2.358 . . . . 72.41 112.693 175.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -52.85 128.98 28.71 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 124.289 0.993 . . . . 73.41 112.249 -174.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 56.9 tp -109.51 99.64 8.82 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.363 -0.835 . . . . 75.33 109.142 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -99.96 97.34 8.23 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.596 -0.89 . . . . 75.43 108.596 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.509 ' HG ' HD12 ' H' ' 6' ' ' ILE . 1.6 tt -67.97 116.43 8.6 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.199 -1.038 . . . . 75.41 108.199 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -57.14 133.51 80.68 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 123.372 0.669 . . . . 52.22 110.025 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 23.7 Cg_exo -62.4 115.38 2.84 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.623 2.216 . . . . 74.52 111.97 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 29.1 m -107.73 111.18 34.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 108.715 -0.846 . . . . 73.05 108.715 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -84.04 107.24 16.27 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.27 -0.877 . . . . 74.14 109.392 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -62.41 -31.63 72.34 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.889 0.743 . . . . 73.25 111.737 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -57.01 -56.06 26.65 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.228 0.611 . . . . 65.02 110.82 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.428 ' HA ' ' HG2' ' D' ' 138' ' ' MET . . . -59.59 -39.26 83.58 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.805 0.842 . . . . 72.04 111.713 -177.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.82 -41.03 99.14 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.364 -0.835 . . . . 75.31 111.073 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -66.97 -31.08 71.41 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.645 0.778 . . . . 74.25 112.343 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.428 ' HG2' ' HA ' ' D' ' 135' ' ' ALA . 13.0 mmt -56.96 -37.53 71.68 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.158 0.504 . . . . 74.2 110.397 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -82.99 -40.66 19.71 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.772 -1.103 . . . . 72.42 110.423 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -60.55 -35.76 76.82 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.604 0.762 . . . . 75.23 111.994 -177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 6.4 mp -70.54 -33.23 70.92 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.913 0.885 . . . . 74.02 111.309 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -89.42 15.03 9.87 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 120.888 0.375 . . . . 75.11 110.786 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -119.39 91.7 3.61 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.422 1.089 . . . . 75.51 108.298 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -144.23 -4.83 0.79 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.102 -0.954 . . . . 74.34 110.879 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -111.02 130.54 55.56 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.748 0.819 . . . . 54.22 109.097 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.83 -72.12 0.48 Allowed Glycine 0 C--N 1.347 1.152 0 O-C-N 123.635 0.584 . . . . 74.05 112.051 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 58.63 82.41 0.14 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.932 1.293 . . . . 74.45 110.53 -173.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.11 146.08 17.93 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.538 -0.755 . . . . 71.55 112.922 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 9.0 t -96.79 68.06 2.36 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-O 122.462 1.125 . . . . 75.33 110.875 -177.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -83.57 91.4 7.42 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.488 -0.778 . . . . 74.23 109.094 174.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.77 150.21 29.43 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.4 -0.593 . . . . 71.14 109.4 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 -143.08 91.36 2.28 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.289 -1.004 . . . . 71.32 108.289 175.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -66.64 96.46 0.39 Allowed 'General case' 0 C--N 1.347 0.469 0 CA-C-N 115.726 -0.67 . . . . 74.11 109.332 175.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -88.03 -36.93 16.71 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.744 0.817 . . . . 73.21 109.585 175.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.254 0 C-N-CA 124.021 0.928 . . . . 73.45 108.693 177.005 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 109.841 -0.429 . . . . 73.33 109.841 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.83 161.39 42.77 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.226 0.61 . . . . 75.23 110.975 175.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -118.22 172.46 7.42 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 109.031 -0.729 . . . . 75.21 109.031 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 49.7 m -142.63 126.23 16.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.259 0.624 . . . . 62.54 109.495 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 5' ' ' THR . . . . . 0.422 HG22 HG13 ' E' ' 6' ' ' ILE . 21.3 m -80.28 169.17 18.12 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.741 0.816 . . . . 75.5 108.815 171.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.422 HG13 HG22 ' E' ' 5' ' ' THR . 2.8 pp -49.95 146.26 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.171 0.988 . . . . 74.43 112.445 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.62 141.18 29.2 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 122.816 0.446 . . . . 72.13 110.043 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . 0.408 ' HB3' HD21 ' A' ' 44' ' ' LEU . 80.2 mt -67.45 135.77 53.62 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.127 -0.694 . . . . 75.34 109.127 172.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.64 158.41 34.14 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.172 0.589 . . . . 75.44 110.891 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 88.1 mt -58.77 124.04 18.43 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.766 0.426 . . . . 71.14 109.914 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.31 109.54 2.43 Favored Pre-proline 0 CA--C 1.549 0.932 0 O-C-N 124.554 1.158 . . . . 74.21 110.668 -176.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -83.68 166.87 13.4 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.713 2.275 . . . . 72.32 111.118 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 55.9 tp 76.5 -37.52 0.29 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.42 1.488 . . . . 64.22 112.36 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . 0.632 HD12 ' HB1' ' A' ' 95' ' ' ALA . 80.3 mt 68.18 106.94 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.87 1.268 . . . . 71.53 110.006 -175.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . 0.5 ' O ' ' HD3' ' E' ' 17' ' ' PRO . 13.5 m-85 -77.01 94.39 3.98 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.374 -0.972 . . . . 63.34 108.374 -174.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 16' ' ' THR . . . . . 0.595 ' HA ' HD22 ' A' ' 98' ' ' LEU . 24.3 m -97.52 97.03 3.56 Favored Pre-proline 0 CA--C 1.557 1.23 0 O-C-N 124.069 0.856 . . . . 72.01 112.029 -169.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 17' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' E' ' 15' ' ' PHE . 25.8 Cg_endo -101.8 5.74 0.53 Allowed 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 124.217 3.278 . . . . 72.32 113.168 178.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 18' ' ' VAL . . . . . 0.503 HG23 ' HA ' ' A' ' 87' ' ' ALA . 7.6 p -148.25 135.96 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.02 0.928 . . . . 74.52 108.975 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 83.6 m 63.84 121.47 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.539 1.149 . . . . 74.12 110.897 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -60.99 94.92 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 122.785 0.434 . . . . 74.13 110.658 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -133.14 100.79 4.97 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.585 0.754 . . . . 73.01 109.721 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -76.47 -30.47 57.3 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.865 0.866 . . . . 74.14 110.94 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 24.1 m 58.17 76.23 0.48 Allowed Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 125.038 1.335 . . . . 71.15 109.74 -168.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.83 177.0 6.8 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.117 2.545 . . . . 65.25 113.736 -170.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 . . . . . 0 C--O 1.251 1.133 0 C-N-CA 124.084 0.954 . . . . 64.32 109.082 -176.352 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 47.4 ttm . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 108.764 -0.828 . . . . 72.5 108.764 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.03 141.42 31.18 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.176 -0.92 . . . . 73.5 109.007 173.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -87.41 -0.06 56.23 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.208 1.003 . . . . 74.13 110.384 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 33.4 t -117.43 156.51 27.82 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.774 1.229 . . . . 73.11 108.861 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 94.1 m -140.89 -56.08 0.5 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.011 0.524 . . . . 75.31 110.914 -175.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . 0.48 HD11 HD23 ' B' ' 128' ' ' LEU . 13.8 tt -153.57 148.01 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.106 0.562 . . . . 65.4 110.162 -170.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -175.81 146.51 0.73 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.364 1.066 . . . . 61.51 110.018 175.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . 0.541 ' HB2' HG23 ' B' ' 131' ' ' VAL . 75.6 mt -77.82 153.34 32.87 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.551 0.74 . . . . 74.41 110.729 176.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.85 163.98 17.78 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.953 0.501 . . . . 74.01 109.82 171.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 10' ' ' LEU . . . . . 0.523 HD13 ' HD1' ' B' ' 133' ' ' PHE . 22.7 tp -79.11 72.23 5.64 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 109.374 -0.602 . . . . 71.1 109.374 177.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . 0.445 HD11 ' H ' ' F' ' 15' ' ' PHE . 55.9 mt 60.31 105.6 0.03 OUTLIER Pre-proline 0 N--CA 1.485 1.308 0 C-N-CA 124.381 1.072 . . . . 65.33 111.95 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -61.33 -11.13 18.02 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 123.039 2.493 . . . . 74.52 113.715 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -129.35 -88.22 0.52 Allowed 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 107.497 -1.297 . . . . 75.12 107.497 171.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 tm? 176.45 138.44 0.06 Allowed 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 106.774 -1.565 . . . . 71.34 106.774 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . 0.466 ' HZ ' ' HB ' ' B' ' 58' ' ' VAL . 14.8 t80 -82.52 116.91 22.16 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.465 -0.939 . . . . 75.2 108.465 177.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 16' ' ' THR . . . . . 0.702 ' H ' HG23 ' B' ' 46' ' ' THR . 44.9 p -50.61 115.98 6.35 Favored Pre-proline 0 CA--C 1.547 0.853 0 O-C-N 124.397 1.061 . . . . 75.43 111.576 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 17' ' ' PRO . . . . . 0.455 ' HA ' HD22 ' B' ' 98' ' ' LEU . 31.0 Cg_exo -62.44 163.72 19.98 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.473 2.115 . . . . 73.2 111.431 173.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . 0.514 ' HB ' HD11 ' B' ' 98' ' ' LEU . 8.4 p -72.55 128.95 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.838 0.351 . . . . 72.12 110.332 177.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 21.1 p -83.29 80.75 8.98 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.3 -1.0 . . . . 75.22 108.3 173.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt 64.98 95.47 0.05 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.101 1.36 . . . . 72.04 111.961 -174.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' B' ' 86' ' ' ILE . . . -65.17 -43.67 90.98 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.736 0.814 . . . . 74.0 109.72 172.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.07 130.2 44.88 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 107.427 -1.323 . . . . 74.32 107.427 173.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -65.87 123.11 84.01 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 123.151 0.581 . . . . 75.44 111.402 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -81.63 -39.09 0.19 Allowed 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.61 2.207 . . . . 74.5 112.389 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.249 1.038 0 C-N-CA 124.692 1.197 . . . . 74.43 108.317 -179.436 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtm . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 108.378 -0.971 . . . . 62.52 108.378 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -127.41 148.93 50.28 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.688 0.795 . . . . 74.42 110.484 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 60.29 74.92 0.43 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.083 1.353 . . . . 73.14 111.177 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 15.2 t -90.98 94.14 9.51 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.158 -0.928 . . . . 70.52 108.925 177.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 9.2 m -69.27 156.34 38.93 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.724 0.81 . . . . 74.23 111.247 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . 0.407 HD12 HG11 ' C' ' 40' ' ' VAL . 22.6 pt -54.19 118.38 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.48 1.112 . . . . 71.44 112.274 -176.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.93 153.23 42.87 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.737 0.815 . . . . 75.5 109.943 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 8' ' ' LEU . . . . . 0.464 ' HA ' HD12 ' C' ' 42' ' ' LEU . 6.2 mp -76.38 143.93 40.39 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.285 0.634 . . . . 75.34 110.469 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.84 152.23 43.39 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.034 0.834 . . . . 73.04 110.683 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 10' ' ' LEU . . . . . 0.4 HD13 HD12 ' C' ' 136' ' ' LEU . 50.9 tp -57.71 159.02 5.58 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 124.39 1.056 . . . . 74.4 110.758 -177.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 11' ' ' LEU . . . . . 0.455 HD21 HD13 ' C' ' 44' ' ' LEU . 58.4 mt -107.69 82.65 1.41 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.561 0.744 . . . . 75.32 110.417 176.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 12' ' ' PRO . . . . . 0.457 ' O ' ' HB ' ' G' ' 23' ' ' THR . 71.1 Cg_endo -74.49 -23.85 14.55 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 121.549 1.5 . . . . 74.12 110.601 170.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 54.8 mt -117.68 109.14 16.28 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.389 1.076 . . . . 73.33 108.521 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.57 -177.78 3.46 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.167 0.587 . . . . 72.33 110.896 175.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -73.32 -177.5 2.6 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.297 1.039 . . . . 75.45 111.749 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 22.3 p -69.36 113.35 16.16 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.564 0.746 . . . . 72.22 110.484 175.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 17' ' ' PRO . . . . . 0.513 ' HB2' ' HE1' ' C' ' 94' ' ' MET . 88.9 Cg_endo -75.23 171.2 18.75 Favored 'Trans proline' 0 CA--C 1.556 1.611 0 C-N-CA 122.804 2.336 . . . . 73.14 113.215 -175.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 18' ' ' VAL . . . . . 0.495 HG21 HD22 ' C' ' 98' ' ' LEU . 23.7 t -76.75 -80.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.253 0.621 . . . . 64.13 110.831 -174.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 3.9 m -96.26 44.06 1.07 Allowed 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 124.188 0.995 . . . . 73.35 110.142 -173.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 70.06 124.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 125.221 1.408 . . . . 74.41 113.093 174.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.16 169.21 23.75 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.469 1.108 . . . . 74.31 109.342 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 22' ' ' ARG . . . . . 0.409 ' NE ' ' HA ' ' G' ' 22' ' ' ARG . 0.2 OUTLIER -120.19 161.85 20.36 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.631 0.372 . . . . 74.41 110.528 179.203 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' G' G ' 23' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' G' ' 12' ' ' PRO . 17.2 p -58.12 122.45 58.58 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.708 1.203 . . . . 73.42 111.044 175.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 24' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 59.3 Cg_endo -89.69 172.51 3.9 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 123.778 2.985 . . . . 72.41 114.018 -174.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 25' ' ' GLU . . . . . 0.631 ' HG3' ' HB3' ' A' ' 150' ' ' GLU . 6.0 mm-40 . . . . . 0 C--O 1.253 1.279 0 C-N-CA 125.497 1.519 . . . . 73.22 107.737 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptt? . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 109.469 -0.567 . . . . 75.41 109.469 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -150.73 101.3 2.91 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.415 -0.957 . . . . 71.23 108.415 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -119.91 92.82 3.87 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.69 0.796 . . . . 74.34 110.483 -176.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 50.9 m -149.17 65.68 1.03 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.981 0.912 . . . . 73.31 109.261 176.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 58.0 m -153.72 -46.41 0.09 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.753 0.821 . . . . 73.3 110.157 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . 0.582 HD11 HD21 ' D' ' 42' ' ' LEU . 10.1 tp -142.91 132.84 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 C-N-CA 123.713 0.805 . . . . 73.1 108.897 -175.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.13 -62.2 0.21 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.722 0.409 . . . . 71.34 110.979 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 8' ' ' LEU . . . . . 0.499 HD21 HD23 ' D' ' 44' ' ' LEU . 5.5 tt 71.36 109.16 0.06 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.013 1.325 . . . . 73.2 109.676 -174.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.0 144.37 38.75 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.748 -0.66 . . . . 74.25 110.923 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 64.2 tp -71.89 144.26 49.07 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 123.763 0.664 . . . . 72.41 110.294 177.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -67.41 121.15 77.6 Favored Pre-proline 0 CA--C 1.549 0.92 0 O-C-N 123.88 0.737 . . . . 72.33 109.825 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.04 -25.4 38.02 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.783 2.322 . . . . 75.34 111.662 174.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 82.9 mt -98.53 138.85 35.14 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.814 0.846 . . . . 74.52 109.107 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 6.5 mp -90.65 49.59 1.69 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.33 0.652 . . . . 71.23 110.173 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . 0.698 ' HB2' ' HA2' ' D' ' 99' ' ' GLY . 1.2 t80 61.78 -90.42 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.881 1.273 . . . . 74.15 111.332 171.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -162.65 154.17 15.2 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.236 1.414 . . . . 75.33 109.157 -177.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -83.08 179.33 5.24 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.655 2.237 . . . . 64.42 112.705 173.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . 0.614 HG21 ' HB2' ' D' ' 94' ' ' MET . 61.4 t -96.23 144.42 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 108.785 -0.82 . . . . 74.44 108.785 173.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 33.2 m 71.15 127.46 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.271 1.428 . . . . 75.14 111.472 -176.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 54.9 tptt 73.42 -5.96 1.86 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.929 1.292 . . . . 75.32 112.804 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.31 82.45 5.46 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.738 0.78 . . . . 64.52 111.297 -174.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -143.26 96.82 2.98 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.429 -1.322 . . . . 74.24 107.429 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 67.6 p -75.34 147.78 82.88 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.623 -0.717 . . . . 74.34 110.638 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -84.7 20.19 1.27 Allowed 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 123.056 2.504 . . . . 62.53 112.02 170.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 124.952 1.301 . . . . 73.44 109.213 -173.839 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.9 mtp . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 109.756 -0.461 . . . . 74.2 109.756 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.8 p -156.68 -55.57 0.08 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.881 0.872 . . . . 65.52 108.979 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -167.68 143.25 3.93 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.461 -1.245 . . . . 75.11 108.657 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -110.93 148.09 33.23 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.059 0.543 . . . . 72.43 111.229 -174.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -122.79 106.58 11.03 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.305 1.042 . . . . 71.13 108.195 173.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -60.74 114.48 3.04 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.468 -0.787 . . . . 75.53 108.927 176.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.1 m 69.62 97.79 0.06 Allowed 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.963 1.305 . . . . 75.31 109.583 -160.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -71.2 173.69 7.35 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 114.762 -1.108 . . . . 74.4 109.397 173.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.447 ' HE3' ' HB ' ' A' ' 86' ' ' ILE . 12.2 tpt -52.02 137.26 27.62 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.125 0.57 . . . . 71.32 111.464 177.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.8 m -138.3 129.71 27.58 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.726 -1.213 . . . . 74.14 107.726 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.694 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 9.4 t80 -135.56 124.26 23.8 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.01 0.524 . . . . 75.2 109.668 -175.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -139.27 111.01 7.17 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.36 -0.978 . . . . 75.42 108.36 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.638 HG12 ' HD2' ' A' ' 84' ' ' PHE . 57.2 mt -82.74 120.44 34.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.421 -0.955 . . . . 71.34 108.421 173.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.43 -41.25 20.1 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 124.146 0.904 . . . . 75.42 109.011 -177.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -173.83 124.09 0.35 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 121.938 0.095 . . . . 75.42 111.061 -169.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.502 HD13 ' HB3' ' C' ' 130' ' ' PRO . 92.2 mt -116.87 138.54 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 C-N-CA 123.924 0.89 . . . . 71.41 109.571 175.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.462 ' HB3' HG21 ' B' ' 122' ' ' THR . 35.3 p90 -169.61 176.26 5.03 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.227 0.955 . . . . 74.32 111.217 -170.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -102.26 119.43 38.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.94 -1.027 . . . . 72.53 108.533 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -83.04 -42.65 17.23 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.957 -0.757 . . . . 72.4 108.957 176.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.624 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 16.2 t70 -134.4 136.62 43.45 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.485 -1.234 . . . . 61.2 109.602 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.8 mt -136.13 143.16 36.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 C-N-CA 125.345 1.458 . . . . 72.42 107.118 174.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.0 t -155.09 119.37 4.68 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-O 121.166 0.507 . . . . 73.44 110.476 171.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.498 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 87.8 t80 -111.34 136.53 50.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.797 -1.557 . . . . 72.44 106.797 169.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -133.53 138.23 45.97 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.638 -0.504 . . . . 74.11 109.638 175.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.85 70.83 16.97 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 106.516 -1.661 . . . . 73.4 106.516 170.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.75 -28.14 30.86 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.539 2.159 . . . . 75.31 111.448 -175.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -101.62 20.42 16.2 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 114.896 -1.047 . . . . 73.4 109.541 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.523 ' HB2' ' HE3' ' B' ' 19' ' ' LYS . . . -48.32 -52.54 41.78 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 114.006 1.113 . . . . 75.1 114.006 -171.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 15.9 Cg_exo -67.16 -18.54 51.04 Favored 'Trans proline' 0 C--N 1.385 2.481 0 CA-C-N 121.748 1.66 . . . . 75.55 113.02 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -90.18 -28.19 19.06 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.407 1.083 . . . . 75.3 110.599 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.494 HG22 ' HA ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -80.55 -21.14 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 115.672 -0.694 . . . . 65.14 111.722 -166.352 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -86.05 -23.99 26.53 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.373 0.669 . . . . 71.44 111.653 -176.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -78.83 -24.26 44.53 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 110.027 -0.36 . . . . 63.12 110.027 174.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -72.48 146.87 46.56 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.794 0.837 . . . . 73.14 110.719 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -67.34 128.91 38.18 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.606 -0.724 . . . . 71.1 109.455 174.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 59.5 t-105 -79.12 89.5 4.83 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.469 0.707 . . . . 74.21 110.426 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -125.11 82.8 61.36 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 108.007 -1.109 . . . . 74.34 108.007 169.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.0 127.93 11.86 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.336 2.024 . . . . 64.54 112.395 -172.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -96.9 93.12 6.46 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 106.354 -1.721 . . . . 70.12 106.354 170.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.8 t -72.67 91.46 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.88 -0.785 . . . . 72.44 108.88 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -98.32 112.46 24.45 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.342 -1.355 . . . . 73.21 107.342 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' E' ' 8' ' ' LEU . 2.5 pp -123.2 135.02 54.11 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.229 0.538 . . . . 75.22 110.885 -171.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -115.94 145.38 42.97 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.698 -1.223 . . . . 71.32 107.698 172.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.581 HD11 ' HB3' ' E' ' 8' ' ' LEU . 1.7 pt? -135.12 123.52 23.28 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.95 -0.759 . . . . 74.33 108.95 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.602 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 24.5 t70 -118.7 139.41 51.59 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.178 0.991 . . . . 75.42 109.246 -174.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.8 p -116.59 121.65 42.35 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.946 0.898 . . . . 71.0 110.476 -170.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.77 131.85 17.29 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.774 0.829 . . . . 72.44 110.636 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.9 m -131.58 157.68 43.0 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.172 0.589 . . . . 73.24 110.482 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.3 t -148.74 123.51 9.9 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.54 0.736 . . . . 65.24 109.359 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -75.41 121.29 22.06 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.284 0.633 . . . . 75.22 110.693 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.581 HD12 HG22 ' A' ' 83' ' ' ILE . 52.9 mt -94.16 -39.37 10.6 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.775 0.83 . . . . 75.1 110.724 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.01 -177.56 5.8 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.878 0.871 . . . . 64.22 109.839 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -63.67 115.36 4.67 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.398 -0.593 . . . . 74.51 109.398 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 70.35 4.07 4.74 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 125.137 1.375 . . . . 73.3 112.929 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.8 t -109.77 114.84 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.115 -1.068 . . . . 72.24 108.115 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -138.63 140.9 39.08 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.568 -0.901 . . . . 72.11 108.568 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -89.79 129.92 36.12 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.753 -0.658 . . . . 72.52 109.435 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.416 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 72.8 t -100.48 126.1 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 107.663 -1.236 . . . . 74.14 107.663 172.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.6 t -120.7 125.56 74.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.662 -0.866 . . . . 73.53 108.662 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -115.25 108.01 16.02 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.153 -1.425 . . . . 61.24 107.153 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.602 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 48.3 ttt180 -83.61 99.94 10.51 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.886 -0.783 . . . . 64.15 108.886 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.9 101.77 12.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.615 -0.721 . . . . 63.24 109.199 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.0 m -97.54 113.46 25.17 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.503 0.721 . . . . 72.13 109.252 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.2 t -116.86 107.64 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.005 0.922 . . . . 72.23 109.097 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.9 m -109.49 129.2 55.57 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.315 -0.994 . . . . 70.4 108.315 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.81 132.71 49.81 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.115 -1.439 . . . . 72.0 107.115 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.0 m -121.32 165.76 15.03 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.199 0.6 . . . . 63.54 110.362 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.9 mt -131.1 43.26 3.12 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.94 -1.133 . . . . 73.24 107.94 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.68 -93.07 1.84 Allowed Glycine 0 C--N 1.339 0.709 0 CA-C-N 114.84 -1.073 . . . . 75.43 111.481 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -95.09 -26.88 15.85 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.194 0.598 . . . . 75.31 111.919 -174.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -105.75 132.63 51.64 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.196 -0.668 . . . . 62.31 109.196 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.4 m -73.44 134.99 44.1 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.732 -0.47 . . . . 71.21 109.732 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.494 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -75.86 -60.91 2.11 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.455 -0.793 . . . . 72.21 109.926 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.422 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 33.4 p90 -160.17 174.29 14.48 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.349 -0.841 . . . . 73.13 111.696 176.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.5 tp -127.79 142.99 51.15 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.445 -1.252 . . . . 74.33 108.482 170.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 80.5 m -143.0 97.39 3.09 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.819 1.248 . . . . 73.25 108.235 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -121.51 115.71 23.35 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.922 -0.77 . . . . 75.23 108.922 -173.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.5 t -129.51 110.63 20.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 123.805 0.842 . . . . 63.31 109.592 -173.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.624 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 28.6 mt-30 -83.69 88.17 7.06 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.14 -1.059 . . . . 73.11 108.14 169.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.485 ' HG3' HD21 ' A' ' 106' ' ' LEU . 9.4 tp-100 -78.48 102.48 7.86 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.692 -1.14 . . . . 74.22 108.691 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.7 145.01 17.43 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.443 -0.663 . . . . 65.4 111.443 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.402 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -151.0 124.5 1.71 Allowed Glycine 0 CA--C 1.508 -0.405 0 N-CA-C 110.78 -0.928 . . . . 50.21 110.78 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.581 HG22 HD12 ' A' ' 51' ' ' LEU . 46.9 mt -81.69 115.68 24.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.864 -0.791 . . . . 73.55 108.864 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.694 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 38.7 m-85 -124.06 120.27 31.91 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.927 -0.768 . . . . 74.12 108.927 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.1 t -95.43 101.84 13.6 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.225 -1.028 . . . . 72.42 108.225 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.49 HD13 HG21 ' E' ' 18' ' ' VAL . 24.4 pt -111.63 150.05 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 122.594 0.357 . . . . 73.3 110.312 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.52 174.37 5.95 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.786 0.834 . . . . 75.51 110.524 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 107.15 -80.87 0.28 Allowed Glycine 0 C--N 1.345 1.044 0 CA-C-N 116.058 -0.519 . . . . 74.05 112.045 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.659 HD12 ' HB3' ' A' ' 93' ' ' GLN . 29.8 pt -91.72 155.86 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.185 0.594 . . . . 74.22 110.948 -175.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 46.6 mt-10 -137.28 -175.7 4.14 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.064 0.945 . . . . 72.12 111.291 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.61 -135.05 23.02 Favored Glycine 0 C--N 1.353 1.506 0 CA-C-N 115.754 -0.657 . . . . 72.01 112.434 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.3 t -67.57 -22.72 65.38 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.313 0.645 . . . . 74.3 111.277 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.659 ' HB3' HD12 ' A' ' 89' ' ' ILE . 13.4 mm-40 -70.52 -45.26 65.92 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.373 0.669 . . . . 73.45 110.375 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.456 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 15.4 tmm? -76.51 -29.79 56.94 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.816 0.446 . . . . 75.54 110.411 176.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.21 -20.92 66.66 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.939 0.496 . . . . 74.33 111.208 176.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -70.63 -47.4 60.26 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.251 0.62 . . . . 72.31 110.818 172.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.599 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 27.4 p -71.67 -43.95 65.13 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.138 0.494 . . . . 74.03 110.949 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.59 -45.35 83.57 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.545 1.138 . . . . 75.11 110.765 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.55 -16.19 47.03 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 114.745 0.658 . . . . 60.21 114.745 -170.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.93 -61.94 0.87 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 117.922 0.861 . . . . 74.52 112.18 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.599 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 88.8 t80 -69.23 -62.28 1.44 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.371 0.878 . . . . 75.22 113.371 -164.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 73.7 m -63.29 -39.3 48.9 Favored Pre-proline 0 CA--C 1.563 1.472 0 N-CA-C 113.697 0.999 . . . . 74.45 113.697 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.21 -32.8 82.55 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 121.854 1.703 . . . . 74.54 113.115 166.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -74.99 -17.98 60.44 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.028 0.531 . . . . 64.15 110.849 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -67.41 -37.46 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 109.186 -0.672 . . . . 71.13 109.186 170.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.485 HD21 ' HG3' ' A' ' 80' ' ' GLN . 77.4 mt -81.23 -17.93 47.8 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.034 0.934 . . . . 73.13 112.191 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -62.81 -47.01 88.16 Favored Pre-proline 0 CA--C 1.572 1.809 0 CA-C-O 118.158 -0.925 . . . . 73.23 113.279 -174.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.61 -37.57 46.36 Favored 'Trans proline' 0 C--N 1.393 2.883 0 C-N-CA 122.35 2.033 . . . . 75.05 112.781 176.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.453 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 95.8 m-85 -66.34 -44.75 82.41 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.466 0.706 . . . . 73.0 111.559 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.22 -41.74 76.65 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.992 -0.549 . . . . 75.35 110.48 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.504 ' NH1' HD13 ' C' ' 105' ' ' ILE . 27.6 ttm180 -52.0 -47.64 64.82 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.969 0.908 . . . . 75.24 110.765 171.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -68.05 -43.96 77.5 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.044 -0.98 . . . . 75.05 111.337 -175.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 39.1 t -65.6 -30.3 71.0 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.189 0.596 . . . . 72.24 111.056 -178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.8 mt -68.69 -58.83 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.888 0.875 . . . . 73.34 109.654 172.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 50.6 m -53.15 -36.51 60.93 Favored 'General case' 0 C--N 1.361 1.094 0 C-N-CA 124.246 1.018 . . . . 65.1 112.097 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -65.24 -51.22 62.27 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.56 -0.745 . . . . 73.41 110.687 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.498 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 61.0 mtm -64.28 -37.87 89.03 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.903 0.481 . . . . 55.31 111.483 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.12 -45.05 99.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.197 0.999 . . . . 73.5 110.335 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.6 t -70.2 -35.5 73.95 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.563 -0.744 . . . . 74.12 110.76 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -69.35 -33.51 73.2 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.543 0.737 . . . . 75.25 109.739 175.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.38 14.34 51.08 Favored Glycine 0 C--N 1.351 1.371 0 CA-C-N 115.344 -0.844 . . . . 63.52 112.879 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.437 HG23 ' HE ' ' B' ' 15' ' ' ARG . 2.5 t 61.4 18.58 9.45 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 126.541 1.936 . . . . 73.22 114.078 170.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -87.46 153.01 53.04 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 123.033 0.533 . . . . 72.54 109.595 176.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -55.16 165.54 2.86 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.521 2.814 . . . . 62.33 114.301 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -59.54 121.95 12.82 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.366 -0.834 . . . . 73.52 111.512 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.422 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 60.4 tp -123.67 94.5 4.26 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.223 1.009 . . . . 74.24 109.362 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -107.79 125.84 51.91 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 107.999 -1.111 . . . . 74.54 107.999 171.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mp -72.8 139.52 47.09 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.708 -0.849 . . . . 75.22 108.708 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.668 ' HB1' ' HB2' ' E' ' 7' ' ' ALA . . . -64.5 146.21 98.19 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.213 0.605 . . . . 74.25 111.242 -177.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.09 116.21 3.58 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.717 2.278 . . . . 73.41 111.751 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.3 t -101.22 113.21 36.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.782 -1.192 . . . . 71.25 107.782 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -86.26 72.32 10.37 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.515 -0.92 . . . . 63.42 108.515 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -49.38 -48.47 46.89 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.491 0.716 . . . . 72.44 110.943 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.04 -51.81 62.87 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.908 -1.042 . . . . 72.5 111.847 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.55 -40.0 88.82 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.714 0.634 . . . . 71.54 111.548 -176.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.75 -45.96 84.24 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.749 0.82 . . . . 75.33 111.424 -177.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -72.41 -36.21 68.56 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.135 -0.484 . . . . 73.41 111.172 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 36.5 mmt -72.5 -23.89 61.09 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.266 0.226 . . . . 63.55 111.181 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.684 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 66.9 m-20 -68.05 -32.02 72.09 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.124 0.569 . . . . 71.32 110.626 171.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -78.56 -39.43 37.72 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 116.244 -0.434 . . . . 74.53 110.145 176.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.49 -49.41 63.62 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.291 0.637 . . . . 74.35 112.268 -175.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -152.04 -2.6 0.28 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.214 0.45 . . . . 74.12 112.214 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.684 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 8.5 tt0 66.69 111.59 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.027 1.331 . . . . 74.45 112.41 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -60.7 -41.99 96.3 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.351 0.66 . . . . 64.11 110.109 170.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 73.83 -68.99 0.2 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.553 1.541 . . . . 74.31 111.325 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.42 -177.11 43.79 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 115.975 -0.557 . . . . 73.25 112.774 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -111.34 -62.72 1.51 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.848 0.859 . . . . 74.22 111.464 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.36 72.46 1.02 Allowed Glycine 0 C--N 1.348 1.199 0 N-CA-C 110.158 -1.177 . . . . 71.31 110.158 -167.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.735 HG22 ' HB2' ' C' ' 90' ' ' GLU . 6.5 t -64.41 161.11 17.66 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.353 1.061 . . . . 74.35 111.893 -175.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -86.55 91.52 8.59 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.869 -0.789 . . . . 74.32 108.869 174.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.36 152.85 40.52 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.431 -0.804 . . . . 75.13 109.635 172.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -104.31 -35.17 8.06 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.684 0.794 . . . . 73.41 110.247 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 64.21 68.13 0.57 Allowed 'General case' 0 C--N 1.359 1.022 0 C-N-CA 125.004 1.321 . . . . 72.21 108.82 -162.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -66.98 93.05 0.26 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.68 -1.145 . . . . 74.04 111.36 -170.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 C-N-CA 124.428 1.091 . . . . 72.5 109.442 177.925 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 111.576 0.213 . . . . 73.21 111.576 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 32.2 t -76.96 85.36 3.49 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.513 0.725 . . . . 75.13 109.745 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -99.04 103.04 14.95 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.045 -0.98 . . . . 72.12 109.274 -176.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -124.23 119.4 29.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.656 0.782 . . . . 75.3 110.135 -174.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -81.58 160.26 23.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.851 0.86 . . . . 74.35 109.893 173.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -70.73 99.29 1.68 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.201 0.6 . . . . 73.13 109.513 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 12.9 t -153.43 175.01 13.63 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.67 0.788 . . . . 62.33 110.226 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 63.82 -94.99 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.913 1.285 . . . . 73.04 109.965 -177.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.56 ' HE3' ' SG ' ' B' ' 97' ' ' CYS . 9.6 tpt 59.64 167.82 0.07 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.256 1.422 . . . . 74.3 112.889 176.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 22.7 m -136.73 123.57 21.29 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 106.37 -1.715 . . . . 73.42 106.37 165.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -151.74 129.16 11.34 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.793 -0.817 . . . . 74.23 108.793 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.464 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -155.07 131.14 10.19 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.419 -0.586 . . . . 74.02 109.419 175.273 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.459 HG13 ' HD3' ' D' ' 130' ' ' PRO . 25.2 mt -75.59 121.54 27.57 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 108.746 -0.835 . . . . 73.1 108.746 173.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -93.05 -37.92 11.91 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.53 -0.759 . . . . 72.54 109.234 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.437 ' HE ' HG23 ' A' ' 122' ' ' THR . 46.5 ttt180 -177.39 132.42 0.17 Allowed 'General case' 0 C--N 1.356 0.856 0 CA-C-N 115.608 -0.723 . . . . 74.21 109.64 -174.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.431 HD11 HD11 ' B' ' 13' ' ' ILE . 94.6 mt -115.21 140.05 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 108.008 -1.108 . . . . 74.32 108.008 176.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -171.17 155.78 4.49 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.805 0.812 . . . . 74.11 112.483 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.9 m -75.69 125.03 28.25 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.546 -1.206 . . . . 74.12 109.191 168.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.523 ' HE3' ' HB2' ' A' ' 28' ' ' ALA . 43.9 mtpt -96.79 -31.86 12.41 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.535 0.734 . . . . 74.44 111.065 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -153.54 140.1 18.82 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.47 -0.332 . . . . 74.15 110.557 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.463 HD12 ' SG ' ' B' ' 113' ' ' CYS . 35.4 mm -135.59 143.61 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.972 1.309 . . . . 75.13 108.577 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -150.28 109.52 3.95 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.07 -1.085 . . . . 64.22 108.07 174.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 89.4 t80 -124.48 108.81 12.52 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 108.002 -1.111 . . . . 75.22 108.002 173.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -124.16 123.56 40.56 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.458 0.703 . . . . 74.34 110.29 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.41 87.1 13.22 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.776 1.23 . . . . 62.45 107.932 178.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.21 -29.98 25.61 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.691 2.261 . . . . 70.4 113.224 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -108.56 18.53 20.8 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.57 0.748 . . . . 75.1 110.821 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.09 -59.26 3.26 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 114.938 1.458 . . . . 73.04 114.938 -164.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -62.25 -28.73 79.42 Favored 'Trans proline' 0 C--N 1.395 3.006 0 C-N-CA 122.388 2.059 . . . . 74.2 112.464 -172.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -96.23 -32.76 12.29 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.167 -0.924 . . . . 74.14 112.22 -172.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.44 HG21 HD11 ' B' ' 68' ' ' LEU . 6.0 p -74.17 -6.29 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 122.998 0.519 . . . . 64.3 111.675 -171.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -72.83 -14.05 61.42 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.218 0.607 . . . . 74.42 112.437 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -61.49 -18.17 57.88 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.31 0.644 . . . . 73.22 111.076 172.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -95.54 88.84 5.18 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.296 1.439 . . . . 75.45 109.112 -178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -98.29 78.38 2.45 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.604 0.716 . . . . 71.4 111.19 -176.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -159.31 172.33 18.18 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.327 -1.306 . . . . 74.42 108.582 170.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -68.58 112.73 12.09 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 109.14 -0.689 . . . . 72.45 109.14 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.491 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 20.8 Cg_endo -61.53 163.82 17.11 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.06 2.506 . . . . 71.4 114.41 -173.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -72.73 102.34 3.32 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 107.519 -1.289 . . . . 75.45 107.519 171.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -93.86 146.2 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 114.545 -1.207 . . . . 72.5 110.179 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.782 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 56.1 mtpt -121.82 142.74 49.92 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.771 0.828 . . . . 74.03 109.49 172.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.427 HD22 HG13 ' F' ' 6' ' ' ILE . 3.2 pp -92.74 134.61 34.88 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 114.33 -1.304 . . . . 74.43 107.781 168.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.671 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 18.5 m-20 -143.74 132.78 22.88 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.143 -1.058 . . . . 61.41 108.143 177.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 86.7 mt -127.92 132.38 49.29 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.485 0.714 . . . . 55.3 109.706 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 7.5 t70 -123.16 138.59 54.62 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.891 1.277 . . . . 74.03 107.587 172.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.494 HG21 ' HA ' ' F' ' 15' ' ' PHE . 43.6 m -108.88 116.19 31.51 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 122.979 0.511 . . . . 72.14 110.083 -174.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.29 135.84 53.54 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.218 1.007 . . . . 64.12 108.42 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.9 m -142.5 161.39 38.19 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 109.527 -0.546 . . . . 72.01 109.527 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 88.6 p -160.63 136.31 8.17 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 123.627 0.579 . . . . 75.51 109.518 174.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -95.08 102.12 13.91 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.119 -1.067 . . . . 74.41 108.119 167.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.468 HD12 HG22 ' B' ' 83' ' ' ILE . 54.3 mt -65.83 -35.95 82.1 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.103 -0.953 . . . . 73.32 111.041 -175.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.49 -179.49 6.02 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.291 1.036 . . . . 70.13 109.443 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.86 122.7 16.06 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.034 -0.984 . . . . 70.42 108.726 173.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 73.95 -4.77 2.19 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 125.371 1.468 . . . . 74.11 113.155 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 56.3 t -113.6 120.7 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 108.978 -0.749 . . . . 70.44 108.978 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -129.19 169.64 14.55 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.214 -0.661 . . . . 72.53 109.214 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -140.87 125.55 17.95 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.475 0.71 . . . . 64.0 109.131 174.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 87.0 t -102.39 119.48 50.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.478 1.111 . . . . 75.02 109.073 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 34.0 t -123.83 111.49 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.732 -0.84 . . . . 75.32 108.732 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 32.3 tp -106.39 119.32 38.96 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 109.059 -0.719 . . . . 72.54 109.059 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 57.7 ttm-85 -86.3 111.76 20.76 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.688 -0.856 . . . . 75.04 108.688 174.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 46.4 t -103.26 102.39 13.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 107.353 -1.351 . . . . 73.32 107.353 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.671 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 17.6 m -101.48 132.15 47.25 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.874 -1.057 . . . . 74.52 109.024 177.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 78.1 t -125.4 112.62 31.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 124.121 0.968 . . . . 75.32 109.153 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.782 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 98.4 m -87.95 149.46 24.03 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.206 -0.906 . . . . 74.43 109.14 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.68 138.4 30.59 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.137 0.575 . . . . 73.04 109.556 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.452 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 45.0 p -146.55 131.29 17.96 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.494 -0.558 . . . . 75.05 109.494 -178.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.491 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 26.0 mt -113.34 113.13 24.82 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.287 1.035 . . . . 74.32 108.962 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.79 -111.32 3.41 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.05 -0.523 . . . . 71.44 112.203 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -113.59 4.87 16.32 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.558 0.743 . . . . 74.43 111.598 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -130.48 151.79 50.58 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.165 0.586 . . . . 74.15 110.699 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 73.9 m -74.24 123.39 24.44 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 122.698 0.399 . . . . 73.15 110.174 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.452 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -76.16 -59.9 2.56 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.14 -0.936 . . . . 74.31 109.085 177.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -149.62 161.75 41.56 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 121.933 0.873 . . . . 75.11 111.468 174.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 78.0 mt -125.49 114.23 18.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 105.127 -2.175 . . . . 73.12 105.127 168.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.4 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 36.3 t -115.72 142.77 46.3 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.343 -1.354 . . . . 74.45 107.343 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -160.9 125.51 3.6 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.937 -0.394 . . . . 71.22 109.937 -169.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 62.0 t -128.67 148.94 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.911 0.884 . . . . 73.14 109.805 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -117.63 111.5 19.26 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.724 -1.213 . . . . 74.42 107.724 163.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -96.95 100.78 12.28 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.797 -1.186 . . . . 71.43 107.797 171.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.02 142.12 15.9 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-N 115.232 -0.894 . . . . 74.44 110.87 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.62 125.99 3.02 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 109.786 -1.326 . . . . 61.41 109.786 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.468 HG22 HD12 ' B' ' 51' ' ' LEU . 57.9 mt -84.69 126.03 40.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 107.788 -1.19 . . . . 74.34 107.788 175.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -131.88 133.37 44.53 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.03 -0.73 . . . . 74.34 109.03 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 67.2 m -89.07 110.69 21.38 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.276 -1.009 . . . . 72.2 108.276 172.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' B' ' 10' ' ' THR . 2.5 pp -124.33 140.76 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.176 0.99 . . . . 72.53 110.213 -172.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.75 171.17 19.31 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.318 0.488 . . . . 72.34 112.318 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.5 -65.7 4.07 Favored Glycine 0 C--N 1.354 1.549 0 CA-C-N 115.148 -0.933 . . . . 73.51 112.946 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.56 ' HB ' ' SD ' ' B' ' 9' ' ' MET . 9.7 mm -68.55 148.86 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.94 1.296 . . . . 75.32 111.026 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -152.38 179.37 8.61 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.641 0.776 . . . . 71.55 111.257 -170.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.02 -127.81 36.18 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 115.968 -0.56 . . . . 63.53 113.374 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 16.3 m -89.28 -18.55 26.77 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.266 0.627 . . . . 64.23 110.787 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -56.34 -41.7 76.53 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 109.338 -0.615 . . . . 74.3 109.338 171.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.513 ' HE1' ' HB2' ' F' ' 17' ' ' PRO . 17.4 ptt? -81.37 -33.53 32.3 Favored 'General case' 0 C--N 1.358 0.97 0 CA-C-N 115.669 -0.696 . . . . 64.22 111.194 177.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.4 -36.16 66.12 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.618 0.723 . . . . 71.45 110.894 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . 0.406 ' O ' ' HB2' ' B' ' 100' ' ' ALA . 43.5 t-80 -69.45 -46.14 67.4 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.295 -1.32 . . . . 73.23 111.137 175.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.56 ' SG ' ' HE3' ' B' ' 9' ' ' MET . 51.6 t -73.14 -31.67 64.43 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.202 0.445 . . . . 74.43 112.202 -173.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.492 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 15.5 mt -95.3 -42.8 8.34 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.859 0.864 . . . . 74.32 111.242 -172.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.61 -24.61 45.66 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.832 -0.622 . . . . 63.54 113.576 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.431 ' HB1' ' N ' ' B' ' 134' ' ' ASP . . . -117.09 -49.69 2.6 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.855 0.462 . . . . 60.15 111.741 -171.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -81.97 -41.86 20.19 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.022 0.379 . . . . 74.14 112.022 -174.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.492 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 85.1 m -61.6 -48.67 89.56 Favored Pre-proline 0 CA--C 1.559 1.292 0 CA-C-O 118.425 -0.798 . . . . 72.51 111.916 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 38.0 Cg_exo -64.5 -22.93 64.97 Favored 'Trans proline' 0 C--N 1.396 3.072 0 C-N-CA 122.167 1.912 . . . . 75.35 112.887 173.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -65.46 -35.97 82.5 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.168 0.587 . . . . 74.53 110.45 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 93.3 mt -63.51 -40.77 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.437 1.095 . . . . 75.41 110.017 171.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 59.8 mt -90.26 -13.01 36.24 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 114.677 -1.147 . . . . 74.2 112.337 -170.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -60.36 -48.28 94.29 Favored Pre-proline 0 N--CA 1.488 1.437 0 CA-C-O 117.911 -1.042 . . . . 75.51 113.473 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.78 -37.99 94.51 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 121.881 1.721 . . . . 74.12 113.173 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -67.64 -47.92 68.19 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.443 0.697 . . . . 73.42 110.508 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.68 -42.35 99.58 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.472 0.709 . . . . 75.2 111.123 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -59.92 -51.44 69.69 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.192 0.997 . . . . 74.14 110.777 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -65.21 -31.32 72.43 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.821 0.701 . . . . 73.11 110.03 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.48 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.0 t -74.04 -34.58 64.14 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.016 0.526 . . . . 63.1 111.204 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.426 ' O ' HG23 ' B' ' 118' ' ' VAL . 57.0 mt -66.66 -57.33 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 109.114 -0.698 . . . . 74.24 109.114 173.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.3 m -62.1 -24.61 67.23 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.637 0.775 . . . . 74.34 111.788 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.1 t -64.32 -52.23 59.51 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 109.379 -0.601 . . . . 73.21 109.379 173.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.5 mmt -69.94 -32.2 70.33 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.11 0.564 . . . . 75.31 111.369 -175.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.426 HG23 ' O ' ' B' ' 114' ' ' ILE . 79.3 t -62.72 -46.19 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.858 0.863 . . . . 73.31 110.184 174.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.0 t -65.72 -35.87 81.97 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.994 -1.003 . . . . 72.04 110.829 177.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.477 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 92.5 mtt-85 -67.12 -33.02 74.56 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.687 -0.688 . . . . 74.54 110.322 178.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.98 7.37 75.18 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 123.837 0.711 . . . . 70.23 112.962 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 17' ' ' TYR . 81.5 p 59.68 23.89 12.73 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 126.291 1.837 . . . . 64.54 113.596 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -86.65 159.22 52.88 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 123.739 0.816 . . . . 75.41 111.409 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -54.69 158.78 9.96 Favored 'Trans proline' 0 C--N 1.393 2.882 0 C-N-CA 123.837 3.025 . . . . 75.31 115.39 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -65.01 133.84 52.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.358 1.063 . . . . 74.44 111.703 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 58.0 tp -140.21 120.66 14.09 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.451 0.7 . . . . 75.02 109.615 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -132.13 117.44 18.31 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.341 1.056 . . . . 75.14 108.917 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 7.1 mp -83.53 150.37 26.01 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.259 0.624 . . . . 74.35 110.653 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.5 156.42 90.27 Favored Pre-proline 0 CA--C 1.557 1.246 0 CA-C-N 115.063 -0.971 . . . . 74.24 110.463 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -66.34 111.24 2.0 Allowed 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 122.679 2.253 . . . . 64.43 110.667 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 36.9 t -89.75 107.24 17.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.003 -1.11 . . . . 74.43 108.003 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . 0.458 ' HB3' ' HB3' ' B' ' 135' ' ' ALA . 7.8 m120 -104.13 88.67 3.06 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.869 -1.06 . . . . 73.11 109.155 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -63.91 -37.61 88.02 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.982 -0.748 . . . . 75.11 108.982 170.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.431 ' N ' ' HB1' ' B' ' 100' ' ' ALA . 6.9 p-10 -62.52 -50.91 69.5 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.745 1.218 . . . . 74.11 111.632 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' B' ' 132' ' ' ASN . . . -68.54 -34.23 75.5 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 123.405 0.682 . . . . 75.02 110.567 -178.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 55.2 tp -61.18 -47.41 86.27 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 123.71 0.631 . . . . 74.31 110.826 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -64.06 -44.85 91.17 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.587 0.554 . . . . 72.31 111.657 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 73.7 mtm -72.81 -37.04 67.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.845 0.458 . . . . 71.01 111.648 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -82.65 -4.67 58.1 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.667 0.387 . . . . 75.31 111.179 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -82.1 -27.98 32.55 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.9 -0.407 . . . . 75.52 109.9 170.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 79.5 mt -96.98 25.97 4.99 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.703 0.801 . . . . 73.24 111.702 -174.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -70.92 140.37 50.97 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.056 0.542 . . . . 74.42 111.029 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -154.71 -53.94 0.1 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.59 1.156 . . . . 71.11 108.611 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -88.08 151.75 22.51 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.833 0.853 . . . . 70.33 109.741 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -139.93 -57.49 0.56 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.279 0.632 . . . . 75.41 110.971 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 120.82 -144.72 17.05 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.745 -0.661 . . . . 74.13 111.673 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -87.66 160.33 18.18 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.666 0.786 . . . . 71.54 111.938 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -126.23 103.77 0.7 Allowed Glycine 0 C--N 1.346 1.115 0 N-CA-C 109.773 -1.331 . . . . 74.31 109.773 173.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' THR . . . . . 0.428 ' HB ' ' HB2' ' D' ' 90' ' ' GLU . 51.3 m -67.41 104.33 1.51 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.683 1.193 . . . . 75.3 110.402 -177.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -85.89 139.19 31.46 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.633 -0.712 . . . . 74.51 109.794 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -134.88 -174.9 3.73 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.195 0.998 . . . . 74.14 109.228 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -157.54 141.3 15.82 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.992 -0.744 . . . . 74.15 108.992 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.88 108.77 16.46 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.915 0.486 . . . . 74.12 110.344 -178.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -76.79 96.27 4.22 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.778 0.831 . . . . 60.22 110.151 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.007 0 C-N-CA 124.041 0.936 . . . . 71.31 109.632 178.467 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptm . . . . . 0 N--CA 1.484 1.25 0 N-CA-C 110.206 -0.294 . . . . 73.43 110.206 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 31.0 m -75.28 101.57 4.74 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.579 0.752 . . . . 64.3 109.657 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -101.75 -39.14 7.56 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.507 0.723 . . . . 63.24 110.689 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -81.34 -64.63 1.15 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.661 0.784 . . . . 74.03 110.159 -172.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -76.29 133.25 40.1 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.036 -0.727 . . . . 71.51 109.036 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -61.99 -56.77 15.73 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.213 1.005 . . . . 75.51 110.367 -177.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 97.6 m -155.82 117.54 3.99 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.47 0.708 . . . . 74.21 109.505 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.46 118.92 6.9 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.27 -1.382 . . . . 73.13 107.27 169.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.534 ' HE1' ' HB ' ' C' ' 86' ' ' ILE . 1.1 tpt 57.88 112.63 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 O-C-N 124.7 1.25 . . . . 51.32 111.638 -173.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 36.9 m -127.37 92.46 3.51 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.571 -0.9 . . . . 74.24 108.571 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.656 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.6 t80 -105.94 133.16 51.1 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.368 0.667 . . . . 71.12 109.672 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -152.41 129.58 11.18 Favored 'General case' 0 C--O 1.242 0.667 0 O-C-N 124.072 0.857 . . . . 74.34 109.219 173.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 86.9 mt -73.36 130.51 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 108.43 -0.952 . . . . 74.52 108.43 172.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -97.05 -42.13 8.03 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.401 0.68 . . . . 73.14 110.283 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -176.19 124.97 0.19 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.701 0.4 . . . . 73.32 110.219 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.9 mt -111.26 146.39 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 109.058 -0.719 . . . . 63.43 109.058 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -172.6 166.5 5.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.12 0.968 . . . . 73.34 109.394 -175.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 63.1 p -85.06 115.43 22.87 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.267 -0.642 . . . . 74.45 109.267 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.638 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 16.3 mmtp -64.67 -44.58 89.91 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.998 -0.741 . . . . 71.03 108.998 171.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 22.6 t70 -147.25 145.55 29.47 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 114.407 -1.27 . . . . 74.11 110.609 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.424 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.8 mt -133.55 145.13 34.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 125.891 1.676 . . . . 71.05 106.712 171.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.1 t -158.37 150.53 21.76 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.414 0.626 . . . . 72.21 109.707 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 72.1 t80 -147.07 137.6 23.58 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.307 -1.368 . . . . 71.01 107.307 173.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -141.11 135.38 30.88 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.632 -0.877 . . . . 73.41 108.632 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.03 83.42 4.68 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 107.701 -1.222 . . . . 73.35 107.701 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.52 -37.39 59.15 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.816 2.344 . . . . 75.43 112.581 -173.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -101.22 21.1 14.53 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.913 -1.04 . . . . 73.03 110.806 -173.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.46 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -48.58 -57.26 11.39 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 114.661 1.356 . . . . 73.51 114.661 -167.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.43 -42.5 54.72 Favored 'Trans proline' 0 C--N 1.386 2.516 0 CA-C-N 122.141 1.801 . . . . 55.44 112.248 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.457 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.3 t60 -70.8 -30.97 67.57 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.823 0.849 . . . . 75.31 112.695 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.607 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.5 p -79.68 -21.31 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 112.501 0.556 . . . . 74.32 112.501 -171.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -72.48 -22.94 60.98 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.489 0.552 . . . . 71.21 112.489 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 20.0 pt20 -85.41 8.5 18.7 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.447 0.299 . . . . 73.35 110.88 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.707 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -97.84 157.31 16.15 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.127 0.971 . . . . 64.32 110.281 175.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.0 132.39 40.14 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.708 0.803 . . . . 70.43 109.504 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 35.1 t-105 -70.36 91.55 0.75 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.842 0.857 . . . . 75.14 110.701 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . 0.547 ' HA ' HE21 ' C' ' 37' ' ' GLN . 0.0 OUTLIER -132.21 71.56 79.56 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.263 1.025 . . . . 74.31 109.112 174.673 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -88.5 158.04 6.54 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.744 2.296 . . . . 73.02 112.842 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -89.06 99.93 12.82 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.013 -1.477 . . . . 71.11 107.013 172.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 15.0 m -66.04 98.36 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-O 122.18 0.99 . . . . 64.22 109.508 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -129.16 103.63 7.08 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.606 -1.179 . . . . 70.44 108.617 -170.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.636 HD21 HG13 ' G' ' 6' ' ' ILE . 2.1 mm? -94.68 148.37 22.34 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.626 -0.879 . . . . 75.45 108.626 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.634 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 11.8 t70 -135.48 123.45 22.72 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.2 -1.037 . . . . 73.55 108.2 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.17 111.78 21.52 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.457 -0.942 . . . . 71.24 108.457 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 16.7 t70 -114.45 137.38 51.91 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.121 0.968 . . . . 73.02 108.472 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 81.7 p -113.17 123.66 50.75 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.743 0.417 . . . . 71.42 111.464 -164.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.62 135.83 42.44 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.807 0.843 . . . . 71.12 109.181 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.65 ' HB3' ' HB3' ' G' ' 17' ' ' PRO . 51.7 m -161.7 149.19 14.62 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.874 0.47 . . . . 64.22 111.472 -172.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 52.9 p -160.26 140.77 11.77 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.688 0.795 . . . . 75.4 110.156 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . 0.438 ' HA ' ' HA ' ' C' ' 56' ' ' TYR . 60.4 tt0 -74.8 123.46 25.03 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.781 -0.822 . . . . 63.12 108.781 170.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.512 HD13 HD13 ' C' ' 83' ' ' ILE . 87.9 mt -84.23 -49.82 8.44 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.169 0.587 . . . . 72.44 110.622 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.78 -169.74 3.47 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.32 0.648 . . . . 74.52 110.873 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.05 106.52 0.27 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.454 1.102 . . . . 72.42 111.06 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 70.32 -5.32 1.37 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 126.004 1.721 . . . . 62.35 112.68 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 73.8 t -96.53 118.13 42.28 Favored 'Isoleucine or valine' 0 C--N 1.347 0.483 0 C-N-CA 124.572 1.149 . . . . 74.24 108.425 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.605 ' HB2' ' HB2' ' G' ' 17' ' ' PRO . 37.1 p90 -127.96 168.78 14.79 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.046 0.939 . . . . 70.44 108.955 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -126.07 130.53 51.29 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.14 0.576 . . . . 73.43 110.427 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 76.3 t -106.61 115.77 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 107.933 -1.136 . . . . 75.32 107.933 167.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 98.2 t -109.3 131.75 59.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 107.718 -1.215 . . . . 71.52 107.718 165.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 35.5 tp -129.19 119.96 24.97 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.083 -0.71 . . . . 74.43 109.083 174.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.519 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.3 ttm180 -80.08 111.98 16.94 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.745 -1.116 . . . . 75.44 109.398 175.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 15.5 t -101.32 110.69 28.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.481 -1.303 . . . . 71.54 107.481 171.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.634 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 90.7 m -118.98 118.08 30.54 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.725 -0.843 . . . . 75.54 108.725 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.574 HG23 HG21 ' C' ' 114' ' ' ILE . 94.4 t -101.72 112.85 36.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 108.388 -0.968 . . . . 72.01 108.388 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -98.87 131.85 44.66 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.359 -0.978 . . . . 74.4 108.359 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.57 101.86 4.93 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.416 -1.328 . . . . 75.24 107.416 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 47.9 m -128.62 130.12 46.85 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.957 0.503 . . . . 75.25 109.994 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.556 HD11 ' HG2' ' C' ' 34' ' ' LYS . 12.5 mt -85.75 42.7 0.98 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 124.941 1.297 . . . . 73.53 109.774 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.87 -118.96 6.05 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 109.798 -1.321 . . . . 74.34 109.798 -167.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -89.21 -18.32 27.32 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.397 0.679 . . . . 60.33 110.072 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.433 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 7.4 tp10 -74.76 91.16 2.38 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.579 1.152 . . . . 73.44 109.656 173.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 76.9 m -71.47 119.82 16.17 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 109.516 -0.55 . . . . 74.45 109.516 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.607 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -76.57 -54.68 6.35 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.745 -1.116 . . . . 43.22 109.154 -178.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -157.15 170.38 22.63 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-O 122.349 1.071 . . . . 75.22 112.452 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -142.7 113.55 7.53 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 105.196 -2.15 . . . . 74.22 105.196 175.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.47 ' SG ' HG22 ' C' ' 114' ' ' ILE . 47.9 t -121.92 112.49 18.37 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.162 -0.681 . . . . 70.11 109.162 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -119.28 121.2 39.09 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.724 0.81 . . . . 74.15 110.056 -172.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 43.7 t -125.84 112.58 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.747 -0.834 . . . . 73.22 108.747 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.611 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.3 mt-30 -91.15 95.98 10.35 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.003 -1.11 . . . . 71.43 108.003 173.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -83.13 117.51 22.94 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.771 0.428 . . . . 72.01 109.871 -175.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.21 145.85 17.89 Favored Glycine 0 C--N 1.342 0.913 0 O-C-N 123.863 0.727 . . . . 70.32 111.643 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.98 116.92 0.83 Allowed Glycine 0 C--O 1.238 0.361 0 N-CA-C 111.164 -0.775 . . . . 72.53 111.164 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.512 HD13 HD13 ' C' ' 51' ' ' LEU . 10.3 mm -84.44 116.59 28.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.856 -1.164 . . . . 74.12 107.856 176.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.656 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 46.9 m-85 -128.1 146.57 50.65 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.064 -1.087 . . . . 75.13 108.064 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 85' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 70.7 p -113.1 122.06 46.41 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.311 -0.626 . . . . 64.53 109.311 170.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.534 ' HB ' ' HE1' ' C' ' 9' ' ' MET . 17.7 pt -130.35 143.93 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 122.957 0.503 . . . . 74.42 109.904 170.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.7 143.33 18.45 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.035 0.934 . . . . 61.54 108.745 171.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 130.99 -52.29 0.83 Allowed Glycine 0 C--N 1.346 1.128 0 O-C-N 123.208 0.317 . . . . 65.13 113.018 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 33.0 pt -94.48 170.38 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-N 117.325 0.563 . . . . 71.43 111.831 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.735 ' HB2' HG22 ' A' ' 149' ' ' THR . 42.5 tt0 -156.89 162.3 39.66 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.626 0.77 . . . . 71.4 110.716 -175.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.11 -132.75 15.58 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.034 -0.53 . . . . 74.11 112.686 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 20.4 p -69.36 -24.36 63.87 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.526 0.73 . . . . 64.44 111.769 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -65.15 -51.58 60.32 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 121.243 0.544 . . . . 73.53 110.039 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.542 ' SD ' HG13 ' G' ' 18' ' ' VAL . 46.3 ttp -64.88 -45.09 87.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.763 -1.108 . . . . 71.33 110.153 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.71 -26.03 68.47 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.062 0.945 . . . . 74.41 111.822 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -73.12 -42.72 62.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.036 0.534 . . . . 74.13 110.577 175.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 40.6 t -62.84 -60.7 3.12 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.709 0.63 . . . . 52.43 110.024 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.581 HD22 ' HD2' ' G' ' 17' ' ' PRO . 4.2 pp -71.3 -29.67 65.32 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 112.151 0.426 . . . . 75.42 112.151 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.56 11.42 56.52 Favored Glycine 0 N--CA 1.48 1.584 0 N-CA-C 115.157 0.823 . . . . 72.53 115.157 -167.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.79 -51.99 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 118.21 1.005 . . . . 74.43 110.335 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.426 ' HE2' ' CE1' ' C' ' 11' ' ' PHE . 27.3 t80 -75.93 -38.28 57.82 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 113.652 -1.613 . . . . 74.35 112.793 -169.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 83.4 m -79.28 -42.35 1.62 Allowed Pre-proline 0 CA--C 1.563 1.451 0 CA-C-O 118.553 -0.737 . . . . 51.11 112.196 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.85 -23.01 68.92 Favored 'Trans proline' 0 C--N 1.397 3.106 0 C-N-CA 122.139 1.893 . . . . 74.34 112.702 171.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -63.84 -32.37 73.86 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.793 0.837 . . . . 74.44 111.019 174.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.504 HD13 ' NH1' ' A' ' 111' ' ' ARG . 47.1 mm -67.63 -35.87 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 123.365 0.666 . . . . 75.35 110.303 175.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.0 -25.16 21.0 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.177 0.991 . . . . 73.14 112.923 -170.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . 0.416 ' N ' ' HD2' ' C' ' 108' ' ' PRO . 0.1 OUTLIER -63.55 -40.34 57.01 Favored Pre-proline 0 CA--C 1.557 1.24 0 CA-C-O 117.729 -1.129 . . . . 75.12 113.905 -171.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' C' ' 107' ' ' PHE . 30.0 Cg_endo -61.16 -36.82 79.0 Favored 'Trans proline' 0 C--N 1.388 2.645 0 CA-C-N 121.685 1.638 . . . . 72.4 112.314 174.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -64.29 -49.29 72.41 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.522 0.729 . . . . 74.31 110.729 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.78 -41.05 96.14 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.365 -0.834 . . . . 74.23 110.888 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -53.2 -56.15 18.73 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.659 1.183 . . . . 74.2 111.39 175.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . 0.444 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.8 tm-20 -66.14 -34.34 77.83 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 123.568 0.542 . . . . 75.33 110.286 -176.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.413 ' SG ' HG12 ' C' ' 21' ' ' ILE . 12.9 t -70.6 -27.45 64.11 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.072 0.549 . . . . 75.22 111.321 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.574 HG21 HG23 ' C' ' 64' ' ' VAL . 82.0 mt -77.66 -55.47 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.228 0.611 . . . . 75.4 110.288 173.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 18.8 m -62.49 -27.76 69.36 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.534 0.734 . . . . 72.43 110.96 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 42.6 t -62.06 -51.77 66.61 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 123.786 0.834 . . . . 73.23 109.38 169.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.665 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.03 -35.54 77.17 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.687 1.195 . . . . 64.42 112.668 178.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.405 HG23 ' O ' ' C' ' 114' ' ' ILE . 63.7 t -63.57 -46.7 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.71 0.804 . . . . 72.33 109.238 174.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 30.7 t -68.31 -28.55 67.27 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.859 -1.064 . . . . 73.41 111.851 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -72.77 -40.48 65.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.625 0.77 . . . . 72.52 109.316 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.34 -2.54 79.75 Favored Glycine 0 C--N 1.355 1.591 0 CA-C-N 115.42 -0.809 . . . . 71.05 112.267 171.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.452 HG21 ' HB3' ' D' ' 17' ' ' TYR . 24.8 p 65.44 27.66 11.74 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.783 2.033 . . . . 73.35 113.193 170.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -84.14 152.26 61.46 Favored Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 109.042 -0.725 . . . . 75.12 109.042 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -54.36 160.82 6.19 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 123.447 2.765 . . . . 74.23 114.106 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -55.38 111.16 0.81 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.715 0.806 . . . . 70.25 111.461 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 26.6 tp -116.38 86.28 2.46 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 106.116 -1.809 . . . . 74.13 106.116 167.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -104.56 125.9 51.15 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.862 -1.063 . . . . 71.31 109.587 -167.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.405 ' HA ' HD11 ' G' ' 6' ' ' ILE . 1.3 tt -70.36 127.35 32.44 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.489 0.715 . . . . 74.21 110.238 -173.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.6 156.05 68.32 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 123.99 0.916 . . . . 74.4 111.531 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.502 ' HB3' HD13 ' A' ' 16' ' ' ILE . 19.7 Cg_endo -61.22 102.34 0.21 Allowed 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.784 2.323 . . . . 72.41 112.975 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.497 ' HB ' HD12 ' G' ' 8' ' ' LEU . 60.3 t -118.86 110.08 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 108.742 -0.836 . . . . 71.45 108.742 173.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -96.1 106.39 18.56 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.057 -1.09 . . . . 73.23 108.057 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -53.87 -41.9 68.02 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.348 0.659 . . . . 74.24 112.494 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -55.41 -51.8 65.67 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.093 0.957 . . . . 74.44 111.229 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.5 -33.18 74.57 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.517 -0.765 . . . . 64.32 111.268 177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 5.1 tt -64.88 -36.72 85.26 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.383 1.073 . . . . 73.5 110.051 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -62.09 -39.6 93.04 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 123.16 0.287 . . . . 74.54 111.453 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 83.3 mtp -78.26 -33.83 49.39 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.575 0.75 . . . . 73.03 111.413 176.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -66.03 -35.83 81.6 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.02 1.328 . . . . 74.11 110.057 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' C' ' 143' ' ' GLN . 10.9 t80 -72.82 -149.41 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 125.476 1.51 . . . . 72.23 109.55 176.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 75.3 mt 68.54 -74.31 0.08 Allowed 'General case' 0 C--N 1.361 1.107 0 C-N-CA 125.094 1.357 . . . . 73.4 110.918 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -86.46 -29.92 22.43 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.162 0.985 . . . . 64.4 111.887 -175.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' C' ' 140' ' ' TYR . 14.9 pt20 -151.93 171.45 17.77 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.089 0.556 . . . . 73.3 111.456 -176.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -151.68 101.02 2.75 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.624 -0.88 . . . . 75.11 108.624 172.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.8 163.13 13.12 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.773 0.829 . . . . 75.3 110.955 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -165.09 151.05 19.69 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.44 -1.064 . . . . 55.11 110.44 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . 0.534 ' HB3' ' H ' ' G' ' 5' ' ' THR . 25.6 tt0 -78.46 79.66 4.88 Favored 'General case' 0 CA--C 1.554 1.129 0 CA-C-O 121.763 0.792 . . . . 73.55 110.124 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -89.99 116.6 4.82 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 110.244 -1.143 . . . . 74.03 110.244 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 5.0 m -144.59 -54.03 0.32 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.397 -0.964 . . . . 73.43 108.397 -177.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 66.25 178.68 0.21 Allowed 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.149 -1.387 . . . . 73.13 111.324 -174.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -154.53 -60.16 0.12 Allowed 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.554 -0.906 . . . . 65.03 108.554 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 64.2 80.0 0.24 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.02 0.928 . . . . 72.2 111.731 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -178.21 135.04 0.16 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.62 1.168 . . . . 75.23 108.675 167.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -154.35 -62.26 0.13 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.873 0.869 . . . . 73.31 109.104 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 N-CA-C 109.12 -0.696 . . . . 73.34 109.12 178.548 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 22.3 mmt . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 109.76 -0.459 . . . . 72.22 109.76 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 44.1 p -126.41 98.82 5.58 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.496 0.719 . . . . 74.1 109.558 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -104.11 102.8 12.54 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.037 -1.097 . . . . 61.41 108.037 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -144.31 -58.49 0.38 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.54 0.736 . . . . 75.32 109.477 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -167.14 159.33 12.86 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.481 -0.781 . . . . 74.04 110.344 -174.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 61.0 t30 177.49 77.27 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 107.392 -1.336 . . . . 74.32 107.392 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.0 m -132.56 -10.83 3.16 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.418 0.687 . . . . 72.03 111.502 -169.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -66.15 -21.12 66.32 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.978 0.511 . . . . 75.2 110.3 175.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.438 ' HE1' HD13 ' D' ' 89' ' ' ILE . 1.5 tmt? -27.72 127.54 0.07 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 126.113 1.765 . . . . 74.45 113.475 165.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 32.7 m -108.44 146.38 33.2 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.758 0.823 . . . . 73.45 110.603 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' D' ' 85' ' ' SER . 29.6 t80 -147.27 119.06 8.06 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.83 -1.174 . . . . 71.21 107.83 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . 0.405 ' HB2' ' HB3' ' D' ' 85' ' ' SER . 44.6 mt-30 -132.08 133.69 44.64 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.438 -0.949 . . . . 65.41 108.438 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.536 HD11 HG22 ' D' ' 105' ' ' ILE . 21.8 mt -84.68 129.31 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 108.51 -0.922 . . . . 75.41 108.51 173.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.626 HE21 ' HB2' ' D' ' 85' ' ' SER . 80.1 mt-30 -97.36 -46.18 6.19 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 122.586 0.354 . . . . 75.1 111.226 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -170.15 128.87 0.89 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.6 0.593 . . . . 71.12 112.6 -173.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.488 HD11 HG22 ' D' ' 13' ' ' ILE . 2.0 mp -107.57 137.92 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.445 -1.317 . . . . 52.11 107.445 174.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.452 ' HB3' HG21 ' C' ' 122' ' ' THR . 30.0 p90 -163.46 163.73 24.73 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 122.277 1.037 . . . . 74.11 110.956 178.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -93.8 120.89 34.66 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.629 -1.623 . . . . 74.41 108.419 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -85.3 -42.59 14.48 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.869 -1.16 . . . . 75.11 107.869 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.588 ' HB2' ' HB2' ' D' ' 79' ' ' GLN . 20.0 m-20 -136.21 144.79 45.08 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 114.755 -1.111 . . . . 74.23 110.217 176.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.665 HG21 ' HE1' ' C' ' 117' ' ' MET . 56.6 mt -140.73 149.65 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.355 1.462 . . . . 74.31 107.367 174.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.1 t -156.49 142.45 18.0 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.021 0.439 . . . . 74.25 110.849 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.1 t80 -147.63 111.59 5.11 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 106.176 -1.787 . . . . 72.15 106.176 173.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.537 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 23.8 mt-10 -123.04 108.23 12.68 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.011 -0.737 . . . . 73.14 109.011 -173.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.577 ' HB3' ' HB3' ' D' ' 28' ' ' ALA . . . -106.44 89.06 3.72 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 123.594 0.758 . . . . 74.23 109.076 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -80.0 -28.13 3.38 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.766 2.311 . . . . 73.11 113.209 -169.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -110.05 6.29 22.84 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.466 0.706 . . . . 62.52 110.627 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.625 ' HB2' ' HE2' ' C' ' 19' ' ' LYS . . . -29.58 -66.89 0.14 Allowed Pre-proline 0 CA--C 1.566 1.588 0 N-CA-C 116.904 2.187 . . . . 63.31 116.904 -165.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.638 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 64.6 Cg_endo -74.64 -14.57 22.04 Favored 'Trans proline' 0 C--N 1.383 2.381 0 CA-C-N 123.38 2.243 . . . . 65.23 112.847 -172.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -84.4 -39.3 19.19 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.048 1.339 . . . . 73.51 110.318 172.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.643 HG22 HD11 ' D' ' 68' ' ' LEU . 5.6 p -82.48 -22.9 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-N 116.436 -0.347 . . . . 73.41 110.98 -170.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -61.67 -24.05 66.48 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.036 0.534 . . . . 75.23 112.251 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -57.6 -30.09 65.02 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.434 1.094 . . . . 75.14 110.861 175.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.676 ' HZ1' ' HG2' ' D' ' 71' ' ' GLU . 96.1 mttt -84.33 71.98 10.61 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.514 -1.221 . . . . 70.42 109.502 174.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.72 81.55 5.97 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.215 -0.902 . . . . 60.44 110.67 -173.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 21.6 p90 -155.75 179.18 9.44 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.833 0.853 . . . . 72.0 109.485 172.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.526 HE21 ' HD2' ' D' ' 38' ' ' PRO . 25.1 tp60 -68.84 116.26 39.43 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.868 0.867 . . . . 73.14 110.609 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.526 ' HD2' HE21 ' D' ' 37' ' ' GLN . 50.9 Cg_exo -56.79 131.97 48.86 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.652 2.235 . . . . 75.22 112.379 176.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.29 111.15 3.84 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.755 -1.202 . . . . 75.24 107.755 172.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.463 HG23 HD13 ' H' ' 6' ' ' ILE . 27.7 m -108.19 137.68 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.42 0.629 . . . . 73.03 110.609 -172.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -123.76 128.21 49.23 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.115 -1.439 . . . . 72.52 107.115 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.636 HD22 ' H ' ' H' ' 8' ' ' LEU . 7.8 mp -96.84 138.5 34.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.195 0.521 . . . . 72.31 110.653 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -128.01 115.87 19.16 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.331 -1.359 . . . . 75.52 107.331 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.458 HD21 HD12 ' H' ' 8' ' ' LEU . 7.5 mp -104.47 138.2 41.21 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.356 0.662 . . . . 71.34 110.28 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.61 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.9 t70 -133.7 145.05 49.54 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.089 -1.078 . . . . 73.34 108.089 177.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.5 t -105.97 158.13 17.01 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.859 0.464 . . . . 75.02 111.298 -175.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -167.66 153.11 7.2 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.935 1.294 . . . . 74.43 108.847 173.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 76.9 p -154.0 156.71 37.9 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.555 0.742 . . . . 63.41 109.813 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 15.3 m -147.6 123.92 10.92 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.357 -0.979 . . . . 74.13 108.357 -174.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -78.46 115.39 18.13 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.789 -1.189 . . . . 73.55 107.789 167.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.525 HD13 HG23 ' D' ' 83' ' ' ILE . 26.3 mt -95.44 -27.89 15.19 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.064 -0.717 . . . . 71.13 109.064 177.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.16 -178.64 6.12 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.042 0.937 . . . . 64.21 110.132 172.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -65.67 123.7 20.43 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.549 -0.75 . . . . 72.33 109.816 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 60.45 20.37 10.06 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.25 1.02 . . . . 73.1 112.475 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.3 t -125.08 118.11 52.0 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 C-N-CA 124.205 1.002 . . . . 72.42 108.511 174.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -134.69 131.26 37.48 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.466 0.707 . . . . 75.13 109.849 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.418 ' HB2' HD11 ' D' ' 51' ' ' LEU . 31.5 tt0 -87.38 128.57 35.2 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.812 -1.086 . . . . 63.42 108.274 166.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 43.2 t -110.0 125.42 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 107.789 -1.189 . . . . 73.11 107.789 173.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 16.5 t -118.69 125.67 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.883 -0.784 . . . . 71.2 108.883 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 6.9 mp -121.8 127.46 50.62 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.545 -0.909 . . . . 72.4 108.545 171.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.61 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 18.9 ttm-85 -83.94 103.66 13.38 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.601 1.16 . . . . 74.53 108.903 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 87.0 t -90.94 115.49 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 108.501 -0.925 . . . . 73.41 108.501 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' D' ' 42' ' ' LEU . 18.7 m -125.82 128.29 47.43 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.064 0.459 . . . . 75.13 109.778 -172.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 42.7 t -118.76 101.01 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 125.541 1.537 . . . . 73.21 108.475 -175.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 32.2 m -92.46 95.23 9.53 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.023 -1.103 . . . . 74.41 108.023 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.66 138.64 39.29 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 115.459 -0.791 . . . . 72.21 111.113 -173.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 47.6 m -146.78 134.4 21.01 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 122.786 0.434 . . . . 71.45 110.989 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.643 HD11 HG22 ' D' ' 31' ' ' VAL . 66.2 mt -94.89 102.24 14.08 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.883 -1.154 . . . . 75.2 107.883 171.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.6 -113.82 3.83 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 116.12 -0.491 . . . . 63.1 112.363 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.73 3.66 11.11 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.108 0.563 . . . . 73.04 110.24 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.676 ' HG2' ' HZ1' ' D' ' 34' ' ' LYS . 9.7 pt-20 -116.0 155.08 28.72 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.685 -0.857 . . . . 64.43 108.685 177.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 35.0 m -70.01 136.43 50.39 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 123.395 0.435 . . . . 73.23 111.293 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.464 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -89.29 -62.77 1.4 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.705 -1.22 . . . . 73.23 107.705 172.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . 0.412 ' HE2' ' HG2' ' D' ' 38' ' ' PRO . 52.6 p90 -158.44 154.85 27.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.558 -1.201 . . . . 73.54 110.311 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 91.5 mt -120.56 112.75 19.31 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.58 1.152 . . . . 63.45 108.002 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.49 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 2.5 m -114.25 140.14 48.83 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.299 1.039 . . . . 73.12 108.918 -174.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -153.92 119.36 5.17 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.295 -1.002 . . . . 74.35 108.295 174.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . 0.438 HG23 HG22 ' D' ' 21' ' ' ILE . 60.3 t -124.5 115.13 43.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.487 -0.931 . . . . 73.41 108.487 174.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.588 ' HB2' ' HB2' ' D' ' 20' ' ' ASP . 51.1 mt-30 -88.13 85.37 6.94 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.92 -1.141 . . . . 74.12 107.92 171.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -80.66 104.03 10.91 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 114.132 -1.394 . . . . 72.22 108.467 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.64 141.74 15.42 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.421 -0.672 . . . . 72.14 111.421 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.487 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -137.11 131.93 5.78 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 111.472 -0.651 . . . . 64.03 111.472 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.525 HG23 HD13 ' D' ' 51' ' ' LEU . 50.8 mt -88.02 124.17 41.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.228 -1.027 . . . . 70.13 108.228 175.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -129.59 157.88 40.83 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.684 0.794 . . . . 73.02 110.071 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.626 ' HB2' HE21 ' D' ' 14' ' ' GLN . 43.4 t -115.56 98.88 6.97 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.986 1.314 . . . . 73.24 107.779 -178.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.9 111.55 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.532 0.733 . . . . 73.44 109.443 -176.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -131.87 149.76 52.35 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.932 0.493 . . . . 74.25 110.457 177.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.52 19.75 63.41 Favored Glycine 0 C--N 1.346 1.104 0 O-C-N 123.788 0.68 . . . . 64.11 114.426 172.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.525 HG23 ' N ' ' D' ' 90' ' ' GLU . 10.2 mt -112.65 154.16 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 117.226 0.513 . . . . 75.13 109.996 175.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.525 ' N ' HG23 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -147.82 -174.35 4.53 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 125.085 1.354 . . . . 74.14 110.7 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.01 -138.03 39.01 Favored Glycine 0 C--N 1.353 1.485 0 CA-C-N 115.948 -0.569 . . . . 52.44 113.622 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 28.1 p -90.05 -13.74 35.33 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.793 0.837 . . . . 74.1 111.017 174.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -31.0 72.03 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.351 1.06 . . . . 75.0 110.09 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.416 ' SD ' ' HA ' ' D' ' 90' ' ' GLU . 8.0 ptm -74.52 -21.18 59.67 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.389 0.676 . . . . 74.21 112.124 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.83 -36.13 50.46 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.704 -0.48 . . . . 71.23 109.704 169.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . 0.482 ' CD2' ' SD ' ' D' ' 138' ' ' MET . 24.7 t-80 -64.52 -37.28 87.02 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.306 0.642 . . . . 72.4 111.31 175.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 35.9 t -59.97 -49.57 77.17 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.011 -0.54 . . . . 73.5 110.491 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 43.7 mt -85.96 -21.7 27.75 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.246 -0.888 . . . . 75.2 111.557 -175.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.23 5.09 45.04 Favored Glycine 0 N--CA 1.476 1.363 0 N-CA-C 114.551 0.58 . . . . 61.43 114.551 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.627 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -150.05 -68.14 0.2 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.534 0.334 . . . . 74.33 110.855 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -65.13 -52.29 56.13 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 112.654 0.613 . . . . 73.45 112.654 -170.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 71.8 m -61.36 -50.17 84.47 Favored Pre-proline 0 CA--C 1.563 1.444 0 CA-C-O 118.76 -0.638 . . . . 71.21 112.218 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.29 -21.44 35.69 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 121.825 1.684 . . . . 74.34 113.421 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -68.74 -27.38 65.87 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 122.911 0.484 . . . . 73.03 110.528 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.536 HG22 HD11 ' D' ' 13' ' ' ILE . 58.5 mt -72.16 -28.43 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 C-N-CA 124.082 0.953 . . . . 75.44 110.441 171.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.487 HD22 ' HA3' ' D' ' 82' ' ' GLY . 94.2 mt -86.28 -22.94 26.53 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.702 0.801 . . . . 73.21 112.563 -176.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -66.9 -35.28 8.86 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.346 1.239 . . . . 75.32 114.346 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.91 -45.28 37.02 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 121.995 1.797 . . . . 75.53 112.939 166.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -74.51 -33.77 62.87 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.748 0.819 . . . . 73.44 111.884 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.41 -53.04 58.51 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.157 0.583 . . . . 63.52 109.889 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -53.77 -51.63 62.81 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-N 114.328 -1.305 . . . . 75.11 110.829 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -62.2 -44.81 95.75 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.274 0.984 . . . . 74.1 111.53 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.534 ' SG ' HD11 ' D' ' 21' ' ' ILE . 36.8 t -58.58 -40.63 83.72 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 123.814 0.696 . . . . 73.34 110.651 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.473 ' O ' HG22 ' D' ' 118' ' ' VAL . 76.7 mt -68.06 -48.79 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.809 0.843 . . . . 72.42 110.381 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 56.5 m -58.2 -42.45 86.18 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.438 1.095 . . . . 74.33 111.519 -175.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 32.8 t -66.5 -42.81 86.82 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.089 -0.96 . . . . 74.05 110.168 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.8 mtm -64.75 -37.57 88.05 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.946 0.498 . . . . 74.52 111.767 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.473 HG22 ' O ' ' D' ' 114' ' ' ILE . 78.1 t -65.96 -41.7 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.063 0.945 . . . . 73.43 110.842 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.8 p -73.31 -31.36 63.96 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 116.009 -0.541 . . . . 73.3 110.952 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' D' ' 116' ' ' SER . 72.9 mtt-85 -70.19 -33.15 71.36 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.436 0.694 . . . . 73.34 110.176 175.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.48 7.63 78.2 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-N 115.919 -0.582 . . . . 65.33 112.516 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.0 p 59.58 24.12 12.87 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 126.683 1.993 . . . . 65.12 114.073 173.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.468 ' HB2' HG13 ' D' ' 118' ' ' VAL . 97.0 m-85 -83.95 156.37 64.06 Favored Pre-proline 0 N--CA 1.479 0.983 0 N-CA-C 108.908 -0.775 . . . . 72.14 108.908 167.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.474 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 18.5 Cg_endo -60.83 139.69 86.54 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.166 1.911 . . . . 74.34 111.771 176.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -55.28 142.48 31.57 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.755 1.222 . . . . 75.11 112.469 -174.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 45.9 tp -127.91 98.65 5.23 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.658 0.783 . . . . 73.13 109.352 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.23 107.4 18.21 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.442 0.697 . . . . 72.01 109.333 175.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 7.4 mp -63.79 117.95 7.64 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.086 0.954 . . . . 71.32 109.789 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.79 145.05 98.95 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.478 0.711 . . . . 65.02 111.115 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.459 ' HD3' HG13 ' B' ' 13' ' ' ILE . 73.9 Cg_exo -54.53 129.23 33.77 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.824 3.016 . . . . 70.52 113.4 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 29.9 m -113.53 146.39 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.467 0.707 . . . . 74.24 110.069 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -90.11 74.94 7.13 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.977 -1.49 . . . . 75.44 106.977 169.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.46 ' HD2' ' HA ' ' D' ' 100' ' ' ALA . 24.1 t80 -63.46 -26.43 68.72 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.921 0.888 . . . . 74.3 110.818 -174.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.627 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 7.1 m-20 -60.48 -61.03 2.89 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 115.013 -0.994 . . . . 60.05 111.14 172.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.1 -29.48 70.84 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.969 0.508 . . . . 54.23 111.727 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 86.8 mt -65.55 -42.68 91.63 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 124.029 0.831 . . . . 74.32 111.349 173.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -66.23 -50.75 62.72 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.053 0.541 . . . . 75.13 109.943 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.482 ' SD ' ' CD2' ' D' ' 96' ' ' HIS . 3.2 mpp? -62.01 -29.33 70.2 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.778 0.431 . . . . 72.53 111.692 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.418 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 9.4 t30 -60.57 -42.99 97.77 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.867 0.867 . . . . 75.11 110.937 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -61.66 -39.84 92.82 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.259 -0.882 . . . . 73.31 111.269 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 mp -74.48 -38.19 62.97 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.954 -0.567 . . . . 72.14 111.506 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.418 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 10.0 pt20 -88.81 5.78 42.04 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.091 0.404 . . . . 64.43 112.091 -172.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -118.78 89.81 3.2 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.713 0.768 . . . . 72.33 109.015 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -155.98 106.67 2.45 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.138 -1.392 . . . . 75.23 107.841 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.25 128.66 52.61 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.765 0.826 . . . . 71.31 108.815 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.99 73.32 1.97 Allowed Glycine 0 C--N 1.348 1.203 0 O-C-N 123.364 0.415 . . . . 73.02 112.379 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -155.86 158.3 37.81 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.285 1.034 . . . . 73.34 108.291 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -54.46 -35.04 55.63 Favored Glycine 0 C--N 1.353 1.525 0 O-C-N 123.824 0.702 . . . . 73.14 114.781 -172.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 71.0 p -83.55 105.12 14.22 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 122.877 0.471 . . . . 73.32 110.152 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -109.44 153.05 24.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.637 0.775 . . . . 72.21 109.139 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -86.67 48.5 1.65 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.638 0.732 . . . . 75.41 109.208 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -84.2 84.37 7.64 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.479 -0.782 . . . . 73.01 109.597 -173.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -137.51 73.92 1.46 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.212 -1.033 . . . . 72.23 108.212 173.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -95.3 -166.31 1.43 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 114.603 -1.18 . . . . 72.41 110.176 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.301 0 C-N-CA 123.452 0.701 . . . . 74.34 111.32 -172.693 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 109.714 -0.476 . . . . 72.33 109.714 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -173.65 106.38 0.13 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.693 1.197 . . . . 74.41 108.258 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.59 104.24 5.07 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 107.667 -1.234 . . . . 70.21 107.667 -176.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 59.0 p -100.45 130.89 46.59 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.509 -0.922 . . . . 72.14 108.509 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 28.8 m -60.57 148.58 37.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.136 0.575 . . . . 74.55 111.026 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 2.6 pp -51.1 139.3 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 125.073 1.349 . . . . 72.12 113.039 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 7' ' ' ALA . . . . . 0.668 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . . . -150.8 161.92 41.74 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.79 0.836 . . . . 72.14 110.1 -175.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . 0.581 ' HB3' HD11 ' A' ' 44' ' ' LEU . 89.3 mt -69.65 -15.28 63.16 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.283 0.633 . . . . 73.15 112.299 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . 66.1 -160.29 0.26 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.356 1.063 . . . . 52.41 110.251 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 5.6 mp -73.25 149.17 42.99 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.396 -0.594 . . . . 74.14 109.396 175.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.54 HD23 HD12 ' A' ' 44' ' ' LEU . 85.2 mt -64.74 135.51 96.41 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 123.101 0.56 . . . . 74.14 110.163 176.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -58.57 -41.33 65.52 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.582 2.855 . . . . 70.11 113.756 -167.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 23.3 tp -135.03 31.62 3.25 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 108.7 -0.852 . . . . 73.23 108.7 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 8.3 mp 59.26 -89.06 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.561 -1.199 . . . . 70.31 110.159 -173.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -165.73 176.22 8.17 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.192 0.997 . . . . 75.53 108.907 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 39.9 p -75.45 116.39 54.38 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 123.085 0.554 . . . . 75.52 110.366 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 17' ' ' PRO . . . . . 0.487 ' HB3' ' HB2' ' E' ' 21' ' ' ALA . 61.6 Cg_exo -53.95 131.21 43.24 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.85 3.033 . . . . 61.14 114.002 -174.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 18' ' ' VAL . . . . . 0.49 HG21 HD13 ' A' ' 86' ' ' ILE . 26.0 t -73.94 -75.35 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.53 0.732 . . . . 73.42 110.55 -176.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 54.7 p -93.14 58.38 2.89 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.335 0.654 . . . . 73.32 110.793 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt 62.05 22.06 12.82 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.878 1.271 . . . . 74.43 113.304 170.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . 0.487 ' HB2' ' HB3' ' E' ' 17' ' ' PRO . . . -55.91 -28.2 55.64 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.753 0.821 . . . . 73.32 112.71 -173.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -151.97 133.14 14.38 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.345 -0.983 . . . . 73.44 108.345 171.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 29.1 m -132.9 121.62 17.08 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 107.778 -1.193 . . . . 75.52 107.778 -173.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -50.53 -37.69 52.76 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 123.591 2.861 . . . . 71.11 114.508 -170.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 CA--C 1.548 0.9 0 N-CA-C 107.943 -1.132 . . . . 72.35 107.943 170.827 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtm . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.126 -0.324 . . . . 74.44 110.126 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' F' F ' 2' ' ' LYS . . . . . 0.501 ' HA ' ' HE2' ' F' ' 2' ' ' LYS . 10.2 mmpt? -117.96 77.36 1.14 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.575 0.75 . . . . 75.24 110.615 -173.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -129.16 105.72 8.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.084 -0.71 . . . . 74.44 109.084 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 46.1 t -74.04 -42.71 59.85 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.556 -0.747 . . . . 74.3 110.779 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 83.6 m -145.63 150.58 36.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.893 0.877 . . . . 75.01 109.63 -174.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . 0.427 HG13 HD22 ' B' ' 42' ' ' LEU . 12.4 tt -65.34 97.65 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 CA-C-O 121.887 0.851 . . . . 74.41 109.712 173.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.39 26.1 9.06 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.092 -0.958 . . . . 74.5 110.936 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . 0.407 HD22 ' HB2' ' B' ' 42' ' ' LEU . 96.9 mt 61.51 168.96 0.11 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.879 1.271 . . . . 74.42 113.203 177.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.22 145.72 26.28 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.091 -0.707 . . . . 62.32 109.091 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 tt -75.4 75.41 2.48 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 108.986 -0.746 . . . . 73.04 108.986 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 82.9 mt 26.83 80.44 0.22 Allowed Pre-proline 0 N--CA 1.491 1.593 0 C-N-CA 126.653 1.981 . . . . 74.54 113.773 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.53 -41.14 74.78 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.761 2.307 . . . . 63.43 112.633 -174.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.05 -20.38 45.39 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.216 -0.902 . . . . 74.15 110.879 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 6.6 mp 59.73 -165.5 0.2 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.739 1.216 . . . . 72.32 110.638 -166.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . 0.494 ' HA ' HG21 ' B' ' 46' ' ' THR . 35.0 t80 -113.76 134.79 54.55 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 110.023 -0.362 . . . . 75.22 110.023 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 41.7 p -72.83 119.02 73.1 Favored Pre-proline 0 CA--C 1.557 1.22 0 N-CA-C 109.399 -0.593 . . . . 63.24 109.399 175.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 17' ' ' PRO . . . . . 0.513 ' HB2' ' HE1' ' B' ' 94' ' ' MET . 69.9 Cg_endo -70.23 174.49 9.83 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.961 2.441 . . . . 73.3 113.582 -175.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . 0.592 ' HB ' ' HB2' ' F' ' 21' ' ' ALA . 30.7 t -91.78 138.96 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.232 1.013 . . . . 71.14 110.174 -175.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 8.0 m -76.93 -55.85 5.11 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 109.835 -0.432 . . . . 62.44 109.835 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -98.82 77.38 2.23 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.284 -0.635 . . . . 65.34 109.284 172.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . 0.592 ' HB2' ' HB ' ' F' ' 18' ' ' VAL . . . -95.37 -58.02 2.24 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.1 -0.955 . . . . 71.32 108.629 170.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 7.6 ppt_? -96.95 160.57 14.27 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.499 -0.773 . . . . 72.53 109.925 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 32.3 p -80.05 144.21 58.6 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.077 0.951 . . . . 74.44 110.621 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.96 -63.17 0.07 OUTLIER 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.342 2.028 . . . . 75.44 110.952 175.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 124.499 1.12 . . . . 74.33 108.33 173.711 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 91.4 mmm . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 109.914 -0.402 . . . . 74.33 109.914 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -152.99 88.79 1.34 Allowed 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 108.905 -0.776 . . . . 74.51 108.905 -166.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -151.4 67.44 0.9 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.55 1.167 . . . . 71.12 110.35 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 69.3 m -141.51 -86.94 0.17 Allowed 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 106.457 -1.683 . . . . 70.51 106.457 164.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 5' ' ' THR . . . . . 0.534 ' H ' ' HB3' ' C' ' 147' ' ' GLU . 4.0 m 55.53 -76.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 125.472 1.509 . . . . 71.12 113.318 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . 0.636 HG13 HD21 ' C' ' 42' ' ' LEU . 10.1 tt -59.5 112.33 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 125.168 1.387 . . . . 75.13 111.36 -178.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -122.11 147.46 46.1 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.146 0.978 . . . . 63.44 110.403 -175.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 8' ' ' LEU . . . . . 0.497 HD12 ' HB ' ' C' ' 131' ' ' VAL . 56.7 mt -90.45 125.28 35.52 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 123.706 0.802 . . . . 73.41 109.43 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.55 164.77 22.48 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 123.86 0.725 . . . . 72.51 111.188 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.72 138.37 57.11 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.407 0.683 . . . . 71.15 109.794 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 96.5 mt -56.19 114.97 8.6 Favored Pre-proline 0 CA--C 1.548 0.872 0 O-C-N 123.985 0.803 . . . . 72.44 110.706 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.49 -22.85 65.08 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.094 2.529 . . . . 73.14 112.717 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 53.7 tp -139.18 135.27 33.83 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.585 0.754 . . . . 73.41 109.666 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 93.3 mt -98.17 102.67 14.48 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.354 -0.98 . . . . 74.45 108.354 172.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . 0.597 ' HD1' ' HD3' ' G' ' 17' ' ' PRO . 38.3 p90 -77.1 165.3 24.78 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.797 0.839 . . . . 74.41 110.913 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -149.53 91.95 4.31 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 123.491 0.716 . . . . 64.51 109.675 173.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 17' ' ' PRO . . . . . 0.65 ' HB3' ' HB3' ' C' ' 48' ' ' SER . 59.8 Cg_endo -73.26 -11.47 24.94 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.28 2.654 . . . . 75.02 112.208 173.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 18' ' ' VAL . . . . . 0.542 HG13 ' SD ' ' C' ' 94' ' ' MET . 46.9 t -92.81 166.9 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.372 0 C-N-CA 124.202 1.001 . . . . 72.23 108.495 172.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 25.7 m -31.35 -64.81 0.14 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 126.463 1.905 . . . . 71.13 114.799 -176.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 20' ' ' LYS . . . . . 0.518 ' HZ3' ' HB2' ' G' ' 20' ' ' LYS . 0.0 OUTLIER -168.06 131.55 1.61 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.233 0.213 . . . . 74.15 111.138 178.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . -102.28 116.62 33.03 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.501 0.72 . . . . 73.03 109.177 173.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 22' ' ' ARG . . . . . 0.493 ' HG2' ' H ' ' G' ' 23' ' ' THR . 20.8 ttt85 -144.77 -174.75 4.42 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.002 -0.74 . . . . 75.34 109.002 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 23' ' ' THR . . . . . 0.493 ' H ' ' HG2' ' G' ' 22' ' ' ARG . 40.6 p -48.66 121.79 10.19 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 124.007 0.923 . . . . 64.54 110.646 167.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.83 170.38 20.49 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.606 2.204 . . . . 75.45 111.203 176.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--O 1.251 1.175 0 N-CA-C 108.129 -1.063 . . . . 73.03 108.129 173.187 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 109.341 -0.614 . . . . 72.14 109.341 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -160.52 89.12 0.81 Allowed 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.764 0.826 . . . . 71.43 108.877 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -95.61 137.27 34.91 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.083 -1.08 . . . . 75.35 108.083 174.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 62.3 p -79.77 72.23 6.47 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.713 0.768 . . . . 73.33 109.568 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 19.4 m -86.06 129.04 34.96 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.984 -1.007 . . . . 60.33 109.406 -177.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . 0.463 HD13 HG23 ' D' ' 40' ' ' VAL . 2.6 pp -66.07 140.28 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 123.614 0.572 . . . . 73.54 110.294 174.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -166.55 105.24 0.62 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.944 -0.762 . . . . 71.25 108.944 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 8' ' ' LEU . . . . . 0.636 ' H ' HD22 ' D' ' 42' ' ' LEU . 3.8 mm? 64.76 -175.27 0.17 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.786 1.234 . . . . 74.01 111.535 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.68 -178.73 4.99 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.156 0.982 . . . . 52.44 109.299 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 87.3 mt -88.79 148.96 23.65 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.825 -0.435 . . . . 74.44 109.825 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 96.7 mt -70.87 130.26 88.69 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-N 115.59 -0.732 . . . . 70.22 110.712 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.98 -28.85 28.55 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.903 2.402 . . . . 75.35 112.323 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 98.4 mt -121.0 160.12 24.2 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.045 0.938 . . . . 75.03 110.149 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 7.3 mp -101.07 -171.2 1.96 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.938 0.895 . . . . 74.05 109.419 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -140.98 -158.29 0.85 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.734 1.213 . . . . 73.43 108.983 -176.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 16' ' ' THR . . . . . 0.519 ' HB ' ' HB2' ' H' ' 21' ' ' ALA . 63.3 p -109.06 147.3 35.65 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 123.638 0.775 . . . . 61.25 110.232 174.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -68.26 -159.01 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.737 2.958 . . . . 74.24 114.0 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 37.7 t -99.29 113.19 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.565 0.746 . . . . 75.12 110.83 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 62.2 m 73.54 137.13 0.05 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.004 1.322 . . . . 73.34 111.169 172.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt 65.21 21.54 12.1 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 122.258 1.028 . . . . 71.25 109.421 -174.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . 0.519 ' HB2' ' HB ' ' H' ' 16' ' ' THR . . . -114.85 -26.25 7.87 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.817 0.847 . . . . 73.32 112.045 -169.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . 0.421 ' NE ' ' HA ' ' H' ' 22' ' ' ARG . 2.6 mmp_? -121.25 115.27 22.68 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.226 0.61 . . . . 75.3 110.95 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 77.5 p -82.42 138.71 44.69 Favored Pre-proline 0 CA--C 1.554 1.099 0 CA-C-N 115.29 -0.868 . . . . 44.11 109.183 172.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.53 152.26 48.41 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.334 2.023 . . . . 63.11 112.411 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--O 1.248 0.99 0 N-CA-C 108.04 -1.096 . . . . 70.34 108.04 177.39 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 109.811 -0.44 . . . . 71.43 109.811 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.8 p -106.08 128.31 53.78 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.274 0.63 . . . . 73.13 109.894 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.496 ' HG3' ' HA ' ' C' ' 140' ' ' TYR . 33.3 tt0 -66.06 122.12 16.67 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.961 0.904 . . . . 75.35 108.988 176.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.407 HE22 ' ND2' ' A' ' 6' ' ' ASN . 20.8 tm0? -66.55 143.22 57.18 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.399 0.68 . . . . 72.44 110.181 -172.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -151.15 129.35 11.92 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.891 -0.781 . . . . 75.33 108.891 176.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.407 ' ND2' HE22 ' A' ' 4' ' ' GLN . 0.9 OUTLIER -79.13 103.54 9.14 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.464 -0.569 . . . . 71.01 109.464 179.208 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.5 p -87.78 -8.0 56.56 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.471 0.708 . . . . 71.4 110.583 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -73.64 -47.77 37.53 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.522 1.129 . . . . 74.41 109.941 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.607 ' HB2' HG23 ' A' ' 89' ' ' ILE . 23.3 ttt -145.23 161.68 38.96 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.911 -1.04 . . . . 65.41 108.194 -174.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.4 t -138.98 144.32 38.9 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.854 -0.425 . . . . 73.4 109.854 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.679 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 4.3 t80 -116.61 133.63 55.78 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.547 0.739 . . . . 74.22 109.841 -177.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.5 tp60 -150.16 127.33 11.29 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.812 -1.181 . . . . 74.42 107.812 172.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.58 HG12 ' HD2' ' A' ' 84' ' ' PHE . 48.6 mt -94.32 126.37 46.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.827 -0.805 . . . . 73.52 108.827 176.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -77.38 -39.75 46.15 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.675 -0.491 . . . . 73.0 109.675 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -169.16 145.55 3.42 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 116.365 -0.38 . . . . 73.4 110.332 -168.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.447 HD11 HD11 ' A' ' 13' ' ' ILE . 78.1 mt -137.46 136.91 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.021 -1.103 . . . . 62.14 108.021 170.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -167.84 176.49 6.24 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.808 0.843 . . . . 72.31 110.973 -172.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.9 p -102.74 126.78 49.98 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.307 -0.86 . . . . 75.33 108.984 177.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -90.71 -40.37 11.89 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.885 0.474 . . . . 74.24 110.122 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -141.2 139.2 33.79 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.224 -1.028 . . . . 62.44 108.224 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 63.8 mt -134.52 140.32 46.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.786 -1.19 . . . . 72.24 107.786 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.521 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 42.7 t -144.43 125.83 14.85 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.363 1.065 . . . . 72.31 108.134 177.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.49 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 85.7 t80 -135.99 115.04 12.3 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 106.667 -1.605 . . . . 65.54 106.667 170.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -120.09 126.05 49.8 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.777 -0.823 . . . . 74.52 108.777 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.47 81.61 4.21 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 107.162 -1.421 . . . . 64.1 107.162 172.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.15 -41.02 46.16 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.988 2.458 . . . . 74.42 113.415 -164.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -114.87 33.07 5.6 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 109.243 -0.651 . . . . 74.21 109.243 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.5 -49.33 34.78 Favored Pre-proline 0 N--CA 1.5 2.059 0 N-CA-C 114.464 1.283 . . . . 51.14 114.464 -177.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -64.12 -20.89 67.86 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.197 1.931 . . . . 75.35 114.088 177.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -101.37 -23.46 14.36 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.728 1.211 . . . . 74.22 111.634 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.533 HG22 ' HA ' ' A' ' 73' ' ' ALA . 2.4 p -78.74 -24.27 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.342 0.657 . . . . 73.14 112.363 -165.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -79.69 -18.63 50.86 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.549 0.74 . . . . 71.4 112.474 -172.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -88.24 -11.63 46.04 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.473 0.709 . . . . 72.42 111.0 173.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -82.21 161.85 22.59 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.644 0.778 . . . . 74.34 111.823 -174.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -72.75 120.49 18.45 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.221 -0.9 . . . . 74.24 109.755 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -76.34 86.03 3.12 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.378 0.608 . . . . 73.24 109.925 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -128.66 73.35 80.94 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 124.559 1.144 . . . . 74.25 107.996 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -86.84 138.44 5.1 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.849 2.366 . . . . 73.41 113.628 -170.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -102.03 86.2 2.83 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 106.988 -1.486 . . . . 75.52 106.988 169.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.1 m -72.8 90.73 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 123.062 1.41 . . . . 75.02 109.611 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -91.97 116.3 28.81 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 112.87 -1.968 . . . . 74.52 108.206 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.495 HD13 HG12 ' A' ' 62' ' ' VAL . 52.2 tp -104.87 129.52 53.2 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.475 0.71 . . . . 75.21 111.444 -170.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -120.73 126.33 49.9 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.348 1.059 . . . . 73.41 108.925 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.1 mt -114.67 133.87 55.52 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.739 0.816 . . . . 71.24 110.306 -173.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.59 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 18.5 t70 -127.05 138.97 53.31 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.819 0.848 . . . . 75.24 110.338 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.3 p -107.78 121.57 44.99 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.752 0.821 . . . . 73.04 110.222 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.97 128.91 25.05 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.696 0.798 . . . . 74.24 109.466 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.461 ' HB3' ' HE1' ' E' ' 15' ' ' PHE . 80.3 p -131.94 164.82 25.3 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.56 0.618 . . . . 72.04 110.432 175.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -156.96 138.96 14.44 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.616 0.766 . . . . 71.1 109.754 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -93.41 118.76 31.71 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.045 -1.094 . . . . 74.24 108.045 169.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.459 HD12 HG22 ' A' ' 83' ' ' ILE . 43.7 mt -90.95 -38.88 12.58 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.945 0.498 . . . . 73.15 110.528 -176.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.16 -176.77 6.1 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.88 0.872 . . . . 62.11 109.951 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -69.2 115.39 8.43 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.166 0.586 . . . . 73.35 109.669 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 75.94 -6.05 2.06 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 125.734 1.613 . . . . 73.15 112.469 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.9 t -100.51 112.96 34.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 108.127 -1.064 . . . . 71.43 108.127 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.429 ' CZ ' ' HA ' ' E' ' 18' ' ' VAL . 31.2 t80 -136.17 127.52 28.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.367 -0.605 . . . . 73.01 109.367 -174.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.428 ' HB2' HD13 ' A' ' 51' ' ' LEU . 36.3 tt0 -97.76 142.42 29.57 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.242 1.017 . . . . 74.51 111.159 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.423 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 56.0 t -125.59 132.47 70.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 106.767 -1.568 . . . . 70.55 106.767 173.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 62.0 t -128.11 129.48 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.32 1.048 . . . . 74.34 108.936 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -119.66 110.48 16.88 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.924 -1.139 . . . . 74.14 107.924 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.59 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 8.4 tmm_? -87.56 104.43 16.49 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.638 -0.875 . . . . 72.42 108.638 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.495 HG12 HD13 ' A' ' 42' ' ' LEU . 59.2 t -100.04 108.54 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.753 1.221 . . . . 75.11 109.195 -177.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.3 m -104.04 110.78 23.07 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.611 0.764 . . . . 64.32 110.539 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.3 t -105.08 108.89 26.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 124.157 0.983 . . . . 73.52 109.659 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.3 m -103.83 127.63 51.32 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.909 -0.774 . . . . 62.43 108.909 171.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.53 115.33 29.96 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.04 -1.096 . . . . 64.35 108.04 175.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.6 m -118.44 126.35 51.88 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.084 0.469 . . . . 72.53 110.811 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.7 mt -89.51 76.64 7.39 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 107.832 -1.173 . . . . 74.41 107.832 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.34 -83.65 0.98 Allowed Glycine 0 C--N 1.351 1.368 0 N-CA-C 111.145 -0.782 . . . . 70.03 111.145 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -119.53 -26.58 5.73 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.695 0.798 . . . . 74.15 111.161 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -88.96 110.76 21.39 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.963 0.505 . . . . 74.03 110.277 -174.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.9 m -64.23 122.59 17.0 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.917 0.389 . . . . 72.53 110.667 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.533 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -70.89 -59.86 2.56 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.028 -0.987 . . . . 65.44 110.157 175.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -153.17 174.03 14.76 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.185 -0.916 . . . . 72.13 111.658 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 64.2 tp -133.69 141.13 47.44 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.134 -1.432 . . . . 73.03 107.134 173.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 73.9 m -137.86 93.89 2.83 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.542 -0.91 . . . . 61.3 108.542 172.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 45.3 tt0 -113.1 116.26 29.59 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.696 -0.853 . . . . 73.22 108.696 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 t -135.39 115.92 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.459 0.703 . . . . 74.32 110.205 -170.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -81.98 94.2 7.1 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.071 -1.085 . . . . 71.51 108.071 169.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.414 ' HG3' HD23 ' A' ' 106' ' ' LEU . 9.6 tp-100 -82.17 99.45 9.26 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.69 -0.856 . . . . 74.04 108.69 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.19 146.26 20.21 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 111.192 -0.763 . . . . 53.43 111.192 176.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.22 120.81 1.14 Allowed Glycine 0 CA--C 1.5 -0.845 0 N-CA-C 110.247 -1.141 . . . . 74.24 110.247 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.459 HG22 HD12 ' A' ' 51' ' ' LEU . 21.7 mt -85.36 114.47 25.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.03 -0.73 . . . . 73.21 109.03 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.679 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 23.3 m-85 -119.37 119.57 34.35 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.401 -0.963 . . . . 63.33 108.401 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.4 p -86.03 101.45 12.94 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.775 -0.824 . . . . 64.11 108.775 174.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.445 ' HB ' ' HE3' ' A' ' 9' ' ' MET . 0.2 OUTLIER -127.74 134.54 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.392 0.677 . . . . 73.51 110.627 -174.182 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 178.65 166.5 0.86 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.125 1.37 . . . . 72.02 110.042 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 153.82 -82.75 0.16 Allowed Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.838 -0.619 . . . . 71.32 111.853 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.607 HG23 ' HB2' ' A' ' 9' ' ' MET . 11.7 tt -97.09 -29.36 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.756 0.822 . . . . 61.22 111.358 -174.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.42 ' HA ' ' HB3' ' A' ' 94' ' ' MET . 3.7 mm-40 62.34 -156.8 0.34 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.92 1.288 . . . . 73.31 110.814 -175.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.91 -128.23 14.22 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 114.245 0.458 . . . . 72.23 114.245 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.2 p -78.34 -28.86 47.34 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.606 0.762 . . . . 74.44 112.222 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -70.54 -40.37 73.46 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.328 0.651 . . . . 64.25 109.995 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.42 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 19.1 ptt? -72.52 -31.28 65.2 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.873 -0.417 . . . . 74.44 109.873 173.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.79 -35.52 80.86 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.438 0.695 . . . . 64.05 111.106 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -67.39 -42.37 83.47 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.693 -0.685 . . . . 75.34 110.091 172.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.625 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 81.6 m -62.71 -55.71 24.24 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 123.918 0.761 . . . . 72.15 111.379 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.632 HD22 ' H ' ' E' ' 18' ' ' VAL . 4.5 pp -73.09 -36.36 66.78 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.338 0.655 . . . . 74.54 111.316 -174.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.69 -16.62 58.1 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 114.764 0.665 . . . . 61.44 114.764 -168.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.74 -54.83 0.19 Allowed 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 117.655 0.728 . . . . 74.52 112.834 -171.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.625 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 79.3 t80 -63.64 -53.19 55.26 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.319 1.047 . . . . 74.43 112.896 -169.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.5 m -72.1 -37.41 4.85 Favored Pre-proline 0 CA--C 1.563 1.453 0 C-N-CA 123.591 0.757 . . . . 74.33 112.678 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.79 -40.48 47.88 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 122.441 2.094 . . . . 71.31 113.588 160.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -70.81 -24.1 62.49 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.87 0.868 . . . . 74.11 111.527 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 51.0 mm -69.6 -36.94 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 109.387 -0.598 . . . . 72.34 109.387 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.414 HD23 ' HG3' ' A' ' 80' ' ' GLN . 83.3 mt -79.58 -23.68 42.57 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.752 0.821 . . . . 75.53 112.445 -177.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -58.72 -49.23 94.54 Favored Pre-proline 0 CA--C 1.571 1.764 0 N-CA-C 113.651 0.982 . . . . 72.45 113.651 -176.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -63.68 -35.74 56.37 Favored 'Trans proline' 0 C--N 1.389 2.672 0 C-N-CA 122.159 1.906 . . . . 73.51 113.484 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.45 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 96.4 m-85 -75.56 -35.67 60.6 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.579 0.752 . . . . 73.14 111.937 -178.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.8 -44.83 65.79 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.376 -0.602 . . . . 70.44 109.376 175.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.424 ' NH1' HG22 ' C' ' 105' ' ' ILE . 17.9 ttm180 -59.5 -33.97 72.02 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.146 0.904 . . . . 75.4 110.165 173.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -66.3 -50.53 63.34 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.864 0.866 . . . . 54.55 110.836 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 36.8 t -61.45 -37.02 82.04 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.744 0.653 . . . . 75.3 110.552 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 118' ' ' VAL . 93.5 mt -62.22 -57.28 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.774 0.83 . . . . 72.35 110.021 172.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.8 m -52.28 -39.66 60.74 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.253 1.421 . . . . 74.12 111.908 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -69.98 -51.42 32.66 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.884 -1.053 . . . . 74.21 110.392 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.417 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 36.7 mtm -64.64 -36.69 85.06 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.93 0.492 . . . . 72.22 111.918 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 114' ' ' ILE . 79.2 t -61.1 -44.94 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.506 0.722 . . . . 72.13 110.227 176.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.9 t -70.47 -34.67 72.66 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.477 -0.783 . . . . 64.52 111.454 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.529 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 93.7 mtt-85 -70.58 -32.56 69.99 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.889 0.876 . . . . 73.03 109.695 176.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.95 1.64 83.66 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-O 119.065 -0.853 . . . . 63.53 112.992 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 122' ' ' THR . 22.5 m 73.71 12.53 4.48 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 122.446 1.117 . . . . 71.44 111.866 173.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.445 ' HB2' HG13 ' A' ' 118' ' ' VAL . 97.9 m-85 -84.13 148.2 52.73 Favored Pre-proline 0 CA--C 1.544 0.736 0 O-C-N 121.369 -0.832 . . . . 71.24 109.591 172.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.1 142.21 96.85 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.533 2.155 . . . . 64.15 110.91 172.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -57.27 145.2 32.74 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 124.281 0.988 . . . . 72.24 113.016 -168.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.5 tp -127.99 114.91 17.73 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.871 0.868 . . . . 73.34 109.41 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -119.69 117.65 28.83 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.534 -0.913 . . . . 74.12 108.534 175.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.9 mp -72.49 146.07 47.11 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.147 0.579 . . . . 74.1 110.232 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.34 136.37 95.65 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.874 0.87 . . . . 72.22 112.15 -174.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -67.83 89.45 0.36 Allowed 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.941 2.427 . . . . 71.5 112.265 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 87.1 t -107.31 112.03 38.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.595 -0.891 . . . . 73.53 108.595 176.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -85.32 96.75 9.63 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 107.688 -1.227 . . . . 72.42 107.688 170.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -55.3 -37.61 67.56 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.059 0.85 . . . . 74.35 111.002 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.84 -36.65 80.71 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.097 -0.956 . . . . 75.32 111.326 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.41 -32.65 72.85 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.751 0.82 . . . . 64.31 111.718 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.593 ' HB2' HD23 ' E' ' 10' ' ' LEU . 91.0 mt -73.2 -41.91 63.26 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.805 -0.634 . . . . 73.3 109.527 174.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -63.53 -25.75 68.39 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.537 0.735 . . . . 74.53 111.316 172.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 13.7 mmt -69.56 -34.28 73.95 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.906 0.882 . . . . 73.44 111.324 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 88.0 m-20 -61.74 -35.44 78.1 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.503 0.721 . . . . 74.45 110.23 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -84.96 -27.84 26.24 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.096 0.958 . . . . 74.34 111.728 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 46.9 tp -62.92 -50.48 70.68 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.415 0.686 . . . . 74.24 110.267 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -174.13 5.86 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.094 -0.957 . . . . 74.33 111.253 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 28.5 tt0 63.57 90.37 0.08 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.911 1.285 . . . . 74.31 110.192 -170.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.492 ' NE2' ' HA ' ' C' ' 144' ' ' GLN . 24.7 tt0 -80.14 165.98 21.92 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.153 -0.931 . . . . 75.15 110.644 -176.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.466 ' N ' ' HG2' ' A' ' 144' ' ' GLN . . . 70.91 -154.82 0.11 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.546 1.138 . . . . 74.23 111.354 168.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.39 13.89 67.2 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 111.603 -0.599 . . . . 54.12 111.603 -169.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -133.59 164.63 26.74 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 124.306 1.042 . . . . 75.21 110.044 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.495 ' HA2' HD11 ' C' ' 141' ' ' LEU . . . 159.29 81.53 0.04 OUTLIER Glycine 0 C--N 1.343 0.917 0 N-CA-C 110.781 -0.927 . . . . 64.21 110.781 178.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.7 p -121.95 134.25 54.84 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.675 0.79 . . . . 70.43 110.589 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -73.61 146.37 44.7 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.854 0.862 . . . . 73.34 110.578 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -134.47 74.37 1.53 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.277 1.031 . . . . 73.45 110.036 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 52.9 m170 -125.21 114.3 18.79 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.886 0.874 . . . . 75.52 109.912 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -161.17 138.61 9.08 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.485 0.714 . . . . 73.43 109.572 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -145.35 -53.7 0.29 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.803 0.841 . . . . 73.42 109.627 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 C-N-CA 123.592 0.757 . . . . 70.03 109.432 -177.673 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 109.941 -0.392 . . . . 74.22 109.941 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 9.1 m -65.24 -90.11 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.857 0.863 . . . . 64.31 109.39 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 48.88 41.51 18.67 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 114.65 1.352 . . . . 73.21 114.65 153.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -139.98 111.94 7.51 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 108.713 -0.847 . . . . 74.54 108.713 173.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -76.98 142.85 39.79 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.389 0.676 . . . . 62.54 110.157 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 60.54 82.98 0.15 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.118 1.367 . . . . 73.31 110.499 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 15.1 t -147.85 172.55 13.98 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.712 -0.676 . . . . 73.44 110.545 -171.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -78.72 -18.41 54.34 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.781 0.832 . . . . 74.44 111.416 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.413 ' HE3' ' SG ' ' B' ' 97' ' ' CYS . 19.6 ptm 62.42 177.26 0.14 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 126.767 2.027 . . . . 70.03 113.63 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 99.9 m -134.79 140.05 45.59 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.831 1.252 . . . . 73.4 107.84 174.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.452 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 46.0 t80 -142.22 132.89 25.44 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.053 -0.721 . . . . 71.43 109.053 172.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.473 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -153.44 121.11 5.96 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.45 -0.945 . . . . 72.44 108.45 174.086 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 54.7 mt -68.75 120.07 15.62 Favored 'Isoleucine or valine' 0 C--N 1.348 0.528 0 N-CA-C 108.186 -1.042 . . . . 73.53 108.186 170.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -89.07 -49.84 6.52 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.711 -0.848 . . . . 75.11 108.711 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.464 ' HE ' HG21 ' A' ' 122' ' ' THR . 34.2 ttt85 -168.74 137.03 2.1 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.55 -0.75 . . . . 74.14 109.636 -175.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 87.1 mt -115.36 142.19 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 108.341 -0.985 . . . . 73.3 108.341 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -168.13 148.98 5.01 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 112.622 0.601 . . . . 75.11 112.622 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.541 HG21 HD13 ' B' ' 21' ' ' ILE . 39.5 m -79.69 114.14 18.39 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.268 -0.878 . . . . 74.02 108.912 172.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -84.09 -25.89 29.41 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.099 0.56 . . . . 74.44 111.375 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 16.2 t70 -163.43 149.06 11.41 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.367 0.603 . . . . 72.14 112.052 -175.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.541 HD13 HG21 ' B' ' 18' ' ' THR . 46.4 mm -137.15 142.85 36.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 126.018 1.727 . . . . 70.4 107.742 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 42.5 t -146.17 137.15 24.43 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.249 -1.019 . . . . 74.15 108.249 168.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.419 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 91.2 t80 -141.15 131.86 25.69 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.301 -1.37 . . . . 72.02 107.301 172.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 34.4 mt-10 -131.66 126.84 35.65 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.798 -1.186 . . . . 73.11 107.798 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.462 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -127.98 81.19 70.84 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 107.146 -1.428 . . . . 61.54 107.146 170.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.46 -30.53 35.94 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.884 2.389 . . . . 65.11 111.33 -177.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -103.96 2.58 32.55 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.281 -1.327 . . . . 74.45 110.86 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.482 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -32.05 -66.76 0.19 Allowed Pre-proline 0 N--CA 1.499 1.997 0 C-N-CA 126.032 1.733 . . . . 73.14 115.096 -172.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 21.7 Cg_exo -62.55 -31.05 80.12 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.899 2.399 . . . . 61.33 113.669 -164.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -96.22 -41.51 8.65 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.426 -0.807 . . . . 72.32 111.158 -174.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.17 -12.71 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 113.074 0.768 . . . . 72.02 113.074 -170.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -62.89 -18.24 62.73 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.485 0.714 . . . . 73.31 112.641 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.479 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 10.6 pt20 -55.15 -29.92 58.76 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.453 1.101 . . . . 55.44 111.499 173.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.479 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 96.5 mttt -92.38 95.31 9.59 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.7 1.2 . . . . 75.51 109.202 177.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -97.95 76.65 2.43 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 122.009 0.909 . . . . 73.24 111.494 -172.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 43.0 p90 -157.51 161.13 38.82 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.61 -0.885 . . . . 72.44 108.61 171.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -68.16 116.42 38.98 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 109.062 -0.718 . . . . 74.45 109.062 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.97 159.33 54.37 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.162 1.908 . . . . 75.43 112.656 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -64.63 113.13 3.53 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 109.195 -0.669 . . . . 73.4 109.195 174.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.23 121.64 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.881 0.848 . . . . 74.54 109.79 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.523 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 37.6 ttpt -107.04 100.55 10.03 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.578 -1.638 . . . . 73.31 106.578 175.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 pp -110.24 140.58 44.24 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.735 0.814 . . . . 72.25 110.174 -169.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -136.06 129.93 32.68 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.173 0.989 . . . . 63.32 108.915 -174.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -100.78 127.39 47.23 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.802 -1.184 . . . . 62.45 107.802 170.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.483 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 24.1 t70 -126.92 155.11 43.58 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.197 0.999 . . . . 72.22 108.731 -175.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 79.2 p -107.63 120.11 41.29 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.706 -0.679 . . . . 74.54 110.685 -172.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.79 131.18 44.52 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 107.174 -1.417 . . . . 71.52 107.174 172.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 10.7 p -145.91 168.29 21.19 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.699 0.681 . . . . 73.0 111.457 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p -152.19 138.33 18.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.115 0.966 . . . . 75.4 108.521 171.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -93.82 114.0 26.16 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.133 -0.691 . . . . 74.12 109.133 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 51.6 mt -77.58 -43.2 32.51 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.867 0.467 . . . . 63.24 110.157 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.7 -179.24 7.69 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.579 0.752 . . . . 61.1 110.501 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.11 124.38 21.97 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.301 -1.318 . . . . 72.13 109.02 172.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 70.85 6.77 5.98 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.889 1.276 . . . . 74.22 112.282 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.484 HG21 ' HG ' ' B' ' 85' ' ' SER . 78.0 t -119.85 111.54 33.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.7 0 N-CA-C 107.698 -1.223 . . . . 73.13 107.698 170.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -122.13 139.84 53.26 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.54 -0.541 . . . . 70.21 109.54 -177.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.43 ' HG2' HG12 ' B' ' 83' ' ' ILE . 6.6 tm-20 -111.35 101.13 9.61 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 107.489 -1.3 . . . . 74.13 107.489 -176.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 63.4 t -96.5 119.6 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.491 1.117 . . . . 70.23 109.601 -173.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.479 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 10.6 t -114.05 123.93 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.826 0.85 . . . . 75.42 108.711 178.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.445 HD21 ' HB3' ' B' ' 103' ' ' PRO . 15.6 tp -103.93 116.26 31.94 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.094 -0.706 . . . . 65.22 109.094 171.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.483 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 41.2 ttm180 -86.04 109.73 19.01 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.438 -0.949 . . . . 73.24 108.438 174.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 46.9 t -101.6 101.26 11.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.34 -1.355 . . . . 64.34 107.34 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.6 m -97.99 128.55 44.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.505 -0.77 . . . . 70.43 109.094 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.611 HG22 HG21 ' B' ' 114' ' ' ILE . 67.5 t -121.57 131.68 72.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 124.578 1.151 . . . . 74.41 108.184 -174.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 60.3 m -120.88 145.46 47.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.873 -1.158 . . . . 74.25 107.873 171.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.52 126.34 12.68 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.643 -0.873 . . . . 74.23 108.643 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 30.8 p -133.63 128.39 35.02 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.966 0.506 . . . . 72.41 110.114 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.461 HD11 ' HB1' ' B' ' 73' ' ' ALA . 70.4 mt -100.79 107.06 18.52 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.014 0.926 . . . . 72.44 108.804 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.16 -129.9 10.0 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 115.877 -0.601 . . . . 70.33 112.497 -176.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -92.4 1.21 57.37 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.647 0.779 . . . . 64.21 110.766 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.43 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 13.4 pt-20 -121.63 162.25 21.02 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.298 0.639 . . . . 75.02 110.444 -175.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 25.9 m -71.2 145.46 49.65 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.654 0.596 . . . . 75.31 109.787 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.461 ' HB1' HD11 ' B' ' 68' ' ' LEU . . . -101.8 -60.2 1.57 Allowed 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.296 -1.002 . . . . 71.34 108.296 168.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -153.04 164.52 37.85 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.001 0.905 . . . . 74.3 111.255 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 31.3 mt -134.48 142.8 47.18 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 105.427 -2.064 . . . . 70.04 105.427 178.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.3 t -154.8 116.42 4.11 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.601 0.637 . . . . 74.14 109.888 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -121.33 122.86 40.79 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 107.883 -1.155 . . . . 73.54 107.883 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.2 141.76 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.73 0.812 . . . . 74.3 108.959 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.41 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.5 mt-30 -118.63 94.54 4.5 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.697 -1.223 . . . . 73.51 107.697 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -90.31 103.93 16.56 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.988 -0.745 . . . . 75.32 108.988 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.46 161.98 29.04 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 123.798 0.686 . . . . 72.1 112.101 177.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.05 125.03 1.34 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.835 -1.306 . . . . 70.24 109.835 177.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.43 HG12 ' HG2' ' B' ' 57' ' ' GLU . 28.3 mt -85.05 130.22 36.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 107.854 -1.165 . . . . 74.04 107.854 175.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -136.6 133.6 36.49 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.037 -1.098 . . . . 74.41 108.037 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.484 ' HG ' HG21 ' B' ' 55' ' ' VAL . 40.3 m -87.25 92.36 9.04 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.452 -0.944 . . . . 71.14 108.452 170.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -107.43 130.3 59.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-N 114.907 -1.042 . . . . 73.23 108.492 176.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.66 168.73 18.16 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.622 0.769 . . . . 75.35 109.997 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.66 -63.44 4.28 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.079 -0.964 . . . . 73.54 112.903 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.478 HG23 ' HB2' ' B' ' 93' ' ' GLN . 43.4 mm -58.83 149.1 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 N-CA-C 114.757 1.392 . . . . 74.4 114.757 -165.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -159.99 -175.76 5.29 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 125.348 1.459 . . . . 71.23 109.548 171.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.01 -111.59 3.93 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 115.423 0.929 . . . . 71.02 115.423 166.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 51.2 m -81.54 -39.03 25.27 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.706 0.802 . . . . 74.44 111.125 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.478 ' HB2' HG23 ' B' ' 89' ' ' ILE . 51.0 mt-30 -66.4 -25.19 66.66 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.306 0.642 . . . . 71.3 112.219 -169.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.576 ' HE1' HD13 ' B' ' 98' ' ' LEU . 22.3 ptm -67.61 -27.54 66.99 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.223 0.609 . . . . 72.44 112.107 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.64 -33.18 69.78 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.796 0.838 . . . . 71.45 110.73 175.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -84.33 -49.24 8.91 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.295 -0.866 . . . . 72.24 109.811 171.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.413 ' SG ' ' HE3' ' B' ' 9' ' ' MET . 43.8 t -58.51 -65.91 0.58 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.974 0.731 . . . . 70.24 112.974 -167.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' F' ' 15' ' ' PHE . 0.6 OUTLIER -103.8 -2.32 26.53 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 111.727 0.269 . . . . 65.33 111.727 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.04 -17.39 37.74 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 123.197 0.311 . . . . 53.3 113.527 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.59 -55.07 0.89 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.579 0.752 . . . . 74.3 110.574 -176.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -73.51 -53.07 11.48 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.359 1.064 . . . . 71.21 112.244 -166.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.452 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 64.3 m -63.77 -46.72 82.32 Favored Pre-proline 0 CA--C 1.56 1.35 0 CA-C-O 118.864 -0.589 . . . . 55.2 111.626 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.445 ' HB3' HD21 ' B' ' 60' ' ' LEU . 31.2 Cg_exo -64.23 -28.33 64.23 Favored 'Trans proline' 0 C--N 1.39 2.762 0 C-N-CA 122.003 1.802 . . . . 74.44 114.124 173.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.611 ' HA ' ' HD2' ' B' ' 107' ' ' PHE . 47.3 t-20 -57.94 -41.23 82.34 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 123.606 0.762 . . . . 71.13 110.412 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.42 HG22 ' NH2' ' D' ' 111' ' ' ARG . 96.8 mt -60.17 -42.49 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 114.415 -1.266 . . . . 71.32 110.888 175.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 56.7 mt -85.05 -15.43 44.08 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 115.21 -0.905 . . . . 70.11 112.277 -170.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.611 ' HD2' ' HA ' ' B' ' 104' ' ' ASN . 5.1 m-85 -54.46 -53.02 64.44 Favored Pre-proline 0 N--CA 1.495 1.776 0 C-N-CA 124.139 0.976 . . . . 73.15 113.592 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.16 -30.26 46.71 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 122.292 1.995 . . . . 74.41 113.849 -177.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -70.96 -44.45 66.02 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.832 0.453 . . . . 75.4 110.243 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.22 -41.24 98.21 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.963 -0.562 . . . . 62.51 110.248 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -59.59 -54.25 48.69 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.792 0.837 . . . . 74.22 110.164 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -61.73 -33.63 74.38 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 123.714 0.634 . . . . 75.34 110.289 -174.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.529 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 4.0 t -74.55 -48.23 28.07 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 116.062 -0.517 . . . . 71.32 111.452 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.611 HG21 HG22 ' B' ' 64' ' ' VAL . 98.6 mt -57.39 -56.07 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 C-N-CA 123.39 0.676 . . . . 74.21 109.867 174.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 33.0 m -59.25 -30.96 68.66 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 124.417 1.073 . . . . 75.23 111.06 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.4 t -63.64 -47.37 81.61 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 109.288 -0.634 . . . . 71.14 109.288 171.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.527 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.0 mmt -67.05 -30.79 70.96 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.089 0.556 . . . . 74.32 111.13 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.494 HG23 ' O ' ' B' ' 114' ' ' ILE . 84.8 t -65.97 -47.31 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.152 0.981 . . . . 74.32 109.171 173.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 71.2 m -66.31 -31.33 72.06 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 114.429 -1.26 . . . . 73.13 111.517 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.511 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 90.5 mtt-85 -73.95 -32.61 63.56 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 124.014 0.926 . . . . 74.5 109.655 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.47 6.33 69.31 Favored Glycine 0 C--N 1.353 1.491 0 O-C-N 124.196 0.935 . . . . 63.44 112.506 174.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 80.5 p 54.92 36.09 25.94 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 125.898 1.679 . . . . 73.13 112.653 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -95.6 157.78 35.54 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.138 0.975 . . . . 73.01 110.544 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -52.99 158.9 5.89 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.607 2.871 . . . . 73.24 115.036 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -64.03 115.07 4.57 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.705 -1.134 . . . . 73.15 111.77 -172.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 55.5 tp -125.35 112.14 15.98 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.366 0.666 . . . . 75.3 109.778 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -132.55 135.54 46.01 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.914 0.886 . . . . 73.44 108.89 176.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.426 ' HA ' ' CG2' ' F' ' 6' ' ' ILE . 8.0 mp -85.71 142.82 28.73 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.112 0.565 . . . . 73.54 111.622 -174.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.99 132.91 49.43 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.064 0.946 . . . . 73.32 110.646 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.37 108.86 2.78 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 123.02 2.48 . . . . 74.52 112.754 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' F' ' 8' ' ' LEU . 98.3 t -93.62 111.6 25.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.639 -1.245 . . . . 75.31 107.639 167.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -74.36 91.33 2.2 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.458 0.703 . . . . 72.43 109.214 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -64.21 -41.12 97.19 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.417 -0.81 . . . . 74.51 110.726 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' B' ' 138' ' ' MET . 2.9 m-20 -50.27 -52.97 31.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.205 1.002 . . . . 72.2 111.526 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.28 -40.99 98.94 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.104 0.877 . . . . 73.34 111.176 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 8.5 tt -59.83 -46.46 89.17 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.847 0.859 . . . . 74.21 110.458 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -65.38 -30.21 71.01 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.033 0.933 . . . . 75.21 111.32 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' B' ' 134' ' ' ASP . 94.5 mmm -69.86 -33.76 72.7 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.061 0.544 . . . . 73.54 111.301 177.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -74.05 -19.82 60.5 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.964 0.505 . . . . 64.41 111.186 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -76.97 -48.35 18.29 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.891 -0.781 . . . . 75.11 108.891 170.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 75.8 mt -91.66 37.07 0.95 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.52 1.128 . . . . 74.22 110.798 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.02 153.09 39.84 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.686 0.794 . . . . 74.11 112.306 -172.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -113.76 121.41 43.99 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.867 -0.79 . . . . 74.24 108.867 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -81.03 130.97 35.26 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.132 0.573 . . . . 64.33 110.146 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -99.75 164.83 11.87 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.913 0.885 . . . . 75.2 110.288 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.28 144.18 6.86 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 116.581 -0.281 . . . . 71.14 112.647 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -149.45 95.39 2.34 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.923 0.889 . . . . 64.14 109.148 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -102.92 111.51 4.0 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 115.657 -0.702 . . . . 64.23 111.538 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 42.3 p -85.77 168.37 14.38 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.311 0.645 . . . . 71.25 109.844 172.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -136.87 147.16 46.32 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.354 0.662 . . . . 72.33 109.868 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -141.42 164.04 31.3 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.74 0.816 . . . . 73.54 110.575 -176.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -170.87 163.21 7.66 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.977 1.311 . . . . 70.25 108.225 169.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -172.51 144.92 1.53 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.977 0.511 . . . . 74.14 109.797 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -62.02 149.86 39.72 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.524 0.729 . . . . 75.52 110.787 175.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.263 0 C-N-CA 123.975 0.91 . . . . 64.34 109.628 -176.224 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.503 ' N ' ' SD ' ' C' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 108.84 -0.8 . . . . 71.42 108.84 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 27.3 m -63.85 -53.44 50.63 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.519 0.727 . . . . 71.33 110.255 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -124.66 -38.14 2.42 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.262 1.025 . . . . 73.53 108.416 170.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -162.38 -56.57 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.607 -0.886 . . . . 74.22 108.607 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 67.16 -79.72 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.273 1.429 . . . . 71.22 112.261 169.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -168.96 150.87 4.66 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.771 1.229 . . . . 72.51 108.157 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 27.5 m 70.44 126.96 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.904 1.282 . . . . 73.4 110.478 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -72.01 175.11 6.19 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.363 0.665 . . . . 73.32 110.32 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.485 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 12.5 tpt 66.25 113.83 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.633 1.173 . . . . 64.04 110.672 -166.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 90.4 m -108.63 109.29 20.46 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.938 -1.504 . . . . 73.13 106.938 171.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.472 ' HD1' ' HH ' ' C' ' 101' ' ' TYR . 1.0 OUTLIER -117.8 133.02 56.36 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.851 0.461 . . . . 70.41 110.332 -173.827 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -150.93 132.77 15.04 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.949 0.899 . . . . 74.14 108.912 168.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 90.4 mt -73.25 127.35 35.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.399 -0.963 . . . . 75.34 108.399 170.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -95.14 -44.08 7.81 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.626 0.77 . . . . 73.44 109.58 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -176.29 134.35 0.25 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.635 0.774 . . . . 73.1 109.464 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.437 HG21 ' CD1' ' C' ' 109' ' ' TYR . 59.4 mt -127.25 151.88 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 118.636 0.653 . . . . 74.42 109.335 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.436 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 21.0 p90 -176.3 168.72 2.79 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.717 0.77 . . . . 74.11 110.978 -172.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 68.8 p -87.69 115.95 25.49 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.571 -1.195 . . . . 71.42 109.489 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.436 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 26.0 mmtp -65.54 -46.91 77.72 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.252 -1.018 . . . . 75.42 108.252 167.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.442 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 18.4 t70 -134.92 142.56 46.57 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 114.207 -1.36 . . . . 62.3 109.667 -174.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.532 HG12 ' SG ' ' C' ' 113' ' ' CYS . 89.0 mt -135.78 141.17 42.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 106.466 -1.679 . . . . 75.23 106.466 167.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.5 t -159.09 150.88 20.7 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.964 -0.384 . . . . 74.44 109.964 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -155.33 106.84 2.6 Favored 'General case' 0 C--O 1.226 -0.16 0 N-CA-C 107.913 -1.143 . . . . 74.33 107.913 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -117.93 111.4 18.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.524 0.73 . . . . 63.24 109.876 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.2 92.15 10.74 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 107.157 -1.423 . . . . 73.12 107.157 170.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.46 -35.58 38.49 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.657 2.238 . . . . 74.15 112.306 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -101.92 24.73 9.56 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.455 -0.793 . . . . 75.34 110.35 -175.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.96 -62.4 1.67 Allowed Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 114.714 1.376 . . . . 72.25 114.714 -167.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.53 -32.73 48.33 Favored 'Trans proline' 0 C--N 1.383 2.387 0 CA-C-N 121.834 1.691 . . . . 72.24 112.306 -174.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.568 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 72.7 t60 -70.84 -40.45 72.37 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.53 0.732 . . . . 74.41 112.012 177.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.736 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.2 p -77.8 -21.44 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 112.081 0.4 . . . . 64.31 112.081 -170.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -63.66 -29.7 70.9 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.44 0.904 . . . . 74.23 113.44 177.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 21.1 pt20 -84.78 5.76 27.21 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 122.727 0.411 . . . . 74.43 111.114 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.711 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -95.21 156.63 16.24 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.427 1.091 . . . . 74.21 110.408 -177.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -67.86 128.78 37.77 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.155 0.982 . . . . 73.14 110.061 169.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -86.07 100.62 12.3 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.331 0.652 . . . . 74.41 111.3 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -156.69 77.35 4.18 Favored Pre-proline 0 N--CA 1.474 0.773 0 N-CA-C 107.82 -1.178 . . . . 72.03 107.82 168.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -86.65 150.03 8.71 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.377 2.051 . . . . 75.42 113.294 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -82.83 81.49 8.53 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 105.953 -1.869 . . . . 72.43 105.953 168.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -69.33 99.51 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-N 114.367 -1.288 . . . . 73.51 109.444 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -96.14 112.14 23.96 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 113.787 -1.551 . . . . 73.21 109.026 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.59 141.99 28.6 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.604 -0.517 . . . . 74.22 109.604 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.452 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 24.1 t70 -135.66 147.09 48.44 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.575 1.15 . . . . 72.15 108.367 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.61 157.13 44.48 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.082 0.553 . . . . 74.42 111.145 -173.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.593 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 17.1 t70 -140.74 144.97 35.83 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.958 0.903 . . . . 72.33 109.029 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 46' ' ' THR . . . . . 0.421 ' HB ' ' HD2' ' G' ' 15' ' ' PHE . 40.8 p -112.78 112.51 24.05 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.19 -0.67 . . . . 64.15 109.19 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.48 150.35 44.0 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.035 0.934 . . . . 75.43 108.787 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 37.7 p -165.99 157.63 13.94 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.363 0.265 . . . . 73.51 111.658 -174.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 23.4 p -166.1 127.73 1.86 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.82 0.848 . . . . 71.41 109.681 173.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -72.12 130.82 41.79 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 108.917 -0.771 . . . . 73.1 108.917 168.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.528 HD13 HD13 ' C' ' 83' ' ' ILE . 60.0 mt -97.64 -37.0 10.09 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.274 0.63 . . . . 74.35 111.264 -175.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.27 -171.39 2.38 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.003 0.521 . . . . 64.44 111.746 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -57.94 109.12 0.68 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.921 1.288 . . . . 74.12 110.081 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 69.67 -7.15 0.92 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 125.224 1.41 . . . . 74.53 112.668 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.7 t -94.0 112.32 26.65 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 N-CA-C 108.061 -1.089 . . . . 73.31 108.061 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -120.17 159.75 24.27 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.128 -0.942 . . . . 72.13 108.492 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -126.66 123.62 37.98 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.237 0.615 . . . . 65.34 110.244 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.488 HG11 ' HD3' ' C' ' 103' ' ' PRO . 89.6 t -104.66 128.19 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 107.974 -1.121 . . . . 64.42 107.974 171.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -121.23 130.98 74.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.071 -1.085 . . . . 74.34 108.071 170.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 29.4 tp -126.17 117.7 23.66 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.187 -1.412 . . . . 75.21 107.187 170.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.593 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 6.9 tmm_? -90.95 128.64 36.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.515 -0.766 . . . . 73.1 109.611 178.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.48 140.56 19.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.971 -1.122 . . . . 73.4 107.971 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 53.8 m -133.93 122.04 22.54 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.882 -0.785 . . . . 65.14 108.882 173.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.562 HG22 HG21 ' C' ' 114' ' ' ILE . 89.4 t -101.55 109.46 25.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 107.979 -1.119 . . . . 71.34 107.979 176.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.411 HG23 HD22 ' C' ' 75' ' ' LEU . 4.2 m -99.57 107.14 19.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.852 -1.166 . . . . 74.22 107.852 175.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.02 108.37 19.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.719 -1.586 . . . . 64.51 106.719 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.4 m -132.23 127.95 36.84 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.149 -0.686 . . . . 73.0 109.149 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.711 HD11 ' HG2' ' C' ' 34' ' ' LYS . 8.2 mt -85.13 48.99 1.65 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.907 1.283 . . . . 72.44 109.56 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.15 -113.63 4.49 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 109.747 -1.341 . . . . 71.41 109.747 -168.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.69 -19.96 17.91 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.411 0.684 . . . . 63.03 110.526 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -67.24 120.66 14.16 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.866 0.867 . . . . 72.32 108.756 169.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.7 m -84.29 125.61 32.41 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 118.764 0.711 . . . . 74.43 109.295 173.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.736 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.79 -63.54 1.28 Allowed 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.364 -0.976 . . . . 74.03 108.364 173.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -155.77 173.09 17.24 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.274 -0.875 . . . . 74.51 110.663 174.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.411 HD22 HG23 ' C' ' 65' ' ' THR . 2.3 tm? -131.03 141.17 50.19 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 105.089 -2.189 . . . . 73.43 105.089 169.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.521 ' SG ' HG22 ' C' ' 114' ' ' ILE . 47.2 t -142.99 136.94 28.96 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.559 -1.274 . . . . 62.12 107.559 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . 0.521 ' HG3' ' HD3' ' C' ' 61' ' ' ARG . 24.4 tt0 -146.4 120.38 9.38 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.658 0.383 . . . . 73.12 110.396 -173.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 54.6 t -129.72 115.9 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.135 0.974 . . . . 73.3 109.231 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.499 ' HG2' ' HB2' ' C' ' 61' ' ' ARG . 22.6 mt-30 -89.56 99.4 12.41 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.747 -1.205 . . . . 74.2 107.747 170.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.515 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 9.0 tp-100 -87.88 109.76 20.02 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.825 -0.806 . . . . 73.2 108.825 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.33 145.45 17.6 Favored Glycine 0 C--N 1.341 0.819 0 O-C-N 123.6 0.562 . . . . 74.01 111.88 176.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.82 126.14 2.67 Favored Glycine 0 CA--C 1.506 -0.487 0 N-CA-C 110.921 -0.872 . . . . 71.2 110.921 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.528 HD13 HD13 ' C' ' 51' ' ' LEU . 9.6 mm -87.27 117.83 32.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 108.383 -0.969 . . . . 64.35 108.383 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.416 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 41.7 m-85 -129.17 120.99 26.78 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.227 1.011 . . . . 74.34 109.256 -173.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 57.3 p -79.4 109.11 13.45 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.633 -0.877 . . . . 74.11 108.633 172.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.432 HG12 ' HE3' ' C' ' 9' ' ' MET . 70.5 mt -119.86 130.43 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.283 1.033 . . . . 72.14 108.855 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -161.63 158.52 26.24 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.741 0.816 . . . . 74.42 110.189 -175.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.1 -57.87 1.05 Allowed Glycine 0 C--N 1.345 1.035 0 O-C-N 123.296 0.372 . . . . 71.25 113.217 174.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 37.9 pt -85.41 161.28 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 122.909 0.483 . . . . 74.04 111.398 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.469 ' HA ' ' HE1' ' C' ' 94' ' ' MET . 10.9 pt-20 -152.73 -178.56 6.96 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.92 0.888 . . . . 74.14 110.465 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.85 -139.39 42.91 Favored Glycine 0 C--N 1.349 1.263 0 O-C-N 123.379 0.425 . . . . 73.0 112.845 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.9 p -64.34 -19.86 65.73 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.54 0.736 . . . . 73.21 111.753 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -64.76 -55.92 16.78 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.496 0.718 . . . . 75.03 110.243 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.469 ' HE1' ' HA ' ' C' ' 90' ' ' GLU . 10.6 ptp -71.97 -29.82 64.64 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 116.579 -0.282 . . . . 74.53 110.479 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.47 -32.68 74.19 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.205 0.602 . . . . 72.5 111.51 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -77.43 -37.2 52.18 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.407 0.683 . . . . 72.32 110.069 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.556 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 28.8 t -59.61 -40.08 86.34 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.862 0.726 . . . . 72.33 110.613 175.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.444 HD13 HG22 ' G' ' 18' ' ' VAL . 67.7 mt -81.49 -40.22 23.56 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.025 0.93 . . . . 75.23 111.54 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.01 -13.68 82.94 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.414 -0.812 . . . . 72.43 114.843 -168.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.571 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -157.97 -54.71 0.07 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 117.237 0.519 . . . . 72.21 112.388 -173.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.556 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 82.4 t80 -57.5 -40.59 79.01 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.711 1.204 . . . . 71.14 113.736 -172.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 89.3 m -82.08 -44.87 1.02 Allowed Pre-proline 0 CA--C 1.561 1.388 0 CA-C-O 118.784 -0.627 . . . . 73.43 112.361 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.488 ' HD3' HG11 ' C' ' 58' ' ' VAL . 37.1 Cg_endo -68.3 -7.79 21.09 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 121.624 1.549 . . . . 74.14 114.287 170.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . 0.547 HD22 ' HB3' ' C' ' 133' ' ' PHE . 0.9 OUTLIER -68.13 -30.97 70.24 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 123.396 0.678 . . . . 75.11 110.741 168.023 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.424 HG22 ' NH1' ' A' ' 111' ' ' ARG . 41.8 mm -68.33 -40.46 82.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-N 115.416 -0.811 . . . . 71.11 109.519 173.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 61.2 mt -83.08 -26.76 30.78 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.323 -1.308 . . . . 74.12 112.166 -168.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . 0.417 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 89.7 t80 -56.14 -53.93 58.13 Favored Pre-proline 0 CA--C 1.562 1.438 0 CA-C-O 118.07 -0.967 . . . . 70.44 112.754 -176.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . 0.417 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 36.1 Cg_exo -59.42 -36.68 93.21 Favored 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 122.319 2.012 . . . . 72.54 113.221 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . 0.437 ' CD1' HG21 ' C' ' 16' ' ' ILE . 4.4 m-30 -63.73 -50.76 67.86 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.156 0.982 . . . . 72.42 111.059 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.515 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -71.21 -29.89 65.7 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.331 -0.849 . . . . 74.41 111.215 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -61.79 -47.82 83.43 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.598 1.159 . . . . 71.25 110.647 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -71.02 -33.71 70.63 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.891 0.476 . . . . 73.42 110.025 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.532 ' SG ' HG12 ' C' ' 21' ' ' ILE . 44.6 t -64.44 -37.1 86.35 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.12 0.568 . . . . 61.43 111.282 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.562 HG21 HG22 ' C' ' 64' ' ' VAL . 97.0 mt -71.7 -51.77 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.155 0.582 . . . . 73.12 110.352 174.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.0 m -62.4 -28.4 69.75 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.124 0.57 . . . . 73.11 111.426 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.416 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 42.5 t -64.07 -49.94 70.3 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.141 -0.688 . . . . 62.14 109.141 170.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.556 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.45 -33.57 75.85 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.286 1.035 . . . . 73.31 112.662 179.658 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.446 HG23 ' O ' ' C' ' 114' ' ' ILE . 58.3 t -62.83 -44.6 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 109.085 -0.709 . . . . 73.54 109.085 175.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 39.9 t -70.8 -31.0 67.61 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.801 -1.09 . . . . 75.03 111.93 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' C' ' 116' ' ' SER . 90.8 mtt-85 -68.97 -37.49 78.83 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.33 0.652 . . . . 74.33 109.342 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.85 6.87 79.62 Favored Glycine 0 C--N 1.353 1.521 0 O-C-N 123.967 0.792 . . . . 73.1 112.639 174.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 50.7 p 57.34 28.56 15.47 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.278 1.831 . . . . 75.23 114.294 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -83.95 144.63 45.03 Favored Pre-proline 0 N--CA 1.472 0.628 0 N-CA-C 109.059 -0.719 . . . . 73.41 109.059 172.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.81 153.31 37.68 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.67 2.247 . . . . 74.21 112.4 175.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -53.85 129.35 33.37 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.042 0.937 . . . . 72.0 113.487 -170.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 31.3 tp -131.72 84.65 2.18 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 107.054 -1.461 . . . . 72.41 107.054 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -98.16 106.1 18.35 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.462 -1.245 . . . . 72.55 108.425 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.38 138.39 58.51 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.31 0.644 . . . . 75.53 111.213 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.74 133.88 90.4 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 124.088 0.868 . . . . 73.4 110.711 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.45 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 32.2 Cg_endo -65.15 107.74 1.01 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.53 2.153 . . . . 61.54 112.492 176.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 23.7 m -100.33 131.3 48.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 108.941 -0.762 . . . . 75.51 108.941 170.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.427 HD22 ' HE1' ' A' ' 11' ' ' PHE . 3.3 m-20 -72.01 84.89 0.99 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.016 -0.538 . . . . 75.35 109.567 177.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.547 ' HB3' HD22 ' C' ' 104' ' ' ASN . 39.1 t80 -65.07 -31.67 72.99 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.227 -0.897 . . . . 73.53 111.32 -172.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.571 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 32.0 t70 -77.63 -38.45 47.88 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.747 0.419 . . . . 74.53 111.584 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.23 -29.66 70.47 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.738 0.649 . . . . 74.23 111.299 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.5 HD11 ' HA ' ' C' ' 133' ' ' PHE . 74.0 mt -60.2 -42.48 95.17 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.179 0.991 . . . . 75.14 111.757 173.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -80.39 -24.86 39.43 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.865 0.466 . . . . 74.42 111.602 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 54.4 ttm -75.02 -31.7 61.42 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.673 0.789 . . . . 74.12 111.996 -175.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -70.71 -37.18 73.54 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 110.061 -0.348 . . . . 72.54 110.061 174.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.496 ' HA ' ' HG3' ' A' ' 3' ' ' GLU . 52.6 t80 -54.05 -81.88 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.685 0.794 . . . . 72.11 111.094 175.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.495 HD11 ' HA2' ' A' ' 148' ' ' GLY . 3.4 tm? -64.76 115.14 4.98 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 107.383 -1.34 . . . . 72.43 107.383 176.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.7 113.02 1.64 Allowed 'General case' 0 CA--C 1.544 0.714 0 O-C-N 124.259 0.974 . . . . 54.1 110.18 -173.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . 0.541 ' HG2' ' H ' ' C' ' 144' ' ' GLN . 10.2 tt0 -143.44 -176.17 4.84 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.432 1.093 . . . . 73.41 108.313 -176.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . 0.541 ' H ' ' HG2' ' C' ' 143' ' ' GLN . 81.1 mm-40 77.35 161.91 0.22 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.346 1.458 . . . . 74.04 112.794 174.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.06 165.28 34.28 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.811 -1.086 . . . . 70.34 110.436 -174.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -136.57 -109.27 0.95 Allowed Glycine 0 C--N 1.348 1.246 0 CA-C-N 116.073 -0.512 . . . . 70.2 112.645 -177.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 67.3 -87.82 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.645 1.178 . . . . 73.45 110.535 -173.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 158.55 150.09 5.68 Favored Glycine 0 C--N 1.358 1.8 0 N-CA-C 114.326 0.49 . . . . 75.14 114.326 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 4.5 t -166.53 177.8 6.44 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.896 1.279 . . . . 73.34 109.53 175.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -160.38 87.93 0.78 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.358 -0.979 . . . . 61.31 108.358 171.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -90.87 138.12 31.83 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.114 0.565 . . . . 73.44 110.114 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -127.09 179.95 5.16 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.012 0.925 . . . . 73.3 110.996 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . 0.553 ' HB3' ' HA ' ' E' ' 12' ' ' PRO . 23.1 tm0? -143.82 98.93 3.32 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 106.236 -1.764 . . . . 73.11 106.236 166.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -86.19 147.04 26.3 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.673 0.389 . . . . 75.11 110.839 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.323 0 CA-C-O 118.508 -0.758 . . . . 75.11 109.242 173.15 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 109.815 -0.439 . . . . 72.25 109.815 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 42.6 m -136.65 82.55 1.95 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.615 1.166 . . . . 63.34 108.925 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -124.93 92.78 3.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.526 -0.761 . . . . 75.03 109.718 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 48.71 100.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.128 1.371 . . . . 74.35 113.671 164.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -73.91 -90.73 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 118.671 -0.681 . . . . 74.31 110.176 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 61.7 t30 43.81 44.84 5.94 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.663 1.185 . . . . 75.44 111.497 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 14.1 p -119.75 -177.86 3.49 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 124.724 1.21 . . . . 74.21 109.987 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.549 ' HG3' ' HG3' ' D' ' 9' ' ' MET . 10.0 tp10 67.44 178.17 0.24 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.588 1.155 . . . . 74.45 110.245 -177.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.642 ' HE2' HD11 ' D' ' 89' ' ' ILE . 4.4 ppp? -29.47 151.12 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 126.036 1.735 . . . . 74.43 114.887 169.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 67.4 m -103.59 135.88 44.35 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.479 -0.564 . . . . 75.01 109.479 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.55 ' HB2' ' HE1' ' D' ' 9' ' ' MET . 35.1 t80 -137.56 119.14 14.93 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.042 -1.095 . . . . 71.3 108.042 -175.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -130.88 129.84 42.79 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.315 -0.994 . . . . 63.11 108.315 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.485 HG21 HD13 ' D' ' 16' ' ' ILE . 56.1 mt -79.05 129.53 37.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.985 -0.746 . . . . 72.04 108.985 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -105.14 -28.39 11.02 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 119.037 -0.506 . . . . 74.24 111.74 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -176.82 140.41 0.33 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 118.157 0.435 . . . . 74.42 111.52 -173.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.485 HD13 HG21 ' D' ' 13' ' ' ILE . 3.0 mp -123.53 136.31 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.566 -1.272 . . . . 74.14 107.566 171.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.423 ' HE1' HG13 ' D' ' 83' ' ' ILE . 28.6 p90 -162.81 175.07 11.64 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-O 122.078 0.942 . . . . 75.33 112.231 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -109.71 122.51 47.65 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.049 -1.432 . . . . 71.42 108.814 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -93.17 -31.81 14.63 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.3 -0.63 . . . . 74.42 109.3 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.419 ' HB2' ' HB2' ' D' ' 79' ' ' GLN . 6.5 m-20 -142.36 131.57 23.39 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 108.315 -0.994 . . . . 63.51 108.315 177.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.556 HG23 ' HE1' ' C' ' 117' ' ' MET . 89.0 mt -128.6 150.29 34.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.505 -1.294 . . . . 75.42 107.505 172.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 22' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 47.3 t -151.69 139.39 19.76 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.258 1.023 . . . . 75.44 108.923 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 84.1 t80 -152.86 127.66 9.53 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.464 -2.05 . . . . 73.31 105.464 169.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -135.96 134.59 38.79 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.876 -1.157 . . . . 75.43 107.876 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.88 90.53 46.81 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 108.032 -1.099 . . . . 63.42 108.032 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.44 -41.07 12.68 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.802 2.335 . . . . 75.24 112.688 -172.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.48 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 27.7 m-20 -106.03 9.81 32.38 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.658 0.783 . . . . 72.02 110.737 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -19.44 -70.26 0.03 OUTLIER Pre-proline 0 CA--C 1.563 1.458 0 N-CA-C 117.396 2.369 . . . . 61.52 117.396 -165.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.05 -24.03 13.15 Favored 'Trans proline' 0 C--N 1.382 2.321 0 CA-C-N 123.647 2.338 . . . . 74.4 113.969 -174.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -75.1 -41.07 59.39 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.265 1.026 . . . . 72.15 110.522 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.599 HG21 ' HA ' ' D' ' 73' ' ' ALA . 12.3 p -75.82 -20.22 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 115.856 -0.611 . . . . 75.2 111.243 -173.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -66.64 -20.04 65.9 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 112.699 0.629 . . . . 73.12 112.699 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -59.1 -26.17 64.44 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.769 0.828 . . . . 73.24 110.627 176.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.484 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 99.3 mttt -91.46 108.72 20.09 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.894 1.278 . . . . 74.25 110.17 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -105.84 88.77 2.89 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.948 0.899 . . . . 74.41 110.978 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 45.5 p90 -161.14 177.26 10.43 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.382 1.073 . . . . 75.3 108.339 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -72.85 115.52 40.91 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 108.845 -0.798 . . . . 75.44 108.845 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -60.82 130.47 33.17 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.33 2.02 . . . . 70.04 111.212 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -63.54 114.44 3.92 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.454 -0.943 . . . . 73.21 108.454 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.494 HG13 HD22 ' D' ' 126' ' ' LEU . 31.1 m -106.91 112.05 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-O 121.526 0.679 . . . . 75.13 110.094 -174.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.423 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 12.0 tmtt? -84.49 119.15 24.83 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 106.467 -1.679 . . . . 75.03 106.467 174.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.57 HD21 HD12 ' H' ' 6' ' ' ILE . 4.1 pp -95.6 150.38 20.41 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.135 0.493 . . . . 75.31 110.187 -173.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.526 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 13.0 t70 -151.29 119.66 6.4 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.023 -0.99 . . . . 74.44 108.741 -176.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.52 133.84 52.6 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.764 -0.458 . . . . 74.24 109.764 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 31.4 t70 -132.99 157.55 44.92 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.094 -1.076 . . . . 75.4 108.094 176.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 46' ' ' THR . . . . . 0.444 ' HB ' HD13 ' H' ' 11' ' ' LEU . 11.8 t -119.93 153.88 35.26 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.395 0.617 . . . . 62.45 112.106 -173.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.653 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.72 152.86 33.31 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.215 1.406 . . . . 63.13 107.885 172.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 21.1 p -164.63 152.37 11.86 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.69 0.223 . . . . 65.51 110.967 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 60.3 p -164.23 135.02 4.3 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.485 0.714 . . . . 72.42 109.756 177.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -77.71 136.47 38.18 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.851 -0.796 . . . . 71.43 108.851 172.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' D' ' 57' ' ' GLU . 40.2 mt -103.24 -35.05 8.59 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.88 0.472 . . . . 75.42 110.375 -177.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.53 -174.0 3.55 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.746 0.818 . . . . 61.45 109.954 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.23 114.92 3.73 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.232 -0.895 . . . . 72.24 110.238 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 63.87 12.2 6.58 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.788 1.235 . . . . 75.4 112.761 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 76.4 t -109.03 122.67 64.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 106.936 -1.505 . . . . 70.34 106.936 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.623 ' HB3' HD11 ' D' ' 86' ' ' ILE . 16.5 t80 -143.06 131.04 21.68 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.769 -0.456 . . . . 74.41 109.769 -173.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.408 ' HB2' HD11 ' D' ' 51' ' ' LEU . 8.1 tt0 -99.7 130.97 45.97 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.052 0.941 . . . . 73.41 109.747 177.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.1 t -119.63 127.13 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.275 -1.009 . . . . 72.34 108.275 174.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.653 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 11.5 t -112.81 135.69 51.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 124.086 0.954 . . . . 72.54 108.725 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' D' ' 103' ' ' PRO . 11.5 tp -125.47 116.87 22.5 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.631 -0.507 . . . . 75.54 109.631 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.446 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 17.9 ttm-85 -83.86 103.14 12.89 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.74 0.816 . . . . 72.34 109.383 175.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 62.1 t -93.27 120.24 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.279 -1.008 . . . . 74.4 108.279 170.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 12.2 m -120.66 146.94 45.9 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 122.963 0.505 . . . . 74.15 109.755 -175.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.418 HG13 ' HB ' ' D' ' 40' ' ' VAL . 53.7 t -137.48 103.88 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 125.383 1.473 . . . . 75.32 109.033 -175.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 48.1 m -94.12 96.96 9.97 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.567 -0.901 . . . . 74.24 108.567 169.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.471 ' HB1' HG12 ' D' ' 40' ' ' VAL . . . -97.96 153.07 18.61 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.694 -0.685 . . . . 70.31 109.802 -171.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.411 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.9 p -155.54 128.61 8.14 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 123.559 0.537 . . . . 52.13 112.11 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.545 HD11 HG23 ' D' ' 31' ' ' VAL . 45.7 mt -96.66 96.18 8.45 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.832 -1.173 . . . . 74.55 107.832 169.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -136.14 17.72 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.808 -0.633 . . . . 74.44 112.719 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -84.41 3.15 37.39 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.547 0.739 . . . . 65.31 111.742 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.484 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 12.7 pt-20 -125.01 147.84 48.75 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.998 -0.371 . . . . 70.0 109.998 -178.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 61.8 m -65.02 135.38 55.54 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 123.825 0.703 . . . . 72.24 111.32 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.599 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -85.61 -65.36 1.02 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.387 -0.968 . . . . 71.53 108.387 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -155.14 144.11 20.83 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.605 -0.725 . . . . 72.24 110.691 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 66.3 mt -106.83 107.67 18.81 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.727 -1.212 . . . . 74.33 107.727 172.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.49 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 45.9 t -121.52 141.41 51.07 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.764 0.826 . . . . 71.01 109.527 -174.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . 0.432 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 21.8 tt0 -154.8 136.68 14.54 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.138 0.575 . . . . 71.41 109.487 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 82.0 t -136.76 114.88 14.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.956 -0.757 . . . . 73.42 108.956 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.419 ' HB2' ' HB2' ' D' ' 20' ' ' ASP . 69.6 mt-30 -87.88 86.93 7.21 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 107.592 -1.262 . . . . 64.54 107.592 170.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -79.89 104.02 10.18 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 114.31 -1.313 . . . . 65.34 108.116 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -107.09 143.09 15.8 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 111.557 -0.617 . . . . 71.14 111.557 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.14 138.34 9.27 Favored Glycine 0 CA--C 1.506 -0.497 0 N-CA-C 111.643 -0.583 . . . . 74.21 111.643 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.423 HG13 ' HE1' ' D' ' 17' ' ' TYR . 74.2 mt -86.58 121.4 37.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.199 -1.408 . . . . 75.3 107.199 172.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -125.33 165.8 17.7 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.288 0.635 . . . . 72.04 109.406 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 4.6 t -112.55 105.41 13.62 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.794 -1.188 . . . . 73.45 107.794 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.634 HG22 HG21 ' H' ' 18' ' ' VAL . 3.3 mp -107.95 105.76 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 108.328 -0.99 . . . . 73.04 108.328 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.72 147.04 49.98 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.328 0.651 . . . . 73.22 110.44 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.11 13.62 76.76 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-O 119.193 -0.781 . . . . 74.53 114.91 172.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.642 HD11 ' HE2' ' D' ' 9' ' ' MET . 7.6 mt -97.57 157.88 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 118.334 1.067 . . . . 74.32 110.477 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.497 ' N ' HG23 ' D' ' 89' ' ' ILE . 1.1 pp20? -153.11 -177.81 6.54 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.446 1.098 . . . . 72.02 108.979 163.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . 0.428 ' H ' ' HB2' ' H' ' 22' ' ' ARG . . . 60.44 -141.96 47.94 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.532 0.587 . . . . 71.21 113.694 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 7.4 m -89.96 -9.92 46.99 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.556 1.142 . . . . 71.04 111.379 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.74 -28.45 68.7 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.045 0.538 . . . . 74.12 111.043 -176.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.44 ' SD ' ' HB1' ' H' ' 21' ' ' ALA . 18.1 ptt? -70.98 -32.35 69.17 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 119.462 -0.304 . . . . 74.13 111.42 176.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.42 84.0 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 120.775 0.322 . . . . 72.45 110.146 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -65.56 -43.82 88.69 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.601 -0.727 . . . . 71.54 110.949 171.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.4 t -61.5 -49.96 74.63 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.886 0.474 . . . . 74.41 110.656 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.743 HD11 HG22 ' H' ' 18' ' ' VAL . 19.4 mt -83.19 -20.51 34.51 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.054 0.942 . . . . 74.45 111.518 -173.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.83 5.93 34.98 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 114.131 0.413 . . . . 63.14 114.131 -174.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.495 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -146.44 -66.45 0.29 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.557 0.343 . . . . 72.41 110.855 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -70.25 -52.05 25.98 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.565 0.58 . . . . 74.14 112.565 -170.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.481 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 56.8 m -58.38 -47.63 98.44 Favored Pre-proline 0 CA--C 1.562 1.42 0 C-N-CA 123.53 0.732 . . . . 73.33 111.388 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.628 ' HB3' HD21 ' D' ' 60' ' ' LEU . 51.7 Cg_exo -59.4 -39.7 74.22 Favored 'Trans proline' 0 C--N 1.397 3.115 0 C-N-CA 122.231 1.954 . . . . 62.05 113.277 169.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -59.31 -36.17 75.12 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.9 0.88 . . . . 74.43 110.697 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.419 HG23 HD11 ' D' ' 13' ' ' ILE . 46.2 mm -63.5 -36.92 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.514 0.726 . . . . 64.01 110.597 174.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 73.6 mt -84.43 -13.82 51.04 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 115.221 -0.9 . . . . 74.52 112.371 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -56.68 -50.36 88.4 Favored Pre-proline 0 N--CA 1.5 2.048 0 C-N-CA 124.072 0.949 . . . . 74.34 113.46 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.38 -41.12 81.29 Favored 'Trans proline' 0 C--N 1.392 2.826 0 C-N-CA 122.181 1.921 . . . . 71.12 112.948 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -75.88 -37.98 58.33 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.329 1.052 . . . . 73.14 112.484 -175.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.94 -43.52 71.44 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.08 0.552 . . . . 74.21 110.346 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.42 ' NH2' HG22 ' B' ' 105' ' ' ILE . 46.6 ttp180 -62.28 -47.78 82.81 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.595 -0.729 . . . . 73.1 110.438 176.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -61.28 -45.76 93.13 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.416 0.686 . . . . 74.15 110.757 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.2 t -59.46 -44.5 92.97 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.657 0.598 . . . . 73.31 111.159 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.437 ' O ' HG22 ' D' ' 118' ' ' VAL . 65.5 mt -60.05 -57.64 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.323 0.649 . . . . 73.51 110.326 174.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.9 m -53.43 -41.87 66.49 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.668 1.187 . . . . 74.03 112.673 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 45.6 t -67.19 -41.74 85.34 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.214 -0.903 . . . . 75.33 110.222 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.49 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 73.4 mtm -68.77 -32.49 72.26 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.903 0.481 . . . . 74.41 111.428 178.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.437 HG22 ' O ' ' D' ' 114' ' ' ILE . 78.0 t -65.76 -43.52 93.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.644 0.777 . . . . 73.02 110.264 176.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.3 p -74.17 -30.36 62.21 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.589 0.356 . . . . 75.53 111.176 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 74.5 mtt-85 -71.75 -27.95 63.32 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.695 0.798 . . . . 74.44 110.373 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.93 7.89 78.42 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-N 115.8 -0.636 . . . . 74.25 112.072 171.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 62.3 p 59.5 15.89 4.85 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 127.015 2.126 . . . . 73.41 113.792 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -78.77 157.98 76.08 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.794 0.838 . . . . 71.11 110.462 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.63 127.34 25.52 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.085 2.523 . . . . 75.12 113.069 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -52.97 136.93 33.96 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.264 1.026 . . . . 74.23 112.048 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.494 HD22 HG13 ' D' ' 40' ' ' VAL . 57.3 tp -118.16 108.77 15.58 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.796 0.838 . . . . 73.54 109.395 -177.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -106.73 99.06 8.66 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.008 -0.738 . . . . 74.1 109.008 175.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.86 130.2 41.05 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.193 -0.669 . . . . 74.32 109.193 173.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.02 137.81 97.16 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.338 0.655 . . . . 63.52 110.427 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -69.44 111.02 2.63 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.644 2.229 . . . . 72.44 110.905 -177.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . 0.48 HG12 ' HB2' ' H' ' 7' ' ' ALA . 15.9 m -108.28 117.73 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 109.226 -0.657 . . . . 75.34 109.226 -177.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -74.25 101.04 3.88 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 115.546 -0.752 . . . . 74.54 110.076 -176.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -68.57 -23.28 64.48 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.99 -1.004 . . . . 62.41 112.012 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.495 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 5.1 m-20 -62.06 -51.68 66.97 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.681 0.393 . . . . 51.35 110.92 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.54 -45.59 93.52 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.916 0.76 . . . . 75.11 111.412 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 2.1 tt -65.78 -44.49 85.62 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.443 0.697 . . . . 72.23 110.6 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -67.85 -48.35 66.41 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.575 0.75 . . . . 74.04 110.275 -175.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 21.4 ptp -67.09 -28.88 68.54 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 116.073 -0.512 . . . . 74.41 110.368 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.444 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 12.7 t30 -65.81 -37.85 87.38 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.476 0.711 . . . . 74.35 110.61 177.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -63.51 -46.49 85.82 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.579 -0.737 . . . . 75.0 109.939 175.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.2 mp -68.99 -29.23 67.39 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.968 0.907 . . . . 75.2 112.695 -177.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.444 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 9.9 pt20 -90.86 7.46 39.85 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.429 0.529 . . . . 74.32 112.429 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -117.53 62.62 0.74 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.963 0.887 . . . . 73.41 108.624 178.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -170.28 138.25 1.58 Allowed 'General case' 0 C--O 1.243 0.748 0 CA-C-N 113.748 -1.569 . . . . 74.53 108.734 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.51 100.74 2.8 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.487 -0.56 . . . . 71.14 109.487 175.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.69 97.79 0.91 Allowed Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.65 -0.705 . . . . 74.53 111.619 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.0 127.31 31.06 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.975 0.91 . . . . 72.21 108.571 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -78.47 68.97 2.87 Favored Glycine 0 C--N 1.35 1.357 0 O-C-N 123.956 0.785 . . . . 65.55 112.898 -177.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 8.9 t -75.7 166.95 22.78 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.268 1.027 . . . . 70.11 110.576 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -75.23 158.87 32.27 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.518 -0.549 . . . . 74.22 109.518 173.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -53.57 88.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.581 1.153 . . . . 65.12 111.741 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -148.87 151.86 35.45 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.272 1.429 . . . . 73.45 108.727 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . 0.587 ' NE2' ' HB3' ' H' ' 24' ' ' PRO . 28.3 pt20 -102.3 124.69 48.33 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.902 -0.777 . . . . 64.43 108.902 171.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -109.72 102.94 11.71 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.508 -0.923 . . . . 75.44 108.508 173.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.946 0 C-N-CA 123.871 0.868 . . . . 72.32 109.382 -179.006 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 109.134 -0.691 . . . . 73.02 109.134 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -140.28 145.23 37.01 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.145 0.978 . . . . 75.35 109.483 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -115.3 119.3 35.86 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.935 -0.765 . . . . 74.03 108.935 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 30.4 p -70.29 140.0 52.22 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.75 0.82 . . . . 73.34 111.261 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 26.1 m -142.22 134.43 27.63 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.776 0.83 . . . . 74.14 109.648 -175.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 49.8 mm 71.78 116.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 125.443 1.497 . . . . 74.34 110.964 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.1 83.19 2.01 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.614 0.766 . . . . 62.3 109.956 -177.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 31.5 mt -140.15 135.26 32.28 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.955 0.902 . . . . 73.53 109.933 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.59 -87.87 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.873 0.869 . . . . 74.01 109.509 178.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . 0.593 HD23 ' HB2' ' A' ' 136' ' ' LEU . 50.3 mt -141.85 162.4 35.58 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.487 1.115 . . . . 72.01 109.874 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 90.7 mt -88.58 139.34 29.72 Favored Pre-proline 0 CA--C 1.552 1.02 0 CA-C-N 115.386 -0.824 . . . . 74.25 109.282 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 12' ' ' PRO . . . . . 0.553 ' HA ' ' HB3' ' C' ' 153' ' ' GLN . 64.1 Cg_exo -55.4 -28.13 61.89 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.894 3.062 . . . . 72.45 113.753 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 pp -142.72 159.19 42.71 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.444 1.098 . . . . 74.12 109.305 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -74.49 151.16 39.58 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.237 -0.653 . . . . 73.21 109.237 174.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . 0.461 ' HE1' ' HB3' ' A' ' 48' ' ' SER . 4.1 t80 -62.46 147.86 47.41 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.844 0.858 . . . . 72.13 110.075 -176.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 16' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' E' ' 17' ' ' PRO . 11.0 p -54.55 122.66 40.07 Favored Pre-proline 0 CA--C 1.562 1.435 0 C-N-CA 124.58 1.152 . . . . 74.21 111.878 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 17' ' ' PRO . . . . . 0.539 ' HA ' HD11 ' A' ' 98' ' ' LEU . 27.7 Cg_exo -63.91 153.16 77.39 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 123.808 3.005 . . . . 73.51 115.665 -167.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 18' ' ' VAL . . . . . 0.632 ' H ' HD22 ' A' ' 98' ' ' LEU . 53.4 t -64.77 -49.29 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.741 1.217 . . . . 75.21 111.079 174.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 9.9 t -140.84 -163.85 1.62 Allowed 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.032 -0.986 . . . . 75.22 108.58 -175.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -54.72 109.34 0.49 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.634 0.774 . . . . 73.2 111.751 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.24 151.65 29.4 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.584 1.154 . . . . 72.35 109.203 172.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 80.91 -38.8 0.14 Allowed 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.272 1.429 . . . . 73.43 113.32 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 59.5 m -57.62 112.15 4.36 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 124.288 1.035 . . . . 73.31 112.585 -175.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -86.67 176.46 4.69 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 123.338 2.692 . . . . 74.45 113.032 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 CA--C 1.559 1.289 0 CA-C-N 115.341 -0.845 . . . . 71.53 110.692 -179.311 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 109.466 -0.568 . . . . 71.14 109.466 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -68.98 100.39 1.21 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.61 0.764 . . . . 74.52 109.29 174.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -140.25 173.4 11.55 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.787 0.835 . . . . 72.44 110.0 -174.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 35.6 m -72.22 82.06 1.01 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.486 0.714 . . . . 71.44 110.085 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 5' ' ' THR . . . . . 0.514 HG23 HG13 ' F' ' 6' ' ' ILE . 58.0 m -90.71 122.01 33.1 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.333 -0.849 . . . . 75.34 110.148 -175.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . 0.514 HG13 HG23 ' F' ' 5' ' ' THR . 26.7 mt 67.29 125.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.708 1.603 . . . . 74.53 110.995 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -160.27 -162.8 1.02 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.126 0.571 . . . . 73.22 110.202 -175.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . 0.407 ' HB2' ' HB ' ' B' ' 131' ' ' VAL . 92.3 mt -135.93 116.23 13.57 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.463 -1.31 . . . . 73.35 107.463 170.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.04 154.11 38.13 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.038 0.535 . . . . 65.42 111.052 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 90.0 mt -59.9 133.7 56.34 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 123.735 0.647 . . . . 75.41 109.686 173.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 mp -70.59 128.76 90.74 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 123.75 0.656 . . . . 64.32 109.27 -171.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -64.65 -25.13 61.96 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 123.22 2.613 . . . . 63.52 112.546 -174.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.62 142.1 47.95 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 106.612 -1.625 . . . . 72.42 106.612 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -102.64 37.05 2.01 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.294 -0.632 . . . . 73.0 109.294 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . 0.652 ' HB2' HD11 ' B' ' 98' ' ' LEU . 76.7 m-85 64.5 175.79 0.19 Allowed 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 125.282 1.433 . . . . 72.31 112.128 -176.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 16' ' ' THR . . . . . 0.565 ' HB ' ' HA ' ' F' ' 21' ' ' ALA . 28.0 m -81.35 140.99 48.94 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-O 118.398 -0.811 . . . . 74.15 110.532 -176.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 17' ' ' PRO . . . . . 0.449 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 3.3 Cg_exo -34.2 136.03 0.11 Allowed 'Trans proline' 0 C--N 1.39 2.745 0 C-N-CA 125.171 3.914 . . . . 74.52 115.988 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 96.5 t -72.25 84.66 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 122.173 0.987 . . . . 75.12 110.15 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 4.7 t -170.52 -44.59 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 113.587 -1.642 . . . . 63.34 108.076 178.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -150.19 72.89 1.13 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.385 -1.339 . . . . 75.04 107.385 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . 0.565 ' HA ' ' HB ' ' F' ' 16' ' ' THR . . . -84.52 103.77 13.94 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.784 -0.644 . . . . 72.3 111.636 -171.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 45.2 ttt85 -150.74 100.51 2.84 Favored 'General case' 0 C--N 1.348 0.514 0 C-N-CA 123.355 0.662 . . . . 74.02 110.152 166.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 3.0 p -77.24 153.31 82.1 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 115.022 -0.99 . . . . 73.45 109.316 166.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -49.85 98.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.289 2.66 . . . . 75.21 113.537 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 . . . . . 0 CA--C 1.548 0.892 0 N-CA-C 108.931 -0.766 . . . . 73.41 108.931 177.775 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' G' G ' 1' ' ' MET . . . . . 0.419 ' N ' ' SD ' ' G' ' 1' ' ' MET . 3.5 mpp? . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 109.582 -0.525 . . . . 73.34 109.582 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 88.4 tttt 56.91 93.27 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.524 1.53 . . . . 73.42 112.843 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -103.69 157.23 17.21 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.184 0.594 . . . . 74.22 109.538 171.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 18.8 t -150.38 162.18 41.06 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.133 0.492 . . . . 71.11 110.988 -173.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 45.6 m -81.71 155.7 25.4 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.252 1.021 . . . . 74.34 110.54 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 pp -53.55 153.64 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.356 1.063 . . . . 72.33 113.326 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -167.71 -177.14 3.37 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.315 0.646 . . . . 62.11 111.594 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 8' ' ' LEU . . . . . 0.595 HD22 ' H ' ' G' ' 8' ' ' LEU . 1.2 pt? -93.55 122.3 35.85 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.238 1.015 . . . . 72.03 108.635 172.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.62 90.07 5.58 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.549 0.74 . . . . 71.15 110.479 -175.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 10' ' ' LEU . . . . . 0.401 HD22 ' HB3' ' C' ' 136' ' ' LEU . 82.6 mt 66.24 -175.94 0.19 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.749 1.22 . . . . 75.54 112.212 177.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -100.44 137.84 20.03 Favored Pre-proline 0 N--CA 1.474 0.726 0 N-CA-C 108.572 -0.899 . . . . 64.0 108.572 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.53 -19.51 24.68 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.513 2.142 . . . . 75.24 112.123 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 58.8 tp -152.62 138.77 18.28 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.289 1.036 . . . . 74.33 108.893 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.84 131.98 35.18 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.368 -0.975 . . . . 73.2 108.368 169.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . 0.421 ' HD2' ' HB ' ' C' ' 46' ' ' THR . 33.8 p90 -73.76 -173.28 1.47 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.61 0.764 . . . . 75.44 111.845 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 62.5 p -55.64 150.41 26.03 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 124.419 1.087 . . . . 75.32 112.984 -172.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 17' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -76.46 167.58 25.37 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.414 2.076 . . . . 73.25 113.078 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 18' ' ' VAL . . . . . 0.444 HG22 HD13 ' C' ' 98' ' ' LEU . 49.1 t -75.74 -39.16 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 115.579 -0.737 . . . . 70.13 109.585 172.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 19.0 m -146.64 -54.63 0.25 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.408 -0.815 . . . . 74.23 110.319 -176.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -153.33 91.64 1.52 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.729 0.411 . . . . 74.23 110.448 -167.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 179.64 77.59 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 125.244 1.418 . . . . 71.43 109.897 177.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -148.3 -69.72 0.22 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.811 -0.44 . . . . 73.15 109.811 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 14.3 m -148.44 142.74 16.61 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 108.356 -0.979 . . . . 75.51 108.356 -174.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.64 98.4 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.272 1.981 . . . . 64.52 111.032 167.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 CA--C 1.557 1.226 0 C-N-CA 123.875 0.87 . . . . 74.2 109.998 -176.079 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.385 -0.598 . . . . 72.44 109.385 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -135.45 157.4 46.98 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.189 0.596 . . . . 73.13 110.182 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -94.48 -56.7 2.71 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.418 0.687 . . . . 70.03 109.886 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 35.7 t -153.4 -36.62 0.1 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.225 -0.898 . . . . 54.02 109.615 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 30.3 m -75.0 150.34 39.01 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.869 0.868 . . . . 73.25 109.396 171.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . 0.57 HD12 HD21 ' D' ' 42' ' ' LEU . 29.1 pt -69.21 164.03 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-O 121.196 0.522 . . . . 74.4 111.675 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 7' ' ' ALA . . . . . 0.48 ' HB2' HG12 ' D' ' 131' ' ' VAL . . . -145.79 146.42 31.18 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.449 -0.796 . . . . 74.43 109.706 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 8' ' ' LEU . . . . . 0.514 HD21 HD22 ' D' ' 42' ' ' LEU . 97.8 mt -66.31 123.76 20.84 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.251 0.62 . . . . 74.45 110.119 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.95 170.13 14.31 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.275 0.63 . . . . 70.23 110.689 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 80.6 mt -73.95 174.23 8.85 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 121.312 0.577 . . . . 73.44 111.546 -177.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . 0.479 HD22 HD13 ' D' ' 60' ' ' LEU . 80.0 mt -76.86 126.91 85.11 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.079 0.951 . . . . 74.15 111.037 -176.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.42 -42.98 3.24 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 123.035 2.49 . . . . 70.2 111.644 177.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 mp -90.85 166.24 13.18 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.544 0.738 . . . . 73.12 109.41 175.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.76 125.65 54.34 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.184 -1.413 . . . . 74.11 107.184 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -71.58 172.07 10.28 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.038 0.935 . . . . 74.42 111.415 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 38.1 p -77.02 142.66 69.23 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 109.47 -0.567 . . . . 72.11 109.47 171.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.93 178.82 6.52 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.659 2.239 . . . . 72.2 112.32 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . 0.743 HG22 HD11 ' D' ' 98' ' ' LEU . 98.2 t -76.17 119.69 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.252 0.621 . . . . 73.42 109.524 175.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 6.6 m -79.03 71.59 5.51 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.887 0.851 . . . . 73.24 109.112 177.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 21.7 tptm 179.36 -52.02 0.01 OUTLIER 'General case' 0 C--O 1.242 0.7 0 CA-C-N 113.802 -1.545 . . . . 74.24 107.747 -176.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . 0.44 ' HB1' ' SD ' ' D' ' 94' ' ' MET . . . -72.77 122.96 22.39 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.944 -1.025 . . . . 71.11 109.526 178.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . 0.428 ' HB2' ' H ' ' D' ' 91' ' ' GLY . 16.7 tpt180 57.74 91.02 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.604 1.162 . . . . 74.1 111.487 -177.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 73.4 p -73.86 131.42 81.68 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 109.323 -0.621 . . . . 73.33 109.323 173.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 24' ' ' PRO . . . . . 0.587 ' HB3' ' NE2' ' D' ' 153' ' ' GLN . 70.9 Cg_exo -53.09 -47.19 28.85 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 123.032 2.488 . . . . 71.34 112.512 175.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 . . . . . 0 C--O 1.248 0.986 0 N-CA-C 107.467 -1.308 . . . . 72.42 107.467 174.752 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.7 ttp . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 109.66 -0.496 . . . . 73.53 109.66 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.2 t 60.8 27.7 17.47 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 124.485 1.114 . . . . 65.41 111.148 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.74 157.59 23.21 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.142 0.977 . . . . 74.33 110.81 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 67.38 -65.77 0.22 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.389 1.476 . . . . 71.13 109.995 -168.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.8 t30 63.46 68.02 0.62 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.421 1.088 . . . . 71.34 110.434 172.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -81.65 174.22 11.59 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.266 -0.879 . . . . 73.45 110.202 178.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.2 m 58.43 35.12 24.53 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-O 122.731 1.253 . . . . 61.23 109.008 -170.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.477 ' HG3' ' H ' ' A' ' 9' ' ' MET . 5.3 tp10 -165.75 -155.43 0.23 Allowed 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 114.17 -1.377 . . . . 65.52 107.631 -170.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.5 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -63.03 138.81 58.67 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.838 -0.801 . . . . 74.24 108.838 171.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.449 ' N ' ' SD ' ' A' ' 9' ' ' MET . 17.1 p -137.26 106.74 6.12 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.649 -0.871 . . . . 74.54 108.649 -171.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.691 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 22.0 t80 -123.15 129.59 51.64 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.739 1.215 . . . . 75.44 109.048 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -149.71 112.75 4.87 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.369 0.668 . . . . 74.53 109.299 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.642 HG12 ' HD2' ' A' ' 84' ' ' PHE . 27.5 mt -83.05 116.15 26.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.555 -0.905 . . . . 71.01 108.555 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.454 ' HB3' HG21 ' A' ' 83' ' ' ILE . 35.2 tt0 -79.28 -36.41 39.79 Favored 'General case' 0 C--O 1.242 0.702 0 O-C-N 123.895 0.747 . . . . 72.15 110.258 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -171.9 142.74 1.53 Allowed 'General case' 0 C--N 1.355 0.844 0 CA-C-N 116.374 -0.375 . . . . 70.43 110.457 -170.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.543 HD13 ' HB3' ' C' ' 130' ' ' PRO . 76.8 mt -133.66 141.31 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 124.243 1.017 . . . . 74.53 109.083 172.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.511 ' HB3' HG23 ' B' ' 122' ' ' THR . 21.1 p90 -165.56 171.9 12.63 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 124.356 1.035 . . . . 73.42 110.499 -172.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.4 p -94.61 119.46 33.31 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.484 -0.932 . . . . 63.42 108.484 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.466 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 35.2 mtpt -83.01 -36.16 25.23 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.019 0.438 . . . . 75.15 109.828 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 16.2 t70 -145.72 126.02 13.93 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.114 -0.948 . . . . 75.22 109.1 -178.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.548 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 77.4 mt -118.78 142.32 34.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.864 -1.161 . . . . 72.44 107.864 172.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.0 t -150.53 125.82 10.06 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.784 -0.821 . . . . 73.42 108.784 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.632 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 75.3 t80 -127.48 121.97 32.16 Favored 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 106.867 -1.531 . . . . 75.41 106.867 174.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -124.09 118.29 26.6 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.18 -0.674 . . . . 74.15 109.18 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.48 79.64 4.22 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 106.867 -1.531 . . . . 74.03 106.867 168.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.49 -24.58 26.19 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.539 2.159 . . . . 71.14 112.915 -166.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -114.04 23.21 13.16 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 118.16 -0.924 . . . . 74.11 109.504 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.416 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -40.96 -58.14 2.88 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 114.192 1.182 . . . . 73.34 114.192 -166.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.416 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 18.0 Cg_exo -65.72 -24.65 54.61 Favored 'Trans proline' 0 C--N 1.389 2.675 0 CA-C-N 121.83 1.689 . . . . 73.11 113.245 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -83.48 -37.57 22.95 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.3 1.04 . . . . 73.22 110.833 -176.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.646 HG22 ' HA ' ' A' ' 73' ' ' ALA . 8.0 p -76.94 -23.82 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-N 115.589 -0.732 . . . . 74.52 111.348 -168.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -68.91 -25.18 64.46 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.884 0.474 . . . . 73.1 110.877 174.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -75.5 -33.02 60.73 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.027 0.931 . . . . 74.33 110.027 175.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -70.94 168.2 17.46 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.43 1.092 . . . . 75.41 111.469 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.87 145.76 27.64 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.828 -0.623 . . . . 75.53 110.025 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.411 ' CE3' HD21 ' A' ' 68' ' ' LEU . 75.1 t-105 -93.86 88.84 5.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.265 0.626 . . . . 75.41 109.583 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.646 ' HG2' ' HE1' ' C' ' 1' ' ' MET . 36.5 tt0 -135.2 79.97 48.35 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 107.113 -1.44 . . . . 73.01 107.113 170.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -91.82 165.33 3.3 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.269 2.646 . . . . 74.42 114.889 -170.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.617 ' HB3' ' HG2' ' C' ' 1' ' ' MET . 10.5 pt-20 -129.71 126.77 39.05 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.954 -1.021 . . . . 74.01 108.7 164.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.545 HG12 HG13 ' A' ' 64' ' ' VAL . 59.8 t -86.82 105.1 14.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.259 -0.645 . . . . 74.25 109.259 174.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -80.89 123.27 28.15 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.604 -1.18 . . . . 74.11 108.488 171.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.413 ' HG ' ' HA ' ' E' ' 8' ' ' LEU . 3.1 mm? -96.39 109.32 21.87 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.374 0.669 . . . . 74.42 109.394 -177.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.696 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 15.5 m-20 -110.14 119.82 40.48 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.532 -0.914 . . . . 73.53 108.532 172.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.739 HD23 HD21 ' A' ' 60' ' ' LEU . 6.3 mp -120.84 136.8 54.82 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.056 0.455 . . . . 75.42 111.103 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -134.72 121.27 20.54 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.36 -1.348 . . . . 71.21 107.36 174.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.465 HG21 ' HG ' ' A' ' 60' ' ' LEU . 43.8 p -107.74 136.51 47.37 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.261 0.624 . . . . 75.34 110.47 -172.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.89 145.56 51.04 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.048 0.939 . . . . 75.31 109.464 -178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.5 m -131.7 152.92 50.53 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.844 0.857 . . . . 53.23 109.569 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.496 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 46.7 t -150.1 142.86 24.67 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.632 0.773 . . . . 72.54 109.678 -175.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -101.56 104.32 15.2 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.029 -1.1 . . . . 70.34 108.029 172.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.761 HD12 ' HB2' ' A' ' 57' ' ' GLU . 59.4 mt -81.52 -41.5 21.59 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.921 -0.581 . . . . 73.4 110.295 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.88 -174.53 4.89 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.448 -0.796 . . . . 65.11 110.474 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.8 118.24 7.45 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.693 0.797 . . . . 61.23 110.057 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.28 -6.04 0.83 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.959 1.304 . . . . 71.21 112.74 -177.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.0 t -104.34 113.24 40.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 N-CA-C 108.191 -1.04 . . . . 71.42 108.191 -175.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -120.66 167.26 12.64 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.796 0.838 . . . . 75.53 109.429 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.761 ' HB2' HD12 ' A' ' 51' ' ' LEU . 36.3 tt0 -129.93 128.21 41.68 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.275 1.03 . . . . 73.35 108.789 174.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.428 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 53.4 t -109.89 122.79 65.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.076 -1.083 . . . . 63.2 108.076 169.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.5 t -110.14 136.38 46.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.14 -1.059 . . . . 75.32 108.14 171.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.739 HD21 HD23 ' A' ' 44' ' ' LEU . 3.3 tt -129.98 122.1 27.82 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.575 -0.898 . . . . 73.51 108.575 175.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.5 ttm-85 -85.66 103.03 14.1 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.518 1.127 . . . . 63.21 109.471 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.7 t -94.8 102.36 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 107.532 -1.284 . . . . 72.43 107.532 171.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.696 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 23.9 m -102.1 107.86 19.09 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.888 -0.782 . . . . 72.15 108.888 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.545 HG13 HG12 ' A' ' 40' ' ' VAL . 19.2 t -104.47 112.91 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 124.976 1.31 . . . . 72.11 109.121 -176.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 3.2 m -112.56 124.91 53.58 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 108.839 -0.8 . . . . 61.4 108.839 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.0 113.26 26.58 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.577 -1.268 . . . . 72.45 107.577 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.5 m -113.95 122.49 47.11 Favored 'General case' 0 C--N 1.351 0.637 0 CA-C-N 118.478 0.581 . . . . 74.25 110.903 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.42 HD13 ' HB1' ' A' ' 73' ' ' ALA . 17.5 mt -92.91 79.88 4.64 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 125.582 1.553 . . . . 75.11 107.677 173.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.46 -101.99 1.44 Allowed Glycine 0 C--N 1.34 0.801 0 CA-C-N 115.398 -0.819 . . . . 61.02 111.433 -175.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -106.64 -1.37 22.9 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.726 0.81 . . . . 73.42 111.292 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -107.33 136.69 46.71 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.956 0.903 . . . . 73.31 110.101 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.1 m -87.45 124.39 33.38 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 118.095 0.407 . . . . 61.21 110.002 167.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.646 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -73.77 -55.1 6.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.433 1.093 . . . . 74.24 109.695 174.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -152.24 164.91 36.41 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 114.45 -1.25 . . . . 74.51 111.687 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 36.0 tp -134.36 105.83 6.79 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.205 -1.361 . . . . 70.2 107.64 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.503 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 61.7 m -108.14 98.8 8.3 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.844 0.858 . . . . 75.2 109.813 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -105.4 125.44 50.99 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.384 0.674 . . . . 72.34 109.424 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.8 t -131.0 112.61 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.252 0.621 . . . . 74.15 109.545 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.521 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 78.3 mt-30 -84.33 87.9 7.23 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.324 1.05 . . . . 64.45 108.471 171.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.471 ' HG3' HD23 ' A' ' 106' ' ' LEU . 8.3 tp-100 -79.53 109.76 14.21 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.869 -1.059 . . . . 73.14 109.416 -177.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.56 146.02 18.09 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 111.481 -0.648 . . . . 74.34 111.481 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.2 124.9 2.04 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 111.387 -0.685 . . . . 61.1 111.387 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.454 HG21 ' HB3' ' A' ' 14' ' ' GLN . 49.0 mt -82.94 110.23 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.347 0.659 . . . . 73.43 109.519 176.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.691 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 36.3 m-85 -121.94 120.33 34.12 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.838 0.855 . . . . 75.34 108.747 -177.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.8 m -89.95 101.32 14.02 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.756 -0.831 . . . . 74.22 108.756 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.2 pt -113.52 135.39 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 123.145 0.578 . . . . 74.41 110.753 -176.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.4 -179.42 5.5 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.567 1.147 . . . . 74.33 109.506 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 102.15 -75.68 0.33 Allowed Glycine 0 C--N 1.346 1.086 0 N-CA-C 112.39 -0.284 . . . . 54.31 112.39 176.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.611 HG13 ' HB2' ' A' ' 94' ' ' MET . 28.2 pt -89.81 -178.43 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 123.413 0.685 . . . . 70.25 110.881 -175.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.515 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 23.7 tt0 -161.0 -176.64 5.61 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.054 0.941 . . . . 75.41 108.801 -178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.515 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 65.01 -152.16 51.16 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-O 119.753 -0.471 . . . . 73.52 113.023 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.568 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 14.8 t -66.26 -19.23 65.76 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.117 0.567 . . . . 64.41 111.701 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -64.14 -50.15 69.34 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.836 0.855 . . . . 75.45 109.85 176.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.611 ' HB2' HG13 ' A' ' 89' ' ' ILE . 41.7 ttm -76.78 -30.69 56.59 Favored 'General case' 0 C--N 1.36 1.058 0 CA-C-N 116.153 -0.476 . . . . 75.11 110.632 175.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.568 ' HB1' ' HA ' ' A' ' 92' ' ' THR . . . -63.34 -25.66 68.4 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.362 0.665 . . . . 42.21 111.707 178.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.425 ' HE2' ' HG2' ' A' ' 138' ' ' MET . 59.5 t-80 -76.03 -38.29 57.39 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.635 -0.711 . . . . 73.32 109.722 172.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.3 t -70.82 -32.81 69.99 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.261 0.624 . . . . 74.53 111.989 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.53 HD11 ' HD2' ' E' ' 17' ' ' PRO . 4.0 pp -101.17 -20.02 15.48 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.065 0.546 . . . . 73.34 111.833 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.04 -16.03 29.16 Favored Glycine 0 N--CA 1.478 1.492 0 N-CA-C 113.694 0.238 . . . . 72.12 113.694 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.46 ' HB1' ' HD2' ' A' ' 137' ' ' PHE . . . -124.54 -62.75 1.23 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.789 0.836 . . . . 74.41 109.64 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.494 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 86.4 t80 -64.47 -60.79 2.74 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.463 1.105 . . . . 74.04 113.957 -167.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 84.7 m -65.71 -37.94 21.75 Favored Pre-proline 0 CA--C 1.566 1.593 0 N-CA-C 113.656 0.984 . . . . 72.43 113.656 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.91 -27.03 43.64 Favored 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 121.729 1.619 . . . . 75.52 112.783 167.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -77.68 -17.45 57.67 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.379 0.672 . . . . 72.31 110.473 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.401 HG22 HD11 ' A' ' 13' ' ' ILE . 43.1 mm -67.84 -41.53 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.89 -0.781 . . . . 72.34 108.89 169.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.471 HD23 ' HG3' ' A' ' 80' ' ' GLN . 90.4 mt -77.06 -21.32 54.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.149 0.979 . . . . 71.31 111.938 -178.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -59.9 -47.53 97.0 Favored Pre-proline 0 CA--C 1.574 1.878 0 C-N-CA 124.293 1.037 . . . . 74.14 113.578 -174.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.92 -40.6 33.95 Favored 'Trans proline' 0 C--N 1.393 2.888 0 C-N-CA 122.051 1.834 . . . . 73.45 112.97 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.461 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 97.5 m-85 -65.42 -44.04 88.64 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.812 0.695 . . . . 75.53 111.314 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.35 -31.81 64.17 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.519 0.728 . . . . 71.43 110.926 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.404 HH12 HD11 ' C' ' 105' ' ' ILE . 32.2 ttm180 -62.11 -50.4 72.07 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 109.321 -0.622 . . . . 73.21 109.321 170.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -66.85 -42.94 84.88 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.269 1.028 . . . . 74.34 112.202 -171.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.3 t -60.42 -42.92 97.01 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 123.786 0.679 . . . . 73.23 109.872 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.438 ' O ' HG23 ' A' ' 118' ' ' VAL . 57.9 mt -64.96 -46.07 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 114.811 -1.086 . . . . 74.02 110.686 175.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.3 m -57.66 -40.82 80.2 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.956 0.902 . . . . 73.54 111.304 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.1 t -66.41 -44.08 83.96 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 115.258 -0.883 . . . . 71.14 110.497 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.632 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 15.9 mtp -64.02 -36.84 85.3 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.895 0.878 . . . . 74.03 111.748 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 114' ' ' ILE . 51.5 t -63.09 -52.34 60.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 124.37 1.068 . . . . 71.24 110.005 176.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.6 t -65.52 -31.31 72.31 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.677 0.791 . . . . 73.52 111.578 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.441 ' HG2' ' HG1' ' B' ' 18' ' ' THR . 44.3 ttm-85 -75.23 -32.53 61.16 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.093 0.957 . . . . 75.25 109.467 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.97 17.04 38.92 Favored Glycine 0 C--N 1.355 1.607 0 CA-C-N 114.97 -1.014 . . . . 62.44 113.254 171.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.492 HG23 ' HE ' ' B' ' 15' ' ' ARG . 1.5 t 62.45 12.65 5.51 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 126.944 2.098 . . . . 74.34 113.838 174.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -79.96 146.5 63.8 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 123.409 0.684 . . . . 74.32 109.474 174.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.54 162.75 35.43 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.61 2.207 . . . . 75.32 113.095 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -54.81 129.2 36.29 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.318 1.447 . . . . 74.13 113.461 -168.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.461 HD12 HG23 ' A' ' 40' ' ' VAL . 59.5 tp -130.4 110.6 11.61 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.392 1.077 . . . . 73.31 109.67 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -125.73 117.19 22.93 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.275 1.03 . . . . 55.24 108.641 175.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.1 mp -66.83 140.75 57.83 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.493 0.717 . . . . 61.14 110.24 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -63.33 130.13 94.03 Favored Pre-proline 0 CA--C 1.552 1.034 0 O-C-N 123.778 0.673 . . . . 60.14 110.417 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 36.8 Cg_exo -64.6 113.63 2.39 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 123.168 2.579 . . . . 71.14 111.893 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.7 t -99.95 114.24 37.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.612 -1.255 . . . . 73.12 107.612 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -74.72 81.42 2.06 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.571 0.748 . . . . 64.23 109.806 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -58.38 -49.71 76.26 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.545 -0.752 . . . . 72.44 110.169 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -56.52 -52.62 64.07 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.855 -1.066 . . . . 74.41 112.106 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.04 -43.56 91.93 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.678 0.612 . . . . 70.1 110.956 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 43.3 tp -61.18 -45.3 95.16 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.862 0.865 . . . . 73.11 111.876 -177.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.46 ' HD2' ' HB1' ' A' ' 100' ' ' ALA . 24.3 m-85 -68.94 -33.89 74.46 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.746 0.419 . . . . 74.43 110.806 176.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.431 ' SD ' HD21 ' A' ' 141' ' ' LEU . 11.6 mmt -69.66 -30.4 68.08 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 118.937 -0.554 . . . . 73.31 111.52 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -58.71 -43.51 90.1 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 123.894 0.746 . . . . 71.22 110.488 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -67.28 -44.28 79.69 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.18 -0.918 . . . . 74.21 110.937 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.431 HD21 ' SD ' ' A' ' 138' ' ' MET . 59.8 tp -57.18 -47.23 81.75 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 123.967 0.792 . . . . 74.04 111.228 -174.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -169.63 -15.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.767 0.827 . . . . 75.02 110.799 173.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? 75.72 101.91 0.07 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.318 1.847 . . . . 75.12 108.826 -171.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.404 ' OE1' ' HG3' ' A' ' 138' ' ' MET . 11.9 pt20 -84.33 154.26 23.02 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.255 0.55 . . . . 74.51 111.114 -176.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.61 -166.63 1.54 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.4 -0.818 . . . . 72.5 108.938 167.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -170.06 -80.03 0.05 OUTLIER Glycine 0 C--N 1.339 0.731 0 N-CA-C 112.031 -0.428 . . . . 62.32 112.031 177.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 63.66 -156.31 0.32 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.057 0.943 . . . . 73.13 111.017 -174.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.483 ' HA2' HD21 ' C' ' 141' ' ' LEU . . . -165.51 -148.4 5.49 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 110.334 -1.106 . . . . 73.35 110.334 176.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 59.1 m -142.18 118.11 10.57 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.855 -0.795 . . . . 73.04 108.855 168.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.522 ' HG3' HG23 ' C' ' 92' ' ' THR . 42.9 mt-10 -88.62 140.46 29.44 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.342 0.657 . . . . 74.21 109.241 173.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -122.31 164.73 17.42 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 123.749 0.819 . . . . 73.52 109.035 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -71.58 91.69 1.09 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.492 0.717 . . . . 75.34 110.929 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -111.09 101.48 10.01 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.924 -1.51 . . . . 75.33 106.924 168.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -86.25 153.29 22.11 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.589 -0.732 . . . . 73.31 109.76 174.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 N-CA-C 108.78 -0.822 . . . . 73.3 108.78 175.54 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 109.407 -0.59 . . . . 74.51 109.407 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 81.0 p -139.51 -47.5 0.46 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.619 0.768 . . . . 72.55 109.416 177.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -71.05 101.66 2.27 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.584 0.754 . . . . 74.1 110.601 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -137.03 102.85 4.97 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 107.132 -1.433 . . . . 72.13 107.132 172.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -157.74 23.94 0.27 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.865 0.866 . . . . 73.44 109.142 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -112.21 112.74 24.56 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.659 1.184 . . . . 75.31 109.44 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 17.7 p -148.33 179.63 7.64 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.804 1.242 . . . . 73.2 109.423 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -84.44 -5.7 59.31 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.801 0.84 . . . . 63.53 111.935 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.559 ' HE1' ' SG ' ' B' ' 97' ' ' CYS . 0.3 OUTLIER 67.11 165.78 0.22 Allowed 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 125.849 1.66 . . . . 75.43 112.346 -178.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.499 ' N ' ' SD ' ' B' ' 9' ' ' MET . 94.0 m -149.64 109.18 4.0 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.866 1.266 . . . . 73.43 108.597 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' B' ' 85' ' ' SER . 35.5 t80 -130.76 138.23 49.84 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.914 0.486 . . . . 73.22 110.326 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -154.53 140.41 18.2 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.039 0.536 . . . . 74.02 110.479 175.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 17.9 mt -76.33 108.61 9.17 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 C-N-CA 123.7 0.8 . . . . 74.12 108.956 173.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -82.86 -43.64 16.36 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.349 -0.611 . . . . 75.13 109.349 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.492 ' HE ' HG23 ' A' ' 122' ' ' THR . 45.6 ttt180 -167.78 140.45 3.21 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.985 0.514 . . . . 74.52 110.612 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 62.9 mt -118.31 141.46 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 107.752 -1.203 . . . . 75.13 107.752 173.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.446 ' HE1' HG13 ' B' ' 83' ' ' ILE . 20.7 p90 -170.2 150.89 3.74 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.024 0.44 . . . . 70.33 111.721 -173.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.441 ' HG1' ' HG2' ' A' ' 120' ' ' ARG . 86.8 m -78.99 124.65 28.46 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.982 -0.747 . . . . 53.12 108.982 171.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -94.45 -27.72 15.86 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.419 0.688 . . . . 71.54 111.449 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -164.58 149.82 9.99 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.382 0.426 . . . . 72.01 111.777 -175.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.796 HD12 ' SG ' ' B' ' 113' ' ' CYS . 47.0 mm -140.26 142.81 30.73 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 C-N-CA 125.808 1.643 . . . . 75.41 109.344 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.555 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 46.5 t -139.17 131.92 29.08 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.261 -1.385 . . . . 73.33 107.261 171.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.548 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.7 t80 -144.46 122.52 12.11 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.1 -1.444 . . . . 64.22 107.1 170.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.411 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 40.4 mt-10 -130.61 119.73 22.92 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.148 0.979 . . . . 72.54 108.696 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.518 ' HB1' ' CB ' ' B' ' 28' ' ' ALA . . . -113.25 87.18 10.63 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 107.303 -1.369 . . . . 74.14 107.303 174.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.25 -44.86 0.72 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.6 2.2 . . . . 71.34 112.448 -174.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -92.76 5.72 50.14 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.419 1.088 . . . . 74.52 110.526 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.518 ' CB ' ' HB1' ' B' ' 25' ' ' ALA . . . -32.28 -63.24 0.26 Allowed Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 126.002 1.721 . . . . 70.15 115.406 -171.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -54.79 -48.44 21.24 Favored 'Trans proline' 0 C--N 1.402 3.364 0 C-N-CA 122.465 2.11 . . . . 71.21 113.27 -167.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -97.67 -18.02 19.12 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.361 0.874 . . . . 71.31 113.361 -171.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.541 HG21 HD13 ' B' ' 68' ' ' LEU . 7.6 p -74.15 -16.19 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 118.875 0.761 . . . . 74.34 110.639 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -58.17 -23.48 55.53 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.26 1.024 . . . . 75.32 113.569 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -61.19 -23.21 65.42 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.038 0.535 . . . . 72.33 111.407 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.463 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 91.2 mttt -91.47 99.47 12.4 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.066 0.947 . . . . 73.44 110.211 -177.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -100.42 80.05 2.19 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.501 -0.772 . . . . 73.22 110.363 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 42.7 p90 -155.02 171.16 20.2 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.443 1.097 . . . . 70.44 108.681 170.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -67.72 112.57 10.8 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 108.916 -0.772 . . . . 73.24 108.916 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.55 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 37.8 Cg_endo -65.74 144.08 76.48 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 121.715 1.61 . . . . 74.51 112.315 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.449 ' HB2' ' HG2' ' F' ' 2' ' ' LYS . 32.3 tt0 -59.71 113.69 2.38 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.499 1.12 . . . . 73.02 109.83 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.647 HG13 HG11 ' B' ' 64' ' ' VAL . 81.6 t -92.23 127.26 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.645 0.778 . . . . 74.2 111.262 -173.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.46 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 38.4 tttp -104.62 107.54 18.54 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.017 -1.475 . . . . 73.43 107.017 173.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.543 HD21 ' HA ' ' F' ' 8' ' ' LEU . 4.1 pp -85.97 145.59 27.06 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 109.153 -0.684 . . . . 74.24 109.153 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.535 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 5.8 m-20 -142.07 110.9 6.21 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 106.992 -1.485 . . . . 74.55 106.992 171.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -98.85 135.31 40.49 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.336 -1.357 . . . . 74.32 107.336 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -144.99 156.28 43.86 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.989 -1.115 . . . . 73.33 107.989 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 6.1 t -137.14 142.76 42.25 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.457 0.646 . . . . 62.44 110.507 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.43 145.36 35.2 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.27 -1.382 . . . . 75.33 107.27 174.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.8 p -146.39 166.45 26.32 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.853 0.297 . . . . 73.14 111.143 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.5 p -151.41 137.74 18.49 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.189 0.996 . . . . 75.23 109.103 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -92.86 110.74 22.19 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.026 -0.731 . . . . 75.34 109.026 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.481 HD12 HG22 ' B' ' 83' ' ' ILE . 22.9 mt -75.59 -46.68 30.4 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.683 0.754 . . . . 65.11 109.635 -178.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.51 179.45 7.8 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 114.572 -1.195 . . . . 74.14 109.774 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -74.92 128.9 36.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.658 -1.155 . . . . 75.23 108.179 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 73.69 -4.77 2.16 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 125.798 1.639 . . . . 71.15 112.83 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 62.2 t -114.18 113.75 44.7 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 N-CA-C 108.253 -1.017 . . . . 75.22 108.253 172.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.627 ' HB3' HD11 ' B' ' 86' ' ' ILE . 23.1 t80 -125.44 138.25 54.01 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.663 -0.865 . . . . 74.34 108.663 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -113.76 119.75 38.45 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.388 -1.338 . . . . 74.12 107.388 -175.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.438 HG21 ' HB3' ' B' ' 102' ' ' CYS . 33.0 m -116.05 148.93 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.136 0.574 . . . . 74.13 110.37 -177.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 19.3 t -129.59 124.16 58.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 C-N-CA 123.652 0.781 . . . . 74.33 109.11 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 20.0 tp -101.83 108.95 20.6 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 109.318 -0.623 . . . . 64.42 109.318 171.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -88.36 118.47 27.99 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.386 0.674 . . . . 73.21 109.994 175.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.1 t -114.12 103.4 15.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 108.242 -1.022 . . . . 72.03 108.242 176.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.535 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 4.7 m -99.62 130.3 45.84 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.267 0.627 . . . . 74.12 109.383 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.647 HG11 HG13 ' B' ' 40' ' ' VAL . 54.3 t -128.43 102.28 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 124.271 1.029 . . . . 75.04 110.564 -176.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.46 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 31.9 m -83.71 150.01 26.11 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.279 -1.008 . . . . 71.41 108.279 165.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.89 147.91 42.96 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.04 0.536 . . . . 74.41 110.033 177.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 36.2 p -138.92 125.31 20.4 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.121 0.568 . . . . 72.25 110.374 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.55 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 53.2 mt -94.23 100.61 12.64 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.022 -1.473 . . . . 74.52 107.022 173.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.36 -114.27 3.95 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 115.006 -0.997 . . . . 63.2 110.833 -170.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.83 6.32 9.9 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.018 0.927 . . . . 73.14 110.676 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.463 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 11.4 pt-20 -114.39 152.32 31.7 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.389 0.676 . . . . 65.23 109.22 175.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.8 m -64.56 137.99 58.15 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 123.648 0.592 . . . . 74.04 111.15 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.468 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -93.19 -63.62 1.19 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.579 -1.267 . . . . 74.12 107.579 170.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -145.56 167.76 22.26 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 114.244 -1.343 . . . . 74.41 110.601 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.411 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 61.0 mt -130.78 140.89 50.33 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.491 -2.04 . . . . 75.32 105.491 172.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.9 t -146.92 158.54 43.95 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.639 -0.874 . . . . 73.12 108.639 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 41.7 tt0 -165.04 132.24 3.01 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.512 -0.922 . . . . 73.04 108.512 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.0 t -128.23 144.54 37.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 123.479 0.712 . . . . 73.51 109.184 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -120.57 101.05 7.49 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.951 -1.129 . . . . 71.51 107.951 169.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.479 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.5 tp-100 -90.71 102.53 15.28 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.147 -1.057 . . . . 74.54 108.147 175.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.5 158.93 27.95 Favored Glycine 0 C--O 1.245 0.79 0 CA-C-N 115.283 -0.871 . . . . 72.02 110.946 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.98 125.87 1.62 Allowed Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 111.02 -0.832 . . . . 64.22 111.02 -178.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.481 HG22 HD12 ' B' ' 51' ' ' LEU . 50.9 mt -85.0 125.28 40.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 106.902 -1.518 . . . . 74.11 106.902 172.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -134.38 154.75 51.19 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.047 -0.724 . . . . 64.42 109.047 176.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 74.0 m -91.7 104.3 16.78 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.674 -0.861 . . . . 75.42 108.674 169.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.627 HD11 ' HB3' ' B' ' 56' ' ' TYR . 3.7 mp -101.37 107.86 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 106.602 -1.629 . . . . 75.31 106.602 173.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.21 171.32 15.11 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.153 0.581 . . . . 61.34 110.632 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.615 ' HA2' ' HB ' ' F' ' 23' ' ' THR . . . 83.11 -72.54 2.83 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.364 -0.834 . . . . 63.14 111.89 -177.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.543 ' HB ' ' HG2' ' B' ' 9' ' ' MET . 1.4 mm -87.16 144.35 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.029 0.932 . . . . 65.52 111.103 -176.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.483 ' HG2' ' H ' ' B' ' 91' ' ' GLY . 14.9 tt0 -154.69 175.35 13.8 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.177 -1.374 . . . . 74.21 107.611 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.483 ' H ' ' HG2' ' B' ' 90' ' ' GLU . . . 80.24 -113.89 3.74 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-O 120.03 -0.317 . . . . 52.25 112.364 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 8.9 m -73.96 -53.52 9.9 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.259 0.624 . . . . 71.23 111.718 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -70.98 -26.54 63.19 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.252 -0.886 . . . . 71.11 112.292 -165.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.643 ' HE1' ' HB3' ' F' ' 17' ' ' PRO . 21.0 ptt? -69.46 -25.08 63.92 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 122.977 0.173 . . . . 75.22 111.115 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.66 -38.72 78.76 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.491 0.716 . . . . 51.34 110.944 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -77.95 -37.4 47.68 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.949 -1.023 . . . . 72.14 110.507 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.559 ' SG ' ' HE1' ' B' ' 9' ' ' MET . 46.5 t -67.74 -25.73 65.79 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.414 0.686 . . . . 65.2 112.12 -177.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.642 HD12 HG22 ' F' ' 18' ' ' VAL . 84.3 mt -93.15 -43.92 8.61 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.184 0.594 . . . . 74.3 110.59 176.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.72 -18.42 73.06 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 115.152 0.821 . . . . 64.45 115.152 -170.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.05 -43.68 1.95 Allowed 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 117.589 0.694 . . . . 63.34 111.799 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.451 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 27.3 t80 -76.77 -52.5 9.45 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.801 -0.636 . . . . 75.05 111.427 -168.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.438 ' HB3' HG21 ' B' ' 58' ' ' VAL . 70.2 m -62.28 -44.4 88.29 Favored Pre-proline 0 CA--C 1.571 1.781 0 CA-C-O 118.269 -0.872 . . . . 75.43 112.959 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -51.68 -43.46 50.79 Favored 'Trans proline' 0 C--N 1.405 3.502 0 C-N-CA 122.832 2.355 . . . . 72.33 113.324 172.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -55.95 -33.3 64.64 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.152 0.981 . . . . 74.41 112.083 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 52.3 mt -77.57 -48.32 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.749 0.82 . . . . 73.11 110.868 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 79.2 mt -87.48 -19.89 27.33 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.661 0.784 . . . . 70.12 112.806 -167.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -64.15 -44.26 76.61 Favored Pre-proline 0 CA--C 1.563 1.479 0 CA-C-O 117.676 -1.154 . . . . 75.1 112.527 -174.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -53.14 -38.46 80.97 Favored 'Trans proline' 0 C--N 1.392 2.862 0 C-N-CA 122.553 2.169 . . . . 71.04 113.83 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.479 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 72.7 m-85 -70.81 -40.69 72.34 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.583 -0.735 . . . . 74.2 110.51 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.8 -37.03 83.75 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.741 0.416 . . . . 73.51 110.673 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -60.85 -55.76 29.19 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.156 1.383 . . . . 75.4 110.717 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -58.86 -37.97 77.7 Favored 'General case' 0 C--N 1.358 0.945 0 O-C-N 124.009 0.818 . . . . 74.43 110.555 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.796 ' SG ' HD12 ' B' ' 21' ' ' ILE . 16.8 t -67.41 -42.61 82.97 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-N 115.374 -0.83 . . . . 75.33 111.293 -175.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.97 -52.68 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 123.741 0.651 . . . . 74.32 109.541 176.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 10.7 m -60.97 -27.29 68.16 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 124.129 0.893 . . . . 74.22 111.689 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -68.52 -52.04 36.4 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 123.187 0.595 . . . . 64.53 109.67 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 33.7 mmt -59.56 -38.7 81.82 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.162 0.585 . . . . 73.31 111.063 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 71.1 t -66.24 -45.63 89.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.789 1.236 . . . . 71.24 111.034 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.7 t -67.63 -29.12 68.35 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.265 0.626 . . . . 64.43 111.107 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -73.34 -38.58 65.7 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.786 0.835 . . . . 74.44 110.042 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.58 -2.5 69.29 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 124.028 0.83 . . . . 65.54 112.5 171.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.511 HG23 ' HB3' ' A' ' 17' ' ' TYR . 20.1 p 63.22 28.87 15.97 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.804 2.042 . . . . 64.5 112.839 174.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -86.93 154.42 55.3 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.886 0.874 . . . . 75.34 110.483 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -48.24 153.37 3.02 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 124.095 3.197 . . . . 74.44 115.567 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.432 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -60.63 126.71 28.42 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.557 1.543 . . . . 74.42 111.797 -175.501 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 38.9 tp -127.8 113.89 16.54 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.822 -0.626 . . . . 73.35 110.386 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -121.36 112.65 18.83 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.295 -1.002 . . . . 72.11 108.295 171.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 9.2 tt -78.31 135.23 37.47 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.497 0.719 . . . . 75.31 109.667 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.93 137.34 87.44 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.487 1.115 . . . . 73.22 112.202 -173.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.458 ' HG3' HD11 ' D' ' 16' ' ' ILE . 38.1 Cg_endo -63.8 100.07 0.28 Allowed 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 123.188 2.592 . . . . 72.32 112.647 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' F' ' 7' ' ' ALA . 2.4 p -91.22 111.2 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-N 115.509 -0.769 . . . . 71.53 109.003 173.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -80.14 100.87 8.46 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.607 0.763 . . . . 75.3 109.113 -177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -66.38 -41.6 89.15 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.41 0.684 . . . . 74.02 110.932 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -57.59 -50.57 72.68 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.452 1.101 . . . . 62.42 111.941 -174.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.33 -24.97 64.89 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.14 0.9 . . . . 75.32 112.091 -175.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 87.9 mt -66.5 -45.39 79.73 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.226 0.61 . . . . 63.51 110.233 176.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.433 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 76.8 m-85 -68.33 -43.01 78.49 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.687 -0.688 . . . . 71.51 110.48 175.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 23.5 ttt -61.68 -38.38 87.58 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.094 0.958 . . . . 74.52 111.451 -174.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -75.55 -31.66 60.14 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.032 -0.985 . . . . 75.31 109.661 -174.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -69.03 -27.99 66.16 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.401 -0.818 . . . . 63.33 110.501 177.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 65.7 mt -87.4 36.37 0.74 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.027 0.931 . . . . 73.35 111.047 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -67.52 125.15 25.26 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.943 0.897 . . . . 54.22 111.027 -178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -130.61 131.56 45.01 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.844 0.858 . . . . 73.42 109.424 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -112.2 -52.62 2.77 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.079 0.952 . . . . 75.4 110.98 -175.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.93 125.61 27.99 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.952 0.501 . . . . 74.42 110.746 -177.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 176.88 61.79 0.06 OUTLIER Glycine 0 C--N 1.347 1.181 0 O-C-N 123.317 0.385 . . . . 65.01 112.336 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.68 164.04 34.76 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.394 1.078 . . . . 73.33 110.116 -176.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -147.28 143.09 10.87 Favored Glycine 0 C--N 1.347 1.191 0 N-CA-C 112.114 -0.394 . . . . 62.4 112.114 -175.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 28.3 p -115.2 103.89 11.3 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.179 0.992 . . . . 74.41 110.187 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -89.79 99.35 12.38 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.759 0.824 . . . . 75.31 110.171 -176.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -108.69 100.16 9.43 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.785 0.834 . . . . 74.42 109.112 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -81.2 154.52 26.62 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.129 0.49 . . . . 73.12 110.331 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -124.68 178.41 5.46 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.31 1.044 . . . . 75.1 109.846 -176.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -154.91 145.22 22.0 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.811 0.845 . . . . 74.14 109.12 173.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 C-N-CA 123.46 0.704 . . . . 75.03 109.827 179.304 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.646 ' HE1' ' HG2' ' A' ' 37' ' ' GLN . 55.9 mtt . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.327 -0.619 . . . . 75.12 109.327 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 53.0 p -146.6 157.46 43.72 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.198 0.599 . . . . 73.43 111.13 -174.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -147.58 127.48 13.56 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.028 -1.101 . . . . 74.35 108.028 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -135.49 98.81 4.04 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.725 -0.843 . . . . 72.42 108.725 -176.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -165.84 115.6 1.01 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.004 0.922 . . . . 73.34 108.551 172.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -139.87 61.76 1.53 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 122.329 1.062 . . . . 60.22 108.805 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 44.7 p -115.46 166.97 11.29 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 114.47 -1.241 . . . . 75.22 108.607 169.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -73.33 164.24 26.96 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 110.534 -0.173 . . . . 50.25 110.534 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.608 ' HE3' ' SG ' ' C' ' 97' ' ' CYS . 23.3 ttt 65.09 116.47 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.022 1.329 . . . . 64.42 110.524 -164.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 91.5 m -84.96 90.73 7.89 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.957 -1.127 . . . . 64.4 107.957 174.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.592 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.6 t80 -104.95 119.18 38.4 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.233 -0.894 . . . . 75.33 109.738 176.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.532 HE22 ' HB3' ' E' ' 3' ' ' GLN . 35.5 tt0 -140.96 123.61 16.07 Favored 'General case' 0 C--O 1.245 0.824 0 N-CA-C 107.611 -1.255 . . . . 72.33 107.611 175.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 70.3 mt -71.4 122.43 23.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.213 -1.032 . . . . 75.34 108.213 171.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.556 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 20.7 mm-40 -85.11 -50.51 7.36 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 124.122 0.889 . . . . 75.33 109.018 -178.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -172.41 124.19 0.48 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.951 -0.568 . . . . 73.43 110.214 -172.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 77.1 mt -112.28 143.74 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.55 -0.908 . . . . 73.32 108.55 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.403 ' HB3' HG21 ' D' ' 122' ' ' THR . 28.0 p90 -174.94 166.03 3.56 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.674 0.79 . . . . 74.11 109.369 -171.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.8 p -89.64 126.0 35.46 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.278 -0.638 . . . . 73.4 109.278 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -74.99 -50.2 17.37 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 122.668 1.223 . . . . 72.34 107.857 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 10.3 t70 -136.0 136.86 40.65 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 112.651 -2.068 . . . . 72.4 108.969 -166.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 75.2 mt -136.28 142.15 39.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.044 -1.465 . . . . 73.34 107.044 172.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -158.46 151.35 22.44 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.312 0.577 . . . . 71.55 110.328 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -150.32 134.42 17.0 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 107.919 -1.141 . . . . 72.45 107.919 174.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -134.35 137.55 44.23 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.465 0.706 . . . . 71.25 109.659 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.36 80.96 8.24 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 106.125 -1.805 . . . . 63.2 106.125 172.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.65 -8.89 24.07 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.9 2.4 . . . . 55.41 112.878 -171.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . 0.463 ' ND2' ' HB ' ' C' ' 31' ' ' VAL . 20.2 p-10 -124.48 20.95 8.67 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.053 1.341 . . . . 74.15 110.277 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.433 ' HA ' HG13 ' C' ' 31' ' ' VAL . . . -43.85 -51.14 17.91 Favored Pre-proline 0 CA--C 1.564 1.511 0 N-CA-C 114.569 1.322 . . . . 72.11 114.569 -168.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.58 -51.13 9.82 Favored 'Trans proline' 0 C--N 1.392 2.845 0 CA-C-N 121.622 1.615 . . . . 70.24 112.169 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.421 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 84.1 t60 -68.38 -29.99 68.82 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.744 0.818 . . . . 72.31 112.28 -174.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.726 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.8 p -77.43 -26.52 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 N-CA-C 112.626 0.602 . . . . 73.22 112.626 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -68.98 -17.98 64.0 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.379 0.881 . . . . 73.35 113.379 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 19.4 pt20 -94.6 8.04 43.66 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.789 0.436 . . . . 72.2 111.181 177.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.751 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -89.78 168.84 11.77 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.005 0.922 . . . . 74.21 110.372 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . 0.448 ' N ' ' HG3' ' C' ' 34' ' ' LYS . 31.6 t70 -74.13 130.56 40.02 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.2 0.6 . . . . 75.03 109.66 165.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -80.7 88.93 5.74 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.059 0.544 . . . . 74.11 109.873 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -143.13 77.85 15.58 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 107.971 -1.122 . . . . 74.24 107.971 172.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.52 ' HB2' HG11 ' C' ' 40' ' ' VAL . 9.2 Cg_endo -88.11 127.09 2.1 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.968 2.445 . . . . 74.33 112.37 -173.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -82.46 86.5 6.75 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.522 -1.658 . . . . 75.01 106.522 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.52 HG11 ' HB2' ' C' ' 38' ' ' PRO . 3.1 m -82.81 111.29 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 113.18 -1.827 . . . . 73.34 111.006 -173.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -106.31 115.97 31.14 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.838 0.855 . . . . 74.54 109.84 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 8.0 mp -85.66 131.18 34.39 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.302 -0.999 . . . . 74.43 108.302 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.51 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 38.6 t70 -123.63 105.7 9.94 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.814 1.246 . . . . 70.21 107.903 -170.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.497 HD23 HD12 ' G' ' 8' ' ' LEU . 32.7 tp -95.66 140.57 30.29 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.728 -0.669 . . . . 74.44 110.006 -173.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.614 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 25.9 t70 -147.14 158.06 43.81 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.853 -1.166 . . . . 71.44 107.853 173.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 73.0 p -122.53 132.25 54.23 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.159 0.584 . . . . 64.55 110.59 -174.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.25 147.43 50.22 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.072 -1.085 . . . . 72.23 108.072 173.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 72.3 p -165.55 159.09 16.33 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.597 0.237 . . . . 62.11 111.609 -174.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 65.2 p -164.15 134.79 4.28 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.536 0.734 . . . . 71.4 110.013 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -77.04 120.6 22.36 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.766 -0.827 . . . . 71.44 108.766 171.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.524 HD12 ' HB2' ' C' ' 57' ' ' GLU . 43.6 mt -94.14 -39.84 10.36 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.638 0.775 . . . . 71.41 110.155 -176.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.41 -179.19 6.77 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.852 0.861 . . . . 65.42 110.146 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -57.23 110.39 0.83 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.629 0.772 . . . . 65.12 109.419 173.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 65.02 1.4 1.47 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.317 1.447 . . . . 73.44 114.35 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.1 t -93.18 110.73 23.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 106.914 -1.513 . . . . 73.31 106.914 173.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.563 ' HB2' HG11 ' G' ' 18' ' ' VAL . 17.7 t80 -125.1 136.25 53.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.911 -0.586 . . . . 75.43 110.137 -171.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.524 ' HB2' HD12 ' C' ' 51' ' ' LEU . 29.6 tt0 -94.05 119.71 33.29 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.222 -0.899 . . . . 53.22 109.234 175.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 61.7 t -104.76 114.04 43.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.419 -1.326 . . . . 73.45 107.419 168.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 63.1 t -105.54 133.24 50.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 107.674 -1.232 . . . . 75.13 107.674 169.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 13.9 tp -116.4 108.62 16.26 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.794 -0.817 . . . . 72.54 108.794 174.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.614 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 0.4 OUTLIER -83.64 114.13 21.33 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.365 -0.976 . . . . 64.31 108.365 179.366 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 12.2 t -110.81 130.13 64.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.076 -1.083 . . . . 74.32 108.076 174.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 31.1 m -124.86 118.52 26.5 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.586 -0.894 . . . . 75.3 108.586 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.547 HG23 HG21 ' C' ' 114' ' ' ILE . 98.9 t -98.77 110.41 26.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.462 -0.94 . . . . 75.31 108.462 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 11.2 m -96.32 137.7 35.01 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.123 -1.436 . . . . 74.24 107.123 174.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.45 118.38 19.25 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.526 -1.287 . . . . 73.52 107.526 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 60.1 m -138.47 127.78 24.43 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 109.253 -0.647 . . . . 63.44 109.253 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.751 HD11 ' HG2' ' C' ' 34' ' ' LYS . 2.9 mt -83.37 15.6 2.93 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.954 1.302 . . . . 72.12 111.291 -175.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.09 -104.49 0.59 Allowed Glycine 0 C--N 1.344 1.013 0 N-CA-C 109.346 -1.502 . . . . 74.13 109.346 -173.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -88.45 -20.79 24.73 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.348 0.659 . . . . 74.22 110.073 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -89.37 122.54 32.7 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.196 0.998 . . . . 74.53 110.156 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 89.1 m -75.97 125.12 28.5 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.998 -0.742 . . . . 73.01 108.998 166.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.726 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.33 -54.12 7.61 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.173 -0.677 . . . . 74.34 109.173 173.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -164.52 166.26 20.54 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 115.56 -0.745 . . . . 74.32 111.856 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -131.6 104.41 6.93 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 106.762 -1.57 . . . . 60.13 106.762 172.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.515 ' SG ' HG22 ' C' ' 114' ' ' ILE . 48.8 t -110.19 146.15 36.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.842 0.857 . . . . 75.44 108.999 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -150.58 133.98 16.36 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.003 0.521 . . . . 53.03 109.877 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.5 t -132.54 132.79 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.507 -0.923 . . . . 74.1 108.507 168.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.47 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 61.0 mt-30 -105.56 98.49 8.18 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.701 -1.222 . . . . 75.42 107.701 173.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -82.57 106.98 14.87 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.888 -0.596 . . . . 74.41 110.43 -174.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.65 145.66 21.98 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.902 -0.59 . . . . 74.23 111.69 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.11 117.2 0.8 Allowed Glycine 0 CA--C 1.509 -0.282 0 N-CA-C 110.477 -1.049 . . . . 71.31 110.477 177.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 13.1 mm -83.87 118.9 32.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.145 -1.057 . . . . 64.32 108.145 177.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.592 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 50.6 m-85 -129.17 128.36 43.23 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.146 0.978 . . . . 72.13 108.71 -176.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.1 p -83.33 115.62 22.08 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.864 -0.791 . . . . 70.21 108.864 172.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.449 ' HB ' HG21 ' G' ' 18' ' ' VAL . 4.4 mp -114.65 100.3 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 107.134 -1.432 . . . . 75.14 107.134 173.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.435 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -124.25 152.66 42.72 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.159 0.984 . . . . 75.25 109.034 176.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.41 -58.25 0.74 Allowed Glycine 0 C--N 1.345 1.04 0 CA-C-O 120.272 -0.182 . . . . 65.12 113.189 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' C' ' 94' ' ' MET . 29.9 pt -81.89 167.44 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 121.111 0.481 . . . . 64.11 111.413 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.61 ' HA ' ' HE1' ' C' ' 94' ' ' MET . 11.2 pt-20 -150.08 -177.24 5.81 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.292 1.037 . . . . 75.52 110.019 177.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.71 -139.07 48.74 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 124.266 0.979 . . . . 70.23 114.618 171.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 92' ' ' THR . . . . . 0.522 HG23 ' HG3' ' A' ' 150' ' ' GLU . 68.0 p -70.58 -18.75 62.9 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.853 0.861 . . . . 74.42 111.953 -175.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -74.91 -39.14 61.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.274 0.63 . . . . 74.22 109.951 174.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.61 ' HE1' ' HA ' ' C' ' 90' ' ' GLU . 46.5 ttm -60.81 -49.09 78.89 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.177 0.591 . . . . 73.24 109.815 172.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.22 -29.98 70.83 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.792 0.837 . . . . 71.13 112.072 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -67.15 -40.92 86.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.215 0.606 . . . . 74.45 110.327 174.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.608 ' SG ' ' HE3' ' C' ' 9' ' ' MET . 15.2 t -64.78 -43.72 92.32 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.529 0.518 . . . . 74.43 110.799 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.58 HD11 HG22 ' G' ' 18' ' ' VAL . 86.1 mt -74.73 -36.79 62.65 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.413 0.685 . . . . 75.45 112.19 -176.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.92 -23.89 31.49 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 114.651 0.62 . . . . 73.33 114.651 -165.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.471 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -135.99 -47.03 0.65 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.446 0.641 . . . . 73.31 111.875 -172.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.567 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 82.4 t80 -74.23 -40.78 62.18 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 125.485 1.514 . . . . 74.45 112.604 -170.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 94.5 m -76.71 -43.23 3.04 Favored Pre-proline 0 N--CA 1.487 1.382 0 CA-C-O 118.568 -0.73 . . . . 74.04 111.194 176.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -47.34 -40.06 28.13 Favored 'Trans proline' 0 C--N 1.395 3.009 0 C-N-CA 122.84 2.36 . . . . 70.44 113.376 165.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -59.02 -38.49 79.38 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 123.668 0.605 . . . . 65.44 111.276 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.404 HD11 HH12 ' A' ' 111' ' ' ARG . 36.8 mm -65.27 -44.47 94.97 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 122.822 0.449 . . . . 75.52 109.842 174.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 94.9 mt -83.82 -15.22 49.13 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.816 1.043 . . . . 75.21 113.816 -169.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -58.72 -53.43 66.43 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-O 117.614 -1.184 . . . . 74.44 112.946 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.75 -32.11 78.3 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 121.702 1.601 . . . . 71.11 112.949 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -66.71 -53.69 30.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.371 0.668 . . . . 74.53 110.626 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.49 83.81 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.703 0.801 . . . . 75.12 110.465 177.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -57.77 -57.11 14.19 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.298 1.439 . . . . 71.32 111.287 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -38.0 83.19 Favored 'General case' 0 C--N 1.366 1.296 0 O-C-N 123.716 0.635 . . . . 75.54 109.713 -177.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.8 t -66.3 -30.52 70.95 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 122.833 0.453 . . . . 62.3 111.761 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.547 HG21 HG23 ' C' ' 64' ' ' VAL . 91.9 mt -74.46 -55.39 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.209 0.604 . . . . 71.33 109.534 173.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 21.8 m -59.99 -27.4 66.83 Favored 'General case' 0 CA--C 1.558 1.27 0 O-C-N 123.787 0.679 . . . . 75.04 111.204 -175.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 46.7 t -63.68 -48.62 76.44 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 124.429 1.092 . . . . 62.11 109.82 174.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.67 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -66.45 -36.26 82.34 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.115 0.966 . . . . 74.5 111.686 179.129 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 76.1 t -61.75 -41.12 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.561 0.744 . . . . 75.44 109.507 172.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.0 t -74.82 -28.86 60.88 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.95 -1.023 . . . . 73.14 111.763 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' C' ' 116' ' ' SER . 80.5 mtt-85 -73.0 -38.62 66.53 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.815 -0.809 . . . . 74.44 108.815 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.27 -4.92 70.22 Favored Glycine 0 C--N 1.356 1.691 0 CA-C-N 115.375 -0.829 . . . . 61.22 112.777 171.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 19.6 p 64.91 27.67 12.75 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.673 1.989 . . . . 75.41 113.157 171.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -83.99 142.25 41.49 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 108.263 -1.014 . . . . 75.32 108.263 170.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.54 163.44 1.16 Allowed 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.65 2.9 . . . . 71.33 114.711 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -54.33 134.08 45.21 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.326 1.05 . . . . 73.12 113.112 -171.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 27.5 tp -134.93 85.96 2.22 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.51 -1.293 . . . . 74.34 107.51 174.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -96.21 115.54 27.59 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.845 -1.07 . . . . 65.13 109.067 -175.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.24 121.61 14.11 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.747 0.819 . . . . 72.43 109.069 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.61 137.9 74.06 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 123.065 0.546 . . . . 71.21 111.286 -177.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.543 ' HB3' HD13 ' A' ' 16' ' ' ILE . 9.6 Cg_endo -52.47 109.51 0.35 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.139 2.559 . . . . 63.22 114.383 175.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 10.1 m -121.19 112.02 33.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 107.784 -1.191 . . . . 74.4 107.784 165.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -74.49 94.04 2.55 Favored 'General case' 0 C--N 1.354 0.774 0 N-CA-C 108.759 -0.83 . . . . 74.32 108.759 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -54.91 -34.18 62.86 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.943 1.697 . . . . 75.15 111.902 -173.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.471 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 9.7 t70 -74.45 -41.45 60.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.42 1.088 . . . . 73.42 111.178 -177.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.77 -30.76 71.05 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.092 0.957 . . . . 75.01 111.324 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 97.1 mt -58.6 -37.5 75.99 Favored 'General case' 0 CA--C 1.554 1.105 0 O-C-N 124.11 0.881 . . . . 74.32 111.022 172.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -80.35 -27.17 38.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.758 0.823 . . . . 64.42 111.851 175.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 23.7 mmt -66.96 -28.25 68.12 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.271 0.628 . . . . 74.34 111.472 175.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -55.79 -35.91 66.81 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.255 1.022 . . . . 75.0 111.332 172.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -72.28 -154.95 0.03 OUTLIER 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.684 0.794 . . . . 74.32 109.679 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.483 HD21 ' HA2' ' A' ' 148' ' ' GLY . 56.3 mt 59.41 -103.59 0.17 Allowed 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 124.344 1.058 . . . . 71.21 111.098 174.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 179.68 136.88 0.11 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.133 1.373 . . . . 72.44 108.487 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -115.44 96.21 5.53 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.436 -1.32 . . . . 74.53 107.436 174.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -108.01 -6.49 16.53 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.78 0.832 . . . . 74.5 111.245 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.42 123.76 34.4 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.411 0.684 . . . . 74.22 110.324 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -170.18 129.9 1.91 Allowed Glycine 0 C--N 1.334 0.446 0 CA-C-O 119.846 -0.419 . . . . 72.51 112.174 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -167.03 118.56 0.92 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.154 0.582 . . . . 75.23 110.035 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -98.59 112.41 4.46 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 111.592 -0.603 . . . . 75.52 111.592 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 149' ' ' THR . . . . . 0.415 ' H ' ' H ' ' A' ' 92' ' ' THR . 21.1 p -71.18 93.67 1.09 Allowed 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 117.2 0.5 . . . . 75.54 109.852 171.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -72.36 -49.21 35.79 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.136 0.975 . . . . 70.4 111.009 -176.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.44 133.13 39.94 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 107.345 -1.354 . . . . 74.42 107.345 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -90.79 -56.87 3.02 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.893 0.477 . . . . 74.13 111.125 -174.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 58.38 79.78 0.2 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.703 0.763 . . . . 72.24 109.819 -166.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.43 83.36 6.26 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.237 -0.892 . . . . 73.14 109.933 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-N 115.053 -0.976 . . . . 63.32 108.932 175.02 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 109.333 -0.617 . . . . 62.5 109.333 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 23.1 t -159.61 175.83 12.74 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.149 0.98 . . . . 64.02 109.169 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -161.66 -149.82 0.18 Allowed 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 107.283 -1.377 . . . . 73.41 107.283 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . 0.659 ' HA ' ' HG3' ' D' ' 93' ' ' GLN . 51.5 mt-30 67.3 97.56 0.06 Allowed 'General case' 0 C--N 1.364 1.22 0 C-N-CA 124.567 1.147 . . . . 73.31 111.872 175.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -85.63 -61.16 1.82 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.294 0.638 . . . . 75.4 111.684 -172.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -75.78 124.36 27.16 Favored 'General case' 0 C--N 1.36 1.054 0 CA-C-O 121.055 0.455 . . . . 65.12 110.98 -175.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 9.2 t -73.33 -11.97 60.67 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.418 1.087 . . . . 75.25 111.131 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -64.78 -23.6 67.29 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.419 1.087 . . . . 63.23 111.869 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.557 ' HG3' HD13 ' D' ' 89' ' ' ILE . 7.6 ttt -32.42 124.68 0.32 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.944 1.298 . . . . 63.22 113.906 168.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 64.5 m -108.67 142.28 39.4 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.718 -0.845 . . . . 75.32 108.718 169.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' D' ' 85' ' ' SER . 25.0 t80 -158.58 119.85 3.43 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.757 -0.831 . . . . 74.34 108.757 177.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -138.86 145.24 39.73 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.759 1.224 . . . . 73.33 108.118 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 52.4 mt -91.77 127.62 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.24 -0.652 . . . . 73.11 109.24 176.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.408 HE22 HG12 ' D' ' 55' ' ' VAL . 51.1 mt-30 -97.53 -46.63 5.97 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 122.531 0.333 . . . . 75.15 111.061 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -167.77 127.53 1.34 Allowed 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 117.816 0.28 . . . . 75.31 111.527 -170.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.458 HD11 ' HG3' ' B' ' 130' ' ' PRO . 2.4 mp -103.82 138.05 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.358 -1.349 . . . . 74.43 107.358 167.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -163.94 149.4 10.79 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 123.813 0.695 . . . . 73.2 110.658 176.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.1 p -83.36 116.85 22.66 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.419 -0.81 . . . . 74.41 109.212 174.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -84.74 -35.87 22.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.635 -0.876 . . . . 71.01 108.635 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.618 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 12.7 t70 -143.25 129.23 19.57 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.283 -1.326 . . . . 74.31 109.129 -174.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.67 HG21 ' HE1' ' C' ' 117' ' ' MET . 62.1 mt -135.56 148.45 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.643 1.177 . . . . 71.14 108.612 174.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.6 t -147.17 142.87 27.77 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.027 0.931 . . . . 70.01 109.536 171.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 83.1 t80 -146.63 119.93 8.96 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 105.252 -2.129 . . . . 74.25 105.252 172.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.505 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.8 mt-10 -134.98 109.94 8.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.311 0.645 . . . . 74.24 109.386 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.24 90.95 5.11 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 107.734 -1.21 . . . . 73.14 107.734 175.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -73.5 -33.36 6.92 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.726 2.284 . . . . 72.4 112.554 -169.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -110.4 18.53 19.73 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.143 0.977 . . . . 74.12 109.897 -175.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -34.22 -61.01 0.45 Allowed Pre-proline 0 CA--C 1.569 1.685 0 N-CA-C 116.309 1.966 . . . . 75.3 116.309 -161.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.431 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 93.1 Cg_endo -76.36 -26.88 8.39 Favored 'Trans proline' 0 C--N 1.385 2.481 0 CA-C-N 122.996 2.106 . . . . 71.34 113.202 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -66.38 -44.36 83.31 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.507 1.123 . . . . 73.01 109.624 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.545 HG22 ' HA ' ' D' ' 73' ' ' ALA . 12.0 p -82.46 -16.42 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-N 115.202 -0.908 . . . . 73.15 111.446 -172.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.431 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 16.7 m-85 -64.75 -26.2 68.26 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.102 0.408 . . . . 72.33 112.102 177.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -58.27 -21.92 50.48 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.842 0.857 . . . . 74.41 111.198 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.655 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 88.3 mttt -93.73 97.5 10.49 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.931 1.292 . . . . 73.04 109.09 173.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -104.9 85.29 2.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.718 0.771 . . . . 74.42 109.324 177.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 19.1 p90 -149.25 -173.16 4.31 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.688 -1.142 . . . . 75.33 108.075 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -77.14 113.13 28.01 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.147 0.579 . . . . 64.44 110.237 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.23 130.37 39.04 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.664 2.243 . . . . 75.54 112.696 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.56 112.18 3.05 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.795 -0.817 . . . . 63.42 108.795 172.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 13.9 m -101.81 125.37 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.745 0.818 . . . . 74.31 110.91 -171.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.626 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 0.1 OUTLIER -104.82 111.92 24.84 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.68 1.192 . . . . 74.43 108.096 179.032 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.627 ' HB2' HG23 ' H' ' 6' ' ' ILE . 50.2 tp -98.45 126.22 43.91 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 122.759 0.423 . . . . 73.22 110.004 -178.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -141.25 125.72 17.7 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.78 0.832 . . . . 75.32 109.019 174.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.95 146.67 27.53 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.519 0.728 . . . . 74.31 110.418 -176.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.459 ' HA ' ' HG3' ' H' ' 12' ' ' PRO . 17.2 t70 -134.53 156.04 49.34 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.842 1.257 . . . . 71.55 108.159 171.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 5.9 t -127.8 151.4 49.08 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.48 0.657 . . . . 65.31 110.937 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.81 152.62 36.82 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.302 -1.37 . . . . 60.34 107.302 168.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 77.6 p -172.75 153.41 2.71 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.831 0.452 . . . . 70.11 110.752 -175.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 37.2 p -169.48 159.11 8.32 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.069 0.948 . . . . 75.42 109.772 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -90.47 134.77 34.13 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.386 -0.598 . . . . 74.13 109.386 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.45 ' HB2' HG13 ' D' ' 55' ' ' VAL . 63.9 mt -99.68 -42.31 6.93 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.035 0.534 . . . . 74.32 110.7 -177.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.42 -168.94 2.73 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.334 0.653 . . . . 71.31 110.388 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.04 118.36 9.7 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.539 -0.541 . . . . 52.03 109.539 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 64.4 4.65 2.28 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.016 1.327 . . . . 74.4 112.779 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.45 HG13 ' HB2' ' D' ' 51' ' ' LEU . 79.3 t -110.67 129.27 66.12 Favored 'Isoleucine or valine' 0 C--N 1.351 0.638 0 C-N-CA 124.624 1.17 . . . . 71.31 108.6 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -145.37 172.9 12.51 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.691 -0.855 . . . . 65.13 108.691 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -132.29 145.48 51.31 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.097 -0.956 . . . . 75.12 110.12 174.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.422 HG21 ' HB3' ' D' ' 102' ' ' CYS . 15.1 m -129.32 142.12 44.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.204 1.002 . . . . 73.34 108.678 167.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 39.4 t -128.44 117.23 44.59 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 C-N-CA 124.322 1.049 . . . . 74.53 108.223 -175.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.548 HD21 ' HB2' ' D' ' 103' ' ' PRO . 60.9 tp -103.61 119.13 38.28 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.714 -0.476 . . . . 65.42 109.714 174.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -88.17 108.09 19.1 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.047 -0.723 . . . . 74.12 109.047 170.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 41.1 t -91.89 128.41 43.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.356 -1.35 . . . . 73.31 107.356 166.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.4 m -125.17 125.2 43.3 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.582 0.706 . . . . 54.14 110.807 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 48.2 t -115.59 100.76 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.034 1.734 . . . . 74.45 108.242 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.626 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 91.8 m -96.35 102.5 14.29 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.062 -1.088 . . . . 65.25 108.062 172.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.16 139.67 39.48 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.371 -0.831 . . . . 71.23 109.441 -170.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 61.3 p -147.53 126.32 12.66 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.054 0.454 . . . . 73.41 111.52 -173.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.484 HD11 HG21 ' D' ' 31' ' ' VAL . 51.4 mt -98.54 113.91 26.13 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.269 1.028 . . . . 75.02 108.479 175.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.73 -128.32 9.1 Favored Glycine 0 C--N 1.343 0.935 0 O-C-N 123.383 0.427 . . . . 72.42 113.04 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.03 18.95 20.98 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.043 0.537 . . . . 73.05 110.879 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.655 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 11.7 pt-20 -140.32 167.41 22.2 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.261 0.624 . . . . 73.23 110.07 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 77.0 m -74.35 139.5 44.16 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.461 0.704 . . . . 71.33 110.551 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.545 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -87.94 -64.77 1.1 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 107.717 -1.216 . . . . 73.13 107.717 171.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -156.8 162.97 39.72 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 114.497 -1.229 . . . . 74.01 110.176 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.505 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 84.8 mt -121.44 112.27 18.33 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 124.728 1.211 . . . . 74.33 107.921 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.488 ' HG ' ' HE2' ' D' ' 117' ' ' MET . 1.3 m -114.05 133.82 55.27 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.208 -1.034 . . . . 75.24 108.208 -178.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -156.6 120.56 4.36 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.186 -0.672 . . . . 65.32 109.186 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 80.8 t -130.61 114.32 27.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.643 -0.873 . . . . 72.43 108.643 -176.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.618 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 37.5 mt-30 -88.94 87.71 7.32 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 108.489 -0.93 . . . . 74.24 108.489 170.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -80.03 104.51 10.64 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 113.745 -1.571 . . . . 74.42 108.167 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.98 150.98 18.38 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 111.236 -0.746 . . . . 54.34 111.236 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.31 131.13 3.94 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.738 -0.545 . . . . 63.42 111.738 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.9 mt -88.38 123.18 40.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 107.572 -1.27 . . . . 74.13 107.572 171.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -131.51 169.35 16.21 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.254 1.021 . . . . 61.43 108.942 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 25.5 m -112.65 136.03 52.68 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.058 0.943 . . . . 73.12 108.862 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.569 HG12 HD11 ' D' ' 89' ' ' ILE . 12.1 tt -145.79 137.57 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.352 -0.981 . . . . 74.14 108.352 176.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.09 127.4 1.83 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.502 0.321 . . . . 74.44 111.073 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.1 4.81 55.21 Favored Glycine 0 C--N 1.346 1.129 0 O-C-N 123.613 0.57 . . . . 74.03 113.228 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.569 HD11 HG12 ' D' ' 86' ' ' ILE . 3.3 mp -115.56 150.21 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.385 0.674 . . . . 74.24 110.208 -175.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.24 176.06 6.99 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.567 1.547 . . . . 72.33 109.004 173.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . 0.469 ' N ' ' HE2' ' D' ' 94' ' ' MET . . . 60.89 -129.32 46.39 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 114.58 0.592 . . . . 75.34 114.58 175.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.8 m -71.56 -33.49 69.14 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.535 1.134 . . . . 74.42 112.225 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.659 ' HG3' ' HA ' ' D' ' 4' ' ' GLN . 50.0 tt0 -64.21 -30.37 71.44 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.823 0.849 . . . . 75.03 111.566 -177.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.609 ' HE3' ' HB2' ' H' ' 20' ' ' LYS . 48.0 mtm -62.18 -39.33 92.34 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.919 0.488 . . . . 73.12 111.473 174.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.99 -36.98 83.13 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.857 0.463 . . . . 75.4 112.08 -173.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . 0.449 ' O ' ' HB2' ' D' ' 100' ' ' ALA . 54.5 t-80 -81.21 -29.27 34.57 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.339 0.256 . . . . 74.53 111.576 177.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 34.5 t -70.75 -49.91 41.73 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.286 0.565 . . . . 75.11 110.832 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.745 HD12 ' HD2' ' H' ' 17' ' ' PRO . 29.4 mt -93.8 -45.0 7.85 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 124.464 1.105 . . . . 72.03 110.973 -166.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.33 -1.25 88.17 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-O 119.825 -0.431 . . . . 73.23 113.534 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.59 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -133.01 -68.46 0.59 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.475 0.637 . . . . 74.23 111.317 -178.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -70.82 -42.9 69.63 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 112.896 0.702 . . . . 74.33 112.896 -167.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.422 ' HB3' HG21 ' D' ' 58' ' ' VAL . 66.6 m -62.04 -50.29 81.29 Favored Pre-proline 0 CA--C 1.568 1.664 0 N-CA-C 112.881 0.697 . . . . 72.41 112.881 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.548 ' HB2' HD21 ' D' ' 60' ' ' LEU . 98.2 Cg_endo -77.52 -7.58 16.86 Favored 'Trans proline' 0 C--N 1.39 2.715 0 C-N-CA 122.267 1.978 . . . . 74.23 112.711 175.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -77.51 -30.57 52.99 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.765 -0.828 . . . . 61.43 108.765 171.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.1 mm -70.51 -38.22 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.518 0.727 . . . . 54.42 109.638 169.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.98 -11.35 59.58 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.488 0.715 . . . . 71.11 111.771 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . 0.433 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 86.5 t80 -65.97 -51.63 45.64 Favored Pre-proline 0 CA--C 1.567 1.634 0 C-N-CA 124.2 1.0 . . . . 73.12 112.605 -177.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 34.3 Cg_exo -60.64 -32.32 93.15 Favored 'Trans proline' 0 C--N 1.395 2.979 0 C-N-CA 122.128 1.885 . . . . 74.04 112.814 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -80.76 -32.07 35.67 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.865 0.866 . . . . 74.14 112.177 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.1 -46.37 81.35 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.804 -0.813 . . . . 71.13 108.804 173.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -62.23 -41.24 98.23 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 124.228 0.955 . . . . 71.42 110.839 177.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -51.68 -53.64 36.83 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.428 1.091 . . . . 74.22 111.131 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.1 t -67.74 -46.75 71.25 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.191 -0.913 . . . . 63.5 111.485 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.464 ' O ' HG23 ' D' ' 118' ' ' VAL . 84.7 mt -62.2 -57.58 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.474 0.71 . . . . 73.22 110.841 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 90.9 m -49.95 -45.75 51.61 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.32 1.013 . . . . 62.42 111.734 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.5 t -64.97 -43.31 93.05 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.083 -0.962 . . . . 73.22 110.955 -175.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.488 ' HE2' ' HG ' ' D' ' 76' ' ' CYS . 73.3 mtm -65.05 -36.35 84.07 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.79 0.436 . . . . 73.53 111.559 179.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.464 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.7 t -62.53 -44.67 99.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.789 0.835 . . . . 73.22 110.366 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.2 p -76.86 -26.25 54.03 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 116.08 -0.509 . . . . 73.02 111.38 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -72.98 -34.24 66.32 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.434 0.694 . . . . 72.3 109.892 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.35 3.17 79.12 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 115.582 -0.736 . . . . 64.24 112.393 171.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.403 HG21 ' HB3' ' C' ' 17' ' ' TYR . 31.0 p 60.39 24.38 13.92 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 126.866 2.067 . . . . 65.14 113.669 175.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -82.43 158.89 65.55 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 124.095 0.958 . . . . 75.41 109.585 169.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -49.64 127.49 18.73 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 123.369 2.713 . . . . 74.12 113.31 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -52.08 131.24 31.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.288 1.035 . . . . 75.11 111.27 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 45.8 tp -124.08 97.86 5.53 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.243 0.617 . . . . 74.32 110.15 -172.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -101.87 121.41 42.06 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.805 0.842 . . . . 75.11 109.664 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 tt -74.3 115.88 14.32 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 108.463 -0.94 . . . . 71.53 108.463 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.47 143.86 98.56 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.684 0.794 . . . . 64.21 111.644 -176.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.451 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 6.8 Cg_exo -70.48 121.88 8.39 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.696 2.264 . . . . 64.3 111.535 -177.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.5 m -115.24 154.14 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.008 0.923 . . . . 74.35 110.743 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -73.07 80.29 1.23 Allowed 'General case' 0 C--N 1.354 0.781 0 N-CA-C 108.536 -0.913 . . . . 75.54 108.536 173.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -57.22 -35.49 69.72 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.243 1.417 . . . . 73.01 110.626 -176.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.59 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 4.1 m-20 -62.48 -56.06 21.71 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.109 -1.405 . . . . 74.33 111.801 -177.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.59 -37.9 87.96 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.924 0.765 . . . . 73.34 111.911 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 79.6 mt -58.05 -47.44 83.14 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.347 1.029 . . . . 73.33 111.572 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -78.22 -30.3 48.78 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.058 0.543 . . . . 74.53 110.92 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 34.1 ttm -63.19 -27.99 69.74 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.33 1.052 . . . . 71.5 112.269 -174.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -63.35 -34.87 78.66 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.547 0.739 . . . . 75.15 111.475 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -60.31 -38.52 83.96 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.822 0.849 . . . . 73.34 110.746 175.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.41 -32.43 73.26 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.655 0.782 . . . . 74.02 111.128 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -84.84 -0.83 55.32 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.372 0.669 . . . . 64.34 112.112 -177.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -121.88 47.97 1.79 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.719 0.808 . . . . 64.35 109.769 -176.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -165.36 126.95 2.01 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.23 -0.441 . . . . 71.25 110.783 -175.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -113.56 100.32 8.41 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.917 0.887 . . . . 75.01 108.73 174.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.29 129.87 9.7 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.886 -0.486 . . . . 71.05 111.886 -176.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -107.51 103.5 12.84 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.372 1.069 . . . . 74.13 109.411 -175.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -98.25 59.27 0.98 Allowed Glycine 0 C--N 1.346 1.131 0 C-N-CA 122.753 0.216 . . . . 71.03 113.069 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 33.1 p -106.31 143.98 33.65 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.282 0.633 . . . . 72.34 109.975 175.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.01 134.27 52.3 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.355 0.662 . . . . 74.44 111.051 -178.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.93 -11.66 14.64 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.3 1.04 . . . . 73.52 109.645 177.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -131.99 100.45 5.07 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.564 1.146 . . . . 74.44 108.132 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.25 82.96 3.72 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.413 0.625 . . . . 72.45 110.146 173.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.07 125.33 26.59 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.592 -0.731 . . . . 71.25 109.341 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.148 0 O-C-N 124.271 0.982 . . . . 73.41 111.325 -176.15 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' E' E ' 1' ' ' MET . . . . . 0.44 ' SD ' ' N ' ' E' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.019 -0.734 . . . . 74.45 109.019 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt 71.73 120.14 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 125.403 1.481 . . . . 73.33 110.833 -174.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . 0.532 ' HB3' HE22 ' C' ' 12' ' ' GLN . 5.3 tp60 -94.84 138.18 32.95 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.165 0.586 . . . . 74.33 110.099 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 35.7 p -67.11 103.64 1.24 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.883 0.873 . . . . 63.22 110.619 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 63.5 m -127.96 134.69 49.31 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.589 0.756 . . . . 72.14 110.153 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.449 HG23 ' H ' ' A' ' 40' ' ' VAL . 2.5 pp -57.93 143.79 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 124.295 1.038 . . . . 64.45 112.13 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -143.39 153.96 43.22 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.084 0.554 . . . . 64.2 110.776 -175.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . 0.484 HD11 HD22 ' A' ' 44' ' ' LEU . 4.0 tt -79.61 133.65 36.43 Favored 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 108.659 -0.867 . . . . 73.35 108.659 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.14 174.89 9.51 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.481 0.712 . . . . 73.4 111.807 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 tt -76.94 134.25 38.97 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 107.931 -1.137 . . . . 74.03 107.931 175.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.63 110.21 3.77 Favored Pre-proline 0 N--CA 1.484 1.226 0 C-N-CA 123.862 0.865 . . . . 72.5 111.159 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.43 99.56 1.3 Allowed 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.418 2.079 . . . . 63.33 110.536 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 tt 64.81 85.69 0.14 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.024 1.33 . . . . 70.42 107.972 -169.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.11 152.15 44.26 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.555 -0.748 . . . . 73.2 110.31 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -61.59 137.0 58.22 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.588 0.755 . . . . 75.54 109.893 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 50.6 p -131.13 79.34 71.09 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.351 0.66 . . . . 71.1 112.019 -171.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 17' ' ' PRO . . . . . 0.53 ' HD2' HD11 ' A' ' 98' ' ' LEU . 73.0 Cg_endo -76.1 179.75 6.03 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.189 1.926 . . . . 65.01 111.908 165.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 18' ' ' VAL . . . . . 0.434 HG13 ' SD ' ' A' ' 94' ' ' MET . 38.0 t 55.86 88.95 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 125.014 1.326 . . . . 74.11 111.982 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m 68.25 9.86 7.48 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 124.468 1.107 . . . . 75.52 112.199 172.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp 56.36 69.75 0.71 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.801 -0.814 . . . . 74.12 108.801 -166.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.95 -31.42 50.5 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.892 0.877 . . . . 54.52 112.914 -172.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -134.04 149.67 51.18 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.465 0.706 . . . . 74.12 109.992 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 12.5 p -140.92 153.86 67.87 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 124.496 1.118 . . . . 74.05 109.431 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -47.36 115.36 1.34 Allowed 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.74 2.96 . . . . 63.55 114.244 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 CA--C 1.553 1.062 0 C-N-CA 125.379 1.471 . . . . 72.15 109.742 -174.688 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 78.0 mtp . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.082 -0.71 . . . . 75.01 109.082 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' F' F ' 2' ' ' LYS . . . . . 0.449 ' HG2' ' HB2' ' B' ' 39' ' ' GLU . 0.5 OUTLIER -87.69 69.15 9.62 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.557 0.743 . . . . 75.45 109.652 -179.491 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -94.82 63.72 2.82 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.151 -0.931 . . . . 75.44 109.111 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 41.0 m -122.63 124.89 44.5 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.76 0.824 . . . . 74.32 109.013 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 15.2 p -68.24 137.14 54.54 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.299 0.64 . . . . 75.0 110.668 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . 0.603 HG12 ' HB ' ' B' ' 40' ' ' VAL . 4.2 mp -104.74 128.03 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.329 1.051 . . . . 72.12 108.995 -175.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 7' ' ' ALA . . . . . 0.418 ' HB2' ' HB ' ' B' ' 131' ' ' VAL . . . -101.36 -102.45 0.26 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.886 -1.153 . . . . 62.55 107.886 170.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . 0.543 ' HA ' HD21 ' B' ' 42' ' ' LEU . 4.5 tt -165.87 -85.02 0.02 OUTLIER 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.77 -1.196 . . . . 72.12 107.77 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . 167.7 170.17 0.03 OUTLIER 'General case' 0 C--O 1.243 0.748 0 C-N-CA 125.973 1.709 . . . . 73.22 108.311 -173.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.63 102.18 9.67 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.029 -1.471 . . . . 73.4 107.029 170.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 60.9 mt -61.92 137.19 95.34 Favored Pre-proline 0 CA--C 1.549 0.914 0 O-C-N 123.5 0.5 . . . . 73.51 110.508 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.3 -158.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.8 2.333 . . . . 54.55 111.522 175.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tt -80.8 84.57 6.29 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 107.251 -1.389 . . . . 75.12 107.251 173.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . 0.581 ' HG ' ' HD1' ' F' ' 15' ' ' PHE . 2.4 pt? -105.65 178.14 4.65 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.854 0.862 . . . . 74.04 109.48 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . 0.581 ' HD1' ' HG ' ' F' ' 14' ' ' LEU . 43.0 m-85 69.13 116.49 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.754 1.222 . . . . 74.23 110.134 -170.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 25.2 p -63.91 128.32 92.77 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 123.2 0.6 . . . . 73.21 111.156 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 17' ' ' PRO . . . . . 0.643 ' HB3' ' HE1' ' B' ' 94' ' ' MET . 46.6 Cg_exo -58.49 140.76 95.93 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.593 2.862 . . . . 74.13 113.786 -175.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . 0.642 HG22 HD12 ' B' ' 98' ' ' LEU . 17.1 t -73.39 127.47 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.198 0.599 . . . . 71.42 109.77 -178.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 19.0 m -70.87 -26.53 63.29 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.547 0.739 . . . . 73.32 111.486 -178.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -136.78 84.8 2.09 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.522 0.677 . . . . 74.0 109.702 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . 0.481 ' HB3' ' HB ' ' F' ' 18' ' ' VAL . . . -116.27 9.12 14.45 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 114.43 -1.259 . . . . 71.11 110.455 172.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -74.0 147.05 43.32 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.254 0.622 . . . . 73.42 109.817 173.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 23' ' ' THR . . . . . 0.615 ' HB ' ' HA2' ' B' ' 88' ' ' GLY . 5.9 t -63.85 136.77 96.87 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 122.757 0.423 . . . . 73.21 111.315 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.84 1.72 7.33 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.177 2.585 . . . . 72.55 113.347 176.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 . . . . . 0 CA--C 1.555 1.137 0 C-N-CA 124.418 1.087 . . . . 73.11 109.114 -179.219 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 83.0 mtp . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.546 0.212 . . . . 73.41 110.598 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -75.15 121.01 21.43 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.495 -1.298 . . . . 75.33 107.495 167.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -70.17 96.85 1.13 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 109.208 -0.664 . . . . 72.32 109.208 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 49.6 m -71.1 77.7 0.68 Allowed 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.266 1.026 . . . . 74.33 109.997 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 18.1 m -138.69 139.38 38.41 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.004 -0.998 . . . . 74.43 108.392 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . 0.462 HG21 ' O ' ' C' ' 40' ' ' VAL . 1.5 pp -84.84 167.22 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.753 0.821 . . . . 75.32 112.153 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -165.77 -175.74 3.58 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.932 -1.031 . . . . 74.21 109.797 -175.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 8' ' ' LEU . . . . . 0.497 HD12 HD23 ' C' ' 44' ' ' LEU . 97.0 mt -104.74 164.67 11.6 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.738 0.815 . . . . 73.33 110.277 174.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.03 -173.97 4.28 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.772 0.829 . . . . 63.32 111.038 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 10.6 mp -83.83 63.68 7.64 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.308 0.643 . . . . 70.41 110.209 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 11' ' ' LEU . . . . . 0.583 HD21 HD12 ' G' ' 14' ' ' LEU . 13.7 tp 38.71 78.09 0.38 Allowed Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 126.201 1.8 . . . . 73.44 113.185 -177.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.49 2.69 7.51 Favored 'Trans proline' 0 C--N 1.367 1.515 0 C-N-CA 122.323 2.016 . . . . 65.42 112.438 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -137.96 92.09 2.64 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 107.654 -1.239 . . . . 70.2 107.654 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . 0.583 HD12 HD21 ' G' ' 11' ' ' LEU . 3.7 mm? -72.12 -172.1 0.84 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.263 1.025 . . . . 74.35 110.313 176.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -154.19 -178.95 7.46 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 120.842 0.354 . . . . 71.54 111.479 174.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 12.4 m -60.01 142.3 89.24 Favored Pre-proline 0 CA--C 1.567 1.614 0 C-N-CA 125.832 1.653 . . . . 73.01 111.996 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 17' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.25 172.58 15.75 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.683 2.256 . . . . 55.01 113.11 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 18' ' ' VAL . . . . . 0.58 HG22 HD11 ' C' ' 98' ' ' LEU . 93.8 t -63.86 -67.01 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.824 0.85 . . . . 73.0 111.045 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 85.9 m -119.5 -45.63 2.51 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.056 -0.975 . . . . 72.14 108.851 177.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -165.69 141.06 4.97 Favored 'General case' 0 C--N 1.357 0.908 0 CA-C-N 116.345 -0.389 . . . . 73.4 111.542 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . -165.34 -162.25 0.58 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.401 1.08 . . . . 64.43 109.362 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -82.43 -25.62 33.48 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.384 0.674 . . . . 74.31 111.223 -175.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 23' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 150' ' ' GLU . 11.0 p -65.68 137.87 96.45 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 122.955 0.502 . . . . 74.12 109.894 173.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.36 143.95 60.06 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.409 2.073 . . . . 71.45 112.518 -174.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 . . . . . 0 CA--C 1.553 1.077 0 C-N-CA 124.349 1.06 . . . . 74.32 109.939 178.18 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' H' H ' 1' ' ' MET . . . . . 0.435 ' N ' ' SD ' ' H' ' 1' ' ' MET . 3.0 mpp? . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 109.526 -0.546 . . . . 74.03 109.526 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -94.08 106.12 18.1 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.838 0.828 . . . . 73.24 109.587 172.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -76.39 97.39 4.25 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.776 -0.824 . . . . 74.54 108.776 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 49.9 m -86.57 -165.51 1.29 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.608 0.763 . . . . 73.02 111.174 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 11.3 m -65.29 163.37 15.55 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 124.272 1.029 . . . . 72.42 111.116 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . 0.627 HG23 ' HB2' ' D' ' 42' ' ' LEU . 29.4 pt -59.23 134.24 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 C-N-CA 123.274 0.63 . . . . 74.02 111.405 175.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.49 -45.63 0.17 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.238 1.015 . . . . 74.25 109.501 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 77.54 91.23 0.07 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.671 1.589 . . . . 72.21 109.337 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.73 134.46 28.56 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.532 1.133 . . . . 75.23 109.245 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 47.4 mt 64.31 106.37 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.383 1.052 . . . . 75.24 111.559 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . 0.431 HD12 ' CD2' ' H' ' 15' ' ' PHE . 95.3 mt -79.21 151.83 75.83 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.097 0.559 . . . . 73.13 110.805 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 12' ' ' PRO . . . . . 0.459 ' HG3' ' HA ' ' D' ' 45' ' ' ASP . 33.5 Cg_endo -60.4 93.4 0.1 OUTLIER 'Trans proline' 0 C--N 1.386 2.544 0 C-N-CA 122.942 2.428 . . . . 75.45 112.287 -175.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 13' ' ' LEU . . . . . 0.646 ' HG ' ' HG ' ' H' ' 14' ' ' LEU . 44.2 tp 65.73 -84.0 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.802 1.641 . . . . 73.35 111.849 177.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . 0.646 ' HG ' ' HG ' ' H' ' 13' ' ' LEU . 97.5 mt -124.91 130.52 52.52 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.797 0.839 . . . . 74.14 110.766 -173.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . 0.431 ' CD2' HD12 ' H' ' 11' ' ' LEU . 6.4 t80 -125.81 79.67 1.84 Allowed 'General case' 0 C--O 1.24 0.591 0 N-CA-C 106.259 -1.756 . . . . 73.25 106.259 172.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 16' ' ' THR . . . . . 0.499 HG21 HD13 ' D' ' 98' ' ' LEU . 87.1 m -157.88 112.86 1.79 Allowed Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.332 0.653 . . . . 63.32 109.61 -170.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 17' ' ' PRO . . . . . 0.745 ' HD2' HD12 ' D' ' 98' ' ' LEU . 33.8 Cg_endo -96.09 -118.7 0.0 OUTLIER 'Trans proline' 0 CA--C 1.568 2.211 0 C-N-CA 123.29 2.66 . . . . 73.1 111.302 161.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . 0.561 HG23 HG21 ' D' ' 86' ' ' ILE . 47.1 t 72.33 -73.69 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.377 1.767 0 C-N-CA 125.782 1.633 . . . . 71.14 111.045 174.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 19' ' ' THR . . . . . 0.575 HG22 ' HG3' ' H' ' 20' ' ' LYS . 8.8 t -162.75 -41.36 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.559 0.577 . . . . 74.41 112.559 177.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 20' ' ' LYS . . . . . 0.609 ' HB2' ' HE3' ' D' ' 94' ' ' MET . 92.9 mttt -116.97 120.24 37.79 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.449 -0.574 . . . . 74.43 109.449 -174.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -173.7 -63.86 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.384 0.674 . . . . 75.21 110.231 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.56 130.68 42.58 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.987 0.915 . . . . 75.0 109.261 -176.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 35.5 p -62.66 121.62 68.91 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 124.561 1.144 . . . . 65.4 110.756 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.74 -67.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.989 2.459 . . . . 71.12 112.795 -177.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 C--O 1.247 0.926 0 C-N-CA 123.279 0.632 . . . . 72.03 109.521 -177.971 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.5 ttm . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.329 -0.619 . . . . 72.31 109.329 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.659 ' HB3' ' SD ' ' A' ' 138' ' ' MET . 25.6 t -166.08 25.01 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.582 1.153 . . . . 72.52 108.849 174.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -82.4 -175.29 5.63 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.493 1.117 . . . . 71.42 111.075 -177.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -87.68 41.64 1.0 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.964 0.906 . . . . 72.43 111.35 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 67.7 19.97 9.61 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.037 1.335 . . . . 71.43 112.082 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -141.0 156.07 46.1 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.995 -0.743 . . . . 75.35 108.995 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.7 p -88.05 94.36 9.77 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.714 0.406 . . . . 65.33 110.437 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.497 ' HB3' HD11 ' A' ' 89' ' ' ILE . 3.0 mp0 -76.85 168.14 20.61 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.697 0.799 . . . . 74.51 110.753 171.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.623 ' HE3' ' SG ' ' A' ' 97' ' ' CYS . 15.0 tpt 77.88 156.8 0.17 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.037 1.335 . . . . 70.33 112.854 169.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.0 m -138.94 101.97 4.43 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 106.727 -1.582 . . . . 73.41 106.727 173.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.543 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 41.2 t80 -132.87 139.63 47.52 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.907 0.883 . . . . 74.15 110.808 -166.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -158.43 116.39 2.96 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.697 0.623 . . . . 74.32 109.872 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.592 HG12 ' HD2' ' A' ' 84' ' ' PHE . 57.7 mt -72.6 114.71 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 109.416 -0.587 . . . . 73.34 109.416 177.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -82.76 -34.58 27.07 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.003 -0.998 . . . . 72.02 109.921 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -173.18 149.34 1.79 Allowed 'General case' 0 C--N 1.36 1.031 0 O-C-N 123.714 0.634 . . . . 75.31 110.679 -171.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.515 HD13 ' HG3' ' C' ' 130' ' ' PRO . 75.0 mt -141.52 134.6 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 124.23 1.012 . . . . 74.51 108.332 174.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -167.32 176.85 6.42 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.983 0.897 . . . . 74.52 110.97 -173.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.1 p -101.54 116.86 33.72 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.737 -1.209 . . . . 71.22 107.737 174.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 42.8 mtpt -75.78 -41.95 51.52 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.733 0.777 . . . . 74.15 109.002 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 15.9 t70 -135.73 143.35 45.29 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 113.731 -1.577 . . . . 64.24 109.72 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.474 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 92.6 mt -138.62 143.66 31.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 125.743 1.617 . . . . 73.34 106.962 176.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -153.46 138.57 17.36 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.477 -0.564 . . . . 71.13 109.477 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 93.9 t80 -143.29 120.57 11.56 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 106.852 -1.536 . . . . 74.44 106.852 176.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -120.53 148.78 43.39 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.241 -0.652 . . . . 74.11 109.241 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.87 80.27 14.02 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 106.359 -1.719 . . . . 72.41 106.359 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.3 -50.26 12.61 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 123.364 2.709 . . . . 72.34 112.841 -169.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.77 33.84 3.58 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 114.867 -1.06 . . . . 61.23 108.614 -176.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.43 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -47.65 -53.09 33.24 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 113.467 0.914 . . . . 73.42 113.467 -176.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.48 -15.41 45.15 Favored 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 121.536 1.491 . . . . 73.33 112.847 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -97.93 -31.14 12.34 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.259 1.023 . . . . 63.15 110.413 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.828 HG22 ' HA ' ' A' ' 73' ' ' ALA . 4.5 p -77.42 -16.78 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.351 0.66 . . . . 62.33 112.27 -164.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -77.76 1.1 21.17 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 122.901 0.48 . . . . 74.15 111.27 174.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -89.9 -24.66 21.29 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.665 1.186 . . . . 73.34 110.568 168.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 71' ' ' GLU . 30.8 mmmt -66.85 165.5 15.18 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.422 1.089 . . . . 74.4 112.513 -176.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -84.49 138.14 32.95 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 108.011 -1.107 . . . . 64.24 108.011 167.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 26.8 t-105 -72.62 89.37 1.31 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.902 -1.147 . . . . 74.51 107.902 173.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.409 ' H ' HD23 ' A' ' 68' ' ' LEU . 35.3 tt0 -131.1 65.35 76.46 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 125.539 1.536 . . . . 74.02 107.115 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.12 120.82 4.24 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.363 2.042 . . . . 71.55 111.996 -168.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -96.11 99.58 11.31 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.4 -1.333 . . . . 64.3 107.4 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.1 m -74.81 120.9 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-N 114.793 -1.094 . . . . 70.32 111.219 -172.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.534 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 39.7 ttmt -118.24 114.13 22.54 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.032 -1.099 . . . . 74.5 108.032 173.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.51 HD23 HG13 ' E' ' 6' ' ' ILE . 2.4 pt? -114.81 131.96 56.64 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.796 -0.816 . . . . 75.23 108.796 173.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -126.37 135.07 51.0 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.33 1.052 . . . . 74.33 108.418 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -113.38 122.75 48.31 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.284 -0.636 . . . . 75.1 109.284 -175.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.61 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 16.6 t70 -119.65 124.17 45.65 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.313 1.045 . . . . 61.01 108.221 177.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.1 p -106.74 125.96 51.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.254 0.621 . . . . 73.14 110.041 -174.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.46 152.42 50.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.03 0.932 . . . . 72.42 109.514 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.9 p -131.37 165.05 24.32 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.383 0.673 . . . . 75.33 110.359 -177.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.7 t -163.51 121.33 1.89 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.805 -0.634 . . . . 63.45 109.653 175.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -82.33 120.03 24.89 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.413 -1.328 . . . . 74.55 107.413 166.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.665 HD12 ' HB2' ' A' ' 57' ' ' GLU . 24.4 mt -93.13 -40.19 10.63 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.754 -0.832 . . . . 73.44 108.754 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.86 -175.66 4.52 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.813 1.245 . . . . 73.35 109.574 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.1 123.12 20.21 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.061 -0.718 . . . . 75.22 109.061 173.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 69.88 -4.71 1.4 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.943 1.297 . . . . 73.44 112.696 -176.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.4 t -109.68 108.93 26.6 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 N-CA-C 108.05 -1.092 . . . . 74.13 108.05 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -130.07 157.63 41.84 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.352 -0.61 . . . . 73.11 109.352 -173.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.665 ' HB2' HD12 ' A' ' 51' ' ' LEU . 38.9 tt0 -130.59 135.54 47.99 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.067 0.947 . . . . 74.24 108.898 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.6 m -121.85 136.16 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 108.041 -1.096 . . . . 71.21 108.041 165.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.4 t -122.71 127.54 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.05 0.94 . . . . 74.34 109.238 -174.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 tt -117.25 107.41 14.39 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.603 -0.888 . . . . 73.24 108.603 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.61 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 10.9 ttm180 -84.88 104.39 14.79 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.284 1.034 . . . . 73.41 109.715 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 37.3 t -96.01 103.28 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 108.598 -0.89 . . . . 75.54 108.598 174.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.9 m -97.04 108.47 21.21 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.62 0.768 . . . . 74.01 109.852 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.588 HG12 HD23 ' A' ' 126' ' ' LEU . 42.1 t -103.04 139.11 24.85 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 C-N-CA 123.974 0.909 . . . . 71.15 110.588 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 25.5 m -132.14 141.05 48.99 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.898 0.879 . . . . 74.52 108.693 175.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.04 109.66 14.37 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.861 -0.792 . . . . 75.43 108.861 174.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.9 m -108.87 127.37 53.98 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.407 0.683 . . . . 75.45 109.282 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.564 HD13 ' HB1' ' A' ' 73' ' ' ALA . 15.8 mt -99.7 78.37 2.14 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.874 -1.158 . . . . 74.13 107.874 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.69 -83.39 1.14 Allowed Glycine 0 C--N 1.349 1.264 0 N-CA-C 111.502 -0.639 . . . . 72.54 111.502 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -119.98 -28.96 5.05 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.737 0.815 . . . . 72.32 111.315 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.412 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 35.7 tt0 -99.95 128.79 46.0 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.633 -0.667 . . . . 73.33 110.589 -174.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.0 m -69.66 131.36 44.48 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.85 0.86 . . . . 72.44 110.902 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.828 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -74.22 -63.2 1.28 Allowed 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.514 -0.921 . . . . 73.33 108.514 168.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -155.47 163.14 40.43 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.402 -1.272 . . . . 74.23 111.322 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.2 tp -119.02 146.0 45.4 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 113.824 -1.534 . . . . 75.54 107.522 167.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.9 m -138.89 134.37 33.16 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.836 -1.172 . . . . 62.0 107.836 178.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -148.16 116.39 6.51 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.171 -0.678 . . . . 64.22 109.171 174.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.8 t -124.74 126.34 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 123.733 0.813 . . . . 74.41 109.051 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.407 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 64.0 mt-30 -101.48 89.05 3.6 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.227 -1.027 . . . . 73.24 108.227 172.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.41 ' HG3' HD21 ' A' ' 106' ' ' LEU . 9.3 tp-100 -76.81 98.25 4.77 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.615 -1.175 . . . . 72.03 108.48 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.51 142.95 16.36 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 111.338 -0.705 . . . . 75.52 111.338 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.42 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -140.85 126.21 3.05 Favored Glycine 0 CA--C 1.502 -0.733 0 N-CA-C 110.815 -0.914 . . . . 72.34 110.815 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.2 mt -82.47 119.01 31.18 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 108.321 -0.992 . . . . 65.23 108.321 173.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.592 ' HD2' HG12 ' A' ' 13' ' ' ILE . 24.2 m-85 -131.04 130.22 43.0 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.533 -0.914 . . . . 74.43 108.533 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 43.9 t -76.2 108.03 8.85 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.513 -0.921 . . . . 70.03 108.513 172.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.621 HG22 ' HE1' ' A' ' 9' ' ' MET . 71.7 mt -116.22 119.41 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.287 0.635 . . . . 73.23 110.332 -173.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.77 -172.12 1.54 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.935 0.894 . . . . 60.24 110.398 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.43 -49.96 0.86 Allowed Glycine 0 C--N 1.349 1.27 0 CA-C-N 116.497 -0.319 . . . . 61.2 113.121 172.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' A' ' 93' ' ' GLN . 10.1 pt -133.03 -179.79 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.827 0.851 . . . . 72.24 111.266 -170.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -143.89 -179.29 6.38 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.122 0.969 . . . . 72.11 109.77 -174.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.88 -142.2 44.78 Favored Glycine 0 C--N 1.347 1.141 0 C-N-CA 123.572 0.606 . . . . 75.12 113.389 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.525 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 19.4 p -74.28 -15.86 60.96 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.661 0.784 . . . . 74.25 112.008 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.53 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.5 mp0 -66.77 -48.84 67.82 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 109.488 -0.56 . . . . 75.22 109.488 176.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 42.6 ttp -77.83 -31.82 51.86 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 116.063 -0.517 . . . . 73.04 110.438 178.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.525 ' HB1' ' HA ' ' A' ' 92' ' ' THR . . . -65.23 -24.62 67.39 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.984 0.514 . . . . 62.35 111.246 176.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.422 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 22.3 t-80 -68.4 -35.15 77.25 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.573 0.749 . . . . 74.54 110.674 172.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.623 ' SG ' ' HE3' ' A' ' 9' ' ' MET . 49.3 t -74.96 -52.11 11.99 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.244 -0.285 . . . . 74.42 110.735 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.443 ' HG ' ' HA ' ' A' ' 95' ' ' ALA . 4.6 pp -76.34 -20.6 57.08 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.353 0.501 . . . . 73.3 112.353 -175.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.46 2.99 20.24 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 114.971 0.749 . . . . 75.22 114.971 -173.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.581 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -142.24 -52.96 0.41 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 118.031 0.915 . . . . 64.23 111.946 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.515 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 79.4 t80 -78.36 -68.18 0.67 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 122.895 0.478 . . . . 53.53 111.776 -172.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.454 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 76.8 m -63.94 -34.09 11.27 Favored Pre-proline 0 CA--C 1.567 1.632 0 N-CA-C 114.534 1.309 . . . . 75.42 114.534 -173.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.496 ' HB3' ' HE2' ' E' ' 15' ' ' PHE . 22.6 Cg_endo -62.25 -33.31 81.38 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 121.834 1.689 . . . . 73.51 112.902 167.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.479 ' ND2' ' HA ' ' A' ' 132' ' ' ASN . 15.7 t-20 -80.18 -17.59 52.0 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.635 0.374 . . . . 73.55 110.921 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.7 mm -65.82 -39.38 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 108.92 -0.77 . . . . 75.04 108.92 168.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.42 HD22 ' HA3' ' A' ' 82' ' ' GLY . 91.6 mt -77.15 -19.97 56.14 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.704 0.802 . . . . 63.43 112.205 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -61.24 -49.31 88.65 Favored Pre-proline 0 CA--C 1.571 1.781 0 N-CA-C 113.954 1.094 . . . . 75.11 113.954 -172.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -63.76 -38.42 39.87 Favored 'Trans proline' 0 C--N 1.391 2.81 0 C-N-CA 122.071 1.847 . . . . 74.43 112.654 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -68.48 -35.56 77.7 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.782 -0.645 . . . . 75.45 110.876 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.88 -42.98 76.25 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.238 0.615 . . . . 72.24 110.489 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.54 ' NH1' HD13 ' C' ' 105' ' ' ILE . 37.6 ttm180 -54.6 -53.82 49.59 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 124.164 0.915 . . . . 74.24 109.936 174.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -66.68 -39.38 88.1 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.366 1.042 . . . . 75.2 111.821 -171.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.79 -42.04 92.53 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.539 0.524 . . . . 72.24 110.287 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.09 -47.5 81.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 115.281 -0.872 . . . . 74.03 110.165 175.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.9 m -56.06 -41.74 75.55 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.742 0.817 . . . . 75.23 111.358 -177.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.2 t -69.6 -45.01 69.57 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.198 -0.91 . . . . 74.22 110.766 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.471 ' SD ' HG22 ' A' ' 21' ' ' ILE . 9.2 mtp -58.51 -44.62 89.53 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.636 0.774 . . . . 75.43 111.238 177.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -64.32 -42.89 96.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 114.774 -1.103 . . . . 74.34 110.766 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.3 t -72.22 -32.87 67.14 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.855 -0.612 . . . . 73.43 111.071 -176.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.444 HH12 ' HG3' ' B' ' 112' ' ' GLU . 81.4 mtt-85 -72.57 -29.42 63.52 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.534 0.734 . . . . 74.41 109.322 175.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.38 10.0 60.03 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-N 115.307 -0.861 . . . . 74.41 113.222 173.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.511 HG23 ' HE ' ' B' ' 15' ' ' ARG . 1.5 t 64.09 12.7 7.2 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 126.928 2.091 . . . . 72.41 113.628 173.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -84.72 150.98 57.51 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 109.119 -0.697 . . . . 74.3 109.119 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.53 141.58 41.89 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.211 2.607 . . . . 62.32 112.855 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -53.93 132.31 41.83 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 124.035 0.834 . . . . 74.5 112.162 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.588 HD23 HG12 ' A' ' 64' ' ' VAL . 60.2 tp -123.79 102.43 7.81 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.781 -1.1 . . . . 73.02 110.176 -171.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -111.01 126.35 54.7 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.111 0.965 . . . . 74.22 109.145 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.446 ' HA ' HG21 ' E' ' 6' ' ' ILE . 3.5 tt -67.55 143.52 56.08 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 108.155 -1.054 . . . . 75.01 108.155 172.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.43 ' HB3' ' HA ' ' E' ' 7' ' ' ALA . . . -56.81 140.42 76.04 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 123.678 0.791 . . . . 71.12 111.407 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.413 ' HA ' HH22 ' A' ' 111' ' ' ARG . 37.0 Cg_endo -65.12 95.35 0.25 Allowed 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.824 2.349 . . . . 73.22 113.015 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.31 112.49 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.156 -0.929 . . . . 74.21 109.318 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.479 ' HA ' ' ND2' ' A' ' 104' ' ' ASN . 27.5 t-20 -100.97 100.27 10.86 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.556 -1.276 . . . . 74.3 107.556 170.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.488 ' HE1' HD23 ' E' ' 8' ' ' LEU . 43.2 m-85 -55.79 -47.56 76.87 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.613 0.765 . . . . 64.23 110.917 -175.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.581 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 10.3 t70 -55.16 -37.61 67.23 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.972 -1.467 . . . . 75.44 112.748 -173.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.94 -46.29 89.97 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.862 0.726 . . . . 65.24 111.28 -177.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.97 -35.43 69.52 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.271 0.628 . . . . 72.13 111.034 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -67.6 -52.4 38.98 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 119.184 -0.436 . . . . 74.4 110.889 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.659 ' SD ' ' HB3' ' A' ' 2' ' ' SER . 0.2 OUTLIER -60.93 -36.52 79.54 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 122.925 0.49 . . . . 74.51 111.426 178.33 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -54.01 -54.8 34.17 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.659 1.224 . . . . 72.24 110.891 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -84.82 -29.68 25.16 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 116.368 -0.378 . . . . 64.33 111.611 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 64.2 tp -66.95 -49.56 65.07 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.562 0.745 . . . . 73.31 111.817 -175.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -147.91 -1.39 0.58 Allowed 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 119.524 -0.274 . . . . 73.15 111.693 -170.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 73.68 127.63 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.007 1.323 . . . . 71.14 111.201 -173.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.9 102.58 0.28 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.551 1.14 . . . . 74.34 109.772 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.55 84.49 2.44 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.64 0.776 . . . . 75.51 110.955 -176.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -104.18 146.59 16.31 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 111.246 -0.742 . . . . 72.12 111.246 174.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -135.12 162.88 31.24 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.302 0.641 . . . . 73.54 110.579 -176.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.02 165.69 53.85 Favored Glycine 0 C--N 1.356 1.678 0 O-C-N 123.4 0.438 . . . . 55.5 113.533 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.8 t -103.65 153.23 20.86 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.983 0.913 . . . . 72.34 110.717 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -170.98 -156.62 0.12 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.854 1.262 . . . . 53.12 109.066 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 82.35 -57.34 0.21 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.473 1.509 . . . . 73.12 111.809 177.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 18.3 t60 58.77 68.19 0.85 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.055 0.942 . . . . 70.31 110.219 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -73.66 92.66 1.98 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.012 -0.995 . . . . 71.2 109.716 176.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -148.63 145.04 27.59 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.356 -0.838 . . . . 73.45 109.123 -173.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.23 0 C-N-CA 124.11 0.964 . . . . 63.11 110.482 -177.3 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 55.7 ttp . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 109.377 -0.601 . . . . 73.44 109.377 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 45.4 t -87.05 141.86 28.35 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.931 -1.137 . . . . 63.34 107.931 169.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -80.36 68.64 6.6 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.996 0.903 . . . . 72.33 109.113 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -137.65 142.91 41.16 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.238 1.415 . . . . 73.43 108.953 -176.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -118.01 41.82 2.81 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.182 0.993 . . . . 73.41 109.16 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -61.97 102.96 0.32 Allowed 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.302 -0.863 . . . . 74.41 110.232 -176.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 70.4 p -67.7 -17.19 64.49 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.848 0.859 . . . . 74.42 111.539 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.73 -54.6 25.05 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 123.599 0.76 . . . . 72.03 109.813 170.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.472 ' HE2' ' SG ' ' B' ' 97' ' ' CYS . 1.6 tmt? 64.41 164.92 0.14 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 125.228 1.411 . . . . 72.15 111.644 -174.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 92.7 m -162.34 138.48 7.6 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.334 1.053 . . . . 72.43 108.895 172.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' B' ' 85' ' ' SER . 0.2 OUTLIER -136.35 154.67 50.77 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.45 0.643 . . . . 74.23 109.598 157.283 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -127.71 140.86 51.8 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 114.687 -1.142 . . . . 74.44 108.239 169.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.563 HD11 HD12 ' B' ' 105' ' ' ILE . 46.7 mt -72.13 119.76 19.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 O-C-N 124.143 0.902 . . . . 74.14 108.739 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -88.54 -49.87 6.64 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.637 0.775 . . . . 71.02 109.302 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.511 ' HE ' HG23 ' A' ' 122' ' ' THR . 48.2 ttt180 -163.38 132.8 4.1 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.952 -0.567 . . . . 75.12 110.488 -176.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 94.6 mt -114.23 136.04 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 107.595 -1.261 . . . . 64.24 107.595 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -164.62 146.21 8.21 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.553 0.692 . . . . 75.14 112.432 -175.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 35.3 m -73.45 121.4 20.48 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.16 -1.382 . . . . 73.14 109.27 171.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.425 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 41.2 mtpt -98.32 -27.73 13.99 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.953 0.901 . . . . 74.55 111.393 -176.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 34.9 t70 -158.39 138.03 11.95 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.458 0.473 . . . . 75.4 110.531 -168.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.496 HD13 ' SG ' ' B' ' 113' ' ' CYS . 45.3 mm -142.07 143.16 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.919 1.288 . . . . 74.04 108.976 -177.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 10.2 m -144.57 128.44 17.37 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.313 1.445 . . . . 73.53 107.665 170.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.2 t80 -133.9 109.56 9.13 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.373 -1.714 . . . . 73.13 106.373 166.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -122.39 110.66 15.91 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.807 -0.812 . . . . 71.15 108.807 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.484 ' HB1' ' HB3' ' B' ' 28' ' ' ALA . . . -107.55 87.28 3.32 Favored Pre-proline 0 C--O 1.241 0.624 0 N-CA-C 107.575 -1.268 . . . . 74.21 107.575 174.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -64.97 -34.67 46.86 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.719 2.279 . . . . 74.34 112.216 -170.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -102.25 6.04 40.37 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 117.645 -1.169 . . . . 71.13 112.06 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.484 ' HB3' ' HB1' ' B' ' 25' ' ' ALA . . . -28.66 -66.71 0.12 Allowed Pre-proline 0 N--CA 1.511 2.618 0 N-CA-C 114.785 1.402 . . . . 75.32 114.785 -168.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 28.2 Cg_endo -63.53 -29.77 70.86 Favored 'Trans proline' 0 C--N 1.398 3.134 0 C-N-CA 122.098 1.865 . . . . 73.24 112.879 -172.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.435 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 63.1 m80 -86.78 -36.31 18.65 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.464 -0.789 . . . . 72.1 112.02 -176.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.663 HG23 HD13 ' B' ' 68' ' ' LEU . 8.5 p -74.77 -16.59 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 C-N-CA 122.903 0.481 . . . . 74.34 111.883 -171.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -62.22 -21.2 64.95 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.422 0.689 . . . . 73.24 112.712 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.444 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.7 pt20 -56.53 -32.0 64.67 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.491 0.716 . . . . 73.21 110.919 174.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.444 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 99.2 mttt -91.28 69.44 6.04 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.476 1.11 . . . . 72.34 109.159 177.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -83.0 89.02 6.85 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.244 0.545 . . . . 72.15 110.95 -174.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 28.2 p90 -156.06 175.44 13.96 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.211 1.004 . . . . 74.4 108.406 169.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -71.87 109.05 4.85 Favored Pre-proline 0 CA--C 1.554 1.106 0 N-CA-C 109.601 -0.518 . . . . 62.25 109.601 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.62 149.12 79.23 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.6 2.2 . . . . 74.53 113.143 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.71 106.59 1.53 Allowed 'General case' 0 C--N 1.352 0.701 0 N-CA-C 108.367 -0.975 . . . . 74.43 108.367 174.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -96.52 137.71 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-O 121.742 0.782 . . . . 73.43 111.362 -175.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.472 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 79.0 tttt -109.03 145.81 34.96 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.015 1.326 . . . . 75.33 108.139 168.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.452 HD23 HD21 ' F' ' 8' ' ' LEU . 1.2 pp -127.83 163.14 25.05 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.844 0.458 . . . . 75.52 110.21 170.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.539 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 32.2 t70 -157.14 154.79 29.92 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.606 0.762 . . . . 72.12 109.247 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -130.94 129.28 41.97 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.251 0.62 . . . . 74.33 109.595 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -124.81 155.69 38.99 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.702 -0.851 . . . . 75.01 108.702 173.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 60.4 p -120.49 133.87 55.35 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.253 0.549 . . . . 72.21 111.497 -170.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.11 161.28 40.54 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.528 1.131 . . . . 72.35 108.764 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 54.5 m -143.13 -175.71 4.63 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.653 0.381 . . . . 74.32 111.048 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' F' ' 24' ' ' PRO . 78.3 p -164.87 137.84 4.68 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.954 0.902 . . . . 65.14 109.58 169.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.63 ' HB2' ' HA ' ' F' ' 22' ' ' ARG . 58.7 tt0 -89.03 133.25 34.41 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 120.732 0.301 . . . . 71.33 110.704 177.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 40.6 mt -102.03 -44.31 5.51 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.846 0.858 . . . . 64.42 110.457 174.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.34 -169.65 2.54 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.197 -0.91 . . . . 62.34 109.884 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.89 117.65 8.57 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.631 -1.168 . . . . 72.3 108.818 171.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 69.07 5.29 4.99 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.374 1.07 . . . . 65.44 112.486 173.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 56.0 t -112.48 106.44 20.76 Favored 'Isoleucine or valine' 0 C--O 1.246 0.887 0 N-CA-C 107.204 -1.406 . . . . 64.03 107.204 171.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -129.28 153.9 47.36 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.178 -0.675 . . . . 61.52 109.178 -176.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -116.01 122.47 45.31 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.623 -1.251 . . . . 74.33 107.623 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 43.1 t -112.39 123.63 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.667 0.787 . . . . 75.32 109.851 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 18.9 t -103.09 125.75 57.48 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 124.306 1.042 . . . . 74.54 109.978 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.603 HD22 HD13 ' B' ' 106' ' ' LEU . 3.3 mm? -107.4 110.95 23.05 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.996 -0.742 . . . . 72.24 108.996 167.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -85.39 114.25 22.3 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.699 0.8 . . . . 73.55 109.062 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.515 HG11 HD11 ' B' ' 114' ' ' ILE . 96.9 t -103.34 109.45 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.569 1.148 . . . . 74.42 108.547 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 87.2 m -94.45 142.19 27.72 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.392 1.077 . . . . 73.13 108.722 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 98.7 t -136.2 131.97 49.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 124.704 1.202 . . . . 73.41 108.197 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 54.3 m -126.01 148.06 49.39 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.736 -1.209 . . . . 73.44 107.736 172.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.92 143.51 27.41 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.532 -0.544 . . . . 72.34 109.532 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.472 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 23.1 p -148.82 130.2 14.73 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 123.768 0.667 . . . . 70.22 111.07 -175.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.663 HD13 HG23 ' B' ' 31' ' ' VAL . 48.3 mt -103.04 111.2 23.43 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.721 -1.215 . . . . 75.34 107.721 173.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.55 -110.75 3.11 Favored Glycine 0 C--N 1.345 1.054 0 O-C-N 123.39 0.431 . . . . 75.24 112.046 -176.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.24 5.34 9.15 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.096 0.558 . . . . 65.54 111.028 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.84 150.04 34.15 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.426 -0.583 . . . . 74.43 109.426 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 68.2 m -70.1 119.55 14.47 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 123.507 0.505 . . . . 74.41 110.348 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.563 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -70.77 -60.71 2.09 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.244 -1.021 . . . . 60.13 108.244 174.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -157.1 166.0 34.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.39 -1.277 . . . . 72.54 111.164 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 72.7 mt -125.78 137.34 53.79 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 105.791 -1.929 . . . . 74.11 105.791 170.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 44.9 t -138.71 150.64 46.38 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.245 -1.02 . . . . 73.11 108.245 173.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -160.15 131.4 5.84 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.12 -0.696 . . . . 73.45 109.12 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 85.4 t -124.22 149.49 28.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.007 -0.997 . . . . 75.45 108.859 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.425 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 16.7 mt-30 -120.56 97.64 5.66 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.903 -1.147 . . . . 74.42 107.903 167.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -88.54 100.61 13.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.34 -1.356 . . . . 73.53 107.34 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.425 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -97.67 147.26 18.56 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.612 -0.995 . . . . 72.21 110.612 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.44 130.15 4.14 Favored Glycine 0 CA--C 1.507 -0.417 0 N-CA-C 110.852 -0.899 . . . . 70.45 110.852 -177.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 57.4 mt -86.06 126.48 40.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.563 -0.903 . . . . 75.05 108.563 173.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -134.87 131.14 37.0 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 107.504 -1.295 . . . . 70.2 107.504 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 70.9 m -95.06 88.59 5.28 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.34 -0.615 . . . . 70.32 109.34 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 12.4 tt -107.86 129.81 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.922 0.889 . . . . 74.02 111.724 -170.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.43 163.61 33.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.78 0.832 . . . . 75.33 110.899 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.39 -70.19 0.29 Allowed Glycine 0 C--N 1.344 0.993 0 CA-C-N 115.681 -0.691 . . . . 72.32 113.336 172.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.513 HG23 ' HB3' ' B' ' 94' ' ' MET . 11.3 mt -89.65 158.23 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.046 0.938 . . . . 74.02 111.523 -175.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -154.02 158.69 40.95 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.838 1.255 . . . . 73.51 109.173 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.94 -134.79 12.34 Favored Glycine 0 C--N 1.347 1.188 0 C-N-CA 123.352 0.501 . . . . 74.01 113.733 173.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 59.4 m -70.16 -33.18 71.45 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.276 0.63 . . . . 70.4 111.423 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -66.82 -36.14 81.69 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.54 -0.755 . . . . 65.24 111.242 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.513 ' HB3' HG23 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -81.1 -22.36 39.2 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 116.307 -0.406 . . . . 64.45 110.686 176.447 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.54 -24.92 64.09 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.106 0.479 . . . . 72.44 111.168 173.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . 0.443 ' CD2' ' HB2' ' B' ' 134' ' ' ASP . 54.9 t-80 -77.78 -30.01 51.14 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.511 0.724 . . . . 74.5 110.661 171.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.472 ' SG ' ' HE2' ' B' ' 9' ' ' MET . 43.8 t -80.14 -68.39 0.68 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.748 0.819 . . . . 71.42 112.488 -175.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.587 ' H ' HD23 ' B' ' 98' ' ' LEU . 1.9 pt? -102.5 -7.28 22.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.853 -0.529 . . . . 74.12 111.759 -174.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.02 0.75 57.54 Favored Glycine 0 C--N 1.344 1.003 0 O-C-N 123.292 0.37 . . . . 74.4 112.452 173.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.19 -60.07 0.22 Allowed 'General case' 0 C--N 1.358 0.977 0 C-N-CA 122.77 0.428 . . . . 72.44 111.98 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -70.52 -36.82 73.95 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 112.233 0.457 . . . . 74.31 112.233 -175.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.525 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 70.9 m -68.76 -44.39 31.19 Favored Pre-proline 0 N--CA 1.482 1.145 0 CA-C-O 118.545 -0.74 . . . . 74.41 110.818 177.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -45.97 -40.07 20.14 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 122.536 2.157 . . . . 74.4 113.766 162.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -68.49 -33.47 74.21 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.143 0.577 . . . . 74.42 112.504 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.563 HD12 HD11 ' B' ' 13' ' ' ILE . 67.1 mt -69.26 -46.09 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.19 0.596 . . . . 75.5 109.9 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.603 HD13 HD22 ' B' ' 60' ' ' LEU . 60.1 mt -84.03 -11.44 56.75 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.677 -1.147 . . . . 74.24 110.763 -172.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.404 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 81.4 t80 -57.65 -54.47 54.87 Favored Pre-proline 0 CA--C 1.557 1.221 0 CA-C-O 117.971 -1.014 . . . . 73.2 112.993 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 36.5 Cg_exo -62.03 -35.85 74.15 Favored 'Trans proline' 0 C--N 1.39 2.745 0 C-N-CA 121.761 1.641 . . . . 74.32 113.029 -177.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -69.02 -44.69 72.23 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.854 0.462 . . . . 74.32 110.61 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.413 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -65.47 -43.66 89.59 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.903 0.481 . . . . 63.34 110.306 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -54.64 -53.13 58.76 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.523 1.129 . . . . 74.5 110.582 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.444 ' HG3' HH12 ' A' ' 120' ' ' ARG . 13.6 tp10 -62.35 -34.36 76.5 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.872 0.869 . . . . 74.33 111.05 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.51 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.9 t -71.23 -37.82 71.99 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.27 0.228 . . . . 71.22 110.862 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.515 HD11 HG11 ' B' ' 62' ' ' VAL . 84.5 mt -67.39 -56.95 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.445 0.698 . . . . 64.22 109.182 176.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 9.9 m -62.64 -24.01 67.38 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 124.288 0.992 . . . . 73.33 111.364 -173.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 39.7 t -67.19 -49.79 63.34 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 122.968 0.507 . . . . 75.54 109.913 170.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.51 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 33.9 mmt -62.02 -39.46 92.37 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 122.877 0.471 . . . . 75.23 110.644 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 114' ' ' ILE . 84.3 t -59.52 -49.5 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.585 1.154 . . . . 73.21 110.077 176.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.8 t -63.68 -37.34 86.97 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.585 -1.189 . . . . 74.43 111.156 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -69.47 -33.47 72.95 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.476 -0.784 . . . . 71.13 110.335 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.74 5.55 74.3 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.872 0.732 . . . . 73.15 112.835 173.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 74.6 p 54.9 55.82 7.34 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 126.012 1.725 . . . . 72.44 111.99 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -117.76 156.98 49.18 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 124.34 1.056 . . . . 73.52 110.509 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.83 161.86 2.91 Favored 'Trans proline' 0 C--N 1.392 2.829 0 C-N-CA 123.938 3.092 . . . . 71.32 116.139 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.517 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -65.13 121.85 15.7 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 113.911 -1.495 . . . . 75.4 111.6 -178.609 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -138.63 109.55 6.74 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 108.342 -0.984 . . . . 74.33 108.342 177.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -124.49 135.1 52.93 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.935 0.894 . . . . 74.42 109.32 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 5.9 mp -87.8 139.27 30.7 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.819 0.848 . . . . 73.3 110.102 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.48 164.72 56.41 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 124.222 1.009 . . . . 65.12 111.067 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -53.88 103.79 0.1 OUTLIER 'Trans proline' 0 C--N 1.39 2.735 0 C-N-CA 122.824 2.349 . . . . 71.14 112.892 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.491 HG22 ' H ' ' F' ' 8' ' ' LEU . 37.6 t -90.72 108.62 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.32 -0.993 . . . . 73.45 108.32 176.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.64 79.95 8.12 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.322 -0.621 . . . . 71.43 109.322 177.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -51.14 -45.36 61.62 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.516 0.726 . . . . 73.3 110.119 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.443 ' HB2' ' CD2' ' B' ' 96' ' ' HIS . 7.6 p-10 -67.19 -24.64 65.88 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 113.444 -1.707 . . . . 71.43 112.531 -176.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.26 -34.64 42.43 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 122.738 0.415 . . . . 54.41 110.642 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.443 ' HB2' HD23 ' F' ' 10' ' ' LEU . 8.8 mp -70.8 -38.63 73.36 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 109.752 -0.462 . . . . 74.11 109.752 172.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.484 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 20.6 m-85 -66.83 -32.52 73.86 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.02 -0.537 . . . . 74.3 110.835 173.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.52 -35.95 73.46 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.278 0.631 . . . . 71.44 109.688 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.82 -24.44 59.8 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.347 -0.842 . . . . 71.24 110.286 176.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -71.34 -30.22 65.93 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.945 -0.391 . . . . 74.12 109.945 171.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 47.9 mt -80.78 2.68 25.21 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.505 0.722 . . . . 73.02 110.756 174.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 83.85 -7.57 1.07 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 126.216 1.806 . . . . 72.41 112.662 169.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -101.99 -179.94 4.15 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.533 0.733 . . . . 73.23 110.475 175.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -132.26 -50.4 0.94 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.609 0.764 . . . . 73.35 109.293 169.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.2 153.01 31.04 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.029 0.531 . . . . 75.12 111.559 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.6 93.97 0.09 OUTLIER Glycine 0 C--N 1.346 1.119 0 N-CA-C 110.816 -0.913 . . . . 70.31 110.816 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -95.14 64.6 2.76 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.817 0.847 . . . . 71.43 111.051 -173.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -77.48 72.59 2.15 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.919 -0.582 . . . . 74.11 112.154 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 75.4 p -96.49 148.78 22.46 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.799 0.84 . . . . 74.54 110.05 -176.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -143.18 100.67 3.67 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.508 0.723 . . . . 75.12 109.634 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.22 105.0 17.08 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 107.379 -1.341 . . . . 74.21 107.379 175.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -111.32 121.66 45.83 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.215 1.006 . . . . 74.45 110.73 -173.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.26 99.75 2.96 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 107.007 -1.479 . . . . 74.14 107.007 164.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -81.23 119.83 24.13 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.747 0.308 . . . . 72.44 110.327 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 CA-C-N 115.407 -0.815 . . . . 72.31 110.54 179.075 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 109.63 -0.507 . . . . 71.33 109.63 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 49.5 m -76.25 125.0 28.37 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.414 0.686 . . . . 73.3 110.977 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -146.98 155.99 42.69 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 108.102 -1.073 . . . . 74.04 108.102 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -52.65 117.25 2.77 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.142 0.977 . . . . 71.23 110.043 -176.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -66.61 -41.71 87.98 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.086 0.554 . . . . 71.01 110.664 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -103.34 86.8 2.73 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.111 0.964 . . . . 75.04 108.679 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 27.9 p -90.15 106.95 18.83 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.109 0.563 . . . . 72.23 110.354 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -128.26 164.0 23.53 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.697 0.799 . . . . 65.53 109.663 174.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.404 ' HE2' ' HA ' ' C' ' 86' ' ' ILE . 3.7 tpt 64.05 111.52 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.218 1.407 . . . . 75.5 111.127 -174.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 25.0 m -114.06 79.18 1.22 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 106.709 -1.589 . . . . 71.24 106.709 171.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.584 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.8 t80 -96.13 130.89 43.05 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 115.055 -0.975 . . . . 73.42 110.565 -171.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -145.53 124.88 13.04 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.095 -1.076 . . . . 72.24 108.095 171.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 51.6 mt -73.95 102.08 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 107.774 -1.195 . . . . 74.55 107.774 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -75.59 -50.92 14.12 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.582 -0.735 . . . . 73.24 110.616 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -167.3 123.88 1.16 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 110.294 -0.261 . . . . 74.22 110.294 -176.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 63.0 mt -108.76 144.46 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 108.002 -1.11 . . . . 71.43 108.002 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.547 ' HB3' HG21 ' D' ' 122' ' ' THR . 21.8 p90 -176.36 172.38 2.27 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.383 0.673 . . . . 74.44 110.11 -174.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.9 p -98.02 122.42 41.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.742 -0.663 . . . . 70.33 109.363 175.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.416 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 18.3 mmtp -70.04 -46.77 64.34 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 107.765 -1.198 . . . . 72.44 107.765 168.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 17.5 t70 -134.51 141.18 46.64 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 113.438 -1.71 . . . . 60.32 109.743 -171.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 87.5 mt -135.81 146.13 30.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 106.082 -1.822 . . . . 71.22 106.082 169.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 22' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' C' ' 77' ' ' GLU . 35.8 t -160.79 151.18 18.01 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.535 0.683 . . . . 74.53 109.859 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 86.9 t80 -144.62 136.43 25.82 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.529 -1.656 . . . . 72.03 106.529 169.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -134.24 129.29 35.46 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.2 -0.667 . . . . 74.52 109.2 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.51 81.01 11.44 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 106.858 -1.534 . . . . 65.32 106.858 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -69.53 -21.54 34.41 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.955 2.437 . . . . 70.1 112.423 -174.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -118.51 25.91 9.95 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.479 1.111 . . . . 64.11 110.147 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.73 -52.9 22.36 Favored Pre-proline 0 CA--C 1.56 1.361 0 CA-C-O 117.818 -1.087 . . . . 71.31 113.683 -173.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.72 -43.76 47.11 Favored 'Trans proline' 0 C--N 1.399 3.212 0 C-N-CA 121.834 1.689 . . . . 75.22 112.434 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.444 ' O ' ' HG3' ' C' ' 33' ' ' GLN . 86.6 t60 -69.45 -43.68 72.78 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.275 -0.875 . . . . 75.23 112.441 -175.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.665 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.2 p -69.82 -18.45 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.324 0 N-CA-C 113.43 0.9 . . . . 75.13 113.43 -174.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -70.19 -20.71 63.1 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 113.099 0.777 . . . . 75.1 113.099 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' C' ' 30' ' ' HIS . 4.9 pp0? -92.67 8.91 37.13 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 111.992 0.367 . . . . 75.24 111.992 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.8 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -91.89 156.59 17.37 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.143 0.577 . . . . 73.44 110.685 179.204 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.35 125.14 22.89 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.171 0.988 . . . . 65.2 109.452 164.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -81.12 88.67 5.98 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.252 0.548 . . . . 74.42 110.49 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -140.28 77.91 23.84 Favored Pre-proline 0 C--O 1.243 0.738 0 N-CA-C 108.234 -1.025 . . . . 61.53 108.234 171.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -84.12 129.84 4.65 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.294 1.996 . . . . 74.11 111.551 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.75 96.49 8.19 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 104.689 -2.338 . . . . 73.32 104.689 166.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 20.8 m -88.8 121.31 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 114.643 -1.162 . . . . 72.54 111.595 -168.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.451 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 35.8 ttpt -97.26 106.48 18.82 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.832 -0.803 . . . . 74.22 108.832 174.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.662 HD23 HG13 ' G' ' 6' ' ' ILE . 2.5 mm? -87.42 121.68 30.17 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.536 -1.283 . . . . 70.52 107.536 175.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -118.5 140.07 50.45 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.086 1.354 . . . . 63.31 108.397 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.618 HD21 HD12 ' C' ' 60' ' ' LEU . 0.0 OUTLIER -137.49 132.53 33.42 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.562 0.345 . . . . 74.23 110.125 172.721 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 15.1 t70 -113.2 148.3 35.73 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.905 0.882 . . . . 74.33 108.906 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 77.0 p -112.76 112.46 23.98 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.449 0.7 . . . . 74.22 109.33 -174.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.2 139.01 48.18 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.568 0.747 . . . . 73.42 109.34 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 55.6 m -157.8 155.62 30.09 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.32 0.648 . . . . 64.41 110.846 -175.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 47.2 t -160.93 130.65 4.92 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.526 -0.761 . . . . 71.44 109.842 -174.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -76.54 122.02 24.0 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.811 -0.44 . . . . 75.32 109.811 174.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.539 HD13 HD13 ' C' ' 83' ' ' ILE . 66.7 mt -86.45 -52.66 5.45 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.539 -0.755 . . . . 74.14 110.119 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.51 -172.04 3.99 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.05 0.54 . . . . 55.44 111.723 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -56.93 103.46 0.11 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.075 1.35 . . . . 63.32 110.875 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 69.51 -1.96 2.07 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 125.907 1.683 . . . . 73.14 113.054 -177.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 75.7 t -93.35 113.7 28.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 108.33 -0.989 . . . . 74.21 108.33 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.557 ' HB3' HD12 ' C' ' 86' ' ' ILE . 50.6 t80 -131.28 126.1 34.52 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.44 -0.8 . . . . 74.13 109.199 -171.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -85.72 124.91 32.76 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.177 0.991 . . . . 63.5 110.223 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 62.9 t -111.94 115.87 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 107.958 -1.127 . . . . 74.3 107.958 171.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.9 t -113.63 129.55 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.493 0.717 . . . . 64.25 109.32 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.618 HD12 HD21 ' C' ' 44' ' ' LEU . 40.9 tp -116.42 113.34 22.73 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.804 -0.814 . . . . 72.43 108.804 173.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.558 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 22.4 ttt180 -81.49 105.74 12.89 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 108.381 -0.97 . . . . 74.31 108.381 176.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 37.3 t -99.0 119.28 46.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 107.7 -1.222 . . . . 70.4 107.7 176.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 60.5 m -130.67 119.74 22.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.757 -0.831 . . . . 73.03 108.757 -174.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.61 HG21 HD12 ' C' ' 114' ' ' ILE . 97.6 t -100.17 114.66 39.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.348 -0.982 . . . . 74.53 108.348 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.506 HG21 HD23 ' C' ' 75' ' ' LEU . 5.2 m -97.69 135.78 38.99 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.104 -1.443 . . . . 75.45 107.104 171.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.12 114.82 16.2 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.308 -1.368 . . . . 74.03 107.308 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 20.1 m -136.15 126.61 26.82 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.113 -0.699 . . . . 75.25 109.113 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.721 HD11 ' HG2' ' C' ' 34' ' ' LYS . 14.2 mt -85.59 13.97 6.28 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.694 1.198 . . . . 73.44 111.588 -176.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.0 -98.77 0.4 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 110.103 -1.199 . . . . 65.23 110.103 -175.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -90.81 -32.85 15.93 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.299 0.64 . . . . 72.25 109.365 171.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -71.8 120.21 17.06 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 114.641 -1.163 . . . . 73.11 109.666 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 62.8 m -76.18 126.13 30.43 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.562 -0.903 . . . . 74.13 108.562 167.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.665 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.87 -58.27 3.39 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.163 -1.051 . . . . 74.25 108.163 170.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -166.22 176.59 7.47 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.623 0.725 . . . . 74.43 111.941 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.506 HD23 HG21 ' C' ' 65' ' ' THR . 2.6 tm? -141.71 104.82 4.6 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 106.983 -1.488 . . . . 73.15 106.983 173.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.488 ' SG ' HG22 ' C' ' 114' ' ' ILE . 49.7 t -109.45 125.76 52.78 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.216 0.606 . . . . 75.04 109.378 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' C' ' 22' ' ' SER . 40.7 tt0 -124.48 139.73 53.62 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.494 0.718 . . . . 73.4 109.527 -177.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' C' ' 110' ' ' ALA . 27.4 t -144.08 114.08 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 108.147 -1.057 . . . . 65.21 108.147 174.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.501 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 77.9 mt-30 -90.69 97.5 11.22 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.545 -0.909 . . . . 72.14 108.545 171.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.544 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 9.0 tp-100 -82.03 105.23 12.96 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.616 -0.513 . . . . 73.52 109.616 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.49 144.73 21.61 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 111.386 -0.686 . . . . 71.42 111.386 175.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.29 116.46 0.84 Allowed Glycine 0 CA--C 1.503 -0.675 0 N-CA-C 110.376 -1.09 . . . . 74.24 110.376 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.539 HD13 HD13 ' C' ' 51' ' ' LEU . 14.6 mm -85.24 118.22 31.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 107.81 -1.182 . . . . 73.52 107.81 177.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.584 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 46.7 m-85 -132.2 142.88 49.59 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.637 0.775 . . . . 75.04 108.975 -174.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -84.54 116.74 23.29 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.671 0.388 . . . . 72.21 109.988 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.557 HD12 ' HB3' ' C' ' 56' ' ' TYR . 3.4 mp -115.09 109.07 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 108.406 -0.961 . . . . 72.31 108.406 172.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.499 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -147.01 161.99 39.69 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.66 1.184 . . . . 73.15 108.916 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.21 -51.14 3.96 Favored Glycine 0 N--CA 1.472 1.064 0 O-C-N 123.136 0.272 . . . . 63.42 112.796 175.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 30.6 pt -91.87 158.22 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.826 0.85 . . . . 73.22 111.48 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.662 ' HA ' ' HE1' ' C' ' 94' ' ' MET . 41.8 tt0 -152.12 162.01 41.75 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.112 0.965 . . . . 72.42 109.589 173.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.67 -117.55 5.8 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.024 -0.535 . . . . 75.21 112.814 172.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 57.3 p -65.1 -37.51 87.73 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.048 0.939 . . . . 74.52 111.497 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -71.8 -42.79 66.63 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.287 0.635 . . . . 64.22 111.6 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.662 ' HE1' ' HA ' ' C' ' 90' ' ' GLU . 9.1 ptp -73.09 -33.33 65.54 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 120.99 -0.284 . . . . 74.52 110.574 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.33 -28.64 69.45 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.004 0.522 . . . . 55.44 110.706 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -70.36 -44.74 67.48 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.449 -0.796 . . . . 74.14 110.206 172.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.582 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 42.3 t -65.54 -40.74 93.24 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 123.292 0.37 . . . . 63.23 110.512 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.447 ' HB3' ' HB2' ' G' ' 15' ' ' PHE . 86.9 mt -77.27 -49.9 14.03 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.22 0.608 . . . . 72.14 111.781 -175.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . 0.442 ' HA3' HD21 ' G' ' 14' ' ' LEU . . . -97.96 12.38 64.03 Favored Glycine 0 N--CA 1.474 1.228 0 N-CA-C 114.898 0.719 . . . . 71.11 114.898 -166.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.707 ' HB2' ' HB2' ' C' ' 134' ' ' ASP . . . -154.67 -62.54 0.13 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 117.624 0.712 . . . . 72.13 110.974 -172.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.582 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 73.9 t80 -76.14 -39.57 54.73 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.139 1.376 . . . . 74.3 113.105 -167.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 96.7 m -77.44 -39.84 2.09 Favored Pre-proline 0 N--CA 1.486 1.328 0 CA-C-O 118.687 -0.673 . . . . 71.02 111.716 176.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -48.5 -35.15 27.99 Favored 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 122.741 2.294 . . . . 75.52 113.683 164.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -38.51 91.2 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.762 0.425 . . . . 74.13 111.022 175.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.54 HD13 ' NH1' ' A' ' 111' ' ' ARG . 33.4 mm -66.99 -46.36 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 109.795 -0.446 . . . . 72.42 109.795 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.13 -20.97 29.48 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 113.547 0.943 . . . . 72.34 113.547 -168.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -58.7 -52.74 72.56 Favored Pre-proline 0 N--CA 1.488 1.449 0 CA-C-O 117.951 -1.023 . . . . 75.33 113.126 -175.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.14 -32.23 83.11 Favored 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 121.647 1.565 . . . . 74.14 113.0 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -64.91 -53.78 41.09 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.253 0.621 . . . . 64.21 110.377 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.544 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -65.96 -33.43 75.79 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.03 -0.986 . . . . 73.44 111.179 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -60.14 -53.85 52.82 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.394 1.078 . . . . 75.0 110.243 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.28 -35.85 78.48 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 110.016 -0.364 . . . . 73.13 110.016 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.413 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 10.2 t -67.06 -27.92 67.78 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.148 0.579 . . . . 73.34 111.323 -178.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.61 HD12 HG21 ' C' ' 64' ' ' VAL . 83.0 mt -76.58 -55.65 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 115.882 -0.599 . . . . 71.4 109.973 171.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 17.1 m -61.15 -27.81 68.66 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 123.389 0.676 . . . . 73.23 111.502 -173.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 41.4 t -62.42 -52.77 62.23 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 124.457 1.103 . . . . 65.44 109.093 170.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.668 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.15 -34.74 75.5 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.46 1.104 . . . . 71.34 112.381 178.352 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 88.8 t -63.38 -44.31 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 109.209 -0.663 . . . . 73.44 109.209 174.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 22.8 t -74.68 -24.04 58.73 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.988 -1.006 . . . . 74.33 111.71 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' C' ' 116' ' ' SER . 87.5 mtt-85 -74.02 -40.7 62.71 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.876 -0.787 . . . . 75.45 108.876 174.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.69 -4.35 70.42 Favored Glycine 0 C--N 1.357 1.719 0 O-C-N 123.951 0.782 . . . . 61.35 112.431 171.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 29.3 p 65.26 28.44 11.97 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.679 1.992 . . . . 73.35 112.934 170.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -83.33 145.96 49.73 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 123.364 0.666 . . . . 74.34 109.323 172.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.81 146.03 29.61 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.137 2.558 . . . . 75.42 113.139 176.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -52.62 111.1 0.59 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.396 1.078 . . . . 74.52 112.254 -172.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 47.3 tp -114.21 88.95 2.97 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.079 -1.452 . . . . 63.24 107.079 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -97.83 126.1 43.02 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.337 -0.847 . . . . 74.44 109.062 -171.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.05 126.48 31.12 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 122.888 0.475 . . . . 74.15 110.218 -172.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.11 152.81 95.66 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 124.29 1.036 . . . . 64.21 111.347 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.515 ' HG3' HD13 ' A' ' 16' ' ' ILE . 38.4 Cg_exo -57.65 117.61 4.34 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.773 2.315 . . . . 62.23 113.104 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -104.06 109.52 27.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 122.397 1.094 . . . . 75.13 108.534 169.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -101.32 76.46 1.71 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.933 -1.031 . . . . 72.45 108.566 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -51.11 -45.78 61.67 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.271 0.628 . . . . 65.34 112.311 -173.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.707 ' HB2' ' HB2' ' C' ' 100' ' ' ALA . 18.4 t0 -66.1 -46.37 77.85 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.01 0.818 . . . . 64.41 110.958 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.99 -30.7 71.12 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.172 -0.922 . . . . 73.02 111.197 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 97.1 mt -78.02 -29.36 49.45 Favored 'General case' 0 CA--C 1.55 0.963 0 O-C-N 124.43 1.081 . . . . 74.5 111.795 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -71.25 -38.6 71.92 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.014 0.435 . . . . 63.51 110.109 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 57.6 mtt -74.26 -30.8 62.29 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.448 -0.796 . . . . 74.31 110.602 175.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -65.19 -37.72 88.21 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.365 1.066 . . . . 73.53 110.33 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -51.34 -84.78 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.987 0 O-C-N 124.158 0.911 . . . . 74.24 111.075 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 64.5 tp 58.42 -81.85 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.794 0.838 . . . . 74.03 109.901 -171.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -174.53 -54.75 0.01 OUTLIER 'General case' 0 C--N 1.355 0.812 0 C-N-CA 124.688 1.195 . . . . 74.43 108.467 174.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -134.95 146.4 49.09 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.858 0.863 . . . . 73.33 109.979 -174.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -127.02 157.71 38.88 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.752 0.821 . . . . 74.45 110.822 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -163.56 99.64 0.91 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.633 1.173 . . . . 71.02 108.392 171.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -141.91 91.33 0.18 Allowed Glycine 0 C--N 1.352 1.439 0 CA-C-N 116.776 -0.193 . . . . 44.41 112.696 -174.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -148.01 147.96 30.19 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.379 1.072 . . . . 72.45 108.775 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 145.95 47.48 0.03 OUTLIER Glycine 0 C--N 1.342 0.871 0 N-CA-C 110.898 -0.881 . . . . 62.2 110.898 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 40.6 p -88.12 155.9 19.55 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.694 0.797 . . . . 74.3 110.824 -175.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -155.1 -170.24 3.42 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.014 0.926 . . . . 73.11 110.062 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' C' ' 152' ' ' HIS . 8.8 pt-20 -133.48 -57.73 0.89 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.604 0.762 . . . . 72.22 110.122 172.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . 0.401 ' N ' ' HG3' ' C' ' 151' ' ' GLU . 11.1 p-80 159.45 164.7 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 127.204 2.201 . . . . 74.11 109.222 -175.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 21.8 tm0? -141.87 118.98 11.33 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.6 -1.259 . . . . 74.42 107.6 170.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 178.47 161.54 0.65 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.185 1.394 . . . . 64.25 108.942 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.645 -0.693 . . . . 63.4 109.951 175.412 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 76.6 mtp . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 110.346 -0.242 . . . . 74.11 110.346 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 29.8 t -157.13 93.41 1.33 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.537 -1.282 . . . . 63.02 107.537 172.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -70.72 -68.24 0.45 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.503 0.721 . . . . 74.3 109.131 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -95.95 116.29 28.71 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.106 -1.442 . . . . 75.31 107.106 168.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -78.63 84.9 4.71 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.526 0.679 . . . . 73.52 110.989 -172.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -136.5 80.27 1.81 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 106.394 -1.706 . . . . 73.21 106.394 171.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 15.1 t -176.0 -30.18 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 114.501 -1.227 . . . . 73.33 109.025 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -65.4 -45.85 82.35 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.336 1.055 . . . . 74.05 110.71 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 26.9 ptm -32.66 143.35 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.393 1.477 . . . . 74.13 114.173 165.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 26.0 m -111.3 138.69 47.44 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.324 0.649 . . . . 75.11 109.41 173.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.439 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 55.1 t80 -158.09 100.82 1.73 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.791 -1.188 . . . . 75.32 107.791 -175.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -127.65 116.76 20.79 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.47 -0.937 . . . . 75.3 108.47 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 7.4 mt -81.8 124.03 38.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.693 -0.484 . . . . 74.52 109.693 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -90.8 -39.24 12.48 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.649 0.78 . . . . 73.22 111.478 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -174.97 123.9 0.25 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 117.805 0.275 . . . . 73.34 111.665 -166.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -103.97 137.1 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 107.986 -1.116 . . . . 73.42 107.986 167.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -160.8 148.57 15.85 Favored 'General case' 0 C--O 1.239 0.533 0 O-C-N 124.142 0.902 . . . . 70.4 109.883 177.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 77.8 p -79.61 114.05 18.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.136 -0.938 . . . . 75.32 108.979 174.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -82.4 -28.59 31.33 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.935 -0.575 . . . . 73.53 110.439 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 30.2 t70 -156.61 140.12 15.86 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.855 -1.066 . . . . 65.3 108.24 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.668 HG21 ' HE1' ' C' ' 117' ' ' MET . 84.6 mt -139.16 150.3 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.203 1.001 . . . . 75.33 108.374 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 22' ' ' SER . . . . . 0.445 ' HB2' ' HB3' ' D' ' 77' ' ' GLU . 71.7 m -147.62 140.57 24.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.689 1.196 . . . . 55.33 109.318 172.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 83.7 t80 -141.23 123.49 15.68 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 105.233 -2.136 . . . . 70.42 105.233 165.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.6 mt-10 -139.7 108.62 6.0 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.187 -0.672 . . . . 74.33 109.187 -170.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.36 94.17 9.35 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 108.422 -0.955 . . . . 65.02 108.422 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.86 -44.36 2.84 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.696 2.264 . . . . 74.23 112.607 -170.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.466 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 36.0 m-20 -96.5 11.75 33.94 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.849 0.86 . . . . 72.21 111.057 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -23.88 -68.38 0.05 OUTLIER Pre-proline 0 CA--C 1.56 1.346 0 N-CA-C 116.941 2.2 . . . . 74.11 116.941 -160.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.21 -27.23 11.82 Favored 'Trans proline' 0 C--N 1.382 2.307 0 CA-C-N 123.334 2.226 . . . . 75.22 113.509 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -66.35 -45.55 79.81 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.758 0.823 . . . . 73.23 110.376 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.642 HG21 ' HA ' ' D' ' 73' ' ' ALA . 11.7 p -76.41 -15.39 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 CA-C-N 115.355 -0.839 . . . . 65.42 112.125 -171.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -69.11 -17.99 63.91 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 112.544 0.572 . . . . 72.22 112.544 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -61.46 -20.95 63.71 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.128 0.571 . . . . 75.2 110.982 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.435 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 98.0 mttt -99.69 90.73 4.57 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.857 1.263 . . . . 74.5 109.477 178.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -96.93 93.08 6.42 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.874 -0.603 . . . . 71.15 109.485 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.442 ' O ' ' HG2' ' D' ' 124' ' ' PRO . 33.1 p90 -160.88 175.86 12.07 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.61 1.164 . . . . 75.15 107.866 167.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -69.62 112.0 10.73 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 122.938 0.495 . . . . 74.21 109.687 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.92 134.55 60.91 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.15 2.567 . . . . 73.24 111.541 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.11 114.27 10.03 Favored 'General case' 0 C--N 1.348 0.524 0 N-CA-C 108.235 -1.024 . . . . 71.04 108.235 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 16.1 m -103.65 108.56 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-O 122.119 0.961 . . . . 71.14 110.997 -166.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.494 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 73.7 mmtt -87.93 128.37 35.37 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.743 -1.117 . . . . 73.35 108.337 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.422 HD21 ' H ' ' D' ' 42' ' ' LEU . 1.0 OUTLIER -96.3 118.89 33.77 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.711 0.767 . . . . 75.43 110.03 -174.393 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.695 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.9 m-20 -110.33 125.69 53.44 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.539 -1.282 . . . . 73.53 107.539 174.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 93.3 mt -122.79 130.77 53.3 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.112 0.565 . . . . 74.25 109.692 -175.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 11.4 t70 -131.73 146.5 52.2 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.154 0.982 . . . . 74.12 108.368 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 42.8 p -119.67 143.73 47.57 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.507 0.723 . . . . 74.11 110.622 -171.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.75 155.68 33.52 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.331 0.653 . . . . 72.11 109.793 175.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 17.7 p -150.2 160.22 43.85 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.901 0.48 . . . . 52.34 110.576 -175.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 2.9 m -152.07 119.65 6.06 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.92 -0.77 . . . . 63.44 108.92 175.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -66.95 116.51 7.87 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.737 -1.209 . . . . 64.2 107.737 163.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.472 HD11 HG23 ' D' ' 83' ' ' ILE . 29.8 mt -95.04 -35.12 12.07 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.296 -0.631 . . . . 73.42 109.296 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.56 -173.12 4.24 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.217 -0.901 . . . . 70.5 110.208 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -68.33 123.57 21.12 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.875 -1.057 . . . . 73.53 110.225 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.512 ' HB3' ' HB3' ' D' ' 87' ' ' ALA . 65.1 m-20 62.25 17.75 9.57 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.699 1.2 . . . . 74.51 112.194 -175.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.6 t -119.44 119.67 61.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.813 -0.81 . . . . 74.24 108.813 174.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.541 ' HD2' ' HB ' ' D' ' 86' ' ' ILE . 78.3 m-85 -134.52 129.06 34.53 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.521 -0.918 . . . . 74.12 108.521 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -92.98 127.53 38.53 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.97 0.908 . . . . 74.44 109.335 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 73.8 t -103.54 112.44 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.856 -1.165 . . . . 71.12 107.856 173.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.411 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 47.5 t -103.68 132.2 50.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 108.094 -1.076 . . . . 74.13 108.094 174.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 53.6 tp -128.54 121.78 29.58 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.722 0.296 . . . . 75.11 110.208 175.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.575 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 20.6 ttm-85 -84.82 98.72 10.45 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.056 0.942 . . . . 74.44 109.404 173.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 93.6 t -90.79 114.49 28.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.31 -0.996 . . . . 54.14 108.31 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.695 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 28.6 m -122.65 133.33 54.52 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.45 0.643 . . . . 72.03 109.666 -174.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.456 HG22 HD12 ' D' ' 114' ' ' ILE . 21.7 t -119.63 101.87 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.863 1.665 . . . . 72.41 108.787 -178.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 59.1 m -92.4 99.79 12.48 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.271 -0.877 . . . . 71.33 108.801 175.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.31 142.21 36.36 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.135 -0.939 . . . . 71.33 109.7 -169.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 70.1 m -142.93 137.45 29.46 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.222 0.534 . . . . 63.43 111.673 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.572 HD11 HG23 ' D' ' 31' ' ' VAL . 55.8 mt -105.53 104.59 14.34 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.629 1.172 . . . . 72.25 108.536 172.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.22 -123.94 6.35 Favored Glycine 0 C--N 1.342 0.896 0 CA-C-N 115.797 -0.638 . . . . 74.52 112.514 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.61 5.87 34.06 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.168 0.587 . . . . 73.55 111.081 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.435 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 13.1 pt-20 -120.49 157.01 30.31 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.327 0.651 . . . . 74.45 109.81 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 63.7 m -71.34 136.45 47.84 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.628 0.58 . . . . 71.53 110.731 178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.642 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -84.45 -64.08 1.22 Allowed 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.329 -0.989 . . . . 71.43 108.329 174.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -157.09 167.5 30.24 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.685 -1.143 . . . . 72.41 110.162 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 83.3 mt -126.42 110.92 13.86 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 106.435 -1.691 . . . . 74.24 106.435 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.545 ' SG ' HG12 ' D' ' 114' ' ' ILE . 42.4 t -114.26 138.1 50.93 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.575 -1.269 . . . . 71.42 107.575 -178.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' D' ' 22' ' ' SER . 43.6 tt0 -155.36 122.58 5.51 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 110.033 -0.358 . . . . 74.22 110.033 -175.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 50.8 t -129.73 114.69 31.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 123.24 0.616 . . . . 75.31 109.368 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.432 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 5.0 mt-30 -86.51 83.65 7.59 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.096 -1.075 . . . . 73.13 108.096 168.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -79.88 98.21 7.02 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 113.346 -1.752 . . . . 74.33 108.145 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -93.71 144.12 16.91 Favored Glycine 0 C--N 1.341 0.85 0 N-CA-C 111.4 -0.68 . . . . 74.12 111.4 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.6 131.33 5.45 Favored Glycine 0 C--N 1.331 0.259 0 N-CA-C 111.162 -0.775 . . . . 75.52 111.162 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.472 HG23 HD11 ' D' ' 51' ' ' LEU . 61.3 mt -88.04 120.23 36.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 107.923 -1.14 . . . . 70.23 107.923 175.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -128.54 126.22 39.93 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.676 0.791 . . . . 75.24 108.97 -175.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.1 m -79.37 99.53 7.19 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.599 -0.889 . . . . 75.44 108.599 172.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.541 ' HB ' ' HD2' ' D' ' 56' ' ' TYR . 17.9 mm -108.98 111.58 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.705 0.802 . . . . 73.33 109.571 -174.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' D' ' 54' ' ' ASP . . . -138.04 147.72 44.39 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.955 0.502 . . . . 73.32 110.705 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.56 10.34 84.68 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 114.724 0.65 . . . . 71.11 114.724 171.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.542 ' HB ' HG23 ' H' ' 18' ' ' VAL . 8.9 mt -106.46 128.02 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 117.433 0.617 . . . . 64.53 109.744 -175.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -148.51 159.69 43.81 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.562 1.145 . . . . 72.53 109.957 -169.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . 0.461 ' O ' ' HG2' ' D' ' 94' ' ' MET . . . 68.1 -132.24 28.23 Favored Glycine 0 C--N 1.349 1.292 0 O-C-N 124.08 0.863 . . . . 52.54 113.428 173.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 18.7 m -61.75 -37.38 84.05 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.654 0.782 . . . . 71.31 111.098 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -65.77 -34.11 77.41 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.033 -0.985 . . . . 70.14 110.701 -174.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.504 ' HB2' HG21 ' H' ' 18' ' ' VAL . 10.6 ptm -75.21 -36.0 61.43 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.168 0.587 . . . . 74.42 111.424 -174.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.65 -31.37 63.46 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.484 -0.78 . . . . 70.32 110.362 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -80.0 -31.73 39.69 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.372 -0.831 . . . . 73.5 111.076 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.0 t -69.59 -53.16 20.19 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.664 0.386 . . . . 54.4 110.702 -175.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.498 ' HB3' ' CD1' ' H' ' 15' ' ' PHE . 10.3 mp -86.82 -22.61 25.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.414 0.286 . . . . 73.44 111.198 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.29 -24.82 56.29 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-O 119.729 -0.484 . . . . 74.43 113.904 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.17 -50.97 0.65 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.494 0.553 . . . . 70.2 112.494 -171.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -73.86 -43.73 57.69 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.834 0.679 . . . . 73.44 112.834 -169.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.439 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 69.0 m -72.76 -44.2 8.81 Favored Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 123.462 0.705 . . . . 73.41 111.822 -176.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.32 -25.14 64.34 Favored 'Trans proline' 0 C--N 1.395 3.017 0 C-N-CA 121.76 1.64 . . . . 71.42 112.681 170.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . 0.524 ' HA ' ' HD2' ' D' ' 107' ' ' PHE . 45.7 t-20 -62.43 -39.89 94.77 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.424 0.689 . . . . 71.23 110.094 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.85 -38.41 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.62 0.768 . . . . 65.32 110.564 174.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 86.4 mt -83.14 -19.73 36.11 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.114 -0.948 . . . . 72.11 112.442 -170.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . 0.524 ' HD2' ' HA ' ' D' ' 104' ' ' ASN . 27.5 m-85 -63.05 -43.79 82.82 Favored Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 114.086 1.143 . . . . 75.43 114.086 -177.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -52.18 -46.14 34.62 Favored 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 122.328 2.019 . . . . 74.55 113.393 172.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -72.86 -36.44 67.42 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.456 -0.793 . . . . 74.23 111.686 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.14 78.67 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.589 0.555 . . . . 71.12 109.639 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -55.58 -50.21 70.69 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 124.953 1.408 . . . . 74.31 110.634 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -65.01 -46.67 80.44 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.728 0.642 . . . . 73.5 111.608 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -57.7 -41.8 82.44 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.578 0.549 . . . . 74.24 110.53 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.545 HG12 ' SG ' ' D' ' 76' ' ' CYS . 81.5 mt -60.93 -56.78 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 115.046 -0.979 . . . . 64.13 110.478 172.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 47.6 m -54.4 -40.77 68.53 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.677 1.191 . . . . 74.23 111.753 -172.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.416 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 32.3 t -67.09 -45.32 77.6 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.034 -0.985 . . . . 70.25 110.567 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.5 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.8 mtm -67.31 -34.5 77.51 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.852 0.461 . . . . 74.44 111.734 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.441 HG23 ' O ' ' D' ' 114' ' ' ILE . 77.3 t -62.08 -45.01 99.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.586 0.754 . . . . 74.44 109.903 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.5 p -75.71 -26.58 57.66 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.901 -0.59 . . . . 73.54 111.401 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' D' ' 116' ' ' SER . 84.3 mtt-85 -72.46 -31.22 65.25 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.374 0.669 . . . . 74.44 110.132 175.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.49 10.75 68.25 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 123.739 0.65 . . . . 34.54 112.139 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.547 HG21 ' HB3' ' C' ' 17' ' ' TYR . 24.3 p 58.63 22.3 9.7 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 126.877 2.071 . . . . 74.11 114.09 174.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -83.96 157.22 63.48 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.846 0.858 . . . . 71.35 110.04 171.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.442 ' HG2' ' O ' ' D' ' 36' ' ' TRP . 77.9 Cg_exo -54.96 134.0 61.12 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.347 2.698 . . . . 73.12 113.835 176.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -55.95 132.1 48.93 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.801 1.241 . . . . 73.53 112.071 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 61.4 tp -110.27 101.88 10.59 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.571 0.748 . . . . 72.51 110.09 -177.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -103.89 104.02 13.96 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.582 -0.896 . . . . 72.41 108.582 175.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 tt -70.9 125.68 27.5 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 108.483 -0.932 . . . . 73.43 108.483 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.91 157.07 81.76 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.173 0.989 . . . . 63.23 112.09 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.51 ' HD3' HG13 ' B' ' 13' ' ' ILE . 54.3 Cg_exo -56.52 103.52 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.046 2.498 . . . . 73.15 112.785 174.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 13.6 m -112.24 133.11 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.052 0.941 . . . . 73.22 109.84 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -94.47 110.5 22.28 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.737 -0.838 . . . . 73.41 108.737 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.469 ' HZ ' ' HG ' ' H' ' 11' ' ' LEU . 1.9 t80 -82.8 -37.54 24.36 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.605 0.762 . . . . 70.54 109.938 -176.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -62.18 -54.0 47.24 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.516 -1.22 . . . . 74.35 111.699 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.73 -40.62 93.06 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.287 0.635 . . . . 73.33 111.059 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 55.7 tp -52.2 -43.88 64.44 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.479 1.112 . . . . 72.34 111.352 176.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -73.4 -48.22 35.67 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.658 -0.701 . . . . 72.4 111.364 175.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.406 ' O ' ' HG3' ' D' ' 142' ' ' GLN . 78.0 mtm -65.37 -23.99 67.12 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.308 0.643 . . . . 71.14 112.166 -171.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -56.81 -48.53 77.77 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.179 0.591 . . . . 64.54 110.238 173.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -65.61 -37.77 87.54 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.982 0.913 . . . . 72.21 111.421 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.8 mp -60.48 -30.08 69.47 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.243 0.617 . . . . 71.33 111.528 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' D' ' 138' ' ' MET . 42.8 mt-30 -90.07 9.29 28.71 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.77 0.828 . . . . 71.15 112.253 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -119.86 74.16 1.01 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.837 -0.801 . . . . 74.33 108.837 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -159.07 -24.03 0.07 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.161 -0.927 . . . . 74.35 111.324 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.71 169.56 10.4 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.21 0.604 . . . . 53.22 111.821 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.85 101.72 2.07 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.588 -0.733 . . . . 75.44 112.607 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.63 150.55 42.93 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.747 0.819 . . . . 74.21 110.125 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.96 -47.48 88.48 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.761 0.663 . . . . 73.21 113.457 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 61.4 p -75.17 175.0 8.69 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.198 0.599 . . . . 64.3 110.754 176.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -72.88 86.63 1.28 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.207 0.527 . . . . 71.52 109.828 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -61.6 96.84 0.06 Allowed 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.304 -0.862 . . . . 71.53 110.901 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -70.84 85.76 0.68 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.753 -0.832 . . . . 71.52 108.753 171.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -82.41 154.16 25.34 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.012 -0.995 . . . . 75.32 109.59 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.4 91.4 0.55 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.503 0.721 . . . . 64.51 110.647 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.152 0 C-N-CA 124.213 1.005 . . . . 64.15 108.972 -179.81 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 53.4 mtt . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 109.311 -0.626 . . . . 72.31 109.311 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -110.85 177.5 4.65 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.868 0.867 . . . . 75.44 110.704 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -157.63 154.57 28.63 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.341 0.657 . . . . 75.21 110.033 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 66.2 m -140.57 156.68 46.22 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.595 0.758 . . . . 73.55 110.724 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 19.3 m -141.44 178.27 7.55 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 124.768 1.227 . . . . 63.24 108.412 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.51 HG13 HD23 ' A' ' 42' ' ' LEU . 9.0 tt -55.46 89.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 124.07 0.948 . . . . 73.1 110.843 173.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 7' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' A' ' 129' ' ' ALA . . . -97.95 147.54 24.38 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.686 0.794 . . . . 74.31 111.293 -174.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . 0.488 HD23 ' HE1' ' A' ' 133' ' ' PHE . 2.5 tt -102.7 114.53 28.86 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 107.678 -1.23 . . . . 74.4 107.678 174.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.12 50.78 2.05 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.785 0.834 . . . . 71.35 111.293 -173.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 81.7 mt 64.6 169.6 0.18 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.636 1.175 . . . . 75.52 111.304 -173.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.525 ' HB2' HD21 ' E' ' 14' ' ' LEU . 89.2 mt -81.42 125.99 77.44 Favored Pre-proline 0 CA--C 1.551 1.002 0 CA-C-O 119.058 -0.496 . . . . 75.34 110.708 -175.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.93 -29.28 87.74 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 123.502 2.802 . . . . 72.12 112.535 176.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 60.1 tp -132.17 129.85 40.32 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.189 -1.411 . . . . 75.54 107.189 169.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . 0.525 HD21 ' HB2' ' E' ' 11' ' ' LEU . 73.1 mt -85.39 43.69 1.04 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.394 0.678 . . . . 75.12 110.407 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . 0.496 ' HE2' ' HB3' ' A' ' 103' ' ' PRO . 82.3 m-85 62.28 -174.11 0.14 Allowed 'General case' 0 C--N 1.362 1.116 0 C-N-CA 124.285 1.034 . . . . 73.11 111.389 -171.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 70.3 p -94.97 144.69 28.24 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.016 0.526 . . . . 74.21 109.799 176.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 17' ' ' PRO . . . . . 0.424 ' HB3' ' H ' ' E' ' 21' ' ' ALA . 57.7 Cg_exo -45.63 108.21 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 123.544 2.83 . . . . 73.53 112.979 166.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 18' ' ' VAL . . . . . 0.534 HG11 HG21 ' A' ' 86' ' ' ILE . 15.0 p -67.07 -39.81 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.58 0.752 . . . . 65.25 111.322 -176.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 11.8 m -105.36 -73.29 0.68 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.384 -0.969 . . . . 74.3 108.384 173.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -167.27 41.95 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 109.932 -0.396 . . . . 61.31 109.932 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . 0.424 ' H ' ' HB3' ' E' ' 17' ' ' PRO . . . -67.84 76.32 0.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.825 0.85 . . . . 74.21 111.984 -175.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -168.72 -2.23 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.893 1.277 . . . . 74.15 109.802 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 92.7 m -46.39 122.15 6.57 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 125.055 1.342 . . . . 72.13 112.019 174.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.12 106.33 0.25 Allowed 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 123.201 2.601 . . . . 72.23 112.377 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 C--O 1.253 1.26 0 C-N-CA 124.296 1.038 . . . . 75.1 109.433 -179.383 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' F' F ' 1' ' ' MET . . . . . 0.455 ' SD ' HG13 ' F' ' 6' ' ' ILE . 54.0 mtm . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.182 -0.673 . . . . 71.04 109.182 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -111.14 -76.97 0.59 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.745 0.418 . . . . 73.23 110.391 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -104.2 2.58 31.91 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.486 0.714 . . . . 74.41 111.09 -173.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 50.5 m -99.64 118.51 36.33 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.453 0.701 . . . . 72.52 110.116 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 74.5 m -69.11 141.44 54.68 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.09 -1.078 . . . . 75.21 108.09 167.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . 0.52 ' H ' HD12 ' F' ' 6' ' ' ILE . 3.0 mp -64.14 -64.35 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 109.238 -0.653 . . . . 63.34 109.238 -174.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . 65.74 139.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 125.292 1.437 . . . . 74.34 112.367 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . 0.491 ' H ' HG22 ' B' ' 131' ' ' VAL . 47.0 mt -58.4 133.22 55.56 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.774 0.321 . . . . 75.14 110.592 175.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.83 169.78 16.07 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.843 -0.617 . . . . 73.31 110.578 176.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 10' ' ' LEU . . . . . 0.443 HD23 ' HB2' ' B' ' 136' ' ' LEU . 89.1 mt -70.65 151.08 45.34 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.249 -0.649 . . . . 72.42 109.249 172.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 71.4 mt -57.95 107.3 0.89 Allowed Pre-proline 0 CA--C 1.557 1.237 0 O-C-N 124.24 0.963 . . . . 75.21 110.674 -177.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -64.77 -44.73 9.86 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 123.113 2.542 . . . . 75.43 110.604 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 mp -97.78 108.31 21.0 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 107.63 -1.248 . . . . 74.05 107.63 169.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.32 116.24 26.39 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 106.694 -1.595 . . . . 73.33 106.694 173.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -61.69 170.83 1.79 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.854 0.861 . . . . 74.3 112.816 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 9.4 p -65.89 148.3 98.36 Favored Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 124.069 0.948 . . . . 75.02 111.29 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -49.26 161.04 0.71 Allowed 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 123.857 3.038 . . . . 74.24 114.596 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 79.3 t -46.14 -45.09 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 C-N-CA 125.072 1.349 . . . . 75.12 113.284 -172.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 50.4 m -73.18 -36.69 66.62 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.676 0.79 . . . . 74.25 111.22 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -88.86 -4.82 58.37 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.007 0.923 . . . . 75.05 111.665 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.55 8.64 11.24 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.64 1.176 . . . . 74.42 110.664 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . 0.63 ' HA ' ' HB2' ' B' ' 50' ' ' GLN . 13.5 ptm180 -61.31 -14.64 28.33 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.848 1.259 . . . . 73.51 113.076 172.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 2.8 t -49.84 113.65 3.55 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 124.256 1.022 . . . . 74.21 111.048 173.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 24' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' B' ' 49' ' ' SER . 19.2 Cg_endo -92.37 -168.73 0.23 Allowed 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.221 2.614 . . . . 71.01 113.997 -173.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 C--O 1.256 1.431 0 C-N-CA 124.321 1.048 . . . . 74.41 109.137 174.599 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.842 -0.429 . . . . 74.22 109.842 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -159.38 -42.95 0.05 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.48 0.312 . . . . 75.2 110.894 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -143.08 114.09 7.71 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.966 0.507 . . . . 74.21 109.67 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 26.2 m -85.74 -9.47 57.08 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.545 0.738 . . . . 61.03 111.108 173.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 37.8 m 65.28 -79.94 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.668 1.587 . . . . 75.15 111.441 -178.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . 0.662 HG13 HD23 ' C' ' 42' ' ' LEU . 19.3 tt -158.0 131.63 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.388 0.675 . . . . 73.03 109.759 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.09 136.62 13.21 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.046 0.939 . . . . 71.43 108.942 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.55 140.75 31.2 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.772 -0.825 . . . . 73.22 108.772 177.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.61 126.84 29.29 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.875 0.87 . . . . 70.54 111.878 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 4.3 tt -65.28 132.53 49.29 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.235 1.014 . . . . 75.03 108.442 175.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 11' ' ' LEU . . . . . 0.433 HD23 ' O ' ' G' ' 13' ' ' LEU . 13.0 mt -60.39 111.3 3.81 Favored Pre-proline 0 N--CA 1.482 1.162 0 O-C-N 124.137 0.898 . . . . 74.32 112.285 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -88.09 -8.61 5.64 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.672 2.248 . . . . 75.5 111.692 172.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . 0.433 ' O ' HD23 ' G' ' 11' ' ' LEU . 1.7 tt -148.85 123.47 9.8 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 106.582 -1.636 . . . . 74.52 106.582 -178.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . 0.442 HD21 ' HA3' ' C' ' 99' ' ' GLY . 83.1 mt -75.17 -179.22 4.27 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.23 0.612 . . . . 74.32 111.639 -177.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . 0.447 ' HB2' ' HB3' ' C' ' 98' ' ' LEU . 7.6 m-85 -69.24 164.36 22.9 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.392 0.677 . . . . 62.23 110.818 174.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -66.85 136.26 94.45 Favored Pre-proline 0 CA--C 1.556 1.201 0 CA-C-N 115.479 -0.782 . . . . 75.43 109.959 173.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 17' ' ' PRO . . . . . 0.505 ' HB3' ' HB3' ' G' ' 21' ' ' ALA . 36.4 Cg_endo -62.34 166.33 13.27 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.552 2.835 . . . . 64.01 114.163 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 18' ' ' VAL . . . . . 0.411 HG21 HD11 ' C' ' 98' ' ' LEU . 39.9 t -90.15 -69.01 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.716 0.806 . . . . 75.33 109.042 176.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 66.8 p -96.55 -149.94 0.33 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.712 0.805 . . . . 74.21 108.941 176.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -80.81 68.21 6.98 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-O 121.436 0.636 . . . . 71.34 111.007 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' G' ' 17' ' ' PRO . . . -99.01 18.77 16.48 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.34 -0.615 . . . . 75.14 109.34 170.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 31.2 ptt85 -134.24 129.39 35.6 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 125.111 1.364 . . . . 74.32 108.887 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 28.7 m 61.45 84.31 0.2 Allowed Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 124.389 1.076 . . . . 74.13 111.588 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.1 -15.18 18.52 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.967 2.445 . . . . 74.23 113.08 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 . . . . . 0 C--O 1.256 1.396 0 C-N-CA 124.163 0.985 . . . . 64.2 108.983 -177.432 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 73.9 mtm . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 110.26 -0.274 . . . . 74.44 110.26 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 59.8 mttm 64.95 21.21 12.28 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.874 1.27 . . . . 72.52 112.218 173.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -83.99 95.07 8.43 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.326 1.051 . . . . 74.43 109.785 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 10.5 p -94.26 -59.36 1.97 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.913 0.885 . . . . 61.51 111.006 -175.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 3.6 p -115.22 -142.82 0.38 Allowed 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.868 0.867 . . . . 73.53 109.957 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . 0.51 ' H ' HD12 ' H' ' 6' ' ' ILE . 4.4 mp -55.37 108.21 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.411 0 C-N-CA 124.533 1.133 . . . . 72.11 111.039 -172.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.99 133.71 41.31 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.49 0.716 . . . . 72.32 109.27 175.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 97.5 mt -77.03 147.12 36.94 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.257 0.623 . . . . 72.13 110.904 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.99 160.88 14.09 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.365 0.666 . . . . 73.2 110.208 175.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 8.5 mp -68.62 120.12 14.13 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 109.093 -0.706 . . . . 75.32 109.093 173.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . 0.469 ' HG ' ' HZ ' ' D' ' 133' ' ' PHE . 96.0 mt -58.21 146.99 68.37 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 123.392 0.677 . . . . 71.22 110.962 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.19 118.8 5.7 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.799 2.333 . . . . 70.35 110.497 176.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 22.9 tp 60.8 18.8 9.0 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.242 1.017 . . . . 71.41 111.237 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 mp 60.52 -83.81 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.86 1.264 . . . . 71.52 110.517 -171.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . 0.498 ' CD1' ' HB3' ' D' ' 98' ' ' LEU . 18.4 t80 -167.14 164.73 15.72 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.431 -0.951 . . . . 74.12 108.431 -176.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 60.4 p -62.31 139.04 96.36 Favored Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 122.828 0.451 . . . . 73.33 110.219 174.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.59 163.74 33.83 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.483 2.122 . . . . 75.32 111.709 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . 0.542 HG23 ' HB ' ' D' ' 89' ' ' ILE . 96.4 t -51.66 -54.91 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 123.941 0.896 . . . . 74.42 110.959 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 89.2 m -56.62 107.0 0.34 Allowed 'General case' 0 CA--C 1.546 0.818 0 O-C-N 124.292 0.995 . . . . 70.24 110.84 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt 63.26 44.84 5.35 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.937 1.295 . . . . 73.44 111.329 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.88 82.5 0.07 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.047 0.539 . . . . 64.44 110.635 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? 52.29 86.13 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.48 1.512 . . . . 74.33 112.556 -174.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 58.8 p -56.31 145.82 55.62 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 123.962 0.905 . . . . 71.31 111.363 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -64.33 132.0 32.11 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.68 2.253 . . . . 75.11 111.876 -174.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 C--O 1.253 1.285 0 C-N-CA 123.923 0.889 . . . . 70.52 110.876 -176.853 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.8 mtt . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 108.287 -1.005 . . . . 73.21 108.287 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.2 m -73.9 100.81 3.6 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 123.777 0.831 . . . . 73.11 110.638 -174.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.22 174.73 13.89 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.872 0.869 . . . . 73.42 110.013 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 70.46 15.68 7.2 Favored 'General case' 0 C--N 1.362 1.152 0 C-N-CA 125.248 1.419 . . . . 72.05 112.191 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -83.93 117.98 23.7 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.19 -0.67 . . . . 74.33 109.19 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -57.41 97.24 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.258 1.423 . . . . 72.34 112.78 -172.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.1 m 54.57 35.23 23.03 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 125.03 1.332 . . . . 63.13 111.091 175.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -80.48 0.79 32.06 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.712 -0.676 . . . . 74.13 111.186 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.732 ' HB3' HG12 ' A' ' 89' ' ' ILE . 25.4 ptm -74.08 175.94 6.99 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.313 0.578 . . . . 74.14 110.002 169.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.5 p -136.58 143.34 43.55 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.879 -0.786 . . . . 74.51 108.879 -173.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.512 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 24.6 t80 -128.54 125.67 38.78 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.433 -0.951 . . . . 72.3 108.433 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -155.14 102.11 2.28 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.193 -0.669 . . . . 74.41 109.193 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.688 HG12 ' HD2' ' A' ' 84' ' ' PHE . 27.5 mt -72.52 120.39 20.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 109.134 -0.691 . . . . 63.13 109.134 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -85.58 -40.87 15.8 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 123.741 0.651 . . . . 72.35 110.001 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.432 ' HB3' HD13 ' A' ' 83' ' ' ILE . 19.9 ttt180 -173.44 120.89 0.34 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.387 -0.37 . . . . 65.05 110.402 -166.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.512 HD13 ' HG3' ' C' ' 130' ' ' PRO . 62.9 mt -114.0 134.47 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 108.78 -0.822 . . . . 74.22 108.78 173.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.431 ' HB3' HG21 ' B' ' 122' ' ' THR . 31.0 p90 -166.32 165.74 17.1 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 124.216 0.947 . . . . 74.32 110.848 -173.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.7 p -89.13 116.94 27.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.978 -1.01 . . . . 75.24 109.088 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -85.58 -32.56 22.04 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.939 0.4 . . . . 71.32 109.996 178.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.655 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 9.9 t70 -142.85 136.41 28.7 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.018 -0.992 . . . . 73.33 109.289 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.0 mt -137.3 146.54 27.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 107.393 -1.336 . . . . 74.13 107.393 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.9 t -155.44 131.7 10.24 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.235 0.614 . . . . 74.5 109.829 172.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.524 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.3 t80 -130.44 141.84 50.52 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.181 -1.414 . . . . 74.22 107.181 171.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -139.48 139.99 37.14 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.021 0.929 . . . . 75.31 108.506 175.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.09 82.81 56.28 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 106.256 -1.757 . . . . 75.14 106.256 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.54 -42.01 29.14 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 123.058 2.505 . . . . 74.45 112.706 -166.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -111.41 25.14 12.0 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 118.13 -0.938 . . . . 72.54 109.654 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.451 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -37.03 -62.8 0.52 Allowed Pre-proline 0 N--CA 1.497 1.924 0 C-N-CA 124.433 1.093 . . . . 75.24 113.915 -166.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.451 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 12.7 Cg_exo -67.87 -24.53 39.98 Favored 'Trans proline' 0 C--N 1.394 2.935 0 C-N-CA 122.175 1.917 . . . . 75.34 112.712 -173.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -78.03 -47.21 18.93 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.88 0.872 . . . . 74.21 109.784 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.607 HG23 ' HA ' ' A' ' 73' ' ' ALA . 4.2 p -79.8 -12.15 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-N 114.645 -1.162 . . . . 63.35 112.654 -163.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -66.81 -27.39 67.52 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.047 0.451 . . . . 71.22 110.623 171.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -78.33 -18.04 55.72 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.284 1.034 . . . . 74.45 111.276 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -80.06 151.08 30.1 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.642 0.777 . . . . 74.54 111.01 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.05 138.82 58.64 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.268 -0.878 . . . . 74.43 110.142 174.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -79.88 83.65 5.77 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.395 0.617 . . . . 74.12 109.837 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -131.62 73.74 78.9 Favored Pre-proline 0 C--O 1.244 0.801 0 N-CA-C 108.039 -1.097 . . . . 72.43 108.039 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -84.4 159.26 12.83 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.269 1.979 . . . . 63.04 111.87 -176.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -111.16 106.4 15.41 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.375 -1.713 . . . . 74.15 106.375 166.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.497 HG13 HD12 ' E' ' 6' ' ' ILE . 53.7 t -66.48 92.25 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 108.557 -0.905 . . . . 65.01 108.557 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -100.32 112.49 24.83 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.612 -1.625 . . . . 72.24 106.612 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.422 HD23 ' O ' ' E' ' 7' ' ' ALA . 0.7 OUTLIER -132.05 150.53 52.13 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.326 0.584 . . . . 71.02 112.318 -174.438 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -136.06 113.08 10.39 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.483 -1.235 . . . . 75.21 108.262 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 mp -98.08 124.18 42.48 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 108.697 -0.853 . . . . 72.42 108.697 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 11.3 t70 -121.76 149.47 43.24 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.778 1.231 . . . . 74.14 109.953 -171.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.4 m -110.54 132.83 53.85 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.926 0.89 . . . . 73.22 109.917 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.656 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -134.52 151.96 51.47 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.723 1.209 . . . . 71.02 108.46 174.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 p -135.55 173.29 11.88 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.911 0.708 . . . . 61.1 112.911 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.402 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 37.7 t -168.58 143.9 3.47 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.456 1.502 . . . . 74.22 108.218 174.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -113.23 109.15 18.29 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.176 -1.046 . . . . 74.41 108.176 170.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.512 HD12 HG22 ' A' ' 83' ' ' ILE . 53.5 mt -80.81 -39.1 27.24 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.069 -0.514 . . . . 74.1 110.735 -176.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.48 -175.92 5.68 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.431 0.693 . . . . 54.21 110.636 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.65 119.74 12.26 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.984 -0.747 . . . . 73.41 108.984 172.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 71.2 -1.68 2.64 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.723 1.209 . . . . 73.25 112.545 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.7 t -107.36 114.17 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.463 -0.94 . . . . 74.13 108.463 177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -122.3 159.61 27.04 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.58 0.752 . . . . 75.43 109.286 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 12.6 tt0 -130.29 124.84 33.31 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.384 -1.339 . . . . 75.31 107.384 170.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.6 m -119.91 138.22 51.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.486 -0.931 . . . . 70.33 108.486 174.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.656 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 59.5 t -118.83 136.97 54.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.488 1.115 . . . . 70.52 109.117 -175.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tt -114.59 106.81 14.69 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.623 -1.251 . . . . 75.25 107.623 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.718 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 36.9 ttp180 -87.22 102.07 14.12 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.563 -0.532 . . . . 75.25 109.563 176.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.71 107.24 19.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 107.864 -1.162 . . . . 70.2 107.864 172.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.4 m -94.62 143.22 26.61 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 107.789 -1.189 . . . . 73.01 107.789 173.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.9 t -141.07 138.97 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.138 1.375 . . . . 73.41 108.405 -173.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.2 m -138.65 138.92 38.27 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.859 -0.793 . . . . 75.31 108.859 175.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.01 104.5 14.19 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 107.143 -1.429 . . . . 64.23 107.143 169.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -108.91 127.8 54.37 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.762 -0.459 . . . . 75.51 109.762 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.448 HD13 ' HB1' ' A' ' 73' ' ' ALA . 6.3 mt -99.06 75.8 2.06 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 106.86 -1.533 . . . . 71.24 106.86 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.95 -83.43 1.17 Allowed Glycine 0 C--N 1.346 1.105 0 N-CA-C 111.942 -0.463 . . . . 72.31 111.942 -175.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -119.03 -29.97 5.13 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.019 0.528 . . . . 70.33 110.883 175.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -88.68 113.68 24.51 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.107 0.563 . . . . 74.43 109.83 -173.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.3 m -73.37 133.23 43.74 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-O 121.06 0.457 . . . . 74.12 110.884 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.607 ' HA ' HG23 ' A' ' 31' ' ' VAL . . . -77.27 -58.97 2.98 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.915 1.286 . . . . 72.43 109.479 176.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.43 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 35.3 p90 -148.24 164.52 33.73 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.959 -1.019 . . . . 73.51 111.185 174.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.9 tp -123.52 142.11 51.34 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.336 1.454 . . . . 74.22 108.186 173.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.3 m -138.07 138.28 38.6 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 124.42 1.088 . . . . 64.11 108.781 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -148.93 120.12 7.79 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.069 -0.715 . . . . 72.12 109.069 173.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 85.9 t -128.51 128.01 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 123.411 0.684 . . . . 64.31 109.611 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.718 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 47.0 mt-30 -95.56 95.01 8.09 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.695 -0.854 . . . . 72.43 108.695 165.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.432 ' HG3' HD23 ' A' ' 106' ' ' LEU . 9.3 tp-100 -78.51 99.74 6.61 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.927 -0.768 . . . . 74.54 108.927 176.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.62 154.25 29.46 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.764 -0.653 . . . . 71.34 111.557 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.89 124.98 1.44 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.232 -0.747 . . . . 55.3 111.232 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.512 HG22 HD12 ' A' ' 51' ' ' LEU . 48.8 mt -85.69 119.6 34.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.553 -0.906 . . . . 74.34 108.553 174.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.688 ' HD2' HG12 ' A' ' 13' ' ' ILE . 17.4 m-85 -129.9 120.26 24.61 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.386 -1.338 . . . . 75.01 107.386 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.7 t -75.44 96.37 3.43 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.848 -1.167 . . . . 71.23 107.848 174.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -127.94 130.85 69.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 123.95 0.9 . . . . 73.54 109.292 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 166.38 -177.78 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 126.581 1.952 . . . . 73.53 108.199 172.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 125.05 -52.24 0.81 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 110.873 -0.891 . . . . 74.34 110.873 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.732 HG12 ' HB3' ' A' ' 9' ' ' MET . 11.3 pt -131.27 168.67 23.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 C-N-CA 123.987 0.915 . . . . 75.13 109.064 174.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -125.15 -154.73 0.64 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.018 1.327 . . . . 74.11 109.607 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.61 -155.5 52.21 Favored Glycine 0 C--N 1.356 1.685 0 C-N-CA 122.841 0.258 . . . . 75.44 113.296 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.1 p -66.54 -25.9 66.88 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.095 0.958 . . . . 74.23 111.432 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -57.88 -58.65 7.45 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.785 1.234 . . . . 72.42 110.681 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 12.7 tmm? -70.14 -35.75 74.28 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.907 -1.042 . . . . 70.32 110.422 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.1 -36.82 75.8 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.325 0.65 . . . . 51.3 111.912 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -79.57 -36.03 38.84 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.519 0.327 . . . . 70.25 111.086 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 101' ' ' TYR . 44.7 t -69.14 -50.42 48.02 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.394 0.616 . . . . 63.34 111.069 -177.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -83.27 -39.31 21.03 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.089 0.955 . . . . 71.31 110.667 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.45 -14.17 57.44 Favored Glycine 0 N--CA 1.473 1.114 0 N-CA-C 114.73 0.652 . . . . 71.03 114.73 -171.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.432 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -123.56 -53.53 1.79 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 117.928 0.864 . . . . 54.4 111.207 -176.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.512 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 68.8 t80 -70.94 -50.55 33.39 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-N 115.231 -0.895 . . . . 74.34 111.98 -176.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.421 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 92.1 m -72.05 -32.57 2.08 Favored Pre-proline 0 CA--C 1.576 1.973 0 N-CA-C 115.69 1.737 . . . . 75.51 115.69 -174.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 29.9 Cg_endo -64.43 -32.55 60.06 Favored 'Trans proline' 0 C--N 1.392 2.818 0 CA-C-N 122.343 1.872 . . . . 74.03 112.039 169.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -65.95 -24.26 66.77 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.565 0.746 . . . . 61.41 110.763 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.4 mm -70.53 -50.79 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.479 0.712 . . . . 75.13 110.304 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.432 HD23 ' HG3' ' A' ' 80' ' ' GLN . 84.5 mt -74.1 -23.77 59.37 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.007 0.743 . . . . 74.14 113.007 -176.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -58.94 -49.91 90.8 Favored Pre-proline 0 CA--C 1.573 1.86 0 N-CA-C 113.883 1.068 . . . . 74.13 113.883 -173.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.86 -32.94 54.61 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 122.176 1.917 . . . . 75.24 113.202 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -67.06 -42.52 84.59 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.938 0.495 . . . . 63.05 110.816 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.43 -42.01 98.68 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.401 -0.818 . . . . 73.54 110.343 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.429 ' NH1' HG23 ' C' ' 105' ' ' ILE . 39.3 ttm180 -56.46 -52.09 65.99 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 124.267 0.98 . . . . 75.54 110.183 175.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -63.93 -44.93 91.37 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.766 0.826 . . . . 65.11 111.073 -174.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -59.51 -34.79 73.06 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.553 0.533 . . . . 64.04 111.182 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.4 ' O ' HG23 ' A' ' 118' ' ' VAL . 98.5 mt -72.74 -51.44 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 115.541 -0.754 . . . . 74.53 110.145 174.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 49.6 m -59.03 -34.48 71.94 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.218 1.007 . . . . 74.25 111.558 -174.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 34.6 t -68.45 -47.19 67.79 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.54 -0.754 . . . . 75.13 110.242 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.524 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 54.6 mtm -61.06 -40.69 94.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 123.676 0.61 . . . . 74.0 111.163 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 114' ' ' ILE . 79.1 t -62.13 -52.82 55.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 124.283 0.989 . . . . 74.5 110.753 178.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.9 t -67.72 -29.42 68.66 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.412 0.685 . . . . 52.24 111.007 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.472 ' HG2' ' HG1' ' B' ' 18' ' ' THR . 20.7 ttm-85 -76.79 -30.87 56.65 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.804 1.242 . . . . 72.11 108.632 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.411 ' O ' HG22 ' A' ' 122' ' ' THR . . . -86.37 13.6 57.28 Favored Glycine 0 C--N 1.355 1.634 0 CA-C-N 114.739 -1.119 . . . . 63.21 112.545 171.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.45 HG23 ' HE ' ' B' ' 15' ' ' ARG . 2.0 t 63.79 15.28 8.92 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 126.969 2.108 . . . . 53.42 114.267 171.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -81.99 149.86 63.92 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 109.478 -0.564 . . . . 74.53 109.478 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.64 165.91 4.19 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.413 2.742 . . . . 71.31 114.497 -176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.571 ' HG2' ' HG3' ' C' ' 15' ' ' ARG . 6.7 tp-100 -57.91 123.48 15.97 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.097 -0.956 . . . . 75.44 111.86 -175.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.43 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 60.5 tp -120.56 106.89 12.21 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.455 1.102 . . . . 74.04 108.817 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.407 HD22 ' HA ' ' C' ' 15' ' ' ARG . 18.3 m-80 -100.65 115.12 29.46 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.822 -0.807 . . . . 73.44 108.822 175.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.51 137.73 44.62 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 108.161 -1.052 . . . . 71.14 108.161 174.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.94 146.8 57.67 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 123.864 0.866 . . . . 72.41 112.791 -174.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.455 ' HG3' HG13 ' C' ' 13' ' ' ILE . 14.1 Cg_exo -71.45 127.66 13.55 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.649 2.233 . . . . 74.25 111.541 172.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.5 p -142.93 125.49 13.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-O 121.376 0.607 . . . . 74.24 109.734 170.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -103.4 101.31 11.21 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.083 -1.08 . . . . 71.13 108.083 174.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -64.6 -30.59 71.62 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 123.743 0.652 . . . . 73.14 110.258 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.432 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 8.1 p-10 -59.67 -45.02 93.31 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.63 0.772 . . . . 73.1 110.921 176.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.03 -41.17 36.49 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.507 0.723 . . . . 71.11 111.309 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.433 ' O ' ' HB3' ' A' ' 139' ' ' ASN . 1.5 tt -70.56 -39.39 73.96 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.751 0.82 . . . . 72.32 110.865 -172.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -77.68 -33.5 53.24 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.758 0.423 . . . . 74.11 110.394 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.487 ' HE1' ' HB2' ' A' ' 138' ' ' MET . 16.8 ptm -80.04 -19.66 47.13 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 120.78 0.324 . . . . 75.31 111.307 175.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 136' ' ' LEU . 21.3 t30 -60.83 -30.93 70.4 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.066 0.946 . . . . 74.42 110.612 168.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -79.82 -31.17 40.6 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 122.233 -0.292 . . . . 70.35 111.228 171.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.594 ' HG ' ' HG2' ' A' ' 142' ' ' GLN . 60.8 tp -61.97 -48.03 82.21 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.106 0.962 . . . . 73.44 111.818 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.594 ' HG2' ' HG ' ' A' ' 141' ' ' LEU . 83.4 mm-40 -143.29 19.21 1.9 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 112.248 0.462 . . . . 74.34 112.248 -170.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 60.54 96.2 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.601 1.161 . . . . 74.4 112.914 170.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 65.82 -80.74 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.327 1.451 . . . . 55.41 111.38 175.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.61 122.54 28.72 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.445 0.698 . . . . 62.55 110.507 -176.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.38 -75.93 1.25 Allowed Glycine 0 C--N 1.342 0.912 0 N-CA-C 110.244 -1.143 . . . . 62.32 110.244 170.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 64.5 153.8 0.06 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.139 1.376 . . . . 70.52 112.855 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -146.05 -119.54 1.22 Allowed Glycine 0 C--N 1.343 0.948 0 N-CA-C 110.626 -0.989 . . . . 64.31 110.626 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.3 t -162.08 110.63 1.44 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.793 0.837 . . . . 70.34 108.919 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -89.13 85.49 6.67 Favored 'General case' 0 C--N 1.348 0.509 0 N-CA-C 108.52 -0.919 . . . . 72.41 108.52 172.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -78.05 143.97 36.99 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.727 -1.124 . . . . 73.53 108.226 165.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.8 p-80 -119.56 158.51 26.19 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.579 0.351 . . . . 73.12 110.708 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -93.17 133.74 36.05 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.962 -1.125 . . . . 72.12 107.962 172.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -72.52 -66.25 0.68 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.738 0.415 . . . . 74.5 109.921 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.769 0 N-CA-C 107.89 -1.152 . . . . 74.42 107.89 176.419 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 59.2 mtt . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 108.861 -0.792 . . . . 64.45 108.861 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t -150.69 40.71 0.75 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.246 0.618 . . . . 73.41 109.627 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -77.71 82.64 4.11 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.051 -0.522 . . . . 74.44 110.39 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -139.15 101.78 4.35 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.27 -1.011 . . . . 74.24 108.27 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -90.28 74.96 6.97 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.863 0.84 . . . . 74.14 110.875 -176.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -165.31 153.96 11.92 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.184 -0.916 . . . . 73.54 109.458 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 41.6 p -75.3 94.42 3.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.933 0.493 . . . . 75.44 110.035 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -118.09 176.1 5.37 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.924 0.889 . . . . 62.51 111.081 177.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.616 ' HB3' HG12 ' B' ' 89' ' ' ILE . 18.0 ptm 59.81 170.4 0.08 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.198 2.199 . . . . 74.12 113.522 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 26.9 m -155.73 135.71 12.84 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.603 -0.726 . . . . 75.14 109.593 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -151.43 156.51 40.79 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.344 -0.613 . . . . 74.42 109.344 157.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.523 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -125.7 134.26 51.87 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 107.423 -1.325 . . . . 74.42 107.423 172.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.481 HD11 ' HG3' ' D' ' 130' ' ' PRO . 36.4 mt -70.59 116.91 12.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.553 0 N-CA-C 107.948 -1.13 . . . . 65.14 107.948 173.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -89.46 -44.63 10.02 Favored 'General case' 0 C--O 1.243 0.746 0 O-C-N 123.822 0.701 . . . . 73.54 109.49 -176.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.45 ' HE ' HG23 ' A' ' 122' ' ' THR . 40.5 ttt180 -165.4 131.05 2.59 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 116.117 -0.492 . . . . 72.41 110.981 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.4 mt -113.9 139.34 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 107.433 -1.321 . . . . 75.11 107.433 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.406 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 33.7 p90 -167.79 158.5 10.94 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.426 0.631 . . . . 74.23 111.788 -176.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.472 ' HG1' ' HG2' ' A' ' 120' ' ' ARG . 90.0 m -80.69 129.94 34.81 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.859 -1.064 . . . . 73.11 109.284 168.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.406 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 29.9 mtpt -97.47 -32.17 11.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.864 0.866 . . . . 73.23 110.084 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -152.82 138.52 17.87 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.642 -0.708 . . . . 75.13 111.037 -169.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.768 HD12 ' SG ' ' B' ' 113' ' ' CYS . 31.9 mm -134.01 146.57 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.253 1.421 . . . . 75.4 109.63 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 98.0 p -147.87 152.43 37.59 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.371 -1.286 . . . . 74.41 109.283 163.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 85.5 t80 -154.91 109.8 3.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.375 -1.343 . . . . 71.43 107.375 167.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.23 122.2 42.37 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.909 -0.775 . . . . 61.33 108.909 -175.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.454 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -118.32 82.98 19.51 Favored Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 108.807 -0.812 . . . . 74.33 108.807 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.88 -30.13 7.71 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.965 2.443 . . . . 73.4 113.008 -172.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -107.69 10.51 28.93 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 118.799 -0.619 . . . . 73.21 110.9 176.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.454 ' HB1' ' CB ' ' B' ' 25' ' ' ALA . . . -40.6 -61.31 1.25 Allowed Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 115.028 1.492 . . . . 52.52 115.028 -168.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -61.53 -30.05 85.64 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 122.392 2.061 . . . . 74.3 112.811 -169.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -97.74 -32.04 11.94 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.606 0.762 . . . . 74.1 112.394 -175.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.403 HG21 ' HA ' ' B' ' 73' ' ' ALA . 4.3 p -72.04 -20.73 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.22 0.608 . . . . 72.12 111.365 -169.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -60.07 -22.93 63.34 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.763 0.825 . . . . 74.1 113.202 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -67.17 -16.28 64.21 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.207 0.603 . . . . 75.54 111.441 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.434 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 92.6 mttt -87.89 102.26 14.53 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.296 1.038 . . . . 74.52 109.685 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -86.8 78.32 9.1 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.732 0.813 . . . . 64.42 111.358 -174.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.63 ' HA ' ' H2 ' ' F' ' 1' ' ' MET . 47.3 p90 -161.68 161.82 29.6 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.777 -0.823 . . . . 75.13 108.777 166.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -70.92 114.86 30.49 Favored Pre-proline 0 C--O 1.246 0.904 0 N-CA-C 107.445 -1.317 . . . . 75.3 107.445 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.523 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 10.3 Cg_endo -53.47 151.19 24.6 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 123.007 2.471 . . . . 73.3 112.712 -173.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.06 104.02 0.67 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.598 -1.26 . . . . 72.14 107.598 172.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.447 HG21 HD21 ' B' ' 126' ' ' LEU . 19.7 m -100.87 155.36 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.244 -0.889 . . . . 74.01 110.449 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -136.2 131.0 34.03 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.263 1.025 . . . . 73.12 108.616 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.558 ' HB2' ' HB ' ' F' ' 6' ' ' ILE . 0.2 OUTLIER -89.9 140.64 29.42 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 107.993 -1.114 . . . . 70.32 107.993 171.214 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -151.3 112.08 4.24 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.745 -1.206 . . . . 74.14 107.745 172.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.548 HD12 ' HG ' ' F' ' 11' ' ' LEU . 2.1 pt? -101.74 156.55 17.43 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 122.635 0.374 . . . . 75.44 110.076 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.4 t70 -139.02 151.92 47.2 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.261 0.624 . . . . 73.32 110.48 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 38.9 p -109.88 126.35 53.76 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.669 1.188 . . . . 72.03 110.108 -174.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.69 144.77 20.7 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.784 0.434 . . . . 74.54 110.141 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 47.5 p -145.43 174.09 11.44 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.78 0.432 . . . . 75.11 111.012 176.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 53.8 p -154.05 138.9 17.13 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.426 -0.806 . . . . 75.11 109.538 171.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -84.74 126.02 33.04 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.048 0.539 . . . . 73.43 110.956 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 62.2 mt -93.68 -40.92 9.98 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.759 0.823 . . . . 75.12 109.63 174.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.51 175.92 13.39 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.718 -1.128 . . . . 75.44 109.338 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.03 125.21 23.25 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.766 -0.828 . . . . 74.32 108.766 172.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 73.53 -5.48 1.98 Allowed 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 125.345 1.458 . . . . 74.35 112.831 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 72.8 t -108.05 111.97 38.21 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 N-CA-C 108.936 -0.765 . . . . 72.33 108.936 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -126.02 150.55 48.02 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.859 0.838 . . . . 73.04 110.206 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -108.12 103.94 13.25 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 113.811 -1.54 . . . . 74.54 106.915 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 74.1 t -88.53 117.28 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.885 1.274 . . . . 73.12 110.638 -173.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 18.5 t -107.31 113.64 44.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 108.507 -0.923 . . . . 74.41 108.507 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.775 HD23 ' HB3' ' B' ' 103' ' ' PRO . 43.1 tp -103.61 115.74 31.06 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.036 -1.098 . . . . 75.4 108.036 169.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.564 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 10.3 ttm180 -86.61 131.64 34.11 Favored 'General case' 0 CA--C 1.526 0.025 0 N-CA-C 108.956 -0.757 . . . . 75.11 108.956 174.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.66 103.34 14.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.781 -1.192 . . . . 73.21 107.781 171.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 9.3 m -99.69 133.58 43.83 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.816 -0.809 . . . . 72.32 108.816 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.553 HG23 HD12 ' B' ' 114' ' ' ILE . 86.8 t -123.25 127.65 74.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 124.075 0.95 . . . . 63.1 108.916 175.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 80.1 m -101.54 148.87 24.7 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.296 -1.001 . . . . 64.13 108.296 169.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.8 134.82 23.91 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.13 0.572 . . . . 74.22 109.819 177.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.552 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 33.7 p -142.1 127.93 19.36 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.748 -0.66 . . . . 73.25 110.707 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.523 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 22.1 mt -95.93 105.06 17.03 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.373 -0.973 . . . . 75.0 108.373 173.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.12 -118.05 8.42 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.804 -1.089 . . . . 44.24 112.913 -173.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -107.89 18.4 21.33 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.809 0.844 . . . . 73.44 110.696 -173.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.434 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 12.3 pt-20 -138.64 143.51 39.29 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.496 -0.753 . . . . 73.12 109.992 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.1 m -67.21 114.71 6.16 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.172 0.589 . . . . 62.01 110.555 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.552 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -69.85 -59.24 3.05 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.101 -1.074 . . . . 72.01 108.101 178.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -156.05 167.07 31.57 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.658 -1.156 . . . . 72.13 111.527 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 99.2 mt -128.83 146.99 50.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 113.622 -1.626 . . . . 73.51 106.635 172.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 44.9 t -150.66 135.22 17.23 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.994 -1.113 . . . . 65.23 107.994 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -143.27 124.87 14.87 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 107.959 -1.126 . . . . 64.2 107.959 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 96.9 t -122.91 146.74 27.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.914 -1.143 . . . . 72.35 107.914 178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.493 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 21.7 mt-30 -126.65 102.89 7.28 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.943 -1.132 . . . . 74.14 107.943 172.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -89.0 99.77 12.69 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.099 -1.074 . . . . 73.4 108.099 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.55 143.09 16.3 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 110.698 -0.961 . . . . 71.42 110.698 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.91 126.97 2.48 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 110.054 -1.218 . . . . 72.32 110.054 -173.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 59.2 mt -86.7 127.59 40.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 109.263 -0.643 . . . . 71.43 109.263 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -134.28 133.36 40.69 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.11 -1.07 . . . . 74.33 108.11 175.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.5 m -99.1 89.4 4.24 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.15 0.58 . . . . 75.14 109.499 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.493 HG23 HD12 ' B' ' 98' ' ' LEU . 7.1 tt -98.17 126.75 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.704 0.802 . . . . 74.25 111.92 -168.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.22 163.18 37.78 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.641 0.776 . . . . 74.11 111.061 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.12 -53.37 0.6 Allowed Glycine 0 C--N 1.35 1.321 0 CA-C-N 115.493 -0.776 . . . . 63.11 112.818 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.616 HG12 ' HB3' ' B' ' 9' ' ' MET . 9.7 mm -90.48 162.08 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 124.089 0.956 . . . . 73.12 112.607 -170.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.675 ' HB2' ' HD2' ' F' ' 22' ' ' ARG . 26.9 tt0 -150.3 162.92 39.58 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.654 0.782 . . . . 73.21 109.855 173.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.81 -135.13 12.83 Favored Glycine 0 C--N 1.348 1.247 0 C-N-CA 123.206 0.431 . . . . 65.43 113.32 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m -89.16 -17.11 29.82 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 117.073 0.436 . . . . 61.25 110.705 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -61.88 -33.6 74.49 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.315 0.646 . . . . 73.12 111.277 175.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.456 ' HB3' HG23 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -80.21 -25.85 39.44 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.462 0.305 . . . . 71.02 110.824 175.701 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.16 -31.06 71.69 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.113 0.565 . . . . 44.23 110.042 171.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -75.92 -39.61 55.9 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.03 0.932 . . . . 70.24 110.613 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 40.6 t -66.52 -52.56 44.52 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.947 0.403 . . . . 74.42 111.389 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.493 HD12 HG23 ' B' ' 86' ' ' ILE . 85.0 mt -89.06 -12.47 41.19 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.358 0.663 . . . . 72.41 111.861 -175.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.98 -6.27 34.59 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-O 119.729 -0.484 . . . . 73.41 113.978 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.36 -65.1 0.62 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 117.24 0.52 . . . . 62.23 110.462 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.473 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 55.2 t80 -59.36 -52.45 65.57 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.78 0.832 . . . . 72.54 112.954 -172.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.468 ' SG ' HD22 ' B' ' 98' ' ' LEU . 61.9 m -67.61 -45.27 46.05 Favored Pre-proline 0 CA--C 1.562 1.411 0 CA-C-N 115.624 -0.716 . . . . 75.4 111.565 -177.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.775 ' HB3' HD23 ' B' ' 60' ' ' LEU . 69.9 Cg_exo -51.88 -38.77 68.84 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.633 2.222 . . . . 64.24 115.161 167.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -60.64 -30.94 70.18 Favored 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 123.123 0.569 . . . . 74.11 111.94 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.433 HD12 HD11 ' B' ' 13' ' ' ILE . 75.2 mt -69.12 -40.19 80.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.909 0.884 . . . . 73.53 110.297 177.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.7 mt -87.34 -21.33 25.76 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.187 -0.915 . . . . 75.33 111.717 -170.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -53.87 -51.09 79.91 Favored Pre-proline 0 CA--C 1.562 1.435 0 C-N-CA 124.141 0.976 . . . . 75.1 113.182 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -54.25 -40.73 81.12 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 122.339 2.026 . . . . 74.31 114.208 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -70.21 -44.99 67.5 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.293 0.637 . . . . 74.12 110.82 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.57 -39.65 91.91 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.483 0.713 . . . . 75.11 111.032 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttt-85 -60.07 -56.22 24.32 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.374 1.07 . . . . 75.45 110.445 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -57.57 -34.69 69.48 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.074 0.95 . . . . 73.35 110.883 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.768 ' SG ' HD12 ' B' ' 21' ' ' ILE . 8.5 t -67.89 -45.85 73.28 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 122.674 0.39 . . . . 73.11 111.187 -178.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.553 HD12 HG23 ' B' ' 64' ' ' VAL . 84.4 mt -63.4 -53.65 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.526 0.73 . . . . 73.54 109.888 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 34.2 m -57.7 -33.32 68.27 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.024 0.929 . . . . 72.34 111.817 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 41.1 t -61.83 -51.1 69.61 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 123.233 0.613 . . . . 75.22 109.795 174.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.483 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -67.16 -37.15 83.25 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.059 0.543 . . . . 74.33 111.407 -175.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.443 HG23 ' O ' ' B' ' 114' ' ' ILE . 95.0 t -59.48 -45.37 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.569 0.748 . . . . 75.52 110.116 174.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.6 t -67.42 -33.66 75.62 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.363 -1.29 . . . . 72.35 111.135 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' B' ' 116' ' ' SER . 93.2 mtt-85 -66.83 -31.61 72.34 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.449 -0.796 . . . . 74.3 110.495 177.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.21 9.36 73.12 Favored Glycine 0 C--N 1.353 1.475 0 CA-C-O 119.036 -0.869 . . . . 63.25 113.343 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.431 HG21 ' HB3' ' A' ' 17' ' ' TYR . 81.6 p 55.73 26.13 9.07 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.624 1.57 . . . . 72.53 113.274 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.428 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 56.3 m-85 -84.76 157.32 60.82 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 123.608 0.763 . . . . 74.35 110.171 176.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -54.74 158.76 10.12 Favored 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 123.274 2.649 . . . . 74.04 113.28 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.427 HE21 ' ND2' ' B' ' 127' ' ' ASN . 66.7 tp60 -64.73 134.17 53.62 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.102 0.961 . . . . 72.14 111.36 -171.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.447 HD21 HG21 ' B' ' 40' ' ' VAL . 2.3 tm? -136.65 120.74 17.75 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.415 -0.957 . . . . 75.2 108.415 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . 0.427 ' ND2' HE21 ' B' ' 125' ' ' GLN . 45.3 m-80 -122.29 136.26 54.87 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.033 0.933 . . . . 65.34 109.292 173.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 5.9 mp -78.92 137.77 37.79 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.785 0.834 . . . . 74.01 109.219 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.613 ' HB3' ' HB1' ' F' ' 7' ' ' ALA . . . -76.64 147.6 78.52 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.517 0.727 . . . . 61.34 110.794 -177.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.529 ' HG3' HD11 ' D' ' 16' ' ' ILE . 89.8 Cg_endo -77.12 114.66 3.83 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.887 2.392 . . . . 75.04 112.389 -175.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 m -121.86 111.36 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.341 0.656 . . . . 73.4 109.956 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -86.41 103.54 15.07 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 108.163 -1.051 . . . . 75.01 108.163 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -60.51 -38.01 82.99 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 124.12 0.888 . . . . 73.31 111.267 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -64.74 -46.29 82.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.831 0.852 . . . . 74.34 111.298 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.64 -40.0 92.06 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 123.812 0.695 . . . . 74.3 111.005 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.543 HD11 HD12 ' F' ' 10' ' ' LEU . 0.7 OUTLIER -65.89 -49.57 67.59 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.008 -0.738 . . . . 74.12 109.008 179.038 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.03 -26.26 66.68 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.636 0.774 . . . . 73.12 111.327 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 14.0 tpt -63.33 -37.57 87.77 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.576 0.75 . . . . 75.45 110.506 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -74.56 -15.95 60.83 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.69 -0.686 . . . . 74.55 111.277 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -85.95 -46.71 10.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 110.118 -0.326 . . . . 73.53 110.118 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 88.9 mt -79.38 -7.14 58.15 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.317 0.647 . . . . 70.34 112.475 -170.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -173.54 152.93 2.2 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.454 0.702 . . . . 74.44 109.238 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -79.71 -60.98 2.14 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.794 -0.817 . . . . 75.54 108.794 172.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 51.91 79.93 0.1 Allowed 'General case' 0 C--N 1.359 0.979 0 O-C-N 124.958 1.411 . . . . 73.42 110.905 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -142.51 126.64 17.45 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.98 -0.554 . . . . 75.25 111.102 -173.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -122.38 158.7 17.06 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.006 -0.838 . . . . 53.52 111.006 174.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -163.94 152.93 13.82 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.422 0.689 . . . . 74.42 109.688 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 107.6 55.65 0.62 Allowed Glycine 0 C--N 1.343 0.931 0 O-C-N 123.425 0.453 . . . . 70.31 113.122 173.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 149' ' ' THR . . . . . 0.549 ' HA ' ' NE2' ' D' ' 153' ' ' GLN . 57.7 p -91.61 123.59 35.13 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.977 0.511 . . . . 63.51 109.764 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -152.8 146.04 24.74 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.158 0.583 . . . . 72.0 111.086 -172.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -168.76 -161.18 0.32 Allowed 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 125.312 1.445 . . . . 65.51 108.697 170.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -87.6 17.03 4.91 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.538 0.94 . . . . 75.45 113.538 -171.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.3 59.87 4.11 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.406 1.483 . . . . 73.21 110.122 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -176.85 100.1 0.05 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.081 -1.418 . . . . 71.43 107.503 -176.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.216 -0.897 . . . . 75.33 109.658 -176.718 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 87.5 mtp . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 119.202 -0.428 . . . . 74.31 111.3 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 71.0 m 65.07 109.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.842 1.257 . . . . 63.3 111.791 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -136.07 96.98 3.5 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 123.39 0.676 . . . . 72.3 109.188 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -150.1 177.09 10.22 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.767 1.227 . . . . 72.3 109.441 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 70.98 -4.72 1.68 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.877 1.271 . . . . 73.24 113.657 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -77.94 79.43 4.41 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.103 -1.073 . . . . 75.34 108.103 175.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 12.5 t -176.67 171.46 2.27 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.847 1.259 . . . . 73.34 109.79 -174.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -94.45 169.65 10.05 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.024 0.93 . . . . 63.14 108.646 171.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.57 ' HE2' ' SG ' ' C' ' 97' ' ' CYS . 24.1 ttt 67.44 125.38 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.32 1.448 . . . . 75.0 112.45 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 53.3 m -85.98 104.3 15.48 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.438 -0.949 . . . . 74.21 108.438 170.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.553 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.5 t80 -123.75 123.28 40.15 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.152 0.581 . . . . 74.14 109.693 178.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -144.21 133.78 23.48 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.278 1.031 . . . . 72.51 108.88 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.559 HD12 HG22 ' C' ' 105' ' ' ILE . 41.7 mt -81.39 128.77 38.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 108.561 -0.903 . . . . 74.13 108.561 173.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.618 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.5 mm-40 -89.84 -42.61 11.16 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.875 0.87 . . . . 72.22 110.381 -176.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.571 ' HG3' ' HG2' ' A' ' 125' ' ' GLN . 33.4 ttt180 -173.98 123.2 0.33 Allowed 'General case' 0 C--N 1.355 0.823 0 O-C-N 123.522 0.514 . . . . 73.31 110.351 -171.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 98.8 mt -110.1 139.7 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 108.818 -0.808 . . . . 74.51 108.818 174.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -170.6 154.06 4.4 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.988 0.915 . . . . 73.54 109.2 -171.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.7 p -80.84 110.14 16.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.322 -0.992 . . . . 55.44 108.322 172.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.597 ' HE2' HG21 ' C' ' 59' ' ' VAL . 6.0 mmmt -67.94 -48.33 66.22 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.141 -1.059 . . . . 75.31 108.141 175.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.69 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 20.4 t70 -135.87 143.37 45.01 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.334 -1.303 . . . . 74.4 110.153 -177.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.7 mt -135.93 149.94 28.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 125.593 1.557 . . . . 75.42 107.005 175.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 37.6 t -158.95 150.6 20.71 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.331 0.653 . . . . 74.53 109.719 173.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -145.85 138.88 25.94 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 106.534 -1.654 . . . . 74.4 106.534 171.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -143.68 113.77 7.3 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.062 -0.718 . . . . 72.31 109.062 -174.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.84 85.1 61.56 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 107.021 -1.474 . . . . 74.25 107.021 169.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.14 -33.13 19.64 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.567 2.178 . . . . 61.53 111.176 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -95.59 11.3 33.65 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 114.625 -1.17 . . . . 74.54 110.348 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.424 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -44.98 -59.19 4.48 Favored Pre-proline 0 C--N 1.377 1.775 0 C-N-CA 124.703 1.201 . . . . 74.24 113.55 -167.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.451 ' HG3' ' HG2' ' D' ' 57' ' ' GLU . 25.1 Cg_exo -58.35 -45.74 28.96 Favored 'Trans proline' 0 C--N 1.399 3.213 0 C-N-CA 121.633 1.555 . . . . 74.22 111.869 -175.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.417 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 83.8 t60 -69.97 -36.16 75.0 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.975 -1.466 . . . . 71.04 112.322 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.604 HG21 ' HA ' ' C' ' 73' ' ' ALA . 3.4 p -78.22 -19.02 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 111.914 0.338 . . . . 65.22 111.914 -168.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -69.74 -28.96 66.23 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.008 0.523 . . . . 75.41 112.028 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 19.5 pt20 -86.39 5.68 33.75 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 122.905 0.482 . . . . 73.4 111.707 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.802 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -84.93 154.34 22.26 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.328 0.651 . . . . 75.21 110.322 177.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -59.96 110.77 1.26 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.032 0.533 . . . . 72.42 109.763 166.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -71.17 90.84 0.9 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.863 0.865 . . . . 72.34 110.401 -177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -142.3 74.45 20.57 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 107.553 -1.277 . . . . 74.01 107.553 172.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -90.61 143.28 3.56 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.476 2.117 . . . . 74.01 112.446 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -88.96 106.48 18.44 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.544 1.138 . . . . 75.13 108.114 172.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 43.1 t -72.22 97.37 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 108.503 -0.925 . . . . 72.33 108.503 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.58 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 87.8 tttt -93.31 129.89 39.24 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.454 -0.793 . . . . 73.45 109.002 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' G' ' 8' ' ' LEU . 16.0 mt -89.23 149.74 22.96 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 124.358 1.063 . . . . 75.32 110.085 -172.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.508 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 31.1 t70 -160.52 118.67 2.55 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.743 0.652 . . . . 74.25 109.532 173.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.618 HD13 HD13 ' G' ' 8' ' ' LEU . 3.3 mm? -118.78 137.58 53.28 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.928 0.891 . . . . 73.4 108.713 176.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.513 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 18.1 t70 -130.5 153.59 48.66 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.263 -1.014 . . . . 74.54 108.263 174.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 71.7 p -114.24 118.36 33.73 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.507 0.723 . . . . 74.51 109.67 -173.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.39 135.63 54.23 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 107.904 -1.147 . . . . 51.0 107.904 172.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.525 ' HB3' ' HD1' ' G' ' 15' ' ' PHE . 58.6 p -167.36 158.91 12.09 Favored 'General case' 0 C--O 1.243 0.73 0 O-C-N 123.469 0.48 . . . . 73.02 111.303 -174.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 50.8 p -166.69 138.73 3.55 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.09 0.869 . . . . 71.32 109.682 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -72.89 121.1 19.46 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.467 -0.938 . . . . 72.2 108.467 170.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.497 HD13 HD13 ' C' ' 83' ' ' ILE . 78.8 mt -85.74 -36.6 20.06 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.91 0.484 . . . . 74.03 111.187 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . 0.476 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -160.7 -176.15 5.38 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.934 0.893 . . . . 73.25 109.957 -173.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -62.46 108.0 1.04 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.62 0.768 . . . . 73.1 109.799 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 66.91 2.02 2.51 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 125.169 1.388 . . . . 60.11 113.017 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 97.9 t -94.4 118.18 39.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.398 -1.334 . . . . 65.23 107.398 173.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -133.46 139.03 46.46 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.679 -0.489 . . . . 71.03 109.679 -172.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -102.1 128.15 48.7 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.555 0.742 . . . . 75.31 109.994 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.466 HG11 ' HD3' ' C' ' 103' ' ' PRO . 91.1 t -112.33 124.05 68.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 107.73 -1.211 . . . . 75.52 107.73 171.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.597 HG21 ' HE2' ' C' ' 19' ' ' LYS . 34.9 t -127.99 116.85 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.387 0.675 . . . . 74.34 109.223 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.516 HD21 ' HB3' ' C' ' 103' ' ' PRO . 42.0 tp -103.99 114.16 28.21 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.403 -0.962 . . . . 70.31 108.403 -176.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.513 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 20.5 ttm-85 -82.0 105.81 13.41 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.95 -1.13 . . . . 74.43 107.95 174.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 10.3 t -100.64 117.25 45.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.736 -1.209 . . . . 73.22 107.736 175.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 34.6 m -121.87 117.99 27.85 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.775 -1.195 . . . . 73.44 107.775 -176.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.479 HG21 HG21 ' C' ' 114' ' ' ILE . 42.1 t -99.24 136.94 28.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.222 -1.354 . . . . 72.04 107.978 174.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.58 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 5.1 m -123.78 140.17 53.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.841 -1.17 . . . . 64.03 107.841 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.54 117.77 19.22 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.588 -1.634 . . . . 70.12 106.588 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.3 m -138.11 126.86 23.75 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.097 0.475 . . . . 63.14 110.965 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.802 HD11 ' HG2' ' C' ' 34' ' ' LYS . 4.3 mt -85.4 53.85 2.9 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.225 1.81 . . . . 70.42 108.427 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.78 -107.76 3.16 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 109.064 -1.614 . . . . 74.11 109.064 -166.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -104.02 -25.14 13.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.61 0.764 . . . . 64.05 110.675 172.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.561 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 5.6 tp10 -62.98 104.07 0.52 Allowed 'General case' 0 C--N 1.353 0.718 0 C-N-CA 123.645 0.778 . . . . 75.44 109.214 175.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 36.7 m -73.99 121.57 21.25 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.402 -0.592 . . . . 74.41 109.402 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.604 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -69.88 -62.45 1.38 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.449 -1.25 . . . . 65.11 108.362 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -153.88 173.02 16.48 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 121.784 0.802 . . . . 72.43 111.043 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.404 HD23 HG21 ' C' ' 65' ' ' THR . 1.7 tm? -137.36 128.3 27.41 Favored 'General case' 0 C--O 1.22 -0.494 0 N-CA-C 105.577 -2.009 . . . . 72.13 105.577 173.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.462 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.1 t -131.15 139.1 49.73 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.98 -1.118 . . . . 75.45 107.98 176.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -145.07 127.14 15.6 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.292 0.637 . . . . 74.3 109.434 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -132.03 114.37 24.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.422 -0.955 . . . . 73.34 108.422 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.69 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 48.1 mt-30 -89.27 87.23 7.05 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.416 -1.327 . . . . 74.03 107.416 171.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -79.34 110.58 14.76 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 114.143 -1.39 . . . . 74.24 109.396 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.36 151.97 20.06 Favored Glycine 0 C--N 1.337 0.626 0 O-C-N 123.673 0.608 . . . . 71.11 112.446 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.96 127.24 2.09 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 109.947 -1.261 . . . . 73.05 109.947 176.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.618 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 14.4 mm -88.45 124.55 41.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 107.648 -1.241 . . . . 72.3 107.648 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.553 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 66.9 m-85 -131.48 123.52 28.24 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.49 0.716 . . . . 72.32 110.001 -174.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 51.1 m -75.12 109.76 8.86 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.859 -0.793 . . . . 72.34 108.859 170.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 67.2 mt -114.13 100.72 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.978 -1.119 . . . . 52.33 107.978 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.33 141.31 29.66 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.09 0.956 . . . . 54.51 109.384 -176.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.07 -19.95 24.47 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-O 119.758 -0.468 . . . . 73.45 112.944 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.41 HD12 ' SD ' ' C' ' 9' ' ' MET . 36.6 pt -121.86 164.46 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.175 0.59 . . . . 73.13 110.856 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -152.49 164.08 38.29 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.188 0.995 . . . . 74.01 109.736 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.04 -133.22 18.26 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.485 0.491 . . . . 74.33 113.045 171.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 45.8 p -63.5 -31.78 73.04 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.014 0.926 . . . . 75.52 111.428 -178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -61.26 -51.12 70.27 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.061 0.945 . . . . 74.53 110.434 176.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.499 ' SD ' ' HB ' ' G' ' 18' ' ' VAL . 56.5 ttm -66.78 -39.84 87.97 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 115.222 -0.899 . . . . 73.13 110.393 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.07 -37.14 76.38 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.253 1.021 . . . . 71.23 111.615 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -71.51 -41.04 69.75 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.443 -0.798 . . . . 72.43 110.804 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.576 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 41.4 t -58.14 -60.89 3.04 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 124.179 0.924 . . . . 73.24 111.036 -177.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.537 HD23 HG23 ' G' ' 18' ' ' VAL . 3.6 pp -69.79 -30.08 67.54 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.988 -0.551 . . . . 73.25 111.766 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . 0.406 ' N ' HD11 ' C' ' 98' ' ' LEU . . . -78.51 -29.94 50.91 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-O 118.896 -0.946 . . . . 74.41 114.672 -168.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.48 -35.87 0.1 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.101 0.95 . . . . 74.4 112.357 -170.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.576 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 18.6 t80 -71.73 -35.57 70.21 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.986 1.315 . . . . 74.44 112.637 -175.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 84.9 m -82.82 -41.55 0.88 Allowed Pre-proline 0 CA--C 1.562 1.434 0 C-N-CA 123.159 0.584 . . . . 72.21 111.001 177.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.516 ' HB3' HD21 ' C' ' 60' ' ' LEU . 52.2 Cg_exo -54.72 -26.77 48.64 Favored 'Trans proline' 0 C--N 1.396 3.068 0 C-N-CA 122.713 2.275 . . . . 54.21 113.779 166.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' C' ' 101' ' ' TYR . 23.4 t-20 -55.75 -44.17 77.37 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 124.194 0.998 . . . . 75.35 110.765 172.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.559 HG22 HD12 ' C' ' 13' ' ' ILE . 45.0 mm -61.97 -40.07 85.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.39 -0.823 . . . . 74.31 110.063 177.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 85.7 mt -86.54 -14.38 43.15 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.161 0.984 . . . . 75.55 112.643 -171.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . 0.439 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 88.7 t80 -55.47 -53.69 59.49 Favored Pre-proline 0 CA--C 1.564 1.486 0 C-N-CA 123.809 0.844 . . . . 75.11 112.481 -177.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . 0.439 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 35.7 Cg_exo -63.23 -34.16 69.06 Favored 'Trans proline' 0 C--N 1.388 2.627 0 C-N-CA 122.243 1.962 . . . . 74.04 113.476 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -64.93 -49.95 68.36 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.583 0.753 . . . . 75.21 111.06 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.37 99.16 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.477 -0.783 . . . . 75.34 110.194 177.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -55.86 -51.8 66.29 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.419 1.488 . . . . 74.04 111.326 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -71.18 -32.26 68.65 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.352 0.661 . . . . 62.02 110.338 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.7 t -70.62 -32.48 69.82 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.953 0.501 . . . . 72.32 111.193 -178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.481 ' O ' HG23 ' C' ' 118' ' ' VAL . 90.0 mt -71.02 -56.38 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 109.072 -0.714 . . . . 72.42 109.072 173.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 23.9 m -60.98 -28.99 69.4 Favored 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 123.574 0.75 . . . . 75.45 111.978 -175.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 43.6 t -64.4 -51.04 65.23 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.671 0.788 . . . . 74.11 109.023 171.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.582 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.37 -35.85 78.61 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.262 1.025 . . . . 75.24 112.781 178.536 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.481 HG23 ' O ' ' C' ' 114' ' ' ILE . 59.5 t -63.45 -43.61 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.332 0.653 . . . . 72.42 109.449 176.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 31.5 t -68.16 -33.37 74.34 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.25 1.02 . . . . 74.33 111.985 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' C' ' 116' ' ' SER . 88.3 mtt-85 -67.59 -36.26 80.55 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.293 0.637 . . . . 74.11 109.786 176.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.22 11.48 60.65 Favored Glycine 0 C--N 1.355 1.616 0 O-C-N 124.059 0.849 . . . . 75.34 112.656 174.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 69.4 p 57.28 23.46 8.82 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.591 1.956 . . . . 73.52 114.746 174.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -82.74 146.07 51.96 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 107.964 -1.124 . . . . 73.55 107.964 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.32 178.75 1.87 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.709 2.273 . . . . 63.01 113.096 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 16.7 mm-40 -56.21 113.02 1.38 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.703 -1.135 . . . . 74.5 113.428 -173.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 39.7 tp -109.41 87.76 2.58 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.852 -1.067 . . . . 73.13 108.241 167.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -91.66 103.89 16.43 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.966 -0.753 . . . . 72.43 108.966 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 6.9 mp -66.14 137.85 57.31 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.224 0.609 . . . . 74.42 109.573 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.514 ' HB1' ' HB ' ' G' ' 5' ' ' THR . . . -81.83 163.09 55.24 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.249 0.62 . . . . 65.33 110.404 177.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.512 ' HG3' HD13 ' A' ' 16' ' ' ILE . 43.2 Cg_exo -58.61 138.06 83.64 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.878 2.385 . . . . 75.24 113.42 174.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.5 HG23 ' HB2' ' G' ' 8' ' ' LEU . 15.7 t -130.13 115.0 31.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.884 -0.784 . . . . 73.01 108.884 175.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.586 ' HB3' ' HB1' ' C' ' 135' ' ' ALA . 2.3 m-20 -96.63 77.79 2.91 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.795 0.838 . . . . 74.45 108.9 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -62.13 -46.0 90.97 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.626 0.727 . . . . 74.14 109.999 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -69.03 -53.23 21.54 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 113.819 -1.537 . . . . 70.01 111.566 -176.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.586 ' HB1' ' HB3' ' C' ' 132' ' ' ASN . . . -65.84 -38.63 89.41 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 123.765 0.665 . . . . 73.41 111.711 -174.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 10.1 tt -54.66 -36.31 64.46 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.938 0.895 . . . . 73.13 112.275 -174.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -56.23 -58.4 8.11 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.643 0.589 . . . . 74.22 111.816 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -78.46 -27.35 46.39 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.433 0.693 . . . . 75.21 112.053 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -64.28 -38.69 91.95 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.833 0.853 . . . . 74.52 110.473 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -73.12 -160.61 0.08 Allowed 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 109.238 -0.652 . . . . 75.44 109.238 173.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 46.8 tp 179.68 139.29 0.12 Allowed 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.156 -1.794 . . . . 73.31 106.156 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -83.08 11.71 6.0 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.59 0.356 . . . . 73.41 111.776 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -120.03 142.86 48.44 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.311 1.044 . . . . 75.23 109.91 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -99.33 118.1 35.23 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.018 0.927 . . . . 73.45 109.508 177.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -164.66 160.44 19.97 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.107 0.963 . . . . 62.14 109.925 174.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 175.28 147.62 6.35 Favored Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.424 -0.807 . . . . 54.32 111.147 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -93.73 176.87 6.19 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.542 0.737 . . . . 75.43 111.217 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -161.76 70.28 0.22 Allowed Glycine 0 CA--C 1.503 -0.684 0 N-CA-C 108.421 -1.872 . . . . 74.41 108.421 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 18.4 m -67.75 85.38 0.21 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.13 0.972 . . . . 73.43 111.324 -172.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -95.03 177.65 5.81 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.436 -1.256 . . . . 75.33 109.295 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 67.99 110.48 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.255 1.022 . . . . 63.11 110.506 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -136.8 148.64 47.3 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.133 0.573 . . . . 73.42 110.74 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -86.7 -0.24 55.92 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 123.639 0.776 . . . . 73.13 110.786 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -61.38 94.19 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.303 0.641 . . . . 51.32 110.357 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 C-N-CA 125.195 1.398 . . . . 64.02 108.169 177.776 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 109.745 -0.465 . . . . 72.35 109.745 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 11.3 m -82.84 84.82 7.24 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 109.151 -0.685 . . . . 60.54 109.151 175.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . 0.592 ' HG3' ' HB2' ' D' ' 93' ' ' GLN . 18.0 mm-40 -110.18 -178.96 3.65 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.569 0.747 . . . . 74.41 112.188 -167.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -99.08 32.4 2.7 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 114.431 -1.259 . . . . 73.33 108.121 168.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.15 156.99 20.56 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.044 1.338 . . . . 63.41 109.859 -174.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -59.84 110.35 1.15 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.178 -0.675 . . . . 75.33 109.178 171.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 5.3 m -72.08 5.3 2.81 Favored 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 124.564 1.146 . . . . 71.41 111.933 -173.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -61.53 -23.95 66.29 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.768 1.227 . . . . 74.13 111.477 171.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -30.13 140.15 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.026 1.73 . . . . 63.12 114.53 170.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 44.8 m -120.86 146.52 46.49 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 124.48 1.112 . . . . 74.52 108.764 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -151.79 103.16 2.9 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.915 -1.143 . . . . 75.11 107.915 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -121.53 142.66 49.85 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.052 -1.092 . . . . 71.42 108.052 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 15.6 mt -90.85 127.66 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 108.265 -1.013 . . . . 72.23 108.265 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -86.77 -37.25 18.04 Favored 'General case' 0 C--O 1.242 0.673 0 O-C-N 123.371 0.419 . . . . 75.21 109.912 175.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -169.22 139.91 2.29 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.436 0.46 . . . . 75.23 111.188 -171.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.529 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.6 mp -117.79 134.04 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 106.986 -1.487 . . . . 71.15 106.986 171.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.401 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 33.9 p90 -164.57 156.54 16.07 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.474 0.654 . . . . 74.3 112.269 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.0 p -81.82 117.35 22.04 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.452 -1.249 . . . . 73.23 109.03 172.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.401 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 42.0 mtpt -88.83 -23.84 22.72 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.444 0.698 . . . . 73.34 110.005 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 18.9 t70 -158.31 143.75 16.7 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 114.616 -1.175 . . . . 74.43 109.01 176.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.582 HG21 ' HE1' ' C' ' 117' ' ' MET . 70.9 mt -142.27 148.21 20.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 106.909 -1.515 . . . . 74.22 106.909 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 30.7 t -155.95 146.25 21.65 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.659 0.784 . . . . 73.32 109.013 170.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.497 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 84.6 t80 -146.4 117.61 7.85 Favored 'General case' 0 C--O 1.213 -0.837 0 N-CA-C 105.411 -2.07 . . . . 74.43 105.411 175.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -127.06 110.16 12.64 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 109.134 -0.691 . . . . 72.41 109.134 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.41 85.91 2.44 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.405 -0.961 . . . . 73.2 108.405 174.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.87 -30.53 5.89 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.084 2.523 . . . . 75.34 113.246 -169.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -103.27 6.67 38.24 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.732 0.813 . . . . 72.43 110.179 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.403 ' HB2' ' HD3' ' D' ' 29' ' ' PRO . . . -29.55 -67.96 0.12 Allowed Pre-proline 0 CA--C 1.562 1.422 0 C-N-CA 126.476 1.91 . . . . 65.33 116.111 -161.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' D' ' 28' ' ' ALA . 54.2 Cg_endo -78.37 -13.69 15.02 Favored 'Trans proline' 0 C--N 1.378 2.122 0 CA-C-N 122.775 2.027 . . . . 72.42 113.782 -172.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -80.34 -40.54 26.5 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.656 0.783 . . . . 72.33 109.589 171.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 5.5 p -81.51 -20.02 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 116.107 -0.497 . . . . 74.01 110.938 -172.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -65.88 -20.21 66.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.215 0.606 . . . . 74.31 112.341 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -61.79 -23.3 66.12 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.639 0.776 . . . . 74.54 110.276 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.468 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 96.7 mttt -93.26 87.15 5.55 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.27 1.428 . . . . 72.35 109.979 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.05 86.81 7.0 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.459 0.704 . . . . 75.4 110.577 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -155.11 173.19 16.94 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.452 -0.944 . . . . 73.54 108.452 167.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -69.41 115.87 36.89 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 108.993 -0.743 . . . . 74.23 108.993 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.23 145.38 78.1 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.676 2.25 . . . . 65.41 111.69 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 37.7 mt-10 -61.59 111.86 1.99 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.662 -0.866 . . . . 74.34 108.662 169.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.714 HG12 HG13 ' D' ' 64' ' ' VAL . 91.9 t -99.48 113.67 35.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.447 -0.946 . . . . 72.34 108.447 -178.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.603 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 10.9 tmtt? -92.53 119.42 31.99 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 106.255 -1.757 . . . . 73.12 106.255 173.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 mp -96.12 137.9 34.51 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.423 -0.954 . . . . 72.34 108.423 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.515 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 8.0 t70 -142.35 148.16 37.47 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.683 -0.858 . . . . 65.13 108.683 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -127.51 147.32 50.32 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.763 0.825 . . . . 74.54 110.358 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.431 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 10.1 t70 -144.18 145.2 31.93 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 107.681 -1.229 . . . . 72.34 107.681 172.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 57.9 p -113.17 144.16 43.14 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.195 0.598 . . . . 72.44 110.336 -175.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.59 151.93 31.22 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.79 0.836 . . . . 75.35 109.284 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 79.4 p -155.88 157.14 35.85 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 120.784 0.326 . . . . 72.11 110.916 -178.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 25.4 p -152.64 119.27 5.67 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.401 1.08 . . . . 71.4 108.917 175.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -79.81 121.05 24.9 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.183 -0.673 . . . . 74.4 109.183 176.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 30.0 mt -91.26 -35.8 14.27 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.054 0.542 . . . . 73.34 109.878 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.75 176.54 12.6 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.987 -1.006 . . . . 74.15 109.707 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -65.56 123.44 19.69 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.558 -0.905 . . . . 75.25 108.558 177.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.594 ' HB3' ' O ' ' D' ' 86' ' ' ILE . 3.8 m-20 71.94 2.95 4.5 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.212 1.005 . . . . 53.52 112.654 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.4 t -114.76 119.05 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.713 0.805 . . . . 74.25 109.255 176.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -133.02 128.43 36.29 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.297 0.639 . . . . 64.22 110.503 -173.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.624 ' HB2' HG12 ' D' ' 83' ' ' ILE . 4.6 tp10 -99.69 110.49 22.9 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 106.759 -1.571 . . . . 75.32 106.759 168.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.505 HG12 HD21 ' D' ' 98' ' ' LEU . 32.7 m -120.56 147.78 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 123.696 0.798 . . . . 73.41 109.111 -174.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 12.8 t -125.48 133.47 69.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 C-N-CA 123.69 0.796 . . . . 74.53 109.898 -169.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.492 HD21 ' HB2' ' D' ' 103' ' ' PRO . 56.3 tp -109.48 110.57 21.72 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.927 -1.138 . . . . 71.3 107.927 165.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.431 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.2 ttm180 -84.72 105.05 15.22 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.539 -0.912 . . . . 74.33 108.539 173.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 79.2 t -91.08 128.97 42.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.932 -1.136 . . . . 73.41 107.932 170.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 27.0 m -125.27 138.06 54.09 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.121 0.568 . . . . 73.35 109.522 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.714 HG13 HG12 ' D' ' 40' ' ' VAL . 24.4 t -129.16 101.04 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 124.945 1.298 . . . . 71.54 108.436 -174.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 36.8 m -95.49 93.86 7.44 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.377 -0.971 . . . . 73.02 108.377 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -95.99 144.19 26.5 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.263 0.625 . . . . 75.52 110.15 -174.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.433 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 64.7 p -145.82 129.29 16.93 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 123.683 0.614 . . . . 73.11 112.145 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 22.5 mt -99.1 112.9 24.92 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.871 0.868 . . . . 73.51 108.852 173.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.84 -111.01 3.18 Favored Glycine 0 C--N 1.345 1.074 0 N-CA-C 111.842 -0.503 . . . . 61.23 111.842 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.25 6.19 9.12 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.975 0.91 . . . . 73.12 110.526 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.468 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 13.1 pt-20 -121.15 165.9 14.71 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.466 0.706 . . . . 74.42 109.788 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.6 m -70.62 129.94 40.5 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.59 0.756 . . . . 74.51 111.924 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.433 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -84.36 -69.4 0.65 Allowed 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.817 -1.179 . . . . 52.25 107.817 170.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -151.07 158.75 44.47 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.74 -0.664 . . . . 72.23 110.803 175.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 74.3 mt -121.46 108.19 13.35 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.372 -1.344 . . . . 73.15 107.372 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.589 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 42.6 t -123.9 107.9 11.86 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.225 0.61 . . . . 74.0 109.506 -169.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -131.15 123.44 28.56 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.756 0.822 . . . . 75.21 109.072 -173.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.41 119.8 51.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 123.578 0.751 . . . . 72.34 109.012 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.532 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.0 mt-30 -87.18 85.7 7.22 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.876 -1.157 . . . . 74.54 107.876 170.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -81.91 110.86 17.58 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.341 -1.299 . . . . 73.45 108.907 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.61 167.58 14.13 Favored Glycine 0 C--N 1.341 0.826 0 O-C-N 123.557 0.536 . . . . 75.32 112.549 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.38 129.18 1.97 Allowed Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.35 -0.7 . . . . 64.32 111.35 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.624 HG12 ' HB2' ' D' ' 57' ' ' GLU . 61.8 mt -89.0 133.41 31.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.884 -1.154 . . . . 71.02 107.884 177.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -132.74 133.99 44.18 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 122.917 0.487 . . . . 71.4 110.879 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.1 m -81.21 104.85 11.96 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.089 0.956 . . . . 64.42 109.095 165.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.594 ' O ' ' HB3' ' D' ' 54' ' ' ASP . 67.3 mt -107.17 145.04 15.1 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 C-N-CA 124.158 0.983 . . . . 72.22 108.577 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.28 157.26 15.16 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 118.325 0.511 . . . . 75.12 110.05 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.96 11.35 74.17 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.568 0.543 . . . . 62.04 114.201 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.488 HG23 ' HB3' ' D' ' 93' ' ' GLN . 11.1 mt -97.57 134.92 33.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 C-N-CA 123.25 0.62 . . . . 75.31 110.696 -175.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -157.41 172.25 18.92 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.498 1.119 . . . . 75.25 109.148 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.89 -133.46 29.34 Favored Glycine 0 CA--C 1.527 0.825 0 O-C-N 123.465 0.478 . . . . 53.13 113.208 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 57.8 p -66.73 -33.19 75.08 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.944 0.898 . . . . 73.42 111.754 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.592 ' HB2' ' HG3' ' D' ' 3' ' ' GLU . 8.4 tt0 -67.71 -22.33 65.26 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.087 -0.506 . . . . 74.34 112.178 -172.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.423 ' O ' ' HA ' ' H' ' 17' ' ' PRO . 91.0 mtp -55.26 -54.18 46.68 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.022 -0.733 . . . . 71.35 109.022 174.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.36 -47.72 54.61 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.935 -1.03 . . . . 65.11 111.263 -178.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . 0.402 ' HE2' ' HA ' ' D' ' 134' ' ' ASP . 22.1 t-160 -76.28 -24.53 54.43 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.15 0.98 . . . . 73.44 112.685 -168.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -63.21 -51.67 65.34 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.935 -0.394 . . . . 74.2 109.935 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.505 HD21 HG12 ' D' ' 58' ' ' VAL . 4.5 mp -84.34 -25.78 28.94 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 122.761 0.424 . . . . 74.43 110.341 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.59 -5.05 72.27 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.62 -0.544 . . . . 75.34 113.925 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.65 -57.71 0.11 Allowed 'General case' 0 C--N 1.358 0.955 0 N-CA-C 112.6 0.593 . . . . 70.24 112.6 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -72.31 -50.57 26.02 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 112.792 0.664 . . . . 74.13 112.792 -166.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 35.2 m -61.64 -47.14 93.36 Favored Pre-proline 0 CA--C 1.564 1.507 0 C-N-CA 123.993 0.917 . . . . 75.44 112.974 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.492 ' HB2' HD21 ' D' ' 60' ' ' LEU . 65.8 Cg_endo -70.39 -20.48 31.81 Favored 'Trans proline' 0 C--N 1.392 2.852 0 C-N-CA 122.176 1.917 . . . . 70.03 112.659 175.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -73.65 -26.96 61.01 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.285 0.634 . . . . 75.13 110.539 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mm -65.77 -37.44 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-O 121.525 0.679 . . . . 74.13 109.876 169.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 50.9 mt -84.57 -13.13 52.63 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 114.832 -1.076 . . . . 74.34 111.423 -176.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . 0.416 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 85.1 t80 -61.61 -53.11 64.45 Favored Pre-proline 0 CA--C 1.567 1.605 0 C-N-CA 124.422 1.089 . . . . 75.02 113.025 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 24.5 Cg_exo -65.05 -31.44 55.17 Favored 'Trans proline' 0 C--N 1.393 2.872 0 C-N-CA 122.14 1.893 . . . . 63.35 112.923 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -76.18 -33.99 59.32 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.773 0.829 . . . . 62.24 111.772 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.46 -48.89 73.58 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.238 -0.653 . . . . 64.02 109.238 172.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -55.58 -47.18 76.88 Favored 'General case' 0 C--N 1.358 0.953 0 O-C-N 124.445 1.09 . . . . 64.34 110.454 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.76 -53.26 58.37 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.066 0.546 . . . . 74.54 110.945 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.8 t -55.64 -44.86 77.56 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 123.825 0.703 . . . . 74.15 111.24 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.481 HG22 ' SG ' ' D' ' 76' ' ' CYS . 59.3 mt -60.45 -59.9 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.987 0.915 . . . . 73.25 110.659 175.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 47.7 m -54.11 -38.61 65.58 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.694 1.198 . . . . 71.2 111.796 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.4 t -65.47 -45.61 82.99 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.236 -0.893 . . . . 74.3 110.1 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.589 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 69.7 mtm -70.63 -28.12 64.58 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.861 0.465 . . . . 65.12 111.889 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.458 HG23 ' O ' ' D' ' 114' ' ' ILE . 99.5 t -66.09 -45.76 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.27 0.628 . . . . 73.32 109.585 174.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.0 p -72.13 -31.06 65.65 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.843 -0.617 . . . . 75.41 110.826 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -69.27 -36.32 76.97 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.974 0.909 . . . . 72.51 109.954 175.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.76 1.2 88.68 Favored Glycine 0 C--N 1.351 1.398 0 O-C-N 123.805 0.69 . . . . 74.32 112.012 174.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.0 p 61.97 23.11 13.57 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 126.832 2.053 . . . . 71.34 113.573 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -81.66 160.04 65.14 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.849 0.86 . . . . 75.42 110.003 170.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.64 132.51 51.9 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.973 2.449 . . . . 62.13 112.737 174.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -56.34 134.86 53.87 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.163 0.985 . . . . 75.13 111.792 -175.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 53.9 tp -111.95 103.38 11.6 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.389 -0.823 . . . . 70.53 109.219 -177.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . 0.429 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 86.3 m-20 -100.54 96.75 7.59 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.487 -0.931 . . . . 75.24 108.487 177.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.447 ' HA ' HG23 ' H' ' 6' ' ' ILE . 31.7 tp -67.3 120.75 14.34 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-N 115.4 -0.818 . . . . 73.11 109.885 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.8 137.44 83.05 Favored Pre-proline 0 C--N 1.354 0.792 0 O-C-N 124.348 1.03 . . . . 73.54 111.43 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.481 ' HG3' HD11 ' B' ' 13' ' ' ILE . 1.8 Cg_endo -76.58 103.38 1.74 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.902 2.401 . . . . 74.4 110.891 -172.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.38 131.45 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.923 -0.58 . . . . 72.2 109.561 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . 0.621 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 30.6 t30 -107.02 104.32 13.96 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 108.412 -0.958 . . . . 75.53 108.412 174.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -60.3 -42.21 95.02 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.898 0.749 . . . . 72.32 110.902 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.402 ' HA ' ' HE2' ' D' ' 96' ' ' HIS . 11.6 t70 -57.93 -36.76 72.96 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.942 -1.026 . . . . 75.14 111.73 -173.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.621 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -70.34 -33.21 71.22 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 124.19 0.931 . . . . 61.44 112.12 -177.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 75.5 mt -69.0 -43.19 75.33 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.307 0.643 . . . . 75.24 110.445 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -72.0 -30.65 65.45 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.303 -0.862 . . . . 75.42 111.0 175.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.475 ' HE3' ' HA ' ' D' ' 135' ' ' ALA . 36.4 ttm -62.41 -31.37 72.05 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.404 1.082 . . . . 71.2 110.389 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -64.54 -26.33 68.37 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.871 0.868 . . . . 72.24 111.177 177.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -76.78 -39.1 52.68 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.409 0.684 . . . . 74.45 110.209 173.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.561 HD23 ' HA ' ' D' ' 3' ' ' GLU . 11.1 mp -74.38 -26.9 60.4 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.231 1.012 . . . . 75.05 112.919 -175.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -78.73 28.13 0.21 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.077 0.551 . . . . 74.42 112.32 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -117.76 55.67 0.86 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.59 1.156 . . . . 75.5 108.391 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -167.68 135.75 2.41 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.107 -1.406 . . . . 74.52 108.822 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.46 99.07 3.45 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.316 -0.624 . . . . 74.22 109.316 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.22 65.47 0.27 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 111.348 -0.701 . . . . 63.54 111.348 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.92 161.13 31.08 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.137 0.575 . . . . 73.41 110.496 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.55 86.92 0.34 Allowed Glycine 0 C--N 1.347 1.175 0 N-CA-C 111.042 -0.823 . . . . 64.12 111.042 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 15.0 t -139.29 27.37 2.33 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.833 0.853 . . . . 74.51 110.209 -175.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.42 109.08 0.55 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.674 0.79 . . . . 74.4 111.217 179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -163.51 -61.5 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 107.491 -1.299 . . . . 71.21 107.491 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -157.34 145.57 19.27 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.11 -0.95 . . . . 64.4 109.147 173.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . 0.549 ' NE2' ' HA ' ' B' ' 149' ' ' THR . 72.2 mt-30 -79.63 100.39 7.8 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.716 -0.846 . . . . 62.14 108.716 170.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.63 137.05 58.22 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.907 0.883 . . . . 72.33 110.919 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 C-N-CA 123.45 0.7 . . . . 74.42 109.77 178.489 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptt? . . . . . 0 CA--C 1.542 0.648 0 CA-C-O 121.935 0.874 . . . . 74.03 109.536 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -136.56 133.01 35.95 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.516 1.126 . . . . 72.11 108.794 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -91.94 144.46 25.44 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.467 1.107 . . . . 75.12 110.013 -177.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 47.0 t -71.07 91.46 0.9 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.531 0.732 . . . . 71.25 110.113 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 6.5 t -74.42 112.91 11.06 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.136 0.574 . . . . 75.31 110.453 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.497 HD12 HG13 ' A' ' 40' ' ' VAL . 9.2 tp -167.3 133.57 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.237 1.015 . . . . 73.11 108.801 178.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 7' ' ' ALA . . . . . 0.422 ' O ' HD23 ' A' ' 42' ' ' LEU . . . -122.8 155.69 36.05 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.893 0.877 . . . . 74.02 108.893 177.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 tt -171.0 138.01 1.25 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.344 -0.984 . . . . 72.54 108.344 174.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -135.33 149.46 49.74 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 124.133 0.973 . . . . 73.22 108.53 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 pp -69.02 163.9 23.61 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 120.865 0.364 . . . . 73.22 110.977 176.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 7.5 mp -79.53 120.52 80.57 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 123.581 0.752 . . . . 73.11 109.464 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.79 -37.93 52.37 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 123.243 2.629 . . . . 74.31 112.286 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.04 -7.26 39.69 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.059 0.543 . . . . 72.21 111.373 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 83.3 mt 66.75 15.77 10.21 Favored 'General case' 0 C--N 1.363 1.155 0 C-N-CA 125.443 1.497 . . . . 75.32 111.798 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 27.4 t80 52.83 38.64 27.21 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.486 1.114 . . . . 75.52 110.302 -175.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 16' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' E' ' 21' ' ' ALA . 36.5 p -116.21 76.71 6.86 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.296 0.638 . . . . 74.02 110.871 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 17' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -88.43 -10.93 4.41 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.224 1.949 . . . . 74.22 112.623 172.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 90.5 t -86.45 105.51 14.83 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 N-CA-C 107.875 -1.157 . . . . 74.43 107.875 176.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 4.8 m 64.47 166.7 0.16 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 124.898 1.279 . . . . 75.43 111.324 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -73.6 83.67 1.55 Allowed 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 108.825 -0.806 . . . . 75.44 108.825 171.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . 0.574 ' HB2' ' HB ' ' E' ' 16' ' ' THR . . . -105.68 -27.97 11.0 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.99 0.916 . . . . 74.33 112.315 -172.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -58.95 -54.13 50.59 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.596 0.758 . . . . 75.52 110.517 176.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 92.3 m -143.12 85.31 9.82 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.628 -0.878 . . . . 72.14 108.628 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.28 -35.95 81.96 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.656 2.238 . . . . 72.41 111.665 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 CA--C 1.553 1.061 0 N-CA-C 107.998 -1.112 . . . . 74.33 107.998 177.977 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' F' F ' 1' ' ' MET . . . . . 0.63 ' H2 ' ' HA ' ' B' ' 36' ' ' TRP . 64.9 mtm . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.879 -0.415 . . . . 74.1 109.879 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt 61.39 179.46 0.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 114.403 1.261 . . . . 75.24 114.403 170.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -161.86 104.07 1.18 Allowed 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 114.583 -1.19 . . . . 73.12 109.553 175.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 15.7 m -92.66 103.47 15.85 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.707 -0.849 . . . . 75.2 108.707 174.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 34.3 m -97.07 126.79 42.47 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.267 0.627 . . . . 75.0 110.443 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' B' ' 42' ' ' LEU . 29.0 pt -128.83 158.93 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.672 0.789 . . . . 75.21 110.602 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 7' ' ' ALA . . . . . 0.613 ' HB1' ' HB3' ' B' ' 129' ' ' ALA . . . -164.12 172.41 13.77 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.572 -1.194 . . . . 55.22 109.833 176.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 mp -83.55 170.67 14.13 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.566 0.746 . . . . 74.34 110.06 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.38 -165.1 2.18 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.711 0.804 . . . . 74.0 109.163 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 10' ' ' LEU . . . . . 0.543 HD12 HD11 ' B' ' 136' ' ' LEU . 8.6 mp -59.33 131.08 49.91 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.698 -0.482 . . . . 73.41 109.698 177.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . 0.548 ' HG ' HD12 ' B' ' 44' ' ' LEU . 5.2 mp -73.24 133.68 80.89 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 123.801 0.84 . . . . 75.12 109.62 -170.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -60.33 -33.36 94.48 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 123.248 2.632 . . . . 71.34 112.227 -175.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.71 133.25 50.75 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.577 -0.897 . . . . 75.24 108.577 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 90.7 mt -69.23 117.55 11.0 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.108 -1.071 . . . . 74.1 108.108 169.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -75.04 88.01 2.38 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 108.828 -0.804 . . . . 74.11 108.828 -176.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 77.6 p -121.53 75.89 34.88 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 123.88 0.872 . . . . 71.42 111.065 -176.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -85.35 -36.23 0.14 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.585 2.19 . . . . 72.33 113.33 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . 0.512 HG23 ' HB3' ' F' ' 21' ' ' ALA . 2.7 m -84.26 122.29 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.285 0.634 . . . . 75.32 109.416 177.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 98.9 m -68.56 -45.58 71.73 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.595 -0.891 . . . . 74.32 108.595 169.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -138.39 110.08 7.11 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.303 -1.369 . . . . 74.42 107.303 173.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . 0.512 ' HB3' HG23 ' F' ' 18' ' ' VAL . . . -82.18 63.28 6.31 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 107.851 -1.166 . . . . 65.42 107.851 169.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . 0.675 ' HD2' ' HB2' ' B' ' 90' ' ' GLU . 50.3 mtp180 -150.04 105.22 3.36 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 106.739 -1.578 . . . . 73.41 106.739 -173.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 9.0 t -67.35 115.21 24.06 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 122.418 0.287 . . . . 75.11 110.929 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -65.28 -48.12 3.77 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.646 2.23 . . . . 72.13 110.952 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 108.215 -1.031 . . . . 74.3 108.215 171.905 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' G' G ' 1' ' ' MET . . . . . 0.467 ' N ' ' SD ' ' G' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.349 -0.611 . . . . 63.32 109.349 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -127.95 142.46 51.24 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.699 0.799 . . . . 74.53 109.542 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -72.49 94.92 1.72 Allowed 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 108.674 -0.861 . . . . 75.13 108.674 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 26.9 p -67.28 -56.9 7.87 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.357 1.063 . . . . 71.51 112.0 -170.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 5' ' ' THR . . . . . 0.514 ' HB ' ' HB1' ' C' ' 129' ' ' ALA . 20.7 m -69.69 143.4 53.14 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 123.447 0.699 . . . . 74.13 109.325 176.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . 0.426 HD13 ' O ' ' G' ' 6' ' ' ILE . 2.6 pp -57.42 129.88 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.301 0.64 . . . . 74.04 111.584 -177.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 7' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' C' ' 129' ' ' ALA . . . -171.72 173.42 4.6 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.053 -0.976 . . . . 72.34 109.907 -175.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 8' ' ' LEU . . . . . 0.618 HD13 HD13 ' C' ' 44' ' ' LEU . 16.6 mt -66.34 159.5 26.64 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 124.137 0.898 . . . . 64.01 109.314 176.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.67 -80.79 0.58 Allowed 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 109.764 -0.458 . . . . 74.52 109.764 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 81.8 mt -137.04 151.3 48.77 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.096 0.958 . . . . 75.14 110.124 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 93.7 mt -69.65 133.52 88.67 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 115.598 -0.728 . . . . 72.25 109.194 174.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.46 -45.43 14.68 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.718 2.278 . . . . 72.33 111.036 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt -136.74 161.05 37.02 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.989 1.316 . . . . 74.31 108.266 174.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.06 -175.9 5.96 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.957 0.503 . . . . 74.05 110.564 176.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . 0.525 ' HD1' ' HB3' ' C' ' 48' ' ' SER . 46.4 m-85 -87.31 174.77 8.36 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.051 0.54 . . . . 74.31 110.287 175.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 70.7 p -77.98 153.44 80.16 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.267 0.627 . . . . 74.41 110.341 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 17' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.47 145.21 95.6 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 122.471 2.114 . . . . 74.13 112.541 174.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 18' ' ' VAL . . . . . 0.537 HG23 HD23 ' C' ' 98' ' ' LEU . 44.5 t -70.03 -51.21 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 108.326 -0.99 . . . . 70.35 108.326 172.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 32.9 p -129.68 -61.14 1.02 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.263 -0.881 . . . . 74.42 111.126 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -151.31 35.2 0.57 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.617 0.722 . . . . 71.53 109.621 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.35 -18.29 63.49 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.973 -0.558 . . . . 61.14 111.706 173.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -147.25 -64.62 0.28 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.295 1.038 . . . . 74.3 108.542 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 36.3 m -143.68 134.67 12.46 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.091 0.956 . . . . 72.12 108.639 -176.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.6 -60.88 0.48 Allowed 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.128 1.886 . . . . 75.44 111.063 171.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 CA--C 1.555 1.164 0 C-N-CA 123.739 0.816 . . . . 75.33 110.07 178.298 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' H' H ' 1' ' ' MET . . . . . 0.423 ' N ' ' SD ' ' H' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 109.838 -0.43 . . . . 74.53 109.838 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -125.02 97.6 5.32 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.365 0.666 . . . . 74.54 109.783 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -81.44 98.05 8.05 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 107.541 -1.281 . . . . 72.4 107.541 172.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 32.3 t 70.12 172.13 0.31 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.729 1.212 . . . . 70.3 110.683 -172.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 90.3 m -96.46 -55.86 2.79 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.641 -0.503 . . . . 72.11 109.641 176.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . 0.447 HG23 ' HA ' ' D' ' 128' ' ' LEU . 22.8 mm -87.43 61.94 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 109.193 -0.669 . . . . 75.21 109.193 -174.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -170.06 154.84 5.25 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.775 0.83 . . . . 71.05 109.93 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 94.2 mt -107.34 118.45 36.75 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.807 -0.812 . . . . 75.42 108.807 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.4 -88.19 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.183 0.593 . . . . 72.44 110.371 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 5.4 mp -134.3 155.96 49.29 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.866 0.867 . . . . 75.22 109.252 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.07 115.82 59.78 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 108.472 -0.936 . . . . 74.41 108.472 175.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.06 -30.82 94.31 Favored 'Trans proline' 0 C--N 1.39 2.739 0 C-N-CA 123.491 2.794 . . . . 60.2 113.074 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -120.94 119.75 33.49 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 106.521 -1.659 . . . . 74.34 106.521 170.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.77 136.62 54.49 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.96 0.504 . . . . 63.43 110.201 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -59.69 140.54 56.37 Favored 'General case' 0 CA--C 1.552 1.052 0 O-C-N 124.061 0.851 . . . . 71.31 108.968 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 16' ' ' THR . . . . . 0.698 ' HB ' ' HB1' ' H' ' 21' ' ' ALA . 21.4 p -52.05 140.2 32.22 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 125.295 1.438 . . . . 74.13 112.51 -177.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 17' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' D' ' 94' ' ' MET . 87.9 Cg_exo -50.35 178.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 124.065 3.177 . . . . 73.53 117.107 177.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.63 -85.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 115.358 -0.837 . . . . 74.52 109.865 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 11.9 t -89.81 156.33 18.57 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 109.729 -0.471 . . . . 72.11 109.729 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? 77.45 -29.75 0.17 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 125.996 1.718 . . . . 74.12 112.748 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . 0.698 ' HB1' ' HB ' ' H' ' 16' ' ' THR . . . -59.13 -57.86 11.19 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.182 1.393 . . . . 72.11 113.61 -166.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . 0.472 ' NH1' ' HA ' ' H' ' 24' ' ' PRO . 0.0 OUTLIER -84.99 30.02 0.61 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.798 0.839 . . . . 73.33 112.615 -169.636 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 10.0 t 47.75 89.51 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.573 0 C-N-CA 125.971 1.708 . . . . 74.4 111.789 -170.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 24' ' ' PRO . . . . . 0.472 ' HA ' ' NH1' ' H' ' 22' ' ' ARG . 55.2 Cg_endo -66.73 -20.8 52.31 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.834 2.356 . . . . 73.1 112.394 -178.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 CA--C 1.548 0.871 0 N-CA-C 108.679 -0.86 . . . . 63.25 108.679 176.313 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 109.217 -0.66 . . . . 72.34 109.217 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.1 t 65.09 172.08 0.21 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.369 1.068 . . . . 62.01 111.333 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 57.05 31.83 20.62 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.47 1.108 . . . . 72.42 112.129 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -76.63 -5.94 49.95 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.95 0.9 . . . . 75.42 111.643 -173.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -90.75 102.78 15.53 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.103 0.961 . . . . 73.22 110.692 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -151.13 16.6 0.74 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 121.752 0.787 . . . . 73.32 110.157 174.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.7 p -94.6 -29.84 14.66 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.775 0.798 . . . . 64.25 110.043 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -89.28 -167.18 1.79 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.16 0.984 . . . . 75.15 110.501 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.451 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 95.1 mmm 73.95 138.74 0.06 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.894 1.678 . . . . 71.12 111.759 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.8 m -147.36 136.5 22.39 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.943 1.297 . . . . 61.4 107.985 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.657 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 15.6 t80 -134.27 123.26 23.93 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.037 0.535 . . . . 75.43 109.89 -175.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -138.19 117.28 12.56 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.753 0.821 . . . . 75.41 108.943 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.64 HG12 ' HD2' ' A' ' 84' ' ' PHE . 53.8 mt -89.92 125.08 42.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 108.871 -0.788 . . . . 75.24 108.871 176.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -85.94 -41.16 15.15 Favored 'General case' 0 C--O 1.242 0.66 0 O-C-N 123.847 0.717 . . . . 71.45 110.159 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -167.9 136.7 2.47 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.874 -0.417 . . . . 63.14 109.874 -167.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.443 HD11 HD11 ' A' ' 13' ' ' ILE . 94.4 mt -130.01 129.34 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.061 -1.089 . . . . 75.15 108.061 172.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -161.52 176.77 10.7 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 124.216 0.948 . . . . 70.42 111.252 -167.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -107.28 116.22 31.56 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 114.944 -1.025 . . . . 72.22 108.836 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.527 ' HE3' ' HB2' ' B' ' 28' ' ' ALA . 34.5 mtpt -82.11 -26.44 33.58 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 110.012 -0.366 . . . . 75.21 110.012 177.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 18.3 t70 -152.78 136.65 16.24 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.218 -0.901 . . . . 73.22 109.72 174.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.447 HG22 ' SD ' ' A' ' 117' ' ' MET . 83.6 mt -129.18 137.48 56.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 106.285 -1.746 . . . . 73.55 106.285 172.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.6 t -152.03 110.63 3.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.419 0.628 . . . . 75.25 110.226 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.508 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 92.3 t80 -110.38 137.34 48.22 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 107.313 -1.366 . . . . 74.34 107.313 173.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -135.16 140.92 45.76 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.701 -1.222 . . . . 74.12 107.701 171.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.9 80.78 50.01 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 105.891 -1.892 . . . . 74.42 105.891 168.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.2 -31.42 89.9 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.076 2.517 . . . . 74.2 112.746 -167.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -118.44 31.69 6.54 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 118.597 -0.716 . . . . 73.23 109.66 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.598 ' HB2' ' HZ3' ' B' ' 19' ' ' LYS . . . -42.41 -54.47 7.91 Favored Pre-proline 0 CA--C 1.573 1.84 0 N-CA-C 114.84 1.422 . . . . 74.41 114.84 -170.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.43 ' HG3' ' HZ1' ' B' ' 19' ' ' LYS . 14.1 Cg_exo -64.13 -31.4 64.89 Favored 'Trans proline' 0 C--N 1.395 3.004 0 CA-C-N 121.652 1.626 . . . . 75.14 112.572 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -80.17 -39.16 29.86 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.863 -1.062 . . . . 75.31 110.51 -175.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.603 HG22 ' HA ' ' A' ' 73' ' ' ALA . 5.2 p -78.52 -22.23 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 CA-C-N 114.821 -1.081 . . . . 73.53 112.714 -161.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -70.91 -21.1 62.41 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.906 0.482 . . . . 72.44 110.754 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -86.46 -18.34 31.94 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.517 1.127 . . . . 71.04 110.519 176.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.4 tmtp? -78.13 146.67 34.99 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.142 0.977 . . . . 71.23 109.734 -175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.07 138.88 58.67 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.816 0.846 . . . . 71.23 110.524 173.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -93.01 82.99 4.64 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.868 0.842 . . . . 74.45 110.6 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -130.87 83.44 61.3 Favored Pre-proline 0 C--O 1.239 0.539 0 N-CA-C 107.017 -1.475 . . . . 60.03 107.017 165.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -85.97 156.6 10.02 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 122.214 1.943 . . . . 73.23 111.959 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -109.66 93.72 4.65 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 105.036 -2.209 . . . . 75.31 105.036 165.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.639 ' HB ' HG23 ' E' ' 6' ' ' ILE . 48.1 t -78.5 92.04 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 122.072 0.939 . . . . 74.44 108.695 -177.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.436 ' HE2' ' HB2' ' A' ' 67' ' ' SER . 62.3 mttm -82.98 113.3 20.47 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.596 -1.638 . . . . 74.12 108.98 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 pp -105.73 128.36 53.64 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.008 0.523 . . . . 74.45 110.625 -174.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.547 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.6 m-20 -114.28 139.2 49.61 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.405 1.082 . . . . 70.32 109.029 177.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.58 HD13 ' HB3' ' E' ' 8' ' ' LEU . 94.1 mt -124.61 119.54 29.34 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.601 0.76 . . . . 74.22 109.513 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 21.8 t70 -120.24 130.31 54.45 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.617 -0.882 . . . . 71.31 108.617 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.3 p -106.98 132.21 53.18 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.878 0.871 . . . . 73.5 110.254 -173.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.18 129.52 10.56 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.049 0.54 . . . . 74.44 110.308 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.2 m -130.82 152.92 49.64 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.223 0.609 . . . . 72.43 110.324 174.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.6 t -149.96 126.71 11.02 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.578 0.751 . . . . 75.33 109.084 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -78.47 132.55 37.31 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.857 0.463 . . . . 75.35 110.927 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.3 mt -101.32 -31.01 11.17 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.441 1.096 . . . . 65.14 111.059 -174.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.63 173.76 12.56 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.489 1.116 . . . . 72.34 109.712 -175.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -56.67 116.47 3.15 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.023 0.529 . . . . 72.12 110.204 171.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 70.49 -10.6 0.68 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 126.215 1.806 . . . . 75.41 113.259 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.7 117.68 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.075 -1.083 . . . . 62.34 108.075 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -142.35 170.33 15.9 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.14 -0.689 . . . . 72.54 109.14 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -120.08 132.99 55.64 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 123.521 0.729 . . . . 73.4 110.021 -175.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.456 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 93.7 t -104.39 126.82 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.008 -1.108 . . . . 73.51 108.008 169.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.99 125.81 74.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 108.269 -1.012 . . . . 74.3 108.269 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.19 110.88 18.11 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.722 -1.214 . . . . 74.5 107.722 176.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.569 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 36.8 ttm180 -81.95 100.26 9.57 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.572 -1.27 . . . . 74.54 107.572 174.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.9 t -98.86 102.46 13.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.679 -1.23 . . . . 71.24 107.679 176.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.547 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 26.5 m -96.91 135.88 38.27 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.444 -0.576 . . . . 73.53 109.444 178.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.53 HG12 HD23 ' A' ' 126' ' ' LEU . 17.9 t -126.73 107.68 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.628 1.171 . . . . 64.41 108.392 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 25.9 m -102.94 134.33 46.54 Favored 'General case' 0 C--O 1.208 -1.083 0 N-CA-C 107.707 -1.22 . . . . 73.31 107.707 173.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.71 105.28 12.56 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 107.699 -1.223 . . . . 75.5 107.699 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 50.2 m -108.72 124.29 50.33 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.304 0.574 . . . . 74.04 110.952 -177.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.454 HD13 ' HB1' ' A' ' 73' ' ' ALA . 20.1 mt -91.04 54.82 2.72 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.889 1.276 . . . . 73.32 108.399 178.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.47 -114.56 4.73 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 110.36 -1.096 . . . . 72.11 110.36 -166.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -91.93 -26.68 18.32 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.007 0.523 . . . . 70.2 110.864 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -86.73 108.8 18.84 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.206 0.602 . . . . 75.11 109.595 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 53.9 m -72.63 124.87 26.16 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.688 0.395 . . . . 73.03 110.625 176.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.603 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -62.26 -58.09 9.0 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.49 1.116 . . . . 71.44 111.183 174.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -155.83 164.54 38.4 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.816 -1.083 . . . . 74.1 111.779 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.5 tp -123.46 138.51 54.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.605 1.162 . . . . 74.21 108.158 173.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.421 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 76.6 m -142.51 96.57 2.97 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.838 0.855 . . . . 72.11 109.555 -178.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -108.29 130.43 55.18 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.788 -0.819 . . . . 74.15 108.788 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.1 t -132.15 112.43 19.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 109.238 -0.653 . . . . 72.35 109.238 173.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.48 ' NE2' HH21 ' A' ' 61' ' ' ARG . 69.6 mt-30 -84.55 84.83 7.53 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.048 -1.093 . . . . 64.43 108.048 172.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.52 ' HG3' HD23 ' A' ' 106' ' ' LEU . 8.4 tp-100 -76.85 102.97 6.55 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.183 -0.917 . . . . 72.12 108.795 -177.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.21 144.92 17.42 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.041 -0.823 . . . . 73.35 111.041 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.427 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -150.86 123.13 1.47 Allowed Glycine 0 CA--C 1.504 -0.615 0 N-CA-C 110.779 -0.928 . . . . 74.43 110.779 -176.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.5 mt -81.22 122.24 36.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 108.973 -0.751 . . . . 75.21 108.973 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.657 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 25.1 m-85 -134.12 137.53 44.61 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.859 -0.793 . . . . 74.41 108.859 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.3 m -102.44 96.79 7.16 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.006 -0.738 . . . . 64.21 109.006 173.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.587 HD13 ' SG ' ' A' ' 102' ' ' CYS . 62.8 mt -96.79 119.99 45.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 108.355 -0.98 . . . . 74.23 108.355 176.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.38 132.43 12.57 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.229 0.611 . . . . 60.14 109.972 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.697 ' HA2' ' HA3' ' C' ' 146' ' ' GLY . . . 170.01 -76.57 0.1 Allowed Glycine 0 C--N 1.339 0.711 0 N-CA-C 112.105 -0.398 . . . . 70.13 112.105 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.8 tp -150.07 150.08 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.419 0.688 . . . . 71.42 109.654 -171.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.402 ' HA ' ' HE3' ' A' ' 94' ' ' MET . 45.2 mt-10 -91.94 -169.55 2.3 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.127 1.371 . . . . 73.42 111.971 -167.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.5 -135.11 23.25 Favored Glycine 0 C--N 1.355 1.584 0 CA-C-N 115.072 -0.967 . . . . 74.55 112.579 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.9 t -67.96 -22.83 65.01 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.851 0.86 . . . . 74.31 111.922 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -70.37 -53.57 16.03 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.148 0.579 . . . . 73.15 111.072 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.402 ' HE3' ' HA ' ' A' ' 90' ' ' GLU . 9.5 ptp -69.16 -30.53 68.78 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 121.018 -0.273 . . . . 74.21 111.204 173.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.98 -38.22 90.28 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.667 0.787 . . . . 74.31 111.545 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -67.83 -39.67 83.84 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.559 1.144 . . . . 73.5 110.582 175.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.421 ' SG ' HD11 ' A' ' 86' ' ' ILE . 18.7 t -72.58 -35.64 67.97 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 116.383 -0.371 . . . . 61.12 111.8 -175.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 pp -83.49 -29.95 27.56 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.932 0.493 . . . . 74.2 111.409 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.632 ' HA3' ' HB3' ' E' ' 14' ' ' LEU . . . -106.25 3.98 37.9 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 114.6 0.6 . . . . 73.35 114.6 -168.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.589 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -146.62 -53.41 0.24 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.832 0.316 . . . . 72.15 111.674 -176.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.434 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 66.4 t80 -73.09 -65.92 0.74 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 123.445 0.465 . . . . 73.1 112.084 -171.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.587 ' SG ' HD13 ' A' ' 86' ' ' ILE . 92.3 m -68.13 -32.91 4.37 Favored Pre-proline 0 CA--C 1.566 1.56 0 N-CA-C 115.135 1.532 . . . . 74.54 115.135 -172.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 25.9 Cg_endo -63.24 -32.04 73.73 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 121.824 1.683 . . . . 75.04 112.554 166.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.444 HD21 ' HD2' ' A' ' 133' ' ' PHE . 29.3 t-20 -76.5 -21.44 55.79 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.997 0.519 . . . . 75.43 110.715 176.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 42.1 mm -67.46 -36.38 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 109.501 -0.555 . . . . 74.54 109.501 170.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.52 HD23 ' HG3' ' A' ' 80' ' ' GLN . 94.7 mt -79.77 -17.52 53.22 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.426 0.69 . . . . 64.3 112.211 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -61.43 -48.79 89.88 Favored Pre-proline 0 CA--C 1.57 1.715 0 CA-C-O 117.933 -1.032 . . . . 75.3 113.546 -175.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.31 -34.1 45.82 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 121.954 1.769 . . . . 73.5 112.909 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -72.67 -40.15 66.54 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.312 0.645 . . . . 72.43 111.382 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.62 -39.45 70.42 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.994 0.518 . . . . 74.24 110.449 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.485 ' NH1' HG23 ' C' ' 105' ' ' ILE . 30.6 ttm180 -54.35 -51.69 63.98 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 124.173 0.921 . . . . 75.11 109.829 173.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -65.75 -42.06 91.37 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.38 1.05 . . . . 73.35 111.558 -175.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 46.2 t -61.51 -42.85 99.43 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.837 0.711 . . . . 72.21 110.329 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.06 -48.1 87.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 O-C-N 124.108 0.88 . . . . 73.23 110.407 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 35.8 m -56.65 -38.55 72.31 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.913 0.885 . . . . 74.23 111.377 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.1 t -68.69 -46.22 69.63 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.435 -0.802 . . . . 65.53 110.353 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.447 ' SD ' HG22 ' A' ' 21' ' ' ILE . 27.1 mtp -59.0 -42.57 90.37 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.884 0.874 . . . . 72.31 111.406 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.473 HG23 HD21 ' A' ' 126' ' ' LEU . 68.9 t -65.72 -44.05 93.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 124.652 1.181 . . . . 74.11 110.71 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 37.5 t -71.43 -31.13 66.85 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.239 0.616 . . . . 65.23 110.935 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.447 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 90.8 mtt-85 -73.98 -32.14 63.3 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.758 0.823 . . . . 72.5 109.512 175.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.417 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.74 12.15 57.55 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 115.453 -0.794 . . . . 63.25 112.823 172.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.417 HG22 ' O ' ' A' ' 121' ' ' GLY . 2.8 t 60.94 15.02 5.7 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 127.234 2.214 . . . . 74.22 114.385 171.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -78.57 155.08 78.82 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 109.019 -0.734 . . . . 74.31 109.019 175.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.68 174.43 2.25 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.636 2.224 . . . . 74.0 113.488 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.1 116.34 1.96 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.2 1.4 . . . . 75.31 111.853 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.53 HD23 HG12 ' A' ' 64' ' ' VAL . 56.9 tp -127.94 106.08 8.85 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.549 0.74 . . . . 72.41 109.152 176.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -130.7 128.33 40.65 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.729 1.212 . . . . 75.14 109.042 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.66 144.92 55.27 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 123.429 0.455 . . . . 75.23 110.079 174.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.491 ' HB3' HG22 ' E' ' 5' ' ' THR . . . -65.17 157.12 78.64 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 124.303 1.041 . . . . 72.3 111.491 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.611 ' HD3' HG13 ' C' ' 13' ' ' ILE . 64.7 Cg_endo -70.37 99.33 0.8 Allowed 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.547 2.165 . . . . 73.22 111.981 176.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.4 t -103.97 112.94 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.793 -0.817 . . . . 73.52 108.793 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 135' ' ' ALA . 1.5 m-20 -95.27 84.12 3.99 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 108.686 -0.857 . . . . 74.31 108.686 177.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.444 ' HD2' HD21 ' A' ' 104' ' ' ASN . 92.5 m-85 -61.57 -54.31 44.75 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 123.333 0.396 . . . . 74.41 110.006 -178.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.589 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 14.7 t70 -63.5 -42.79 98.49 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.593 -1.185 . . . . 72.24 111.231 -173.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.468 ' HB2' ' HB3' ' A' ' 132' ' ' ASN . . . -69.36 -19.5 63.85 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.125 -0.943 . . . . 73.43 112.121 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.627 HD23 HD21 ' E' ' 10' ' ' LEU . 40.0 tp -80.38 -41.39 24.74 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.601 0.36 . . . . 73.15 110.301 173.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -67.42 -30.33 70.05 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.692 0.397 . . . . 71.54 110.891 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 97.1 mmm -78.83 -38.23 38.57 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.314 0.646 . . . . 75.35 110.723 175.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 143' ' ' GLN . 39.3 t30 -57.32 -36.61 71.33 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.286 1.035 . . . . 74.03 110.65 174.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -80.92 -31.84 34.9 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.684 -1.144 . . . . 75.44 110.753 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 28.4 tp -67.27 -53.05 33.41 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.21 0.604 . . . . 75.35 111.81 -173.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 172.82 -18.16 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 124.391 1.076 . . . . 74.34 109.534 -178.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 139' ' ' ASN . 62.5 tt0 -80.77 155.99 26.42 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 109.676 -0.49 . . . . 75.31 109.676 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -155.55 120.06 4.68 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.254 -1.387 . . . . 74.22 107.254 175.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 63.85 100.56 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.336 1.023 . . . . 63.4 110.889 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -53.86 98.38 0.04 OUTLIER Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.979 -0.555 . . . . 63.14 111.856 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -69.47 137.19 52.41 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.298 -1.001 . . . . 71.35 108.298 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -77.19 -162.88 17.21 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-O 121.753 0.64 . . . . 62.22 113.994 -172.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.478 ' H ' HD11 ' G' ' 13' ' ' LEU . 14.5 m -140.76 172.36 12.81 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 108.038 -1.097 . . . . 75.43 108.038 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -129.74 149.28 51.56 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.964 -1.495 . . . . 72.14 106.964 167.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.428 ' HB3' ' HE1' ' C' ' 137' ' ' PHE . 0.1 OUTLIER -128.78 155.17 45.57 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.499 0.666 . . . . 73.35 111.219 -170.572 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -162.38 116.46 1.79 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.164 -1.38 . . . . 74.23 108.13 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -103.63 172.83 6.59 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.854 0.862 . . . . 74.44 111.003 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -126.38 132.49 51.54 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.477 1.111 . . . . 75.44 109.218 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 C-N-CA 123.531 0.732 . . . . 73.04 109.475 179.076 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.448 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 120.65 0.262 . . . . 74.04 110.753 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 45.1 t -164.81 134.07 3.61 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.91 -1.144 . . . . 64.14 107.91 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -85.4 71.04 10.86 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.445 0.64 . . . . 73.42 109.564 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 18.7 tm0? -167.55 135.66 2.46 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 114.478 -1.237 . . . . 75.51 108.663 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -132.48 135.25 45.9 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.871 -1.159 . . . . 74.32 107.871 171.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -80.87 50.26 1.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.793 0.837 . . . . 63.35 110.861 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.1 t -67.05 -35.32 79.6 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.088 0.955 . . . . 75.22 111.018 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -83.46 145.52 28.9 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.97 -0.752 . . . . 73.34 108.97 173.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.541 ' SD ' ' N ' ' B' ' 10' ' ' THR . 1.0 OUTLIER 66.48 163.32 0.17 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 125.736 1.615 . . . . 73.44 110.339 -167.169 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.541 ' N ' ' SD ' ' B' ' 9' ' ' MET . 54.6 m -167.08 130.66 1.85 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.801 0.84 . . . . 73.44 109.685 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' B' ' 85' ' ' SER 0.283 0.5 OUTLIER -155.25 155.85 34.54 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.561 0.696 . . . . 71.14 111.204 143.406 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.741 HE22 ' HB1' ' D' ' 129' ' ' ALA . 25.4 tp60 -127.03 128.38 46.24 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 106.424 -1.695 . . . . 75.35 106.424 172.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.508 HD11 HD12 ' B' ' 105' ' ' ILE . 27.8 mt -68.52 121.34 17.61 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 N-CA-C 108.784 -0.821 . . . . 72.12 108.784 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -90.29 -40.62 12.03 Favored 'General case' 0 C--O 1.243 0.761 0 O-C-N 124.233 0.958 . . . . 74.02 109.583 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.492 ' HA ' ' ND2' ' D' ' 127' ' ' ASN . 28.3 ttt180 -167.56 133.77 2.12 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 116.396 -0.366 . . . . 74.5 111.022 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 86.1 mt -115.56 135.97 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 107.48 -1.304 . . . . 75.04 107.48 173.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -168.73 170.69 9.18 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.98 0.895 . . . . 73.15 113.052 -177.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 86.9 m -96.42 118.03 32.1 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.828 -1.533 . . . . 65.14 108.743 174.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.598 ' HZ3' ' HB2' ' A' ' 28' ' ' ALA . 24.8 mtpp -79.8 -28.99 40.19 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.985 0.514 . . . . 73.32 110.543 176.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -162.7 149.93 13.37 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.218 0.533 . . . . 73.24 112.045 -171.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.622 HD12 ' SG ' ' B' ' 113' ' ' CYS . 28.3 mm -137.89 144.88 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 126.216 1.806 . . . . 75.23 108.612 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 46.2 t -147.64 126.66 12.83 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.965 -1.016 . . . . 75.02 108.786 169.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 85.3 t80 -138.81 109.82 6.8 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 107.529 -1.286 . . . . 74.05 107.529 171.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -119.09 115.47 24.34 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.922 0.889 . . . . 74.52 108.724 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.95 86.35 1.91 Allowed Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 107.091 -1.448 . . . . 55.12 107.091 169.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.88 -45.23 8.6 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.567 2.178 . . . . 73.4 112.131 -169.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 49.4 m-20 -100.59 18.05 20.2 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.674 0.79 . . . . 73.21 110.748 -176.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.527 ' HB2' ' HE3' ' A' ' 19' ' ' LYS . . . -31.12 -68.67 0.13 Allowed Pre-proline 0 N--CA 1.504 2.242 0 N-CA-C 115.419 1.637 . . . . 73.43 115.419 -166.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.37 -13.48 33.19 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 122.336 2.024 . . . . 71.34 113.078 -171.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -92.2 -45.7 8.12 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.544 0.738 . . . . 73.31 110.258 177.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.59 HG21 HD13 ' B' ' 68' ' ' LEU . 9.0 p -69.57 -17.62 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 112.295 0.48 . . . . 73.23 112.295 -171.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -62.92 -18.8 63.55 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.013 0.525 . . . . 63.1 112.383 173.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -65.98 -20.96 66.37 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.609 0.764 . . . . 75.22 110.817 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.505 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 95.4 mttt -103.99 71.27 1.03 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.835 1.254 . . . . 73.15 108.743 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -82.75 91.95 7.12 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.178 -0.919 . . . . 74.31 111.727 -173.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -158.64 -175.18 5.16 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.136 0.974 . . . . 73.2 109.52 170.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -72.74 111.59 11.84 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 123.663 0.785 . . . . 75.15 110.145 176.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.46 153.77 75.67 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.336 2.024 . . . . 72.44 112.216 178.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -69.31 113.93 7.09 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.56 -0.745 . . . . 71.51 109.16 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 12.8 t -86.46 121.35 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 122.991 0.517 . . . . 65.11 109.899 -173.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -115.86 128.63 55.96 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 107.244 -1.391 . . . . 71.42 107.244 172.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.738 HD23 ' HA ' ' F' ' 6' ' ' ILE . 0.2 OUTLIER -131.19 148.76 52.75 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.134 0.573 . . . . 74.32 109.763 174.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -153.2 129.82 10.77 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.066 0.946 . . . . 72.12 108.713 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 85.7 mt -99.47 150.91 21.71 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.691 0.797 . . . . 73.45 110.04 -176.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.543 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.0 t70 -137.14 139.68 41.35 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.777 -0.823 . . . . 64.31 108.777 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.8 p -109.8 124.23 50.93 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.392 0.677 . . . . 73.52 110.808 -175.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.94 135.36 46.54 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.42 1.088 . . . . 74.33 108.965 176.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 16.2 m -144.35 161.77 38.15 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.76 0.424 . . . . 75.22 111.385 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 53.9 p -160.55 143.39 13.17 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.328 -0.851 . . . . 72.01 109.769 174.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.404 ' NE2' ' HB2' ' F' ' 20' ' ' LYS . 41.0 tp60 -80.29 107.08 12.8 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 107.821 -1.178 . . . . 72.4 107.821 172.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.602 HD12 ' HB2' ' B' ' 57' ' ' GLU . 40.2 mt -77.09 -42.08 39.6 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.275 0.559 . . . . 74.53 110.295 -174.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.22 -166.06 1.85 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.248 1.019 . . . . 75.43 109.827 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . 0.482 ' HB3' ' HB3' ' F' ' 25' ' ' GLU . 8.1 p-10 -69.96 131.39 44.33 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.251 0.62 . . . . 62.4 109.764 175.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 64.75 -10.4 0.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 125.727 1.611 . . . . 72.42 112.343 -171.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.406 HG13 ' HB2' ' B' ' 51' ' ' LEU . 91.1 t -110.7 121.82 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 O-C-N 121.502 -0.749 . . . . 74.44 109.468 -165.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -133.58 -176.48 4.17 Favored 'General case' 0 C--O 1.247 0.973 0 N-CA-C 107.796 -1.187 . . . . 70.4 107.796 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.602 ' HB2' HD12 ' B' ' 51' ' ' LEU . 35.4 tt0 -139.19 129.24 25.15 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.391 0.276 . . . . 72.52 110.608 -177.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 82.8 t -97.11 117.99 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.433 -0.951 . . . . 72.24 108.433 170.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 41.2 t -116.79 110.58 31.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.963 -1.125 . . . . 73.34 107.963 174.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 30.3 tp -107.28 107.85 18.98 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.337 -0.986 . . . . 73.15 108.337 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.543 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 45.9 ttt180 -84.74 114.44 22.05 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.52 -0.918 . . . . 73.43 108.52 176.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.6 t -102.69 105.07 17.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.968 -1.123 . . . . 73.03 107.968 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 33.1 m -95.45 138.37 33.23 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.511 -0.922 . . . . 74.53 108.511 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.55 133.26 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.563 0.745 . . . . 73.42 109.612 177.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.2 m -119.39 145.3 46.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.396 1.078 . . . . 74.34 108.421 169.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.57 129.34 26.49 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.849 -0.797 . . . . 74.54 108.849 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 30.9 p -123.11 127.83 49.25 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.587 0.755 . . . . 73.11 110.638 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.59 HD13 HG21 ' B' ' 31' ' ' VAL . 44.6 mt -102.63 109.39 20.99 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.061 0.944 . . . . 75.11 109.176 172.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.81 -110.56 3.55 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 114.958 -1.019 . . . . 62.11 113.398 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -105.08 4.02 31.04 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.007 0.923 . . . . 74.24 111.708 -174.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.505 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 12.6 pt-20 -139.53 164.79 28.97 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.743 0.417 . . . . 70.35 110.863 -176.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 63.3 m -79.07 125.6 29.61 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.479 0.712 . . . . 73.3 110.719 -177.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.536 ' HA ' HG22 ' B' ' 31' ' ' VAL . . . -70.55 -63.2 1.14 Allowed 'General case' 0 C--O 1.24 0.559 0 O-C-N 123.966 0.792 . . . . 71.45 109.16 171.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -155.08 164.54 38.72 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.462 -1.245 . . . . 74.22 111.724 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 55.4 mt -126.13 111.36 14.56 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 105.545 -2.02 . . . . 74.02 105.545 173.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.494 ' SG ' HG21 ' B' ' 114' ' ' ILE . 31.5 t -119.12 140.18 50.56 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.733 -0.84 . . . . 74.41 108.733 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -160.02 136.2 8.74 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.101 0.477 . . . . 70.34 110.045 -170.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 88.7 t -132.94 151.6 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.746 1.219 . . . . 75.35 108.248 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.54 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 17.3 mt-30 -124.52 98.85 5.91 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.795 -1.187 . . . . 73.23 107.795 170.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.436 ' HB2' ' HB1' ' B' ' 110' ' ' ALA . 7.8 tp-100 -88.76 99.86 12.69 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.645 -0.872 . . . . 74.3 108.645 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.84 141.51 15.62 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.303 -1.119 . . . . 64.4 110.303 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.12 127.08 3.13 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 110.673 -0.971 . . . . 75.45 110.673 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 55.3 mt -89.78 127.41 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.788 0.835 . . . . 71.24 109.084 176.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -135.56 135.06 40.02 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.129 -1.434 . . . . 75.2 107.129 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 67.6 m -99.45 89.92 4.34 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.403 0.547 . . . . 72.23 110.864 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.531 HG23 HG22 ' F' ' 18' ' ' VAL . 12.7 tt -95.54 141.43 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.221 1.008 . . . . 72.22 111.607 -172.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.16 166.73 32.42 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.604 0.761 . . . . 71.21 110.436 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.96 -51.55 1.3 Allowed Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.742 -0.663 . . . . 71.11 112.54 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 17.4 mm -90.71 152.82 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.483 0.713 . . . . 75.13 112.315 -174.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.663 ' HA ' ' HE2' ' B' ' 94' ' ' MET . 40.1 tt0 -157.07 157.52 34.74 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 114.628 -1.169 . . . . 74.54 110.056 176.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.11 -135.0 12.59 Favored Glycine 0 C--N 1.353 1.503 0 C-N-CA 123.264 0.459 . . . . 64.33 113.191 170.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m -82.97 -18.32 40.35 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.212 0.605 . . . . 71.45 110.587 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -57.06 -38.74 73.71 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.887 0.875 . . . . 74.15 111.203 173.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.663 ' HE2' ' HA ' ' B' ' 90' ' ' GLU . 17.1 ptp -78.57 -25.37 45.31 Favored 'General case' 0 C--O 1.208 -1.107 0 CA-C-O 119.112 -0.471 . . . . 73.21 111.412 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.63 -34.67 67.5 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 122.963 0.505 . . . . 72.45 111.967 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -75.27 -47.3 28.62 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.815 0.846 . . . . 75.12 111.184 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.401 ' SG ' ' HE3' ' B' ' 9' ' ' MET . 43.2 t -64.11 -49.62 71.47 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.248 0.619 . . . . 64.43 111.415 -175.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.503 HD12 HG23 ' F' ' 18' ' ' VAL . 60.4 mt -72.51 -27.99 62.6 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.27 -0.877 . . . . 75.12 111.321 -176.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.7 -0.26 64.56 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-O 119.688 -0.507 . . . . 70.24 113.88 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.5 -62.73 0.46 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 117.384 0.592 . . . . 65.11 111.643 -176.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.444 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 33.7 t80 -64.6 -46.36 82.98 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.986 0.914 . . . . 72.45 111.646 -171.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 39.9 m -73.58 -46.66 7.33 Favored Pre-proline 0 CA--C 1.567 1.624 0 N-CA-C 113.128 0.788 . . . . 64.04 113.128 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -69.12 -21.64 36.16 Favored 'Trans proline' 0 C--N 1.395 2.994 0 C-N-CA 122.022 1.815 . . . . 73.13 113.264 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -57.62 -36.34 71.67 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 124.112 0.965 . . . . 73.51 111.118 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.508 HD12 HD11 ' B' ' 13' ' ' ILE . 68.9 mt -68.74 -43.14 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.666 1.186 . . . . 75.22 110.945 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 78.4 mt -82.94 -22.39 33.82 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.858 -1.065 . . . . 61.14 111.923 -172.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -55.54 -51.34 80.88 Favored Pre-proline 0 CA--C 1.562 1.433 0 CA-C-O 117.655 -1.164 . . . . 73.12 113.062 -175.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.14 -38.47 94.84 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 122.257 1.972 . . . . 75.54 113.744 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -69.41 -48.88 59.68 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.183 0.593 . . . . 74.32 110.747 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.436 ' HB1' ' HB2' ' B' ' 80' ' ' GLN . . . -62.93 -39.87 95.91 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.066 0.546 . . . . 64.43 111.194 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -59.38 -53.97 52.13 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.064 1.346 . . . . 73.23 111.146 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -68.19 -31.63 71.29 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.533 0.733 . . . . 73.12 110.032 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.622 ' SG ' HD12 ' B' ' 21' ' ' ILE . 12.6 t -68.16 -33.67 74.9 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.984 0.514 . . . . 74.31 111.188 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.494 HG21 ' SG ' ' B' ' 76' ' ' CYS . 78.9 mt -68.14 -52.23 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.162 0.585 . . . . 63.34 109.764 172.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.4 m -59.19 -30.44 68.21 Favored 'General case' 0 CA--C 1.553 1.074 0 O-C-N 123.971 0.794 . . . . 74.3 111.666 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 37.3 t -64.38 -50.77 66.37 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 123.498 0.719 . . . . 75.44 109.976 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.483 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.4 mmt -69.27 -32.48 71.69 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 123.615 0.572 . . . . 74.45 111.223 -174.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 114' ' ' ILE . 89.4 t -61.95 -47.44 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.653 0.781 . . . . 75.51 110.307 173.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 34.6 t -62.14 -37.3 84.65 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.81 -1.087 . . . . 74.32 110.799 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.417 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 93.1 mtt-85 -67.68 -32.3 72.87 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 115.435 -0.802 . . . . 74.11 110.612 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.76 4.7 84.36 Favored Glycine 0 C--N 1.349 1.302 0 O-C-N 123.717 0.636 . . . . 50.14 112.905 174.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 68.2 p 57.96 33.97 23.77 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 126.113 1.765 . . . . 74.32 113.204 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -93.99 163.8 22.55 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 123.99 0.916 . . . . 74.3 110.726 177.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.09 170.4 1.12 Allowed 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.537 2.825 . . . . 65.43 115.198 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -64.05 114.36 4.1 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.41 1.084 . . . . 72.14 110.903 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.94 84.72 2.24 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.157 -1.053 . . . . 72.45 108.157 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -108.81 118.53 37.02 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.629 0.772 . . . . 74.33 109.073 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.581 HD22 HD13 ' B' ' 42' ' ' LEU . 0.3 OUTLIER -70.85 133.03 46.14 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.505 0.722 . . . . 72.44 109.23 -177.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -66.76 144.04 98.38 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.428 0.691 . . . . 73.41 111.773 -176.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 12.3 Cg_exo -71.18 92.58 0.65 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.9 2.4 . . . . 74.23 112.686 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' F' ' 8' ' ' LEU . 48.3 t -98.13 110.11 25.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.434 -0.95 . . . . 74.43 108.434 172.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . 0.491 HD21 ' HB3' ' B' ' 135' ' ' ALA . 34.4 t30 -89.87 114.09 25.8 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.026 -0.731 . . . . 73.03 109.026 176.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -60.88 -43.16 98.82 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.521 0.728 . . . . 74.52 111.0 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -57.74 -49.7 75.68 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 114.837 -1.074 . . . . 65.24 112.734 -173.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.491 ' HB3' HD21 ' B' ' 132' ' ' ASN . . . -57.63 -38.33 74.82 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.277 0.985 . . . . 74.21 112.801 -171.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 mp -77.43 -37.42 51.72 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.863 -0.608 . . . . 75.34 110.181 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -68.18 -28.7 67.5 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.457 0.303 . . . . 65.31 111.611 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 84.4 mtp -60.33 -39.91 88.76 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.323 0.649 . . . . 74.32 111.147 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -85.69 -24.54 26.95 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.655 -1.157 . . . . 74.23 110.169 -170.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -71.7 -33.52 68.85 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.978 0.418 . . . . 74.32 110.151 173.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 80.7 mt -92.61 27.38 2.33 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.52 0.728 . . . . 74.34 110.95 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -63.55 138.75 58.63 Favored 'General case' 0 C--N 1.358 0.954 0 C-N-CA 123.195 0.598 . . . . 73.51 111.122 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -175.19 122.59 0.22 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.123 1.369 . . . . 71.2 107.45 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -91.56 128.08 37.26 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.809 0.444 . . . . 74.33 110.563 -176.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.95 178.23 5.18 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.096 0.559 . . . . 53.43 109.652 170.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -149.17 152.91 24.84 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.453 -0.659 . . . . 73.43 111.453 178.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . 0.61 ' HA ' ' HA ' ' D' ' 147' ' ' GLU . 41.1 mt-10 -88.47 173.54 8.63 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.784 0.802 . . . . 71.43 111.038 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 166.69 -173.43 42.05 Favored Glycine 0 C--O 1.239 0.466 0 CA-C-N 114.293 -1.321 . . . . 73.52 109.99 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 31.2 p 64.18 156.51 0.07 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.773 1.629 . . . . 63.53 113.196 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -173.85 133.74 0.45 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 106.156 -1.794 . . . . 74.03 106.156 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -136.94 99.89 4.14 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.789 0.328 . . . . 74.53 110.676 -175.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -91.95 160.06 15.45 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.37 0.668 . . . . 75.45 109.496 164.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -165.83 140.07 4.57 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.487 1.115 . . . . 71.21 108.681 174.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -137.12 2.38 2.55 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.483 0.713 . . . . 75.42 110.302 175.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.959 0 C-N-CA 124.087 0.955 . . . . 64.01 109.235 178.699 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 86.0 mtp . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 109.976 -0.379 . . . . 74.13 109.976 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 71.9 p -114.0 127.38 55.93 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.345 0.658 . . . . 74.13 109.743 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -82.2 173.69 11.88 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.276 0.63 . . . . 72.32 110.63 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -64.84 119.08 9.97 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.309 0.644 . . . . 71.33 109.785 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -65.36 -75.95 0.08 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.252 1.021 . . . . 74.44 110.378 -176.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -174.63 117.3 0.2 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 107.591 -1.262 . . . . 73.14 107.591 175.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 7' ' ' THR . . . . . 0.465 HG21 ' HB2' ' A' ' 136' ' ' LEU . 46.7 p -101.66 158.15 16.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.559 0.744 . . . . 74.44 109.665 177.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -62.38 145.79 53.01 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.18 0.592 . . . . 71.12 109.89 167.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.509 ' HE1' ' SG ' ' C' ' 97' ' ' CYS . 0.0 OUTLIER 65.75 133.99 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.917 1.287 . . . . 71.3 111.412 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 35.6 m -127.37 94.93 4.12 Favored 'General case' 0 C--O 1.244 0.768 0 O-C-N 121.644 -0.66 . . . . 74.01 109.91 175.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.503 ' HB3' ' HE3' ' C' ' 9' ' ' MET . 0.2 OUTLIER -123.76 165.22 17.66 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 115.901 -0.591 . . . . 75.43 109.5 162.486 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -134.74 128.28 32.61 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 107.84 -1.17 . . . . 75.01 107.84 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.611 HG13 ' HD3' ' A' ' 130' ' ' PRO . 63.0 mt -65.75 118.27 8.17 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 N-CA-C 107.987 -1.116 . . . . 73.2 107.987 173.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.503 ' HA ' HE21 ' C' ' 14' ' ' GLN . 0.0 OUTLIER -93.82 -36.82 12.07 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 123.981 0.801 . . . . 75.01 108.959 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -178.51 123.28 0.1 Allowed 'General case' 0 C--N 1.361 1.075 0 O-C-N 123.68 0.612 . . . . 75.22 110.766 -172.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.2 mt -109.85 137.91 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.838 1.255 . . . . 71.11 108.923 172.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.483 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 21.1 p90 -174.34 166.77 4.04 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.862 0.865 . . . . 74.31 109.972 -172.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.2 p -91.72 126.33 36.77 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.174 0.589 . . . . 72.14 109.532 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.483 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 14.9 mmtp -74.5 -50.07 19.68 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 107.759 -1.2 . . . . 74.13 107.759 168.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 19.8 t70 -136.08 141.98 44.28 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 113.627 -1.624 . . . . 74.3 109.883 -168.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 88.7 mt -138.37 145.51 28.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 106.604 -1.628 . . . . 75.33 106.604 175.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 22' ' ' SER . . . . . 0.424 ' HB3' ' HB3' ' C' ' 77' ' ' GLU . 42.2 t -154.9 150.11 27.09 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.763 0.825 . . . . 74.15 109.295 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 88.9 t80 -156.86 117.03 3.54 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 107.568 -1.271 . . . . 75.41 107.568 173.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -120.53 111.66 17.96 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.127 0.571 . . . . 73.42 110.146 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.97 82.96 43.68 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.379 1.072 . . . . 72.41 108.274 168.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -69.39 -31.39 22.26 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.588 2.192 . . . . 75.33 110.687 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -96.11 13.82 25.93 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.156 -1.384 . . . . 74.54 110.583 -175.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.99 -56.67 14.26 Favored Pre-proline 0 CA--C 1.566 1.59 0 N-CA-C 113.97 1.1 . . . . 73.54 113.97 -170.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -60.35 -41.41 50.13 Favored 'Trans proline' 0 C--N 1.395 3.014 0 C-N-CA 122.002 1.801 . . . . 71.22 112.075 -177.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -70.24 -38.1 75.1 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.447 -1.251 . . . . 73.43 112.298 -175.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.691 HG21 ' HA ' ' C' ' 73' ' ' ALA . 12.4 p -77.91 -23.02 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 112.471 0.545 . . . . 74.54 112.471 -173.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -64.77 -22.89 67.08 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.081 0.4 . . . . 73.41 112.081 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -103.98 29.51 5.83 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.952 0.901 . . . . 74.53 110.808 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.632 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -114.11 163.35 15.3 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.787 0.835 . . . . 73.23 109.533 173.412 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.52 120.87 11.36 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.621 0.768 . . . . 73.44 109.937 168.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -85.97 90.44 8.09 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.877 0.471 . . . . 75.54 111.133 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -150.25 76.97 8.39 Favored Pre-proline 0 N--CA 1.483 1.208 0 C-N-CA 124.913 1.285 . . . . 74.54 108.216 169.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -84.04 160.57 13.64 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.27 1.98 . . . . 74.53 112.609 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -87.1 119.47 27.35 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 106.207 -1.775 . . . . 74.33 106.207 168.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.548 HG12 HD13 ' C' ' 126' ' ' LEU . 34.9 m -91.36 97.19 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 122.469 1.128 . . . . 65.22 109.47 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.561 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 3.7 ttmp? -96.78 100.32 11.86 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 114.541 -1.208 . . . . 74.03 107.988 177.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 pp -87.93 149.53 24.01 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 109.358 -0.608 . . . . 74.11 109.358 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.476 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 33.6 t70 -149.0 114.17 5.49 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.276 0.63 . . . . 71.21 109.951 -173.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.459 HD21 HD12 ' G' ' 8' ' ' LEU . 9.1 mp -105.26 147.83 27.65 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.226 0.536 . . . . 73.32 110.519 177.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 5.7 t70 -136.36 151.06 49.15 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.334 1.454 . . . . 64.4 107.821 175.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 30.4 p -113.48 112.23 23.26 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.601 -0.518 . . . . 73.41 109.601 -177.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.11 151.62 37.19 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.349 1.06 . . . . 65.52 109.074 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.0 p -166.11 173.59 10.14 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.167 0.432 . . . . 73.32 112.167 -173.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 45.3 t -166.7 146.65 5.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.276 1.031 . . . . 73.51 109.286 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -88.38 118.61 28.12 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.891 -0.781 . . . . 65.03 108.891 170.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.448 HD13 HD13 ' C' ' 83' ' ' ILE . 65.4 mt -89.09 -38.98 13.95 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.352 0.661 . . . . 75.04 110.55 -177.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.53 -174.85 4.18 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.117 -0.947 . . . . 72.51 110.746 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -61.4 104.66 0.43 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 114.317 -1.311 . . . . 75.12 110.001 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 70.9 -2.71 2.22 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 125.894 1.677 . . . . 74.53 113.79 -175.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 71.2 t -93.71 115.61 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 107.748 -1.204 . . . . 70.13 107.748 175.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -133.35 136.99 45.7 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.718 0.771 . . . . 70.35 110.191 -170.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -86.98 113.13 22.48 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.664 1.586 . . . . 74.33 109.211 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 91.2 t -104.47 113.83 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 108.007 -1.109 . . . . 72.12 108.007 174.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -121.57 136.18 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 109.233 -0.655 . . . . 72.33 109.233 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.401 HD22 ' HB3' ' C' ' 103' ' ' PRO . 34.5 tp -120.44 115.96 24.52 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.596 -0.89 . . . . 75.11 108.596 175.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.488 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 15.3 ttm-85 -81.77 130.09 34.95 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.398 -0.964 . . . . 73.44 108.398 173.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.459 ' HB ' HD11 ' C' ' 114' ' ' ILE . 4.2 t -119.02 132.23 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 106.839 -1.541 . . . . 74.15 106.839 171.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 16.1 m -133.36 116.75 16.47 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.014 -0.736 . . . . 74.41 109.014 -177.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.681 HG23 HG21 ' C' ' 114' ' ' ILE . 62.7 t -105.31 114.71 45.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 123.835 0.854 . . . . 74.21 109.464 -175.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 18.5 m -101.79 139.11 37.87 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.559 -0.904 . . . . 75.42 108.559 172.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.46 114.58 13.03 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.887 -1.153 . . . . 74.34 107.887 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 31.4 m -137.0 130.42 31.41 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.104 0.478 . . . . 61.44 111.295 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.632 HD11 ' HG2' ' C' ' 34' ' ' LYS . 11.6 mt -86.32 46.88 1.39 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.795 1.238 . . . . 74.4 109.72 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.88 -109.67 3.56 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 110.699 -0.96 . . . . 75.14 110.699 -174.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -89.6 -23.93 21.82 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.467 0.707 . . . . 54.02 110.241 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -72.54 122.64 21.67 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 123.798 0.839 . . . . 73.54 110.005 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.0 m -82.94 128.04 34.09 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.976 -0.75 . . . . 74.04 108.976 168.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.691 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -80.52 -55.27 4.98 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 123.789 0.68 . . . . 73.3 109.525 172.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -162.6 175.65 11.18 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.116 0.96 . . . . 75.02 111.575 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -137.53 147.36 45.11 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 105.997 -1.853 . . . . 71.21 105.997 171.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 41.9 t -147.78 153.26 38.99 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.588 -0.893 . . . . 71.34 108.588 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' C' ' 22' ' ' SER . 34.6 tt0 -158.1 133.25 8.66 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 122.847 0.459 . . . . 75.21 110.243 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' C' ' 110' ' ' ALA . 49.1 t -137.52 114.43 12.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.481 1.112 . . . . 75.0 108.547 177.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.482 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 58.4 mt-30 -95.85 94.17 7.49 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.693 -0.854 . . . . 75.15 108.693 174.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.467 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 9.5 tp-100 -82.27 111.01 17.96 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.454 -0.794 . . . . 74.52 109.693 -176.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.46 148.08 18.86 Favored Glycine 0 C--N 1.335 0.522 0 O-C-N 123.827 0.705 . . . . 63.25 112.079 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.05 118.57 0.97 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.096 -1.201 . . . . 72.31 110.096 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.448 HD13 HD13 ' C' ' 51' ' ' LEU . 15.0 mm -84.42 128.13 39.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.617 -0.883 . . . . 65.03 108.617 176.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.433 ' HB2' HD11 ' C' ' 86' ' ' ILE . 26.5 m-85 -136.42 149.13 48.12 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.883 -1.154 . . . . 74.25 107.883 176.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 19.4 p -102.61 109.75 21.46 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 108.949 -0.759 . . . . 64.33 108.949 174.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.433 HD11 ' HB2' ' C' ' 84' ' ' PHE . 4.4 mp -108.58 122.08 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.107 0.563 . . . . 75.04 109.95 -167.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.56 167.58 27.62 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 114.538 -1.21 . . . . 60.53 109.651 175.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.46 -60.67 0.36 Allowed Glycine 0 C--N 1.344 0.973 0 CA-C-N 116.104 -0.498 . . . . 71.45 113.088 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 41.0 pt -113.33 167.55 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.202 0.525 . . . . 75.2 111.294 -176.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -149.18 -177.49 5.85 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.975 -1.011 . . . . 71.34 110.106 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.36 -139.99 42.56 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.68 -0.691 . . . . 44.04 114.077 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 39.4 p -68.99 -27.52 65.78 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.91 0.884 . . . . 64.34 111.33 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -61.48 -45.28 94.9 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.302 0.641 . . . . 74.15 110.157 175.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.649 ' HE1' HD12 ' C' ' 98' ' ' LEU . 9.8 ptm -77.32 -21.8 52.9 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-O 119.221 -0.419 . . . . 63.53 111.068 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.32 -36.72 82.05 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.193 0.52 . . . . 73.22 109.947 172.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.557 ' HA ' HD13 ' G' ' 13' ' ' LEU . 46.3 t-80 -60.9 -33.26 72.86 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.783 0.833 . . . . 73.43 110.744 173.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.509 ' SG ' ' HE1' ' C' ' 9' ' ' MET . 42.8 t -77.79 -57.87 3.57 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.039 -0.528 . . . . 73.03 110.704 176.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.649 HD12 ' HE1' ' C' ' 94' ' ' MET . 96.0 mt -71.18 -37.84 72.15 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.101 0.96 . . . . 63.22 113.386 -165.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.2 -11.15 34.69 Favored Glycine 0 N--CA 1.471 0.993 0 CA-C-O 120.007 -0.329 . . . . 71.34 113.871 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' C' ' 96' ' ' HIS . . . -116.82 -57.61 2.16 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 117.161 0.481 . . . . 74.41 110.742 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -76.74 -47.72 20.92 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.467 0.707 . . . . 75.53 112.506 -174.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.41 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 58.6 m -65.11 -46.57 73.25 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 123.886 0.875 . . . . 54.44 112.722 -173.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.401 ' HB3' HD22 ' C' ' 60' ' ' LEU . 14.1 Cg_exo -72.1 -15.83 28.83 Favored 'Trans proline' 0 C--N 1.392 2.858 0 C-N-CA 122.148 1.899 . . . . 75.54 112.352 176.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -74.48 -33.26 62.81 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.465 0.706 . . . . 75.35 110.083 175.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.485 HG23 ' NH1' ' A' ' 111' ' ' ARG . 48.0 mm -61.34 -40.74 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 115.607 -0.724 . . . . 73.42 109.279 170.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 81.4 mt -87.25 -18.9 29.17 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.852 -1.067 . . . . 73.11 112.923 -173.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -57.72 -51.6 80.55 Favored Pre-proline 0 CA--C 1.559 1.316 0 CA-C-O 117.755 -1.117 . . . . 71.12 113.5 -174.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.17 -30.73 91.97 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 122.032 1.821 . . . . 72.41 113.399 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -68.77 -49.48 58.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.248 0.619 . . . . 72.02 110.643 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.511 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -65.16 -35.85 82.39 Favored 'General case' 0 C--N 1.355 0.843 0 CA-C-N 115.759 -0.655 . . . . 74.12 110.684 177.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -58.82 -51.08 71.51 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.381 1.073 . . . . 72.34 110.746 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.74 -37.57 79.52 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.789 -0.448 . . . . 75.12 109.789 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.9 t -66.06 -31.83 72.94 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.042 0.537 . . . . 71.1 111.51 -176.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.681 HG21 HG23 ' C' ' 64' ' ' VAL . 96.7 mt -72.63 -54.98 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.358 -0.608 . . . . 74.41 109.358 173.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.9 m -60.31 -28.25 67.97 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.935 0.772 . . . . 75.31 111.278 -175.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 30.6 t -66.7 -49.83 64.8 Favored 'General case' 0 C--O 1.213 -0.844 0 N-CA-C 108.734 -0.839 . . . . 64.41 108.734 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.527 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.4 -37.31 83.0 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.454 1.102 . . . . 75.51 112.401 178.17 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.407 HG23 ' O ' ' C' ' 114' ' ' ILE . 76.4 t -63.24 -45.29 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.718 0.807 . . . . 75.31 109.044 174.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 44.5 t -70.55 -26.26 63.47 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.561 -1.2 . . . . 71.21 112.113 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -75.83 -40.56 54.66 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.632 0.773 . . . . 75.4 108.949 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.27 -0.39 61.56 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 123.903 0.752 . . . . 74.13 112.348 168.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.461 HG21 ' HB3' ' D' ' 17' ' ' TYR . 31.0 p 62.75 28.4 16.49 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.692 1.997 . . . . 74.5 113.415 170.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -83.57 141.24 41.72 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 107.997 -1.112 . . . . 73.2 107.997 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -50.98 156.46 4.82 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 123.682 2.922 . . . . 64.34 114.232 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -50.62 111.83 0.6 Allowed 'General case' 0 N--CA 1.481 1.094 0 O-C-N 124.473 1.108 . . . . 74.21 112.695 -171.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.548 HD13 HG12 ' C' ' 40' ' ' VAL . 31.2 tp -112.73 87.51 2.6 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.217 -1.401 . . . . 75.02 107.217 171.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -107.69 107.67 18.57 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.149 -1.056 . . . . 72.1 108.149 -172.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 30.7 tp -65.99 142.59 57.79 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.519 0.512 . . . . 75.54 111.157 -174.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.29 152.92 95.65 Favored Pre-proline 0 CA--C 1.555 1.141 0 O-C-N 124.072 0.858 . . . . 72.41 110.888 178.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.77 143.84 68.58 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.965 2.443 . . . . 75.13 113.559 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.664 HG11 HD13 ' G' ' 8' ' ' LEU . 7.0 p -128.6 110.35 21.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-O 122.665 1.221 . . . . 74.22 109.595 173.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -92.06 84.39 5.29 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.63 -1.989 . . . . 64.13 105.63 169.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -47.15 -44.29 21.7 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.765 0.826 . . . . 74.53 111.883 -171.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.428 ' HB2' ' HB1' ' C' ' 100' ' ' ALA . 16.1 t70 -62.92 -45.28 93.22 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.628 -1.169 . . . . 64.11 112.468 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.45 -21.08 65.56 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.257 0.623 . . . . 74.31 112.386 -175.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.26 -41.2 97.06 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.044 0.538 . . . . 73.51 110.612 169.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.428 ' HE1' ' HB3' ' A' ' 151' ' ' GLU . 83.5 m-85 -70.15 -38.25 75.43 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.571 0.749 . . . . 75.41 111.419 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 85.8 mtp -68.11 -37.92 81.68 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.757 -0.656 . . . . 74.41 110.342 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.14 -37.01 68.9 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.985 1.314 . . . . 75.42 111.266 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -56.43 -82.26 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.353 1.061 . . . . 74.51 111.389 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -62.24 -33.14 74.02 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 113.513 0.931 . . . . 75.23 113.513 -170.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -67.23 151.61 47.22 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 120.833 0.349 . . . . 71.45 111.379 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -66.96 -53.02 35.78 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.295 -0.866 . . . . 72.23 109.25 171.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 62.26 96.39 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.676 1.191 . . . . 70.11 110.711 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.32 157.84 28.68 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.307 0.643 . . . . 71.52 110.019 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . 0.697 ' HA3' ' HA2' ' A' ' 88' ' ' GLY . . . 149.34 -157.09 27.11 Favored Glycine 0 C--N 1.343 0.947 0 C-N-CA 121.02 -0.61 . . . . 75.14 114.446 172.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -152.38 142.99 22.79 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.046 0.938 . . . . 71.44 109.195 -170.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.27 -119.06 4.17 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 111.011 -0.836 . . . . 73.24 111.011 172.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 8.3 m -162.92 156.6 20.13 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.586 0.754 . . . . 75.01 110.491 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -111.23 101.78 10.25 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 108.031 -1.1 . . . . 75.1 108.031 170.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -101.48 133.44 46.12 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.812 -0.81 . . . . 72.2 108.812 169.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -70.24 95.11 0.97 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.228 0.611 . . . . 74.21 109.631 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -153.56 129.39 10.17 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.797 0.839 . . . . 74.13 109.158 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -142.85 117.96 10.09 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.191 0.596 . . . . 73.34 109.499 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.168 0 C-N-CA 123.25 0.62 . . . . 72.01 110.457 -179.07 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.1 pmm? . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 121.04 0.448 . . . . 74.42 110.642 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 17.0 t -149.79 162.02 41.11 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.699 0.8 . . . . 73.13 109.197 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -158.02 -42.37 0.06 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.408 0.283 . . . . 73.11 110.891 -174.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -69.63 96.84 0.98 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.506 0.723 . . . . 75.45 111.252 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -153.8 15.56 0.49 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.069 0.948 . . . . 64.12 111.334 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -53.02 -71.28 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.524 1.13 . . . . 74.54 111.302 -174.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 12.3 t 176.18 -170.69 0.07 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.708 1.603 . . . . 74.34 107.678 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.13 132.37 42.18 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 118.887 0.767 . . . . 71.22 109.372 174.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 28.2 ttt -33.28 129.12 0.27 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 115.16 1.541 . . . . 75.1 115.16 174.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 59.8 m -107.96 142.47 38.03 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.504 1.121 . . . . 75.24 108.307 165.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -157.38 118.74 3.66 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.486 -1.302 . . . . 74.45 107.486 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -123.87 115.29 21.07 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.255 -1.017 . . . . 72.41 108.255 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.481 HG21 HD13 ' D' ' 16' ' ' ILE . 56.7 mt -75.72 123.95 32.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.586 -0.894 . . . . 72.43 108.586 173.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -89.81 -40.14 12.65 Favored 'General case' 0 C--O 1.245 0.836 0 O-C-N 123.473 0.483 . . . . 73.32 111.239 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -175.9 128.74 0.24 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 119.645 -0.217 . . . . 75.05 110.929 -163.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.481 HD13 HG21 ' D' ' 13' ' ' ILE . 3.4 mp -112.05 140.89 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.924 -1.139 . . . . 75.23 107.924 166.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.468 ' HE1' HG13 ' D' ' 83' ' ' ILE . 26.0 p90 -161.91 168.43 22.95 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 124.257 0.973 . . . . 72.24 110.41 -177.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -99.46 120.74 40.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.595 -1.184 . . . . 73.23 109.251 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -90.29 -18.32 25.81 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.92 -0.582 . . . . 72.43 109.56 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.1 t70 -160.99 141.05 10.98 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 114.691 -1.141 . . . . 71.22 109.686 177.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.527 HG23 ' HE1' ' C' ' 117' ' ' MET . 67.0 mt -139.14 140.55 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.978 1.311 . . . . 75.23 107.475 174.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.7 t -142.49 140.04 31.73 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.089 0.955 . . . . 54.41 108.927 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.577 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 94.3 t80 -152.19 119.02 5.76 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 106.527 -1.657 . . . . 73.53 106.527 173.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 28.9 mt-10 -134.58 108.64 8.18 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.834 -0.802 . . . . 70.3 108.834 -173.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.4 92.03 9.26 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 109.007 -0.738 . . . . 74.44 109.007 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.74 -52.72 0.39 Allowed 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.044 2.496 . . . . 73.35 112.342 -172.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -94.23 13.25 23.99 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-N 114.943 -1.026 . . . . 73.33 110.32 -174.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -28.7 -61.97 0.21 Allowed Pre-proline 0 CA--C 1.566 1.591 0 N-CA-C 115.984 1.846 . . . . 74.14 115.984 -165.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.414 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 91.2 Cg_endo -78.04 -22.97 9.57 Favored 'Trans proline' 0 C--N 1.384 2.401 0 CA-C-N 122.782 2.029 . . . . 74.52 113.905 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -71.08 -41.3 70.85 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.592 1.157 . . . . 75.43 109.359 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.484 HG23 ' HA ' ' D' ' 73' ' ' ALA . 9.9 p -83.52 -20.69 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.614 -0.721 . . . . 75.2 111.617 -171.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.414 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.4 m-85 -61.85 -28.37 69.44 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.002 0.429 . . . . 75.12 111.71 176.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -59.4 -25.62 64.44 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.79 -1.095 . . . . 54.42 110.341 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.729 ' HZ1' ' HG2' ' D' ' 71' ' ' GLU . 99.4 mttt -86.28 87.01 7.35 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.538 1.135 . . . . 74.42 109.834 170.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -84.04 93.07 8.01 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.003 -0.999 . . . . 72.42 110.944 -177.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 36.9 p90 -164.36 171.27 15.0 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.21 1.004 . . . . 72.21 109.428 167.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.539 HE21 ' HD2' ' D' ' 38' ' ' PRO . 27.7 tp60 -60.76 113.37 7.5 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 123.792 0.837 . . . . 72.33 109.051 176.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.725 ' HD3' ' HG2' ' D' ' 124' ' ' PRO . 62.7 Cg_exo -52.93 124.03 14.52 Favored 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 122.77 2.313 . . . . 74.23 111.693 -177.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -68.02 111.63 4.54 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 124.38 1.05 . . . . 75.55 108.186 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.448 HG13 ' O ' ' D' ' 38' ' ' PRO . 16.6 m -99.86 144.66 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.973 0.892 . . . . 74.12 112.507 -165.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.493 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 17.7 tppt? -113.93 113.46 24.88 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.622 -1.621 . . . . 73.43 106.622 171.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 pp -94.87 141.06 29.08 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 108.069 -1.086 . . . . 74.52 108.069 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.601 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 32.8 t70 -145.68 138.13 25.67 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.487 0.715 . . . . 72.22 109.081 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -116.21 134.96 54.34 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.901 -0.777 . . . . 72.53 108.901 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 35.4 t70 -136.67 157.76 46.03 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 106.832 -1.544 . . . . 64.31 106.832 170.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.9 t -137.09 154.09 50.4 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.256 0.55 . . . . 75.54 111.328 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.38 165.77 32.08 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.906 1.283 . . . . 71.24 108.838 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 32.0 p -172.55 153.89 2.96 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.047 0.539 . . . . 75.32 111.649 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 33.7 p -157.2 120.33 4.06 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 114.722 -1.127 . . . . 42.54 108.554 173.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' D' ' 56' ' ' TYR . 61.7 tt0 -65.59 129.16 38.77 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.353 -0.61 . . . . 74.23 109.353 173.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 76.9 mt -94.96 -38.16 10.81 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.073 0.549 . . . . 71.13 110.971 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.89 -170.3 2.68 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.128 0.49 . . . . 74.23 111.294 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.44 118.13 7.67 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.839 -1.073 . . . . 74.1 109.739 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 67.83 -1.29 1.73 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.833 1.253 . . . . 64.24 112.794 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.56 123.91 65.83 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 N-CA-C 108.954 -0.758 . . . . 73.21 108.954 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' D' ' 50' ' ' GLN . 0.1 OUTLIER -136.13 150.05 48.92 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.959 -0.756 . . . . 73.32 108.959 177.002 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -110.55 134.38 52.44 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.504 -1.295 . . . . 71.22 107.504 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 76.9 t -127.28 131.16 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.617 1.167 . . . . 75.3 108.814 -172.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.479 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 21.7 t -121.56 131.94 71.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 123.446 0.699 . . . . 74.53 109.67 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.494 HD21 HD11 ' D' ' 106' ' ' LEU . 3.9 mm? -117.87 107.97 14.76 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.447 -0.946 . . . . 74.23 108.447 168.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.552 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 15.8 ttm-85 -82.24 101.9 10.81 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.876 0.87 . . . . 75.45 109.08 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 84.7 t -94.09 129.99 43.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.725 -0.843 . . . . 74.42 108.725 174.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 21.7 m -125.03 133.33 53.0 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.804 0.442 . . . . 73.55 110.194 -176.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 42.2 t -124.81 101.07 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.667 1.187 . . . . 64.22 108.703 175.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 93.4 m -92.99 106.45 18.41 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.881 -1.155 . . . . 74.14 107.881 170.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.61 142.37 42.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.893 -0.594 . . . . 70.35 110.011 -171.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.4 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 19.8 m -145.15 137.01 25.59 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.122 -0.49 . . . . 75.33 110.57 -175.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 21.2 mt -105.14 110.82 23.34 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.071 -1.085 . . . . 74.34 108.071 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.54 -130.01 17.48 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 116.229 -0.441 . . . . 43.11 113.242 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -89.6 4.19 50.18 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.348 0.659 . . . . 74.14 111.92 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.729 ' HG2' ' HZ1' ' D' ' 34' ' ' LYS . 12.1 pt-20 -131.8 158.78 40.35 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.695 0.398 . . . . 74.23 110.518 -173.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.3 m -71.29 138.01 49.0 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.355 -0.839 . . . . 74.22 111.103 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.484 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -89.48 -62.24 1.52 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.946 -1.131 . . . . 70.42 107.946 173.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -156.61 159.53 38.56 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.583 -1.19 . . . . 74.34 110.556 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 85.7 mt -121.97 108.84 13.87 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.48 -1.304 . . . . 74.41 107.48 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.608 ' SG ' HG12 ' D' ' 114' ' ' ILE . 45.9 t -117.14 135.27 53.88 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.749 0.82 . . . . 75.32 109.272 -173.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -155.43 126.18 6.96 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.78 0.432 . . . . 63.42 110.033 175.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.43 118.74 46.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 123.819 0.848 . . . . 70.3 109.527 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.4 mt-30 -87.71 88.45 7.67 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.272 -1.01 . . . . 73.14 108.272 170.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -80.85 98.38 7.81 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 115.092 -0.958 . . . . 72.54 109.102 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.32 169.55 33.26 Favored Glycine 0 C--O 1.244 0.772 0 CA-C-N 115.74 -0.663 . . . . 74.23 112.33 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.63 133.33 2.86 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 112.058 -0.417 . . . . 70.14 112.058 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.468 HG13 ' HE1' ' D' ' 17' ' ' TYR . 57.7 mt -88.41 123.84 41.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 107.847 -1.168 . . . . 73.41 107.847 173.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -131.61 157.12 44.52 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.123 0.969 . . . . 74.42 109.718 -175.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 43.2 m -117.21 136.23 53.21 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.029 0.932 . . . . 73.44 110.2 175.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.77 141.71 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.554 1.141 . . . . 75.2 109.956 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.13 161.07 10.18 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.158 0.983 . . . . 72.03 108.639 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.44 21.04 79.93 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 121.426 -0.416 . . . . 75.42 113.382 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.408 HG22 ' HG2' ' D' ' 93' ' ' GLN . 12.7 mt -118.86 152.56 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.464 0.705 . . . . 73.53 109.933 -172.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.578 ' HA ' ' HE1' ' D' ' 94' ' ' MET . 42.1 mt-10 -157.4 148.12 21.28 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.945 1.298 . . . . 71.12 110.557 175.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.57 -125.53 28.79 Favored Glycine 0 C--N 1.353 1.492 0 O-C-N 124.085 0.866 . . . . 71.22 114.9 169.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 92' ' ' THR . . . . . 0.584 HG22 HD22 ' D' ' 141' ' ' LEU . 11.2 m -72.0 -24.9 61.65 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.763 0.825 . . . . 75.35 111.803 -175.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.408 ' HG2' HG22 ' D' ' 89' ' ' ILE . 25.6 tt0 -61.78 -29.9 70.45 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.328 0.651 . . . . 75.3 109.976 175.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.578 ' HE1' ' HA ' ' D' ' 90' ' ' GLU . 49.5 mtt -70.8 -44.09 67.33 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.918 0.887 . . . . 72.3 110.692 173.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.85 -36.83 82.36 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.379 0.672 . . . . 73.2 111.34 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -78.85 -29.97 44.91 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.116 0.566 . . . . 75.54 110.696 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 41.1 t -60.38 -51.09 70.99 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.413 0.685 . . . . 54.24 112.311 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.15 -17.07 14.43 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 115.492 -0.776 . . . . 72.31 112.258 -174.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.89 -25.62 29.02 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-O 120.119 -0.267 . . . . 72.54 112.867 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.14 -63.37 1.45 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.009 0.524 . . . . 73.3 110.935 -178.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -62.38 -53.99 46.83 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 112.744 0.646 . . . . 75.01 112.744 -169.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 59.1 m -59.04 -45.43 99.52 Favored Pre-proline 0 N--CA 1.494 1.753 0 CA-C-O 118.612 -0.709 . . . . 75.44 112.563 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -51.71 -46.64 30.68 Favored 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.639 2.226 . . . . 71.24 113.665 165.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -67.64 -15.54 63.7 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 123.376 0.67 . . . . 70.03 112.202 -178.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 35.9 mm -86.61 -49.43 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.285 0.634 . . . . 75.52 109.863 173.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.494 HD11 HD21 ' D' ' 60' ' ' LEU . 91.4 mt -79.52 -30.53 41.92 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.352 0.871 . . . . 74.44 113.352 -168.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -65.6 -39.25 31.23 Favored Pre-proline 0 N--CA 1.49 1.572 0 CA-C-O 118.174 -0.917 . . . . 74.14 113.264 -177.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -49.55 -45.97 28.78 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 122.62 2.213 . . . . 74.23 114.626 166.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -74.57 -36.16 63.06 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.063 0.545 . . . . 64.43 111.581 -177.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.16 -46.59 86.42 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.641 -0.503 . . . . 70.45 109.641 174.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -54.49 -49.59 69.77 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 124.706 1.254 . . . . 65.42 110.606 177.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -62.56 -43.63 98.34 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.797 0.686 . . . . 64.34 111.093 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.9 t -61.76 -44.0 97.76 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 123.761 0.663 . . . . 75.34 110.859 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.608 HG12 ' SG ' ' D' ' 76' ' ' CYS . 97.2 mt -60.61 -59.1 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.14 0.976 . . . . 73.21 110.217 175.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 37.0 m -52.98 -38.95 62.66 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.461 1.504 . . . . 64.22 111.551 -176.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.0 t -66.76 -47.06 73.4 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 114.889 -1.05 . . . . 64.15 110.344 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.8 mtm -67.17 -32.28 73.26 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.787 0.435 . . . . 73.12 111.763 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.5 t -61.9 -46.66 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.776 0.83 . . . . 63.34 109.887 174.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.1 p -76.89 -24.99 52.53 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.809 -0.632 . . . . 75.33 111.51 -177.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -74.02 -37.31 64.4 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.389 0.676 . . . . 74.45 109.52 175.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.8 4.39 65.6 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 115.561 -0.745 . . . . 62.44 112.27 170.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 47.8 p 59.12 23.09 11.3 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 126.947 2.099 . . . . 53.23 114.012 174.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -78.02 149.79 77.11 Favored Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 108.643 -0.873 . . . . 74.35 108.643 169.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.725 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 4.8 Cg_endo -53.42 133.82 54.8 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.675 2.25 . . . . 73.3 112.295 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -50.98 135.76 24.14 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.833 1.333 . . . . 73.13 112.654 -171.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 64.6 tp -114.77 103.06 10.59 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.881 0.872 . . . . 73.4 109.006 -177.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . 0.492 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 86.2 m-20 -99.51 101.29 12.48 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.829 -0.804 . . . . 74.5 108.829 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.626 HD21 ' HG ' ' H' ' 8' ' ' LEU . 3.2 tt -66.78 115.98 7.17 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 108.172 -1.047 . . . . 73.22 108.172 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.741 ' HB1' HE22 ' B' ' 12' ' ' GLN . . . -65.15 140.54 97.99 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 123.515 0.726 . . . . 75.5 110.72 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.444 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 5.6 Cg_exo -72.18 151.25 54.83 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.81 2.34 . . . . 72.24 111.981 -171.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.9 m -127.8 128.19 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.637 0.775 . . . . 75.12 110.182 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -102.77 88.27 3.17 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.03 0.932 . . . . 62.13 109.57 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.403 ' HE1' ' HA ' ' H' ' 10' ' ' LEU . 78.9 m-85 -66.42 -30.88 71.33 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.21 0.604 . . . . 72.43 111.024 175.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -53.88 -43.66 69.8 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.314 1.009 . . . . 72.3 111.573 -174.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.0 -48.06 82.0 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.269 0.98 . . . . 74.21 111.368 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.421 HD21 HD21 ' H' ' 10' ' ' LEU . 7.9 mp -61.81 -36.39 80.99 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 123.792 0.682 . . . . 71.14 111.613 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -75.45 -44.08 46.13 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.134 0.574 . . . . 75.11 112.01 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 24.1 ptp -74.73 -44.99 47.02 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 111.743 0.275 . . . . 74.3 111.743 -172.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -73.58 -23.58 59.96 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.009 0.524 . . . . 75.42 111.579 -174.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -56.94 -34.48 68.05 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.864 0.865 . . . . 75.2 111.208 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.584 HD22 HG22 ' D' ' 92' ' ' THR . 10.0 mp -77.96 -32.2 51.26 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.792 0.837 . . . . 73.14 112.498 -176.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -90.66 12.28 19.51 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 112.289 0.477 . . . . 75.51 112.289 -175.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -119.94 58.57 0.9 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.604 0.762 . . . . 73.51 110.067 -176.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -147.31 -52.16 0.2 Allowed 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 115.637 -0.711 . . . . 72.54 110.734 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.77 -50.89 4.07 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.408 -0.59 . . . . 71.3 109.408 178.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.59 -123.74 2.33 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 110.809 -0.916 . . . . 71.51 110.809 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . 0.61 ' HA ' ' HA ' ' B' ' 147' ' ' GLU . 28.5 tt0 -163.05 129.82 3.45 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 109.172 -0.677 . . . . 74.5 109.172 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -106.95 127.78 8.99 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.032 -0.827 . . . . 63.23 111.032 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 80.4 m -71.6 118.61 14.64 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.378 0.671 . . . . 73.42 110.469 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -71.52 159.68 34.05 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.496 -0.557 . . . . 71.52 109.496 171.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -156.19 123.05 5.24 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 110.142 -0.318 . . . . 75.15 110.142 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -72.66 113.59 9.85 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.203 1.001 . . . . 74.5 110.322 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -72.49 152.29 42.0 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.638 -0.875 . . . . 74.34 108.638 170.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -154.44 147.43 24.58 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.638 -0.256 . . . . 73.44 110.499 -171.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.935 0 C-N-CA 123.852 0.861 . . . . 70.22 109.581 -178.127 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.595 -0.521 . . . . 73.33 109.595 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -165.48 149.3 8.27 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.685 1.194 . . . . 72.54 108.656 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -98.14 -89.29 0.3 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.851 0.46 . . . . 73.42 111.308 -174.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 47.2 t 52.34 83.59 0.06 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.907 0.883 . . . . 72.22 110.043 -167.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 5' ' ' THR . . . . . 0.491 HG22 ' HB3' ' A' ' 129' ' ' ALA . 33.4 m -65.39 125.8 26.25 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 116.148 -0.478 . . . . 75.02 110.944 -173.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.639 HG23 ' HB ' ' A' ' 40' ' ' VAL . 44.6 pt -60.63 120.68 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 124.729 1.212 . . . . 73.24 112.74 -169.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.05 136.9 47.56 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.11 0.564 . . . . 75.2 109.594 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . 0.58 ' HB3' HD13 ' A' ' 44' ' ' LEU . 43.6 mt -71.78 107.48 4.6 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 123.854 0.721 . . . . 75.32 109.224 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.11 72.97 3.69 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.626 0.77 . . . . 64.32 110.534 -177.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . 0.627 HD21 HD23 ' A' ' 136' ' ' LEU . 93.5 mt 59.88 -175.63 0.1 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.023 1.329 . . . . 75.23 112.841 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 56.0 mt -122.76 130.37 24.65 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 124.148 0.979 . . . . 63.11 109.082 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.01 124.67 13.4 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.803 2.335 . . . . 73.01 111.871 176.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 68.65 19.68 8.5 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.021 1.329 . . . . 63.45 110.457 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . 0.632 ' HB3' ' HA3' ' A' ' 99' ' ' GLY . 10.3 mp 65.57 -73.1 0.07 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.754 1.222 . . . . 74.2 110.357 -173.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . 0.57 ' HB2' ' HA2' ' A' ' 99' ' ' GLY . 0.5 OUTLIER -166.82 174.45 8.57 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.105 -0.702 . . . . 72.23 109.105 174.322 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 14.5 p -68.71 138.32 90.72 Favored Pre-proline 0 CA--C 1.557 1.231 0 CA-C-N 115.562 -0.745 . . . . 73.34 110.371 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 17' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -61.88 149.06 91.68 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 123.282 2.655 . . . . 74.14 113.287 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 67.8 t -62.23 -60.59 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 108.837 -0.801 . . . . 64.52 108.837 173.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 8.3 p -156.31 -77.71 0.09 Allowed 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 114.257 -1.338 . . . . 72.12 109.662 -172.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -105.56 31.85 4.7 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.949 0.9 . . . . 74.53 110.489 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.79 81.0 5.12 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.192 -0.67 . . . . 74.14 109.192 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -74.15 113.34 11.23 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.449 -1.25 . . . . 73.42 109.721 -177.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 62.8 p 53.97 87.9 0.13 Allowed Pre-proline 0 CA--C 1.561 1.371 0 C-N-CA 125.935 1.694 . . . . 74.12 111.546 -175.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.0 82.78 0.15 Allowed 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.519 2.812 . . . . 73.34 113.128 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 . . . . . 0 C--O 1.256 1.411 0 C-N-CA 125.591 1.556 . . . . 72.5 107.946 -178.82 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 120.516 0.198 . . . . 71.03 110.785 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 40.7 tptt -166.58 65.67 0.1 Allowed 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 107.661 -1.237 . . . . 72.43 107.661 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -61.03 -53.54 55.88 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.622 1.169 . . . . 73.24 113.033 -169.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 31.0 t -81.61 66.91 7.37 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.748 0.819 . . . . 75.12 109.992 -174.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 36.4 m -152.63 147.66 26.41 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.773 1.229 . . . . 71.02 108.55 -175.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . 0.738 ' HA ' HD23 ' B' ' 42' ' ' LEU . 41.7 mm 72.62 91.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.008 1.323 . . . . 73.21 110.47 -178.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.76 19.97 2.74 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.338 -1.301 . . . . 75.53 111.928 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . 0.461 ' HB3' HG22 ' B' ' 131' ' ' VAL . 2.7 tt -78.53 85.28 4.61 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.195 -1.039 . . . . 73.35 108.195 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.36 51.87 1.02 Allowed 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.527 1.131 . . . . 73.43 109.726 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 79.8 mt 62.95 -166.38 0.23 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.546 1.138 . . . . 70.43 111.195 -177.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt -103.13 104.92 43.3 Favored Pre-proline 0 CA--C 1.554 1.117 0 N-CA-C 108.59 -0.893 . . . . 71.34 108.59 168.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -64.37 -23.02 65.73 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 123.259 2.64 . . . . 73.14 114.136 -177.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -97.31 3.38 51.21 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.564 0.745 . . . . 73.33 110.814 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 86.6 mt 60.13 -86.22 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.682 1.193 . . . . 75.31 109.98 -169.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . 0.414 ' CD2' ' HB3' ' B' ' 98' ' ' LEU . 9.6 t80 -177.87 160.49 1.49 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.443 0.697 . . . . 74.11 109.396 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 16.8 p -82.17 125.04 77.98 Favored Pre-proline 0 CA--C 1.562 1.43 0 C-N-CA 123.468 0.707 . . . . 71.4 110.655 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -64.9 146.79 88.64 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.678 2.919 . . . . 75.42 114.541 -174.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . 0.531 HG22 HG23 ' B' ' 86' ' ' ILE . 39.7 t -76.74 132.99 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 124.246 1.018 . . . . 74.32 109.665 176.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 17.3 m -74.9 -59.23 2.83 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-O 120.918 0.389 . . . . 64.25 110.06 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 20' ' ' LYS . . . . . 0.404 ' HB2' ' NE2' ' B' ' 50' ' ' GLN . 54.3 mttp -94.92 75.86 3.57 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.09 0.556 . . . . 75.13 109.789 178.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . -126.06 -1.81 7.1 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.353 1.061 . . . . 73.25 109.975 170.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -97.4 -26.02 15.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.249 0.62 . . . . 75.23 111.187 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 27.5 p -146.25 130.09 8.48 Favored Pre-proline 0 N--CA 1.482 1.158 0 C-N-CA 123.813 0.845 . . . . 74.44 111.028 -172.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -70.96 101.12 1.04 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.788 2.325 . . . . 70.22 110.893 166.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 25' ' ' GLU . . . . . 0.482 ' HB3' ' HB3' ' B' ' 53' ' ' ASP . 11.6 tp10 . . . . . 0 CA--C 1.559 1.316 0 C-N-CA 123.29 0.636 . . . . 75.13 111.058 -174.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 1' ' ' MET . . . . . 0.455 ' N ' ' SD ' ' G' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 109.531 -0.544 . . . . 64.43 109.531 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -152.13 137.79 17.86 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.947 0.899 . . . . 74.25 109.176 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -66.51 101.53 0.78 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 122.985 0.514 . . . . 64.25 110.046 173.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 76.1 p -164.21 -54.49 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.038 1.335 . . . . 73.41 108.404 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 30.6 m 59.03 -83.69 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.595 1.558 . . . . 73.32 112.714 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . . . . . . . . . 47.9 mm -78.48 -27.52 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.243 0.617 . . . . 72.35 109.937 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.25 153.17 20.16 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.783 -0.644 . . . . 71.34 109.832 171.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 8' ' ' LEU . . . . . 0.664 HD13 HG11 ' C' ' 131' ' ' VAL . 7.2 tt -79.45 141.57 36.66 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 108.821 -0.807 . . . . 74.03 108.821 176.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.0 179.88 2.14 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.789 0.836 . . . . 75.25 112.544 -174.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 39.4 tp -74.6 94.82 2.71 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-O 121.073 0.463 . . . . 74.2 110.098 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 11' ' ' LEU . . . . . 0.452 HD21 ' HD2' ' G' ' 12' ' ' PRO . 3.5 tm? -78.63 118.08 70.28 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 107.695 -1.224 . . . . 62.32 107.695 175.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 12' ' ' PRO . . . . . 0.452 ' HD2' HD21 ' G' ' 11' ' ' LEU . 29.4 Cg_endo -61.58 125.47 16.82 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.805 2.337 . . . . 74.12 112.162 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . 0.557 HD13 ' HA ' ' C' ' 96' ' ' HIS . 2.5 pt? -75.2 -10.42 59.45 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.406 0.283 . . . . 72.23 111.367 -177.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -71.85 79.27 0.88 Allowed 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 109.188 -0.671 . . . . 71.53 109.188 172.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -91.75 162.37 14.49 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.203 -1.036 . . . . 74.24 108.203 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 39.0 p -57.67 114.62 8.76 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 124.021 0.928 . . . . 74.43 111.285 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 17' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.34 149.97 75.77 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.567 2.178 . . . . 63.43 113.43 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 18' ' ' VAL . . . . . . . . . . . . . 35.5 t -93.73 -50.38 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 114.813 -1.085 . . . . 72.42 109.163 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 19' ' ' THR . . . . . 0.578 ' H ' ' HE2' ' C' ' 94' ' ' MET . 69.4 p -82.79 -173.65 4.79 Favored 'General case' 0 C--O 1.248 1.015 0 CA-C-N 114.588 -1.187 . . . . 74.31 110.205 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -83.45 56.18 3.48 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-O 122.048 0.928 . . . . 72.02 110.278 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.54 -30.73 61.87 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.134 0.973 . . . . 51.45 109.66 170.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -120.74 170.33 9.55 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 114.993 -1.003 . . . . 74.22 109.49 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 4.9 t -99.11 107.58 45.0 Favored Pre-proline 0 CA--C 1.556 1.212 0 C-N-CA 123.184 0.594 . . . . 74.22 109.658 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -63.7 126.74 18.09 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.719 2.279 . . . . 73.4 110.504 173.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 . . . . . 0 CA--C 1.56 1.333 0 C-N-CA 123.336 0.654 . . . . 75.23 110.926 -173.2 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.483 1.225 0 CA-C-O 120.62 0.248 . . . . 71.44 110.67 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -76.16 132.14 39.79 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.52 0.728 . . . . 71.0 110.721 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -136.37 115.28 12.24 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.663 1.185 . . . . 75.21 108.254 172.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 29.7 p -71.36 87.2 0.84 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.27 0.628 . . . . 75.23 109.381 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 41.3 m -87.11 -43.78 12.02 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.333 -0.848 . . . . 71.41 110.593 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . 0.498 HG22 ' H ' ' D' ' 129' ' ' ALA . 6.6 tt -157.23 -71.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 C-N-CA 123.22 0.608 . . . . 74.55 110.979 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 7' ' ' ALA . . . . . 0.474 ' H ' HG22 ' H' ' 6' ' ' ILE . . . 54.76 -158.66 0.19 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.456 1.102 . . . . 71.52 112.259 -175.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 8' ' ' LEU . . . . . 0.626 ' HG ' HD21 ' D' ' 128' ' ' LEU . 68.3 mt -141.83 179.57 6.78 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 125.099 1.36 . . . . 75.24 108.473 173.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.32 -179.18 3.98 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.014 0.925 . . . . 75.11 109.835 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 10' ' ' LEU . . . . . 0.421 HD21 HD21 ' D' ' 136' ' ' LEU . 79.8 mt -65.96 160.64 23.12 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.339 0.656 . . . . 74.14 111.299 175.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 72.3 mt -65.89 130.77 94.49 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-N 115.291 -0.868 . . . . 73.13 109.537 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -75.7 0.12 9.55 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.349 2.699 . . . . 74.32 113.331 -173.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 40.3 tp -153.43 139.85 18.66 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 107.465 -1.309 . . . . 75.33 107.465 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.78 130.7 43.81 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 107.498 -1.297 . . . . 73.15 107.498 175.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -70.6 161.89 29.89 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.762 0.825 . . . . 75.22 111.421 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 62.4 p -59.27 150.43 63.57 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.37 1.068 . . . . 74.51 111.805 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -79.97 154.34 22.68 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.535 2.157 . . . . 64.42 114.097 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 63.5 t -85.18 83.65 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 105.883 -1.895 . . . . 74.04 105.883 155.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 26.9 m 63.08 -79.77 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 124.604 1.162 . . . . 72.15 112.702 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 20' ' ' LYS . . . . . 0.421 ' HZ1' ' HB3' ' H' ' 20' ' ' LYS . 0.4 OUTLIER -96.25 -7.77 34.66 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.169 0.988 . . . . 74.34 113.514 -170.465 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.19 -48.51 61.95 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.371 0.668 . . . . 64.34 112.389 -173.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.5 123.3 1.83 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.402 1.081 . . . . 71.44 108.911 176.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 42.4 p -70.83 131.57 87.49 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 109.927 -0.397 . . . . 74.41 109.927 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -56.0 -32.57 86.52 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.893 2.395 . . . . 74.34 112.196 170.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 C--O 1.248 1.002 0 N-CA-C 107.738 -1.208 . . . . 74.0 107.738 171.953 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.418 ' SD ' ' N ' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 107.923 -1.14 . . . . 75.13 107.923 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.418 ' N ' ' SD ' ' A' ' 1' ' ' MET . 19.8 m -47.22 134.4 11.17 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.933 1.293 . . . . 63.02 112.618 -174.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -68.48 91.25 0.4 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.264 0.626 . . . . 73.51 111.656 -172.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -146.2 -51.77 0.23 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.799 -1.091 . . . . 74.42 108.235 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -69.2 -53.85 17.86 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.081 -0.963 . . . . 75.54 110.239 176.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -89.54 -74.63 0.47 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.945 0.498 . . . . 71.53 110.574 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.9 m 64.51 127.61 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.879 1.272 . . . . 73.32 111.512 -169.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.423 ' HB3' ' HG2' ' C' ' 143' ' ' GLN . 39.6 tt0 -156.72 -62.77 0.1 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.145 0.578 . . . . 75.55 110.357 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.536 ' HE1' ' SG ' ' A' ' 97' ' ' CYS . 15.9 tpt -149.44 147.4 28.21 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.046 -0.524 . . . . 71.44 110.683 -164.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.5 m -135.06 104.61 6.0 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 106.939 -1.504 . . . . 73.01 106.939 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.661 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 35.7 t80 -133.25 138.61 46.54 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 123.98 0.912 . . . . 65.33 109.908 -171.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -152.92 132.96 13.38 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.201 1.0 . . . . 62.11 108.818 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.67 HG12 ' HD2' ' A' ' 84' ' ' PHE . 57.6 mt -93.49 121.25 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.104 -0.702 . . . . 75.25 109.104 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -85.3 -33.98 21.99 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.591 0.756 . . . . 71.31 110.328 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -171.06 142.47 1.82 Allowed 'General case' 0 C--N 1.352 0.717 0 O-C-N 123.411 0.445 . . . . 73.32 110.65 -174.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.425 HD13 ' HG3' ' C' ' 130' ' ' PRO . 78.6 mt -131.75 134.02 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 107.962 -1.125 . . . . 75.45 107.962 170.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.522 ' HB3' HG23 ' B' ' 122' ' ' THR . 37.1 p90 -163.06 176.94 9.57 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 124.168 0.917 . . . . 65.14 110.838 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.4 p -100.06 121.52 41.52 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.178 -0.919 . . . . 73.33 109.035 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -84.28 -37.36 21.78 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.975 0.417 . . . . 74.43 109.935 178.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 24.4 t70 -143.28 135.28 26.84 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.122 -0.944 . . . . 74.53 109.288 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.476 HD11 ' SD ' ' B' ' 117' ' ' MET . 77.5 mt -128.74 140.02 50.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.217 -1.401 . . . . 73.43 107.217 175.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.9 t -151.31 110.98 4.02 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.071 0.462 . . . . 74.4 110.1 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -110.4 132.76 53.89 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.306 -1.368 . . . . 75.44 107.306 169.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -130.57 140.35 50.46 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.878 -1.156 . . . . 73.31 107.878 173.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.38 76.4 56.25 Favored Pre-proline 0 C--O 1.241 0.644 0 N-CA-C 106.208 -1.775 . . . . 75.24 106.208 169.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -62.5 -34.49 75.5 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.985 2.457 . . . . 65.15 112.794 -168.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 -109.1 22.79 15.43 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.467 -0.778 . . . . 72.31 110.224 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.555 ' HB2' ' HE3' ' B' ' 19' ' ' LYS . . . -42.46 -53.84 8.74 Favored Pre-proline 0 N--CA 1.499 1.998 0 N-CA-C 114.097 1.147 . . . . 75.51 114.097 -170.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -65.17 -29.24 55.92 Favored 'Trans proline' 0 C--N 1.387 2.581 0 CA-C-N 121.174 1.455 . . . . 73.15 112.641 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -82.56 -35.21 27.4 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.485 1.114 . . . . 65.25 110.843 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.643 HG22 ' HA ' ' A' ' 73' ' ' ALA . 4.3 p -78.68 -20.95 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 115.125 -0.943 . . . . 73.23 112.54 -161.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -71.85 -19.13 62.01 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-O 120.972 0.415 . . . . 75.31 111.002 176.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -77.88 -25.31 48.48 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.464 1.105 . . . . 64.23 110.695 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -76.58 149.49 36.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.805 0.842 . . . . 74.23 110.863 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.2 138.1 58.43 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 124.007 0.817 . . . . 74.42 109.303 170.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -84.01 92.0 7.75 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.713 -0.477 . . . . 73.23 109.713 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -127.53 82.89 67.42 Favored Pre-proline 0 C--O 1.243 0.755 0 N-CA-C 107.962 -1.125 . . . . 71.42 107.962 170.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.95 125.13 7.81 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.48 2.12 . . . . 75.42 112.677 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -98.87 96.62 7.99 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 106.76 -1.57 . . . . 74.32 106.76 165.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.7 t -75.55 94.51 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 115.948 -0.569 . . . . 74.33 109.662 -175.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.469 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 14.2 mptt -78.68 111.74 15.08 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 107.641 -1.244 . . . . 73.51 107.641 170.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.98 138.52 47.28 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.707 0.803 . . . . 73.34 108.925 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.532 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 21.2 t70 -141.64 140.75 33.35 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.784 1.234 . . . . 73.45 108.483 -172.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.428 HD21 HD13 ' E' ' 8' ' ' LEU . 75.4 mt -123.16 136.95 54.99 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.13 0.572 . . . . 74.22 110.453 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 18.0 t70 -134.25 147.14 50.62 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 114.781 -1.099 . . . . 71.5 108.428 175.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.1 m -106.57 131.65 53.48 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.958 0.903 . . . . 73.11 110.258 -173.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.735 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -131.53 105.41 7.54 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.795 -1.187 . . . . 72.1 107.795 169.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.551 ' HB3' ' HB3' ' E' ' 17' ' ' PRO . 24.5 m -95.93 152.01 18.9 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.246 -1.02 . . . . 53.0 108.246 176.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.532 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 31.2 t -159.25 142.59 14.59 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.121 0.568 . . . . 72.1 109.961 -176.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -112.72 130.28 56.11 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.016 -1.105 . . . . 72.11 108.016 168.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.0 mt -104.26 -38.1 7.01 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.215 0.606 . . . . 75.24 110.524 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.05 -170.46 3.4 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.241 0.617 . . . . 73.1 110.381 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.82 113.89 3.7 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.509 1.124 . . . . 52.54 110.023 173.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 85' ' ' SER . 32.1 m-20 69.71 -2.56 1.93 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.369 1.468 . . . . 65.33 112.906 -176.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.3 t -95.75 113.29 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 107.574 -1.269 . . . . 73.3 107.574 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -127.29 125.87 41.64 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.943 -0.762 . . . . 72.21 108.943 -176.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 40.5 tt0 -92.94 116.83 29.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.304 -0.862 . . . . 72.34 108.947 175.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.421 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 54.1 t -100.2 118.61 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 106.368 -1.716 . . . . 72.53 106.368 174.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.735 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 29.5 t -118.46 121.19 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.732 -0.84 . . . . 62.45 108.732 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.35 113.52 26.24 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.476 -0.935 . . . . 74.43 108.476 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 50.1 ttt180 -83.01 101.75 11.3 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.326 -0.991 . . . . 74.0 108.326 174.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.07 102.46 13.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.96 -1.126 . . . . 73.23 107.96 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 28.5 m -97.34 126.03 42.32 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.036 -0.727 . . . . 73.14 109.036 178.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.553 HG13 HD23 ' A' ' 126' ' ' LEU . 75.1 t -122.54 139.92 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.345 1.058 . . . . 74.01 108.265 176.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 17.5 m -136.03 141.69 44.35 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.375 -0.972 . . . . 75.24 108.375 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.61 117.2 32.86 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.619 -1.252 . . . . 71.44 107.619 171.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.6 m -113.06 126.36 55.39 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.878 0.471 . . . . 75.42 109.905 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.471 HD13 ' HB1' ' A' ' 73' ' ' ALA . 13.8 mt -98.92 83.25 2.88 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.42 1.088 . . . . 72.42 108.326 176.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.43 -83.84 1.09 Allowed Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.902 -0.59 . . . . 72.41 112.003 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.73 -25.07 3.72 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.113 0.965 . . . . 73.24 110.188 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -95.85 133.79 39.58 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.688 0.795 . . . . 74.55 109.945 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.5 m -74.34 139.48 44.18 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 122.852 0.461 . . . . 63.12 110.545 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.643 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -82.11 -61.31 1.94 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.696 0.798 . . . . 73.42 109.067 172.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -154.63 168.5 26.58 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.597 -1.183 . . . . 72.24 111.413 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 64' ' ' VAL . 54.5 tp -122.61 139.53 53.83 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.948 1.299 . . . . 75.11 108.376 172.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 79.2 m -140.81 98.18 3.34 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.48 1.112 . . . . 70.22 110.098 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -115.94 127.99 55.4 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.556 0.742 . . . . 73.04 109.25 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.2 t -133.03 113.47 19.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 C-N-CA 123.267 0.627 . . . . 74.41 109.668 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -85.59 89.0 7.6 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.07 -0.968 . . . . 72.42 108.845 173.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.465 ' HG3' HD23 ' A' ' 106' ' ' LEU . 7.9 tp-100 -80.83 107.5 13.7 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.331 -0.849 . . . . 74.21 109.298 -177.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.41 144.44 17.24 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 111.537 -0.625 . . . . 73.45 111.537 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.29 125.56 2.48 Favored Glycine 0 C--N 1.33 0.197 0 N-CA-C 111.54 -0.624 . . . . 62.2 111.54 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.1 mt -81.49 120.48 33.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.663 -0.866 . . . . 75.35 108.663 173.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.67 ' HD2' HG12 ' A' ' 13' ' ' ILE . 21.5 m-85 -136.23 120.44 17.83 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.553 -0.906 . . . . 75.11 108.553 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 66.7 m -89.84 113.27 24.83 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.456 -0.572 . . . . 71.41 109.456 171.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.454 ' HB ' ' HE2' ' A' ' 9' ' ' MET . 2.3 pp -112.35 148.94 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.546 0.739 . . . . 75.13 109.996 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.56 -163.27 0.11 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.092 1.357 . . . . 72.42 108.926 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 121.24 -76.12 0.33 Allowed Glycine 0 C--N 1.348 1.238 0 N-CA-C 111.271 -0.732 . . . . 75.13 111.271 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.4 mt -130.11 -25.65 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.467 1.107 . . . . 75.52 109.396 175.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 61.01 -156.4 0.35 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.482 1.113 . . . . 74.42 110.654 -170.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.52 -129.47 16.85 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-O 119.451 -0.638 . . . . 40.12 112.592 177.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.4 t -71.25 -22.51 61.97 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.011 0.524 . . . . 72.11 111.559 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -67.55 -49.99 60.65 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.496 0.718 . . . . 73.54 109.738 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.482 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 24.1 ptt? -76.27 -27.89 56.84 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.014 -0.539 . . . . 70.04 110.537 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.89 -33.94 76.83 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.122 0.569 . . . . 72.32 111.228 -177.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -67.42 -35.61 79.61 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.858 -0.61 . . . . 71.4 110.582 171.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.649 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 71.5 m -71.08 -66.07 0.66 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.179 0.192 . . . . 74.13 111.215 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 94' ' ' MET . 3.4 pp -65.63 -25.4 67.35 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.455 0.702 . . . . 72.0 112.751 -175.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.81 -24.81 22.15 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-O 119.909 -0.384 . . . . 63.3 113.752 -176.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.484 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . . . -129.46 -64.66 0.88 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 117.206 0.503 . . . . 74.55 111.301 -175.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.649 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 83.3 t80 -69.29 -60.47 2.32 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.303 1.041 . . . . 73.14 112.967 -164.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.7 m -62.29 -39.01 52.77 Favored Pre-proline 0 CA--C 1.569 1.701 0 N-CA-C 114.024 1.12 . . . . 53.03 114.024 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -66.49 -28.61 45.64 Favored 'Trans proline' 0 C--N 1.389 2.679 0 CA-C-N 121.366 1.524 . . . . 74.3 112.853 166.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -79.96 -14.64 58.44 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.358 0.663 . . . . 73.22 110.477 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 35.1 mm -68.2 -39.75 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 108.472 -0.936 . . . . 73.21 108.472 168.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.465 HD23 ' HG3' ' A' ' 80' ' ' GLN . 77.2 mt -78.29 -23.66 47.1 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.135 -0.939 . . . . 73.23 112.129 -177.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -59.45 -47.41 97.99 Favored Pre-proline 0 CA--C 1.571 1.759 0 CA-C-O 117.862 -1.066 . . . . 75.54 113.502 -174.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -63.15 -37.13 53.81 Favored 'Trans proline' 0 C--N 1.392 2.857 0 C-N-CA 121.988 1.792 . . . . 71.45 113.224 176.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -72.14 -38.02 69.32 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.131 0.572 . . . . 74.24 111.097 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.52 -42.06 71.76 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.242 0.617 . . . . 53.23 110.207 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.419 ' NH1' HG22 ' C' ' 105' ' ' ILE . 25.7 ttm180 -60.58 -44.82 95.79 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.171 0.919 . . . . 74.51 109.597 175.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -65.24 -43.58 90.92 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.136 0.974 . . . . 75.24 111.687 -176.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.5 t -61.7 -43.49 98.76 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.959 0.787 . . . . 73.31 109.816 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 67.4 mt -61.69 -47.81 91.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 124.436 1.094 . . . . 64.12 110.756 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.3 m -59.52 -39.23 83.22 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.376 1.07 . . . . 75.44 110.816 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 42.9 t -67.64 -46.71 71.67 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 115.184 -0.916 . . . . 74.41 110.605 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 18.2 mtp -59.21 -41.59 88.95 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.969 0.908 . . . . 65.23 111.504 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.412 HG23 HD21 ' A' ' 126' ' ' LEU . 74.0 t -65.8 -51.28 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.237 1.015 . . . . 73.34 110.631 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.4 t -66.11 -27.78 68.31 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.597 -0.728 . . . . 73.23 111.091 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.546 ' HG2' ' HG1' ' B' ' 18' ' ' THR . 30.2 ttm-85 -77.59 -31.61 53.14 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.302 1.041 . . . . 74.23 109.334 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.42 11.27 61.63 Favored Glycine 0 C--N 1.356 1.657 0 CA-C-N 114.673 -1.148 . . . . 55.14 112.811 170.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.43 HG23 ' HE ' ' B' ' 15' ' ' ARG . 1.3 t 64.23 15.59 9.49 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 127.045 2.138 . . . . 72.2 113.925 172.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -80.61 153.12 73.25 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.06 0.544 . . . . 75.1 109.91 178.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.8 155.14 23.49 Favored 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 123.252 2.635 . . . . 62.04 113.569 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -56.41 120.21 7.3 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.383 1.073 . . . . 64.41 112.645 -170.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.553 HD23 HG13 ' A' ' 64' ' ' VAL . 64.0 tp -121.86 106.13 10.99 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.417 1.087 . . . . 64.21 109.894 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -127.09 126.15 42.49 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.947 0.899 . . . . 73.33 108.853 169.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.8 mp -72.15 142.11 49.1 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.215 -0.661 . . . . 71.41 109.215 174.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.551 ' HB2' ' HB ' ' E' ' 5' ' ' THR . . . -64.58 150.13 94.33 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 122.82 0.448 . . . . 72.13 110.171 176.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.696 ' HG3' ' HD2' ' C' ' 11' ' ' PHE . 44.7 Cg_endo -61.33 154.14 60.62 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.718 2.279 . . . . 74.33 112.779 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.518 HG11 ' HB2' ' E' ' 8' ' ' LEU . 22.1 m -119.17 116.25 50.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 109.079 -0.712 . . . . 73.42 109.079 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -94.09 64.85 3.35 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.333 0.587 . . . . 74.41 109.581 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -62.85 -46.87 85.89 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.336 -0.847 . . . . 73.04 109.855 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -57.25 -37.92 73.07 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.766 1.226 . . . . 61.4 112.19 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.71 -41.2 79.4 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.78 0.675 . . . . 72.2 110.913 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.65 -37.83 79.99 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.069 0.548 . . . . 74.4 111.528 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.484 ' CD2' ' HB2' ' A' ' 100' ' ' ALA . 45.4 m-85 -75.11 -26.55 59.34 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.184 0.594 . . . . 71.45 111.307 175.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.6 tpt -70.31 -39.24 74.94 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 109.475 -0.565 . . . . 72.34 109.475 173.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.665 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 92.7 m-20 -64.83 -45.73 84.91 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-N 115.026 -0.988 . . . . 74.33 110.177 175.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -62.04 -39.86 93.76 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.856 -0.611 . . . . 75.42 110.972 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.41 ' HG ' ' HG3' ' A' ' 142' ' ' GLN . 31.8 tp -69.45 -51.22 38.2 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 123.42 0.45 . . . . 72.41 112.049 -175.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.41 ' HG3' ' HG ' ' A' ' 141' ' ' LEU . 78.5 mt-30 -149.25 -15.12 0.29 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 112.766 0.654 . . . . 62.33 112.766 -170.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.665 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 49.8 mt-30 64.54 -71.51 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.805 1.242 . . . . 62.3 111.486 -169.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 65.18 100.43 0.04 OUTLIER 'General case' 0 C--N 1.357 0.913 0 C-N-CA 125.115 1.366 . . . . 73.11 110.242 -178.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.54 99.27 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.041 0.937 . . . . 74.14 110.771 -177.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -72.44 154.95 50.95 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.255 -0.884 . . . . 74.24 113.106 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.492 ' HG2' ' H ' ' A' ' 148' ' ' GLY . 22.9 tt0 -138.76 -149.48 0.3 Allowed 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 106.476 -1.675 . . . . 74.34 106.476 -177.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.492 ' H ' ' HG2' ' A' ' 147' ' ' GLU . . . 68.62 71.58 0.95 Allowed Glycine 0 C--N 1.351 1.368 0 CA-C-N 118.791 0.723 . . . . 62.4 111.852 175.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.1 t -155.95 133.61 11.05 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 107.735 -1.209 . . . . 70.54 107.735 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -126.37 138.21 53.54 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.436 -0.579 . . . . 75.32 109.436 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -76.59 83.51 3.26 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.406 1.083 . . . . 75.54 110.269 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -154.68 144.81 21.88 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.149 0.58 . . . . 72.23 110.978 173.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -151.06 144.92 25.15 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.521 1.129 . . . . 73.3 108.119 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -146.68 155.07 42.15 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.418 0.687 . . . . 74.22 110.112 -170.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 C-N-CA 123.808 0.843 . . . . 64.41 109.63 177.949 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.416 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 110.34 -0.244 . . . . 72.45 110.34 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 38.9 t -157.93 70.76 0.58 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.588 0.708 . . . . 73.32 109.537 -176.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -93.03 86.54 5.44 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.935 0.894 . . . . 75.4 109.714 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -89.43 69.51 8.0 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.67 0.748 . . . . 73.24 109.178 171.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -84.84 79.34 9.65 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.156 -1.053 . . . . 74.12 108.156 175.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . 0.483 ' HB3' HG13 ' B' ' 89' ' ' ILE . 24.8 t-20 -89.01 156.35 18.92 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.468 -0.787 . . . . 74.01 110.145 -177.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t -77.18 79.05 3.7 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.157 0.983 . . . . 73.24 111.357 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 64.76 12.97 8.1 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.788 1.235 . . . . 73.13 113.89 169.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.614 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 14.6 ptm 57.29 179.69 0.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 126.438 1.895 . . . . 71.32 114.65 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 40.5 m -133.34 144.85 49.89 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.459 1.103 . . . . 75.34 108.491 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.658 ' CZ ' HG13 ' B' ' 13' ' ' ILE . 0.3 OUTLIER -130.53 149.88 51.99 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 106.916 -1.513 . . . . 74.02 106.916 178.206 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.462 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -156.29 101.11 2.03 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 123.339 0.399 . . . . 71.42 111.605 164.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.658 HG13 ' CZ ' ' B' ' 11' ' ' PHE . 44.6 mt -51.99 123.1 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.855 -0.794 . . . . 75.43 108.855 162.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -100.33 -45.07 5.71 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.048 0.842 . . . . 73.35 109.607 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.43 ' HE ' HG23 ' A' ' 122' ' ' THR . 47.9 ttt180 -162.92 135.58 5.54 Favored 'General case' 0 C--N 1.349 0.565 0 N-CA-C 109.259 -0.645 . . . . 75.45 109.259 -177.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.5 mt -114.89 137.17 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 107.896 -1.149 . . . . 74.24 107.896 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -167.29 158.32 11.73 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.11 0.481 . . . . 73.14 111.632 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.546 ' HG1' ' HG2' ' A' ' 120' ' ' ARG . 87.1 m -85.29 131.13 34.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.708 -0.678 . . . . 74.42 109.184 171.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.555 ' HE3' ' HB2' ' A' ' 28' ' ' ALA . 45.9 mtpt -97.76 -32.63 11.63 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.212 0.605 . . . . 72.31 110.665 177.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -151.13 138.21 19.19 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.613 0.244 . . . . 70.04 111.627 -175.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.736 HD12 ' SG ' ' B' ' 113' ' ' CYS . 45.6 mm -129.52 141.99 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.129 1.371 . . . . 73.03 108.914 173.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.612 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.1 t -144.46 137.43 26.94 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.052 -1.092 . . . . 44.31 108.052 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.2 t80 -154.35 121.47 5.65 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.844 -1.169 . . . . 65.21 107.844 174.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -127.81 122.09 31.83 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.7 0.8 . . . . 75.41 109.572 176.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.477 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -115.72 87.26 17.47 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.986 -1.116 . . . . 74.54 107.986 169.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -71.39 -40.44 3.06 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.431 2.088 . . . . 72.12 111.706 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.475 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 3.4 m-20 -93.98 3.21 55.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.259 1.024 . . . . 74.3 110.244 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.477 ' HB1' ' CB ' ' B' ' 25' ' ' ALA . . . -31.07 -65.84 0.19 Allowed Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 125.825 1.65 . . . . 63.12 114.653 -178.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 37.9 Cg_exo -55.23 -39.21 92.2 Favored 'Trans proline' 0 C--N 1.398 3.138 0 C-N-CA 122.975 2.45 . . . . 73.31 113.564 -162.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -95.51 -41.15 9.09 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 114.689 -1.141 . . . . 71.12 111.848 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.401 HG21 HD13 ' B' ' 68' ' ' LEU . 4.0 p -60.4 -19.22 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.48 0 C-N-CA 123.076 0.55 . . . . 72.13 112.4 -166.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -56.27 -28.89 60.17 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.56 1.144 . . . . 74.41 113.036 175.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -63.63 -21.93 66.63 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.923 0.889 . . . . 64.33 111.67 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -81.48 90.81 6.25 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.354 0.662 . . . . 74.21 109.664 172.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -83.94 89.08 7.17 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.402 -0.817 . . . . 63.21 110.844 -174.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 30.6 p90 -165.37 170.27 14.8 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.401 1.08 . . . . 74.13 109.713 167.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -75.52 111.34 13.75 Favored Pre-proline 0 N--CA 1.48 1.039 0 N-CA-C 109.038 -0.727 . . . . 74.41 109.038 173.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.98 165.69 13.87 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.015 2.476 . . . . 71.53 114.207 -172.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -73.58 103.91 4.35 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.478 -1.237 . . . . 74.32 108.974 175.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.418 HG23 HD11 ' B' ' 126' ' ' LEU . 61.7 t -102.46 123.08 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 115.333 -0.849 . . . . 74.43 111.08 -170.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -107.54 123.26 48.19 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.41 1.084 . . . . 73.43 108.688 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.84 126.1 51.57 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.768 -0.827 . . . . 73.21 108.768 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -122.95 128.47 50.29 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.582 1.153 . . . . 73.21 108.671 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -100.09 164.04 12.15 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.84 -0.8 . . . . 71.53 108.84 172.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.616 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.0 t70 -156.03 152.06 27.63 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.293 -0.867 . . . . 71.53 109.3 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 91.3 m -107.57 115.9 30.97 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.32 -1.309 . . . . 74.2 108.893 -171.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.463 ' HB2' ' HB ' ' B' ' 59' ' ' VAL . . . -137.03 119.32 15.66 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 109.045 -0.724 . . . . 62.54 109.045 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.5 p -142.97 161.83 37.09 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.939 0.496 . . . . 65.4 110.399 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -152.22 142.64 22.58 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.583 0.753 . . . . 74.24 109.836 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.444 ' HB2' ' HB2' ' F' ' 21' ' ' ALA . 51.0 tt0 -94.87 112.45 24.17 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.466 -0.568 . . . . 72.41 109.466 175.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 77.8 mt -80.69 -45.46 17.11 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.488 0.661 . . . . 72.14 109.314 175.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.38 -177.46 6.61 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.387 -1.278 . . . . 54.45 109.018 176.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.79 123.55 25.81 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.946 -1.025 . . . . 73.42 108.328 173.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 67.53 23.52 8.92 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.121 1.368 . . . . 74.25 111.26 -175.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.529 HG21 ' HG ' ' B' ' 85' ' ' SER . 92.2 t -139.51 103.49 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 107.912 -1.144 . . . . 72.35 107.912 168.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -125.96 138.12 53.74 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.833 -0.803 . . . . 71.04 108.833 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -107.9 103.5 12.76 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.459 -1.312 . . . . 73.32 107.459 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.538 HG22 ' HB2' ' B' ' 98' ' ' LEU . 95.1 t -101.06 118.87 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.65 1.18 . . . . 75.13 109.426 -173.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.564 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 15.3 t -104.34 141.22 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.315 1.046 . . . . 75.14 109.427 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 18.5 tp -118.87 112.7 20.0 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 108.676 -0.861 . . . . 64.43 108.676 172.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.616 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 20.0 ttm-85 -88.47 113.28 23.89 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.581 -0.525 . . . . 74.13 109.581 175.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.469 HG11 HD11 ' B' ' 114' ' ' ILE . 39.8 t -108.19 101.24 12.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 107.356 -1.35 . . . . 74.25 107.356 171.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 16.0 m -97.09 139.97 32.29 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.634 -0.876 . . . . 73.41 108.634 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.524 HG22 HG21 ' B' ' 114' ' ' ILE . 89.7 t -128.16 136.45 60.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 124.339 1.056 . . . . 74.04 109.295 -174.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 95.5 m -124.81 148.31 48.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.121 -1.066 . . . . 74.21 108.121 172.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.71 139.15 31.0 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.92 -0.77 . . . . 74.41 108.92 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.454 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 36.1 p -140.35 128.1 21.78 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 123.716 0.635 . . . . 70.2 110.331 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.401 HD13 HG21 ' B' ' 31' ' ' VAL . 45.0 mt -99.61 103.56 15.27 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.476 -1.305 . . . . 73.44 107.476 173.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.86 -113.96 4.01 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.202 -0.759 . . . . 74.0 111.202 -174.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -121.88 6.05 9.89 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.864 0.466 . . . . 63.22 109.815 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.475 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 4.0 pm0 -113.48 150.89 32.2 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.161 0.584 . . . . 72.15 109.892 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 45.4 m -67.97 118.73 11.55 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.245 1.018 . . . . 73.23 111.095 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.454 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -73.14 -63.92 1.08 Allowed 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.622 -0.881 . . . . 74.4 108.622 173.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -147.77 167.76 23.86 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 114.726 -1.124 . . . . 74.21 110.958 175.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.2 mt -129.13 141.34 51.21 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.278 -1.749 . . . . 74.32 106.278 173.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.0 t -147.44 158.88 44.16 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.346 -0.983 . . . . 72.22 108.346 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.612 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 42.8 tt0 -165.95 133.27 2.79 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.577 -0.897 . . . . 73.2 108.577 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.436 HG11 ' HA ' ' B' ' 110' ' ' ALA . 91.4 t -128.05 142.15 44.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.131 -1.063 . . . . 70.32 108.131 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -124.51 87.87 2.8 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.568 -1.271 . . . . 73.22 107.568 174.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -81.09 102.13 10.05 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.068 -0.969 . . . . 71.21 108.666 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.43 171.71 38.59 Favored Glycine 0 C--O 1.245 0.83 0 CA-C-N 116.017 -0.538 . . . . 62.41 111.935 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.46 132.12 2.31 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 111.083 -0.807 . . . . 72.01 111.083 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 50.2 mt -84.17 125.01 40.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.491 -1.299 . . . . 70.12 107.491 171.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -130.61 129.09 42.27 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.39 -0.966 . . . . 73.32 108.39 174.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.529 ' HG ' HG21 ' B' ' 55' ' ' VAL . 69.2 m -93.52 88.75 6.02 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.522 0.729 . . . . 63.12 109.34 170.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 37.2 pt -103.34 146.28 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 N-CA-C 107.73 -1.211 . . . . 71.24 107.73 176.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.11 164.62 34.17 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 112.722 0.638 . . . . 64.04 112.722 -169.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.29 -71.35 1.19 Allowed Glycine 0 C--N 1.348 1.246 0 CA-C-N 114.822 -1.081 . . . . 72.5 114.579 167.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.614 ' HB ' ' HB3' ' B' ' 9' ' ' MET . 0.4 OUTLIER -89.39 171.7 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 123.876 0.87 . . . . 72.21 111.602 -166.17 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -150.82 158.53 44.26 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.059 0.544 . . . . 62.0 111.865 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.53 -135.81 12.77 Favored Glycine 0 C--N 1.355 1.617 0 C-N-CA 124.789 1.185 . . . . 74.22 112.875 172.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 11.2 m -69.15 -26.59 64.95 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.57 0.7 . . . . 71.34 110.389 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.436 ' NE2' HG12 ' B' ' 89' ' ' ILE . 23.1 mt-30 -62.47 -44.07 97.29 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.539 -1.209 . . . . 75.44 111.315 177.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.601 ' HE2' ' HA ' ' F' ' 17' ' ' PRO . 0.0 OUTLIER -80.11 -26.88 39.29 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 110.363 -0.236 . . . . 74.52 110.363 178.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.09 -13.98 60.98 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.554 0.742 . . . . 64.13 111.55 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . 0.432 ' HE2' ' HB3' ' B' ' 134' ' ' ASP . 52.5 t-80 -77.38 -34.67 54.9 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.806 0.443 . . . . 70.55 110.672 169.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.626 ' HG ' ' HD2' ' B' ' 11' ' ' PHE . 49.2 t -76.33 -67.58 0.67 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 119.161 -0.447 . . . . 74.32 111.356 -175.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.538 ' HB2' HG22 ' B' ' 58' ' ' VAL . 2.3 pt? -91.88 -12.37 33.78 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 118.255 0.48 . . . . 73.43 111.809 -175.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . 0.447 ' HA2' ' HD1' ' F' ' 15' ' ' PHE . . . -97.76 -24.24 12.34 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-O 119.837 -0.424 . . . . 71.24 113.489 -177.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.2 -55.83 2.03 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.994 0.518 . . . . 71.31 111.197 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.481 ' O ' HG13 ' B' ' 105' ' ' ILE . 56.5 t80 -83.39 -37.06 23.79 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.558 0.577 . . . . 74.35 112.558 -169.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.502 ' HG ' ' HE2' ' B' ' 11' ' ' PHE . 86.9 m -64.47 -43.58 72.06 Favored Pre-proline 0 N--CA 1.482 1.149 0 CA-C-O 118.338 -0.839 . . . . 74.22 110.364 177.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.49 -41.83 43.2 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 122.531 2.154 . . . . 53.34 113.622 163.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -66.27 -33.8 76.55 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 124.119 0.968 . . . . 74.35 111.187 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.652 HG21 HD11 ' B' ' 13' ' ' ILE . 73.5 mt -71.91 -46.1 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.682 0.793 . . . . 73.51 110.082 177.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 93.6 mt -77.39 -19.53 56.05 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 114.727 -1.124 . . . . 75.23 111.173 -175.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -59.91 -52.05 76.36 Favored Pre-proline 0 N--CA 1.483 1.205 0 CA-C-O 117.585 -1.198 . . . . 73.21 113.41 -173.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.02 -27.41 42.51 Favored 'Trans proline' 0 C--N 1.385 2.489 0 CA-C-N 121.546 1.588 . . . . 73.15 112.516 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -70.62 -43.17 69.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.856 0.463 . . . . 73.23 110.302 175.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.436 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -64.73 -43.66 92.66 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.553 -0.749 . . . . 75.31 110.327 176.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -60.98 -49.44 77.42 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.717 1.207 . . . . 75.13 110.506 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -63.17 -32.94 74.45 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 123.903 0.752 . . . . 74.24 109.427 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.736 ' SG ' HD12 ' B' ' 21' ' ' ILE . 17.1 t -72.79 -41.77 64.64 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 123.406 0.442 . . . . 74.22 112.128 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.524 HG21 HG22 ' B' ' 64' ' ' VAL . 84.7 mt -60.6 -57.0 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 108.792 -0.818 . . . . 72.25 108.792 176.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.2 m -61.43 -25.79 67.44 Favored 'General case' 0 CA--C 1.554 1.111 0 O-C-N 124.776 1.297 . . . . 75.41 111.053 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 43.0 t -65.95 -51.36 59.26 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 123.186 0.594 . . . . 51.43 109.641 170.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.487 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.1 mmt -68.16 -30.17 69.23 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.188 0.595 . . . . 73.32 111.613 -177.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.444 HG23 ' O ' ' B' ' 114' ' ' ILE . 95.5 t -66.79 -44.3 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.31 1.044 . . . . 74.12 109.08 173.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.0 t -69.07 -29.38 67.48 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.924 -1.035 . . . . 73.2 111.48 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' B' ' 116' ' ' SER . 89.2 mtt-85 -74.85 -37.44 62.23 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.517 0.727 . . . . 71.43 109.637 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.26 -5.74 77.79 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 123.84 0.713 . . . . 74.32 112.236 170.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.522 HG23 ' HB3' ' A' ' 17' ' ' TYR . 33.8 p 63.55 25.96 14.57 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.608 1.963 . . . . 72.51 112.953 174.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -81.09 159.78 67.34 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 124.511 1.124 . . . . 75.32 110.495 174.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.58 165.09 6.49 Favored 'Trans proline' 0 C--N 1.39 2.714 0 C-N-CA 123.5 2.8 . . . . 75.5 114.273 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.4 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 65.5 tp60 -61.07 136.71 58.16 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.388 -1.278 . . . . 65.23 112.135 -173.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.418 HD11 HG23 ' B' ' 40' ' ' VAL . 43.0 tp -136.25 121.78 19.52 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.887 0.875 . . . . 73.34 109.443 -178.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -132.83 129.07 38.02 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.873 0.869 . . . . 62.34 109.098 175.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.21 149.9 30.3 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.576 0.75 . . . . 72.21 110.261 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.04 129.08 86.87 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 123.429 0.692 . . . . 72.35 111.919 -172.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.86 98.23 0.36 Allowed 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.274 2.649 . . . . 72.04 113.216 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 21.1 m -109.83 135.96 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 109.018 -0.734 . . . . 75.24 109.018 171.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -90.55 100.98 13.72 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.006 -1.109 . . . . 75.24 108.006 177.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -60.78 -43.04 98.58 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.79 0.836 . . . . 75.03 110.816 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.432 ' HB3' ' HE2' ' B' ' 96' ' ' HIS . 6.9 m-20 -60.72 -43.13 98.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.851 -1.068 . . . . 64.12 111.339 -176.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.73 -34.87 64.96 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.45 0.7 . . . . 75.32 111.516 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 tt -59.8 -51.79 68.24 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.96 0.904 . . . . 75.03 110.363 -176.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -77.6 -16.84 58.34 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.611 0.765 . . . . 74.21 111.931 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 46.9 ttm -75.27 -32.04 60.93 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.78 0.832 . . . . 70.31 110.865 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -74.21 -14.31 60.92 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.408 0.683 . . . . 71.24 111.168 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -71.79 -32.42 67.61 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.963 0.505 . . . . 74.52 109.771 171.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 32.7 mt -88.75 14.93 9.1 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.143 0.977 . . . . 75.23 111.562 -175.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.81 131.44 46.85 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.672 1.189 . . . . 71.14 110.6 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -142.87 126.92 17.37 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.612 0.765 . . . . 72.51 109.379 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -132.5 152.02 51.7 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.019 0.928 . . . . 75.22 109.93 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.58 132.01 7.47 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.447 0.699 . . . . 64.41 110.019 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.84 139.56 14.54 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 123.442 0.464 . . . . 73.32 112.342 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.65 129.25 40.56 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 107.404 -1.332 . . . . 73.21 107.404 177.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -91.04 -129.75 4.45 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 113.746 0.259 . . . . 75.33 113.746 -171.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 11.7 t -149.77 170.47 18.66 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.513 1.125 . . . . 51.53 109.189 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.54 153.3 43.85 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.959 0.503 . . . . 55.52 109.976 175.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -116.25 166.45 12.02 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.576 0.751 . . . . 72.42 111.15 -173.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -134.76 154.72 51.47 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 107.84 -1.17 . . . . 75.24 107.84 172.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -158.52 113.8 2.61 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.672 -0.492 . . . . 71.22 109.672 172.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -85.58 124.26 31.93 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.059 0.944 . . . . 72.42 108.781 173.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.99 0 CA-C-O 118.979 -0.534 . . . . 75.23 109.787 -179.888 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 109.824 -0.435 . . . . 65.03 109.824 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.1 p -91.62 90.64 7.67 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 108.872 -0.788 . . . . 74.25 108.872 170.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 60.8 -172.17 0.14 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 124.829 1.251 . . . . 75.33 113.313 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -138.5 132.9 31.94 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.299 1.039 . . . . 72.31 108.846 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -160.5 -71.87 0.07 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 108.41 -0.959 . . . . 73.12 108.41 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -139.57 89.41 2.32 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 106.999 -1.482 . . . . 65.01 106.999 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 29.8 p -102.3 125.27 48.95 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.841 0.856 . . . . 70.33 111.558 -171.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -132.39 161.79 32.74 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.661 1.184 . . . . 73.32 108.025 169.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.766 ' HE3' HG13 ' C' ' 86' ' ' ILE . 15.0 tpt 61.82 113.56 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.208 1.003 . . . . 74.1 112.357 177.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 12.2 m -98.26 101.71 13.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.625 0.77 . . . . 74.0 109.139 174.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.696 ' HD2' ' HG3' ' A' ' 130' ' ' PRO . 71.0 t80 -115.15 129.23 56.61 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.868 0.867 . . . . 72.44 108.674 175.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.552 ' HB3' ' HB2' ' C' ' 85' ' ' SER . 38.9 tt0 -142.84 144.21 32.42 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.541 0.736 . . . . 74.44 109.403 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mt -92.72 131.17 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 109.253 -0.647 . . . . 71.24 109.253 173.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.428 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.4 mm-40 -98.96 -43.21 6.79 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.954 0.902 . . . . 74.15 109.84 176.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -172.54 137.18 0.81 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.628 -0.879 . . . . 74.13 108.628 -168.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 85.5 mt -129.64 138.17 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.236 -1.024 . . . . 75.12 108.236 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -170.4 166.64 8.5 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.672 0.749 . . . . 73.44 111.43 -173.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -84.77 109.81 18.34 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.922 -1.035 . . . . 74.24 109.045 174.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -64.33 -44.32 91.88 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 121.994 0.902 . . . . 72.25 108.844 174.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.547 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.0 t70 -147.97 149.89 33.0 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 113.392 -1.731 . . . . 74.15 109.254 -175.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 79.5 mt -140.3 145.43 26.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 125.798 1.639 . . . . 72.53 106.725 177.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.5 t -155.72 150.21 25.97 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.609 0.719 . . . . 74.11 110.057 176.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -148.49 147.94 29.68 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.323 -1.362 . . . . 63.52 107.323 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -144.08 133.52 23.34 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.562 1.145 . . . . 74.52 108.804 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.01 78.68 4.27 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 107.117 -1.438 . . . . 73.4 107.117 171.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.44 -11.2 22.55 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.948 2.432 . . . . 73.33 112.333 -174.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -126.08 26.39 6.53 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.09 1.356 . . . . 72.41 109.791 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.83 -58.5 5.34 Favored Pre-proline 0 CA--C 1.57 1.724 0 CA-C-O 117.831 -1.08 . . . . 72.23 113.574 -172.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -59.95 -38.69 77.13 Favored 'Trans proline' 0 C--N 1.401 3.314 0 C-N-CA 122.162 1.908 . . . . 74.34 112.255 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -70.72 -39.79 73.17 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.331 -0.85 . . . . 71.34 111.831 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.58 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.5 p -78.78 -17.29 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.428 0 N-CA-C 112.224 0.453 . . . . 72.0 112.224 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -66.2 -37.21 85.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.194 -0.316 . . . . 74.53 111.538 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -85.19 13.49 6.29 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.493 0.717 . . . . 74.42 111.709 -176.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.62 169.29 9.61 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.545 1.138 . . . . 72.45 110.308 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -74.7 122.94 24.02 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.402 -0.592 . . . . 71.42 109.402 171.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -84.1 92.26 7.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.511 0.724 . . . . 73.33 110.49 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -146.95 80.96 9.26 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 106.928 -1.508 . . . . 71.54 106.928 168.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -88.22 155.35 6.86 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.597 2.198 . . . . 72.22 112.843 -176.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -86.02 99.49 11.5 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 106.548 -1.649 . . . . 71.12 106.548 166.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.404 ' HB ' HD11 ' G' ' 6' ' ' ILE . 43.9 t -74.77 96.55 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 107.826 -1.175 . . . . 75.45 107.826 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.582 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 88.4 mttt -93.81 100.74 12.88 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.209 -1.404 . . . . 74.0 107.209 178.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.56 HD11 ' HA ' ' G' ' 8' ' ' LEU . 2.0 pp -88.71 149.7 23.35 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.187 0.518 . . . . 73.01 109.794 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.627 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 26.1 t70 -144.36 144.84 31.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.306 -0.861 . . . . 51.23 108.964 -176.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.66 142.39 41.15 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.387 0.675 . . . . 74.55 109.782 174.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 25.8 t70 -137.66 146.54 43.98 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.363 1.065 . . . . 74.21 108.605 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 46' ' ' THR . . . . . 0.545 HG22 HD23 ' G' ' 11' ' ' LEU . 47.3 p -115.53 120.52 39.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.94 0.496 . . . . 75.15 111.283 -170.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.31 160.12 35.9 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.183 0.993 . . . . 74.11 109.447 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 35.4 p -164.55 166.46 20.3 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.908 0.385 . . . . 72.42 112.006 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 83.9 p -151.92 152.81 33.02 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.346 1.058 . . . . 75.22 108.993 171.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -102.22 124.08 47.18 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.498 -0.927 . . . . 74.22 108.498 172.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.434 HD13 HD13 ' C' ' 83' ' ' ILE . 51.2 mt -101.97 -32.27 10.27 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.251 0.62 . . . . 71.31 111.12 -174.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.52 -166.04 1.28 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.351 0.66 . . . . 74.21 110.686 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -63.36 115.62 4.76 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 124.005 0.816 . . . . 64.03 109.42 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 67.49 -5.25 0.79 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 125.017 1.327 . . . . 75.04 113.113 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 67.4 t -92.64 106.7 18.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.54 -1.281 . . . . 75.44 107.54 -177.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -124.64 128.65 49.19 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.521 -1.289 . . . . 74.24 107.521 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -81.36 119.31 23.52 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.001 -1.0 . . . . 72.34 108.547 172.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.464 HG13 ' HE2' ' G' ' 15' ' ' PHE . 65.5 t -96.45 120.44 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.339 -1.356 . . . . 72.42 107.339 171.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 55.7 t -115.09 132.76 63.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 108.671 -0.863 . . . . 71.23 108.671 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 29.9 tp -124.18 117.2 24.07 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.304 -0.999 . . . . 74.23 108.304 170.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 33.3 ttm180 -81.74 135.76 35.48 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.098 0.959 . . . . 72.2 108.955 172.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.509 ' HB ' HD11 ' C' ' 114' ' ' ILE . 14.9 t -122.89 130.06 74.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.258 -1.386 . . . . 63.21 107.258 169.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.627 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 18.0 m -129.65 116.62 19.11 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.534 -0.913 . . . . 74.24 108.534 -177.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.67 HG23 HG21 ' C' ' 114' ' ' ILE . 59.5 t -108.53 113.3 43.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 124.202 1.001 . . . . 71.2 108.978 -173.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 2.5 m -101.62 131.1 48.01 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.936 -0.764 . . . . 73.3 108.936 175.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.2 109.62 16.06 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.434 -1.691 . . . . 64.43 106.434 174.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 24.7 m -131.47 125.46 32.55 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 117.791 0.269 . . . . 71.42 110.358 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.7 mt -85.76 49.59 1.8 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.497 1.119 . . . . 73.42 108.96 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.62 -114.64 4.96 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 110.096 -1.202 . . . . 74.41 110.096 -169.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -91.97 -24.08 19.36 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.36 0.664 . . . . 70.55 110.17 172.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -67.72 101.91 1.12 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.19 -0.67 . . . . 65.13 109.19 176.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 90.3 m -70.78 122.62 20.2 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.617 -0.512 . . . . 73.04 109.617 175.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.58 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.47 -56.92 4.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.291 -1.003 . . . . 71.3 108.291 171.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -159.48 163.32 35.41 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.29 -0.868 . . . . 65.43 111.352 177.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -127.57 131.68 49.96 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 105.966 -1.864 . . . . 75.14 105.966 164.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.442 ' SG ' HG22 ' C' ' 114' ' ' ILE . 42.6 t -137.73 111.19 8.02 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.111 -0.7 . . . . 72.23 109.111 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . 0.406 ' HB2' HG22 ' C' ' 63' ' ' THR . 33.0 tt0 -119.51 116.59 26.39 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.31 0.644 . . . . 74.4 109.841 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -117.11 132.59 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 108.531 -0.914 . . . . 75.23 108.531 172.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.547 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 44.3 mt-30 -105.24 100.46 10.05 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.19 -1.041 . . . . 75.1 108.19 172.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -87.71 121.33 30.0 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.609 -0.723 . . . . 75.31 109.584 -177.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.88 146.92 18.87 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 112.042 -0.423 . . . . 65.42 112.042 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.476 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -143.12 124.58 2.36 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.435 -1.066 . . . . 75.33 110.435 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.511 HD11 ' HB3' ' D' ' 29' ' ' PRO . 16.6 mm -81.04 123.55 37.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.984 -1.117 . . . . 62.14 107.984 176.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -132.47 135.56 46.11 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.738 0.415 . . . . 75.33 110.646 -174.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 85' ' ' SER . . . . . 0.615 ' HB3' ' HG3' ' E' ' 2' ' ' LYS . 43.3 m -83.96 99.91 10.69 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 107.667 -1.235 . . . . 62.15 107.667 167.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.766 HG13 ' HE3' ' C' ' 9' ' ' MET . 3.6 tt -120.0 117.76 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.519 1.128 . . . . 74.54 110.592 -172.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.24 169.89 16.99 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.458 1.103 . . . . 75.35 109.715 177.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 122.63 -60.5 0.57 Allowed Glycine 0 N--CA 1.472 1.094 0 N-CA-C 112.5 -0.24 . . . . 71.33 112.5 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.468 HG12 ' SD ' ' C' ' 9' ' ' MET . 23.5 pt -96.4 173.44 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.113 0.565 . . . . 74.11 111.015 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.486 ' HA ' ' HE2' ' C' ' 94' ' ' MET . 12.0 tp10 -153.47 160.39 42.54 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.833 0.853 . . . . 73.34 110.539 -172.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.04 -145.87 30.16 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.762 -0.654 . . . . 62.14 111.646 175.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 46.6 p -63.88 -17.38 63.12 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.082 0.553 . . . . 74.13 112.011 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -67.3 -51.01 57.83 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 123.403 0.681 . . . . 75.32 110.458 173.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.502 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 7.0 ptp -70.24 -37.14 74.9 Favored 'General case' 0 C--N 1.362 1.14 0 N-CA-C 109.839 -0.43 . . . . 75.42 109.839 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.67 -35.88 66.48 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.525 0.73 . . . . 75.14 110.988 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -71.35 -39.64 71.18 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.397 1.079 . . . . 74.21 111.518 173.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.621 ' SG ' ' HE2' ' C' ' 9' ' ' MET . 52.3 t -71.28 -62.0 1.56 Allowed 'General case' 0 N--CA 1.481 1.106 0 O-C-N 122.094 -0.379 . . . . 62.4 111.613 -175.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.507 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 1.2 pp -71.14 -21.94 62.12 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.99 0.516 . . . . 74.15 112.34 -178.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.44 4.97 62.36 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 119.594 -0.559 . . . . 52.25 113.466 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.98 -60.14 0.2 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 117.917 0.859 . . . . 75.01 112.348 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -66.7 -51.56 54.6 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.672 0.789 . . . . 75.21 112.087 -175.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.507 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 19.9 m -63.87 -44.77 80.14 Favored Pre-proline 0 CA--C 1.57 1.719 0 C-N-CA 123.738 0.815 . . . . 72.32 112.805 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -68.1 -22.82 40.57 Favored 'Trans proline' 0 C--N 1.397 3.08 0 C-N-CA 122.298 1.999 . . . . 74.12 113.347 171.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -71.16 -32.12 68.53 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 122.974 0.51 . . . . 75.11 110.673 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.419 HG22 ' NH1' ' A' ' 111' ' ' ARG . 37.7 mm -59.33 -42.01 85.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.725 0.81 . . . . 73.34 109.884 171.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.476 HD21 ' HA3' ' C' ' 82' ' ' GLY . 93.8 mt -80.22 -21.22 43.09 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.732 -1.122 . . . . 74.14 112.595 -172.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -53.79 -50.84 81.44 Favored Pre-proline 0 CA--C 1.567 1.618 0 CA-C-O 117.555 -1.212 . . . . 74.4 113.377 -175.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.77 -33.19 96.52 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 122.145 1.897 . . . . 74.22 114.134 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -73.07 -44.46 60.57 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.077 0.551 . . . . 74.54 110.03 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.22 -40.01 88.63 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.242 -0.89 . . . . 64.3 110.261 173.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -59.09 -53.8 54.25 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.962 1.305 . . . . 75.43 110.765 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.79 -36.79 78.72 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 123.358 0.411 . . . . 72.43 109.903 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 20.3 t -65.73 -32.37 73.88 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.978 0.511 . . . . 74.32 111.495 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.67 HG21 HG23 ' C' ' 64' ' ' VAL . 81.5 mt -74.1 -55.8 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.187 0.595 . . . . 75.22 109.859 173.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.8 m -61.37 -27.44 68.52 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.452 0.701 . . . . 54.21 110.964 -174.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.7 t -65.65 -50.17 65.96 Favored 'General case' 0 C--O 1.214 -0.77 0 C-N-CA 123.782 0.833 . . . . 53.01 109.034 171.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.512 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.7 -33.06 74.33 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.218 1.007 . . . . 73.44 112.364 178.286 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 66.4 t -67.85 -41.48 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 123.493 0.717 . . . . 73.53 109.066 174.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 39.9 t -74.07 -23.46 59.37 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.528 1.131 . . . . 75.43 111.986 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -78.12 -39.6 40.74 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.719 -0.845 . . . . 73.45 108.719 176.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.38 -0.65 62.7 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.549 -0.751 . . . . 71.24 112.347 167.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 31.4 p 62.24 29.73 17.46 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.695 1.998 . . . . 74.23 113.653 169.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -81.84 156.29 70.12 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 123.627 0.771 . . . . 72.33 108.947 169.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 25.3 Cg_endo -62.12 168.07 9.78 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.54 2.16 . . . . 62.54 112.485 173.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -59.79 110.47 1.17 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.279 -0.873 . . . . 73.12 112.17 -173.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.41 86.38 2.28 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 105.893 -1.891 . . . . 71.45 105.893 171.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -107.93 108.42 19.56 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.565 -0.902 . . . . 71.11 108.565 -173.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.41 HD23 ' N ' ' C' ' 129' ' ' ALA . 3.5 tt -73.03 144.75 47.03 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.485 0.714 . . . . 74.42 109.796 -174.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.41 ' N ' HD23 ' C' ' 128' ' ' LEU . . . -60.47 157.92 33.01 Favored Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 124.706 1.202 . . . . 73.32 112.417 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.425 ' HG3' HD13 ' A' ' 16' ' ' ILE . 43.6 Cg_exo -57.65 110.53 0.63 Allowed 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 122.735 2.29 . . . . 73.02 112.285 173.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.642 HG13 ' HB2' ' G' ' 8' ' ' LEU . 20.4 t -98.73 108.41 22.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.769 -0.826 . . . . 75.35 108.769 177.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -107.13 90.8 3.41 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 107.836 -1.172 . . . . 74.34 107.836 173.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -55.55 -41.39 73.16 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.044 0.84 . . . . 75.43 110.578 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.13 -48.6 62.01 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 114.328 -1.305 . . . . 73.44 111.458 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.98 -44.31 55.12 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.524 -1.217 . . . . 64.14 111.591 -174.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.7 -32.67 73.81 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.66 0.784 . . . . 74.23 110.581 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -62.15 -44.13 97.3 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.432 0.693 . . . . 74.44 110.869 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 56.8 mtt -75.9 -45.66 34.15 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.564 -0.744 . . . . 71.12 110.627 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -59.09 -37.99 78.43 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.617 1.167 . . . . 73.33 111.419 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -48.86 -79.06 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.481 1.513 . . . . 75.1 111.519 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 53.4 tp -57.83 -40.69 80.64 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.615 0.766 . . . . 73.2 112.239 -177.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -78.55 -81.42 0.1 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.032 0.382 . . . . 74.45 112.032 -172.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . 0.423 ' HG2' ' HB3' ' A' ' 8' ' ' GLU . 2.6 mp0 -99.06 -160.22 0.79 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.891 0.876 . . . . 74.32 110.297 -173.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -139.83 137.22 34.78 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.052 0.541 . . . . 73.43 109.912 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.45 99.25 2.43 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.891 -0.781 . . . . 64.54 108.891 172.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.04 169.9 55.05 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 123.406 0.441 . . . . 71.54 113.123 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -68.91 114.82 7.56 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.497 0.719 . . . . 74.51 109.768 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.53 139.98 19.26 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 111.233 -0.747 . . . . 64.21 111.233 174.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 27.4 m -65.49 137.15 57.24 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.727 0.811 . . . . 73.4 111.167 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -108.24 123.1 48.25 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.339 -0.986 . . . . 70.23 108.339 174.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -66.76 91.56 0.2 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.077 0.951 . . . . 73.43 111.792 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -86.41 70.21 10.47 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.354 0.661 . . . . 74.05 109.647 176.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -93.91 -178.06 4.54 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.892 0.877 . . . . 72.41 111.115 -176.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -88.46 -47.91 8.0 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.318 -0.623 . . . . 75.43 109.318 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.256 0 C-N-CA 124.462 1.105 . . . . 63.15 109.641 173.208 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.401 ' HE3' ' HA ' ' D' ' 1' ' ' MET . 22.7 mmt . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 109.594 -0.521 . . . . 75.31 109.594 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 17.2 t -164.58 12.6 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.746 0.818 . . . . 71.34 110.149 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.61 104.78 7.41 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.993 0.917 . . . . 72.51 110.328 -171.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -137.54 154.35 49.84 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.553 1.141 . . . . 75.24 109.135 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -155.64 168.43 27.19 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 120.991 0.424 . . . . 75.05 111.948 -175.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -78.09 139.6 39.06 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.049 -0.978 . . . . 63.32 109.785 174.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -159.51 -174.21 4.54 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.838 0.855 . . . . 72.51 109.772 -175.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -86.25 28.6 0.82 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.341 1.057 . . . . 53.44 111.927 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 22.9 ttt -29.39 123.57 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 126.193 1.797 . . . . 75.44 114.413 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 57.0 m -111.01 139.2 46.56 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.864 0.865 . . . . 70.22 109.449 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -157.73 96.72 1.52 Allowed 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.721 -1.214 . . . . 75.13 107.721 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -113.86 115.7 28.15 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.477 -0.935 . . . . 71.54 108.477 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.504 HG21 HD11 ' D' ' 16' ' ' ILE . 46.8 mt -71.32 123.06 24.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.913 -0.773 . . . . 65.32 108.913 177.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.43 HE22 HG12 ' D' ' 55' ' ' VAL . 51.7 mt-30 -93.41 -34.05 13.6 Favored 'General case' 0 C--O 1.246 0.881 0 O-C-N 123.59 0.557 . . . . 74.25 110.664 178.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -173.55 144.52 1.13 Allowed 'General case' 0 C--N 1.364 1.224 0 N-CA-C 112.303 0.483 . . . . 75.22 112.303 -170.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.504 HD11 HG21 ' D' ' 13' ' ' ILE . 3.6 mp -123.34 136.92 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 107.243 -1.391 . . . . 73.2 107.243 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.407 ' HE1' HG13 ' D' ' 83' ' ' ILE . 24.6 p90 -164.61 152.31 11.86 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.64 0.733 . . . . 73.42 110.649 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 56.7 p -84.2 117.47 23.52 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.532 -1.213 . . . . 73.14 108.525 174.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -85.53 -18.02 34.66 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.785 0.326 . . . . 73.2 110.21 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -166.24 140.49 4.33 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.429 1.092 . . . . 70.24 108.283 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.512 HG23 ' HE1' ' C' ' 117' ' ' MET . 77.5 mt -137.18 150.14 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 108.12 -1.067 . . . . 75.54 108.12 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.9 t -156.8 103.43 2.07 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.299 1.04 . . . . 75.23 109.298 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.521 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 80.8 t80 -109.09 122.1 46.56 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 106.366 -1.716 . . . . 74.54 106.366 171.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -130.48 110.47 11.48 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.502 -0.555 . . . . 73.35 109.502 -172.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.4 89.45 4.89 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 108.234 -1.025 . . . . 63.42 108.234 173.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.22 -38.15 3.97 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.555 2.17 . . . . 73.5 112.289 -172.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.458 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 58.2 m-20 -101.7 11.24 39.15 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.899 0.88 . . . . 72.53 110.072 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -20.63 -68.03 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 116.151 1.908 . . . . 73.05 116.151 -168.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.511 ' HB3' HD11 ' C' ' 83' ' ' ILE . 43.6 Cg_endo -79.94 -18.24 10.33 Favored 'Trans proline' 0 C--N 1.379 2.167 0 CA-C-N 122.844 2.052 . . . . 74.24 114.029 -173.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.433 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 7.7 t-160 -76.68 -39.79 50.95 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.511 1.124 . . . . 64.31 109.576 176.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.706 HG22 HD11 ' D' ' 68' ' ' LEU . 11.3 p -82.79 -18.01 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 CA-C-N 115.799 -0.637 . . . . 74.32 111.296 -172.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.402 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 21.2 m-85 -65.86 -22.51 66.53 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 112.094 0.405 . . . . 75.44 112.094 177.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.433 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 58.8 mt-30 -60.31 -20.23 58.42 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.1 0.96 . . . . 73.22 111.26 177.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.57 ' HZ3' ' HG2' ' D' ' 71' ' ' GLU . 93.1 mttt -95.92 102.14 13.9 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.659 1.183 . . . . 75.13 109.816 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -101.16 87.23 3.2 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.759 0.424 . . . . 74.23 110.151 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -158.66 179.79 8.78 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.176 0.991 . . . . 74.4 108.599 167.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -67.19 112.34 9.69 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 123.622 0.769 . . . . 74.42 110.441 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -56.39 141.62 89.26 Favored 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 122.736 2.291 . . . . 62.35 112.016 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 42.6 mt-10 -57.84 118.41 5.3 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.59 1.181 . . . . 73.13 111.291 -177.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 25.6 t -93.58 107.18 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 107.568 -1.271 . . . . 73.41 107.568 -172.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' D' ' 39' ' ' GLU . 31.1 mmtp -125.98 118.92 26.4 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.555 -1.276 . . . . 75.04 107.555 -177.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.91 115.55 27.62 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.203 0.601 . . . . 74.22 109.725 -174.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.599 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.3 m-20 -107.85 119.25 38.93 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.425 1.09 . . . . 75.43 108.066 172.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.431 HD23 ' HB2' ' H' ' 9' ' ' ALA . 3.4 mm? -111.58 152.88 27.08 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.754 0.421 . . . . 75.22 110.537 -175.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -157.01 152.82 27.05 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.881 -1.155 . . . . 73.1 107.881 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 57.9 p -118.78 149.21 41.88 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.871 0.468 . . . . 71.23 111.611 -170.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.401 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -152.54 164.03 38.42 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.426 1.09 . . . . 74.21 109.038 172.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 50.8 p -176.95 177.5 1.28 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.702 0.801 . . . . 75.25 110.03 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 50.8 p -173.02 143.83 1.2 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.164 0.986 . . . . 62.41 109.889 169.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -76.3 116.71 17.25 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.794 -1.187 . . . . 75.42 107.794 167.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' D' ' 57' ' ' GLU . 61.3 mt -88.94 -26.66 21.42 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.997 0.519 . . . . 72.43 110.054 -175.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -174.06 -172.98 0.76 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.692 1.197 . . . . 72.43 109.777 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -68.88 126.75 30.74 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.477 -0.783 . . . . 71.43 109.131 174.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.525 ' HA ' HG21 ' H' ' 19' ' ' THR . 9.1 m-20 69.08 -2.36 1.82 Allowed 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 124.956 1.302 . . . . 73.44 113.059 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.43 HG12 HE22 ' D' ' 14' ' ' GLN . 94.6 t -110.47 124.55 67.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.029 -1.1 . . . . 74.52 108.029 176.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.62 ' HB3' HD11 ' D' ' 86' ' ' ILE . 66.4 t80 -146.57 137.43 24.1 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.371 0.605 . . . . 73.33 110.142 -177.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.5 ' HB2' HD11 ' D' ' 51' ' ' LEU . 21.9 tt0 -104.13 137.61 41.83 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.964 1.306 . . . . 71.13 110.029 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.88 126.19 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 108.058 -1.09 . . . . 63.24 108.058 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.434 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 25.9 t -124.12 131.82 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.448 0.699 . . . . 74.31 109.388 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.415 HD22 HD12 ' D' ' 106' ' ' LEU . 3.9 mm? -123.81 122.14 37.24 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.518 -0.549 . . . . 73.21 109.518 173.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' D' ' 79' ' ' GLN . 12.5 ttm180 -83.54 106.39 15.24 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.387 -0.968 . . . . 74.34 108.387 170.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -92.02 125.95 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 107.601 -1.259 . . . . 74.41 107.601 169.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 22.1 m -123.83 133.34 53.81 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.041 -0.725 . . . . 72.52 109.041 177.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 73.1 t -114.19 101.36 12.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 107.85 -1.167 . . . . 74.4 107.85 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 78.6 m -90.58 92.43 8.85 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.568 -1.271 . . . . 72.31 107.568 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.572 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -100.98 135.93 41.64 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 114.831 -1.077 . . . . 75.24 109.964 -175.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.408 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 70.1 m -143.21 133.6 24.74 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.005 0.522 . . . . 73.13 110.699 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.706 HD11 HG22 ' D' ' 31' ' ' VAL . 77.2 mt -101.0 110.04 22.02 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.867 -1.16 . . . . 75.01 107.867 172.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.19 -114.02 3.75 Favored Glycine 0 C--N 1.344 0.981 0 O-C-N 123.237 0.336 . . . . 53.54 113.038 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.67 4.46 12.32 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.607 0.763 . . . . 74.12 110.576 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.57 ' HG2' ' HZ3' ' D' ' 34' ' ' LYS . 12.7 pt-20 -120.68 156.11 32.44 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.567 0.747 . . . . 75.43 109.229 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 43.8 m -70.26 135.32 48.86 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 123.676 0.61 . . . . 61.3 110.545 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.476 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -85.91 -65.53 1.0 Allowed 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.062 -1.459 . . . . 65.11 107.062 172.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -157.43 148.57 21.63 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.606 -1.179 . . . . 75.1 110.342 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 60.1 mt -111.86 107.77 16.92 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 105.908 -1.886 . . . . 73.04 105.908 171.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.666 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 46.3 t -116.38 105.53 12.62 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.305 -0.998 . . . . 73.3 108.305 -171.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . 0.465 ' HB2' HG23 ' D' ' 63' ' ' THR . 41.8 tt0 -130.12 131.57 45.76 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.137 0.975 . . . . 64.13 108.994 -165.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.4 t -140.0 119.21 12.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 108.359 -0.978 . . . . 75.34 108.359 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' D' ' 61' ' ' ARG . 71.1 mt-30 -86.93 80.89 8.3 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 107.365 -1.346 . . . . 75.4 107.365 171.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -81.76 106.55 13.79 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 113.527 -1.669 . . . . 72.44 108.901 -172.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -110.36 158.46 14.42 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 115.844 -0.616 . . . . 74.11 112.442 -176.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.93 132.18 3.9 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.828 -0.509 . . . . 74.35 111.828 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.407 HG13 ' HE1' ' D' ' 17' ' ' TYR . 74.5 mt -89.4 130.8 38.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.229 -1.026 . . . . 74.53 108.229 174.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -133.36 166.84 21.58 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 123.512 0.508 . . . . 73.32 110.466 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.0 m -114.69 107.06 14.96 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.036 0.934 . . . . 75.44 108.526 175.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.62 HD11 ' HB3' ' D' ' 56' ' ' TYR . 4.2 mp -109.23 118.13 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 C-N-CA 123.402 0.681 . . . . 74.14 109.223 -176.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.7 139.65 16.33 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.707 0.803 . . . . 75.24 110.326 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.45 21.92 49.5 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-O 120.221 -0.21 . . . . 70.24 113.099 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.411 HG23 ' N ' ' D' ' 90' ' ' GLU . 3.6 mp -116.34 146.72 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.681 0.792 . . . . 73.23 109.035 176.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.411 ' N ' HG23 ' D' ' 89' ' ' ILE . 50.9 mt-10 -149.69 153.85 37.62 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.411 1.084 . . . . 73.44 110.411 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' D' ' 94' ' ' MET . . . 76.98 -133.81 13.97 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 114.835 0.694 . . . . 55.41 114.835 167.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.8 m -85.68 -11.66 53.19 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.259 1.024 . . . . 75.31 110.955 -178.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -57.11 -40.32 76.8 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.314 1.046 . . . . 74.24 110.618 176.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.413 ' HG2' ' O ' ' D' ' 91' ' ' GLY . 23.5 ptt? -74.45 -27.07 60.43 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.572 -0.74 . . . . 74.13 111.72 177.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.11 -34.88 77.22 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.523 0.329 . . . . 75.13 110.608 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -79.7 -32.0 41.3 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.988 -0.551 . . . . 64.42 110.621 174.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.7 t -63.1 -51.12 67.84 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.176 0.512 . . . . 73.44 110.705 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.691 HD11 HG21 ' H' ' 18' ' ' VAL . 57.8 mt -82.03 -28.52 32.45 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.096 -0.956 . . . . 71.11 111.252 -174.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.6 11.36 72.29 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-O 119.61 -0.55 . . . . 53.45 113.519 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.82 -65.3 0.11 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 117.728 0.764 . . . . 60.02 111.84 -177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -73.82 -42.26 61.15 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 112.664 0.616 . . . . 74.2 112.664 -168.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.433 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 62.3 m -64.13 -46.48 79.92 Favored Pre-proline 0 CA--C 1.566 1.562 0 CA-C-O 118.55 -0.738 . . . . 74.41 111.904 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.433 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 31.3 Cg_exo -62.42 -28.64 78.34 Favored 'Trans proline' 0 C--N 1.4 3.263 0 C-N-CA 122.423 2.082 . . . . 75.11 113.078 169.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -69.33 -30.3 68.31 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.579 0.751 . . . . 74.54 111.063 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.5 mm -69.12 -36.47 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 121.42 0.628 . . . . 73.12 109.84 172.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.415 HD12 HD22 ' D' ' 60' ' ' LEU . 68.6 mt -86.16 -10.61 54.46 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.27 -0.877 . . . . 74.43 111.819 -176.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -66.0 -49.89 55.0 Favored Pre-proline 0 CA--C 1.565 1.558 0 CA-C-O 117.935 -1.031 . . . . 75.32 112.667 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -60.61 -32.13 93.0 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 122.272 1.981 . . . . 70.53 112.932 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -81.02 -35.24 32.14 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.382 -0.826 . . . . 73.01 112.206 -176.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.17 -52.0 61.09 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.003 -1.11 . . . . 64.21 108.003 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -49.28 -50.01 40.99 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.923 1.389 . . . . 72.13 111.84 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -67.05 -50.38 62.1 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.718 0.636 . . . . 65.33 111.254 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -58.19 -44.17 87.95 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 124.178 0.924 . . . . 71.22 110.611 -177.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.526 ' HA ' ' SG ' ' D' ' 76' ' ' CYS . 91.0 mt -58.53 -63.06 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 124.463 1.105 . . . . 74.31 110.862 173.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 92.0 m -55.04 -38.33 67.84 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.225 1.01 . . . . 71.43 112.287 -173.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 42.0 t -67.89 -42.81 80.63 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.409 -0.814 . . . . 72.1 110.172 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.666 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 73.2 mtm -69.11 -29.9 68.07 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.67 0.388 . . . . 75.24 111.645 177.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.426 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.4 t -62.45 -50.04 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 O-C-N 123.797 0.686 . . . . 74.13 109.457 174.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 81.9 p -71.12 -30.35 66.39 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.942 -0.572 . . . . 73.12 110.855 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 71.8 mtt-85 -70.16 -32.19 70.04 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.369 0.668 . . . . 73.32 109.961 174.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.84 10.72 71.42 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.825 -0.625 . . . . 60.02 112.502 174.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 45.5 p 56.12 30.8 17.03 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 126.444 1.898 . . . . 75.11 114.144 175.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -93.47 159.44 35.07 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 123.813 0.845 . . . . 62.31 110.188 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -51.75 125.03 15.81 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.502 2.801 . . . . 74.22 113.501 171.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -57.59 136.2 56.75 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.844 1.258 . . . . 74.33 111.664 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 59.0 tp -128.53 97.38 4.69 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.454 0.702 . . . . 73.03 109.573 -175.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -100.57 110.07 22.2 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.568 0.747 . . . . 74.42 110.058 -176.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.559 ' HA ' HD12 ' H' ' 6' ' ' ILE . 89.1 mt -71.0 115.24 9.9 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.919 0.488 . . . . 73.04 110.264 178.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.31 157.28 88.33 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 122.967 0.507 . . . . 64.14 110.568 176.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -51.0 110.06 0.37 Allowed 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.419 2.746 . . . . 74.23 112.959 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 29.6 m -108.78 121.13 61.37 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 108.639 -0.874 . . . . 75.14 108.639 172.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -74.73 89.32 2.27 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 108.664 -0.865 . . . . 73.34 108.664 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -69.5 -17.25 63.58 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.357 -0.838 . . . . 72.32 110.823 -177.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.68 -60.42 3.71 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.961 0.904 . . . . 75.51 110.398 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.29 -37.99 84.31 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.556 0.742 . . . . 72.11 111.512 -178.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.0 tt -58.68 -43.44 89.94 Favored 'General case' 0 CA--C 1.556 1.192 0 O-C-N 123.969 0.793 . . . . 64.44 110.556 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -74.02 -46.59 42.53 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.229 0.611 . . . . 72.31 110.775 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.462 ' O ' ' HG3' ' D' ' 142' ' ' GLN . 69.0 mtm -60.36 -33.45 72.46 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.168 0.587 . . . . 72.2 111.332 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -60.28 -35.24 75.1 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.878 0.871 . . . . 73.12 111.28 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -64.75 -39.71 94.09 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.841 0.856 . . . . 72.23 110.721 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.1 mp -68.86 -28.12 66.42 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.751 0.821 . . . . 71.44 111.185 178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' D' ' 138' ' ' MET . 75.7 mt-30 -80.1 0.55 31.58 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 113.052 0.76 . . . . 73.12 113.052 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.19 52.73 1.02 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 122.116 0.96 . . . . 75.21 111.009 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -143.94 158.27 43.81 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.93 -1.032 . . . . 75.34 110.334 174.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -101.7 143.06 32.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.055 0.942 . . . . 75.32 109.674 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.08 72.14 2.52 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.532 0.52 . . . . 71.01 112.253 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -86.34 -46.11 10.59 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.274 1.03 . . . . 74.21 110.092 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 149.78 -139.73 7.59 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 115.529 -0.76 . . . . 71.4 111.653 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 14.0 t -158.54 167.96 28.21 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.436 1.094 . . . . 73.23 108.9 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -91.69 141.51 28.61 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.903 0.481 . . . . 63.32 110.594 177.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -132.72 97.82 4.16 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.876 -1.157 . . . . 74.43 107.876 178.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -136.32 119.2 16.27 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.647 0.779 . . . . 73.11 109.218 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -82.48 77.25 9.28 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.402 -0.962 . . . . 73.53 108.402 172.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -72.72 -45.1 60.5 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.205 0.602 . . . . 72.14 109.382 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.987 0 CA-C-N 115.04 -0.982 . . . . 72.13 108.618 168.965 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 109.519 -0.548 . . . . 71.23 109.519 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' E' E ' 2' ' ' LYS . . . . . 0.615 ' HG3' ' HB3' ' C' ' 85' ' ' SER . 4.1 mppt? 68.06 134.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.919 1.688 . . . . 75.43 112.644 -178.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . 0.496 ' HB2' HE22 ' C' ' 12' ' ' GLN . 20.1 mp0 -105.55 -161.39 0.8 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.142 0.977 . . . . 75.32 108.565 174.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -138.51 92.66 2.65 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.09 0.556 . . . . 72.52 109.893 174.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 5' ' ' THR . . . . . 0.551 ' HB ' ' HB2' ' A' ' 129' ' ' ALA . 29.0 m -69.7 146.17 51.77 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.104 -0.702 . . . . 72.44 109.104 171.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 pp -54.34 140.6 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.164 0.986 . . . . 64.22 112.574 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 7' ' ' ALA . . . . . 0.527 ' HB3' ' HB1' ' A' ' 129' ' ' ALA . . . -150.68 163.4 38.64 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.758 0.823 . . . . 62.4 110.061 -177.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . 0.518 ' HB2' HG11 ' A' ' 131' ' ' VAL . 16.4 mt -91.34 145.7 24.43 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.137 0.975 . . . . 74.4 110.137 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.36 173.33 12.44 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.456 0.702 . . . . 64.51 109.786 169.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 7.7 tt -59.42 146.72 39.04 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 109.222 -0.658 . . . . 74.44 109.222 175.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 76.2 mt -55.82 118.76 21.55 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 123.367 0.667 . . . . 65.25 110.48 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.13 -8.28 11.8 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 123.073 2.515 . . . . 73.34 113.759 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . 0.413 ' H ' HD11 ' E' ' 13' ' ' LEU . 0.0 OUTLIER -130.7 162.2 29.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.801 1.241 . . . . 74.52 110.102 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 78.7 mt -83.19 110.78 18.35 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.056 -0.72 . . . . 74.15 109.056 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.48 75.17 6.1 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 108.912 -0.773 . . . . 75.21 108.912 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -121.13 104.0 41.67 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.183 0.593 . . . . 72.34 111.32 -176.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 17' ' ' PRO . . . . . 0.551 ' HB3' ' HB3' ' A' ' 48' ' ' SER . 98.3 Cg_endo -82.52 -0.69 10.28 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.421 2.081 . . . . 74.31 112.634 166.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 t -101.88 140.99 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.924 0.89 . . . . 65.04 109.828 -172.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 24.2 m -68.15 126.46 29.59 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.643 0.777 . . . . 75.1 111.048 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 86.7 tttt 68.28 92.33 0.08 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.56 1.144 . . . . 74.13 112.038 169.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.66 -9.37 59.41 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.641 0.776 . . . . 73.44 112.992 -172.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -79.87 -75.97 0.23 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.851 0.46 . . . . 72.42 110.876 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 95.6 m -158.22 90.91 2.19 Favored Pre-proline 0 N--CA 1.485 1.304 0 C-N-CA 123.548 0.739 . . . . 73.12 109.884 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -69.13 128.62 16.88 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.705 2.27 . . . . 73.34 111.826 167.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 . . . . . 0 CA--C 1.552 1.051 0 C-N-CA 124.295 1.038 . . . . 65.54 108.584 175.683 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 68.7 mtm . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 109.995 -0.372 . . . . 73.45 109.995 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -144.74 144.34 31.14 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.616 -1.253 . . . . 73.45 107.616 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -83.9 55.88 3.45 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.646 0.736 . . . . 75.33 110.357 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 54.3 m -145.26 90.2 2.01 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.02 1.328 . . . . 71.55 107.92 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 9.1 p -150.73 129.24 12.18 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.16 1.384 . . . . 74.33 107.965 177.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 29.6 mm 57.67 96.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 124.517 1.127 . . . . 63.23 110.875 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -160.2 -174.76 4.69 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.026 0.53 . . . . 74.24 110.258 -173.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 10.8 mt -154.86 -58.19 0.11 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.912 1.285 . . . . 74.02 108.892 172.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . 67.59 -173.47 0.19 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.521 1.129 . . . . 75.21 111.424 -175.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 84.4 mt -85.67 154.42 21.68 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.3 0.571 . . . . 74.03 110.923 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 6.1 mp -83.34 152.41 64.37 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 114.743 -1.117 . . . . 73.14 110.089 -176.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.49 85.71 1.07 Allowed 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 122.699 2.266 . . . . 74.14 110.775 175.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 35.0 tp 69.0 155.46 0.13 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.303 1.441 . . . . 74.55 111.143 -175.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.96 177.51 6.97 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.175 0.59 . . . . 74.5 110.344 175.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . 0.447 ' HD1' ' HA2' ' B' ' 99' ' ' GLY . 80.3 m-85 -75.83 156.55 34.32 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.227 0.611 . . . . 75.02 111.44 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 36.0 p -58.93 151.64 54.04 Favored Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 125.18 1.392 . . . . 74.03 113.057 -172.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 17' ' ' PRO . . . . . 0.601 ' HA ' ' HE2' ' B' ' 94' ' ' MET . 11.8 Cg_endo -53.74 140.96 66.37 Favored 'Trans proline' 0 C--N 1.391 2.802 0 C-N-CA 123.311 2.674 . . . . 72.31 113.36 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.33 -20.8 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.136 0.975 . . . . 74.43 111.453 -175.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 7.4 t -67.2 -48.1 68.91 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 122.036 -0.415 . . . . 73.31 110.381 175.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -147.63 114.86 6.23 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.048 0.939 . . . . 73.01 109.674 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . 0.444 ' HB2' ' HB2' ' B' ' 50' ' ' GLN . . . -120.51 161.71 20.82 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.863 -1.162 . . . . 73.23 107.863 173.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . 0.545 ' HG3' ' H ' ' F' ' 23' ' ' THR . 7.6 ptp180 -141.47 -76.53 0.29 Allowed 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 118.009 0.368 . . . . 75.21 111.122 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 23' ' ' THR . . . . . 0.545 ' H ' ' HG3' ' F' ' 22' ' ' ARG . 6.1 t -168.59 155.15 6.92 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.737 0.815 . . . . 75.24 108.812 -176.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.36 143.55 35.2 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 121.929 1.752 . . . . 73.35 111.006 166.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 . . . . . 0 C--O 1.25 1.098 0 N-CA-C 108.31 -0.996 . . . . 74.43 108.31 176.62 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.358 -0.608 . . . . 65.41 109.358 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -75.34 80.1 2.42 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.407 0.683 . . . . 74.13 109.729 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -85.91 143.47 28.19 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.223 -0.899 . . . . 64.0 109.346 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 26.0 p -72.76 171.81 11.93 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 123.291 0.637 . . . . 73.41 110.42 175.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 28.0 m -63.66 131.19 47.18 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.416 -0.587 . . . . 70.44 109.416 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . 0.404 HD11 ' HB ' ' C' ' 40' ' ' VAL . 32.1 pt -56.28 135.22 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 O-C-N 124.338 1.024 . . . . 71.31 112.811 -173.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -112.61 161.17 17.11 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 124.612 1.165 . . . . 72.54 109.207 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 8' ' ' LEU . . . . . 0.642 ' HB2' HG13 ' C' ' 131' ' ' VAL . 97.3 mt -55.25 135.57 49.63 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.622 0.769 . . . . 74.21 110.802 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.8 176.3 3.12 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.115 0.966 . . . . 60.24 111.683 -176.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.4 151.24 44.62 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.294 0.637 . . . . 73.33 110.534 176.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 11' ' ' LEU . . . . . 0.545 HD23 HG22 ' C' ' 46' ' ' THR . 7.0 mp -70.08 124.73 91.27 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 123.667 0.787 . . . . 73.43 109.624 -173.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -63.92 -49.43 4.0 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 122.522 2.148 . . . . 73.55 111.318 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 51.9 tp -87.86 138.24 31.63 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.688 -0.856 . . . . 75.23 108.688 168.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.63 89.56 1.75 Allowed 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 106.728 -1.582 . . . . 75.33 106.728 170.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . 0.464 ' HE2' HG13 ' C' ' 58' ' ' VAL . 11.4 t80 -62.74 106.96 0.87 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.364 -1.289 . . . . 74.51 111.068 -172.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 9.8 p -145.03 81.21 10.73 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 124.256 1.022 . . . . 72.31 110.331 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 17' ' ' PRO . . . . . 0.409 ' HD2' HD13 ' C' ' 98' ' ' LEU . 56.3 Cg_endo -69.89 -16.62 37.1 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 122.585 2.19 . . . . 73.32 113.298 175.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 18' ' ' VAL . . . . . . . . . . . . . 4.6 t -115.22 112.86 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 108.429 -0.952 . . . . 72.22 108.429 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 2.7 m 66.77 167.86 0.23 Allowed 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 125.395 1.478 . . . . 74.44 112.435 173.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -80.35 65.21 5.42 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.807 0.813 . . . . 74.11 109.297 165.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.02 -31.1 70.55 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.537 -1.21 . . . . 72.22 110.435 178.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 49.3 ttt-85 -73.99 103.36 4.45 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 106.679 -1.6 . . . . 72.02 106.679 157.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 74.1 m -66.91 107.61 1.8 Allowed Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 123.434 0.694 . . . . 74.12 110.382 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -95.1 177.82 0.81 Allowed 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 123.166 2.577 . . . . 62.31 112.74 -176.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 CA--C 1.552 1.031 0 CA-C-N 115.285 -0.871 . . . . 65.11 108.892 177.901 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 110.05 -0.352 . . . . 64.22 110.05 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -140.31 120.79 14.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.652 1.181 . . . . 75.33 108.42 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 65.59 115.26 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.432 1.493 . . . . 63.41 110.237 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 17.7 m -82.47 31.52 0.4 Allowed 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 112.736 0.643 . . . . 72.04 112.736 -172.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 11.3 p -60.84 107.75 0.75 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.03 0.932 . . . . 75.43 110.999 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . 0.559 HD12 ' HA ' ' D' ' 128' ' ' LEU . 27.9 mm 62.91 63.64 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 124.716 1.206 . . . . 74.54 110.151 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.48 176.35 10.11 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.579 -1.191 . . . . 74.13 109.268 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 tt -139.03 109.29 6.45 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.386 -1.339 . . . . 75.45 107.386 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 9' ' ' ALA . . . . . 0.431 ' HB2' HD23 ' D' ' 44' ' ' LEU . . . -68.96 150.31 47.85 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.124 0.57 . . . . 63.34 110.932 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 88.4 mt -57.92 141.19 50.21 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.724 0.81 . . . . 75.34 110.962 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 83.4 mt -67.69 112.48 10.53 Favored Pre-proline 0 CA--C 1.56 1.335 0 C-N-CA 123.365 0.666 . . . . 73.12 110.077 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.25 -8.73 18.79 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.84 2.36 . . . . 73.34 112.6 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 44.6 tp -133.08 150.59 52.08 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.664 1.186 . . . . 72.1 108.166 174.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 mp -112.65 144.26 42.46 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.747 -0.834 . . . . 73.53 108.747 174.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -93.04 -177.54 4.52 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.438 0.695 . . . . 74.53 110.19 176.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 81.3 p -69.28 162.91 62.62 Favored Pre-proline 0 N--CA 1.488 1.443 0 C-N-CA 123.174 0.59 . . . . 71.54 110.843 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -82.7 -172.52 1.43 Allowed 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 121.679 1.586 . . . . 75.31 112.242 173.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . 0.691 HG21 HD11 ' D' ' 98' ' ' LEU . 60.0 t -62.15 161.16 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 C-N-CA 124.457 1.103 . . . . 74.15 110.709 174.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 19' ' ' THR . . . . . 0.525 HG21 ' HA ' ' D' ' 54' ' ' ASP . 5.2 t -51.2 134.24 27.52 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.23 0.612 . . . . 73.15 110.612 166.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp 64.32 13.23 7.84 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.502 1.121 . . . . 71.25 113.364 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.06 59.06 5.39 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.482 0.713 . . . . 61.03 111.711 -173.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -155.96 -71.17 0.11 Allowed 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.893 1.277 . . . . 74.53 108.318 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 23.7 m 50.81 66.94 4.82 Favored Pre-proline 0 CA--C 1.561 1.403 0 O-C-N 124.561 1.163 . . . . 70.11 110.113 -171.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.91 90.02 1.29 Allowed 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.429 2.086 . . . . 74.14 111.796 -171.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 . . . . . 0 C--O 1.254 1.298 0 C-N-CA 125.26 1.424 . . . . 73.22 110.813 179.117 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 109.244 -0.65 . . . . 74.54 109.244 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.8 m -77.49 94.19 4.26 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.652 0.781 . . . . 75.1 110.702 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -166.59 -55.42 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.804 1.242 . . . . 62.03 108.558 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.509 ' HG2' ' H ' ' A' ' 5' ' ' ASN . 46.8 tt0 -87.32 -176.26 5.58 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-N 114.706 -1.134 . . . . 74.02 109.481 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.509 ' H ' ' HG2' ' A' ' 4' ' ' GLN . 66.2 t30 71.27 24.01 3.89 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.959 1.303 . . . . 74.25 110.309 -177.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -137.82 -44.23 0.53 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.229 0.612 . . . . 73.32 110.677 -175.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.458 ' HB ' ' HA3' ' C' ' 146' ' ' GLY . 7.8 m -94.48 3.55 54.99 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.878 0.871 . . . . 71.42 111.794 -172.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.66 88.61 0.36 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.43 1.092 . . . . 72.31 111.434 -171.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.522 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 27.9 ttt -163.36 161.58 24.57 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.426 -1.261 . . . . 75.24 108.357 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.6 t -139.55 129.1 24.38 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.707 -0.849 . . . . 71.44 108.707 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.591 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 19.4 t80 -137.65 120.31 16.2 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.678 -0.86 . . . . 75.15 108.678 169.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.7 tp60 -138.92 127.61 23.35 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.329 -0.989 . . . . 72.45 108.329 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.684 HG12 ' HD2' ' A' ' 84' ' ' PHE . 42.6 mt -95.06 112.97 28.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.639 -0.874 . . . . 74.22 108.639 172.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -86.09 -24.33 26.32 Favored 'General case' 0 C--O 1.243 0.722 0 O-C-N 123.386 0.429 . . . . 74.32 111.064 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -173.42 146.42 1.37 Allowed 'General case' 0 N--CA 1.48 1.068 0 O-C-N 123.213 0.321 . . . . 73.05 110.373 -173.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.534 HD13 ' HG3' ' C' ' 130' ' ' PRO . 80.9 mt -138.47 134.9 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 124.021 0.929 . . . . 75.21 108.634 171.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.436 ' HB3' HG21 ' B' ' 122' ' ' THR . 27.6 p90 -167.98 176.19 6.3 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 124.42 1.075 . . . . 73.24 111.58 -168.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.6 p -99.64 120.6 39.95 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.433 -0.951 . . . . 74.43 108.433 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.44 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 43.9 mtpt -87.64 -27.4 22.5 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.069 -0.345 . . . . 75.44 110.069 174.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.629 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.7 t70 -149.14 139.59 22.45 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.649 -0.705 . . . . 74.15 109.989 177.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.4 mt -136.62 146.12 29.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 C-N-CA 125.3 1.44 . . . . 74.45 107.242 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -153.73 136.51 15.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 123.495 0.497 . . . . 65.33 110.064 170.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.579 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 86.3 t80 -133.47 143.45 48.83 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.416 -1.328 . . . . 72.35 107.416 171.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -140.38 144.32 36.17 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 108.949 -0.76 . . . . 63.44 108.949 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.61 74.03 11.49 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 106.151 -1.796 . . . . 52.23 106.151 171.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -64.57 -34.78 51.16 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.39 2.06 . . . . 73.04 111.956 -170.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -101.42 20.52 15.79 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.982 0.913 . . . . 75.14 109.896 -175.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.422 ' O ' HG11 ' A' ' 31' ' ' VAL . . . -45.73 -52.01 26.61 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-O 118.009 -0.996 . . . . 73.32 113.627 -171.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.456 ' HG3' ' HG3' ' B' ' 57' ' ' GLU . 48.4 Cg_exo -57.89 -33.7 97.39 Favored 'Trans proline' 0 C--N 1.39 2.723 0 C-N-CA 121.882 1.721 . . . . 65.41 113.564 176.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -82.1 -30.88 30.98 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.055 0.942 . . . . 72.4 110.687 -177.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.657 HG22 ' HA ' ' A' ' 73' ' ' ALA . 1.3 p -78.96 -22.38 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 C-N-CA 123.169 0.588 . . . . 73.41 112.518 -163.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -77.84 -25.85 49.02 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.697 0.799 . . . . 75.51 112.67 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -83.39 -12.81 56.08 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.407 0.683 . . . . 75.02 111.012 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -82.77 167.88 17.72 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.962 0.905 . . . . 74.43 111.96 -175.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.68 126.54 31.03 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.986 -1.006 . . . . 74.24 109.324 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.5 ' HD1' ' HB3' ' E' ' 2' ' ' LYS . 54.1 t-105 -75.47 85.5 2.57 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.326 0.584 . . . . 72.0 110.094 175.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.432 ' H ' HD23 ' A' ' 68' ' ' LEU . 35.4 tt0 -122.88 75.2 48.01 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.689 1.196 . . . . 75.25 108.258 173.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -83.9 135.75 6.78 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.866 2.378 . . . . 74.33 112.994 -171.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -104.9 106.47 16.98 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 106.97 -1.493 . . . . 72.04 106.97 170.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.562 HG22 ' HA ' ' E' ' 6' ' ' ILE . 15.2 m -75.78 91.49 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-O 122.031 0.92 . . . . 74.21 110.652 -175.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.7 tptt -80.52 111.81 17.28 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 107.118 -1.438 . . . . 72.33 107.118 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 pp -127.53 141.92 51.52 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.046 0.539 . . . . 71.45 110.549 -168.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -146.19 134.16 21.41 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.758 -0.83 . . . . 73.22 108.758 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -103.69 118.61 37.12 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.917 -0.771 . . . . 74.14 108.917 177.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 33.0 t70 -119.55 143.9 47.36 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.758 -0.83 . . . . 73.41 108.758 177.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.1 p -106.94 147.86 29.33 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.195 0.598 . . . . 70.13 110.047 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.674 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -147.76 144.05 27.97 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.153 0.981 . . . . 73.23 108.667 176.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 64.2 m -136.54 162.39 33.24 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 118.162 0.437 . . . . 75.1 111.799 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.9 t -149.92 121.86 8.2 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.843 0.857 . . . . 74.21 109.439 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -81.24 125.8 30.75 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.632 -0.507 . . . . 63.13 109.632 175.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.461 HD12 HG22 ' A' ' 83' ' ' ILE . 27.4 mt -107.8 -26.61 10.7 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.915 0.886 . . . . 72.33 110.264 -177.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.38 179.01 6.44 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.252 -1.34 . . . . 74.12 108.672 174.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -67.12 113.02 4.75 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.977 -0.749 . . . . 71.01 108.977 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.406 ' HB3' ' HB1' ' A' ' 87' ' ' ALA . 5.6 m-20 76.07 0.32 3.27 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 125.245 1.418 . . . . 74.34 112.401 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.52 109.46 24.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.896 0 N-CA-C 106.744 -1.576 . . . . 74.13 106.744 168.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -133.72 123.38 24.85 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.974 -1.121 . . . . 71.11 107.974 -170.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -86.31 128.3 34.9 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.595 -0.891 . . . . 72.14 108.595 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.457 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 56.5 t -101.93 125.97 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.767 -1.197 . . . . 75.45 107.767 176.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.674 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 36.8 t -116.13 143.18 26.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 108.229 -1.026 . . . . 75.02 108.229 173.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tt -128.9 117.62 21.31 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.765 -0.828 . . . . 73.24 108.765 174.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.569 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 28.1 ttm105 -81.95 101.56 10.35 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 108.025 -1.102 . . . . 74.02 108.025 170.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.83 101.16 12.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 N-CA-C 107.132 -1.432 . . . . 71.54 107.132 171.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -96.47 126.45 41.67 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.906 -0.776 . . . . 75.11 108.906 176.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.613 HG22 HD11 ' E' ' 6' ' ' ILE . 67.4 t -128.06 139.76 51.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 125.189 1.396 . . . . 75.23 107.356 176.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 6.4 m -131.24 149.82 52.41 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.702 -1.222 . . . . 70.31 107.702 174.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.19 113.57 22.42 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.203 -1.406 . . . . 74.15 107.203 170.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.0 m -113.85 124.38 52.07 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.157 0.503 . . . . 74.14 110.064 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 37' ' ' GLN . 66.0 mt -90.09 65.52 6.5 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.771 1.228 . . . . 75.13 109.001 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.34 -90.79 0.73 Allowed Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.838 -0.619 . . . . 71.2 111.828 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -102.17 -27.16 13.05 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.291 0.636 . . . . 73.33 111.644 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -100.19 128.5 46.26 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 109.585 -0.524 . . . . 74.34 109.585 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.9 m -71.49 135.91 47.34 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 118.175 0.443 . . . . 62.35 109.92 172.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.657 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -80.61 -63.1 1.48 Allowed 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.448 -0.796 . . . . 70.14 109.729 173.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -156.04 174.88 14.71 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.915 -1.038 . . . . 74.25 111.635 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.6 tp -134.87 137.62 43.41 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.171 1.388 . . . . 73.44 107.853 174.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 82.5 m -136.51 102.92 5.09 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.96 1.304 . . . . 74.22 109.589 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -122.05 117.17 25.69 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.77 -0.826 . . . . 63.45 108.77 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.7 t -128.96 112.08 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.552 0.741 . . . . 75.31 109.976 -174.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.629 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.8 mt-30 -85.76 91.2 8.25 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.873 -0.788 . . . . 74.51 108.873 168.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -80.75 107.87 13.93 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.969 -1.014 . . . . 73.23 108.995 178.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.59 145.28 17.43 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.033 -0.427 . . . . 74.11 112.033 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.06 128.45 3.07 Favored Glycine 0 CA--C 1.507 -0.445 0 N-CA-C 110.942 -0.863 . . . . 74.21 110.942 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.461 HG22 HD12 ' A' ' 51' ' ' LEU . 62.0 mt -79.54 122.38 34.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.867 -0.79 . . . . 75.23 108.867 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.684 ' HD2' HG12 ' A' ' 13' ' ' ILE . 12.6 m-85 -137.54 151.69 48.66 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.744 -0.836 . . . . 75.15 108.744 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 44.3 m -121.01 106.64 11.78 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.325 0.65 . . . . 65.44 109.348 170.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.648 ' HB ' HG12 ' E' ' 18' ' ' VAL . 4.0 mp -115.26 121.05 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 108.692 -0.855 . . . . 72.31 108.692 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.406 ' HB1' ' HB3' ' A' ' 54' ' ' ASP . . . -164.2 158.59 19.21 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.746 0.819 . . . . 74.32 110.152 175.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.522 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 132.15 -37.34 2.06 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-O 119.873 -0.404 . . . . 62.42 113.921 173.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.8 mt -122.44 -52.6 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-N 117.492 0.646 . . . . 73.43 110.909 -171.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.419 ' HG2' ' HB3' ' E' ' 20' ' ' LYS . 0.5 OUTLIER 65.02 -164.17 0.25 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.638 1.175 . . . . 74.44 112.058 177.273 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.59 -140.43 33.4 Favored Glycine 0 C--N 1.352 1.469 0 O-C-N 123.277 0.361 . . . . 61.24 113.433 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.9 t -72.38 -18.65 61.72 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.459 0.704 . . . . 73.24 111.295 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.4 mm100 -74.42 -44.99 49.45 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.234 0.613 . . . . 72.13 110.468 178.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.655 ' HG2' HD23 ' A' ' 98' ' ' LEU . 52.9 ttm -72.16 -27.02 62.31 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.689 -0.485 . . . . 72.24 109.689 173.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.82 -29.06 69.91 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.871 0.468 . . . . 73.44 111.718 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -72.64 -39.28 67.31 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.965 0.506 . . . . 70.12 110.608 171.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.544 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 58.4 m -64.36 -56.21 15.9 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.224 0.61 . . . . 61.11 110.972 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.681 HD21 ' HA ' ' E' ' 17' ' ' PRO . 3.7 pp -71.62 -29.37 64.59 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.196 0.599 . . . . 65.33 111.332 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.61 -20.69 57.86 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-O 119.575 -0.569 . . . . 61.11 114.273 -173.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.08 -54.67 0.21 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.063 0.764 . . . . 74.51 113.063 -172.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.544 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 87.5 t80 -60.89 -63.48 1.28 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.524 0.73 . . . . 74.43 112.844 -171.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 78.2 m -65.63 -35.22 10.92 Favored Pre-proline 0 CA--C 1.57 1.732 0 C-N-CA 123.779 0.831 . . . . 75.55 113.073 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.2 -45.73 32.1 Favored 'Trans proline' 0 C--N 1.393 2.914 0 C-N-CA 122.777 2.318 . . . . 64.41 113.374 161.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -70.64 -17.69 62.87 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.401 0.681 . . . . 73.13 112.075 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 46.2 mm -69.71 -43.81 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 N-CA-C 109.209 -0.663 . . . . 72.13 109.209 171.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 89.1 mt -81.89 -23.48 36.27 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.012 0.925 . . . . 73.23 112.549 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -56.22 -47.21 99.3 Favored Pre-proline 0 CA--C 1.572 1.792 0 C-N-CA 124.956 1.303 . . . . 75.13 113.953 -172.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.67 -32.76 14.25 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.119 1.879 . . . . 70.04 112.939 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -68.26 -40.68 81.83 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.058 0.543 . . . . 75.41 110.912 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.73 -39.92 80.13 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.766 -0.652 . . . . 65.22 110.507 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.4 ttm105 -54.67 -47.81 73.13 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.849 0.86 . . . . 75.22 110.912 173.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -68.94 -43.27 75.41 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.709 0.803 . . . . 70.04 111.408 -175.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 43.8 t -63.88 -29.65 70.81 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 123.607 0.567 . . . . 72.33 110.823 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 70.8 mt -68.2 -56.06 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 123.862 0.865 . . . . 73.25 110.011 169.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.2 m -56.28 -35.74 67.83 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.842 1.257 . . . . 72.34 112.339 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.4 t -64.38 -49.61 70.94 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 123.409 0.683 . . . . 51.01 110.647 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.579 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 57.9 mtm -65.9 -37.48 86.21 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.725 0.64 . . . . 72.34 111.25 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.0 t -60.07 -53.19 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.499 1.12 . . . . 72.02 110.403 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 40.2 t -69.78 -29.46 66.79 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.933 0.893 . . . . 61.22 111.49 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.497 ' HG2' ' HG1' ' B' ' 18' ' ' THR . 52.0 ttm-85 -75.75 -28.92 58.68 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.256 1.023 . . . . 74.33 109.362 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.411 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.66 15.56 46.07 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 114.741 -1.118 . . . . 75.15 112.607 172.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.435 HG23 ' HE ' ' B' ' 15' ' ' ARG . 2.8 t 60.81 14.46 5.16 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 127.214 2.205 . . . . 74.45 113.77 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -80.08 155.07 75.1 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 123.681 0.792 . . . . 75.1 110.223 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.68 170.13 10.39 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.853 2.369 . . . . 74.44 113.15 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -63.68 127.69 32.5 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.193 -0.912 . . . . 74.45 111.55 -173.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.6 tp -121.88 103.96 9.21 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.651 1.18 . . . . 73.52 108.306 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -97.22 126.65 42.56 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.713 0.805 . . . . 72.53 108.867 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.491 ' HA ' ' HB ' ' E' ' 6' ' ' ILE . 1.2 tt -72.51 130.78 41.43 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.948 -1.13 . . . . 75.2 107.948 171.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.05 133.22 83.91 Favored Pre-proline 0 CA--C 1.548 0.893 0 O-C-N 123.575 0.547 . . . . 75.52 110.743 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -70.59 95.83 0.64 Allowed 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 122.343 2.028 . . . . 72.53 111.593 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.7 t -102.24 111.45 32.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 108.911 -0.774 . . . . 72.31 108.911 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -86.67 82.9 7.72 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.122 -1.066 . . . . 64.34 108.122 172.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -50.03 -35.1 23.56 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.498 1.119 . . . . 74.12 111.785 -176.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -53.34 -51.29 62.9 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.691 1.196 . . . . 75.11 111.356 178.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.8 -50.39 74.01 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.885 0.741 . . . . 62.21 111.821 -177.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.84 -42.94 94.51 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.599 0.759 . . . . 74.52 110.799 -175.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.509 ' HE2' HD22 ' E' ' 11' ' ' LEU . 25.7 m-85 -70.31 -27.68 64.57 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.286 0.634 . . . . 73.13 111.772 177.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 53.3 mtp -77.71 -26.22 49.93 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 119.02 -0.514 . . . . 75.13 111.571 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.614 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 65.7 m-80 -66.81 -38.52 86.63 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.906 -0.405 . . . . 75.12 109.906 173.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -69.95 -39.59 75.94 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.643 -0.708 . . . . 74.44 111.031 172.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.6 tp -61.8 -49.46 76.25 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.89 0.876 . . . . 74.45 111.908 -175.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -166.09 -11.41 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 O-C-N 123.557 0.536 . . . . 72.24 111.714 -171.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.614 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 75.3 mt-30 73.76 118.34 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.688 1.595 . . . . 74.04 109.733 -162.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -69.07 140.11 54.86 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.574 0.75 . . . . 75.11 112.02 -174.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.42 -54.54 0.17 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.262 1.025 . . . . 73.2 108.922 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 104.8 -113.72 4.44 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-N 115.39 -0.823 . . . . 63.24 111.552 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -155.35 -50.28 0.08 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.855 0.862 . . . . 75.5 108.765 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 101.9 98.57 2.39 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 111.018 -0.833 . . . . 74.24 111.018 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 37.3 p -68.44 93.91 0.52 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.124 0.97 . . . . 72.3 110.75 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.67 110.57 13.92 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.266 -1.013 . . . . 75.31 108.266 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -112.66 87.09 2.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.631 0.772 . . . . 71.43 109.61 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -95.37 140.72 29.85 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.42 -0.809 . . . . 64.51 109.873 175.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -138.29 115.46 11.0 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.871 0.868 . . . . 73.52 109.255 171.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -109.62 98.65 7.97 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.83 -1.174 . . . . 63.32 107.83 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 C-N-CA 123.696 0.799 . . . . 65.41 109.105 178.103 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 35.8 tpp . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 121.688 0.756 . . . . 74.01 109.389 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 26.5 m -153.58 115.68 4.33 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 124.107 0.963 . . . . 63.22 108.794 173.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -81.71 3.69 24.66 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.208 0.603 . . . . 64.25 111.05 169.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -65.24 95.1 0.17 Allowed 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.873 -0.788 . . . . 72.3 108.873 170.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -148.85 144.16 26.75 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.91 0.884 . . . . 73.21 108.686 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -169.65 174.33 5.87 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 108.661 -0.866 . . . . 63.41 108.661 -173.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 11.3 m 72.1 171.91 0.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.4 1.08 . . . . 74.41 111.029 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -82.59 58.19 4.09 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.562 0.745 . . . . 74.12 109.314 172.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.584 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 25.3 ptm 44.62 -166.52 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 126.981 2.112 . . . . 72.03 115.473 174.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 90.2 m -134.78 132.35 38.6 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 106.559 -1.645 . . . . 73.55 106.559 162.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.425 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 37.9 t80 -124.13 137.65 54.53 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.738 -0.838 . . . . 75.44 108.738 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.28 132.94 13.05 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.399 -0.593 . . . . 72.31 109.399 176.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.409 HD12 HD11 ' B' ' 16' ' ' ILE . 32.5 mt -83.32 120.39 34.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 108.438 -0.949 . . . . 72.34 108.438 173.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -88.28 -46.1 9.5 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.539 -0.541 . . . . 71.33 109.539 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.435 ' HE ' HG23 ' A' ' 122' ' ' THR . 49.2 ttt180 -167.67 137.74 2.77 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.704 0.402 . . . . 73.21 110.167 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.409 HD11 HD12 ' B' ' 13' ' ' ILE . 74.1 mt -114.79 142.32 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.407 -0.961 . . . . 75.2 108.407 175.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -169.77 158.53 7.52 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-O 121.682 0.753 . . . . 74.4 112.499 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.497 ' HG1' ' HG2' ' A' ' 120' ' ' ARG . 88.4 m -86.71 129.58 34.81 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.007 -0.997 . . . . 70.12 109.188 170.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.431 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 41.1 mtpt -97.72 -29.22 13.51 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.796 0.838 . . . . 73.12 110.343 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -159.97 141.12 12.43 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.56 0.219 . . . . 73.13 111.334 -170.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.702 HD12 ' SG ' ' B' ' 113' ' ' CYS . 45.7 mm -135.53 146.13 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.291 1.437 . . . . 75.42 109.07 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.593 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 42.4 t -148.21 138.31 22.58 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.851 1.261 . . . . 71.33 107.965 173.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.1 t80 -153.57 109.38 3.27 Favored 'General case' 0 C--O 1.215 -0.755 0 N-CA-C 106.783 -1.562 . . . . 72.31 106.783 170.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -118.53 113.48 21.36 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.33 -1.359 . . . . 73.3 107.33 176.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.14 86.64 1.64 Allowed Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 106.975 -1.491 . . . . 53.34 106.975 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.37 -37.5 13.45 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.902 2.401 . . . . 73.41 112.502 -166.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -108.45 21.84 16.76 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.598 0.759 . . . . 73.0 110.069 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.36 -62.25 0.84 Allowed Pre-proline 0 N--CA 1.497 1.908 0 N-CA-C 114.792 1.404 . . . . 74.1 114.792 -166.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.44 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 46.8 Cg_endo -67.89 -27.54 36.93 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 121.823 1.682 . . . . 73.23 112.631 -174.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.407 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 26.3 m80 -75.38 -48.45 22.87 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 115.36 -0.837 . . . . 75.04 110.896 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.06 -0.49 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.365 0 C-N-CA 123.868 0.867 . . . . 64.41 112.353 -167.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -75.7 -13.38 60.31 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.985 -0.447 . . . . 73.43 112.155 173.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 10.2 pt20 -63.36 -16.97 62.03 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.756 0.822 . . . . 73.53 111.183 171.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -93.72 89.87 6.36 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.058 1.343 . . . . 75.34 110.148 -176.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -89.17 84.5 6.53 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.988 0.515 . . . . 62.44 111.08 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 46.7 p90 -168.11 173.05 8.24 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.332 1.053 . . . . 75.35 109.497 169.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -65.17 116.77 33.37 Favored Pre-proline 0 N--CA 1.478 0.937 0 N-CA-C 108.602 -0.888 . . . . 74.01 108.602 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -60.06 154.15 53.19 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 121.995 1.797 . . . . 74.22 111.881 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 30.3 tt0 -57.23 104.5 0.17 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.014 -0.736 . . . . 70.13 109.014 175.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.427 ' HB ' HD11 ' F' ' 6' ' ' ILE . 26.2 m -85.2 139.08 17.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-N 114.924 -1.035 . . . . 72.45 110.565 -172.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.473 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 34.3 ttmt -150.5 107.13 3.51 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.723 -0.843 . . . . 74.23 108.723 -175.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.481 HD21 HG12 ' F' ' 6' ' ' ILE . 0.1 OUTLIER -85.43 141.14 30.17 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 107.672 -1.233 . . . . 70.22 107.672 176.391 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -143.51 142.04 30.99 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.459 1.103 . . . . 73.22 108.417 174.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.741 HD23 HD22 ' F' ' 8' ' ' LEU . 5.4 mp -123.92 167.31 14.3 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.539 0.685 . . . . 74.32 110.991 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.582 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.0 t70 -149.65 148.55 29.43 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 113.879 -1.51 . . . . 74.44 109.002 175.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 3.4 t -108.27 127.02 53.49 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.236 1.015 . . . . 74.4 108.938 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -158.4 136.85 10.97 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.202 0.601 . . . . 72.3 110.216 -175.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.4 p -146.57 -179.63 6.9 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.264 0.625 . . . . 71.14 111.155 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 65.1 p -152.51 136.38 16.3 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.174 -1.047 . . . . 63.5 108.174 164.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.682 HE22 ' HE3' ' F' ' 20' ' ' LYS . 54.0 tt0 -89.94 118.68 29.69 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.18 -0.674 . . . . 64.25 109.18 175.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.42 HD12 HG22 ' B' ' 83' ' ' ILE . 17.8 mt -84.19 -48.59 9.65 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.596 -0.891 . . . . 75.41 108.596 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.43 179.29 8.26 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.317 -1.31 . . . . 74.01 109.793 175.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.71 130.71 43.11 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.506 -1.224 . . . . 63.11 107.933 172.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 71.12 -5.37 1.55 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 125.145 1.378 . . . . 72.41 112.843 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 86.6 t -119.29 102.52 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.933 0.893 . . . . 72.44 108.714 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -121.68 139.76 53.15 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.447 0.699 . . . . 73.54 109.616 -173.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.456 ' HG3' ' HG3' ' A' ' 29' ' ' PRO . 8.9 tm-20 -106.5 107.48 18.52 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 107.645 -1.243 . . . . 73.43 107.645 -178.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 85.6 t -94.53 126.21 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.163 1.385 . . . . 74.14 110.295 -175.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.442 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 13.6 t -112.9 145.88 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.755 -0.831 . . . . 74.41 108.755 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.413 HD12 HD21 ' B' ' 44' ' ' LEU . 41.9 tp -129.44 112.02 13.37 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 108.026 -1.101 . . . . 72.53 108.026 168.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.582 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 11.4 ttm180 -88.56 110.4 20.86 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.923 -0.769 . . . . 72.21 108.923 173.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 24.9 t -105.36 102.77 14.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 107.189 -1.412 . . . . 72.51 107.189 177.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 25.4 m -99.54 134.0 43.05 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.939 -0.763 . . . . 72.43 108.939 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.463 HG21 HD12 ' B' ' 114' ' ' ILE . 40.6 t -120.28 126.16 74.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 123.53 0.732 . . . . 64.42 109.734 174.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.473 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 78.6 m -103.54 143.56 32.57 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.964 0.906 . . . . 74.35 109.476 171.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -146.82 135.94 22.55 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.703 0.801 . . . . 73.11 109.648 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.511 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 38.0 p -141.81 134.28 28.17 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 123.373 0.669 . . . . 75.55 110.16 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 26.2 mt -108.85 100.87 10.03 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 123.78 0.832 . . . . 71.21 109.647 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.83 -119.58 6.97 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.505 -0.77 . . . . 74.21 113.385 176.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -95.21 18.12 12.93 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.394 0.677 . . . . 74.53 112.21 -173.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -152.74 155.16 36.67 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.928 0.491 . . . . 73.0 110.562 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 96.7 m -73.12 132.38 43.22 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 116.05 -0.523 . . . . 71.44 110.045 174.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.511 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -82.83 -62.23 1.66 Allowed 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.29 -1.004 . . . . 64.25 108.29 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -158.61 160.31 36.41 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 114.882 -1.053 . . . . 72.11 111.658 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 79.6 mt -128.59 113.06 14.97 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.577 -1.638 . . . . 71.22 106.577 173.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.1 t -115.63 153.37 31.4 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.47 -0.937 . . . . 74.35 108.47 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.593 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.8 tt0 -162.03 126.77 3.34 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.286 -0.635 . . . . 74.24 109.286 -175.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.435 HG11 ' HA ' ' B' ' 110' ' ' ALA . 95.9 t -126.3 145.52 33.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 124.095 0.958 . . . . 74.52 108.773 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -123.47 98.75 5.99 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.199 -1.037 . . . . 74.43 108.199 173.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.448 ' HB2' ' HB1' ' B' ' 110' ' ' ALA . 8.1 tp-100 -91.82 101.09 13.68 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.29 -1.004 . . . . 74.41 108.29 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.74 162.7 30.42 Favored Glycine 0 C--O 1.242 0.61 0 N-CA-C 110.9 -0.88 . . . . 73.2 110.9 174.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.74 126.31 1.51 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.821 -0.911 . . . . 63.31 110.821 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.42 HG22 HD12 ' B' ' 51' ' ' LEU . 61.0 mt -84.16 129.46 37.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 107.757 -1.201 . . . . 74.15 107.757 174.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -133.04 168.97 17.53 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.498 0.719 . . . . 75.05 109.244 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 73.7 m -126.64 109.53 12.2 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.574 0.75 . . . . 73.45 109.207 170.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -118.74 126.16 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.7 1.2 . . . . 75.33 108.306 -175.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.47 142.97 17.25 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.718 0.407 . . . . 74.53 111.219 -174.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 107.27 -34.44 5.68 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.274 0.359 . . . . 73.12 113.145 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.584 ' HB ' ' HB3' ' B' ' 9' ' ' MET . 0.6 OUTLIER -94.08 160.48 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.751 0.82 . . . . 71.11 110.121 172.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -161.26 160.8 30.32 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.065 0.546 . . . . 74.11 111.207 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.73 -128.68 9.14 Favored Glycine 0 C--N 1.353 1.505 0 C-N-CA 123.818 0.723 . . . . 72.43 112.641 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 35.9 m -65.34 -31.2 72.2 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.654 0.782 . . . . 74.22 110.636 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -69.91 -37.92 76.12 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.259 -0.882 . . . . 75.42 111.01 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.418 ' SD ' ' HB ' ' F' ' 18' ' ' VAL . 0.0 OUTLIER -80.35 -28.8 38.0 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.952 -0.388 . . . . 61.24 109.952 177.197 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.6 -31.86 73.16 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.775 0.83 . . . . 61.45 110.546 172.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -81.92 -37.93 26.06 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.662 1.185 . . . . 75.53 110.466 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.434 ' SG ' ' HE1' ' B' ' 9' ' ' MET . 51.8 t -64.73 -46.64 81.41 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.861 0.464 . . . . 53.24 110.918 -175.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 5.5 mp -96.26 -9.51 30.13 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.72 0.408 . . . . 71.31 111.281 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.98 -15.36 33.7 Favored Glycine 0 N--CA 1.476 1.313 0 N-CA-C 114.008 0.363 . . . . 73.33 114.008 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.56 -61.71 0.89 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.467 0.707 . . . . 74.42 109.856 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -67.03 -55.11 15.77 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.409 0.684 . . . . 74.33 112.59 -168.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.467 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 83.1 m -61.46 -49.95 85.09 Favored Pre-proline 0 CA--C 1.559 1.307 0 CA-C-O 118.362 -0.828 . . . . 72.03 111.78 -177.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.467 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 37.7 Cg_exo -61.9 -25.89 78.51 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 122.318 2.012 . . . . 74.32 113.442 174.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -77.02 -25.61 52.82 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.499 0.72 . . . . 75.43 110.927 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 65.2 mt -68.74 -42.86 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.635 0.774 . . . . 64.4 109.529 169.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' B' ' 102' ' ' CYS . 53.6 mt -82.03 -18.76 42.13 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.412 -1.267 . . . . 74.14 111.311 -174.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -57.64 -52.01 77.48 Favored Pre-proline 0 CA--C 1.559 1.306 0 CA-C-O 117.121 -1.419 . . . . 74.41 112.708 -177.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -53.61 -37.86 83.59 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 122.727 2.285 . . . . 70.41 114.477 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -70.34 -44.38 68.28 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.072 0.549 . . . . 73.33 109.871 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' B' ' 80' ' ' GLN . . . -67.18 -32.43 73.51 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 115.351 -0.84 . . . . 63.34 111.591 177.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.412 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 45.3 ttt-85 -70.3 -51.11 32.78 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.985 1.314 . . . . 75.03 109.967 -176.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -35.79 78.52 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 124.324 1.015 . . . . 65.02 108.957 176.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.702 ' SG ' HD12 ' B' ' 21' ' ' ILE . 19.1 t -65.31 -47.71 75.6 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 123.687 0.617 . . . . 74.44 112.432 -177.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.504 ' O ' HG23 ' B' ' 118' ' ' VAL . 75.5 mt -60.33 -54.72 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 108.924 -0.769 . . . . 74.03 108.924 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 45.2 m -58.27 -30.04 66.27 Favored 'General case' 0 CA--C 1.555 1.146 0 O-C-N 124.583 1.177 . . . . 50.31 111.661 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 48.0 t -69.66 -46.15 66.78 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 123.431 0.693 . . . . 73.44 109.194 176.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.565 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 9.4 mmt -70.13 -32.92 71.17 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 123.482 0.489 . . . . 75.54 110.886 -177.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 114' ' ' ILE . 99.4 t -59.96 -47.5 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 124.302 1.041 . . . . 74.51 109.317 171.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.0 t -70.47 -29.73 66.36 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 113.755 -1.566 . . . . 74.23 111.672 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.565 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 92.3 mtt-85 -70.05 -37.01 75.42 Favored 'General case' 0 C--O 1.214 -0.774 0 C-N-CA 123.346 0.658 . . . . 74.41 109.339 176.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.93 8.82 55.85 Favored Glycine 0 C--N 1.353 1.5 0 O-C-N 124.167 0.917 . . . . 71.12 112.863 173.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.436 HG21 ' HB3' ' A' ' 17' ' ' TYR . 76.9 p 55.38 25.32 7.49 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 126.395 1.878 . . . . 74.53 113.62 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -78.39 155.03 79.31 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 123.888 0.875 . . . . 75.34 111.118 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -46.88 143.96 8.77 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.873 3.049 . . . . 74.02 113.707 176.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -58.6 116.19 3.52 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.174 0.99 . . . . 75.14 111.679 -172.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 41.8 tp -121.25 105.08 10.23 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.328 0.651 . . . . 75.21 110.19 -176.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -105.17 126.37 52.01 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 108.913 -0.773 . . . . 73.11 108.913 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.412 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 49.3 mt -74.33 137.85 43.11 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 109.508 -0.552 . . . . 72.53 109.508 175.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.536 ' HB2' ' HB1' ' F' ' 7' ' ' ALA . . . -85.78 136.83 36.29 Favored Pre-proline 0 N--CA 1.479 1.013 0 CA-C-O 119.282 -0.39 . . . . 75.14 110.077 176.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.562 ' HG3' HD13 ' D' ' 16' ' ' ILE . 69.9 Cg_endo -73.94 141.42 30.01 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.334 2.023 . . . . 71.23 111.978 178.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 27.5 m -128.75 131.38 68.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.567 -0.901 . . . . 73.1 108.567 172.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -73.67 95.86 2.4 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.469 -0.567 . . . . 74.33 109.469 174.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.403 ' HZ ' HD23 ' F' ' 8' ' ' LEU . 45.3 m-85 -61.93 -43.59 98.54 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.671 -0.863 . . . . 71.0 108.671 171.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -55.06 -62.66 1.51 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 113.603 -1.635 . . . . 64.42 111.704 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.22 -37.08 71.69 Favored 'General case' 0 C--N 1.363 1.159 0 O-C-N 123.979 0.799 . . . . 60.54 112.341 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -58.83 -52.25 66.53 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.074 0.95 . . . . 71.33 110.125 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -70.81 -22.62 62.33 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 116.144 -0.48 . . . . 65.01 111.687 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 99.7 mtp -69.32 -36.2 76.72 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 122.874 0.47 . . . . 71.53 110.833 175.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.556 ' HA ' ' HG2' ' B' ' 142' ' ' GLN . 21.3 m-80 -73.05 -16.77 61.48 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.868 0.467 . . . . 74.33 111.067 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -75.3 -34.82 61.31 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.054 0.542 . . . . 73.33 110.131 171.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 64.8 mt -98.01 -7.9 28.99 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 113.002 0.742 . . . . 75.45 113.002 -171.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . 0.556 ' HG2' ' HA ' ' B' ' 139' ' ' ASN . 12.2 pt20 -113.86 166.01 12.0 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.832 0.453 . . . . 75.24 110.754 -176.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -149.55 155.6 40.59 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.784 0.834 . . . . 73.04 109.651 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -114.8 92.75 4.05 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.829 -0.804 . . . . 75.02 108.829 173.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.05 99.7 11.43 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.768 0.827 . . . . 74.53 110.461 -175.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -103.52 109.76 3.51 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 111.019 -0.832 . . . . 75.04 111.019 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -117.29 123.91 47.71 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.124 0.97 . . . . 74.42 110.011 -175.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -93.62 145.84 17.83 Favored Glycine 0 C--N 1.352 1.417 0 CA-C-O 120.129 -0.261 . . . . 72.43 113.044 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 38.2 p -84.59 154.13 22.78 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.797 0.839 . . . . 65.41 110.865 176.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -73.13 146.23 45.84 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.535 0.734 . . . . 75.31 110.047 177.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -142.23 73.59 1.42 Allowed 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.906 0.882 . . . . 63.31 109.28 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -71.32 113.77 8.7 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 109.806 -0.442 . . . . 73.42 109.806 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -85.78 148.33 25.89 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.864 -0.607 . . . . 74.33 109.667 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -127.06 104.74 8.15 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.45 -0.944 . . . . 75.23 108.45 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.85 0 C-N-CA 123.359 0.664 . . . . 72.21 109.614 -179.447 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 109.081 -0.711 . . . . 72.22 109.081 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 22.5 m 64.41 56.58 1.26 Allowed 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.395 1.078 . . . . 74.35 111.395 177.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -64.1 177.92 0.74 Allowed 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 114.539 -1.21 . . . . 72.13 110.668 173.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -61.1 104.14 0.35 Allowed 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.322 -0.621 . . . . 73.23 109.322 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -59.85 -44.46 94.11 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.997 0.919 . . . . 72.41 110.87 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -106.93 61.18 0.63 Allowed 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.087 -1.079 . . . . 73.32 108.087 174.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -66.41 -22.87 66.23 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 114.723 -1.126 . . . . 74.3 112.082 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.722 ' HG2' ' HG3' ' C' ' 9' ' ' MET . 49.1 tt0 -131.58 136.7 48.0 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.824 0.85 . . . . 73.21 109.539 -176.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.722 ' HG3' ' HG2' ' C' ' 8' ' ' GLU . 86.2 mtp 66.03 158.25 0.11 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.029 1.332 . . . . 71.31 114.521 172.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.483 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 93.6 m -96.45 80.15 3.13 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 106.61 -1.626 . . . . 74.21 106.61 154.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.479 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.7 t80 -111.47 130.92 55.56 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.127 -0.942 . . . . 72.13 109.907 -175.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -152.58 137.35 17.03 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.077 -1.453 . . . . 72.43 107.077 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.504 HD12 HG22 ' C' ' 105' ' ' ILE . 64.7 mt -79.81 116.42 23.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 108.332 -0.988 . . . . 75.11 108.332 173.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.467 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 22.2 mm-40 -80.35 -39.0 29.38 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.214 -0.903 . . . . 73.14 109.72 -173.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -179.8 124.33 0.08 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.983 0.513 . . . . 73.21 109.968 -172.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 91.8 mt -109.61 141.21 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 108.848 -0.797 . . . . 71.31 108.848 173.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.434 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 23.5 p90 -174.79 163.97 3.47 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 123.91 0.756 . . . . 74.34 110.236 -173.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.3 p -90.06 125.74 35.52 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.383 0.673 . . . . 70.01 109.369 173.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.434 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 25.8 mmtp -71.07 -49.45 44.43 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 107.887 -1.153 . . . . 74.4 107.887 168.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.719 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 7.9 t70 -139.44 140.77 37.41 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 113.124 -1.853 . . . . 74.22 109.711 -165.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 73.8 mt -139.18 147.03 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.899 -1.519 . . . . 75.41 106.899 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.9 t -158.95 151.76 21.99 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.418 0.687 . . . . 73.44 109.871 176.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -153.93 110.68 3.36 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 107.813 -1.18 . . . . 72.23 107.813 173.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -120.61 110.27 16.23 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.516 0.726 . . . . 64.52 109.557 -173.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.24 87.09 22.73 Favored Pre-proline 0 C--O 1.24 0.6 0 N-CA-C 107.253 -1.388 . . . . 62.03 107.253 170.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.05 -37.2 26.79 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.509 2.139 . . . . 71.22 111.992 -176.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -103.97 28.76 6.41 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.512 0.725 . . . . 75.14 109.999 -175.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.94 -53.8 29.32 Favored Pre-proline 0 CA--C 1.561 1.372 0 N-CA-C 114.322 1.23 . . . . 75.14 114.322 -169.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.78 -49.61 14.1 Favored 'Trans proline' 0 C--N 1.389 2.702 0 CA-C-N 121.747 1.66 . . . . 74.04 112.788 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.451 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 83.2 t60 -69.82 -28.18 65.48 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.859 -0.609 . . . . 70.14 112.087 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.553 HG22 ' HA ' ' C' ' 73' ' ' ALA . 3.7 p -80.93 -13.8 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 O-C-N 121.27 -0.894 . . . . 75.1 112.123 -177.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -81.75 -14.97 55.76 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 112.694 0.627 . . . . 71.41 112.694 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 18.9 pt20 -92.11 9.25 34.25 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.658 0.383 . . . . 74.5 110.559 171.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.494 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 0.0 OUTLIER -101.07 145.72 28.38 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.517 0.727 . . . . 73.03 110.439 -174.394 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -71.21 129.94 40.18 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.2 -0.667 . . . . 72.04 109.2 174.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -76.82 84.92 3.41 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.509 0.724 . . . . 73.41 110.292 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -134.14 63.36 61.37 Favored Pre-proline 0 N--CA 1.478 0.967 0 C-N-CA 124.014 0.926 . . . . 71.25 109.351 173.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.427 ' HG2' HG12 ' C' ' 40' ' ' VAL . 92.5 Cg_endo -88.49 159.72 6.6 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.196 1.93 . . . . 74.14 112.855 -172.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -86.44 86.69 7.34 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.011 -1.477 . . . . 74.03 107.011 161.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.427 HG12 ' HG2' ' C' ' 38' ' ' PRO . 15.9 m -65.99 115.03 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 114.411 -1.268 . . . . 74.32 108.593 172.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -127.43 112.35 14.88 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.613 0.765 . . . . 75.21 109.117 -174.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.53 127.68 34.91 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.846 -0.798 . . . . 74.14 108.846 174.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -120.16 135.47 54.96 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.976 1.31 . . . . 74.22 107.91 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.623 HD13 ' HB3' ' G' ' 8' ' ' LEU . 1.8 pt? -122.05 125.81 47.07 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.561 0.696 . . . . 74.13 110.627 -177.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 2.0 t70 -113.78 143.13 45.15 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.575 -1.268 . . . . 73.02 107.575 171.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 62.1 p -112.4 122.38 47.55 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.325 0.65 . . . . 74.15 109.673 -172.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.591 ' HB2' ' HB ' ' C' ' 59' ' ' VAL . . . -115.02 139.85 49.52 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.696 -0.853 . . . . 73.44 108.696 173.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.425 ' HG ' ' HD2' ' G' ' 15' ' ' PHE . 15.8 m -141.44 143.18 33.75 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.492 0.717 . . . . 72.31 109.677 -175.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 48.3 t -165.8 128.67 2.08 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.082 0.553 . . . . 73.31 109.775 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -82.3 115.67 21.46 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.064 -1.458 . . . . 74.4 107.064 168.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.559 HD12 ' HB2' ' C' ' 57' ' ' GLU . 31.4 mt -84.94 -33.85 22.59 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.554 0.741 . . . . 73.34 110.438 -173.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.96 -175.73 5.52 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.45 -1.25 . . . . 75.3 109.681 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -65.98 121.45 15.14 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.927 -1.033 . . . . 73.44 108.968 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 69.75 -5.64 1.18 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.348 1.459 . . . . 72.31 113.288 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 93.1 t -110.8 100.48 10.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 123.652 0.781 . . . . 73.13 109.028 -175.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -105.26 166.25 10.54 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.335 -0.848 . . . . 73.44 109.373 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.559 ' HB2' HD12 ' C' ' 51' ' ' LEU . 37.5 tt0 -127.3 129.66 48.09 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 114.673 -1.149 . . . . 73.43 108.986 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 m -120.56 114.81 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.372 -0.973 . . . . 74.34 108.372 168.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' C' ' 47' ' ' ALA . 57.6 t -111.23 130.92 63.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 123.823 0.849 . . . . 75.41 108.717 176.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mp -112.79 116.59 30.31 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.114 -0.698 . . . . 71.15 109.114 176.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.601 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 19.1 ttm-85 -82.18 106.91 14.46 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.164 -1.05 . . . . 72.44 108.164 171.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 26.4 t -99.12 111.37 28.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.548 -1.279 . . . . 72.54 107.548 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 25.9 m -120.45 121.61 38.9 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.917 -0.772 . . . . 73.12 108.917 -172.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.534 HG23 HG21 ' C' ' 114' ' ' ILE . 74.5 t -98.87 114.58 37.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.905 -0.776 . . . . 73.03 108.905 176.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.5 m -101.1 110.25 22.25 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.586 -0.894 . . . . 73.21 108.586 165.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.01 110.56 21.87 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 105.951 -1.87 . . . . 75.24 105.951 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -132.23 126.62 33.93 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.162 0.506 . . . . 73.15 110.782 -177.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 14.1 mt -86.55 40.44 0.89 Allowed 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 125.741 1.616 . . . . 74.24 110.341 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.24 -101.37 2.14 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 111.467 -0.653 . . . . 63.42 111.467 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -88.33 -30.84 19.28 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.186 0.594 . . . . 65.44 109.847 175.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.494 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 4.7 tp10 -79.37 121.28 24.94 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.704 0.802 . . . . 61.31 109.585 176.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.3 m -82.48 126.7 32.54 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.488 -0.93 . . . . 70.41 108.488 167.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.553 ' HA ' HG22 ' C' ' 31' ' ' VAL . . . -69.58 -64.4 0.89 Allowed 'General case' 0 C--O 1.238 0.499 0 O-C-N 124.136 0.897 . . . . 75.32 108.792 175.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -155.35 163.13 40.53 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.804 0.811 . . . . 75.4 111.111 173.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -124.16 102.82 7.91 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 105.719 -1.956 . . . . 75.11 105.719 171.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.42 ' SG ' HG22 ' C' ' 114' ' ' ILE . 49.1 t -106.76 151.11 25.58 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 107.742 -1.207 . . . . 60.42 107.742 178.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -158.06 135.89 10.6 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 120.608 0.242 . . . . 72.23 110.489 -173.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' C' ' 110' ' ' ALA . 42.6 t -142.25 114.51 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.52 1.128 . . . . 63.14 108.579 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.719 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 47.1 mt-30 -89.22 91.95 8.98 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.473 -0.936 . . . . 71.51 108.473 169.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.416 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 10.2 tp-100 -80.87 114.61 19.87 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.49 -0.777 . . . . 75.31 109.422 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.86 144.43 16.05 Favored Glycine 0 C--N 1.336 0.538 0 O-C-N 123.808 0.692 . . . . 64.24 111.499 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.76 123.02 2.14 Favored Glycine 0 CA--C 1.5 -0.848 0 N-CA-C 109.657 -1.377 . . . . 74.33 109.657 175.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.467 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 14.1 mm -85.81 123.67 39.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.436 -0.949 . . . . 74.34 108.436 176.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.479 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 59.7 m-85 -130.69 134.15 46.69 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.905 -0.776 . . . . 74.43 108.905 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 20.6 p -89.81 140.71 29.33 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 109.528 -0.545 . . . . 74.12 109.528 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.641 HG13 ' HE1' ' C' ' 9' ' ' MET . 18.1 tt -137.79 139.08 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.815 0.846 . . . . 74.5 109.14 -178.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.483 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -164.25 164.25 22.51 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.387 0.675 . . . . 42.43 109.374 171.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.92 -59.71 2.79 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-N 116.188 -0.46 . . . . 75.34 112.646 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 35.4 pt -91.49 156.26 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.078 0.551 . . . . 73.44 111.204 -173.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -148.78 -176.68 5.43 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.124 0.97 . . . . 72.23 109.385 -177.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.13 -126.42 40.49 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 114.369 0.508 . . . . 72.24 114.369 176.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 38.6 p -79.12 -19.34 51.36 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.617 0.767 . . . . 73.55 111.635 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -62.27 -49.28 76.3 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.784 0.834 . . . . 74.54 109.593 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.417 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 24.3 ptt? -76.15 -28.19 57.31 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 114.665 -1.152 . . . . 74.52 111.006 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.75 -34.17 74.04 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.284 0.633 . . . . 75.21 111.104 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -63.09 -45.1 93.66 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.242 -0.89 . . . . 75.44 110.865 171.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.565 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 47.6 t -66.96 -62.67 1.32 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.763 -0.653 . . . . 65.55 111.084 -174.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.482 HD11 ' H ' ' G' ' 16' ' ' THR . 4.2 pp -71.71 -21.57 61.75 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.234 0.614 . . . . 64.13 112.647 -174.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.05 6.67 43.46 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-O 119.445 -0.642 . . . . 73.12 114.312 -173.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -160.37 -59.4 0.06 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.027 0.913 . . . . 73.52 111.686 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.565 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 15.9 t80 -70.89 -36.25 72.66 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 125.385 1.474 . . . . 74.24 113.0 -167.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.52 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 85.3 m -83.31 -44.06 0.84 Allowed Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 123.249 0.62 . . . . 71.22 111.527 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -53.57 -29.99 52.75 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 122.304 2.003 . . . . 74.43 113.34 165.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -60.07 -36.16 76.74 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.5 1.12 . . . . 71.22 111.1 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.504 HG22 HD12 ' C' ' 13' ' ' ILE . 35.1 mm -62.92 -36.18 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 CA-C-N 115.257 -0.883 . . . . 70.1 110.245 175.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 81.1 mt -89.73 -21.24 22.78 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.286 1.217 . . . . 75.11 114.286 -166.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . 0.534 ' HE1' HD21 ' G' ' 8' ' ' LEU . 34.6 m-85 -55.77 -48.16 97.17 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 113.989 1.107 . . . . 71.31 113.989 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.31 -35.39 84.57 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 122.231 1.954 . . . . 73.52 113.272 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -66.78 -48.78 67.96 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.576 0.751 . . . . 74.42 110.79 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.471 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -66.51 -39.92 88.92 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-N 115.898 -0.592 . . . . 73.03 110.859 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -56.73 -52.36 65.3 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.369 1.043 . . . . 71.31 110.42 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -67.95 -35.52 78.54 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.706 0.629 . . . . 74.54 110.141 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.5 t -70.31 -27.52 64.45 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.955 0.502 . . . . 73.32 111.097 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.534 HG21 HG23 ' C' ' 64' ' ' VAL . 85.6 mt -75.64 -55.41 11.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 109.6 -0.518 . . . . 71.33 109.6 172.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.2 m -66.57 -27.78 68.0 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.955 0.902 . . . . 74.5 111.335 -170.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 46.1 t -63.33 -49.43 73.97 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.655 0.782 . . . . 75.21 109.243 169.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.536 ' HG3' HD12 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.86 -34.74 78.61 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.255 1.022 . . . . 74.52 112.214 178.588 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.412 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.8 t -62.55 -46.41 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.556 0.743 . . . . 73.41 109.114 175.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 30.9 t -66.03 -34.72 78.73 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.194 -1.366 . . . . 64.24 111.6 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -68.2 -31.71 71.43 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.503 0.721 . . . . 75.25 110.054 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.55 10.42 74.63 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.694 0.621 . . . . 73.43 112.839 173.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 62.6 p 56.71 29.27 15.54 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 126.016 1.726 . . . . 75.55 113.941 175.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -88.17 151.73 49.44 Favored Pre-proline 0 N--CA 1.483 1.181 0 C-N-CA 123.357 0.663 . . . . 64.32 109.475 173.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.56 162.98 11.44 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 123.283 2.655 . . . . 75.41 113.98 175.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -52.73 137.53 31.11 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.836 1.254 . . . . 70.34 113.236 -175.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 35.9 tp -150.43 101.53 2.97 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.122 -0.945 . . . . 71.25 109.094 173.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -108.35 133.22 52.85 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.015 0.926 . . . . 74.03 110.142 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.39 138.66 58.6 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.037 0.935 . . . . 73.04 111.705 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.625 ' HB2' ' HB1' ' G' ' 7' ' ' ALA . . . -70.75 147.03 94.15 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.091 0.956 . . . . 53.11 110.559 175.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.534 ' HG3' HD13 ' A' ' 16' ' ' ILE . 10.8 Cg_exo -68.26 93.79 0.41 Allowed 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.468 2.112 . . . . 74.45 111.762 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 p -98.56 110.12 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-O 121.304 0.574 . . . . 74.42 109.649 176.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -113.96 104.03 11.75 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 106.879 -1.526 . . . . 73.51 106.879 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -55.41 -44.35 76.11 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.106 0.879 . . . . 72.12 112.575 -167.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -70.89 -30.65 67.07 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 123.241 0.338 . . . . 72.53 111.352 -176.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.94 -36.52 84.65 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 123.305 0.378 . . . . 64.21 110.316 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 27.7 tp -75.69 -26.9 58.01 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.78 -0.645 . . . . 73.33 110.602 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -74.65 -31.0 61.82 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.067 0.547 . . . . 71.3 111.567 175.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 66.1 mtt -76.34 -40.37 51.46 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.202 0.601 . . . . 54.4 109.75 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -61.97 -37.48 84.93 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.815 1.246 . . . . 61.54 110.56 173.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -69.09 -83.53 0.03 OUTLIER 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.309 1.044 . . . . 75.15 110.04 174.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 tm? 68.67 -71.89 0.11 Allowed 'General case' 0 C--N 1.363 1.177 0 C-N-CA 125.394 1.477 . . . . 75.42 109.055 -172.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -162.45 -69.66 0.05 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.126 -1.065 . . . . 74.43 108.126 174.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -149.88 74.01 1.19 Allowed 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.52 -1.289 . . . . 75.41 107.52 174.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -78.79 82.51 5.0 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 114.746 -1.115 . . . . 70.24 109.653 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.96 137.32 38.97 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.986 -1.006 . . . . 64.14 111.73 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . 0.458 ' HA3' ' HB ' ' A' ' 7' ' ' THR . . . -169.61 -162.77 22.48 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 115.679 -0.691 . . . . 51.22 112.014 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -113.53 133.62 55.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.931 0.892 . . . . 74.43 109.523 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -108.5 102.88 1.77 Allowed Glycine 0 C--N 1.343 0.966 0 N-CA-C 111.184 -0.766 . . . . 54.21 111.184 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 26.9 m -65.45 97.05 0.27 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.011 0.924 . . . . 73.32 110.987 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -82.85 154.26 24.75 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.766 0.827 . . . . 74.31 110.375 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -174.82 155.05 2.03 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.608 0.763 . . . . 75.21 109.571 177.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -90.52 148.68 22.57 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.517 0.727 . . . . 73.12 110.224 175.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -103.0 135.38 44.8 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.609 1.163 . . . . 74.54 108.363 173.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -72.57 -30.17 64.17 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 109.783 -0.451 . . . . 75.54 109.783 168.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.246 0 O-C-N 124.961 1.413 . . . . 75.5 109.247 -172.938 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 120.434 0.159 . . . . 61.3 110.731 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 21.6 m -135.96 82.73 1.96 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.404 0.682 . . . . 62.14 109.338 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -114.58 94.45 4.79 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.602 0.761 . . . . 71.12 109.465 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . 0.526 ' HB2' ' HB2' ' D' ' 93' ' ' GLN . 25.1 mp0 -105.36 116.53 32.1 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.873 0.869 . . . . 71.45 108.787 177.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -100.44 122.25 42.88 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.147 -0.686 . . . . 74.44 109.147 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -154.68 109.3 3.01 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 109.661 -0.496 . . . . 72.21 109.661 -175.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 25.3 m -99.61 -29.21 12.82 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.874 0.87 . . . . 63.24 111.036 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.11 -18.45 60.84 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.678 0.791 . . . . 75.32 111.155 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.504 ' HG2' HG12 ' D' ' 89' ' ' ILE . 1.5 tmt? -28.76 127.19 0.09 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.956 2.102 . . . . 74.42 112.598 162.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 29.9 m -106.28 142.73 35.47 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 123.613 0.765 . . . . 72.45 110.204 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -155.85 98.85 1.94 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.608 -1.256 . . . . 75.23 107.608 -177.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . 0.524 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 49.6 mt-30 -113.46 118.85 35.65 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.74 -0.837 . . . . 75.2 108.74 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.498 HG22 ' HG2' ' B' ' 130' ' ' PRO . 38.0 mt -67.7 123.82 21.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 122.673 0.389 . . . . 75.12 110.14 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -96.92 -45.43 6.62 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 123.467 0.479 . . . . 71.51 110.358 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -167.55 131.36 1.77 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 119.417 -0.325 . . . . 74.14 110.908 -169.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.562 HD13 ' HG3' ' B' ' 130' ' ' PRO . 3.1 mp -115.28 138.28 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 107.7 -1.222 . . . . 74.01 107.7 169.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.418 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 41.8 p90 -165.79 176.27 8.08 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 124.293 0.995 . . . . 72.42 111.142 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -106.71 122.95 47.38 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.573 -1.194 . . . . 74.21 109.356 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.418 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 32.8 mtpt -94.23 -24.41 17.48 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.675 -0.693 . . . . 73.3 109.753 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.515 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.6 t70 -152.52 133.28 13.98 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 114.527 -1.215 . . . . 74.32 108.632 176.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.536 HD12 ' HG3' ' C' ' 117' ' ' MET . 80.6 mt -131.07 147.59 33.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.155 -1.424 . . . . 73.3 107.155 172.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 22' ' ' SER . . . . . 0.53 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 34.6 t -150.49 140.36 21.87 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.789 1.236 . . . . 74.1 107.936 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.504 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.5 t80 -152.84 125.92 8.53 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 105.706 -1.961 . . . . 73.32 105.706 171.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 37.0 mt-10 -137.34 111.63 8.52 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.129 0.572 . . . . 70.13 109.644 -175.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.25 85.38 10.43 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 108.396 -0.965 . . . . 71.15 108.396 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.09 -21.12 12.38 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 122.844 2.362 . . . . 75.15 112.697 -173.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -102.64 0.84 33.83 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.786 0.834 . . . . 75.34 110.675 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -28.66 -64.88 0.16 Allowed Pre-proline 0 CA--C 1.565 1.529 0 N-CA-C 116.392 1.997 . . . . 71.32 116.392 -158.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.46 -22.41 10.83 Favored 'Trans proline' 0 C--N 1.383 2.391 0 CA-C-N 123.091 2.14 . . . . 72.43 113.907 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -69.05 -42.67 75.97 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.266 1.027 . . . . 72.31 109.75 174.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.57 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.2 p -83.17 -19.88 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 CA-C-N 115.829 -0.623 . . . . 71.43 111.404 -172.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -63.36 -26.49 68.78 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 112.454 0.539 . . . . 75.21 112.454 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -58.69 -20.59 49.86 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.627 0.771 . . . . 72.23 110.784 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.677 ' HZ2' ' HB3' ' D' ' 71' ' ' GLU . 92.2 mttt -90.52 87.39 6.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.277 1.031 . . . . 73.11 108.63 166.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -97.17 82.13 3.14 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.383 0.611 . . . . 74.14 110.15 -173.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 38.9 p90 -156.94 -174.21 4.82 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.736 1.214 . . . . 75.42 108.691 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.13 114.46 23.63 Favored Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 123.976 0.91 . . . . 72.33 111.108 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.59 127.99 18.25 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.553 2.169 . . . . 74.52 111.847 171.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -75.66 134.99 40.45 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.304 -0.628 . . . . 74.33 109.304 177.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.528 HG11 HG13 ' D' ' 64' ' ' VAL . 74.1 t -102.23 132.81 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.889 0.876 . . . . 72.13 111.306 -174.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.443 ' HB2' ' OG1' ' D' ' 65' ' ' THR . 74.6 mmtt -98.2 130.38 44.94 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.915 -1.143 . . . . 72.53 107.915 168.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.515 ' HB2' ' HA ' ' H' ' 6' ' ' ILE . 3.0 tm? -96.69 126.08 41.6 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.544 0.738 . . . . 74.3 109.403 -175.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.789 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 22.4 m-20 -127.66 142.85 51.23 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.136 0.974 . . . . 72.21 108.402 171.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 89.9 mt -129.69 143.26 50.74 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.588 0.755 . . . . 64.5 109.998 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 9.9 t70 -141.36 144.76 34.72 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.209 1.004 . . . . 60.13 108.53 175.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 35.9 p -104.26 143.53 32.83 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.532 0.733 . . . . 52.45 111.327 -173.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.681 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.92 141.74 22.83 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.898 0.879 . . . . 70.11 108.771 171.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.1 p -166.42 154.27 10.07 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.92 0.488 . . . . 73.33 109.795 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 60.2 p -164.04 142.56 7.45 Favored 'General case' 0 C--O 1.24 0.558 0 O-C-N 123.877 0.736 . . . . 64.43 110.224 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -76.36 126.02 30.24 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.104 -0.702 . . . . 75.13 109.104 168.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.536 HD11 HG22 ' D' ' 83' ' ' ILE . 73.9 mt -97.45 -30.73 12.74 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.25 0.62 . . . . 72.52 110.55 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.23 -175.06 2.81 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.693 0.797 . . . . 75.44 110.53 177.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -61.9 116.44 4.87 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.821 -1.081 . . . . 73.22 110.087 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 64.41 9.86 5.29 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.926 1.29 . . . . 73.5 112.48 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.7 t -109.73 114.98 48.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 108.157 -1.053 . . . . 73.34 108.157 173.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.465 ' HB2' HD12 ' D' ' 86' ' ' ILE . 72.7 m-85 -134.69 133.08 39.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.509 -0.923 . . . . 73.53 108.509 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -104.55 136.86 43.31 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.844 0.858 . . . . 73.42 109.322 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 38.2 t -121.69 129.21 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 107.737 -1.209 . . . . 64.13 107.737 174.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.681 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 20.4 t -121.56 132.07 71.59 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 C-N-CA 124.221 1.008 . . . . 71.04 108.674 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.563 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 3.9 mm? -119.09 120.2 36.47 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.305 0.642 . . . . 75.32 109.767 176.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.564 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 18.9 ttm-85 -88.67 101.25 13.8 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.404 -0.816 . . . . 72.12 108.82 173.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 55.1 t -90.99 126.37 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 107.574 -1.269 . . . . 63.32 107.574 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.789 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 9.3 m -122.57 125.7 46.23 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.761 0.791 . . . . 75.43 109.983 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.528 HG13 HG11 ' D' ' 40' ' ' VAL . 25.3 t -111.09 99.43 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.959 1.704 . . . . 72.44 108.137 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.463 HG22 HD21 ' D' ' 75' ' ' LEU . 1.8 p -99.64 94.98 6.66 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 107.887 -1.153 . . . . 73.31 107.887 174.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.23 155.62 16.66 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.935 -1.03 . . . . 61.33 111.141 -170.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.451 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.5 p -153.58 132.45 12.41 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.713 -0.676 . . . . 64.11 111.932 -176.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.551 HD11 HG23 ' D' ' 31' ' ' VAL . 24.9 mt -93.74 99.18 11.63 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 124.893 1.277 . . . . 75.43 108.856 172.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.37 -119.86 7.4 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.129 -0.941 . . . . 74.25 112.015 -174.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.77 5.4 49.22 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.428 1.091 . . . . 72.1 111.241 -177.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.677 ' HB3' ' HZ2' ' D' ' 34' ' ' LYS . 5.5 tp10 -129.08 139.72 51.88 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.063 0.945 . . . . 63.41 109.513 -169.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.4 m -61.55 128.59 37.02 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.809 0.843 . . . . 75.12 111.471 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.57 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -83.95 -70.42 0.57 Allowed 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.838 -1.171 . . . . 73.24 107.838 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -146.33 166.74 25.41 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.623 -1.171 . . . . 75.14 109.025 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.463 HD21 HG22 ' D' ' 65' ' ' THR . 48.2 mt -116.24 151.17 36.3 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 105.842 -1.91 . . . . 74.53 105.842 171.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.46 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 50.3 t -157.1 140.23 15.44 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.247 -1.02 . . . . 74.44 108.247 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 36.7 tt0 -156.75 131.11 8.61 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 122.853 0.461 . . . . 72.52 109.839 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -136.81 118.55 19.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 123.337 0.655 . . . . 72.14 109.742 -177.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.2 mt-30 -86.41 87.13 7.37 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.811 -1.181 . . . . 74.23 107.811 166.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . 0.413 ' O ' HD11 ' D' ' 106' ' ' LEU . 8.5 tp-100 -79.9 105.2 11.01 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.279 -1.328 . . . . 70.23 107.698 176.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -110.45 143.69 16.96 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.854 -0.498 . . . . 74.22 111.854 -177.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.49 131.43 5.51 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 111.371 -0.691 . . . . 63.32 111.371 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.536 HG22 HD11 ' D' ' 51' ' ' LEU . 60.4 mt -89.32 128.42 41.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 C-N-CA 124.497 1.119 . . . . 74.32 107.985 175.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -136.79 145.66 44.8 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.883 0.373 . . . . 74.43 110.876 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 16.6 m -78.04 99.47 6.11 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.274 -1.009 . . . . 72.1 108.274 166.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.465 HD12 ' HB2' ' D' ' 56' ' ' TYR . 66.1 mt -107.22 108.6 25.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 123.867 0.867 . . . . 72.05 108.845 -175.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.52 163.77 34.67 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.545 1.138 . . . . 73.2 109.786 -175.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.71 20.82 79.82 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.693 -0.685 . . . . 74.35 114.373 173.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.521 HG23 ' N ' ' D' ' 90' ' ' GLU . 6.0 mt -104.6 156.88 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 117.374 0.587 . . . . 75.31 110.386 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.521 ' N ' HG23 ' D' ' 89' ' ' ILE . 6.8 pt-20 -140.22 147.62 40.3 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.431 1.092 . . . . 70.42 111.118 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.84 -136.11 48.93 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 115.216 0.847 . . . . 51.32 115.216 169.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 16.0 m -85.67 -9.17 57.63 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.911 0.885 . . . . 71.54 111.554 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.526 ' HB2' ' HB2' ' D' ' 4' ' ' GLN . 0.1 OUTLIER -53.05 -31.1 39.62 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.673 -0.862 . . . . 53.05 108.673 166.147 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.446 ' HB3' ' H ' ' H' ' 18' ' ' VAL . 51.9 mtt -57.32 -55.24 37.31 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.975 0.91 . . . . 73.34 111.357 172.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . 0.43 ' HB1' HD21 ' H' ' 14' ' ' LEU . . . -63.3 -29.66 70.94 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.417 0.687 . . . . 65.15 111.516 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -72.4 -40.71 66.98 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.06 0.944 . . . . 64.41 111.139 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.0 t -64.18 -49.56 71.57 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.364 0.666 . . . . 72.44 109.916 -176.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 34.0 mt -75.53 -26.94 58.46 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.275 -1.329 . . . . 74.32 110.914 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.01 -2.5 58.2 Favored Glycine 0 C--N 1.352 1.461 0 CA-C-O 119.368 -0.685 . . . . 74.24 114.399 -176.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.71 -58.98 0.57 Allowed 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 117.905 0.853 . . . . 74.25 111.338 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -71.11 -38.22 72.34 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 111.841 0.311 . . . . 70.4 111.841 -170.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 62.2 m -72.8 -47.98 8.61 Favored Pre-proline 0 CA--C 1.559 1.316 0 CA-C-O 118.576 -0.726 . . . . 75.12 111.776 -177.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.563 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 17.1 Cg_endo -61.5 -22.59 74.88 Favored 'Trans proline' 0 C--N 1.401 3.31 0 C-N-CA 122.27 1.98 . . . . 74.42 112.875 170.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -66.96 -37.46 84.31 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.223 0.609 . . . . 73.25 110.266 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 48.9 mm -71.08 -39.14 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.501 0.72 . . . . 65.11 110.333 175.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.413 HD11 ' O ' ' D' ' 80' ' ' GLN . 86.7 mt -79.28 -18.64 52.29 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.33 -0.85 . . . . 73.51 111.876 -177.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -61.21 -50.1 85.4 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-O 117.87 -1.062 . . . . 72.22 113.487 -175.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.78 -38.99 93.74 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 122.116 1.877 . . . . 71.35 112.667 178.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -78.17 -36.96 46.9 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.087 0.955 . . . . 62.13 112.26 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.79 73.84 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.046 0.539 . . . . 75.35 109.952 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.581 HH12 ' HG3' ' D' ' 130' ' ' PRO . 40.1 ttp180 -57.27 -51.48 69.17 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 124.164 0.915 . . . . 75.13 110.097 174.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -62.54 -43.82 97.87 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.719 0.807 . . . . 74.01 111.729 -174.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.8 t -58.78 -45.51 89.67 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.809 0.693 . . . . 74.51 110.779 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.455 ' O ' HG23 ' D' ' 118' ' ' VAL . 97.5 mt -62.55 -55.14 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.883 -1.053 . . . . 73.1 110.586 174.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 43.5 m -53.24 -40.06 64.29 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.849 1.26 . . . . 71.1 111.449 -174.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.0 t -66.36 -45.15 81.09 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.729 -1.123 . . . . 74.22 110.439 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.451 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 76.1 mtm -70.01 -28.54 65.58 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.781 0.432 . . . . 71.45 112.08 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.455 HG23 ' O ' ' D' ' 114' ' ' ILE . 96.0 t -64.85 -44.86 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.395 0.678 . . . . 74.55 109.633 174.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.8 p -77.3 -25.42 51.26 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 115.444 -0.798 . . . . 73.44 111.007 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' D' ' 116' ' ' SER . 91.0 mtt-85 -72.69 -35.22 67.59 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.438 0.695 . . . . 73.12 109.538 173.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.48 -0.14 86.42 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 115.644 -0.707 . . . . 64.42 112.122 171.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 42.6 p 62.97 22.02 13.22 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.938 2.095 . . . . 62.12 113.972 174.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -82.23 152.07 67.26 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 123.545 0.738 . . . . 75.42 109.286 169.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -49.59 132.2 29.91 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.372 2.715 . . . . 74.24 113.934 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -51.43 141.02 16.4 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.651 1.58 . . . . 73.34 113.002 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 62.5 tp -114.48 109.58 18.51 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.224 1.01 . . . . 74.5 109.577 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -113.62 97.14 6.25 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.645 -0.872 . . . . 75.41 108.645 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 20.1 tp -70.85 126.59 29.99 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 110.008 -0.367 . . . . 74.33 110.008 177.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -62.09 130.26 92.67 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.079 0.952 . . . . 72.11 110.676 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.581 ' HG3' HH12 ' D' ' 111' ' ' ARG . 2.4 Cg_endo -79.74 106.02 1.91 Allowed 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.657 2.238 . . . . 71.43 110.181 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 35.9 m -107.01 149.44 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 109.281 -0.637 . . . . 73.1 109.281 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -80.29 75.34 7.11 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.613 0.721 . . . . 71.21 109.181 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -73.62 -24.42 60.02 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.855 0.862 . . . . 71.14 110.95 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' D' ' 138' ' ' MET . 4.3 m-20 -51.77 -50.63 60.31 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.648 1.579 . . . . 63.21 111.868 176.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.0 -45.26 94.38 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.601 0.76 . . . . 52.24 111.663 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 51.7 tp -63.7 -34.96 79.04 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.379 0.671 . . . . 73.02 110.817 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -70.82 -30.05 66.38 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.684 0.793 . . . . 51.3 110.789 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.44 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 45.1 mtt -62.85 -30.69 71.69 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.573 0.749 . . . . 74.25 111.102 176.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -77.85 -20.05 53.77 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.993 0.917 . . . . 71.14 111.738 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -62.97 -37.2 86.14 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.87 0.868 . . . . 74.43 110.399 174.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.9 mp -65.43 -30.67 71.5 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.026 0.931 . . . . 75.15 110.648 175.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -86.14 0.76 52.82 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.104 -0.953 . . . . 74.4 112.101 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -135.16 47.39 2.34 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.578 0.704 . . . . 73.0 109.65 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -151.57 127.64 10.43 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.091 -0.958 . . . . 74.11 109.249 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.56 -23.35 62.59 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.506 0.722 . . . . 73.43 111.612 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 75.88 18.4 79.58 Favored Glycine 0 C--N 1.351 1.404 0 CA-C-N 115.992 -0.549 . . . . 35.12 112.119 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -89.04 171.53 9.78 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.805 0.842 . . . . 74.45 109.948 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 147.5 116.55 0.93 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 111.314 -0.714 . . . . 63.33 111.314 177.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 7.7 t -64.34 135.86 56.58 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 123.194 0.598 . . . . 72.23 110.632 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -87.26 71.89 9.95 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.852 0.834 . . . . 54.34 108.802 175.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -146.63 135.93 22.77 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.01 -1.45 . . . . 54.23 107.964 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -159.05 82.89 0.79 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.416 -0.957 . . . . 75.35 108.416 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -70.85 -41.08 71.92 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.992 -1.003 . . . . 73.35 110.518 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -74.26 136.85 42.69 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.501 0.72 . . . . 65.53 110.096 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 N-CA-C 108.394 -0.965 . . . . 72.45 108.394 179.655 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' E' E ' 1' ' ' MET . . . . . 0.422 ' SD ' ' N ' ' E' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 110.117 -0.327 . . . . 75.15 110.117 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 2' ' ' LYS . . . . . 0.5 ' HB3' ' HD1' ' A' ' 36' ' ' TRP . 37.9 ttmt -75.57 135.81 40.55 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.572 0.749 . . . . 73.34 110.337 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -73.84 149.13 41.79 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.163 -0.68 . . . . 74.44 109.163 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 22.4 p -136.99 155.05 50.2 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.85 0.86 . . . . 61.02 109.69 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 13.2 t -139.57 158.63 43.8 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.63 0.372 . . . . 74.12 110.989 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.613 HD11 HG22 ' A' ' 64' ' ' VAL . 18.6 mt -109.33 87.31 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.447 1.099 . . . . 75.44 109.041 -176.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.86 91.39 1.51 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.285 0.564 . . . . 73.0 110.643 -176.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 8.7 tt -89.8 147.17 23.96 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.754 1.221 . . . . 73.45 109.804 -175.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -101.02 -84.33 0.44 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.577 0.751 . . . . 75.5 111.244 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 27.7 mt -154.1 -170.56 3.59 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 124.404 1.082 . . . . 71.52 111.077 -176.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.509 HD22 ' HE2' ' A' ' 137' ' ' PHE . 3.6 mm? -74.21 158.94 84.9 Favored Pre-proline 0 CA--C 1.562 1.412 0 C-N-CA 124.22 1.008 . . . . 70.23 109.483 171.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.83 -24.48 79.2 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.971 2.447 . . . . 73.11 113.283 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 tt -162.27 -75.66 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 107.41 -1.329 . . . . 75.14 107.41 175.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 86.2 mt -130.61 -160.34 1.03 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.001 1.32 . . . . 74.02 108.715 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -125.8 159.72 31.68 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 107.925 -1.139 . . . . 74.2 107.925 175.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 43.8 m -59.1 133.36 87.54 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 123.928 0.891 . . . . 72.43 111.044 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 17' ' ' PRO . . . . . 0.681 ' HA ' HD21 ' A' ' 98' ' ' LEU . 39.2 Cg_endo -64.43 147.26 90.58 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.714 2.276 . . . . 73.0 113.174 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 18' ' ' VAL . . . . . 0.663 HG23 ' HB3' ' A' ' 98' ' ' LEU . 85.7 t -74.76 -76.19 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 123.252 0.621 . . . . 74.45 109.341 175.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 19' ' ' THR . . . . . 0.539 HG23 HG11 ' E' ' 18' ' ' VAL . 5.0 t -156.02 124.96 6.04 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.86 0.464 . . . . 73.54 110.036 -178.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 20' ' ' LYS . . . . . 0.419 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 50.3 tptt 76.1 -36.14 0.27 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.178 1.391 . . . . 74.13 112.739 173.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.82 93.11 0.05 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.967 0.907 . . . . 74.23 111.223 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 55.9 ttt85 -95.07 133.1 39.24 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.328 1.051 . . . . 74.42 109.145 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 13.7 t -63.39 143.29 97.83 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-O 118.11 -0.947 . . . . 74.23 109.288 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -36.52 120.6 0.25 Allowed 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 124.326 3.35 . . . . 72.33 114.136 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 . . . . . 0 C--O 1.251 1.157 0 O-C-N 124.264 0.978 . . . . 75.25 111.395 -173.073 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 110.161 -0.311 . . . . 75.15 110.161 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 68.38 6.86 5.6 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.424 1.49 . . . . 75.22 112.986 174.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 62.69 -69.79 0.06 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.657 1.583 . . . . 74.42 111.83 -175.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 19.5 t 64.54 80.73 0.22 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.64 1.176 . . . . 72.23 110.744 173.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 89.9 m -80.94 120.16 24.4 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.915 0.886 . . . . 73.1 109.784 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . 0.481 HG12 HD21 ' B' ' 42' ' ' LEU . 19.2 tt -75.38 133.12 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 122.815 0.446 . . . . 73.32 111.003 -178.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 7' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' B' ' 129' ' ' ALA . . . -163.02 172.24 15.28 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.655 0.782 . . . . 62.43 110.467 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . 0.741 HD22 HD23 ' B' ' 44' ' ' LEU . 4.2 mp -95.7 -177.05 3.92 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.251 1.021 . . . . 75.52 108.626 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -154.42 -169.89 3.37 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.527 0.331 . . . . 63.13 111.545 -173.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 10' ' ' LEU . . . . . 0.404 ' O ' ' HD3' ' F' ' 12' ' ' PRO . 6.3 tt -56.96 130.03 44.23 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.377 1.071 . . . . 75.1 108.147 170.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 82.5 mt -102.78 99.47 13.69 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.384 0.674 . . . . 72.41 109.986 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 12' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' F' ' 10' ' ' LEU . 13.9 Cg_exo -70.43 -16.84 34.8 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 122.685 2.257 . . . . 71.33 111.561 175.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 88.1 mt -58.09 -34.66 70.41 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 124.064 0.946 . . . . 75.31 110.993 175.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 90.0 mt 61.19 -171.38 0.15 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.686 1.194 . . . . 73.05 111.474 -176.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -167.1 92.94 0.43 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.081 -1.081 . . . . 74.21 108.081 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 68.2 p -129.95 73.63 81.25 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 123.791 0.837 . . . . 74.33 110.534 -177.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 17' ' ' PRO . . . . . 0.4 ' HD2' HG21 ' F' ' 18' ' ' VAL . 30.5 Cg_endo -94.75 9.2 1.94 Allowed 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.696 2.264 . . . . 75.23 112.382 176.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . 0.456 HG12 ' H ' ' F' ' 20' ' ' LYS . 33.6 t -93.49 -88.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.56 0 C-N-CA 123.061 0.544 . . . . 73.14 110.732 -171.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 9.0 m 67.8 -5.38 0.83 Allowed 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 124.791 1.237 . . . . 74.43 112.504 -176.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 20' ' ' LYS . . . . . 0.682 ' HE3' HE22 ' B' ' 50' ' ' GLN . 48.7 pttt -159.75 77.66 0.68 Allowed 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.881 0.872 . . . . 75.42 110.276 -177.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . -117.52 99.12 6.77 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 107.799 -1.185 . . . . 71.13 107.799 168.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . 0.496 ' HG3' ' HD3' ' F' ' 24' ' ' PRO . 22.5 ptt180 -109.88 -179.03 3.68 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.926 0.891 . . . . 75.35 111.315 -167.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 85.1 m -138.19 99.68 8.88 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 106.577 -1.638 . . . . 75.22 106.577 164.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 24' ' ' PRO . . . . . 0.496 ' HD3' ' HG3' ' F' ' 22' ' ' ARG . 71.9 Cg_endo -76.7 67.13 7.38 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.781 2.321 . . . . 75.34 111.746 178.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 . . . . . 0 C--O 1.246 0.906 0 N-CA-C 107.231 -1.396 . . . . 63.43 107.231 -177.838 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 20.2 mmt . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 109.128 -0.693 . . . . 55.11 109.128 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt 69.0 26.38 5.68 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.301 1.441 . . . . 75.21 112.759 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -77.64 88.95 3.93 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.207 0.527 . . . . 74.42 110.16 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 17.5 m -85.06 -5.95 59.33 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.646 -0.706 . . . . 74.22 110.326 170.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 5' ' ' THR . . . . . 0.447 HG21 ' HB3' ' C' ' 129' ' ' ALA . 2.9 m -61.11 104.68 0.4 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.833 1.253 . . . . 72.04 110.025 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 pp -70.83 157.07 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 123.278 0.631 . . . . 74.21 112.351 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 7' ' ' ALA . . . . . 0.625 ' HB1' ' HB2' ' C' ' 129' ' ' ALA . . . -166.78 -165.48 0.74 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.063 0.945 . . . . 72.3 109.68 -176.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 8' ' ' LEU . . . . . 0.623 ' HB3' HD13 ' C' ' 44' ' ' LEU . 6.7 mp -69.78 -35.71 75.11 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.623 0.769 . . . . 72.31 110.817 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . 63.78 -77.44 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.461 1.504 . . . . 71.34 113.279 174.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 97.2 mt -124.51 148.4 47.76 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.413 1.085 . . . . 71.12 109.978 -176.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 60.1 mt -82.37 122.5 79.12 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 123.218 0.607 . . . . 74.2 109.788 173.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.04 1.67 9.05 Favored 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 122.294 1.996 . . . . 74.52 113.098 171.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 52.4 tp -157.08 133.01 9.51 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.363 0.665 . . . . 74.0 109.629 173.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 93.7 mt -82.19 127.48 33.2 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.273 -1.01 . . . . 71.14 108.273 172.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . 0.425 ' HD2' ' HG ' ' C' ' 48' ' ' SER . 90.8 m-85 -57.95 -58.75 7.03 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.845 0.858 . . . . 75.34 111.775 -175.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 16' ' ' THR . . . . . 0.482 ' H ' HD11 ' C' ' 98' ' ' LEU . 81.1 p 41.59 53.41 7.29 Favored Pre-proline 0 CA--C 1.57 1.742 0 C-N-CA 125.905 1.682 . . . . 73.2 114.615 177.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 17' ' ' PRO . . . . . 0.416 ' HD2' HG22 ' G' ' 18' ' ' VAL . 37.4 Cg_endo -96.59 26.44 0.24 Allowed 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 123.088 2.525 . . . . 75.32 112.176 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 18' ' ' VAL . . . . . 0.416 HG22 ' HD2' ' G' ' 17' ' ' PRO . 38.2 t -117.78 -75.81 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 123.963 0.905 . . . . 75.24 108.814 -177.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 16.2 p -139.75 -165.33 1.86 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.745 1.218 . . . . 75.3 109.453 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.28 122.66 26.61 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.194 0.597 . . . . 74.51 109.71 175.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.7 2.98 31.02 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.589 0.755 . . . . 75.02 112.747 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -140.89 142.52 34.46 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.429 0.692 . . . . 72.43 109.484 176.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 37.6 p -90.56 133.7 32.26 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 108.09 -1.078 . . . . 74.1 108.09 167.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -47.32 -61.15 0.65 Allowed 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.153 2.569 . . . . 75.23 112.888 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 108.157 -1.053 . . . . 74.54 108.157 176.289 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 110.082 -0.34 . . . . 73.24 110.082 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.07 102.04 5.53 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.749 -0.834 . . . . 73.33 108.749 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -73.53 88.31 1.64 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.698 0.799 . . . . 71.24 109.307 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 20.2 m -80.73 99.98 8.5 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.164 -0.925 . . . . 75.52 110.783 -174.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 63.1 m -156.35 -58.68 0.09 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.763 1.225 . . . . 74.32 107.717 172.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . 0.515 ' HA ' ' HB2' ' D' ' 42' ' ' LEU . 9.4 tt -149.14 102.43 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 CA-C-N 114.522 -1.217 . . . . 71.22 107.877 175.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 7' ' ' ALA . . . . . 0.44 ' H ' ' HG ' ' D' ' 42' ' ' LEU . . . -108.74 174.53 5.83 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.281 1.033 . . . . 73.01 112.561 -167.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 94.4 mt -129.06 167.0 18.16 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.148 1.379 . . . . 75.3 108.734 173.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . 63.12 -168.32 0.2 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.436 1.094 . . . . 73.41 111.148 -173.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 82.5 mt 61.82 24.31 14.45 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.071 0.948 . . . . 72.31 111.257 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . 0.504 HD21 HD12 ' D' ' 60' ' ' LEU . 2.0 pp -69.99 146.45 95.14 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 124.711 1.204 . . . . 74.12 110.83 -176.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -28.82 96.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.395 3.018 1 C-N-CA 125.707 4.272 . . . . 74.32 116.164 -173.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 57.53 -94.47 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.778 1.631 . . . . 74.34 109.93 -178.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . 0.43 HD21 ' HB1' ' D' ' 95' ' ' ALA . 67.2 mt -155.73 161.54 40.69 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.815 1.646 . . . . 73.31 108.029 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -82.67 6.05 19.17 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 118.629 -0.7 . . . . 74.22 112.084 174.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 47.4 m 72.2 138.62 0.06 OUTLIER Pre-proline 0 CA--C 1.565 1.53 0 C-N-CA 124.613 1.165 . . . . 73.21 110.881 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.33 148.84 24.46 Favored 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 122.623 2.215 . . . . 74.55 112.808 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . 0.446 ' H ' ' HB3' ' D' ' 94' ' ' MET . 76.3 t -61.66 -29.88 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 125.191 1.396 . . . . 64.23 111.892 -176.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 17.2 m -59.35 -37.53 78.11 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.742 0.817 . . . . 72.52 111.194 172.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -107.11 4.3 26.72 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.787 1.235 . . . . 74.51 111.98 -175.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.53 74.71 6.18 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.825 0.821 . . . . 71.24 110.318 -176.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 41.2 ttp85 -169.61 129.96 1.04 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.287 1.435 . . . . 75.15 107.241 -175.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 14.1 m 55.97 62.73 6.67 Favored Pre-proline 0 CA--C 1.57 1.74 0 C-N-CA 124.087 0.955 . . . . 75.01 110.886 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -89.38 12.33 2.69 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 122.929 2.419 . . . . 73.22 113.244 -176.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 . . . . . 0 CA--C 1.55 0.971 0 C-N-CA 123.474 0.709 . . . . 71.55 109.151 177.399 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.9 mtm . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 109.976 -0.379 . . . . 75.43 109.976 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.6 t -141.13 100.76 3.88 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.996 0.918 . . . . 63.34 108.907 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -120.12 35.97 4.69 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 108.573 -0.899 . . . . 71.1 108.573 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 65.03 175.48 0.2 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.753 1.221 . . . . 65.1 111.402 -173.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.551 ' HA ' ' HB3' ' C' ' 145' ' ' ALA . 61.0 t30 -144.37 91.69 2.22 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.426 0.631 . . . . 72.12 111.113 -175.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -126.79 99.04 5.59 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 106.608 -1.627 . . . . 71.11 106.608 164.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.0 p -72.6 -62.9 1.28 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.589 -0.732 . . . . 75.45 110.663 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -141.0 -63.81 0.46 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.946 0.898 . . . . 74.54 108.708 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.482 ' HE3' ' SG ' ' A' ' 97' ' ' CYS . 15.0 tpt -91.42 147.81 22.76 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.887 0.875 . . . . 72.41 108.86 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -141.82 145.56 34.85 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.845 0.858 . . . . 73.14 110.31 -174.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.686 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 8.4 t80 -137.99 134.86 35.37 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.668 0.787 . . . . 70.34 110.917 -168.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -147.16 108.84 4.35 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.788 0.835 . . . . 73.15 109.412 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.611 HG12 ' HD2' ' A' ' 84' ' ' PHE . 66.7 mt -78.61 124.04 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 109.494 -0.558 . . . . 74.44 109.494 176.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -84.69 -40.05 17.83 Favored 'General case' 0 C--O 1.241 0.639 0 O-C-N 124.192 0.933 . . . . 74.03 110.667 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.411 ' HB3' HD13 ' A' ' 83' ' ' ILE . 23.7 ttt180 -173.35 137.41 0.66 Allowed 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.526 0.516 . . . . 73.13 110.179 -172.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 83.5 mt -126.2 138.81 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.321 -0.992 . . . . 75.32 108.321 174.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.497 ' HB3' HG23 ' B' ' 122' ' ' THR . 21.1 p90 -168.25 168.85 11.26 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.627 0.727 . . . . 73.04 111.599 -173.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -94.52 120.37 34.64 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.104 -0.953 . . . . 74.31 109.143 176.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.473 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 38.2 mtpt -91.34 -30.24 16.67 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.891 0.376 . . . . 74.35 110.635 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 18.8 t70 -148.34 134.39 19.23 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.229 -0.896 . . . . 73.24 109.141 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.464 HG22 ' SD ' ' A' ' 117' ' ' MET . 60.0 mt -132.17 139.31 50.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.061 -1.459 . . . . 60.33 107.061 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.1 t -146.49 122.15 10.49 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.693 -0.854 . . . . 74.53 108.693 173.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.598 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 93.5 t80 -126.0 129.56 49.45 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.699 -1.593 . . . . 75.4 106.699 171.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -139.74 119.31 13.12 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.676 -0.861 . . . . 74.33 108.676 -178.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.38 83.53 8.58 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 106.987 -1.486 . . . . 74.43 106.987 173.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.93 -30.24 67.22 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.916 2.41 . . . . 75.12 112.637 -167.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -117.47 26.45 9.72 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 124.145 0.978 . . . . 72.13 109.45 -174.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.55 ' HB2' ' HE3' ' B' ' 19' ' ' LYS . . . -45.62 -56.34 10.14 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 114.116 1.154 . . . . 74.34 114.116 -169.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 22.3 Cg_exo -64.16 -19.9 66.57 Favored 'Trans proline' 0 C--N 1.385 2.486 0 CA-C-N 121.62 1.614 . . . . 65.53 113.392 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -90.15 -38.19 13.67 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.235 1.014 . . . . 72.44 110.551 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.594 HG22 ' HA ' ' A' ' 73' ' ' ALA . 4.1 p -77.13 -21.19 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 115.246 -0.888 . . . . 70.45 112.185 -159.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -71.45 -24.62 62.05 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.013 -0.54 . . . . 74.34 110.841 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -76.0 -27.53 57.44 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.108 0.963 . . . . 74.13 110.297 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -71.18 148.9 46.86 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.081 0.952 . . . . 75.33 110.866 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.15 124.55 23.4 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.117 0.967 . . . . 71.53 109.333 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -82.04 79.4 8.56 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.704 0.764 . . . . 74.23 110.826 -176.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -132.53 77.15 70.43 Favored Pre-proline 0 C--O 1.245 0.846 0 N-CA-C 106.584 -1.635 . . . . 73.13 106.584 169.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -85.41 154.57 10.67 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 121.986 1.79 . . . . 60.11 112.848 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -94.99 83.79 4.01 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 105.355 -2.091 . . . . 75.44 105.355 161.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.574 HG21 HD11 ' A' ' 126' ' ' LEU . 2.8 p -76.48 92.17 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-O 122.575 1.179 . . . . 74.04 108.15 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -87.01 115.33 24.32 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.214 -1.357 . . . . 72.34 109.363 -175.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.579 HD23 HD23 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -95.45 151.75 19.02 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.44 0.638 . . . . 74.24 110.282 177.24 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.599 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 13.4 t70 -145.38 150.57 36.8 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.603 -1.258 . . . . 73.42 107.603 -177.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.656 HD12 HD12 ' E' ' 8' ' ' LEU . 2.4 pt? -136.96 130.63 31.83 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.091 0.472 . . . . 73.14 110.44 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 13.7 t70 -122.94 151.08 42.14 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.46 1.104 . . . . 72.13 109.71 -178.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.0 p -106.71 127.71 53.6 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.379 -0.828 . . . . 74.34 110.923 -172.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.677 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -134.97 137.48 43.09 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.817 0.847 . . . . 64.2 109.019 172.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.0 p -132.12 163.08 29.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.941 0.496 . . . . 73.33 110.756 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.546 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 35.4 t -161.44 153.11 19.15 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.971 0.908 . . . . 64.32 109.82 176.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -113.58 120.18 40.04 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.433 -0.951 . . . . 75.31 108.433 167.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.489 HD12 HG22 ' A' ' 83' ' ' ILE . 52.8 mt -94.35 -32.15 13.72 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.988 0.515 . . . . 72.31 110.265 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.459 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -164.45 -177.11 4.69 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.372 1.069 . . . . 54.33 109.344 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -71.94 130.53 41.21 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.224 -0.658 . . . . 74.42 109.224 174.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 85' ' ' SER . 35.7 m-20 66.15 -2.08 1.04 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.495 1.118 . . . . 73.11 112.657 -174.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.459 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 65.5 t -116.45 107.61 22.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.637 0 N-CA-C 108.53 -0.915 . . . . 72.44 108.53 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -126.31 155.89 41.28 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.871 -0.789 . . . . 74.13 108.871 -174.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 35.5 tt0 -117.93 122.75 44.09 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 123.255 0.622 . . . . 74.14 109.424 175.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.2 t -105.48 122.35 58.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 107.017 -1.475 . . . . 74.14 107.017 170.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.677 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 47.5 t -114.98 129.44 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.453 -0.943 . . . . 62.53 108.453 176.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.477 HD21 ' HB2' ' A' ' 44' ' ' LEU . 1.4 tt -119.8 112.44 19.24 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.978 -0.749 . . . . 73.33 108.978 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.576 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 18.8 ttt180 -86.94 100.64 12.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.18 0.992 . . . . 71.34 109.354 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.8 t -95.46 104.74 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 109.117 -0.697 . . . . 74.44 109.117 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 25.5 m -96.08 106.79 19.01 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.6 0.76 . . . . 64.14 109.515 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.8 t -105.19 108.54 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.876 0.871 . . . . 64.34 109.818 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.2 m -102.23 142.96 32.64 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.827 -1.175 . . . . 71.53 107.827 174.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.01 120.64 35.99 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.334 -1.358 . . . . 62.02 107.334 170.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.2 m -117.64 124.36 48.4 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.736 -0.468 . . . . 72.13 109.736 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.521 ' HG ' ' HB1' ' A' ' 73' ' ' ALA . 94.0 mt -88.67 85.53 6.82 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.118 -1.067 . . . . 71.53 108.118 173.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.1 -93.87 1.44 Allowed Glycine 0 C--N 1.343 0.951 0 CA-C-N 114.845 -1.071 . . . . 74.21 111.276 -175.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -119.24 -20.54 7.91 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.503 0.721 . . . . 74.53 110.795 176.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.91 134.15 35.09 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.473 0.709 . . . . 73.15 109.364 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.1 m -73.41 126.62 30.6 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.298 0.499 . . . . 74.41 110.269 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.594 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -75.35 -58.77 3.08 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.628 0.771 . . . . 70.23 109.543 172.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.436 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 26.2 p90 -158.79 176.08 12.8 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.76 -1.109 . . . . 72.22 111.064 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.1 tp -138.06 142.44 40.29 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.904 1.282 . . . . 74.23 108.144 173.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.467 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 59.6 m -142.43 95.44 2.79 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.001 -1.111 . . . . 74.35 108.001 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -112.41 115.95 29.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.64 0.776 . . . . 75.53 108.937 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.5 t -126.96 117.4 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.637 0.775 . . . . 75.14 110.068 -176.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.425 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 75.5 mt-30 -84.61 96.1 9.08 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.246 -1.02 . . . . 73.15 108.246 168.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.407 ' HG3' HD23 ' A' ' 106' ' ' LEU . 9.5 tp-100 -82.79 103.6 12.4 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.009 -0.737 . . . . 75.32 109.009 177.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.81 146.08 20.4 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.33 -0.708 . . . . 64.52 111.33 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.439 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.23 121.02 1.16 Allowed Glycine 0 CA--C 1.505 -0.59 0 N-CA-C 111.031 -0.827 . . . . 42.42 111.031 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.489 HG22 HD12 ' A' ' 51' ' ' LEU . 34.7 mt -83.03 120.43 34.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 108.814 -0.809 . . . . 73.31 108.814 173.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.686 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 26.6 m-85 -130.1 124.29 32.42 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 109.358 -0.608 . . . . 74.12 109.358 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 73.9 m -86.6 98.34 11.04 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.535 -0.542 . . . . 72.13 109.535 168.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 28.6 pt -108.99 131.2 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 115.187 -0.915 . . . . 74.4 109.286 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.68 167.1 29.18 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.682 0.793 . . . . 73.21 109.852 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 133.35 -76.49 0.4 Allowed Glycine 0 C--N 1.338 0.673 0 N-CA-C 111.406 -0.677 . . . . 71.55 111.406 174.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.9 mm -125.23 124.22 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 109.062 -0.718 . . . . 74.32 109.062 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.499 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 1.7 mp0 -89.54 -166.27 1.55 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.803 0.841 . . . . 75.14 110.243 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.93 -143.42 34.88 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-O 119.708 -0.496 . . . . 75.13 112.331 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.8 p -66.15 -22.63 66.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.538 0.735 . . . . 72.4 112.577 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -70.64 -49.87 42.87 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.419 0.688 . . . . 74.22 109.776 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.499 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 47.3 ttp -63.69 -34.36 77.68 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.798 -0.637 . . . . 74.31 111.037 173.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.92 80.06 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.291 0.637 . . . . 61.55 111.105 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -69.11 -35.36 76.35 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.471 -0.786 . . . . 75.54 110.975 174.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.482 ' SG ' ' HE3' ' A' ' 9' ' ' MET . 78.8 m -69.37 -63.51 1.05 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 122.865 0.466 . . . . 64.23 111.201 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.555 HD23 ' HD2' ' E' ' 17' ' ' PRO . 3.4 pp -73.94 -14.05 60.99 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.03 0.532 . . . . 75.34 112.429 -177.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.45 -12.85 29.84 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-O 119.528 -0.595 . . . . 74.41 114.193 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.464 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . . . -141.43 -57.9 0.49 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 117.773 0.786 . . . . 71.33 112.044 -178.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -63.59 -58.74 6.0 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.294 1.038 . . . . 72.13 112.191 -169.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.2 m -70.86 -35.79 4.65 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 113.189 0.811 . . . . 75.12 113.189 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.87 -41.72 54.4 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 122.447 2.098 . . . . 74.53 113.497 162.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -71.48 -23.54 61.83 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.895 0.878 . . . . 73.13 110.5 -176.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -67.03 -39.77 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 123.094 0.558 . . . . 74.52 110.027 173.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.439 HD21 ' HA3' ' A' ' 82' ' ' GLY . 93.9 mt -76.48 -26.71 55.64 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.663 0.785 . . . . 72.14 112.507 -175.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -63.89 -44.12 77.95 Favored Pre-proline 0 CA--C 1.564 1.483 0 N-CA-C 114.003 1.112 . . . . 73.51 114.003 -171.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.33 -33.85 79.08 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 121.88 1.72 . . . . 75.12 113.205 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.507 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 77.5 m-85 -75.66 -37.92 59.23 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.463 0.705 . . . . 75.51 111.929 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.58 -39.19 70.72 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.842 -0.429 . . . . 55.34 109.842 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.662 ' NH1' HD13 ' C' ' 105' ' ' ILE . 33.4 ttm180 -61.96 -38.28 87.91 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 124.06 0.85 . . . . 74.12 109.62 172.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.519 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 2.9 tm-20 -65.95 -48.34 71.65 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.854 0.862 . . . . 72.33 111.071 -177.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 34.4 t -60.31 -44.77 95.12 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 124.273 0.983 . . . . 71.34 110.231 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 82.9 mt -66.47 -43.5 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.909 0.883 . . . . 73.43 111.149 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.1 m -59.81 -40.37 88.19 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.816 0.846 . . . . 60.14 110.606 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.7 t -72.22 -43.69 64.04 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.219 -0.901 . . . . 71.52 110.696 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.598 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 18.8 mtp -60.35 -40.28 90.19 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.466 0.706 . . . . 73.31 111.661 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.46 HG11 ' HB2' ' A' ' 123' ' ' PHE . 48.6 t -66.99 -45.07 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.98 0.912 . . . . 73.21 110.848 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.6 p -71.7 -30.81 66.08 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 120.73 0.3 . . . . 61.32 111.003 -176.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -70.05 -33.73 72.32 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.655 0.782 . . . . 75.35 109.591 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.7 11.97 43.72 Favored Glycine 0 C--N 1.356 1.653 0 O-C-N 123.88 0.738 . . . . 75.41 113.053 173.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.509 HG23 ' HE ' ' B' ' 15' ' ' ARG . 3.4 t 61.56 18.18 9.24 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 127.348 2.259 . . . . 74.32 113.819 172.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.46 ' HB2' HG11 ' A' ' 118' ' ' VAL . 90.3 m-85 -84.84 147.44 48.53 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 107.296 -1.372 . . . . 75.54 107.296 170.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.47 171.85 7.51 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.236 1.957 . . . . 75.15 112.156 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.545 ' HG2' ' H ' ' C' ' 16' ' ' ILE . 9.0 tp-100 -53.31 124.45 14.71 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.035 0.934 . . . . 75.23 112.065 -172.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.574 HD11 HG21 ' A' ' 40' ' ' VAL . 57.4 tp -116.9 118.3 32.09 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.39 -0.823 . . . . 72.1 108.945 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.501 ' ND2' HD13 ' C' ' 16' ' ' ILE . 15.4 m120 -123.65 115.77 21.99 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.755 0.822 . . . . 75.53 111.182 -174.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.579 HD23 HD23 ' A' ' 42' ' ' LEU . 71.1 mt -74.4 121.98 22.26 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.789 -0.819 . . . . 75.04 108.789 167.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.542 ' HB3' ' HB2' ' E' ' 7' ' ' ALA . . . -66.17 130.21 94.28 Favored Pre-proline 0 CA--C 1.555 1.159 0 N-CA-C 110.106 -0.331 . . . . 71.31 110.106 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.511 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 40.0 Cg_endo -67.56 119.35 6.36 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.785 2.324 . . . . 70.05 111.872 -174.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.708 HG13 ' HB2' ' E' ' 8' ' ' LEU . 4.2 p -101.97 125.24 56.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 114.97 -1.013 . . . . 63.42 109.982 -176.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -102.66 98.09 8.18 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.616 -0.883 . . . . 75.32 108.616 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -66.71 -28.18 68.23 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.309 0.644 . . . . 73.4 110.366 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -54.36 -37.84 65.41 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.792 1.637 . . . . 63.42 112.41 -175.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.78 -41.17 96.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.47 0.708 . . . . 70.11 110.881 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' E' ' 10' ' ' LEU . 6.5 mp -74.44 -25.88 59.71 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.607 0.763 . . . . 71.21 110.628 -178.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.464 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 9.0 m-85 -63.91 -54.12 39.67 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.542 0.737 . . . . 72.11 110.591 173.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 31.5 mmt -68.16 -33.24 74.11 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.089 0.556 . . . . 74.5 110.807 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -66.22 -40.28 90.18 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.411 -0.813 . . . . 63.22 111.597 175.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -75.55 -37.68 59.82 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 120.745 0.307 . . . . 75.23 110.552 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.55 -48.7 59.45 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.715 0.806 . . . . 75.11 112.068 -174.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -150.46 6.84 0.57 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 111.856 0.317 . . . . 72.34 111.856 -171.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 71.47 164.95 0.29 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 125.263 1.425 . . . . 75.03 112.167 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -166.51 161.2 15.99 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.516 0.726 . . . . 75.23 110.363 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.49 140.36 46.36 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.875 -0.602 . . . . 71.2 109.777 169.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -134.0 37.03 2.02 Favored Glycine 0 CA--C 1.504 -0.635 0 N-CA-C 111.29 -0.724 . . . . 55.4 111.29 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.471 ' HB3' HD22 ' C' ' 5' ' ' ASN . 10.1 pt-20 -109.51 -171.57 1.87 Allowed 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.722 0.809 . . . . 75.31 110.792 -175.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' C' ' 88' ' ' GLY . . . 167.54 97.47 0.11 Allowed Glycine 0 C--N 1.342 0.914 0 N-CA-C 110.628 -0.989 . . . . 70.22 110.628 175.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.9 m -86.83 48.71 1.68 Allowed 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 122.002 0.906 . . . . 73.23 109.376 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -87.21 145.04 26.55 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 124.258 1.023 . . . . 72.53 109.324 -175.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.51 137.47 57.43 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.842 0.714 . . . . 62.43 111.678 -174.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -114.03 168.92 9.4 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.187 0.995 . . . . 61.22 108.574 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.07 147.56 31.4 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.601 -0.518 . . . . 73.23 109.601 173.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -52.86 -47.73 67.57 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.373 1.069 . . . . 64.33 110.973 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.187 0 O-C-N 124.993 1.433 . . . . 61.5 110.718 175.514 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 20.2 mmt . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 108.951 -0.759 . . . . 73.34 108.951 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.2 p -171.17 -179.91 2.83 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.654 1.182 . . . . 75.45 109.033 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -103.25 98.41 8.34 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.355 0.662 . . . . 71.42 109.6 -178.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -79.38 137.56 37.34 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.372 0.669 . . . . 73.33 111.266 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -83.84 115.65 22.36 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.714 -1.217 . . . . 73.25 107.714 173.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -76.62 80.91 3.28 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 122.121 0.962 . . . . 73.44 110.313 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -141.0 160.93 39.03 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 114.044 -1.435 . . . . 74.25 109.062 -178.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 74.72 -63.37 0.42 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.852 1.661 . . . . 74.3 111.927 176.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.56 ' HE2' ' HB2' ' B' ' 11' ' ' PHE . 26.0 ttt 66.68 165.29 0.2 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.872 1.669 . . . . 73.22 111.962 -176.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 86.0 m -141.94 126.79 18.17 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 105.921 -1.881 . . . . 64.54 105.921 167.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.56 ' HB2' ' HE2' ' B' ' 9' ' ' MET . 60.6 t80 -143.28 140.47 30.63 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.202 0.456 . . . . 74.3 110.337 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.478 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -150.39 139.53 21.15 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.552 0.741 . . . . 74.33 109.401 173.059 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 25.7 mt -82.8 124.81 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.194 -1.039 . . . . 75.02 108.194 169.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -93.81 -38.12 11.41 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.074 -0.713 . . . . 75.14 109.074 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.509 ' HE ' HG23 ' A' ' 122' ' ' THR . 32.4 ttt180 -169.9 151.64 4.19 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.252 0.621 . . . . 73.31 110.218 -177.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.7 mt -132.95 140.97 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.364 -1.347 . . . . 72.51 107.364 174.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.407 ' HE1' HG13 ' B' ' 83' ' ' ILE . 31.1 p90 -169.72 157.23 6.84 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.61 0.719 . . . . 74.53 112.515 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 87.6 m -82.08 127.5 33.18 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.682 -1.144 . . . . 73.32 108.561 170.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.55 ' HE3' ' HB2' ' A' ' 28' ' ' ALA . 40.4 mtpt -98.39 -35.77 10.19 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.452 0.701 . . . . 72.11 110.39 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 13.1 t70 -150.81 137.72 19.1 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.72 -0.673 . . . . 71.53 110.954 -167.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.476 HD13 ' SG ' ' B' ' 113' ' ' CYS . 46.5 mm -137.92 143.83 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.088 1.355 . . . . 70.23 108.461 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 44.2 t -149.44 114.99 5.57 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.525 -1.287 . . . . 70.13 107.525 174.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 87.5 t80 -132.38 110.81 10.82 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.235 -1.024 . . . . 72.55 108.235 173.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -117.48 137.51 52.49 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.527 0.731 . . . . 64.41 109.363 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.24 84.3 17.23 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 106.489 -1.671 . . . . 72.31 106.489 177.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -63.83 -48.35 5.51 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.829 2.352 . . . . 72.23 112.275 -167.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -104.62 20.13 19.16 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.392 -0.822 . . . . 75.21 110.828 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.78 -59.51 3.46 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 115.56 1.689 . . . . 73.22 115.56 -168.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.75 -31.04 94.23 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 122.657 2.238 . . . . 63.22 113.121 -170.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -96.8 -37.19 10.37 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.173 -0.921 . . . . 74.31 111.6 -176.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.431 HG21 ' HA ' ' B' ' 73' ' ' ALA . 4.0 p -65.45 -20.3 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 123.214 0.606 . . . . 73.11 111.352 -172.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -61.94 -18.47 60.45 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.102 0.961 . . . . 73.52 113.421 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -62.82 -30.78 71.75 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.261 0.553 . . . . 61.42 110.205 176.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -87.71 80.77 7.83 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.45 1.1 . . . . 73.04 109.709 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -84.38 90.42 7.58 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.186 0.517 . . . . 72.11 110.143 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 27.5 p90 -158.73 172.38 18.36 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.711 1.204 . . . . 74.4 108.298 167.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -75.59 110.45 10.63 Favored Pre-proline 0 N--CA 1.477 0.895 0 N-CA-C 109.263 -0.643 . . . . 74.11 109.263 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.14 159.7 51.96 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.23 1.953 . . . . 72.21 112.653 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.44 112.19 3.01 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.685 0.615 . . . . 70.33 109.353 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.464 ' HB ' HG21 ' F' ' 6' ' ' ILE . 48.0 t -85.94 119.95 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.587 -0.894 . . . . 64.15 108.587 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.508 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 24.3 mtpp -119.45 98.56 6.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.332 -1.358 . . . . 71.24 107.332 177.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.453 HD21 HD21 ' F' ' 8' ' ' LEU . 2.2 pp -94.3 158.07 15.75 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.808 -0.633 . . . . 74.02 110.457 -176.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -162.8 119.44 1.91 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.468 -0.567 . . . . 61.31 109.468 -175.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.773 HD22 HD11 ' F' ' 8' ' ' LEU . 5.2 mp -100.61 143.83 30.31 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.766 0.426 . . . . 74.45 110.1 -178.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -125.2 151.21 46.15 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.128 0.971 . . . . 74.23 109.409 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.1 p -109.02 133.78 52.54 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.338 0.655 . . . . 63.31 110.919 -170.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.624 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -148.65 148.83 30.54 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.617 0.767 . . . . 54.42 109.243 170.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.489 ' HB2' ' HB ' ' F' ' 16' ' ' THR . 49.8 m -146.76 177.21 9.27 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.455 0.702 . . . . 74.23 109.951 172.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 1.4 m -151.55 138.63 19.16 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.681 0.792 . . . . 74.23 108.934 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -92.33 108.99 20.37 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.381 -1.34 . . . . 75.23 107.381 165.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 21.7 mt -83.77 -56.08 3.9 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.131 0.491 . . . . 74.04 109.797 -176.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' B' ' 55' ' ' VAL . . . -138.09 -170.22 2.74 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.197 -0.91 . . . . 71.41 109.257 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.45 109.94 4.47 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 114.75 -1.114 . . . . 55.34 109.542 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 70.45 2.63 4.14 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 125.081 1.352 . . . . 71.41 113.232 -177.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.402 ' HB ' ' HB1' ' B' ' 52' ' ' ALA . 78.3 t -105.74 123.08 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 108.435 -0.95 . . . . 73.21 108.435 173.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.43 ' HE2' ' HB3' ' B' ' 98' ' ' LEU . 4.9 p90 -133.37 175.35 9.49 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.142 0.977 . . . . 71.14 108.739 -176.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -145.4 116.0 7.66 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.806 -0.813 . . . . 71.32 108.806 -175.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 60.2 t -97.91 132.3 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.188 0.595 . . . . 73.51 109.989 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.624 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 20.7 t -115.96 119.06 60.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 124.339 1.056 . . . . 75.3 108.931 176.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.596 HD11 ' HZ ' ' F' ' 15' ' ' PHE . 50.5 tp -106.49 112.44 25.44 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.428 -0.582 . . . . 63.03 109.428 170.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.533 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 31.2 ttm180 -85.52 132.43 34.2 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.708 -0.849 . . . . 73.44 108.708 170.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 17.5 t -126.22 120.96 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 107.819 -1.178 . . . . 72.45 107.819 172.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 9.0 m -114.08 152.54 30.91 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.702 0.801 . . . . 70.4 109.265 -176.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.533 HG22 HG21 ' B' ' 114' ' ' ILE . 97.2 t -139.6 103.62 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.682 1.193 . . . . 53.41 108.559 -175.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.508 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 97.4 m -83.08 140.24 32.77 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.29 -1.004 . . . . 73.11 108.29 162.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.03 137.49 23.57 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.092 -0.707 . . . . 74.23 109.092 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.461 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 36.8 p -144.06 128.73 18.2 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 123.614 0.571 . . . . 70.43 111.584 -174.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.405 HD13 HG23 ' B' ' 31' ' ' VAL . 61.2 mt -95.91 101.41 13.09 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.97 -1.122 . . . . 65.34 107.97 174.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.0 -112.69 3.5 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 116.049 -0.523 . . . . 64.12 112.546 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.71 21.47 11.48 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.034 0.934 . . . . 63.32 111.285 -176.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -137.96 151.63 48.13 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.05 0.54 . . . . 74.24 110.007 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 86.9 m -72.11 118.11 14.58 Favored 'General case' 0 C--O 1.241 0.629 0 O-C-N 123.391 0.432 . . . . 75.1 110.777 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.461 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -71.59 -62.25 1.48 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.228 -0.896 . . . . 75.11 108.738 172.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -152.08 164.73 36.66 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.079 0.942 . . . . 75.35 112.214 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 91.0 mt -132.69 114.02 13.68 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 106.043 -1.836 . . . . 75.42 106.043 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.7 t -116.36 151.28 36.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.568 -0.901 . . . . 72.34 108.568 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -163.42 126.84 2.73 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.42 -0.585 . . . . 75.24 109.42 -175.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 64.4 t -123.63 153.84 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 123.698 0.799 . . . . 74.13 109.117 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.551 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 20.9 mt-30 -127.91 103.54 7.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.235 -1.024 . . . . 65.21 108.235 166.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -91.21 102.29 15.01 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.979 -0.748 . . . . 73.25 108.979 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.412 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.19 164.39 28.39 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.522 -0.763 . . . . 75.53 111.666 174.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.77 127.75 1.72 Allowed Glycine 0 CA--C 1.504 -0.638 0 N-CA-C 111.413 -0.675 . . . . 75.31 111.413 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.407 HG13 ' HE1' ' B' ' 17' ' ' TYR . 66.4 mt -84.21 127.93 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.056 -1.09 . . . . 74.13 108.056 176.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -134.29 164.12 28.11 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.404 1.082 . . . . 75.34 109.136 -176.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.6 m -132.26 133.32 43.97 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.624 0.769 . . . . 63.42 109.454 175.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.59 HG23 HG22 ' F' ' 18' ' ' VAL . 9.5 tt -135.53 146.36 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.837 0.855 . . . . 75.42 109.045 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.99 152.45 33.55 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.319 0.248 . . . . 73.12 110.433 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.91 -32.9 5.53 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.581 -0.736 . . . . 71.13 112.563 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.41 HG23 ' N ' ' B' ' 90' ' ' GLU . 46.6 mm -92.89 153.34 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.183 0.993 . . . . 74.44 111.756 -175.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.663 ' HA ' ' HE1' ' B' ' 94' ' ' MET . 0.0 OUTLIER -161.06 -172.0 3.28 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.664 1.186 . . . . 75.44 110.342 177.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.21 -133.44 52.35 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 114.935 0.734 . . . . 73.23 114.935 175.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.6 m -65.66 -37.75 87.39 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.545 0.738 . . . . 70.21 111.231 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -75.46 -20.82 58.58 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.513 -0.767 . . . . 75.2 110.741 -172.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.663 ' HE1' ' HA ' ' B' ' 90' ' ' GLU . 57.3 ttm -64.87 -45.11 87.37 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.425 -0.583 . . . . 75.5 109.425 168.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.02 -30.67 71.67 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.958 0.903 . . . . 62.11 111.168 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -69.94 -35.84 74.83 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.827 0.851 . . . . 75.55 110.995 176.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.419 ' SG ' HD11 ' B' ' 86' ' ' ILE . 42.0 t -69.11 -66.52 0.57 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.024 0.53 . . . . 70.1 110.952 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.548 HD22 ' HA ' ' F' ' 17' ' ' PRO . 1.2 pp -76.67 -5.88 49.77 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 112.731 0.641 . . . . 71.41 112.731 -176.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.97 -36.9 8.1 Favored Glycine 0 C--N 1.336 0.535 0 O-C-N 123.452 0.47 . . . . 72.02 113.391 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.84 -52.45 1.33 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.898 0.479 . . . . 73.21 111.569 -169.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -64.46 -46.52 82.74 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.307 1.043 . . . . 73.45 111.66 -174.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.422 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 84.2 m -75.36 -46.55 4.44 Favored Pre-proline 0 CA--C 1.563 1.467 0 N-CA-C 112.74 0.644 . . . . 72.53 112.74 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.486 ' HB3' HD22 ' B' ' 60' ' ' LEU . 53.8 Cg_exo -59.72 -25.29 78.66 Favored 'Trans proline' 0 C--N 1.388 2.612 0 C-N-CA 122.294 1.996 . . . . 75.44 113.887 171.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -62.17 -40.73 97.02 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.442 0.697 . . . . 70.52 110.397 174.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.423 ' HA ' ' NH2' ' D' ' 111' ' ' ARG . 73.9 mt -63.59 -43.67 98.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 CA-C-N 114.795 -1.093 . . . . 74.52 110.253 177.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 78.9 mt -81.98 -19.93 39.56 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.303 -1.317 . . . . 74.12 112.332 -171.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.422 ' CE1' HD13 ' F' ' 8' ' ' LEU . 60.4 t80 -54.13 -53.25 60.76 Favored Pre-proline 0 CA--C 1.563 1.447 0 N-CA-C 113.945 1.091 . . . . 74.33 113.945 -174.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.98 -33.5 95.55 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.164 1.91 . . . . 73.45 113.711 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -71.74 -45.92 60.19 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.889 -0.596 . . . . 74.2 110.428 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.91 91.0 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.034 0.534 . . . . 75.1 110.563 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.0 ttt-85 -62.28 -51.67 66.76 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.24 1.416 . . . . 71.55 110.872 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.5 -32.72 72.9 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.356 0.663 . . . . 75.42 109.878 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.507 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.3 t -69.93 -35.93 74.93 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 122.653 0.381 . . . . 72.32 111.291 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.533 HG21 HG22 ' B' ' 64' ' ' VAL . 71.6 mt -64.25 -55.25 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 108.66 -0.867 . . . . 74.5 108.66 172.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 37.9 m -57.83 -31.51 66.7 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 124.374 1.047 . . . . 72.02 111.367 -175.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.1 t -62.65 -53.66 51.18 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 123.318 0.647 . . . . 72.52 109.533 175.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.3 mmt -65.92 -35.38 80.48 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.375 0.67 . . . . 75.44 111.582 -174.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.402 HG21 ' O ' ' B' ' 114' ' ' ILE . 85.2 t -64.23 -43.23 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.665 0.786 . . . . 74.23 110.154 175.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 39.7 t -70.08 -28.38 65.38 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.227 -0.897 . . . . 74.15 111.334 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.497 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 89.0 mtt-85 -71.06 -39.19 72.38 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.644 0.777 . . . . 74.44 110.205 176.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.98 -0.88 71.12 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.852 0.72 . . . . 72.43 112.643 172.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.497 HG23 ' HB3' ' A' ' 17' ' ' TYR . 19.0 p 63.76 31.88 13.96 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.561 1.945 . . . . 71.02 112.363 173.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -90.64 160.49 38.69 Favored Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 124.545 1.138 . . . . 74.34 110.407 176.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -50.77 159.64 2.22 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 123.969 3.113 . . . . 74.03 115.874 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -64.08 112.55 3.04 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.868 -1.06 . . . . 73.3 111.42 -173.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 50.6 tp -111.1 122.46 47.94 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.524 0.73 . . . . 74.12 109.271 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -132.8 122.5 24.58 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.303 -0.999 . . . . 73.3 108.303 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 93.3 mt -68.86 145.49 53.66 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.578 0.351 . . . . 75.3 110.816 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.18 142.13 40.79 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.225 0.61 . . . . 74.32 110.463 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.31 116.12 3.42 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.356 2.704 . . . . 75.41 111.844 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.41 HG22 ' HB2' ' F' ' 8' ' ' LEU . 35.2 m -124.55 140.34 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.179 0.592 . . . . 70.2 109.688 175.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . 0.476 ' ND2' ' HB3' ' B' ' 135' ' ' ALA . 51.7 t30 -111.52 98.2 7.28 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.942 -0.762 . . . . 75.44 108.942 174.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -56.76 -34.99 68.12 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.87 0.868 . . . . 75.35 110.545 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -61.76 -48.98 78.26 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 113.67 -1.604 . . . . 72.14 111.764 -172.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.476 ' HB3' ' ND2' ' B' ' 132' ' ' ASN . . . -62.17 -37.16 84.2 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.617 0.767 . . . . 61.21 112.2 -176.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.461 HD23 ' HG ' ' F' ' 10' ' ' LEU . 9.8 mp -67.44 -43.48 81.06 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.704 -0.68 . . . . 73.51 110.178 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.441 ' HZ ' ' HA ' ' F' ' 12' ' ' PRO . 29.5 m-85 -80.66 -14.77 57.86 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.005 0.743 . . . . 74.35 113.005 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 89.2 mtp -68.05 -39.85 82.96 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.323 0.582 . . . . 70.33 109.442 169.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -93.81 -12.21 29.55 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.91 -1.041 . . . . 74.21 110.764 -173.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -67.79 -29.56 68.78 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 109.377 -0.601 . . . . 74.41 109.377 169.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 56.9 mt -96.85 29.63 2.97 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.342 1.057 . . . . 75.15 110.419 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -73.95 95.28 2.46 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.185 0.517 . . . . 74.13 110.337 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -136.25 137.42 40.76 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.205 1.002 . . . . 72.43 108.621 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -111.45 177.04 4.78 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.345 0.658 . . . . 74.31 110.705 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.12 -174.38 3.74 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.411 0.684 . . . . 71.33 111.04 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -159.21 153.08 24.17 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.771 -0.532 . . . . 65.11 111.771 178.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -78.36 131.97 37.2 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.486 0.714 . . . . 74.51 110.715 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -76.19 154.61 44.78 Favored Glycine 0 C--N 1.346 1.084 0 O-C-N 123.745 0.653 . . . . 72.21 113.612 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 44.9 m -75.61 136.83 40.48 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.127 0.971 . . . . 75.33 110.601 177.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -67.34 133.44 49.64 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 123.513 0.508 . . . . 75.22 111.105 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -106.38 163.67 12.66 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.157 0.983 . . . . 75.44 110.877 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -151.39 169.04 22.96 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.588 0.755 . . . . 75.33 110.708 -178.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.03 -176.51 6.23 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.457 0.703 . . . . 74.31 111.582 176.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -147.06 139.24 24.58 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.185 0.994 . . . . 74.54 108.352 176.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.135 0 N-CA-C 109.038 -0.727 . . . . 73.2 109.038 176.009 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.422 ' SD ' ' N ' ' C' ' 1' ' ' MET . 3.1 mpp? . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.573 -0.529 . . . . 62.3 109.573 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -137.78 104.85 5.41 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.724 0.81 . . . . 75.23 109.083 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -74.74 111.23 9.73 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.73 -0.841 . . . . 74.43 108.73 175.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -65.1 -73.21 0.13 Allowed 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.031 0.832 . . . . 74.34 111.659 -170.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . 0.471 HD22 ' HB3' ' A' ' 147' ' ' GLU . 64.8 t30 -150.67 35.81 0.63 Allowed 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 122.516 1.15 . . . . 74.22 108.526 -178.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -103.93 -19.72 14.13 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.181 -1.372 . . . . 75.45 110.201 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -85.51 104.28 15.14 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.194 0.998 . . . . 75.52 108.882 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -77.15 152.58 34.8 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.693 -0.685 . . . . 73.45 109.576 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.489 ' HE2' ' SG ' ' C' ' 97' ' ' CYS . 0.0 OUTLIER 68.12 140.27 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.929 1.292 . . . . 71.14 112.418 178.672 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.413 ' N ' ' SD ' ' C' ' 9' ' ' MET . 44.3 m -119.47 86.32 2.53 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.104 0.962 . . . . 70.44 108.83 176.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.473 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 23.3 t80 -101.83 139.96 36.77 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.26 -0.882 . . . . 70.44 108.828 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -152.55 132.81 13.6 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.883 -0.784 . . . . 75.12 108.883 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 16.7 mt -87.65 131.58 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.83 -0.804 . . . . 74.01 108.83 174.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -92.94 -48.61 6.44 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.558 0.743 . . . . 71.12 110.325 177.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -173.92 130.42 0.4 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 115.963 -0.562 . . . . 75.35 109.778 -168.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.545 ' H ' ' HG2' ' A' ' 125' ' ' GLN . 61.3 mt -123.2 147.76 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.962 -0.755 . . . . 74.22 108.962 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.423 ' HH ' HD11 ' C' ' 83' ' ' ILE . 20.5 p90 -175.33 157.39 2.18 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.515 0.674 . . . . 74.33 110.076 -173.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.0 p -77.99 123.9 27.37 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.767 -1.106 . . . . 73.2 108.712 172.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -70.35 -49.19 51.85 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 107.479 -1.304 . . . . 74.11 107.479 167.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 11.4 t70 -136.68 136.92 39.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 112.874 -1.966 . . . . 55.21 109.203 -166.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.442 HG12 ' SG ' ' C' ' 113' ' ' CYS . 75.3 mt -134.63 142.59 40.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.663 -1.606 . . . . 74.43 106.663 171.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.4 t -156.2 150.47 25.51 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.89 -0.411 . . . . 73.3 109.89 175.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -152.26 116.69 5.01 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.446 1.098 . . . . 74.31 108.043 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -120.72 129.44 53.65 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.642 0.777 . . . . 74.21 109.757 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.38 82.7 33.79 Favored Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 107.25 -1.389 . . . . 74.22 107.25 170.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.92 -14.01 23.96 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.953 2.435 . . . . 72.24 112.06 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -110.79 17.21 20.82 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.138 0.975 . . . . 73.35 109.881 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.446 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -49.28 -56.53 15.57 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 114.514 1.302 . . . . 65.13 114.514 -167.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 35.1 Cg_exo -61.84 -38.9 55.95 Favored 'Trans proline' 0 C--N 1.385 2.474 0 CA-C-N 121.824 1.687 . . . . 73.53 112.39 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -69.5 -34.92 75.0 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.684 -1.144 . . . . 73.41 112.308 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.684 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.4 p -82.75 -16.68 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 N-CA-C 112.724 0.639 . . . . 73.24 112.724 -176.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -78.37 -16.9 57.19 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.257 0.466 . . . . 55.31 112.257 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -94.07 36.77 1.11 Allowed 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.344 0.592 . . . . 74.11 109.906 172.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.472 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 0.2 OUTLIER -126.79 167.21 16.09 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.27 1.028 . . . . 74.25 110.663 -178.55 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -89.97 132.19 35.47 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.804 0.842 . . . . 75.25 109.95 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 50.9 t-105 -81.97 90.51 6.49 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.192 0.52 . . . . 74.32 112.053 -173.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -143.55 77.95 14.9 Favored Pre-proline 0 CA--C 1.559 1.296 0 C-N-CA 124.496 1.119 . . . . 74.4 108.744 171.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -92.74 145.93 2.56 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.967 2.445 . . . . 53.53 114.623 -176.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.75 97.71 10.76 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 107.496 -1.298 . . . . 73.53 107.496 166.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' C' ' 65' ' ' THR . 9.6 m -83.85 100.29 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.745 0.783 . . . . 64.3 111.135 -176.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -92.57 109.09 20.49 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.628 0.771 . . . . 74.44 109.552 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.474 HD22 HD22 ' G' ' 8' ' ' LEU . 2.2 pp -86.0 163.02 18.22 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.781 -0.645 . . . . 72.41 111.196 -177.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.545 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 31.2 t70 -150.48 112.57 4.59 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.918 -0.771 . . . . 60.33 108.918 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' C' ' 61' ' ' ARG . 5.7 mp -113.51 112.87 24.31 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.035 -0.728 . . . . 74.35 109.035 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -116.87 152.63 34.08 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.098 0.959 . . . . 74.33 109.369 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 33.7 p -112.42 126.93 55.83 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.329 0.652 . . . . 75.02 111.028 -169.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.47 141.31 39.44 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.434 1.094 . . . . 73.42 108.534 174.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 36.0 p -165.73 164.96 18.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.337 0.255 . . . . 73.23 111.258 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 67.8 p -167.07 138.0 3.14 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.856 0.862 . . . . 73.15 109.511 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . 0.461 ' HA ' ' HA ' ' C' ' 56' ' ' TYR . 51.8 tt0 -78.7 117.76 20.15 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.742 -0.836 . . . . 75.31 108.742 174.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.557 HD12 ' HB2' ' C' ' 57' ' ' GLU . 33.3 mt -84.75 -39.91 17.9 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.981 0.912 . . . . 73.0 110.982 -171.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.88 -170.49 3.64 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.654 -0.703 . . . . 74.01 110.943 -175.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -59.05 107.51 0.55 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.315 1.046 . . . . 71.12 110.716 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 63.12 6.82 2.46 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.288 1.035 . . . . 52.02 112.677 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 91.9 t -103.68 113.19 39.85 Favored 'Isoleucine or valine' 0 C--N 1.345 0.38 0 N-CA-C 107.584 -1.265 . . . . 74.11 107.584 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' C' ' 50' ' ' GLN . 50.9 t80 -131.39 135.09 46.91 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.062 0.945 . . . . 74.41 108.8 -173.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.557 ' HB2' HD12 ' C' ' 51' ' ' LEU . 39.3 tt0 -92.43 136.95 32.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.785 -1.098 . . . . 72.22 110.377 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 86.3 t -119.35 115.36 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.312 -1.366 . . . . 75.32 107.312 173.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.3 122.1 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 109.208 -0.664 . . . . 75.41 109.208 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 tp -116.55 125.57 52.07 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.656 -0.868 . . . . 73.13 108.656 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 29.8 ttm180 -79.06 130.96 36.07 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.749 -1.204 . . . . 72.33 107.749 172.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.4 HG13 ' CD1' ' C' ' 114' ' ' ILE . 23.5 t -124.02 111.37 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.13 -1.433 . . . . 75.41 107.13 172.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 63.9 m -121.43 139.89 52.87 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.446 -0.946 . . . . 61.21 108.446 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 85.6 t -131.42 111.6 19.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 108.184 -1.043 . . . . 73.12 108.184 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' C' ' 40' ' ' VAL . 3.2 m -98.5 132.81 43.63 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 107.567 -1.271 . . . . 72.24 107.567 173.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.76 121.47 37.33 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.47 -0.937 . . . . 73.21 108.47 -177.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 47.1 m -136.17 126.08 25.86 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.04 0.447 . . . . 65.13 111.061 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 14.1 mt -86.06 57.92 4.76 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.135 1.374 . . . . 75.23 109.076 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.08 -92.64 1.07 Allowed Glycine 0 C--N 1.343 0.938 0 N-CA-C 110.245 -1.142 . . . . 60.53 110.245 -175.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -126.6 2.01 6.84 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.895 0.878 . . . . 73.35 110.064 172.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.472 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 11.9 tp10 -82.02 114.26 20.46 Favored 'General case' 0 C--N 1.347 0.481 0 N-CA-C 108.151 -1.055 . . . . 71.42 108.151 169.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.2 m -79.02 120.49 23.67 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 119.281 0.946 . . . . 73.15 109.146 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.684 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -79.81 -58.71 3.04 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.885 -1.052 . . . . 71.1 109.006 178.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -159.09 174.85 14.27 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 122.017 0.913 . . . . 72.43 112.321 -178.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.455 HD23 HG21 ' C' ' 65' ' ' THR . 2.4 tm? -138.61 142.57 39.13 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 105.37 -2.085 . . . . 63.24 105.37 170.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.47 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 48.1 t -150.29 112.84 4.71 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.586 -0.524 . . . . 74.22 109.586 176.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -118.01 130.9 56.46 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.568 0.747 . . . . 74.44 109.545 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 55.6 t -131.19 113.23 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.195 0.998 . . . . 75.54 108.542 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -91.03 95.17 9.97 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.885 -1.154 . . . . 74.31 107.885 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.515 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 7.3 tp-100 -86.08 115.42 23.66 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.158 0.583 . . . . 63.31 110.098 -176.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.69 146.88 18.07 Favored Glycine 0 C--N 1.338 0.652 0 O-C-N 123.489 0.493 . . . . 70.32 112.344 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.51 119.18 1.23 Allowed Glycine 0 C--O 1.237 0.308 0 N-CA-C 110.698 -0.961 . . . . 72.11 110.698 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.524 HD13 HD12 ' C' ' 51' ' ' LEU . 16.4 mm -83.86 123.75 39.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.595 -0.891 . . . . 71.1 108.595 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -132.31 123.85 27.67 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.98 0.512 . . . . 71.51 110.851 -173.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 58.7 m -80.19 105.27 11.33 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.394 -0.965 . . . . 72.34 108.394 166.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.4 ' H ' HD11 ' C' ' 86' ' ' ILE . 0.2 OUTLIER -116.0 139.2 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.052 -0.721 . . . . 72.31 109.052 -179.563 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.63 170.2 16.01 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.351 0.661 . . . . 71.45 110.247 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . 0.46 ' O ' ' HA3' ' A' ' 148' ' ' GLY . . . 93.81 -30.02 7.94 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-O 119.625 -0.542 . . . . 54.33 113.823 172.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 47.4 pt -123.7 151.31 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 118.001 0.901 . . . . 73.34 110.333 176.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.505 ' HA ' ' HE1' ' C' ' 94' ' ' MET . 41.5 tt0 -147.75 157.9 43.76 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.921 0.889 . . . . 73.54 109.774 178.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.58 -148.19 21.77 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 119.167 -0.796 . . . . 74.54 111.878 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 92' ' ' THR . . . . . 0.42 ' H ' ' HD3' ' G' ' 24' ' ' PRO . 9.8 t -56.77 -26.56 57.81 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.394 0.677 . . . . 75.43 111.681 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -55.33 -59.12 5.24 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.225 1.41 . . . . 63.1 110.423 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.505 ' HE1' ' HA ' ' C' ' 90' ' ' GLU . 32.9 ttp -77.78 -22.47 50.11 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.358 -0.837 . . . . 74.43 111.425 -177.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.92 -35.08 79.49 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.261 0.624 . . . . 74.02 110.706 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -73.82 -31.67 63.34 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.396 -0.82 . . . . 73.02 110.617 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.489 ' SG ' ' HE2' ' C' ' 9' ' ' MET . 42.8 t -66.47 -60.93 2.29 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.314 0.246 . . . . 71.55 110.716 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 pp -66.5 -29.96 70.18 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.192 0.597 . . . . 74.03 111.585 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.92 12.4 59.12 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-O 119.251 -0.749 . . . . 74.32 114.475 -173.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.41 -55.38 0.06 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.269 1.035 . . . . 72.33 112.045 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.511 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 56.1 t80 -71.23 -35.67 71.55 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.76 0.824 . . . . 71.23 111.555 -172.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.473 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 60.7 m -76.19 -50.91 2.83 Favored Pre-proline 0 CA--C 1.564 1.5 0 C-N-CA 123.603 0.761 . . . . 73.1 112.249 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.58 -13.54 35.27 Favored 'Trans proline' 0 C--N 1.398 3.138 0 C-N-CA 122.03 1.82 . . . . 75.41 112.959 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -60.89 -37.41 82.12 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.999 0.919 . . . . 75.14 110.154 171.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.662 HD13 ' NH1' ' A' ' 111' ' ' ARG . 37.9 mm -70.02 -36.06 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.229 -0.896 . . . . 74.34 111.19 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 53.6 mt -91.94 -24.59 19.22 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.862 -1.063 . . . . 72.32 111.985 -166.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -57.25 -52.64 72.71 Favored Pre-proline 0 CA--C 1.557 1.241 0 CA-C-O 117.99 -1.005 . . . . 75.33 112.733 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . 0.519 ' HB2' ' HG3' ' A' ' 112' ' ' GLU . 42.0 Cg_endo -63.45 -27.3 70.58 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 121.683 1.589 . . . . 75.32 112.788 -177.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . 0.523 ' CD1' HG21 ' C' ' 16' ' ' ILE . 3.2 m-30 -71.17 -50.4 33.67 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.801 0.84 . . . . 70.34 110.435 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.515 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -63.56 -35.34 80.17 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.303 -0.862 . . . . 73.43 110.914 176.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -60.02 -50.71 72.66 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.349 1.459 . . . . 74.51 111.587 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.7 -37.94 87.86 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 123.552 0.533 . . . . 75.24 109.696 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.442 ' SG ' HG12 ' C' ' 21' ' ' ILE . 42.4 t -63.9 -34.84 78.85 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.338 0.655 . . . . 70.23 111.766 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.47 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 68.0 mt -71.04 -52.19 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.127 0.571 . . . . 73.33 110.414 174.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 35.1 m -62.74 -30.02 71.12 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.25 0.62 . . . . 72.23 111.438 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.1 t -65.97 -48.71 70.36 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.899 -0.778 . . . . 73.14 108.899 174.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.655 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.11 -37.83 81.18 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.673 1.189 . . . . 71.31 112.32 178.496 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.4 HG23 ' O ' ' C' ' 114' ' ' ILE . 93.8 t -65.68 -42.94 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.365 0.666 . . . . 63.22 110.1 177.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.0 t -70.16 -29.1 65.92 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.38 -0.827 . . . . 74.04 111.714 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -69.92 -34.61 73.7 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.324 0.65 . . . . 73.53 109.3 175.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.46 11.27 64.08 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.713 0.633 . . . . 65.52 113.108 174.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 73.0 p 56.23 24.33 8.02 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 126.276 1.83 . . . . 74.23 114.23 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -84.77 140.53 37.85 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.057 -1.09 . . . . 63.23 108.057 169.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.48 168.84 2.67 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 123.028 2.485 . . . . 71.35 114.273 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -50.69 118.71 3.27 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.79 1.236 . . . . 74.53 113.594 -171.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.04 86.57 2.45 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 106.947 -1.501 . . . . 71.34 106.947 174.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -106.08 118.82 37.61 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.642 -0.873 . . . . 73.14 108.642 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.93 133.19 47.87 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.502 0.721 . . . . 70.12 109.459 -177.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.09 152.25 96.25 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 123.355 0.662 . . . . 73.33 112.486 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.507 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 19.3 Cg_endo -61.63 106.28 0.42 Allowed 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.076 2.518 . . . . 73.14 112.712 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.12 109.73 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 108.568 -0.901 . . . . 72.54 108.568 171.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -81.71 110.83 17.41 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.837 1.255 . . . . 73.42 109.996 175.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -49.83 -45.06 49.77 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.428 0.691 . . . . 73.23 111.345 174.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -56.27 -53.82 52.66 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.743 1.217 . . . . 73.31 112.051 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.18 -25.49 61.7 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 123.431 0.692 . . . . 73.1 111.335 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 36.0 tp -69.16 -39.79 78.56 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.701 0.8 . . . . 73.45 110.697 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -65.15 -32.52 74.25 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.546 0.338 . . . . 75.04 110.27 173.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 56.3 ttp -72.13 -31.74 66.29 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.683 0.793 . . . . 64.13 110.8 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -68.03 -49.65 60.17 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.472 -0.566 . . . . 61.12 109.472 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -72.74 -104.49 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.995 0.918 . . . . 75.21 111.225 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 54.4 tp 51.88 -80.84 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.009 1.324 . . . . 73.31 111.489 -172.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -150.39 98.89 2.72 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 106.602 -1.629 . . . . 75.15 106.602 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -75.98 86.27 2.9 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.544 0.687 . . . . 75.21 110.528 -175.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -136.31 79.21 1.75 Allowed 'General case' 0 C--O 1.244 0.778 0 CA-C-N 114.551 -1.204 . . . . 74.43 107.768 177.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . 0.551 ' HB3' ' HA ' ' A' ' 5' ' ' ASN . . . -164.38 -170.97 2.21 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 114.409 -1.269 . . . . 74.3 109.16 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.46 -170.68 28.46 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 121.184 0.324 . . . . 71.11 113.767 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -112.42 146.86 37.64 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.588 0.755 . . . . 75.24 109.732 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -126.18 107.42 0.93 Allowed Glycine 0 C--N 1.342 0.88 0 CA-C-N 115.917 -0.583 . . . . 72.41 111.835 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 43.1 p -126.79 93.54 3.8 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.6 0.76 . . . . 75.42 109.252 174.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.27 131.91 42.51 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.107 0.563 . . . . 65.32 109.729 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -68.81 108.95 3.64 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.102 0.561 . . . . 74.13 109.795 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -101.59 144.15 30.69 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 116.088 -0.505 . . . . 73.35 110.587 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -81.82 107.96 14.97 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.586 -0.894 . . . . 74.43 108.586 173.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -91.73 157.83 16.71 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.899 0.48 . . . . 61.44 110.201 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.922 0 C-N-CA 123.612 0.765 . . . . 72.51 110.087 178.52 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.718 -0.475 . . . . 73.43 109.718 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' D' D ' 2' ' ' SER . . . . . 0.437 ' O ' ' HA3' ' D' ' 91' ' ' GLY . 33.3 p -147.2 65.86 1.15 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.912 0.885 . . . . 71.15 109.023 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.69 112.13 2.38 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.81 -0.811 . . . . 72.22 108.81 172.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' D' ' 90' ' ' GLU . 18.1 mm-40 -120.23 143.99 47.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.561 -0.745 . . . . 73.13 109.058 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -127.66 42.45 3.32 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.016 0.926 . . . . 74.32 109.489 -177.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -60.64 104.89 0.38 Allowed 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.156 -0.929 . . . . 64.33 109.437 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 58.9 p -64.82 -58.64 5.67 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.34 1.456 . . . . 72.23 113.595 -164.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -86.72 32.73 0.65 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.389 0.676 . . . . 74.32 112.382 -169.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 11.7 ptp -33.17 148.8 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 124.63 1.172 . . . . 73.42 113.7 163.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 49.3 m -103.56 139.9 38.25 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.468 -0.938 . . . . 75.13 108.468 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -150.35 108.7 3.78 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.976 -1.12 . . . . 74.14 107.976 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . 0.605 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 43.5 mt-30 -126.46 118.51 25.1 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.194 -1.039 . . . . 75.21 108.194 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 19.8 mt -86.76 125.98 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 109.26 -0.644 . . . . 75.53 109.26 177.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -98.23 -29.06 13.42 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.411 0.684 . . . . 71.12 111.41 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -173.05 131.49 0.5 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 111.934 0.346 . . . . 74.34 111.934 -167.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.74 136.02 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 107.366 -1.346 . . . . 74.32 107.366 167.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.43 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 40.5 p90 -164.64 175.84 9.42 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.779 0.8 . . . . 73.44 112.234 178.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.4 p -110.64 127.69 55.37 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.703 -1.135 . . . . 74.34 109.408 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.43 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 37.9 mtpt -100.38 -18.1 16.91 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.611 0.764 . . . . 73.01 110.134 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.648 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 11.4 t70 -159.27 133.51 7.68 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.575 1.15 . . . . 75.21 108.207 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.655 HG21 ' HE1' ' C' ' 117' ' ' MET . 69.5 mt -136.27 146.52 28.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 106.704 -1.591 . . . . 74.44 106.704 173.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 22' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 23.0 t -152.61 143.82 23.19 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.142 0.577 . . . . 73.32 109.767 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.3 t80 -151.41 125.87 9.46 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 105.806 -1.924 . . . . 74.23 105.806 175.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -140.65 111.48 6.99 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.243 0.617 . . . . 71.42 109.807 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.56 92.0 9.43 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 108.508 -0.923 . . . . 64.13 108.508 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.82 -30.77 2.73 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.921 2.414 . . . . 71.31 113.559 -171.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -102.62 9.07 39.56 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.092 0.957 . . . . 64.01 111.081 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.414 ' O ' HG11 ' D' ' 31' ' ' VAL . . . -30.63 -65.59 0.19 Allowed Pre-proline 0 CA--C 1.556 1.211 0 N-CA-C 117.272 2.323 . . . . 75.32 117.272 -160.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.492 ' HB3' HD11 ' C' ' 83' ' ' ILE . 87.7 Cg_endo -75.09 -29.05 8.49 Favored 'Trans proline' 0 C--N 1.378 2.102 0 CA-C-N 123.173 2.169 . . . . 72.14 113.751 -171.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -85.72 -21.63 28.19 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.598 0.237 . . . . 71.15 110.508 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.414 HG11 ' O ' ' D' ' 28' ' ' ALA . 9.7 p -82.7 -15.72 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 116.037 -0.528 . . . . 72.33 110.827 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -69.69 -22.18 63.44 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 112.5 0.556 . . . . 70.44 112.5 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -57.81 -29.28 64.78 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.637 0.732 . . . . 54.12 109.6 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.535 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 90.4 mttt -88.11 71.13 9.32 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.073 -1.421 . . . . 72.24 109.328 173.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -88.65 84.54 6.73 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.293 0.568 . . . . 61.02 109.753 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.474 ' O ' ' HG2' ' D' ' 124' ' ' PRO . 8.9 p90 -147.49 178.48 8.4 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.379 1.071 . . . . 75.51 108.578 171.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -61.12 111.94 5.01 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 123.098 0.559 . . . . 73.45 109.903 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.11 127.63 24.83 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 121.914 1.743 . . . . 73.02 111.139 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.72 112.71 2.97 Favored 'General case' 0 C--N 1.347 0.469 0 N-CA-C 108.57 -0.9 . . . . 74.23 108.57 173.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 4.5 m -108.56 143.07 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 114.751 -1.113 . . . . 73.34 110.704 -169.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.54 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 13.9 tmtt? -125.46 122.33 36.34 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.224 -1.398 . . . . 74.32 107.224 177.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.572 HD22 ' HA ' ' H' ' 6' ' ' ILE . 4.5 pp -95.75 146.48 24.5 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 121.267 0.556 . . . . 74.2 110.037 -177.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.464 ' HB2' ' HZ2' ' D' ' 41' ' ' LYS . 25.9 t70 -147.41 132.02 17.81 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.139 -1.059 . . . . 75.02 108.139 175.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -110.29 144.11 39.49 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.066 -0.716 . . . . 75.4 109.066 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.485 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.3 t70 -132.11 146.37 52.0 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.146 -1.057 . . . . 73.43 108.146 174.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 46' ' ' THR . . . . . 0.469 HG21 ' H ' ' H' ' 15' ' ' PHE . 94.5 m -105.52 144.23 32.57 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.436 0.694 . . . . 73.42 111.158 -173.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.717 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.72 154.58 35.52 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.823 0.849 . . . . 75.21 109.373 170.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 21.6 p -168.59 159.99 10.51 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.699 0.8 . . . . 61.41 109.503 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 51.9 p -160.73 140.53 10.96 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.402 0.681 . . . . 72.44 109.847 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -87.76 124.79 33.97 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.807 -0.442 . . . . 75.32 109.807 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.417 HD11 ' HB2' ' D' ' 57' ' ' GLU . 35.9 mt -95.58 -36.45 11.26 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.015 0.526 . . . . 71.2 110.165 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.85 178.7 9.81 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.303 1.041 . . . . 51.05 109.489 174.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -64.69 119.01 9.75 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.816 -0.809 . . . . 72.43 108.816 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 72.19 9.08 5.94 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 124.316 1.046 . . . . 75.12 111.723 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 90.1 t -118.45 115.1 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.21 -1.034 . . . . 73.52 108.21 171.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.46 ' HB2' HD13 ' D' ' 86' ' ' ILE . 69.8 m-85 -133.47 130.02 38.01 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.349 -0.612 . . . . 70.33 109.349 -175.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.417 ' HB2' HD11 ' D' ' 51' ' ' LEU . 12.8 tm-20 -92.58 124.7 36.8 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.619 -1.252 . . . . 75.33 107.619 174.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 84.6 t -119.98 132.49 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.336 1.054 . . . . 73.24 108.529 -169.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.717 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 14.7 t -125.0 136.73 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.263 0.625 . . . . 72.23 109.886 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 57.2 tp -125.72 118.79 26.35 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.408 -0.96 . . . . 70.54 108.408 167.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.485 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 16.9 ttm-85 -85.88 111.96 20.7 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.619 0.768 . . . . 73.22 109.497 176.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 45.8 t -91.85 128.65 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.521 -0.918 . . . . 74.21 108.521 170.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 9.9 m -122.67 134.82 54.47 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.337 -0.616 . . . . 74.4 109.337 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 57.3 t -127.18 101.53 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 125.86 1.664 . . . . 74.45 107.978 -173.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 21.4 m -92.25 94.34 9.12 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.744 -0.836 . . . . 75.32 108.744 176.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.5 141.39 30.63 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.99 -0.55 . . . . 73.44 110.377 -175.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 66.0 p -147.73 128.88 14.64 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.0 -0.546 . . . . 75.43 110.296 -178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 43.5 mt -93.46 108.83 20.45 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.965 -1.124 . . . . 72.33 107.965 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.91 -115.88 4.33 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.381 -0.827 . . . . 73.41 111.193 -171.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.29 6.15 10.71 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.731 0.812 . . . . 65.35 110.511 -174.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.535 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 11.6 pt-20 -121.59 152.83 38.83 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.905 0.882 . . . . 75.42 109.343 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 35.1 m -64.33 132.13 49.27 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.161 0.505 . . . . 73.21 111.512 -176.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.36 -60.44 1.95 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.492 -1.299 . . . . 73.04 107.492 174.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -157.19 159.38 37.67 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.332 -1.304 . . . . 74.25 110.135 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 86.8 mt -124.31 114.26 19.32 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 107.506 -1.294 . . . . 74.34 107.506 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.482 ' HG ' ' HE2' ' D' ' 117' ' ' MET . 1.2 m -114.12 135.47 53.99 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.061 -1.089 . . . . 72.11 108.061 -175.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 37.5 tt0 -156.18 121.05 4.66 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.624 -0.51 . . . . 75.4 109.624 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.5 t -135.12 116.93 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.025 0.53 . . . . 75.23 109.578 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.648 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 13.9 mt-30 -85.43 91.15 8.13 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.001 -1.111 . . . . 75.14 108.001 166.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -81.61 109.43 16.04 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.103 -1.073 . . . . 70.53 108.103 174.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.94 166.43 14.09 Favored Glycine 0 C--O 1.244 0.745 0 O-C-N 123.72 0.638 . . . . 62.12 111.993 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.89 136.49 4.2 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 112.054 -0.418 . . . . 64.4 112.054 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.8 mt -89.68 122.21 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.536 0.734 . . . . 75.54 109.102 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -130.87 125.48 33.67 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.727 0.811 . . . . 74.23 109.421 -175.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.605 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 45.5 m -89.91 96.74 10.82 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.828 0.851 . . . . 64.24 109.264 173.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.593 ' HB ' HD11 ' D' ' 89' ' ' ILE . 0.2 OUTLIER -110.79 114.92 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 123.588 0.755 . . . . 74.44 110.712 -178.118 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.41 162.47 25.5 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.783 0.833 . . . . 63.51 109.552 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.04 20.34 78.9 Favored Glycine 0 C--N 1.347 1.151 0 C-N-CA 121.783 -0.246 . . . . 71.54 112.74 178.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.593 HD11 ' HB ' ' D' ' 86' ' ' ILE . 55.8 mt -116.36 136.62 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.776 0.83 . . . . 73.23 109.137 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' D' ' 4' ' ' GLN . 9.2 pt-20 -151.05 152.36 33.34 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.433 0.693 . . . . 75.22 110.935 -170.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' D' ' 2' ' ' SER . . . 67.92 -138.9 33.76 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 115.409 -0.814 . . . . 72.32 115.006 176.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 32.1 m -62.74 -25.58 68.26 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.118 0.967 . . . . 74.12 111.557 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.423 HE21 HG23 ' D' ' 89' ' ' ILE . 21.5 tt0 -62.11 -26.61 68.39 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.53 0.732 . . . . 64.54 111.073 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.419 ' HE2' ' HB2' ' H' ' 17' ' ' PRO . 69.5 mtm -68.7 -46.56 68.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.804 0.841 . . . . 74.34 111.227 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.04 -30.13 68.43 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.31 -0.859 . . . . 75.0 110.69 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -77.42 -27.15 52.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.414 0.685 . . . . 73.3 110.98 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.8 t -72.1 -52.95 14.36 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.398 0.618 . . . . 73.24 110.278 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 24.2 mt -86.47 -19.36 29.68 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 114.62 -1.173 . . . . 73.05 110.704 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.91 3.4 57.21 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-O 119.35 -0.694 . . . . 63.14 114.16 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -144.75 -65.9 0.34 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.105 0.952 . . . . 70.44 111.566 -178.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -69.9 -45.95 66.48 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 112.373 0.508 . . . . 70.02 112.373 -173.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 84.0 m -62.94 -45.35 87.01 Favored Pre-proline 0 CA--C 1.569 1.686 0 CA-C-O 118.782 -0.627 . . . . 75.44 112.218 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -59.03 -27.66 85.65 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 122.786 2.324 . . . . 54.25 114.201 169.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -70.87 -26.51 63.29 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 122.854 0.462 . . . . 60.41 111.419 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 43.8 mm -72.02 -35.61 54.42 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-O 121.415 0.626 . . . . 73.14 109.465 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 86.0 mt -84.3 -23.3 30.36 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.058 -0.974 . . . . 63.43 112.114 -175.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 94.0 t80 -58.99 -49.1 95.16 Favored Pre-proline 0 CA--C 1.562 1.407 0 N-CA-C 113.662 0.986 . . . . 74.25 113.662 -174.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.06 -37.48 95.64 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 121.851 1.701 . . . . 75.22 113.116 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -75.9 -37.66 58.56 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.499 -0.773 . . . . 73.41 111.529 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.62 -41.39 96.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.081 0.552 . . . . 74.33 110.086 177.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.423 ' NH2' ' HA ' ' B' ' 105' ' ' ILE . 36.9 ttp180 -58.44 -53.42 58.53 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 124.214 0.946 . . . . 74.33 110.394 174.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.24 -43.26 96.25 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.187 0.929 . . . . 74.15 111.46 -174.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.8 t -59.58 -45.73 91.01 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.637 0.586 . . . . 64.33 111.081 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.43 ' O ' HG23 ' D' ' 118' ' ' VAL . 91.7 mt -64.35 -55.72 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 115.741 -0.663 . . . . 74.13 110.415 177.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 57.6 m -52.79 -40.36 63.14 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.693 1.197 . . . . 73.41 111.753 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.5 t -69.42 -42.39 75.08 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.33 -0.85 . . . . 63.54 110.075 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.482 ' HE2' ' HG ' ' D' ' 76' ' ' CYS . 75.8 mtm -64.85 -34.34 78.14 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.906 0.482 . . . . 62.41 111.482 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.43 HG23 ' O ' ' D' ' 114' ' ' ILE . 93.6 t -63.68 -47.8 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.538 0.735 . . . . 70.51 110.002 176.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.2 p -71.78 -27.33 62.88 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.918 -0.583 . . . . 61.22 110.93 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 74.7 mtt-85 -73.67 -29.29 62.22 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.462 0.705 . . . . 74.44 109.834 173.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.85 3.78 85.88 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 119.523 -0.598 . . . . 32.05 112.723 174.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 44.7 p 60.19 24.98 14.33 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 126.401 1.88 . . . . 73.22 113.733 177.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -89.09 156.43 49.03 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.282 0.633 . . . . 73.43 109.764 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.474 ' HG2' ' O ' ' D' ' 36' ' ' TRP . 71.5 Cg_exo -49.23 123.54 10.27 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.368 2.712 . . . . 73.04 113.338 171.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -53.87 141.17 28.2 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.749 1.22 . . . . 73.35 112.205 -177.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -121.3 116.97 25.85 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.493 -1.299 . . . . 71.42 107.493 -177.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -112.25 103.5 11.64 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.389 0.676 . . . . 73.41 109.513 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.1 116.22 10.2 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.049 0.539 . . . . 73.25 110.558 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.49 143.46 97.86 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.232 0.613 . . . . 62.42 110.28 175.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.72 123.17 13.17 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.082 2.521 . . . . 74.31 112.832 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 98.6 t -107.71 112.86 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.634 0.774 . . . . 73.35 108.941 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . 0.427 ' ND2' ' HB1' ' D' ' 135' ' ' ALA . 44.9 t30 -81.71 89.02 6.24 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.089 -1.078 . . . . 73.45 108.089 172.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.481 ' HZ ' HD21 ' H' ' 11' ' ' LEU . 0.9 OUTLIER -64.82 -22.97 67.1 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.874 -1.057 . . . . 75.43 111.011 -176.495 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.478 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 7.8 m-20 -61.3 -48.52 81.01 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.33 0.652 . . . . 74.51 111.185 172.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.427 ' HB1' ' ND2' ' D' ' 132' ' ' ASN . . . -62.49 -43.68 98.23 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.457 0.703 . . . . 72.31 111.559 -176.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 84.7 mt -57.79 -36.21 71.87 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.154 0.909 . . . . 72.51 111.485 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -81.77 -37.01 27.85 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.731 0.812 . . . . 73.32 111.657 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.448 ' HA ' ' HB2' ' D' ' 141' ' ' LEU . 75.8 mtm -70.06 -15.2 62.96 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.816 0.446 . . . . 72.51 110.887 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -62.72 -43.52 98.59 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.501 0.72 . . . . 71.42 110.757 169.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -65.15 -42.02 94.19 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.185 0.594 . . . . 72.43 110.13 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.448 ' HB2' ' HA ' ' D' ' 138' ' ' MET . 10.9 mp -62.2 -36.07 80.79 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.114 0.566 . . . . 74.41 111.545 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -90.71 36.32 0.9 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.504 0.668 . . . . 61.21 111.823 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -117.72 79.24 1.33 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 107.79 -1.189 . . . . 74.54 107.79 173.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -166.7 134.85 2.72 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.488 -1.233 . . . . 72.35 107.996 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . 0.488 ' H ' HG23 ' D' ' 149' ' ' THR . . . -159.72 15.77 0.15 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.738 0.815 . . . . 61.14 110.447 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 69.01 -86.12 0.22 Allowed Glycine 0 C--N 1.351 1.414 0 N-CA-C 112.17 -0.372 . . . . 62.53 112.17 -172.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.27 154.33 17.58 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.447 0.699 . . . . 75.21 110.126 176.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.02 -76.85 1.02 Allowed Glycine 0 C--N 1.352 1.459 0 O-C-N 123.532 0.52 . . . . 65.12 112.466 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 149' ' ' THR . . . . . 0.488 HG23 ' H ' ' D' ' 145' ' ' ALA . 60.1 p 60.72 -75.66 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.757 2.023 . . . . 73.23 113.474 174.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -151.34 -161.34 1.31 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.669 1.188 . . . . 72.31 108.598 -175.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.94 -173.83 4.94 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.684 0.394 . . . . 71.01 110.941 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -70.71 107.32 3.89 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.993 -0.549 . . . . 74.51 110.158 173.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -86.66 140.52 29.73 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.517 -0.549 . . . . 74.32 109.517 174.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -70.49 85.35 0.61 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.471 0.708 . . . . 63.34 109.655 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 C-N-CA 124.093 0.957 . . . . 73.3 109.245 -177.281 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' E' E ' 1' ' ' MET . . . . . 0.437 ' N ' ' SD ' ' E' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.111 -0.7 . . . . 72.54 109.111 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -140.46 129.87 23.94 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.619 0.768 . . . . 74.2 109.904 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -115.66 115.13 25.85 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.699 -1.223 . . . . 75.34 107.699 174.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -112.92 158.97 19.56 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.057 0.543 . . . . 63.51 111.12 -175.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 36.8 m -139.31 152.44 47.22 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.052 0.941 . . . . 61.54 109.129 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.433 HD11 HG12 ' A' ' 40' ' ' VAL . 38.0 pt -59.92 145.55 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 123.813 0.845 . . . . 73.05 112.583 176.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 7' ' ' ALA . . . . . 0.542 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . . . -154.99 158.52 39.3 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.972 0.909 . . . . 75.23 109.565 175.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . 0.708 ' HB2' HG13 ' A' ' 131' ' ' VAL . 78.9 mt -80.05 174.41 11.62 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.859 0.464 . . . . 74.45 110.129 177.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.04 176.66 7.45 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.641 0.776 . . . . 64.52 109.348 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . 0.425 ' HB2' HD21 ' A' ' 136' ' ' LEU . 55.2 tp -61.54 129.89 43.33 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.897 0.479 . . . . 74.33 110.202 178.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.702 ' HB2' HD22 ' E' ' 14' ' ' LEU . 4.4 mp -68.35 119.69 69.78 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 108.837 -0.801 . . . . 73.43 108.837 -178.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -82.64 34.66 0.55 Allowed 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.854 2.369 . . . . 64.24 112.187 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 tt -158.83 -44.6 0.06 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.909 -1.145 . . . . 75.2 107.909 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . 0.702 HD22 ' HB2' ' E' ' 11' ' ' LEU . 58.2 mt 66.14 -167.77 0.21 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.549 1.14 . . . . 74.02 110.876 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . 0.485 ' HB3' ' HD3' ' E' ' 17' ' ' PRO . 83.4 m-85 -101.32 158.91 15.7 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.336 0.654 . . . . 74.24 110.418 174.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 16.7 p -143.43 62.3 11.09 Favored Pre-proline 0 CA--C 1.568 1.635 0 C-N-CA 123.913 0.885 . . . . 65.01 110.623 172.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 17' ' ' PRO . . . . . 0.555 ' HD2' HD23 ' A' ' 98' ' ' LEU . 74.6 Cg_endo -77.32 -27.84 6.19 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 122.205 1.936 . . . . 74.44 112.462 176.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 19.2 t -103.14 -29.62 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 123.501 0.72 . . . . 63.41 110.347 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 9.1 m 65.79 167.36 0.2 Allowed 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 124.705 1.202 . . . . 72.4 110.728 -172.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 50.7 tptt 68.83 20.34 8.06 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.234 1.016 . . . . 75.53 109.68 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.36 -75.34 0.27 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.723 -1.126 . . . . 74.12 109.382 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.97 -85.58 0.29 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 107.879 -1.156 . . . . 73.52 107.879 177.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 20.3 m 51.8 103.48 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 125.146 1.378 . . . . 73.12 112.821 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.64 -74.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.079 1.853 . . . . 73.43 110.693 175.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 . . . . . 0 C--O 1.248 0.984 0 N-CA-C 107.79 -1.189 . . . . 73.44 107.79 173.885 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 109.693 -0.484 . . . . 75.23 109.693 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -146.48 -91.83 0.09 Allowed 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 108.681 -0.859 . . . . 74.44 108.681 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -124.92 -57.57 1.52 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.202 -1.036 . . . . 74.41 108.202 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -86.98 51.9 2.37 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.259 -0.882 . . . . 74.42 110.017 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 37.6 m -65.39 -58.99 4.51 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 123.829 0.852 . . . . 71.42 109.551 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . 0.464 HG21 ' HB ' ' B' ' 40' ' ' VAL . 4.8 pt -145.44 -60.13 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 114.1 -1.409 . . . . 71.13 108.311 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 7' ' ' ALA . . . . . 0.462 ' H ' HG13 ' F' ' 6' ' ' ILE . . . 59.31 158.68 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.313 1.445 . . . . 75.24 113.054 -176.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . 0.773 HD11 HD22 ' B' ' 44' ' ' LEU . 60.4 mt -85.25 21.31 1.73 Allowed 'General case' 0 N--CA 1.482 1.146 0 O-C-N 121.878 -0.514 . . . . 75.12 112.164 -176.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . 66.98 -76.01 0.05 Allowed 'General case' 0 C--N 1.362 1.152 0 C-N-CA 126.011 1.724 . . . . 73.43 111.926 176.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 10' ' ' LEU . . . . . 0.461 ' HG ' HD23 ' B' ' 136' ' ' LEU . 7.0 tt -156.27 -56.1 0.09 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.311 -1.366 . . . . 75.4 107.311 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 2.7 tm? 63.36 103.76 0.03 OUTLIER Pre-proline 0 C--N 1.361 1.1 0 C-N-CA 125.226 1.41 . . . . 70.45 110.436 -173.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 12' ' ' PRO . . . . . 0.441 ' HA ' ' HZ ' ' B' ' 137' ' ' PHE . 20.9 Cg_exo -67.21 121.72 8.9 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.398 2.065 . . . . 63.54 110.645 170.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 pp -76.59 80.95 3.26 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-O 122.332 1.063 . . . . 75.33 111.955 -175.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 37.7 mt -100.77 30.55 3.95 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.671 -0.695 . . . . 75.33 110.957 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . 0.596 ' HZ ' HD11 ' B' ' 60' ' ' LEU . 70.4 m-85 -70.0 143.32 52.61 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.902 0.881 . . . . 75.11 110.03 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 16' ' ' THR . . . . . 0.489 ' HB ' ' HB2' ' B' ' 48' ' ' SER . 32.3 m -70.6 130.48 88.86 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.021 0.528 . . . . 75.34 110.259 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 17' ' ' PRO . . . . . 0.548 ' HA ' HD22 ' B' ' 98' ' ' LEU . 52.2 Cg_endo -64.96 167.74 15.24 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 123.308 2.672 . . . . 74.24 114.314 -177.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . 0.59 HG22 HG23 ' B' ' 86' ' ' ILE . 29.5 t -60.23 -44.29 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 114.678 -1.147 . . . . 71.42 109.394 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 8.8 t -162.94 121.32 2.06 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 114.722 -1.127 . . . . 74.41 109.499 168.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 56.1 tptt 60.39 -81.88 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.881 1.673 . . . . 72.0 112.913 174.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . 0.567 ' HB3' ' SD ' ' B' ' 94' ' ' MET . . . 52.67 -78.28 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.195 1.398 . . . . 74.42 112.225 -178.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -146.37 -30.12 0.38 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.435 1.094 . . . . 74.34 109.753 166.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 27.9 m 61.56 92.81 0.06 OUTLIER Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 125.083 1.353 . . . . 75.42 111.335 -175.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.92 105.01 0.89 Allowed 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.525 2.15 . . . . 71.45 111.32 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 . . . . . 0 C--O 1.258 1.52 0 C-N-CA 124.095 0.958 . . . . 73.54 109.516 178.631 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtt . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 109.354 -0.61 . . . . 74.11 109.354 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -81.82 66.94 7.61 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.246 0.619 . . . . 75.11 109.826 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -83.36 97.13 8.77 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.15 0.5 . . . . 75.14 109.684 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 40.8 m -132.24 164.55 26.14 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.478 1.111 . . . . 65.31 108.582 174.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 22.7 m -60.57 -59.81 4.8 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.937 -0.394 . . . . 75.23 109.937 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . . . . . . . . . 13.1 pt -147.97 156.93 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.888 0.875 . . . . 71.12 110.3 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.77 139.11 24.86 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.067 -0.97 . . . . 73.34 108.484 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 8' ' ' LEU . . . . . 0.474 HD22 HD22 ' C' ' 42' ' ' LEU . 53.0 mt -70.59 148.39 48.19 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.321 0.388 . . . . 72.41 110.135 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.48 163.2 27.3 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.83 0.452 . . . . 74.14 111.164 176.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -86.33 39.58 0.83 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 123.349 0.66 . . . . 75.51 110.364 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 11' ' ' LEU . . . . . 0.432 ' HB2' HD21 ' G' ' 14' ' ' LEU . 71.4 mt 55.62 95.15 0.05 OUTLIER Pre-proline 0 C--N 1.368 1.395 0 C-N-CA 125.56 1.544 . . . . 75.32 111.672 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -55.26 -56.25 2.48 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 123.833 3.022 . . . . 73.33 113.932 -166.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 40.1 tp -93.22 -16.4 24.85 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.996 0.518 . . . . 72.33 110.983 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . 0.432 HD21 ' HB2' ' G' ' 11' ' ' LEU . 59.1 mt 68.06 167.4 0.26 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.901 1.28 . . . . 74.12 111.059 -171.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -84.78 142.15 30.01 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.138 -0.69 . . . . 74.43 109.138 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 41.6 p -66.82 124.89 89.75 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 123.633 0.773 . . . . 72.14 111.715 -172.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 17' ' ' PRO . . . . . 0.402 ' HB3' ' H ' ' G' ' 21' ' ' ALA . 98.3 Cg_exo -48.16 123.51 8.96 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 123.726 2.95 . . . . 74.53 114.189 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 18' ' ' VAL . . . . . . . . . . . . . 54.3 t -54.19 -55.23 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 124.183 0.993 . . . . 74.35 109.833 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 3.4 t -154.92 101.97 2.31 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.246 -1.343 . . . . 75.5 108.379 171.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 20' ' ' LYS . . . . . 0.506 ' HZ1' ' HB3' ' G' ' 20' ' ' LYS . 5.7 ttpm? 55.05 33.65 20.79 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 125.06 1.344 . . . . 74.41 112.354 175.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . 0.456 ' HB3' ' HE3' ' C' ' 94' ' ' MET . . . -75.54 81.14 2.56 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.14 0.576 . . . . 74.33 110.944 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -162.32 -52.94 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.838 1.255 . . . . 74.53 109.746 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 23.0 p -136.54 107.37 9.22 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 123.953 0.901 . . . . 64.55 109.99 -174.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 24' ' ' PRO . . . . . 0.42 ' HD3' ' H ' ' C' ' 92' ' ' THR . 95.2 Cg_endo -94.77 78.54 0.16 Allowed 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.703 2.936 . . . . 74.04 112.108 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 CA--C 1.554 1.101 0 C-N-CA 123.748 0.819 . . . . 64.51 110.109 -176.458 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 N-CA-C 109.948 -0.39 . . . . 72.42 109.948 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -131.94 159.13 39.58 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.658 0.783 . . . . 74.24 110.386 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -68.34 -34.8 76.74 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.533 -0.758 . . . . 74.21 109.435 167.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 24.3 m -83.12 85.2 7.23 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.033 -0.985 . . . . 71.44 109.469 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 61.8 m -138.38 155.51 48.45 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.666 1.187 . . . . 75.4 108.101 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . 0.572 ' HA ' HD22 ' D' ' 42' ' ' LEU . 16.0 tt -74.21 82.34 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 CA-C-O 123.49 1.614 . . . . 75.55 110.121 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.01 28.03 0.94 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 113.928 -1.487 . . . . 63.3 109.341 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 5.5 tt 61.2 112.98 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.037 1.335 . . . . 74.51 110.277 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.62 -87.32 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 122.604 0.361 . . . . 54.25 111.061 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 tt -170.32 126.59 0.79 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.734 -0.839 . . . . 75.31 108.734 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . 0.483 ' HB3' HD21 ' H' ' 14' ' ' LEU . 10.6 mp -96.01 128.32 37.66 Favored Pre-proline 0 N--CA 1.483 1.197 0 N-CA-C 108.9 -0.778 . . . . 72.41 108.9 172.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -42.27 -65.16 0.2 Allowed 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 123.85 3.033 . . . . 64.11 113.415 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 37.6 mt -149.69 -63.37 0.22 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.422 1.089 . . . . 75.22 108.234 168.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' H' ' 11' ' ' LEU . 3.8 mm? 58.95 -170.45 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.22 0.608 . . . . 74.23 111.219 -177.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . 0.469 ' H ' HG21 ' D' ' 46' ' ' THR . 80.9 m-85 64.47 -178.46 0.17 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.429 1.091 . . . . 74.51 112.711 176.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 43.0 p -117.3 158.02 45.7 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-N 115.271 -0.877 . . . . 72.41 109.995 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 17' ' ' PRO . . . . . 0.419 ' HB2' ' HE2' ' D' ' 94' ' ' MET . 93.7 Cg_endo -75.71 -152.02 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.994 0 C-N-CA 122.796 2.33 . . . . 74.04 112.639 174.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 49.9 t -128.38 154.62 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.461 -1.311 . . . . 75.5 107.461 175.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 84.1 m 66.39 95.1 0.06 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.645 1.178 . . . . 63.51 109.417 -165.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt 53.05 67.59 0.97 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.676 1.191 . . . . 72.23 111.185 -172.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.46 -61.44 1.91 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.015 -0.993 . . . . 71.42 111.135 -176.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -58.04 4.74 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.573 -0.899 . . . . 74.53 108.573 -175.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 18.4 m 48.07 74.03 0.89 Allowed Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 124.671 1.188 . . . . 71.12 111.808 -176.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -80.69 -5.99 13.33 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.084 2.523 . . . . 74.13 113.136 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 CA--C 1.556 1.176 0 C-N-CA 124.009 0.924 . . . . 64.21 109.675 -177.686 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 109.932 -0.396 . . . . 74.03 109.932 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.0 t -63.15 133.04 53.73 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.863 0.865 . . . . 72.21 110.559 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.05 41.72 1.08 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.885 0.874 . . . . 72.3 111.241 -174.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -64.7 94.59 0.13 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.566 0.746 . . . . 73.3 110.305 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -113.4 165.07 12.81 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.823 -1.081 . . . . 72.44 108.937 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 67.39 86.49 0.13 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.571 1.149 . . . . 72.34 110.036 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.8 p -125.55 -49.98 1.64 Allowed 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.373 1.069 . . . . 72.45 109.075 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -94.49 179.98 5.09 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.969 -1.014 . . . . 74.22 110.606 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.3 ttt 73.81 155.92 0.17 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 125.16 1.384 . . . . 64.32 111.574 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 56.2 m -137.16 101.36 4.52 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.621 -1.251 . . . . 74.03 107.621 175.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.59 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 20.5 t80 -98.92 127.53 44.86 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.314 -1.312 . . . . 70.41 109.296 -176.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -146.72 115.02 6.66 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.912 -0.773 . . . . 74.33 108.912 176.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.688 HG12 ' HD2' ' A' ' 84' ' ' PHE . 32.8 mt -84.38 115.33 26.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.79 -0.818 . . . . 73.33 108.79 176.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -75.77 -33.56 60.2 Favored 'General case' 0 C--O 1.242 0.684 0 O-C-N 123.687 0.617 . . . . 71.05 110.816 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -171.51 148.04 2.46 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.329 0.393 . . . . 74.51 110.912 -170.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.458 HD13 ' HB3' ' C' ' 130' ' ' PRO . 87.6 mt -138.68 133.84 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 107.983 -1.117 . . . . 71.5 107.983 172.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -164.32 157.38 17.57 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.147 0.979 . . . . 75.44 110.701 -171.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -84.42 113.18 20.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.888 -1.051 . . . . 62.44 108.636 177.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 32.7 mtpt -82.27 -31.86 29.88 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.844 0.354 . . . . 74.03 110.287 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.8 t70 -137.45 137.94 39.26 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.392 -0.822 . . . . 74.13 109.634 171.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 64.5 mt -127.23 139.98 50.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 C-N-CA 124.973 1.309 . . . . 75.02 107.535 171.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.9 t -150.45 128.17 11.64 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 123.822 0.701 . . . . 63.05 109.56 173.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 83.2 t80 -129.89 121.85 27.49 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 106.849 -1.537 . . . . 74.1 106.849 172.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 47.2 mt-10 -127.05 112.78 15.61 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.929 0.492 . . . . 62.3 110.0 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.5 81.77 4.33 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 107.287 -1.375 . . . . 72.22 107.287 169.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.43 -16.38 19.31 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.728 2.285 . . . . 65.12 112.599 -171.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -113.01 12.84 19.35 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.381 1.072 . . . . 71.22 110.567 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.35 -59.33 2.37 Favored Pre-proline 0 C--N 1.37 1.468 0 CA-C-O 117.337 -1.316 . . . . 73.32 114.38 -165.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -53.72 -45.23 42.59 Favored 'Trans proline' 0 C--N 1.39 2.737 0 C-N-CA 121.934 1.756 . . . . 75.44 113.881 -174.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -97.75 -14.12 21.02 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.105 0.78 . . . . 72.43 113.105 -170.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.613 HG22 ' HA ' ' A' ' 73' ' ' ALA . 8.0 p -75.46 -22.21 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-N 118.288 0.495 . . . . 74.43 111.341 -175.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -65.85 -22.24 66.52 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.23 0.612 . . . . 73.52 111.124 173.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -80.68 -19.53 44.98 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.143 0.977 . . . . 75.54 111.079 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.429 ' NZ ' ' HB2' ' A' ' 71' ' ' GLU . 31.8 mmtp -81.62 155.02 25.85 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.707 0.803 . . . . 70.45 111.453 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.59 132.37 49.61 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.094 0.958 . . . . 63.32 110.296 174.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -81.59 85.68 6.5 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.012 0.525 . . . . 75.13 110.196 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -121.82 82.25 42.23 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 107.509 -1.293 . . . . 73.43 107.509 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -75.14 115.18 4.19 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 122.435 2.09 . . . . 72.24 111.948 -172.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -91.95 96.53 10.43 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.091 -1.818 . . . . 71.4 106.091 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.587 HG11 HG12 ' E' ' 6' ' ' ILE . 15.9 m -66.5 90.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.615 0 CA-C-O 122.69 1.233 . . . . 74.55 110.3 -175.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.527 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 54.2 tptt -96.85 110.69 23.13 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.541 -1.651 . . . . 74.54 106.541 175.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.493 HD21 ' H ' ' A' ' 42' ' ' LEU . 2.0 pt? -110.37 147.14 34.56 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.875 -0.417 . . . . 71.13 109.875 -172.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.561 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 13.5 t70 -130.91 129.11 41.81 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.295 -1.372 . . . . 74.44 107.295 177.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -126.57 129.52 48.73 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.108 0.563 . . . . 72.02 109.564 -174.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -152.33 163.06 40.24 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.184 0.994 . . . . 74.12 108.852 -177.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.2 m -147.39 144.11 28.46 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.429 0.692 . . . . 71.22 110.804 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.52 122.22 25.77 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.171 -1.418 . . . . 74.4 107.171 173.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.68 ' HB2' ' HB3' ' E' ' 17' ' ' PRO . 66.5 p -131.52 153.5 49.75 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.727 0.299 . . . . 65.31 110.851 -173.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.8 t -155.74 146.83 22.43 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.744 0.818 . . . . 72.52 109.966 -173.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -76.53 141.26 41.27 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.905 -0.776 . . . . 74.35 108.905 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.463 HD13 ' HB2' ' A' ' 57' ' ' GLU . 69.0 mt -113.73 -39.54 4.0 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.095 0.958 . . . . 75.34 109.605 176.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.96 -170.48 3.41 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.242 0.617 . . . . 75.35 110.296 -177.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -60.9 108.33 0.85 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.564 0.746 . . . . 73.34 110.059 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 65.01 7.13 3.82 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.69 1.196 . . . . 73.01 112.79 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.3 t -98.93 116.32 41.66 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 N-CA-C 107.239 -1.393 . . . . 73.25 107.239 178.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.605 ' HB3' ' HB2' ' E' ' 17' ' ' PRO . 67.5 m-85 -131.81 128.67 39.22 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.173 0.989 . . . . 75.1 109.391 -172.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.463 ' HB2' HD13 ' A' ' 51' ' ' LEU . 38.3 tt0 -87.33 131.42 34.27 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.588 0.755 . . . . 73.4 109.743 172.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.464 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 98.3 t -118.77 116.18 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.156 -1.053 . . . . 60.43 108.156 171.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.543 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 35.6 t -101.31 117.76 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 109.044 -0.724 . . . . 63.42 109.044 175.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.39 113.77 26.68 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.252 -0.647 . . . . 75.12 109.252 -176.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -82.6 101.99 11.14 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.668 -0.864 . . . . 75.52 108.668 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.6 t -100.14 102.6 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 107.404 -1.332 . . . . 74.11 107.404 170.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 37.2 m -106.59 135.92 47.27 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.935 0.894 . . . . 54.12 109.715 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.553 HG12 HD23 ' A' ' 126' ' ' LEU . 40.5 t -130.98 126.6 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.765 1.226 . . . . 75.23 108.753 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 10.8 m -112.44 135.33 53.27 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.545 -0.909 . . . . 74.43 108.545 174.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.92 105.63 14.87 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.364 -1.346 . . . . 65.11 107.364 170.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.7 m -107.1 133.81 51.15 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.903 -1.147 . . . . 74.3 107.903 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.513 HD13 ' HB1' ' A' ' 73' ' ' ALA . 52.7 mt -103.48 47.87 0.87 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.413 -0.958 . . . . 72.52 108.413 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.18 -84.44 1.35 Allowed Glycine 0 C--N 1.342 0.881 0 N-CA-C 110.848 -0.901 . . . . 74.12 110.848 -170.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -90.69 -31.41 16.6 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.615 0.766 . . . . 73.41 111.588 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.429 ' HB2' ' NZ ' ' A' ' 34' ' ' LYS . 3.8 tp10 -115.9 112.69 22.27 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 116.282 -0.417 . . . . 63.11 110.294 -162.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.2 m -70.73 119.57 15.08 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.881 -0.414 . . . . 74.25 109.881 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.613 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -70.01 -58.56 3.69 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 114.951 -1.022 . . . . 75.33 109.52 175.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -155.68 171.57 19.77 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.141 -0.936 . . . . 72.1 112.528 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 28.0 tp -141.31 107.63 5.26 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 113.701 -1.59 . . . . 73.33 107.754 175.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.0 m -106.39 101.68 11.14 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.373 1.069 . . . . 52.44 110.556 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -116.43 117.3 29.55 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.918 0.887 . . . . 73.23 109.292 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.0 t -131.07 110.45 18.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 123.818 0.847 . . . . 75.25 109.326 -174.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 69.9 mt-30 -85.92 88.52 7.58 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.811 -0.811 . . . . 63.35 108.811 171.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -80.46 100.47 8.53 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.347 -0.842 . . . . 64.51 109.537 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.29 144.94 19.45 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 111.678 -0.569 . . . . 64.42 111.678 176.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.98 127.48 2.8 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.408 -0.677 . . . . 53.31 111.408 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.3 mt -85.2 124.75 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.629 0.772 . . . . 75.32 108.946 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.688 ' HD2' HG12 ' A' ' 13' ' ' ILE . 12.5 m-85 -133.41 159.87 39.04 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.111 0.564 . . . . 73.02 109.557 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.0 p -111.24 114.18 27.19 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.063 -0.718 . . . . 62.52 109.063 170.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.6 HG12 HD21 ' A' ' 98' ' ' LEU . 4.1 mp -109.73 117.57 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 107.754 -1.202 . . . . 73.43 107.754 175.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.54 137.15 7.73 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.905 0.882 . . . . 74.12 109.225 -174.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 140.55 -74.51 0.36 Allowed Glycine 0 C--N 1.341 0.845 0 O-C-N 123.392 0.433 . . . . 75.21 112.068 176.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.2 tt -149.84 144.16 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 122.749 0.42 . . . . 72.2 110.855 -170.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.475 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 5.6 mp0 -104.3 -152.97 0.47 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.796 1.238 . . . . 74.0 109.539 -176.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.38 -140.51 29.63 Favored Glycine 0 C--N 1.355 1.614 0 CA-C-O 119.923 -0.376 . . . . 73.21 112.812 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.5 p -67.6 -26.04 66.07 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.775 0.83 . . . . 72.25 111.832 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -68.07 -51.73 43.25 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.038 0.935 . . . . 74.32 110.373 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.475 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 53.5 ttp -70.82 -25.75 62.99 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 122.315 0.246 . . . . 74.32 111.317 176.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.07 -30.47 71.0 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 120.909 0.385 . . . . 75.54 110.682 175.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.423 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 58.9 t-80 -83.76 -37.16 22.98 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.774 -0.648 . . . . 74.41 111.071 176.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 74.3 m -77.75 -64.29 1.19 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 122.724 0.41 . . . . 52.2 111.104 -177.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.6 HD21 HG12 ' A' ' 86' ' ' ILE . 3.2 tm? -72.92 -39.75 66.05 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.883 0.873 . . . . 71.35 110.867 -175.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.82 0.44 76.56 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-O 119.378 -0.679 . . . . 74.31 114.672 -171.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 96' ' ' HIS . . . -146.55 -50.61 0.21 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.113 0.957 . . . . 71.21 112.43 -172.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.476 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 65.1 t80 -76.21 -49.99 15.71 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.556 0.743 . . . . 74.4 111.994 -174.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.2 m -68.47 -34.27 5.49 Favored Pre-proline 0 CA--C 1.568 1.667 0 N-CA-C 113.435 0.902 . . . . 73.32 113.435 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -50.93 -44.36 42.3 Favored 'Trans proline' 0 C--N 1.396 3.065 0 C-N-CA 122.68 2.254 . . . . 72.53 112.954 162.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -70.2 -22.41 62.93 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 114.846 -1.07 . . . . 73.42 111.614 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.1 mm -70.31 -43.93 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 123.299 0.64 . . . . 74.42 110.714 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 88.9 mt -76.31 -19.31 58.38 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.804 -0.634 . . . . 75.31 111.596 -176.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -64.33 -48.33 76.08 Favored Pre-proline 0 CA--C 1.568 1.657 0 N-CA-C 114.153 1.168 . . . . 74.41 114.153 -172.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.28 -34.48 67.29 Favored 'Trans proline' 0 C--N 1.388 2.649 0 CA-C-N 122.035 1.763 . . . . 71.41 112.754 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.444 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 86.4 m-85 -69.2 -45.17 70.56 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.607 0.763 . . . . 73.32 111.435 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.2 -37.83 78.29 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.963 -0.562 . . . . 74.24 110.716 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -60.68 -45.6 93.55 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 124.004 0.815 . . . . 75.04 109.641 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -66.14 -44.56 83.82 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.651 0.78 . . . . 75.54 111.5 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -60.21 -42.21 94.65 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.532 0.52 . . . . 74.41 110.107 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 59.0 mt -59.53 -52.56 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 124.082 0.953 . . . . 74.23 110.5 172.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.407 HG22 ' HE2' ' C' ' 109' ' ' TYR . 94.9 m -54.58 -46.7 73.78 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.472 1.109 . . . . 75.33 111.969 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 44.3 t -70.41 -34.53 72.63 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.331 -0.849 . . . . 71.14 111.22 -176.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.404 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 9.3 mtp -67.44 -40.53 85.44 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.318 0.647 . . . . 75.31 110.863 175.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 51.4 t -62.92 -51.1 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.695 1.198 . . . . 75.45 110.799 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.4 p -68.35 -29.24 67.92 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.356 0.662 . . . . 73.42 111.373 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.602 ' HG2' ' HG1' ' B' ' 18' ' ' THR . 18.5 ttm-85 -74.31 -30.28 61.99 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.207 1.003 . . . . 74.41 110.042 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.441 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.93 11.6 59.6 Favored Glycine 0 C--N 1.353 1.522 0 CA-C-N 115.23 -0.895 . . . . 73.41 112.603 172.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.441 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.0 OUTLIER 66.17 11.59 7.95 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 127.025 2.13 . . . . 72.41 113.148 175.532 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -78.64 148.99 74.07 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 123.263 0.625 . . . . 75.03 109.722 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.02 158.81 41.56 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.622 2.215 . . . . 73.32 112.34 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.403 ' OE1' HG23 ' A' ' 115' ' ' THR . 6.1 tp-100 -58.77 132.56 54.25 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.546 1.138 . . . . 61.21 112.829 -167.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.553 HD23 HG12 ' A' ' 64' ' ' VAL . 51.9 tp -129.31 110.74 12.19 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.986 1.314 . . . . 65.43 109.726 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -129.8 121.16 26.25 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.65 0.78 . . . . 71.03 108.957 172.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.449 ' HG ' HG21 ' E' ' 6' ' ' ILE . 6.4 mp -71.83 147.0 47.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.615 0.366 . . . . 73.31 110.649 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.76 140.47 96.33 Favored Pre-proline 0 CA--C 1.554 1.124 0 O-C-N 123.771 0.669 . . . . 71.3 110.86 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.31 133.21 42.21 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 123.265 2.643 . . . . 52.53 112.125 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 m -127.1 113.95 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 121.666 0.746 . . . . 65.33 110.391 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -87.88 96.89 10.65 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.242 -1.022 . . . . 75.11 108.242 168.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -57.12 -40.27 76.78 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 123.879 0.737 . . . . 72.42 110.474 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -62.67 -41.75 99.24 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.299 -1.319 . . . . 71.43 112.28 -177.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.8 88.83 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.069 0.548 . . . . 71.3 110.905 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.634 ' HB2' HD22 ' E' ' 10' ' ' LEU . 85.8 mt -74.1 -29.31 61.78 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.807 -0.633 . . . . 72.02 110.984 178.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -71.4 -31.75 67.63 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.029 0.532 . . . . 72.42 110.544 173.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 33.6 mmt -71.97 -38.03 69.81 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.103 0.561 . . . . 72.44 110.309 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -62.11 -44.5 96.51 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 123.841 0.713 . . . . 73.23 109.744 175.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -65.45 -41.39 93.47 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.081 0.952 . . . . 74.22 110.983 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.8 tp -67.74 -14.58 63.07 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.118 0.967 . . . . 72.32 112.232 -174.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -146.33 30.45 1.03 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.466 0.651 . . . . 73.01 110.003 -176.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -64.4 94.12 0.11 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.777 1.231 . . . . 73.15 111.655 -176.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -137.19 110.63 7.96 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.912 0.885 . . . . 74.42 109.384 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 66.84 -75.69 0.06 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.374 1.47 . . . . 71.31 111.843 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.85 62.85 2.87 Favored Glycine 0 C--N 1.344 1.01 0 N-CA-C 111.268 -0.733 . . . . 42.13 111.268 -174.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -74.44 -28.93 61.27 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.457 1.103 . . . . 73.52 112.525 -170.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -79.5 70.81 2.78 Favored Glycine 0 C--N 1.347 1.192 0 O-C-N 123.248 0.342 . . . . 75.32 112.653 -177.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.1 t -144.33 153.91 42.48 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.769 0.827 . . . . 74.31 110.7 -174.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -77.78 144.78 36.85 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.363 0.665 . . . . 72.33 110.371 177.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -83.99 144.62 29.01 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.168 0.987 . . . . 75.34 110.804 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -92.43 153.15 19.31 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.264 1.026 . . . . 73.33 109.57 176.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -93.38 -37.44 11.99 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.204 0.602 . . . . 72.1 110.502 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -117.9 147.4 43.14 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.489 1.116 . . . . 73.23 109.622 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 C-N-CA 123.685 0.794 . . . . 74.23 109.43 176.743 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.507 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 108.835 -0.802 . . . . 73.35 108.835 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 69.6 p -161.28 -174.4 4.3 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.85 0.86 . . . . 75.22 110.219 174.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -136.57 124.56 22.83 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.452 -0.944 . . . . 73.12 108.452 173.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -92.96 -67.27 0.87 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.572 0.749 . . . . 70.02 109.161 -176.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 168.73 -30.9 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.968 1.707 . . . . 75.23 107.359 -174.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.53 64.93 0.57 Allowed 'General case' 0 C--N 1.364 1.201 0 C-N-CA 124.97 1.308 . . . . 74.25 111.118 172.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.6 p -135.38 161.94 34.01 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.596 -1.183 . . . . 63.41 110.366 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 63.32 -77.69 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.889 1.676 . . . . 75.11 111.96 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.546 ' HE1' HG21 ' B' ' 86' ' ' ILE . 1.9 tmt? 66.01 161.01 0.14 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.824 1.65 . . . . 74.05 111.766 -176.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 87.6 m -169.03 139.58 2.32 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 125.078 1.351 . . . . 75.23 107.936 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.35 157.37 45.65 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.413 0.625 . . . . 75.32 110.105 157.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.475 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -124.56 131.45 53.48 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 107.185 -1.413 . . . . 74.03 107.185 175.558 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 59.7 mt -67.87 117.32 9.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.215 -1.032 . . . . 74.4 108.215 174.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . 0.438 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 11.5 mm-40 -86.9 -37.89 17.24 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 124.038 0.836 . . . . 74.25 108.745 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.421 ' HE ' HG23 ' A' ' 122' ' ' THR . 42.4 ttt180 -175.27 137.61 0.4 Allowed 'General case' 0 C--N 1.355 0.828 0 CA-C-N 115.4 -0.818 . . . . 74.33 109.606 -176.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 94.2 mt -115.49 141.51 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 107.273 -1.38 . . . . 63.53 107.273 173.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.407 ' HE2' ' HZ3' ' B' ' 19' ' ' LYS . 31.2 p90 -165.88 146.41 6.66 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.989 0.423 . . . . 75.54 111.484 -174.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.658 HG21 HD13 ' B' ' 21' ' ' ILE . 96.2 m -75.97 123.48 25.81 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.382 -0.826 . . . . 71.24 109.049 169.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.468 ' HD2' HG23 ' B' ' 59' ' ' VAL . 23.0 mtpp -89.17 -38.84 13.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.817 -0.629 . . . . 74.32 109.965 178.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 14.6 t70 -153.21 142.44 21.49 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.174 0.435 . . . . 75.12 112.174 -169.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.658 HD13 HG21 ' B' ' 18' ' ' THR . 38.2 mm -134.79 146.34 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.029 1.332 . . . . 74.22 108.775 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.512 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 47.7 t -147.9 140.51 24.59 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.905 -1.146 . . . . 55.24 107.905 175.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.1 t80 -157.65 114.15 2.9 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.893 -1.151 . . . . 64.34 107.893 173.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -121.98 112.45 18.29 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.298 -0.63 . . . . 73.52 109.298 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.474 ' HB1' ' CB ' ' B' ' 28' ' ' ALA . . . -108.6 86.81 3.82 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 107.429 -1.323 . . . . 74.4 107.429 172.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.37 -40.79 2.83 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.331 2.021 . . . . 65.21 112.013 -176.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -92.44 9.29 34.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.805 0.842 . . . . 73.32 111.367 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.474 ' CB ' ' HB1' ' B' ' 25' ' ' ALA . . . -40.4 -66.04 0.4 Allowed Pre-proline 0 CA--C 1.57 1.722 0 C-N-CA 125.225 1.41 . . . . 74.0 114.58 -170.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.05 -34.99 94.12 Favored 'Trans proline' 0 C--N 1.399 3.202 0 C-N-CA 122.915 2.41 . . . . 73.33 113.536 -167.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -95.25 -28.85 14.81 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.545 -0.752 . . . . 73.35 111.972 -174.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 p -74.81 -12.44 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-N 118.271 0.487 . . . . 74.3 111.351 -176.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -68.82 -14.51 63.08 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.294 0.85 . . . . 73.22 113.294 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -64.49 -27.07 68.72 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.096 0.474 . . . . 74.44 110.148 172.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.503 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 99.1 mttt -87.75 84.01 7.1 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.647 1.179 . . . . 64.42 110.134 -177.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -93.27 87.56 5.69 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.377 -0.829 . . . . 73.15 109.873 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -160.23 177.03 11.06 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.298 1.039 . . . . 74.12 108.739 171.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -69.83 111.77 10.14 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 109.502 -0.555 . . . . 72.32 109.502 176.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -67.04 157.46 61.61 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.317 2.012 . . . . 74.24 111.89 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 24.9 tt0 -66.23 103.54 1.01 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.16 -1.052 . . . . 71.23 108.16 169.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -86.94 141.59 14.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.579 -0.896 . . . . 71.01 108.579 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -147.05 99.43 3.17 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 108.27 -1.011 . . . . 63.05 108.27 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.19 165.66 12.29 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.213 0.53 . . . . 71.22 111.097 -177.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -159.79 136.61 9.27 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.534 1.133 . . . . 65.22 108.206 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.498 HD12 HD11 ' F' ' 8' ' ' LEU . 95.5 mt -99.85 158.26 15.93 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.631 -0.507 . . . . 73.54 109.631 175.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.486 ' HB3' ' HD3' ' B' ' 61' ' ' ARG . 23.0 t70 -145.74 151.85 38.63 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 124.427 1.091 . . . . 72.34 108.163 170.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 46.1 p -107.59 106.26 16.54 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.473 0.709 . . . . 73.23 109.554 -174.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.39 135.81 53.54 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.726 -1.213 . . . . 62.12 107.726 176.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.3 p -148.13 167.54 24.76 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.321 0.581 . . . . 74.22 112.33 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.5 p -153.89 155.66 36.12 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.277 -1.329 . . . . 64.25 108.378 167.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -121.16 119.76 33.28 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.002 -0.74 . . . . 74.33 109.002 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 61.8 mt -84.18 -34.82 23.9 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.335 0.654 . . . . 74.12 111.341 -173.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.51 -175.73 4.35 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.49 -0.777 . . . . 42.34 110.119 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -76.03 119.12 19.54 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.539 -0.755 . . . . 64.54 109.207 178.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 71.45 13.5 6.49 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.099 1.76 . . . . 64.33 111.292 -176.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 99.0 t -122.41 113.19 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 108.114 -1.069 . . . . 65.22 108.114 170.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -118.75 171.52 8.15 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.255 -0.646 . . . . 74.31 109.255 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -141.68 102.79 4.25 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 107.306 -1.368 . . . . 63.15 107.306 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 92.9 t -95.23 135.67 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.219 1.007 . . . . 74.45 110.302 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.468 HG23 ' HD2' ' B' ' 19' ' ' LYS . 22.2 t -128.94 116.39 40.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 124.027 0.931 . . . . 73.54 109.38 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.425 HD22 ' HB3' ' B' ' 103' ' ' PRO . 43.5 tp -95.44 109.41 21.6 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.9 -0.778 . . . . 74.52 108.9 172.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.63 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 59.5 ttt180 -92.34 108.55 20.04 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.465 0.706 . . . . 73.45 109.43 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 38.5 t -106.24 102.49 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.316 1.046 . . . . 72.21 108.99 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 7.9 m -98.2 135.93 39.13 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.436 0.694 . . . . 74.45 109.353 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' B' ' 76' ' ' CYS . 85.8 t -126.9 139.25 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.181 0.993 . . . . 75.15 110.414 -175.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.6 m -124.78 149.44 47.36 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.524 1.13 . . . . 74.14 108.093 172.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.79 142.09 26.24 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 122.927 0.491 . . . . 64.32 110.249 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.503 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 75.8 p -141.06 128.62 21.38 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 123.477 0.485 . . . . 75.04 111.03 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 29.7 mt -100.21 118.85 37.38 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.152 0.981 . . . . 73.2 109.052 175.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.6 -112.34 4.82 Favored Glycine 0 CA--C 1.526 0.726 0 O-C-N 123.932 0.77 . . . . 75.4 112.296 -175.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -115.37 3.05 14.09 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.273 0.629 . . . . 61.35 111.192 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.503 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 13.3 pt-20 -120.4 159.24 25.49 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.952 0.501 . . . . 75.05 110.69 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 58.6 m -68.94 120.78 15.36 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.618 0.767 . . . . 71.12 110.129 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.503 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -77.61 -61.17 2.08 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.259 -1.015 . . . . 63.12 108.259 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -156.34 164.57 38.14 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.628 -1.169 . . . . 75.44 111.427 177.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 45.5 mt -122.49 153.53 39.04 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 106.093 -1.818 . . . . 74.54 106.093 173.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.429 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 49.5 t -157.92 159.67 36.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.393 -0.595 . . . . 74.33 109.393 -179.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.8 tt0 -165.39 135.32 3.59 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.147 -1.056 . . . . 53.45 108.147 174.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 44.9 t -132.92 145.7 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 108.536 -0.912 . . . . 75.21 108.536 174.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.63 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 14.8 mt-30 -126.06 100.34 6.3 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.601 -0.888 . . . . 73.21 108.601 177.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -90.43 114.83 27.06 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.18 -0.674 . . . . 75.24 109.18 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.432 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -104.93 167.9 15.48 Favored Glycine 0 C--O 1.242 0.641 0 O-C-N 123.851 0.719 . . . . 65.41 111.652 177.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.29 134.41 3.14 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.992 -0.843 . . . . 73.21 110.992 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.438 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 45.0 mt -86.43 126.19 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 108.549 -0.908 . . . . 75.15 108.549 173.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -135.96 139.34 43.15 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 106.883 -1.525 . . . . 72.45 106.883 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 67.8 m -108.73 91.17 3.53 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.499 0.59 . . . . 62.5 111.531 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.546 HG21 ' HE1' ' B' ' 9' ' ' MET . 2.8 mp -97.6 130.92 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.772 0.829 . . . . 73.5 110.509 -171.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.79 165.57 27.13 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.737 0.815 . . . . 73.01 110.304 173.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.04 -56.9 0.65 Allowed Glycine 0 C--N 1.347 1.192 0 CA-C-N 116.161 -0.472 . . . . 41.54 112.133 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.408 HG23 ' N ' ' B' ' 90' ' ' GLU . 30.8 mm -87.93 161.83 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.774 0.83 . . . . 75.11 109.798 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.408 ' N ' HG23 ' B' ' 89' ' ' ILE . 40.4 tt0 -167.89 149.72 5.46 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.859 0.864 . . . . 75.5 110.339 166.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.47 -136.83 12.95 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.907 0.765 . . . . 74.31 112.625 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.2 m -81.86 -23.02 36.61 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 117.256 0.528 . . . . 72.44 111.253 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -68.1 -28.22 67.16 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.934 0.493 . . . . 74.44 109.885 169.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 12.4 ttm -79.16 -28.77 42.78 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.215 0.606 . . . . 63.25 111.081 175.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . 0.594 ' HB2' ' HB3' ' F' ' 14' ' ' LEU . . . -58.61 -26.76 64.02 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.15 0.58 . . . . 75.21 111.093 174.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -71.42 -51.33 24.53 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.331 1.053 . . . . 73.43 110.606 172.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 39.2 t -59.66 -45.83 90.86 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.375 0.67 . . . . 63.51 112.418 -175.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.602 HD12 HG21 ' F' ' 18' ' ' VAL . 72.9 mt -87.5 -17.63 31.69 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.388 0.675 . . . . 74.22 111.551 -176.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.7 3.88 32.38 Favored Glycine 0 C--N 1.35 1.325 0 O-C-N 123.244 0.34 . . . . 70.25 113.79 -175.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.53 -58.22 0.53 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.019 0.527 . . . . 74.03 110.4 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -73.64 -48.66 30.81 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.772 0.67 . . . . 74.21 112.378 -169.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.406 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 84.2 m -66.04 -46.92 63.81 Favored Pre-proline 0 CA--C 1.566 1.595 0 CA-C-O 118.699 -0.667 . . . . 63.12 111.322 177.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.425 ' HB3' HD22 ' B' ' 60' ' ' LEU . 85.5 Cg_exo -55.21 -33.1 83.26 Favored 'Trans proline' 0 C--N 1.402 3.356 0 C-N-CA 122.819 2.346 . . . . 74.51 114.094 168.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -63.13 -40.25 97.05 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.943 0.897 . . . . 64.13 110.25 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 84.2 mt -68.52 -47.53 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 115.121 -0.945 . . . . 75.23 110.45 175.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.08 -4.44 50.28 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.358 -0.837 . . . . 65.22 111.968 -173.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.07 -61.73 7.34 Favored Pre-proline 0 N--CA 1.478 0.958 0 CA-C-O 117.914 -1.041 . . . . 75.54 112.617 -177.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.77 -25.81 68.17 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 121.842 1.694 . . . . 74.53 112.976 -172.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -71.4 -49.59 40.39 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.812 0.845 . . . . 74.23 110.709 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.74 -42.18 97.91 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.47 0.708 . . . . 64.52 110.866 175.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.407 ' NH2' ' HB3' ' B' ' 127' ' ' ASN . 75.2 ttt-85 -59.17 -59.89 4.73 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.93 1.692 . . . . 74.14 111.512 -176.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -64.01 -25.29 68.06 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.147 0.979 . . . . 72.05 110.845 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.557 ' SG ' HD12 ' B' ' 21' ' ' ILE . 17.5 t -70.38 -46.87 63.19 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 122.293 -0.254 . . . . 71.11 111.604 178.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.414 HG22 HG22 ' B' ' 64' ' ' VAL . 97.8 mt -59.61 -49.98 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.491 0.716 . . . . 74.34 110.004 173.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 14.2 m -60.32 -28.54 68.21 Favored 'General case' 0 CA--C 1.556 1.198 0 O-C-N 123.853 0.721 . . . . 75.44 111.796 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -66.78 -46.86 73.96 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.497 0.719 . . . . 73.13 110.319 173.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.533 ' HE1' HG22 ' B' ' 21' ' ' ILE . 11.9 mmt -71.44 -30.28 65.85 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.979 0.512 . . . . 74.1 111.26 -175.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.5 t -61.23 -47.31 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.537 1.135 . . . . 75.52 109.761 170.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 40.8 t -65.35 -36.79 85.09 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.011 -0.995 . . . . 70.12 111.59 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -71.75 -32.44 67.71 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.694 0.798 . . . . 75.51 110.513 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.19 5.89 81.45 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 123.942 0.776 . . . . 65.43 112.665 174.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 54.7 p 56.7 55.79 6.05 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 125.766 1.626 . . . . 74.41 112.658 176.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -119.95 158.39 50.24 Favored Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 124.585 1.154 . . . . 74.54 110.873 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.93 164.83 5.66 Favored 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 123.845 3.03 . . . . 75.24 115.527 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.475 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -65.19 129.84 41.16 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.653 1.181 . . . . 74.51 112.056 -176.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -139.01 119.21 13.56 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.914 -0.773 . . . . 73.2 108.914 174.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . 0.407 ' HB3' ' NH2' ' B' ' 111' ' ' ARG . 31.8 m-80 -116.45 135.33 53.93 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.233 1.013 . . . . 74.44 109.416 173.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 54.5 tp -78.78 149.18 32.7 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.274 0.63 . . . . 75.31 109.861 175.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.35 148.75 86.28 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 123.192 0.597 . . . . 73.33 110.857 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.528 ' HG3' HD11 ' D' ' 16' ' ' ILE . 72.7 Cg_endo -71.15 88.6 0.7 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.118 2.545 . . . . 72.11 111.391 176.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.58 110.45 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 109.416 -0.587 . . . . 71.03 109.416 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -101.58 93.14 5.21 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 107.529 -1.286 . . . . 64.04 107.529 176.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -62.17 -35.95 80.38 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.461 0.476 . . . . 75.51 110.687 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' B' ' 138' ' ' MET . 10.2 m-20 -53.68 -52.49 59.85 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.652 0.781 . . . . 71.31 110.335 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.13 -40.64 90.45 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 124.899 1.374 . . . . 63.44 111.478 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 59.9 tp -62.65 -47.56 83.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.331 0.652 . . . . 70.5 111.234 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.402 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 56.5 m-85 -62.16 -34.62 76.75 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.189 0.596 . . . . 70.23 111.293 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.437 ' HG2' ' O ' ' B' ' 134' ' ' ASP . 22.2 mmt -59.41 -34.15 72.11 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.779 0.432 . . . . 72.33 111.941 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -79.98 -26.21 40.02 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.723 0.409 . . . . 75.32 111.274 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -73.18 -50.38 22.9 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 120.757 0.313 . . . . 72.54 110.952 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 2.7 pp -117.03 30.33 7.39 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.107 0.563 . . . . 73.31 110.878 -168.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -55.34 122.24 10.7 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.172 0.989 . . . . 73.12 111.332 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -115.67 111.51 20.72 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.642 -0.873 . . . . 72.24 108.642 177.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -138.76 128.4 24.76 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.216 -0.661 . . . . 73.34 109.216 176.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -166.39 -179.99 5.28 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.249 1.02 . . . . 73.1 109.582 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 177.09 -111.27 0.33 Allowed Glycine 0 C--N 1.341 0.807 0 N-CA-C 111.279 -0.728 . . . . 75.42 111.279 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -92.05 87.18 6.06 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.556 0.743 . . . . 72.33 109.63 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -98.54 -170.41 31.65 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 115.856 -0.611 . . . . 73.53 111.87 173.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 4.5 t -162.82 88.21 0.61 Allowed 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.783 0.801 . . . . 64.24 110.621 177.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -94.29 144.13 25.8 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.607 0.763 . . . . 74.44 109.597 173.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.47 131.76 34.45 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 106.997 -1.483 . . . . 74.5 106.997 173.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 -73.51 135.52 44.03 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.606 0.362 . . . . 75.11 110.462 -175.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -133.42 157.78 44.71 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.104 0.962 . . . . 71.24 108.562 174.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -153.77 174.08 15.01 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.435 0.294 . . . . 74.15 110.734 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 C-N-CA 123.686 0.794 . . . . 74.22 110.484 -179.338 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 109.577 -0.527 . . . . 73.51 109.577 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 48.5 m -143.04 24.16 1.83 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.084 0.954 . . . . 73.41 109.77 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -65.62 108.92 2.21 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.222 1.009 . . . . 73.02 110.459 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -119.99 110.34 16.57 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.005 0.922 . . . . 73.53 108.621 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -74.38 87.66 2.04 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.956 -0.565 . . . . 72.04 110.32 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -64.26 -21.22 66.51 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.043 0.937 . . . . 74.14 110.358 174.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 74.1 p -55.93 -47.19 77.99 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.619 1.168 . . . . 75.01 110.633 174.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -82.57 77.54 9.32 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.548 -0.751 . . . . 74.33 109.01 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.619 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 0.1 OUTLIER 65.49 116.66 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.045 1.338 . . . . 74.23 111.138 -177.247 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.504 ' HB ' ' HB1' ' C' ' 87' ' ' ALA . 49.7 m -85.12 90.94 7.99 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.212 0.605 . . . . 75.5 109.489 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.619 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 1.1 t80 -111.13 123.22 49.77 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.58 -0.896 . . . . 74.54 108.58 174.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -137.68 120.89 16.84 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.83 -0.804 . . . . 75.23 108.83 173.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 32.9 mt -69.59 123.76 23.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.68 -0.859 . . . . 73.43 108.68 172.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -87.57 -49.18 7.35 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.518 -0.764 . . . . 72.25 109.564 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -174.41 125.76 0.32 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.754 -0.657 . . . . 75.35 109.728 -169.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 77.2 mt -116.12 138.42 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.315 -0.995 . . . . 73.4 108.315 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.476 ' HH ' HD11 ' C' ' 83' ' ' ILE . 26.5 p90 -175.28 165.45 3.32 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-O 121.484 0.659 . . . . 75.23 110.864 -172.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -86.25 125.07 33.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.501 -0.772 . . . . 75.53 109.389 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.442 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 20.6 mmtp -74.02 -48.47 29.86 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 106.895 -1.52 . . . . 74.12 106.895 167.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 24.4 t70 -134.99 146.56 49.18 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 113.64 -1.618 . . . . 62.33 110.403 -172.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 78.1 mt -140.64 146.04 24.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.088 -1.819 . . . . 75.04 106.088 175.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 31.2 t -160.54 150.32 17.65 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.18 0.514 . . . . 73.43 110.403 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 82.4 t80 -157.18 118.8 3.73 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.042 -1.096 . . . . 71.31 108.042 174.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' D' ' 19' ' ' LYS . 34.1 mt-10 -126.66 130.35 50.25 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.816 0.446 . . . . 74.41 110.204 169.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.57 92.99 12.96 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 107.263 -1.384 . . . . 63.21 107.263 172.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -59.4 -36.18 94.61 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.621 2.881 . . . . 71.42 114.11 -171.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -114.96 29.93 7.7 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.375 0.67 . . . . 63.45 110.245 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.79 -63.79 0.96 Allowed Pre-proline 0 CA--C 1.567 1.597 0 N-CA-C 114.51 1.3 . . . . 74.01 114.51 -164.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -62.67 -40.52 36.72 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 121.918 1.746 . . . . 65.41 112.708 -175.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -69.49 -33.11 72.38 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.075 0.95 . . . . 72.42 112.213 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.513 HG21 ' HA ' ' C' ' 73' ' ' ALA . 3.9 p -81.59 -23.1 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 122.761 0.424 . . . . 74.23 111.857 -177.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -65.45 -28.75 69.44 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.181 0.438 . . . . 74.41 112.181 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -90.23 32.13 0.95 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.696 0.798 . . . . 73.34 110.839 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.487 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 0.5 OUTLIER -125.7 162.63 24.6 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.248 0.619 . . . . 74.52 111.21 -173.494 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.19 129.56 38.31 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.302 1.041 . . . . 75.43 110.89 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 49.2 t-105 -87.4 85.11 7.11 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.698 0.799 . . . . 75.22 111.943 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -138.28 76.42 37.9 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 123.976 0.911 . . . . 74.34 108.804 166.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -81.69 156.76 18.59 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.606 2.204 . . . . 74.43 112.533 -176.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . 0.546 ' HB3' ' HE2' ' C' ' 41' ' ' LYS . 2.6 mp0 -85.36 93.61 8.76 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 106.255 -1.758 . . . . 75.53 106.255 164.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 13.7 m -67.28 95.56 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-O 122.184 0.993 . . . . 74.23 109.302 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.762 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 75.3 mmtt -95.54 100.74 12.44 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.259 -1.015 . . . . 74.14 108.259 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.503 HD21 HD22 ' G' ' 8' ' ' LEU . 2.5 pp -88.11 137.28 32.47 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.624 -1.171 . . . . 72.43 108.57 -178.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -146.79 107.71 4.17 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.78 -0.822 . . . . 73.03 108.78 -175.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.511 ' H ' HD23 ' C' ' 44' ' ' LEU . 2.0 pt? -119.99 122.86 42.1 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.761 0.791 . . . . 74.3 109.417 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.755 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 22.2 t70 -113.17 157.3 21.85 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 125.168 1.387 . . . . 62.24 109.208 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 74.9 p -113.64 122.27 46.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.2 1.0 . . . . 71.22 109.909 -174.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.59 136.44 41.06 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.578 -0.897 . . . . 75.43 108.578 175.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 25.8 p -164.09 151.65 12.29 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.779 0.431 . . . . 73.52 110.227 -175.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 73.1 p -153.75 154.14 33.49 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.507 0.723 . . . . 75.42 109.713 -175.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -89.3 128.93 35.92 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.529 -0.545 . . . . 73.31 109.529 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.507 HD13 HD13 ' C' ' 83' ' ' ILE . 65.1 mt -96.33 -42.87 7.94 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.638 0.775 . . . . 75.35 111.008 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.86 -166.03 1.51 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.181 -0.918 . . . . 73.2 110.449 -176.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.89 103.77 1.54 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.185 0.994 . . . . 73.2 109.758 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 71.13 -1.67 2.63 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.638 1.575 . . . . 71.13 113.162 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.3 t -91.64 96.3 6.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 106.917 -1.512 . . . . 63.23 106.917 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -110.1 126.69 54.3 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.11 -0.95 . . . . 75.41 110.58 -173.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -83.66 127.79 34.04 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.058 0.943 . . . . 75.01 109.521 175.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 99.1 t -119.28 115.87 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 107.696 -1.224 . . . . 75.2 107.696 170.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 77.5 t -116.38 122.35 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.481 0.712 . . . . 75.14 109.571 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 49.8 tp -106.06 106.8 17.48 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.07 -0.715 . . . . 71.43 109.07 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.755 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 3.1 tmt_? -82.79 108.23 15.99 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.884 -1.154 . . . . 75.51 107.884 177.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.442 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.7 t -106.89 133.64 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.27 -1.011 . . . . 74.31 108.27 176.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 17.7 m -134.19 118.24 17.41 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.033 -0.729 . . . . 73.31 109.033 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 88.7 t -109.75 120.93 61.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.881 -1.054 . . . . 63.41 108.743 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.762 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 6.9 m -107.85 144.3 35.24 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.981 -0.748 . . . . 73.43 108.981 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.9 112.98 10.41 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.499 -0.926 . . . . 71.4 108.499 176.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 51.3 m -133.16 127.39 33.74 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.281 -0.637 . . . . 65.2 109.281 174.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 36.2 mt -84.78 54.98 3.25 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.766 1.226 . . . . 73.22 108.75 176.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.66 -115.8 5.36 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 109.541 -1.424 . . . . 63.25 109.541 -170.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -92.12 -25.7 18.61 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.023 0.929 . . . . 74.43 109.663 170.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.487 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 13.9 tp10 -63.48 94.89 0.09 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.178 1.391 . . . . 72.21 110.101 177.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 30.7 m -75.37 121.48 22.32 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 120.869 0.366 . . . . 75.04 110.56 -174.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.513 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.93 -58.4 3.31 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.999 -1.0 . . . . 70.3 108.604 173.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -163.63 175.58 10.48 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.349 1.071 . . . . 75.22 112.65 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -141.8 141.02 33.15 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 105.046 -2.205 . . . . 75.11 105.046 170.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.48 ' SG ' HG21 ' C' ' 114' ' ' ILE . 49.4 t -147.8 134.74 20.21 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.85 -0.796 . . . . 72.05 108.85 -176.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -142.3 117.35 10.01 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.651 0.38 . . . . 64.43 110.499 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 83.3 t -119.1 122.32 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.828 -0.804 . . . . 74.41 108.828 171.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.468 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 57.4 mt-30 -98.46 89.78 4.55 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 107.782 -1.192 . . . . 75.41 107.782 177.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -78.82 108.95 12.64 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.08 -0.964 . . . . 73.41 110.051 -175.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.35 154.66 25.38 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-O 121.51 0.505 . . . . 71.41 111.855 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.482 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -153.42 117.58 0.81 Allowed Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 109.56 -1.416 . . . . 71.11 109.56 176.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.507 HD13 HD13 ' C' ' 51' ' ' LEU . 16.4 mm -85.61 118.51 32.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.018 -1.104 . . . . 75.04 108.018 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -130.61 129.77 43.14 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.924 0.889 . . . . 72.34 109.256 -171.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 68.6 m -84.31 118.13 24.01 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 109.141 -0.689 . . . . 74.54 109.141 170.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 3.8 mp -114.57 114.01 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 107.656 -1.238 . . . . 70.54 107.656 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.504 ' HB1' ' HB ' ' C' ' 10' ' ' THR . . . -147.85 162.06 40.03 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.626 0.77 . . . . 70.13 110.259 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.36 -25.61 14.55 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.694 -0.684 . . . . 34.54 113.723 175.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.442 HG13 ' HB3' ' C' ' 94' ' ' MET . 46.3 pt -120.46 162.18 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.675 0.79 . . . . 72.41 110.039 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -147.44 -177.21 5.57 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.768 0.827 . . . . 73.13 109.634 -177.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.0 -136.38 42.05 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 114.569 0.588 . . . . 71.25 114.569 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 34.8 p -65.18 -22.25 66.88 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.535 1.134 . . . . 75.51 112.802 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -60.59 -55.99 26.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.414 0.685 . . . . 74.14 110.045 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.442 ' HB3' HG13 ' C' ' 89' ' ' ILE . 27.7 ptt? -80.79 -20.92 41.51 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.93 -0.577 . . . . 73.21 111.663 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.5 -35.1 79.85 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.315 0.579 . . . . 72.05 110.742 171.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -74.35 -37.11 63.62 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.324 -0.853 . . . . 72.34 110.386 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.478 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 41.6 t -58.35 -55.97 28.13 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.079 0.862 . . . . 64.03 110.552 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.603 HD22 HG23 ' G' ' 18' ' ' VAL . 4.0 pp -70.46 -28.3 64.9 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.94 0.496 . . . . 65.15 111.852 179.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.79 -30.04 60.25 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 114.428 0.531 . . . . 75.54 114.428 -171.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.59 -43.2 0.22 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 117.121 0.461 . . . . 72.01 111.878 -173.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.45 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 70.0 t80 -73.85 -35.73 64.81 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 124.822 1.249 . . . . 72.22 113.095 -170.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.478 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 85.8 m -82.09 -43.7 1.02 Allowed Pre-proline 0 N--CA 1.486 1.333 0 CA-C-O 118.759 -0.639 . . . . 74.24 112.477 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.1 -22.94 61.25 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 121.796 1.664 . . . . 71.03 112.115 171.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . 0.498 ' HA ' ' HD2' ' C' ' 107' ' ' PHE . 25.0 t-20 -56.36 -41.28 75.91 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.906 0.883 . . . . 71.2 111.002 175.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 44.0 mm -59.88 -42.08 88.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 115.156 -0.929 . . . . 73.2 109.802 175.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.482 HD21 ' HA3' ' C' ' 82' ' ' GLY . 96.6 mt -82.34 -20.61 36.97 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.077 -0.965 . . . . 73.03 113.484 -169.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . 0.498 ' HD2' ' HA ' ' C' ' 104' ' ' ASN . 16.5 m-85 -55.56 -49.25 93.71 Favored Pre-proline 0 N--CA 1.496 1.837 0 CA-C-O 118.008 -0.996 . . . . 75.01 113.43 -177.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -58.0 -39.81 82.97 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 122.274 1.983 . . . . 74.32 113.999 178.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . 0.407 ' HE2' HG22 ' A' ' 115' ' ' THR . 68.5 m-85 -68.11 -48.32 65.77 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.411 0.685 . . . . 72.42 110.757 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.61 -42.06 91.76 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.128 -0.942 . . . . 74.32 110.466 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -54.59 -57.98 9.3 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.405 1.065 . . . . 72.34 110.819 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -68.02 -30.94 70.29 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.48 0.488 . . . . 75.54 111.09 -173.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 12.5 t -72.31 -32.9 66.96 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.661 0.384 . . . . 72.3 111.289 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.48 HG21 ' SG ' ' C' ' 76' ' ' CYS . 96.9 mt -73.03 -48.1 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.565 0.746 . . . . 72.14 109.706 173.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 27.1 m -67.55 -30.22 69.81 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.409 0.684 . . . . 70.12 111.413 -174.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 43.5 t -66.0 -44.82 83.69 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.708 -0.849 . . . . 74.1 108.708 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.763 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.06 -38.32 90.71 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.383 1.073 . . . . 75.44 112.474 177.763 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.52 -39.92 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.718 0.807 . . . . 71.31 109.983 174.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.5 t -72.11 -30.99 65.62 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.143 -0.935 . . . . 73.23 111.282 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 73.2 mtt-85 -71.79 -34.1 69.13 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.826 0.851 . . . . 74.53 109.181 175.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.33 6.4 72.49 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 123.985 0.803 . . . . 63.12 112.958 173.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.2 p 61.11 26.81 16.68 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.425 1.89 . . . . 72.03 114.393 171.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -88.15 150.44 47.28 Favored Pre-proline 0 N--CA 1.474 0.765 0 N-CA-C 109.619 -0.511 . . . . 74.44 109.619 173.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.64 143.11 22.85 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.471 2.781 . . . . 61.15 113.762 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -58.08 114.97 2.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.41 1.084 . . . . 75.0 112.262 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 53.9 tp -117.08 103.83 10.63 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.025 0.93 . . . . 73.34 108.915 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -95.35 130.36 42.16 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.838 0.855 . . . . 72.23 109.18 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 tt -74.57 128.21 35.0 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 108.302 -0.999 . . . . 72.21 108.302 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.11 147.3 93.49 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.556 0.742 . . . . 74.3 111.72 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.458 ' HB3' HD13 ' A' ' 16' ' ' ILE . 11.6 Cg_endo -57.89 95.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.821 2.347 . . . . 75.55 112.981 171.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.544 HG22 ' H ' ' G' ' 8' ' ' LEU . 47.4 t -101.59 108.8 24.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.778 -1.194 . . . . 73.12 107.778 172.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -90.7 88.01 6.92 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.588 -0.893 . . . . 73.44 108.588 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -54.71 -44.71 73.69 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.663 0.785 . . . . 71.54 111.757 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -59.6 -45.61 91.42 Favored 'General case' 0 CA--C 1.549 0.915 0 O-C-N 124.954 1.408 . . . . 71.33 110.131 -177.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.47 -24.81 57.0 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.459 -1.246 . . . . 75.34 111.909 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.663 ' HA ' ' HB3' ' C' ' 139' ' ' ASN . 7.4 mp -81.34 -20.67 40.2 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.805 0.842 . . . . 71.24 111.375 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -71.55 -40.77 69.79 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 109.416 -0.587 . . . . 74.32 109.416 167.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 60.3 mtt -67.38 -40.15 85.69 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.402 -0.817 . . . . 75.11 110.516 174.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . 0.663 ' HB3' ' HA ' ' C' ' 136' ' ' LEU . 5.1 t30 -65.25 -37.15 86.31 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.596 -1.184 . . . . 74.35 110.28 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -64.61 -87.18 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.078 -0.712 . . . . 73.44 109.078 173.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 47.4 tp 32.22 -88.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.94 1.696 . . . . 75.32 113.234 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -147.73 67.71 1.11 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.644 1.577 . . . . 75.54 107.648 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . 0.513 ' HB3' ' O ' ' C' ' 139' ' ' ASN . 11.1 pt20 -66.67 93.56 0.26 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.694 0.797 . . . . 74.04 112.357 -175.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -93.29 -37.58 11.96 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.307 -0.861 . . . . 73.13 108.909 165.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 61.99 -179.69 0.13 Allowed 'General case' 0 C--N 1.362 1.133 0 C-N-CA 125.252 1.421 . . . . 53.42 113.4 175.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -145.7 108.81 0.48 Allowed Glycine 0 C--N 1.343 0.955 0 N-CA-C 110.226 -1.149 . . . . 54.14 110.226 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -75.9 97.68 4.02 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.481 0.712 . . . . 71.15 110.53 -175.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -103.46 -138.5 9.87 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-O 119.416 -0.658 . . . . 72.13 111.642 175.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 48.0 m 53.92 69.79 0.67 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.604 1.162 . . . . 74.55 111.79 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -128.69 -72.82 0.59 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.071 -1.085 . . . . 74.05 108.071 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 66.53 -69.67 0.12 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.139 1.376 . . . . 74.41 111.044 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -134.48 -177.52 4.64 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.059 1.344 . . . . 75.12 109.082 175.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -88.08 -28.15 21.5 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 109.395 -0.595 . . . . 75.23 109.395 168.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -156.73 107.24 2.34 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 107.721 -1.215 . . . . 73.31 107.721 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 C-N-CA 123.861 0.864 . . . . 73.1 110.714 -173.17 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 121.075 0.464 . . . . 73.22 110.007 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 70.4 m -149.43 26.37 0.85 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.838 1.255 . . . . 71.43 109.525 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -69.51 82.52 0.4 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.981 0.912 . . . . 71.34 111.259 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -152.07 43.94 0.72 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.865 1.666 . . . . 74.2 106.963 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -50.26 126.75 15.56 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.949 0.9 . . . . 51.34 112.641 -165.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -115.44 129.7 56.65 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.047 -0.979 . . . . 73.34 108.51 -174.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -94.71 -22.31 18.2 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.358 0.663 . . . . 64.12 111.235 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -101.43 -16.85 16.72 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.626 0.77 . . . . 73.13 111.964 -172.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.544 ' SD ' HG13 ' D' ' 89' ' ' ILE . 12.5 tpt -30.78 129.01 0.13 Allowed 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 125.728 1.611 . . . . 74.4 114.554 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 89.5 m -104.8 135.28 46.46 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.047 0.939 . . . . 74.33 109.314 175.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -153.88 91.52 1.47 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.896 -1.52 . . . . 71.22 106.896 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -119.11 116.36 26.19 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.94 -0.763 . . . . 72.15 108.94 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.532 HD11 HG21 ' D' ' 105' ' ' ILE . 8.7 mt -74.32 116.43 16.85 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 N-CA-C 108.898 -0.779 . . . . 73.43 108.898 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.617 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 11.7 mm100 -81.68 -44.94 16.44 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.555 0.742 . . . . 74.31 110.492 -176.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -171.26 143.67 1.91 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.425 -0.352 . . . . 75.11 111.373 -170.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.528 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.4 mp -117.8 132.66 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 107.223 -1.399 . . . . 74.42 107.223 173.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -161.39 141.49 10.69 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.43 0.633 . . . . 74.45 111.056 177.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 77.0 p -77.36 110.96 12.53 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.004 -0.998 . . . . 73.12 109.265 175.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' C' ' 24' ' ' GLU . 36.9 mtpt -85.53 -23.46 27.69 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.565 -0.289 . . . . 75.41 110.481 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.791 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 4.5 t70 -143.19 139.72 30.43 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.333 1.053 . . . . 64.53 108.84 173.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.763 HG21 ' HE1' ' C' ' 117' ' ' MET . 94.4 mt -139.0 146.88 25.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 106.909 -1.515 . . . . 75.55 106.909 169.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.0 t -159.87 110.26 1.89 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.347 0.659 . . . . 44.54 110.062 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.449 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 94.0 t80 -109.54 131.41 55.09 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 106.106 -1.812 . . . . 75.12 106.106 168.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 39.0 mt-10 -138.61 119.77 14.6 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.97 0.508 . . . . 73.34 109.974 -172.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.36 83.71 37.11 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 108.833 -0.803 . . . . 71.15 108.833 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.75 -33.74 7.76 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.834 2.356 . . . . 73.11 112.237 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -89.22 -3.09 58.68 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.422 1.089 . . . . 74.4 111.89 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -32.39 -61.99 0.31 Allowed Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 116.795 2.146 . . . . 74.44 116.795 -164.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.34 -27.54 7.83 Favored 'Trans proline' 0 C--N 1.376 2.023 0 CA-C-N 122.708 2.003 . . . . 72.24 114.262 -172.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -86.86 -21.4 26.4 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 117.931 0.332 . . . . 71.22 110.838 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.58 -16.19 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 122.794 0.437 . . . . 64.04 110.041 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -68.04 -20.11 64.96 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.46 0.304 . . . . 71.44 111.648 175.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -56.01 -32.12 63.68 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.276 0.56 . . . . 73.13 110.057 171.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.652 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 97.3 mttt -85.99 85.57 7.37 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.831 1.252 . . . . 74.31 109.32 174.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -93.74 78.21 4.25 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.416 0.626 . . . . 74.05 110.418 -176.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -149.73 -178.03 6.22 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.49 -0.777 . . . . 65.15 109.612 170.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -76.42 110.96 12.91 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.65 0.78 . . . . 72.45 109.627 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.551 ' HB3' ' HG ' ' D' ' 68' ' ' LEU . 18.5 Cg_endo -63.22 147.44 93.94 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.472 2.114 . . . . 73.25 112.408 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -64.55 119.34 10.27 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.979 0.799 . . . . 75.0 108.954 172.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.639 HG12 HG13 ' D' ' 64' ' ' VAL . 99.5 t -96.54 131.04 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.856 -0.794 . . . . 72.34 108.856 -176.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.659 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 43.4 mtpt -106.33 157.36 17.67 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.807 0.843 . . . . 75.54 109.31 169.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.46 113.43 16.82 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 106.664 -1.606 . . . . 75.51 106.664 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.716 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 7.5 m-20 -117.71 144.22 45.47 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.992 -1.004 . . . . 64.44 108.912 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.33 154.72 33.11 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.023 0.529 . . . . 74.3 110.18 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.524 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 30.1 t70 -153.11 140.29 19.42 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.819 -1.178 . . . . 71.05 107.819 167.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 87.7 m -104.54 143.82 32.52 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.674 0.79 . . . . 74.2 110.454 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.449 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -154.14 152.76 30.78 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.014 0.925 . . . . 61.35 109.377 171.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 67.0 p -169.04 154.21 5.98 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.441 0.696 . . . . 74.33 110.256 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 82.9 p -156.02 156.06 33.78 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.291 0.637 . . . . 75.44 109.524 171.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -96.13 118.2 32.24 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.185 -1.043 . . . . 75.44 108.185 173.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.577 HD13 HG22 ' D' ' 83' ' ' ILE . 32.1 mt -92.85 -27.43 17.14 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.933 0.493 . . . . 74.32 110.757 -174.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.478 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -163.87 -178.68 5.82 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.264 1.025 . . . . 65.11 110.157 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.95 107.88 4.92 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.24 -0.891 . . . . 74.53 110.038 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 68.51 21.55 8.08 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.424 1.49 . . . . 75.34 111.367 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 42.3 t -124.11 115.31 44.5 Favored 'Isoleucine or valine' 0 C--N 1.35 0.599 0 N-CA-C 107.535 -1.283 . . . . 72.23 107.535 170.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -124.38 170.41 10.86 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.338 0.655 . . . . 73.3 109.489 -171.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.533 ' HB2' HD11 ' D' ' 51' ' ' LEU . 26.4 tt0 -130.31 117.99 20.61 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.649 -0.705 . . . . 75.34 109.397 178.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 88.0 t -100.99 117.38 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.424 1.09 . . . . 75.25 108.291 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.449 ' HB ' ' HB1' ' D' ' 47' ' ' ALA . 24.4 t -119.14 117.45 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.552 -0.907 . . . . 75.33 108.552 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.01 122.24 44.62 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.885 -0.783 . . . . 73.31 108.885 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.524 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 49.6 ttm-85 -87.26 101.87 13.94 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.226 -0.657 . . . . 74.22 109.226 175.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 83.2 t -90.72 114.73 28.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.203 -1.036 . . . . 75.14 108.203 174.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.716 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 28.0 m -116.02 139.62 50.09 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.277 0.561 . . . . 64.11 109.543 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.639 HG13 HG12 ' D' ' 40' ' ' VAL . 7.7 t -125.25 100.26 6.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 124.381 1.072 . . . . 73.41 108.136 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.659 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 58.2 m -93.39 93.75 8.33 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.185 -1.042 . . . . 73.13 108.185 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.72 141.2 29.48 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.026 -0.988 . . . . 64.53 109.487 -176.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.485 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 55.7 m -143.76 126.12 15.73 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.656 0.597 . . . . 75.14 111.105 -177.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.551 ' HG ' ' HB3' ' D' ' 38' ' ' PRO . 26.0 mt -93.75 115.6 28.03 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.348 1.059 . . . . 65.23 108.392 172.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.84 -137.73 32.46 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.402 -0.679 . . . . 71.5 111.402 -171.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -90.88 4.35 52.08 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.212 0.605 . . . . 70.21 111.84 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.652 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 13.6 pt-20 -118.72 160.2 22.29 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.61 0.364 . . . . 75.43 110.279 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 48.7 m -68.34 133.18 48.33 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 123.753 0.658 . . . . 74.23 111.312 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.485 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.51 -68.13 0.78 Allowed 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.519 -1.289 . . . . 75.42 107.519 171.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -151.24 159.51 44.33 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 115.641 -0.709 . . . . 72.32 110.874 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 31.6 mt -117.7 110.12 17.47 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 105.778 -1.934 . . . . 74.04 105.778 173.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.677 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 14.8 t -119.69 112.17 18.95 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.818 -0.808 . . . . 63.35 108.818 -172.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -139.91 141.1 36.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.574 0.75 . . . . 75.03 109.891 -162.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 91.6 t -147.45 121.44 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.126 0.97 . . . . 74.53 109.228 -177.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.791 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 15.4 mt-30 -86.56 91.19 8.49 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 107.802 -1.184 . . . . 64.45 107.802 161.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -80.38 98.63 7.57 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.392 -1.336 . . . . 75.4 107.392 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.16 147.43 18.59 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.628 -0.989 . . . . 72.03 110.628 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.7 133.71 4.81 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.0 -0.84 . . . . 60.41 111.0 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.617 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 25.6 mt -89.17 131.2 37.07 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 108.053 -1.092 . . . . 74.51 108.053 174.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -134.74 124.12 24.72 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.407 -0.59 . . . . 71.03 109.407 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 37.8 m -82.86 97.39 8.63 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.683 -0.858 . . . . 73.33 108.683 169.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.52 143.51 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.599 -0.519 . . . . 73.3 109.599 -177.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.82 142.33 9.03 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.954 0.502 . . . . 72.33 110.437 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.56 -22.72 14.57 Favored Glycine 0 C--N 1.345 1.035 0 O-C-N 123.658 0.599 . . . . 74.54 113.175 174.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.544 HG13 ' SD ' ' D' ' 9' ' ' MET . 63.7 mt -100.07 146.91 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 117.414 0.607 . . . . 75.1 110.16 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -160.3 176.15 12.03 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.576 1.151 . . . . 75.53 110.041 -178.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.61 -130.74 12.2 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 115.366 -0.834 . . . . 74.21 113.743 174.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 72.8 p -79.57 -24.59 41.99 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.15 0.58 . . . . 73.14 111.027 -177.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -70.06 -38.39 75.75 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.948 -0.569 . . . . 73.13 109.938 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -72.33 -27.25 62.3 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 116.49 -0.323 . . . . 73.4 110.682 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.9 -40.95 90.52 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 120.964 0.411 . . . . 75.15 111.293 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -78.66 -37.28 42.3 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.526 0.73 . . . . 75.43 111.206 175.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 50.0 t -61.29 -41.05 96.31 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.233 0.539 . . . . 75.12 111.275 -176.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 23.6 mt -92.47 -31.92 15.08 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.238 -0.892 . . . . 75.42 110.707 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' H' ' 15' ' ' PHE . . . -91.15 4.83 81.28 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.719 -0.673 . . . . 71.13 113.823 -178.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -156.81 -57.47 0.09 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 117.867 0.834 . . . . 73.22 112.384 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -66.36 -37.06 84.46 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 112.796 0.665 . . . . 73.43 112.796 -169.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 73.5 m -74.84 -48.2 4.8 Favored Pre-proline 0 CA--C 1.566 1.574 0 CA-C-O 118.689 -0.672 . . . . 54.21 111.824 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.42 -13.76 38.35 Favored 'Trans proline' 0 C--N 1.4 3.274 0 C-N-CA 121.766 1.644 . . . . 74.21 113.404 170.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -65.86 -39.35 90.67 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.601 0.76 . . . . 73.24 109.914 173.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.532 HG21 HD11 ' D' ' 13' ' ' ILE . 49.3 mm -66.02 -39.18 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 115.361 -0.836 . . . . 72.01 110.45 175.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 87.7 mt -80.49 -10.47 59.74 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 115.068 -0.969 . . . . 72.1 111.761 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -65.25 -47.57 70.7 Favored Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 124.403 1.081 . . . . 73.44 113.103 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.88 -45.46 40.86 Favored 'Trans proline' 0 C--N 1.39 2.758 0 C-N-CA 122.378 2.052 . . . . 74.22 113.378 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -69.68 -36.43 75.99 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.481 -0.781 . . . . 73.14 111.855 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.16 -47.35 80.18 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.891 0.476 . . . . 60.12 109.819 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -59.09 -49.48 77.73 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 114.59 -1.186 . . . . 73.53 111.146 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -64.64 -45.57 86.24 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 123.671 0.607 . . . . 74.13 111.277 -175.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.7 t -59.58 -42.17 91.91 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 123.662 0.601 . . . . 62.53 110.666 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.453 ' O ' HG23 ' D' ' 118' ' ' VAL . 69.9 mt -59.99 -57.96 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.856 0.863 . . . . 71.24 110.779 172.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.423 HG23 ' HG3' ' D' ' 125' ' ' GLN . 97.4 m -53.54 -41.97 66.98 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 124.765 1.226 . . . . 71.12 111.841 -174.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 45.2 t -66.94 -42.54 85.12 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.76 -1.109 . . . . 73.51 110.268 -177.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.677 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 73.6 mtm -68.14 -31.71 71.47 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.909 0.484 . . . . 73.25 111.716 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.453 HG23 ' O ' ' D' ' 114' ' ' ILE . 84.8 t -62.0 -47.11 94.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.327 0.651 . . . . 71.34 109.835 174.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.7 p -74.41 -24.98 59.19 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.642 -0.708 . . . . 70.11 111.235 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' D' ' 116' ' ' SER . 91.0 mtt-85 -70.54 -34.69 72.54 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.635 0.774 . . . . 75.31 109.896 174.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.46 9.44 73.37 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 123.889 0.743 . . . . 71.41 112.592 175.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.429 HG22 ' HB3' ' C' ' 17' ' ' TYR . 64.0 p 59.27 19.62 7.75 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 126.383 1.873 . . . . 75.12 113.883 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -84.16 154.38 63.49 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.429 0.692 . . . . 73.45 109.443 171.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -56.32 131.51 46.21 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.195 2.596 . . . . 73.34 112.513 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.423 ' HG3' HG23 ' D' ' 115' ' ' THR . 32.9 tt0 -50.75 137.55 20.06 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.747 1.219 . . . . 72.2 111.827 -177.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -128.96 101.7 6.18 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.724 -0.843 . . . . 73.05 108.724 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -100.65 121.04 40.97 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.775 0.83 . . . . 74.4 108.984 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 6.7 mp -73.65 119.26 17.63 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 109.198 -0.667 . . . . 72.51 109.198 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.44 148.58 79.95 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 123.771 0.829 . . . . 74.14 112.012 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -68.94 98.77 0.62 Allowed 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.871 2.381 . . . . 74.32 111.462 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 35.4 m -110.79 142.63 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.398 0.679 . . . . 71.35 111.027 -177.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -99.86 81.91 2.51 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.626 -1.249 . . . . 71.1 107.626 169.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -71.19 -16.7 62.53 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 114.943 -1.026 . . . . 74.54 111.345 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -48.72 -53.32 19.39 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.229 1.412 . . . . 72.33 111.937 173.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.42 -32.74 74.26 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.497 0.719 . . . . 43.41 111.883 -176.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 37.7 tp -77.14 -32.16 56.18 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.453 -0.794 . . . . 74.32 110.591 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -64.67 -30.9 71.93 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.008 0.923 . . . . 75.25 110.709 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 12.6 mmt -56.7 -36.09 69.24 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.155 0.582 . . . . 73.13 110.455 176.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.416 ' HA ' ' NE2' ' D' ' 142' ' ' GLN . 24.6 t-20 -63.75 -33.11 74.93 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.468 1.107 . . . . 74.04 111.735 -176.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . 0.521 ' HB2' HD22 ' H' ' 10' ' ' LEU . 78.2 t80 -71.71 -33.33 68.66 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.477 0.711 . . . . 73.2 110.746 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.8 mp -84.63 -30.28 25.04 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.657 0.783 . . . . 70.54 112.708 -177.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.416 ' NE2' ' HA ' ' D' ' 139' ' ' ASN . 26.2 pt20 -82.17 23.33 0.73 Allowed 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 113.641 0.978 . . . . 73.44 113.641 -165.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -117.37 61.26 0.75 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.73 1.252 . . . . 72.15 109.446 -172.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -140.56 102.41 4.31 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.692 -1.14 . . . . 74.55 108.363 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.86 155.77 47.84 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 124.448 1.099 . . . . 75.21 109.499 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 100.26 61.3 0.82 Allowed Glycine 0 C--N 1.347 1.189 0 O-C-N 123.376 0.423 . . . . 73.52 112.228 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -64.56 145.54 55.99 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.633 0.773 . . . . 74.3 110.708 175.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 85.75 -64.94 4.02 Favored Glycine 0 C--N 1.348 1.215 0 C-N-CA 123.303 0.477 . . . . 42.13 113.125 173.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 4.3 m -77.18 -24.69 51.39 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.31 0.644 . . . . 74.32 110.767 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 66.29 41.28 3.43 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.302 1.441 . . . . 75.42 111.489 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -76.53 78.78 3.22 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.377 0.608 . . . . 70.25 110.516 177.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -152.24 -64.43 0.17 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.06 0.944 . . . . 70.24 109.132 176.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -169.36 120.77 0.72 Allowed 'General case' 0 C--N 1.355 0.838 0 C-N-CA 122.822 0.449 . . . . 73.15 110.626 -176.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -85.13 141.98 29.82 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.615 0.766 . . . . 72.13 109.208 171.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.302 0 C-N-CA 124.481 1.112 . . . . 51.24 111.565 179.919 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.486 1.345 0 N-CA-C 111.026 0.009 . . . . 72.41 111.026 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -71.18 128.1 34.79 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.074 0.55 . . . . 74.23 110.388 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -101.45 165.74 11.1 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.751 0.82 . . . . 74.22 111.847 -170.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 30.9 m -118.39 150.15 40.02 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.075 -1.083 . . . . 71.0 108.075 165.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 5' ' ' THR . . . . . 0.511 HG22 HG13 ' E' ' 6' ' ' ILE . 28.9 m -139.48 119.93 13.98 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.311 -0.625 . . . . 70.12 109.311 -176.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.587 HG12 HG11 ' A' ' 40' ' ' VAL . 40.9 mt 72.29 143.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.798 1.639 . . . . 75.22 111.319 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.96 161.94 34.66 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.735 0.814 . . . . 74.32 110.235 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 3.6 tt -144.05 120.54 11.02 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 106.699 -1.593 . . . . 74.55 106.699 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.13 166.75 22.84 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.692 0.797 . . . . 74.43 111.777 -177.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . 0.634 HD22 ' HB2' ' A' ' 136' ' ' LEU . 86.2 mt -61.76 156.65 19.83 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.309 0.644 . . . . 74.52 110.974 171.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 47.1 mt -72.8 119.92 78.01 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-N 115.286 -0.87 . . . . 72.44 109.811 -177.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.47 -32.66 88.68 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.09 2.526 . . . . 75.51 111.851 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.22 122.31 19.1 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 106.817 -1.549 . . . . 75.53 106.817 175.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 7.2 mp -70.97 160.53 32.74 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.339 0.656 . . . . 73.44 110.692 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -75.84 150.03 37.73 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.939 -0.573 . . . . 74.24 109.726 -174.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 7.3 t -141.0 51.89 2.68 Favored Pre-proline 0 CA--C 1.571 1.751 0 N-CA-C 113.371 0.878 . . . . 74.44 113.371 -174.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 17' ' ' PRO . . . . . 0.68 ' HB3' ' HB2' ' A' ' 48' ' ' SER . 75.8 Cg_endo -76.24 -33.07 3.65 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 121.601 1.534 . . . . 72.41 112.035 170.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 23.6 t -79.7 94.77 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.872 0.869 . . . . 74.3 109.456 -171.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 63.4 p 52.99 -80.7 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.689 1.596 . . . . 74.24 111.378 -173.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 20' ' ' LYS . . . . . 0.589 ' HZ3' ' HB2' ' E' ' 20' ' ' LYS . 4.5 ttmp? -168.77 118.49 0.72 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.196 -1.039 . . . . 72.1 108.196 175.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.5 76.11 2.55 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.811 0.844 . . . . 53.02 110.39 178.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -163.91 122.98 1.97 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.326 -1.306 . . . . 70.14 108.38 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 4.6 t -111.67 100.15 47.22 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 108.012 -1.107 . . . . 75.12 108.012 171.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.87 -43.3 38.3 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.61 2.207 . . . . 71.03 111.887 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 . . . . . 0 C--O 1.25 1.129 0 N-CA-C 107.996 -1.113 . . . . 73.42 107.996 175.874 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 110.362 -0.236 . . . . 60.43 110.362 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 88.4 tttt 73.16 136.54 0.05 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.153 1.381 . . . . 74.54 111.859 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -144.18 133.93 23.73 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.971 0.909 . . . . 74.01 108.819 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 19.0 p -141.51 99.6 3.59 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.174 0.99 . . . . 74.44 109.359 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 32.6 m -79.22 -44.48 21.75 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.236 0.614 . . . . 71.31 109.889 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 19.0 pt -134.54 -166.94 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.908 0.883 . . . . 70.54 109.724 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . 69.81 167.95 0.29 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.579 1.151 . . . . 61.11 111.692 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . 0.498 HD11 HD12 ' B' ' 44' ' ' LEU . 71.7 mt -137.16 163.1 31.66 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.862 0.865 . . . . 70.53 109.793 -174.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -127.93 -61.51 1.11 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.726 0.81 . . . . 73.31 109.437 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 96.1 mt -139.77 163.68 31.96 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.137 0.975 . . . . 74.11 109.972 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 7.6 mp -84.76 155.85 61.61 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 123.548 0.739 . . . . 74.53 109.348 172.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.09 91.35 0.38 Allowed 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.624 2.216 . . . . 55.41 110.088 174.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 13' ' ' LEU . . . . . 0.447 HD12 ' N ' ' F' ' 14' ' ' LEU . 1.4 tm? 71.84 146.25 0.07 Allowed 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 125.221 1.408 . . . . 63.0 109.555 -172.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . 0.594 ' HB3' ' HB2' ' B' ' 95' ' ' ALA . 6.2 mp -61.75 140.79 58.18 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.771 0.828 . . . . 72.32 110.808 -178.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -65.74 144.74 56.7 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.826 0.85 . . . . 75.11 110.875 -170.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 25.2 p -59.87 121.41 58.02 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 124.426 1.091 . . . . 74.43 111.97 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -63.54 159.29 41.29 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.461 2.774 . . . . 75.42 114.043 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . 0.815 ' HB ' ' HB1' ' F' ' 21' ' ' ALA . 15.8 t -71.19 114.39 9.27 Favored 'Isoleucine or valine' 0 C--N 1.355 0.809 0 N-CA-C 107.616 -1.253 . . . . 75.05 107.616 172.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 42.1 m -71.18 116.68 11.76 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.126 0.57 . . . . 73.22 109.831 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt 82.3 23.82 0.2 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.806 1.642 . . . . 75.52 111.052 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . 0.815 ' HB1' ' HB ' ' F' ' 18' ' ' VAL . . . -67.12 101.52 0.9 Allowed 'General case' 0 C--N 1.359 0.982 0 C-N-CA 123.292 0.637 . . . . 73.14 109.451 174.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 45.5 ttm180 -143.9 143.17 31.15 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.296 -0.411 . . . . 71.32 110.852 -166.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 3.8 t -99.96 103.67 23.83 Favored Pre-proline 0 CA--C 1.558 1.255 0 CA-C-N 115.301 -0.863 . . . . 72.2 108.71 172.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.59 -35.67 87.0 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 123.194 2.596 . . . . 75.3 113.002 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 . . . . . 0 CA--C 1.552 1.042 0 N-CA-C 108.77 -0.826 . . . . 75.35 108.77 172.975 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 109.295 -0.631 . . . . 53.33 109.295 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.34 142.01 33.47 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.84 0.856 . . . . 74.13 109.3 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -153.01 136.59 15.98 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.06 0.544 . . . . 75.12 109.807 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 42.1 m -139.63 127.87 22.58 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.792 0.837 . . . . 75.31 109.12 176.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 5' ' ' THR . . . . . 0.51 HG21 ' H ' ' G' ' 6' ' ' ILE . 3.2 m -77.0 -179.84 5.77 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 124.123 0.969 . . . . 72.3 109.673 178.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . 0.51 ' H ' HG21 ' G' ' 5' ' ' THR . 39.3 pt -52.59 138.25 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 124.45 1.1 . . . . 73.14 112.668 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -122.33 137.39 54.87 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.359 0.663 . . . . 52.41 110.215 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 8' ' ' LEU . . . . . 0.544 ' H ' HG22 ' C' ' 131' ' ' VAL . 87.2 mt -85.98 151.25 23.89 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.368 0.667 . . . . 75.43 110.447 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.28 130.57 36.39 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.322 0.649 . . . . 71.13 109.712 174.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 9.7 mp -60.1 144.39 49.8 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.173 0.989 . . . . 74.24 110.728 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 75.8 mt -69.14 109.32 4.17 Favored Pre-proline 0 CA--C 1.552 1.049 0 O-C-N 124.427 1.079 . . . . 75.13 111.047 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.81 -40.55 0.39 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.938 2.425 . . . . 75.2 111.004 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 5.3 mp -72.79 -39.8 66.42 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.167 -0.924 . . . . 72.42 110.09 -177.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 88.3 mt 61.43 172.61 0.11 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.387 1.075 . . . . 62.31 111.503 -173.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -76.86 161.84 28.11 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.982 -0.377 . . . . 75.24 109.982 172.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 41.7 p -73.99 150.78 88.22 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.093 0.557 . . . . 75.3 110.171 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 17' ' ' PRO . . . . . 0.544 ' HB3' ' HB2' ' G' ' 21' ' ' ALA . 85.6 Cg_exo -50.11 148.54 13.42 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.748 2.965 . . . . 72.31 114.252 174.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 18' ' ' VAL . . . . . 0.603 HG23 HD22 ' C' ' 98' ' ' LEU . 99.0 t -62.27 -59.15 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 109.111 -0.7 . . . . 70.03 109.111 174.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 11.8 p -139.82 -74.38 0.36 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.422 1.089 . . . . 73.04 109.314 175.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -120.64 79.36 1.48 Allowed 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.764 -0.828 . . . . 73.23 108.764 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . 0.544 ' HB2' ' HB3' ' G' ' 17' ' ' PRO . . . -129.78 5.24 5.03 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.503 -0.771 . . . . 71.12 112.062 -175.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -91.18 71.94 6.26 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.556 0.742 . . . . 75.44 109.738 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 33.9 m -147.06 66.55 10.39 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 108.995 -0.743 . . . . 72.24 108.995 170.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.34 134.82 8.0 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.571 2.181 . . . . 71.01 111.292 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 . . . . . 0 CA--C 1.562 1.42 0 C-N-CA 123.338 0.655 . . . . 74.21 111.17 -176.506 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 109.383 -0.599 . . . . 71.21 109.383 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -157.81 141.33 15.48 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.653 0.781 . . . . 72.41 109.316 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -119.57 120.94 38.19 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.384 0.674 . . . . 73.31 109.784 -176.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 42.5 m -144.74 119.88 10.11 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.917 0.887 . . . . 74.43 109.208 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 91.7 m -148.82 -70.81 0.21 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.962 0.505 . . . . 74.02 110.388 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . . . . . . . . . 12.6 tt -147.09 143.87 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.993 -0.442 . . . . 75.12 109.954 -173.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . 68.93 161.59 0.2 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.152 1.381 . . . . 75.33 112.139 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 74.9 mt -69.73 147.89 49.91 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.882 -0.599 . . . . 75.2 110.383 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.84 -73.1 0.37 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.372 0.669 . . . . 62.32 110.113 -177.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 10' ' ' LEU . . . . . 0.521 HD22 ' HB2' ' D' ' 140' ' ' TYR . 78.7 mt -130.86 142.83 50.4 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.199 1.0 . . . . 74.04 109.734 177.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . 0.412 ' HA ' ' HD3' ' H' ' 12' ' ' PRO . 7.6 mp -92.92 124.06 59.52 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 108.434 -0.95 . . . . 65.3 108.434 173.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 12' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' H' ' 11' ' ' LEU . 24.6 Cg_exo -64.35 -16.41 54.91 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.424 2.749 . . . . 71.54 113.555 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 54.9 tp -133.29 148.95 51.94 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.849 0.86 . . . . 64.03 108.954 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 87.6 mt -69.01 97.55 0.88 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.316 0.646 . . . . 70.51 110.088 177.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . 0.418 ' HB3' ' HA2' ' D' ' 99' ' ' GLY . 0.9 OUTLIER -76.05 91.19 3.08 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 107.927 -1.138 . . . . 74.52 107.927 174.677 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 21.0 m -143.65 84.2 10.1 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 123.391 0.677 . . . . 73.32 110.35 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -78.28 -152.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.928 2.419 . . . . 73.02 111.486 162.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 95.8 t 75.81 141.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 124.826 1.25 . . . . 74.35 111.797 174.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 15.2 m 65.17 46.96 2.56 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.008 0.923 . . . . 72.41 109.289 -175.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 58.5 mttp 76.51 -13.68 0.89 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.726 1.61 . . . . 75.42 112.283 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.06 136.07 54.65 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 108.276 -1.009 . . . . 74.22 108.276 166.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -177.34 172.08 1.91 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.269 1.028 . . . . 74.41 109.406 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 20.1 p -91.44 103.09 6.81 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 108.653 -0.869 . . . . 73.54 108.653 168.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.96 172.05 13.51 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.917 2.411 . . . . 75.2 112.25 -177.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 CA--C 1.556 1.185 0 C-N-CA 123.839 0.856 . . . . 75.11 110.179 179.494 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.6 ttm . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 110.012 -0.366 . . . . 75.42 110.012 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.1 m -147.87 21.95 1.12 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.873 1.269 . . . . 72.31 109.447 176.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 6' ' ' ASN . 8.1 mp0 -85.13 143.04 29.08 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.205 0.602 . . . . 71.33 110.352 -173.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -71.52 119.71 16.07 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 107.397 -1.335 . . . . 73.34 107.397 169.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.9 t30 75.38 3.05 3.96 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 125.529 1.532 . . . . 75.42 111.783 -174.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.482 ' HA ' ' HB2' ' A' ' 3' ' ' GLU . 14.9 m120 60.31 -98.29 0.08 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.421 1.489 . . . . 52.31 112.18 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 p -151.86 86.66 1.32 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.267 1.027 . . . . 74.51 109.451 -173.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -122.78 3.68 9.48 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.352 0.661 . . . . 75.12 110.793 171.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 38.7 ttm -72.31 152.57 42.03 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.42 0.628 . . . . 75.42 111.143 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 t -137.61 140.64 41.04 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.33 -1.359 . . . . 74.25 107.33 170.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.724 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 33.4 t80 -136.68 127.75 27.81 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.028 0.531 . . . . 74.22 109.637 -175.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -148.5 127.71 12.93 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.21 -1.033 . . . . 74.24 108.21 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.649 HG12 ' HD2' ' A' ' 84' ' ' PHE . 53.7 mt -85.36 122.9 38.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 108.575 -0.898 . . . . 71.45 108.575 174.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -85.02 -41.47 15.77 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.899 -0.778 . . . . 72.44 108.899 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -173.34 128.83 0.44 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 111.453 0.168 . . . . 73.24 111.453 -167.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.436 HD13 ' CG ' ' C' ' 130' ' ' PRO . 91.8 mt -123.17 132.9 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 124.141 0.976 . . . . 64.24 109.219 176.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.402 ' HB3' HG21 ' B' ' 122' ' ' THR . 30.0 p90 -167.12 154.2 8.74 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.853 0.861 . . . . 73.53 111.119 -169.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.4 p -75.28 126.08 30.28 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.713 -0.676 . . . . 73.31 109.466 170.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -93.48 -21.21 19.61 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.75 -0.463 . . . . 65.34 109.75 173.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 25.0 t70 -153.3 138.49 17.41 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.051 -0.977 . . . . 74.1 110.045 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.419 HG22 ' SD ' ' A' ' 117' ' ' MET . 74.2 mt -133.28 144.29 36.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 C-N-CA 124.989 1.316 . . . . 74.03 108.09 176.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.594 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 42.8 t -147.64 126.37 12.61 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.889 -0.782 . . . . 74.33 108.889 170.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 84.9 t80 -131.3 117.44 18.95 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 106.289 -1.745 . . . . 75.24 106.289 170.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -125.5 120.02 29.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.134 0.425 . . . . 74.42 109.93 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.1 80.65 15.43 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 106.93 -1.507 . . . . 74.32 106.93 171.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.35 -35.54 39.62 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 122.578 2.185 . . . . 73.13 111.488 -174.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -106.01 25.51 10.85 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.922 -1.035 . . . . 73.32 109.457 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.459 ' O ' HG11 ' A' ' 31' ' ' VAL . . . -49.11 -50.83 61.04 Favored Pre-proline 0 CA--C 1.561 1.393 0 N-CA-C 113.471 0.915 . . . . 74.24 113.471 -177.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.22 -21.35 67.4 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 121.647 1.565 . . . . 75.52 113.441 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -91.53 -35.11 14.48 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.105 0.962 . . . . 72.22 110.657 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.542 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.8 p -75.35 -25.03 17.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.564 -0.743 . . . . 64.54 112.569 -163.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -73.35 -17.69 61.26 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.325 0.65 . . . . 74.03 110.874 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -85.65 -32.1 22.18 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.483 1.113 . . . . 75.45 110.134 174.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -68.92 157.88 35.74 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.75 0.82 . . . . 73.1 111.349 -175.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -70.87 131.67 44.12 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.385 0.674 . . . . 73.44 109.386 171.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -84.11 88.3 7.18 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.487 0.661 . . . . 74.33 110.189 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -120.98 81.17 34.92 Favored Pre-proline 0 C--O 1.245 0.829 0 N-CA-C 107.977 -1.12 . . . . 71.34 107.977 169.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.59 112.11 3.39 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 121.972 1.781 . . . . 73.34 112.015 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -94.58 88.84 5.57 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 105.826 -1.916 . . . . 75.1 105.826 167.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.4 m -77.55 114.85 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 113.985 -1.461 . . . . 74.03 111.228 -172.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.439 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 87.0 tttt -87.29 130.98 34.39 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.286 -0.87 . . . . 72.31 109.085 173.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.596 ' HB3' HD13 ' E' ' 6' ' ' ILE . 4.5 pp -103.35 148.84 25.38 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.992 -0.744 . . . . 73.42 108.992 173.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.489 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 21.3 t70 -147.56 133.54 19.19 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.134 -0.691 . . . . 75.12 109.134 172.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.552 HD11 ' HB3' ' E' ' 8' ' ' LEU . 96.6 mt -126.38 128.87 47.72 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.033 0.933 . . . . 75.43 109.805 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -140.15 156.98 46.31 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.253 -0.647 . . . . 74.22 109.253 171.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.3 p -115.36 152.96 31.86 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.467 0.707 . . . . 73.41 110.804 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.409 ' HB1' ' HB ' ' A' ' 59' ' ' VAL . . . -145.57 111.85 5.73 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.179 -1.045 . . . . 74.34 108.179 173.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -89.85 152.47 21.25 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.109 0.563 . . . . 75.2 109.7 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.2 t -157.54 142.12 16.48 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.557 0.743 . . . . 74.41 109.851 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -112.76 134.66 54.17 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.706 -0.85 . . . . 75.43 108.706 171.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.747 HD12 ' HB2' ' A' ' 57' ' ' GLU . 27.0 mt -112.59 -28.86 7.67 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.303 0.641 . . . . 74.33 110.528 -174.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.63 179.64 8.4 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.163 0.985 . . . . 70.35 109.058 175.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.49 120.84 13.59 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.898 -0.778 . . . . 75.24 108.898 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 72.59 -1.88 2.83 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.92 1.288 . . . . 62.15 112.272 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.8 t -101.16 112.0 32.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 107.9 -1.148 . . . . 74.25 107.9 176.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -115.84 156.37 26.22 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 123.653 0.781 . . . . 75.22 108.996 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.747 ' HB2' HD12 ' A' ' 51' ' ' LEU . 48.3 tt0 -128.18 120.72 27.85 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.387 -0.968 . . . . 73.32 108.387 177.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.1 t -99.45 112.68 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.583 -1.636 . . . . 63.13 106.583 174.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.409 ' HB ' ' HB1' ' A' ' 47' ' ' ALA . 49.2 t -102.55 127.37 56.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 107.633 -1.247 . . . . 61.54 107.633 170.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.24 117.03 28.44 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.289 -1.004 . . . . 73.51 108.289 177.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.517 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 57.6 mtt180 -84.92 100.95 11.96 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.064 0.945 . . . . 73.13 108.81 176.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.8 t -103.43 103.29 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.613 -0.884 . . . . 75.15 108.613 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 26.0 m -109.3 109.32 20.19 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.224 0.61 . . . . 73.14 109.78 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.43 HG12 HD23 ' A' ' 126' ' ' LEU . 2.6 t -105.97 133.36 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.944 1.298 . . . . 73.3 109.537 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.439 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 41.7 m -120.47 143.14 48.68 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.538 -0.912 . . . . 72.45 108.538 173.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.14 109.58 18.64 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.612 -1.255 . . . . 74.14 107.612 168.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 50.2 m -111.79 127.39 55.79 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.773 -0.825 . . . . 74.21 108.773 175.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.6 mt -89.63 49.21 1.7 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.265 1.026 . . . . 73.13 109.314 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.28 -92.0 1.37 Allowed Glycine 0 CA--C 1.529 0.906 0 N-CA-C 111.766 -0.534 . . . . 72.02 111.766 -173.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -88.68 -30.53 19.06 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.027 0.531 . . . . 73.45 112.011 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -113.36 126.78 55.74 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 109.779 -0.452 . . . . 75.34 109.779 -175.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 68.4 m -71.12 126.06 28.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.839 0.456 . . . . 75.45 109.81 173.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.542 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -71.87 -57.44 4.33 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.677 0.791 . . . . 72.53 109.923 176.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -157.33 174.94 14.67 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.599 -1.182 . . . . 72.12 111.249 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 tp -132.42 143.55 49.88 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 113.878 -1.51 . . . . 75.14 108.123 175.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 76.1 m -137.65 129.21 28.26 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.968 1.307 . . . . 75.21 107.878 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.594 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 39.7 tt0 -147.73 116.33 6.68 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.489 -0.93 . . . . 72.42 108.489 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.4 t -133.08 110.8 15.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 123.364 0.665 . . . . 75.31 109.743 -173.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.517 ' HG2' ' HG2' ' A' ' 61' ' ' ARG . 18.6 mt-30 -86.4 85.94 7.33 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.092 -1.077 . . . . 72.41 108.092 172.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.44 ' HG3' HD23 ' A' ' 106' ' ' LEU . 9.1 tp-100 -77.61 101.02 6.36 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.27 -0.877 . . . . 75.14 108.907 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.98 146.26 20.35 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.694 -0.962 . . . . 71.43 110.694 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.489 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -149.88 122.51 1.43 Allowed Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 111.399 -0.68 . . . . 74.53 111.399 -176.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 24.6 mt -82.84 116.88 27.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 109.079 -0.711 . . . . 75.32 109.079 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.724 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 14.6 m-85 -133.14 120.56 21.38 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.507 -1.294 . . . . 74.13 107.507 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.0 m -85.17 99.47 11.1 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.854 -0.795 . . . . 60.2 108.854 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.5 pt -123.84 118.56 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 123.909 0.884 . . . . 74.54 110.67 -172.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.41 167.06 5.72 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.551 1.14 . . . . 75.51 109.625 178.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 150.79 2.58 0.24 Allowed Glycine 0 N--CA 1.477 1.388 0 O-C-N 123.564 0.54 . . . . 74.31 114.093 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.403 ' O ' HG21 ' A' ' 89' ' ' ILE . 3.6 mp 61.5 29.21 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.747 0 CA-C-O 122.952 1.358 . . . . 74.53 109.571 177.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 94' ' ' MET . 2.6 tp10 -73.32 -24.49 60.39 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 114.788 -1.096 . . . . 75.44 111.696 -171.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' E' ' 21' ' ' ALA . . . 72.42 -111.62 3.65 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-N 116.057 -0.52 . . . . 71.42 113.618 172.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.6 p -62.52 -35.3 78.96 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.845 0.858 . . . . 73.22 111.59 -176.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -74.77 -34.53 62.47 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.887 0.875 . . . . 63.11 111.046 173.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.464 ' HG2' HD22 ' A' ' 98' ' ' LEU . 53.2 ttp -60.34 -30.37 69.48 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 122.527 0.331 . . . . 75.54 111.127 172.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.37 -33.1 74.08 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.68 0.792 . . . . 73.12 111.532 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.514 ' HD2' ' HG3' ' A' ' 138' ' ' MET . 41.3 t-80 -63.24 -37.87 88.92 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.036 0.534 . . . . 74.44 110.749 174.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 22.2 t -74.66 -54.55 7.2 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.442 0.297 . . . . 74.02 111.09 -175.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.464 HD22 ' HG2' ' A' ' 94' ' ' MET . 4.6 pp -75.42 -30.64 60.11 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.352 0.661 . . . . 75.31 112.347 -172.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.92 3.94 25.75 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.368 -0.684 . . . . 64.33 114.386 -170.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.591 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -147.73 -51.9 0.19 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 118.089 0.945 . . . . 73.24 112.612 -175.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.519 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 91.4 t80 -78.74 -61.7 1.93 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.509 0.723 . . . . 72.35 112.327 -170.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.409 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 71.2 m -65.12 -36.78 16.85 Favored Pre-proline 0 CA--C 1.564 1.495 0 N-CA-C 113.627 0.973 . . . . 61.4 113.627 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 18.0 Cg_endo -61.3 -32.36 89.82 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 121.905 1.737 . . . . 73.14 113.603 165.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -74.31 -21.85 59.53 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 122.988 0.515 . . . . 75.05 110.563 177.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 23.2 mm -65.63 -38.86 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.215 0.606 . . . . 73.24 109.411 170.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.489 HD21 ' HA3' ' A' ' 82' ' ' GLY . 86.4 mt -74.33 -23.55 59.07 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.901 0.881 . . . . 74.45 112.438 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.444 ' HE2' ' HA ' ' A' ' 130' ' ' PRO . 54.7 t80 -61.17 -47.59 94.28 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-O 118.209 -0.9 . . . . 71.33 113.268 -174.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -60.76 -34.86 91.14 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.225 1.95 . . . . 75.3 113.479 174.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.408 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 93.6 m-85 -75.41 -37.51 60.44 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.365 0.666 . . . . 74.44 112.03 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.28 -35.95 63.76 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.813 0.445 . . . . 55.4 109.909 177.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.492 ' NH1' HG23 ' C' ' 105' ' ' ILE . 27.3 ttm105 -63.73 -39.99 95.65 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 108.67 -0.863 . . . . 75.51 108.67 172.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.437 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 3.3 tm-20 -64.52 -48.16 76.16 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.131 0.972 . . . . 75.13 111.461 -177.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 36.0 t -60.68 -43.2 98.0 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 123.906 0.754 . . . . 74.14 110.16 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 72.4 mt -65.08 -44.31 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.353 0.661 . . . . 73.41 110.511 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.9 m -57.83 -41.75 82.94 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.564 1.145 . . . . 75.42 110.793 -177.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.3 t -77.71 -42.84 33.03 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.209 -0.905 . . . . 71.32 111.056 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.419 ' SD ' HG22 ' A' ' 21' ' ' ILE . 9.8 mtp -56.91 -46.85 81.7 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 123.84 0.856 . . . . 71.33 111.621 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.6 t -64.06 -41.9 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.567 1.147 . . . . 75.53 110.949 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.68 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 38.2 t -67.33 -35.11 78.75 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.769 -0.65 . . . . 52.44 111.165 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -74.46 -28.31 60.97 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.814 0.846 . . . . 74.51 110.141 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.9 6.79 64.94 Favored Glycine 0 C--N 1.354 1.53 0 O-C-N 123.899 0.75 . . . . 41.23 112.508 171.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.459 HG23 ' HE ' ' B' ' 15' ' ' ARG . 1.7 t 62.64 19.49 11.37 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 127.108 2.163 . . . . 61.22 113.299 172.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -81.95 161.78 59.52 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 109.174 -0.676 . . . . 74.33 109.174 175.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -53.53 115.13 2.11 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.343 2.029 . . . . 72.1 110.286 169.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.68 ' HG3' ' HB2' ' A' ' 119' ' ' SER . 4.0 tt0 -55.37 131.54 46.01 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 124.289 0.993 . . . . 73.45 111.24 -166.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.43 HD23 HG12 ' A' ' 64' ' ' VAL . 55.7 tp -107.08 106.73 17.38 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.425 -0.807 . . . . 74.02 110.605 -162.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -121.64 107.66 12.64 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.556 1.142 . . . . 74.52 108.582 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.431 ' O ' HD12 ' C' ' 13' ' ' ILE . 7.5 mp -72.75 145.88 46.78 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.826 0.45 . . . . 74.25 110.52 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.49 149.18 92.57 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 123.975 0.91 . . . . 61.42 111.145 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.609 ' HD3' HG13 ' C' ' 13' ' ' ILE . 44.0 Cg_endo -66.16 131.07 25.75 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 123.014 2.476 . . . . 72.22 112.194 -178.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.2 t -113.32 112.98 42.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.735 -1.209 . . . . 74.25 107.735 173.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -81.1 86.69 6.12 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.036 -0.727 . . . . 61.1 109.036 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -62.51 -39.84 94.81 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.9 -0.591 . . . . 70.3 109.925 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.591 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 8.9 p-10 -57.27 -29.27 63.71 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.225 1.01 . . . . 73.13 112.472 177.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -89.94 -60.39 1.95 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.22 0.608 . . . . 71.34 110.924 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.4 mp -69.45 -38.26 77.7 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.947 0.899 . . . . 74.15 113.158 -168.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -68.37 -43.2 77.9 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.517 0.675 . . . . 73.42 109.678 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.514 ' HG3' ' HD2' ' A' ' 96' ' ' HIS . 95.9 mmm -76.99 -22.7 52.74 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 114.915 -1.039 . . . . 75.11 111.184 177.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -64.37 -42.19 96.32 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.54 0.736 . . . . 73.24 109.466 174.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -65.25 -39.05 92.15 Favored 'General case' 0 CA--C 1.551 1.01 0 O-C-N 124.146 0.904 . . . . 72.23 110.573 176.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 21.2 tp -67.61 -7.0 22.86 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.868 1.267 . . . . 72.44 112.434 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -142.11 19.38 2.1 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.335 0.654 . . . . 75.21 109.324 -178.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -81.41 82.51 7.21 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.809 0.814 . . . . 75.41 109.224 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -159.87 14.34 0.14 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.542 -1.208 . . . . 74.42 110.728 -173.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 61.83 91.46 0.06 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.707 1.203 . . . . 73.53 110.768 -172.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.0 -128.98 2.29 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.652 -0.704 . . . . 75.21 111.44 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -160.11 163.24 33.96 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 117.228 0.514 . . . . 71.41 110.811 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -85.3 -177.71 50.68 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.396 -0.82 . . . . 73.01 113.194 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.7 t -131.91 168.24 18.22 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.125 0.97 . . . . 70.54 108.97 176.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -89.69 40.75 1.01 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.297 0.639 . . . . 65.11 110.208 177.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 59.69 -80.07 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.714 1.606 . . . . 74.45 111.745 -177.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 -152.04 149.67 29.1 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.901 0.88 . . . . 70.23 109.699 -177.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -82.45 135.39 35.15 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.322 0.649 . . . . 70.54 109.354 168.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -91.94 85.97 5.72 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.713 -0.847 . . . . 72.11 108.713 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.096 0 C-N-CA 123.875 0.87 . . . . 74.14 109.659 177.358 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 120.512 0.196 . . . . 71.21 111.174 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 32.7 t -88.54 75.3 8.36 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.602 0.715 . . . . 74.52 111.299 -173.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -128.68 91.55 3.25 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.207 -1.034 . . . . 74.54 108.207 171.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -76.5 -96.06 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.564 -0.743 . . . . 74.52 109.52 -175.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 179.99 160.05 0.84 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.184 0.594 . . . . 74.45 110.785 -176.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . 0.408 ' HB3' ' HA ' ' B' ' 89' ' ' ILE . 18.5 t-20 -171.48 143.88 1.85 Allowed 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 107.992 -1.114 . . . . 73.05 107.992 167.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 59.6 p -117.59 -1.57 11.63 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.771 0.828 . . . . 75.41 111.08 -176.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -101.81 -81.21 0.49 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.81 0.844 . . . . 75.35 111.171 -173.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.563 ' HB2' ' HB ' ' B' ' 89' ' ' ILE . 16.8 ttt 60.27 164.45 0.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.436 1.494 . . . . 64.33 112.415 -170.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 85.3 m -159.24 143.35 15.16 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 124.171 0.988 . . . . 65.24 108.573 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -145.97 156.86 43.79 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.652 0.739 . . . . 72.41 110.448 158.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -125.26 130.59 52.35 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 106.257 -1.757 . . . . 75.42 106.257 172.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.535 HD11 HD12 ' B' ' 105' ' ' ILE . 34.0 mt -67.09 112.68 2.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 108.567 -0.901 . . . . 72.52 108.567 176.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . 0.445 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 16.9 mm-40 -80.15 -49.65 11.39 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.015 -0.993 . . . . 75.4 109.179 -178.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.459 ' HE ' HG23 ' A' ' 122' ' ' THR . 42.6 ttt180 -167.07 139.54 3.44 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.67 -0.695 . . . . 74.25 110.244 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.5 mt -114.86 141.56 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 107.424 -1.325 . . . . 74.04 107.424 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -167.78 153.43 7.26 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.689 0.757 . . . . 64.42 112.362 -176.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.6 m -80.54 122.93 27.65 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.822 -1.081 . . . . 73.45 108.707 168.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.435 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 38.0 mtpt -91.4 -41.89 10.62 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.015 0.526 . . . . 74.4 109.669 176.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 24.5 t70 -142.59 139.03 31.19 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.845 -0.616 . . . . 75.32 111.18 -168.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.55 HD13 ' SG ' ' B' ' 113' ' ' CYS . 48.8 mm -133.15 137.97 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.198 1.399 . . . . 70.43 108.174 173.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.53 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 42.8 t -144.75 117.46 8.68 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.338 -1.356 . . . . 74.51 107.338 -177.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 84.3 t80 -140.07 116.54 10.71 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.76 -1.2 . . . . 74.14 107.76 176.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -124.46 113.84 18.66 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.667 0.787 . . . . 74.1 109.34 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.485 ' HB3' ' HB3' ' B' ' 28' ' ' ALA . . . -108.24 85.45 2.74 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 107.989 -1.115 . . . . 53.43 107.989 170.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -73.38 -23.34 17.66 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.776 2.318 . . . . 72.54 112.667 -171.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -114.99 5.46 15.02 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.169 0.988 . . . . 74.31 110.936 -173.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.485 ' HB3' ' HB3' ' B' ' 25' ' ' ALA . . . -43.71 -61.63 1.84 Allowed Pre-proline 0 N--CA 1.492 1.643 0 C-N-CA 125.638 1.575 . . . . 73.21 114.382 -167.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.86 -24.99 77.84 Favored 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 122.56 2.174 . . . . 75.12 113.245 -171.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -96.04 -33.08 12.25 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.652 0.781 . . . . 74.34 111.496 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 p -74.44 -16.03 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 122.601 0.361 . . . . 71.22 110.571 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -67.88 -7.98 32.64 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.63 0.772 . . . . 72.31 112.838 176.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -67.54 -13.29 61.92 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 122.444 0.297 . . . . 75.54 110.902 171.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -105.55 110.42 22.74 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.445 1.498 . . . . 71.15 109.346 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -107.53 79.71 1.32 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.452 0.701 . . . . 71.01 110.93 -170.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 43.0 p90 -156.93 175.75 13.67 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.584 0.754 . . . . 73.54 109.217 171.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -77.37 113.13 28.64 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.197 -1.038 . . . . 75.55 108.197 173.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.28 148.53 88.6 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.171 1.914 . . . . 74.51 111.925 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -66.53 122.43 17.55 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.727 -0.842 . . . . 75.34 108.727 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.451 HG11 HG12 ' B' ' 64' ' ' VAL . 57.7 t -111.23 131.35 62.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 124.042 0.937 . . . . 70.11 111.021 -171.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -106.02 135.23 47.85 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.942 -1.133 . . . . 72.12 107.942 169.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 pp -109.24 154.83 21.86 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.06 0.944 . . . . 74.55 109.542 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -159.81 150.45 19.05 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.566 0.746 . . . . 74.34 109.273 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.454 HD13 HD13 ' B' ' 60' ' ' LEU . 62.4 mt -123.94 152.27 42.65 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.388 0.675 . . . . 75.33 110.197 175.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 11.4 t70 -138.5 142.6 39.35 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.635 1.174 . . . . 75.22 107.925 173.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 39.4 p -109.94 111.92 23.62 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.428 0.691 . . . . 73.32 109.959 -176.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.452 ' HB2' ' HB ' ' B' ' 59' ' ' VAL . . . -116.71 149.08 40.43 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.179 0.992 . . . . 75.11 108.379 176.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 46.5 p -145.45 162.14 38.05 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.292 0.479 . . . . 73.45 112.292 -174.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.8 p -153.55 136.2 15.22 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 114.691 -1.14 . . . . 70.44 108.532 164.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -93.86 110.18 21.85 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.157 -1.053 . . . . 65.03 108.157 173.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.449 HD12 HG22 ' B' ' 83' ' ' ILE . 63.6 mt -78.01 -39.81 41.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.189 0.596 . . . . 72.04 111.2 -174.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.47 -167.5 1.6 Allowed 'General case' 0 C--O 1.242 0.705 0 CA-C-N 115.184 -0.916 . . . . 60.42 110.167 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -71.71 120.22 16.99 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.985 -1.007 . . . . 71.05 109.083 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 70.35 -4.77 1.5 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.989 1.316 . . . . 74.55 112.362 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 85.3 t -104.88 115.29 46.48 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 N-CA-C 107.504 -1.295 . . . . 74.52 107.504 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -129.46 154.94 46.48 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.587 -0.894 . . . . 72.22 108.587 -175.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -126.25 111.36 14.48 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.341 -0.985 . . . . 74.23 108.341 -174.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 88.0 t -100.81 119.26 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.215 1.406 . . . . 74.14 110.134 -173.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' B' ' 47' ' ' ALA . 20.1 t -109.43 114.21 46.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 109.01 -0.737 . . . . 73.31 109.01 178.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.454 HD13 HD13 ' B' ' 44' ' ' LEU . 35.3 tp -99.51 111.38 23.74 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.804 -0.813 . . . . 74.3 108.804 169.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 33.7 ttm180 -86.09 127.21 34.64 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.824 -0.806 . . . . 72.41 108.824 170.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 36.2 t -113.98 103.92 16.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.579 -1.267 . . . . 74.03 107.579 172.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 9.6 m -98.1 136.27 38.57 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.166 0.586 . . . . 65.2 109.644 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.507 HG23 HD12 ' B' ' 114' ' ' ILE . 69.4 t -125.57 135.89 62.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.862 1.265 . . . . 75.55 109.584 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 95.5 m -117.5 148.86 41.46 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.934 -1.135 . . . . 72.05 107.934 167.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.37 147.0 29.84 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.036 0.534 . . . . 65.12 109.96 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.457 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 15.6 p -147.98 128.13 13.76 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.64 -0.709 . . . . 63.41 111.055 -175.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 53.1 mt -92.55 100.46 12.99 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 106.904 -1.517 . . . . 73.11 106.904 173.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.36 -139.01 26.06 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 111.345 -0.702 . . . . 44.11 111.345 -172.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -92.89 23.01 4.43 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.356 0.662 . . . . 64.25 110.138 175.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -118.93 138.95 52.42 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.276 1.03 . . . . 74.43 108.963 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 55.5 m -69.62 119.74 14.32 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.75 -0.463 . . . . 75.24 109.75 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.457 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -78.16 -62.61 1.62 Allowed 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.246 -1.02 . . . . 63.33 108.246 176.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -157.79 163.04 38.46 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.851 -1.068 . . . . 74.44 111.282 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 23.9 mt -123.34 127.37 48.41 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 105.977 -1.86 . . . . 74.13 105.977 172.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -128.74 155.35 45.24 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.323 -0.621 . . . . 73.13 109.323 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 37.2 tt0 -166.06 129.98 2.16 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.194 -0.669 . . . . 73.05 109.194 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.416 HG21 HD12 ' B' ' 21' ' ' ILE . 99.0 t -128.1 151.33 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.925 0.89 . . . . 71.22 108.708 177.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -125.37 108.93 12.17 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.681 -0.859 . . . . 61.45 108.681 168.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.409 ' HB2' ' HB1' ' B' ' 110' ' ' ALA . 7.5 tp-100 -92.81 100.41 12.9 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.43 -0.952 . . . . 73.53 108.43 174.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.435 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.09 145.32 17.62 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.895 -0.882 . . . . 73.43 110.895 176.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.13 127.7 2.48 Favored Glycine 0 CA--C 1.506 -0.518 0 N-CA-C 110.55 -1.02 . . . . 55.43 110.55 -174.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.449 HG22 HD12 ' B' ' 51' ' ' LEU . 27.8 mt -85.0 119.48 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 108.238 -1.023 . . . . 74.44 108.238 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -126.39 132.18 51.59 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 107.133 -1.432 . . . . 73.32 107.133 175.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 70.1 m -88.98 87.76 7.34 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.344 0.52 . . . . 63.25 109.861 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.437 HG12 HD21 ' B' ' 98' ' ' LEU . 2.6 pp -96.67 131.24 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.092 0.957 . . . . 65.55 109.959 -171.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.21 160.5 37.23 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.737 0.415 . . . . 75.05 111.359 173.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.47 -69.31 0.21 Allowed Glycine 0 C--N 1.343 0.949 0 CA-C-N 115.537 -0.756 . . . . 74.1 112.802 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' B' ' 9' ' ' MET . 0.1 OUTLIER -78.82 154.58 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.248 0.619 . . . . 74.41 110.759 -173.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' F' ' 21' ' ' ALA . 15.7 pt-20 -154.41 -175.1 5.24 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.706 -0.679 . . . . 72.04 111.717 -164.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.62 -113.52 5.94 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 115.127 -0.942 . . . . 74.43 112.53 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 77.7 m -88.21 -31.33 19.14 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.535 0.734 . . . . 60.24 110.773 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -65.96 -30.98 71.63 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 116.165 -0.47 . . . . 63.22 111.338 -171.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -68.42 -33.38 74.12 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.091 0.472 . . . . 74.55 110.686 174.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.02 -25.79 61.09 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.864 0.866 . . . . 74.13 110.927 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -77.97 -40.18 40.11 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.698 0.799 . . . . 73.33 110.786 174.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.1 t -68.22 -57.62 5.72 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.848 0.356 . . . . 74.3 110.599 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.437 HD21 HG12 ' B' ' 86' ' ' ILE . 6.3 mp -81.43 -8.34 59.72 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 116.384 -0.371 . . . . 72.15 111.638 -177.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.97 4.06 31.88 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 119.763 -0.465 . . . . 74.35 114.037 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.424 ' HB1' ' N ' ' B' ' 134' ' ' ASP . . . -151.91 -49.07 0.11 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 117.157 0.479 . . . . 64.4 111.937 -175.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.418 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 54.0 t80 -78.58 -50.86 10.8 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.942 -0.572 . . . . 73.22 111.148 -173.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 70.3 m -64.24 -46.3 79.14 Favored Pre-proline 0 CA--C 1.568 1.657 0 C-N-CA 123.434 0.694 . . . . 74.12 111.307 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -49.94 -36.93 45.38 Favored 'Trans proline' 0 C--N 1.404 3.473 0 C-N-CA 123.163 2.575 . . . . 72.14 114.996 168.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -63.62 -40.12 96.1 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 122.883 0.473 . . . . 74.44 110.381 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.535 HD12 HD11 ' B' ' 13' ' ' ILE . 64.7 mt -66.11 -42.66 91.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.515 0.726 . . . . 73.14 110.595 178.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 85.2 mt -82.68 -19.2 38.57 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.498 -0.774 . . . . 73.14 112.166 -174.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -57.85 -53.86 61.41 Favored Pre-proline 0 CA--C 1.561 1.367 0 CA-C-O 117.877 -1.058 . . . . 73.22 112.974 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -58.39 -33.42 97.81 Favored 'Trans proline' 0 C--N 1.392 2.854 0 C-N-CA 122.43 2.087 . . . . 74.31 114.209 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -71.02 -51.33 26.02 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.984 0.514 . . . . 74.43 110.46 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' B' ' 80' ' ' GLN . . . -58.07 -37.74 75.04 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.442 -0.799 . . . . 64.33 110.932 176.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -59.73 -57.02 14.73 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.747 1.619 . . . . 74.45 110.696 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -64.83 -29.8 70.78 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.706 0.803 . . . . 74.41 110.413 -178.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.55 ' SG ' HD13 ' B' ' 21' ' ' ILE . 4.2 t -70.3 -43.38 70.52 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 122.957 0.503 . . . . 74.01 110.909 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.507 HD12 HG23 ' B' ' 64' ' ' VAL . 83.6 mt -60.88 -53.15 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.287 -0.634 . . . . 75.31 109.287 175.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.4 m -55.12 -34.87 64.09 Favored 'General case' 0 CA--C 1.551 0.996 0 O-C-N 124.563 1.164 . . . . 74.11 111.744 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 42.7 t -65.85 -51.23 60.57 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 115.39 -0.823 . . . . 71.33 110.197 175.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.594 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 15.1 mmt -67.82 -30.5 69.92 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.355 0.662 . . . . 75.45 111.797 -174.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.94 -44.73 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.392 1.077 . . . . 75.04 109.969 174.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 27.7 t -70.1 -25.49 63.53 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.224 -0.898 . . . . 73.22 110.543 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.594 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 89.8 mtt-85 -70.38 -30.48 67.4 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.804 -0.443 . . . . 75.32 109.804 174.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.46 12.65 54.95 Favored Glycine 0 C--N 1.355 1.62 0 O-C-N 123.549 0.531 . . . . 73.4 112.644 170.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.402 HG21 ' HB3' ' A' ' 17' ' ' TYR . 38.1 p 54.15 24.68 5.05 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 126.464 1.906 . . . . 72.23 113.992 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -83.86 156.76 64.23 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 123.318 0.647 . . . . 73.42 110.673 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -64.41 178.28 1.72 Allowed 'Trans proline' 0 C--N 1.389 2.668 0 C-N-CA 123.429 2.753 . . . . 73.22 114.072 -177.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.627 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 23.2 tp60 -65.16 125.9 26.42 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.443 -1.253 . . . . 64.1 112.27 -169.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -135.52 114.41 12.05 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 108.89 -0.781 . . . . 75.32 108.89 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -130.46 135.04 47.56 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.319 1.047 . . . . 75.32 108.209 171.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 tt -87.78 142.52 27.76 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.787 0.835 . . . . 73.32 109.143 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' F' ' 7' ' ' ALA . . . -71.24 152.47 94.44 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 123.327 0.651 . . . . 51.11 110.995 176.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.52 139.79 60.27 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.89 2.393 . . . . 73.02 111.372 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.56 110.34 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.786 0.803 . . . . 74.32 109.56 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -92.0 83.97 5.25 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.249 -0.887 . . . . 73.12 109.27 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -58.79 -42.41 88.99 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.766 -0.827 . . . . 73.4 108.766 172.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.424 ' N ' ' HB1' ' B' ' 100' ' ' ALA . 6.4 p-10 -57.6 -53.83 53.68 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 113.909 -1.496 . . . . 75.13 112.264 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.71 -37.19 85.74 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.568 0.747 . . . . 61.15 112.122 -175.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.21 -46.99 63.4 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.329 0.652 . . . . 74.11 111.264 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -72.47 -23.07 60.99 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.828 0.451 . . . . 65.1 111.304 178.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -70.27 -38.57 75.13 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.391 0.676 . . . . 75.24 109.491 175.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -76.43 -14.48 60.06 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.922 -1.036 . . . . 72.45 111.278 -172.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -64.78 -30.91 71.94 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.93 0.892 . . . . 72.14 111.142 173.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 62.4 mt -82.42 8.87 10.31 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.565 0.746 . . . . 71.11 112.207 -174.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.33 111.16 10.31 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.33 -0.989 . . . . 62.35 108.33 175.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -128.6 160.41 32.49 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.017 0.927 . . . . 74.34 110.23 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -167.18 152.24 7.31 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.083 0.953 . . . . 72.22 109.167 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -142.64 146.55 34.6 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.692 0.797 . . . . 74.12 109.893 177.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.94 -157.51 31.91 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 123.665 0.603 . . . . 61.55 113.149 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -161.89 128.09 3.68 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.49 0.716 . . . . 54.43 109.223 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -148.98 128.6 2.82 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 110.668 -0.973 . . . . 63.33 110.668 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 79.6 p -117.35 103.97 10.67 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.124 0.569 . . . . 72.21 110.131 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -94.29 126.84 39.79 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 107.935 -1.135 . . . . 72.23 107.935 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -141.33 143.73 34.19 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.337 0.655 . . . . 72.34 110.372 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -154.5 138.75 16.61 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.536 1.134 . . . . 74.32 108.655 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -80.56 73.91 7.48 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.749 0.785 . . . . 65.4 111.019 -176.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -77.61 96.91 4.92 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.089 -0.708 . . . . 75.13 109.089 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.9 0 C-N-CA 124.495 1.118 . . . . 74.21 108.369 -179.482 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 86.0 mtp . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.822 -0.436 . . . . 75.0 109.822 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 48.0 m -124.24 -64.52 1.12 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.81 -0.811 . . . . 74.25 108.81 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 71.06 -56.2 0.63 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.742 1.617 . . . . 72.41 111.339 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 14.1 tp60 -65.86 153.76 41.07 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 124.496 1.119 . . . . 75.11 109.728 169.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 13.7 m120 73.83 170.31 0.3 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 125.194 1.398 . . . . 64.34 111.13 -172.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 4.1 t30 62.48 41.86 9.36 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.52 1.128 . . . . 75.32 109.651 -173.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 17.7 m -62.98 -46.51 87.34 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.411 -1.268 . . . . 75.3 110.959 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -75.29 122.98 24.53 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.468 -0.787 . . . . 74.13 109.053 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.5 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 0.0 OUTLIER 64.9 114.16 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.937 1.295 . . . . 75.11 110.96 -176.412 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 30.0 m -98.75 109.17 21.97 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.703 -0.851 . . . . 72.55 108.703 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.5 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 0.3 OUTLIER -120.15 123.6 43.72 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.83 -0.804 . . . . 73.31 108.83 -177.453 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -138.31 118.08 13.19 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.248 -1.019 . . . . 73.34 108.248 174.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.609 HG13 ' HD3' ' A' ' 130' ' ' PRO . 75.8 mt -67.95 122.4 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.844 -0.798 . . . . 74.23 108.844 173.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -86.13 -45.63 11.18 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 124.079 0.862 . . . . 72.11 109.481 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -179.4 124.79 0.08 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.293 -0.867 . . . . 74.42 109.414 -170.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.456 HG21 ' CD1' ' C' ' 109' ' ' TYR . 30.1 mt -116.28 150.55 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 108.06 -1.089 . . . . 73.2 108.06 173.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.43 ' HE2' ' HD2' ' C' ' 19' ' ' LYS . 22.8 p90 -174.49 171.54 3.32 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.057 0.943 . . . . 75.23 109.765 -173.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -90.85 118.31 30.16 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.612 -0.884 . . . . 75.23 108.612 174.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.486 ' HE3' ' HB2' ' D' ' 28' ' ' ALA . 10.0 mmmm -69.64 -45.78 67.68 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 122.102 0.953 . . . . 74.22 108.469 171.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.663 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 12.0 t70 -146.0 147.16 31.37 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 113.71 -1.587 . . . . 73.21 109.771 -169.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 63.5 mt -142.9 150.48 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.459 1.503 . . . . 71.25 107.456 177.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -160.57 151.91 19.29 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.389 0.614 . . . . 75.32 110.428 175.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -153.78 109.18 3.19 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.975 -1.12 . . . . 73.1 107.975 171.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -117.09 110.42 18.18 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.214 0.605 . . . . 73.1 110.028 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.509 ' HB1' ' HB3' ' C' ' 28' ' ' ALA . . . -117.56 87.39 25.62 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 106.619 -1.623 . . . . 65.03 106.619 167.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.42 -29.92 19.97 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.37 2.046 . . . . 74.03 111.531 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -91.93 12.57 21.25 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.568 1.147 . . . . 64.55 111.112 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.509 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . . . -53.54 -58.59 12.28 Favored Pre-proline 0 CA--C 1.562 1.442 0 N-CA-C 114.031 1.123 . . . . 74.2 114.031 -166.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -57.85 -39.9 83.08 Favored 'Trans proline' 0 C--N 1.397 3.09 0 C-N-CA 122.182 1.921 . . . . 72.55 112.414 -174.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -69.38 -45.75 68.58 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.449 -1.25 . . . . 74.51 111.688 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.9 p -73.72 -20.89 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 N-CA-C 113.131 0.789 . . . . 75.52 113.131 -165.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -62.15 -25.61 67.85 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 113.99 1.107 . . . . 73.44 113.99 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -98.07 16.89 19.76 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.508 0.723 . . . . 62.22 111.259 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.799 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -94.59 157.13 16.12 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.94 0.896 . . . . 75.3 109.461 173.104 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -67.13 123.24 19.71 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.295 0.638 . . . . 72.41 109.508 166.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -79.14 99.02 6.79 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.765 0.826 . . . . 73.53 110.434 -175.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -151.69 71.31 8.12 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 108.468 -0.938 . . . . 74.24 108.468 176.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -87.41 153.46 7.88 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.916 2.411 . . . . 70.12 112.21 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -89.94 112.33 23.68 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.551 -1.278 . . . . 74.12 107.551 168.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 40.2 t -72.74 102.3 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 109.147 -0.686 . . . . 74.32 109.147 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.498 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 54.0 mmtt -93.24 113.11 25.23 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.193 0.997 . . . . 74.53 109.33 175.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.44 HD22 HD23 ' G' ' 8' ' ' LEU . 4.2 mp -96.43 123.96 40.27 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.07 -1.085 . . . . 72.24 108.07 176.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -131.87 106.87 8.35 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.971 0.909 . . . . 73.21 109.004 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.35 123.17 48.4 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.258 -0.645 . . . . 74.04 109.258 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 15.5 t70 -112.58 147.79 35.9 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.132 1.373 . . . . 75.43 107.941 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 57.5 p -114.45 126.32 54.83 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.099 0.56 . . . . 75.32 110.904 -170.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.33 151.95 51.9 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.424 1.089 . . . . 71.44 108.494 175.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 6.4 p -163.29 163.43 25.3 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.73 0.412 . . . . 71.45 110.015 -176.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 25.8 t -165.55 133.66 3.08 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.996 0.518 . . . . 71.25 110.25 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -82.24 139.02 34.48 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.038 0.535 . . . . 74.15 109.563 173.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.468 HD13 HD13 ' C' ' 83' ' ' ILE . 84.1 mt -110.46 -41.8 4.26 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.486 0.714 . . . . 72.45 110.039 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.4 -174.36 4.91 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.56 -0.746 . . . . 71.12 110.642 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -68.93 126.22 29.11 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.747 -1.115 . . . . 73.53 108.488 172.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 67.28 6.52 4.89 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.737 1.215 . . . . 73.33 112.561 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 80.9 t -122.5 115.3 45.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 108.171 -1.048 . . . . 71.54 108.171 177.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -137.25 130.13 30.46 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.515 -0.766 . . . . 73.44 109.282 -173.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -92.35 127.26 37.77 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.214 -0.903 . . . . 74.51 109.605 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.449 HG21 HD13 ' C' ' 106' ' ' LEU . 26.9 m -111.87 136.99 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 108.141 -1.059 . . . . 75.33 108.141 166.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -126.66 121.23 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.436 1.094 . . . . 71.33 108.928 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.434 HD22 ' HB3' ' C' ' 103' ' ' PRO . 47.9 tp -111.95 113.8 26.33 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.4 -0.592 . . . . 74.44 109.4 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.444 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 34.5 ttm180 -82.92 107.69 15.71 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 108.856 -0.794 . . . . 72.53 108.856 173.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.472 ' HB ' HD11 ' C' ' 114' ' ' ILE . 6.6 t -99.5 121.34 50.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.053 -1.092 . . . . 71.23 108.053 171.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 72.0 m -112.7 128.21 56.34 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.404 -1.332 . . . . 62.22 107.404 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.514 HG21 HD12 ' C' ' 114' ' ' ILE . 99.5 t -116.03 115.18 48.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.626 -0.879 . . . . 75.22 108.626 172.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 4.4 m -100.78 139.27 36.7 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.73 -0.841 . . . . 74.14 108.73 175.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.33 113.1 15.18 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.577 -1.268 . . . . 75.43 107.577 176.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -136.18 131.44 34.64 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.032 -0.729 . . . . 75.02 109.032 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.799 HD11 ' HG2' ' C' ' 34' ' ' LYS . 3.5 mt -87.13 35.93 0.72 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.575 1.55 . . . . 73.14 110.037 -177.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.02 -117.31 4.9 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 109.682 -1.367 . . . . 74.32 109.682 -164.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -89.93 -20.43 23.36 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.611 0.764 . . . . 72.04 111.221 176.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -78.5 103.2 8.29 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.788 -0.819 . . . . 75.3 108.788 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 37.2 m -72.76 123.49 23.43 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.485 -0.561 . . . . 61.14 109.485 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.64 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.43 -56.03 5.1 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.422 -0.808 . . . . 72.4 109.017 174.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -159.66 168.18 26.63 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 122.223 1.011 . . . . 74.55 112.146 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.453 HD23 HG21 ' C' ' 65' ' ' THR . 1.7 tm? -130.01 130.75 45.37 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 105.386 -2.079 . . . . 74.33 105.386 167.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.428 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 44.6 t -128.75 138.23 52.0 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.228 -1.397 . . . . 65.41 107.228 174.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.16 118.77 5.29 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.979 -0.378 . . . . 73.52 109.979 -172.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' C' ' 61' ' ' ARG . 95.6 t -128.74 136.85 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.564 0.746 . . . . 75.53 109.105 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.663 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 26.4 mt-30 -109.33 97.17 6.81 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.55 -0.908 . . . . 73.12 108.55 169.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -84.85 116.91 23.57 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.351 -0.84 . . . . 72.21 109.136 178.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.6 145.79 16.87 Favored Glycine 0 C--N 1.343 0.921 0 N-CA-C 111.742 -0.543 . . . . 72.32 111.742 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.39 121.3 1.75 Allowed Glycine 0 CA--C 1.507 -0.433 0 N-CA-C 111.751 -0.54 . . . . 72.31 111.751 -176.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.503 HD11 ' HB3' ' D' ' 29' ' ' PRO . 9.5 mm -82.55 118.94 31.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 108.054 -1.091 . . . . 72.4 108.054 174.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -133.71 123.79 25.56 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.393 0.677 . . . . 64.31 109.987 -172.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 70.2 m -71.17 108.17 4.55 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.787 -0.82 . . . . 71.03 108.787 167.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.446 HG22 ' HE3' ' C' ' 9' ' ' MET . 78.2 mt -117.7 119.74 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.462 1.105 . . . . 73.14 108.412 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.15 168.28 26.46 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.53 0.732 . . . . 61.31 110.442 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.72 -33.78 5.97 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 116.26 -0.427 . . . . 74.44 113.936 170.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 40.2 pt -117.67 163.4 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.493 0.717 . . . . 65.12 110.957 -176.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -146.15 158.04 43.86 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.511 0.724 . . . . 75.15 110.696 -175.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.08 -129.72 15.64 Favored Glycine 0 C--N 1.349 1.258 0 CA-C-N 115.784 -0.644 . . . . 73.33 113.48 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 75.5 p -66.02 -26.79 67.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.685 0.794 . . . . 74.11 111.534 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -62.49 -54.12 44.7 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.959 0.504 . . . . 75.42 110.028 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.496 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 7.6 ptt? -76.79 -23.79 52.86 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.896 -0.593 . . . . 64.45 111.099 -176.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.48 -37.18 77.14 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.377 0.608 . . . . 60.22 110.364 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -67.78 -33.21 74.39 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.643 -1.162 . . . . 72.54 110.442 173.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.529 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 43.9 t -68.86 -60.59 2.27 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.802 -0.635 . . . . 64.53 110.682 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.589 HD23 HG22 ' G' ' 18' ' ' VAL . 3.7 pp -69.42 -28.3 66.03 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.44 0.696 . . . . 73.32 112.411 -174.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . 0.408 ' N ' HD11 ' C' ' 98' ' ' LEU . . . -94.57 -3.9 62.5 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-O 119.558 -0.579 . . . . 64.34 114.21 -172.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.58 -62.15 0.13 Allowed 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 117.496 0.648 . . . . 74.11 112.639 -172.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.529 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 54.7 t80 -66.41 -37.92 86.3 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 124.391 1.076 . . . . 70.1 113.106 -170.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.427 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 29.7 m -80.72 -42.64 1.26 Allowed Pre-proline 0 CA--C 1.564 1.511 0 C-N-CA 123.561 0.745 . . . . 64.4 111.034 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.434 ' HB3' HD22 ' C' ' 60' ' ' LEU . 89.0 Cg_exo -54.13 -24.21 32.36 Favored 'Trans proline' 0 C--N 1.398 3.151 0 C-N-CA 122.995 2.464 . . . . 72.55 114.617 166.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -67.77 -24.72 65.37 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.399 0.68 . . . . 73.21 111.792 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.492 HG23 ' NH1' ' A' ' 111' ' ' ARG . 31.7 mm -77.3 -35.17 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 109.24 -0.652 . . . . 75.45 109.24 173.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.449 HD13 HG21 ' C' ' 58' ' ' VAL . 82.0 mt -79.41 -24.9 42.24 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.671 -1.15 . . . . 73.11 111.818 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -57.11 -55.27 45.81 Favored Pre-proline 0 CA--C 1.557 1.226 0 CA-C-O 118.198 -0.906 . . . . 75.13 113.09 -173.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . 0.437 ' HB2' ' HG3' ' A' ' 112' ' ' GLU . 57.5 Cg_endo -66.57 -23.33 49.93 Favored 'Trans proline' 0 C--N 1.387 2.6 0 CA-C-N 121.174 1.455 . . . . 63.1 112.342 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . 0.456 ' CD1' HG21 ' C' ' 16' ' ' ILE . 2.3 m-30 -75.51 -49.31 19.11 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.13 0.972 . . . . 74.42 110.15 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.68 -38.24 84.29 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.149 0.98 . . . . 64.31 110.07 174.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -58.48 -53.07 62.42 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.253 1.421 . . . . 73.2 110.753 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.47 -32.61 73.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 123.694 0.622 . . . . 73.42 110.278 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.6 t -68.8 -34.41 75.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.001 0.52 . . . . 75.02 111.006 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.514 HD12 HG21 ' C' ' 64' ' ' VAL . 95.5 mt -73.33 -51.93 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.666 0.786 . . . . 74.32 109.84 175.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.0 m -64.56 -28.9 69.96 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.844 0.858 . . . . 71.32 111.426 -175.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.3 t -67.77 -48.62 65.85 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.238 -0.653 . . . . 64.41 109.238 172.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.655 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.1 -38.66 87.09 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.512 1.125 . . . . 74.44 112.836 -179.838 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 82.2 t -62.12 -45.38 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.769 0.828 . . . . 72.4 109.668 175.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 44.8 t -68.2 -32.47 72.71 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.239 -0.891 . . . . 74.43 111.947 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -68.88 -31.61 70.66 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.537 0.735 . . . . 75.13 109.703 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.82 10.79 73.83 Favored Glycine 0 C--N 1.355 1.607 0 O-C-N 123.969 0.793 . . . . 73.22 112.998 173.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.448 HG22 ' HB3' ' D' ' 17' ' ' TYR . 43.2 p 60.19 29.48 19.04 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 126.151 1.78 . . . . 61.44 114.257 173.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -96.03 147.0 32.31 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.494 -0.928 . . . . 75.21 108.494 171.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.627 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 80.6 Cg_exo -49.44 141.06 26.33 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.712 2.941 . . . . 75.51 114.421 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.494 ' HA ' HE21 ' C' ' 125' ' ' GLN . 0.0 OUTLIER -55.49 113.81 1.58 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.175 0.99 . . . . 73.23 111.354 -177.805 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 41.6 tp -107.78 92.81 4.22 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.601 -0.889 . . . . 73.53 108.601 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -93.03 114.71 27.33 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.197 -0.911 . . . . 45.05 108.976 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 tt -73.09 135.89 44.84 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.922 0.889 . . . . 75.4 110.252 -171.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.41 148.76 90.95 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 123.666 0.786 . . . . 70.12 111.997 -175.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.436 ' CG ' HD13 ' A' ' 16' ' ' ILE . 6.6 Cg_exo -70.86 116.57 4.73 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.145 2.563 . . . . 72.11 112.49 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.637 HG22 ' H ' ' G' ' 8' ' ' LEU . 90.5 t -126.96 110.58 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.784 -0.821 . . . . 75.15 108.784 173.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -71.97 104.69 3.61 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.281 1.032 . . . . 71.24 109.726 174.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -62.75 -44.63 95.71 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.283 0.563 . . . . 74.24 110.052 172.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -59.71 -43.82 93.98 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.372 -1.285 . . . . 74.11 111.184 -174.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.82 -48.77 35.11 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.521 -0.763 . . . . 71.41 110.302 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 5.7 tt -48.89 -59.94 3.17 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 124.537 1.135 . . . . 74.14 112.168 -171.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -58.23 -42.93 87.4 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 123.739 0.65 . . . . 73.4 112.127 -174.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 90.7 mtp -78.41 -32.59 48.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.877 0.471 . . . . 71.31 111.93 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -71.6 -35.35 70.48 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.503 0.721 . . . . 74.02 111.578 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -69.19 -151.71 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 124.387 1.075 . . . . 75.54 111.498 -171.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 77.2 mt 70.32 -69.87 0.16 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.691 1.196 . . . . 74.12 110.13 -174.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -80.07 87.33 5.45 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.736 -0.838 . . . . 73.32 108.736 170.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -74.95 103.72 5.27 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.427 0.691 . . . . 72.51 110.851 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -149.01 16.22 0.95 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.158 0.983 . . . . 74.45 108.733 170.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -78.31 92.84 4.57 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.695 0.798 . . . . 63.42 110.323 -176.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -177.92 -143.35 5.03 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 115.678 -0.692 . . . . 71.41 112.137 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 65.9 -168.09 0.21 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.1 1.36 . . . . 72.33 111.943 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 178.61 179.72 48.52 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 111.854 -0.499 . . . . 74.44 111.854 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 18.7 m -123.43 123.26 40.26 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 108.191 -1.04 . . . . 75.54 108.191 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -163.48 132.29 3.89 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 107.939 -1.134 . . . . 72.22 107.939 174.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -83.9 -74.09 0.39 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.891 0.876 . . . . 74.31 111.145 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -175.08 37.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.921 0.889 . . . . 74.24 110.116 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -69.19 136.68 52.43 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.546 0.738 . . . . 73.22 111.372 -175.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -166.16 -38.53 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.226 0.611 . . . . 73.34 110.932 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 C-N-CA 123.78 0.832 . . . . 72.33 109.413 -177.017 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.603 ' HE1' ' HG3' ' D' ' 147' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 108.298 -1.001 . . . . 75.55 108.298 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 60.2 p -80.15 169.85 17.25 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.361 0.664 . . . . 74.11 109.712 169.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 54.94 51.32 13.77 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.44 1.114 . . . . 74.31 110.102 -175.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . 0.436 ' HA ' ' HG3' ' D' ' 90' ' ' GLU . 10.9 pt20 -81.97 -14.6 55.81 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 113.79 -1.55 . . . . 74.03 112.668 -172.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . 0.61 HD22 ' HB2' ' D' ' 8' ' ' GLU . 44.0 t-20 75.15 122.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 125.698 1.599 . . . . 64.02 111.063 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -132.89 15.44 4.29 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.999 0.92 . . . . 74.04 110.738 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 62.1 m -133.27 -57.15 0.91 Allowed 'General case' 0 N--CA 1.482 1.141 0 O-C-N 122.104 -0.373 . . . . 64.41 111.239 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.61 ' HB2' HD22 ' D' ' 5' ' ' ASN . 1.8 mp0 -77.32 -28.7 53.27 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.135 0.174 . . . . 71.44 110.709 -177.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.519 ' HE3' ' HB2' ' D' ' 11' ' ' PHE . 1.2 tmt? -30.23 125.55 0.16 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 126.121 1.768 . . . . 74.42 113.005 174.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 87.8 m -110.59 144.43 39.48 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.57 0.748 . . . . 74.3 110.929 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.519 ' HB2' ' HE3' ' D' ' 9' ' ' MET . 31.3 t80 -159.12 89.13 0.91 Allowed 'General case' 0 C--O 1.238 0.45 0 N-CA-C 107.051 -1.463 . . . . 73.41 107.051 171.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -113.96 116.38 29.14 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.018 -1.104 . . . . 74.15 108.018 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.494 HG21 HD13 ' D' ' 16' ' ' ILE . 54.3 mt -72.09 122.95 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 109.588 -0.523 . . . . 70.04 109.588 -178.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -85.61 -42.91 13.92 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.994 0.809 . . . . 72.43 111.189 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -170.97 135.12 1.0 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 111.81 0.3 . . . . 74.35 111.81 -163.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.494 HD13 HG21 ' D' ' 13' ' ' ILE . 2.7 mp -115.76 134.58 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.609 -1.256 . . . . 73.01 107.609 170.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.448 ' HB3' HG22 ' C' ' 122' ' ' THR . 32.9 p90 -166.42 169.57 13.81 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 122.18 0.991 . . . . 71.21 111.394 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.5 p -103.03 120.33 40.46 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 113.567 -1.651 . . . . 72.52 108.534 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -89.96 -31.02 17.43 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.088 -0.708 . . . . 74.42 109.088 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -140.4 134.73 31.24 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 114.385 -1.28 . . . . 61.11 108.343 173.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.655 HG21 ' HE1' ' C' ' 117' ' ' MET . 63.7 mt -128.18 145.08 35.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.021 -1.474 . . . . 74.25 107.021 168.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 30.9 t -147.25 140.89 25.61 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.9 0.88 . . . . 70.3 108.834 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.513 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.1 t80 -146.48 136.22 23.21 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 105.89 -1.892 . . . . 64.01 105.89 168.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 43.8 mt-10 -138.52 152.37 48.18 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.338 -1.356 . . . . 74.14 107.338 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.77 84.33 7.05 Favored Pre-proline 0 C--O 1.239 0.535 0 N-CA-C 107.307 -1.368 . . . . 72.3 107.307 172.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -66.57 -36.91 23.96 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.0 2.467 . . . . 70.13 113.025 -170.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.458 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 52.6 m-20 -101.35 6.84 42.85 Favored 'General case' 0 C--O 1.211 -0.973 0 CA-C-O 118.542 -0.742 . . . . 71.42 110.747 -177.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.486 ' HB2' ' HE3' ' C' ' 19' ' ' LYS . . . -26.08 -65.09 0.11 Allowed Pre-proline 0 N--CA 1.496 1.85 0 N-CA-C 116.621 2.082 . . . . 73.43 116.621 -162.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.503 ' HB3' HD11 ' C' ' 83' ' ' ILE . 67.1 Cg_endo -78.85 -21.97 9.23 Favored 'Trans proline' 0 C--N 1.382 2.314 0 CA-C-N 122.878 2.063 . . . . 72.53 113.842 -177.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -73.74 -37.16 65.16 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.88 1.272 . . . . 75.51 110.37 175.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.583 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.5 p -84.13 -18.93 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.066 0.546 . . . . 74.11 111.531 -174.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -65.45 -15.83 63.02 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 112.529 0.566 . . . . 73.12 112.529 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -58.65 -33.43 70.07 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.55 0.69 . . . . 72.23 110.03 173.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.605 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 97.6 mttt -89.28 93.39 9.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.126 -1.397 . . . . 74.23 109.373 178.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -102.43 91.64 4.34 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.17 0.509 . . . . 64.04 109.981 -177.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 35.6 p90 -158.28 174.0 15.82 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.949 1.3 . . . . 72.4 108.009 169.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -65.43 112.91 9.6 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-O 118.938 -0.553 . . . . 72.1 109.565 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -59.07 141.24 97.99 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.582 2.188 . . . . 74.41 112.713 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -59.42 118.19 5.71 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.607 0.763 . . . . 74.43 109.959 172.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.611 ' HB ' HG23 ' H' ' 5' ' ' THR . 59.0 t -97.21 106.94 19.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 123.219 0.608 . . . . 74.53 109.426 -175.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -95.69 127.92 42.12 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.097 -0.956 . . . . 71.12 108.648 173.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -97.51 146.08 25.59 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.139 0.576 . . . . 72.42 109.602 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -149.54 116.76 6.05 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.226 -1.027 . . . . 63.41 108.226 177.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.471 HD21 ' H ' ' H' ' 9' ' ' ALA . 6.6 mp -108.05 140.12 41.69 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.722 0.409 . . . . 75.42 110.926 -173.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.59 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.2 t70 -136.88 151.82 49.52 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.56 1.144 . . . . 73.15 108.595 173.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 46' ' ' THR . . . . . 0.446 ' HB ' HD21 ' H' ' 11' ' ' LEU . 13.0 t -116.85 150.3 38.64 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.149 0.579 . . . . 74.1 110.839 -172.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.659 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.05 155.09 28.67 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.991 0.917 . . . . 74.54 109.229 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 13.4 p -167.09 162.12 15.16 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.697 0.399 . . . . 73.23 111.323 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 3.0 m -153.38 144.8 23.2 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.243 1.017 . . . . 71.14 108.669 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -97.92 116.49 30.23 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.152 -1.055 . . . . 74.15 108.152 165.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 24.6 mt -95.51 -40.58 9.38 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.044 0.538 . . . . 72.4 110.455 -172.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.546 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -146.11 -176.56 5.2 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.077 -0.965 . . . . 72.34 109.908 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -68.4 105.92 2.34 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.387 0.675 . . . . 73.51 109.652 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 62.85 18.55 10.85 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.759 1.224 . . . . 74.41 112.128 -177.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 57.3 t -109.23 104.83 17.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 107.353 -1.351 . . . . 63.23 107.353 171.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -119.6 131.33 55.46 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.96 -1.473 . . . . 74.43 109.686 -164.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -98.58 132.23 44.15 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.947 -0.57 . . . . 75.15 109.868 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 75.4 t -115.46 118.86 60.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 107.582 -1.266 . . . . 74.51 107.582 175.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 24.9 t -117.96 129.53 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.574 0.75 . . . . 71.12 109.276 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.423 HD21 ' HG3' ' D' ' 103' ' ' PRO . 2.5 mm? -122.74 129.47 51.8 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 110.328 -0.249 . . . . 74.11 110.328 176.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.59 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 14.3 ttm-85 -86.44 100.05 12.07 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.82 -0.807 . . . . 75.11 108.82 172.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 99.1 t -90.41 116.84 32.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.048 -1.093 . . . . 70.21 108.048 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 17.6 m -123.34 126.29 46.57 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.339 0.59 . . . . 71.43 109.671 -172.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.495 HG13 HG11 ' D' ' 40' ' ' VAL . 40.6 t -117.33 100.36 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.742 1.617 . . . . 75.35 107.977 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 60.7 m -93.53 94.26 8.55 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.832 -1.076 . . . . 71.0 108.157 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.16 143.77 28.33 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.712 -0.677 . . . . 65.22 110.456 -174.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.43 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 54.2 p -144.6 135.35 24.78 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 115.735 -0.666 . . . . 74.43 110.429 -177.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.484 HD11 HG23 ' D' ' 31' ' ' VAL . 39.0 mt -98.24 100.0 11.26 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.642 0.777 . . . . 74.44 109.052 172.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.01 -115.06 4.53 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.025 -0.989 . . . . 71.22 112.487 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -102.69 5.64 39.12 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.715 0.806 . . . . 74.2 112.15 -176.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.605 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 13.1 pt-20 -131.7 155.79 47.03 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.81 -0.441 . . . . 73.41 109.81 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 71.8 m -65.67 136.17 55.95 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 123.784 0.677 . . . . 73.51 110.977 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.583 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.6 -64.07 1.19 Allowed 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.577 -1.268 . . . . 74.41 107.577 174.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -155.94 152.14 27.86 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.382 -1.281 . . . . 73.34 110.194 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 78.3 mt -118.5 111.91 19.24 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.319 -0.993 . . . . 72.12 108.319 177.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.522 ' SG ' HG12 ' D' ' 114' ' ' ILE . 44.8 t -116.06 138.79 50.92 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.765 -0.828 . . . . 73.2 108.765 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -155.31 122.32 5.45 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.579 0.352 . . . . 73.3 110.258 -178.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.17 123.89 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.153 0.581 . . . . 72.32 109.957 -175.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -87.3 88.41 7.68 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.17 -1.048 . . . . 74.23 108.17 165.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -80.41 99.76 8.13 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.646 -1.242 . . . . 74.21 107.646 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.63 142.38 15.8 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.448 -0.661 . . . . 40.32 111.448 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.426 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -136.7 131.96 5.85 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.19 -0.764 . . . . 74.25 111.19 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 43.8 mt -90.77 124.78 43.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 108.088 -1.079 . . . . 72.01 108.088 176.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -132.99 123.65 26.27 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.762 0.825 . . . . 74.43 109.483 -174.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.9 m -84.25 97.76 9.59 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.97 -0.752 . . . . 64.31 108.97 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.564 HG13 ' SG ' ' D' ' 97' ' ' CYS . 0.0 OUTLIER -120.66 130.81 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.771 0.828 . . . . 75.23 109.724 -174.073 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.26 164.91 36.44 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.785 0.834 . . . . 73.45 110.76 -176.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.67 -10.55 71.67 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.725 -0.671 . . . . 53.24 114.15 173.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.553 HD13 HD13 ' D' ' 86' ' ' ILE . 34.4 mt -94.5 145.08 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.63 0.772 . . . . 74.34 109.81 -174.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.74 ' HA ' ' HE1' ' D' ' 94' ' ' MET . 0.0 OUTLIER -132.7 166.48 22.1 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.666 0.786 . . . . 70.01 110.62 178.728 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.65 -136.6 41.71 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 114.951 -1.022 . . . . 74.14 114.902 169.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 16.4 m -77.47 -18.33 57.23 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.361 1.065 . . . . 72.11 111.565 -173.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.405 ' OE1' ' HB2' ' D' ' 4' ' ' GLN . 51.3 tt0 -66.16 -24.84 66.73 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.826 0.45 . . . . 73.21 110.723 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.74 ' HE1' ' HA ' ' D' ' 90' ' ' GLU . 63.3 mtt -60.02 -43.91 94.97 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.967 0.507 . . . . 71.43 110.167 173.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.55 -26.41 67.12 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.399 -0.819 . . . . 73.24 111.53 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -85.26 -34.52 21.94 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.251 0.62 . . . . 71.21 111.111 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . 0.564 ' SG ' HG13 ' D' ' 86' ' ' ILE . 42.6 t -72.43 -52.44 15.92 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.265 0.555 . . . . 70.23 109.747 -175.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 26.2 mt -80.95 -29.57 35.4 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.523 -1.217 . . . . 73.41 110.24 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . 0.663 ' HA2' ' HE1' ' H' ' 15' ' ' PHE . . . -93.4 -17.89 40.89 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 114.968 0.747 . . . . 61.22 114.968 -171.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.562 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -132.65 -50.22 0.91 Allowed 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 117.788 0.794 . . . . 73.53 111.602 -174.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -73.94 -42.24 60.85 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 122.809 0.444 . . . . 74.2 112.043 -174.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.458 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 69.4 m -67.77 -47.31 44.28 Favored Pre-proline 0 CA--C 1.567 1.609 0 C-N-CA 123.161 0.585 . . . . 61.34 111.76 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 51.4 Cg_exo -59.75 -28.57 87.6 Favored 'Trans proline' 0 C--N 1.401 3.327 0 C-N-CA 122.597 2.198 . . . . 64.4 113.385 170.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -64.25 -40.93 97.02 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.95 0.9 . . . . 74.45 110.05 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 48.0 mm -61.73 -42.19 93.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 123.447 0.699 . . . . 74.33 110.193 173.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.426 HD22 ' HA3' ' D' ' 82' ' ' GLY . 96.1 mt -82.99 -13.37 56.09 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.975 -1.011 . . . . 61.41 112.49 -172.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -64.65 -48.15 74.35 Favored Pre-proline 0 N--CA 1.49 1.546 0 C-N-CA 123.929 0.892 . . . . 74.33 112.775 -176.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.52 -36.89 96.82 Favored 'Trans proline' 0 C--N 1.391 2.791 0 C-N-CA 122.201 1.934 . . . . 72.33 113.164 175.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -73.98 -36.08 64.53 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.893 0.877 . . . . 73.14 112.135 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.47 -49.65 72.79 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.209 -0.664 . . . . 64.51 109.209 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -55.1 -48.53 73.46 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 124.933 1.396 . . . . 74.24 110.781 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -61.81 -50.97 70.17 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 123.794 0.684 . . . . 73.11 111.365 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 38.9 t -55.43 -45.58 76.78 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 123.944 0.777 . . . . 75.33 111.039 -177.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.522 HG12 ' SG ' ' D' ' 76' ' ' CYS . 98.8 mt -59.31 -58.2 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.366 1.066 . . . . 71.1 110.817 174.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 60.7 m -54.19 -43.24 70.53 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.596 1.158 . . . . 64.21 112.16 -173.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -66.75 -40.32 88.25 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.026 -0.988 . . . . 71.44 110.045 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.1 mtm -70.28 -29.79 66.64 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.947 0.499 . . . . 74.33 111.616 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.451 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.0 t -64.99 -45.42 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.503 0.721 . . . . 75.13 110.178 175.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -74.33 -30.14 61.91 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.838 -0.619 . . . . 72.15 111.067 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 59.0 mtt-85 -69.83 -34.11 73.22 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.529 0.731 . . . . 75.44 109.867 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.12 -0.82 90.04 Favored Glycine 0 C--N 1.355 1.628 0 O-C-N 123.65 0.594 . . . . 70.44 112.388 173.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.42 HG21 ' HB3' ' C' ' 17' ' ' TYR . 31.1 p 64.21 23.18 13.06 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 126.952 2.101 . . . . 64.32 113.698 174.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -85.27 155.41 60.18 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.537 0.735 . . . . 74.22 110.055 171.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -53.2 125.63 19.0 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.182 2.588 . . . . 65.43 112.643 173.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -50.93 142.77 11.24 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.38 1.472 . . . . 75.43 112.864 -174.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.402 HD12 HG23 ' D' ' 40' ' ' VAL . 43.4 tp -114.35 125.07 53.45 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.613 0.765 . . . . 73.11 109.183 177.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -119.88 100.22 7.1 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.519 -0.919 . . . . 74.22 108.519 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.493 HD23 HD12 ' H' ' 6' ' ' ILE . 76.4 mt -61.55 114.84 3.48 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.289 -0.634 . . . . 73.41 109.289 174.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.409 ' H ' HG22 ' H' ' 6' ' ' ILE . . . -57.02 145.22 65.92 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 124.19 0.996 . . . . 72.42 111.979 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.418 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 39.3 Cg_endo -72.33 97.2 0.84 Allowed 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 122.131 1.887 . . . . 62.45 110.343 177.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 19.7 m -108.84 142.83 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 114.567 -1.197 . . . . 75.52 109.513 -175.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -76.66 96.48 4.19 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.243 0.617 . . . . 73.23 110.165 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -63.94 -40.06 95.58 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.961 -1.018 . . . . 75.24 109.663 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.562 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 7.1 m-20 -55.12 -45.34 75.54 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.325 1.05 . . . . 74.13 112.621 -176.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.94 -47.07 55.0 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.762 0.425 . . . . 74.15 111.412 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.99 -48.92 77.29 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.915 0.76 . . . . 75.04 110.112 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.525 ' HE1' ' H ' ' H' ' 11' ' ' LEU . 30.4 t80 -73.84 -28.01 61.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.648 0.779 . . . . 74.15 111.741 -177.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.46 ' HB2' ' O ' ' D' ' 134' ' ' ASP . 28.7 ttm -60.67 -17.24 46.5 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.694 0.797 . . . . 74.24 111.604 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.424 ' HA ' ' NE2' ' D' ' 142' ' ' GLN . 66.2 t30 -66.24 -33.28 75.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.833 0.853 . . . . 73.33 110.997 174.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -71.47 -31.78 67.54 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.513 0.725 . . . . 74.51 110.918 175.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 mp -82.63 -31.54 28.75 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.733 0.813 . . . . 74.33 112.942 -176.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.424 ' NE2' ' HA ' ' D' ' 139' ' ' ASN . 10.6 pt20 -75.05 4.43 6.73 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 112.991 0.737 . . . . 75.11 112.991 -173.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -121.46 44.94 2.41 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.977 0.911 . . . . 75.51 108.983 175.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -141.72 126.64 18.24 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.673 0.789 . . . . 74.52 108.948 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.75 -36.69 62.61 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.08 0.552 . . . . 75.24 110.068 172.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 107.73 -51.4 0.72 Allowed Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.079 -0.964 . . . . 74.13 111.11 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . 0.603 ' HG3' ' HE1' ' D' ' 1' ' ' MET . 50.0 mt-10 -81.87 175.59 10.28 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.562 0.745 . . . . 75.04 110.786 175.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 153.73 -139.33 6.78 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 110.844 -0.902 . . . . 75.14 110.844 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 88.3 m -132.56 117.82 18.45 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.828 -0.805 . . . . 62.52 108.828 173.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -133.44 160.2 38.1 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.796 0.838 . . . . 62.35 110.116 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -156.4 89.29 1.11 Allowed 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.105 -1.443 . . . . 61.51 107.105 170.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -88.38 127.9 35.5 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.322 0.649 . . . . 74.04 110.15 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -65.22 94.95 0.17 Allowed 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.735 1.272 . . . . 64.53 109.774 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.04 154.98 40.23 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.148 0.579 . . . . 75.51 110.265 176.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.249 0 CA-C-O 119.059 -0.496 . . . . 54.21 110.42 -178.079 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 61.3 mtt . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 120.83 0.347 . . . . 74.24 111.259 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.84 155.06 43.99 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.715 0.806 . . . . 73.31 108.968 169.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -122.92 90.53 3.31 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.589 0.756 . . . . 74.33 109.41 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 30.8 m -72.97 102.87 3.59 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.693 0.797 . . . . 73.34 109.42 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 26.6 m -57.74 -63.55 1.2 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.05 0.94 . . . . 74.44 111.741 -172.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.596 HD13 ' HB3' ' A' ' 42' ' ' LEU . 7.2 tt -162.88 -74.41 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 C-N-CA 123.246 0.618 . . . . 74.12 110.238 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 7' ' ' ALA . . . . . 0.539 ' H ' HG21 ' E' ' 6' ' ' ILE . . . 63.32 127.05 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 125.313 1.445 . . . . 65.12 113.289 -177.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . 0.552 ' HB3' HD11 ' A' ' 44' ' ' LEU . 80.5 mt -73.74 161.29 30.39 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.748 0.819 . . . . 74.02 110.749 175.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.63 170.13 8.17 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.685 0.794 . . . . 70.44 110.901 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 91.2 mt -76.42 151.21 36.6 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.981 -0.554 . . . . 72.3 110.162 174.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . 0.59 HD11 ' HB2' ' E' ' 13' ' ' LEU . 1.1 pt? -137.2 140.28 30.56 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.69 0.796 . . . . 74.41 109.751 -174.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.73 -6.34 18.06 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.153 2.568 . . . . 64.12 112.578 175.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . 0.59 ' HB2' HD11 ' E' ' 11' ' ' LEU . 85.0 mt -72.41 108.2 5.38 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.604 0.762 . . . . 72.42 110.097 178.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . 0.437 ' HB2' ' HG3' ' E' ' 17' ' ' PRO . 83.2 mt -71.19 116.61 11.7 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.88 -0.785 . . . . 74.01 108.88 174.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -58.28 -45.33 88.12 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.433 1.093 . . . . 75.44 111.698 -170.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 92.1 m -146.99 104.82 3.86 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 107.653 -1.24 . . . . 54.33 107.653 164.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 17' ' ' PRO . . . . . 0.437 ' HG3' ' HB2' ' E' ' 14' ' ' LEU . 6.0 Cg_exo -75.43 79.12 2.84 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 123.053 2.502 . . . . 71.12 111.875 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.2 102.64 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 107.833 -1.173 . . . . 74.11 107.833 173.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 7.3 m 67.65 7.03 5.37 Favored 'General case' 0 CA--C 1.57 1.743 0 C-N-CA 124.972 1.309 . . . . 75.21 111.849 -178.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 56.9 mttp 49.17 57.56 6.34 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.726 1.21 . . . . 73.42 110.805 -169.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 91' ' ' GLY . . . -52.42 -46.73 66.48 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.878 0.871 . . . . 54.13 110.985 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -92.67 94.15 8.86 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.299 -0.864 . . . . 72.31 108.975 168.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 14.6 t -85.61 156.07 59.0 Favored Pre-proline 0 CA--C 1.558 1.268 0 N-CA-C 108.902 -0.777 . . . . 72.42 108.902 172.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -65.29 66.09 0.33 Allowed 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.755 2.303 . . . . 72.43 113.245 168.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 . . . . . 0 CA--C 1.552 1.051 0 N-CA-C 105.859 -1.904 . . . . 74.45 105.859 -178.879 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' F' F ' 1' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' F' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 109.571 -0.529 . . . . 74.21 109.571 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -178.94 123.19 0.09 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.275 1.03 . . . . 71.33 108.869 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -107.58 -79.39 0.58 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.567 0.747 . . . . 64.52 109.477 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 22.7 m 60.36 -172.81 0.13 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.482 1.113 . . . . 75.32 112.251 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 47.5 m -146.22 142.05 28.0 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.499 0.72 . . . . 71.23 109.378 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 44.4 pt -66.37 128.82 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.887 0.875 . . . . 75.13 110.796 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 7' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' B' ' 129' ' ' ALA . . . -103.77 144.41 31.51 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.47 0.708 . . . . 74.34 110.175 -178.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . 0.426 HD13 HD22 ' B' ' 44' ' ' LEU . 1.1 tt -83.84 135.68 34.42 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.363 0.665 . . . . 75.13 109.359 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.37 157.01 29.22 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.56 0.744 . . . . 63.12 111.056 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 95.5 mt -71.26 148.25 47.38 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.341 0.656 . . . . 72.44 111.1 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . 0.445 HD21 ' HB2' ' B' ' 44' ' ' LEU . 96.0 mt -79.8 112.82 32.68 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.746 0.819 . . . . 75.1 110.042 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -72.28 -21.88 22.73 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.139 2.559 . . . . 73.5 111.615 176.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.04 124.81 52.91 Favored 'General case' 0 C--N 1.347 0.465 0 N-CA-C 107.591 -1.263 . . . . 73.34 107.591 170.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 92.3 mt -73.09 -174.81 1.63 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.26 0.624 . . . . 72.25 110.74 174.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -74.53 163.24 27.98 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.661 0.384 . . . . 63.03 110.94 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 23.9 m -51.06 120.83 14.6 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.397 1.079 . . . . 75.03 110.951 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.38 111.41 0.71 Allowed 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.077 2.518 . . . . 74.41 111.728 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.06 -51.62 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.037 0.935 . . . . 75.32 110.385 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 54.9 p 70.58 -43.3 0.55 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 127.226 2.21 . . . . 75.34 112.963 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -87.92 79.32 8.09 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.553 -1.277 . . . . 74.43 107.553 169.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' B' ' 90' ' ' GLU . . . -157.7 88.75 0.99 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.451 -0.795 . . . . 75.21 109.029 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -169.4 135.76 1.64 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.793 1.237 . . . . 74.5 108.217 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 17.5 p -106.6 93.82 9.15 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 123.448 0.699 . . . . 71.22 110.251 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.93 -173.53 1.8 Allowed 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.749 2.299 . . . . 75.4 111.639 175.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 . . . . . 0 CA--C 1.555 1.161 0 C-N-CA 124.397 1.079 . . . . 74.43 111.205 -178.692 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 42.0 ttm . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 109.667 -0.494 . . . . 73.41 109.667 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -145.1 130.54 18.75 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.415 -0.957 . . . . 75.04 108.415 174.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -78.13 154.39 31.28 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.154 0.582 . . . . 72.0 111.778 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 30.5 p -122.78 110.23 15.2 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.999 -1.111 . . . . 74.51 107.999 168.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 5.4 t -62.31 -39.05 91.74 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.934 0.894 . . . . 75.42 112.102 -177.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . . . . . . . . . 63.4 mt -116.58 135.08 58.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.778 0.831 . . . . 73.42 108.817 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.62 132.29 23.95 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.728 0.811 . . . . 63.51 109.85 177.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 8' ' ' LEU . . . . . 0.637 ' H ' HG22 ' C' ' 131' ' ' VAL . 88.1 mt -72.79 141.42 48.07 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.268 1.027 . . . . 74.14 110.555 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.42 132.68 45.14 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.627 0.771 . . . . 51.31 110.569 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 8.5 mp -59.01 118.95 6.39 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 108.592 -0.892 . . . . 73.3 108.592 171.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 90.0 mt -56.69 111.04 2.81 Favored Pre-proline 0 CA--C 1.554 1.115 0 O-C-N 124.577 1.173 . . . . 75.11 111.75 -174.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -65.14 -29.35 56.15 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 123.059 2.506 . . . . 75.34 111.64 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 61.1 tp -125.41 129.4 49.79 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 106.927 -1.509 . . . . 75.24 106.927 171.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.03 -175.11 5.42 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.753 -0.462 . . . . 72.2 109.753 171.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -79.0 154.8 29.22 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.302 -0.629 . . . . 75.44 109.302 176.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 76.2 p -75.47 150.23 84.57 Favored Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 122.93 0.492 . . . . 70.01 110.716 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 17' ' ' PRO . . . . . 0.576 ' HB3' ' H ' ' G' ' 21' ' ' ALA . 70.9 Cg_exo -52.18 143.56 41.72 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.777 2.985 . . . . 75.44 115.137 -177.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 18' ' ' VAL . . . . . 0.589 HG22 HD23 ' C' ' 98' ' ' LEU . 46.9 t -70.08 -68.02 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 108.401 -0.963 . . . . 74.12 108.401 168.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 19' ' ' THR . . . . . 0.441 ' H ' ' HE3' ' C' ' 94' ' ' MET . 17.0 p -99.4 -89.44 0.32 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.266 1.027 . . . . 72.33 109.421 170.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -137.31 85.71 2.14 Favored 'General case' 0 C--N 1.366 1.322 0 CA-C-N 118.671 0.669 . . . . 73.33 110.844 -175.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . 0.576 ' H ' ' HB3' ' G' ' 17' ' ' PRO . . . -92.95 -7.4 46.09 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.992 0.517 . . . . 73.5 109.933 171.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -89.2 124.16 34.1 Favored 'General case' 0 C--N 1.35 0.615 0 C-N-CA 123.29 0.636 . . . . 74.11 110.62 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 6.3 t -77.62 137.63 63.0 Favored Pre-proline 0 CA--C 1.551 1.012 0 CA-C-N 115.237 -0.892 . . . . 71.44 109.91 169.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -62.18 -26.13 77.54 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.732 2.288 . . . . 74.1 112.527 172.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 CA--C 1.563 1.458 0 C-N-CA 124.963 1.305 . . . . 72.41 110.304 176.655 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 110.665 -0.124 . . . . 75.31 110.665 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -156.52 110.82 2.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.507 0.723 . . . . 71.25 109.154 171.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -78.14 178.74 7.33 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.872 0.869 . . . . 72.42 110.711 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 27.1 m 73.04 133.4 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.969 1.307 . . . . 75.51 110.948 -173.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 5' ' ' THR . . . . . 0.611 HG23 ' HB ' ' D' ' 40' ' ' VAL . 32.1 m -75.55 132.48 40.73 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.4 0.68 . . . . 61.11 109.752 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . 0.493 HD12 HD23 ' D' ' 128' ' ' LEU . 15.0 mm 58.05 84.03 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 C-N-CA 125.15 1.38 . . . . 74.53 110.068 -172.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.53 165.8 32.14 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.641 0.376 . . . . 64.13 111.683 -169.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 80.3 mt -131.94 153.44 50.29 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.273 1.029 . . . . 75.51 110.255 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 9' ' ' ALA . . . . . 0.471 ' H ' HD21 ' D' ' 44' ' ' LEU . . . -125.5 154.0 42.75 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.982 0.913 . . . . 73.43 109.998 178.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 91.4 mt -70.43 140.4 52.01 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.602 0.761 . . . . 74.03 109.871 175.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . 0.525 ' H ' ' HE1' ' D' ' 137' ' ' PHE . 36.8 mt -86.78 104.99 6.79 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 108.109 -1.071 . . . . 74.11 108.109 177.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.24 -30.25 31.19 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.144 2.563 . . . . 74.1 113.908 -169.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -93.85 -7.39 43.41 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.144 0.578 . . . . 73.32 110.976 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 62.2 tp 57.3 -105.5 0.27 Allowed 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.526 0.73 . . . . 74.04 109.952 -175.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . 0.663 ' HE1' ' HA2' ' D' ' 99' ' ' GLY . 84.5 m-85 -166.34 -166.85 0.93 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.36 1.864 . . . . 74.41 106.378 -172.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 28.7 p -100.22 107.1 45.85 Favored Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 108.474 -0.936 . . . . 72.44 108.474 163.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -53.18 165.41 1.39 Allowed 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.735 2.29 . . . . 74.45 113.482 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . 0.633 ' HA ' ' HB3' ' H' ' 21' ' ' ALA . 7.3 t -72.65 -0.67 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 CA-C-N 115.627 -0.715 . . . . 75.44 111.222 -173.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 34.0 m -66.11 -52.95 43.9 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.934 0.894 . . . . 74.41 111.075 177.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -86.17 -28.41 23.95 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.619 0.768 . . . . 74.53 110.527 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . 0.633 ' HB3' ' HA ' ' H' ' 18' ' ' VAL . . . -65.76 -30.96 71.69 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.835 0.709 . . . . 72.55 110.78 177.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' H' ' 18' ' ' VAL . 0.0 OUTLIER -63.67 87.71 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.989 -1.115 . . . . 63.14 107.989 174.454 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 6.3 t -112.19 131.15 22.67 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 123.954 0.902 . . . . 75.14 109.742 -175.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.5 -28.63 38.3 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.635 2.223 . . . . 73.11 111.768 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 CA--C 1.553 1.075 0 C-N-CA 124.233 1.013 . . . . 64.12 109.055 177.17 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.57 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.8 t80 . . . . . 0 CA--C 1.538 0.504 0 N-CA-C 109.63 -0.508 . . . . 65.0 109.63 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -147.78 120.35 8.54 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.048 -1.093 . . . . 64.52 108.048 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.49 HD13 HD11 ' A' ' 16' ' ' ILE . 20.2 mt -85.85 120.56 36.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 109.374 -0.602 . . . . 65.32 109.374 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.28 -41.91 19.54 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.463 -0.94 . . . . 73.53 108.463 178.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -169.03 148.91 4.17 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 116.183 -0.462 . . . . 73.42 111.116 -170.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.49 HD11 HD13 ' A' ' 13' ' ' ILE . 69.0 mt -137.65 130.35 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 124.61 1.164 . . . . 63.52 108.151 175.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.456 ' HB3' HG23 ' B' ' 122' ' ' THR . 28.2 p90 -167.83 154.52 7.92 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.61 0.719 . . . . 70.31 111.605 -174.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.1 p -83.9 122.35 28.6 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.467 -1.242 . . . . 55.41 109.111 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -94.59 -14.93 24.5 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.161 0.584 . . . . 74.24 110.638 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 18.0 t0 -158.6 139.55 12.97 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.9 -1.148 . . . . 73.3 107.9 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.408 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 59.2 mt -141.16 141.9 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 106.977 -1.49 . . . . 74.21 106.977 177.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.9 t -157.06 116.48 3.4 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.821 0.343 . . . . 41.24 110.259 177.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.591 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 81.6 t80 -110.86 139.82 45.86 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 107.206 -1.405 . . . . 72.23 107.206 170.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 49.1 mt-10 -141.68 109.69 5.82 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 123.321 0.648 . . . . 75.02 109.35 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.429 ' CB ' ' HB2' ' A' ' 28' ' ' ALA . . . -103.05 88.56 1.59 Allowed Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.064 -1.828 . . . . 51.13 106.064 165.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -66.92 -34.05 31.07 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.722 2.281 . . . . 64.31 112.097 -169.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -112.82 26.37 10.58 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 114.959 -1.019 . . . . 73.52 109.311 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.467 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -44.62 -53.91 13.89 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 113.972 1.101 . . . . 51.11 113.972 -169.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.76 -28.47 86.52 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 121.971 1.781 . . . . 63.14 112.824 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.474 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.2 m80 -89.34 -31.19 17.92 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.439 1.096 . . . . 70.42 110.269 -176.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.564 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.0 p -73.26 -17.82 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.065 0.546 . . . . 60.35 112.186 -162.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -82.6 -23.71 34.25 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.255 0.622 . . . . 64.44 111.203 -176.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 28.9 pt20 -91.21 -11.86 37.04 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.253 0.621 . . . . 53.51 110.556 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 13.5 mmmm -76.75 168.43 20.1 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.491 0.716 . . . . 73.44 111.842 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.64 117.0 10.69 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.743 -0.836 . . . . 74.51 108.743 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.416 ' CE3' HD21 ' A' ' 68' ' ' LEU . 58.1 t-105 -83.54 85.21 7.29 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.378 0.608 . . . . 65.42 109.766 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.407 ' H ' HD22 ' A' ' 68' ' ' LEU . 6.8 tp-100 -127.82 81.38 70.4 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 107.889 -1.152 . . . . 64.51 107.889 171.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -72.94 108.2 2.53 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.532 2.154 . . . . 75.03 112.514 -174.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -95.43 90.49 5.8 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.911 -1.514 . . . . 62.51 106.911 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 65' ' ' THR . 60.3 t -88.13 113.46 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 CA-C-N 115.021 -0.991 . . . . 71.02 111.044 -171.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.425 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 80.7 tttt -79.82 136.86 36.81 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.346 1.058 . . . . 75.11 110.104 172.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.4 125.37 53.17 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.976 -1.12 . . . . 75.44 107.976 175.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.593 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 22.8 t70 -135.57 126.24 27.17 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.379 -0.6 . . . . 72.12 109.379 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -107.94 133.27 52.52 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.368 0.667 . . . . 75.31 110.278 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 11.7 t70 -124.18 146.29 48.78 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.382 1.073 . . . . 71.4 108.372 173.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 79.3 m -119.8 139.87 51.66 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.701 0.8 . . . . 71.32 110.073 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.671 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -132.53 131.59 41.73 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.922 0.889 . . . . 44.05 109.286 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.2 m -102.58 151.88 21.82 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.629 0.772 . . . . 64.34 109.946 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.6 t -162.96 127.95 3.12 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.084 -0.709 . . . . 63.34 109.084 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -112.84 119.15 36.99 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.337 -0.986 . . . . 70.24 108.337 171.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.4 mt -96.17 -30.18 13.64 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.216 0.606 . . . . 64.13 111.405 -174.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.22 -175.47 3.98 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.293 0.637 . . . . 55.55 110.469 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.51 117.79 7.24 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.326 -0.852 . . . . 74.41 108.776 171.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 71.93 -5.03 1.8 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.541 1.136 . . . . 62.14 112.93 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.0 t -99.22 106.02 18.3 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 N-CA-C 107.544 -1.28 . . . . 64.43 107.544 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -124.02 125.01 43.81 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.97 -1.122 . . . . 74.15 107.97 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -102.09 114.16 28.05 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.636 -0.876 . . . . 64.3 108.636 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.9 m -102.92 136.1 37.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.702 -1.221 . . . . 62.15 107.702 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 60.7 t -124.93 138.97 52.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 108.751 -0.833 . . . . 74.32 108.751 -174.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -128.19 112.84 14.96 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.593 -0.891 . . . . 62.23 108.593 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.564 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 19.5 ttt180 -93.23 102.44 14.73 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.029 0.932 . . . . 52.41 109.122 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -94.09 127.76 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.49 0.716 . . . . 74.0 109.444 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 13.9 m -113.31 130.45 56.26 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.836 0.855 . . . . 64.14 109.584 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.7 t -126.65 106.69 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.162 1.385 . . . . 55.51 107.851 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 23.5 m -104.61 134.4 47.85 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 107.762 -1.199 . . . . 75.33 107.762 175.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.52 127.29 55.18 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.835 -1.172 . . . . 23.43 107.835 174.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -126.94 126.33 43.06 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.302 0.641 . . . . 62.33 110.023 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.53 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 30.9 mt -86.91 78.02 9.11 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.394 1.078 . . . . 52.11 108.363 173.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.58 -84.6 0.87 Allowed Glycine 0 C--N 1.342 0.911 0 CA-C-N 115.229 -0.896 . . . . 74.0 111.443 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -115.27 -28.48 6.89 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.143 0.977 . . . . 71.33 110.621 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -87.94 132.59 34.17 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.289 -0.634 . . . . 74.03 109.289 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.2 m -72.8 123.42 23.31 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.745 0.702 . . . . 71.25 110.307 175.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.564 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -72.21 -57.35 4.31 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.52 -0.764 . . . . 40.32 109.633 174.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.437 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 35.7 p90 -162.58 176.96 9.85 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.612 -1.177 . . . . 54.22 111.093 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 58.6 tp -139.77 142.22 36.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.397 1.479 . . . . 65.53 107.31 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.452 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 76.0 m -145.5 106.96 4.21 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.114 0.965 . . . . 72.01 108.654 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -130.33 122.23 27.52 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.402 0.681 . . . . 73.12 109.492 -174.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 t -132.14 114.44 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.209 1.004 . . . . 53.32 109.685 -172.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 7.1 tt0 -84.56 90.12 7.59 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.359 -0.978 . . . . 51.14 108.359 173.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.537 ' HG3' HD22 ' A' ' 106' ' ' LEU . 6.8 tp-100 -85.13 104.13 14.74 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.288 -0.634 . . . . 75.32 109.288 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.61 153.39 21.61 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 111.485 -0.646 . . . . 62.03 111.485 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.438 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -155.8 122.0 1.16 Allowed Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 111.262 -0.735 . . . . 63.34 111.262 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.4 mt -83.04 116.15 26.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 N-CA-C 108.962 -0.755 . . . . 64.23 108.962 176.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.57 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 38.0 m-85 -127.19 120.82 29.68 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.267 0.627 . . . . 74.53 109.941 -175.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.8 m -81.1 102.02 9.98 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.434 -0.95 . . . . 71.32 108.434 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.3 pt . . . . . 0 CA--C 1.543 0.704 0 C-N-CA 123.87 0.868 . . . . 62.11 109.991 -175.378 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.945 0.402 . . . . 42.13 110.99 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.553 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 41.6 t-80 -68.79 -24.91 64.47 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.772 0.829 . . . . 73.05 110.584 173.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 69.1 m -75.77 -64.95 0.97 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.565 0.346 . . . . 72.33 110.675 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.53 HD12 ' N ' ' A' ' 99' ' ' GLY . 3.4 pp -71.1 -32.27 68.84 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.149 0.98 . . . . 74.42 112.687 -170.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.53 ' N ' HD12 ' A' ' 98' ' ' LEU . . . -105.54 3.22 39.59 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-O 119.688 -0.506 . . . . 73.03 113.597 -171.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -136.93 -60.5 0.69 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.525 0.663 . . . . 70.42 112.072 -177.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.4 ' O ' HG12 ' A' ' 105' ' ' ILE . 0.0 OUTLIER -79.13 -34.82 42.98 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 112.166 0.432 . . . . 72.14 112.166 -174.874 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 70.9 m -64.55 -43.56 71.43 Favored Pre-proline 0 N--CA 1.491 1.611 0 CA-C-N 115.627 -0.715 . . . . 54.4 112.416 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -48.53 -45.09 28.36 Favored 'Trans proline' 0 C--N 1.391 2.811 0 C-N-CA 122.829 2.353 . . . . 63.32 113.322 163.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -64.52 -21.57 66.72 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.652 0.781 . . . . 72.24 112.03 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 101' ' ' TYR . 45.8 mm -74.85 -48.95 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 109.667 -0.494 . . . . 62.02 109.667 174.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.537 HD22 ' HG3' ' A' ' 80' ' ' GLN . 88.4 mt -75.94 -27.05 57.44 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.401 -0.818 . . . . 71.11 112.276 -174.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.514 ' HZ ' HD22 ' A' ' 128' ' ' LEU . 31.7 t80 -63.44 -43.76 79.95 Favored Pre-proline 0 CA--C 1.564 1.504 0 N-CA-C 113.817 1.043 . . . . 71.23 113.817 -169.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.63 -40.11 82.59 Favored 'Trans proline' 0 C--N 1.387 2.578 0 C-N-CA 122.207 1.938 . . . . 75.33 112.887 173.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -69.69 -40.98 76.02 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.497 0.719 . . . . 73.21 111.415 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.0 -36.04 74.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.425 0.69 . . . . 74.13 110.29 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.552 ' NH1' HD12 ' C' ' 105' ' ' ILE . 37.3 ttm180 -57.8 -55.78 30.44 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.093 0.871 . . . . 71.02 109.6 172.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -63.98 -41.06 97.65 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.024 -0.989 . . . . 75.34 111.73 -173.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 39.0 t -66.45 -30.94 71.41 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.798 0.439 . . . . 72.33 111.167 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 60.7 mt -72.85 -50.99 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.831 0.853 . . . . 62.21 109.857 172.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 63.7 m -57.99 -34.04 69.55 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.667 1.187 . . . . 72.45 111.509 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.8 t -67.35 -46.35 73.64 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 115.439 -0.801 . . . . 73.31 109.8 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.591 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 42.6 mtm -67.49 -36.15 80.53 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.876 0.47 . . . . 72.11 111.483 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.417 HG13 ' HB2' ' A' ' 123' ' ' PHE . 72.2 t -61.59 -46.85 95.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.369 0.668 . . . . 72.23 110.075 174.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 41.2 t -67.56 -36.35 80.77 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 115.428 -0.805 . . . . 53.03 111.118 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -72.96 -29.38 63.03 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.686 0.794 . . . . 75.14 109.891 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.55 10.51 61.64 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.869 0.73 . . . . 50.54 112.198 173.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.486 HG21 ' HE ' ' B' ' 15' ' ' ARG . 2.1 t 62.17 20.18 11.49 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.84 2.056 . . . . 64.42 113.266 170.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.417 ' HB2' HG13 ' A' ' 118' ' ' VAL . 87.3 m-85 -84.28 154.89 63.4 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 122.956 0.503 . . . . 72.21 109.65 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -53.16 159.63 5.42 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.461 2.774 . . . . 75.15 113.97 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.477 HE21 HG21 ' D' ' 122' ' ' THR . 6.5 tp-100 -62.03 125.53 24.18 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.627 -0.715 . . . . 43.24 111.435 -174.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.437 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 54.9 tp -130.27 113.11 14.0 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.779 1.231 . . . . 71.34 109.407 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -129.22 123.28 31.58 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.364 0.666 . . . . 73.21 109.562 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.514 HD22 ' HZ ' ' A' ' 107' ' ' PHE . 4.2 tt -73.8 127.85 33.92 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 108.333 -0.988 . . . . 64.3 108.333 175.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.51 137.26 96.44 Favored Pre-proline 0 CA--C 1.564 1.49 0 C-N-CA 123.067 0.547 . . . . 74.41 112.051 -174.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.471 ' HG2' ' CE1' ' C' ' 11' ' ' PHE . 36.8 Cg_exo -63.95 127.32 19.17 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.974 3.116 . . . . 54.31 113.429 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.5 t -117.47 114.78 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.04 0.936 . . . . 63.15 108.738 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -83.42 88.31 6.98 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.039 -0.726 . . . . 74.21 109.039 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 . . . . . 0 N--CA 1.478 0.927 0 CA-C-N 115.279 -0.873 . . . . 52.53 110.506 -179.873 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.498 ' SD ' ' N ' ' B' ' 10' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.557 1.216 0 CA-C-O 121.349 0.595 . . . . 74.21 110.777 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 99.9 m -157.87 125.26 5.14 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 106.187 -1.783 . . . . 74.21 106.187 170.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -138.53 125.33 21.0 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.181 -0.674 . . . . 73.41 109.181 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -148.3 137.7 22.09 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.315 -0.624 . . . . 74.43 109.315 174.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 48.6 mt -85.4 122.6 38.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.608 -0.886 . . . . 74.32 108.608 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLN . . . . . 0.514 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 12.4 mm100 -89.83 -43.51 10.59 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.677 0.791 . . . . 73.32 109.999 -175.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.486 ' HE ' HG21 ' A' ' 122' ' ' THR . 44.2 ttt180 -178.96 130.63 0.11 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.298 -0.631 . . . . 74.13 109.298 -173.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 77.4 mt -116.73 137.08 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 108.31 -0.996 . . . . 75.25 108.31 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -162.99 145.27 10.3 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.455 0.645 . . . . 75.12 111.182 -170.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.3 m -73.68 117.9 16.0 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.471 -1.24 . . . . 35.15 108.091 170.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.495 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 45.1 mtpt -92.78 -25.01 18.36 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.795 0.838 . . . . 63.3 111.354 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -163.45 147.35 10.6 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.528 0.518 . . . . 74.2 109.851 -172.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.437 HD11 ' SG ' ' B' ' 113' ' ' CYS . 28.4 mm -141.81 145.28 24.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 125.35 1.46 . . . . 72.32 108.427 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 44.2 t -144.01 141.08 29.93 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.727 -1.124 . . . . 72.14 108.387 167.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 81.5 t80 -147.75 126.69 12.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.279 -1.749 . . . . 74.51 106.279 171.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -135.3 116.6 14.55 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.147 -1.057 . . . . 63.43 108.147 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.574 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -106.35 86.48 2.13 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 107.593 -1.262 . . . . 64.54 107.593 174.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.12 -50.35 2.15 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.89 2.393 . . . . 52.5 111.946 -168.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -96.78 15.53 21.74 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.484 0.713 . . . . 72.35 111.191 -175.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.574 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -40.36 -65.06 0.48 Allowed Pre-proline 0 N--CA 1.491 1.602 0 C-N-CA 125.242 1.417 . . . . 53.14 114.575 -165.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.17 -25.54 72.68 Favored 'Trans proline' 0 C--N 1.392 2.821 0 C-N-CA 122.262 1.975 . . . . 62.11 113.92 -169.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -94.37 -41.66 9.3 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.138 0.575 . . . . 71.35 111.182 -175.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.89 -12.69 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 123.573 0.749 . . . . 73.32 111.685 -172.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -62.66 -14.3 41.94 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.569 0.748 . . . . 71.03 112.86 174.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.546 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.0 pt20 -60.79 -29.0 69.17 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.663 0.785 . . . . 73.33 110.98 172.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.546 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 96.3 mttt -93.66 108.46 20.19 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.91 1.284 . . . . 74.31 109.959 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -114.97 105.94 13.57 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.074 0.549 . . . . 73.12 110.427 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 21.6 p90 -165.82 -166.04 0.89 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.911 1.284 . . . . 74.33 108.121 169.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 -82.15 103.62 2.46 Favored Pre-proline 0 N--CA 1.477 0.914 0 N-CA-C 108.403 -0.962 . . . . 64.13 108.403 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.69 144.18 87.19 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.769 2.312 . . . . 61.45 113.126 -173.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.472 ' HB2' ' HB2' ' B' ' 67' ' ' SER . 5.6 mp0 -55.42 103.36 0.09 Allowed 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.677 1.591 . . . . 70.32 110.311 172.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.435 HG22 HD21 ' B' ' 126' ' ' LEU . 20.3 t -85.62 155.18 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 115.182 -0.917 . . . . 71.13 109.118 -174.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.6 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 50.2 tttm -151.45 101.14 2.79 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.177 -1.786 . . . . 72.23 106.177 166.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.4 HD23 ' N ' ' B' ' 43' ' ' ASP . 7.8 tt -87.1 144.15 26.99 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.029 -1.471 . . . . 65.23 107.029 172.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.422 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 8.8 t70 -140.28 116.48 10.55 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 106.315 -1.735 . . . . 72.34 106.315 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 15.2 tp -98.13 127.89 44.33 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.182 -1.044 . . . . 73.11 108.182 -173.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -130.18 156.13 45.1 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.013 0.925 . . . . 64.34 109.136 -172.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 49.0 p -106.88 139.02 41.96 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.06 0.544 . . . . 60.21 111.131 -171.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.38 128.46 12.74 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 106.836 -1.542 . . . . 74.2 106.836 172.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.8 m -144.79 163.79 32.99 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.308 0.243 . . . . 71.11 111.16 -173.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 80.8 p -165.76 137.13 3.84 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.006 0.816 . . . . 63.15 110.049 167.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -94.72 108.82 20.82 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.093 -1.077 . . . . 71.14 108.093 171.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 35.3 mt -70.45 -53.49 16.16 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 121.643 0.735 . . . . 74.22 109.789 -175.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.89 -170.31 2.83 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.276 -1.329 . . . . 64.33 108.431 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -86.7 145.58 26.62 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.818 -1.179 . . . . 64.42 107.818 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 67.3 -2.44 1.25 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.815 1.246 . . . . 64.02 112.132 -172.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 45.9 t -126.45 116.75 46.3 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 C-N-CA 124.791 1.237 . . . . 74.4 108.0 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -127.11 139.25 53.11 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.019 -1.104 . . . . 74.02 108.019 175.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -105.51 105.65 15.78 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.628 -1.249 . . . . 74.53 107.628 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 75.1 t -94.94 124.35 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 124.938 1.295 . . . . 55.42 109.8 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.441 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 6.5 t -112.97 146.81 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.251 -1.018 . . . . 60.42 108.251 172.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 20.6 tp -125.4 111.41 15.1 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.258 -1.016 . . . . 65.03 108.258 169.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -87.83 112.23 22.24 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.13 -0.693 . . . . 72.35 109.13 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 60.9 t -104.69 104.02 16.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.7 -1.136 . . . . 73.23 108.049 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.422 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 27.0 m -94.92 136.38 35.3 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.114 -1.069 . . . . 55.31 108.114 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.518 HG21 HD13 ' B' ' 114' ' ' ILE . 95.0 t -127.85 130.7 70.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 124.096 0.958 . . . . 40.42 109.246 -175.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.6 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 53.5 m -121.53 139.65 53.22 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.899 -1.519 . . . . 64.01 106.899 168.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.05 136.72 30.48 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.668 -1.234 . . . . 63.25 107.668 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.501 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 3.7 m -139.08 145.5 39.59 Favored 'General case' 0 C--O 1.215 -0.726 0 N-CA-C 109.455 -0.572 . . . . 71.43 109.455 -168.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 42.6 mt -113.26 108.48 17.32 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.605 0.716 . . . . 72.15 109.487 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.12 -110.7 3.62 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 114.082 -1.417 . . . . 44.25 113.361 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.72 2.12 35.31 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.268 1.027 . . . . 74.34 110.489 -170.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -133.19 158.23 43.38 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.523 0.729 . . . . 72.1 109.701 -175.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 97.0 m -75.31 137.8 41.39 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.168 0.509 . . . . 72.4 110.081 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.501 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -93.35 -61.33 1.58 Allowed 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.458 1.103 . . . . 61.21 108.281 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -151.99 167.74 27.45 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 114.688 -1.142 . . . . 71.21 110.742 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 70.5 mt -133.87 138.0 45.33 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 106.008 -1.849 . . . . 73.12 106.008 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 47.1 t -138.4 159.17 42.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.869 -1.16 . . . . 74.42 107.869 175.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.466 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 40.5 tt0 -165.77 134.15 3.09 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.985 -0.746 . . . . 73.02 108.985 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.91 145.32 35.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.577 -0.897 . . . . 61.43 108.577 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -121.13 93.99 4.2 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.108 -1.071 . . . . 64.3 108.108 171.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.456 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -87.88 102.44 14.71 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.725 -0.843 . . . . 74.41 108.725 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.495 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.94 156.58 23.02 Favored Glycine 0 N--CA 1.449 -0.492 0 O-C-N 123.965 0.79 . . . . 54.23 111.305 175.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.96 126.35 1.66 Allowed Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 109.99 -1.244 . . . . 73.33 109.99 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.514 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 27.1 mt -85.67 130.1 36.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.626 -1.25 . . . . 62.35 107.626 176.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -133.83 134.23 42.55 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.36 -0.978 . . . . 74.3 108.36 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 74.1 m -92.99 110.43 21.9 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.101 -0.703 . . . . 54.51 109.101 172.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.574 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -124.81 132.71 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.623 1.169 . . . . 74.44 109.122 -178.807 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.3 172.29 18.75 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.209 0.604 . . . . 53.03 110.741 -172.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.42 -63.6 4.31 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.932 0.77 . . . . 62.35 112.408 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.593 HG22 ' HB3' ' B' ' 94' ' ' MET . 2.5 mm -68.8 157.84 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.474 1.11 . . . . 75.55 112.224 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -160.06 153.5 22.29 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 115.118 -0.947 . . . . 74.21 110.777 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.76 -136.81 13.36 Favored Glycine 0 C--N 1.351 1.413 0 C-N-CA 124.297 0.951 . . . . 61.22 112.933 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 19.5 m -67.14 -27.68 67.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.542 0.737 . . . . 75.24 110.94 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.432 ' HB2' HG23 ' B' ' 89' ' ' ILE . 42.8 mt-30 -63.99 -39.77 94.86 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.689 -1.141 . . . . 74.32 110.965 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.593 ' HB3' HG22 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -88.17 -25.81 22.75 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.565 0.346 . . . . 72.34 110.82 177.379 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.65 -34.2 73.95 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.149 0.58 . . . . 60.44 110.954 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -78.86 -37.57 40.02 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.655 0.782 . . . . 64.02 111.034 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.5 t -62.71 -43.2 99.4 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.201 0.601 . . . . 44.53 111.49 -175.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.412 HD11 HG13 ' B' ' 86' ' ' ILE . 6.6 mp -90.58 -23.33 20.89 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.874 0.47 . . . . 72.34 111.112 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.06 -17.62 66.86 Favored Glycine 0 C--N 1.346 1.104 0 N-CA-C 114.358 0.503 . . . . 73.44 114.358 -174.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.19 -55.56 0.59 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.068 0.547 . . . . 71.33 110.97 -177.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -66.75 -53.31 34.59 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.436 0.902 . . . . 75.43 113.436 -166.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.516 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 76.0 m -60.13 -50.08 87.88 Favored Pre-proline 0 CA--C 1.564 1.504 0 CA-C-O 118.561 -0.733 . . . . 53.22 111.493 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.516 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 47.7 Cg_exo -60.33 -29.37 88.7 Favored 'Trans proline' 0 C--N 1.401 3.296 0 C-N-CA 122.4 2.067 . . . . 73.1 113.384 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -71.15 -30.99 67.16 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.578 0.751 . . . . 62.13 110.928 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.423 HG23 ' NH2' ' D' ' 111' ' ' ARG . 53.1 mt -66.87 -37.87 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 109.568 -0.53 . . . . 45.0 109.568 171.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 54.8 mt -84.18 -18.82 35.41 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.026 0.93 . . . . 62.03 112.1 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.421 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 85.7 t80 -57.86 -50.34 88.66 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-O 118.088 -0.958 . . . . 73.52 112.338 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.421 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 51.5 Cg_exo -57.89 -38.02 94.01 Favored 'Trans proline' 0 C--N 1.394 2.929 0 C-N-CA 122.401 2.067 . . . . 74.43 113.798 177.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.456 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 38.8 m-85 -68.12 -43.29 78.73 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.281 0.632 . . . . 74.03 110.576 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.449 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -64.8 -40.61 95.51 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.285 0.634 . . . . 73.24 110.427 175.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.497 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 37.9 ttt180 -57.41 -49.57 75.8 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.542 1.537 . . . . 75.11 111.402 -176.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.428 ' HG3' ' NH2' ' C' ' 120' ' ' ARG . 2.1 tm-20 -68.79 -34.6 75.83 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 123.84 0.712 . . . . 55.33 110.033 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.476 ' O ' ' HG2' ' B' ' 117' ' ' MET . 9.3 t -67.27 -33.63 75.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.99 0.516 . . . . 54.41 111.268 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.518 HD13 HG21 ' B' ' 64' ' ' VAL . 73.7 mt -67.69 -56.04 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 108.91 -0.774 . . . . 41.12 108.91 174.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.1 m -59.84 -26.54 65.89 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 124.336 1.023 . . . . 63.1 111.396 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 29.4 t -64.78 -50.55 66.33 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.273 0.629 . . . . 72.35 109.614 174.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.0 mmt -70.44 -31.21 68.3 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.08 0.552 . . . . 73.52 111.005 -176.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.49 HG23 ' O ' ' B' ' 114' ' ' ILE . 57.7 t -60.57 -47.77 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.487 0.715 . . . . 55.02 109.414 171.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 21.0 t -65.08 -34.62 78.85 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.546 -1.206 . . . . 75.41 111.191 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.423 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 92.6 mtt-85 -70.81 -31.95 68.86 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.986 -1.006 . . . . 75.42 110.384 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.56 5.66 76.96 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.944 0.778 . . . . 52.45 112.656 174.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.456 HG23 ' HB3' ' A' ' 17' ' ' TYR . 80.6 p 54.42 29.95 11.93 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 126.0 1.72 . . . . 62.25 113.015 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -91.02 159.87 38.97 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.264 0.625 . . . . 74.14 111.317 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -48.93 158.11 1.39 Allowed 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 123.732 2.955 . . . . 62.03 114.76 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -57.9 114.6 2.39 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.978 -1.01 . . . . 73.52 111.236 -176.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.435 HD21 HG22 ' B' ' 40' ' ' VAL . 0.3 OUTLIER -121.58 101.87 7.88 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.867 -1.16 . . . . 62.13 107.867 -178.703 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -119.23 133.99 55.45 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.726 0.811 . . . . 71.43 109.224 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.497 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 6.6 mp -75.42 144.97 41.92 Favored 'General case' 0 C--O 1.242 0.668 0 O-C-N 123.655 0.597 . . . . 71.23 109.956 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 129' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -70.76 134.14 86.18 Favored Pre-proline 0 CA--C 1.549 0.911 0 O-C-N 123.816 0.697 . . . . 50.53 111.093 -177.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 7.0 Cg_exo -72.47 104.81 1.77 Allowed 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.886 2.391 . . . . 71.42 111.692 176.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 34.1 m -110.99 139.95 32.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 123.327 0.651 . . . . 63.33 109.63 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -92.08 90.61 7.44 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 106.414 -1.699 . . . . 61.31 106.414 169.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -67.09 -32.0 72.86 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.946 -1.025 . . . . 63.33 111.289 -171.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 . . . . . 0 N--CA 1.471 0.607 0 C-N-CA 123.941 0.896 . . . . 54.42 111.484 175.586 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.652 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.3 t80 . . . . . 0 C--O 1.236 0.356 0 CA-C-O 121.138 0.494 . . . . 72.03 110.406 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -155.31 126.43 7.15 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.839 -1.171 . . . . 74.24 107.839 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 88.4 mt -73.32 120.05 21.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.291 -1.003 . . . . 71.42 108.291 172.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.62 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 10.8 mm100 -82.54 -42.64 18.11 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.208 -0.905 . . . . 71.11 109.6 -177.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -179.27 134.02 0.12 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.284 0.633 . . . . 75.32 110.345 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.8 mt -117.68 145.95 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.867 0.867 . . . . 74.44 108.855 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -174.65 158.02 2.65 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.276 0.631 . . . . 74.3 110.729 -174.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 63.7 p -83.39 114.69 21.61 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.381 -0.97 . . . . 71.2 108.381 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -77.05 -47.06 21.62 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.736 -0.838 . . . . 74.12 108.736 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.662 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.0 t70 -133.97 137.84 45.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.336 -1.302 . . . . 64.54 109.572 -174.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 71.8 mt -136.81 144.52 32.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.021 -1.474 . . . . 72.03 107.021 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.1 t -161.82 150.66 15.61 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.976 0.417 . . . . 71.11 110.798 174.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -152.36 121.25 6.57 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 114.797 -1.092 . . . . 61.03 108.143 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -122.63 122.27 38.41 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.921 0.888 . . . . 74.11 110.451 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.09 83.01 34.71 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 107.73 -1.211 . . . . 65.4 107.73 168.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.43 -13.61 20.48 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.558 2.172 . . . . 74.55 111.764 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -103.01 14.59 31.58 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.9 1.28 . . . . 74.11 109.862 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.402 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -48.16 -53.52 32.76 Favored Pre-proline 0 C--N 1.37 1.48 0 C-N-CA 124.64 1.176 . . . . 73.01 113.55 -170.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 52.5 Cg_exo -54.59 -50.6 12.82 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 121.871 1.714 . . . . 72.12 112.828 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -68.57 -35.46 77.41 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.911 -1.041 . . . . 63.22 112.173 -172.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.728 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.0 p -78.59 -24.97 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 N-CA-C 113.182 0.808 . . . . 61.15 113.182 -172.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -67.13 -28.36 68.07 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.528 0.566 . . . . 75.14 112.528 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -86.92 5.16 38.44 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.128 0.571 . . . . 73.43 111.773 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.777 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -88.76 150.16 23.09 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.483 0.713 . . . . 73.31 110.369 178.493 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.25 124.07 19.88 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.292 0.637 . . . . 74.1 109.755 167.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -78.71 97.62 5.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.365 0.666 . . . . 74.32 111.211 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -153.6 78.16 5.69 Favored Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 108.605 -0.887 . . . . 71.2 108.605 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -90.45 149.66 4.36 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.013 2.475 . . . . 61.42 113.856 -176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -88.23 102.86 15.24 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 114.028 -1.442 . . . . 75.43 107.365 167.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -81.23 101.71 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.933 -0.576 . . . . 72.21 109.764 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.481 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 11.0 tmtt? -92.38 109.94 21.34 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.23 -1.396 . . . . 72.21 107.23 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 pp -85.14 161.69 19.54 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.585 -0.524 . . . . 73.42 109.585 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.612 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 12.5 t70 -147.19 134.41 20.55 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.674 -1.232 . . . . 65.43 107.674 171.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -128.79 111.24 12.9 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.104 -1.443 . . . . 74.13 107.104 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 21.6 t70 -123.54 152.68 41.55 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.022 0.929 . . . . 71.31 109.124 -177.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 52.5 p -117.92 134.48 54.91 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.519 0.728 . . . . 63.24 111.458 -169.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.53 160.19 42.45 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.377 0.671 . . . . 51.21 110.471 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 72.8 m -160.03 170.93 20.27 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.422 0.689 . . . . 74.52 111.242 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 95.8 p -153.98 140.74 19.06 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.964 0.906 . . . . 62.32 108.934 166.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -86.43 121.43 28.97 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.2 -1.037 . . . . 64.1 108.2 173.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.601 HD11 HD12 ' C' ' 83' ' ' ILE . 53.6 mt -99.22 -30.38 12.29 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.472 0.709 . . . . 73.31 109.923 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.81 -174.39 2.72 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.453 1.101 . . . . 61.02 109.604 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -71.24 125.0 25.79 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.334 -0.987 . . . . 70.43 108.334 171.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 69.37 3.67 4.26 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.876 1.27 . . . . 74.32 113.204 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 96.3 t -117.69 110.64 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 107.892 -1.151 . . . . 44.42 107.892 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -134.34 137.57 44.26 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.537 0.735 . . . . 75.12 109.573 -173.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -86.69 120.93 28.52 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.949 -1.023 . . . . 65.44 109.748 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 55.2 t -96.7 115.39 36.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.818 -1.179 . . . . 64.31 107.818 168.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 64.0 t -112.93 136.26 49.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 N-CA-C 107.603 -1.258 . . . . 72.52 107.603 171.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.719 HD22 ' HB2' ' C' ' 103' ' ' PRO . 11.6 tp -126.73 118.36 24.56 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.619 -0.882 . . . . 70.33 108.619 172.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 14.2 ttm180 -81.79 115.66 21.11 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.567 -0.742 . . . . 71.44 109.212 176.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 24.9 t -110.5 116.56 52.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.537 -1.283 . . . . 45.23 107.537 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.612 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 17.9 m -128.86 115.52 18.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.424 0.63 . . . . 63.14 109.348 -174.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 84.4 t -108.07 116.04 50.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 124.817 1.247 . . . . 74.14 109.364 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 4.1 m -100.53 145.91 27.74 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.838 -1.171 . . . . 54.53 107.838 171.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.85 119.74 18.48 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.347 -1.353 . . . . 62.31 107.347 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -133.04 125.52 29.85 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.945 0.339 . . . . 51.25 110.361 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.777 HD13 ' HG2' ' C' ' 34' ' ' LYS . 9.0 mt -86.44 41.04 0.92 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.661 1.184 . . . . 54.03 109.776 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.2 -114.2 4.54 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 110.138 -1.185 . . . . 71.22 110.138 -169.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.29 -28.12 21.27 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.346 0.658 . . . . 70.51 109.928 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.94 118.05 9.19 Favored 'General case' 0 C--N 1.345 0.402 0 N-CA-C 108.923 -0.769 . . . . 64.33 108.923 171.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 29.4 m -81.19 121.92 26.75 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 108.06 -1.089 . . . . 64.3 108.06 167.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.728 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.5 -58.14 3.61 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.41 -0.959 . . . . 64.33 108.41 177.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -162.69 170.73 17.95 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 114.95 -1.023 . . . . 74.43 111.708 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.434 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -127.6 146.39 50.55 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 106.002 -1.851 . . . . 72.21 106.002 166.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.434 ' N ' HD13 ' C' ' 75' ' ' LEU . 46.2 t -147.31 130.17 16.19 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.984 -1.117 . . . . 65.23 107.984 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -136.33 117.84 14.82 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.428 -0.582 . . . . 72.34 109.428 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 77.4 t -120.03 122.4 68.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.45 -0.945 . . . . 70.44 108.45 170.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.662 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.3 mt-30 -103.42 94.25 5.39 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 108.023 -1.102 . . . . 70.44 108.023 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -80.07 114.81 19.25 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.963 -1.017 . . . . 65.1 109.655 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.22 146.12 18.14 Favored Glycine 0 C--N 1.34 0.779 0 O-C-N 123.826 0.704 . . . . 70.34 111.423 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.449 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.54 119.66 0.95 Allowed Glycine 0 CA--C 1.503 -0.697 0 N-CA-C 110.554 -1.019 . . . . 75.21 110.554 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.62 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 8.4 mm -85.37 126.74 40.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 108.287 -1.005 . . . . 73.42 108.287 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.652 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 69.7 m-85 -132.23 147.39 52.41 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.365 0.666 . . . . 63.32 109.883 -176.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 45.4 m -87.49 123.66 32.64 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.935 0.894 . . . . 62.2 109.352 171.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.52 HG12 HD21 ' C' ' 98' ' ' LEU . 4.4 mp -121.72 121.03 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 109.675 -0.491 . . . . 74.24 109.675 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.28 167.89 21.29 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.235 1.014 . . . . 53.22 109.903 173.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.67 -60.8 1.2 Allowed Glycine 0 N--CA 1.471 1.026 0 C-N-CA 123.137 0.399 . . . . 74.23 112.661 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 pt -96.06 150.9 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.658 0.783 . . . . 74.4 110.393 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -147.61 146.77 29.49 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.69 0.796 . . . . 75.42 109.555 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.36 -139.18 14.65 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 111.671 -0.571 . . . . 74.45 111.671 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 10.3 p -68.23 -21.35 64.85 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 113.477 0.917 . . . . 64.45 113.477 -174.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -77.23 -40.72 43.94 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 109.337 -0.616 . . . . 51.41 109.337 177.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.511 ' SD ' HD12 ' C' ' 98' ' ' LEU . 14.3 tmm? -65.48 -36.16 83.04 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.274 -0.876 . . . . 62.43 110.136 172.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.68 -34.72 77.48 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.995 0.918 . . . . 40.52 111.412 176.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -65.65 -40.99 93.08 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.697 -0.683 . . . . 73.01 110.224 173.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.495 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 43.0 t -63.34 -45.25 92.12 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.598 0.561 . . . . 73.53 110.412 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.52 HD21 HG12 ' C' ' 86' ' ' ILE . 75.2 mt -80.98 -51.99 7.92 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.135 0.574 . . . . 72.5 112.397 -175.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.75 11.12 65.17 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 115.081 0.792 . . . . 60.11 115.081 -169.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.35 -61.82 0.14 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.425 0.631 . . . . 51.4 110.813 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.495 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 35.0 t80 -75.2 -37.15 61.3 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 125.502 1.521 . . . . 63.54 113.735 -165.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 91.7 m -77.84 -44.12 2.38 Favored Pre-proline 0 N--CA 1.486 1.344 0 C-N-CA 123.252 0.621 . . . . 73.43 112.033 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.719 ' HB2' HD22 ' C' ' 60' ' ' LEU . 78.6 Cg_endo -75.57 -9.48 19.99 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 121.849 1.699 . . . . 73.05 112.344 172.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -68.08 -37.41 81.21 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.751 -0.833 . . . . 72.05 108.751 168.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.552 HD12 ' NH1' ' A' ' 111' ' ' ARG . 39.8 mm -59.38 -43.41 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 115.455 -0.793 . . . . 70.25 109.366 171.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.449 HD21 ' HA3' ' C' ' 82' ' ' GLY . 82.0 mt -81.92 -16.02 51.96 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.307 1.043 . . . . 75.21 112.913 -173.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -55.03 -53.93 55.88 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-O 118.257 -0.878 . . . . 74.3 112.63 -175.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.13 -30.62 65.36 Favored 'Trans proline' 0 C--N 1.388 2.635 0 C-N-CA 121.951 1.767 . . . . 64.11 113.508 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -67.57 -49.85 61.19 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.297 0.639 . . . . 54.35 110.539 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.18 -42.79 95.76 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.196 -0.911 . . . . 73.2 110.276 176.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -58.81 -52.66 64.76 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.173 1.389 . . . . 70.43 111.359 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -66.84 -37.1 83.83 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.738 0.649 . . . . 72.24 110.052 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 35.2 t -67.7 -32.62 73.39 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.332 0.395 . . . . 63.15 111.59 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 83.9 mt -72.54 -52.99 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.127 0.571 . . . . 65.55 110.23 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 12.3 m -65.01 -29.31 70.22 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.176 0.59 . . . . 72.13 111.321 -175.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 40.6 t -65.72 -49.7 67.52 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.077 -0.712 . . . . 64.45 109.077 173.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.689 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.75 -37.29 78.59 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.157 0.983 . . . . 72.2 112.39 179.257 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 83.0 t -60.74 -48.26 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.226 0.61 . . . . 75.24 110.035 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 26.5 t -72.39 -22.24 61.16 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 115.325 -0.852 . . . . 74.05 111.581 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.428 ' NH2' ' HG3' ' B' ' 112' ' ' GLU . 89.2 mtt-85 -73.93 -35.0 64.54 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.856 0.862 . . . . 72.35 109.705 174.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.05 7.65 70.16 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 115.457 -0.792 . . . . 75.41 112.086 171.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 64.7 p 60.02 26.68 16.01 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.415 1.886 . . . . 72.13 113.412 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -88.65 144.95 34.17 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 108.202 -1.036 . . . . 63.33 108.202 171.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -54.63 154.25 21.01 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 123.121 2.548 . . . . 71.12 113.505 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -54.68 124.33 16.04 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.901 1.28 . . . . 52.03 113.43 -171.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 40.1 tp -127.22 90.47 3.14 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.41 -0.959 . . . . 72.21 108.41 176.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -92.31 131.24 37.67 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.067 0.947 . . . . 63.12 109.545 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.72 134.16 46.07 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.172 0.589 . . . . 64.51 109.512 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.33 151.07 77.75 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 123.291 0.636 . . . . 61.01 110.978 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.74 110.67 2.39 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.892 2.395 . . . . 60.21 112.141 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.38 111.61 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.256 0.622 . . . . 60.42 109.595 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -85.41 89.68 7.75 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.716 0.806 . . . . 73.24 110.438 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -59.63 -38.09 80.39 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 109.663 -0.495 . . . . 71.13 109.663 169.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 N--CA 1.472 0.636 0 C-N-CA 125.259 1.424 . . . . 75.2 111.362 179.013 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 65.1 m . . . . . 0 C--O 1.241 0.639 0 N-CA-C 108.071 -1.085 . . . . 72.23 108.071 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.751 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 20.8 t80 -164.79 90.63 0.53 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.673 -1.232 . . . . 63.41 107.673 -177.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -113.05 116.28 29.67 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.13 -1.433 . . . . 71.52 107.13 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.482 HG21 HD11 ' D' ' 16' ' ' ILE . 18.2 mt -68.75 123.26 21.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 109.331 -0.618 . . . . 61.34 109.331 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 14' ' ' GLN . . . . . 0.529 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 21.0 mm-40 -83.01 -46.46 12.83 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 123.795 0.684 . . . . 53.02 109.687 175.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.409 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 27.7 ttt180 -178.5 141.08 0.21 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 116.603 -0.271 . . . . 75.2 111.706 -164.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.482 HD11 HG21 ' D' ' 13' ' ' ILE . 3.7 mp -122.97 142.0 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.464 -1.31 . . . . 63.12 107.464 172.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.409 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 26.3 p90 -165.46 174.48 9.95 Favored 'General case' 0 C--O 1.238 0.496 0 O-C-N 124.062 0.851 . . . . 72.51 111.187 -175.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 62.3 p -108.71 119.56 39.9 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 114.557 -1.202 . . . . 71.21 109.642 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -92.42 -19.13 22.37 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.378 0.671 . . . . 71.3 110.165 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.606 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 15.9 t70 -158.09 133.27 8.68 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.774 -1.103 . . . . 65.2 108.699 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.689 HG21 ' HE2' ' C' ' 117' ' ' MET . 68.8 mt -131.94 147.78 32.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 107.083 -1.451 . . . . 61.43 107.083 173.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -156.24 144.74 20.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 123.741 0.651 . . . . 54.31 110.114 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 87.4 t80 -148.17 122.05 9.36 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 105.346 -2.094 . . . . 63.24 105.346 173.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -133.38 110.8 10.27 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.061 0.544 . . . . 74.21 109.806 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.32 88.13 12.34 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 107.772 -1.195 . . . . 54.34 107.772 175.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -74.2 -39.85 1.47 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.907 2.405 . . . . 64.5 112.06 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -92.34 5.11 51.8 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.749 -1.114 . . . . 72.43 111.021 -176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.506 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -30.04 -67.8 0.13 Allowed Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 116.459 2.022 . . . . 63.01 116.459 -164.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.42 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 93.5 Cg_endo -75.07 -23.91 13.22 Favored 'Trans proline' 0 C--N 1.374 1.909 0 CA-C-N 122.831 2.047 . . . . 73.33 113.119 -173.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -73.12 -39.21 65.93 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.932 0.893 . . . . 43.52 109.57 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.506 HG12 ' O ' ' D' ' 28' ' ' ALA . 4.8 p -83.03 -16.11 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-N 115.817 -0.628 . . . . 74.51 110.442 -173.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.42 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.1 m-85 -69.02 -22.82 64.04 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.524 0.33 . . . . 61.33 111.77 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -57.51 -27.04 62.22 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.587 0.755 . . . . 75.45 109.976 172.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -88.43 70.74 9.04 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.818 1.247 . . . . 65.23 109.198 172.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -79.71 87.64 5.22 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.72 -0.673 . . . . 73.4 109.714 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 18.6 p90 -163.29 174.82 11.56 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.337 1.055 . . . . 74.41 109.112 172.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -68.45 115.98 35.37 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.62 0.768 . . . . 74.11 109.565 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -63.18 151.87 82.59 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.709 2.273 . . . . 62.43 112.616 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -73.24 113.09 9.92 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.359 -1.349 . . . . 74.55 107.359 172.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.71 HG21 ' HG ' ' D' ' 126' ' ' LEU . 98.8 t -105.93 137.98 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 123.879 0.871 . . . . 73.25 109.739 -172.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -128.32 126.72 41.33 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.616 1.166 . . . . 62.34 108.131 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.49 HD22 HD23 ' D' ' 128' ' ' LEU . 45.2 tp -96.99 144.07 27.24 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.07 -0.715 . . . . 63.13 109.07 176.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.535 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 7.5 t70 -144.14 153.82 42.53 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.538 0.735 . . . . 75.32 109.081 176.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.6 mt -133.23 146.41 51.44 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.417 0.687 . . . . 74.11 111.108 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.653 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 5.8 t70 -135.58 155.18 50.88 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.919 1.287 . . . . 75.3 108.215 169.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 97.7 m -101.39 140.48 35.63 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.94 0.896 . . . . 71.0 108.812 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -166.91 142.56 4.29 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.222 -1.029 . . . . 53.01 108.222 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.8 p -176.36 162.44 2.38 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.941 0.496 . . . . 72.4 110.425 -176.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 77.5 p -153.77 150.16 28.2 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.647 0.379 . . . . 75.54 110.936 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -88.14 119.61 28.7 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.72 -0.844 . . . . 73.12 108.72 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' D' ' 57' ' ' GLU . 23.2 mt -94.72 -31.81 13.62 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.793 0.437 . . . . 73.13 111.161 -175.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -161.27 -175.72 5.0 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.739 0.816 . . . . 74.33 110.602 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.07 109.83 3.16 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.771 -1.104 . . . . 75.44 109.389 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 66.89 6.91 4.93 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.588 1.155 . . . . 64.2 112.677 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 64.1 t -110.91 120.55 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 107.427 -1.323 . . . . 73.25 107.427 175.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -140.85 131.7 25.91 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 122.917 0.487 . . . . 73.41 110.008 -165.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.456 ' HB2' HD11 ' D' ' 51' ' ' LEU . 15.9 tt0 -92.72 135.0 34.49 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.793 0.837 . . . . 73.11 110.5 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 98.0 t -117.5 128.75 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.163 1.385 . . . . 72.52 108.39 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 29.1 t -125.58 130.93 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.408 0.683 . . . . 64.2 109.594 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.495 HD23 HD12 ' D' ' 106' ' ' LEU . 4.6 mm? -117.81 121.09 39.87 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.087 -0.708 . . . . 45.33 109.087 172.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.653 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 41.2 ttm-85 -83.2 96.4 8.43 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.513 -1.291 . . . . 61.2 107.513 172.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.487 HG13 HD11 ' D' ' 42' ' ' LEU . 88.3 t -90.34 128.16 42.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.009 -1.108 . . . . 71.31 108.009 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 29.8 m -125.68 139.63 53.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.878 -0.416 . . . . 60.44 109.878 -176.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.688 HG13 HG13 ' D' ' 40' ' ' VAL . 17.8 t -128.61 102.01 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.441 1.096 . . . . 74.51 108.556 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 17.6 m -93.31 112.53 24.48 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.478 -0.934 . . . . 72.34 108.478 173.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.07 141.16 48.49 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.657 0.783 . . . . 62.11 109.186 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.435 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 59.8 p -148.8 127.02 12.12 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 123.52 0.513 . . . . 74.41 111.236 -177.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 28.8 mt -94.16 115.51 27.81 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 124.423 1.089 . . . . 73.22 109.076 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.65 -111.75 3.58 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 111.495 -0.642 . . . . 72.43 111.495 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.97 12.14 10.4 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.702 0.801 . . . . 72.05 110.863 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -131.56 165.21 24.13 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.849 0.459 . . . . 73.5 109.965 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -65.63 131.25 45.88 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.762 0.825 . . . . 71.25 111.961 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.435 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -90.97 -68.38 0.79 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.83 -1.174 . . . . 51.24 107.83 171.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -151.17 153.55 35.18 Favored 'General case' 0 C--N 1.353 0.72 0 CA-C-N 115.757 -0.656 . . . . 71.32 111.003 175.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 46.5 mt -118.97 110.56 17.27 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 106.773 -1.566 . . . . 54.44 106.773 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 76' ' ' CYS . . . . . . . . . . . . . 45.9 t -126.11 105.93 9.22 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 122.943 0.497 . . . . 54.24 109.972 -170.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -122.73 128.99 51.25 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.442 0.697 . . . . 70.43 109.701 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 25.6 t -126.96 121.19 57.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 123.419 0.688 . . . . 74.42 109.696 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.606 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.7 mt-30 -87.35 87.36 7.4 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.149 -1.056 . . . . 53.23 108.149 167.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -81.85 110.6 17.3 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.01 -1.45 . . . . 73.42 108.719 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.79 153.23 17.23 Favored Glycine 0 C--N 1.341 0.859 0 O-C-N 123.545 0.528 . . . . 73.13 111.842 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.8 130.87 2.88 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 111.578 -0.609 . . . . 73.51 111.578 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 22.2 mt -89.4 136.41 23.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 C-N-CA 123.801 0.84 . . . . 75.31 108.949 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -137.85 128.49 26.72 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.351 0.661 . . . . 74.23 110.26 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.1 m -78.78 98.36 6.26 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.638 0.775 . . . . 33.32 109.287 168.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 10.2 pt -115.37 139.66 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.397 1.079 . . . . 72.3 110.302 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.65 167.91 20.56 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.877 0.471 . . . . 60.31 111.048 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.56 17.35 79.98 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.954 -0.566 . . . . 65.02 113.308 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 8.4 mt -110.99 147.05 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.081 0.952 . . . . 73.21 108.832 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.42 165.31 27.13 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.687 0.795 . . . . 73.04 110.127 177.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.99 -142.17 46.62 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.168 0.917 . . . . 30.12 115.073 173.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 20.3 m -76.33 -16.25 59.8 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.93 0.892 . . . . 74.13 111.694 -172.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -68.1 -22.36 64.91 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.617 0.367 . . . . 54.44 110.764 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 92.1 mtp -64.02 -35.68 81.51 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.365 0.666 . . . . 54.1 110.432 172.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.71 -26.36 57.45 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.472 -0.786 . . . . 72.32 110.92 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -74.97 -40.35 60.78 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.812 0.445 . . . . 74.45 110.804 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -56.29 -46.79 79.61 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.422 0.689 . . . . 71.13 110.033 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 47.7 mt -87.23 -20.33 27.07 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.627 -1.169 . . . . 63.41 111.566 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.35 1.89 56.12 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-O 119.489 -0.617 . . . . 44.3 114.04 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.12 -67.82 0.28 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 117.585 0.692 . . . . 43.33 111.713 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -71.51 -38.43 71.12 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.716 0.636 . . . . 75.22 112.716 -170.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.751 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 76.3 m -68.23 -49.66 32.67 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 118.706 -0.664 . . . . 63.33 111.556 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -58.7 -29.44 89.49 Favored 'Trans proline' 0 C--N 1.401 3.308 0 C-N-CA 122.63 2.22 . . . . 51.14 113.139 170.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -63.36 -35.67 81.17 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.681 0.793 . . . . 54.23 110.575 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.8 mm -68.91 -38.09 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.626 0.77 . . . . 74.54 110.351 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.495 HD12 HD23 ' D' ' 60' ' ' LEU . 87.7 mt -81.75 -21.7 37.71 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.534 0.734 . . . . 73.13 112.576 -172.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -62.44 -46.71 89.83 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-O 118.425 -0.798 . . . . 62.11 113.121 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.14 -39.15 93.04 Favored 'Trans proline' 0 C--N 1.391 2.768 0 C-N-CA 122.348 2.032 . . . . 70.23 113.262 174.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -73.97 -36.85 64.62 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.582 0.753 . . . . 65.54 111.707 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.81 -49.25 71.4 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.661 -0.496 . . . . 54.34 109.661 176.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.423 ' NH2' HG23 ' B' ' 105' ' ' ILE . 38.9 ttp180 -58.78 -45.68 89.27 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 124.432 1.082 . . . . 74.13 110.312 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -61.08 -52.73 63.67 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.841 0.713 . . . . 65.23 110.881 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.6 t -56.42 -44.61 80.53 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 123.882 0.738 . . . . 65.42 110.925 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.498 ' O ' HG23 ' D' ' 118' ' ' VAL . 67.8 mt -61.39 -55.67 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.198 0.999 . . . . 70.12 110.69 175.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.403 HG23 ' HG3' ' D' ' 125' ' ' GLN . 92.5 m -58.77 -36.19 73.99 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.141 0.976 . . . . 64.54 111.501 -173.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 40.8 t -67.87 -43.69 78.82 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.375 -0.83 . . . . 74.32 109.794 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.6 mtm -70.02 -27.56 64.77 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.761 0.424 . . . . 71.43 111.841 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.498 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.3 t -64.52 -49.31 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.303 0.641 . . . . 61.21 109.509 174.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.6 p -69.04 -32.51 72.06 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.797 -0.638 . . . . 53.13 110.899 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.4 mtt-85 -68.39 -37.61 80.53 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.924 0.89 . . . . 71.34 110.246 174.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.91 0.97 87.81 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 115.738 -0.664 . . . . 63.11 112.259 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.477 HG21 HE21 ' A' ' 125' ' ' GLN . 30.7 p 63.07 26.79 15.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.7 2.0 . . . . 74.15 113.104 172.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -87.44 152.63 52.57 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 109.239 -0.652 . . . . 74.33 109.239 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.94 124.51 15.68 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.931 2.421 . . . . 54.12 112.341 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.403 ' HG3' HG23 ' D' ' 115' ' ' THR . 35.2 tt0 -55.42 146.7 19.12 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.633 1.173 . . . . 70.01 112.251 -174.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.71 ' HG ' HG21 ' D' ' 40' ' ' VAL . 3.2 tm? -143.58 117.14 9.17 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.138 -1.06 . . . . 73.24 108.138 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -109.9 118.88 37.65 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.415 -0.958 . . . . 74.1 108.415 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.49 HD23 HD22 ' D' ' 42' ' ' LEU . 6.5 mp -66.73 128.17 35.26 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.781 0.833 . . . . 72.22 110.428 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -67.97 133.74 91.94 Favored Pre-proline 0 CA--C 1.552 1.026 0 O-C-N 123.842 0.714 . . . . 63.42 110.931 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 14.8 Cg_exo -68.83 130.38 20.4 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.902 2.401 . . . . 72.42 112.373 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.479 1.003 0 C-N-CA 123.909 0.884 . . . . 73.43 109.897 177.443 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.736 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 2.9 t80 . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 109.478 -0.564 . . . . 74.44 109.478 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -145.48 114.59 7.01 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.477 -0.935 . . . . 74.14 108.477 176.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.612 HG12 ' HD2' ' A' ' 84' ' ' PHE . 47.7 mt -90.29 129.62 40.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.649 -0.871 . . . . 74.4 108.649 174.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -87.88 -41.79 12.97 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.818 -0.628 . . . . 73.21 110.133 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -175.93 129.46 0.24 Allowed 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.18 0.3 . . . . 65.12 111.197 -170.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.46 HD11 HD13 ' A' ' 13' ' ' ILE . 97.3 mt -121.61 139.9 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 123.653 0.781 . . . . 75.33 108.985 177.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.514 ' HB3' HG23 ' B' ' 122' ' ' THR . 35.0 p90 -169.92 177.18 4.46 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.02 0.928 . . . . 74.42 110.597 -169.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.0 p -102.33 121.19 41.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.284 -1.006 . . . . 64.41 108.284 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 33.8 mtpt -83.15 -44.08 15.48 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.639 -0.875 . . . . 72.31 108.639 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 21.9 t70 -135.59 134.8 39.72 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.19 -1.368 . . . . 51.33 108.921 -175.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.421 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 80.9 mt -135.14 142.44 39.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.148 -1.427 . . . . 73.25 107.148 178.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -154.17 115.16 4.04 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.095 0.474 . . . . 64.25 110.535 172.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.636 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 75.4 t80 -110.22 138.91 45.95 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 106.838 -1.542 . . . . 64.51 106.838 170.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -138.3 140.62 39.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.227 -1.027 . . . . 74.32 108.227 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.88 78.61 35.44 Favored Pre-proline 0 C--O 1.238 0.48 0 N-CA-C 107.314 -1.365 . . . . 53.42 107.314 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.93 -28.1 36.12 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.968 2.445 . . . . 71.13 112.293 -170.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -114.49 28.8 8.48 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.945 0.898 . . . . 70.11 109.591 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.472 ' HB3' ' HZ2' ' B' ' 19' ' ' LYS . . . -47.29 -52.38 35.97 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.03 0.932 . . . . 72.35 113.422 -178.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HG3' ' HZ1' ' B' ' 19' ' ' LYS . 15.1 Cg_exo -63.74 -21.74 69.68 Favored 'Trans proline' 0 C--N 1.39 2.751 0 CA-C-N 121.413 1.541 . . . . 61.2 112.751 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.446 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.9 m80 -94.9 -32.93 13.0 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 124.123 0.969 . . . . 63.41 110.788 -174.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.492 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.5 p -76.32 -16.87 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 112.724 0.639 . . . . 73.45 112.724 -163.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -77.72 -32.58 52.96 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.027 0.531 . . . . 74.15 112.0 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -75.91 -18.62 59.31 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.821 0.449 . . . . 71.21 110.721 174.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 14.5 mmmm -75.29 148.02 39.72 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.61 0.764 . . . . 64.13 111.749 -175.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.06 127.64 32.91 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 124.238 0.961 . . . . 61.42 109.424 171.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -78.98 86.06 4.87 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.529 0.68 . . . . 72.34 110.358 -177.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -136.53 78.59 43.57 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.014 1.325 . . . . 72.14 107.907 176.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -86.45 171.4 7.48 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.448 2.099 . . . . 64.53 113.61 -174.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -115.96 101.08 8.44 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 107.095 -1.446 . . . . 72.42 107.095 170.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -77.59 93.94 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.935 0.874 . . . . 65.44 111.081 -172.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.545 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 8.4 mtpm? -82.63 114.28 20.9 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.196 -1.038 . . . . 74.02 108.196 173.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 63' ' ' THR . 0.5 OUTLIER -123.83 107.94 11.94 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.711 0.767 . . . . 74.12 109.847 -174.715 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.449 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.2 m-20 -114.01 136.61 52.72 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.61 -1.177 . . . . 74.13 109.42 -174.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.15 142.17 46.57 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.437 -0.949 . . . . 60.33 108.437 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.682 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 5.9 t70 -147.11 127.6 14.09 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.537 -0.542 . . . . 74.25 109.537 -169.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 64.1 p -105.78 126.96 52.78 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.455 0.702 . . . . 52.45 110.886 -168.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.571 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -133.03 141.84 48.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.726 0.81 . . . . 53.45 109.438 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.3 m -132.61 154.98 49.52 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.378 0.671 . . . . 70.21 110.668 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.6 t -153.78 139.59 18.07 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.595 0.758 . . . . 62.05 109.565 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -96.67 120.53 37.17 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.879 -0.785 . . . . 64.22 108.879 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.723 HD11 ' HB2' ' A' ' 57' ' ' GLU . 25.8 mt -107.27 -35.81 6.71 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.553 0.741 . . . . 75.23 110.336 -172.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.544 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -156.71 -176.88 6.22 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.368 1.067 . . . . 71.14 109.687 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -71.75 116.12 11.75 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.68 0.792 . . . . 71.14 109.956 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 70.12 0.22 3.04 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.79 1.236 . . . . 71.04 112.235 -176.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 58.9 t -111.26 112.43 40.5 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 108.247 -1.02 . . . . 73.34 108.247 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -124.84 173.32 8.68 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.438 1.095 . . . . 71.43 108.972 -173.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.723 ' HB2' HD11 ' A' ' 51' ' ' LEU . 41.3 tt0 -127.17 127.79 45.09 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.195 0.598 . . . . 74.14 109.513 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.428 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 84.3 t -105.44 122.56 58.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.761 -1.2 . . . . 65.2 107.761 170.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 46.1 t -116.78 138.57 46.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 N-CA-C 108.139 -1.06 . . . . 72.31 108.139 174.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.8 tp -127.31 118.08 23.5 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.26 -0.644 . . . . 72.23 109.26 174.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.682 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 16.9 ttm-85 -85.18 102.37 13.25 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.448 -0.945 . . . . 63.23 108.448 173.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.5 t -95.1 108.68 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.559 -0.904 . . . . 72.25 108.559 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 26.8 m -95.46 124.77 39.66 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.623 0.769 . . . . 34.45 108.993 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.9 t -124.74 107.41 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.197 -1.038 . . . . 62.4 108.197 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 18.3 m -108.12 136.16 48.27 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.515 -0.92 . . . . 63.11 108.515 175.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.12 110.99 20.36 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.29 -1.374 . . . . 72.43 107.29 172.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.9 m -115.31 124.33 51.03 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.598 0.359 . . . . 73.3 110.09 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.4 mt -90.64 84.71 5.93 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.285 -1.006 . . . . 62.34 108.285 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.86 -83.44 0.93 Allowed Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.85 -0.5 . . . . 53.43 111.85 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -125.01 -29.16 3.37 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.861 0.864 . . . . 72.23 109.203 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -77.93 109.94 12.41 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.284 -0.636 . . . . 71.33 109.284 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.8 m -69.53 122.9 19.96 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 110.234 -0.284 . . . . 72.02 110.234 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.492 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -69.03 -61.25 1.87 Allowed 'General case' 0 C--O 1.24 0.596 0 O-C-N 123.843 0.714 . . . . 51.15 110.271 176.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.437 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 26.8 p90 -160.41 172.83 16.58 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.076 -0.965 . . . . 74.32 111.966 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.2 tp -131.41 138.23 49.0 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.984 -1.462 . . . . 62.13 107.497 173.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.429 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 86.1 m -139.12 97.66 3.35 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.28 -1.007 . . . . 73.14 108.28 176.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -120.09 117.23 27.43 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.281 -1.007 . . . . 71.52 108.281 -175.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.0 t -129.31 113.54 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 123.932 0.893 . . . . 42.31 109.867 -170.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.485 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 70.5 mt-30 -84.44 89.01 7.32 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 108.322 -0.992 . . . . 63.32 108.322 170.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.522 ' HG3' HD22 ' A' ' 106' ' ' LEU . 68.3 tp60 -77.0 103.08 6.73 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.002 -0.999 . . . . 75.53 109.079 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.71 145.83 19.0 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.978 -0.555 . . . . 74.55 111.811 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.416 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.19 123.16 1.46 Allowed Glycine 0 CA--C 1.503 -0.7 0 N-CA-C 110.731 -0.948 . . . . 64.24 110.731 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.446 HG23 HD12 ' A' ' 51' ' ' LEU . 55.5 mt -83.46 121.02 35.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.865 -0.791 . . . . 64.23 108.865 176.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.736 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 23.5 m-85 -134.26 130.13 36.65 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.337 0.655 . . . . 70.23 109.675 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.9 t -99.61 113.93 26.65 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.612 -0.884 . . . . 61.13 108.612 173.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.556 1.176 0 C-N-CA 123.96 0.904 . . . . 62.15 110.787 -175.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 121.166 0.508 . . . . 73.44 110.314 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -68.31 -44.43 75.45 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.219 1.008 . . . . 72.5 110.352 174.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.642 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 83.4 m -64.22 -44.78 90.85 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.369 0.667 . . . . 71.2 111.555 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.59 -50.86 11.67 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.668 0.787 . . . . 65.54 111.735 -173.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.4 5.08 67.42 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-O 119.186 -0.786 . . . . 72.55 114.759 -169.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.72 -51.8 0.15 Allowed 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.582 1.191 . . . . 52.22 113.48 -175.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.642 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 88.0 t80 -75.59 -49.23 19.17 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.826 0.851 . . . . 71.31 112.248 -168.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 99.3 m -69.65 -36.26 6.56 Favored Pre-proline 0 CA--C 1.563 1.478 0 CA-C-O 118.897 -0.573 . . . . 75.3 112.256 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -48.63 -42.43 35.98 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 122.504 2.136 . . . . 63.32 113.839 160.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 101' ' ' TYR . 84.0 m-20 -64.15 -34.44 78.08 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 123.537 0.735 . . . . 72.1 111.553 176.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.6 mm -66.02 -40.39 87.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 N-CA-C 109.587 -0.523 . . . . 74.13 109.587 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.522 HD22 ' HG3' ' A' ' 80' ' ' GLN . 96.5 mt -79.0 -22.44 45.52 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.755 0.822 . . . . 41.42 112.254 -178.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -58.14 -48.83 96.36 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 113.914 1.079 . . . . 62.5 113.914 -172.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -63.1 -39.83 37.11 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 122.111 1.874 . . . . 63.34 112.812 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -69.3 -40.75 77.51 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.298 0.639 . . . . 74.02 111.281 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.23 -40.63 70.97 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.071 0.548 . . . . 43.43 110.367 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.472 HH12 HD12 ' C' ' 105' ' ' ILE . 23.7 ttm180 -49.91 -51.99 36.57 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.01 0.924 . . . . 71.03 110.205 171.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -71.48 -37.54 71.3 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.006 -0.997 . . . . 54.31 111.64 -173.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.8 t -66.06 -32.66 74.25 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 121.061 0.457 . . . . 62.23 110.916 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 93.0 mt -69.18 -54.51 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 115.255 -0.884 . . . . 65.32 109.432 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.466 HG21 ' HE2' ' C' ' 109' ' ' TYR . 95.2 m -51.79 -40.6 60.66 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.994 1.317 . . . . 64.03 112.278 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.9 t -64.12 -47.6 79.36 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 115.249 -0.887 . . . . 73.34 110.656 -177.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.636 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 39.6 mtm -67.84 -36.07 79.69 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.807 0.692 . . . . 74.12 111.373 -178.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.9 -51.47 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 123.677 0.791 . . . . 74.14 110.254 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.5 t -69.46 -29.45 67.13 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.43 -0.804 . . . . 43.13 111.5 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.0 ttm-85 -77.93 -28.82 49.73 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.988 0.915 . . . . 71.51 109.2 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.425 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.96 12.65 59.33 Favored Glycine 0 C--N 1.351 1.411 0 CA-C-N 114.933 -1.03 . . . . 63.23 112.648 170.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.521 HG21 ' HE ' ' B' ' 15' ' ' ARG . 2.0 t 60.66 18.51 8.54 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 126.89 2.076 . . . . 70.35 113.523 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -77.93 158.39 77.79 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 123.938 0.895 . . . . 73.34 110.951 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.46 143.38 77.86 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.831 2.354 . . . . 64.32 112.995 173.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.414 HE21 HG21 ' D' ' 122' ' ' THR . 5.4 tp-100 -53.73 127.74 26.9 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.674 1.19 . . . . 72.13 112.183 -175.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.437 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 43.5 tp -126.92 101.37 6.55 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.048 0.939 . . . . 64.4 109.45 -177.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.429 ' ND2' ' H ' ' C' ' 16' ' ' ILE . 91.4 m-20 -123.34 102.11 7.73 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.605 -0.887 . . . . 53.21 108.605 175.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.62 144.62 56.29 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.985 0.514 . . . . 70.0 109.687 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.41 151.25 97.34 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 123.833 0.853 . . . . 41.33 111.845 -173.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.489 ' HD3' HG13 ' C' ' 13' ' ' ILE . 52.1 Cg_endo -68.97 114.63 3.64 Favored 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 123.094 2.53 . . . . 73.24 113.111 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.1 m -111.61 112.68 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 108.184 -1.043 . . . . 63.44 108.184 165.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -81.61 93.61 6.76 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.63 -1.248 . . . . 70.4 107.63 175.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 . . . . . 0 N--CA 1.481 1.096 0 C-N-CA 124.242 1.017 . . . . 60.4 111.634 -175.415 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 121.225 0.536 . . . . 74.23 110.262 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 61.6 m -133.27 129.35 37.51 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.285 -1.376 . . . . 73.31 107.285 168.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.525 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 42.7 t80 -129.35 126.61 39.3 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.799 -1.185 . . . . 75.04 107.799 175.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -144.53 126.43 15.36 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.271 -0.64 . . . . 73.34 109.271 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 27.9 mt -74.8 121.51 26.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.562 -0.903 . . . . 74.3 108.562 172.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -92.06 -50.06 5.88 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.248 -0.649 . . . . 70.52 109.248 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.521 ' HE ' HG21 ' A' ' 122' ' ' THR . 45.8 ttt180 -166.52 131.16 2.14 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.727 -0.67 . . . . 70.02 110.209 -175.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 75.6 mt -114.68 137.18 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 108.029 -1.1 . . . . 73.3 108.029 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.406 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 39.2 p90 -169.87 161.79 9.12 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.442 0.639 . . . . 75.21 111.5 -176.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.525 HG21 HD11 ' B' ' 21' ' ' ILE . 42.7 m -83.17 130.63 35.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.771 -1.104 . . . . 73.33 109.249 170.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.472 ' HZ2' ' HB3' ' A' ' 28' ' ' ALA . 24.0 mtpp -96.51 -34.22 11.56 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.261 0.625 . . . . 55.11 109.851 176.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -147.72 145.45 28.86 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.084 0.469 . . . . 73.14 111.177 -173.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.578 HD11 ' SG ' ' B' ' 113' ' ' CYS . 40.3 mm -136.35 146.5 28.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 126.047 1.739 . . . . 72.3 108.708 177.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.502 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 36.7 t -150.9 133.32 15.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.558 -1.201 . . . . 71.03 108.324 171.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 74.0 t80 -141.07 135.99 31.54 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.098 -1.445 . . . . 75.1 107.098 172.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -141.51 128.48 20.68 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.218 1.007 . . . . 75.12 108.666 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -130.17 80.95 69.8 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 107.018 -1.475 . . . . 63.51 107.018 174.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.82 -26.73 31.96 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.142 2.561 . . . . 72.01 113.152 -171.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -115.11 18.73 16.13 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.674 0.79 . . . . 73.54 110.047 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.501 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -45.86 -59.17 5.02 Favored Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 125.06 1.344 . . . . 74.52 114.129 -170.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.413 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 23.8 Cg_exo -61.43 -28.49 83.89 Favored 'Trans proline' 0 C--N 1.393 2.89 0 C-N-CA 122.233 1.955 . . . . 74.3 113.346 -169.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.437 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 78.1 m80 -93.96 -38.21 11.29 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.702 -0.681 . . . . 72.23 111.404 -175.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.502 HG22 HD12 ' B' ' 68' ' ' LEU . 4.5 p -67.88 -16.74 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.129 0.572 . . . . 62.1 111.757 -173.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -65.11 -21.03 66.74 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.222 0.823 . . . . 74.23 113.222 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 10.3 pt20 -68.28 -15.27 63.5 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.308 0.643 . . . . 61.02 111.179 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.41 ' HB2' HD13 ' B' ' 68' ' ' LEU . 89.6 mttt -95.27 105.71 17.68 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.597 1.159 . . . . 64.44 109.791 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -110.72 93.08 4.31 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.09 0.556 . . . . 72.53 109.829 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 39.7 p90 -162.65 179.7 7.52 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.716 1.206 . . . . 75.5 108.411 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -69.05 114.71 25.26 Favored Pre-proline 0 N--CA 1.477 0.915 0 N-CA-C 109.578 -0.527 . . . . 73.53 109.578 177.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.485 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 43.2 Cg_endo -65.72 139.11 56.4 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 121.901 1.734 . . . . 63.52 111.027 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -66.45 103.68 1.09 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.561 -0.903 . . . . 73.15 108.561 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.565 HG11 HD21 ' B' ' 126' ' ' LEU . 31.2 m -99.83 160.82 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 115.41 -0.813 . . . . 62.24 111.815 -172.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -145.04 133.59 22.01 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.67 -1.15 . . . . 65.34 108.524 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 pp -86.7 164.98 16.44 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 123.038 0.535 . . . . 74.23 110.15 175.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.595 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 17.5 t70 -164.72 126.31 2.15 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.072 -0.967 . . . . 75.13 108.545 175.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.431 HD23 HD21 ' B' ' 60' ' ' LEU . 5.5 mp -123.04 134.15 54.3 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.576 0.75 . . . . 70.21 109.073 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.669 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 10.9 t70 -131.32 133.65 45.55 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.845 0.858 . . . . 63.22 108.758 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 17.9 p -106.37 102.02 11.45 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.244 0.618 . . . . 64.32 109.678 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.474 ' O ' ' HB ' ' B' ' 59' ' ' VAL . . . -119.85 114.21 21.75 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 107.111 -1.44 . . . . 65.22 107.111 174.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 52.6 m -144.77 161.06 40.17 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.385 -0.598 . . . . 72.21 109.385 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 76.1 p -164.73 150.17 9.95 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.906 0.482 . . . . 71.01 110.445 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -82.24 129.5 34.86 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.205 0.602 . . . . 71.25 109.65 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' B' ' 57' ' ' GLU . 20.7 mt -91.07 -49.97 6.11 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.796 0.839 . . . . 71.2 109.971 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.03 -173.49 4.18 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.193 -0.912 . . . . 61.42 110.224 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -65.65 120.73 13.48 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.947 -1.024 . . . . 75.42 109.313 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 68.17 9.2 7.05 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.115 1.366 . . . . 64.11 111.773 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -120.92 109.36 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.048 0.939 . . . . 74.12 109.21 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -119.48 149.04 42.54 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.505 1.122 . . . . 73.52 108.443 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.448 ' HB2' HD11 ' B' ' 51' ' ' LEU . 40.3 tt0 -118.76 122.08 41.58 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.925 0.49 . . . . 73.54 109.78 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 61.9 t -100.93 118.91 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 108.375 -0.972 . . . . 65.41 108.375 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' B' ' 47' ' ' ALA . 21.4 t -118.67 130.82 72.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 107.646 -1.242 . . . . 65.55 107.646 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.431 HD21 HD23 ' B' ' 44' ' ' LEU . 14.2 tp -123.32 124.59 43.31 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 110.128 -0.323 . . . . 65.34 110.128 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.669 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 39.0 ttm180 -87.31 113.5 23.08 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.864 0.865 . . . . 43.13 109.001 173.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 43.1 t -104.88 101.32 12.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.475 -1.306 . . . . 70.03 107.475 173.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.595 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 18.1 m -103.06 132.36 49.38 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.569 0.748 . . . . 75.54 109.065 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 89.6 t -123.24 127.02 74.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 124.773 1.229 . . . . 73.02 108.825 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.1 m -103.98 148.08 26.62 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.822 -0.807 . . . . 65.01 108.822 169.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.485 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -148.53 140.14 23.6 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.544 0.738 . . . . 72.32 109.563 176.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.504 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 35.3 p -143.98 137.7 27.91 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 123.635 0.584 . . . . 73.23 110.826 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.502 HD12 HG22 ' B' ' 31' ' ' VAL . 67.4 mt -110.52 110.82 21.69 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.043 -1.095 . . . . 63.41 108.043 174.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.55 -129.93 10.29 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 123.245 0.34 . . . . 44.24 113.056 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -96.61 16.44 18.86 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.683 0.793 . . . . 61.0 111.919 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.06 152.81 43.69 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.699 0.399 . . . . 72.33 110.952 -175.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 58.2 m -64.94 132.65 49.9 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 123.636 0.585 . . . . 43.2 110.136 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.504 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -85.44 -66.64 0.88 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.14 -1.43 . . . . 74.31 107.14 171.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -149.21 159.55 44.15 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 122.01 0.91 . . . . 74.12 112.178 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 71.3 mt -131.45 113.1 13.3 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 105.946 -1.872 . . . . 74.31 105.946 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.576 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 48.3 t -118.9 147.83 43.57 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.739 -0.837 . . . . 74.03 108.739 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.502 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 40.0 tt0 -155.9 128.67 7.91 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.92 -0.77 . . . . 72.3 108.92 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 96.1 t -130.36 145.83 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.789 0.836 . . . . 52.24 108.947 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -122.29 101.21 7.38 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.23 -1.026 . . . . 65.22 108.23 172.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -91.25 104.62 17.14 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.079 -0.711 . . . . 74.11 109.079 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.5 142.91 16.27 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.507 -0.769 . . . . 70.44 111.643 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.42 124.0 2.92 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 109.875 -1.29 . . . . 74.43 109.875 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 53.1 mt -86.26 128.61 39.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.957 -1.127 . . . . 71.44 107.957 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -137.44 134.91 36.38 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.816 0.847 . . . . 74.41 109.001 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 74.3 m -91.11 108.34 19.81 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.597 -0.52 . . . . 72.14 109.597 171.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.674 HD13 HD21 ' B' ' 98' ' ' LEU . 48.4 pt -121.9 143.67 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.41 1.084 . . . . 72.33 110.586 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.8 152.04 22.64 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.185 0.594 . . . . 73.25 110.771 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.95 -69.59 0.23 Allowed Glycine 0 C--N 1.347 1.18 0 O-C-N 123.429 0.455 . . . . 44.22 112.869 170.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.402 HG22 ' HB2' ' B' ' 94' ' ' MET . 18.5 mt -75.07 152.75 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.394 0.678 . . . . 73.1 110.947 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -155.81 -175.04 5.22 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 124.118 0.967 . . . . 71.31 108.92 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.67 -135.07 26.46 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 123.364 0.507 . . . . 62.11 114.152 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 31.6 m -71.25 -36.51 71.8 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.58 0.752 . . . . 72.41 111.832 -174.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -60.91 -38.22 84.99 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.766 -0.652 . . . . 64.33 110.361 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.402 ' HB2' HG22 ' B' ' 89' ' ' ILE . 42.0 ttp -80.03 -28.07 39.39 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.561 -0.745 . . . . 72.21 110.569 177.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.4 -31.89 72.94 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.106 0.562 . . . . 74.25 110.708 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -75.58 -39.01 58.69 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.232 0.613 . . . . 65.1 110.573 173.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.1 t -64.12 -64.52 0.86 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.083 0.553 . . . . 64.14 110.912 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.674 HD21 HD13 ' B' ' 86' ' ' ILE . 65.9 mt -72.47 -30.74 64.82 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.122 0.569 . . . . 65.01 111.968 -176.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.74 -10.44 72.8 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 119.717 -0.491 . . . . 61.34 114.208 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.688 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -142.35 -58.58 0.45 Allowed 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 117.433 0.616 . . . . 54.34 111.948 -175.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -60.51 -49.22 78.43 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.168 0.987 . . . . 63.33 112.385 -176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.525 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 64.1 m -67.65 -50.3 36.02 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-O 118.484 -0.77 . . . . 63.13 112.579 -175.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.428 ' HB2' HD22 ' B' ' 60' ' ' LEU . 74.0 Cg_endo -72.17 -12.62 28.03 Favored 'Trans proline' 0 C--N 1.385 2.473 0 CA-C-N 121.248 1.481 . . . . 73.0 112.84 177.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' B' ' 100' ' ' ALA . 0.2 OUTLIER -73.99 -33.49 63.84 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.071 0.548 . . . . 64.22 109.548 173.619 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.484 HG23 ' NH2' ' D' ' 111' ' ' ARG . 97.7 mt -60.76 -42.24 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 124.031 0.932 . . . . 64.3 109.738 170.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.8 mt -87.34 -14.5 40.61 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.413 -1.267 . . . . 61.52 111.396 -171.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -54.39 -51.82 74.74 Favored Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 124.321 1.048 . . . . 73.22 112.7 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' B' ' 105' ' ' ILE . 83.1 Cg_exo -52.46 -40.15 72.33 Favored 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 122.866 2.378 . . . . 63.4 114.791 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -75.07 -41.31 59.18 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.927 -0.579 . . . . 74.5 110.51 -175.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.86 -40.27 96.16 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.196 0.598 . . . . 71.41 110.43 174.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -57.11 -59.59 4.86 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.468 1.507 . . . . 73.35 110.564 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.82 -37.74 74.35 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 124.124 0.89 . . . . 72.14 110.759 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.578 ' SG ' HD11 ' B' ' 21' ' ' ILE . 19.0 t -68.61 -40.65 80.3 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.336 -0.847 . . . . 53.0 111.593 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.576 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 63.6 mt -62.18 -50.77 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.233 -0.654 . . . . 70.02 109.233 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.402 HG21 ' OG ' ' C' ' 119' ' ' SER . 4.6 m -61.99 -29.6 70.37 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 124.133 0.896 . . . . 64.13 111.431 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -66.4 -50.42 63.51 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 109.487 -0.56 . . . . 73.31 109.487 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 117' ' ' MET . . . . . . . . . . . . . 35.5 mmt -62.44 -41.69 98.91 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 123.699 0.624 . . . . 63.11 110.876 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 114' ' ' ILE . 70.0 t -61.78 -48.12 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 124.209 1.004 . . . . 63.52 110.857 177.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 26.0 t -67.48 -30.36 70.04 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.58 -0.736 . . . . 73.21 110.792 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -69.92 -31.31 69.01 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.992 0.517 . . . . 71.1 110.12 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.76 9.66 55.07 Favored Glycine 0 C--N 1.353 1.521 0 O-C-N 123.883 0.739 . . . . 64.21 112.314 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.514 HG23 ' HB3' ' A' ' 17' ' ' TYR . 82.8 p 60.5 22.18 11.88 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 126.825 2.05 . . . . 62.55 113.627 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -84.63 161.93 52.13 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 123.476 0.71 . . . . 75.04 111.062 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -61.9 174.58 2.3 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 123.057 2.505 . . . . 72.22 113.875 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.567 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -62.42 115.13 3.95 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.312 -1.313 . . . . 50.04 111.343 -175.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.565 HD21 HG11 ' B' ' 40' ' ' VAL . 1.6 tm? -131.92 96.08 3.84 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.361 -0.977 . . . . 73.15 108.361 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -123.1 137.01 55.03 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.475 1.11 . . . . 73.13 108.773 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 6.9 mp -70.67 138.01 50.31 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.749 0.655 . . . . 52.51 110.524 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.77 151.26 89.29 Favored Pre-proline 0 CA--C 1.553 1.077 0 O-C-N 124.331 1.019 . . . . 74.31 112.173 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.83 92.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.533 2.822 . . . . 72.41 112.636 173.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 16.1 m -115.09 112.37 39.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 115.673 -0.694 . . . . 73.55 109.194 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -82.57 94.11 7.44 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 107.498 -1.297 . . . . 75.22 107.498 173.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -68.7 -29.9 68.44 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.317 -1.311 . . . . 74.4 110.638 -172.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 134' ' ' ASP . . . . . 0.688 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 17.5 t70 . . . . . 0 C--N 1.35 0.589 0 C-N-CA 124.048 0.939 . . . . 74.34 110.898 172.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.474 ' CD1' ' HE2' ' C' ' 101' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 121.254 0.55 . . . . 74.23 110.161 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -148.74 126.24 11.65 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.152 -1.425 . . . . 42.02 107.152 173.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.489 HG13 ' HD3' ' A' ' 130' ' ' PRO . 65.2 mt -78.35 123.48 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 109.336 -0.616 . . . . 60.3 109.336 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -86.03 -43.11 13.39 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.331 -0.849 . . . . 74.21 110.315 -177.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -178.79 124.92 0.1 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.554 0.534 . . . . 63.41 110.23 -174.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.429 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 97.0 mt -114.03 143.64 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 108.263 -1.014 . . . . 73.03 108.263 175.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.468 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 31.3 p90 -174.82 172.7 2.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.34 1.056 . . . . 74.34 109.411 -170.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 66.6 p -96.94 126.06 41.81 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.844 0.458 . . . . 70.42 110.085 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.468 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 27.6 mmtp -76.37 -49.08 17.72 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.196 -1.038 . . . . 74.53 108.196 169.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 11.7 t70 -135.38 147.45 49.05 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 113.858 -1.519 . . . . 54.52 109.473 -170.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.5 mt -144.09 145.75 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 106.542 -1.651 . . . . 71.11 106.542 172.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -160.16 152.12 20.28 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.294 0.568 . . . . 61.35 110.397 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 70.0 t80 -149.87 136.59 19.3 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.356 -1.35 . . . . 74.41 107.356 175.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -138.96 127.83 23.58 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.346 0.658 . . . . 65.25 109.92 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.77 80.36 5.59 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 107.336 -1.357 . . . . 74.43 107.336 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.44 -35.53 38.84 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.749 2.299 . . . . 72.32 112.094 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -92.29 21.9 4.88 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.547 -1.206 . . . . 71.32 111.217 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.59 -49.44 45.83 Favored Pre-proline 0 CA--C 1.564 1.506 0 N-CA-C 113.849 1.055 . . . . 72.42 113.849 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.41 -44.23 34.54 Favored 'Trans proline' 0 C--N 1.388 2.614 0 CA-C-N 121.584 1.601 . . . . 72.24 112.652 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.421 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 86.4 t60 -69.34 -32.53 71.68 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.072 -0.967 . . . . 64.32 112.56 -175.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.759 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.9 p -78.68 -25.1 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 N-CA-C 112.695 0.628 . . . . 72.22 112.695 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -71.44 -16.02 62.36 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 112.811 0.671 . . . . 72.53 112.811 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 14.0 pt20 -94.9 19.17 10.62 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.282 0.633 . . . . 64.23 110.837 175.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.67 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -109.88 159.66 17.04 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.859 0.864 . . . . 75.15 110.576 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -82.11 131.04 35.24 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.118 0.967 . . . . 63.44 108.982 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -77.05 82.86 3.56 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.261 1.024 . . . . 72.33 112.341 -170.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -126.33 69.84 68.98 Favored Pre-proline 0 N--CA 1.484 1.235 0 C-N-CA 124.087 0.955 . . . . 60.24 109.865 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -88.96 135.06 2.72 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.864 2.376 . . . . 74.11 112.529 -173.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -86.44 115.79 24.17 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 106.902 -1.518 . . . . 64.21 106.902 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.2 t -79.49 100.2 3.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 108.911 -0.774 . . . . 75.42 108.911 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.629 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 4.3 mptp? -90.1 99.63 12.61 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.362 -1.718 . . . . 74.21 106.362 170.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 pp -95.52 145.01 25.52 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.867 -0.79 . . . . 74.24 108.867 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.434 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 23.0 t70 -142.86 145.29 32.99 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.845 -0.798 . . . . 64.13 108.845 -177.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -121.06 113.65 20.35 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.699 0.8 . . . . 71.2 109.312 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -113.59 163.03 15.48 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.267 1.427 . . . . 40.25 107.831 171.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.4 t -144.58 153.83 42.21 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.32 0.581 . . . . 72.41 111.27 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.91 152.17 41.78 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.039 1.336 . . . . 73.41 107.707 172.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.9 p -167.33 167.54 13.92 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 120.996 0.427 . . . . 73.42 111.454 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 69.9 p -161.21 153.61 20.28 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.063 -0.971 . . . . 70.23 109.011 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -88.54 124.11 33.71 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.26 -1.015 . . . . 72.04 108.26 168.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.559 HD11 HD12 ' C' ' 83' ' ' ILE . 64.9 mt -92.74 -38.67 11.68 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.521 0.728 . . . . 71.31 110.755 -176.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -157.07 178.03 10.82 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.515 0.726 . . . . 53.32 110.7 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -60.65 117.93 5.95 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.401 0.68 . . . . 75.15 109.811 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 70.01 -6.71 1.05 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 125.827 1.651 . . . . 63.52 113.596 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 57.6 t -97.55 111.67 27.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.932 -1.136 . . . . 65.2 107.932 177.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -127.78 134.89 49.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.299 -0.63 . . . . 72.41 109.299 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -92.24 126.89 37.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.895 -1.048 . . . . 64.42 109.679 177.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 72.9 t -116.4 116.05 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 107.739 -1.208 . . . . 74.02 107.739 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 38.9 t -116.01 132.57 65.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 108.746 -0.835 . . . . 74.32 108.746 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 54.3 tp -116.72 112.85 21.78 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.504 -0.924 . . . . 70.33 108.504 175.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.573 ' HB2' ' HG2' ' C' ' 79' ' ' GLN . 50.4 ttm-85 -91.62 111.02 22.36 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.882 -0.784 . . . . 73.42 108.882 173.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.557 ' HB ' HD11 ' C' ' 114' ' ' ILE . 20.8 t -99.33 129.16 50.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 N-CA-C 107.785 -1.191 . . . . 73.23 107.785 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 16.5 m -123.05 118.97 28.97 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.114 -0.698 . . . . 72.54 109.114 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 65.4 t -113.55 108.62 25.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-N 114.571 -1.195 . . . . 74.52 108.749 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.629 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 16.5 m -98.25 140.41 32.59 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.873 -1.158 . . . . 64.42 107.873 171.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.48 121.24 28.45 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.169 -1.419 . . . . 45.0 107.169 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 51.0 m -132.43 126.34 32.85 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.941 0.337 . . . . 74.05 110.68 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.67 HD13 ' HG2' ' C' ' 34' ' ' LYS . 10.3 mt -85.49 42.83 0.98 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.562 1.145 . . . . 63.22 109.7 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.03 -113.67 4.51 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 111.108 -0.797 . . . . 54.12 111.108 -172.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.83 -18.6 28.94 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.535 0.734 . . . . 64.43 110.044 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -80.04 120.75 24.63 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.392 1.077 . . . . 73.43 109.145 172.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 99.0 m -78.93 123.01 26.84 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.476 -0.935 . . . . 44.32 108.476 164.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.759 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.16 -56.72 5.51 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.649 0.593 . . . . 70.24 109.614 175.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -158.47 168.94 25.6 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.927 0.87 . . . . 71.44 111.392 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -128.08 141.53 51.47 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 105.859 -1.904 . . . . 72.21 105.859 166.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.485 ' SG ' HG23 ' C' ' 114' ' ' ILE . 37.3 t -145.36 136.85 25.18 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.427 -1.323 . . . . 74.01 107.427 177.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 77' ' ' GLU . . . . . 0.402 ' HG2' HH11 ' C' ' 61' ' ' ARG . 39.1 tt0 -156.24 121.14 4.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.532 0.206 . . . . 74.51 110.465 -168.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 84.7 t -132.59 135.56 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.644 0.778 . . . . 71.12 109.671 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.573 ' HG2' ' HB2' ' C' ' 61' ' ' ARG . 68.7 mt-30 -96.89 108.19 20.84 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.657 -0.868 . . . . 64.43 108.657 164.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -90.62 104.24 16.85 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.638 -0.875 . . . . 71.02 108.638 172.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.75 145.55 22.76 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.511 -0.768 . . . . 62.5 111.475 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.2 115.48 0.72 Allowed Glycine 0 CA--C 1.504 -0.656 0 N-CA-C 110.157 -1.177 . . . . 51.23 110.157 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.559 HD12 HD11 ' C' ' 51' ' ' LEU . 15.8 mm -83.76 121.74 36.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.886 -1.153 . . . . 60.53 107.886 175.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -129.04 119.35 24.07 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.851 -0.796 . . . . 71.45 108.851 -174.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 57.3 p -77.35 107.71 9.96 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.264 -1.013 . . . . 75.3 108.264 170.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 6.7 tt -116.25 131.91 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.831 1.252 . . . . 74.44 108.997 -177.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.02 171.03 20.8 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.913 0.885 . . . . 63.33 110.087 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.73 -58.44 3.71 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 112.228 -0.349 . . . . 65.21 112.228 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 36.2 pt -84.76 158.61 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.276 0.631 . . . . 74.24 110.669 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -149.9 164.71 34.68 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.839 0.855 . . . . 74.35 109.363 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.79 -125.31 30.4 Favored Glycine 0 C--N 1.346 1.094 0 C-N-CA 123.197 0.427 . . . . 72.31 113.69 171.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 45.5 p -56.43 -34.75 67.1 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.841 1.256 . . . . 75.02 112.531 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -73.47 -38.57 65.38 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.763 0.425 . . . . 70.53 111.592 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.434 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 47.3 mtt -62.15 -49.03 77.47 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.496 -0.557 . . . . 74.51 109.496 171.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.66 -35.88 71.14 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.787 0.835 . . . . 74.24 111.286 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -64.41 -46.55 82.79 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.292 1.037 . . . . 61.42 110.739 173.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.558 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 24.2 t -64.06 -42.02 97.16 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.497 -0.774 . . . . 54.42 111.465 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' C' ' 94' ' ' MET . 70.9 mt -85.37 -36.7 20.57 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.567 0.747 . . . . 71.21 111.706 -170.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.95 11.52 58.95 Favored Glycine 0 N--CA 1.474 1.168 0 CA-C-N 116.206 -0.452 . . . . 45.25 114.009 -171.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.43 -60.07 0.14 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.54 0.686 . . . . 70.04 110.616 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.558 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 83.1 t80 -75.79 -35.45 60.07 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 125.138 1.375 . . . . 74.22 113.49 -168.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 91.3 m -79.07 -41.68 1.64 Allowed Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 123.169 0.588 . . . . 75.32 111.49 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.58 -33.37 30.71 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 122.626 2.217 . . . . 64.12 113.705 166.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -66.02 -39.69 90.44 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.633 0.773 . . . . 62.5 111.399 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.472 HD12 HH12 ' A' ' 111' ' ' ARG . 50.6 mm -67.03 -42.64 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.127 0.571 . . . . 63.12 110.062 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 87.8 mt -88.36 -10.21 50.14 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.826 0.851 . . . . 51.33 112.209 -174.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -58.04 -55.29 46.76 Favored Pre-proline 0 N--CA 1.481 1.092 0 CA-C-O 117.892 -1.051 . . . . 72.32 112.493 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.14 -35.56 74.64 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 121.99 1.794 . . . . 74.32 113.158 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.466 ' HE2' HG21 ' A' ' 115' ' ' THR . 91.6 m-85 -64.33 -54.43 33.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.485 0.714 . . . . 54.2 110.659 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.01 -39.13 91.23 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 114.803 -1.09 . . . . 71.21 110.501 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -56.0 -51.43 67.79 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.11 1.364 . . . . 72.05 110.453 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.49 -38.18 77.54 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 123.508 0.505 . . . . 75.24 109.802 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.1 t -64.41 -32.85 74.64 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 122.971 0.508 . . . . 73.22 111.639 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.557 HD11 ' HB ' ' C' ' 62' ' ' VAL . 97.4 mt -73.42 -56.14 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.832 0.853 . . . . 70.22 109.33 175.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 15.0 m -61.88 -27.25 68.67 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.936 0.895 . . . . 73.1 111.688 -175.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.451 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 47.6 t -68.03 -47.47 68.33 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.984 0.914 . . . . 71.32 109.71 174.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.548 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.82 -36.77 84.27 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.849 0.86 . . . . 73.44 111.596 178.052 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.5 t -63.35 -39.46 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.377 0.671 . . . . 72.43 110.011 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.402 ' OG ' HG21 ' B' ' 115' ' ' THR . 32.6 t -73.06 -29.52 63.03 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.845 0.858 . . . . 53.03 112.061 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' C' ' 116' ' ' SER . 85.4 mtt-85 -71.66 -39.48 70.29 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.014 -0.735 . . . . 75.01 109.014 176.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.18 2.55 60.98 Favored Glycine 0 C--N 1.36 1.874 0 O-C-N 124.103 0.877 . . . . 75.12 112.61 172.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.2 p 61.81 26.35 15.98 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.89 2.076 . . . . 71.41 113.545 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -83.37 146.91 51.81 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 109.066 -0.716 . . . . 71.11 109.066 170.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.526 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 80.1 Cg_exo -49.86 138.21 34.43 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 123.329 2.686 . . . . 64.34 112.688 173.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -60.11 111.36 1.48 Allowed 'General case' 0 C--N 1.354 0.761 0 O-C-N 123.955 0.784 . . . . 55.2 110.609 -176.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -105.88 88.05 2.72 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 104.587 -2.375 . . . . 74.03 104.587 174.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -92.34 126.19 37.32 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.261 -0.881 . . . . 71.14 109.046 -171.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.49 136.08 51.0 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 124.128 0.892 . . . . 70.33 109.881 -173.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.06 157.82 83.43 Favored Pre-proline 0 CA--C 1.551 0.996 0 O-C-N 124.148 0.905 . . . . 73.12 111.395 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.439 ' HB3' HD12 ' A' ' 16' ' ' ILE . 55.5 Cg_exo -54.03 110.33 0.49 Allowed 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 123.03 2.487 . . . . 65.42 113.485 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.23 109.86 30.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.26 -0.644 . . . . 72.12 109.26 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -107.8 91.93 3.86 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 105.866 -1.901 . . . . 60.03 105.866 169.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -53.63 -43.27 68.58 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 124.319 1.012 . . . . 65.13 111.586 -172.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 42.1 t0 . . . . . 0 C--O 1.241 0.647 0 CA-C-N 114.928 -1.033 . . . . 72.4 111.205 -179.232 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 96.1 m . . . . . 0 C--O 1.24 0.605 0 CA-C-O 121.029 0.442 . . . . 74.34 110.047 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.632 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 62.6 t80 -154.66 93.09 1.54 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 107.433 -1.321 . . . . 73.32 107.433 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -120.5 115.34 23.26 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.441 -0.948 . . . . 70.02 108.441 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.578 HD13 HG21 ' D' ' 105' ' ' ILE . 11.2 mt -74.0 134.31 29.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 109.952 -0.388 . . . . 53.21 109.952 -175.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -93.83 -46.42 7.21 Favored 'General case' 0 C--O 1.241 0.656 0 O-C-N 123.426 0.454 . . . . 72.14 110.675 175.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -167.18 142.7 4.13 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.66 0.615 . . . . 61.24 112.66 -165.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.439 HG21 ' CG ' ' D' ' 109' ' ' TYR . 3.0 mp -122.56 135.94 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.791 1.236 . . . . 75.55 107.725 171.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.414 ' HE1' HG13 ' D' ' 83' ' ' ILE . 25.2 p90 -163.63 157.14 19.0 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.671 0.789 . . . . 72.34 110.737 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.3 p -91.36 114.69 27.29 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.209 -0.905 . . . . 51.45 108.859 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -78.71 -44.88 22.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.354 -0.98 . . . . 74.15 108.354 175.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 14.1 t70 -135.62 139.38 43.75 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.374 -1.284 . . . . 74.04 109.577 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.548 HG21 ' HE2' ' C' ' 117' ' ' MET . 67.4 mt -138.06 151.23 25.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 124.968 1.307 . . . . 63.13 107.895 174.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -152.23 145.8 24.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.358 1.063 . . . . 75.01 108.986 172.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.523 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 84.9 t80 -152.27 133.41 14.31 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 105.584 -2.006 . . . . 73.3 105.584 173.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -141.79 139.56 32.81 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.353 -0.98 . . . . 72.43 108.353 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.89 89.78 20.31 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 107.646 -1.242 . . . . 71.53 107.646 176.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.2 -32.31 5.26 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 123.022 2.481 . . . . 73.44 113.935 -170.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -103.53 17.32 24.35 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.191 0.596 . . . . 54.35 110.32 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -38.76 -65.81 0.36 Allowed Pre-proline 0 CA--C 1.562 1.416 0 N-CA-C 115.235 1.568 . . . . 73.01 115.235 -159.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.53 -23.87 22.88 Favored 'Trans proline' 0 C--N 1.389 2.688 0 CA-C-N 121.849 1.696 . . . . 74.44 113.337 -173.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -79.4 -39.01 33.51 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.11 0.964 . . . . 73.4 110.808 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -80.67 -18.68 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 122.537 0.335 . . . . 63.23 110.752 -170.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -62.54 -23.39 66.96 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.346 0.659 . . . . 74.02 112.623 173.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -60.33 -23.09 63.96 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.574 0.749 . . . . 72.52 110.603 175.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -92.54 82.14 4.84 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.151 1.381 . . . . 71.11 109.657 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.19 84.31 7.72 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.231 0.613 . . . . 74.32 110.353 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.2 p90 -156.82 -178.97 7.76 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.35 0.66 . . . . 74.53 109.343 170.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -66.76 109.84 4.05 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.457 1.103 . . . . 71.25 110.455 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.75 137.68 64.83 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.259 1.973 . . . . 75.44 111.415 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -63.21 108.58 1.31 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.709 -0.849 . . . . 63.25 108.709 172.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.557 HG13 HG13 ' D' ' 64' ' ' VAL . 87.6 t -99.13 148.81 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.034 -1.098 . . . . 62.51 108.034 -175.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.552 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 34.6 ttpt -129.83 138.91 51.26 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.663 -0.866 . . . . 65.53 108.663 169.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 53.7 tp -109.05 112.2 24.26 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.277 -1.008 . . . . 73.34 108.277 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.606 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 71.9 m-20 -111.37 120.95 43.92 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.316 1.046 . . . . 41.21 108.412 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -100.36 128.01 46.53 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.846 -0.428 . . . . 54.3 109.846 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 9.1 t70 -133.1 157.79 44.41 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 105.75 -1.945 . . . . 61.03 105.75 172.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.3 t -146.96 161.11 41.45 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.144 0.497 . . . . 70.11 111.761 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -163.01 169.41 19.63 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.187 1.395 . . . . 71.51 108.771 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 19.1 p -176.82 -179.75 0.99 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 112.454 0.538 . . . . 65.21 112.454 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 52.2 p -164.77 147.52 8.52 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.624 1.17 . . . . 60.2 109.245 172.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -82.42 119.22 23.9 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.275 -1.009 . . . . 72.04 108.275 171.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' D' ' 57' ' ' GLU . 21.1 mt -89.82 -31.3 17.44 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.779 0.432 . . . . 74.34 110.718 -173.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -162.73 178.33 8.57 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.22 1.008 . . . . 55.2 109.696 177.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -73.59 129.36 37.8 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.808 -0.812 . . . . 74.35 108.808 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 69.65 10.59 7.66 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.983 1.313 . . . . 72.41 111.311 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 87.7 t -132.67 118.23 33.65 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 124.034 0.934 . . . . 71.15 108.978 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -140.91 131.25 25.09 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.77 -0.826 . . . . 73.24 108.77 -174.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.416 ' HB2' HD11 ' D' ' 51' ' ' LEU . 31.2 tt0 -91.27 143.57 26.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.669 -1.15 . . . . 75.11 109.941 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.485 HG22 ' HE1' ' D' ' 84' ' ' PHE . 3.9 m -121.49 139.48 48.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 107.887 -1.153 . . . . 51.02 107.887 167.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 23.7 t -127.94 124.51 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 108.328 -0.99 . . . . 52.21 108.328 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.585 HD23 HD12 ' D' ' 106' ' ' LEU . 3.9 mm? -118.23 114.07 22.46 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.358 0.663 . . . . 74.45 109.497 -176.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.519 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 22.0 ttm-85 -86.22 99.62 11.68 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.67 0.788 . . . . 64.04 109.609 176.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 85.7 t -91.2 115.04 29.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 108.357 -0.979 . . . . 61.33 108.357 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 9.1 m -115.46 129.09 56.44 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.358 0.599 . . . . 74.44 109.701 -175.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.557 HG13 HG13 ' D' ' 40' ' ' VAL . 24.5 t -118.13 101.56 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.005 1.722 . . . . 75.44 108.693 -177.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 51.5 m -95.57 93.92 7.45 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.467 -0.938 . . . . 75.12 108.467 176.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.38 143.62 27.94 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.373 0.669 . . . . 72.11 110.163 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.44 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 13.7 m -149.3 124.39 10.07 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 123.027 0.531 . . . . 72.03 110.914 -174.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 17.9 mt -94.86 104.76 16.65 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.076 -0.712 . . . . 53.24 109.076 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.24 -120.87 5.26 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.832 -0.622 . . . . 70.44 111.948 -176.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.09 2.28 29.25 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.389 0.676 . . . . 71.35 111.296 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -124.11 163.45 21.47 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.315 0.646 . . . . 74.21 109.863 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 16.0 m -68.6 137.42 54.25 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 123.772 0.67 . . . . 71.14 111.503 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.44 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -92.43 -65.41 1.0 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.408 -1.33 . . . . 61.52 107.408 170.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -155.98 143.71 19.56 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 115.787 -0.642 . . . . 74.5 110.619 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 59.6 mt -106.74 109.97 22.02 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.264 -1.013 . . . . 73.01 108.264 173.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 76' ' ' CYS . . . . . . . . . . . . . 40.7 t -115.4 143.83 44.7 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.304 -0.998 . . . . 65.31 108.304 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -156.77 127.72 6.8 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.931 0.492 . . . . 65.22 109.895 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -132.41 119.18 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 122.972 0.509 . . . . 65.51 109.879 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.576 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 40.9 mt-30 -88.79 88.74 7.71 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.848 -0.797 . . . . 71.03 108.848 168.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -80.24 106.44 12.25 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.308 -1.315 . . . . 75.2 108.501 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.32 147.89 16.62 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.408 -0.677 . . . . 64.42 111.408 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.28 136.99 6.57 Favored Glycine 0 C--N 1.331 0.284 0 N-CA-C 111.539 -0.625 . . . . 42.31 111.539 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.414 HG13 ' HE1' ' D' ' 17' ' ' TYR . 54.1 mt -91.04 126.47 43.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 C-N-CA 123.728 0.811 . . . . 74.1 108.884 174.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.485 ' HE1' HG22 ' D' ' 58' ' ' VAL . 64.9 m-85 -131.79 131.77 43.2 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.765 0.426 . . . . 74.11 110.321 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 15.3 m -84.5 103.96 14.09 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.519 0.727 . . . . 74.21 109.242 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.607 HD13 HD21 ' D' ' 98' ' ' LEU . 37.7 pt -114.13 127.08 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.869 0.867 . . . . 72.35 110.024 -177.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.74 148.92 29.13 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.598 0.359 . . . . 71.54 110.641 -174.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.17 15.99 76.82 Favored Glycine 0 C--N 1.345 1.077 0 O-C-N 123.391 0.432 . . . . 62.41 113.271 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.441 HD12 ' HB ' ' D' ' 86' ' ' ILE . 41.3 mt -97.19 148.65 5.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 109.268 -0.641 . . . . 72.21 109.268 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -162.02 178.48 8.8 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.394 1.078 . . . . 63.4 109.963 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.29 -144.43 44.41 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 115.286 -0.87 . . . . 74.53 113.747 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 2.8 p -82.62 -10.64 58.86 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.599 0.76 . . . . 73.21 111.751 176.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -27.63 68.5 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 109.458 -0.571 . . . . 74.41 109.458 174.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 40.9 mtt -54.03 -43.42 70.14 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.195 0.598 . . . . 74.53 110.913 171.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.05 -46.18 62.48 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.696 -1.138 . . . . 32.23 110.939 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -64.32 -37.26 86.88 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.996 0.519 . . . . 65.11 111.702 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 47.9 t -62.03 -48.51 79.97 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.794 0.684 . . . . 53.34 110.553 -174.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.607 HD21 HD13 ' D' ' 86' ' ' ILE . 66.1 mt -98.1 -24.8 15.17 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.359 -0.837 . . . . 63.1 112.163 -169.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.04 -3.75 56.78 Favored Glycine 0 N--CA 1.47 0.925 0 CA-C-O 119.83 -0.428 . . . . 73.52 113.705 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.77 -55.35 0.33 Allowed 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.317 0.558 . . . . 71.02 111.74 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -72.81 -42.77 63.52 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 112.492 0.552 . . . . 74.41 112.492 -168.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.632 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 60.2 m -70.49 -45.66 18.77 Favored Pre-proline 0 CA--C 1.562 1.439 0 CA-C-O 119.07 -0.49 . . . . 71.02 110.881 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.477 ' HG3' HD21 ' D' ' 60' ' ' LEU . 72.7 Cg_exo -53.51 -33.78 69.41 Favored 'Trans proline' 0 C--N 1.394 2.922 0 C-N-CA 122.587 2.191 . . . . 73.5 113.922 168.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -64.98 -40.2 94.61 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.577 0.751 . . . . 74.42 110.078 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.578 HG21 HD13 ' D' ' 13' ' ' ILE . 49.3 mm -60.02 -42.83 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 115.913 -0.585 . . . . 65.11 109.726 173.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.585 HD12 HD23 ' D' ' 60' ' ' LEU . 83.9 mt -80.19 -15.31 57.32 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.004 -0.998 . . . . 61.13 112.558 -172.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -62.7 -48.82 85.05 Favored Pre-proline 0 CA--C 1.563 1.457 0 N-CA-C 113.207 0.817 . . . . 61.51 113.207 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -56.35 -35.56 96.18 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 122.097 1.865 . . . . 72.32 112.955 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 109' ' ' TYR . . . . . 0.439 ' CG ' HG21 ' D' ' 16' ' ' ILE . 98.5 m-85 -78.61 -29.66 46.12 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.017 0.927 . . . . 74.41 111.978 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.34 -48.03 68.71 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.735 -0.839 . . . . 62.51 108.735 174.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.484 ' NH2' HG23 ' B' ' 105' ' ' ILE . 45.4 ttp180 -65.08 -33.54 76.28 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.376 -1.283 . . . . 74.11 110.489 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -54.48 -58.52 7.13 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.067 0.947 . . . . 75.31 110.632 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.15 -45.13 89.84 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.693 -1.14 . . . . 73.04 111.271 -174.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.452 ' O ' HG23 ' D' ' 118' ' ' VAL . 79.8 mt -59.79 -62.06 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.576 0.75 . . . . 71.41 110.87 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.445 HG23 ' HG3' ' D' ' 125' ' ' GLN . 57.9 m -52.82 -38.38 61.22 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.347 1.059 . . . . 72.11 111.97 -175.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.0 t -66.73 -46.6 74.93 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.244 -0.889 . . . . 44.2 110.767 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.5 mtm -67.61 -30.02 69.5 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.782 0.433 . . . . 55.44 111.613 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.452 HG23 ' O ' ' D' ' 114' ' ' ILE . 91.2 t -63.62 -49.99 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 O-C-N 123.786 0.679 . . . . 71.23 109.819 174.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.8 p -69.06 -31.52 70.34 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 116.139 -0.482 . . . . 55.11 110.97 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 77.6 mtt-85 -69.79 -35.51 74.92 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.87 0.868 . . . . 73.54 110.384 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.59 2.62 85.26 Favored Glycine 0 C--N 1.351 1.376 0 O-C-N 123.733 0.646 . . . . 15.23 112.347 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.414 HG21 HE21 ' A' ' 125' ' ' GLN . 22.8 p 57.17 35.76 26.64 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.629 1.971 . . . . 72.42 113.384 176.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -94.7 159.41 33.53 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.267 1.027 . . . . 75.52 110.035 172.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.84 123.2 12.49 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.009 2.473 . . . . 65.32 112.774 170.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.445 ' HG3' HG23 ' D' ' 115' ' ' THR . 34.2 tt0 -53.47 142.73 21.31 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.148 1.379 . . . . 64.34 112.583 -176.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 66.4 tp -125.81 106.27 9.56 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.768 0.827 . . . . 74.52 109.735 -174.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -116.53 95.92 5.27 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.651 0.78 . . . . 73.11 109.517 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 6.2 mp -66.71 116.93 8.17 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.981 -0.748 . . . . 74.22 108.981 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -58.09 143.86 77.43 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 123.746 0.818 . . . . 71.43 110.626 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 6.0 Cg_exo -74.26 107.82 2.53 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.625 2.216 . . . . 61.11 110.524 -174.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.474 0.763 0 C-N-CA 123.254 0.622 . . . . 64.01 110.185 -174.388 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.722 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 4.8 t80 . . . . . 0 C--O 1.238 0.465 0 N-CA-C 108.283 -1.006 . . . . 74.11 108.283 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -152.1 108.44 3.43 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 123.744 0.653 . . . . 72.24 109.501 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.595 HD12 ' HB2' ' C' ' 130' ' ' PRO . 34.5 mt -76.96 125.73 37.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 109.664 -0.495 . . . . 70.0 109.664 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -86.29 -40.32 15.62 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 124.284 0.99 . . . . 72.14 110.113 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -175.38 121.75 0.2 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.489 0.316 . . . . 73.32 110.579 -174.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.6 mt -108.85 135.05 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.79 -0.818 . . . . 71.21 108.79 172.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -164.74 159.4 18.65 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 123.827 0.705 . . . . 74.34 111.784 -172.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.5 p -81.53 115.87 21.04 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.241 -0.89 . . . . 63.31 109.447 173.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -82.19 -25.92 33.83 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.43 -0.581 . . . . 65.32 109.43 174.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.4 t70 -148.38 142.29 25.8 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.167 -0.924 . . . . 74.54 109.676 176.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.557 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 69.1 mt -137.55 142.69 35.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 126.042 1.737 . . . . 64.34 106.617 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.0 t -155.0 135.73 13.58 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.186 0.594 . . . . 64.52 109.465 172.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -135.72 144.68 46.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.252 -1.388 . . . . 71.33 107.252 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -137.18 151.87 49.26 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.803 -0.814 . . . . 74.22 108.803 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.99 79.04 12.17 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 106.937 -1.505 . . . . 73.24 106.937 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.77 -33.93 42.1 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.844 2.363 . . . . 73.33 113.098 -167.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -107.62 24.68 12.52 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.752 0.821 . . . . 74.1 110.281 -176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.613 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -40.88 -62.94 0.86 Allowed Pre-proline 0 CA--C 1.574 1.902 0 CA-C-O 117.547 -1.216 . . . . 65.31 114.245 -167.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 39.1 Cg_exo -59.09 -29.78 91.48 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 122.4 2.067 . . . . 72.1 114.059 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -78.84 -41.54 29.79 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.692 0.797 . . . . 74.23 110.396 -177.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.664 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.2 p -77.36 -20.26 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.714 -1.13 . . . . 45.22 111.784 -161.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -70.97 -22.87 62.14 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.557 0.743 . . . . 71.0 110.923 175.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -83.84 -36.41 23.48 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.503 1.121 . . . . 73.31 109.676 175.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.521 ' HD2' HD13 ' A' ' 68' ' ' LEU . 2.9 tmtp? -67.3 146.98 53.57 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.456 1.502 . . . . 72.44 110.532 -173.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.446 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 7.9 m-20 -58.3 124.99 21.35 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.445 1.098 . . . . 72.01 111.266 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 50.9 t-105 -79.26 82.29 5.43 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.412 0.625 . . . . 74.01 109.733 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -123.24 80.6 52.39 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 108.093 -1.077 . . . . 73.34 108.093 176.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -83.55 124.4 3.58 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.489 2.126 . . . . 60.03 113.718 -168.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -95.9 92.09 6.34 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 106.76 -1.571 . . . . 75.3 106.76 167.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 65' ' ' THR . 16.0 m -79.81 112.41 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 113.911 -1.495 . . . . 55.22 110.965 -172.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 26.3 ttpp -95.56 112.61 24.3 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.71 -1.219 . . . . 74.45 107.71 171.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mp -98.47 107.4 19.85 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.092 -1.077 . . . . 71.45 108.092 -177.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.754 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 3.3 m-20 -104.02 135.34 45.72 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.691 -0.855 . . . . 63.3 108.691 -174.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 pp -137.3 145.35 43.34 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.35 0.66 . . . . 73.4 110.001 177.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.636 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 33.0 t70 -141.66 155.02 45.72 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 123.287 0.635 . . . . 70.31 109.937 -175.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.7 p -105.54 122.78 46.72 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.401 1.081 . . . . 60.24 110.413 -174.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.87 119.93 14.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.806 0.842 . . . . 71.44 109.032 175.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.9 t -131.91 153.28 50.42 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 122.967 0.507 . . . . 73.03 109.789 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.7 t -160.49 143.68 13.45 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.509 0.724 . . . . 51.01 110.318 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -97.18 117.74 32.06 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.618 -0.882 . . . . 74.35 108.618 173.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 58.4 mt -85.61 -40.7 15.95 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.066 0.546 . . . . 75.03 109.857 177.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.453 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -153.59 176.44 12.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.285 -0.87 . . . . 72.32 110.379 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -69.05 122.8 19.46 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.505 -0.924 . . . . 44.42 108.505 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 74.92 -2.86 2.74 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.616 1.566 . . . . 72.14 112.115 -174.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 60.8 t -111.63 105.38 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.092 0.957 . . . . 72.41 108.698 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -124.95 127.61 47.32 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.967 0.907 . . . . 54.02 109.407 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -102.29 120.9 41.24 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.911 0.884 . . . . 73.11 109.958 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.446 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 43.2 t -102.3 129.17 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.038 -1.468 . . . . 71.4 107.038 171.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.0 t -122.5 120.05 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 108.55 -0.907 . . . . 73.34 108.55 174.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.467 HD22 HG22 ' A' ' 62' ' ' VAL . 1.0 OUTLIER -104.98 112.94 26.25 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.845 -1.168 . . . . 75.34 107.845 177.667 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.636 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 68.3 ttt180 -83.07 97.47 8.79 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.061 -1.459 . . . . 72.01 107.061 175.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.467 HG22 HD22 ' A' ' 60' ' ' LEU . 42.7 t -97.81 135.1 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 107.695 -1.224 . . . . 34.1 107.695 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.754 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 30.9 m -137.64 141.5 41.2 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.515 -0.55 . . . . 74.01 109.515 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 20.7 t -129.31 108.37 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 125.172 1.389 . . . . 44.21 107.337 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.536 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 29.3 m -102.25 138.06 39.69 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.999 -1.111 . . . . 75.23 107.999 175.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.5 106.05 10.28 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.661 -1.237 . . . . 71.21 107.661 173.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 59.0 m -111.13 123.31 49.94 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.836 -0.431 . . . . 71.3 109.836 177.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.521 HD13 ' HD2' ' A' ' 34' ' ' LYS . 12.8 mt -90.54 73.71 6.83 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 107.295 -1.372 . . . . 51.24 107.295 176.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.15 -122.83 6.19 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 110.851 -0.9 . . . . 42.43 110.851 -171.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -86.87 -24.98 24.71 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.661 0.785 . . . . 73.45 109.005 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -77.92 132.7 38.02 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.369 1.068 . . . . 73.11 109.772 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 70.1 m -89.25 133.23 34.54 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.238 0.472 . . . . 72.31 110.753 173.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.664 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.67 -62.61 1.52 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.803 0.841 . . . . 61.34 109.836 170.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -153.34 173.7 15.28 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.188 -0.914 . . . . 62.52 111.472 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.9 tp -133.59 139.95 46.84 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.731 -1.122 . . . . 65.01 108.479 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.401 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 71.4 m -134.69 97.48 3.79 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.917 0.887 . . . . 74.21 110.294 176.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -113.71 118.8 35.33 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.178 0.591 . . . . 63.5 109.738 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.2 t -128.15 113.64 31.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 124.142 0.977 . . . . 71.1 109.282 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.545 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 71.6 mt-30 -84.66 90.05 7.61 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.276 -1.009 . . . . 74.14 108.276 171.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -79.41 102.97 9.01 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.198 -0.91 . . . . 73.21 109.231 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.12 158.47 31.67 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 111.329 -0.708 . . . . 62.32 111.329 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.35 121.14 1.02 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.93 -0.868 . . . . 55.4 110.93 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.9 mt -81.65 120.87 34.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 108.117 -1.068 . . . . 63.13 108.117 171.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.722 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 46.1 m-85 -128.77 119.12 23.97 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.922 -0.77 . . . . 72.31 108.922 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.7 t -84.77 96.22 9.2 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.628 -0.879 . . . . 62.53 108.628 174.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.6 pt . . . . . 0 C--O 1.242 0.669 0 C-N-CA 124.518 1.127 . . . . 64.35 109.425 -177.425 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 120.567 0.223 . . . . 74.54 110.646 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -82.95 -35.04 26.33 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.274 0.63 . . . . 75.42 110.685 172.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 81.7 m -63.51 -47.66 80.79 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.129 0.572 . . . . 72.24 111.322 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.84 -25.06 32.99 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.551 0.741 . . . . 62.03 109.59 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.45 -21.26 45.14 Favored Glycine 0 C--N 1.353 1.502 0 N-CA-C 115.263 0.865 . . . . 73.12 115.263 -170.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.83 -53.85 0.23 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 117.89 0.845 . . . . 60.33 111.837 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -57.7 -60.21 4.03 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 114.352 -1.294 . . . . 72.05 112.509 -171.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.6 m -74.5 -36.28 2.48 Favored Pre-proline 0 CA--C 1.568 1.661 0 N-CA-C 113.144 0.794 . . . . 74.34 113.144 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -50.83 -38.23 56.88 Favored 'Trans proline' 0 C--N 1.397 3.095 0 C-N-CA 122.767 2.311 . . . . 73.51 113.966 164.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -66.03 -38.87 89.51 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.711 0.804 . . . . 72.51 109.983 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.6 mm -58.84 -34.77 53.29 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 C-N-CA 123.784 0.833 . . . . 71.32 111.145 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 88.5 mt -76.27 -28.99 57.27 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.999 0.92 . . . . 72.34 112.665 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.568 ' HZ ' HD22 ' A' ' 128' ' ' LEU . 36.1 t80 -62.35 -44.28 87.61 Favored Pre-proline 0 CA--C 1.569 1.701 0 CA-C-O 117.806 -1.092 . . . . 55.22 113.811 -171.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.56 -31.79 87.47 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.339 2.026 . . . . 54.24 113.52 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -78.19 -35.34 48.76 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.421 0.688 . . . . 74.23 112.028 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.45 -36.58 71.28 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.641 -0.503 . . . . 71.1 109.641 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.644 HH12 HD12 ' C' ' 105' ' ' ILE . 31.9 ttm180 -60.68 -43.77 97.3 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.557 1.143 . . . . 75.22 110.366 172.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -53.99 -54.31 40.86 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.555 1.142 . . . . 75.3 111.207 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 117' ' ' MET . 48.5 t -66.81 -45.85 77.04 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.586 -1.188 . . . . 54.14 111.297 -174.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.456 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 61.6 mt -60.15 -51.89 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.749 0.82 . . . . 71.02 111.123 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.559 HG21 ' HE2' ' C' ' 109' ' ' TYR . 67.6 m -54.6 -44.19 72.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.884 0.874 . . . . 54.3 111.555 177.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 44.8 t -63.57 -41.5 98.38 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.651 -0.704 . . . . 73.4 111.166 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 113' ' ' CYS . 27.0 mtm -69.86 -37.81 76.22 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.94 0.496 . . . . 54.42 111.65 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.92 -50.62 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.38 0.672 . . . . 73.42 109.839 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.1 t -66.22 -31.35 72.13 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 114.801 -1.09 . . . . 63.33 111.192 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 116' ' ' SER . 33.9 ttm-85 -77.5 -31.73 53.74 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.181 0.992 . . . . 62.12 109.404 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.441 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.8 12.15 57.78 Favored Glycine 0 C--N 1.355 1.595 0 CA-C-N 114.804 -1.089 . . . . 51.51 112.508 172.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.441 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.2 t 68.47 13.33 8.96 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 126.964 2.106 . . . . 50.03 113.852 169.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -81.76 155.44 70.72 Favored Pre-proline 0 CA--C 1.555 1.147 0 N-CA-C 108.705 -0.85 . . . . 74.11 108.705 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.04 163.76 13.54 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 122.892 2.395 . . . . 74.31 112.928 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -57.3 124.26 18.26 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 123.802 0.689 . . . . 70.35 111.315 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 66.0 tp -130.06 106.38 8.59 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.695 1.198 . . . . 65.23 109.098 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -119.15 117.34 28.41 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.163 0.985 . . . . 53.5 108.861 176.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.568 HD22 ' HZ ' ' A' ' 107' ' ' PHE . 2.4 tt -70.99 116.61 11.48 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 108.031 -1.1 . . . . 72.11 108.031 178.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.54 145.45 97.29 Favored Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 123.893 0.877 . . . . 73.25 111.021 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.472 ' HD3' HG13 ' C' ' 13' ' ' ILE . 84.6 Cg_endo -75.96 158.69 38.33 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.203 1.935 . . . . 64.32 112.694 -174.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.8 m -128.2 116.16 41.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 114.461 -1.245 . . . . 65.05 108.427 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -72.94 82.69 1.22 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.359 0.664 . . . . 61.32 109.749 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 121.404 0.621 . . . . 73.21 109.528 177.234 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' B' ' 10' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 120.866 0.365 . . . . 52.44 110.813 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.619 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 94.0 m -145.49 114.81 7.11 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.28 -0.888 . . . . 64.25 108.99 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.613 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 51.5 t80 -131.39 132.69 44.59 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 122.957 0.503 . . . . 74.11 110.258 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -160.21 141.31 12.25 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.159 0.584 . . . . 75.51 110.285 174.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 23.2 mt -82.82 123.76 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.792 -0.818 . . . . 71.12 108.792 172.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -89.71 -49.91 6.37 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.438 -0.578 . . . . 71.12 109.438 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.419 ' HE ' HG21 ' A' ' 122' ' ' THR . 42.2 ttt180 -166.23 135.8 3.21 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.816 -0.629 . . . . 72.5 110.021 -175.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.7 mt -115.22 141.47 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 107.547 -1.279 . . . . 62.02 107.547 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -166.36 147.94 6.59 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.935 0.874 . . . . 72.11 112.369 -173.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.8 m -79.58 122.0 25.96 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.142 -1.39 . . . . 53.43 108.387 172.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.411 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 41.9 mtpt -97.33 -19.09 18.75 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.482 0.713 . . . . 73.23 111.138 -177.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -167.71 142.83 3.81 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.831 0.707 . . . . 71.33 110.377 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 38.7 mm -131.63 142.87 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.79 1.236 . . . . 75.32 108.736 172.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 44.3 t -143.78 110.27 5.5 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.414 1.086 . . . . 71.23 108.159 174.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.557 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 92.0 t80 -128.77 109.98 11.77 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.986 -1.116 . . . . 73.12 107.986 172.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -118.75 127.25 53.37 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.893 -0.781 . . . . 73.45 108.893 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.476 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -112.53 86.4 8.32 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 107.769 -1.197 . . . . 64.5 107.769 176.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -65.94 -43.08 9.94 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.87 2.38 . . . . 64.12 112.648 -168.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -104.26 16.78 25.46 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.098 0.959 . . . . 71.35 110.579 -175.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.476 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -38.73 -64.8 0.44 Allowed Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 115.007 1.484 . . . . 61.5 115.007 -162.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.29 -26.05 49.18 Favored 'Trans proline' 0 C--N 1.389 2.682 0 C-N-CA 121.992 1.794 . . . . 61.21 113.451 -170.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -97.5 -23.24 16.13 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.351 0.661 . . . . 53.4 112.736 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.535 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.3 p -80.58 -18.87 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 117.869 0.304 . . . . 75.24 111.08 -176.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -61.51 -27.58 68.7 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.792 0.837 . . . . 62.0 113.249 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -57.3 -23.25 47.31 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.452 0.701 . . . . 73.13 112.159 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -89.52 89.0 7.65 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.41 1.084 . . . . 71.34 109.974 -176.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.49 87.65 6.21 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.447 -0.797 . . . . 61.42 110.949 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -163.19 173.23 13.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.343 1.057 . . . . 74.44 108.722 167.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -71.83 117.08 54.62 Favored Pre-proline 0 N--CA 1.474 0.739 0 N-CA-C 109.192 -0.67 . . . . 63.51 109.192 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.19 153.82 71.65 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.279 1.986 . . . . 54.43 112.626 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.05 120.42 10.82 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 107.756 -1.201 . . . . 73.5 107.756 170.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 m -116.51 123.03 71.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.435 -0.802 . . . . 74.12 110.219 -167.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.587 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 77.2 tttt -106.98 121.31 44.2 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.66 1.184 . . . . 61.44 107.835 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.795 HD22 HD11 ' B' ' 128' ' ' LEU . 46.5 tp -96.89 137.39 36.04 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.655 -0.869 . . . . 64.25 108.655 169.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -144.01 152.54 41.17 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.22 1.008 . . . . 73.12 109.034 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 27.7 tp -128.7 157.29 41.79 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.688 0.795 . . . . 73.52 109.102 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.402 ' HB3' ' HD3' ' B' ' 61' ' ' ARG . 29.0 t70 -145.28 140.4 27.77 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.654 -0.869 . . . . 54.52 108.654 170.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 54.7 p -108.84 113.87 27.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.914 0.886 . . . . 52.51 109.401 -172.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.61 132.05 36.62 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.242 1.017 . . . . 62.41 108.692 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 59.6 p -147.55 178.87 8.1 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.009 0.433 . . . . 63.44 111.464 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.7 p -160.35 137.94 9.6 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.675 1.19 . . . . 41.34 108.91 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -88.63 128.16 35.58 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.209 -0.663 . . . . 73.0 109.209 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 78.2 mt -91.38 -40.09 11.64 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.106 0.563 . . . . 54.33 110.552 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.55 -172.49 2.93 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.332 0.586 . . . . 64.35 110.801 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.75 128.66 37.31 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.358 -1.292 . . . . 74.55 108.289 172.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.562 ' HB3' ' HB2' ' B' ' 87' ' ' ALA . 9.9 m-20 64.81 3.28 1.98 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.367 1.067 . . . . 75.2 113.31 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 91.6 t -120.45 120.19 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.879 0.872 . . . . 72.25 109.226 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.636 ' HB2' HD11 ' B' ' 86' ' ' ILE . 0.4 OUTLIER -129.21 154.54 46.67 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.931 -0.766 . . . . 64.03 108.931 178.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -125.44 108.1 11.31 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.418 -1.697 . . . . 73.23 106.418 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 31.2 m -109.42 139.43 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 122.964 0.506 . . . . 72.23 110.386 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.518 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 31.7 t -120.86 111.8 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.475 1.11 . . . . 42.43 109.128 -176.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.606 HD13 ' HB3' ' B' ' 103' ' ' PRO . 14.5 tp -94.38 100.07 12.16 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.702 -0.851 . . . . 62.32 108.702 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.497 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 70.2 ttt180 -88.62 106.8 18.55 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.161 0.584 . . . . 74.42 109.867 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.81 106.07 19.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.087 -1.079 . . . . 60.42 108.087 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 27.9 m -109.33 138.41 45.73 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.641 0.776 . . . . 72.34 109.895 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 88.4 t -134.33 134.18 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.33 1.052 . . . . 75.43 109.502 -175.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.587 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 62.8 m -109.78 149.2 30.15 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.869 0.868 . . . . 72.01 109.56 170.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.18 137.22 38.92 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.777 0.831 . . . . 44.33 109.176 177.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 11.0 m -137.4 124.31 21.36 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.292 0.637 . . . . 74.23 110.898 -175.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.466 HD12 HG22 ' B' ' 31' ' ' VAL . 47.0 mt -104.34 113.85 27.69 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.992 -0.744 . . . . 72.55 108.992 176.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.09 -110.57 3.31 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 114.987 -1.006 . . . . 33.52 111.859 -172.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -117.33 5.33 12.59 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.945 0.898 . . . . 73.14 109.943 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -125.52 164.65 20.05 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.884 0.474 . . . . 55.31 110.59 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 62.1 m -79.92 122.91 27.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.652 0.781 . . . . 70.42 110.641 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.535 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -70.83 -63.63 1.06 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.311 0.645 . . . . 71.3 109.358 172.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -150.7 167.73 26.48 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 115.066 -0.97 . . . . 72.23 111.977 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 65.4 mt -129.98 113.57 14.74 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.141 -1.8 . . . . 72.21 106.141 175.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.475 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 30.2 t -123.01 130.45 52.82 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 109.518 -0.549 . . . . 74.22 109.518 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -149.55 131.88 15.58 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.757 -0.831 . . . . 73.03 108.757 -170.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' B' ' 113' ' ' CYS . 66.1 t -129.81 144.29 38.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 123.946 0.899 . . . . 74.24 109.005 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.497 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 73.2 mt-30 -118.61 93.61 4.17 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.165 -1.05 . . . . 73.01 108.165 172.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -91.82 100.75 13.38 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.891 -0.595 . . . . 74.12 109.495 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.2 164.06 30.68 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 115.813 -0.63 . . . . 43.23 111.75 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.8 129.48 1.98 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 112.083 -0.407 . . . . 44.4 112.083 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 38.4 mt -85.42 126.85 40.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 108.214 -1.032 . . . . 74.41 108.214 171.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -133.5 144.22 49.27 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.479 0.712 . . . . 71.52 109.723 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 31.5 m -90.41 113.98 26.01 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.179 0.992 . . . . 54.11 108.837 170.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.636 HD11 ' HB2' ' B' ' 56' ' ' TYR . 0.2 OUTLIER -128.09 125.1 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.055 0.942 . . . . 71.14 109.024 178.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.619 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.32 172.96 17.58 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.153 0.427 . . . . 54.33 112.153 -175.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.49 -54.68 3.84 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.525 -0.761 . . . . 75.4 112.056 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 32.5 mm -91.25 157.2 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 124.22 1.008 . . . . 70.13 110.601 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.528 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 30.8 tt0 -161.5 153.66 19.75 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.755 0.822 . . . . 73.35 109.619 173.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 102.6 -136.0 12.58 Favored Glycine 0 C--N 1.352 1.453 0 C-N-CA 123.711 0.672 . . . . 73.35 112.917 -175.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 63.5 m -71.95 -43.24 65.55 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 117.421 0.611 . . . . 72.33 111.552 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -58.51 -32.25 68.64 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.508 0.723 . . . . 71.41 110.555 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.528 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 7.2 tpt -72.1 -44.78 62.69 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.246 -0.888 . . . . 75.15 110.426 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.33 -23.18 67.3 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.011 -0.995 . . . . 71.22 111.424 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.533 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 58.1 t-80 -82.82 -20.75 35.08 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.337 1.055 . . . . 64.44 110.874 174.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.7 t -86.11 -67.25 0.82 Allowed 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.993 -0.442 . . . . 63.13 111.314 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.689 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 1.7 pt? -83.94 -14.73 50.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.551 -0.718 . . . . 72.11 111.809 -174.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.83 1.65 55.42 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.376 0.422 . . . . 65.41 113.855 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -143.43 -59.7 0.41 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.438 0.695 . . . . 73.4 109.833 -176.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -71.63 -48.58 46.96 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.215 0.606 . . . . 63.14 112.494 -173.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.689 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 59.2 m -64.35 -43.14 71.4 Favored Pre-proline 0 CA--C 1.56 1.345 0 N-CA-C 112.872 0.693 . . . . 64.33 112.872 -175.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.606 ' HB3' HD13 ' B' ' 60' ' ' LEU . 51.8 Cg_exo -60.12 -30.65 91.88 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 122.191 1.927 . . . . 73.14 113.384 172.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -65.79 -26.89 67.9 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 122.945 0.498 . . . . 63.21 111.641 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 74.2 mt -71.25 -43.71 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.515 0.726 . . . . 74.43 109.49 173.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 99.1 mt -74.13 -23.53 59.3 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.011 -0.995 . . . . 73.14 112.087 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -57.42 -51.9 78.29 Favored Pre-proline 0 CA--C 1.563 1.466 0 CA-C-O 117.696 -1.145 . . . . 71.14 113.42 -173.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.22 -32.04 94.9 Favored 'Trans proline' 0 C--N 1.392 2.854 0 C-N-CA 122.314 2.009 . . . . 54.41 113.7 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.416 ' HE2' HG21 ' D' ' 115' ' ' THR . 33.7 m-85 -72.57 -40.27 66.76 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.552 0.741 . . . . 50.53 110.229 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.79 -37.87 87.48 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.305 0.642 . . . . 61.21 110.491 173.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.412 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 56.8 ttt-85 -69.4 -50.33 46.89 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.415 1.486 . . . . 72.34 111.223 -171.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.55 -37.4 87.17 Favored 'General case' 0 N--CA 1.484 1.225 0 O-C-N 123.898 0.749 . . . . 73.35 109.286 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.473 ' O ' ' HG2' ' B' ' 117' ' ' MET . 28.8 t -64.07 -40.73 96.9 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.371 0.669 . . . . 62.31 112.003 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.477 ' O ' HG23 ' B' ' 118' ' ' VAL . 70.9 mt -61.05 -56.48 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.692 -0.485 . . . . 75.43 109.692 175.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.8 m -61.77 -26.86 68.35 Favored 'General case' 0 CA--C 1.557 1.216 0 O-C-N 123.752 0.658 . . . . 75.45 111.586 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.8 t -71.66 -43.25 66.4 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.726 0.81 . . . . 72.43 110.078 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.6 mmt -71.11 -31.92 68.37 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.538 0.335 . . . . 61.13 110.528 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.477 HG23 ' O ' ' B' ' 114' ' ' ILE . 99.1 t -62.7 -43.22 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 124.068 0.947 . . . . 65.33 109.914 170.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 64.0 m -65.89 -36.42 83.37 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.24 -0.891 . . . . 44.5 111.764 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' B' ' 116' ' ' SER . 68.8 mtt-85 -68.53 -38.16 80.62 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.521 -0.763 . . . . 65.23 109.554 176.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.72 -0.29 79.94 Favored Glycine 0 C--N 1.354 1.571 0 O-C-N 124.026 0.829 . . . . 70.14 113.264 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 73.0 p 61.17 16.52 7.28 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 126.343 1.857 . . . . 51.14 113.831 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -77.09 160.06 76.91 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 123.496 0.718 . . . . 64.14 111.493 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -47.14 146.21 6.73 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 123.748 2.965 . . . . 72.31 114.724 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -58.86 122.59 13.98 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.558 1.143 . . . . 74.24 111.095 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 52.8 tp -138.98 99.26 3.72 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.208 0.603 . . . . 65.33 109.851 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -99.12 131.51 45.1 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.739 0.816 . . . . 71.53 108.886 172.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.795 HD11 HD22 ' B' ' 42' ' ' LEU . 25.6 tp -81.99 152.43 26.7 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.23 0.612 . . . . 65.51 112.067 -174.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.54 146.22 83.31 Favored Pre-proline 0 N--CA 1.482 1.126 0 C-N-CA 123.835 0.854 . . . . 63.4 111.644 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -70.82 119.18 6.13 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.158 2.572 . . . . 53.1 111.15 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 26.7 m -107.5 110.88 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.892 0.853 . . . . 73.33 108.912 174.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -110.42 88.8 2.85 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.19 -1.041 . . . . 74.02 108.19 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -61.33 -34.21 74.88 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.636 -0.711 . . . . 73.02 110.73 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 N--CA 1.472 0.625 0 C-N-CA 124.563 1.145 . . . . 64.45 111.255 -177.248 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.701 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 14.7 t80 . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 108.125 -1.065 . . . . 61.14 108.125 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -136.46 119.26 16.19 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.014 -0.736 . . . . 71.34 109.014 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.472 HG13 ' HD3' ' A' ' 130' ' ' PRO . 35.5 mt -73.13 128.02 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.936 -0.764 . . . . 60.43 108.936 175.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -92.65 -48.23 6.7 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.149 -0.685 . . . . 53.53 109.149 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -173.22 134.44 0.54 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.92 -0.77 . . . . 75.33 108.92 -169.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 94.5 mt -126.27 142.23 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 108.017 -1.105 . . . . 54.41 108.017 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.554 ' HB3' HG23 ' D' ' 122' ' ' THR . 26.6 p90 -173.68 167.3 4.51 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 123.942 0.776 . . . . 65.35 110.488 -174.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -86.57 119.07 26.43 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.84 -1.073 . . . . 65.31 109.062 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.7 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 10.8 mmmm -70.44 -45.8 65.12 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.999 -1.112 . . . . 53.43 107.999 169.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.606 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 5.1 t70 -139.53 147.83 41.77 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 113.776 -1.556 . . . . 75.55 110.258 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.4 mt -137.94 149.08 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.977 1.711 . . . . 60.25 107.24 174.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.4 t -162.04 150.3 14.91 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.427 0.632 . . . . 71.43 110.614 172.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 91.6 t80 -143.65 146.18 33.04 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 107.029 -1.471 . . . . 53.31 107.029 170.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -149.35 115.87 5.86 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.28 1.032 . . . . 64.25 109.011 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.05 92.01 12.21 Favored Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 105.649 -1.982 . . . . 71.04 105.649 165.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -57.25 -49.93 12.55 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.277 2.652 . . . . 65.23 112.513 -171.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -106.73 39.16 1.9 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.504 0.722 . . . . 64.35 109.488 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.545 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -37.86 -58.56 1.35 Allowed Pre-proline 0 CA--C 1.571 1.75 0 N-CA-C 115.183 1.549 . . . . 62.14 115.183 -171.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.419 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 20.3 Cg_exo -60.56 -43.29 33.93 Favored 'Trans proline' 0 C--N 1.387 2.6 0 CA-C-N 122.198 1.821 . . . . 65.51 112.418 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -69.13 -32.44 71.81 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.14 -0.937 . . . . 75.21 112.258 -175.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.724 HG21 ' HA ' ' C' ' 73' ' ' ALA . 12.4 p -79.38 -27.47 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 122.528 0.331 . . . . 62.44 111.769 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -66.69 -23.08 66.08 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 112.114 0.413 . . . . 75.52 112.114 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -95.55 15.58 19.43 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.392 0.677 . . . . 63.43 111.841 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.792 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -91.52 160.83 15.23 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.369 0.668 . . . . 70.13 110.451 177.239 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -69.01 130.26 42.28 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.833 0.853 . . . . 71.35 108.784 162.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -84.55 102.34 12.79 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.913 0.485 . . . . 75.31 110.607 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -155.37 77.4 4.85 Favored Pre-proline 0 N--CA 1.476 0.83 0 N-CA-C 108.674 -0.861 . . . . 71.13 108.674 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -88.31 148.65 6.52 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.71 2.273 . . . . 71.31 113.819 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -86.52 99.34 11.61 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 107.013 -1.477 . . . . 70.43 107.013 159.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 t -78.54 101.04 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 108.591 -0.892 . . . . 75.45 108.591 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.556 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 62.3 mttm -99.26 105.38 17.4 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.899 -0.778 . . . . 72.11 108.899 -176.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.406 HD13 HD21 ' C' ' 128' ' ' LEU . 42.5 tp -83.64 130.02 34.97 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 109.134 -0.691 . . . . 54.3 109.134 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -129.19 139.74 51.77 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.326 1.45 . . . . 73.44 108.284 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.33 147.59 50.25 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.844 0.458 . . . . 62.23 110.702 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 1.5 t70 -130.09 147.49 51.84 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.117 1.367 . . . . 71.22 108.693 173.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 87.9 m -111.51 114.17 27.08 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.709 0.804 . . . . 73.04 109.643 -174.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -118.36 139.9 50.66 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.29 1.036 . . . . 52.21 108.317 173.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.47 ' HB2' ' OH ' ' C' ' 56' ' ' TYR . 64.8 p -154.26 143.76 21.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.172 -0.33 . . . . 73.53 111.179 -172.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 27.8 p -159.0 128.01 5.4 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 123.923 0.764 . . . . 73.11 109.808 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -80.1 138.27 36.92 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.974 -0.75 . . . . 73.51 108.974 173.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.566 HD11 HD12 ' C' ' 83' ' ' ILE . 49.1 mt -105.48 -38.9 6.3 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.004 0.522 . . . . 73.32 110.712 -176.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.69 -170.55 2.79 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.379 0.672 . . . . 71.31 110.957 -177.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -70.39 112.25 6.56 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.261 -0.881 . . . . 62.2 109.785 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 71.24 -1.42 2.74 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 125.396 1.479 . . . . 73.13 112.944 -175.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.476 HG12 ' HB2' ' C' ' 51' ' ' LEU . 66.2 t -102.31 120.02 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.096 -0.705 . . . . 74.23 109.096 175.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 56' ' ' TYR . . . . . 0.47 ' OH ' ' HB2' ' C' ' 48' ' ' SER . 51.0 t80 -138.62 132.07 30.39 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.104 -1.073 . . . . 70.35 108.104 -174.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.501 ' HB2' HD11 ' C' ' 51' ' ' LEU . 39.9 tt0 -94.48 117.67 30.48 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.384 -0.825 . . . . 71.12 109.045 173.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 35.7 m -96.65 130.14 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.625 -1.25 . . . . 70.23 107.625 168.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 61.9 t -124.02 125.34 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.85 -1.167 . . . . 63.43 107.85 172.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 tp -125.9 116.41 21.47 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.013 -1.106 . . . . 73.24 108.013 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.506 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.7 ttm180 -79.12 122.25 26.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.772 -1.103 . . . . 75.14 109.036 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 11.4 t -100.81 129.06 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.019 -1.474 . . . . 72.23 107.019 171.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 62.8 m -131.95 110.53 10.83 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.089 -1.078 . . . . 75.11 108.089 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 85.1 t -101.75 112.33 34.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.578 -1.192 . . . . 62.22 108.231 -175.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.556 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 20.7 m -97.92 141.15 31.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.014 -1.106 . . . . 73.31 108.014 173.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.33 107.5 6.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 106.233 -1.766 . . . . 55.21 106.233 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 46.2 m -127.16 146.34 50.43 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.611 -0.514 . . . . 70.41 109.611 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.792 HD13 ' HG2' ' C' ' 34' ' ' LYS . 13.1 mt -110.41 35.59 3.39 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.661 1.584 . . . . 65.23 108.2 -173.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.88 -109.68 2.99 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 110.096 -1.202 . . . . 72.12 110.096 -169.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.93 -30.01 18.13 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.869 0.868 . . . . 73.13 110.314 176.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -73.52 103.07 4.02 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.726 0.81 . . . . 74.2 109.77 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 92.6 m -73.26 118.87 16.73 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.544 -0.91 . . . . 75.23 108.544 170.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.724 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -67.68 -57.75 5.85 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 124.464 1.102 . . . . 51.34 109.11 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -156.89 171.65 20.05 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.663 -1.153 . . . . 63.34 111.656 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -139.44 140.02 37.21 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 104.839 -2.282 . . . . 74.44 104.839 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.484 ' SG ' HG23 ' C' ' 114' ' ' ILE . 38.3 t -147.54 112.43 5.42 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.964 -0.754 . . . . 72.21 108.964 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -121.8 116.46 24.5 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.708 0.803 . . . . 75.52 110.147 -171.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 55.5 t -125.06 115.45 44.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.955 0.902 . . . . 73.41 109.357 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.606 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.1 mt-30 -90.96 97.85 11.43 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.807 -0.812 . . . . 73.25 108.807 173.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.671 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 67.1 tp60 -86.98 117.32 25.62 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.339 0.655 . . . . 73.21 109.766 -177.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.3 146.35 18.23 Favored Glycine 0 C--N 1.342 0.909 0 O-C-N 123.813 0.695 . . . . 71.42 111.831 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.411 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -143.4 116.35 0.99 Allowed Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.754 -0.538 . . . . 43.5 111.754 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.566 HD12 HD11 ' C' ' 51' ' ' LEU . 7.7 mm -82.97 122.16 37.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 107.945 -1.131 . . . . 64.02 107.945 174.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.413 ' HD2' ' HA ' ' C' ' 13' ' ' ILE . 54.7 m-85 -138.26 132.16 31.3 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.426 0.691 . . . . 74.24 109.956 -176.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 21.8 p -95.22 103.97 15.85 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 108.17 -1.048 . . . . 72.14 108.17 169.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.525 HD13 ' H ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -124.15 137.04 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 124.144 0.977 . . . . 74.4 111.459 -171.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.67 173.38 11.96 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.352 1.061 . . . . 73.41 110.934 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 116.89 -49.03 0.88 Allowed Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.941 -0.572 . . . . 63.21 111.74 172.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 30.0 pt -92.31 170.17 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.488 0.715 . . . . 71.12 110.284 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -146.17 148.47 32.58 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.975 0.51 . . . . 73.24 111.226 -168.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.51 -133.32 23.46 Favored Glycine 0 C--N 1.35 1.33 0 O-C-N 123.745 0.653 . . . . 74.3 114.222 172.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.4 p -66.69 -18.55 65.43 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.111 0.964 . . . . 73.2 112.229 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -68.35 -43.22 77.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.196 0.598 . . . . 70.11 110.144 172.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 15.5 ttt -76.72 -31.57 57.25 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.601 -0.727 . . . . 74.53 110.55 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.19 -40.23 90.27 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.373 0.669 . . . . 63.21 110.558 172.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -59.56 -41.75 90.87 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.473 1.109 . . . . 74.5 111.006 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 50.4 t -63.79 -54.27 37.73 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.539 0.524 . . . . 64.33 110.223 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.03 -36.36 83.31 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.332 0.653 . . . . 72.24 112.036 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.6 11.28 66.7 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.497 -0.613 . . . . 73.01 114.304 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.65 -58.02 0.1 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 117.555 0.677 . . . . 43.11 111.999 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -74.51 -48.4 27.37 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.662 0.385 . . . . 63.24 112.002 -172.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.701 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 41.9 m -60.51 -47.2 96.88 Favored Pre-proline 0 CA--C 1.563 1.458 0 C-N-CA 123.97 0.908 . . . . 75.44 112.11 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.87 -12.07 19.87 Favored 'Trans proline' 0 C--N 1.395 3.024 0 C-N-CA 122.026 1.818 . . . . 64.52 113.608 172.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 104' ' ' ASN . . . . . 0.506 ' HA ' ' CD2' ' C' ' 107' ' ' PHE . 59.7 t30 -71.76 -32.66 67.93 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.434 0.635 . . . . 73.13 109.914 173.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.644 HD12 HH12 ' A' ' 111' ' ' ARG . 30.0 mm -65.54 -30.84 51.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 115.143 -0.935 . . . . 73.33 109.822 170.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.411 HD21 ' HA3' ' C' ' 82' ' ' GLY . 65.5 mt -88.14 -22.64 23.97 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.887 0.875 . . . . 71.14 113.208 -175.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 107' ' ' PHE . . . . . 0.506 ' CD2' ' HA ' ' C' ' 104' ' ' ASN . 11.8 m-85 -55.38 -48.36 96.48 Favored Pre-proline 0 N--CA 1.49 1.536 0 CA-C-O 117.242 -1.361 . . . . 75.12 113.218 -177.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -54.46 -39.53 87.43 Favored 'Trans proline' 0 C--N 1.39 2.75 0 C-N-CA 122.881 2.387 . . . . 73.41 114.461 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.559 ' HE2' HG21 ' A' ' 115' ' ' THR . 73.9 m-85 -70.04 -49.33 52.34 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.214 0.605 . . . . 72.34 110.901 -176.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.671 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -67.75 -31.97 72.25 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 115.615 -0.72 . . . . 73.42 111.081 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 26.6 ttt-85 -59.21 -54.19 49.76 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.675 1.19 . . . . 71.14 110.328 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -69.33 -29.05 66.79 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.767 0.667 . . . . 64.41 110.425 -177.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 42.7 t -70.22 -38.39 75.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.186 0.594 . . . . 71.3 110.813 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.484 HG23 ' SG ' ' C' ' 76' ' ' CYS . 87.3 mt -69.54 -49.09 62.24 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.157 0 C-N-CA 123.259 0.624 . . . . 65.33 109.742 174.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 90.5 m -63.25 -33.08 74.72 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.012 0.925 . . . . 75.25 110.977 -175.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 41.8 t -64.62 -46.67 81.6 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 115.349 -0.841 . . . . 74.31 109.092 172.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.49 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.98 -36.43 84.38 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.895 1.278 . . . . 62.4 112.929 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' C' ' 114' ' ' ILE . 97.4 t -65.56 -44.54 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.093 0.957 . . . . 72.14 108.774 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 30.6 t -66.13 -33.62 76.19 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.162 -1.381 . . . . 61.32 111.496 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -70.94 -32.2 69.01 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.648 0.779 . . . . 72.13 109.453 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.3 9.06 76.73 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 123.717 0.636 . . . . 75.03 112.947 174.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 46.0 p 58.19 30.62 19.67 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 126.143 1.777 . . . . 74.15 114.016 174.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -93.02 147.27 33.54 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 108.81 -0.811 . . . . 74.33 108.81 172.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.34 159.76 5.63 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 123.386 2.724 . . . . 62.01 113.742 174.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -47.39 125.59 8.36 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.797 1.239 . . . . 65.31 112.934 -176.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.81 91.25 3.31 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.327 -1.36 . . . . 75.42 107.327 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -116.62 122.18 43.86 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.407 1.083 . . . . 63.12 108.168 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.406 HD21 HD13 ' C' ' 42' ' ' LEU . 6.7 mp -69.11 145.94 52.97 Favored 'General case' 0 C--O 1.245 0.832 0 O-C-N 123.406 0.441 . . . . 61.13 110.479 177.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 129' ' ' ALA . . . . . 0.44 ' HA ' ' HD3' ' C' ' 130' ' ' PRO . . . -72.8 136.22 80.33 Favored Pre-proline 0 CA--C 1.552 1.041 0 O-C-N 124.107 0.879 . . . . 73.01 110.013 177.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.595 ' HB2' HD12 ' A' ' 13' ' ' ILE . 11.1 Cg_exo -69.22 100.7 0.77 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 123.173 2.582 . . . . 52.15 113.725 -170.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.0 t -101.04 108.62 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 108.051 -1.092 . . . . 65.51 108.051 170.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -81.41 92.61 6.46 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 107.091 -1.448 . . . . 71.5 107.091 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -65.43 -35.91 82.33 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.057 0.943 . . . . 71.42 112.642 -161.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.479 1.014 0 C-N-CA 123.516 0.727 . . . . 73.55 111.589 177.899 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 CA--C 1.54 0.571 0 CA-C-O 120.655 0.264 . . . . 72.53 110.579 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.581 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 57.6 t80 -154.14 99.85 2.27 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.703 1.201 . . . . 75.22 107.837 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -117.48 115.43 25.15 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.024 -0.732 . . . . 74.44 109.024 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.442 HG21 HD11 ' D' ' 16' ' ' ILE . 28.5 mt -75.23 121.64 27.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.23 -1.026 . . . . 71.32 108.23 176.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -96.45 -26.94 15.12 Favored 'General case' 0 C--O 1.245 0.819 0 O-C-N 123.417 0.448 . . . . 75.12 111.347 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -171.72 136.04 0.91 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 117.705 0.23 . . . . 55.34 111.364 -168.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.455 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.9 mp -120.5 133.4 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 107.107 -1.442 . . . . 54.25 107.107 174.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -160.6 173.03 16.11 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 122.582 1.182 . . . . 75.42 112.53 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -111.38 120.42 42.14 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 113.613 -1.631 . . . . 61.33 108.136 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.545 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 42.6 mtpt -87.93 -24.07 23.72 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.275 0.56 . . . . 61.41 109.552 176.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 10.3 t70 -154.57 143.3 20.82 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.124 -1.398 . . . . 64.21 109.138 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.498 HG23 HG22 ' D' ' 78' ' ' VAL . 47.1 mt -139.96 150.28 21.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 106.539 -1.652 . . . . 75.25 106.539 173.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -157.56 144.84 18.42 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.571 0.701 . . . . 73.5 110.739 169.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.489 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.2 t80 -140.17 128.64 22.76 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 105.872 -1.899 . . . . 72.32 105.872 173.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.592 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.7 mt-10 -136.89 123.44 20.93 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.441 -0.948 . . . . 75.43 108.441 -176.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.06 86.62 57.64 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 107.605 -1.257 . . . . 63.44 107.605 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.67 -36.78 10.41 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 122.676 2.25 . . . . 75.43 112.431 -175.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -96.95 16.76 18.54 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.867 0.867 . . . . 74.54 110.43 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.7 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -43.66 -64.93 0.65 Allowed Pre-proline 0 CA--C 1.561 1.386 0 N-CA-C 115.336 1.606 . . . . 74.14 115.336 -162.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.69 -12.77 22.24 Favored 'Trans proline' 0 C--N 1.386 2.542 0 CA-C-N 122.626 1.973 . . . . 63.11 113.348 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -84.58 -40.83 17.07 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.119 1.368 . . . . 72.44 110.856 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.481 HG22 HD12 ' D' ' 68' ' ' LEU . 9.9 p -83.72 -17.21 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.123 0 CA-C-N 115.886 -0.597 . . . . 64.31 111.446 -170.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -62.42 -17.62 59.72 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 113.025 0.75 . . . . 74.11 113.025 173.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -65.02 -11.95 44.95 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.369 0.668 . . . . 73.32 110.951 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.4 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 87.2 mttt -109.79 92.13 3.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.303 1.441 . . . . 53.42 109.194 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -90.9 92.5 8.8 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.844 0.457 . . . . 51.42 109.873 177.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 30.7 p90 -162.31 176.87 10.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.69 0.796 . . . . 73.13 109.448 168.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -69.9 114.34 24.3 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 123.689 0.796 . . . . 55.42 110.342 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.539 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 16.4 Cg_exo -68.08 134.98 33.34 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 123.104 2.536 . . . . 72.44 111.096 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.68 122.25 16.83 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.262 0.625 . . . . 73.35 110.033 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 35.8 t -97.87 114.93 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.631 0.773 . . . . 72.3 110.894 -168.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -104.39 152.63 22.06 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.186 -1.413 . . . . 73.03 107.186 166.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 pp -140.34 156.07 46.57 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.025 0.53 . . . . 73.42 110.967 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -150.35 152.61 34.68 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.777 0.831 . . . . 72.35 108.89 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 87.9 mt -126.92 146.92 50.13 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.483 0.713 . . . . 73.5 110.838 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.56 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 7.2 t70 -136.84 140.82 42.7 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.738 1.215 . . . . 51.54 108.19 172.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 58.0 m -102.03 142.91 32.57 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.401 0.68 . . . . 53.21 109.655 -173.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.628 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -155.04 155.25 33.78 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.08 0.952 . . . . 62.02 109.032 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 77.3 p -174.62 178.44 1.92 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.007 0.432 . . . . 71.15 111.272 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 73.0 p -168.77 146.58 3.92 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.491 -1.231 . . . . 72.51 108.935 174.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -82.66 128.54 34.44 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.879 -0.786 . . . . 73.24 108.879 171.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.627 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.5 mt -101.28 -34.5 9.62 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.024 0.53 . . . . 44.33 110.18 -175.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.54 -175.89 3.72 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.318 1.047 . . . . 62.13 110.131 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.7 114.51 7.98 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.642 -1.163 . . . . 65.13 109.306 173.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 68.46 18.77 8.95 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.151 1.381 . . . . 73.0 112.461 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 94.7 t -124.16 124.69 69.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 C-N-CA 124.927 1.291 . . . . 75.44 107.609 168.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -144.66 137.72 26.82 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.625 -0.509 . . . . 74.51 109.625 -176.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.627 ' HB2' HD11 ' D' ' 51' ' ' LEU . 27.3 tt0 -91.9 133.53 35.59 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.645 -0.707 . . . . 64.12 109.972 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 78.4 t -111.86 118.28 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.678 -1.23 . . . . 72.15 107.678 172.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.628 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 14.7 t -114.61 131.77 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.21 -1.033 . . . . 62.04 108.21 173.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.416 HD12 ' O ' ' D' ' 45' ' ' ASP . 18.8 tp -130.69 123.5 29.48 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.229 -0.656 . . . . 61.25 109.229 174.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.56 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 14.1 ttm180 -83.53 104.77 13.93 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.702 -0.851 . . . . 71.52 108.702 176.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 70.4 t -89.12 129.39 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 107.979 -1.119 . . . . 53.35 107.979 173.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 20.7 m -121.75 142.6 50.03 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.289 -0.634 . . . . 72.33 109.289 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 69.5 t -139.44 100.45 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 126.04 1.736 . . . . 55.13 107.307 -174.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 62.5 m -99.69 112.33 24.57 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.757 -0.831 . . . . 73.53 108.757 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -115.42 141.05 48.57 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.586 0.754 . . . . 61.1 109.972 -173.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 14.4 p -147.7 128.79 14.59 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 123.526 0.516 . . . . 60.53 111.906 -174.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.481 HD12 HG22 ' D' ' 31' ' ' VAL . 41.2 mt -96.93 114.81 26.46 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 124.758 1.223 . . . . 62.34 108.661 175.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.86 -121.09 8.38 Favored Glycine 0 C--N 1.341 0.858 0 O-C-N 123.737 0.648 . . . . 64.44 112.106 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.07 5.59 22.23 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.177 0.591 . . . . 75.43 111.444 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 71' ' ' GLU . . . . . 0.4 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 10.9 pt-20 -122.37 162.62 21.24 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.22 0.608 . . . . 65.35 109.727 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 58.8 m -69.65 132.67 46.54 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.457 0.703 . . . . 65.04 111.284 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.482 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -84.95 -68.93 0.69 Allowed 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.414 -1.328 . . . . 62.4 107.414 172.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 74' ' ' PHE . . . . . 0.456 ' HZ ' HD22 ' D' ' 126' ' ' LEU . 51.5 p90 -149.83 167.28 27.0 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.654 -1.157 . . . . 75.32 110.657 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.592 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 77.5 mt -134.49 112.42 10.9 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.794 1.238 . . . . 70.41 108.269 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.537 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 10.6 m -114.81 133.32 56.04 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.189 0.996 . . . . 73.51 108.782 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -152.62 118.42 5.4 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.196 -1.409 . . . . 63.14 107.196 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 78' ' ' VAL . . . . . 0.498 HG22 HG23 ' D' ' 21' ' ' ILE . 80.0 t -130.09 122.17 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.989 0.916 . . . . 74.32 108.777 -175.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.611 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.9 mt-30 -88.61 87.49 7.28 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.376 -0.972 . . . . 74.41 108.376 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -80.46 110.9 16.36 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.115 -1.402 . . . . 72.13 108.569 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.36 144.55 18.34 Favored Glycine 0 N--CA 1.469 0.887 0 N-CA-C 111.471 -0.651 . . . . 72.21 111.471 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.61 138.3 8.04 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 117.038 0.419 . . . . 71.53 112.199 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.6 mt -88.39 122.86 40.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 108.203 -1.036 . . . . 74.32 108.203 173.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -128.64 156.02 44.07 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.389 0.675 . . . . 71.0 109.253 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 48.8 m -115.36 102.12 9.55 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.424 -0.954 . . . . 71.24 108.424 175.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 3.6 mp -108.05 130.49 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 108.812 -0.81 . . . . 73.2 108.812 -176.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.81 166.9 28.09 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.868 0.867 . . . . 40.42 110.385 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.44 21.71 74.61 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.452 -0.795 . . . . 64.11 114.094 173.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.421 HG22 ' N ' ' D' ' 90' ' ' GLU . 17.5 mt -125.22 157.29 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.458 0.703 . . . . 74.22 110.47 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.421 ' N ' HG22 ' D' ' 89' ' ' ILE . 29.6 mt-10 -135.0 151.84 51.19 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.844 1.257 . . . . 65.42 110.213 172.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.58 -145.79 41.0 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 116.05 1.18 . . . . 72.31 116.05 168.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 4.3 p -74.51 -10.42 59.54 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.208 1.003 . . . . 74.12 111.711 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -30.86 71.56 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.808 0.843 . . . . 72.43 109.426 172.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 56.9 ttm -77.73 -39.04 45.73 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.883 0.473 . . . . 75.24 109.818 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.69 -31.49 68.27 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.238 0.542 . . . . 75.22 111.008 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -70.82 -48.9 51.57 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.471 1.108 . . . . 73.22 110.572 174.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 50.9 t -59.67 -46.29 89.48 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.047 0.539 . . . . 60.21 110.867 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.486 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 7.3 mp -83.89 -18.99 35.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.337 0.655 . . . . 62.42 111.96 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.38 -1.74 60.63 Favored Glycine 0 N--CA 1.476 1.314 0 CA-C-O 119.992 -0.338 . . . . 60.31 113.564 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' D' ' 104' ' ' ASN . . . -140.34 -65.22 0.46 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.887 0.475 . . . . 51.3 110.967 -176.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -73.93 -40.12 63.33 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.828 0.677 . . . . 73.05 112.828 -170.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.581 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 51.5 m -69.45 -45.91 27.05 Favored Pre-proline 0 CA--C 1.559 1.3 0 CA-C-O 118.881 -0.581 . . . . 75.23 112.213 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.52 -18.93 28.94 Favored 'Trans proline' 0 C--N 1.393 2.892 0 C-N-CA 121.66 1.573 . . . . 70.14 112.412 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 104' ' ' ASN . . . . . 0.454 ' HA ' ' HD2' ' D' ' 107' ' ' PHE . 35.4 t-20 -64.19 -31.12 72.2 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.463 0.705 . . . . 74.03 109.992 175.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.4 mm -68.24 -33.44 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.566 0.746 . . . . 73.51 110.277 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 79.5 mt -81.35 -25.66 36.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.666 0.786 . . . . 73.43 112.664 -173.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 107' ' ' PHE . . . . . 0.454 ' HD2' ' HA ' ' D' ' 104' ' ' ASN . 41.0 m-85 -64.06 -42.71 71.03 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 114.255 1.206 . . . . 71.13 114.255 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.27 -39.81 85.12 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 122.409 2.073 . . . . 63.52 113.329 172.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -80.59 -32.25 36.55 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.758 0.823 . . . . 73.11 112.045 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.3 -53.03 50.01 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.836 -0.801 . . . . 73.43 108.836 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.42 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 37.4 ttp180 -55.07 -46.9 75.45 Favored 'General case' 0 C--O 1.211 -0.937 0 O-C-N 124.61 1.194 . . . . 72.02 111.313 177.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -64.69 -45.63 85.79 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.217 0.607 . . . . 71.32 111.086 -175.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.408 ' O ' ' HG3' ' D' ' 117' ' ' MET . 44.7 t -57.72 -45.97 85.06 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.413 0.685 . . . . 61.43 110.456 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.537 HD13 HG21 ' D' ' 64' ' ' VAL . 93.4 mt -62.79 -52.18 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.755 -1.111 . . . . 63.31 111.101 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.416 HG21 ' HE2' ' B' ' 109' ' ' TYR . 96.8 m -56.13 -41.03 74.69 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.891 1.277 . . . . 60.22 111.119 -177.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 30.6 t -66.72 -43.45 84.23 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.621 -1.172 . . . . 61.24 109.818 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.432 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 74.4 mtm -65.7 -33.03 74.93 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.088 0.555 . . . . 72.4 111.874 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.513 HG23 ' O ' ' D' ' 114' ' ' ILE . 76.4 t -64.68 -45.71 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.432 1.093 . . . . 60.24 109.945 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 82.5 p -75.58 -28.36 58.92 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 115.503 -0.771 . . . . 54.45 111.053 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' D' ' 116' ' ' SER . 78.0 mtt-85 -72.63 -29.11 63.19 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.374 0.67 . . . . 72.04 109.805 174.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.63 9.64 75.17 Favored Glycine 0 C--N 1.353 1.494 0 O-C-N 123.849 0.718 . . . . 75.34 112.29 173.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.554 HG23 ' HB3' ' C' ' 17' ' ' TYR . 44.8 p 60.06 20.01 9.19 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 126.533 1.933 . . . . 54.42 114.476 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -82.19 155.24 69.72 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.418 0.687 . . . . 74.45 109.66 171.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.01 132.4 49.27 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.642 2.228 . . . . 44.14 111.221 174.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -49.76 130.47 21.2 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.195 1.398 . . . . 72.14 112.499 -174.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.456 HD22 ' HZ ' ' D' ' 74' ' ' PHE . 17.8 tp -117.51 96.44 5.4 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.908 0.483 . . . . 74.3 109.783 -172.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -99.9 104.45 16.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.579 0.752 . . . . 72.33 109.245 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.42 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 6.6 mp -69.92 115.39 9.09 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.293 0.637 . . . . 63.42 109.813 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.73 126.93 86.37 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 122.898 0.479 . . . . 50.44 110.196 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -73.35 133.25 18.93 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.504 2.136 . . . . 63.44 111.855 -171.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 89.3 t . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 108.473 -0.936 . . . . 74.25 108.473 179.349 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.567 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 25.5 t80 . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 109.274 -0.639 . . . . 73.51 109.274 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -144.67 112.9 6.48 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.991 0.916 . . . . 71.44 109.05 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.648 HG12 ' HD2' ' A' ' 84' ' ' PHE . 43.0 mt -77.88 115.06 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 109.702 -0.481 . . . . 64.44 109.702 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -73.39 -27.96 61.75 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 123.801 0.688 . . . . 52.52 111.1 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.2 ttt85 -177.57 149.01 0.6 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 123.265 0.353 . . . . 72.51 111.448 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.48 HD12 ' HB3' ' C' ' 130' ' ' PRO . 91.6 mt -137.23 130.63 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.239 -1.022 . . . . 71.51 108.239 168.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.496 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 35.1 p90 -166.14 157.63 13.62 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 124.19 0.931 . . . . 74.3 110.484 -168.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.3 p -83.28 109.82 17.58 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.773 -1.103 . . . . 75.44 108.375 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 35.3 mtpt -75.05 -38.3 61.43 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.083 -0.71 . . . . 62.22 109.083 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.525 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 31.4 t70 -140.33 136.48 33.25 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 113.93 -1.486 . . . . 70.15 109.617 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.4 mt -130.23 144.73 37.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 125.406 1.482 . . . . 65.23 107.043 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.498 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 48.3 t -148.82 130.28 14.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.815 -0.809 . . . . 74.23 108.815 174.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -134.72 142.08 46.67 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.375 -1.343 . . . . 74.2 107.375 173.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -141.45 151.16 43.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.446 -0.946 . . . . 74.22 108.446 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.52 81.22 17.66 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 106.905 -1.517 . . . . 74.45 106.905 171.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.16 -46.39 33.91 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.589 2.859 . . . . 71.01 114.303 -166.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.18 37.56 3.97 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.549 -0.908 . . . . 74.53 108.549 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.599 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -40.18 -57.26 2.92 Favored Pre-proline 0 CA--C 1.569 1.686 0 N-CA-C 114.274 1.212 . . . . 51.34 114.274 -172.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.599 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 27.9 Cg_exo -62.17 -29.69 81.05 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.042 1.828 . . . . 74.25 114.006 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -83.0 -32.64 26.84 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.689 0.796 . . . . 75.24 111.347 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.702 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.2 p -77.52 -22.31 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.542 0.737 . . . . 53.32 111.265 -166.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -71.47 -22.38 61.82 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.708 -0.678 . . . . 74.13 110.773 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -80.83 -21.61 40.67 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.284 1.033 . . . . 70.1 110.633 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -82.03 170.8 15.13 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.149 0.98 . . . . 62.1 111.568 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -88.3 131.54 34.75 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.687 0.795 . . . . 75.02 110.044 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.454 ' CE3' HD21 ' A' ' 68' ' ' LEU . 66.4 t-105 -84.47 85.53 7.39 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 121.582 0.706 . . . . 72.32 111.058 -176.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -135.16 80.63 46.76 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 107.225 -1.398 . . . . 54.23 107.225 167.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -82.01 154.24 17.09 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.666 2.244 . . . . 73.12 112.658 -173.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -102.41 85.85 2.7 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.782 -1.562 . . . . 72.34 106.782 170.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 65' ' ' THR . 55.7 t -78.89 97.26 2.33 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 CA-C-N 115.54 -0.755 . . . . 75.52 109.965 -173.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.495 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 56.8 mtpt -79.39 124.18 28.19 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.127 -0.942 . . . . 74.04 109.196 174.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -97.71 108.37 21.07 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 105.922 -1.881 . . . . 52.41 105.922 169.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.782 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 15.0 m-20 -104.5 117.68 34.75 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.628 -0.878 . . . . 52.22 108.628 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -97.53 122.41 40.56 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.892 0.877 . . . . 64.35 109.512 -171.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -136.22 139.36 42.7 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.296 0.638 . . . . 75.05 109.404 172.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.1 p -111.98 136.94 50.66 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.661 0.784 . . . . 74.31 110.239 -175.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.08 110.82 5.64 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 108.341 -0.985 . . . . 62.04 108.341 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 p -132.0 152.04 51.38 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.947 -0.471 . . . . 73.54 109.931 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -152.36 132.38 13.42 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.155 0.582 . . . . 62.31 110.982 -170.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -75.11 126.05 30.21 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 108.936 -0.764 . . . . 75.45 108.936 172.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.411 HD12 HG23 ' A' ' 83' ' ' ILE . 76.1 mt -97.99 -33.24 11.27 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.723 0.409 . . . . 63.01 110.387 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.4 -176.15 5.44 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.178 0.991 . . . . 53.41 110.014 176.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.61 124.2 21.27 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 108.631 -0.877 . . . . 64.22 108.631 169.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 65.04 11.79 7.4 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.465 1.106 . . . . 62.41 112.62 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.405 HG12 ' HB2' ' A' ' 51' ' ' LEU . 61.2 t -123.06 122.59 65.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 107.938 -1.134 . . . . 62.54 107.938 174.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -140.06 169.01 18.49 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.103 -0.702 . . . . 73.11 109.103 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -129.92 127.31 39.87 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.197 -0.91 . . . . 74.51 108.807 176.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.558 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 91.9 t -102.52 120.91 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.509 -1.293 . . . . 61.42 107.509 168.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.499 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 25.9 t -107.76 131.24 58.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 107.408 -1.331 . . . . 74.14 107.408 168.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 tt -119.24 107.49 13.48 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.627 -0.879 . . . . 64.4 108.627 176.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -84.47 102.09 12.55 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.373 1.069 . . . . 72.11 109.366 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.4 t -98.41 102.51 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 108.196 -1.038 . . . . 72.03 108.196 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.782 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 33.2 m -94.82 108.02 20.04 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.976 -1.12 . . . . 75.51 107.976 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.3 t -103.22 110.23 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.218 0.607 . . . . 73.24 109.698 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 11.6 m -100.56 141.18 33.78 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.304 -0.998 . . . . 72.31 108.304 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.89 119.21 20.85 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.239 -1.023 . . . . 64.3 108.239 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.3 m -130.02 126.9 38.82 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.451 0.469 . . . . 72.14 110.724 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.454 HD21 ' CE3' ' A' ' 36' ' ' TRP . 29.6 mt -87.4 80.86 8.01 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 124.722 1.209 . . . . 74.44 109.163 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.5 -84.05 0.87 Allowed Glycine 0 C--N 1.34 0.782 0 CA-C-N 116.168 -0.469 . . . . 71.32 112.038 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -112.63 -27.9 8.02 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.368 0.667 . . . . 74.43 111.403 177.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -95.86 122.47 38.69 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 122.062 -0.399 . . . . 74.03 111.154 -173.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.3 m -65.77 126.8 29.61 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.06 0.457 . . . . 71.41 110.283 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.702 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -78.8 -56.77 4.15 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 114.975 -1.012 . . . . 72.24 109.531 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -159.45 172.71 17.4 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.601 -1.181 . . . . 63.3 111.257 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.9 tp -131.54 139.37 49.23 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 107.5 -1.296 . . . . 75.21 107.5 167.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 59.3 m -138.31 95.47 3.01 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.827 -0.805 . . . . 75.14 108.827 175.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 33.9 tt0 -105.61 121.16 43.4 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.407 0.683 . . . . 74.21 109.293 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.2 t -129.59 112.47 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.158 0.504 . . . . 72.24 110.008 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -84.78 88.82 7.41 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.43 -0.952 . . . . 72.42 108.43 172.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -80.01 96.91 6.58 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.452 -0.794 . . . . 74.23 109.407 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.9 151.25 24.8 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 115.944 -0.571 . . . . 23.51 112.085 177.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.413 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -152.77 122.01 1.24 Allowed Glycine 0 CA--C 1.504 -0.631 0 N-CA-C 111.006 -0.837 . . . . 72.43 111.006 176.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.411 HG23 HD12 ' A' ' 51' ' ' LEU . 46.4 mt -82.1 122.97 37.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 108.188 -1.042 . . . . 71.35 108.188 173.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.648 ' HD2' HG12 ' A' ' 13' ' ' ILE . 22.6 m-85 -124.96 147.98 48.63 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 109.109 -0.7 . . . . 75.03 109.109 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.2 m -113.98 122.77 47.94 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.476 -0.935 . . . . 51.51 108.476 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.549 0.921 0 N-CA-C 108.555 -0.906 . . . . 71.44 108.555 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.804 0.335 . . . . 74.11 110.921 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -67.49 -27.71 67.24 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.918 -0.583 . . . . 71.34 110.732 172.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.519 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 58.3 m -76.78 -63.91 1.24 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 122.71 0.404 . . . . 54.1 110.404 177.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.21 -30.65 71.15 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.978 0.911 . . . . 75.13 112.28 -171.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.42 -1.28 40.75 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-O 119.115 -0.825 . . . . 64.1 114.389 -172.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.86 -59.82 0.23 Allowed 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.985 1.106 . . . . 72.52 113.985 -173.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.519 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 80.1 t80 -74.15 -55.33 6.2 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.167 0.587 . . . . 72.12 111.491 -169.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 79.3 m -65.58 -36.24 14.02 Favored Pre-proline 0 CA--C 1.567 1.632 0 N-CA-C 113.084 0.772 . . . . 74.34 113.084 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.02 -46.65 27.13 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 122.68 2.253 . . . . 70.43 113.735 160.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -27.68 65.46 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.546 0.739 . . . . 74.12 110.432 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.62 -38.59 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 C-N-CA 123.382 0.673 . . . . 64.1 110.22 173.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.413 HD21 ' HA3' ' A' ' 82' ' ' GLY . 70.2 mt -76.8 -22.96 52.9 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.616 0.766 . . . . 75.44 112.36 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -61.12 -45.67 95.95 Favored Pre-proline 0 CA--C 1.567 1.607 0 N-CA-C 114.387 1.254 . . . . 73.2 114.387 -171.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -62.6 -34.79 73.55 Favored 'Trans proline' 0 C--N 1.384 2.435 0 CA-C-N 121.676 1.634 . . . . 73.11 113.038 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -70.37 -43.59 69.82 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.229 0.612 . . . . 72.22 111.078 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.11 -36.7 80.19 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.991 -0.55 . . . . 71.03 110.484 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.515 ' NH1' HD12 ' C' ' 105' ' ' ILE . 28.7 ttm180 -54.58 -56.78 15.38 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.859 0.863 . . . . 70.13 109.903 172.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.09 -43.39 95.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.956 0.902 . . . . 73.52 111.768 -174.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 38.2 t -59.51 -42.56 92.49 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.785 0.678 . . . . 43.04 110.613 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.3 mt -68.24 -47.61 77.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 115.497 -0.774 . . . . 72.41 110.328 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 60.2 m -55.49 -41.42 72.99 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.96 0.904 . . . . 63.14 111.527 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.0 t -70.79 -44.61 66.28 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 114.994 -1.003 . . . . 53.32 110.381 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 21.1 mtp -61.6 -41.47 97.49 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.543 0.737 . . . . 71.34 111.727 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.16 -45.87 97.73 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 123.931 0.892 . . . . 71.54 110.503 175.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 26.0 t -72.28 -30.17 64.57 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.706 -0.679 . . . . 55.11 111.764 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -74.77 -28.62 60.83 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.334 0.653 . . . . 71.31 109.572 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.3 15.83 37.58 Favored Glycine 0 C--N 1.352 1.444 0 O-C-N 123.831 0.707 . . . . 62.15 113.04 172.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.434 HG21 ' HE ' ' B' ' 15' ' ' ARG . 3.0 t 59.94 12.56 3.16 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 127.054 2.142 . . . . 71.31 113.685 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -79.8 147.44 66.61 Favored Pre-proline 0 C--O 1.244 0.781 0 C-N-CA 123.25 0.62 . . . . 62.51 109.502 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.03 141.47 98.34 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.651 2.234 . . . . 60.54 111.748 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -56.28 143.11 35.2 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.029 1.122 . . . . 75.0 114.029 -168.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.1 tp -129.14 113.79 15.53 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.451 1.1 . . . . 61.03 109.195 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -112.75 126.2 55.15 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.381 0.672 . . . . 72.55 109.823 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.13 134.93 46.03 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.389 -0.597 . . . . 74.54 109.389 172.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.62 143.22 84.67 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 122.666 0.386 . . . . 54.12 110.879 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -61.11 126.85 20.49 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.537 2.825 . . . . 70.42 112.558 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.3 m -129.61 113.56 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 123.641 0.777 . . . . 72.34 109.825 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -95.91 89.58 5.29 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.285 0.634 . . . . 73.43 109.597 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 . . . . . 0 N--CA 1.471 0.611 0 CA-C-N 115.349 -0.842 . . . . 73.53 110.362 176.206 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.645 ' HB3' HG12 ' B' ' 89' ' ' ILE . 5.5 ppp? . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 113.614 0.968 . . . . 71.41 113.614 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 93.8 m -134.03 107.1 7.57 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.897 -0.779 . . . . 71.33 108.897 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.536 ' HB2' ' SD ' ' B' ' 9' ' ' MET . 41.4 t80 -123.53 142.95 50.51 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.536 -0.756 . . . . 70.21 110.057 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -160.04 140.79 12.09 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.677 0.611 . . . . 72.45 109.61 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.539 HD13 HD11 ' B' ' 16' ' ' ILE . 42.8 mt -79.69 125.99 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 108.693 -0.854 . . . . 62.55 108.693 170.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -98.14 -37.31 9.77 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.394 0.678 . . . . 63.43 109.22 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.434 ' HE ' HG21 ' A' ' 122' ' ' THR . 45.4 ttt180 -174.19 144.32 0.95 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.479 -0.782 . . . . 74.11 109.037 -176.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.539 HD11 HD13 ' B' ' 13' ' ' ILE . 96.5 mt -128.23 142.45 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.55 -1.278 . . . . 64.12 107.55 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -168.63 148.91 4.53 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.664 0.745 . . . . 73.52 112.712 -174.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.5 m -73.72 124.87 26.84 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.147 -1.388 . . . . 74.12 108.945 167.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.452 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 37.6 mtpt -98.41 -21.51 16.54 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.635 0.774 . . . . 70.32 110.863 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -165.56 138.64 4.38 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.761 0.663 . . . . 64.23 110.706 -167.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.478 HD12 HG22 ' B' ' 78' ' ' VAL . 48.5 mm -132.96 143.87 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.076 0.951 . . . . 65.11 110.191 174.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.638 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 75.6 m -134.24 136.47 43.66 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 125.911 1.684 . . . . 52.24 107.199 169.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.4 t80 -151.48 114.83 4.8 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.474 -1.306 . . . . 63.31 107.474 165.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -119.31 155.83 31.12 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.379 -0.971 . . . . 63.32 108.379 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.451 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -144.52 86.06 8.27 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 107.766 -1.198 . . . . 64.01 107.766 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.24 -45.79 21.43 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.593 2.862 . . . . 63.11 113.86 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -104.0 24.59 11.12 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.186 0.594 . . . . 72.15 110.849 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.451 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -42.24 -62.73 1.09 Allowed Pre-proline 0 N--CA 1.485 1.283 0 N-CA-C 115.202 1.556 . . . . 74.52 115.202 -165.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 51.9 Cg_exo -53.44 -43.23 59.26 Favored 'Trans proline' 0 C--N 1.39 2.751 0 C-N-CA 122.072 1.848 . . . . 44.41 113.878 -168.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -97.12 -22.43 16.77 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.285 0.846 . . . . 74.45 113.285 -171.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.64 -17.56 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 118.452 0.569 . . . . 52.25 112.06 -173.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -70.48 -15.61 62.82 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 113.305 0.854 . . . . 72.32 113.305 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -61.6 -27.19 68.47 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.152 0.501 . . . . 63.43 109.765 173.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -86.92 80.34 8.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.336 1.054 . . . . 73.23 110.067 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -91.47 90.41 7.64 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.923 -0.581 . . . . 73.0 109.493 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -161.51 -175.64 4.89 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.723 1.209 . . . . 63.23 108.549 172.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -81.32 109.63 14.94 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 122.951 0.501 . . . . 74.51 110.109 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.68 160.22 50.54 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.442 2.095 . . . . 70.52 113.109 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -66.17 112.64 4.03 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.269 0.628 . . . . 65.54 109.63 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 51.5 t -88.86 134.66 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.803 0.841 . . . . 61.41 109.747 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -140.87 118.0 11.26 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 106.532 -1.655 . . . . 64.0 106.532 175.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 pp -114.34 166.58 11.52 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.01 0.433 . . . . 65.4 111.771 -176.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.534 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 14.2 m-20 -147.31 155.87 42.41 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.412 1.085 . . . . 73.41 109.206 174.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -120.98 146.58 46.52 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.31 -0.996 . . . . 62.41 108.31 172.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.602 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 7.4 t70 -137.91 138.19 38.78 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.856 0.862 . . . . 73.14 108.935 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 36.7 p -109.64 127.77 54.77 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.301 0.64 . . . . 72.31 111.166 -175.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.49 142.78 29.53 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.018 0.927 . . . . 74.41 108.622 174.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 35.2 p -144.53 163.62 33.32 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 122.705 0.402 . . . . 73.41 110.855 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 79.6 p -151.1 138.41 19.39 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.875 0.87 . . . . 72.33 109.018 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -96.83 134.06 40.62 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.23 -0.656 . . . . 61.3 109.23 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 46.7 mt -101.12 -39.92 7.44 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.196 0.598 . . . . 70.2 110.64 -175.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.73 -173.98 4.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.388 -0.824 . . . . 53.15 110.449 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.12 121.68 19.68 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.009 -0.996 . . . . 71.41 108.864 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 75.51 -7.5 1.77 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 126.246 1.818 . . . . 71.53 112.584 -175.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 96.1 t -110.87 112.28 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.279 -0.637 . . . . 50.32 109.279 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -119.6 -179.77 3.98 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.572 -0.899 . . . . 72.04 108.572 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -144.05 107.01 4.48 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.988 -1.115 . . . . 73.54 107.988 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 74.1 t -96.83 128.55 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.233 1.013 . . . . 63.33 110.212 -175.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.492 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 12.7 t -118.37 126.28 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.86 0.864 . . . . 72.22 109.563 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.712 HD22 ' HB3' ' B' ' 103' ' ' PRO . 52.2 tp -112.85 115.5 28.56 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.482 -0.933 . . . . 73.44 108.482 164.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.602 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 17.2 ttt180 -92.47 118.22 30.74 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.884 -0.784 . . . . 41.44 108.884 175.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.74 121.21 54.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.361 -0.977 . . . . 71.24 108.361 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.534 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 22.6 m -104.82 143.78 32.67 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.881 -0.785 . . . . 71.54 108.881 177.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 95.0 t -136.29 136.22 49.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 123.785 0.834 . . . . 75.33 108.854 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.8 m -125.86 143.75 50.94 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.609 1.163 . . . . 73.23 108.068 172.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.68 139.2 23.81 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.083 -0.71 . . . . 63.24 109.083 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.54 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 33.2 p -140.37 128.16 21.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.887 -0.597 . . . . 54.51 110.192 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 61.6 mt -96.89 105.42 17.56 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.027 -1.101 . . . . 73.41 108.027 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.26 -111.85 3.52 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 115.663 -0.699 . . . . 75.44 111.644 -173.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -121.76 3.99 10.04 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.781 0.832 . . . . 71.13 110.328 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -113.56 139.02 49.34 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.46 -0.571 . . . . 74.53 109.46 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 94.4 m -67.52 113.41 5.33 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.319 0.581 . . . . 64.42 109.97 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.54 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -70.44 -62.03 1.54 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.258 -1.337 . . . . 75.02 108.331 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -150.22 155.04 39.0 Favored 'General case' 0 C--N 1.347 0.491 0 N-CA-C 112.853 0.686 . . . . 74.25 112.853 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 64.8 mt -123.27 110.94 15.84 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.076 -1.453 . . . . 75.44 107.076 171.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.41 ' SG ' HG23 ' B' ' 114' ' ' ILE . 37.8 t -118.46 139.23 51.74 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 108.809 -0.811 . . . . 75.41 108.809 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.638 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 39.6 tt0 -156.72 131.9 9.15 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.589 -0.522 . . . . 72.12 109.589 -172.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.478 HG22 HD12 ' B' ' 21' ' ' ILE . 98.3 t -128.15 147.91 32.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 123.715 0.806 . . . . 72.33 109.183 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -110.92 103.72 12.25 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.305 -1.368 . . . . 63.12 107.305 165.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.479 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 7.8 tp-100 -92.96 98.99 11.71 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.387 -1.338 . . . . 73.22 107.387 173.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -96.01 171.31 28.42 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.732 -1.122 . . . . 63.33 110.662 173.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.51 137.11 4.18 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 111.275 -0.73 . . . . 32.11 111.275 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 45.4 mt -84.18 127.14 40.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 107.596 -1.261 . . . . 73.14 107.596 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -136.49 142.69 43.54 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.956 0.902 . . . . 75.31 109.159 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 27.3 m -89.13 113.46 24.63 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.03 -1.1 . . . . 45.34 108.03 168.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.494 HD13 ' SG ' ' B' ' 97' ' ' CYS . 0.4 OUTLIER -130.27 107.83 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.329 1.052 . . . . 70.21 108.322 -176.624 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' B' ' 9' ' ' MET . . . -156.65 171.89 19.54 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.54 1.136 . . . . 75.41 110.286 -177.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.75 -57.18 1.13 Allowed Glycine 0 C--N 1.346 1.094 0 N-CA-C 112.444 -0.262 . . . . 53.42 112.444 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.645 HG12 ' HB3' ' B' ' 9' ' ' MET . 4.2 mm -83.01 156.31 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.216 0.607 . . . . 74.25 110.394 175.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -152.34 -173.31 4.51 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.195 -0.912 . . . . 74.22 110.665 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.71 -120.46 8.15 Favored Glycine 0 C--N 1.351 1.392 0 CA-C-N 115.607 -0.724 . . . . 54.42 113.289 170.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.8 m -83.48 -37.48 23.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.513 0.673 . . . . 75.15 110.643 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -72.61 -23.17 60.9 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.96 -1.018 . . . . 70.4 111.462 -167.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -71.46 -29.8 65.28 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.028 0.531 . . . . 72.0 111.09 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.64 -37.47 78.78 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.481 0.712 . . . . 70.45 110.692 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -75.15 -30.63 60.81 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.355 -0.839 . . . . 62.53 111.321 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.494 ' SG ' HD13 ' B' ' 86' ' ' ILE . 46.1 t -69.41 -66.7 0.55 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 122.296 0.238 . . . . 73.32 111.544 -174.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.471 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.0 pt? -88.32 -3.59 58.82 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.263 -0.898 . . . . 72.31 111.393 -178.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.79 -4.47 59.0 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-O 119.824 -0.431 . . . . 65.52 114.114 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.646 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -148.46 -50.0 0.16 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 117.576 0.688 . . . . 75.33 111.493 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.504 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 46.3 t80 -67.84 -47.83 67.88 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.148 0.579 . . . . 73.04 111.617 -175.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.489 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 59.2 m -66.46 -48.18 56.52 Favored Pre-proline 0 N--CA 1.488 1.468 0 CA-C-O 119.056 -0.497 . . . . 61.11 112.208 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.712 ' HB3' HD22 ' B' ' 60' ' ' LEU . 72.3 Cg_exo -55.77 -29.98 74.13 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.293 1.996 . . . . 64.33 114.283 170.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -66.68 -37.09 84.03 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.686 0.795 . . . . 74.13 110.618 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.28 -42.76 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 123.544 0.738 . . . . 75.04 110.169 175.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.416 HD22 ' HG3' ' B' ' 80' ' ' GLN . 78.7 mt -78.88 -17.21 55.97 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.298 -1.319 . . . . 72.24 111.728 -174.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.431 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 71.9 t80 -56.92 -53.91 60.01 Favored Pre-proline 0 CA--C 1.563 1.464 0 C-N-CA 124.365 1.066 . . . . 70.13 113.372 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 35.5 Cg_exo -63.27 -32.8 72.89 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 121.796 1.664 . . . . 74.21 113.292 -178.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -70.98 -44.01 66.87 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.441 0.697 . . . . 65.45 110.815 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -65.97 -36.79 84.29 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.677 0.391 . . . . 73.1 110.344 175.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -55.5 -56.36 21.09 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 124.311 1.007 . . . . 72.02 110.682 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -60.68 -40.24 91.43 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 123.633 0.583 . . . . 61.34 110.501 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.561 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.8 t -66.37 -38.87 88.54 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 123.505 0.503 . . . . 73.05 111.226 -175.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.41 HG23 ' SG ' ' B' ' 76' ' ' CYS . 97.2 mt -64.71 -52.21 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 123.132 0.573 . . . . 74.05 109.765 174.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 32.3 m -60.72 -32.48 71.74 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.784 0.834 . . . . 44.23 111.493 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.465 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.2 m -65.29 -46.58 79.86 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.852 0.461 . . . . 74.01 110.691 175.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.561 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -69.13 -34.4 74.96 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 123.229 0.331 . . . . 73.11 111.099 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.53 -40.91 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.607 0.763 . . . . 72.55 110.437 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -67.32 -37.04 82.68 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 114.95 -1.023 . . . . 50.11 111.561 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.48 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 85.6 mtt-85 -66.99 -36.38 82.03 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.314 -0.857 . . . . 74.3 109.368 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -83.62 11.65 55.33 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 124.278 0.986 . . . . 71.14 113.496 174.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 50.4 p 56.84 19.58 4.58 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 125.839 1.656 . . . . 62.2 114.648 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -78.9 166.64 40.9 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 123.63 0.772 . . . . 74.25 112.063 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.96 160.14 8.34 Favored 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 123.199 2.599 . . . . 64.33 114.059 171.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -65.37 139.27 58.55 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.527 -0.761 . . . . 53.34 112.443 -173.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 51.5 tp -142.07 119.89 11.92 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.583 0.753 . . . . 73.45 109.667 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -127.51 135.48 50.42 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.117 0.967 . . . . 70.01 108.581 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 tt -78.5 124.26 27.94 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 108.743 -0.836 . . . . 74.35 108.743 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.28 141.94 98.23 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.982 0.913 . . . . 71.42 111.993 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.402 ' HG3' HD13 ' D' ' 16' ' ' ILE . 16.4 Cg_exo -65.67 92.76 0.25 Allowed 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.627 2.218 . . . . 54.21 112.709 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.08 120.4 46.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 108.374 -0.973 . . . . 63.54 108.374 172.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -74.44 85.33 2.01 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 108.176 -1.046 . . . . 64.0 108.176 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -69.15 -34.63 75.29 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.109 -1.405 . . . . 72.31 110.765 -173.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 134' ' ' ASP . . . . . 0.646 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 19.0 t70 . . . . . 0 CA--C 1.536 0.423 0 CA-C-N 114.118 -1.401 . . . . 64.33 110.785 175.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.421 ' CE1' ' HE2' ' C' ' 101' ' ' TYR . 1.1 t80 . . . . . 0 C--O 1.238 0.471 0 N-CA-C 108.512 -0.921 . . . . 74.43 108.512 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -143.49 128.93 19.01 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 108.886 -0.783 . . . . 74.21 108.886 171.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 37.8 mt -79.5 118.64 27.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.693 -0.855 . . . . 73.03 108.693 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.495 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 18.1 mm-40 -89.99 -33.07 16.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.996 -1.002 . . . . 45.21 109.635 -175.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -177.96 149.47 0.57 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.676 0.79 . . . . 54.34 109.353 -175.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 93.8 mt -137.25 140.25 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 107.965 -1.124 . . . . 65.04 107.965 174.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.415 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 21.1 p90 -171.04 167.37 7.23 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 120.796 0.331 . . . . 75.45 111.342 -171.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.5 p -95.69 127.97 42.17 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 109.456 -0.572 . . . . 72.42 109.456 175.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.415 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 16.7 mmtp -79.24 -50.13 11.42 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 122.597 1.189 . . . . 71.35 108.391 172.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 16.6 t70 -139.15 144.37 38.59 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 112.597 -2.092 . . . . 75.12 108.468 -167.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.408 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 81.4 mt -138.38 149.35 24.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 106.767 -1.568 . . . . 51.53 106.767 175.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 43.2 t -157.24 150.32 23.67 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.34 0.656 . . . . 65.44 109.412 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.403 ' CE1' ' HA3' ' C' ' 121' ' ' GLY . 86.4 t80 -152.31 134.48 15.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.55 -1.278 . . . . 71.35 107.55 173.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 24' ' ' GLU . . . . . 0.436 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 42.2 mt-10 -133.89 110.85 10.01 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.484 0.713 . . . . 74.31 109.696 -176.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.02 79.11 73.66 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 106.979 -1.489 . . . . 63.14 106.979 163.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.19 -21.52 31.39 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.688 2.259 . . . . 70.11 111.947 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.467 ' ND2' ' HB ' ' C' ' 31' ' ' VAL . 22.9 p-10 -102.38 22.12 13.95 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.586 1.155 . . . . 64.11 110.735 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.59 -58.39 4.51 Favored Pre-proline 0 CA--C 1.562 1.405 0 N-CA-C 114.738 1.385 . . . . 50.23 114.738 -169.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -63.2 -35.64 62.41 Favored 'Trans proline' 0 C--N 1.38 2.236 0 CA-C-N 121.889 1.71 . . . . 75.43 112.169 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -69.82 -37.26 76.17 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.193 0.997 . . . . 73.35 112.247 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.722 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.0 p -80.43 -16.69 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 N-CA-C 113.109 0.781 . . . . 54.44 113.109 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-30 -73.47 -23.14 60.04 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.735 -0.603 . . . . 72.24 111.983 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -90.02 17.93 6.36 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.123 0.569 . . . . 74.54 111.764 175.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -109.45 146.84 33.85 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.922 0.889 . . . . 61.22 110.535 -172.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.51 131.41 49.04 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.679 0.792 . . . . 62.12 110.647 173.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -79.48 89.32 5.04 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.467 0.707 . . . . 70.23 110.421 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 37' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' C' ' 68' ' ' LEU . 18.7 tt0 -138.42 67.08 45.11 Favored Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 124.062 0.945 . . . . 70.31 109.297 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -90.27 140.4 3.22 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.824 2.349 . . . . 64.44 113.316 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -88.74 101.21 13.79 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.832 -1.173 . . . . 73.04 107.832 166.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.56 97.84 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.779 -0.823 . . . . 54.05 108.779 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.53 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 94.0 mttt -97.97 105.11 17.2 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 114.562 -1.199 . . . . 55.21 108.338 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.499 HD11 HD21 ' C' ' 128' ' ' LEU . 2.8 mm? -85.61 139.68 31.22 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.997 -0.742 . . . . 71.32 108.997 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -141.86 106.69 4.9 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.47 -1.307 . . . . 64.23 107.47 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 8.1 mp -109.02 148.28 31.02 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.256 0.551 . . . . 51.52 110.176 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.538 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 14.1 t70 -130.48 145.22 51.8 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.923 1.289 . . . . 74.12 108.896 -174.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 61.7 p -116.71 112.83 21.76 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.984 0.914 . . . . 55.21 110.432 -167.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.26 143.18 39.95 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.102 0.561 . . . . 72.53 110.945 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 22.1 p -160.72 155.61 24.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.245 0.618 . . . . 73.13 110.657 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 90.1 p -143.96 154.07 42.92 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.489 0.715 . . . . 64.52 110.157 -175.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -84.89 123.23 30.25 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.954 0.502 . . . . 73.42 110.29 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.638 HD11 HD12 ' C' ' 83' ' ' ILE . 25.4 mt -100.23 -41.86 6.91 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.946 -0.761 . . . . 54.23 108.946 172.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.35 -172.68 4.31 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.304 1.041 . . . . 74.13 109.611 177.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.75 117.1 11.83 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.225 -0.898 . . . . 65.51 109.498 173.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 71.95 -5.91 1.6 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.937 1.295 . . . . 64.13 112.78 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 92.2 t -105.9 107.6 23.04 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.396 -0.964 . . . . 74.44 108.396 174.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -127.41 141.3 51.72 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.715 0.806 . . . . 75.34 109.131 -175.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.456 ' HB2' HD11 ' C' ' 51' ' ' LEU . 16.9 tt0 -83.2 111.52 19.01 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.103 -1.408 . . . . 72.23 108.826 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 92.0 t -97.03 119.46 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 108.789 -0.819 . . . . 51.33 108.789 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 33.3 t -123.75 118.21 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.517 0.727 . . . . 70.34 110.477 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 50.0 tp -105.34 110.81 23.31 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.269 -1.011 . . . . 73.02 108.269 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.538 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 0.3 OUTLIER -91.91 107.09 18.96 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.417 -0.586 . . . . 72.21 109.417 178.23 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.08 131.63 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.3 -1.0 . . . . 61.35 108.3 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 26.7 m -127.77 117.82 22.6 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.919 -0.771 . . . . 61.21 108.919 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.56 HG21 HG21 ' C' ' 114' ' ' ILE . 61.1 t -102.27 114.58 42.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 115.106 -0.952 . . . . 62.15 109.139 -177.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 27.8 m -98.01 137.11 37.3 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.008 -1.108 . . . . 74.03 108.008 170.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.18 109.5 6.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.235 -1.394 . . . . 64.3 107.235 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 62.6 m -131.38 128.63 40.0 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.013 0.435 . . . . 54.34 110.531 -176.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' C' ' 37' ' ' GLN . 10.4 mt -85.51 42.6 0.97 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.303 1.441 . . . . 74.44 110.916 -174.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.48 -89.54 0.54 Allowed Glycine 0 C--N 1.348 1.208 0 N-CA-C 110.898 -0.881 . . . . 72.42 110.898 -173.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.9 -25.58 5.8 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.247 1.019 . . . . 61.55 109.544 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -76.37 120.98 22.35 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.107 1.363 . . . . 75.11 109.157 169.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 85.1 m -75.4 126.71 31.57 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.761 0.71 . . . . 34.14 109.422 171.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.722 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.31 -58.91 3.23 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.13 -0.692 . . . . 63.0 109.13 173.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 74' ' ' PHE . . . . . 0.451 ' HZ ' ' HG ' ' C' ' 126' ' ' LEU . 34.8 p90 -159.36 169.86 23.07 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.601 -1.181 . . . . 55.21 111.19 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.436 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.0 tm? -130.03 145.99 51.69 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 105.381 -2.081 . . . . 70.43 105.381 169.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.421 ' N ' HD13 ' C' ' 75' ' ' LEU . 46.2 t -144.74 148.91 34.7 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.929 -1.138 . . . . 61.34 107.929 176.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -158.36 124.76 4.71 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 120.695 0.283 . . . . 72.21 110.628 -173.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 90.0 t -133.97 134.11 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.939 0.896 . . . . 70.34 109.139 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -101.31 93.37 5.39 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.354 -0.98 . . . . 63.11 108.354 170.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -81.53 101.49 9.98 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.393 -0.595 . . . . 71.11 109.393 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.16 169.43 45.93 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 115.797 -0.638 . . . . 63.42 112.472 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.51 126.9 1.08 Allowed Glycine 0 C--O 1.237 0.3 0 N-CA-C 111.452 -0.659 . . . . 64.42 111.452 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.638 HD12 HD11 ' C' ' 51' ' ' LEU . 10.7 mm -85.12 121.28 36.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 108.82 -0.808 . . . . 42.43 108.82 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -131.96 139.91 48.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.371 0.669 . . . . 70.52 109.317 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 16.9 p -92.39 114.51 27.08 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 109.19 -0.67 . . . . 70.53 109.19 170.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.39 104.55 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.405 -0.961 . . . . 72.31 108.405 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.01 165.89 25.94 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.845 0.858 . . . . 44.53 110.197 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.9 -59.72 2.07 Favored Glycine 0 C--N 1.344 1.004 0 O-C-N 123.242 0.339 . . . . 74.52 113.351 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 30.5 pt -81.09 162.65 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 122.923 0.489 . . . . 74.44 110.086 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -147.82 174.24 12.03 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.844 0.458 . . . . 72.04 111.191 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.11 -132.41 50.76 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.909 0.756 . . . . 43.14 114.022 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.0 p -64.17 -21.93 66.75 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.788 0.835 . . . . 64.13 112.259 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -65.29 -54.51 28.12 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.507 0.723 . . . . 73.13 110.629 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 10.2 ptp -72.17 -28.16 63.05 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 116.208 -0.451 . . . . 74.14 110.746 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.9 -32.83 74.56 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.226 0.611 . . . . 72.03 110.912 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -79.36 -32.08 43.12 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.592 -0.731 . . . . 71.51 110.795 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -59.84 -48.15 82.85 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.393 0.677 . . . . 74.03 111.29 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.24 -20.07 24.6 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.595 0.358 . . . . 75.32 111.633 176.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.49 -29.68 39.18 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 115.064 0.786 . . . . 30.32 115.064 -172.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.88 -39.6 0.3 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.835 0.826 . . . . 63.02 111.265 -172.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.421 ' HE2' ' CE1' ' C' ' 11' ' ' PHE . 67.3 t80 -74.28 -41.03 61.89 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 113.792 -1.549 . . . . 75.34 112.801 -174.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 90.4 m -76.53 -39.45 2.44 Favored Pre-proline 0 N--CA 1.486 1.325 0 CA-C-O 118.959 -0.544 . . . . 75.42 111.938 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -45.55 -35.76 12.92 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.739 2.292 . . . . 75.44 114.652 163.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -66.13 -40.3 90.53 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.237 0.615 . . . . 74.42 110.205 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.515 HD12 ' NH1' ' A' ' 111' ' ' ARG . 45.5 mm -64.81 -40.56 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.142 0.577 . . . . 75.04 110.159 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 91.6 mt -89.06 -8.09 54.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.905 0.882 . . . . 74.31 112.244 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -59.77 -52.21 75.39 Favored Pre-proline 0 N--CA 1.484 1.257 0 C-N-CA 123.883 0.873 . . . . 72.01 113.165 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.41 -30.14 36.84 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 121.614 1.542 . . . . 75.41 112.969 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -70.46 -48.77 54.26 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.184 0.594 . . . . 75.45 110.624 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.25 -41.67 93.7 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.154 -0.93 . . . . 70.11 109.969 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -55.8 -52.22 64.74 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.261 0.976 . . . . 75.2 110.996 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -67.47 -30.12 69.74 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.035 0.534 . . . . 70.4 110.641 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.2 t -74.34 -32.22 62.72 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.071 0.549 . . . . 72.1 111.179 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.56 HG21 HG21 ' C' ' 64' ' ' VAL . 96.1 mt -75.71 -51.64 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.208 0.603 . . . . 75.32 109.995 176.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 12.1 m -63.96 -31.17 72.26 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 123.347 0.659 . . . . 73.42 110.893 -173.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 40.2 t -58.08 -55.25 37.33 Favored 'General case' 0 C--N 1.351 0.63 0 CA-C-N 115.494 -0.775 . . . . 73.2 109.302 169.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.443 ' HG3' HD12 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.43 -36.57 76.15 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.746 1.218 . . . . 70.44 113.138 -179.304 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.45 HG23 ' O ' ' C' ' 114' ' ' ILE . 91.4 t -62.9 -49.46 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.312 0.645 . . . . 74.25 109.798 176.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 42.7 t -71.83 -25.75 62.1 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.03 -0.986 . . . . 45.32 111.656 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 -70.24 -40.56 74.39 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.362 0.665 . . . . 72.34 109.463 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 121' ' ' GLY . . . . . 0.403 ' HA3' ' CE1' ' C' ' 23' ' ' PHE . . . -82.14 8.18 61.47 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.871 0.732 . . . . 74.52 112.915 173.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 82.7 p 54.9 63.7 2.05 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.975 1.71 . . . . 75.35 113.087 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -120.94 155.86 57.2 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 124.321 1.048 . . . . 75.3 108.41 169.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -55.76 161.63 7.83 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.335 2.69 . . . . 73.43 113.891 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -55.1 113.14 1.25 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.424 -0.807 . . . . 61.21 112.406 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.451 ' HG ' ' HZ ' ' C' ' 74' ' ' PHE . 2.4 tm? -117.75 90.16 3.27 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.534 -1.284 . . . . 72.2 107.534 -175.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -114.38 132.66 56.14 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.719 0.807 . . . . 71.01 108.995 176.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.499 HD21 HD11 ' C' ' 42' ' ' LEU . 96.2 mt -69.75 144.28 52.78 Favored 'General case' 0 C--O 1.246 0.871 0 O-C-N 123.682 0.614 . . . . 73.34 111.113 176.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.79 148.52 98.19 Favored Pre-proline 0 C--N 1.351 0.669 0 O-C-N 124.006 0.816 . . . . 55.13 109.849 172.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.491 ' HB2' HD12 ' A' ' 13' ' ' ILE . 31.1 Cg_exo -61.64 87.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.51 2.14 . . . . 64.43 113.199 177.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 95.0 t -104.41 107.71 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.371 -0.831 . . . . 72.04 108.923 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -83.46 106.55 15.3 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.076 -1.083 . . . . 63.11 108.076 171.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -48.44 -38.54 20.05 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.843 1.34 . . . . 70.2 113.035 -174.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t70 . . . . . 0 N--CA 1.485 1.289 0 C-N-CA 123.587 0.755 . . . . 61.41 111.25 177.541 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 36.2 m . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 107.349 -1.352 . . . . 74.31 107.349 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -162.76 89.51 0.66 Allowed 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.798 -0.815 . . . . 71.12 108.798 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -113.81 114.98 27.04 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.568 -1.271 . . . . 72.31 107.568 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mt -82.11 115.97 25.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 108.347 -0.983 . . . . 65.25 108.347 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -75.62 -44.2 44.07 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 123.27 0.356 . . . . 74.44 111.224 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.409 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 22.0 ttt180 -166.87 136.4 2.95 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.072 0.397 . . . . 64.15 112.072 -162.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.402 HD13 ' HG3' ' B' ' 130' ' ' PRO . 1.8 mp -115.31 137.5 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 107.92 -1.141 . . . . 73.04 107.92 171.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.409 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 30.6 p90 -159.74 172.24 18.07 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.201 1.001 . . . . 73.14 112.209 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.9 p -113.69 121.91 45.54 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.179 -1.373 . . . . 74.13 108.751 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -90.7 -22.15 21.27 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.048 -0.524 . . . . 53.22 109.75 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -156.85 128.82 7.26 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 114.719 -1.128 . . . . 74.25 108.325 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.443 HD12 ' HG3' ' C' ' 117' ' ' MET . 12.2 mt -128.68 150.47 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 107.866 -1.161 . . . . 73.3 107.866 174.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -154.79 146.16 23.0 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.837 0.827 . . . . 72.34 110.555 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 88.4 t80 -146.15 141.32 27.38 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 105.894 -1.891 . . . . 73.2 105.894 171.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.512 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.1 mt-10 -142.11 143.48 33.06 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.355 -0.979 . . . . 72.14 108.355 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.4 88.08 5.85 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 107.912 -1.144 . . . . 71.44 107.912 173.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.86 -17.4 13.9 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.975 2.45 . . . . 73.15 113.37 -176.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -113.84 12.88 18.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.436 1.095 . . . . 72.33 110.941 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.449 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -38.18 -67.55 0.25 Allowed Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 126.957 2.103 . . . . 54.43 116.492 -160.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.453 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 74.2 Cg_endo -71.86 -26.79 18.54 Favored 'Trans proline' 0 C--N 1.382 2.3 0 CA-C-N 123.22 2.186 . . . . 75.24 114.368 -171.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -86.45 -25.03 25.42 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 117.755 0.252 . . . . 73.42 110.568 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.638 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.5 p -82.14 -16.0 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 122.78 0.432 . . . . 74.25 111.013 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.453 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.3 m-85 -65.24 -22.83 66.92 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.105 0.409 . . . . 73.51 112.105 177.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -65.14 -15.03 61.96 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.036 0.935 . . . . 64.43 111.385 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -94.9 86.53 4.7 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.057 0.943 . . . . 75.34 110.064 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -87.47 90.86 8.53 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.701 -0.681 . . . . 74.43 109.785 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 42.3 p90 -164.76 175.72 9.43 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.022 0.929 . . . . 72.33 109.197 167.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -73.16 111.56 12.1 Favored Pre-proline 0 N--CA 1.474 0.762 0 N-CA-C 109.178 -0.675 . . . . 45.25 109.178 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -62.77 151.52 83.5 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.574 2.182 . . . . 73.44 111.771 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 56.6 mm-40 -62.77 111.67 2.21 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.018 -1.104 . . . . 65.23 108.018 169.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.771 HG13 HG13 ' D' ' 64' ' ' VAL . 57.8 t -104.68 105.19 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.687 0.795 . . . . 73.44 108.92 -175.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -86.72 129.14 34.99 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.69 -0.856 . . . . 74.4 108.69 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -97.68 110.66 23.18 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.696 -1.224 . . . . 70.4 107.696 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.516 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 10.3 t70 -116.31 130.13 56.62 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.081 -1.451 . . . . 60.31 107.081 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.6 mt -122.29 140.27 52.83 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.142 0.496 . . . . 60.11 111.104 -171.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.55 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 11.7 t70 -136.49 139.48 42.34 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.851 1.26 . . . . 63.2 108.112 174.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 45.4 p -104.03 144.75 31.12 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.361 0.664 . . . . 54.44 110.316 -174.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.413 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -160.7 157.32 26.85 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.46 0.704 . . . . 70.14 110.07 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 32.7 p -175.84 167.96 3.06 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.244 0.545 . . . . 71.34 112.178 -178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 62.5 p -156.63 126.65 6.41 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.002 -0.999 . . . . 75.21 108.471 169.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -74.24 121.09 20.73 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.422 -0.584 . . . . 74.04 109.422 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 46.8 mt -90.09 -25.5 20.72 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.273 0.629 . . . . 74.31 110.86 -172.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -172.53 -173.54 1.05 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.028 1.331 . . . . 63.02 109.56 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.87 120.49 12.65 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.886 -0.413 . . . . 73.51 109.886 176.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 69.57 -2.88 1.79 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.964 1.305 . . . . 65.53 112.595 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 97.4 t -110.92 120.06 60.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.432 -1.321 . . . . 74.24 107.432 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -150.36 142.39 23.97 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.385 0.612 . . . . 63.13 109.742 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -88.66 122.69 32.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.166 -1.379 . . . . 73.44 109.3 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 96.0 t -100.48 119.17 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 107.879 -1.156 . . . . 71.11 107.879 173.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.413 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 38.7 t -106.84 131.33 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.316 -0.994 . . . . 55.31 108.316 173.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 15.8 tp -128.58 120.1 26.03 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 109.307 -0.627 . . . . 72.13 109.307 174.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.55 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 28.3 ttm-85 -82.62 99.09 9.35 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.555 -0.906 . . . . 72.11 108.555 177.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 77.1 t -91.25 117.55 34.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.987 -1.116 . . . . 73.21 107.987 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 28.7 m -117.01 135.38 53.74 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.478 -0.564 . . . . 74.13 109.478 -176.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.771 HG13 HG13 ' D' ' 40' ' ' VAL . 41.2 t -128.23 101.21 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.927 1.291 . . . . 74.52 108.684 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 92.8 m -93.04 116.74 29.33 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 107.878 -1.156 . . . . 73.12 107.878 172.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -106.02 133.96 49.9 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.604 -0.517 . . . . 72.21 109.604 -177.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 18.2 m -128.22 123.04 33.24 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.534 -0.543 . . . . 63.44 109.534 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 31.0 mt -108.9 113.22 25.94 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.693 -1.225 . . . . 73.01 107.693 173.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.78 -133.64 21.22 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 123.467 0.479 . . . . 31.3 112.871 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.76 6.82 39.89 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.718 0.807 . . . . 75.11 111.663 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -140.83 174.93 10.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.153 0.502 . . . . 55.45 111.482 -172.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 32.7 m -73.72 135.44 43.64 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.484 1.114 . . . . 73.22 111.322 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.638 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -86.35 -65.27 1.03 Allowed 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.024 -0.732 . . . . 60.33 109.024 168.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -150.36 151.98 33.69 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.593 -1.185 . . . . 75.15 110.894 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 60.9 mt -110.86 109.84 20.19 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.883 -1.155 . . . . 74.04 107.883 171.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.468 ' SG ' HG23 ' D' ' 114' ' ' ILE . 48.1 t -116.9 142.14 47.32 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.607 0.763 . . . . 72.4 109.191 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -157.01 142.68 17.61 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.0 0.52 . . . . 75.15 109.793 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 77.7 t -138.89 139.33 40.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 108.173 -1.047 . . . . 73.05 108.173 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -110.58 87.1 2.45 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 107.3 -1.37 . . . . 75.34 107.3 173.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -80.1 99.53 7.77 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.258 -1.337 . . . . 63.41 109.398 -171.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.29 142.78 16.14 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 110.88 -0.888 . . . . 61.43 110.88 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.11 132.71 4.19 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 111.657 -0.577 . . . . 45.04 111.657 -177.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 60.2 mt -87.94 120.39 36.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 109.236 -0.653 . . . . 33.31 109.236 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -121.15 133.14 55.19 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.179 0.591 . . . . 73.1 109.929 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.9 m -111.37 92.99 4.25 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.747 -0.834 . . . . 54.33 108.747 175.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.47 HD11 HD12 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -123.19 142.71 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.103 0.961 . . . . 75.21 108.622 -176.718 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.99 160.62 39.52 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 122.967 0.507 . . . . 44.25 111.342 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.62 21.07 52.52 Favored Glycine 0 C--N 1.34 0.759 0 CA-C-N 114.572 -1.195 . . . . 75.44 114.414 171.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.47 HD12 HD11 ' D' ' 86' ' ' ILE . 33.2 mt -134.04 127.88 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 117.287 0.543 . . . . 75.34 109.665 176.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -140.96 171.85 13.49 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.942 0.897 . . . . 62.34 111.097 -171.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.97 -118.77 13.93 Favored Glycine 0 C--N 1.354 1.565 0 CA-C-N 114.944 -1.025 . . . . 63.55 114.861 172.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 20.4 m -86.94 -28.18 22.88 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.343 0.657 . . . . 54.03 111.046 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -68.36 -34.06 75.4 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.78 -0.646 . . . . 54.51 111.025 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -23.3 62.8 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 116.039 -0.528 . . . . 74.12 111.164 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.26 -26.95 68.68 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.86 0.464 . . . . 73.35 110.926 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -78.62 -40.73 33.52 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.843 0.857 . . . . 65.44 111.396 174.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -65.51 -43.97 88.41 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.907 0.483 . . . . 65.2 110.585 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 8.7 mp -67.54 -53.17 30.73 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.365 1.066 . . . . 55.12 109.981 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.81 -3.63 68.5 Favored Glycine 0 C--N 1.342 0.887 0 N-CA-C 115.057 0.783 . . . . 74.41 115.057 -171.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.13 -65.57 0.27 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.046 0.923 . . . . 65.35 112.906 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -61.91 -58.76 6.7 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.955 0.724 . . . . 73.31 112.955 -162.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 75.3 m -63.54 -44.79 82.41 Favored Pre-proline 0 CA--C 1.567 1.626 0 N-CA-C 113.923 1.083 . . . . 74.22 113.923 -175.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.73 -25.49 39.82 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 121.7 1.6 . . . . 73.53 113.132 172.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 104' ' ' ASN . . . . . 0.565 ' HA ' ' HD2' ' D' ' 107' ' ' PHE . 2.4 t-20 -69.47 -28.7 66.31 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.845 0.458 . . . . 62.13 110.75 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 51.6 mm -65.07 -35.27 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.402 0.681 . . . . 50.42 110.109 171.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.95 -19.04 48.89 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.587 -0.733 . . . . 71.1 112.619 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 107' ' ' PHE . . . . . 0.565 ' HD2' ' HA ' ' D' ' 104' ' ' ASN . 27.9 m-85 -60.9 -44.36 94.51 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 113.724 1.009 . . . . 71.1 113.724 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -51.14 -44.99 39.38 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 122.519 2.146 . . . . 73.32 114.329 170.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -77.16 -31.66 55.69 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.376 0.67 . . . . 75.13 111.897 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.14 -48.95 71.74 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.075 -0.713 . . . . 52.41 109.075 175.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -54.61 -47.15 73.76 Favored 'General case' 0 C--N 1.352 0.682 0 O-C-N 124.855 1.347 . . . . 74.32 110.937 177.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.35 -46.81 87.0 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.399 0.679 . . . . 72.4 111.311 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 36.4 t -62.05 -42.78 99.54 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.407 0.442 . . . . 71.24 111.238 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.468 HG23 ' SG ' ' D' ' 76' ' ' CYS . 96.9 mt -61.31 -58.3 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.119 0.967 . . . . 61.01 111.114 175.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 89.4 m -55.92 -40.77 73.56 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.569 1.148 . . . . 63.23 112.068 -173.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 44.7 t -65.04 -42.16 94.54 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.573 -0.739 . . . . 75.54 110.707 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.1 mtm -68.46 -31.69 71.17 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.811 0.444 . . . . 73.33 111.452 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.43 HG23 ' O ' ' D' ' 114' ' ' ILE . 73.6 t -63.43 -44.65 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 123.525 0.73 . . . . 64.3 110.373 174.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.7 p -77.77 -25.83 49.37 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.056 -0.52 . . . . 74.14 111.572 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -71.64 -36.27 70.67 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.316 0.647 . . . . 53.23 109.6 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.95 0.24 73.13 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.36 -0.837 . . . . 70.13 112.509 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.6 p 61.37 25.29 15.27 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.642 1.977 . . . . 72.22 113.405 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -80.37 164.13 53.53 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.266 1.027 . . . . 62.43 109.717 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.4 129.82 29.64 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.109 1.873 . . . . 72.55 111.423 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -51.32 123.64 10.09 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.402 1.081 . . . . 62.45 111.577 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -116.41 96.73 5.66 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.98 -1.118 . . . . 41.2 107.98 -174.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -98.66 117.89 34.14 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.897 -0.779 . . . . 74.31 108.897 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 6.4 mp -73.97 113.47 11.18 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 109.686 -0.487 . . . . 73.53 109.686 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -54.51 134.62 62.96 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 124.154 0.982 . . . . 74.21 110.953 176.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.504 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 2.8 Cg_exo -72.94 144.64 38.73 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.875 2.383 . . . . 73.24 111.756 -171.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--O 1.24 0.589 0 C-N-CA 123.643 0.777 . . . . 74.11 109.357 -177.358 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.589 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 26.6 t80 . . . . . 0 C--O 1.235 0.338 0 N-CA-C 109.334 -0.617 . . . . 74.13 109.334 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -143.33 119.58 10.84 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.701 0.8 . . . . 71.4 108.859 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.622 HG12 ' HD2' ' A' ' 84' ' ' PHE . 49.5 mt -80.2 124.6 38.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.513 -0.551 . . . . 74.52 109.513 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.23 -42.28 13.92 Favored 'General case' 0 C--O 1.245 0.848 0 O-C-N 123.993 0.808 . . . . 73.14 109.36 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -173.43 122.36 0.36 Allowed 'General case' 0 N--CA 1.483 1.185 0 O-C-N 123.081 0.238 . . . . 73.44 111.477 -168.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.416 HD11 HD13 ' A' ' 13' ' ' ILE . 94.8 mt -113.79 138.53 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.99 0.916 . . . . 65.33 109.26 175.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HB3' HG23 ' B' ' 122' ' ' THR . 32.3 p90 -167.3 166.69 14.54 Favored 'General case' 0 C--N 1.347 0.496 0 O-C-N 123.902 0.751 . . . . 72.31 111.511 -173.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -89.24 127.29 35.75 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.116 -0.698 . . . . 74.51 109.116 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.402 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 33.6 mtpt -96.52 -21.88 17.43 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 120.913 0.387 . . . . 61.52 109.958 176.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.739 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.0 t70 -152.16 141.27 21.29 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 114.7 -1.136 . . . . 75.01 109.588 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 82.6 mt -141.51 138.29 32.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 106.556 -1.646 . . . . 73.43 106.556 175.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.5 t -144.66 128.32 17.17 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.55 -0.907 . . . . 72.35 108.55 174.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.519 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 87.4 t80 -138.48 124.84 20.49 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.164 -1.421 . . . . 72.24 107.164 175.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -125.59 142.68 51.38 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.915 -0.772 . . . . 64.22 108.915 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.33 71.53 39.15 Favored Pre-proline 0 C--O 1.243 0.755 0 N-CA-C 105.83 -1.915 . . . . 72.44 105.83 168.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.53 -15.16 34.18 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.39 2.06 . . . . 73.22 112.181 -170.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -117.18 21.6 13.07 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 118.169 -0.92 . . . . 73.0 109.495 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.413 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -45.37 -59.17 4.72 Favored Pre-proline 0 N--CA 1.495 1.804 0 CA-C-O 117.998 -1.001 . . . . 61.12 113.329 -171.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -72.16 -9.44 24.46 Favored 'Trans proline' 0 C--N 1.381 2.288 0 CA-C-N 121.629 1.617 . . . . 64.43 112.783 -176.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -90.31 -39.46 12.71 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.858 0.863 . . . . 75.44 110.251 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.859 HG21 ' HA ' ' A' ' 73' ' ' ALA . 6.5 p -79.21 -23.17 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 114.906 -1.043 . . . . 73.31 112.059 -162.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -67.48 -21.12 65.53 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.094 0.558 . . . . 74.22 110.928 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -74.46 -39.23 62.66 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.141 0.976 . . . . 74.13 110.307 173.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.511 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 3.3 tmtp? -69.01 143.35 54.37 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.71 1.204 . . . . 72.01 110.374 -169.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.511 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 12.9 m-20 -57.82 121.5 10.62 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.098 0.959 . . . . 74.14 110.843 175.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -77.7 90.66 4.0 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.191 0.597 . . . . 73.21 110.691 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.403 ' H ' HD22 ' A' ' 68' ' ' LEU . 40.6 tt0 -125.81 82.05 64.7 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 107.582 -1.266 . . . . 74.4 107.582 168.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.0 118.86 4.52 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.327 2.018 . . . . 52.12 112.836 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -95.79 94.67 7.8 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.512 -1.292 . . . . 71.55 107.512 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.433 HG13 HG13 ' A' ' 64' ' ' VAL . 44.0 t -67.7 101.21 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 114.622 -1.172 . . . . 75.23 109.594 -177.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.23 115.76 19.96 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.535 1.134 . . . . 74.43 109.221 175.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -96.8 134.99 39.39 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.123 -0.695 . . . . 74.42 109.123 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.628 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 27.5 t70 -145.07 107.53 4.4 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.31 -0.996 . . . . 55.31 108.31 172.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.64 132.3 48.84 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.957 -0.757 . . . . 74.53 108.957 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.667 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 16.2 t70 -129.72 132.54 46.65 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.876 -0.787 . . . . 75.52 108.876 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.4 p -108.01 137.72 45.52 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.815 0.846 . . . . 61.53 110.158 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.57 139.28 18.84 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.745 0.818 . . . . 73.43 110.066 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.7 m -132.53 156.03 47.55 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.844 0.457 . . . . 73.13 110.472 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.3 t -148.8 118.12 6.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.149 0.979 . . . . 74.34 108.739 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 46.5 tt0 -76.93 122.53 25.0 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.95 -0.759 . . . . 64.13 108.95 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 57' ' ' GLU . 75.7 mt -95.11 -31.72 13.43 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.528 0.731 . . . . 43.04 111.774 -172.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.52 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -155.8 -179.45 8.13 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.454 0.701 . . . . 73.34 110.008 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -65.88 117.7 8.63 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.901 -0.777 . . . . 64.24 108.901 172.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 65.96 18.24 11.01 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.828 1.251 . . . . 71.42 112.083 -178.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 58.4 t -126.22 121.94 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 108.391 -0.966 . . . . 64.34 108.391 174.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -129.02 172.29 11.53 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.259 0.552 . . . . 72.54 109.584 174.049 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.407 ' HB2' HD11 ' A' ' 51' ' ' LEU . 35.7 tt0 -127.55 132.5 49.87 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.135 -0.938 . . . . 71.23 108.62 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.547 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 77.0 t -107.28 119.8 57.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 107.474 -1.306 . . . . 61.45 107.474 173.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.2 t -115.74 129.35 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 108.813 -0.81 . . . . 73.33 108.813 174.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tt -128.21 116.58 20.11 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.582 -0.896 . . . . 70.35 108.582 -176.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.667 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 15.6 ttm180 -84.34 106.06 15.66 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.43 1.092 . . . . 71.33 109.433 176.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.6 t -98.74 101.38 12.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 107.581 -1.266 . . . . 65.02 107.581 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 21.1 m -98.28 107.08 19.46 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.622 0.769 . . . . 71.53 109.076 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.433 HG13 HG13 ' A' ' 40' ' ' VAL . 8.2 t -113.38 109.1 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.231 1.012 . . . . 71.12 109.456 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -104.09 130.88 51.82 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 108.044 -1.095 . . . . 74.14 108.044 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.1 109.95 21.79 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.006 -1.479 . . . . 74.51 107.006 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.7 m -114.06 125.13 53.63 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.135 0.493 . . . . 41.12 110.019 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.403 HD22 ' H ' ' A' ' 37' ' ' GLN . 25.9 mt -93.36 76.14 4.51 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 107.896 -1.149 . . . . 71.45 107.896 176.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.38 -84.67 0.95 Allowed Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.414 -0.674 . . . . 64.23 111.414 -175.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -123.46 -25.28 4.42 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.29 1.036 . . . . 74.22 110.124 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -79.05 107.72 12.01 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.511 0.724 . . . . 73.11 109.98 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.5 m -66.14 130.68 44.08 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.113 0.483 . . . . 73.43 110.386 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.859 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -81.89 -58.96 2.75 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.16 -0.927 . . . . 53.14 109.179 175.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -154.99 169.01 25.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 114.396 -1.275 . . . . 75.33 110.945 176.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 23.8 tp -128.13 132.0 48.96 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.857 -1.535 . . . . 73.22 106.857 169.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.422 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 65.3 m -132.96 95.72 3.62 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.606 -0.887 . . . . 42.22 108.606 176.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -111.92 114.63 27.66 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.49 -0.929 . . . . 74.34 108.49 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -124.67 131.98 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 109.435 -0.579 . . . . 64.03 109.435 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.739 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 51.3 mt-30 -103.61 99.09 8.88 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.411 -0.588 . . . . 55.43 109.411 170.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -85.22 114.36 22.27 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.917 -1.038 . . . . 73.04 109.527 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.12 146.71 17.51 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.816 -0.514 . . . . 71.1 111.816 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.579 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -143.29 123.33 2.07 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 112.079 -0.408 . . . . 63.42 112.079 176.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.2 mt -81.98 124.29 38.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.752 -0.833 . . . . 73.12 108.752 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.622 ' HD2' HG12 ' A' ' 13' ' ' ILE . 18.9 m-85 -135.08 135.73 41.45 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.085 -0.709 . . . . 75.03 109.085 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.8 t -99.82 116.02 30.91 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.777 -0.823 . . . . 64.23 108.777 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.581 HD13 ' H ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.95 0 C-N-CA 124.639 1.176 . . . . 74.0 110.155 -173.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.619 0.247 . . . . 62.12 111.227 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -68.98 -31.86 71.02 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 116.044 -0.525 . . . . 73.15 110.634 173.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 42.0 t -68.65 -55.22 12.21 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.891 0.477 . . . . 54.44 110.742 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 pp -76.39 -16.7 59.66 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.42 0.526 . . . . 71.4 112.42 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.48 -7.24 46.06 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-O 119.465 -0.631 . . . . 64.43 114.57 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -144.01 -61.96 0.39 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 117.594 0.697 . . . . 53.44 110.891 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.426 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 70.7 t80 -62.08 -66.06 0.6 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.468 1.107 . . . . 65.14 113.581 -169.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.4 m -64.37 -38.24 31.69 Favored Pre-proline 0 CA--C 1.566 1.594 0 N-CA-C 113.741 1.015 . . . . 74.12 113.741 -175.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -65.3 -27.1 55.79 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 121.672 1.581 . . . . 73.43 113.769 167.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -72.41 -28.53 63.04 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 122.952 0.501 . . . . 72.4 109.744 176.597 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.505 HG21 ' CD1' ' A' ' 13' ' ' ILE . 49.2 mm -61.92 -40.41 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.457 0.703 . . . . 54.51 109.716 171.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.579 HD21 ' HA3' ' A' ' 82' ' ' GLY . 95.5 mt -77.41 -25.38 50.71 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.386 -0.825 . . . . 71.32 112.239 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -57.2 -45.06 99.96 Favored Pre-proline 0 CA--C 1.57 1.742 0 N-CA-C 113.683 0.994 . . . . 72.41 113.683 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -60.48 -31.63 92.71 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.245 1.963 . . . . 74.43 113.368 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -77.04 -35.63 56.73 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.297 0.639 . . . . 74.21 111.786 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.66 -38.81 84.3 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.478 -0.564 . . . . 62.41 109.478 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.469 HH12 HD12 ' C' ' 105' ' ' ILE . 37.7 ttm180 -64.35 -42.3 96.3 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.675 -1.148 . . . . 74.13 110.549 173.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -53.1 -51.68 61.07 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.142 0.977 . . . . 73.31 110.75 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 30.3 t -66.77 -47.82 71.0 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.569 -1.196 . . . . 61.21 111.173 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.84 -54.69 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.426 0.69 . . . . 62.45 111.041 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.0 m -55.91 -38.62 70.49 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.945 0.898 . . . . 54.25 111.723 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.0 t -65.69 -45.54 82.42 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.03 -0.532 . . . . 71.52 110.221 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.6 mtp -63.03 -39.92 96.18 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.009 0.924 . . . . 72.33 111.927 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.7 t -61.9 -45.65 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.935 0.894 . . . . 60.42 110.501 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.9 t -67.24 -37.89 84.3 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.242 -0.89 . . . . 62.02 111.415 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.498 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 83.6 mtt-85 -70.79 -27.72 64.11 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.34 0.656 . . . . 73.33 110.455 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.55 14.18 47.99 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-O 119.227 -0.763 . . . . 64.51 113.278 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.4 t 58.31 16.47 4.05 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 127.059 2.144 . . . . 72.43 113.47 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -82.53 150.83 64.1 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.471 0.708 . . . . 73.11 110.363 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -55.39 153.6 27.48 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.248 2.632 . . . . 74.12 113.548 174.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.406 HE21 HG21 ' D' ' 122' ' ' THR . 6.0 tp-100 -59.97 132.2 53.21 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.327 1.051 . . . . 73.14 112.552 -171.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.1 tp -131.64 110.42 10.91 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.575 1.15 . . . . 61.24 109.432 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -127.13 114.71 18.08 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 108.401 -0.963 . . . . 73.13 108.401 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.2 mp -67.17 148.85 51.27 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.82 0.448 . . . . 64.12 110.983 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -68.83 128.66 92.78 Favored Pre-proline 0 CA--C 1.551 0.997 0 O-C-N 123.955 0.785 . . . . 71.51 110.256 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.442 ' HG2' ' CE2' ' C' ' 11' ' ' PHE . 10.4 Cg_exo -74.68 111.9 3.43 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 122.955 2.436 . . . . 71.32 112.178 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.4 m -102.29 116.87 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.314 0.645 . . . . 42.01 109.601 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -76.05 91.07 3.07 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 115.543 -0.753 . . . . 74.04 109.469 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 . . . . . 0 N--CA 1.476 0.854 0 C-N-CA 124.279 1.032 . . . . 62.41 110.673 -179.435 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 26.8 ptm . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 115.969 1.841 . . . . 75.31 115.969 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 56.6 m -143.64 123.07 13.13 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 107.232 -1.396 . . . . 74.25 107.232 166.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -131.37 139.36 49.47 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.874 0.87 . . . . 72.42 108.888 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -155.82 128.98 8.13 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 109.81 -0.441 . . . . 64.33 109.81 174.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.545 HD11 HD13 ' B' ' 105' ' ' ILE . 18.8 mt -77.92 121.5 30.78 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 N-CA-C 108.272 -1.011 . . . . 73.15 108.272 173.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -100.35 -32.77 10.68 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 123.754 0.659 . . . . 70.24 110.056 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -172.37 143.58 1.44 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.959 0.504 . . . . 74.54 109.974 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 84.6 mt -128.34 137.54 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 107.953 -1.128 . . . . 64.5 107.953 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -163.37 160.75 23.95 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-O 121.591 0.71 . . . . 72.21 112.287 -175.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.508 HG21 HD11 ' B' ' 21' ' ' ILE . 91.7 m -92.49 126.98 37.81 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.0 -1.0 . . . . 73.31 108.309 168.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -91.83 -25.51 18.95 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.353 0.661 . . . . 63.54 111.002 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -158.94 135.49 9.34 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 120.679 0.276 . . . . 71.2 111.713 -172.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 44.4 mm -125.74 141.4 45.61 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 C-N-CA 124.809 1.244 . . . . 63.0 109.585 173.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.531 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 46.5 t -138.01 141.76 40.4 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 107.686 -1.228 . . . . 64.32 107.686 175.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -159.28 134.55 8.33 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.66 -1.237 . . . . 61.13 107.66 169.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -137.36 157.84 45.72 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.027 0.931 . . . . 73.32 108.644 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.505 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -143.12 82.03 12.22 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 106.917 -1.512 . . . . 73.11 106.917 172.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.95 -25.32 27.84 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 123.042 2.495 . . . . 62.43 113.53 -169.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -112.75 14.27 19.92 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.663 0.785 . . . . 72.52 110.706 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.508 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -40.78 -62.93 0.85 Allowed Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 115.122 1.527 . . . . 52.44 115.122 -163.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 23.1 Cg_exo -61.3 -33.52 89.41 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 122.252 1.968 . . . . 71.12 112.793 -171.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -95.88 -20.5 18.74 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.358 -0.837 . . . . 61.1 112.633 -173.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.44 HG21 ' HA ' ' B' ' 73' ' ' ALA . 5.0 p -82.34 -11.5 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-N 118.459 0.572 . . . . 73.52 110.749 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -70.12 -14.94 62.88 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 112.879 0.696 . . . . 74.14 112.879 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -68.27 -12.54 61.19 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.046 0.538 . . . . 73.43 111.209 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -104.31 105.81 16.08 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.647 1.179 . . . . 64.42 109.29 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -111.01 92.47 4.06 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.743 -0.836 . . . . 51.44 108.743 175.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 8.1 p90 -159.27 -175.69 5.38 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.91 0.884 . . . . 73.14 109.262 170.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -68.4 110.27 5.49 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 123.899 0.88 . . . . 72.35 110.494 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -67.62 137.28 41.93 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 121.069 1.179 . . . . 74.42 111.334 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.83 110.13 3.18 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 109.09 -0.707 . . . . 75.15 109.09 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 59.3 t -94.5 123.73 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 123.858 0.863 . . . . 70.14 110.692 -174.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -103.45 102.03 11.94 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 106.76 -1.57 . . . . 74.14 106.76 169.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 pp -97.21 148.08 23.45 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.918 -0.583 . . . . 72.1 109.597 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -135.93 154.26 51.17 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.838 1.255 . . . . 55.3 108.056 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 21.1 tp -133.44 126.48 31.28 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.663 -0.865 . . . . 72.4 108.663 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -127.45 147.45 50.3 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.663 1.185 . . . . 75.11 109.972 -172.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 76.0 p -121.9 117.48 26.58 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.056 0.942 . . . . 62.31 110.486 -172.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.13 142.11 44.2 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.906 0.882 . . . . 43.41 108.657 174.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 52.4 p -148.44 176.06 10.61 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.196 0.443 . . . . 73.1 112.196 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 74.9 p -155.79 153.12 29.33 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.299 1.04 . . . . 61.43 109.006 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -102.27 121.52 42.42 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.889 -0.782 . . . . 61.33 108.889 170.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' B' ' 57' ' ' GLU . 18.7 mt -85.21 -50.48 7.35 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.747 0.819 . . . . 71.25 109.764 -173.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.78 -176.1 4.64 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.69 -1.141 . . . . 73.05 109.225 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -59.69 110.49 1.15 Allowed 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.025 0.828 . . . . 70.13 109.32 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 64.11 20.21 12.09 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.278 1.031 . . . . 70.22 112.653 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 79.7 t -116.61 112.93 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 106.868 -1.53 . . . . 64.15 106.868 168.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -129.17 137.02 50.92 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.518 -0.919 . . . . 75.21 108.518 -169.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.473 ' HB2' HD11 ' B' ' 51' ' ' LEU . 4.1 tt0 -101.02 124.82 47.33 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.207 -1.035 . . . . 73.33 108.207 174.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 18.5 m -109.26 134.77 50.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.515 -0.92 . . . . 75.51 108.515 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.78 134.32 54.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.529 -0.915 . . . . 72.11 108.529 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 24.8 tp -115.12 101.18 8.74 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 109.18 -0.674 . . . . 71.21 109.18 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -87.48 117.5 26.31 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 123.014 0.526 . . . . 74.1 109.617 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 18.9 t -107.37 122.0 61.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 107.616 -1.253 . . . . 72.04 107.616 171.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.6 m -114.39 138.01 51.09 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.481 -0.562 . . . . 45.31 109.481 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.669 HG21 HG21 ' B' ' 114' ' ' ILE . 71.0 t -129.2 125.2 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.204 1.002 . . . . 73.35 109.81 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 65.3 m -116.04 146.3 42.29 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.299 -1.371 . . . . 63.15 107.299 162.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.55 139.53 35.03 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.285 -1.006 . . . . 62.22 108.285 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.559 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 34.3 p -140.5 136.22 32.71 Favored 'General case' 0 C--O 1.226 -0.183 0 O-C-N 123.413 0.445 . . . . 65.42 110.667 -175.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 92.5 mt -109.51 109.38 20.17 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.799 -1.186 . . . . 73.35 107.799 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.23 -137.7 20.17 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.78 -0.645 . . . . 72.02 112.271 -173.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -94.57 14.13 21.89 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.18 0.992 . . . . 73.51 110.818 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -132.17 152.14 51.43 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.345 0.658 . . . . 71.51 110.558 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 64.8 m -75.15 125.65 29.39 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.448 0.699 . . . . 41.01 111.224 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.559 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -78.59 -59.17 2.89 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 114.897 -1.047 . . . . 70.23 108.683 176.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -153.25 160.82 42.84 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 115.179 -0.918 . . . . 65.44 112.483 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 59.5 mt -118.84 154.21 33.26 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.496 1.519 . . . . 72.21 107.812 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.405 ' SG ' HG23 ' B' ' 114' ' ' ILE . 42.2 t -161.06 157.5 26.23 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.371 0.668 . . . . 72.0 109.23 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.531 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 34.8 tt0 -166.02 130.77 2.29 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.044 -0.724 . . . . 74.24 109.044 175.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 96.7 t -123.66 143.65 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 108.707 -0.849 . . . . 72.32 108.707 173.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -124.8 96.33 4.84 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.563 -0.903 . . . . 74.0 108.563 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.419 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 8.5 tp-100 -85.72 100.07 11.75 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.568 -0.53 . . . . 74.45 109.568 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.15 144.66 17.19 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 111.357 -0.697 . . . . 60.15 111.357 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.49 131.81 4.35 Favored Glycine 0 C--O 1.236 0.274 0 N-CA-C 111.704 -0.558 . . . . 72.21 111.704 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.7 mt -84.63 126.95 40.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 N-CA-C 108.375 -0.972 . . . . 63.52 108.375 172.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -138.62 149.42 45.19 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.199 -0.667 . . . . 74.41 109.199 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 70.4 m -92.38 120.87 33.32 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.783 -0.821 . . . . 75.31 108.783 170.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.446 HD13 ' SG ' ' B' ' 97' ' ' CYS . 3.9 tp -120.71 118.83 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.438 1.095 . . . . 53.14 109.584 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.56 167.08 30.7 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.196 0.598 . . . . 72.23 109.981 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.14 -67.8 3.07 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.36 -0.382 . . . . 71.11 112.83 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mm -82.25 141.78 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.233 0.613 . . . . 54.54 110.813 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.441 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 11.3 pt-20 -153.09 -175.28 5.26 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.114 0.965 . . . . 65.51 109.803 -173.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.87 -133.74 37.43 Favored Glycine 0 C--N 1.354 1.582 0 C-N-CA 123.471 0.557 . . . . 51.04 113.396 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 55.4 m -66.0 -37.52 86.16 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.952 0.901 . . . . 50.23 110.614 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -67.79 -23.22 65.18 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 115.614 -0.721 . . . . 71.34 111.436 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.441 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 22.5 ttp -65.25 -29.49 70.28 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.966 0.906 . . . . 71.4 111.599 175.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.18 -29.99 71.08 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.764 0.826 . . . . 54.22 111.491 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.493 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 45.6 t-80 -69.42 -30.15 68.03 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.444 0.698 . . . . 63.4 111.427 175.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.446 ' SG ' HD13 ' B' ' 86' ' ' ILE . 44.6 t -79.62 -56.42 4.31 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.458 0.303 . . . . 64.42 111.134 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mp -81.61 -35.6 29.9 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.926 0.491 . . . . 64.35 112.27 -172.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.18 3.87 82.56 Favored Glycine 0 N--CA 1.47 0.961 0 CA-C-O 119.676 -0.514 . . . . 72.52 113.69 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -148.8 -66.88 0.23 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.531 0.567 . . . . 53.42 112.531 -172.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -60.51 -47.9 84.1 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.272 1.029 . . . . 73.2 111.945 -171.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 67.4 m -70.15 -45.5 21.43 Favored Pre-proline 0 CA--C 1.567 1.631 0 CA-C-O 118.339 -0.839 . . . . 62.11 112.241 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -48.07 -40.43 33.81 Favored 'Trans proline' 0 C--N 1.4 3.271 0 C-N-CA 123.137 2.558 . . . . 71.34 114.389 167.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -62.66 -26.06 68.45 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 112.295 0.48 . . . . 71.31 112.295 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.545 HD13 HD11 ' B' ' 13' ' ' ILE . 57.6 mt -84.53 -45.87 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.452 0.701 . . . . 51.12 110.663 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 99.2 mt -82.03 -21.69 36.83 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.329 0.652 . . . . 74.34 112.461 -170.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -57.3 -50.74 86.43 Favored Pre-proline 0 N--CA 1.489 1.497 0 CA-C-O 117.654 -1.165 . . . . 70.22 113.329 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.54 -40.57 83.14 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 122.343 2.029 . . . . 75.34 114.105 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -67.69 -47.98 67.87 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.193 0.597 . . . . 70.31 110.366 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -63.9 -35.59 81.14 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.466 -0.788 . . . . 63.51 111.292 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -59.05 -58.2 9.72 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.366 1.067 . . . . 74.02 110.399 177.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -62.7 -33.03 74.26 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 123.924 0.765 . . . . 74.33 110.178 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.514 ' SG ' HD11 ' B' ' 21' ' ' ILE . 2.0 t -69.64 -38.59 77.21 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 122.902 0.481 . . . . 63.01 111.735 -176.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.669 HG21 HG21 ' B' ' 64' ' ' VAL . 89.4 mt -65.29 -56.02 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.879 -0.786 . . . . 75.01 108.879 172.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 9.7 m -59.43 -27.74 66.31 Favored 'General case' 0 CA--C 1.554 1.101 0 O-C-N 124.579 1.174 . . . . 65.31 111.619 -174.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.5 t -65.55 -48.67 71.62 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 123.682 0.793 . . . . 64.51 109.847 175.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.2 mmt -70.59 -33.96 71.64 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.236 0.614 . . . . 74.31 110.83 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.438 HG23 ' O ' ' B' ' 114' ' ' ILE . 97.8 t -58.12 -45.23 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 124.046 0.938 . . . . 72.44 109.803 172.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.403 ' HB2' ' NE2' ' C' ' 125' ' ' GLN . 22.6 t -71.8 -30.14 65.2 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.161 -1.381 . . . . 74.22 111.421 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' B' ' 116' ' ' SER . 82.1 mtt-85 -68.76 -31.97 71.39 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.145 -0.48 . . . . 72.02 109.871 175.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.5 6.85 67.01 Favored Glycine 0 C--N 1.355 1.609 0 O-C-N 123.837 0.71 . . . . 73.43 113.116 173.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.49 HG23 ' HB3' ' A' ' 17' ' ' TYR . 59.6 p 59.83 25.84 14.96 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 126.244 1.818 . . . . 73.03 113.166 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -88.39 160.59 44.89 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 123.805 0.842 . . . . 75.41 111.204 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.49 164.65 5.3 Favored 'Trans proline' 0 C--N 1.39 2.759 0 C-N-CA 123.454 2.77 . . . . 65.51 114.834 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.549 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -64.59 132.15 49.0 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.241 1.016 . . . . 75.45 111.302 -178.76 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 49.6 tp -137.9 114.56 10.51 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.134 0.573 . . . . 70.22 109.825 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -128.82 129.5 45.7 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.65 0.78 . . . . 72.11 109.173 174.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mp -82.41 145.42 29.88 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 123.578 0.751 . . . . 63.32 109.225 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.73 133.25 95.02 Favored Pre-proline 0 CA--C 1.554 1.101 0 O-C-N 123.664 0.603 . . . . 71.42 110.929 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.431 ' HG3' HD13 ' D' ' 16' ' ' ILE . 29.4 Cg_endo -63.32 100.23 0.26 Allowed 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.898 2.398 . . . . 62.34 111.859 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 48.8 t -90.42 109.52 20.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 108.58 -0.896 . . . . 74.22 108.58 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -89.86 90.36 8.15 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 107.949 -1.13 . . . . 71.22 107.949 176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -58.55 -35.54 72.49 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.127 -0.942 . . . . 71.34 110.355 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 t70 . . . . . 0 N--CA 1.472 0.634 0 C-N-CA 124.531 1.132 . . . . 63.14 111.097 -174.365 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.442 ' CE2' ' HG2' ' A' ' 130' ' ' PRO . 50.6 t80 . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 108.817 -0.809 . . . . 73.22 108.817 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -150.61 140.1 21.5 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.632 -0.507 . . . . 74.22 109.632 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.413 HG12 ' HE2' ' C' ' 84' ' ' PHE . 43.5 mt -83.38 127.14 40.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.828 -0.804 . . . . 75.12 108.828 173.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.472 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 23.5 mm-40 -92.34 -40.0 11.16 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 123.666 0.604 . . . . 74.14 109.639 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -176.74 124.66 0.16 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.378 0.671 . . . . 75.41 109.812 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.5 mt -110.23 148.22 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 108.454 -0.943 . . . . 74.21 108.454 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -173.61 160.02 3.69 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.046 0.938 . . . . 73.23 109.235 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.8 p -81.18 107.78 14.27 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.199 -0.667 . . . . 71.11 109.199 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt -65.27 -47.72 75.71 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.822 0.82 . . . . 71.22 109.262 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.3 t70 -143.33 144.54 32.13 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.114 -1.403 . . . . 73.41 109.513 -174.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.3 mt -139.13 147.12 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.229 1.411 . . . . 73.21 107.335 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -157.25 150.8 24.12 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.32 0.648 . . . . 42.33 110.008 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -151.91 149.03 28.49 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.713 -1.217 . . . . 52.13 107.713 171.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -147.5 149.55 32.86 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.112 1.365 . . . . 62.41 107.617 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.8 84.72 3.73 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 107.316 -1.364 . . . . 71.34 107.316 169.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.65 -38.3 73.08 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.228 2.619 . . . . 73.41 113.139 -173.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -107.18 19.71 20.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.812 0.845 . . . . 53.21 110.999 -172.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.467 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -45.94 -58.33 6.47 Favored Pre-proline 0 CA--C 1.562 1.426 0 CA-C-O 117.355 -1.307 . . . . 52.41 114.259 -170.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 49.5 Cg_exo -54.55 -47.46 26.7 Favored 'Trans proline' 0 C--N 1.389 2.694 0 C-N-CA 122.106 1.871 . . . . 71.51 112.255 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.516 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.9 t60 -71.38 -32.9 69.01 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.11 -0.95 . . . . 70.2 112.843 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.694 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.8 p -77.3 -24.02 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 112.541 0.571 . . . . 72.45 112.541 -169.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -63.44 -26.19 68.62 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.085 0.772 . . . . 71.04 113.085 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 10.4 pt20 -87.53 6.6 33.43 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.017 0.527 . . . . 74.14 111.521 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.719 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -88.38 154.89 20.03 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.937 0.895 . . . . 75.35 110.509 179.246 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -66.13 128.2 35.17 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.509 -0.768 . . . . 73.5 109.067 165.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -78.69 90.18 4.59 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.388 0.675 . . . . 74.24 110.796 -174.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -132.96 76.99 69.35 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 124.275 1.03 . . . . 75.4 108.927 174.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -85.83 123.43 2.43 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.521 2.147 . . . . 61.51 112.295 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -83.26 83.68 7.77 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 106.788 -1.56 . . . . 64.11 106.788 167.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 5.6 p -71.83 116.24 13.36 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 CA-C-N 114.081 -1.418 . . . . 54.14 110.787 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -108.24 102.51 11.63 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.298 -1.001 . . . . 73.0 108.298 173.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.65 137.44 32.33 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.305 -0.628 . . . . 70.32 109.305 176.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.433 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 16.0 t70 -119.59 147.72 44.17 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.384 1.074 . . . . 73.52 108.141 -177.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 16.3 tp -130.0 112.5 13.54 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.148 0.499 . . . . 74.2 110.01 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.613 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 13.5 t70 -113.73 154.08 27.93 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.156 1.382 . . . . 75.55 109.153 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 34.0 p -135.32 132.12 37.29 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.489 0.716 . . . . 60.12 110.48 -173.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.46 154.7 48.45 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.918 0.887 . . . . 73.42 109.288 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 48.3 p -160.99 146.68 14.47 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.799 0.333 . . . . 64.04 111.811 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 68.1 p -150.11 133.38 16.37 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.064 0.946 . . . . 74.23 109.154 174.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -76.98 120.82 22.63 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.315 0.646 . . . . 74.01 109.897 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.531 HD11 HD12 ' C' ' 83' ' ' ILE . 26.2 mt -94.1 -30.25 14.76 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.154 0.582 . . . . 53.52 110.517 -177.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.33 -178.92 6.99 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.299 1.04 . . . . 70.12 109.882 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.25 113.05 2.95 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.731 -0.668 . . . . 74.14 109.978 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 54' ' ' ASP . . . . . 0.439 ' HA ' ' HE1' ' C' ' 56' ' ' TYR . 3.6 m-20 63.26 18.63 11.13 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.536 1.134 . . . . 72.5 112.503 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 83.9 t -115.4 114.47 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.131 -1.063 . . . . 65.25 108.131 170.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 56' ' ' TYR . . . . . 0.439 ' HE1' ' HA ' ' C' ' 54' ' ' ASP . 83.4 m-85 -126.64 134.29 50.78 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.921 0.888 . . . . 64.34 109.018 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.529 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.2 tt0 -84.58 114.3 21.88 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.082 -1.081 . . . . 71.14 108.082 170.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.9 t -95.93 124.22 48.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 107.693 -1.225 . . . . 74.45 107.693 173.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 94.9 t -117.66 133.27 64.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 107.759 -1.2 . . . . 74.24 107.759 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.487 HD13 ' HB3' ' C' ' 103' ' ' PRO . 23.7 tp -127.8 105.76 8.66 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.691 -0.855 . . . . 71.01 108.691 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.613 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 9.2 ttm180 -82.89 122.61 28.47 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.34 -0.615 . . . . 75.15 109.34 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.418 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.2 t -113.83 127.78 71.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.031 -1.1 . . . . 73.42 108.031 171.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 31.5 m -123.5 110.12 14.68 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.017 0.527 . . . . 73.3 109.607 -177.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.495 HG23 HD13 ' C' ' 114' ' ' ILE . 69.3 t -99.72 108.43 22.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 108.883 -0.784 . . . . 71.12 108.883 -177.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.446 HG23 HD23 ' C' ' 75' ' ' LEU . 3.8 m -99.5 126.32 45.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.982 -0.748 . . . . 53.11 108.982 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.38 106.69 13.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.307 -0.997 . . . . 63.32 108.307 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 22.1 m -127.02 129.46 48.1 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.814 -0.81 . . . . 71.33 108.814 175.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.719 HD13 ' HG2' ' C' ' 34' ' ' LYS . 8.1 mt -85.09 32.64 0.54 Allowed 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 125.109 1.364 . . . . 51.5 110.78 -178.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.81 -108.83 2.36 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 110.728 -0.949 . . . . 75.25 110.728 -171.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.71 -23.06 23.06 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.393 0.677 . . . . 73.34 109.943 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.13 115.83 22.07 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 123.993 0.917 . . . . 70.13 109.48 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 79.3 m -84.39 123.84 30.66 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 118.756 0.707 . . . . 74.12 109.164 169.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.694 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -77.38 -57.32 3.89 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.007 -0.997 . . . . 72.22 109.281 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -157.86 172.48 18.39 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 122.103 0.954 . . . . 72.34 111.639 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.446 HD23 HG23 ' C' ' 65' ' ' THR . 2.4 tm? -135.18 128.36 31.87 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 105.611 -1.996 . . . . 75.03 105.611 170.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.46 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 44.4 t -128.26 143.5 51.03 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.134 -1.061 . . . . 52.21 108.134 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.48 123.29 5.18 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.206 0.316 . . . . 71.11 110.367 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 61.8 t -134.12 125.25 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.457 0.703 . . . . 72.44 109.526 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.604 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 25.8 mt-30 -96.02 98.48 10.41 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.926 -1.138 . . . . 72.23 107.926 172.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -84.25 121.48 27.56 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.053 -0.522 . . . . 55.01 110.153 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.9 147.23 16.7 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 112.168 -0.373 . . . . 63.53 112.168 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.406 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.75 125.14 1.98 Allowed Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.169 -1.173 . . . . 72.04 110.169 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.531 HD12 HD11 ' C' ' 51' ' ' LEU . 13.1 mm -80.63 127.62 39.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 107.554 -1.276 . . . . 74.52 107.554 174.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.413 ' HE2' HG12 ' C' ' 13' ' ' ILE . 64.6 m-85 -134.42 142.28 47.08 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.976 0.417 . . . . 72.31 110.667 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 11.5 p -96.28 107.61 19.99 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 108.246 -1.02 . . . . 51.55 108.246 168.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 69.9 mt -115.36 116.47 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.368 1.067 . . . . 73.45 109.245 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.08 172.38 18.51 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.749 0.82 . . . . 63.22 111.181 -171.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.46 -59.2 0.94 Allowed Glycine 0 C--N 1.349 1.264 0 CA-C-N 116.302 -0.408 . . . . 71.12 113.308 170.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 38.1 pt -94.36 -177.24 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.634 0.774 . . . . 74.22 110.172 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -164.49 155.12 14.78 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 122.974 0.51 . . . . 62.34 110.93 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.04 -130.78 11.69 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 119.25 -0.75 . . . . 65.31 113.845 171.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 21.5 m -55.72 -40.29 72.23 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.5 1.12 . . . . 73.41 111.577 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -56.25 -48.21 77.0 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.404 -1.271 . . . . 73.14 109.817 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.504 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 56.2 ttm -80.33 -27.16 38.41 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 114.822 -1.081 . . . . 73.24 111.234 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.25 81.9 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.53 0.732 . . . . 62.14 111.359 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.549 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 57.8 t-80 -70.75 -28.54 64.77 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.189 -0.914 . . . . 75.03 111.157 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 50.3 t -77.43 -55.33 5.48 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 122.229 -0.294 . . . . 73.24 111.222 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' C' ' 94' ' ' MET . 1.0 OUTLIER -78.09 -22.78 48.45 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 112.968 0.729 . . . . 72.43 112.968 -173.443 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 99' ' ' GLY . . . . . 0.439 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -97.59 0.62 59.69 Favored Glycine 0 C--N 1.346 1.089 0 O-C-N 123.403 0.44 . . . . 74.35 112.871 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -140.62 -69.18 0.4 Allowed 'General case' 0 C--N 1.347 0.485 0 C-N-CA 123.344 0.658 . . . . 72.14 110.455 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -65.24 -51.85 58.28 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.496 0.924 . . . . 74.2 113.496 -168.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.459 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 19.9 m -61.63 -47.05 93.61 Favored Pre-proline 0 CA--C 1.564 1.506 0 CA-C-O 118.845 -0.598 . . . . 74.3 112.363 -173.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.487 ' HB3' HD13 ' C' ' 60' ' ' LEU . 21.7 Cg_exo -68.91 -26.11 32.0 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 121.997 1.798 . . . . 71.12 112.971 172.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -72.49 -25.43 61.41 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.447 0.699 . . . . 73.24 110.719 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.469 HD12 HH12 ' A' ' 111' ' ' ARG . 28.7 mm -66.02 -35.27 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.036 0.534 . . . . 74.21 109.586 169.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.406 HD21 ' HA3' ' C' ' 82' ' ' GLY . 84.3 mt -87.18 -17.68 32.11 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.048 0.939 . . . . 75.22 112.452 -176.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -54.39 -50.77 83.15 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 117.534 -1.222 . . . . 73.35 112.863 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -55.24 -36.75 94.12 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.75 2.3 . . . . 73.13 114.594 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -75.46 -44.16 45.65 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.808 0.443 . . . . 72.51 110.55 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.31 -45.74 90.48 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.453 -0.794 . . . . 73.51 109.662 174.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 41.2 ttt-85 -54.26 -51.49 64.39 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.497 1.519 . . . . 71.53 111.506 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.85 -35.58 74.84 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.319 0.648 . . . . 74.44 110.421 -176.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.6 t -71.75 -31.62 66.85 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.005 0.522 . . . . 74.14 110.901 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.495 HD13 HG23 ' C' ' 64' ' ' VAL . 89.4 mt -70.89 -53.47 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.451 0.7 . . . . 73.11 109.661 174.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.9 m -64.35 -28.79 69.94 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.366 0.667 . . . . 64.22 111.249 -176.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.1 t -65.2 -48.63 72.71 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 109.061 -0.718 . . . . 70.33 109.061 173.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.525 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.86 -36.68 84.08 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.508 1.123 . . . . 71.23 112.354 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.426 HG23 ' O ' ' C' ' 114' ' ' ILE . 97.2 t -67.89 -40.89 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.436 0.694 . . . . 74.01 110.094 176.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 48.4 t -70.18 -29.66 66.59 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.162 -0.926 . . . . 75.35 111.371 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.412 ' HD2' ' SD ' ' C' ' 117' ' ' MET . 86.5 mtt-85 -72.26 -32.18 66.44 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.622 0.769 . . . . 74.32 109.598 176.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.17 5.96 69.67 Favored Glycine 0 C--N 1.354 1.564 0 O-C-N 124.014 0.821 . . . . 65.43 112.91 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.497 HG23 ' HB3' ' D' ' 17' ' ' TYR . 76.7 p 57.73 28.3 15.65 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 126.273 1.829 . . . . 73.42 113.278 178.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -88.16 155.38 52.12 Favored Pre-proline 0 CA--C 1.555 1.153 0 N-CA-C 109.213 -0.662 . . . . 75.3 109.213 171.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.39 142.66 29.19 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 123.166 2.577 . . . . 70.3 113.382 172.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.403 ' NE2' ' HB2' ' B' ' 119' ' ' SER . 21.2 mm-40 -59.98 112.27 1.81 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.694 0.798 . . . . 73.31 111.411 -176.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 48.8 tp -113.38 93.08 4.23 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.469 -0.937 . . . . 42.53 108.469 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -91.48 127.84 37.08 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.364 -0.976 . . . . 74.32 108.364 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 89.0 mt -69.54 134.47 48.88 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 123.375 0.422 . . . . 72.33 110.18 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.09 158.73 76.94 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 123.822 0.849 . . . . 74.52 110.751 -178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.467 ' HG3' HG21 ' A' ' 13' ' ' ILE . 23.5 Cg_endo -56.85 112.0 0.97 Allowed 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.918 2.412 . . . . 73.35 112.666 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 p -96.97 107.49 19.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 107.507 -1.294 . . . . 62.33 107.507 170.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -90.86 82.83 5.65 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.812 -1.085 . . . . 72.05 109.121 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -58.61 -44.83 90.06 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.223 0.535 . . . . 64.44 109.566 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 . . . . . 0 N--CA 1.468 0.457 0 CA-C-N 114.453 -1.249 . . . . 62.13 112.127 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 85.4 m . . . . . 0 C--O 1.241 0.62 0 N-CA-C 108.469 -0.937 . . . . 75.43 108.469 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -154.81 108.25 2.86 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.99 -1.115 . . . . 72.14 107.99 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -122.42 119.78 32.0 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.84 -0.8 . . . . 62.21 108.84 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 65.7 mt -68.09 135.52 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 109.872 -0.418 . . . . 74.1 109.872 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -101.41 -39.54 7.51 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.069 0.547 . . . . 74.43 111.405 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 15.4 ttt180 -172.03 135.8 0.83 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.706 0.23 . . . . 71.14 111.374 -169.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.431 HD13 ' HG3' ' B' ' 130' ' ' PRO . 3.4 mp -120.6 135.51 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 107.59 -1.263 . . . . 71.05 107.59 167.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.497 ' HB3' HG23 ' C' ' 122' ' ' THR . 37.1 p90 -163.53 168.78 19.66 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.941 0.877 . . . . 70.23 111.301 177.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.2 p -99.15 128.33 45.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.316 -1.311 . . . . 74.52 109.082 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.457 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 39.0 mtpt -104.66 -15.14 15.36 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.025 0.53 . . . . 70.2 110.384 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.729 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 28.3 t70 -158.62 132.66 7.8 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.484 -1.235 . . . . 62.52 108.157 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.525 HG21 ' HE2' ' C' ' 117' ' ' MET . 57.4 mt -138.8 148.14 24.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.545 -1.279 . . . . 73.51 107.545 176.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 27.2 t -154.13 145.42 22.96 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.416 0.686 . . . . 64.2 109.818 173.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.1 t80 -149.97 122.02 8.26 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 105.55 -2.018 . . . . 75.31 105.55 172.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 26.6 mt-10 -130.4 111.54 12.42 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.96 -0.756 . . . . 64.13 108.96 -173.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -116.69 86.22 18.46 Favored Pre-proline 0 C--O 1.241 0.615 0 N-CA-C 108.683 -0.858 . . . . 73.23 108.683 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.77 -39.89 2.24 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.36 2.04 . . . . 71.31 111.727 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -86.72 -3.34 59.03 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.812 1.245 . . . . 74.25 111.31 -176.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.515 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -23.74 -67.95 0.05 OUTLIER Pre-proline 0 C--N 1.361 1.096 0 C-N-CA 127.465 2.306 . . . . 75.43 116.737 -165.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.459 ' HB3' HD11 ' C' ' 83' ' ' ILE . 86.2 Cg_endo -73.64 -29.74 10.44 Favored 'Trans proline' 0 C--N 1.375 1.951 0 CA-C-N 123.133 2.155 . . . . 74.0 113.582 -168.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -87.36 -22.52 25.01 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.623 0.249 . . . . 74.1 110.672 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.515 HG12 ' O ' ' D' ' 28' ' ' ALA . 10.0 p -81.75 -18.1 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 122.866 0.466 . . . . 74.41 110.482 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -65.62 -18.77 65.57 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 112.562 0.578 . . . . 75.22 112.562 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -64.58 -12.35 44.2 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.131 0.972 . . . . 74.14 111.602 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -102.62 106.83 17.57 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.167 1.387 . . . . 71.44 110.463 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -102.96 83.81 2.28 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.998 0.919 . . . . 74.11 110.158 -176.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -158.28 175.65 13.47 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.698 0.799 . . . . 72.22 109.171 169.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -66.5 111.95 8.12 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 123.412 0.685 . . . . 64.44 110.101 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.428 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 73.9 Cg_exo -56.12 119.44 6.62 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.004 2.469 . . . . 55.2 111.649 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -60.56 113.74 2.6 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.561 1.145 . . . . 64.53 110.419 -176.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 71.7 t -97.18 126.1 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.339 0.656 . . . . 74.22 111.226 -169.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.629 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 17.0 tppt? -101.72 110.52 22.52 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.312 -1.736 . . . . 70.42 106.312 166.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.52 114.06 25.69 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.287 -1.005 . . . . 74.01 108.287 -172.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.73 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 11.7 m-20 -107.21 150.06 27.04 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.389 1.075 . . . . 73.35 109.451 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 94.4 mt -129.5 151.02 50.58 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.571 0.748 . . . . 55.42 110.476 -176.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 33.6 t70 -156.88 136.06 11.98 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.795 -1.187 . . . . 54.34 107.795 174.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 41.1 p -107.23 144.43 34.03 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.01 0.524 . . . . 71.43 110.987 -171.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.611 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.44 156.43 41.44 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.931 0.893 . . . . 71.2 109.303 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 10.5 p -172.18 155.78 3.74 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.025 0.53 . . . . 45.32 111.129 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 56.0 p -151.93 123.12 7.68 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.343 -0.844 . . . . 73.34 109.045 175.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -76.64 123.36 26.01 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.956 -0.757 . . . . 64.21 108.956 173.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 35.8 mt -90.01 -31.02 17.38 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.293 0.568 . . . . 64.22 109.997 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -164.5 171.91 13.99 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.304 1.441 . . . . 72.35 108.397 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -68.08 127.25 32.2 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.299 -0.876 . . . . 74.4 108.978 171.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 75.63 -2.85 2.7 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 125.926 1.69 . . . . 74.42 112.494 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 64.1 t -117.06 115.7 49.73 Favored 'Isoleucine or valine' 0 C--N 1.354 0.783 0 N-CA-C 108.099 -1.075 . . . . 60.35 108.099 172.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -144.38 169.12 18.54 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.516 -0.549 . . . . 73.21 109.516 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -130.04 132.36 46.18 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.105 -0.952 . . . . 61.22 109.568 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 64.2 t -105.94 124.75 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.464 -1.31 . . . . 63.22 107.464 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 20.9 t -114.84 130.02 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.457 -1.312 . . . . 74.44 107.457 172.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' D' ' 103' ' ' PRO . 15.4 tp -125.93 120.55 30.7 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.847 -0.797 . . . . 63.51 108.847 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.565 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 55.3 ttm-85 -83.99 102.78 12.72 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.157 -0.683 . . . . 75.41 109.157 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 71.7 t -91.15 126.86 43.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 107.862 -1.162 . . . . 73.35 107.862 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.73 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 26.8 m -124.14 126.62 46.49 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.486 0.66 . . . . 74.53 110.101 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 53.4 t -111.36 98.69 7.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 124.853 1.261 . . . . 65.41 107.781 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.629 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 31.0 m -95.98 90.04 5.43 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.335 -1.357 . . . . 71.2 107.335 177.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -97.93 148.18 23.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.458 -0.792 . . . . 32.24 110.576 -170.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.48 ' HA ' ' N ' ' D' ' 73' ' ' ALA . 54.8 m -145.34 135.5 23.88 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.259 0.466 . . . . 73.53 112.259 -174.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.467 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 82.0 mt -108.35 105.73 15.54 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.714 0.806 . . . . 54.33 109.151 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.47 -135.68 14.45 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.301 0.376 . . . . 64.43 113.653 175.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.29 5.74 25.6 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.32 0.648 . . . . 74.11 111.616 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -136.93 173.2 11.96 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.243 0.617 . . . . 72.34 110.797 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 37.7 m -66.34 153.08 43.62 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.976 1.31 . . . . 73.23 111.574 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.48 ' N ' ' HA ' ' D' ' 67' ' ' SER . . . -101.67 -65.51 0.97 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.378 -1.341 . . . . 54.13 107.378 168.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -155.21 146.86 23.17 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.478 -1.237 . . . . 74.23 110.246 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.499 HD22 HG23 ' D' ' 65' ' ' THR . 31.7 mt -104.57 111.12 23.69 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.468 -1.308 . . . . 74.12 107.468 172.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.561 ' SG ' HG12 ' D' ' 114' ' ' ILE . 35.0 t -117.26 137.64 52.26 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.621 -0.881 . . . . 73.31 108.621 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -154.86 121.42 5.38 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.646 -0.502 . . . . 74.44 109.646 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 65.4 t -129.47 124.0 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.392 0.677 . . . . 74.11 109.492 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.729 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 22.0 mt-30 -86.95 93.99 9.48 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 107.947 -1.131 . . . . 65.24 107.947 164.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -83.35 105.19 14.1 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.266 -1.013 . . . . 71.23 108.266 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -98.39 150.2 19.32 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-N 116.0 -0.545 . . . . 34.2 112.019 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.497 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -152.78 129.63 2.8 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.76 -0.257 . . . . 41.34 112.511 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.5 mt -91.2 126.89 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 108.211 -1.033 . . . . 61.32 108.211 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -130.68 153.81 48.58 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.639 0.776 . . . . 62.51 110.747 -174.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.3 m -106.71 138.21 43.31 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.504 1.121 . . . . 75.02 108.5 173.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.766 HG12 HD13 ' D' ' 89' ' ' ILE . 8.8 tt -146.4 144.2 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 108.849 -0.797 . . . . 74.11 108.849 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.47 146.62 8.62 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.18 0.592 . . . . 45.53 110.219 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.94 10.4 57.58 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.278 0.361 . . . . 70.32 113.122 -177.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.766 HD13 HG12 ' D' ' 86' ' ' ILE . 3.4 mp -123.65 151.06 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.018 0.927 . . . . 51.42 109.569 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.55 178.36 9.96 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.087 1.355 . . . . 73.23 109.737 174.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.09 -134.0 31.43 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 114.481 0.552 . . . . 64.21 114.481 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 34.6 p -88.88 -12.84 40.66 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.064 0.946 . . . . 74.23 112.419 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -61.7 -40.57 95.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.179 0.592 . . . . 73.31 110.559 177.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -75.61 -20.26 58.68 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.624 -0.716 . . . . 62.31 112.2 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.24 -38.57 91.51 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.935 0.494 . . . . 72.42 110.677 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -78.01 -29.44 49.55 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.397 -0.82 . . . . 72.05 111.056 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 97' ' ' CYS . . . . . 0.427 ' SG ' HD12 ' D' ' 86' ' ' ILE . 44.3 t -68.5 -52.85 27.66 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 122.895 0.122 . . . . 75.14 111.085 -175.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.2 -22.06 42.27 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 110.612 -0.144 . . . . 74.42 110.612 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.29 -3.52 81.9 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-O 119.697 -0.502 . . . . 73.11 114.079 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.39 -58.76 0.13 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 117.479 0.64 . . . . 62.33 111.774 -177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -66.07 -47.96 72.57 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 112.658 0.614 . . . . 71.43 112.658 -170.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.421 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 44.6 m -67.85 -44.88 42.78 Favored Pre-proline 0 CA--C 1.565 1.523 0 CA-C-O 118.819 -0.61 . . . . 72.11 112.36 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.681 ' HB3' HD22 ' D' ' 60' ' ' LEU . 50.8 Cg_exo -59.12 -28.81 88.81 Favored 'Trans proline' 0 C--N 1.39 2.75 0 C-N-CA 122.54 2.16 . . . . 72.41 113.618 168.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -69.67 -33.57 72.76 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.507 0.723 . . . . 60.3 110.347 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.9 mm -67.33 -33.27 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-O 121.334 0.588 . . . . 74.04 110.212 174.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.497 HD21 ' HA3' ' D' ' 82' ' ' GLY . 65.4 mt -85.22 -15.97 41.83 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.885 0.874 . . . . 73.52 111.883 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -61.38 -48.51 90.84 Favored Pre-proline 0 CA--C 1.567 1.622 0 CA-C-O 118.002 -0.999 . . . . 62.13 113.262 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -59.92 -31.37 93.61 Favored 'Trans proline' 0 C--N 1.388 2.646 0 C-N-CA 122.093 1.862 . . . . 71.5 112.923 177.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -82.24 -32.04 29.92 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.727 0.811 . . . . 74.24 111.803 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.08 -48.1 72.08 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.847 -0.797 . . . . 55.33 108.847 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.449 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 34.4 ttp180 -55.39 -49.61 71.88 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 124.405 1.066 . . . . 73.44 111.141 176.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -64.68 -50.31 67.51 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 123.898 0.749 . . . . 74.41 111.144 -174.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 44.8 t -57.85 -44.39 86.52 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 124.005 0.816 . . . . 71.14 110.801 -178.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.561 HG12 ' SG ' ' D' ' 76' ' ' CYS . 91.4 mt -63.56 -55.34 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.727 0.811 . . . . 73.43 111.119 175.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 77.1 m -57.37 -39.91 77.04 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.146 0.979 . . . . 73.41 111.217 -174.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 86.5 p -66.7 -41.83 87.38 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.402 -0.817 . . . . 74.41 109.533 -177.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 65.3 mtm -69.97 -28.89 65.91 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.151 0.58 . . . . 72.14 111.734 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.487 HG23 ' O ' ' D' ' 114' ' ' ILE . 88.3 t -63.23 -49.18 84.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.23 0.612 . . . . 74.43 109.391 172.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.1 p -73.61 -26.1 60.63 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.867 -0.606 . . . . 63.3 111.039 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' D' ' 116' ' ' SER . 74.1 mtt-85 -71.94 -37.79 69.93 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.492 0.717 . . . . 62.41 109.246 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.78 4.86 77.77 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 115.362 -0.835 . . . . 50.12 112.448 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.406 HG21 HE21 ' A' ' 125' ' ' GLN . 22.4 p 58.7 30.67 20.26 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 126.683 1.993 . . . . 60.35 113.703 173.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -84.75 159.62 57.53 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 123.988 0.915 . . . . 74.24 109.883 171.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.35 126.13 21.32 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.693 2.262 . . . . 73.52 112.136 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -64.51 124.72 22.57 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.889 0.876 . . . . 73.2 111.652 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 7.0 tt -124.59 115.08 20.24 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.125 -1.435 . . . . 73.02 107.125 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -99.59 121.62 41.46 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.907 0.883 . . . . 73.12 108.653 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.449 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 7.3 mp -68.77 113.63 6.39 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 109.897 -0.409 . . . . 75.23 109.897 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -64.7 140.06 97.93 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.017 0.527 . . . . 72.31 110.432 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 9.3 Cg_exo -66.53 126.57 15.72 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.106 1.871 . . . . 74.03 110.708 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.484 1.225 0 C-N-CA 123.27 0.628 . . . . 75.42 110.725 -174.356 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.602 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 48.1 t80 . . . . . 0 C--O 1.237 0.406 0 N-CA-C 110.18 -0.304 . . . . 74.43 110.18 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -160.48 129.34 4.82 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.873 0.869 . . . . 72.54 109.372 173.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.567 ' CD1' HG21 ' A' ' 105' ' ' ILE . 58.2 mt -94.14 122.11 45.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.809 -0.811 . . . . 64.22 108.809 172.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -90.98 -31.15 16.44 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.278 0.361 . . . . 74.42 110.759 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.49 ' HB3' HD12 ' A' ' 83' ' ' ILE . 39.8 ttt180 -167.0 122.19 1.09 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 111.99 0.367 . . . . 72.55 111.99 -169.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.433 HD11 HD13 ' A' ' 13' ' ' ILE . 73.7 mt -115.02 137.14 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 123.842 0.857 . . . . 74.53 109.24 173.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HB3' HG23 ' B' ' 122' ' ' THR . 26.9 p90 -163.01 174.94 11.66 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 123.791 0.836 . . . . 73.11 111.069 -174.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -106.89 118.74 37.49 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.95 -0.759 . . . . 61.11 108.95 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -86.76 -25.75 24.52 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.857 -0.423 . . . . 64.22 109.857 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.696 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 26.3 t70 -145.91 135.39 23.1 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.604 -0.726 . . . . 62.4 109.703 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.7 mt -139.06 140.52 38.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 C-N-CA 125.477 1.511 . . . . 74.21 107.187 176.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -150.35 124.96 9.67 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.235 0.614 . . . . 73.22 109.381 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.428 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 88.1 t80 -124.08 136.6 54.35 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.052 -1.462 . . . . 74.42 107.052 168.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -137.29 135.95 37.58 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.895 0.478 . . . . 64.31 110.069 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.09 74.41 49.7 Favored Pre-proline 0 C--O 1.242 0.696 0 N-CA-C 106.6 -1.63 . . . . 72.55 106.6 167.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.58 -32.09 39.66 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.118 1.878 . . . . 74.51 110.906 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -96.98 19.59 12.53 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.226 -0.897 . . . . 73.14 110.685 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.455 ' HB3' ' HZ1' ' B' ' 19' ' ' LYS . . . -50.31 -45.94 83.51 Favored Pre-proline 0 CA--C 1.567 1.614 0 N-CA-C 114.469 1.285 . . . . 62.12 114.469 -172.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -66.37 -19.51 55.56 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 121.767 1.644 . . . . 33.04 113.479 175.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -97.15 -26.07 15.09 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.01 0.924 . . . . 72.31 111.564 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.585 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.1 p -79.61 -30.26 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 N-CA-C 113.459 0.911 . . . . 74.31 113.459 -158.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -81.75 -23.9 36.4 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.813 0.445 . . . . 73.14 111.189 -171.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -79.91 -11.6 59.79 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.474 0.71 . . . . 74.21 111.038 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -81.47 162.3 23.32 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.872 0.469 . . . . 64.05 111.417 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -68.9 126.52 30.04 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.259 -0.882 . . . . 73.22 108.967 173.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 44.3 t-105 -76.4 81.92 3.13 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.762 0.791 . . . . 72.41 109.862 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -130.94 76.19 77.42 Favored Pre-proline 0 C--O 1.246 0.876 0 N-CA-C 107.512 -1.292 . . . . 71.44 107.512 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -85.48 140.22 7.21 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.295 1.997 . . . . 72.23 112.226 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -97.06 101.74 13.37 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.411 -1.329 . . . . 71.12 107.411 169.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 65' ' ' THR . 19.3 t -85.88 93.78 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.846 -0.798 . . . . 74.25 108.846 -176.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -86.12 115.34 23.63 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.531 1.132 . . . . 75.11 109.424 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -97.9 107.81 20.38 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.02 -0.733 . . . . 65.34 109.02 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.55 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 18.1 t70 -106.9 121.75 45.04 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.275 1.03 . . . . 61.24 108.552 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 mp -103.67 145.96 29.29 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.98 -0.378 . . . . 72.11 109.98 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.636 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 23.1 t70 -148.76 159.65 43.94 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.067 0.947 . . . . 53.01 108.847 177.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.6 m -135.44 136.85 41.68 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.571 0.749 . . . . 70.41 110.41 -178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.85 144.07 49.95 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.734 1.214 . . . . 74.51 108.279 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.0 p -132.9 167.22 20.62 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.716 0.406 . . . . 72.34 111.478 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.0 t -166.67 122.51 1.19 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.336 -0.847 . . . . 70.01 109.952 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -77.29 110.93 12.41 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 107.871 -1.159 . . . . 65.25 107.871 168.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 57' ' ' GLU . 31.3 mt -84.94 -36.68 21.25 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.177 0.591 . . . . 65.14 110.75 -173.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.66 -174.47 4.23 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.848 0.859 . . . . 73.33 110.035 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -65.53 119.08 10.44 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.381 -0.6 . . . . 73.0 109.381 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 85' ' ' SER . 35.8 m-20 68.22 2.17 3.14 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.91 1.284 . . . . 74.11 113.015 -177.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.5 t -105.91 111.22 34.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 108.214 -1.032 . . . . 54.12 108.214 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -131.53 137.33 48.45 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.845 -0.798 . . . . 70.25 108.845 -174.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.454 ' HB2' HD11 ' A' ' 51' ' ' LEU . 40.5 tt0 -108.7 118.25 36.3 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.879 -1.055 . . . . 62.4 109.786 -176.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.5 t -103.43 123.74 57.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.043 -1.466 . . . . 74.34 107.043 170.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.8 131.25 70.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 107.817 -1.179 . . . . 62.41 107.817 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 tt -121.8 115.08 22.01 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.179 -1.045 . . . . 71.41 108.179 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.636 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 35.9 ttp180 -85.45 109.49 18.5 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.831 0.852 . . . . 75.34 109.93 175.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.4 t -99.48 102.77 13.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.537 -1.283 . . . . 75.15 107.537 170.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 39.8 m -94.84 108.86 20.89 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.985 0.914 . . . . 75.54 108.907 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.7 t -103.78 110.15 29.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.264 -0.88 . . . . 74.4 109.142 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 21.6 m -102.11 134.74 44.88 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.963 -1.125 . . . . 50.21 107.963 171.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.68 117.22 19.99 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.963 -1.495 . . . . 72.42 106.963 174.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 54.0 m -128.0 132.7 49.14 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.943 0.497 . . . . 71.33 110.97 -175.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.7 mt -90.85 48.01 1.48 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.484 1.114 . . . . 65.43 108.805 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.42 -90.41 0.93 Allowed Glycine 0 C--N 1.351 1.376 0 CA-C-N 114.993 -1.003 . . . . 74.5 112.552 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -87.83 -22.87 24.23 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.785 0.834 . . . . 71.41 111.034 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -118.55 98.82 6.44 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.857 -1.164 . . . . 73.14 107.857 -172.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 93.1 m -59.08 129.19 40.94 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 118.44 0.563 . . . . 53.42 110.597 177.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.585 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -70.18 -60.62 2.17 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.241 -0.891 . . . . 72.15 109.643 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -161.19 164.19 30.65 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 114.863 -1.062 . . . . 73.32 110.99 177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.1 tp -128.62 108.9 10.88 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.502 -0.925 . . . . 73.22 108.502 171.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.403 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 73.9 m -106.48 96.61 6.58 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.59 0.756 . . . . 74.53 109.824 174.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -111.04 115.27 29.18 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.866 -0.79 . . . . 60.11 108.866 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -124.11 132.04 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.048 0.539 . . . . 33.41 109.563 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.696 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 45.2 mt-30 -98.72 95.59 7.34 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.262 0.625 . . . . 71.53 109.521 168.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -80.41 105.16 11.46 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.807 -1.088 . . . . 70.14 109.03 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.7 150.92 20.59 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.908 -0.587 . . . . 42.24 111.821 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.53 147.49 18.6 Favored Glycine 0 C--O 1.237 0.284 0 N-CA-C 111.529 -0.628 . . . . 32.44 111.529 174.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 15' ' ' ARG . 64.1 mt -104.13 112.23 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.06 -1.089 . . . . 71.33 108.06 176.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.602 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 5.1 m-85 -123.16 154.83 38.14 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.258 1.023 . . . . 74.34 108.294 -176.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 87.9 p -109.04 116.04 31.22 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.742 -0.836 . . . . 71.24 108.742 172.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 N--CA 1.486 1.365 0 N-CA-C 109.279 -0.637 . . . . 62.42 109.279 178.741 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 120.522 0.201 . . . . 41.22 111.501 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -89.51 -47.49 7.95 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.41 0.684 . . . . 74.34 111.324 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 22.0 p -62.36 -42.86 99.74 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.228 0.537 . . . . 55.32 110.372 -174.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -88.02 -41.4 13.13 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.985 -1.007 . . . . 71.22 109.984 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.94 0.09 89.08 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-O 119.443 -0.643 . . . . 71.42 114.647 -171.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.22 -51.83 0.14 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 117.939 0.869 . . . . 73.43 112.464 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.469 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 85.6 t80 -69.86 -58.64 3.64 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.712 0.634 . . . . 74.0 112.712 -170.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.409 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 71.7 m -62.59 -40.49 65.24 Favored Pre-proline 0 CA--C 1.563 1.471 0 N-CA-C 113.651 0.982 . . . . 55.3 113.651 -175.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 34.8 Cg_endo -65.23 -27.84 56.04 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 121.941 1.761 . . . . 71.4 113.166 169.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -75.29 -23.36 57.36 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 122.843 0.457 . . . . 72.34 110.696 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.567 HG21 ' CD1' ' A' ' 13' ' ' ILE . 46.9 mm -62.35 -40.86 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.338 0.655 . . . . 64.32 109.751 170.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 80.1 mt -74.19 -21.56 59.77 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.935 -1.029 . . . . 61.42 111.607 -177.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -60.51 -49.17 91.29 Favored Pre-proline 0 CA--C 1.565 1.536 0 N-CA-C 113.982 1.104 . . . . 71.32 113.982 -172.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.29 -34.17 88.26 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 121.941 1.761 . . . . 73.24 112.829 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -70.13 -41.25 74.17 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.362 0.665 . . . . 72.25 111.455 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.32 -44.02 89.15 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.661 -0.699 . . . . 74.32 109.764 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.528 ' NH1' HD12 ' C' ' 105' ' ' ILE . 30.6 ttm180 -52.6 -48.66 66.15 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.639 1.175 . . . . 74.13 110.64 174.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.07 -49.71 66.69 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.446 0.698 . . . . 75.51 111.33 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 33.1 t -61.54 -26.43 67.93 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.473 0.709 . . . . 73.21 111.495 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 81.1 mt -77.81 -57.3 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 123.84 0.856 . . . . 65.32 110.117 174.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.5 m -55.59 -34.74 65.1 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.823 0.849 . . . . 62.25 111.89 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.0 t -63.73 -49.99 70.88 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.318 -0.856 . . . . 72.24 110.058 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 30.4 mtm -66.5 -37.51 85.23 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.103 0.561 . . . . 71.33 111.229 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.0 t -57.07 -47.98 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 124.02 0.825 . . . . 75.13 110.048 175.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 29.3 t -73.45 -28.89 62.2 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 115.039 -0.982 . . . . 62.05 111.438 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -72.83 -28.64 62.66 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.207 0.603 . . . . 73.22 109.872 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.13 4.67 75.21 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 123.659 0.599 . . . . 64.33 112.918 172.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.57 HG23 HH21 ' B' ' 15' ' ' ARG . 0.6 OUTLIER 65.72 16.33 10.45 Favored 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 126.515 1.926 . . . . 72.11 112.347 177.356 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -79.16 152.93 76.95 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 123.575 0.75 . . . . 61.33 109.666 172.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.98 134.31 63.72 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.474 2.116 . . . . 74.42 111.14 171.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -56.65 158.08 4.85 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.557 0.743 . . . . 72.42 112.416 -173.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.0 tp -135.85 93.73 2.97 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.28 -0.873 . . . . 75.52 109.333 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -98.12 99.14 10.38 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.986 -1.116 . . . . 71.51 107.986 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 19.0 tp -59.26 136.7 58.04 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.294 -0.867 . . . . 61.3 110.346 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.04 145.14 81.16 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 124.284 1.033 . . . . 72.31 112.147 -175.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.06 123.34 11.75 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.204 2.603 . . . . 52.25 111.759 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 77.1 t -116.02 115.94 50.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 108.96 -0.755 . . . . 74.3 108.96 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -73.26 74.69 1.32 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.88 0.872 . . . . 71.54 108.654 173.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 24.9 t80 . . . . . 0 N--CA 1.473 0.714 0 C-N-CA 125.037 1.335 . . . . 72.25 111.903 -163.318 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.507 ' HB3' HG13 ' B' ' 89' ' ' ILE . 4.2 ppp? . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 113.218 0.822 . . . . 63.22 113.218 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 93.8 m -133.57 113.59 12.61 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.134 0.574 . . . . 64.31 109.504 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -123.61 143.68 50.08 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.102 0.961 . . . . 75.45 109.342 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -162.88 141.43 8.48 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.38 0.672 . . . . 73.54 110.268 169.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.513 HD13 HD11 ' B' ' 16' ' ' ILE . 49.2 mt -68.68 129.39 33.23 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 109.014 -0.735 . . . . 75.12 109.014 171.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -97.95 -42.27 7.61 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.209 0.604 . . . . 64.32 109.537 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.57 HH21 HG23 ' A' ' 122' ' ' THR . 21.7 ttt85 -168.48 144.89 3.77 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.79 -0.641 . . . . 54.03 109.457 -174.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.513 HD11 HD13 ' B' ' 13' ' ' ILE . 96.4 mt -128.73 144.65 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 107.56 -1.274 . . . . 74.44 107.56 175.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -171.12 156.03 4.62 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.182 0.515 . . . . 65.11 111.462 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 95.2 m -85.2 126.28 33.53 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.634 -0.712 . . . . 55.42 109.244 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.455 ' HZ1' ' HB3' ' A' ' 28' ' ' ALA . 33.4 mttp -86.49 -48.36 8.47 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.27 0.628 . . . . 71.33 110.61 172.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -144.96 136.91 25.74 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 110.115 -0.328 . . . . 74.32 110.115 -165.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 44.7 mm -131.69 142.41 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.389 1.076 . . . . 74.13 109.309 176.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.687 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 69.3 m -138.84 136.67 35.85 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.83 1.252 . . . . 60.21 108.439 177.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' B' ' 75' ' ' LEU . 75.7 t80 -149.91 107.46 3.65 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 107.858 -1.164 . . . . 54.23 107.858 165.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -121.79 112.12 17.97 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.096 0.959 . . . . 74.24 108.945 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.484 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -113.53 87.6 12.0 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.688 1.195 . . . . 64.11 108.231 174.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.9 -41.93 12.72 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.867 2.378 . . . . 71.03 111.837 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.464 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 2.5 m-20 -90.87 3.49 54.36 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.874 -1.057 . . . . 72.32 111.345 -175.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.484 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -37.06 -60.51 0.8 Allowed Pre-proline 0 N--CA 1.49 1.552 0 C-N-CA 125.668 1.587 . . . . 71.34 114.973 -164.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.7 -31.63 58.55 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 122.474 2.116 . . . . 53.32 113.278 -173.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -88.62 -38.08 15.12 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.06 0.544 . . . . 71.44 111.103 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.695 HG22 HD12 ' B' ' 68' ' ' LEU . 8.9 p -69.5 -19.15 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 123.339 0.656 . . . . 75.14 111.486 -174.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -58.74 -20.66 51.24 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 113.372 0.879 . . . . 72.21 113.372 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.48 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.1 pt20 -59.82 -31.97 70.21 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.462 0.705 . . . . 72.44 111.33 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.48 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 99.8 mttt -87.91 95.95 10.3 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.878 0.871 . . . . 64.3 109.944 -176.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -91.07 87.52 6.61 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.783 -0.644 . . . . 65.21 110.597 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -163.17 -179.22 6.5 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.886 0.874 . . . . 74.23 109.726 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -77.81 108.36 7.18 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.589 0.755 . . . . 73.12 109.812 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.4 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 37.7 Cg_endo -64.77 142.1 74.91 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.433 2.089 . . . . 70.51 113.109 -176.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -68.79 119.95 13.97 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.77 0.828 . . . . 73.31 109.395 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 24.4 m -106.98 161.31 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 123.727 0.811 . . . . 72.13 112.173 -169.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.523 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 55.9 tttm -135.5 109.66 8.31 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.387 1.075 . . . . 72.53 108.794 175.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mp -90.15 138.06 31.83 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.015 -0.735 . . . . 73.21 109.015 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.559 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 7.2 t70 -149.79 158.26 43.99 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 107.838 -1.171 . . . . 62.02 107.838 -176.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.4 ' HB2' HD11 ' B' ' 60' ' ' LEU . 2.4 pt? -140.52 158.97 43.2 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.034 0.445 . . . . 54.35 110.478 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 28.9 t70 -146.86 155.58 42.44 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.881 0.872 . . . . 73.3 108.903 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 58.6 m -108.45 137.35 46.57 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.699 0.8 . . . . 72.44 110.854 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.675 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -142.8 146.31 34.09 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.739 -1.208 . . . . 52.42 107.739 166.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.4 p -142.74 168.63 19.27 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.23 0.612 . . . . 62.43 109.935 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' SER . . . . . 0.573 ' HB2' ' HB3' ' B' ' 57' ' ' GLU . 2.3 m -150.65 151.93 33.23 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.149 -1.056 . . . . 74.1 108.149 170.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -115.57 106.59 14.1 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.23 -1.396 . . . . 73.2 107.23 168.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' B' ' 57' ' ' GLU . 21.1 mt -87.53 -38.12 16.3 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.477 0.711 . . . . 64.24 109.771 -173.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.8 -171.24 3.59 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.521 -1.218 . . . . 72.14 109.416 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -69.59 125.59 27.17 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.091 -0.959 . . . . 72.4 108.445 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 68.92 -2.09 1.86 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.771 1.229 . . . . 73.25 112.811 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 88.9 t -107.1 105.25 18.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 108.818 -0.808 . . . . 63.34 108.818 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.584 ' HB2' HD11 ' B' ' 86' ' ' ILE . 1.2 m-85 -116.36 141.65 47.88 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.524 1.129 . . . . 74.31 108.902 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.573 ' HB3' ' HB2' ' B' ' 49' ' ' SER . 6.7 tm-20 -113.8 97.0 6.14 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.39 -1.337 . . . . 74.45 107.39 -176.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 46.4 t -92.32 128.09 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.964 0.905 . . . . 64.22 109.765 -174.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.675 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 17.6 t -120.64 118.18 55.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 C-N-CA 124.105 0.962 . . . . 74.42 108.761 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.424 ' HB2' ' HB3' ' B' ' 103' ' ' PRO . 43.9 tp -102.88 127.63 50.0 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.986 -0.746 . . . . 65.23 108.986 170.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.445 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 12.7 ttm180 -86.25 135.91 33.38 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.876 -0.787 . . . . 71.02 108.876 169.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.451 ' CG1' HD11 ' B' ' 114' ' ' ILE . 93.9 t -122.32 103.48 13.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 106.958 -1.497 . . . . 71.34 106.958 175.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 52.9 m -95.43 135.99 36.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.918 0.887 . . . . 72.03 108.74 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.599 HG21 HG21 ' B' ' 114' ' ' ILE . 98.3 t -132.44 117.65 32.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.854 -1.165 . . . . 74.43 107.854 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 32.2 m -105.53 149.97 25.77 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.89 -1.152 . . . . 54.22 107.89 170.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.79 145.12 29.81 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.09 -0.707 . . . . 45.23 109.09 176.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.501 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 54.3 p -150.39 128.45 11.88 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 123.865 0.728 . . . . 71.31 110.517 -176.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.695 HD12 HG22 ' B' ' 31' ' ' VAL . 71.1 mt -93.51 98.25 11.06 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 107.281 -1.377 . . . . 54.2 107.281 172.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.97 -129.02 12.41 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 114.91 -1.041 . . . . 74.44 113.568 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -86.72 4.05 42.32 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.469 0.708 . . . . 72.43 112.063 -173.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.464 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 13.2 pt-20 -129.63 152.91 48.63 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.927 0.491 . . . . 75.15 110.213 -177.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 85.6 m -72.33 132.87 44.58 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.327 0.651 . . . . 75.23 110.277 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.536 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -86.44 -62.73 1.45 Allowed 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.851 -1.166 . . . . 53.14 107.851 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -156.01 160.73 40.29 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 115.141 -0.936 . . . . 74.24 111.783 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 23.2 mt -124.74 114.75 19.69 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 106.321 -1.733 . . . . 64.21 106.321 174.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.464 ' SG ' HG23 ' B' ' 114' ' ' ILE . 35.2 t -119.41 146.18 45.59 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.876 -0.787 . . . . 72.22 108.876 175.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.687 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 42.9 tt0 -158.45 134.61 9.22 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.345 -0.613 . . . . 72.4 109.345 -175.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 91.5 t -129.75 142.81 42.92 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 C-N-CA 123.726 0.81 . . . . 71.11 109.107 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -124.28 96.97 5.12 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 107.651 -1.24 . . . . 71.44 107.651 172.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -89.32 107.67 19.19 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.198 -1.038 . . . . 73.55 108.198 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.99 143.56 17.12 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.187 -0.765 . . . . 74.33 111.187 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.8 126.9 2.47 Favored Glycine 0 CA--C 1.51 -0.273 0 N-CA-C 112.04 -0.424 . . . . 60.14 112.04 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 38.9 mt -85.92 128.19 39.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.37 -0.974 . . . . 71.31 108.37 173.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -137.46 147.94 45.69 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.242 0.617 . . . . 73.32 110.039 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 62.8 m -97.41 125.6 42.14 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.118 -0.697 . . . . 70.21 109.118 170.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.584 HD11 ' HB2' ' B' ' 56' ' ' TYR . 1.8 pt -138.26 118.13 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 125.049 1.34 . . . . 72.13 108.993 -174.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' B' ' 9' ' ' MET . . . -152.25 168.04 26.65 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.237 0.615 . . . . 73.51 111.055 -173.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.27 -71.0 1.43 Allowed Glycine 0 C--N 1.348 1.225 0 O-C-N 123.496 0.497 . . . . 64.22 112.673 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.685 HG22 ' HB2' ' B' ' 94' ' ' MET . 10.7 mt -75.02 157.61 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.716 0.807 . . . . 74.41 110.651 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.598 ' HG2' ' H ' ' B' ' 91' ' ' GLY . 11.7 tt0 -151.96 -176.48 5.66 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.93 0.892 . . . . 73.21 108.667 173.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.598 ' H ' ' HG2' ' B' ' 90' ' ' GLU . . . 75.51 -136.27 19.81 Favored Glycine 0 C--N 1.345 1.053 0 C-N-CA 123.139 0.399 . . . . 52.33 113.187 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 44.0 m -70.17 -41.64 73.53 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.569 0.748 . . . . 70.02 111.352 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -60.14 -35.53 75.5 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.941 -1.027 . . . . 61.14 111.052 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.685 ' HB2' HG22 ' B' ' 89' ' ' ILE . 9.9 tmm? -85.14 -31.26 23.38 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.129 0.971 . . . . 74.15 111.52 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.61 -27.58 67.86 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.4 0.619 . . . . 72.42 110.324 170.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -79.64 -29.33 40.93 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.111 1.365 . . . . 53.22 111.646 173.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -63.22 -51.71 65.16 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.873 0.469 . . . . 65.32 111.746 -175.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 pp -89.62 -13.33 37.37 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 117.853 0.297 . . . . 54.42 110.99 171.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.95 3.12 85.94 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-O 119.479 -0.623 . . . . 73.0 114.099 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.69 -54.92 0.09 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.231 0.612 . . . . 62.34 110.724 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -72.88 -49.72 28.2 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.366 0.876 . . . . 73.03 113.366 -165.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.484 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 62.7 m -59.7 -47.81 96.7 Favored Pre-proline 0 CA--C 1.565 1.526 0 CA-C-O 119.189 -0.434 . . . . 44.13 111.907 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 23.9 Cg_exo -67.14 -24.97 43.95 Favored 'Trans proline' 0 C--N 1.393 2.879 0 C-N-CA 122.263 1.975 . . . . 71.53 113.599 173.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -63.96 -37.5 87.65 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.365 0.666 . . . . 75.35 110.213 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.413 HG23 ' NH2' ' D' ' 111' ' ' ARG . 68.4 mt -65.54 -39.12 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 115.671 -0.695 . . . . 72.55 110.485 175.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.24 -17.26 52.76 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.24 -0.891 . . . . 62.12 111.735 -175.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -58.99 -49.51 92.98 Favored Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 124.789 1.236 . . . . 73.32 113.556 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -60.79 -39.4 62.92 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 122.262 1.974 . . . . 71.43 113.019 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -64.38 -33.73 76.54 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.487 -0.779 . . . . 71.11 110.491 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.494 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -72.35 -42.16 65.64 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 115.857 -0.611 . . . . 62.23 110.341 174.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -53.36 -55.52 24.21 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.218 1.007 . . . . 71.42 111.527 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.419 ' HG3' ' NH2' ' C' ' 120' ' ' ARG . 2.1 tm-20 -64.03 -34.77 78.76 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.802 0.689 . . . . 44.35 110.106 -177.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.512 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.2 t -73.5 -27.59 61.45 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.734 0.414 . . . . 72.53 111.7 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.599 HG21 HG21 ' B' ' 64' ' ' VAL . 73.0 mt -71.11 -58.62 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 108.578 -0.897 . . . . 74.54 108.578 173.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 4.8 m -65.0 -23.08 67.11 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.906 -1.043 . . . . 73.24 111.441 -173.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 37.7 t -61.52 -49.87 74.96 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.302 0.641 . . . . 73.42 109.454 171.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.2 mmt -71.53 -34.14 69.78 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.415 0.686 . . . . 73.32 110.82 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 114' ' ' ILE . 87.5 t -59.76 -46.1 93.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.709 0.804 . . . . 61.43 109.85 172.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -64.56 -36.67 84.98 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.724 -1.125 . . . . 71.23 110.834 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.483 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 93.5 mtt-85 -65.46 -32.84 74.67 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.247 0.619 . . . . 74.11 110.125 177.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.64 8.71 70.97 Favored Glycine 0 C--N 1.353 1.495 0 O-C-N 123.639 0.587 . . . . 71.33 113.146 174.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.49 HG23 ' HB3' ' A' ' 17' ' ' TYR . 75.7 p 57.47 26.92 13.23 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 126.235 1.814 . . . . 42.34 113.5 177.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -88.08 158.21 50.1 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 123.519 0.728 . . . . 64.35 111.02 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -58.04 157.63 24.32 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 123.403 2.735 . . . . 73.32 114.338 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.591 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -65.33 123.19 18.95 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.482 -1.235 . . . . 64.33 112.186 -177.231 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -138.43 115.3 10.78 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 108.388 -0.967 . . . . 71.44 108.388 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -110.9 136.06 50.49 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.874 0.87 . . . . 74.22 109.819 176.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.417 HD12 ' H ' ' B' ' 129' ' ' ALA . 10.0 tp -86.78 135.52 33.33 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.334 0.653 . . . . 73.21 110.739 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 129' ' ' ALA . . . . . 0.417 ' H ' HD12 ' B' ' 128' ' ' LEU . . . -68.05 147.0 98.42 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.733 1.213 . . . . 74.23 111.779 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.489 ' HG2' HD13 ' D' ' 16' ' ' ILE . 7.1 Cg_exo -70.06 104.16 1.32 Allowed 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.75 2.3 . . . . 72.04 111.994 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 10.8 m -92.84 108.16 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 122.092 0.948 . . . . 64.41 109.601 173.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.54 83.89 3.87 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.949 -1.023 . . . . 75.04 108.423 172.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -52.67 -46.74 67.33 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.608 -0.723 . . . . 71.33 109.633 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 C--N 1.344 0.35 0 CA-C-N 113.411 -1.722 . . . . 64.34 112.458 179.658 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.533 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.6 t80 . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 110.276 -0.268 . . . . 63.11 110.276 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -150.85 131.17 13.66 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.536 0.735 . . . . 63.21 109.384 171.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 78.9 mt -74.99 124.06 31.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 108.445 -0.946 . . . . 70.14 108.445 172.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.44 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 18.1 mm100 -93.74 -39.53 10.71 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.301 0.64 . . . . 71.31 110.915 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -177.19 127.01 0.15 Allowed 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.228 0.33 . . . . 71.35 110.714 -175.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 84.1 mt -114.69 133.42 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.51 0.724 . . . . 74.23 109.473 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.514 ' HE2' ' HD3' ' C' ' 19' ' ' LYS . 23.6 p90 -170.54 172.43 5.95 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-O 121.43 0.633 . . . . 74.21 110.53 -171.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.8 p -97.08 121.65 39.2 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.417 -0.811 . . . . 72.31 109.1 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.514 ' HD3' ' HE2' ' C' ' 17' ' ' TYR . 29.9 mmtp -68.98 -46.69 67.44 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.35 1.072 . . . . 74.05 108.186 167.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 13.1 t70 -141.76 138.36 32.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 112.989 -1.914 . . . . 72.43 109.041 -167.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.563 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.2 mt -134.38 152.59 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 107.258 -1.386 . . . . 61.3 107.258 174.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -160.4 152.87 20.78 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.395 0.617 . . . . 71.11 110.843 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -149.01 135.43 19.39 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.572 -1.27 . . . . 65.04 107.572 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -140.82 110.38 6.36 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.743 0.817 . . . . 75.44 109.313 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.54 85.67 56.04 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 105.371 -2.085 . . . . 64.44 105.371 165.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.82 -17.99 41.75 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 122.866 2.378 . . . . 74.45 112.397 -175.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -112.88 19.27 17.47 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.956 1.302 . . . . 74.25 110.289 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.02 -56.88 6.89 Favored Pre-proline 0 N--CA 1.489 1.475 0 N-CA-C 114.297 1.221 . . . . 62.01 114.297 -170.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.456 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 38.0 Cg_endo -62.02 -35.72 74.95 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.103 1.869 . . . . 75.22 112.582 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -68.34 -50.57 52.35 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.171 0.588 . . . . 74.11 110.972 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.704 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.0 p -69.46 -23.65 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 N-CA-C 112.772 0.656 . . . . 74.2 112.772 -169.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -62.74 -33.16 74.56 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.52 0.563 . . . . 71.25 112.52 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -88.36 15.68 7.43 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.759 0.424 . . . . 63.0 112.099 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.726 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -95.56 158.68 15.35 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.915 0.886 . . . . 72.35 109.993 175.643 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -70.18 129.5 39.56 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 109.047 -0.723 . . . . 75.52 109.047 170.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 55.6 t-105 -78.44 80.41 4.83 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.429 0.692 . . . . 72.44 110.44 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -129.14 74.05 81.34 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 108.279 -1.008 . . . . 75.42 108.279 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -95.92 176.51 0.79 Allowed 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.068 2.512 . . . . 75.04 112.688 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 39' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' C' ' 67' ' ' SER . 0.9 OUTLIER -117.82 120.2 37.21 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.417 -1.698 . . . . 75.24 106.417 169.636 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.68 97.42 5.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.257 -1.016 . . . . 75.42 108.257 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.506 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 10.1 tmtt? -91.6 108.67 20.07 Favored 'General case' 0 CA--C 1.527 0.081 0 N-CA-C 106.851 -1.537 . . . . 63.34 106.851 175.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 mp -86.53 136.38 33.1 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.695 -0.854 . . . . 74.51 108.695 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.58 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 23.4 t70 -123.04 137.95 54.81 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 124.993 1.317 . . . . 72.23 107.948 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.53 HD21 HD11 ' C' ' 60' ' ' LEU . 6.1 tt -135.48 139.9 44.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.585 -1.265 . . . . 73.4 107.585 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.499 ' N ' HD23 ' C' ' 44' ' ' LEU . 29.9 t70 -143.41 152.64 41.8 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.523 0.729 . . . . 61.23 109.36 170.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 72.4 p -115.48 112.28 22.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.84 0.856 . . . . 75.11 109.486 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.91 157.18 20.96 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.662 -0.866 . . . . 61.2 108.662 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 31.4 p -164.86 169.63 16.36 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.449 0.537 . . . . 64.34 112.449 -170.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 41.9 t -170.12 129.31 0.91 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.232 1.013 . . . . 61.35 109.345 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -77.67 115.5 17.47 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.597 -1.26 . . . . 70.45 107.597 166.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.685 HD11 HD12 ' C' ' 83' ' ' ILE . 62.9 mt -89.48 -36.3 15.48 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.175 0.59 . . . . 74.11 110.805 -175.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.33 -168.68 0.84 Allowed 'General case' 0 CA--C 1.54 0.585 0 O-C-N 124.139 0.9 . . . . 54.3 111.15 -174.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -66.53 114.12 5.26 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.671 1.188 . . . . 74.21 110.084 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 65.82 -3.03 0.79 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 125.234 1.413 . . . . 72.34 113.227 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.418 HG12 ' HB2' ' C' ' 51' ' ' LEU . 78.9 t -98.7 107.17 19.95 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.429 -0.952 . . . . 55.01 108.429 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 56' ' ' TYR . . . . . 0.443 ' HB3' HD13 ' C' ' 86' ' ' ILE . 49.2 t80 -122.12 137.12 54.94 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.809 -0.632 . . . . 72.23 110.064 -176.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -94.65 119.53 33.44 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.117 0.967 . . . . 75.11 109.735 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.09 117.5 55.17 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.137 -1.06 . . . . 75.14 108.137 174.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.07 136.04 56.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 108.366 -0.976 . . . . 72.01 108.366 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.53 HD11 HD21 ' C' ' 44' ' ' LEU . 16.2 tp -121.58 114.26 20.94 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 109.189 -0.671 . . . . 61.54 109.189 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 13.3 ttm180 -82.08 108.46 15.57 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.626 -0.879 . . . . 75.25 108.626 172.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 22.2 t -103.93 123.28 57.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.093 -1.447 . . . . 72.45 107.093 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.58 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 86.0 m -136.92 119.56 16.05 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 123.194 0.598 . . . . 61.22 109.448 -173.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 54.3 t -103.95 113.47 40.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 123.608 0.763 . . . . 63.21 109.135 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 4.9 m -99.4 134.94 41.53 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.674 -1.232 . . . . 74.45 107.674 171.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.01 120.28 25.74 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.791 -1.559 . . . . 71.33 106.791 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 67' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 57.0 m -135.52 130.37 34.49 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.081 0.467 . . . . 75.23 110.938 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.726 HD13 ' HG2' ' C' ' 34' ' ' LYS . 8.6 mt -84.67 46.62 1.27 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.93 1.292 . . . . 71.44 109.246 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.41 -119.72 6.48 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 109.46 -1.456 . . . . 62.12 109.46 -165.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -91.17 -19.49 23.01 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.235 0.614 . . . . 74.31 110.198 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -70.62 84.67 0.63 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.747 0.819 . . . . 63.14 108.962 174.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 72' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 62.4 m -62.42 121.6 13.65 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 110.291 -0.263 . . . . 74.21 110.291 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.704 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -67.92 -61.76 1.72 Allowed 'General case' 0 C--O 1.235 0.342 0 O-C-N 124.069 0.856 . . . . 54.14 108.739 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -155.06 172.76 17.59 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-O 122.211 1.005 . . . . 71.03 111.196 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.42 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.3 tm? -130.74 144.21 51.28 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 105.043 -2.206 . . . . 61.33 105.043 169.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.438 ' SG ' HG23 ' C' ' 114' ' ' ILE . 51.2 t -151.52 135.31 16.4 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.649 -0.871 . . . . 63.34 108.649 177.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -139.66 138.79 36.38 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.081 0.552 . . . . 74.41 109.928 -174.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.403 HG21 ' HB3' ' C' ' 113' ' ' CYS . 48.2 t -141.91 113.46 3.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.959 -1.126 . . . . 72.1 107.959 176.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -91.07 88.31 6.93 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.235 -1.024 . . . . 72.41 108.235 172.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -78.76 101.15 7.43 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.007 -0.997 . . . . 73.34 108.996 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.25 143.4 17.99 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 111.614 -0.594 . . . . 43.21 111.614 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.56 116.47 0.99 Allowed Glycine 0 CA--C 1.499 -0.949 0 N-CA-C 109.968 -1.253 . . . . 72.23 109.968 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.685 HD12 HD11 ' C' ' 51' ' ' LEU . 12.6 mm -81.63 120.44 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.736 -1.209 . . . . 74.22 107.736 177.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.533 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 54.7 m-85 -130.9 134.74 47.05 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.453 -0.943 . . . . 61.44 108.453 -177.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 49.3 m -80.24 117.42 21.0 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.949 -0.76 . . . . 64.21 108.949 170.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.443 HD13 ' HB3' ' C' ' 56' ' ' TYR . 4.1 mp -115.43 118.07 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.051 -1.092 . . . . 73.23 108.051 173.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.03 162.77 34.42 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.745 0.818 . . . . 74.34 109.86 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.12 -63.24 3.47 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.335 -0.848 . . . . 41.42 112.496 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 28.5 pt -90.03 145.86 6.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-O 120.876 0.37 . . . . 60.13 110.675 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -146.32 150.47 35.8 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.319 -0.855 . . . . 65.22 109.088 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.49 -135.89 13.02 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-O 119.721 -0.488 . . . . 41.31 112.262 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 15.5 m -67.24 -35.11 78.87 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.819 0.848 . . . . 53.11 111.412 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -56.72 -48.66 77.26 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.728 1.211 . . . . 44.43 109.682 176.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 2.7 ttp -66.62 -43.83 83.71 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 113.305 -1.77 . . . . 71.44 110.998 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.21 69.82 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.719 0.808 . . . . 55.31 111.68 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -67.09 -41.89 85.55 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.754 0.822 . . . . 73.2 110.621 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 30.1 t -63.95 -53.16 54.66 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.832 -0.622 . . . . 72.13 109.86 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 80.3 mt -70.14 -28.54 65.44 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.828 0.851 . . . . 72.43 112.695 -175.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.43 12.76 33.29 Favored Glycine 0 N--CA 1.475 1.27 0 N-CA-C 114.322 0.489 . . . . 71.24 114.322 -167.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' C' ' 133' ' ' PHE . . . -155.89 -60.08 0.1 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.787 0.803 . . . . 64.22 110.8 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.404 ' CE2' ' CE1' ' C' ' 11' ' ' PHE . 53.5 t80 -75.28 -38.2 60.54 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-N 113.607 -1.633 . . . . 74.44 112.324 -170.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 79.0 m -83.14 -43.8 0.86 Allowed Pre-proline 0 CA--C 1.565 1.528 0 C-N-CA 123.883 0.873 . . . . 61.31 112.699 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.417 ' HB3' HD13 ' C' ' 60' ' ' LEU . 32.7 Cg_exo -64.86 -20.94 64.7 Favored 'Trans proline' 0 C--N 1.394 2.938 0 C-N-CA 122.325 2.016 . . . . 74.11 112.312 173.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -67.5 -33.83 75.89 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.661 0.784 . . . . 75.01 110.512 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.528 HD12 ' NH1' ' A' ' 111' ' ' ARG . 44.0 mm -65.19 -35.56 75.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-N 115.67 -0.696 . . . . 62.24 109.752 174.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 82.7 mt -89.62 -22.35 22.36 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.201 1.001 . . . . 51.42 112.449 -174.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -54.92 -51.13 81.94 Favored Pre-proline 0 CA--C 1.559 1.297 0 N-CA-C 113.299 0.852 . . . . 74.43 113.299 -174.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -64.23 -34.45 56.28 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.083 1.855 . . . . 34.53 112.871 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -66.32 -44.81 82.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.185 0.594 . . . . 64.12 110.854 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.17 -38.6 88.46 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.527 -0.761 . . . . 73.34 110.661 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -57.64 -53.82 53.84 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.454 1.101 . . . . 72.31 110.594 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.27 -32.58 74.08 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.59 0.556 . . . . 52.42 110.463 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.403 ' HB3' HG21 ' C' ' 78' ' ' VAL . 8.0 t -73.1 -33.12 65.39 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 122.939 0.495 . . . . 74.43 111.257 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.438 HG23 ' SG ' ' C' ' 76' ' ' CYS . 57.3 mt -71.57 -52.88 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.039 0.536 . . . . 64.13 109.758 174.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.4 m -65.98 -27.05 67.85 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.424 0.689 . . . . 75.31 111.009 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -62.6 -49.4 75.36 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 109.279 -0.637 . . . . 53.42 109.279 169.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.679 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.8 -36.4 81.01 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.208 1.003 . . . . 71.2 112.546 178.222 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.1 -44.35 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.407 0.683 . . . . 72.12 109.343 173.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.457 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 22.7 t -73.27 -25.06 60.54 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.121 -0.945 . . . . 65.3 111.565 -177.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.419 ' NH2' ' HG3' ' B' ' 112' ' ' GLU . 78.3 mtt-85 -75.02 -41.66 58.87 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.567 0.747 . . . . 71.34 108.995 176.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.12 1.6 68.93 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 124.254 0.971 . . . . 61.2 112.364 172.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 22.3 p 60.96 29.84 19.26 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.632 1.973 . . . . 54.44 113.523 170.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -83.65 148.44 54.83 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 123.457 0.703 . . . . 63.12 110.193 173.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -52.83 139.35 59.72 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.351 2.701 . . . . 73.22 113.341 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.419 HE21 ' NE2' ' B' ' 125' ' ' GLN . 73.1 mm-40 -56.88 112.95 1.47 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.615 1.166 . . . . 53.24 112.353 -175.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.38 100.9 7.58 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.291 -1.744 . . . . 71.53 106.291 174.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -99.09 131.4 45.16 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.284 0.634 . . . . 65.32 110.318 -172.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.94 142.04 38.62 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.542 0.737 . . . . 73.14 110.041 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.46 162.05 74.15 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.055 0.942 . . . . 72.2 111.58 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.33 109.34 0.97 Allowed 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.385 2.057 . . . . 55.3 111.972 173.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.24 106.85 19.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 108.006 -1.109 . . . . 74.44 108.006 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -101.81 91.6 4.46 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.725 -1.583 . . . . 72.44 106.725 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 133' ' ' PHE . . . . . 0.487 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 45.8 m-85 -58.09 -37.79 75.18 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.597 0.713 . . . . 73.33 109.534 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 2.6 t70 . . . . . 0 C--N 1.347 0.486 0 CA-C-N 113.789 -1.55 . . . . 72.23 111.059 -177.575 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 55.7 m . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 109.926 -0.398 . . . . 73.13 109.926 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -159.04 113.88 2.47 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.203 -1.036 . . . . 74.02 108.203 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 12' ' ' GLN . . . . . 0.465 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 49.3 mt-30 -133.33 135.91 45.07 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.865 0.866 . . . . 54.31 108.895 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 16.6 mt -92.47 120.21 41.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 109.48 -0.563 . . . . 73.12 109.48 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -91.61 -47.21 7.52 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.284 0.365 . . . . 62.41 111.404 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -166.6 123.41 1.27 Allowed 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 111.434 0.161 . . . . 71.1 111.434 -168.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.489 HD13 ' HG2' ' B' ' 130' ' ' PRO . 1.7 mp -103.73 137.54 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 108.462 -0.94 . . . . 75.51 108.462 170.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.467 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 22.7 p90 -162.05 168.76 22.15 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 124.16 0.912 . . . . 70.22 110.861 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.1 p -96.98 122.66 40.21 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.405 -0.961 . . . . 74.11 108.405 171.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.467 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 34.4 mtpt -85.13 -40.17 17.06 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.986 -0.746 . . . . 74.42 108.986 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.515 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.8 t70 -140.62 141.26 35.13 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 113.978 -1.464 . . . . 71.04 108.99 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.679 HG21 ' HE2' ' C' ' 117' ' ' MET . 94.0 mt -135.44 147.75 28.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.695 1.198 . . . . 75.11 107.922 174.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -147.32 143.4 28.02 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.416 1.086 . . . . 74.42 108.523 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.563 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.9 t80 -149.47 132.24 15.99 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.577 -1.638 . . . . 70.13 106.577 171.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 46.5 mt-10 -135.68 151.16 49.92 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.716 -1.216 . . . . 62.42 107.716 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.66 91.59 5.27 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 108.332 -0.988 . . . . 62.55 108.332 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.78 -50.9 3.52 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.398 2.732 . . . . 53.53 113.551 -171.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.494 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 18.6 m-20 -99.86 14.1 31.54 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.832 0.853 . . . . 64.01 110.071 -171.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.484 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -28.48 -68.72 0.1 OUTLIER Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 126.826 2.05 . . . . 61.13 115.82 -163.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.29 -19.67 19.47 Favored 'Trans proline' 0 C--N 1.382 2.322 0 CA-C-N 123.162 2.165 . . . . 71.14 114.05 -173.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -79.11 -43.01 24.94 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.848 0.859 . . . . 74.5 109.944 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' D' ' 27' ' ' ASN . 10.0 p -75.01 -15.33 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-N 115.613 -0.721 . . . . 62.2 110.744 -172.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -70.56 -17.71 62.92 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 112.281 0.474 . . . . 72.13 112.281 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -64.36 -11.21 30.23 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.372 0.669 . . . . 74.3 110.879 173.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -105.55 97.17 7.04 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.014 1.726 . . . . 73.41 109.438 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -104.91 89.72 3.24 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.547 0.739 . . . . 71.34 109.329 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -162.43 171.88 16.43 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.141 0.976 . . . . 71.43 109.124 171.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -63.56 110.75 4.03 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 123.26 0.624 . . . . 63.21 109.634 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -64.73 143.92 82.16 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.629 2.219 . . . . 70.24 112.325 -176.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -71.48 116.02 11.33 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.442 0.697 . . . . 72.5 109.166 173.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.589 HG13 HG13 ' D' ' 64' ' ' VAL . 78.5 t -115.45 130.28 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.611 0.764 . . . . 74.41 110.963 -169.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.566 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 16.6 tptm -106.11 134.74 48.76 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.656 1.183 . . . . 74.25 108.579 173.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -110.17 114.81 28.6 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.611 0.764 . . . . 64.45 109.741 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.49 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 3.7 m-20 -108.87 113.64 26.72 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.993 0.917 . . . . 51.31 108.532 174.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 8.7 mp -101.29 132.05 47.01 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.182 -0.673 . . . . 52.5 109.182 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 25.0 t70 -132.48 150.11 52.21 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.027 0.931 . . . . 73.44 108.749 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 52.2 m -105.83 144.04 33.13 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.07 0.948 . . . . 71.31 110.955 -171.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.433 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.65 161.38 39.89 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.86 1.264 . . . . 54.4 108.994 171.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.3 p -175.71 166.63 3.16 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.127 0.571 . . . . 42.25 111.349 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 80.3 p -161.96 143.3 10.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.528 0.731 . . . . 54.54 110.044 172.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -78.91 121.47 24.91 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.628 -0.878 . . . . 71.33 108.628 171.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 76.3 mt -99.84 -29.03 12.83 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.809 0.444 . . . . 71.42 111.318 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.26 -175.43 4.84 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.483 0.659 . . . . 74.5 111.135 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -62.62 122.49 15.97 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.1 -1.409 . . . . 43.13 109.479 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 60.09 16.29 5.82 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.786 0.834 . . . . 63.12 112.592 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 81.8 t -119.6 125.74 74.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 C-N-CA 123.806 0.843 . . . . 71.24 108.756 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -135.09 130.85 36.18 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.874 -0.603 . . . . 64.14 109.598 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -91.23 139.81 30.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.317 -0.856 . . . . 74.14 109.579 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 62.5 t -120.8 126.12 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 107.777 -1.194 . . . . 51.05 107.777 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 21.5 t -125.07 129.28 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.463 0.705 . . . . 75.54 109.363 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.569 HD23 HD12 ' D' ' 106' ' ' LEU . 3.6 mm? -121.7 120.58 35.1 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.031 0.532 . . . . 65.43 110.218 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 32.9 ttm-85 -87.93 102.98 15.24 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.152 -0.931 . . . . 70.14 108.978 172.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.6 t -91.6 126.3 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 107.72 -1.215 . . . . 75.11 107.72 169.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 8.5 m -121.02 131.76 54.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.474 -0.565 . . . . 35.44 109.474 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.589 HG13 HG13 ' D' ' 40' ' ' VAL . 35.3 t -116.4 102.35 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 124.73 1.212 . . . . 71.5 108.856 -173.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.566 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 9.4 m -94.04 91.68 6.97 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.947 -1.131 . . . . 75.21 107.947 173.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.87 150.0 20.91 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.59 -0.732 . . . . 64.04 109.405 -175.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.419 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 67.9 m -149.35 128.95 13.13 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.222 0.534 . . . . 55.11 112.294 -173.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 34.9 mt -110.73 134.55 52.38 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.048 1.339 . . . . 72.25 109.184 174.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.03 -111.85 3.68 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 112.203 -0.359 . . . . 74.45 112.203 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.81 4.47 8.79 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.733 0.813 . . . . 74.52 110.174 178.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -125.22 173.76 8.56 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.688 0.795 . . . . 51.42 110.065 -174.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 82.3 m -72.7 139.58 47.32 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.208 0.528 . . . . 61.24 110.558 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.459 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.7 -67.85 0.8 Allowed 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.012 0.925 . . . . 72.51 108.57 173.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -152.38 160.9 43.24 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.857 -0.611 . . . . 55.45 110.653 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.407 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 68.5 mt -122.84 110.95 16.08 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.739 -1.208 . . . . 72.44 107.739 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.478 ' SG ' HG23 ' D' ' 114' ' ' ILE . 46.0 t -123.73 115.09 20.83 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.124 0.57 . . . . 52.44 109.906 -173.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -130.83 122.83 27.79 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.534 0.734 . . . . 73.33 109.855 -171.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.14 119.21 48.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 C-N-CA 123.259 0.624 . . . . 71.34 109.676 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.4 mt-30 -89.65 87.8 7.16 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.214 -0.662 . . . . 72.44 109.214 170.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.21 109.89 15.1 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.742 -1.117 . . . . 63.12 108.826 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.3 143.83 16.92 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 111.524 -0.63 . . . . 72.55 111.524 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.92 134.41 6.57 Favored Glycine 0 CA--C 1.509 -0.287 0 N-CA-C 110.933 -0.867 . . . . 52.32 110.933 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 48.3 mt -89.0 121.96 39.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 108.251 -1.018 . . . . 74.44 108.251 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -131.13 127.8 38.83 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.202 0.314 . . . . 63.12 110.366 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.465 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 21.2 m -75.96 104.82 6.68 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.064 -0.717 . . . . 71.24 109.064 170.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.465 HD11 HD12 ' D' ' 89' ' ' ILE . 16.4 tt -126.6 133.23 69.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-O 121.38 0.609 . . . . 74.34 111.077 -174.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.49 168.38 26.34 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.244 1.017 . . . . 45.22 109.601 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.07 13.37 81.12 Favored Glycine 0 N--CA 1.473 1.114 0 N-CA-C 114.289 0.476 . . . . 74.33 114.289 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.465 HD12 HD11 ' D' ' 86' ' ' ILE . 37.1 mt -113.49 139.34 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.433 1.093 . . . . 74.41 109.175 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.455 ' HA ' ' HE3' ' D' ' 94' ' ' MET . 8.7 pt-20 -153.77 158.22 40.61 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.51 0.506 . . . . 73.24 112.205 -171.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.56 -137.34 23.37 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.097 -0.956 . . . . 25.44 112.445 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 40.9 p -69.68 -20.6 63.56 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.581 0.753 . . . . 42.01 111.342 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.401 ' NE2' HG12 ' D' ' 89' ' ' ILE . 46.1 tt0 -60.11 -32.53 71.08 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.953 0.901 . . . . 74.11 111.262 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.455 ' HE3' ' HA ' ' D' ' 90' ' ' GLU . 54.4 mtt -62.49 -47.61 83.22 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.38 0.672 . . . . 74.42 110.717 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.51 94.04 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.039 -0.982 . . . . 42.14 110.471 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -66.81 -43.71 83.12 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.214 0.606 . . . . 72.41 111.785 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 39.5 t -63.13 -51.04 68.08 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.326 0.584 . . . . 61.51 110.463 -172.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.401 HD21 HD13 ' D' ' 86' ' ' ILE . 73.9 mt -85.91 -21.24 28.06 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.23 -0.895 . . . . 64.54 111.448 -175.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.39 8.62 55.31 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 119.628 -0.54 . . . . 51.43 114.03 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.92 -54.29 0.09 Allowed 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 117.28 0.54 . . . . 74.45 111.586 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -70.13 -51.1 34.12 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.662 0.385 . . . . 72.32 111.871 -173.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 30.6 m -67.15 -42.16 38.73 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 123.175 0.59 . . . . 40.12 111.904 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -53.72 -35.35 78.04 Favored 'Trans proline' 0 C--N 1.393 2.888 0 C-N-CA 122.667 2.244 . . . . 72.1 113.346 166.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -68.8 -32.92 72.99 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.514 0.726 . . . . 65.15 110.319 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 50.2 mm -67.5 -40.23 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 121.394 0.616 . . . . 75.11 110.146 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.569 HD12 HD23 ' D' ' 60' ' ' LEU . 95.6 mt -84.05 -15.52 47.19 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.274 -0.875 . . . . 63.51 112.064 -176.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 107' ' ' PHE . . . . . 0.402 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 83.3 t80 -61.68 -50.08 83.61 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 124.437 1.095 . . . . 63.4 112.945 -175.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 108' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 38.1 Cg_exo -59.72 -34.6 96.05 Favored 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 122.144 1.896 . . . . 52.33 112.945 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -78.34 -37.22 45.0 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.562 0.745 . . . . 64.21 112.211 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.0 -46.35 78.29 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.426 -0.583 . . . . 75.5 109.426 176.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.413 ' NH2' HG23 ' B' ' 105' ' ' ILE . 46.7 ttp180 -57.37 -47.74 80.86 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 124.41 1.068 . . . . 71.34 110.921 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -60.42 -49.88 75.8 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.808 0.843 . . . . 64.15 111.185 -177.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -56.2 -41.8 76.18 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 123.882 0.739 . . . . 42.12 111.101 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.478 HG23 ' SG ' ' D' ' 76' ' ' CYS . 98.0 mt -63.46 -56.44 17.06 Favored 'Isoleucine or valine' 0 C--N 1.349 0.568 0 CA-C-N 115.17 -0.923 . . . . 71.53 110.202 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -55.14 -36.82 66.18 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.438 1.095 . . . . 74.22 111.739 -173.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 37.2 t -66.97 -43.94 81.76 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.403 -0.817 . . . . 73.51 110.553 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 78.2 mtm -70.64 -25.88 63.22 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.74 0.416 . . . . 72.1 111.956 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.2 t -65.73 -43.79 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.274 0.63 . . . . 61.21 109.638 174.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.7 p -77.03 -27.44 54.49 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.998 -0.546 . . . . 54.22 111.142 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' D' ' 116' ' ' SER . 89.9 mtt-85 -73.02 -35.83 66.85 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.416 0.686 . . . . 65.01 109.866 174.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.4 -2.34 89.32 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.547 -0.751 . . . . 74.25 112.024 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.7 p 65.9 20.44 11.36 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 127.054 2.142 . . . . 63.24 113.657 172.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -79.16 155.0 77.38 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.418 0.687 . . . . 65.44 110.129 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.58 133.71 54.91 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.078 2.519 . . . . 64.32 112.548 172.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -54.41 140.75 32.9 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.416 1.086 . . . . 73.23 112.644 -172.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 62.4 tp -121.2 110.07 15.73 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.165 0.986 . . . . 71.04 109.141 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -111.21 104.96 13.51 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.812 -0.81 . . . . 64.25 108.812 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 tt -70.53 114.21 8.41 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 107.609 -1.256 . . . . 55.44 107.609 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.65 138.32 88.37 Favored Pre-proline 0 N--CA 1.475 0.823 0 CA-C-O 119.609 -0.234 . . . . 61.24 110.408 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -73.62 141.15 30.63 Favored 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 122.457 2.105 . . . . 72.1 111.693 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.241 0.635 0 C-N-CA 123.88 0.872 . . . . 74.24 108.961 -177.836 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.3 t80 . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 109.172 -0.677 . . . . 63.44 109.172 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -153.29 130.96 11.53 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.47 -1.308 . . . . 55.02 107.47 169.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.497 HD12 ' HB2' ' C' ' 130' ' ' PRO . 14.5 mt -80.71 114.76 22.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.778 -0.823 . . . . 74.05 108.778 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -72.55 -39.34 67.55 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 123.891 0.745 . . . . 72.22 110.055 -177.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -177.52 120.93 0.11 Allowed 'General case' 0 C--N 1.366 1.309 0 N-CA-C 111.74 0.274 . . . . 73.3 111.74 -172.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 78.6 mt -106.32 135.0 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.023 -0.732 . . . . 74.13 109.023 173.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.438 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 20.0 p90 -162.52 147.61 12.29 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 124.11 0.881 . . . . 65.32 109.968 -176.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.0 p -75.59 119.15 19.25 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.242 -0.651 . . . . 70.54 109.242 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.2 mtpt -83.22 -32.11 26.67 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.418 -0.586 . . . . 73.53 109.418 176.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 25.0 t70 -144.23 139.54 28.74 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.207 -0.906 . . . . 65.45 110.354 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.6 mt -133.22 145.61 33.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.941 1.296 . . . . 74.15 108.182 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.577 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 48.1 t -149.73 124.83 10.04 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.458 -0.792 . . . . 72.23 109.295 173.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.507 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 86.4 t80 -129.49 111.28 12.6 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 106.62 -1.622 . . . . 71.23 106.62 169.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -121.51 110.41 16.0 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.513 -0.551 . . . . 73.51 109.513 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.32 84.26 0.87 Allowed Pre-proline 0 C--O 1.241 0.654 0 N-CA-C 107.156 -1.424 . . . . 51.25 107.156 168.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.34 -19.3 29.17 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.161 1.908 . . . . 63.43 112.589 -168.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -120.26 22.76 11.24 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.933 0.893 . . . . 74.22 109.77 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.461 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -45.38 -55.04 12.78 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 113.969 1.1 . . . . 60.14 113.969 -170.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 23.2 Cg_exo -64.98 -16.95 57.93 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 121.989 1.792 . . . . 64.51 114.119 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.94 -26.01 13.88 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.305 1.042 . . . . 73.31 110.933 -176.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.81 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.5 p -80.78 -25.18 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 115.839 -0.619 . . . . 63.51 112.584 -166.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -71.08 -26.76 63.2 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.882 0.473 . . . . 72.32 110.779 -175.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -85.28 -13.77 48.7 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.534 0.733 . . . . 75.11 111.527 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.501 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 2.0 tmtp? -81.63 132.84 35.31 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.387 -0.968 . . . . 72.31 108.387 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.501 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 12.5 m-20 -52.51 132.35 35.05 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.663 1.185 . . . . 52.43 112.314 178.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.41 ' CE3' HD21 ' A' ' 68' ' ' LEU . 55.3 t-105 -78.57 89.17 4.5 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.374 0.607 . . . . 71.42 110.334 -175.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.488 ' H ' HD22 ' A' ' 68' ' ' LEU . 35.9 tt0 -120.21 78.49 26.18 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.905 1.282 . . . . 74.52 108.465 171.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.6 111.7 2.84 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.307 2.005 . . . . 71.23 113.239 -171.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -95.86 99.11 10.95 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 107.5 -1.296 . . . . 72.44 107.5 173.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.573 HG13 HG13 ' A' ' 64' ' ' VAL . 57.7 t -90.64 100.21 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 123.57 0.748 . . . . 52.02 110.5 -169.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -84.53 114.77 22.2 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.621 0.768 . . . . 60.54 109.754 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mp -104.67 108.35 19.76 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.918 -0.771 . . . . 73.32 108.918 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.542 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 10.7 t70 -102.35 124.49 48.02 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.949 1.3 . . . . 63.32 108.04 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.446 HD23 HD21 ' A' ' 60' ' ' LEU . 6.8 mp -111.77 125.81 54.4 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.901 0.382 . . . . 75.03 110.533 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 4.2 t70 -119.32 136.17 54.37 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.577 1.151 . . . . 71.04 108.716 175.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 46.9 p -107.75 136.44 47.48 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.243 0.617 . . . . 71.05 110.43 -174.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.618 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -139.13 137.09 35.81 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.575 0.75 . . . . 53.51 109.454 177.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.4 p -133.62 152.8 51.97 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.516 0.726 . . . . 74.45 110.381 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.9 t -161.07 127.38 3.93 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.049 0.54 . . . . 64.04 110.014 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -88.13 105.27 17.4 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.25 -1.019 . . . . 75.42 108.25 171.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.4 mt -79.33 -36.41 39.53 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.039 0.535 . . . . 73.51 111.541 -171.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.05 -174.13 3.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.475 0.71 . . . . 70.13 110.297 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -67.55 118.84 11.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.109 0.564 . . . . 72.34 109.534 171.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 67.69 13.16 9.17 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.819 1.248 . . . . 64.03 111.825 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.25 109.48 24.37 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 N-CA-C 107.864 -1.162 . . . . 72.34 107.864 175.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -129.58 155.49 45.72 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.272 -1.01 . . . . 74.43 108.272 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -129.6 124.59 34.15 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.089 0.556 . . . . 72.45 110.864 -174.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.421 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 85.3 t -109.07 113.42 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.317 -1.364 . . . . 60.33 107.317 166.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 40.3 t -103.55 135.05 42.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.554 -0.906 . . . . 74.12 108.554 171.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.446 HD21 HD23 ' A' ' 44' ' ' LEU . 2.6 tt -129.0 119.12 23.72 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.385 -0.598 . . . . 73.1 109.385 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 12.1 ttm180 -84.84 110.33 18.75 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.251 1.02 . . . . 72.44 109.63 175.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.8 t -100.47 101.33 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 107.719 -1.215 . . . . 65.31 107.719 170.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 20.9 m -99.46 104.23 16.05 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.686 0.794 . . . . 72.41 109.029 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.724 HG11 HD21 ' A' ' 126' ' ' LEU . 14.1 t -104.9 119.63 54.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 123.754 0.822 . . . . 72.13 109.966 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.5 m -112.29 123.88 51.24 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.586 -0.894 . . . . 62.04 108.586 177.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.51 110.5 22.46 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 106.603 -1.629 . . . . 74.31 106.603 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.8 m -109.87 124.9 52.15 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.195 -0.669 . . . . 44.24 109.195 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.488 HD22 ' H ' ' A' ' 37' ' ' GLN . 40.2 mt -88.99 75.76 7.94 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.193 -1.41 . . . . 62.21 107.193 176.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.49 -88.75 0.72 Allowed Glycine 0 C--N 1.345 1.043 0 CA-C-N 114.949 -1.023 . . . . 52.13 110.991 -173.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -120.85 -4.93 9.65 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.501 0.721 . . . . 70.21 111.499 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -101.9 103.6 14.28 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.652 -0.499 . . . . 74.13 109.652 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.0 m -60.52 121.15 11.41 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.139 0.495 . . . . 61.11 110.976 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.81 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -69.55 -58.29 4.13 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.959 -1.019 . . . . 51.21 109.999 175.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -158.65 174.6 14.8 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.353 -1.294 . . . . 72.42 111.16 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.9 tp -132.11 142.6 49.56 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 113.778 -1.556 . . . . 72.24 107.636 173.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 75.1 m -142.7 94.96 2.71 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.293 0.637 . . . . 63.31 109.546 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 39.0 tt0 -115.07 115.62 27.11 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.549 -0.908 . . . . 52.1 108.549 -175.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.73 109.12 18.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.781 -0.822 . . . . 74.44 108.781 -175.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 76.0 mt-30 -85.58 84.09 7.71 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.117 -1.068 . . . . 73.13 108.117 173.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -76.48 99.4 4.9 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.508 -1.224 . . . . 72.51 108.949 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.99 144.82 22.11 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 110.298 -1.121 . . . . 60.44 110.298 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.468 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -144.78 120.92 1.47 Allowed Glycine 0 CA--C 1.5 -0.865 0 N-CA-C 110.382 -1.087 . . . . 63.43 110.382 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.0 mt -88.84 123.24 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 108.529 -0.915 . . . . 75.3 108.529 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.421 ' HE1' ' HB ' ' A' ' 58' ' ' VAL . 90.1 m-85 -121.44 119.87 33.32 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.49 -1.3 . . . . 72.35 107.49 -177.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.7 m -84.78 88.5 7.39 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.199 0.6 . . . . 64.44 109.504 173.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.426 HD13 ' H ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.119 0 CA-C-N 115.581 -0.736 . . . . 61.11 110.04 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 121.046 0.451 . . . . 70.2 111.308 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -72.24 -36.58 69.13 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.234 1.014 . . . . 70.12 110.704 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 81.9 m -66.39 -60.99 2.24 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.768 -0.456 . . . . 72.22 109.768 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 69.5 mt -60.24 -40.32 89.84 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.241 1.016 . . . . 65.12 112.061 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.66 -28.13 30.32 Favored Glycine 0 C--N 1.342 0.866 0 O-C-N 123.753 0.658 . . . . 71.42 114.128 -172.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.71 -59.71 1.2 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.982 0.734 . . . . 73.23 112.982 -171.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -73.55 -56.83 4.51 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.597 0.359 . . . . 73.55 111.86 -166.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 66.6 m -55.33 -41.09 88.92 Favored Pre-proline 0 CA--C 1.571 1.785 0 CA-C-O 118.308 -0.853 . . . . 62.13 112.855 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -49.33 -51.39 10.76 Favored 'Trans proline' 0 C--N 1.399 3.224 0 C-N-CA 122.728 2.286 . . . . 73.01 113.207 164.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.5 HD21 ' N ' ' A' ' 133' ' ' PHE . 95.0 m-20 -71.98 -15.4 62.06 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.748 0.819 . . . . 64.25 112.445 -177.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.457 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 30.3 mm -80.72 -45.1 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.259 0.623 . . . . 74.33 109.494 172.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.468 HD21 ' HA3' ' A' ' 82' ' ' GLY . 90.0 mt -74.66 -22.98 58.59 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.06 -0.518 . . . . 51.44 111.053 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -61.96 -46.0 91.96 Favored Pre-proline 0 CA--C 1.559 1.319 0 CA-C-O 117.499 -1.238 . . . . 73.52 113.002 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 34.5 Cg_exo -60.35 -35.37 91.48 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 121.837 1.692 . . . . 71.34 113.926 174.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -78.34 -35.82 47.07 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 122.899 0.479 . . . . 71.12 111.093 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.57 -37.91 68.07 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.2 0.6 . . . . 72.11 109.76 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.579 ' NH1' HG23 ' C' ' 105' ' ' ILE . 26.3 ttm180 -63.51 -39.95 95.77 Favored 'General case' 0 C--O 1.209 -1.05 0 C-N-CA 124.061 0.945 . . . . 72.51 109.309 173.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -63.39 -48.3 78.42 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.992 0.917 . . . . 73.11 111.038 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 32.9 t -60.58 -41.32 94.44 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 124.385 1.053 . . . . 74.43 110.04 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 69.1 mt -65.25 -46.77 89.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 123.579 0.752 . . . . 72.0 110.83 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 55.3 m -59.44 -39.22 82.86 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.449 1.1 . . . . 75.41 110.424 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.8 t -75.03 -47.19 30.23 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.893 -1.049 . . . . 64.22 110.476 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 13.7 mtp -57.44 -45.15 85.02 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.606 0.763 . . . . 75.45 111.948 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.2 t -63.61 -43.66 98.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 124.468 1.107 . . . . 74.43 110.878 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.0 t -70.83 -31.65 68.44 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.215 0.606 . . . . 72.52 111.463 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -73.8 -30.14 62.56 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.287 0.635 . . . . 74.24 109.726 176.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.38 -0.52 78.68 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.286 -0.87 . . . . 63.33 113.41 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.499 HG22 HH21 ' B' ' 15' ' ' ARG . 17.2 m 73.42 15.59 4.2 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-O 122.574 1.178 . . . . 64.55 111.425 173.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -86.27 154.82 57.4 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-N 115.588 -0.733 . . . . 63.4 110.221 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.25 129.7 34.79 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.772 2.315 . . . . 75.12 111.851 171.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -51.76 129.56 26.62 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 124.289 0.993 . . . . 75.53 112.268 -172.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.724 HD21 HG11 ' A' ' 64' ' ' VAL . 56.1 tp -109.47 97.99 7.46 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.229 -0.896 . . . . 55.14 110.177 -174.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -103.28 112.28 25.07 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.432 0.693 . . . . 64.5 109.401 174.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.0 mp -72.43 117.73 14.45 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.103 -1.073 . . . . 60.1 108.103 172.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.24 145.02 94.36 Favored Pre-proline 0 CA--C 1.56 1.354 0 CA-C-N 117.925 0.33 . . . . 73.1 110.716 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.45 ' HD3' HG13 ' C' ' 13' ' ' ILE . 13.7 Cg_exo -69.44 110.67 2.54 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.743 2.296 . . . . 71.22 112.084 -170.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.2 m -99.49 115.25 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 108.676 -0.861 . . . . 63.02 108.676 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -90.75 98.81 12.0 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.643 -0.873 . . . . 70.44 108.643 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.5 ' N ' HD21 ' A' ' 104' ' ' ASN . 72.7 m-85 . . . . . 0 CA--C 1.542 0.651 0 O-C-N 123.445 0.465 . . . . 74.31 110.278 170.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.42 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 26.2 ttt . . . . . 0 CA--C 1.561 1.398 0 CA-C-O 121.517 0.675 . . . . 74.11 111.942 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m -143.35 133.57 24.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.446 -1.316 . . . . 73.01 107.446 166.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -141.22 137.67 32.75 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.396 -0.594 . . . . 71.54 109.396 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -158.75 129.0 5.92 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.026 0.93 . . . . 62.33 108.753 173.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.449 HD11 HD13 ' B' ' 105' ' ' ILE . 15.8 mt -75.05 119.06 21.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.629 0 N-CA-C 108.001 -1.111 . . . . 71.11 108.001 169.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -96.3 -42.58 8.09 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 123.537 0.523 . . . . 63.44 110.199 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.499 HH21 HG22 ' A' ' 122' ' ' THR . 23.0 ttt85 -165.64 133.13 2.91 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.9 -0.591 . . . . 72.32 109.739 -175.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 71.8 mt -116.66 143.05 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 107.622 -1.251 . . . . 74.3 107.622 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -166.91 155.68 10.28 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.528 0.68 . . . . 74.32 112.129 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 89.1 m -84.27 120.46 26.26 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.771 -1.104 . . . . 52.32 108.361 170.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.543 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 33.1 mtpt -87.83 -33.74 18.48 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.031 0.532 . . . . 74.11 110.383 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 19.7 t70 -157.62 144.49 18.11 Favored 'General case' 0 C--N 1.347 0.48 0 N-CA-C 112.707 0.632 . . . . 73.4 112.707 -170.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 45.3 mm -137.51 142.14 37.55 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 C-N-CA 125.648 1.579 . . . . 62.4 108.472 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.3 t -147.21 127.22 13.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.924 -1.139 . . . . 63.44 107.924 173.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 90.7 t80 -139.57 110.91 7.02 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.435 -0.95 . . . . 75.32 108.435 175.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -118.04 115.44 24.87 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.351 1.061 . . . . 73.54 108.534 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.406 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.7 87.91 3.13 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.032 -1.099 . . . . 54.02 108.032 174.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.54 -44.52 4.41 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.649 2.232 . . . . 61.22 112.562 -170.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -97.29 16.48 19.83 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.936 0.894 . . . . 74.34 110.666 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.406 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -38.31 -59.92 1.15 Allowed Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 115.303 1.594 . . . . 75.24 115.303 -168.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -66.61 -26.44 46.45 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 122.039 1.826 . . . . 72.32 112.89 -170.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -93.96 -41.21 9.71 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 115.022 -0.99 . . . . 72.41 111.176 -172.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.6 p -71.18 -12.47 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.344 0.658 . . . . 54.24 111.837 -170.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -66.25 -12.56 57.01 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.584 0.754 . . . . 65.51 112.716 174.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -65.21 -16.41 63.5 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.321 0.648 . . . . 73.01 111.427 174.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -107.53 111.62 23.98 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.023 1.329 . . . . 72.0 111.09 -176.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -107.53 95.16 5.5 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.309 0.644 . . . . 71.53 110.935 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 39.3 p90 -169.27 175.45 5.61 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.7 1.2 . . . . 63.15 108.78 167.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -73.79 107.89 4.11 Favored Pre-proline 0 CA--C 1.555 1.142 0 N-CA-C 109.891 -0.411 . . . . 73.14 109.891 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.485 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 30.5 Cg_endo -64.71 149.73 89.27 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.663 2.242 . . . . 74.32 113.565 -173.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -63.09 114.87 3.99 Favored 'General case' 0 C--N 1.359 1.006 0 O-C-N 124.087 0.867 . . . . 75.3 110.052 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.563 HG13 HG13 ' B' ' 64' ' ' VAL . 88.3 t -92.57 144.09 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 123.983 0.913 . . . . 72.21 111.29 -172.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.512 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 23.6 ttpp -128.82 116.43 19.44 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.845 -1.539 . . . . 74.31 106.845 168.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.555 ' H ' HD23 ' B' ' 42' ' ' LEU . 1.6 pt? -84.11 149.07 26.45 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.146 -0.687 . . . . 75.25 109.146 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.756 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 6.9 m-20 -139.52 110.0 6.62 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.16 -1.422 . . . . 74.21 107.16 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 84.0 mt -104.46 127.12 52.09 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.502 -0.925 . . . . 74.54 108.502 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 14.5 t70 -133.11 143.92 49.61 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.801 0.84 . . . . 64.2 109.409 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 81.3 p -109.98 126.17 53.65 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.755 0.822 . . . . 63.14 110.246 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.06 148.91 52.2 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.837 0.855 . . . . 73.33 109.355 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.9 p -144.48 164.39 31.0 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.703 0.631 . . . . 73.25 112.703 -174.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 69.7 p -155.13 146.74 23.17 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.152 -0.931 . . . . 73.51 109.552 166.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -97.62 128.89 44.67 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.95 -0.759 . . . . 70.35 108.95 174.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.9 mt -97.58 -54.15 3.21 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.315 0.578 . . . . 73.55 110.238 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.38 -168.15 2.98 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.065 -0.971 . . . . 72.32 110.051 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -67.43 103.23 1.26 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.651 -1.158 . . . . 74.44 110.602 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 67.12 15.23 10.03 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.136 1.375 . . . . 64.13 112.414 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 68.0 t -105.74 105.71 19.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 107.52 -1.289 . . . . 72.31 107.52 172.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.648 ' HB2' HD11 ' B' ' 86' ' ' ILE . 6.1 t80 -110.53 165.87 11.46 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.339 -0.846 . . . . 63.23 109.003 -172.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -136.23 114.08 11.21 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.966 -1.124 . . . . 72.03 107.966 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 95.8 t -104.09 118.43 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.829 1.252 . . . . 62.51 110.443 -171.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 13.3 t -109.76 122.55 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 109.496 -0.557 . . . . 72.42 109.496 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.523 HD22 ' HB2' ' B' ' 103' ' ' PRO . 51.8 tp -106.3 110.28 22.46 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.76 -0.83 . . . . 72.45 108.76 170.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.514 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 22.1 ttm-85 -85.94 109.38 18.71 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.223 -0.658 . . . . 71.24 109.223 173.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 30.7 t -106.26 101.86 13.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 108.143 -1.058 . . . . 75.31 108.143 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.756 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 10.4 m -102.32 128.76 48.74 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.747 -0.834 . . . . 42.14 108.747 175.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.563 HG13 HG13 ' B' ' 40' ' ' VAL . 61.3 t -119.91 108.16 22.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 123.85 0.86 . . . . 61.42 109.289 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 96.4 m -82.34 144.66 30.42 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.409 -0.96 . . . . 70.33 108.409 169.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.15 144.56 29.08 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 122.952 0.501 . . . . 73.04 109.928 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.442 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 36.1 p -147.65 127.13 13.19 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.501 0.501 . . . . 74.32 111.127 -175.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.507 HD12 HG22 ' B' ' 31' ' ' VAL . 72.7 mt -94.66 110.16 22.02 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.234 -1.025 . . . . 51.15 108.234 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.41 -112.86 3.67 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 115.477 -0.783 . . . . 62.45 111.771 -176.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -120.96 9.46 10.61 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.435 0.694 . . . . 74.3 110.421 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -123.19 155.15 37.65 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.47 0.708 . . . . 61.1 109.66 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 29.6 m -68.98 133.71 48.53 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.961 0.41 . . . . 63.45 109.984 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.514 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -87.98 -63.58 1.28 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.713 -1.217 . . . . 73.24 107.713 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -150.8 161.31 42.91 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.439 -1.255 . . . . 72.43 110.857 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 85.7 mt -125.73 113.28 17.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.564 -2.013 . . . . 61.53 105.564 172.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.8 t -116.66 151.37 36.45 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.5 -0.926 . . . . 72.3 108.5 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.425 ' HB2' HG23 ' B' ' 63' ' ' THR . 42.8 tt0 -161.14 133.18 5.82 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.055 0.455 . . . . 60.25 109.812 -175.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 93.3 t -134.12 149.0 29.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 124.697 1.199 . . . . 74.31 108.261 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.459 HE21 ' HB3' ' B' ' 20' ' ' ASP . 25.6 mt-30 -125.25 107.01 10.3 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.121 -1.066 . . . . 73.14 108.121 169.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.401 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.8 tp-100 -96.5 101.22 12.81 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.656 -0.868 . . . . 74.11 108.656 178.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.543 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -95.09 144.39 17.17 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.366 -0.834 . . . . 63.52 111.275 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.59 126.84 3.13 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.427 -0.669 . . . . 74.13 111.427 -176.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 70.2 mt -83.96 127.43 39.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.795 -0.817 . . . . 74.21 108.795 174.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -137.85 135.77 36.51 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.936 -0.764 . . . . 73.43 108.936 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.8 m -89.24 98.32 11.7 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.693 -0.855 . . . . 72.3 108.693 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.648 HD11 ' HB2' ' B' ' 56' ' ' TYR . 1.7 pp -111.48 129.53 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.93 0.892 . . . . 62.51 110.702 -175.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.65 167.31 22.86 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.153 0.581 . . . . 73.41 109.815 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 88.28 -59.42 4.14 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 114.017 0.367 . . . . 42.42 114.017 172.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 15.4 mm -78.85 138.21 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 123.632 0.773 . . . . 71.53 110.067 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -157.24 174.65 15.14 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 115.846 -0.615 . . . . 63.1 111.928 -163.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.11 -127.83 44.82 Favored Glycine 0 C--N 1.354 1.562 0 C-N-CA 123.418 0.532 . . . . 34.42 113.78 -177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 51.8 m -66.29 -30.87 71.37 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.983 0.913 . . . . 74.03 110.94 175.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -65.79 -45.3 82.94 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.707 -0.679 . . . . 71.13 110.544 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -71.17 -24.83 62.32 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.534 0.334 . . . . 73.33 111.425 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.82 -45.15 95.08 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 123.664 0.603 . . . . 43.42 109.875 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -64.66 -40.77 96.0 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.233 0.613 . . . . 71.41 111.307 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.4 t -62.14 -44.57 96.32 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.766 0.427 . . . . 65.43 111.648 -176.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 9.2 mp -92.75 -16.86 24.91 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.046 0.539 . . . . 73.34 111.708 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.11 2.87 47.61 Favored Glycine 0 N--CA 1.474 1.211 0 CA-C-O 120.052 -0.304 . . . . 64.32 113.643 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' B' ' 104' ' ' ASN . . . -145.07 -57.36 0.34 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.22 0.608 . . . . 74.01 110.57 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -74.02 -51.81 14.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.997 0.519 . . . . 75.44 112.293 -171.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 72.0 m -60.8 -49.23 90.35 Favored Pre-proline 0 CA--C 1.565 1.536 0 CA-C-O 118.59 -0.719 . . . . 65.11 112.44 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.523 ' HB2' HD22 ' B' ' 60' ' ' LEU . 71.5 Cg_endo -71.56 -16.7 30.41 Favored 'Trans proline' 0 C--N 1.393 2.87 0 C-N-CA 122.08 1.853 . . . . 75.21 113.319 176.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' B' ' 100' ' ' ALA . 51.4 t-20 -65.64 -41.21 92.89 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 123.469 0.708 . . . . 63.22 109.594 174.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.449 HD13 HD11 ' B' ' 13' ' ' ILE . 73.7 mt -60.54 -45.36 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.538 1.135 . . . . 73.13 110.741 175.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 49.5 mt -84.01 -13.22 53.81 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.224 -1.353 . . . . 74.34 111.612 -170.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -57.24 -55.74 41.13 Favored Pre-proline 0 CA--C 1.561 1.366 0 CA-C-O 117.946 -1.026 . . . . 70.43 113.549 -176.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -64.85 -27.1 59.26 Favored 'Trans proline' 0 C--N 1.383 2.368 0 CA-C-N 121.338 1.514 . . . . 62.14 113.186 -174.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.401 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.0 m-85 -68.69 -48.45 63.85 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.839 0.456 . . . . 74.52 109.888 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.59 90.12 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.449 -0.796 . . . . 62.4 110.745 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 45.2 ttt-85 -62.45 -49.03 77.04 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.757 1.223 . . . . 72.32 111.376 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -65.88 -36.85 84.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 123.711 0.632 . . . . 75.54 109.791 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.513 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.5 t -70.96 -33.8 70.82 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.892 -0.595 . . . . 61.15 111.369 -178.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.471 ' O ' HG23 ' B' ' 118' ' ' VAL . 55.6 mt -64.48 -54.64 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 109.17 -0.678 . . . . 73.51 109.17 173.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 4.3 m -63.72 -23.41 67.36 Favored 'General case' 0 CA--C 1.555 1.168 0 O-C-N 123.85 0.719 . . . . 71.02 111.353 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.434 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.0 t -67.25 -49.02 66.0 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 123.075 0.55 . . . . 73.23 109.812 172.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.513 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.4 mmt -68.68 -31.83 71.22 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.804 0.442 . . . . 73.22 111.042 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.471 HG23 ' O ' ' B' ' 114' ' ' ILE . 90.9 t -64.17 -42.67 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.837 0.855 . . . . 72.35 109.962 172.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.6 t -67.18 -31.39 71.75 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.924 -1.034 . . . . 63.41 111.336 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.438 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 81.7 mtt-85 -73.45 -38.11 65.6 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.26 0.624 . . . . 61.4 110.061 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.95 -3.94 75.98 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 123.729 0.643 . . . . 75.13 112.609 169.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 34.3 p 63.46 24.08 13.96 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 126.426 1.89 . . . . 72.24 113.129 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -77.77 160.58 74.05 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 124.533 1.133 . . . . 74.32 111.36 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -51.95 162.29 1.92 Allowed 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 123.677 2.918 . . . . 74.44 115.049 173.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.674 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 56.3 tp60 -60.24 128.81 38.6 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.287 1.035 . . . . 74.13 111.574 -173.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.436 HD21 HG21 ' B' ' 40' ' ' VAL . 1.4 tm? -146.4 99.79 3.27 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.647 -0.871 . . . . 74.34 108.647 -174.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -131.53 132.2 43.98 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.722 0.809 . . . . 72.35 109.505 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.98 150.41 45.69 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.332 0.653 . . . . 73.33 112.383 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.0 153.19 69.47 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 124.114 0.966 . . . . 70.34 111.702 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.407 ' HB2' HD12 ' D' ' 13' ' ' ILE . 57.8 Cg_endo -68.03 116.72 4.47 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.112 2.541 . . . . 74.14 112.406 176.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 72.3 t -127.79 111.44 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.89 -0.781 . . . . 71.11 108.89 173.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -80.27 94.27 6.06 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 107.688 -1.227 . . . . 73.15 107.688 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -56.69 -41.55 77.53 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.136 0.974 . . . . 53.22 111.487 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 . . . . . 0 C--O 1.239 0.504 0 C-N-CA 124.324 1.049 . . . . 74.03 112.034 -176.56 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.52 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 42.0 t80 . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 109.691 -0.485 . . . . 75.42 109.691 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -159.72 134.31 7.77 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.082 0.953 . . . . 73.14 108.581 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.45 HG13 ' HD3' ' A' ' 130' ' ' PRO . 74.9 mt -72.8 120.46 21.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.492 -0.929 . . . . 65.55 108.492 168.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -89.86 -45.48 9.22 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.698 -0.683 . . . . 75.11 109.36 175.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -176.47 141.31 0.4 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.005 -0.998 . . . . 73.01 108.481 -168.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.401 HG21 ' CD1' ' C' ' 109' ' ' TYR . 56.0 mt -137.01 144.96 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 108.993 -0.743 . . . . 74.44 108.993 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.466 ' HB3' HG23 ' D' ' 122' ' ' THR . 22.3 p90 -174.89 159.94 2.79 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.576 0.703 . . . . 72.13 110.077 -173.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 18' ' ' THR . . . . . 0.46 HG21 ' SG ' ' C' ' 113' ' ' CYS . 81.0 p -78.91 119.36 21.97 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.911 -1.04 . . . . 65.35 108.988 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -69.44 -46.43 66.77 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 107.133 -1.432 . . . . 51.03 107.133 168.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.2 t70 -135.04 143.05 46.52 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 113.016 -1.902 . . . . 53.12 109.748 -171.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 70.4 mt -136.8 150.44 26.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 105.928 -1.878 . . . . 73.4 105.928 170.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -163.86 151.16 12.24 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.333 0.587 . . . . 72.03 110.012 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -146.21 124.45 12.23 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.183 -1.414 . . . . 61.31 107.183 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -126.98 110.43 12.97 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.086 -0.709 . . . . 72.43 109.086 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.38 84.65 29.39 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 107.292 -1.373 . . . . 50.03 107.292 167.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.41 -37.03 24.73 Favored 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 122.331 2.02 . . . . 72.24 111.011 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -95.83 22.69 7.03 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.044 -0.98 . . . . 71.03 110.64 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.71 -54.45 27.1 Favored Pre-proline 0 CA--C 1.564 1.518 0 N-CA-C 114.127 1.158 . . . . 32.1 114.127 -172.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.54 -40.48 47.04 Favored 'Trans proline' 0 C--N 1.39 2.726 0 CA-C-N 121.797 1.677 . . . . 60.43 111.961 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -70.69 -31.83 68.86 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.659 -1.155 . . . . 74.4 112.563 -175.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.65 HG21 ' HA ' ' C' ' 73' ' ' ALA . 11.7 p -81.46 -26.0 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 112.756 0.65 . . . . 70.54 112.756 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -67.6 -24.58 65.51 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 120.793 0.33 . . . . 74.15 111.71 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -90.49 25.5 2.26 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.789 0.836 . . . . 53.21 110.95 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.539 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -121.32 157.83 29.54 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.603 0.761 . . . . 62.33 110.485 178.547 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -70.19 131.91 44.96 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.956 0.902 . . . . 72.21 110.134 170.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -84.5 88.13 7.29 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.344 0.658 . . . . 72.24 110.779 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -132.48 78.97 66.36 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 108.021 -1.103 . . . . 72.43 108.021 171.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 38' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' C' ' 67' ' ' SER . 3.2 Cg_exo -78.54 126.71 7.64 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.574 2.183 . . . . 65.25 113.919 -172.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -85.05 91.6 8.14 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 106.249 -1.76 . . . . 74.15 106.249 160.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 28.6 m -80.15 142.69 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 114.345 -1.298 . . . . 62.44 111.262 -173.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.525 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 45.5 mmtm -124.52 103.1 7.97 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.597 -0.89 . . . . 54.45 108.597 172.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' C' ' 42' ' ' LEU . 2.2 pp -86.83 151.5 23.29 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.158 -0.682 . . . . 73.34 109.158 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -144.73 138.75 27.43 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.021 -0.733 . . . . 65.01 109.021 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 mp -125.35 114.97 19.59 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.254 -1.017 . . . . 75.33 108.254 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.592 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 11.3 t70 -111.98 144.5 41.23 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.945 0.898 . . . . 74.31 109.045 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -113.28 113.07 24.77 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.489 -0.778 . . . . 74.11 110.613 -169.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.77 141.56 50.37 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.833 0.853 . . . . 70.15 109.362 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 35.2 p -165.84 158.62 15.2 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.626 0.37 . . . . 75.24 111.832 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -161.46 148.93 14.88 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.646 0.779 . . . . 62.43 110.464 -174.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -92.23 126.7 37.42 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.35 -0.611 . . . . 63.25 109.35 172.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.669 HD11 HD12 ' C' ' 83' ' ' ILE . 74.9 mt -89.21 -54.0 4.31 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.563 0.745 . . . . 62.21 111.137 -176.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.91 -166.88 2.46 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.738 -0.665 . . . . 70.14 110.564 -174.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -57.35 103.57 0.13 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.476 1.111 . . . . 71.24 110.401 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 64.14 7.05 3.21 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.05 1.34 . . . . 65.5 113.033 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 88.1 t -97.12 113.92 32.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 107.665 -1.235 . . . . 74.05 107.665 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -118.44 159.85 22.75 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.343 -0.844 . . . . 74.05 109.119 -175.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -126.28 122.68 36.19 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.048 0.939 . . . . 74.22 109.156 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 87.4 t -109.59 125.33 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 107.738 -1.208 . . . . 63.23 107.738 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 66.2 t -124.05 125.67 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 109.083 -0.71 . . . . 43.35 109.083 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.526 HD22 ' HB2' ' C' ' 103' ' ' PRO . 33.4 tp -112.69 116.58 30.36 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 109.229 -0.656 . . . . 63.44 109.229 175.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.592 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 16.7 ttm-85 -82.09 109.31 16.3 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.446 -0.797 . . . . 73.22 109.005 174.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 36.4 t -103.56 119.17 51.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.033 -1.099 . . . . 55.11 108.033 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 27.3 m -125.41 121.49 34.02 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.228 -0.656 . . . . 51.31 109.228 -175.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.664 HG23 HD13 ' C' ' 114' ' ' ILE . 68.4 t -105.82 115.51 47.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 123.767 0.827 . . . . 60.22 109.019 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 3.7 m -98.48 139.45 34.2 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.359 -1.349 . . . . 60.11 107.359 169.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.94 122.96 31.33 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.072 -1.085 . . . . 43.52 108.072 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 67' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' C' ' 38' ' ' PRO . 54.1 m -132.54 156.28 47.12 Favored 'General case' 0 C--O 1.213 -0.851 0 C-N-CA 123.393 0.677 . . . . 62.4 109.181 175.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.539 HD13 ' HG2' ' C' ' 34' ' ' LYS . 39.0 mt -119.07 38.76 3.73 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.439 -1.319 . . . . 75.43 107.439 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.82 -99.59 1.65 Allowed Glycine 0 C--N 1.347 1.178 0 CA-C-N 114.606 -1.179 . . . . 73.35 110.469 -170.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -90.33 -30.8 17.23 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.343 0.657 . . . . 72.41 110.438 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -73.22 116.1 13.36 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.87 0.868 . . . . 74.52 110.654 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.1 m -76.85 118.35 19.36 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.376 -0.972 . . . . 73.44 108.376 168.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.65 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.88 -53.02 9.82 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.953 0.783 . . . . 53.24 109.02 176.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -165.96 173.39 10.5 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-N 115.509 -0.769 . . . . 72.55 112.392 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.505 HD23 HG23 ' C' ' 65' ' ' THR . 2.4 tm? -140.94 102.45 4.27 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 105.836 -1.913 . . . . 74.01 105.836 172.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.474 ' SG ' HG23 ' C' ' 114' ' ' ILE . 46.4 t -109.97 112.0 23.74 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.194 -0.669 . . . . 74.54 109.194 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -118.23 127.57 53.87 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.064 0.546 . . . . 70.15 110.162 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 73.2 t -124.33 138.49 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 108.714 -0.847 . . . . 72.24 108.714 170.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.576 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 47.9 mt-30 -113.1 95.17 5.25 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.714 -0.847 . . . . 64.52 108.714 172.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -81.8 106.93 14.12 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.385 -0.825 . . . . 73.42 109.405 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.52 149.13 20.4 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.539 -0.625 . . . . 72.12 111.539 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.18 117.05 0.92 Allowed Glycine 0 CA--C 1.506 -0.482 0 N-CA-C 111.012 -0.835 . . . . 71.04 111.012 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.669 HD12 HD11 ' C' ' 51' ' ' LEU . 12.5 mm -81.92 125.99 39.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 108.395 -0.965 . . . . 75.34 108.395 175.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.416 ' HD2' ' HA ' ' C' ' 13' ' ' ILE . 48.2 m-85 -138.77 142.02 38.8 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.277 -0.638 . . . . 74.33 109.277 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 85' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 60.7 m -70.76 115.56 10.05 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.354 -1.35 . . . . 54.51 107.354 164.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 69.8 mt -133.64 110.99 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 109.122 -0.696 . . . . 65.31 109.122 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.55 167.52 19.26 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.91 0.884 . . . . 72.13 110.591 177.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.43 -40.44 2.54 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 116.349 -0.387 . . . . 72.31 113.299 171.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 23.6 pt -101.78 174.77 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.237 0.615 . . . . 71.31 111.038 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -150.31 153.69 36.55 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 111.999 0.37 . . . . 74.31 111.999 -175.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.54 -115.92 8.59 Favored Glycine 0 C--N 1.353 1.486 0 N-CA-C 114.844 0.698 . . . . 54.43 114.844 169.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 75.5 p -74.49 -29.53 61.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.331 0.652 . . . . 72.1 110.986 -175.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -60.43 -48.26 82.53 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.695 -0.854 . . . . 74.34 108.695 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.473 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 51.8 ttm -69.71 -33.81 73.02 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.868 -1.514 . . . . 70.02 110.9 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.26 88.15 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.388 0.675 . . . . 65.22 111.66 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -71.2 -32.57 69.01 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.222 -0.445 . . . . 63.35 110.454 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.9 t -67.96 -61.57 1.8 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 122.628 0.371 . . . . 64.43 111.056 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' C' ' 94' ' ' MET . 2.5 pp -70.24 -25.61 63.46 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.069 0.396 . . . . 64.24 112.069 -178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.95 -17.22 44.76 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 114.584 0.593 . . . . 62.53 114.584 -172.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.73 -53.19 0.87 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 117.466 0.633 . . . . 72.15 111.231 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -72.6 -46.65 53.13 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.615 0.766 . . . . 74.03 112.622 -168.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.52 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 33.7 m -73.35 -46.94 7.74 Favored Pre-proline 0 CA--C 1.569 1.683 0 N-CA-C 113.123 0.786 . . . . 65.42 113.123 -175.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.526 ' HB2' HD22 ' C' ' 60' ' ' LEU . 87.7 Cg_endo -75.87 -10.37 19.81 Favored 'Trans proline' 0 C--N 1.387 2.557 0 C-N-CA 122.094 1.863 . . . . 71.42 112.762 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.66 -32.73 74.53 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.487 0.715 . . . . 62.54 110.314 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.579 HG23 ' NH1' ' A' ' 111' ' ' ARG . 14.6 mm -70.74 -36.5 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.208 -0.905 . . . . 73.44 110.067 177.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 43.8 mt -85.86 -22.52 27.5 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.719 -1.128 . . . . 73.33 111.677 -172.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -58.72 -52.94 71.18 Favored Pre-proline 0 CA--C 1.56 1.352 0 CA-C-O 118.198 -0.906 . . . . 75.22 112.795 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -65.65 -32.02 48.54 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 121.54 1.493 . . . . 75.31 112.382 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.401 ' CD1' HG21 ' C' ' 16' ' ' ILE . 2.6 m-30 -67.23 -45.47 76.68 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.859 0.863 . . . . 72.12 110.025 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.7 -37.87 87.64 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.236 1.014 . . . . 65.35 110.735 176.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -60.8 -49.08 78.91 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.6 1.16 . . . . 72.5 110.794 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -69.98 -34.07 72.89 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.119 0.568 . . . . 73.5 110.058 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.46 ' SG ' HG21 ' C' ' 18' ' ' THR . 21.4 t -69.26 -31.29 69.73 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.936 0.494 . . . . 40.43 111.502 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.664 HD13 HG23 ' C' ' 64' ' ' VAL . 86.3 mt -73.53 -55.31 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.081 0.553 . . . . 73.21 109.662 173.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 17.1 m -63.87 -27.6 69.27 Favored 'General case' 0 CA--C 1.553 1.074 0 O-C-N 123.653 0.596 . . . . 71.3 111.374 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 36.6 t -62.02 -50.86 70.36 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.232 -0.655 . . . . 70.11 109.232 171.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.552 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.64 -36.07 79.72 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.318 1.047 . . . . 75.42 112.409 178.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.73 -45.23 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.38 0.672 . . . . 72.55 109.821 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 31.0 t -70.6 -25.35 63.01 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 114.907 -1.042 . . . . 71.4 111.809 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' C' ' 116' ' ' SER . 87.2 mtt-85 -74.18 -40.65 62.37 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.35 0.66 . . . . 71.22 109.417 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.72 -0.12 62.88 Favored Glycine 0 C--N 1.354 1.553 0 CA-C-N 115.617 -0.72 . . . . 34.24 112.575 169.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 25.3 p 62.64 30.89 16.97 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 126.787 2.035 . . . . 74.24 113.378 170.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -83.92 148.91 55.19 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 109.044 -0.725 . . . . 74.3 109.044 170.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.674 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 86.3 Cg_exo -51.41 146.91 23.59 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 123.422 2.748 . . . . 75.23 114.2 176.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -58.81 112.11 1.52 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.985 -1.007 . . . . 75.34 112.358 -173.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 42.8 tp -112.83 86.3 2.34 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.373 -0.973 . . . . 75.33 108.373 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -94.2 106.44 18.41 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.224 -0.898 . . . . 74.4 108.816 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 56.9 tp -65.47 144.98 56.69 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.133 0.573 . . . . 44.21 111.525 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.07 143.94 92.09 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 124.03 0.932 . . . . 63.44 110.882 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.497 ' HB2' HD12 ' A' ' 13' ' ' ILE . 5.6 Cg_exo -71.4 127.42 13.29 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.77 2.314 . . . . 42.15 112.237 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -119.18 111.8 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.722 0.809 . . . . 74.44 109.401 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -80.69 97.52 7.3 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.481 0.712 . . . . 44.31 110.448 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -65.07 -41.8 94.75 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.241 -0.652 . . . . 75.45 109.241 170.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 20.4 t70 . . . . . 0 CA--C 1.538 0.494 0 CA-C-N 114.163 -1.381 . . . . 42.45 112.112 177.18 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 30.8 m . . . . . 0 C--O 1.241 0.636 0 N-CA-C 108.542 -0.911 . . . . 51.43 108.542 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -157.66 114.63 2.96 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.858 -0.793 . . . . 63.24 108.858 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -134.06 126.18 29.59 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.038 -1.097 . . . . 75.42 108.038 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.566 HD13 HG21 ' D' ' 105' ' ' ILE . 10.4 mt -78.23 127.76 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.165 -0.68 . . . . 63.31 109.165 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -87.37 -41.61 13.48 Favored 'General case' 0 C--O 1.24 0.583 0 O-C-N 123.704 0.627 . . . . 42.5 110.001 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 -175.17 142.83 0.65 Allowed 'General case' 0 N--CA 1.484 1.273 0 O-C-N 123.173 0.296 . . . . 61.1 111.676 -172.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.502 HD11 HG21 ' D' ' 13' ' ' ILE . 3.4 mp -117.14 136.45 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.303 -1.369 . . . . 72.04 107.303 168.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.457 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 24.5 p90 -163.87 147.39 9.94 Favored 'General case' 0 C--O 1.242 0.659 0 O-C-N 123.871 0.732 . . . . 74.5 110.236 176.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 78.4 p -77.97 106.75 10.04 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.351 -0.84 . . . . 71.25 108.887 173.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.457 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 37.6 mtpt -73.19 -30.57 63.62 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.466 0.65 . . . . 74.44 109.994 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.424 ' HB3' ' HB3' ' D' ' 79' ' ' GLN . 10.6 t70 -152.42 141.46 21.26 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.012 -1.449 . . . . 75.12 108.934 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.552 HG21 ' HE2' ' C' ' 117' ' ' MET . 79.7 mt -141.71 147.76 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.598 -1.26 . . . . 75.35 107.598 175.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 41.5 t -149.46 128.49 12.69 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 123.799 0.839 . . . . 71.13 109.149 170.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.538 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.6 t80 -128.34 135.58 49.77 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.129 -1.804 . . . . 64.12 106.129 169.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 44.0 mt-10 -141.78 150.15 41.35 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 124.288 1.035 . . . . 63.45 108.432 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.96 87.22 5.47 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 107.699 -1.223 . . . . 55.2 107.699 173.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.74 -27.93 17.57 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.701 2.267 . . . . 63.14 112.823 -173.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -107.82 7.21 28.1 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.001 0.921 . . . . 72.22 110.53 -176.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.419 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -29.95 -64.64 0.19 Allowed Pre-proline 0 CA--C 1.559 1.312 0 N-CA-C 116.74 2.126 . . . . 72.33 116.74 -165.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.424 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 88.7 Cg_endo -76.14 -26.4 9.2 Favored 'Trans proline' 0 C--N 1.381 2.239 0 CA-C-N 122.897 2.07 . . . . 74.23 113.382 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -70.92 -36.14 72.54 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.839 1.256 . . . . 73.41 109.75 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.7 p -84.86 -12.63 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 CA-C-N 115.708 -0.678 . . . . 75.13 111.741 -176.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.424 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.8 m-85 -72.37 -12.22 61.03 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 112.445 0.535 . . . . 72.13 112.445 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -58.13 -23.48 55.21 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.673 0.749 . . . . 62.45 110.066 169.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.443 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 79.3 mttt -104.37 102.61 12.28 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.664 1.586 . . . . 64.34 108.987 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -111.82 90.72 3.42 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.482 0.313 . . . . 74.14 110.442 -175.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 38.3 p90 -164.36 174.35 11.16 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.65 1.18 . . . . 72.42 108.763 172.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -59.08 110.47 2.69 Favored Pre-proline 0 N--CA 1.486 1.328 0 CA-C-O 119.079 -0.486 . . . . 73.44 109.831 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.523 ' HD3' ' HG2' ' D' ' 124' ' ' PRO . 24.5 Cg_exo -63.17 136.74 57.54 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.368 2.045 . . . . 73.04 110.706 -177.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -62.05 107.77 0.93 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.356 -0.979 . . . . 72.03 108.356 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 6.9 m -103.56 121.29 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-N 115.165 -0.925 . . . . 44.11 110.092 -171.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -101.44 119.45 38.78 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 106.313 -1.736 . . . . 75.34 106.313 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 pp -94.66 143.1 26.71 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.193 -0.669 . . . . 63.32 109.193 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.52 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 17.0 t70 -139.38 146.82 40.67 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.411 -0.959 . . . . 72.45 108.411 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -116.33 143.56 45.39 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.126 0.57 . . . . 62.12 110.841 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.6 t70 -139.05 134.37 32.89 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.354 -1.293 . . . . 42.43 107.731 169.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 22.4 p -103.7 148.27 26.25 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.203 0.601 . . . . 54.14 110.407 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.43 160.9 41.88 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.394 1.078 . . . . 75.23 109.115 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 46.4 p -174.62 167.88 3.78 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.013 0.525 . . . . 61.23 111.275 -175.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.9 p -166.51 147.56 6.27 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.394 -0.821 . . . . 63.5 110.375 174.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -89.23 118.27 28.8 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.602 -0.888 . . . . 74.52 108.602 170.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 44.1 mt -98.69 -27.28 14.05 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.176 0.59 . . . . 61.41 110.878 -173.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -158.8 -178.53 7.32 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.021 0.928 . . . . 73.15 110.121 174.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.09 111.31 2.85 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.102 -0.954 . . . . 65.31 109.844 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 65.72 9.06 5.67 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.763 1.225 . . . . 65.15 113.252 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 83.2 t -108.07 114.15 45.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 107.468 -1.308 . . . . 73.11 107.468 172.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -134.72 131.3 37.47 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.871 -1.059 . . . . 73.43 109.497 -165.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -93.28 129.22 39.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.157 -0.929 . . . . 72.55 110.12 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 78.3 t -109.36 118.96 57.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.209 -1.034 . . . . 71.03 108.209 172.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.46 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 35.7 t -113.78 133.09 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 108.523 -0.918 . . . . 64.32 108.523 177.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 26.4 tp -129.56 120.33 25.14 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.921 -0.4 . . . . 64.15 109.921 171.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.564 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 19.5 ttm-85 -84.54 111.82 19.85 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.952 0.901 . . . . 74.53 109.849 175.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.569 HG21 ' HB1' ' D' ' 110' ' ' ALA . 40.6 t -91.78 122.32 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 108.262 -1.014 . . . . 71.44 108.262 173.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 46.4 m -112.45 143.59 43.32 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.451 -0.574 . . . . 75.01 109.451 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 88.5 t -132.29 101.94 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.663 1.185 . . . . 54.14 108.34 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 19.8 m -93.58 94.92 8.9 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.154 -1.424 . . . . 50.4 107.154 169.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.08 147.47 24.0 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.063 0.545 . . . . 72.3 110.338 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.475 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 63.8 p -150.15 133.72 16.62 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-O 121.068 0.461 . . . . 43.02 111.621 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.7 mt -106.86 114.48 28.59 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.447 -1.316 . . . . 74.13 107.447 171.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.33 -140.96 31.68 Favored Glycine 0 C--N 1.343 0.939 0 O-C-N 123.373 0.42 . . . . 64.35 112.562 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -83.13 3.45 30.66 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.19 0.596 . . . . 71.13 112.302 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 71' ' ' GLU . . . . . 0.443 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 12.2 pt-20 -131.04 166.0 21.99 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.879 0.472 . . . . 74.44 110.75 -174.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.7 m -72.73 136.93 45.63 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.386 -0.824 . . . . 63.23 110.963 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.551 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.68 -69.55 0.68 Allowed 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.588 -1.264 . . . . 71.42 107.588 174.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 74' ' ' PHE . . . . . 0.511 ' HE2' ' HG2' ' D' ' 38' ' ' PRO . 52.1 p90 -149.58 150.26 31.97 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-N 115.313 -0.858 . . . . 70.32 110.685 177.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 45.4 mt -106.44 107.2 18.09 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.458 -1.312 . . . . 54.32 107.458 170.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.446 ' SG ' HG23 ' D' ' 114' ' ' ILE . 36.8 t -116.54 140.03 49.83 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.905 0.882 . . . . 72.34 108.967 -176.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -157.98 141.64 15.51 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.995 0.518 . . . . 72.02 109.948 -174.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -140.82 116.29 6.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.138 -1.06 . . . . 50.45 108.138 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' D' ' 61' ' ' ARG . 5.9 tt0 -87.41 81.06 7.95 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.37 -1.344 . . . . 70.55 107.37 171.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -80.09 105.18 11.18 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.353 -1.294 . . . . 73.21 108.761 -173.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -104.3 148.32 16.76 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.72 -0.673 . . . . 73.42 111.661 -178.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.408 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -144.93 131.43 4.28 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.057 -0.817 . . . . 44.11 111.057 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 45.1 mt -88.86 133.3 31.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 108.239 -1.022 . . . . 73.55 108.239 174.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.421 ' HB2' HD11 ' D' ' 86' ' ' ILE . 55.5 m-85 -130.87 159.24 37.97 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.943 0.497 . . . . 54.0 109.87 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 3.9 t -115.27 101.09 8.62 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.248 -1.019 . . . . 53.22 108.248 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.421 HD11 ' HB2' ' D' ' 84' ' ' PHE . 4.1 mp -108.92 109.84 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 109.25 -0.648 . . . . 71.44 109.25 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.34 154.34 45.09 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.398 0.679 . . . . 72.51 109.798 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.92 21.35 65.96 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-O 119.811 -0.439 . . . . 64.41 113.941 175.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.411 HG22 ' N ' ' D' ' 90' ' ' GLU . 10.9 mt -131.97 158.35 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 117.384 0.592 . . . . 63.44 110.255 178.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.411 ' N ' HG22 ' D' ' 89' ' ' ILE . 2.9 pp20? -159.44 -175.97 5.51 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.265 1.026 . . . . 70.51 110.056 171.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.46 -141.07 46.67 Favored Glycine 0 N--CA 1.473 1.132 0 N-CA-C 114.839 0.696 . . . . 73.45 114.839 174.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 41.5 p -78.81 -13.98 59.51 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.083 0.953 . . . . 51.22 112.037 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -47.01 70.79 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.556 0.742 . . . . 61.14 109.685 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 13.5 ptp -68.78 -34.62 75.86 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 110.271 -0.27 . . . . 62.43 110.271 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.45 -26.93 68.77 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.975 0.51 . . . . 60.53 111.461 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -73.03 -51.81 16.77 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.079 0.552 . . . . 74.13 110.579 171.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.7 t -56.64 -43.78 80.62 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 124.074 0.859 . . . . 32.13 111.411 -174.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 16.3 mt -78.3 -30.21 48.25 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.734 -1.121 . . . . 72.4 110.737 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.79 14.58 64.98 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 116.002 -0.545 . . . . 72.3 113.19 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.02 -79.27 0.1 Allowed 'General case' 0 C--N 1.353 0.742 0 C-N-CA 122.929 0.492 . . . . 74.12 111.235 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -65.41 -41.15 93.9 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.101 0.778 . . . . 73.12 113.101 -166.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 81.5 m -64.56 -48.96 73.18 Favored Pre-proline 0 CA--C 1.564 1.494 0 CA-C-O 118.726 -0.654 . . . . 63.51 112.595 -175.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.14 -22.73 34.52 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 121.717 1.611 . . . . 64.52 112.754 170.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -66.75 -25.88 66.71 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 122.539 0.336 . . . . 75.33 111.237 175.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.566 HG21 HD13 ' D' ' 13' ' ' ILE . 43.3 mm -67.99 -39.55 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.346 0.658 . . . . 72.45 109.983 170.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.408 HD21 ' HA3' ' D' ' 82' ' ' GLY . 79.4 mt -79.5 -17.68 53.58 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 115.155 -0.929 . . . . 72.43 111.941 -171.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -64.69 -45.07 75.61 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 114.214 1.19 . . . . 71.14 114.214 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -54.11 -43.88 54.37 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.065 1.843 . . . . 64.4 112.902 173.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -73.52 -34.01 65.03 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.239 -0.892 . . . . 63.52 111.911 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 110' ' ' ALA . . . . . 0.569 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -65.02 -49.61 69.49 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.458 -0.571 . . . . 70.15 109.458 177.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.8 ttp180 -54.54 -53.43 54.55 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 124.827 1.33 . . . . 65.41 110.801 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -60.16 -46.29 90.17 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.421 1.075 . . . . 64.11 111.378 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 39.6 t -62.12 -41.66 98.46 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.724 0.64 . . . . 63.15 110.935 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.448 ' O ' HG23 ' D' ' 118' ' ' VAL . 82.3 mt -60.48 -58.05 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.674 0.79 . . . . 60.44 110.508 173.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 40.6 m -54.7 -39.23 67.96 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.148 1.379 . . . . 75.45 111.537 -173.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 24.7 t -68.23 -43.45 77.91 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.953 -1.022 . . . . 74.33 110.506 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.8 mtm -68.6 -32.98 73.26 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 122.646 0.378 . . . . 74.42 111.715 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.448 HG23 ' O ' ' D' ' 114' ' ' ILE . 90.6 t -63.57 -45.48 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.548 0.739 . . . . 73.4 109.859 176.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.6 p -74.52 -29.91 61.59 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.877 -0.602 . . . . 64.33 111.281 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -72.24 -27.85 62.77 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.2 0.6 . . . . 74.03 110.138 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.26 8.29 74.74 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 123.621 0.575 . . . . 62.54 112.587 172.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.466 HG23 ' HB3' ' C' ' 17' ' ' TYR . 80.7 p 55.3 22.64 4.96 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 126.669 1.988 . . . . 73.14 114.105 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -82.96 151.18 63.33 Favored Pre-proline 0 CA--C 1.552 1.04 0 N-CA-C 108.717 -0.846 . . . . 73.24 108.717 168.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.523 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 17.7 Cg_endo -57.74 138.99 88.8 Favored 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.737 2.292 . . . . 75.31 112.872 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -53.03 134.33 38.14 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.58 1.152 . . . . 74.01 112.375 -175.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.83 104.76 9.8 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.526 -1.287 . . . . 74.25 107.526 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -99.58 109.4 21.91 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.605 0.762 . . . . 74.15 109.211 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.432 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 6.5 mp -70.38 119.06 14.0 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.135 0.574 . . . . 65.55 109.548 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.98 137.19 95.43 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.05 0.54 . . . . 74.24 110.774 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.72 130.77 6.92 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.269 1.979 . . . . 72.03 112.108 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.478 0.931 0 C-N-CA 122.879 0.472 . . . . 54.22 110.902 177.066 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.697 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.5 t80 . . . . . 0 C--O 1.238 0.476 0 N-CA-C 109.289 -0.634 . . . . 75.42 109.289 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -155.65 97.41 1.85 Allowed 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.29 -1.004 . . . . 64.21 108.29 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.451 HG12 ' HD2' ' A' ' 84' ' ' PHE . 29.5 mt -68.21 120.47 15.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 108.729 -0.841 . . . . 74.34 108.729 176.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -81.8 -40.19 22.94 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 123.832 0.707 . . . . 73.23 109.994 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -175.66 122.67 0.2 Allowed 'General case' 0 C--N 1.359 0.994 0 O-C-N 123.426 0.454 . . . . 74.05 111.352 -171.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.434 HD12 ' HG3' ' C' ' 130' ' ' PRO . 88.8 mt -106.96 136.16 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.603 -0.888 . . . . 63.11 108.603 169.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.4 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 24.0 p90 -164.13 166.19 21.49 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.189 0.996 . . . . 62.24 110.597 -174.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.5 p -96.61 119.12 34.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.534 -0.757 . . . . 73.24 109.012 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 36.1 mtpt -87.09 -30.14 21.35 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.166 -0.679 . . . . 72.25 109.166 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 16.7 t70 -144.83 137.13 26.13 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.189 -0.914 . . . . 75.35 109.276 177.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.9 mt -133.69 142.97 40.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 106.384 -1.71 . . . . 75.23 106.384 174.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.6 t -150.26 135.36 17.83 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.624 -0.51 . . . . 63.22 109.624 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.57 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 87.9 t80 -136.79 137.67 40.05 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.421 -1.696 . . . . 75.13 106.421 172.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -137.75 141.45 40.97 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 108.521 -0.918 . . . . 74.53 108.521 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.68 75.27 31.77 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 106.549 -1.649 . . . . 74.44 106.549 171.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.36 -42.84 31.74 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.284 2.656 . . . . 52.55 112.76 -171.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -101.64 22.76 12.25 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 118.35 -0.834 . . . . 63.51 109.913 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.443 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -42.61 -58.31 3.87 Favored Pre-proline 0 N--CA 1.497 1.906 0 N-CA-C 113.867 1.062 . . . . 74.52 113.867 -170.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 14.4 Cg_exo -65.66 -24.76 54.92 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 121.7 1.6 . . . . 60.31 112.778 -174.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -81.26 -43.33 19.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.114 -0.948 . . . . 72.43 109.91 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.796 HG21 ' HA ' ' A' ' 73' ' ' ALA . 5.2 p -76.32 -14.01 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 115.039 -0.982 . . . . 70.15 112.505 -162.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -69.62 -12.14 61.4 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.871 0.468 . . . . 65.51 111.68 173.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -83.34 -25.59 31.31 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.389 1.076 . . . . 71.51 110.823 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.412 ' NZ ' ' HB3' ' A' ' 71' ' ' GLU . 23.3 mmtp -68.14 149.61 49.37 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.658 0.783 . . . . 73.21 111.808 -177.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -71.13 131.96 44.35 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.301 -1.0 . . . . 70.33 108.301 171.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -77.77 82.01 4.18 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.798 0.809 . . . . 73.22 110.608 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -128.8 81.23 71.21 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 106.938 -1.504 . . . . 73.44 106.938 168.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -82.98 145.59 12.53 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.65 2.233 . . . . 61.22 112.318 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -97.83 89.83 4.73 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 105.823 -1.917 . . . . 63.45 105.823 168.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.526 HG13 HG13 ' A' ' 64' ' ' VAL . 96.6 t -72.16 92.42 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.425 -0.954 . . . . 75.41 108.425 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -87.58 115.47 25.03 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.591 -1.186 . . . . 72.52 108.285 174.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.7 pp -95.41 130.59 42.16 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.788 -1.19 . . . . 65.03 107.788 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.605 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.1 m-20 -120.21 105.71 11.23 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 107.796 -1.187 . . . . 74.23 107.796 176.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.7 mp -98.22 146.7 25.36 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.789 -0.819 . . . . 71.23 108.789 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.592 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 24.9 t70 -145.81 148.27 32.74 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 109.491 -0.559 . . . . 74.24 109.491 177.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 49.1 p -106.44 125.99 51.69 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.556 -0.747 . . . . 63.11 110.247 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -132.91 133.37 43.16 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.035 0.934 . . . . 62.43 108.733 176.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.9 m -133.66 159.26 41.05 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.235 0.614 . . . . 63.34 110.96 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.3 t -158.22 147.77 19.65 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.856 0.863 . . . . 72.12 109.184 174.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -106.81 119.09 38.4 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.118 -1.067 . . . . 63.02 108.118 172.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 50.3 mt -93.09 -37.72 11.99 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.163 0.585 . . . . 72.32 111.087 -173.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.79 -171.98 3.31 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.718 0.807 . . . . 61.44 110.3 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -63.59 119.45 9.87 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.553 0.741 . . . . 75.13 109.633 170.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 70.74 -7.19 1.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.773 1.229 . . . . 64.32 112.598 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.62 110.72 28.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 N-CA-C 107.965 -1.124 . . . . 63.52 107.965 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -134.1 128.48 34.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.363 -0.835 . . . . 74.53 109.28 -170.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -96.12 127.58 42.25 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.853 0.861 . . . . 72.43 110.921 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.442 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 68.0 t -107.44 124.58 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 107.106 -1.442 . . . . 74.41 107.106 168.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.479 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 44.0 t -119.62 124.57 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.367 -0.975 . . . . 70.34 108.367 172.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.415 HD22 HG22 ' A' ' 62' ' ' VAL . 1.8 tt -115.85 115.47 26.31 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.774 -1.195 . . . . 74.14 107.774 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.592 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 49.2 ttt180 -84.11 99.72 10.66 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.897 -1.149 . . . . 71.01 107.897 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.415 HG22 HD22 ' A' ' 60' ' ' LEU . 49.9 t -97.96 101.67 12.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.027 -1.101 . . . . 70.01 108.027 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.605 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 21.9 m -102.6 143.7 31.95 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.891 -0.781 . . . . 74.41 108.891 175.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.555 HG11 HD21 ' A' ' 126' ' ' LEU . 24.7 t -136.87 137.55 46.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 125.445 1.498 . . . . 72.11 107.201 173.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.4 m -132.29 127.15 35.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.719 -0.845 . . . . 71.54 108.719 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.62 104.26 14.28 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 107.949 -1.13 . . . . 72.41 107.949 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 50.5 m -108.0 126.86 53.21 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.572 0.349 . . . . 65.32 110.464 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.2 mt -103.94 83.11 2.06 Favored 'General case' 0 C--O 1.249 1.065 0 C-N-CA 124.052 0.941 . . . . 74.13 108.535 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.13 -84.79 1.13 Allowed Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.282 -0.872 . . . . 75.53 111.715 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.38 -26.2 3.36 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.925 0.89 . . . . 54.33 110.045 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.412 ' HB3' ' NZ ' ' A' ' 34' ' ' LYS . 45.5 tt0 -94.17 112.65 24.47 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.784 0.834 . . . . 75.4 109.643 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 94.0 m -73.25 135.37 44.49 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.018 0.437 . . . . 54.34 110.441 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.796 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -72.61 -61.99 1.61 Allowed 'General case' 0 C--O 1.243 0.75 0 CA-C-N 114.679 -1.146 . . . . 70.43 110.078 176.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -156.23 174.85 14.78 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 114.806 -1.088 . . . . 74.43 112.124 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.3 tp -133.67 135.46 44.12 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.778 1.631 . . . . 62.22 107.647 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 79.2 m -134.96 105.41 6.37 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.042 0.937 . . . . 71.05 109.632 178.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -126.54 115.91 20.26 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.257 1.023 . . . . 62.42 109.141 -174.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.4 t -129.74 114.52 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.277 0.631 . . . . 71.31 109.487 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.564 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 75.6 mt-30 -85.0 88.14 7.43 Favored 'General case' 0 C--O 1.249 1.048 0 N-CA-C 108.334 -0.987 . . . . 62.44 108.334 170.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.402 ' HG3' HD22 ' A' ' 106' ' ' LEU . 59.6 tp60 -77.34 104.96 8.15 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 114.849 -1.069 . . . . 72.41 109.16 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.98 147.35 20.94 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 111.325 -0.71 . . . . 62.14 111.325 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.522 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -152.05 120.77 1.11 Allowed Glycine 0 CA--C 1.499 -0.93 0 N-CA-C 110.78 -0.928 . . . . 73.54 110.78 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.1 mt -83.61 121.49 36.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 108.308 -0.997 . . . . 73.32 108.308 173.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.697 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 33.0 m-85 -129.67 137.49 50.65 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.66 -0.867 . . . . 74.22 108.66 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.1 t -103.69 98.33 8.22 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.995 -0.743 . . . . 61.44 108.995 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.478 0.928 0 C-N-CA 124.626 1.17 . . . . 63.42 109.315 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 121.088 0.471 . . . . 62.25 110.934 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -68.53 -39.47 81.16 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.033 0.933 . . . . 71.0 109.888 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.559 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 43.7 t -69.34 -52.92 22.55 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 123.732 0.645 . . . . 51.12 111.429 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 pp -77.5 -20.96 53.48 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.893 0.477 . . . . 72.13 111.782 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.57 -16.11 23.13 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 115.223 0.849 . . . . 63.33 115.223 -170.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.02 -43.83 0.14 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.616 0.708 . . . . 45.12 112.727 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.559 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 67.9 t80 -67.9 -68.97 0.35 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.815 0.846 . . . . 75.1 111.301 -170.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 76.0 m -65.56 -35.85 12.93 Favored Pre-proline 0 CA--C 1.568 1.641 0 C-N-CA 123.573 0.749 . . . . 64.11 112.781 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -47.56 -48.56 15.25 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 122.774 2.316 . . . . 74.21 114.383 162.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.45 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 29.7 t-20 -69.72 -24.35 63.55 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.089 0.555 . . . . 72.25 110.516 -177.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 38.8 mm -63.39 -39.46 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.218 0.532 . . . . 72.23 110.567 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.522 HD21 ' HA3' ' A' ' 82' ' ' GLY . 91.2 mt -78.63 -24.94 44.99 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.617 0.767 . . . . 72.11 112.056 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -60.65 -47.38 96.18 Favored Pre-proline 0 CA--C 1.565 1.557 0 N-CA-C 114.256 1.206 . . . . 75.21 114.256 -171.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 104' ' ' ASN . 37.0 Cg_exo -62.61 -32.48 79.27 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.034 1.823 . . . . 73.24 113.121 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -77.37 -38.29 50.41 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.685 0.794 . . . . 74.22 111.002 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.11 -37.25 75.32 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.146 0.578 . . . . 74.31 110.046 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.426 ' NH1' HD12 ' C' ' 105' ' ' ILE . 24.1 ttm180 -60.63 -50.64 72.71 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.215 1.006 . . . . 74.22 109.732 174.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.1 -42.86 88.71 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.81 0.693 . . . . 61.34 110.646 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 43.5 t -62.65 -32.76 73.86 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.813 0.445 . . . . 64.14 110.666 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.512 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 32.3 mt -67.55 -55.76 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 123.518 0.727 . . . . 74.3 109.932 170.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.539 HG21 ' HE2' ' C' ' 109' ' ' TYR . 87.8 m -55.22 -38.38 68.36 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.016 1.326 . . . . 75.2 111.894 -175.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.504 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 47.5 t -63.29 -50.03 71.71 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.479 -0.782 . . . . 63.12 110.07 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.57 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 50.9 mtm -63.67 -38.25 90.4 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.373 0.669 . . . . 71.33 111.578 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.9 t -64.18 -53.17 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.807 0.843 . . . . 75.14 110.62 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.2 t -67.52 -31.41 71.51 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.613 -0.722 . . . . 73.04 110.839 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 116' ' ' SER . 24.9 ttm-85 -72.13 -32.77 67.24 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.489 1.116 . . . . 74.41 108.46 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.425 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.82 14.25 53.11 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-N 114.561 -1.2 . . . . 60.05 113.47 173.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.548 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.3 t 63.38 12.28 6.15 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 126.471 1.908 . . . . 73.23 114.178 172.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -83.16 148.51 56.48 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 108.562 -0.903 . . . . 63.25 108.562 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.15 163.11 10.42 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.215 2.61 . . . . 73.54 113.205 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -57.04 122.46 12.39 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.32 -0.855 . . . . 71.41 112.367 -171.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.555 HD21 HG11 ' A' ' 64' ' ' VAL . 52.0 tp -121.95 106.77 11.53 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.588 1.155 . . . . 62.31 109.022 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -130.14 121.09 25.63 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.996 0.918 . . . . 73.05 108.945 176.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.5 mt -68.25 143.72 55.16 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.797 0.439 . . . . 73.41 109.895 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.41 136.86 91.0 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.123 0.569 . . . . 35.32 110.384 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.423 ' HG2' ' CE2' ' C' ' 11' ' ' PHE . 2.7 Cg_endo -79.29 92.12 1.15 Allowed 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.84 2.36 . . . . 74.2 110.609 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.2 t -101.64 113.39 37.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.338 -0.986 . . . . 63.13 108.338 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -69.73 100.05 1.44 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.804 -0.813 . . . . 71.11 108.804 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 . . . . . 0 N--CA 1.485 1.286 0 C-N-CA 123.968 0.907 . . . . 72.53 111.017 -178.24 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 57.6 ttm . . . . . 0 CA--C 1.561 1.396 0 CA-C-O 121.962 0.887 . . . . 75.03 111.336 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 96.6 m -150.1 118.34 6.39 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 106.163 -1.791 . . . . 75.45 106.163 171.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.438 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 58.9 t80 -127.17 144.59 51.0 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.342 -0.614 . . . . 72.22 109.342 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -155.52 136.44 13.64 Favored 'General case' 0 C--O 1.243 0.715 0 O-C-N 123.671 0.607 . . . . 72.14 110.064 173.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.563 HD13 HD11 ' B' ' 16' ' ' ILE . 58.4 mt -76.75 125.4 36.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.492 0 N-CA-C 108.456 -0.942 . . . . 71.24 108.456 169.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -92.17 -49.86 5.97 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.833 -0.803 . . . . 72.53 108.833 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.548 ' HE ' HG21 ' A' ' 122' ' ' THR . 42.9 ttt180 -164.5 134.04 3.81 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.685 -0.689 . . . . 52.12 110.217 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.563 HD11 HD13 ' B' ' 13' ' ' ILE . 76.1 mt -115.24 140.42 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 124.042 0.937 . . . . 72.21 108.603 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -169.18 152.1 4.91 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 112.707 0.632 . . . . 75.15 112.707 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 82.5 m -76.76 125.45 29.3 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.968 -1.015 . . . . 72.23 109.008 169.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.412 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 40.3 mtpt -97.87 -31.83 12.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.099 0.56 . . . . 71.42 111.482 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.45 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 10.9 t70 -155.66 136.62 13.65 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.275 -0.421 . . . . 72.22 109.992 -168.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.474 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.7 mm -135.15 142.36 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.69 1.196 . . . . 75.11 108.68 177.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.8 t -149.34 108.17 3.86 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.803 -1.184 . . . . 63.34 107.803 173.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -122.56 118.89 29.29 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 107.644 -1.243 . . . . 64.44 107.644 172.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -118.91 153.03 35.23 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.13 0.972 . . . . 75.42 108.697 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.513 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -142.37 80.32 14.86 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 106.32 -1.733 . . . . 63.05 106.32 173.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.49 -31.0 42.93 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.059 2.506 . . . . 72.23 113.095 -168.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -108.94 14.78 23.91 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.188 0.595 . . . . 71.14 110.828 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.513 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -42.51 -64.34 0.73 Allowed Pre-proline 0 N--CA 1.492 1.661 0 N-CA-C 114.959 1.466 . . . . 62.31 114.959 -166.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.403 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 34.6 Cg_endo -63.3 -30.62 73.69 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.215 1.943 . . . . 73.4 113.702 -168.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -94.24 -28.68 15.48 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.744 0.418 . . . . 72.25 111.401 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.533 HG22 HD12 ' B' ' 68' ' ' LEU . 2.8 p -73.04 -20.12 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 122.594 0.357 . . . . 71.23 110.464 -176.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -65.43 -14.78 61.68 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.903 0.881 . . . . 75.11 113.104 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -68.05 -19.21 64.87 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.818 0.447 . . . . 74.35 110.701 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -90.6 106.34 18.44 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.451 1.101 . . . . 73.23 109.932 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -93.93 83.87 4.44 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.313 0.645 . . . . 64.35 110.626 -174.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -169.03 173.52 6.84 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.231 1.013 . . . . 75.33 109.854 170.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -85.16 121.54 73.99 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 109.14 -0.689 . . . . 75.44 109.14 176.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.12 165.53 31.07 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.772 2.315 . . . . 75.24 113.863 -175.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 10.1 tp10 -69.76 126.33 29.41 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.388 -0.824 . . . . 75.14 109.483 176.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.7 140.54 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.394 0.616 . . . . 65.22 111.16 -171.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.608 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 63.2 mttp -126.91 143.73 51.19 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.432 1.093 . . . . 63.23 109.696 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -114.07 132.5 56.0 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.924 0.89 . . . . 74.33 108.634 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -151.2 109.29 3.72 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 108.23 -1.026 . . . . 71.44 108.23 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' B' ' 62' ' ' VAL . 9.9 mp -102.41 157.03 17.2 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.471 -0.566 . . . . 64.3 109.471 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -139.28 153.9 47.86 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 108.445 -0.946 . . . . 75.53 108.445 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 74.3 p -107.66 118.39 36.61 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.362 -0.835 . . . . 74.25 108.929 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.427 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -126.87 136.37 52.24 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.552 -1.277 . . . . 32.22 107.552 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 59.7 p -143.25 163.04 34.05 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-O 120.628 0.251 . . . . 73.44 111.132 -174.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 74.9 p -153.28 137.03 16.09 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.739 0.816 . . . . 74.03 109.499 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -94.62 111.47 23.23 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.529 -1.286 . . . . 74.31 107.529 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.5 mt -81.15 -53.55 6.28 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.041 0.448 . . . . 65.2 110.809 -176.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -145.01 -177.09 5.36 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.123 -0.944 . . . . 75.14 109.517 -175.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.43 109.74 1.45 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.349 0.66 . . . . 71.21 110.011 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 69.15 4.88 4.79 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 125.011 1.324 . . . . 55.2 113.347 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 98.4 t -104.77 117.54 50.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.615 -1.254 . . . . 60.04 107.615 172.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -123.16 177.26 5.63 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 121.352 0.596 . . . . 75.41 109.822 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -142.66 102.64 4.09 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.446 -1.316 . . . . 51.1 107.446 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 65.5 t -89.43 121.25 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.626 1.171 . . . . 75.03 109.739 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.501 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.6 t -109.2 109.57 28.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 C-N-CA 123.529 0.732 . . . . 54.23 109.26 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 35.6 tp -93.31 109.42 20.96 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.306 -0.627 . . . . 74.41 109.306 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -86.83 117.99 25.92 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 108.614 -0.884 . . . . 74.22 108.614 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.441 ' HA ' ' HG ' ' B' ' 44' ' ' LEU . 14.3 t -112.19 116.82 53.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 108.392 -0.966 . . . . 72.53 108.392 172.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.8 m -112.36 138.45 49.06 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.827 0.822 . . . . 72.31 109.404 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.725 HG21 HG21 ' B' ' 114' ' ' ILE . 54.4 t -127.19 131.41 70.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 125.644 1.578 . . . . 64.21 108.284 -174.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.608 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 89.2 m -117.95 146.19 44.16 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.31 -0.626 . . . . 62.12 109.31 173.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.94 139.34 23.62 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.602 0.761 . . . . 43.41 110.085 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.594 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 17.7 p -147.49 127.21 13.4 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.486 0.492 . . . . 61.35 111.619 -176.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.533 HD12 HG22 ' B' ' 31' ' ' VAL . 54.7 mt -98.32 107.39 19.84 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 107.812 -1.181 . . . . 75.41 107.812 174.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.98 -131.53 12.54 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 120.024 -0.32 . . . . 72.34 112.572 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -99.01 17.47 19.62 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.592 0.757 . . . . 73.02 111.687 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -138.84 154.24 48.42 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.424 0.689 . . . . 73.52 109.9 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 49.5 m -77.94 123.32 26.65 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.908 0.385 . . . . 72.23 111.061 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.594 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -74.4 -60.77 2.12 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.322 -0.992 . . . . 61.42 108.322 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -155.85 156.92 35.53 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 115.252 -0.885 . . . . 74.52 112.328 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 79.7 mt -125.68 119.87 29.17 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 125.74 1.616 . . . . 65.32 106.973 175.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.511 ' SG ' HG23 ' B' ' 114' ' ' ILE . 49.3 t -118.28 150.39 39.54 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.709 -0.848 . . . . 42.23 108.709 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -159.88 126.43 4.38 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.419 -0.956 . . . . 74.31 108.419 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 86.9 t -122.69 145.94 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.325 -0.852 . . . . 74.14 109.146 176.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.45 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 18.1 mt-30 -120.65 97.1 5.4 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.271 -1.011 . . . . 74.24 108.271 169.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -87.07 101.53 13.55 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.8 -0.815 . . . . 63.55 108.8 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.08 164.08 33.55 Favored Glycine 0 C--O 1.246 0.848 0 O-C-N 123.903 0.752 . . . . 61.22 111.862 177.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.39 126.07 1.44 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.867 -0.493 . . . . 73.42 111.867 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 59.9 mt -84.61 130.02 36.71 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 108.31 -0.996 . . . . 75.44 108.31 172.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -139.22 156.5 47.05 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.147 0.579 . . . . 71.0 109.473 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 69.1 m -121.27 133.07 55.13 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.999 0.92 . . . . 71.25 109.126 175.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 12.4 tt -130.56 148.96 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.526 0.73 . . . . 74.43 110.576 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.25 175.07 14.48 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.909 0.884 . . . . 73.43 109.621 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.51 -56.29 4.72 Favored Glycine 0 N--CA 1.473 1.128 0 C-N-CA 123.128 0.394 . . . . 72.53 112.586 175.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.539 HG22 ' HB3' ' B' ' 94' ' ' MET . 7.4 mm -90.9 153.02 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.04 0.936 . . . . 75.0 110.93 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -147.21 -178.6 6.31 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.757 1.223 . . . . 70.25 109.104 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.31 -134.42 22.86 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 115.548 -0.751 . . . . 61.3 113.973 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 54.1 m -75.38 -33.64 61.03 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.559 0.744 . . . . 72.5 111.944 -177.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -60.78 -33.04 72.37 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.369 0.668 . . . . 72.03 111.854 -175.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.539 ' HB3' HG22 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -86.12 -24.62 26.16 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.695 0.398 . . . . 72.15 111.816 176.215 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.75 -32.26 73.71 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.033 0.533 . . . . 70.1 110.817 172.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -76.42 -36.08 58.19 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.554 -0.748 . . . . 61.44 110.966 172.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.0 t -60.67 -52.4 65.28 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.016 0.527 . . . . 51.45 111.354 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.52 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 0.5 OUTLIER -80.52 -13.53 59.01 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.251 0.463 . . . . 51.11 112.251 175.772 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.23 1.44 62.63 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-O 119.608 -0.551 . . . . 63.42 113.784 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.47 -53.38 0.11 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 117.482 0.641 . . . . 73.13 110.957 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -70.73 -50.33 37.32 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.174 0.59 . . . . 73.23 112.559 -172.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 61.2 m -60.79 -47.26 96.29 Favored Pre-proline 0 CA--C 1.563 1.452 0 CA-C-O 118.811 -0.614 . . . . 72.51 111.626 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.49 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 48.4 Cg_exo -60.8 -32.7 93.14 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 122.432 2.088 . . . . 70.34 114.106 171.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -61.01 -38.09 84.86 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.828 0.851 . . . . 61.12 110.202 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.414 HG23 ' NH2' ' D' ' 111' ' ' ARG . 74.8 mt -62.47 -40.79 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 114.976 -1.011 . . . . 72.03 110.606 174.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 56.3 mt -86.4 -13.12 47.27 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.975 -1.011 . . . . 72.3 111.765 -171.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -55.31 -52.29 72.73 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 124.019 0.928 . . . . 75.11 112.915 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -59.76 -37.0 89.75 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.324 2.016 . . . . 72.33 114.088 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -67.83 -44.57 76.89 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.03 0.532 . . . . 73.45 110.635 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.98 -36.42 83.26 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.726 -0.67 . . . . 65.43 110.822 176.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -61.96 -50.5 71.86 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.967 1.307 . . . . 60.15 110.256 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -68.73 -33.61 74.22 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 115.309 -0.86 . . . . 73.14 109.704 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.474 ' SG ' HD11 ' B' ' 21' ' ' ILE . 13.5 t -66.55 -44.47 82.26 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.934 0.494 . . . . 72.31 111.77 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.725 HG21 HG21 ' B' ' 64' ' ' VAL . 95.2 mt -60.05 -53.5 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 108.894 -0.78 . . . . 64.24 108.894 175.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 38.5 m -57.02 -36.05 69.98 Favored 'General case' 0 CA--C 1.553 1.064 0 O-C-N 124.371 1.045 . . . . 51.35 111.602 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.2 t -62.74 -47.21 84.56 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 123.526 0.73 . . . . 53.54 109.749 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 9.7 mmt -70.38 -35.8 73.73 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.006 0.523 . . . . 74.14 111.172 -176.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' B' ' 114' ' ' ILE . 97.0 t -60.24 -43.92 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.763 0.825 . . . . 65.45 109.801 172.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.2 t -65.34 -33.0 74.94 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.646 -1.161 . . . . 71.43 111.355 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' B' ' 116' ' ' SER . 83.0 mtt-85 -71.04 -36.21 72.27 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.536 -0.756 . . . . 70.54 110.187 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.95 -3.65 81.21 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 123.752 0.658 . . . . 72.11 112.316 172.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 23.6 p 62.82 35.01 14.01 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.446 1.899 . . . . 64.24 112.428 173.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -93.69 164.45 20.83 Favored Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 124.103 0.961 . . . . 73.34 110.67 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.04 166.15 1.04 Allowed 'Trans proline' 0 C--N 1.393 2.869 0 C-N-CA 123.663 2.909 . . . . 63.4 115.524 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -63.54 121.4 13.77 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 115.375 -0.83 . . . . 65.31 111.127 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 18.6 tp -129.2 98.43 4.9 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.046 -0.524 . . . . 73.41 109.922 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -124.38 121.26 34.45 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.863 0.865 . . . . 75.43 109.591 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mp -64.88 149.25 49.89 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.949 0.5 . . . . 72.55 111.117 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.9 150.99 73.05 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.452 0.701 . . . . 54.23 110.023 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -67.64 129.45 19.99 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 123.031 2.487 . . . . 34.55 112.395 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 26.0 m -131.95 128.4 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.46 0.704 . . . . 52.11 109.257 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -109.13 102.13 11.12 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 107.252 -1.388 . . . . 73.23 107.252 173.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -60.93 -47.73 85.09 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.17 0.918 . . . . 73.43 110.102 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 C--O 1.221 -0.445 0 CA-C-N 114.283 -1.326 . . . . 62.12 112.014 -174.215 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.599 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 33.8 t80 . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 108.093 -1.077 . . . . 72.43 108.093 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -155.16 136.55 14.1 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.887 -0.412 . . . . 71.41 109.887 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.492 HG12 ' HE2' ' C' ' 84' ' ' PHE . 56.4 mt -79.2 128.54 38.47 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 N-CA-C 109.036 -0.728 . . . . 43.43 109.036 171.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -101.0 -34.99 9.53 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.598 0.759 . . . . 62.12 110.073 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -176.63 139.29 0.31 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.167 0.587 . . . . 73.14 109.74 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.422 HD11 HD13 ' C' ' 13' ' ' ILE . 95.0 mt -129.89 142.58 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 108.187 -1.042 . . . . 71.32 108.187 175.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.421 ' HE1' HG12 ' C' ' 83' ' ' ILE . 32.9 p90 -172.47 167.02 5.66 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.162 0.985 . . . . 72.4 109.334 -169.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -91.76 114.2 26.68 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 122.893 0.477 . . . . 72.31 109.912 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.693 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 21.8 mmtp -65.44 -42.58 92.26 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 109.362 -0.607 . . . . 64.45 109.362 168.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.7 t70 -145.53 146.8 31.57 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.932 -1.031 . . . . 73.35 110.391 -174.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.541 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.1 mt -141.72 147.48 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.819 1.648 . . . . 74.33 106.813 174.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.0 t -160.46 151.47 18.95 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.225 0.61 . . . . 72.24 110.174 176.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -155.52 112.21 3.2 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 124.384 1.074 . . . . 74.12 108.104 174.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -122.77 132.15 54.1 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.407 0.683 . . . . 71.34 110.477 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.61 86.35 4.67 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 107.634 -1.247 . . . . 74.43 107.634 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.43 -40.81 29.26 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.088 2.525 . . . . 75.44 112.03 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -91.53 18.16 7.72 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 113.902 -1.499 . . . . 64.32 111.625 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.99 -56.32 6.42 Favored Pre-proline 0 N--CA 1.486 1.354 0 N-CA-C 114.029 1.122 . . . . 63.43 114.029 -171.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -60.99 -40.35 53.0 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 121.76 1.64 . . . . 64.24 112.415 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -68.75 -38.03 79.83 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.16 0.984 . . . . 75.33 112.493 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.662 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.6 p -79.04 -13.98 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 C-N-CA 123.329 0.652 . . . . 62.02 111.903 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -75.3 -17.67 60.22 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 112.521 0.563 . . . . 73.43 112.521 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -103.22 36.23 2.31 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.16 0.505 . . . . 70.01 110.208 175.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.435 ' HG2' HD13 ' C' ' 68' ' ' LEU . 1.0 OUTLIER -119.35 149.45 41.8 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.005 0.522 . . . . 72.42 111.358 -174.536 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -59.17 101.97 0.11 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.237 1.015 . . . . 72.21 109.802 176.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -79.07 101.76 8.03 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.153 0.502 . . . . 75.34 111.528 -171.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -163.04 76.65 1.86 Allowed Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 107.876 -1.157 . . . . 74.32 107.876 167.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -88.0 153.41 7.11 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.776 2.317 . . . . 62.32 113.316 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -87.6 109.04 19.36 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.079 -0.964 . . . . 55.31 108.927 167.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.468 HG23 HG13 ' C' ' 64' ' ' VAL . 2.7 p -72.02 100.35 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-O 121.85 0.833 . . . . 74.03 109.825 173.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -92.28 98.83 11.75 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.835 -1.172 . . . . 71.42 107.835 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 pp -103.19 154.12 19.65 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.661 0.384 . . . . 73.21 110.145 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -143.88 140.44 29.77 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.355 -0.609 . . . . 72.55 109.355 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -118.85 111.96 19.07 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.0 -0.741 . . . . 73.31 109.0 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.49 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 5.8 t70 -112.24 150.85 30.33 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.732 1.213 . . . . 63.23 108.513 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 76.8 p -116.48 138.07 51.67 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.506 0.723 . . . . 63.45 111.259 -170.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.34 150.19 38.81 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.253 1.021 . . . . 74.14 109.105 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 11.7 p -165.49 158.16 15.55 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.425 0.528 . . . . 51.05 112.425 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 67.7 p -160.2 143.93 14.05 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.277 1.031 . . . . 61.45 109.559 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -80.95 131.13 35.31 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.166 -0.679 . . . . 64.45 109.166 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' C' ' 57' ' ' GLU . 29.1 mt -107.57 -32.98 7.46 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.259 0.624 . . . . 72.03 110.846 -176.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.17 -174.53 4.76 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.459 0.704 . . . . 64.22 110.68 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -66.15 130.31 42.8 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.943 -1.026 . . . . 73.54 109.166 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 64.86 -6.89 0.29 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.836 1.255 . . . . 74.32 113.274 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 71.0 t -108.87 119.6 58.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 C-N-CA 123.259 0.623 . . . . 63.22 110.432 -167.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 56' ' ' TYR . . . . . 0.525 ' HB2' HD11 ' C' ' 86' ' ' ILE . 13.6 m-85 -119.99 143.58 47.97 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.72 -1.127 . . . . 74.52 108.864 171.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.629 ' HB2' HD11 ' C' ' 51' ' ' LEU . 24.2 tt0 -83.56 110.24 18.07 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.396 -1.729 . . . . 75.41 107.862 167.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 78.6 t -96.9 112.17 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.033 -1.469 . . . . 63.22 107.033 172.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.466 HG23 ' HG2' ' C' ' 57' ' ' GLU . 90.3 t -113.04 134.05 56.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 107.983 -1.117 . . . . 74.21 107.983 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.444 HD22 ' HB2' ' C' ' 103' ' ' PRO . 26.8 tp -127.61 119.96 27.08 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.037 -0.727 . . . . 72.25 109.037 175.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.49 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.7 ttm180 -81.21 123.68 28.66 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 124.211 0.945 . . . . 72.22 109.45 173.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.1 114.94 48.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.699 -1.222 . . . . 63.1 107.699 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 36.0 m -114.63 142.82 45.96 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.426 -0.953 . . . . 74.12 108.426 -175.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.468 HG13 HG23 ' C' ' 40' ' ' VAL . 53.5 t -136.25 110.0 9.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.717 1.207 . . . . 62.11 107.894 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.502 HG23 HD23 ' C' ' 75' ' ' LEU . 3.7 m -107.0 107.2 18.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.059 -1.46 . . . . 73.3 107.059 172.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.88 122.34 40.88 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.989 -1.485 . . . . 50.01 106.989 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 44.5 m -132.87 127.35 34.24 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.889 0.376 . . . . 32.44 111.115 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.435 HD13 ' HG2' ' C' ' 34' ' ' LYS . 10.2 mt -86.02 43.76 1.07 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.385 1.474 . . . . 71.22 109.787 174.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.49 -113.51 4.61 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 109.748 -1.341 . . . . 74.41 109.748 -171.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -90.01 -28.83 18.82 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.192 0.597 . . . . 72.45 110.2 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -72.38 102.29 3.12 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.714 -0.847 . . . . 73.31 108.714 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 30.1 m -68.99 123.85 22.13 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.294 -0.632 . . . . 71.11 109.294 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.662 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -66.08 -64.46 0.85 Allowed 'General case' 0 C--O 1.239 0.51 0 O-C-N 123.99 0.806 . . . . 74.52 108.908 177.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -154.61 171.85 18.8 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.47 -0.786 . . . . 73.32 110.632 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.502 HD23 HG23 ' C' ' 65' ' ' THR . 2.6 tm? -127.53 144.36 51.07 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.372 -1.714 . . . . 71.53 106.372 172.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.461 ' SG ' HG23 ' C' ' 114' ' ' ILE . 38.3 t -152.73 145.4 24.26 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.309 -0.997 . . . . 74.41 108.309 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -159.24 126.28 4.7 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.383 0.273 . . . . 74.3 110.531 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.501 HG11 ' HA ' ' C' ' 110' ' ' ALA . 54.9 t -133.93 113.26 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.296 1.039 . . . . 71.01 109.154 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.507 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 27.8 mt-30 -90.55 95.92 10.4 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.611 -0.885 . . . . 62.43 108.611 172.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.582 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.0 tp-100 -79.61 108.39 13.12 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.32 -0.854 . . . . 71.23 109.58 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.09 145.39 21.43 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.711 -0.677 . . . . 71.33 111.681 175.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.87 114.81 0.71 Allowed Glycine 0 CA--C 1.507 -0.467 0 N-CA-C 110.279 -1.128 . . . . 71.15 110.279 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.433 HD12 ' CD1' ' C' ' 51' ' ' LEU . 19.0 mm -82.66 123.32 38.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 N-CA-C 108.259 -1.015 . . . . 72.45 108.259 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.492 ' HE2' HG12 ' C' ' 13' ' ' ILE . 58.4 m-85 -132.64 138.8 47.48 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.164 0.586 . . . . 71.05 109.842 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 41.2 p -94.05 100.98 13.0 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.128 -1.064 . . . . 71.32 108.128 167.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.572 HD13 ' H ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -116.83 128.79 74.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 C-N-CA 123.752 0.821 . . . . 64.02 109.766 -178.133 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.73 165.98 29.53 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.418 -0.81 . . . . 74.24 110.641 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.08 -59.97 0.36 Allowed Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.85 -0.614 . . . . 71.31 112.838 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 23.7 pt -90.91 172.71 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.634 0.774 . . . . 75.43 111.813 -170.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -157.4 151.23 24.32 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.204 0.602 . . . . 75.23 111.012 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.29 -132.34 11.06 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.915 -0.584 . . . . 53.51 112.529 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 42.6 p -65.76 -27.05 68.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.744 0.818 . . . . 72.51 111.495 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -58.91 -52.37 66.04 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.972 0.909 . . . . 74.23 109.629 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 50.8 ttm -67.88 -39.63 83.67 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 114.655 -1.157 . . . . 64.44 110.109 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.86 88.88 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.109 0.963 . . . . 71.04 111.856 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -70.16 -43.46 70.8 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.977 -0.556 . . . . 63.34 110.793 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.59 -41.87 95.59 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.233 0.613 . . . . 73.31 111.013 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 64.4 mt -84.15 -37.48 21.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.641 0.777 . . . . 74.51 111.457 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.35 10.11 75.39 Favored Glycine 0 N--CA 1.476 1.335 0 N-CA-C 114.212 0.445 . . . . 41.22 114.212 -172.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' C' ' 104' ' ' ASN . . . -153.62 -59.6 0.13 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.083 0.553 . . . . 62.14 110.513 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -72.77 -42.3 64.13 Favored 'General case' 0 CA--C 1.556 1.188 0 N-CA-C 113.013 0.746 . . . . 71.32 113.013 -166.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.599 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 60.3 m -67.25 -49.91 41.96 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 123.112 0.565 . . . . 60.13 111.944 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.444 ' HB2' HD22 ' C' ' 60' ' ' LEU . 70.1 Cg_endo -71.73 -23.71 22.38 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 121.722 1.615 . . . . 72.51 112.799 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 104' ' ' ASN . . . . . 0.497 ' HA ' ' HD2' ' C' ' 107' ' ' PHE . 46.6 t-20 -56.22 -39.98 73.36 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 123.952 0.901 . . . . 74.1 110.153 176.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.426 HD12 ' NH1' ' A' ' 111' ' ' ARG . 34.8 mm -60.16 -41.1 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 114.382 -1.281 . . . . 65.33 111.12 175.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 68.1 mt -87.07 -19.62 28.33 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.444 0.698 . . . . 73.34 112.689 -168.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 107' ' ' PHE . . . . . 0.497 ' HD2' ' HA ' ' C' ' 104' ' ' ASN . 28.1 m-85 -55.47 -53.23 64.54 Favored Pre-proline 0 N--CA 1.489 1.509 0 CA-C-O 118.081 -0.961 . . . . 75.33 112.832 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -54.76 -40.19 85.94 Favored 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 122.857 2.372 . . . . 75.12 114.658 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.539 ' HE2' HG21 ' A' ' 115' ' ' THR . 39.7 m-85 -66.62 -50.1 64.1 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.56 0.744 . . . . 74.23 110.77 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.582 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.75 -35.33 80.74 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.016 -0.993 . . . . 64.34 111.041 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -61.27 -48.28 82.15 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.159 1.384 . . . . 71.25 110.638 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.73 -35.94 77.77 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 123.515 0.51 . . . . 63.22 109.73 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.4 t -67.99 -33.2 74.18 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.376 0.67 . . . . 72.12 111.151 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.461 HG23 ' SG ' ' C' ' 76' ' ' CYS . 78.1 mt -72.53 -54.35 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 109.545 -0.539 . . . . 60.53 109.545 174.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 22.6 m -62.37 -28.38 69.73 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 122.909 0.484 . . . . 64.31 111.25 -175.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.6 t -65.27 -49.03 71.11 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.996 -0.742 . . . . 52.2 108.996 171.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.668 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.03 -38.16 85.13 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.602 1.161 . . . . 64.52 112.264 178.902 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.458 HG23 ' O ' ' C' ' 114' ' ' ILE . 68.0 t -59.39 -47.19 91.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 108.765 -0.828 . . . . 74.23 108.765 175.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 37.9 t -74.64 -23.29 58.65 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.572 -1.195 . . . . 73.33 112.272 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.422 ' HD2' ' SD ' ' C' ' 117' ' ' MET . 90.2 mtt-85 -74.43 -39.06 62.83 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.015 -0.735 . . . . 73.34 109.015 175.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.11 0.96 82.19 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 124.168 0.917 . . . . 64.53 112.172 170.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.9 p 60.87 30.7 19.81 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.687 1.995 . . . . 61.15 113.602 171.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -83.29 143.8 45.63 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 108.242 -1.022 . . . . 64.43 108.242 170.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -51.27 152.16 11.75 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.211 2.608 . . . . 55.31 113.45 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -54.17 125.98 21.15 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.575 0.954 . . . . 71.1 113.575 -170.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 21.7 tp -122.84 86.09 2.53 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 107.682 -1.229 . . . . 73.11 107.682 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -95.7 115.9 28.1 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.387 -0.824 . . . . 72.5 108.994 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.11 129.01 37.12 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.334 0.654 . . . . 73.24 110.155 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.58 145.14 74.83 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 122.633 0.373 . . . . 65.34 110.932 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.434 ' HG3' HD12 ' A' ' 16' ' ' ILE . 71.4 Cg_endo -72.92 144.76 39.04 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.272 2.648 . . . . 73.41 113.369 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 18.5 m -137.91 134.76 45.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.213 1.005 . . . . 73.33 108.65 171.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.71 90.24 6.33 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 118.694 -0.669 . . . . 62.21 109.644 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -54.64 -44.66 73.4 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 118.363 0.529 . . . . 51.24 112.084 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 N--CA 1.478 0.929 0 C-N-CA 124.366 1.066 . . . . 65.3 111.582 178.797 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 86.6 m . . . . . 0 C--O 1.241 0.611 0 N-CA-C 108.528 -0.916 . . . . 74.42 108.528 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -163.16 105.4 1.01 Allowed 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.524 -0.917 . . . . 72.4 108.524 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -128.37 127.63 42.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.069 -1.086 . . . . 74.0 108.069 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.528 HG21 HD11 ' D' ' 16' ' ' ILE . 10.8 mt -86.82 131.42 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 109.001 -0.74 . . . . 73.32 109.001 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -98.48 -35.28 10.31 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.325 0.65 . . . . 71.14 110.931 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -167.21 142.03 3.94 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.857 0.688 . . . . 70.24 112.857 -171.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.528 HD11 HG21 ' D' ' 13' ' ' ILE . 3.4 mp -119.65 134.87 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 106.798 -1.556 . . . . 74.42 106.798 170.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.431 ' HE1' HG13 ' D' ' 83' ' ' ILE . 31.9 p90 -164.97 165.49 20.15 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.77 0.795 . . . . 72.32 110.744 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.2 p -102.68 124.11 47.62 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.461 -1.245 . . . . 72.42 108.636 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -89.78 -42.51 11.25 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.75 -0.833 . . . . 74.41 108.75 175.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -130.9 138.13 49.65 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.433 -0.803 . . . . 75.02 109.354 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.668 HG21 ' HE2' ' C' ' 117' ' ' MET . 61.0 mt -138.1 151.45 25.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 107.259 -1.385 . . . . 64.54 107.259 172.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 22' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 46.9 t -157.89 146.04 18.85 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.466 1.106 . . . . 71.11 108.734 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.541 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.0 t80 -149.45 133.44 17.11 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 105.771 -1.937 . . . . 75.23 105.771 169.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.8 mt-10 -132.6 149.64 52.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.487 -0.931 . . . . 73.01 108.487 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.669 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -145.64 77.36 12.47 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 107.355 -1.35 . . . . 62.34 107.355 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -67.16 -39.54 13.2 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.709 2.273 . . . . 53.32 112.464 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -98.31 5.8 47.95 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 118.526 -0.749 . . . . 53.41 110.817 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.669 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -29.22 -63.2 0.2 Allowed Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 117.091 2.256 . . . . 72.1 117.091 -166.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.693 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 42.5 Cg_endo -82.36 -15.0 9.08 Favored 'Trans proline' 0 C--N 1.379 2.175 0 CA-C-N 122.827 2.045 . . . . 62.21 113.838 -174.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -77.07 -41.68 41.34 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.493 1.117 . . . . 74.02 109.332 173.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.8 p -83.64 -11.03 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 C-N-CA 124.294 1.038 . . . . 64.0 111.173 -175.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.403 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 12.0 m-85 -69.77 -19.06 63.53 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 112.112 0.412 . . . . 70.12 112.112 174.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -59.67 -25.74 64.97 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.408 0.623 . . . . 74.11 110.229 169.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -100.08 90.78 4.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.966 1.306 . . . . 64.54 109.355 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -105.34 93.01 4.45 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.371 -0.603 . . . . 74.24 109.371 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -156.43 175.06 14.52 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.074 0.949 . . . . 74.51 108.74 169.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -67.25 106.98 1.39 Allowed Pre-proline 0 CA--C 1.554 1.099 0 CA-C-O 118.855 -0.593 . . . . 71.44 109.408 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.509 ' HB3' ' HG ' ' D' ' 68' ' ' LEU . 30.5 Cg_endo -69.16 148.7 69.55 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.169 1.913 . . . . 54.14 112.716 -172.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -69.62 113.31 6.78 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 108.443 -0.947 . . . . 74.5 108.443 172.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.493 HG13 HG13 ' D' ' 64' ' ' VAL . 88.3 t -104.52 122.76 57.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 123.184 0.594 . . . . 71.2 109.632 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -94.36 128.47 40.9 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.803 -1.184 . . . . 74.53 107.803 170.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.4 ' H ' ' HG ' ' D' ' 42' ' ' LEU . 3.2 pp -95.87 146.76 24.31 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.816 0.846 . . . . 74.01 109.468 -171.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.568 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 12.5 t70 -149.66 131.49 15.1 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.272 -1.01 . . . . 54.42 108.272 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -124.82 138.84 54.25 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.847 0.459 . . . . 74.31 109.94 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -133.03 155.8 48.52 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.723 1.209 . . . . 74.42 108.48 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 3.1 m -106.07 152.04 23.9 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.097 0.559 . . . . 51.12 111.62 -167.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.751 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -155.12 142.51 19.54 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.783 -0.821 . . . . 43.11 108.783 169.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.4 p -165.47 152.32 10.25 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 123.193 0.597 . . . . 75.11 109.682 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.2 p -158.91 143.62 15.82 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.112 0.565 . . . . 71.34 109.836 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -77.04 121.73 23.94 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.264 -0.643 . . . . 74.43 109.264 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.55 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.3 mt -94.91 -26.42 16.15 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.171 0.588 . . . . 72.23 109.812 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.56 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -170.35 -179.73 3.14 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.712 1.605 . . . . 52.53 109.082 175.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -76.0 123.95 26.58 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.014 -1.106 . . . . 62.34 108.014 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 73.79 -3.12 2.58 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 125.597 1.559 . . . . 65.22 112.269 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 78.3 t -117.53 118.04 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 108.302 -0.999 . . . . 73.24 108.302 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -135.03 172.26 13.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.041 0.448 . . . . 55.13 109.904 -174.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.55 ' HB2' HD11 ' D' ' 51' ' ' LEU . 24.7 tt0 -125.1 126.29 45.09 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.113 0.965 . . . . 72.44 108.714 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.83 115.88 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 107.569 -1.271 . . . . 60.34 107.569 175.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.751 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 26.2 t -117.96 134.68 60.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 123.866 0.866 . . . . 54.1 108.944 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 7.8 mp -121.5 130.73 53.73 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.968 0.413 . . . . 72.33 110.1 171.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -85.47 106.18 16.63 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.809 -1.087 . . . . 63.3 109.071 173.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 94.9 t -91.46 116.19 32.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 108.248 -1.019 . . . . 52.33 108.248 171.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 72.5 m -114.64 142.16 46.83 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 108.816 -0.809 . . . . 70.45 108.816 -176.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.493 HG13 HG13 ' D' ' 40' ' ' VAL . 58.7 t -132.16 102.93 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 125.099 1.36 . . . . 74.33 108.333 -173.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 42.2 m -95.83 91.51 6.08 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.571 -1.27 . . . . 74.22 107.571 168.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.2 143.47 26.59 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.898 -0.779 . . . . 73.22 108.898 -175.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.473 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 41.1 m -143.17 127.36 17.57 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.481 0.488 . . . . 73.52 111.175 -176.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.509 ' HG ' ' HB3' ' D' ' 38' ' ' PRO . 21.7 mt -97.12 105.57 17.75 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.029 -1.101 . . . . 61.12 108.029 173.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.64 -114.12 4.95 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.377 -0.829 . . . . 64.44 111.973 -177.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.48 4.7 30.85 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 112.957 0.725 . . . . 74.24 112.957 -172.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -136.24 161.7 35.02 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.496 0.319 . . . . 73.14 110.469 -175.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 70.9 m -62.74 125.17 23.04 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 124.208 0.942 . . . . 71.23 111.45 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.473 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -78.56 -70.84 0.47 Allowed 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.788 -1.096 . . . . 74.22 108.188 170.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -149.34 146.78 27.69 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.493 -0.776 . . . . 65.33 110.382 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.447 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 72.4 mt -111.69 108.24 17.62 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.96 -1.126 . . . . 73.34 107.96 174.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.5 ' SG ' HG23 ' D' ' 114' ' ' ILE . 43.7 t -116.97 146.7 42.85 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.253 -0.647 . . . . 73.14 109.253 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 77' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 19.8 tt0 -153.55 133.13 12.95 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.449 0.699 . . . . 74.14 109.66 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 45.3 t -138.82 116.95 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.081 -0.711 . . . . 71.31 109.081 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -87.83 88.63 7.71 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 108.07 -1.085 . . . . 72.32 108.07 169.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -80.86 114.51 19.79 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.413 -1.267 . . . . 73.21 108.471 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.29 144.5 18.09 Favored Glycine 0 C--N 1.337 0.594 0 O-C-N 123.465 0.478 . . . . 72.53 112.441 -176.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.68 137.83 9.47 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 111.221 -0.752 . . . . 74.41 111.221 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.431 HG13 ' HE1' ' D' ' 17' ' ' TYR . 72.8 mt -88.71 120.45 37.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.66 -1.237 . . . . 74.45 107.66 173.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -128.72 122.07 29.87 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.863 0.865 . . . . 70.32 109.244 -175.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 31.9 m -85.04 93.99 8.73 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.206 -1.035 . . . . 65.04 108.206 169.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 11.7 tt -123.31 131.55 72.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 123.91 0.884 . . . . 73.23 109.161 -173.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.7 166.63 32.83 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.371 0.668 . . . . 64.34 110.902 -173.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.35 17.09 76.94 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.619 -0.718 . . . . 63.33 113.683 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 6.7 mt -125.61 154.13 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.059 0.543 . . . . 74.23 109.861 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.555 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 0.0 OUTLIER -159.51 -174.06 4.47 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 123.934 0.893 . . . . 75.44 110.184 174.268 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.61 -142.29 45.28 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.492 0.495 . . . . 51.21 113.425 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 51.6 m -76.84 -28.31 55.45 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.606 0.762 . . . . 73.4 111.692 -176.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -60.11 -44.17 95.07 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.84 0.456 . . . . 75.23 111.298 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.555 ' SD ' ' HA ' ' D' ' 90' ' ' GLU . 25.6 ptt? -72.38 -30.63 64.85 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 123.111 0.257 . . . . 60.44 111.477 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.76 -36.14 82.72 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.316 0.579 . . . . 73.43 110.24 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -85.86 -18.2 33.47 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.774 -0.648 . . . . 74.4 110.653 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 47.3 t -70.52 -51.07 31.33 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.536 0.684 . . . . 70.15 109.487 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 30.0 mt -77.32 -18.95 57.04 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.87 -1.059 . . . . 61.52 110.545 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.06 15.46 51.33 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 115.764 -0.653 . . . . 74.42 113.815 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.47 -65.8 0.08 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 117.235 0.517 . . . . 51.34 111.911 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -64.21 -53.47 48.74 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.68 0.792 . . . . 73.24 112.681 -169.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 21.7 m -63.67 -43.83 78.52 Favored Pre-proline 0 CA--C 1.565 1.541 0 C-N-CA 123.819 0.847 . . . . 73.34 111.798 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -52.76 -39.05 78.16 Favored 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 122.759 2.306 . . . . 74.45 113.996 166.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -64.54 -28.58 69.75 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.525 0.73 . . . . 73.24 111.682 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.2 mm -69.78 -42.17 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-O 121.491 0.662 . . . . 71.32 109.761 173.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 93.8 mt -82.62 -12.65 57.52 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.819 -1.082 . . . . 65.22 111.887 -177.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 107' ' ' PHE . . . . . 0.4 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 83.7 t80 -60.83 -52.73 70.34 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.489 1.116 . . . . 73.41 113.184 -176.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 108' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 39.6 Cg_exo -61.47 -35.48 82.38 Favored 'Trans proline' 0 C--N 1.385 2.482 0 C-N-CA 121.863 1.708 . . . . 63.44 112.384 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -71.29 -43.98 66.09 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.311 1.045 . . . . 65.44 111.991 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.72 -42.17 86.75 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.416 0.686 . . . . 30.23 110.127 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.414 ' NH2' HG23 ' B' ' 105' ' ' ILE . 38.8 ttp180 -57.34 -54.61 44.88 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 124.199 0.937 . . . . 73.14 110.08 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -59.04 -46.03 89.26 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.199 0.937 . . . . 73.52 111.198 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.7 t -58.05 -43.31 86.82 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 123.749 0.656 . . . . 74.35 111.041 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.5 HG23 ' SG ' ' D' ' 76' ' ' CYS . 74.1 mt -65.21 -55.45 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 123.565 0.541 . . . . 63.42 109.994 175.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 62.8 m -51.17 -44.0 61.4 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.927 1.291 . . . . 62.23 111.736 -173.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 35.9 t -65.67 -43.11 90.31 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 114.683 -1.144 . . . . 61.42 109.958 -178.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 79.3 mtm -67.86 -32.94 73.8 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.116 0.566 . . . . 61.33 111.866 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.436 HG23 ' O ' ' D' ' 114' ' ' ILE . 85.5 t -65.13 -44.19 95.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.469 0.708 . . . . 53.15 109.744 176.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 80.9 p -74.6 -28.46 60.91 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.952 -0.567 . . . . 52.14 111.153 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' D' ' 116' ' ' SER . 82.5 mtt-85 -70.88 -32.89 70.01 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.663 0.785 . . . . 70.34 109.973 174.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.73 5.69 77.46 Favored Glycine 0 C--N 1.353 1.49 0 O-C-N 123.902 0.751 . . . . 42.53 112.068 171.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.2 p 55.78 24.05 6.96 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 127.27 2.228 . . . . 73.24 113.982 176.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -79.59 155.17 76.23 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.571 0.748 . . . . 71.22 109.663 170.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -48.57 126.32 14.07 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.531 2.82 . . . . 74.44 112.327 172.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -51.92 132.39 32.06 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.617 1.167 . . . . 73.21 112.223 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 5.8 tt -108.07 101.77 10.98 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.611 -1.255 . . . . 75.23 107.611 -177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -100.95 102.89 14.0 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.299 -1.001 . . . . 74.2 108.299 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 tt -69.16 115.21 8.18 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 107.794 -1.187 . . . . 72.3 107.794 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.76 139.31 97.1 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 123.201 0.6 . . . . 62.14 110.756 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -58.72 106.26 0.27 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.007 2.471 . . . . 70.54 111.682 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 17.4 m . . . . . 0 C--O 1.241 0.64 0 CA-C-N 115.203 -0.908 . . . . 74.23 109.678 -177.002 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.649 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 16.4 t80 . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 108.491 -0.929 . . . . 74.42 108.491 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -137.7 121.85 18.0 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.552 -0.907 . . . . 75.22 108.552 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.67 HG12 ' HD2' ' A' ' 84' ' ' PHE . 58.8 mt -93.94 123.01 45.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.416 -0.957 . . . . 71.12 108.416 174.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -84.32 -40.85 17.44 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 123.493 0.496 . . . . 74.01 110.158 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -169.61 134.98 1.47 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 116.389 -0.369 . . . . 73.22 110.692 -168.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 85.8 mt -125.39 129.85 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 123.708 0.803 . . . . 70.2 109.218 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -162.24 148.06 13.01 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 124.222 0.951 . . . . 74.51 110.715 -167.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.7 p -75.05 129.04 36.93 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 109.407 -0.59 . . . . 61.33 109.407 173.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.492 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 39.3 mtpt -97.99 -27.82 14.07 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.6 0.36 . . . . 72.11 110.399 176.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 13.6 t70 -141.98 138.47 31.92 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.382 -0.599 . . . . 61.34 109.382 171.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.425 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 60.4 mt -130.5 140.64 48.3 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 N-CA-C 107.087 -1.449 . . . . 41.04 107.087 172.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.0 t -150.58 128.2 11.55 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.036 0.534 . . . . 71.1 110.19 175.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.422 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 75.9 t80 -130.48 142.46 50.49 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.416 -1.327 . . . . 64.14 107.416 171.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -141.92 139.36 32.52 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.495 -0.928 . . . . 70.4 108.495 171.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.429 ' CB ' ' HB2' ' A' ' 28' ' ' ALA . . . -118.09 86.49 26.36 Favored Pre-proline 0 C--O 1.241 0.615 0 N-CA-C 106.118 -1.808 . . . . 54.43 106.118 169.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -53.41 -42.69 63.59 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.578 2.852 . . . . 65.21 113.774 -168.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.32 37.46 4.25 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.22 -0.659 . . . . 72.11 109.22 -177.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -41.75 -60.89 1.68 Allowed Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 113.74 1.015 . . . . 72.13 113.74 -169.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 23.4 Cg_exo -63.19 -27.07 72.52 Favored 'Trans proline' 0 C--N 1.385 2.496 0 CA-C-N 121.786 1.673 . . . . 51.43 112.776 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -84.69 -32.15 23.73 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.225 1.01 . . . . 63.44 111.311 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.731 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.8 p -79.08 -23.66 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.595 -0.729 . . . . 53.25 111.642 -168.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -72.39 -12.04 60.95 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.171 0.588 . . . . 71.31 111.51 176.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -81.63 -29.79 33.1 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.123 0.969 . . . . 54.3 110.156 173.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -74.46 153.83 38.99 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.178 0.991 . . . . 73.41 111.288 -174.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.78 136.81 45.52 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.594 -0.73 . . . . 75.23 109.259 170.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.416 ' CE3' HD21 ' A' ' 68' ' ' LEU . 62.1 t-105 -80.21 85.09 5.79 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.365 0.666 . . . . 73.44 110.45 -175.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.4 ' H ' HD22 ' A' ' 68' ' ' LEU . 6.5 tp60 -125.24 79.21 66.45 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.209 1.004 . . . . 70.23 108.5 170.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -89.97 140.79 3.5 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.694 2.263 . . . . 74.13 113.364 -173.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -99.43 90.75 4.63 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 107.805 -1.183 . . . . 72.34 107.805 167.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -70.52 92.36 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 122.477 1.132 . . . . 74.04 109.609 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -79.66 147.68 31.9 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 113.971 -1.468 . . . . 43.42 109.224 172.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 pp -133.64 131.77 39.97 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.535 0.734 . . . . 64.54 110.219 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.589 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 32.8 m-20 -115.89 135.76 53.69 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.294 -1.002 . . . . 70.52 108.294 175.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.8 mp -104.58 121.92 44.51 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.92 0.888 . . . . 73.05 109.176 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -141.99 144.59 33.76 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.884 -0.784 . . . . 65.03 108.884 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.7 m -146.69 140.26 25.81 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.066 0.547 . . . . 75.44 110.14 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.25 152.38 51.37 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.987 1.315 . . . . 54.21 108.603 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.6 p -132.01 160.61 35.35 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.15 0.58 . . . . 63.44 109.867 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -149.78 119.41 6.99 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.946 -0.761 . . . . 62.22 108.946 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -84.91 111.5 19.72 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.486 -0.561 . . . . 63.34 109.486 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.3 mt -85.36 -29.95 24.05 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.555 0.742 . . . . 73.41 111.25 -175.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.598 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -164.61 -171.58 2.37 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.254 1.022 . . . . 65.2 110.142 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.14 100.75 0.63 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.31 0.644 . . . . 64.11 109.545 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 70.05 8.08 6.51 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.002 1.321 . . . . 73.44 112.613 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 57.2 t -100.27 118.37 46.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 106.303 -1.739 . . . . 74.41 106.303 166.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -142.46 173.58 11.41 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.321 0.581 . . . . 61.44 110.283 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -127.65 131.68 49.82 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.262 -1.335 . . . . 74.32 108.878 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.49 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 84.5 t -106.01 135.8 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.731 -1.211 . . . . 75.25 107.731 166.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.439 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 39.8 t -123.95 129.67 74.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.863 -1.532 . . . . 71.41 106.863 174.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tt -124.98 117.91 25.08 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.051 -0.722 . . . . 74.43 109.051 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.584 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 21.3 ttp180 -89.59 111.04 21.86 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.884 -1.053 . . . . 62.52 109.661 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.411 HG11 HD11 ' A' ' 128' ' ' LEU . 43.9 t -100.36 110.87 28.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.979 -1.119 . . . . 74.34 107.979 172.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.589 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 26.3 m -97.75 108.92 21.73 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.677 -0.49 . . . . 73.34 109.677 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.4 t -103.68 108.38 24.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.405 1.082 . . . . 75.53 109.065 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.5 m -102.86 137.05 41.58 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.929 -1.137 . . . . 72.23 107.929 171.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.51 118.91 25.87 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 107.457 -1.312 . . . . 55.45 107.457 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -130.87 132.04 44.92 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.746 0.654 . . . . 70.03 111.092 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.416 HD21 ' CE3' ' A' ' 36' ' ' TRP . 15.6 mt -87.92 75.09 8.87 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.613 -1.254 . . . . 72.01 107.613 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.0 -115.69 4.07 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 114.953 -1.021 . . . . 62.2 110.737 -170.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -90.37 -19.63 23.76 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.722 0.809 . . . . 75.24 111.355 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -94.37 119.0 32.46 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.073 0.549 . . . . 74.51 109.993 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.8 m -72.58 121.89 20.45 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.311 0.382 . . . . 74.35 110.859 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.731 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -68.67 -56.27 8.71 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.763 -0.653 . . . . 75.21 109.697 176.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.465 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 42.7 p90 -156.26 175.55 13.84 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.018 -0.992 . . . . 73.45 111.371 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.6 tp -138.52 140.47 39.14 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.056 -1.429 . . . . 64.42 107.268 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 90.1 m -144.26 95.87 2.79 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.834 0.854 . . . . 65.31 108.819 -177.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -116.07 115.27 25.79 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.499 -0.926 . . . . 73.31 108.499 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.4 t -127.91 118.03 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.398 0.679 . . . . 74.24 110.244 -175.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.584 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 78.2 mt-30 -86.31 92.3 8.76 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 108.825 -0.805 . . . . 50.04 108.825 169.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -82.67 112.5 19.59 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.979 -0.748 . . . . 70.43 108.979 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -102.66 166.49 16.96 Favored Glycine 0 C--N 1.335 0.519 0 O-C-N 123.206 0.316 . . . . 64.24 112.855 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.58 131.7 2.3 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.793 -0.523 . . . . 75.42 111.793 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.1 mt -81.33 124.58 39.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 123.316 0.646 . . . . 75.52 109.369 174.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.67 ' HD2' HG12 ' A' ' 13' ' ' ILE . 10.0 m-85 -130.58 118.39 20.96 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.296 -1.001 . . . . 74.43 108.296 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.9 p -96.89 93.33 6.58 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.634 -0.876 . . . . 61.15 108.634 173.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.535 ' HB ' ' HD2' ' A' ' 11' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.475 0.792 0 C-N-CA 124.033 0.933 . . . . 64.21 109.79 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.902 0 CA-C-O 121.202 0.525 . . . . 75.24 111.068 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -68.3 -30.24 69.19 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.426 1.09 . . . . 74.13 111.156 176.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.456 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 48.7 t -68.76 -57.78 5.14 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.202 0.525 . . . . 40.24 110.21 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 pp -76.04 -19.91 58.22 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.566 -0.743 . . . . 75.5 112.093 -177.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.17 -4.49 53.71 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-O 119.519 -0.601 . . . . 63.22 114.225 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.34 -61.37 0.22 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 117.709 0.755 . . . . 74.4 112.155 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.487 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 91.2 t80 -59.92 -61.96 2.22 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 113.21 0.819 . . . . 74.03 113.21 -168.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 73.7 m -64.3 -38.16 31.54 Favored Pre-proline 0 CA--C 1.565 1.543 0 N-CA-C 112.829 0.677 . . . . 72.24 112.829 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.24 -46.12 23.85 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.528 2.152 . . . . 73.31 113.529 161.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.697 HD21 ' HB2' ' A' ' 133' ' ' PHE . 87.7 m-20 -75.88 -12.91 60.25 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.873 0.869 . . . . 71.53 112.224 -177.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.0 mm -70.59 -41.07 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 109.199 -0.667 . . . . 75.44 109.199 169.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 83.7 mt -82.33 -22.62 35.51 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.147 0.979 . . . . 74.15 111.919 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -57.49 -48.91 96.47 Favored Pre-proline 0 CA--C 1.569 1.702 0 N-CA-C 114.245 1.202 . . . . 65.35 114.245 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -63.79 -36.03 53.5 Favored 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 122.001 1.8 . . . . 64.33 112.582 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -69.18 -42.73 75.45 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.526 0.73 . . . . 62.31 111.383 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.88 -37.68 82.08 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.355 0.662 . . . . 52.24 109.995 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.471 ' NH1' HG23 ' C' ' 105' ' ' ILE . 28.0 ttm180 -54.02 -55.18 29.73 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.804 0.842 . . . . 54.2 110.279 171.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -67.49 -40.36 85.23 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.175 0.99 . . . . 74.43 111.736 -172.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.6 t -63.4 -36.6 84.25 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.366 0.416 . . . . 73.42 110.69 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.417 ' O ' HG23 ' A' ' 118' ' ' VAL . 60.0 mt -68.6 -49.58 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 115.461 -0.79 . . . . 74.21 110.039 174.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.6 m -56.32 -37.47 69.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.289 1.035 . . . . 73.42 111.496 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.9 t -62.23 -48.8 78.35 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 115.647 -0.706 . . . . 70.44 110.261 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.422 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 36.2 mtm -67.48 -36.27 80.8 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.158 0.583 . . . . 73.52 111.569 -176.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.5 t -62.88 -53.72 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 O-C-N 123.739 0.649 . . . . 60.35 110.278 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 38.7 t -66.51 -30.17 70.44 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.339 -0.846 . . . . 61.2 110.812 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.438 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 52.4 ttm-85 -77.43 -28.78 52.69 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.475 1.11 . . . . 72.41 109.343 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.417 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.72 9.6 67.84 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 115.283 -0.871 . . . . 55.23 112.23 171.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.559 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.1 t 67.83 13.5 9.21 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 127.166 2.186 . . . . 63.31 113.568 170.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -81.47 148.56 62.85 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 108.23 -1.026 . . . . 75.44 108.23 172.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -59.31 164.29 10.97 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.922 2.415 . . . . 61.2 113.371 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -54.51 120.25 6.39 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.009 0.923 . . . . 64.22 112.189 -173.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.465 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 62.2 tp -115.19 103.32 10.73 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.378 1.071 . . . . 64.21 108.563 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -99.12 111.16 23.62 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 107.537 -1.283 . . . . 74.04 107.537 177.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.411 HD11 HG11 ' A' ' 62' ' ' VAL . 2.2 tt -64.96 121.51 14.84 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.396 -0.964 . . . . 61.3 108.396 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.45 139.14 97.65 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 122.722 0.409 . . . . 51.41 111.363 -175.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.21 132.58 10.39 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 123.044 2.496 . . . . 62.2 112.199 -175.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.7 t -112.1 114.73 47.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.605 -1.258 . . . . 73.13 107.605 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -82.25 65.93 7.61 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 123.599 0.562 . . . . 75.53 110.345 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.697 ' HB2' HD21 ' A' ' 104' ' ' ASN . 80.4 m-85 . . . . . 0 C--N 1.366 1.301 0 C-N-CA 123.865 0.866 . . . . 72.41 110.789 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.672 ' HB2' ' HB ' ' B' ' 89' ' ' ILE . 12.6 ttt . . . . . 0 CA--C 1.555 1.16 0 CA-C-O 121.646 0.736 . . . . 72.32 111.592 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 87.5 m -139.79 136.18 33.8 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.138 -1.06 . . . . 63.53 108.138 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.579 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 86.0 t80 -126.31 145.16 50.54 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.858 0.863 . . . . 71.34 109.254 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -157.32 139.29 14.31 Favored 'General case' 0 C--N 1.346 0.441 0 O-C-N 123.501 0.5 . . . . 74.43 109.806 170.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.465 HD13 HD11 ' B' ' 16' ' ' ILE . 26.2 mt -79.8 126.32 39.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.846 -0.798 . . . . 71.34 108.846 172.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -94.45 -51.09 4.92 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.763 -0.458 . . . . 73.11 109.763 175.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.559 ' HE ' HG21 ' A' ' 122' ' ' THR . 33.7 ttt180 -162.67 139.87 7.94 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.547 -0.297 . . . . 64.45 110.758 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.465 HD11 HD13 ' B' ' 13' ' ' ILE . 98.1 mt -120.56 134.68 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 107.672 -1.233 . . . . 73.23 107.672 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -168.47 158.0 9.28 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.302 0.572 . . . . 75.32 111.949 -171.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 85.3 m -89.41 129.6 35.9 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.14 -0.936 . . . . 72.41 109.559 173.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.401 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.4 mtpt -100.37 -20.33 15.88 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.558 0.743 . . . . 75.42 111.412 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -167.52 144.22 4.31 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.52 0.513 . . . . 62.23 111.583 -173.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 43.0 mm -138.42 147.09 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.996 1.319 . . . . 74.35 109.468 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.568 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.2 t -146.01 136.14 23.71 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.638 1.175 . . . . 72.44 108.467 170.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.4 t80 -150.51 108.14 3.66 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 107.749 -1.204 . . . . 65.35 107.749 170.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -120.18 113.94 21.19 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.154 0.982 . . . . 75.24 109.013 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.42 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.55 87.94 3.06 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 108.269 -1.011 . . . . 71.25 108.269 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -66.57 -45.25 5.07 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.182 2.588 . . . . 72.35 113.043 -168.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -103.36 23.56 12.32 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.661 0.785 . . . . 75.33 110.494 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.492 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -40.86 -62.15 1.07 Allowed Pre-proline 0 N--CA 1.49 1.548 0 C-N-CA 124.749 1.219 . . . . 60.35 113.981 -168.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.55 -23.64 76.84 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.468 2.112 . . . . 43.43 113.5 -173.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -94.28 -39.86 10.28 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.386 0.674 . . . . 71.32 111.954 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' B' ' 73' ' ' ALA . 8.7 p -69.71 -15.89 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 122.996 0.518 . . . . 60.15 112.072 -171.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -68.3 -11.98 60.32 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.561 0.744 . . . . 53.22 112.766 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.6 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.9 pt20 -58.16 -28.82 65.07 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.401 0.62 . . . . 71.34 109.962 172.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.6 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 88.7 mttt -95.94 92.91 6.72 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.253 1.421 . . . . 72.01 109.504 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -95.09 87.92 5.05 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.31 -0.405 . . . . 72.51 110.084 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -165.71 178.18 6.78 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.126 0.97 . . . . 74.42 108.994 170.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -70.9 112.12 12.2 Favored Pre-proline 0 CA--C 1.562 1.412 0 C-N-CA 123.277 0.631 . . . . 62.34 111.302 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.55 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 18.1 Cg_endo -62.66 143.76 92.97 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.278 1.985 . . . . 65.23 112.421 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.84 108.71 4.08 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.985 -0.746 . . . . 73.24 108.985 176.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 30.8 m -93.93 147.53 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.231 -0.895 . . . . 73.34 112.592 -172.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.47 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 61.7 mtpt -125.51 100.94 6.7 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.003 1.321 . . . . 73.44 108.29 174.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pp -96.58 155.6 16.7 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.626 -0.715 . . . . 73.53 111.443 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -150.28 150.92 32.17 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.326 1.05 . . . . 74.34 109.205 -175.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 90.5 mt -125.48 127.29 46.25 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.191 0.996 . . . . 63.25 108.615 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.556 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 25.1 t70 -124.21 146.26 48.82 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.016 0.526 . . . . 70.32 110.455 -171.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 90.7 m -110.41 122.76 48.49 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.944 -1.026 . . . . 72.31 110.983 -176.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.36 122.58 11.52 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 107.061 -1.459 . . . . 54.15 107.061 169.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 36.1 p -145.82 163.16 35.89 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.795 0.27 . . . . 52.33 110.804 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 52.5 p -151.99 141.53 21.69 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.83 0.852 . . . . 71.5 109.35 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -84.22 129.82 34.86 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.196 -0.668 . . . . 71.14 109.196 175.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 50.9 mt -92.22 -44.37 8.81 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.03 0.532 . . . . 74.23 110.312 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.85 -171.86 3.58 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.052 0.941 . . . . 24.41 109.569 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -68.3 129.32 39.58 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.455 -0.793 . . . . 73.15 109.157 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 68.57 -4.67 1.09 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.489 1.515 . . . . 74.44 113.085 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 82.4 t -113.76 117.61 55.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 108.642 -0.873 . . . . 64.5 108.642 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -135.12 140.84 45.77 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.155 -0.683 . . . . 74.54 109.155 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -114.07 114.31 25.93 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.204 -1.035 . . . . 71.25 108.204 -174.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 34.3 m -108.22 136.73 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.616 0.766 . . . . 71.24 110.431 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 19.5 t -120.92 121.65 65.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 108.393 -0.966 . . . . 72.52 108.393 177.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.33 108.86 20.61 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 106.84 -1.541 . . . . 74.43 106.84 170.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.623 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 26.9 ttp180 -86.9 118.73 26.48 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.036 -0.728 . . . . 72.31 109.036 173.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 16.6 t -103.92 121.16 55.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.71 -1.218 . . . . 60.31 107.71 174.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 23.8 m -120.26 124.96 46.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.111 -0.7 . . . . 65.24 109.111 -178.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 97.9 t -123.9 113.53 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 124.216 1.006 . . . . 75.23 109.101 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 67.3 m -84.84 149.38 25.74 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.354 -0.98 . . . . 74.42 108.354 166.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.43 140.77 30.57 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.334 0.653 . . . . 64.24 109.663 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.542 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 21.0 p -145.71 130.05 17.69 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.17 0.51 . . . . 61.14 111.383 -176.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.55 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 28.6 mt -104.59 128.09 52.5 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.323 1.049 . . . . 73.4 109.004 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.99 -111.37 4.09 Favored Glycine 0 C--N 1.344 0.981 0 O-C-N 123.733 0.646 . . . . 63.14 112.196 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -118.46 10.79 12.78 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.575 0.75 . . . . 73.23 111.55 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -129.7 159.31 36.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.732 0.413 . . . . 61.23 110.759 -175.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.1 m -73.19 121.19 19.89 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 116.043 -0.526 . . . . 60.11 110.317 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.558 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -76.48 -61.68 1.88 Allowed 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.049 -1.093 . . . . 63.35 108.049 177.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -157.52 165.11 36.5 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.953 -1.022 . . . . 73.11 111.9 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 46.1 mt -125.6 112.0 15.65 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 106.043 -1.836 . . . . 62.24 106.043 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.419 ' SG ' HG23 ' B' ' 114' ' ' ILE . 34.8 t -117.15 148.93 41.15 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.665 -0.865 . . . . 75.13 108.665 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 41.9 tt0 -163.88 132.42 3.7 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.167 0.587 . . . . 73.22 109.531 -173.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 98.8 t -132.86 147.04 31.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 123.757 0.823 . . . . 74.23 109.186 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.623 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 64.4 mt-30 -118.41 103.96 10.27 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.601 -0.889 . . . . 64.11 108.601 169.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -94.62 100.52 12.45 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.195 -1.039 . . . . 61.45 108.195 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.401 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -90.12 153.42 22.9 Favored Glycine 0 C--O 1.242 0.606 0 CA-C-N 114.998 -1.001 . . . . 72.45 111.159 175.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.8 126.25 1.85 Allowed Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 111.316 -0.714 . . . . 72.34 111.316 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 48.3 mt -85.49 128.21 39.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 107.546 -1.279 . . . . 71.24 107.546 170.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -138.61 149.95 45.77 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.129 -0.693 . . . . 64.43 109.129 176.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 69.8 m -94.52 100.33 12.33 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.464 -0.939 . . . . 73.32 108.464 170.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 1.8 pp -116.1 110.77 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.358 -0.979 . . . . 64.33 108.358 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.32 170.13 21.71 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.33 0.652 . . . . 74.41 110.886 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.84 -65.63 0.25 Allowed Glycine 0 C--N 1.346 1.138 0 CA-C-O 119.672 -0.516 . . . . 74.34 113.151 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' B' ' 9' ' ' MET . 3.4 tt -82.55 170.07 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 117.597 0.698 . . . . 74.54 110.037 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -152.62 160.74 43.17 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.028 0.931 . . . . 75.33 109.172 -167.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.83 -134.47 11.7 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 110.947 -0.861 . . . . 65.41 110.947 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' B' ' 95' ' ' ALA . 12.4 m -93.47 -18.32 22.45 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 117.247 0.523 . . . . 73.43 110.575 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.39 -26.04 60.82 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.695 -0.628 . . . . 52.0 111.108 -174.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -64.84 -31.76 73.15 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 119.485 -0.293 . . . . 74.53 110.439 171.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' B' ' 92' ' ' THR . . . -59.81 -38.73 82.77 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.665 0.786 . . . . 72.51 111.135 176.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -65.34 -39.21 92.1 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.404 -0.817 . . . . 74.11 111.359 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 40.2 t -66.56 -41.46 88.58 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.626 0.602 . . . . 72.15 112.626 -173.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.574 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.0 pt? -101.35 -14.31 17.66 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 117.862 0.301 . . . . 63.13 111.664 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.32 -21.43 24.81 Favored Glycine 0 C--N 1.352 1.425 0 N-CA-C 114.3 0.48 . . . . 73.23 114.3 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.23 -54.12 1.7 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.487 0.715 . . . . 72.24 110.159 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -69.69 -52.74 23.0 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.299 0.64 . . . . 73.41 112.288 -171.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.579 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 69.0 m -59.11 -49.02 95.29 Favored Pre-proline 0 CA--C 1.565 1.555 0 CA-C-O 119.04 -0.505 . . . . 74.21 112.143 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 39.1 Cg_exo -63.54 -27.73 69.95 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 122.217 1.944 . . . . 75.22 113.835 173.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -63.54 -37.68 88.25 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.032 0.533 . . . . 53.42 109.771 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.455 HD13 HD11 ' B' ' 13' ' ' ILE . 72.1 mt -65.48 -42.43 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.781 0.832 . . . . 65.43 110.2 175.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 91.9 mt -76.96 -20.36 56.21 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.949 -1.023 . . . . 75.42 111.833 -175.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -54.03 -55.79 32.57 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 124.136 0.974 . . . . 72.25 113.151 -176.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -59.34 -31.38 94.88 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.085 1.857 . . . . 74.41 113.737 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -69.73 -46.31 66.2 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.395 0.678 . . . . 73.33 110.503 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.2 -38.66 88.5 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.582 0.753 . . . . 43.23 110.992 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -61.88 -53.37 56.79 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.092 1.357 . . . . 74.04 110.778 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.01 -33.38 75.92 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.524 -0.762 . . . . 74.33 109.716 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.485 ' O ' ' HG2' ' B' ' 117' ' ' MET . 38.0 t -64.6 -44.52 90.37 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 123.51 0.506 . . . . 74.0 111.715 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.494 ' O ' HG23 ' B' ' 118' ' ' VAL . 72.9 mt -59.59 -55.01 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 109.12 -0.696 . . . . 62.24 109.12 175.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.1 m -62.26 -28.1 69.48 Favored 'General case' 0 CA--C 1.552 1.044 0 O-C-N 123.633 0.583 . . . . 55.31 112.122 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.7 t -64.5 -48.04 76.66 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.258 -0.645 . . . . 43.42 109.258 175.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.8 mmt -70.75 -33.86 71.26 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.053 0.541 . . . . 71.44 110.663 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.494 HG23 ' O ' ' B' ' 114' ' ' ILE . 97.2 t -61.51 -43.4 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.536 0.734 . . . . 73.21 110.067 173.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.8 t -64.56 -37.59 88.08 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.058 -0.974 . . . . 72.23 110.806 178.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' B' ' 116' ' ' SER . 89.7 mtt-85 -66.58 -32.87 74.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.601 -0.727 . . . . 62.32 110.411 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.6 12.21 59.68 Favored Glycine 0 C--N 1.349 1.29 0 O-C-N 123.933 0.771 . . . . 64.41 113.013 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 76.4 p 53.08 27.95 6.31 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 126.161 1.784 . . . . 73.43 113.324 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -86.69 155.37 56.21 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.417 0.687 . . . . 74.43 110.292 177.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.0 176.45 2.47 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.112 2.541 . . . . 65.02 113.784 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.639 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 0.0 OUTLIER -62.93 124.71 21.77 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.878 -1.056 . . . . 73.3 111.8 -173.091 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -144.05 102.92 3.95 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.218 -1.031 . . . . 54.51 108.218 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -119.05 135.08 54.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.02 0.928 . . . . 72.33 108.987 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.39 145.32 52.97 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.127 0.571 . . . . 62.51 110.589 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.3 150.92 65.12 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 122.94 0.496 . . . . 73.4 110.992 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.444 ' CG ' HD13 ' D' ' 16' ' ' ILE . 33.0 Cg_exo -61.54 108.35 0.6 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.149 2.566 . . . . 72.13 111.893 175.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 66.1 t -112.33 111.04 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.573 -0.899 . . . . 63.32 108.573 176.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -96.88 93.04 6.42 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.258 -1.016 . . . . 71.12 108.258 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -61.48 -40.63 95.23 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.89 0.876 . . . . 74.41 110.301 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 . . . . . 0 N--CA 1.47 0.567 0 C-N-CA 124.914 1.286 . . . . 71.53 111.677 -178.836 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.668 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 4.2 t80 . . . . . 0 C--O 1.236 0.385 0 CA-C-O 120.922 0.392 . . . . 75.54 110.383 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -148.19 121.8 9.19 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.86 -1.163 . . . . 61.4 107.86 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.403 HG12 ' CD2' ' C' ' 84' ' ' PHE . 69.2 mt -73.15 124.43 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 109.491 -0.559 . . . . 65.44 109.491 178.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.411 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 19.1 mm-40 -88.8 -47.87 7.9 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.102 -0.954 . . . . 74.04 109.636 -175.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -170.04 133.6 1.18 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.797 0.439 . . . . 73.35 110.529 -173.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 83.8 mt -116.11 146.28 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 108.007 -1.109 . . . . 62.41 108.007 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -174.9 169.19 3.48 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.366 0.666 . . . . 72.15 110.08 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 66.7 p -92.09 115.77 28.36 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.347 0.659 . . . . 71.54 109.364 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.639 ' HE2' ' HB3' ' D' ' 28' ' ' ALA . 23.1 mmtp -66.22 -47.62 73.24 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.615 0.721 . . . . 72.14 109.705 172.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 14.1 t70 -144.41 148.79 35.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.132 -1.394 . . . . 64.11 110.147 -175.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.499 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.7 mt -142.28 145.57 23.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.121 -1.437 . . . . 74.5 107.121 176.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 42.8 t -157.46 151.7 24.79 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.26 0.624 . . . . 64.21 110.676 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 86.1 t80 -148.5 146.12 28.21 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.674 -1.232 . . . . 63.54 107.674 170.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -145.71 132.04 19.58 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.815 0.846 . . . . 72.32 109.763 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.41 77.9 4.73 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 106.192 -1.781 . . . . 60.32 106.192 172.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -62.97 -37.65 52.16 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.902 2.402 . . . . 73.11 111.877 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -95.62 21.4 8.36 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.371 -1.286 . . . . 75.31 111.154 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.81 -53.67 9.66 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 113.744 1.016 . . . . 53.34 113.744 -173.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.68 -41.55 38.29 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 121.844 1.696 . . . . 71.53 112.4 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -69.52 -32.88 71.98 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.544 0.738 . . . . 75.13 112.197 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.756 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.1 p -78.14 -27.78 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 N-CA-C 112.359 0.503 . . . . 72.33 112.359 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -64.24 -28.31 69.65 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.466 0.543 . . . . 72.53 112.466 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -87.69 17.67 4.55 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.019 0.528 . . . . 72.21 111.409 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.541 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -109.8 158.25 18.34 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.944 0.898 . . . . 72.34 109.85 178.569 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -65.4 128.09 34.45 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.551 -0.537 . . . . 74.14 109.551 169.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -81.0 89.35 5.92 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.69 -0.686 . . . . 71.12 110.292 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 37' ' ' GLN . . . . . 0.401 ' H ' HD22 ' C' ' 68' ' ' LEU . 20.4 tp60 -142.07 79.58 16.08 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.598 0.759 . . . . 64.34 109.131 171.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -89.21 178.23 2.64 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 122.553 2.169 . . . . 72.15 112.704 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -109.84 117.46 33.9 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.416 -1.327 . . . . 74.35 107.416 166.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.5 t -80.29 96.45 2.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 107.613 -1.254 . . . . 50.51 107.613 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.405 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 3.1 tppp? -105.66 100.2 9.77 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.284 -1.006 . . . . 71.34 108.284 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.42 HD23 HD21 ' C' ' 128' ' ' LEU . 1.0 OUTLIER -91.36 158.55 16.47 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.107 -0.952 . . . . 72.11 110.069 -177.392 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.443 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 27.7 t70 -152.95 148.27 26.92 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.609 0.764 . . . . 74.31 109.012 -177.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.403 HD23 ' N ' ' C' ' 45' ' ' ASP . 9.7 tt -128.5 147.19 50.67 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.839 -0.8 . . . . 53.42 108.839 -176.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 25.6 t0 -146.36 147.11 30.97 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.592 -1.262 . . . . 72.04 107.592 173.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 18.5 p -114.84 112.3 22.54 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.459 0.704 . . . . 74.32 109.931 -173.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.22 151.75 27.89 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.463 1.105 . . . . 72.53 108.87 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 69.9 m -162.13 158.1 24.21 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.763 0.425 . . . . 55.52 111.787 -174.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 88.1 p -157.29 144.43 18.51 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.08 0.952 . . . . 53.53 109.121 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -87.83 126.19 34.88 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.767 -0.457 . . . . 70.25 109.767 176.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.703 HD11 HD12 ' C' ' 83' ' ' ILE . 71.6 mt -96.75 -43.92 7.31 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.548 -0.751 . . . . 74.32 110.109 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -156.35 -171.51 3.73 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.593 -0.73 . . . . 53.05 110.91 -176.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -66.64 108.22 2.39 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.115 -0.948 . . . . 71.42 110.038 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 70.94 -6.45 1.28 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.92 1.288 . . . . 75.15 112.772 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 42.2 t -92.2 97.06 6.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 107.011 -1.477 . . . . 71.32 107.011 173.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -120.93 124.92 46.11 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.244 -1.343 . . . . 54.41 107.985 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -83.5 125.42 31.73 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.169 -0.923 . . . . 43.1 109.778 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 6.0 m -112.09 127.09 69.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 108.026 -1.102 . . . . 72.44 108.026 171.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.578 HG12 ' HG2' ' C' ' 79' ' ' GLN . 21.9 t -121.29 134.97 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.799 -1.186 . . . . 54.21 107.799 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 13.1 tp -116.07 108.33 16.06 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.604 -0.517 . . . . 55.14 109.604 -175.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.48 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 7.3 tmm_? -84.39 105.84 15.54 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.882 -0.784 . . . . 74.44 108.882 177.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.477 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.6 t -100.32 136.31 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.585 -0.894 . . . . 63.34 108.585 175.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 51.4 m -122.94 141.67 51.66 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.239 -1.022 . . . . 64.11 108.239 173.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 75.4 t -132.85 110.05 15.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 107.75 -1.204 . . . . 72.3 107.75 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 4.5 m -99.01 144.21 28.42 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.146 -1.057 . . . . 71.53 108.146 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.71 119.41 17.16 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.443 -0.947 . . . . 41.3 108.443 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 51.6 m -136.91 132.8 34.97 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.696 0.622 . . . . 54.44 110.251 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.541 HD13 ' HG2' ' C' ' 34' ' ' LYS . 11.3 mt -85.22 47.96 1.5 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.133 1.373 . . . . 75.44 109.224 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.93 -109.56 3.53 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 110.256 -1.138 . . . . 73.14 110.256 -171.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -89.94 -32.15 16.95 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.988 0.515 . . . . 73.14 109.729 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -66.01 111.75 3.51 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.284 0.634 . . . . 53.43 109.374 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 26.4 m -79.66 125.65 29.91 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.306 -0.628 . . . . 75.42 109.306 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.756 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -81.98 -55.18 4.75 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.408 0.683 . . . . 63.04 109.837 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -157.59 166.81 31.89 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.704 0.764 . . . . 70.52 111.988 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -135.47 122.49 21.37 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 105.866 -1.901 . . . . 74.15 105.866 170.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.414 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 46.2 t -127.48 134.58 49.81 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.121 -1.066 . . . . 54.21 108.121 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -148.6 125.17 11.04 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.258 0.348 . . . . 70.35 110.644 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.6 t -131.51 134.4 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 124.107 0.963 . . . . 70.21 108.927 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.578 ' HG2' HG12 ' C' ' 59' ' ' VAL . 5.4 tt0 -112.52 90.82 3.45 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.606 -1.627 . . . . 74.44 106.606 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -83.19 111.86 19.32 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.061 0.544 . . . . 75.42 110.437 -171.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.41 146.57 18.24 Favored Glycine 0 C--N 1.337 0.63 0 O-C-N 123.491 0.494 . . . . 74.2 112.492 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.99 118.07 0.92 Allowed Glycine 0 C--O 1.243 0.697 0 N-CA-C 110.987 -0.845 . . . . 54.43 110.987 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.703 HD12 HD11 ' C' ' 51' ' ' LEU . 12.9 mm -81.98 116.93 27.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 108.556 -0.905 . . . . 74.33 108.556 174.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.668 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 54.8 m-85 -130.92 144.27 51.35 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.955 -0.757 . . . . 73.13 108.955 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 13.1 p -91.16 118.76 30.71 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 108.915 -0.772 . . . . 71.31 108.915 170.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.478 HG21 HD23 ' C' ' 98' ' ' LEU . 4.4 mp -113.68 101.37 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.944 0.898 . . . . 61.11 108.621 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.19 170.45 16.7 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.109 0.963 . . . . 72.52 110.037 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.76 -49.35 2.55 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 116.341 -0.39 . . . . 64.41 112.141 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 33.8 pt -118.67 159.73 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.707 0.803 . . . . 71.11 110.252 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -147.67 -178.15 6.1 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.776 0.83 . . . . 53.02 109.907 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.98 -142.9 45.68 Favored Glycine 0 C--N 1.351 1.373 0 O-C-N 123.222 0.326 . . . . 70.35 112.94 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 1.2 m -68.82 -23.78 64.31 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.983 0.513 . . . . 74.22 110.699 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -57.74 -57.15 14.03 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 124.118 0.967 . . . . 70.44 109.891 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.466 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 22.3 ptt? -69.8 -30.27 67.77 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.146 -0.479 . . . . 64.1 110.766 178.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.04 -30.65 69.33 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.133 0.573 . . . . 33.15 111.181 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.476 ' NE2' ' HB2' ' C' ' 134' ' ' ASP . 32.3 t-80 -62.5 -46.02 90.33 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.263 -0.88 . . . . 64.11 110.862 170.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.553 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 31.4 t -69.21 -64.57 0.85 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.05 0.219 . . . . 74.34 111.072 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.478 HD23 HG21 ' C' ' 86' ' ' ILE . 3.7 pp -67.6 -31.47 71.54 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 113.146 0.795 . . . . 74.24 113.146 -173.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 99' ' ' GLY . . . . . 0.419 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -102.8 6.99 52.56 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 114.63 0.612 . . . . 43.32 114.63 -171.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -151.12 -60.83 0.18 Allowed 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.365 0.603 . . . . 75.45 110.824 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.553 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 5.0 t80 -74.81 -34.3 62.34 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 125.011 1.324 . . . . 74.51 112.757 -171.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.416 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 80.1 m -78.39 -43.81 2.07 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 123.356 0.662 . . . . 61.23 111.057 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 51.7 Cg_exo -60.92 -27.14 84.34 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 121.943 1.762 . . . . 71.14 112.403 166.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -64.92 -34.93 79.58 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 123.313 0.645 . . . . 62.11 110.696 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.471 HG23 ' NH1' ' A' ' 111' ' ' ARG . 45.6 mm -60.46 -38.33 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 121.326 0.584 . . . . 64.41 109.49 172.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 79.5 mt -89.12 -13.71 37.9 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.549 1.14 . . . . 63.32 112.655 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -57.43 -49.83 91.61 Favored Pre-proline 0 N--CA 1.485 1.281 0 CA-C-O 118.126 -0.94 . . . . 72.34 112.87 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.96 -35.18 78.64 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.179 1.919 . . . . 71.24 113.07 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -66.02 -50.75 63.13 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.517 0.727 . . . . 70.43 111.367 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.63 -42.83 99.82 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.747 -0.66 . . . . 71.34 109.901 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -54.85 -53.22 58.23 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.124 1.37 . . . . 75.22 111.052 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -69.09 -36.56 77.72 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.945 0.778 . . . . 74.2 110.283 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.0 t -68.78 -34.54 75.73 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.929 0.491 . . . . 53.2 111.049 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.477 HD11 ' HB ' ' C' ' 62' ' ' VAL . 87.5 mt -69.62 -53.61 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.349 0.66 . . . . 61.44 109.611 175.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 16.8 m -64.56 -29.16 70.18 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.269 0.628 . . . . 75.42 111.28 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.3 t -64.29 -49.94 69.83 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.063 -0.717 . . . . 63.23 109.063 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.733 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.54 -37.92 82.79 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.325 1.05 . . . . 74.2 112.179 178.685 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 69.9 t -66.84 -40.41 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 123.274 0.63 . . . . 73.02 110.137 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 20.9 t -74.09 -23.25 59.3 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.714 0.805 . . . . 74.05 111.576 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 86.3 mtt-85 -76.2 -38.88 55.94 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.706 0.803 . . . . 74.11 108.86 174.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.02 -1.18 67.39 Favored Glycine 0 C--N 1.355 1.627 0 O-C-N 123.974 0.797 . . . . 34.2 112.256 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.7 p 64.64 23.41 12.8 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.926 2.09 . . . . 73.1 113.14 171.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -81.75 143.28 50.21 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 108.209 -1.034 . . . . 62.51 108.209 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.639 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 66.6 Cg_exo -45.23 145.21 3.69 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 123.645 2.896 . . . . 60.04 114.826 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -53.96 114.38 1.56 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.592 1.157 . . . . 71.14 112.593 -175.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 36.8 tp -109.52 94.09 4.85 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.139 -0.937 . . . . 74.15 109.224 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -94.45 115.54 27.73 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.213 0.605 . . . . 62.55 109.709 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.479 HD13 ' H ' ' C' ' 129' ' ' ALA . 0.2 OUTLIER -72.13 149.03 45.12 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.644 0.778 . . . . 73.52 109.781 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 129' ' ' ALA . . . . . 0.479 ' H ' HD13 ' C' ' 128' ' ' LEU . . . -80.54 156.32 73.33 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.471 0.709 . . . . 52.32 111.194 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.429 ' HG3' HG21 ' A' ' 13' ' ' ILE . 28.7 Cg_endo -61.69 137.39 68.34 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 123.117 2.544 . . . . 63.04 112.274 172.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 15.7 t -128.75 110.27 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 108.948 -0.76 . . . . 63.0 108.948 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -100.17 91.43 4.75 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.771 0.828 . . . . 73.13 109.336 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -65.84 -40.56 91.86 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.163 -0.68 . . . . 53.42 109.163 171.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 134' ' ' ASP . . . . . 0.476 ' HB2' ' NE2' ' C' ' 96' ' ' HIS . 7.0 p-10 . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 125.538 1.535 . . . . 70.4 112.35 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 24.3 m . . . . . 0 C--O 1.24 0.555 0 N-CA-C 109.171 -0.677 . . . . 72.34 109.171 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -158.73 97.88 1.47 Allowed 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.625 -1.25 . . . . 70.02 107.625 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -117.02 120.56 38.74 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.367 0.667 . . . . 75.52 109.263 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 19.4 mt -78.0 115.16 19.58 Favored 'Isoleucine or valine' 0 C--N 1.345 0.412 0 N-CA-C 108.968 -0.753 . . . . 45.12 108.968 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -90.7 -44.61 9.38 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 122.857 0.463 . . . . 73.22 111.721 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.435 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 40.8 ttt180 -173.85 126.11 0.37 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 112.049 0.388 . . . . 74.44 112.049 -171.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.444 HD13 ' CG ' ' B' ' 130' ' ' PRO . 2.2 mp -104.17 141.57 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.421 -0.955 . . . . 74.52 108.421 170.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.435 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 22.4 p90 -162.72 151.4 14.66 Favored 'General case' 0 C--O 1.238 0.487 0 O-C-N 124.221 0.95 . . . . 74.13 110.571 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.7 p -83.88 120.32 25.93 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.281 -0.872 . . . . 71.31 108.856 172.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -91.33 -17.34 26.05 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.7 0.4 . . . . 72.1 110.525 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.721 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 17.5 t70 -162.7 134.98 5.46 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.641 -0.874 . . . . 73.44 108.641 -174.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.733 HG21 ' HE2' ' C' ' 117' ' ' MET . 88.1 mt -139.28 151.77 23.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 C-N-CA 124.337 1.055 . . . . 70.41 108.321 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 22' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 26.6 t -152.02 145.44 24.81 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 124.402 1.081 . . . . 72.23 109.628 175.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.499 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.7 t80 -151.55 122.46 7.58 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 105.703 -1.962 . . . . 75.44 105.703 169.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -136.51 111.43 8.86 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.821 -0.807 . . . . 74.23 108.821 -176.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.85 91.21 4.09 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.249 -1.019 . . . . 74.41 108.249 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.09 -34.5 10.18 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.968 2.445 . . . . 64.53 113.003 -169.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -112.22 10.81 20.16 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 118.556 -0.735 . . . . 73.13 110.711 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.639 ' HB3' ' HE2' ' C' ' 19' ' ' LYS . . . -18.4 -72.77 0.02 OUTLIER Pre-proline 0 CA--C 1.565 1.556 0 N-CA-C 116.455 2.02 . . . . 72.0 116.455 -168.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 44.1 Cg_endo -80.29 -13.48 12.4 Favored 'Trans proline' 0 C--N 1.377 2.072 0 CA-C-N 123.903 2.43 . . . . 74.21 114.041 -172.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -77.51 -39.79 45.02 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.573 1.149 . . . . 53.4 109.136 172.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.557 HG22 HD12 ' D' ' 68' ' ' LEU . 4.8 p -84.12 -20.53 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.461 -0.791 . . . . 73.31 111.647 -175.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.404 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 21.1 m-85 -66.04 -25.16 66.92 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 120.669 0.271 . . . . 74.41 111.455 177.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -60.07 -26.34 66.09 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.25 -0.886 . . . . 73.01 110.183 175.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -90.94 76.54 6.24 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.972 1.309 . . . . 70.13 109.647 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -85.35 92.11 8.37 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.947 -0.569 . . . . 74.32 111.132 -176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -155.25 177.84 10.89 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.881 0.873 . . . . 74.2 108.979 166.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -66.43 110.5 4.89 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.8 0.84 . . . . 73.52 109.272 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -59.48 120.51 8.38 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.954 2.436 . . . . 54.22 111.631 -175.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -69.58 115.03 8.36 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.763 0.664 . . . . 71.52 109.489 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.414 HG13 HG13 ' D' ' 64' ' ' VAL . 58.3 t -105.91 137.48 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.003 0.921 . . . . 74.04 111.105 -169.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -109.04 142.08 40.24 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.358 -1.349 . . . . 73.13 107.358 166.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -103.28 148.86 25.32 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.283 -0.636 . . . . 71.3 109.283 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -149.56 130.11 13.96 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.111 -1.07 . . . . 75.23 108.111 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.461 HD23 HD11 ' D' ' 60' ' ' LEU . 5.4 mp -119.51 146.85 45.08 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.251 0.548 . . . . 73.1 110.325 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 16.2 t70 -132.42 144.17 50.31 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.388 1.075 . . . . 75.32 108.236 175.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 57.2 m -104.21 143.15 33.33 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.864 0.866 . . . . 73.15 109.689 -175.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.579 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.51 142.08 17.68 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.98 0.912 . . . . 64.35 108.983 178.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 25.4 p -162.73 158.41 22.93 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 122.911 0.484 . . . . 45.43 110.132 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 81.4 p -151.82 144.28 24.14 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.799 -0.815 . . . . 63.23 108.799 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -87.3 117.8 26.3 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.096 -0.705 . . . . 72.35 109.096 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' D' ' 57' ' ' GLU . 26.1 mt -91.09 -24.3 20.05 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.721 -0.672 . . . . 60.14 110.204 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -172.79 178.55 2.59 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.529 1.131 . . . . 72.44 109.284 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -75.3 135.44 40.91 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.484 -0.932 . . . . 74.24 108.484 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 69.05 2.18 3.49 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.65 1.18 . . . . 73.34 113.024 -171.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 68.9 t -124.13 131.24 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.251 0.621 . . . . 71.41 109.817 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -134.66 153.97 51.74 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 123.189 0.595 . . . . 73.12 110.922 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.54 ' HB2' HD11 ' D' ' 51' ' ' LEU . 14.3 tt0 -110.83 120.3 41.95 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.3 -1.318 . . . . 72.52 107.851 165.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' D' ' 102' ' ' CYS . 33.2 m -106.89 132.45 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 108.485 -0.931 . . . . 61.21 108.485 173.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 38.7 t -125.89 125.49 68.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 N-CA-C 108.934 -0.765 . . . . 60.32 108.934 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.629 HD22 ' HB3' ' D' ' 103' ' ' PRO . 52.0 tp -115.91 117.49 30.33 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.2 -0.667 . . . . 72.43 109.2 177.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 46.4 ttm-85 -87.34 101.52 13.64 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.948 -0.76 . . . . 74.13 108.948 176.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 99.4 t -91.53 121.31 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.975 -0.75 . . . . 74.24 108.975 174.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.6 m -120.11 142.78 48.59 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.454 0.645 . . . . 74.11 109.789 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.414 HG13 HG13 ' D' ' 40' ' ' VAL . 25.4 t -130.59 102.37 6.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 126.134 1.774 . . . . 71.31 107.606 -171.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 21.2 m -95.2 97.61 10.02 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.487 -0.931 . . . . 74.13 108.487 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.4 147.02 27.23 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.114 -0.948 . . . . 71.23 108.994 -172.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.457 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.0 p -149.75 138.06 20.59 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 123.535 0.522 . . . . 75.33 111.6 -177.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.557 HD12 HG22 ' D' ' 31' ' ' VAL . 26.1 mt -115.8 111.66 20.83 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.444 -1.253 . . . . 62.22 107.619 171.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.3 -134.72 21.56 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 116.477 -0.328 . . . . 71.44 113.084 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -86.15 2.89 45.09 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.344 0.658 . . . . 75.0 112.571 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -131.57 160.55 34.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.875 0.47 . . . . 64.41 110.064 -171.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 62.5 m -69.39 136.07 51.16 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.265 -0.879 . . . . 73.41 110.492 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.524 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -84.08 -65.8 0.97 Allowed 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.664 -1.235 . . . . 71.5 107.664 174.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -152.43 158.96 43.37 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.154 -0.93 . . . . 71.23 110.458 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 69.5 mt -122.82 108.26 12.81 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.621 -1.622 . . . . 61.34 106.621 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.421 ' SG ' HG23 ' D' ' 114' ' ' ILE . 52.8 t -117.48 138.16 52.05 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.924 -0.769 . . . . 61.14 108.924 -175.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 77' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 38.2 tt0 -152.98 133.73 13.88 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.785 -0.45 . . . . 74.12 109.785 -175.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 54.0 t -139.96 119.3 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.395 0.678 . . . . 74.33 109.678 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.721 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.9 mt-30 -86.58 89.94 8.08 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 108.366 -0.975 . . . . 73.13 108.366 165.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 80' ' ' GLN . . . . . 0.446 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.7 tp-100 -83.01 104.91 13.57 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.937 -1.134 . . . . 75.42 107.937 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -103.92 162.09 15.55 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 111.934 -0.466 . . . . 32.01 111.934 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.0 133.75 3.51 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 112.117 -0.393 . . . . 64.04 112.117 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.402 HG23 HD12 ' D' ' 51' ' ' LEU . 39.0 mt -88.79 128.12 41.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 108.558 -0.905 . . . . 61.11 108.558 174.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.462 ' HB2' HD11 ' D' ' 86' ' ' ILE . 79.8 m-85 -133.97 157.07 46.98 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.888 1.275 . . . . 73.54 108.624 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.8 m -114.63 99.15 7.31 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.802 0.841 . . . . 71.13 108.913 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.462 HD11 ' HB2' ' D' ' 84' ' ' PHE . 2.8 mp -109.66 126.73 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.463 0.705 . . . . 74.44 109.637 -173.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.24 165.04 33.1 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.932 0.893 . . . . 72.13 109.702 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.93 20.97 79.2 Favored Glycine 0 C--N 1.346 1.115 0 N-CA-C 114.413 0.525 . . . . 71.15 114.413 173.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 7.3 mt -129.21 157.26 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.32 0.648 . . . . 73.44 109.443 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.81 -174.5 4.8 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.481 0.712 . . . . 65.34 111.01 175.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.98 -141.45 39.8 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.26 -0.882 . . . . 25.13 114.274 173.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 15.6 m -90.22 -13.56 35.22 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.234 0.613 . . . . 42.55 110.095 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -63.0 -37.69 88.21 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.953 0.901 . . . . 73.43 110.806 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -73.04 -33.13 65.51 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.879 0.472 . . . . 71.12 111.614 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.97 -33.67 74.08 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.778 0.431 . . . . 34.44 110.364 174.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -74.18 -32.45 63.08 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.557 0.743 . . . . 65.03 110.612 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.1 t -63.18 -50.66 69.47 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.395 0.617 . . . . 75.11 110.242 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.406 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 47.5 mt -83.04 -21.08 33.91 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.893 -1.048 . . . . 52.14 111.26 -176.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.32 -16.95 59.72 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.612 0.57 . . . . 61.52 114.289 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.2 -64.09 0.7 Allowed 'General case' 0 C--O 1.239 0.515 0 C-N-CA 122.685 0.394 . . . . 74.11 111.799 -172.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -63.53 -44.58 93.81 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 112.485 0.55 . . . . 62.53 112.485 -172.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.511 ' HB3' HG21 ' D' ' 58' ' ' VAL . 56.7 m -66.91 -47.3 53.98 Favored Pre-proline 0 CA--C 1.57 1.723 0 CA-C-O 118.943 -0.551 . . . . 70.24 112.105 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.629 ' HB3' HD22 ' D' ' 60' ' ' LEU . 72.2 Cg_exo -56.8 -29.66 81.89 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 122.427 2.084 . . . . 71.32 113.932 168.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -68.59 -26.0 65.16 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.109 0.564 . . . . 75.55 111.81 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 30.3 mm -71.91 -39.22 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 121.243 0.544 . . . . 73.03 109.648 171.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.495 HD11 HG23 ' D' ' 58' ' ' VAL . 79.1 mt -80.08 -25.57 40.0 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.216 -0.902 . . . . 53.33 111.938 -175.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -59.5 -48.33 95.91 Favored Pre-proline 0 CA--C 1.562 1.409 0 N-CA-C 113.517 0.932 . . . . 73.44 113.517 -174.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.57 -40.05 83.5 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.079 1.853 . . . . 62.34 112.956 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -71.56 -38.63 70.94 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.837 0.855 . . . . 72.13 111.803 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.15 -47.27 74.6 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.281 0.632 . . . . 71.12 109.953 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -58.07 -46.93 84.62 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.154 0.909 . . . . 72.44 110.409 176.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -59.84 -49.67 76.81 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 123.923 0.764 . . . . 71.15 110.364 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.4 t -57.55 -45.33 85.26 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.74 0.65 . . . . 72.55 111.097 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.492 ' O ' HG23 ' D' ' 118' ' ' VAL . 94.4 mt -59.59 -58.09 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.688 0.795 . . . . 63.02 110.17 175.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 90.0 m -55.59 -39.59 70.93 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.254 1.022 . . . . 52.32 111.88 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 37.8 t -66.32 -41.7 89.27 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.321 -0.854 . . . . 64.24 109.754 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.402 ' HB2' ' HE3' ' D' ' 117' ' ' MET . 75.0 mtm -71.45 -28.37 63.92 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.937 0.495 . . . . 63.14 111.65 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.492 HG23 ' O ' ' D' ' 114' ' ' ILE . 97.3 t -63.45 -48.69 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.277 -0.638 . . . . 74.34 109.277 173.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 83.1 p -71.91 -28.62 63.61 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.791 -0.641 . . . . 65.31 110.985 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -69.97 -36.47 75.23 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.798 0.839 . . . . 64.2 109.948 173.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.9 2.15 87.88 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.923 0.764 . . . . 43.01 112.138 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.1 p 61.17 29.0 18.56 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.836 2.054 . . . . 65.13 114.0 173.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.438 ' HB2' HG13 ' D' ' 118' ' ' VAL . 97.8 m-85 -86.36 154.62 57.04 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.776 -0.824 . . . . 70.2 108.776 168.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -53.0 136.84 61.68 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.838 2.358 . . . . 72.41 112.693 175.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -52.85 128.98 28.71 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 124.289 0.993 . . . . 73.41 112.249 -174.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 56.9 tp -109.51 99.64 8.82 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.363 -0.835 . . . . 72.23 109.142 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -99.96 97.34 8.23 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.596 -0.89 . . . . 75.43 108.596 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.6 tt -67.97 116.43 8.6 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.199 -1.038 . . . . 75.41 108.199 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -57.14 133.51 80.68 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 123.372 0.669 . . . . 52.03 110.025 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 23.7 Cg_exo -62.4 115.38 2.84 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.623 2.216 . . . . 61.23 111.97 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 108.715 -0.846 . . . . 73.05 108.715 -179.174 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.691 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 9.4 t80 . . . . . 0 C--O 1.235 0.294 0 N-CA-C 109.668 -0.493 . . . . 75.2 109.668 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -139.27 111.01 7.17 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.36 -0.978 . . . . 75.42 108.36 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.638 HG12 ' HD2' ' A' ' 84' ' ' PHE . 57.2 mt -82.74 120.44 34.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.421 -0.955 . . . . 71.34 108.421 173.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.43 -41.25 20.1 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 124.146 0.904 . . . . 74.52 109.011 -177.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -173.83 124.09 0.35 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 121.938 0.095 . . . . 73.44 111.061 -169.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' C' ' 130' ' ' PRO . 92.2 mt -116.87 138.54 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 C-N-CA 123.924 0.89 . . . . 62.34 109.571 175.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.519 ' HB3' HG23 ' B' ' 122' ' ' THR . 35.3 p90 -169.61 176.26 5.03 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.227 0.955 . . . . 74.32 111.217 -170.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -102.26 119.43 38.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.94 -1.027 . . . . 63.23 108.533 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.459 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 36.9 mtpt -83.04 -42.65 17.23 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.957 -0.757 . . . . 72.4 108.957 176.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 16.2 t70 -134.4 136.62 43.45 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.485 -1.234 . . . . 61.2 109.602 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.8 mt -136.13 143.16 36.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 C-N-CA 125.345 1.458 . . . . 72.42 107.118 174.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.0 t -155.09 119.37 4.68 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-O 121.166 0.507 . . . . 72.04 110.476 171.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.509 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 87.8 t80 -111.34 136.53 50.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.797 -1.557 . . . . 72.44 106.797 169.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -133.53 138.23 45.97 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.638 -0.504 . . . . 74.11 109.638 175.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.85 70.83 16.97 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 106.516 -1.661 . . . . 73.4 106.516 170.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.75 -28.14 30.86 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.539 2.159 . . . . 75.31 111.448 -175.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -101.62 20.42 16.2 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 114.896 -1.047 . . . . 73.4 109.541 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.54 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -48.32 -52.54 41.78 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 114.006 1.113 . . . . 75.1 114.006 -171.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 15.9 Cg_exo -67.16 -18.54 51.04 Favored 'Trans proline' 0 C--N 1.385 2.481 0 CA-C-N 121.748 1.66 . . . . 60.23 113.02 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -90.18 -28.19 19.06 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.407 1.083 . . . . 74.22 110.599 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.523 HG21 ' HA ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -80.55 -21.14 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 115.672 -0.694 . . . . 65.14 111.722 -166.352 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -86.05 -23.99 26.53 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.373 0.669 . . . . 71.44 111.653 -176.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -78.83 -24.26 44.53 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 110.027 -0.36 . . . . 63.12 110.027 174.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -72.48 146.87 46.56 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.794 0.837 . . . . 73.14 110.719 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -67.34 128.91 38.18 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.606 -0.724 . . . . 71.1 109.455 174.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 59.5 t-105 -79.12 89.5 4.83 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.469 0.707 . . . . 74.21 110.426 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -125.11 82.8 61.36 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 108.007 -1.109 . . . . 62.11 108.007 169.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.0 127.93 11.86 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.336 2.024 . . . . 64.54 112.395 -172.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -96.9 93.12 6.46 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 106.354 -1.721 . . . . 70.12 106.354 170.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.8 t -72.67 91.46 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.88 -0.785 . . . . 70.45 108.88 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -98.32 112.46 24.45 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.342 -1.355 . . . . 73.21 107.342 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 pp -123.2 135.02 54.11 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.229 0.538 . . . . 75.22 110.885 -171.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -115.94 145.38 42.97 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.698 -1.223 . . . . 71.32 107.698 172.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.12 123.52 23.28 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.95 -0.759 . . . . 62.54 108.95 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.613 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 24.5 t70 -118.7 139.41 51.59 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.178 0.991 . . . . 62.15 109.246 -174.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.8 p -116.59 121.65 42.35 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.946 0.898 . . . . 63.34 110.476 -170.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.77 131.85 17.29 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.774 0.829 . . . . 64.2 110.636 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.9 m -131.58 157.68 43.0 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.172 0.589 . . . . 73.24 110.482 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.3 t -148.74 123.51 9.9 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.54 0.736 . . . . 52.02 109.359 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -75.41 121.29 22.06 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.284 0.633 . . . . 73.44 110.693 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.405 HD12 HG23 ' A' ' 83' ' ' ILE . 52.9 mt -94.16 -39.37 10.6 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.775 0.83 . . . . 75.1 110.724 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.452 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -148.01 -177.56 5.8 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.878 0.871 . . . . 64.22 109.839 176.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -63.67 115.36 4.67 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.398 -0.593 . . . . 74.51 109.398 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 70.35 4.07 4.74 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 125.137 1.375 . . . . 73.3 112.929 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 99.8 t -109.77 114.84 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.115 -1.068 . . . . 72.24 108.115 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -138.63 140.9 39.08 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.568 -0.901 . . . . 72.11 108.568 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -89.79 129.92 36.12 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.753 -0.658 . . . . 62.13 109.435 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.421 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 72.8 t -100.48 126.1 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 107.663 -1.236 . . . . 53.24 107.663 172.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.6 t -120.7 125.56 74.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.662 -0.866 . . . . 63.25 108.662 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -115.25 108.01 16.02 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.153 -1.425 . . . . 50.34 107.153 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.613 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 48.3 ttt180 -83.61 99.94 10.51 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.886 -0.783 . . . . 52.33 108.886 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.9 101.77 12.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.615 -0.721 . . . . 63.24 109.199 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.0 m -97.54 113.46 25.17 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.503 0.721 . . . . 72.13 109.252 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.4 HG11 HD21 ' A' ' 126' ' ' LEU . 18.2 t -116.86 107.64 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.005 0.922 . . . . 70.34 109.097 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.9 m -109.49 129.2 55.57 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.315 -0.994 . . . . 70.4 108.315 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.81 132.71 49.81 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.115 -1.439 . . . . 72.0 107.115 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.0 m -121.32 165.76 15.03 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.199 0.6 . . . . 63.52 110.362 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.409 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 82.9 mt -131.1 43.26 3.12 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.94 -1.133 . . . . 73.24 107.94 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.68 -93.07 1.84 Allowed Glycine 0 C--N 1.339 0.709 0 CA-C-N 114.84 -1.073 . . . . 42.4 111.481 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -95.09 -26.88 15.85 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.194 0.598 . . . . 75.31 111.919 -174.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -105.75 132.63 51.64 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.196 -0.668 . . . . 62.31 109.196 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.4 m -73.44 134.99 44.1 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.732 -0.47 . . . . 71.21 109.732 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.523 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.86 -60.91 2.11 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.455 -0.793 . . . . 71.44 109.926 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.427 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 33.4 p90 -160.17 174.29 14.48 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.349 -0.841 . . . . 72.21 111.696 176.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.5 tp -127.79 142.99 51.15 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.445 -1.252 . . . . 71.41 108.482 170.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 80.5 m -143.0 97.39 3.09 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.819 1.248 . . . . 64.15 108.235 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -121.51 115.71 23.35 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.922 -0.77 . . . . 74.24 108.922 -173.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.5 t -129.51 110.63 20.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 123.805 0.842 . . . . 63.31 109.592 -173.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.623 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 28.6 mt-30 -83.69 88.17 7.06 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.14 -1.059 . . . . 64.54 108.14 169.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.51 ' HG3' HD22 ' A' ' 106' ' ' LEU . 67.5 tp60 -78.48 102.48 7.86 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.692 -1.14 . . . . 73.42 108.691 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.7 145.01 17.43 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.443 -0.663 . . . . 51.51 111.443 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.407 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.0 124.5 1.71 Allowed Glycine 0 CA--C 1.508 -0.405 0 N-CA-C 110.78 -0.928 . . . . 42.24 110.78 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.405 HG23 HD12 ' A' ' 51' ' ' LEU . 46.9 mt -81.69 115.68 24.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.864 -0.791 . . . . 73.55 108.864 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.691 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 38.7 m-85 -124.06 120.27 31.91 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.927 -0.768 . . . . 74.12 108.927 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.1 t -95.43 101.84 13.6 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.225 -1.028 . . . . 72.42 108.225 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.4 pt . . . . . 0 N--CA 1.478 0.966 0 C-N-CA 122.594 0.357 . . . . 73.3 110.312 178.907 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.483 0.183 . . . . 74.33 111.208 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -70.63 -47.4 60.26 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.251 0.62 . . . . 71.33 110.818 172.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.628 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 27.4 p -71.67 -43.95 65.13 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.138 0.494 . . . . 72.33 110.949 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.59 -45.35 83.57 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.545 1.138 . . . . 73.43 110.765 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.55 -16.19 47.03 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 114.745 0.658 . . . . 60.21 114.745 -170.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.93 -61.94 0.87 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 117.922 0.861 . . . . 72.13 112.18 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.628 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 88.8 t80 -69.23 -62.28 1.44 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.371 0.878 . . . . 75.22 113.371 -164.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 73.7 m -63.29 -39.3 48.9 Favored Pre-proline 0 CA--C 1.563 1.472 0 N-CA-C 113.697 0.999 . . . . 74.45 113.697 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.21 -32.8 82.55 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 121.854 1.703 . . . . 73.34 113.115 166.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -74.99 -17.98 60.44 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.028 0.531 . . . . 64.15 110.849 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -67.41 -37.46 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 109.186 -0.672 . . . . 63.11 109.186 170.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.51 HD22 ' HG3' ' A' ' 80' ' ' GLN . 77.4 mt -81.23 -17.93 47.8 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.034 0.934 . . . . 63.21 112.191 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -62.81 -47.01 88.16 Favored Pre-proline 0 CA--C 1.572 1.809 0 CA-C-O 118.158 -0.925 . . . . 73.23 113.279 -174.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.61 -37.57 46.36 Favored 'Trans proline' 0 C--N 1.393 2.883 0 C-N-CA 122.35 2.033 . . . . 75.05 112.781 176.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -66.34 -44.75 82.41 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.466 0.706 . . . . 63.31 111.559 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.22 -41.74 76.65 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.992 -0.549 . . . . 73.4 110.48 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.474 ' NH1' HD12 ' C' ' 105' ' ' ILE . 27.6 ttm180 -52.0 -47.64 64.82 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.969 0.908 . . . . 75.24 110.765 171.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -68.05 -43.96 77.5 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.044 -0.98 . . . . 75.05 111.337 -175.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 39.1 t -65.6 -30.3 71.0 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.189 0.596 . . . . 72.24 111.056 -178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.8 mt -68.69 -58.83 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.888 0.875 . . . . 53.24 109.654 172.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 50.6 m -53.15 -36.51 60.93 Favored 'General case' 0 C--N 1.361 1.094 0 C-N-CA 124.246 1.018 . . . . 63.03 112.097 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -65.24 -51.22 62.27 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.56 -0.745 . . . . 73.41 110.687 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.509 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 61.0 mtm -64.28 -37.87 89.03 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.903 0.481 . . . . 55.31 111.483 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.442 HG21 HD23 ' A' ' 126' ' ' LEU . 76.0 t -62.12 -45.05 99.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.197 0.999 . . . . 73.5 110.335 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.6 t -70.2 -35.5 73.95 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.563 -0.744 . . . . 74.12 110.76 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -69.35 -33.51 73.2 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.543 0.737 . . . . 75.25 109.739 175.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.38 14.34 51.08 Favored Glycine 0 C--N 1.351 1.371 0 CA-C-N 115.344 -0.844 . . . . 63.52 112.879 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.413 HG21 ' HE ' ' B' ' 15' ' ' ARG . 2.5 t 61.4 18.58 9.45 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 126.541 1.936 . . . . 73.22 114.078 170.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -87.46 153.01 53.04 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 123.033 0.533 . . . . 72.54 109.595 176.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -55.16 165.54 2.86 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.521 2.814 . . . . 62.33 114.301 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -59.54 121.95 12.82 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.366 -0.834 . . . . 73.52 111.512 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.442 HD23 HG21 ' A' ' 118' ' ' VAL . 60.4 tp -123.67 94.5 4.26 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.223 1.009 . . . . 74.24 109.362 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -107.79 125.84 51.91 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 107.999 -1.111 . . . . 74.54 107.999 171.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mp -72.8 139.52 47.09 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.708 -0.849 . . . . 60.32 108.708 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.5 146.21 98.19 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.213 0.605 . . . . 44.15 111.242 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.09 116.21 3.58 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.717 2.278 . . . . 73.41 111.751 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.3 t -101.22 113.21 36.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.782 -1.192 . . . . 63.3 107.782 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -86.26 72.32 10.37 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.515 -0.92 . . . . 63.14 108.515 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 N--CA 1.482 1.157 0 C-N-CA 123.491 0.716 . . . . 72.44 110.943 -178.479 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.544 ' SD ' ' HB ' ' B' ' 89' ' ' ILE . 9.6 tpt . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 121.851 0.834 . . . . 70.13 112.889 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 22.7 m -136.73 123.57 21.29 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 106.37 -1.715 . . . . 54.22 106.37 165.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -151.74 129.16 11.34 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.793 -0.817 . . . . 72.14 108.793 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -155.07 131.14 10.19 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.419 -0.586 . . . . 74.02 109.419 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.515 HD13 HD11 ' B' ' 16' ' ' ILE . 25.2 mt -75.59 121.54 27.57 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 108.746 -0.835 . . . . 71.33 108.746 173.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -93.05 -37.92 11.91 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.53 -0.759 . . . . 71.02 109.234 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.413 ' HE ' HG21 ' A' ' 122' ' ' THR . 46.5 ttt180 -177.39 132.42 0.17 Allowed 'General case' 0 C--N 1.356 0.856 0 CA-C-N 115.608 -0.723 . . . . 71.41 109.64 -174.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.515 HD11 HD13 ' B' ' 13' ' ' ILE . 94.6 mt -115.21 140.05 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 108.008 -1.108 . . . . 74.32 108.008 176.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -171.17 155.78 4.49 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.805 0.812 . . . . 74.11 112.483 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.9 m -75.69 125.03 28.25 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.546 -1.206 . . . . 74.12 109.191 168.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.54 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 43.9 mtpt -96.79 -31.86 12.41 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.535 0.734 . . . . 74.44 111.065 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -153.54 140.1 18.82 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.47 -0.332 . . . . 70.4 110.557 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.496 HD11 ' SG ' ' B' ' 113' ' ' CYS . 35.4 mm -135.59 143.61 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.972 1.309 . . . . 72.45 108.577 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -150.28 109.52 3.95 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.07 -1.085 . . . . 64.22 108.07 174.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 89.4 t80 -124.48 108.81 12.52 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 108.002 -1.111 . . . . 75.22 108.002 173.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -124.16 123.56 40.56 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.458 0.703 . . . . 74.34 110.29 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.425 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -114.41 87.1 13.22 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.776 1.23 . . . . 62.45 107.932 178.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.21 -29.98 25.61 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.691 2.261 . . . . 65.31 113.224 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -108.56 18.53 20.8 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.57 0.748 . . . . 73.23 110.821 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.459 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -43.09 -59.26 3.26 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 114.938 1.458 . . . . 73.04 114.938 -164.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -62.25 -28.73 79.42 Favored 'Trans proline' 0 C--N 1.395 3.006 0 C-N-CA 122.388 2.059 . . . . 74.2 112.464 -172.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -96.23 -32.76 12.29 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.167 -0.924 . . . . 72.42 112.22 -172.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.501 HG21 ' HA ' ' B' ' 73' ' ' ALA . 6.0 p -74.17 -6.29 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 122.998 0.519 . . . . 64.3 111.675 -171.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -72.83 -14.05 61.42 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.218 0.607 . . . . 74.42 112.437 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -61.49 -18.17 57.88 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.31 0.644 . . . . 62.15 111.076 172.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.615 ' HB2' HD13 ' B' ' 68' ' ' LEU . 30.3 mmtp -95.54 88.84 5.18 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.296 1.439 . . . . 75.45 109.112 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -98.29 78.38 2.45 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.604 0.716 . . . . 71.4 111.19 -176.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -159.31 172.33 18.18 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.327 -1.306 . . . . 74.42 108.582 170.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -68.58 112.73 12.09 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 109.14 -0.689 . . . . 72.45 109.14 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.491 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 20.8 Cg_endo -61.53 163.82 17.11 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.06 2.506 . . . . 71.4 114.41 -173.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -72.73 102.34 3.32 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 107.519 -1.289 . . . . 75.45 107.519 171.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -93.86 146.2 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 114.545 -1.207 . . . . 72.5 110.179 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.787 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 56.1 mtpt -121.82 142.74 49.92 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.771 0.828 . . . . 74.03 109.49 172.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.42 ' H ' ' HG ' ' B' ' 42' ' ' LEU . 3.2 pp -92.74 134.61 34.88 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 114.33 -1.304 . . . . 74.43 107.781 168.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.697 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 18.5 m-20 -143.74 132.78 22.88 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.143 -1.058 . . . . 61.41 108.143 177.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 86.7 mt -127.92 132.38 49.29 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.485 0.714 . . . . 55.3 109.706 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 7.5 t70 -123.16 138.59 54.62 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.891 1.277 . . . . 74.03 107.587 172.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 43.6 m -108.88 116.19 31.51 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 122.979 0.511 . . . . 72.14 110.083 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.29 135.84 53.54 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.218 1.007 . . . . 23.25 108.42 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.9 m -142.5 161.39 38.19 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 109.527 -0.546 . . . . 72.01 109.527 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 88.6 p -160.63 136.31 8.17 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 123.627 0.579 . . . . 75.51 109.518 174.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -95.08 102.12 13.91 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.119 -1.067 . . . . 74.41 108.119 167.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 54.3 mt -65.83 -35.95 82.1 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.103 -0.953 . . . . 73.32 111.041 -175.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.49 -179.49 6.02 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.291 1.036 . . . . 61.4 109.443 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.86 122.7 16.06 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.034 -0.984 . . . . 61.31 108.726 173.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 73.95 -4.77 2.19 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 125.371 1.468 . . . . 74.11 113.155 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 56.3 t -113.6 120.7 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 108.978 -0.749 . . . . 60.52 108.978 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -129.19 169.64 14.55 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.214 -0.661 . . . . 72.53 109.214 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -140.87 125.55 17.95 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.475 0.71 . . . . 52.15 109.131 174.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 87.0 t -102.39 119.48 50.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.478 1.111 . . . . 75.02 109.073 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 34.0 t -123.83 111.49 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.732 -0.84 . . . . 75.32 108.732 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 32.3 tp -106.39 119.32 38.96 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 109.059 -0.719 . . . . 54.41 109.059 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 57.7 ttm-85 -86.3 111.76 20.76 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.688 -0.856 . . . . 71.25 108.688 174.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 46.4 t -103.26 102.39 13.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 107.353 -1.351 . . . . 73.32 107.353 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.697 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 17.6 m -101.48 132.15 47.25 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.874 -1.057 . . . . 52.02 109.024 177.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 78.1 t -125.4 112.62 31.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 124.121 0.968 . . . . 75.32 109.153 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.787 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 98.4 m -87.95 149.46 24.03 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.206 -0.906 . . . . 74.43 109.14 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.68 138.4 30.59 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.137 0.575 . . . . 73.04 109.556 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.464 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 45.0 p -146.55 131.29 17.96 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.494 -0.558 . . . . 63.33 109.494 -178.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.615 HD13 ' HB2' ' B' ' 34' ' ' LYS . 26.0 mt -113.34 113.13 24.82 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.287 1.035 . . . . 74.32 108.962 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.79 -111.32 3.41 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.05 -0.523 . . . . 54.31 112.203 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -113.59 4.87 16.32 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.558 0.743 . . . . 74.43 111.598 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -130.48 151.79 50.58 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.165 0.586 . . . . 74.15 110.699 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 73.9 m -74.24 123.39 24.44 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 122.698 0.399 . . . . 73.15 110.174 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.501 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -76.16 -59.9 2.56 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.14 -0.936 . . . . 33.2 109.085 177.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -149.62 161.75 41.56 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 121.933 0.873 . . . . 71.23 111.468 174.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 78.0 mt -125.49 114.23 18.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 105.127 -2.175 . . . . 73.12 105.127 168.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.4 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 36.3 t -115.72 142.77 46.3 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.343 -1.354 . . . . 71.23 107.343 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -160.9 125.51 3.6 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.937 -0.394 . . . . 55.22 109.937 -169.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 62.0 t -128.67 148.94 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.911 0.884 . . . . 73.14 109.805 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -117.63 111.5 19.26 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.724 -1.213 . . . . 62.41 107.724 163.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -96.95 100.78 12.28 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.797 -1.186 . . . . 43.54 107.797 171.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.02 142.12 15.9 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-N 115.232 -0.894 . . . . 74.44 110.87 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.62 125.99 3.02 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 109.786 -1.326 . . . . 42.05 109.786 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 57.9 mt -84.69 126.03 40.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 107.788 -1.19 . . . . 74.34 107.788 175.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -131.88 133.37 44.53 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.03 -0.73 . . . . 74.34 109.03 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 67.2 m -89.07 110.69 21.38 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.276 -1.009 . . . . 72.2 108.276 172.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.439 ' O ' HD12 ' B' ' 86' ' ' ILE . 2.5 pp -124.33 140.76 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.176 0.99 . . . . 72.53 110.213 -172.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.75 171.17 19.31 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.318 0.488 . . . . 72.34 112.318 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.5 -65.7 4.07 Favored Glycine 0 C--N 1.354 1.549 0 CA-C-N 115.148 -0.933 . . . . 73.51 112.946 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.544 ' HB ' ' SD ' ' B' ' 9' ' ' MET . 9.7 mm -68.55 148.86 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.94 1.296 . . . . 75.32 111.026 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -152.38 179.37 8.61 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.641 0.776 . . . . 71.55 111.257 -170.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.02 -127.81 36.18 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 115.968 -0.56 . . . . 63.53 113.374 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 16.3 m -89.28 -18.55 26.77 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.266 0.627 . . . . 62.14 110.787 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -56.34 -41.7 76.53 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 109.338 -0.615 . . . . 74.3 109.338 171.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 17.4 ptt? -81.37 -33.53 32.3 Favored 'General case' 0 C--N 1.358 0.97 0 CA-C-N 115.669 -0.696 . . . . 64.22 111.194 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.4 -36.16 66.12 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.618 0.723 . . . . 71.45 110.894 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.464 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 43.5 t-80 -69.45 -46.14 67.4 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.295 -1.32 . . . . 72.13 111.137 175.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -73.14 -31.67 64.43 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.202 0.445 . . . . 74.43 112.202 -173.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.5 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 15.5 mt -95.3 -42.8 8.34 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.859 0.864 . . . . 74.32 111.242 -172.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.61 -24.61 45.66 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.832 -0.622 . . . . 63.54 113.576 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -117.09 -49.69 2.6 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.855 0.462 . . . . 54.0 111.741 -171.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -81.97 -41.86 20.19 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.022 0.379 . . . . 74.14 112.022 -174.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 85.1 m -61.6 -48.67 89.56 Favored Pre-proline 0 CA--C 1.559 1.292 0 CA-C-O 118.425 -0.798 . . . . 50.41 111.916 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 38.0 Cg_exo -64.5 -22.93 64.97 Favored 'Trans proline' 0 C--N 1.396 3.072 0 C-N-CA 122.167 1.912 . . . . 75.35 112.887 173.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -65.46 -35.97 82.5 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.168 0.587 . . . . 74.53 110.45 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 93.3 mt -63.51 -40.77 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.437 1.095 . . . . 75.41 110.017 171.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 59.8 mt -90.26 -13.01 36.24 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 114.677 -1.147 . . . . 74.2 112.337 -170.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -60.36 -48.28 94.29 Favored Pre-proline 0 N--CA 1.488 1.437 0 CA-C-O 117.911 -1.042 . . . . 71.33 113.473 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.78 -37.99 94.51 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 121.881 1.721 . . . . 72.11 113.173 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -67.64 -47.92 68.19 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.443 0.697 . . . . 73.42 110.508 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.68 -42.35 99.58 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.472 0.709 . . . . 75.2 111.123 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -59.92 -51.44 69.69 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.192 0.997 . . . . 74.12 110.777 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -65.21 -31.32 72.43 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.821 0.701 . . . . 55.54 110.03 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.496 ' SG ' HD11 ' B' ' 21' ' ' ILE . 6.0 t -74.04 -34.58 64.14 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.016 0.526 . . . . 63.1 111.204 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.423 ' O ' HG23 ' B' ' 118' ' ' VAL . 57.0 mt -66.66 -57.33 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 109.114 -0.698 . . . . 51.13 109.114 173.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.3 m -62.1 -24.61 67.23 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.637 0.775 . . . . 70.35 111.788 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 27.1 t -64.32 -52.23 59.51 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 109.379 -0.601 . . . . 73.21 109.379 173.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.5 mmt -69.94 -32.2 70.33 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.11 0.564 . . . . 72.15 111.369 -175.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.423 HG23 ' O ' ' B' ' 114' ' ' ILE . 79.3 t -62.72 -46.19 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.858 0.863 . . . . 62.43 110.184 174.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.0 t -65.72 -35.87 81.97 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.994 -1.003 . . . . 55.52 110.829 177.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.483 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 92.5 mtt-85 -67.12 -33.02 74.56 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.687 -0.688 . . . . 74.54 110.322 178.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.98 7.37 75.18 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 123.837 0.711 . . . . 70.23 112.962 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.519 HG23 ' HB3' ' A' ' 17' ' ' TYR . 81.5 p 59.68 23.89 12.73 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 126.291 1.837 . . . . 54.21 113.596 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -86.65 159.22 52.88 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 123.739 0.816 . . . . 73.3 111.409 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -54.69 158.78 9.96 Favored 'Trans proline' 0 C--N 1.393 2.882 0 C-N-CA 123.837 3.025 . . . . 75.31 115.39 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -65.01 133.84 52.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.358 1.063 . . . . 74.44 111.703 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 58.0 tp -140.21 120.66 14.09 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.451 0.7 . . . . 72.4 109.615 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -132.13 117.44 18.31 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.341 1.056 . . . . 65.21 108.917 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 7.1 mp -83.53 150.37 26.01 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.259 0.624 . . . . 52.43 110.653 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.5 156.42 90.27 Favored Pre-proline 0 CA--C 1.557 1.246 0 CA-C-N 115.063 -0.971 . . . . 74.24 110.463 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -66.34 111.24 2.0 Allowed 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 122.679 2.253 . . . . 64.43 110.667 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 36.9 t -89.75 107.24 17.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.003 -1.11 . . . . 74.43 108.003 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -104.13 88.67 3.06 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.869 -1.06 . . . . 64.41 109.155 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -63.91 -37.61 88.02 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.982 -0.748 . . . . 73.33 108.982 170.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 134' ' ' ASP . . . . . 0.452 ' N ' ' HB1' ' B' ' 100' ' ' ALA . 6.9 p-10 . . . . . 0 C--O 1.24 0.59 0 C-N-CA 124.745 1.218 . . . . 45.13 111.632 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.651 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.6 t80 . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 109.672 -0.492 . . . . 70.45 109.672 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -152.41 129.58 11.18 Favored 'General case' 0 C--O 1.242 0.667 0 O-C-N 124.072 0.857 . . . . 73.54 109.219 173.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 86.9 mt -73.36 130.51 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 108.43 -0.952 . . . . 63.01 108.43 172.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -97.05 -42.13 8.03 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.401 0.68 . . . . 60.25 110.283 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -176.19 124.97 0.19 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.701 0.4 . . . . 73.32 110.219 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.9 mt -111.26 146.39 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 109.058 -0.719 . . . . 63.43 109.058 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -172.6 166.5 5.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.12 0.968 . . . . 65.12 109.394 -175.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 63.1 p -85.06 115.43 22.87 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.267 -0.642 . . . . 63.21 109.267 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.67 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 16.3 mmtp -64.67 -44.58 89.91 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.998 -0.741 . . . . 71.03 108.998 171.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 22.6 t70 -147.25 145.55 29.47 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 114.407 -1.27 . . . . 74.11 110.609 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.8 mt -133.55 145.13 34.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 125.891 1.676 . . . . 65.54 106.712 171.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.1 t -158.37 150.53 21.76 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.414 0.626 . . . . 72.21 109.707 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 72.1 t80 -147.07 137.6 23.58 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.307 -1.368 . . . . 71.01 107.307 173.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -141.11 135.38 30.88 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.632 -0.877 . . . . 51.14 108.632 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.03 83.42 4.68 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 107.701 -1.222 . . . . 62.42 107.701 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.52 -37.39 59.15 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.816 2.344 . . . . 64.53 112.581 -173.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -101.22 21.1 14.53 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.913 -1.04 . . . . 73.03 110.806 -173.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.467 ' HA ' HG12 ' C' ' 31' ' ' VAL . . . -48.58 -57.26 11.39 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 114.661 1.356 . . . . 73.51 114.661 -167.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.43 -42.5 54.72 Favored 'Trans proline' 0 C--N 1.386 2.516 0 CA-C-N 122.141 1.801 . . . . 54.55 112.248 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.479 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.3 t60 -70.8 -30.97 67.57 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.823 0.849 . . . . 75.31 112.695 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.648 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.5 p -79.68 -21.31 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 112.501 0.556 . . . . 74.32 112.501 -171.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -72.48 -22.94 60.98 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.489 0.552 . . . . 71.21 112.489 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 20.0 pt20 -85.41 8.5 18.7 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.447 0.299 . . . . 64.41 110.88 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.573 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -97.84 157.31 16.15 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.127 0.971 . . . . 50.43 110.281 175.722 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.0 132.39 40.14 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.708 0.803 . . . . 70.43 109.504 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 35.1 t-105 -70.36 91.55 0.75 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.842 0.857 . . . . 62.15 110.701 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 37' ' ' GLN . . . . . 0.512 ' H ' HD22 ' C' ' 68' ' ' LEU . 8.2 tp60 -132.21 71.56 79.56 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.263 1.025 . . . . 64.41 109.112 174.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -88.5 158.04 6.54 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.744 2.296 . . . . 73.02 112.842 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -89.06 99.93 12.82 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.013 -1.477 . . . . 71.11 107.013 172.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 15.0 m -66.04 98.36 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-O 122.18 0.99 . . . . 55.44 109.508 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -129.16 103.63 7.08 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.606 -1.179 . . . . 54.12 108.617 -170.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -94.68 148.37 22.34 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.626 -0.879 . . . . 64.53 108.626 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.663 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 11.8 t70 -135.48 123.45 22.72 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.2 -1.037 . . . . 73.55 108.2 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.17 111.78 21.52 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.457 -0.942 . . . . 64.02 108.457 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.522 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 16.7 t70 -114.45 137.38 51.91 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.121 0.968 . . . . 54.24 108.472 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 81.7 p -113.17 123.66 50.75 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.743 0.417 . . . . 53.34 111.464 -164.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.62 135.83 42.44 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.807 0.843 . . . . 61.22 109.181 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 51.7 m -161.7 149.19 14.62 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.874 0.47 . . . . 55.24 111.472 -172.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 52.9 p -160.26 140.77 11.77 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.688 0.795 . . . . 74.34 110.156 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 50' ' ' GLN . . . . . 0.445 ' HA ' ' HA ' ' C' ' 56' ' ' TYR . 60.4 tt0 -74.8 123.46 25.03 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.781 -0.822 . . . . 61.15 108.781 170.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.629 HD11 HD12 ' C' ' 83' ' ' ILE . 87.9 mt -84.23 -49.82 8.44 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.169 0.587 . . . . 70.25 110.622 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.78 -169.74 3.47 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.32 0.648 . . . . 73.11 110.873 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.05 106.52 0.27 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.454 1.102 . . . . 72.42 111.06 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 70.32 -5.32 1.37 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 126.004 1.721 . . . . 62.35 112.68 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 73.8 t -96.53 118.13 42.28 Favored 'Isoleucine or valine' 0 C--N 1.347 0.483 0 C-N-CA 124.572 1.149 . . . . 74.24 108.425 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 56' ' ' TYR . . . . . 0.494 ' CE1' HG12 ' C' ' 86' ' ' ILE . 37.1 p90 -127.96 168.78 14.79 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.046 0.939 . . . . 63.34 108.955 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -126.07 130.53 51.29 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.14 0.576 . . . . 73.04 110.427 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 76.3 t -106.61 115.77 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 107.933 -1.136 . . . . 75.32 107.933 167.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 98.2 t -109.3 131.75 59.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 107.718 -1.215 . . . . 64.41 107.718 165.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 35.5 tp -129.19 119.96 24.97 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.083 -0.71 . . . . 74.41 109.083 174.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.522 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.3 ttm180 -80.08 111.98 16.94 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.745 -1.116 . . . . 75.44 109.398 175.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 15.5 t -101.32 110.69 28.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.481 -1.303 . . . . 40.32 107.481 171.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.663 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 90.7 m -118.98 118.08 30.54 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.725 -0.843 . . . . 75.54 108.725 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.636 HG23 HD13 ' C' ' 114' ' ' ILE . 94.4 t -101.72 112.85 36.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 108.388 -0.968 . . . . 53.44 108.388 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -98.87 131.85 44.66 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.359 -0.978 . . . . 72.21 108.359 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.57 101.86 4.93 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.416 -1.328 . . . . 64.51 107.416 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 47.9 m -128.62 130.12 46.85 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.957 0.503 . . . . 64.52 109.994 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.573 HD13 ' HG2' ' C' ' 34' ' ' LYS . 12.5 mt -85.75 42.7 0.98 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 124.941 1.297 . . . . 73.53 109.774 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.87 -118.96 6.05 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 109.798 -1.321 . . . . 54.2 109.798 -167.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -89.21 -18.32 27.32 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.397 0.679 . . . . 60.33 110.072 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -74.76 91.16 2.38 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.579 1.152 . . . . 73.44 109.656 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 76.9 m -71.47 119.82 16.17 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 109.516 -0.55 . . . . 73.45 109.516 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.648 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -76.57 -54.68 6.35 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.745 -1.116 . . . . 25.51 109.154 -178.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -157.15 170.38 22.63 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-O 122.349 1.071 . . . . 75.22 112.452 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -142.7 113.55 7.53 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 105.196 -2.15 . . . . 74.22 105.196 175.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.503 ' SG ' HG23 ' C' ' 114' ' ' ILE . 47.9 t -121.92 112.49 18.37 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.162 -0.681 . . . . 70.11 109.162 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -119.28 121.2 39.09 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.724 0.81 . . . . 74.15 110.056 -172.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.427 HG11 ' HA ' ' C' ' 110' ' ' ALA . 43.7 t -125.84 112.58 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.747 -0.834 . . . . 63.23 108.747 173.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.3 mt-30 -91.15 95.98 10.35 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.003 -1.11 . . . . 71.43 108.003 173.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.491 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 63.5 tp60 -83.13 117.51 22.94 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.771 0.428 . . . . 63.42 109.871 -175.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.21 145.85 17.89 Favored Glycine 0 C--N 1.342 0.913 0 O-C-N 123.863 0.727 . . . . 70.32 111.643 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.41 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.98 116.92 0.83 Allowed Glycine 0 C--O 1.238 0.361 0 N-CA-C 111.164 -0.775 . . . . 42.4 111.164 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.629 HD12 HD11 ' C' ' 51' ' ' LEU . 10.3 mm -84.44 116.59 28.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.856 -1.164 . . . . 72.32 107.856 176.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.651 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 46.9 m-85 -128.1 146.57 50.65 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.064 -1.087 . . . . 63.41 108.064 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 85' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 70.7 p -113.1 122.06 46.41 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.311 -0.626 . . . . 64.53 109.311 170.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.494 HG12 ' CE1' ' C' ' 56' ' ' TYR . 17.7 pt -130.35 143.93 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 122.957 0.503 . . . . 64.22 109.904 170.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.7 143.33 18.45 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.035 0.934 . . . . 61.32 108.745 171.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 130.99 -52.29 0.83 Allowed Glycine 0 C--N 1.346 1.128 0 O-C-N 123.208 0.317 . . . . 65.13 113.018 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 33.0 pt -94.48 170.38 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-N 117.325 0.563 . . . . 64.25 111.831 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -156.89 162.3 39.66 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.626 0.77 . . . . 71.4 110.716 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.11 -132.75 15.58 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.034 -0.53 . . . . 74.11 112.686 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 20.4 p -69.36 -24.36 63.87 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.526 0.73 . . . . 63.25 111.769 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -65.15 -51.58 60.32 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 121.243 0.544 . . . . 73.53 110.039 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 46.3 ttp -64.88 -45.09 87.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.763 -1.108 . . . . 70.51 110.153 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.71 -26.03 68.47 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.062 0.945 . . . . 74.41 111.822 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -73.12 -42.72 62.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.036 0.534 . . . . 74.13 110.577 175.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 40.6 t -62.84 -60.7 3.12 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.709 0.63 . . . . 52.43 110.024 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.3 -29.67 65.32 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 112.151 0.426 . . . . 74.41 112.151 -177.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.56 11.42 56.52 Favored Glycine 0 N--CA 1.48 1.584 0 N-CA-C 115.157 0.823 . . . . 72.53 115.157 -167.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.79 -51.99 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 118.21 1.005 . . . . 42.34 110.335 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.413 ' HE2' ' CE1' ' C' ' 11' ' ' PHE . 27.3 t80 -75.93 -38.28 57.82 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 113.652 -1.613 . . . . 62.21 112.793 -169.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 83.4 m -79.28 -42.35 1.62 Allowed Pre-proline 0 CA--C 1.563 1.451 0 CA-C-O 118.553 -0.737 . . . . 45.13 112.196 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.85 -23.01 68.92 Favored 'Trans proline' 0 C--N 1.397 3.106 0 C-N-CA 122.139 1.893 . . . . 74.34 112.702 171.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -63.84 -32.37 73.86 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.793 0.837 . . . . 74.44 111.019 174.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.474 HD12 ' NH1' ' A' ' 111' ' ' ARG . 47.1 mm -67.63 -35.87 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 123.365 0.666 . . . . 75.35 110.303 175.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.41 HD21 ' HA3' ' C' ' 82' ' ' GLY . 84.3 mt -90.0 -25.16 21.0 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.177 0.991 . . . . 73.14 112.923 -170.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 107' ' ' PHE . . . . . 0.423 ' N ' ' HD2' ' C' ' 108' ' ' PRO . 0.1 OUTLIER -63.55 -40.34 57.01 Favored Pre-proline 0 CA--C 1.557 1.24 0 CA-C-O 117.729 -1.129 . . . . 75.12 113.905 -171.652 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' C' ' 107' ' ' PHE . 30.0 Cg_endo -61.16 -36.82 79.0 Favored 'Trans proline' 0 C--N 1.388 2.645 0 CA-C-N 121.685 1.638 . . . . 72.4 112.314 174.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -64.29 -49.29 72.41 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.522 0.729 . . . . 72.45 110.729 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.491 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.78 -41.05 96.14 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.365 -0.834 . . . . 70.21 110.888 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -53.2 -56.15 18.73 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.659 1.183 . . . . 61.34 111.39 175.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 112' ' ' GLU . . . . . 0.441 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.8 tm-20 -66.14 -34.34 77.83 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 123.568 0.542 . . . . 74.02 110.286 -176.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 12.9 t -70.6 -27.45 64.11 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.072 0.549 . . . . 75.22 111.321 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.636 HD13 HG23 ' C' ' 64' ' ' VAL . 82.0 mt -77.66 -55.47 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.228 0.611 . . . . 75.4 110.288 173.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 18.8 m -62.49 -27.76 69.36 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.534 0.734 . . . . 71.4 110.96 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 42.6 t -62.06 -51.77 66.61 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 123.786 0.834 . . . . 73.23 109.38 169.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.625 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.03 -35.54 77.17 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.687 1.195 . . . . 64.42 112.668 178.877 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.418 HG23 ' O ' ' C' ' 114' ' ' ILE . 63.7 t -63.57 -46.7 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.71 0.804 . . . . 63.11 109.238 174.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 30.7 t -68.31 -28.55 67.27 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.859 -1.064 . . . . 63.53 111.851 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -72.77 -40.48 65.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.625 0.77 . . . . 72.52 109.316 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.34 -2.54 79.75 Favored Glycine 0 C--N 1.355 1.591 0 CA-C-N 115.42 -0.809 . . . . 71.05 112.267 171.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 24.8 p 65.44 27.66 11.74 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.783 2.033 . . . . 73.35 113.193 170.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -84.14 152.26 61.46 Favored Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 109.042 -0.725 . . . . 75.12 109.042 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -54.36 160.82 6.19 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 123.447 2.765 . . . . 74.23 114.106 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -55.38 111.16 0.81 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.715 0.806 . . . . 61.32 111.461 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 26.6 tp -116.38 86.28 2.46 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 106.116 -1.809 . . . . 74.13 106.116 167.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -104.56 125.9 51.15 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.862 -1.063 . . . . 71.31 109.587 -167.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.36 127.35 32.44 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.489 0.715 . . . . 74.21 110.238 -173.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.6 156.05 68.32 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 123.99 0.916 . . . . 62.22 111.531 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.539 ' HB3' HD12 ' A' ' 16' ' ' ILE . 19.7 Cg_endo -61.22 102.34 0.21 Allowed 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.784 2.323 . . . . 72.11 112.975 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 60.3 t -118.86 110.08 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 108.742 -0.836 . . . . 71.45 108.742 173.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -96.1 106.39 18.56 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.057 -1.09 . . . . 73.23 108.057 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -53.87 -41.9 68.02 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.348 0.659 . . . . 74.24 112.494 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 10.6 t70 . . . . . 0 CA--C 1.547 0.845 0 C-N-CA 124.093 0.957 . . . . 74.44 111.229 176.991 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 C--O 1.238 0.489 0 CA-C-O 120.996 0.427 . . . . 73.45 110.603 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -147.27 119.06 8.06 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.83 -1.174 . . . . 71.21 107.83 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 12' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' D' ' 85' ' ' SER . 44.6 mt-30 -132.08 133.69 44.64 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.438 -0.949 . . . . 65.41 108.438 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.595 HG21 HD11 ' D' ' 16' ' ' ILE . 21.8 mt -84.68 129.31 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 108.51 -0.922 . . . . 63.03 108.51 173.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -97.36 -46.18 6.19 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 122.586 0.354 . . . . 74.41 111.226 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -170.15 128.87 0.89 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.6 0.593 . . . . 50.03 112.6 -173.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.595 HD11 HG21 ' D' ' 13' ' ' ILE . 2.0 mp -107.57 137.92 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.445 -1.317 . . . . 43.45 107.445 174.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -163.46 163.73 24.73 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 122.277 1.037 . . . . 74.11 110.956 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -93.8 120.89 34.66 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.629 -1.623 . . . . 72.12 108.419 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -85.3 -42.59 14.48 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.869 -1.16 . . . . 74.43 107.869 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' D' ' 79' ' ' GLN . 20.0 m-20 -136.21 144.79 45.08 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 114.755 -1.111 . . . . 74.23 110.217 176.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.625 HG21 ' HE2' ' C' ' 117' ' ' MET . 56.6 mt -140.73 149.65 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.355 1.462 . . . . 65.22 107.367 174.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.1 t -156.49 142.45 18.0 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.021 0.439 . . . . 74.25 110.849 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.1 t80 -147.63 111.59 5.11 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 106.176 -1.787 . . . . 72.15 106.176 173.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 23.8 mt-10 -123.04 108.23 12.68 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.011 -0.737 . . . . 73.14 109.011 -173.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.558 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -106.44 89.06 3.72 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 123.594 0.758 . . . . 35.14 109.076 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -80.0 -28.13 3.38 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.766 2.311 . . . . 73.11 113.209 -169.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -110.05 6.29 22.84 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.466 0.706 . . . . 62.52 110.627 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.637 ' HB3' ' HE2' ' C' ' 19' ' ' LYS . . . -29.58 -66.89 0.14 Allowed Pre-proline 0 CA--C 1.566 1.588 0 N-CA-C 116.904 2.187 . . . . 50.5 116.904 -165.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.67 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 64.6 Cg_endo -74.64 -14.57 22.04 Favored 'Trans proline' 0 C--N 1.383 2.381 0 CA-C-N 123.38 2.243 . . . . 61.25 112.847 -172.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -84.4 -39.3 19.19 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.048 1.339 . . . . 73.51 110.318 172.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.665 HG22 HD12 ' D' ' 68' ' ' LEU . 5.6 p -82.48 -22.9 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-N 116.436 -0.347 . . . . 65.4 110.98 -170.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -61.67 -24.05 66.48 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.036 0.534 . . . . 64.33 112.251 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -57.6 -30.09 65.02 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.434 1.094 . . . . 75.14 110.861 175.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -84.33 71.98 10.61 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.514 -1.221 . . . . 70.12 109.502 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.72 81.55 5.97 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.215 -0.902 . . . . 50.42 110.67 -173.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 21.6 p90 -155.75 179.18 9.44 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.833 0.853 . . . . 72.0 109.485 172.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -68.84 116.26 39.43 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.868 0.867 . . . . 63.3 110.609 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.522 ' HD3' ' HG2' ' D' ' 124' ' ' PRO . 50.9 Cg_exo -56.79 131.97 48.86 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.652 2.235 . . . . 74.12 112.379 176.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.29 111.15 3.84 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.755 -1.202 . . . . 75.24 107.755 172.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' D' ' 66' ' ' ALA . 27.7 m -108.19 137.68 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.42 0.629 . . . . 73.03 110.609 -172.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -123.76 128.21 49.23 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.115 -1.439 . . . . 72.52 107.115 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' D' ' 63' ' ' THR . 7.8 mp -96.84 138.5 34.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.195 0.521 . . . . 72.31 110.653 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -128.01 115.87 19.16 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.331 -1.359 . . . . 74.52 107.331 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 mp -104.47 138.2 41.21 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.356 0.662 . . . . 70.04 110.28 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.632 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.9 t70 -133.7 145.05 49.54 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.089 -1.078 . . . . 73.34 108.089 177.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.5 t -105.97 158.13 17.01 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.859 0.464 . . . . 75.02 111.298 -175.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.458 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -167.66 153.11 7.2 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.935 1.294 . . . . 71.55 108.847 173.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 76.9 p -154.0 156.71 37.9 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.555 0.742 . . . . 63.41 109.813 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 15.3 m -147.6 123.92 10.92 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.357 -0.979 . . . . 73.41 108.357 -174.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -78.46 115.39 18.13 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.789 -1.189 . . . . 73.55 107.789 167.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.529 HD12 HG23 ' D' ' 83' ' ' ILE . 26.3 mt -95.44 -27.89 15.19 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.064 -0.717 . . . . 71.13 109.064 177.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.16 -178.64 6.12 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.042 0.937 . . . . 45.35 110.132 172.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -65.67 123.7 20.43 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.549 -0.75 . . . . 72.33 109.816 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 60.45 20.37 10.06 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.25 1.02 . . . . 63.23 112.475 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.3 t -125.08 118.11 52.0 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 C-N-CA 124.205 1.002 . . . . 53.54 108.511 174.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -134.69 131.26 37.48 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.466 0.707 . . . . 62.41 109.849 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.412 ' HB2' HD11 ' D' ' 51' ' ' LEU . 31.5 tt0 -87.38 128.57 35.2 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.812 -1.086 . . . . 63.42 108.274 166.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 43.2 t -110.0 125.42 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 107.789 -1.189 . . . . 61.21 107.789 173.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 16.5 t -118.69 125.67 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.883 -0.784 . . . . 71.2 108.883 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 6.9 mp -121.8 127.46 50.62 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.545 -0.909 . . . . 72.4 108.545 171.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.632 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 18.9 ttm-85 -83.94 103.66 13.38 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.601 1.16 . . . . 74.53 108.903 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 87.0 t -90.94 115.49 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 108.501 -0.925 . . . . 43.11 108.501 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' D' ' 42' ' ' LEU . 18.7 m -125.82 128.29 47.43 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.064 0.459 . . . . 61.14 109.778 -172.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 42.7 t -118.76 101.01 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 125.541 1.537 . . . . 71.42 108.475 -175.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 32.2 m -92.46 95.23 9.53 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.023 -1.103 . . . . 74.41 108.023 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.511 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -102.66 138.64 39.29 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 115.459 -0.791 . . . . 42.4 111.113 -173.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.431 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 47.6 m -146.78 134.4 21.01 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 122.786 0.434 . . . . 60.31 110.989 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.665 HD12 HG22 ' D' ' 31' ' ' VAL . 66.2 mt -94.89 102.24 14.08 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.883 -1.154 . . . . 73.33 107.883 171.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.6 -113.82 3.83 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 116.12 -0.491 . . . . 51.14 112.363 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.73 3.66 11.11 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.108 0.563 . . . . 73.04 110.24 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -116.0 155.08 28.72 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.685 -0.857 . . . . 64.43 108.685 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 35.0 m -70.01 136.43 50.39 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 123.395 0.435 . . . . 73.23 111.293 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.452 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -89.29 -62.77 1.4 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.705 -1.22 . . . . 43.53 107.705 172.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 74' ' ' PHE . . . . . 0.414 ' HE2' ' HG2' ' D' ' 38' ' ' PRO . 52.6 p90 -158.44 154.85 27.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.558 -1.201 . . . . 61.24 110.311 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 91.5 mt -120.56 112.75 19.31 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.58 1.152 . . . . 63.45 108.002 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.529 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 2.5 m -114.25 140.14 48.83 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.299 1.039 . . . . 72.1 108.918 -174.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -153.92 119.36 5.17 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.295 -1.002 . . . . 74.01 108.295 174.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 78' ' ' VAL . . . . . 0.462 HG22 HG23 ' D' ' 21' ' ' ILE . 60.3 t -124.5 115.13 43.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.487 -0.931 . . . . 73.15 108.487 174.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.577 ' HB2' ' HB2' ' D' ' 20' ' ' ASP . 51.1 mt-30 -88.13 85.37 6.94 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.92 -1.141 . . . . 65.45 107.92 171.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -80.66 104.03 10.91 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 114.132 -1.394 . . . . 62.22 108.467 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.64 141.74 15.42 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.421 -0.672 . . . . 23.22 111.421 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.507 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -137.11 131.93 5.78 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 111.472 -0.651 . . . . 64.03 111.472 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.529 HG23 HD12 ' D' ' 51' ' ' LEU . 50.8 mt -88.02 124.17 41.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.228 -1.027 . . . . 70.13 108.228 175.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -129.59 157.88 40.83 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.684 0.794 . . . . 73.02 110.071 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.408 ' HB3' ' HB2' ' D' ' 12' ' ' GLN . 43.4 t -115.56 98.88 6.97 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.986 1.314 . . . . 73.24 107.779 -178.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.9 111.55 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.532 0.733 . . . . 71.11 109.443 -176.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -131.87 149.76 52.35 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.932 0.493 . . . . 73.55 110.457 177.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.52 19.75 63.41 Favored Glycine 0 C--N 1.346 1.104 0 O-C-N 123.788 0.68 . . . . 64.11 114.426 172.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 10.2 mt -112.65 154.16 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 117.226 0.513 . . . . 64.01 109.996 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.422 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 0.0 OUTLIER -147.82 -174.35 4.53 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 125.085 1.354 . . . . 74.14 110.7 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.01 -138.03 39.01 Favored Glycine 0 C--N 1.353 1.485 0 CA-C-N 115.948 -0.569 . . . . 41.33 113.622 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 28.1 p -90.05 -13.74 35.33 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.793 0.837 . . . . 74.1 111.017 174.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -31.0 72.03 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.351 1.06 . . . . 75.0 110.09 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.422 ' SD ' ' HA ' ' D' ' 90' ' ' GLU . 8.0 ptm -74.52 -21.18 59.67 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.389 0.676 . . . . 73.23 112.124 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.83 -36.13 50.46 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.704 -0.48 . . . . 71.23 109.704 169.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -64.52 -37.28 87.02 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.306 0.642 . . . . 72.4 111.31 175.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 35.9 t -59.97 -49.57 77.17 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.011 -0.54 . . . . 64.15 110.491 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 43.7 mt -85.96 -21.7 27.75 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.246 -0.888 . . . . 75.2 111.557 -175.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.23 5.09 45.04 Favored Glycine 0 N--CA 1.476 1.363 0 N-CA-C 114.551 0.58 . . . . 61.43 114.551 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.05 -68.14 0.2 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.534 0.334 . . . . 63.31 110.855 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -65.13 -52.29 56.13 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 112.654 0.613 . . . . 73.45 112.654 -170.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 71.8 m -61.36 -50.17 84.47 Favored Pre-proline 0 CA--C 1.563 1.444 0 CA-C-O 118.76 -0.638 . . . . 70.23 112.218 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.29 -21.44 35.69 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 121.825 1.684 . . . . 72.42 113.421 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -68.74 -27.38 65.87 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 122.911 0.484 . . . . 72.42 110.528 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.432 HD13 HD11 ' D' ' 13' ' ' ILE . 58.5 mt -72.16 -28.43 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 C-N-CA 124.082 0.953 . . . . 70.11 110.441 171.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.507 HD21 ' HA3' ' D' ' 82' ' ' GLY . 94.2 mt -86.28 -22.94 26.53 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.702 0.801 . . . . 72.21 112.563 -176.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -66.9 -35.28 8.86 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.346 1.239 . . . . 75.32 114.346 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.91 -45.28 37.02 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 121.995 1.797 . . . . 75.53 112.939 166.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -74.51 -33.77 62.87 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.748 0.819 . . . . 73.44 111.884 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.41 -53.04 58.51 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.157 0.583 . . . . 41.24 109.889 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -53.77 -51.63 62.81 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-N 114.328 -1.305 . . . . 65.14 110.829 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -62.2 -44.81 95.75 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.274 0.984 . . . . 55.25 111.53 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 36.8 t -58.58 -40.63 83.72 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 123.814 0.696 . . . . 71.3 110.651 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.473 ' O ' HG23 ' D' ' 118' ' ' VAL . 76.7 mt -68.06 -48.79 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.809 0.843 . . . . 64.41 110.381 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.408 HG23 ' HG3' ' D' ' 125' ' ' GLN . 56.5 m -58.2 -42.45 86.18 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.438 1.095 . . . . 74.33 111.519 -175.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 32.8 t -66.5 -42.81 86.82 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.089 -0.96 . . . . 74.05 110.168 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.407 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 73.8 mtm -64.75 -37.57 88.05 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.946 0.498 . . . . 62.24 111.767 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.473 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.1 t -65.96 -41.7 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.063 0.945 . . . . 73.43 110.842 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.8 p -73.31 -31.36 63.96 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 116.009 -0.541 . . . . 73.3 110.952 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' D' ' 116' ' ' SER . 72.9 mtt-85 -70.19 -33.15 71.36 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.436 0.694 . . . . 73.34 110.176 175.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.48 7.63 78.2 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-N 115.919 -0.582 . . . . 50.42 112.516 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.0 p 59.58 24.12 12.87 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 126.683 1.993 . . . . 65.12 114.073 173.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.433 ' HB2' HG13 ' D' ' 118' ' ' VAL . 97.0 m-85 -83.95 156.37 64.06 Favored Pre-proline 0 N--CA 1.479 0.983 0 N-CA-C 108.908 -0.775 . . . . 64.42 108.908 167.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.522 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 18.5 Cg_endo -60.83 139.69 86.54 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.166 1.911 . . . . 74.25 111.771 176.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.408 ' HG3' HG23 ' D' ' 115' ' ' THR . 33.0 tt0 -55.28 142.48 31.57 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.755 1.222 . . . . 64.04 112.469 -174.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 45.9 tp -127.91 98.65 5.23 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.658 0.783 . . . . 73.13 109.352 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.23 107.4 18.21 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.442 0.697 . . . . 72.01 109.333 175.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 7.4 mp -63.79 117.95 7.64 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.086 0.954 . . . . 71.32 109.789 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.79 145.05 98.95 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.478 0.711 . . . . 52.43 111.115 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.471 ' HD3' HG13 ' B' ' 13' ' ' ILE . 73.9 Cg_exo -54.53 129.23 33.77 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.824 3.016 . . . . 61.31 113.4 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.474 0.754 0 C-N-CA 123.467 0.707 . . . . 74.24 110.069 177.738 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.685 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 4.3 t80 . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 109.841 -0.429 . . . . 72.14 109.841 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.5 tp60 -150.16 127.33 11.29 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.812 -1.181 . . . . 71.32 107.812 172.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.577 HG12 ' HD2' ' A' ' 84' ' ' PHE . 48.6 mt -94.32 126.37 46.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.827 -0.805 . . . . 73.52 108.827 176.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -77.38 -39.75 46.15 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.675 -0.491 . . . . 73.0 109.675 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -169.16 145.55 3.42 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 116.365 -0.38 . . . . 73.4 110.332 -168.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 78.1 mt -137.46 136.91 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.021 -1.103 . . . . 60.34 108.021 170.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.467 ' HB3' HG23 ' B' ' 122' ' ' THR . 39.7 p90 -167.84 176.49 6.24 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.808 0.843 . . . . 72.31 110.973 -172.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.9 p -102.74 126.78 49.98 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.307 -0.86 . . . . 54.41 108.984 177.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -90.71 -40.37 11.89 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.885 0.474 . . . . 65.1 110.122 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -141.2 139.2 33.79 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.224 -1.028 . . . . 61.43 108.224 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.432 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 63.8 mt -134.52 140.32 46.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.786 -1.19 . . . . 72.24 107.786 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.531 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 42.7 t -144.43 125.83 14.85 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.363 1.065 . . . . 72.31 108.134 177.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.497 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 85.7 t80 -135.99 115.04 12.3 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 106.667 -1.605 . . . . 65.54 106.667 170.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -120.09 126.05 49.8 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.777 -0.823 . . . . 74.52 108.777 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.47 81.61 4.21 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 107.162 -1.421 . . . . 64.1 107.162 172.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.15 -41.02 46.16 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.988 2.458 . . . . 74.42 113.415 -164.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -114.87 33.07 5.6 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 109.243 -0.651 . . . . 74.21 109.243 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.5 -49.33 34.78 Favored Pre-proline 0 N--CA 1.5 2.059 0 N-CA-C 114.464 1.283 . . . . 51.14 114.464 -177.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -64.12 -20.89 67.86 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.197 1.931 . . . . 55.53 114.088 177.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -101.37 -23.46 14.36 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.728 1.211 . . . . 65.33 111.634 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.573 HG21 ' HA ' ' A' ' 73' ' ' ALA . 2.4 p -78.74 -24.27 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.342 0.657 . . . . 73.14 112.363 -165.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -79.69 -18.63 50.86 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.549 0.74 . . . . 53.22 112.474 -172.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -88.24 -11.63 46.04 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.473 0.709 . . . . 72.42 111.0 173.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -82.21 161.85 22.59 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.644 0.778 . . . . 64.45 111.823 -174.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -72.75 120.49 18.45 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.221 -0.9 . . . . 73.44 109.755 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -76.34 86.03 3.12 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.378 0.608 . . . . 72.13 109.925 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -128.66 73.35 80.94 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 124.559 1.144 . . . . 52.54 107.996 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -86.84 138.44 5.1 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.849 2.366 . . . . 64.04 113.628 -170.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -102.03 86.2 2.83 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 106.988 -1.486 . . . . 75.52 106.988 169.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.1 m -72.8 90.73 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 123.062 1.41 . . . . 75.02 109.611 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -91.97 116.3 28.81 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 112.87 -1.968 . . . . 74.52 108.206 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.525 HD11 HG13 ' A' ' 62' ' ' VAL . 52.2 tp -104.87 129.52 53.2 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.475 0.71 . . . . 75.21 111.444 -170.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -120.73 126.33 49.9 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.348 1.059 . . . . 73.41 108.925 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.1 mt -114.67 133.87 55.52 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.739 0.816 . . . . 71.24 110.306 -173.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.604 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 18.5 t70 -127.05 138.97 53.31 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.819 0.848 . . . . 75.24 110.338 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.3 p -107.78 121.57 44.99 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.752 0.821 . . . . 63.24 110.222 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.97 128.91 25.05 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.696 0.798 . . . . 73.42 109.466 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.3 p -131.94 164.82 25.3 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.56 0.618 . . . . 60.23 110.432 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -156.96 138.96 14.44 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.616 0.766 . . . . 71.1 109.754 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -93.41 118.76 31.71 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.045 -1.094 . . . . 74.24 108.045 169.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' A' ' 57' ' ' GLU . 43.7 mt -90.95 -38.88 12.58 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.945 0.498 . . . . 63.13 110.528 -176.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.16 -176.77 6.1 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.88 0.872 . . . . 62.11 109.951 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -69.2 115.39 8.43 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.166 0.586 . . . . 52.05 109.669 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 75.94 -6.05 2.06 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 125.734 1.613 . . . . 73.15 112.469 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.9 t -100.51 112.96 34.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 108.127 -1.064 . . . . 62.23 108.127 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -136.17 127.52 28.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.367 -0.605 . . . . 73.01 109.367 -174.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.449 ' HB2' HD11 ' A' ' 51' ' ' LEU . 36.3 tt0 -97.76 142.42 29.57 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.242 1.017 . . . . 74.51 111.159 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.43 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 56.0 t -125.59 132.47 70.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 106.767 -1.568 . . . . 60.44 106.767 173.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 62.0 t -128.11 129.48 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.32 1.048 . . . . 74.12 108.936 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -119.66 110.48 16.88 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.924 -1.139 . . . . 72.31 107.924 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.604 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 8.4 tmm_? -87.56 104.43 16.49 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.638 -0.875 . . . . 54.15 108.638 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.525 HG13 HD11 ' A' ' 42' ' ' LEU . 59.2 t -100.04 108.54 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.753 1.221 . . . . 74.43 109.195 -177.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.3 m -104.04 110.78 23.07 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.611 0.764 . . . . 63.51 110.539 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.3 t -105.08 108.89 26.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 124.157 0.983 . . . . 73.52 109.659 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.3 m -103.83 127.63 51.32 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.909 -0.774 . . . . 55.21 108.909 171.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.53 115.33 29.96 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.04 -1.096 . . . . 64.35 108.04 175.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.6 m -118.44 126.35 51.88 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.084 0.469 . . . . 72.53 110.811 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.7 mt -89.51 76.64 7.39 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 107.832 -1.173 . . . . 53.41 107.832 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.34 -83.65 0.98 Allowed Glycine 0 C--N 1.351 1.368 0 N-CA-C 111.145 -0.782 . . . . 60.33 111.145 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -119.53 -26.58 5.73 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.695 0.798 . . . . 74.15 111.161 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -88.96 110.76 21.39 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.963 0.505 . . . . 74.03 110.277 -174.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.9 m -64.23 122.59 17.0 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.917 0.389 . . . . 72.53 110.667 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.573 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -70.89 -59.86 2.56 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.028 -0.987 . . . . 65.44 110.157 175.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -153.17 174.03 14.76 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.185 -0.916 . . . . 72.13 111.658 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 64.2 tp -133.69 141.13 47.44 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.134 -1.432 . . . . 73.03 107.134 173.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 73.9 m -137.86 93.89 2.83 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.542 -0.91 . . . . 43.12 108.542 172.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 45.3 tt0 -113.1 116.26 29.59 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.696 -0.853 . . . . 73.12 108.696 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 t -135.39 115.92 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.459 0.703 . . . . 74.32 110.205 -170.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -81.98 94.2 7.1 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.071 -1.085 . . . . 70.12 108.071 169.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -82.17 99.45 9.26 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.69 -0.856 . . . . 74.04 108.69 176.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.19 146.26 20.21 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 111.192 -0.763 . . . . 53.43 111.192 176.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.22 120.81 1.14 Allowed Glycine 0 CA--C 1.5 -0.845 0 N-CA-C 110.247 -1.141 . . . . 74.24 110.247 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 21.7 mt -85.36 114.47 25.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.03 -0.73 . . . . 73.21 109.03 177.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.685 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 23.3 m-85 -119.37 119.57 34.35 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.401 -0.963 . . . . 63.33 108.401 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.4 p -86.03 101.45 12.94 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.775 -0.824 . . . . 64.11 108.775 174.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.423 ' H ' HD13 ' A' ' 86' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 C-N-CA 123.392 0.677 . . . . 73.51 110.627 -174.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.811 0.338 . . . . 64.05 111.106 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -67.39 -42.37 83.47 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.693 -0.685 . . . . 75.34 110.091 172.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.648 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 81.6 m -62.71 -55.71 24.24 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 123.918 0.761 . . . . 64.14 111.379 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -73.09 -36.36 66.78 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.338 0.655 . . . . 73.11 111.316 -174.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.69 -16.62 58.1 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 114.764 0.665 . . . . 61.44 114.764 -168.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.74 -54.83 0.19 Allowed 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 117.655 0.728 . . . . 74.02 112.834 -171.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.648 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 79.3 t80 -63.64 -53.19 55.26 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.319 1.047 . . . . 65.04 112.896 -169.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.5 m -72.1 -37.41 4.85 Favored Pre-proline 0 CA--C 1.563 1.453 0 C-N-CA 123.591 0.757 . . . . 74.33 112.678 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.79 -40.48 47.88 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 122.441 2.094 . . . . 70.41 113.588 160.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -70.81 -24.1 62.49 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.87 0.868 . . . . 74.11 111.527 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 51.0 mm -69.6 -36.94 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 109.387 -0.598 . . . . 72.34 109.387 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 83.3 mt -79.58 -23.68 42.57 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.752 0.821 . . . . 75.53 112.445 -177.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -58.72 -49.23 94.54 Favored Pre-proline 0 CA--C 1.571 1.764 0 N-CA-C 113.651 0.982 . . . . 72.45 113.651 -176.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -63.68 -35.74 56.37 Favored 'Trans proline' 0 C--N 1.389 2.672 0 C-N-CA 122.159 1.906 . . . . 73.51 113.484 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -75.56 -35.67 60.6 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.579 0.752 . . . . 73.14 111.937 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.8 -44.83 65.79 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.376 -0.602 . . . . 70.44 109.376 175.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.583 HH12 HD12 ' C' ' 105' ' ' ILE . 17.9 ttm180 -59.5 -33.97 72.02 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.146 0.904 . . . . 75.4 110.165 173.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -66.3 -50.53 63.34 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.864 0.866 . . . . 50.24 110.836 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 36.8 t -61.45 -37.02 82.04 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.744 0.653 . . . . 71.32 110.552 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 118' ' ' VAL . 93.5 mt -62.22 -57.28 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.774 0.83 . . . . 63.54 110.021 172.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.8 m -52.28 -39.66 60.74 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.253 1.421 . . . . 63.54 111.908 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -69.98 -51.42 32.66 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.884 -1.053 . . . . 74.21 110.392 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.435 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 36.7 mtm -64.64 -36.69 85.06 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.93 0.492 . . . . 72.22 111.918 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 114' ' ' ILE . 79.2 t -61.1 -44.94 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.506 0.722 . . . . 71.44 110.227 176.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.9 t -70.47 -34.67 72.66 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.477 -0.783 . . . . 61.42 111.454 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.535 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 93.7 mtt-85 -70.58 -32.56 69.99 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.889 0.876 . . . . 54.34 109.695 176.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.95 1.64 83.66 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-O 119.065 -0.853 . . . . 63.53 112.992 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.493 HG22 HH21 ' B' ' 15' ' ' ARG . 22.5 m 73.71 12.53 4.48 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 122.446 1.117 . . . . 71.13 111.866 173.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -84.13 148.2 52.73 Favored Pre-proline 0 CA--C 1.544 0.736 0 O-C-N 121.369 -0.832 . . . . 71.24 109.591 172.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.1 142.21 96.85 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.533 2.155 . . . . 64.15 110.91 172.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -57.27 145.2 32.74 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 124.281 0.988 . . . . 71.11 113.016 -168.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.5 tp -127.99 114.91 17.73 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.871 0.868 . . . . 60.24 109.41 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -119.69 117.65 28.83 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.534 -0.913 . . . . 74.12 108.534 175.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.9 mp -72.49 146.07 47.11 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.147 0.579 . . . . 71.22 110.232 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -62.34 136.37 95.65 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.874 0.87 . . . . 72.22 112.15 -174.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 22.5 Cg_exo -67.83 89.45 0.36 Allowed 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.941 2.427 . . . . 70.04 112.265 175.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 87.1 t -107.31 112.03 38.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.595 -0.891 . . . . 73.41 108.595 176.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -85.32 96.75 9.63 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 107.688 -1.227 . . . . 72.42 107.688 170.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 . . . . . 0 N--CA 1.479 0.993 0 O-C-N 124.059 0.85 . . . . 74.34 111.002 -179.493 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 19.6 ptm . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 113.63 0.974 . . . . 70.03 113.63 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 99.9 m -134.79 140.05 45.59 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.831 1.252 . . . . 63.21 107.84 174.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.451 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 46.0 t80 -142.22 132.89 25.44 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.053 -0.721 . . . . 71.43 109.053 172.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -153.44 121.11 5.96 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.45 -0.945 . . . . 72.44 108.45 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 54.7 mt -68.75 120.07 15.62 Favored 'Isoleucine or valine' 0 C--N 1.348 0.528 0 N-CA-C 108.186 -1.042 . . . . 72.31 108.186 170.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -89.07 -49.84 6.52 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.711 -0.848 . . . . 72.22 108.711 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.493 HH21 HG22 ' A' ' 122' ' ' THR . 34.2 ttt85 -168.74 137.03 2.1 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.55 -0.75 . . . . 71.05 109.636 -175.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 87.1 mt -115.36 142.19 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 108.341 -0.985 . . . . 61.32 108.341 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -168.13 148.98 5.01 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 112.622 0.601 . . . . 75.11 112.622 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.579 HG21 HD11 ' B' ' 21' ' ' ILE . 39.5 m -79.69 114.14 18.39 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.268 -0.878 . . . . 63.04 108.912 172.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -84.09 -25.89 29.41 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.099 0.56 . . . . 72.35 111.375 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 16.2 t70 -163.43 149.06 11.41 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.367 0.603 . . . . 65.12 112.052 -175.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.579 HD11 HG21 ' B' ' 18' ' ' THR . 46.4 mm -137.15 142.85 36.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 126.018 1.727 . . . . 70.4 107.742 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 42.5 t -146.17 137.15 24.43 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.249 -1.019 . . . . 72.41 108.249 168.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.432 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 91.2 t80 -141.15 131.86 25.69 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.301 -1.37 . . . . 62.4 107.301 172.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 34.4 mt-10 -131.66 126.84 35.65 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.798 -1.186 . . . . 73.11 107.798 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.696 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -127.98 81.19 70.84 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 107.146 -1.428 . . . . 53.12 107.146 170.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.46 -30.53 35.94 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.884 2.389 . . . . 33.32 111.33 -177.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -103.96 2.58 32.55 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.281 -1.327 . . . . 74.45 110.86 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.696 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -32.05 -66.76 0.19 Allowed Pre-proline 0 N--CA 1.499 1.997 0 C-N-CA 126.032 1.733 . . . . 72.32 115.096 -172.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 21.7 Cg_exo -62.55 -31.05 80.12 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.899 2.399 . . . . 61.33 113.669 -164.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -96.22 -41.51 8.65 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.426 -0.807 . . . . 72.32 111.158 -174.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.17 -12.71 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 113.074 0.768 . . . . 53.14 113.074 -170.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -62.89 -18.24 62.73 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.485 0.714 . . . . 73.31 112.641 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.502 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 10.6 pt20 -55.15 -29.92 58.76 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.453 1.101 . . . . 55.44 111.499 173.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.502 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 96.5 mttt -92.38 95.31 9.59 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.7 1.2 . . . . 75.51 109.202 177.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -97.95 76.65 2.43 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 122.009 0.909 . . . . 71.22 111.494 -172.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 43.0 p90 -157.51 161.13 38.82 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.61 -0.885 . . . . 70.33 108.61 171.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -68.16 116.42 38.98 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 109.062 -0.718 . . . . 74.45 109.062 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.97 159.33 54.37 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.162 1.908 . . . . 64.43 112.656 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -64.63 113.13 3.53 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 109.195 -0.669 . . . . 72.5 109.195 174.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.23 121.64 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.881 0.848 . . . . 74.54 109.79 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.538 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 37.6 ttpt -107.04 100.55 10.03 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.578 -1.638 . . . . 63.21 106.578 175.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 pp -110.24 140.58 44.24 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.735 0.814 . . . . 61.45 110.174 -169.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -136.06 129.93 32.68 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.173 0.989 . . . . 63.32 108.915 -174.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -100.78 127.39 47.23 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.802 -1.184 . . . . 62.45 107.802 170.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.477 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 24.1 t70 -126.92 155.11 43.58 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.197 0.999 . . . . 72.22 108.731 -175.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 79.2 p -107.63 120.11 41.29 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.706 -0.679 . . . . 61.34 110.685 -172.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.79 131.18 44.52 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 107.174 -1.417 . . . . 45.34 107.174 172.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 10.7 p -145.91 168.29 21.19 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.699 0.681 . . . . 64.12 111.457 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p -152.19 138.33 18.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.115 0.966 . . . . 75.4 108.521 171.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -93.82 114.0 26.16 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.133 -0.691 . . . . 61.22 109.133 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 51.6 mt -77.58 -43.2 32.51 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.867 0.467 . . . . 63.24 110.157 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.7 -179.24 7.69 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.579 0.752 . . . . 60.35 110.501 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.11 124.38 21.97 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.301 -1.318 . . . . 70.02 109.02 172.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 70.85 6.77 5.98 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.889 1.276 . . . . 74.22 112.282 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 78.0 t -119.85 111.54 33.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.7 0 N-CA-C 107.698 -1.223 . . . . 65.31 107.698 170.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -122.13 139.84 53.26 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.54 -0.541 . . . . 70.21 109.54 -177.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.444 ' HG2' HG12 ' B' ' 83' ' ' ILE . 6.6 tm-20 -111.35 101.13 9.61 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 107.489 -1.3 . . . . 71.24 107.489 -176.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 63.4 t -96.5 119.6 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.491 1.117 . . . . 62.11 109.601 -173.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.493 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 10.6 t -114.05 123.93 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.826 0.85 . . . . 75.42 108.711 178.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.488 HD22 ' HB3' ' B' ' 103' ' ' PRO . 15.6 tp -103.93 116.26 31.94 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.094 -0.706 . . . . 65.22 109.094 171.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.477 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 41.2 ttm180 -86.04 109.73 19.01 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.438 -0.949 . . . . 73.24 108.438 174.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 46.9 t -101.6 101.26 11.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.34 -1.355 . . . . 64.14 107.34 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.6 m -97.99 128.55 44.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.505 -0.77 . . . . 70.43 109.094 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.653 HG21 HG21 ' B' ' 114' ' ' ILE . 67.5 t -121.57 131.68 72.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 124.578 1.151 . . . . 73.52 108.184 -174.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 60.3 m -120.88 145.46 47.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.873 -1.158 . . . . 74.25 107.873 171.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.52 126.34 12.68 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.643 -0.873 . . . . 74.23 108.643 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 30.8 p -133.63 128.39 35.02 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.966 0.506 . . . . 65.54 110.114 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 70.4 mt -100.79 107.06 18.52 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.014 0.926 . . . . 63.33 108.804 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.16 -129.9 10.0 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 115.877 -0.601 . . . . 70.33 112.497 -176.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -92.4 1.21 57.37 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.647 0.779 . . . . 60.35 110.766 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -121.63 162.25 21.02 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.298 0.639 . . . . 75.02 110.444 -175.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 25.9 m -71.2 145.46 49.65 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.654 0.596 . . . . 73.01 109.787 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.8 -60.2 1.57 Allowed 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.296 -1.002 . . . . 71.34 108.296 168.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -153.04 164.52 37.85 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.001 0.905 . . . . 74.3 111.255 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.529 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 31.3 mt -134.48 142.8 47.18 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 105.427 -2.064 . . . . 70.04 105.427 178.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.3 t -154.8 116.42 4.11 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.601 0.637 . . . . 71.55 109.888 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -121.33 122.86 40.79 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 107.883 -1.155 . . . . 62.24 107.883 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.2 141.76 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.73 0.812 . . . . 74.3 108.959 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.5 mt-30 -118.63 94.54 4.5 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.697 -1.223 . . . . 73.51 107.697 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -90.31 103.93 16.56 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.988 -0.745 . . . . 75.32 108.988 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.46 161.98 29.04 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 123.798 0.686 . . . . 72.1 112.101 177.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.05 125.03 1.34 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.835 -1.306 . . . . 70.24 109.835 177.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.444 HG12 ' HG2' ' B' ' 57' ' ' GLU . 28.3 mt -85.05 130.22 36.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 107.854 -1.165 . . . . 74.04 107.854 175.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -136.6 133.6 36.49 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.037 -1.098 . . . . 74.41 108.037 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 40.3 m -87.25 92.36 9.04 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.452 -0.944 . . . . 71.14 108.452 170.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -107.43 130.3 59.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-N 114.907 -1.042 . . . . 71.55 108.492 176.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.66 168.73 18.16 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.622 0.769 . . . . 74.52 109.997 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.66 -63.44 4.28 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.079 -0.964 . . . . 73.54 112.903 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.56 HG23 ' HB2' ' B' ' 93' ' ' GLN . 43.4 mm -58.83 149.1 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 N-CA-C 114.757 1.392 . . . . 65.12 114.757 -165.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -159.99 -175.76 5.29 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 125.348 1.459 . . . . 61.12 109.548 171.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.01 -111.59 3.93 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 115.423 0.929 . . . . 35.25 115.423 166.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 51.2 m -81.54 -39.03 25.27 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.706 0.802 . . . . 74.44 111.125 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.56 ' HB2' HG23 ' B' ' 89' ' ' ILE . 51.0 mt-30 -66.4 -25.19 66.66 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.306 0.642 . . . . 71.3 112.219 -169.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 22.3 ptm -67.61 -27.54 66.99 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.223 0.609 . . . . 63.31 112.107 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.64 -33.18 69.78 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.796 0.838 . . . . 64.25 110.73 175.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -84.33 -49.24 8.91 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.295 -0.866 . . . . 72.24 109.811 171.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.8 t -58.51 -65.91 0.58 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.974 0.731 . . . . 70.24 112.974 -167.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.8 -2.32 26.53 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 111.727 0.269 . . . . 53.45 111.727 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.04 -17.39 37.74 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 123.197 0.311 . . . . 42.22 113.527 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.59 -55.07 0.89 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.579 0.752 . . . . 74.3 110.574 -176.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -73.51 -53.07 11.48 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.359 1.064 . . . . 71.21 112.244 -166.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.452 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 64.3 m -63.77 -46.72 82.32 Favored Pre-proline 0 CA--C 1.56 1.35 0 CA-C-O 118.864 -0.589 . . . . 55.2 111.626 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.488 ' HB3' HD22 ' B' ' 60' ' ' LEU . 31.2 Cg_exo -64.23 -28.33 64.23 Favored 'Trans proline' 0 C--N 1.39 2.762 0 C-N-CA 122.003 1.802 . . . . 51.14 114.124 173.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.611 ' HA ' ' HD2' ' B' ' 107' ' ' PHE . 47.3 t-20 -57.94 -41.23 82.34 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 123.606 0.762 . . . . 71.13 110.412 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.448 HG23 ' NH2' ' D' ' 111' ' ' ARG . 96.8 mt -60.17 -42.49 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 114.415 -1.266 . . . . 71.32 110.888 175.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 56.7 mt -85.05 -15.43 44.08 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 115.21 -0.905 . . . . 62.32 112.277 -170.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.611 ' HD2' ' HA ' ' B' ' 104' ' ' ASN . 5.1 m-85 -54.46 -53.02 64.44 Favored Pre-proline 0 N--CA 1.495 1.776 0 C-N-CA 124.139 0.976 . . . . 71.04 113.592 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.16 -30.26 46.71 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 122.292 1.995 . . . . 74.41 113.849 -177.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -70.96 -44.45 66.02 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.832 0.453 . . . . 75.4 110.243 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.22 -41.24 98.21 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.963 -0.562 . . . . 62.51 110.248 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -59.59 -54.25 48.69 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.792 0.837 . . . . 74.22 110.164 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -61.73 -33.63 74.38 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 123.714 0.634 . . . . 72.13 110.289 -174.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.535 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 4.0 t -74.55 -48.23 28.07 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 116.062 -0.517 . . . . 71.32 111.452 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.653 HG21 HG21 ' B' ' 64' ' ' VAL . 98.6 mt -57.39 -56.07 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 C-N-CA 123.39 0.676 . . . . 54.34 109.867 174.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 33.0 m -59.25 -30.96 68.66 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 124.417 1.073 . . . . 75.23 111.06 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.4 t -63.64 -47.37 81.61 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 109.288 -0.634 . . . . 71.14 109.288 171.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.0 mmt -67.05 -30.79 70.96 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.089 0.556 . . . . 72.04 111.13 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.506 HG23 ' O ' ' B' ' 114' ' ' ILE . 84.8 t -65.97 -47.31 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.152 0.981 . . . . 74.32 109.171 173.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 71.2 m -66.31 -31.33 72.06 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 114.429 -1.26 . . . . 73.13 111.517 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.519 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 90.5 mtt-85 -73.95 -32.61 63.56 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 124.014 0.926 . . . . 74.41 109.655 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.47 6.33 69.31 Favored Glycine 0 C--N 1.353 1.491 0 O-C-N 124.196 0.935 . . . . 63.44 112.506 174.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.467 HG23 ' HB3' ' A' ' 17' ' ' TYR . 80.5 p 54.92 36.09 25.94 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 125.898 1.679 . . . . 73.13 112.653 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -95.6 157.78 35.54 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.138 0.975 . . . . 73.01 110.544 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -52.99 158.9 5.89 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.607 2.871 . . . . 63.34 115.036 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -64.03 115.07 4.57 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.705 -1.134 . . . . 73.15 111.77 -172.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 55.5 tp -125.35 112.14 15.98 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.366 0.666 . . . . 64.44 109.778 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -132.55 135.54 46.01 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.914 0.886 . . . . 73.44 108.89 176.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 8.0 mp -85.71 142.82 28.73 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.112 0.565 . . . . 73.54 111.622 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.99 132.91 49.43 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.064 0.946 . . . . 73.32 110.646 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.37 108.86 2.78 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 123.02 2.48 . . . . 74.52 112.754 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 98.3 t -93.62 111.6 25.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.639 -1.245 . . . . 74.5 107.639 167.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -74.36 91.33 2.2 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.458 0.703 . . . . 72.43 109.214 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -64.21 -41.12 97.19 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.417 -0.81 . . . . 74.34 110.726 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 N--CA 1.475 0.787 0 C-N-CA 124.205 1.002 . . . . 72.2 111.526 178.876 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.405 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.473 0.688 0 CA-C-O 120.622 0.249 . . . . 64.22 110.332 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -150.93 132.77 15.04 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.949 0.899 . . . . 74.14 108.912 168.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 90.4 mt -73.25 127.35 35.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.399 -0.963 . . . . 72.13 108.399 170.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -95.14 -44.08 7.81 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.626 0.77 . . . . 73.44 109.58 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -176.29 134.35 0.25 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.635 0.774 . . . . 73.1 109.464 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 59.4 mt -127.25 151.88 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 118.636 0.653 . . . . 62.25 109.335 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.465 ' HB3' HG23 ' D' ' 122' ' ' THR . 21.0 p90 -176.3 168.72 2.79 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.717 0.77 . . . . 72.3 110.978 -172.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 68.8 p -87.69 115.95 25.49 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.571 -1.195 . . . . 71.42 109.489 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.446 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 26.0 mmtp -65.54 -46.91 77.72 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.252 -1.018 . . . . 75.42 108.252 167.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 18.4 t70 -134.92 142.56 46.57 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 114.207 -1.36 . . . . 62.3 109.667 -174.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.524 HG12 ' SG ' ' C' ' 113' ' ' CYS . 89.0 mt -135.78 141.17 42.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 106.466 -1.679 . . . . 53.42 106.466 167.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.5 t -159.09 150.88 20.7 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.964 -0.384 . . . . 74.22 109.964 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -155.33 106.84 2.6 Favored 'General case' 0 C--O 1.226 -0.16 0 N-CA-C 107.913 -1.143 . . . . 74.33 107.913 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -117.93 111.4 18.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.524 0.73 . . . . 63.24 109.876 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.2 92.15 10.74 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 107.157 -1.423 . . . . 73.12 107.157 170.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.46 -35.58 38.49 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.657 2.238 . . . . 72.32 112.306 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -101.92 24.73 9.56 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.455 -0.793 . . . . 75.34 110.35 -175.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.96 -62.4 1.67 Allowed Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 114.714 1.376 . . . . 72.25 114.714 -167.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.53 -32.73 48.33 Favored 'Trans proline' 0 C--N 1.383 2.387 0 CA-C-N 121.834 1.691 . . . . 72.24 112.306 -174.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.583 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 72.7 t60 -70.84 -40.45 72.37 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.53 0.732 . . . . 74.41 112.012 177.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.773 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.2 p -77.8 -21.44 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 112.081 0.4 . . . . 64.31 112.081 -170.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -63.66 -29.7 70.9 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.44 0.904 . . . . 74.23 113.44 177.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 21.1 pt20 -84.78 5.76 27.21 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 122.727 0.411 . . . . 74.43 111.114 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.724 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -95.21 156.63 16.24 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.427 1.091 . . . . 74.21 110.408 -177.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -67.86 128.78 37.77 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.155 0.982 . . . . 71.13 110.061 169.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -86.07 100.62 12.3 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.331 0.652 . . . . 74.41 111.3 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -156.69 77.35 4.18 Favored Pre-proline 0 N--CA 1.474 0.773 0 N-CA-C 107.82 -1.178 . . . . 71.15 107.82 168.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -86.65 150.03 8.71 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.377 2.051 . . . . 75.42 113.294 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -82.83 81.49 8.53 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 105.953 -1.869 . . . . 72.43 105.953 168.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -69.33 99.51 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-N 114.367 -1.288 . . . . 71.15 109.444 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -96.14 112.14 23.96 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 113.787 -1.551 . . . . 73.21 109.026 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.59 141.99 28.6 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.604 -0.517 . . . . 71.44 109.604 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.454 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 24.1 t70 -135.66 147.09 48.44 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.575 1.15 . . . . 72.14 108.367 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.61 157.13 44.48 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.082 0.553 . . . . 65.11 111.145 -173.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.608 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 17.1 t70 -140.74 144.97 35.83 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.958 0.903 . . . . 72.33 109.029 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -112.78 112.51 24.05 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.19 -0.67 . . . . 62.05 109.19 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.48 150.35 44.0 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.035 0.934 . . . . 75.43 108.787 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 37.7 p -165.99 157.63 13.94 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.363 0.265 . . . . 73.51 111.658 -174.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 23.4 p -166.1 127.73 1.86 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.82 0.848 . . . . 65.15 109.681 173.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -72.12 130.82 41.79 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 108.917 -0.771 . . . . 72.41 108.917 168.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.61 HD11 HD12 ' C' ' 83' ' ' ILE . 60.0 mt -97.64 -37.0 10.09 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.274 0.63 . . . . 64.31 111.264 -175.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.27 -171.39 2.38 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.003 0.521 . . . . 64.44 111.746 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -57.94 109.12 0.68 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.921 1.288 . . . . 74.12 110.081 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 69.67 -7.15 0.92 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 125.224 1.41 . . . . 74.53 112.668 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.7 t -94.0 112.32 26.65 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 N-CA-C 108.061 -1.089 . . . . 62.41 108.061 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -120.17 159.75 24.27 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.128 -0.942 . . . . 72.13 108.492 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -126.66 123.62 37.98 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.237 0.615 . . . . 54.23 110.244 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.476 HG11 ' HD3' ' C' ' 103' ' ' PRO . 89.6 t -104.66 128.19 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 107.974 -1.121 . . . . 62.05 107.974 171.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -121.23 130.98 74.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.071 -1.085 . . . . 71.13 108.071 170.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.401 HD22 ' HB2' ' C' ' 103' ' ' PRO . 29.4 tp -126.17 117.7 23.66 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.187 -1.412 . . . . 75.21 107.187 170.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.608 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 6.9 tmm_? -90.95 128.64 36.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.515 -0.766 . . . . 54.03 109.611 178.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.48 140.56 19.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.971 -1.122 . . . . 64.2 107.971 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 53.8 m -133.93 122.04 22.54 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.882 -0.785 . . . . 62.45 108.882 173.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.426 HG21 HG21 ' C' ' 114' ' ' ILE . 89.4 t -101.55 109.46 25.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 107.979 -1.119 . . . . 44.42 107.979 176.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.447 HG23 HD23 ' C' ' 75' ' ' LEU . 4.2 m -99.57 107.14 19.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.852 -1.166 . . . . 74.22 107.852 175.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.02 108.37 19.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.719 -1.586 . . . . 64.51 106.719 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.4 m -132.23 127.95 36.84 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.149 -0.686 . . . . 73.0 109.149 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.724 HD13 ' HG2' ' C' ' 34' ' ' LYS . 8.2 mt -85.13 48.99 1.65 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.907 1.283 . . . . 53.32 109.56 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.15 -113.63 4.49 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 109.747 -1.341 . . . . 35.3 109.747 -168.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.69 -19.96 17.91 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.411 0.684 . . . . 63.03 110.526 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -67.24 120.66 14.16 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.866 0.867 . . . . 72.32 108.756 169.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.7 m -84.29 125.61 32.41 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 118.764 0.711 . . . . 74.43 109.295 173.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.773 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.79 -63.54 1.28 Allowed 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.364 -0.976 . . . . 71.32 108.364 173.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -155.77 173.09 17.24 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.274 -0.875 . . . . 71.0 110.663 174.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.447 HD23 HG23 ' C' ' 65' ' ' THR . 2.3 tm? -131.03 141.17 50.19 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 105.089 -2.189 . . . . 61.31 105.089 169.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.532 ' SG ' HG23 ' C' ' 114' ' ' ILE . 47.2 t -142.99 136.94 28.96 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.559 -1.274 . . . . 52.41 107.559 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 77' ' ' GLU . . . . . 0.508 ' HG3' ' HD3' ' C' ' 61' ' ' ARG . 24.4 tt0 -146.4 120.38 9.38 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.658 0.383 . . . . 72.31 110.396 -173.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 54.6 t -129.72 115.9 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.135 0.974 . . . . 64.24 109.231 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.505 ' HG2' ' HB2' ' C' ' 61' ' ' ARG . 93.8 mt-30 -89.56 99.4 12.41 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.747 -1.205 . . . . 61.24 107.747 170.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.648 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.0 tp-100 -87.88 109.76 20.02 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.825 -0.806 . . . . 73.2 108.825 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.33 145.45 17.6 Favored Glycine 0 C--N 1.341 0.819 0 O-C-N 123.6 0.562 . . . . 74.01 111.88 176.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.82 126.14 2.67 Favored Glycine 0 CA--C 1.506 -0.487 0 N-CA-C 110.921 -0.872 . . . . 64.31 110.921 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.61 HD12 HD11 ' C' ' 51' ' ' LEU . 9.6 mm -87.27 117.83 32.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 108.383 -0.969 . . . . 64.35 108.383 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.405 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 41.7 m-85 -129.17 120.99 26.78 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.227 1.011 . . . . 71.13 109.256 -173.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 57.3 p -79.4 109.11 13.45 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.633 -0.877 . . . . 74.11 108.633 172.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 70.5 mt -119.86 130.43 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.283 1.033 . . . . 72.14 108.855 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.63 158.52 26.24 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.741 0.816 . . . . 74.42 110.189 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.1 -57.87 1.05 Allowed Glycine 0 C--N 1.345 1.035 0 O-C-N 123.296 0.372 . . . . 61.24 113.217 174.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 37.9 pt -85.41 161.28 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 122.909 0.483 . . . . 65.33 111.398 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -152.73 -178.56 6.96 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.92 0.888 . . . . 74.14 110.465 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.85 -139.39 42.91 Favored Glycine 0 C--N 1.349 1.263 0 O-C-N 123.379 0.425 . . . . 45.24 112.845 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 92' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' C' ' 95' ' ' ALA . 40.9 p -64.34 -19.86 65.73 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.54 0.736 . . . . 73.21 111.753 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -64.76 -55.92 16.78 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.496 0.718 . . . . 41.43 110.243 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.419 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 10.6 ptp -71.97 -29.82 64.64 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 116.579 -0.282 . . . . 64.12 110.479 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 95' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' C' ' 92' ' ' THR . . . -66.47 -32.68 74.19 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.205 0.602 . . . . 72.14 111.51 178.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -77.43 -37.2 52.18 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.407 0.683 . . . . 72.32 110.069 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.568 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 28.8 t -59.61 -40.08 86.34 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.862 0.726 . . . . 72.33 110.613 175.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' C' ' 94' ' ' MET . 67.7 mt -81.49 -40.22 23.56 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.025 0.93 . . . . 71.25 111.54 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.01 -13.68 82.94 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.414 -0.812 . . . . 41.54 114.843 -168.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.627 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -157.97 -54.71 0.07 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 117.237 0.519 . . . . 63.01 112.388 -173.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.568 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 82.4 t80 -57.5 -40.59 79.01 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.711 1.204 . . . . 64.24 113.736 -172.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 89.3 m -82.08 -44.87 1.02 Allowed Pre-proline 0 CA--C 1.561 1.388 0 CA-C-O 118.784 -0.627 . . . . 65.23 112.361 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.476 ' HD3' HG11 ' C' ' 58' ' ' VAL . 37.1 Cg_endo -68.3 -7.79 21.09 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 121.624 1.549 . . . . 74.14 114.287 170.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -68.13 -30.97 70.24 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 123.396 0.678 . . . . 40.02 110.741 168.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.583 HD12 HH12 ' A' ' 111' ' ' ARG . 41.8 mm -68.33 -40.46 82.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-N 115.416 -0.811 . . . . 65.15 109.519 173.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 61.2 mt -83.08 -26.76 30.78 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.323 -1.308 . . . . 74.12 112.166 -168.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 107' ' ' PHE . . . . . 0.416 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 89.7 t80 -56.14 -53.93 58.13 Favored Pre-proline 0 CA--C 1.562 1.438 0 CA-C-O 118.07 -0.967 . . . . 70.44 112.754 -176.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 36.1 Cg_exo -59.42 -36.68 93.21 Favored 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 122.319 2.012 . . . . 72.54 113.221 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -63.73 -50.76 67.86 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.156 0.982 . . . . 72.42 111.059 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.648 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -71.21 -29.89 65.7 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.331 -0.849 . . . . 63.01 111.215 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -61.79 -47.82 83.43 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.598 1.159 . . . . 62.54 110.647 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -71.02 -33.71 70.63 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.891 0.476 . . . . 73.42 110.025 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.524 ' SG ' HG12 ' C' ' 21' ' ' ILE . 44.6 t -64.44 -37.1 86.35 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.12 0.568 . . . . 61.43 111.282 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.532 HG23 ' SG ' ' C' ' 76' ' ' CYS . 97.0 mt -71.7 -51.77 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.155 0.582 . . . . 64.0 110.352 174.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.0 m -62.4 -28.4 69.75 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.124 0.57 . . . . 63.32 111.426 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 42.5 t -64.07 -49.94 70.3 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.141 -0.688 . . . . 62.14 109.141 170.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.525 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.45 -33.57 75.85 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.286 1.035 . . . . 63.12 112.662 179.658 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.454 HG23 ' O ' ' C' ' 114' ' ' ILE . 58.3 t -62.83 -44.6 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 109.085 -0.709 . . . . 73.54 109.085 175.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 39.9 t -70.8 -31.0 67.61 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.801 -1.09 . . . . 75.03 111.93 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' C' ' 116' ' ' SER . 90.8 mtt-85 -68.97 -37.49 78.83 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.33 0.652 . . . . 74.33 109.342 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.85 6.87 79.62 Favored Glycine 0 C--N 1.353 1.521 0 O-C-N 123.967 0.792 . . . . 72.54 112.639 174.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 50.7 p 57.34 28.56 15.47 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.278 1.831 . . . . 73.33 114.294 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -83.95 144.63 45.03 Favored Pre-proline 0 N--CA 1.472 0.628 0 N-CA-C 109.059 -0.719 . . . . 73.41 109.059 172.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.81 153.31 37.68 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.67 2.247 . . . . 70.43 112.4 175.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -53.85 129.35 33.37 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.042 0.937 . . . . 72.0 113.487 -170.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 31.3 tp -131.72 84.65 2.18 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 107.054 -1.461 . . . . 72.24 107.054 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -98.16 106.1 18.35 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.462 -1.245 . . . . 72.55 108.425 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.38 138.39 58.51 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.31 0.644 . . . . 74.34 111.213 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.74 133.88 90.4 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 124.088 0.868 . . . . 73.4 110.711 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.15 107.74 1.01 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.53 2.153 . . . . 61.54 112.492 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 23.7 m -100.33 131.3 48.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 108.941 -0.762 . . . . 75.51 108.941 170.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.01 84.89 0.99 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.016 -0.538 . . . . 72.32 109.567 177.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -65.07 -31.67 72.99 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.227 -0.897 . . . . 73.53 111.32 -172.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 134' ' ' ASP . . . . . 0.627 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 32.0 t70 . . . . . 0 N--CA 1.481 1.123 0 C-N-CA 122.747 0.419 . . . . 35.45 111.584 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 67.4 m . . . . . 0 C--O 1.242 0.668 0 N-CA-C 109.479 -0.564 . . . . 75.01 109.479 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -137.56 119.14 14.93 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.042 -1.095 . . . . 71.3 108.042 -175.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -130.88 129.84 42.79 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.315 -0.994 . . . . 63.11 108.315 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.491 HG21 HD11 ' D' ' 16' ' ' ILE . 56.1 mt -79.05 129.53 37.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.985 -0.746 . . . . 72.04 108.985 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -105.14 -28.39 11.02 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 119.037 -0.506 . . . . 72.04 111.74 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -176.82 140.41 0.33 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 118.157 0.435 . . . . 74.42 111.52 -173.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.491 HD11 HG21 ' D' ' 13' ' ' ILE . 3.0 mp -123.53 136.31 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.566 -1.272 . . . . 74.14 107.566 171.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.427 ' HE1' HG13 ' D' ' 83' ' ' ILE . 28.6 p90 -162.81 175.07 11.64 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-O 122.078 0.942 . . . . 75.33 112.231 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 18' ' ' THR . . . . . 0.406 HG21 HD11 ' D' ' 21' ' ' ILE . 70.1 p -109.71 122.51 47.65 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.049 -1.432 . . . . 64.53 108.814 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -93.17 -31.81 14.63 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.3 -0.63 . . . . 74.42 109.3 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' D' ' 79' ' ' GLN . 6.5 m-20 -142.36 131.57 23.39 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 108.315 -0.994 . . . . 63.51 108.315 177.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.525 HG21 ' HE2' ' C' ' 117' ' ' MET . 89.0 mt -128.6 150.29 34.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.505 -1.294 . . . . 73.21 107.505 172.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 22' ' ' SER . . . . . 0.442 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 47.3 t -151.69 139.39 19.76 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.258 1.023 . . . . 71.12 108.923 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 84.1 t80 -152.86 127.66 9.53 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.464 -2.05 . . . . 65.43 105.464 169.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -135.96 134.59 38.79 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.876 -1.157 . . . . 75.43 107.876 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.422 ' CB ' ' HB2' ' D' ' 28' ' ' ALA . . . -120.88 90.53 46.81 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 108.032 -1.099 . . . . 43.22 108.032 175.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.44 -41.07 12.68 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.802 2.335 . . . . 75.24 112.688 -172.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.491 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 6.5 m120 -106.03 9.81 32.38 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.658 0.783 . . . . 51.54 110.737 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.451 ' HB1' ' CE2' ' C' ' 17' ' ' TYR . . . -19.44 -70.26 0.03 OUTLIER Pre-proline 0 CA--C 1.563 1.458 0 N-CA-C 117.396 2.369 . . . . 52.2 117.396 -165.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.05 -24.03 13.15 Favored 'Trans proline' 0 C--N 1.382 2.321 0 CA-C-N 123.647 2.338 . . . . 74.4 113.969 -174.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -75.1 -41.07 59.39 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.265 1.026 . . . . 72.15 110.522 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.567 HG22 HD12 ' D' ' 68' ' ' LEU . 12.3 p -75.82 -20.22 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 115.856 -0.611 . . . . 70.25 111.243 -173.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -66.64 -20.04 65.9 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 112.699 0.629 . . . . 73.12 112.699 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -59.1 -26.17 64.44 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.769 0.828 . . . . 73.24 110.627 176.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.46 108.72 20.09 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.894 1.278 . . . . 74.25 110.17 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -105.84 88.77 2.89 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.948 0.899 . . . . 74.23 110.978 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 45.5 p90 -161.14 177.26 10.43 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.382 1.073 . . . . 74.53 108.339 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -72.85 115.52 40.91 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 108.845 -0.798 . . . . 75.44 108.845 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -60.82 130.47 33.17 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.33 2.02 . . . . 62.11 111.212 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -63.54 114.44 3.92 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.454 -0.943 . . . . 73.21 108.454 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.487 HG11 HD22 ' D' ' 126' ' ' LEU . 31.1 m -106.91 112.05 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-O 121.526 0.679 . . . . 71.02 110.094 -174.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.43 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 12.0 tmtt? -84.49 119.15 24.83 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 106.467 -1.679 . . . . 55.11 106.467 174.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 pp -95.6 150.38 20.41 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.135 0.493 . . . . 75.31 110.187 -173.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.535 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 13.0 t70 -151.29 119.66 6.4 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.023 -0.99 . . . . 74.44 108.741 -176.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.52 133.84 52.6 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.764 -0.458 . . . . 50.25 109.764 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.451 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 31.4 t70 -132.99 157.55 44.92 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.094 -1.076 . . . . 75.4 108.094 176.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -119.93 153.88 35.26 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.395 0.617 . . . . 62.45 112.106 -173.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.626 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.72 152.86 33.31 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.215 1.406 . . . . 63.13 107.885 172.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 21.1 p -164.63 152.37 11.86 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.69 0.223 . . . . 64.32 110.967 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 60.3 p -164.23 135.02 4.3 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.485 0.714 . . . . 72.42 109.756 177.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -77.71 136.47 38.18 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.851 -0.796 . . . . 71.41 108.851 172.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' D' ' 57' ' ' GLU . 40.2 mt -103.24 -35.05 8.59 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.88 0.472 . . . . 75.25 110.375 -177.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.53 -174.0 3.55 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.746 0.818 . . . . 61.45 109.954 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.23 114.92 3.73 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.232 -0.895 . . . . 64.32 110.238 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 63.87 12.2 6.58 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.788 1.235 . . . . 75.4 112.761 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 76.4 t -109.03 122.67 64.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 106.936 -1.505 . . . . 60.43 106.936 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.643 ' HB3' HD13 ' D' ' 86' ' ' ILE . 16.5 t80 -143.06 131.04 21.68 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.769 -0.456 . . . . 74.41 109.769 -173.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.42 ' HB2' HD11 ' D' ' 51' ' ' LEU . 8.1 tt0 -99.7 130.97 45.97 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.052 0.941 . . . . 73.41 109.747 177.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.1 t -119.63 127.13 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.275 -1.009 . . . . 72.34 108.275 174.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.626 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 11.5 t -112.81 135.69 51.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 124.086 0.954 . . . . 65.45 108.725 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.646 HD22 ' HB3' ' D' ' 103' ' ' PRO . 11.5 tp -125.47 116.87 22.5 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.631 -0.507 . . . . 62.01 109.631 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.451 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 17.9 ttm-85 -83.86 103.14 12.89 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.74 0.816 . . . . 72.34 109.383 175.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 62.1 t -93.27 120.24 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.279 -1.008 . . . . 64.11 108.279 170.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 12.2 m -120.66 146.94 45.9 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 122.963 0.505 . . . . 74.15 109.755 -175.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.417 HG13 ' HB ' ' D' ' 40' ' ' VAL . 53.7 t -137.48 103.88 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 125.383 1.473 . . . . 75.32 109.033 -175.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 48.1 m -94.12 96.96 9.97 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.567 -0.901 . . . . 61.1 108.567 169.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.442 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -97.96 153.07 18.61 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.694 -0.685 . . . . 70.31 109.802 -171.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.433 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.9 p -155.54 128.61 8.14 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 123.559 0.537 . . . . 44.41 112.11 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.567 HD12 HG22 ' D' ' 31' ' ' VAL . 45.7 mt -96.66 96.18 8.45 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.832 -1.173 . . . . 71.31 107.832 169.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -136.14 17.72 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.808 -0.633 . . . . 74.44 112.719 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -84.41 3.15 37.39 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.547 0.739 . . . . 65.31 111.742 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -125.01 147.84 48.75 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.998 -0.371 . . . . 70.0 109.998 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 61.8 m -65.02 135.38 55.54 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 123.825 0.703 . . . . 72.24 111.32 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.555 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -85.61 -65.36 1.02 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.387 -0.968 . . . . 51.21 108.387 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -155.14 144.11 20.83 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.605 -0.725 . . . . 62.41 110.691 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 66.3 mt -106.83 107.67 18.81 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.727 -1.212 . . . . 62.23 107.727 172.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.416 ' SG ' HG23 ' D' ' 114' ' ' ILE . 45.9 t -121.52 141.41 51.07 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.764 0.826 . . . . 65.11 109.527 -174.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 77' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 21.8 tt0 -154.8 136.68 14.54 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.138 0.575 . . . . 62.54 109.487 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 82.0 t -136.76 114.88 14.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.956 -0.757 . . . . 72.12 108.956 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.403 ' HB2' ' HB2' ' D' ' 20' ' ' ASP . 69.6 mt-30 -87.88 86.93 7.21 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 107.592 -1.262 . . . . 64.54 107.592 170.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -79.89 104.02 10.18 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 114.31 -1.313 . . . . 63.23 108.116 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -107.09 143.09 15.8 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 111.557 -0.617 . . . . 51.24 111.557 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.14 138.34 9.27 Favored Glycine 0 CA--C 1.506 -0.497 0 N-CA-C 111.643 -0.583 . . . . 74.21 111.643 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.427 HG13 ' HE1' ' D' ' 17' ' ' TYR . 74.2 mt -86.58 121.4 37.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.199 -1.408 . . . . 75.3 107.199 172.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -125.33 165.8 17.7 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.288 0.635 . . . . 72.04 109.406 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 4.6 t -112.55 105.41 13.62 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.794 -1.188 . . . . 54.35 107.794 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.643 HD13 ' HB3' ' D' ' 56' ' ' TYR . 3.3 mp -107.95 105.76 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 108.328 -0.99 . . . . 64.41 108.328 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.72 147.04 49.98 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.328 0.651 . . . . 73.22 110.44 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.11 13.62 76.76 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-O 119.193 -0.781 . . . . 61.02 114.91 172.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.475 HG22 ' N ' ' D' ' 90' ' ' GLU . 7.6 mt -97.57 157.88 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 118.334 1.067 . . . . 55.33 110.477 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.475 ' N ' HG22 ' D' ' 89' ' ' ILE . 1.1 pp20? -153.11 -177.81 6.54 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.446 1.098 . . . . 72.02 108.979 163.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.44 -141.96 47.94 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.532 0.587 . . . . 70.15 113.694 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 7.4 m -89.96 -9.92 46.99 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.556 1.142 . . . . 62.11 111.379 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -60.74 -28.45 68.7 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.045 0.538 . . . . 74.12 111.043 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 18.1 ptt? -70.98 -32.35 69.17 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 119.462 -0.304 . . . . 72.33 111.42 176.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.42 84.0 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 120.775 0.322 . . . . 72.45 110.146 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -65.56 -43.82 88.69 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.601 -0.727 . . . . 71.54 110.949 171.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.4 t -61.5 -49.96 74.63 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.886 0.474 . . . . 40.32 110.656 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 19.4 mt -83.19 -20.51 34.51 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.054 0.942 . . . . 63.45 111.518 -173.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.83 5.93 34.98 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 114.131 0.413 . . . . 63.14 114.131 -174.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.44 -66.45 0.29 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.557 0.343 . . . . 51.51 110.855 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -70.25 -52.05 25.98 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.565 0.58 . . . . 74.14 112.565 -170.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.498 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 56.8 m -58.38 -47.63 98.44 Favored Pre-proline 0 CA--C 1.562 1.42 0 C-N-CA 123.53 0.732 . . . . 73.33 111.388 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.646 ' HB3' HD22 ' D' ' 60' ' ' LEU . 51.7 Cg_exo -59.4 -39.7 74.22 Favored 'Trans proline' 0 C--N 1.397 3.115 0 C-N-CA 122.231 1.954 . . . . 62.05 113.277 169.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -59.31 -36.17 75.12 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.9 0.88 . . . . 74.43 110.697 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.2 mm -63.5 -36.92 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.514 0.726 . . . . 50.03 110.597 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 73.6 mt -84.43 -13.82 51.04 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 115.221 -0.9 . . . . 71.43 112.371 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -56.68 -50.36 88.4 Favored Pre-proline 0 N--CA 1.5 2.048 0 C-N-CA 124.072 0.949 . . . . 73.32 113.46 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.38 -41.12 81.29 Favored 'Trans proline' 0 C--N 1.392 2.826 0 C-N-CA 122.181 1.921 . . . . 63.01 112.948 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -75.88 -37.98 58.33 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.329 1.052 . . . . 62.35 112.484 -175.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.94 -43.52 71.44 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.08 0.552 . . . . 53.43 110.346 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.448 ' NH2' HG23 ' B' ' 105' ' ' ILE . 46.6 ttp180 -62.28 -47.78 82.81 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.595 -0.729 . . . . 72.43 110.438 176.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -61.28 -45.76 93.13 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.416 0.686 . . . . 73.33 110.757 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.2 t -59.46 -44.5 92.97 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.657 0.598 . . . . 73.31 111.159 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.443 ' O ' HG23 ' D' ' 118' ' ' VAL . 65.5 mt -60.05 -57.64 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.323 0.649 . . . . 73.51 110.326 174.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.9 m -53.43 -41.87 66.49 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.668 1.187 . . . . 73.01 112.673 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 45.6 t -67.19 -41.74 85.34 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.214 -0.903 . . . . 75.33 110.222 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.4 mtm -68.77 -32.49 72.26 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.903 0.481 . . . . 74.41 111.428 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.443 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.0 t -65.76 -43.52 93.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.644 0.777 . . . . 73.02 110.264 176.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.3 p -74.17 -30.36 62.21 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.589 0.356 . . . . 75.53 111.176 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 74.5 mtt-85 -71.75 -27.95 63.32 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.695 0.798 . . . . 74.44 110.373 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.93 7.89 78.42 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-N 115.8 -0.636 . . . . 70.44 112.072 171.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.465 HG23 ' HB3' ' C' ' 17' ' ' TYR . 62.3 p 59.5 15.89 4.85 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 127.015 2.126 . . . . 73.41 113.792 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -78.77 157.98 76.08 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.794 0.838 . . . . 71.11 110.462 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.63 127.34 25.52 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.085 2.523 . . . . 75.12 113.069 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -52.97 136.93 33.96 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.264 1.026 . . . . 73.11 112.048 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.487 HD22 HG11 ' D' ' 40' ' ' VAL . 57.3 tp -118.16 108.77 15.58 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.796 0.838 . . . . 72.14 109.395 -177.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -106.73 99.06 8.66 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.008 -0.738 . . . . 74.1 109.008 175.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.86 130.2 41.05 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.193 -0.669 . . . . 63.42 109.193 173.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -63.02 137.81 97.16 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.338 0.655 . . . . 63.52 110.427 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 8.3 Cg_exo -69.44 111.02 2.63 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.644 2.229 . . . . 72.44 110.905 -177.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 109.226 -0.657 . . . . 45.13 109.226 -177.103 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.693 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 22.0 t80 . . . . . 0 C--O 1.238 0.494 0 N-CA-C 109.048 -0.723 . . . . 62.41 109.048 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -149.71 112.75 4.87 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.369 0.668 . . . . 74.53 109.299 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.645 HG12 ' HD2' ' A' ' 84' ' ' PHE . 27.5 mt -83.05 116.15 26.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.555 -0.905 . . . . 71.01 108.555 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -79.28 -36.41 39.79 Favored 'General case' 0 C--O 1.242 0.702 0 O-C-N 123.895 0.747 . . . . 61.43 110.258 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -171.9 142.74 1.53 Allowed 'General case' 0 C--N 1.355 0.844 0 CA-C-N 116.374 -0.375 . . . . 70.43 110.457 -170.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.588 HD12 ' HB3' ' C' ' 130' ' ' PRO . 76.8 mt -133.66 141.31 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 124.243 1.017 . . . . 63.21 109.083 172.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.472 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 21.1 p90 -165.56 171.9 12.63 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 124.356 1.035 . . . . 73.42 110.499 -172.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.4 p -94.61 119.46 33.31 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.484 -0.932 . . . . 63.42 108.484 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.472 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 35.2 mtpt -83.01 -36.16 25.23 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.019 0.438 . . . . 64.11 109.828 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.515 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 16.2 t70 -145.72 126.02 13.93 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.114 -0.948 . . . . 75.22 109.1 -178.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.562 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 77.4 mt -118.78 142.32 34.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.864 -1.161 . . . . 70.15 107.864 172.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.0 t -150.53 125.82 10.06 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.784 -0.821 . . . . 73.42 108.784 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.501 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 75.3 t80 -127.48 121.97 32.16 Favored 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 106.867 -1.531 . . . . 75.41 106.867 174.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -124.09 118.29 26.6 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.18 -0.674 . . . . 74.15 109.18 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.48 79.64 4.22 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 106.867 -1.531 . . . . 74.03 106.867 168.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.49 -24.58 26.19 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.539 2.159 . . . . 63.24 112.915 -166.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -114.04 23.21 13.16 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 118.16 -0.924 . . . . 64.55 109.504 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.425 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -40.96 -58.14 2.88 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 114.192 1.182 . . . . 61.31 114.192 -166.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 18.0 Cg_exo -65.72 -24.65 54.61 Favored 'Trans proline' 0 C--N 1.389 2.675 0 CA-C-N 121.83 1.689 . . . . 73.11 113.245 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -83.48 -37.57 22.95 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.3 1.04 . . . . 73.22 110.833 -176.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.735 HG21 ' HA ' ' A' ' 73' ' ' ALA . 8.0 p -76.94 -23.82 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-N 115.589 -0.732 . . . . 74.45 111.348 -168.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -68.91 -25.18 64.46 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.884 0.474 . . . . 73.1 110.877 174.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -75.5 -33.02 60.73 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.027 0.931 . . . . 74.33 110.027 175.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -70.94 168.2 17.46 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.43 1.092 . . . . 73.05 111.469 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.87 145.76 27.64 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.828 -0.623 . . . . 75.53 110.025 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.407 ' CE3' HD21 ' A' ' 68' ' ' LEU . 75.1 t-105 -93.86 88.84 5.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.265 0.626 . . . . 75.41 109.583 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -135.2 79.97 48.35 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 107.113 -1.44 . . . . 73.01 107.113 170.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -91.82 165.33 3.3 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.269 2.646 . . . . 74.42 114.889 -170.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.71 126.77 39.05 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.954 -1.021 . . . . 73.13 108.7 164.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.576 HG13 HG13 ' A' ' 64' ' ' VAL . 59.8 t -86.82 105.1 14.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.259 -0.645 . . . . 74.25 109.259 174.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -80.89 123.27 28.15 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.604 -1.18 . . . . 71.4 108.488 171.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -96.39 109.32 21.87 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.374 0.669 . . . . 72.13 109.394 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.689 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 15.5 m-20 -110.14 119.82 40.48 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.532 -0.914 . . . . 73.53 108.532 172.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.782 HD23 HD21 ' A' ' 60' ' ' LEU . 6.3 mp -120.84 136.8 54.82 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.056 0.455 . . . . 73.45 111.103 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -134.72 121.27 20.54 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.36 -1.348 . . . . 71.21 107.36 174.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.47 HG22 ' HG ' ' A' ' 60' ' ' LEU . 43.8 p -107.74 136.51 47.37 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.261 0.624 . . . . 72.24 110.47 -172.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.89 145.56 51.04 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.048 0.939 . . . . 64.2 109.464 -178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.5 m -131.7 152.92 50.53 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.844 0.857 . . . . 45.33 109.569 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 46.7 t -150.1 142.86 24.67 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.632 0.773 . . . . 62.32 109.678 -175.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -101.56 104.32 15.2 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.029 -1.1 . . . . 70.34 108.029 172.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.671 HD11 ' HB2' ' A' ' 57' ' ' GLU . 59.4 mt -81.52 -41.5 21.59 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.921 -0.581 . . . . 73.4 110.295 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.404 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -157.88 -174.53 4.89 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.448 -0.796 . . . . 45.33 110.474 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.8 118.24 7.45 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.693 0.797 . . . . 61.23 110.057 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.28 -6.04 0.83 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.959 1.304 . . . . 71.21 112.74 -177.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 92.0 t -104.34 113.24 40.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 N-CA-C 108.191 -1.04 . . . . 71.41 108.191 -175.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -120.66 167.26 12.64 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.796 0.838 . . . . 72.01 109.429 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.671 ' HB2' HD11 ' A' ' 51' ' ' LEU . 36.3 tt0 -129.93 128.21 41.68 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.275 1.03 . . . . 71.45 108.789 174.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.434 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 53.4 t -109.89 122.79 65.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.076 -1.083 . . . . 63.2 108.076 169.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.5 t -110.14 136.38 46.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.14 -1.059 . . . . 55.33 108.14 171.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.782 HD21 HD23 ' A' ' 44' ' ' LEU . 3.3 tt -129.98 122.1 27.82 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.575 -0.898 . . . . 72.41 108.575 175.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.5 ttm-85 -85.66 103.03 14.1 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.518 1.127 . . . . 52.34 109.471 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.7 t -94.8 102.36 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 107.532 -1.284 . . . . 72.43 107.532 171.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.689 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 23.9 m -102.1 107.86 19.09 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.888 -0.782 . . . . 70.42 108.888 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.576 HG13 HG13 ' A' ' 40' ' ' VAL . 19.2 t -104.47 112.91 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 124.976 1.31 . . . . 60.22 109.121 -176.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 3.2 m -112.56 124.91 53.58 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 108.839 -0.8 . . . . 61.4 108.839 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.0 113.26 26.58 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.577 -1.268 . . . . 72.45 107.577 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.5 m -113.95 122.49 47.11 Favored 'General case' 0 C--N 1.351 0.637 0 CA-C-N 118.478 0.581 . . . . 52.05 110.903 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.407 HD21 ' CE3' ' A' ' 36' ' ' TRP . 17.5 mt -92.91 79.88 4.64 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 125.582 1.553 . . . . 53.24 107.677 173.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.46 -101.99 1.44 Allowed Glycine 0 C--N 1.34 0.801 0 CA-C-N 115.398 -0.819 . . . . 60.34 111.433 -175.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -106.64 -1.37 22.9 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.726 0.81 . . . . 62.34 111.292 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -107.33 136.69 46.71 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.956 0.903 . . . . 73.31 110.101 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.1 m -87.45 124.39 33.38 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 118.095 0.407 . . . . 54.31 110.002 167.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.735 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -73.77 -55.1 6.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.433 1.093 . . . . 74.24 109.695 174.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -152.24 164.91 36.41 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 114.45 -1.25 . . . . 54.43 111.687 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 36.0 tp -134.36 105.83 6.79 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.205 -1.361 . . . . 65.52 107.64 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.501 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 61.7 m -108.14 98.8 8.3 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.844 0.858 . . . . 75.2 109.813 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -105.4 125.44 50.99 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.384 0.674 . . . . 72.14 109.424 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.8 t -131.0 112.61 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.252 0.621 . . . . 70.21 109.545 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 78.3 mt-30 -84.33 87.9 7.23 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.324 1.05 . . . . 64.45 108.471 171.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.477 ' HG3' HD22 ' A' ' 106' ' ' LEU . 60.4 tp60 -79.53 109.76 14.21 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.869 -1.059 . . . . 71.3 109.416 -177.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.56 146.02 18.09 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 111.481 -0.648 . . . . 74.34 111.481 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.2 124.9 2.04 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 111.387 -0.685 . . . . 61.1 111.387 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.0 mt -82.94 110.23 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.347 0.659 . . . . 73.43 109.519 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.693 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 36.3 m-85 -121.94 120.33 34.12 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.838 0.855 . . . . 74.22 108.747 -177.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.8 m -89.95 101.32 14.02 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.756 -0.831 . . . . 61.55 108.756 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.2 pt . . . . . 0 N--CA 1.484 1.248 0 C-N-CA 123.145 0.578 . . . . 74.41 110.753 -176.214 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.652 0.263 . . . . 35.45 111.707 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -76.03 -38.29 57.39 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.635 -0.711 . . . . 73.32 109.722 172.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.3 t -70.82 -32.81 69.99 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.261 0.624 . . . . 74.53 111.989 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 pp -101.17 -20.02 15.48 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.065 0.546 . . . . 72.43 111.833 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.04 -16.03 29.16 Favored Glycine 0 N--CA 1.478 1.492 0 N-CA-C 113.694 0.238 . . . . 72.12 113.694 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.54 -62.75 1.23 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.789 0.836 . . . . 73.42 109.64 179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.497 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 86.4 t80 -64.47 -60.79 2.74 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.463 1.105 . . . . 72.41 113.957 -167.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 84.7 m -65.71 -37.94 21.75 Favored Pre-proline 0 CA--C 1.566 1.593 0 N-CA-C 113.656 0.984 . . . . 72.21 113.656 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.91 -27.03 43.64 Favored 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 121.729 1.619 . . . . 75.44 112.783 167.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -77.68 -17.45 57.67 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.379 0.672 . . . . 64.42 110.473 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.1 mm -67.84 -41.53 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.89 -0.781 . . . . 72.34 108.89 169.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.477 HD22 ' HG3' ' A' ' 80' ' ' GLN . 90.4 mt -77.06 -21.32 54.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.149 0.979 . . . . 62.5 111.938 -178.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -59.9 -47.53 97.0 Favored Pre-proline 0 CA--C 1.574 1.878 0 C-N-CA 124.293 1.037 . . . . 64.24 113.578 -174.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.92 -40.6 33.95 Favored 'Trans proline' 0 C--N 1.393 2.888 0 C-N-CA 122.051 1.834 . . . . 63.21 112.97 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -65.42 -44.04 88.64 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.812 0.695 . . . . 75.53 111.314 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.35 -31.81 64.17 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.519 0.728 . . . . 52.24 110.926 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.455 HH12 HD12 ' C' ' 105' ' ' ILE . 32.2 ttm180 -62.11 -50.4 72.07 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 109.321 -0.622 . . . . 73.21 109.321 170.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -66.85 -42.94 84.88 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.269 1.028 . . . . 74.34 112.202 -171.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.3 t -60.42 -42.92 97.01 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 123.786 0.679 . . . . 73.23 109.872 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 118' ' ' VAL . 57.9 mt -64.96 -46.07 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 114.811 -1.086 . . . . 73.21 110.686 175.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.3 m -57.66 -40.82 80.2 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.956 0.902 . . . . 54.43 111.304 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 44.1 t -66.41 -44.08 83.96 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 115.258 -0.883 . . . . 71.14 110.497 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 15.9 mtp -64.02 -36.84 85.3 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.895 0.878 . . . . 74.03 111.748 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 114' ' ' ILE . 51.5 t -63.09 -52.34 60.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 124.37 1.068 . . . . 70.14 110.005 176.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.6 t -65.52 -31.31 72.31 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.677 0.791 . . . . 64.54 111.578 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 116' ' ' SER . 44.3 ttm-85 -75.23 -32.53 61.16 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.093 0.957 . . . . 72.25 109.467 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.426 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.97 17.04 38.92 Favored Glycine 0 C--N 1.355 1.607 0 CA-C-N 114.97 -1.014 . . . . 62.44 113.254 171.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.462 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.5 t 62.45 12.65 5.51 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 126.944 2.098 . . . . 74.34 113.838 174.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -79.96 146.5 63.8 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 123.409 0.684 . . . . 74.32 109.474 174.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.54 162.75 35.43 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.61 2.207 . . . . 73.23 113.095 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -54.81 129.2 36.29 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.318 1.447 . . . . 74.13 113.461 -168.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.473 HD11 HG21 ' A' ' 40' ' ' VAL . 59.5 tp -130.4 110.6 11.61 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.392 1.077 . . . . 73.31 109.67 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -125.73 117.19 22.93 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.275 1.03 . . . . 55.24 108.641 175.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.1 mp -66.83 140.75 57.83 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.493 0.717 . . . . 61.14 110.24 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -63.33 130.13 94.03 Favored Pre-proline 0 CA--C 1.552 1.034 0 O-C-N 123.778 0.673 . . . . 60.14 110.417 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 36.8 Cg_exo -64.6 113.63 2.39 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 123.168 2.579 . . . . 61.2 111.893 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.7 t -99.95 114.24 37.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.612 -1.255 . . . . 73.12 107.612 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -74.72 81.42 2.06 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.571 0.748 . . . . 63.01 109.806 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 . . . . . 0 N--CA 1.478 0.949 0 CA-C-N 115.545 -0.752 . . . . 72.44 110.169 179.731 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.56 ' HG2' ' HB ' ' B' ' 89' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 112.346 0.499 . . . . 62.32 112.346 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.499 ' N ' ' SD ' ' B' ' 9' ' ' MET . 94.0 m -149.64 109.18 4.0 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.866 1.266 . . . . 71.23 108.597 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' B' ' 85' ' ' SER . 35.5 t80 -130.76 138.23 49.84 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.914 0.486 . . . . 72.01 110.326 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -154.53 140.41 18.2 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.039 0.536 . . . . 51.42 110.479 175.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.415 ' HA ' ' HD2' ' B' ' 84' ' ' PHE . 17.9 mt -76.33 108.61 9.17 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 C-N-CA 123.7 0.8 . . . . 74.12 108.956 173.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -82.86 -43.64 16.36 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.349 -0.611 . . . . 75.13 109.349 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.462 ' HE ' HG21 ' A' ' 122' ' ' THR . 45.6 ttt180 -167.78 140.45 3.21 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.985 0.514 . . . . 74.52 110.612 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 62.9 mt -118.31 141.46 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 107.752 -1.203 . . . . 55.22 107.752 173.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.449 ' HE1' HG13 ' B' ' 83' ' ' ILE . 20.7 p90 -170.2 150.89 3.74 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.024 0.44 . . . . 70.33 111.721 -173.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 86.8 m -78.99 124.65 28.46 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.982 -0.747 . . . . 53.12 108.982 171.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -94.45 -27.72 15.86 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.419 0.688 . . . . 71.54 111.449 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -164.58 149.82 9.99 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.382 0.426 . . . . 64.5 111.777 -175.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 47.0 mm -140.26 142.81 30.73 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 C-N-CA 125.808 1.643 . . . . 74.22 109.344 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.573 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 46.5 t -139.17 131.92 29.08 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.261 -1.385 . . . . 73.33 107.261 171.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.562 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.7 t80 -144.46 122.52 12.11 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.1 -1.444 . . . . 61.1 107.1 170.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 40.4 mt-10 -130.61 119.73 22.92 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.148 0.979 . . . . 63.14 108.696 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.658 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -113.25 87.18 10.63 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 107.303 -1.369 . . . . 45.22 107.303 174.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.25 -44.86 0.72 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.6 2.2 . . . . 70.35 112.448 -174.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -92.76 5.72 50.14 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.419 1.088 . . . . 70.35 110.526 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.658 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -32.28 -63.24 0.26 Allowed Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 126.002 1.721 . . . . 42.01 115.406 -171.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 32.4 Cg_exo -54.79 -48.44 21.24 Favored 'Trans proline' 0 C--N 1.402 3.364 0 C-N-CA 122.465 2.11 . . . . 71.04 113.27 -167.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -97.67 -18.02 19.12 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.361 0.874 . . . . 71.31 113.361 -171.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.49 HG22 HD12 ' B' ' 68' ' ' LEU . 7.6 p -74.15 -16.19 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 118.875 0.761 . . . . 74.34 110.639 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -58.17 -23.48 55.53 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.26 1.024 . . . . 75.32 113.569 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -61.19 -23.21 65.42 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.038 0.535 . . . . 64.22 111.407 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.449 ' HB2' HD13 ' B' ' 68' ' ' LEU . 91.2 mttt -91.47 99.47 12.4 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.066 0.947 . . . . 73.35 110.211 -177.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -100.42 80.05 2.19 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.501 -0.772 . . . . 73.22 110.363 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 42.7 p90 -155.02 171.16 20.2 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.443 1.097 . . . . 70.44 108.681 170.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -67.72 112.57 10.8 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 108.916 -0.772 . . . . 73.24 108.916 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.538 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 37.8 Cg_endo -65.74 144.08 76.48 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 121.715 1.61 . . . . 74.43 112.315 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -59.71 113.69 2.38 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.499 1.12 . . . . 73.02 109.83 177.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.666 HG13 HG13 ' B' ' 64' ' ' VAL . 81.6 t -92.23 127.26 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.645 0.778 . . . . 70.35 111.262 -173.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.499 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 38.4 tttp -104.62 107.54 18.54 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.017 -1.475 . . . . 73.43 107.017 173.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 pp -85.97 145.59 27.06 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 109.153 -0.684 . . . . 61.35 109.153 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.537 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 5.8 m-20 -142.07 110.9 6.21 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 106.992 -1.485 . . . . 74.55 106.992 171.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -98.85 135.31 40.49 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.336 -1.357 . . . . 74.32 107.336 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -144.99 156.28 43.86 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.989 -1.115 . . . . 73.15 107.989 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 6.1 t -137.14 142.76 42.25 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.457 0.646 . . . . 55.34 110.507 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.43 145.36 35.2 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.27 -1.382 . . . . 75.33 107.27 174.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.8 p -146.39 166.45 26.32 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.853 0.297 . . . . 73.14 111.143 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.5 p -151.41 137.74 18.49 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.189 0.996 . . . . 71.43 109.103 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -92.86 110.74 22.19 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.026 -0.731 . . . . 75.34 109.026 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 22.9 mt -75.59 -46.68 30.4 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.683 0.754 . . . . 63.2 109.635 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.51 179.45 7.8 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 114.572 -1.195 . . . . 74.14 109.774 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -74.92 128.9 36.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.658 -1.155 . . . . 75.23 108.179 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 73.69 -4.77 2.16 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 125.798 1.639 . . . . 63.42 112.83 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 62.2 t -114.18 113.75 44.7 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 N-CA-C 108.253 -1.017 . . . . 64.13 108.253 172.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.638 ' HB3' HD13 ' B' ' 86' ' ' ILE . 23.1 t80 -125.44 138.25 54.01 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.663 -0.865 . . . . 74.34 108.663 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -113.76 119.75 38.45 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.388 -1.338 . . . . 74.12 107.388 -175.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.431 HG21 ' HB3' ' B' ' 102' ' ' CYS . 33.0 m -116.05 148.93 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.136 0.574 . . . . 32.01 110.37 -177.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 19.3 t -129.59 124.16 58.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 C-N-CA 123.652 0.781 . . . . 60.31 109.11 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 20.0 tp -101.83 108.95 20.6 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 109.318 -0.623 . . . . 64.42 109.318 171.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -88.36 118.47 27.99 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.386 0.674 . . . . 70.13 109.994 175.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.1 t -114.12 103.4 15.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 108.242 -1.022 . . . . 71.22 108.242 176.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 4.7 m -99.62 130.3 45.84 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.267 0.627 . . . . 64.13 109.383 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.666 HG13 HG13 ' B' ' 40' ' ' VAL . 54.3 t -128.43 102.28 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 124.271 1.029 . . . . 74.31 110.564 -176.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 31.9 m -83.71 150.01 26.11 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.279 -1.008 . . . . 62.13 108.279 165.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -138.89 147.91 42.96 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.04 0.536 . . . . 61.42 110.033 177.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 36.2 p -138.92 125.31 20.4 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.121 0.568 . . . . 71.43 110.374 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.538 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 53.2 mt -94.23 100.61 12.64 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.022 -1.473 . . . . 72.32 107.022 173.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.36 -114.27 3.95 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 115.006 -0.997 . . . . 63.2 110.833 -170.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.83 6.32 9.9 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.018 0.927 . . . . 73.14 110.676 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -114.39 152.32 31.7 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.389 0.676 . . . . 65.23 109.22 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.8 m -64.56 137.99 58.15 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 123.648 0.592 . . . . 60.51 111.15 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.535 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -93.19 -63.62 1.19 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.579 -1.267 . . . . 74.12 107.579 170.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -145.56 167.76 22.26 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 114.244 -1.343 . . . . 74.41 110.601 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 61.0 mt -130.78 140.89 50.33 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.491 -2.04 . . . . 75.32 105.491 172.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.9 t -146.92 158.54 43.95 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.639 -0.874 . . . . 73.12 108.639 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.573 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 41.7 tt0 -165.04 132.24 3.01 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.512 -0.922 . . . . 73.04 108.512 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.0 t -128.23 144.54 37.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 123.479 0.712 . . . . 73.51 109.184 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -120.57 101.05 7.49 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.951 -1.129 . . . . 71.2 107.951 169.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.472 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.5 tp-100 -90.71 102.53 15.28 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.147 -1.057 . . . . 74.54 108.147 175.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.5 158.93 27.95 Favored Glycine 0 C--O 1.245 0.79 0 CA-C-N 115.283 -0.871 . . . . 72.02 110.946 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.98 125.87 1.62 Allowed Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 111.02 -0.832 . . . . 61.35 111.02 -178.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.449 HG13 ' HE1' ' B' ' 17' ' ' TYR . 50.9 mt -85.0 125.28 40.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 106.902 -1.518 . . . . 74.11 106.902 172.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 84' ' ' PHE . . . . . 0.415 ' HD2' ' HA ' ' B' ' 13' ' ' ILE . 58.1 m-85 -134.38 154.75 51.19 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.047 -0.724 . . . . 62.22 109.047 176.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 74.0 m -91.7 104.3 16.78 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.674 -0.861 . . . . 75.42 108.674 169.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.638 HD13 ' HB3' ' B' ' 56' ' ' TYR . 3.7 mp -101.37 107.86 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 106.602 -1.629 . . . . 72.4 106.602 173.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.21 171.32 15.11 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.153 0.581 . . . . 51.43 110.632 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.11 -72.54 2.83 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.364 -0.834 . . . . 60.42 111.89 -177.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.56 ' HB ' ' HG2' ' B' ' 9' ' ' MET . 1.4 mm -87.16 144.35 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.029 0.932 . . . . 65.52 111.103 -176.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.48 ' HG2' ' H ' ' B' ' 91' ' ' GLY . 14.9 tt0 -154.69 175.35 13.8 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.177 -1.374 . . . . 74.21 107.611 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.48 ' H ' ' HG2' ' B' ' 90' ' ' GLU . . . 80.24 -113.89 3.74 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-O 120.03 -0.317 . . . . 52.25 112.364 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 8.9 m -73.96 -53.52 9.9 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.259 0.624 . . . . 60.25 111.718 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -70.98 -26.54 63.19 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.252 -0.886 . . . . 65.23 112.292 -165.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 21.0 ptt? -69.46 -25.08 63.92 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 122.977 0.173 . . . . 54.03 111.115 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.66 -38.72 78.76 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.491 0.716 . . . . 44.24 110.944 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -77.95 -37.4 47.68 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.949 -1.023 . . . . 72.14 110.507 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -67.74 -25.73 65.79 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.414 0.686 . . . . 65.2 112.12 -177.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 84.3 mt -93.15 -43.92 8.61 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.184 0.594 . . . . 74.3 110.59 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.72 -18.42 73.06 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 115.152 0.821 . . . . 64.43 115.152 -170.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.05 -43.68 1.95 Allowed 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 117.589 0.694 . . . . 43.1 111.799 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.46 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 27.3 t80 -76.77 -52.5 9.45 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.801 -0.636 . . . . 73.03 111.427 -168.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.431 ' HB3' HG21 ' B' ' 58' ' ' VAL . 70.2 m -62.28 -44.4 88.29 Favored Pre-proline 0 CA--C 1.571 1.781 0 CA-C-O 118.269 -0.872 . . . . 73.21 112.959 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -51.68 -43.46 50.79 Favored 'Trans proline' 0 C--N 1.405 3.502 0 C-N-CA 122.832 2.355 . . . . 55.24 113.324 172.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -55.95 -33.3 64.64 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.152 0.981 . . . . 73.22 112.083 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 52.3 mt -77.57 -48.32 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.749 0.82 . . . . 73.11 110.868 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 79.2 mt -87.48 -19.89 27.33 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.661 0.784 . . . . 64.1 112.806 -167.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -64.15 -44.26 76.61 Favored Pre-proline 0 CA--C 1.563 1.479 0 CA-C-O 117.676 -1.154 . . . . 75.1 112.527 -174.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -53.14 -38.46 80.97 Favored 'Trans proline' 0 C--N 1.392 2.862 0 C-N-CA 122.553 2.169 . . . . 71.04 113.83 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.472 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 72.7 m-85 -70.81 -40.69 72.34 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.583 -0.735 . . . . 74.14 110.51 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.8 -37.03 83.75 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.741 0.416 . . . . 55.41 110.673 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -60.85 -55.76 29.19 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.156 1.383 . . . . 72.32 110.717 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -58.86 -37.97 77.7 Favored 'General case' 0 C--N 1.358 0.945 0 O-C-N 124.009 0.818 . . . . 74.43 110.555 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.434 ' O ' ' HG2' ' B' ' 117' ' ' MET . 16.8 t -67.41 -42.61 82.97 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-N 115.374 -0.83 . . . . 75.33 111.293 -175.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.97 -52.68 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 123.741 0.651 . . . . 74.32 109.541 176.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 10.7 m -60.97 -27.29 68.16 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 124.129 0.893 . . . . 62.01 111.689 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -68.52 -52.04 36.4 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 123.187 0.595 . . . . 62.53 109.67 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.434 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 33.7 mmt -59.56 -38.7 81.82 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.162 0.585 . . . . 63.53 111.063 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' B' ' 123' ' ' PHE . 71.1 t -66.24 -45.63 89.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.789 1.236 . . . . 71.24 111.034 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.7 t -67.63 -29.12 68.35 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.265 0.626 . . . . 52.31 111.107 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -73.34 -38.58 65.7 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.786 0.835 . . . . 74.44 110.042 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.58 -2.5 69.29 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 124.028 0.83 . . . . 65.54 112.5 171.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 20.1 p 63.22 28.87 15.97 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.804 2.042 . . . . 64.5 112.839 174.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.426 ' HB2' HG13 ' B' ' 118' ' ' VAL . 92.2 m-85 -86.93 154.42 55.3 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.886 0.874 . . . . 75.34 110.483 176.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -48.24 153.37 3.02 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 124.095 3.197 . . . . 74.44 115.567 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.474 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -60.63 126.71 28.42 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.557 1.543 . . . . 74.42 111.797 -175.501 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 38.9 tp -127.8 113.89 16.54 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.822 -0.626 . . . . 72.14 110.386 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -121.36 112.65 18.83 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.295 -1.002 . . . . 72.11 108.295 171.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 9.2 tt -78.31 135.23 37.47 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.497 0.719 . . . . 74.44 109.667 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.93 137.34 87.44 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.487 1.115 . . . . 65.4 112.202 -173.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.525 ' HG3' HD13 ' D' ' 16' ' ' ILE . 38.1 Cg_endo -63.8 100.07 0.28 Allowed 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 123.188 2.592 . . . . 72.32 112.647 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 p -91.22 111.2 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-N 115.509 -0.769 . . . . 62.43 109.003 173.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -80.14 100.87 8.46 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.607 0.763 . . . . 74.53 109.113 -177.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -66.38 -41.6 89.15 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.41 0.684 . . . . 74.02 110.932 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 26.2 t70 . . . . . 0 N--CA 1.474 0.745 0 C-N-CA 124.452 1.101 . . . . 62.42 111.941 -174.5 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.589 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.6 t80 . . . . . 0 C--O 1.239 0.532 0 N-CA-C 109.738 -0.467 . . . . 75.33 109.738 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -140.96 123.61 16.07 Favored 'General case' 0 C--O 1.245 0.824 0 N-CA-C 107.611 -1.255 . . . . 70.15 107.611 175.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 70.3 mt -71.4 122.43 23.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.213 -1.032 . . . . 75.34 108.213 171.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.537 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 20.7 mm-40 -85.11 -50.51 7.36 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 124.122 0.889 . . . . 60.22 109.018 -178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -172.41 124.19 0.48 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.951 -0.568 . . . . 70.23 110.214 -172.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 77.1 mt -112.28 143.74 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.55 -0.908 . . . . 72.3 108.55 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -174.94 166.03 3.56 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.674 0.79 . . . . 74.11 109.369 -171.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 18' ' ' THR . . . . . 0.431 HG21 ' SG ' ' C' ' 113' ' ' CYS . 71.8 p -89.64 126.0 35.46 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.278 -0.638 . . . . 61.12 109.278 177.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -74.99 -50.2 17.37 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 122.668 1.223 . . . . 72.34 107.857 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.494 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 10.3 t70 -136.0 136.86 40.65 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 112.651 -2.068 . . . . 51.2 108.969 -166.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 75.2 mt -136.28 142.15 39.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.044 -1.465 . . . . 73.34 107.044 172.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -158.46 151.35 22.44 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.312 0.577 . . . . 45.02 110.328 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -150.32 134.42 17.0 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 107.919 -1.141 . . . . 72.45 107.919 174.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -134.35 137.55 44.23 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.465 0.706 . . . . 71.25 109.659 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.36 80.96 8.24 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 106.125 -1.805 . . . . 51.31 106.125 172.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.65 -8.89 24.07 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.9 2.4 . . . . 54.21 112.878 -171.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.456 ' ND2' ' HB ' ' C' ' 31' ' ' VAL . 20.2 p-10 -124.48 20.95 8.67 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.053 1.341 . . . . 74.15 110.277 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.85 -51.14 17.91 Favored Pre-proline 0 CA--C 1.564 1.511 0 N-CA-C 114.569 1.322 . . . . 64.34 114.569 -168.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.58 -51.13 9.82 Favored 'Trans proline' 0 C--N 1.392 2.845 0 CA-C-N 121.622 1.615 . . . . 54.03 112.169 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.438 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 84.1 t60 -68.38 -29.99 68.82 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.744 0.818 . . . . 53.44 112.28 -174.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.749 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.8 p -77.43 -26.52 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 N-CA-C 112.626 0.602 . . . . 73.22 112.626 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -68.98 -17.98 64.0 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.379 0.881 . . . . 73.3 113.379 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 19.4 pt20 -94.6 8.04 43.66 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.789 0.436 . . . . 70.45 111.181 177.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.766 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -89.78 168.84 11.77 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.005 0.922 . . . . 63.12 110.372 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 35' ' ' ASP . . . . . 0.438 ' N ' ' HG3' ' C' ' 34' ' ' LYS . 31.6 t70 -74.13 130.56 40.02 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.2 0.6 . . . . 75.03 109.66 165.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -80.7 88.93 5.74 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.059 0.544 . . . . 65.34 109.873 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -143.13 77.85 15.58 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 107.971 -1.122 . . . . 74.24 107.971 172.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 38' ' ' PRO . . . . . 0.515 ' HB2' HG13 ' C' ' 40' ' ' VAL . 9.2 Cg_endo -88.11 127.09 2.1 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.968 2.445 . . . . 72.24 112.37 -173.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -82.46 86.5 6.75 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.522 -1.658 . . . . 75.01 106.522 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.515 HG13 ' HB2' ' C' ' 38' ' ' PRO . 3.1 m -82.81 111.29 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 113.18 -1.827 . . . . 64.23 111.006 -173.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -106.31 115.97 31.14 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.838 0.855 . . . . 63.3 109.84 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 8.0 mp -85.66 131.18 34.39 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.302 -0.999 . . . . 60.45 108.302 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.527 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 38.6 t70 -123.63 105.7 9.94 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.814 1.246 . . . . 70.21 107.903 -170.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 32.7 tp -95.66 140.57 30.29 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.728 -0.669 . . . . 74.44 110.006 -173.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.62 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 25.9 t70 -147.14 158.06 43.81 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.853 -1.166 . . . . 71.44 107.853 173.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 73.0 p -122.53 132.25 54.23 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.159 0.584 . . . . 50.45 110.59 -174.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.25 147.43 50.22 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.072 -1.085 . . . . 72.23 108.072 173.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 72.3 p -165.55 159.09 16.33 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.597 0.237 . . . . 62.11 111.609 -174.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 65.2 p -164.15 134.79 4.28 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.536 0.734 . . . . 63.02 110.013 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -77.04 120.6 22.36 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.766 -0.827 . . . . 53.34 108.766 171.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.579 HD11 HD12 ' C' ' 83' ' ' ILE . 43.6 mt -94.14 -39.84 10.36 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.638 0.775 . . . . 55.31 110.155 -176.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.451 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -148.41 -179.19 6.77 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.852 0.861 . . . . 65.42 110.146 177.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -57.23 110.39 0.83 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.629 0.772 . . . . 65.12 109.419 173.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 65.02 1.4 1.47 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.317 1.447 . . . . 61.33 114.35 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 90.1 t -93.18 110.73 23.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 106.914 -1.513 . . . . 73.31 106.914 173.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -125.1 136.25 53.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.911 -0.586 . . . . 75.43 110.137 -171.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.414 ' HB2' HD11 ' C' ' 51' ' ' LEU . 29.6 tt0 -94.05 119.71 33.29 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.222 -0.899 . . . . 52.23 109.234 175.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 61.7 t -104.76 114.04 43.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.419 -1.326 . . . . 71.22 107.419 168.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 63.1 t -105.54 133.24 50.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 107.674 -1.232 . . . . 62.34 107.674 169.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 13.9 tp -116.4 108.62 16.26 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.794 -0.817 . . . . 72.54 108.794 174.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.62 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 0.4 OUTLIER -83.64 114.13 21.33 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.365 -0.976 . . . . 64.31 108.365 179.366 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 12.2 t -110.81 130.13 64.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.076 -1.083 . . . . 64.13 108.076 174.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 31.1 m -124.86 118.52 26.5 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.586 -0.894 . . . . 54.43 108.586 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.543 HG23 HD13 ' C' ' 114' ' ' ILE . 98.9 t -98.77 110.41 26.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.462 -0.94 . . . . 75.31 108.462 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.4 HG23 HD23 ' C' ' 75' ' ' LEU . 11.2 m -96.32 137.7 35.01 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.123 -1.436 . . . . 74.13 107.123 174.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.45 118.38 19.25 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.526 -1.287 . . . . 63.5 107.526 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 60.1 m -138.47 127.78 24.43 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 109.253 -0.647 . . . . 63.44 109.253 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.766 HD13 ' HG2' ' C' ' 34' ' ' LYS . 2.9 mt -83.37 15.6 2.93 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.954 1.302 . . . . 72.12 111.291 -175.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.09 -104.49 0.59 Allowed Glycine 0 C--N 1.344 1.013 0 N-CA-C 109.346 -1.502 . . . . 74.13 109.346 -173.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -88.45 -20.79 24.73 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.348 0.659 . . . . 74.22 110.073 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -89.37 122.54 32.7 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.196 0.998 . . . . 74.53 110.156 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 89.1 m -75.97 125.12 28.5 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.998 -0.742 . . . . 44.45 108.998 166.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.749 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.33 -54.12 7.61 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.173 -0.677 . . . . 74.34 109.173 173.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -164.52 166.26 20.54 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 115.56 -0.745 . . . . 64.43 111.856 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.4 HD23 HG23 ' C' ' 65' ' ' THR . 2.3 tm? -131.6 104.41 6.93 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 106.762 -1.57 . . . . 60.13 106.762 172.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.51 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.8 t -110.19 146.15 36.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.842 0.857 . . . . 71.01 108.999 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -150.58 133.98 16.36 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.003 0.521 . . . . 53.03 109.877 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.5 t -132.54 132.79 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.507 -0.923 . . . . 74.1 108.507 168.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.497 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 61.0 mt-30 -105.56 98.49 8.18 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.701 -1.222 . . . . 74.42 107.701 173.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -82.57 106.98 14.87 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.888 -0.596 . . . . 74.4 110.43 -174.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.65 145.66 21.98 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.902 -0.59 . . . . 74.23 111.69 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.11 117.2 0.8 Allowed Glycine 0 CA--C 1.509 -0.282 0 N-CA-C 110.477 -1.049 . . . . 63.53 110.477 177.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.579 HD12 HD11 ' C' ' 51' ' ' LEU . 13.1 mm -83.87 118.9 32.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.145 -1.057 . . . . 64.32 108.145 177.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.589 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 50.6 m-85 -129.17 128.36 43.23 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.146 0.978 . . . . 71.03 108.71 -176.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.1 p -83.33 115.62 22.08 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.864 -0.791 . . . . 70.21 108.864 172.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 4.4 mp -114.65 100.3 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 107.134 -1.432 . . . . 74.42 107.134 173.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -124.25 152.66 42.72 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.159 0.984 . . . . 63.44 109.034 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.41 -58.25 0.74 Allowed Glycine 0 C--N 1.345 1.04 0 CA-C-O 120.272 -0.182 . . . . 65.12 113.189 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 29.9 pt -81.89 167.44 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 121.111 0.481 . . . . 55.41 111.413 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -150.08 -177.24 5.81 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.292 1.037 . . . . 75.52 110.019 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.71 -139.07 48.74 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 124.266 0.979 . . . . 50.2 114.618 171.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 68.0 p -70.58 -18.75 62.9 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.853 0.861 . . . . 73.34 111.953 -175.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -74.91 -39.14 61.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.274 0.63 . . . . 61.02 109.951 174.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 46.5 ttm -60.81 -49.09 78.89 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.177 0.591 . . . . 73.24 109.815 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.22 -29.98 70.83 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.792 0.837 . . . . 71.13 112.072 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -67.15 -40.92 86.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.215 0.606 . . . . 74.45 110.327 174.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.568 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 15.2 t -64.78 -43.72 92.32 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.529 0.518 . . . . 74.43 110.799 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 86.1 mt -74.73 -36.79 62.65 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.413 0.685 . . . . 73.02 112.19 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.92 -23.89 31.49 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 114.651 0.62 . . . . 72.13 114.651 -165.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.483 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -135.99 -47.03 0.65 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.446 0.641 . . . . 73.31 111.875 -172.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.568 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 82.4 t80 -74.23 -40.78 62.18 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 125.485 1.514 . . . . 74.45 112.604 -170.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 94.5 m -76.71 -43.23 3.04 Favored Pre-proline 0 N--CA 1.487 1.382 0 CA-C-O 118.568 -0.73 . . . . 71.41 111.194 176.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -47.34 -40.06 28.13 Favored 'Trans proline' 0 C--N 1.395 3.009 0 C-N-CA 122.84 2.36 . . . . 70.44 113.376 165.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -59.02 -38.49 79.38 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 123.668 0.605 . . . . 65.44 111.276 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.455 HD12 HH12 ' A' ' 111' ' ' ARG . 36.8 mm -65.27 -44.47 94.97 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 122.822 0.449 . . . . 64.4 109.842 174.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 94.9 mt -83.82 -15.22 49.13 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.816 1.043 . . . . 75.21 113.816 -169.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -58.72 -53.43 66.43 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-O 117.614 -1.184 . . . . 74.12 112.946 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.75 -32.11 78.3 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 121.702 1.601 . . . . 71.11 112.949 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -66.71 -53.69 30.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.371 0.668 . . . . 74.53 110.626 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.49 83.81 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.703 0.801 . . . . 74.4 110.465 177.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -57.77 -57.11 14.19 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.298 1.439 . . . . 71.32 111.287 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -38.0 83.19 Favored 'General case' 0 C--N 1.366 1.296 0 O-C-N 123.716 0.635 . . . . 75.54 109.713 -177.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.431 ' SG ' HG21 ' C' ' 18' ' ' THR . 8.8 t -66.3 -30.52 70.95 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 122.833 0.453 . . . . 62.3 111.761 -176.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.543 HD13 HG23 ' C' ' 64' ' ' VAL . 91.9 mt -74.46 -55.39 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.209 0.604 . . . . 71.33 109.534 173.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 21.8 m -59.99 -27.4 66.83 Favored 'General case' 0 CA--C 1.558 1.27 0 O-C-N 123.787 0.679 . . . . 61.41 111.204 -175.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 46.7 t -63.68 -48.62 76.44 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 124.429 1.092 . . . . 43.31 109.82 174.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.647 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -66.45 -36.26 82.34 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.115 0.966 . . . . 74.5 111.686 179.129 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 76.1 t -61.75 -41.12 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.561 0.744 . . . . 74.31 109.507 172.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.0 t -74.82 -28.86 60.88 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.95 -1.023 . . . . 73.14 111.763 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' C' ' 116' ' ' SER . 80.5 mtt-85 -73.0 -38.62 66.53 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.815 -0.809 . . . . 74.22 108.815 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.27 -4.92 70.22 Favored Glycine 0 C--N 1.356 1.691 0 CA-C-N 115.375 -0.829 . . . . 61.22 112.777 171.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 19.6 p 64.91 27.67 12.75 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.673 1.989 . . . . 75.41 113.157 171.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -83.99 142.25 41.49 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 108.263 -1.014 . . . . 75.32 108.263 170.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.54 163.44 1.16 Allowed 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.65 2.9 . . . . 70.35 114.711 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -54.33 134.08 45.21 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.326 1.05 . . . . 64.34 113.112 -171.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 27.5 tp -134.93 85.96 2.22 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.51 -1.293 . . . . 74.34 107.51 174.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -96.21 115.54 27.59 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.845 -1.07 . . . . 63.2 109.067 -175.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.24 121.61 14.11 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.747 0.819 . . . . 72.43 109.069 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.61 137.9 74.06 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 123.065 0.546 . . . . 71.21 111.286 -177.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.588 ' HB3' HD12 ' A' ' 16' ' ' ILE . 9.6 Cg_endo -52.47 109.51 0.35 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.139 2.559 . . . . 63.22 114.383 175.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 10.1 m -121.19 112.02 33.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 107.784 -1.191 . . . . 74.23 107.784 165.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -74.49 94.04 2.55 Favored 'General case' 0 C--N 1.354 0.774 0 N-CA-C 108.759 -0.83 . . . . 74.32 108.759 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -54.91 -34.18 62.86 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.943 1.697 . . . . 72.44 111.902 -173.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 134' ' ' ASP . . . . . 0.483 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 9.7 t70 . . . . . 0 CA--C 1.54 0.592 0 C-N-CA 124.42 1.088 . . . . 73.42 111.178 -177.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 64.5 m . . . . . 0 C--O 1.242 0.701 0 N-CA-C 108.718 -0.845 . . . . 75.32 108.718 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' D' ' 85' ' ' SER . 25.0 t80 -158.58 119.85 3.43 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.757 -0.831 . . . . 74.34 108.757 177.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -138.86 145.24 39.73 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.759 1.224 . . . . 73.33 108.118 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 52.4 mt -91.77 127.62 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.24 -0.652 . . . . 73.11 109.24 176.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -97.53 -46.63 5.97 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 122.531 0.333 . . . . 75.15 111.061 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -167.77 127.53 1.34 Allowed 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 117.816 0.28 . . . . 75.31 111.527 -170.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.525 HD13 ' HG3' ' B' ' 130' ' ' PRO . 2.4 mp -103.82 138.05 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.358 -1.349 . . . . 74.31 107.358 167.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -163.94 149.4 10.79 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 123.813 0.695 . . . . 73.2 110.658 176.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.1 p -83.36 116.85 22.66 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.419 -0.81 . . . . 74.41 109.212 174.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -84.74 -35.87 22.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.635 -0.876 . . . . 71.01 108.635 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.619 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 12.7 t70 -143.25 129.23 19.57 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.283 -1.326 . . . . 74.31 109.129 -174.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.647 HG21 ' HE2' ' C' ' 117' ' ' MET . 62.1 mt -135.56 148.45 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.643 1.177 . . . . 71.12 108.612 174.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.6 t -147.17 142.87 27.77 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.027 0.931 . . . . 55.21 109.536 171.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 83.1 t80 -146.63 119.93 8.96 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 105.252 -2.129 . . . . 73.04 105.252 172.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.8 mt-10 -134.98 109.94 8.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.311 0.645 . . . . 73.22 109.386 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.24 90.95 5.11 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 107.734 -1.21 . . . . 73.14 107.734 175.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -73.5 -33.36 6.92 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.726 2.284 . . . . 72.4 112.554 -169.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -110.4 18.53 19.73 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.143 0.977 . . . . 74.12 109.897 -175.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -34.22 -61.01 0.45 Allowed Pre-proline 0 CA--C 1.569 1.685 0 N-CA-C 116.309 1.966 . . . . 50.43 116.309 -161.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.436 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 93.1 Cg_endo -76.36 -26.88 8.39 Favored 'Trans proline' 0 C--N 1.385 2.481 0 CA-C-N 122.996 2.106 . . . . 71.34 113.202 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -66.38 -44.36 83.31 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.507 1.123 . . . . 64.44 109.624 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' D' ' 73' ' ' ALA . 12.0 p -82.46 -16.42 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-N 115.202 -0.908 . . . . 71.41 111.446 -172.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.436 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 16.7 m-85 -64.75 -26.2 68.26 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.102 0.408 . . . . 64.51 112.102 177.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -58.27 -21.92 50.48 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.842 0.857 . . . . 71.02 111.198 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.403 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 88.3 mttt -93.73 97.5 10.49 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.931 1.292 . . . . 72.12 109.09 173.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -104.9 85.29 2.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.718 0.771 . . . . 74.42 109.324 177.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 19.1 p90 -149.25 -173.16 4.31 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.688 -1.142 . . . . 73.44 108.075 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -77.14 113.13 28.01 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.147 0.579 . . . . 64.44 110.237 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.23 130.37 39.04 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.664 2.243 . . . . 75.54 112.696 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.56 112.18 3.05 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.795 -0.817 . . . . 63.42 108.795 172.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 13.9 m -101.81 125.37 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.745 0.818 . . . . 74.31 110.91 -171.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.646 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 0.1 OUTLIER -104.82 111.92 24.84 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.68 1.192 . . . . 73.1 108.096 179.032 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 50.2 tp -98.45 126.22 43.91 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 122.759 0.423 . . . . 73.1 110.004 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -141.25 125.72 17.7 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.78 0.832 . . . . 75.32 109.019 174.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.95 146.67 27.53 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.519 0.728 . . . . 73.22 110.418 -176.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -134.53 156.04 49.34 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.842 1.257 . . . . 71.55 108.159 171.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 5.9 t -127.8 151.4 49.08 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.48 0.657 . . . . 65.31 110.937 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.81 152.62 36.82 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.302 -1.37 . . . . 32.42 107.302 168.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 77.6 p -172.75 153.41 2.71 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.831 0.452 . . . . 70.11 110.752 -175.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 37.2 p -169.48 159.11 8.32 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.069 0.948 . . . . 75.42 109.772 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -90.47 134.77 34.13 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.386 -0.598 . . . . 73.53 109.386 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.508 ' HB2' HG12 ' D' ' 55' ' ' VAL . 63.9 mt -99.68 -42.31 6.93 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.035 0.534 . . . . 71.3 110.7 -177.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.42 -168.94 2.73 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.334 0.653 . . . . 63.33 110.388 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.04 118.36 9.7 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.539 -0.541 . . . . 52.03 109.539 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 64.4 4.65 2.28 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.016 1.327 . . . . 74.4 112.779 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.508 HG12 ' HB2' ' D' ' 51' ' ' LEU . 79.3 t -110.67 129.27 66.12 Favored 'Isoleucine or valine' 0 C--N 1.351 0.638 0 C-N-CA 124.624 1.17 . . . . 71.31 108.6 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -145.37 172.9 12.51 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.691 -0.855 . . . . 65.13 108.691 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -132.29 145.48 51.31 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.097 -0.956 . . . . 75.12 110.12 174.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.459 HG21 ' HB3' ' D' ' 102' ' ' CYS . 15.1 m -129.32 142.12 44.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.204 1.002 . . . . 73.34 108.678 167.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.405 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 39.4 t -128.44 117.23 44.59 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 C-N-CA 124.322 1.049 . . . . 62.24 108.223 -175.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.571 HD22 ' HB2' ' D' ' 103' ' ' PRO . 60.9 tp -103.61 119.13 38.28 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.714 -0.476 . . . . 65.42 109.714 174.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -88.17 108.09 19.1 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.047 -0.723 . . . . 74.12 109.047 170.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 41.1 t -91.89 128.41 43.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.356 -1.35 . . . . 73.31 107.356 166.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.4 m -125.17 125.2 43.3 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.582 0.706 . . . . 54.14 110.807 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 48.2 t -115.59 100.76 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.034 1.734 . . . . 74.45 108.242 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.646 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 91.8 m -96.35 102.5 14.29 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.062 -1.088 . . . . 65.25 108.062 172.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.16 139.67 39.48 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.371 -0.831 . . . . 71.01 109.441 -170.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.428 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 61.3 p -147.53 126.32 12.66 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.054 0.454 . . . . 64.33 111.52 -173.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.444 HD12 HG22 ' D' ' 31' ' ' VAL . 51.4 mt -98.54 113.91 26.13 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.269 1.028 . . . . 75.02 108.479 175.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.73 -128.32 9.1 Favored Glycine 0 C--N 1.343 0.935 0 O-C-N 123.383 0.427 . . . . 72.42 113.04 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.03 18.95 20.98 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.043 0.537 . . . . 73.05 110.879 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 71' ' ' GLU . . . . . 0.403 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 11.7 pt-20 -140.32 167.41 22.2 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.261 0.624 . . . . 61.3 110.07 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 77.0 m -74.35 139.5 44.16 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.461 0.704 . . . . 71.33 110.551 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.601 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.94 -64.77 1.1 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 107.717 -1.216 . . . . 64.11 107.717 171.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -156.8 162.97 39.72 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 114.497 -1.229 . . . . 74.01 110.176 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 84.8 mt -121.44 112.27 18.33 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 124.728 1.211 . . . . 63.02 107.921 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -114.05 133.82 55.27 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.208 -1.034 . . . . 72.11 108.208 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -156.6 120.56 4.36 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.186 -0.672 . . . . 65.32 109.186 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 80.8 t -130.61 114.32 27.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.643 -0.873 . . . . 72.33 108.643 -176.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.619 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 37.5 mt-30 -88.94 87.71 7.32 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 108.489 -0.93 . . . . 73.52 108.489 170.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -80.03 104.51 10.64 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 113.745 -1.571 . . . . 74.42 108.167 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -101.98 150.98 18.38 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 111.236 -0.746 . . . . 54.34 111.236 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.31 131.13 3.94 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.738 -0.545 . . . . 63.22 111.738 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.9 mt -88.38 123.18 40.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 107.572 -1.27 . . . . 74.13 107.572 171.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -131.51 169.35 16.21 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.254 1.021 . . . . 45.14 108.942 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 25.5 m -112.65 136.03 52.68 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.058 0.943 . . . . 73.12 108.862 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.59 HG12 HD13 ' D' ' 89' ' ' ILE . 12.1 tt -145.79 137.57 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.352 -0.981 . . . . 72.54 108.352 176.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.09 127.4 1.83 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.502 0.321 . . . . 63.31 111.073 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.1 4.81 55.21 Favored Glycine 0 C--N 1.346 1.129 0 O-C-N 123.613 0.57 . . . . 74.03 113.228 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.59 HD13 HG12 ' D' ' 86' ' ' ILE . 3.3 mp -115.56 150.21 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.385 0.674 . . . . 65.54 110.208 -175.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.24 176.06 6.99 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.567 1.547 . . . . 60.33 109.004 173.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.89 -129.32 46.39 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 114.58 0.592 . . . . 75.34 114.58 175.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.8 m -71.56 -33.49 69.14 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.535 1.134 . . . . 51.34 112.225 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -64.21 -30.37 71.44 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.823 0.849 . . . . 65.14 111.566 -177.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 48.0 mtm -62.18 -39.33 92.34 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.919 0.488 . . . . 73.12 111.473 174.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.99 -36.98 83.13 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.857 0.463 . . . . 75.4 112.08 -173.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 96' ' ' HIS . . . . . 0.491 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 54.5 t-80 -81.21 -29.27 34.57 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.339 0.256 . . . . 74.53 111.576 177.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 34.5 t -70.75 -49.91 41.73 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.286 0.565 . . . . 75.11 110.832 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 29.4 mt -93.8 -45.0 7.85 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 124.464 1.105 . . . . 62.35 110.973 -166.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.33 -1.25 88.17 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-O 119.825 -0.431 . . . . 73.23 113.534 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -133.01 -68.46 0.59 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.475 0.637 . . . . 54.2 111.317 -178.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -70.82 -42.9 69.63 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 112.896 0.702 . . . . 70.42 112.896 -167.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.459 ' HB3' HG21 ' D' ' 58' ' ' VAL . 66.6 m -62.04 -50.29 81.29 Favored Pre-proline 0 CA--C 1.568 1.664 0 N-CA-C 112.881 0.697 . . . . 54.44 112.881 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.571 ' HB2' HD22 ' D' ' 60' ' ' LEU . 98.2 Cg_endo -77.52 -7.58 16.86 Favored 'Trans proline' 0 C--N 1.39 2.715 0 C-N-CA 122.267 1.978 . . . . 74.23 112.711 175.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -77.51 -30.57 52.99 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.765 -0.828 . . . . 61.33 108.765 171.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.1 mm -70.51 -38.22 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.518 0.727 . . . . 54.42 109.638 169.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.98 -11.35 59.58 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.488 0.715 . . . . 63.3 111.771 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 107' ' ' PHE . . . . . 0.432 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 86.5 t80 -65.97 -51.63 45.64 Favored Pre-proline 0 CA--C 1.567 1.634 0 C-N-CA 124.2 1.0 . . . . 73.12 112.605 -177.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 108' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 34.3 Cg_exo -60.64 -32.32 93.15 Favored 'Trans proline' 0 C--N 1.395 2.979 0 C-N-CA 122.128 1.885 . . . . 74.04 112.814 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -80.76 -32.07 35.67 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.865 0.866 . . . . 74.14 112.177 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.1 -46.37 81.35 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.804 -0.813 . . . . 64.05 108.804 173.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -62.23 -41.24 98.23 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 124.228 0.955 . . . . 71.42 110.839 177.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -51.68 -53.64 36.83 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.428 1.091 . . . . 65.11 111.131 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.1 t -67.74 -46.75 71.25 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.191 -0.913 . . . . 55.31 111.485 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.484 ' O ' HG23 ' D' ' 118' ' ' VAL . 84.7 mt -62.2 -57.58 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.474 0.71 . . . . 73.22 110.841 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 90.9 m -49.95 -45.75 51.61 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.32 1.013 . . . . 53.44 111.734 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.5 t -64.97 -43.31 93.05 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.083 -0.962 . . . . 73.22 110.955 -175.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.423 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 73.3 mtm -65.05 -36.35 84.07 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.79 0.436 . . . . 64.14 111.559 179.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.484 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.7 t -62.53 -44.67 99.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.789 0.835 . . . . 51.12 110.366 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.2 p -76.86 -26.25 54.03 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 116.08 -0.509 . . . . 51.54 111.38 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -72.98 -34.24 66.32 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.434 0.694 . . . . 70.5 109.892 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.35 3.17 79.12 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 115.582 -0.736 . . . . 43.23 112.393 171.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.0 p 60.39 24.38 13.92 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 126.866 2.067 . . . . 55.52 113.669 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -82.43 158.89 65.55 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 124.095 0.958 . . . . 75.41 109.585 169.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -49.64 127.49 18.73 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 123.369 2.713 . . . . 74.12 113.31 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -52.08 131.24 31.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.288 1.035 . . . . 72.32 111.27 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 45.8 tp -124.08 97.86 5.53 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.243 0.617 . . . . 74.32 110.15 -172.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -101.87 121.41 42.06 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.805 0.842 . . . . 73.12 109.664 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 tt -74.3 115.88 14.32 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 108.463 -0.94 . . . . 61.05 108.463 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.47 143.86 98.56 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.684 0.794 . . . . 61.15 111.644 -176.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.46 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 6.8 Cg_exo -70.48 121.88 8.39 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.696 2.264 . . . . 64.14 111.535 -177.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 N--CA 1.482 1.165 0 C-N-CA 124.008 0.923 . . . . 74.24 110.743 -178.747 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.535 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 41.2 t80 . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.287 0.089 . . . . 63.22 110.808 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -158.43 116.39 2.96 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.697 0.623 . . . . 74.21 109.872 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.617 HG12 ' HD2' ' A' ' 84' ' ' PHE . 57.7 mt -72.6 114.71 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 109.416 -0.587 . . . . 73.13 109.416 177.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -82.76 -34.58 27.07 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.003 -0.998 . . . . 72.02 109.921 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -173.18 149.34 1.79 Allowed 'General case' 0 C--N 1.36 1.031 0 O-C-N 123.714 0.634 . . . . 75.31 110.679 -171.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.567 HD12 ' HG3' ' C' ' 130' ' ' PRO . 75.0 mt -141.52 134.6 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 124.23 1.012 . . . . 62.4 108.332 174.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.48 ' HB3' HG23 ' B' ' 122' ' ' THR . 32.9 p90 -167.32 176.85 6.42 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.983 0.897 . . . . 74.52 110.97 -173.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.1 p -101.54 116.86 33.72 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.737 -1.209 . . . . 63.02 107.737 174.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 42.8 mtpt -75.78 -41.95 51.52 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.733 0.777 . . . . 72.3 109.002 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 15.9 t70 -135.73 143.35 45.29 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 113.731 -1.577 . . . . 64.24 109.72 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 92.6 mt -138.62 143.66 31.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 125.743 1.617 . . . . 73.34 106.962 176.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -153.46 138.57 17.36 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.477 -0.564 . . . . 71.13 109.477 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.457 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 93.9 t80 -143.29 120.57 11.56 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 106.852 -1.536 . . . . 74.44 106.852 176.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -120.53 148.78 43.39 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.241 -0.652 . . . . 73.21 109.241 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.87 80.27 14.02 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 106.359 -1.719 . . . . 51.03 106.359 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.3 -50.26 12.61 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 123.364 2.709 . . . . 72.34 112.841 -169.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.77 33.84 3.58 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 114.867 -1.06 . . . . 61.23 108.614 -176.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.445 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -47.65 -53.09 33.24 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 113.467 0.914 . . . . 73.25 113.467 -176.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.48 -15.41 45.15 Favored 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 121.536 1.491 . . . . 73.33 112.847 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -97.93 -31.14 12.34 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.259 1.023 . . . . 63.15 110.413 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.862 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.5 p -77.42 -16.78 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.351 0.66 . . . . 51.32 112.27 -164.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -77.76 1.1 21.17 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 122.901 0.48 . . . . 74.15 111.27 174.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -89.9 -24.66 21.29 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.665 1.186 . . . . 64.22 110.568 168.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 71' ' ' GLU . 30.8 mmmt -66.85 165.5 15.18 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.422 1.089 . . . . 52.14 112.513 -176.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -84.49 138.14 32.95 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 108.011 -1.107 . . . . 62.11 108.011 167.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 26.8 t-105 -72.62 89.37 1.31 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.902 -1.147 . . . . 73.1 107.902 173.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.475 ' H ' HD22 ' A' ' 68' ' ' LEU . 35.3 tt0 -131.1 65.35 76.46 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 125.539 1.536 . . . . 74.02 107.115 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.12 120.82 4.24 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.363 2.042 . . . . 71.55 111.996 -168.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -96.11 99.58 11.31 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.4 -1.333 . . . . 64.3 107.4 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.1 m -74.81 120.9 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-N 114.793 -1.094 . . . . 64.32 111.219 -172.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.537 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 39.7 ttmt -118.24 114.13 22.54 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.032 -1.099 . . . . 72.45 108.032 173.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.468 HD23 ' H ' ' A' ' 42' ' ' LEU . 2.4 pt? -114.81 131.96 56.64 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.796 -0.816 . . . . 75.23 108.796 173.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -126.37 135.07 51.0 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.33 1.052 . . . . 70.14 108.418 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -113.38 122.75 48.31 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.284 -0.636 . . . . 73.35 109.284 -175.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.626 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 16.6 t70 -119.65 124.17 45.65 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.313 1.045 . . . . 61.01 108.221 177.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.1 p -106.74 125.96 51.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.254 0.621 . . . . 64.22 110.041 -174.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.46 152.42 50.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.03 0.932 . . . . 70.23 109.514 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.9 p -131.37 165.05 24.32 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.383 0.673 . . . . 71.42 110.359 -177.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.7 t -163.51 121.33 1.89 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.805 -0.634 . . . . 63.45 109.653 175.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -82.33 120.03 24.89 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.413 -1.328 . . . . 74.55 107.413 166.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.645 HD11 ' HB2' ' A' ' 57' ' ' GLU . 24.4 mt -93.13 -40.19 10.63 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.754 -0.832 . . . . 73.44 108.754 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.86 -175.66 4.52 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.813 1.245 . . . . 72.34 109.574 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.1 123.12 20.21 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.061 -0.718 . . . . 75.22 109.061 173.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 69.88 -4.71 1.4 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.943 1.297 . . . . 54.42 112.696 -176.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.4 t -109.68 108.93 26.6 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 N-CA-C 108.05 -1.092 . . . . 62.35 108.05 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -130.07 157.63 41.84 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.352 -0.61 . . . . 73.11 109.352 -173.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.645 ' HB2' HD11 ' A' ' 51' ' ' LEU . 38.9 tt0 -130.59 135.54 47.99 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.067 0.947 . . . . 74.24 108.898 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.6 m -121.85 136.16 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 108.041 -1.096 . . . . 51.11 108.041 165.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.4 t -122.71 127.54 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.05 0.94 . . . . 60.34 109.238 -174.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 tt -117.25 107.41 14.39 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.603 -0.888 . . . . 73.24 108.603 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.626 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 10.9 ttm180 -84.88 104.39 14.79 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.284 1.034 . . . . 53.31 109.715 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 37.3 t -96.01 103.28 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 108.598 -0.89 . . . . 75.54 108.598 174.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.9 m -97.04 108.47 21.21 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.62 0.768 . . . . 73.41 109.852 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.763 HG11 HD21 ' A' ' 126' ' ' LEU . 42.1 t -103.04 139.11 24.85 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 C-N-CA 123.974 0.909 . . . . 71.15 110.588 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 25.5 m -132.14 141.05 48.99 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.898 0.879 . . . . 74.52 108.693 175.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.04 109.66 14.37 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.861 -0.792 . . . . 72.22 108.861 174.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.9 m -108.87 127.37 53.98 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.407 0.683 . . . . 75.45 109.282 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.475 HD22 ' H ' ' A' ' 37' ' ' GLN . 15.8 mt -99.7 78.37 2.14 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.874 -1.158 . . . . 74.13 107.874 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.69 -83.39 1.14 Allowed Glycine 0 C--N 1.349 1.264 0 N-CA-C 111.502 -0.639 . . . . 61.2 111.502 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -119.98 -28.96 5.05 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.737 0.815 . . . . 72.32 111.315 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.404 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 35.7 tt0 -99.95 128.79 46.0 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.633 -0.667 . . . . 71.45 110.589 -174.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.0 m -69.66 131.36 44.48 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.85 0.86 . . . . 45.2 110.902 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.862 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -74.22 -63.2 1.28 Allowed 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.514 -0.921 . . . . 73.33 108.514 168.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -155.47 163.14 40.43 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.402 -1.272 . . . . 74.23 111.322 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.2 tp -119.02 146.0 45.4 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 113.824 -1.534 . . . . 71.22 107.522 167.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.9 m -138.89 134.37 33.16 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.836 -1.172 . . . . 62.0 107.836 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -148.16 116.39 6.51 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.171 -0.678 . . . . 64.22 109.171 174.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.8 t -124.74 126.34 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 123.733 0.813 . . . . 63.02 109.051 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.414 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 64.0 mt-30 -101.48 89.05 3.6 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.227 -1.027 . . . . 73.14 108.227 172.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.42 ' HG3' HD22 ' A' ' 106' ' ' LEU . 66.5 tp60 -76.81 98.25 4.77 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.615 -1.175 . . . . 72.03 108.48 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.51 142.95 16.36 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 111.338 -0.705 . . . . 75.52 111.338 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.428 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -140.85 126.21 3.05 Favored Glycine 0 CA--C 1.502 -0.733 0 N-CA-C 110.815 -0.914 . . . . 72.34 110.815 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.2 mt -82.47 119.01 31.18 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 108.321 -0.992 . . . . 65.23 108.321 173.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.617 ' HD2' HG12 ' A' ' 13' ' ' ILE . 24.2 m-85 -131.04 130.22 43.0 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.533 -0.914 . . . . 74.42 108.533 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 43.9 t -76.2 108.03 8.85 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.513 -0.921 . . . . 55.31 108.513 172.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.7 mt . . . . . 0 N--CA 1.481 1.095 0 C-N-CA 123.287 0.635 . . . . 73.12 110.332 -173.603 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.421 ' HA ' ' HG ' ' A' ' 98' ' ' LEU . . . . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 120.591 0.234 . . . . 62.35 111.246 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.494 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 22.3 t-80 -68.4 -35.15 77.25 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.573 0.749 . . . . 73.4 110.674 172.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.3 t -74.96 -52.11 11.99 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.244 -0.285 . . . . 74.42 110.735 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.421 ' HG ' ' HA ' ' A' ' 95' ' ' ALA . 4.6 pp -76.34 -20.6 57.08 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.353 0.501 . . . . 64.31 112.353 -175.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.46 2.99 20.24 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 114.971 0.749 . . . . 75.22 114.971 -173.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -142.24 -52.96 0.41 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 118.031 0.915 . . . . 64.23 111.946 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.52 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 79.4 t80 -78.36 -68.18 0.67 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 122.895 0.478 . . . . 50.43 111.776 -172.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.46 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 76.8 m -63.94 -34.09 11.27 Favored Pre-proline 0 CA--C 1.567 1.632 0 N-CA-C 114.534 1.309 . . . . 63.42 114.534 -173.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 22.6 Cg_endo -62.25 -33.31 81.38 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 121.834 1.689 . . . . 51.51 112.902 167.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -80.18 -17.59 52.0 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.635 0.374 . . . . 73.55 110.921 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.7 mm -65.82 -39.38 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 108.92 -0.77 . . . . 75.04 108.92 168.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.428 HD21 ' HA3' ' A' ' 82' ' ' GLY . 91.6 mt -77.15 -19.97 56.14 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.704 0.802 . . . . 61.12 112.205 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -61.24 -49.31 88.65 Favored Pre-proline 0 CA--C 1.571 1.781 0 N-CA-C 113.954 1.094 . . . . 75.11 113.954 -172.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -63.76 -38.42 39.87 Favored 'Trans proline' 0 C--N 1.391 2.81 0 C-N-CA 122.071 1.847 . . . . 61.44 112.654 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -68.48 -35.56 77.7 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.782 -0.645 . . . . 74.51 110.876 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.88 -42.98 76.25 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.238 0.615 . . . . 72.24 110.489 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.538 ' NH1' HD12 ' C' ' 105' ' ' ILE . 37.6 ttm180 -54.6 -53.82 49.59 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 124.164 0.915 . . . . 74.24 109.936 174.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -66.68 -39.38 88.1 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.366 1.042 . . . . 75.2 111.821 -171.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.79 -42.04 92.53 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.539 0.524 . . . . 72.24 110.287 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.414 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.2 mt -67.09 -47.5 81.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 115.281 -0.872 . . . . 74.03 110.165 175.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.9 m -56.06 -41.74 75.55 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.742 0.817 . . . . 75.23 111.358 -177.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.2 t -69.6 -45.01 69.57 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.198 -0.91 . . . . 74.22 110.766 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.459 ' SD ' HG23 ' A' ' 21' ' ' ILE . 9.2 mtp -58.51 -44.62 89.53 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.636 0.774 . . . . 75.43 111.238 177.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 114' ' ' ILE . 77.8 t -64.32 -42.89 96.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 114.774 -1.103 . . . . 74.34 110.766 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.3 t -72.22 -32.87 67.14 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.855 -0.612 . . . . 73.43 111.071 -176.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.465 HH12 ' HG3' ' B' ' 112' ' ' GLU . 81.4 mtt-85 -72.57 -29.42 63.52 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.534 0.734 . . . . 62.35 109.322 175.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.454 ' O ' HG22 ' A' ' 122' ' ' THR . . . -83.38 10.0 60.03 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-N 115.307 -0.861 . . . . 74.41 113.222 173.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.5 t 64.09 12.7 7.2 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 126.928 2.091 . . . . 54.23 113.628 173.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -84.72 150.98 57.51 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 109.119 -0.697 . . . . 74.3 109.119 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.53 141.58 41.89 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.211 2.607 . . . . 62.32 112.855 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -53.93 132.31 41.83 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 124.035 0.834 . . . . 74.5 112.162 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.763 HD21 HG11 ' A' ' 64' ' ' VAL . 60.2 tp -123.79 102.43 7.81 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.781 -1.1 . . . . 73.02 110.176 -171.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -111.01 126.35 54.7 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.111 0.965 . . . . 63.02 109.145 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 129' ' ' ALA . 3.5 tt -67.55 143.52 56.08 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 108.155 -1.054 . . . . 75.01 108.155 172.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.407 ' N ' HD23 ' A' ' 128' ' ' LEU . . . -56.81 140.42 76.04 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 123.678 0.791 . . . . 71.12 111.407 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.405 ' HA ' HH22 ' A' ' 111' ' ' ARG . 37.0 Cg_endo -65.12 95.35 0.25 Allowed 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.824 2.349 . . . . 73.22 113.015 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.31 112.49 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.156 -0.929 . . . . 74.21 109.318 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -100.97 100.27 10.86 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.556 -1.276 . . . . 74.3 107.556 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 . . . . . 0 N--CA 1.483 1.205 0 C-N-CA 123.613 0.765 . . . . 61.43 110.917 -175.492 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 1.6 tmt? . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 111.644 0.239 . . . . 72.15 111.644 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 92.7 m -162.34 138.48 7.6 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.334 1.053 . . . . 72.43 108.895 172.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' B' ' 85' ' ' SER . 0.2 OUTLIER -136.35 154.67 50.77 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.45 0.643 . . . . 72.04 109.598 157.283 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -127.71 140.86 51.8 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 114.687 -1.142 . . . . 74.44 108.239 169.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.57 HD11 HD13 ' B' ' 105' ' ' ILE . 46.7 mt -72.13 119.76 19.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 O-C-N 124.143 0.902 . . . . 70.3 108.739 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -88.54 -49.87 6.64 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.637 0.775 . . . . 71.02 109.302 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.417 ' HE ' HG21 ' A' ' 122' ' ' THR . 48.2 ttt180 -163.38 132.8 4.1 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.952 -0.567 . . . . 75.12 110.488 -176.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 94.6 mt -114.23 136.04 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 107.595 -1.261 . . . . 64.24 107.595 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -164.62 146.21 8.21 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.553 0.692 . . . . 75.1 112.432 -175.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 35.3 m -73.45 121.4 20.48 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.16 -1.382 . . . . 53.41 109.27 171.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.447 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 41.2 mtpt -98.32 -27.73 13.99 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.953 0.901 . . . . 65.12 111.393 -176.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 34.9 t70 -158.39 138.03 11.95 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.458 0.473 . . . . 75.4 110.531 -168.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.425 HD11 ' SG ' ' B' ' 113' ' ' CYS . 45.3 mm -142.07 143.16 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.919 1.288 . . . . 74.04 108.976 -177.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 10.2 m -144.57 128.44 17.37 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.313 1.445 . . . . 73.53 107.665 170.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.495 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.2 t80 -133.9 109.56 9.13 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.373 -1.714 . . . . 71.53 106.373 166.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -122.39 110.66 15.91 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.807 -0.812 . . . . 65.43 108.807 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.484 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -107.55 87.28 3.32 Favored Pre-proline 0 C--O 1.241 0.624 0 N-CA-C 107.575 -1.268 . . . . 74.21 107.575 174.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -64.97 -34.67 46.86 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.719 2.279 . . . . 60.21 112.216 -170.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -102.25 6.04 40.37 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 117.645 -1.169 . . . . 71.02 112.06 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.484 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -28.66 -66.71 0.12 Allowed Pre-proline 0 N--CA 1.511 2.618 0 N-CA-C 114.785 1.402 . . . . 71.23 114.785 -168.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.432 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 28.2 Cg_endo -63.53 -29.77 70.86 Favored 'Trans proline' 0 C--N 1.398 3.134 0 C-N-CA 122.098 1.865 . . . . 73.24 112.879 -172.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.437 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 63.1 m80 -86.78 -36.31 18.65 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.464 -0.789 . . . . 72.1 112.02 -176.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.667 HG22 HD12 ' B' ' 68' ' ' LEU . 8.5 p -74.77 -16.59 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 C-N-CA 122.903 0.481 . . . . 51.02 111.883 -171.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -62.22 -21.2 64.95 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.422 0.689 . . . . 70.13 112.712 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.458 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.7 pt20 -56.53 -32.0 64.67 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.491 0.716 . . . . 73.21 110.919 174.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.458 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 99.2 mttt -91.28 69.44 6.04 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.476 1.11 . . . . 72.2 109.159 177.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -83.0 89.02 6.85 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.244 0.545 . . . . 72.15 110.95 -174.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 28.2 p90 -156.06 175.44 13.96 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.211 1.004 . . . . 74.4 108.406 169.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -71.87 109.05 4.85 Favored Pre-proline 0 CA--C 1.554 1.106 0 N-CA-C 109.601 -0.518 . . . . 61.45 109.601 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.62 149.12 79.23 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.6 2.2 . . . . 70.24 113.143 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.71 106.59 1.53 Allowed 'General case' 0 C--N 1.352 0.701 0 N-CA-C 108.367 -0.975 . . . . 74.43 108.367 174.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -96.52 137.71 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-O 121.742 0.782 . . . . 70.4 111.362 -175.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.478 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 79.0 tttt -109.03 145.81 34.96 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.015 1.326 . . . . 44.53 108.139 168.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 pp -127.83 163.14 25.05 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.844 0.458 . . . . 75.52 110.21 170.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.54 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 32.2 t70 -157.14 154.79 29.92 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.606 0.762 . . . . 63.33 109.247 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -130.94 129.28 41.97 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.251 0.62 . . . . 74.33 109.595 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -124.81 155.69 38.99 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.702 -0.851 . . . . 75.01 108.702 173.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 60.4 p -120.49 133.87 55.35 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.253 0.549 . . . . 71.44 111.497 -170.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.11 161.28 40.54 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.528 1.131 . . . . 63.44 108.764 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 54.5 m -143.13 -175.71 4.63 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.653 0.381 . . . . 74.32 111.048 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.3 p -164.87 137.84 4.68 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.954 0.902 . . . . 62.22 109.58 169.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -89.03 133.25 34.41 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 120.732 0.301 . . . . 71.33 110.704 177.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 40.6 mt -102.03 -44.31 5.51 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.846 0.858 . . . . 63.23 110.457 174.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.34 -169.65 2.54 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.197 -0.91 . . . . 42.51 109.884 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.89 117.65 8.57 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.631 -1.168 . . . . 72.3 108.818 171.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 69.07 5.29 4.99 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.374 1.07 . . . . 65.44 112.486 173.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 56.0 t -112.48 106.44 20.76 Favored 'Isoleucine or valine' 0 C--O 1.246 0.887 0 N-CA-C 107.204 -1.406 . . . . 60.15 107.204 171.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -129.28 153.9 47.36 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.178 -0.675 . . . . 53.52 109.178 -176.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -116.01 122.47 45.31 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.623 -1.251 . . . . 65.21 107.623 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 43.1 t -112.39 123.63 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.667 0.787 . . . . 75.32 109.851 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 18.9 t -103.09 125.75 57.48 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 124.306 1.042 . . . . 53.44 109.978 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.629 HD23 HD12 ' B' ' 106' ' ' LEU . 3.3 mm? -107.4 110.95 23.05 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.996 -0.742 . . . . 52.31 108.996 167.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -85.39 114.25 22.3 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.699 0.8 . . . . 64.02 109.062 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.404 ' CG1' HD11 ' B' ' 114' ' ' ILE . 96.9 t -103.34 109.45 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.569 1.148 . . . . 72.04 108.547 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 87.2 m -94.45 142.19 27.72 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.392 1.077 . . . . 73.13 108.722 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.564 HG21 HG21 ' B' ' 114' ' ' ILE . 98.7 t -136.2 131.97 49.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 124.704 1.202 . . . . 73.41 108.197 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 54.3 m -126.01 148.06 49.39 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.736 -1.209 . . . . 72.34 107.736 172.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.92 143.51 27.41 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.532 -0.544 . . . . 72.34 109.532 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.517 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 23.1 p -148.82 130.2 14.73 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 123.768 0.667 . . . . 40.41 111.07 -175.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.667 HD12 HG22 ' B' ' 31' ' ' VAL . 48.3 mt -103.04 111.2 23.43 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.721 -1.215 . . . . 75.34 107.721 173.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.55 -110.75 3.11 Favored Glycine 0 C--N 1.345 1.054 0 O-C-N 123.39 0.431 . . . . 74.04 112.046 -176.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.24 5.34 9.15 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.096 0.558 . . . . 61.33 111.028 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.84 150.04 34.15 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.426 -0.583 . . . . 74.43 109.426 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 68.2 m -70.1 119.55 14.47 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 123.507 0.505 . . . . 71.01 110.348 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.634 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -70.77 -60.71 2.09 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.244 -1.021 . . . . 54.04 108.244 174.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -157.1 166.0 34.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.39 -1.277 . . . . 72.54 111.164 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 72.7 mt -125.78 137.34 53.79 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 105.791 -1.929 . . . . 74.11 105.791 170.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 44.9 t -138.71 150.64 46.38 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.245 -1.02 . . . . 73.11 108.245 173.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -160.15 131.4 5.84 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.12 -0.696 . . . . 73.45 109.12 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.405 ' HA ' HD13 ' B' ' 21' ' ' ILE . 85.4 t -124.22 149.49 28.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.007 -0.997 . . . . 75.45 108.859 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.424 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 16.7 mt-30 -120.56 97.64 5.66 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.903 -1.147 . . . . 74.42 107.903 167.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -88.54 100.61 13.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.34 -1.356 . . . . 73.25 107.34 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.447 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -97.67 147.26 18.56 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.612 -0.995 . . . . 72.21 110.612 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.44 130.15 4.14 Favored Glycine 0 CA--C 1.507 -0.417 0 N-CA-C 110.852 -0.899 . . . . 70.45 110.852 -177.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 57.4 mt -86.06 126.48 40.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.563 -0.903 . . . . 54.45 108.563 173.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -134.87 131.14 37.0 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 107.504 -1.295 . . . . 64.13 107.504 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 70.9 m -95.06 88.59 5.28 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.34 -0.615 . . . . 70.32 109.34 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 12.4 tt -107.86 129.81 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.922 0.889 . . . . 74.02 111.724 -170.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.43 163.61 33.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.78 0.832 . . . . 61.11 110.899 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.39 -70.19 0.29 Allowed Glycine 0 C--N 1.344 0.993 0 CA-C-N 115.681 -0.691 . . . . 72.32 113.336 172.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.537 HG22 ' HB3' ' B' ' 94' ' ' MET . 11.3 mt -89.65 158.23 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.046 0.938 . . . . 73.12 111.523 -175.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -154.02 158.69 40.95 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.838 1.255 . . . . 73.51 109.173 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.94 -134.79 12.34 Favored Glycine 0 C--N 1.347 1.188 0 C-N-CA 123.352 0.501 . . . . 74.01 113.733 173.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 59.4 m -70.16 -33.18 71.45 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.276 0.63 . . . . 63.14 111.423 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -66.82 -36.14 81.69 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.54 -0.755 . . . . 64.11 111.242 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.537 ' HB3' HG22 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -81.1 -22.36 39.2 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 116.307 -0.406 . . . . 53.35 110.686 176.447 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.54 -24.92 64.09 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.106 0.479 . . . . 72.43 111.168 173.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.45 ' CD2' ' HB2' ' B' ' 134' ' ' ASP . 54.9 t-80 -77.78 -30.01 51.14 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.511 0.724 . . . . 74.5 110.661 171.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.8 t -80.14 -68.39 0.68 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.748 0.819 . . . . 70.23 112.488 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.632 ' H ' HD23 ' B' ' 98' ' ' LEU . 1.9 pt? -102.5 -7.28 22.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.853 -0.529 . . . . 74.12 111.759 -174.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.02 0.75 57.54 Favored Glycine 0 C--N 1.344 1.003 0 O-C-N 123.292 0.37 . . . . 44.04 112.452 173.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' B' ' 134' ' ' ASP . . . -149.19 -60.07 0.22 Allowed 'General case' 0 C--N 1.358 0.977 0 C-N-CA 122.77 0.428 . . . . 53.01 111.98 -176.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -70.52 -36.82 73.95 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 112.233 0.457 . . . . 74.31 112.233 -175.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.538 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 70.9 m -68.76 -44.39 31.19 Favored Pre-proline 0 N--CA 1.482 1.145 0 CA-C-O 118.545 -0.74 . . . . 74.41 110.818 177.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -45.97 -40.07 20.14 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 122.536 2.157 . . . . 74.4 113.766 162.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -68.49 -33.47 74.21 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.143 0.577 . . . . 74.42 112.504 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.57 HD13 HD11 ' B' ' 13' ' ' ILE . 67.1 mt -69.26 -46.09 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.19 0.596 . . . . 52.41 109.9 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.629 HD12 HD23 ' B' ' 60' ' ' LEU . 60.1 mt -84.03 -11.44 56.75 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.677 -1.147 . . . . 73.23 110.763 -172.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.408 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 81.4 t80 -57.65 -54.47 54.87 Favored Pre-proline 0 CA--C 1.557 1.221 0 CA-C-O 117.971 -1.014 . . . . 72.24 112.993 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 36.5 Cg_exo -62.03 -35.85 74.15 Favored 'Trans proline' 0 C--N 1.39 2.745 0 C-N-CA 121.761 1.641 . . . . 55.23 113.029 -177.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -69.02 -44.69 72.23 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.854 0.462 . . . . 73.12 110.61 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.41 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -65.47 -43.66 89.59 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.903 0.481 . . . . 51.03 110.306 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -54.64 -53.13 58.76 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.523 1.129 . . . . 65.43 110.582 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.465 ' HG3' HH12 ' A' ' 120' ' ' ARG . 13.6 tp10 -62.35 -34.36 76.5 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.872 0.869 . . . . 74.33 111.05 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.524 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.9 t -71.23 -37.82 71.99 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.27 0.228 . . . . 71.22 110.862 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.564 HG21 HG21 ' B' ' 64' ' ' VAL . 84.5 mt -67.39 -56.95 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.445 0.698 . . . . 45.42 109.182 176.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 9.9 m -62.64 -24.01 67.38 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 124.288 0.992 . . . . 65.51 111.364 -173.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 39.7 t -67.19 -49.79 63.34 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 122.968 0.507 . . . . 75.54 109.913 170.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.524 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 33.9 mmt -62.02 -39.46 92.37 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 122.877 0.471 . . . . 71.3 110.644 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 114' ' ' ILE . 84.3 t -59.52 -49.5 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.585 1.154 . . . . 71.23 110.077 176.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.8 t -63.68 -37.34 86.97 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.585 -1.189 . . . . 74.11 111.156 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -69.47 -33.47 72.95 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.476 -0.784 . . . . 64.34 110.335 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.74 5.55 74.3 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.872 0.732 . . . . 54.12 112.835 173.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 17' ' ' TYR . 74.6 p 54.9 55.82 7.34 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 126.012 1.725 . . . . 64.22 111.99 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -117.76 156.98 49.18 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 124.34 1.056 . . . . 73.05 110.509 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.83 161.86 2.91 Favored 'Trans proline' 0 C--N 1.392 2.829 0 C-N-CA 123.938 3.092 . . . . 55.33 116.139 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.537 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -65.13 121.85 15.7 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 113.911 -1.495 . . . . 75.4 111.6 -178.609 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -138.63 109.55 6.74 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 108.342 -0.984 . . . . 74.33 108.342 177.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -124.49 135.1 52.93 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.935 0.894 . . . . 73.4 109.32 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 5.9 mp -87.8 139.27 30.7 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.819 0.848 . . . . 71.33 110.102 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.48 164.72 56.41 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 124.222 1.009 . . . . 65.12 111.067 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -53.88 103.79 0.1 OUTLIER 'Trans proline' 0 C--N 1.39 2.735 0 C-N-CA 122.824 2.349 . . . . 61.44 112.892 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 37.6 t -90.72 108.62 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.32 -0.993 . . . . 73.45 108.32 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.64 79.95 8.12 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.322 -0.621 . . . . 71.43 109.322 177.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -51.14 -45.36 61.62 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.516 0.726 . . . . 73.3 110.119 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 134' ' ' ASP . . . . . 0.45 ' HB2' ' CD2' ' B' ' 96' ' ' HIS . 7.6 p-10 . . . . . 0 C--O 1.222 -0.348 0 CA-C-N 113.444 -1.707 . . . . 71.43 112.531 -176.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.584 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.8 t80 . . . . . 0 C--O 1.236 0.362 0 CA-C-O 120.852 0.358 . . . . 73.42 110.565 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -145.53 124.88 13.04 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.095 -1.076 . . . . 71.42 108.095 171.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 51.6 mt -73.95 102.08 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 107.774 -1.195 . . . . 74.55 107.774 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -75.59 -50.92 14.12 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.582 -0.735 . . . . 73.24 110.616 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -167.3 123.88 1.16 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 110.294 -0.261 . . . . 63.33 110.294 -176.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 63.0 mt -108.76 144.46 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 108.002 -1.11 . . . . 64.34 108.002 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.47 ' HB3' HG23 ' D' ' 122' ' ' THR . 21.8 p90 -176.36 172.38 2.27 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.383 0.673 . . . . 64.55 110.11 -174.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.9 p -98.02 122.42 41.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.742 -0.663 . . . . 70.33 109.363 175.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.432 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 18.3 mmtp -70.04 -46.77 64.34 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 107.765 -1.198 . . . . 72.44 107.765 168.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 17.5 t70 -134.51 141.18 46.64 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 113.438 -1.71 . . . . 41.14 109.743 -171.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 87.5 mt -135.81 146.13 30.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 106.082 -1.822 . . . . 71.22 106.082 169.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 22' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' C' ' 77' ' ' GLU . 35.8 t -160.79 151.18 18.01 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.535 0.683 . . . . 74.53 109.859 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 86.9 t80 -144.62 136.43 25.82 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.529 -1.656 . . . . 72.03 106.529 169.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -134.24 129.29 35.46 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.2 -0.667 . . . . 74.52 109.2 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.51 81.01 11.44 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 106.858 -1.534 . . . . 65.32 106.858 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -69.53 -21.54 34.41 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.955 2.437 . . . . 62.25 112.423 -174.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -118.51 25.91 9.95 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.479 1.111 . . . . 63.41 110.147 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.73 -52.9 22.36 Favored Pre-proline 0 CA--C 1.56 1.361 0 CA-C-O 117.818 -1.087 . . . . 71.31 113.683 -173.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.72 -43.76 47.11 Favored 'Trans proline' 0 C--N 1.399 3.212 0 C-N-CA 121.834 1.689 . . . . 72.41 112.434 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.45 ' O ' ' HG3' ' C' ' 33' ' ' GLN . 86.6 t60 -69.45 -43.68 72.78 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.275 -0.875 . . . . 75.23 112.441 -175.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.728 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.2 p -69.82 -18.45 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.324 0 N-CA-C 113.43 0.9 . . . . 75.13 113.43 -174.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -70.19 -20.71 63.1 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 113.099 0.777 . . . . 75.1 113.099 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' C' ' 30' ' ' HIS . 4.9 pp0? -92.67 8.91 37.13 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 111.992 0.367 . . . . 61.22 111.992 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.68 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -91.89 156.59 17.37 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.143 0.577 . . . . 73.44 110.685 179.204 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.35 125.14 22.89 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.171 0.988 . . . . 65.2 109.452 164.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -81.12 88.67 5.98 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.252 0.548 . . . . 60.14 110.49 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -140.28 77.91 23.84 Favored Pre-proline 0 C--O 1.243 0.738 0 N-CA-C 108.234 -1.025 . . . . 61.53 108.234 171.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -84.12 129.84 4.65 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.294 1.996 . . . . 74.11 111.551 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.75 96.49 8.19 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 104.689 -2.338 . . . . 73.32 104.689 166.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 20.8 m -88.8 121.31 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 114.643 -1.162 . . . . 71.22 111.595 -168.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.439 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 35.8 ttpt -97.26 106.48 18.82 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.832 -0.803 . . . . 74.22 108.832 174.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -87.42 121.68 30.17 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.536 -1.283 . . . . 70.52 107.536 175.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -118.5 140.07 50.45 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.086 1.354 . . . . 61.13 108.397 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.604 HD23 HD11 ' C' ' 60' ' ' LEU . 0.0 OUTLIER -137.49 132.53 33.42 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.562 0.345 . . . . 74.23 110.125 172.721 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.579 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 15.1 t70 -113.2 148.3 35.73 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.905 0.882 . . . . 74.33 108.906 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 77.0 p -112.76 112.46 23.98 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.449 0.7 . . . . 71.23 109.33 -174.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.2 139.01 48.18 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.568 0.747 . . . . 73.42 109.34 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 55.6 m -157.8 155.62 30.09 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.32 0.648 . . . . 64.41 110.846 -175.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 47.2 t -160.93 130.65 4.92 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.526 -0.761 . . . . 71.44 109.842 -174.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -76.54 122.02 24.0 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.811 -0.44 . . . . 75.32 109.811 174.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.657 HD11 HD12 ' C' ' 83' ' ' ILE . 66.7 mt -86.45 -52.66 5.45 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.539 -0.755 . . . . 74.14 110.119 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.51 -172.04 3.99 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.05 0.54 . . . . 54.11 111.723 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -56.93 103.46 0.11 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.075 1.35 . . . . 61.22 110.875 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 69.51 -1.96 2.07 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 125.907 1.683 . . . . 73.14 113.054 -177.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 75.7 t -93.35 113.7 28.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 108.33 -0.989 . . . . 74.21 108.33 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 56' ' ' TYR . . . . . 0.571 ' HB3' HD13 ' C' ' 86' ' ' ILE . 50.6 t80 -131.28 126.1 34.52 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.44 -0.8 . . . . 74.03 109.199 -171.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -85.72 124.91 32.76 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.177 0.991 . . . . 63.5 110.223 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 62.9 t -111.94 115.87 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 107.958 -1.127 . . . . 72.11 107.958 171.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.9 t -113.63 129.55 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.493 0.717 . . . . 62.51 109.32 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.604 HD11 HD23 ' C' ' 44' ' ' LEU . 40.9 tp -116.42 113.34 22.73 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.804 -0.814 . . . . 72.43 108.804 173.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.579 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 22.4 ttt180 -81.49 105.74 12.89 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 108.381 -0.97 . . . . 74.31 108.381 176.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 37.3 t -99.0 119.28 46.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 107.7 -1.222 . . . . 70.4 107.7 176.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 60.5 m -130.67 119.74 22.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.757 -0.831 . . . . 61.44 108.757 -174.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.793 HG23 HD13 ' C' ' 114' ' ' ILE . 97.6 t -100.17 114.66 39.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.348 -0.982 . . . . 74.53 108.348 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.504 HG23 HD23 ' C' ' 75' ' ' LEU . 5.2 m -97.69 135.78 38.99 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.104 -1.443 . . . . 64.51 107.104 171.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.12 114.82 16.2 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.308 -1.368 . . . . 74.03 107.308 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 20.1 m -136.15 126.61 26.82 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.113 -0.699 . . . . 75.25 109.113 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.68 HD13 ' HG2' ' C' ' 34' ' ' LYS . 14.2 mt -85.59 13.97 6.28 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.694 1.198 . . . . 71.15 111.588 -176.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.0 -98.77 0.4 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 110.103 -1.199 . . . . 65.23 110.103 -175.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -90.81 -32.85 15.93 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.299 0.64 . . . . 72.25 109.365 171.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -71.8 120.21 17.06 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 114.641 -1.163 . . . . 73.11 109.666 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 62.8 m -76.18 126.13 30.43 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.562 -0.903 . . . . 72.14 108.562 167.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.728 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.87 -58.27 3.39 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.163 -1.051 . . . . 74.25 108.163 170.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -166.22 176.59 7.47 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.623 0.725 . . . . 43.55 111.941 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.504 HD23 HG23 ' C' ' 65' ' ' THR . 2.6 tm? -141.71 104.82 4.6 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 106.983 -1.488 . . . . 73.15 106.983 173.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.522 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.7 t -109.45 125.76 52.78 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.216 0.606 . . . . 75.04 109.378 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 77' ' ' GLU . . . . . 0.418 ' HB3' ' HB3' ' C' ' 22' ' ' SER . 40.7 tt0 -124.48 139.73 53.62 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.494 0.718 . . . . 73.4 109.527 -177.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.401 HG11 ' HA ' ' C' ' 110' ' ' ALA . 27.4 t -144.08 114.08 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 108.147 -1.057 . . . . 63.14 108.147 174.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 77.9 mt-30 -90.69 97.5 11.22 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.545 -0.909 . . . . 72.14 108.545 171.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.607 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.0 tp-100 -82.03 105.23 12.96 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.616 -0.513 . . . . 73.24 109.616 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.49 144.73 21.61 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 111.386 -0.686 . . . . 32.34 111.386 175.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.29 116.46 0.84 Allowed Glycine 0 CA--C 1.503 -0.675 0 N-CA-C 110.376 -1.09 . . . . 74.24 110.376 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.657 HD12 HD11 ' C' ' 51' ' ' LEU . 14.6 mm -85.24 118.22 31.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 107.81 -1.182 . . . . 64.3 107.81 177.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.584 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 46.7 m-85 -132.2 142.88 49.59 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.637 0.775 . . . . 75.04 108.975 -174.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -84.54 116.74 23.29 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.671 0.388 . . . . 72.21 109.988 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.571 HD13 ' HB3' ' C' ' 56' ' ' TYR . 3.4 mp -115.09 109.07 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 108.406 -0.961 . . . . 71.02 108.406 172.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.01 161.99 39.69 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.66 1.184 . . . . 73.15 108.916 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.21 -51.14 3.96 Favored Glycine 0 N--CA 1.472 1.064 0 O-C-N 123.136 0.272 . . . . 63.42 112.796 175.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 30.6 pt -91.87 158.22 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.826 0.85 . . . . 73.22 111.48 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -152.12 162.01 41.75 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.112 0.965 . . . . 70.14 109.589 173.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.67 -117.55 5.8 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.024 -0.535 . . . . 75.21 112.814 172.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 57.3 p -65.1 -37.51 87.73 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.048 0.939 . . . . 74.52 111.497 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -71.8 -42.79 66.63 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.287 0.635 . . . . 63.12 111.6 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.417 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 9.1 ptp -73.09 -33.33 65.54 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 120.99 -0.284 . . . . 72.23 110.574 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.33 -28.64 69.45 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.004 0.522 . . . . 55.23 110.706 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -70.36 -44.74 67.48 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.449 -0.796 . . . . 74.14 110.206 172.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.586 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 42.3 t -65.54 -40.74 93.24 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 123.292 0.37 . . . . 63.22 110.512 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' C' ' 94' ' ' MET . 86.9 mt -77.27 -49.9 14.03 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.22 0.608 . . . . 72.14 111.781 -175.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.96 12.38 64.03 Favored Glycine 0 N--CA 1.474 1.228 0 N-CA-C 114.898 0.719 . . . . 71.11 114.898 -166.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.684 ' HB1' ' HB2' ' C' ' 134' ' ' ASP . . . -154.67 -62.54 0.13 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 117.624 0.712 . . . . 72.13 110.974 -172.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.586 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 73.9 t80 -76.14 -39.57 54.73 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.139 1.376 . . . . 73.42 113.105 -167.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 96.7 m -77.44 -39.84 2.09 Favored Pre-proline 0 N--CA 1.486 1.328 0 CA-C-O 118.687 -0.673 . . . . 71.02 111.716 176.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -48.5 -35.15 27.99 Favored 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 122.741 2.294 . . . . 64.53 113.683 164.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -64.94 -38.51 91.2 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.762 0.425 . . . . 71.35 111.022 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.538 HD12 ' NH1' ' A' ' 111' ' ' ARG . 33.4 mm -66.99 -46.36 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 109.795 -0.446 . . . . 72.42 109.795 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.13 -20.97 29.48 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 113.547 0.943 . . . . 72.34 113.547 -168.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -58.7 -52.74 72.56 Favored Pre-proline 0 N--CA 1.488 1.449 0 CA-C-O 117.951 -1.023 . . . . 72.44 113.126 -175.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.14 -32.23 83.11 Favored 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 121.647 1.565 . . . . 64.5 113.0 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -64.91 -53.78 41.09 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.253 0.621 . . . . 63.42 110.377 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.607 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -65.96 -33.43 75.79 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.03 -0.986 . . . . 73.15 111.179 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -60.14 -53.85 52.82 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.394 1.078 . . . . 75.0 110.243 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.28 -35.85 78.48 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 110.016 -0.364 . . . . 73.13 110.016 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.417 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 10.2 t -67.06 -27.92 67.78 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.148 0.579 . . . . 61.2 111.323 -178.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.793 HD13 HG23 ' C' ' 64' ' ' VAL . 83.0 mt -76.58 -55.65 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 115.882 -0.599 . . . . 71.4 109.973 171.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 17.1 m -61.15 -27.81 68.66 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 123.389 0.676 . . . . 73.23 111.502 -173.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.4 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 41.4 t -62.42 -52.77 62.23 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 124.457 1.103 . . . . 65.44 109.093 170.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.583 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.15 -34.74 75.5 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.46 1.104 . . . . 71.34 112.381 178.352 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 88.8 t -63.38 -44.31 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 109.209 -0.663 . . . . 73.44 109.209 174.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 22.8 t -74.68 -24.04 58.73 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.988 -1.006 . . . . 74.33 111.71 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' C' ' 116' ' ' SER . 87.5 mtt-85 -74.02 -40.7 62.71 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.876 -0.787 . . . . 75.45 108.876 174.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.69 -4.35 70.42 Favored Glycine 0 C--N 1.357 1.719 0 O-C-N 123.951 0.782 . . . . 61.35 112.431 171.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 29.3 p 65.26 28.44 11.97 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.679 1.992 . . . . 73.35 112.934 170.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -83.33 145.96 49.73 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 123.364 0.666 . . . . 74.34 109.323 172.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.81 146.03 29.61 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.137 2.558 . . . . 61.11 113.139 176.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -52.62 111.1 0.59 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.396 1.078 . . . . 74.52 112.254 -172.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 47.3 tp -114.21 88.95 2.97 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.079 -1.452 . . . . 53.34 107.079 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -97.83 126.1 43.02 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.337 -0.847 . . . . 74.44 109.062 -171.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.05 126.48 31.12 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 122.888 0.475 . . . . 65.55 110.218 -172.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.11 152.81 95.66 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 124.29 1.036 . . . . 64.21 111.347 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.567 ' HG3' HD12 ' A' ' 16' ' ' ILE . 38.4 Cg_exo -57.65 117.61 4.34 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.773 2.315 . . . . 62.23 113.104 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -104.06 109.52 27.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 122.397 1.094 . . . . 75.13 108.534 169.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -101.32 76.46 1.71 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.933 -1.031 . . . . 72.45 108.566 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -51.11 -45.78 61.67 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.271 0.628 . . . . 65.34 112.311 -173.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 134' ' ' ASP . . . . . 0.684 ' HB2' ' HB1' ' C' ' 100' ' ' ALA . 18.4 t0 . . . . . 0 N--CA 1.482 1.155 0 O-C-N 124.01 0.818 . . . . 64.41 110.958 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 109.41 -0.589 . . . . 75.11 109.41 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.442 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 55.1 t80 -158.09 100.82 1.73 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.791 -1.188 . . . . 73.34 107.791 -175.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -127.65 116.76 20.79 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.47 -0.937 . . . . 75.3 108.47 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.558 HD13 HG21 ' D' ' 105' ' ' ILE . 7.4 mt -81.8 124.03 38.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.693 -0.484 . . . . 72.22 109.693 -177.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -90.8 -39.24 12.48 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.649 0.78 . . . . 73.22 111.478 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -174.97 123.9 0.25 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 117.805 0.275 . . . . 40.05 111.665 -166.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -103.97 137.1 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 107.986 -1.116 . . . . 73.42 107.986 167.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -160.8 148.57 15.85 Favored 'General case' 0 C--O 1.239 0.533 0 O-C-N 124.142 0.902 . . . . 70.4 109.883 177.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 77.8 p -79.61 114.05 18.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.136 -0.938 . . . . 75.32 108.979 174.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -82.4 -28.59 31.33 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.935 -0.575 . . . . 73.53 110.439 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 30.2 t70 -156.61 140.12 15.86 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.855 -1.066 . . . . 65.3 108.24 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.583 HG21 ' HE2' ' C' ' 117' ' ' MET . 84.6 mt -139.16 150.3 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.203 1.001 . . . . 72.34 108.374 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 22' ' ' SER . . . . . 0.454 ' HB2' ' HB3' ' D' ' 77' ' ' GLU . 71.7 m -147.62 140.57 24.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.689 1.196 . . . . 55.33 109.318 172.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.514 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 83.7 t80 -141.23 123.49 15.68 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 105.233 -2.136 . . . . 70.42 105.233 165.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.6 mt-10 -139.7 108.62 6.0 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.187 -0.672 . . . . 74.33 109.187 -170.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.36 94.17 9.35 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 108.422 -0.955 . . . . 33.14 108.422 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.86 -44.36 2.84 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.696 2.264 . . . . 72.51 112.607 -170.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.482 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 7.9 m120 -96.5 11.75 33.94 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.849 0.86 . . . . 72.21 111.057 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.416 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -23.88 -68.38 0.05 OUTLIER Pre-proline 0 CA--C 1.56 1.346 0 N-CA-C 116.941 2.2 . . . . 70.2 116.941 -160.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.403 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 97.2 Cg_endo -74.21 -27.23 11.82 Favored 'Trans proline' 0 C--N 1.382 2.307 0 CA-C-N 123.334 2.226 . . . . 43.03 113.509 -176.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -66.35 -45.55 79.81 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.758 0.823 . . . . 73.23 110.376 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.644 HG21 ' HA ' ' D' ' 73' ' ' ALA . 11.7 p -76.41 -15.39 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 CA-C-N 115.355 -0.839 . . . . 60.31 112.125 -171.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.403 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 21.4 m-85 -69.11 -17.99 63.91 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 112.544 0.572 . . . . 72.22 112.544 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -61.46 -20.95 63.71 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.128 0.571 . . . . 75.2 110.982 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -99.69 90.73 4.57 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.857 1.263 . . . . 72.42 109.477 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -96.93 93.08 6.42 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.874 -0.603 . . . . 63.15 109.485 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.448 ' O ' ' HG2' ' D' ' 124' ' ' PRO . 33.1 p90 -160.88 175.86 12.07 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.61 1.164 . . . . 74.33 107.866 167.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -69.62 112.0 10.73 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 122.938 0.495 . . . . 74.21 109.687 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.92 134.55 60.91 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.15 2.567 . . . . 70.41 111.541 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.11 114.27 10.03 Favored 'General case' 0 C--N 1.348 0.524 0 N-CA-C 108.235 -1.024 . . . . 71.04 108.235 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 16.1 m -103.65 108.56 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-O 122.119 0.961 . . . . 60.31 110.997 -166.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.502 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 73.7 mmtt -87.93 128.37 35.37 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.743 -1.117 . . . . 71.34 108.337 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.51 ' H ' HD23 ' D' ' 42' ' ' LEU . 1.0 OUTLIER -96.3 118.89 33.77 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.711 0.767 . . . . 72.15 110.03 -174.393 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.712 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.9 m-20 -110.33 125.69 53.44 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.539 -1.282 . . . . 73.53 107.539 174.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 93.3 mt -122.79 130.77 53.3 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.112 0.565 . . . . 74.25 109.692 -175.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.588 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 11.4 t70 -131.73 146.5 52.2 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.154 0.982 . . . . 74.12 108.368 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 42.8 p -119.67 143.73 47.57 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.507 0.723 . . . . 74.11 110.622 -171.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.75 155.68 33.52 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.331 0.653 . . . . 72.11 109.793 175.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 17.7 p -150.2 160.22 43.85 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.901 0.48 . . . . 52.34 110.576 -175.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 2.9 m -152.07 119.65 6.06 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.92 -0.77 . . . . 63.44 108.92 175.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -66.95 116.51 7.87 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.737 -1.209 . . . . 51.14 107.737 163.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.475 HD12 HG23 ' D' ' 83' ' ' ILE . 29.8 mt -95.04 -35.12 12.07 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.296 -0.631 . . . . 42.3 109.296 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.56 -173.12 4.24 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.217 -0.901 . . . . 70.5 110.208 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -68.33 123.57 21.12 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.875 -1.057 . . . . 73.53 110.225 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 54' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 65.1 m-20 62.25 17.75 9.57 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.699 1.2 . . . . 71.41 112.194 -175.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.6 t -119.44 119.67 61.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.813 -0.81 . . . . 61.45 108.813 174.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.543 ' HD2' ' HB ' ' D' ' 86' ' ' ILE . 78.3 m-85 -134.52 129.06 34.53 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.521 -0.918 . . . . 74.12 108.521 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -92.98 127.53 38.53 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.97 0.908 . . . . 74.44 109.335 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.4 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 73.8 t -103.54 112.44 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.856 -1.165 . . . . 62.53 107.856 173.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.421 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 47.5 t -103.68 132.2 50.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 108.094 -1.076 . . . . 64.34 108.094 174.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 53.6 tp -128.54 121.78 29.58 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.722 0.296 . . . . 75.11 110.208 175.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.588 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 20.6 ttm-85 -84.82 98.72 10.45 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.056 0.942 . . . . 74.44 109.404 173.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 93.6 t -90.79 114.49 28.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.31 -0.996 . . . . 45.01 108.31 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.712 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 28.6 m -122.65 133.33 54.52 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.45 0.643 . . . . 72.03 109.666 -174.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 t -119.63 101.87 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.863 1.665 . . . . 72.41 108.787 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.502 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 59.1 m -92.4 99.79 12.48 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.271 -0.877 . . . . 54.15 108.801 175.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.31 142.21 36.36 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.135 -0.939 . . . . 71.33 109.7 -169.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 70.1 m -142.93 137.45 29.46 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.222 0.534 . . . . 53.13 111.673 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.53 HD12 HG22 ' D' ' 31' ' ' VAL . 55.8 mt -105.53 104.59 14.34 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.629 1.172 . . . . 61.42 108.536 172.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.22 -123.94 6.35 Favored Glycine 0 C--N 1.342 0.896 0 CA-C-N 115.797 -0.638 . . . . 74.52 112.514 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.61 5.87 34.06 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.168 0.587 . . . . 73.55 111.081 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -120.49 157.01 30.31 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.327 0.651 . . . . 74.45 109.81 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 63.7 m -71.34 136.45 47.84 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.628 0.58 . . . . 71.53 110.731 178.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.644 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -84.45 -64.08 1.22 Allowed 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.329 -0.989 . . . . 61.25 108.329 174.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -157.09 167.5 30.24 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.685 -1.143 . . . . 72.41 110.162 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.484 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 83.3 mt -126.42 110.92 13.86 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 106.435 -1.691 . . . . 73.41 106.435 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.56 ' SG ' HG12 ' D' ' 114' ' ' ILE . 42.4 t -114.26 138.1 50.93 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.575 -1.269 . . . . 71.42 107.575 -178.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 77' ' ' GLU . . . . . 0.454 ' HB3' ' HB2' ' D' ' 22' ' ' SER . 43.6 tt0 -155.36 122.58 5.51 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 110.033 -0.358 . . . . 74.22 110.033 -175.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 50.8 t -129.73 114.69 31.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 123.24 0.616 . . . . 75.31 109.368 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.448 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 22.2 mt-30 -86.51 83.65 7.59 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.096 -1.075 . . . . 65.32 108.096 168.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -79.88 98.21 7.02 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 113.346 -1.752 . . . . 74.33 108.145 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -93.71 144.12 16.91 Favored Glycine 0 C--N 1.341 0.85 0 N-CA-C 111.4 -0.68 . . . . 74.12 111.4 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.6 131.33 5.45 Favored Glycine 0 C--N 1.331 0.259 0 N-CA-C 111.162 -0.775 . . . . 73.53 111.162 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.475 HG23 HD12 ' D' ' 51' ' ' LEU . 61.3 mt -88.04 120.23 36.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 107.923 -1.14 . . . . 65.24 107.923 175.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.4 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 61.7 m-85 -128.54 126.22 39.93 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.676 0.791 . . . . 71.41 108.97 -175.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.1 m -79.37 99.53 7.19 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.599 -0.889 . . . . 75.44 108.599 172.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.543 ' HB ' ' HD2' ' D' ' 56' ' ' TYR . 17.9 mm -108.98 111.58 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.705 0.802 . . . . 73.33 109.571 -174.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.518 ' HB2' ' HB3' ' D' ' 54' ' ' ASP . . . -138.04 147.72 44.39 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.955 0.502 . . . . 73.32 110.705 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.56 10.34 84.68 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 114.724 0.65 . . . . 71.11 114.724 171.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.522 HD12 HG23 ' D' ' 86' ' ' ILE . 8.9 mt -106.46 128.02 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 117.433 0.617 . . . . 54.43 109.744 -175.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -148.51 159.69 43.81 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.562 1.145 . . . . 72.53 109.957 -169.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 91' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' D' ' 94' ' ' MET . . . 68.1 -132.24 28.23 Favored Glycine 0 C--N 1.349 1.292 0 O-C-N 124.08 0.863 . . . . 52.54 113.428 173.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 18.7 m -61.75 -37.38 84.05 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.654 0.782 . . . . 71.31 111.098 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -65.77 -34.11 77.41 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.033 -0.985 . . . . 65.32 110.701 -174.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' D' ' 91' ' ' GLY . 10.6 ptm -75.21 -36.0 61.43 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.168 0.587 . . . . 74.42 111.424 -174.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.65 -31.37 63.46 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.484 -0.78 . . . . 63.31 110.362 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -80.0 -31.73 39.69 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.372 -0.831 . . . . 73.5 111.076 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.0 t -69.59 -53.16 20.19 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.664 0.386 . . . . 54.4 110.702 -175.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 10.3 mp -86.82 -22.61 25.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.414 0.286 . . . . 73.34 111.198 -178.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.29 -24.82 56.29 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-O 119.729 -0.484 . . . . 72.5 113.904 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.17 -50.97 0.65 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.494 0.553 . . . . 62.11 112.494 -171.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -73.86 -43.73 57.69 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.834 0.679 . . . . 73.44 112.834 -169.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.442 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 69.0 m -72.76 -44.2 8.81 Favored Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 123.462 0.705 . . . . 73.41 111.822 -176.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.32 -25.14 64.34 Favored 'Trans proline' 0 C--N 1.395 3.017 0 C-N-CA 121.76 1.64 . . . . 71.42 112.681 170.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 104' ' ' ASN . . . . . 0.516 ' HA ' ' HD2' ' D' ' 107' ' ' PHE . 45.7 t-20 -62.43 -39.89 94.77 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.424 0.689 . . . . 71.23 110.094 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.558 HG21 HD13 ' D' ' 13' ' ' ILE . 48.6 mm -58.85 -38.41 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.62 0.768 . . . . 63.02 110.564 174.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 86.4 mt -83.14 -19.73 36.11 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.114 -0.948 . . . . 63.53 112.442 -170.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 107' ' ' PHE . . . . . 0.516 ' HD2' ' HA ' ' D' ' 104' ' ' ASN . 27.5 m-85 -63.05 -43.79 82.82 Favored Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 114.086 1.143 . . . . 62.51 114.086 -177.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -52.18 -46.14 34.62 Favored 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 122.328 2.019 . . . . 74.55 113.393 172.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -72.86 -36.44 67.42 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.456 -0.793 . . . . 74.23 111.686 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.14 78.67 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.589 0.555 . . . . 71.12 109.639 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -55.58 -50.21 70.69 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 124.953 1.408 . . . . 74.31 110.634 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -65.01 -46.67 80.44 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.728 0.642 . . . . 73.5 111.608 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -57.7 -41.8 82.44 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.578 0.549 . . . . 61.13 110.53 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.56 HG12 ' SG ' ' D' ' 76' ' ' CYS . 81.5 mt -60.93 -56.78 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 115.046 -0.979 . . . . 64.13 110.478 172.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 47.6 m -54.4 -40.77 68.53 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.677 1.191 . . . . 71.45 111.753 -172.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 32.3 t -67.09 -45.32 77.6 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.034 -0.985 . . . . 70.25 110.567 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.8 mtm -67.31 -34.5 77.51 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.852 0.461 . . . . 64.35 111.734 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' D' ' 114' ' ' ILE . 77.3 t -62.08 -45.01 99.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.586 0.754 . . . . 45.13 109.903 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.5 p -75.71 -26.58 57.66 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.901 -0.59 . . . . 73.54 111.401 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.417 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 84.3 mtt-85 -72.46 -31.22 65.25 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.374 0.669 . . . . 74.44 110.132 175.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.49 10.75 68.25 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 123.739 0.65 . . . . 34.54 112.139 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.47 HG23 ' HB3' ' C' ' 17' ' ' TYR . 24.3 p 58.63 22.3 9.7 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 126.877 2.071 . . . . 74.11 114.09 174.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -83.96 157.22 63.48 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.846 0.858 . . . . 70.01 110.04 171.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.448 ' HG2' ' O ' ' D' ' 36' ' ' TRP . 77.9 Cg_exo -54.96 134.0 61.12 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.347 2.698 . . . . 64.24 113.835 176.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -55.95 132.1 48.93 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.801 1.241 . . . . 73.53 112.071 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 61.4 tp -110.27 101.88 10.59 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.571 0.748 . . . . 65.14 110.09 -177.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -103.89 104.02 13.96 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.582 -0.896 . . . . 72.41 108.582 175.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 tt -70.9 125.68 27.5 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 108.483 -0.932 . . . . 73.43 108.483 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.91 157.07 81.76 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.173 0.989 . . . . 52.23 112.09 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.508 ' HD3' HG13 ' B' ' 13' ' ' ILE . 54.3 Cg_exo -56.52 103.52 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.046 2.498 . . . . 73.15 112.785 174.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 124.052 0.941 . . . . 64.34 109.84 -179.428 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.51 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 24.6 t80 . . . . . 0 C--O 1.236 0.389 0 N-CA-C 108.433 -0.951 . . . . 72.3 108.433 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -155.14 102.11 2.28 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.193 -0.669 . . . . 74.41 109.193 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.699 HG12 ' HD2' ' A' ' 84' ' ' PHE . 27.5 mt -72.52 120.39 20.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 109.134 -0.691 . . . . 43.35 109.134 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -85.58 -40.87 15.8 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 123.741 0.651 . . . . 71.54 110.001 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.433 ' HB3' HD12 ' A' ' 83' ' ' ILE . 19.9 ttt180 -173.44 120.89 0.34 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.387 -0.37 . . . . 65.05 110.402 -166.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.551 HD12 ' HG3' ' C' ' 130' ' ' PRO . 62.9 mt -114.0 134.47 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 108.78 -0.822 . . . . 72.42 108.78 173.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.522 ' HB3' HG23 ' B' ' 122' ' ' THR . 31.0 p90 -166.32 165.74 17.1 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 124.216 0.947 . . . . 74.32 110.848 -173.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.7 p -89.13 116.94 27.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.978 -1.01 . . . . 75.24 109.088 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.405 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.3 mtpt -85.58 -32.56 22.04 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.939 0.4 . . . . 71.32 109.996 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.663 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 9.9 t70 -142.85 136.41 28.7 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.018 -0.992 . . . . 51.0 109.289 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.0 mt -137.3 146.54 27.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 107.393 -1.336 . . . . 52.15 107.393 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.9 t -155.44 131.7 10.24 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.235 0.614 . . . . 74.5 109.829 172.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.541 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.3 t80 -130.44 141.84 50.52 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.181 -1.414 . . . . 74.12 107.181 171.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -139.48 139.99 37.14 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.021 0.929 . . . . 74.01 108.506 175.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.451 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -124.09 82.81 56.28 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 106.256 -1.757 . . . . 41.43 106.256 171.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.54 -42.01 29.14 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 123.058 2.505 . . . . 74.45 112.706 -166.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -111.41 25.14 12.0 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 118.13 -0.938 . . . . 72.54 109.654 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.493 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -37.03 -62.8 0.52 Allowed Pre-proline 0 N--CA 1.497 1.924 0 C-N-CA 124.433 1.093 . . . . 54.3 113.915 -166.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 12.7 Cg_exo -67.87 -24.53 39.98 Favored 'Trans proline' 0 C--N 1.394 2.935 0 C-N-CA 122.175 1.917 . . . . 62.52 112.712 -173.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -78.03 -47.21 18.93 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.88 0.872 . . . . 74.21 109.784 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.685 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.2 p -79.8 -12.15 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-N 114.645 -1.162 . . . . 63.35 112.654 -163.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -66.81 -27.39 67.52 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.047 0.451 . . . . 71.22 110.623 171.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -78.33 -18.04 55.72 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.284 1.034 . . . . 45.24 111.276 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -80.06 151.08 30.1 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.642 0.777 . . . . 73.22 111.01 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.05 138.82 58.64 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.268 -0.878 . . . . 74.43 110.142 174.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -79.88 83.65 5.77 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.395 0.617 . . . . 72.14 109.837 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -131.62 73.74 78.9 Favored Pre-proline 0 C--O 1.244 0.801 0 N-CA-C 108.039 -1.097 . . . . 72.43 108.039 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -84.4 159.26 12.83 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.269 1.979 . . . . 61.55 111.87 -176.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -111.16 106.4 15.41 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.375 -1.713 . . . . 74.15 106.375 166.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.7 t -66.48 92.25 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 108.557 -0.905 . . . . 65.01 108.557 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -100.32 112.49 24.83 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.612 -1.625 . . . . 71.14 106.612 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.05 150.53 52.13 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.326 0.584 . . . . 55.21 112.318 -174.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -136.06 113.08 10.39 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.483 -1.235 . . . . 45.41 108.262 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 mp -98.08 124.18 42.48 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 108.697 -0.853 . . . . 71.54 108.697 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.59 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 11.3 t70 -121.76 149.47 43.24 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.778 1.231 . . . . 74.14 109.953 -171.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.4 m -110.54 132.83 53.85 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.926 0.89 . . . . 72.03 109.917 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.664 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -134.52 151.96 51.47 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.723 1.209 . . . . 71.02 108.46 174.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 p -135.55 173.29 11.88 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.911 0.708 . . . . 53.13 112.911 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 37.7 t -168.58 143.9 3.47 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.456 1.502 . . . . 74.22 108.218 174.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -113.23 109.15 18.29 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.176 -1.046 . . . . 74.41 108.176 170.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 53.5 mt -80.81 -39.1 27.24 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.069 -0.514 . . . . 72.45 110.735 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -155.48 -175.92 5.68 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.431 0.693 . . . . 51.32 110.636 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.65 119.74 12.26 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.984 -0.747 . . . . 73.41 108.984 172.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 71.2 -1.68 2.64 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.723 1.209 . . . . 73.25 112.545 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 48.7 t -107.36 114.17 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.463 -0.94 . . . . 60.53 108.463 177.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -122.3 159.61 27.04 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.58 0.752 . . . . 75.43 109.286 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 12.6 tt0 -130.29 124.84 33.31 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.384 -1.339 . . . . 65.1 107.384 170.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.6 m -119.91 138.22 51.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.486 -0.931 . . . . 70.33 108.486 174.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.664 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 59.5 t -118.83 136.97 54.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.488 1.115 . . . . 61.22 109.117 -175.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tt -114.59 106.81 14.69 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.623 -1.251 . . . . 63.22 107.623 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.713 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 36.9 ttp180 -87.22 102.07 14.12 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.563 -0.532 . . . . 73.32 109.563 176.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.71 107.24 19.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 107.864 -1.162 . . . . 70.2 107.864 172.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.4 m -94.62 143.22 26.61 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 107.789 -1.189 . . . . 65.32 107.789 173.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.9 t -141.07 138.97 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.138 1.375 . . . . 73.41 108.405 -173.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.2 m -138.65 138.92 38.27 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.859 -0.793 . . . . 75.31 108.859 175.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.01 104.5 14.19 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 107.143 -1.429 . . . . 63.42 107.143 169.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -108.91 127.8 54.37 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.762 -0.459 . . . . 75.51 109.762 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.3 mt -99.06 75.8 2.06 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 106.86 -1.533 . . . . 63.43 106.86 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.95 -83.43 1.17 Allowed Glycine 0 C--N 1.346 1.105 0 N-CA-C 111.942 -0.463 . . . . 72.31 111.942 -175.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -119.03 -29.97 5.13 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.019 0.528 . . . . 70.33 110.883 175.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -88.68 113.68 24.51 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.107 0.563 . . . . 74.43 109.83 -173.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.3 m -73.37 133.23 43.74 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-O 121.06 0.457 . . . . 74.12 110.884 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.685 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -77.27 -58.97 2.98 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.915 1.286 . . . . 63.23 109.479 176.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.435 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 35.3 p90 -148.24 164.52 33.73 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.959 -1.019 . . . . 61.22 111.185 174.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.9 tp -123.52 142.11 51.34 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.336 1.454 . . . . 74.22 108.186 173.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.3 m -138.07 138.28 38.6 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 124.42 1.088 . . . . 43.1 108.781 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -148.93 120.12 7.79 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.069 -0.715 . . . . 72.12 109.069 173.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 85.9 t -128.51 128.01 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 123.411 0.684 . . . . 51.12 109.611 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.713 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 47.0 mt-30 -95.56 95.01 8.09 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.695 -0.854 . . . . 72.22 108.695 165.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.434 ' HG3' HD22 ' A' ' 106' ' ' LEU . 64.1 tp60 -78.51 99.74 6.61 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.927 -0.768 . . . . 73.5 108.927 176.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.62 154.25 29.46 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.764 -0.653 . . . . 71.34 111.557 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.89 124.98 1.44 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.232 -0.747 . . . . 55.3 111.232 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' A' ' 15' ' ' ARG . 48.8 mt -85.69 119.6 34.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.553 -0.906 . . . . 64.41 108.553 174.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.699 ' HD2' HG12 ' A' ' 13' ' ' ILE . 17.4 m-85 -129.9 120.26 24.61 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.386 -1.338 . . . . 65.43 107.386 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.7 t -75.44 96.37 3.43 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.848 -1.167 . . . . 71.23 107.848 174.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 CA--C 1.542 0.649 0 C-N-CA 123.95 0.9 . . . . 71.21 109.292 -178.622 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 111.912 0.338 . . . . 42.41 111.912 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.487 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 62.8 t-80 -79.57 -36.03 38.84 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.519 0.327 . . . . 64.12 111.086 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 101' ' ' TYR . 44.7 t -69.14 -50.42 48.02 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.394 0.616 . . . . 54.42 111.069 -177.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -83.27 -39.31 21.03 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.089 0.955 . . . . 62.14 110.667 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.45 -14.17 57.44 Favored Glycine 0 N--CA 1.473 1.114 0 N-CA-C 114.73 0.652 . . . . 64.15 114.73 -171.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -123.56 -53.53 1.79 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 117.928 0.864 . . . . 51.42 111.207 -176.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.51 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 68.8 t80 -70.94 -50.55 33.39 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-N 115.231 -0.895 . . . . 74.34 111.98 -176.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.425 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 92.1 m -72.05 -32.57 2.08 Favored Pre-proline 0 CA--C 1.576 1.973 0 N-CA-C 115.69 1.737 . . . . 75.51 115.69 -174.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 29.9 Cg_endo -64.43 -32.55 60.06 Favored 'Trans proline' 0 C--N 1.392 2.818 0 CA-C-N 122.343 1.872 . . . . 71.51 112.039 169.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -65.95 -24.26 66.77 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.565 0.746 . . . . 61.41 110.763 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.4 mm -70.53 -50.79 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.479 0.712 . . . . 75.13 110.304 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.434 HD22 ' HG3' ' A' ' 80' ' ' GLN . 84.5 mt -74.1 -23.77 59.37 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.007 0.743 . . . . 74.14 113.007 -176.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -58.94 -49.91 90.8 Favored Pre-proline 0 CA--C 1.573 1.86 0 N-CA-C 113.883 1.068 . . . . 74.13 113.883 -173.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.86 -32.94 54.61 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 122.176 1.917 . . . . 74.23 113.202 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -67.06 -42.52 84.59 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.938 0.495 . . . . 63.05 110.816 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.43 -42.01 98.68 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.401 -0.818 . . . . 73.54 110.343 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.43 ' NH1' HG23 ' C' ' 105' ' ' ILE . 39.3 ttm180 -56.46 -52.09 65.99 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 124.267 0.98 . . . . 65.51 110.183 175.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -63.93 -44.93 91.37 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.766 0.826 . . . . 64.45 111.073 -174.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -59.51 -34.79 73.06 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.553 0.533 . . . . 64.04 111.182 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 98.5 mt -72.74 -51.44 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 115.541 -0.754 . . . . 74.53 110.145 174.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 49.6 m -59.03 -34.48 71.94 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.218 1.007 . . . . 74.25 111.558 -174.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 34.6 t -68.45 -47.19 67.79 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.54 -0.754 . . . . 64.4 110.242 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.541 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 54.6 mtm -61.06 -40.69 94.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 123.676 0.61 . . . . 72.32 111.163 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.13 -52.82 55.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 124.283 0.989 . . . . 74.34 110.753 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.9 t -67.72 -29.42 68.66 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.412 0.685 . . . . 52.24 111.007 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 116' ' ' SER . 20.7 ttm-85 -76.79 -30.87 56.65 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.804 1.242 . . . . 71.23 108.632 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.428 ' O ' HG22 ' A' ' 122' ' ' THR . . . -86.37 13.6 57.28 Favored Glycine 0 C--N 1.355 1.634 0 CA-C-N 114.739 -1.119 . . . . 63.21 112.545 171.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.505 HG21 ' HE ' ' B' ' 15' ' ' ARG . 2.0 t 63.79 15.28 8.92 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 126.969 2.108 . . . . 32.21 114.267 171.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -81.99 149.86 63.92 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 109.478 -0.564 . . . . 72.34 109.478 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.64 165.91 4.19 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.413 2.742 . . . . 71.13 114.497 -176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.598 ' HG2' ' HG3' ' C' ' 15' ' ' ARG . 6.7 tp-100 -57.91 123.48 15.97 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.097 -0.956 . . . . 75.44 111.86 -175.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.435 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 60.5 tp -120.56 106.89 12.21 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.455 1.102 . . . . 71.4 108.817 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.416 HD21 ' HA ' ' C' ' 15' ' ' ARG . 18.3 m-80 -100.65 115.12 29.46 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.822 -0.807 . . . . 65.34 108.822 175.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.51 137.73 44.62 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 108.161 -1.052 . . . . 64.42 108.161 174.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.94 146.8 57.67 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 123.864 0.866 . . . . 72.41 112.791 -174.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.459 ' HG3' HG13 ' C' ' 13' ' ' ILE . 14.1 Cg_exo -71.45 127.66 13.55 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.649 2.233 . . . . 71.35 111.541 172.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.5 p -142.93 125.49 13.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-O 121.376 0.607 . . . . 64.44 109.734 170.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -103.4 101.31 11.21 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.083 -1.08 . . . . 71.13 108.083 174.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 . . . . . 0 CA--C 1.544 0.722 0 O-C-N 123.743 0.652 . . . . 73.04 110.258 -179.378 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.644 ' HB3' HG12 ' B' ' 89' ' ' ILE . 18.0 ptm . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 113.522 0.934 . . . . 64.23 113.522 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 26.9 m -155.73 135.71 12.84 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.603 -0.726 . . . . 75.14 109.593 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -151.43 156.51 40.79 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.344 -0.613 . . . . 73.31 109.344 157.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -125.7 134.26 51.87 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 107.423 -1.325 . . . . 74.42 107.423 172.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.527 HD11 ' HG3' ' D' ' 130' ' ' PRO . 36.4 mt -70.59 116.91 12.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.553 0 N-CA-C 107.948 -1.13 . . . . 65.14 107.948 173.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -89.46 -44.63 10.02 Favored 'General case' 0 C--O 1.243 0.746 0 O-C-N 123.822 0.701 . . . . 72.4 109.49 -176.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.505 ' HE ' HG21 ' A' ' 122' ' ' THR . 40.5 ttt180 -165.4 131.05 2.59 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 116.117 -0.492 . . . . 61.33 110.981 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.4 mt -113.9 139.34 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 107.433 -1.321 . . . . 74.42 107.433 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.408 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 33.7 p90 -167.79 158.5 10.94 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.426 0.631 . . . . 74.23 111.788 -176.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.524 HG21 HD11 ' B' ' 21' ' ' ILE . 90.0 m -80.69 129.94 34.81 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.859 -1.064 . . . . 61.23 109.284 168.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.408 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 29.9 mtpt -97.47 -32.17 11.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.864 0.866 . . . . 62.52 110.084 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -152.82 138.52 17.87 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.642 -0.708 . . . . 75.13 111.037 -169.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.618 HD11 ' SG ' ' B' ' 113' ' ' CYS . 31.9 mm -134.01 146.57 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.253 1.421 . . . . 73.42 109.63 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 98.0 p -147.87 152.43 37.59 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.371 -1.286 . . . . 74.41 109.283 163.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 85.5 t80 -154.91 109.8 3.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.375 -1.343 . . . . 71.43 107.375 167.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.23 122.2 42.37 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.909 -0.775 . . . . 61.33 108.909 -175.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.942 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -118.32 82.98 19.51 Favored Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 108.807 -0.812 . . . . 74.33 108.807 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.88 -30.13 7.71 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.965 2.443 . . . . 73.4 113.008 -172.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -107.69 10.51 28.93 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 118.799 -0.619 . . . . 73.21 110.9 176.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.942 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -40.6 -61.31 1.25 Allowed Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 115.028 1.492 . . . . 52.52 115.028 -168.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 23.4 Cg_exo -61.53 -30.05 85.64 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 122.392 2.061 . . . . 52.21 112.811 -169.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -97.74 -32.04 11.94 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.606 0.762 . . . . 71.1 112.394 -175.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.436 HG22 ' HB2' ' B' ' 68' ' ' LEU . 4.3 p -72.04 -20.73 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.22 0.608 . . . . 63.15 111.365 -169.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -60.07 -22.93 63.34 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.763 0.825 . . . . 74.1 113.202 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -67.17 -16.28 64.21 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.207 0.603 . . . . 75.54 111.441 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.421 ' HD2' ' HB3' ' B' ' 68' ' ' LEU . 92.6 mttt -87.89 102.26 14.53 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.296 1.038 . . . . 73.31 109.685 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -86.8 78.32 9.1 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.732 0.813 . . . . 61.44 111.358 -174.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -161.68 161.82 29.6 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.777 -0.823 . . . . 74.3 108.777 166.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -70.92 114.86 30.49 Favored Pre-proline 0 C--O 1.246 0.904 0 N-CA-C 107.445 -1.317 . . . . 63.44 107.445 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.506 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 10.3 Cg_endo -53.47 151.19 24.6 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 123.007 2.471 . . . . 71.23 112.712 -173.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.06 104.02 0.67 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.598 -1.26 . . . . 72.14 107.598 172.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.466 HG21 HD21 ' B' ' 126' ' ' LEU . 19.7 m -100.87 155.36 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.244 -0.889 . . . . 71.13 110.449 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -136.2 131.0 34.03 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.263 1.025 . . . . 60.34 108.616 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.9 140.64 29.42 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 107.993 -1.114 . . . . 70.32 107.993 171.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -151.3 112.08 4.24 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.745 -1.206 . . . . 61.45 107.745 172.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -101.74 156.55 17.43 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 122.635 0.374 . . . . 74.21 110.076 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.4 t70 -139.02 151.92 47.2 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.261 0.624 . . . . 73.32 110.48 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 38.9 p -109.88 126.35 53.76 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.669 1.188 . . . . 70.04 110.108 -174.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.69 144.77 20.7 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.784 0.434 . . . . 74.54 110.141 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 47.5 p -145.43 174.09 11.44 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.78 0.432 . . . . 75.11 111.012 176.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 53.8 p -154.05 138.9 17.13 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.426 -0.806 . . . . 63.35 109.538 171.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -84.74 126.02 33.04 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.048 0.539 . . . . 72.23 110.956 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 62.2 mt -93.68 -40.92 9.98 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.759 0.823 . . . . 72.45 109.63 174.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.51 175.92 13.39 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.718 -1.128 . . . . 75.44 109.338 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.03 125.21 23.25 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.766 -0.828 . . . . 74.32 108.766 172.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 73.53 -5.48 1.98 Allowed 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 125.345 1.458 . . . . 74.35 112.831 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 72.8 t -108.05 111.97 38.21 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 N-CA-C 108.936 -0.765 . . . . 72.33 108.936 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -126.02 150.55 48.02 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.859 0.838 . . . . 73.04 110.206 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -108.12 103.94 13.25 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 113.811 -1.54 . . . . 53.25 106.915 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 74.1 t -88.53 117.28 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.885 1.274 . . . . 32.02 110.638 -173.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 18.5 t -107.31 113.64 44.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 108.507 -0.923 . . . . 74.21 108.507 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.77 HD22 ' HB3' ' B' ' 103' ' ' PRO . 43.1 tp -103.61 115.74 31.06 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.036 -1.098 . . . . 61.33 108.036 169.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 10.3 ttm180 -86.61 131.64 34.11 Favored 'General case' 0 CA--C 1.526 0.025 0 N-CA-C 108.956 -0.757 . . . . 75.11 108.956 174.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.66 103.34 14.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.781 -1.192 . . . . 72.43 107.781 171.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 9.3 m -99.69 133.58 43.83 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.816 -0.809 . . . . 71.42 108.816 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.442 HG23 HD13 ' B' ' 114' ' ' ILE . 86.8 t -123.25 127.65 74.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 124.075 0.95 . . . . 62.05 108.916 175.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 80.1 m -101.54 148.87 24.7 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.296 -1.001 . . . . 43.32 108.296 169.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.8 134.82 23.91 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.13 0.572 . . . . 74.22 109.819 177.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.589 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 33.7 p -142.1 127.93 19.36 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.748 -0.66 . . . . 64.15 110.707 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.506 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 22.1 mt -95.93 105.06 17.03 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.373 -0.973 . . . . 51.23 108.373 173.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.12 -118.05 8.42 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.804 -1.089 . . . . 44.24 112.913 -173.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -107.89 18.4 21.33 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.809 0.844 . . . . 73.34 110.696 -173.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -138.64 143.51 39.29 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.496 -0.753 . . . . 73.12 109.992 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.1 m -67.21 114.71 6.16 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.172 0.589 . . . . 62.01 110.555 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.589 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -69.85 -59.24 3.05 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.101 -1.074 . . . . 53.15 108.101 178.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -156.05 167.07 31.57 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.658 -1.156 . . . . 72.13 111.527 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 99.2 mt -128.83 146.99 50.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 113.622 -1.626 . . . . 54.03 106.635 172.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 44.9 t -150.66 135.22 17.23 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.994 -1.113 . . . . 64.23 107.994 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -143.27 124.87 14.87 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 107.959 -1.126 . . . . 60.41 107.959 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 96.9 t -122.91 146.74 27.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.914 -1.143 . . . . 71.12 107.914 178.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.496 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 21.7 mt-30 -126.65 102.89 7.28 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.943 -1.132 . . . . 74.14 107.943 172.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -89.0 99.77 12.69 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.099 -1.074 . . . . 73.4 108.099 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.55 143.09 16.3 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 110.698 -0.961 . . . . 34.24 110.698 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.91 126.97 2.48 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 110.054 -1.218 . . . . 54.1 110.054 -173.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 59.2 mt -86.7 127.59 40.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 109.263 -0.643 . . . . 63.51 109.263 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -134.28 133.36 40.69 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.11 -1.07 . . . . 74.33 108.11 175.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.5 m -99.1 89.4 4.24 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.15 0.58 . . . . 72.33 109.499 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.543 HG21 HD11 ' B' ' 98' ' ' LEU . 7.1 tt -98.17 126.75 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.704 0.802 . . . . 74.25 111.92 -168.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.22 163.18 37.78 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.641 0.776 . . . . 74.11 111.061 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.12 -53.37 0.6 Allowed Glycine 0 C--N 1.35 1.321 0 CA-C-N 115.493 -0.776 . . . . 63.11 112.818 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.644 HG12 ' HB3' ' B' ' 9' ' ' MET . 9.7 mm -90.48 162.08 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 124.089 0.956 . . . . 64.5 112.607 -170.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -150.3 162.92 39.58 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.654 0.782 . . . . 70.24 109.855 173.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.81 -135.13 12.83 Favored Glycine 0 C--N 1.348 1.247 0 C-N-CA 123.206 0.431 . . . . 65.43 113.32 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m -89.16 -17.11 29.82 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 117.073 0.436 . . . . 53.44 110.705 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -61.88 -33.6 74.49 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.315 0.646 . . . . 73.12 111.277 175.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.493 ' HB3' HG22 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -80.21 -25.85 39.44 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.462 0.305 . . . . 71.02 110.824 175.701 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.16 -31.06 71.69 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.113 0.565 . . . . 33.25 110.042 171.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.433 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 32.4 t-80 -75.92 -39.61 55.9 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.03 0.932 . . . . 63.41 110.613 174.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 40.6 t -66.52 -52.56 44.52 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.947 0.403 . . . . 74.42 111.389 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.543 HD11 HG21 ' B' ' 86' ' ' ILE . 85.0 mt -89.06 -12.47 41.19 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.358 0.663 . . . . 52.32 111.861 -175.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.98 -6.27 34.59 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-O 119.729 -0.484 . . . . 73.41 113.978 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -135.36 -65.1 0.62 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 117.24 0.52 . . . . 60.24 110.462 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.48 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 55.2 t80 -59.36 -52.45 65.57 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.78 0.832 . . . . 72.32 112.954 -172.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.473 ' SG ' HD23 ' B' ' 98' ' ' LEU . 61.9 m -67.61 -45.27 46.05 Favored Pre-proline 0 CA--C 1.562 1.411 0 CA-C-N 115.624 -0.716 . . . . 71.33 111.565 -177.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.77 ' HB3' HD22 ' B' ' 60' ' ' LEU . 69.9 Cg_exo -51.88 -38.77 68.84 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.633 2.222 . . . . 64.24 115.161 167.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -60.64 -30.94 70.18 Favored 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 123.123 0.569 . . . . 74.11 111.94 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.425 HD13 HD11 ' B' ' 13' ' ' ILE . 75.2 mt -69.12 -40.19 80.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.909 0.884 . . . . 73.53 110.297 177.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.7 mt -87.34 -21.33 25.76 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.187 -0.915 . . . . 71.22 111.717 -170.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -53.87 -51.09 79.91 Favored Pre-proline 0 CA--C 1.562 1.435 0 C-N-CA 124.141 0.976 . . . . 73.44 113.182 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -54.25 -40.73 81.12 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 122.339 2.026 . . . . 61.31 114.208 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -70.21 -44.99 67.5 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.293 0.637 . . . . 61.21 110.82 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.57 -39.65 91.91 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.483 0.713 . . . . 75.11 111.032 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.445 HH21 ' ND2' ' B' ' 127' ' ' ASN . 33.9 ttt-85 -60.07 -56.22 24.32 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.374 1.07 . . . . 75.45 110.445 176.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -57.57 -34.69 69.48 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.074 0.95 . . . . 73.35 110.883 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.618 ' SG ' HD11 ' B' ' 21' ' ' ILE . 8.5 t -67.89 -45.85 73.28 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 122.674 0.39 . . . . 73.11 111.187 -178.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.449 ' O ' HG23 ' B' ' 118' ' ' VAL . 84.4 mt -63.4 -53.65 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.526 0.73 . . . . 52.2 109.888 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 34.2 m -57.7 -33.32 68.27 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.024 0.929 . . . . 72.34 111.817 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.464 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 41.1 t -61.83 -51.1 69.61 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 123.233 0.613 . . . . 75.22 109.795 174.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.494 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -67.16 -37.15 83.25 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.059 0.543 . . . . 74.33 111.407 -175.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.449 HG23 ' O ' ' B' ' 114' ' ' ILE . 95.0 t -59.48 -45.37 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.569 0.748 . . . . 75.52 110.116 174.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.6 t -67.42 -33.66 75.62 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.363 -1.29 . . . . 64.53 111.135 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' B' ' 116' ' ' SER . 93.2 mtt-85 -66.83 -31.61 72.34 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.449 -0.796 . . . . 73.22 110.495 177.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.21 9.36 73.12 Favored Glycine 0 C--N 1.353 1.475 0 CA-C-O 119.036 -0.869 . . . . 63.25 113.343 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.522 HG23 ' HB3' ' A' ' 17' ' ' TYR . 81.6 p 55.73 26.13 9.07 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.624 1.57 . . . . 72.1 113.274 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.431 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 56.3 m-85 -84.76 157.32 60.82 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 123.608 0.763 . . . . 74.35 110.171 176.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -54.74 158.76 10.12 Favored 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 123.274 2.649 . . . . 74.04 113.28 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -64.73 134.17 53.62 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.102 0.961 . . . . 72.14 111.36 -171.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.466 HD21 HG21 ' B' ' 40' ' ' VAL . 2.3 tm? -136.65 120.74 17.75 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.415 -0.957 . . . . 75.2 108.415 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 127' ' ' ASN . . . . . 0.445 ' ND2' HH21 ' B' ' 111' ' ' ARG . 16.3 m120 -122.29 136.26 54.87 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.033 0.933 . . . . 65.34 109.292 173.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 5.9 mp -78.92 137.77 37.79 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.785 0.834 . . . . 64.31 109.219 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.64 147.6 78.52 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.517 0.727 . . . . 61.31 110.794 -177.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.545 ' HG3' HD11 ' D' ' 16' ' ' ILE . 89.8 Cg_endo -77.12 114.66 3.83 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.887 2.392 . . . . 73.11 112.389 -175.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 m -121.86 111.36 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.341 0.656 . . . . 71.12 109.956 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -86.41 103.54 15.07 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 108.163 -1.051 . . . . 75.01 108.163 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -60.51 -38.01 82.99 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 124.12 0.888 . . . . 73.31 111.267 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 123.831 0.852 . . . . 74.34 111.298 -178.592 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.566 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.5 t80 . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 121.235 0.54 . . . . 60.11 109.693 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -144.21 133.78 23.48 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.278 1.031 . . . . 72.51 108.88 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.459 HG13 ' HG3' ' A' ' 130' ' ' PRO . 41.7 mt -81.39 128.77 38.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 108.561 -0.903 . . . . 74.13 108.561 173.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.605 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.5 mm-40 -89.84 -42.61 11.16 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.875 0.87 . . . . 55.14 110.381 -176.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.598 ' HG3' ' HG2' ' A' ' 125' ' ' GLN . 33.4 ttt180 -173.98 123.2 0.33 Allowed 'General case' 0 C--N 1.355 0.823 0 O-C-N 123.522 0.514 . . . . 64.11 110.351 -171.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 98.8 mt -110.1 139.7 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 108.818 -0.808 . . . . 51.41 108.818 174.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -170.6 154.06 4.4 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.988 0.915 . . . . 73.54 109.2 -171.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.7 p -80.84 110.14 16.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.322 -0.992 . . . . 55.44 108.322 172.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.619 ' HE2' HG21 ' C' ' 59' ' ' VAL . 6.0 mmmt -67.94 -48.33 66.22 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.141 -1.059 . . . . 75.12 108.141 175.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.697 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 20.4 t70 -135.87 143.37 45.01 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.334 -1.303 . . . . 65.3 110.153 -177.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.7 mt -135.93 149.94 28.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 125.593 1.557 . . . . 75.35 107.005 175.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 37.6 t -158.95 150.6 20.71 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.331 0.653 . . . . 74.53 109.719 173.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -145.85 138.88 25.94 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 106.534 -1.654 . . . . 74.4 106.534 171.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -143.68 113.77 7.3 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.062 -0.718 . . . . 72.31 109.062 -174.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.411 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -126.84 85.1 61.56 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 107.021 -1.474 . . . . 74.25 107.021 169.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.14 -33.13 19.64 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.567 2.178 . . . . 51.25 111.176 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -95.59 11.3 33.65 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 114.625 -1.17 . . . . 74.54 110.348 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.446 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -44.98 -59.19 4.48 Favored Pre-proline 0 C--N 1.377 1.775 0 C-N-CA 124.703 1.201 . . . . 74.24 113.55 -167.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.47 ' HG3' ' HG2' ' D' ' 57' ' ' GLU . 25.1 Cg_exo -58.35 -45.74 28.96 Favored 'Trans proline' 0 C--N 1.399 3.213 0 C-N-CA 121.633 1.555 . . . . 74.22 111.869 -175.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.438 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 83.8 t60 -69.97 -36.16 75.0 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.975 -1.466 . . . . 71.04 112.322 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.642 HG21 ' HA ' ' C' ' 73' ' ' ALA . 3.4 p -78.22 -19.02 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 111.914 0.338 . . . . 65.22 111.914 -168.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -69.74 -28.96 66.23 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.008 0.523 . . . . 75.41 112.028 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 19.5 pt20 -86.39 5.68 33.75 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 122.905 0.482 . . . . 73.4 111.707 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.759 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -84.93 154.34 22.26 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.328 0.651 . . . . 73.43 110.322 177.527 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -59.96 110.77 1.26 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.032 0.533 . . . . 72.42 109.763 166.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -71.17 90.84 0.9 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.863 0.865 . . . . 72.34 110.401 -177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -142.3 74.45 20.57 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 107.553 -1.277 . . . . 62.25 107.553 172.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -90.61 143.28 3.56 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.476 2.117 . . . . 74.01 112.446 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -88.96 106.48 18.44 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.544 1.138 . . . . 75.13 108.114 172.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 43.1 t -72.22 97.37 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 108.503 -0.925 . . . . 55.1 108.503 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.59 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 87.8 tttt -93.31 129.89 39.24 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.454 -0.793 . . . . 73.45 109.002 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 16.0 mt -89.23 149.74 22.96 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 124.358 1.063 . . . . 75.32 110.085 -172.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.517 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 31.1 t70 -160.52 118.67 2.55 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.743 0.652 . . . . 74.25 109.532 173.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -118.78 137.58 53.28 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.928 0.891 . . . . 70.1 108.713 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 18.1 t70 -130.5 153.59 48.66 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.263 -1.014 . . . . 73.11 108.263 174.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 71.7 p -114.24 118.36 33.73 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.507 0.723 . . . . 74.51 109.67 -173.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.39 135.63 54.23 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 107.904 -1.147 . . . . 51.0 107.904 172.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.6 p -167.36 158.91 12.09 Favored 'General case' 0 C--O 1.243 0.73 0 O-C-N 123.469 0.48 . . . . 72.41 111.303 -174.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 50.8 p -166.69 138.73 3.55 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.09 0.869 . . . . 71.32 109.682 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -72.89 121.1 19.46 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.467 -0.938 . . . . 72.2 108.467 170.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.641 HD11 HD12 ' C' ' 83' ' ' ILE . 78.8 mt -85.74 -36.6 20.06 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.91 0.484 . . . . 73.03 111.187 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.509 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -160.7 -176.15 5.38 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.934 0.893 . . . . 54.35 109.957 -173.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -62.46 108.0 1.04 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.62 0.768 . . . . 72.14 109.799 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 66.91 2.02 2.51 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 125.169 1.388 . . . . 53.33 113.017 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 97.9 t -94.4 118.18 39.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.398 -1.334 . . . . 65.23 107.398 173.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -133.46 139.03 46.46 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.679 -0.489 . . . . 61.14 109.679 -172.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -102.1 128.15 48.7 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.555 0.742 . . . . 75.31 109.994 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.46 HG11 ' HD3' ' C' ' 103' ' ' PRO . 91.1 t -112.33 124.05 68.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 107.73 -1.211 . . . . 63.14 107.73 171.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.619 HG21 ' HE2' ' C' ' 19' ' ' LYS . 34.9 t -127.99 116.85 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.387 0.675 . . . . 73.04 109.223 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.544 HD22 ' HB3' ' C' ' 103' ' ' PRO . 42.0 tp -103.99 114.16 28.21 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.403 -0.962 . . . . 51.35 108.403 -176.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.514 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 20.5 ttm-85 -82.0 105.81 13.41 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.95 -1.13 . . . . 74.34 107.95 174.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 10.3 t -100.64 117.25 45.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.736 -1.209 . . . . 73.12 107.736 175.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 34.6 m -121.87 117.99 27.85 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.775 -1.195 . . . . 73.12 107.775 -176.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.518 HG23 HD13 ' C' ' 114' ' ' ILE . 42.1 t -99.24 136.94 28.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.222 -1.354 . . . . 72.04 107.978 174.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.59 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 5.1 m -123.78 140.17 53.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.841 -1.17 . . . . 64.03 107.841 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.54 117.77 19.22 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.588 -1.634 . . . . 70.12 106.588 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.3 m -138.11 126.86 23.75 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.097 0.475 . . . . 55.12 110.965 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.759 HD13 ' HG2' ' C' ' 34' ' ' LYS . 4.3 mt -85.4 53.85 2.9 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.225 1.81 . . . . 70.42 108.427 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.78 -107.76 3.16 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 109.064 -1.614 . . . . 64.35 109.064 -166.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -104.02 -25.14 13.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.61 0.764 . . . . 61.52 110.675 172.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -62.98 104.07 0.52 Allowed 'General case' 0 C--N 1.353 0.718 0 C-N-CA 123.645 0.778 . . . . 75.44 109.214 175.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 36.7 m -73.99 121.57 21.25 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.402 -0.592 . . . . 74.41 109.402 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.642 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -69.88 -62.45 1.38 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.449 -1.25 . . . . 65.11 108.362 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -153.88 173.02 16.48 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 121.784 0.802 . . . . 64.51 111.043 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -137.36 128.3 27.41 Favored 'General case' 0 C--O 1.22 -0.494 0 N-CA-C 105.577 -2.009 . . . . 53.22 105.577 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.1 t -131.15 139.1 49.73 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.98 -1.118 . . . . 75.45 107.98 176.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -145.07 127.14 15.6 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.292 0.637 . . . . 74.3 109.434 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -132.03 114.37 24.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.422 -0.955 . . . . 64.2 108.422 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.697 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 48.1 mt-30 -89.27 87.23 7.05 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.416 -1.327 . . . . 72.35 107.416 171.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -79.34 110.58 14.76 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 114.143 -1.39 . . . . 73.41 109.396 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.36 151.97 20.06 Favored Glycine 0 C--N 1.337 0.626 0 O-C-N 123.673 0.608 . . . . 63.23 112.446 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.96 127.24 2.09 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 109.947 -1.261 . . . . 73.05 109.947 176.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.641 HD12 HD11 ' C' ' 51' ' ' LEU . 14.4 mm -88.45 124.55 41.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 107.648 -1.241 . . . . 45.54 107.648 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.566 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 66.9 m-85 -131.48 123.52 28.24 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.49 0.716 . . . . 72.32 110.001 -174.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 51.1 m -75.12 109.76 8.86 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.859 -0.793 . . . . 60.14 108.859 170.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 67.2 mt -114.13 100.72 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.978 -1.119 . . . . 42.15 107.978 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.33 141.31 29.66 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.09 0.956 . . . . 51.14 109.384 -176.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.07 -19.95 24.47 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-O 119.758 -0.468 . . . . 21.51 112.944 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 36.6 pt -121.86 164.46 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.175 0.59 . . . . 73.13 110.856 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -152.49 164.08 38.29 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.188 0.995 . . . . 74.01 109.736 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.04 -133.22 18.26 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.485 0.491 . . . . 63.51 113.045 171.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 45.8 p -63.5 -31.78 73.04 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.014 0.926 . . . . 64.41 111.428 -178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -61.26 -51.12 70.27 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.061 0.945 . . . . 74.53 110.434 176.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.421 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 56.5 ttm -66.78 -39.84 87.97 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 115.222 -0.899 . . . . 73.13 110.393 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.07 -37.14 76.38 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.253 1.021 . . . . 64.1 111.615 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -71.51 -41.04 69.75 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.443 -0.798 . . . . 72.43 110.804 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.579 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 41.4 t -58.14 -60.89 3.04 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 124.179 0.924 . . . . 61.15 111.036 -177.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.6 pp -69.79 -30.08 67.54 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.988 -0.551 . . . . 73.25 111.766 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 99' ' ' GLY . . . . . 0.41 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -78.51 -29.94 50.91 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-O 118.896 -0.946 . . . . 74.41 114.672 -168.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.48 -35.87 0.1 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.101 0.95 . . . . 64.51 112.357 -170.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.579 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 18.6 t80 -71.73 -35.57 70.21 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.986 1.315 . . . . 74.44 112.637 -175.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 84.9 m -82.82 -41.55 0.88 Allowed Pre-proline 0 CA--C 1.562 1.434 0 C-N-CA 123.159 0.584 . . . . 62.45 111.001 177.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.544 ' HB3' HD22 ' C' ' 60' ' ' LEU . 52.2 Cg_exo -54.72 -26.77 48.64 Favored 'Trans proline' 0 C--N 1.396 3.068 0 C-N-CA 122.713 2.275 . . . . 43.34 113.779 166.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 104' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' C' ' 101' ' ' TYR . 23.4 t-20 -55.75 -44.17 77.37 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 124.194 0.998 . . . . 75.35 110.765 172.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.43 HG23 ' NH1' ' A' ' 111' ' ' ARG . 45.0 mm -61.97 -40.07 85.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.39 -0.823 . . . . 74.31 110.063 177.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 85.7 mt -86.54 -14.38 43.15 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.161 0.984 . . . . 64.22 112.643 -171.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 107' ' ' PHE . . . . . 0.434 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 88.7 t80 -55.47 -53.69 59.49 Favored Pre-proline 0 CA--C 1.564 1.486 0 C-N-CA 123.809 0.844 . . . . 70.13 112.481 -177.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.434 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 35.7 Cg_exo -63.23 -34.16 69.06 Favored 'Trans proline' 0 C--N 1.388 2.627 0 C-N-CA 122.243 1.962 . . . . 74.04 113.476 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -64.93 -49.95 68.36 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.583 0.753 . . . . 74.43 111.06 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.37 99.16 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.477 -0.783 . . . . 31.22 110.194 177.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -55.86 -51.8 66.29 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.419 1.488 . . . . 63.13 111.326 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -71.18 -32.26 68.65 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.352 0.661 . . . . 61.42 110.338 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.7 t -70.62 -32.48 69.82 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.953 0.501 . . . . 72.32 111.193 -178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.518 HD13 HG23 ' C' ' 64' ' ' VAL . 90.0 mt -71.02 -56.38 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 109.072 -0.714 . . . . 43.02 109.072 173.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 23.9 m -60.98 -28.99 69.4 Favored 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 123.574 0.75 . . . . 75.45 111.978 -175.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 43.6 t -64.4 -51.04 65.23 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.671 0.788 . . . . 74.11 109.023 171.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.561 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.37 -35.85 78.61 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.262 1.025 . . . . 71.12 112.781 178.536 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.506 HG23 ' O ' ' C' ' 114' ' ' ILE . 59.5 t -63.45 -43.61 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.332 0.653 . . . . 51.12 109.449 176.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 31.5 t -68.16 -33.37 74.34 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.25 1.02 . . . . 74.33 111.985 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' C' ' 116' ' ' SER . 88.3 mtt-85 -67.59 -36.26 80.55 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.293 0.637 . . . . 74.11 109.786 176.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.22 11.48 60.65 Favored Glycine 0 C--N 1.355 1.616 0 O-C-N 124.059 0.849 . . . . 75.34 112.656 174.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 69.4 p 57.28 23.46 8.82 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.591 1.956 . . . . 65.14 114.746 174.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -82.74 146.07 51.96 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 107.964 -1.124 . . . . 73.23 107.964 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.32 178.75 1.87 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.709 2.273 . . . . 61.13 113.096 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 16.7 mm-40 -56.21 113.02 1.38 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.703 -1.135 . . . . 74.5 113.428 -173.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 39.7 tp -109.41 87.76 2.58 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.852 -1.067 . . . . 70.44 108.241 167.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -91.66 103.89 16.43 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.966 -0.753 . . . . 54.12 108.966 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 6.9 mp -66.14 137.85 57.31 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.224 0.609 . . . . 72.42 109.573 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.83 163.09 55.24 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.249 0.62 . . . . 65.33 110.404 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.624 ' HG2' HG21 ' A' ' 13' ' ' ILE . 43.2 Cg_exo -58.61 138.06 83.64 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.878 2.385 . . . . 75.24 113.42 174.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 15.7 t -130.13 115.0 31.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.884 -0.784 . . . . 72.11 108.884 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -96.63 77.79 2.91 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.795 0.838 . . . . 51.21 108.9 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -62.13 -46.0 90.97 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.626 0.727 . . . . 74.14 109.999 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 . . . . . 0 C--O 1.237 0.406 0 CA-C-N 113.819 -1.537 . . . . 64.13 111.566 -176.483 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 44.8 m . . . . . 0 C--O 1.243 0.743 0 N-CA-C 108.764 -0.828 . . . . 74.43 108.764 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -151.79 103.16 2.9 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.915 -1.143 . . . . 75.11 107.915 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -121.53 142.66 49.85 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.052 -1.092 . . . . 65.43 108.052 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 15.6 mt -90.85 127.66 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 108.265 -1.013 . . . . 72.23 108.265 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -86.77 -37.25 18.04 Favored 'General case' 0 C--O 1.242 0.673 0 O-C-N 123.371 0.419 . . . . 75.21 109.912 175.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -169.22 139.91 2.29 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.436 0.46 . . . . 62.11 111.188 -171.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.545 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.6 mp -117.79 134.04 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 106.986 -1.487 . . . . 71.15 106.986 171.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.408 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 33.9 p90 -164.57 156.54 16.07 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.474 0.654 . . . . 63.13 112.269 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.0 p -81.82 117.35 22.04 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.452 -1.249 . . . . 73.23 109.03 172.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.408 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 42.0 mtpt -88.83 -23.84 22.72 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.444 0.698 . . . . 63.04 110.005 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 18.9 t70 -158.31 143.75 16.7 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 114.616 -1.175 . . . . 74.43 109.01 176.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.561 HG21 ' HE2' ' C' ' 117' ' ' MET . 70.9 mt -142.27 148.21 20.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 106.909 -1.515 . . . . 74.22 106.909 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 30.7 t -155.95 146.25 21.65 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.659 0.784 . . . . 73.32 109.013 170.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 84.6 t80 -146.4 117.61 7.85 Favored 'General case' 0 C--O 1.213 -0.837 0 N-CA-C 105.411 -2.07 . . . . 74.43 105.411 175.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -127.06 110.16 12.64 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 109.134 -0.691 . . . . 72.41 109.134 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.41 85.91 2.44 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.405 -0.961 . . . . 73.2 108.405 174.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.87 -30.53 5.89 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.084 2.523 . . . . 73.34 113.246 -169.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -103.27 6.67 38.24 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.732 0.813 . . . . 70.21 110.179 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.445 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -29.55 -67.96 0.12 Allowed Pre-proline 0 CA--C 1.562 1.422 0 C-N-CA 126.476 1.91 . . . . 65.33 116.111 -161.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -78.37 -13.69 15.02 Favored 'Trans proline' 0 C--N 1.378 2.122 0 CA-C-N 122.775 2.027 . . . . 65.23 113.782 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -80.34 -40.54 26.5 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.656 0.783 . . . . 64.32 109.589 171.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.445 HG12 ' O ' ' D' ' 28' ' ' ALA . 5.5 p -81.51 -20.02 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 116.107 -0.497 . . . . 74.01 110.938 -172.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -65.88 -20.21 66.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.215 0.606 . . . . 71.14 112.341 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -61.79 -23.3 66.12 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.639 0.776 . . . . 60.01 110.276 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -93.26 87.15 5.55 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.27 1.428 . . . . 72.22 109.979 176.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.05 86.81 7.0 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.459 0.704 . . . . 75.4 110.577 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -155.11 173.19 16.94 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.452 -0.944 . . . . 73.54 108.452 167.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -69.41 115.87 36.89 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 108.993 -0.743 . . . . 74.23 108.993 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.23 145.38 78.1 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.676 2.25 . . . . 62.42 111.69 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 37.7 mt-10 -61.59 111.86 1.99 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.662 -0.866 . . . . 72.14 108.662 169.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.764 HG13 HG13 ' D' ' 64' ' ' VAL . 91.9 t -99.48 113.67 35.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.447 -0.946 . . . . 61.15 108.447 -178.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.612 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 10.9 tmtt? -92.53 119.42 31.99 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 106.255 -1.757 . . . . 60.53 106.255 173.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 mp -96.12 137.9 34.51 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.423 -0.954 . . . . 65.52 108.423 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.518 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 8.0 t70 -142.35 148.16 37.47 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.683 -0.858 . . . . 62.41 108.683 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -127.51 147.32 50.32 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.763 0.825 . . . . 74.54 110.358 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.436 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 10.1 t70 -144.18 145.2 31.93 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 107.681 -1.229 . . . . 72.34 107.681 172.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 57.9 p -113.17 144.16 43.14 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.195 0.598 . . . . 72.44 110.336 -175.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.488 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.59 151.93 31.22 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.79 0.836 . . . . 75.35 109.284 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 79.4 p -155.88 157.14 35.85 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 120.784 0.326 . . . . 72.11 110.916 -178.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 25.4 p -152.64 119.27 5.67 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.401 1.08 . . . . 71.4 108.917 175.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -79.81 121.05 24.9 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.183 -0.673 . . . . 74.4 109.183 176.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 30.0 mt -91.26 -35.8 14.27 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.054 0.542 . . . . 63.22 109.878 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.75 176.54 12.6 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.987 -1.006 . . . . 74.15 109.707 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -65.56 123.44 19.69 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.558 -0.905 . . . . 75.25 108.558 177.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 54' ' ' ASP . . . . . 0.604 ' HB3' ' O ' ' D' ' 86' ' ' ILE . 3.8 m-20 71.94 2.95 4.5 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.212 1.005 . . . . 53.52 112.654 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.4 t -114.76 119.05 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.713 0.805 . . . . 74.1 109.255 176.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -133.02 128.43 36.29 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.297 0.639 . . . . 54.03 110.503 -173.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.642 ' HB2' HG12 ' D' ' 83' ' ' ILE . 4.6 tp10 -99.69 110.49 22.9 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 106.759 -1.571 . . . . 75.32 106.759 168.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.535 HG11 HD23 ' D' ' 98' ' ' LEU . 32.7 m -120.56 147.78 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 123.696 0.798 . . . . 73.41 109.111 -174.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 12.8 t -125.48 133.47 69.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 C-N-CA 123.69 0.796 . . . . 74.53 109.898 -169.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.494 HD22 ' HB2' ' D' ' 103' ' ' PRO . 56.3 tp -109.48 110.57 21.72 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.927 -1.138 . . . . 71.11 107.927 165.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.436 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.2 ttm180 -84.72 105.05 15.22 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.539 -0.912 . . . . 74.33 108.539 173.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 79.2 t -91.08 128.97 42.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.932 -1.136 . . . . 73.41 107.932 170.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 27.0 m -125.27 138.06 54.09 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.121 0.568 . . . . 73.35 109.522 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.764 HG13 HG13 ' D' ' 40' ' ' VAL . 24.4 t -129.16 101.04 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 124.945 1.298 . . . . 71.54 108.436 -174.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.612 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 36.8 m -95.49 93.86 7.44 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.377 -0.971 . . . . 73.02 108.377 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -95.99 144.19 26.5 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.263 0.625 . . . . 75.52 110.15 -174.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.471 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 64.7 p -145.82 129.29 16.93 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 123.683 0.614 . . . . 64.44 112.145 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.402 HD12 HG22 ' D' ' 31' ' ' VAL . 22.5 mt -99.1 112.9 24.92 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.871 0.868 . . . . 73.33 108.852 173.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.84 -111.01 3.18 Favored Glycine 0 C--N 1.345 1.074 0 N-CA-C 111.842 -0.503 . . . . 44.44 111.842 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.25 6.19 9.12 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.975 0.91 . . . . 73.12 110.526 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -121.15 165.9 14.71 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.466 0.706 . . . . 74.42 109.788 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.6 m -70.62 129.94 40.5 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.59 0.756 . . . . 74.23 111.924 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.471 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -84.36 -69.4 0.65 Allowed 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.817 -1.179 . . . . 42.43 107.817 170.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -151.07 158.75 44.47 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.74 -0.664 . . . . 72.23 110.803 175.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 74.3 mt -121.46 108.19 13.35 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.372 -1.344 . . . . 72.22 107.372 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.493 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.6 t -123.9 107.9 11.86 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.225 0.61 . . . . 72.14 109.506 -169.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -131.15 123.44 28.56 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.756 0.822 . . . . 75.21 109.072 -173.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.41 119.8 51.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 123.578 0.751 . . . . 72.34 109.012 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.532 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.0 mt-30 -87.18 85.7 7.22 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.876 -1.157 . . . . 71.15 107.876 170.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -81.91 110.86 17.58 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.341 -1.299 . . . . 64.33 108.907 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.61 167.58 14.13 Favored Glycine 0 C--N 1.341 0.826 0 O-C-N 123.557 0.536 . . . . 70.15 112.549 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.38 129.18 1.97 Allowed Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.35 -0.7 . . . . 64.32 111.35 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.642 HG12 ' HB2' ' D' ' 57' ' ' GLU . 61.8 mt -89.0 133.41 31.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.884 -1.154 . . . . 63.25 107.884 177.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -132.74 133.99 44.18 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 122.917 0.487 . . . . 71.4 110.879 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.1 m -81.21 104.85 11.96 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.089 0.956 . . . . 54.31 109.095 165.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.604 ' O ' ' HB3' ' D' ' 54' ' ' ASP . 67.3 mt -107.17 145.04 15.1 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 C-N-CA 124.158 0.983 . . . . 64.33 108.577 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.28 157.26 15.16 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 118.325 0.511 . . . . 75.12 110.05 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.96 11.35 74.17 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.568 0.543 . . . . 62.04 114.201 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.489 HG23 ' HB3' ' D' ' 93' ' ' GLN . 11.1 mt -97.57 134.92 33.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 C-N-CA 123.25 0.62 . . . . 75.31 110.696 -175.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -157.41 172.25 18.92 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.498 1.119 . . . . 75.25 109.148 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.89 -133.46 29.34 Favored Glycine 0 CA--C 1.527 0.825 0 O-C-N 123.465 0.478 . . . . 43.03 113.208 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 57.8 p -66.73 -33.19 75.08 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.944 0.898 . . . . 70.04 111.754 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.489 ' HB3' HG23 ' D' ' 89' ' ' ILE . 50.2 tt0 -67.71 -22.33 65.26 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.087 -0.506 . . . . 74.34 112.178 -172.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 91.0 mtp -55.26 -54.18 46.68 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.022 -0.733 . . . . 71.35 109.022 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.36 -47.72 54.61 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.935 -1.03 . . . . 65.11 111.263 -178.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -76.28 -24.53 54.43 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.15 0.98 . . . . 73.44 112.685 -168.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -63.21 -51.67 65.34 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.935 -0.394 . . . . 61.41 109.935 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.535 HD23 HG11 ' D' ' 58' ' ' VAL . 4.5 mp -84.34 -25.78 28.94 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 122.761 0.424 . . . . 74.43 110.341 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.59 -5.05 72.27 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.62 -0.544 . . . . 75.34 113.925 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.65 -57.71 0.11 Allowed 'General case' 0 C--N 1.358 0.955 0 N-CA-C 112.6 0.593 . . . . 63.13 112.6 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -72.31 -50.57 26.02 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 112.792 0.664 . . . . 73.02 112.792 -166.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 35.2 m -61.64 -47.14 93.36 Favored Pre-proline 0 CA--C 1.564 1.507 0 C-N-CA 123.993 0.917 . . . . 75.44 112.974 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.494 ' HB2' HD22 ' D' ' 60' ' ' LEU . 65.8 Cg_endo -70.39 -20.48 31.81 Favored 'Trans proline' 0 C--N 1.392 2.852 0 C-N-CA 122.176 1.917 . . . . 70.03 112.659 175.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -73.65 -26.96 61.01 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.285 0.634 . . . . 75.13 110.539 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mm -65.77 -37.44 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-O 121.525 0.679 . . . . 71.33 109.876 169.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 50.9 mt -84.57 -13.13 52.63 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 114.832 -1.076 . . . . 64.14 111.423 -176.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 107' ' ' PHE . . . . . 0.415 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 85.1 t80 -61.61 -53.11 64.45 Favored Pre-proline 0 CA--C 1.567 1.605 0 C-N-CA 124.422 1.089 . . . . 65.21 113.025 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 108' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 24.5 Cg_exo -65.05 -31.44 55.17 Favored 'Trans proline' 0 C--N 1.393 2.872 0 C-N-CA 122.14 1.893 . . . . 52.22 112.923 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -76.18 -33.99 59.32 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.773 0.829 . . . . 52.43 111.772 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.46 -48.89 73.58 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.238 -0.653 . . . . 63.33 109.238 172.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -55.58 -47.18 76.88 Favored 'General case' 0 C--N 1.358 0.953 0 O-C-N 124.445 1.09 . . . . 64.12 110.454 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.76 -53.26 58.37 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.066 0.546 . . . . 74.54 110.945 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.8 t -55.64 -44.86 77.56 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 123.825 0.703 . . . . 73.41 111.24 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.493 HG23 ' SG ' ' D' ' 76' ' ' CYS . 59.3 mt -60.45 -59.9 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.987 0.915 . . . . 72.12 110.659 175.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 47.7 m -54.11 -38.61 65.58 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.694 1.198 . . . . 52.22 111.796 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.4 t -65.47 -45.61 82.99 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.236 -0.893 . . . . 64.33 110.1 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.41 ' HB2' ' HE3' ' D' ' 117' ' ' MET . 69.7 mtm -70.63 -28.12 64.58 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.861 0.465 . . . . 65.12 111.889 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' D' ' 114' ' ' ILE . 99.5 t -66.09 -45.76 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.27 0.628 . . . . 73.32 109.585 174.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.0 p -72.13 -31.06 65.65 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.843 -0.617 . . . . 55.31 110.826 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -69.27 -36.32 76.97 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.974 0.909 . . . . 72.51 109.954 175.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.76 1.2 88.68 Favored Glycine 0 C--N 1.351 1.398 0 O-C-N 123.805 0.69 . . . . 74.32 112.012 174.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.0 p 61.97 23.11 13.57 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 126.832 2.053 . . . . 64.33 113.573 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -81.66 160.04 65.14 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.849 0.86 . . . . 74.34 110.003 170.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.64 132.51 51.9 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.973 2.449 . . . . 62.13 112.737 174.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -56.34 134.86 53.87 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.163 0.985 . . . . 70.34 111.792 -175.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.402 HD13 HG21 ' D' ' 40' ' ' VAL . 53.9 tp -111.95 103.38 11.6 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.389 -0.823 . . . . 70.53 109.219 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 127' ' ' ASN . . . . . 0.432 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 86.3 m-20 -100.54 96.75 7.59 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.487 -0.931 . . . . 74.42 108.487 177.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 31.7 tp -67.3 120.75 14.34 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-N 115.4 -0.818 . . . . 73.11 109.885 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.8 137.44 83.05 Favored Pre-proline 0 C--N 1.354 0.792 0 O-C-N 124.348 1.03 . . . . 73.54 111.43 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.527 ' HG3' HD11 ' B' ' 13' ' ' ILE . 1.8 Cg_endo -76.58 103.38 1.74 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.902 2.401 . . . . 74.4 110.891 -172.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 CA--C 1.539 0.523 0 CA-C-N 115.923 -0.58 . . . . 34.24 109.561 179.742 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.668 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 15.6 t80 . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 109.89 -0.411 . . . . 73.35 109.89 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -138.19 117.28 12.56 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.753 0.821 . . . . 75.41 108.943 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.632 HG12 ' HD2' ' A' ' 84' ' ' PHE . 53.8 mt -89.92 125.08 42.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 108.871 -0.788 . . . . 72.23 108.871 176.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -85.94 -41.16 15.15 Favored 'General case' 0 C--O 1.242 0.66 0 O-C-N 123.847 0.717 . . . . 71.45 110.159 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -167.9 136.7 2.47 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.874 -0.417 . . . . 63.14 109.874 -167.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.47 HD11 HD13 ' A' ' 13' ' ' ILE . 94.4 mt -130.01 129.34 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.061 -1.089 . . . . 63.23 108.061 172.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -161.52 176.77 10.7 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 124.216 0.948 . . . . 65.24 111.252 -167.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -107.28 116.22 31.56 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 114.944 -1.025 . . . . 64.35 108.836 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.501 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 34.5 mtpt -82.11 -26.44 33.58 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 110.012 -0.366 . . . . 70.1 110.012 177.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 18.3 t70 -152.78 136.65 16.24 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.218 -0.901 . . . . 72.24 109.72 174.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.447 HG23 ' SD ' ' A' ' 117' ' ' MET . 83.6 mt -129.18 137.48 56.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 106.285 -1.746 . . . . 73.55 106.285 172.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.6 t -152.03 110.63 3.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.419 0.628 . . . . 75.25 110.226 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.512 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 92.3 t80 -110.38 137.34 48.22 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 107.313 -1.366 . . . . 74.22 107.313 173.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -135.16 140.92 45.76 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.701 -1.222 . . . . 74.12 107.701 171.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.407 ' CB ' ' HB2' ' A' ' 28' ' ' ALA . . . -122.9 80.78 50.01 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 105.891 -1.892 . . . . 71.43 105.891 168.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.2 -31.42 89.9 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.076 2.517 . . . . 74.2 112.746 -167.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -118.44 31.69 6.54 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 118.597 -0.716 . . . . 73.23 109.66 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.415 ' HB3' ' HZ1' ' B' ' 19' ' ' LYS . . . -42.41 -54.47 7.91 Favored Pre-proline 0 CA--C 1.573 1.84 0 N-CA-C 114.84 1.422 . . . . 74.41 114.84 -170.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HD3' ' HZ1' ' B' ' 19' ' ' LYS . 14.1 Cg_exo -64.13 -31.4 64.89 Favored 'Trans proline' 0 C--N 1.395 3.004 0 CA-C-N 121.652 1.626 . . . . 52.1 112.572 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -80.17 -39.16 29.86 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.863 -1.062 . . . . 62.13 110.51 -175.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.658 HG21 ' HA ' ' A' ' 73' ' ' ALA . 5.2 p -78.52 -22.23 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 CA-C-N 114.821 -1.081 . . . . 73.1 112.714 -161.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -70.91 -21.1 62.41 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.906 0.482 . . . . 72.44 110.754 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -86.46 -18.34 31.94 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.517 1.127 . . . . 65.11 110.519 176.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.4 tmtp? -78.13 146.67 34.99 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.142 0.977 . . . . 71.23 109.734 -175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.07 138.88 58.67 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.816 0.846 . . . . 65.24 110.524 173.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -93.01 82.99 4.64 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.868 0.842 . . . . 72.32 110.6 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -130.87 83.44 61.3 Favored Pre-proline 0 C--O 1.239 0.539 0 N-CA-C 107.017 -1.475 . . . . 60.03 107.017 165.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -85.97 156.6 10.02 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 122.214 1.943 . . . . 71.43 111.959 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -109.66 93.72 4.65 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 105.036 -2.209 . . . . 74.33 105.036 165.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 65' ' ' THR . 48.1 t -78.5 92.04 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 122.072 0.939 . . . . 74.44 108.695 -177.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.446 ' HE2' ' HB2' ' A' ' 67' ' ' SER . 62.3 mttm -82.98 113.3 20.47 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.596 -1.638 . . . . 62.32 108.98 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 pp -105.73 128.36 53.64 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.008 0.523 . . . . 71.45 110.625 -174.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.538 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.6 m-20 -114.28 139.2 49.61 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.405 1.082 . . . . 70.32 109.029 177.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.1 mt -124.61 119.54 29.34 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.601 0.76 . . . . 74.22 109.513 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 21.8 t70 -120.24 130.31 54.45 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.617 -0.882 . . . . 71.31 108.617 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.3 p -106.98 132.21 53.18 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.878 0.871 . . . . 52.05 110.254 -173.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.18 129.52 10.56 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.049 0.54 . . . . 74.44 110.308 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.2 m -130.82 152.92 49.64 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.223 0.609 . . . . 72.43 110.324 174.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.6 t -149.96 126.71 11.02 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.578 0.751 . . . . 75.33 109.084 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -78.47 132.55 37.31 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.857 0.463 . . . . 72.32 110.927 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.3 mt -101.32 -31.01 11.17 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.441 1.096 . . . . 60.22 111.059 -174.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.581 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -163.63 173.76 12.56 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.489 1.116 . . . . 52.22 109.712 -175.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -56.67 116.47 3.15 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.023 0.529 . . . . 50.32 110.204 171.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 70.49 -10.6 0.68 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 126.215 1.806 . . . . 74.24 113.259 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 21.6 t -100.7 117.68 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.075 -1.083 . . . . 53.1 108.075 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -142.35 170.33 15.9 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.14 -0.689 . . . . 72.54 109.14 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -120.08 132.99 55.64 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 123.521 0.729 . . . . 73.4 110.021 -175.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.446 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 93.7 t -104.39 126.82 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.008 -1.108 . . . . 73.04 108.008 169.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.99 125.81 74.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 108.269 -1.012 . . . . 74.3 108.269 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.19 110.88 18.11 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.722 -1.214 . . . . 70.11 107.722 176.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.577 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 36.8 ttm180 -81.95 100.26 9.57 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.572 -1.27 . . . . 74.54 107.572 174.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.9 t -98.86 102.46 13.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.679 -1.23 . . . . 71.24 107.679 176.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.538 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 26.5 m -96.91 135.88 38.27 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.444 -0.576 . . . . 73.53 109.444 178.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.542 HG11 HD21 ' A' ' 126' ' ' LEU . 17.9 t -126.73 107.68 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.628 1.171 . . . . 45.43 108.392 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 25.9 m -102.94 134.33 46.54 Favored 'General case' 0 C--O 1.208 -1.083 0 N-CA-C 107.707 -1.22 . . . . 54.44 107.707 173.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.71 105.28 12.56 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 107.699 -1.223 . . . . 75.5 107.699 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 50.2 m -108.72 124.29 50.33 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.304 0.574 . . . . 74.04 110.952 -177.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.1 mt -91.04 54.82 2.72 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.889 1.276 . . . . 64.41 108.399 178.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.47 -114.56 4.73 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 110.36 -1.096 . . . . 71.01 110.36 -166.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -91.93 -26.68 18.32 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.007 0.523 . . . . 70.2 110.864 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -86.73 108.8 18.84 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.206 0.602 . . . . 72.11 109.595 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 53.9 m -72.63 124.87 26.16 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.688 0.395 . . . . 70.33 110.625 176.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.658 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -62.26 -58.09 9.0 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.49 1.116 . . . . 54.12 111.183 174.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -155.83 164.54 38.4 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.816 -1.083 . . . . 74.1 111.779 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.5 tp -123.46 138.51 54.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.605 1.162 . . . . 71.53 108.158 173.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.418 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 76.6 m -142.51 96.57 2.97 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.838 0.855 . . . . 72.11 109.555 -178.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -108.29 130.43 55.18 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.788 -0.819 . . . . 70.2 108.788 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.1 t -132.15 112.43 19.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 109.238 -0.653 . . . . 63.31 109.238 173.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -84.55 84.83 7.53 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.048 -1.093 . . . . 64.43 108.048 172.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.53 ' HG3' HD22 ' A' ' 106' ' ' LEU . 61.1 tp60 -76.85 102.97 6.55 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.183 -0.917 . . . . 71.21 108.795 -177.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.21 144.92 17.42 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.041 -0.823 . . . . 73.35 111.041 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.44 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -150.86 123.13 1.47 Allowed Glycine 0 CA--C 1.504 -0.615 0 N-CA-C 110.779 -0.928 . . . . 74.43 110.779 -176.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.5 mt -81.22 122.24 36.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 108.973 -0.751 . . . . 72.53 108.973 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.668 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 25.1 m-85 -134.12 137.53 44.61 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.859 -0.793 . . . . 73.14 108.859 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.3 m -102.44 96.79 7.16 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.006 -0.738 . . . . 64.21 109.006 173.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.647 HD11 ' SG ' ' A' ' 102' ' ' CYS . 62.8 mt . . . . . 0 C--O 1.241 0.648 0 N-CA-C 108.355 -0.98 . . . . 74.23 108.355 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.454 0.645 . . . . 74.31 111.545 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -67.83 -39.67 83.84 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.559 1.144 . . . . 60.25 110.582 175.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 18.7 t -72.58 -35.64 67.97 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 116.383 -0.371 . . . . 42.32 111.8 -175.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 pp -83.49 -29.95 27.56 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.932 0.493 . . . . 71.21 111.409 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.25 3.98 37.9 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 114.6 0.6 . . . . 73.35 114.6 -168.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.62 -53.41 0.24 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.832 0.316 . . . . 72.15 111.674 -176.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.435 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 66.4 t80 -73.09 -65.92 0.74 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 123.445 0.465 . . . . 73.1 112.084 -171.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.647 ' SG ' HD11 ' A' ' 86' ' ' ILE . 92.3 m -68.13 -32.91 4.37 Favored Pre-proline 0 CA--C 1.566 1.56 0 N-CA-C 115.135 1.532 . . . . 61.04 115.135 -172.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 25.9 Cg_endo -63.24 -32.04 73.73 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 121.824 1.683 . . . . 75.04 112.554 166.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -76.5 -21.44 55.79 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.997 0.519 . . . . 73.24 110.715 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 42.1 mm -67.46 -36.38 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 109.501 -0.555 . . . . 70.43 109.501 170.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.53 HD22 ' HG3' ' A' ' 80' ' ' GLN . 94.7 mt -79.77 -17.52 53.22 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.426 0.69 . . . . 62.14 112.211 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -61.43 -48.79 89.88 Favored Pre-proline 0 CA--C 1.57 1.715 0 CA-C-O 117.933 -1.032 . . . . 75.3 113.546 -175.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.31 -34.1 45.82 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 121.954 1.769 . . . . 51.01 112.909 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -72.67 -40.15 66.54 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.312 0.645 . . . . 45.45 111.382 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.62 -39.45 70.42 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.994 0.518 . . . . 43.44 110.449 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.521 HH12 HD12 ' C' ' 105' ' ' ILE . 30.6 ttm180 -54.35 -51.69 63.98 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 124.173 0.921 . . . . 75.11 109.829 173.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -65.75 -42.06 91.37 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.38 1.05 . . . . 71.2 111.558 -175.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 46.2 t -61.51 -42.85 99.43 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.837 0.711 . . . . 70.54 110.329 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.06 -48.1 87.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 O-C-N 124.108 0.88 . . . . 51.34 110.407 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 35.8 m -56.65 -38.55 72.31 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.913 0.885 . . . . 73.54 111.377 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.1 t -68.69 -46.22 69.63 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.435 -0.802 . . . . 63.22 110.353 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.447 ' SD ' HG23 ' A' ' 21' ' ' ILE . 27.1 mtp -59.0 -42.57 90.37 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.884 0.874 . . . . 62.31 111.406 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.547 HG21 HD23 ' A' ' 126' ' ' LEU . 68.9 t -65.72 -44.05 93.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 124.652 1.181 . . . . 73.24 110.71 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 37.5 t -71.43 -31.13 66.85 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.239 0.616 . . . . 51.13 110.935 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.451 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 90.8 mtt-85 -73.98 -32.14 63.3 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.758 0.823 . . . . 72.5 109.512 175.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.41 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.74 12.15 57.55 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 115.453 -0.794 . . . . 63.25 112.823 172.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.487 HG21 ' HE ' ' B' ' 15' ' ' ARG . 2.8 t 60.94 15.02 5.7 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 127.234 2.214 . . . . 71.43 114.385 171.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.458 ' HB2' HG13 ' A' ' 118' ' ' VAL . 74.7 m-85 -78.57 155.08 78.82 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 109.019 -0.734 . . . . 74.31 109.019 175.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.68 174.43 2.25 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.636 2.224 . . . . 63.44 113.488 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.1 116.34 1.96 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.2 1.4 . . . . 75.31 111.853 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.547 HD23 HG21 ' A' ' 118' ' ' VAL . 56.9 tp -127.94 106.08 8.85 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.549 0.74 . . . . 63.33 109.152 176.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -130.7 128.33 40.65 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.729 1.212 . . . . 71.5 109.042 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.66 144.92 55.27 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 123.429 0.455 . . . . 53.4 110.079 174.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.17 157.12 78.64 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 124.303 1.041 . . . . 72.3 111.491 -178.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.607 ' HD3' HG13 ' C' ' 13' ' ' ILE . 64.7 Cg_endo -70.37 99.33 0.8 Allowed 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.547 2.165 . . . . 53.54 111.981 176.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.4 t -103.97 112.94 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.793 -0.817 . . . . 73.52 108.793 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -95.27 84.12 3.99 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 108.686 -0.857 . . . . 74.31 108.686 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 . . . . . 0 N--CA 1.483 1.213 0 O-C-N 123.333 0.396 . . . . 74.41 110.006 -178.643 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.541 ' SD ' ' N ' ' B' ' 10' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 110.339 -0.245 . . . . 72.52 110.339 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.541 ' N ' ' SD ' ' B' ' 9' ' ' MET . 54.6 m -167.08 130.66 1.85 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.801 0.84 . . . . 71.31 109.685 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' B' ' 85' ' ' SER 0.283 0.5 OUTLIER -155.25 155.85 34.54 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.561 0.696 . . . . 71.14 111.204 143.406 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -127.03 128.38 46.24 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 106.424 -1.695 . . . . 75.35 106.424 172.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.491 HD11 HD13 ' B' ' 105' ' ' ILE . 27.8 mt -68.52 121.34 17.61 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 N-CA-C 108.784 -0.821 . . . . 72.12 108.784 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -90.29 -40.62 12.03 Favored 'General case' 0 C--O 1.243 0.761 0 O-C-N 124.233 0.958 . . . . 74.02 109.583 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.493 ' HA ' ' ND2' ' D' ' 127' ' ' ASN . 28.3 ttt180 -167.56 133.77 2.12 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 116.396 -0.366 . . . . 53.01 111.022 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.426 HD11 HD13 ' B' ' 13' ' ' ILE . 86.1 mt -115.56 135.97 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 107.48 -1.304 . . . . 73.34 107.48 173.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.401 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 42.3 p90 -168.73 170.69 9.18 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.98 0.895 . . . . 73.15 113.052 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.421 HG21 HD11 ' B' ' 21' ' ' ILE . 86.9 m -96.42 118.03 32.1 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.828 -1.533 . . . . 65.14 108.743 174.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.415 ' HZ1' ' HB3' ' A' ' 28' ' ' ALA . 24.8 mtpp -79.8 -28.99 40.19 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.985 0.514 . . . . 73.32 110.543 176.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -162.7 149.93 13.37 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.218 0.533 . . . . 73.24 112.045 -171.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 28.3 mm -137.89 144.88 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 126.216 1.806 . . . . 65.31 108.612 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 46.2 t -147.64 126.66 12.83 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.965 -1.016 . . . . 71.42 108.786 169.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 85.3 t80 -138.81 109.82 6.8 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 107.529 -1.286 . . . . 73.41 107.529 171.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -119.09 115.47 24.34 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.922 0.889 . . . . 74.52 108.724 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.95 86.35 1.91 Allowed Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 107.091 -1.448 . . . . 40.52 107.091 169.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.88 -45.23 8.6 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.567 2.178 . . . . 72.13 112.131 -169.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -100.59 18.05 20.2 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.674 0.79 . . . . 73.11 110.748 -176.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.501 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -31.12 -68.67 0.13 Allowed Pre-proline 0 N--CA 1.504 2.242 0 N-CA-C 115.419 1.637 . . . . 54.14 115.419 -166.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 54.8 Cg_endo -70.37 -13.48 33.19 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 122.336 2.024 . . . . 65.31 113.078 -171.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -92.2 -45.7 8.12 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.544 0.738 . . . . 73.31 110.258 177.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.564 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.0 p -69.57 -17.62 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 112.295 0.48 . . . . 73.03 112.295 -171.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -62.92 -18.8 63.55 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.013 0.525 . . . . 54.33 112.383 173.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -65.98 -20.96 66.37 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.609 0.764 . . . . 65.13 110.817 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -103.99 71.27 1.03 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.835 1.254 . . . . 73.15 108.743 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -82.75 91.95 7.12 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.178 -0.919 . . . . 73.44 111.727 -173.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -158.64 -175.18 5.16 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.136 0.974 . . . . 73.2 109.52 170.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -72.74 111.59 11.84 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 123.663 0.785 . . . . 75.11 110.145 176.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.46 153.77 75.67 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.336 2.024 . . . . 72.44 112.216 178.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -69.31 113.93 7.09 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.56 -0.745 . . . . 71.24 109.16 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 12.8 t -86.46 121.35 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 122.991 0.517 . . . . 63.55 109.899 -173.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -115.86 128.63 55.96 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 107.244 -1.391 . . . . 70.5 107.244 172.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.606 HD13 HD21 ' B' ' 128' ' ' LEU . 0.2 OUTLIER -131.19 148.76 52.75 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.134 0.573 . . . . 73.21 109.763 174.867 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -153.2 129.82 10.77 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.066 0.946 . . . . 65.25 108.713 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 85.7 mt -99.47 150.91 21.71 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.691 0.797 . . . . 61.04 110.04 -176.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.0 t70 -137.14 139.68 41.35 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.777 -0.823 . . . . 62.41 108.777 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.8 p -109.8 124.23 50.93 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.392 0.677 . . . . 71.15 110.808 -175.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -131.94 135.36 46.54 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.42 1.088 . . . . 74.33 108.965 176.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 16.2 m -144.35 161.77 38.15 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.76 0.424 . . . . 52.21 111.385 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 53.9 p -160.55 143.39 13.17 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.328 -0.851 . . . . 72.01 109.769 174.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -80.29 107.08 12.8 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 107.821 -1.178 . . . . 72.4 107.821 172.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.622 HD11 ' HB2' ' B' ' 57' ' ' GLU . 40.2 mt -77.09 -42.08 39.6 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.275 0.559 . . . . 74.53 110.295 -174.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.22 -166.06 1.85 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.248 1.019 . . . . 75.43 109.827 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -69.96 131.39 44.33 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.251 0.62 . . . . 61.23 109.764 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 64.75 -10.4 0.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 125.727 1.611 . . . . 72.35 112.343 -171.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' B' ' 51' ' ' LEU . 91.1 t -110.7 121.82 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 O-C-N 121.502 -0.749 . . . . 72.13 109.468 -165.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -133.58 -176.48 4.17 Favored 'General case' 0 C--O 1.247 0.973 0 N-CA-C 107.796 -1.187 . . . . 65.13 107.796 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.622 ' HB2' HD11 ' B' ' 51' ' ' LEU . 35.4 tt0 -139.19 129.24 25.15 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.391 0.276 . . . . 62.33 110.608 -177.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 82.8 t -97.11 117.99 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.433 -0.951 . . . . 72.24 108.433 170.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 41.2 t -116.79 110.58 31.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.963 -1.125 . . . . 64.05 107.963 174.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 30.3 tp -107.28 107.85 18.98 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.337 -0.986 . . . . 64.23 108.337 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.552 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 45.9 ttt180 -84.74 114.44 22.05 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.52 -0.918 . . . . 73.43 108.52 176.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.6 t -102.69 105.07 17.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.968 -1.123 . . . . 71.35 107.968 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 33.1 m -95.45 138.37 33.23 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.511 -0.922 . . . . 73.53 108.511 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.55 133.26 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.563 0.745 . . . . 73.42 109.612 177.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.2 m -119.39 145.3 46.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.396 1.078 . . . . 60.31 108.421 169.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.57 129.34 26.49 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.849 -0.797 . . . . 74.54 108.849 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 30.9 p -123.11 127.83 49.25 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.587 0.755 . . . . 62.51 110.638 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.512 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 44.6 mt -102.63 109.39 20.99 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.061 0.944 . . . . 75.11 109.176 172.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.81 -110.56 3.55 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 114.958 -1.019 . . . . 53.51 113.398 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -105.08 4.02 31.04 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.007 0.923 . . . . 72.55 111.708 -174.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -139.53 164.79 28.97 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.743 0.417 . . . . 70.35 110.863 -176.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 63.3 m -79.07 125.6 29.61 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.479 0.712 . . . . 73.3 110.719 -177.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.564 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -70.55 -63.2 1.14 Allowed 'General case' 0 C--O 1.24 0.559 0 O-C-N 123.966 0.792 . . . . 71.45 109.16 171.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -155.08 164.54 38.72 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.462 -1.245 . . . . 72.25 111.724 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 55.4 mt -126.13 111.36 14.56 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 105.545 -2.02 . . . . 63.34 105.545 173.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.477 ' SG ' HG23 ' B' ' 114' ' ' ILE . 31.5 t -119.12 140.18 50.56 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.733 -0.84 . . . . 73.52 108.733 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -160.02 136.2 8.74 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.101 0.477 . . . . 70.24 110.045 -170.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' B' ' 113' ' ' CYS . 88.7 t -132.94 151.6 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.746 1.219 . . . . 71.14 108.248 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.542 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 17.3 mt-30 -124.52 98.85 5.91 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.795 -1.187 . . . . 64.42 107.795 170.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.443 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 7.8 tp-100 -88.76 99.86 12.69 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.645 -0.872 . . . . 74.3 108.645 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.84 141.51 15.62 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.303 -1.119 . . . . 64.4 110.303 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.12 127.08 3.13 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 110.673 -0.971 . . . . 60.44 110.673 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 55.3 mt -89.78 127.41 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.788 0.835 . . . . 64.42 109.084 176.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -135.56 135.06 40.02 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.129 -1.434 . . . . 75.2 107.129 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 67.6 m -99.45 89.92 4.34 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.403 0.547 . . . . 63.24 110.864 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' B' ' 10' ' ' THR . 12.7 tt -95.54 141.43 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.221 1.008 . . . . 44.42 111.607 -172.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.16 166.73 32.42 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.604 0.761 . . . . 71.21 110.436 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.96 -51.55 1.3 Allowed Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.742 -0.663 . . . . 71.11 112.54 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 17.4 mm -90.71 152.82 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.483 0.713 . . . . 75.13 112.315 -174.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -157.07 157.52 34.74 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 114.628 -1.169 . . . . 74.54 110.056 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.11 -135.0 12.59 Favored Glycine 0 C--N 1.353 1.503 0 C-N-CA 123.264 0.459 . . . . 64.33 113.191 170.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m -82.97 -18.32 40.35 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.212 0.605 . . . . 62.13 110.587 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -57.06 -38.74 73.71 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.887 0.875 . . . . 64.44 111.203 173.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 17.1 ptp -78.57 -25.37 45.31 Favored 'General case' 0 C--O 1.208 -1.107 0 CA-C-O 119.112 -0.471 . . . . 72.14 111.412 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.63 -34.67 67.5 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 122.963 0.505 . . . . 72.45 111.967 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -75.27 -47.3 28.62 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.815 0.846 . . . . 53.43 111.184 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.11 -49.62 71.47 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.248 0.619 . . . . 64.43 111.415 -175.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 60.4 mt -72.51 -27.99 62.6 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.27 -0.877 . . . . 75.12 111.321 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.7 -0.26 64.56 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-O 119.688 -0.507 . . . . 70.24 113.88 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.5 -62.73 0.46 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 117.384 0.592 . . . . 65.11 111.643 -176.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.451 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 33.7 t80 -64.6 -46.36 82.98 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.986 0.914 . . . . 72.25 111.646 -171.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 39.9 m -73.58 -46.66 7.33 Favored Pre-proline 0 CA--C 1.567 1.624 0 N-CA-C 113.128 0.788 . . . . 64.04 113.128 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -69.12 -21.64 36.16 Favored 'Trans proline' 0 C--N 1.395 2.994 0 C-N-CA 122.022 1.815 . . . . 70.11 113.264 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -57.62 -36.34 71.67 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 124.112 0.965 . . . . 64.11 111.118 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.491 HD13 HD11 ' B' ' 13' ' ' ILE . 68.9 mt -68.74 -43.14 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.666 1.186 . . . . 75.22 110.945 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 78.4 mt -82.94 -22.39 33.82 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.858 -1.065 . . . . 60.33 111.923 -172.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -55.54 -51.34 80.88 Favored Pre-proline 0 CA--C 1.562 1.433 0 CA-C-O 117.655 -1.164 . . . . 73.12 113.062 -175.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.14 -38.47 94.84 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 122.257 1.972 . . . . 65.13 113.744 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -69.41 -48.88 59.68 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.183 0.593 . . . . 74.15 110.747 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -62.93 -39.87 95.91 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.066 0.546 . . . . 64.43 111.194 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -59.38 -53.97 52.13 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.064 1.346 . . . . 71.4 111.146 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -68.19 -31.63 71.29 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.533 0.733 . . . . 43.15 110.032 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.492 ' O ' ' HG2' ' B' ' 117' ' ' MET . 12.6 t -68.16 -33.67 74.9 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.984 0.514 . . . . 74.31 111.188 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.477 HG23 ' SG ' ' B' ' 76' ' ' CYS . 78.9 mt -68.14 -52.23 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.162 0.585 . . . . 62.22 109.764 172.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.4 m -59.19 -30.44 68.21 Favored 'General case' 0 CA--C 1.553 1.074 0 O-C-N 123.971 0.794 . . . . 74.3 111.666 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 37.3 t -64.38 -50.77 66.37 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 123.498 0.719 . . . . 71.23 109.976 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.4 mmt -69.27 -32.48 71.69 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 123.615 0.572 . . . . 74.45 111.223 -174.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 114' ' ' ILE . 89.4 t -61.95 -47.44 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.653 0.781 . . . . 72.54 110.307 173.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 34.6 t -62.14 -37.3 84.65 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.81 -1.087 . . . . 73.44 110.799 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.424 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 93.1 mtt-85 -67.68 -32.3 72.87 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 115.435 -0.802 . . . . 74.11 110.612 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.76 4.7 84.36 Favored Glycine 0 C--N 1.349 1.302 0 O-C-N 123.717 0.636 . . . . 50.14 112.905 174.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 68.2 p 57.96 33.97 23.77 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 126.113 1.765 . . . . 74.32 113.204 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -93.99 163.8 22.55 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 123.99 0.916 . . . . 72.15 110.726 177.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.09 170.4 1.12 Allowed 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.537 2.825 . . . . 65.43 115.198 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -64.05 114.36 4.1 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.41 1.084 . . . . 72.14 110.903 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.94 84.72 2.24 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.157 -1.053 . . . . 54.3 108.157 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -108.81 118.53 37.02 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.629 0.772 . . . . 64.5 109.073 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.606 HD21 HD13 ' B' ' 42' ' ' LEU . 0.3 OUTLIER -70.85 133.03 46.14 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.505 0.722 . . . . 71.13 109.23 -177.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.76 144.04 98.38 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.428 0.691 . . . . 73.02 111.773 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.18 92.58 0.65 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.9 2.4 . . . . 73.15 112.686 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 48.3 t -98.13 110.11 25.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.434 -0.95 . . . . 74.43 108.434 172.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -89.87 114.09 25.8 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.026 -0.731 . . . . 73.03 109.026 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -60.88 -43.16 98.82 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.521 0.728 . . . . 73.51 111.0 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 N--CA 1.478 0.956 0 CA-C-N 114.837 -1.074 . . . . 65.24 112.734 -173.472 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' C' ' 85' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.472 0.673 0 CA-C-O 121.313 0.578 . . . . 75.43 109.5 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -134.74 128.28 32.61 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 107.84 -1.17 . . . . 75.01 107.84 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.607 HG13 ' HD3' ' A' ' 130' ' ' PRO . 63.0 mt -65.75 118.27 8.17 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 N-CA-C 107.987 -1.116 . . . . 62.41 107.987 173.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -93.82 -36.82 12.07 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 123.981 0.801 . . . . 71.33 108.959 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -178.51 123.28 0.1 Allowed 'General case' 0 C--N 1.361 1.075 0 O-C-N 123.68 0.612 . . . . 61.21 110.766 -172.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.2 mt -109.85 137.91 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.838 1.255 . . . . 71.11 108.923 172.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.497 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 21.1 p90 -174.34 166.77 4.04 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.862 0.865 . . . . 74.31 109.972 -172.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.2 p -91.72 126.33 36.77 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.174 0.589 . . . . 51.23 109.532 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.497 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 14.9 mmtp -74.5 -50.07 19.68 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 107.759 -1.2 . . . . 72.12 107.759 168.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 19.8 t70 -136.08 141.98 44.28 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 113.627 -1.624 . . . . 73.33 109.883 -168.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.582 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 88.7 mt -138.37 145.51 28.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 106.604 -1.628 . . . . 73.51 106.604 175.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 22' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' C' ' 77' ' ' GLU . 42.2 t -154.9 150.11 27.09 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.763 0.825 . . . . 72.22 109.295 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 88.9 t80 -156.86 117.03 3.54 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 107.568 -1.271 . . . . 75.41 107.568 173.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -120.53 111.66 17.96 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.127 0.571 . . . . 73.42 110.146 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.97 82.96 43.68 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.379 1.072 . . . . 71.22 108.274 168.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -69.39 -31.39 22.26 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.588 2.192 . . . . 74.44 110.687 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -96.11 13.82 25.93 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.156 -1.384 . . . . 74.54 110.583 -175.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.99 -56.67 14.26 Favored Pre-proline 0 CA--C 1.566 1.59 0 N-CA-C 113.97 1.1 . . . . 64.4 113.97 -170.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -60.35 -41.41 50.13 Favored 'Trans proline' 0 C--N 1.395 3.014 0 C-N-CA 122.002 1.801 . . . . 71.22 112.075 -177.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -70.24 -38.1 75.1 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.447 -1.251 . . . . 73.43 112.298 -175.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.727 HG21 ' HA ' ' C' ' 73' ' ' ALA . 12.4 p -77.91 -23.02 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 112.471 0.545 . . . . 64.44 112.471 -173.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -64.77 -22.89 67.08 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.081 0.4 . . . . 73.41 112.081 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -103.98 29.51 5.83 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.952 0.901 . . . . 74.53 110.808 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.556 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -114.11 163.35 15.3 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.787 0.835 . . . . 73.23 109.533 173.412 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.52 120.87 11.36 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.621 0.768 . . . . 71.1 109.937 168.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -85.97 90.44 8.09 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.877 0.471 . . . . 75.54 111.133 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -150.25 76.97 8.39 Favored Pre-proline 0 N--CA 1.483 1.208 0 C-N-CA 124.913 1.285 . . . . 74.54 108.216 169.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -84.04 160.57 13.64 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.27 1.98 . . . . 74.32 112.609 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -87.1 119.47 27.35 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 106.207 -1.775 . . . . 65.23 106.207 168.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.578 HG11 HD11 ' C' ' 126' ' ' LEU . 34.9 m -91.36 97.19 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 122.469 1.128 . . . . 60.01 109.47 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.554 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 3.7 ttmp? -96.78 100.32 11.86 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 114.541 -1.208 . . . . 61.42 107.988 177.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 pp -87.93 149.53 24.01 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 109.358 -0.608 . . . . 63.02 109.358 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.482 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 33.6 t70 -149.0 114.17 5.49 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.276 0.63 . . . . 71.21 109.951 -173.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 9.1 mp -105.26 147.83 27.65 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.226 0.536 . . . . 71.44 110.519 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.496 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 5.7 t70 -136.36 151.06 49.15 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.334 1.454 . . . . 41.42 107.821 175.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 30.4 p -113.48 112.23 23.26 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.601 -0.518 . . . . 73.41 109.601 -177.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.11 151.62 37.19 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.349 1.06 . . . . 65.52 109.074 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.0 p -166.11 173.59 10.14 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.167 0.432 . . . . 73.32 112.167 -173.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 45.3 t -166.7 146.65 5.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.276 1.031 . . . . 72.52 109.286 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -88.38 118.61 28.12 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.891 -0.781 . . . . 65.03 108.891 170.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.618 HD11 HD12 ' C' ' 83' ' ' ILE . 65.4 mt -89.09 -38.98 13.95 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.352 0.661 . . . . 64.53 110.55 -177.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.53 -174.85 4.18 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.117 -0.947 . . . . 71.33 110.746 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -61.4 104.66 0.43 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 114.317 -1.311 . . . . 73.32 110.001 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 70.9 -2.71 2.22 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 125.894 1.677 . . . . 74.53 113.79 -175.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 71.2 t -93.71 115.61 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 107.748 -1.204 . . . . 54.11 107.748 175.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -133.35 136.99 45.7 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.718 0.771 . . . . 63.44 110.191 -170.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -86.98 113.13 22.48 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.664 1.586 . . . . 74.33 109.211 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 91.2 t -104.47 113.83 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 108.007 -1.109 . . . . 62.32 108.007 174.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -121.57 136.18 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 109.233 -0.655 . . . . 72.23 109.233 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.456 HD22 ' HB3' ' C' ' 103' ' ' PRO . 34.5 tp -120.44 115.96 24.52 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.596 -0.89 . . . . 53.2 108.596 175.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.496 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 15.3 ttm-85 -81.77 130.09 34.95 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.398 -0.964 . . . . 63.3 108.398 173.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.469 ' HB ' HD11 ' C' ' 114' ' ' ILE . 4.2 t -119.02 132.23 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 106.839 -1.541 . . . . 74.15 106.839 171.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.482 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 16.1 m -133.36 116.75 16.47 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.014 -0.736 . . . . 63.21 109.014 -177.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.632 HG21 HG21 ' C' ' 114' ' ' ILE . 62.7 t -105.31 114.71 45.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 123.835 0.854 . . . . 74.21 109.464 -175.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.554 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 18.5 m -101.79 139.11 37.87 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.559 -0.904 . . . . 64.11 108.559 172.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.46 114.58 13.03 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.887 -1.153 . . . . 74.34 107.887 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 31.4 m -137.0 130.42 31.41 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.104 0.478 . . . . 55.01 111.295 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.556 HD13 ' HG2' ' C' ' 34' ' ' LYS . 11.6 mt -86.32 46.88 1.39 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.795 1.238 . . . . 74.4 109.72 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.88 -109.67 3.56 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 110.699 -0.96 . . . . 75.14 110.699 -174.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -89.6 -23.93 21.82 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.467 0.707 . . . . 53.2 110.241 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -72.54 122.64 21.67 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 123.798 0.839 . . . . 72.23 110.005 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.0 m -82.94 128.04 34.09 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.976 -0.75 . . . . 74.04 108.976 168.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.727 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -80.52 -55.27 4.98 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 123.789 0.68 . . . . 73.3 109.525 172.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -162.6 175.65 11.18 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.116 0.96 . . . . 75.02 111.575 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.424 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -137.53 147.36 45.11 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 105.997 -1.853 . . . . 64.14 105.997 171.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.424 ' N ' HD13 ' C' ' 75' ' ' LEU . 41.9 t -147.78 153.26 38.99 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.588 -0.893 . . . . 71.34 108.588 176.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 77' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' C' ' 22' ' ' SER . 34.6 tt0 -158.1 133.25 8.66 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 122.847 0.459 . . . . 75.21 110.243 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.488 HG11 ' HA ' ' C' ' 110' ' ' ALA . 49.1 t -137.52 114.43 12.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.481 1.112 . . . . 65.24 108.547 177.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.486 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 58.4 mt-30 -95.85 94.17 7.49 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.693 -0.854 . . . . 75.15 108.693 174.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.51 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.5 tp-100 -82.27 111.01 17.96 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.454 -0.794 . . . . 74.52 109.693 -176.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.46 148.08 18.86 Favored Glycine 0 C--N 1.335 0.522 0 O-C-N 123.827 0.705 . . . . 51.44 112.079 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.05 118.57 0.97 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.096 -1.201 . . . . 72.31 110.096 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.618 HD12 HD11 ' C' ' 51' ' ' LEU . 15.0 mm -84.42 128.13 39.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.617 -0.883 . . . . 55.34 108.617 176.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.466 ' HB2' HD11 ' C' ' 86' ' ' ILE . 26.5 m-85 -136.42 149.13 48.12 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.883 -1.154 . . . . 74.25 107.883 176.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 85' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 19.4 p -102.61 109.75 21.46 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 108.949 -0.759 . . . . 62.22 108.949 174.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.466 HD11 ' HB2' ' C' ' 84' ' ' PHE . 4.4 mp -108.58 122.08 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.107 0.563 . . . . 75.04 109.95 -167.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.56 167.58 27.62 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 114.538 -1.21 . . . . 51.04 109.651 175.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.46 -60.67 0.36 Allowed Glycine 0 C--N 1.344 0.973 0 CA-C-N 116.104 -0.498 . . . . 71.45 113.088 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 41.0 pt -113.33 167.55 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.202 0.525 . . . . 75.2 111.294 -176.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -149.18 -177.49 5.85 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.975 -1.011 . . . . 71.34 110.106 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.36 -139.99 42.56 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.68 -0.691 . . . . 44.04 114.077 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 39.4 p -68.99 -27.52 65.78 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.91 0.884 . . . . 64.34 111.33 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -61.48 -45.28 94.9 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.302 0.641 . . . . 74.15 110.157 175.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 9.8 ptm -77.32 -21.8 52.9 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-O 119.221 -0.419 . . . . 62.33 111.068 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.32 -36.72 82.05 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.193 0.52 . . . . 65.22 109.947 172.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.481 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 46.3 t-80 -60.9 -33.26 72.86 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.783 0.833 . . . . 73.33 110.744 173.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -77.79 -57.87 3.57 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.039 -0.528 . . . . 73.03 110.704 176.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.428 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 96.0 mt -71.18 -37.84 72.15 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.101 0.96 . . . . 62.1 113.386 -165.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.2 -11.15 34.69 Favored Glycine 0 N--CA 1.471 0.993 0 CA-C-O 120.007 -0.329 . . . . 71.34 113.871 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.482 ' HB1' ' HB2' ' C' ' 134' ' ' ASP . . . -116.82 -57.61 2.16 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 117.161 0.481 . . . . 74.41 110.742 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -76.74 -47.72 20.92 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.467 0.707 . . . . 74.14 112.506 -174.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.428 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 58.6 m -65.11 -46.57 73.25 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 123.886 0.875 . . . . 54.44 112.722 -173.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.456 ' HB3' HD22 ' C' ' 60' ' ' LEU . 14.1 Cg_exo -72.1 -15.83 28.83 Favored 'Trans proline' 0 C--N 1.392 2.858 0 C-N-CA 122.148 1.899 . . . . 74.45 112.352 176.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -74.48 -33.26 62.81 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.465 0.706 . . . . 75.35 110.083 175.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.521 HD12 HH12 ' A' ' 111' ' ' ARG . 48.0 mm -61.34 -40.74 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 115.607 -0.724 . . . . 73.13 109.279 170.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 81.4 mt -87.25 -18.9 29.17 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.852 -1.067 . . . . 65.5 112.923 -173.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -57.72 -51.6 80.55 Favored Pre-proline 0 CA--C 1.559 1.316 0 CA-C-O 117.755 -1.117 . . . . 62.24 113.5 -174.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.17 -30.73 91.97 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 122.032 1.821 . . . . 72.41 113.399 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -68.77 -49.48 58.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.248 0.619 . . . . 63.43 110.643 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -65.16 -35.85 82.39 Favored 'General case' 0 C--N 1.355 0.843 0 CA-C-N 115.759 -0.655 . . . . 74.12 110.684 177.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -58.82 -51.08 71.51 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.381 1.073 . . . . 70.01 110.746 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.74 -37.57 79.52 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.789 -0.448 . . . . 53.05 109.789 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.9 t -66.06 -31.83 72.94 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.042 0.537 . . . . 71.1 111.51 -176.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.632 HG21 HG21 ' C' ' 64' ' ' VAL . 96.7 mt -72.63 -54.98 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.358 -0.608 . . . . 73.22 109.358 173.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.9 m -60.31 -28.25 67.97 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.935 0.772 . . . . 40.45 111.278 -175.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 30.6 t -66.7 -49.83 64.8 Favored 'General case' 0 C--O 1.213 -0.844 0 N-CA-C 108.734 -0.839 . . . . 62.22 108.734 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.553 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.4 -37.31 83.0 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.454 1.102 . . . . 75.4 112.401 178.17 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.443 HG23 ' O ' ' C' ' 114' ' ' ILE . 76.4 t -63.24 -45.29 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.718 0.807 . . . . 64.35 109.044 174.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 44.5 t -70.55 -26.26 63.47 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.561 -1.2 . . . . 71.21 112.113 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -75.83 -40.56 54.66 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.632 0.773 . . . . 73.24 108.949 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.27 -0.39 61.56 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 123.903 0.752 . . . . 64.35 112.348 168.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 31.0 p 62.75 28.4 16.49 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.692 1.997 . . . . 74.5 113.415 170.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -83.57 141.24 41.72 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 107.997 -1.112 . . . . 73.2 107.997 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -50.98 156.46 4.82 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 123.682 2.922 . . . . 64.34 114.232 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -50.62 111.83 0.6 Allowed 'General case' 0 N--CA 1.481 1.094 0 O-C-N 124.473 1.108 . . . . 71.23 112.695 -171.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.578 HD11 HG11 ' C' ' 40' ' ' VAL . 31.2 tp -112.73 87.51 2.6 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.217 -1.401 . . . . 62.24 107.217 171.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -107.69 107.67 18.57 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.149 -1.056 . . . . 72.1 108.149 -172.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 30.7 tp -65.99 142.59 57.79 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.519 0.512 . . . . 62.34 111.157 -174.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.29 152.92 95.65 Favored Pre-proline 0 CA--C 1.555 1.141 0 O-C-N 124.072 0.858 . . . . 63.52 110.888 178.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.473 ' HG2' HG21 ' A' ' 13' ' ' ILE . 51.4 Cg_exo -54.77 143.84 68.58 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.965 2.443 . . . . 75.13 113.559 177.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.0 p -128.6 110.35 21.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-O 122.665 1.221 . . . . 72.43 109.595 173.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -92.06 84.39 5.29 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.63 -1.989 . . . . 63.04 105.63 169.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -47.15 -44.29 21.7 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.765 0.826 . . . . 73.13 111.883 -171.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 134' ' ' ASP . . . . . 0.482 ' HB2' ' HB1' ' C' ' 100' ' ' ALA . 16.1 t70 . . . . . 0 N--CA 1.476 0.841 0 CA-C-N 114.628 -1.169 . . . . 64.11 112.468 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 59.8 m . . . . . 0 C--O 1.242 0.693 0 N-CA-C 108.307 -0.997 . . . . 75.24 108.307 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -157.38 118.74 3.66 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.486 -1.302 . . . . 74.45 107.486 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -123.87 115.29 21.07 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.255 -1.017 . . . . 71.24 108.255 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.438 HG21 HD11 ' D' ' 16' ' ' ILE . 56.7 mt -75.72 123.95 32.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.586 -0.894 . . . . 72.3 108.586 173.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -89.81 -40.14 12.65 Favored 'General case' 0 C--O 1.245 0.836 0 O-C-N 123.473 0.483 . . . . 73.32 111.239 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -175.9 128.74 0.24 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 119.645 -0.217 . . . . 73.4 110.929 -163.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.438 HD11 HG21 ' D' ' 13' ' ' ILE . 3.4 mp -112.05 140.89 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.924 -1.139 . . . . 75.23 107.924 166.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.472 ' HE1' HG13 ' D' ' 83' ' ' ILE . 26.0 p90 -161.91 168.43 22.95 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 124.257 0.973 . . . . 71.24 110.41 -177.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -99.46 120.74 40.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.595 -1.184 . . . . 73.23 109.251 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -90.29 -18.32 25.81 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.92 -0.582 . . . . 70.44 109.56 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.1 t70 -160.99 141.05 10.98 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 114.691 -1.141 . . . . 71.22 109.686 177.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.553 HG21 ' HE2' ' C' ' 117' ' ' MET . 67.0 mt -139.14 140.55 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.978 1.311 . . . . 75.23 107.475 174.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.7 t -142.49 140.04 31.73 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.089 0.955 . . . . 42.25 108.927 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.582 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 94.3 t80 -152.19 119.02 5.76 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 106.527 -1.657 . . . . 73.53 106.527 173.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 28.9 mt-10 -134.58 108.64 8.18 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.834 -0.802 . . . . 70.3 108.834 -173.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.4 92.03 9.26 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 109.007 -0.738 . . . . 74.44 109.007 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.74 -52.72 0.39 Allowed 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.044 2.496 . . . . 73.35 112.342 -172.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -94.23 13.25 23.99 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-N 114.943 -1.026 . . . . 73.33 110.32 -174.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -28.7 -61.97 0.21 Allowed Pre-proline 0 CA--C 1.566 1.591 0 N-CA-C 115.984 1.846 . . . . 74.14 115.984 -165.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.408 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 91.2 Cg_endo -78.04 -22.97 9.57 Favored 'Trans proline' 0 C--N 1.384 2.401 0 CA-C-N 122.782 2.029 . . . . 74.11 113.905 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -71.08 -41.3 70.85 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.592 1.157 . . . . 75.43 109.359 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.633 HG22 HD12 ' D' ' 68' ' ' LEU . 9.9 p -83.52 -20.69 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.614 -0.721 . . . . 72.41 111.617 -171.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.4 m-85 -61.85 -28.37 69.44 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.002 0.429 . . . . 75.12 111.71 176.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -59.4 -25.62 64.44 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.79 -1.095 . . . . 51.14 110.341 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -86.28 87.01 7.35 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.538 1.135 . . . . 74.42 109.834 170.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -84.04 93.07 8.01 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.003 -0.999 . . . . 72.42 110.944 -177.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 36.9 p90 -164.36 171.27 15.0 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.21 1.004 . . . . 64.42 109.428 167.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -60.76 113.37 7.5 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 123.792 0.837 . . . . 72.33 109.051 176.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.741 ' HD3' ' HG2' ' D' ' 124' ' ' PRO . 62.7 Cg_exo -52.93 124.03 14.52 Favored 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 122.77 2.313 . . . . 43.04 111.693 -177.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -68.02 111.63 4.54 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 124.38 1.05 . . . . 64.13 108.186 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.462 HG13 ' O ' ' D' ' 38' ' ' PRO . 16.6 m -99.86 144.66 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.973 0.892 . . . . 73.23 112.507 -165.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.503 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 17.7 tppt? -113.93 113.46 24.88 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.622 -1.621 . . . . 72.1 106.622 171.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 pp -94.87 141.06 29.08 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 108.069 -1.086 . . . . 51.42 108.069 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.599 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 32.8 t70 -145.68 138.13 25.67 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.487 0.715 . . . . 72.22 109.081 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -116.21 134.96 54.34 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.901 -0.777 . . . . 60.43 108.901 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 35.4 t70 -136.67 157.76 46.03 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 106.832 -1.544 . . . . 64.31 106.832 170.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.9 t -137.09 154.09 50.4 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.256 0.55 . . . . 73.15 111.328 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.494 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.38 165.77 32.08 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.906 1.283 . . . . 61.31 108.838 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 32.0 p -172.55 153.89 2.96 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.047 0.539 . . . . 71.44 111.649 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 33.7 p -157.2 120.33 4.06 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 114.722 -1.127 . . . . 42.54 108.554 173.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 50' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' D' ' 56' ' ' TYR . 61.7 tt0 -65.59 129.16 38.77 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.353 -0.61 . . . . 74.21 109.353 173.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 76.9 mt -94.96 -38.16 10.81 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.073 0.549 . . . . 63.53 110.971 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.89 -170.3 2.68 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.128 0.49 . . . . 63.24 111.294 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.44 118.13 7.67 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.839 -1.073 . . . . 74.1 109.739 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 67.83 -1.29 1.73 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.833 1.253 . . . . 64.24 112.794 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.56 123.91 65.83 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 N-CA-C 108.954 -0.758 . . . . 43.3 108.954 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.475 ' HA ' ' HA ' ' D' ' 50' ' ' GLN . 0.1 OUTLIER -136.13 150.05 48.92 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.959 -0.756 . . . . 72.0 108.959 177.002 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -110.55 134.38 52.44 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.504 -1.295 . . . . 61.22 107.504 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 76.9 t -127.28 131.16 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.617 1.167 . . . . 75.3 108.814 -172.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 21.7 t -121.56 131.94 71.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 123.446 0.699 . . . . 74.53 109.67 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.579 HD23 HD12 ' D' ' 106' ' ' LEU . 3.9 mm? -117.87 107.97 14.76 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.447 -0.946 . . . . 73.52 108.447 168.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.559 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 15.8 ttm-85 -82.24 101.9 10.81 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.876 0.87 . . . . 74.31 109.08 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 84.7 t -94.09 129.99 43.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.725 -0.843 . . . . 74.42 108.725 174.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 21.7 m -125.03 133.33 53.0 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.804 0.442 . . . . 73.55 110.194 -176.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 42.2 t -124.81 101.07 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.667 1.187 . . . . 64.22 108.703 175.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 93.4 m -92.99 106.45 18.41 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.881 -1.155 . . . . 74.14 107.881 170.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.61 142.37 42.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.893 -0.594 . . . . 50.12 110.011 -171.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.429 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 19.8 m -145.15 137.01 25.59 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.122 -0.49 . . . . 75.33 110.57 -175.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.633 HD12 HG22 ' D' ' 31' ' ' VAL . 21.2 mt -105.14 110.82 23.34 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.071 -1.085 . . . . 65.34 108.071 172.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.54 -130.01 17.48 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 116.229 -0.441 . . . . 43.11 113.242 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -89.6 4.19 50.18 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.348 0.659 . . . . 65.55 111.92 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -131.8 158.78 40.35 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.695 0.398 . . . . 74.23 110.518 -173.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.3 m -71.29 138.01 49.0 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.355 -0.839 . . . . 74.22 111.103 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.461 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.48 -62.24 1.52 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.946 -1.131 . . . . 60.25 107.946 173.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -156.61 159.53 38.56 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.583 -1.19 . . . . 74.34 110.556 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 85.7 mt -121.97 108.84 13.87 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.48 -1.304 . . . . 63.12 107.48 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.626 ' SG ' HG12 ' D' ' 114' ' ' ILE . 45.9 t -117.14 135.27 53.88 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.749 0.82 . . . . 75.32 109.272 -173.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -155.43 126.18 6.96 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.78 0.432 . . . . 63.42 110.033 175.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.43 118.74 46.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 123.819 0.848 . . . . 63.5 109.527 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.4 mt-30 -87.71 88.45 7.67 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.272 -1.01 . . . . 73.14 108.272 170.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -80.85 98.38 7.81 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 115.092 -0.958 . . . . 72.54 109.102 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.32 169.55 33.26 Favored Glycine 0 C--O 1.244 0.772 0 CA-C-N 115.74 -0.663 . . . . 64.01 112.33 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.63 133.33 2.86 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 112.058 -0.417 . . . . 60.2 112.058 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.472 HG13 ' HE1' ' D' ' 17' ' ' TYR . 57.7 mt -88.41 123.84 41.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 107.847 -1.168 . . . . 71.1 107.847 173.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -131.61 157.12 44.52 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.123 0.969 . . . . 35.02 109.718 -175.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 43.2 m -117.21 136.23 53.21 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.029 0.932 . . . . 73.44 110.2 175.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.412 HD12 ' O ' ' D' ' 86' ' ' ILE . 2.3 pp -130.77 141.71 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.554 1.141 . . . . 71.15 109.956 175.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.13 161.07 10.18 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.158 0.983 . . . . 71.55 108.639 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.44 21.04 79.93 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 121.426 -0.416 . . . . 54.12 113.382 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 12.7 mt -118.86 152.56 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.464 0.705 . . . . 73.53 109.933 -172.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -157.4 148.12 21.28 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.945 1.298 . . . . 64.3 110.557 175.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.57 -125.53 28.79 Favored Glycine 0 C--N 1.353 1.492 0 O-C-N 124.085 0.866 . . . . 62.53 114.9 169.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.2 m -72.0 -24.9 61.65 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.763 0.825 . . . . 53.43 111.803 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -61.78 -29.9 70.45 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.328 0.651 . . . . 74.24 109.976 175.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 49.5 mtt -70.8 -44.09 67.33 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.918 0.887 . . . . 72.3 110.692 173.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.85 -36.83 82.36 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.379 0.672 . . . . 73.2 111.34 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -78.85 -29.97 44.91 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.116 0.566 . . . . 45.33 110.696 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 41.1 t -60.38 -51.09 70.99 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.413 0.685 . . . . 54.24 112.311 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.15 -17.07 14.43 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 115.492 -0.776 . . . . 72.31 112.258 -174.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.89 -25.62 29.02 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-O 120.119 -0.267 . . . . 72.54 112.867 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.14 -63.37 1.45 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.009 0.524 . . . . 62.3 110.935 -178.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -62.38 -53.99 46.83 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 112.744 0.646 . . . . 75.01 112.744 -169.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 59.1 m -59.04 -45.43 99.52 Favored Pre-proline 0 N--CA 1.494 1.753 0 CA-C-O 118.612 -0.709 . . . . 75.44 112.563 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -51.71 -46.64 30.68 Favored 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.639 2.226 . . . . 62.15 113.665 165.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -67.64 -15.54 63.7 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 123.376 0.67 . . . . 63.31 112.202 -178.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 35.9 mm -86.61 -49.43 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.285 0.634 . . . . 61.33 109.863 173.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.579 HD12 HD23 ' D' ' 60' ' ' LEU . 91.4 mt -79.52 -30.53 41.92 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.352 0.871 . . . . 50.33 113.352 -168.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -65.6 -39.25 31.23 Favored Pre-proline 0 N--CA 1.49 1.572 0 CA-C-O 118.174 -0.917 . . . . 73.51 113.264 -177.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -49.55 -45.97 28.78 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 122.62 2.213 . . . . 74.23 114.626 166.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -74.57 -36.16 63.06 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.063 0.545 . . . . 64.14 111.581 -177.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.16 -46.59 86.42 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.641 -0.503 . . . . 51.14 109.641 174.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -54.49 -49.59 69.77 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 124.706 1.254 . . . . 54.33 110.606 177.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -62.56 -43.63 98.34 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.797 0.686 . . . . 64.34 111.093 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.9 t -61.76 -44.0 97.76 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 123.761 0.663 . . . . 75.34 110.859 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.626 HG12 ' SG ' ' D' ' 76' ' ' CYS . 97.2 mt -60.61 -59.1 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.14 0.976 . . . . 73.21 110.217 175.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 37.0 m -52.98 -38.95 62.66 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.461 1.504 . . . . 64.22 111.551 -176.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.0 t -66.76 -47.06 73.4 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 114.889 -1.05 . . . . 53.14 110.344 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.8 mtm -67.17 -32.28 73.26 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.787 0.435 . . . . 72.5 111.763 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.5 t -61.9 -46.66 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.776 0.83 . . . . 63.34 109.887 174.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.1 p -76.89 -24.99 52.53 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.809 -0.632 . . . . 75.33 111.51 -177.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -74.02 -37.31 64.4 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.389 0.676 . . . . 73.04 109.52 175.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.8 4.39 65.6 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 115.561 -0.745 . . . . 62.44 112.27 170.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 47.8 p 59.12 23.09 11.3 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 126.947 2.099 . . . . 44.42 114.012 174.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -78.02 149.79 77.11 Favored Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 108.643 -0.873 . . . . 72.41 108.643 169.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.741 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 4.8 Cg_endo -53.42 133.82 54.8 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.675 2.25 . . . . 71.12 112.295 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -50.98 135.76 24.14 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.833 1.333 . . . . 73.13 112.654 -171.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 64.6 tp -114.77 103.06 10.59 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.881 0.872 . . . . 53.21 109.006 -177.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 127' ' ' ASN . . . . . 0.493 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 86.2 m-20 -99.51 101.29 12.48 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.829 -0.804 . . . . 74.44 108.829 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 tt -66.78 115.98 7.17 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 108.172 -1.047 . . . . 71.14 108.172 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -65.15 140.54 97.99 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 123.515 0.726 . . . . 75.5 110.72 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.451 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 5.6 Cg_exo -72.18 151.25 54.83 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.81 2.34 . . . . 72.24 111.981 -171.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 123.637 0.775 . . . . 74.44 110.182 -178.796 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.663 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 35.7 t80 . . . . . 0 C--O 1.239 0.525 0 N-CA-C 109.908 -0.404 . . . . 63.35 109.908 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -152.92 132.96 13.38 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.201 1.0 . . . . 52.03 108.818 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.68 HG12 ' HD2' ' A' ' 84' ' ' PHE . 57.6 mt -93.49 121.25 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.104 -0.702 . . . . 65.13 109.104 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -85.3 -33.98 21.99 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.591 0.756 . . . . 64.25 110.328 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -171.06 142.47 1.82 Allowed 'General case' 0 C--N 1.352 0.717 0 O-C-N 123.411 0.445 . . . . 72.1 110.65 -174.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.458 HD12 ' HG3' ' C' ' 130' ' ' PRO . 78.6 mt -131.75 134.02 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 107.962 -1.125 . . . . 75.45 107.962 170.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -163.06 176.94 9.57 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 124.168 0.917 . . . . 64.32 110.838 -174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.4 p -100.06 121.52 41.52 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.178 -0.919 . . . . 72.21 109.035 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HG3' ' HA3' ' A' ' 81' ' ' GLY . 24.8 mtpt -84.28 -37.36 21.78 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.975 0.417 . . . . 74.43 109.935 178.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 24.4 t70 -143.28 135.28 26.84 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.122 -0.944 . . . . 74.53 109.288 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.485 HD13 ' SD ' ' B' ' 117' ' ' MET . 77.5 mt -128.74 140.02 50.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.217 -1.401 . . . . 72.24 107.217 175.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.9 t -151.31 110.98 4.02 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.071 0.462 . . . . 74.4 110.1 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -110.4 132.76 53.89 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.306 -1.368 . . . . 75.44 107.306 169.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -130.57 140.35 50.46 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.878 -1.156 . . . . 73.31 107.878 173.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.38 76.4 56.25 Favored Pre-proline 0 C--O 1.241 0.644 0 N-CA-C 106.208 -1.775 . . . . 71.25 106.208 169.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -62.5 -34.49 75.5 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.985 2.457 . . . . 65.15 112.794 -168.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 -109.1 22.79 15.43 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.467 -0.778 . . . . 63.01 110.224 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.583 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -42.46 -53.84 8.74 Favored Pre-proline 0 N--CA 1.499 1.998 0 N-CA-C 114.097 1.147 . . . . 75.51 114.097 -170.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -65.17 -29.24 55.92 Favored 'Trans proline' 0 C--N 1.387 2.581 0 CA-C-N 121.174 1.455 . . . . 73.15 112.641 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -82.56 -35.21 27.4 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.485 1.114 . . . . 65.25 110.843 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.692 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.3 p -78.68 -20.95 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 115.125 -0.943 . . . . 73.23 112.54 -161.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -71.85 -19.13 62.01 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-O 120.972 0.415 . . . . 72.21 111.002 176.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -77.88 -25.31 48.48 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.464 1.105 . . . . 64.23 110.695 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -76.58 149.49 36.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.805 0.842 . . . . 74.23 110.863 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.2 138.1 58.43 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 124.007 0.817 . . . . 74.42 109.303 170.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -84.01 92.0 7.75 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.713 -0.477 . . . . 72.13 109.713 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -127.53 82.89 67.42 Favored Pre-proline 0 C--O 1.243 0.755 0 N-CA-C 107.962 -1.125 . . . . 71.02 107.962 170.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.95 125.13 7.81 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.48 2.12 . . . . 75.42 112.677 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -98.87 96.62 7.99 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 106.76 -1.57 . . . . 61.32 106.76 165.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.7 t -75.55 94.51 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 115.948 -0.569 . . . . 74.33 109.662 -175.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.473 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 14.2 mptt -78.68 111.74 15.08 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 107.641 -1.244 . . . . 73.51 107.641 170.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.98 138.52 47.28 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.707 0.803 . . . . 63.14 108.925 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.543 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 21.2 t70 -141.64 140.75 33.35 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.784 1.234 . . . . 71.34 108.483 -172.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.4 mt -123.16 136.95 54.99 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.13 0.572 . . . . 74.22 110.453 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 18.0 t70 -134.25 147.14 50.62 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 114.781 -1.099 . . . . 71.5 108.428 175.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.1 m -106.57 131.65 53.48 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.958 0.903 . . . . 73.11 110.258 -173.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.71 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -131.53 105.41 7.54 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.795 -1.187 . . . . 54.13 107.795 169.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 24.5 m -95.93 152.01 18.9 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.246 -1.02 . . . . 53.0 108.246 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 31.2 t -159.25 142.59 14.59 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.121 0.568 . . . . 71.41 109.961 -176.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -112.72 130.28 56.11 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.016 -1.105 . . . . 62.34 108.016 168.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.0 mt -104.26 -38.1 7.01 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.215 0.606 . . . . 75.24 110.524 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.516 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -156.05 -170.46 3.4 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.241 0.617 . . . . 53.22 110.381 -178.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.82 113.89 3.7 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.509 1.124 . . . . 44.44 110.023 173.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 85' ' ' SER . 32.1 m-20 69.71 -2.56 1.93 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.369 1.468 . . . . 65.33 112.906 -176.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.516 ' CG2' ' HB3' ' A' ' 52' ' ' ALA . 39.3 t -95.75 113.29 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 107.574 -1.269 . . . . 62.44 107.574 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -127.29 125.87 41.64 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.943 -0.762 . . . . 72.21 108.943 -176.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 40.5 tt0 -92.94 116.83 29.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.304 -0.862 . . . . 72.34 108.947 175.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.434 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 54.1 t -100.2 118.61 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 106.368 -1.716 . . . . 72.53 106.368 174.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.71 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 29.5 t -118.46 121.19 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.732 -0.84 . . . . 62.45 108.732 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.35 113.52 26.24 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.476 -0.935 . . . . 73.04 108.476 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.506 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 50.1 ttt180 -83.01 101.75 11.3 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.326 -0.991 . . . . 64.23 108.326 174.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.07 102.46 13.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.96 -1.126 . . . . 73.23 107.96 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 28.5 m -97.34 126.03 42.32 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.036 -0.727 . . . . 73.14 109.036 178.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.54 HG11 HD21 ' A' ' 126' ' ' LEU . 75.1 t -122.54 139.92 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.345 1.058 . . . . 72.32 108.265 176.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 17.5 m -136.03 141.69 44.35 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.375 -0.972 . . . . 75.24 108.375 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.61 117.2 32.86 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.619 -1.252 . . . . 71.31 107.619 171.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.6 m -113.06 126.36 55.39 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.878 0.471 . . . . 73.12 109.905 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 mt -98.92 83.25 2.88 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.42 1.088 . . . . 72.42 108.326 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.43 -83.84 1.09 Allowed Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.902 -0.59 . . . . 62.35 112.003 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.73 -25.07 3.72 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.113 0.965 . . . . 73.24 110.188 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -95.85 133.79 39.58 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.688 0.795 . . . . 63.44 109.945 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.5 m -74.34 139.48 44.18 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 122.852 0.461 . . . . 63.12 110.545 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.692 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -82.11 -61.31 1.94 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.696 0.798 . . . . 73.21 109.067 172.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -154.63 168.5 26.58 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.597 -1.183 . . . . 64.44 111.413 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 64' ' ' VAL . 54.5 tp -122.61 139.53 53.83 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.948 1.299 . . . . 62.44 108.376 172.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 79.2 m -140.81 98.18 3.34 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.48 1.112 . . . . 63.51 110.098 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -115.94 127.99 55.4 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.556 0.742 . . . . 73.04 109.25 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.2 t -133.03 113.47 19.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 C-N-CA 123.267 0.627 . . . . 74.41 109.668 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -85.59 89.0 7.6 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.07 -0.968 . . . . 72.35 108.845 173.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.458 ' HG3' HD22 ' A' ' 106' ' ' LEU . 57.9 tp60 -80.83 107.5 13.7 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.331 -0.849 . . . . 74.21 109.298 -177.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.406 ' HA3' ' HG3' ' A' ' 19' ' ' LYS . . . -98.41 144.44 17.24 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 111.537 -0.625 . . . . 73.45 111.537 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.29 125.56 2.48 Favored Glycine 0 C--N 1.33 0.197 0 N-CA-C 111.54 -0.624 . . . . 62.2 111.54 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.1 mt -81.49 120.48 33.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.663 -0.866 . . . . 63.0 108.663 173.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.68 ' HD2' HG12 ' A' ' 13' ' ' ILE . 21.5 m-85 -136.23 120.44 17.83 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.553 -0.906 . . . . 73.33 108.553 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 66.7 m -89.84 113.27 24.83 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.456 -0.572 . . . . 71.41 109.456 171.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.477 0.909 0 C-N-CA 123.546 0.739 . . . . 75.13 109.996 -179.799 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.599 0.238 . . . . 51.31 111.228 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -67.42 -35.61 79.61 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.858 -0.61 . . . . 71.4 110.582 171.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.682 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 71.5 m -71.08 -66.07 0.66 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.179 0.192 . . . . 61.43 111.215 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.63 -25.4 67.35 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.455 0.702 . . . . 72.0 112.751 -175.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.81 -24.81 22.15 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-O 119.909 -0.384 . . . . 63.3 113.752 -176.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.46 -64.66 0.88 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 117.206 0.503 . . . . 74.55 111.301 -175.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.682 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 83.3 t80 -69.29 -60.47 2.32 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.303 1.041 . . . . 73.14 112.967 -164.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.7 m -62.29 -39.01 52.77 Favored Pre-proline 0 CA--C 1.569 1.701 0 N-CA-C 114.024 1.12 . . . . 44.15 114.024 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -66.49 -28.61 45.64 Favored 'Trans proline' 0 C--N 1.389 2.679 0 CA-C-N 121.366 1.524 . . . . 74.3 112.853 166.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -79.96 -14.64 58.44 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.358 0.663 . . . . 73.22 110.477 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 35.1 mm -68.2 -39.75 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 108.472 -0.936 . . . . 73.15 108.472 168.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.458 HD22 ' HG3' ' A' ' 80' ' ' GLN . 77.2 mt -78.29 -23.66 47.1 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.135 -0.939 . . . . 73.23 112.129 -177.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -59.45 -47.41 97.99 Favored Pre-proline 0 CA--C 1.571 1.759 0 CA-C-O 117.862 -1.066 . . . . 75.54 113.502 -174.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -63.15 -37.13 53.81 Favored 'Trans proline' 0 C--N 1.392 2.857 0 C-N-CA 121.988 1.792 . . . . 71.45 113.224 176.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -72.14 -38.02 69.32 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.131 0.572 . . . . 74.24 111.097 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.52 -42.06 71.76 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.242 0.617 . . . . 51.3 110.207 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.43 ' NH1' HG23 ' C' ' 105' ' ' ILE . 25.7 ttm180 -60.58 -44.82 95.79 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.171 0.919 . . . . 74.51 109.597 175.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -65.24 -43.58 90.92 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.136 0.974 . . . . 75.24 111.687 -176.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.403 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 47.5 t -61.7 -43.49 98.76 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.959 0.787 . . . . 73.31 109.816 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' ' 118' ' ' VAL . 67.4 mt -61.69 -47.81 91.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 124.436 1.094 . . . . 53.21 110.756 174.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.3 m -59.52 -39.23 83.22 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.376 1.07 . . . . 75.44 110.816 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 42.9 t -67.64 -46.71 71.67 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 115.184 -0.916 . . . . 74.41 110.605 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 18.2 mtp -59.21 -41.59 88.95 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.969 0.908 . . . . 55.23 111.504 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.506 HG21 HD23 ' A' ' 126' ' ' LEU . 74.0 t -65.8 -51.28 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.237 1.015 . . . . 73.34 110.631 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.4 t -66.11 -27.78 68.31 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.597 -0.728 . . . . 73.23 111.091 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 116' ' ' SER . 30.2 ttm-85 -77.59 -31.61 53.14 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.302 1.041 . . . . 74.23 109.334 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.425 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.42 11.27 61.63 Favored Glycine 0 C--N 1.356 1.657 0 CA-C-N 114.673 -1.148 . . . . 54.3 112.811 170.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.503 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.3 t 64.23 15.59 9.49 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 127.045 2.138 . . . . 64.22 113.925 172.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -80.61 153.12 73.25 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.06 0.544 . . . . 64.44 109.91 178.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.8 155.14 23.49 Favored 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 123.252 2.635 . . . . 62.04 113.569 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -56.41 120.21 7.3 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.383 1.073 . . . . 61.45 112.645 -170.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.54 HD21 HG11 ' A' ' 64' ' ' VAL . 64.0 tp -121.86 106.13 10.99 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.417 1.087 . . . . 64.21 109.894 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -127.09 126.15 42.49 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.947 0.899 . . . . 62.14 108.853 169.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.8 mp -72.15 142.11 49.1 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.215 -0.661 . . . . 71.41 109.215 174.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.58 150.13 94.33 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 122.82 0.448 . . . . 72.13 110.171 176.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.721 ' HG3' ' HD2' ' C' ' 11' ' ' PHE . 44.7 Cg_endo -61.33 154.14 60.62 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.718 2.279 . . . . 74.33 112.779 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.1 m -119.17 116.25 50.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 109.079 -0.712 . . . . 73.42 109.079 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -94.09 64.85 3.35 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.333 0.587 . . . . 71.52 109.581 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 . . . . . 0 N--CA 1.474 0.751 0 CA-C-N 115.336 -0.847 . . . . 73.04 109.855 176.292 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.608 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 14.6 ptm . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 114.65 1.352 . . . . 71.32 114.65 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 40.5 m -133.34 144.85 49.89 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.459 1.103 . . . . 74.02 108.491 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.643 ' CZ ' HG13 ' B' ' 13' ' ' ILE . 0.3 OUTLIER -130.53 149.88 51.99 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 106.916 -1.513 . . . . 72.42 106.916 178.206 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -156.29 101.11 2.03 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 123.339 0.399 . . . . 71.42 111.605 164.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.907 HD11 HD13 ' B' ' 105' ' ' ILE . 44.6 mt -51.99 123.1 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.855 -0.794 . . . . 75.43 108.855 162.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -100.33 -45.07 5.71 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.048 0.842 . . . . 73.35 109.607 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.503 ' HE ' HG21 ' A' ' 122' ' ' THR . 47.9 ttt180 -162.92 135.58 5.54 Favored 'General case' 0 C--N 1.349 0.565 0 N-CA-C 109.259 -0.645 . . . . 75.45 109.259 -177.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.5 mt -114.89 137.17 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 107.896 -1.149 . . . . 74.24 107.896 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -167.29 158.32 11.73 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.11 0.481 . . . . 73.14 111.632 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.448 HG21 HD11 ' B' ' 21' ' ' ILE . 87.1 m -85.29 131.13 34.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.708 -0.678 . . . . 74.42 109.184 171.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.583 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 45.9 mtpt -97.76 -32.63 11.63 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.212 0.605 . . . . 72.11 110.665 177.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -151.13 138.21 19.19 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.613 0.244 . . . . 53.34 111.627 -175.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.486 ' CD1' ' SG ' ' B' ' 113' ' ' CYS . 45.6 mm -129.52 141.99 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.129 1.371 . . . . 73.03 108.914 173.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.628 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.1 t -144.46 137.43 26.94 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.052 -1.092 . . . . 32.34 108.052 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.2 t80 -154.35 121.47 5.65 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.844 -1.169 . . . . 65.21 107.844 174.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -127.81 122.09 31.83 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.7 0.8 . . . . 72.13 109.572 176.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.713 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -115.72 87.26 17.47 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.986 -1.116 . . . . 41.32 107.986 169.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -71.39 -40.44 3.06 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.431 2.088 . . . . 71.45 111.706 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.487 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 3.4 m-20 -93.98 3.21 55.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.259 1.024 . . . . 74.3 110.244 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.713 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -31.07 -65.84 0.19 Allowed Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 125.825 1.65 . . . . 63.12 114.653 -178.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 37.9 Cg_exo -55.23 -39.21 92.2 Favored 'Trans proline' 0 C--N 1.398 3.138 0 C-N-CA 122.975 2.45 . . . . 72.4 113.564 -162.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -95.51 -41.15 9.09 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 114.689 -1.141 . . . . 71.12 111.848 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.497 HG22 HD12 ' B' ' 68' ' ' LEU . 4.0 p -60.4 -19.22 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.48 0 C-N-CA 123.076 0.55 . . . . 72.13 112.4 -166.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -56.27 -28.89 60.17 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.56 1.144 . . . . 74.41 113.036 175.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -63.63 -21.93 66.63 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.923 0.889 . . . . 64.3 111.67 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -81.48 90.81 6.25 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.354 0.662 . . . . 73.25 109.664 172.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -83.94 89.08 7.17 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.402 -0.817 . . . . 55.2 110.844 -174.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 30.6 p90 -165.37 170.27 14.8 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.401 1.08 . . . . 74.12 109.713 167.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -75.52 111.34 13.75 Favored Pre-proline 0 N--CA 1.48 1.039 0 N-CA-C 109.038 -0.727 . . . . 74.41 109.038 173.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.98 165.69 13.87 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.015 2.476 . . . . 62.31 114.207 -172.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -73.58 103.91 4.35 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.478 -1.237 . . . . 64.5 108.974 175.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.444 HG21 HD13 ' B' ' 126' ' ' LEU . 61.7 t -102.46 123.08 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 115.333 -0.849 . . . . 60.54 111.08 -170.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -107.54 123.26 48.19 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.41 1.084 . . . . 73.43 108.688 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.84 126.1 51.57 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.768 -0.827 . . . . 73.11 108.768 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -122.95 128.47 50.29 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.582 1.153 . . . . 61.5 108.671 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -100.09 164.04 12.15 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.84 -0.8 . . . . 71.31 108.84 172.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.635 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.0 t70 -156.03 152.06 27.63 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.293 -0.867 . . . . 71.53 109.3 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 91.3 m -107.57 115.9 30.97 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.32 -1.309 . . . . 72.34 108.893 -171.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -137.03 119.32 15.66 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 109.045 -0.724 . . . . 62.54 109.045 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.5 p -142.97 161.83 37.09 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.939 0.496 . . . . 65.24 110.399 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -152.22 142.64 22.58 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.583 0.753 . . . . 74.24 109.836 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -94.87 112.45 24.17 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.466 -0.568 . . . . 72.41 109.466 175.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 77.8 mt -80.69 -45.46 17.11 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.488 0.661 . . . . 72.14 109.314 175.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.38 -177.46 6.61 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.387 -1.278 . . . . 43.22 109.018 176.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.79 123.55 25.81 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.946 -1.025 . . . . 73.42 108.328 173.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 67.53 23.52 8.92 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.121 1.368 . . . . 74.25 111.26 -175.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 92.2 t -139.51 103.49 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 107.912 -1.144 . . . . 60.44 107.912 168.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -125.96 138.12 53.74 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.833 -0.803 . . . . 71.04 108.833 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -107.9 103.5 12.76 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.459 -1.312 . . . . 73.32 107.459 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.584 HG21 ' HB2' ' B' ' 98' ' ' LEU . 95.1 t -101.06 118.87 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.65 1.18 . . . . 70.13 109.426 -173.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.59 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 15.3 t -104.34 141.22 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.315 1.046 . . . . 72.25 109.427 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 18.5 tp -118.87 112.7 20.0 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 108.676 -0.861 . . . . 64.43 108.676 172.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.635 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 20.0 ttm-85 -88.47 113.28 23.89 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.581 -0.525 . . . . 72.53 109.581 175.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 39.8 t -108.19 101.24 12.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 107.356 -1.35 . . . . 71.1 107.356 171.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 16.0 m -97.09 139.97 32.29 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.634 -0.876 . . . . 73.14 108.634 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.698 HG21 HG21 ' B' ' 114' ' ' ILE . 89.7 t -128.16 136.45 60.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 124.339 1.056 . . . . 71.51 109.295 -174.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 95.5 m -124.81 148.31 48.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.121 -1.066 . . . . 33.34 108.121 172.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.71 139.15 31.0 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.92 -0.77 . . . . 74.41 108.92 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.476 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 36.1 p -140.35 128.1 21.78 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 123.716 0.635 . . . . 70.2 110.331 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.497 HD12 HG22 ' B' ' 31' ' ' VAL . 45.0 mt -99.61 103.56 15.27 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.476 -1.305 . . . . 63.51 107.476 173.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.86 -113.96 4.01 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.202 -0.759 . . . . 43.14 111.202 -174.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -121.88 6.05 9.89 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.864 0.466 . . . . 63.22 109.815 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.487 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 4.0 pm0 -113.48 150.89 32.2 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.161 0.584 . . . . 62.2 109.892 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 45.4 m -67.97 118.73 11.55 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.245 1.018 . . . . 72.12 111.095 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.488 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -73.14 -63.92 1.08 Allowed 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.622 -0.881 . . . . 72.42 108.622 173.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -147.77 167.76 23.86 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 114.726 -1.124 . . . . 74.21 110.958 175.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.2 mt -129.13 141.34 51.21 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.278 -1.749 . . . . 74.32 106.278 173.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.408 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 42.0 t -147.44 158.88 44.16 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.346 -0.983 . . . . 61.43 108.346 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.628 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 42.8 tt0 -165.95 133.27 2.79 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.577 -0.897 . . . . 72.33 108.577 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 91.4 t -128.05 142.15 44.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.131 -1.063 . . . . 70.32 108.131 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -124.51 87.87 2.8 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.568 -1.271 . . . . 73.22 107.568 174.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -81.09 102.13 10.05 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.068 -0.969 . . . . 71.21 108.666 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.43 171.71 38.59 Favored Glycine 0 C--O 1.245 0.83 0 CA-C-N 116.017 -0.538 . . . . 62.41 111.935 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.46 132.12 2.31 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 111.083 -0.807 . . . . 72.01 111.083 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 50.2 mt -84.17 125.01 40.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.491 -1.299 . . . . 70.12 107.491 171.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -130.61 129.09 42.27 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.39 -0.966 . . . . 63.04 108.39 174.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 69.2 m -93.52 88.75 6.02 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.522 0.729 . . . . 62.32 109.34 170.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 37.2 pt -103.34 146.28 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 N-CA-C 107.73 -1.211 . . . . 61.44 107.73 176.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.11 164.62 34.17 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 112.722 0.638 . . . . 42.43 112.722 -169.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.29 -71.35 1.19 Allowed Glycine 0 C--N 1.348 1.246 0 CA-C-N 114.822 -1.081 . . . . 65.34 114.579 167.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.608 ' HB ' ' HB3' ' B' ' 9' ' ' MET . 0.4 OUTLIER -89.39 171.7 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 123.876 0.87 . . . . 72.21 111.602 -166.17 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -150.82 158.53 44.26 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.059 0.544 . . . . 41.05 111.865 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.53 -135.81 12.77 Favored Glycine 0 C--N 1.355 1.617 0 C-N-CA 124.789 1.185 . . . . 53.1 112.875 172.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 11.2 m -69.15 -26.59 64.95 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.57 0.7 . . . . 65.51 110.389 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -62.47 -44.07 97.29 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.539 -1.209 . . . . 70.22 111.315 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.485 ' SD ' HD21 ' B' ' 98' ' ' LEU . 0.0 OUTLIER -80.11 -26.88 39.29 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 110.363 -0.236 . . . . 61.33 110.363 178.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.09 -13.98 60.98 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.554 0.742 . . . . 53.02 111.55 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -77.38 -34.67 54.9 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.806 0.443 . . . . 70.55 110.672 169.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.531 ' SG ' ' HD2' ' B' ' 11' ' ' PHE . 49.2 t -76.33 -67.58 0.67 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 119.161 -0.447 . . . . 74.32 111.356 -175.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.584 ' HB2' HG21 ' B' ' 58' ' ' VAL . 2.3 pt? -91.88 -12.37 33.78 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 118.255 0.48 . . . . 73.41 111.809 -175.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.76 -24.24 12.34 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-O 119.837 -0.424 . . . . 71.24 113.489 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.2 -55.83 2.03 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.994 0.518 . . . . 70.33 111.197 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.476 ' O ' HG13 ' B' ' 105' ' ' ILE . 56.5 t80 -83.39 -37.06 23.79 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.558 0.577 . . . . 74.35 112.558 -169.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.441 ' HA ' HD12 ' B' ' 105' ' ' ILE . 86.9 m -64.47 -43.58 72.06 Favored Pre-proline 0 N--CA 1.482 1.149 0 CA-C-O 118.338 -0.839 . . . . 72.54 110.364 177.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.49 -41.83 43.2 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 122.531 2.154 . . . . 53.34 113.622 163.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -66.27 -33.8 76.55 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 124.119 0.968 . . . . 72.45 111.187 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.907 HD13 HD11 ' B' ' 13' ' ' ILE . 73.5 mt -71.91 -46.1 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.682 0.793 . . . . 73.51 110.082 177.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 93.6 mt -77.39 -19.53 56.05 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 114.727 -1.124 . . . . 75.23 111.173 -175.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -59.91 -52.05 76.36 Favored Pre-proline 0 N--CA 1.483 1.205 0 CA-C-O 117.585 -1.198 . . . . 73.02 113.41 -173.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.02 -27.41 42.51 Favored 'Trans proline' 0 C--N 1.385 2.489 0 CA-C-N 121.546 1.588 . . . . 54.44 112.516 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -70.62 -43.17 69.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.856 0.463 . . . . 63.03 110.302 175.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.73 -43.66 92.66 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.553 -0.749 . . . . 53.54 110.327 176.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -60.98 -49.44 77.42 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.717 1.207 . . . . 71.42 110.506 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -63.17 -32.94 74.45 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 123.903 0.752 . . . . 74.24 109.427 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.496 ' O ' ' HG2' ' B' ' 117' ' ' MET . 17.1 t -72.79 -41.77 64.64 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 123.406 0.442 . . . . 74.22 112.128 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.698 HG21 HG21 ' B' ' 64' ' ' VAL . 84.7 mt -60.6 -57.0 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 108.792 -0.818 . . . . 72.25 108.792 176.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.2 m -61.43 -25.79 67.44 Favored 'General case' 0 CA--C 1.554 1.111 0 O-C-N 124.776 1.297 . . . . 74.02 111.053 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 43.0 t -65.95 -51.36 59.26 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 123.186 0.594 . . . . 51.43 109.641 170.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.1 mmt -68.16 -30.17 69.23 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.188 0.595 . . . . 73.32 111.613 -177.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 114' ' ' ILE . 95.5 t -66.79 -44.3 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.31 1.044 . . . . 74.12 109.08 173.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.0 t -69.07 -29.38 67.48 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.924 -1.035 . . . . 34.02 111.48 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.44 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 89.2 mtt-85 -74.85 -37.44 62.23 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.517 0.727 . . . . 71.43 109.637 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.26 -5.74 77.79 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 123.84 0.713 . . . . 63.25 112.236 170.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 33.8 p 63.55 25.96 14.57 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.608 1.963 . . . . 63.25 112.953 174.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -81.09 159.78 67.34 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 124.511 1.124 . . . . 75.32 110.495 174.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.58 165.09 6.49 Favored 'Trans proline' 0 C--N 1.39 2.714 0 C-N-CA 123.5 2.8 . . . . 75.5 114.273 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.439 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 65.5 tp60 -61.07 136.71 58.16 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.388 -1.278 . . . . 64.41 112.135 -173.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.444 HD13 HG21 ' B' ' 40' ' ' VAL . 43.0 tp -136.25 121.78 19.52 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.887 0.875 . . . . 73.34 109.443 -178.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -132.83 129.07 38.02 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.873 0.869 . . . . 55.11 109.098 175.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.21 149.9 30.3 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.576 0.75 . . . . 64.32 110.261 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 129' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -73.04 129.08 86.87 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 123.429 0.692 . . . . 72.35 111.919 -172.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 24.1 Cg_exo -65.86 98.23 0.36 Allowed 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.274 2.649 . . . . 60.03 113.216 177.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 21.1 m -109.83 135.96 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 109.018 -0.734 . . . . 72.54 109.018 171.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -90.55 100.98 13.72 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.006 -1.109 . . . . 75.24 108.006 177.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -60.78 -43.04 98.58 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.79 0.836 . . . . 75.03 110.816 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 . . . . . 0 CA--C 1.539 0.524 0 CA-C-N 114.851 -1.068 . . . . 64.12 111.339 -176.942 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.721 ' HD2' ' HG3' ' A' ' 130' ' ' PRO . 71.0 t80 . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 108.674 -0.861 . . . . 72.44 108.674 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 12' ' ' GLN . . . . . 0.549 ' HB3' ' HB2' ' C' ' 85' ' ' SER . 6.3 tt0 -142.84 144.21 32.42 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.541 0.736 . . . . 74.44 109.403 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.446 HD13 HD11 ' C' ' 16' ' ' ILE . 27.6 mt -92.72 131.17 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 109.253 -0.647 . . . . 65.2 109.253 173.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.421 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.4 mm-40 -98.96 -43.21 6.79 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.954 0.902 . . . . 74.15 109.84 176.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -172.54 137.18 0.81 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.628 -0.879 . . . . 70.12 108.628 -168.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.446 HD11 HD13 ' C' ' 13' ' ' ILE . 85.5 mt -129.64 138.17 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.236 -1.024 . . . . 73.33 108.236 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.447 ' HB3' HG23 ' D' ' 122' ' ' THR . 37.1 p90 -170.4 166.64 8.5 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.672 0.749 . . . . 73.4 111.43 -173.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -84.77 109.81 18.34 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.922 -1.035 . . . . 74.24 109.045 174.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -64.33 -44.32 91.88 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 121.994 0.902 . . . . 64.31 108.844 174.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.0 t70 -147.97 149.89 33.0 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 113.392 -1.731 . . . . 73.13 109.254 -175.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 79.5 mt -140.3 145.43 26.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 125.798 1.639 . . . . 64.24 106.725 177.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.5 t -155.72 150.21 25.97 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.609 0.719 . . . . 72.44 110.057 176.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -148.49 147.94 29.68 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.323 -1.362 . . . . 63.52 107.323 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -144.08 133.52 23.34 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.562 1.145 . . . . 73.1 108.804 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.01 78.68 4.27 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 107.117 -1.438 . . . . 73.4 107.117 171.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.44 -11.2 22.55 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.948 2.432 . . . . 60.31 112.333 -174.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -126.08 26.39 6.53 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.09 1.356 . . . . 72.41 109.791 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.83 -58.5 5.34 Favored Pre-proline 0 CA--C 1.57 1.724 0 CA-C-O 117.831 -1.08 . . . . 72.23 113.574 -172.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -59.95 -38.69 77.13 Favored 'Trans proline' 0 C--N 1.401 3.314 0 C-N-CA 122.162 1.908 . . . . 74.34 112.255 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -70.72 -39.79 73.17 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.331 -0.85 . . . . 71.34 111.831 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.701 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.5 p -78.78 -17.29 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.428 0 N-CA-C 112.224 0.453 . . . . 64.11 112.224 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -66.2 -37.21 85.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.194 -0.316 . . . . 74.53 111.538 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -85.19 13.49 6.29 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.493 0.717 . . . . 70.43 111.709 -176.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.62 169.29 9.61 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.545 1.138 . . . . 72.45 110.308 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -74.7 122.94 24.02 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.402 -0.592 . . . . 71.42 109.402 171.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -84.1 92.26 7.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.511 0.724 . . . . 73.33 110.49 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -146.95 80.96 9.26 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 106.928 -1.508 . . . . 71.54 106.928 168.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -88.22 155.35 6.86 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.597 2.198 . . . . 72.22 112.843 -176.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -86.02 99.49 11.5 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 106.548 -1.649 . . . . 62.43 106.548 166.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 43.9 t -74.77 96.55 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 107.826 -1.175 . . . . 73.04 107.826 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.568 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 88.4 mttt -93.81 100.74 12.88 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.209 -1.404 . . . . 74.0 107.209 178.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 pp -88.71 149.7 23.35 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.187 0.518 . . . . 73.01 109.794 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.645 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 26.1 t70 -144.36 144.84 31.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.306 -0.861 . . . . 51.23 108.964 -176.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.66 142.39 41.15 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.387 0.675 . . . . 74.55 109.782 174.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 25.8 t70 -137.66 146.54 43.98 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.363 1.065 . . . . 74.21 108.605 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 47.3 p -115.53 120.52 39.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.94 0.496 . . . . 75.15 111.283 -170.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.31 160.12 35.9 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.183 0.993 . . . . 74.11 109.447 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 35.4 p -164.55 166.46 20.3 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.908 0.385 . . . . 64.34 112.006 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 83.9 p -151.92 152.81 33.02 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.346 1.058 . . . . 75.22 108.993 171.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -102.22 124.08 47.18 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.498 -0.927 . . . . 74.22 108.498 172.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.524 HD11 HD12 ' C' ' 83' ' ' ILE . 51.2 mt -101.97 -32.27 10.27 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.251 0.62 . . . . 71.25 111.12 -174.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.52 -166.04 1.28 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.351 0.66 . . . . 74.21 110.686 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -63.36 115.62 4.76 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 124.005 0.816 . . . . 61.41 109.42 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 67.49 -5.25 0.79 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 125.017 1.327 . . . . 52.31 113.113 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 67.4 t -92.64 106.7 18.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.54 -1.281 . . . . 75.44 107.54 -177.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -124.64 128.65 49.19 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.521 -1.289 . . . . 61.45 107.521 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -81.36 119.31 23.52 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.001 -1.0 . . . . 72.25 108.547 172.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 65.5 t -96.45 120.44 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.339 -1.356 . . . . 50.41 107.339 171.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 55.7 t -115.09 132.76 63.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 108.671 -0.863 . . . . 71.23 108.671 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 29.9 tp -124.18 117.2 24.07 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.304 -0.999 . . . . 74.23 108.304 170.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 33.3 ttm180 -81.74 135.76 35.48 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.098 0.959 . . . . 70.53 108.955 172.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.502 ' HB ' HD11 ' C' ' 114' ' ' ILE . 14.9 t -122.89 130.06 74.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.258 -1.386 . . . . 63.21 107.258 169.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.645 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 18.0 m -129.65 116.62 19.11 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.534 -0.913 . . . . 74.24 108.534 -177.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.474 HG21 HG21 ' C' ' 114' ' ' ILE . 59.5 t -108.53 113.3 43.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 124.202 1.001 . . . . 61.1 108.978 -173.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 2.5 m -101.62 131.1 48.01 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.936 -0.764 . . . . 72.14 108.936 175.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.2 109.62 16.06 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.434 -1.691 . . . . 64.43 106.434 174.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 24.7 m -131.47 125.46 32.55 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 117.791 0.269 . . . . 71.23 110.358 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.7 mt -85.76 49.59 1.8 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.497 1.119 . . . . 52.42 108.96 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.62 -114.64 4.96 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 110.096 -1.202 . . . . 74.41 110.096 -169.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -91.97 -24.08 19.36 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.36 0.664 . . . . 64.41 110.17 172.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -67.72 101.91 1.12 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.19 -0.67 . . . . 65.13 109.19 176.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 90.3 m -70.78 122.62 20.2 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.617 -0.512 . . . . 72.12 109.617 175.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.701 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.47 -56.92 4.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.291 -1.003 . . . . 52.42 108.291 171.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -159.48 163.32 35.41 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.29 -0.868 . . . . 65.43 111.352 177.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -127.57 131.68 49.96 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 105.966 -1.864 . . . . 75.14 105.966 164.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.442 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.6 t -137.73 111.19 8.02 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.111 -0.7 . . . . 51.05 109.111 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 77' ' ' GLU . . . . . 0.438 ' HB2' HG23 ' C' ' 63' ' ' THR . 33.0 tt0 -119.51 116.59 26.39 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.31 0.644 . . . . 63.23 109.841 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -117.11 132.59 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 108.531 -0.914 . . . . 75.23 108.531 172.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.544 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 44.3 mt-30 -105.24 100.46 10.05 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.19 -1.041 . . . . 75.1 108.19 172.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -87.71 121.33 30.0 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.609 -0.723 . . . . 73.44 109.584 -177.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.88 146.92 18.87 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 112.042 -0.423 . . . . 41.25 112.042 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.505 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -143.12 124.58 2.36 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.435 -1.066 . . . . 75.33 110.435 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.524 HD12 HD11 ' C' ' 51' ' ' LEU . 16.6 mm -81.04 123.55 37.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.984 -1.117 . . . . 44.54 107.984 176.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -132.47 135.56 46.11 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.738 0.415 . . . . 72.23 110.646 -174.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 85' ' ' SER . . . . . 0.549 ' HB2' ' HB3' ' C' ' 12' ' ' GLN . 43.3 m -83.96 99.91 10.69 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 107.667 -1.235 . . . . 62.15 107.667 167.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 3.6 tt -120.0 117.76 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.519 1.128 . . . . 74.54 110.592 -172.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.24 169.89 16.99 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.458 1.103 . . . . 54.32 109.715 177.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 122.63 -60.5 0.57 Allowed Glycine 0 N--CA 1.472 1.094 0 N-CA-C 112.5 -0.24 . . . . 32.23 112.5 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 23.5 pt -96.4 173.44 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.113 0.565 . . . . 64.35 111.015 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -153.47 160.39 42.54 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.833 0.853 . . . . 53.13 110.539 -172.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.04 -145.87 30.16 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.762 -0.654 . . . . 62.14 111.646 175.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 46.6 p -63.88 -17.38 63.12 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.082 0.553 . . . . 74.13 112.011 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -67.3 -51.01 57.83 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 123.403 0.681 . . . . 75.32 110.458 173.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.502 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 7.0 ptp -70.24 -37.14 74.9 Favored 'General case' 0 C--N 1.362 1.14 0 N-CA-C 109.839 -0.43 . . . . 64.33 109.839 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.67 -35.88 66.48 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.525 0.73 . . . . 73.12 110.988 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.52 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 17.5 t-80 -71.35 -39.64 71.18 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.397 1.079 . . . . 74.03 111.518 173.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -71.28 -62.0 1.56 Allowed 'General case' 0 N--CA 1.481 1.106 0 O-C-N 122.094 -0.379 . . . . 62.4 111.613 -175.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' C' ' 94' ' ' MET . 1.2 pp -71.14 -21.94 62.12 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.99 0.516 . . . . 64.44 112.34 -178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.44 4.97 62.36 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 119.594 -0.559 . . . . 52.25 113.466 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -149.98 -60.14 0.2 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 117.917 0.859 . . . . 75.01 112.348 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -66.7 -51.56 54.6 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.672 0.789 . . . . 72.43 112.087 -175.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 19.9 m -63.87 -44.77 80.14 Favored Pre-proline 0 CA--C 1.57 1.719 0 C-N-CA 123.738 0.815 . . . . 51.22 112.805 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.405 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 22.5 Cg_exo -68.1 -22.82 40.57 Favored 'Trans proline' 0 C--N 1.397 3.08 0 C-N-CA 122.298 1.999 . . . . 71.12 113.347 171.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -71.16 -32.12 68.53 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 122.974 0.51 . . . . 75.11 110.673 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.43 HG23 ' NH1' ' A' ' 111' ' ' ARG . 37.7 mm -59.33 -42.01 85.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.725 0.81 . . . . 42.43 109.884 171.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.505 HD21 ' HA3' ' C' ' 82' ' ' GLY . 93.8 mt -80.22 -21.22 43.09 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.732 -1.122 . . . . 74.14 112.595 -172.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -53.79 -50.84 81.44 Favored Pre-proline 0 CA--C 1.567 1.618 0 CA-C-O 117.555 -1.212 . . . . 74.4 113.377 -175.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.77 -33.19 96.52 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 122.145 1.897 . . . . 74.22 114.134 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -73.07 -44.46 60.57 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.077 0.551 . . . . 72.44 110.03 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.22 -40.01 88.63 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.242 -0.89 . . . . 64.3 110.261 173.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -59.09 -53.8 54.25 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.962 1.305 . . . . 71.45 110.765 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.79 -36.79 78.72 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 123.358 0.411 . . . . 70.24 109.903 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 20.3 t -65.73 -32.37 73.88 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.978 0.511 . . . . 74.32 111.495 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.502 HD11 ' HB ' ' C' ' 62' ' ' VAL . 81.5 mt -74.1 -55.8 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.187 0.595 . . . . 75.22 109.859 173.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.8 m -61.37 -27.44 68.52 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.452 0.701 . . . . 54.21 110.964 -174.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.7 t -65.65 -50.17 65.96 Favored 'General case' 0 C--O 1.214 -0.77 0 C-N-CA 123.782 0.833 . . . . 44.14 109.034 171.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.534 ' HG3' HD12 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.7 -33.06 74.33 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.218 1.007 . . . . 72.03 112.364 178.286 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.412 HG23 ' O ' ' C' ' 114' ' ' ILE . 66.4 t -67.85 -41.48 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 123.493 0.717 . . . . 63.33 109.066 174.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 39.9 t -74.07 -23.46 59.37 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.528 1.131 . . . . 41.1 111.986 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -78.12 -39.6 40.74 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.719 -0.845 . . . . 64.14 108.719 176.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.38 -0.65 62.7 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.549 -0.751 . . . . 43.13 112.347 167.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 31.4 p 62.24 29.73 17.46 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.695 1.998 . . . . 71.34 113.653 169.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -81.84 156.29 70.12 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 123.627 0.771 . . . . 72.33 108.947 169.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.439 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 25.3 Cg_endo -62.12 168.07 9.78 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.54 2.16 . . . . 62.54 112.485 173.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -59.79 110.47 1.17 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.279 -0.873 . . . . 64.22 112.17 -173.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.41 86.38 2.28 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 105.893 -1.891 . . . . 54.41 105.893 171.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -107.93 108.42 19.56 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.565 -0.902 . . . . 70.13 108.565 -173.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.432 HD23 ' N ' ' C' ' 129' ' ' ALA . 3.5 tt -73.03 144.75 47.03 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.485 0.714 . . . . 74.42 109.796 -174.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 129' ' ' ALA . . . . . 0.432 ' N ' HD23 ' C' ' 128' ' ' LEU . . . -60.47 157.92 33.01 Favored Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 124.706 1.202 . . . . 62.41 112.417 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.458 ' HG3' HD12 ' A' ' 16' ' ' ILE . 43.6 Cg_exo -57.65 110.53 0.63 Allowed 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 122.735 2.29 . . . . 71.34 112.285 173.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 20.4 t -98.73 108.41 22.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.769 -0.826 . . . . 75.35 108.769 177.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -107.13 90.8 3.41 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 107.836 -1.172 . . . . 72.15 107.836 173.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -55.55 -41.39 73.16 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.044 0.84 . . . . 75.43 110.578 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 134' ' ' ASP . . . . . 0.4 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 7.7 t70 . . . . . 0 C--O 1.242 0.67 0 CA-C-N 114.328 -1.305 . . . . 64.03 111.458 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 57.0 m . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 109.449 -0.574 . . . . 70.22 109.449 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -157.73 96.72 1.52 Allowed 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.721 -1.214 . . . . 73.32 107.721 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -113.86 115.7 28.15 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.477 -0.935 . . . . 65.53 108.477 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.464 HG21 HD11 ' D' ' 16' ' ' ILE . 46.8 mt -71.32 123.06 24.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.913 -0.773 . . . . 61.31 108.913 177.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -93.41 -34.05 13.6 Favored 'General case' 0 C--O 1.246 0.881 0 O-C-N 123.59 0.557 . . . . 72.55 110.664 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -173.55 144.52 1.13 Allowed 'General case' 0 C--N 1.364 1.224 0 N-CA-C 112.303 0.483 . . . . 75.22 112.303 -170.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.464 HD11 HG21 ' D' ' 13' ' ' ILE . 3.6 mp -123.34 136.92 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 107.243 -1.391 . . . . 71.32 107.243 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.4 ' HE1' HG13 ' D' ' 83' ' ' ILE . 24.6 p90 -164.61 152.31 11.86 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.64 0.733 . . . . 73.42 110.649 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 56.7 p -84.2 117.47 23.52 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.532 -1.213 . . . . 72.1 108.525 174.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -85.53 -18.02 34.66 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.785 0.326 . . . . 73.2 110.21 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -166.24 140.49 4.33 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.429 1.092 . . . . 62.22 108.283 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.534 HD12 ' HG3' ' C' ' 117' ' ' MET . 77.5 mt -137.18 150.14 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 108.12 -1.067 . . . . 75.44 108.12 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.9 t -156.8 103.43 2.07 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.299 1.04 . . . . 71.01 109.298 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.539 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 80.8 t80 -109.09 122.1 46.56 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 106.366 -1.716 . . . . 73.23 106.366 171.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -130.48 110.47 11.48 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.502 -0.555 . . . . 65.23 109.502 -172.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.4 89.45 4.89 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 108.234 -1.025 . . . . 52.53 108.234 173.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.22 -38.15 3.97 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.555 2.17 . . . . 55.03 112.289 -172.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -101.7 11.24 39.15 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.899 0.88 . . . . 71.1 110.072 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -20.63 -68.03 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 116.151 1.908 . . . . 73.05 116.151 -168.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.415 ' HB3' HD11 ' C' ' 83' ' ' ILE . 43.6 Cg_endo -79.94 -18.24 10.33 Favored 'Trans proline' 0 C--N 1.379 2.167 0 CA-C-N 122.844 2.052 . . . . 34.42 114.029 -173.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -76.68 -39.79 50.95 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.511 1.124 . . . . 64.31 109.576 176.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.695 HG22 HD12 ' D' ' 68' ' ' LEU . 11.3 p -82.79 -18.01 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 CA-C-N 115.799 -0.637 . . . . 61.3 111.296 -172.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -65.86 -22.51 66.53 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 112.094 0.405 . . . . 71.55 112.094 177.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -60.31 -20.23 58.42 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.1 0.96 . . . . 73.22 111.26 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.417 ' HB2' HD13 ' D' ' 68' ' ' LEU . 93.1 mttt -95.92 102.14 13.9 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.659 1.183 . . . . 71.4 109.816 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -101.16 87.23 3.2 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.759 0.424 . . . . 74.23 110.151 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -158.66 179.79 8.78 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.176 0.991 . . . . 73.05 108.599 167.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -67.19 112.34 9.69 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 123.622 0.769 . . . . 73.25 110.441 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -56.39 141.62 89.26 Favored 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 122.736 2.291 . . . . 61.31 112.016 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 42.6 mt-10 -57.84 118.41 5.3 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.59 1.181 . . . . 73.13 111.291 -177.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 25.6 t -93.58 107.18 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 107.568 -1.271 . . . . 73.41 107.568 -172.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.442 ' HE3' ' HB3' ' D' ' 39' ' ' GLU . 31.1 mmtp -125.98 118.92 26.4 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.555 -1.276 . . . . 75.04 107.555 -177.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.91 115.55 27.62 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.203 0.601 . . . . 74.22 109.725 -174.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.627 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.3 m-20 -107.85 119.25 38.93 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.425 1.09 . . . . 75.43 108.066 172.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.58 152.88 27.08 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.754 0.421 . . . . 73.1 110.537 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -157.01 152.82 27.05 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.881 -1.155 . . . . 64.52 107.881 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 57.9 p -118.78 149.21 41.88 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.871 0.468 . . . . 71.23 111.611 -170.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.54 164.03 38.42 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.426 1.09 . . . . 74.21 109.038 172.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 50.8 p -176.95 177.5 1.28 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.702 0.801 . . . . 62.32 110.03 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 50.8 p -173.02 143.83 1.2 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.164 0.986 . . . . 35.41 109.889 169.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -76.3 116.71 17.25 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.794 -1.187 . . . . 74.14 107.794 167.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.487 HD11 ' HB2' ' D' ' 57' ' ' GLU . 61.3 mt -88.94 -26.66 21.42 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.997 0.519 . . . . 50.11 110.054 -175.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -174.06 -172.98 0.76 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.692 1.197 . . . . 72.4 109.777 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -68.88 126.75 30.74 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.477 -0.783 . . . . 71.43 109.131 174.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 69.08 -2.36 1.82 Allowed 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 124.956 1.302 . . . . 73.24 113.059 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 94.6 t -110.47 124.55 67.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.029 -1.1 . . . . 74.23 108.029 176.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.628 ' HB3' HD13 ' D' ' 86' ' ' ILE . 66.4 t80 -146.57 137.43 24.1 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.371 0.605 . . . . 72.03 110.142 -177.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.487 ' HB2' HD11 ' D' ' 51' ' ' LEU . 21.9 tt0 -104.13 137.61 41.83 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.964 1.306 . . . . 71.13 110.029 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.88 126.19 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 108.058 -1.09 . . . . 63.24 108.058 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.442 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 25.9 t -124.12 131.82 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.448 0.699 . . . . 70.22 109.388 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.438 HD23 HD12 ' D' ' 106' ' ' LEU . 3.9 mm? -123.81 122.14 37.24 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.518 -0.549 . . . . 61.51 109.518 173.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' D' ' 79' ' ' GLN . 12.5 ttm180 -83.54 106.39 15.24 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.387 -0.968 . . . . 74.34 108.387 170.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -92.02 125.95 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 107.601 -1.259 . . . . 74.41 107.601 169.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.627 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 22.1 m -123.83 133.34 53.81 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.041 -0.725 . . . . 33.54 109.041 177.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.415 HG21 HG21 ' D' ' 114' ' ' ILE . 73.1 t -114.19 101.36 12.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 107.85 -1.167 . . . . 72.11 107.85 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 78.6 m -90.58 92.43 8.85 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.568 -1.271 . . . . 65.14 107.568 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -100.98 135.93 41.64 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 114.831 -1.077 . . . . 64.42 109.964 -175.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.467 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 70.1 m -143.21 133.6 24.74 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.005 0.522 . . . . 72.5 110.699 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.695 HD12 HG22 ' D' ' 31' ' ' VAL . 77.2 mt -101.0 110.04 22.02 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.867 -1.16 . . . . 64.02 107.867 172.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.19 -114.02 3.75 Favored Glycine 0 C--N 1.344 0.981 0 O-C-N 123.237 0.336 . . . . 53.32 113.038 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.67 4.46 12.32 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.607 0.763 . . . . 74.12 110.576 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -120.68 156.11 32.44 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.567 0.747 . . . . 75.32 109.229 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 43.8 m -70.26 135.32 48.86 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 123.676 0.61 . . . . 61.3 110.545 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.655 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -85.91 -65.53 1.0 Allowed 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.062 -1.459 . . . . 62.21 107.062 172.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -157.43 148.57 21.63 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.606 -1.179 . . . . 73.02 110.342 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 60.1 mt -111.86 107.77 16.92 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 105.908 -1.886 . . . . 64.14 105.908 171.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' D' ' 114' ' ' ILE . 46.3 t -116.38 105.53 12.62 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.305 -0.998 . . . . 51.02 108.305 -171.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 77' ' ' GLU . . . . . 0.473 ' HB2' HG23 ' D' ' 63' ' ' THR . 41.8 tt0 -130.12 131.57 45.76 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.137 0.975 . . . . 64.04 108.994 -165.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.4 t -140.0 119.21 12.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 108.359 -0.978 . . . . 75.34 108.359 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.405 ' HA ' ' HA ' ' D' ' 61' ' ' ARG . 71.1 mt-30 -86.93 80.89 8.3 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 107.365 -1.346 . . . . 70.14 107.365 171.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -81.76 106.55 13.79 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 113.527 -1.669 . . . . 72.44 108.901 -172.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -110.36 158.46 14.42 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 115.844 -0.616 . . . . 74.11 112.442 -176.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.93 132.18 3.9 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.828 -0.509 . . . . 74.35 111.828 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.4 HG13 ' HE1' ' D' ' 17' ' ' TYR . 74.5 mt -89.4 130.8 38.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.229 -1.026 . . . . 74.53 108.229 174.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -133.36 166.84 21.58 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 123.512 0.508 . . . . 73.32 110.466 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.0 m -114.69 107.06 14.96 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.036 0.934 . . . . 70.24 108.526 175.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.628 HD13 ' HB3' ' D' ' 56' ' ' TYR . 4.2 mp -109.23 118.13 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 C-N-CA 123.402 0.681 . . . . 65.45 109.223 -176.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.7 139.65 16.33 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.707 0.803 . . . . 60.1 110.326 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.45 21.92 49.5 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-O 120.221 -0.21 . . . . 61.34 113.099 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.462 HD13 HG23 ' D' ' 86' ' ' ILE . 3.6 mp -116.34 146.72 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.681 0.792 . . . . 72.43 109.035 176.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -149.69 153.85 37.62 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.411 1.084 . . . . 52.31 110.411 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 91' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' D' ' 94' ' ' MET . . . 76.98 -133.81 13.97 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 114.835 0.694 . . . . 55.41 114.835 167.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.8 m -85.68 -11.66 53.19 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.259 1.024 . . . . 75.31 110.955 -178.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -57.11 -40.32 76.8 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.314 1.046 . . . . 54.44 110.618 176.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.43 ' HG2' ' O ' ' D' ' 91' ' ' GLY . 23.5 ptt? -74.45 -27.07 60.43 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.572 -0.74 . . . . 73.55 111.72 177.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.11 -34.88 77.22 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.523 0.329 . . . . 44.22 110.608 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -79.7 -32.0 41.3 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.988 -0.551 . . . . 60.33 110.621 174.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.7 t -63.1 -51.12 67.84 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.176 0.512 . . . . 62.4 110.705 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 57.8 mt -82.03 -28.52 32.45 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.096 -0.956 . . . . 63.41 111.252 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.6 11.36 72.29 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-O 119.61 -0.55 . . . . 53.45 113.519 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.82 -65.3 0.11 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 117.728 0.764 . . . . 60.02 111.84 -177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -73.82 -42.26 61.15 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 112.664 0.616 . . . . 74.2 112.664 -168.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.456 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 62.3 m -64.13 -46.48 79.92 Favored Pre-proline 0 CA--C 1.566 1.562 0 CA-C-O 118.55 -0.738 . . . . 74.41 111.904 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.456 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 31.3 Cg_exo -62.42 -28.64 78.34 Favored 'Trans proline' 0 C--N 1.4 3.263 0 C-N-CA 122.423 2.082 . . . . 75.11 113.078 169.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -69.33 -30.3 68.31 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.579 0.751 . . . . 74.54 111.063 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.5 mm -69.12 -36.47 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 121.42 0.628 . . . . 63.32 109.84 172.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.438 HD12 HD23 ' D' ' 60' ' ' LEU . 68.6 mt -86.16 -10.61 54.46 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.27 -0.877 . . . . 44.34 111.819 -176.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -66.0 -49.89 55.0 Favored Pre-proline 0 CA--C 1.565 1.558 0 CA-C-O 117.935 -1.031 . . . . 75.32 112.667 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -60.61 -32.13 93.0 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 122.272 1.981 . . . . 64.21 112.932 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -81.02 -35.24 32.14 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.382 -0.826 . . . . 73.01 112.206 -176.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.17 -52.0 61.09 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.003 -1.11 . . . . 64.21 108.003 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -49.28 -50.01 40.99 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.923 1.389 . . . . 72.13 111.84 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -67.05 -50.38 62.1 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.718 0.636 . . . . 65.33 111.254 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -58.19 -44.17 87.95 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 124.178 0.924 . . . . 41.33 110.611 -177.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.54 ' HA ' ' SG ' ' D' ' 76' ' ' CYS . 91.0 mt -58.53 -63.06 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 124.463 1.105 . . . . 74.31 110.862 173.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 92.0 m -55.04 -38.33 67.84 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.225 1.01 . . . . 71.43 112.287 -173.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 42.0 t -67.89 -42.81 80.63 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.409 -0.814 . . . . 65.52 110.172 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.2 mtm -69.11 -29.9 68.07 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.67 0.388 . . . . 75.24 111.645 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.445 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.4 t -62.45 -50.04 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 O-C-N 123.797 0.686 . . . . 74.13 109.457 174.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 81.9 p -71.12 -30.35 66.39 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.942 -0.572 . . . . 61.11 110.855 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 71.8 mtt-85 -70.16 -32.19 70.04 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.369 0.668 . . . . 61.45 109.961 174.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.84 10.72 71.42 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.825 -0.625 . . . . 53.41 112.502 174.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.447 HG23 ' HB3' ' C' ' 17' ' ' TYR . 45.5 p 56.12 30.8 17.03 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 126.444 1.898 . . . . 74.01 114.144 175.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -93.47 159.44 35.07 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 123.813 0.845 . . . . 62.31 110.188 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -51.75 125.03 15.81 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.502 2.801 . . . . 74.22 113.501 171.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -57.59 136.2 56.75 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.844 1.258 . . . . 74.33 111.664 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 59.0 tp -128.53 97.38 4.69 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.454 0.702 . . . . 73.03 109.573 -175.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -100.57 110.07 22.2 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.568 0.747 . . . . 73.11 110.058 -176.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 89.1 mt -71.0 115.24 9.9 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.919 0.488 . . . . 71.54 110.264 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.31 157.28 88.33 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 122.967 0.507 . . . . 64.14 110.568 176.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -51.0 110.06 0.37 Allowed 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.419 2.746 . . . . 63.44 112.959 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 C--O 1.244 0.809 0 N-CA-C 108.639 -0.874 . . . . 75.14 108.639 172.128 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.595 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 19.4 t80 . . . . . 0 C--O 1.235 0.335 0 N-CA-C 108.678 -0.86 . . . . 72.12 108.678 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -138.92 127.61 23.35 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.329 -0.989 . . . . 72.45 108.329 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.692 HG12 ' HD2' ' A' ' 84' ' ' PHE . 42.6 mt -95.06 112.97 28.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.639 -0.874 . . . . 63.54 108.639 172.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -86.09 -24.33 26.32 Favored 'General case' 0 C--O 1.243 0.722 0 O-C-N 123.386 0.429 . . . . 72.4 111.064 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -173.42 146.42 1.37 Allowed 'General case' 0 N--CA 1.48 1.068 0 O-C-N 123.213 0.321 . . . . 72.02 110.373 -173.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.548 HD12 ' HG3' ' C' ' 130' ' ' PRO . 80.9 mt -138.47 134.9 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 124.021 0.929 . . . . 75.21 108.634 171.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.462 ' HB3' HG23 ' B' ' 122' ' ' THR . 27.6 p90 -167.98 176.19 6.3 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 124.42 1.075 . . . . 73.24 111.58 -168.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.6 p -99.64 120.6 39.95 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.433 -0.951 . . . . 74.43 108.433 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.457 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 43.9 mtpt -87.64 -27.4 22.5 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.069 -0.345 . . . . 75.44 110.069 174.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.627 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.7 t70 -149.14 139.59 22.45 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.649 -0.705 . . . . 71.34 109.989 177.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.4 mt -136.62 146.12 29.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 C-N-CA 125.3 1.44 . . . . 72.22 107.242 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -153.73 136.51 15.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 123.495 0.497 . . . . 44.23 110.064 170.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.59 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 86.3 t80 -133.47 143.45 48.83 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.416 -1.328 . . . . 72.35 107.416 171.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -140.38 144.32 36.17 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 108.949 -0.76 . . . . 53.11 108.949 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.61 74.03 11.49 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 106.151 -1.796 . . . . 44.23 106.151 171.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -64.57 -34.78 51.16 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.39 2.06 . . . . 73.04 111.956 -170.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -101.42 20.52 15.79 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.982 0.913 . . . . 71.43 109.896 -175.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.431 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -45.73 -52.01 26.61 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-O 118.009 -0.996 . . . . 73.32 113.627 -171.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.462 ' HG3' ' HG3' ' B' ' 57' ' ' GLU . 48.4 Cg_exo -57.89 -33.7 97.39 Favored 'Trans proline' 0 C--N 1.39 2.723 0 C-N-CA 121.882 1.721 . . . . 65.41 113.564 176.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -82.1 -30.88 30.98 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.055 0.942 . . . . 22.21 110.687 -177.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.725 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.3 p -78.96 -22.38 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 C-N-CA 123.169 0.588 . . . . 63.21 112.518 -163.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -77.84 -25.85 49.02 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.697 0.799 . . . . 75.51 112.67 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -83.39 -12.81 56.08 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.407 0.683 . . . . 70.54 111.012 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -82.77 167.88 17.72 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.962 0.905 . . . . 74.43 111.96 -175.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.68 126.54 31.03 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.986 -1.006 . . . . 74.24 109.324 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.416 ' CE3' HD21 ' A' ' 68' ' ' LEU . 54.1 t-105 -75.47 85.5 2.57 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.326 0.584 . . . . 53.43 110.094 175.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.45 ' H ' HD22 ' A' ' 68' ' ' LEU . 35.4 tt0 -122.88 75.2 48.01 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.689 1.196 . . . . 74.2 108.258 173.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -83.9 135.75 6.78 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.866 2.378 . . . . 73.52 112.994 -171.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -104.9 106.47 16.98 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 106.97 -1.493 . . . . 72.04 106.97 170.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 65' ' ' THR . 15.2 m -75.78 91.49 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-O 122.031 0.92 . . . . 71.53 110.652 -175.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.7 tptt -80.52 111.81 17.28 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 107.118 -1.438 . . . . 54.43 107.118 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 pp -127.53 141.92 51.52 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.046 0.539 . . . . 71.45 110.549 -168.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -146.19 134.16 21.41 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.758 -0.83 . . . . 71.55 108.758 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -103.69 118.61 37.12 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.917 -0.771 . . . . 71.23 108.917 177.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 33.0 t70 -119.55 143.9 47.36 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.758 -0.83 . . . . 73.41 108.758 177.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.1 p -106.94 147.86 29.33 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.195 0.598 . . . . 70.13 110.047 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -147.76 144.05 27.97 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.153 0.981 . . . . 73.23 108.667 176.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 64.2 m -136.54 162.39 33.24 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 118.162 0.437 . . . . 63.5 111.799 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.9 t -149.92 121.86 8.2 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.843 0.857 . . . . 71.11 109.439 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -81.24 125.8 30.75 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.632 -0.507 . . . . 63.13 109.632 175.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.419 HD12 HG23 ' A' ' 83' ' ' ILE . 27.4 mt -107.8 -26.61 10.7 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.915 0.886 . . . . 72.33 110.264 -177.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.38 179.01 6.44 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.252 -1.34 . . . . 74.12 108.672 174.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -67.12 113.02 4.75 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.977 -0.749 . . . . 61.0 108.977 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 76.07 0.32 3.27 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 125.245 1.418 . . . . 64.22 112.401 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.52 109.46 24.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.896 0 N-CA-C 106.744 -1.576 . . . . 74.13 106.744 168.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -133.72 123.38 24.85 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.974 -1.121 . . . . 63.14 107.974 -170.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.403 ' HB2' HD11 ' A' ' 51' ' ' LEU . 14.4 tt0 -86.31 128.3 34.9 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.595 -0.891 . . . . 64.1 108.595 177.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.464 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 56.5 t -101.93 125.97 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.767 -1.197 . . . . 64.5 107.767 176.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 36.8 t -116.13 143.18 26.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 108.229 -1.026 . . . . 64.44 108.229 173.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tt -128.9 117.62 21.31 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.765 -0.828 . . . . 62.4 108.765 174.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.576 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 28.1 ttm105 -81.95 101.56 10.35 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 108.025 -1.102 . . . . 74.02 108.025 170.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.83 101.16 12.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 N-CA-C 107.132 -1.432 . . . . 71.11 107.132 171.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -96.47 126.45 41.67 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.906 -0.776 . . . . 73.02 108.906 176.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.411 ' O ' HD12 ' A' ' 75' ' ' LEU . 67.4 t -128.06 139.76 51.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 125.189 1.396 . . . . 64.25 107.356 176.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 6.4 m -131.24 149.82 52.41 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.702 -1.222 . . . . 70.31 107.702 174.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.19 113.57 22.42 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.203 -1.406 . . . . 63.04 107.203 170.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.0 m -113.85 124.38 52.07 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.157 0.503 . . . . 74.14 110.064 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.45 HD22 ' H ' ' A' ' 37' ' ' GLN . 66.0 mt -90.09 65.52 6.5 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.771 1.228 . . . . 75.13 109.001 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.34 -90.79 0.73 Allowed Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.838 -0.619 . . . . 71.2 111.828 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -102.17 -27.16 13.05 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.291 0.636 . . . . 73.33 111.644 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -100.19 128.5 46.26 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 109.585 -0.524 . . . . 72.54 109.585 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.9 m -71.49 135.91 47.34 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 118.175 0.443 . . . . 55.42 109.92 172.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.725 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -80.61 -63.1 1.48 Allowed 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.448 -0.796 . . . . 53.41 109.729 173.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -156.04 174.88 14.71 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.915 -1.038 . . . . 73.02 111.635 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.411 HD12 ' O ' ' A' ' 64' ' ' VAL . 44.6 tp -134.87 137.62 43.41 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.171 1.388 . . . . 73.44 107.853 174.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 82.5 m -136.51 102.92 5.09 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.96 1.304 . . . . 72.21 109.589 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -122.05 117.17 25.69 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.77 -0.826 . . . . 63.45 108.77 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.7 t -128.96 112.08 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.552 0.741 . . . . 75.31 109.976 -174.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.627 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.8 mt-30 -85.76 91.2 8.25 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.873 -0.788 . . . . 72.41 108.873 168.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.4 ' HG3' HD22 ' A' ' 106' ' ' LEU . 67.7 tp60 -80.75 107.87 13.93 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.969 -1.014 . . . . 73.1 108.995 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.59 145.28 17.43 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.033 -0.427 . . . . 62.21 112.033 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.06 128.45 3.07 Favored Glycine 0 CA--C 1.507 -0.445 0 N-CA-C 110.942 -0.863 . . . . 74.21 110.942 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.419 HG23 HD12 ' A' ' 51' ' ' LEU . 62.0 mt -79.54 122.38 34.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.867 -0.79 . . . . 73.12 108.867 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.692 ' HD2' HG12 ' A' ' 13' ' ' ILE . 12.6 m-85 -137.54 151.69 48.66 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.744 -0.836 . . . . 74.24 108.744 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 44.3 m -121.01 106.64 11.78 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.325 0.65 . . . . 64.33 109.348 170.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 108.692 -0.855 . . . . 45.44 108.692 178.592 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 111.718 0.266 . . . . 22.23 111.718 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -72.64 -39.28 67.31 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.965 0.506 . . . . 70.12 110.608 171.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.565 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 58.4 m -64.36 -56.21 15.9 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.224 0.61 . . . . 61.1 110.972 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 pp -71.62 -29.37 64.59 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.196 0.599 . . . . 62.22 111.332 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.61 -20.69 57.86 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-O 119.575 -0.569 . . . . 52.31 114.273 -173.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.08 -54.67 0.21 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.063 0.764 . . . . 74.51 113.063 -172.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.565 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 87.5 t80 -60.89 -63.48 1.28 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.524 0.73 . . . . 61.21 112.844 -171.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 78.2 m -65.63 -35.22 10.92 Favored Pre-proline 0 CA--C 1.57 1.732 0 C-N-CA 123.779 0.831 . . . . 75.55 113.073 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.2 -45.73 32.1 Favored 'Trans proline' 0 C--N 1.393 2.914 0 C-N-CA 122.777 2.318 . . . . 55.05 113.374 161.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -70.64 -17.69 62.87 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.401 0.681 . . . . 73.13 112.075 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 46.2 mm -69.71 -43.81 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 N-CA-C 109.209 -0.663 . . . . 72.13 109.209 171.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.4 HD22 ' HG3' ' A' ' 80' ' ' GLN . 89.1 mt -81.89 -23.48 36.27 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.012 0.925 . . . . 71.05 112.549 -177.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -56.22 -47.21 99.3 Favored Pre-proline 0 CA--C 1.572 1.792 0 C-N-CA 124.956 1.303 . . . . 71.52 113.953 -172.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.67 -32.76 14.25 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.119 1.879 . . . . 70.04 112.939 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -68.26 -40.68 81.83 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.058 0.543 . . . . 75.41 110.912 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.73 -39.92 80.13 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.766 -0.652 . . . . 65.22 110.507 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.4 ttm105 -54.67 -47.81 73.13 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.849 0.86 . . . . 70.2 110.912 173.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -68.94 -43.27 75.41 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.709 0.803 . . . . 70.04 111.408 -175.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 43.8 t -63.88 -29.65 70.81 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 123.607 0.567 . . . . 72.33 110.823 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 70.8 mt -68.2 -56.06 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 123.862 0.865 . . . . 71.33 110.011 169.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.2 m -56.28 -35.74 67.83 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.842 1.257 . . . . 44.31 112.339 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.4 t -64.38 -49.61 70.94 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 123.409 0.683 . . . . 51.01 110.647 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.59 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 57.9 mtm -65.9 -37.48 86.21 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.725 0.64 . . . . 60.15 111.25 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.0 t -60.07 -53.19 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.499 1.12 . . . . 72.02 110.403 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 40.2 t -69.78 -29.46 66.79 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.933 0.893 . . . . 61.22 111.49 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 52.0 ttm-85 -75.75 -28.92 58.68 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.256 1.023 . . . . 74.33 109.362 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.432 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.66 15.56 46.07 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 114.741 -1.118 . . . . 75.15 112.607 172.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.477 HG21 ' HE ' ' B' ' 15' ' ' ARG . 2.8 t 60.81 14.46 5.16 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 127.214 2.205 . . . . 74.11 113.77 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -80.08 155.07 75.1 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 123.681 0.792 . . . . 75.1 110.223 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.68 170.13 10.39 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.853 2.369 . . . . 74.44 113.15 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -63.68 127.69 32.5 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.193 -0.912 . . . . 74.45 111.55 -173.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.6 tp -121.88 103.96 9.21 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.651 1.18 . . . . 53.42 108.306 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -97.22 126.65 42.56 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.713 0.805 . . . . 72.43 108.867 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 tt -72.51 130.78 41.43 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.948 -1.13 . . . . 73.15 107.948 171.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.05 133.22 83.91 Favored Pre-proline 0 CA--C 1.548 0.893 0 O-C-N 123.575 0.547 . . . . 63.24 110.743 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -70.59 95.83 0.64 Allowed 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 122.343 2.028 . . . . 51.42 111.593 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.7 t -102.24 111.45 32.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 108.911 -0.774 . . . . 72.31 108.911 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -86.67 82.9 7.72 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.122 -1.066 . . . . 54.04 108.122 172.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 . . . . . 0 N--CA 1.489 1.488 0 C-N-CA 124.498 1.119 . . . . 74.12 111.785 -176.966 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.589 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 25.3 ptm . . . . . 0 N--CA 1.486 1.351 0 N-CA-C 115.473 1.657 . . . . 60.32 115.473 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 90.2 m -134.78 132.35 38.6 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 106.559 -1.645 . . . . 73.55 106.559 162.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.452 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 37.9 t80 -124.13 137.65 54.53 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.738 -0.838 . . . . 75.44 108.738 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -153.28 132.94 13.05 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.399 -0.593 . . . . 72.31 109.399 176.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.409 HD13 HD11 ' B' ' 16' ' ' ILE . 32.5 mt -83.32 120.39 34.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 108.438 -0.949 . . . . 62.32 108.438 173.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -88.28 -46.1 9.5 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.539 -0.541 . . . . 62.34 109.539 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.477 ' HE ' HG21 ' A' ' 122' ' ' THR . 49.2 ttt180 -167.67 137.74 2.77 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.704 0.402 . . . . 71.54 110.167 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.409 HD11 HD13 ' B' ' 13' ' ' ILE . 74.1 mt -114.79 142.32 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.407 -0.961 . . . . 75.2 108.407 175.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -169.77 158.53 7.52 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-O 121.682 0.753 . . . . 62.44 112.499 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.402 ' H ' ' HA2' ' A' ' 121' ' ' GLY . 88.4 m -86.71 129.58 34.81 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.007 -0.997 . . . . 51.12 109.188 170.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.456 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 41.1 mtpt -97.72 -29.22 13.51 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.796 0.838 . . . . 73.12 110.343 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -159.97 141.12 12.43 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.56 0.219 . . . . 73.13 111.334 -170.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 45.7 mm -135.53 146.13 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.291 1.437 . . . . 75.42 109.07 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.603 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 42.4 t -148.21 138.31 22.58 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.851 1.261 . . . . 71.33 107.965 173.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.1 t80 -153.57 109.38 3.27 Favored 'General case' 0 C--O 1.215 -0.755 0 N-CA-C 106.783 -1.562 . . . . 71.51 106.783 170.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -118.53 113.48 21.36 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.33 -1.359 . . . . 73.15 107.33 176.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.431 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -105.14 86.64 1.64 Allowed Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 106.975 -1.491 . . . . 53.34 106.975 172.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.37 -37.5 13.45 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.902 2.401 . . . . 70.1 112.502 -166.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -108.45 21.84 16.76 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.598 0.759 . . . . 71.11 110.069 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.431 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -39.36 -62.25 0.84 Allowed Pre-proline 0 N--CA 1.497 1.908 0 N-CA-C 114.792 1.404 . . . . 74.1 114.792 -166.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.457 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 46.8 Cg_endo -67.89 -27.54 36.93 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 121.823 1.682 . . . . 73.23 112.631 -174.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.405 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 26.3 m80 -75.38 -48.45 22.87 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 115.36 -0.837 . . . . 75.04 110.896 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' B' ' 68' ' ' LEU . 9.1 p -76.06 -0.49 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.365 0 C-N-CA 123.868 0.867 . . . . 64.41 112.353 -167.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -75.7 -13.38 60.31 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.985 -0.447 . . . . 72.02 112.155 173.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 10.2 pt20 -63.36 -16.97 62.03 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.756 0.822 . . . . 73.32 111.183 171.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.461 ' HB2' HD13 ' B' ' 68' ' ' LEU . 33.1 mmtp -93.72 89.87 6.36 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.058 1.343 . . . . 75.34 110.148 -176.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -89.17 84.5 6.53 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.988 0.515 . . . . 62.44 111.08 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 46.7 p90 -168.11 173.05 8.24 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.332 1.053 . . . . 71.01 109.497 169.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -65.17 116.77 33.37 Favored Pre-proline 0 N--CA 1.478 0.937 0 N-CA-C 108.602 -0.888 . . . . 62.04 108.602 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.404 ' O ' HG13 ' B' ' 40' ' ' VAL . 33.9 Cg_endo -60.06 154.15 53.19 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 121.995 1.797 . . . . 74.22 111.881 -175.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 30.3 tt0 -57.23 104.5 0.17 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.014 -0.736 . . . . 65.52 109.014 175.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.404 HG13 ' O ' ' B' ' 38' ' ' PRO . 26.2 m -85.2 139.08 17.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-N 114.924 -1.035 . . . . 63.32 110.565 -172.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.502 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 34.3 ttmt -150.5 107.13 3.51 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.723 -0.843 . . . . 74.23 108.723 -175.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.43 141.14 30.17 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 107.672 -1.233 . . . . 62.03 107.672 176.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -143.51 142.04 30.99 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.459 1.103 . . . . 73.22 108.417 174.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.435 HD23 HD11 ' B' ' 60' ' ' LEU . 5.4 mp -123.92 167.31 14.3 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.539 0.685 . . . . 74.32 110.991 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.599 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.0 t70 -149.65 148.55 29.43 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 113.879 -1.51 . . . . 74.44 109.002 175.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 3.4 t -108.27 127.02 53.49 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.236 1.015 . . . . 74.4 108.938 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -158.4 136.85 10.97 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.202 0.601 . . . . 72.3 110.216 -175.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.4 p -146.57 -179.63 6.9 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.264 0.625 . . . . 63.21 111.155 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 65.1 p -152.51 136.38 16.3 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.174 -1.047 . . . . 63.32 108.174 164.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -89.94 118.68 29.69 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.18 -0.674 . . . . 64.25 109.18 175.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 17.8 mt -84.19 -48.59 9.65 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.596 -0.891 . . . . 75.41 108.596 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.43 179.29 8.26 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.317 -1.31 . . . . 74.01 109.793 175.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.71 130.71 43.11 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.506 -1.224 . . . . 63.11 107.933 172.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 71.12 -5.37 1.55 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 125.145 1.378 . . . . 72.41 112.843 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 86.6 t -119.29 102.52 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.933 0.893 . . . . 61.12 108.714 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -121.68 139.76 53.15 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.447 0.699 . . . . 73.54 109.616 -173.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.462 ' HG3' ' HG3' ' A' ' 29' ' ' PRO . 8.9 tm-20 -106.5 107.48 18.52 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 107.645 -1.243 . . . . 73.43 107.645 -178.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 85.6 t -94.53 126.21 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.163 1.385 . . . . 74.14 110.295 -175.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 13.6 t -112.9 145.88 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.755 -0.831 . . . . 74.41 108.755 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.435 HD11 HD23 ' B' ' 44' ' ' LEU . 41.9 tp -129.44 112.02 13.37 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 108.026 -1.101 . . . . 65.32 108.026 168.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.599 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 11.4 ttm180 -88.56 110.4 20.86 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.923 -0.769 . . . . 72.13 108.923 173.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 24.9 t -105.36 102.77 14.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 107.189 -1.412 . . . . 72.51 107.189 177.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 25.4 m -99.54 134.0 43.05 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.939 -0.763 . . . . 64.2 108.939 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.438 HG23 HD13 ' B' ' 114' ' ' ILE . 40.6 t -120.28 126.16 74.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 123.53 0.732 . . . . 64.42 109.734 174.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 78.6 m -103.54 143.56 32.57 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.964 0.906 . . . . 74.35 109.476 171.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -146.82 135.94 22.55 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.703 0.801 . . . . 73.11 109.648 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.558 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 38.0 p -141.81 134.28 28.17 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 123.373 0.669 . . . . 75.55 110.16 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.461 HD13 ' HB2' ' B' ' 34' ' ' LYS . 26.2 mt -108.85 100.87 10.03 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 123.78 0.832 . . . . 71.21 109.647 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.83 -119.58 6.97 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.505 -0.77 . . . . 74.21 113.385 176.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -95.21 18.12 12.93 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.394 0.677 . . . . 74.53 112.21 -173.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -152.74 155.16 36.67 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.928 0.491 . . . . 73.0 110.562 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 96.7 m -73.12 132.38 43.22 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 116.05 -0.523 . . . . 70.32 110.045 174.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.558 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -82.83 -62.23 1.66 Allowed 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.29 -1.004 . . . . 64.25 108.29 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -158.61 160.31 36.41 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 114.882 -1.053 . . . . 71.2 111.658 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 79.6 mt -128.59 113.06 14.97 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.577 -1.638 . . . . 55.43 106.577 173.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.1 t -115.63 153.37 31.4 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.47 -0.937 . . . . 71.12 108.47 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.603 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.8 tt0 -162.03 126.77 3.34 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.286 -0.635 . . . . 74.24 109.286 -175.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 95.9 t -126.3 145.52 33.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 124.095 0.958 . . . . 74.52 108.773 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -123.47 98.75 5.99 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.199 -1.037 . . . . 70.12 108.199 173.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.484 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 8.1 tp-100 -91.82 101.09 13.68 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.29 -1.004 . . . . 74.41 108.29 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.74 162.7 30.42 Favored Glycine 0 C--O 1.242 0.61 0 N-CA-C 110.9 -0.88 . . . . 73.2 110.9 174.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.74 126.31 1.51 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.821 -0.911 . . . . 35.1 110.821 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 61.0 mt -84.16 129.46 37.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 107.757 -1.201 . . . . 64.41 107.757 174.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -133.04 168.97 17.53 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.498 0.719 . . . . 75.05 109.244 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 73.7 m -126.64 109.53 12.2 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.574 0.75 . . . . 72.21 109.207 170.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -118.74 126.16 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.7 1.2 . . . . 75.33 108.306 -175.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.47 142.97 17.25 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.718 0.407 . . . . 71.22 111.219 -174.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 107.27 -34.44 5.68 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.274 0.359 . . . . 73.12 113.145 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.589 ' HB ' ' HB3' ' B' ' 9' ' ' MET . 0.6 OUTLIER -94.08 160.48 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.751 0.82 . . . . 61.34 110.121 172.668 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -161.26 160.8 30.32 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.065 0.546 . . . . 74.11 111.207 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.73 -128.68 9.14 Favored Glycine 0 C--N 1.353 1.505 0 C-N-CA 123.818 0.723 . . . . 72.43 112.641 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 35.9 m -65.34 -31.2 72.2 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.654 0.782 . . . . 74.22 110.636 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -69.91 -37.92 76.12 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.259 -0.882 . . . . 75.42 111.01 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -28.8 38.0 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.952 -0.388 . . . . 61.24 109.952 177.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.6 -31.86 73.16 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.775 0.83 . . . . 61.14 110.546 172.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -81.92 -37.93 26.06 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.662 1.185 . . . . 71.01 110.466 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.8 t -64.73 -46.64 81.41 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.861 0.464 . . . . 53.24 110.918 -175.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 5.5 mp -96.26 -9.51 30.13 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.72 0.408 . . . . 71.31 111.281 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.98 -15.36 33.7 Favored Glycine 0 N--CA 1.476 1.313 0 N-CA-C 114.008 0.363 . . . . 64.41 114.008 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.56 -61.71 0.89 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.467 0.707 . . . . 70.24 109.856 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -67.03 -55.11 15.77 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.409 0.684 . . . . 73.22 112.59 -168.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.483 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 83.1 m -61.46 -49.95 85.09 Favored Pre-proline 0 CA--C 1.559 1.307 0 CA-C-O 118.362 -0.828 . . . . 64.24 111.78 -177.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 37.7 Cg_exo -61.9 -25.89 78.51 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 122.318 2.012 . . . . 74.32 113.442 174.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -77.02 -25.61 52.82 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.499 0.72 . . . . 75.43 110.927 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.409 HG23 ' NH2' ' D' ' 111' ' ' ARG . 65.2 mt -68.74 -42.86 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.635 0.774 . . . . 64.4 109.529 169.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' B' ' 102' ' ' CYS . 53.6 mt -82.03 -18.76 42.13 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.412 -1.267 . . . . 72.44 111.311 -174.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -57.64 -52.01 77.48 Favored Pre-proline 0 CA--C 1.559 1.306 0 CA-C-O 117.121 -1.419 . . . . 74.41 112.708 -177.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -53.61 -37.86 83.59 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 122.727 2.285 . . . . 64.43 114.477 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -70.34 -44.38 68.28 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.072 0.549 . . . . 73.02 109.871 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -67.18 -32.43 73.51 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 115.351 -0.84 . . . . 62.33 111.591 177.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.414 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 45.3 ttt-85 -70.3 -51.11 32.78 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.985 1.314 . . . . 72.45 109.967 -176.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -35.79 78.52 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 124.324 1.015 . . . . 61.23 108.957 176.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.487 ' O ' ' HG2' ' B' ' 117' ' ' MET . 19.1 t -65.31 -47.71 75.6 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 123.687 0.617 . . . . 41.23 112.432 -177.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.516 ' O ' HG23 ' B' ' 118' ' ' VAL . 75.5 mt -60.33 -54.72 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 108.924 -0.769 . . . . 74.03 108.924 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 45.2 m -58.27 -30.04 66.27 Favored 'General case' 0 CA--C 1.555 1.146 0 O-C-N 124.583 1.177 . . . . 45.22 111.661 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 48.0 t -69.66 -46.15 66.78 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 123.431 0.693 . . . . 73.44 109.194 176.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.561 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 9.4 mmt -70.13 -32.92 71.17 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 123.482 0.489 . . . . 63.2 110.886 -177.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.516 HG23 ' O ' ' B' ' 114' ' ' ILE . 99.4 t -59.96 -47.5 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 124.302 1.041 . . . . 74.51 109.317 171.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.0 t -70.47 -29.73 66.36 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 113.755 -1.566 . . . . 74.23 111.672 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.561 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 92.3 mtt-85 -70.05 -37.01 75.42 Favored 'General case' 0 C--O 1.214 -0.774 0 C-N-CA 123.346 0.658 . . . . 71.12 109.339 176.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.93 8.82 55.85 Favored Glycine 0 C--N 1.353 1.5 0 O-C-N 124.167 0.917 . . . . 71.12 112.863 173.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.462 HG23 ' HB3' ' A' ' 17' ' ' TYR . 76.9 p 55.38 25.32 7.49 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 126.395 1.878 . . . . 74.53 113.62 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -78.39 155.03 79.31 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 123.888 0.875 . . . . 75.34 111.118 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -46.88 143.96 8.77 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.873 3.049 . . . . 74.02 113.707 176.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -58.6 116.19 3.52 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.174 0.99 . . . . 75.14 111.679 -172.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 41.8 tp -121.25 105.08 10.23 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.328 0.651 . . . . 72.44 110.19 -176.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -105.17 126.37 52.01 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 108.913 -0.773 . . . . 50.33 108.913 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.414 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 49.3 mt -74.33 137.85 43.11 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 109.508 -0.552 . . . . 61.34 109.508 175.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.78 136.83 36.29 Favored Pre-proline 0 N--CA 1.479 1.013 0 CA-C-O 119.282 -0.39 . . . . 62.31 110.077 176.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.664 ' HG3' HD13 ' D' ' 16' ' ' ILE . 69.9 Cg_endo -73.94 141.42 30.01 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.334 2.023 . . . . 54.31 111.978 178.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 27.5 m -128.75 131.38 68.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.567 -0.901 . . . . 73.1 108.567 172.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -73.67 95.86 2.4 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.469 -0.567 . . . . 54.2 109.469 174.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -61.93 -43.59 98.54 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.671 -0.863 . . . . 65.22 108.671 171.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 . . . . . 0 CA--C 1.537 0.462 0 CA-C-N 113.603 -1.635 . . . . 55.44 111.704 -179.619 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.475 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.7 t80 . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 121.311 0.577 . . . . 61.41 109.907 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -152.58 137.35 17.03 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.077 -1.453 . . . . 71.32 107.077 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 64.7 mt -79.81 116.42 23.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 108.332 -0.988 . . . . 64.01 108.332 173.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.456 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 9.8 mm100 -80.35 -39.0 29.38 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.214 -0.903 . . . . 62.04 109.72 -173.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -179.8 124.33 0.08 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.983 0.513 . . . . 73.21 109.968 -172.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 91.8 mt -109.61 141.21 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 108.848 -0.797 . . . . 64.32 108.848 173.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.448 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 23.5 p90 -174.79 163.97 3.47 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 123.91 0.756 . . . . 74.34 110.236 -173.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.3 p -90.06 125.74 35.52 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.383 0.673 . . . . 64.43 109.369 173.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.448 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 25.8 mmtp -71.07 -49.45 44.43 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 107.887 -1.153 . . . . 74.4 107.887 168.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.718 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 7.9 t70 -139.44 140.77 37.41 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 113.124 -1.853 . . . . 74.22 109.711 -165.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.506 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 73.8 mt -139.18 147.03 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.899 -1.519 . . . . 72.13 106.899 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.9 t -158.95 151.76 21.99 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.418 0.687 . . . . 73.44 109.871 176.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.413 ' CE1' ' HA3' ' C' ' 121' ' ' GLY . 79.0 t80 -153.93 110.68 3.36 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 107.813 -1.18 . . . . 64.44 107.813 173.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -120.61 110.27 16.23 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.516 0.726 . . . . 53.22 109.557 -173.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.24 87.09 22.73 Favored Pre-proline 0 C--O 1.24 0.6 0 N-CA-C 107.253 -1.388 . . . . 62.03 107.253 170.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.05 -37.2 26.79 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.509 2.139 . . . . 65.02 111.992 -176.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -103.97 28.76 6.41 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.512 0.725 . . . . 63.14 109.999 -175.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.501 ' HA ' HG12 ' C' ' 31' ' ' VAL . . . -47.94 -53.8 29.32 Favored Pre-proline 0 CA--C 1.561 1.372 0 N-CA-C 114.322 1.23 . . . . 75.14 114.322 -169.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.78 -49.61 14.1 Favored 'Trans proline' 0 C--N 1.389 2.702 0 CA-C-N 121.747 1.66 . . . . 74.04 112.788 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.475 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 83.2 t60 -69.82 -28.18 65.48 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.859 -0.609 . . . . 61.52 112.087 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.817 HG21 ' HA ' ' C' ' 73' ' ' ALA . 3.7 p -80.93 -13.8 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 O-C-N 121.27 -0.894 . . . . 75.1 112.123 -177.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -81.75 -14.97 55.76 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 112.694 0.627 . . . . 63.13 112.694 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 18.9 pt20 -92.11 9.25 34.25 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.658 0.383 . . . . 74.24 110.559 171.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.07 145.72 28.38 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.517 0.727 . . . . 73.03 110.439 -174.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -71.21 129.94 40.18 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.2 -0.667 . . . . 72.04 109.2 174.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -76.82 84.92 3.41 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.509 0.724 . . . . 72.4 110.292 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -134.14 63.36 61.37 Favored Pre-proline 0 N--CA 1.478 0.967 0 C-N-CA 124.014 0.926 . . . . 70.34 109.351 173.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 38' ' ' PRO . . . . . 0.42 ' HG2' HG13 ' C' ' 40' ' ' VAL . 92.5 Cg_endo -88.49 159.72 6.6 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.196 1.93 . . . . 73.4 112.855 -172.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -86.44 86.69 7.34 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.011 -1.477 . . . . 74.03 107.011 161.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.42 HG13 ' HG2' ' C' ' 38' ' ' PRO . 15.9 m -65.99 115.03 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 114.411 -1.268 . . . . 73.12 108.593 172.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -127.43 112.35 14.88 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.613 0.765 . . . . 63.53 109.117 -174.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.53 127.68 34.91 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.846 -0.798 . . . . 74.14 108.846 174.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -120.16 135.47 54.96 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.976 1.31 . . . . 74.22 107.91 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.47 ' H ' HD23 ' C' ' 44' ' ' LEU . 1.8 pt? -122.05 125.81 47.07 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.561 0.696 . . . . 71.52 110.627 -177.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.615 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 2.0 t70 -113.78 143.13 45.15 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.575 -1.268 . . . . 73.02 107.575 171.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 62.1 p -112.4 122.38 47.55 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.325 0.65 . . . . 54.34 109.673 -172.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.647 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -115.02 139.85 49.52 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.696 -0.853 . . . . 53.44 108.696 173.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 15.8 m -141.44 143.18 33.75 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.492 0.717 . . . . 72.23 109.677 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 48.3 t -165.8 128.67 2.08 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.082 0.553 . . . . 73.3 109.775 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -82.3 115.67 21.46 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.064 -1.458 . . . . 74.4 107.064 168.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.496 HD11 HD12 ' C' ' 83' ' ' ILE . 31.4 mt -84.94 -33.85 22.59 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.554 0.741 . . . . 73.34 110.438 -173.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.96 -175.73 5.52 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.45 -1.25 . . . . 34.41 109.681 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -65.98 121.45 15.14 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.927 -1.033 . . . . 73.44 108.968 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 69.75 -5.64 1.18 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.348 1.459 . . . . 65.21 113.288 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 93.1 t -110.8 100.48 10.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 123.652 0.781 . . . . 73.13 109.028 -175.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -105.26 166.25 10.54 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.335 -0.848 . . . . 73.44 109.373 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.471 ' HB2' HD11 ' C' ' 51' ' ' LEU . 37.5 tt0 -127.3 129.66 48.09 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 114.673 -1.149 . . . . 73.43 108.986 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 m -120.56 114.81 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.372 -0.973 . . . . 74.34 108.372 168.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.647 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 57.6 t -111.23 130.92 63.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 123.823 0.849 . . . . 75.41 108.717 176.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mp -112.79 116.59 30.31 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.114 -0.698 . . . . 71.15 109.114 176.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.615 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 19.1 ttm-85 -82.18 106.91 14.46 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.164 -1.05 . . . . 65.32 108.164 171.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 26.4 t -99.12 111.37 28.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.548 -1.279 . . . . 64.22 107.548 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 25.9 m -120.45 121.61 38.9 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.917 -0.772 . . . . 54.4 108.917 -172.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.436 HG21 HG21 ' C' ' 114' ' ' ILE . 74.5 t -98.87 114.58 37.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.905 -0.776 . . . . 73.03 108.905 176.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.5 m -101.1 110.25 22.25 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.586 -0.894 . . . . 62.42 108.586 165.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.01 110.56 21.87 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 105.951 -1.87 . . . . 63.15 105.951 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -132.23 126.62 33.93 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.162 0.506 . . . . 73.15 110.782 -177.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 14.1 mt -86.55 40.44 0.89 Allowed 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 125.741 1.616 . . . . 72.05 110.341 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.24 -101.37 2.14 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 111.467 -0.653 . . . . 63.42 111.467 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -88.33 -30.84 19.28 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.186 0.594 . . . . 52.1 109.847 175.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -79.37 121.28 24.94 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.704 0.802 . . . . 54.24 109.585 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.3 m -82.48 126.7 32.54 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.488 -0.93 . . . . 70.41 108.488 167.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.817 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -69.58 -64.4 0.89 Allowed 'General case' 0 C--O 1.238 0.499 0 O-C-N 124.136 0.897 . . . . 75.32 108.792 175.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -155.35 163.13 40.53 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.804 0.811 . . . . 75.4 111.111 173.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -124.16 102.82 7.91 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 105.719 -1.956 . . . . 71.43 105.719 171.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.421 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.1 t -106.76 151.11 25.58 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 107.742 -1.207 . . . . 54.22 107.742 178.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -158.06 135.89 10.6 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 120.608 0.242 . . . . 72.23 110.489 -173.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' C' ' 110' ' ' ALA . 42.6 t -142.25 114.51 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.52 1.128 . . . . 54.2 108.579 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.718 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 47.1 mt-30 -89.22 91.95 8.98 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.473 -0.936 . . . . 71.25 108.473 169.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.476 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 10.2 tp-100 -80.87 114.61 19.87 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.49 -0.777 . . . . 54.42 109.422 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.86 144.43 16.05 Favored Glycine 0 C--N 1.336 0.538 0 O-C-N 123.808 0.692 . . . . 64.24 111.499 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.427 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -141.76 123.02 2.14 Favored Glycine 0 CA--C 1.5 -0.848 0 N-CA-C 109.657 -1.377 . . . . 74.24 109.657 175.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.496 HD12 HD11 ' C' ' 51' ' ' LEU . 14.1 mm -85.81 123.67 39.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.436 -0.949 . . . . 74.34 108.436 176.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.475 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 59.7 m-85 -130.69 134.15 46.69 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.905 -0.776 . . . . 72.33 108.905 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 20.6 p -89.81 140.71 29.33 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 109.528 -0.545 . . . . 74.12 109.528 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 18.1 tt -137.79 139.08 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.815 0.846 . . . . 52.43 109.14 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.25 164.25 22.51 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.387 0.675 . . . . 42.43 109.374 171.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.92 -59.71 2.79 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-N 116.188 -0.46 . . . . 75.34 112.646 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 35.4 pt -91.49 156.26 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.078 0.551 . . . . 73.44 111.204 -173.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -148.78 -176.68 5.43 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.124 0.97 . . . . 72.23 109.385 -177.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.13 -126.42 40.49 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 114.369 0.508 . . . . 32.51 114.369 176.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 38.6 p -79.12 -19.34 51.36 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.617 0.767 . . . . 73.55 111.635 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -62.27 -49.28 76.3 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.784 0.834 . . . . 63.02 109.593 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.418 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 24.3 ptt? -76.15 -28.19 57.31 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 114.665 -1.152 . . . . 74.52 111.006 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.75 -34.17 74.04 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.284 0.633 . . . . 75.21 111.104 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -63.09 -45.1 93.66 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.242 -0.89 . . . . 73.31 110.865 171.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.573 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 47.6 t -66.96 -62.67 1.32 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.763 -0.653 . . . . 65.55 111.084 -174.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' C' ' 94' ' ' MET . 4.2 pp -71.71 -21.57 61.75 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.234 0.614 . . . . 64.13 112.647 -174.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.05 6.67 43.46 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-O 119.445 -0.642 . . . . 73.12 114.312 -173.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -160.37 -59.4 0.06 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.027 0.913 . . . . 73.52 111.686 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.573 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 15.9 t80 -70.89 -36.25 72.66 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 125.385 1.474 . . . . 74.24 113.0 -167.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.509 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 85.3 m -83.31 -44.06 0.84 Allowed Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 123.249 0.62 . . . . 61.31 111.527 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -53.57 -29.99 52.75 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 122.304 2.003 . . . . 74.43 113.34 165.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -60.07 -36.16 76.74 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.5 1.12 . . . . 71.22 111.1 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 35.1 mm -62.92 -36.18 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 CA-C-N 115.257 -0.883 . . . . 55.2 110.245 175.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.427 HD21 ' HA3' ' C' ' 82' ' ' GLY . 81.1 mt -89.73 -21.24 22.78 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.286 1.217 . . . . 75.11 114.286 -166.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 107' ' ' PHE . . . . . 0.404 ' HZ ' ' CE2' ' C' ' 133' ' ' PHE . 34.6 m-85 -55.77 -48.16 97.17 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 113.989 1.107 . . . . 71.31 113.989 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.31 -35.39 84.57 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 122.231 1.954 . . . . 73.52 113.272 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -66.78 -48.78 67.96 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.576 0.751 . . . . 74.42 110.79 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.476 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -66.51 -39.92 88.92 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-N 115.898 -0.592 . . . . 72.13 110.859 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -56.73 -52.36 65.3 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.369 1.043 . . . . 71.31 110.42 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -67.95 -35.52 78.54 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.706 0.629 . . . . 74.54 110.141 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.5 t -70.31 -27.52 64.45 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.955 0.502 . . . . 64.54 111.097 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.436 HG21 HG21 ' C' ' 64' ' ' VAL . 85.6 mt -75.64 -55.41 11.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 109.6 -0.518 . . . . 65.33 109.6 172.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.2 m -66.57 -27.78 68.0 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.955 0.902 . . . . 74.5 111.335 -170.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 46.1 t -63.33 -49.43 73.97 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.655 0.782 . . . . 75.21 109.243 169.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.535 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.86 -34.74 78.61 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.255 1.022 . . . . 73.11 112.214 178.588 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.42 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.8 t -62.55 -46.41 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.556 0.743 . . . . 73.21 109.114 175.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 30.9 t -66.03 -34.72 78.73 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.194 -1.366 . . . . 61.52 111.6 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -68.2 -31.71 71.43 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.503 0.721 . . . . 74.13 110.054 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 121' ' ' GLY . . . . . 0.413 ' HA3' ' CE1' ' C' ' 23' ' ' PHE . . . -90.55 10.42 74.63 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.694 0.621 . . . . 73.43 112.839 173.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.491 HG23 ' HB3' ' D' ' 17' ' ' TYR . 62.6 p 56.71 29.27 15.54 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 126.016 1.726 . . . . 75.55 113.941 175.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -88.17 151.73 49.44 Favored Pre-proline 0 N--CA 1.483 1.181 0 C-N-CA 123.357 0.663 . . . . 64.32 109.475 173.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.56 162.98 11.44 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 123.283 2.655 . . . . 75.41 113.98 175.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -52.73 137.53 31.11 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.836 1.254 . . . . 64.24 113.236 -175.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 35.9 tp -150.43 101.53 2.97 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.122 -0.945 . . . . 71.25 109.094 173.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -108.35 133.22 52.85 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.015 0.926 . . . . 60.01 110.142 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.39 138.66 58.6 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.037 0.935 . . . . 73.04 111.705 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.75 147.03 94.15 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.091 0.956 . . . . 53.11 110.559 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.548 ' HG3' HD12 ' A' ' 16' ' ' ILE . 10.8 Cg_exo -68.26 93.79 0.41 Allowed 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.468 2.112 . . . . 74.45 111.762 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 p -98.56 110.12 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-O 121.304 0.574 . . . . 74.11 109.649 176.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -113.96 104.03 11.75 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 106.879 -1.526 . . . . 73.51 106.879 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 133' ' ' PHE . . . . . 0.404 ' CE2' ' HZ ' ' C' ' 107' ' ' PHE . 55.4 m-85 -55.41 -44.35 76.11 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.106 0.879 . . . . 63.1 112.575 -167.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 N--CA 1.479 0.998 0 O-C-N 123.241 0.338 . . . . 70.52 111.352 -176.578 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 29.9 m . . . . . 0 C--O 1.242 0.683 0 CA-C-O 120.967 0.413 . . . . 71.22 110.204 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -155.85 98.85 1.94 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.608 -1.256 . . . . 75.23 107.608 -177.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 12' ' ' GLN . . . . . 0.51 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 49.6 mt-30 -113.46 118.85 35.65 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.74 -0.837 . . . . 74.41 108.74 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.489 HG21 ' HG2' ' B' ' 130' ' ' PRO . 38.0 mt -67.7 123.82 21.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 122.673 0.389 . . . . 64.12 110.14 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -96.92 -45.43 6.62 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 123.467 0.479 . . . . 71.51 110.358 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -167.55 131.36 1.77 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 119.417 -0.325 . . . . 74.14 110.908 -169.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.664 HD13 ' HG3' ' B' ' 130' ' ' PRO . 3.1 mp -115.28 138.28 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 107.7 -1.222 . . . . 60.04 107.7 169.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.491 ' HB3' HG23 ' C' ' 122' ' ' THR . 41.8 p90 -165.79 176.27 8.08 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 124.293 0.995 . . . . 71.44 111.142 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 18' ' ' THR . . . . . 0.406 HG21 HD11 ' D' ' 21' ' ' ILE . 80.4 p -106.71 122.95 47.38 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.573 -1.194 . . . . 72.2 109.356 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.425 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 32.8 mtpt -94.23 -24.41 17.48 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.675 -0.693 . . . . 64.34 109.753 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.6 t70 -152.52 133.28 13.98 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 114.527 -1.215 . . . . 51.44 108.632 176.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.535 HG21 ' HE2' ' C' ' 117' ' ' MET . 80.6 mt -131.07 147.59 33.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.155 -1.424 . . . . 71.13 107.155 172.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 22' ' ' SER . . . . . 0.54 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 34.6 t -150.49 140.36 21.87 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.789 1.236 . . . . 74.1 107.936 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.506 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.5 t80 -152.84 125.92 8.53 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 105.706 -1.961 . . . . 73.32 105.706 171.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 37.0 mt-10 -137.34 111.63 8.52 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.129 0.572 . . . . 70.13 109.644 -175.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.25 85.38 10.43 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 108.396 -0.965 . . . . 64.12 108.396 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.09 -21.12 12.38 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 122.844 2.362 . . . . 74.11 112.697 -173.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -102.64 0.84 33.83 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.786 0.834 . . . . 75.34 110.675 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -28.66 -64.88 0.16 Allowed Pre-proline 0 CA--C 1.565 1.529 0 N-CA-C 116.392 1.997 . . . . 71.32 116.392 -158.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.46 -22.41 10.83 Favored 'Trans proline' 0 C--N 1.383 2.391 0 CA-C-N 123.091 2.14 . . . . 65.01 113.907 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -69.05 -42.67 75.97 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.266 1.027 . . . . 54.42 109.75 174.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.2 p -83.17 -19.88 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 CA-C-N 115.829 -0.623 . . . . 71.43 111.404 -172.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -63.36 -26.49 68.78 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 112.454 0.539 . . . . 75.21 112.454 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -58.69 -20.59 49.86 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.627 0.771 . . . . 72.23 110.784 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.44 ' NZ ' ' HB3' ' D' ' 71' ' ' GLU . 92.2 mttt -90.52 87.39 6.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.277 1.031 . . . . 54.34 108.63 166.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -97.17 82.13 3.14 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.383 0.611 . . . . 74.14 110.15 -173.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 38.9 p90 -156.94 -174.21 4.82 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.736 1.214 . . . . 75.42 108.691 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -69.13 114.46 23.63 Favored Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 123.976 0.91 . . . . 72.33 111.108 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.59 127.99 18.25 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.553 2.169 . . . . 74.52 111.847 171.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -75.66 134.99 40.45 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.304 -0.628 . . . . 74.33 109.304 177.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.578 HG13 HG13 ' D' ' 64' ' ' VAL . 74.1 t -102.23 132.81 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.889 0.876 . . . . 65.03 111.306 -174.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.459 ' HB2' ' OG1' ' D' ' 65' ' ' THR . 74.6 mmtt -98.2 130.38 44.94 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.915 -1.143 . . . . 72.53 107.915 168.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -96.69 126.08 41.6 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.544 0.738 . . . . 74.3 109.403 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.808 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 22.4 m-20 -127.66 142.85 51.23 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.136 0.974 . . . . 72.21 108.402 171.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 89.9 mt -129.69 143.26 50.74 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.588 0.755 . . . . 53.43 109.998 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 9.9 t70 -141.36 144.76 34.72 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.209 1.004 . . . . 54.42 108.53 175.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 35.9 p -104.26 143.53 32.83 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.532 0.733 . . . . 52.24 111.327 -173.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.656 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.92 141.74 22.83 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.898 0.879 . . . . 70.11 108.771 171.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.1 p -166.42 154.27 10.07 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.92 0.488 . . . . 61.11 109.795 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 60.2 p -164.04 142.56 7.45 Favored 'General case' 0 C--O 1.24 0.558 0 O-C-N 123.877 0.736 . . . . 64.43 110.224 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -76.36 126.02 30.24 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.104 -0.702 . . . . 54.11 109.104 168.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 73.9 mt -97.45 -30.73 12.74 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.25 0.62 . . . . 64.12 110.55 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.23 -175.06 2.81 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.693 0.797 . . . . 71.54 110.53 177.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -61.9 116.44 4.87 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.821 -1.081 . . . . 73.22 110.087 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 64.41 9.86 5.29 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.926 1.29 . . . . 63.32 112.48 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.7 t -109.73 114.98 48.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 108.157 -1.053 . . . . 73.34 108.157 173.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.483 ' HB2' HD12 ' D' ' 86' ' ' ILE . 72.7 m-85 -134.69 133.08 39.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.509 -0.923 . . . . 73.53 108.509 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -104.55 136.86 43.31 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.844 0.858 . . . . 72.43 109.322 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 38.2 t -121.69 129.21 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 107.737 -1.209 . . . . 64.13 107.737 174.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.656 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 20.4 t -121.56 132.07 71.59 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 C-N-CA 124.221 1.008 . . . . 71.04 108.674 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.59 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 3.9 mm? -119.09 120.2 36.47 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.305 0.642 . . . . 75.32 109.767 176.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.577 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 18.9 ttm-85 -88.67 101.25 13.8 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.404 -0.816 . . . . 71.14 108.82 173.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 55.1 t -90.99 126.37 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 107.574 -1.269 . . . . 52.25 107.574 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.808 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 9.3 m -122.57 125.7 46.23 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.761 0.791 . . . . 71.34 109.983 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.578 HG13 HG13 ' D' ' 40' ' ' VAL . 25.3 t -111.09 99.43 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.959 1.704 . . . . 72.44 108.137 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.47 HG22 HD22 ' D' ' 75' ' ' LEU . 1.8 p -99.64 94.98 6.66 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 107.887 -1.153 . . . . 73.31 107.887 174.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.23 155.62 16.66 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.935 -1.03 . . . . 42.52 111.141 -170.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.49 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.5 p -153.58 132.45 12.41 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.713 -0.676 . . . . 64.11 111.932 -176.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.521 HD12 HG22 ' D' ' 31' ' ' VAL . 24.9 mt -93.74 99.18 11.63 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 124.893 1.277 . . . . 50.14 108.856 172.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.37 -119.86 7.4 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.129 -0.941 . . . . 74.22 112.015 -174.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.77 5.4 49.22 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.428 1.091 . . . . 60.51 111.241 -177.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 71' ' ' GLU . . . . . 0.44 ' HB3' ' NZ ' ' D' ' 34' ' ' LYS . 5.5 tp10 -129.08 139.72 51.88 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.063 0.945 . . . . 63.41 109.513 -169.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.4 m -61.55 128.59 37.02 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.809 0.843 . . . . 73.25 111.471 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.527 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -83.95 -70.42 0.57 Allowed 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.838 -1.171 . . . . 73.24 107.838 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -146.33 166.74 25.41 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.623 -1.171 . . . . 70.1 109.025 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.47 HD22 HG22 ' D' ' 65' ' ' THR . 48.2 mt -116.24 151.17 36.3 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 105.842 -1.91 . . . . 72.34 105.842 171.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.48 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 50.3 t -157.1 140.23 15.44 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.247 -1.02 . . . . 71.42 108.247 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 77' ' ' GLU . . . . . 0.54 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 36.7 tt0 -156.75 131.11 8.61 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 122.853 0.461 . . . . 72.52 109.839 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -136.81 118.55 19.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 123.337 0.655 . . . . 65.13 109.742 -177.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.513 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.2 mt-30 -86.41 87.13 7.37 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.811 -1.181 . . . . 74.23 107.811 166.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 80' ' ' GLN . . . . . 0.442 ' O ' HD13 ' D' ' 106' ' ' LEU . 8.5 tp-100 -79.9 105.2 11.01 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.279 -1.328 . . . . 70.23 107.698 176.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -110.45 143.69 16.96 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.854 -0.498 . . . . 74.22 111.854 -177.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.49 131.43 5.51 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 111.371 -0.691 . . . . 63.32 111.371 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 60.4 mt -89.32 128.42 41.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 C-N-CA 124.497 1.119 . . . . 74.32 107.985 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -136.79 145.66 44.8 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.883 0.373 . . . . 73.42 110.876 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.51 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 16.6 m -78.04 99.47 6.11 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.274 -1.009 . . . . 63.13 108.274 166.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.483 HD12 ' HB2' ' D' ' 56' ' ' TYR . 66.1 mt -107.22 108.6 25.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 123.867 0.867 . . . . 72.05 108.845 -175.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.52 163.77 34.67 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.545 1.138 . . . . 64.41 109.786 -175.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.71 20.82 79.82 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.693 -0.685 . . . . 72.24 114.373 173.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 6.0 mt -104.6 156.88 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 117.374 0.587 . . . . 70.53 110.386 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -140.22 147.62 40.3 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.431 1.092 . . . . 70.21 111.118 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.84 -136.11 48.93 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 115.216 0.847 . . . . 43.42 115.216 169.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 16.0 m -85.67 -9.17 57.63 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.911 0.885 . . . . 62.22 111.554 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.05 -31.1 39.62 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.673 -0.862 . . . . 45.03 108.673 166.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 51.9 mtt -57.32 -55.24 37.31 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.975 0.91 . . . . 73.34 111.357 172.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.3 -29.66 70.94 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.417 0.687 . . . . 65.15 111.516 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -72.4 -40.71 66.98 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.06 0.944 . . . . 63.15 111.139 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.0 t -64.18 -49.56 71.57 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.364 0.666 . . . . 62.51 109.916 -176.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 34.0 mt -75.53 -26.94 58.46 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.275 -1.329 . . . . 74.32 110.914 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.01 -2.5 58.2 Favored Glycine 0 C--N 1.352 1.461 0 CA-C-O 119.368 -0.685 . . . . 63.25 114.399 -176.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.71 -58.98 0.57 Allowed 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 117.905 0.853 . . . . 51.25 111.338 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -71.11 -38.22 72.34 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 111.841 0.311 . . . . 61.31 111.841 -170.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 62.2 m -72.8 -47.98 8.61 Favored Pre-proline 0 CA--C 1.559 1.316 0 CA-C-O 118.576 -0.726 . . . . 63.34 111.776 -177.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.59 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 17.1 Cg_endo -61.5 -22.59 74.88 Favored 'Trans proline' 0 C--N 1.401 3.31 0 C-N-CA 122.27 1.98 . . . . 74.42 112.875 170.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -66.96 -37.46 84.31 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.223 0.609 . . . . 73.25 110.266 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 48.9 mm -71.08 -39.14 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.501 0.72 . . . . 65.11 110.333 175.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.442 HD13 ' O ' ' D' ' 80' ' ' GLN . 86.7 mt -79.28 -18.64 52.29 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.33 -0.85 . . . . 64.1 111.876 -177.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -61.21 -50.1 85.4 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-O 117.87 -1.062 . . . . 72.22 113.487 -175.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.78 -38.99 93.74 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 122.116 1.877 . . . . 42.24 112.667 178.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -78.17 -36.96 46.9 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.087 0.955 . . . . 60.41 112.26 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.79 73.84 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.046 0.539 . . . . 75.35 109.952 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.584 HH12 ' HG3' ' D' ' 130' ' ' PRO . 40.1 ttp180 -57.27 -51.48 69.17 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 124.164 0.915 . . . . 75.13 110.097 174.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -62.54 -43.82 97.87 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.719 0.807 . . . . 73.23 111.729 -174.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.8 t -58.78 -45.51 89.67 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.809 0.693 . . . . 62.51 110.779 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.463 ' O ' HG23 ' D' ' 118' ' ' VAL . 97.5 mt -62.55 -55.14 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.883 -1.053 . . . . 72.4 110.586 174.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 43.5 m -53.24 -40.06 64.29 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.849 1.26 . . . . 71.1 111.449 -174.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.4 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.0 t -66.36 -45.15 81.09 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.729 -1.123 . . . . 65.01 110.439 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.1 mtm -70.01 -28.54 65.58 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.781 0.432 . . . . 64.51 112.08 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.463 HG23 ' O ' ' D' ' 114' ' ' ILE . 96.0 t -64.85 -44.86 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.395 0.678 . . . . 74.55 109.633 174.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.8 p -77.3 -25.42 51.26 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 115.444 -0.798 . . . . 73.44 111.007 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' D' ' 116' ' ' SER . 91.0 mtt-85 -72.69 -35.22 67.59 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.438 0.695 . . . . 62.51 109.538 173.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.48 -0.14 86.42 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 115.644 -0.707 . . . . 64.42 112.122 171.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 42.6 p 62.97 22.02 13.22 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.938 2.095 . . . . 62.03 113.972 174.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -82.23 152.07 67.26 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 123.545 0.738 . . . . 75.42 109.286 169.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -49.59 132.2 29.91 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.372 2.715 . . . . 74.24 113.934 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -51.43 141.02 16.4 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.651 1.58 . . . . 63.25 113.002 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 62.5 tp -114.48 109.58 18.51 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.224 1.01 . . . . 74.5 109.577 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -113.62 97.14 6.25 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.645 -0.872 . . . . 75.41 108.645 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 20.1 tp -70.85 126.59 29.99 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 110.008 -0.367 . . . . 55.41 110.008 177.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -62.09 130.26 92.67 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.079 0.952 . . . . 72.11 110.676 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.584 ' HG3' HH12 ' D' ' 111' ' ' ARG . 2.4 Cg_endo -79.74 106.02 1.91 Allowed 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.657 2.238 . . . . 62.33 110.181 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 109.281 -0.637 . . . . 73.1 109.281 -178.783 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.699 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 8.4 t80 . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 120.26 0.076 . . . . 70.34 110.917 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -147.16 108.84 4.35 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.788 0.835 . . . . 73.11 109.412 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.61 HG12 ' HD2' ' A' ' 84' ' ' PHE . 66.7 mt -78.61 124.04 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 109.494 -0.558 . . . . 62.21 109.494 176.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -84.69 -40.05 17.83 Favored 'General case' 0 C--O 1.241 0.639 0 O-C-N 124.192 0.933 . . . . 62.53 110.667 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.417 ' HB3' HD12 ' A' ' 83' ' ' ILE . 23.7 ttt180 -173.35 137.41 0.66 Allowed 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.526 0.516 . . . . 61.34 110.179 -172.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.436 HD11 HD13 ' A' ' 13' ' ' ILE . 83.5 mt -126.2 138.81 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.321 -0.992 . . . . 73.42 108.321 174.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.481 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 21.1 p90 -168.25 168.85 11.26 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.627 0.727 . . . . 73.04 111.599 -173.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -94.52 120.37 34.64 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.104 -0.953 . . . . 60.31 109.143 176.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 38.2 mtpt -91.34 -30.24 16.67 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.891 0.376 . . . . 74.35 110.635 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 18.8 t70 -148.34 134.39 19.23 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.229 -0.896 . . . . 73.24 109.141 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.411 HG23 ' SD ' ' A' ' 117' ' ' MET . 60.0 mt -132.17 139.31 50.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.061 -1.459 . . . . 60.33 107.061 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.1 t -146.49 122.15 10.49 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.693 -0.854 . . . . 61.4 108.693 173.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.468 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 93.5 t80 -126.0 129.56 49.45 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.699 -1.593 . . . . 73.34 106.699 171.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -139.74 119.31 13.12 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.676 -0.861 . . . . 74.33 108.676 -178.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.38 83.53 8.58 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 106.987 -1.486 . . . . 63.54 106.987 173.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.93 -30.24 67.22 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.916 2.41 . . . . 75.12 112.637 -167.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -117.47 26.45 9.72 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 124.145 0.978 . . . . 72.13 109.45 -174.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.565 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -45.62 -56.34 10.14 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 114.116 1.154 . . . . 74.34 114.116 -169.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 22.3 Cg_exo -64.16 -19.9 66.57 Favored 'Trans proline' 0 C--N 1.385 2.486 0 CA-C-N 121.62 1.614 . . . . 65.53 113.392 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -90.15 -38.19 13.67 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.235 1.014 . . . . 72.25 110.551 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.578 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.1 p -77.13 -21.19 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 115.246 -0.888 . . . . 70.45 112.185 -159.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -71.45 -24.62 62.05 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.013 -0.54 . . . . 74.34 110.841 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -76.0 -27.53 57.44 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.108 0.963 . . . . 74.13 110.297 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -71.18 148.9 46.86 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.081 0.952 . . . . 72.11 110.866 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.15 124.55 23.4 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.117 0.967 . . . . 71.53 109.333 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -82.04 79.4 8.56 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.704 0.764 . . . . 64.3 110.826 -176.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -132.53 77.15 70.43 Favored Pre-proline 0 C--O 1.245 0.846 0 N-CA-C 106.584 -1.635 . . . . 72.51 106.584 169.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -85.41 154.57 10.67 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 121.986 1.79 . . . . 60.11 112.848 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -94.99 83.79 4.01 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 105.355 -2.091 . . . . 75.44 105.355 161.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.598 HG21 HD11 ' A' ' 126' ' ' LEU . 2.8 p -76.48 92.17 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-O 122.575 1.179 . . . . 74.04 108.15 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -87.01 115.33 24.32 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.214 -1.357 . . . . 71.43 109.363 -175.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.575 HD23 HD22 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -95.45 151.75 19.02 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.44 0.638 . . . . 74.24 110.282 177.24 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.607 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 13.4 t70 -145.38 150.57 36.8 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.603 -1.258 . . . . 73.42 107.603 -177.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.493 ' HB2' HD21 ' A' ' 60' ' ' LEU . 2.4 pt? -136.96 130.63 31.83 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.091 0.472 . . . . 70.13 110.44 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 13.7 t70 -122.94 151.08 42.14 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.46 1.104 . . . . 65.14 109.71 -178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.0 p -106.71 127.71 53.6 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.379 -0.828 . . . . 71.31 110.923 -172.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.659 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -134.97 137.48 43.09 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.817 0.847 . . . . 54.32 109.019 172.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.0 p -132.12 163.08 29.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.941 0.496 . . . . 73.33 110.756 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.555 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 35.4 t -161.44 153.11 19.15 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.971 0.908 . . . . 64.32 109.82 176.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -113.58 120.18 40.04 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.433 -0.951 . . . . 75.31 108.433 167.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 52.8 mt -94.35 -32.15 13.72 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.988 0.515 . . . . 72.31 110.265 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.464 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -164.45 -177.11 4.69 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.372 1.069 . . . . 53.11 109.344 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -71.94 130.53 41.21 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.224 -0.658 . . . . 74.42 109.224 174.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 85' ' ' SER . 35.7 m-20 66.15 -2.08 1.04 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.495 1.118 . . . . 73.11 112.657 -174.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 65.5 t -116.45 107.61 22.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.637 0 N-CA-C 108.53 -0.915 . . . . 65.35 108.53 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -126.31 155.89 41.28 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.871 -0.789 . . . . 72.15 108.871 -174.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 35.5 tt0 -117.93 122.75 44.09 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 123.255 0.622 . . . . 73.44 109.424 175.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.2 t -105.48 122.35 58.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 107.017 -1.475 . . . . 63.22 107.017 170.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 47.5 t -114.98 129.44 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.453 -0.943 . . . . 62.53 108.453 176.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.493 HD21 ' HB2' ' A' ' 44' ' ' LEU . 1.4 tt -119.8 112.44 19.24 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.978 -0.749 . . . . 73.33 108.978 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 18.8 ttt180 -86.94 100.64 12.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.18 0.992 . . . . 71.34 109.354 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.8 t -95.46 104.74 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 109.117 -0.697 . . . . 74.32 109.117 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 25.5 m -96.08 106.79 19.01 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.6 0.76 . . . . 64.14 109.515 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.8 t -105.19 108.54 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.876 0.871 . . . . 64.34 109.818 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.2 m -102.23 142.96 32.64 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.827 -1.175 . . . . 71.53 107.827 174.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.01 120.64 35.99 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.334 -1.358 . . . . 62.02 107.334 170.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.2 m -117.64 124.36 48.4 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.736 -0.468 . . . . 72.13 109.736 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.534 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 94.0 mt -88.67 85.53 6.82 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.118 -1.067 . . . . 63.44 108.118 173.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.1 -93.87 1.44 Allowed Glycine 0 C--N 1.343 0.951 0 CA-C-N 114.845 -1.071 . . . . 74.21 111.276 -175.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -119.24 -20.54 7.91 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.503 0.721 . . . . 70.24 110.795 176.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.91 134.15 35.09 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.473 0.709 . . . . 73.15 109.364 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.1 m -73.41 126.62 30.6 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.298 0.499 . . . . 74.41 110.269 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.578 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.35 -58.77 3.08 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.628 0.771 . . . . 52.21 109.543 172.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.431 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 26.2 p90 -158.79 176.08 12.8 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.76 -1.109 . . . . 60.02 111.064 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.1 tp -138.06 142.44 40.29 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.904 1.282 . . . . 74.23 108.144 173.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.468 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 59.6 m -142.43 95.44 2.79 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.001 -1.111 . . . . 74.35 108.001 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -112.41 115.95 29.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.64 0.776 . . . . 75.21 108.937 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.5 t -126.96 117.4 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.637 0.775 . . . . 73.23 110.068 -176.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 75.5 mt-30 -84.61 96.1 9.08 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.246 -1.02 . . . . 73.15 108.246 168.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.413 ' HG3' HD22 ' A' ' 106' ' ' LEU . 67.9 tp60 -82.79 103.6 12.4 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.009 -0.737 . . . . 75.32 109.009 177.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.81 146.08 20.4 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.33 -0.708 . . . . 34.5 111.33 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.445 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.23 121.02 1.16 Allowed Glycine 0 CA--C 1.505 -0.59 0 N-CA-C 111.031 -0.827 . . . . 42.42 111.031 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.417 HD12 ' HB3' ' A' ' 15' ' ' ARG . 34.7 mt -83.03 120.43 34.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 108.814 -0.809 . . . . 73.31 108.814 173.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.699 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 26.6 m-85 -130.1 124.29 32.42 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 109.358 -0.608 . . . . 74.12 109.358 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 73.9 m -86.6 98.34 11.04 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.535 -0.542 . . . . 61.35 109.535 168.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 28.6 pt . . . . . 0 N--CA 1.473 0.687 0 CA-C-N 115.187 -0.915 . . . . 72.25 109.286 177.911 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.865 0.364 . . . . 61.23 111.105 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -69.11 -35.36 76.35 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.471 -0.786 . . . . 75.54 110.975 174.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 78.8 m -69.37 -63.51 1.05 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 122.865 0.466 . . . . 64.23 111.201 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 pp -73.94 -14.05 60.99 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.03 0.532 . . . . 75.34 112.429 -177.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.45 -12.85 29.84 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-O 119.528 -0.595 . . . . 74.41 114.193 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.43 -57.9 0.49 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 117.773 0.786 . . . . 61.11 112.044 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.401 ' HE2' ' CD1' ' A' ' 11' ' ' PHE . 62.6 t80 -63.59 -58.74 6.0 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.294 1.038 . . . . 72.13 112.191 -169.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.2 m -70.86 -35.79 4.65 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 113.189 0.811 . . . . 62.01 113.189 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.87 -41.72 54.4 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 122.447 2.098 . . . . 74.53 113.497 162.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.48 -23.54 61.83 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.895 0.878 . . . . 73.13 110.5 -176.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -67.03 -39.77 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 123.094 0.558 . . . . 74.52 110.027 173.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.445 HD21 ' HA3' ' A' ' 82' ' ' GLY . 93.9 mt -76.48 -26.71 55.64 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.663 0.785 . . . . 41.04 112.507 -175.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -63.89 -44.12 77.95 Favored Pre-proline 0 CA--C 1.564 1.483 0 N-CA-C 114.003 1.112 . . . . 62.52 114.003 -171.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.33 -33.85 79.08 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 121.88 1.72 . . . . 75.12 113.205 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -75.66 -37.92 59.23 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.463 0.705 . . . . 75.51 111.929 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.58 -39.19 70.72 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.842 -0.429 . . . . 55.34 109.842 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.508 ' NH1' HD12 ' C' ' 105' ' ' ILE . 33.4 ttm180 -61.96 -38.28 87.91 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 124.06 0.85 . . . . 72.34 109.62 172.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.515 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 2.9 tm-20 -65.95 -48.34 71.65 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.854 0.862 . . . . 72.33 111.071 -177.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 34.4 t -60.31 -44.77 95.12 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 124.273 0.983 . . . . 71.11 110.231 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 82.9 mt -66.47 -43.5 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.909 0.883 . . . . 64.33 111.149 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.1 m -59.81 -40.37 88.19 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.816 0.846 . . . . 52.34 110.606 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.7 t -72.22 -43.69 64.04 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.219 -0.901 . . . . 64.25 110.696 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.411 ' SD ' HG23 ' A' ' 21' ' ' ILE . 18.8 mtp -60.35 -40.28 90.19 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.466 0.706 . . . . 73.31 111.661 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.529 HG13 ' HB2' ' A' ' 123' ' ' PHE . 48.6 t -66.99 -45.07 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.98 0.912 . . . . 70.25 110.848 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.6 p -71.7 -30.81 66.08 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 120.73 0.3 . . . . 45.44 111.003 -176.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -70.05 -33.73 72.32 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.655 0.782 . . . . 73.14 109.591 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.7 11.97 43.72 Favored Glycine 0 C--N 1.356 1.653 0 O-C-N 123.88 0.738 . . . . 75.41 113.053 173.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.54 HG21 ' HE ' ' B' ' 15' ' ' ARG . 3.4 t 61.56 18.18 9.24 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 127.348 2.259 . . . . 74.32 113.819 172.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.529 ' HB2' HG13 ' A' ' 118' ' ' VAL . 90.3 m-85 -84.84 147.44 48.53 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 107.296 -1.372 . . . . 75.1 107.296 170.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.47 171.85 7.51 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.236 1.957 . . . . 75.15 112.156 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.574 ' HG2' ' H ' ' C' ' 16' ' ' ILE . 67.3 tp60 -53.31 124.45 14.71 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.035 0.934 . . . . 75.23 112.065 -172.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.598 HD11 HG21 ' A' ' 40' ' ' VAL . 57.4 tp -116.9 118.3 32.09 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.39 -0.823 . . . . 72.1 108.945 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -123.65 115.77 21.99 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.755 0.822 . . . . 75.53 111.182 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.575 HD22 HD23 ' A' ' 42' ' ' LEU . 71.1 mt -74.4 121.98 22.26 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.789 -0.819 . . . . 72.42 108.789 167.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.17 130.21 94.28 Favored Pre-proline 0 CA--C 1.555 1.159 0 N-CA-C 110.106 -0.331 . . . . 71.31 110.106 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.56 119.35 6.36 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.785 2.324 . . . . 70.05 111.872 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.2 p -101.97 125.24 56.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 114.97 -1.013 . . . . 50.12 109.982 -176.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -102.66 98.09 8.18 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.616 -0.883 . . . . 73.51 108.616 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 123.309 0.644 . . . . 73.4 110.366 178.4 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 122.029 0.919 . . . . 63.41 111.962 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 86.0 m -141.94 126.79 18.17 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 105.921 -1.881 . . . . 64.54 105.921 167.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -143.28 140.47 30.63 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.202 0.456 . . . . 74.3 110.337 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -150.39 139.53 21.15 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.552 0.741 . . . . 51.32 109.401 173.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 25.7 mt -82.8 124.81 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.194 -1.039 . . . . 65.43 108.194 169.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -93.81 -38.12 11.41 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.074 -0.713 . . . . 64.23 109.074 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.54 ' HE ' HG21 ' A' ' 122' ' ' THR . 32.4 ttt180 -169.9 151.64 4.19 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.252 0.621 . . . . 73.31 110.218 -177.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.7 mt -132.95 140.97 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.364 -1.347 . . . . 72.51 107.364 174.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -169.72 157.23 6.84 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.61 0.719 . . . . 74.53 112.515 -175.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 87.6 m -82.08 127.5 33.18 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.682 -1.144 . . . . 60.11 108.561 170.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.565 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 40.4 mtpt -98.39 -35.77 10.19 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.452 0.701 . . . . 54.44 110.39 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.547 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 13.1 t70 -150.81 137.72 19.1 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.72 -0.673 . . . . 71.53 110.954 -167.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.424 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.5 mm -137.92 143.83 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.088 1.355 . . . . 70.23 108.461 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 44.2 t -149.44 114.99 5.57 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.525 -1.287 . . . . 70.13 107.525 174.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -132.38 110.81 10.82 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.235 -1.024 . . . . 72.31 108.235 173.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -117.48 137.51 52.49 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.527 0.731 . . . . 64.41 109.363 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.893 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -117.24 84.3 17.23 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 106.489 -1.671 . . . . 72.31 106.489 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -63.83 -48.35 5.51 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.829 2.352 . . . . 43.0 112.275 -167.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -104.62 20.13 19.16 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.392 -0.822 . . . . 74.43 110.828 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.893 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -43.78 -59.51 3.46 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 115.56 1.689 . . . . 72.13 115.56 -168.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.466 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 38.2 Cg_exo -58.75 -31.04 94.23 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 122.657 2.238 . . . . 61.11 113.121 -170.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -96.8 -37.19 10.37 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.173 -0.921 . . . . 74.31 111.6 -176.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.486 HG22 HD12 ' B' ' 68' ' ' LEU . 4.0 p -65.45 -20.3 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 123.214 0.606 . . . . 72.12 111.352 -172.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -61.94 -18.47 60.45 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.102 0.961 . . . . 73.52 113.421 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -62.82 -30.78 71.75 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.261 0.553 . . . . 61.42 110.205 176.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -87.71 80.77 7.83 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.45 1.1 . . . . 73.04 109.709 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -84.38 90.42 7.58 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.186 0.517 . . . . 72.11 110.143 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 27.5 p90 -158.73 172.38 18.36 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.711 1.204 . . . . 74.4 108.298 167.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -75.59 110.45 10.63 Favored Pre-proline 0 N--CA 1.477 0.895 0 N-CA-C 109.263 -0.643 . . . . 74.11 109.263 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.14 159.7 51.96 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.23 1.953 . . . . 72.21 112.653 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.44 112.19 3.01 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.685 0.615 . . . . 70.33 109.353 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 48.0 t -85.94 119.95 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.587 -0.894 . . . . 64.15 108.587 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.54 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 24.3 mtpp -119.45 98.56 6.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.332 -1.358 . . . . 71.24 107.332 177.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 pp -94.3 158.07 15.75 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.808 -0.633 . . . . 73.03 110.457 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -162.8 119.44 1.91 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.468 -0.567 . . . . 61.31 109.468 -175.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.582 HD23 HD11 ' B' ' 60' ' ' LEU . 5.2 mp -100.61 143.83 30.31 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.766 0.426 . . . . 72.22 110.1 -178.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -125.2 151.21 46.15 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.128 0.971 . . . . 74.23 109.409 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.1 p -109.02 133.78 52.54 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.338 0.655 . . . . 54.0 110.919 -170.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.627 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -148.65 148.83 30.54 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.617 0.767 . . . . 52.12 109.243 170.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.8 m -146.76 177.21 9.27 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.455 0.702 . . . . 71.11 109.951 172.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 1.4 m -151.55 138.63 19.16 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.681 0.792 . . . . 74.23 108.934 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -92.33 108.99 20.37 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.381 -1.34 . . . . 72.12 107.381 165.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.426 HD11 ' HB2' ' B' ' 57' ' ' GLU . 21.7 mt -83.77 -56.08 3.9 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.131 0.491 . . . . 63.22 109.797 -176.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.09 -170.22 2.74 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.197 -0.91 . . . . 53.51 109.257 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.45 109.94 4.47 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 114.75 -1.114 . . . . 55.34 109.542 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 70.45 2.63 4.14 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 125.081 1.352 . . . . 71.41 113.232 -177.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 78.3 t -105.74 123.08 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 108.435 -0.95 . . . . 72.35 108.435 173.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.429 ' HE2' ' HB3' ' B' ' 98' ' ' LEU . 4.9 p90 -133.37 175.35 9.49 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.142 0.977 . . . . 64.3 108.739 -176.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.426 ' HB2' HD11 ' B' ' 51' ' ' LEU . 12.0 tm-20 -145.4 116.0 7.66 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.806 -0.813 . . . . 71.32 108.806 -175.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 60.2 t -97.91 132.3 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.188 0.595 . . . . 53.2 109.989 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.627 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 20.7 t -115.96 119.06 60.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 124.339 1.056 . . . . 65.34 108.931 176.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.582 HD11 HD23 ' B' ' 44' ' ' LEU . 50.5 tp -106.49 112.44 25.44 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.428 -0.582 . . . . 61.15 109.428 170.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.532 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 31.2 ttm180 -85.52 132.43 34.2 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.708 -0.849 . . . . 73.44 108.708 170.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 17.5 t -126.22 120.96 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 107.819 -1.178 . . . . 60.0 107.819 172.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 9.0 m -114.08 152.54 30.91 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.702 0.801 . . . . 70.4 109.265 -176.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.472 HG21 HG21 ' B' ' 114' ' ' ILE . 97.2 t -139.6 103.62 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.682 1.193 . . . . 53.41 108.559 -175.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 97.4 m -83.08 140.24 32.77 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.29 -1.004 . . . . 62.31 108.29 162.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.03 137.49 23.57 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.092 -0.707 . . . . 74.23 109.092 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.497 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 36.8 p -144.06 128.73 18.2 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 123.614 0.571 . . . . 65.14 111.584 -174.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.486 HD12 HG22 ' B' ' 31' ' ' VAL . 61.2 mt -95.91 101.41 13.09 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.97 -1.122 . . . . 65.34 107.97 174.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.0 -112.69 3.5 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 116.049 -0.523 . . . . 64.12 112.546 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.71 21.47 11.48 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.034 0.934 . . . . 63.32 111.285 -176.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -137.96 151.63 48.13 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.05 0.54 . . . . 74.24 110.007 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 86.9 m -72.11 118.11 14.58 Favored 'General case' 0 C--O 1.241 0.629 0 O-C-N 123.391 0.432 . . . . 75.1 110.777 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.497 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -71.59 -62.25 1.48 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.228 -0.896 . . . . 75.11 108.738 172.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -152.08 164.73 36.66 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.079 0.942 . . . . 75.35 112.214 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 91.0 mt -132.69 114.02 13.68 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 106.043 -1.836 . . . . 75.42 106.043 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.403 ' SG ' HG23 ' B' ' 114' ' ' ILE . 46.7 t -116.36 151.28 36.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.568 -0.901 . . . . 62.51 108.568 178.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -163.42 126.84 2.73 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.42 -0.585 . . . . 75.24 109.42 -175.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 64.4 t -123.63 153.84 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 123.698 0.799 . . . . 74.13 109.117 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.547 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 20.9 mt-30 -127.91 103.54 7.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.235 -1.024 . . . . 65.21 108.235 166.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -91.21 102.29 15.01 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.979 -0.748 . . . . 52.14 108.979 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.439 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.19 164.39 28.39 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.522 -0.763 . . . . 75.53 111.666 174.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.77 127.75 1.72 Allowed Glycine 0 CA--C 1.504 -0.638 0 N-CA-C 111.413 -0.675 . . . . 55.11 111.413 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 66.4 mt -84.21 127.93 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.056 -1.09 . . . . 74.13 108.056 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -134.29 164.12 28.11 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.404 1.082 . . . . 75.34 109.136 -176.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.6 m -132.26 133.32 43.97 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.624 0.769 . . . . 55.01 109.454 175.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' B' ' 10' ' ' THR . 9.5 tt -135.53 146.36 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.837 0.855 . . . . 75.42 109.045 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.99 152.45 33.55 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.319 0.248 . . . . 73.12 110.433 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.91 -32.9 5.53 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.581 -0.736 . . . . 44.14 112.563 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 46.6 mm -92.89 153.34 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.183 0.993 . . . . 74.44 111.756 -175.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.06 -172.0 3.28 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.664 1.186 . . . . 72.13 110.342 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.21 -133.44 52.35 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 114.935 0.734 . . . . 73.23 114.935 175.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.6 m -65.66 -37.75 87.39 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.545 0.738 . . . . 70.21 111.231 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -75.46 -20.82 58.58 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.513 -0.767 . . . . 75.2 110.741 -172.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 57.3 ttm -64.87 -45.11 87.37 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.425 -0.583 . . . . 75.5 109.425 168.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.02 -30.67 71.67 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.958 0.903 . . . . 52.2 111.168 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -69.94 -35.84 74.83 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.827 0.851 . . . . 75.55 110.995 176.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.434 ' SG ' HD12 ' B' ' 86' ' ' ILE . 42.0 t -69.11 -66.52 0.57 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.024 0.53 . . . . 63.43 110.952 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.429 ' HB3' ' HE2' ' B' ' 56' ' ' TYR . 1.2 pp -76.67 -5.88 49.77 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 112.731 0.641 . . . . 71.11 112.731 -176.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.97 -36.9 8.1 Favored Glycine 0 C--N 1.336 0.535 0 O-C-N 123.452 0.47 . . . . 72.02 113.391 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.84 -52.45 1.33 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.898 0.479 . . . . 73.21 111.569 -169.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -64.46 -46.52 82.74 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.307 1.043 . . . . 73.15 111.66 -174.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.439 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 84.2 m -75.36 -46.55 4.44 Favored Pre-proline 0 CA--C 1.563 1.467 0 N-CA-C 112.74 0.644 . . . . 61.14 112.74 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.517 ' HB3' HD22 ' B' ' 60' ' ' LEU . 53.8 Cg_exo -59.72 -25.29 78.66 Favored 'Trans proline' 0 C--N 1.388 2.612 0 C-N-CA 122.294 1.996 . . . . 75.44 113.887 171.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -62.17 -40.73 97.02 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.442 0.697 . . . . 62.44 110.397 174.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.416 ' HA ' ' NH2' ' D' ' 111' ' ' ARG . 73.9 mt -63.59 -43.67 98.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 CA-C-N 114.795 -1.093 . . . . 74.52 110.253 177.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 78.9 mt -81.98 -19.93 39.56 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.303 -1.317 . . . . 74.12 112.332 -171.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -54.13 -53.25 60.76 Favored Pre-proline 0 CA--C 1.563 1.447 0 N-CA-C 113.945 1.091 . . . . 74.33 113.945 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.98 -33.5 95.55 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.164 1.91 . . . . 73.45 113.711 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -71.74 -45.92 60.19 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.889 -0.596 . . . . 71.34 110.428 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.91 91.0 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.034 0.534 . . . . 61.31 110.563 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.0 ttt-85 -62.28 -51.67 66.76 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.24 1.416 . . . . 71.55 110.872 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.5 -32.72 72.9 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.356 0.663 . . . . 73.02 109.878 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.514 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.3 t -69.93 -35.93 74.93 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 122.653 0.381 . . . . 64.53 111.291 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.472 HG21 HG21 ' B' ' 64' ' ' VAL . 71.6 mt -64.25 -55.25 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 108.66 -0.867 . . . . 72.42 108.66 172.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 37.9 m -57.83 -31.51 66.7 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 124.374 1.047 . . . . 72.02 111.367 -175.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.1 t -62.65 -53.66 51.18 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 123.318 0.647 . . . . 70.55 109.533 175.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.514 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.3 mmt -65.92 -35.38 80.48 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.375 0.67 . . . . 61.24 111.582 -174.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 85.2 t -64.23 -43.23 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.665 0.786 . . . . 73.32 110.154 175.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 39.7 t -70.08 -28.38 65.38 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.227 -0.897 . . . . 74.15 111.334 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.494 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 89.0 mtt-85 -71.06 -39.19 72.38 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.644 0.777 . . . . 74.31 110.205 176.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.98 -0.88 71.12 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.852 0.72 . . . . 72.13 112.643 172.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 19.0 p 63.76 31.88 13.96 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.561 1.945 . . . . 53.51 112.363 173.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -90.64 160.49 38.69 Favored Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 124.545 1.138 . . . . 71.21 110.407 176.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -50.77 159.64 2.22 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 123.969 3.113 . . . . 71.35 115.874 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -64.08 112.55 3.04 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.868 -1.06 . . . . 72.21 111.42 -173.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 50.6 tp -111.1 122.46 47.94 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.524 0.73 . . . . 63.44 109.271 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -132.8 122.5 24.58 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.303 -0.999 . . . . 73.3 108.303 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 93.3 mt -68.86 145.49 53.66 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.578 0.351 . . . . 72.14 110.816 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.18 142.13 40.79 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.225 0.61 . . . . 74.32 110.463 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.31 116.12 3.42 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.356 2.704 . . . . 64.33 111.844 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 35.2 m -124.55 140.34 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.179 0.592 . . . . 70.2 109.688 175.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -111.52 98.2 7.28 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.942 -0.762 . . . . 75.44 108.942 174.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -56.76 -34.99 68.12 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.87 0.868 . . . . 75.35 110.545 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 t70 . . . . . 0 CA--C 1.536 0.442 0 CA-C-N 113.67 -1.604 . . . . 64.22 111.764 -172.207 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.706 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 23.3 t80 . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 108.828 -0.804 . . . . 60.15 108.828 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -152.55 132.81 13.6 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.883 -0.784 . . . . 75.01 108.883 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.407 HD13 HD11 ' C' ' 16' ' ' ILE . 16.7 mt -87.65 131.58 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.83 -0.804 . . . . 55.25 108.83 174.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -92.94 -48.61 6.44 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.558 0.743 . . . . 70.15 110.325 177.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -173.92 130.42 0.4 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 115.963 -0.562 . . . . 72.41 109.778 -168.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.574 ' H ' ' HG2' ' A' ' 125' ' ' GLN . 61.3 mt -123.2 147.76 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.962 -0.755 . . . . 73.15 108.962 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.504 ' HB3' HG23 ' D' ' 122' ' ' THR . 20.5 p90 -175.33 157.39 2.18 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.515 0.674 . . . . 72.21 110.076 -173.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.0 p -77.99 123.9 27.37 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.767 -1.106 . . . . 73.2 108.712 172.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -70.35 -49.19 51.85 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 107.479 -1.304 . . . . 63.0 107.479 167.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 11.4 t70 -136.68 136.92 39.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 112.874 -1.966 . . . . 55.21 109.203 -166.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.431 HG12 ' SG ' ' C' ' 113' ' ' CYS . 75.3 mt -134.63 142.59 40.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.663 -1.606 . . . . 60.24 106.663 171.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.4 t -156.2 150.47 25.51 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.89 -0.411 . . . . 73.3 109.89 175.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -152.26 116.69 5.01 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.446 1.098 . . . . 64.23 108.043 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -120.72 129.44 53.65 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.642 0.777 . . . . 74.21 109.757 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.38 82.7 33.79 Favored Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 107.25 -1.389 . . . . 74.22 107.25 170.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.92 -14.01 23.96 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.953 2.435 . . . . 72.12 112.06 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -110.79 17.21 20.82 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.138 0.975 . . . . 72.23 109.881 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.439 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -49.28 -56.53 15.57 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 114.514 1.302 . . . . 52.21 114.514 -167.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.439 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 35.1 Cg_exo -61.84 -38.9 55.95 Favored 'Trans proline' 0 C--N 1.385 2.474 0 CA-C-N 121.824 1.687 . . . . 73.53 112.39 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -69.5 -34.92 75.0 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.684 -1.144 . . . . 71.12 112.308 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.718 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.4 p -82.75 -16.68 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 N-CA-C 112.724 0.639 . . . . 60.34 112.724 -176.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -78.37 -16.9 57.19 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.257 0.466 . . . . 55.31 112.257 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -94.07 36.77 1.11 Allowed 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.344 0.592 . . . . 71.11 109.906 172.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.79 167.21 16.09 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.27 1.028 . . . . 74.25 110.663 -178.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -89.97 132.19 35.47 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.804 0.842 . . . . 75.25 109.95 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 50.9 t-105 -81.97 90.51 6.49 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.192 0.52 . . . . 74.32 112.053 -173.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -143.55 77.95 14.9 Favored Pre-proline 0 CA--C 1.559 1.296 0 C-N-CA 124.496 1.119 . . . . 74.4 108.744 171.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -92.74 145.93 2.56 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.967 2.445 . . . . 53.53 114.623 -176.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.75 97.71 10.76 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 107.496 -1.298 . . . . 62.43 107.496 166.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' C' ' 65' ' ' THR . 9.6 m -83.85 100.29 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.745 0.783 . . . . 62.2 111.135 -176.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -92.57 109.09 20.49 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.628 0.771 . . . . 74.34 109.552 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 pp -86.0 163.02 18.22 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.781 -0.645 . . . . 62.23 111.196 -177.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.522 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 31.2 t70 -150.48 112.57 4.59 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.918 -0.771 . . . . 60.33 108.918 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' C' ' 61' ' ' ARG . 5.7 mp -113.51 112.87 24.31 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.035 -0.728 . . . . 74.35 109.035 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -116.87 152.63 34.08 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.098 0.959 . . . . 74.33 109.369 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 33.7 p -112.42 126.93 55.83 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.329 0.652 . . . . 75.02 111.028 -169.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.47 141.31 39.44 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.434 1.094 . . . . 64.2 108.534 174.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 36.0 p -165.73 164.96 18.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.337 0.255 . . . . 70.11 111.258 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 67.8 p -167.07 138.0 3.14 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.856 0.862 . . . . 73.15 109.511 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 50' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' C' ' 56' ' ' TYR . 51.8 tt0 -78.7 117.76 20.15 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.742 -0.836 . . . . 75.31 108.742 174.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.533 HD11 HD12 ' C' ' 83' ' ' ILE . 33.3 mt -84.75 -39.91 17.9 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.981 0.912 . . . . 71.23 110.982 -171.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.405 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -152.88 -170.49 3.64 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.654 -0.703 . . . . 62.21 110.943 -175.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -59.05 107.51 0.55 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.315 1.046 . . . . 71.12 110.716 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 63.12 6.82 2.46 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.288 1.035 . . . . 52.02 112.677 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 91.9 t -103.68 113.19 39.85 Favored 'Isoleucine or valine' 0 C--N 1.345 0.38 0 N-CA-C 107.584 -1.265 . . . . 74.11 107.584 177.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 56' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' C' ' 50' ' ' GLN . 50.9 t80 -131.39 135.09 46.91 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.062 0.945 . . . . 74.41 108.8 -173.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.51 ' HB2' HD11 ' C' ' 51' ' ' LEU . 39.3 tt0 -92.43 136.95 32.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.785 -1.098 . . . . 72.22 110.377 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 86.3 t -119.35 115.36 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.312 -1.366 . . . . 74.32 107.312 173.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.3 122.1 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 109.208 -0.664 . . . . 65.41 109.208 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 tp -116.55 125.57 52.07 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.656 -0.868 . . . . 62.33 108.656 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 29.8 ttm180 -79.06 130.96 36.07 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.749 -1.204 . . . . 72.1 107.749 172.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 23.5 t -124.02 111.37 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.13 -1.433 . . . . 72.33 107.13 172.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 63.9 m -121.43 139.89 52.87 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.446 -0.946 . . . . 53.24 108.446 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 85.6 t -131.42 111.6 19.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 108.184 -1.043 . . . . 73.12 108.184 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' C' ' 40' ' ' VAL . 3.2 m -98.5 132.81 43.63 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 107.567 -1.271 . . . . 64.45 107.567 173.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.76 121.47 37.33 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.47 -0.937 . . . . 72.14 108.47 -177.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 47.1 m -136.17 126.08 25.86 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.04 0.447 . . . . 65.13 111.061 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 14.1 mt -86.06 57.92 4.76 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.135 1.374 . . . . 75.23 109.076 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.08 -92.64 1.07 Allowed Glycine 0 C--N 1.343 0.938 0 N-CA-C 110.245 -1.142 . . . . 60.53 110.245 -175.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -126.6 2.01 6.84 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.895 0.878 . . . . 73.35 110.064 172.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -82.02 114.26 20.46 Favored 'General case' 0 C--N 1.347 0.481 0 N-CA-C 108.151 -1.055 . . . . 64.3 108.151 169.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.2 m -79.02 120.49 23.67 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 119.281 0.946 . . . . 63.31 109.146 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.718 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -79.81 -58.71 3.04 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.885 -1.052 . . . . 65.33 109.006 178.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -159.09 174.85 14.27 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 122.017 0.913 . . . . 72.43 112.321 -178.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.434 HD23 HG23 ' C' ' 65' ' ' THR . 2.4 tm? -138.61 142.57 39.13 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 105.37 -2.085 . . . . 61.23 105.37 170.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 48.1 t -150.29 112.84 4.71 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.586 -0.524 . . . . 74.22 109.586 176.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -118.01 130.9 56.46 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.568 0.747 . . . . 73.31 109.545 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.44 HG11 ' HA ' ' C' ' 110' ' ' ALA . 55.6 t -131.19 113.23 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.195 0.998 . . . . 71.43 108.542 175.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -91.03 95.17 9.97 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.885 -1.154 . . . . 74.31 107.885 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.538 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.3 tp-100 -86.08 115.42 23.66 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.158 0.583 . . . . 61.12 110.098 -176.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.69 146.88 18.07 Favored Glycine 0 C--N 1.338 0.652 0 O-C-N 123.489 0.493 . . . . 34.54 112.344 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.415 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -144.51 119.18 1.23 Allowed Glycine 0 C--O 1.237 0.308 0 N-CA-C 110.698 -0.961 . . . . 72.11 110.698 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.533 HD12 HD11 ' C' ' 51' ' ' LEU . 16.4 mm -83.86 123.75 39.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.595 -0.891 . . . . 62.34 108.595 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -132.31 123.85 27.67 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.98 0.512 . . . . 65.1 110.851 -173.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 58.7 m -80.19 105.27 11.33 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.394 -0.965 . . . . 51.03 108.394 166.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.51 HD13 ' H ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -116.0 139.2 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.052 -0.721 . . . . 72.22 109.052 -179.563 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.63 170.2 16.01 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.351 0.661 . . . . 50.23 110.247 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.81 -30.02 7.94 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-O 119.625 -0.542 . . . . 54.33 113.823 172.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 47.4 pt -123.7 151.31 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 118.001 0.901 . . . . 73.31 110.333 176.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -147.75 157.9 43.76 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.921 0.889 . . . . 64.25 109.774 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.58 -148.19 21.77 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 119.167 -0.796 . . . . 74.54 111.878 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 9.8 t -56.77 -26.56 57.81 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.394 0.677 . . . . 75.43 111.681 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -55.33 -59.12 5.24 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.225 1.41 . . . . 63.1 110.423 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 32.9 ttp -77.78 -22.47 50.11 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.358 -0.837 . . . . 74.33 111.425 -177.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.92 -35.08 79.49 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.261 0.624 . . . . 74.02 110.706 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -73.82 -31.67 63.34 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.396 -0.82 . . . . 73.02 110.617 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -66.47 -60.93 2.29 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.314 0.246 . . . . 71.55 110.716 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 pp -66.5 -29.96 70.18 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.192 0.597 . . . . 61.31 111.585 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.92 12.4 59.12 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-O 119.251 -0.749 . . . . 74.32 114.475 -173.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.41 -55.38 0.06 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.269 1.035 . . . . 63.53 112.045 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -71.23 -35.67 71.55 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.76 0.824 . . . . 52.22 111.555 -172.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.706 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 60.7 m -76.19 -50.91 2.83 Favored Pre-proline 0 CA--C 1.564 1.5 0 C-N-CA 123.603 0.761 . . . . 73.1 112.249 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.58 -13.54 35.27 Favored 'Trans proline' 0 C--N 1.398 3.138 0 C-N-CA 122.03 1.82 . . . . 75.41 112.959 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -60.89 -37.41 82.12 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.999 0.919 . . . . 75.14 110.154 171.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.508 HD12 ' NH1' ' A' ' 111' ' ' ARG . 37.9 mm -70.02 -36.06 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.229 -0.896 . . . . 63.54 111.19 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.415 HD21 ' HA3' ' C' ' 82' ' ' GLY . 53.6 mt -91.94 -24.59 19.22 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.862 -1.063 . . . . 72.32 111.985 -166.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -57.25 -52.64 72.71 Favored Pre-proline 0 CA--C 1.557 1.241 0 CA-C-O 117.99 -1.005 . . . . 75.33 112.733 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.515 ' HB2' ' HG3' ' A' ' 112' ' ' GLU . 42.0 Cg_endo -63.45 -27.3 70.58 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 121.683 1.589 . . . . 73.45 112.788 -177.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.427 ' CD1' HG21 ' C' ' 16' ' ' ILE . 3.2 m-30 -71.17 -50.4 33.67 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.801 0.84 . . . . 65.11 110.435 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.538 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -63.56 -35.34 80.17 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.303 -0.862 . . . . 73.43 110.914 176.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -60.02 -50.71 72.66 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.349 1.459 . . . . 73.44 111.587 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.7 -37.94 87.86 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 123.552 0.533 . . . . 73.45 109.696 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.431 ' SG ' HG12 ' C' ' 21' ' ' ILE . 42.4 t -63.9 -34.84 78.85 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.338 0.655 . . . . 41.22 111.766 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.473 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 68.0 mt -71.04 -52.19 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.127 0.571 . . . . 73.33 110.414 174.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 35.1 m -62.74 -30.02 71.12 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.25 0.62 . . . . 72.23 111.438 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.1 t -65.97 -48.71 70.36 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.899 -0.778 . . . . 60.24 108.899 174.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.558 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.11 -37.83 81.18 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.673 1.189 . . . . 71.31 112.32 178.496 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.415 HG23 ' O ' ' C' ' 114' ' ' ILE . 93.8 t -65.68 -42.94 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.365 0.666 . . . . 63.22 110.1 177.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.0 t -70.16 -29.1 65.92 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.38 -0.827 . . . . 73.24 111.714 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -69.92 -34.61 73.7 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.324 0.65 . . . . 73.53 109.3 175.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.46 11.27 64.08 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.713 0.633 . . . . 50.52 113.108 174.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.421 HG23 ' HB3' ' D' ' 17' ' ' TYR . 73.0 p 56.23 24.33 8.02 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 126.276 1.83 . . . . 71.44 114.23 176.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -84.77 140.53 37.85 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.057 -1.09 . . . . 63.23 108.057 169.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.48 168.84 2.67 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 123.028 2.485 . . . . 64.32 114.273 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -50.69 118.71 3.27 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.79 1.236 . . . . 62.04 113.594 -171.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.04 86.57 2.45 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 106.947 -1.501 . . . . 53.34 106.947 174.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -106.08 118.82 37.61 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.642 -0.873 . . . . 73.14 108.642 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.93 133.19 47.87 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.502 0.721 . . . . 44.35 109.459 -177.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.09 152.25 96.25 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 123.355 0.662 . . . . 73.3 112.486 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.63 106.28 0.42 Allowed 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.076 2.518 . . . . 54.04 112.712 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.12 109.73 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 108.568 -0.901 . . . . 64.35 108.568 171.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -81.71 110.83 17.41 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.837 1.255 . . . . 72.32 109.996 175.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -49.83 -45.06 49.77 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.428 0.691 . . . . 73.23 111.345 174.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 N--CA 1.477 0.888 0 C-N-CA 124.743 1.217 . . . . 73.02 112.051 178.112 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 49.3 m . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 108.468 -0.938 . . . . 44.12 108.468 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -150.35 108.7 3.78 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.976 -1.12 . . . . 74.14 107.976 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 12' ' ' GLN . . . . . 0.617 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 43.5 mt-30 -126.46 118.51 25.1 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.194 -1.039 . . . . 75.21 108.194 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.469 HG21 HD11 ' D' ' 16' ' ' ILE . 19.8 mt -86.76 125.98 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 109.26 -0.644 . . . . 75.53 109.26 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -98.23 -29.06 13.42 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.411 0.684 . . . . 71.12 111.41 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -173.05 131.49 0.5 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 111.934 0.346 . . . . 74.34 111.934 -167.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.469 HD11 HG21 ' D' ' 13' ' ' ILE . 1.8 mp -112.74 136.02 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 107.366 -1.346 . . . . 72.34 107.366 167.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.441 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 40.5 p90 -164.64 175.84 9.42 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.779 0.8 . . . . 72.45 112.234 178.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.4 p -110.64 127.69 55.37 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.703 -1.135 . . . . 74.34 109.408 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.441 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 37.9 mtpt -100.38 -18.1 16.91 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.611 0.764 . . . . 72.53 110.134 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.657 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 11.4 t70 -159.27 133.51 7.68 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.575 1.15 . . . . 75.21 108.207 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.558 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.5 mt -136.27 146.52 28.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 106.704 -1.591 . . . . 74.44 106.704 173.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 22' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 23.0 t -152.61 143.82 23.19 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.142 0.577 . . . . 42.3 109.767 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.3 t80 -151.41 125.87 9.46 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 105.806 -1.924 . . . . 73.42 105.806 175.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -140.65 111.48 6.99 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.243 0.617 . . . . 71.42 109.807 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.56 92.0 9.43 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 108.508 -0.923 . . . . 64.13 108.508 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.82 -30.77 2.73 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.921 2.414 . . . . 64.44 113.559 -171.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -102.62 9.07 39.56 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.092 0.957 . . . . 64.01 111.081 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.512 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -30.63 -65.59 0.19 Allowed Pre-proline 0 CA--C 1.556 1.211 0 N-CA-C 117.272 2.323 . . . . 75.15 117.272 -160.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.09 -29.05 8.49 Favored 'Trans proline' 0 C--N 1.378 2.102 0 CA-C-N 123.173 2.169 . . . . 53.43 113.751 -171.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -85.72 -21.63 28.19 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.598 0.237 . . . . 71.15 110.508 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.512 HG12 ' O ' ' D' ' 28' ' ' ALA . 9.7 p -82.7 -15.72 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 116.037 -0.528 . . . . 53.5 110.827 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -69.69 -22.18 63.44 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 112.5 0.556 . . . . 70.44 112.5 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -57.81 -29.28 64.78 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.637 0.732 . . . . 51.21 109.6 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -88.11 71.13 9.32 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.073 -1.421 . . . . 71.14 109.328 173.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -88.65 84.54 6.73 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.293 0.568 . . . . 61.02 109.753 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.475 ' O ' ' HG2' ' D' ' 124' ' ' PRO . 8.9 p90 -147.49 178.48 8.4 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.379 1.071 . . . . 64.22 108.578 171.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -61.12 111.94 5.01 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 123.098 0.559 . . . . 60.42 109.903 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.11 127.63 24.83 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 121.914 1.743 . . . . 73.02 111.139 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.72 112.71 2.97 Favored 'General case' 0 C--N 1.347 0.469 0 N-CA-C 108.57 -0.9 . . . . 74.23 108.57 173.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 4.5 m -108.56 143.07 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 114.751 -1.113 . . . . 65.34 110.704 -169.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.54 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 13.9 tmtt? -125.46 122.33 36.34 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.224 -1.398 . . . . 72.43 107.224 177.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 pp -95.75 146.48 24.5 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 121.267 0.556 . . . . 74.2 110.037 -177.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -147.41 132.02 17.81 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.139 -1.059 . . . . 52.44 108.139 175.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -110.29 144.11 39.49 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.066 -0.716 . . . . 75.4 109.066 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.3 t70 -132.11 146.37 52.0 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.146 -1.057 . . . . 73.43 108.146 174.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 94.5 m -105.52 144.23 32.57 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.436 0.694 . . . . 73.42 111.158 -173.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.679 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.72 154.58 35.52 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.823 0.849 . . . . 75.21 109.373 170.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 21.6 p -168.59 159.99 10.51 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.699 0.8 . . . . 61.23 109.503 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 51.9 p -160.73 140.53 10.96 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.402 0.681 . . . . 64.35 109.847 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -87.76 124.79 33.97 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.807 -0.442 . . . . 74.23 109.807 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 35.9 mt -95.58 -36.45 11.26 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.015 0.526 . . . . 62.43 110.165 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.85 178.7 9.81 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.303 1.041 . . . . 43.21 109.489 174.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -64.69 119.01 9.75 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.816 -0.809 . . . . 72.43 108.816 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 72.19 9.08 5.94 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 124.316 1.046 . . . . 75.12 111.723 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 90.1 t -118.45 115.1 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.21 -1.034 . . . . 73.52 108.21 171.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.467 ' HB2' HD11 ' D' ' 86' ' ' ILE . 69.8 m-85 -133.47 130.02 38.01 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.349 -0.612 . . . . 70.33 109.349 -175.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -92.58 124.7 36.8 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.619 -1.252 . . . . 73.42 107.619 174.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 84.6 t -119.98 132.49 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.336 1.054 . . . . 63.5 108.529 -169.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.679 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 14.7 t -125.0 136.73 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.263 0.625 . . . . 72.23 109.886 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.437 HD22 ' HB3' ' D' ' 103' ' ' PRO . 57.2 tp -125.72 118.79 26.35 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.408 -0.96 . . . . 70.54 108.408 167.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.491 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 16.9 ttm-85 -85.88 111.96 20.7 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.619 0.768 . . . . 73.11 109.497 176.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 45.8 t -91.85 128.65 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.521 -0.918 . . . . 74.21 108.521 170.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 9.9 m -122.67 134.82 54.47 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.337 -0.616 . . . . 72.43 109.337 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 57.3 t -127.18 101.53 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 125.86 1.664 . . . . 71.52 107.978 -173.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 21.4 m -92.25 94.34 9.12 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.744 -0.836 . . . . 53.42 108.744 176.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.5 141.39 30.63 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.99 -0.55 . . . . 73.44 110.377 -175.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.401 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 66.0 p -147.73 128.88 14.64 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.0 -0.546 . . . . 75.43 110.296 -178.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.445 HD12 HG22 ' D' ' 31' ' ' VAL . 43.5 mt -93.46 108.83 20.45 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.965 -1.124 . . . . 72.22 107.965 175.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.91 -115.88 4.33 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.381 -0.827 . . . . 60.43 111.193 -171.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.29 6.15 10.71 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.731 0.812 . . . . 53.1 110.511 -174.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -121.59 152.83 38.83 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.905 0.882 . . . . 63.25 109.343 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 35.1 m -64.33 132.13 49.27 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.161 0.505 . . . . 73.21 111.512 -176.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.401 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -89.36 -60.44 1.95 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.492 -1.299 . . . . 63.11 107.492 174.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -157.19 159.38 37.67 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.332 -1.304 . . . . 71.23 110.135 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 86.8 mt -124.31 114.26 19.32 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 107.506 -1.294 . . . . 71.45 107.506 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.438 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 1.2 m -114.12 135.47 53.99 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.061 -1.089 . . . . 52.04 108.061 -175.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 77' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 37.5 tt0 -156.18 121.05 4.66 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.624 -0.51 . . . . 75.4 109.624 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.5 t -135.12 116.93 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.025 0.53 . . . . 61.42 109.578 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.657 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 13.9 mt-30 -85.43 91.15 8.13 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.001 -1.111 . . . . 73.35 108.001 166.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -81.61 109.43 16.04 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.103 -1.073 . . . . 62.04 108.103 174.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.94 166.43 14.09 Favored Glycine 0 C--O 1.244 0.745 0 O-C-N 123.72 0.638 . . . . 43.35 111.993 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.89 136.49 4.2 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 112.054 -0.418 . . . . 52.2 112.054 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.8 mt -89.68 122.21 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.536 0.734 . . . . 75.54 109.102 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -130.87 125.48 33.67 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.727 0.811 . . . . 71.13 109.421 -175.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.617 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 45.5 m -89.91 96.74 10.82 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.828 0.851 . . . . 64.24 109.264 173.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.632 ' HB ' HD12 ' D' ' 89' ' ' ILE . 0.2 OUTLIER -110.79 114.92 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 123.588 0.755 . . . . 74.44 110.712 -178.118 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.41 162.47 25.5 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.783 0.833 . . . . 52.54 109.552 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.04 20.34 78.9 Favored Glycine 0 C--N 1.347 1.151 0 C-N-CA 121.783 -0.246 . . . . 63.33 112.74 178.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.632 HD12 ' HB ' ' D' ' 86' ' ' ILE . 55.8 mt -116.36 136.62 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.776 0.83 . . . . 73.23 109.137 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -151.05 152.36 33.34 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.433 0.693 . . . . 70.44 110.935 -170.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.92 -138.9 33.76 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 115.409 -0.814 . . . . 72.32 115.006 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 32.1 m -62.74 -25.58 68.26 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.118 0.967 . . . . 74.12 111.557 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -62.11 -26.61 68.39 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.53 0.732 . . . . 64.54 111.073 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 69.5 mtm -68.7 -46.56 68.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.804 0.841 . . . . 71.33 111.227 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.04 -30.13 68.43 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.31 -0.859 . . . . 63.45 110.69 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 96' ' ' HIS . . . . . 0.404 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 25.2 t-80 -77.42 -27.15 52.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.414 0.685 . . . . 73.3 110.98 177.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.8 t -72.1 -52.95 14.36 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.398 0.618 . . . . 73.24 110.278 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 24.2 mt -86.47 -19.36 29.68 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 114.62 -1.173 . . . . 73.05 110.704 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.91 3.4 57.21 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-O 119.35 -0.694 . . . . 63.14 114.16 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -144.75 -65.9 0.34 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.105 0.952 . . . . 70.44 111.566 -178.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -69.9 -45.95 66.48 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 112.373 0.508 . . . . 70.02 112.373 -173.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 84.0 m -62.94 -45.35 87.01 Favored Pre-proline 0 CA--C 1.569 1.686 0 CA-C-O 118.782 -0.627 . . . . 75.44 112.218 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.437 ' HB3' HD22 ' D' ' 60' ' ' LEU . 51.5 Cg_exo -59.03 -27.66 85.65 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 122.786 2.324 . . . . 32.22 114.201 169.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -70.87 -26.51 63.29 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 122.854 0.462 . . . . 60.12 111.419 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 43.8 mm -72.02 -35.61 54.42 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-O 121.415 0.626 . . . . 63.14 109.465 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 86.0 mt -84.3 -23.3 30.36 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.058 -0.974 . . . . 63.43 112.114 -175.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 94.0 t80 -58.99 -49.1 95.16 Favored Pre-proline 0 CA--C 1.562 1.407 0 N-CA-C 113.662 0.986 . . . . 74.25 113.662 -174.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.06 -37.48 95.64 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 121.851 1.701 . . . . 44.52 113.116 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -75.9 -37.66 58.56 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.499 -0.773 . . . . 73.41 111.529 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.62 -41.39 96.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.081 0.552 . . . . 74.33 110.086 177.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.416 ' NH2' ' HA ' ' B' ' 105' ' ' ILE . 36.9 ttp180 -58.44 -53.42 58.53 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 124.214 0.946 . . . . 72.32 110.394 174.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.24 -43.26 96.25 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.187 0.929 . . . . 74.15 111.46 -174.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.8 t -59.58 -45.73 91.01 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.637 0.586 . . . . 63.43 111.081 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.466 ' O ' HG23 ' D' ' 118' ' ' VAL . 91.7 mt -64.35 -55.72 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 115.741 -0.663 . . . . 74.0 110.415 177.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 57.6 m -52.79 -40.36 63.14 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.693 1.197 . . . . 65.34 111.753 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.5 t -69.42 -42.39 75.08 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.33 -0.85 . . . . 63.54 110.075 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.8 mtm -64.85 -34.34 78.14 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.906 0.482 . . . . 55.21 111.482 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.466 HG23 ' O ' ' D' ' 114' ' ' ILE . 93.6 t -63.68 -47.8 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.538 0.735 . . . . 70.51 110.002 176.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.2 p -71.78 -27.33 62.88 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.918 -0.583 . . . . 61.22 110.93 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 74.7 mtt-85 -73.67 -29.29 62.22 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.462 0.705 . . . . 64.32 109.834 173.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.85 3.78 85.88 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 119.523 -0.598 . . . . 32.05 112.723 174.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.504 HG23 ' HB3' ' C' ' 17' ' ' TYR . 44.7 p 60.19 24.98 14.33 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 126.401 1.88 . . . . 73.22 113.733 177.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -89.09 156.43 49.03 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.282 0.633 . . . . 71.11 109.764 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.475 ' HG2' ' O ' ' D' ' 36' ' ' TRP . 71.5 Cg_exo -49.23 123.54 10.27 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.368 2.712 . . . . 64.15 113.338 171.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -53.87 141.17 28.2 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.749 1.22 . . . . 72.12 112.205 -177.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -121.3 116.97 25.85 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.493 -1.299 . . . . 70.44 107.493 -177.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -112.25 103.5 11.64 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.389 0.676 . . . . 52.44 109.513 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.1 116.22 10.2 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.049 0.539 . . . . 73.25 110.558 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.49 143.46 97.86 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.232 0.613 . . . . 62.42 110.28 175.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.72 123.17 13.17 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.082 2.521 . . . . 74.31 112.832 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 98.6 t . . . . . 0 N--CA 1.465 0.316 0 C-N-CA 123.634 0.774 . . . . 53.34 108.941 -176.371 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.585 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 20.5 t80 . . . . . 0 C--O 1.237 0.396 0 N-CA-C 109.296 -0.631 . . . . 70.41 109.296 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -146.72 115.02 6.66 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.912 -0.773 . . . . 74.33 108.912 176.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.677 HG12 ' HD2' ' A' ' 84' ' ' PHE . 32.8 mt -84.38 115.33 26.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.79 -0.818 . . . . 70.42 108.79 176.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -75.77 -33.56 60.2 Favored 'General case' 0 C--O 1.242 0.684 0 O-C-N 123.687 0.617 . . . . 71.05 110.816 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -171.51 148.04 2.46 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.329 0.393 . . . . 61.32 110.912 -170.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.47 HD12 ' HB3' ' C' ' 130' ' ' PRO . 87.6 mt -138.68 133.84 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 107.983 -1.117 . . . . 71.5 107.983 172.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.425 ' HB3' HG23 ' B' ' 122' ' ' THR . 19.7 p90 -164.32 157.38 17.57 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.147 0.979 . . . . 75.44 110.701 -171.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -84.42 113.18 20.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.888 -1.051 . . . . 62.44 108.636 177.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 32.7 mtpt -82.27 -31.86 29.88 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.844 0.354 . . . . 61.42 110.287 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.8 t70 -137.45 137.94 39.26 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.392 -0.822 . . . . 74.13 109.634 171.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.415 HD13 ' SD ' ' B' ' 117' ' ' MET . 64.5 mt -127.23 139.98 50.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 C-N-CA 124.973 1.309 . . . . 62.25 107.535 171.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.9 t -150.45 128.17 11.64 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 123.822 0.701 . . . . 40.34 109.56 173.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.45 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 83.2 t80 -129.89 121.85 27.49 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 106.849 -1.537 . . . . 74.1 106.849 172.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 47.2 mt-10 -127.05 112.78 15.61 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.929 0.492 . . . . 62.3 110.0 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.5 81.77 4.33 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 107.287 -1.375 . . . . 70.41 107.287 169.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.43 -16.38 19.31 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.728 2.285 . . . . 62.3 112.599 -171.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -113.01 12.84 19.35 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.381 1.072 . . . . 71.22 110.567 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -41.35 -59.33 2.37 Favored Pre-proline 0 C--N 1.37 1.468 0 CA-C-O 117.337 -1.316 . . . . 72.43 114.38 -165.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 44.8 Cg_exo -53.72 -45.23 42.59 Favored 'Trans proline' 0 C--N 1.39 2.737 0 C-N-CA 121.934 1.756 . . . . 73.3 113.881 -174.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -97.75 -14.12 21.02 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.105 0.78 . . . . 72.43 113.105 -170.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.801 HG21 ' HA ' ' A' ' 73' ' ' ALA . 8.0 p -75.46 -22.21 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-N 118.288 0.495 . . . . 53.23 111.341 -175.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -65.85 -22.24 66.52 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.23 0.612 . . . . 73.52 111.124 173.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -80.68 -19.53 44.98 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.143 0.977 . . . . 75.54 111.079 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.431 ' NZ ' ' HB2' ' A' ' 71' ' ' GLU . 31.8 mmtp -81.62 155.02 25.85 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.707 0.803 . . . . 61.41 111.453 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.59 132.37 49.61 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.094 0.958 . . . . 63.32 110.296 174.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -81.59 85.68 6.5 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.012 0.525 . . . . 74.2 110.196 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -121.82 82.25 42.23 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 107.509 -1.293 . . . . 73.43 107.509 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -75.14 115.18 4.19 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 122.435 2.09 . . . . 72.24 111.948 -172.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -91.95 96.53 10.43 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.091 -1.818 . . . . 71.4 106.091 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 m -66.5 90.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.615 0 CA-C-O 122.69 1.233 . . . . 74.52 110.3 -175.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 54.2 tptt -96.85 110.69 23.13 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.541 -1.651 . . . . 74.54 106.541 175.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.565 HD23 ' H ' ' A' ' 42' ' ' LEU . 2.0 pt? -110.37 147.14 34.56 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.875 -0.417 . . . . 71.13 109.875 -172.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.565 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 13.5 t70 -130.91 129.11 41.81 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.295 -1.372 . . . . 74.44 107.295 177.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.467 ' H ' HD23 ' A' ' 44' ' ' LEU . 2.2 pt? -126.57 129.52 48.73 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.108 0.563 . . . . 72.02 109.564 -174.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -152.33 163.06 40.24 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.184 0.994 . . . . 52.44 108.852 -177.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.2 m -147.39 144.11 28.46 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.429 0.692 . . . . 71.22 110.804 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.52 122.22 25.77 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.171 -1.418 . . . . 65.44 107.171 173.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.5 p -131.52 153.5 49.75 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.727 0.299 . . . . 63.33 110.851 -173.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.8 t -155.74 146.83 22.43 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.744 0.818 . . . . 72.52 109.966 -173.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -76.53 141.26 41.27 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.905 -0.776 . . . . 74.35 108.905 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 57' ' ' GLU . 69.0 mt -113.73 -39.54 4.0 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.095 0.958 . . . . 73.43 109.605 176.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -155.96 -170.48 3.41 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.242 0.617 . . . . 72.23 110.296 -177.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -60.9 108.33 0.85 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.564 0.746 . . . . 73.34 110.059 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 65.01 7.13 3.82 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.69 1.196 . . . . 73.01 112.79 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 85.3 t -98.93 116.32 41.66 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 N-CA-C 107.239 -1.393 . . . . 71.31 107.239 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -131.81 128.67 39.22 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.173 0.989 . . . . 75.1 109.391 -172.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.473 ' HB2' HD11 ' A' ' 51' ' ' LEU . 38.3 tt0 -87.33 131.42 34.27 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.588 0.755 . . . . 73.4 109.743 172.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.463 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 98.3 t -118.77 116.18 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.156 -1.053 . . . . 53.24 108.156 171.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.56 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 35.6 t -101.31 117.76 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 109.044 -0.724 . . . . 63.42 109.044 175.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.39 113.77 26.68 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.252 -0.647 . . . . 70.34 109.252 -176.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -82.6 101.99 11.14 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.668 -0.864 . . . . 72.41 108.668 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.6 t -100.14 102.6 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 107.404 -1.332 . . . . 63.42 107.404 170.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 37.2 m -106.59 135.92 47.27 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.935 0.894 . . . . 53.32 109.715 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.706 HG11 HD21 ' A' ' 126' ' ' LEU . 40.5 t -130.98 126.6 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.765 1.226 . . . . 54.14 108.753 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 10.8 m -112.44 135.33 53.27 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.545 -0.909 . . . . 71.55 108.545 174.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.92 105.63 14.87 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.364 -1.346 . . . . 65.11 107.364 170.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.7 m -107.1 133.81 51.15 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.903 -1.147 . . . . 71.14 107.903 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.7 mt -103.48 47.87 0.87 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.413 -0.958 . . . . 72.25 108.413 -176.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.18 -84.44 1.35 Allowed Glycine 0 C--N 1.342 0.881 0 N-CA-C 110.848 -0.901 . . . . 74.12 110.848 -170.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -90.69 -31.41 16.6 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.615 0.766 . . . . 73.41 111.588 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.431 ' HB2' ' NZ ' ' A' ' 34' ' ' LYS . 3.8 tp10 -115.9 112.69 22.27 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 116.282 -0.417 . . . . 63.11 110.294 -162.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.2 m -70.73 119.57 15.08 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.881 -0.414 . . . . 74.25 109.881 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.801 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -70.01 -58.56 3.69 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 114.951 -1.022 . . . . 61.21 109.52 175.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -155.68 171.57 19.77 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.141 -0.936 . . . . 72.1 112.528 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 28.0 tp -141.31 107.63 5.26 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 113.701 -1.59 . . . . 72.41 107.754 175.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.0 m -106.39 101.68 11.14 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.373 1.069 . . . . 52.44 110.556 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -116.43 117.3 29.55 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.918 0.887 . . . . 73.23 109.292 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.0 t -131.07 110.45 18.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 123.818 0.847 . . . . 74.3 109.326 -174.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 69.9 mt-30 -85.92 88.52 7.58 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.811 -0.811 . . . . 63.35 108.811 171.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -80.46 100.47 8.53 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.347 -0.842 . . . . 63.53 109.537 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.29 144.94 19.45 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 111.678 -0.569 . . . . 64.42 111.678 176.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.404 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -145.98 127.48 2.8 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.408 -0.677 . . . . 53.31 111.408 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.3 mt -85.2 124.75 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.629 0.772 . . . . 74.03 108.946 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.677 ' HD2' HG12 ' A' ' 13' ' ' ILE . 12.5 m-85 -133.41 159.87 39.04 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.111 0.564 . . . . 73.02 109.557 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.0 p -111.24 114.18 27.19 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.063 -0.718 . . . . 62.52 109.063 170.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.593 HG12 HD23 ' A' ' 98' ' ' LEU . 4.1 mp . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 107.754 -1.202 . . . . 73.43 107.754 175.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.909 0.385 . . . . 75.54 110.682 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.454 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 58.9 t-80 -83.76 -37.16 22.98 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.774 -0.648 . . . . 71.12 111.071 176.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 74.3 m -77.75 -64.29 1.19 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 122.724 0.41 . . . . 52.2 111.104 -177.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.593 HD23 HG12 ' A' ' 86' ' ' ILE . 3.2 tm? -72.92 -39.75 66.05 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.883 0.873 . . . . 71.35 110.867 -175.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.82 0.44 76.56 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-O 119.378 -0.679 . . . . 45.01 114.672 -171.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -146.55 -50.61 0.21 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.113 0.957 . . . . 54.03 112.43 -172.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.478 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 65.1 t80 -76.21 -49.99 15.71 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.556 0.743 . . . . 72.44 111.994 -174.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.408 ' HA ' HG12 ' A' ' 105' ' ' ILE . 77.2 m -68.47 -34.27 5.49 Favored Pre-proline 0 CA--C 1.568 1.667 0 N-CA-C 113.435 0.902 . . . . 65.43 113.435 -178.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -50.93 -44.36 42.3 Favored 'Trans proline' 0 C--N 1.396 3.065 0 C-N-CA 122.68 2.254 . . . . 60.23 112.954 162.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -70.2 -22.41 62.93 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 114.846 -1.07 . . . . 73.42 111.614 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.408 HG12 ' HA ' ' A' ' 102' ' ' CYS . 44.1 mm -70.31 -43.93 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 123.299 0.64 . . . . 71.04 110.714 177.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.404 HD21 ' HA3' ' A' ' 82' ' ' GLY . 88.9 mt -76.31 -19.31 58.38 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.804 -0.634 . . . . 75.31 111.596 -176.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -64.33 -48.33 76.08 Favored Pre-proline 0 CA--C 1.568 1.657 0 N-CA-C 114.153 1.168 . . . . 61.04 114.153 -172.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.28 -34.48 67.29 Favored 'Trans proline' 0 C--N 1.388 2.649 0 CA-C-N 122.035 1.763 . . . . 51.52 112.754 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -69.2 -45.17 70.56 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.607 0.763 . . . . 73.32 111.435 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.2 -37.83 78.29 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.963 -0.562 . . . . 74.24 110.716 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.457 HH12 HD12 ' C' ' 105' ' ' ILE . 24.4 ttm180 -60.68 -45.6 93.55 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 124.004 0.815 . . . . 54.31 109.641 174.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -66.14 -44.56 83.82 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.651 0.78 . . . . 75.54 111.5 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -60.21 -42.21 94.65 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.532 0.52 . . . . 73.45 110.107 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 118' ' ' VAL . 59.0 mt -59.53 -52.56 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 124.082 0.953 . . . . 65.55 110.5 172.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.426 HG21 ' HE2' ' C' ' 109' ' ' TYR . 94.9 m -54.58 -46.7 73.78 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.472 1.109 . . . . 73.45 111.969 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 44.3 t -70.41 -34.53 72.63 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.331 -0.849 . . . . 71.14 111.22 -176.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.45 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 9.3 mtp -67.44 -40.53 85.44 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.318 0.647 . . . . 75.31 110.863 175.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 114' ' ' ILE . 51.4 t -62.92 -51.1 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.695 1.198 . . . . 74.5 110.799 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.4 p -68.35 -29.24 67.92 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.356 0.662 . . . . 73.42 111.373 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' A' ' 116' ' ' SER . 18.5 ttm-85 -74.31 -30.28 61.99 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.207 1.003 . . . . 74.41 110.042 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.444 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.93 11.6 59.6 Favored Glycine 0 C--N 1.353 1.522 0 CA-C-N 115.23 -0.895 . . . . 63.21 112.603 172.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.489 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.0 OUTLIER 66.17 11.59 7.95 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 127.025 2.13 . . . . 62.23 113.148 175.532 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -78.64 148.99 74.07 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 123.263 0.625 . . . . 74.41 109.722 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.02 158.81 41.56 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.622 2.215 . . . . 73.32 112.34 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.417 ' OE1' HG23 ' A' ' 115' ' ' THR . 6.1 tp-100 -58.77 132.56 54.25 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.546 1.138 . . . . 61.21 112.829 -167.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.706 HD21 HG11 ' A' ' 64' ' ' VAL . 51.9 tp -129.31 110.74 12.19 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.986 1.314 . . . . 65.43 109.726 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -129.8 121.16 26.25 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.65 0.78 . . . . 62.34 108.957 172.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.461 HD11 HG21 ' A' ' 64' ' ' VAL . 6.4 mp -71.83 147.0 47.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.615 0.366 . . . . 73.31 110.649 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.76 140.47 96.33 Favored Pre-proline 0 CA--C 1.554 1.124 0 O-C-N 123.771 0.669 . . . . 71.3 110.86 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.401 ' HD3' HG13 ' C' ' 13' ' ' ILE . 30.8 Cg_endo -62.31 133.21 42.21 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 123.265 2.643 . . . . 52.34 112.125 177.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 m -127.1 113.95 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 121.666 0.746 . . . . 65.33 110.391 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -87.88 96.89 10.65 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.242 -1.022 . . . . 75.11 108.242 168.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 . . . . . 0 N--CA 1.475 0.809 0 O-C-N 123.879 0.737 . . . . 72.42 110.474 178.703 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 1.9 tmt? . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 120.907 0.384 . . . . 74.05 111.766 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 87.6 m -169.03 139.58 2.32 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 125.078 1.351 . . . . 75.23 107.936 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.35 157.37 45.65 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.413 0.625 . . . . 72.42 110.105 157.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -124.56 131.45 53.48 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 107.185 -1.413 . . . . 74.03 107.185 175.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.449 HD13 HD11 ' B' ' 16' ' ' ILE . 59.7 mt -67.87 117.32 9.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.215 -1.032 . . . . 74.4 108.215 174.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 14' ' ' GLN . . . . . 0.434 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 11.5 mm-40 -86.9 -37.89 17.24 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 124.038 0.836 . . . . 74.25 108.745 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.489 ' HE ' HG21 ' A' ' 122' ' ' THR . 42.4 ttt180 -175.27 137.61 0.4 Allowed 'General case' 0 C--N 1.355 0.828 0 CA-C-N 115.4 -0.818 . . . . 74.33 109.606 -176.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.449 HD11 HD13 ' B' ' 13' ' ' ILE . 94.2 mt -115.49 141.51 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 107.273 -1.38 . . . . 63.53 107.273 173.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -165.88 146.41 6.66 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.989 0.423 . . . . 70.2 111.484 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.594 HG21 HD11 ' B' ' 21' ' ' ILE . 96.2 m -75.97 123.48 25.81 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.382 -0.826 . . . . 71.24 109.049 169.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.457 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 23.0 mtpp -89.17 -38.84 13.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.817 -0.629 . . . . 74.01 109.965 178.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 14.6 t70 -153.21 142.44 21.49 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.174 0.435 . . . . 63.44 112.174 -169.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.594 HD11 HG21 ' B' ' 18' ' ' THR . 38.2 mm -134.79 146.34 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.029 1.332 . . . . 74.22 108.775 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.52 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 47.7 t -147.9 140.51 24.59 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.905 -1.146 . . . . 50.33 107.905 175.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.411 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 92.1 t80 -157.65 114.15 2.9 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.893 -1.151 . . . . 64.34 107.893 173.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -121.98 112.45 18.29 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.298 -0.63 . . . . 73.52 109.298 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.53 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -108.6 86.81 3.82 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 107.429 -1.323 . . . . 61.33 107.429 172.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.37 -40.79 2.83 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.331 2.021 . . . . 65.21 112.013 -176.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -92.44 9.29 34.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.805 0.842 . . . . 63.4 111.367 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.53 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -40.4 -66.04 0.4 Allowed Pre-proline 0 CA--C 1.57 1.722 0 C-N-CA 125.225 1.41 . . . . 74.0 114.58 -170.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.05 -34.99 94.12 Favored 'Trans proline' 0 C--N 1.399 3.202 0 C-N-CA 122.915 2.41 . . . . 73.33 113.536 -167.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -95.25 -28.85 14.81 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.545 -0.752 . . . . 71.42 111.972 -174.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.447 HG21 ' HA ' ' B' ' 73' ' ' ALA . 4.5 p -74.81 -12.44 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-N 118.271 0.487 . . . . 64.15 111.351 -176.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -68.82 -14.51 63.08 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.294 0.85 . . . . 73.22 113.294 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -64.49 -27.07 68.72 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.096 0.474 . . . . 74.44 110.148 172.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -87.75 84.01 7.1 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.647 1.179 . . . . 62.33 110.134 -177.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -93.27 87.56 5.69 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.377 -0.829 . . . . 73.15 109.873 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -160.23 177.03 11.06 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.298 1.039 . . . . 74.12 108.739 171.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -69.83 111.77 10.14 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 109.502 -0.555 . . . . 71.33 109.502 176.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -67.04 157.46 61.61 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.317 2.012 . . . . 63.25 111.89 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 24.9 tt0 -66.23 103.54 1.01 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.16 -1.052 . . . . 71.23 108.16 169.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -86.94 141.59 14.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.579 -0.896 . . . . 63.01 108.579 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -147.05 99.43 3.17 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 108.27 -1.011 . . . . 55.12 108.27 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.19 165.66 12.29 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.213 0.53 . . . . 70.51 111.097 -177.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -159.79 136.61 9.27 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.534 1.133 . . . . 65.22 108.206 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 95.5 mt -99.85 158.26 15.93 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.631 -0.507 . . . . 73.54 109.631 175.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.502 ' HB3' ' HD3' ' B' ' 61' ' ' ARG . 23.0 t70 -145.74 151.85 38.63 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 124.427 1.091 . . . . 72.34 108.163 170.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 46.1 p -107.59 106.26 16.54 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.473 0.709 . . . . 73.23 109.554 -174.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.39 135.81 53.54 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.726 -1.213 . . . . 62.12 107.726 176.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.3 p -148.13 167.54 24.76 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.321 0.581 . . . . 74.22 112.33 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.5 p -153.89 155.66 36.12 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.277 -1.329 . . . . 64.25 108.378 167.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -121.16 119.76 33.28 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.002 -0.74 . . . . 62.41 109.002 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 61.8 mt -84.18 -34.82 23.9 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.335 0.654 . . . . 74.12 111.341 -173.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.51 -175.73 4.35 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.49 -0.777 . . . . 42.34 110.119 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -76.03 119.12 19.54 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.539 -0.755 . . . . 61.23 109.207 178.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 71.45 13.5 6.49 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.099 1.76 . . . . 62.31 111.292 -176.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 99.0 t -122.41 113.19 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 108.114 -1.069 . . . . 65.22 108.114 170.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -118.75 171.52 8.15 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.255 -0.646 . . . . 64.54 109.255 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -141.68 102.79 4.25 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 107.306 -1.368 . . . . 62.24 107.306 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 92.9 t -95.23 135.67 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.219 1.007 . . . . 74.45 110.302 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 22.2 t -128.94 116.39 40.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 124.027 0.931 . . . . 73.42 109.38 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' B' ' 103' ' ' PRO . 43.5 tp -95.44 109.41 21.6 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.9 -0.778 . . . . 74.52 108.9 172.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.632 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 59.5 ttt180 -92.34 108.55 20.04 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.465 0.706 . . . . 73.45 109.43 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 38.5 t -106.24 102.49 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.316 1.046 . . . . 54.04 108.99 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 7.9 m -98.2 135.93 39.13 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.436 0.694 . . . . 74.45 109.353 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.522 HG21 HG21 ' B' ' 114' ' ' ILE . 85.8 t -126.9 139.25 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.181 0.993 . . . . 62.11 110.414 -175.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.6 m -124.78 149.44 47.36 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.524 1.13 . . . . 74.14 108.093 172.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.79 142.09 26.24 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 122.927 0.491 . . . . 64.32 110.249 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.558 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 75.8 p -141.06 128.62 21.38 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 123.477 0.485 . . . . 75.04 111.03 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 29.7 mt -100.21 118.85 37.38 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.152 0.981 . . . . 73.2 109.052 175.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.6 -112.34 4.82 Favored Glycine 0 CA--C 1.526 0.726 0 O-C-N 123.932 0.77 . . . . 75.4 112.296 -175.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -115.37 3.05 14.09 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.273 0.629 . . . . 61.35 111.192 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -120.4 159.24 25.49 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.952 0.501 . . . . 75.05 110.69 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 58.6 m -68.94 120.78 15.36 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.618 0.767 . . . . 61.2 110.129 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.558 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -77.61 -61.17 2.08 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.259 -1.015 . . . . 61.23 108.259 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -156.34 164.57 38.14 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.628 -1.169 . . . . 75.44 111.427 177.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 45.5 mt -122.49 153.53 39.04 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 106.093 -1.818 . . . . 72.1 106.093 173.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.439 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 49.5 t -157.92 159.67 36.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.393 -0.595 . . . . 74.11 109.393 -179.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.8 tt0 -165.39 135.32 3.59 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.147 -1.056 . . . . 53.45 108.147 174.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 44.9 t -132.92 145.7 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 108.536 -0.912 . . . . 75.21 108.536 174.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.632 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 61.5 mt-30 -126.06 100.34 6.3 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.601 -0.888 . . . . 73.01 108.601 177.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.431 ' HG3' HD22 ' B' ' 106' ' ' LEU . 8.9 tp-100 -90.43 114.83 27.06 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.18 -0.674 . . . . 75.24 109.18 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.457 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -104.93 167.9 15.48 Favored Glycine 0 C--O 1.242 0.641 0 O-C-N 123.851 0.719 . . . . 43.2 111.652 177.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.29 134.41 3.14 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.992 -0.843 . . . . 73.21 110.992 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.434 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 45.0 mt -86.43 126.19 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 108.549 -0.908 . . . . 75.15 108.549 173.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -135.96 139.34 43.15 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 106.883 -1.525 . . . . 63.45 106.883 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 67.8 m -108.73 91.17 3.53 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.499 0.59 . . . . 62.5 111.531 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 mp -97.6 130.92 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.772 0.829 . . . . 73.5 110.509 -171.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.79 165.57 27.13 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.737 0.815 . . . . 44.44 110.304 173.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.04 -56.9 0.65 Allowed Glycine 0 C--N 1.347 1.192 0 CA-C-N 116.161 -0.472 . . . . 41.54 112.133 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 30.8 mm -87.93 161.83 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.774 0.83 . . . . 75.11 109.798 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -167.89 149.72 5.46 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.859 0.864 . . . . 75.5 110.339 166.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.47 -136.83 12.95 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.907 0.765 . . . . 74.31 112.625 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.2 m -81.86 -23.02 36.61 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 117.256 0.528 . . . . 72.0 111.253 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -68.1 -28.22 67.16 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.934 0.493 . . . . 74.44 109.885 169.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 12.4 ttm -79.16 -28.77 42.78 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.215 0.606 . . . . 63.25 111.081 175.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.61 -26.76 64.02 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.15 0.58 . . . . 75.21 111.093 174.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -71.42 -51.33 24.53 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.331 1.053 . . . . 73.43 110.606 172.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 39.2 t -59.66 -45.83 90.86 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.375 0.67 . . . . 63.51 112.418 -175.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 72.9 mt -87.5 -17.63 31.69 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.388 0.675 . . . . 74.11 111.551 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.7 3.88 32.38 Favored Glycine 0 C--N 1.35 1.325 0 O-C-N 123.244 0.34 . . . . 70.25 113.79 -175.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.53 -58.22 0.53 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.019 0.527 . . . . 74.03 110.4 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -73.64 -48.66 30.81 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.772 0.67 . . . . 74.21 112.378 -169.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.433 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 84.2 m -66.04 -46.92 63.81 Favored Pre-proline 0 CA--C 1.566 1.595 0 CA-C-O 118.699 -0.667 . . . . 63.12 111.322 177.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.433 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 85.5 Cg_exo -55.21 -33.1 83.26 Favored 'Trans proline' 0 C--N 1.402 3.356 0 C-N-CA 122.819 2.346 . . . . 65.22 114.094 168.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -63.13 -40.25 97.05 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.943 0.897 . . . . 64.13 110.25 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 84.2 mt -68.52 -47.53 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 115.121 -0.945 . . . . 74.04 110.45 175.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.431 HD22 ' HG3' ' B' ' 80' ' ' GLN . 96.0 mt -79.08 -4.44 50.28 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.358 -0.837 . . . . 63.12 111.968 -173.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.07 -61.73 7.34 Favored Pre-proline 0 N--CA 1.478 0.958 0 CA-C-O 117.914 -1.041 . . . . 75.54 112.617 -177.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.77 -25.81 68.17 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 121.842 1.694 . . . . 74.53 112.976 -172.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -71.4 -49.59 40.39 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.812 0.845 . . . . 74.23 110.709 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.74 -42.18 97.91 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.47 0.708 . . . . 64.52 110.866 175.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 75.2 ttt-85 -59.17 -59.89 4.73 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.93 1.692 . . . . 74.14 111.512 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -64.01 -25.29 68.06 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.147 0.979 . . . . 72.05 110.845 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.545 ' SG ' HD12 ' B' ' 21' ' ' ILE . 17.5 t -70.38 -46.87 63.19 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 122.293 -0.254 . . . . 71.11 111.604 178.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.522 HG21 HG21 ' B' ' 64' ' ' VAL . 97.8 mt -59.61 -49.98 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.491 0.716 . . . . 72.32 110.004 173.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 14.2 m -60.32 -28.54 68.21 Favored 'General case' 0 CA--C 1.556 1.198 0 O-C-N 123.853 0.721 . . . . 75.44 111.796 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -66.78 -46.86 73.96 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.497 0.719 . . . . 64.41 110.319 173.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.9 mmt -71.44 -30.28 65.85 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.979 0.512 . . . . 74.1 111.26 -175.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 114' ' ' ILE . 73.5 t -61.23 -47.31 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.537 1.135 . . . . 74.22 109.761 170.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 40.8 t -65.35 -36.79 85.09 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.011 -0.995 . . . . 70.12 111.59 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -71.75 -32.44 67.71 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.694 0.798 . . . . 75.51 110.513 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.19 5.89 81.45 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 123.942 0.776 . . . . 65.43 112.665 174.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.425 HG23 ' HB3' ' A' ' 17' ' ' TYR . 54.7 p 56.7 55.79 6.05 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 125.766 1.626 . . . . 62.22 112.658 176.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -119.95 158.39 50.24 Favored Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 124.585 1.154 . . . . 70.43 110.873 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.93 164.83 5.66 Favored 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 123.845 3.03 . . . . 52.33 115.527 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.512 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -65.19 129.84 41.16 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.653 1.181 . . . . 74.51 112.056 -176.706 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -139.01 119.21 13.56 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.914 -0.773 . . . . 71.42 108.914 174.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -116.45 135.33 53.93 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.233 1.013 . . . . 73.45 109.416 173.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 54.5 tp -78.78 149.18 32.7 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.274 0.63 . . . . 71.21 109.861 175.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.35 148.75 86.28 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 123.192 0.597 . . . . 72.53 110.857 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.492 ' HG3' HD11 ' D' ' 16' ' ' ILE . 72.7 Cg_endo -71.15 88.6 0.7 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.118 2.545 . . . . 63.33 111.391 176.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.58 110.45 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 109.416 -0.587 . . . . 64.13 109.416 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -101.58 93.14 5.21 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 107.529 -1.286 . . . . 64.04 107.529 176.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -62.17 -35.95 80.38 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.461 0.476 . . . . 75.51 110.687 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 . . . . . 0 N--CA 1.481 1.103 0 C-N-CA 123.652 0.781 . . . . 71.31 110.335 179.192 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.411 ' CD1' ' HE2' ' C' ' 101' ' ' TYR . 1.1 t80 . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 108.58 -0.896 . . . . 74.54 108.58 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -137.68 120.89 16.84 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.83 -0.804 . . . . 75.23 108.83 173.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.465 HD13 HD11 ' C' ' 16' ' ' ILE . 32.9 mt -69.59 123.76 23.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.68 -0.859 . . . . 73.43 108.68 172.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -87.57 -49.18 7.35 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.518 -0.764 . . . . 71.51 109.564 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -174.41 125.76 0.32 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.754 -0.657 . . . . 75.35 109.728 -169.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.465 HD11 HD13 ' C' ' 13' ' ' ILE . 77.2 mt -116.12 138.42 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.315 -0.995 . . . . 73.4 108.315 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.575 ' HB3' HG23 ' D' ' 122' ' ' THR . 26.5 p90 -175.28 165.45 3.32 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-O 121.484 0.659 . . . . 75.23 110.864 -172.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -86.25 125.07 33.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.501 -0.772 . . . . 71.44 109.389 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.458 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 20.6 mmtp -74.02 -48.47 29.86 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 106.895 -1.52 . . . . 52.23 106.895 167.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 24.4 t70 -134.99 146.56 49.18 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 113.64 -1.618 . . . . 62.33 110.403 -172.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 78.1 mt -140.64 146.04 24.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.088 -1.819 . . . . 71.51 106.088 175.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 31.2 t -160.54 150.32 17.65 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.18 0.514 . . . . 73.43 110.403 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 82.4 t80 -157.18 118.8 3.73 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.042 -1.096 . . . . 63.23 108.042 174.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 24' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' D' ' 19' ' ' LYS . 34.1 mt-10 -126.66 130.35 50.25 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.816 0.446 . . . . 74.41 110.204 169.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' C' ' 28' ' ' ALA . . . -109.57 92.99 12.96 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 107.263 -1.384 . . . . 63.21 107.263 172.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -59.4 -36.18 94.61 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.621 2.881 . . . . 70.4 114.11 -171.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -114.96 29.93 7.7 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.375 0.67 . . . . 40.52 110.245 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.495 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -43.79 -63.79 0.96 Allowed Pre-proline 0 CA--C 1.567 1.597 0 N-CA-C 114.51 1.3 . . . . 74.01 114.51 -164.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -62.67 -40.52 36.72 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 121.918 1.746 . . . . 63.22 112.708 -175.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -69.49 -33.11 72.38 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.075 0.95 . . . . 72.42 112.213 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.646 HG21 ' HA ' ' C' ' 73' ' ' ALA . 3.9 p -81.59 -23.1 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 122.761 0.424 . . . . 63.14 111.857 -177.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -65.45 -28.75 69.44 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.181 0.438 . . . . 74.41 112.181 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -90.23 32.13 0.95 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.696 0.798 . . . . 72.0 110.839 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.7 162.63 24.6 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.248 0.619 . . . . 74.52 111.21 -173.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.19 129.56 38.31 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.302 1.041 . . . . 75.43 110.89 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 49.2 t-105 -87.4 85.11 7.11 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.698 0.799 . . . . 60.41 111.943 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -138.28 76.42 37.9 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 123.976 0.911 . . . . 74.34 108.804 166.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -81.69 156.76 18.59 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.606 2.204 . . . . 73.43 112.533 -176.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 39' ' ' GLU . . . . . 0.557 ' HB3' ' HE2' ' C' ' 41' ' ' LYS . 2.6 mp0 -85.36 93.61 8.76 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 106.255 -1.758 . . . . 75.53 106.255 164.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 13.7 m -67.28 95.56 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-O 122.184 0.993 . . . . 62.4 109.302 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.748 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 75.3 mmtt -95.54 100.74 12.44 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.259 -1.015 . . . . 61.53 108.259 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 pp -88.11 137.28 32.47 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.624 -1.171 . . . . 65.33 108.57 -178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -146.79 107.71 4.17 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.78 -0.822 . . . . 73.03 108.78 -175.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.578 ' H ' HD23 ' C' ' 44' ' ' LEU . 2.0 pt? -119.99 122.86 42.1 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.761 0.791 . . . . 65.52 109.417 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.779 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 22.2 t70 -113.17 157.3 21.85 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 125.168 1.387 . . . . 62.24 109.208 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 74.9 p -113.64 122.27 46.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.2 1.0 . . . . 71.22 109.909 -174.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.59 136.44 41.06 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.578 -0.897 . . . . 71.45 108.578 175.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 25.8 p -164.09 151.65 12.29 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.779 0.431 . . . . 73.52 110.227 -175.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 73.1 p -153.75 154.14 33.49 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.507 0.723 . . . . 75.42 109.713 -175.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -89.3 128.93 35.92 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.529 -0.545 . . . . 73.31 109.529 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.673 HD11 HD12 ' C' ' 83' ' ' ILE . 65.1 mt -96.33 -42.87 7.94 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.638 0.775 . . . . 55.21 111.008 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.86 -166.03 1.51 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.181 -0.918 . . . . 73.2 110.449 -176.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.89 103.77 1.54 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.185 0.994 . . . . 73.2 109.758 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 71.13 -1.67 2.63 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.638 1.575 . . . . 71.13 113.162 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.3 t -91.64 96.3 6.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 106.917 -1.512 . . . . 52.33 106.917 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -110.1 126.69 54.3 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.11 -0.95 . . . . 75.41 110.58 -173.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -83.66 127.79 34.04 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.058 0.943 . . . . 75.01 109.521 175.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 99.1 t -119.28 115.87 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 107.696 -1.224 . . . . 75.2 107.696 170.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 77.5 t -116.38 122.35 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.481 0.712 . . . . 75.14 109.571 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 49.8 tp -106.06 106.8 17.48 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.07 -0.715 . . . . 71.43 109.07 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.779 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 3.1 tmt_? -82.79 108.23 15.99 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.884 -1.154 . . . . 75.51 107.884 177.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.43 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.7 t -106.89 133.64 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.27 -1.011 . . . . 62.23 108.27 176.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 17.7 m -134.19 118.24 17.41 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.033 -0.729 . . . . 60.34 109.033 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 88.7 t -109.75 120.93 61.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.881 -1.054 . . . . 63.41 108.743 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.748 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 6.9 m -107.85 144.3 35.24 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.981 -0.748 . . . . 73.43 108.981 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.9 112.98 10.41 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.499 -0.926 . . . . 52.22 108.499 176.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 51.3 m -133.16 127.39 33.74 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.281 -0.637 . . . . 65.2 109.281 174.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 36.2 mt -84.78 54.98 3.25 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.766 1.226 . . . . 73.22 108.75 176.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.66 -115.8 5.36 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 109.541 -1.424 . . . . 63.25 109.541 -170.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -92.12 -25.7 18.61 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.023 0.929 . . . . 61.1 109.663 170.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -63.48 94.89 0.09 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.178 1.391 . . . . 65.13 110.101 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 30.7 m -75.37 121.48 22.32 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 120.869 0.366 . . . . 75.04 110.56 -174.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.646 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.93 -58.4 3.31 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.999 -1.0 . . . . 70.3 108.604 173.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -163.63 175.58 10.48 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.349 1.071 . . . . 75.05 112.65 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -141.8 141.02 33.15 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 105.046 -2.205 . . . . 75.11 105.046 170.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.483 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.4 t -147.8 134.74 20.21 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.85 -0.796 . . . . 72.05 108.85 -176.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -142.3 117.35 10.01 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.651 0.38 . . . . 64.12 110.499 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 83.3 t -119.1 122.32 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.828 -0.804 . . . . 72.22 108.828 171.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.446 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 57.4 mt-30 -98.46 89.78 4.55 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 107.782 -1.192 . . . . 75.41 107.782 177.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 69.9 tp60 -78.82 108.95 12.64 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.08 -0.964 . . . . 73.22 110.051 -175.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.35 154.66 25.38 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-O 121.51 0.505 . . . . 71.41 111.855 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.522 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -153.42 117.58 0.81 Allowed Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 109.56 -1.416 . . . . 71.11 109.56 176.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.673 HD12 HD11 ' C' ' 51' ' ' LEU . 16.4 mm -85.61 118.51 32.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.018 -1.104 . . . . 65.13 108.018 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.4 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 34.6 m-85 -130.61 129.77 43.14 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.924 0.889 . . . . 72.34 109.256 -171.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 68.6 m -84.31 118.13 24.01 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 109.141 -0.689 . . . . 55.42 109.141 170.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 3.8 mp -114.57 114.01 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 107.656 -1.238 . . . . 64.32 107.656 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.85 162.06 40.03 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.626 0.77 . . . . 70.13 110.259 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.36 -25.61 14.55 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.694 -0.684 . . . . 30.14 113.723 175.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.434 HG13 ' HB3' ' C' ' 94' ' ' MET . 46.3 pt -120.46 162.18 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.675 0.79 . . . . 43.51 110.039 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -147.44 -177.21 5.57 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.768 0.827 . . . . 73.13 109.634 -177.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.0 -136.38 42.05 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 114.569 0.588 . . . . 71.25 114.569 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 92' ' ' THR . . . . . 0.415 ' HA ' ' HB3' ' C' ' 95' ' ' ALA . 34.8 p -65.18 -22.25 66.88 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.535 1.134 . . . . 64.44 112.802 -178.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -60.59 -55.99 26.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.414 0.685 . . . . 70.04 110.045 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.434 ' HB3' HG13 ' C' ' 89' ' ' ILE . 27.7 ptt? -80.79 -20.92 41.51 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.93 -0.577 . . . . 73.13 111.663 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 95' ' ' ALA . . . . . 0.415 ' HB3' ' HA ' ' C' ' 92' ' ' THR . . . -64.5 -35.1 79.85 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.315 0.579 . . . . 72.05 110.742 171.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -74.35 -37.11 63.62 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.324 -0.853 . . . . 72.34 110.386 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.47 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 41.6 t -58.35 -55.97 28.13 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.079 0.862 . . . . 62.1 110.552 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 pp -70.46 -28.3 64.9 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.94 0.496 . . . . 51.34 111.852 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.79 -30.04 60.25 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 114.428 0.531 . . . . 75.23 114.428 -171.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.59 -43.2 0.22 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 117.121 0.461 . . . . 72.01 111.878 -173.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.47 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 70.0 t80 -73.85 -35.73 64.81 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 124.822 1.249 . . . . 72.22 113.095 -170.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.416 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 85.8 m -82.09 -43.7 1.02 Allowed Pre-proline 0 N--CA 1.486 1.333 0 CA-C-O 118.759 -0.639 . . . . 74.24 112.477 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.1 -22.94 61.25 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 121.796 1.664 . . . . 71.03 112.115 171.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 104' ' ' ASN . . . . . 0.495 ' HA ' ' HD2' ' C' ' 107' ' ' PHE . 25.0 t-20 -56.36 -41.28 75.91 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.906 0.883 . . . . 71.2 111.002 175.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.457 HD12 HH12 ' A' ' 111' ' ' ARG . 44.0 mm -59.88 -42.08 88.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 115.156 -0.929 . . . . 73.2 109.802 175.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.522 HD21 ' HA3' ' C' ' 82' ' ' GLY . 96.6 mt -82.34 -20.61 36.97 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.077 -0.965 . . . . 73.03 113.484 -169.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 107' ' ' PHE . . . . . 0.495 ' HD2' ' HA ' ' C' ' 104' ' ' ASN . 16.5 m-85 -55.56 -49.25 93.71 Favored Pre-proline 0 N--CA 1.496 1.837 0 CA-C-O 118.008 -0.996 . . . . 75.01 113.43 -177.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -58.0 -39.81 82.97 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 122.274 1.983 . . . . 62.4 113.999 178.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.426 ' HE2' HG21 ' A' ' 115' ' ' THR . 68.5 m-85 -68.11 -48.32 65.77 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.411 0.685 . . . . 72.42 110.757 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.61 -42.06 91.76 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.128 -0.942 . . . . 63.51 110.466 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -54.59 -57.98 9.3 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.405 1.065 . . . . 72.34 110.819 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -68.02 -30.94 70.29 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.48 0.488 . . . . 71.14 111.09 -173.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 12.5 t -72.31 -32.9 66.96 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.661 0.384 . . . . 61.32 111.289 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.483 HG23 ' SG ' ' C' ' 76' ' ' CYS . 96.9 mt -73.03 -48.1 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.565 0.746 . . . . 72.14 109.706 173.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 27.1 m -67.55 -30.22 69.81 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.409 0.684 . . . . 70.12 111.413 -174.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 43.5 t -66.0 -44.82 83.69 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.708 -0.849 . . . . 74.1 108.708 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.797 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.06 -38.32 90.71 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.383 1.073 . . . . 74.34 112.474 177.763 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' C' ' 123' ' ' PHE . 79.0 t -65.52 -39.92 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.718 0.807 . . . . 65.53 109.983 174.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.5 t -72.11 -30.99 65.62 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.143 -0.935 . . . . 72.25 111.282 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 73.2 mtt-85 -71.79 -34.1 69.13 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.826 0.851 . . . . 62.5 109.181 175.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.33 6.4 72.49 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 123.985 0.803 . . . . 63.12 112.958 173.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.2 p 61.11 26.81 16.68 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.425 1.89 . . . . 70.12 114.393 171.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.424 ' HB2' HG13 ' C' ' 118' ' ' VAL . 96.5 m-85 -88.15 150.44 47.28 Favored Pre-proline 0 N--CA 1.474 0.765 0 N-CA-C 109.619 -0.511 . . . . 71.5 109.619 173.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.64 143.11 22.85 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.471 2.781 . . . . 54.51 113.762 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -58.08 114.97 2.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.41 1.084 . . . . 72.54 112.262 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 53.9 tp -117.08 103.83 10.63 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.025 0.93 . . . . 73.04 108.915 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -95.35 130.36 42.16 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.838 0.855 . . . . 72.23 109.18 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 tt -74.57 128.21 35.0 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 108.302 -0.999 . . . . 71.51 108.302 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.11 147.3 93.49 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.556 0.742 . . . . 74.3 111.72 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.47 ' HB3' HD12 ' A' ' 16' ' ' ILE . 11.6 Cg_endo -57.89 95.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.821 2.347 . . . . 63.2 112.981 171.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 47.4 t -101.59 108.8 24.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.778 -1.194 . . . . 62.24 107.778 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -90.7 88.01 6.92 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.588 -0.893 . . . . 54.43 108.588 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -54.71 -44.71 73.69 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.663 0.785 . . . . 71.54 111.757 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.5 t70 . . . . . 0 CA--C 1.549 0.915 0 O-C-N 124.954 1.408 . . . . 53.24 110.131 -177.628 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 89.5 m . . . . . 0 N--CA 1.467 0.384 0 N-CA-C 109.314 -0.625 . . . . 72.44 109.314 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -153.88 91.52 1.47 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.896 -1.52 . . . . 54.12 106.896 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -119.11 116.36 26.19 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.94 -0.763 . . . . 70.24 108.94 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.496 HD13 HG21 ' D' ' 105' ' ' ILE . 8.7 mt -74.32 116.43 16.85 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 N-CA-C 108.898 -0.779 . . . . 72.55 108.898 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 14' ' ' GLN . . . . . 0.607 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 6.9 mm-40 -81.68 -44.94 16.44 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.555 0.742 . . . . 74.31 110.492 -176.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -171.26 143.67 1.91 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.425 -0.352 . . . . 72.13 111.373 -170.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.492 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.4 mp -117.8 132.66 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 107.223 -1.399 . . . . 74.42 107.223 173.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -161.39 141.49 10.69 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.43 0.633 . . . . 74.45 111.056 177.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 77.0 p -77.36 110.96 12.53 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.004 -0.998 . . . . 71.41 109.265 175.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' C' ' 24' ' ' GLU . 36.9 mtpt -85.53 -23.46 27.69 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.565 -0.289 . . . . 75.41 110.481 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.799 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 4.5 t70 -143.19 139.72 30.43 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.333 1.053 . . . . 61.43 108.84 173.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.797 HG21 ' HE2' ' C' ' 117' ' ' MET . 94.4 mt -139.0 146.88 25.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 106.909 -1.515 . . . . 74.21 106.909 169.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.0 t -159.87 110.26 1.89 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.347 0.659 . . . . 44.54 110.062 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.456 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 94.0 t80 -109.54 131.41 55.09 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 106.106 -1.812 . . . . 72.03 106.106 168.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.474 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 39.0 mt-10 -138.61 119.77 14.6 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.97 0.508 . . . . 73.34 109.974 -172.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -135.36 83.71 37.11 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 108.833 -0.803 . . . . 70.2 108.833 178.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.75 -33.74 7.76 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.834 2.356 . . . . 72.33 112.237 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -89.22 -3.09 58.68 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.422 1.089 . . . . 74.4 111.89 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.453 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -32.39 -61.99 0.31 Allowed Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 116.795 2.146 . . . . 71.51 116.795 -164.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.409 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 89.3 Cg_endo -76.34 -27.54 7.83 Favored 'Trans proline' 0 C--N 1.376 2.023 0 CA-C-N 122.708 2.003 . . . . 63.23 114.262 -172.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -86.86 -21.4 26.4 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 117.931 0.332 . . . . 64.23 110.838 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.453 HG12 ' O ' ' D' ' 28' ' ' ALA . 9.9 p -82.58 -16.19 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 122.794 0.437 . . . . 64.04 110.041 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.409 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.5 m-85 -68.04 -20.11 64.96 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.46 0.304 . . . . 65.54 111.648 175.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -56.01 -32.12 63.68 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.276 0.56 . . . . 73.13 110.057 171.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -85.99 85.57 7.37 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.831 1.252 . . . . 61.41 109.32 174.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -93.74 78.21 4.25 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.416 0.626 . . . . 73.1 110.418 -176.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -149.73 -178.03 6.22 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.49 -0.777 . . . . 65.15 109.612 170.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -76.42 110.96 12.91 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.65 0.78 . . . . 72.12 109.627 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.542 ' HB3' ' HG ' ' D' ' 68' ' ' LEU . 18.5 Cg_endo -63.22 147.44 93.94 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.472 2.114 . . . . 50.24 112.408 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -64.55 119.34 10.27 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.979 0.799 . . . . 72.23 108.954 172.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.693 HG13 HG13 ' D' ' 64' ' ' VAL . 99.5 t -96.54 131.04 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.856 -0.794 . . . . 63.14 108.856 -176.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.661 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 43.4 mtpt -106.33 157.36 17.67 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.807 0.843 . . . . 73.24 109.31 169.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.46 113.43 16.82 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 106.664 -1.606 . . . . 74.1 106.664 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.723 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 7.5 m-20 -117.71 144.22 45.47 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.992 -1.004 . . . . 64.44 108.912 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.33 154.72 33.11 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.023 0.529 . . . . 71.43 110.18 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 30.1 t70 -153.11 140.29 19.42 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.819 -1.178 . . . . 71.05 107.819 167.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 87.7 m -104.54 143.82 32.52 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.674 0.79 . . . . 65.12 110.454 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -154.14 152.76 30.78 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.014 0.925 . . . . 34.14 109.377 171.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 67.0 p -169.04 154.21 5.98 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.441 0.696 . . . . 63.22 110.256 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 82.9 p -156.02 156.06 33.78 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.291 0.637 . . . . 75.44 109.524 171.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -96.13 118.2 32.24 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.185 -1.043 . . . . 75.44 108.185 173.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.1 mt -92.85 -27.43 17.14 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.933 0.493 . . . . 74.32 110.757 -174.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.509 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -163.87 -178.68 5.82 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.264 1.025 . . . . 41.54 110.157 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.95 107.88 4.92 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.24 -0.891 . . . . 74.53 110.038 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 68.51 21.55 8.08 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.424 1.49 . . . . 75.34 111.367 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 42.3 t -124.11 115.31 44.5 Favored 'Isoleucine or valine' 0 C--N 1.35 0.599 0 N-CA-C 107.535 -1.283 . . . . 63.25 107.535 170.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -124.38 170.41 10.86 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.338 0.655 . . . . 73.3 109.489 -171.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.524 ' HB2' HD11 ' D' ' 51' ' ' LEU . 26.4 tt0 -130.31 117.99 20.61 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.649 -0.705 . . . . 75.34 109.397 178.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 88.0 t -100.99 117.38 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.424 1.09 . . . . 74.32 108.291 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 24.4 t -119.14 117.45 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.552 -0.907 . . . . 75.33 108.552 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.01 122.24 44.62 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.885 -0.783 . . . . 73.31 108.885 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.533 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 49.6 ttm-85 -87.26 101.87 13.94 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.226 -0.657 . . . . 74.22 109.226 175.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 83.2 t -90.72 114.73 28.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.203 -1.036 . . . . 75.14 108.203 174.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.723 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 28.0 m -116.02 139.62 50.09 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.277 0.561 . . . . 62.2 109.543 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.693 HG13 HG13 ' D' ' 40' ' ' VAL . 7.7 t -125.25 100.26 6.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 124.381 1.072 . . . . 73.41 108.136 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.661 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 58.2 m -93.39 93.75 8.33 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.185 -1.042 . . . . 73.13 108.185 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.72 141.2 29.48 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.026 -0.988 . . . . 45.34 109.487 -176.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.523 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 55.7 m -143.76 126.12 15.73 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.656 0.597 . . . . 75.14 111.105 -177.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.542 ' HG ' ' HB3' ' D' ' 38' ' ' PRO . 26.0 mt -93.75 115.6 28.03 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.348 1.059 . . . . 61.0 108.392 172.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.84 -137.73 32.46 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.402 -0.679 . . . . 65.41 111.402 -171.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -90.88 4.35 52.08 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.212 0.605 . . . . 70.21 111.84 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -118.72 160.2 22.29 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.61 0.364 . . . . 75.43 110.279 -177.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 48.7 m -68.34 133.18 48.33 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 123.753 0.658 . . . . 74.23 111.312 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.523 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.51 -68.13 0.78 Allowed 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.519 -1.289 . . . . 75.42 107.519 171.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -151.24 159.51 44.33 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 115.641 -0.709 . . . . 72.32 110.874 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.474 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 31.6 mt -117.7 110.12 17.47 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 105.778 -1.934 . . . . 73.13 105.778 173.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.486 ' SG ' HG23 ' D' ' 114' ' ' ILE . 14.8 t -119.69 112.17 18.95 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.818 -0.808 . . . . 63.35 108.818 -172.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -139.91 141.1 36.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.574 0.75 . . . . 55.45 109.891 -162.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 91.6 t -147.45 121.44 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.126 0.97 . . . . 71.34 109.228 -177.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.799 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.4 mt-30 -86.56 91.19 8.49 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 107.802 -1.184 . . . . 64.45 107.802 161.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 80' ' ' GLN . . . . . 0.411 ' O ' HD13 ' D' ' 106' ' ' LEU . 31.8 tp60 -80.38 98.63 7.57 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.392 -1.336 . . . . 75.4 107.392 175.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.16 147.43 18.59 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.628 -0.989 . . . . 72.03 110.628 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.7 133.71 4.81 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.0 -0.84 . . . . 60.41 111.0 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.607 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 25.6 mt -89.17 131.2 37.07 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 108.053 -1.092 . . . . 71.51 108.053 174.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -134.74 124.12 24.72 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.407 -0.59 . . . . 71.03 109.407 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 37.8 m -82.86 97.39 8.63 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.683 -0.858 . . . . 73.13 108.683 169.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.52 143.51 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.599 -0.519 . . . . 73.3 109.599 -177.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.82 142.33 9.03 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.954 0.502 . . . . 51.44 110.437 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.56 -22.72 14.57 Favored Glycine 0 C--N 1.345 1.035 0 O-C-N 123.658 0.599 . . . . 74.54 113.175 174.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 63.7 mt -100.07 146.91 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 117.414 0.607 . . . . 51.33 110.16 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -160.3 176.15 12.03 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.576 1.151 . . . . 75.53 110.041 -178.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 91' ' ' GLY . . . . . 0.401 ' O ' ' HG2' ' D' ' 94' ' ' MET . . . 74.61 -130.74 12.2 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 115.366 -0.834 . . . . 70.2 113.743 174.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 72.8 p -79.57 -24.59 41.99 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.15 0.58 . . . . 73.14 111.027 -177.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -70.06 -38.39 75.75 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.948 -0.569 . . . . 73.13 109.938 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' D' ' 91' ' ' GLY . 25.5 ptt? -72.33 -27.25 62.3 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 116.49 -0.323 . . . . 73.4 110.682 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.9 -40.95 90.52 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 120.964 0.411 . . . . 75.15 111.293 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -78.66 -37.28 42.3 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.526 0.73 . . . . 75.43 111.206 175.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 50.0 t -61.29 -41.05 96.31 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.233 0.539 . . . . 75.12 111.275 -176.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 23.6 mt -92.47 -31.92 15.08 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.238 -0.892 . . . . 64.42 110.707 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.15 4.83 81.28 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.719 -0.673 . . . . 71.13 113.823 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -156.81 -57.47 0.09 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 117.867 0.834 . . . . 63.53 112.384 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -66.36 -37.06 84.46 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 112.796 0.665 . . . . 73.43 112.796 -169.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 73.5 m -74.84 -48.2 4.8 Favored Pre-proline 0 CA--C 1.566 1.574 0 CA-C-O 118.689 -0.672 . . . . 54.21 111.824 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.42 -13.76 38.35 Favored 'Trans proline' 0 C--N 1.4 3.274 0 C-N-CA 121.766 1.644 . . . . 71.4 113.404 170.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -65.86 -39.35 90.67 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.601 0.76 . . . . 73.24 109.914 173.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.496 HG21 HD13 ' D' ' 13' ' ' ILE . 49.3 mm -66.02 -39.18 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 115.361 -0.836 . . . . 71.45 110.45 175.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.411 HD13 ' O ' ' D' ' 80' ' ' GLN . 87.7 mt -80.49 -10.47 59.74 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 115.068 -0.969 . . . . 72.1 111.761 -174.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -65.25 -47.57 70.7 Favored Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 124.403 1.081 . . . . 73.44 113.103 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 108' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 72.7 Cg_exo -53.88 -45.46 40.86 Favored 'Trans proline' 0 C--N 1.39 2.758 0 C-N-CA 122.378 2.052 . . . . 74.22 113.378 173.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -69.68 -36.43 75.99 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.481 -0.781 . . . . 73.14 111.855 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.16 -47.35 80.18 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.891 0.476 . . . . 41.54 109.819 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -59.09 -49.48 77.73 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 114.59 -1.186 . . . . 65.3 111.146 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -64.64 -45.57 86.24 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 123.671 0.607 . . . . 74.13 111.277 -175.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.7 t -59.58 -42.17 91.91 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 123.662 0.601 . . . . 52.25 110.666 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.486 HG23 ' SG ' ' D' ' 76' ' ' CYS . 69.9 mt -59.99 -57.96 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.856 0.863 . . . . 71.24 110.779 172.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.454 HG23 ' HG3' ' D' ' 125' ' ' GLN . 97.4 m -53.54 -41.97 66.98 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 124.765 1.226 . . . . 52.23 111.841 -174.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 45.2 t -66.94 -42.54 85.12 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.76 -1.109 . . . . 73.51 110.268 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.6 mtm -68.14 -31.71 71.47 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.909 0.484 . . . . 73.25 111.716 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.468 HG23 ' O ' ' D' ' 114' ' ' ILE . 84.8 t -62.0 -47.11 94.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.327 0.651 . . . . 63.33 109.835 174.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.7 p -74.41 -24.98 59.19 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.642 -0.708 . . . . 62.55 111.235 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -70.54 -34.69 72.54 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.635 0.774 . . . . 75.31 109.896 174.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.46 9.44 73.37 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 123.889 0.743 . . . . 71.41 112.592 175.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.575 HG23 ' HB3' ' C' ' 17' ' ' TYR . 64.0 p 59.27 19.62 7.75 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 126.383 1.873 . . . . 64.02 113.883 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -84.16 154.38 63.49 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.429 0.692 . . . . 73.45 109.443 171.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -56.32 131.51 46.21 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.195 2.596 . . . . 73.34 112.513 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.454 ' HG3' HG23 ' D' ' 115' ' ' THR . 32.9 tt0 -50.75 137.55 20.06 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.747 1.219 . . . . 72.2 111.827 -177.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -128.96 101.7 6.18 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.724 -0.843 . . . . 73.05 108.724 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -100.65 121.04 40.97 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.775 0.83 . . . . 74.4 108.984 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 6.7 mp -73.65 119.26 17.63 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 109.198 -0.667 . . . . 64.22 109.198 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.44 148.58 79.95 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 123.771 0.829 . . . . 70.44 112.012 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -68.94 98.77 0.62 Allowed 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.871 2.381 . . . . 74.32 111.462 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.48 1.062 0 C-N-CA 123.398 0.679 . . . . 52.31 111.027 -177.698 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.722 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 33.4 t80 . . . . . 0 C--O 1.235 0.317 0 N-CA-C 109.637 -0.505 . . . . 74.22 109.637 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -148.5 127.71 12.93 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.21 -1.033 . . . . 54.21 108.21 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.643 HG12 ' HD2' ' A' ' 84' ' ' PHE . 53.7 mt -85.36 122.9 38.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 108.575 -0.898 . . . . 71.33 108.575 174.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -85.02 -41.47 15.77 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.899 -0.778 . . . . 72.41 108.899 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -173.34 128.83 0.44 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 111.453 0.168 . . . . 73.24 111.453 -167.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.4 HD12 ' CG ' ' C' ' 130' ' ' PRO . 91.8 mt -123.17 132.9 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 124.141 0.976 . . . . 51.23 109.219 176.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.475 ' HB3' HG23 ' B' ' 122' ' ' THR . 30.0 p90 -167.12 154.2 8.74 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.853 0.861 . . . . 73.53 111.119 -169.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.4 p -75.28 126.08 30.28 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.713 -0.676 . . . . 73.31 109.466 170.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.401 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 39.8 mtpt -93.48 -21.21 19.61 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.75 -0.463 . . . . 61.02 109.75 173.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.497 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 25.0 t70 -153.3 138.49 17.41 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.051 -0.977 . . . . 74.1 110.045 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.2 mt -133.28 144.29 36.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 C-N-CA 124.989 1.316 . . . . 55.24 108.09 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.609 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 42.8 t -147.64 126.37 12.61 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.889 -0.782 . . . . 74.33 108.889 170.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 84.9 t80 -131.3 117.44 18.95 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 106.289 -1.745 . . . . 71.01 106.289 170.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -125.5 120.02 29.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.134 0.425 . . . . 74.42 109.93 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.1 80.65 15.43 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 106.93 -1.507 . . . . 74.32 106.93 171.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.35 -35.54 39.62 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 122.578 2.185 . . . . 71.14 111.488 -174.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -106.01 25.51 10.85 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.922 -1.035 . . . . 63.12 109.457 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.457 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -49.11 -50.83 61.04 Favored Pre-proline 0 CA--C 1.561 1.393 0 N-CA-C 113.471 0.915 . . . . 71.24 113.471 -177.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.22 -21.35 67.4 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 121.647 1.565 . . . . 72.35 113.441 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -91.53 -35.11 14.48 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.105 0.962 . . . . 61.02 110.657 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.8 p -75.35 -25.03 17.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.564 -0.743 . . . . 64.54 112.569 -163.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -73.35 -17.69 61.26 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.325 0.65 . . . . 74.03 110.874 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -85.65 -32.1 22.18 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.483 1.113 . . . . 74.23 110.134 174.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -68.92 157.88 35.74 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.75 0.82 . . . . 53.21 111.349 -175.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -70.87 131.67 44.12 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.385 0.674 . . . . 73.44 109.386 171.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -84.11 88.3 7.18 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.487 0.661 . . . . 73.15 110.189 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -120.98 81.17 34.92 Favored Pre-proline 0 C--O 1.245 0.829 0 N-CA-C 107.977 -1.12 . . . . 64.3 107.977 169.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.59 112.11 3.39 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 121.972 1.781 . . . . 70.0 112.015 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -94.58 88.84 5.57 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 105.826 -1.916 . . . . 75.1 105.826 167.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.4 m -77.55 114.85 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 113.985 -1.461 . . . . 74.03 111.228 -172.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.437 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 87.0 tttt -87.29 130.98 34.39 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.286 -0.87 . . . . 70.05 109.085 173.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 pp -103.35 148.84 25.38 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.992 -0.744 . . . . 71.44 108.992 173.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.501 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 21.3 t70 -147.56 133.54 19.19 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.134 -0.691 . . . . 43.13 109.134 172.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.6 mt -126.38 128.87 47.72 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.033 0.933 . . . . 73.03 109.805 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -140.15 156.98 46.31 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.253 -0.647 . . . . 74.22 109.253 171.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.3 p -115.36 152.96 31.86 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.467 0.707 . . . . 73.41 110.804 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -145.57 111.85 5.73 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.179 -1.045 . . . . 74.34 108.179 173.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -89.85 152.47 21.25 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.109 0.563 . . . . 75.2 109.7 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.2 t -157.54 142.12 16.48 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.557 0.743 . . . . 74.41 109.851 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -112.76 134.66 54.17 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.706 -0.85 . . . . 71.22 108.706 171.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.594 HD11 ' HB2' ' A' ' 57' ' ' GLU . 27.0 mt -112.59 -28.86 7.67 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.303 0.641 . . . . 64.34 110.528 -174.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.44 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -160.63 179.64 8.4 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.163 0.985 . . . . 34.14 109.058 175.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.49 120.84 13.59 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.898 -0.778 . . . . 75.24 108.898 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 72.59 -1.88 2.83 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.92 1.288 . . . . 62.15 112.272 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.44 ' CG2' ' HB3' ' A' ' 52' ' ' ALA . 57.8 t -101.16 112.0 32.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 107.9 -1.148 . . . . 74.25 107.9 176.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -115.84 156.37 26.22 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 123.653 0.781 . . . . 75.22 108.996 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.594 ' HB2' HD11 ' A' ' 51' ' ' LEU . 48.3 tt0 -128.18 120.72 27.85 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.387 -0.968 . . . . 73.32 108.387 177.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.1 t -99.45 112.68 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.583 -1.636 . . . . 54.24 106.583 174.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 49.2 t -102.55 127.37 56.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 107.633 -1.247 . . . . 45.11 107.633 170.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.24 117.03 28.44 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.289 -1.004 . . . . 73.34 108.289 177.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.515 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 57.6 mtt180 -84.92 100.95 11.96 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.064 0.945 . . . . 70.35 108.81 176.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.8 t -103.43 103.29 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.613 -0.884 . . . . 61.22 108.613 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 26.0 m -109.3 109.32 20.19 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.224 0.61 . . . . 71.53 109.78 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.584 HG11 HD21 ' A' ' 126' ' ' LEU . 2.6 t -105.97 133.36 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.944 1.298 . . . . 71.53 109.537 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 41.7 m -120.47 143.14 48.68 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.538 -0.912 . . . . 72.31 108.538 173.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.14 109.58 18.64 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.612 -1.255 . . . . 74.14 107.612 168.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.2 m -111.79 127.39 55.79 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.773 -0.825 . . . . 61.24 108.773 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.6 mt -89.63 49.21 1.7 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.265 1.026 . . . . 72.22 109.314 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.28 -92.0 1.37 Allowed Glycine 0 CA--C 1.529 0.906 0 N-CA-C 111.766 -0.534 . . . . 64.33 111.766 -173.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -88.68 -30.53 19.06 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.027 0.531 . . . . 53.34 112.011 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -113.36 126.78 55.74 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 109.779 -0.452 . . . . 75.34 109.779 -175.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.4 m -71.12 126.06 28.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.839 0.456 . . . . 63.52 109.81 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.528 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -71.87 -57.44 4.33 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.677 0.791 . . . . 72.53 109.923 176.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -157.33 174.94 14.67 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.599 -1.182 . . . . 64.45 111.249 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 tp -132.42 143.55 49.88 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 113.878 -1.51 . . . . 75.14 108.123 175.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 76.1 m -137.65 129.21 28.26 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.968 1.307 . . . . 71.5 107.878 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 39.7 tt0 -147.73 116.33 6.68 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.489 -0.93 . . . . 72.42 108.489 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.4 t -133.08 110.8 15.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 123.364 0.665 . . . . 74.23 109.743 -173.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.515 ' HG2' ' HG2' ' A' ' 61' ' ' ARG . 18.6 mt-30 -86.4 85.94 7.33 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.092 -1.077 . . . . 71.23 108.092 172.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.456 ' HG3' HD22 ' A' ' 106' ' ' LEU . 9.1 tp-100 -77.61 101.02 6.36 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.27 -0.877 . . . . 75.14 108.907 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.98 146.26 20.35 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.694 -0.962 . . . . 71.24 110.694 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.508 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -149.88 122.51 1.43 Allowed Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 111.399 -0.68 . . . . 74.53 111.399 -176.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 24.6 mt -82.84 116.88 27.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 109.079 -0.711 . . . . 75.32 109.079 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.722 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 14.6 m-85 -133.14 120.56 21.38 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.507 -1.294 . . . . 74.13 107.507 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.0 m -85.17 99.47 11.1 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.854 -0.795 . . . . 51.31 108.854 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.5 pt . . . . . 0 CA--C 1.547 0.862 0 C-N-CA 123.909 0.884 . . . . 74.54 110.67 -172.372 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 111.532 0.197 . . . . 73.12 111.532 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -63.24 -37.87 88.92 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.036 0.534 . . . . 74.03 110.749 174.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 22.2 t -74.66 -54.55 7.2 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.442 0.297 . . . . 74.02 111.09 -175.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 pp -75.42 -30.64 60.11 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.352 0.661 . . . . 74.45 112.347 -172.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.92 3.94 25.75 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.368 -0.684 . . . . 64.33 114.386 -170.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.73 -51.9 0.19 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 118.089 0.945 . . . . 70.31 112.612 -175.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.519 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 91.4 t80 -78.74 -61.7 1.93 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.509 0.723 . . . . 72.35 112.327 -170.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.41 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 71.2 m -65.12 -36.78 16.85 Favored Pre-proline 0 CA--C 1.564 1.495 0 N-CA-C 113.627 0.973 . . . . 61.4 113.627 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 18.0 Cg_endo -61.3 -32.36 89.82 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 121.905 1.737 . . . . 73.14 113.603 165.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -74.31 -21.85 59.53 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 122.988 0.515 . . . . 71.21 110.563 177.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 23.2 mm -65.63 -38.86 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.215 0.606 . . . . 73.24 109.411 170.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.508 HD21 ' HA3' ' A' ' 82' ' ' GLY . 86.4 mt -74.33 -23.55 59.07 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.901 0.881 . . . . 74.2 112.438 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.465 ' HE2' ' HA ' ' A' ' 130' ' ' PRO . 54.7 t80 -61.17 -47.59 94.28 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-O 118.209 -0.9 . . . . 60.21 113.268 -174.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -60.76 -34.86 91.14 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.225 1.95 . . . . 74.43 113.479 174.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -75.41 -37.51 60.44 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.365 0.666 . . . . 74.44 112.03 -178.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.28 -35.95 63.76 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.813 0.445 . . . . 55.4 109.909 177.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.647 ' NH1' HG23 ' C' ' 105' ' ' ILE . 27.3 ttm105 -63.73 -39.99 95.65 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 108.67 -0.863 . . . . 75.51 108.67 172.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.43 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 3.3 tm-20 -64.52 -48.16 76.16 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.131 0.972 . . . . 75.13 111.461 -177.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 36.0 t -60.68 -43.2 98.0 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 123.906 0.754 . . . . 74.14 110.16 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 72.4 mt -65.08 -44.31 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.353 0.661 . . . . 71.24 110.511 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.9 m -57.83 -41.75 82.94 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.564 1.145 . . . . 75.42 110.793 -177.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.3 t -77.71 -42.84 33.03 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.209 -0.905 . . . . 63.55 111.056 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 9.8 mtp -56.91 -46.85 81.7 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 123.84 0.856 . . . . 53.23 111.621 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.6 t -64.06 -41.9 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.567 1.147 . . . . 75.53 110.949 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.687 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 38.2 t -67.33 -35.11 78.75 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.769 -0.65 . . . . 52.44 111.165 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -74.46 -28.31 60.97 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.814 0.846 . . . . 74.51 110.141 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.9 6.79 64.94 Favored Glycine 0 C--N 1.354 1.53 0 O-C-N 123.899 0.75 . . . . 41.23 112.508 171.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.498 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.7 t 62.64 19.49 11.37 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 127.108 2.163 . . . . 43.43 113.299 172.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -81.95 161.78 59.52 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 109.174 -0.676 . . . . 61.44 109.174 175.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -53.53 115.13 2.11 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.343 2.029 . . . . 71.01 110.286 169.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.687 ' HG3' ' HB2' ' A' ' 119' ' ' SER . 29.2 tt0 -55.37 131.54 46.01 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 124.289 0.993 . . . . 72.13 111.24 -166.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.584 HD21 HG11 ' A' ' 64' ' ' VAL . 55.7 tp -107.08 106.73 17.38 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.425 -0.807 . . . . 71.21 110.605 -162.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -121.64 107.66 12.64 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.556 1.142 . . . . 71.24 108.582 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.451 ' O ' HD12 ' C' ' 13' ' ' ILE . 7.5 mp -72.75 145.88 46.78 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.826 0.45 . . . . 71.32 110.52 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.49 149.18 92.57 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 123.975 0.91 . . . . 61.42 111.145 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.628 ' HD3' HG13 ' C' ' 13' ' ' ILE . 44.0 Cg_endo -66.16 131.07 25.75 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 123.014 2.476 . . . . 33.32 112.194 -178.09 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.2 t -113.32 112.98 42.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.735 -1.209 . . . . 74.25 107.735 173.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -81.1 86.69 6.12 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.036 -0.727 . . . . 61.1 109.036 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 . . . . . 0 N--CA 1.475 0.793 0 CA-C-N 115.9 -0.591 . . . . 65.11 109.925 177.941 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.559 ' HB2' ' HB ' ' B' ' 89' ' ' ILE . 16.8 ttt . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.384 0.611 . . . . 64.33 112.415 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 85.3 m -159.24 143.35 15.16 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 124.171 0.988 . . . . 54.41 108.573 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -145.97 156.86 43.79 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.652 0.739 . . . . 72.41 110.448 158.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -125.26 130.59 52.35 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 106.257 -1.757 . . . . 75.42 106.257 172.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.566 HD11 HD13 ' B' ' 105' ' ' ILE . 34.0 mt -67.09 112.68 2.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 108.567 -0.901 . . . . 70.21 108.567 176.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 14' ' ' GLN . . . . . 0.448 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 16.9 mm-40 -80.15 -49.65 11.39 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.015 -0.993 . . . . 75.4 109.179 -178.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.498 ' HE ' HG21 ' A' ' 122' ' ' THR . 42.6 ttt180 -167.07 139.54 3.44 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.67 -0.695 . . . . 74.25 110.244 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.5 mt -114.86 141.56 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 107.424 -1.325 . . . . 74.0 107.424 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -167.78 153.43 7.26 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.689 0.757 . . . . 64.42 112.362 -176.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.6 m -80.54 122.93 27.65 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.822 -1.081 . . . . 73.45 108.707 168.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.459 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 38.0 mtpt -91.4 -41.89 10.62 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.015 0.526 . . . . 72.23 109.669 176.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 24.5 t70 -142.59 139.03 31.19 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.845 -0.616 . . . . 75.32 111.18 -168.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.415 HD11 ' SG ' ' B' ' 113' ' ' CYS . 48.8 mm -133.15 137.97 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.198 1.399 . . . . 70.43 108.174 173.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.535 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 42.8 t -144.75 117.46 8.68 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.338 -1.356 . . . . 73.51 107.338 -177.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.497 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 84.3 t80 -140.07 116.54 10.71 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.76 -1.2 . . . . 72.33 107.76 176.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -124.46 113.84 18.66 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.667 0.787 . . . . 74.1 109.34 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.728 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -108.24 85.45 2.74 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 107.989 -1.115 . . . . 53.43 107.989 170.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -73.38 -23.34 17.66 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.776 2.318 . . . . 64.35 112.667 -171.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -114.99 5.46 15.02 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.169 0.988 . . . . 70.22 110.936 -173.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.728 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -43.71 -61.63 1.84 Allowed Pre-proline 0 N--CA 1.492 1.643 0 C-N-CA 125.638 1.575 . . . . 73.21 114.382 -167.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.401 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 29.0 Cg_endo -61.86 -24.99 77.84 Favored 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 122.56 2.174 . . . . 72.33 113.245 -171.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -96.04 -33.08 12.25 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.652 0.781 . . . . 74.34 111.496 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.429 HG22 HD12 ' B' ' 68' ' ' LEU . 2.8 p -74.44 -16.03 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 122.601 0.361 . . . . 64.31 110.571 -175.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -67.88 -7.98 32.64 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.63 0.772 . . . . 71.12 112.838 176.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -67.54 -13.29 61.92 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 122.444 0.297 . . . . 72.03 110.902 171.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -105.55 110.42 22.74 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.445 1.498 . . . . 64.24 109.346 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -107.53 79.71 1.32 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.452 0.701 . . . . 64.13 110.93 -170.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 43.0 p90 -156.93 175.75 13.67 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.584 0.754 . . . . 73.54 109.217 171.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -77.37 113.13 28.64 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.197 -1.038 . . . . 75.55 108.197 173.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.28 148.53 88.6 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.171 1.914 . . . . 74.51 111.925 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -66.53 122.43 17.55 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.727 -0.842 . . . . 74.15 108.727 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.489 HG13 HG13 ' B' ' 64' ' ' VAL . 57.7 t -111.23 131.35 62.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 124.042 0.937 . . . . 63.24 111.021 -171.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -106.02 135.23 47.85 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.942 -1.133 . . . . 53.25 107.942 169.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 pp -109.24 154.83 21.86 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.06 0.944 . . . . 74.55 109.542 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -159.81 150.45 19.05 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.566 0.746 . . . . 74.34 109.273 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.475 HD13 HD11 ' B' ' 60' ' ' LEU . 62.4 mt -123.94 152.27 42.65 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.388 0.675 . . . . 65.41 110.197 175.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 11.4 t70 -138.5 142.6 39.35 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.635 1.174 . . . . 75.22 107.925 173.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 39.4 p -109.94 111.92 23.62 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.428 0.691 . . . . 73.32 109.959 -176.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.464 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -116.71 149.08 40.43 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.179 0.992 . . . . 75.11 108.379 176.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 46.5 p -145.45 162.14 38.05 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.292 0.479 . . . . 63.31 112.292 -174.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.8 p -153.55 136.2 15.22 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 114.691 -1.14 . . . . 70.44 108.532 164.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -93.86 110.18 21.85 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.157 -1.053 . . . . 63.32 108.157 173.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 63.6 mt -78.01 -39.81 41.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.189 0.596 . . . . 72.04 111.2 -174.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.47 -167.5 1.6 Allowed 'General case' 0 C--O 1.242 0.705 0 CA-C-N 115.184 -0.916 . . . . 60.42 110.167 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -71.71 120.22 16.99 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.985 -1.007 . . . . 71.05 109.083 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 70.35 -4.77 1.5 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.989 1.316 . . . . 74.55 112.362 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 85.3 t -104.88 115.29 46.48 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 N-CA-C 107.504 -1.295 . . . . 62.45 107.504 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -129.46 154.94 46.48 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.587 -0.894 . . . . 72.22 108.587 -175.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -126.25 111.36 14.48 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.341 -0.985 . . . . 72.24 108.341 -174.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 88.0 t -100.81 119.26 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.215 1.406 . . . . 61.22 110.134 -173.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 20.1 t -109.43 114.21 46.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 109.01 -0.737 . . . . 71.43 109.01 178.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.475 HD11 HD13 ' B' ' 44' ' ' LEU . 35.3 tp -99.51 111.38 23.74 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.804 -0.813 . . . . 61.04 108.804 169.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.535 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 33.7 ttm180 -86.09 127.21 34.64 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.824 -0.806 . . . . 72.41 108.824 170.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 36.2 t -113.98 103.92 16.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.579 -1.267 . . . . 74.03 107.579 172.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 9.6 m -98.1 136.27 38.57 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.166 0.586 . . . . 53.4 109.644 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.523 HG21 HG21 ' B' ' 114' ' ' ILE . 69.4 t -125.57 135.89 62.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.862 1.265 . . . . 73.33 109.584 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 95.5 m -117.5 148.86 41.46 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.934 -1.135 . . . . 63.03 107.934 167.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.37 147.0 29.84 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.036 0.534 . . . . 60.44 109.96 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.516 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 15.6 p -147.98 128.13 13.76 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.64 -0.709 . . . . 63.41 111.055 -175.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.429 HD12 HG22 ' B' ' 31' ' ' VAL . 53.1 mt -92.55 100.46 12.99 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 106.904 -1.517 . . . . 73.11 106.904 173.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.36 -139.01 26.06 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 111.345 -0.702 . . . . 44.11 111.345 -172.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -92.89 23.01 4.43 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.356 0.662 . . . . 62.42 110.138 175.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -118.93 138.95 52.42 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.276 1.03 . . . . 74.43 108.963 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 55.5 m -69.62 119.74 14.32 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.75 -0.463 . . . . 75.24 109.75 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.516 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -78.16 -62.61 1.62 Allowed 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.246 -1.02 . . . . 63.33 108.246 176.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -157.79 163.04 38.46 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.851 -1.068 . . . . 63.3 111.282 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 23.9 mt -123.34 127.37 48.41 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 105.977 -1.86 . . . . 73.33 105.977 172.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -128.74 155.35 45.24 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.323 -0.621 . . . . 73.13 109.323 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.535 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 37.2 tt0 -166.06 129.98 2.16 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.194 -0.669 . . . . 73.05 109.194 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.0 t -128.1 151.33 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.925 0.89 . . . . 71.22 108.708 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -125.37 108.93 12.17 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.681 -0.859 . . . . 61.45 108.681 168.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.44 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 7.5 tp-100 -92.81 100.41 12.9 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.43 -0.952 . . . . 73.41 108.43 174.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.459 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.09 145.32 17.62 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.895 -0.882 . . . . 73.43 110.895 176.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.13 127.7 2.48 Favored Glycine 0 CA--C 1.506 -0.518 0 N-CA-C 110.55 -1.02 . . . . 55.43 110.55 -174.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.448 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 27.8 mt -85.0 119.48 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 108.238 -1.023 . . . . 73.24 108.238 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -126.39 132.18 51.59 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 107.133 -1.432 . . . . 73.32 107.133 175.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 70.1 m -88.98 87.76 7.34 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.344 0.52 . . . . 63.25 109.861 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.409 HG12 HD21 ' B' ' 98' ' ' LEU . 2.6 pp -96.67 131.24 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.092 0.957 . . . . 55.21 109.959 -171.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.21 160.5 37.23 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.737 0.415 . . . . 40.01 111.359 173.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.47 -69.31 0.21 Allowed Glycine 0 C--N 1.343 0.949 0 CA-C-N 115.537 -0.756 . . . . 74.1 112.802 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.559 ' HB ' ' HB2' ' B' ' 9' ' ' MET . 0.1 OUTLIER -78.82 154.58 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.248 0.619 . . . . 74.41 110.759 -173.746 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -154.41 -175.1 5.24 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.706 -0.679 . . . . 72.04 111.717 -164.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.62 -113.52 5.94 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 115.127 -0.942 . . . . 72.41 112.53 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 77.7 m -88.21 -31.33 19.14 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.535 0.734 . . . . 53.12 110.773 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -65.96 -30.98 71.63 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 116.165 -0.47 . . . . 62.31 111.338 -171.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -68.42 -33.38 74.12 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.091 0.472 . . . . 74.55 110.686 174.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.02 -25.79 61.09 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.864 0.866 . . . . 52.14 110.927 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.445 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 35.7 t-80 -77.97 -40.18 40.11 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.698 0.799 . . . . 73.33 110.786 174.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.1 t -68.22 -57.62 5.72 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.848 0.356 . . . . 74.3 110.599 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.409 HD21 HG12 ' B' ' 86' ' ' ILE . 6.3 mp -81.43 -8.34 59.72 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 116.384 -0.371 . . . . 70.34 111.638 -177.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.97 4.06 31.88 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 119.763 -0.465 . . . . 71.51 114.037 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.447 ' HB1' ' N ' ' B' ' 134' ' ' ASP . . . -151.91 -49.07 0.11 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 117.157 0.479 . . . . 64.4 111.937 -175.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.424 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 54.0 t80 -78.58 -50.86 10.8 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.942 -0.572 . . . . 73.22 111.148 -173.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.427 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 70.3 m -64.24 -46.3 79.14 Favored Pre-proline 0 CA--C 1.568 1.657 0 C-N-CA 123.434 0.694 . . . . 54.12 111.307 177.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 56.6 Cg_exo -49.94 -36.93 45.38 Favored 'Trans proline' 0 C--N 1.404 3.473 0 C-N-CA 123.163 2.575 . . . . 50.32 114.996 168.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -63.62 -40.12 96.1 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 122.883 0.473 . . . . 74.44 110.381 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.566 HD13 HD11 ' B' ' 13' ' ' ILE . 64.7 mt -66.11 -42.66 91.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.515 0.726 . . . . 70.05 110.595 178.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 85.2 mt -82.68 -19.2 38.57 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.498 -0.774 . . . . 63.24 112.166 -174.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -57.85 -53.86 61.41 Favored Pre-proline 0 CA--C 1.561 1.367 0 CA-C-O 117.877 -1.058 . . . . 63.31 112.974 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -58.39 -33.42 97.81 Favored 'Trans proline' 0 C--N 1.392 2.854 0 C-N-CA 122.43 2.087 . . . . 72.42 114.209 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -71.02 -51.33 26.02 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.984 0.514 . . . . 74.43 110.46 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.44 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -58.07 -37.74 75.04 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.442 -0.799 . . . . 62.31 110.932 176.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -59.73 -57.02 14.73 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.747 1.619 . . . . 73.42 110.696 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -64.83 -29.8 70.78 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.706 0.803 . . . . 74.41 110.413 -178.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.524 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.2 t -70.3 -43.38 70.52 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 122.957 0.503 . . . . 74.01 110.909 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.523 HG21 HG21 ' B' ' 64' ' ' VAL . 83.6 mt -60.88 -53.15 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.287 -0.634 . . . . 75.31 109.287 175.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.4 m -55.12 -34.87 64.09 Favored 'General case' 0 CA--C 1.551 0.996 0 O-C-N 124.563 1.164 . . . . 74.11 111.744 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 42.7 t -65.85 -51.23 60.57 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 115.39 -0.823 . . . . 71.33 110.197 175.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.6 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 15.1 mmt -67.82 -30.5 69.92 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.355 0.662 . . . . 75.45 111.797 -174.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.94 -44.73 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.392 1.077 . . . . 75.04 109.969 174.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 27.7 t -70.1 -25.49 63.53 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.224 -0.898 . . . . 73.22 110.543 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.6 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 89.8 mtt-85 -70.38 -30.48 67.4 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.804 -0.443 . . . . 75.32 109.804 174.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.46 12.65 54.95 Favored Glycine 0 C--N 1.355 1.62 0 O-C-N 123.549 0.531 . . . . 64.11 112.644 170.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 17' ' ' TYR . 38.1 p 54.15 24.68 5.05 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 126.464 1.906 . . . . 72.23 113.992 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -83.86 156.76 64.23 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 123.318 0.647 . . . . 73.42 110.673 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -64.41 178.28 1.72 Allowed 'Trans proline' 0 C--N 1.389 2.668 0 C-N-CA 123.429 2.753 . . . . 73.22 114.072 -177.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.649 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 6.6 tp-100 -65.16 125.9 26.42 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.443 -1.253 . . . . 53.13 112.27 -169.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -135.52 114.41 12.05 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 108.89 -0.781 . . . . 74.42 108.89 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -130.46 135.04 47.56 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.319 1.047 . . . . 72.14 108.209 171.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 tt -87.78 142.52 27.76 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.787 0.835 . . . . 64.43 109.143 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.24 152.47 94.44 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 123.327 0.651 . . . . 41.01 110.995 176.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.52 139.79 60.27 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.89 2.393 . . . . 71.42 111.372 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.56 110.34 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.786 0.803 . . . . 74.32 109.56 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -92.0 83.97 5.25 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.249 -0.887 . . . . 73.12 109.27 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -58.79 -42.41 88.99 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.766 -0.827 . . . . 73.4 108.766 172.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 134' ' ' ASP . . . . . 0.447 ' N ' ' HB1' ' B' ' 100' ' ' ALA . 6.4 p-10 . . . . . 0 CA--C 1.538 0.511 0 CA-C-N 113.909 -1.496 . . . . 75.13 112.264 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.456 ' CD1' ' HE2' ' C' ' 101' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 108.83 -0.804 . . . . 51.4 108.83 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -138.31 118.08 13.19 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.248 -1.019 . . . . 60.51 108.248 174.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.628 HG13 ' HD3' ' A' ' 130' ' ' PRO . 75.8 mt -67.95 122.4 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.844 -0.798 . . . . 71.53 108.844 173.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -86.13 -45.63 11.18 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 124.079 0.862 . . . . 72.11 109.481 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -179.4 124.79 0.08 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.293 -0.867 . . . . 74.42 109.414 -170.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.487 HD11 HD13 ' C' ' 13' ' ' ILE . 30.1 mt -116.28 150.55 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 108.06 -1.089 . . . . 72.52 108.06 173.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.438 ' HE2' ' HD2' ' C' ' 19' ' ' LYS . 22.8 p90 -174.49 171.54 3.32 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.057 0.943 . . . . 72.13 109.765 -173.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -90.85 118.31 30.16 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.612 -0.884 . . . . 64.13 108.612 174.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.683 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 10.0 mmmm -69.64 -45.78 67.68 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 122.102 0.953 . . . . 65.35 108.469 171.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.668 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 12.0 t70 -146.0 147.16 31.37 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 113.71 -1.587 . . . . 73.21 109.771 -169.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 63.5 mt -142.9 150.48 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.459 1.503 . . . . 71.25 107.456 177.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -160.57 151.91 19.29 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.389 0.614 . . . . 65.15 110.428 175.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -153.78 109.18 3.19 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.975 -1.12 . . . . 71.51 107.975 171.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -117.09 110.42 18.18 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.214 0.605 . . . . 73.1 110.028 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.56 87.39 25.62 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 106.619 -1.623 . . . . 54.31 106.619 167.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.42 -29.92 19.97 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.37 2.046 . . . . 74.03 111.531 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -91.93 12.57 21.25 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.568 1.147 . . . . 64.55 111.112 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.54 -58.59 12.28 Favored Pre-proline 0 CA--C 1.562 1.442 0 N-CA-C 114.031 1.123 . . . . 74.2 114.031 -166.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -57.85 -39.9 83.08 Favored 'Trans proline' 0 C--N 1.397 3.09 0 C-N-CA 122.182 1.921 . . . . 72.55 112.414 -174.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.415 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.3 t60 -69.38 -45.75 68.58 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.449 -1.25 . . . . 74.51 111.688 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.69 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.9 p -73.72 -20.89 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 N-CA-C 113.131 0.789 . . . . 64.11 113.131 -165.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -62.15 -25.61 67.85 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 113.99 1.107 . . . . 73.44 113.99 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 20.1 pt20 -98.07 16.89 19.76 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.508 0.723 . . . . 55.52 111.259 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.818 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -94.59 157.13 16.12 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.94 0.896 . . . . 71.33 109.461 173.104 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -67.13 123.24 19.71 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.295 0.638 . . . . 72.41 109.508 166.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -79.14 99.02 6.79 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.765 0.826 . . . . 73.53 110.434 -175.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -151.69 71.31 8.12 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 108.468 -0.938 . . . . 74.24 108.468 176.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -87.41 153.46 7.88 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.916 2.411 . . . . 44.53 112.21 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -89.94 112.33 23.68 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.551 -1.278 . . . . 74.12 107.551 168.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 40.2 t -72.74 102.3 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 109.147 -0.686 . . . . 51.44 109.147 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.512 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 54.0 mmtt -93.24 113.11 25.23 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.193 0.997 . . . . 74.41 109.33 175.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 mp -96.43 123.96 40.27 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.07 -1.085 . . . . 71.52 108.07 176.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -131.87 106.87 8.35 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.971 0.909 . . . . 72.52 109.004 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.35 123.17 48.4 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.258 -0.645 . . . . 74.04 109.258 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.455 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 15.5 t70 -112.58 147.79 35.9 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.132 1.373 . . . . 72.33 107.941 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 57.5 p -114.45 126.32 54.83 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.099 0.56 . . . . 75.32 110.904 -170.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.33 151.95 51.9 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.424 1.089 . . . . 53.31 108.494 175.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 6.4 p -163.29 163.43 25.3 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.73 0.412 . . . . 71.45 110.015 -176.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 25.8 t -165.55 133.66 3.08 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.996 0.518 . . . . 70.42 110.25 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -82.24 139.02 34.48 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.038 0.535 . . . . 53.43 109.563 173.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.599 HD11 HD12 ' C' ' 83' ' ' ILE . 84.1 mt -110.46 -41.8 4.26 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.486 0.714 . . . . 62.13 110.039 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.4 -174.36 4.91 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.56 -0.746 . . . . 71.12 110.642 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -68.93 126.22 29.11 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.747 -1.115 . . . . 73.53 108.488 172.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 67.28 6.52 4.89 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.737 1.215 . . . . 73.33 112.561 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 80.9 t -122.5 115.3 45.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 108.171 -1.048 . . . . 63.24 108.171 177.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -137.25 130.13 30.46 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.515 -0.766 . . . . 72.13 109.282 -173.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -92.35 127.26 37.77 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.214 -0.903 . . . . 74.51 109.605 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.477 HG23 HD11 ' C' ' 106' ' ' LEU . 26.9 m -111.87 136.99 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 108.141 -1.059 . . . . 75.33 108.141 166.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -126.66 121.23 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.436 1.094 . . . . 55.31 108.928 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.468 HD22 ' HB3' ' C' ' 103' ' ' PRO . 47.9 tp -111.95 113.8 26.33 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.4 -0.592 . . . . 74.44 109.4 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.455 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 34.5 ttm180 -82.92 107.69 15.71 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 108.856 -0.794 . . . . 72.53 108.856 173.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.445 ' HB ' HD11 ' C' ' 114' ' ' ILE . 6.6 t -99.5 121.34 50.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.053 -1.092 . . . . 71.23 108.053 171.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 72.0 m -112.7 128.21 56.34 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.404 -1.332 . . . . 60.32 107.404 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.544 HG23 HD13 ' C' ' 114' ' ' ILE . 99.5 t -116.03 115.18 48.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.626 -0.879 . . . . 70.03 108.626 172.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 4.4 m -100.78 139.27 36.7 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.73 -0.841 . . . . 71.44 108.73 175.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.33 113.1 15.18 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.577 -1.268 . . . . 75.43 107.577 176.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -136.18 131.44 34.64 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.032 -0.729 . . . . 74.55 109.032 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.818 HD13 ' HG2' ' C' ' 34' ' ' LYS . 3.5 mt -87.13 35.93 0.72 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.575 1.55 . . . . 73.14 110.037 -177.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.02 -117.31 4.9 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 109.682 -1.367 . . . . 74.32 109.682 -164.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -89.93 -20.43 23.36 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.611 0.764 . . . . 71.21 111.221 176.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -78.5 103.2 8.29 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.788 -0.819 . . . . 75.3 108.788 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 37.2 m -72.76 123.49 23.43 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.485 -0.561 . . . . 61.14 109.485 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.69 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.43 -56.03 5.1 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.422 -0.808 . . . . 72.13 109.017 174.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -159.66 168.18 26.63 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 122.223 1.011 . . . . 74.55 112.146 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -130.01 130.75 45.37 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 105.386 -2.079 . . . . 73.04 105.386 167.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.431 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 44.6 t -128.75 138.23 52.0 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.228 -1.397 . . . . 65.41 107.228 174.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.16 118.77 5.29 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.979 -0.378 . . . . 71.13 109.979 -172.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' C' ' 61' ' ' ARG . 95.6 t -128.74 136.85 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.564 0.746 . . . . 75.53 109.105 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.668 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 26.4 mt-30 -109.33 97.17 6.81 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.55 -0.908 . . . . 63.4 108.55 169.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -84.85 116.91 23.57 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.351 -0.84 . . . . 54.42 109.136 178.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.6 145.79 16.87 Favored Glycine 0 C--N 1.343 0.921 0 N-CA-C 111.742 -0.543 . . . . 72.32 111.742 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.39 121.3 1.75 Allowed Glycine 0 CA--C 1.507 -0.433 0 N-CA-C 111.751 -0.54 . . . . 34.15 111.751 -176.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.599 HD12 HD11 ' C' ' 51' ' ' LEU . 9.5 mm -82.55 118.94 31.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 108.054 -1.091 . . . . 61.15 108.054 174.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -133.71 123.79 25.56 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.393 0.677 . . . . 64.31 109.987 -172.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 70.2 m -71.17 108.17 4.55 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.787 -0.82 . . . . 43.05 108.787 167.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 78.2 mt -117.7 119.74 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.462 1.105 . . . . 73.14 108.412 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.15 168.28 26.46 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.53 0.732 . . . . 61.31 110.442 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.72 -33.78 5.97 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 116.26 -0.427 . . . . 74.44 113.936 170.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 40.2 pt -117.67 163.4 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.493 0.717 . . . . 55.44 110.957 -176.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -146.15 158.04 43.86 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.511 0.724 . . . . 75.15 110.696 -175.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.08 -129.72 15.64 Favored Glycine 0 C--N 1.349 1.258 0 CA-C-N 115.784 -0.644 . . . . 73.33 113.48 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 75.5 p -66.02 -26.79 67.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.685 0.794 . . . . 73.31 111.534 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -62.49 -54.12 44.7 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.959 0.504 . . . . 55.14 110.028 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.504 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 7.6 ptt? -76.79 -23.79 52.86 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.896 -0.593 . . . . 64.45 111.099 -176.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.48 -37.18 77.14 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.377 0.608 . . . . 60.22 110.364 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -67.78 -33.21 74.39 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.643 -1.162 . . . . 72.54 110.442 173.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.564 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 43.9 t -68.86 -60.59 2.27 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.802 -0.635 . . . . 64.41 110.682 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.7 pp -69.42 -28.3 66.03 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.44 0.696 . . . . 72.33 112.411 -174.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 99' ' ' GLY . . . . . 0.416 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -94.57 -3.9 62.5 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-O 119.558 -0.579 . . . . 64.34 114.21 -172.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.58 -62.15 0.13 Allowed 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 117.496 0.648 . . . . 74.11 112.639 -172.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.564 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 54.7 t80 -66.41 -37.92 86.3 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 124.391 1.076 . . . . 64.23 113.106 -170.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 29.7 m -80.72 -42.64 1.26 Allowed Pre-proline 0 CA--C 1.564 1.511 0 C-N-CA 123.561 0.745 . . . . 63.31 111.034 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.468 ' HB3' HD22 ' C' ' 60' ' ' LEU . 89.0 Cg_exo -54.13 -24.21 32.36 Favored 'Trans proline' 0 C--N 1.398 3.151 0 C-N-CA 122.995 2.464 . . . . 72.55 114.617 166.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -67.77 -24.72 65.37 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.399 0.68 . . . . 73.21 111.792 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.647 HG23 ' NH1' ' A' ' 111' ' ' ARG . 31.7 mm -77.3 -35.17 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 109.24 -0.652 . . . . 64.2 109.24 173.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.477 HD11 HG23 ' C' ' 58' ' ' VAL . 82.0 mt -79.41 -24.9 42.24 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.671 -1.15 . . . . 72.32 111.818 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -57.11 -55.27 45.81 Favored Pre-proline 0 CA--C 1.557 1.226 0 CA-C-O 118.198 -0.906 . . . . 75.13 113.09 -173.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.43 ' HB2' ' HG3' ' A' ' 112' ' ' GLU . 57.5 Cg_endo -66.57 -23.33 49.93 Favored 'Trans proline' 0 C--N 1.387 2.6 0 CA-C-N 121.174 1.455 . . . . 63.1 112.342 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -75.51 -49.31 19.11 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.13 0.972 . . . . 74.42 110.15 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.68 -38.24 84.29 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.149 0.98 . . . . 43.43 110.07 174.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -58.48 -53.07 62.42 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.253 1.421 . . . . 73.04 110.753 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.47 -32.61 73.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 123.694 0.622 . . . . 73.42 110.278 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.6 t -68.8 -34.41 75.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.001 0.52 . . . . 75.02 111.006 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.544 HD13 HG23 ' C' ' 64' ' ' VAL . 95.5 mt -73.33 -51.93 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.666 0.786 . . . . 74.32 109.84 175.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.0 m -64.56 -28.9 69.96 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.844 0.858 . . . . 64.32 111.426 -175.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.3 t -67.77 -48.62 65.85 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.238 -0.653 . . . . 64.41 109.238 172.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.589 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.1 -38.66 87.09 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.512 1.125 . . . . 74.44 112.836 -179.838 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' C' ' 123' ' ' PHE . 82.2 t -62.12 -45.38 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.769 0.828 . . . . 62.44 109.668 175.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 44.8 t -68.2 -32.47 72.71 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.239 -0.891 . . . . 74.43 111.947 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -68.88 -31.61 70.66 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.537 0.735 . . . . 75.13 109.703 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.82 10.79 73.83 Favored Glycine 0 C--N 1.355 1.607 0 O-C-N 123.969 0.793 . . . . 73.22 112.998 173.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.507 HG23 ' HB3' ' D' ' 17' ' ' TYR . 43.2 p 60.19 29.48 19.04 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 126.151 1.78 . . . . 61.44 114.257 173.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.402 ' HB2' HG13 ' C' ' 118' ' ' VAL . 96.8 m-85 -96.03 147.0 32.31 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.494 -0.928 . . . . 75.21 108.494 171.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.649 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 80.6 Cg_exo -49.44 141.06 26.33 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.712 2.941 . . . . 75.51 114.421 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -55.49 113.81 1.58 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.175 0.99 . . . . 73.23 111.354 -177.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 41.6 tp -107.78 92.81 4.22 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.601 -0.889 . . . . 73.53 108.601 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -93.03 114.71 27.33 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.197 -0.911 . . . . 45.05 108.976 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 tt -73.09 135.89 44.84 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.922 0.889 . . . . 75.4 110.252 -171.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.41 148.76 90.95 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 123.666 0.786 . . . . 63.3 111.997 -175.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.526 ' HG2' HG21 ' A' ' 13' ' ' ILE . 6.6 Cg_exo -70.86 116.57 4.73 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.145 2.563 . . . . 72.11 112.49 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 90.5 t -126.96 110.58 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.784 -0.821 . . . . 75.15 108.784 173.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -71.97 104.69 3.61 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.281 1.032 . . . . 63.21 109.726 174.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -62.75 -44.63 95.71 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.283 0.563 . . . . 64.42 110.052 172.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 . . . . . 0 CA--C 1.54 0.577 0 CA-C-N 114.372 -1.285 . . . . 72.52 111.184 -174.476 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 87.8 m . . . . . 0 C--O 1.237 0.438 0 CA-C-O 120.613 0.244 . . . . 74.3 110.929 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.497 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 31.3 t80 -159.12 89.13 0.91 Allowed 'General case' 0 C--O 1.238 0.45 0 N-CA-C 107.051 -1.463 . . . . 72.23 107.051 171.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -113.96 116.38 29.14 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.018 -1.104 . . . . 74.15 108.018 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.499 HG21 HD11 ' D' ' 16' ' ' ILE . 54.3 mt -72.09 122.95 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 109.588 -0.523 . . . . 70.04 109.588 -178.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -85.61 -42.91 13.92 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.994 0.809 . . . . 72.43 111.189 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -170.97 135.12 1.0 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 111.81 0.3 . . . . 73.43 111.81 -163.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.499 HD11 HG21 ' D' ' 13' ' ' ILE . 2.7 mp -115.76 134.58 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.609 -1.256 . . . . 73.01 107.609 170.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.507 ' HB3' HG23 ' C' ' 122' ' ' THR . 32.9 p90 -166.42 169.57 13.81 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 122.18 0.991 . . . . 71.21 111.394 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.5 p -103.03 120.33 40.46 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 113.567 -1.651 . . . . 72.52 108.534 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -89.96 -31.02 17.43 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.088 -0.708 . . . . 65.34 109.088 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -140.4 134.73 31.24 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 114.385 -1.28 . . . . 54.31 108.343 173.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.589 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.7 mt -128.18 145.08 35.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.021 -1.474 . . . . 63.13 107.021 168.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 30.9 t -147.25 140.89 25.61 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.9 0.88 . . . . 70.3 108.834 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.523 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.1 t80 -146.48 136.22 23.21 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 105.89 -1.892 . . . . 64.01 105.89 168.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.535 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 43.8 mt-10 -138.52 152.37 48.18 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.338 -1.356 . . . . 74.14 107.338 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.77 84.33 7.05 Favored Pre-proline 0 C--O 1.239 0.535 0 N-CA-C 107.307 -1.368 . . . . 72.3 107.307 172.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -66.57 -36.91 23.96 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.0 2.467 . . . . 65.32 113.025 -170.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.478 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 52.6 m-20 -101.35 6.84 42.85 Favored 'General case' 0 C--O 1.211 -0.973 0 CA-C-O 118.542 -0.742 . . . . 64.01 110.747 -177.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.683 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -26.08 -65.09 0.11 Allowed Pre-proline 0 N--CA 1.496 1.85 0 N-CA-C 116.621 2.082 . . . . 73.43 116.621 -162.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -78.85 -21.97 9.23 Favored 'Trans proline' 0 C--N 1.382 2.314 0 CA-C-N 122.878 2.063 . . . . 72.53 113.842 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -73.74 -37.16 65.16 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.88 1.272 . . . . 75.51 110.37 175.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.557 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.5 p -84.13 -18.93 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.066 0.546 . . . . 65.01 111.531 -174.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -65.45 -15.83 63.02 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 112.529 0.566 . . . . 73.04 112.529 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -58.65 -33.43 70.07 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.55 0.69 . . . . 53.14 110.03 173.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -89.28 93.39 9.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.126 -1.397 . . . . 73.54 109.373 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -102.43 91.64 4.34 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.17 0.509 . . . . 63.11 109.981 -177.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 35.6 p90 -158.28 174.0 15.82 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.949 1.3 . . . . 72.4 108.009 169.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -65.43 112.91 9.6 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-O 118.938 -0.553 . . . . 42.33 109.565 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -59.07 141.24 97.99 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.582 2.188 . . . . 53.02 112.713 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -59.42 118.19 5.71 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.607 0.763 . . . . 73.42 109.959 172.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.538 HG13 HG13 ' D' ' 64' ' ' VAL . 59.0 t -97.21 106.94 19.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 123.219 0.608 . . . . 73.03 109.426 -175.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -95.69 127.92 42.12 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.097 -0.956 . . . . 71.12 108.648 173.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -97.51 146.08 25.59 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.139 0.576 . . . . 71.54 109.602 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -149.54 116.76 6.05 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.226 -1.027 . . . . 63.41 108.226 177.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.05 140.12 41.69 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.722 0.409 . . . . 70.12 110.926 -173.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.2 t70 -136.88 151.82 49.52 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.56 1.144 . . . . 51.44 108.595 173.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.0 t -116.85 150.3 38.64 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.149 0.579 . . . . 73.12 110.839 -172.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.593 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.05 155.09 28.67 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.991 0.917 . . . . 63.54 109.229 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 13.4 p -167.09 162.12 15.16 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.697 0.399 . . . . 63.02 111.323 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 3.0 m -153.38 144.8 23.2 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.243 1.017 . . . . 61.12 108.669 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -97.92 116.49 30.23 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.152 -1.055 . . . . 60.23 108.152 165.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 24.6 mt -95.51 -40.58 9.38 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.044 0.538 . . . . 54.23 110.455 -172.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.584 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -146.11 -176.56 5.2 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.077 -0.965 . . . . 72.34 109.908 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -68.4 105.92 2.34 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.387 0.675 . . . . 73.31 109.652 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 62.85 18.55 10.85 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.759 1.224 . . . . 74.41 112.128 -177.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.584 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 57.3 t -109.23 104.83 17.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 107.353 -1.351 . . . . 52.3 107.353 171.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -119.6 131.33 55.46 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.96 -1.473 . . . . 71.2 109.686 -164.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -98.58 132.23 44.15 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.947 -0.57 . . . . 75.15 109.868 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 75.4 t -115.46 118.86 60.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 107.582 -1.266 . . . . 61.13 107.582 175.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 24.9 t -117.96 129.53 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.574 0.75 . . . . 71.12 109.276 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -122.74 129.47 51.8 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 110.328 -0.249 . . . . 74.11 110.328 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.606 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 14.3 ttm-85 -86.44 100.05 12.07 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.82 -0.807 . . . . 74.41 108.82 172.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 99.1 t -90.41 116.84 32.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.048 -1.093 . . . . 55.13 108.048 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 17.6 m -123.34 126.29 46.57 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.339 0.59 . . . . 71.43 109.671 -172.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.538 HG13 HG13 ' D' ' 40' ' ' VAL . 40.6 t -117.33 100.36 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.742 1.617 . . . . 50.22 107.977 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 60.7 m -93.53 94.26 8.55 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.832 -1.076 . . . . 71.0 108.157 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.16 143.77 28.33 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.712 -0.677 . . . . 65.22 110.456 -174.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.481 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 54.2 p -144.6 135.35 24.78 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 115.735 -0.666 . . . . 63.01 110.429 -177.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.465 HD12 HG22 ' D' ' 31' ' ' VAL . 39.0 mt -98.24 100.0 11.26 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.642 0.777 . . . . 74.44 109.052 172.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.01 -115.06 4.53 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.025 -0.989 . . . . 71.22 112.487 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -102.69 5.64 39.12 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.715 0.806 . . . . 54.34 112.15 -176.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -131.7 155.79 47.03 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.81 -0.441 . . . . 73.41 109.81 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 71.8 m -65.67 136.17 55.95 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 123.784 0.677 . . . . 73.51 110.977 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.557 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.6 -64.07 1.19 Allowed 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.577 -1.268 . . . . 74.41 107.577 174.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -155.94 152.14 27.86 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.382 -1.281 . . . . 73.33 110.194 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.535 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 78.3 mt -118.5 111.91 19.24 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.319 -0.993 . . . . 72.12 108.319 177.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.538 ' SG ' HG12 ' D' ' 114' ' ' ILE . 44.8 t -116.06 138.79 50.92 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.765 -0.828 . . . . 71.25 108.765 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -155.31 122.32 5.45 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.579 0.352 . . . . 73.3 110.258 -178.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.17 123.89 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.153 0.581 . . . . 72.32 109.957 -175.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -87.3 88.41 7.68 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.17 -1.048 . . . . 63.22 108.17 165.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -80.41 99.76 8.13 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.646 -1.242 . . . . 74.21 107.646 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.63 142.38 15.8 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.448 -0.661 . . . . 33.22 111.448 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.446 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -136.7 131.96 5.85 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.19 -0.764 . . . . 64.45 111.19 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 43.8 mt -90.77 124.78 43.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 108.088 -1.079 . . . . 54.31 108.088 176.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -132.99 123.65 26.27 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.762 0.825 . . . . 74.43 109.483 -174.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.9 m -84.25 97.76 9.59 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.97 -0.752 . . . . 64.31 108.97 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.582 HD11 HD12 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -120.66 130.81 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.771 0.828 . . . . 75.23 109.724 -174.073 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.26 164.91 36.44 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.785 0.834 . . . . 73.45 110.76 -176.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.67 -10.55 71.67 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.725 -0.671 . . . . 53.24 114.15 173.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.582 HD12 HD11 ' D' ' 86' ' ' ILE . 34.4 mt -94.5 145.08 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.63 0.772 . . . . 71.21 109.81 -174.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.7 166.48 22.1 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.666 0.786 . . . . 65.34 110.62 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.65 -136.6 41.71 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 114.951 -1.022 . . . . 74.14 114.902 169.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 16.4 m -77.47 -18.33 57.23 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.361 1.065 . . . . 72.11 111.565 -173.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -66.16 -24.84 66.73 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.826 0.45 . . . . 52.34 110.723 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 63.3 mtt -60.02 -43.91 94.97 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.967 0.507 . . . . 71.43 110.167 173.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.55 -26.41 67.12 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.399 -0.819 . . . . 73.24 111.53 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -85.26 -34.52 21.94 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.251 0.62 . . . . 71.21 111.111 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 97' ' ' CYS . . . . . 0.564 ' SG ' HG13 ' D' ' 86' ' ' ILE . 42.6 t -72.43 -52.44 15.92 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.265 0.555 . . . . 70.23 109.747 -175.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 26.2 mt -80.95 -29.57 35.4 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.523 -1.217 . . . . 73.41 110.24 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.4 -17.89 40.89 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 114.968 0.747 . . . . 35.52 114.968 -171.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.65 -50.22 0.91 Allowed 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 117.788 0.794 . . . . 70.44 111.602 -174.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -73.94 -42.24 60.85 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 122.809 0.444 . . . . 74.2 112.043 -174.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.497 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 69.4 m -67.77 -47.31 44.28 Favored Pre-proline 0 CA--C 1.567 1.609 0 C-N-CA 123.161 0.585 . . . . 54.22 111.76 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 51.4 Cg_exo -59.75 -28.57 87.6 Favored 'Trans proline' 0 C--N 1.401 3.327 0 C-N-CA 122.597 2.198 . . . . 62.31 113.385 170.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -64.25 -40.93 97.02 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.95 0.9 . . . . 74.45 110.05 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 48.0 mm -61.73 -42.19 93.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 123.447 0.699 . . . . 74.33 110.193 173.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.446 HD21 ' HA3' ' D' ' 82' ' ' GLY . 96.1 mt -82.99 -13.37 56.09 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.975 -1.011 . . . . 61.41 112.49 -172.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -64.65 -48.15 74.35 Favored Pre-proline 0 N--CA 1.49 1.546 0 C-N-CA 123.929 0.892 . . . . 74.33 112.775 -176.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.52 -36.89 96.82 Favored 'Trans proline' 0 C--N 1.391 2.791 0 C-N-CA 122.201 1.934 . . . . 72.33 113.164 175.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -73.98 -36.08 64.53 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.893 0.877 . . . . 72.45 112.135 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.47 -49.65 72.79 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.209 -0.664 . . . . 61.53 109.209 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -55.1 -48.53 73.46 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 124.933 1.396 . . . . 72.03 110.781 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -61.81 -50.97 70.17 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 123.794 0.684 . . . . 73.11 111.365 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 38.9 t -55.43 -45.58 76.78 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 123.944 0.777 . . . . 53.14 111.039 -177.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.538 HG12 ' SG ' ' D' ' 76' ' ' CYS . 98.8 mt -59.31 -58.2 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.366 1.066 . . . . 70.01 110.817 174.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 60.7 m -54.19 -43.24 70.53 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.596 1.158 . . . . 64.21 112.16 -173.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -66.75 -40.32 88.25 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.026 -0.988 . . . . 45.31 110.045 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.1 mtm -70.28 -29.79 66.64 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.947 0.499 . . . . 73.51 111.616 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.467 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.0 t -64.99 -45.42 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.503 0.721 . . . . 75.13 110.178 175.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -74.33 -30.14 61.91 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.838 -0.619 . . . . 63.22 111.067 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 59.0 mtt-85 -69.83 -34.11 73.22 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.529 0.731 . . . . 75.21 109.867 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.12 -0.82 90.04 Favored Glycine 0 C--N 1.355 1.628 0 O-C-N 123.65 0.594 . . . . 62.5 112.388 173.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.1 p 64.21 23.18 13.06 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 126.952 2.101 . . . . 64.32 113.698 174.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -85.27 155.41 60.18 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.537 0.735 . . . . 74.22 110.055 171.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -53.2 125.63 19.0 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.182 2.588 . . . . 65.43 112.643 173.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -50.93 142.77 11.24 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.38 1.472 . . . . 75.43 112.864 -174.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.481 HD13 HG21 ' D' ' 40' ' ' VAL . 43.4 tp -114.35 125.07 53.45 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.613 0.765 . . . . 72.43 109.183 177.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -119.88 100.22 7.1 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.519 -0.919 . . . . 74.22 108.519 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 76.4 mt -61.55 114.84 3.48 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.289 -0.634 . . . . 73.41 109.289 174.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.02 145.22 65.92 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 124.19 0.996 . . . . 72.42 111.979 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.424 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 39.3 Cg_endo -72.33 97.2 0.84 Allowed 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 122.131 1.887 . . . . 61.22 110.343 177.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.47 0.569 0 CA-C-N 114.567 -1.197 . . . . 54.45 109.513 -175.934 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 119.335 -0.364 . . . . 73.23 111.923 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.0 m 53.02 66.92 1.09 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.195 0.998 . . . . 75.14 111.108 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.604 ' HG3' ' HG3' ' A' ' 4' ' ' GLN . 9.6 pt-20 -74.21 -32.2 62.94 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.633 -1.167 . . . . 71.22 111.48 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.604 ' HG3' ' HG3' ' A' ' 3' ' ' GLU . 40.2 mt-30 -96.48 144.88 26.17 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.672 0.789 . . . . 75.51 109.851 -176.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.402 ' OD1' ' HG2' ' C' ' 143' ' ' GLN . 4.5 p30 -67.85 130.93 44.49 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.289 -1.004 . . . . 74.14 108.289 173.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.579 ' HA ' ' HG3' ' C' ' 143' ' ' GLN . 28.6 t-20 -172.13 -42.81 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.605 0.565 . . . . 62.25 110.101 -176.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 m 69.12 72.06 0.26 Allowed 'General case' 0 CA--C 1.546 0.789 0 O-C-N 124.48 1.112 . . . . 64.4 109.023 -171.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -75.2 -50.75 15.21 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.715 -1.13 . . . . 72.3 109.639 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.4 ' SD ' ' N ' ' A' ' 10' ' ' THR . 0.1 OUTLIER -68.3 144.98 54.63 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.034 -0.985 . . . . 73.5 109.105 176.55 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.4 ' N ' ' SD ' ' A' ' 9' ' ' MET . 76.5 m -138.75 143.41 39.01 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.218 0.532 . . . . 75.04 110.776 -170.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.57 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.8 t80 -131.81 137.98 48.34 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.875 -1.057 . . . . 65.0 109.63 -172.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -147.78 120.35 8.54 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.048 -1.093 . . . . 64.52 108.048 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.49 HD13 HD11 ' A' ' 16' ' ' ILE . 20.2 mt -85.85 120.56 36.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 109.374 -0.602 . . . . 65.32 109.374 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.28 -41.91 19.54 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.463 -0.94 . . . . 73.53 108.463 178.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -169.03 148.91 4.17 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 116.183 -0.462 . . . . 73.42 111.116 -170.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.49 HD11 HD13 ' A' ' 13' ' ' ILE . 69.0 mt -137.65 130.35 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 124.61 1.164 . . . . 63.52 108.151 175.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.456 ' HB3' HG23 ' B' ' 122' ' ' THR . 28.2 p90 -167.83 154.52 7.92 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.61 0.719 . . . . 70.31 111.605 -174.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.1 p -83.9 122.35 28.6 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.467 -1.242 . . . . 55.41 109.111 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -94.59 -14.93 24.5 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.161 0.584 . . . . 74.24 110.638 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 18.0 t0 -158.6 139.55 12.97 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.9 -1.148 . . . . 73.3 107.9 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.408 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 59.2 mt -141.16 141.9 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 106.977 -1.49 . . . . 74.21 106.977 177.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.9 t -157.06 116.48 3.4 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.821 0.343 . . . . 41.24 110.259 177.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.591 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 81.6 t80 -110.86 139.82 45.86 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 107.206 -1.405 . . . . 72.23 107.206 170.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 49.1 mt-10 -141.68 109.69 5.82 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 123.321 0.648 . . . . 75.02 109.35 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.429 ' CB ' ' HB2' ' A' ' 28' ' ' ALA . . . -103.05 88.56 1.59 Allowed Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.064 -1.828 . . . . 51.13 106.064 165.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -66.92 -34.05 31.07 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.722 2.281 . . . . 64.31 112.097 -169.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -112.82 26.37 10.58 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 114.959 -1.019 . . . . 73.52 109.311 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.467 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -44.62 -53.91 13.89 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 113.972 1.101 . . . . 51.11 113.972 -169.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.76 -28.47 86.52 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 121.971 1.781 . . . . 63.14 112.824 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.474 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.2 m80 -89.34 -31.19 17.92 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.439 1.096 . . . . 70.42 110.269 -176.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.564 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.0 p -73.26 -17.82 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.065 0.546 . . . . 60.35 112.186 -162.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -82.6 -23.71 34.25 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.255 0.622 . . . . 64.44 111.203 -176.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 28.9 pt20 -91.21 -11.86 37.04 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.253 0.621 . . . . 53.51 110.556 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 13.5 mmmm -76.75 168.43 20.1 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.491 0.716 . . . . 73.44 111.842 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.64 117.0 10.69 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.743 -0.836 . . . . 74.51 108.743 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.416 ' CE3' HD21 ' A' ' 68' ' ' LEU . 58.1 t-105 -83.54 85.21 7.29 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.378 0.608 . . . . 65.42 109.766 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.407 ' H ' HD22 ' A' ' 68' ' ' LEU . 6.8 tp-100 -127.82 81.38 70.4 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 107.889 -1.152 . . . . 64.51 107.889 171.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -72.94 108.2 2.53 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.532 2.154 . . . . 75.03 112.514 -174.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -95.43 90.49 5.8 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.911 -1.514 . . . . 62.51 106.911 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 65' ' ' THR . 60.3 t -88.13 113.46 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 CA-C-N 115.021 -0.991 . . . . 71.02 111.044 -171.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.425 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 80.7 tttt -79.82 136.86 36.81 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.346 1.058 . . . . 75.11 110.104 172.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.46 HD21 HG12 ' E' ' 6' ' ' ILE . 0.6 OUTLIER -110.4 125.37 53.17 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.976 -1.12 . . . . 75.44 107.976 175.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.593 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 22.8 t70 -135.57 126.24 27.17 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.379 -0.6 . . . . 72.12 109.379 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.613 HD21 HD22 ' E' ' 8' ' ' LEU . 2.5 mm? -107.94 133.27 52.52 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.368 0.667 . . . . 75.31 110.278 -177.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 11.7 t70 -124.18 146.29 48.78 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.382 1.073 . . . . 71.4 108.372 173.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 79.3 m -119.8 139.87 51.66 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.701 0.8 . . . . 71.32 110.073 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.671 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -132.53 131.59 41.73 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.922 0.889 . . . . 44.05 109.286 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.2 m -102.58 151.88 21.82 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.629 0.772 . . . . 64.34 109.946 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.6 t -162.96 127.95 3.12 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.084 -0.709 . . . . 63.34 109.084 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -112.84 119.15 36.99 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.337 -0.986 . . . . 70.24 108.337 171.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.4 mt -96.17 -30.18 13.64 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.216 0.606 . . . . 64.13 111.405 -174.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.22 -175.47 3.98 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.293 0.637 . . . . 55.55 110.469 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.51 117.79 7.24 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.326 -0.852 . . . . 74.41 108.776 171.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 71.93 -5.03 1.8 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.541 1.136 . . . . 62.14 112.93 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.0 t -99.22 106.02 18.3 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 N-CA-C 107.544 -1.28 . . . . 64.43 107.544 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -124.02 125.01 43.81 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.97 -1.122 . . . . 74.15 107.97 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -102.09 114.16 28.05 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.636 -0.876 . . . . 64.3 108.636 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.9 m -102.92 136.1 37.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.702 -1.221 . . . . 62.15 107.702 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 60.7 t -124.93 138.97 52.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 108.751 -0.833 . . . . 74.32 108.751 -174.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -128.19 112.84 14.96 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.593 -0.891 . . . . 62.23 108.593 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.564 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 19.5 ttt180 -93.23 102.44 14.73 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.029 0.932 . . . . 52.41 109.122 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -94.09 127.76 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.49 0.716 . . . . 74.0 109.444 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 13.9 m -113.31 130.45 56.26 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.836 0.855 . . . . 64.14 109.584 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.7 t -126.65 106.69 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.162 1.385 . . . . 55.51 107.851 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 23.5 m -104.61 134.4 47.85 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 107.762 -1.199 . . . . 75.33 107.762 175.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.52 127.29 55.18 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.835 -1.172 . . . . 23.43 107.835 174.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -126.94 126.33 43.06 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.302 0.641 . . . . 62.33 110.023 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.53 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 30.9 mt -86.91 78.02 9.11 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.394 1.078 . . . . 52.11 108.363 173.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.58 -84.6 0.87 Allowed Glycine 0 C--N 1.342 0.911 0 CA-C-N 115.229 -0.896 . . . . 74.0 111.443 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -115.27 -28.48 6.89 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.143 0.977 . . . . 71.33 110.621 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -87.94 132.59 34.17 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.289 -0.634 . . . . 74.03 109.289 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.2 m -72.8 123.42 23.31 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.745 0.702 . . . . 71.25 110.307 175.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.564 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -72.21 -57.35 4.31 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.52 -0.764 . . . . 40.32 109.633 174.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.437 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 35.7 p90 -162.58 176.96 9.85 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.612 -1.177 . . . . 54.22 111.093 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 58.6 tp -139.77 142.22 36.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.397 1.479 . . . . 65.53 107.31 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.452 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 76.0 m -145.5 106.96 4.21 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.114 0.965 . . . . 72.01 108.654 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -130.33 122.23 27.52 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.402 0.681 . . . . 73.12 109.492 -174.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 t -132.14 114.44 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.209 1.004 . . . . 53.32 109.685 -172.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 7.1 tt0 -84.56 90.12 7.59 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.359 -0.978 . . . . 51.14 108.359 173.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.537 ' HG3' HD22 ' A' ' 106' ' ' LEU . 6.8 tp-100 -85.13 104.13 14.74 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.288 -0.634 . . . . 75.32 109.288 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.61 153.39 21.61 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 111.485 -0.646 . . . . 62.03 111.485 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.438 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -155.8 122.0 1.16 Allowed Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 111.262 -0.735 . . . . 63.34 111.262 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.4 mt -83.04 116.15 26.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 N-CA-C 108.962 -0.755 . . . . 64.23 108.962 176.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.57 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 38.0 m-85 -127.19 120.82 29.68 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.267 0.627 . . . . 74.53 109.941 -175.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.8 m -81.1 102.02 9.98 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.434 -0.95 . . . . 71.32 108.434 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.3 pt -126.23 121.38 59.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.87 0.868 . . . . 62.11 109.991 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.46 169.3 8.98 Favored 'General case' 0 C--O 1.247 0.927 0 C-N-CA 124.654 1.181 . . . . 51.32 109.42 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.35 97.13 0.35 Allowed Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.383 -1.087 . . . . 71.45 110.383 -172.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.7 mm 88.05 108.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.185 1.394 . . . . 75.22 109.996 170.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -105.26 -163.6 0.96 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.976 1.311 . . . . 75.52 111.031 -166.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.82 -148.87 40.57 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 116.004 -0.544 . . . . 60.11 112.949 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.461 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 17.8 p -62.22 -25.29 67.73 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.268 1.027 . . . . 74.03 111.963 177.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -61.73 -53.93 49.36 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.28 1.032 . . . . 74.31 109.428 176.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.476 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 46.3 ttp -71.82 -27.71 63.1 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.321 -0.854 . . . . 70.21 111.228 175.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.461 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -66.67 -34.21 77.35 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.868 0.467 . . . . 42.13 110.99 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.553 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 41.6 t-80 -68.79 -24.91 64.47 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.772 0.829 . . . . 73.05 110.584 173.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 69.1 m -75.77 -64.95 0.97 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.565 0.346 . . . . 72.33 110.675 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.53 HD12 ' N ' ' A' ' 99' ' ' GLY . 3.4 pp -71.1 -32.27 68.84 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.149 0.98 . . . . 74.42 112.687 -170.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.53 ' N ' HD12 ' A' ' 98' ' ' LEU . . . -105.54 3.22 39.59 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-O 119.688 -0.506 . . . . 73.03 113.597 -171.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.565 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -136.93 -60.5 0.69 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.525 0.663 . . . . 70.42 112.072 -177.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.4 ' O ' HG12 ' A' ' 105' ' ' ILE . 0.0 OUTLIER -79.13 -34.82 42.98 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 112.166 0.432 . . . . 72.14 112.166 -174.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 70.9 m -64.55 -43.56 71.43 Favored Pre-proline 0 N--CA 1.491 1.611 0 CA-C-N 115.627 -0.715 . . . . 54.4 112.416 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -48.53 -45.09 28.36 Favored 'Trans proline' 0 C--N 1.391 2.811 0 C-N-CA 122.829 2.353 . . . . 63.32 113.322 163.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -64.52 -21.57 66.72 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.652 0.781 . . . . 72.24 112.03 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 101' ' ' TYR . 45.8 mm -74.85 -48.95 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 109.667 -0.494 . . . . 62.02 109.667 174.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.537 HD22 ' HG3' ' A' ' 80' ' ' GLN . 88.4 mt -75.94 -27.05 57.44 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.401 -0.818 . . . . 71.11 112.276 -174.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.514 ' HZ ' HD22 ' A' ' 128' ' ' LEU . 31.7 t80 -63.44 -43.76 79.95 Favored Pre-proline 0 CA--C 1.564 1.504 0 N-CA-C 113.817 1.043 . . . . 71.23 113.817 -169.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.63 -40.11 82.59 Favored 'Trans proline' 0 C--N 1.387 2.578 0 C-N-CA 122.207 1.938 . . . . 75.33 112.887 173.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -69.69 -40.98 76.02 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.497 0.719 . . . . 73.21 111.415 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.0 -36.04 74.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.425 0.69 . . . . 74.13 110.29 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.552 ' NH1' HD12 ' C' ' 105' ' ' ILE . 37.3 ttm180 -57.8 -55.78 30.44 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.093 0.871 . . . . 71.02 109.6 172.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -63.98 -41.06 97.65 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.024 -0.989 . . . . 75.34 111.73 -173.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 39.0 t -66.45 -30.94 71.41 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.798 0.439 . . . . 72.33 111.167 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 60.7 mt -72.85 -50.99 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.831 0.853 . . . . 62.21 109.857 172.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 63.7 m -57.99 -34.04 69.55 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.667 1.187 . . . . 72.45 111.509 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.8 t -67.35 -46.35 73.64 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 115.439 -0.801 . . . . 73.31 109.8 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.591 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 42.6 mtm -67.49 -36.15 80.53 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.876 0.47 . . . . 72.11 111.483 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.417 HG13 ' HB2' ' A' ' 123' ' ' PHE . 72.2 t -61.59 -46.85 95.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.369 0.668 . . . . 72.23 110.075 174.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 41.2 t -67.56 -36.35 80.77 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 115.428 -0.805 . . . . 53.03 111.118 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -72.96 -29.38 63.03 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.686 0.794 . . . . 75.14 109.891 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.55 10.51 61.64 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.869 0.73 . . . . 50.54 112.198 173.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.486 HG21 ' HE ' ' B' ' 15' ' ' ARG . 2.1 t 62.17 20.18 11.49 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.84 2.056 . . . . 64.42 113.266 170.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.417 ' HB2' HG13 ' A' ' 118' ' ' VAL . 87.3 m-85 -84.28 154.89 63.4 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 122.956 0.503 . . . . 72.21 109.65 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -53.16 159.63 5.42 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.461 2.774 . . . . 75.15 113.97 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.477 HE21 HG21 ' D' ' 122' ' ' THR . 6.5 tp-100 -62.03 125.53 24.18 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.627 -0.715 . . . . 43.24 111.435 -174.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.437 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 54.9 tp -130.27 113.11 14.0 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.779 1.231 . . . . 71.34 109.407 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -129.22 123.28 31.58 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.364 0.666 . . . . 73.21 109.562 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.514 HD22 ' HZ ' ' A' ' 107' ' ' PHE . 4.2 tt -73.8 127.85 33.92 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 108.333 -0.988 . . . . 64.3 108.333 175.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.593 ' HB3' ' HB2' ' E' ' 7' ' ' ALA . . . -65.51 137.26 96.44 Favored Pre-proline 0 CA--C 1.564 1.49 0 C-N-CA 123.067 0.547 . . . . 74.41 112.051 -174.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.471 ' HG2' ' CE1' ' C' ' 11' ' ' PHE . 36.8 Cg_exo -63.95 127.32 19.17 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.974 3.116 . . . . 54.31 113.429 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.5 t -117.47 114.78 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.04 0.936 . . . . 63.15 108.738 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -83.42 88.31 6.98 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.039 -0.726 . . . . 74.21 109.039 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -63.09 -44.22 96.33 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.279 -0.873 . . . . 52.53 110.506 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.565 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 18.6 p-10 -58.09 -41.82 84.31 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.165 1.386 . . . . 65.23 113.201 -170.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.12 96.61 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.246 0.618 . . . . 64.31 111.15 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.52 ' HB2' HD21 ' E' ' 10' ' ' LEU . 87.7 mt -76.38 -15.18 60.01 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.744 -0.662 . . . . 73.14 111.64 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -84.41 -26.52 28.26 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.63 0.372 . . . . 74.14 110.781 169.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 99.4 mmm -69.87 -28.75 65.91 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 110.019 -0.363 . . . . 64.14 110.019 170.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -59.18 -34.62 72.34 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.835 1.254 . . . . 75.34 110.576 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -94.29 -29.07 15.24 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.602 0.761 . . . . 74.4 111.89 177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 40.2 tp -63.54 -49.4 73.64 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.405 0.282 . . . . 74.0 110.675 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -164.5 27.1 0.07 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.521 0.729 . . . . 73.31 111.289 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 67.83 164.52 0.22 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.82 1.248 . . . . 73.43 112.483 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -100.2 101.6 12.67 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.44 0.696 . . . . 53.14 110.201 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.01 169.81 14.23 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.168 0.987 . . . . 75.41 109.498 173.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 100.63 60.71 0.81 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.16 -0.776 . . . . 70.03 111.16 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -75.85 100.64 4.85 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.196 -0.668 . . . . 73.25 109.196 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -90.11 146.0 18.46 Favored Glycine 0 C--N 1.338 0.662 0 N-CA-C 110.921 -0.872 . . . . 60.2 110.921 172.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.5 p -151.38 66.97 0.89 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.06 0.944 . . . . 74.32 108.681 174.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -78.08 87.34 4.21 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.949 -1.13 . . . . 73.11 107.949 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -92.36 157.76 16.45 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.236 1.015 . . . . 73.34 111.122 -170.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -147.0 90.27 1.88 Allowed 'General case' 0 C--O 1.241 0.605 0 C-N-CA 124.276 1.03 . . . . 70.33 108.482 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -75.42 101.84 4.95 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.48 -0.933 . . . . 63.11 108.48 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -174.51 153.88 1.96 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.389 1.076 . . . . 74.1 109.079 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 C-N-CA 124.024 0.93 . . . . 74.54 108.657 177.22 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 110.855 -0.054 . . . . 71.1 110.855 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.5 p -162.86 85.83 0.54 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.535 0.734 . . . . 75.44 109.578 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.65 132.91 35.31 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 108.199 -1.038 . . . . 61.42 108.199 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -74.77 77.69 2.08 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.191 0.596 . . . . 72.14 110.596 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -158.09 159.19 36.01 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.631 -1.248 . . . . 61.11 107.631 -175.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -66.5 89.28 0.14 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.036 0.534 . . . . 71.4 110.159 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -73.49 126.04 29.3 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.286 -0.87 . . . . 75.44 110.693 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 61.47 -84.13 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.22 1.408 . . . . 72.44 111.773 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.498 ' SD ' ' N ' ' B' ' 10' ' ' THR . 0.0 OUTLIER 63.49 166.84 0.14 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 125.603 1.561 . . . . 74.21 110.777 -173.329 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 99.9 m -157.87 125.26 5.14 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 106.187 -1.783 . . . . 74.21 106.187 170.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -138.53 125.33 21.0 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.181 -0.674 . . . . 73.41 109.181 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -148.3 137.7 22.09 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.315 -0.624 . . . . 74.43 109.315 174.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 48.6 mt -85.4 122.6 38.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.608 -0.886 . . . . 74.32 108.608 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLN . . . . . 0.514 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 12.4 mm100 -89.83 -43.51 10.59 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.677 0.791 . . . . 73.32 109.999 -175.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.486 ' HE ' HG21 ' A' ' 122' ' ' THR . 44.2 ttt180 -178.96 130.63 0.11 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.298 -0.631 . . . . 74.13 109.298 -173.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 77.4 mt -116.73 137.08 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 108.31 -0.996 . . . . 75.25 108.31 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -162.99 145.27 10.3 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.455 0.645 . . . . 75.12 111.182 -170.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.3 m -73.68 117.9 16.0 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.471 -1.24 . . . . 35.15 108.091 170.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.495 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 45.1 mtpt -92.78 -25.01 18.36 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.795 0.838 . . . . 63.3 111.354 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -163.45 147.35 10.6 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.528 0.518 . . . . 74.2 109.851 -172.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.437 HD11 ' SG ' ' B' ' 113' ' ' CYS . 28.4 mm -141.81 145.28 24.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 125.35 1.46 . . . . 72.32 108.427 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 44.2 t -144.01 141.08 29.93 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.727 -1.124 . . . . 72.14 108.387 167.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 81.5 t80 -147.75 126.69 12.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.279 -1.749 . . . . 74.51 106.279 171.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -135.3 116.6 14.55 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.147 -1.057 . . . . 63.43 108.147 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.574 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -106.35 86.48 2.13 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 107.593 -1.262 . . . . 64.54 107.593 174.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.12 -50.35 2.15 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.89 2.393 . . . . 52.5 111.946 -168.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -96.78 15.53 21.74 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.484 0.713 . . . . 72.35 111.191 -175.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.574 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -40.36 -65.06 0.48 Allowed Pre-proline 0 N--CA 1.491 1.602 0 C-N-CA 125.242 1.417 . . . . 53.14 114.575 -165.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.17 -25.54 72.68 Favored 'Trans proline' 0 C--N 1.392 2.821 0 C-N-CA 122.262 1.975 . . . . 62.11 113.92 -169.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -94.37 -41.66 9.3 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.138 0.575 . . . . 71.35 111.182 -175.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.89 -12.69 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 123.573 0.749 . . . . 73.32 111.685 -172.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -62.66 -14.3 41.94 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.569 0.748 . . . . 71.03 112.86 174.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.546 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.0 pt20 -60.79 -29.0 69.17 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.663 0.785 . . . . 73.33 110.98 172.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.546 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 96.3 mttt -93.66 108.46 20.19 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.91 1.284 . . . . 74.31 109.959 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -114.97 105.94 13.57 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.074 0.549 . . . . 73.12 110.427 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 21.6 p90 -165.82 -166.04 0.89 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.911 1.284 . . . . 74.33 108.121 169.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 -82.15 103.62 2.46 Favored Pre-proline 0 N--CA 1.477 0.914 0 N-CA-C 108.403 -0.962 . . . . 64.13 108.403 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.69 144.18 87.19 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.769 2.312 . . . . 61.45 113.126 -173.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.532 ' HB3' ' HA ' ' F' ' 3' ' ' GLN . 5.6 mp0 -55.42 103.36 0.09 Allowed 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.677 1.591 . . . . 70.32 110.311 172.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.435 HG22 HD21 ' B' ' 126' ' ' LEU . 20.3 t -85.62 155.18 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 115.182 -0.917 . . . . 71.13 109.118 -174.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.6 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 50.2 tttm -151.45 101.14 2.79 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.177 -1.786 . . . . 72.23 106.177 166.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.4 HD23 ' N ' ' B' ' 43' ' ' ASP . 7.8 tt -87.1 144.15 26.99 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.029 -1.471 . . . . 65.23 107.029 172.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.422 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 8.8 t70 -140.28 116.48 10.55 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 106.315 -1.735 . . . . 72.34 106.315 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 15.2 tp -98.13 127.89 44.33 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.182 -1.044 . . . . 73.11 108.182 -173.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -130.18 156.13 45.1 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.013 0.925 . . . . 64.34 109.136 -172.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 49.0 p -106.88 139.02 41.96 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.06 0.544 . . . . 60.21 111.131 -171.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.38 128.46 12.74 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 106.836 -1.542 . . . . 74.2 106.836 172.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.8 m -144.79 163.79 32.99 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.308 0.243 . . . . 71.11 111.16 -173.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 80.8 p -165.76 137.13 3.84 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.006 0.816 . . . . 63.15 110.049 167.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -94.72 108.82 20.82 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.093 -1.077 . . . . 71.14 108.093 171.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 35.3 mt -70.45 -53.49 16.16 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 121.643 0.735 . . . . 74.22 109.789 -175.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.89 -170.31 2.83 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.276 -1.329 . . . . 64.33 108.431 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -86.7 145.58 26.62 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.818 -1.179 . . . . 64.42 107.818 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 67.3 -2.44 1.25 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.815 1.246 . . . . 64.02 112.132 -172.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 45.9 t -126.45 116.75 46.3 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 C-N-CA 124.791 1.237 . . . . 74.4 108.0 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -127.11 139.25 53.11 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.019 -1.104 . . . . 74.02 108.019 175.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -105.51 105.65 15.78 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.628 -1.249 . . . . 74.53 107.628 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 75.1 t -94.94 124.35 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 124.938 1.295 . . . . 55.42 109.8 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.441 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 6.5 t -112.97 146.81 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.251 -1.018 . . . . 60.42 108.251 172.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 20.6 tp -125.4 111.41 15.1 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.258 -1.016 . . . . 65.03 108.258 169.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -87.83 112.23 22.24 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.13 -0.693 . . . . 72.35 109.13 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 60.9 t -104.69 104.02 16.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.7 -1.136 . . . . 73.23 108.049 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.422 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 27.0 m -94.92 136.38 35.3 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.114 -1.069 . . . . 55.31 108.114 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.518 HG21 HD13 ' B' ' 114' ' ' ILE . 95.0 t -127.85 130.7 70.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 124.096 0.958 . . . . 40.42 109.246 -175.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.6 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 53.5 m -121.53 139.65 53.22 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.899 -1.519 . . . . 64.01 106.899 168.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.05 136.72 30.48 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.668 -1.234 . . . . 63.25 107.668 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.501 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 3.7 m -139.08 145.5 39.59 Favored 'General case' 0 C--O 1.215 -0.726 0 N-CA-C 109.455 -0.572 . . . . 71.43 109.455 -168.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 42.6 mt -113.26 108.48 17.32 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.605 0.716 . . . . 72.15 109.487 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.12 -110.7 3.62 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 114.082 -1.417 . . . . 44.25 113.361 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.72 2.12 35.31 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.268 1.027 . . . . 74.34 110.489 -170.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -133.19 158.23 43.38 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.523 0.729 . . . . 72.1 109.701 -175.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 97.0 m -75.31 137.8 41.39 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.168 0.509 . . . . 72.4 110.081 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.501 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -93.35 -61.33 1.58 Allowed 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.458 1.103 . . . . 61.21 108.281 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -151.99 167.74 27.45 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 114.688 -1.142 . . . . 71.21 110.742 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 70.5 mt -133.87 138.0 45.33 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 106.008 -1.849 . . . . 73.12 106.008 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 47.1 t -138.4 159.17 42.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.869 -1.16 . . . . 74.42 107.869 175.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.466 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 40.5 tt0 -165.77 134.15 3.09 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.985 -0.746 . . . . 73.02 108.985 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.91 145.32 35.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.577 -0.897 . . . . 61.43 108.577 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -121.13 93.99 4.2 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.108 -1.071 . . . . 64.3 108.108 171.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.456 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -87.88 102.44 14.71 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.725 -0.843 . . . . 74.41 108.725 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.495 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.94 156.58 23.02 Favored Glycine 0 N--CA 1.449 -0.492 0 O-C-N 123.965 0.79 . . . . 54.23 111.305 175.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.96 126.35 1.66 Allowed Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 109.99 -1.244 . . . . 73.33 109.99 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.514 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 27.1 mt -85.67 130.1 36.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.626 -1.25 . . . . 62.35 107.626 176.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -133.83 134.23 42.55 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.36 -0.978 . . . . 74.3 108.36 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 74.1 m -92.99 110.43 21.9 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.101 -0.703 . . . . 54.51 109.101 172.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.574 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -124.81 132.71 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.623 1.169 . . . . 74.44 109.122 -178.807 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.3 172.29 18.75 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.209 0.604 . . . . 53.03 110.741 -172.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.42 -63.6 4.31 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.932 0.77 . . . . 62.35 112.408 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.593 HG22 ' HB3' ' B' ' 94' ' ' MET . 2.5 mm -68.8 157.84 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.474 1.11 . . . . 75.55 112.224 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.525 ' HB3' HH21 ' F' ' 22' ' ' ARG . 17.2 tp10 -160.06 153.5 22.29 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 115.118 -0.947 . . . . 74.21 110.777 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.76 -136.81 13.36 Favored Glycine 0 C--N 1.351 1.413 0 C-N-CA 124.297 0.951 . . . . 61.22 112.933 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 19.5 m -67.14 -27.68 67.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.542 0.737 . . . . 75.24 110.94 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.432 ' HB2' HG23 ' B' ' 89' ' ' ILE . 42.8 mt-30 -63.99 -39.77 94.86 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.689 -1.141 . . . . 74.32 110.965 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.593 ' HB3' HG22 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -88.17 -25.81 22.75 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.565 0.346 . . . . 72.34 110.82 177.379 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.65 -34.2 73.95 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.149 0.58 . . . . 60.44 110.954 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -78.86 -37.57 40.02 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.655 0.782 . . . . 64.02 111.034 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.5 t -62.71 -43.2 99.4 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.201 0.601 . . . . 44.53 111.49 -175.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.412 HD11 HG13 ' B' ' 86' ' ' ILE . 6.6 mp -90.58 -23.33 20.89 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.874 0.47 . . . . 72.34 111.112 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.06 -17.62 66.86 Favored Glycine 0 C--N 1.346 1.104 0 N-CA-C 114.358 0.503 . . . . 73.44 114.358 -174.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.19 -55.56 0.59 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.068 0.547 . . . . 71.33 110.97 -177.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -66.75 -53.31 34.59 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.436 0.902 . . . . 75.43 113.436 -166.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.516 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 76.0 m -60.13 -50.08 87.88 Favored Pre-proline 0 CA--C 1.564 1.504 0 CA-C-O 118.561 -0.733 . . . . 53.22 111.493 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.516 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 47.7 Cg_exo -60.33 -29.37 88.7 Favored 'Trans proline' 0 C--N 1.401 3.296 0 C-N-CA 122.4 2.067 . . . . 73.1 113.384 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -71.15 -30.99 67.16 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.578 0.751 . . . . 62.13 110.928 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.423 HG23 ' NH2' ' D' ' 111' ' ' ARG . 53.1 mt -66.87 -37.87 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 109.568 -0.53 . . . . 45.0 109.568 171.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 54.8 mt -84.18 -18.82 35.41 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.026 0.93 . . . . 62.03 112.1 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.421 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 85.7 t80 -57.86 -50.34 88.66 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-O 118.088 -0.958 . . . . 73.52 112.338 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.421 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 51.5 Cg_exo -57.89 -38.02 94.01 Favored 'Trans proline' 0 C--N 1.394 2.929 0 C-N-CA 122.401 2.067 . . . . 74.43 113.798 177.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.456 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 38.8 m-85 -68.12 -43.29 78.73 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.281 0.632 . . . . 74.03 110.576 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.449 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -64.8 -40.61 95.51 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.285 0.634 . . . . 73.24 110.427 175.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.497 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 37.9 ttt180 -57.41 -49.57 75.8 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.542 1.537 . . . . 75.11 111.402 -176.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.428 ' HG3' ' NH2' ' C' ' 120' ' ' ARG . 2.1 tm-20 -68.79 -34.6 75.83 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 123.84 0.712 . . . . 55.33 110.033 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.476 ' O ' ' HG2' ' B' ' 117' ' ' MET . 9.3 t -67.27 -33.63 75.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.99 0.516 . . . . 54.41 111.268 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.518 HD13 HG21 ' B' ' 64' ' ' VAL . 73.7 mt -67.69 -56.04 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 108.91 -0.774 . . . . 41.12 108.91 174.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.1 m -59.84 -26.54 65.89 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 124.336 1.023 . . . . 63.1 111.396 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 29.4 t -64.78 -50.55 66.33 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.273 0.629 . . . . 72.35 109.614 174.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.0 mmt -70.44 -31.21 68.3 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.08 0.552 . . . . 73.52 111.005 -176.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.49 HG23 ' O ' ' B' ' 114' ' ' ILE . 57.7 t -60.57 -47.77 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.487 0.715 . . . . 55.02 109.414 171.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 21.0 t -65.08 -34.62 78.85 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.546 -1.206 . . . . 75.41 111.191 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.423 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 92.6 mtt-85 -70.81 -31.95 68.86 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.986 -1.006 . . . . 75.42 110.384 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.56 5.66 76.96 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.944 0.778 . . . . 52.45 112.656 174.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.456 HG23 ' HB3' ' A' ' 17' ' ' TYR . 80.6 p 54.42 29.95 11.93 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 126.0 1.72 . . . . 62.25 113.015 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -91.02 159.87 38.97 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.264 0.625 . . . . 74.14 111.317 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -48.93 158.11 1.39 Allowed 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 123.732 2.955 . . . . 62.03 114.76 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -57.9 114.6 2.39 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.978 -1.01 . . . . 73.52 111.236 -176.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.435 HD21 HG22 ' B' ' 40' ' ' VAL . 0.3 OUTLIER -121.58 101.87 7.88 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.867 -1.16 . . . . 62.13 107.867 -178.703 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -119.23 133.99 55.45 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.726 0.811 . . . . 71.43 109.224 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.535 ' HA ' HD12 ' F' ' 6' ' ' ILE . 6.6 mp -75.42 144.97 41.92 Favored 'General case' 0 C--O 1.242 0.668 0 O-C-N 123.655 0.597 . . . . 71.23 109.956 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -70.76 134.14 86.18 Favored Pre-proline 0 CA--C 1.549 0.911 0 O-C-N 123.816 0.697 . . . . 50.53 111.093 -177.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 7.0 Cg_exo -72.47 104.81 1.77 Allowed 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.886 2.391 . . . . 71.42 111.692 176.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.525 HG21 ' HG ' ' F' ' 8' ' ' LEU . 34.1 m -110.99 139.95 32.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 123.327 0.651 . . . . 63.33 109.63 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -92.08 90.61 7.44 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 106.414 -1.699 . . . . 61.31 106.414 169.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -67.09 -32.0 72.86 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.946 -1.025 . . . . 63.33 111.289 -171.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -65.72 -37.76 87.3 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.941 0.896 . . . . 54.42 111.484 175.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' B' ' 138' ' ' MET . . . -63.48 -32.34 73.76 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.587 0.755 . . . . 71.52 111.668 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.435 ' HB3' HD11 ' F' ' 10' ' ' LEU . 89.5 mt -60.33 -35.2 75.09 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.779 0.832 . . . . 75.12 111.587 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -83.87 -39.07 20.34 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.362 0.665 . . . . 71.14 110.638 174.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.493 ' HB3' ' HA ' ' B' ' 135' ' ' ALA . 1.8 tmt? -62.12 -36.27 81.26 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.243 1.017 . . . . 62.01 111.968 -174.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -74.2 -24.31 59.34 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.267 0.627 . . . . 55.35 110.502 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -75.68 -35.42 60.36 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 122.681 0.392 . . . . 73.53 110.031 175.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 83.4 mt -87.51 -3.57 58.99 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 112.594 0.59 . . . . 65.24 112.594 -172.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 142' ' ' GLN . . . . . 0.49 HE22 ' HB3' ' D' ' 5' ' ' ASN . 57.3 tt0 -116.12 137.71 51.89 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.668 0.387 . . . . 72.02 110.609 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -73.1 118.14 15.68 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.457 -0.942 . . . . 64.33 108.457 167.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -74.76 124.53 26.96 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 122.897 0.479 . . . . 75.11 109.733 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -148.36 145.79 28.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.551 0.74 . . . . 73.25 109.533 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -141.89 -164.86 10.22 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.682 -0.567 . . . . 60.14 111.682 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.48 -167.98 1.91 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.527 0.731 . . . . 65.13 109.633 176.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.53 145.86 12.59 Favored Glycine 0 C--N 1.342 0.877 0 C-N-CA 121.727 -0.273 . . . . 71.22 112.523 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 21.2 m -67.87 136.22 53.73 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.384 0.674 . . . . 73.31 110.071 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -120.92 140.6 51.62 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.017 0.927 . . . . 71.42 110.035 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -142.8 172.27 12.92 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.701 0.8 . . . . 74.24 110.614 -176.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -154.43 140.41 18.3 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.648 0.779 . . . . 72.41 109.097 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -154.72 129.72 9.5 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.796 0.839 . . . . 42.34 109.017 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -126.26 110.54 13.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.199 0.999 . . . . 73.53 108.818 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 C-N-CA 123.551 0.74 . . . . 63.24 109.557 176.846 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tmm? . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 108.359 -0.978 . . . . 53.21 108.359 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 20.2 p -171.47 9.14 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.892 1.677 . . . . 72.3 109.69 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -80.61 149.89 29.7 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 124.349 1.059 . . . . 71.1 109.906 -169.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -89.24 -68.74 0.75 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.057 0.943 . . . . 70.14 108.467 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 63.4 t30 64.1 143.98 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.514 1.526 . . . . 75.11 113.05 173.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -81.69 159.48 23.92 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.849 0.459 . . . . 45.23 109.777 175.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 29.0 m -97.02 -72.34 0.64 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.786 -0.82 . . . . 63.44 108.786 173.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 49.28 -93.03 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.882 1.273 . . . . 62.04 110.87 -171.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.445 ' HG3' ' HB2' ' C' ' 11' ' ' PHE . 15.6 tpt 33.28 111.03 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 126.991 2.116 . . . . 74.12 115.141 174.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.597 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 19.9 m -86.24 92.91 8.92 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.975 -1.12 . . . . 75.51 107.975 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.652 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.3 t80 -121.31 135.66 55.07 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.959 -1.018 . . . . 72.03 110.406 -173.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -155.31 126.43 7.15 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.839 -1.171 . . . . 74.24 107.839 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 88.4 mt -73.32 120.05 21.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.291 -1.003 . . . . 71.42 108.291 172.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.62 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 10.8 mm100 -82.54 -42.64 18.11 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.208 -0.905 . . . . 71.11 109.6 -177.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -179.27 134.02 0.12 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.284 0.633 . . . . 75.32 110.345 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.8 mt -117.68 145.95 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.867 0.867 . . . . 74.44 108.855 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -174.65 158.02 2.65 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.276 0.631 . . . . 74.3 110.729 -174.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 63.7 p -83.39 114.69 21.61 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.381 -0.97 . . . . 71.2 108.381 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -77.05 -47.06 21.62 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.736 -0.838 . . . . 74.12 108.736 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.662 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.0 t70 -133.97 137.84 45.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.336 -1.302 . . . . 64.54 109.572 -174.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 71.8 mt -136.81 144.52 32.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.021 -1.474 . . . . 72.03 107.021 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.1 t -161.82 150.66 15.61 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.976 0.417 . . . . 71.11 110.798 174.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -152.36 121.25 6.57 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 114.797 -1.092 . . . . 61.03 108.143 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -122.63 122.27 38.41 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.921 0.888 . . . . 74.11 110.451 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.09 83.01 34.71 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 107.73 -1.211 . . . . 65.4 107.73 168.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.43 -13.61 20.48 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.558 2.172 . . . . 74.55 111.764 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -103.01 14.59 31.58 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.9 1.28 . . . . 74.11 109.862 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.402 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -48.16 -53.52 32.76 Favored Pre-proline 0 C--N 1.37 1.48 0 C-N-CA 124.64 1.176 . . . . 73.01 113.55 -170.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 52.5 Cg_exo -54.59 -50.6 12.82 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 121.871 1.714 . . . . 72.12 112.828 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -68.57 -35.46 77.41 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.911 -1.041 . . . . 63.22 112.173 -172.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.728 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.0 p -78.59 -24.97 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 N-CA-C 113.182 0.808 . . . . 61.15 113.182 -172.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -67.13 -28.36 68.07 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.528 0.566 . . . . 75.14 112.528 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -86.92 5.16 38.44 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.128 0.571 . . . . 73.43 111.773 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.777 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -88.76 150.16 23.09 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.483 0.713 . . . . 73.31 110.369 178.493 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.25 124.07 19.88 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.292 0.637 . . . . 74.1 109.755 167.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -78.71 97.62 5.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.365 0.666 . . . . 74.32 111.211 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -153.6 78.16 5.69 Favored Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 108.605 -0.887 . . . . 71.2 108.605 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -90.45 149.66 4.36 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.013 2.475 . . . . 61.42 113.856 -176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -88.23 102.86 15.24 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 114.028 -1.442 . . . . 75.43 107.365 167.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -81.23 101.71 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.933 -0.576 . . . . 72.21 109.764 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.481 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 11.0 tmtt? -92.38 109.94 21.34 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.23 -1.396 . . . . 72.21 107.23 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.643 HD23 ' HB ' ' G' ' 6' ' ' ILE . 4.1 pp -85.14 161.69 19.54 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.585 -0.524 . . . . 73.42 109.585 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.612 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 12.5 t70 -147.19 134.41 20.55 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.674 -1.232 . . . . 65.43 107.674 171.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.557 HD12 HD21 ' G' ' 11' ' ' LEU . 1.7 tm? -128.79 111.24 12.9 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.104 -1.443 . . . . 74.13 107.104 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 21.6 t70 -123.54 152.68 41.55 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.022 0.929 . . . . 71.31 109.124 -177.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 46' ' ' THR . . . . . 0.504 ' HB ' ' CD1' ' G' ' 15' ' ' PHE . 52.5 p -117.92 134.48 54.91 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.519 0.728 . . . . 63.24 111.458 -169.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.53 160.19 42.45 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.377 0.671 . . . . 51.21 110.471 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 72.8 m -160.03 170.93 20.27 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.422 0.689 . . . . 74.52 111.242 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 95.8 p -153.98 140.74 19.06 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.964 0.906 . . . . 62.32 108.934 166.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -86.43 121.43 28.97 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.2 -1.037 . . . . 64.1 108.2 173.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.601 HD11 HD12 ' C' ' 83' ' ' ILE . 53.6 mt -99.22 -30.38 12.29 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.472 0.709 . . . . 73.31 109.923 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.81 -174.39 2.72 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.453 1.101 . . . . 61.02 109.604 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -71.24 125.0 25.79 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.334 -0.987 . . . . 70.43 108.334 171.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 69.37 3.67 4.26 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.876 1.27 . . . . 74.32 113.204 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 96.3 t -117.69 110.64 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 107.892 -1.151 . . . . 44.42 107.892 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -134.34 137.57 44.26 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.537 0.735 . . . . 75.12 109.573 -173.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -86.69 120.93 28.52 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.949 -1.023 . . . . 65.44 109.748 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 55.2 t -96.7 115.39 36.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.818 -1.179 . . . . 64.31 107.818 168.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 64.0 t -112.93 136.26 49.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 N-CA-C 107.603 -1.258 . . . . 72.52 107.603 171.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.719 HD22 ' HB2' ' C' ' 103' ' ' PRO . 11.6 tp -126.73 118.36 24.56 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.619 -0.882 . . . . 70.33 108.619 172.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 14.2 ttm180 -81.79 115.66 21.11 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.567 -0.742 . . . . 71.44 109.212 176.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 24.9 t -110.5 116.56 52.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.537 -1.283 . . . . 45.23 107.537 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.612 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 17.9 m -128.86 115.52 18.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.424 0.63 . . . . 63.14 109.348 -174.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 84.4 t -108.07 116.04 50.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 124.817 1.247 . . . . 74.14 109.364 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 4.1 m -100.53 145.91 27.74 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.838 -1.171 . . . . 54.53 107.838 171.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.85 119.74 18.48 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.347 -1.353 . . . . 62.31 107.347 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -133.04 125.52 29.85 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.945 0.339 . . . . 51.25 110.361 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.777 HD13 ' HG2' ' C' ' 34' ' ' LYS . 9.0 mt -86.44 41.04 0.92 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.661 1.184 . . . . 54.03 109.776 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.2 -114.2 4.54 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 110.138 -1.185 . . . . 71.22 110.138 -169.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.29 -28.12 21.27 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.346 0.658 . . . . 70.51 109.928 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.94 118.05 9.19 Favored 'General case' 0 C--N 1.345 0.402 0 N-CA-C 108.923 -0.769 . . . . 64.33 108.923 171.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 29.4 m -81.19 121.92 26.75 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 108.06 -1.089 . . . . 64.3 108.06 167.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.728 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.5 -58.14 3.61 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.41 -0.959 . . . . 64.33 108.41 177.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -162.69 170.73 17.95 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 114.95 -1.023 . . . . 74.43 111.708 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.434 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -127.6 146.39 50.55 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 106.002 -1.851 . . . . 72.21 106.002 166.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.434 ' N ' HD13 ' C' ' 75' ' ' LEU . 46.2 t -147.31 130.17 16.19 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.984 -1.117 . . . . 65.23 107.984 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -136.33 117.84 14.82 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.428 -0.582 . . . . 72.34 109.428 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 77.4 t -120.03 122.4 68.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.45 -0.945 . . . . 70.44 108.45 170.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.662 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.3 mt-30 -103.42 94.25 5.39 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 108.023 -1.102 . . . . 70.44 108.023 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -80.07 114.81 19.25 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.963 -1.017 . . . . 65.1 109.655 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.22 146.12 18.14 Favored Glycine 0 C--N 1.34 0.779 0 O-C-N 123.826 0.704 . . . . 70.34 111.423 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.449 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.54 119.66 0.95 Allowed Glycine 0 CA--C 1.503 -0.697 0 N-CA-C 110.554 -1.019 . . . . 75.21 110.554 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.62 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 8.4 mm -85.37 126.74 40.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 108.287 -1.005 . . . . 73.42 108.287 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.652 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 69.7 m-85 -132.23 147.39 52.41 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.365 0.666 . . . . 63.32 109.883 -176.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 45.4 m -87.49 123.66 32.64 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.935 0.894 . . . . 62.2 109.352 171.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.52 HG12 HD21 ' C' ' 98' ' ' LEU . 4.4 mp -121.72 121.03 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 109.675 -0.491 . . . . 74.24 109.675 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.597 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -163.28 167.89 21.29 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.235 1.014 . . . . 53.22 109.903 173.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.67 -60.8 1.2 Allowed Glycine 0 N--CA 1.471 1.026 0 C-N-CA 123.137 0.399 . . . . 74.23 112.661 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 pt -96.06 150.9 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.658 0.783 . . . . 74.4 110.393 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -147.61 146.77 29.49 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.69 0.796 . . . . 75.42 109.555 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.36 -139.18 14.65 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 111.671 -0.571 . . . . 74.45 111.671 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 10.3 p -68.23 -21.35 64.85 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 113.477 0.917 . . . . 64.45 113.477 -174.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -77.23 -40.72 43.94 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 109.337 -0.616 . . . . 51.41 109.337 177.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.511 ' SD ' HD12 ' C' ' 98' ' ' LEU . 14.3 tmm? -65.48 -36.16 83.04 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.274 -0.876 . . . . 62.43 110.136 172.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 95' ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' G' ' 21' ' ' ALA . . . -67.68 -34.72 77.48 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.995 0.918 . . . . 40.52 111.412 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -65.65 -40.99 93.08 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.697 -0.683 . . . . 73.01 110.224 173.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.495 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 43.0 t -63.34 -45.25 92.12 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.598 0.561 . . . . 73.53 110.412 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.68 HD13 ' HD2' ' G' ' 17' ' ' PRO . 75.2 mt -80.98 -51.99 7.92 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.135 0.574 . . . . 72.5 112.397 -175.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.75 11.12 65.17 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 115.081 0.792 . . . . 60.11 115.081 -169.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.35 -61.82 0.14 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.425 0.631 . . . . 51.4 110.813 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.495 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 35.0 t80 -75.2 -37.15 61.3 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 125.502 1.521 . . . . 63.54 113.735 -165.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 91.7 m -77.84 -44.12 2.38 Favored Pre-proline 0 N--CA 1.486 1.344 0 C-N-CA 123.252 0.621 . . . . 73.43 112.033 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.719 ' HB2' HD22 ' C' ' 60' ' ' LEU . 78.6 Cg_endo -75.57 -9.48 19.99 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 121.849 1.699 . . . . 73.05 112.344 172.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -68.08 -37.41 81.21 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.751 -0.833 . . . . 72.05 108.751 168.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.552 HD12 ' NH1' ' A' ' 111' ' ' ARG . 39.8 mm -59.38 -43.41 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 115.455 -0.793 . . . . 70.25 109.366 171.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.449 HD21 ' HA3' ' C' ' 82' ' ' GLY . 82.0 mt -81.92 -16.02 51.96 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.307 1.043 . . . . 75.21 112.913 -173.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -55.03 -53.93 55.88 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-O 118.257 -0.878 . . . . 74.3 112.63 -175.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.13 -30.62 65.36 Favored 'Trans proline' 0 C--N 1.388 2.635 0 C-N-CA 121.951 1.767 . . . . 64.11 113.508 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -67.57 -49.85 61.19 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.297 0.639 . . . . 54.35 110.539 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.18 -42.79 95.76 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.196 -0.911 . . . . 73.2 110.276 176.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -58.81 -52.66 64.76 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.173 1.389 . . . . 70.43 111.359 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -66.84 -37.1 83.83 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.738 0.649 . . . . 72.24 110.052 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 35.2 t -67.7 -32.62 73.39 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.332 0.395 . . . . 63.15 111.59 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 83.9 mt -72.54 -52.99 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.127 0.571 . . . . 65.55 110.23 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 12.3 m -65.01 -29.31 70.22 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.176 0.59 . . . . 72.13 111.321 -175.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 40.6 t -65.72 -49.7 67.52 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.077 -0.712 . . . . 64.45 109.077 173.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.689 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.75 -37.29 78.59 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.157 0.983 . . . . 72.2 112.39 179.257 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 83.0 t -60.74 -48.26 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.226 0.61 . . . . 75.24 110.035 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 26.5 t -72.39 -22.24 61.16 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 115.325 -0.852 . . . . 74.05 111.581 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.428 ' NH2' ' HG3' ' B' ' 112' ' ' GLU . 89.2 mtt-85 -73.93 -35.0 64.54 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.856 0.862 . . . . 72.35 109.705 174.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.05 7.65 70.16 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 115.457 -0.792 . . . . 75.41 112.086 171.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 64.7 p 60.02 26.68 16.01 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.415 1.886 . . . . 72.13 113.412 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -88.65 144.95 34.17 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 108.202 -1.036 . . . . 63.33 108.202 171.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -54.63 154.25 21.01 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 123.121 2.548 . . . . 71.12 113.505 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -54.68 124.33 16.04 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.901 1.28 . . . . 52.03 113.43 -171.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 40.1 tp -127.22 90.47 3.14 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.41 -0.959 . . . . 72.21 108.41 176.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -92.31 131.24 37.67 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.067 0.947 . . . . 63.12 109.545 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.72 134.16 46.07 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.172 0.589 . . . . 64.51 109.512 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.33 151.07 77.75 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 123.291 0.636 . . . . 61.01 110.978 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.74 110.67 2.39 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.892 2.395 . . . . 60.21 112.141 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.597 HG21 ' H ' ' G' ' 8' ' ' LEU . 39.6 t -105.38 111.61 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.256 0.622 . . . . 60.42 109.595 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -85.41 89.68 7.75 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.716 0.806 . . . . 73.24 110.438 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -59.63 -38.09 80.39 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 109.663 -0.495 . . . . 71.13 109.663 169.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.09 -51.21 67.09 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.259 1.424 . . . . 75.2 111.362 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.55 -30.84 67.68 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.869 0.868 . . . . 64.51 111.237 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.411 ' HA ' ' ND2' ' C' ' 139' ' ' ASN . 96.0 mt -67.65 -32.89 73.89 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.628 -0.715 . . . . 71.31 111.538 173.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -78.07 -25.38 47.65 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.996 0.518 . . . . 73.55 110.944 173.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 66.9 mtt -67.32 -27.95 67.59 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.755 0.422 . . . . 71.42 110.353 172.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 139' ' ' ASN . . . . . 0.411 ' ND2' ' HA ' ' C' ' 136' ' ' LEU . 95.0 m-20 -59.62 -44.59 93.4 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 123.448 0.699 . . . . 73.12 112.279 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -72.29 -165.74 0.21 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 119.154 0.888 . . . . 61.23 110.498 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 37.5 tp 64.53 -17.43 0.08 Allowed 'General case' 0 CA--C 1.577 1.986 0 C-N-CA 124.615 1.166 . . . . 63.24 114.004 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -156.53 -174.41 4.92 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.891 0.876 . . . . 70.14 110.44 -167.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 143' ' ' GLN . . . . . 0.579 ' HG3' ' HA ' ' A' ' 6' ' ' ASN . 10.5 pt20 -90.86 147.46 23.15 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.51 0.724 . . . . 55.24 109.681 174.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -122.82 112.79 18.31 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.809 -0.811 . . . . 74.53 108.809 -176.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -116.56 -176.05 2.89 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.781 0.832 . . . . 62.1 108.857 173.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -167.31 121.83 1.0 Allowed Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.668 -0.573 . . . . 72.11 111.668 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -76.78 151.41 35.99 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.072 0.949 . . . . 73.44 110.115 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -95.05 166.84 26.18 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 116.455 -0.339 . . . . 34.41 112.48 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 4.5 t -66.89 114.99 6.16 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.432 0.693 . . . . 41.2 110.051 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -79.41 -27.42 41.8 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.279 1.031 . . . . 74.24 111.689 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 60.21 84.47 0.12 Allowed 'General case' 0 C--N 1.357 0.91 0 C-N-CA 124.225 1.01 . . . . 73.2 110.707 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -139.62 115.89 10.5 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 120.941 0.401 . . . . 75.23 111.38 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -131.61 135.35 46.89 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.539 1.136 . . . . 74.4 108.589 166.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -142.37 159.09 42.91 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.949 0.9 . . . . 64.0 109.438 175.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.883 0 N-CA-C 108.974 -0.75 . . . . 61.5 108.974 -177.016 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 119.88 -0.105 . . . . 72.41 111.018 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 36.9 m -144.04 170.68 15.47 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.897 0.479 . . . . 64.0 110.348 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -161.96 -174.64 4.24 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.418 1.087 . . . . 52.42 109.938 172.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -70.59 85.41 0.63 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.111 0.964 . . . . 63.43 110.688 -174.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 5' ' ' ASN . . . . . 0.49 ' HB3' HE22 ' B' ' 142' ' ' GLN . 52.2 t30 -85.56 85.46 7.42 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.508 -0.769 . . . . 63.22 109.046 175.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -128.23 23.19 6.03 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.238 1.015 . . . . 75.14 109.693 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.44 HG23 ' H ' ' D' ' 9' ' ' MET . 10.9 t -143.16 -170.97 3.38 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.281 1.032 . . . . 73.43 108.611 -174.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -83.12 24.84 0.75 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.571 0.749 . . . . 53.01 111.763 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.44 ' H ' HG23 ' D' ' 7' ' ' THR . 14.4 tpt -30.28 123.59 0.18 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.996 1.718 . . . . 75.11 113.331 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 65.1 m -123.95 142.26 51.31 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.071 -1.085 . . . . 72.23 108.071 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.751 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 20.8 t80 -164.79 90.63 0.53 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.673 -1.232 . . . . 63.41 107.673 -177.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -113.05 116.28 29.67 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.13 -1.433 . . . . 71.52 107.13 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.482 HG21 HD11 ' D' ' 16' ' ' ILE . 18.2 mt -68.75 123.26 21.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 109.331 -0.618 . . . . 61.34 109.331 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 14' ' ' GLN . . . . . 0.529 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 21.0 mm-40 -83.01 -46.46 12.83 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 123.795 0.684 . . . . 53.02 109.687 175.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.409 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 27.7 ttt180 -178.5 141.08 0.21 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 116.603 -0.271 . . . . 75.2 111.706 -164.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.482 HD11 HG21 ' D' ' 13' ' ' ILE . 3.7 mp -122.97 142.0 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.464 -1.31 . . . . 63.12 107.464 172.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.409 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 26.3 p90 -165.46 174.48 9.95 Favored 'General case' 0 C--O 1.238 0.496 0 O-C-N 124.062 0.851 . . . . 72.51 111.187 -175.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 62.3 p -108.71 119.56 39.9 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 114.557 -1.202 . . . . 71.21 109.642 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -92.42 -19.13 22.37 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.378 0.671 . . . . 71.3 110.165 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.606 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 15.9 t70 -158.09 133.27 8.68 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.774 -1.103 . . . . 65.2 108.699 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.689 HG21 ' HE2' ' C' ' 117' ' ' MET . 68.8 mt -131.94 147.78 32.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 107.083 -1.451 . . . . 61.43 107.083 173.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -156.24 144.74 20.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 123.741 0.651 . . . . 54.31 110.114 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 87.4 t80 -148.17 122.05 9.36 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 105.346 -2.094 . . . . 63.24 105.346 173.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -133.38 110.8 10.27 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.061 0.544 . . . . 74.21 109.806 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.32 88.13 12.34 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 107.772 -1.195 . . . . 54.34 107.772 175.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -74.2 -39.85 1.47 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.907 2.405 . . . . 64.5 112.06 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -92.34 5.11 51.8 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.749 -1.114 . . . . 72.43 111.021 -176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.506 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -30.04 -67.8 0.13 Allowed Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 116.459 2.022 . . . . 63.01 116.459 -164.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.42 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 93.5 Cg_endo -75.07 -23.91 13.22 Favored 'Trans proline' 0 C--N 1.374 1.909 0 CA-C-N 122.831 2.047 . . . . 73.33 113.119 -173.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -73.12 -39.21 65.93 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.932 0.893 . . . . 43.52 109.57 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.506 HG12 ' O ' ' D' ' 28' ' ' ALA . 4.8 p -83.03 -16.11 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-N 115.817 -0.628 . . . . 74.51 110.442 -173.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.42 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.1 m-85 -69.02 -22.82 64.04 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.524 0.33 . . . . 61.33 111.77 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -57.51 -27.04 62.22 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.587 0.755 . . . . 75.45 109.976 172.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -88.43 70.74 9.04 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.818 1.247 . . . . 65.23 109.198 172.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -79.71 87.64 5.22 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.72 -0.673 . . . . 73.4 109.714 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 18.6 p90 -163.29 174.82 11.56 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.337 1.055 . . . . 74.41 109.112 172.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -68.45 115.98 35.37 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.62 0.768 . . . . 74.11 109.565 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -63.18 151.87 82.59 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.709 2.273 . . . . 62.43 112.616 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -73.24 113.09 9.92 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.359 -1.349 . . . . 74.55 107.359 172.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.71 HG21 ' HG ' ' D' ' 126' ' ' LEU . 98.8 t -105.93 137.98 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 123.879 0.871 . . . . 73.25 109.739 -172.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -128.32 126.72 41.33 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.616 1.166 . . . . 62.34 108.131 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.49 HD22 HD23 ' D' ' 128' ' ' LEU . 45.2 tp -96.99 144.07 27.24 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.07 -0.715 . . . . 63.13 109.07 176.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.535 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 7.5 t70 -144.14 153.82 42.53 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.538 0.735 . . . . 75.32 109.081 176.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.6 mt -133.23 146.41 51.44 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.417 0.687 . . . . 74.11 111.108 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.653 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 5.8 t70 -135.58 155.18 50.88 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.919 1.287 . . . . 75.3 108.215 169.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 46' ' ' THR . . . . . 0.433 HG23 ' CD1' ' H' ' 15' ' ' PHE . 97.7 m -101.39 140.48 35.63 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.94 0.896 . . . . 71.0 108.812 -176.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' D' ' 152' ' ' HIS . . . -166.91 142.56 4.29 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.222 -1.029 . . . . 53.01 108.222 175.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.8 p -176.36 162.44 2.38 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.941 0.496 . . . . 72.4 110.425 -176.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 77.5 p -153.77 150.16 28.2 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.647 0.379 . . . . 75.54 110.936 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -88.14 119.61 28.7 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.72 -0.844 . . . . 73.12 108.72 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' D' ' 57' ' ' GLU . 23.2 mt -94.72 -31.81 13.62 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.793 0.437 . . . . 73.13 111.161 -175.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -161.27 -175.72 5.0 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.739 0.816 . . . . 74.33 110.602 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.07 109.83 3.16 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.771 -1.104 . . . . 75.44 109.389 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 66.89 6.91 4.93 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.588 1.155 . . . . 64.2 112.677 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 64.1 t -110.91 120.55 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 107.427 -1.323 . . . . 73.25 107.427 175.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -140.85 131.7 25.91 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 122.917 0.487 . . . . 73.41 110.008 -165.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.456 ' HB2' HD11 ' D' ' 51' ' ' LEU . 15.9 tt0 -92.72 135.0 34.49 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.793 0.837 . . . . 73.11 110.5 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 98.0 t -117.5 128.75 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.163 1.385 . . . . 72.52 108.39 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 29.1 t -125.58 130.93 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.408 0.683 . . . . 64.2 109.594 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.495 HD23 HD12 ' D' ' 106' ' ' LEU . 4.6 mm? -117.81 121.09 39.87 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.087 -0.708 . . . . 45.33 109.087 172.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.653 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 41.2 ttm-85 -83.2 96.4 8.43 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.513 -1.291 . . . . 61.2 107.513 172.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.487 HG13 HD11 ' D' ' 42' ' ' LEU . 88.3 t -90.34 128.16 42.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.009 -1.108 . . . . 71.31 108.009 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 29.8 m -125.68 139.63 53.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.878 -0.416 . . . . 60.44 109.878 -176.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.688 HG13 HG13 ' D' ' 40' ' ' VAL . 17.8 t -128.61 102.01 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.441 1.096 . . . . 74.51 108.556 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 17.6 m -93.31 112.53 24.48 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.478 -0.934 . . . . 72.34 108.478 173.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.07 141.16 48.49 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.657 0.783 . . . . 62.11 109.186 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.435 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 59.8 p -148.8 127.02 12.12 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 123.52 0.513 . . . . 74.41 111.236 -177.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 28.8 mt -94.16 115.51 27.81 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 124.423 1.089 . . . . 73.22 109.076 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.65 -111.75 3.58 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 111.495 -0.642 . . . . 72.43 111.495 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.97 12.14 10.4 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.702 0.801 . . . . 72.05 110.863 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -131.56 165.21 24.13 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.849 0.459 . . . . 73.5 109.965 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -65.63 131.25 45.88 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.762 0.825 . . . . 71.25 111.961 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.435 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -90.97 -68.38 0.79 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.83 -1.174 . . . . 51.24 107.83 171.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -151.17 153.55 35.18 Favored 'General case' 0 C--N 1.353 0.72 0 CA-C-N 115.757 -0.656 . . . . 71.32 111.003 175.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 46.5 mt -118.97 110.56 17.27 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 106.773 -1.566 . . . . 54.44 106.773 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 76' ' ' CYS . . . . . . . . . . . . . 45.9 t -126.11 105.93 9.22 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 122.943 0.497 . . . . 54.24 109.972 -170.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -122.73 128.99 51.25 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.442 0.697 . . . . 70.43 109.701 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 25.6 t -126.96 121.19 57.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 123.419 0.688 . . . . 74.42 109.696 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.606 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.7 mt-30 -87.35 87.36 7.4 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.149 -1.056 . . . . 53.23 108.149 167.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -81.85 110.6 17.3 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.01 -1.45 . . . . 73.42 108.719 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.79 153.23 17.23 Favored Glycine 0 C--N 1.341 0.859 0 O-C-N 123.545 0.528 . . . . 73.13 111.842 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.8 130.87 2.88 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 111.578 -0.609 . . . . 73.51 111.578 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 22.2 mt -89.4 136.41 23.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 C-N-CA 123.801 0.84 . . . . 75.31 108.949 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -137.85 128.49 26.72 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.351 0.661 . . . . 74.23 110.26 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.1 m -78.78 98.36 6.26 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.638 0.775 . . . . 33.32 109.287 168.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 10.2 pt -115.37 139.66 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.397 1.079 . . . . 72.3 110.302 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.65 167.91 20.56 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.877 0.471 . . . . 60.31 111.048 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.56 17.35 79.98 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.954 -0.566 . . . . 65.02 113.308 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 8.4 mt -110.99 147.05 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.081 0.952 . . . . 73.21 108.832 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.42 165.31 27.13 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.687 0.795 . . . . 73.04 110.127 177.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.99 -142.17 46.62 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.168 0.917 . . . . 30.12 115.073 173.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 20.3 m -76.33 -16.25 59.8 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.93 0.892 . . . . 74.13 111.694 -172.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -68.1 -22.36 64.91 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.617 0.367 . . . . 54.44 110.764 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 92.1 mtp -64.02 -35.68 81.51 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.365 0.666 . . . . 54.1 110.432 172.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.71 -26.36 57.45 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.472 -0.786 . . . . 72.32 110.92 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -74.97 -40.35 60.78 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.812 0.445 . . . . 74.45 110.804 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -56.29 -46.79 79.61 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.422 0.689 . . . . 71.13 110.033 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 47.7 mt -87.23 -20.33 27.07 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.627 -1.169 . . . . 63.41 111.566 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.35 1.89 56.12 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-O 119.489 -0.617 . . . . 44.3 114.04 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.464 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -146.12 -67.82 0.28 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 117.585 0.692 . . . . 43.33 111.713 -178.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -71.51 -38.43 71.12 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.716 0.636 . . . . 75.22 112.716 -170.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.751 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 76.3 m -68.23 -49.66 32.67 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 118.706 -0.664 . . . . 63.33 111.556 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -58.7 -29.44 89.49 Favored 'Trans proline' 0 C--N 1.401 3.308 0 C-N-CA 122.63 2.22 . . . . 51.14 113.139 170.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -63.36 -35.67 81.17 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.681 0.793 . . . . 54.23 110.575 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.8 mm -68.91 -38.09 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.626 0.77 . . . . 74.54 110.351 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.495 HD12 HD23 ' D' ' 60' ' ' LEU . 87.7 mt -81.75 -21.7 37.71 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.534 0.734 . . . . 73.13 112.576 -172.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -62.44 -46.71 89.83 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-O 118.425 -0.798 . . . . 62.11 113.121 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.14 -39.15 93.04 Favored 'Trans proline' 0 C--N 1.391 2.768 0 C-N-CA 122.348 2.032 . . . . 70.23 113.262 174.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -73.97 -36.85 64.62 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.582 0.753 . . . . 65.54 111.707 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.81 -49.25 71.4 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.661 -0.496 . . . . 54.34 109.661 176.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.423 ' NH2' HG23 ' B' ' 105' ' ' ILE . 38.9 ttp180 -58.78 -45.68 89.27 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 124.432 1.082 . . . . 74.13 110.312 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -61.08 -52.73 63.67 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.841 0.713 . . . . 65.23 110.881 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.6 t -56.42 -44.61 80.53 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 123.882 0.738 . . . . 65.42 110.925 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.498 ' O ' HG23 ' D' ' 118' ' ' VAL . 67.8 mt -61.39 -55.67 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.198 0.999 . . . . 70.12 110.69 175.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.403 HG23 ' HG3' ' D' ' 125' ' ' GLN . 92.5 m -58.77 -36.19 73.99 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.141 0.976 . . . . 64.54 111.501 -173.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 40.8 t -67.87 -43.69 78.82 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.375 -0.83 . . . . 74.32 109.794 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.6 mtm -70.02 -27.56 64.77 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.761 0.424 . . . . 71.43 111.841 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.498 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.3 t -64.52 -49.31 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.303 0.641 . . . . 61.21 109.509 174.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.6 p -69.04 -32.51 72.06 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.797 -0.638 . . . . 53.13 110.899 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.4 mtt-85 -68.39 -37.61 80.53 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.924 0.89 . . . . 71.34 110.246 174.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.91 0.97 87.81 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 115.738 -0.664 . . . . 63.11 112.259 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.477 HG21 HE21 ' A' ' 125' ' ' GLN . 30.7 p 63.07 26.79 15.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.7 2.0 . . . . 74.15 113.104 172.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -87.44 152.63 52.57 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 109.239 -0.652 . . . . 74.33 109.239 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.94 124.51 15.68 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.931 2.421 . . . . 54.12 112.341 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.403 ' HG3' HG23 ' D' ' 115' ' ' THR . 35.2 tt0 -55.42 146.7 19.12 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.633 1.173 . . . . 70.01 112.251 -174.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.71 ' HG ' HG21 ' D' ' 40' ' ' VAL . 3.2 tm? -143.58 117.14 9.17 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.138 -1.06 . . . . 73.24 108.138 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -109.9 118.88 37.65 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.415 -0.958 . . . . 74.1 108.415 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.546 ' HA ' HD12 ' H' ' 6' ' ' ILE . 6.5 mp -66.73 128.17 35.26 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.781 0.833 . . . . 72.22 110.428 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -67.97 133.74 91.94 Favored Pre-proline 0 CA--C 1.552 1.026 0 O-C-N 123.842 0.714 . . . . 63.42 110.931 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 14.8 Cg_exo -68.83 130.38 20.4 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.902 2.401 . . . . 72.42 112.373 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 29.4 m -116.25 142.0 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.909 0.884 . . . . 73.43 109.897 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -92.97 72.34 4.73 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 122.11 0.957 . . . . 75.25 108.597 173.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.424 ' HD1' ' H ' ' D' ' 133' ' ' PHE . 4.8 p90 -73.31 -23.48 60.27 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.353 -1.294 . . . . 72.23 110.645 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' D' ' 138' ' ' MET . 2.8 m-20 -48.42 -51.29 27.44 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.724 1.209 . . . . 75.34 111.046 174.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.22 -46.61 86.18 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.279 0.987 . . . . 75.51 111.248 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 49.3 tp -57.9 -40.29 79.96 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.17 0.918 . . . . 75.13 111.156 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.506 ' O ' HD13 ' D' ' 141' ' ' LEU . 14.2 m-85 -60.29 -47.94 83.85 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 115.554 -0.748 . . . . 72.11 110.826 173.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 41.6 mtt -58.55 -48.65 80.18 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 123.272 0.358 . . . . 74.42 110.748 -175.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -54.15 -40.48 67.47 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 124.308 1.005 . . . . 73.44 111.558 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -76.75 -43.66 36.23 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.972 -0.558 . . . . 74.31 111.162 -177.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.506 HD13 ' O ' ' D' ' 137' ' ' PHE . 5.2 mp -65.18 -42.51 93.55 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.33 1.052 . . . . 72.12 111.688 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -75.44 -1.57 24.67 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.759 -0.655 . . . . 70.51 111.864 -172.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -128.94 43.62 3.11 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 123.481 0.713 . . . . 73.11 109.485 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -177.0 153.46 1.0 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.109 0.964 . . . . 64.34 110.513 171.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.74 8.35 45.05 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.366 0.667 . . . . 73.33 110.506 171.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.3 79.16 0.79 Allowed Glycine 0 C--N 1.353 1.481 0 C-N-CA 123.489 0.566 . . . . 61.42 112.642 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -88.9 85.05 6.65 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.153 0.981 . . . . 71.1 108.439 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -93.85 162.49 25.27 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.519 -0.764 . . . . 35.22 111.945 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 9.5 t -164.58 153.26 12.76 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.576 0.75 . . . . 74.31 110.433 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -113.18 143.15 44.88 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.097 0.559 . . . . 74.22 109.495 174.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -92.52 99.25 12.01 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 106.643 -1.614 . . . . 73.44 106.643 173.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 152' ' ' HIS . . . . . 0.438 ' O ' ' HA ' ' D' ' 47' ' ' ALA . 58.1 t-80 -146.15 114.75 6.8 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.375 -0.972 . . . . 52.22 108.375 -175.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -130.2 21.02 5.29 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.138 0.575 . . . . 73.43 111.733 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.19 88.47 0.62 Allowed 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 109.291 -0.633 . . . . 64.13 109.291 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.503 0 C-N-CA 124.645 1.178 . . . . 74.14 109.397 -177.606 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 110.062 -0.348 . . . . 70.13 110.062 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -141.79 154.41 45.2 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.752 0.821 . . . . 72.34 110.11 173.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -134.12 177.79 7.47 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.124 0.97 . . . . 72.01 109.447 173.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 41.9 p -143.83 136.73 27.4 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.127 0.571 . . . . 74.34 109.94 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 92.0 m -75.28 152.92 38.19 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.541 0.736 . . . . 74.2 109.536 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.46 HG12 HD21 ' A' ' 42' ' ' LEU . 11.7 tt -52.14 132.99 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 C-N-CA 125.374 1.47 . . . . 62.33 112.766 -176.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 7' ' ' ALA . . . . . 0.593 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . . . -147.97 162.5 39.21 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.016 0.926 . . . . 74.21 110.522 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.613 HD22 HD21 ' A' ' 44' ' ' LEU . 76.6 mt -81.61 -179.72 7.49 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.599 0.76 . . . . 75.2 110.848 174.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -135.84 175.1 9.9 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.333 1.053 . . . . 74.13 108.758 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 10' ' ' LEU . . . . . 0.52 HD21 ' HB2' ' A' ' 136' ' ' LEU . 90.0 mt -56.11 129.93 42.02 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.193 0.597 . . . . 72.21 110.639 177.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' E' ' 12' ' ' PRO . 72.4 mt -62.71 109.1 2.05 Favored Pre-proline 0 CA--C 1.549 0.937 0 O-C-N 124.335 1.022 . . . . 71.22 109.303 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 12' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' E' ' 11' ' ' LEU . 6.0 Cg_exo -77.96 68.03 7.89 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 123.786 2.991 . . . . 72.14 111.85 -172.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 6.3 tt -175.91 -49.69 0.01 OUTLIER 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.421 -1.326 . . . . 65.24 107.421 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 61.6 tp 60.03 89.38 0.07 Allowed 'General case' 0 C--N 1.36 1.062 0 O-C-N 124.622 1.201 . . . . 74.15 109.042 -170.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -68.59 136.35 52.9 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.924 -0.58 . . . . 74.1 110.582 -172.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 16' ' ' THR . . . . . 0.474 HG22 HD11 ' A' ' 98' ' ' LEU . 7.5 p -132.86 81.77 57.31 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.176 0.991 . . . . 75.43 109.266 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 17' ' ' PRO . . . . . 0.524 ' HD2' HD13 ' A' ' 98' ' ' LEU . 84.1 Cg_endo -78.87 -23.84 7.63 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.946 2.431 . . . . 71.53 112.999 -176.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 65.4 t -82.8 143.94 11.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 123.64 0.776 . . . . 71.31 109.319 -176.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 35.0 p -68.21 151.54 46.81 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.867 0.867 . . . . 63.55 110.577 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? 68.13 16.14 9.43 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.707 1.203 . . . . 73.24 112.714 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.9 51.29 1.94 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.187 0.595 . . . . 53.12 110.083 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -60.37 128.49 36.95 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.195 0.998 . . . . 73.13 110.59 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 24.4 p -116.44 82.83 12.54 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.14 0.576 . . . . 64.21 110.359 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.92 105.16 2.03 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.579 2.186 . . . . 44.31 111.612 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 . . . . . 0 C--O 1.251 1.163 0 C-N-CA 123.682 0.793 . . . . 62.11 109.368 176.312 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 58.1 mtm . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 109.801 -0.444 . . . . 71.24 109.801 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.37 -56.52 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.635 -0.876 . . . . 72.41 108.635 176.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 3' ' ' GLN . . . . . 0.532 ' HA ' ' HB3' ' B' ' 39' ' ' GLU . 34.9 tt0 81.07 106.61 0.07 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.7 1.6 . . . . 71.13 110.745 -172.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 32.3 t -166.43 -175.03 3.06 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.917 1.287 . . . . 73.11 108.227 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 25.1 m -139.9 107.55 5.62 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.686 -0.857 . . . . 70.42 108.686 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.584 HG22 ' H ' ' F' ' 7' ' ' ALA . 7.3 mm 57.48 -149.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 124.829 1.251 . . . . 75.33 108.5 -176.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 7' ' ' ALA . . . . . 0.584 ' H ' HG22 ' F' ' 6' ' ' ILE . . . -169.4 -92.0 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.63 1.105 . . . . 53.15 109.685 174.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 8' ' ' LEU . . . . . 0.525 ' HG ' HG21 ' B' ' 131' ' ' VAL . 4.1 mm? 57.02 108.67 0.01 OUTLIER 'General case' 0 C--N 1.363 1.183 0 C-N-CA 124.974 1.309 . . . . 64.11 112.425 -174.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.82 142.41 50.69 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.983 0.913 . . . . 64.14 108.757 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 10' ' ' LEU . . . . . 0.435 HD11 ' HB3' ' B' ' 136' ' ' LEU . 6.3 mp -61.65 117.05 5.29 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.832 -1.173 . . . . 63.1 107.832 174.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 8.6 mp -47.07 108.84 0.93 Allowed Pre-proline 0 CA--C 1.557 1.226 0 O-C-N 125.002 1.439 . . . . 72.2 111.461 -172.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.4 -28.72 26.65 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 122.806 2.337 . . . . 63.25 112.028 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 7.3 mp -82.15 -8.05 59.64 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.993 0.917 . . . . 75.0 109.966 173.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 94.5 mt 61.61 -168.58 0.18 Allowed 'General case' 0 C--N 1.359 0.99 0 C-N-CA 124.77 1.228 . . . . 63.12 110.177 -168.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -112.28 139.84 47.49 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.335 -0.987 . . . . 65.15 108.335 174.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 25.7 p -66.63 108.62 2.5 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.524 0.73 . . . . 64.43 109.092 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 17' ' ' PRO . . . . . 0.506 ' HB2' ' SD ' ' B' ' 94' ' ' MET . 33.4 Cg_endo -86.14 -169.92 0.62 Allowed 'Trans proline' 0 C--N 1.364 1.381 0 C-N-CA 122.84 2.36 . . . . 73.43 112.309 -170.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.04 135.96 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.44 -0.578 . . . . 70.22 109.44 177.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 35.4 m -79.22 104.2 9.68 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.125 -1.065 . . . . 71.23 108.125 170.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 93.7 mttt 56.07 79.68 0.16 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.363 1.065 . . . . 63.2 111.359 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.71 52.85 2.0 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.697 0.799 . . . . 73.14 110.485 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 22' ' ' ARG . . . . . 0.525 HH21 ' HB3' ' B' ' 90' ' ' GLU . 97.9 mtt180 -143.41 -59.45 0.41 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.945 0.898 . . . . 63.53 109.777 -176.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 23' ' ' THR . . . . . 0.401 ' HA ' ' HD2' ' F' ' 24' ' ' PRO . 52.6 p -117.36 113.24 38.96 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.167 0.587 . . . . 65.14 110.55 -173.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 24' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' F' ' 23' ' ' THR . 18.0 Cg_endo -61.72 82.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 122.969 2.446 . . . . 71.32 111.909 165.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 . . . . . 0 C--O 1.254 1.314 0 C-N-CA 123.853 0.861 . . . . 74.1 108.74 -176.748 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 109.951 -0.389 . . . . 72.53 109.951 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -128.13 117.76 22.17 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.175 -0.676 . . . . 62.42 109.175 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -88.74 61.86 6.19 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 122.015 0.912 . . . . 73.33 108.859 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 52.0 m -152.0 157.15 41.31 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.335 -0.848 . . . . 72.11 109.559 -175.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 25.5 m -63.08 111.23 2.1 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.946 0.779 . . . . 70.22 109.812 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 6' ' ' ILE . . . . . 0.643 ' HB ' HD23 ' C' ' 42' ' ' LEU 0.278 38.8 pt 51.91 -73.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 127.087 2.155 . . . . 75.03 114.309 178.124 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 7' ' ' ALA . . . . . 0.534 ' H ' HG13 ' G' ' 6' ' ' ILE . . . 67.72 123.63 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.219 1.408 . . . . 50.51 112.657 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 8' ' ' LEU . . . . . 0.597 ' H ' HG21 ' C' ' 131' ' ' VAL . 29.3 mt -71.99 174.83 6.5 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.213 1.005 . . . . 62.24 110.803 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.52 169.65 11.67 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.822 0.849 . . . . 70.13 110.14 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 45.0 mt -68.78 162.67 25.81 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.624 0.726 . . . . 64.43 111.091 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 11' ' ' LEU . . . . . 0.557 HD21 HD12 ' C' ' 44' ' ' LEU . 34.8 mt -97.35 137.31 21.14 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 114.359 -1.291 . . . . 63.22 109.38 -175.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.86 -46.77 24.17 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 123.258 2.638 . . . . 61.44 111.485 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mp -96.88 142.15 29.21 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 106.906 -1.516 . . . . 73.52 106.906 168.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 mp -75.06 8.82 2.3 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.977 0.732 . . . . 52.44 112.977 -171.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 15' ' ' PHE . . . . . 0.504 ' CD1' ' HB ' ' C' ' 46' ' ' THR . 93.8 t80 58.62 92.0 0.04 OUTLIER 'General case' 0 C--N 1.36 1.065 0 C-N-CA 124.559 1.144 . . . . 75.24 110.511 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 16' ' ' THR . . . . . 0.616 HG21 ' HB3' ' G' ' 21' ' ' ALA . 7.3 p -141.42 87.36 10.48 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 122.562 0.345 . . . . 75.11 111.54 -175.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 17' ' ' PRO . . . . . 0.68 ' HD2' HD13 ' C' ' 98' ' ' LEU . 57.1 Cg_endo -71.74 -20.85 25.88 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.742 2.294 . . . . 71.5 113.208 172.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 18' ' ' VAL . . . . . 0.408 HG21 HG21 ' C' ' 86' ' ' ILE . 93.6 t -65.4 -64.41 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.067 0.547 . . . . 64.42 110.727 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 31.7 p -122.48 -98.12 0.44 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.953 -1.129 . . . . 72.34 107.953 171.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 82.3 tttt 176.5 84.73 0.01 OUTLIER 'General case' 0 C--N 1.352 0.687 0 N-CA-C 107.647 -1.242 . . . . 64.3 107.647 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 21' ' ' ALA . . . . . 0.616 ' HB3' HG21 ' G' ' 16' ' ' THR . . . -91.57 119.27 31.34 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 122.925 0.49 . . . . 62.14 110.051 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 22' ' ' ARG . . . . . 0.422 ' HG2' ' N ' ' G' ' 23' ' ' THR . 66.7 ttt-85 -172.28 173.9 4.08 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.427 1.491 . . . . 73.54 107.503 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 23' ' ' THR . . . . . 0.422 ' N ' ' HG2' ' G' ' 22' ' ' ARG . 39.2 p -70.71 144.73 91.37 Favored Pre-proline 0 CA--C 1.556 1.182 0 N-CA-C 109.091 -0.707 . . . . 64.21 109.091 164.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.8 -0.63 8.68 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.755 2.303 . . . . 72.0 113.215 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 CA--C 1.555 1.147 0 C-N-CA 124.62 1.168 . . . . 64.54 108.675 -178.984 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 74.0 mtp . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 121.212 0.53 . . . . 62.23 110.298 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -127.68 69.11 1.31 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 106.141 -1.8 . . . . 63.53 106.141 167.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -57.54 -38.22 74.36 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 114.038 -1.437 . . . . 71.3 111.58 -170.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 16.1 m 61.69 -163.38 0.26 Allowed 'General case' 0 C--N 1.353 0.721 0 CA-C-N 114.793 -1.094 . . . . 71.24 110.342 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 98.5 m -63.76 -58.26 7.39 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 109.591 -0.522 . . . . 70.32 109.591 168.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' D' ' 128' ' ' LEU . 6.8 pt -149.03 84.69 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 124.293 1.037 . . . . 43.32 109.814 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -154.86 141.73 19.13 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.188 0.595 . . . . 41.21 110.668 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 8' ' ' LEU . . . . . 0.441 HD23 HD21 ' D' ' 42' ' ' LEU . 57.8 mt -75.65 -57.72 3.71 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.05 -0.722 . . . . 71.31 109.05 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . 64.74 -74.19 0.05 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.645 1.578 . . . . 64.22 112.525 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tt -152.69 134.61 14.76 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.63 -1.248 . . . . 72.31 107.63 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.24 152.78 95.76 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 124.083 0.953 . . . . 75.24 111.204 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.71 -28.02 86.33 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.187 2.591 . . . . 74.33 112.852 -176.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 13' ' ' LEU . . . . . 0.461 HD13 ' N ' ' H' ' 14' ' ' LEU . 2.6 tm? -152.17 150.47 29.88 Favored 'General case' 0 C--O 1.245 0.867 0 N-CA-C 106.293 -1.743 . . . . 71.32 106.293 176.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 14' ' ' LEU . . . . . 0.461 ' N ' HD13 ' H' ' 13' ' ' LEU . 94.9 mt -54.29 120.29 6.34 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.331 -0.618 . . . . 64.43 109.331 176.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 15' ' ' PHE . . . . . 0.433 ' CD1' HG23 ' D' ' 46' ' ' THR . 32.9 t80 -49.03 -89.23 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.156 0 O-C-N 125.133 1.52 . . . . 53.3 112.314 -164.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 21.3 p -156.89 155.03 27.81 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 124.281 1.032 . . . . 73.32 109.194 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 17' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' H' ' 21' ' ' ALA . 53.1 Cg_endo -90.49 168.1 4.12 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 122.881 2.387 . . . . 75.12 109.733 163.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 t -81.09 -9.31 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 121.84 -0.537 . . . . 74.25 109.825 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -56.69 -68.64 0.2 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.543 1.537 . . . . 53.03 112.152 -170.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -122.49 -64.6 1.18 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.033 -1.099 . . . . 74.45 108.033 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 21' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' H' ' 17' ' ' PRO . . . 64.96 14.92 9.65 Favored 'General case' 0 C--N 1.362 1.111 0 CA-C-N 114.338 -1.301 . . . . 72.34 112.76 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -163.89 159.94 21.55 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 123.972 0.909 . . . . 75.43 109.366 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 23' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' H' ' 24' ' ' PRO . 64.0 p -62.9 128.77 92.53 Favored Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 108.873 -0.788 . . . . 70.15 108.873 165.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 24' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' H' ' 23' ' ' THR . 21.7 Cg_exo -65.2 -3.26 7.05 Favored 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 123.407 2.738 . . . . 74.32 115.671 -165.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 CA--C 1.55 0.943 0 C-N-CA 123.709 0.804 . . . . 70.03 109.7 -177.761 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 mmt . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 110.134 -0.321 . . . . 73.41 110.134 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 m 63.79 -77.69 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.792 1.237 . . . . 62.42 109.507 -168.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -86.83 166.12 15.44 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.197 0.999 . . . . 75.22 111.174 173.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.465 HE22 ' HB3' ' A' ' 142' ' ' GLN . 28.5 pt20 -147.91 -3.93 0.5 Allowed 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 114.505 -1.225 . . . . 71.14 109.875 171.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -114.55 160.87 18.77 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.963 1.305 . . . . 75.42 109.32 -175.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -125.86 -85.75 0.62 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.377 0.671 . . . . 72.54 110.163 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.8 m -158.56 109.08 2.08 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.175 0.59 . . . . 74.31 110.319 -173.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.475 ' HG3' HD12 ' A' ' 89' ' ' ILE . 53.7 mm-40 -137.57 163.13 31.95 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.639 1.175 . . . . 73.05 109.578 175.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.7 ttm 69.95 172.67 0.3 Allowed 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.803 1.241 . . . . 61.42 110.666 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.7 m -136.59 113.45 10.36 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.013 -1.106 . . . . 75.44 108.013 175.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.736 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 2.9 t80 -96.45 134.89 39.07 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.969 -1.014 . . . . 74.44 109.478 -174.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -145.48 114.59 7.01 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.477 -0.935 . . . . 74.14 108.477 176.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.612 HG12 ' HD2' ' A' ' 84' ' ' PHE . 47.7 mt -90.29 129.62 40.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.649 -0.871 . . . . 74.4 108.649 174.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -87.88 -41.79 12.97 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.818 -0.628 . . . . 73.21 110.133 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -175.93 129.46 0.24 Allowed 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.18 0.3 . . . . 65.12 111.197 -170.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.46 HD11 HD13 ' A' ' 13' ' ' ILE . 97.3 mt -121.61 139.9 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 123.653 0.781 . . . . 75.33 108.985 177.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.514 ' HB3' HG23 ' B' ' 122' ' ' THR . 35.0 p90 -169.92 177.18 4.46 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.02 0.928 . . . . 74.42 110.597 -169.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.0 p -102.33 121.19 41.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.284 -1.006 . . . . 64.41 108.284 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 33.8 mtpt -83.15 -44.08 15.48 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.639 -0.875 . . . . 72.31 108.639 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 21.9 t70 -135.59 134.8 39.72 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.19 -1.368 . . . . 51.33 108.921 -175.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.421 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 80.9 mt -135.14 142.44 39.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.148 -1.427 . . . . 73.25 107.148 178.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -154.17 115.16 4.04 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.095 0.474 . . . . 64.25 110.535 172.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.636 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 75.4 t80 -110.22 138.91 45.95 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 106.838 -1.542 . . . . 64.51 106.838 170.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -138.3 140.62 39.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.227 -1.027 . . . . 74.32 108.227 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.88 78.61 35.44 Favored Pre-proline 0 C--O 1.238 0.48 0 N-CA-C 107.314 -1.365 . . . . 53.42 107.314 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.93 -28.1 36.12 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.968 2.445 . . . . 71.13 112.293 -170.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -114.49 28.8 8.48 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.945 0.898 . . . . 70.11 109.591 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.472 ' HB3' ' HZ2' ' B' ' 19' ' ' LYS . . . -47.29 -52.38 35.97 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.03 0.932 . . . . 72.35 113.422 -178.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HG3' ' HZ1' ' B' ' 19' ' ' LYS . 15.1 Cg_exo -63.74 -21.74 69.68 Favored 'Trans proline' 0 C--N 1.39 2.751 0 CA-C-N 121.413 1.541 . . . . 61.2 112.751 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.446 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.9 m80 -94.9 -32.93 13.0 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 124.123 0.969 . . . . 63.41 110.788 -174.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.492 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.5 p -76.32 -16.87 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 112.724 0.639 . . . . 73.45 112.724 -163.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -77.72 -32.58 52.96 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.027 0.531 . . . . 74.15 112.0 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -75.91 -18.62 59.31 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.821 0.449 . . . . 71.21 110.721 174.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 14.5 mmmm -75.29 148.02 39.72 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.61 0.764 . . . . 64.13 111.749 -175.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.06 127.64 32.91 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 124.238 0.961 . . . . 61.42 109.424 171.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -78.98 86.06 4.87 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.529 0.68 . . . . 72.34 110.358 -177.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -136.53 78.59 43.57 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.014 1.325 . . . . 72.14 107.907 176.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -86.45 171.4 7.48 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.448 2.099 . . . . 64.53 113.61 -174.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -115.96 101.08 8.44 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 107.095 -1.446 . . . . 72.42 107.095 170.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -77.59 93.94 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.935 0.874 . . . . 65.44 111.081 -172.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.545 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 8.4 mtpm? -82.63 114.28 20.9 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.196 -1.038 . . . . 74.02 108.196 173.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.538 HD13 ' H ' ' E' ' 9' ' ' ALA . 0.5 OUTLIER -123.83 107.94 11.94 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.711 0.767 . . . . 74.12 109.847 -174.715 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.449 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.2 m-20 -114.01 136.61 52.72 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.61 -1.177 . . . . 74.13 109.42 -174.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.15 142.17 46.57 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.437 -0.949 . . . . 60.33 108.437 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.682 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 5.9 t70 -147.11 127.6 14.09 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.537 -0.542 . . . . 74.25 109.537 -169.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 64.1 p -105.78 126.96 52.78 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.455 0.702 . . . . 52.45 110.886 -168.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.571 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -133.03 141.84 48.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.726 0.81 . . . . 53.45 109.438 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.3 m -132.61 154.98 49.52 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.378 0.671 . . . . 70.21 110.668 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.6 t -153.78 139.59 18.07 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.595 0.758 . . . . 62.05 109.565 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -96.67 120.53 37.17 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.879 -0.785 . . . . 64.22 108.879 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.723 HD11 ' HB2' ' A' ' 57' ' ' GLU . 25.8 mt -107.27 -35.81 6.71 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.553 0.741 . . . . 75.23 110.336 -172.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.544 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -156.71 -176.88 6.22 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.368 1.067 . . . . 71.14 109.687 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -71.75 116.12 11.75 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.68 0.792 . . . . 71.14 109.956 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 70.12 0.22 3.04 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.79 1.236 . . . . 71.04 112.235 -176.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 58.9 t -111.26 112.43 40.5 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 108.247 -1.02 . . . . 73.34 108.247 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -124.84 173.32 8.68 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.438 1.095 . . . . 71.43 108.972 -173.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.723 ' HB2' HD11 ' A' ' 51' ' ' LEU . 41.3 tt0 -127.17 127.79 45.09 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.195 0.598 . . . . 74.14 109.513 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.428 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 84.3 t -105.44 122.56 58.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.761 -1.2 . . . . 65.2 107.761 170.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 46.1 t -116.78 138.57 46.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 N-CA-C 108.139 -1.06 . . . . 72.31 108.139 174.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.8 tp -127.31 118.08 23.5 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.26 -0.644 . . . . 72.23 109.26 174.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.682 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 16.9 ttm-85 -85.18 102.37 13.25 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.448 -0.945 . . . . 63.23 108.448 173.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.5 t -95.1 108.68 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.559 -0.904 . . . . 72.25 108.559 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 26.8 m -95.46 124.77 39.66 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.623 0.769 . . . . 34.45 108.993 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.9 t -124.74 107.41 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.197 -1.038 . . . . 62.4 108.197 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 18.3 m -108.12 136.16 48.27 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.515 -0.92 . . . . 63.11 108.515 175.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.12 110.99 20.36 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.29 -1.374 . . . . 72.43 107.29 172.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.9 m -115.31 124.33 51.03 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.598 0.359 . . . . 73.3 110.09 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.4 mt -90.64 84.71 5.93 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.285 -1.006 . . . . 62.34 108.285 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.86 -83.44 0.93 Allowed Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.85 -0.5 . . . . 53.43 111.85 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -125.01 -29.16 3.37 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.861 0.864 . . . . 72.23 109.203 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -77.93 109.94 12.41 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.284 -0.636 . . . . 71.33 109.284 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.8 m -69.53 122.9 19.96 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 110.234 -0.284 . . . . 72.02 110.234 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.492 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -69.03 -61.25 1.87 Allowed 'General case' 0 C--O 1.24 0.596 0 O-C-N 123.843 0.714 . . . . 51.15 110.271 176.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.437 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 26.8 p90 -160.41 172.83 16.58 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.076 -0.965 . . . . 74.32 111.966 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.2 tp -131.41 138.23 49.0 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.984 -1.462 . . . . 62.13 107.497 173.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.429 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 86.1 m -139.12 97.66 3.35 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.28 -1.007 . . . . 73.14 108.28 176.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -120.09 117.23 27.43 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.281 -1.007 . . . . 71.52 108.281 -175.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.0 t -129.31 113.54 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 123.932 0.893 . . . . 42.31 109.867 -170.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.485 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 70.5 mt-30 -84.44 89.01 7.32 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 108.322 -0.992 . . . . 63.32 108.322 170.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.522 ' HG3' HD22 ' A' ' 106' ' ' LEU . 68.3 tp60 -77.0 103.08 6.73 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.002 -0.999 . . . . 75.53 109.079 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.71 145.83 19.0 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.978 -0.555 . . . . 74.55 111.811 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.416 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.19 123.16 1.46 Allowed Glycine 0 CA--C 1.503 -0.7 0 N-CA-C 110.731 -0.948 . . . . 64.24 110.731 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.446 HG23 HD12 ' A' ' 51' ' ' LEU . 55.5 mt -83.46 121.02 35.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.865 -0.791 . . . . 64.23 108.865 176.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.736 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 23.5 m-85 -134.26 130.13 36.65 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.337 0.655 . . . . 70.23 109.675 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.9 t -99.61 113.93 26.65 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.612 -0.884 . . . . 61.13 108.612 173.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -139.21 120.36 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 C-N-CA 123.96 0.904 . . . . 62.15 110.787 -175.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.54 160.11 10.7 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.202 1.001 . . . . 64.1 110.301 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 145.17 -85.04 0.18 Allowed Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.467 -0.788 . . . . 34.54 112.407 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.475 HD12 ' HG3' ' A' ' 8' ' ' GLU . 9.0 tt -80.98 -40.49 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 112.514 0.561 . . . . 64.42 112.514 -168.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 67.58 -166.68 0.2 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.078 0.951 . . . . 73.51 110.946 -172.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.34 -135.77 22.78 Favored Glycine 0 C--N 1.353 1.477 0 C-N-CA 122.915 0.293 . . . . 72.01 113.694 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.5 p -68.76 -37.56 79.44 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.172 0.989 . . . . 32.24 111.759 -174.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -63.19 -42.7 99.39 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.82 0.848 . . . . 73.14 111.534 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 18.6 ttt -77.18 -34.78 56.27 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 116.6 -0.273 . . . . 73.43 110.522 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.47 -35.13 79.42 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.156 0.582 . . . . 73.44 110.314 172.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.557 ' NE2' ' HB2' ' A' ' 134' ' ' ASP . 26.9 t-80 -68.31 -44.43 75.45 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.219 1.008 . . . . 72.5 110.352 174.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.642 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 83.4 m -64.22 -44.78 90.85 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.369 0.667 . . . . 71.2 111.555 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.59 -50.86 11.67 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.668 0.787 . . . . 65.54 111.735 -173.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.4 5.08 67.42 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-O 119.186 -0.786 . . . . 72.55 114.759 -169.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.497 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -149.72 -51.8 0.15 Allowed 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.582 1.191 . . . . 52.22 113.48 -175.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.642 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 88.0 t80 -75.59 -49.23 19.17 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.826 0.851 . . . . 71.31 112.248 -168.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 99.3 m -69.65 -36.26 6.56 Favored Pre-proline 0 CA--C 1.563 1.478 0 CA-C-O 118.897 -0.573 . . . . 75.3 112.256 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -48.63 -42.43 35.98 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 122.504 2.136 . . . . 63.32 113.839 160.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.611 HD21 ' H ' ' A' ' 134' ' ' ASP . 84.0 m-20 -64.15 -34.44 78.08 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 123.537 0.735 . . . . 72.1 111.553 176.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.6 mm -66.02 -40.39 87.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 N-CA-C 109.587 -0.523 . . . . 74.13 109.587 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.522 HD22 ' HG3' ' A' ' 80' ' ' GLN . 96.5 mt -79.0 -22.44 45.52 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.755 0.822 . . . . 41.42 112.254 -178.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -58.14 -48.83 96.36 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 113.914 1.079 . . . . 62.5 113.914 -172.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -63.1 -39.83 37.11 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 122.111 1.874 . . . . 63.34 112.812 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -69.3 -40.75 77.51 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.298 0.639 . . . . 74.02 111.281 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.23 -40.63 70.97 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.071 0.548 . . . . 43.43 110.367 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.472 HH12 HD12 ' C' ' 105' ' ' ILE . 23.7 ttm180 -49.91 -51.99 36.57 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.01 0.924 . . . . 71.03 110.205 171.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -71.48 -37.54 71.3 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.006 -0.997 . . . . 54.31 111.64 -173.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.8 t -66.06 -32.66 74.25 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 121.061 0.457 . . . . 62.23 110.916 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 93.0 mt -69.18 -54.51 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 115.255 -0.884 . . . . 65.32 109.432 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.466 HG21 ' HE2' ' C' ' 109' ' ' TYR . 95.2 m -51.79 -40.6 60.66 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.994 1.317 . . . . 64.03 112.278 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.9 t -64.12 -47.6 79.36 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 115.249 -0.887 . . . . 73.34 110.656 -177.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.636 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 39.6 mtm -67.84 -36.07 79.69 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.807 0.692 . . . . 74.12 111.373 -178.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.9 -51.47 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 123.677 0.791 . . . . 74.14 110.254 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.5 t -69.46 -29.45 67.13 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.43 -0.804 . . . . 43.13 111.5 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.0 ttm-85 -77.93 -28.82 49.73 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.988 0.915 . . . . 71.51 109.2 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.425 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.96 12.65 59.33 Favored Glycine 0 C--N 1.351 1.411 0 CA-C-N 114.933 -1.03 . . . . 63.23 112.648 170.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.521 HG21 ' HE ' ' B' ' 15' ' ' ARG . 2.0 t 60.66 18.51 8.54 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 126.89 2.076 . . . . 70.35 113.523 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -77.93 158.39 77.79 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 123.938 0.895 . . . . 73.34 110.951 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.46 143.38 77.86 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.831 2.354 . . . . 64.32 112.995 173.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.414 HE21 HG21 ' D' ' 122' ' ' THR . 5.4 tp-100 -53.73 127.74 26.9 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.674 1.19 . . . . 72.13 112.183 -175.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.437 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 43.5 tp -126.92 101.37 6.55 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.048 0.939 . . . . 64.4 109.45 -177.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.429 ' ND2' ' H ' ' C' ' 16' ' ' ILE . 91.4 m-20 -123.34 102.11 7.73 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.605 -0.887 . . . . 53.21 108.605 175.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.62 144.62 56.29 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.985 0.514 . . . . 70.0 109.687 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' E' ' 7' ' ' ALA . . . -68.41 151.25 97.34 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 123.833 0.853 . . . . 41.33 111.845 -173.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.489 ' HD3' HG13 ' C' ' 13' ' ' ILE . 52.1 Cg_endo -68.97 114.63 3.64 Favored 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 123.094 2.53 . . . . 73.24 113.111 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.1 m -111.61 112.68 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 108.184 -1.043 . . . . 63.44 108.184 165.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -81.61 93.61 6.76 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.63 -1.248 . . . . 70.4 107.63 175.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 137' ' ' PHE . 79.9 m-85 -49.52 -37.72 27.83 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.242 1.017 . . . . 60.4 111.634 -175.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.611 ' H ' HD21 ' A' ' 104' ' ' ASN . 5.4 p-10 -75.49 -39.54 58.43 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.784 0.834 . . . . 74.2 111.855 -172.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.27 -42.06 93.58 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.523 0.729 . . . . 63.11 111.008 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.21 -26.17 47.35 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.322 -0.854 . . . . 53.42 110.565 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 133' ' ' PHE . 9.5 t80 -75.06 -38.5 61.35 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.165 0.586 . . . . 74.13 109.565 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.569 ' HB3' ' HB3' ' A' ' 144' ' ' GLN . 34.6 mmt -76.12 -27.23 57.01 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.397 0.679 . . . . 75.33 110.272 177.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -63.78 -44.98 91.78 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.832 0.853 . . . . 73.54 109.053 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -65.15 -37.7 88.23 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.356 0.662 . . . . 74.34 110.757 172.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 138' ' ' MET . 0.2 OUTLIER -64.8 -50.68 65.77 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.105 0.962 . . . . 73.45 110.465 -171.51 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.465 ' HB3' HE22 ' A' ' 4' ' ' GLN . 6.2 tp-100 -166.39 28.65 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.791 -0.641 . . . . 71.32 110.391 -170.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 56.5 33.29 22.3 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.155 0.982 . . . . 74.14 111.73 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.569 ' HB3' ' HB3' ' A' ' 138' ' ' MET . 0.6 OUTLIER -80.62 91.09 5.78 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.283 -1.377 . . . . 73.44 107.283 173.585 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -175.38 168.34 3.29 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.758 1.223 . . . . 30.14 109.62 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 109.82 128.28 5.51 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 116.11 -0.495 . . . . 71.53 112.077 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -118.74 175.73 5.6 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.304 1.041 . . . . 72.53 109.03 171.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 152.4 76.81 0.02 OUTLIER Glycine 0 C--N 1.345 1.071 0 C-N-CA 121.757 -0.259 . . . . 64.02 113.088 174.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.42 ' H ' ' NE2' ' C' ' 93' ' ' GLN . 65.4 p -105.3 116.7 32.39 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.937 -0.764 . . . . 53.14 108.937 170.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -100.39 103.54 14.93 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.097 0.959 . . . . 65.3 108.497 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -122.03 116.41 24.23 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.727 0.811 . . . . 73.31 109.721 -175.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -128.43 120.4 26.83 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.903 0.881 . . . . 75.51 109.431 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.503 ' H ' ' HD3' ' G' ' 20' ' ' LYS . 16.6 mm100 -126.67 98.83 5.54 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.6 -1.259 . . . . 72.3 107.6 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -63.14 121.8 14.53 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.455 0.702 . . . . 74.41 110.864 -175.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 O-C-N 124.112 0.882 . . . . 64.41 110.468 178.616 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.912 0.387 . . . . 74.21 110.353 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 41.0 t -131.03 127.19 37.76 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.43 1.092 . . . . 71.01 109.216 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -117.78 28.62 8.31 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.788 0.835 . . . . 75.2 109.736 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -59.28 132.83 55.19 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.553 0.741 . . . . 64.33 110.121 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -58.7 100.35 0.06 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.746 0.818 . . . . 71.43 110.864 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -69.19 146.65 52.23 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.495 -0.775 . . . . 75.45 109.692 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.7 t -105.2 175.5 5.47 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.149 0.98 . . . . 75.03 110.323 -176.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 74.97 -61.41 0.49 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 126.118 1.767 . . . . 73.2 112.033 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 25.2 ttt 66.18 175.79 0.23 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.396 1.078 . . . . 74.23 110.262 -174.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 61.6 m -133.27 129.35 37.51 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.285 -1.376 . . . . 73.31 107.285 168.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.525 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 42.7 t80 -129.35 126.61 39.3 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.799 -1.185 . . . . 75.04 107.799 175.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -144.53 126.43 15.36 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.271 -0.64 . . . . 73.34 109.271 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 27.9 mt -74.8 121.51 26.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.562 -0.903 . . . . 74.3 108.562 172.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -92.06 -50.06 5.88 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.248 -0.649 . . . . 70.52 109.248 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.521 ' HE ' HG21 ' A' ' 122' ' ' THR . 45.8 ttt180 -166.52 131.16 2.14 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.727 -0.67 . . . . 70.02 110.209 -175.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 75.6 mt -114.68 137.18 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 108.029 -1.1 . . . . 73.3 108.029 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.406 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 39.2 p90 -169.87 161.79 9.12 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.442 0.639 . . . . 75.21 111.5 -176.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.525 HG21 HD11 ' B' ' 21' ' ' ILE . 42.7 m -83.17 130.63 35.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.771 -1.104 . . . . 73.33 109.249 170.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.472 ' HZ2' ' HB3' ' A' ' 28' ' ' ALA . 24.0 mtpp -96.51 -34.22 11.56 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.261 0.625 . . . . 55.11 109.851 176.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -147.72 145.45 28.86 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.084 0.469 . . . . 73.14 111.177 -173.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.578 HD11 ' SG ' ' B' ' 113' ' ' CYS . 40.3 mm -136.35 146.5 28.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 126.047 1.739 . . . . 72.3 108.708 177.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.502 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 36.7 t -150.9 133.32 15.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.558 -1.201 . . . . 71.03 108.324 171.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 74.0 t80 -141.07 135.99 31.54 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.098 -1.445 . . . . 75.1 107.098 172.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -141.51 128.48 20.68 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.218 1.007 . . . . 75.12 108.666 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -130.17 80.95 69.8 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 107.018 -1.475 . . . . 63.51 107.018 174.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.82 -26.73 31.96 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.142 2.561 . . . . 72.01 113.152 -171.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -115.11 18.73 16.13 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.674 0.79 . . . . 73.54 110.047 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.501 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -45.86 -59.17 5.02 Favored Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 125.06 1.344 . . . . 74.52 114.129 -170.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.413 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 23.8 Cg_exo -61.43 -28.49 83.89 Favored 'Trans proline' 0 C--N 1.393 2.89 0 C-N-CA 122.233 1.955 . . . . 74.3 113.346 -169.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.437 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 78.1 m80 -93.96 -38.21 11.29 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.702 -0.681 . . . . 72.23 111.404 -175.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.502 HG22 HD12 ' B' ' 68' ' ' LEU . 4.5 p -67.88 -16.74 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.129 0.572 . . . . 62.1 111.757 -173.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -65.11 -21.03 66.74 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.222 0.823 . . . . 74.23 113.222 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 10.3 pt20 -68.28 -15.27 63.5 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.308 0.643 . . . . 61.02 111.179 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.41 ' HB2' HD13 ' B' ' 68' ' ' LEU . 89.6 mttt -95.27 105.71 17.68 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.597 1.159 . . . . 64.44 109.791 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -110.72 93.08 4.31 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.09 0.556 . . . . 72.53 109.829 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 39.7 p90 -162.65 179.7 7.52 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.716 1.206 . . . . 75.5 108.411 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -69.05 114.71 25.26 Favored Pre-proline 0 N--CA 1.477 0.915 0 N-CA-C 109.578 -0.527 . . . . 73.53 109.578 177.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.485 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 43.2 Cg_endo -65.72 139.11 56.4 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 121.901 1.734 . . . . 63.52 111.027 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -66.45 103.68 1.09 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.561 -0.903 . . . . 73.15 108.561 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.565 HG11 HD21 ' B' ' 126' ' ' LEU . 31.2 m -99.83 160.82 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 115.41 -0.813 . . . . 62.24 111.815 -172.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -145.04 133.59 22.01 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.67 -1.15 . . . . 65.34 108.524 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 pp -86.7 164.98 16.44 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 123.038 0.535 . . . . 74.23 110.15 175.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.595 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 17.5 t70 -164.72 126.31 2.15 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.072 -0.967 . . . . 75.13 108.545 175.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.431 HD23 HD21 ' B' ' 60' ' ' LEU . 5.5 mp -123.04 134.15 54.3 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.576 0.75 . . . . 70.21 109.073 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.669 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 10.9 t70 -131.32 133.65 45.55 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.845 0.858 . . . . 63.22 108.758 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' F' ' 15' ' ' PHE . 17.9 p -106.37 102.02 11.45 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.244 0.618 . . . . 64.32 109.678 -175.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.474 ' O ' ' HB ' ' B' ' 59' ' ' VAL . . . -119.85 114.21 21.75 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 107.111 -1.44 . . . . 65.22 107.111 174.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 52.6 m -144.77 161.06 40.17 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.385 -0.598 . . . . 72.21 109.385 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 76.1 p -164.73 150.17 9.95 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.906 0.482 . . . . 71.01 110.445 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -82.24 129.5 34.86 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.205 0.602 . . . . 71.25 109.65 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' B' ' 57' ' ' GLU . 20.7 mt -91.07 -49.97 6.11 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.796 0.839 . . . . 71.2 109.971 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.03 -173.49 4.18 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.193 -0.912 . . . . 61.42 110.224 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -65.65 120.73 13.48 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.947 -1.024 . . . . 75.42 109.313 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 68.17 9.2 7.05 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.115 1.366 . . . . 64.11 111.773 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -120.92 109.36 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.048 0.939 . . . . 74.12 109.21 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -119.48 149.04 42.54 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.505 1.122 . . . . 73.52 108.443 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.448 ' HB2' HD11 ' B' ' 51' ' ' LEU . 40.3 tt0 -118.76 122.08 41.58 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.925 0.49 . . . . 73.54 109.78 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 61.9 t -100.93 118.91 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 108.375 -0.972 . . . . 65.41 108.375 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' B' ' 47' ' ' ALA . 21.4 t -118.67 130.82 72.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 107.646 -1.242 . . . . 65.55 107.646 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.431 HD21 HD23 ' B' ' 44' ' ' LEU . 14.2 tp -123.32 124.59 43.31 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 110.128 -0.323 . . . . 65.34 110.128 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.669 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 39.0 ttm180 -87.31 113.5 23.08 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.864 0.865 . . . . 43.13 109.001 173.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 43.1 t -104.88 101.32 12.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.475 -1.306 . . . . 70.03 107.475 173.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.595 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 18.1 m -103.06 132.36 49.38 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.569 0.748 . . . . 75.54 109.065 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 89.6 t -123.24 127.02 74.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 124.773 1.229 . . . . 73.02 108.825 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.1 m -103.98 148.08 26.62 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.822 -0.807 . . . . 65.01 108.822 169.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.485 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -148.53 140.14 23.6 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.544 0.738 . . . . 72.32 109.563 176.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.504 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 35.3 p -143.98 137.7 27.91 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 123.635 0.584 . . . . 73.23 110.826 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.502 HD12 HG22 ' B' ' 31' ' ' VAL . 67.4 mt -110.52 110.82 21.69 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.043 -1.095 . . . . 63.41 108.043 174.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.55 -129.93 10.29 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 123.245 0.34 . . . . 44.24 113.056 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -96.61 16.44 18.86 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.683 0.793 . . . . 61.0 111.919 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.06 152.81 43.69 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.699 0.399 . . . . 72.33 110.952 -175.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 58.2 m -64.94 132.65 49.9 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 123.636 0.585 . . . . 43.2 110.136 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.504 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -85.44 -66.64 0.88 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.14 -1.43 . . . . 74.31 107.14 171.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -149.21 159.55 44.15 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 122.01 0.91 . . . . 74.12 112.178 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 71.3 mt -131.45 113.1 13.3 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 105.946 -1.872 . . . . 74.31 105.946 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.576 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 48.3 t -118.9 147.83 43.57 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.739 -0.837 . . . . 74.03 108.739 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.502 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 40.0 tt0 -155.9 128.67 7.91 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.92 -0.77 . . . . 72.3 108.92 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 96.1 t -130.36 145.83 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.789 0.836 . . . . 52.24 108.947 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -122.29 101.21 7.38 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.23 -1.026 . . . . 65.22 108.23 172.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -91.25 104.62 17.14 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.079 -0.711 . . . . 74.11 109.079 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.5 142.91 16.27 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.507 -0.769 . . . . 70.44 111.643 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.42 124.0 2.92 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 109.875 -1.29 . . . . 74.43 109.875 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 53.1 mt -86.26 128.61 39.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.957 -1.127 . . . . 71.44 107.957 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -137.44 134.91 36.38 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.816 0.847 . . . . 74.41 109.001 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 74.3 m -91.11 108.34 19.81 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.597 -0.52 . . . . 72.14 109.597 171.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.674 HD13 HD21 ' B' ' 98' ' ' LEU . 48.4 pt -121.9 143.67 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.41 1.084 . . . . 72.33 110.586 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.8 152.04 22.64 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.185 0.594 . . . . 73.25 110.771 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.95 -69.59 0.23 Allowed Glycine 0 C--N 1.347 1.18 0 O-C-N 123.429 0.455 . . . . 44.22 112.869 170.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.402 HG22 ' HB2' ' B' ' 94' ' ' MET . 18.5 mt -75.07 152.75 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.394 0.678 . . . . 73.1 110.947 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -155.81 -175.04 5.22 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 124.118 0.967 . . . . 71.31 108.92 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.67 -135.07 26.46 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 123.364 0.507 . . . . 62.11 114.152 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 31.6 m -71.25 -36.51 71.8 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.58 0.752 . . . . 72.41 111.832 -174.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -60.91 -38.22 84.99 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.766 -0.652 . . . . 64.33 110.361 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.402 ' HB2' HG22 ' B' ' 89' ' ' ILE . 42.0 ttp -80.03 -28.07 39.39 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.561 -0.745 . . . . 72.21 110.569 177.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.4 -31.89 72.94 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.106 0.562 . . . . 74.25 110.708 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -75.58 -39.01 58.69 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.232 0.613 . . . . 65.1 110.573 173.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.1 t -64.12 -64.52 0.86 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.083 0.553 . . . . 64.14 110.912 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.674 HD21 HD13 ' B' ' 86' ' ' ILE . 65.9 mt -72.47 -30.74 64.82 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.122 0.569 . . . . 65.01 111.968 -176.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.74 -10.44 72.8 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 119.717 -0.491 . . . . 61.34 114.208 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.688 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -142.35 -58.58 0.45 Allowed 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 117.433 0.616 . . . . 54.34 111.948 -175.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -60.51 -49.22 78.43 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.168 0.987 . . . . 63.33 112.385 -176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.525 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 64.1 m -67.65 -50.3 36.02 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-O 118.484 -0.77 . . . . 63.13 112.579 -175.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.428 ' HB2' HD22 ' B' ' 60' ' ' LEU . 74.0 Cg_endo -72.17 -12.62 28.03 Favored 'Trans proline' 0 C--N 1.385 2.473 0 CA-C-N 121.248 1.481 . . . . 73.0 112.84 177.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' B' ' 100' ' ' ALA . 0.2 OUTLIER -73.99 -33.49 63.84 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.071 0.548 . . . . 64.22 109.548 173.619 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.484 HG23 ' NH2' ' D' ' 111' ' ' ARG . 97.7 mt -60.76 -42.24 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 124.031 0.932 . . . . 64.3 109.738 170.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.8 mt -87.34 -14.5 40.61 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.413 -1.267 . . . . 61.52 111.396 -171.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -54.39 -51.82 74.74 Favored Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 124.321 1.048 . . . . 73.22 112.7 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' B' ' 105' ' ' ILE . 83.1 Cg_exo -52.46 -40.15 72.33 Favored 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 122.866 2.378 . . . . 63.4 114.791 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -75.07 -41.31 59.18 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.927 -0.579 . . . . 74.5 110.51 -175.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.86 -40.27 96.16 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.196 0.598 . . . . 71.41 110.43 174.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -57.11 -59.59 4.86 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.468 1.507 . . . . 73.35 110.564 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.82 -37.74 74.35 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 124.124 0.89 . . . . 72.14 110.759 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.578 ' SG ' HD11 ' B' ' 21' ' ' ILE . 19.0 t -68.61 -40.65 80.3 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.336 -0.847 . . . . 53.0 111.593 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.576 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 63.6 mt -62.18 -50.77 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.233 -0.654 . . . . 70.02 109.233 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.402 HG21 ' OG ' ' C' ' 119' ' ' SER . 4.6 m -61.99 -29.6 70.37 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 124.133 0.896 . . . . 64.13 111.431 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -66.4 -50.42 63.51 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 109.487 -0.56 . . . . 73.31 109.487 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' MET . . . . . . . . . . . . . 35.5 mmt -62.44 -41.69 98.91 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 123.699 0.624 . . . . 63.11 110.876 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 114' ' ' ILE . 70.0 t -61.78 -48.12 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 124.209 1.004 . . . . 63.52 110.857 177.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 26.0 t -67.48 -30.36 70.04 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.58 -0.736 . . . . 73.21 110.792 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -69.92 -31.31 69.01 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.992 0.517 . . . . 71.1 110.12 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.76 9.66 55.07 Favored Glycine 0 C--N 1.353 1.521 0 O-C-N 123.883 0.739 . . . . 64.21 112.314 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.514 HG23 ' HB3' ' A' ' 17' ' ' TYR . 82.8 p 60.5 22.18 11.88 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 126.825 2.05 . . . . 62.55 113.627 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -84.63 161.93 52.13 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 123.476 0.71 . . . . 75.04 111.062 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -61.9 174.58 2.3 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 123.057 2.505 . . . . 72.22 113.875 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.567 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -62.42 115.13 3.95 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.312 -1.313 . . . . 50.04 111.343 -175.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.565 HD21 HG11 ' B' ' 40' ' ' VAL . 1.6 tm? -131.92 96.08 3.84 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.361 -0.977 . . . . 73.15 108.361 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -123.1 137.01 55.03 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.475 1.11 . . . . 73.13 108.773 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 6.9 mp -70.67 138.01 50.31 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.749 0.655 . . . . 52.51 110.524 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.77 151.26 89.29 Favored Pre-proline 0 CA--C 1.553 1.077 0 O-C-N 124.331 1.019 . . . . 74.31 112.173 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.83 92.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.533 2.822 . . . . 72.41 112.636 173.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 16.1 m -115.09 112.37 39.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 115.673 -0.694 . . . . 73.55 109.194 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' ASN . . . . . 0.442 ' ND2' ' HB2' ' B' ' 135' ' ' ALA . 49.2 t30 -82.57 94.11 7.44 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 107.498 -1.297 . . . . 75.22 107.498 173.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -68.7 -29.9 68.44 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.317 -1.311 . . . . 74.4 110.638 -172.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.688 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 17.5 t70 -58.34 -45.34 88.34 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.048 0.939 . . . . 74.34 110.898 172.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' B' ' 138' ' ' MET . . . -66.51 -32.31 73.59 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.885 0.741 . . . . 70.22 111.481 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 48.6 tp -58.88 -37.06 75.7 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.468 0.707 . . . . 75.41 110.836 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.423 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 38.5 m-85 -91.06 -27.51 18.56 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.641 -0.709 . . . . 75.22 111.57 175.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.464 ' HB3' ' HA ' ' B' ' 135' ' ' ALA . 1.5 tmt? -68.15 -35.74 78.57 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.195 0.598 . . . . 71.34 111.247 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.457 ' HA ' ' NE2' ' B' ' 142' ' ' GLN . 64.3 m-80 -74.68 -16.26 60.77 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.65 0.38 . . . . 74.0 111.184 178.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -77.13 -33.3 56.78 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.623 0.369 . . . . 65.44 110.353 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 67.2 mt -77.88 -6.2 53.48 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.8 0.667 . . . . 70.33 112.8 -172.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 142' ' ' GLN . . . . . 0.457 ' NE2' ' HA ' ' B' ' 139' ' ' ASN . 3.2 pp0? -152.38 176.21 11.88 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.115 0.566 . . . . 71.31 110.705 177.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -131.78 161.34 33.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.237 1.015 . . . . 63.55 108.755 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -66.32 140.49 58.11 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.186 0.595 . . . . 75.12 111.101 -176.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.16 169.04 25.43 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.152 0.981 . . . . 75.32 110.215 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.77 110.27 0.34 Allowed Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.53 -0.628 . . . . 64.1 111.53 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.81 -21.89 34.35 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.587 0.755 . . . . 64.33 111.034 173.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.83 -179.79 44.38 Favored Glycine 0 C--N 1.351 1.362 0 N-CA-C 113.987 0.355 . . . . 63.4 113.987 170.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 11.7 t -156.79 35.37 0.3 Allowed 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.028 0.931 . . . . 73.35 109.991 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -77.83 151.27 34.02 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 115.463 -0.79 . . . . 71.41 110.291 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.47 172.23 7.1 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.219 0.608 . . . . 74.41 110.972 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -147.49 61.53 1.15 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.286 1.034 . . . . 74.45 108.214 170.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -74.08 148.26 42.04 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.324 -0.853 . . . . 61.23 110.209 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -70.39 96.41 1.14 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.76 0.791 . . . . 74.11 109.315 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 CA-C-N 115.016 -0.993 . . . . 73.42 110.053 -176.917 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 48.8 tpp . . . . . 0 N--CA 1.473 0.675 0 N-CA-C 109.699 -0.482 . . . . 73.25 109.699 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 32.5 t -159.85 154.02 23.47 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.517 0.727 . . . . 71.25 109.728 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -159.72 117.11 2.63 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.985 -0.746 . . . . 73.51 108.985 170.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -146.09 -71.03 0.25 Allowed 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.201 -1.407 . . . . 44.15 107.201 166.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 60.43 178.08 0.1 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.253 1.021 . . . . 74.43 110.725 -176.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 40.5 t30 66.32 154.25 0.08 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.788 0.835 . . . . 74.33 110.758 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 5.6 m 56.43 32.74 21.23 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-O 122.076 0.941 . . . . 73.14 109.982 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -81.87 46.34 0.98 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.474 1.11 . . . . 61.14 110.933 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.657 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 0.0 OUTLIER 63.13 112.87 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.068 1.747 . . . . 71.14 110.731 -172.567 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 72.6 m -87.6 93.19 9.36 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.924 -1.139 . . . . 52.33 107.924 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.657 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 0.9 OUTLIER -123.02 129.55 51.65 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.643 -0.708 . . . . 74.23 110.161 -173.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -148.74 126.24 11.65 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.152 -1.425 . . . . 42.02 107.152 173.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.489 HG13 ' HD3' ' A' ' 130' ' ' PRO . 65.2 mt -78.35 123.48 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 109.336 -0.616 . . . . 60.3 109.336 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -86.03 -43.11 13.39 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.331 -0.849 . . . . 74.21 110.315 -177.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -178.79 124.92 0.1 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.554 0.534 . . . . 63.41 110.23 -174.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.429 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 97.0 mt -114.03 143.64 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 108.263 -1.014 . . . . 73.03 108.263 175.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.468 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 31.3 p90 -174.82 172.7 2.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.34 1.056 . . . . 74.34 109.411 -170.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 66.6 p -96.94 126.06 41.81 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.844 0.458 . . . . 70.42 110.085 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.468 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 27.6 mmtp -76.37 -49.08 17.72 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.196 -1.038 . . . . 74.53 108.196 169.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 11.7 t70 -135.38 147.45 49.05 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 113.858 -1.519 . . . . 54.52 109.473 -170.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.5 mt -144.09 145.75 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 106.542 -1.651 . . . . 71.11 106.542 172.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -160.16 152.12 20.28 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.294 0.568 . . . . 61.35 110.397 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 70.0 t80 -149.87 136.59 19.3 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.356 -1.35 . . . . 74.41 107.356 175.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -138.96 127.83 23.58 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.346 0.658 . . . . 65.25 109.92 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.77 80.36 5.59 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 107.336 -1.357 . . . . 74.43 107.336 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.44 -35.53 38.84 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.749 2.299 . . . . 72.32 112.094 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -92.29 21.9 4.88 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.547 -1.206 . . . . 71.32 111.217 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.59 -49.44 45.83 Favored Pre-proline 0 CA--C 1.564 1.506 0 N-CA-C 113.849 1.055 . . . . 72.42 113.849 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.41 -44.23 34.54 Favored 'Trans proline' 0 C--N 1.388 2.614 0 CA-C-N 121.584 1.601 . . . . 72.24 112.652 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.421 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 86.4 t60 -69.34 -32.53 71.68 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.072 -0.967 . . . . 64.32 112.56 -175.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.759 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.9 p -78.68 -25.1 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 N-CA-C 112.695 0.628 . . . . 72.22 112.695 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -71.44 -16.02 62.36 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 112.811 0.671 . . . . 72.53 112.811 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 14.0 pt20 -94.9 19.17 10.62 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.282 0.633 . . . . 64.23 110.837 175.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.67 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -109.88 159.66 17.04 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.859 0.864 . . . . 75.15 110.576 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -82.11 131.04 35.24 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.118 0.967 . . . . 63.44 108.982 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -77.05 82.86 3.56 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.261 1.024 . . . . 72.33 112.341 -170.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -126.33 69.84 68.98 Favored Pre-proline 0 N--CA 1.484 1.235 0 C-N-CA 124.087 0.955 . . . . 60.24 109.865 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -88.96 135.06 2.72 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.864 2.376 . . . . 74.11 112.529 -173.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -86.44 115.79 24.17 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 106.902 -1.518 . . . . 64.21 106.902 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.2 t -79.49 100.2 3.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 108.911 -0.774 . . . . 75.42 108.911 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.629 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 4.3 mptp? -90.1 99.63 12.61 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.362 -1.718 . . . . 74.21 106.362 170.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 pp -95.52 145.01 25.52 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.867 -0.79 . . . . 74.24 108.867 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.434 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 23.0 t70 -142.86 145.29 32.99 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.845 -0.798 . . . . 64.13 108.845 -177.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.56 HD11 HD13 ' G' ' 8' ' ' LEU . 3.1 mm? -121.06 113.65 20.35 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.699 0.8 . . . . 71.2 109.312 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -113.59 163.03 15.48 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.267 1.427 . . . . 40.25 107.831 171.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.4 t -144.58 153.83 42.21 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.32 0.581 . . . . 72.41 111.27 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.91 152.17 41.78 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.039 1.336 . . . . 73.41 107.707 172.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.9 p -167.33 167.54 13.92 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 120.996 0.427 . . . . 73.42 111.454 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 69.9 p -161.21 153.61 20.28 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.063 -0.971 . . . . 70.23 109.011 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -88.54 124.11 33.71 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.26 -1.015 . . . . 72.04 108.26 168.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.559 HD11 HD12 ' C' ' 83' ' ' ILE . 64.9 mt -92.74 -38.67 11.68 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.521 0.728 . . . . 71.31 110.755 -176.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -157.07 178.03 10.82 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.515 0.726 . . . . 53.32 110.7 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -60.65 117.93 5.95 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.401 0.68 . . . . 75.15 109.811 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 70.01 -6.71 1.05 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 125.827 1.651 . . . . 63.52 113.596 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 57.6 t -97.55 111.67 27.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.932 -1.136 . . . . 65.2 107.932 177.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -127.78 134.89 49.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.299 -0.63 . . . . 72.41 109.299 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -92.24 126.89 37.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.895 -1.048 . . . . 64.42 109.679 177.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 72.9 t -116.4 116.05 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 107.739 -1.208 . . . . 74.02 107.739 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 38.9 t -116.01 132.57 65.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 108.746 -0.835 . . . . 74.32 108.746 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 54.3 tp -116.72 112.85 21.78 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.504 -0.924 . . . . 70.33 108.504 175.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.573 ' HB2' ' HG2' ' C' ' 79' ' ' GLN . 50.4 ttm-85 -91.62 111.02 22.36 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.882 -0.784 . . . . 73.42 108.882 173.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.557 ' HB ' HD11 ' C' ' 114' ' ' ILE . 20.8 t -99.33 129.16 50.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 N-CA-C 107.785 -1.191 . . . . 73.23 107.785 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 16.5 m -123.05 118.97 28.97 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.114 -0.698 . . . . 72.54 109.114 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 65.4 t -113.55 108.62 25.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-N 114.571 -1.195 . . . . 74.52 108.749 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.629 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 16.5 m -98.25 140.41 32.59 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.873 -1.158 . . . . 64.42 107.873 171.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.48 121.24 28.45 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.169 -1.419 . . . . 45.0 107.169 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 51.0 m -132.43 126.34 32.85 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.941 0.337 . . . . 74.05 110.68 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.67 HD13 ' HG2' ' C' ' 34' ' ' LYS . 10.3 mt -85.49 42.83 0.98 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.562 1.145 . . . . 63.22 109.7 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.03 -113.67 4.51 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 111.108 -0.797 . . . . 54.12 111.108 -172.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.83 -18.6 28.94 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.535 0.734 . . . . 64.43 110.044 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -80.04 120.75 24.63 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.392 1.077 . . . . 73.43 109.145 172.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 99.0 m -78.93 123.01 26.84 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.476 -0.935 . . . . 44.32 108.476 164.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.759 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.16 -56.72 5.51 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.649 0.593 . . . . 70.24 109.614 175.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -158.47 168.94 25.6 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.927 0.87 . . . . 71.44 111.392 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -128.08 141.53 51.47 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 105.859 -1.904 . . . . 72.21 105.859 166.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.485 ' SG ' HG23 ' C' ' 114' ' ' ILE . 37.3 t -145.36 136.85 25.18 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.427 -1.323 . . . . 74.01 107.427 177.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 77' ' ' GLU . . . . . 0.402 ' HG2' HH11 ' C' ' 61' ' ' ARG . 39.1 tt0 -156.24 121.14 4.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.532 0.206 . . . . 74.51 110.465 -168.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 84.7 t -132.59 135.56 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.644 0.778 . . . . 71.12 109.671 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.573 ' HG2' ' HB2' ' C' ' 61' ' ' ARG . 68.7 mt-30 -96.89 108.19 20.84 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.657 -0.868 . . . . 64.43 108.657 164.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -90.62 104.24 16.85 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.638 -0.875 . . . . 71.02 108.638 172.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.75 145.55 22.76 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.511 -0.768 . . . . 62.5 111.475 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.2 115.48 0.72 Allowed Glycine 0 CA--C 1.504 -0.656 0 N-CA-C 110.157 -1.177 . . . . 51.23 110.157 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.559 HD12 HD11 ' C' ' 51' ' ' LEU . 15.8 mm -83.76 121.74 36.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.886 -1.153 . . . . 60.53 107.886 175.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -129.04 119.35 24.07 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.851 -0.796 . . . . 71.45 108.851 -174.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 57.3 p -77.35 107.71 9.96 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.264 -1.013 . . . . 75.3 108.264 170.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.509 HD13 HG21 ' G' ' 18' ' ' VAL . 6.7 tt -116.25 131.91 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.831 1.252 . . . . 74.44 108.997 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.02 171.03 20.8 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.913 0.885 . . . . 63.33 110.087 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.73 -58.44 3.71 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 112.228 -0.349 . . . . 65.21 112.228 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.589 HD13 ' HG2' ' C' ' 9' ' ' MET . 36.2 pt -84.76 158.61 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.276 0.631 . . . . 74.24 110.669 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -149.9 164.71 34.68 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.839 0.855 . . . . 74.35 109.363 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' G' ' 21' ' ' ALA . . . 64.79 -125.31 30.4 Favored Glycine 0 C--N 1.346 1.094 0 C-N-CA 123.197 0.427 . . . . 72.31 113.69 171.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 45.5 p -56.43 -34.75 67.1 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.841 1.256 . . . . 75.02 112.531 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.42 ' NE2' ' H ' ' A' ' 149' ' ' THR . 26.3 mt-30 -73.47 -38.57 65.38 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.763 0.425 . . . . 70.53 111.592 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.545 ' SD ' ' HB ' ' G' ' 18' ' ' VAL . 47.3 mtt -62.15 -49.03 77.47 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.496 -0.557 . . . . 74.51 109.496 171.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.66 -35.88 71.14 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.787 0.835 . . . . 74.24 111.286 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -64.41 -46.55 82.79 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.292 1.037 . . . . 61.42 110.739 173.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.558 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 24.2 t -64.06 -42.02 97.16 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.497 -0.774 . . . . 54.42 111.465 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.68 HD11 HG23 ' G' ' 18' ' ' VAL . 70.9 mt -85.37 -36.7 20.57 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.567 0.747 . . . . 71.21 111.706 -170.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.95 11.52 58.95 Favored Glycine 0 N--CA 1.474 1.168 0 CA-C-N 116.206 -0.452 . . . . 45.25 114.009 -171.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.43 -60.07 0.14 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.54 0.686 . . . . 70.04 110.616 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.558 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 83.1 t80 -75.79 -35.45 60.07 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 125.138 1.375 . . . . 74.22 113.49 -168.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 91.3 m -79.07 -41.68 1.64 Allowed Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 123.169 0.588 . . . . 75.32 111.49 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.58 -33.37 30.71 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 122.626 2.217 . . . . 64.12 113.705 166.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -66.02 -39.69 90.44 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.633 0.773 . . . . 62.5 111.399 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.472 HD12 HH12 ' A' ' 111' ' ' ARG . 50.6 mm -67.03 -42.64 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.127 0.571 . . . . 63.12 110.062 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 87.8 mt -88.36 -10.21 50.14 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.826 0.851 . . . . 51.33 112.209 -174.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -58.04 -55.29 46.76 Favored Pre-proline 0 N--CA 1.481 1.092 0 CA-C-O 117.892 -1.051 . . . . 72.32 112.493 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.14 -35.56 74.64 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 121.99 1.794 . . . . 74.32 113.158 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.466 ' HE2' HG21 ' A' ' 115' ' ' THR . 91.6 m-85 -64.33 -54.43 33.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.485 0.714 . . . . 54.2 110.659 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.01 -39.13 91.23 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 114.803 -1.09 . . . . 71.21 110.501 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -56.0 -51.43 67.79 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.11 1.364 . . . . 72.05 110.453 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.49 -38.18 77.54 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 123.508 0.505 . . . . 75.24 109.802 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.1 t -64.41 -32.85 74.64 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 122.971 0.508 . . . . 73.22 111.639 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.557 HD11 ' HB ' ' C' ' 62' ' ' VAL . 97.4 mt -73.42 -56.14 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.832 0.853 . . . . 70.22 109.33 175.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 15.0 m -61.88 -27.25 68.67 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.936 0.895 . . . . 73.1 111.688 -175.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.451 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 47.6 t -68.03 -47.47 68.33 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.984 0.914 . . . . 71.32 109.71 174.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.548 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.82 -36.77 84.27 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.849 0.86 . . . . 73.44 111.596 178.052 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.5 t -63.35 -39.46 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.377 0.671 . . . . 72.43 110.011 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.402 ' OG ' HG21 ' B' ' 115' ' ' THR . 32.6 t -73.06 -29.52 63.03 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.845 0.858 . . . . 53.03 112.061 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' C' ' 116' ' ' SER . 85.4 mtt-85 -71.66 -39.48 70.29 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.014 -0.735 . . . . 75.01 109.014 176.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.18 2.55 60.98 Favored Glycine 0 C--N 1.36 1.874 0 O-C-N 124.103 0.877 . . . . 75.12 112.61 172.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.2 p 61.81 26.35 15.98 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.89 2.076 . . . . 71.41 113.545 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -83.37 146.91 51.81 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 109.066 -0.716 . . . . 71.11 109.066 170.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.526 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 80.1 Cg_exo -49.86 138.21 34.43 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 123.329 2.686 . . . . 64.34 112.688 173.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -60.11 111.36 1.48 Allowed 'General case' 0 C--N 1.354 0.761 0 O-C-N 123.955 0.784 . . . . 55.2 110.609 -176.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -105.88 88.05 2.72 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 104.587 -2.375 . . . . 74.03 104.587 174.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -92.34 126.19 37.32 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.261 -0.881 . . . . 71.14 109.046 -171.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.49 136.08 51.0 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 124.128 0.892 . . . . 70.33 109.881 -173.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.06 157.82 83.43 Favored Pre-proline 0 CA--C 1.551 0.996 0 O-C-N 124.148 0.905 . . . . 73.12 111.395 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.439 ' HB3' HD12 ' A' ' 16' ' ' ILE . 55.5 Cg_exo -54.03 110.33 0.49 Allowed 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 123.03 2.487 . . . . 65.42 113.485 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.606 HG11 ' HB2' ' G' ' 8' ' ' LEU . 40.9 t -112.23 109.86 30.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.26 -0.644 . . . . 72.12 109.26 175.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -107.8 91.93 3.86 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 105.866 -1.901 . . . . 60.03 105.866 169.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -53.63 -43.27 68.58 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 124.319 1.012 . . . . 65.13 111.586 -172.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -60.75 -47.2 87.38 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 114.928 -1.033 . . . . 72.4 111.205 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.19 -22.19 63.91 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.119 -0.946 . . . . 64.23 111.74 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.83 -38.36 90.72 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.902 0.481 . . . . 74.01 110.849 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -66.88 -39.75 87.58 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 116.043 -0.526 . . . . 75.01 110.519 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 61.4 mtt -73.43 -30.98 63.57 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.947 0.899 . . . . 61.14 111.848 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -73.63 -38.0 65.17 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.598 0.759 . . . . 71.01 111.026 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -57.76 -86.28 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.133 0 O-C-N 124.344 1.027 . . . . 74.34 112.511 -170.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 9.2 mp 61.99 -74.35 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.519 1.127 . . . . 72.22 110.86 -171.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -158.68 -74.9 0.08 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.566 -0.902 . . . . 62.3 108.566 174.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -171.07 171.22 5.88 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.419 1.088 . . . . 64.24 108.491 -175.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 73.07 119.23 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.131 1.372 . . . . 62.23 111.355 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -153.31 -52.52 0.1 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.312 0.645 . . . . 71.52 110.0 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 110.53 -166.39 12.38 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.945 -0.57 . . . . 73.0 112.408 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.09 -154.26 0.54 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.565 1.146 . . . . 74.54 109.771 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.96 37.57 2.35 Favored Glycine 0 C--N 1.354 1.578 0 N-CA-C 114.922 0.729 . . . . 73.12 114.922 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 17.4 m 61.47 79.37 0.25 Allowed 'General case' 0 C--N 1.362 1.15 0 C-N-CA 125.108 1.363 . . . . 71.41 111.005 171.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 68.37 -75.63 0.06 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.814 1.246 . . . . 74.31 109.269 -171.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -178.71 -104.89 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.205 1.402 . . . . 73.13 107.692 172.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -162.1 -68.82 0.05 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.227 1.411 . . . . 71.22 108.223 -174.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 70.88 -4.29 1.77 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.624 1.57 . . . . 74.24 113.047 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -90.01 154.92 19.45 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.231 0.612 . . . . 73.41 110.461 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.182 0 C-N-CA 124.89 1.276 . . . . 71.42 108.296 172.769 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 108.94 -0.763 . . . . 74.21 108.94 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 55.5 p -162.8 75.66 0.42 Allowed 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.75 0.786 . . . . 63.42 109.982 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -88.5 67.65 8.59 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.08 0.943 . . . . 73.15 108.974 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -160.66 134.57 7.02 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 106.677 -1.601 . . . . 64.45 106.677 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 64.57 -164.14 0.25 Allowed 'General case' 0 CA--C 1.566 1.576 0 O-C-N 123.909 0.756 . . . . 62.22 109.472 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -57.39 106.44 0.33 Allowed 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 118.918 0.781 . . . . 72.41 110.113 170.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 39.8 p -71.25 -9.16 57.65 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.252 1.021 . . . . 65.21 111.984 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.66 -25.23 68.12 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.287 1.035 . . . . 53.24 111.169 173.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.505 ' HB2' HG12 ' D' ' 89' ' ' ILE . 14.6 ptm -30.42 140.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 125.38 1.472 . . . . 73.45 114.053 173.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 96.1 m -105.92 143.01 34.67 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.475 1.11 . . . . 74.34 110.047 -175.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.632 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 62.6 t80 -154.66 93.09 1.54 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 107.433 -1.321 . . . . 73.32 107.433 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -120.5 115.34 23.26 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.441 -0.948 . . . . 70.02 108.441 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.578 HD13 HG21 ' D' ' 105' ' ' ILE . 11.2 mt -74.0 134.31 29.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 109.952 -0.388 . . . . 53.21 109.952 -175.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -93.83 -46.42 7.21 Favored 'General case' 0 C--O 1.241 0.656 0 O-C-N 123.426 0.454 . . . . 72.14 110.675 175.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -167.18 142.7 4.13 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.66 0.615 . . . . 61.24 112.66 -165.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.439 HG21 ' CG ' ' D' ' 109' ' ' TYR . 3.0 mp -122.56 135.94 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.791 1.236 . . . . 75.55 107.725 171.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.414 ' HE1' HG13 ' D' ' 83' ' ' ILE . 25.2 p90 -163.63 157.14 19.0 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.671 0.789 . . . . 72.34 110.737 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.3 p -91.36 114.69 27.29 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.209 -0.905 . . . . 51.45 108.859 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -78.71 -44.88 22.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.354 -0.98 . . . . 74.15 108.354 175.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 14.1 t70 -135.62 139.38 43.75 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.374 -1.284 . . . . 74.04 109.577 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.548 HG21 ' HE2' ' C' ' 117' ' ' MET . 67.4 mt -138.06 151.23 25.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 124.968 1.307 . . . . 63.13 107.895 174.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -152.23 145.8 24.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.358 1.063 . . . . 75.01 108.986 172.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.523 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 84.9 t80 -152.27 133.41 14.31 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 105.584 -2.006 . . . . 73.3 105.584 173.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -141.79 139.56 32.81 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.353 -0.98 . . . . 72.43 108.353 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.89 89.78 20.31 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 107.646 -1.242 . . . . 71.53 107.646 176.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.2 -32.31 5.26 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 123.022 2.481 . . . . 73.44 113.935 -170.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -103.53 17.32 24.35 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.191 0.596 . . . . 54.35 110.32 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -38.76 -65.81 0.36 Allowed Pre-proline 0 CA--C 1.562 1.416 0 N-CA-C 115.235 1.568 . . . . 73.01 115.235 -159.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.53 -23.87 22.88 Favored 'Trans proline' 0 C--N 1.389 2.688 0 CA-C-N 121.849 1.696 . . . . 74.44 113.337 -173.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -79.4 -39.01 33.51 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.11 0.964 . . . . 73.4 110.808 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -80.67 -18.68 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 122.537 0.335 . . . . 63.23 110.752 -170.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -62.54 -23.39 66.96 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.346 0.659 . . . . 74.02 112.623 173.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -60.33 -23.09 63.96 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.574 0.749 . . . . 72.52 110.603 175.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -92.54 82.14 4.84 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.151 1.381 . . . . 71.11 109.657 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.19 84.31 7.72 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.231 0.613 . . . . 74.32 110.353 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.2 p90 -156.82 -178.97 7.76 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.35 0.66 . . . . 74.53 109.343 170.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -66.76 109.84 4.05 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.457 1.103 . . . . 71.25 110.455 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.75 137.68 64.83 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.259 1.973 . . . . 75.44 111.415 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -63.21 108.58 1.31 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.709 -0.849 . . . . 63.25 108.709 172.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.557 HG13 HG13 ' D' ' 64' ' ' VAL . 87.6 t -99.13 148.81 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.034 -1.098 . . . . 62.51 108.034 -175.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.552 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 34.6 ttpt -129.83 138.91 51.26 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.663 -0.866 . . . . 65.53 108.663 169.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.658 HD21 HD23 ' H' ' 8' ' ' LEU . 53.7 tp -109.05 112.2 24.26 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.277 -1.008 . . . . 73.34 108.277 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.606 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 71.9 m-20 -111.37 120.95 43.92 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.316 1.046 . . . . 41.21 108.412 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.417 HD22 ' O ' ' H' ' 10' ' ' LEU . 5.2 mp -100.36 128.01 46.53 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.846 -0.428 . . . . 54.3 109.846 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 9.1 t70 -133.1 157.79 44.41 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 105.75 -1.945 . . . . 61.03 105.75 172.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.3 t -146.96 161.11 41.45 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.144 0.497 . . . . 70.11 111.761 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -163.01 169.41 19.63 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.187 1.395 . . . . 71.51 108.771 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 19.1 p -176.82 -179.75 0.99 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 112.454 0.538 . . . . 65.21 112.454 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 52.2 p -164.77 147.52 8.52 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.624 1.17 . . . . 60.2 109.245 172.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -82.42 119.22 23.9 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.275 -1.009 . . . . 72.04 108.275 171.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' D' ' 57' ' ' GLU . 21.1 mt -89.82 -31.3 17.44 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.779 0.432 . . . . 74.34 110.718 -173.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -162.73 178.33 8.57 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.22 1.008 . . . . 55.2 109.696 177.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -73.59 129.36 37.8 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.808 -0.812 . . . . 74.35 108.808 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 69.65 10.59 7.66 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.983 1.313 . . . . 72.41 111.311 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 87.7 t -132.67 118.23 33.65 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 124.034 0.934 . . . . 71.15 108.978 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -140.91 131.25 25.09 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.77 -0.826 . . . . 73.24 108.77 -174.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.416 ' HB2' HD11 ' D' ' 51' ' ' LEU . 31.2 tt0 -91.27 143.57 26.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.669 -1.15 . . . . 75.11 109.941 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.485 HG22 ' HE1' ' D' ' 84' ' ' PHE . 3.9 m -121.49 139.48 48.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 107.887 -1.153 . . . . 51.02 107.887 167.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 23.7 t -127.94 124.51 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 108.328 -0.99 . . . . 52.21 108.328 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.585 HD23 HD12 ' D' ' 106' ' ' LEU . 3.9 mm? -118.23 114.07 22.46 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.358 0.663 . . . . 74.45 109.497 -176.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.519 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 22.0 ttm-85 -86.22 99.62 11.68 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.67 0.788 . . . . 64.04 109.609 176.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 85.7 t -91.2 115.04 29.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 108.357 -0.979 . . . . 61.33 108.357 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 9.1 m -115.46 129.09 56.44 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.358 0.599 . . . . 74.44 109.701 -175.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.557 HG13 HG13 ' D' ' 40' ' ' VAL . 24.5 t -118.13 101.56 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.005 1.722 . . . . 75.44 108.693 -177.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 51.5 m -95.57 93.92 7.45 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.467 -0.938 . . . . 75.12 108.467 176.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.38 143.62 27.94 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.373 0.669 . . . . 72.11 110.163 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.44 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 13.7 m -149.3 124.39 10.07 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 123.027 0.531 . . . . 72.03 110.914 -174.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 17.9 mt -94.86 104.76 16.65 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.076 -0.712 . . . . 53.24 109.076 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.24 -120.87 5.26 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.832 -0.622 . . . . 70.44 111.948 -176.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.09 2.28 29.25 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.389 0.676 . . . . 71.35 111.296 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -124.11 163.45 21.47 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.315 0.646 . . . . 74.21 109.863 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 16.0 m -68.6 137.42 54.25 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 123.772 0.67 . . . . 71.14 111.503 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.44 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -92.43 -65.41 1.0 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.408 -1.33 . . . . 61.52 107.408 170.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -155.98 143.71 19.56 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 115.787 -0.642 . . . . 74.5 110.619 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 59.6 mt -106.74 109.97 22.02 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.264 -1.013 . . . . 73.01 108.264 173.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 76' ' ' CYS . . . . . . . . . . . . . 40.7 t -115.4 143.83 44.7 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.304 -0.998 . . . . 65.31 108.304 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -156.77 127.72 6.8 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.931 0.492 . . . . 65.22 109.895 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -132.41 119.18 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 122.972 0.509 . . . . 65.51 109.879 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.576 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 40.9 mt-30 -88.79 88.74 7.71 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.848 -0.797 . . . . 71.03 108.848 168.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -80.24 106.44 12.25 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.308 -1.315 . . . . 75.2 108.501 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.32 147.89 16.62 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.408 -0.677 . . . . 64.42 111.408 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.28 136.99 6.57 Favored Glycine 0 C--N 1.331 0.284 0 N-CA-C 111.539 -0.625 . . . . 42.31 111.539 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.414 HG13 ' HE1' ' D' ' 17' ' ' TYR . 54.1 mt -91.04 126.47 43.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 C-N-CA 123.728 0.811 . . . . 74.1 108.884 174.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.485 ' HE1' HG22 ' D' ' 58' ' ' VAL . 64.9 m-85 -131.79 131.77 43.2 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.765 0.426 . . . . 74.11 110.321 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 15.3 m -84.5 103.96 14.09 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.519 0.727 . . . . 74.21 109.242 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.607 HD13 HD21 ' D' ' 98' ' ' LEU . 37.7 pt -114.13 127.08 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.869 0.867 . . . . 72.35 110.024 -177.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.74 148.92 29.13 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.598 0.359 . . . . 71.54 110.641 -174.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.17 15.99 76.82 Favored Glycine 0 C--N 1.345 1.077 0 O-C-N 123.391 0.432 . . . . 62.41 113.271 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.505 HG12 ' HB2' ' D' ' 9' ' ' MET . 41.3 mt -97.19 148.65 5.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 109.268 -0.641 . . . . 72.21 109.268 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -162.02 178.48 8.8 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.394 1.078 . . . . 63.4 109.963 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.29 -144.43 44.41 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 115.286 -0.87 . . . . 74.53 113.747 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 2.8 p -82.62 -10.64 58.86 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.599 0.76 . . . . 73.21 111.751 176.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -27.63 68.5 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 109.458 -0.571 . . . . 74.41 109.458 174.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.474 ' HB3' ' H ' ' H' ' 18' ' ' VAL . 40.9 mtt -54.03 -43.42 70.14 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.195 0.598 . . . . 74.53 110.913 171.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.05 -46.18 62.48 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.696 -1.138 . . . . 32.23 110.939 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -64.32 -37.26 86.88 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.996 0.519 . . . . 65.11 111.702 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 47.9 t -62.03 -48.51 79.97 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.794 0.684 . . . . 53.34 110.553 -174.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.607 HD21 HD13 ' D' ' 86' ' ' ILE . 66.1 mt -98.1 -24.8 15.17 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.359 -0.837 . . . . 63.1 112.163 -169.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.04 -3.75 56.78 Favored Glycine 0 N--CA 1.47 0.925 0 CA-C-O 119.83 -0.428 . . . . 73.52 113.705 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.77 -55.35 0.33 Allowed 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.317 0.558 . . . . 71.02 111.74 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -72.81 -42.77 63.52 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 112.492 0.552 . . . . 74.41 112.492 -168.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.632 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 60.2 m -70.49 -45.66 18.77 Favored Pre-proline 0 CA--C 1.562 1.439 0 CA-C-O 119.07 -0.49 . . . . 71.02 110.881 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.477 ' HG3' HD21 ' D' ' 60' ' ' LEU . 72.7 Cg_exo -53.51 -33.78 69.41 Favored 'Trans proline' 0 C--N 1.394 2.922 0 C-N-CA 122.587 2.191 . . . . 73.5 113.922 168.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -64.98 -40.2 94.61 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.577 0.751 . . . . 74.42 110.078 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.578 HG21 HD13 ' D' ' 13' ' ' ILE . 49.3 mm -60.02 -42.83 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 115.913 -0.585 . . . . 65.11 109.726 173.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.585 HD12 HD23 ' D' ' 60' ' ' LEU . 83.9 mt -80.19 -15.31 57.32 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.004 -0.998 . . . . 61.13 112.558 -172.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -62.7 -48.82 85.05 Favored Pre-proline 0 CA--C 1.563 1.457 0 N-CA-C 113.207 0.817 . . . . 61.51 113.207 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -56.35 -35.56 96.18 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 122.097 1.865 . . . . 72.32 112.955 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 109' ' ' TYR . . . . . 0.439 ' CG ' HG21 ' D' ' 16' ' ' ILE . 98.5 m-85 -78.61 -29.66 46.12 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.017 0.927 . . . . 74.41 111.978 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.34 -48.03 68.71 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.735 -0.839 . . . . 62.51 108.735 174.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.484 ' NH2' HG23 ' B' ' 105' ' ' ILE . 45.4 ttp180 -65.08 -33.54 76.28 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.376 -1.283 . . . . 74.11 110.489 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -54.48 -58.52 7.13 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.067 0.947 . . . . 75.31 110.632 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.15 -45.13 89.84 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.693 -1.14 . . . . 73.04 111.271 -174.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.452 ' O ' HG23 ' D' ' 118' ' ' VAL . 79.8 mt -59.79 -62.06 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.576 0.75 . . . . 71.41 110.87 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.445 HG23 ' HG3' ' D' ' 125' ' ' GLN . 57.9 m -52.82 -38.38 61.22 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.347 1.059 . . . . 72.11 111.97 -175.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.0 t -66.73 -46.6 74.93 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.244 -0.889 . . . . 44.2 110.767 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.5 mtm -67.61 -30.02 69.5 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.782 0.433 . . . . 55.44 111.613 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.452 HG23 ' O ' ' D' ' 114' ' ' ILE . 91.2 t -63.62 -49.99 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 O-C-N 123.786 0.679 . . . . 71.23 109.819 174.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.8 p -69.06 -31.52 70.34 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 116.139 -0.482 . . . . 55.11 110.97 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 77.6 mtt-85 -69.79 -35.51 74.92 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.87 0.868 . . . . 73.54 110.384 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.59 2.62 85.26 Favored Glycine 0 C--N 1.351 1.376 0 O-C-N 123.733 0.646 . . . . 15.23 112.347 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.414 HG21 HE21 ' A' ' 125' ' ' GLN . 22.8 p 57.17 35.76 26.64 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.629 1.971 . . . . 72.42 113.384 176.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -94.7 159.41 33.53 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.267 1.027 . . . . 75.52 110.035 172.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.84 123.2 12.49 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.009 2.473 . . . . 65.32 112.774 170.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.445 ' HG3' HG23 ' D' ' 115' ' ' THR . 34.2 tt0 -53.47 142.73 21.31 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.148 1.379 . . . . 64.34 112.583 -176.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 66.4 tp -125.81 106.27 9.56 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.768 0.827 . . . . 74.52 109.735 -174.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -116.53 95.92 5.27 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.651 0.78 . . . . 73.11 109.517 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.45 ' HA ' HD12 ' H' ' 6' ' ' ILE . 6.2 mp -66.71 116.93 8.17 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.981 -0.748 . . . . 74.22 108.981 175.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -58.09 143.86 77.43 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 123.746 0.818 . . . . 71.43 110.626 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 6.0 Cg_exo -74.26 107.82 2.53 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.625 2.216 . . . . 61.11 110.524 -174.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 131' ' ' VAL . . . . . 0.643 HG21 ' HA ' ' H' ' 7' ' ' ALA . 27.7 m -107.47 140.3 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.254 0.622 . . . . 64.01 110.185 -174.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -83.99 79.42 9.5 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.865 0.84 . . . . 74.55 109.116 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -76.17 -18.74 58.96 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.785 -1.098 . . . . 74.12 110.962 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' D' ' 138' ' ' MET . 1.7 m-20 -50.77 -47.73 59.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.519 1.128 . . . . 71.1 111.412 171.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.67 -44.12 97.56 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.802 0.841 . . . . 53.21 111.82 -176.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 53.6 tp -63.26 -36.21 82.91 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.538 -0.755 . . . . 74.12 110.715 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.428 ' O ' HD13 ' D' ' 141' ' ' LEU . 38.4 t80 -72.73 -32.29 65.59 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.294 -0.866 . . . . 65.34 110.278 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.46 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 39.9 mtt -67.45 -29.45 68.91 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.578 0.751 . . . . 73.32 110.701 176.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -59.04 -29.59 67.4 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.604 0.761 . . . . 72.25 110.824 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -86.31 -32.65 20.92 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.743 0.817 . . . . 74.3 110.302 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.428 HD13 ' O ' ' D' ' 137' ' ' PHE . 7.7 mp -83.54 -25.97 30.54 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.651 1.18 . . . . 72.25 113.594 -175.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -65.98 2.84 0.96 Allowed 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 114.913 1.449 . . . . 71.51 114.913 -167.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.23 40.74 2.78 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.057 -0.72 . . . . 72.55 109.057 -174.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 174.51 146.12 0.06 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-N 113.464 -1.698 . . . . 70.43 107.663 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -142.56 -77.38 0.25 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.189 -1.412 . . . . 71.42 107.189 172.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 72.38 56.63 6.06 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 116.094 -0.503 . . . . 75.54 113.158 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -67.83 120.87 14.85 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.678 -0.49 . . . . 72.43 109.678 173.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.81 88.95 0.46 Allowed Glycine 0 C--N 1.345 1.051 0 N-CA-C 110.547 -1.021 . . . . 73.1 110.547 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 41.4 p -73.98 74.87 1.69 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.813 0.845 . . . . 73.23 110.532 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.81 137.99 31.87 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 114.919 -1.037 . . . . 63.13 108.304 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.48 134.53 53.6 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 107.964 -1.124 . . . . 75.33 107.964 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -57.82 -32.7 67.84 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.859 0.864 . . . . 73.2 112.686 -171.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 53.53 73.42 0.37 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.73 1.212 . . . . 72.42 110.809 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -81.22 153.86 26.94 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.248 -0.887 . . . . 60.0 110.213 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.235 0 C-N-CA 123.618 0.767 . . . . 42.13 108.933 -176.677 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 61.9 mtt . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 109.7 -0.481 . . . . 73.05 109.7 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -167.69 150.26 5.83 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.972 0.909 . . . . 55.54 109.247 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.64 101.08 5.16 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.007 -1.108 . . . . 75.11 108.007 177.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 42.8 t -69.9 95.55 0.93 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 109.316 -0.624 . . . . 71.24 109.316 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 11.6 t -71.55 -17.24 62.32 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.046 -0.979 . . . . 60.13 111.56 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 10.1 pt -89.96 90.55 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 123.939 0.896 . . . . 74.35 110.922 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 7' ' ' ALA . . . . . 0.525 ' HA ' ' HB3' ' A' ' 129' ' ' ALA . . . -110.4 -39.8 4.84 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.058 0.943 . . . . 70.22 109.95 176.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 tt 77.0 130.65 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.982 1.713 . . . . 71.31 110.591 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 9' ' ' ALA . . . . . 0.538 ' H ' HD13 ' A' ' 42' ' ' LEU . . . -84.14 159.13 21.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.724 0.81 . . . . 72.33 111.112 -175.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 8.7 mp -71.8 172.16 10.34 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.64 0.376 . . . . 72.13 110.163 172.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 78.7 mt -54.57 112.23 3.76 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.437 0.695 . . . . 70.32 110.799 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.76 -19.14 18.76 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.999 2.466 . . . . 74.0 111.602 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 4.2 mp -114.8 159.12 20.99 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.249 1.02 . . . . 62.24 109.491 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 95.7 mt -82.11 141.03 33.47 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.98 0.512 . . . . 73.11 109.871 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -80.8 134.37 35.78 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.557 -0.534 . . . . 71.24 109.557 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 12.4 p -64.7 114.71 15.61 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 123.959 0.903 . . . . 73.32 110.126 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 17' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.91 -179.27 5.24 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.714 2.276 . . . . 54.32 112.788 -171.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 55.8 t -86.94 141.87 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 123.51 0.724 . . . . 61.33 109.185 173.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 38.4 p -70.75 75.7 0.61 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.006 0.922 . . . . 53.1 109.691 173.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? 176.93 -47.19 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.142 1.377 . . . . 64.22 108.177 -171.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.55 115.64 5.38 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 114.921 -1.036 . . . . 72.11 111.276 -175.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -76.6 164.2 26.15 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.627 -0.508 . . . . 74.42 109.627 169.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 81.8 p -63.36 151.12 88.1 Favored Pre-proline 0 CA--C 1.553 1.081 0 CA-C-N 115.405 -0.816 . . . . 61.34 111.757 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -61.36 93.88 0.11 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.635 2.223 . . . . 71.42 112.363 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 C--O 1.25 1.126 0 C-N-CA 124.589 1.155 . . . . 64.3 107.969 174.966 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 18.4 ptt? . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 110.369 -0.234 . . . . 70.21 110.369 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -74.46 106.45 6.07 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.562 0.745 . . . . 75.21 109.839 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -158.74 158.63 34.01 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.972 0.909 . . . . 72.01 109.962 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 34.0 m -103.52 11.07 36.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.808 0.843 . . . . 64.23 110.006 169.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 32.8 m 63.83 -78.13 0.03 OUTLIER 'General case' 0 C--N 1.36 1.061 0 C-N-CA 125.307 1.443 . . . . 75.24 109.945 -170.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 8.2 tt -175.67 -54.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 125.393 1.477 . . . . 71.34 108.826 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . 62.89 -167.46 0.21 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.003 1.321 . . . . 72.42 111.959 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 69.4 mt -123.89 -179.44 4.4 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.965 0.906 . . . . 71.52 109.337 169.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.4 177.05 9.77 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.245 1.018 . . . . 71.23 109.318 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 83.7 mt -62.08 156.71 20.74 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.894 0.478 . . . . 73.24 110.925 175.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.413 HD22 HD11 ' B' ' 60' ' ' LEU . 0.3 OUTLIER -126.91 89.29 52.43 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 123.939 0.896 . . . . 65.35 109.406 -178.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.58 44.86 1.77 Allowed 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 123.853 3.036 . . . . 70.02 112.557 -176.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.09 -50.9 2.94 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 108.539 -0.912 . . . . 73.01 108.539 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 85.1 mt 66.42 -175.36 0.19 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.326 1.451 . . . . 73.23 111.832 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 15' ' ' PHE . . . . . 0.499 ' HD2' ' HB ' ' B' ' 46' ' ' THR . 2.8 p90 -146.97 -178.76 6.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.756 0.822 . . . . 52.43 110.286 -173.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 53.6 p -68.4 130.89 91.95 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 123.931 0.892 . . . . 65.12 112.33 -173.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.72 136.88 76.77 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.737 2.291 . . . . 72.22 111.46 169.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 18' ' ' VAL . . . . . 0.406 HG21 HD11 ' B' ' 86' ' ' ILE . 13.8 t -76.84 116.91 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 109.622 -0.511 . . . . 73.12 109.622 -172.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 38.9 m -63.07 -47.1 84.38 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.007 0.923 . . . . 74.22 111.022 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -103.04 60.12 0.77 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 122.104 0.954 . . . . 71.33 109.877 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.16 -21.59 1.84 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.531 -1.213 . . . . 74.54 108.964 166.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -55.08 137.39 46.65 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 125.057 1.343 . . . . 70.3 110.221 171.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 23' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' F' ' 24' ' ' PRO . 6.7 t -65.21 120.25 65.84 Favored Pre-proline 0 CA--C 1.554 1.097 0 N-CA-C 109.366 -0.605 . . . . 75.22 109.366 173.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 24' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' F' ' 23' ' ' THR . 3.8 Cg_exo -79.29 9.26 3.46 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.686 2.258 . . . . 75.01 112.902 -174.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 C--O 1.251 1.161 0 C-N-CA 125.014 1.326 . . . . 71.13 111.43 179.208 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' G' G ' 1' ' ' MET . . . . . 0.43 ' SD ' ' N ' ' G' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 121.801 0.81 . . . . 54.44 111.2 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -116.21 76.76 1.04 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 107.99 -1.115 . . . . 65.02 107.99 170.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -138.47 25.27 2.65 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.342 1.057 . . . . 73.42 109.055 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 77.4 p -65.45 148.71 51.25 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.057 0.543 . . . . 75.4 109.9 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 7.5 m -59.49 122.86 15.07 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.76 0.824 . . . . 61.1 111.045 -173.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 6' ' ' ILE . . . . . . . . . . . . . 2.9 pp -67.44 140.26 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.304 0.642 . . . . 54.35 111.082 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 7' ' ' ALA . . . . . 0.413 ' HB1' HG22 ' C' ' 131' ' ' VAL . . . -156.23 152.85 28.29 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.642 0.777 . . . . 61.3 109.529 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 8' ' ' LEU . . . . . 0.606 ' HB2' HG11 ' C' ' 131' ' ' VAL . 48.2 mt -62.16 135.51 57.53 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.497 0.719 . . . . 74.5 109.905 177.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.21 -175.38 4.12 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.457 0.703 . . . . 61.23 111.71 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.86 158.97 29.25 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.548 0.739 . . . . 53.44 109.042 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 11' ' ' LEU . . . . . 0.4 HD21 ' HG ' ' C' ' 44' ' ' LEU . 88.9 mt -106.26 97.83 17.4 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 123.027 0.531 . . . . 45.01 110.9 -176.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.01 -13.77 13.93 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 122.58 2.187 . . . . 73.44 111.499 168.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.94 -36.87 83.21 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.0 0.92 . . . . 61.14 109.623 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 86.9 mt 63.53 -159.01 0.31 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.888 1.275 . . . . 74.14 111.248 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -146.34 153.6 40.71 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-O 120.899 0.381 . . . . 71.21 110.317 -174.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 22.0 p -66.33 164.85 27.2 Favored Pre-proline 0 CA--C 1.563 1.449 0 C-N-CA 126.173 1.789 . . . . 35.23 112.423 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 17' ' ' PRO . . . . . 0.658 ' HA ' ' HB3' ' G' ' 21' ' ' ALA . 67.3 Cg_endo -82.55 150.82 14.95 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.537 2.158 . . . . 72.51 114.607 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 18' ' ' VAL . . . . . 0.68 HG23 HD11 ' C' ' 98' ' ' LEU . 55.0 t -76.53 -44.85 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 108.427 -0.953 . . . . 65.14 108.427 164.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 28.8 m -132.41 -67.06 0.67 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.06 -0.973 . . . . 73.25 109.746 174.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 20' ' ' LYS . . . . . 0.577 ' HA ' ' HE3' ' G' ' 20' ' ' LYS . 0.3 OUTLIER -138.32 23.57 2.75 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.151 0.581 . . . . 71.04 110.716 -171.454 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 21' ' ' ALA . . . . . 0.658 ' HB3' ' HA ' ' G' ' 17' ' ' PRO . . . -60.6 -29.67 69.36 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.726 0.81 . . . . 64.53 113.051 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 22' ' ' ARG . . . . . 0.541 ' H ' ' HB3' ' G' ' 17' ' ' PRO . 0.1 OUTLIER -92.51 60.82 3.63 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.486 -0.931 . . . . 74.31 108.486 -179.184 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 70.1 m -54.17 101.58 0.27 Allowed Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 126.012 1.725 . . . . 71.42 112.093 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 24' ' ' PRO . . . . . 0.451 ' HD2' ' HG3' ' A' ' 153' ' ' GLN . 78.2 Cg_endo -75.43 160.24 38.94 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.632 2.222 . . . . 71.23 112.318 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 C--O 1.251 1.183 0 C-N-CA 123.968 0.907 . . . . 54.35 109.292 179.727 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.254 0 N-CA-C 108.773 -0.825 . . . . 71.44 108.773 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -171.22 131.09 0.76 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.864 0.865 . . . . 70.33 109.924 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -37.32 72.37 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.058 0.543 . . . . 53.4 111.662 -177.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 48.7 p -93.84 96.51 9.79 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 108.258 -1.016 . . . . 74.51 108.258 170.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 76.0 p -68.61 -29.12 67.56 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.521 1.128 . . . . 45.34 113.031 -170.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' D' ' 128' ' ' LEU . 29.0 mm -85.31 72.26 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 109.41 -0.589 . . . . 74.22 109.41 -177.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 7' ' ' ALA . . . . . 0.643 ' HA ' HG21 ' D' ' 131' ' ' VAL . . . -176.01 116.18 0.13 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.987 0.915 . . . . 62.55 110.191 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 8' ' ' LEU . . . . . 0.658 HD23 HD21 ' D' ' 42' ' ' LEU . 81.7 mt -75.73 74.27 2.7 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 109.193 -0.669 . . . . 65.32 109.193 171.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.5 100.41 11.88 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.177 0.591 . . . . 72.53 110.8 -173.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 10' ' ' LEU . . . . . 0.417 ' O ' HD22 ' D' ' 44' ' ' LEU . 82.2 mt 65.86 174.32 0.23 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.871 1.268 . . . . 74.3 111.917 176.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -154.29 149.86 21.22 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 109.008 -0.738 . . . . 72.25 109.008 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -45.34 126.39 8.23 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 124.253 3.302 . . . . 62.14 114.698 -174.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 49.3 tp 63.25 -91.95 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.352 1.461 . . . . 71.12 110.668 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 14' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' H' ' 14' ' ' LEU . 0.4 OUTLIER -167.05 28.43 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 106.632 -1.618 . . . . 73.12 106.632 -179.04 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 67.9 t80 58.41 -98.86 0.09 Allowed 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 114.819 -1.082 . . . . 74.45 109.694 -170.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 87.5 m -174.59 122.77 0.37 Allowed Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 126.055 1.742 . . . . 73.14 106.947 -175.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.26 169.07 19.1 Favored 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 122.487 2.125 . . . . 74.43 112.048 172.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 18' ' ' VAL . . . . . 0.513 HG22 HD12 ' D' ' 86' ' ' ILE . 44.7 t -62.3 -45.33 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 108.78 -0.822 . . . . 70.41 108.78 173.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 23.6 m 65.48 -71.96 0.08 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.974 1.71 . . . . 71.05 112.186 174.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -147.93 16.43 1.09 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.069 0.547 . . . . 72.45 110.611 -176.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.4 75.27 1.4 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.853 0.861 . . . . 64.45 111.219 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 22' ' ' ARG . . . . . 0.543 ' HG3' HG23 ' H' ' 23' ' ' THR . 20.3 ptt85 -174.95 -34.15 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.513 1.125 . . . . 74.1 110.267 -175.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 23' ' ' THR . . . . . 0.543 HG23 ' HG3' ' H' ' 22' ' ' ARG . 41.4 p -110.51 126.83 28.05 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.78 0.832 . . . . 55.33 109.519 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.71 135.06 61.44 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.438 2.759 . . . . 62.32 112.73 -171.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 . . . . . 0 CA--C 1.56 1.333 0 C-N-CA 123.579 0.751 . . . . 71.03 111.083 -177.607 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 111.774 0.287 . . . . 71.51 111.774 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.72 ' HA ' ' HB2' ' A' ' 151' ' ' GLU . 32.3 p -137.59 74.23 1.47 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.827 0.822 . . . . 60.44 109.901 -175.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -102.07 74.37 1.44 Allowed 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.261 -0.881 . . . . 71.42 109.776 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -83.43 129.53 34.99 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.519 -0.764 . . . . 72.43 109.413 174.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -71.62 -59.68 2.63 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.741 -0.837 . . . . 73.34 108.741 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -178.51 149.48 0.5 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.373 1.469 . . . . 43.45 108.241 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.2 p -86.46 126.47 34.43 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 109.292 -0.633 . . . . 73.43 109.292 172.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -71.4 149.76 45.65 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.581 -0.896 . . . . 74.34 108.581 169.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.6 tmt? 74.46 155.08 0.16 Allowed 'General case' 0 N--CA 1.485 1.316 0 O-C-N 124.407 1.067 . . . . 74.23 109.587 -174.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.4 m -138.28 120.62 15.91 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.595 -0.69 . . . . 54.25 110.089 -177.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.722 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 4.8 t80 -115.55 133.59 55.89 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.732 1.213 . . . . 74.11 108.283 177.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -152.1 108.44 3.43 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 123.744 0.653 . . . . 72.24 109.501 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.595 HD12 ' HB2' ' C' ' 130' ' ' PRO . 34.5 mt -76.96 125.73 37.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 109.664 -0.495 . . . . 70.0 109.664 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -86.29 -40.32 15.62 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 124.284 0.99 . . . . 72.14 110.113 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -175.38 121.75 0.2 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.489 0.316 . . . . 73.32 110.579 -174.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.6 mt -108.85 135.05 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.79 -0.818 . . . . 71.21 108.79 172.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -164.74 159.4 18.65 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 123.827 0.705 . . . . 74.34 111.784 -172.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.5 p -81.53 115.87 21.04 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.241 -0.89 . . . . 63.31 109.447 173.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -82.19 -25.92 33.83 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.43 -0.581 . . . . 65.32 109.43 174.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.4 t70 -148.38 142.29 25.8 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.167 -0.924 . . . . 74.54 109.676 176.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.557 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 69.1 mt -137.55 142.69 35.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 126.042 1.737 . . . . 64.34 106.617 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.0 t -155.0 135.73 13.58 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.186 0.594 . . . . 64.52 109.465 172.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -135.72 144.68 46.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.252 -1.388 . . . . 71.33 107.252 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -137.18 151.87 49.26 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.803 -0.814 . . . . 74.22 108.803 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.99 79.04 12.17 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 106.937 -1.505 . . . . 73.24 106.937 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.77 -33.93 42.1 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.844 2.363 . . . . 73.33 113.098 -167.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -107.62 24.68 12.52 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.752 0.821 . . . . 74.1 110.281 -176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.613 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -40.88 -62.94 0.86 Allowed Pre-proline 0 CA--C 1.574 1.902 0 CA-C-O 117.547 -1.216 . . . . 65.31 114.245 -167.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 39.1 Cg_exo -59.09 -29.78 91.48 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 122.4 2.067 . . . . 72.1 114.059 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -78.84 -41.54 29.79 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.692 0.797 . . . . 74.23 110.396 -177.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.664 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.2 p -77.36 -20.26 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.714 -1.13 . . . . 45.22 111.784 -161.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -70.97 -22.87 62.14 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.557 0.743 . . . . 71.0 110.923 175.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -83.84 -36.41 23.48 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.503 1.121 . . . . 73.31 109.676 175.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.521 ' HD2' HD13 ' A' ' 68' ' ' LEU . 2.9 tmtp? -67.3 146.98 53.57 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.456 1.502 . . . . 72.44 110.532 -173.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.446 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 7.9 m-20 -58.3 124.99 21.35 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.445 1.098 . . . . 72.01 111.266 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 50.9 t-105 -79.26 82.29 5.43 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.412 0.625 . . . . 74.01 109.733 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -123.24 80.6 52.39 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 108.093 -1.077 . . . . 73.34 108.093 176.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -83.55 124.4 3.58 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.489 2.126 . . . . 60.03 113.718 -168.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -95.9 92.09 6.34 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 106.76 -1.571 . . . . 75.3 106.76 167.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.682 HG21 HG21 ' E' ' 6' ' ' ILE . 16.0 m -79.81 112.41 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 113.911 -1.495 . . . . 55.22 110.965 -172.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 26.3 ttpp -95.56 112.61 24.3 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.71 -1.219 . . . . 74.45 107.71 171.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mp -98.47 107.4 19.85 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.092 -1.077 . . . . 71.45 108.092 -177.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.754 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 3.3 m-20 -104.02 135.34 45.72 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.691 -0.855 . . . . 63.3 108.691 -174.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.441 HD23 HD22 ' E' ' 8' ' ' LEU . 1.2 pp -137.3 145.35 43.34 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.35 0.66 . . . . 73.4 110.001 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.636 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 33.0 t70 -141.66 155.02 45.72 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 123.287 0.635 . . . . 70.31 109.937 -175.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.7 p -105.54 122.78 46.72 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.401 1.081 . . . . 60.24 110.413 -174.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.87 119.93 14.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.806 0.842 . . . . 71.44 109.032 175.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.9 t -131.91 153.28 50.42 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 122.967 0.507 . . . . 73.03 109.789 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' E' ' 22' ' ' ARG . 31.7 t -160.49 143.68 13.45 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.509 0.724 . . . . 51.01 110.318 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.506 ' HB2' ' O ' ' E' ' 20' ' ' LYS . 54.5 tt0 -97.18 117.74 32.06 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.618 -0.882 . . . . 74.35 108.618 173.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 58.4 mt -85.61 -40.7 15.95 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.066 0.546 . . . . 75.03 109.857 177.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.453 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -153.59 176.44 12.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.285 -0.87 . . . . 72.32 110.379 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -69.05 122.8 19.46 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.505 -0.924 . . . . 44.42 108.505 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 74.92 -2.86 2.74 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.616 1.566 . . . . 72.14 112.115 -174.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 60.8 t -111.63 105.38 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.092 0.957 . . . . 72.41 108.698 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -124.95 127.61 47.32 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.967 0.907 . . . . 54.02 109.407 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -102.29 120.9 41.24 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.911 0.884 . . . . 73.11 109.958 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.446 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 43.2 t -102.3 129.17 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.038 -1.468 . . . . 71.4 107.038 171.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.0 t -122.5 120.05 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 108.55 -0.907 . . . . 73.34 108.55 174.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.467 HD22 HG22 ' A' ' 62' ' ' VAL . 1.0 OUTLIER -104.98 112.94 26.25 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.845 -1.168 . . . . 75.34 107.845 177.667 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.636 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 68.3 ttt180 -83.07 97.47 8.79 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.061 -1.459 . . . . 72.01 107.061 175.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.467 HG22 HD22 ' A' ' 60' ' ' LEU . 42.7 t -97.81 135.1 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 107.695 -1.224 . . . . 34.1 107.695 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.754 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 30.9 m -137.64 141.5 41.2 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.515 -0.55 . . . . 74.01 109.515 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 20.7 t -129.31 108.37 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 125.172 1.389 . . . . 44.21 107.337 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.536 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 29.3 m -102.25 138.06 39.69 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.999 -1.111 . . . . 75.23 107.999 175.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.5 106.05 10.28 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.661 -1.237 . . . . 71.21 107.661 173.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 59.0 m -111.13 123.31 49.94 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.836 -0.431 . . . . 71.3 109.836 177.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.521 HD13 ' HD2' ' A' ' 34' ' ' LYS . 12.8 mt -90.54 73.71 6.83 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 107.295 -1.372 . . . . 51.24 107.295 176.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.15 -122.83 6.19 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 110.851 -0.9 . . . . 42.43 110.851 -171.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -86.87 -24.98 24.71 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.661 0.785 . . . . 73.45 109.005 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -77.92 132.7 38.02 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.369 1.068 . . . . 73.11 109.772 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 70.1 m -89.25 133.23 34.54 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.238 0.472 . . . . 72.31 110.753 173.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.664 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.67 -62.61 1.52 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.803 0.841 . . . . 61.34 109.836 170.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -153.34 173.7 15.28 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.188 -0.914 . . . . 62.52 111.472 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.9 tp -133.59 139.95 46.84 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.731 -1.122 . . . . 65.01 108.479 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.401 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 71.4 m -134.69 97.48 3.79 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.917 0.887 . . . . 74.21 110.294 176.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -113.71 118.8 35.33 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.178 0.591 . . . . 63.5 109.738 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.2 t -128.15 113.64 31.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 124.142 0.977 . . . . 71.1 109.282 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.545 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 71.6 mt-30 -84.66 90.05 7.61 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.276 -1.009 . . . . 74.14 108.276 171.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -79.41 102.97 9.01 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.198 -0.91 . . . . 73.21 109.231 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.12 158.47 31.67 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 111.329 -0.708 . . . . 62.32 111.329 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.35 121.14 1.02 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.93 -0.868 . . . . 55.4 110.93 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.9 mt -81.65 120.87 34.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 108.117 -1.068 . . . . 63.13 108.117 171.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.722 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 46.1 m-85 -128.77 119.12 23.97 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.922 -0.77 . . . . 72.31 108.922 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.7 t -84.77 96.22 9.2 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.628 -0.879 . . . . 62.53 108.628 174.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.6 pt -112.58 135.66 51.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 124.518 1.127 . . . . 64.35 109.425 -177.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.34 165.64 34.25 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.444 0.697 . . . . 71.05 110.798 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.26 41.43 79.12 Favored Glycine 0 C--N 1.347 1.178 0 O-C-N 123.965 0.79 . . . . 70.3 111.908 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.552 HD12 HG21 ' E' ' 18' ' ' VAL . 14.9 pt -139.18 131.32 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 124.501 1.12 . . . . 64.52 110.165 -174.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -142.38 159.0 43.1 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.931 0.892 . . . . 72.45 110.209 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.2 -125.28 39.15 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 115.447 0.939 . . . . 64.23 115.447 170.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -78.73 -25.39 44.57 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.013 0.925 . . . . 60.13 111.001 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.24 -42.29 93.51 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.174 0.99 . . . . 73.52 109.216 178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -78.63 -28.72 45.62 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 116.069 -0.514 . . . . 30.21 111.175 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.92 -25.04 65.28 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.225 0.61 . . . . 74.54 110.646 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -82.95 -35.04 26.33 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.274 0.63 . . . . 75.42 110.685 172.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 81.7 m -63.51 -47.66 80.79 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.129 0.572 . . . . 72.24 111.322 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.43 HD23 HG22 ' E' ' 18' ' ' VAL . 0.2 OUTLIER -82.84 -25.06 32.99 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.551 0.741 . . . . 62.03 109.59 177.647 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.45 -21.26 45.14 Favored Glycine 0 C--N 1.353 1.502 0 N-CA-C 115.263 0.865 . . . . 73.12 115.263 -170.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.83 -53.85 0.23 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 117.89 0.845 . . . . 60.33 111.837 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -57.7 -60.21 4.03 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 114.352 -1.294 . . . . 72.05 112.509 -171.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.6 m -74.5 -36.28 2.48 Favored Pre-proline 0 CA--C 1.568 1.661 0 N-CA-C 113.144 0.794 . . . . 74.34 113.144 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -50.83 -38.23 56.88 Favored 'Trans proline' 0 C--N 1.397 3.095 0 C-N-CA 122.767 2.311 . . . . 73.51 113.966 164.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -66.03 -38.87 89.51 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.711 0.804 . . . . 72.51 109.983 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.6 mm -58.84 -34.77 53.29 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 C-N-CA 123.784 0.833 . . . . 71.32 111.145 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 88.5 mt -76.27 -28.99 57.27 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.999 0.92 . . . . 72.34 112.665 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.568 ' HZ ' HD22 ' A' ' 128' ' ' LEU . 36.1 t80 -62.35 -44.28 87.61 Favored Pre-proline 0 CA--C 1.569 1.701 0 CA-C-O 117.806 -1.092 . . . . 55.22 113.811 -171.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.56 -31.79 87.47 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.339 2.026 . . . . 54.24 113.52 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -78.19 -35.34 48.76 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.421 0.688 . . . . 74.23 112.028 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.45 -36.58 71.28 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.641 -0.503 . . . . 71.1 109.641 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.644 HH12 HD12 ' C' ' 105' ' ' ILE . 31.9 ttm180 -60.68 -43.77 97.3 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.557 1.143 . . . . 75.22 110.366 172.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -53.99 -54.31 40.86 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.555 1.142 . . . . 75.3 111.207 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 117' ' ' MET . 48.5 t -66.81 -45.85 77.04 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.586 -1.188 . . . . 54.14 111.297 -174.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.456 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 61.6 mt -60.15 -51.89 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.749 0.82 . . . . 71.02 111.123 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.559 HG21 ' HE2' ' C' ' 109' ' ' TYR . 67.6 m -54.6 -44.19 72.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.884 0.874 . . . . 54.3 111.555 177.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 44.8 t -63.57 -41.5 98.38 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.651 -0.704 . . . . 73.4 111.166 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 113' ' ' CYS . 27.0 mtm -69.86 -37.81 76.22 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.94 0.496 . . . . 54.42 111.65 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.92 -50.62 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.38 0.672 . . . . 73.42 109.839 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.1 t -66.22 -31.35 72.13 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 114.801 -1.09 . . . . 63.33 111.192 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 116' ' ' SER . 33.9 ttm-85 -77.5 -31.73 53.74 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.181 0.992 . . . . 62.12 109.404 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.441 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.8 12.15 57.78 Favored Glycine 0 C--N 1.355 1.595 0 CA-C-N 114.804 -1.089 . . . . 51.51 112.508 172.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.441 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.2 t 68.47 13.33 8.96 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 126.964 2.106 . . . . 50.03 113.852 169.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -81.76 155.44 70.72 Favored Pre-proline 0 CA--C 1.555 1.147 0 N-CA-C 108.705 -0.85 . . . . 74.11 108.705 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.04 163.76 13.54 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 122.892 2.395 . . . . 74.31 112.928 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -57.3 124.26 18.26 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 123.802 0.689 . . . . 70.35 111.315 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 66.0 tp -130.06 106.38 8.59 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.695 1.198 . . . . 65.23 109.098 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -119.15 117.34 28.41 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.163 0.985 . . . . 53.5 108.861 176.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.568 HD22 ' HZ ' ' A' ' 107' ' ' PHE . 2.4 tt -70.99 116.61 11.48 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 108.031 -1.1 . . . . 72.11 108.031 178.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.54 145.45 97.29 Favored Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 123.893 0.877 . . . . 73.25 111.021 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.472 ' HD3' HG13 ' C' ' 13' ' ' ILE . 84.6 Cg_endo -75.96 158.69 38.33 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.203 1.935 . . . . 64.32 112.694 -174.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.413 HG13 ' HB1' ' E' ' 7' ' ' ALA . 1.8 m -128.2 116.16 41.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 114.461 -1.245 . . . . 65.05 108.427 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.511 ' HB3' ' HB3' ' A' ' 135' ' ' ALA . 75.6 m-20 -72.94 82.69 1.22 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.359 0.664 . . . . 61.32 109.749 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -62.0 -53.33 57.03 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.404 0.621 . . . . 73.21 109.528 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.61 -42.92 81.61 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 113.661 -1.609 . . . . 62.42 111.005 -169.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.511 ' HB3' ' HB3' ' A' ' 132' ' ' ASN . . . -63.2 -46.03 88.94 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 123.894 0.746 . . . . 71.45 110.634 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.408 HD22 ' HG ' ' E' ' 10' ' ' LEU . 6.4 tt -62.49 -41.32 98.72 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.738 0.815 . . . . 63.5 109.896 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -63.19 -37.03 85.62 Favored 'General case' 0 C--O 1.211 -0.941 0 O-C-N 123.733 0.646 . . . . 74.44 111.269 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.1 mmt -72.47 -39.47 67.7 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 118.013 0.37 . . . . 73.14 111.22 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -69.29 -19.22 63.9 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 122.885 0.474 . . . . 71.1 111.328 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -90.99 -46.62 8.04 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.064 0.459 . . . . 74.23 110.351 176.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.7 tp -69.67 -43.88 71.62 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.621 1.168 . . . . 61.34 112.468 -170.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -158.45 39.14 0.24 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.238 -0.437 . . . . 71.13 110.36 -163.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -42.92 77.83 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 124.586 1.154 . . . . 75.43 113.31 170.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -174.37 117.63 0.22 Allowed 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.891 1.276 . . . . 73.41 108.18 -173.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -126.48 129.68 49.14 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.801 0.84 . . . . 62.21 109.831 -177.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.44 -42.5 14.32 Favored Glycine 0 C--N 1.344 0.989 0 N-CA-C 110.539 -1.024 . . . . 43.14 110.539 169.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -155.59 172.59 18.02 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.384 0.674 . . . . 75.14 110.984 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -146.28 18.1 1.71 Allowed Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.643 -0.708 . . . . 54.41 112.526 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.47 110.96 10.28 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 123.217 0.607 . . . . 64.31 110.864 177.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.18 148.45 28.46 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.313 1.045 . . . . 72.44 110.213 176.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.72 ' HB2' ' HA ' ' A' ' 2' ' ' SER . 8.5 pt-20 -87.1 74.88 9.54 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 121.884 0.85 . . . . 74.42 110.23 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -67.29 116.02 7.61 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.167 -0.924 . . . . 64.44 110.417 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -86.86 169.44 12.54 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.723 0.809 . . . . 72.42 110.945 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -143.92 153.14 41.99 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.633 -1.247 . . . . 71.21 107.633 170.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' G' ' 12' ' ' PRO . . . . . . . . 0 C--O 1.247 0.951 0 N-CA-C 109.11 -0.7 . . . . 73.14 109.11 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 54.7 mtt . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 121.22 0.533 . . . . 71.41 109.939 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 54.9 p -105.13 -4.68 21.56 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.834 0.854 . . . . 72.21 110.959 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.67 114.88 17.91 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.678 1.191 . . . . 64.23 107.789 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -122.86 130.61 53.08 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.207 0.603 . . . . 64.34 110.592 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -88.22 -176.18 5.3 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.219 1.008 . . . . 73.22 109.564 170.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -151.4 138.49 19.18 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.737 -0.838 . . . . 74.25 108.737 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -142.21 16.86 2.07 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 122.903 0.481 . . . . 54.01 111.294 -173.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -147.97 60.95 1.12 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.522 0.729 . . . . 74.02 110.634 -173.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' B' ' 10' ' ' THR . 0.9 OUTLIER 66.01 165.92 0.19 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 125.067 1.347 . . . . 52.44 110.813 -174.309 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.619 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 94.0 m -145.49 114.81 7.11 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.28 -0.888 . . . . 64.25 108.99 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.613 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 51.5 t80 -131.39 132.69 44.59 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 122.957 0.503 . . . . 74.11 110.258 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -160.21 141.31 12.25 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.159 0.584 . . . . 75.51 110.285 174.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 23.2 mt -82.82 123.76 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.792 -0.818 . . . . 71.12 108.792 172.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -89.71 -49.91 6.37 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.438 -0.578 . . . . 71.12 109.438 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.419 ' HE ' HG21 ' A' ' 122' ' ' THR . 42.2 ttt180 -166.23 135.8 3.21 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.816 -0.629 . . . . 72.5 110.021 -175.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.7 mt -115.22 141.47 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 107.547 -1.279 . . . . 62.02 107.547 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -166.36 147.94 6.59 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.935 0.874 . . . . 72.11 112.369 -173.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.8 m -79.58 122.0 25.96 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.142 -1.39 . . . . 53.43 108.387 172.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.411 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 41.9 mtpt -97.33 -19.09 18.75 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.482 0.713 . . . . 73.23 111.138 -177.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -167.71 142.83 3.81 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.831 0.707 . . . . 71.33 110.377 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 38.7 mm -131.63 142.87 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.79 1.236 . . . . 75.32 108.736 172.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 44.3 t -143.78 110.27 5.5 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.414 1.086 . . . . 71.23 108.159 174.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.557 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 92.0 t80 -128.77 109.98 11.77 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.986 -1.116 . . . . 73.12 107.986 172.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -118.75 127.25 53.37 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.893 -0.781 . . . . 73.45 108.893 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.476 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -112.53 86.4 8.32 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 107.769 -1.197 . . . . 64.5 107.769 176.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -65.94 -43.08 9.94 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.87 2.38 . . . . 64.12 112.648 -168.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -104.26 16.78 25.46 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.098 0.959 . . . . 71.35 110.579 -175.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.476 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -38.73 -64.8 0.44 Allowed Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 115.007 1.484 . . . . 61.5 115.007 -162.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.29 -26.05 49.18 Favored 'Trans proline' 0 C--N 1.389 2.682 0 C-N-CA 121.992 1.794 . . . . 61.21 113.451 -170.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -97.5 -23.24 16.13 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.351 0.661 . . . . 53.4 112.736 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.535 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.3 p -80.58 -18.87 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 117.869 0.304 . . . . 75.24 111.08 -176.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -61.51 -27.58 68.7 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.792 0.837 . . . . 62.0 113.249 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -57.3 -23.25 47.31 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.452 0.701 . . . . 73.13 112.159 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -89.52 89.0 7.65 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.41 1.084 . . . . 71.34 109.974 -176.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.49 87.65 6.21 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.447 -0.797 . . . . 61.42 110.949 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -163.19 173.23 13.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.343 1.057 . . . . 74.44 108.722 167.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -71.83 117.08 54.62 Favored Pre-proline 0 N--CA 1.474 0.739 0 N-CA-C 109.192 -0.67 . . . . 63.51 109.192 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.19 153.82 71.65 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.279 1.986 . . . . 54.43 112.626 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.05 120.42 10.82 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 107.756 -1.201 . . . . 73.5 107.756 170.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 m -116.51 123.03 71.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.435 -0.802 . . . . 74.12 110.219 -167.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.587 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 77.2 tttt -106.98 121.31 44.2 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.66 1.184 . . . . 61.44 107.835 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.795 HD22 HD11 ' B' ' 128' ' ' LEU . 46.5 tp -96.89 137.39 36.04 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.655 -0.869 . . . . 64.25 108.655 169.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -144.01 152.54 41.17 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.22 1.008 . . . . 73.12 109.034 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.613 HD22 HD13 ' F' ' 8' ' ' LEU . 27.7 tp -128.7 157.29 41.79 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.688 0.795 . . . . 73.52 109.102 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.402 ' HB3' ' HD3' ' B' ' 61' ' ' ARG . 29.0 t70 -145.28 140.4 27.77 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.654 -0.869 . . . . 54.52 108.654 170.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 54.7 p -108.84 113.87 27.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.914 0.886 . . . . 52.51 109.401 -172.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.61 132.05 36.62 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.242 1.017 . . . . 62.41 108.692 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.513 ' HB3' ' HE2' ' F' ' 15' ' ' PHE . 59.6 p -147.55 178.87 8.1 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.009 0.433 . . . . 63.44 111.464 174.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.7 p -160.35 137.94 9.6 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.675 1.19 . . . . 41.34 108.91 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -88.63 128.16 35.58 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.209 -0.663 . . . . 73.0 109.209 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 78.2 mt -91.38 -40.09 11.64 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.106 0.563 . . . . 54.33 110.552 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.55 -172.49 2.93 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.332 0.586 . . . . 64.35 110.801 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.75 128.66 37.31 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.358 -1.292 . . . . 74.55 108.289 172.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.562 ' HB3' ' HB2' ' B' ' 87' ' ' ALA . 9.9 m-20 64.81 3.28 1.98 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.367 1.067 . . . . 75.2 113.31 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 91.6 t -120.45 120.19 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.879 0.872 . . . . 72.25 109.226 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.636 ' HB2' HD11 ' B' ' 86' ' ' ILE . 0.4 OUTLIER -129.21 154.54 46.67 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.931 -0.766 . . . . 64.03 108.931 178.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -125.44 108.1 11.31 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.418 -1.697 . . . . 73.23 106.418 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 31.2 m -109.42 139.43 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 122.964 0.506 . . . . 72.23 110.386 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.518 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 31.7 t -120.86 111.8 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.475 1.11 . . . . 42.43 109.128 -176.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.606 HD13 ' HB3' ' B' ' 103' ' ' PRO . 14.5 tp -94.38 100.07 12.16 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.702 -0.851 . . . . 62.32 108.702 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.497 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 70.2 ttt180 -88.62 106.8 18.55 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.161 0.584 . . . . 74.42 109.867 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.81 106.07 19.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.087 -1.079 . . . . 60.42 108.087 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 27.9 m -109.33 138.41 45.73 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.641 0.776 . . . . 72.34 109.895 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 88.4 t -134.33 134.18 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.33 1.052 . . . . 75.43 109.502 -175.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.587 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 62.8 m -109.78 149.2 30.15 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.869 0.868 . . . . 72.01 109.56 170.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.18 137.22 38.92 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.777 0.831 . . . . 44.33 109.176 177.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 11.0 m -137.4 124.31 21.36 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.292 0.637 . . . . 74.23 110.898 -175.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.466 HD12 HG22 ' B' ' 31' ' ' VAL . 47.0 mt -104.34 113.85 27.69 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.992 -0.744 . . . . 72.55 108.992 176.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.09 -110.57 3.31 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 114.987 -1.006 . . . . 33.52 111.859 -172.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -117.33 5.33 12.59 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.945 0.898 . . . . 73.14 109.943 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -125.52 164.65 20.05 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.884 0.474 . . . . 55.31 110.59 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 62.1 m -79.92 122.91 27.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.652 0.781 . . . . 70.42 110.641 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.535 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -70.83 -63.63 1.06 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.311 0.645 . . . . 71.3 109.358 172.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -150.7 167.73 26.48 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 115.066 -0.97 . . . . 72.23 111.977 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 65.4 mt -129.98 113.57 14.74 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.141 -1.8 . . . . 72.21 106.141 175.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.475 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 30.2 t -123.01 130.45 52.82 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 109.518 -0.549 . . . . 74.22 109.518 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -149.55 131.88 15.58 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.757 -0.831 . . . . 73.03 108.757 -170.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' B' ' 113' ' ' CYS . 66.1 t -129.81 144.29 38.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 123.946 0.899 . . . . 74.24 109.005 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.497 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 73.2 mt-30 -118.61 93.61 4.17 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.165 -1.05 . . . . 73.01 108.165 172.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -91.82 100.75 13.38 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.891 -0.595 . . . . 74.12 109.495 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.2 164.06 30.68 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 115.813 -0.63 . . . . 43.23 111.75 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.8 129.48 1.98 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 112.083 -0.407 . . . . 44.4 112.083 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 38.4 mt -85.42 126.85 40.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 108.214 -1.032 . . . . 74.41 108.214 171.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -133.5 144.22 49.27 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.479 0.712 . . . . 71.52 109.723 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 31.5 m -90.41 113.98 26.01 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.179 0.992 . . . . 54.11 108.837 170.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.636 HD11 ' HB2' ' B' ' 56' ' ' TYR . 0.2 OUTLIER -128.09 125.1 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.055 0.942 . . . . 71.14 109.024 178.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.619 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.32 172.96 17.58 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.153 0.427 . . . . 54.33 112.153 -175.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.49 -54.68 3.84 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.525 -0.761 . . . . 75.4 112.056 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 32.5 mm -91.25 157.2 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 124.22 1.008 . . . . 70.13 110.601 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.528 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 30.8 tt0 -161.5 153.66 19.75 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.755 0.822 . . . . 73.35 109.619 173.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 102.6 -136.0 12.58 Favored Glycine 0 C--N 1.352 1.453 0 C-N-CA 123.711 0.672 . . . . 73.35 112.917 -175.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 63.5 m -71.95 -43.24 65.55 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 117.421 0.611 . . . . 72.33 111.552 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -58.51 -32.25 68.64 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.508 0.723 . . . . 71.41 110.555 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.528 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 7.2 tpt -72.1 -44.78 62.69 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.246 -0.888 . . . . 75.15 110.426 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.693 ' HB1' ' HB3' ' F' ' 14' ' ' LEU . . . -63.33 -23.18 67.3 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.011 -0.995 . . . . 71.22 111.424 176.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.533 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 58.1 t-80 -82.82 -20.75 35.08 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.337 1.055 . . . . 64.44 110.874 174.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.7 t -86.11 -67.25 0.82 Allowed 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.993 -0.442 . . . . 63.13 111.314 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.689 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 1.7 pt? -83.94 -14.73 50.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.551 -0.718 . . . . 72.11 111.809 -174.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.83 1.65 55.42 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.376 0.422 . . . . 65.41 113.855 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -143.43 -59.7 0.41 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.438 0.695 . . . . 73.4 109.833 -176.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -71.63 -48.58 46.96 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.215 0.606 . . . . 63.14 112.494 -173.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.689 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 59.2 m -64.35 -43.14 71.4 Favored Pre-proline 0 CA--C 1.56 1.345 0 N-CA-C 112.872 0.693 . . . . 64.33 112.872 -175.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.606 ' HB3' HD13 ' B' ' 60' ' ' LEU . 51.8 Cg_exo -60.12 -30.65 91.88 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 122.191 1.927 . . . . 73.14 113.384 172.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -65.79 -26.89 67.9 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 122.945 0.498 . . . . 63.21 111.641 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 74.2 mt -71.25 -43.71 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.515 0.726 . . . . 74.43 109.49 173.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 99.1 mt -74.13 -23.53 59.3 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.011 -0.995 . . . . 73.14 112.087 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -57.42 -51.9 78.29 Favored Pre-proline 0 CA--C 1.563 1.466 0 CA-C-O 117.696 -1.145 . . . . 71.14 113.42 -173.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.22 -32.04 94.9 Favored 'Trans proline' 0 C--N 1.392 2.854 0 C-N-CA 122.314 2.009 . . . . 54.41 113.7 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.416 ' HE2' HG21 ' D' ' 115' ' ' THR . 33.7 m-85 -72.57 -40.27 66.76 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.552 0.741 . . . . 50.53 110.229 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.79 -37.87 87.48 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.305 0.642 . . . . 61.21 110.491 173.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.412 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 56.8 ttt-85 -69.4 -50.33 46.89 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.415 1.486 . . . . 72.34 111.223 -171.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.55 -37.4 87.17 Favored 'General case' 0 N--CA 1.484 1.225 0 O-C-N 123.898 0.749 . . . . 73.35 109.286 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.473 ' O ' ' HG2' ' B' ' 117' ' ' MET . 28.8 t -64.07 -40.73 96.9 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.371 0.669 . . . . 62.31 112.003 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.477 ' O ' HG23 ' B' ' 118' ' ' VAL . 70.9 mt -61.05 -56.48 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.692 -0.485 . . . . 75.43 109.692 175.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.8 m -61.77 -26.86 68.35 Favored 'General case' 0 CA--C 1.557 1.216 0 O-C-N 123.752 0.658 . . . . 75.45 111.586 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.8 t -71.66 -43.25 66.4 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.726 0.81 . . . . 72.43 110.078 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.6 mmt -71.11 -31.92 68.37 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.538 0.335 . . . . 61.13 110.528 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.477 HG23 ' O ' ' B' ' 114' ' ' ILE . 99.1 t -62.7 -43.22 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 124.068 0.947 . . . . 65.33 109.914 170.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 64.0 m -65.89 -36.42 83.37 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.24 -0.891 . . . . 44.5 111.764 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' B' ' 116' ' ' SER . 68.8 mtt-85 -68.53 -38.16 80.62 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.521 -0.763 . . . . 65.23 109.554 176.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.72 -0.29 79.94 Favored Glycine 0 C--N 1.354 1.571 0 O-C-N 124.026 0.829 . . . . 70.14 113.264 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 73.0 p 61.17 16.52 7.28 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 126.343 1.857 . . . . 51.14 113.831 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -77.09 160.06 76.91 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 123.496 0.718 . . . . 64.14 111.493 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -47.14 146.21 6.73 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 123.748 2.965 . . . . 72.31 114.724 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -58.86 122.59 13.98 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.558 1.143 . . . . 74.24 111.095 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 52.8 tp -138.98 99.26 3.72 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.208 0.603 . . . . 65.33 109.851 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -99.12 131.51 45.1 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.739 0.816 . . . . 71.53 108.886 172.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.795 HD11 HD22 ' B' ' 42' ' ' LEU . 25.6 tp -81.99 152.43 26.7 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.23 0.612 . . . . 65.51 112.067 -174.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.54 146.22 83.31 Favored Pre-proline 0 N--CA 1.482 1.126 0 C-N-CA 123.835 0.854 . . . . 63.4 111.644 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -70.82 119.18 6.13 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.158 2.572 . . . . 53.1 111.15 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.662 HG21 HD12 ' F' ' 8' ' ' LEU . 26.7 m -107.5 110.88 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.892 0.853 . . . . 73.33 108.912 174.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -110.42 88.8 2.85 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.19 -1.041 . . . . 74.02 108.19 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -61.33 -34.21 74.88 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.636 -0.711 . . . . 73.02 110.73 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.74 -54.11 46.97 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.563 1.145 . . . . 64.45 111.255 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.95 -22.65 65.93 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.367 -0.833 . . . . 61.32 111.541 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.51 -53.68 13.06 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 109.125 -0.695 . . . . 74.51 109.125 175.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -69.37 -15.85 63.4 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.108 0.563 . . . . 74.03 111.869 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -63.19 -29.54 70.86 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.105 0.962 . . . . 72.32 111.028 174.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -72.88 -24.8 60.9 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.162 0.585 . . . . 63.14 110.908 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -70.47 -29.2 65.69 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.19 0.596 . . . . 75.43 110.017 173.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 59.0 mt -107.09 19.6 20.2 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.09 0.956 . . . . 71.43 111.039 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -70.28 138.56 51.68 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.523 0.729 . . . . 75.43 111.749 -174.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -115.01 -178.48 3.37 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.521 1.128 . . . . 71.53 111.38 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -105.84 134.85 48.3 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.011 0.924 . . . . 73.3 109.518 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -169.26 -146.21 0.06 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.273 1.429 . . . . 75.3 108.01 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' GLY . . . . . 0.444 ' HA2' ' H ' ' D' ' 3' ' ' GLU . . . 73.85 37.33 51.16 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-N 117.926 0.33 . . . . 72.52 113.923 171.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -81.03 96.22 7.06 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.258 -1.016 . . . . 72.42 108.258 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -107.47 142.64 15.83 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 116.364 -0.38 . . . . 64.34 112.18 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 22.6 p -132.26 139.56 48.3 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.916 0.886 . . . . 70.0 110.236 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.83 -175.14 2.66 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.632 0.773 . . . . 74.13 110.573 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -144.67 157.94 43.99 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.61 0.764 . . . . 63.41 109.446 172.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -128.68 29.29 5.28 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.515 1.126 . . . . 71.31 108.87 -173.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -60.44 114.25 2.85 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.869 0.867 . . . . 72.13 110.826 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -146.97 89.15 1.79 Allowed 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.666 -0.864 . . . . 71.21 108.666 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.168 0 CA-C-N 115.565 -0.743 . . . . 64.51 109.792 178.181 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.645 0 N-CA-C 106.777 -1.564 . . . . 73.41 106.777 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 44.9 m -71.97 -76.12 0.12 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.066 0.854 . . . . 73.52 111.208 -173.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -172.87 -75.56 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.453 -0.573 . . . . 61.14 109.453 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -139.22 150.08 45.1 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.28 1.032 . . . . 62.13 108.429 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -70.89 95.26 1.14 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.071 0.548 . . . . 74.43 109.933 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -75.66 140.35 42.49 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.027 -1.101 . . . . 72.3 108.027 172.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 19.5 p -62.38 97.39 0.09 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.757 0.823 . . . . 50.23 111.491 -176.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 68.9 104.95 0.06 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.864 1.666 . . . . 73.14 110.825 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.407 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 0.0 OUTLIER 66.62 114.03 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 126.017 1.727 . . . . 62.51 111.869 179.076 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 42.6 m -98.28 97.53 8.91 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.034 0.934 . . . . 51.35 109.165 173.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.701 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 14.7 t80 -106.98 125.34 50.88 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.125 -1.065 . . . . 61.14 108.125 176.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -136.46 119.26 16.19 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.014 -0.736 . . . . 71.34 109.014 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.472 HG13 ' HD3' ' A' ' 130' ' ' PRO . 35.5 mt -73.13 128.02 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.936 -0.764 . . . . 60.43 108.936 175.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -92.65 -48.23 6.7 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.149 -0.685 . . . . 53.53 109.149 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -173.22 134.44 0.54 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.92 -0.77 . . . . 75.33 108.92 -169.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 94.5 mt -126.27 142.23 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 108.017 -1.105 . . . . 54.41 108.017 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.554 ' HB3' HG23 ' D' ' 122' ' ' THR . 26.6 p90 -173.68 167.3 4.51 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 123.942 0.776 . . . . 65.35 110.488 -174.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -86.57 119.07 26.43 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.84 -1.073 . . . . 65.31 109.062 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.7 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 10.8 mmmm -70.44 -45.8 65.12 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.999 -1.112 . . . . 53.43 107.999 169.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.606 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 5.1 t70 -139.53 147.83 41.77 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 113.776 -1.556 . . . . 75.55 110.258 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.4 mt -137.94 149.08 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.977 1.711 . . . . 60.25 107.24 174.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.4 t -162.04 150.3 14.91 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.427 0.632 . . . . 71.43 110.614 172.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 91.6 t80 -143.65 146.18 33.04 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 107.029 -1.471 . . . . 53.31 107.029 170.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -149.35 115.87 5.86 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.28 1.032 . . . . 64.25 109.011 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.05 92.01 12.21 Favored Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 105.649 -1.982 . . . . 71.04 105.649 165.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -57.25 -49.93 12.55 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.277 2.652 . . . . 65.23 112.513 -171.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -106.73 39.16 1.9 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.504 0.722 . . . . 64.35 109.488 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.545 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -37.86 -58.56 1.35 Allowed Pre-proline 0 CA--C 1.571 1.75 0 N-CA-C 115.183 1.549 . . . . 62.14 115.183 -171.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.419 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 20.3 Cg_exo -60.56 -43.29 33.93 Favored 'Trans proline' 0 C--N 1.387 2.6 0 CA-C-N 122.198 1.821 . . . . 65.51 112.418 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -69.13 -32.44 71.81 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.14 -0.937 . . . . 75.21 112.258 -175.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.724 HG21 ' HA ' ' C' ' 73' ' ' ALA . 12.4 p -79.38 -27.47 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 122.528 0.331 . . . . 62.44 111.769 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -66.69 -23.08 66.08 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 112.114 0.413 . . . . 75.52 112.114 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -95.55 15.58 19.43 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.392 0.677 . . . . 63.43 111.841 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.792 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -91.52 160.83 15.23 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.369 0.668 . . . . 70.13 110.451 177.239 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -69.01 130.26 42.28 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.833 0.853 . . . . 71.35 108.784 162.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -84.55 102.34 12.79 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.913 0.485 . . . . 75.31 110.607 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -155.37 77.4 4.85 Favored Pre-proline 0 N--CA 1.476 0.83 0 N-CA-C 108.674 -0.861 . . . . 71.13 108.674 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -88.31 148.65 6.52 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.71 2.273 . . . . 71.31 113.819 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -86.52 99.34 11.61 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 107.013 -1.477 . . . . 70.43 107.013 159.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.513 ' HB ' HG21 ' G' ' 6' ' ' ILE . 35.3 t -78.54 101.04 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 108.591 -0.892 . . . . 75.45 108.591 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.556 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 62.3 mttm -99.26 105.38 17.4 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.899 -0.778 . . . . 72.11 108.899 -176.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.406 HD13 HD21 ' C' ' 128' ' ' LEU . 42.5 tp -83.64 130.02 34.97 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 109.134 -0.691 . . . . 54.3 109.134 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -129.19 139.74 51.77 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.326 1.45 . . . . 73.44 108.284 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.33 147.59 50.25 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.844 0.458 . . . . 62.23 110.702 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 1.5 t70 -130.09 147.49 51.84 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.117 1.367 . . . . 71.22 108.693 173.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 87.9 m -111.51 114.17 27.08 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.709 0.804 . . . . 73.04 109.643 -174.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -118.36 139.9 50.66 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.29 1.036 . . . . 52.21 108.317 173.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.47 ' HB2' ' OH ' ' C' ' 56' ' ' TYR . 64.8 p -154.26 143.76 21.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.172 -0.33 . . . . 73.53 111.179 -172.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 27.8 p -159.0 128.01 5.4 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 123.923 0.764 . . . . 73.11 109.808 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -80.1 138.27 36.92 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.974 -0.75 . . . . 73.51 108.974 173.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.566 HD11 HD12 ' C' ' 83' ' ' ILE . 49.1 mt -105.48 -38.9 6.3 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.004 0.522 . . . . 73.32 110.712 -176.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.69 -170.55 2.79 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.379 0.672 . . . . 71.31 110.957 -177.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -70.39 112.25 6.56 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.261 -0.881 . . . . 62.2 109.785 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 71.24 -1.42 2.74 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 125.396 1.479 . . . . 73.13 112.944 -175.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.559 HG21 ' HA ' ' E' ' 1' ' ' MET . 66.2 t -102.31 120.02 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.096 -0.705 . . . . 74.23 109.096 175.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.47 ' OH ' ' HB2' ' C' ' 48' ' ' SER . 51.0 t80 -138.62 132.07 30.39 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.104 -1.073 . . . . 70.35 108.104 -174.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.501 ' HB2' HD11 ' C' ' 51' ' ' LEU . 39.9 tt0 -94.48 117.67 30.48 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.384 -0.825 . . . . 71.12 109.045 173.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 35.7 m -96.65 130.14 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.625 -1.25 . . . . 70.23 107.625 168.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 61.9 t -124.02 125.34 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.85 -1.167 . . . . 63.43 107.85 172.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 tp -125.9 116.41 21.47 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.013 -1.106 . . . . 73.24 108.013 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.506 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.7 ttm180 -79.12 122.25 26.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.772 -1.103 . . . . 75.14 109.036 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 11.4 t -100.81 129.06 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.019 -1.474 . . . . 72.23 107.019 171.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 62.8 m -131.95 110.53 10.83 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.089 -1.078 . . . . 75.11 108.089 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 85.1 t -101.75 112.33 34.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.578 -1.192 . . . . 62.22 108.231 -175.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.556 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 20.7 m -97.92 141.15 31.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.014 -1.106 . . . . 73.31 108.014 173.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.33 107.5 6.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 106.233 -1.766 . . . . 55.21 106.233 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 46.2 m -127.16 146.34 50.43 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.611 -0.514 . . . . 70.41 109.611 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.792 HD13 ' HG2' ' C' ' 34' ' ' LYS . 13.1 mt -110.41 35.59 3.39 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.661 1.584 . . . . 65.23 108.2 -173.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.88 -109.68 2.99 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 110.096 -1.202 . . . . 72.12 110.096 -169.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.93 -30.01 18.13 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.869 0.868 . . . . 73.13 110.314 176.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -73.52 103.07 4.02 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.726 0.81 . . . . 74.2 109.77 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 92.6 m -73.26 118.87 16.73 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.544 -0.91 . . . . 75.23 108.544 170.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.724 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -67.68 -57.75 5.85 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 124.464 1.102 . . . . 51.34 109.11 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -156.89 171.65 20.05 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.663 -1.153 . . . . 63.34 111.656 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -139.44 140.02 37.21 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 104.839 -2.282 . . . . 74.44 104.839 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.484 ' SG ' HG23 ' C' ' 114' ' ' ILE . 38.3 t -147.54 112.43 5.42 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.964 -0.754 . . . . 72.21 108.964 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -121.8 116.46 24.5 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.708 0.803 . . . . 75.52 110.147 -171.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 55.5 t -125.06 115.45 44.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.955 0.902 . . . . 73.41 109.357 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.606 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.1 mt-30 -90.96 97.85 11.43 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.807 -0.812 . . . . 73.25 108.807 173.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.671 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 67.1 tp60 -86.98 117.32 25.62 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.339 0.655 . . . . 73.21 109.766 -177.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.3 146.35 18.23 Favored Glycine 0 C--N 1.342 0.909 0 O-C-N 123.813 0.695 . . . . 71.42 111.831 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.411 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -143.4 116.35 0.99 Allowed Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.754 -0.538 . . . . 43.5 111.754 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.566 HD12 HD11 ' C' ' 51' ' ' LEU . 7.7 mm -82.97 122.16 37.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 107.945 -1.131 . . . . 64.02 107.945 174.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.413 ' HD2' ' HA ' ' C' ' 13' ' ' ILE . 54.7 m-85 -138.26 132.16 31.3 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.426 0.691 . . . . 74.24 109.956 -176.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 21.8 p -95.22 103.97 15.85 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 108.17 -1.048 . . . . 72.14 108.17 169.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.525 HD13 ' H ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -124.15 137.04 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 124.144 0.977 . . . . 74.4 111.459 -171.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.67 173.38 11.96 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.352 1.061 . . . . 73.41 110.934 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 116.89 -49.03 0.88 Allowed Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.941 -0.572 . . . . 63.21 111.74 172.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 30.0 pt -92.31 170.17 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.488 0.715 . . . . 71.12 110.284 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -146.17 148.47 32.58 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.975 0.51 . . . . 73.24 111.226 -168.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.51 -133.32 23.46 Favored Glycine 0 C--N 1.35 1.33 0 O-C-N 123.745 0.653 . . . . 74.3 114.222 172.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.4 p -66.69 -18.55 65.43 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.111 0.964 . . . . 73.2 112.229 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -68.35 -43.22 77.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.196 0.598 . . . . 70.11 110.144 172.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 15.5 ttt -76.72 -31.57 57.25 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.601 -0.727 . . . . 74.53 110.55 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.19 -40.23 90.27 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.373 0.669 . . . . 63.21 110.558 172.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -59.56 -41.75 90.87 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.473 1.109 . . . . 74.5 111.006 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 50.4 t -63.79 -54.27 37.73 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.539 0.524 . . . . 64.33 110.223 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.534 HD11 HG23 ' G' ' 18' ' ' VAL . 90.0 mt -63.03 -36.36 83.31 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.332 0.653 . . . . 72.24 112.036 -177.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.6 11.28 66.7 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.497 -0.613 . . . . 73.01 114.304 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.65 -58.02 0.1 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 117.555 0.677 . . . . 43.11 111.999 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -74.51 -48.4 27.37 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.662 0.385 . . . . 63.24 112.002 -172.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.701 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 41.9 m -60.51 -47.2 96.88 Favored Pre-proline 0 CA--C 1.563 1.458 0 C-N-CA 123.97 0.908 . . . . 75.44 112.11 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.87 -12.07 19.87 Favored 'Trans proline' 0 C--N 1.395 3.024 0 C-N-CA 122.026 1.818 . . . . 64.52 113.608 172.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 104' ' ' ASN . . . . . 0.506 ' HA ' ' CD2' ' C' ' 107' ' ' PHE . 59.7 t30 -71.76 -32.66 67.93 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.434 0.635 . . . . 73.13 109.914 173.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.644 HD12 HH12 ' A' ' 111' ' ' ARG . 30.0 mm -65.54 -30.84 51.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 115.143 -0.935 . . . . 73.33 109.822 170.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.411 HD21 ' HA3' ' C' ' 82' ' ' GLY . 65.5 mt -88.14 -22.64 23.97 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.887 0.875 . . . . 71.14 113.208 -175.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.506 ' CD2' ' HA ' ' C' ' 104' ' ' ASN . 11.8 m-85 -55.38 -48.36 96.48 Favored Pre-proline 0 N--CA 1.49 1.536 0 CA-C-O 117.242 -1.361 . . . . 75.12 113.218 -177.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -54.46 -39.53 87.43 Favored 'Trans proline' 0 C--N 1.39 2.75 0 C-N-CA 122.881 2.387 . . . . 73.41 114.461 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.559 ' HE2' HG21 ' A' ' 115' ' ' THR . 73.9 m-85 -70.04 -49.33 52.34 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.214 0.605 . . . . 72.34 110.901 -176.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.671 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -67.75 -31.97 72.25 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 115.615 -0.72 . . . . 73.42 111.081 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 26.6 ttt-85 -59.21 -54.19 49.76 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.675 1.19 . . . . 71.14 110.328 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -69.33 -29.05 66.79 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.767 0.667 . . . . 64.41 110.425 -177.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 42.7 t -70.22 -38.39 75.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.186 0.594 . . . . 71.3 110.813 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.484 HG23 ' SG ' ' C' ' 76' ' ' CYS . 87.3 mt -69.54 -49.09 62.24 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.157 0 C-N-CA 123.259 0.624 . . . . 65.33 109.742 174.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 90.5 m -63.25 -33.08 74.72 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.012 0.925 . . . . 75.25 110.977 -175.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 41.8 t -64.62 -46.67 81.6 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 115.349 -0.841 . . . . 74.31 109.092 172.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.49 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.98 -36.43 84.38 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.895 1.278 . . . . 62.4 112.929 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' C' ' 114' ' ' ILE . 97.4 t -65.56 -44.54 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.093 0.957 . . . . 72.14 108.774 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 30.6 t -66.13 -33.62 76.19 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.162 -1.381 . . . . 61.32 111.496 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -70.94 -32.2 69.01 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.648 0.779 . . . . 72.13 109.453 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.3 9.06 76.73 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 123.717 0.636 . . . . 75.03 112.947 174.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 46.0 p 58.19 30.62 19.67 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 126.143 1.777 . . . . 74.15 114.016 174.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -93.02 147.27 33.54 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 108.81 -0.811 . . . . 74.33 108.81 172.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.34 159.76 5.63 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 123.386 2.724 . . . . 62.01 113.742 174.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -47.39 125.59 8.36 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.797 1.239 . . . . 65.31 112.934 -176.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.81 91.25 3.31 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.327 -1.36 . . . . 75.42 107.327 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -116.62 122.18 43.86 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.407 1.083 . . . . 63.12 108.168 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.406 HD21 HD13 ' C' ' 42' ' ' LEU . 6.7 mp -69.11 145.94 52.97 Favored 'General case' 0 C--O 1.245 0.832 0 O-C-N 123.406 0.441 . . . . 61.13 110.479 177.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.44 ' HA ' ' HD3' ' C' ' 130' ' ' PRO . . . -72.8 136.22 80.33 Favored Pre-proline 0 CA--C 1.552 1.041 0 O-C-N 124.107 0.879 . . . . 73.01 110.013 177.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.595 ' HB2' HD12 ' A' ' 13' ' ' ILE . 11.1 Cg_exo -69.22 100.7 0.77 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 123.173 2.582 . . . . 52.15 113.725 -170.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.0 t -101.04 108.62 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 108.051 -1.092 . . . . 65.51 108.051 170.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.404 HD22 ' H ' ' C' ' 135' ' ' ALA . 1.9 t30 -81.41 92.61 6.46 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 107.091 -1.448 . . . . 71.5 107.091 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -65.43 -35.91 82.33 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.057 0.943 . . . . 71.42 112.642 -161.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -70.1 -41.1 74.46 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.516 0.727 . . . . 73.55 111.589 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.404 ' H ' HD22 ' C' ' 132' ' ' ASN . . . -62.66 -33.36 74.9 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.883 0.739 . . . . 54.21 111.181 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 7.7 tt -54.14 -47.45 71.9 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.957 0.903 . . . . 71.41 110.477 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -80.8 -26.25 37.28 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.438 0.695 . . . . 71.23 111.816 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -77.38 -36.59 53.36 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.719 0.808 . . . . 65.23 111.414 -175.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -55.14 -35.52 64.79 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.053 0.941 . . . . 73.22 111.685 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -59.65 -86.14 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.367 0 O-C-N 123.891 0.745 . . . . 73.44 110.349 172.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 50.7 tp 57.64 -81.5 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.216 1.406 . . . . 65.12 112.759 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -163.28 -172.93 3.16 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.408 1.083 . . . . 62.22 109.914 -172.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -94.39 -27.05 16.26 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.592 0.757 . . . . 60.24 111.746 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -55.41 116.9 3.12 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 124.543 1.137 . . . . 64.42 112.165 -170.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.41 150.71 30.76 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.29 1.036 . . . . 44.03 109.825 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.5 174.05 37.56 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 111.188 -0.765 . . . . 74.42 111.188 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -103.12 156.88 17.39 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.572 0.749 . . . . 74.42 111.452 -172.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -163.49 78.36 0.15 Allowed Glycine 0 C--N 1.342 0.872 0 N-CA-C 110.791 -0.924 . . . . 74.04 110.791 -175.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 8.8 t -156.74 134.82 11.16 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.34 0.656 . . . . 44.1 110.111 -177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -166.8 113.58 0.81 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.395 1.078 . . . . 73.52 108.365 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -147.34 160.78 42.14 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.489 0.716 . . . . 73.32 110.651 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -158.43 -81.29 0.06 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.141 0.976 . . . . 64.32 108.424 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 173.36 127.79 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.799 1.64 . . . . 74.11 107.082 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.67 -51.93 65.29 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.995 0.518 . . . . 52.12 109.711 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 1.398 0 C-N-CA 124.667 1.187 . . . . 64.43 110.962 179.768 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptt? . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.517 -0.549 . . . . 73.11 109.517 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 20.9 p 173.33 102.6 0.01 OUTLIER 'General case' 0 C--N 1.363 1.159 0 C-N-CA 124.629 1.172 . . . . 74.25 110.063 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 3' ' ' GLU . . . . . 0.475 ' HB2' ' SD ' ' D' ' 138' ' ' MET . 1.2 pm0 -148.53 -179.36 6.9 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.914 0.885 . . . . 64.44 110.913 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -66.42 147.66 52.98 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 112.457 0.54 . . . . 74.3 112.457 -174.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -153.81 153.85 32.91 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.466 1.106 . . . . 61.25 109.369 -175.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -63.64 97.68 0.16 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.462 0.705 . . . . 71.23 109.494 173.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.406 HG22 ' H ' ' D' ' 9' ' ' MET . 34.2 m -142.35 160.95 39.25 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.966 0.906 . . . . 72.3 109.842 -174.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.49 -4.72 6.27 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.992 1.317 . . . . 73.2 112.963 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.406 ' H ' HG22 ' D' ' 7' ' ' THR . 1.1 tmt? -28.58 125.36 0.1 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 126.585 1.954 . . . . 71.34 113.27 170.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 28.7 m -112.81 146.71 38.37 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.642 0.777 . . . . 72.53 110.579 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.581 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 57.6 t80 -154.14 99.85 2.27 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.703 1.201 . . . . 75.22 107.837 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -117.48 115.43 25.15 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.024 -0.732 . . . . 74.44 109.024 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.442 HG21 HD11 ' D' ' 16' ' ' ILE . 28.5 mt -75.23 121.64 27.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.23 -1.026 . . . . 71.32 108.23 176.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -96.45 -26.94 15.12 Favored 'General case' 0 C--O 1.245 0.819 0 O-C-N 123.417 0.448 . . . . 75.12 111.347 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -171.72 136.04 0.91 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 117.705 0.23 . . . . 55.34 111.364 -168.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.455 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.9 mp -120.5 133.4 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 107.107 -1.442 . . . . 54.25 107.107 174.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -160.6 173.03 16.11 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 122.582 1.182 . . . . 75.42 112.53 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -111.38 120.42 42.14 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 113.613 -1.631 . . . . 61.33 108.136 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.545 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 42.6 mtpt -87.93 -24.07 23.72 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.275 0.56 . . . . 61.41 109.552 176.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 10.3 t70 -154.57 143.3 20.82 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.124 -1.398 . . . . 64.21 109.138 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.498 HG23 HG22 ' D' ' 78' ' ' VAL . 47.1 mt -139.96 150.28 21.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 106.539 -1.652 . . . . 75.25 106.539 173.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -157.56 144.84 18.42 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.571 0.701 . . . . 73.5 110.739 169.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.489 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.2 t80 -140.17 128.64 22.76 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 105.872 -1.899 . . . . 72.32 105.872 173.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.592 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.7 mt-10 -136.89 123.44 20.93 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.441 -0.948 . . . . 75.43 108.441 -176.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.06 86.62 57.64 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 107.605 -1.257 . . . . 63.44 107.605 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.67 -36.78 10.41 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 122.676 2.25 . . . . 75.43 112.431 -175.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -96.95 16.76 18.54 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.867 0.867 . . . . 74.54 110.43 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.7 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -43.66 -64.93 0.65 Allowed Pre-proline 0 CA--C 1.561 1.386 0 N-CA-C 115.336 1.606 . . . . 74.14 115.336 -162.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.69 -12.77 22.24 Favored 'Trans proline' 0 C--N 1.386 2.542 0 CA-C-N 122.626 1.973 . . . . 63.11 113.348 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -84.58 -40.83 17.07 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.119 1.368 . . . . 72.44 110.856 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.481 HG22 HD12 ' D' ' 68' ' ' LEU . 9.9 p -83.72 -17.21 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.123 0 CA-C-N 115.886 -0.597 . . . . 64.31 111.446 -170.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -62.42 -17.62 59.72 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 113.025 0.75 . . . . 74.11 113.025 173.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -65.02 -11.95 44.95 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.369 0.668 . . . . 73.32 110.951 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.4 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 87.2 mttt -109.79 92.13 3.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.303 1.441 . . . . 53.42 109.194 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -90.9 92.5 8.8 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.844 0.457 . . . . 51.42 109.873 177.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 30.7 p90 -162.31 176.87 10.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.69 0.796 . . . . 73.13 109.448 168.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -69.9 114.34 24.3 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 123.689 0.796 . . . . 55.42 110.342 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.539 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 16.4 Cg_exo -68.08 134.98 33.34 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 123.104 2.536 . . . . 72.44 111.096 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.68 122.25 16.83 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.262 0.625 . . . . 73.35 110.033 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 35.8 t -97.87 114.93 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.631 0.773 . . . . 72.3 110.894 -168.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -104.39 152.63 22.06 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.186 -1.413 . . . . 73.03 107.186 166.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 pp -140.34 156.07 46.57 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.025 0.53 . . . . 73.42 110.967 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -150.35 152.61 34.68 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.777 0.831 . . . . 72.35 108.89 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 87.9 mt -126.92 146.92 50.13 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.483 0.713 . . . . 73.5 110.838 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.56 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 7.2 t70 -136.84 140.82 42.7 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.738 1.215 . . . . 51.54 108.19 172.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 58.0 m -102.03 142.91 32.57 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.401 0.68 . . . . 53.21 109.655 -173.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.628 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -155.04 155.25 33.78 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.08 0.952 . . . . 62.02 109.032 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 77.3 p -174.62 178.44 1.92 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.007 0.432 . . . . 71.15 111.272 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 73.0 p -168.77 146.58 3.92 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.491 -1.231 . . . . 72.51 108.935 174.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -82.66 128.54 34.44 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.879 -0.786 . . . . 73.24 108.879 171.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.627 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.5 mt -101.28 -34.5 9.62 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.024 0.53 . . . . 44.33 110.18 -175.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.54 -175.89 3.72 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.318 1.047 . . . . 62.13 110.131 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.7 114.51 7.98 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.642 -1.163 . . . . 65.13 109.306 173.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 68.46 18.77 8.95 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.151 1.381 . . . . 73.0 112.461 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 94.7 t -124.16 124.69 69.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 C-N-CA 124.927 1.291 . . . . 75.44 107.609 168.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.691 ' HB2' HG13 ' H' ' 18' ' ' VAL . 21.3 t80 -144.66 137.72 26.82 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.625 -0.509 . . . . 74.51 109.625 -176.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.627 ' HB2' HD11 ' D' ' 51' ' ' LEU . 27.3 tt0 -91.9 133.53 35.59 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.645 -0.707 . . . . 64.12 109.972 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 78.4 t -111.86 118.28 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.678 -1.23 . . . . 72.15 107.678 172.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.628 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 14.7 t -114.61 131.77 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.21 -1.033 . . . . 62.04 108.21 173.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.416 HD12 ' O ' ' D' ' 45' ' ' ASP . 18.8 tp -130.69 123.5 29.48 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.229 -0.656 . . . . 61.25 109.229 174.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.56 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 14.1 ttm180 -83.53 104.77 13.93 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.702 -0.851 . . . . 71.52 108.702 176.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 70.4 t -89.12 129.39 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 107.979 -1.119 . . . . 53.35 107.979 173.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 20.7 m -121.75 142.6 50.03 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.289 -0.634 . . . . 72.33 109.289 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 69.5 t -139.44 100.45 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 126.04 1.736 . . . . 55.13 107.307 -174.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 62.5 m -99.69 112.33 24.57 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.757 -0.831 . . . . 73.53 108.757 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -115.42 141.05 48.57 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.586 0.754 . . . . 61.1 109.972 -173.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 14.4 p -147.7 128.79 14.59 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 123.526 0.516 . . . . 60.53 111.906 -174.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.481 HD12 HG22 ' D' ' 31' ' ' VAL . 41.2 mt -96.93 114.81 26.46 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 124.758 1.223 . . . . 62.34 108.661 175.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.86 -121.09 8.38 Favored Glycine 0 C--N 1.341 0.858 0 O-C-N 123.737 0.648 . . . . 64.44 112.106 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.07 5.59 22.23 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.177 0.591 . . . . 75.43 111.444 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 71' ' ' GLU . . . . . 0.4 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 10.9 pt-20 -122.37 162.62 21.24 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.22 0.608 . . . . 65.35 109.727 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 58.8 m -69.65 132.67 46.54 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.457 0.703 . . . . 65.04 111.284 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.482 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -84.95 -68.93 0.69 Allowed 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.414 -1.328 . . . . 62.4 107.414 172.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 74' ' ' PHE . . . . . 0.456 ' HZ ' HD22 ' D' ' 126' ' ' LEU . 51.5 p90 -149.83 167.28 27.0 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.654 -1.157 . . . . 75.32 110.657 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.592 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 77.5 mt -134.49 112.42 10.9 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.794 1.238 . . . . 70.41 108.269 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.537 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 10.6 m -114.81 133.32 56.04 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.189 0.996 . . . . 73.51 108.782 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -152.62 118.42 5.4 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.196 -1.409 . . . . 63.14 107.196 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 78' ' ' VAL . . . . . 0.498 HG22 HG23 ' D' ' 21' ' ' ILE . 80.0 t -130.09 122.17 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.989 0.916 . . . . 74.32 108.777 -175.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.611 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.9 mt-30 -88.61 87.49 7.28 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.376 -0.972 . . . . 74.41 108.376 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 67.3 tp60 -80.46 110.9 16.36 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.115 -1.402 . . . . 72.13 108.569 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.36 144.55 18.34 Favored Glycine 0 N--CA 1.469 0.887 0 N-CA-C 111.471 -0.651 . . . . 72.21 111.471 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.61 138.3 8.04 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 117.038 0.419 . . . . 71.53 112.199 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.6 mt -88.39 122.86 40.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 108.203 -1.036 . . . . 74.32 108.203 173.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -128.64 156.02 44.07 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.389 0.675 . . . . 71.0 109.253 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 48.8 m -115.36 102.12 9.55 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.424 -0.954 . . . . 71.24 108.424 175.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.742 ' HB ' HG21 ' H' ' 18' ' ' VAL . 3.6 mp -108.05 130.49 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 108.812 -0.81 . . . . 73.2 108.812 -176.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.81 166.9 28.09 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.868 0.867 . . . . 40.42 110.385 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.44 21.71 74.61 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.452 -0.795 . . . . 64.11 114.094 173.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.421 HG22 ' N ' ' D' ' 90' ' ' GLU . 17.5 mt -125.22 157.29 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.458 0.703 . . . . 74.22 110.47 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.421 ' N ' HG22 ' D' ' 89' ' ' ILE . 29.6 mt-10 -135.0 151.84 51.19 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.844 1.257 . . . . 65.42 110.213 172.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 91' ' ' GLY . . . . . 0.43 ' O ' ' HB1' ' H' ' 21' ' ' ALA . . . 70.58 -145.79 41.0 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 116.05 1.18 . . . . 72.31 116.05 168.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 4.3 p -74.51 -10.42 59.54 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.208 1.003 . . . . 74.12 111.711 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -30.86 71.56 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.808 0.843 . . . . 72.43 109.426 172.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.462 ' SD ' ' HB2' ' H' ' 21' ' ' ALA . 56.9 ttm -77.73 -39.04 45.73 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.883 0.473 . . . . 75.24 109.818 174.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 95' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' H' ' 14' ' ' LEU . . . -58.69 -31.49 68.27 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.238 0.542 . . . . 75.22 111.008 171.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -70.82 -48.9 51.57 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.471 1.108 . . . . 73.22 110.572 174.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 50.9 t -59.67 -46.29 89.48 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.047 0.539 . . . . 60.21 110.867 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.486 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 7.3 mp -83.89 -18.99 35.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.337 0.655 . . . . 62.42 111.96 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.38 -1.74 60.63 Favored Glycine 0 N--CA 1.476 1.314 0 CA-C-O 119.992 -0.338 . . . . 60.31 113.564 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.525 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -140.34 -65.22 0.46 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.887 0.475 . . . . 51.3 110.967 -176.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -73.93 -40.12 63.33 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.828 0.677 . . . . 73.05 112.828 -170.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.581 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 51.5 m -69.45 -45.91 27.05 Favored Pre-proline 0 CA--C 1.559 1.3 0 CA-C-O 118.881 -0.581 . . . . 75.23 112.213 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.52 -18.93 28.94 Favored 'Trans proline' 0 C--N 1.393 2.892 0 C-N-CA 121.66 1.573 . . . . 70.14 112.412 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 104' ' ' ASN . . . . . 0.454 ' HA ' ' HD2' ' D' ' 107' ' ' PHE . 35.4 t-20 -64.19 -31.12 72.2 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.463 0.705 . . . . 74.03 109.992 175.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.4 mm -68.24 -33.44 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.566 0.746 . . . . 73.51 110.277 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 79.5 mt -81.35 -25.66 36.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.666 0.786 . . . . 73.43 112.664 -173.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 107' ' ' PHE . . . . . 0.454 ' HD2' ' HA ' ' D' ' 104' ' ' ASN . 41.0 m-85 -64.06 -42.71 71.03 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 114.255 1.206 . . . . 71.13 114.255 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.27 -39.81 85.12 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 122.409 2.073 . . . . 63.52 113.329 172.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -80.59 -32.25 36.55 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.758 0.823 . . . . 73.11 112.045 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.3 -53.03 50.01 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.836 -0.801 . . . . 73.43 108.836 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.42 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 37.4 ttp180 -55.07 -46.9 75.45 Favored 'General case' 0 C--O 1.211 -0.937 0 O-C-N 124.61 1.194 . . . . 72.02 111.313 177.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -64.69 -45.63 85.79 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.217 0.607 . . . . 71.32 111.086 -175.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.408 ' O ' ' HG3' ' D' ' 117' ' ' MET . 44.7 t -57.72 -45.97 85.06 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.413 0.685 . . . . 61.43 110.456 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.537 HD13 HG21 ' D' ' 64' ' ' VAL . 93.4 mt -62.79 -52.18 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.755 -1.111 . . . . 63.31 111.101 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.416 HG21 ' HE2' ' B' ' 109' ' ' TYR . 96.8 m -56.13 -41.03 74.69 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.891 1.277 . . . . 60.22 111.119 -177.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 30.6 t -66.72 -43.45 84.23 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.621 -1.172 . . . . 61.24 109.818 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.432 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 74.4 mtm -65.7 -33.03 74.93 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.088 0.555 . . . . 72.4 111.874 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.513 HG23 ' O ' ' D' ' 114' ' ' ILE . 76.4 t -64.68 -45.71 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.432 1.093 . . . . 60.24 109.945 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 82.5 p -75.58 -28.36 58.92 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 115.503 -0.771 . . . . 54.45 111.053 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' D' ' 116' ' ' SER . 78.0 mtt-85 -72.63 -29.11 63.19 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.374 0.67 . . . . 72.04 109.805 174.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.63 9.64 75.17 Favored Glycine 0 C--N 1.353 1.494 0 O-C-N 123.849 0.718 . . . . 75.34 112.29 173.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.554 HG23 ' HB3' ' C' ' 17' ' ' TYR . 44.8 p 60.06 20.01 9.19 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 126.533 1.933 . . . . 54.42 114.476 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -82.19 155.24 69.72 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.418 0.687 . . . . 74.45 109.66 171.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.01 132.4 49.27 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.642 2.228 . . . . 44.14 111.221 174.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -49.76 130.47 21.2 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.195 1.398 . . . . 72.14 112.499 -174.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.456 HD22 ' HZ ' ' D' ' 74' ' ' PHE . 17.8 tp -117.51 96.44 5.4 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.908 0.483 . . . . 74.3 109.783 -172.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -99.9 104.45 16.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.579 0.752 . . . . 72.33 109.245 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.42 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 6.6 mp -69.92 115.39 9.09 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.293 0.637 . . . . 63.42 109.813 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.73 126.93 86.37 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 122.898 0.479 . . . . 50.44 110.196 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -73.35 133.25 18.93 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.504 2.136 . . . . 63.44 111.855 -171.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 89.3 t -108.9 136.14 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.473 -0.936 . . . . 74.25 108.473 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -77.91 87.69 4.1 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.252 -0.647 . . . . 72.4 109.252 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -58.84 -30.52 67.74 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.088 -0.96 . . . . 71.33 112.272 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.525 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 2.2 t70 -60.4 -46.17 90.97 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.261 0.976 . . . . 62.33 110.203 -174.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.24 -48.27 71.05 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.599 0.76 . . . . 73.53 111.954 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 10.0 mp -66.25 -35.22 79.85 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.755 -0.657 . . . . 70.45 111.519 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.468 ' HZ ' ' HA ' ' H' ' 14' ' ' LEU . 12.8 t80 -74.44 -43.86 54.33 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.254 0.622 . . . . 71.23 109.53 -177.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.475 ' SD ' ' HB2' ' D' ' 3' ' ' GLU . 74.3 mtm -57.71 -40.58 79.88 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.668 0.387 . . . . 73.11 110.292 175.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -59.07 -35.02 72.66 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 123.918 0.761 . . . . 74.24 111.621 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -71.0 -49.99 39.06 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.118 0.567 . . . . 73.22 110.755 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.436 HD13 ' O ' ' D' ' 137' ' ' PHE . 10.5 mp -66.83 -33.73 76.25 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.857 0.863 . . . . 74.11 112.438 -172.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -76.09 9.75 2.32 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.309 0.643 . . . . 73.11 112.25 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -118.28 89.26 3.09 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.419 -0.956 . . . . 74.35 108.419 176.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -163.69 148.95 10.91 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.376 1.07 . . . . 64.4 109.087 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.29 135.4 8.91 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.756 0.822 . . . . 72.54 109.227 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.23 -60.89 4.77 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 110.854 -0.898 . . . . 24.5 110.854 -174.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.71 127.88 34.39 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.213 1.005 . . . . 62.5 110.554 171.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -98.74 -110.54 3.03 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 109.825 -1.31 . . . . 72.12 109.825 172.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 4.9 t -166.91 118.88 0.94 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.075 0.95 . . . . 74.23 108.887 175.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 150' ' ' GLU . . . . . 0.65 ' HB2' ' HG3' ' H' ' 24' ' ' PRO . 6.6 mm-40 -63.06 132.73 52.9 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.696 1.198 . . . . 74.22 113.183 -173.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -142.67 116.06 9.04 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.104 -1.073 . . . . 74.44 108.104 167.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -124.92 46.91 2.23 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.142 -1.058 . . . . 65.44 108.142 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -70.42 -38.32 74.58 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 113.457 -1.701 . . . . 75.51 110.811 -176.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -75.53 -29.48 59.47 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.512 -0.767 . . . . 73.52 110.388 176.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.36 0 C-N-CA 124.83 1.252 . . . . 74.44 111.34 179.044 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 1' ' ' MET . . . . . 0.559 ' HA ' HG21 ' C' ' 55' ' ' VAL . 67.1 mtm . . . . . 0 N--CA 1.477 0.908 0 CA-C-O 120.704 0.287 . . . . 75.35 110.303 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.82 93.82 9.71 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.812 -0.81 . . . . 65.24 108.812 172.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -88.8 -26.76 21.53 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 116.148 -0.478 . . . . 55.33 110.689 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 44.9 m 62.44 91.09 0.07 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.105 0.962 . . . . 42.14 111.021 -173.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 62.0 p -111.95 176.35 5.05 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.879 0.472 . . . . 63.03 110.353 174.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.682 HG21 HG21 ' A' ' 40' ' ' VAL . 41.9 pt -102.73 135.56 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 123.496 0.718 . . . . 63.41 111.219 -169.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 7' ' ' ALA . . . . . 0.413 ' HB1' HG13 ' A' ' 131' ' ' VAL . . . -127.17 162.88 25.1 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.79 0.836 . . . . 61.4 109.773 178.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.441 HD22 HD23 ' A' ' 44' ' ' LEU . 93.3 mt -67.9 -90.69 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 122.691 0.397 . . . . 71.43 110.437 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . 166.3 -170.93 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.129 1.772 . . . . 64.25 108.331 -173.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 10' ' ' LEU . . . . . 0.408 ' HG ' HD22 ' A' ' 136' ' ' LEU . 3.3 tm? -96.38 135.56 38.07 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.304 -1.369 . . . . 62.35 107.304 167.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt -71.51 111.09 9.02 Favored Pre-proline 0 N--CA 1.483 1.218 0 C-N-CA 123.128 0.571 . . . . 64.32 110.368 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.99 -12.58 17.68 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 122.904 2.403 . . . . 52.32 111.869 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 70.6 mt -117.83 140.27 49.93 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.647 1.179 . . . . 71.54 108.494 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 97.9 mt -73.66 157.07 37.27 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.762 0.425 . . . . 64.2 110.116 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -91.38 27.48 1.94 Allowed 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.756 0.822 . . . . 74.11 109.826 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 36.7 m 68.15 123.65 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.45 0 C-N-CA 125.254 1.422 . . . . 75.55 110.597 -170.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 17' ' ' PRO . . . . . 0.444 ' HB2' HG22 ' E' ' 19' ' ' THR . 24.2 Cg_exo -65.54 177.62 2.63 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.877 2.384 . . . . 74.24 113.309 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 18' ' ' VAL . . . . . 0.552 HG21 HD12 ' A' ' 89' ' ' ILE . 22.2 t -81.64 13.29 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 123.845 0.858 . . . . 73.2 111.032 -175.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 19' ' ' THR . . . . . 0.444 HG22 ' HB2' ' E' ' 17' ' ' PRO . 4.6 t -74.43 78.92 1.9 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.69 0.796 . . . . 71.45 109.815 172.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 20' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 96.4 mttt 70.6 -59.24 0.53 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.813 1.645 . . . . 70.21 111.578 -173.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 69.95 -4.22 1.54 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.204 1.002 . . . . 73.31 113.134 172.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 22' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 49' ' ' SER . 45.5 ttt180 -82.83 80.83 8.79 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 107.913 -1.143 . . . . 73.24 107.913 177.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 9.5 t -159.13 135.73 6.57 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-N 115.395 -0.821 . . . . 74.45 110.956 -173.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -66.12 -34.46 37.08 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.691 2.26 . . . . 72.03 112.233 169.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 . . . . . 0 C--O 1.249 1.066 0 N-CA-C 108.215 -1.032 . . . . 72.54 108.215 176.958 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 109.962 -0.384 . . . . 61.45 109.962 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -116.56 177.15 4.8 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 107.981 -1.118 . . . . 72.35 107.981 173.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -77.1 157.34 31.1 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 108.631 -0.877 . . . . 53.1 108.631 162.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 81.1 p -54.7 -41.37 70.18 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.802 0.841 . . . . 52.44 112.066 -173.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 30.5 m -151.6 125.99 9.41 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.137 0.975 . . . . 71.03 108.486 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.509 HD12 ' HB2' ' B' ' 42' ' ' LEU . 33.9 pt -78.12 137.56 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 122.775 0.43 . . . . 65.32 111.18 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -152.69 150.4 29.41 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.595 0.758 . . . . 74.33 110.381 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 8' ' ' LEU . . . . . 0.662 HD12 HG21 ' B' ' 131' ' ' VAL . 94.4 mt -68.6 143.78 54.74 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.064 0.946 . . . . 71.21 110.199 174.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.67 -74.11 0.18 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.797 0.839 . . . . 54.42 111.666 -172.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 8.5 tt -179.2 149.52 0.41 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.154 -1.054 . . . . 72.12 108.154 -170.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.488 HD21 HD23 ' B' ' 44' ' ' LEU . 91.1 mt -104.83 91.18 4.05 Favored Pre-proline 0 N--CA 1.486 1.344 0 C-N-CA 123.61 0.764 . . . . 72.54 110.476 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.34 -17.47 18.79 Favored 'Trans proline' 0 C--N 1.388 2.615 0 C-N-CA 122.43 2.087 . . . . 74.24 111.596 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 55.9 mt -68.73 -19.32 64.34 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 124.236 1.015 . . . . 60.55 110.621 170.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 14' ' ' LEU . . . . . 0.693 ' HB3' ' HB1' ' B' ' 95' ' ' ALA . 84.7 mt 61.53 30.47 18.75 Favored 'General case' 0 C--N 1.367 1.35 0 C-N-CA 124.484 1.114 . . . . 74.14 109.97 -173.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 15' ' ' PHE . . . . . 0.513 ' HE2' ' HB3' ' B' ' 48' ' ' SER . 26.2 t80 59.66 -87.27 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 125.609 1.564 . . . . 62.41 109.728 -174.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 6.6 p -154.3 113.15 2.46 Favored Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 125.0 1.32 . . . . 32.11 108.537 173.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.57 141.53 46.29 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 121.938 1.759 . . . . 73.15 110.552 168.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 18' ' ' VAL . . . . . 0.593 HG12 ' H ' ' F' ' 20' ' ' LYS . 8.2 t -68.92 138.73 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 110.007 -0.368 . . . . 75.23 110.007 -175.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 6.3 m -65.28 -34.3 78.01 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.482 0.713 . . . . 75.43 110.488 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 20' ' ' LYS . . . . . 0.593 ' H ' HG12 ' F' ' 18' ' ' VAL . 0.1 OUTLIER -156.52 102.72 2.08 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.916 1.286 . . . . 74.23 110.326 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . -124.97 40.43 3.75 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 122.129 0.966 . . . . 73.13 109.011 174.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -163.97 164.73 23.1 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-N 114.512 -1.222 . . . . 74.31 109.028 175.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 49.6 p -61.6 147.73 87.96 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.876 0.871 . . . . 75.45 110.739 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.78 -27.77 73.13 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.165 2.576 . . . . 74.02 112.179 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 124.52 1.128 . . . . 72.11 109.214 171.082 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 110.197 -0.297 . . . . 73.35 110.197 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -162.47 -39.73 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.435 1.094 . . . . 71.41 109.253 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 52.82 13.37 0.34 Allowed 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 125.822 1.649 . . . . 74.33 115.227 166.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 4' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' G' ' 7' ' ' ALA . 15.6 m -80.94 154.39 27.02 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.199 0.6 . . . . 70.22 109.986 -177.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 5.2 t -54.91 -33.01 61.66 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.122 0.889 . . . . 50.52 111.399 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 6' ' ' ILE . . . . . 0.513 HG21 ' HB ' ' C' ' 40' ' ' VAL . 21.3 pt -130.3 -47.15 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.477 0.711 . . . . 74.2 111.089 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 7' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' G' ' 4' ' ' SER . . . 59.9 -160.18 0.29 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.239 1.016 . . . . 70.4 112.454 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.0 135.58 54.55 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 107.74 -1.207 . . . . 75.32 107.74 171.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.29 139.47 32.29 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.481 0.712 . . . . 61.14 110.308 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 89.8 mt -61.82 126.04 25.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.702 0.801 . . . . 75.12 110.822 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 95.2 mt -67.9 133.45 92.11 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 123.293 0.637 . . . . 63.43 111.064 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 12' ' ' PRO . . . . . 0.425 ' HB3' ' HB3' ' A' ' 155' ' ' ALA . 60.8 Cg_endo -70.72 -23.88 25.89 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.967 2.445 . . . . 72.03 112.552 174.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 52.5 tp -150.48 137.69 19.45 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.14 0.976 . . . . 72.22 108.718 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 73.2 mt -95.16 -178.53 4.5 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.516 0.726 . . . . 63.51 110.16 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 15' ' ' PHE . . . . . 0.421 ' HB2' ' HB3' ' C' ' 98' ' ' LEU . 5.8 m-85 -71.0 152.58 43.43 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.299 0.639 . . . . 72.12 110.498 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 59.9 p -73.7 138.89 77.06 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 123.329 0.651 . . . . 61.21 110.867 -174.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 17' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -52.53 134.5 52.87 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.751 2.967 . . . . 31.44 114.553 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 18' ' ' VAL . . . . . 0.534 HG23 HD11 ' C' ' 98' ' ' LEU . 22.1 t -66.03 128.92 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.521 0.728 . . . . 72.41 110.291 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 94.2 m 68.34 -72.0 0.1 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.813 1.245 . . . . 74.23 111.32 176.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 20' ' ' LYS . . . . . 0.486 ' HD3' ' HG2' ' G' ' 25' ' ' GLU . 4.1 ttmp? -169.63 37.73 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 108.306 -0.998 . . . . 74.24 108.306 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.95 75.53 0.21 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 122.126 0.965 . . . . 64.41 111.379 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -164.56 -71.03 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.331 -1.359 . . . . 71.51 107.331 -169.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -168.33 139.8 2.26 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 125.067 1.347 . . . . 61.42 108.6 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -60.97 141.72 95.34 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.743 2.296 . . . . 72.15 112.31 172.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 25' ' ' GLU . . . . . 0.486 ' HG2' ' HD3' ' G' ' 20' ' ' LYS . 6.7 pt-20 . . . . . 0 CA--C 1.554 1.122 0 C-N-CA 124.376 1.071 . . . . 73.31 109.13 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 49.0 ttm . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 109.901 -0.407 . . . . 74.42 109.901 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.56 82.25 7.39 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.324 0.65 . . . . 75.22 110.55 -171.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.43 28.34 0.24 Allowed 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 114.654 -1.157 . . . . 72.4 108.342 171.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 26.2 m -89.46 123.12 33.3 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.71 0.804 . . . . 72.01 109.69 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 16.4 m -60.34 -32.02 70.86 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.955 0.902 . . . . 42.15 111.081 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 6' ' ' ILE . . . . . . . . . . . . . 14.2 tt -138.95 129.11 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 123.946 0.898 . . . . 73.22 109.209 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -168.44 -156.15 0.17 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.199 1.0 . . . . 71.44 109.408 -175.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 78.9 mt -136.97 142.47 42.6 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.867 1.267 . . . . 71.31 108.848 173.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -99.9 144.55 28.82 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.395 0.678 . . . . 54.5 111.069 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 35.7 tp -69.11 155.42 40.4 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.716 0.806 . . . . 74.02 111.461 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 mp -86.19 128.13 58.83 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 123.385 0.674 . . . . 61.53 109.228 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.67 -31.71 8.33 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.623 2.216 . . . . 64.3 113.316 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -97.91 135.68 39.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.884 0.873 . . . . 74.12 109.241 -173.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 14' ' ' LEU . . . . . 0.477 ' HB3' ' HB1' ' D' ' 95' ' ' ALA . 8.2 mp -76.64 125.46 29.29 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.431 0.692 . . . . 74.5 109.861 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -65.45 146.2 55.18 Favored 'General case' 0 CA--C 1.551 1.018 0 O-C-N 124.159 0.912 . . . . 65.03 110.774 -171.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 19.5 p -62.43 147.47 91.88 Favored Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 124.808 1.243 . . . . 72.5 112.233 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 17' ' ' PRO . . . . . 0.737 ' HB3' ' HB3' ' H' ' 21' ' ' ALA . 55.9 Cg_endo -67.04 169.12 15.64 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.256 2.637 . . . . 74.23 113.815 -177.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 18' ' ' VAL . . . . . 0.742 HG21 ' HB ' ' D' ' 86' ' ' ILE . 45.6 t -81.06 -74.76 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.002 0.921 . . . . 55.21 110.121 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 46.1 m -111.92 -58.82 2.07 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.432 -0.951 . . . . 75.13 108.432 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -141.63 123.52 15.32 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 115.436 -0.802 . . . . 75.24 109.697 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 21' ' ' ALA . . . . . 0.737 ' HB3' ' HB3' ' H' ' 17' ' ' PRO . . . -163.08 138.72 6.83 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.526 1.13 . . . . 53.2 108.092 171.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 22' ' ' ARG . . . . . 0.633 ' HD2' ' H ' ' H' ' 22' ' ' ARG . 0.1 OUTLIER -69.5 87.22 0.46 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.97 0.908 . . . . 75.21 108.558 177.159 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 90.9 m -151.01 93.36 3.68 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 124.376 1.07 . . . . 64.41 108.459 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 24' ' ' PRO . . . . . 0.65 ' HG3' ' HB2' ' D' ' 150' ' ' GLU . 32.6 Cg_endo -87.68 166.59 7.45 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 123.109 2.539 . . . . 74.03 111.814 174.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 C--O 1.253 1.278 0 N-CA-C 108.643 -0.873 . . . . 71.32 108.643 176.95 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 mtt . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 121.533 0.682 . . . . 74.2 109.411 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.4 p -90.77 -57.79 2.7 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.122 -0.945 . . . . 64.51 109.795 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -129.59 47.17 2.53 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 107.887 -1.153 . . . . 71.24 107.887 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 68.61 133.74 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 113.404 -1.726 . . . . 75.45 112.39 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -76.38 79.56 3.12 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.45 -0.944 . . . . 73.55 108.45 172.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -90.89 123.96 34.82 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.932 -0.766 . . . . 61.54 108.932 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.9 p -75.84 75.05 2.78 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.897 0.879 . . . . 74.22 110.388 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -85.64 -59.27 2.36 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.922 0.889 . . . . 74.34 109.793 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -155.88 142.19 18.44 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.204 -1.036 . . . . 63.4 108.204 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 91.0 m -140.44 143.72 35.72 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.468 0.707 . . . . 73.04 110.253 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.567 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 25.5 t80 -136.52 124.33 22.58 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.004 0.922 . . . . 73.51 109.274 177.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -144.67 112.9 6.48 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.991 0.916 . . . . 71.44 109.05 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.648 HG12 ' HD2' ' A' ' 84' ' ' PHE . 43.0 mt -77.88 115.06 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 109.702 -0.481 . . . . 64.44 109.702 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -73.39 -27.96 61.75 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 123.801 0.688 . . . . 52.52 111.1 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.2 ttt85 -177.57 149.01 0.6 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 123.265 0.353 . . . . 72.51 111.448 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.48 HD12 ' HB3' ' C' ' 130' ' ' PRO . 91.6 mt -137.23 130.63 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.239 -1.022 . . . . 71.51 108.239 168.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.496 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 35.1 p90 -166.14 157.63 13.62 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 124.19 0.931 . . . . 74.3 110.484 -168.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.3 p -83.28 109.82 17.58 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.773 -1.103 . . . . 75.44 108.375 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 35.3 mtpt -75.05 -38.3 61.43 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.083 -0.71 . . . . 62.22 109.083 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.525 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 31.4 t70 -140.33 136.48 33.25 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 113.93 -1.486 . . . . 70.15 109.617 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.4 mt -130.23 144.73 37.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 125.406 1.482 . . . . 65.23 107.043 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.498 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 48.3 t -148.82 130.28 14.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.815 -0.809 . . . . 74.23 108.815 174.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -134.72 142.08 46.67 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.375 -1.343 . . . . 74.2 107.375 173.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -141.45 151.16 43.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.446 -0.946 . . . . 74.22 108.446 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.52 81.22 17.66 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 106.905 -1.517 . . . . 74.45 106.905 171.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.16 -46.39 33.91 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.589 2.859 . . . . 71.01 114.303 -166.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.18 37.56 3.97 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.549 -0.908 . . . . 74.53 108.549 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.599 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -40.18 -57.26 2.92 Favored Pre-proline 0 CA--C 1.569 1.686 0 N-CA-C 114.274 1.212 . . . . 51.34 114.274 -172.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.599 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 27.9 Cg_exo -62.17 -29.69 81.05 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.042 1.828 . . . . 74.25 114.006 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -83.0 -32.64 26.84 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.689 0.796 . . . . 75.24 111.347 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.702 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.2 p -77.52 -22.31 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.542 0.737 . . . . 53.32 111.265 -166.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -71.47 -22.38 61.82 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.708 -0.678 . . . . 74.13 110.773 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -80.83 -21.61 40.67 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.284 1.033 . . . . 70.1 110.633 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -82.03 170.8 15.13 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.149 0.98 . . . . 62.1 111.568 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -88.3 131.54 34.75 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.687 0.795 . . . . 75.02 110.044 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.454 ' CE3' HD21 ' A' ' 68' ' ' LEU . 66.4 t-105 -84.47 85.53 7.39 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 121.582 0.706 . . . . 72.32 111.058 -176.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -135.16 80.63 46.76 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 107.225 -1.398 . . . . 54.23 107.225 167.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -82.01 154.24 17.09 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.666 2.244 . . . . 73.12 112.658 -173.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -102.41 85.85 2.7 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.782 -1.562 . . . . 72.34 106.782 170.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.682 ' HB ' HG21 ' E' ' 6' ' ' ILE . 55.7 t -78.89 97.26 2.33 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 CA-C-N 115.54 -0.755 . . . . 75.52 109.965 -173.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.495 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 56.8 mtpt -79.39 124.18 28.19 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.127 -0.942 . . . . 74.04 109.196 174.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.737 HD21 ' HB ' ' E' ' 6' ' ' ILE . 1.9 mm? -97.71 108.37 21.07 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 105.922 -1.881 . . . . 52.41 105.922 169.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.782 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 15.0 m-20 -104.5 117.68 34.75 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.628 -0.878 . . . . 52.22 108.628 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.409 HD11 ' HB2' ' E' ' 8' ' ' LEU . 5.2 mp -97.53 122.41 40.56 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.892 0.877 . . . . 64.35 109.512 -171.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -136.22 139.36 42.7 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.296 0.638 . . . . 75.05 109.404 172.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.1 p -111.98 136.94 50.66 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.661 0.784 . . . . 74.31 110.239 -175.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.08 110.82 5.64 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 108.341 -0.985 . . . . 62.04 108.341 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 p -132.0 152.04 51.38 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.947 -0.471 . . . . 73.54 109.931 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -152.36 132.38 13.42 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.155 0.582 . . . . 62.31 110.982 -170.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -75.11 126.05 30.21 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 108.936 -0.764 . . . . 75.45 108.936 172.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.411 HD12 HG23 ' A' ' 83' ' ' ILE . 76.1 mt -97.99 -33.24 11.27 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.723 0.409 . . . . 63.01 110.387 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.4 -176.15 5.44 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.178 0.991 . . . . 53.41 110.014 176.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.61 124.2 21.27 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 108.631 -0.877 . . . . 64.22 108.631 169.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 65.04 11.79 7.4 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.465 1.106 . . . . 62.41 112.62 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.405 HG12 ' HB2' ' A' ' 51' ' ' LEU . 61.2 t -123.06 122.59 65.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 107.938 -1.134 . . . . 62.54 107.938 174.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -140.06 169.01 18.49 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.103 -0.702 . . . . 73.11 109.103 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -129.92 127.31 39.87 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.197 -0.91 . . . . 74.51 108.807 176.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.558 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 91.9 t -102.52 120.91 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.509 -1.293 . . . . 61.42 107.509 168.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.499 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 25.9 t -107.76 131.24 58.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 107.408 -1.331 . . . . 74.14 107.408 168.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 tt -119.24 107.49 13.48 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.627 -0.879 . . . . 64.4 108.627 176.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -84.47 102.09 12.55 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.373 1.069 . . . . 72.11 109.366 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.4 t -98.41 102.51 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 108.196 -1.038 . . . . 72.03 108.196 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.782 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 33.2 m -94.82 108.02 20.04 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.976 -1.12 . . . . 75.51 107.976 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.3 t -103.22 110.23 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.218 0.607 . . . . 73.24 109.698 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 11.6 m -100.56 141.18 33.78 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.304 -0.998 . . . . 72.31 108.304 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.89 119.21 20.85 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.239 -1.023 . . . . 64.3 108.239 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.3 m -130.02 126.9 38.82 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.451 0.469 . . . . 72.14 110.724 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.454 HD21 ' CE3' ' A' ' 36' ' ' TRP . 29.6 mt -87.4 80.86 8.01 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 124.722 1.209 . . . . 74.44 109.163 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.5 -84.05 0.87 Allowed Glycine 0 C--N 1.34 0.782 0 CA-C-N 116.168 -0.469 . . . . 71.32 112.038 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -112.63 -27.9 8.02 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.368 0.667 . . . . 74.43 111.403 177.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -95.86 122.47 38.69 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 122.062 -0.399 . . . . 74.03 111.154 -173.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.3 m -65.77 126.8 29.61 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.06 0.457 . . . . 71.41 110.283 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.702 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -78.8 -56.77 4.15 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 114.975 -1.012 . . . . 72.24 109.531 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -159.45 172.71 17.4 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.601 -1.181 . . . . 63.3 111.257 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.9 tp -131.54 139.37 49.23 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 107.5 -1.296 . . . . 75.21 107.5 167.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 59.3 m -138.31 95.47 3.01 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.827 -0.805 . . . . 75.14 108.827 175.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 33.9 tt0 -105.61 121.16 43.4 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.407 0.683 . . . . 74.21 109.293 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.2 t -129.59 112.47 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.158 0.504 . . . . 72.24 110.008 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -84.78 88.82 7.41 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.43 -0.952 . . . . 72.42 108.43 172.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -80.01 96.91 6.58 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.452 -0.794 . . . . 74.23 109.407 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.9 151.25 24.8 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 115.944 -0.571 . . . . 23.51 112.085 177.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.413 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -152.77 122.01 1.24 Allowed Glycine 0 CA--C 1.504 -0.631 0 N-CA-C 111.006 -0.837 . . . . 72.43 111.006 176.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.411 HG23 HD12 ' A' ' 51' ' ' LEU . 46.4 mt -82.1 122.97 37.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 108.188 -1.042 . . . . 71.35 108.188 173.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.648 ' HD2' HG12 ' A' ' 13' ' ' ILE . 22.6 m-85 -124.96 147.98 48.63 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 109.109 -0.7 . . . . 75.03 109.109 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.2 m -113.98 122.77 47.94 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.476 -0.935 . . . . 51.51 108.476 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 10' ' ' THR . 0.1 OUTLIER -135.8 125.97 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 N-CA-C 108.555 -0.906 . . . . 71.44 108.555 178.328 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.72 135.74 22.48 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.474 0.71 . . . . 63.14 110.347 -176.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.95 -62.29 0.34 Allowed Glycine 0 C--N 1.352 1.444 0 N-CA-C 114.038 0.375 . . . . 45.33 114.038 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 48.7 mm -120.88 -40.69 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 112.144 0.424 . . . . 73.12 112.144 -167.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.413 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 31.8 mt-10 64.54 -163.7 0.26 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.227 1.011 . . . . 72.22 111.229 -166.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.37 -137.82 26.77 Favored Glycine 0 C--N 1.356 1.681 0 CA-C-O 119.672 -0.515 . . . . 32.12 113.393 175.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.509 HG23 ' HD2' ' E' ' 24' ' ' PRO . 27.8 p -72.42 -26.48 61.87 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.8 0.84 . . . . 62.45 111.727 -177.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -59.64 -52.44 65.52 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.782 0.833 . . . . 73.21 110.159 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.413 ' SD ' ' HA ' ' A' ' 90' ' ' GLU . 14.0 ptt? -83.29 -16.05 47.77 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.84 -0.618 . . . . 74.11 111.508 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.57 -32.48 73.27 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 118.093 0.406 . . . . 74.11 110.921 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.454 ' NE2' ' HB2' ' A' ' 134' ' ' ASP . 45.3 t-80 -67.49 -27.71 67.24 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.918 -0.583 . . . . 71.34 110.732 172.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.519 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 58.3 m -76.78 -63.91 1.24 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 122.71 0.404 . . . . 54.1 110.404 177.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.21 -30.65 71.15 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.978 0.911 . . . . 75.13 112.28 -171.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.42 -1.28 40.75 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-O 119.115 -0.825 . . . . 64.1 114.389 -172.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.426 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.86 -59.82 0.23 Allowed 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.985 1.106 . . . . 72.52 113.985 -173.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.519 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 80.1 t80 -74.15 -55.33 6.2 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.167 0.587 . . . . 72.12 111.491 -169.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 79.3 m -65.58 -36.24 14.02 Favored Pre-proline 0 CA--C 1.567 1.632 0 N-CA-C 113.084 0.772 . . . . 74.34 113.084 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.02 -46.65 27.13 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 122.68 2.253 . . . . 70.43 113.735 160.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -27.68 65.46 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.546 0.739 . . . . 74.12 110.432 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.62 -38.59 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 C-N-CA 123.382 0.673 . . . . 64.1 110.22 173.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.413 HD21 ' HA3' ' A' ' 82' ' ' GLY . 70.2 mt -76.8 -22.96 52.9 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.616 0.766 . . . . 75.44 112.36 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -61.12 -45.67 95.95 Favored Pre-proline 0 CA--C 1.567 1.607 0 N-CA-C 114.387 1.254 . . . . 73.2 114.387 -171.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -62.6 -34.79 73.55 Favored 'Trans proline' 0 C--N 1.384 2.435 0 CA-C-N 121.676 1.634 . . . . 73.11 113.038 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -70.37 -43.59 69.82 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.229 0.612 . . . . 72.22 111.078 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.11 -36.7 80.19 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.991 -0.55 . . . . 71.03 110.484 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.515 ' NH1' HD12 ' C' ' 105' ' ' ILE . 28.7 ttm180 -54.58 -56.78 15.38 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.859 0.863 . . . . 70.13 109.903 172.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.09 -43.39 95.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.956 0.902 . . . . 73.52 111.768 -174.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 38.2 t -59.51 -42.56 92.49 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.785 0.678 . . . . 43.04 110.613 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.3 mt -68.24 -47.61 77.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 115.497 -0.774 . . . . 72.41 110.328 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 60.2 m -55.49 -41.42 72.99 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.96 0.904 . . . . 63.14 111.527 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.0 t -70.79 -44.61 66.28 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 114.994 -1.003 . . . . 53.32 110.381 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 21.1 mtp -61.6 -41.47 97.49 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.543 0.737 . . . . 71.34 111.727 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.16 -45.87 97.73 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 123.931 0.892 . . . . 71.54 110.503 175.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 26.0 t -72.28 -30.17 64.57 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.706 -0.679 . . . . 55.11 111.764 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -74.77 -28.62 60.83 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.334 0.653 . . . . 71.31 109.572 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.3 15.83 37.58 Favored Glycine 0 C--N 1.352 1.444 0 O-C-N 123.831 0.707 . . . . 62.15 113.04 172.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.434 HG21 ' HE ' ' B' ' 15' ' ' ARG . 3.0 t 59.94 12.56 3.16 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 127.054 2.142 . . . . 71.31 113.685 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -79.8 147.44 66.61 Favored Pre-proline 0 C--O 1.244 0.781 0 C-N-CA 123.25 0.62 . . . . 62.51 109.502 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.03 141.47 98.34 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.651 2.234 . . . . 60.54 111.748 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -56.28 143.11 35.2 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.029 1.122 . . . . 75.0 114.029 -168.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.1 tp -129.14 113.79 15.53 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.451 1.1 . . . . 61.03 109.195 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -112.75 126.2 55.15 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.381 0.672 . . . . 72.55 109.823 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.13 134.93 46.03 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.389 -0.597 . . . . 74.54 109.389 172.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.42 ' HB2' HE22 ' C' ' 12' ' ' GLN . . . -72.62 143.22 84.67 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 122.666 0.386 . . . . 54.12 110.879 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -61.11 126.85 20.49 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.537 2.825 . . . . 70.42 112.558 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.3 m -129.61 113.56 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 123.641 0.777 . . . . 72.34 109.825 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -95.91 89.58 5.29 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.285 0.634 . . . . 73.43 109.597 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -63.48 -36.11 82.69 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.349 -0.842 . . . . 73.53 110.362 176.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.454 ' HB2' ' NE2' ' A' ' 96' ' ' HIS . 8.6 p-10 -56.82 -42.7 80.05 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.654 1.182 . . . . 75.31 112.139 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.72 -42.3 97.94 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.569 0.543 . . . . 65.31 110.965 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 75.1 mt -65.28 -44.5 87.8 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.323 -0.853 . . . . 74.25 110.955 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -65.23 -30.89 71.82 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.337 0.655 . . . . 71.31 112.024 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 30.1 mmt -70.18 -33.96 72.39 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.391 0.276 . . . . 73.34 110.969 176.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 87.5 m-20 -68.62 -20.92 64.5 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.677 0.791 . . . . 64.2 111.529 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -95.55 -38.37 10.45 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.124 0.57 . . . . 63.34 111.733 175.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 57.2 tp -68.87 -46.47 68.38 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.233 0.613 . . . . 53.51 112.017 -174.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -147.07 0.21 0.72 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.767 0.427 . . . . 70.35 110.581 -172.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 1.8 mp0 63.63 164.74 0.13 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.628 1.171 . . . . 63.14 110.929 -171.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -73.36 93.9 1.99 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.604 0.716 . . . . 75.43 109.361 174.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.95 163.6 32.98 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 114.489 -1.232 . . . . 64.13 109.084 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 150.25 158.39 8.19 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.993 -0.548 . . . . 73.51 112.04 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -134.74 -73.78 0.47 Allowed 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.526 -0.916 . . . . 72.35 108.526 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 62.44 66.38 2.63 Favored Glycine 0 C--N 1.351 1.386 0 O-C-N 123.542 0.527 . . . . 55.41 113.299 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.2 p -106.01 -73.25 0.69 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.27 0.628 . . . . 62.24 109.826 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 55.83 23.09 6.11 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.083 0.953 . . . . 73.33 111.532 -175.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -92.98 149.02 21.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.032 1.333 . . . . 74.02 108.026 -173.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 83.2 t60 70.35 97.28 0.07 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.446 1.098 . . . . 55.53 109.919 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -141.29 92.22 2.46 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.683 -1.228 . . . . 72.52 107.683 177.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -133.95 173.1 11.93 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.599 0.76 . . . . 65.13 110.509 -167.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 C-N-CA 123.739 0.815 . . . . 72.13 109.201 179.422 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 109.848 -0.427 . . . . 74.11 109.848 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 17.6 m -97.68 -77.07 0.51 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.741 -0.836 . . . . 75.42 108.741 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -174.15 134.25 0.43 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.6 0.76 . . . . 72.52 109.311 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -87.01 24.12 1.6 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.813 0.845 . . . . 64.14 112.07 -177.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -70.59 124.91 25.37 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.349 1.06 . . . . 72.15 110.48 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 64.7 t30 68.67 144.44 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 125.939 1.696 . . . . 74.43 111.395 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t -134.03 120.24 19.99 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.421 0.629 . . . . 74.44 111.343 -173.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -142.95 -45.61 0.3 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.763 1.225 . . . . 74.3 108.046 168.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.645 ' HB3' HG12 ' B' ' 89' ' ' ILE . 5.5 ppp? 51.58 -171.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 126.485 1.914 . . . . 71.41 113.614 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 93.8 m -134.03 107.1 7.57 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.897 -0.779 . . . . 71.33 108.897 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.536 ' HB2' ' SD ' ' B' ' 9' ' ' MET . 41.4 t80 -123.53 142.95 50.51 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.536 -0.756 . . . . 70.21 110.057 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -160.04 140.79 12.09 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.677 0.611 . . . . 72.45 109.61 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.539 HD13 HD11 ' B' ' 16' ' ' ILE . 42.8 mt -79.69 125.99 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 108.693 -0.854 . . . . 62.55 108.693 170.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -98.14 -37.31 9.77 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.394 0.678 . . . . 63.43 109.22 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.434 ' HE ' HG21 ' A' ' 122' ' ' THR . 45.4 ttt180 -174.19 144.32 0.95 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.479 -0.782 . . . . 74.11 109.037 -176.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.539 HD11 HD13 ' B' ' 13' ' ' ILE . 96.5 mt -128.23 142.45 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.55 -1.278 . . . . 64.12 107.55 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -168.63 148.91 4.53 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.664 0.745 . . . . 73.52 112.712 -174.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.5 m -73.72 124.87 26.84 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.147 -1.388 . . . . 74.12 108.945 167.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.452 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 37.6 mtpt -98.41 -21.51 16.54 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.635 0.774 . . . . 70.32 110.863 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -165.56 138.64 4.38 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.761 0.663 . . . . 64.23 110.706 -167.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.478 HD12 HG22 ' B' ' 78' ' ' VAL . 48.5 mm -132.96 143.87 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.076 0.951 . . . . 65.11 110.191 174.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.638 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 75.6 m -134.24 136.47 43.66 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 125.911 1.684 . . . . 52.24 107.199 169.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.4 t80 -151.48 114.83 4.8 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.474 -1.306 . . . . 63.31 107.474 165.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -119.31 155.83 31.12 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.379 -0.971 . . . . 63.32 108.379 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.451 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -144.52 86.06 8.27 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 107.766 -1.198 . . . . 64.01 107.766 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.24 -45.79 21.43 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.593 2.862 . . . . 63.11 113.86 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -104.0 24.59 11.12 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.186 0.594 . . . . 72.15 110.849 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.451 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -42.24 -62.73 1.09 Allowed Pre-proline 0 N--CA 1.485 1.283 0 N-CA-C 115.202 1.556 . . . . 74.52 115.202 -165.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 51.9 Cg_exo -53.44 -43.23 59.26 Favored 'Trans proline' 0 C--N 1.39 2.751 0 C-N-CA 122.072 1.848 . . . . 44.41 113.878 -168.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -97.12 -22.43 16.77 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.285 0.846 . . . . 74.45 113.285 -171.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.64 -17.56 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 118.452 0.569 . . . . 52.25 112.06 -173.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -70.48 -15.61 62.82 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 113.305 0.854 . . . . 72.32 113.305 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -61.6 -27.19 68.47 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.152 0.501 . . . . 63.43 109.765 173.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -86.92 80.34 8.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.336 1.054 . . . . 73.23 110.067 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -91.47 90.41 7.64 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.923 -0.581 . . . . 73.0 109.493 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -161.51 -175.64 4.89 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.723 1.209 . . . . 63.23 108.549 172.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -81.32 109.63 14.94 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 122.951 0.501 . . . . 74.51 110.109 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.68 160.22 50.54 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.442 2.095 . . . . 70.52 113.109 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -66.17 112.64 4.03 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.269 0.628 . . . . 65.54 109.63 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 51.5 t -88.86 134.66 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.803 0.841 . . . . 61.41 109.747 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -140.87 118.0 11.26 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 106.532 -1.655 . . . . 64.0 106.532 175.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 pp -114.34 166.58 11.52 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.01 0.433 . . . . 65.4 111.771 -176.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.534 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 14.2 m-20 -147.31 155.87 42.41 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.412 1.085 . . . . 73.41 109.206 174.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -120.98 146.58 46.52 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.31 -0.996 . . . . 62.41 108.31 172.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.602 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 7.4 t70 -137.91 138.19 38.78 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.856 0.862 . . . . 73.14 108.935 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 36.7 p -109.64 127.77 54.77 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.301 0.64 . . . . 72.31 111.166 -175.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.49 142.78 29.53 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.018 0.927 . . . . 74.41 108.622 174.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 35.2 p -144.53 163.62 33.32 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 122.705 0.402 . . . . 73.41 110.855 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 79.6 p -151.1 138.41 19.39 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.875 0.87 . . . . 72.33 109.018 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -96.83 134.06 40.62 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.23 -0.656 . . . . 61.3 109.23 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 46.7 mt -101.12 -39.92 7.44 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.196 0.598 . . . . 70.2 110.64 -175.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.73 -173.98 4.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.388 -0.824 . . . . 53.15 110.449 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.12 121.68 19.68 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.009 -0.996 . . . . 71.41 108.864 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 75.51 -7.5 1.77 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 126.246 1.818 . . . . 71.53 112.584 -175.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 96.1 t -110.87 112.28 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.279 -0.637 . . . . 50.32 109.279 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -119.6 -179.77 3.98 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.572 -0.899 . . . . 72.04 108.572 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -144.05 107.01 4.48 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.988 -1.115 . . . . 73.54 107.988 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 74.1 t -96.83 128.55 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.233 1.013 . . . . 63.33 110.212 -175.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.492 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 12.7 t -118.37 126.28 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.86 0.864 . . . . 72.22 109.563 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.712 HD22 ' HB3' ' B' ' 103' ' ' PRO . 52.2 tp -112.85 115.5 28.56 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.482 -0.933 . . . . 73.44 108.482 164.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.602 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 17.2 ttt180 -92.47 118.22 30.74 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.884 -0.784 . . . . 41.44 108.884 175.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.74 121.21 54.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.361 -0.977 . . . . 71.24 108.361 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.534 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 22.6 m -104.82 143.78 32.67 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.881 -0.785 . . . . 71.54 108.881 177.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 95.0 t -136.29 136.22 49.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 123.785 0.834 . . . . 75.33 108.854 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.8 m -125.86 143.75 50.94 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.609 1.163 . . . . 73.23 108.068 172.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.68 139.2 23.81 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.083 -0.71 . . . . 63.24 109.083 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.54 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 33.2 p -140.37 128.16 21.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.887 -0.597 . . . . 54.51 110.192 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 61.6 mt -96.89 105.42 17.56 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.027 -1.101 . . . . 73.41 108.027 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.26 -111.85 3.52 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 115.663 -0.699 . . . . 75.44 111.644 -173.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -121.76 3.99 10.04 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.781 0.832 . . . . 71.13 110.328 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -113.56 139.02 49.34 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.46 -0.571 . . . . 74.53 109.46 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 94.4 m -67.52 113.41 5.33 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.319 0.581 . . . . 64.42 109.97 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.54 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -70.44 -62.03 1.54 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.258 -1.337 . . . . 75.02 108.331 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -150.22 155.04 39.0 Favored 'General case' 0 C--N 1.347 0.491 0 N-CA-C 112.853 0.686 . . . . 74.25 112.853 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 64.8 mt -123.27 110.94 15.84 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.076 -1.453 . . . . 75.44 107.076 171.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.41 ' SG ' HG23 ' B' ' 114' ' ' ILE . 37.8 t -118.46 139.23 51.74 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 108.809 -0.811 . . . . 75.41 108.809 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.638 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 39.6 tt0 -156.72 131.9 9.15 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.589 -0.522 . . . . 72.12 109.589 -172.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.478 HG22 HD12 ' B' ' 21' ' ' ILE . 98.3 t -128.15 147.91 32.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 123.715 0.806 . . . . 72.33 109.183 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -110.92 103.72 12.25 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.305 -1.368 . . . . 63.12 107.305 165.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.479 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 7.8 tp-100 -92.96 98.99 11.71 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.387 -1.338 . . . . 73.22 107.387 173.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -96.01 171.31 28.42 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.732 -1.122 . . . . 63.33 110.662 173.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.51 137.11 4.18 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 111.275 -0.73 . . . . 32.11 111.275 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 45.4 mt -84.18 127.14 40.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 107.596 -1.261 . . . . 73.14 107.596 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -136.49 142.69 43.54 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.956 0.902 . . . . 75.31 109.159 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 27.3 m -89.13 113.46 24.63 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.03 -1.1 . . . . 45.34 108.03 168.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.494 HD13 ' SG ' ' B' ' 97' ' ' CYS . 0.4 OUTLIER -130.27 107.83 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.329 1.052 . . . . 70.21 108.322 -176.624 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' B' ' 9' ' ' MET . . . -156.65 171.89 19.54 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.54 1.136 . . . . 75.41 110.286 -177.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.75 -57.18 1.13 Allowed Glycine 0 C--N 1.346 1.094 0 N-CA-C 112.444 -0.262 . . . . 53.42 112.444 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.645 HG12 ' HB3' ' B' ' 9' ' ' MET . 4.2 mm -83.01 156.31 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.216 0.607 . . . . 74.25 110.394 175.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -152.34 -173.31 4.51 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.195 -0.912 . . . . 74.22 110.665 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.71 -120.46 8.15 Favored Glycine 0 C--N 1.351 1.392 0 CA-C-N 115.607 -0.724 . . . . 54.42 113.289 170.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.8 m -83.48 -37.48 23.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.513 0.673 . . . . 75.15 110.643 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -72.61 -23.17 60.9 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.96 -1.018 . . . . 70.4 111.462 -167.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -71.46 -29.8 65.28 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.028 0.531 . . . . 72.0 111.09 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.64 -37.47 78.78 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.481 0.712 . . . . 70.45 110.692 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -75.15 -30.63 60.81 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.355 -0.839 . . . . 62.53 111.321 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.494 ' SG ' HD13 ' B' ' 86' ' ' ILE . 46.1 t -69.41 -66.7 0.55 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 122.296 0.238 . . . . 73.32 111.544 -174.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.56 HD11 ' HD2' ' F' ' 17' ' ' PRO . 2.0 pt? -88.32 -3.59 58.82 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.263 -0.898 . . . . 72.31 111.393 -178.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.79 -4.47 59.0 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-O 119.824 -0.431 . . . . 65.52 114.114 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.646 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -148.46 -50.0 0.16 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 117.576 0.688 . . . . 75.33 111.493 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.504 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 46.3 t80 -67.84 -47.83 67.88 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.148 0.579 . . . . 73.04 111.617 -175.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.489 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 59.2 m -66.46 -48.18 56.52 Favored Pre-proline 0 N--CA 1.488 1.468 0 CA-C-O 119.056 -0.497 . . . . 61.11 112.208 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.712 ' HB3' HD22 ' B' ' 60' ' ' LEU . 72.3 Cg_exo -55.77 -29.98 74.13 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.293 1.996 . . . . 64.33 114.283 170.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -66.68 -37.09 84.03 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.686 0.795 . . . . 74.13 110.618 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.28 -42.76 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 123.544 0.738 . . . . 75.04 110.169 175.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.416 HD22 ' HG3' ' B' ' 80' ' ' GLN . 78.7 mt -78.88 -17.21 55.97 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.298 -1.319 . . . . 72.24 111.728 -174.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.431 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 71.9 t80 -56.92 -53.91 60.01 Favored Pre-proline 0 CA--C 1.563 1.464 0 C-N-CA 124.365 1.066 . . . . 70.13 113.372 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 35.5 Cg_exo -63.27 -32.8 72.89 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 121.796 1.664 . . . . 74.21 113.292 -178.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -70.98 -44.01 66.87 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.441 0.697 . . . . 65.45 110.815 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -65.97 -36.79 84.29 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.677 0.391 . . . . 73.1 110.344 175.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -55.5 -56.36 21.09 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 124.311 1.007 . . . . 72.02 110.682 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -60.68 -40.24 91.43 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 123.633 0.583 . . . . 61.34 110.501 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.561 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.8 t -66.37 -38.87 88.54 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 123.505 0.503 . . . . 73.05 111.226 -175.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.41 HG23 ' SG ' ' B' ' 76' ' ' CYS . 97.2 mt -64.71 -52.21 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 123.132 0.573 . . . . 74.05 109.765 174.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 32.3 m -60.72 -32.48 71.74 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.784 0.834 . . . . 44.23 111.493 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.465 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.2 m -65.29 -46.58 79.86 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.852 0.461 . . . . 74.01 110.691 175.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.561 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -69.13 -34.4 74.96 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 123.229 0.331 . . . . 73.11 111.099 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.53 -40.91 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.607 0.763 . . . . 72.55 110.437 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -67.32 -37.04 82.68 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 114.95 -1.023 . . . . 50.11 111.561 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.48 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 85.6 mtt-85 -66.99 -36.38 82.03 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.314 -0.857 . . . . 74.3 109.368 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -83.62 11.65 55.33 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 124.278 0.986 . . . . 71.14 113.496 174.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 50.4 p 56.84 19.58 4.58 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 125.839 1.656 . . . . 62.2 114.648 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -78.9 166.64 40.9 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 123.63 0.772 . . . . 74.25 112.063 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.96 160.14 8.34 Favored 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 123.199 2.599 . . . . 64.33 114.059 171.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -65.37 139.27 58.55 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.527 -0.761 . . . . 53.34 112.443 -173.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 51.5 tp -142.07 119.89 11.92 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.583 0.753 . . . . 73.45 109.667 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -127.51 135.48 50.42 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.117 0.967 . . . . 70.01 108.581 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.658 ' HA ' HD11 ' F' ' 6' ' ' ILE . 1.3 tt -78.5 124.26 27.94 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 108.743 -0.836 . . . . 74.35 108.743 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.28 141.94 98.23 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.982 0.913 . . . . 71.42 111.993 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.402 ' HG3' HD13 ' D' ' 16' ' ' ILE . 16.4 Cg_exo -65.67 92.76 0.25 Allowed 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.627 2.218 . . . . 54.21 112.709 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.419 HG21 ' HA ' ' F' ' 7' ' ' ALA . 60.6 t -97.08 120.4 46.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 108.374 -0.973 . . . . 63.54 108.374 172.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -74.44 85.33 2.01 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 108.176 -1.046 . . . . 64.0 108.176 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.436 ' HZ ' ' HG ' ' F' ' 11' ' ' LEU . 12.9 t80 -69.15 -34.63 75.29 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.109 -1.405 . . . . 72.31 110.765 -173.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.646 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 19.0 t70 -58.94 -49.18 78.79 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.118 -1.401 . . . . 64.33 110.785 175.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.82 -38.29 86.16 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.497 0.719 . . . . 73.4 111.898 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.3 tt -62.63 -50.64 70.4 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.688 0.795 . . . . 72.11 109.663 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -71.26 -33.91 70.24 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.106 -0.952 . . . . 74.12 111.113 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 13.9 tmm? -64.46 -37.04 86.16 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.494 0.718 . . . . 72.2 110.188 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -74.13 -24.89 59.5 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.791 -1.095 . . . . 72.43 110.926 -171.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -62.46 -35.92 80.84 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.743 -0.662 . . . . 63.44 111.041 176.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 pp -120.75 18.96 11.88 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.545 0.738 . . . . 63.01 111.965 -173.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -71.59 -29.45 64.71 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 112.628 0.603 . . . . 73.43 112.628 -173.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -55.57 103.0 0.08 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.488 0.715 . . . . 72.44 111.87 -174.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -135.78 144.71 45.93 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.909 0.884 . . . . 62.21 109.873 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -111.52 144.99 39.86 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.878 0.871 . . . . 72.1 111.029 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.57 120.97 6.45 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 111.045 -0.822 . . . . 72.23 111.045 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -90.76 -173.99 3.91 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.586 0.754 . . . . 65.23 111.951 -174.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.91 -178.3 29.97 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.443 -0.799 . . . . 62.43 111.776 173.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 96.7 m -133.03 127.36 33.91 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.046 0.938 . . . . 74.44 109.545 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -91.88 127.79 37.48 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.9 -0.778 . . . . 74.23 108.9 171.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -99.46 171.6 7.85 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.899 0.879 . . . . 75.22 109.95 174.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -144.69 163.03 35.22 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.363 0.665 . . . . 62.02 110.154 -176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -72.17 157.43 37.76 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 120.883 0.373 . . . . 54.34 111.316 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -161.14 124.16 3.22 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.471 0.708 . . . . 75.34 109.314 177.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.077 0 C-N-CA 123.679 0.791 . . . . 37.92 110.392 178.151 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 109.342 -0.614 . . . . 62.24 109.342 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 41.1 t -84.96 63.61 8.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.904 0.882 . . . . 73.0 108.774 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -173.61 146.87 1.36 Allowed 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.532 1.133 . . . . 61.02 109.32 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -170.84 -47.75 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.229 1.012 . . . . 65.03 108.702 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 9.8 t30 66.79 98.26 0.05 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.067 1.347 . . . . 74.42 111.726 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -123.66 116.68 23.48 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.994 0.918 . . . . 72.1 108.78 174.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 40.0 p -110.09 112.39 24.34 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.675 0.79 . . . . 62.4 109.365 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 68.95 129.74 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.356 1.462 . . . . 73.24 110.646 -172.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.624 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 0.0 OUTLIER 64.74 113.08 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.883 1.273 . . . . 71.43 110.596 -174.835 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 93.4 m -97.55 102.41 14.17 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.789 -0.819 . . . . 71.13 108.789 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.624 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 1.1 t80 -112.87 128.71 56.53 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.512 -0.921 . . . . 74.43 108.512 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 12' ' ' GLN . . . . . 0.502 ' NE2' ' H ' ' E' ' 5' ' ' THR . 43.8 tp60 -143.49 128.93 19.01 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 108.886 -0.783 . . . . 74.21 108.886 171.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 37.8 mt -79.5 118.64 27.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.693 -0.855 . . . . 73.03 108.693 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.495 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 18.1 mm-40 -89.99 -33.07 16.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.996 -1.002 . . . . 45.21 109.635 -175.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -177.96 149.47 0.57 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.676 0.79 . . . . 54.34 109.353 -175.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 93.8 mt -137.25 140.25 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 107.965 -1.124 . . . . 65.04 107.965 174.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.415 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 21.1 p90 -171.04 167.37 7.23 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 120.796 0.331 . . . . 75.45 111.342 -171.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.5 p -95.69 127.97 42.17 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 109.456 -0.572 . . . . 72.42 109.456 175.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.415 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 16.7 mmtp -79.24 -50.13 11.42 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 122.597 1.189 . . . . 71.35 108.391 172.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 16.6 t70 -139.15 144.37 38.59 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 112.597 -2.092 . . . . 75.12 108.468 -167.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.408 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 81.4 mt -138.38 149.35 24.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 106.767 -1.568 . . . . 51.53 106.767 175.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 43.2 t -157.24 150.32 23.67 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.34 0.656 . . . . 65.44 109.412 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.403 ' CE1' ' HA3' ' C' ' 121' ' ' GLY . 86.4 t80 -152.31 134.48 15.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.55 -1.278 . . . . 71.35 107.55 173.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 24' ' ' GLU . . . . . 0.436 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 42.2 mt-10 -133.89 110.85 10.01 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.484 0.713 . . . . 74.31 109.696 -176.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.02 79.11 73.66 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 106.979 -1.489 . . . . 63.14 106.979 163.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.19 -21.52 31.39 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.688 2.259 . . . . 70.11 111.947 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.467 ' ND2' ' HB ' ' C' ' 31' ' ' VAL . 22.9 p-10 -102.38 22.12 13.95 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.586 1.155 . . . . 64.11 110.735 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.59 -58.39 4.51 Favored Pre-proline 0 CA--C 1.562 1.405 0 N-CA-C 114.738 1.385 . . . . 50.23 114.738 -169.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -63.2 -35.64 62.41 Favored 'Trans proline' 0 C--N 1.38 2.236 0 CA-C-N 121.889 1.71 . . . . 75.43 112.169 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -69.82 -37.26 76.17 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.193 0.997 . . . . 73.35 112.247 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.722 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.0 p -80.43 -16.69 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 N-CA-C 113.109 0.781 . . . . 54.44 113.109 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-30 -73.47 -23.14 60.04 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.735 -0.603 . . . . 72.24 111.983 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -90.02 17.93 6.36 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.123 0.569 . . . . 74.54 111.764 175.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -109.45 146.84 33.85 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.922 0.889 . . . . 61.22 110.535 -172.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.51 131.41 49.04 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.679 0.792 . . . . 62.12 110.647 173.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -79.48 89.32 5.04 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.467 0.707 . . . . 70.23 110.421 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' C' ' 68' ' ' LEU . 18.7 tt0 -138.42 67.08 45.11 Favored Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 124.062 0.945 . . . . 70.31 109.297 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -90.27 140.4 3.22 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.824 2.349 . . . . 64.44 113.316 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -88.74 101.21 13.79 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.832 -1.173 . . . . 73.04 107.832 166.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.517 HG11 HD12 ' G' ' 6' ' ' ILE . 38.6 t -78.56 97.84 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.779 -0.823 . . . . 54.05 108.779 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.53 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 94.0 mttt -97.97 105.11 17.2 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 114.562 -1.199 . . . . 55.21 108.338 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.499 HD11 HD21 ' C' ' 128' ' ' LEU . 2.8 mm? -85.61 139.68 31.22 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.997 -0.742 . . . . 71.32 108.997 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -141.86 106.69 4.9 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.47 -1.307 . . . . 64.23 107.47 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 8.1 mp -109.02 148.28 31.02 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.256 0.551 . . . . 51.52 110.176 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.538 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 14.1 t70 -130.48 145.22 51.8 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.923 1.289 . . . . 74.12 108.896 -174.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 61.7 p -116.71 112.83 21.76 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.984 0.914 . . . . 55.21 110.432 -167.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.26 143.18 39.95 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.102 0.561 . . . . 72.53 110.945 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 22.1 p -160.72 155.61 24.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.245 0.618 . . . . 73.13 110.657 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 90.1 p -143.96 154.07 42.92 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.489 0.715 . . . . 64.52 110.157 -175.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -84.89 123.23 30.25 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.954 0.502 . . . . 73.42 110.29 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.638 HD11 HD12 ' C' ' 83' ' ' ILE . 25.4 mt -100.23 -41.86 6.91 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.946 -0.761 . . . . 54.23 108.946 172.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.35 -172.68 4.31 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.304 1.041 . . . . 74.13 109.611 177.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.75 117.1 11.83 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.225 -0.898 . . . . 65.51 109.498 173.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 71.95 -5.91 1.6 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.937 1.295 . . . . 64.13 112.78 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 92.2 t -105.9 107.6 23.04 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.396 -0.964 . . . . 74.44 108.396 174.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.485 ' CD1' HG23 ' G' ' 18' ' ' VAL . 7.4 m-85 -127.41 141.3 51.72 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.715 0.806 . . . . 75.34 109.131 -175.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.456 ' HB2' HD11 ' C' ' 51' ' ' LEU . 16.9 tt0 -83.2 111.52 19.01 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.103 -1.408 . . . . 72.23 108.826 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 92.0 t -97.03 119.46 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 108.789 -0.819 . . . . 51.33 108.789 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 33.3 t -123.75 118.21 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.517 0.727 . . . . 70.34 110.477 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 50.0 tp -105.34 110.81 23.31 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.269 -1.011 . . . . 73.02 108.269 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.538 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 0.3 OUTLIER -91.91 107.09 18.96 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.417 -0.586 . . . . 72.21 109.417 178.23 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.08 131.63 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.3 -1.0 . . . . 61.35 108.3 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 26.7 m -127.77 117.82 22.6 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.919 -0.771 . . . . 61.21 108.919 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.56 HG21 HG21 ' C' ' 114' ' ' ILE . 61.1 t -102.27 114.58 42.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 115.106 -0.952 . . . . 62.15 109.139 -177.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 27.8 m -98.01 137.11 37.3 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.008 -1.108 . . . . 74.03 108.008 170.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.18 109.5 6.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.235 -1.394 . . . . 64.3 107.235 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 62.6 m -131.38 128.63 40.0 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.013 0.435 . . . . 54.34 110.531 -176.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' C' ' 37' ' ' GLN . 10.4 mt -85.51 42.6 0.97 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.303 1.441 . . . . 74.44 110.916 -174.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.48 -89.54 0.54 Allowed Glycine 0 C--N 1.348 1.208 0 N-CA-C 110.898 -0.881 . . . . 72.42 110.898 -173.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.9 -25.58 5.8 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.247 1.019 . . . . 61.55 109.544 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -76.37 120.98 22.35 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.107 1.363 . . . . 75.11 109.157 169.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 85.1 m -75.4 126.71 31.57 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.761 0.71 . . . . 34.14 109.422 171.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.722 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.31 -58.91 3.23 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.13 -0.692 . . . . 63.0 109.13 173.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 74' ' ' PHE . . . . . 0.451 ' HZ ' ' HG ' ' C' ' 126' ' ' LEU . 34.8 p90 -159.36 169.86 23.07 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.601 -1.181 . . . . 55.21 111.19 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.436 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.0 tm? -130.03 145.99 51.69 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 105.381 -2.081 . . . . 70.43 105.381 169.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.421 ' N ' HD13 ' C' ' 75' ' ' LEU . 46.2 t -144.74 148.91 34.7 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.929 -1.138 . . . . 61.34 107.929 176.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -158.36 124.76 4.71 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 120.695 0.283 . . . . 72.21 110.628 -173.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 90.0 t -133.97 134.11 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.939 0.896 . . . . 70.34 109.139 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -101.31 93.37 5.39 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.354 -0.98 . . . . 63.11 108.354 170.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -81.53 101.49 9.98 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.393 -0.595 . . . . 71.11 109.393 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.16 169.43 45.93 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 115.797 -0.638 . . . . 63.42 112.472 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.51 126.9 1.08 Allowed Glycine 0 C--O 1.237 0.3 0 N-CA-C 111.452 -0.659 . . . . 64.42 111.452 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.638 HD12 HD11 ' C' ' 51' ' ' LEU . 10.7 mm -85.12 121.28 36.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 108.82 -0.808 . . . . 42.43 108.82 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -131.96 139.91 48.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.371 0.669 . . . . 70.52 109.317 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 16.9 p -92.39 114.51 27.08 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 109.19 -0.67 . . . . 70.53 109.19 170.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.39 104.55 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.405 -0.961 . . . . 72.31 108.405 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.01 165.89 25.94 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.845 0.858 . . . . 44.53 110.197 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.9 -59.72 2.07 Favored Glycine 0 C--N 1.344 1.004 0 O-C-N 123.242 0.339 . . . . 74.52 113.351 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 30.5 pt -81.09 162.65 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 122.923 0.489 . . . . 74.44 110.086 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -147.82 174.24 12.03 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.844 0.458 . . . . 72.04 111.191 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.11 -132.41 50.76 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.909 0.756 . . . . 43.14 114.022 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.0 p -64.17 -21.93 66.75 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.788 0.835 . . . . 64.13 112.259 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -65.29 -54.51 28.12 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.507 0.723 . . . . 73.13 110.629 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.506 ' SD ' HG13 ' G' ' 18' ' ' VAL . 10.2 ptp -72.17 -28.16 63.05 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 116.208 -0.451 . . . . 74.14 110.746 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 95' ' ' ALA . . . . . 0.432 ' HB2' ' HB1' ' G' ' 21' ' ' ALA . . . -65.9 -32.83 74.56 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.226 0.611 . . . . 72.03 110.912 173.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -79.36 -32.08 43.12 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.592 -0.731 . . . . 71.51 110.795 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -59.84 -48.15 82.85 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.393 0.677 . . . . 74.03 111.29 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.611 HD13 ' HB2' ' G' ' 15' ' ' PHE . 1.0 OUTLIER -89.24 -20.07 24.6 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.595 0.358 . . . . 75.32 111.633 176.126 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.49 -29.68 39.18 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 115.064 0.786 . . . . 30.32 115.064 -172.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.88 -39.6 0.3 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.835 0.826 . . . . 63.02 111.265 -172.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.421 ' HE2' ' CE1' ' C' ' 11' ' ' PHE . 67.3 t80 -74.28 -41.03 61.89 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 113.792 -1.549 . . . . 75.34 112.801 -174.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 90.4 m -76.53 -39.45 2.44 Favored Pre-proline 0 N--CA 1.486 1.325 0 CA-C-O 118.959 -0.544 . . . . 75.42 111.938 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -45.55 -35.76 12.92 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.739 2.292 . . . . 75.44 114.652 163.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -66.13 -40.3 90.53 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.237 0.615 . . . . 74.42 110.205 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.515 HD12 ' NH1' ' A' ' 111' ' ' ARG . 45.5 mm -64.81 -40.56 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.142 0.577 . . . . 75.04 110.159 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 91.6 mt -89.06 -8.09 54.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.905 0.882 . . . . 74.31 112.244 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -59.77 -52.21 75.39 Favored Pre-proline 0 N--CA 1.484 1.257 0 C-N-CA 123.883 0.873 . . . . 72.01 113.165 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.41 -30.14 36.84 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 121.614 1.542 . . . . 75.41 112.969 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -70.46 -48.77 54.26 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.184 0.594 . . . . 75.45 110.624 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.25 -41.67 93.7 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.154 -0.93 . . . . 70.11 109.969 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -55.8 -52.22 64.74 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.261 0.976 . . . . 75.2 110.996 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -67.47 -30.12 69.74 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.035 0.534 . . . . 70.4 110.641 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.2 t -74.34 -32.22 62.72 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.071 0.549 . . . . 72.1 111.179 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.56 HG21 HG21 ' C' ' 64' ' ' VAL . 96.1 mt -75.71 -51.64 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.208 0.603 . . . . 75.32 109.995 176.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 12.1 m -63.96 -31.17 72.26 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 123.347 0.659 . . . . 73.42 110.893 -173.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 40.2 t -58.08 -55.25 37.33 Favored 'General case' 0 C--N 1.351 0.63 0 CA-C-N 115.494 -0.775 . . . . 73.2 109.302 169.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.443 ' HG3' HD12 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.43 -36.57 76.15 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.746 1.218 . . . . 70.44 113.138 -179.304 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.45 HG23 ' O ' ' C' ' 114' ' ' ILE . 91.4 t -62.9 -49.46 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.312 0.645 . . . . 74.25 109.798 176.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 42.7 t -71.83 -25.75 62.1 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.03 -0.986 . . . . 45.32 111.656 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 -70.24 -40.56 74.39 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.362 0.665 . . . . 72.34 109.463 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 121' ' ' GLY . . . . . 0.403 ' HA3' ' CE1' ' C' ' 23' ' ' PHE . . . -82.14 8.18 61.47 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.871 0.732 . . . . 74.52 112.915 173.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 82.7 p 54.9 63.7 2.05 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.975 1.71 . . . . 75.35 113.087 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -120.94 155.86 57.2 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 124.321 1.048 . . . . 75.3 108.41 169.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -55.76 161.63 7.83 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.335 2.69 . . . . 73.43 113.891 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -55.1 113.14 1.25 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.424 -0.807 . . . . 61.21 112.406 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.451 ' HG ' ' HZ ' ' C' ' 74' ' ' PHE . 2.4 tm? -117.75 90.16 3.27 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.534 -1.284 . . . . 72.2 107.534 -175.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -114.38 132.66 56.14 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.719 0.807 . . . . 71.01 108.995 176.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.499 HD21 HD11 ' C' ' 42' ' ' LEU . 96.2 mt -69.75 144.28 52.78 Favored 'General case' 0 C--O 1.246 0.871 0 O-C-N 123.682 0.614 . . . . 73.34 111.113 176.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.79 148.52 98.19 Favored Pre-proline 0 C--N 1.351 0.669 0 O-C-N 124.006 0.816 . . . . 55.13 109.849 172.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.491 ' HB2' HD12 ' A' ' 13' ' ' ILE . 31.1 Cg_exo -61.64 87.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.51 2.14 . . . . 64.43 113.199 177.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 95.0 t -104.41 107.71 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.371 -0.831 . . . . 72.04 108.923 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -83.46 106.55 15.3 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.076 -1.083 . . . . 63.11 108.076 171.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -48.44 -38.54 20.05 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.843 1.34 . . . . 70.2 113.035 -174.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.04 -59.22 4.01 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.587 0.755 . . . . 61.41 111.25 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.63 -23.59 67.44 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.867 -0.606 . . . . 71.14 112.077 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 55.0 tp -63.41 -34.15 77.1 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.907 0.883 . . . . 71.43 110.766 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -64.1 -40.16 95.61 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.776 0.43 . . . . 75.43 111.053 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 84.9 mtp -77.49 -43.34 32.51 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.519 0.728 . . . . 74.53 111.367 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -64.18 -36.04 82.76 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.088 0.955 . . . . 65.2 111.078 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -67.65 -84.85 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 108.039 -1.097 . . . . 71.14 108.039 172.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 1.2 tm? 14.77 -79.91 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 127.851 2.46 . . . . 63.21 114.639 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.63 -56.02 5.27 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.931 0.892 . . . . 73.41 110.34 -171.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -145.32 125.61 13.87 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.754 0.821 . . . . 62.33 109.557 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -116.85 162.12 18.23 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.034 0.534 . . . . 71.11 111.748 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 178.73 170.75 0.83 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.724 1.61 . . . . 75.43 108.465 171.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -151.15 -90.76 0.08 OUTLIER Glycine 0 C--N 1.345 1.066 0 CA-C-O 119.961 -0.355 . . . . 44.13 112.782 -176.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 62.39 -179.86 0.13 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.639 1.176 . . . . 62.45 112.177 -174.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.62 -130.24 5.45 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-O 119.605 -0.553 . . . . 75.01 113.422 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 53.2 m 72.38 93.52 0.08 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.402 1.481 . . . . 63.45 110.907 -172.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -80.31 137.22 36.56 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.478 -0.783 . . . . 70.5 109.068 168.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -73.86 -57.32 4.06 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.7 0.8 . . . . 44.41 110.06 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 33.5 m170 70.56 -59.23 0.53 Allowed 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 125.515 1.526 . . . . 70.43 113.112 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -136.67 165.75 25.17 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.009 0.924 . . . . 72.24 109.543 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -60.16 -62.69 1.68 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.227 1.011 . . . . 74.52 111.135 174.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 107.665 -1.235 . . . . 62.33 107.665 177.228 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 1' ' ' MET . . . . . 0.422 ' SD ' ' N ' ' D' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 121.47 0.652 . . . . 73.45 109.703 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 19.7 m -76.14 169.18 18.69 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.719 0.808 . . . . 75.32 112.691 -173.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -158.03 134.26 9.43 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.297 1.039 . . . . 73.24 108.695 172.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 4' ' ' GLN . . . . . 0.569 HE22 ' HB2' ' D' ' 90' ' ' GLU . 0.6 OUTLIER -147.75 139.6 24.05 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.161 0.505 . . . . 74.1 111.862 -172.358 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -98.4 23.61 8.25 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 122.156 0.979 . . . . 54.41 108.463 167.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -70.27 143.01 52.23 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.621 1.169 . . . . 70.22 111.016 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -79.4 22.44 0.44 Allowed 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 123.243 0.617 . . . . 70.32 112.564 -172.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -66.6 -17.65 64.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.394 0.677 . . . . 61.34 111.229 165.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 3.8 tpt -30.94 123.67 0.21 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.839 1.656 . . . . 74.23 113.811 172.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 36.2 m -144.45 150.45 37.66 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.349 -1.352 . . . . 74.31 107.349 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -162.76 89.51 0.66 Allowed 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.798 -0.815 . . . . 71.12 108.798 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -113.81 114.98 27.04 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.568 -1.271 . . . . 72.31 107.568 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mt -82.11 115.97 25.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 108.347 -0.983 . . . . 65.25 108.347 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -75.62 -44.2 44.07 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 123.27 0.356 . . . . 74.44 111.224 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.409 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 22.0 ttt180 -166.87 136.4 2.95 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.072 0.397 . . . . 64.15 112.072 -162.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.402 HD13 ' HG3' ' B' ' 130' ' ' PRO . 1.8 mp -115.31 137.5 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 107.92 -1.141 . . . . 73.04 107.92 171.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.409 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 30.6 p90 -159.74 172.24 18.07 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.201 1.001 . . . . 73.14 112.209 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.9 p -113.69 121.91 45.54 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.179 -1.373 . . . . 74.13 108.751 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -90.7 -22.15 21.27 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.048 -0.524 . . . . 53.22 109.75 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -156.85 128.82 7.26 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 114.719 -1.128 . . . . 74.25 108.325 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.443 HD12 ' HG3' ' C' ' 117' ' ' MET . 12.2 mt -128.68 150.47 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 107.866 -1.161 . . . . 73.3 107.866 174.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -154.79 146.16 23.0 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.837 0.827 . . . . 72.34 110.555 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 88.4 t80 -146.15 141.32 27.38 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 105.894 -1.891 . . . . 73.2 105.894 171.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.512 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.1 mt-10 -142.11 143.48 33.06 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.355 -0.979 . . . . 72.14 108.355 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.4 88.08 5.85 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 107.912 -1.144 . . . . 71.44 107.912 173.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.86 -17.4 13.9 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.975 2.45 . . . . 73.15 113.37 -176.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -113.84 12.88 18.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.436 1.095 . . . . 72.33 110.941 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.449 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -38.18 -67.55 0.25 Allowed Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 126.957 2.103 . . . . 54.43 116.492 -160.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.453 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 74.2 Cg_endo -71.86 -26.79 18.54 Favored 'Trans proline' 0 C--N 1.382 2.3 0 CA-C-N 123.22 2.186 . . . . 75.24 114.368 -171.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -86.45 -25.03 25.42 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 117.755 0.252 . . . . 73.42 110.568 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.638 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.5 p -82.14 -16.0 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 122.78 0.432 . . . . 74.25 111.013 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.453 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.3 m-85 -65.24 -22.83 66.92 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.105 0.409 . . . . 73.51 112.105 177.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -65.14 -15.03 61.96 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.036 0.935 . . . . 64.43 111.385 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -94.9 86.53 4.7 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.057 0.943 . . . . 75.34 110.064 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -87.47 90.86 8.53 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.701 -0.681 . . . . 74.43 109.785 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 42.3 p90 -164.76 175.72 9.43 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.022 0.929 . . . . 72.33 109.197 167.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -73.16 111.56 12.1 Favored Pre-proline 0 N--CA 1.474 0.762 0 N-CA-C 109.178 -0.675 . . . . 45.25 109.178 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -62.77 151.52 83.5 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.574 2.182 . . . . 73.44 111.771 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 56.6 mm-40 -62.77 111.67 2.21 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.018 -1.104 . . . . 65.23 108.018 169.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.771 HG13 HG13 ' D' ' 64' ' ' VAL . 57.8 t -104.68 105.19 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.687 0.795 . . . . 73.44 108.92 -175.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -86.72 129.14 34.99 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.69 -0.856 . . . . 74.4 108.69 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -97.68 110.66 23.18 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.696 -1.224 . . . . 70.4 107.696 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.516 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 10.3 t70 -116.31 130.13 56.62 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.081 -1.451 . . . . 60.31 107.081 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.6 mt -122.29 140.27 52.83 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.142 0.496 . . . . 60.11 111.104 -171.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.55 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 11.7 t70 -136.49 139.48 42.34 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.851 1.26 . . . . 63.2 108.112 174.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 45.4 p -104.03 144.75 31.12 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.361 0.664 . . . . 54.44 110.316 -174.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.413 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -160.7 157.32 26.85 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.46 0.704 . . . . 70.14 110.07 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 32.7 p -175.84 167.96 3.06 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.244 0.545 . . . . 71.34 112.178 -178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 62.5 p -156.63 126.65 6.41 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.002 -0.999 . . . . 75.21 108.471 169.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -74.24 121.09 20.73 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.422 -0.584 . . . . 74.04 109.422 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 46.8 mt -90.09 -25.5 20.72 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.273 0.629 . . . . 74.31 110.86 -172.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -172.53 -173.54 1.05 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.028 1.331 . . . . 63.02 109.56 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.87 120.49 12.65 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.886 -0.413 . . . . 73.51 109.886 176.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 69.57 -2.88 1.79 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.964 1.305 . . . . 65.53 112.595 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 97.4 t -110.92 120.06 60.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.432 -1.321 . . . . 74.24 107.432 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -150.36 142.39 23.97 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.385 0.612 . . . . 63.13 109.742 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -88.66 122.69 32.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.166 -1.379 . . . . 73.44 109.3 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 96.0 t -100.48 119.17 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 107.879 -1.156 . . . . 71.11 107.879 173.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.413 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 38.7 t -106.84 131.33 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.316 -0.994 . . . . 55.31 108.316 173.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.424 HD13 ' HZ ' ' H' ' 15' ' ' PHE . 15.8 tp -128.58 120.1 26.03 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 109.307 -0.627 . . . . 72.13 109.307 174.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.55 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 28.3 ttm-85 -82.62 99.09 9.35 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.555 -0.906 . . . . 72.11 108.555 177.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 77.1 t -91.25 117.55 34.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.987 -1.116 . . . . 73.21 107.987 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 28.7 m -117.01 135.38 53.74 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.478 -0.564 . . . . 74.13 109.478 -176.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.771 HG13 HG13 ' D' ' 40' ' ' VAL . 41.2 t -128.23 101.21 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.927 1.291 . . . . 74.52 108.684 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 92.8 m -93.04 116.74 29.33 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 107.878 -1.156 . . . . 73.12 107.878 172.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -106.02 133.96 49.9 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.604 -0.517 . . . . 72.21 109.604 -177.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 18.2 m -128.22 123.04 33.24 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.534 -0.543 . . . . 63.44 109.534 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 31.0 mt -108.9 113.22 25.94 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.693 -1.225 . . . . 73.01 107.693 173.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.78 -133.64 21.22 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 123.467 0.479 . . . . 31.3 112.871 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.76 6.82 39.89 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.718 0.807 . . . . 75.11 111.663 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -140.83 174.93 10.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.153 0.502 . . . . 55.45 111.482 -172.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 32.7 m -73.72 135.44 43.64 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.484 1.114 . . . . 73.22 111.322 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.638 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -86.35 -65.27 1.03 Allowed 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.024 -0.732 . . . . 60.33 109.024 168.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -150.36 151.98 33.69 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.593 -1.185 . . . . 75.15 110.894 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 60.9 mt -110.86 109.84 20.19 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.883 -1.155 . . . . 74.04 107.883 171.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.468 ' SG ' HG23 ' D' ' 114' ' ' ILE . 48.1 t -116.9 142.14 47.32 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.607 0.763 . . . . 72.4 109.191 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -157.01 142.68 17.61 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.0 0.52 . . . . 75.15 109.793 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 77.7 t -138.89 139.33 40.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 108.173 -1.047 . . . . 73.05 108.173 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -110.58 87.1 2.45 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 107.3 -1.37 . . . . 75.34 107.3 173.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -80.1 99.53 7.77 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.258 -1.337 . . . . 63.41 109.398 -171.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.29 142.78 16.14 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 110.88 -0.888 . . . . 61.43 110.88 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.11 132.71 4.19 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 111.657 -0.577 . . . . 45.04 111.657 -177.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 60.2 mt -87.94 120.39 36.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 109.236 -0.653 . . . . 33.31 109.236 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -121.15 133.14 55.19 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.179 0.591 . . . . 73.1 109.929 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.9 m -111.37 92.99 4.25 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.747 -0.834 . . . . 54.33 108.747 175.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.76 HG23 HG21 ' H' ' 18' ' ' VAL . 0.0 OUTLIER -123.19 142.71 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.103 0.961 . . . . 75.21 108.622 -176.718 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.99 160.62 39.52 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 122.967 0.507 . . . . 44.25 111.342 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.62 21.07 52.52 Favored Glycine 0 C--N 1.34 0.759 0 CA-C-N 114.572 -1.195 . . . . 75.44 114.414 171.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.47 HD12 HD11 ' D' ' 86' ' ' ILE . 33.2 mt -134.04 127.88 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 117.287 0.543 . . . . 75.34 109.665 176.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.569 ' HB2' HE22 ' D' ' 4' ' ' GLN . 38.1 mt-10 -140.96 171.85 13.49 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.942 0.897 . . . . 62.34 111.097 -171.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.97 -118.77 13.93 Favored Glycine 0 C--N 1.354 1.565 0 CA-C-N 114.944 -1.025 . . . . 63.55 114.861 172.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 20.4 m -86.94 -28.18 22.88 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.343 0.657 . . . . 54.03 111.046 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -68.36 -34.06 75.4 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.78 -0.646 . . . . 54.51 111.025 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.516 ' HG2' ' HB1' ' H' ' 21' ' ' ALA . 0.0 OUTLIER -70.33 -23.3 62.8 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 116.039 -0.528 . . . . 74.12 111.164 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.26 -26.95 68.68 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.86 0.464 . . . . 73.35 110.926 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -78.62 -40.73 33.52 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.843 0.857 . . . . 65.44 111.396 174.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -65.51 -43.97 88.41 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.907 0.483 . . . . 65.2 110.585 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.445 HD21 ' HA ' ' H' ' 17' ' ' PRO . 8.7 mp -67.54 -53.17 30.73 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.365 1.066 . . . . 55.12 109.981 173.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.81 -3.63 68.5 Favored Glycine 0 C--N 1.342 0.887 0 N-CA-C 115.057 0.783 . . . . 74.41 115.057 -171.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.64 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -147.13 -65.57 0.27 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.046 0.923 . . . . 65.35 112.906 -177.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -61.91 -58.76 6.7 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.955 0.724 . . . . 73.31 112.955 -162.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 75.3 m -63.54 -44.79 82.41 Favored Pre-proline 0 CA--C 1.567 1.626 0 N-CA-C 113.923 1.083 . . . . 74.22 113.923 -175.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.73 -25.49 39.82 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 121.7 1.6 . . . . 73.53 113.132 172.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 104' ' ' ASN . . . . . 0.565 ' HA ' ' HD2' ' D' ' 107' ' ' PHE . 2.4 t-20 -69.47 -28.7 66.31 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.845 0.458 . . . . 62.13 110.75 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 51.6 mm -65.07 -35.27 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.402 0.681 . . . . 50.42 110.109 171.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.95 -19.04 48.89 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.587 -0.733 . . . . 71.1 112.619 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 107' ' ' PHE . . . . . 0.565 ' HD2' ' HA ' ' D' ' 104' ' ' ASN . 27.9 m-85 -60.9 -44.36 94.51 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 113.724 1.009 . . . . 71.1 113.724 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -51.14 -44.99 39.38 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 122.519 2.146 . . . . 73.32 114.329 170.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -77.16 -31.66 55.69 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.376 0.67 . . . . 75.13 111.897 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.14 -48.95 71.74 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.075 -0.713 . . . . 52.41 109.075 175.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -54.61 -47.15 73.76 Favored 'General case' 0 C--N 1.352 0.682 0 O-C-N 124.855 1.347 . . . . 74.32 110.937 177.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.35 -46.81 87.0 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.399 0.679 . . . . 72.4 111.311 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 36.4 t -62.05 -42.78 99.54 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.407 0.442 . . . . 71.24 111.238 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.468 HG23 ' SG ' ' D' ' 76' ' ' CYS . 96.9 mt -61.31 -58.3 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.119 0.967 . . . . 61.01 111.114 175.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 89.4 m -55.92 -40.77 73.56 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.569 1.148 . . . . 63.23 112.068 -173.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 44.7 t -65.04 -42.16 94.54 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.573 -0.739 . . . . 75.54 110.707 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.1 mtm -68.46 -31.69 71.17 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.811 0.444 . . . . 73.33 111.452 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.43 HG23 ' O ' ' D' ' 114' ' ' ILE . 73.6 t -63.43 -44.65 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 123.525 0.73 . . . . 64.3 110.373 174.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.7 p -77.77 -25.83 49.37 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.056 -0.52 . . . . 74.14 111.572 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -71.64 -36.27 70.67 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.316 0.647 . . . . 53.23 109.6 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.95 0.24 73.13 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.36 -0.837 . . . . 70.13 112.509 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.6 p 61.37 25.29 15.27 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.642 1.977 . . . . 72.22 113.405 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -80.37 164.13 53.53 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.266 1.027 . . . . 62.43 109.717 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.4 129.82 29.64 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.109 1.873 . . . . 72.55 111.423 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -51.32 123.64 10.09 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.402 1.081 . . . . 62.45 111.577 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -116.41 96.73 5.66 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.98 -1.118 . . . . 41.2 107.98 -174.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -98.66 117.89 34.14 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.897 -0.779 . . . . 74.31 108.897 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.597 ' HA ' HD11 ' H' ' 6' ' ' ILE . 6.4 mp -73.97 113.47 11.18 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 109.686 -0.487 . . . . 73.53 109.686 176.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -54.51 134.62 62.96 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 124.154 0.982 . . . . 74.21 110.953 176.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.504 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 2.8 Cg_exo -72.94 144.64 38.73 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.875 2.383 . . . . 73.24 111.756 -171.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.55 131.95 54.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 123.643 0.777 . . . . 74.11 109.357 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -81.54 82.68 7.24 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.076 -1.083 . . . . 72.23 108.076 174.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -71.03 -21.37 62.28 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.414 -1.266 . . . . 74.01 110.732 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.64 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 15.5 t70 -54.58 -52.72 61.26 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.567 1.147 . . . . 65.21 110.841 172.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.488 ' HA ' ' SD ' ' D' ' 138' ' ' MET . . . -65.26 -37.06 86.04 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.663 0.785 . . . . 71.14 112.37 -179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.92 -42.43 98.12 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.229 0.612 . . . . 64.11 112.075 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -75.17 -26.87 59.41 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.632 -0.713 . . . . 72.42 111.211 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.488 ' SD ' ' HA ' ' D' ' 135' ' ' ALA . 61.5 mtt -54.56 -33.77 60.73 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.199 0.6 . . . . 72.4 111.67 176.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -64.98 -28.54 69.58 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.781 0.833 . . . . 64.45 111.977 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -66.46 -38.07 86.53 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.45 0.7 . . . . 73.1 110.408 172.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.4 -27.6 62.46 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.028 0.531 . . . . 65.34 110.935 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -74.99 -0.79 19.96 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.901 0.48 . . . . 70.2 111.303 173.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -129.35 44.16 3.02 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.206 -1.035 . . . . 72.2 108.206 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -173.97 114.62 0.21 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.173 0.989 . . . . 75.11 108.8 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -153.25 -177.1 6.11 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.445 0.698 . . . . 62.21 110.697 -176.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 58.49 -136.32 51.16 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-N 115.583 -0.735 . . . . 71.02 112.972 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -86.85 73.59 9.94 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.383 0.673 . . . . 74.41 109.405 175.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -106.23 59.15 0.41 Allowed Glycine 0 C--N 1.351 1.408 0 N-CA-C 109.947 -1.261 . . . . 45.03 109.947 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 6.1 m -73.61 82.54 1.53 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.719 0.807 . . . . 71.12 110.279 -177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -100.87 93.42 5.52 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.665 0.745 . . . . 62.31 109.282 174.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -102.89 -164.49 1.09 Allowed 'General case' 0 C--O 1.244 0.766 0 CA-C-N 114.351 -1.295 . . . . 74.3 109.215 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -71.97 86.5 1.01 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.008 0.432 . . . . 64.34 110.151 173.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -64.54 111.05 2.53 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.271 -0.64 . . . . 71.23 109.271 172.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -85.42 80.73 9.01 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.367 0.603 . . . . 72.25 110.361 -171.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.268 0 N-CA-C 107.915 -1.143 . . . . 71.05 107.915 175.288 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 109.83 -0.433 . . . . 51.21 109.83 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -105.86 172.68 6.67 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.998 0.919 . . . . 75.1 110.404 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -158.11 149.0 20.8 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.343 0.657 . . . . 75.34 109.759 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 40.7 m -144.11 103.74 4.04 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.195 0.998 . . . . 44.25 108.569 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 5' ' ' THR . . . . . 0.502 ' H ' ' NE2' ' C' ' 12' ' ' GLN . 28.8 m -65.33 -76.61 0.07 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.212 0.605 . . . . 73.41 109.946 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.737 ' HB ' HD21 ' A' ' 42' ' ' LEU . 1.6 pp -157.78 156.03 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.28 1.032 . . . . 61.52 109.119 171.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -161.25 172.24 17.01 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.135 0.574 . . . . 40.54 110.527 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.563 ' H ' HD23 ' E' ' 8' ' ' LEU . 1.3 pt? -122.96 152.38 40.91 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.133 0.973 . . . . 51.54 109.855 -175.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.78 -174.98 4.2 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.761 0.824 . . . . 71.4 112.046 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 30.0 tp -77.72 17.93 0.51 Allowed 'General case' 0 CA--C 1.568 1.648 0 C-N-CA 124.442 1.097 . . . . 74.41 112.037 -173.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 7.3 mp 70.45 142.18 0.09 OUTLIER Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 125.295 1.438 . . . . 52.31 111.229 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.39 -20.53 20.85 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.242 1.961 . . . . 74.25 112.096 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 pp -154.22 170.36 21.43 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.202 1.001 . . . . 74.22 110.229 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 84.4 mt -104.37 179.64 4.21 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.155 0.582 . . . . 43.52 111.101 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -86.99 154.28 20.9 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.359 1.064 . . . . 65.11 109.038 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 64.2 p -65.87 146.65 98.99 Favored Pre-proline 0 CA--C 1.557 1.216 0 C-N-CA 123.471 0.708 . . . . 74.34 110.917 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 17' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -51.08 150.69 13.24 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.644 2.896 . . . . 74.03 114.483 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 99.2 t -54.79 -41.92 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 124.137 0.975 . . . . 73.31 110.907 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 5.8 t -155.32 -39.73 0.09 Allowed 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.998 -1.001 . . . . 72.31 110.678 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -150.12 -59.93 0.2 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.895 0.478 . . . . 75.25 110.424 -176.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 57.23 69.73 0.72 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.514 1.126 . . . . 63.4 111.248 -174.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -70.42 107.85 4.0 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.449 -0.945 . . . . 74.52 108.449 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 33.0 m -54.58 116.1 10.15 Favored Pre-proline 0 CA--C 1.552 1.05 0 O-C-N 124.509 1.131 . . . . 71.54 110.399 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 24' ' ' PRO . . . . . 0.509 ' HD2' HG23 ' A' ' 92' ' ' THR . 95.1 Cg_endo -86.73 -151.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.708 2.272 . . . . 53.3 110.671 174.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.12 0 N-CA-C 106.338 -1.727 . . . . 71.34 106.338 172.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 70.6 mtp . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.555 0.217 . . . . 63.55 110.662 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -101.14 -156.78 0.57 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.766 1.226 . . . . 73.04 107.911 168.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -62.9 -52.78 61.76 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.265 0.555 . . . . 74.11 109.523 173.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 37.9 m -110.28 110.64 21.54 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.295 1.038 . . . . 53.11 109.691 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 59.5 m -148.02 -40.63 0.17 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.272 0.629 . . . . 63.23 110.185 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' B' ' 128' ' ' LEU . 14.7 tt -139.84 90.93 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-O 122.26 1.029 . . . . 74.4 110.164 -176.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 7' ' ' ALA . . . . . 0.419 ' HA ' HG21 ' B' ' 131' ' ' VAL . . . -157.34 143.51 17.8 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.943 -1.026 . . . . 70.13 110.04 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 20.8 mt -76.59 87.86 3.29 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 109.726 -0.472 . . . . 55.45 109.726 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.52 77.14 10.08 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.15 0.58 . . . . 63.12 110.363 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 97.4 mt 60.4 -170.32 0.15 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.349 1.06 . . . . 75.52 112.678 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.436 ' HG ' ' HZ ' ' B' ' 133' ' ' PHE . 98.8 mt -113.95 151.37 44.75 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.16 0.984 . . . . 74.22 109.683 177.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -59.34 -49.41 10.79 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 122.964 2.443 . . . . 75.24 111.636 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.7 153.91 23.61 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.764 0.826 . . . . 62.42 108.865 172.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -69.73 109.34 4.33 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 107.349 -1.352 . . . . 74.15 107.349 175.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -78.56 79.25 4.99 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.696 0.76 . . . . 73.44 109.41 -172.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 7.3 t -134.56 68.33 72.26 Favored Pre-proline 0 CA--C 1.556 1.183 0 CA-C-N 114.668 -1.151 . . . . 74.44 109.157 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 17' ' ' PRO . . . . . 0.56 ' HD2' HD11 ' B' ' 98' ' ' LEU . 32.8 Cg_exo -62.35 -38.68 51.95 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.369 2.046 . . . . 73.23 111.809 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -49.77 -23.96 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 125.218 1.407 . . . . 71.24 113.12 -172.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 24.2 m -49.52 -48.25 48.32 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.514 1.126 . . . . 72.35 112.237 175.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -115.06 -20.17 10.58 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.454 0.702 . . . . 71.21 110.884 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.4 87.5 0.45 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.46 0.704 . . . . 74.13 111.372 -172.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -158.69 97.49 1.45 Allowed 'General case' 0 C--O 1.237 0.413 0 N-CA-C 106.791 -1.559 . . . . 73.23 106.791 167.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 9.3 t -64.55 141.84 98.33 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 115.958 -0.564 . . . . 72.11 110.793 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.63 165.45 11.53 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.333 2.022 . . . . 75.21 112.155 169.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 CA--C 1.562 1.416 0 C-N-CA 123.492 0.717 . . . . 71.1 111.282 175.952 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' G' G ' 1' ' ' MET . . . . . 0.42 ' SD ' ' N ' ' G' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 110.032 -0.358 . . . . 75.34 110.032 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -139.63 118.72 12.65 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.738 -1.208 . . . . 75.22 107.738 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -140.07 138.79 35.63 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.67 0.788 . . . . 74.44 109.603 -174.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 34.7 m -65.21 -37.36 87.04 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.694 0.797 . . . . 74.41 110.987 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -79.91 152.52 29.55 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.03 -0.986 . . . . 43.42 109.748 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 6' ' ' ILE . . . . . 0.517 HD12 HG11 ' C' ' 40' ' ' VAL . 27.3 pt -63.73 131.42 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.028 0.931 . . . . 72.12 112.011 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.84 -179.03 5.17 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.153 0.581 . . . . 74.15 111.993 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 8' ' ' LEU . . . . . 0.409 HD23 ' N ' ' G' ' 9' ' ' ALA . 3.8 tt -136.56 137.56 40.35 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 107.442 -1.318 . . . . 72.32 107.442 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 9' ' ' ALA . . . . . 0.409 ' N ' HD23 ' G' ' 8' ' ' LEU . . . -76.11 -179.84 5.22 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.779 0.832 . . . . 25.15 112.47 -177.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 59.1 mt -75.43 164.29 26.54 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.489 0.716 . . . . 71.42 110.708 175.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 89.4 mt -86.97 129.93 50.28 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 109.023 -0.732 . . . . 75.22 109.023 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.86 -45.47 10.62 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.885 2.39 . . . . 62.13 112.25 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 95.6 mt -134.99 175.89 9.16 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.633 1.173 . . . . 75.35 108.79 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 83.6 mt -103.13 -178.04 3.55 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.106 0.562 . . . . 73.5 109.667 173.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 15' ' ' PHE . . . . . 0.611 ' HB2' HD13 ' C' ' 98' ' ' LEU . 2.2 m-85 -78.11 171.37 15.12 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.463 0.705 . . . . 73.24 110.774 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 12.4 m -66.81 128.41 93.85 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-O 118.511 -0.757 . . . . 72.43 109.387 174.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 17' ' ' PRO . . . . . 0.496 ' HB3' ' HB3' ' G' ' 21' ' ' ALA . 41.6 Cg_exo -43.69 142.32 3.4 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.962 3.108 . . . . 74.53 114.587 174.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 18' ' ' VAL . . . . . 0.53 HG13 ' H ' ' G' ' 19' ' ' THR . 2.2 p -74.17 -91.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 CA-C-O 119.083 -0.484 . . . . 64.53 109.926 176.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 19' ' ' THR . . . . . 0.53 ' H ' HG13 ' G' ' 18' ' ' VAL . 8.4 m -86.58 -52.5 5.52 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.603 1.092 . . . . 74.31 110.486 -174.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -162.83 105.85 1.06 Allowed 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 116.084 -0.507 . . . . 62.25 110.248 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 21' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' G' ' 17' ' ' PRO . . . -140.15 16.08 2.43 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.526 0.73 . . . . 74.02 110.751 176.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -83.32 160.94 21.57 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.541 0.736 . . . . 74.42 110.333 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 86.5 m 56.98 81.93 0.25 Allowed Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 124.106 0.962 . . . . 74.14 111.35 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -64.73 -67.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 121.759 1.639 . . . . 51.4 109.501 167.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.338 1.455 . . . . 74.53 107.95 166.481 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 12.3 tpt . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 109.275 -0.639 . . . . 60.22 109.275 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -85.68 -174.25 5.05 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.582 0.753 . . . . 74.14 109.89 172.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -82.09 64.2 6.66 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.639 1.209 . . . . 74.24 109.486 169.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 50.2 m -83.17 62.26 6.54 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 114.489 -1.232 . . . . 74.31 109.451 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 43.6 m -163.8 99.22 0.88 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 106.004 -1.85 . . . . 73.45 106.004 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.597 HD11 ' HA ' ' D' ' 128' ' ' LEU . 3.1 mp 62.17 98.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 124.3 1.04 . . . . 63.22 110.119 -174.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.35 96.1 3.41 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.629 0.772 . . . . 72.41 110.185 -174.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.41 121.12 42.14 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.211 1.004 . . . . 71.13 109.51 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.75 29.17 6.63 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.91 0.884 . . . . 75.34 110.273 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 9.7 mp 66.09 176.08 0.22 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 125.114 1.366 . . . . 51.32 111.174 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.37 123.45 39.54 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 123.256 0.622 . . . . 65.2 110.593 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.26 129.55 18.33 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.796 2.331 . . . . 71.14 110.636 168.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 64.21 179.88 0.17 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.715 1.206 . . . . 71.1 111.448 -172.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 88.3 mt -122.64 173.09 7.93 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.242 1.017 . . . . 73.35 109.701 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 15' ' ' PHE . . . . . 0.424 ' HZ ' HD13 ' D' ' 60' ' ' LEU . 76.6 m-85 -89.45 -168.83 2.27 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.333 0.653 . . . . 62.2 109.734 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 21.4 p -68.62 131.17 91.52 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.047 0.539 . . . . 73.13 110.411 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 17' ' ' PRO . . . . . 0.445 ' HA ' HD21 ' D' ' 98' ' ' LEU . 53.4 Cg_endo -65.59 146.45 84.57 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 123.061 2.507 . . . . 71.43 113.461 -171.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 18' ' ' VAL . . . . . 0.76 HG21 HG23 ' D' ' 86' ' ' ILE . 8.3 p -110.4 151.65 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.438 0.695 . . . . 73.01 110.267 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 3.4 m 58.07 29.8 18.34 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.326 1.05 . . . . 73.21 110.226 -176.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 72.16 -48.97 0.69 Allowed 'General case' 0 C--N 1.369 1.435 0 C-N-CA 126.04 1.736 . . . . 72.42 111.439 -175.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 21' ' ' ALA . . . . . 0.516 ' HB1' ' HG2' ' D' ' 94' ' ' MET . . . 75.07 -75.94 0.07 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.854 1.262 . . . . 75.41 113.299 163.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -41.1 80.91 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.178 0.591 . . . . 75.33 109.469 -178.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 31.6 p -108.57 92.46 10.17 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.667 1.187 . . . . 75.32 109.204 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.29 -177.76 0.71 Allowed 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.853 2.369 . . . . 64.31 113.607 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 . . . . . 0 C--O 1.256 1.406 0 C-N-CA 124.143 0.977 . . . . 75.33 110.888 -179.217 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 ppp? . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 110.431 -0.211 . . . . 71.42 110.431 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -138.58 143.69 39.49 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.232 0.613 . . . . 70.41 111.289 -170.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -83.15 98.02 9.12 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.314 0.646 . . . . 64.35 109.303 170.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -78.96 68.04 4.81 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.981 0.512 . . . . 44.01 110.474 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -133.0 112.02 11.49 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.048 -0.723 . . . . 72.35 109.048 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.414 ' HB2' HG22 ' A' ' 89' ' ' ILE . 15.2 m120 -71.71 173.96 7.44 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.59 -0.732 . . . . 73.22 110.217 173.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.568 ' HB ' ' HA2' ' A' ' 88' ' ' GLY . 81.7 m -73.69 156.2 38.18 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.601 -0.727 . . . . 72.24 110.029 176.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.29 130.99 46.0 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.583 -0.525 . . . . 74.12 109.583 172.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.464 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -64.58 138.75 58.58 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.603 0.564 . . . . 74.42 109.662 -176.118 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.9 m -137.91 130.79 29.97 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 108.529 -0.915 . . . . 43.45 108.529 -170.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.589 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 26.6 t80 -136.4 124.28 22.68 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.422 0.689 . . . . 74.13 109.334 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -143.33 119.58 10.84 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.701 0.8 . . . . 71.4 108.859 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.622 HG12 ' HD2' ' A' ' 84' ' ' PHE . 49.5 mt -80.2 124.6 38.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.513 -0.551 . . . . 74.52 109.513 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.23 -42.28 13.92 Favored 'General case' 0 C--O 1.245 0.848 0 O-C-N 123.993 0.808 . . . . 73.14 109.36 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -173.43 122.36 0.36 Allowed 'General case' 0 N--CA 1.483 1.185 0 O-C-N 123.081 0.238 . . . . 73.44 111.477 -168.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.416 HD11 HD13 ' A' ' 13' ' ' ILE . 94.8 mt -113.79 138.53 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.99 0.916 . . . . 65.33 109.26 175.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HB3' HG23 ' B' ' 122' ' ' THR . 32.3 p90 -167.3 166.69 14.54 Favored 'General case' 0 C--N 1.347 0.496 0 O-C-N 123.902 0.751 . . . . 72.31 111.511 -173.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -89.24 127.29 35.75 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.116 -0.698 . . . . 74.51 109.116 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.402 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 33.6 mtpt -96.52 -21.88 17.43 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 120.913 0.387 . . . . 61.52 109.958 176.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.739 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.0 t70 -152.16 141.27 21.29 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 114.7 -1.136 . . . . 75.01 109.588 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 82.6 mt -141.51 138.29 32.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 106.556 -1.646 . . . . 73.43 106.556 175.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.5 t -144.66 128.32 17.17 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.55 -0.907 . . . . 72.35 108.55 174.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.519 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 87.4 t80 -138.48 124.84 20.49 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.164 -1.421 . . . . 72.24 107.164 175.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -125.59 142.68 51.38 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.915 -0.772 . . . . 64.22 108.915 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.33 71.53 39.15 Favored Pre-proline 0 C--O 1.243 0.755 0 N-CA-C 105.83 -1.915 . . . . 72.44 105.83 168.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.53 -15.16 34.18 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.39 2.06 . . . . 73.22 112.181 -170.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -117.18 21.6 13.07 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 118.169 -0.92 . . . . 73.0 109.495 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.413 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -45.37 -59.17 4.72 Favored Pre-proline 0 N--CA 1.495 1.804 0 CA-C-O 117.998 -1.001 . . . . 61.12 113.329 -171.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -72.16 -9.44 24.46 Favored 'Trans proline' 0 C--N 1.381 2.288 0 CA-C-N 121.629 1.617 . . . . 64.43 112.783 -176.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -90.31 -39.46 12.71 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.858 0.863 . . . . 75.44 110.251 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.859 HG21 ' HA ' ' A' ' 73' ' ' ALA . 6.5 p -79.21 -23.17 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 114.906 -1.043 . . . . 73.31 112.059 -162.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -67.48 -21.12 65.53 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.094 0.558 . . . . 74.22 110.928 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -74.46 -39.23 62.66 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.141 0.976 . . . . 74.13 110.307 173.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.511 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 3.3 tmtp? -69.01 143.35 54.37 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.71 1.204 . . . . 72.01 110.374 -169.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.511 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 12.9 m-20 -57.82 121.5 10.62 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.098 0.959 . . . . 74.14 110.843 175.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -77.7 90.66 4.0 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.191 0.597 . . . . 73.21 110.691 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.403 ' H ' HD22 ' A' ' 68' ' ' LEU . 40.6 tt0 -125.81 82.05 64.7 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 107.582 -1.266 . . . . 74.4 107.582 168.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.0 118.86 4.52 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.327 2.018 . . . . 52.12 112.836 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -95.79 94.67 7.8 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.512 -1.292 . . . . 71.55 107.512 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.433 HG13 HG13 ' A' ' 64' ' ' VAL . 44.0 t -67.7 101.21 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 114.622 -1.172 . . . . 75.23 109.594 -177.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.23 115.76 19.96 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.535 1.134 . . . . 74.43 109.221 175.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -96.8 134.99 39.39 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.123 -0.695 . . . . 74.42 109.123 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.628 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 27.5 t70 -145.07 107.53 4.4 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.31 -0.996 . . . . 55.31 108.31 172.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.64 132.3 48.84 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.957 -0.757 . . . . 74.53 108.957 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.667 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 16.2 t70 -129.72 132.54 46.65 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.876 -0.787 . . . . 75.52 108.876 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.4 p -108.01 137.72 45.52 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.815 0.846 . . . . 61.53 110.158 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.57 139.28 18.84 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.745 0.818 . . . . 73.43 110.066 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.685 ' HB2' HG22 ' E' ' 16' ' ' THR . 56.7 m -132.53 156.03 47.55 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.844 0.457 . . . . 73.13 110.472 173.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.3 t -148.8 118.12 6.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.149 0.979 . . . . 74.34 108.739 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 46.5 tt0 -76.93 122.53 25.0 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.95 -0.759 . . . . 64.13 108.95 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 57' ' ' GLU . 75.7 mt -95.11 -31.72 13.43 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.528 0.731 . . . . 43.04 111.774 -172.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.52 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -155.8 -179.45 8.13 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.454 0.701 . . . . 73.34 110.008 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -65.88 117.7 8.63 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.901 -0.777 . . . . 64.24 108.901 172.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 65.96 18.24 11.01 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.828 1.251 . . . . 71.42 112.083 -178.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 58.4 t -126.22 121.94 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 108.391 -0.966 . . . . 64.34 108.391 174.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -129.02 172.29 11.53 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.259 0.552 . . . . 72.54 109.584 174.049 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.407 ' HB2' HD11 ' A' ' 51' ' ' LEU . 35.7 tt0 -127.55 132.5 49.87 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.135 -0.938 . . . . 71.23 108.62 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.547 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 77.0 t -107.28 119.8 57.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 107.474 -1.306 . . . . 61.45 107.474 173.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.2 t -115.74 129.35 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 108.813 -0.81 . . . . 73.33 108.813 174.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tt -128.21 116.58 20.11 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.582 -0.896 . . . . 70.35 108.582 -176.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.667 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 15.6 ttm180 -84.34 106.06 15.66 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.43 1.092 . . . . 71.33 109.433 176.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.6 t -98.74 101.38 12.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 107.581 -1.266 . . . . 65.02 107.581 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 21.1 m -98.28 107.08 19.46 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.622 0.769 . . . . 71.53 109.076 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.433 HG13 HG13 ' A' ' 40' ' ' VAL . 8.2 t -113.38 109.1 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.231 1.012 . . . . 71.12 109.456 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -104.09 130.88 51.82 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 108.044 -1.095 . . . . 74.14 108.044 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.1 109.95 21.79 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.006 -1.479 . . . . 74.51 107.006 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.7 m -114.06 125.13 53.63 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.135 0.493 . . . . 41.12 110.019 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.403 HD22 ' H ' ' A' ' 37' ' ' GLN . 25.9 mt -93.36 76.14 4.51 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 107.896 -1.149 . . . . 71.45 107.896 176.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.38 -84.67 0.95 Allowed Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.414 -0.674 . . . . 64.23 111.414 -175.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -123.46 -25.28 4.42 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.29 1.036 . . . . 74.22 110.124 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -79.05 107.72 12.01 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.511 0.724 . . . . 73.11 109.98 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.5 m -66.14 130.68 44.08 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.113 0.483 . . . . 73.43 110.386 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.859 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -81.89 -58.96 2.75 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.16 -0.927 . . . . 53.14 109.179 175.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -154.99 169.01 25.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 114.396 -1.275 . . . . 75.33 110.945 176.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 23.8 tp -128.13 132.0 48.96 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.857 -1.535 . . . . 73.22 106.857 169.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.422 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 65.3 m -132.96 95.72 3.62 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.606 -0.887 . . . . 42.22 108.606 176.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -111.92 114.63 27.66 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.49 -0.929 . . . . 74.34 108.49 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -124.67 131.98 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 109.435 -0.579 . . . . 64.03 109.435 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.739 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 51.3 mt-30 -103.61 99.09 8.88 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.411 -0.588 . . . . 55.43 109.411 170.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -85.22 114.36 22.27 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.917 -1.038 . . . . 73.04 109.527 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.12 146.71 17.51 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.816 -0.514 . . . . 71.1 111.816 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.579 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -143.29 123.33 2.07 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 112.079 -0.408 . . . . 63.42 112.079 176.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.2 mt -81.98 124.29 38.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.752 -0.833 . . . . 73.12 108.752 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.622 ' HD2' HG12 ' A' ' 13' ' ' ILE . 18.9 m-85 -135.08 135.73 41.45 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.085 -0.709 . . . . 75.03 109.085 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.8 t -99.82 116.02 30.91 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.777 -0.823 . . . . 64.23 108.777 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.7 HD11 HG21 ' E' ' 18' ' ' VAL . 0.1 OUTLIER -130.48 150.66 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.639 1.176 . . . . 74.0 110.155 -173.575 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -177.47 -178.08 0.73 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.025 0.93 . . . . 54.01 110.083 173.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.568 ' HA2' ' HB ' ' A' ' 7' ' ' THR . . . 117.41 -83.96 0.36 Allowed Glycine 0 C--N 1.339 0.721 0 O-C-N 123.73 0.644 . . . . 73.3 112.117 175.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 94' ' ' MET . 26.6 pt -120.01 139.61 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.952 0.901 . . . . 71.41 108.998 -175.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -115.38 -165.24 1.01 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.725 0.81 . . . . 64.4 111.101 -171.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.632 ' HA3' HG23 ' E' ' 23' ' ' THR . . . 72.5 -140.59 29.6 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-O 119.577 -0.569 . . . . 73.11 112.712 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -62.62 -26.5 68.65 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.724 0.81 . . . . 70.33 112.031 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -68.63 -47.47 66.53 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.924 0.89 . . . . 62.33 110.724 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 89' ' ' ILE . 55.8 ttm -80.38 -24.35 39.81 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.86 0.464 . . . . 74.41 111.145 176.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.42 -32.24 73.5 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.034 0.534 . . . . 62.12 111.227 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -68.98 -31.86 71.02 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 116.044 -0.525 . . . . 73.15 110.634 173.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 42.0 t -68.65 -55.22 12.21 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.891 0.477 . . . . 54.44 110.742 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 pp -76.39 -16.7 59.66 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.42 0.526 . . . . 71.4 112.42 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.48 -7.24 46.06 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-O 119.465 -0.631 . . . . 64.43 114.57 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -144.01 -61.96 0.39 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 117.594 0.697 . . . . 53.44 110.891 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.426 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 70.7 t80 -62.08 -66.06 0.6 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.468 1.107 . . . . 65.14 113.581 -169.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.4 m -64.37 -38.24 31.69 Favored Pre-proline 0 CA--C 1.566 1.594 0 N-CA-C 113.741 1.015 . . . . 74.12 113.741 -175.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -65.3 -27.1 55.79 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 121.672 1.581 . . . . 73.43 113.769 167.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 37.6 t-20 -72.41 -28.53 63.04 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 122.952 0.501 . . . . 72.4 109.744 176.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.505 HG21 ' CD1' ' A' ' 13' ' ' ILE . 49.2 mm -61.92 -40.41 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.457 0.703 . . . . 54.51 109.716 171.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.579 HD21 ' HA3' ' A' ' 82' ' ' GLY . 95.5 mt -77.41 -25.38 50.71 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.386 -0.825 . . . . 71.32 112.239 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -57.2 -45.06 99.96 Favored Pre-proline 0 CA--C 1.57 1.742 0 N-CA-C 113.683 0.994 . . . . 72.41 113.683 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -60.48 -31.63 92.71 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.245 1.963 . . . . 74.43 113.368 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -77.04 -35.63 56.73 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.297 0.639 . . . . 74.21 111.786 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.66 -38.81 84.3 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.478 -0.564 . . . . 62.41 109.478 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.469 HH12 HD12 ' C' ' 105' ' ' ILE . 37.7 ttm180 -64.35 -42.3 96.3 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.675 -1.148 . . . . 74.13 110.549 173.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -53.1 -51.68 61.07 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.142 0.977 . . . . 73.31 110.75 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 30.3 t -66.77 -47.82 71.0 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.569 -1.196 . . . . 61.21 111.173 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.84 -54.69 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.426 0.69 . . . . 62.45 111.041 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.0 m -55.91 -38.62 70.49 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.945 0.898 . . . . 54.25 111.723 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.0 t -65.69 -45.54 82.42 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.03 -0.532 . . . . 71.52 110.221 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.6 mtp -63.03 -39.92 96.18 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.009 0.924 . . . . 72.33 111.927 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.7 t -61.9 -45.65 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.935 0.894 . . . . 60.42 110.501 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.9 t -67.24 -37.89 84.3 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.242 -0.89 . . . . 62.02 111.415 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.498 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 83.6 mtt-85 -70.79 -27.72 64.11 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.34 0.656 . . . . 73.33 110.455 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.55 14.18 47.99 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-O 119.227 -0.763 . . . . 64.51 113.278 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.4 t 58.31 16.47 4.05 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 127.059 2.144 . . . . 72.43 113.47 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -82.53 150.83 64.1 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.471 0.708 . . . . 73.11 110.363 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -55.39 153.6 27.48 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.248 2.632 . . . . 74.12 113.548 174.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.406 HE21 HG21 ' D' ' 122' ' ' THR . 6.0 tp-100 -59.97 132.2 53.21 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.327 1.051 . . . . 73.14 112.552 -171.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.1 tp -131.64 110.42 10.91 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.575 1.15 . . . . 61.24 109.432 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -127.13 114.71 18.08 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 108.401 -0.963 . . . . 73.13 108.401 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.421 ' HA ' HG21 ' E' ' 6' ' ' ILE . 8.2 mp -67.17 148.85 51.27 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.82 0.448 . . . . 64.12 110.983 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -68.83 128.66 92.78 Favored Pre-proline 0 CA--C 1.551 0.997 0 O-C-N 123.955 0.785 . . . . 71.51 110.256 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.442 ' HG2' ' CE2' ' C' ' 11' ' ' PHE . 10.4 Cg_exo -74.68 111.9 3.43 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 122.955 2.436 . . . . 71.32 112.178 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.4 m -102.29 116.87 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.314 0.645 . . . . 42.01 109.601 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -76.05 91.07 3.07 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 115.543 -0.753 . . . . 74.04 109.469 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -53.59 -47.78 69.82 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.279 1.032 . . . . 62.41 110.673 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -51.31 -52.06 48.7 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.285 -1.325 . . . . 71.21 112.442 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.51 97.04 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.365 1.041 . . . . 42.43 111.445 -177.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.412 HD22 HD11 ' E' ' 10' ' ' LEU . 5.4 tt -66.92 -43.79 82.38 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 124.137 0.898 . . . . 74.35 110.398 -174.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -66.44 -36.35 82.57 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.884 0.474 . . . . 71.13 111.438 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.427 ' HA ' ' HB3' ' A' ' 141' ' ' LEU . 78.1 mtp -74.11 -20.02 60.4 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.472 0.545 . . . . 63.12 112.472 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.637 ' HA ' ' HB2' ' A' ' 143' ' ' GLN . 94.1 m-20 -60.13 -46.38 89.82 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.989 0.515 . . . . 74.2 110.447 172.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -74.15 -29.74 61.94 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.58 0.352 . . . . 73.1 111.15 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 138' ' ' MET . 58.8 tp -64.39 -47.94 77.32 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.549 0.74 . . . . 71.5 111.457 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -163.08 -15.51 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 114.364 1.246 . . . . 71.32 114.364 -174.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.637 ' HB2' ' HA ' ' A' ' 139' ' ' ASN . 42.2 mt-30 -86.46 151.07 23.82 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 119.126 0.875 . . . . 74.23 111.102 -174.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -162.96 -71.74 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.673 0.389 . . . . 75.54 110.074 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.05 73.58 9.08 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.357 0.663 . . . . 63.25 109.451 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.2 78.4 1.73 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.08 -0.964 . . . . 71.22 111.167 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.89 147.52 29.68 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.864 -0.791 . . . . 73.53 108.864 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -174.51 145.15 7.86 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.616 -0.594 . . . . 62.43 111.616 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.2 p -142.25 168.58 19.41 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.249 1.02 . . . . 61.01 109.76 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -154.38 141.15 19.08 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 122.486 0.315 . . . . 74.24 111.568 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -80.92 87.41 5.96 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.188 -1.041 . . . . 73.53 108.188 171.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.508 ' HB2' ' HA ' ' G' ' 20' ' ' LYS . 15.1 p-80 -78.94 102.42 8.27 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 114.487 -1.233 . . . . 63.24 111.541 -174.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -135.69 92.72 2.86 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.288 -1.005 . . . . 74.55 108.288 171.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -79.12 160.25 27.12 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.543 -0.753 . . . . 73.0 110.209 -176.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 C-N-CA 123.901 0.881 . . . . 75.13 109.609 -175.749 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mmt . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.613 -0.514 . . . . 75.01 109.613 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 42.7 m -142.53 96.24 2.91 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.61 -1.256 . . . . 60.34 107.61 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -109.42 144.0 38.24 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.194 0.598 . . . . 74.53 111.078 -168.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -129.95 12.71 5.72 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.708 0.803 . . . . 64.11 112.587 -173.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 43.5 p30 -68.4 -16.68 64.0 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 113.276 0.843 . . . . 74.33 113.276 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -58.99 121.2 10.63 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.068 0.547 . . . . 61.33 110.064 177.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 10.3 t -71.12 131.82 44.14 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.022 0.826 . . . . 72.14 110.942 -172.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -102.8 -87.52 0.41 Allowed 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 107.552 -1.277 . . . . 73.32 107.552 169.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 26.8 ptm 40.9 -171.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 126.448 1.899 . . . . 75.31 115.969 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 56.6 m -143.64 123.07 13.13 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 107.232 -1.396 . . . . 74.25 107.232 166.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -131.37 139.36 49.47 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.874 0.87 . . . . 72.42 108.888 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -155.82 128.98 8.13 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 109.81 -0.441 . . . . 64.33 109.81 174.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.545 HD11 HD13 ' B' ' 105' ' ' ILE . 18.8 mt -77.92 121.5 30.78 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 N-CA-C 108.272 -1.011 . . . . 73.15 108.272 173.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -100.35 -32.77 10.68 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 123.754 0.659 . . . . 70.24 110.056 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -172.37 143.58 1.44 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.959 0.504 . . . . 74.54 109.974 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 84.6 mt -128.34 137.54 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 107.953 -1.128 . . . . 64.5 107.953 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -163.37 160.75 23.95 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-O 121.591 0.71 . . . . 72.21 112.287 -175.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.508 HG21 HD11 ' B' ' 21' ' ' ILE . 91.7 m -92.49 126.98 37.81 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.0 -1.0 . . . . 73.31 108.309 168.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -91.83 -25.51 18.95 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.353 0.661 . . . . 63.54 111.002 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -158.94 135.49 9.34 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 120.679 0.276 . . . . 71.2 111.713 -172.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 44.4 mm -125.74 141.4 45.61 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 C-N-CA 124.809 1.244 . . . . 63.0 109.585 173.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.531 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 46.5 t -138.01 141.76 40.4 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 107.686 -1.228 . . . . 64.32 107.686 175.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -159.28 134.55 8.33 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.66 -1.237 . . . . 61.13 107.66 169.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -137.36 157.84 45.72 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.027 0.931 . . . . 73.32 108.644 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.505 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -143.12 82.03 12.22 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 106.917 -1.512 . . . . 73.11 106.917 172.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.95 -25.32 27.84 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 123.042 2.495 . . . . 62.43 113.53 -169.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -112.75 14.27 19.92 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.663 0.785 . . . . 72.52 110.706 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.508 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -40.78 -62.93 0.85 Allowed Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 115.122 1.527 . . . . 52.44 115.122 -163.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 23.1 Cg_exo -61.3 -33.52 89.41 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 122.252 1.968 . . . . 71.12 112.793 -171.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -95.88 -20.5 18.74 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.358 -0.837 . . . . 61.1 112.633 -173.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.44 HG21 ' HA ' ' B' ' 73' ' ' ALA . 5.0 p -82.34 -11.5 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-N 118.459 0.572 . . . . 73.52 110.749 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -70.12 -14.94 62.88 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 112.879 0.696 . . . . 74.14 112.879 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -68.27 -12.54 61.19 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.046 0.538 . . . . 73.43 111.209 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -104.31 105.81 16.08 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.647 1.179 . . . . 64.42 109.29 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -111.01 92.47 4.06 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.743 -0.836 . . . . 51.44 108.743 175.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 8.1 p90 -159.27 -175.69 5.38 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.91 0.884 . . . . 73.14 109.262 170.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -68.4 110.27 5.49 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 123.899 0.88 . . . . 72.35 110.494 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -67.62 137.28 41.93 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 121.069 1.179 . . . . 74.42 111.334 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.83 110.13 3.18 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 109.09 -0.707 . . . . 75.15 109.09 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.426 ' HB ' HG21 ' F' ' 6' ' ' ILE . 59.3 t -94.5 123.73 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 123.858 0.863 . . . . 70.14 110.692 -174.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -103.45 102.03 11.94 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 106.76 -1.57 . . . . 74.14 106.76 169.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 pp -97.21 148.08 23.45 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.918 -0.583 . . . . 72.1 109.597 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -135.93 154.26 51.17 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.838 1.255 . . . . 55.3 108.056 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 21.1 tp -133.44 126.48 31.28 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.663 -0.865 . . . . 72.4 108.663 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -127.45 147.45 50.3 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.663 1.185 . . . . 75.11 109.972 -172.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 76.0 p -121.9 117.48 26.58 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.056 0.942 . . . . 62.31 110.486 -172.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.13 142.11 44.2 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.906 0.882 . . . . 43.41 108.657 174.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 52.4 p -148.44 176.06 10.61 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.196 0.443 . . . . 73.1 112.196 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 74.9 p -155.79 153.12 29.33 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.299 1.04 . . . . 61.43 109.006 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -102.27 121.52 42.42 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.889 -0.782 . . . . 61.33 108.889 170.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' B' ' 57' ' ' GLU . 18.7 mt -85.21 -50.48 7.35 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.747 0.819 . . . . 71.25 109.764 -173.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.78 -176.1 4.64 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.69 -1.141 . . . . 73.05 109.225 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -59.69 110.49 1.15 Allowed 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.025 0.828 . . . . 70.13 109.32 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 64.11 20.21 12.09 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.278 1.031 . . . . 70.22 112.653 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 79.7 t -116.61 112.93 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 106.868 -1.53 . . . . 64.15 106.868 168.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -129.17 137.02 50.92 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.518 -0.919 . . . . 75.21 108.518 -169.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.473 ' HB2' HD11 ' B' ' 51' ' ' LEU . 4.1 tt0 -101.02 124.82 47.33 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.207 -1.035 . . . . 73.33 108.207 174.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 18.5 m -109.26 134.77 50.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.515 -0.92 . . . . 75.51 108.515 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.78 134.32 54.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.529 -0.915 . . . . 72.11 108.529 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 24.8 tp -115.12 101.18 8.74 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 109.18 -0.674 . . . . 71.21 109.18 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -87.48 117.5 26.31 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 123.014 0.526 . . . . 74.1 109.617 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.493 HG13 HD21 ' F' ' 8' ' ' LEU . 18.9 t -107.37 122.0 61.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 107.616 -1.253 . . . . 72.04 107.616 171.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.6 m -114.39 138.01 51.09 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.481 -0.562 . . . . 45.31 109.481 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.669 HG21 HG21 ' B' ' 114' ' ' ILE . 71.0 t -129.2 125.2 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.204 1.002 . . . . 73.35 109.81 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 65.3 m -116.04 146.3 42.29 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.299 -1.371 . . . . 63.15 107.299 162.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.55 139.53 35.03 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.285 -1.006 . . . . 62.22 108.285 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.559 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 34.3 p -140.5 136.22 32.71 Favored 'General case' 0 C--O 1.226 -0.183 0 O-C-N 123.413 0.445 . . . . 65.42 110.667 -175.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 92.5 mt -109.51 109.38 20.17 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.799 -1.186 . . . . 73.35 107.799 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.23 -137.7 20.17 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.78 -0.645 . . . . 72.02 112.271 -173.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -94.57 14.13 21.89 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.18 0.992 . . . . 73.51 110.818 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -132.17 152.14 51.43 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.345 0.658 . . . . 71.51 110.558 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 64.8 m -75.15 125.65 29.39 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.448 0.699 . . . . 41.01 111.224 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.559 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -78.59 -59.17 2.89 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 114.897 -1.047 . . . . 70.23 108.683 176.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -153.25 160.82 42.84 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 115.179 -0.918 . . . . 65.44 112.483 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 59.5 mt -118.84 154.21 33.26 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.496 1.519 . . . . 72.21 107.812 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.405 ' SG ' HG23 ' B' ' 114' ' ' ILE . 42.2 t -161.06 157.5 26.23 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.371 0.668 . . . . 72.0 109.23 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.531 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 34.8 tt0 -166.02 130.77 2.29 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.044 -0.724 . . . . 74.24 109.044 175.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 96.7 t -123.66 143.65 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 108.707 -0.849 . . . . 72.32 108.707 173.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -124.8 96.33 4.84 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.563 -0.903 . . . . 74.0 108.563 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.419 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 8.5 tp-100 -85.72 100.07 11.75 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.568 -0.53 . . . . 74.45 109.568 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.15 144.66 17.19 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 111.357 -0.697 . . . . 60.15 111.357 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.49 131.81 4.35 Favored Glycine 0 C--O 1.236 0.274 0 N-CA-C 111.704 -0.558 . . . . 72.21 111.704 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.7 mt -84.63 126.95 40.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 N-CA-C 108.375 -0.972 . . . . 63.52 108.375 172.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -138.62 149.42 45.19 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.199 -0.667 . . . . 74.41 109.199 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 70.4 m -92.38 120.87 33.32 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.783 -0.821 . . . . 75.31 108.783 170.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.534 HG12 HG21 ' F' ' 18' ' ' VAL . 3.9 tp -120.71 118.83 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.438 1.095 . . . . 53.14 109.584 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.56 167.08 30.7 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.196 0.598 . . . . 72.23 109.981 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.14 -67.8 3.07 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.36 -0.382 . . . . 71.11 112.83 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mm -82.25 141.78 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.233 0.613 . . . . 54.54 110.813 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.441 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 11.3 pt-20 -153.09 -175.28 5.26 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.114 0.965 . . . . 65.51 109.803 -173.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.87 -133.74 37.43 Favored Glycine 0 C--N 1.354 1.582 0 C-N-CA 123.471 0.557 . . . . 51.04 113.396 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 55.4 m -66.0 -37.52 86.16 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.952 0.901 . . . . 50.23 110.614 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -67.79 -23.22 65.18 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 115.614 -0.721 . . . . 71.34 111.436 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.441 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 22.5 ttp -65.25 -29.49 70.28 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.966 0.906 . . . . 71.4 111.599 175.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.509 ' HB1' ' HB3' ' F' ' 14' ' ' LEU . . . -64.18 -29.99 71.08 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.764 0.826 . . . . 54.22 111.491 175.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.493 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 45.6 t-80 -69.42 -30.15 68.03 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.444 0.698 . . . . 63.4 111.427 175.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.446 ' SG ' HD13 ' B' ' 86' ' ' ILE . 44.6 t -79.62 -56.42 4.31 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.458 0.303 . . . . 64.42 111.134 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mp -81.61 -35.6 29.9 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.926 0.491 . . . . 64.35 112.27 -172.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.18 3.87 82.56 Favored Glycine 0 N--CA 1.47 0.961 0 CA-C-O 119.676 -0.514 . . . . 72.52 113.69 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -148.8 -66.88 0.23 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.531 0.567 . . . . 53.42 112.531 -172.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -60.51 -47.9 84.1 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.272 1.029 . . . . 73.2 111.945 -171.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 67.4 m -70.15 -45.5 21.43 Favored Pre-proline 0 CA--C 1.567 1.631 0 CA-C-O 118.339 -0.839 . . . . 62.11 112.241 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -48.07 -40.43 33.81 Favored 'Trans proline' 0 C--N 1.4 3.271 0 C-N-CA 123.137 2.558 . . . . 71.34 114.389 167.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -62.66 -26.06 68.45 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 112.295 0.48 . . . . 71.31 112.295 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.545 HD13 HD11 ' B' ' 13' ' ' ILE . 57.6 mt -84.53 -45.87 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.452 0.701 . . . . 51.12 110.663 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 99.2 mt -82.03 -21.69 36.83 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.329 0.652 . . . . 74.34 112.461 -170.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -57.3 -50.74 86.43 Favored Pre-proline 0 N--CA 1.489 1.497 0 CA-C-O 117.654 -1.165 . . . . 70.22 113.329 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.54 -40.57 83.14 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 122.343 2.029 . . . . 75.34 114.105 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -67.69 -47.98 67.87 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.193 0.597 . . . . 70.31 110.366 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -63.9 -35.59 81.14 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.466 -0.788 . . . . 63.51 111.292 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -59.05 -58.2 9.72 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.366 1.067 . . . . 74.02 110.399 177.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -62.7 -33.03 74.26 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 123.924 0.765 . . . . 74.33 110.178 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.514 ' SG ' HD11 ' B' ' 21' ' ' ILE . 2.0 t -69.64 -38.59 77.21 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 122.902 0.481 . . . . 63.01 111.735 -176.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.669 HG21 HG21 ' B' ' 64' ' ' VAL . 89.4 mt -65.29 -56.02 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.879 -0.786 . . . . 75.01 108.879 172.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 9.7 m -59.43 -27.74 66.31 Favored 'General case' 0 CA--C 1.554 1.101 0 O-C-N 124.579 1.174 . . . . 65.31 111.619 -174.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.5 t -65.55 -48.67 71.62 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 123.682 0.793 . . . . 64.51 109.847 175.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.2 mmt -70.59 -33.96 71.64 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.236 0.614 . . . . 74.31 110.83 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.438 HG23 ' O ' ' B' ' 114' ' ' ILE . 97.8 t -58.12 -45.23 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 124.046 0.938 . . . . 72.44 109.803 172.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.403 ' HB2' ' NE2' ' C' ' 125' ' ' GLN . 22.6 t -71.8 -30.14 65.2 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.161 -1.381 . . . . 74.22 111.421 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' B' ' 116' ' ' SER . 82.1 mtt-85 -68.76 -31.97 71.39 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.145 -0.48 . . . . 72.02 109.871 175.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.5 6.85 67.01 Favored Glycine 0 C--N 1.355 1.609 0 O-C-N 123.837 0.71 . . . . 73.43 113.116 173.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.49 HG23 ' HB3' ' A' ' 17' ' ' TYR . 59.6 p 59.83 25.84 14.96 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 126.244 1.818 . . . . 73.03 113.166 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -88.39 160.59 44.89 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 123.805 0.842 . . . . 75.41 111.204 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.49 164.65 5.3 Favored 'Trans proline' 0 C--N 1.39 2.759 0 C-N-CA 123.454 2.77 . . . . 65.51 114.834 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.549 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -64.59 132.15 49.0 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.241 1.016 . . . . 75.45 111.302 -178.76 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 49.6 tp -137.9 114.56 10.51 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.134 0.573 . . . . 70.22 109.825 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -128.82 129.5 45.7 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.65 0.78 . . . . 72.11 109.173 174.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mp -82.41 145.42 29.88 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 123.578 0.751 . . . . 63.32 109.225 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' F' ' 7' ' ' ALA . . . -65.73 133.25 95.02 Favored Pre-proline 0 CA--C 1.554 1.101 0 O-C-N 123.664 0.603 . . . . 71.42 110.929 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.431 ' HG3' HD13 ' D' ' 16' ' ' ILE . 29.4 Cg_endo -63.32 100.23 0.26 Allowed 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.898 2.398 . . . . 62.34 111.859 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 48.8 t -90.42 109.52 20.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 108.58 -0.896 . . . . 74.22 108.58 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -89.86 90.36 8.15 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 107.949 -1.13 . . . . 71.22 107.949 176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -58.55 -35.54 72.49 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.127 -0.942 . . . . 71.34 110.355 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -66.97 -42.21 85.52 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.531 1.132 . . . . 63.14 111.097 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.62 -38.34 90.68 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.978 0.799 . . . . 63.55 111.076 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -66.02 -50.49 64.03 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 123.746 0.654 . . . . 62.45 109.529 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -61.12 -40.23 92.97 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 123.588 0.555 . . . . 73.4 111.06 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 38.2 mtt -63.56 -40.2 96.38 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 123.386 0.429 . . . . 72.25 111.093 177.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -84.01 -25.92 29.55 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 120.931 0.396 . . . . 72.43 110.82 -171.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -70.93 -35.56 72.28 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.729 -0.669 . . . . 74.55 109.851 176.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 66.0 mt -93.84 -5.71 47.48 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.638 -0.71 . . . . 65.14 111.097 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 142' ' ' GLN . . . . . 0.765 ' HG3' ' HB3' ' D' ' 6' ' ' ASN . 7.1 tp60 -147.05 98.78 3.08 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.818 0.818 . . . . 65.3 110.511 -176.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -141.13 149.28 41.33 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 125.052 1.341 . . . . 72.35 107.81 174.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -154.07 128.39 9.12 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.585 -0.524 . . . . 73.3 109.585 -176.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.31 121.19 19.02 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 124.108 0.88 . . . . 72.45 110.983 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -151.8 -157.84 8.11 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.922 -0.581 . . . . 73.54 111.88 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' GLU . . . . . 0.549 ' HB3' HG23 ' B' ' 149' ' ' THR . 4.9 mp0 -71.3 115.2 10.17 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.526 0.73 . . . . 63.32 111.513 -173.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -79.79 69.47 3.05 Favored Glycine 0 C--N 1.347 1.17 0 N-CA-C 110.889 -0.884 . . . . 31.22 110.889 170.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.549 HG23 ' HB3' ' B' ' 147' ' ' GLU . 10.8 p -82.95 67.38 9.01 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.808 0.843 . . . . 74.43 111.313 -174.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -85.14 18.23 2.66 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.883 0.873 . . . . 70.44 110.655 173.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.02 156.29 25.13 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 124.526 1.13 . . . . 73.43 110.052 171.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -134.46 93.64 3.09 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.51 -0.922 . . . . 63.12 108.51 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -78.75 65.78 4.08 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 122.517 1.151 . . . . 62.42 109.727 172.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.3 176.83 7.05 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.515 -1.22 . . . . 60.32 110.997 -174.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 C-N-CA 123.664 0.785 . . . . 74.33 109.176 -179.513 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 1' ' ' MET . . . . . 0.461 ' SD ' ' N ' ' C' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.924 0.393 . . . . 75.24 110.449 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m -131.86 148.18 52.53 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.974 0.91 . . . . 62.54 108.904 174.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -71.66 139.37 49.23 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.127 0.489 . . . . 61.35 110.461 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 4' ' ' GLN . . . . . 0.434 ' HG2' ' HA ' ' A' ' 143' ' ' GLN . 71.6 mt-30 -102.69 98.7 8.69 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.418 1.087 . . . . 65.31 109.715 -168.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -78.07 151.3 33.5 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.828 0.851 . . . . 71.42 110.725 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 6' ' ' ASN . . . . . 0.459 ' HB3' ' NE2' ' C' ' 93' ' ' GLN . 45.4 t-20 -73.63 93.45 2.06 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.865 -0.791 . . . . 71.23 108.865 174.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 14.8 t -105.93 21.44 17.31 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 114.677 -1.147 . . . . 72.14 110.136 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -57.44 -74.23 0.06 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.088 0.955 . . . . 65.43 108.969 -178.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.669 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 0.0 OUTLIER 63.36 115.26 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 124.872 1.269 . . . . 71.0 113.124 167.348 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 45.0 m -98.32 98.48 9.72 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.683 0.793 . . . . 72.14 109.285 171.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.669 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 50.6 t80 -121.53 130.77 53.74 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.817 -0.809 . . . . 73.22 108.817 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -150.61 140.1 21.5 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.632 -0.507 . . . . 74.22 109.632 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.413 HG12 ' HE2' ' C' ' 84' ' ' PHE . 43.5 mt -83.38 127.14 40.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.828 -0.804 . . . . 75.12 108.828 173.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.472 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 23.5 mm-40 -92.34 -40.0 11.16 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 123.666 0.604 . . . . 74.14 109.639 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -176.74 124.66 0.16 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.378 0.671 . . . . 75.41 109.812 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.5 mt -110.23 148.22 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 108.454 -0.943 . . . . 74.21 108.454 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -173.61 160.02 3.69 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.046 0.938 . . . . 73.23 109.235 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.8 p -81.18 107.78 14.27 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.199 -0.667 . . . . 71.11 109.199 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt -65.27 -47.72 75.71 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.822 0.82 . . . . 71.22 109.262 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.3 t70 -143.33 144.54 32.13 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.114 -1.403 . . . . 73.41 109.513 -174.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.3 mt -139.13 147.12 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.229 1.411 . . . . 73.21 107.335 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -157.25 150.8 24.12 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.32 0.648 . . . . 42.33 110.008 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -151.91 149.03 28.49 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.713 -1.217 . . . . 52.13 107.713 171.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -147.5 149.55 32.86 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.112 1.365 . . . . 62.41 107.617 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.8 84.72 3.73 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 107.316 -1.364 . . . . 71.34 107.316 169.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.65 -38.3 73.08 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.228 2.619 . . . . 73.41 113.139 -173.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -107.18 19.71 20.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.812 0.845 . . . . 53.21 110.999 -172.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.467 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -45.94 -58.33 6.47 Favored Pre-proline 0 CA--C 1.562 1.426 0 CA-C-O 117.355 -1.307 . . . . 52.41 114.259 -170.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 49.5 Cg_exo -54.55 -47.46 26.7 Favored 'Trans proline' 0 C--N 1.389 2.694 0 C-N-CA 122.106 1.871 . . . . 71.51 112.255 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.516 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.9 t60 -71.38 -32.9 69.01 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.11 -0.95 . . . . 70.2 112.843 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.694 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.8 p -77.3 -24.02 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 112.541 0.571 . . . . 72.45 112.541 -169.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -63.44 -26.19 68.62 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.085 0.772 . . . . 71.04 113.085 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 10.4 pt20 -87.53 6.6 33.43 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.017 0.527 . . . . 74.14 111.521 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.719 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -88.38 154.89 20.03 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.937 0.895 . . . . 75.35 110.509 179.246 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -66.13 128.2 35.17 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.509 -0.768 . . . . 73.5 109.067 165.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -78.69 90.18 4.59 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.388 0.675 . . . . 74.24 110.796 -174.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -132.96 76.99 69.35 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 124.275 1.03 . . . . 75.4 108.927 174.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -85.83 123.43 2.43 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.521 2.147 . . . . 61.51 112.295 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -83.26 83.68 7.77 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 106.788 -1.56 . . . . 64.11 106.788 167.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 5.6 p -71.83 116.24 13.36 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 CA-C-N 114.081 -1.418 . . . . 54.14 110.787 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -108.24 102.51 11.63 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.298 -1.001 . . . . 73.0 108.298 173.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.65 137.44 32.33 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.305 -0.628 . . . . 70.32 109.305 176.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.433 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 16.0 t70 -119.59 147.72 44.17 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.384 1.074 . . . . 73.52 108.141 -177.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.536 HD13 HD13 ' G' ' 8' ' ' LEU . 16.3 tp -130.0 112.5 13.54 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.148 0.499 . . . . 74.2 110.01 -177.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.613 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 13.5 t70 -113.73 154.08 27.93 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.156 1.382 . . . . 75.55 109.153 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 34.0 p -135.32 132.12 37.29 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.489 0.716 . . . . 60.12 110.48 -173.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.46 154.7 48.45 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.918 0.887 . . . . 73.42 109.288 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 48.3 p -160.99 146.68 14.47 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.799 0.333 . . . . 64.04 111.811 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 68.1 p -150.11 133.38 16.37 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.064 0.946 . . . . 74.23 109.154 174.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -76.98 120.82 22.63 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.315 0.646 . . . . 74.01 109.897 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.531 HD11 HD12 ' C' ' 83' ' ' ILE . 26.2 mt -94.1 -30.25 14.76 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.154 0.582 . . . . 53.52 110.517 -177.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.33 -178.92 6.99 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.299 1.04 . . . . 70.12 109.882 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.25 113.05 2.95 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.731 -0.668 . . . . 74.14 109.978 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 54' ' ' ASP . . . . . 0.439 ' HA ' ' HE1' ' C' ' 56' ' ' TYR . 3.6 m-20 63.26 18.63 11.13 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.536 1.134 . . . . 72.5 112.503 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 83.9 t -115.4 114.47 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.131 -1.063 . . . . 65.25 108.131 170.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.439 ' HE1' ' HA ' ' C' ' 54' ' ' ASP . 83.4 m-85 -126.64 134.29 50.78 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.921 0.888 . . . . 64.34 109.018 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.529 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.2 tt0 -84.58 114.3 21.88 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.082 -1.081 . . . . 71.14 108.082 170.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.467 HG13 ' HE2' ' G' ' 15' ' ' PHE . 98.9 t -95.93 124.22 48.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 107.693 -1.225 . . . . 74.45 107.693 173.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 94.9 t -117.66 133.27 64.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 107.759 -1.2 . . . . 74.24 107.759 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.487 HD13 ' HB3' ' C' ' 103' ' ' PRO . 23.7 tp -127.8 105.76 8.66 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.691 -0.855 . . . . 71.01 108.691 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.613 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 9.2 ttm180 -82.89 122.61 28.47 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.34 -0.615 . . . . 75.15 109.34 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.418 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.2 t -113.83 127.78 71.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.031 -1.1 . . . . 73.42 108.031 171.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 31.5 m -123.5 110.12 14.68 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.017 0.527 . . . . 73.3 109.607 -177.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.495 HG23 HD13 ' C' ' 114' ' ' ILE . 69.3 t -99.72 108.43 22.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 108.883 -0.784 . . . . 71.12 108.883 -177.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.446 HG23 HD23 ' C' ' 75' ' ' LEU . 3.8 m -99.5 126.32 45.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.982 -0.748 . . . . 53.11 108.982 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.38 106.69 13.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.307 -0.997 . . . . 63.32 108.307 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 22.1 m -127.02 129.46 48.1 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.814 -0.81 . . . . 71.33 108.814 175.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.719 HD13 ' HG2' ' C' ' 34' ' ' LYS . 8.1 mt -85.09 32.64 0.54 Allowed 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 125.109 1.364 . . . . 51.5 110.78 -178.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.81 -108.83 2.36 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 110.728 -0.949 . . . . 75.25 110.728 -171.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.71 -23.06 23.06 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.393 0.677 . . . . 73.34 109.943 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.13 115.83 22.07 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 123.993 0.917 . . . . 70.13 109.48 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 79.3 m -84.39 123.84 30.66 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 118.756 0.707 . . . . 74.12 109.164 169.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.694 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -77.38 -57.32 3.89 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.007 -0.997 . . . . 72.22 109.281 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -157.86 172.48 18.39 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 122.103 0.954 . . . . 72.34 111.639 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.446 HD23 HG23 ' C' ' 65' ' ' THR . 2.4 tm? -135.18 128.36 31.87 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 105.611 -1.996 . . . . 75.03 105.611 170.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.46 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 44.4 t -128.26 143.5 51.03 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.134 -1.061 . . . . 52.21 108.134 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.48 123.29 5.18 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.206 0.316 . . . . 71.11 110.367 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 61.8 t -134.12 125.25 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.457 0.703 . . . . 72.44 109.526 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.604 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 25.8 mt-30 -96.02 98.48 10.41 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.926 -1.138 . . . . 72.23 107.926 172.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -84.25 121.48 27.56 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.053 -0.522 . . . . 55.01 110.153 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.9 147.23 16.7 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 112.168 -0.373 . . . . 63.53 112.168 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.406 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.75 125.14 1.98 Allowed Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.169 -1.173 . . . . 72.04 110.169 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.531 HD12 HD11 ' C' ' 51' ' ' LEU . 13.1 mm -80.63 127.62 39.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 107.554 -1.276 . . . . 74.52 107.554 174.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.413 ' HE2' HG12 ' C' ' 13' ' ' ILE . 64.6 m-85 -134.42 142.28 47.08 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.976 0.417 . . . . 72.31 110.667 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 11.5 p -96.28 107.61 19.99 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 108.246 -1.02 . . . . 51.55 108.246 168.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.456 HG23 ' HE1' ' C' ' 9' ' ' MET . 69.9 mt -115.36 116.47 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.368 1.067 . . . . 73.45 109.245 -176.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.08 172.38 18.51 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.749 0.82 . . . . 63.22 111.181 -171.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.46 -59.2 0.94 Allowed Glycine 0 C--N 1.349 1.264 0 CA-C-N 116.302 -0.408 . . . . 71.12 113.308 170.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.418 ' CD1' ' HG2' ' C' ' 9' ' ' MET . 38.1 pt -94.36 -177.24 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.634 0.774 . . . . 74.22 110.172 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -164.49 155.12 14.78 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 122.974 0.51 . . . . 62.34 110.93 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.52 ' H ' ' HA ' ' G' ' 21' ' ' ALA . . . 75.04 -130.78 11.69 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 119.25 -0.75 . . . . 65.31 113.845 171.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 21.5 m -55.72 -40.29 72.23 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.5 1.12 . . . . 73.41 111.577 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.459 ' NE2' ' HB3' ' C' ' 6' ' ' ASN . 14.0 mt-30 -56.25 -48.21 77.0 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.404 -1.271 . . . . 73.14 109.817 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.564 ' SD ' ' HB2' ' G' ' 21' ' ' ALA . 56.2 ttm -80.33 -27.16 38.41 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 114.822 -1.081 . . . . 73.24 111.234 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.25 81.9 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.53 0.732 . . . . 62.14 111.359 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.549 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 57.8 t-80 -70.75 -28.54 64.77 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.189 -0.914 . . . . 75.03 111.157 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 50.3 t -77.43 -55.33 5.48 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 122.229 -0.294 . . . . 73.24 111.222 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' C' ' 94' ' ' MET . 1.0 OUTLIER -78.09 -22.78 48.45 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 112.968 0.729 . . . . 72.43 112.968 -173.443 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 99' ' ' GLY . . . . . 0.439 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -97.59 0.62 59.69 Favored Glycine 0 C--N 1.346 1.089 0 O-C-N 123.403 0.44 . . . . 74.35 112.871 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -140.62 -69.18 0.4 Allowed 'General case' 0 C--N 1.347 0.485 0 C-N-CA 123.344 0.658 . . . . 72.14 110.455 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -65.24 -51.85 58.28 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.496 0.924 . . . . 74.2 113.496 -168.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.459 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 19.9 m -61.63 -47.05 93.61 Favored Pre-proline 0 CA--C 1.564 1.506 0 CA-C-O 118.845 -0.598 . . . . 74.3 112.363 -173.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.487 ' HB3' HD13 ' C' ' 60' ' ' LEU . 21.7 Cg_exo -68.91 -26.11 32.0 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 121.997 1.798 . . . . 71.12 112.971 172.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -72.49 -25.43 61.41 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.447 0.699 . . . . 73.24 110.719 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.469 HD12 HH12 ' A' ' 111' ' ' ARG . 28.7 mm -66.02 -35.27 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.036 0.534 . . . . 74.21 109.586 169.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.406 HD21 ' HA3' ' C' ' 82' ' ' GLY . 84.3 mt -87.18 -17.68 32.11 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.048 0.939 . . . . 75.22 112.452 -176.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -54.39 -50.77 83.15 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 117.534 -1.222 . . . . 73.35 112.863 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -55.24 -36.75 94.12 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.75 2.3 . . . . 73.13 114.594 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -75.46 -44.16 45.65 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.808 0.443 . . . . 72.51 110.55 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.31 -45.74 90.48 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.453 -0.794 . . . . 73.51 109.662 174.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 41.2 ttt-85 -54.26 -51.49 64.39 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.497 1.519 . . . . 71.53 111.506 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.85 -35.58 74.84 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.319 0.648 . . . . 74.44 110.421 -176.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.6 t -71.75 -31.62 66.85 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.005 0.522 . . . . 74.14 110.901 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.495 HD13 HG23 ' C' ' 64' ' ' VAL . 89.4 mt -70.89 -53.47 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.451 0.7 . . . . 73.11 109.661 174.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.9 m -64.35 -28.79 69.94 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.366 0.667 . . . . 64.22 111.249 -176.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.1 t -65.2 -48.63 72.71 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 109.061 -0.718 . . . . 70.33 109.061 173.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.525 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.86 -36.68 84.08 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.508 1.123 . . . . 71.23 112.354 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.426 HG23 ' O ' ' C' ' 114' ' ' ILE . 97.2 t -67.89 -40.89 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.436 0.694 . . . . 74.01 110.094 176.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 48.4 t -70.18 -29.66 66.59 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.162 -0.926 . . . . 75.35 111.371 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.412 ' HD2' ' SD ' ' C' ' 117' ' ' MET . 86.5 mtt-85 -72.26 -32.18 66.44 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.622 0.769 . . . . 74.32 109.598 176.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.17 5.96 69.67 Favored Glycine 0 C--N 1.354 1.564 0 O-C-N 124.014 0.821 . . . . 65.43 112.91 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.497 HG23 ' HB3' ' D' ' 17' ' ' TYR . 76.7 p 57.73 28.3 15.65 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 126.273 1.829 . . . . 73.42 113.278 178.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -88.16 155.38 52.12 Favored Pre-proline 0 CA--C 1.555 1.153 0 N-CA-C 109.213 -0.662 . . . . 75.3 109.213 171.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.39 142.66 29.19 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 123.166 2.577 . . . . 70.3 113.382 172.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.403 ' NE2' ' HB2' ' B' ' 119' ' ' SER . 21.2 mm-40 -59.98 112.27 1.81 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.694 0.798 . . . . 73.31 111.411 -176.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 48.8 tp -113.38 93.08 4.23 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.469 -0.937 . . . . 42.53 108.469 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -91.48 127.84 37.08 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.364 -0.976 . . . . 74.32 108.364 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 89.0 mt -69.54 134.47 48.88 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 123.375 0.422 . . . . 72.33 110.18 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' G' ' 6' ' ' ILE . . . -78.09 158.73 76.94 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 123.822 0.849 . . . . 74.52 110.751 -178.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.467 ' HG3' HG21 ' A' ' 13' ' ' ILE . 23.5 Cg_endo -56.85 112.0 0.97 Allowed 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.918 2.412 . . . . 73.35 112.666 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 p -96.97 107.49 19.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 107.507 -1.294 . . . . 62.33 107.507 170.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -90.86 82.83 5.65 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.812 -1.085 . . . . 72.05 109.121 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -58.61 -44.83 90.06 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.223 0.535 . . . . 64.44 109.566 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -58.23 -46.86 85.16 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.453 -1.249 . . . . 62.13 112.127 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.75 -41.34 87.94 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.885 0.74 . . . . 53.1 111.406 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.42 HD12 HD21 ' G' ' 10' ' ' LEU . 95.4 mt -68.78 -45.05 72.33 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.559 0.344 . . . . 74.12 110.777 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -68.05 -21.63 65.0 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.8 0.44 . . . . 73.32 111.855 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 49.2 ttm -70.44 -35.33 73.3 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.873 0.869 . . . . 70.11 110.633 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -69.31 -43.65 73.33 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.821 0.449 . . . . 72.34 110.089 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -72.07 -154.6 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.728 0.811 . . . . 75.5 112.077 175.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 20.6 tp 71.23 -70.6 0.15 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.431 1.492 . . . . 60.03 110.961 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -120.23 89.19 3.08 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.541 -0.911 . . . . 75.25 108.541 166.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -71.76 -18.71 62.1 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.565 0.746 . . . . 74.44 110.567 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -66.62 -26.2 66.96 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.315 0.646 . . . . 74.12 110.615 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 68.9 -177.34 0.21 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.764 1.226 . . . . 54.54 111.295 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -173.44 55.82 0.15 Allowed Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.445 -0.662 . . . . 73.11 111.445 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -74.76 -90.66 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.879 0.872 . . . . 72.32 109.628 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 51.93 20.34 6.2 Favored Glycine 0 C--N 1.361 1.941 0 N-CA-C 115.446 0.938 . . . . 74.33 115.446 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 88.8 m -123.16 102.17 7.81 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.823 0.849 . . . . 54.11 110.35 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -163.24 124.45 2.4 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.115 -1.439 . . . . 71.11 107.115 172.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -153.17 91.27 1.5 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.926 -0.768 . . . . 72.53 108.926 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -137.52 109.28 7.07 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.089 0.956 . . . . 74.52 108.572 173.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -94.12 -76.23 0.49 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.82 0.848 . . . . 74.01 109.888 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -179.42 -65.04 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.9 1.28 . . . . 72.43 108.894 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.904 0 N-CA-C 108.307 -0.997 . . . . 54.32 108.307 -175.228 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 76.3 mtp . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 121.128 0.49 . . . . 54.44 109.997 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 40.7 p -163.54 85.39 0.49 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.239 -1.393 . . . . 65.5 107.239 -172.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -142.65 82.86 1.79 Allowed 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.874 0.845 . . . . 73.2 109.156 -177.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -127.73 154.95 44.75 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.092 0.957 . . . . 72.12 110.142 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -145.84 107.37 4.24 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.583 0.753 . . . . 65.23 109.598 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 6' ' ' ASN . . . . . 0.765 ' HB3' ' HG3' ' B' ' 142' ' ' GLN . 2.8 p30 -144.95 93.16 2.36 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.959 0.903 . . . . 70.21 109.931 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.53 HG23 ' HB3' ' D' ' 9' ' ' MET . 2.1 t -164.54 168.45 18.28 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.961 -1.018 . . . . 72.02 110.01 -173.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -68.36 -27.47 66.28 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.735 1.214 . . . . 71.14 110.614 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.715 ' HG3' HD11 ' D' ' 89' ' ' ILE . 16.9 ttt -24.12 125.69 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 127.11 2.164 . . . . 73.0 116.196 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 85.4 m -104.81 142.63 34.39 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.469 -0.937 . . . . 75.43 108.469 168.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -154.81 108.25 2.86 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.99 -1.115 . . . . 72.14 107.99 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -122.42 119.78 32.0 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.84 -0.8 . . . . 62.21 108.84 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 65.7 mt -68.09 135.52 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 109.872 -0.418 . . . . 74.1 109.872 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -101.41 -39.54 7.51 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.069 0.547 . . . . 74.43 111.405 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 15.4 ttt180 -172.03 135.8 0.83 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.706 0.23 . . . . 71.14 111.374 -169.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.431 HD13 ' HG3' ' B' ' 130' ' ' PRO . 3.4 mp -120.6 135.51 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 107.59 -1.263 . . . . 71.05 107.59 167.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.497 ' HB3' HG23 ' C' ' 122' ' ' THR . 37.1 p90 -163.53 168.78 19.66 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.941 0.877 . . . . 70.23 111.301 177.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.2 p -99.15 128.33 45.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.316 -1.311 . . . . 74.52 109.082 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.457 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 39.0 mtpt -104.66 -15.14 15.36 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.025 0.53 . . . . 70.2 110.384 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.729 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 28.3 t70 -158.62 132.66 7.8 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.484 -1.235 . . . . 62.52 108.157 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.525 HG21 ' HE2' ' C' ' 117' ' ' MET . 57.4 mt -138.8 148.14 24.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.545 -1.279 . . . . 73.51 107.545 176.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 27.2 t -154.13 145.42 22.96 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.416 0.686 . . . . 64.2 109.818 173.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.1 t80 -149.97 122.02 8.26 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 105.55 -2.018 . . . . 75.31 105.55 172.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 26.6 mt-10 -130.4 111.54 12.42 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.96 -0.756 . . . . 64.13 108.96 -173.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -116.69 86.22 18.46 Favored Pre-proline 0 C--O 1.241 0.615 0 N-CA-C 108.683 -0.858 . . . . 73.23 108.683 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.77 -39.89 2.24 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.36 2.04 . . . . 71.31 111.727 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -86.72 -3.34 59.03 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.812 1.245 . . . . 74.25 111.31 -176.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.515 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -23.74 -67.95 0.05 OUTLIER Pre-proline 0 C--N 1.361 1.096 0 C-N-CA 127.465 2.306 . . . . 75.43 116.737 -165.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.459 ' HB3' HD11 ' C' ' 83' ' ' ILE . 86.2 Cg_endo -73.64 -29.74 10.44 Favored 'Trans proline' 0 C--N 1.375 1.951 0 CA-C-N 123.133 2.155 . . . . 74.0 113.582 -168.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -87.36 -22.52 25.01 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.623 0.249 . . . . 74.1 110.672 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.515 HG12 ' O ' ' D' ' 28' ' ' ALA . 10.0 p -81.75 -18.1 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 122.866 0.466 . . . . 74.41 110.482 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -65.62 -18.77 65.57 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 112.562 0.578 . . . . 75.22 112.562 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -64.58 -12.35 44.2 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.131 0.972 . . . . 74.14 111.602 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -102.62 106.83 17.57 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.167 1.387 . . . . 71.44 110.463 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -102.96 83.81 2.28 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.998 0.919 . . . . 74.11 110.158 -176.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -158.28 175.65 13.47 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.698 0.799 . . . . 72.22 109.171 169.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -66.5 111.95 8.12 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 123.412 0.685 . . . . 64.44 110.101 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.428 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 73.9 Cg_exo -56.12 119.44 6.62 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.004 2.469 . . . . 55.2 111.649 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -60.56 113.74 2.6 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.561 1.145 . . . . 64.53 110.419 -176.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 71.7 t -97.18 126.1 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.339 0.656 . . . . 74.22 111.226 -169.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.629 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 17.0 tppt? -101.72 110.52 22.52 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.312 -1.736 . . . . 70.42 106.312 166.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.52 114.06 25.69 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.287 -1.005 . . . . 74.01 108.287 -172.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.73 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 11.7 m-20 -107.21 150.06 27.04 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.389 1.075 . . . . 73.35 109.451 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.414 HD21 HD23 ' H' ' 8' ' ' LEU . 94.4 mt -129.5 151.02 50.58 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.571 0.748 . . . . 55.42 110.476 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 33.6 t70 -156.88 136.06 11.98 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.795 -1.187 . . . . 54.34 107.795 174.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 41.1 p -107.23 144.43 34.03 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.01 0.524 . . . . 71.43 110.987 -171.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.611 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.44 156.43 41.44 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.931 0.893 . . . . 71.2 109.303 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.484 ' HB3' ' HE2' ' H' ' 15' ' ' PHE . 10.5 p -172.18 155.78 3.74 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.025 0.53 . . . . 45.32 111.129 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 56.0 p -151.93 123.12 7.68 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.343 -0.844 . . . . 73.34 109.045 175.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -76.64 123.36 26.01 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.956 -0.757 . . . . 64.21 108.956 173.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 35.8 mt -90.01 -31.02 17.38 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.293 0.568 . . . . 64.22 109.997 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -164.5 171.91 13.99 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.304 1.441 . . . . 72.35 108.397 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -68.08 127.25 32.2 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.299 -0.876 . . . . 74.4 108.978 171.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 75.63 -2.85 2.7 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 125.926 1.69 . . . . 74.42 112.494 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 64.1 t -117.06 115.7 49.73 Favored 'Isoleucine or valine' 0 C--N 1.354 0.783 0 N-CA-C 108.099 -1.075 . . . . 60.35 108.099 172.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -144.38 169.12 18.54 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.516 -0.549 . . . . 73.21 109.516 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -130.04 132.36 46.18 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.105 -0.952 . . . . 61.22 109.568 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 64.2 t -105.94 124.75 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.464 -1.31 . . . . 63.22 107.464 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 20.9 t -114.84 130.02 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.457 -1.312 . . . . 74.44 107.457 172.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' D' ' 103' ' ' PRO . 15.4 tp -125.93 120.55 30.7 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.847 -0.797 . . . . 63.51 108.847 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.565 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 55.3 ttm-85 -83.99 102.78 12.72 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.157 -0.683 . . . . 75.41 109.157 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 71.7 t -91.15 126.86 43.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 107.862 -1.162 . . . . 73.35 107.862 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.73 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 26.8 m -124.14 126.62 46.49 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.486 0.66 . . . . 74.53 110.101 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 53.4 t -111.36 98.69 7.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 124.853 1.261 . . . . 65.41 107.781 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.629 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 31.0 m -95.98 90.04 5.43 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.335 -1.357 . . . . 71.2 107.335 177.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -97.93 148.18 23.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.458 -0.792 . . . . 32.24 110.576 -170.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.48 ' HA ' ' N ' ' D' ' 73' ' ' ALA . 54.8 m -145.34 135.5 23.88 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.259 0.466 . . . . 73.53 112.259 -174.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.467 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 82.0 mt -108.35 105.73 15.54 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.714 0.806 . . . . 54.33 109.151 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.47 -135.68 14.45 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.301 0.376 . . . . 64.43 113.653 175.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.29 5.74 25.6 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.32 0.648 . . . . 74.11 111.616 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -136.93 173.2 11.96 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.243 0.617 . . . . 72.34 110.797 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 37.7 m -66.34 153.08 43.62 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.976 1.31 . . . . 73.23 111.574 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.48 ' N ' ' HA ' ' D' ' 67' ' ' SER . . . -101.67 -65.51 0.97 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.378 -1.341 . . . . 54.13 107.378 168.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -155.21 146.86 23.17 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.478 -1.237 . . . . 74.23 110.246 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.499 HD22 HG23 ' D' ' 65' ' ' THR . 31.7 mt -104.57 111.12 23.69 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.468 -1.308 . . . . 74.12 107.468 172.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.561 ' SG ' HG12 ' D' ' 114' ' ' ILE . 35.0 t -117.26 137.64 52.26 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.621 -0.881 . . . . 73.31 108.621 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -154.86 121.42 5.38 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.646 -0.502 . . . . 74.44 109.646 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 65.4 t -129.47 124.0 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.392 0.677 . . . . 74.11 109.492 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.729 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 22.0 mt-30 -86.95 93.99 9.48 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 107.947 -1.131 . . . . 65.24 107.947 164.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -83.35 105.19 14.1 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.266 -1.013 . . . . 71.23 108.266 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -98.39 150.2 19.32 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-N 116.0 -0.545 . . . . 34.2 112.019 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.497 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -152.78 129.63 2.8 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.76 -0.257 . . . . 41.34 112.511 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.5 mt -91.2 126.89 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 108.211 -1.033 . . . . 61.32 108.211 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -130.68 153.81 48.58 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.639 0.776 . . . . 62.51 110.747 -174.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.3 m -106.71 138.21 43.31 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.504 1.121 . . . . 75.02 108.5 173.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.766 HG12 HD13 ' D' ' 89' ' ' ILE . 8.8 tt -146.4 144.2 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 108.849 -0.797 . . . . 74.11 108.849 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.47 146.62 8.62 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.18 0.592 . . . . 45.53 110.219 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.94 10.4 57.58 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.278 0.361 . . . . 70.32 113.122 -177.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.766 HD13 HG12 ' D' ' 86' ' ' ILE . 3.4 mp -123.65 151.06 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.018 0.927 . . . . 51.42 109.569 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.55 178.36 9.96 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.087 1.355 . . . . 73.23 109.737 174.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.09 -134.0 31.43 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 114.481 0.552 . . . . 64.21 114.481 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 34.6 p -88.88 -12.84 40.66 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.064 0.946 . . . . 74.23 112.419 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -61.7 -40.57 95.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.179 0.592 . . . . 73.31 110.559 177.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.611 ' HB2' HG23 ' H' ' 18' ' ' VAL . 26.4 ptt? -75.61 -20.26 58.68 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.624 -0.716 . . . . 62.31 112.2 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.24 -38.57 91.51 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.935 0.494 . . . . 72.42 110.677 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -78.01 -29.44 49.55 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.397 -0.82 . . . . 72.05 111.056 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 97' ' ' CYS . . . . . 0.427 ' SG ' HD12 ' D' ' 86' ' ' ILE . 44.3 t -68.5 -52.85 27.66 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 122.895 0.122 . . . . 75.14 111.085 -175.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.2 -22.06 42.27 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 110.612 -0.144 . . . . 74.42 110.612 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.29 -3.52 81.9 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-O 119.697 -0.502 . . . . 73.11 114.079 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.39 -58.76 0.13 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 117.479 0.64 . . . . 62.33 111.774 -177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -66.07 -47.96 72.57 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 112.658 0.614 . . . . 71.43 112.658 -170.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.421 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 44.6 m -67.85 -44.88 42.78 Favored Pre-proline 0 CA--C 1.565 1.523 0 CA-C-O 118.819 -0.61 . . . . 72.11 112.36 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.681 ' HB3' HD22 ' D' ' 60' ' ' LEU . 50.8 Cg_exo -59.12 -28.81 88.81 Favored 'Trans proline' 0 C--N 1.39 2.75 0 C-N-CA 122.54 2.16 . . . . 72.41 113.618 168.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -69.67 -33.57 72.76 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.507 0.723 . . . . 60.3 110.347 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.9 mm -67.33 -33.27 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-O 121.334 0.588 . . . . 74.04 110.212 174.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.497 HD21 ' HA3' ' D' ' 82' ' ' GLY . 65.4 mt -85.22 -15.97 41.83 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.885 0.874 . . . . 73.52 111.883 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -61.38 -48.51 90.84 Favored Pre-proline 0 CA--C 1.567 1.622 0 CA-C-O 118.002 -0.999 . . . . 62.13 113.262 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -59.92 -31.37 93.61 Favored 'Trans proline' 0 C--N 1.388 2.646 0 C-N-CA 122.093 1.862 . . . . 71.5 112.923 177.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -82.24 -32.04 29.92 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.727 0.811 . . . . 74.24 111.803 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.08 -48.1 72.08 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.847 -0.797 . . . . 55.33 108.847 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.449 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 34.4 ttp180 -55.39 -49.61 71.88 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 124.405 1.066 . . . . 73.44 111.141 176.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -64.68 -50.31 67.51 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 123.898 0.749 . . . . 74.41 111.144 -174.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 44.8 t -57.85 -44.39 86.52 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 124.005 0.816 . . . . 71.14 110.801 -178.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.561 HG12 ' SG ' ' D' ' 76' ' ' CYS . 91.4 mt -63.56 -55.34 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.727 0.811 . . . . 73.43 111.119 175.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 77.1 m -57.37 -39.91 77.04 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.146 0.979 . . . . 73.41 111.217 -174.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 86.5 p -66.7 -41.83 87.38 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.402 -0.817 . . . . 74.41 109.533 -177.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 65.3 mtm -69.97 -28.89 65.91 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.151 0.58 . . . . 72.14 111.734 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.487 HG23 ' O ' ' D' ' 114' ' ' ILE . 88.3 t -63.23 -49.18 84.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.23 0.612 . . . . 74.43 109.391 172.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.1 p -73.61 -26.1 60.63 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.867 -0.606 . . . . 63.3 111.039 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' D' ' 116' ' ' SER . 74.1 mtt-85 -71.94 -37.79 69.93 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.492 0.717 . . . . 62.41 109.246 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.78 4.86 77.77 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 115.362 -0.835 . . . . 50.12 112.448 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.406 HG21 HE21 ' A' ' 125' ' ' GLN . 22.4 p 58.7 30.67 20.26 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 126.683 1.993 . . . . 60.35 113.703 173.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -84.75 159.62 57.53 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 123.988 0.915 . . . . 74.24 109.883 171.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.35 126.13 21.32 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.693 2.262 . . . . 73.52 112.136 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -64.51 124.72 22.57 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.889 0.876 . . . . 73.2 111.652 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 7.0 tt -124.59 115.08 20.24 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.125 -1.435 . . . . 73.02 107.125 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -99.59 121.62 41.46 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.907 0.883 . . . . 73.12 108.653 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.69 ' HA ' HD11 ' H' ' 6' ' ' ILE . 7.3 mp -68.77 113.63 6.39 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 109.897 -0.409 . . . . 75.23 109.897 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -64.7 140.06 97.93 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.017 0.527 . . . . 72.31 110.432 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 9.3 Cg_exo -66.53 126.57 15.72 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.106 1.871 . . . . 74.03 110.708 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.6 m -107.85 146.71 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 C-N-CA 123.27 0.628 . . . . 75.42 110.725 -174.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -97.33 68.7 2.21 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.916 0.865 . . . . 63.41 109.207 -176.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -87.91 -26.6 22.64 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.191 -0.913 . . . . 52.4 111.485 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' D' ' 138' ' ' MET . 1.2 m-20 -52.69 -44.4 66.23 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.292 0.637 . . . . 71.14 110.779 169.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.07 -43.94 97.76 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 124.222 0.951 . . . . 75.22 111.772 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.84 -45.16 93.91 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.572 0.749 . . . . 73.22 111.161 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.429 ' O ' HD13 ' D' ' 141' ' ' LEU . 32.2 m-85 -69.32 -30.78 68.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.671 0.788 . . . . 63.11 111.695 175.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' D' ' 134' ' ' ASP . 21.1 ttm -68.72 -42.92 76.99 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.41 0.684 . . . . 73.23 109.617 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -70.13 -24.92 63.26 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.165 -0.925 . . . . 73.21 111.2 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -68.27 -50.03 56.55 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.981 0.513 . . . . 73.31 110.736 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.429 HD13 ' O ' ' D' ' 137' ' ' PHE . 9.0 mp -63.56 -32.26 73.67 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.612 0.765 . . . . 63.43 112.6 -176.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -89.99 31.77 0.95 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.075 0.55 . . . . 75.01 112.389 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -119.77 58.4 0.89 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.727 -0.842 . . . . 71.01 108.727 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -142.49 143.81 32.72 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.087 0.955 . . . . 70.11 108.879 -176.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.7 157.06 35.48 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.661 0.384 . . . . 72.24 110.386 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.63 50.59 4.27 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 112.149 -0.38 . . . . 73.13 112.149 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -150.16 141.84 23.61 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.537 1.135 . . . . 74.25 108.627 -176.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.81 71.36 2.88 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 111.673 -0.571 . . . . 72.03 111.673 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 47.4 p -58.13 142.25 47.75 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.188 0.995 . . . . 74.45 110.656 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -60.78 98.53 0.07 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.187 0.595 . . . . 72.32 110.536 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -72.49 123.77 23.83 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.372 -0.973 . . . . 74.4 108.372 173.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 -78.89 117.51 20.04 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.315 0.579 . . . . 73.2 110.984 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -88.02 66.76 8.74 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.01 0.924 . . . . 74.23 108.783 173.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -75.33 159.13 31.82 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.861 -1.063 . . . . 73.53 110.933 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.965 0 N-CA-C 108.942 -0.762 . . . . 40.04 108.942 178.959 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptp . . . . . 0 N--CA 1.478 0.963 0 CA-C-O 121.616 0.722 . . . . 70.2 110.013 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -154.01 108.15 3.02 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.901 -0.778 . . . . 75.14 108.901 174.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -92.35 103.47 15.91 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.695 -0.854 . . . . 61.45 108.695 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 23.0 t -134.59 93.86 3.11 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.753 -0.832 . . . . 74.24 108.753 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 48.6 p -113.99 144.28 43.35 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.112 0.965 . . . . 75.45 109.327 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.421 HG21 ' HA ' ' A' ' 128' ' ' LEU . 79.9 mt 69.99 133.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 124.784 1.233 . . . . 72.42 111.433 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.47 141.01 29.28 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.492 0.717 . . . . 42.14 109.803 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 16.2 mt -157.06 160.68 39.16 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.41 1.084 . . . . 70.45 108.954 173.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -158.01 -77.91 0.08 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.376 0.67 . . . . 65.43 109.796 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 10' ' ' LEU . . . . . 0.412 HD11 HD22 ' A' ' 136' ' ' LEU . 96.6 mt -136.96 175.92 9.18 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.779 0.831 . . . . 62.34 110.864 -174.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 86.9 mt -86.8 145.87 39.82 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 115.016 -0.993 . . . . 52.11 109.63 174.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -61.98 -46.43 13.28 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.507 2.138 . . . . 63.2 111.341 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -121.97 154.97 36.49 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.883 0.873 . . . . 75.45 108.718 172.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 82.5 mt -89.09 35.67 0.8 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.474 0.709 . . . . 61.23 110.338 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 60.64 -166.58 0.2 Allowed 'General case' 0 C--N 1.359 0.991 0 C-N-CA 124.231 1.012 . . . . 72.14 111.227 -174.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 16' ' ' THR . . . . . 0.685 HG22 ' HB2' ' A' ' 48' ' ' SER . 6.8 t -106.85 145.65 31.51 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 109.368 -0.605 . . . . 72.4 109.368 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 17' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.8 135.43 67.69 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.547 2.165 . . . . 73.22 112.664 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 18' ' ' VAL . . . . . 0.7 HG21 HD11 ' A' ' 86' ' ' ILE . 5.2 p -66.51 -44.84 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.437 0.695 . . . . 70.34 111.177 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 23.2 p -138.0 49.76 1.94 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.211 1.005 . . . . 73.21 110.097 -174.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 59.7 tttm 62.86 25.75 15.23 Favored 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 123.799 0.839 . . . . 74.35 110.147 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.98 87.55 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.785 1.234 . . . . 63.33 112.755 -172.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -147.34 125.4 12.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.019 1.328 . . . . 73.12 108.619 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 23' ' ' THR . . . . . 0.632 HG23 ' HA3' ' A' ' 91' ' ' GLY . 3.5 p -97.28 142.32 24.37 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 123.274 0.63 . . . . 65.43 110.329 175.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -48.59 111.74 0.51 Allowed 'Trans proline' 0 C--N 1.39 2.763 0 C-N-CA 123.587 2.858 . . . . 72.41 113.27 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--O 1.253 1.244 0 C-N-CA 124.269 1.028 . . . . 45.23 111.549 -175.718 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 110.259 -0.274 . . . . 52.1 110.259 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -81.21 152.92 27.45 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.266 0.627 . . . . 74.34 110.375 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -77.86 167.42 21.54 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.181 0.593 . . . . 61.32 110.105 168.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 26.7 m 59.15 36.58 24.02 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.813 0.845 . . . . 42.34 111.323 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 22.2 m -53.59 -58.42 7.22 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.843 1.257 . . . . 63.12 112.166 -175.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.426 HG21 ' HB ' ' B' ' 40' ' ' VAL . 1.9 pp -137.23 135.5 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.22 1.008 . . . . 32.21 109.069 176.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 7' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' B' ' 129' ' ' ALA . . . -166.81 149.09 6.36 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.393 1.077 . . . . 62.31 109.097 -176.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 8' ' ' LEU . . . . . 0.493 HD21 HG13 ' B' ' 62' ' ' VAL . 92.4 mt -65.28 129.02 38.22 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.672 0.389 . . . . 73.12 111.122 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.99 147.93 52.56 Favored 'General case' 0 C--O 1.243 0.731 0 O-C-N 123.756 0.66 . . . . 74.35 110.849 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 6.9 tt -60.92 133.24 55.9 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.884 0.874 . . . . 51.11 108.667 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 86.8 mt -66.02 106.53 1.12 Allowed Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.492 0.717 . . . . 71.51 111.589 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.26 -17.27 10.47 Favored 'Trans proline' 0 C--N 1.383 2.35 0 C-N-CA 122.377 2.051 . . . . 75.12 111.589 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 73.0 mt -78.41 -24.74 46.06 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 124.539 1.136 . . . . 75.23 110.379 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 14' ' ' LEU . . . . . 0.509 ' HB3' ' HB1' ' B' ' 95' ' ' ALA . 90.3 mt 64.82 16.8 10.68 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.95 1.3 . . . . 75.45 111.653 -174.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 21.1 t80 68.94 145.54 0.05 Allowed 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 125.965 1.706 . . . . 74.25 111.369 -177.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 8.2 p -62.66 119.1 47.76 Favored Pre-proline 0 CA--C 1.559 1.296 0 C-N-CA 123.706 0.802 . . . . 74.05 110.976 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.03 165.69 30.76 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.201 2.601 . . . . 73.22 114.1 -167.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 18' ' ' VAL . . . . . 0.534 HG21 HG12 ' B' ' 86' ' ' ILE . 39.6 t -77.62 140.27 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.607 0.763 . . . . 72.13 109.267 176.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 38.3 m -62.43 -34.77 77.42 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.115 0.566 . . . . 42.33 111.057 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 20' ' ' LYS . . . . . 0.454 ' H ' HG12 ' F' ' 18' ' ' VAL . 99.4 mttt -114.05 -81.66 0.6 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.905 0.482 . . . . 63.45 110.426 175.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 21' ' ' ALA . . . . . 0.463 ' HB2' ' HB ' ' F' ' 18' ' ' VAL . . . 65.69 30.25 10.4 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 122.093 0.949 . . . . 64.42 110.479 -170.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 22.9 ptt85 -162.96 108.49 1.14 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.73 1.612 . . . . 71.52 108.412 -176.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 15.5 p -63.77 153.07 85.08 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.471 0.708 . . . . 74.0 111.79 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.6 -13.84 32.14 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.058 2.506 . . . . 74.43 112.715 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 CA--C 1.561 1.366 0 C-N-CA 125.523 1.529 . . . . 71.05 108.922 178.582 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ptt? . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 110.175 -0.306 . . . . 73.21 110.175 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -111.78 133.7 53.83 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.051 0.94 . . . . 74.11 109.367 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 55.41 70.47 0.63 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.328 1.051 . . . . 50.43 110.656 -170.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 22.8 p -112.17 -78.54 0.58 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.735 0.814 . . . . 51.13 110.224 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 7.6 m -108.3 163.11 13.48 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.622 0.769 . . . . 74.4 109.635 -175.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 6' ' ' ILE . . . . . 0.438 ' O ' ' HB3' ' C' ' 129' ' ' ALA . 49.2 pt -64.64 141.82 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.537 0.735 . . . . 64.44 111.571 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -163.33 156.74 19.29 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.584 0.753 . . . . 74.51 109.617 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 8' ' ' LEU . . . . . 0.536 HD13 HD13 ' C' ' 44' ' ' LEU . 83.7 mt -72.23 152.4 42.23 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.478 0.711 . . . . 73.24 111.056 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.74 144.38 37.28 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.027 -0.533 . . . . 45.14 110.361 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 10' ' ' LEU . . . . . 0.42 HD21 HD12 ' C' ' 136' ' ' LEU . 96.5 mt -62.05 134.49 56.68 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.289 0.636 . . . . 64.54 109.816 173.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.9 101.73 0.29 Allowed Pre-proline 0 CA--C 1.558 1.261 0 O-C-N 124.298 0.999 . . . . 71.53 110.776 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.25 -36.02 7.71 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.094 2.529 . . . . 73.04 112.292 -169.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 5.4 mp -73.21 -12.13 60.76 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.194 0.998 . . . . 62.3 111.174 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 84.6 mt 63.12 81.56 0.2 Allowed 'General case' 0 C--N 1.36 1.046 0 C-N-CA 124.77 1.228 . . . . 74.32 109.651 -174.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 15' ' ' PHE . . . . . 0.467 ' HE2' HG13 ' C' ' 58' ' ' VAL . 28.9 t80 -59.17 104.08 0.22 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.781 -0.645 . . . . 74.23 110.217 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 16' ' ' THR . . . . . 0.416 ' HA ' HD13 ' C' ' 98' ' ' LEU . 36.4 m -113.23 87.02 10.32 Favored Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 124.403 1.081 . . . . 73.44 109.796 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 17' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.36 -35.77 13.16 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 123.296 2.664 . . . . 61.24 113.035 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 18' ' ' VAL . . . . . 0.496 HG11 ' SD ' ' C' ' 94' ' ' MET . 61.5 t -84.72 135.82 24.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 115.782 -0.644 . . . . 64.44 110.695 -172.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 80.4 p -67.52 142.68 56.49 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 123.978 0.799 . . . . 72.02 110.375 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 20' ' ' LYS . . . . . 0.508 ' HA ' ' HB2' ' A' ' 152' ' ' HIS . 9.4 mtmp? 77.55 -8.77 1.62 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.982 1.713 . . . . 60.32 113.232 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 21' ' ' ALA . . . . . 0.564 ' HB2' ' SD ' ' C' ' 94' ' ' MET . . . -80.18 2.01 25.96 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.145 0.578 . . . . 72.44 111.849 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -62.88 124.14 20.29 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 123.695 0.798 . . . . 71.42 110.704 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -120.61 149.8 51.03 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.64 1.176 . . . . 74.14 109.084 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.65 141.4 90.88 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.248 1.965 . . . . 73.35 111.744 171.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 CA--C 1.553 1.093 0 C-N-CA 123.328 0.651 . . . . 63.43 109.446 175.365 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' H' H ' 1' ' ' MET . . . . . 0.517 ' SD ' ' HG2' ' H' ' 3' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 120.529 0.204 . . . . 73.25 110.556 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -154.0 98.73 2.19 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.541 -1.281 . . . . 75.41 107.541 172.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 3' ' ' GLN . . . . . 0.517 ' HG2' ' SD ' ' H' ' 1' ' ' MET . 15.8 mm-40 -80.81 88.31 5.83 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.435 0.694 . . . . 73.22 110.04 -177.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 19.9 m -64.62 92.71 0.09 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.16 0.984 . . . . 75.42 110.551 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 9.9 t -140.28 142.96 35.68 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.366 0.666 . . . . 51.11 110.129 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.69 HD11 ' HA ' ' D' ' 128' ' ' LEU . 9.4 tp -160.53 127.97 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.814 -0.63 . . . . 71.41 109.379 173.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . 58.89 -100.15 0.11 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.575 1.15 . . . . 65.05 112.604 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 8' ' ' LEU . . . . . 0.414 HD23 HD21 ' D' ' 44' ' ' LEU . 2.4 pp -157.28 173.88 16.29 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 122.054 -0.404 . . . . 72.51 111.388 -171.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.91 -71.47 0.27 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.707 0.803 . . . . 62.4 109.15 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 6.4 mp -127.66 146.04 50.68 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.654 0.782 . . . . 73.31 109.522 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.07 140.52 31.58 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.065 0.946 . . . . 74.11 109.429 177.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.36 172.54 16.13 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 122.816 2.344 . . . . 72.14 112.919 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tm? 67.27 -74.78 0.07 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.729 1.612 . . . . 72.14 109.08 -173.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 16.2 tp 69.28 160.85 0.2 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.13 1.372 . . . . 73.02 111.721 174.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 15' ' ' PHE . . . . . 0.484 ' HE2' ' HB3' ' D' ' 48' ' ' SER . 22.1 m-85 -77.49 153.34 33.57 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.317 0.647 . . . . 74.11 110.081 176.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 28.9 m -137.88 -56.78 0.02 OUTLIER Pre-proline 0 CA--C 1.572 1.801 0 N-CA-C 113.208 0.818 . . . . 65.51 113.208 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -95.18 169.34 1.47 Allowed 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 122.327 2.018 . . . . 43.15 114.49 -175.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 18' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' D' ' 94' ' ' MET . 11.8 t -106.61 -57.36 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.437 1.095 . . . . 75.13 108.324 166.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 8.4 t -75.7 128.34 34.99 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.175 -0.921 . . . . 64.01 109.578 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt 61.38 27.92 17.45 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.38 1.472 . . . . 71.52 111.189 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.57 120.1 14.83 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.943 0.897 . . . . 65.43 111.157 -175.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 70.02 -75.12 0.08 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.846 1.659 . . . . 70.45 110.29 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 5.4 m 58.26 72.41 0.87 Allowed Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 124.724 1.21 . . . . 74.41 109.978 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.86 103.46 0.72 Allowed 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 123.073 2.515 . . . . 65.13 112.009 -172.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.553 1.07 0 N-CA-C 108.027 -1.101 . . . . 73.3 108.027 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.2 ttp . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.265 0.079 . . . . 54.43 110.927 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 m -70.64 84.56 0.63 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.728 0.775 . . . . 54.14 111.672 -172.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -104.98 87.17 2.58 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.252 1.021 . . . . 75.52 108.932 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.14 -178.45 4.32 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.639 0.776 . . . . 74.23 111.177 -172.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.6 t30 65.98 -74.12 0.06 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.667 1.587 . . . . 64.2 112.42 170.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -117.62 87.81 2.78 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.398 1.479 . . . . 74.24 109.37 -176.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.6 p -98.79 -54.63 2.95 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.51 0.724 . . . . 74.12 110.153 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -84.37 88.21 7.25 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 123.354 0.661 . . . . 75.34 109.483 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.56 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.9 OUTLIER 70.86 157.9 0.18 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.764 1.226 . . . . 74.53 110.894 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.442 ' N ' ' SD ' ' A' ' 9' ' ' MET . 5.7 t -145.78 134.49 22.27 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 123.054 0.542 . . . . 71.33 110.329 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.602 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 48.1 t80 -137.27 135.68 37.38 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.728 -0.669 . . . . 74.43 110.18 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -160.48 129.34 4.82 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.873 0.869 . . . . 72.54 109.372 173.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.567 ' CD1' HG21 ' A' ' 105' ' ' ILE . 58.2 mt -94.14 122.11 45.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.809 -0.811 . . . . 64.22 108.809 172.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -90.98 -31.15 16.44 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.278 0.361 . . . . 74.42 110.759 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.49 ' HB3' HD12 ' A' ' 83' ' ' ILE . 39.8 ttt180 -167.0 122.19 1.09 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 111.99 0.367 . . . . 72.55 111.99 -169.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.433 HD11 HD13 ' A' ' 13' ' ' ILE . 73.7 mt -115.02 137.14 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 123.842 0.857 . . . . 74.53 109.24 173.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HB3' HG23 ' B' ' 122' ' ' THR . 26.9 p90 -163.01 174.94 11.66 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 123.791 0.836 . . . . 73.11 111.069 -174.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -106.89 118.74 37.49 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.95 -0.759 . . . . 61.11 108.95 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -86.76 -25.75 24.52 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.857 -0.423 . . . . 64.22 109.857 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.696 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 26.3 t70 -145.91 135.39 23.1 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.604 -0.726 . . . . 62.4 109.703 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.7 mt -139.06 140.52 38.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 C-N-CA 125.477 1.511 . . . . 74.21 107.187 176.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -150.35 124.96 9.67 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.235 0.614 . . . . 73.22 109.381 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.428 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 88.1 t80 -124.08 136.6 54.35 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.052 -1.462 . . . . 74.42 107.052 168.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -137.29 135.95 37.58 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.895 0.478 . . . . 64.31 110.069 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.09 74.41 49.7 Favored Pre-proline 0 C--O 1.242 0.696 0 N-CA-C 106.6 -1.63 . . . . 72.55 106.6 167.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.58 -32.09 39.66 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.118 1.878 . . . . 74.51 110.906 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -96.98 19.59 12.53 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.226 -0.897 . . . . 73.14 110.685 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.455 ' HB3' ' HZ1' ' B' ' 19' ' ' LYS . . . -50.31 -45.94 83.51 Favored Pre-proline 0 CA--C 1.567 1.614 0 N-CA-C 114.469 1.285 . . . . 62.12 114.469 -172.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -66.37 -19.51 55.56 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 121.767 1.644 . . . . 33.04 113.479 175.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -97.15 -26.07 15.09 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.01 0.924 . . . . 72.31 111.564 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.585 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.1 p -79.61 -30.26 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 N-CA-C 113.459 0.911 . . . . 74.31 113.459 -158.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -81.75 -23.9 36.4 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.813 0.445 . . . . 73.14 111.189 -171.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -79.91 -11.6 59.79 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.474 0.71 . . . . 74.21 111.038 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -81.47 162.3 23.32 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.872 0.469 . . . . 64.05 111.417 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -68.9 126.52 30.04 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.259 -0.882 . . . . 73.22 108.967 173.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 44.3 t-105 -76.4 81.92 3.13 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.762 0.791 . . . . 72.41 109.862 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -130.94 76.19 77.42 Favored Pre-proline 0 C--O 1.246 0.876 0 N-CA-C 107.512 -1.292 . . . . 71.44 107.512 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -85.48 140.22 7.21 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.295 1.997 . . . . 72.23 112.226 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -97.06 101.74 13.37 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.411 -1.329 . . . . 71.12 107.411 169.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 65' ' ' THR . 19.3 t -85.88 93.78 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.846 -0.798 . . . . 74.25 108.846 -176.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -86.12 115.34 23.63 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.531 1.132 . . . . 75.11 109.424 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.459 HD21 HG23 ' E' ' 6' ' ' ILE . 1.9 mm? -97.9 107.81 20.38 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.02 -0.733 . . . . 65.34 109.02 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.55 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 18.1 t70 -106.9 121.75 45.04 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.275 1.03 . . . . 61.24 108.552 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.468 HD21 HD22 ' E' ' 8' ' ' LEU . 6.5 mp -103.67 145.96 29.29 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.98 -0.378 . . . . 72.11 109.98 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.636 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 23.1 t70 -148.76 159.65 43.94 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.067 0.947 . . . . 53.01 108.847 177.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.6 m -135.44 136.85 41.68 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.571 0.749 . . . . 70.41 110.41 -178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.85 144.07 49.95 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.734 1.214 . . . . 74.51 108.279 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.0 p -132.9 167.22 20.62 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.716 0.406 . . . . 72.34 111.478 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.0 t -166.67 122.51 1.19 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.336 -0.847 . . . . 70.01 109.952 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -77.29 110.93 12.41 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 107.871 -1.159 . . . . 65.25 107.871 168.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 57' ' ' GLU . 31.3 mt -84.94 -36.68 21.25 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.177 0.591 . . . . 65.14 110.75 -173.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.66 -174.47 4.23 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.848 0.859 . . . . 73.33 110.035 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -65.53 119.08 10.44 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.381 -0.6 . . . . 73.0 109.381 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 85' ' ' SER . 35.8 m-20 68.22 2.17 3.14 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.91 1.284 . . . . 74.11 113.015 -177.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.5 t -105.91 111.22 34.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 108.214 -1.032 . . . . 54.12 108.214 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -131.53 137.33 48.45 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.845 -0.798 . . . . 70.25 108.845 -174.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.454 ' HB2' HD11 ' A' ' 51' ' ' LEU . 40.5 tt0 -108.7 118.25 36.3 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.879 -1.055 . . . . 62.4 109.786 -176.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.5 t -103.43 123.74 57.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.043 -1.466 . . . . 74.34 107.043 170.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.8 131.25 70.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 107.817 -1.179 . . . . 62.41 107.817 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 tt -121.8 115.08 22.01 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.179 -1.045 . . . . 71.41 108.179 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.636 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 35.9 ttp180 -85.45 109.49 18.5 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.831 0.852 . . . . 75.34 109.93 175.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.4 t -99.48 102.77 13.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.537 -1.283 . . . . 75.15 107.537 170.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 39.8 m -94.84 108.86 20.89 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.985 0.914 . . . . 75.54 108.907 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.7 t -103.78 110.15 29.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.264 -0.88 . . . . 74.4 109.142 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 21.6 m -102.11 134.74 44.88 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.963 -1.125 . . . . 50.21 107.963 171.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.68 117.22 19.99 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.963 -1.495 . . . . 72.42 106.963 174.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 54.0 m -128.0 132.7 49.14 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.943 0.497 . . . . 71.33 110.97 -175.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.7 mt -90.85 48.01 1.48 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.484 1.114 . . . . 65.43 108.805 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.42 -90.41 0.93 Allowed Glycine 0 C--N 1.351 1.376 0 CA-C-N 114.993 -1.003 . . . . 74.5 112.552 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -87.83 -22.87 24.23 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.785 0.834 . . . . 71.41 111.034 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -118.55 98.82 6.44 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.857 -1.164 . . . . 73.14 107.857 -172.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 93.1 m -59.08 129.19 40.94 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 118.44 0.563 . . . . 53.42 110.597 177.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.585 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -70.18 -60.62 2.17 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.241 -0.891 . . . . 72.15 109.643 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -161.19 164.19 30.65 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 114.863 -1.062 . . . . 73.32 110.99 177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.1 tp -128.62 108.9 10.88 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.502 -0.925 . . . . 73.22 108.502 171.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.403 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 73.9 m -106.48 96.61 6.58 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.59 0.756 . . . . 74.53 109.824 174.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -111.04 115.27 29.18 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.866 -0.79 . . . . 60.11 108.866 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -124.11 132.04 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.048 0.539 . . . . 33.41 109.563 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.696 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 45.2 mt-30 -98.72 95.59 7.34 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.262 0.625 . . . . 71.53 109.521 168.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -80.41 105.16 11.46 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.807 -1.088 . . . . 70.14 109.03 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.7 150.92 20.59 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.908 -0.587 . . . . 42.24 111.821 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.53 147.49 18.6 Favored Glycine 0 C--O 1.237 0.284 0 N-CA-C 111.529 -0.628 . . . . 32.44 111.529 174.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 15' ' ' ARG . 64.1 mt -104.13 112.23 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.06 -1.089 . . . . 71.33 108.06 176.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.602 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 5.1 m-85 -123.16 154.83 38.14 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.258 1.023 . . . . 74.34 108.294 -176.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 87.9 p -109.04 116.04 31.22 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.742 -0.836 . . . . 71.24 108.742 172.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.47 122.0 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 109.279 -0.637 . . . . 62.42 109.279 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.96 166.47 7.52 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.315 1.046 . . . . 53.34 110.005 173.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 122.07 -81.01 0.34 Allowed Glycine 0 C--N 1.34 0.78 0 O-C-N 123.657 0.598 . . . . 73.34 111.623 174.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.9 mm -117.18 132.88 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.262 -0.644 . . . . 75.23 109.262 -173.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -94.57 -144.91 0.25 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.832 0.853 . . . . 70.43 109.519 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.607 ' HA2' ' HB2' ' E' ' 22' ' ' ARG . . . 72.48 -148.86 42.78 Favored Glycine 0 C--N 1.354 1.561 0 N-CA-C 112.24 -0.344 . . . . 74.12 112.24 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.5 p -71.14 -18.19 62.52 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.732 0.813 . . . . 63.31 111.653 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -72.33 -55.27 7.4 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 123.142 0.577 . . . . 75.02 110.485 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.637 ' HA ' ' SG ' ' A' ' 97' ' ' CYS . 58.0 ttm -65.62 -31.7 72.87 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.801 0.273 . . . . 72.35 110.705 176.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.96 -26.96 67.08 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.152 0.581 . . . . 41.22 111.501 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.402 ' NE2' ' HB2' ' A' ' 134' ' ' ASP . 34.1 t-80 -89.51 -47.49 7.95 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.41 0.684 . . . . 74.34 111.324 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.637 ' SG ' ' HA ' ' A' ' 94' ' ' MET . 22.0 p -62.36 -42.86 99.74 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.228 0.537 . . . . 55.32 110.372 -174.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.526 ' HG ' HG23 ' E' ' 18' ' ' VAL . 3.2 tm? -88.02 -41.4 13.13 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.985 -1.007 . . . . 71.22 109.984 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.94 0.09 89.08 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-O 119.443 -0.643 . . . . 71.42 114.647 -171.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.22 -51.83 0.14 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 117.939 0.869 . . . . 73.43 112.464 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.469 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 85.6 t80 -69.86 -58.64 3.64 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.712 0.634 . . . . 74.0 112.712 -170.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.409 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 71.7 m -62.59 -40.49 65.24 Favored Pre-proline 0 CA--C 1.563 1.471 0 N-CA-C 113.651 0.982 . . . . 55.3 113.651 -175.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 34.8 Cg_endo -65.23 -27.84 56.04 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 121.941 1.761 . . . . 71.4 113.166 169.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -75.29 -23.36 57.36 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 122.843 0.457 . . . . 72.34 110.696 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.567 HG21 ' CD1' ' A' ' 13' ' ' ILE . 46.9 mm -62.35 -40.86 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.338 0.655 . . . . 64.32 109.751 170.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 80.1 mt -74.19 -21.56 59.77 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.935 -1.029 . . . . 61.42 111.607 -177.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -60.51 -49.17 91.29 Favored Pre-proline 0 CA--C 1.565 1.536 0 N-CA-C 113.982 1.104 . . . . 71.32 113.982 -172.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.29 -34.17 88.26 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 121.941 1.761 . . . . 73.24 112.829 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -70.13 -41.25 74.17 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.362 0.665 . . . . 72.25 111.455 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.32 -44.02 89.15 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.661 -0.699 . . . . 74.32 109.764 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.528 ' NH1' HD12 ' C' ' 105' ' ' ILE . 30.6 ttm180 -52.6 -48.66 66.15 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.639 1.175 . . . . 74.13 110.64 174.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.07 -49.71 66.69 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.446 0.698 . . . . 75.51 111.33 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 33.1 t -61.54 -26.43 67.93 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.473 0.709 . . . . 73.21 111.495 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 81.1 mt -77.81 -57.3 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 123.84 0.856 . . . . 65.32 110.117 174.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.5 m -55.59 -34.74 65.1 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.823 0.849 . . . . 62.25 111.89 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.0 t -63.73 -49.99 70.88 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.318 -0.856 . . . . 72.24 110.058 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 30.4 mtm -66.5 -37.51 85.23 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.103 0.561 . . . . 71.33 111.229 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.0 t -57.07 -47.98 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 124.02 0.825 . . . . 75.13 110.048 175.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 29.3 t -73.45 -28.89 62.2 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 115.039 -0.982 . . . . 62.05 111.438 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -72.83 -28.64 62.66 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.207 0.603 . . . . 73.22 109.872 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.13 4.67 75.21 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 123.659 0.599 . . . . 64.33 112.918 172.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.57 HG23 HH21 ' B' ' 15' ' ' ARG . 0.6 OUTLIER 65.72 16.33 10.45 Favored 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 126.515 1.926 . . . . 72.11 112.347 177.356 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -79.16 152.93 76.95 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 123.575 0.75 . . . . 61.33 109.666 172.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.98 134.31 63.72 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.474 2.116 . . . . 74.42 111.14 171.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -56.65 158.08 4.85 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.557 0.743 . . . . 72.42 112.416 -173.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.0 tp -135.85 93.73 2.97 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.28 -0.873 . . . . 75.52 109.333 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -98.12 99.14 10.38 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.986 -1.116 . . . . 71.51 107.986 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.687 HD13 HG22 ' E' ' 6' ' ' ILE . 19.0 tp -59.26 136.7 58.04 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.294 -0.867 . . . . 61.3 110.346 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.04 145.14 81.16 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 124.284 1.033 . . . . 72.31 112.147 -175.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.06 123.34 11.75 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.204 2.603 . . . . 52.25 111.759 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 77.1 t -116.02 115.94 50.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 108.96 -0.755 . . . . 74.3 108.96 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.473 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 2.8 m-20 -73.26 74.69 1.32 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.88 0.872 . . . . 71.54 108.654 173.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -58.69 -52.02 67.47 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.037 1.335 . . . . 72.25 111.903 -163.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.402 ' HB2' ' NE2' ' A' ' 96' ' ' HIS . 5.2 p-10 -69.95 -32.63 70.98 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.98 -1.009 . . . . 61.01 111.29 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.485 ' HA ' ' HB2' ' A' ' 138' ' ' MET . . . -67.65 -33.76 75.6 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.086 0.954 . . . . 52.1 111.935 -175.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 132' ' ' ASN . 77.5 mt -64.35 -38.69 91.92 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.362 0.665 . . . . 74.33 110.272 177.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -75.12 -33.56 61.6 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.409 -0.814 . . . . 64.54 110.597 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.485 ' HB2' ' HA ' ' A' ' 135' ' ' ALA . 7.6 mmt -66.83 -25.9 66.66 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.164 0.986 . . . . 62.03 112.008 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -64.49 -27.74 69.18 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.422 0.689 . . . . 74.55 111.303 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -95.06 -34.87 12.15 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.831 0.452 . . . . 75.21 110.359 172.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.454 HD23 ' SD ' ' A' ' 138' ' ' MET . 11.7 tp -64.91 -46.23 82.58 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.189 0.996 . . . . 73.32 110.948 -170.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.86 -0.28 0.82 Allowed 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.1 -0.5 . . . . 74.42 111.356 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 64.73 100.51 0.04 OUTLIER 'General case' 0 C--N 1.36 1.025 0 C-N-CA 124.541 1.136 . . . . 72.32 111.531 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -75.23 129.21 37.08 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 110.072 -0.344 . . . . 75.23 110.072 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.2 -17.96 38.18 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.364 0.666 . . . . 71.13 110.771 172.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 84.24 176.93 51.26 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 115.497 -0.774 . . . . 42.43 112.094 -173.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -155.68 96.38 1.75 Allowed 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.232 -1.025 . . . . 53.2 108.232 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -178.06 163.37 31.5 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.17 -0.923 . . . . 62.02 112.98 -176.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.5 p -93.08 165.36 12.88 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.933 0.893 . . . . 65.14 109.962 175.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.44 ' O ' ' HA2' ' C' ' 88' ' ' GLY . 33.0 tt0 -81.17 -59.48 2.63 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.275 -0.639 . . . . 64.32 109.275 172.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.42 ' HB3' HE21 ' A' ' 153' ' ' GLN . 49.1 mm-40 54.5 170.03 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.217 1.407 . . . . 43.31 114.426 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -149.58 100.71 3.02 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 113.623 -1.626 . . . . 72.23 106.675 171.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.42 HE21 ' HB3' ' A' ' 151' ' ' GLU . 33.5 mm-40 -83.64 66.7 9.13 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.778 0.431 . . . . 72.5 110.274 -177.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -71.73 78.92 0.84 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.751 -0.833 . . . . 71.13 108.751 174.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.966 0 C-N-CA 124.173 0.989 . . . . 72.31 108.613 -177.026 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.737 0.303 . . . . 63.22 110.786 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 28.6 p -104.03 121.24 42.77 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.759 0.824 . . . . 54.44 109.357 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.43 -169.48 1.85 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.761 0.824 . . . . 64.41 110.727 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -72.49 115.17 11.43 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.469 0.708 . . . . 74.0 110.94 -176.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 10.9 t30 174.07 121.18 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.974 1.709 . . . . 75.45 108.444 168.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -154.26 134.52 13.29 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.255 0.622 . . . . 60.12 109.819 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 13.1 t -61.63 172.79 1.13 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.429 1.092 . . . . 52.12 112.18 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' B' ' 9' ' ' MET . 42.4 tt0 79.6 -59.66 0.35 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.686 1.594 . . . . 73.34 110.437 -174.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.507 ' HB3' HG13 ' B' ' 89' ' ' ILE . 4.2 ppp? 57.5 178.97 0.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 126.293 1.837 . . . . 63.22 113.218 176.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 93.8 m -133.57 113.59 12.61 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.134 0.574 . . . . 64.31 109.504 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -123.61 143.68 50.08 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.102 0.961 . . . . 75.45 109.342 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -162.88 141.43 8.48 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.38 0.672 . . . . 73.54 110.268 169.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.513 HD13 HD11 ' B' ' 16' ' ' ILE . 49.2 mt -68.68 129.39 33.23 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 109.014 -0.735 . . . . 75.12 109.014 171.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -97.95 -42.27 7.61 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.209 0.604 . . . . 64.32 109.537 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.57 HH21 HG23 ' A' ' 122' ' ' THR . 21.7 ttt85 -168.48 144.89 3.77 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.79 -0.641 . . . . 54.03 109.457 -174.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.513 HD11 HD13 ' B' ' 13' ' ' ILE . 96.4 mt -128.73 144.65 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 107.56 -1.274 . . . . 74.44 107.56 175.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -171.12 156.03 4.62 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.182 0.515 . . . . 65.11 111.462 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 95.2 m -85.2 126.28 33.53 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.634 -0.712 . . . . 55.42 109.244 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.455 ' HZ1' ' HB3' ' A' ' 28' ' ' ALA . 33.4 mttp -86.49 -48.36 8.47 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.27 0.628 . . . . 71.33 110.61 172.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -144.96 136.91 25.74 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 110.115 -0.328 . . . . 74.32 110.115 -165.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 44.7 mm -131.69 142.41 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.389 1.076 . . . . 74.13 109.309 176.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.687 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 69.3 m -138.84 136.67 35.85 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.83 1.252 . . . . 60.21 108.439 177.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' B' ' 75' ' ' LEU . 75.7 t80 -149.91 107.46 3.65 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 107.858 -1.164 . . . . 54.23 107.858 165.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -121.79 112.12 17.97 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.096 0.959 . . . . 74.24 108.945 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.484 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -113.53 87.6 12.0 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.688 1.195 . . . . 64.11 108.231 174.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.9 -41.93 12.72 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.867 2.378 . . . . 71.03 111.837 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.464 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 2.5 m-20 -90.87 3.49 54.36 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.874 -1.057 . . . . 72.32 111.345 -175.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.484 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -37.06 -60.51 0.8 Allowed Pre-proline 0 N--CA 1.49 1.552 0 C-N-CA 125.668 1.587 . . . . 71.34 114.973 -164.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.7 -31.63 58.55 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 122.474 2.116 . . . . 53.32 113.278 -173.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -88.62 -38.08 15.12 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.06 0.544 . . . . 71.44 111.103 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.695 HG22 HD12 ' B' ' 68' ' ' LEU . 8.9 p -69.5 -19.15 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 123.339 0.656 . . . . 75.14 111.486 -174.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -58.74 -20.66 51.24 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 113.372 0.879 . . . . 72.21 113.372 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.48 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.1 pt20 -59.82 -31.97 70.21 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.462 0.705 . . . . 72.44 111.33 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.48 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 99.8 mttt -87.91 95.95 10.3 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.878 0.871 . . . . 64.3 109.944 -176.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -91.07 87.52 6.61 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.783 -0.644 . . . . 65.21 110.597 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -163.17 -179.22 6.5 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.886 0.874 . . . . 74.23 109.726 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -77.81 108.36 7.18 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.589 0.755 . . . . 73.12 109.812 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.4 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 37.7 Cg_endo -64.77 142.1 74.91 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.433 2.089 . . . . 70.51 113.109 -176.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -68.79 119.95 13.97 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.77 0.828 . . . . 73.31 109.395 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.462 HG21 HG12 ' F' ' 6' ' ' ILE . 24.4 m -106.98 161.31 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 123.727 0.811 . . . . 72.13 112.173 -169.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.523 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 55.9 tttm -135.5 109.66 8.31 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.387 1.075 . . . . 72.53 108.794 175.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.425 HD21 HD13 ' F' ' 6' ' ' ILE . 5.3 mp -90.15 138.06 31.83 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.015 -0.735 . . . . 73.21 109.015 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.559 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 7.2 t70 -149.79 158.26 43.99 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 107.838 -1.171 . . . . 62.02 107.838 -176.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.4 ' HB2' HD11 ' B' ' 60' ' ' LEU . 2.4 pt? -140.52 158.97 43.2 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.034 0.445 . . . . 54.35 110.478 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 28.9 t70 -146.86 155.58 42.44 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.881 0.872 . . . . 73.3 108.903 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 58.6 m -108.45 137.35 46.57 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.699 0.8 . . . . 72.44 110.854 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.675 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -142.8 146.31 34.09 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.739 -1.208 . . . . 52.42 107.739 166.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.4 p -142.74 168.63 19.27 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.23 0.612 . . . . 62.43 109.935 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' SER . . . . . 0.573 ' HB2' ' HB3' ' B' ' 57' ' ' GLU . 2.3 m -150.65 151.93 33.23 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.149 -1.056 . . . . 74.1 108.149 170.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -115.57 106.59 14.1 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.23 -1.396 . . . . 73.2 107.23 168.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' B' ' 57' ' ' GLU . 21.1 mt -87.53 -38.12 16.3 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.477 0.711 . . . . 64.24 109.771 -173.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.8 -171.24 3.59 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.521 -1.218 . . . . 72.14 109.416 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -69.59 125.59 27.17 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.091 -0.959 . . . . 72.4 108.445 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 68.92 -2.09 1.86 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.771 1.229 . . . . 73.25 112.811 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 88.9 t -107.1 105.25 18.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 108.818 -0.808 . . . . 63.34 108.818 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.584 ' HB2' HD11 ' B' ' 86' ' ' ILE . 1.2 m-85 -116.36 141.65 47.88 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.524 1.129 . . . . 74.31 108.902 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.573 ' HB3' ' HB2' ' B' ' 49' ' ' SER . 6.7 tm-20 -113.8 97.0 6.14 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.39 -1.337 . . . . 74.45 107.39 -176.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 46.4 t -92.32 128.09 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.964 0.905 . . . . 64.22 109.765 -174.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.675 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 17.6 t -120.64 118.18 55.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 C-N-CA 124.105 0.962 . . . . 74.42 108.761 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.424 ' HB2' ' HB3' ' B' ' 103' ' ' PRO . 43.9 tp -102.88 127.63 50.0 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.986 -0.746 . . . . 65.23 108.986 170.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.445 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 12.7 ttm180 -86.25 135.91 33.38 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.876 -0.787 . . . . 71.02 108.876 169.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.451 ' CG1' HD11 ' B' ' 114' ' ' ILE . 93.9 t -122.32 103.48 13.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 106.958 -1.497 . . . . 71.34 106.958 175.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 52.9 m -95.43 135.99 36.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.918 0.887 . . . . 72.03 108.74 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.599 HG21 HG21 ' B' ' 114' ' ' ILE . 98.3 t -132.44 117.65 32.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.854 -1.165 . . . . 74.43 107.854 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 32.2 m -105.53 149.97 25.77 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.89 -1.152 . . . . 54.22 107.89 170.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.79 145.12 29.81 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.09 -0.707 . . . . 45.23 109.09 176.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.501 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 54.3 p -150.39 128.45 11.88 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 123.865 0.728 . . . . 71.31 110.517 -176.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.695 HD12 HG22 ' B' ' 31' ' ' VAL . 71.1 mt -93.51 98.25 11.06 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 107.281 -1.377 . . . . 54.2 107.281 172.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.97 -129.02 12.41 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 114.91 -1.041 . . . . 74.44 113.568 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -86.72 4.05 42.32 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.469 0.708 . . . . 72.43 112.063 -173.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.464 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 13.2 pt-20 -129.63 152.91 48.63 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.927 0.491 . . . . 75.15 110.213 -177.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 85.6 m -72.33 132.87 44.58 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.327 0.651 . . . . 75.23 110.277 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.536 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -86.44 -62.73 1.45 Allowed 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.851 -1.166 . . . . 53.14 107.851 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -156.01 160.73 40.29 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 115.141 -0.936 . . . . 74.24 111.783 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 23.2 mt -124.74 114.75 19.69 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 106.321 -1.733 . . . . 64.21 106.321 174.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.464 ' SG ' HG23 ' B' ' 114' ' ' ILE . 35.2 t -119.41 146.18 45.59 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.876 -0.787 . . . . 72.22 108.876 175.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.687 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 42.9 tt0 -158.45 134.61 9.22 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.345 -0.613 . . . . 72.4 109.345 -175.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 91.5 t -129.75 142.81 42.92 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 C-N-CA 123.726 0.81 . . . . 71.11 109.107 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -124.28 96.97 5.12 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 107.651 -1.24 . . . . 71.44 107.651 172.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -89.32 107.67 19.19 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.198 -1.038 . . . . 73.55 108.198 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.99 143.56 17.12 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.187 -0.765 . . . . 74.33 111.187 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.8 126.9 2.47 Favored Glycine 0 CA--C 1.51 -0.273 0 N-CA-C 112.04 -0.424 . . . . 60.14 112.04 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 38.9 mt -85.92 128.19 39.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.37 -0.974 . . . . 71.31 108.37 173.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -137.46 147.94 45.69 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.242 0.617 . . . . 73.32 110.039 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 62.8 m -97.41 125.6 42.14 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.118 -0.697 . . . . 70.21 109.118 170.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.584 HD11 ' HB2' ' B' ' 56' ' ' TYR . 1.8 pt -138.26 118.13 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 125.049 1.34 . . . . 72.13 108.993 -174.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' B' ' 9' ' ' MET . . . -152.25 168.04 26.65 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.237 0.615 . . . . 73.51 111.055 -173.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.27 -71.0 1.43 Allowed Glycine 0 C--N 1.348 1.225 0 O-C-N 123.496 0.497 . . . . 64.22 112.673 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.685 HG22 ' HB2' ' B' ' 94' ' ' MET . 10.7 mt -75.02 157.61 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.716 0.807 . . . . 74.41 110.651 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.598 ' HG2' ' H ' ' B' ' 91' ' ' GLY . 11.7 tt0 -151.96 -176.48 5.66 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.93 0.892 . . . . 73.21 108.667 173.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.598 ' H ' ' HG2' ' B' ' 90' ' ' GLU . . . 75.51 -136.27 19.81 Favored Glycine 0 C--N 1.345 1.053 0 C-N-CA 123.139 0.399 . . . . 52.33 113.187 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 44.0 m -70.17 -41.64 73.53 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.569 0.748 . . . . 70.02 111.352 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -60.14 -35.53 75.5 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.941 -1.027 . . . . 61.14 111.052 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.685 ' HB2' HG22 ' B' ' 89' ' ' ILE . 9.9 tmm? -85.14 -31.26 23.38 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.129 0.971 . . . . 74.15 111.52 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.61 -27.58 67.86 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.4 0.619 . . . . 72.42 110.324 170.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.43 ' HA ' HD22 ' F' ' 14' ' ' LEU . 18.7 t-80 -79.64 -29.33 40.93 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.111 1.365 . . . . 53.22 111.646 173.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -63.22 -51.71 65.16 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.873 0.469 . . . . 65.32 111.746 -175.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.498 HD23 HG22 ' F' ' 18' ' ' VAL . 1.6 pp -89.62 -13.33 37.37 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 117.853 0.297 . . . . 54.42 110.99 171.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.95 3.12 85.94 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-O 119.479 -0.623 . . . . 73.0 114.099 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.69 -54.92 0.09 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.231 0.612 . . . . 62.34 110.724 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -72.88 -49.72 28.2 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.366 0.876 . . . . 73.03 113.366 -165.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.484 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 62.7 m -59.7 -47.81 96.7 Favored Pre-proline 0 CA--C 1.565 1.526 0 CA-C-O 119.189 -0.434 . . . . 44.13 111.907 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 23.9 Cg_exo -67.14 -24.97 43.95 Favored 'Trans proline' 0 C--N 1.393 2.879 0 C-N-CA 122.263 1.975 . . . . 71.53 113.599 173.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -63.96 -37.5 87.65 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.365 0.666 . . . . 75.35 110.213 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.413 HG23 ' NH2' ' D' ' 111' ' ' ARG . 68.4 mt -65.54 -39.12 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 115.671 -0.695 . . . . 72.55 110.485 175.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.24 -17.26 52.76 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.24 -0.891 . . . . 62.12 111.735 -175.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -58.99 -49.51 92.98 Favored Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 124.789 1.236 . . . . 73.32 113.556 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -60.79 -39.4 62.92 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 122.262 1.974 . . . . 71.43 113.019 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -64.38 -33.73 76.54 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.487 -0.779 . . . . 71.11 110.491 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.494 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -72.35 -42.16 65.64 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 115.857 -0.611 . . . . 62.23 110.341 174.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -53.36 -55.52 24.21 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.218 1.007 . . . . 71.42 111.527 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.419 ' HG3' ' NH2' ' C' ' 120' ' ' ARG . 2.1 tm-20 -64.03 -34.77 78.76 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.802 0.689 . . . . 44.35 110.106 -177.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.512 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.2 t -73.5 -27.59 61.45 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.734 0.414 . . . . 72.53 111.7 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.599 HG21 HG21 ' B' ' 64' ' ' VAL . 73.0 mt -71.11 -58.62 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 108.578 -0.897 . . . . 74.54 108.578 173.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 4.8 m -65.0 -23.08 67.11 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.906 -1.043 . . . . 73.24 111.441 -173.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 37.7 t -61.52 -49.87 74.96 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.302 0.641 . . . . 73.42 109.454 171.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.2 mmt -71.53 -34.14 69.78 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.415 0.686 . . . . 73.32 110.82 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 114' ' ' ILE . 87.5 t -59.76 -46.1 93.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.709 0.804 . . . . 61.43 109.85 172.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -64.56 -36.67 84.98 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.724 -1.125 . . . . 71.23 110.834 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.483 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 93.5 mtt-85 -65.46 -32.84 74.67 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.247 0.619 . . . . 74.11 110.125 177.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.64 8.71 70.97 Favored Glycine 0 C--N 1.353 1.495 0 O-C-N 123.639 0.587 . . . . 71.33 113.146 174.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.49 HG23 ' HB3' ' A' ' 17' ' ' TYR . 75.7 p 57.47 26.92 13.23 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 126.235 1.814 . . . . 42.34 113.5 177.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -88.08 158.21 50.1 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 123.519 0.728 . . . . 64.35 111.02 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -58.04 157.63 24.32 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 123.403 2.735 . . . . 73.32 114.338 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.591 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -65.33 123.19 18.95 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.482 -1.235 . . . . 64.33 112.186 -177.231 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.539 HD11 HD11 ' F' ' 6' ' ' ILE . 2.3 tm? -138.43 115.3 10.78 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 108.388 -0.967 . . . . 71.44 108.388 176.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -110.9 136.06 50.49 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.874 0.87 . . . . 74.22 109.819 176.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.417 HD12 ' H ' ' B' ' 129' ' ' ALA . 10.0 tp -86.78 135.52 33.33 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.334 0.653 . . . . 73.21 110.739 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.417 ' H ' HD12 ' B' ' 128' ' ' LEU . . . -68.05 147.0 98.42 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.733 1.213 . . . . 74.23 111.779 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.489 ' HG2' HD13 ' D' ' 16' ' ' ILE . 7.1 Cg_exo -70.06 104.16 1.32 Allowed 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.75 2.3 . . . . 72.04 111.994 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.403 HG11 ' H ' ' F' ' 8' ' ' LEU . 10.8 m -92.84 108.16 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 122.092 0.948 . . . . 64.41 109.601 173.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.54 83.89 3.87 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.949 -1.023 . . . . 75.04 108.423 172.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -52.67 -46.74 67.33 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.608 -0.723 . . . . 71.33 109.633 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -55.11 -41.87 72.2 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 113.411 -1.722 . . . . 64.34 112.458 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.1 -42.58 84.33 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 123.665 0.603 . . . . 72.23 110.755 -171.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.421 ' HB2' HD21 ' F' ' 10' ' ' LEU . 9.4 mp -74.31 -24.67 59.26 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.572 0.349 . . . . 74.32 111.38 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -69.56 -37.6 77.07 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 110.006 -0.368 . . . . 75.2 110.006 170.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 95.8 mmm -69.19 -35.9 76.73 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.314 0.645 . . . . 64.11 110.708 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -76.4 -21.52 55.92 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 116.127 -0.488 . . . . 74.11 110.999 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -69.07 -26.42 64.94 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.24 0.543 . . . . 75.14 109.718 172.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 51.4 mt -94.54 34.77 1.27 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.906 0.883 . . . . 64.4 110.101 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.42 133.69 55.39 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.686 0.795 . . . . 74.12 110.506 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -116.25 144.52 44.11 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.027 0.931 . . . . 54.52 110.021 -176.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -76.86 146.31 37.8 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.213 1.005 . . . . 73.2 111.185 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.85 139.0 32.21 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.077 0.551 . . . . 73.11 110.596 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.61 75.22 0.36 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 111.866 -0.494 . . . . 65.14 111.866 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -101.88 141.26 35.0 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.568 0.747 . . . . 52.53 110.196 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -158.84 140.07 6.66 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 116.293 -0.412 . . . . 53.13 112.24 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 11.5 t -156.86 148.46 22.47 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.371 0.669 . . . . 65.41 110.054 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -121.66 121.82 38.2 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.471 0.708 . . . . 52.01 110.506 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -110.19 122.91 48.75 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.267 1.027 . . . . 71.43 108.363 168.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -149.63 116.45 5.92 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.734 0.414 . . . . 63.23 110.771 -175.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -112.92 142.08 46.0 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.243 -1.021 . . . . 75.23 108.243 169.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -106.17 162.88 13.25 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.152 0.581 . . . . 71.11 110.16 176.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 C-N-CA 124.132 0.973 . . . . 62.44 108.759 178.378 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tpt . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 110.441 -0.207 . . . . 64.21 110.441 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 49.8 m 57.84 -153.31 0.38 Allowed 'General case' 0 N--CA 1.483 1.192 0 O-C-N 124.002 0.814 . . . . 73.25 110.641 -174.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 3' ' ' GLU . . . . . 0.454 ' HG2' ' H ' ' C' ' 4' ' ' GLN . 19.5 tt0 61.97 -146.12 0.41 Allowed 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 118.444 -0.789 . . . . 74.25 108.953 175.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 4' ' ' GLN . . . . . 0.454 ' H ' ' HG2' ' C' ' 3' ' ' GLU . 7.0 tp60 72.24 -65.91 0.33 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.897 1.279 . . . . 73.0 111.702 171.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -75.5 89.92 2.71 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.689 0.757 . . . . 61.23 110.397 176.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -109.16 4.0 22.46 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 114.81 -1.086 . . . . 73.13 108.527 166.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 31.8 m -73.52 -59.41 2.73 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 124.088 0.955 . . . . 75.53 111.031 -171.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.06 117.88 6.66 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.844 -0.799 . . . . 70.34 108.844 -176.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.401 ' SD ' ' N ' ' C' ' 10' ' ' THR . 0.0 OUTLIER 64.49 142.6 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 125.331 1.452 . . . . 74.13 112.26 177.486 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.732 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 40.5 m -129.1 109.88 11.56 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.991 -0.744 . . . . 61.4 108.991 174.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.533 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.6 t80 -124.58 134.03 53.09 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.412 0.685 . . . . 63.11 110.276 -176.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -150.85 131.17 13.66 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.536 0.735 . . . . 63.21 109.384 171.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 78.9 mt -74.99 124.06 31.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 108.445 -0.946 . . . . 70.14 108.445 172.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.44 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 18.1 mm100 -93.74 -39.53 10.71 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.301 0.64 . . . . 71.31 110.915 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -177.19 127.01 0.15 Allowed 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.228 0.33 . . . . 71.35 110.714 -175.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 84.1 mt -114.69 133.42 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.51 0.724 . . . . 74.23 109.473 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.514 ' HE2' ' HD3' ' C' ' 19' ' ' LYS . 23.6 p90 -170.54 172.43 5.95 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-O 121.43 0.633 . . . . 74.21 110.53 -171.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.8 p -97.08 121.65 39.2 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.417 -0.811 . . . . 72.31 109.1 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.514 ' HD3' ' HE2' ' C' ' 17' ' ' TYR . 29.9 mmtp -68.98 -46.69 67.44 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.35 1.072 . . . . 74.05 108.186 167.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 13.1 t70 -141.76 138.36 32.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 112.989 -1.914 . . . . 72.43 109.041 -167.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.563 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.2 mt -134.38 152.59 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 107.258 -1.386 . . . . 61.3 107.258 174.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -160.4 152.87 20.78 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.395 0.617 . . . . 71.11 110.843 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -149.01 135.43 19.39 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.572 -1.27 . . . . 65.04 107.572 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -140.82 110.38 6.36 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.743 0.817 . . . . 75.44 109.313 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.54 85.67 56.04 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 105.371 -2.085 . . . . 64.44 105.371 165.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.82 -17.99 41.75 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 122.866 2.378 . . . . 74.45 112.397 -175.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -112.88 19.27 17.47 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.956 1.302 . . . . 74.25 110.289 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.02 -56.88 6.89 Favored Pre-proline 0 N--CA 1.489 1.475 0 N-CA-C 114.297 1.221 . . . . 62.01 114.297 -170.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.456 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 38.0 Cg_endo -62.02 -35.72 74.95 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.103 1.869 . . . . 75.22 112.582 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -68.34 -50.57 52.35 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.171 0.588 . . . . 74.11 110.972 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.704 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.0 p -69.46 -23.65 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 N-CA-C 112.772 0.656 . . . . 74.2 112.772 -169.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -62.74 -33.16 74.56 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.52 0.563 . . . . 71.25 112.52 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -88.36 15.68 7.43 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.759 0.424 . . . . 63.0 112.099 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.726 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -95.56 158.68 15.35 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.915 0.886 . . . . 72.35 109.993 175.643 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -70.18 129.5 39.56 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 109.047 -0.723 . . . . 75.52 109.047 170.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 55.6 t-105 -78.44 80.41 4.83 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.429 0.692 . . . . 72.44 110.44 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -129.14 74.05 81.34 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 108.279 -1.008 . . . . 75.42 108.279 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -95.92 176.51 0.79 Allowed 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.068 2.512 . . . . 75.04 112.688 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 39' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' C' ' 67' ' ' SER . 0.9 OUTLIER -117.82 120.2 37.21 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.417 -1.698 . . . . 75.24 106.417 169.636 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.68 97.42 5.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.257 -1.016 . . . . 75.42 108.257 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.506 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 10.1 tmtt? -91.6 108.67 20.07 Favored 'General case' 0 CA--C 1.527 0.081 0 N-CA-C 106.851 -1.537 . . . . 63.34 106.851 175.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.487 HD11 ' HB ' ' G' ' 6' ' ' ILE . 4.4 mp -86.53 136.38 33.1 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.695 -0.854 . . . . 74.51 108.695 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.58 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 23.4 t70 -123.04 137.95 54.81 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 124.993 1.317 . . . . 72.23 107.948 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.53 HD21 HD11 ' C' ' 60' ' ' LEU . 6.1 tt -135.48 139.9 44.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.585 -1.265 . . . . 73.4 107.585 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.499 ' N ' HD23 ' C' ' 44' ' ' LEU . 29.9 t70 -143.41 152.64 41.8 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.523 0.729 . . . . 61.23 109.36 170.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 72.4 p -115.48 112.28 22.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.84 0.856 . . . . 75.11 109.486 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.91 157.18 20.96 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.662 -0.866 . . . . 61.2 108.662 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 31.4 p -164.86 169.63 16.36 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.449 0.537 . . . . 64.34 112.449 -170.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 41.9 t -170.12 129.31 0.91 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.232 1.013 . . . . 61.35 109.345 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -77.67 115.5 17.47 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.597 -1.26 . . . . 70.45 107.597 166.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.685 HD11 HD12 ' C' ' 83' ' ' ILE . 62.9 mt -89.48 -36.3 15.48 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.175 0.59 . . . . 74.11 110.805 -175.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.33 -168.68 0.84 Allowed 'General case' 0 CA--C 1.54 0.585 0 O-C-N 124.139 0.9 . . . . 54.3 111.15 -174.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -66.53 114.12 5.26 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.671 1.188 . . . . 74.21 110.084 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 65.82 -3.03 0.79 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 125.234 1.413 . . . . 72.34 113.227 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.418 HG12 ' HB2' ' C' ' 51' ' ' LEU . 78.9 t -98.7 107.17 19.95 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.429 -0.952 . . . . 55.01 108.429 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.443 ' HB3' HD13 ' C' ' 86' ' ' ILE . 49.2 t80 -122.12 137.12 54.94 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.809 -0.632 . . . . 72.23 110.064 -176.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -94.65 119.53 33.44 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.117 0.967 . . . . 75.11 109.735 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.09 117.5 55.17 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.137 -1.06 . . . . 75.14 108.137 174.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.07 136.04 56.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 108.366 -0.976 . . . . 72.01 108.366 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.53 HD11 HD21 ' C' ' 44' ' ' LEU . 16.2 tp -121.58 114.26 20.94 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 109.189 -0.671 . . . . 61.54 109.189 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 13.3 ttm180 -82.08 108.46 15.57 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.626 -0.879 . . . . 75.25 108.626 172.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 22.2 t -103.93 123.28 57.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.093 -1.447 . . . . 72.45 107.093 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.58 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 86.0 m -136.92 119.56 16.05 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 123.194 0.598 . . . . 61.22 109.448 -173.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 54.3 t -103.95 113.47 40.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 123.608 0.763 . . . . 63.21 109.135 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 4.9 m -99.4 134.94 41.53 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.674 -1.232 . . . . 74.45 107.674 171.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.01 120.28 25.74 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.791 -1.559 . . . . 71.33 106.791 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 67' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 57.0 m -135.52 130.37 34.49 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.081 0.467 . . . . 75.23 110.938 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.726 HD13 ' HG2' ' C' ' 34' ' ' LYS . 8.6 mt -84.67 46.62 1.27 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.93 1.292 . . . . 71.44 109.246 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.41 -119.72 6.48 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 109.46 -1.456 . . . . 62.12 109.46 -165.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -91.17 -19.49 23.01 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.235 0.614 . . . . 74.31 110.198 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -70.62 84.67 0.63 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.747 0.819 . . . . 63.14 108.962 174.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 72' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 62.4 m -62.42 121.6 13.65 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 110.291 -0.263 . . . . 74.21 110.291 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.704 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -67.92 -61.76 1.72 Allowed 'General case' 0 C--O 1.235 0.342 0 O-C-N 124.069 0.856 . . . . 54.14 108.739 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -155.06 172.76 17.59 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-O 122.211 1.005 . . . . 71.03 111.196 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.42 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.3 tm? -130.74 144.21 51.28 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 105.043 -2.206 . . . . 61.33 105.043 169.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.438 ' SG ' HG23 ' C' ' 114' ' ' ILE . 51.2 t -151.52 135.31 16.4 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.649 -0.871 . . . . 63.34 108.649 177.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -139.66 138.79 36.38 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.081 0.552 . . . . 74.41 109.928 -174.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.403 HG21 ' HB3' ' C' ' 113' ' ' CYS . 48.2 t -141.91 113.46 3.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.959 -1.126 . . . . 72.1 107.959 176.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -91.07 88.31 6.93 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.235 -1.024 . . . . 72.41 108.235 172.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -78.76 101.15 7.43 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.007 -0.997 . . . . 73.34 108.996 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.25 143.4 17.99 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 111.614 -0.594 . . . . 43.21 111.614 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.56 116.47 0.99 Allowed Glycine 0 CA--C 1.499 -0.949 0 N-CA-C 109.968 -1.253 . . . . 72.23 109.968 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.685 HD12 HD11 ' C' ' 51' ' ' LEU . 12.6 mm -81.63 120.44 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.736 -1.209 . . . . 74.22 107.736 177.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.533 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 54.7 m-85 -130.9 134.74 47.05 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.453 -0.943 . . . . 61.44 108.453 -177.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 49.3 m -80.24 117.42 21.0 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.949 -0.76 . . . . 64.21 108.949 170.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.443 HD13 ' HB3' ' C' ' 56' ' ' TYR . 4.1 mp -115.43 118.07 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.051 -1.092 . . . . 73.23 108.051 173.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.732 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -140.03 162.77 34.42 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.745 0.818 . . . . 74.34 109.86 176.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 88' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 150' ' ' GLU . . . 89.12 -63.24 3.47 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.335 -0.848 . . . . 41.42 112.496 176.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 28.5 pt -90.03 145.86 6.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-O 120.876 0.37 . . . . 60.13 110.675 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -146.32 150.47 35.8 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.319 -0.855 . . . . 65.22 109.088 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.49 -135.89 13.02 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-O 119.721 -0.488 . . . . 41.31 112.262 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 15.5 m -67.24 -35.11 78.87 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.819 0.848 . . . . 53.11 111.412 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -56.72 -48.66 77.26 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.728 1.211 . . . . 44.43 109.682 176.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.574 ' HE1' ' HA ' ' G' ' 17' ' ' PRO . 2.7 ttp -66.62 -43.83 83.71 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 113.305 -1.77 . . . . 71.44 110.998 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.21 69.82 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.719 0.808 . . . . 55.31 111.68 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -67.09 -41.89 85.55 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.754 0.822 . . . . 73.2 110.621 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 30.1 t -63.95 -53.16 54.66 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.832 -0.622 . . . . 72.13 109.86 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.729 HD11 HG23 ' G' ' 18' ' ' VAL . 80.3 mt -70.14 -28.54 65.44 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.828 0.851 . . . . 72.43 112.695 -175.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.43 12.76 33.29 Favored Glycine 0 N--CA 1.475 1.27 0 N-CA-C 114.322 0.489 . . . . 71.24 114.322 -167.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' C' ' 133' ' ' PHE . . . -155.89 -60.08 0.1 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.787 0.803 . . . . 64.22 110.8 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.404 ' CE2' ' CE1' ' C' ' 11' ' ' PHE . 53.5 t80 -75.28 -38.2 60.54 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-N 113.607 -1.633 . . . . 74.44 112.324 -170.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 79.0 m -83.14 -43.8 0.86 Allowed Pre-proline 0 CA--C 1.565 1.528 0 C-N-CA 123.883 0.873 . . . . 61.31 112.699 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.417 ' HB3' HD13 ' C' ' 60' ' ' LEU . 32.7 Cg_exo -64.86 -20.94 64.7 Favored 'Trans proline' 0 C--N 1.394 2.938 0 C-N-CA 122.325 2.016 . . . . 74.11 112.312 173.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -67.5 -33.83 75.89 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.661 0.784 . . . . 75.01 110.512 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.528 HD12 ' NH1' ' A' ' 111' ' ' ARG . 44.0 mm -65.19 -35.56 75.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-N 115.67 -0.696 . . . . 62.24 109.752 174.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 82.7 mt -89.62 -22.35 22.36 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.201 1.001 . . . . 51.42 112.449 -174.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -54.92 -51.13 81.94 Favored Pre-proline 0 CA--C 1.559 1.297 0 N-CA-C 113.299 0.852 . . . . 74.43 113.299 -174.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -64.23 -34.45 56.28 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.083 1.855 . . . . 34.53 112.871 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -66.32 -44.81 82.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.185 0.594 . . . . 64.12 110.854 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.17 -38.6 88.46 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.527 -0.761 . . . . 73.34 110.661 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -57.64 -53.82 53.84 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.454 1.101 . . . . 72.31 110.594 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.27 -32.58 74.08 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.59 0.556 . . . . 52.42 110.463 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.403 ' HB3' HG21 ' C' ' 78' ' ' VAL . 8.0 t -73.1 -33.12 65.39 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 122.939 0.495 . . . . 74.43 111.257 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.438 HG23 ' SG ' ' C' ' 76' ' ' CYS . 57.3 mt -71.57 -52.88 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.039 0.536 . . . . 64.13 109.758 174.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.4 m -65.98 -27.05 67.85 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.424 0.689 . . . . 75.31 111.009 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -62.6 -49.4 75.36 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 109.279 -0.637 . . . . 53.42 109.279 169.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.679 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.8 -36.4 81.01 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.208 1.003 . . . . 71.2 112.546 178.222 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.1 -44.35 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.407 0.683 . . . . 72.12 109.343 173.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.457 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 22.7 t -73.27 -25.06 60.54 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.121 -0.945 . . . . 65.3 111.565 -177.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.419 ' NH2' ' HG3' ' B' ' 112' ' ' GLU . 78.3 mtt-85 -75.02 -41.66 58.87 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.567 0.747 . . . . 71.34 108.995 176.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.12 1.6 68.93 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 124.254 0.971 . . . . 61.2 112.364 172.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 22.3 p 60.96 29.84 19.26 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.632 1.973 . . . . 54.44 113.523 170.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -83.65 148.44 54.83 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 123.457 0.703 . . . . 63.12 110.193 173.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -52.83 139.35 59.72 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.351 2.701 . . . . 73.22 113.341 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.419 HE21 ' NE2' ' B' ' 125' ' ' GLN . 73.1 mm-40 -56.88 112.95 1.47 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.615 1.166 . . . . 53.24 112.353 -175.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.38 100.9 7.58 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.291 -1.744 . . . . 71.53 106.291 174.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -99.09 131.4 45.16 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.284 0.634 . . . . 65.32 110.318 -172.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.94 142.04 38.62 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.542 0.737 . . . . 73.14 110.041 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.704 ' HB2' ' HB ' ' G' ' 5' ' ' THR . . . -75.46 162.05 74.15 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.055 0.942 . . . . 72.2 111.58 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.33 109.34 0.97 Allowed 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.385 2.057 . . . . 55.3 111.972 173.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.666 HG11 ' HB2' ' G' ' 8' ' ' LEU . 21.6 t -98.24 106.85 19.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 108.006 -1.109 . . . . 74.44 108.006 174.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -101.81 91.6 4.46 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.725 -1.583 . . . . 72.44 106.725 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.487 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 45.8 m-85 -58.09 -37.79 75.18 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.597 0.713 . . . . 73.33 109.534 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -67.01 -30.76 70.95 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 113.789 -1.55 . . . . 72.23 111.059 -177.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.68 -23.23 64.37 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.369 0.667 . . . . 31.1 111.459 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 8.5 mp -80.22 -26.66 39.01 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.999 0.52 . . . . 40.35 110.37 173.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -78.52 -28.05 46.12 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.754 0.422 . . . . 73.15 110.523 172.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 67.1 mtt -77.01 -30.34 55.83 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.827 0.851 . . . . 75.23 110.04 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -66.71 -38.53 86.91 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.139 0.976 . . . . 63.3 109.665 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -68.2 -84.11 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 115.16 -0.927 . . . . 75.42 108.765 172.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 19.5 tp 63.89 -175.07 0.16 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.227 1.011 . . . . 72.5 110.844 172.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.409 HE22 ' HB3' ' C' ' 144' ' ' GLN . 0.1 OUTLIER -94.3 144.7 25.31 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 107.582 -1.266 . . . . 73.03 107.582 169.332 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.39 -53.44 44.87 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.221 1.008 . . . . 71.02 111.373 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 144' ' ' GLN . . . . . 0.409 ' HB3' HE22 ' C' ' 142' ' ' GLN . 63.9 tt0 -74.74 95.27 2.85 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 109.407 -0.59 . . . . 63.52 109.407 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.27 131.25 6.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.583 1.153 . . . . 61.31 109.006 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.7 137.75 4.74 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 111.971 -0.452 . . . . 53.35 111.971 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -92.28 124.11 36.1 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.946 0.898 . . . . 73.13 110.261 -177.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -163.58 128.77 1.89 Allowed Glycine 0 C--N 1.345 1.034 0 N-CA-C 111.29 -0.724 . . . . 51.42 111.29 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 2.5 m -139.13 97.45 3.3 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.211 0.505 . . . . 64.22 109.74 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -86.96 -4.27 59.16 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.199 0.6 . . . . 73.14 110.662 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -82.17 133.16 35.25 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.824 -0.806 . . . . 64.14 108.824 168.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -137.54 149.09 46.47 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.826 0.45 . . . . 71.11 111.391 -171.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -155.8 126.35 6.8 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.109 0.964 . . . . 74.3 109.227 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -115.41 108.18 16.17 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.0 -0.741 . . . . 74.12 109.0 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 C-N-CA 123.702 0.801 . . . . 63.02 108.924 179.464 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 109.213 -0.662 . . . . 54.55 109.213 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 49.6 p 46.19 45.3 12.79 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.195 1.398 . . . . 73.43 111.412 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -70.93 132.53 45.35 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 114.522 -1.217 . . . . 64.15 111.822 -171.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 4' ' ' GLN . . . . . 0.585 ' HG3' ' HG3' ' D' ' 93' ' ' GLN . 42.4 tt0 -137.74 135.34 36.29 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.846 1.258 . . . . 73.11 108.848 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -79.88 74.8 6.61 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 107.848 -1.167 . . . . 74.54 107.848 174.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -88.44 70.51 9.02 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.97 0.89 . . . . 63.01 110.089 -172.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 13.1 t -162.41 166.96 24.4 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 113.904 -1.498 . . . . 45.2 108.769 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 59.04 -96.26 0.06 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 117.771 -1.109 . . . . 74.2 110.435 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 5.2 ppp? 22.16 171.96 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 118.766 2.876 . . . . 74.14 118.766 -174.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 55.7 m -140.73 142.06 34.84 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 120.91 -1.119 . . . . 73.13 109.926 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -159.04 113.88 2.47 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.203 -1.036 . . . . 74.02 108.203 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 12' ' ' GLN . . . . . 0.465 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 49.3 mt-30 -133.33 135.91 45.07 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.865 0.866 . . . . 54.31 108.895 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 16.6 mt -92.47 120.21 41.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 109.48 -0.563 . . . . 73.12 109.48 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -91.61 -47.21 7.52 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.284 0.365 . . . . 62.41 111.404 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -166.6 123.41 1.27 Allowed 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 111.434 0.161 . . . . 71.1 111.434 -168.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.489 HD13 ' HG2' ' B' ' 130' ' ' PRO . 1.7 mp -103.73 137.54 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 108.462 -0.94 . . . . 75.51 108.462 170.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.467 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 22.7 p90 -162.05 168.76 22.15 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 124.16 0.912 . . . . 70.22 110.861 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.1 p -96.98 122.66 40.21 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.405 -0.961 . . . . 74.11 108.405 171.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.467 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 34.4 mtpt -85.13 -40.17 17.06 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.986 -0.746 . . . . 74.42 108.986 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.515 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.8 t70 -140.62 141.26 35.13 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 113.978 -1.464 . . . . 71.04 108.99 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.679 HG21 ' HE2' ' C' ' 117' ' ' MET . 94.0 mt -135.44 147.75 28.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.695 1.198 . . . . 75.11 107.922 174.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -147.32 143.4 28.02 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.416 1.086 . . . . 74.42 108.523 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.563 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.9 t80 -149.47 132.24 15.99 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.577 -1.638 . . . . 70.13 106.577 171.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 46.5 mt-10 -135.68 151.16 49.92 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.716 -1.216 . . . . 62.42 107.716 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.66 91.59 5.27 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 108.332 -0.988 . . . . 62.55 108.332 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.78 -50.9 3.52 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.398 2.732 . . . . 53.53 113.551 -171.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.494 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 18.6 m-20 -99.86 14.1 31.54 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.832 0.853 . . . . 64.01 110.071 -171.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.484 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -28.48 -68.72 0.1 OUTLIER Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 126.826 2.05 . . . . 61.13 115.82 -163.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.29 -19.67 19.47 Favored 'Trans proline' 0 C--N 1.382 2.322 0 CA-C-N 123.162 2.165 . . . . 71.14 114.05 -173.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -79.11 -43.01 24.94 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.848 0.859 . . . . 74.5 109.944 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' D' ' 27' ' ' ASN . 10.0 p -75.01 -15.33 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-N 115.613 -0.721 . . . . 62.2 110.744 -172.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -70.56 -17.71 62.92 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 112.281 0.474 . . . . 72.13 112.281 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -64.36 -11.21 30.23 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.372 0.669 . . . . 74.3 110.879 173.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -105.55 97.17 7.04 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.014 1.726 . . . . 73.41 109.438 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -104.91 89.72 3.24 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.547 0.739 . . . . 71.34 109.329 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -162.43 171.88 16.43 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.141 0.976 . . . . 71.43 109.124 171.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -63.56 110.75 4.03 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 123.26 0.624 . . . . 63.21 109.634 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -64.73 143.92 82.16 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.629 2.219 . . . . 70.24 112.325 -176.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -71.48 116.02 11.33 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.442 0.697 . . . . 72.5 109.166 173.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.589 HG13 HG13 ' D' ' 64' ' ' VAL . 78.5 t -115.45 130.28 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.611 0.764 . . . . 74.41 110.963 -169.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.566 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 16.6 tptm -106.11 134.74 48.76 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.656 1.183 . . . . 74.25 108.579 173.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -110.17 114.81 28.6 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.611 0.764 . . . . 64.45 109.741 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.49 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 3.7 m-20 -108.87 113.64 26.72 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.993 0.917 . . . . 51.31 108.532 174.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.64 HD13 ' H ' ' H' ' 9' ' ' ALA . 8.7 mp -101.29 132.05 47.01 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.182 -0.673 . . . . 52.5 109.182 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 25.0 t70 -132.48 150.11 52.21 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.027 0.931 . . . . 73.44 108.749 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 52.2 m -105.83 144.04 33.13 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.07 0.948 . . . . 71.31 110.955 -171.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.433 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.65 161.38 39.89 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.86 1.264 . . . . 54.4 108.994 171.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.3 p -175.71 166.63 3.16 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.127 0.571 . . . . 42.25 111.349 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 80.3 p -161.96 143.3 10.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.528 0.731 . . . . 54.54 110.044 172.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -78.91 121.47 24.91 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.628 -0.878 . . . . 71.33 108.628 171.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 76.3 mt -99.84 -29.03 12.83 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.809 0.444 . . . . 71.42 111.318 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.26 -175.43 4.84 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.483 0.659 . . . . 74.5 111.135 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -62.62 122.49 15.97 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.1 -1.409 . . . . 43.13 109.479 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 60.09 16.29 5.82 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.786 0.834 . . . . 63.12 112.592 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 81.8 t -119.6 125.74 74.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 C-N-CA 123.806 0.843 . . . . 71.24 108.756 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -135.09 130.85 36.18 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.874 -0.603 . . . . 64.14 109.598 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -91.23 139.81 30.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.317 -0.856 . . . . 74.14 109.579 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 62.5 t -120.8 126.12 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 107.777 -1.194 . . . . 51.05 107.777 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 21.5 t -125.07 129.28 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.463 0.705 . . . . 75.54 109.363 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.569 HD23 HD12 ' D' ' 106' ' ' LEU . 3.6 mm? -121.7 120.58 35.1 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.031 0.532 . . . . 65.43 110.218 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 32.9 ttm-85 -87.93 102.98 15.24 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.152 -0.931 . . . . 70.14 108.978 172.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.6 t -91.6 126.3 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 107.72 -1.215 . . . . 75.11 107.72 169.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 8.5 m -121.02 131.76 54.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.474 -0.565 . . . . 35.44 109.474 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.589 HG13 HG13 ' D' ' 40' ' ' VAL . 35.3 t -116.4 102.35 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 124.73 1.212 . . . . 71.5 108.856 -173.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.566 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 9.4 m -94.04 91.68 6.97 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.947 -1.131 . . . . 75.21 107.947 173.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.87 150.0 20.91 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.59 -0.732 . . . . 64.04 109.405 -175.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.419 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 67.9 m -149.35 128.95 13.13 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.222 0.534 . . . . 55.11 112.294 -173.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 34.9 mt -110.73 134.55 52.38 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.048 1.339 . . . . 72.25 109.184 174.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.03 -111.85 3.68 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 112.203 -0.359 . . . . 74.45 112.203 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.81 4.47 8.79 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.733 0.813 . . . . 74.52 110.174 178.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -125.22 173.76 8.56 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.688 0.795 . . . . 51.42 110.065 -174.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 82.3 m -72.7 139.58 47.32 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.208 0.528 . . . . 61.24 110.558 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.459 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.7 -67.85 0.8 Allowed 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.012 0.925 . . . . 72.51 108.57 173.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -152.38 160.9 43.24 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.857 -0.611 . . . . 55.45 110.653 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.407 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 68.5 mt -122.84 110.95 16.08 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.739 -1.208 . . . . 72.44 107.739 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.478 ' SG ' HG23 ' D' ' 114' ' ' ILE . 46.0 t -123.73 115.09 20.83 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.124 0.57 . . . . 52.44 109.906 -173.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -130.83 122.83 27.79 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.534 0.734 . . . . 73.33 109.855 -171.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.14 119.21 48.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 C-N-CA 123.259 0.624 . . . . 71.34 109.676 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.4 mt-30 -89.65 87.8 7.16 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.214 -0.662 . . . . 72.44 109.214 170.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.21 109.89 15.1 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.742 -1.117 . . . . 63.12 108.826 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.3 143.83 16.92 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 111.524 -0.63 . . . . 72.55 111.524 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.92 134.41 6.57 Favored Glycine 0 CA--C 1.509 -0.287 0 N-CA-C 110.933 -0.867 . . . . 52.32 110.933 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 48.3 mt -89.0 121.96 39.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 108.251 -1.018 . . . . 74.44 108.251 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -131.13 127.8 38.83 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.202 0.314 . . . . 63.12 110.366 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.465 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 21.2 m -75.96 104.82 6.68 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.064 -0.717 . . . . 71.24 109.064 170.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.465 HD11 HD12 ' D' ' 89' ' ' ILE . 16.4 tt -126.6 133.23 69.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-O 121.38 0.609 . . . . 74.34 111.077 -174.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.49 168.38 26.34 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.244 1.017 . . . . 45.22 109.601 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.07 13.37 81.12 Favored Glycine 0 N--CA 1.473 1.114 0 N-CA-C 114.289 0.476 . . . . 74.33 114.289 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.465 HD12 HD11 ' D' ' 86' ' ' ILE . 37.1 mt -113.49 139.34 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.433 1.093 . . . . 74.41 109.175 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.748 ' HA ' ' HE3' ' D' ' 94' ' ' MET . 8.7 pt-20 -153.77 158.22 40.61 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.51 0.506 . . . . 73.24 112.205 -171.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.56 -137.34 23.37 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.097 -0.956 . . . . 25.44 112.445 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 92' ' ' THR . . . . . 0.457 ' HB ' HD23 ' D' ' 141' ' ' LEU . 40.9 p -69.68 -20.6 63.56 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.581 0.753 . . . . 42.01 111.342 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.585 ' HG3' ' HG3' ' D' ' 4' ' ' GLN . 46.1 tt0 -60.11 -32.53 71.08 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.953 0.901 . . . . 74.11 111.262 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.748 ' HE3' ' HA ' ' D' ' 90' ' ' GLU . 54.4 mtt -62.49 -47.61 83.22 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.38 0.672 . . . . 74.42 110.717 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.51 94.04 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.039 -0.982 . . . . 42.14 110.471 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -66.81 -43.71 83.12 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.214 0.606 . . . . 72.41 111.785 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 39.5 t -63.13 -51.04 68.08 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.326 0.584 . . . . 61.51 110.463 -172.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.557 HD11 HG22 ' H' ' 18' ' ' VAL . 73.9 mt -85.91 -21.24 28.06 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.23 -0.895 . . . . 64.54 111.448 -175.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.39 8.62 55.31 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 119.628 -0.54 . . . . 51.43 114.03 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.458 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -154.92 -54.29 0.09 Allowed 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 117.28 0.54 . . . . 74.45 111.586 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -70.13 -51.1 34.12 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.662 0.385 . . . . 72.32 111.871 -173.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 30.6 m -67.15 -42.16 38.73 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 123.175 0.59 . . . . 40.12 111.904 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -53.72 -35.35 78.04 Favored 'Trans proline' 0 C--N 1.393 2.888 0 C-N-CA 122.667 2.244 . . . . 72.1 113.346 166.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -68.8 -32.92 72.99 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.514 0.726 . . . . 65.15 110.319 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 50.2 mm -67.5 -40.23 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 121.394 0.616 . . . . 75.11 110.146 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.569 HD12 HD23 ' D' ' 60' ' ' LEU . 95.6 mt -84.05 -15.52 47.19 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.274 -0.875 . . . . 63.51 112.064 -176.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 107' ' ' PHE . . . . . 0.402 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 83.3 t80 -61.68 -50.08 83.61 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 124.437 1.095 . . . . 63.4 112.945 -175.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 108' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 38.1 Cg_exo -59.72 -34.6 96.05 Favored 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 122.144 1.896 . . . . 52.33 112.945 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -78.34 -37.22 45.0 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.562 0.745 . . . . 64.21 112.211 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.0 -46.35 78.29 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.426 -0.583 . . . . 75.5 109.426 176.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.413 ' NH2' HG23 ' B' ' 105' ' ' ILE . 46.7 ttp180 -57.37 -47.74 80.86 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 124.41 1.068 . . . . 71.34 110.921 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -60.42 -49.88 75.8 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.808 0.843 . . . . 64.15 111.185 -177.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -56.2 -41.8 76.18 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 123.882 0.739 . . . . 42.12 111.101 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.478 HG23 ' SG ' ' D' ' 76' ' ' CYS . 98.0 mt -63.46 -56.44 17.06 Favored 'Isoleucine or valine' 0 C--N 1.349 0.568 0 CA-C-N 115.17 -0.923 . . . . 71.53 110.202 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -55.14 -36.82 66.18 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.438 1.095 . . . . 74.22 111.739 -173.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 37.2 t -66.97 -43.94 81.76 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.403 -0.817 . . . . 73.51 110.553 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 78.2 mtm -70.64 -25.88 63.22 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.74 0.416 . . . . 72.1 111.956 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.2 t -65.73 -43.79 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.274 0.63 . . . . 61.21 109.638 174.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.7 p -77.03 -27.44 54.49 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.998 -0.546 . . . . 54.22 111.142 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' D' ' 116' ' ' SER . 89.9 mtt-85 -73.02 -35.83 66.85 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.416 0.686 . . . . 65.01 109.866 174.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.4 -2.34 89.32 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.547 -0.751 . . . . 74.25 112.024 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.7 p 65.9 20.44 11.36 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 127.054 2.142 . . . . 63.24 113.657 172.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -79.16 155.0 77.38 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.418 0.687 . . . . 65.44 110.129 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.58 133.71 54.91 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.078 2.519 . . . . 64.32 112.548 172.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -54.41 140.75 32.9 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.416 1.086 . . . . 73.23 112.644 -172.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 62.4 tp -121.2 110.07 15.73 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.165 0.986 . . . . 71.04 109.141 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -111.21 104.96 13.51 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.812 -0.81 . . . . 64.25 108.812 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 tt -70.53 114.21 8.41 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 107.609 -1.256 . . . . 55.44 107.609 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.65 138.32 88.37 Favored Pre-proline 0 N--CA 1.475 0.823 0 CA-C-O 119.609 -0.234 . . . . 61.24 110.408 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -73.62 141.15 30.63 Favored 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 122.457 2.105 . . . . 72.1 111.693 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.74 147.73 24.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 C-N-CA 123.88 0.872 . . . . 74.24 108.961 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 132' ' ' ASN . . . . . 0.466 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 60.0 t30 -75.42 82.54 2.5 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.657 -0.868 . . . . 64.12 108.657 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -71.41 -25.86 62.52 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.586 -1.188 . . . . 74.24 110.106 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.458 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 3.8 m-20 -54.55 -43.53 72.09 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 114.818 -1.083 . . . . 74.24 111.146 172.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.466 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -61.66 -45.68 93.01 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.842 0.857 . . . . 73.22 111.303 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 7.6 tt -63.02 -42.48 99.8 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.014 -0.993 . . . . 51.24 110.048 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -72.89 -44.51 61.21 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.566 -0.743 . . . . 65.24 110.941 -174.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 70.2 mtm -64.17 -24.83 67.83 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.162 0.585 . . . . 53.51 111.934 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.451 ' HA ' HE21 ' D' ' 142' ' ' GLN . 59.5 t30 -60.42 -39.76 88.6 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.769 0.668 . . . . 74.33 110.711 176.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -64.94 -43.14 93.72 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.295 0.638 . . . . 74.24 110.663 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.457 HD23 ' HB ' ' D' ' 92' ' ' THR . 9.0 mp -66.48 -29.27 69.35 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.312 -0.858 . . . . 62.22 111.992 -175.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.451 HE21 ' HA ' ' D' ' 139' ' ' ASN . 28.2 pt20 -89.93 18.44 5.73 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.088 0.403 . . . . 72.43 112.088 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -121.06 77.07 1.27 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.285 0.564 . . . . 64.35 110.001 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.54 116.37 1.74 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.627 -1.249 . . . . 74.11 107.627 171.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.09 83.25 3.59 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.131 0.491 . . . . 53.34 109.693 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.5 -176.08 38.53 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 115.462 -0.79 . . . . 60.32 112.373 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.69 156.89 46.1 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.895 0.878 . . . . 75.54 109.732 -176.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 85.03 -30.74 3.86 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 116.229 -0.441 . . . . 23.43 113.453 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 63.9 p 51.72 -159.44 0.1 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.622 1.569 . . . . 63.54 111.797 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -162.94 135.22 5.36 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 110.013 -0.366 . . . . 75.23 110.013 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -86.93 64.6 8.57 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 108.136 -1.061 . . . . 73.55 108.136 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -70.67 104.24 2.78 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.61 -0.723 . . . . 45.44 110.491 -171.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -98.34 154.24 17.97 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.202 1.001 . . . . 60.41 110.247 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -145.97 19.65 1.44 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.274 -0.875 . . . . 63.54 109.06 169.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 C-N-CA 124.756 1.222 . . . . 61.41 108.606 176.481 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 58.6 mtt . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.228 -0.656 . . . . 64.01 109.228 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 2' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' C' ' 14' ' ' GLN . 52.7 mtpt -129.53 105.62 8.2 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.631 0.772 . . . . 71.34 110.747 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -105.51 101.79 11.29 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.177 -1.416 . . . . 73.14 107.177 168.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 37.2 t -68.03 147.92 51.72 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.698 0.761 . . . . 63.14 112.675 -171.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 5' ' ' THR . . . . . 0.504 ' H ' HD12 ' E' ' 6' ' ' ILE . 7.0 t -130.55 8.0 4.93 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 114.197 -1.365 . . . . 74.23 109.442 176.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.687 HG22 HD13 ' A' ' 128' ' ' LEU . 2.7 mp -114.14 119.0 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.76 0.824 . . . . 75.1 108.983 -173.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.51 159.73 37.51 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.126 0.57 . . . . 50.42 111.31 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.468 HD22 HD21 ' A' ' 44' ' ' LEU . 64.7 mt -73.37 151.0 41.37 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.944 0.498 . . . . 74.45 111.066 175.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.76 126.21 41.76 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.443 -0.947 . . . . 25.25 108.443 171.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 mp -63.73 127.42 31.28 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.582 0.753 . . . . 72.15 110.15 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 7.8 mp -76.9 126.66 85.38 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.011 0.524 . . . . 63.35 109.876 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.31 -21.77 30.46 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.717 2.278 . . . . 72.04 112.246 176.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 90.2 mt -114.9 157.95 22.64 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.99 0.916 . . . . 64.31 109.677 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 93.1 mt -90.82 175.13 7.11 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.143 0.577 . . . . 71.43 110.337 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -80.26 160.09 25.66 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.61 0.764 . . . . 73.41 110.265 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 16' ' ' THR . . . . . 0.413 ' O ' HD11 ' A' ' 98' ' ' LEU . 34.1 p -66.62 126.01 91.53 Favored Pre-proline 0 CA--C 1.557 1.216 0 C-N-CA 123.842 0.857 . . . . 60.34 112.159 -171.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 17' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.71 163.53 21.32 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 123.816 3.011 . . . . 73.42 114.156 -171.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 18' ' ' VAL . . . . . 0.526 HG23 ' HG ' ' A' ' 98' ' ' LEU . 58.2 t -102.6 -80.48 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 114.9 -1.045 . . . . 63.22 110.883 -175.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 2.6 m -82.5 -45.48 14.66 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 115.585 -0.734 . . . . 61.53 109.058 -174.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -164.31 -70.9 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.494 -1.23 . . . . 54.23 109.327 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 63.56 159.78 0.09 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.557 1.143 . . . . 63.22 112.134 -171.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 22' ' ' ARG . . . . . 0.607 ' HB2' ' HA2' ' A' ' 91' ' ' GLY . 2.7 mmp_? -134.09 111.1 10.07 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.214 -0.662 . . . . 74.4 109.214 174.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 4.4 t -130.93 100.22 17.54 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.398 1.079 . . . . 73.24 108.32 173.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.93 -22.35 68.41 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 123.074 2.516 . . . . 63.53 112.318 172.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.256 1.427 0 C-N-CA 124.505 1.122 . . . . 74.33 109.076 174.351 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.969 -0.382 . . . . 74.35 109.969 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -161.91 -44.62 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.292 1.037 . . . . 75.42 109.501 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 52.14 82.53 0.07 Allowed 'General case' 0 C--N 1.356 0.879 0 C-N-CA 124.958 1.303 . . . . 72.22 111.248 -173.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 31.5 p -65.82 94.49 0.22 Allowed 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.873 -0.788 . . . . 62.41 108.873 173.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 20.5 m -64.96 97.5 0.24 Allowed 'General case' 0 C--N 1.349 0.576 0 CA-C-N 115.304 -0.862 . . . . 54.53 110.188 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.539 HD11 HD11 ' B' ' 126' ' ' LEU . 2.4 pp -72.37 156.72 6.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 CA-C-N 114.743 -1.117 . . . . 73.12 111.348 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -154.75 177.9 10.73 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.342 -0.845 . . . . 42.03 109.571 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 8' ' ' LEU . . . . . 0.403 ' H ' HG11 ' B' ' 131' ' ' VAL . 98.7 mt -90.29 163.2 14.85 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.983 0.513 . . . . 73.52 109.763 173.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.77 173.49 8.13 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.548 0.739 . . . . 51.13 111.367 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 10' ' ' LEU . . . . . 0.421 HD21 ' HB2' ' B' ' 136' ' ' LEU . 0.4 OUTLIER -84.5 12.96 6.03 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.985 0.514 . . . . 71.42 110.446 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 82.1 mt 61.42 90.08 0.1 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.118 0.967 . . . . 64.41 110.039 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -65.67 -9.34 22.35 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.844 2.362 . . . . 74.45 113.244 -174.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.7 143.36 23.63 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.355 -0.98 . . . . 62.44 108.355 175.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 14' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' B' ' 96' ' ' HIS . 88.6 mt -69.76 159.09 34.2 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.349 0.659 . . . . 71.12 110.31 173.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -75.96 -86.63 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.01 0.524 . . . . 73.04 112.065 -168.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 16' ' ' THR . . . . . 0.415 ' O ' HD11 ' B' ' 98' ' ' LEU . 21.9 p -145.05 149.29 41.64 Favored Pre-proline 0 N--CA 1.486 1.359 0 C-N-CA 123.086 0.554 . . . . 73.21 110.994 -172.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 17' ' ' PRO . . . . . 0.546 ' HB2' HG22 ' F' ' 19' ' ' THR . 88.2 Cg_endo -82.76 114.89 2.38 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.69 2.26 . . . . 73.04 113.2 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 18' ' ' VAL . . . . . 0.498 HG22 HD23 ' B' ' 98' ' ' LEU . 88.3 t -48.07 -32.43 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 125.626 1.571 . . . . 74.53 113.387 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 19' ' ' THR . . . . . 0.546 HG22 ' HB2' ' F' ' 17' ' ' PRO . 13.5 t -49.79 -35.86 24.16 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 124.306 1.043 . . . . 72.44 112.136 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -174.49 79.54 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.73 1.212 . . . . 74.22 107.989 177.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.07 -71.7 0.7 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.455 0.702 . . . . 75.44 110.225 -175.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 22' ' ' ARG . . . . . 0.405 ' HG2' ' HA ' ' B' ' 49' ' ' SER . 3.3 tpm_? -69.67 -45.24 68.79 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 115.781 -0.645 . . . . 71.33 110.565 -176.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 21.1 m 65.46 106.38 0.03 OUTLIER Pre-proline 0 CA--C 1.56 1.34 0 O-C-N 124.752 1.283 . . . . 74.43 110.295 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.14 83.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.332 2.688 . . . . 55.42 113.638 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 CA--C 1.55 0.961 0 C-N-CA 124.146 0.979 . . . . 75.53 108.96 177.722 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 109.33 -0.618 . . . . 73.11 109.33 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -88.89 -85.22 0.2 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.525 -0.546 . . . . 71.22 109.525 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -90.75 89.86 7.69 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.096 -0.705 . . . . 74.21 109.096 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 15.0 m -69.75 139.86 53.38 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.942 -0.572 . . . . 54.41 109.954 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 5' ' ' THR . . . . . 0.704 ' HB ' ' HB2' ' C' ' 129' ' ' ALA . 8.9 p -66.95 109.38 2.93 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.196 0.599 . . . . 74.31 110.353 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 6' ' ' ILE . . . . . 0.487 ' HB ' HD11 ' C' ' 42' ' ' LEU . 0.2 OUTLIER -60.92 145.78 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.475 1.51 . . . . 54.1 112.772 -173.053 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.85 154.4 46.17 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.167 0.587 . . . . 61.15 110.785 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 8' ' ' LEU . . . . . 0.666 ' HB2' HG11 ' C' ' 131' ' ' VAL . 56.2 mt -75.0 157.85 34.22 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.396 1.079 . . . . 72.4 110.345 177.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.99 159.34 26.29 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.542 0.737 . . . . 74.14 111.165 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 40.8 tp -73.55 147.4 43.97 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.071 0.549 . . . . 72.22 109.838 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 90.4 mt -86.17 110.76 33.57 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.729 0.812 . . . . 72.22 110.399 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.04 -34.94 27.26 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 123.127 2.551 . . . . 72.34 112.661 -175.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 35.4 tp -90.28 -5.41 56.33 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.707 -0.679 . . . . 63.23 110.525 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 7.7 mp 65.71 -77.02 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.734 1.213 . . . . 61.31 109.239 -169.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -166.33 168.47 15.02 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.253 0.621 . . . . 71.42 109.417 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 35.1 p -71.44 155.01 93.22 Favored Pre-proline 0 CA--C 1.561 1.393 0 C-N-CA 124.379 1.071 . . . . 74.4 111.418 176.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 17' ' ' PRO . . . . . 0.677 ' HB3' ' HB3' ' G' ' 21' ' ' ALA . 45.6 Cg_endo -65.67 150.52 86.23 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 123.375 2.717 . . . . 73.42 114.098 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 18' ' ' VAL . . . . . 0.729 HG23 HD11 ' C' ' 98' ' ' LEU . 46.2 t -77.22 -55.57 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 109.207 -0.664 . . . . 55.34 109.207 169.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 19' ' ' THR . . . . . 0.537 HG22 ' HG3' ' G' ' 20' ' ' LYS . 21.7 m -137.01 -62.94 0.62 Allowed 'General case' 0 CA--C 1.553 1.074 0 O-C-N 123.211 0.319 . . . . 62.03 111.434 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 20' ' ' LYS . . . . . 0.537 ' HG3' HG22 ' G' ' 19' ' ' THR . 91.1 mttt -125.94 20.6 7.64 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.6 0.76 . . . . 63.51 112.298 -167.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 21' ' ' ALA . . . . . 0.677 ' HB3' ' HB3' ' G' ' 17' ' ' PRO . . . -65.47 103.74 0.88 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 120.806 0.336 . . . . 62.12 111.613 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -155.66 162.39 40.6 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 115.215 -0.902 . . . . 65.4 109.718 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 32.1 p -116.53 83.79 14.03 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 108.47 -0.937 . . . . 71.44 108.47 172.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -93.29 179.96 0.98 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.49 2.793 . . . . 71.34 113.628 -172.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 . . . . . 0 CA--C 1.551 1.002 0 C-N-CA 123.496 0.718 . . . . 71.2 109.945 176.962 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptm . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.148 -0.315 . . . . 72.32 110.148 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' H' H ' 2' ' ' LYS . . . . . 0.638 ' HE3' ' HA ' ' H' ' 5' ' ' THR . 58.0 tptt -73.93 94.33 2.31 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.121 0.569 . . . . 73.44 110.443 -176.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -113.94 -35.81 4.99 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.047 0.939 . . . . 75.42 109.518 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 16.6 m -82.27 69.07 8.93 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.429 0.692 . . . . 65.21 109.563 175.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 5' ' ' THR . . . . . 0.638 ' HA ' ' HE3' ' H' ' 2' ' ' LYS . 9.9 m -83.31 -23.27 32.65 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.463 -0.79 . . . . 63.42 110.094 176.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 6' ' ' ILE . . . . . . . . . . . . . 10.7 tp -152.19 137.56 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.018 -1.104 . . . . 71.21 108.018 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.84 144.2 18.91 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.439 0.296 . . . . 62.54 110.817 -176.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -89.85 170.1 10.69 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.272 0.629 . . . . 71.3 110.58 175.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 9' ' ' ALA . . . . . 0.64 ' H ' HD13 ' D' ' 44' ' ' LEU . . . -111.17 148.39 32.86 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.871 -1.059 . . . . 54.01 108.549 170.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 10' ' ' LEU . . . . . 0.403 HD23 ' N ' ' H' ' 11' ' ' LEU . 2.3 tt -66.87 147.5 53.16 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.162 -1.051 . . . . 70.41 108.162 177.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.403 ' N ' HD23 ' H' ' 10' ' ' LEU . 75.7 mt -65.64 137.1 96.22 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-O 119.425 -0.321 . . . . 73.02 110.402 175.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.99 103.17 0.28 Allowed 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.785 2.324 . . . . 44.5 111.371 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 91.7 mt 67.99 -179.19 0.22 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.064 1.346 . . . . 73.24 111.503 -173.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.88 148.48 48.96 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.472 0.309 . . . . 73.32 110.426 174.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -72.61 149.41 43.96 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 109.049 -0.723 . . . . 72.03 109.049 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 16' ' ' THR . . . . . 0.456 ' HA ' ' HD3' ' H' ' 17' ' ' PRO . 40.7 p -57.54 116.71 14.85 Favored Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 124.755 1.222 . . . . 63.13 111.1 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 17' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' H' ' 16' ' ' THR . 34.3 Cg_exo -62.53 164.85 16.93 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.565 2.843 . . . . 72.12 115.095 -172.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 18' ' ' VAL . . . . . 0.557 HG22 HD11 ' D' ' 98' ' ' LEU . 12.1 t -81.23 1.75 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.63 0 C-N-CA 124.131 0.972 . . . . 73.43 110.669 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 6.6 m -54.48 -44.42 72.62 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.267 1.027 . . . . 71.43 113.517 -168.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -97.2 -19.31 18.7 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.621 0.368 . . . . 52.31 111.505 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.17 97.13 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.261 0.624 . . . . 75.44 109.703 176.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.08 107.13 8.09 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.361 -1.291 . . . . 71.34 107.763 176.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 23' ' ' THR . . . . . 0.426 ' HA ' ' HD3' ' H' ' 24' ' ' PRO . 5.7 t -157.86 140.52 10.61 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 123.064 0.545 . . . . 74.42 110.079 -174.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 24' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' H' ' 23' ' ' THR . 15.1 Cg_exo -71.48 -18.88 29.14 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 123.218 2.612 . . . . 60.41 113.36 176.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 CA--C 1.553 1.082 0 C-N-CA 124.543 1.137 . . . . 64.3 109.532 -172.075 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 110.384 -0.228 . . . . 73.14 110.384 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m -68.75 102.51 1.54 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.3 0.64 . . . . 54.54 111.443 -176.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -129.04 110.49 12.09 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.097 -1.075 . . . . 72.12 108.097 171.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -67.71 -22.33 65.26 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.814 0.846 . . . . 61.05 111.937 -176.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -65.11 102.06 0.59 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.882 0.473 . . . . 71.43 110.478 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -94.46 105.62 17.59 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.253 -1.017 . . . . 72.45 108.253 173.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.5 t -100.52 -13.96 18.43 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.201 0.6 . . . . 74.22 110.624 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -104.76 122.99 46.87 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.034 -0.728 . . . . 52.11 109.034 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.53 173.39 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 125.065 1.346 . . . . 53.32 112.29 178.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 49.7 p -137.3 108.5 6.81 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 106.481 -1.674 . . . . 74.33 106.481 171.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -131.48 123.76 28.75 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.172 -0.677 . . . . 63.44 109.172 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -153.29 130.96 11.53 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.47 -1.308 . . . . 55.02 107.47 169.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.497 HD12 ' HB2' ' C' ' 130' ' ' PRO . 14.5 mt -80.71 114.76 22.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.778 -0.823 . . . . 74.05 108.778 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -72.55 -39.34 67.55 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 123.891 0.745 . . . . 72.22 110.055 -177.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -177.52 120.93 0.11 Allowed 'General case' 0 C--N 1.366 1.309 0 N-CA-C 111.74 0.274 . . . . 73.3 111.74 -172.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 78.6 mt -106.32 135.0 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.023 -0.732 . . . . 74.13 109.023 173.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.438 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 20.0 p90 -162.52 147.61 12.29 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 124.11 0.881 . . . . 65.32 109.968 -176.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.0 p -75.59 119.15 19.25 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.242 -0.651 . . . . 70.54 109.242 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.2 mtpt -83.22 -32.11 26.67 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.418 -0.586 . . . . 73.53 109.418 176.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 25.0 t70 -144.23 139.54 28.74 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.207 -0.906 . . . . 65.45 110.354 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.6 mt -133.22 145.61 33.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.941 1.296 . . . . 74.15 108.182 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.577 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 48.1 t -149.73 124.83 10.04 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.458 -0.792 . . . . 72.23 109.295 173.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.507 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 86.4 t80 -129.49 111.28 12.6 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 106.62 -1.622 . . . . 71.23 106.62 169.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -121.51 110.41 16.0 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.513 -0.551 . . . . 73.51 109.513 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.32 84.26 0.87 Allowed Pre-proline 0 C--O 1.241 0.654 0 N-CA-C 107.156 -1.424 . . . . 51.25 107.156 168.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.34 -19.3 29.17 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.161 1.908 . . . . 63.43 112.589 -168.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -120.26 22.76 11.24 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.933 0.893 . . . . 74.22 109.77 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.461 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -45.38 -55.04 12.78 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 113.969 1.1 . . . . 60.14 113.969 -170.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 23.2 Cg_exo -64.98 -16.95 57.93 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 121.989 1.792 . . . . 64.51 114.119 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.94 -26.01 13.88 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.305 1.042 . . . . 73.31 110.933 -176.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.81 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.5 p -80.78 -25.18 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 115.839 -0.619 . . . . 63.51 112.584 -166.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -71.08 -26.76 63.2 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.882 0.473 . . . . 72.32 110.779 -175.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -85.28 -13.77 48.7 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.534 0.733 . . . . 75.11 111.527 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.501 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 2.0 tmtp? -81.63 132.84 35.31 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.387 -0.968 . . . . 72.31 108.387 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.501 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 12.5 m-20 -52.51 132.35 35.05 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.663 1.185 . . . . 52.43 112.314 178.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.41 ' CE3' HD21 ' A' ' 68' ' ' LEU . 55.3 t-105 -78.57 89.17 4.5 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.374 0.607 . . . . 71.42 110.334 -175.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.488 ' H ' HD22 ' A' ' 68' ' ' LEU . 35.9 tt0 -120.21 78.49 26.18 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.905 1.282 . . . . 74.52 108.465 171.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.6 111.7 2.84 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.307 2.005 . . . . 71.23 113.239 -171.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -95.86 99.11 10.95 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 107.5 -1.296 . . . . 72.44 107.5 173.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.573 HG13 HG13 ' A' ' 64' ' ' VAL . 57.7 t -90.64 100.21 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 123.57 0.748 . . . . 52.02 110.5 -169.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -84.53 114.77 22.2 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.621 0.768 . . . . 60.54 109.754 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mp -104.67 108.35 19.76 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.918 -0.771 . . . . 73.32 108.918 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.542 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 10.7 t70 -102.35 124.49 48.02 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.949 1.3 . . . . 63.32 108.04 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.842 HD21 HD11 ' E' ' 8' ' ' LEU . 6.8 mp -111.77 125.81 54.4 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.901 0.382 . . . . 75.03 110.533 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 4.2 t70 -119.32 136.17 54.37 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.577 1.151 . . . . 71.04 108.716 175.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 46.9 p -107.75 136.44 47.48 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.243 0.617 . . . . 71.05 110.43 -174.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.618 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -139.13 137.09 35.81 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.575 0.75 . . . . 53.51 109.454 177.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.4 p -133.62 152.8 51.97 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.516 0.726 . . . . 74.45 110.381 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.9 t -161.07 127.38 3.93 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.049 0.54 . . . . 64.04 110.014 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -88.13 105.27 17.4 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.25 -1.019 . . . . 75.42 108.25 171.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.4 mt -79.33 -36.41 39.53 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.039 0.535 . . . . 73.51 111.541 -171.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.05 -174.13 3.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.475 0.71 . . . . 70.13 110.297 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -67.55 118.84 11.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.109 0.564 . . . . 72.34 109.534 171.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 67.69 13.16 9.17 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.819 1.248 . . . . 64.03 111.825 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.25 109.48 24.37 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 N-CA-C 107.864 -1.162 . . . . 72.34 107.864 175.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -129.58 155.49 45.72 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.272 -1.01 . . . . 74.43 108.272 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -129.6 124.59 34.15 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.089 0.556 . . . . 72.45 110.864 -174.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.421 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 85.3 t -109.07 113.42 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.317 -1.364 . . . . 60.33 107.317 166.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 40.3 t -103.55 135.05 42.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.554 -0.906 . . . . 74.12 108.554 171.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.446 HD21 HD23 ' A' ' 44' ' ' LEU . 2.6 tt -129.0 119.12 23.72 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.385 -0.598 . . . . 73.1 109.385 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 12.1 ttm180 -84.84 110.33 18.75 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.251 1.02 . . . . 72.44 109.63 175.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.8 t -100.47 101.33 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 107.719 -1.215 . . . . 65.31 107.719 170.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 20.9 m -99.46 104.23 16.05 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.686 0.794 . . . . 72.41 109.029 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.724 HG11 HD21 ' A' ' 126' ' ' LEU . 14.1 t -104.9 119.63 54.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 123.754 0.822 . . . . 72.13 109.966 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.5 m -112.29 123.88 51.24 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.586 -0.894 . . . . 62.04 108.586 177.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.51 110.5 22.46 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 106.603 -1.629 . . . . 74.31 106.603 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.8 m -109.87 124.9 52.15 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.195 -0.669 . . . . 44.24 109.195 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.488 HD22 ' H ' ' A' ' 37' ' ' GLN . 40.2 mt -88.99 75.76 7.94 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.193 -1.41 . . . . 62.21 107.193 176.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.49 -88.75 0.72 Allowed Glycine 0 C--N 1.345 1.043 0 CA-C-N 114.949 -1.023 . . . . 52.13 110.991 -173.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -120.85 -4.93 9.65 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.501 0.721 . . . . 70.21 111.499 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -101.9 103.6 14.28 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.652 -0.499 . . . . 74.13 109.652 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.0 m -60.52 121.15 11.41 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.139 0.495 . . . . 61.11 110.976 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.81 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -69.55 -58.29 4.13 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.959 -1.019 . . . . 51.21 109.999 175.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -158.65 174.6 14.8 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.353 -1.294 . . . . 72.42 111.16 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.9 tp -132.11 142.6 49.56 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 113.778 -1.556 . . . . 72.24 107.636 173.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 75.1 m -142.7 94.96 2.71 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.293 0.637 . . . . 63.31 109.546 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 39.0 tt0 -115.07 115.62 27.11 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.549 -0.908 . . . . 52.1 108.549 -175.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.73 109.12 18.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.781 -0.822 . . . . 74.44 108.781 -175.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 76.0 mt-30 -85.58 84.09 7.71 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.117 -1.068 . . . . 73.13 108.117 173.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -76.48 99.4 4.9 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.508 -1.224 . . . . 72.51 108.949 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.99 144.82 22.11 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 110.298 -1.121 . . . . 60.44 110.298 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.468 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -144.78 120.92 1.47 Allowed Glycine 0 CA--C 1.5 -0.865 0 N-CA-C 110.382 -1.087 . . . . 63.43 110.382 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.0 mt -88.84 123.24 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 108.529 -0.915 . . . . 75.3 108.529 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.421 ' HE1' ' HB ' ' A' ' 58' ' ' VAL . 90.1 m-85 -121.44 119.87 33.32 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.49 -1.3 . . . . 72.35 107.49 -177.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.7 m -84.78 88.5 7.39 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.199 0.6 . . . . 64.44 109.504 173.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.426 HD13 ' H ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -123.18 141.4 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 115.581 -0.736 . . . . 61.11 110.04 178.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.23 23.81 0.07 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.554 0.742 . . . . 70.33 110.663 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.77 -71.34 0.93 Allowed Glycine 0 C--N 1.348 1.228 0 CA-C-N 116.193 -0.458 . . . . 54.23 112.262 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 pp -158.94 173.4 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.501 1.12 . . . . 70.44 111.02 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.503 ' HG3' ' H ' ' A' ' 91' ' ' GLY . 6.3 tp10 -114.66 -159.14 0.69 Allowed 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 125.982 1.713 . . . . 65.34 106.74 -175.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.503 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . 75.68 -141.96 28.2 Favored Glycine 0 N--CA 1.468 0.831 0 CA-C-O 119.575 -0.569 . . . . 53.55 112.697 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.9 p -58.35 -42.9 87.95 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.525 0.73 . . . . 74.43 112.761 -174.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -73.1 -43.84 61.2 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 118.887 -0.577 . . . . 72.54 112.383 -172.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.572 ' SD ' ' HB ' ' E' ' 18' ' ' VAL . 58.0 ttm -67.13 -38.82 86.21 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 118.899 0.772 . . . . 75.15 110.809 174.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.42 -31.08 72.14 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 122.853 0.461 . . . . 70.2 111.308 175.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -72.24 -36.58 69.13 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.234 1.014 . . . . 70.12 110.704 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 81.9 m -66.39 -60.99 2.24 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.768 -0.456 . . . . 72.22 109.768 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.688 HD11 HG23 ' E' ' 18' ' ' VAL . 69.5 mt -60.24 -40.32 89.84 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.241 1.016 . . . . 65.12 112.061 -177.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.66 -28.13 30.32 Favored Glycine 0 C--N 1.342 0.866 0 O-C-N 123.753 0.658 . . . . 71.42 114.128 -172.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.71 -59.71 1.2 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.982 0.734 . . . . 73.23 112.982 -171.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -73.55 -56.83 4.51 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.597 0.359 . . . . 73.55 111.86 -166.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 66.6 m -55.33 -41.09 88.92 Favored Pre-proline 0 CA--C 1.571 1.785 0 CA-C-O 118.308 -0.853 . . . . 62.13 112.855 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -49.33 -51.39 10.76 Favored 'Trans proline' 0 C--N 1.399 3.224 0 C-N-CA 122.728 2.286 . . . . 73.01 113.207 164.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.5 HD21 ' N ' ' A' ' 133' ' ' PHE . 95.0 m-20 -71.98 -15.4 62.06 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.748 0.819 . . . . 64.25 112.445 -177.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.457 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 30.3 mm -80.72 -45.1 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.259 0.623 . . . . 74.33 109.494 172.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.468 HD21 ' HA3' ' A' ' 82' ' ' GLY . 90.0 mt -74.66 -22.98 58.59 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.06 -0.518 . . . . 51.44 111.053 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -61.96 -46.0 91.96 Favored Pre-proline 0 CA--C 1.559 1.319 0 CA-C-O 117.499 -1.238 . . . . 73.52 113.002 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 34.5 Cg_exo -60.35 -35.37 91.48 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 121.837 1.692 . . . . 71.34 113.926 174.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -78.34 -35.82 47.07 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 122.899 0.479 . . . . 71.12 111.093 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.57 -37.91 68.07 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.2 0.6 . . . . 72.11 109.76 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.579 ' NH1' HG23 ' C' ' 105' ' ' ILE . 26.3 ttm180 -63.51 -39.95 95.77 Favored 'General case' 0 C--O 1.209 -1.05 0 C-N-CA 124.061 0.945 . . . . 72.51 109.309 173.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -63.39 -48.3 78.42 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.992 0.917 . . . . 73.11 111.038 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 32.9 t -60.58 -41.32 94.44 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 124.385 1.053 . . . . 74.43 110.04 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 69.1 mt -65.25 -46.77 89.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 123.579 0.752 . . . . 72.0 110.83 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 55.3 m -59.44 -39.22 82.86 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.449 1.1 . . . . 75.41 110.424 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.8 t -75.03 -47.19 30.23 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.893 -1.049 . . . . 64.22 110.476 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 13.7 mtp -57.44 -45.15 85.02 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.606 0.763 . . . . 75.45 111.948 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.2 t -63.61 -43.66 98.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 124.468 1.107 . . . . 74.43 110.878 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.0 t -70.83 -31.65 68.44 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.215 0.606 . . . . 72.52 111.463 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -73.8 -30.14 62.56 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.287 0.635 . . . . 74.24 109.726 176.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.38 -0.52 78.68 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.286 -0.87 . . . . 63.33 113.41 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.499 HG22 HH21 ' B' ' 15' ' ' ARG . 17.2 m 73.42 15.59 4.2 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-O 122.574 1.178 . . . . 64.55 111.425 173.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -86.27 154.82 57.4 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-N 115.588 -0.733 . . . . 63.4 110.221 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.25 129.7 34.79 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.772 2.315 . . . . 75.12 111.851 171.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -51.76 129.56 26.62 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 124.289 0.993 . . . . 75.53 112.268 -172.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.724 HD21 HG11 ' A' ' 64' ' ' VAL . 56.1 tp -109.47 97.99 7.46 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.229 -0.896 . . . . 55.14 110.177 -174.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -103.28 112.28 25.07 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.432 0.693 . . . . 64.5 109.401 174.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.0 mp -72.43 117.73 14.45 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.103 -1.073 . . . . 60.1 108.103 172.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' E' ' 7' ' ' ALA . . . -62.24 145.02 94.36 Favored Pre-proline 0 CA--C 1.56 1.354 0 CA-C-N 117.925 0.33 . . . . 73.1 110.716 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.45 ' HD3' HG13 ' C' ' 13' ' ' ILE . 13.7 Cg_exo -69.44 110.67 2.54 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.743 2.296 . . . . 71.22 112.084 -170.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.43 HG21 ' HB3' ' E' ' 8' ' ' LEU . 15.2 m -99.49 115.25 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 108.676 -0.861 . . . . 63.02 108.676 175.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -90.75 98.81 12.0 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.643 -0.873 . . . . 70.44 108.643 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.5 ' N ' HD21 ' A' ' 104' ' ' ASN . 72.7 m-85 -55.58 -34.56 64.92 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 123.445 0.465 . . . . 74.31 110.278 170.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.36 -51.55 19.24 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.864 0.866 . . . . 73.31 111.957 170.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.51 -50.08 74.22 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.315 0.646 . . . . 61.32 111.768 -173.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.08 -40.95 74.7 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.798 0.439 . . . . 72.25 110.932 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -74.96 -27.64 60.26 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.128 0.571 . . . . 74.44 111.533 -174.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 30.1 mmt -79.91 -37.03 35.53 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.542 0.337 . . . . 73.05 110.186 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -59.92 -41.69 92.31 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 123.713 0.633 . . . . 73.25 110.356 173.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -65.15 -47.12 78.16 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.722 -0.672 . . . . 73.15 110.926 173.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.431 HD23 ' HG3' ' C' ' 144' ' ' GLN . 26.3 tp -58.04 -43.2 86.68 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.001 0.813 . . . . 75.13 111.566 -170.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.413 ' H ' ' H ' ' A' ' 143' ' ' GLN . 33.0 tt0 -173.93 -17.72 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 O-C-N 123.859 0.724 . . . . 62.1 111.304 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.413 ' H ' ' H ' ' A' ' 142' ' ' GLN . 14.5 tm0? 67.15 122.42 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.956 1.702 . . . . 72.42 110.554 -176.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -106.63 138.54 42.61 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.226 0.61 . . . . 73.43 110.009 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -148.22 133.83 18.79 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.381 0.672 . . . . 74.1 109.794 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.93 -163.34 9.69 Favored Glycine 0 C--N 1.349 1.266 0 O-C-N 123.445 0.466 . . . . 52.34 112.226 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -71.24 141.17 50.6 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.738 0.415 . . . . 73.03 111.292 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -96.75 -174.19 35.05 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.369 -0.693 . . . . 72.31 111.369 171.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.736 HG21 ' HA3' ' C' ' 91' ' ' GLY . 6.1 m -99.81 127.55 45.96 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.681 -0.488 . . . . 71.3 109.681 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -97.58 149.83 21.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.936 0.494 . . . . 74.54 110.261 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.566 ' HG2' HG22 ' G' ' 23' ' ' THR . 0.3 OUTLIER -138.45 168.74 19.12 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 107.738 -1.208 . . . . 64.21 107.738 176.066 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.413 ' HE1' ' HG2' ' G' ' 24' ' ' PRO . 54.1 m80 -62.5 89.65 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.845 0.858 . . . . 72.42 109.658 172.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -90.62 136.73 32.87 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.188 0.995 . . . . 73.31 109.776 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -98.37 143.98 28.25 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.391 -0.596 . . . . 64.52 109.391 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 C-N-CA 123.895 0.878 . . . . 74.14 109.109 -178.647 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.896 0.379 . . . . 75.34 110.936 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 27.1 p -111.06 128.15 55.78 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.391 -0.966 . . . . 73.3 108.391 169.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -74.45 91.59 2.27 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.58 0.705 . . . . 74.41 110.129 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -90.28 109.7 20.78 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.785 -1.098 . . . . 72.15 109.774 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -68.47 -39.13 81.51 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.423 0.63 . . . . 63.45 109.328 170.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -127.08 120.96 30.19 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.92 -1.511 . . . . 74.12 106.92 169.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 58.0 p -78.35 -29.0 47.27 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.546 0.738 . . . . 73.41 111.494 -174.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 69.07 -2.31 1.83 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.989 1.316 . . . . 72.22 112.984 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.42 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 26.2 ttt 64.07 168.18 0.16 Allowed 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 125.25 1.42 . . . . 74.11 111.942 -170.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m -143.35 133.57 24.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.446 -1.316 . . . . 73.01 107.446 166.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -141.22 137.67 32.75 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.396 -0.594 . . . . 71.54 109.396 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -158.75 129.0 5.92 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.026 0.93 . . . . 62.33 108.753 173.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.449 HD11 HD13 ' B' ' 105' ' ' ILE . 15.8 mt -75.05 119.06 21.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.629 0 N-CA-C 108.001 -1.111 . . . . 71.11 108.001 169.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -96.3 -42.58 8.09 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 123.537 0.523 . . . . 63.44 110.199 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.499 HH21 HG22 ' A' ' 122' ' ' THR . 23.0 ttt85 -165.64 133.13 2.91 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.9 -0.591 . . . . 72.32 109.739 -175.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 71.8 mt -116.66 143.05 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 107.622 -1.251 . . . . 74.3 107.622 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -166.91 155.68 10.28 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.528 0.68 . . . . 74.32 112.129 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 89.1 m -84.27 120.46 26.26 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.771 -1.104 . . . . 52.32 108.361 170.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.543 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 33.1 mtpt -87.83 -33.74 18.48 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.031 0.532 . . . . 74.11 110.383 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 19.7 t70 -157.62 144.49 18.11 Favored 'General case' 0 C--N 1.347 0.48 0 N-CA-C 112.707 0.632 . . . . 73.4 112.707 -170.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 45.3 mm -137.51 142.14 37.55 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 C-N-CA 125.648 1.579 . . . . 62.4 108.472 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.3 t -147.21 127.22 13.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.924 -1.139 . . . . 63.44 107.924 173.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 90.7 t80 -139.57 110.91 7.02 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.435 -0.95 . . . . 75.32 108.435 175.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -118.04 115.44 24.87 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.351 1.061 . . . . 73.54 108.534 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.406 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.7 87.91 3.13 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.032 -1.099 . . . . 54.02 108.032 174.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.54 -44.52 4.41 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.649 2.232 . . . . 61.22 112.562 -170.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -97.29 16.48 19.83 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.936 0.894 . . . . 74.34 110.666 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.406 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -38.31 -59.92 1.15 Allowed Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 115.303 1.594 . . . . 75.24 115.303 -168.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -66.61 -26.44 46.45 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 122.039 1.826 . . . . 72.32 112.89 -170.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -93.96 -41.21 9.71 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 115.022 -0.99 . . . . 72.41 111.176 -172.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.6 p -71.18 -12.47 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.344 0.658 . . . . 54.24 111.837 -170.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -66.25 -12.56 57.01 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.584 0.754 . . . . 65.51 112.716 174.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -65.21 -16.41 63.5 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.321 0.648 . . . . 73.01 111.427 174.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -107.53 111.62 23.98 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.023 1.329 . . . . 72.0 111.09 -176.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -107.53 95.16 5.5 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.309 0.644 . . . . 71.53 110.935 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 39.3 p90 -169.27 175.45 5.61 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.7 1.2 . . . . 63.15 108.78 167.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -73.79 107.89 4.11 Favored Pre-proline 0 CA--C 1.555 1.142 0 N-CA-C 109.891 -0.411 . . . . 73.14 109.891 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.485 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 30.5 Cg_endo -64.71 149.73 89.27 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.663 2.242 . . . . 74.32 113.565 -173.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.621 ' HA ' HG23 ' F' ' 5' ' ' THR . 32.7 tt0 -63.09 114.87 3.99 Favored 'General case' 0 C--N 1.359 1.006 0 O-C-N 124.087 0.867 . . . . 75.3 110.052 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.563 HG13 HG13 ' B' ' 64' ' ' VAL . 88.3 t -92.57 144.09 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 123.983 0.913 . . . . 72.21 111.29 -172.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.512 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 23.6 ttpp -128.82 116.43 19.44 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.845 -1.539 . . . . 74.31 106.845 168.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.62 HD13 ' HA ' ' F' ' 8' ' ' LEU . 1.6 pt? -84.11 149.07 26.45 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.146 -0.687 . . . . 75.25 109.146 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.756 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 6.9 m-20 -139.52 110.0 6.62 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.16 -1.422 . . . . 74.21 107.16 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 84.0 mt -104.46 127.12 52.09 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.502 -0.925 . . . . 74.54 108.502 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 14.5 t70 -133.11 143.92 49.61 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.801 0.84 . . . . 64.2 109.409 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 81.3 p -109.98 126.17 53.65 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.755 0.822 . . . . 63.14 110.246 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.06 148.91 52.2 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.837 0.855 . . . . 73.33 109.355 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.9 p -144.48 164.39 31.0 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.703 0.631 . . . . 73.25 112.703 -174.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 69.7 p -155.13 146.74 23.17 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.152 -0.931 . . . . 73.51 109.552 166.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -97.62 128.89 44.67 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.95 -0.759 . . . . 70.35 108.95 174.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.9 mt -97.58 -54.15 3.21 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.315 0.578 . . . . 73.55 110.238 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.38 -168.15 2.98 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.065 -0.971 . . . . 72.32 110.051 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -67.43 103.23 1.26 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.651 -1.158 . . . . 74.44 110.602 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 67.12 15.23 10.03 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.136 1.375 . . . . 64.13 112.414 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 68.0 t -105.74 105.71 19.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 107.52 -1.289 . . . . 72.31 107.52 172.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.648 ' HB2' HD11 ' B' ' 86' ' ' ILE . 6.1 t80 -110.53 165.87 11.46 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.339 -0.846 . . . . 63.23 109.003 -172.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -136.23 114.08 11.21 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.966 -1.124 . . . . 72.03 107.966 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 95.8 t -104.09 118.43 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.829 1.252 . . . . 62.51 110.443 -171.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 13.3 t -109.76 122.55 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 109.496 -0.557 . . . . 72.42 109.496 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.523 HD22 ' HB2' ' B' ' 103' ' ' PRO . 51.8 tp -106.3 110.28 22.46 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.76 -0.83 . . . . 72.45 108.76 170.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.514 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 22.1 ttm-85 -85.94 109.38 18.71 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.223 -0.658 . . . . 71.24 109.223 173.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 30.7 t -106.26 101.86 13.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 108.143 -1.058 . . . . 75.31 108.143 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.756 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 10.4 m -102.32 128.76 48.74 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.747 -0.834 . . . . 42.14 108.747 175.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.563 HG13 HG13 ' B' ' 40' ' ' VAL . 61.3 t -119.91 108.16 22.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 123.85 0.86 . . . . 61.42 109.289 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 96.4 m -82.34 144.66 30.42 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.409 -0.96 . . . . 70.33 108.409 169.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.15 144.56 29.08 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 122.952 0.501 . . . . 73.04 109.928 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.442 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 36.1 p -147.65 127.13 13.19 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.501 0.501 . . . . 74.32 111.127 -175.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.507 HD12 HG22 ' B' ' 31' ' ' VAL . 72.7 mt -94.66 110.16 22.02 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.234 -1.025 . . . . 51.15 108.234 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.41 -112.86 3.67 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 115.477 -0.783 . . . . 62.45 111.771 -176.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -120.96 9.46 10.61 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.435 0.694 . . . . 74.3 110.421 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -123.19 155.15 37.65 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.47 0.708 . . . . 61.1 109.66 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 29.6 m -68.98 133.71 48.53 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.961 0.41 . . . . 63.45 109.984 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.514 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -87.98 -63.58 1.28 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.713 -1.217 . . . . 73.24 107.713 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -150.8 161.31 42.91 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.439 -1.255 . . . . 72.43 110.857 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 85.7 mt -125.73 113.28 17.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.564 -2.013 . . . . 61.53 105.564 172.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.8 t -116.66 151.37 36.45 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.5 -0.926 . . . . 72.3 108.5 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.425 ' HB2' HG23 ' B' ' 63' ' ' THR . 42.8 tt0 -161.14 133.18 5.82 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.055 0.455 . . . . 60.25 109.812 -175.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 93.3 t -134.12 149.0 29.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 124.697 1.199 . . . . 74.31 108.261 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.459 HE21 ' HB3' ' B' ' 20' ' ' ASP . 25.6 mt-30 -125.25 107.01 10.3 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.121 -1.066 . . . . 73.14 108.121 169.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.401 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.8 tp-100 -96.5 101.22 12.81 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.656 -0.868 . . . . 74.11 108.656 178.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.543 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -95.09 144.39 17.17 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.366 -0.834 . . . . 63.52 111.275 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.59 126.84 3.13 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.427 -0.669 . . . . 74.13 111.427 -176.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 70.2 mt -83.96 127.43 39.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.795 -0.817 . . . . 74.21 108.795 174.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -137.85 135.77 36.51 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.936 -0.764 . . . . 73.43 108.936 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.8 m -89.24 98.32 11.7 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.693 -0.855 . . . . 72.3 108.693 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.648 HD11 ' HB2' ' B' ' 56' ' ' TYR . 1.7 pp -111.48 129.53 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.93 0.892 . . . . 62.51 110.702 -175.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.65 167.31 22.86 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.153 0.581 . . . . 73.41 109.815 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 88.28 -59.42 4.14 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 114.017 0.367 . . . . 42.42 114.017 172.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 15.4 mm -78.85 138.21 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 123.632 0.773 . . . . 71.53 110.067 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -157.24 174.65 15.14 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 115.846 -0.615 . . . . 63.1 111.928 -163.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.11 -127.83 44.82 Favored Glycine 0 C--N 1.354 1.562 0 C-N-CA 123.418 0.532 . . . . 34.42 113.78 -177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 51.8 m -66.29 -30.87 71.37 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.983 0.913 . . . . 74.03 110.94 175.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -65.79 -45.3 82.94 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.707 -0.679 . . . . 71.13 110.544 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -71.17 -24.83 62.32 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.534 0.334 . . . . 73.33 111.425 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.82 -45.15 95.08 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 123.664 0.603 . . . . 43.42 109.875 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -64.66 -40.77 96.0 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.233 0.613 . . . . 71.41 111.307 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.4 t -62.14 -44.57 96.32 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.766 0.427 . . . . 65.43 111.648 -176.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.435 ' HB3' ' CD2' ' F' ' 15' ' ' PHE . 9.2 mp -92.75 -16.86 24.91 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.046 0.539 . . . . 73.34 111.708 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.11 2.87 47.61 Favored Glycine 0 N--CA 1.474 1.211 0 CA-C-O 120.052 -0.304 . . . . 64.32 113.643 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' B' ' 104' ' ' ASN . . . -145.07 -57.36 0.34 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.22 0.608 . . . . 74.01 110.57 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -74.02 -51.81 14.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.997 0.519 . . . . 75.44 112.293 -171.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 72.0 m -60.8 -49.23 90.35 Favored Pre-proline 0 CA--C 1.565 1.536 0 CA-C-O 118.59 -0.719 . . . . 65.11 112.44 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.523 ' HB2' HD22 ' B' ' 60' ' ' LEU . 71.5 Cg_endo -71.56 -16.7 30.41 Favored 'Trans proline' 0 C--N 1.393 2.87 0 C-N-CA 122.08 1.853 . . . . 75.21 113.319 176.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' B' ' 100' ' ' ALA . 51.4 t-20 -65.64 -41.21 92.89 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 123.469 0.708 . . . . 63.22 109.594 174.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.449 HD13 HD11 ' B' ' 13' ' ' ILE . 73.7 mt -60.54 -45.36 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.538 1.135 . . . . 73.13 110.741 175.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 49.5 mt -84.01 -13.22 53.81 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.224 -1.353 . . . . 74.34 111.612 -170.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -57.24 -55.74 41.13 Favored Pre-proline 0 CA--C 1.561 1.366 0 CA-C-O 117.946 -1.026 . . . . 70.43 113.549 -176.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -64.85 -27.1 59.26 Favored 'Trans proline' 0 C--N 1.383 2.368 0 CA-C-N 121.338 1.514 . . . . 62.14 113.186 -174.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.401 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.0 m-85 -68.69 -48.45 63.85 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.839 0.456 . . . . 74.52 109.888 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.59 90.12 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.449 -0.796 . . . . 62.4 110.745 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 45.2 ttt-85 -62.45 -49.03 77.04 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.757 1.223 . . . . 72.32 111.376 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -65.88 -36.85 84.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 123.711 0.632 . . . . 75.54 109.791 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.513 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.5 t -70.96 -33.8 70.82 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.892 -0.595 . . . . 61.15 111.369 -178.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.471 ' O ' HG23 ' B' ' 118' ' ' VAL . 55.6 mt -64.48 -54.64 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 109.17 -0.678 . . . . 73.51 109.17 173.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 4.3 m -63.72 -23.41 67.36 Favored 'General case' 0 CA--C 1.555 1.168 0 O-C-N 123.85 0.719 . . . . 71.02 111.353 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.434 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.0 t -67.25 -49.02 66.0 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 123.075 0.55 . . . . 73.23 109.812 172.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.513 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.4 mmt -68.68 -31.83 71.22 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.804 0.442 . . . . 73.22 111.042 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.471 HG23 ' O ' ' B' ' 114' ' ' ILE . 90.9 t -64.17 -42.67 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.837 0.855 . . . . 72.35 109.962 172.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.6 t -67.18 -31.39 71.75 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.924 -1.034 . . . . 63.41 111.336 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.438 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 81.7 mtt-85 -73.45 -38.11 65.6 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.26 0.624 . . . . 61.4 110.061 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.95 -3.94 75.98 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 123.729 0.643 . . . . 75.13 112.609 169.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 34.3 p 63.46 24.08 13.96 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 126.426 1.89 . . . . 72.24 113.129 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -77.77 160.58 74.05 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 124.533 1.133 . . . . 74.32 111.36 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -51.95 162.29 1.92 Allowed 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 123.677 2.918 . . . . 74.44 115.049 173.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.674 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 56.3 tp60 -60.24 128.81 38.6 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.287 1.035 . . . . 74.13 111.574 -173.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.436 HD21 HG21 ' B' ' 40' ' ' VAL . 1.4 tm? -146.4 99.79 3.27 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.647 -0.871 . . . . 74.34 108.647 -174.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -131.53 132.2 43.98 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.722 0.809 . . . . 72.35 109.505 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.594 HD23 HD11 ' F' ' 6' ' ' ILE . 96.1 mt -70.98 150.41 45.69 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.332 0.653 . . . . 73.33 112.383 -175.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.0 153.19 69.47 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 124.114 0.966 . . . . 70.34 111.702 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.407 ' HB2' HD12 ' D' ' 13' ' ' ILE . 57.8 Cg_endo -68.03 116.72 4.47 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.112 2.541 . . . . 74.14 112.406 176.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.613 HG21 ' HB2' ' F' ' 8' ' ' LEU . 72.3 t -127.79 111.44 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.89 -0.781 . . . . 71.11 108.89 173.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -80.27 94.27 6.06 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 107.688 -1.227 . . . . 73.15 107.688 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -56.69 -41.55 77.53 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.136 0.974 . . . . 53.22 111.487 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -64.09 -46.13 85.62 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.324 1.049 . . . . 74.03 112.034 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.68 -27.22 67.48 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.805 0.69 . . . . 50.02 112.2 -175.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 88.2 mt -60.44 -46.51 89.77 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.246 0.618 . . . . 65.51 110.636 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -80.47 -27.39 37.87 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.367 -0.833 . . . . 74.54 111.077 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 25.9 ttt -70.8 -39.47 73.08 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.085 0.554 . . . . 74.23 111.206 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -75.49 -17.25 60.17 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.937 0.495 . . . . 54.1 110.874 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -72.39 -40.08 67.51 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.769 -0.456 . . . . 74.41 109.769 172.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 51.2 mt -86.42 -8.1 57.9 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.799 -0.637 . . . . 73.31 111.275 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -109.11 147.41 32.48 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.787 0.835 . . . . 74.22 109.68 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -142.4 147.52 36.33 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.847 0.859 . . . . 73.43 109.554 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -170.8 152.85 3.79 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.025 0.93 . . . . 73.21 109.844 174.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -164.18 -164.87 0.9 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.325 1.05 . . . . 64.22 109.314 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 126.44 129.05 3.24 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 112.328 -0.309 . . . . 34.11 112.328 173.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -150.35 100.54 2.89 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 107.792 -1.188 . . . . 70.25 107.792 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -69.48 82.15 0.28 Allowed Glycine 0 C--N 1.348 1.22 0 N-CA-C 111.0 -0.84 . . . . 74.14 111.0 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 16.0 p -65.76 88.2 0.1 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.921 0.888 . . . . 64.3 110.738 -177.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.01 137.97 39.31 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.504 -1.225 . . . . 74.43 110.352 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -131.08 146.64 52.44 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.434 -0.95 . . . . 73.21 108.434 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -134.81 118.87 17.48 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.057 -0.519 . . . . 71.14 109.991 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -144.52 134.5 23.95 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.013 0.925 . . . . 73.35 109.111 175.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -165.54 153.32 10.92 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.741 0.816 . . . . 70.54 109.317 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.777 0 N-CA-C 108.583 -0.895 . . . . 63.3 108.583 175.02 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 108.667 -0.864 . . . . 73.12 108.667 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 31.0 m 66.83 169.4 0.24 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.06 1.344 . . . . 73.14 112.189 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -80.13 -43.42 21.69 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.988 -0.745 . . . . 73.3 108.988 170.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -76.83 91.34 3.52 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.296 -0.865 . . . . 65.41 109.49 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -71.16 -54.36 11.28 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.184 -1.043 . . . . 74.02 108.184 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -170.58 133.78 1.04 Allowed 'General case' 0 C--N 1.351 0.659 0 CA-C-N 115.114 -0.948 . . . . 75.41 109.637 167.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 44.1 m -88.79 -52.39 5.15 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 107.351 -1.352 . . . . 72.11 107.351 167.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -137.4 147.22 45.28 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.446 -1.252 . . . . 73.54 108.288 167.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.633 ' HE1' HG23 ' C' ' 86' ' ' ILE . 13.4 tpt 65.61 122.97 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.149 1.38 . . . . 71.12 113.064 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 20.2 m -111.51 99.68 8.4 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.237 -1.023 . . . . 71.0 108.237 173.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.52 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 42.0 t80 -111.62 140.04 46.56 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.011 0.524 . . . . 75.42 109.691 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -159.72 134.31 7.77 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.082 0.953 . . . . 73.14 108.581 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.45 HG13 ' HD3' ' A' ' 130' ' ' PRO . 74.9 mt -72.8 120.46 21.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.492 -0.929 . . . . 65.55 108.492 168.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -89.86 -45.48 9.22 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.698 -0.683 . . . . 75.11 109.36 175.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -176.47 141.31 0.4 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.005 -0.998 . . . . 73.01 108.481 -168.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.401 HG21 ' CD1' ' C' ' 109' ' ' TYR . 56.0 mt -137.01 144.96 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 108.993 -0.743 . . . . 74.44 108.993 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.466 ' HB3' HG23 ' D' ' 122' ' ' THR . 22.3 p90 -174.89 159.94 2.79 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.576 0.703 . . . . 72.13 110.077 -173.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 18' ' ' THR . . . . . 0.46 HG21 ' SG ' ' C' ' 113' ' ' CYS . 81.0 p -78.91 119.36 21.97 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.911 -1.04 . . . . 65.35 108.988 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -69.44 -46.43 66.77 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 107.133 -1.432 . . . . 51.03 107.133 168.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.2 t70 -135.04 143.05 46.52 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 113.016 -1.902 . . . . 53.12 109.748 -171.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 70.4 mt -136.8 150.44 26.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 105.928 -1.878 . . . . 73.4 105.928 170.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -163.86 151.16 12.24 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.333 0.587 . . . . 72.03 110.012 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -146.21 124.45 12.23 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.183 -1.414 . . . . 61.31 107.183 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -126.98 110.43 12.97 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.086 -0.709 . . . . 72.43 109.086 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.38 84.65 29.39 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 107.292 -1.373 . . . . 50.03 107.292 167.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.41 -37.03 24.73 Favored 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 122.331 2.02 . . . . 72.24 111.011 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -95.83 22.69 7.03 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.044 -0.98 . . . . 71.03 110.64 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.71 -54.45 27.1 Favored Pre-proline 0 CA--C 1.564 1.518 0 N-CA-C 114.127 1.158 . . . . 32.1 114.127 -172.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.54 -40.48 47.04 Favored 'Trans proline' 0 C--N 1.39 2.726 0 CA-C-N 121.797 1.677 . . . . 60.43 111.961 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -70.69 -31.83 68.86 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.659 -1.155 . . . . 74.4 112.563 -175.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.65 HG21 ' HA ' ' C' ' 73' ' ' ALA . 11.7 p -81.46 -26.0 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 112.756 0.65 . . . . 70.54 112.756 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -67.6 -24.58 65.51 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 120.793 0.33 . . . . 74.15 111.71 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -90.49 25.5 2.26 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.789 0.836 . . . . 53.21 110.95 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.539 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -121.32 157.83 29.54 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.603 0.761 . . . . 62.33 110.485 178.547 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -70.19 131.91 44.96 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.956 0.902 . . . . 72.21 110.134 170.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -84.5 88.13 7.29 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.344 0.658 . . . . 72.24 110.779 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -132.48 78.97 66.36 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 108.021 -1.103 . . . . 72.43 108.021 171.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' C' ' 67' ' ' SER . 3.2 Cg_exo -78.54 126.71 7.64 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.574 2.183 . . . . 65.25 113.919 -172.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -85.05 91.6 8.14 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 106.249 -1.76 . . . . 74.15 106.249 160.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 28.6 m -80.15 142.69 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 114.345 -1.298 . . . . 62.44 111.262 -173.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.525 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 45.5 mmtm -124.52 103.1 7.97 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.597 -0.89 . . . . 54.45 108.597 172.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.482 HD22 HD23 ' G' ' 8' ' ' LEU . 2.2 pp -86.83 151.5 23.29 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.158 -0.682 . . . . 73.34 109.158 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -144.73 138.75 27.43 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.021 -0.733 . . . . 65.01 109.021 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.492 HD11 HD22 ' G' ' 8' ' ' LEU . 2.4 mp -125.35 114.97 19.59 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.254 -1.017 . . . . 75.33 108.254 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.592 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 11.3 t70 -111.98 144.5 41.23 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.945 0.898 . . . . 74.31 109.045 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -113.28 113.07 24.77 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.489 -0.778 . . . . 74.11 110.613 -169.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.77 141.56 50.37 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.833 0.853 . . . . 70.15 109.362 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 35.2 p -165.84 158.62 15.2 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.626 0.37 . . . . 75.24 111.832 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -161.46 148.93 14.88 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.646 0.779 . . . . 62.43 110.464 -174.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -92.23 126.7 37.42 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.35 -0.611 . . . . 63.25 109.35 172.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.669 HD11 HD12 ' C' ' 83' ' ' ILE . 74.9 mt -89.21 -54.0 4.31 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.563 0.745 . . . . 62.21 111.137 -176.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.91 -166.88 2.46 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.738 -0.665 . . . . 70.14 110.564 -174.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -57.35 103.57 0.13 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.476 1.111 . . . . 71.24 110.401 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 64.14 7.05 3.21 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.05 1.34 . . . . 65.5 113.033 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 88.1 t -97.12 113.92 32.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 107.665 -1.235 . . . . 74.05 107.665 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -118.44 159.85 22.75 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.343 -0.844 . . . . 74.05 109.119 -175.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -126.28 122.68 36.19 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.048 0.939 . . . . 74.22 109.156 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 87.4 t -109.59 125.33 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 107.738 -1.208 . . . . 63.23 107.738 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 66.2 t -124.05 125.67 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 109.083 -0.71 . . . . 43.35 109.083 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.526 HD22 ' HB2' ' C' ' 103' ' ' PRO . 33.4 tp -112.69 116.58 30.36 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 109.229 -0.656 . . . . 63.44 109.229 175.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.592 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 16.7 ttm-85 -82.09 109.31 16.3 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.446 -0.797 . . . . 73.22 109.005 174.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 36.4 t -103.56 119.17 51.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.033 -1.099 . . . . 55.11 108.033 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 27.3 m -125.41 121.49 34.02 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.228 -0.656 . . . . 51.31 109.228 -175.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.664 HG23 HD13 ' C' ' 114' ' ' ILE . 68.4 t -105.82 115.51 47.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 123.767 0.827 . . . . 60.22 109.019 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 3.7 m -98.48 139.45 34.2 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.359 -1.349 . . . . 60.11 107.359 169.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.94 122.96 31.33 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.072 -1.085 . . . . 43.52 108.072 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 67' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' C' ' 38' ' ' PRO . 54.1 m -132.54 156.28 47.12 Favored 'General case' 0 C--O 1.213 -0.851 0 C-N-CA 123.393 0.677 . . . . 62.4 109.181 175.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.539 HD13 ' HG2' ' C' ' 34' ' ' LYS . 39.0 mt -119.07 38.76 3.73 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.439 -1.319 . . . . 75.43 107.439 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.82 -99.59 1.65 Allowed Glycine 0 C--N 1.347 1.178 0 CA-C-N 114.606 -1.179 . . . . 73.35 110.469 -170.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -90.33 -30.8 17.23 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.343 0.657 . . . . 72.41 110.438 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -73.22 116.1 13.36 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.87 0.868 . . . . 74.52 110.654 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.1 m -76.85 118.35 19.36 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.376 -0.972 . . . . 73.44 108.376 168.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.65 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.88 -53.02 9.82 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.953 0.783 . . . . 53.24 109.02 176.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -165.96 173.39 10.5 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-N 115.509 -0.769 . . . . 72.55 112.392 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.505 HD23 HG23 ' C' ' 65' ' ' THR . 2.4 tm? -140.94 102.45 4.27 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 105.836 -1.913 . . . . 74.01 105.836 172.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.474 ' SG ' HG23 ' C' ' 114' ' ' ILE . 46.4 t -109.97 112.0 23.74 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.194 -0.669 . . . . 74.54 109.194 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -118.23 127.57 53.87 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.064 0.546 . . . . 70.15 110.162 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 73.2 t -124.33 138.49 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 108.714 -0.847 . . . . 72.24 108.714 170.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.576 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 47.9 mt-30 -113.1 95.17 5.25 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.714 -0.847 . . . . 64.52 108.714 172.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -81.8 106.93 14.12 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.385 -0.825 . . . . 73.42 109.405 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.52 149.13 20.4 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.539 -0.625 . . . . 72.12 111.539 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.18 117.05 0.92 Allowed Glycine 0 CA--C 1.506 -0.482 0 N-CA-C 111.012 -0.835 . . . . 71.04 111.012 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.669 HD12 HD11 ' C' ' 51' ' ' LEU . 12.5 mm -81.92 125.99 39.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 108.395 -0.965 . . . . 75.34 108.395 175.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.416 ' HD2' ' HA ' ' C' ' 13' ' ' ILE . 48.2 m-85 -138.77 142.02 38.8 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.277 -0.638 . . . . 74.33 109.277 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 85' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 60.7 m -70.76 115.56 10.05 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.354 -1.35 . . . . 54.51 107.354 164.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.633 HG23 ' HE1' ' C' ' 9' ' ' MET . 69.8 mt -133.64 110.99 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 109.122 -0.696 . . . . 65.31 109.122 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.55 167.52 19.26 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.91 0.884 . . . . 72.13 110.591 177.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.43 -40.44 2.54 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 116.349 -0.387 . . . . 72.31 113.299 171.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 23.6 pt -101.78 174.77 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.237 0.615 . . . . 71.31 111.038 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -150.31 153.69 36.55 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 111.999 0.37 . . . . 74.31 111.999 -175.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.736 ' HA3' HG21 ' A' ' 149' ' ' THR . . . 63.54 -115.92 8.59 Favored Glycine 0 C--N 1.353 1.486 0 N-CA-C 114.844 0.698 . . . . 54.43 114.844 169.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 75.5 p -74.49 -29.53 61.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.331 0.652 . . . . 72.1 110.986 -175.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -60.43 -48.26 82.53 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.695 -0.854 . . . . 74.34 108.695 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.576 ' SD ' ' HB ' ' G' ' 18' ' ' VAL . 51.8 ttm -69.71 -33.81 73.02 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.868 -1.514 . . . . 70.02 110.9 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.26 88.15 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.388 0.675 . . . . 65.22 111.66 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -71.2 -32.57 69.01 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.222 -0.445 . . . . 63.35 110.454 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.9 t -67.96 -61.57 1.8 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 122.628 0.371 . . . . 64.43 111.056 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.549 HD23 HG23 ' G' ' 18' ' ' VAL . 2.5 pp -70.24 -25.61 63.46 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.069 0.396 . . . . 64.24 112.069 -178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.95 -17.22 44.76 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 114.584 0.593 . . . . 62.53 114.584 -172.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.73 -53.19 0.87 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 117.466 0.633 . . . . 72.15 111.231 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -72.6 -46.65 53.13 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.615 0.766 . . . . 74.03 112.622 -168.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.52 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 33.7 m -73.35 -46.94 7.74 Favored Pre-proline 0 CA--C 1.569 1.683 0 N-CA-C 113.123 0.786 . . . . 65.42 113.123 -175.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.526 ' HB2' HD22 ' C' ' 60' ' ' LEU . 87.7 Cg_endo -75.87 -10.37 19.81 Favored 'Trans proline' 0 C--N 1.387 2.557 0 C-N-CA 122.094 1.863 . . . . 71.42 112.762 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.66 -32.73 74.53 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.487 0.715 . . . . 62.54 110.314 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.579 HG23 ' NH1' ' A' ' 111' ' ' ARG . 14.6 mm -70.74 -36.5 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.208 -0.905 . . . . 73.44 110.067 177.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 43.8 mt -85.86 -22.52 27.5 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.719 -1.128 . . . . 73.33 111.677 -172.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -58.72 -52.94 71.18 Favored Pre-proline 0 CA--C 1.56 1.352 0 CA-C-O 118.198 -0.906 . . . . 75.22 112.795 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -65.65 -32.02 48.54 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 121.54 1.493 . . . . 75.31 112.382 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.401 ' CD1' HG21 ' C' ' 16' ' ' ILE . 2.6 m-30 -67.23 -45.47 76.68 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.859 0.863 . . . . 72.12 110.025 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.7 -37.87 87.64 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.236 1.014 . . . . 65.35 110.735 176.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -60.8 -49.08 78.91 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.6 1.16 . . . . 72.5 110.794 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -69.98 -34.07 72.89 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.119 0.568 . . . . 73.5 110.058 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.46 ' SG ' HG21 ' C' ' 18' ' ' THR . 21.4 t -69.26 -31.29 69.73 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.936 0.494 . . . . 40.43 111.502 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.664 HD13 HG23 ' C' ' 64' ' ' VAL . 86.3 mt -73.53 -55.31 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.081 0.553 . . . . 73.21 109.662 173.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 17.1 m -63.87 -27.6 69.27 Favored 'General case' 0 CA--C 1.553 1.074 0 O-C-N 123.653 0.596 . . . . 71.3 111.374 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 36.6 t -62.02 -50.86 70.36 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.232 -0.655 . . . . 70.11 109.232 171.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.552 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.64 -36.07 79.72 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.318 1.047 . . . . 75.42 112.409 178.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.73 -45.23 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.38 0.672 . . . . 72.55 109.821 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 31.0 t -70.6 -25.35 63.01 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 114.907 -1.042 . . . . 71.4 111.809 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' C' ' 116' ' ' SER . 87.2 mtt-85 -74.18 -40.65 62.37 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.35 0.66 . . . . 71.22 109.417 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.72 -0.12 62.88 Favored Glycine 0 C--N 1.354 1.553 0 CA-C-N 115.617 -0.72 . . . . 34.24 112.575 169.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 25.3 p 62.64 30.89 16.97 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 126.787 2.035 . . . . 74.24 113.378 170.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -83.92 148.91 55.19 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 109.044 -0.725 . . . . 74.3 109.044 170.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.674 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 86.3 Cg_exo -51.41 146.91 23.59 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 123.422 2.748 . . . . 75.23 114.2 176.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -58.81 112.11 1.52 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.985 -1.007 . . . . 75.34 112.358 -173.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 42.8 tp -112.83 86.3 2.34 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.373 -0.973 . . . . 75.33 108.373 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -94.2 106.44 18.41 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.224 -0.898 . . . . 74.4 108.816 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 56.9 tp -65.47 144.98 56.69 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.133 0.573 . . . . 44.21 111.525 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.07 143.94 92.09 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 124.03 0.932 . . . . 63.44 110.882 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.497 ' HB2' HD12 ' A' ' 13' ' ' ILE . 5.6 Cg_exo -71.4 127.42 13.29 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.77 2.314 . . . . 42.15 112.237 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.79 HG21 ' H ' ' G' ' 8' ' ' LEU . 61.6 t -119.18 111.8 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.722 0.809 . . . . 74.44 109.401 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -80.69 97.52 7.3 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.481 0.712 . . . . 44.31 110.448 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -65.07 -41.8 94.75 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.241 -0.652 . . . . 75.45 109.241 170.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -53.34 -52.38 59.4 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.163 -1.381 . . . . 42.45 112.112 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.84 -31.0 68.1 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 123.854 0.722 . . . . 71.42 112.563 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 89.7 mt -70.05 -41.64 73.92 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.513 0.725 . . . . 71.14 110.658 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -80.79 -15.69 55.74 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.184 0.594 . . . . 64.25 111.795 175.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.406 ' O ' ' HB3' ' C' ' 142' ' ' GLN . 24.4 ttt -78.48 -44.82 23.56 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.805 0.842 . . . . 63.51 111.059 -175.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -60.4 -33.41 72.44 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 120.819 0.343 . . . . 63.52 110.296 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -61.89 -83.53 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.884 0.874 . . . . 73.53 111.642 170.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 84.8 mt -92.37 49.62 1.52 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.529 0.732 . . . . 73.11 112.441 -168.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.406 ' HB3' ' O ' ' C' ' 138' ' ' MET . 0.9 OUTLIER -158.21 129.83 6.71 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 109.041 -0.726 . . . . 63.34 109.041 171.419 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -146.92 86.94 1.66 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.498 -1.297 . . . . 54.24 107.498 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 144' ' ' GLN . . . . . 0.431 ' HG3' HD23 ' A' ' 141' ' ' LEU . 6.5 tp-100 -135.45 -24.52 1.37 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.173 0.589 . . . . 62.23 111.245 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.63 86.9 0.21 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 120.994 0.426 . . . . 64.13 110.44 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.92 87.01 0.07 OUTLIER Glycine 0 C--N 1.343 0.928 0 CA-C-N 115.484 -0.78 . . . . 73.21 111.814 -175.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -151.76 -98.8 0.06 Allowed 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 107.151 -1.426 . . . . 65.31 107.151 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 82.52 43.14 8.03 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 116.414 1.325 . . . . 62.34 116.414 166.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 17.4 p -78.52 -49.43 13.38 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.479 -0.934 . . . . 72.31 108.479 163.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 150' ' ' GLU . . . . . 0.498 ' HA ' ' HB3' ' E' ' 24' ' ' PRO . 30.3 tt0 52.33 90.7 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.671 1.588 . . . . 72.22 112.876 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 151' ' ' GLU . . . . . 0.544 ' HG3' ' H ' ' C' ' 152' ' ' HIS . 5.5 pt-20 -69.74 -67.94 0.45 Allowed 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 123.822 0.849 . . . . 71.4 112.26 -178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 152' ' ' HIS . . . . . 0.544 ' H ' ' HG3' ' C' ' 151' ' ' GLU . 15.9 t60 179.24 146.8 0.19 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.436 1.094 . . . . 71.12 108.812 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 153' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' E' ' 22' ' ' ARG . 0.0 OUTLIER -79.72 108.31 13.18 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 109.036 -0.727 . . . . 63.25 109.036 174.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -125.8 152.17 45.79 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.113 0.565 . . . . 75.3 110.242 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.184 0 C-N-CA 124.073 0.949 . . . . 62.51 108.974 175.089 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 1' ' ' MET . . . . . 0.438 ' HB2' ' HA3' ' D' ' 146' ' ' GLY . 1.8 mpt? . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.741 0.305 . . . . 53.1 110.485 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 63.8 p -82.21 175.06 10.61 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.034 0.534 . . . . 53.1 110.186 169.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -81.91 -34.12 30.09 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.784 0.434 . . . . 74.32 110.713 176.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 4' ' ' GLN . . . . . 0.445 ' HA ' ' HA2' ' D' ' 148' ' ' GLY . 35.3 tt0 -163.94 -79.85 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.123 0.969 . . . . 73.15 108.644 170.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 55.35 37.83 29.46 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.051 0.94 . . . . 74.33 112.464 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 6' ' ' ASN . . . . . 0.414 ' H ' ' HG2' ' D' ' 4' ' ' GLN . 15.0 m120 -78.76 80.64 5.11 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.446 -0.946 . . . . 62.51 108.446 169.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 29.0 m -149.59 142.89 25.18 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.005 -1.452 . . . . 62.4 107.633 -177.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -75.73 87.69 2.78 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.526 0.33 . . . . 61.33 110.121 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.581 ' HG3' HD11 ' D' ' 89' ' ' ILE . 23.1 ttt -31.79 125.73 0.25 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 125.089 1.356 . . . . 65.32 113.686 170.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 30.8 m -107.66 137.9 44.86 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.542 -0.911 . . . . 51.43 108.542 169.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -157.66 114.63 2.96 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.858 -0.793 . . . . 63.24 108.858 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -134.06 126.18 29.59 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.038 -1.097 . . . . 75.42 108.038 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.566 HD13 HG21 ' D' ' 105' ' ' ILE . 10.4 mt -78.23 127.76 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.165 -0.68 . . . . 63.31 109.165 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -87.37 -41.61 13.48 Favored 'General case' 0 C--O 1.24 0.583 0 O-C-N 123.704 0.627 . . . . 42.5 110.001 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 -175.17 142.83 0.65 Allowed 'General case' 0 N--CA 1.484 1.273 0 O-C-N 123.173 0.296 . . . . 61.1 111.676 -172.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.502 HD11 HG21 ' D' ' 13' ' ' ILE . 3.4 mp -117.14 136.45 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.303 -1.369 . . . . 72.04 107.303 168.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.457 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 24.5 p90 -163.87 147.39 9.94 Favored 'General case' 0 C--O 1.242 0.659 0 O-C-N 123.871 0.732 . . . . 74.5 110.236 176.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 78.4 p -77.97 106.75 10.04 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.351 -0.84 . . . . 71.25 108.887 173.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.457 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 37.6 mtpt -73.19 -30.57 63.62 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.466 0.65 . . . . 74.44 109.994 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.424 ' HB3' ' HB3' ' D' ' 79' ' ' GLN . 10.6 t70 -152.42 141.46 21.26 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.012 -1.449 . . . . 75.12 108.934 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.552 HG21 ' HE2' ' C' ' 117' ' ' MET . 79.7 mt -141.71 147.76 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.598 -1.26 . . . . 75.35 107.598 175.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 41.5 t -149.46 128.49 12.69 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 123.799 0.839 . . . . 71.13 109.149 170.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.538 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.6 t80 -128.34 135.58 49.77 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.129 -1.804 . . . . 64.12 106.129 169.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 44.0 mt-10 -141.78 150.15 41.35 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 124.288 1.035 . . . . 63.45 108.432 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.96 87.22 5.47 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 107.699 -1.223 . . . . 55.2 107.699 173.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.74 -27.93 17.57 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.701 2.267 . . . . 63.14 112.823 -173.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -107.82 7.21 28.1 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.001 0.921 . . . . 72.22 110.53 -176.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.419 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -29.95 -64.64 0.19 Allowed Pre-proline 0 CA--C 1.559 1.312 0 N-CA-C 116.74 2.126 . . . . 72.33 116.74 -165.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.424 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 88.7 Cg_endo -76.14 -26.4 9.2 Favored 'Trans proline' 0 C--N 1.381 2.239 0 CA-C-N 122.897 2.07 . . . . 74.23 113.382 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -70.92 -36.14 72.54 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.839 1.256 . . . . 73.41 109.75 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.7 p -84.86 -12.63 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 CA-C-N 115.708 -0.678 . . . . 75.13 111.741 -176.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.424 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.8 m-85 -72.37 -12.22 61.03 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 112.445 0.535 . . . . 72.13 112.445 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -58.13 -23.48 55.21 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.673 0.749 . . . . 62.45 110.066 169.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.443 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 79.3 mttt -104.37 102.61 12.28 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.664 1.586 . . . . 64.34 108.987 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -111.82 90.72 3.42 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.482 0.313 . . . . 74.14 110.442 -175.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 38.3 p90 -164.36 174.35 11.16 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.65 1.18 . . . . 72.42 108.763 172.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -59.08 110.47 2.69 Favored Pre-proline 0 N--CA 1.486 1.328 0 CA-C-O 119.079 -0.486 . . . . 73.44 109.831 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.523 ' HD3' ' HG2' ' D' ' 124' ' ' PRO . 24.5 Cg_exo -63.17 136.74 57.54 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.368 2.045 . . . . 73.04 110.706 -177.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -62.05 107.77 0.93 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.356 -0.979 . . . . 72.03 108.356 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 6.9 m -103.56 121.29 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-N 115.165 -0.925 . . . . 44.11 110.092 -171.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -101.44 119.45 38.78 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 106.313 -1.736 . . . . 75.34 106.313 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.605 HD23 HG13 ' H' ' 6' ' ' ILE . 4.4 pp -94.66 143.1 26.71 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.193 -0.669 . . . . 63.32 109.193 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.52 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 17.0 t70 -139.38 146.82 40.67 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.411 -0.959 . . . . 72.45 108.411 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -116.33 143.56 45.39 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.126 0.57 . . . . 62.12 110.841 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.6 t70 -139.05 134.37 32.89 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.354 -1.293 . . . . 42.43 107.731 169.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 22.4 p -103.7 148.27 26.25 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.203 0.601 . . . . 54.14 110.407 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.43 160.9 41.88 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.394 1.078 . . . . 75.23 109.115 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 46.4 p -174.62 167.88 3.78 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.013 0.525 . . . . 61.23 111.275 -175.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.9 p -166.51 147.56 6.27 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.394 -0.821 . . . . 63.5 110.375 174.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -89.23 118.27 28.8 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.602 -0.888 . . . . 74.52 108.602 170.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 44.1 mt -98.69 -27.28 14.05 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.176 0.59 . . . . 61.41 110.878 -173.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -158.8 -178.53 7.32 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.021 0.928 . . . . 73.15 110.121 174.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.09 111.31 2.85 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.102 -0.954 . . . . 65.31 109.844 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 65.72 9.06 5.67 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.763 1.225 . . . . 65.15 113.252 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 83.2 t -108.07 114.15 45.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 107.468 -1.308 . . . . 73.11 107.468 172.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.553 ' HB2' HG13 ' H' ' 18' ' ' VAL . 36.0 t80 -134.72 131.3 37.47 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.871 -1.059 . . . . 73.43 109.497 -165.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -93.28 129.22 39.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.157 -0.929 . . . . 72.55 110.12 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 78.3 t -109.36 118.96 57.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.209 -1.034 . . . . 71.03 108.209 172.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.46 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 35.7 t -113.78 133.09 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 108.523 -0.918 . . . . 64.32 108.523 177.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 26.4 tp -129.56 120.33 25.14 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.921 -0.4 . . . . 64.15 109.921 171.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.564 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 19.5 ttm-85 -84.54 111.82 19.85 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.952 0.901 . . . . 74.53 109.849 175.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.569 HG21 ' HB1' ' D' ' 110' ' ' ALA . 40.6 t -91.78 122.32 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 108.262 -1.014 . . . . 71.44 108.262 173.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 46.4 m -112.45 143.59 43.32 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.451 -0.574 . . . . 75.01 109.451 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 88.5 t -132.29 101.94 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.663 1.185 . . . . 54.14 108.34 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 19.8 m -93.58 94.92 8.9 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.154 -1.424 . . . . 50.4 107.154 169.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.08 147.47 24.0 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.063 0.545 . . . . 72.3 110.338 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.475 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 63.8 p -150.15 133.72 16.62 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-O 121.068 0.461 . . . . 43.02 111.621 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.7 mt -106.86 114.48 28.59 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.447 -1.316 . . . . 74.13 107.447 171.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.33 -140.96 31.68 Favored Glycine 0 C--N 1.343 0.939 0 O-C-N 123.373 0.42 . . . . 64.35 112.562 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -83.13 3.45 30.66 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.19 0.596 . . . . 71.13 112.302 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 71' ' ' GLU . . . . . 0.443 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 12.2 pt-20 -131.04 166.0 21.99 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.879 0.472 . . . . 74.44 110.75 -174.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.7 m -72.73 136.93 45.63 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.386 -0.824 . . . . 63.23 110.963 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.551 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.68 -69.55 0.68 Allowed 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.588 -1.264 . . . . 71.42 107.588 174.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 74' ' ' PHE . . . . . 0.511 ' HE2' ' HG2' ' D' ' 38' ' ' PRO . 52.1 p90 -149.58 150.26 31.97 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-N 115.313 -0.858 . . . . 70.32 110.685 177.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 45.4 mt -106.44 107.2 18.09 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.458 -1.312 . . . . 54.32 107.458 170.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.446 ' SG ' HG23 ' D' ' 114' ' ' ILE . 36.8 t -116.54 140.03 49.83 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.905 0.882 . . . . 72.34 108.967 -176.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -157.98 141.64 15.51 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.995 0.518 . . . . 72.02 109.948 -174.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -140.82 116.29 6.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.138 -1.06 . . . . 50.45 108.138 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' D' ' 61' ' ' ARG . 5.9 tt0 -87.41 81.06 7.95 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.37 -1.344 . . . . 70.55 107.37 171.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -80.09 105.18 11.18 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.353 -1.294 . . . . 73.21 108.761 -173.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -104.3 148.32 16.76 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.72 -0.673 . . . . 73.42 111.661 -178.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.408 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -144.93 131.43 4.28 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.057 -0.817 . . . . 44.11 111.057 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 45.1 mt -88.86 133.3 31.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 108.239 -1.022 . . . . 73.55 108.239 174.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.421 ' HB2' HD11 ' D' ' 86' ' ' ILE . 55.5 m-85 -130.87 159.24 37.97 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.943 0.497 . . . . 54.0 109.87 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 3.9 t -115.27 101.09 8.62 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.248 -1.019 . . . . 53.22 108.248 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.421 HD11 ' HB2' ' D' ' 84' ' ' PHE . 4.1 mp -108.92 109.84 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 109.25 -0.648 . . . . 71.44 109.25 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.34 154.34 45.09 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.398 0.679 . . . . 72.51 109.798 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.92 21.35 65.96 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-O 119.811 -0.439 . . . . 64.41 113.941 175.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.581 HD11 ' HG3' ' D' ' 9' ' ' MET . 10.9 mt -131.97 158.35 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 117.384 0.592 . . . . 63.44 110.255 178.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.411 ' N ' HG22 ' D' ' 89' ' ' ILE . 2.9 pp20? -159.44 -175.97 5.51 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.265 1.026 . . . . 70.51 110.056 171.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 91' ' ' GLY . . . . . 0.428 ' H ' ' HA ' ' H' ' 21' ' ' ALA . . . 62.46 -141.07 46.67 Favored Glycine 0 N--CA 1.473 1.132 0 N-CA-C 114.839 0.696 . . . . 73.45 114.839 174.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 41.5 p -78.81 -13.98 59.51 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.083 0.953 . . . . 51.22 112.037 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -47.01 70.79 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.556 0.742 . . . . 61.14 109.685 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.576 ' SD ' ' HB2' ' H' ' 21' ' ' ALA . 13.5 ptp -68.78 -34.62 75.86 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 110.271 -0.27 . . . . 62.43 110.271 176.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.45 -26.93 68.77 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.975 0.51 . . . . 60.53 111.461 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -73.03 -51.81 16.77 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.079 0.552 . . . . 74.13 110.579 171.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.7 t -56.64 -43.78 80.62 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 124.074 0.859 . . . . 32.13 111.411 -174.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.698 HD11 HG23 ' H' ' 18' ' ' VAL . 16.3 mt -78.3 -30.21 48.25 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.734 -1.121 . . . . 72.4 110.737 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.79 14.58 64.98 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 116.002 -0.545 . . . . 72.3 113.19 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.547 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -153.02 -79.27 0.1 Allowed 'General case' 0 C--N 1.353 0.742 0 C-N-CA 122.929 0.492 . . . . 74.12 111.235 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -65.41 -41.15 93.9 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.101 0.778 . . . . 73.12 113.101 -166.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 81.5 m -64.56 -48.96 73.18 Favored Pre-proline 0 CA--C 1.564 1.494 0 CA-C-O 118.726 -0.654 . . . . 63.51 112.595 -175.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.14 -22.73 34.52 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 121.717 1.611 . . . . 64.52 112.754 170.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -66.75 -25.88 66.71 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 122.539 0.336 . . . . 75.33 111.237 175.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.566 HG21 HD13 ' D' ' 13' ' ' ILE . 43.3 mm -67.99 -39.55 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.346 0.658 . . . . 72.45 109.983 170.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.408 HD21 ' HA3' ' D' ' 82' ' ' GLY . 79.4 mt -79.5 -17.68 53.58 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 115.155 -0.929 . . . . 72.43 111.941 -171.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -64.69 -45.07 75.61 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 114.214 1.19 . . . . 71.14 114.214 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -54.11 -43.88 54.37 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.065 1.843 . . . . 64.4 112.902 173.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -73.52 -34.01 65.03 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.239 -0.892 . . . . 63.52 111.911 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 110' ' ' ALA . . . . . 0.569 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -65.02 -49.61 69.49 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.458 -0.571 . . . . 70.15 109.458 177.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.8 ttp180 -54.54 -53.43 54.55 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 124.827 1.33 . . . . 65.41 110.801 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -60.16 -46.29 90.17 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.421 1.075 . . . . 64.11 111.378 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 39.6 t -62.12 -41.66 98.46 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.724 0.64 . . . . 63.15 110.935 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.448 ' O ' HG23 ' D' ' 118' ' ' VAL . 82.3 mt -60.48 -58.05 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.674 0.79 . . . . 60.44 110.508 173.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 40.6 m -54.7 -39.23 67.96 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.148 1.379 . . . . 75.45 111.537 -173.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 24.7 t -68.23 -43.45 77.91 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.953 -1.022 . . . . 74.33 110.506 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.8 mtm -68.6 -32.98 73.26 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 122.646 0.378 . . . . 74.42 111.715 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.448 HG23 ' O ' ' D' ' 114' ' ' ILE . 90.6 t -63.57 -45.48 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.548 0.739 . . . . 73.4 109.859 176.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.6 p -74.52 -29.91 61.59 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.877 -0.602 . . . . 64.33 111.281 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -72.24 -27.85 62.77 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.2 0.6 . . . . 74.03 110.138 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.26 8.29 74.74 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 123.621 0.575 . . . . 62.54 112.587 172.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.466 HG23 ' HB3' ' C' ' 17' ' ' TYR . 80.7 p 55.3 22.64 4.96 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 126.669 1.988 . . . . 73.14 114.105 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -82.96 151.18 63.33 Favored Pre-proline 0 CA--C 1.552 1.04 0 N-CA-C 108.717 -0.846 . . . . 73.24 108.717 168.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.523 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 17.7 Cg_endo -57.74 138.99 88.8 Favored 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.737 2.292 . . . . 75.31 112.872 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -53.03 134.33 38.14 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.58 1.152 . . . . 74.01 112.375 -175.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.83 104.76 9.8 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.526 -1.287 . . . . 74.25 107.526 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -99.58 109.4 21.91 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.605 0.762 . . . . 74.15 109.211 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.714 ' HA ' HG23 ' H' ' 6' ' ' ILE . 6.5 mp -70.38 119.06 14.0 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.135 0.574 . . . . 65.55 109.548 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.98 137.19 95.43 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.05 0.54 . . . . 74.24 110.774 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.72 130.77 6.92 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.269 1.979 . . . . 72.03 112.108 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 17.6 m -117.43 136.35 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 122.879 0.472 . . . . 54.22 110.902 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -86.92 77.32 9.25 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 107.023 -1.473 . . . . 63.11 107.023 163.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -68.34 -26.18 65.47 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 115.026 -0.988 . . . . 44.31 109.925 -176.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.547 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 14.4 t70 -55.98 -43.08 77.24 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 124.154 0.909 . . . . 71.31 111.548 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.59 -45.78 64.68 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.809 0.444 . . . . 71.54 111.696 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.4 tt -58.87 -35.46 73.01 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.511 0.724 . . . . 65.51 110.112 176.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -80.74 -29.57 36.27 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.982 0.913 . . . . 75.41 110.92 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.411 ' O ' ' HG3' ' D' ' 142' ' ' GLN . 59.4 mtm -60.54 -42.19 96.01 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 119.109 -0.472 . . . . 51.33 110.295 174.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -47.91 -49.05 31.22 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 124.414 1.071 . . . . 75.05 111.442 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -56.14 -45.67 79.52 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.008 0.923 . . . . 53.1 111.863 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mp -68.61 -29.98 68.62 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.215 0.606 . . . . 71.14 111.988 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' D' ' 138' ' ' MET . 77.7 mt-30 -83.8 2.06 39.95 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.526 0.73 . . . . 75.51 111.28 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -121.35 48.48 1.66 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.509 1.123 . . . . 52.03 108.132 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -142.53 -174.16 4.06 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.448 1.099 . . . . 70.44 109.78 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.62 165.54 12.47 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.318 0.647 . . . . 73.21 109.533 167.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 146' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' D' ' 1' ' ' MET . . . 135.56 176.65 14.47 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 111.9 -0.48 . . . . 70.54 111.9 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -160.62 -173.02 3.75 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.225 0.61 . . . . 72.54 110.731 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 148' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' D' ' 4' ' ' GLN . . . -176.0 79.1 0.07 OUTLIER Glycine 0 C--N 1.338 0.641 0 N-CA-C 110.352 -1.099 . . . . 51.54 110.352 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 5.9 t -65.38 91.41 0.11 Allowed 'General case' 0 CA--C 1.551 1.013 0 CA-C-O 121.976 0.893 . . . . 64.24 110.357 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.44 100.32 2.67 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-N 114.549 -1.205 . . . . 73.24 108.215 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 151' ' ' GLU . . . . . 0.524 ' HB3' HE22 ' D' ' 153' ' ' GLN . 42.7 mt-10 -115.03 163.24 15.88 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.121 -0.945 . . . . 74.11 109.446 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 36.7 p-80 -166.05 79.36 0.27 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.751 0.821 . . . . 74.23 109.537 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 153' ' ' GLN . . . . . 0.524 HE22 ' HB3' ' D' ' 151' ' ' GLU . 24.8 mp0 -70.3 162.31 28.75 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 115.631 -0.713 . . . . 74.12 109.8 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -135.65 75.78 1.58 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 109.735 -0.468 . . . . 33.1 109.735 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.017 0 C-N-CA 123.62 0.768 . . . . 72.11 109.883 -178.79 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 110.135 -0.32 . . . . 74.44 110.135 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 95.7 mttt 62.81 93.46 0.05 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.545 1.138 . . . . 64.43 112.177 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -119.26 89.67 3.18 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.416 -1.328 . . . . 75.24 107.416 168.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 50.9 m -145.38 106.1 4.12 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.195 0.998 . . . . 72.32 109.439 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 21.4 m -90.09 160.83 16.1 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.705 0.802 . . . . 61.41 109.783 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.35 160.24 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-O 121.14 0.495 . . . . 75.11 111.129 170.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 7' ' ' ALA . . . . . 0.54 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . . . -152.65 -62.26 0.16 Allowed 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.674 -0.694 . . . . 73.42 110.023 -171.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.842 HD11 HD21 ' A' ' 44' ' ' LEU . 3.3 tt 170.69 148.07 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.067 1.747 . . . . 55.25 106.349 -176.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 9' ' ' ALA . . . . . 0.428 ' N ' HD23 ' E' ' 8' ' ' LEU . . . -77.73 -83.59 0.08 Allowed 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 109.862 -0.421 . . . . 54.1 109.862 175.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 6.9 mt -172.45 -176.57 1.58 Allowed 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 125.058 1.343 . . . . 65.31 109.727 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 81.9 mt -112.91 133.07 22.05 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 124.178 0.991 . . . . 72.2 109.433 172.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.2 -5.67 17.31 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.582 2.188 . . . . 75.33 113.297 176.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -146.82 171.43 15.19 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.699 0.8 . . . . 55.2 109.792 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 14' ' ' LEU . . . . . 0.586 HD12 ' HB ' ' E' ' 23' ' ' THR . 75.1 mt -75.68 -84.15 0.06 Allowed 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 109.65 -0.5 . . . . 72.03 109.65 173.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 35.3 t80 177.63 161.18 0.51 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.713 1.205 . . . . 75.01 108.147 -176.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 17.7 p -73.47 128.41 87.29 Favored Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 123.061 0.545 . . . . 62.32 111.23 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 17' ' ' PRO . . . . . 0.42 ' HB3' ' HB3' ' E' ' 21' ' ' ALA . 59.4 Cg_endo -66.96 155.28 71.51 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.602 2.868 . . . . 70.03 113.927 -173.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 18' ' ' VAL . . . . . 0.688 HG23 HD11 ' A' ' 98' ' ' LEU . 43.9 t -77.16 -71.98 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.945 0 N-CA-C 109.058 -0.719 . . . . 44.42 109.058 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 33.8 m -76.45 -74.94 0.21 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.618 0.767 . . . . 73.11 111.193 -169.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -164.84 25.59 0.06 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.515 0.931 . . . . 73.54 113.515 -171.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 21' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' E' ' 17' ' ' PRO . . . -71.77 172.34 9.98 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 117.998 0.363 . . . . 54.13 110.426 168.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 22' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' C' ' 153' ' ' GLN . 0.1 OUTLIER -119.15 -17.22 8.99 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 108.881 -0.785 . . . . 72.42 108.881 173.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 23' ' ' THR . . . . . 0.586 ' HB ' HD12 ' E' ' 14' ' ' LEU . 60.1 p 60.89 121.96 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.622 0 C-N-CA 126.744 2.018 . . . . 71.35 112.69 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 24' ' ' PRO . . . . . 0.498 ' HB3' ' HA ' ' C' ' 150' ' ' GLU . 73.7 Cg_endo -77.81 93.73 1.08 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.381 2.054 . . . . 64.12 111.94 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 CA--C 1.562 1.415 0 C-N-CA 125.015 1.326 . . . . 70.31 110.437 -178.97 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' F' F ' 1' ' ' MET . . . . . 0.426 ' SD ' ' N ' ' F' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 108.882 -0.784 . . . . 71.44 108.882 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 2' ' ' LYS . . . . . 0.416 ' N ' ' HE3' ' F' ' 2' ' ' LYS . 0.0 OUTLIER 63.03 103.33 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.958 1.303 . . . . 64.11 110.903 -173.029 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -60.88 -27.8 68.41 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.44 0.696 . . . . 74.21 111.225 174.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 42.4 m -118.27 50.87 1.12 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.895 0.878 . . . . 74.12 109.612 174.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 5' ' ' THR . . . . . 0.621 HG23 ' HA ' ' B' ' 39' ' ' GLU . 24.4 m -48.25 -48.04 35.58 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.531 0.732 . . . . 54.42 110.532 171.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.594 HD11 HD23 ' B' ' 128' ' ' LEU . 11.8 tt -120.83 125.56 74.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 114.655 -1.157 . . . . 74.35 108.925 174.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -160.46 166.22 29.6 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.026 0.93 . . . . 53.24 109.247 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 8' ' ' LEU . . . . . 0.62 ' HA ' HD13 ' B' ' 42' ' ' LEU . 91.9 mt -121.58 146.39 47.01 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.214 0.606 . . . . 70.31 110.006 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -118.29 178.19 4.53 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.13 0.972 . . . . 51.1 109.509 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 8.0 mp -71.35 151.54 44.04 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 108.877 -0.786 . . . . 72.24 108.877 172.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 7.5 mp -69.22 117.16 49.46 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 122.923 0.489 . . . . 75.34 109.967 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.62 -37.21 95.5 Favored 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 123.486 2.791 . . . . 60.02 112.546 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 61.0 tp -112.78 121.87 45.98 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.153 -1.054 . . . . 73.53 108.153 166.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 14' ' ' LEU . . . . . 0.464 HD13 ' N ' ' F' ' 15' ' ' PHE . 2.2 tm? -69.72 142.24 53.34 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 108.051 -1.092 . . . . 64.32 108.051 172.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 15' ' ' PHE . . . . . 0.464 ' N ' HD13 ' F' ' 14' ' ' LEU . 45.9 t80 -58.26 152.0 18.25 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.788 0.835 . . . . 74.25 112.089 -174.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 40.8 p -62.18 128.83 91.56 Favored Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 124.16 0.984 . . . . 73.11 111.909 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.71 164.34 11.73 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 123.052 2.502 . . . . 22.43 113.205 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 18' ' ' VAL . . . . . 0.568 HG12 ' H ' ' F' ' 20' ' ' LYS . 16.2 t -76.51 149.83 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 122.683 0.393 . . . . 65.3 110.298 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 20.1 m -57.81 -34.89 70.13 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.952 0.901 . . . . 73.55 111.58 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 20' ' ' LYS . . . . . 0.604 ' HA ' ' HE3' ' F' ' 20' ' ' LYS . 0.5 OUTLIER -144.32 -79.15 0.2 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 122.913 0.485 . . . . 74.14 111.096 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 21' ' ' ALA . . . . . 0.458 ' HB2' HG11 ' F' ' 18' ' ' VAL . . . 55.38 57.0 5.76 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.386 1.075 . . . . 72.45 111.46 -173.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -161.44 -88.72 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.329 -0.85 . . . . 75.04 109.938 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 22.0 p -145.67 87.28 6.95 Favored Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 123.871 0.869 . . . . 65.23 108.734 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -78.76 112.8 3.18 Favored 'Trans proline' 0 CA--C 1.555 1.545 0 C-N-CA 122.96 2.44 . . . . 72.34 111.735 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.489 1.489 0 C-N-CA 124.964 1.306 . . . . 64.24 110.771 -173.731 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.473 0.719 0 N-CA-C 109.131 -0.692 . . . . 75.0 109.131 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -77.7 106.9 9.82 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.411 -0.959 . . . . 74.14 108.411 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -146.8 138.39 24.38 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.969 -1.014 . . . . 74.23 108.683 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 45.4 t 178.78 150.4 0.27 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.562 1.145 . . . . 73.31 109.047 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 5' ' ' THR . . . . . 0.49 HG22 HD12 ' G' ' 6' ' ' ILE . 5.2 m -79.58 -86.6 0.07 Allowed 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 108.664 -0.865 . . . . 61.34 108.664 173.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 6' ' ' ILE . . . . . 0.49 HD12 HG22 ' G' ' 5' ' ' THR . 3.8 mp -124.38 132.09 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 106.586 -1.635 . . . . 73.4 106.586 166.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -122.43 157.5 31.77 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.133 0.573 . . . . 62.44 112.296 -172.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 8' ' ' LEU . . . . . 0.79 ' H ' HG21 ' C' ' 131' ' ' VAL . 30.8 mt -88.21 150.01 23.54 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.942 1.297 . . . . 63.31 109.919 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.29 157.07 25.24 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.243 0.617 . . . . 55.4 109.998 173.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 17.3 mt -62.4 172.32 1.58 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.383 0.611 . . . . 70.12 111.841 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 mt -118.33 85.81 26.21 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 115.517 -0.765 . . . . 61.23 109.432 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 12' ' ' PRO . . . . . 0.419 ' HD2' HD12 ' G' ' 13' ' ' LEU . 2.8 Cg_exo -76.98 -13.82 17.25 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.83 2.353 . . . . 64.33 112.267 174.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 13' ' ' LEU . . . . . 0.419 HD12 ' HD2' ' G' ' 12' ' ' PRO . 5.4 mp -71.38 -47.24 57.48 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.248 0.619 . . . . 74.52 110.522 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 59.55 172.61 0.08 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.73 1.212 . . . . 73.34 111.818 -169.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 15' ' ' PHE . . . . . 0.497 ' HB2' HD13 ' C' ' 98' ' ' LEU . 28.5 m-85 -91.02 164.32 14.0 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 109.129 -0.693 . . . . 72.22 109.129 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 73.3 p -63.84 151.88 88.13 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 123.462 0.705 . . . . 64.54 111.014 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 17' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.14 128.88 30.41 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.643 2.229 . . . . 64.2 112.788 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 18' ' ' VAL . . . . . 0.576 ' HB ' ' SD ' ' C' ' 94' ' ' MET . 61.8 t -69.52 -34.43 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.061 0.545 . . . . 63.44 109.919 174.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 19' ' ' THR . . . . . 0.471 HG22 ' HG3' ' G' ' 20' ' ' LYS . 20.5 m -133.16 -77.8 0.49 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.544 -0.753 . . . . 73.25 109.732 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 20' ' ' LYS . . . . . 0.471 ' HG3' HG22 ' G' ' 19' ' ' THR . 42.7 mtpt -137.62 20.46 2.9 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.891 0.476 . . . . 71.11 110.302 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 21' ' ' ALA . . . . . 0.564 ' HB2' ' SD ' ' C' ' 94' ' ' MET . . . -62.75 87.95 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.674 0.79 . . . . 62.31 111.45 -175.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -159.78 -58.94 0.06 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.336 -1.302 . . . . 75.04 107.661 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 23' ' ' THR . . . . . 0.566 HG22 ' HG2' ' A' ' 151' ' ' GLU . 66.2 p 49.9 93.97 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 125.494 1.518 . . . . 70.05 112.454 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 24' ' ' PRO . . . . . 0.413 ' HG2' ' HE1' ' A' ' 152' ' ' HIS . 19.5 Cg_endo -59.29 -32.8 97.43 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.533 2.155 . . . . 61.4 111.764 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 CA--C 1.552 1.032 0 C-N-CA 123.769 0.827 . . . . 75.43 109.009 173.769 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 109.452 -0.573 . . . . 72.42 109.452 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' H' H ' 2' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' H' ' 9' ' ' ALA . 13.2 tmtt? -162.78 85.81 0.55 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.092 -1.077 . . . . 75.51 108.092 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -104.41 17.29 24.4 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.915 0.886 . . . . 71.11 109.511 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 6.2 m -63.88 111.55 2.52 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.727 0.811 . . . . 65.31 109.921 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 9.6 m -50.88 -53.67 30.52 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.274 1.43 . . . . 74.31 112.648 -170.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.714 HG23 ' HA ' ' D' ' 128' ' ' LEU . 4.4 tt -145.98 101.14 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.202 0.601 . . . . 63.25 109.584 172.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -177.39 93.43 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.805 1.242 . . . . 62.32 109.295 174.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 82.4 mt 57.81 -165.15 0.17 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.281 1.032 . . . . 71.15 112.535 175.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 9' ' ' ALA . . . . . 0.425 ' HA ' ' HE3' ' H' ' 2' ' ' LYS . . . -150.21 -62.61 0.2 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.326 -1.361 . . . . 63.22 107.326 161.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.89 124.75 6.04 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 107.987 -1.116 . . . . 73.23 107.987 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 67.8 mt -68.05 156.94 88.57 Favored Pre-proline 0 N--CA 1.487 1.392 0 C-N-CA 123.675 0.79 . . . . 53.23 110.958 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -47.59 -51.98 8.8 Favored 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 123.612 2.875 . . . . 73.42 112.608 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 19.7 tp -170.63 -84.46 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.696 0.798 . . . . 74.33 108.881 166.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 92.1 mt -109.9 -161.95 0.78 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.96 0.904 . . . . 72.04 110.232 -173.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -141.27 158.95 43.21 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.204 -1.035 . . . . 73.33 108.204 172.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 16' ' ' THR . . . . . 0.421 ' O ' HD13 ' D' ' 98' ' ' LEU . 24.6 p -56.88 131.4 79.21 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 124.435 1.094 . . . . 75.54 112.095 -175.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.87 152.22 77.46 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.125 2.55 . . . . 60.15 113.616 -173.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 18' ' ' VAL . . . . . 0.698 HG23 HD11 ' D' ' 98' ' ' LEU . 88.9 t -63.28 -56.52 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.035 0.934 . . . . 64.05 110.448 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 19' ' ' THR . . . . . 0.534 HG23 HG12 ' H' ' 18' ' ' VAL . 12.4 p -144.0 -149.79 0.29 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 113.954 -1.475 . . . . 70.31 108.658 -172.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -62.69 99.12 0.14 Allowed 'General case' 0 C--N 1.36 1.056 0 CA-C-O 121.102 0.477 . . . . 74.2 111.054 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 21' ' ' ALA . . . . . 0.576 ' HB2' ' SD ' ' D' ' 94' ' ' MET . . . -110.4 128.38 55.55 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.86 0.864 . . . . 51.34 109.243 175.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -69.8 88.94 0.55 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.868 0.842 . . . . 72.23 110.432 174.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 9.6 t -153.56 142.58 14.63 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-N 113.98 -1.464 . . . . 71.13 108.384 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.9 89.84 0.43 Allowed 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.524 2.149 . . . . 74.53 112.344 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 CA--C 1.551 1.008 0 C-N-CA 123.742 0.817 . . . . 75.02 110.525 177.609 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.486 1.345 0 N-CA-C 109.606 -0.516 . . . . 53.44 109.606 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 p -60.44 96.29 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.153 0.981 . . . . 71.15 111.6 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -90.14 -52.74 4.8 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.804 0.842 . . . . 63.33 109.066 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -134.18 35.59 3.26 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 122.275 1.036 . . . . 71.05 109.071 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.15 80.43 9.06 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.572 0.701 . . . . 63.34 109.427 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -76.27 -49.28 17.45 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.777 -1.101 . . . . 54.5 110.418 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.9 p -70.11 -14.7 62.78 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.429 -0.805 . . . . 74.23 112.069 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -63.91 -37.09 86.12 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.465 0.706 . . . . 62.11 109.898 172.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.437 ' SD ' ' N ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -73.46 148.23 43.41 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.645 -0.872 . . . . 74.41 108.645 174.108 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.437 ' N ' ' SD ' ' A' ' 9' ' ' MET . 87.9 m -138.13 124.47 20.56 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.481 0.713 . . . . 61.41 109.308 -173.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.697 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.5 t80 -136.79 136.36 38.79 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 124.046 0.842 . . . . 75.42 109.289 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -155.65 97.41 1.85 Allowed 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.29 -1.004 . . . . 64.21 108.29 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.451 HG12 ' HD2' ' A' ' 84' ' ' PHE . 29.5 mt -68.21 120.47 15.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 108.729 -0.841 . . . . 74.34 108.729 176.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -81.8 -40.19 22.94 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 123.832 0.707 . . . . 73.23 109.994 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -175.66 122.67 0.2 Allowed 'General case' 0 C--N 1.359 0.994 0 O-C-N 123.426 0.454 . . . . 74.05 111.352 -171.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.434 HD12 ' HG3' ' C' ' 130' ' ' PRO . 88.8 mt -106.96 136.16 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.603 -0.888 . . . . 63.11 108.603 169.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.4 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 24.0 p90 -164.13 166.19 21.49 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.189 0.996 . . . . 62.24 110.597 -174.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.5 p -96.61 119.12 34.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.534 -0.757 . . . . 73.24 109.012 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 36.1 mtpt -87.09 -30.14 21.35 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.166 -0.679 . . . . 72.25 109.166 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 16.7 t70 -144.83 137.13 26.13 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.189 -0.914 . . . . 75.35 109.276 177.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.9 mt -133.69 142.97 40.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 106.384 -1.71 . . . . 75.23 106.384 174.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.6 t -150.26 135.36 17.83 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.624 -0.51 . . . . 63.22 109.624 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.57 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 87.9 t80 -136.79 137.67 40.05 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.421 -1.696 . . . . 75.13 106.421 172.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -137.75 141.45 40.97 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 108.521 -0.918 . . . . 74.53 108.521 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.68 75.27 31.77 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 106.549 -1.649 . . . . 74.44 106.549 171.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.36 -42.84 31.74 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.284 2.656 . . . . 52.55 112.76 -171.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -101.64 22.76 12.25 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 118.35 -0.834 . . . . 63.51 109.913 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.443 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -42.61 -58.31 3.87 Favored Pre-proline 0 N--CA 1.497 1.906 0 N-CA-C 113.867 1.062 . . . . 74.52 113.867 -170.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 14.4 Cg_exo -65.66 -24.76 54.92 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 121.7 1.6 . . . . 60.31 112.778 -174.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -81.26 -43.33 19.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.114 -0.948 . . . . 72.43 109.91 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.796 HG21 ' HA ' ' A' ' 73' ' ' ALA . 5.2 p -76.32 -14.01 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 115.039 -0.982 . . . . 70.15 112.505 -162.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -69.62 -12.14 61.4 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.871 0.468 . . . . 65.51 111.68 173.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -83.34 -25.59 31.31 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.389 1.076 . . . . 71.51 110.823 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.412 ' NZ ' ' HB3' ' A' ' 71' ' ' GLU . 23.3 mmtp -68.14 149.61 49.37 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.658 0.783 . . . . 73.21 111.808 -177.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -71.13 131.96 44.35 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.301 -1.0 . . . . 70.33 108.301 171.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -77.77 82.01 4.18 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.798 0.809 . . . . 73.22 110.608 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -128.8 81.23 71.21 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 106.938 -1.504 . . . . 73.44 106.938 168.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -82.98 145.59 12.53 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.65 2.233 . . . . 61.22 112.318 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -97.83 89.83 4.73 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 105.823 -1.917 . . . . 63.45 105.823 168.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.526 HG13 HG13 ' A' ' 64' ' ' VAL . 96.6 t -72.16 92.42 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.425 -0.954 . . . . 75.41 108.425 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -87.58 115.47 25.03 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.591 -1.186 . . . . 72.52 108.285 174.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.7 pp -95.41 130.59 42.16 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.788 -1.19 . . . . 65.03 107.788 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.605 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.1 m-20 -120.21 105.71 11.23 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 107.796 -1.187 . . . . 74.23 107.796 176.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.7 mp -98.22 146.7 25.36 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.789 -0.819 . . . . 71.23 108.789 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.592 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 24.9 t70 -145.81 148.27 32.74 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 109.491 -0.559 . . . . 74.24 109.491 177.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 49.1 p -106.44 125.99 51.69 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.556 -0.747 . . . . 63.11 110.247 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -132.91 133.37 43.16 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.035 0.934 . . . . 62.43 108.733 176.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.9 m -133.66 159.26 41.05 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.235 0.614 . . . . 63.34 110.96 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.3 t -158.22 147.77 19.65 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.856 0.863 . . . . 72.12 109.184 174.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -106.81 119.09 38.4 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.118 -1.067 . . . . 63.02 108.118 172.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 50.3 mt -93.09 -37.72 11.99 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.163 0.585 . . . . 72.32 111.087 -173.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.79 -171.98 3.31 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.718 0.807 . . . . 61.44 110.3 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -63.59 119.45 9.87 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.553 0.741 . . . . 75.13 109.633 170.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 70.74 -7.19 1.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.773 1.229 . . . . 64.32 112.598 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.62 110.72 28.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 N-CA-C 107.965 -1.124 . . . . 63.52 107.965 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -134.1 128.48 34.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.363 -0.835 . . . . 74.53 109.28 -170.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -96.12 127.58 42.25 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.853 0.861 . . . . 72.43 110.921 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.442 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 68.0 t -107.44 124.58 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 107.106 -1.442 . . . . 74.41 107.106 168.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.479 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 44.0 t -119.62 124.57 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.367 -0.975 . . . . 70.34 108.367 172.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.415 HD22 HG22 ' A' ' 62' ' ' VAL . 1.8 tt -115.85 115.47 26.31 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.774 -1.195 . . . . 74.14 107.774 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.592 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 49.2 ttt180 -84.11 99.72 10.66 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.897 -1.149 . . . . 71.01 107.897 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.415 HG22 HD22 ' A' ' 60' ' ' LEU . 49.9 t -97.96 101.67 12.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.027 -1.101 . . . . 70.01 108.027 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.605 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 21.9 m -102.6 143.7 31.95 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.891 -0.781 . . . . 74.41 108.891 175.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.555 HG11 HD21 ' A' ' 126' ' ' LEU . 24.7 t -136.87 137.55 46.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 125.445 1.498 . . . . 72.11 107.201 173.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.4 m -132.29 127.15 35.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.719 -0.845 . . . . 71.54 108.719 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.62 104.26 14.28 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 107.949 -1.13 . . . . 72.41 107.949 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 50.5 m -108.0 126.86 53.21 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.572 0.349 . . . . 65.32 110.464 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.2 mt -103.94 83.11 2.06 Favored 'General case' 0 C--O 1.249 1.065 0 C-N-CA 124.052 0.941 . . . . 74.13 108.535 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.13 -84.79 1.13 Allowed Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.282 -0.872 . . . . 75.53 111.715 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.38 -26.2 3.36 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.925 0.89 . . . . 54.33 110.045 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.412 ' HB3' ' NZ ' ' A' ' 34' ' ' LYS . 45.5 tt0 -94.17 112.65 24.47 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.784 0.834 . . . . 75.4 109.643 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 94.0 m -73.25 135.37 44.49 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.018 0.437 . . . . 54.34 110.441 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.796 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -72.61 -61.99 1.61 Allowed 'General case' 0 C--O 1.243 0.75 0 CA-C-N 114.679 -1.146 . . . . 70.43 110.078 176.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -156.23 174.85 14.78 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 114.806 -1.088 . . . . 74.43 112.124 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.3 tp -133.67 135.46 44.12 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.778 1.631 . . . . 62.22 107.647 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 79.2 m -134.96 105.41 6.37 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.042 0.937 . . . . 71.05 109.632 178.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -126.54 115.91 20.26 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.257 1.023 . . . . 62.42 109.141 -174.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.4 t -129.74 114.52 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.277 0.631 . . . . 71.31 109.487 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.564 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 75.6 mt-30 -85.0 88.14 7.43 Favored 'General case' 0 C--O 1.249 1.048 0 N-CA-C 108.334 -0.987 . . . . 62.44 108.334 170.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.402 ' HG3' HD22 ' A' ' 106' ' ' LEU . 59.6 tp60 -77.34 104.96 8.15 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 114.849 -1.069 . . . . 72.41 109.16 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.98 147.35 20.94 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 111.325 -0.71 . . . . 62.14 111.325 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.522 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -152.05 120.77 1.11 Allowed Glycine 0 CA--C 1.499 -0.93 0 N-CA-C 110.78 -0.928 . . . . 73.54 110.78 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.1 mt -83.61 121.49 36.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 108.308 -0.997 . . . . 73.32 108.308 173.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.697 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 33.0 m-85 -129.67 137.49 50.65 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.66 -0.867 . . . . 74.22 108.66 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.1 t -103.69 98.33 8.22 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.995 -0.743 . . . . 61.44 108.995 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.488 HG12 HG21 ' E' ' 18' ' ' VAL . 0.2 OUTLIER -136.11 153.45 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.626 1.17 . . . . 63.42 109.315 179.172 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.31 -32.39 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.552 -0.749 . . . . 51.1 111.127 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.0 64.52 3.91 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.229 -0.441 . . . . 65.13 112.998 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.486 ' HB ' ' HA ' ' A' ' 94' ' ' MET . 4.0 pt -147.58 123.39 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.636 1.174 . . . . 74.45 108.836 -175.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -137.38 167.02 22.45 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.934 0.893 . . . . 72.5 110.299 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.02 -136.78 29.12 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.406 0.441 . . . . 75.02 112.599 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.0 t -80.32 -15.27 57.29 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.008 0.523 . . . . 55.14 110.598 174.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -67.65 -34.78 77.62 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.613 0.765 . . . . 74.32 111.011 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.486 ' HA ' ' HB ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -66.77 -41.29 87.96 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 109.845 -0.428 . . . . 74.24 109.845 176.834 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.86 -29.38 66.6 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.948 0.899 . . . . 62.25 110.934 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -68.53 -39.47 81.16 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.033 0.933 . . . . 71.0 109.888 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.559 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 43.7 t -69.34 -52.92 22.55 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 123.732 0.645 . . . . 51.12 111.429 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.62 HD23 HG12 ' E' ' 18' ' ' VAL . 3.7 pp -77.5 -20.96 53.48 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.893 0.477 . . . . 72.13 111.782 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.619 ' HA3' HD22 ' E' ' 14' ' ' LEU . . . -102.57 -16.11 23.13 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 115.223 0.849 . . . . 63.33 115.223 -170.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.02 -43.83 0.14 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.616 0.708 . . . . 45.12 112.727 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.559 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 67.9 t80 -67.9 -68.97 0.35 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.815 0.846 . . . . 75.1 111.301 -170.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 76.0 m -65.56 -35.85 12.93 Favored Pre-proline 0 CA--C 1.568 1.641 0 C-N-CA 123.573 0.749 . . . . 64.11 112.781 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -47.56 -48.56 15.25 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 122.774 2.316 . . . . 74.21 114.383 162.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.45 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 29.7 t-20 -69.72 -24.35 63.55 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.089 0.555 . . . . 72.25 110.516 -177.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 38.8 mm -63.39 -39.46 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.218 0.532 . . . . 72.23 110.567 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.522 HD21 ' HA3' ' A' ' 82' ' ' GLY . 91.2 mt -78.63 -24.94 44.99 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.617 0.767 . . . . 72.11 112.056 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -60.65 -47.38 96.18 Favored Pre-proline 0 CA--C 1.565 1.557 0 N-CA-C 114.256 1.206 . . . . 75.21 114.256 -171.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 104' ' ' ASN . 37.0 Cg_exo -62.61 -32.48 79.27 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.034 1.823 . . . . 73.24 113.121 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -77.37 -38.29 50.41 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.685 0.794 . . . . 74.22 111.002 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.11 -37.25 75.32 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.146 0.578 . . . . 74.31 110.046 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.426 ' NH1' HD12 ' C' ' 105' ' ' ILE . 24.1 ttm180 -60.63 -50.64 72.71 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.215 1.006 . . . . 74.22 109.732 174.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.1 -42.86 88.71 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.81 0.693 . . . . 61.34 110.646 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 43.5 t -62.65 -32.76 73.86 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.813 0.445 . . . . 64.14 110.666 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.512 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 32.3 mt -67.55 -55.76 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 123.518 0.727 . . . . 74.3 109.932 170.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.539 HG21 ' HE2' ' C' ' 109' ' ' TYR . 87.8 m -55.22 -38.38 68.36 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.016 1.326 . . . . 75.2 111.894 -175.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.504 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 47.5 t -63.29 -50.03 71.71 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.479 -0.782 . . . . 63.12 110.07 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.57 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 50.9 mtm -63.67 -38.25 90.4 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.373 0.669 . . . . 71.33 111.578 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.9 t -64.18 -53.17 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.807 0.843 . . . . 75.14 110.62 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.2 t -67.52 -31.41 71.51 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.613 -0.722 . . . . 73.04 110.839 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 116' ' ' SER . 24.9 ttm-85 -72.13 -32.77 67.24 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.489 1.116 . . . . 74.41 108.46 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.425 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.82 14.25 53.11 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-N 114.561 -1.2 . . . . 60.05 113.47 173.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.548 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.3 t 63.38 12.28 6.15 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 126.471 1.908 . . . . 73.23 114.178 172.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -83.16 148.51 56.48 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 108.562 -0.903 . . . . 63.25 108.562 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.15 163.11 10.42 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.215 2.61 . . . . 73.54 113.205 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -57.04 122.46 12.39 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.32 -0.855 . . . . 71.41 112.367 -171.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.555 HD21 HG11 ' A' ' 64' ' ' VAL . 52.0 tp -121.95 106.77 11.53 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.588 1.155 . . . . 62.31 109.022 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -130.14 121.09 25.63 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.996 0.918 . . . . 73.05 108.945 176.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.659 HD23 HD12 ' E' ' 6' ' ' ILE . 96.5 mt -68.25 143.72 55.16 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.797 0.439 . . . . 73.41 109.895 173.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.501 ' HB3' ' HA ' ' E' ' 7' ' ' ALA . . . -68.41 136.86 91.0 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.123 0.569 . . . . 35.32 110.384 178.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.423 ' HG2' ' CE2' ' C' ' 11' ' ' PHE . 2.7 Cg_endo -79.29 92.12 1.15 Allowed 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.84 2.36 . . . . 74.2 110.609 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.2 t -101.64 113.39 37.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.338 -0.986 . . . . 63.13 108.338 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -69.73 100.05 1.44 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.804 -0.813 . . . . 71.11 108.804 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -50.71 -44.76 58.19 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.968 0.907 . . . . 72.53 111.017 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -66.09 -36.91 84.44 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.171 -1.377 . . . . 45.55 112.644 -176.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.64 -40.25 96.4 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 123.623 0.577 . . . . 73.43 110.408 176.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.7 mp -71.42 -32.24 68.16 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 116.025 -0.534 . . . . 75.12 110.723 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -68.4 -28.12 66.81 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.876 0.47 . . . . 73.13 110.602 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 22.5 mmt -69.7 -33.3 72.33 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.449 0.7 . . . . 74.21 110.491 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 143' ' ' GLN . 0.9 OUTLIER -59.16 -35.57 73.77 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 123.679 0.612 . . . . 55.44 111.052 174.726 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -85.45 -29.69 24.12 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.726 0.811 . . . . 72.41 111.389 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.2 tp -66.04 -48.8 69.87 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.086 0.555 . . . . 72.25 110.408 -174.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -169.72 -15.45 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.785 0.661 . . . . 64.3 112.785 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' A' ' 139' ' ' ASN . 63.8 mm-40 -99.47 70.84 1.72 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.135 0.574 . . . . 71.54 110.388 -170.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -66.09 88.08 0.11 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.214 0.606 . . . . 64.42 110.586 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.64 ' HA ' HG22 ' C' ' 7' ' ' THR . . . 61.42 -163.97 0.25 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.345 1.058 . . . . 74.32 112.209 175.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 97.53 103.75 2.25 Favored Glycine 0 C--N 1.344 1.027 0 N-CA-C 111.267 -0.733 . . . . 75.04 111.267 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -165.36 140.3 5.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.04 0.936 . . . . 61.44 109.15 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -77.92 169.43 54.6 Favored Glycine 0 C--N 1.35 1.347 0 O-C-N 123.636 0.585 . . . . 50.32 111.829 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.617 ' HA ' ' HA2' ' C' ' 88' ' ' GLY . 12.7 p -135.84 148.61 48.74 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.694 0.798 . . . . 74.22 109.33 176.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.69 105.63 3.46 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 107.564 -1.273 . . . . 70.45 107.564 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.64 -27.48 68.41 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.912 0.885 . . . . 74.33 111.71 -174.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 80.0 t60 66.86 115.76 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.095 1.358 . . . . 64.44 112.94 171.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -131.05 1.1 4.24 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.923 0.489 . . . . 73.23 111.283 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -76.29 94.71 3.62 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.286 0.565 . . . . 74.03 110.536 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 N-CA-C 108.494 -0.928 . . . . 73.02 108.494 177.191 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 C--O 1.244 0.804 0 N-CA-C 110.004 -0.369 . . . . 64.02 110.004 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 67.9 m -137.67 122.34 18.63 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.177 0.991 . . . . 64.33 109.023 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -137.9 111.62 8.23 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.85 0.86 . . . . 65.22 109.114 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -148.28 115.29 6.11 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.087 -0.709 . . . . 54.1 109.087 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -85.77 162.49 18.67 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.347 0.659 . . . . 62.34 110.46 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -114.89 88.33 2.85 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.899 -1.148 . . . . 73.03 107.899 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 32.3 m -137.37 103.67 5.15 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.485 0.714 . . . . 75.41 109.191 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.23 -175.24 5.23 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 124.251 1.02 . . . . 74.52 108.788 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 57.6 ttm 66.17 166.21 0.2 Allowed 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 125.003 1.321 . . . . 75.03 111.336 -174.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 96.6 m -150.1 118.34 6.39 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 106.163 -1.791 . . . . 75.45 106.163 171.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.438 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 58.9 t80 -127.17 144.59 51.0 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.342 -0.614 . . . . 72.22 109.342 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -155.52 136.44 13.64 Favored 'General case' 0 C--O 1.243 0.715 0 O-C-N 123.671 0.607 . . . . 72.14 110.064 173.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.563 HD13 HD11 ' B' ' 16' ' ' ILE . 58.4 mt -76.75 125.4 36.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.492 0 N-CA-C 108.456 -0.942 . . . . 71.24 108.456 169.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -92.17 -49.86 5.97 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.833 -0.803 . . . . 72.53 108.833 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.548 ' HE ' HG21 ' A' ' 122' ' ' THR . 42.9 ttt180 -164.5 134.04 3.81 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.685 -0.689 . . . . 52.12 110.217 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.563 HD11 HD13 ' B' ' 13' ' ' ILE . 76.1 mt -115.24 140.42 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 124.042 0.937 . . . . 72.21 108.603 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -169.18 152.1 4.91 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 112.707 0.632 . . . . 75.15 112.707 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 82.5 m -76.76 125.45 29.3 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.968 -1.015 . . . . 72.23 109.008 169.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.412 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 40.3 mtpt -97.87 -31.83 12.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.099 0.56 . . . . 71.42 111.482 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.45 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 10.9 t70 -155.66 136.62 13.65 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.275 -0.421 . . . . 72.22 109.992 -168.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.474 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.7 mm -135.15 142.36 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.69 1.196 . . . . 75.11 108.68 177.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.8 t -149.34 108.17 3.86 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.803 -1.184 . . . . 63.34 107.803 173.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -122.56 118.89 29.29 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 107.644 -1.243 . . . . 64.44 107.644 172.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -118.91 153.03 35.23 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.13 0.972 . . . . 75.42 108.697 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.513 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -142.37 80.32 14.86 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 106.32 -1.733 . . . . 63.05 106.32 173.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.49 -31.0 42.93 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.059 2.506 . . . . 72.23 113.095 -168.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -108.94 14.78 23.91 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.188 0.595 . . . . 71.14 110.828 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.513 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -42.51 -64.34 0.73 Allowed Pre-proline 0 N--CA 1.492 1.661 0 N-CA-C 114.959 1.466 . . . . 62.31 114.959 -166.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.403 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 34.6 Cg_endo -63.3 -30.62 73.69 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.215 1.943 . . . . 73.4 113.702 -168.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -94.24 -28.68 15.48 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.744 0.418 . . . . 72.25 111.401 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.533 HG22 HD12 ' B' ' 68' ' ' LEU . 2.8 p -73.04 -20.12 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 122.594 0.357 . . . . 71.23 110.464 -176.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -65.43 -14.78 61.68 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.903 0.881 . . . . 75.11 113.104 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -68.05 -19.21 64.87 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.818 0.447 . . . . 74.35 110.701 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -90.6 106.34 18.44 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.451 1.101 . . . . 73.23 109.932 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -93.93 83.87 4.44 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.313 0.645 . . . . 64.35 110.626 -174.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -169.03 173.52 6.84 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.231 1.013 . . . . 75.33 109.854 170.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -85.16 121.54 73.99 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 109.14 -0.689 . . . . 75.44 109.14 176.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.12 165.53 31.07 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.772 2.315 . . . . 75.24 113.863 -175.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 10.1 tp10 -69.76 126.33 29.41 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.388 -0.824 . . . . 75.14 109.483 176.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.7 140.54 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.394 0.616 . . . . 65.22 111.16 -171.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.608 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 63.2 mttp -126.91 143.73 51.19 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.432 1.093 . . . . 63.23 109.696 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.718 HD21 HG13 ' F' ' 6' ' ' ILE . 3.4 mm? -114.07 132.5 56.0 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.924 0.89 . . . . 74.33 108.634 175.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -151.2 109.29 3.72 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 108.23 -1.026 . . . . 71.44 108.23 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.522 HD21 HD11 ' F' ' 8' ' ' LEU . 9.9 mp -102.41 157.03 17.2 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.471 -0.566 . . . . 64.3 109.471 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -139.28 153.9 47.86 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 108.445 -0.946 . . . . 75.53 108.445 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 74.3 p -107.66 118.39 36.61 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.362 -0.835 . . . . 74.25 108.929 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.427 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -126.87 136.37 52.24 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.552 -1.277 . . . . 32.22 107.552 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 59.7 p -143.25 163.04 34.05 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-O 120.628 0.251 . . . . 73.44 111.132 -174.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' SER . . . . . 0.481 ' HA ' ' HB3' ' F' ' 22' ' ' ARG . 74.9 p -153.28 137.03 16.09 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.739 0.816 . . . . 74.03 109.499 173.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -94.62 111.47 23.23 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.529 -1.286 . . . . 74.31 107.529 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.5 mt -81.15 -53.55 6.28 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.041 0.448 . . . . 65.2 110.809 -176.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -145.01 -177.09 5.36 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.123 -0.944 . . . . 75.14 109.517 -175.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.43 109.74 1.45 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.349 0.66 . . . . 71.21 110.011 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 69.15 4.88 4.79 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 125.011 1.324 . . . . 55.2 113.347 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 98.4 t -104.77 117.54 50.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.615 -1.254 . . . . 60.04 107.615 172.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -123.16 177.26 5.63 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 121.352 0.596 . . . . 75.41 109.822 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -142.66 102.64 4.09 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.446 -1.316 . . . . 51.1 107.446 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 65.5 t -89.43 121.25 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.626 1.171 . . . . 75.03 109.739 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.501 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.6 t -109.2 109.57 28.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 C-N-CA 123.529 0.732 . . . . 54.23 109.26 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 35.6 tp -93.31 109.42 20.96 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.306 -0.627 . . . . 74.41 109.306 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -86.83 117.99 25.92 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 108.614 -0.884 . . . . 74.22 108.614 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.441 ' HA ' ' HG ' ' B' ' 44' ' ' LEU . 14.3 t -112.19 116.82 53.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 108.392 -0.966 . . . . 72.53 108.392 172.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.8 m -112.36 138.45 49.06 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.827 0.822 . . . . 72.31 109.404 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.725 HG21 HG21 ' B' ' 114' ' ' ILE . 54.4 t -127.19 131.41 70.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 125.644 1.578 . . . . 64.21 108.284 -174.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.608 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 89.2 m -117.95 146.19 44.16 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.31 -0.626 . . . . 62.12 109.31 173.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.94 139.34 23.62 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.602 0.761 . . . . 43.41 110.085 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.594 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 17.7 p -147.49 127.21 13.4 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.486 0.492 . . . . 61.35 111.619 -176.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.533 HD12 HG22 ' B' ' 31' ' ' VAL . 54.7 mt -98.32 107.39 19.84 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 107.812 -1.181 . . . . 75.41 107.812 174.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.98 -131.53 12.54 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 120.024 -0.32 . . . . 72.34 112.572 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -99.01 17.47 19.62 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.592 0.757 . . . . 73.02 111.687 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -138.84 154.24 48.42 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.424 0.689 . . . . 73.52 109.9 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 49.5 m -77.94 123.32 26.65 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.908 0.385 . . . . 72.23 111.061 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.594 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -74.4 -60.77 2.12 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.322 -0.992 . . . . 61.42 108.322 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -155.85 156.92 35.53 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 115.252 -0.885 . . . . 74.52 112.328 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 79.7 mt -125.68 119.87 29.17 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 125.74 1.616 . . . . 65.32 106.973 175.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.511 ' SG ' HG23 ' B' ' 114' ' ' ILE . 49.3 t -118.28 150.39 39.54 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.709 -0.848 . . . . 42.23 108.709 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -159.88 126.43 4.38 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.419 -0.956 . . . . 74.31 108.419 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 86.9 t -122.69 145.94 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.325 -0.852 . . . . 74.14 109.146 176.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.45 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 18.1 mt-30 -120.65 97.1 5.4 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.271 -1.011 . . . . 74.24 108.271 169.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -87.07 101.53 13.55 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.8 -0.815 . . . . 63.55 108.8 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.08 164.08 33.55 Favored Glycine 0 C--O 1.246 0.848 0 O-C-N 123.903 0.752 . . . . 61.22 111.862 177.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.39 126.07 1.44 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.867 -0.493 . . . . 73.42 111.867 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 59.9 mt -84.61 130.02 36.71 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 108.31 -0.996 . . . . 75.44 108.31 172.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -139.22 156.5 47.05 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.147 0.579 . . . . 71.0 109.473 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 69.1 m -121.27 133.07 55.13 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.999 0.92 . . . . 71.25 109.126 175.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.494 HG21 HG21 ' F' ' 18' ' ' VAL . 12.4 tt -130.56 148.96 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.526 0.73 . . . . 74.43 110.576 -177.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.25 175.07 14.48 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.909 0.884 . . . . 73.43 109.621 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.51 -56.29 4.72 Favored Glycine 0 N--CA 1.473 1.128 0 C-N-CA 123.128 0.394 . . . . 72.53 112.586 175.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.539 HG22 ' HB3' ' B' ' 94' ' ' MET . 7.4 mm -90.9 153.02 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.04 0.936 . . . . 75.0 110.93 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -147.21 -178.6 6.31 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.757 1.223 . . . . 70.25 109.104 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.31 -134.42 22.86 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 115.548 -0.751 . . . . 61.3 113.973 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 54.1 m -75.38 -33.64 61.03 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.559 0.744 . . . . 72.5 111.944 -177.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -60.78 -33.04 72.37 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.369 0.668 . . . . 72.03 111.854 -175.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.539 ' HB3' HG22 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -86.12 -24.62 26.16 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.695 0.398 . . . . 72.15 111.816 176.215 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.75 -32.26 73.71 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.033 0.533 . . . . 70.1 110.817 172.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -76.42 -36.08 58.19 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.554 -0.748 . . . . 61.44 110.966 172.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.0 t -60.67 -52.4 65.28 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.016 0.527 . . . . 51.45 111.354 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.52 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 0.5 OUTLIER -80.52 -13.53 59.01 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.251 0.463 . . . . 51.11 112.251 175.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.23 1.44 62.63 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-O 119.608 -0.551 . . . . 63.42 113.784 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.47 -53.38 0.11 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 117.482 0.641 . . . . 73.13 110.957 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -70.73 -50.33 37.32 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.174 0.59 . . . . 73.23 112.559 -172.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 61.2 m -60.79 -47.26 96.29 Favored Pre-proline 0 CA--C 1.563 1.452 0 CA-C-O 118.811 -0.614 . . . . 72.51 111.626 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.49 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 48.4 Cg_exo -60.8 -32.7 93.14 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 122.432 2.088 . . . . 70.34 114.106 171.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -61.01 -38.09 84.86 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.828 0.851 . . . . 61.12 110.202 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.414 HG23 ' NH2' ' D' ' 111' ' ' ARG . 74.8 mt -62.47 -40.79 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 114.976 -1.011 . . . . 72.03 110.606 174.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 56.3 mt -86.4 -13.12 47.27 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.975 -1.011 . . . . 72.3 111.765 -171.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -55.31 -52.29 72.73 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 124.019 0.928 . . . . 75.11 112.915 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -59.76 -37.0 89.75 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.324 2.016 . . . . 72.33 114.088 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -67.83 -44.57 76.89 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.03 0.532 . . . . 73.45 110.635 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.98 -36.42 83.26 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.726 -0.67 . . . . 65.43 110.822 176.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -61.96 -50.5 71.86 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.967 1.307 . . . . 60.15 110.256 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -68.73 -33.61 74.22 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 115.309 -0.86 . . . . 73.14 109.704 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.474 ' SG ' HD11 ' B' ' 21' ' ' ILE . 13.5 t -66.55 -44.47 82.26 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.934 0.494 . . . . 72.31 111.77 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.725 HG21 HG21 ' B' ' 64' ' ' VAL . 95.2 mt -60.05 -53.5 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 108.894 -0.78 . . . . 64.24 108.894 175.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 38.5 m -57.02 -36.05 69.98 Favored 'General case' 0 CA--C 1.553 1.064 0 O-C-N 124.371 1.045 . . . . 51.35 111.602 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.2 t -62.74 -47.21 84.56 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 123.526 0.73 . . . . 53.54 109.749 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 9.7 mmt -70.38 -35.8 73.73 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.006 0.523 . . . . 74.14 111.172 -176.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' B' ' 114' ' ' ILE . 97.0 t -60.24 -43.92 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.763 0.825 . . . . 65.45 109.801 172.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.2 t -65.34 -33.0 74.94 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.646 -1.161 . . . . 71.43 111.355 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' B' ' 116' ' ' SER . 83.0 mtt-85 -71.04 -36.21 72.27 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.536 -0.756 . . . . 70.54 110.187 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.95 -3.65 81.21 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 123.752 0.658 . . . . 72.11 112.316 172.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 23.6 p 62.82 35.01 14.01 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.446 1.899 . . . . 64.24 112.428 173.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -93.69 164.45 20.83 Favored Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 124.103 0.961 . . . . 73.34 110.67 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.04 166.15 1.04 Allowed 'Trans proline' 0 C--N 1.393 2.869 0 C-N-CA 123.663 2.909 . . . . 63.4 115.524 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -63.54 121.4 13.77 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 115.375 -0.83 . . . . 65.31 111.127 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 18.6 tp -129.2 98.43 4.9 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.046 -0.524 . . . . 73.41 109.922 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -124.38 121.26 34.45 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.863 0.865 . . . . 75.43 109.591 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mp -64.88 149.25 49.89 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.949 0.5 . . . . 72.55 111.117 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.9 150.99 73.05 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.452 0.701 . . . . 54.23 110.023 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -67.64 129.45 19.99 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 123.031 2.487 . . . . 34.55 112.395 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 26.0 m -131.95 128.4 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.46 0.704 . . . . 52.11 109.257 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -109.13 102.13 11.12 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 107.252 -1.388 . . . . 73.23 107.252 173.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -60.93 -47.73 85.09 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.17 0.918 . . . . 73.43 110.102 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -60.85 -40.73 93.99 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 114.283 -1.326 . . . . 62.12 112.014 -174.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.98 -40.13 79.89 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 123.906 0.754 . . . . 65.05 111.927 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.705 HD12 HD21 ' F' ' 10' ' ' LEU . 62.9 mt -76.67 -44.25 34.54 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.576 -0.738 . . . . 64.31 111.219 -176.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -70.98 -27.43 63.71 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.055 0.542 . . . . 75.2 111.756 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 10.7 tmm? -68.42 -35.0 76.99 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.509 0.724 . . . . 73.13 109.293 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -75.33 -5.82 46.71 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.763 -1.108 . . . . 71.22 111.856 -172.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -82.31 -26.83 32.7 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 122.791 0.436 . . . . 62.43 110.028 171.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 63.5 mt -104.43 13.69 31.45 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.244 1.018 . . . . 74.1 111.35 -176.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -65.98 129.58 40.27 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.05 0.54 . . . . 65.34 110.384 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -163.2 129.49 3.31 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.148 -0.686 . . . . 73.4 109.148 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -150.35 153.27 35.76 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.392 0.677 . . . . 73.5 110.137 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.18 98.7 1.31 Allowed 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.377 1.071 . . . . 32.14 108.547 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.5 156.95 15.26 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.698 -0.561 . . . . 73.12 111.698 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.91 142.12 37.04 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 108.805 -0.813 . . . . 54.24 108.805 178.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -139.03 103.39 0.39 Allowed Glycine 0 C--N 1.345 1.065 0 N-CA-C 111.488 -0.645 . . . . 64.21 111.488 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 14.7 t -138.57 162.08 35.46 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.657 0.783 . . . . 63.13 110.399 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -150.59 169.3 21.87 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.991 0.916 . . . . 74.32 109.639 171.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -157.84 136.47 11.28 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.553 0.741 . . . . 73.15 110.047 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -164.75 96.3 0.73 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.268 1.027 . . . . 74.14 109.171 174.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -81.23 160.83 24.19 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.386 0.675 . . . . 62.25 110.709 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -147.92 95.91 2.57 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.713 0.805 . . . . 65.1 108.875 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.19 0 C-N-CA 123.812 0.845 . . . . 44.03 109.234 -175.543 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.8 ttp . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.442 -0.577 . . . . 74.14 109.442 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 43.8 p -71.8 96.62 1.66 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.213 0.605 . . . . 74.43 110.256 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 65.17 -148.78 0.25 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.282 1.033 . . . . 75.21 111.88 169.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -77.38 174.81 10.39 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.013 0.925 . . . . 71.4 112.443 -170.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -129.55 -43.11 1.28 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.192 0.997 . . . . 73.32 110.159 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -84.07 57.27 4.1 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 122.115 0.959 . . . . 71.14 109.669 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 145' ' ' ALA . 11.8 p -142.5 83.09 1.8 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.764 1.225 . . . . 71.01 108.966 -172.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 62.59 86.47 0.11 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.579 1.151 . . . . 72.52 112.112 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 12.6 tpt 65.8 151.85 0.06 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.196 1.398 . . . . 75.03 113.367 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 53.4 m -117.46 92.76 3.93 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.884 -0.784 . . . . 73.11 108.884 170.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.599 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 33.8 t80 -113.21 136.31 52.87 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.093 -1.077 . . . . 72.43 108.093 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -155.16 136.55 14.1 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.887 -0.412 . . . . 71.41 109.887 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.492 HG12 ' HE2' ' C' ' 84' ' ' PHE . 56.4 mt -79.2 128.54 38.47 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 N-CA-C 109.036 -0.728 . . . . 43.43 109.036 171.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -101.0 -34.99 9.53 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.598 0.759 . . . . 62.12 110.073 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -176.63 139.29 0.31 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.167 0.587 . . . . 73.14 109.74 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.422 HD11 HD13 ' C' ' 13' ' ' ILE . 95.0 mt -129.89 142.58 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 108.187 -1.042 . . . . 71.32 108.187 175.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.421 ' HE1' HG12 ' C' ' 83' ' ' ILE . 32.9 p90 -172.47 167.02 5.66 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.162 0.985 . . . . 72.4 109.334 -169.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -91.76 114.2 26.68 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 122.893 0.477 . . . . 72.31 109.912 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.693 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 21.8 mmtp -65.44 -42.58 92.26 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 109.362 -0.607 . . . . 64.45 109.362 168.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.7 t70 -145.53 146.8 31.57 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.932 -1.031 . . . . 73.35 110.391 -174.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.541 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.1 mt -141.72 147.48 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.819 1.648 . . . . 74.33 106.813 174.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.0 t -160.46 151.47 18.95 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.225 0.61 . . . . 72.24 110.174 176.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -155.52 112.21 3.2 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 124.384 1.074 . . . . 74.12 108.104 174.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -122.77 132.15 54.1 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.407 0.683 . . . . 71.34 110.477 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.61 86.35 4.67 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 107.634 -1.247 . . . . 74.43 107.634 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.43 -40.81 29.26 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.088 2.525 . . . . 75.44 112.03 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -91.53 18.16 7.72 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 113.902 -1.499 . . . . 64.32 111.625 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.99 -56.32 6.42 Favored Pre-proline 0 N--CA 1.486 1.354 0 N-CA-C 114.029 1.122 . . . . 63.43 114.029 -171.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -60.99 -40.35 53.0 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 121.76 1.64 . . . . 64.24 112.415 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -68.75 -38.03 79.83 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.16 0.984 . . . . 75.33 112.493 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.662 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.6 p -79.04 -13.98 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 C-N-CA 123.329 0.652 . . . . 62.02 111.903 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -75.3 -17.67 60.22 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 112.521 0.563 . . . . 73.43 112.521 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -103.22 36.23 2.31 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.16 0.505 . . . . 70.01 110.208 175.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.435 ' HG2' HD13 ' C' ' 68' ' ' LEU . 1.0 OUTLIER -119.35 149.45 41.8 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.005 0.522 . . . . 72.42 111.358 -174.536 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -59.17 101.97 0.11 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.237 1.015 . . . . 72.21 109.802 176.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.602 ' HD1' ' HB3' ' C' ' 154' ' ' ASP . 75.9 t-105 -79.07 101.76 8.03 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.153 0.502 . . . . 75.34 111.528 -171.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.484 ' HB2' ' HG2' ' C' ' 153' ' ' GLN . 62.4 tt0 -163.04 76.65 1.86 Allowed Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 107.876 -1.157 . . . . 74.32 107.876 167.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -88.0 153.41 7.11 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.776 2.317 . . . . 62.32 113.316 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -87.6 109.04 19.36 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.079 -0.964 . . . . 55.31 108.927 167.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.468 HG23 HG13 ' C' ' 64' ' ' VAL . 2.7 p -72.02 100.35 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-O 121.85 0.833 . . . . 74.03 109.825 173.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -92.28 98.83 11.75 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.835 -1.172 . . . . 71.42 107.835 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 pp -103.19 154.12 19.65 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.661 0.384 . . . . 73.21 110.145 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -143.88 140.44 29.77 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.355 -0.609 . . . . 72.55 109.355 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -118.85 111.96 19.07 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.0 -0.741 . . . . 73.31 109.0 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.49 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 5.8 t70 -112.24 150.85 30.33 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.732 1.213 . . . . 63.23 108.513 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 46' ' ' THR . . . . . 0.608 ' HB ' ' HD2' ' G' ' 15' ' ' PHE . 76.8 p -116.48 138.07 51.67 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.506 0.723 . . . . 63.45 111.259 -170.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.34 150.19 38.81 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.253 1.021 . . . . 74.14 109.105 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 11.7 p -165.49 158.16 15.55 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.425 0.528 . . . . 51.05 112.425 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 67.7 p -160.2 143.93 14.05 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.277 1.031 . . . . 61.45 109.559 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -80.95 131.13 35.31 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.166 -0.679 . . . . 64.45 109.166 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' C' ' 57' ' ' GLU . 29.1 mt -107.57 -32.98 7.46 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.259 0.624 . . . . 72.03 110.846 -176.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.17 -174.53 4.76 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.459 0.704 . . . . 64.22 110.68 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -66.15 130.31 42.8 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.943 -1.026 . . . . 73.54 109.166 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 64.86 -6.89 0.29 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.836 1.255 . . . . 74.32 113.274 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 71.0 t -108.87 119.6 58.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 C-N-CA 123.259 0.623 . . . . 63.22 110.432 -167.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.525 ' HB2' HD11 ' C' ' 86' ' ' ILE . 13.6 m-85 -119.99 143.58 47.97 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.72 -1.127 . . . . 74.52 108.864 171.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.629 ' HB2' HD11 ' C' ' 51' ' ' LEU . 24.2 tt0 -83.56 110.24 18.07 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.396 -1.729 . . . . 75.41 107.862 167.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 78.6 t -96.9 112.17 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.033 -1.469 . . . . 63.22 107.033 172.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.466 HG23 ' HG2' ' C' ' 57' ' ' GLU . 90.3 t -113.04 134.05 56.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 107.983 -1.117 . . . . 74.21 107.983 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.444 HD22 ' HB2' ' C' ' 103' ' ' PRO . 26.8 tp -127.61 119.96 27.08 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.037 -0.727 . . . . 72.25 109.037 175.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.49 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.7 ttm180 -81.21 123.68 28.66 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 124.211 0.945 . . . . 72.22 109.45 173.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.1 114.94 48.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.699 -1.222 . . . . 63.1 107.699 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 36.0 m -114.63 142.82 45.96 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.426 -0.953 . . . . 74.12 108.426 -175.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.468 HG13 HG23 ' C' ' 40' ' ' VAL . 53.5 t -136.25 110.0 9.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.717 1.207 . . . . 62.11 107.894 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.502 HG23 HD23 ' C' ' 75' ' ' LEU . 3.7 m -107.0 107.2 18.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.059 -1.46 . . . . 73.3 107.059 172.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.88 122.34 40.88 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.989 -1.485 . . . . 50.01 106.989 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 44.5 m -132.87 127.35 34.24 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.889 0.376 . . . . 32.44 111.115 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.435 HD13 ' HG2' ' C' ' 34' ' ' LYS . 10.2 mt -86.02 43.76 1.07 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.385 1.474 . . . . 71.22 109.787 174.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.49 -113.51 4.61 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 109.748 -1.341 . . . . 74.41 109.748 -171.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -90.01 -28.83 18.82 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.192 0.597 . . . . 72.45 110.2 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -72.38 102.29 3.12 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.714 -0.847 . . . . 73.31 108.714 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 30.1 m -68.99 123.85 22.13 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.294 -0.632 . . . . 71.11 109.294 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.662 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -66.08 -64.46 0.85 Allowed 'General case' 0 C--O 1.239 0.51 0 O-C-N 123.99 0.806 . . . . 74.52 108.908 177.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -154.61 171.85 18.8 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.47 -0.786 . . . . 73.32 110.632 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.502 HD23 HG23 ' C' ' 65' ' ' THR . 2.6 tm? -127.53 144.36 51.07 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.372 -1.714 . . . . 71.53 106.372 172.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.461 ' SG ' HG23 ' C' ' 114' ' ' ILE . 38.3 t -152.73 145.4 24.26 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.309 -0.997 . . . . 74.41 108.309 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -159.24 126.28 4.7 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.383 0.273 . . . . 74.3 110.531 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.501 HG11 ' HA ' ' C' ' 110' ' ' ALA . 54.9 t -133.93 113.26 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.296 1.039 . . . . 71.01 109.154 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.507 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 27.8 mt-30 -90.55 95.92 10.4 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.611 -0.885 . . . . 62.43 108.611 172.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.582 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.0 tp-100 -79.61 108.39 13.12 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.32 -0.854 . . . . 71.23 109.58 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.09 145.39 21.43 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.711 -0.677 . . . . 71.33 111.681 175.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.87 114.81 0.71 Allowed Glycine 0 CA--C 1.507 -0.467 0 N-CA-C 110.279 -1.128 . . . . 71.15 110.279 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.433 HD12 ' CD1' ' C' ' 51' ' ' LEU . 19.0 mm -82.66 123.32 38.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 N-CA-C 108.259 -1.015 . . . . 72.45 108.259 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.492 ' HE2' HG12 ' C' ' 13' ' ' ILE . 58.4 m-85 -132.64 138.8 47.48 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.164 0.586 . . . . 71.05 109.842 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 41.2 p -94.05 100.98 13.0 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.128 -1.064 . . . . 71.32 108.128 167.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.572 HD13 ' H ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -116.83 128.79 74.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 C-N-CA 123.752 0.821 . . . . 64.02 109.766 -178.133 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.73 165.98 29.53 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.418 -0.81 . . . . 74.24 110.641 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 88' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 149' ' ' THR . . . 113.08 -59.97 0.36 Allowed Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.85 -0.614 . . . . 71.31 112.838 173.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 23.7 pt -90.91 172.71 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.634 0.774 . . . . 75.43 111.813 -170.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -157.4 151.23 24.32 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.204 0.602 . . . . 75.23 111.012 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.29 -132.34 11.06 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.915 -0.584 . . . . 53.51 112.529 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 42.6 p -65.76 -27.05 68.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.744 0.818 . . . . 72.51 111.495 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -58.91 -52.37 66.04 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.972 0.909 . . . . 74.23 109.629 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.477 ' SD ' ' HB2' ' G' ' 21' ' ' ALA . 50.8 ttm -67.88 -39.63 83.67 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 114.655 -1.157 . . . . 64.44 110.109 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.86 88.88 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.109 0.963 . . . . 71.04 111.856 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -70.16 -43.46 70.8 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.977 -0.556 . . . . 63.34 110.793 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.59 -41.87 95.59 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.233 0.613 . . . . 73.31 111.013 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.584 HD13 ' HD2' ' G' ' 17' ' ' PRO . 64.4 mt -84.15 -37.48 21.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.641 0.777 . . . . 74.51 111.457 -177.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.35 10.11 75.39 Favored Glycine 0 N--CA 1.476 1.335 0 N-CA-C 114.212 0.445 . . . . 41.22 114.212 -172.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' C' ' 104' ' ' ASN . . . -153.62 -59.6 0.13 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.083 0.553 . . . . 62.14 110.513 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -72.77 -42.3 64.13 Favored 'General case' 0 CA--C 1.556 1.188 0 N-CA-C 113.013 0.746 . . . . 71.32 113.013 -166.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.599 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 60.3 m -67.25 -49.91 41.96 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 123.112 0.565 . . . . 60.13 111.944 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.444 ' HB2' HD22 ' C' ' 60' ' ' LEU . 70.1 Cg_endo -71.73 -23.71 22.38 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 121.722 1.615 . . . . 72.51 112.799 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 104' ' ' ASN . . . . . 0.497 ' HA ' ' HD2' ' C' ' 107' ' ' PHE . 46.6 t-20 -56.22 -39.98 73.36 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 123.952 0.901 . . . . 74.1 110.153 176.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.426 HD12 ' NH1' ' A' ' 111' ' ' ARG . 34.8 mm -60.16 -41.1 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 114.382 -1.281 . . . . 65.33 111.12 175.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 68.1 mt -87.07 -19.62 28.33 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.444 0.698 . . . . 73.34 112.689 -168.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.497 ' HD2' ' HA ' ' C' ' 104' ' ' ASN . 28.1 m-85 -55.47 -53.23 64.54 Favored Pre-proline 0 N--CA 1.489 1.509 0 CA-C-O 118.081 -0.961 . . . . 75.33 112.832 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -54.76 -40.19 85.94 Favored 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 122.857 2.372 . . . . 75.12 114.658 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.539 ' HE2' HG21 ' A' ' 115' ' ' THR . 39.7 m-85 -66.62 -50.1 64.1 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.56 0.744 . . . . 74.23 110.77 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.582 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.75 -35.33 80.74 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.016 -0.993 . . . . 64.34 111.041 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -61.27 -48.28 82.15 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.159 1.384 . . . . 71.25 110.638 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.73 -35.94 77.77 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 123.515 0.51 . . . . 63.22 109.73 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.4 t -67.99 -33.2 74.18 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.376 0.67 . . . . 72.12 111.151 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.461 HG23 ' SG ' ' C' ' 76' ' ' CYS . 78.1 mt -72.53 -54.35 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 109.545 -0.539 . . . . 60.53 109.545 174.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 22.6 m -62.37 -28.38 69.73 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 122.909 0.484 . . . . 64.31 111.25 -175.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.6 t -65.27 -49.03 71.11 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.996 -0.742 . . . . 52.2 108.996 171.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.668 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.03 -38.16 85.13 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.602 1.161 . . . . 64.52 112.264 178.902 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.458 HG23 ' O ' ' C' ' 114' ' ' ILE . 68.0 t -59.39 -47.19 91.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 108.765 -0.828 . . . . 74.23 108.765 175.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 37.9 t -74.64 -23.29 58.65 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.572 -1.195 . . . . 73.33 112.272 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.422 ' HD2' ' SD ' ' C' ' 117' ' ' MET . 90.2 mtt-85 -74.43 -39.06 62.83 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.015 -0.735 . . . . 73.34 109.015 175.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.11 0.96 82.19 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 124.168 0.917 . . . . 64.53 112.172 170.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.9 p 60.87 30.7 19.81 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.687 1.995 . . . . 61.15 113.602 171.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -83.29 143.8 45.63 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 108.242 -1.022 . . . . 64.43 108.242 170.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -51.27 152.16 11.75 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.211 2.608 . . . . 55.31 113.45 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -54.17 125.98 21.15 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.575 0.954 . . . . 71.1 113.575 -170.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 21.7 tp -122.84 86.09 2.53 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 107.682 -1.229 . . . . 73.11 107.682 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -95.7 115.9 28.1 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.387 -0.824 . . . . 72.5 108.994 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.541 ' HG ' HD11 ' G' ' 6' ' ' ILE . 6.1 mp -73.11 129.01 37.12 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.334 0.654 . . . . 73.24 110.155 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.58 145.14 74.83 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 122.633 0.373 . . . . 65.34 110.932 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.434 ' HG3' HD12 ' A' ' 16' ' ' ILE . 71.4 Cg_endo -72.92 144.76 39.04 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.272 2.648 . . . . 73.41 113.369 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.736 ' HB ' HD11 ' C' ' 136' ' ' LEU . 18.5 m -137.91 134.76 45.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.213 1.005 . . . . 73.33 108.65 171.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.458 ' O ' ' HG ' ' C' ' 136' ' ' LEU . 0.7 OUTLIER -81.71 90.24 6.33 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 118.694 -0.669 . . . . 62.21 109.644 178.624 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -54.64 -44.66 73.4 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 118.363 0.529 . . . . 51.24 112.084 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -56.35 -38.55 71.55 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.366 1.066 . . . . 65.3 111.582 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.32 -28.89 21.98 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.683 0.793 . . . . 51.12 111.7 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.736 HD11 ' HB ' ' C' ' 131' ' ' VAL . 50.4 mt -62.97 -45.91 90.21 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.451 0.701 . . . . 62.34 111.362 -175.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -60.98 -29.18 69.53 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.561 0.538 . . . . 73.4 111.61 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 64.9 mtt -78.08 -59.99 2.55 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.868 0.867 . . . . 74.24 110.855 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -58.75 -35.67 73.12 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.296 1.439 . . . . 73.34 112.058 -175.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -54.99 -84.89 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.576 1.15 . . . . 60.34 109.591 175.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 55.2 tp 61.75 -78.83 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.237 1.015 . . . . 72.35 110.705 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -138.93 2.64 2.16 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 123.5 0.72 . . . . 72.3 111.164 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -118.73 149.33 41.63 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.182 0.593 . . . . 73.43 110.796 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -167.67 102.93 0.49 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 106.604 -1.628 . . . . 73.01 106.604 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.88 157.36 33.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.633 0.773 . . . . 62.14 110.37 -177.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 176.68 176.39 44.8 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.78 -0.645 . . . . 64.03 111.769 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -88.84 54.85 3.15 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.846 0.858 . . . . 75.03 109.916 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.35 81.5 0.48 Allowed Glycine 0 C--N 1.351 1.373 0 CA-C-N 114.87 -1.059 . . . . 30.53 112.89 -177.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 5.8 t -158.67 127.5 5.44 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.696 1.198 . . . . 65.41 108.231 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 150' ' ' GLU . . . . . 0.565 ' HG2' ' HA ' ' G' ' 2' ' ' LYS . 0.6 OUTLIER -161.54 143.17 11.49 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.588 -0.523 . . . . 64.14 109.588 -175.3 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -98.62 -90.9 0.28 Allowed 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.827 0.851 . . . . 64.54 110.72 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 27.3 m80 43.29 79.05 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.688 1.195 . . . . 74.02 112.802 -168.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 153' ' ' GLN . . . . . 0.484 ' HG2' ' HB2' ' C' ' 37' ' ' GLN . 15.8 tm0? -95.31 134.3 38.24 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 107.687 -1.227 . . . . 64.34 107.687 171.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 154' ' ' ASP . . . . . 0.602 ' HB3' ' HD1' ' C' ' 36' ' ' TRP . 34.8 t70 -120.55 158.46 27.27 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.995 0.918 . . . . 72.41 109.961 -176.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.089 0 C-N-CA 124.1 0.96 . . . . 62.23 111.624 -176.782 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.755 0.312 . . . . 73.42 111.056 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m -63.5 110.67 2.04 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.876 0.87 . . . . 33.52 111.231 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -101.16 177.54 4.91 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.397 0.617 . . . . 74.22 110.758 173.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -128.18 166.6 18.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.54 1.136 . . . . 73.2 109.683 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -100.98 161.92 13.26 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.126 0.571 . . . . 74.43 109.877 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -128.99 108.75 10.65 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.356 0.662 . . . . 70.21 109.327 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -88.84 12.13 16.0 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.051 0.941 . . . . 74.3 111.859 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -96.58 -60.26 1.64 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.253 0.621 . . . . 74.4 110.38 -176.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 27.9 ptm 24.17 169.52 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 119.154 3.02 . . . . 65.4 119.154 -170.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 86.6 m -129.46 143.24 50.75 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 113.805 -1.543 . . . . 74.42 108.528 170.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -163.16 105.4 1.01 Allowed 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.524 -0.917 . . . . 72.4 108.524 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -128.37 127.63 42.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.069 -1.086 . . . . 74.0 108.069 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.528 HG21 HD11 ' D' ' 16' ' ' ILE . 10.8 mt -86.82 131.42 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 109.001 -0.74 . . . . 73.32 109.001 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -98.48 -35.28 10.31 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.325 0.65 . . . . 71.14 110.931 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -167.21 142.03 3.94 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.857 0.688 . . . . 70.24 112.857 -171.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.528 HD11 HG21 ' D' ' 13' ' ' ILE . 3.4 mp -119.65 134.87 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 106.798 -1.556 . . . . 74.42 106.798 170.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.431 ' HE1' HG13 ' D' ' 83' ' ' ILE . 31.9 p90 -164.97 165.49 20.15 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.77 0.795 . . . . 72.32 110.744 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.2 p -102.68 124.11 47.62 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.461 -1.245 . . . . 72.42 108.636 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -89.78 -42.51 11.25 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.75 -0.833 . . . . 74.41 108.75 175.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -130.9 138.13 49.65 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.433 -0.803 . . . . 75.02 109.354 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.668 HG21 ' HE2' ' C' ' 117' ' ' MET . 61.0 mt -138.1 151.45 25.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 107.259 -1.385 . . . . 64.54 107.259 172.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 22' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 46.9 t -157.89 146.04 18.85 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.466 1.106 . . . . 71.11 108.734 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.541 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.0 t80 -149.45 133.44 17.11 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 105.771 -1.937 . . . . 75.23 105.771 169.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.8 mt-10 -132.6 149.64 52.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.487 -0.931 . . . . 73.01 108.487 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.669 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -145.64 77.36 12.47 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 107.355 -1.35 . . . . 62.34 107.355 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -67.16 -39.54 13.2 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.709 2.273 . . . . 53.32 112.464 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -98.31 5.8 47.95 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 118.526 -0.749 . . . . 53.41 110.817 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.669 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -29.22 -63.2 0.2 Allowed Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 117.091 2.256 . . . . 72.1 117.091 -166.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.693 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 42.5 Cg_endo -82.36 -15.0 9.08 Favored 'Trans proline' 0 C--N 1.379 2.175 0 CA-C-N 122.827 2.045 . . . . 62.21 113.838 -174.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -77.07 -41.68 41.34 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.493 1.117 . . . . 74.02 109.332 173.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.8 p -83.64 -11.03 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 C-N-CA 124.294 1.038 . . . . 64.0 111.173 -175.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.403 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 12.0 m-85 -69.77 -19.06 63.53 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 112.112 0.412 . . . . 70.12 112.112 174.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -59.67 -25.74 64.97 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.408 0.623 . . . . 74.11 110.229 169.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -100.08 90.78 4.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.966 1.306 . . . . 64.54 109.355 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -105.34 93.01 4.45 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.371 -0.603 . . . . 74.24 109.371 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -156.43 175.06 14.52 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.074 0.949 . . . . 74.51 108.74 169.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -67.25 106.98 1.39 Allowed Pre-proline 0 CA--C 1.554 1.099 0 CA-C-O 118.855 -0.593 . . . . 71.44 109.408 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.509 ' HB3' ' HG ' ' D' ' 68' ' ' LEU . 30.5 Cg_endo -69.16 148.7 69.55 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.169 1.913 . . . . 54.14 112.716 -172.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -69.62 113.31 6.78 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 108.443 -0.947 . . . . 74.5 108.443 172.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.493 HG13 HG13 ' D' ' 64' ' ' VAL . 88.3 t -104.52 122.76 57.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 123.184 0.594 . . . . 71.2 109.632 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -94.36 128.47 40.9 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.803 -1.184 . . . . 74.53 107.803 170.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.4 ' H ' ' HG ' ' D' ' 42' ' ' LEU . 3.2 pp -95.87 146.76 24.31 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.816 0.846 . . . . 74.01 109.468 -171.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.568 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 12.5 t70 -149.66 131.49 15.1 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.272 -1.01 . . . . 54.42 108.272 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -124.82 138.84 54.25 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.847 0.459 . . . . 74.31 109.94 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -133.03 155.8 48.52 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.723 1.209 . . . . 74.42 108.48 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 3.1 m -106.07 152.04 23.9 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.097 0.559 . . . . 51.12 111.62 -167.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.751 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -155.12 142.51 19.54 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.783 -0.821 . . . . 43.11 108.783 169.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.4 p -165.47 152.32 10.25 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 123.193 0.597 . . . . 75.11 109.682 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.2 p -158.91 143.62 15.82 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.112 0.565 . . . . 71.34 109.836 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -77.04 121.73 23.94 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.264 -0.643 . . . . 74.43 109.264 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.55 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.3 mt -94.91 -26.42 16.15 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.171 0.588 . . . . 72.23 109.812 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.56 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -170.35 -179.73 3.14 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.712 1.605 . . . . 52.53 109.082 175.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -76.0 123.95 26.58 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.014 -1.106 . . . . 62.34 108.014 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 73.79 -3.12 2.58 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 125.597 1.559 . . . . 65.22 112.269 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 78.3 t -117.53 118.04 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 108.302 -0.999 . . . . 73.24 108.302 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -135.03 172.26 13.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.041 0.448 . . . . 55.13 109.904 -174.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.55 ' HB2' HD11 ' D' ' 51' ' ' LEU . 24.7 tt0 -125.1 126.29 45.09 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.113 0.965 . . . . 72.44 108.714 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.83 115.88 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 107.569 -1.271 . . . . 60.34 107.569 175.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.751 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 26.2 t -117.96 134.68 60.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 123.866 0.866 . . . . 54.1 108.944 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 7.8 mp -121.5 130.73 53.73 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.968 0.413 . . . . 72.33 110.1 171.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -85.47 106.18 16.63 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.809 -1.087 . . . . 63.3 109.071 173.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 94.9 t -91.46 116.19 32.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 108.248 -1.019 . . . . 52.33 108.248 171.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 72.5 m -114.64 142.16 46.83 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 108.816 -0.809 . . . . 70.45 108.816 -176.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.493 HG13 HG13 ' D' ' 40' ' ' VAL . 58.7 t -132.16 102.93 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 125.099 1.36 . . . . 74.33 108.333 -173.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 42.2 m -95.83 91.51 6.08 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.571 -1.27 . . . . 74.22 107.571 168.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.2 143.47 26.59 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.898 -0.779 . . . . 73.22 108.898 -175.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.473 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 41.1 m -143.17 127.36 17.57 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.481 0.488 . . . . 73.52 111.175 -176.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.509 ' HG ' ' HB3' ' D' ' 38' ' ' PRO . 21.7 mt -97.12 105.57 17.75 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.029 -1.101 . . . . 61.12 108.029 173.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.64 -114.12 4.95 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.377 -0.829 . . . . 64.44 111.973 -177.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.48 4.7 30.85 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 112.957 0.725 . . . . 74.24 112.957 -172.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -136.24 161.7 35.02 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.496 0.319 . . . . 73.14 110.469 -175.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 70.9 m -62.74 125.17 23.04 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 124.208 0.942 . . . . 71.23 111.45 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.473 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -78.56 -70.84 0.47 Allowed 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.788 -1.096 . . . . 74.22 108.188 170.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -149.34 146.78 27.69 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.493 -0.776 . . . . 65.33 110.382 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.447 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 72.4 mt -111.69 108.24 17.62 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.96 -1.126 . . . . 73.34 107.96 174.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.5 ' SG ' HG23 ' D' ' 114' ' ' ILE . 43.7 t -116.97 146.7 42.85 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.253 -0.647 . . . . 73.14 109.253 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 77' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 19.8 tt0 -153.55 133.13 12.95 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.449 0.699 . . . . 74.14 109.66 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 45.3 t -138.82 116.95 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.081 -0.711 . . . . 71.31 109.081 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -87.83 88.63 7.71 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 108.07 -1.085 . . . . 72.32 108.07 169.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -80.86 114.51 19.79 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.413 -1.267 . . . . 73.21 108.471 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.29 144.5 18.09 Favored Glycine 0 C--N 1.337 0.594 0 O-C-N 123.465 0.478 . . . . 72.53 112.441 -176.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.68 137.83 9.47 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 111.221 -0.752 . . . . 74.41 111.221 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.431 HG13 ' HE1' ' D' ' 17' ' ' TYR . 72.8 mt -88.71 120.45 37.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.66 -1.237 . . . . 74.45 107.66 173.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -128.72 122.07 29.87 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.863 0.865 . . . . 70.32 109.244 -175.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 31.9 m -85.04 93.99 8.73 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.206 -1.035 . . . . 65.04 108.206 169.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 11.7 tt -123.31 131.55 72.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 123.91 0.884 . . . . 73.23 109.161 -173.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.7 166.63 32.83 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.371 0.668 . . . . 64.34 110.902 -173.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.35 17.09 76.94 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.619 -0.718 . . . . 63.33 113.683 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 6.7 mt -125.61 154.13 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.059 0.543 . . . . 74.23 109.861 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.555 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 0.0 OUTLIER -159.51 -174.06 4.47 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 123.934 0.893 . . . . 75.44 110.184 174.268 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.61 -142.29 45.28 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.492 0.495 . . . . 51.21 113.425 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 51.6 m -76.84 -28.31 55.45 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.606 0.762 . . . . 73.4 111.692 -176.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -60.11 -44.17 95.07 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.84 0.456 . . . . 75.23 111.298 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.555 ' SD ' ' HA ' ' D' ' 90' ' ' GLU . 25.6 ptt? -72.38 -30.63 64.85 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 123.111 0.257 . . . . 60.44 111.477 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.76 -36.14 82.72 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.316 0.579 . . . . 73.43 110.24 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -85.86 -18.2 33.47 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.774 -0.648 . . . . 74.4 110.653 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 47.3 t -70.52 -51.07 31.33 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.536 0.684 . . . . 70.15 109.487 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 30.0 mt -77.32 -18.95 57.04 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.87 -1.059 . . . . 61.52 110.545 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.06 15.46 51.33 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 115.764 -0.653 . . . . 74.42 113.815 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.484 ' HA ' ' HD2' ' D' ' 133' ' ' PHE . . . -159.47 -65.8 0.08 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 117.235 0.517 . . . . 51.34 111.911 176.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -64.21 -53.47 48.74 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.68 0.792 . . . . 73.24 112.681 -169.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 21.7 m -63.67 -43.83 78.52 Favored Pre-proline 0 CA--C 1.565 1.541 0 C-N-CA 123.819 0.847 . . . . 73.34 111.798 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -52.76 -39.05 78.16 Favored 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 122.759 2.306 . . . . 74.45 113.996 166.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -64.54 -28.58 69.75 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.525 0.73 . . . . 73.24 111.682 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.2 mm -69.78 -42.17 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-O 121.491 0.662 . . . . 71.32 109.761 173.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 93.8 mt -82.62 -12.65 57.52 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.819 -1.082 . . . . 65.22 111.887 -177.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 107' ' ' PHE . . . . . 0.4 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 83.7 t80 -60.83 -52.73 70.34 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.489 1.116 . . . . 73.41 113.184 -176.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 108' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 39.6 Cg_exo -61.47 -35.48 82.38 Favored 'Trans proline' 0 C--N 1.385 2.482 0 C-N-CA 121.863 1.708 . . . . 63.44 112.384 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -71.29 -43.98 66.09 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.311 1.045 . . . . 65.44 111.991 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.72 -42.17 86.75 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.416 0.686 . . . . 30.23 110.127 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.414 ' NH2' HG23 ' B' ' 105' ' ' ILE . 38.8 ttp180 -57.34 -54.61 44.88 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 124.199 0.937 . . . . 73.14 110.08 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -59.04 -46.03 89.26 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.199 0.937 . . . . 73.52 111.198 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.7 t -58.05 -43.31 86.82 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 123.749 0.656 . . . . 74.35 111.041 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.5 HG23 ' SG ' ' D' ' 76' ' ' CYS . 74.1 mt -65.21 -55.45 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 123.565 0.541 . . . . 63.42 109.994 175.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 62.8 m -51.17 -44.0 61.4 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.927 1.291 . . . . 62.23 111.736 -173.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 35.9 t -65.67 -43.11 90.31 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 114.683 -1.144 . . . . 61.42 109.958 -178.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 79.3 mtm -67.86 -32.94 73.8 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.116 0.566 . . . . 61.33 111.866 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.436 HG23 ' O ' ' D' ' 114' ' ' ILE . 85.5 t -65.13 -44.19 95.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.469 0.708 . . . . 53.15 109.744 176.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 80.9 p -74.6 -28.46 60.91 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.952 -0.567 . . . . 52.14 111.153 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' D' ' 116' ' ' SER . 82.5 mtt-85 -70.88 -32.89 70.01 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.663 0.785 . . . . 70.34 109.973 174.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.73 5.69 77.46 Favored Glycine 0 C--N 1.353 1.49 0 O-C-N 123.902 0.751 . . . . 42.53 112.068 171.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.2 p 55.78 24.05 6.96 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 127.27 2.228 . . . . 73.24 113.982 176.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -79.59 155.17 76.23 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.571 0.748 . . . . 71.22 109.663 170.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -48.57 126.32 14.07 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.531 2.82 . . . . 74.44 112.327 172.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -51.92 132.39 32.06 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.617 1.167 . . . . 73.21 112.223 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.505 HD21 HG21 ' H' ' 6' ' ' ILE . 5.8 tt -108.07 101.77 10.98 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.611 -1.255 . . . . 75.23 107.611 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -100.95 102.89 14.0 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.299 -1.001 . . . . 74.2 108.299 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 tt -69.16 115.21 8.18 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 107.794 -1.187 . . . . 72.3 107.794 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.76 139.31 97.1 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 123.201 0.6 . . . . 62.14 110.756 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -58.72 106.26 0.27 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.007 2.471 . . . . 70.54 111.682 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 17.4 m -109.14 138.48 36.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 115.203 -0.908 . . . . 74.23 109.678 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -79.78 96.78 6.38 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.384 -0.969 . . . . 71.52 108.384 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.484 ' HD2' ' HA ' ' D' ' 100' ' ' ALA . 7.9 t80 -64.47 -23.67 67.36 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.854 0.862 . . . . 74.24 110.964 -177.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.58 -54.03 51.22 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 124.066 0.946 . . . . 73.12 110.601 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.77 -50.25 73.1 Favored 'General case' 0 C--O 1.22 -0.469 0 O-C-N 124.202 0.939 . . . . 72.13 110.065 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 94.2 mt -49.49 -43.57 45.41 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.952 0.901 . . . . 74.4 112.212 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.497 ' HA ' HD11 ' H' ' 10' ' ' LEU . 48.7 t80 -59.79 -55.19 37.32 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.137 -0.938 . . . . 72.33 110.711 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.469 ' O ' ' HA3' ' D' ' 148' ' ' GLY . 21.7 ptp -73.72 -20.43 60.53 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.819 0.448 . . . . 52.45 111.302 -177.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -73.99 -30.41 62.47 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.19 0.596 . . . . 72.41 111.112 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 140' ' ' TYR . . . . . 0.434 ' HB2' HD13 ' H' ' 10' ' ' LEU . 92.9 t80 -60.38 -45.47 93.42 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.276 0.63 . . . . 74.54 111.906 -177.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.483 HD22 ' H ' ' D' ' 141' ' ' LEU . 1.0 OUTLIER -63.27 -38.41 91.05 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.67 0.388 . . . . 65.05 110.518 -175.604 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.43 ' HB3' ' H ' ' D' ' 148' ' ' GLY . 10.0 pt20 -84.95 4.85 31.67 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.772 -0.649 . . . . 73.0 112.561 -174.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 143' ' ' GLN . . . . . 0.456 ' NE2' ' HG2' ' D' ' 144' ' ' GLN . 1.0 OUTLIER -133.21 41.1 3.14 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.005 0.431 . . . . 64.42 110.344 168.427 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 144' ' ' GLN . . . . . 0.456 ' HG2' ' NE2' ' D' ' 143' ' ' GLN . 27.1 mm-40 -152.23 -70.2 0.16 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.461 1.104 . . . . 73.32 109.341 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.33 117.91 3.54 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.56 -0.904 . . . . 53.05 108.56 -174.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 78.69 -154.96 40.58 Favored Glycine 0 C--N 1.341 0.85 0 O-C-N 123.544 0.527 . . . . 62.43 112.245 -176.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -127.78 160.52 31.48 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.512 0.725 . . . . 65.32 110.96 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 148' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' D' ' 138' ' ' MET . . . -82.96 134.29 12.73 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.626 -0.715 . . . . 72.12 112.532 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 25.7 m -80.88 108.65 14.73 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.245 0.618 . . . . 51.42 110.041 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.88 110.88 15.41 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.827 -1.175 . . . . 75.31 107.827 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -93.78 160.54 14.71 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.499 0.666 . . . . 65.33 111.779 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -84.39 61.43 6.61 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 114.44 -1.255 . . . . 73.15 110.621 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -61.49 -35.96 79.13 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.361 0.664 . . . . 75.2 110.595 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 29.2 t70 74.9 -64.41 0.38 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.681 1.593 . . . . 75.22 111.049 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.354 0 C-N-CA 124.294 1.038 . . . . 73.24 108.811 172.101 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 110.332 -0.248 . . . . 74.21 110.332 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -67.85 136.08 53.53 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.885 0.474 . . . . 51.14 111.144 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -160.12 169.55 23.08 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.853 0.861 . . . . 71.55 109.503 174.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 16.8 p -96.0 137.97 34.31 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.028 0.531 . . . . 54.1 110.431 175.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 76.8 m -66.36 -52.87 42.44 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.637 0.775 . . . . 74.41 109.979 173.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.659 HD12 HD23 ' A' ' 128' ' ' LEU . 28.0 pt -127.52 163.29 31.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 CA-C-N 115.599 -0.728 . . . . 71.24 109.675 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 7' ' ' ALA . . . . . 0.501 ' HA ' ' HB3' ' A' ' 129' ' ' ALA . . . -151.53 -151.1 0.37 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.931 0.893 . . . . 55.13 108.669 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 90.7 mt -126.51 161.87 26.96 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.775 0.83 . . . . 64.52 111.039 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.37 131.28 44.79 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.627 -0.879 . . . . 72.3 108.627 171.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 6.6 mp -63.35 163.51 10.52 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.328 0.651 . . . . 63.3 110.251 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 75.6 mt -113.3 86.54 9.89 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 123.13 0.572 . . . . 65.01 109.493 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.61 -10.95 14.36 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.396 2.064 . . . . 71.52 111.677 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 tt -81.14 -41.6 22.19 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.824 0.849 . . . . 42.3 108.815 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 14' ' ' LEU . . . . . 0.619 HD22 ' HA3' ' A' ' 99' ' ' GLY . 47.7 mt 66.48 175.36 0.24 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.005 1.322 . . . . 71.12 111.3 -175.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -91.41 167.69 12.09 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.74 -0.467 . . . . 73.23 109.74 170.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 45.3 p -68.13 154.61 93.68 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-O 119.092 -0.48 . . . . 73.21 110.965 -174.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 17' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -54.8 102.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.042 2.495 . . . . 70.43 112.58 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 18' ' ' VAL . . . . . 0.62 HG12 HD23 ' A' ' 98' ' ' LEU . 1.9 p -58.14 121.32 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.629 1.171 . . . . 72.33 112.077 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 12.8 t 42.26 40.38 1.75 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.888 1.675 . . . . 55.13 112.176 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 93.9 mttt 66.8 65.69 0.45 Allowed 'General case' 0 C--N 1.366 1.32 0 CA-C-N 113.951 -1.477 . . . . 63.43 110.375 -172.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 21' ' ' ALA . . . . . 0.436 ' HB1' ' SD ' ' A' ' 94' ' ' MET . . . -69.49 107.79 3.51 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.142 -0.935 . . . . 72.43 109.92 178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 66.44 87.42 0.12 Allowed 'General case' 0 CA--C 1.543 0.692 0 O-C-N 124.515 1.134 . . . . 54.23 111.263 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 4.8 p -110.22 151.44 42.58 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 123.83 0.852 . . . . 74.13 110.687 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.74 -25.48 53.7 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.77 2.313 . . . . 74.55 112.237 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 C--O 1.252 1.197 0 N-CA-C 107.568 -1.271 . . . . 52.41 107.568 179.195 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 109.018 -0.734 . . . . 72.45 109.018 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -67.38 -32.97 74.24 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.595 0.758 . . . . 74.33 112.218 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -73.73 -29.85 62.49 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.849 0.46 . . . . 70.14 111.205 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -84.92 69.1 10.74 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 122.012 0.91 . . . . 73.41 110.07 175.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 64.8 m -119.95 154.73 34.03 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-N 114.536 -1.211 . . . . 74.25 107.869 173.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.718 HG13 HD21 ' B' ' 42' ' ' LEU . 10.3 tt -59.01 100.42 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.215 0 CA-C-O 121.688 0.756 . . . . 73.13 110.865 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -125.93 158.93 33.93 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.403 1.081 . . . . 70.14 109.478 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 8' ' ' LEU . . . . . 0.522 HD11 HD21 ' B' ' 44' ' ' LEU . 1.6 tt -100.25 127.96 46.42 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 109.14 -0.689 . . . . 74.21 109.14 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.2 45.11 1.1 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.619 0.767 . . . . 74.24 110.805 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 10' ' ' LEU . . . . . 0.705 HD21 HD12 ' B' ' 136' ' ' LEU . 94.0 mt 65.55 178.47 0.2 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.382 1.073 . . . . 64.21 112.593 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 73.4 mt -79.81 143.67 58.61 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.327 -0.851 . . . . 74.43 109.717 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -59.67 -31.64 94.59 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.1 2.534 . . . . 34.54 112.22 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 28.3 tp -165.66 164.39 19.06 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.48 1.112 . . . . 74.15 108.528 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 79.6 mt -67.38 161.9 24.17 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.335 -0.616 . . . . 65.1 109.335 170.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -70.46 -93.33 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.997 0.519 . . . . 62.31 111.11 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 2.3 p -165.38 133.55 2.47 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 124.564 1.146 . . . . 61.52 108.028 -172.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.02 150.71 77.06 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 122.789 2.326 . . . . 64.33 112.365 -174.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 18' ' ' VAL . . . . . 0.494 HG21 HG21 ' B' ' 86' ' ' ILE . 58.4 t -54.99 -30.48 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 C-N-CA 124.501 1.121 . . . . 73.22 113.108 -174.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 9.4 t -57.0 -30.42 64.16 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.571 0.748 . . . . 72.24 111.54 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -158.44 74.16 0.68 Allowed 'General case' 0 C--O 1.244 0.805 0 N-CA-C 107.925 -1.139 . . . . 73.21 107.925 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.57 57.0 4.08 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.63 0.729 . . . . 72.54 110.673 -177.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 22' ' ' ARG . . . . . 0.481 ' HB3' ' HA ' ' B' ' 49' ' ' SER . 0.0 OUTLIER -162.78 123.17 2.37 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.6 1.16 . . . . 74.31 109.289 178.77 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 48.5 m -167.03 -50.66 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.353 0 C-N-CA 125.707 1.603 . . . . 74.53 109.129 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.55 133.01 11.4 Favored 'Trans proline' 0 C--N 1.399 3.19 0 C-N-CA 121.697 1.598 . . . . 70.54 112.168 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 . . . . . 0 CA--C 1.55 0.972 0 C-N-CA 124.421 1.088 . . . . 75.01 108.279 -178.426 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 109.29 -0.633 . . . . 71.3 109.29 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' G' G ' 2' ' ' LYS . . . . . 0.565 ' HA ' ' HG2' ' C' ' 150' ' ' GLU . 9.8 mtmp? 74.21 82.01 0.11 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.319 1.447 . . . . 72.34 111.538 175.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -162.59 154.56 18.55 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.07 -0.968 . . . . 73.41 109.396 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 24.4 m 64.82 25.3 12.87 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.565 1.146 . . . . 75.24 112.303 174.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 2.2 m -58.2 -53.38 58.97 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.406 1.082 . . . . 73.33 110.915 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 6' ' ' ILE . . . . . 0.541 HD11 ' HG ' ' C' ' 128' ' ' LEU . 10.5 tt -150.28 130.97 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 113.974 -1.466 . . . . 52.21 108.352 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -167.24 154.95 9.13 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.252 0.621 . . . . 51.25 110.601 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 8' ' ' LEU . . . . . . . . . . . . . 40.9 mt -68.61 131.25 44.9 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.908 0.883 . . . . 72.45 110.602 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.96 151.67 28.39 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.104 0.562 . . . . 50.14 110.075 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 10' ' ' LEU . . . . . 0.423 HD11 HD13 ' C' ' 136' ' ' LEU . 6.6 mp -65.65 153.95 40.21 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.128 0.571 . . . . 63.14 109.665 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.95 108.99 5.21 Favored Pre-proline 0 CA--C 1.548 0.867 0 CA-C-O 118.884 -0.579 . . . . 72.25 110.056 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.42 -33.91 21.96 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 122.236 1.958 . . . . 75.11 110.572 177.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 7.4 mp -101.33 106.57 17.76 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.245 -1.391 . . . . 64.31 107.245 169.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.95 113.62 9.18 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.31 -0.626 . . . . 72.13 109.31 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 15' ' ' PHE . . . . . 0.608 ' HD2' ' HB ' ' C' ' 46' ' ' THR . 55.9 t80 -62.0 112.86 2.51 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 124.153 0.908 . . . . 73.35 109.347 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 9.5 t -159.22 62.32 2.04 Favored Pre-proline 0 CA--C 1.561 1.39 0 CA-C-O 121.445 0.64 . . . . 61.52 111.227 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 17' ' ' PRO . . . . . 0.584 ' HD2' HD13 ' C' ' 98' ' ' LEU . 23.8 Cg_endo -90.01 -6.89 4.65 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.11 2.54 . . . . 61.43 114.395 -172.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 18' ' ' VAL . . . . . 0.476 ' HB ' ' SD ' ' C' ' 94' ' ' MET . 89.0 t -73.89 123.38 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 110.09 -0.337 . . . . 70.13 110.09 -174.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 1.9 m 63.93 -104.18 0.12 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.914 1.285 . . . . 72.44 109.728 -176.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -150.48 38.7 0.71 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 106.688 -1.597 . . . . 74.21 106.688 176.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 21' ' ' ALA . . . . . 0.477 ' HB2' ' SD ' ' C' ' 94' ' ' MET . . . -61.28 87.81 0.02 OUTLIER 'General case' 0 C--N 1.362 1.128 0 C-N-CA 124.153 0.981 . . . . 73.31 111.181 -174.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -145.07 -0.67 0.88 Allowed 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 114.155 -1.384 . . . . 73.3 108.353 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 23' ' ' THR . . . . . 0.486 ' HA ' ' HD3' ' G' ' 24' ' ' PRO . 37.6 p -69.58 128.72 91.97 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.408 1.083 . . . . 53.34 110.454 -177.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 24' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' G' ' 23' ' ' THR . 16.4 Cg_exo -69.11 179.87 3.06 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 123.353 2.702 . . . . 60.13 112.904 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 C--O 1.248 1.008 0 N-CA-C 108.135 -1.061 . . . . 64.22 108.135 178.254 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 110.23 -0.285 . . . . 64.42 110.23 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -147.73 137.53 22.7 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 107.195 -1.409 . . . . 73.22 107.195 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -67.0 87.79 0.15 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.633 0.773 . . . . 72.33 110.266 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 32.0 t -167.94 170.44 10.57 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-N 114.487 -1.233 . . . . 70.42 108.658 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 27.4 m -79.65 158.41 27.03 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 108.653 -0.869 . . . . 72.24 108.653 173.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.505 HG21 HD21 ' D' ' 126' ' ' LEU . 14.7 tt -56.48 95.29 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 CA-C-O 122.417 1.103 . . . . 72.4 111.98 -177.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.45 13.51 4.55 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 113.937 -1.483 . . . . 60.04 109.888 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 81.0 mt 66.15 175.16 0.23 Allowed 'General case' 0 C--N 1.357 0.904 0 C-N-CA 125.015 1.326 . . . . 62.15 112.368 -176.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -163.79 -163.06 0.76 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.765 1.226 . . . . 44.14 107.953 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 10' ' ' LEU . . . . . 0.497 HD11 ' HA ' ' D' ' 137' ' ' PHE . 7.3 mp -92.71 168.12 11.43 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.821 0.819 . . . . 74.13 110.946 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' H' ' 12' ' ' PRO . 0.5 OUTLIER -111.21 137.16 20.91 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-N 114.164 -1.38 . . . . 75.43 109.293 -178.12 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 12' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' H' ' 11' ' ' LEU . 23.0 Cg_exo -66.31 -44.74 6.3 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.623 2.882 . . . . 72.51 113.157 -176.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 tt -73.02 119.53 17.4 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.2 -1.037 . . . . 54.44 108.2 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.47 118.02 20.22 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 107.578 -1.268 . . . . 63.44 107.578 176.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -58.13 171.86 0.5 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.676 1.19 . . . . 71.22 112.715 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 16' ' ' THR . . . . . 0.403 ' HB ' ' HA ' ' H' ' 21' ' ' ALA . 41.7 p -83.99 131.18 52.19 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-N 114.729 -1.123 . . . . 74.24 110.61 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.98 145.12 31.12 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.593 2.862 . . . . 71.12 113.352 -173.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 77.2 t -52.03 -28.82 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 C-N-CA 124.551 1.141 . . . . 71.51 113.519 -173.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 6.6 p -50.84 -44.99 59.48 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.221 0.608 . . . . 62.43 111.901 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -116.77 -62.18 1.62 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.922 0.889 . . . . 74.51 108.952 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 21' ' ' ALA . . . . . 0.403 ' HA ' ' HB ' ' H' ' 16' ' ' THR . . . 60.75 26.9 16.68 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.308 1.443 . . . . 64.44 111.919 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -112.85 149.26 33.36 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 113.958 -1.474 . . . . 61.42 108.314 174.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 26.8 p -95.65 101.09 7.2 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 123.979 0.912 . . . . 74.32 109.913 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -71.91 -28.62 16.21 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.272 1.981 . . . . 73.12 111.605 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 CA--C 1.548 0.867 0 N-CA-C 106.262 -1.755 . . . . 75.52 106.262 175.342 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 mmt . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.61 0.243 . . . . 64.12 111.009 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 m -138.91 33.09 2.18 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.906 0.483 . . . . 64.51 111.251 -164.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.488 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -125.17 78.91 1.75 Allowed 'General case' 0 CA--C 1.555 1.156 0 CA-C-O 122.019 0.914 . . . . 70.35 110.899 -171.265 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -148.49 66.04 1.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.47 1.108 . . . . 71.15 109.547 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 65.61 -73.93 0.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.647 1.179 . . . . 72.04 111.709 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -78.63 76.98 5.12 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 108.61 -0.885 . . . . 74.52 108.61 174.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 3' ' ' GLU . 50.5 p -88.78 -168.85 2.32 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 114.323 -1.308 . . . . 74.31 111.169 -170.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -75.84 118.17 18.35 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 107.824 -1.176 . . . . 72.41 107.824 161.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.614 ' HB2' ' HB ' ' C' ' 149' ' ' THR . 22.5 mmt -75.23 126.16 30.44 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.078 -0.712 . . . . 71.32 109.078 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t 174.78 147.15 0.07 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.935 0.894 . . . . 70.42 109.329 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.649 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 16.4 t80 -96.03 120.71 36.8 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.491 -0.929 . . . . 74.42 108.491 164.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -137.7 121.85 18.0 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.552 -0.907 . . . . 75.22 108.552 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.67 HG12 ' HD2' ' A' ' 84' ' ' PHE . 58.8 mt -93.94 123.01 45.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.416 -0.957 . . . . 71.12 108.416 174.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -84.32 -40.85 17.44 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 123.493 0.496 . . . . 74.01 110.158 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -169.61 134.98 1.47 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 116.389 -0.369 . . . . 73.22 110.692 -168.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 85.8 mt -125.39 129.85 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 123.708 0.803 . . . . 70.2 109.218 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -162.24 148.06 13.01 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 124.222 0.951 . . . . 74.51 110.715 -167.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.7 p -75.05 129.04 36.93 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 109.407 -0.59 . . . . 61.33 109.407 173.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.492 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 39.3 mtpt -97.99 -27.82 14.07 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.6 0.36 . . . . 72.11 110.399 176.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 13.6 t70 -141.98 138.47 31.92 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.382 -0.599 . . . . 61.34 109.382 171.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.425 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 60.4 mt -130.5 140.64 48.3 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 N-CA-C 107.087 -1.449 . . . . 41.04 107.087 172.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.0 t -150.58 128.2 11.55 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.036 0.534 . . . . 71.1 110.19 175.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.422 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 75.9 t80 -130.48 142.46 50.49 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.416 -1.327 . . . . 64.14 107.416 171.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -141.92 139.36 32.52 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.495 -0.928 . . . . 70.4 108.495 171.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.429 ' CB ' ' HB2' ' A' ' 28' ' ' ALA . . . -118.09 86.49 26.36 Favored Pre-proline 0 C--O 1.241 0.615 0 N-CA-C 106.118 -1.808 . . . . 54.43 106.118 169.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -53.41 -42.69 63.59 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.578 2.852 . . . . 65.21 113.774 -168.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.32 37.46 4.25 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.22 -0.659 . . . . 72.11 109.22 -177.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -41.75 -60.89 1.68 Allowed Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 113.74 1.015 . . . . 72.13 113.74 -169.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 23.4 Cg_exo -63.19 -27.07 72.52 Favored 'Trans proline' 0 C--N 1.385 2.496 0 CA-C-N 121.786 1.673 . . . . 51.43 112.776 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -84.69 -32.15 23.73 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.225 1.01 . . . . 63.44 111.311 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.731 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.8 p -79.08 -23.66 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.595 -0.729 . . . . 53.25 111.642 -168.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -72.39 -12.04 60.95 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.171 0.588 . . . . 71.31 111.51 176.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -81.63 -29.79 33.1 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.123 0.969 . . . . 54.3 110.156 173.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -74.46 153.83 38.99 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.178 0.991 . . . . 73.41 111.288 -174.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.78 136.81 45.52 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.594 -0.73 . . . . 75.23 109.259 170.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.416 ' CE3' HD21 ' A' ' 68' ' ' LEU . 62.1 t-105 -80.21 85.09 5.79 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.365 0.666 . . . . 73.44 110.45 -175.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.4 ' H ' HD22 ' A' ' 68' ' ' LEU . 6.5 tp60 -125.24 79.21 66.45 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.209 1.004 . . . . 70.23 108.5 170.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -89.97 140.79 3.5 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.694 2.263 . . . . 74.13 113.364 -173.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -99.43 90.75 4.63 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 107.805 -1.183 . . . . 72.34 107.805 167.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -70.52 92.36 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 122.477 1.132 . . . . 74.04 109.609 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -79.66 147.68 31.9 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 113.971 -1.468 . . . . 43.42 109.224 172.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.417 HD23 HD13 ' E' ' 6' ' ' ILE . 2.2 pp -133.64 131.77 39.97 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.535 0.734 . . . . 64.54 110.219 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.589 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 32.8 m-20 -115.89 135.76 53.69 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.294 -1.002 . . . . 70.52 108.294 175.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' E' ' 8' ' ' LEU . 4.8 mp -104.58 121.92 44.51 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.92 0.888 . . . . 73.05 109.176 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -141.99 144.59 33.76 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.884 -0.784 . . . . 65.03 108.884 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.7 m -146.69 140.26 25.81 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.066 0.547 . . . . 75.44 110.14 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.25 152.38 51.37 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.987 1.315 . . . . 54.21 108.603 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.6 p -132.01 160.61 35.35 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.15 0.58 . . . . 63.44 109.867 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -149.78 119.41 6.99 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.946 -0.761 . . . . 62.22 108.946 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -84.91 111.5 19.72 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.486 -0.561 . . . . 63.34 109.486 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.3 mt -85.36 -29.95 24.05 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.555 0.742 . . . . 73.41 111.25 -175.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.598 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -164.61 -171.58 2.37 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.254 1.022 . . . . 65.2 110.142 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.14 100.75 0.63 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.31 0.644 . . . . 64.11 109.545 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 70.05 8.08 6.51 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.002 1.321 . . . . 73.44 112.613 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 57.2 t -100.27 118.37 46.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 106.303 -1.739 . . . . 74.41 106.303 166.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -142.46 173.58 11.41 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.321 0.581 . . . . 61.44 110.283 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -127.65 131.68 49.82 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.262 -1.335 . . . . 74.32 108.878 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.49 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 84.5 t -106.01 135.8 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.731 -1.211 . . . . 75.25 107.731 166.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.439 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 39.8 t -123.95 129.67 74.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.863 -1.532 . . . . 71.41 106.863 174.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tt -124.98 117.91 25.08 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.051 -0.722 . . . . 74.43 109.051 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.584 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 21.3 ttp180 -89.59 111.04 21.86 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.884 -1.053 . . . . 62.52 109.661 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.411 HG11 HD11 ' A' ' 128' ' ' LEU . 43.9 t -100.36 110.87 28.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.979 -1.119 . . . . 74.34 107.979 172.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.589 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 26.3 m -97.75 108.92 21.73 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.677 -0.49 . . . . 73.34 109.677 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.4 t -103.68 108.38 24.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.405 1.082 . . . . 75.53 109.065 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.5 m -102.86 137.05 41.58 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.929 -1.137 . . . . 72.23 107.929 171.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.51 118.91 25.87 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 107.457 -1.312 . . . . 55.45 107.457 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -130.87 132.04 44.92 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.746 0.654 . . . . 70.03 111.092 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.416 HD21 ' CE3' ' A' ' 36' ' ' TRP . 15.6 mt -87.92 75.09 8.87 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.613 -1.254 . . . . 72.01 107.613 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.0 -115.69 4.07 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 114.953 -1.021 . . . . 62.2 110.737 -170.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -90.37 -19.63 23.76 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.722 0.809 . . . . 75.24 111.355 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -94.37 119.0 32.46 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.073 0.549 . . . . 74.51 109.993 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.8 m -72.58 121.89 20.45 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.311 0.382 . . . . 74.35 110.859 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.731 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -68.67 -56.27 8.71 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.763 -0.653 . . . . 75.21 109.697 176.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.465 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 42.7 p90 -156.26 175.55 13.84 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.018 -0.992 . . . . 73.45 111.371 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.6 tp -138.52 140.47 39.14 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.056 -1.429 . . . . 64.42 107.268 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 90.1 m -144.26 95.87 2.79 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.834 0.854 . . . . 65.31 108.819 -177.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -116.07 115.27 25.79 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.499 -0.926 . . . . 73.31 108.499 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.4 t -127.91 118.03 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.398 0.679 . . . . 74.24 110.244 -175.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.584 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 78.2 mt-30 -86.31 92.3 8.76 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 108.825 -0.805 . . . . 50.04 108.825 169.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -82.67 112.5 19.59 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.979 -0.748 . . . . 70.43 108.979 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -102.66 166.49 16.96 Favored Glycine 0 C--N 1.335 0.519 0 O-C-N 123.206 0.316 . . . . 64.24 112.855 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.58 131.7 2.3 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.793 -0.523 . . . . 75.42 111.793 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.1 mt -81.33 124.58 39.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 123.316 0.646 . . . . 75.52 109.369 174.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.67 ' HD2' HG12 ' A' ' 13' ' ' ILE . 10.0 m-85 -130.58 118.39 20.96 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.296 -1.001 . . . . 74.43 108.296 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.9 p -96.89 93.33 6.58 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.634 -0.876 . . . . 61.15 108.634 173.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.535 ' HB ' ' HD2' ' A' ' 11' ' ' PHE . 1.0 OUTLIER -139.53 122.67 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.033 0.933 . . . . 64.21 109.79 -175.443 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.506 ' HA ' HG21 ' E' ' 18' ' ' VAL . . . -129.13 -13.22 4.53 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.737 1.215 . . . . 74.1 109.983 169.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.462 ' H ' HD12 ' A' ' 86' ' ' ILE . . . -88.64 70.09 2.63 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.701 -0.681 . . . . 73.33 114.315 -170.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.591 HD13 ' HB2' ' A' ' 97' ' ' CYS . 19.3 tt -166.09 144.85 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 108.641 -0.874 . . . . 72.03 108.641 175.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.51 170.31 16.23 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.392 0.677 . . . . 73.43 110.224 -166.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.517 ' O ' ' HG3' ' A' ' 94' ' ' MET . . . 69.0 -147.29 46.06 Favored Glycine 0 C--N 1.352 1.462 0 CA-C-N 115.463 -0.79 . . . . 53.45 113.575 174.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.9 p -68.79 -20.84 64.35 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.231 0.613 . . . . 64.34 111.026 173.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -67.78 -35.37 78.55 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 123.664 0.785 . . . . 64.0 112.169 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.517 ' HG3' ' O ' ' A' ' 91' ' ' GLY . 4.0 ppp? -64.79 -40.61 95.51 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 118.128 0.422 . . . . 65.25 110.199 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.61 ' HB1' HD13 ' E' ' 14' ' ' LEU . . . -69.36 -36.21 76.63 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.817 0.847 . . . . 75.24 111.068 176.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -68.3 -30.24 69.19 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.426 1.09 . . . . 74.13 111.156 176.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.591 ' HB2' HD13 ' A' ' 89' ' ' ILE . 48.7 t -68.76 -57.78 5.14 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.202 0.525 . . . . 40.24 110.21 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.592 HD22 ' HA ' ' E' ' 16' ' ' THR . 4.0 pp -76.04 -19.91 58.22 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.566 -0.743 . . . . 75.5 112.093 -177.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.17 -4.49 53.71 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-O 119.519 -0.601 . . . . 63.22 114.225 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.34 -61.37 0.22 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 117.709 0.755 . . . . 74.4 112.155 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.487 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 91.2 t80 -59.92 -61.96 2.22 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 113.21 0.819 . . . . 74.03 113.21 -168.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 73.7 m -64.3 -38.16 31.54 Favored Pre-proline 0 CA--C 1.565 1.543 0 N-CA-C 112.829 0.677 . . . . 72.24 112.829 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.24 -46.12 23.85 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.528 2.152 . . . . 73.31 113.529 161.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.697 HD21 ' HB2' ' A' ' 133' ' ' PHE . 87.7 m-20 -75.88 -12.91 60.25 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.873 0.869 . . . . 71.53 112.224 -177.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.0 mm -70.59 -41.07 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 109.199 -0.667 . . . . 75.44 109.199 169.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 83.7 mt -82.33 -22.62 35.51 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.147 0.979 . . . . 74.15 111.919 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -57.49 -48.91 96.47 Favored Pre-proline 0 CA--C 1.569 1.702 0 N-CA-C 114.245 1.202 . . . . 65.35 114.245 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -63.79 -36.03 53.5 Favored 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 122.001 1.8 . . . . 64.33 112.582 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -69.18 -42.73 75.45 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.526 0.73 . . . . 62.31 111.383 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.88 -37.68 82.08 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.355 0.662 . . . . 52.24 109.995 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.471 ' NH1' HG23 ' C' ' 105' ' ' ILE . 28.0 ttm180 -54.02 -55.18 29.73 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.804 0.842 . . . . 54.2 110.279 171.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -67.49 -40.36 85.23 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.175 0.99 . . . . 74.43 111.736 -172.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.6 t -63.4 -36.6 84.25 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.366 0.416 . . . . 73.42 110.69 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.417 ' O ' HG23 ' A' ' 118' ' ' VAL . 60.0 mt -68.6 -49.58 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 115.461 -0.79 . . . . 74.21 110.039 174.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.6 m -56.32 -37.47 69.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.289 1.035 . . . . 73.42 111.496 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.9 t -62.23 -48.8 78.35 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 115.647 -0.706 . . . . 70.44 110.261 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.422 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 36.2 mtm -67.48 -36.27 80.8 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.158 0.583 . . . . 73.52 111.569 -176.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.5 t -62.88 -53.72 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 O-C-N 123.739 0.649 . . . . 60.35 110.278 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 38.7 t -66.51 -30.17 70.44 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.339 -0.846 . . . . 61.2 110.812 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.438 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 52.4 ttm-85 -77.43 -28.78 52.69 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.475 1.11 . . . . 72.41 109.343 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.417 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.72 9.6 67.84 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 115.283 -0.871 . . . . 55.23 112.23 171.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.559 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.1 t 67.83 13.5 9.21 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 127.166 2.186 . . . . 63.31 113.568 170.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -81.47 148.56 62.85 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 108.23 -1.026 . . . . 75.44 108.23 172.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -59.31 164.29 10.97 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.922 2.415 . . . . 61.2 113.371 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -54.51 120.25 6.39 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.009 0.923 . . . . 64.22 112.189 -173.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.465 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 62.2 tp -115.19 103.32 10.73 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.378 1.071 . . . . 64.21 108.563 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -99.12 111.16 23.62 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 107.537 -1.283 . . . . 74.04 107.537 177.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.411 HD11 HG11 ' A' ' 62' ' ' VAL . 2.2 tt -64.96 121.51 14.84 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.396 -0.964 . . . . 61.3 108.396 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' E' ' 6' ' ' ILE . . . -64.45 139.14 97.65 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 122.722 0.409 . . . . 51.41 111.363 -175.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.21 132.58 10.39 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 123.044 2.496 . . . . 62.2 112.199 -175.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.7 t -112.1 114.73 47.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.605 -1.258 . . . . 73.13 107.605 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -82.25 65.93 7.61 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 123.599 0.562 . . . . 75.53 110.345 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.697 ' HB2' HD21 ' A' ' 104' ' ' ASN . 80.4 m-85 -52.6 -41.95 64.11 Favored 'General case' 0 C--N 1.366 1.301 0 C-N-CA 123.865 0.866 . . . . 72.41 110.789 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -55.35 -50.92 68.42 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 124.448 1.092 . . . . 70.21 111.187 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.46 -43.95 95.88 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.657 0.598 . . . . 64.24 111.12 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.2 mt -60.5 -48.72 80.51 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.913 0.885 . . . . 72.53 111.662 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -71.4 -35.62 71.08 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.126 0.57 . . . . 72.51 111.499 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 85.7 mtp -72.12 -22.77 61.28 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 119.079 -0.486 . . . . 64.4 111.651 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -58.75 -29.19 66.55 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 122.924 0.489 . . . . 64.23 111.259 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -84.51 -29.69 25.77 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.242 0.617 . . . . 73.21 110.738 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.2 tp -67.69 -54.97 15.18 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.462 0.705 . . . . 72.34 110.945 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 172.34 15.09 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 125.039 1.336 . . . . 63.3 110.394 -175.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 59.1 -74.18 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.672 1.189 . . . . 63.24 110.468 -163.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 70.17 137.76 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.459 1.503 . . . . 71.04 112.118 174.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -141.01 -174.62 4.05 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.987 0.915 . . . . 43.42 109.751 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -173.43 108.18 0.27 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.611 -0.995 . . . . 70.04 110.611 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -113.72 86.01 2.32 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.645 0.778 . . . . 73.04 110.875 -174.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -96.31 121.68 7.07 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 110.014 -1.235 . . . . 21.33 110.014 171.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' G' ' 24' ' ' PRO . 45.3 p -131.44 134.08 45.83 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.29 0.636 . . . . 72.22 110.386 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.644 ' HB3' ' HG3' ' G' ' 25' ' ' GLU . 9.0 tp10 -160.91 140.44 10.66 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.032 0.933 . . . . 54.21 109.995 172.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -80.33 77.9 7.05 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.445 -0.946 . . . . 74.44 108.445 171.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -106.42 104.51 14.22 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.177 -0.92 . . . . 65.04 108.694 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -89.37 135.38 33.62 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.475 -0.565 . . . . 72.24 109.475 175.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -132.04 140.67 48.97 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 107.896 -1.15 . . . . 53.5 107.896 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 N-CA-C 109.473 -0.566 . . . . 72.2 109.473 -178.105 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttm . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 109.023 -0.732 . . . . 71.4 109.023 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m -79.88 75.18 6.6 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.679 0.792 . . . . 53.41 110.432 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -88.55 96.81 10.77 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.476 -0.784 . . . . 63.14 109.285 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -155.02 133.34 11.79 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.879 0.871 . . . . 72.41 109.034 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -151.11 94.71 2.08 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 107.763 -1.199 . . . . 71.24 107.763 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -125.51 82.24 2.05 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.206 0.527 . . . . 75.54 110.808 -173.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 23.9 p -141.25 18.48 2.25 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.634 1.173 . . . . 71.45 108.458 169.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.584 ' HG2' ' H ' ' B' ' 9' ' ' MET . 12.1 tt0 -82.44 -166.97 1.41 Allowed 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 114.767 -1.106 . . . . 73.14 111.131 -166.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.672 ' HB2' ' HB ' ' B' ' 89' ' ' ILE . 12.6 ttt 67.26 168.32 0.24 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 125.71 1.604 . . . . 72.32 111.592 -176.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 87.5 m -139.79 136.18 33.8 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.138 -1.06 . . . . 63.53 108.138 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.579 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 86.0 t80 -126.31 145.16 50.54 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.858 0.863 . . . . 71.34 109.254 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -157.32 139.29 14.31 Favored 'General case' 0 C--N 1.346 0.441 0 O-C-N 123.501 0.5 . . . . 74.43 109.806 170.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.465 HD13 HD11 ' B' ' 16' ' ' ILE . 26.2 mt -79.8 126.32 39.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.846 -0.798 . . . . 71.34 108.846 172.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -94.45 -51.09 4.92 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.763 -0.458 . . . . 73.11 109.763 175.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.559 ' HE ' HG21 ' A' ' 122' ' ' THR . 33.7 ttt180 -162.67 139.87 7.94 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.547 -0.297 . . . . 64.45 110.758 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.465 HD11 HD13 ' B' ' 13' ' ' ILE . 98.1 mt -120.56 134.68 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 107.672 -1.233 . . . . 73.23 107.672 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -168.47 158.0 9.28 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.302 0.572 . . . . 75.32 111.949 -171.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 85.3 m -89.41 129.6 35.9 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.14 -0.936 . . . . 72.41 109.559 173.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.401 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.4 mtpt -100.37 -20.33 15.88 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.558 0.743 . . . . 75.42 111.412 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -167.52 144.22 4.31 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.52 0.513 . . . . 62.23 111.583 -173.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 43.0 mm -138.42 147.09 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.996 1.319 . . . . 74.35 109.468 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.568 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.2 t -146.01 136.14 23.71 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.638 1.175 . . . . 72.44 108.467 170.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.4 t80 -150.51 108.14 3.66 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 107.749 -1.204 . . . . 65.35 107.749 170.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -120.18 113.94 21.19 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.154 0.982 . . . . 75.24 109.013 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.42 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.55 87.94 3.06 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 108.269 -1.011 . . . . 71.25 108.269 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -66.57 -45.25 5.07 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.182 2.588 . . . . 72.35 113.043 -168.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -103.36 23.56 12.32 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.661 0.785 . . . . 75.33 110.494 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.492 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -40.86 -62.15 1.07 Allowed Pre-proline 0 N--CA 1.49 1.548 0 C-N-CA 124.749 1.219 . . . . 60.35 113.981 -168.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.55 -23.64 76.84 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.468 2.112 . . . . 43.43 113.5 -173.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -94.28 -39.86 10.28 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.386 0.674 . . . . 71.32 111.954 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' B' ' 73' ' ' ALA . 8.7 p -69.71 -15.89 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 122.996 0.518 . . . . 60.15 112.072 -171.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -68.3 -11.98 60.32 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.561 0.744 . . . . 53.22 112.766 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.6 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.9 pt20 -58.16 -28.82 65.07 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.401 0.62 . . . . 71.34 109.962 172.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.6 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 88.7 mttt -95.94 92.91 6.72 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.253 1.421 . . . . 72.01 109.504 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -95.09 87.92 5.05 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.31 -0.405 . . . . 72.51 110.084 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -165.71 178.18 6.78 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.126 0.97 . . . . 74.42 108.994 170.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -70.9 112.12 12.2 Favored Pre-proline 0 CA--C 1.562 1.412 0 C-N-CA 123.277 0.631 . . . . 62.34 111.302 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.55 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 18.1 Cg_endo -62.66 143.76 92.97 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.278 1.985 . . . . 65.23 112.421 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.84 108.71 4.08 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.985 -0.746 . . . . 73.24 108.985 176.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 30.8 m -93.93 147.53 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.231 -0.895 . . . . 73.34 112.592 -172.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.47 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 61.7 mtpt -125.51 100.94 6.7 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.003 1.321 . . . . 73.44 108.29 174.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.519 HD22 HD23 ' F' ' 8' ' ' LEU . 1.1 pp -96.58 155.6 16.7 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.626 -0.715 . . . . 73.53 111.443 -174.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -150.28 150.92 32.17 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.326 1.05 . . . . 74.34 109.205 -175.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.5 HD21 HD13 ' F' ' 8' ' ' LEU . 90.5 mt -125.48 127.29 46.25 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.191 0.996 . . . . 63.25 108.615 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.556 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 25.1 t70 -124.21 146.26 48.82 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.016 0.526 . . . . 70.32 110.455 -171.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.742 HG21 ' H ' ' F' ' 16' ' ' THR . 90.7 m -110.41 122.76 48.49 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.944 -1.026 . . . . 72.31 110.983 -176.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.36 122.58 11.52 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 107.061 -1.459 . . . . 54.15 107.061 169.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 36.1 p -145.82 163.16 35.89 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.795 0.27 . . . . 52.33 110.804 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 52.5 p -151.99 141.53 21.69 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.83 0.852 . . . . 71.5 109.35 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -84.22 129.82 34.86 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.196 -0.668 . . . . 71.14 109.196 175.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 50.9 mt -92.22 -44.37 8.81 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.03 0.532 . . . . 74.23 110.312 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.85 -171.86 3.58 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.052 0.941 . . . . 24.41 109.569 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -68.3 129.32 39.58 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.455 -0.793 . . . . 73.15 109.157 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 68.57 -4.67 1.09 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.489 1.515 . . . . 74.44 113.085 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 82.4 t -113.76 117.61 55.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 108.642 -0.873 . . . . 64.5 108.642 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -135.12 140.84 45.77 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.155 -0.683 . . . . 74.54 109.155 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -114.07 114.31 25.93 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.204 -1.035 . . . . 71.25 108.204 -174.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.461 ' HB ' ' HZ ' ' F' ' 15' ' ' PHE . 34.3 m -108.22 136.73 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.616 0.766 . . . . 71.24 110.431 -178.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 19.5 t -120.92 121.65 65.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 108.393 -0.966 . . . . 72.52 108.393 177.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.33 108.86 20.61 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 106.84 -1.541 . . . . 74.43 106.84 170.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.623 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 26.9 ttp180 -86.9 118.73 26.48 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.036 -0.728 . . . . 72.31 109.036 173.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 16.6 t -103.92 121.16 55.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.71 -1.218 . . . . 60.31 107.71 174.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 23.8 m -120.26 124.96 46.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.111 -0.7 . . . . 65.24 109.111 -178.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 97.9 t -123.9 113.53 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 124.216 1.006 . . . . 75.23 109.101 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 67.3 m -84.84 149.38 25.74 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.354 -0.98 . . . . 74.42 108.354 166.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.43 140.77 30.57 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.334 0.653 . . . . 64.24 109.663 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.542 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 21.0 p -145.71 130.05 17.69 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.17 0.51 . . . . 61.14 111.383 -176.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.55 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 28.6 mt -104.59 128.09 52.5 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.323 1.049 . . . . 73.4 109.004 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.99 -111.37 4.09 Favored Glycine 0 C--N 1.344 0.981 0 O-C-N 123.733 0.646 . . . . 63.14 112.196 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -118.46 10.79 12.78 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.575 0.75 . . . . 73.23 111.55 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -129.7 159.31 36.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.732 0.413 . . . . 61.23 110.759 -175.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.1 m -73.19 121.19 19.89 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 116.043 -0.526 . . . . 60.11 110.317 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.558 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -76.48 -61.68 1.88 Allowed 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.049 -1.093 . . . . 63.35 108.049 177.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -157.52 165.11 36.5 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.953 -1.022 . . . . 73.11 111.9 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 46.1 mt -125.6 112.0 15.65 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 106.043 -1.836 . . . . 62.24 106.043 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.419 ' SG ' HG23 ' B' ' 114' ' ' ILE . 34.8 t -117.15 148.93 41.15 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.665 -0.865 . . . . 75.13 108.665 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 41.9 tt0 -163.88 132.42 3.7 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.167 0.587 . . . . 73.22 109.531 -173.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 98.8 t -132.86 147.04 31.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 123.757 0.823 . . . . 74.23 109.186 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.623 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 64.4 mt-30 -118.41 103.96 10.27 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.601 -0.889 . . . . 64.11 108.601 169.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -94.62 100.52 12.45 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.195 -1.039 . . . . 61.45 108.195 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.401 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -90.12 153.42 22.9 Favored Glycine 0 C--O 1.242 0.606 0 CA-C-N 114.998 -1.001 . . . . 72.45 111.159 175.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.8 126.25 1.85 Allowed Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 111.316 -0.714 . . . . 72.34 111.316 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 48.3 mt -85.49 128.21 39.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 107.546 -1.279 . . . . 71.24 107.546 170.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -138.61 149.95 45.77 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.129 -0.693 . . . . 64.43 109.129 176.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 69.8 m -94.52 100.33 12.33 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.464 -0.939 . . . . 73.32 108.464 170.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.449 ' O ' ' HB1' ' F' ' 21' ' ' ALA . 1.8 pp -116.1 110.77 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.358 -0.979 . . . . 64.33 108.358 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.32 170.13 21.71 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.33 0.652 . . . . 74.41 110.886 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.84 -65.63 0.25 Allowed Glycine 0 C--N 1.346 1.138 0 CA-C-O 119.672 -0.516 . . . . 74.34 113.151 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' B' ' 9' ' ' MET . 3.4 tt -82.55 170.07 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 117.597 0.698 . . . . 74.54 110.037 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -152.62 160.74 43.17 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.028 0.931 . . . . 75.33 109.172 -167.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.83 -134.47 11.7 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 110.947 -0.861 . . . . 65.41 110.947 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' B' ' 95' ' ' ALA . 12.4 m -93.47 -18.32 22.45 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 117.247 0.523 . . . . 73.43 110.575 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.39 -26.04 60.82 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.695 -0.628 . . . . 52.0 111.108 -174.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -64.84 -31.76 73.15 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 119.485 -0.293 . . . . 74.53 110.439 171.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' B' ' 92' ' ' THR . . . -59.81 -38.73 82.77 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.665 0.786 . . . . 72.51 111.135 176.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -65.34 -39.21 92.1 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.404 -0.817 . . . . 74.11 111.359 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 40.2 t -66.56 -41.46 88.58 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.626 0.602 . . . . 72.15 112.626 -173.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.574 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.0 pt? -101.35 -14.31 17.66 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 117.862 0.301 . . . . 63.13 111.664 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.32 -21.43 24.81 Favored Glycine 0 C--N 1.352 1.425 0 N-CA-C 114.3 0.48 . . . . 73.23 114.3 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.23 -54.12 1.7 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.487 0.715 . . . . 72.24 110.159 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -69.69 -52.74 23.0 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.299 0.64 . . . . 73.41 112.288 -171.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.579 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 69.0 m -59.11 -49.02 95.29 Favored Pre-proline 0 CA--C 1.565 1.555 0 CA-C-O 119.04 -0.505 . . . . 74.21 112.143 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 39.1 Cg_exo -63.54 -27.73 69.95 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 122.217 1.944 . . . . 75.22 113.835 173.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -63.54 -37.68 88.25 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.032 0.533 . . . . 53.42 109.771 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.455 HD13 HD11 ' B' ' 13' ' ' ILE . 72.1 mt -65.48 -42.43 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.781 0.832 . . . . 65.43 110.2 175.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 91.9 mt -76.96 -20.36 56.21 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.949 -1.023 . . . . 75.42 111.833 -175.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -54.03 -55.79 32.57 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 124.136 0.974 . . . . 72.25 113.151 -176.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -59.34 -31.38 94.88 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.085 1.857 . . . . 74.41 113.737 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -69.73 -46.31 66.2 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.395 0.678 . . . . 73.33 110.503 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.2 -38.66 88.5 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.582 0.753 . . . . 43.23 110.992 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -61.88 -53.37 56.79 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.092 1.357 . . . . 74.04 110.778 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.01 -33.38 75.92 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.524 -0.762 . . . . 74.33 109.716 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.485 ' O ' ' HG2' ' B' ' 117' ' ' MET . 38.0 t -64.6 -44.52 90.37 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 123.51 0.506 . . . . 74.0 111.715 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.494 ' O ' HG23 ' B' ' 118' ' ' VAL . 72.9 mt -59.59 -55.01 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 109.12 -0.696 . . . . 62.24 109.12 175.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.1 m -62.26 -28.1 69.48 Favored 'General case' 0 CA--C 1.552 1.044 0 O-C-N 123.633 0.583 . . . . 55.31 112.122 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.7 t -64.5 -48.04 76.66 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.258 -0.645 . . . . 43.42 109.258 175.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.8 mmt -70.75 -33.86 71.26 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.053 0.541 . . . . 71.44 110.663 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.494 HG23 ' O ' ' B' ' 114' ' ' ILE . 97.2 t -61.51 -43.4 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.536 0.734 . . . . 73.21 110.067 173.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.8 t -64.56 -37.59 88.08 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.058 -0.974 . . . . 72.23 110.806 178.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' B' ' 116' ' ' SER . 89.7 mtt-85 -66.58 -32.87 74.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.601 -0.727 . . . . 62.32 110.411 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.6 12.21 59.68 Favored Glycine 0 C--N 1.349 1.29 0 O-C-N 123.933 0.771 . . . . 64.41 113.013 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 76.4 p 53.08 27.95 6.31 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 126.161 1.784 . . . . 73.43 113.324 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -86.69 155.37 56.21 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.417 0.687 . . . . 74.43 110.292 177.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.0 176.45 2.47 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.112 2.541 . . . . 65.02 113.784 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.639 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 0.0 OUTLIER -62.93 124.71 21.77 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.878 -1.056 . . . . 73.3 111.8 -173.091 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -144.05 102.92 3.95 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.218 -1.031 . . . . 54.51 108.218 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -119.05 135.08 54.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.02 0.928 . . . . 72.33 108.987 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.485 HD23 HD11 ' F' ' 6' ' ' ILE . 91.8 mt -69.39 145.32 52.97 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.127 0.571 . . . . 62.51 110.589 174.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.3 150.92 65.12 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 122.94 0.496 . . . . 73.4 110.992 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.444 ' CG ' HD13 ' D' ' 16' ' ' ILE . 33.0 Cg_exo -61.54 108.35 0.6 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.149 2.566 . . . . 72.13 111.893 175.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.536 HG21 ' HB2' ' F' ' 8' ' ' LEU . 66.1 t -112.33 111.04 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.573 -0.899 . . . . 63.32 108.573 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -96.88 93.04 6.42 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.258 -1.016 . . . . 71.12 108.258 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.532 ' HD1' HD12 ' F' ' 10' ' ' LEU . 63.8 m-85 -61.48 -40.63 95.23 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.89 0.876 . . . . 74.41 110.301 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -57.61 -43.64 84.86 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.914 1.286 . . . . 71.53 111.677 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.53 -40.13 95.03 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.623 0.769 . . . . 71.0 111.072 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.454 HD22 HD22 ' F' ' 10' ' ' LEU . 4.1 tt -66.4 -42.81 87.31 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.026 0.53 . . . . 74.12 109.66 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -66.03 -30.97 71.6 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.143 0.577 . . . . 72.32 111.404 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -67.9 -37.48 81.78 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.975 0.51 . . . . 51.52 110.723 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -73.67 -23.03 59.78 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 122.656 0.382 . . . . 63.15 110.472 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -70.4 -36.62 74.17 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.905 0.482 . . . . 74.12 110.472 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 71.7 mt -89.52 4.53 48.93 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.537 0.735 . . . . 62.34 111.847 -176.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -73.26 101.09 3.29 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.01 0.524 . . . . 64.42 110.384 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -134.3 108.01 7.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.803 0.841 . . . . 74.04 108.954 176.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -170.49 110.11 0.37 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.097 -1.446 . . . . 73.34 107.097 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.56 131.44 44.78 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.173 0.589 . . . . 60.42 110.624 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.64 117.55 5.22 Favored Glycine 0 C--N 1.348 1.239 0 O-C-N 123.659 0.6 . . . . 73.12 111.658 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -111.65 140.68 46.07 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.467 0.707 . . . . 65.45 110.484 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 140.02 152.86 5.91 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.726 -0.55 . . . . 74.2 111.726 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 15.3 t -163.74 170.76 16.52 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.288 0.635 . . . . 75.11 110.718 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -143.22 163.1 33.87 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.77 0.828 . . . . 61.44 110.042 173.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -166.75 119.74 1.01 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.153 0.981 . . . . 62.34 108.739 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -129.62 101.79 6.07 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.698 0.799 . . . . 73.44 109.939 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -84.89 84.01 7.85 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 108.809 -0.811 . . . . 72.42 108.809 171.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -89.96 151.57 21.63 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.843 0.857 . . . . 72.41 110.44 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 C-N-CA 124.068 0.947 . . . . 63.51 108.988 178.844 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 58.6 ttp . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.986 -0.375 . . . . 73.33 109.986 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 49.3 m -75.03 80.87 2.21 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.291 0.636 . . . . 73.03 109.855 173.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -77.11 -75.06 0.22 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.864 -0.791 . . . . 62.14 108.864 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -104.52 89.9 3.35 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 108.322 -0.992 . . . . 70.11 108.322 171.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -142.02 147.45 36.9 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 108.093 -1.077 . . . . 75.22 108.093 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -56.14 -48.04 77.01 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.065 0.853 . . . . 71.31 109.366 174.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 17.7 m 65.51 146.39 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 O-C-N 125.083 1.489 . . . . 75.22 111.757 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -112.14 120.67 42.6 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 106.599 -1.63 . . . . 72.54 106.599 174.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.873 ' HE1' ' HA ' ' C' ' 86' ' ' ILE . 0.0 OUTLIER 65.08 120.77 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.304 0 O-C-N 124.605 1.191 . . . . 72.53 111.456 178.789 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 28.0 m -86.57 85.29 7.3 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.282 -1.007 . . . . 65.54 108.282 175.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.676 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 4.2 t80 -121.08 126.79 50.72 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 114.83 -1.077 . . . . 75.54 110.383 -171.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -148.19 121.8 9.19 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.86 -1.163 . . . . 61.4 107.86 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.403 HG12 ' CD2' ' C' ' 84' ' ' PHE . 69.2 mt -73.15 124.43 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 109.491 -0.559 . . . . 65.44 109.491 178.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.411 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 9.6 mm100 -88.8 -47.87 7.9 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.102 -0.954 . . . . 74.04 109.636 -175.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -170.04 133.6 1.18 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.797 0.439 . . . . 73.35 110.529 -173.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 83.8 mt -116.11 146.28 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 108.007 -1.109 . . . . 62.41 108.007 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -174.9 169.19 3.48 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.366 0.666 . . . . 72.15 110.08 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 66.7 p -92.09 115.77 28.36 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.347 0.659 . . . . 71.54 109.364 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.639 ' HE2' ' HB3' ' D' ' 28' ' ' ALA . 23.1 mmtp -66.22 -47.62 73.24 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.615 0.721 . . . . 72.14 109.705 172.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 14.1 t70 -144.41 148.79 35.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.132 -1.394 . . . . 64.11 110.147 -175.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.499 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.7 mt -142.28 145.57 23.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.121 -1.437 . . . . 74.5 107.121 176.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 42.8 t -157.46 151.7 24.79 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.26 0.624 . . . . 64.21 110.676 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 86.1 t80 -148.5 146.12 28.21 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.674 -1.232 . . . . 63.54 107.674 170.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -145.71 132.04 19.58 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.815 0.846 . . . . 72.32 109.763 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.41 77.9 4.73 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 106.192 -1.781 . . . . 60.32 106.192 172.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -62.97 -37.65 52.16 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.902 2.402 . . . . 73.11 111.877 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -95.62 21.4 8.36 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.371 -1.286 . . . . 75.31 111.154 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.81 -53.67 9.66 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 113.744 1.016 . . . . 53.34 113.744 -173.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.68 -41.55 38.29 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 121.844 1.696 . . . . 71.53 112.4 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -69.52 -32.88 71.98 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.544 0.738 . . . . 75.13 112.197 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.756 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.1 p -78.14 -27.78 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 N-CA-C 112.359 0.503 . . . . 72.33 112.359 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -64.24 -28.31 69.65 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.466 0.543 . . . . 72.53 112.466 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -87.69 17.67 4.55 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.019 0.528 . . . . 72.21 111.409 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.541 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -109.8 158.25 18.34 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.944 0.898 . . . . 72.34 109.85 178.569 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -65.4 128.09 34.45 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.551 -0.537 . . . . 74.14 109.551 169.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -81.0 89.35 5.92 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.69 -0.686 . . . . 71.12 110.292 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.401 ' H ' HD22 ' C' ' 68' ' ' LEU . 20.4 tp60 -142.07 79.58 16.08 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.598 0.759 . . . . 64.34 109.131 171.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -89.21 178.23 2.64 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 122.553 2.169 . . . . 72.15 112.704 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -109.84 117.46 33.9 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.416 -1.327 . . . . 74.35 107.416 166.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.411 HG11 HD12 ' G' ' 6' ' ' ILE . 46.5 t -80.29 96.45 2.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 107.613 -1.254 . . . . 50.51 107.613 174.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.405 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 3.1 tppp? -105.66 100.2 9.77 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.284 -1.006 . . . . 71.34 108.284 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.471 HD13 ' HA ' ' G' ' 8' ' ' LEU . 1.0 OUTLIER -91.36 158.55 16.47 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.107 -0.952 . . . . 72.11 110.069 -177.392 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.443 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 27.7 t70 -152.95 148.27 26.92 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.609 0.764 . . . . 74.31 109.012 -177.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.473 HD13 HD21 ' G' ' 11' ' ' LEU . 9.7 tt -128.5 147.19 50.67 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.839 -0.8 . . . . 53.42 108.839 -176.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 25.6 t0 -146.36 147.11 30.97 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.592 -1.262 . . . . 72.04 107.592 173.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 18.5 p -114.84 112.3 22.54 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.459 0.704 . . . . 74.32 109.931 -173.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.22 151.75 27.89 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.463 1.105 . . . . 72.53 108.87 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 69.9 m -162.13 158.1 24.21 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.763 0.425 . . . . 55.52 111.787 -174.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 88.1 p -157.29 144.43 18.51 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.08 0.952 . . . . 53.53 109.121 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -87.83 126.19 34.88 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.767 -0.457 . . . . 70.25 109.767 176.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.703 HD11 HD12 ' C' ' 83' ' ' ILE . 71.6 mt -96.75 -43.92 7.31 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.548 -0.751 . . . . 74.32 110.109 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -156.35 -171.51 3.73 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.593 -0.73 . . . . 53.05 110.91 -176.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -66.64 108.22 2.39 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.115 -0.948 . . . . 71.42 110.038 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 70.94 -6.45 1.28 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.92 1.288 . . . . 75.15 112.772 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 42.2 t -92.2 97.06 6.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 107.011 -1.477 . . . . 71.32 107.011 173.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -120.93 124.92 46.11 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.244 -1.343 . . . . 54.41 107.985 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -83.5 125.42 31.73 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.169 -0.923 . . . . 43.1 109.778 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 6.0 m -112.09 127.09 69.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 108.026 -1.102 . . . . 72.44 108.026 171.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.578 HG12 ' HG2' ' C' ' 79' ' ' GLN . 21.9 t -121.29 134.97 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.799 -1.186 . . . . 54.21 107.799 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 13.1 tp -116.07 108.33 16.06 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.604 -0.517 . . . . 55.14 109.604 -175.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.48 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 7.3 tmm_? -84.39 105.84 15.54 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.882 -0.784 . . . . 74.44 108.882 177.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.477 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.6 t -100.32 136.31 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.585 -0.894 . . . . 63.34 108.585 175.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 51.4 m -122.94 141.67 51.66 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.239 -1.022 . . . . 64.11 108.239 173.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 75.4 t -132.85 110.05 15.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 107.75 -1.204 . . . . 72.3 107.75 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 4.5 m -99.01 144.21 28.42 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.146 -1.057 . . . . 71.53 108.146 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.71 119.41 17.16 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.443 -0.947 . . . . 41.3 108.443 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 51.6 m -136.91 132.8 34.97 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.696 0.622 . . . . 54.44 110.251 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.541 HD13 ' HG2' ' C' ' 34' ' ' LYS . 11.3 mt -85.22 47.96 1.5 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.133 1.373 . . . . 75.44 109.224 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.93 -109.56 3.53 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 110.256 -1.138 . . . . 73.14 110.256 -171.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -89.94 -32.15 16.95 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.988 0.515 . . . . 73.14 109.729 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -66.01 111.75 3.51 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.284 0.634 . . . . 53.43 109.374 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 26.4 m -79.66 125.65 29.91 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.306 -0.628 . . . . 75.42 109.306 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.756 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -81.98 -55.18 4.75 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.408 0.683 . . . . 63.04 109.837 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -157.59 166.81 31.89 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.704 0.764 . . . . 70.52 111.988 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -135.47 122.49 21.37 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 105.866 -1.901 . . . . 74.15 105.866 170.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.414 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 46.2 t -127.48 134.58 49.81 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.121 -1.066 . . . . 54.21 108.121 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -148.6 125.17 11.04 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.258 0.348 . . . . 70.35 110.644 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.6 t -131.51 134.4 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 124.107 0.963 . . . . 70.21 108.927 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.578 ' HG2' HG12 ' C' ' 59' ' ' VAL . 5.4 tt0 -112.52 90.82 3.45 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.606 -1.627 . . . . 74.44 106.606 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -83.19 111.86 19.32 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.061 0.544 . . . . 75.42 110.437 -171.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.41 146.57 18.24 Favored Glycine 0 C--N 1.337 0.63 0 O-C-N 123.491 0.494 . . . . 74.2 112.492 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.99 118.07 0.92 Allowed Glycine 0 C--O 1.243 0.697 0 N-CA-C 110.987 -0.845 . . . . 54.43 110.987 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.703 HD12 HD11 ' C' ' 51' ' ' LEU . 12.9 mm -81.98 116.93 27.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 108.556 -0.905 . . . . 74.33 108.556 174.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.668 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 54.8 m-85 -130.92 144.27 51.35 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.955 -0.757 . . . . 73.13 108.955 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 13.1 p -91.16 118.76 30.71 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 108.915 -0.772 . . . . 71.31 108.915 170.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.873 ' HA ' ' HE1' ' C' ' 9' ' ' MET . 4.4 mp -113.68 101.37 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.944 0.898 . . . . 61.11 108.621 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.474 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -146.19 170.45 16.7 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.109 0.963 . . . . 72.52 110.037 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.76 -49.35 2.55 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 116.341 -0.39 . . . . 64.41 112.141 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 33.8 pt -118.67 159.73 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.707 0.803 . . . . 71.11 110.252 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -147.67 -178.15 6.1 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.776 0.83 . . . . 53.02 109.907 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.98 -142.9 45.68 Favored Glycine 0 C--N 1.351 1.373 0 O-C-N 123.222 0.326 . . . . 70.35 112.94 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 1.2 m -68.82 -23.78 64.31 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.983 0.513 . . . . 74.22 110.699 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -57.74 -57.15 14.03 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 124.118 0.967 . . . . 70.44 109.891 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.466 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 22.3 ptt? -69.8 -30.27 67.77 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.146 -0.479 . . . . 64.1 110.766 178.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.04 -30.65 69.33 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.133 0.573 . . . . 33.15 111.181 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.476 ' NE2' ' HB2' ' C' ' 134' ' ' ASP . 32.3 t-80 -62.5 -46.02 90.33 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.263 -0.88 . . . . 64.11 110.862 170.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.553 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 31.4 t -69.21 -64.57 0.85 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.05 0.219 . . . . 74.34 111.072 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.52 HD22 HG23 ' G' ' 18' ' ' VAL . 3.7 pp -67.6 -31.47 71.54 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 113.146 0.795 . . . . 74.24 113.146 -173.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 99' ' ' GLY . . . . . 0.419 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -102.8 6.99 52.56 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 114.63 0.612 . . . . 43.32 114.63 -171.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -151.12 -60.83 0.18 Allowed 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.365 0.603 . . . . 75.45 110.824 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.553 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 5.0 t80 -74.81 -34.3 62.34 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 125.011 1.324 . . . . 74.51 112.757 -171.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.416 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 80.1 m -78.39 -43.81 2.07 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 123.356 0.662 . . . . 61.23 111.057 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 51.7 Cg_exo -60.92 -27.14 84.34 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 121.943 1.762 . . . . 71.14 112.403 166.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -64.92 -34.93 79.58 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 123.313 0.645 . . . . 62.11 110.696 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.471 HG23 ' NH1' ' A' ' 111' ' ' ARG . 45.6 mm -60.46 -38.33 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 121.326 0.584 . . . . 64.41 109.49 172.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 79.5 mt -89.12 -13.71 37.9 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.549 1.14 . . . . 63.32 112.655 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -57.43 -49.83 91.61 Favored Pre-proline 0 N--CA 1.485 1.281 0 CA-C-O 118.126 -0.94 . . . . 72.34 112.87 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.96 -35.18 78.64 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.179 1.919 . . . . 71.24 113.07 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -66.02 -50.75 63.13 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.517 0.727 . . . . 70.43 111.367 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.63 -42.83 99.82 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.747 -0.66 . . . . 71.34 109.901 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -54.85 -53.22 58.23 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.124 1.37 . . . . 75.22 111.052 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -69.09 -36.56 77.72 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.945 0.778 . . . . 74.2 110.283 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.0 t -68.78 -34.54 75.73 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.929 0.491 . . . . 53.2 111.049 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.477 HD11 ' HB ' ' C' ' 62' ' ' VAL . 87.5 mt -69.62 -53.61 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.349 0.66 . . . . 61.44 109.611 175.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 16.8 m -64.56 -29.16 70.18 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.269 0.628 . . . . 75.42 111.28 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.3 t -64.29 -49.94 69.83 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.063 -0.717 . . . . 63.23 109.063 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.733 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.54 -37.92 82.79 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.325 1.05 . . . . 74.2 112.179 178.685 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 69.9 t -66.84 -40.41 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 123.274 0.63 . . . . 73.02 110.137 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 20.9 t -74.09 -23.25 59.3 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.714 0.805 . . . . 74.05 111.576 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 86.3 mtt-85 -76.2 -38.88 55.94 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.706 0.803 . . . . 74.11 108.86 174.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.02 -1.18 67.39 Favored Glycine 0 C--N 1.355 1.627 0 O-C-N 123.974 0.797 . . . . 34.2 112.256 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.7 p 64.64 23.41 12.8 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.926 2.09 . . . . 73.1 113.14 171.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -81.75 143.28 50.21 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 108.209 -1.034 . . . . 62.51 108.209 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.639 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 66.6 Cg_exo -45.23 145.21 3.69 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 123.645 2.896 . . . . 60.04 114.826 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -53.96 114.38 1.56 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.592 1.157 . . . . 71.14 112.593 -175.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 36.8 tp -109.52 94.09 4.85 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.139 -0.937 . . . . 74.15 109.224 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -94.45 115.54 27.73 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.213 0.605 . . . . 62.55 109.709 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.479 HD13 ' H ' ' C' ' 129' ' ' ALA . 0.2 OUTLIER -72.13 149.03 45.12 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.644 0.778 . . . . 73.52 109.781 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.479 ' H ' HD13 ' C' ' 128' ' ' LEU . . . -80.54 156.32 73.33 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.471 0.709 . . . . 52.32 111.194 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.429 ' HG3' HG21 ' A' ' 13' ' ' ILE . 28.7 Cg_endo -61.69 137.39 68.34 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 123.117 2.544 . . . . 63.04 112.274 172.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.494 HG21 ' H ' ' G' ' 8' ' ' LEU . 15.7 t -128.75 110.27 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 108.948 -0.76 . . . . 63.0 108.948 176.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.416 ' O ' ' HB2' ' C' ' 136' ' ' LEU . 12.8 m120 -100.17 91.43 4.75 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.771 0.828 . . . . 73.13 109.336 175.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -65.84 -40.56 91.86 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.163 -0.68 . . . . 53.42 109.163 171.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.476 ' HB2' ' NE2' ' C' ' 96' ' ' HIS . 7.0 p-10 -55.01 -42.14 72.16 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.538 1.535 . . . . 70.4 112.35 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.46 -32.11 24.2 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.046 0.938 . . . . 71.14 110.959 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.477 HD12 HD13 ' G' ' 10' ' ' LEU . 1.5 tm? -59.73 -44.5 93.73 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.833 0.853 . . . . 72.24 110.791 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -62.95 -31.73 72.89 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.14 0.576 . . . . 73.1 111.299 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 62.7 mtt -73.16 -38.55 66.17 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.977 0.511 . . . . 60.12 110.981 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -70.75 -44.1 67.45 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.561 0.745 . . . . 72.42 110.489 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -72.2 -87.1 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.898 0.879 . . . . 74.43 110.321 175.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 46.3 tp 63.95 -72.39 0.06 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 125.108 1.363 . . . . 71.01 111.884 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -76.96 -65.07 0.99 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.836 -0.801 . . . . 64.24 108.836 172.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -179.72 161.21 0.98 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.507 1.123 . . . . 74.33 108.528 -174.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -71.06 82.19 0.69 Allowed 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.727 0.811 . . . . 62.53 110.569 174.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.15 -35.46 77.15 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.814 0.846 . . . . 74.32 111.316 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.42 71.03 1.02 Allowed Glycine 0 C--N 1.348 1.234 0 CA-C-N 115.693 -0.685 . . . . 74.43 112.271 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -72.38 144.64 48.15 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.365 0.666 . . . . 74.53 111.151 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -73.13 69.82 1.29 Allowed Glycine 0 C--N 1.345 1.038 0 N-CA-C 111.379 -0.689 . . . . 60.21 111.379 169.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 149' ' ' THR . . . . . 0.614 ' HB ' ' HB2' ' A' ' 9' ' ' MET . 41.3 p -70.16 -25.8 63.63 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.609 1.163 . . . . 62.12 112.123 -172.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.69 122.15 30.18 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.299 0.639 . . . . 74.52 110.453 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -99.39 -33.75 10.57 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.192 -0.67 . . . . 63.45 109.192 167.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 56.38 82.79 0.11 Allowed 'General case' 0 C--N 1.358 0.941 0 C-N-CA 125.084 1.354 . . . . 74.33 111.53 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -75.0 132.38 41.32 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.146 -1.057 . . . . 73.11 108.146 170.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -144.33 -67.99 0.32 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.037 0.535 . . . . 70.22 110.353 -168.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.522 -0.751 . . . . 70.32 109.026 -179.891 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.972 -0.381 . . . . 73.35 109.972 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 25.7 p -69.98 85.17 0.51 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.917 0.887 . . . . 62.33 110.102 175.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -132.06 168.45 17.93 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.636 1.174 . . . . 75.41 107.833 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -53.2 104.77 0.1 Allowed 'General case' 0 C--N 1.353 0.735 0 N-CA-C 108.864 -0.791 . . . . 54.42 108.864 171.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -74.43 74.57 1.91 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 122.207 1.003 . . . . 74.22 111.822 -172.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -124.32 83.19 2.12 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 106.807 -1.553 . . . . 74.01 106.807 174.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 10.7 t -164.5 168.4 18.39 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.913 -1.04 . . . . 73.32 109.273 -175.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -104.31 85.7 2.41 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.55 -0.907 . . . . 75.23 108.55 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 17.9 ptm -31.33 141.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.407 1.483 . . . . 72.22 114.451 175.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 24.3 m -106.38 143.53 34.36 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 109.171 -0.677 . . . . 72.34 109.171 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -158.73 97.88 1.47 Allowed 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.625 -1.25 . . . . 70.02 107.625 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -117.02 120.56 38.74 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.367 0.667 . . . . 75.52 109.263 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 19.4 mt -78.0 115.16 19.58 Favored 'Isoleucine or valine' 0 C--N 1.345 0.412 0 N-CA-C 108.968 -0.753 . . . . 45.12 108.968 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -90.7 -44.61 9.38 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 122.857 0.463 . . . . 73.22 111.721 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.435 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 40.8 ttt180 -173.85 126.11 0.37 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 112.049 0.388 . . . . 74.44 112.049 -171.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.444 HD13 ' CG ' ' B' ' 130' ' ' PRO . 2.2 mp -104.17 141.57 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.421 -0.955 . . . . 74.52 108.421 170.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.435 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 22.4 p90 -162.72 151.4 14.66 Favored 'General case' 0 C--O 1.238 0.487 0 O-C-N 124.221 0.95 . . . . 74.13 110.571 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.7 p -83.88 120.32 25.93 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.281 -0.872 . . . . 71.31 108.856 172.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -91.33 -17.34 26.05 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.7 0.4 . . . . 72.1 110.525 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.721 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 17.5 t70 -162.7 134.98 5.46 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.641 -0.874 . . . . 73.44 108.641 -174.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.733 HG21 ' HE2' ' C' ' 117' ' ' MET . 88.1 mt -139.28 151.77 23.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 C-N-CA 124.337 1.055 . . . . 70.41 108.321 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 22' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 26.6 t -152.02 145.44 24.81 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 124.402 1.081 . . . . 72.23 109.628 175.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.499 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.7 t80 -151.55 122.46 7.58 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 105.703 -1.962 . . . . 75.44 105.703 169.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -136.51 111.43 8.86 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.821 -0.807 . . . . 74.23 108.821 -176.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.85 91.21 4.09 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.249 -1.019 . . . . 74.41 108.249 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.09 -34.5 10.18 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.968 2.445 . . . . 64.53 113.003 -169.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -112.22 10.81 20.16 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 118.556 -0.735 . . . . 73.13 110.711 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.639 ' HB3' ' HE2' ' C' ' 19' ' ' LYS . . . -18.4 -72.77 0.02 OUTLIER Pre-proline 0 CA--C 1.565 1.556 0 N-CA-C 116.455 2.02 . . . . 72.0 116.455 -168.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 44.1 Cg_endo -80.29 -13.48 12.4 Favored 'Trans proline' 0 C--N 1.377 2.072 0 CA-C-N 123.903 2.43 . . . . 74.21 114.041 -172.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -77.51 -39.79 45.02 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.573 1.149 . . . . 53.4 109.136 172.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.557 HG22 HD12 ' D' ' 68' ' ' LEU . 4.8 p -84.12 -20.53 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.461 -0.791 . . . . 73.31 111.647 -175.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.404 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 21.1 m-85 -66.04 -25.16 66.92 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 120.669 0.271 . . . . 74.41 111.455 177.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -60.07 -26.34 66.09 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.25 -0.886 . . . . 73.01 110.183 175.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -90.94 76.54 6.24 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.972 1.309 . . . . 70.13 109.647 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -85.35 92.11 8.37 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.947 -0.569 . . . . 74.32 111.132 -176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -155.25 177.84 10.89 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.881 0.873 . . . . 74.2 108.979 166.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -66.43 110.5 4.89 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.8 0.84 . . . . 73.52 109.272 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -59.48 120.51 8.38 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.954 2.436 . . . . 54.22 111.631 -175.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -69.58 115.03 8.36 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.763 0.664 . . . . 71.52 109.489 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.414 HG13 HG13 ' D' ' 64' ' ' VAL . 58.3 t -105.91 137.48 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.003 0.921 . . . . 74.04 111.105 -169.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -109.04 142.08 40.24 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.358 -1.349 . . . . 73.13 107.358 166.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.579 HD21 HD12 ' H' ' 6' ' ' ILE . 3.4 mm? -103.28 148.86 25.32 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.283 -0.636 . . . . 71.3 109.283 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -149.56 130.11 13.96 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.111 -1.07 . . . . 75.23 108.111 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.536 HD21 HD21 ' H' ' 8' ' ' LEU . 5.4 mp -119.51 146.85 45.08 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.251 0.548 . . . . 73.1 110.325 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 16.2 t70 -132.42 144.17 50.31 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.388 1.075 . . . . 75.32 108.236 175.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 57.2 m -104.21 143.15 33.33 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.864 0.866 . . . . 73.15 109.689 -175.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.579 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.51 142.08 17.68 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.98 0.912 . . . . 64.35 108.983 178.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.43 ' HB3' ' HE2' ' H' ' 15' ' ' PHE . 25.4 p -162.73 158.41 22.93 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 122.911 0.484 . . . . 45.43 110.132 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 81.4 p -151.82 144.28 24.14 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.799 -0.815 . . . . 63.23 108.799 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -87.3 117.8 26.3 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.096 -0.705 . . . . 72.35 109.096 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' D' ' 57' ' ' GLU . 26.1 mt -91.09 -24.3 20.05 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.721 -0.672 . . . . 60.14 110.204 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -172.79 178.55 2.59 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.529 1.131 . . . . 72.44 109.284 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -75.3 135.44 40.91 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.484 -0.932 . . . . 74.24 108.484 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 69.05 2.18 3.49 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.65 1.18 . . . . 73.34 113.024 -171.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 68.9 t -124.13 131.24 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.251 0.621 . . . . 71.41 109.817 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -134.66 153.97 51.74 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 123.189 0.595 . . . . 73.12 110.922 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.54 ' HB2' HD11 ' D' ' 51' ' ' LEU . 14.3 tt0 -110.83 120.3 41.95 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.3 -1.318 . . . . 72.52 107.851 165.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' D' ' 102' ' ' CYS . 33.2 m -106.89 132.45 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 108.485 -0.931 . . . . 61.21 108.485 173.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 38.7 t -125.89 125.49 68.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 N-CA-C 108.934 -0.765 . . . . 60.32 108.934 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.629 HD22 ' HB3' ' D' ' 103' ' ' PRO . 52.0 tp -115.91 117.49 30.33 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.2 -0.667 . . . . 72.43 109.2 177.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 46.4 ttm-85 -87.34 101.52 13.64 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.948 -0.76 . . . . 74.13 108.948 176.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 99.4 t -91.53 121.31 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.975 -0.75 . . . . 74.24 108.975 174.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.6 m -120.11 142.78 48.59 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.454 0.645 . . . . 74.11 109.789 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.414 HG13 HG13 ' D' ' 40' ' ' VAL . 25.4 t -130.59 102.37 6.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 126.134 1.774 . . . . 71.31 107.606 -171.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 21.2 m -95.2 97.61 10.02 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.487 -0.931 . . . . 74.13 108.487 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.4 147.02 27.23 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.114 -0.948 . . . . 71.23 108.994 -172.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.457 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.0 p -149.75 138.06 20.59 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 123.535 0.522 . . . . 75.33 111.6 -177.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.557 HD12 HG22 ' D' ' 31' ' ' VAL . 26.1 mt -115.8 111.66 20.83 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.444 -1.253 . . . . 62.22 107.619 171.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.3 -134.72 21.56 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 116.477 -0.328 . . . . 71.44 113.084 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -86.15 2.89 45.09 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.344 0.658 . . . . 75.0 112.571 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -131.57 160.55 34.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.875 0.47 . . . . 64.41 110.064 -171.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 62.5 m -69.39 136.07 51.16 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.265 -0.879 . . . . 73.41 110.492 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.524 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -84.08 -65.8 0.97 Allowed 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.664 -1.235 . . . . 71.5 107.664 174.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -152.43 158.96 43.37 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.154 -0.93 . . . . 71.23 110.458 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 69.5 mt -122.82 108.26 12.81 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.621 -1.622 . . . . 61.34 106.621 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.421 ' SG ' HG23 ' D' ' 114' ' ' ILE . 52.8 t -117.48 138.16 52.05 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.924 -0.769 . . . . 61.14 108.924 -175.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 77' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 38.2 tt0 -152.98 133.73 13.88 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.785 -0.45 . . . . 74.12 109.785 -175.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 54.0 t -139.96 119.3 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.395 0.678 . . . . 74.33 109.678 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.721 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.9 mt-30 -86.58 89.94 8.08 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 108.366 -0.975 . . . . 73.13 108.366 165.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 80' ' ' GLN . . . . . 0.446 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.7 tp-100 -83.01 104.91 13.57 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.937 -1.134 . . . . 75.42 107.937 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -103.92 162.09 15.55 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 111.934 -0.466 . . . . 32.01 111.934 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.0 133.75 3.51 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 112.117 -0.393 . . . . 64.04 112.117 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.402 HG23 HD12 ' D' ' 51' ' ' LEU . 39.0 mt -88.79 128.12 41.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 108.558 -0.905 . . . . 61.11 108.558 174.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.462 ' HB2' HD11 ' D' ' 86' ' ' ILE . 79.8 m-85 -133.97 157.07 46.98 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.888 1.275 . . . . 73.54 108.624 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.8 m -114.63 99.15 7.31 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.802 0.841 . . . . 71.13 108.913 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.462 HD11 ' HB2' ' D' ' 84' ' ' PHE . 2.8 mp -109.66 126.73 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.463 0.705 . . . . 74.44 109.637 -173.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.24 165.04 33.1 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.932 0.893 . . . . 72.13 109.702 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.93 20.97 79.2 Favored Glycine 0 C--N 1.346 1.115 0 N-CA-C 114.413 0.525 . . . . 71.15 114.413 173.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 7.3 mt -129.21 157.26 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.32 0.648 . . . . 73.44 109.443 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.81 -174.5 4.8 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.481 0.712 . . . . 65.34 111.01 175.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.98 -141.45 39.8 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.26 -0.882 . . . . 25.13 114.274 173.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 15.6 m -90.22 -13.56 35.22 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.234 0.613 . . . . 42.55 110.095 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -63.0 -37.69 88.21 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.953 0.901 . . . . 73.43 110.806 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.657 ' HB2' HG23 ' H' ' 18' ' ' VAL . 25.5 ptt? -73.04 -33.13 65.51 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.879 0.472 . . . . 71.12 111.614 177.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.97 -33.67 74.08 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.778 0.431 . . . . 34.44 110.364 174.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -74.18 -32.45 63.08 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.557 0.743 . . . . 65.03 110.612 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.1 t -63.18 -50.66 69.47 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.395 0.617 . . . . 75.11 110.242 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.406 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 47.5 mt -83.04 -21.08 33.91 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.893 -1.048 . . . . 52.14 111.26 -176.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 99' ' ' GLY . . . . . 0.716 ' HA2' ' HB2' ' H' ' 15' ' ' PHE . . . -87.32 -16.95 59.72 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.612 0.57 . . . . 61.52 114.289 -178.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.2 -64.09 0.7 Allowed 'General case' 0 C--O 1.239 0.515 0 C-N-CA 122.685 0.394 . . . . 74.11 111.799 -172.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -63.53 -44.58 93.81 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 112.485 0.55 . . . . 62.53 112.485 -172.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.511 ' HB3' HG21 ' D' ' 58' ' ' VAL . 56.7 m -66.91 -47.3 53.98 Favored Pre-proline 0 CA--C 1.57 1.723 0 CA-C-O 118.943 -0.551 . . . . 70.24 112.105 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.629 ' HB3' HD22 ' D' ' 60' ' ' LEU . 72.2 Cg_exo -56.8 -29.66 81.89 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 122.427 2.084 . . . . 71.32 113.932 168.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -68.59 -26.0 65.16 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.109 0.564 . . . . 75.55 111.81 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 30.3 mm -71.91 -39.22 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 121.243 0.544 . . . . 73.03 109.648 171.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.495 HD11 HG23 ' D' ' 58' ' ' VAL . 79.1 mt -80.08 -25.57 40.0 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.216 -0.902 . . . . 53.33 111.938 -175.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -59.5 -48.33 95.91 Favored Pre-proline 0 CA--C 1.562 1.409 0 N-CA-C 113.517 0.932 . . . . 73.44 113.517 -174.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.57 -40.05 83.5 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.079 1.853 . . . . 62.34 112.956 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -71.56 -38.63 70.94 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.837 0.855 . . . . 72.13 111.803 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.15 -47.27 74.6 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.281 0.632 . . . . 71.12 109.953 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -58.07 -46.93 84.62 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.154 0.909 . . . . 72.44 110.409 176.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -59.84 -49.67 76.81 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 123.923 0.764 . . . . 71.15 110.364 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.4 t -57.55 -45.33 85.26 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.74 0.65 . . . . 72.55 111.097 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.492 ' O ' HG23 ' D' ' 118' ' ' VAL . 94.4 mt -59.59 -58.09 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.688 0.795 . . . . 63.02 110.17 175.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 90.0 m -55.59 -39.59 70.93 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.254 1.022 . . . . 52.32 111.88 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 37.8 t -66.32 -41.7 89.27 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.321 -0.854 . . . . 64.24 109.754 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.402 ' HB2' ' HE3' ' D' ' 117' ' ' MET . 75.0 mtm -71.45 -28.37 63.92 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.937 0.495 . . . . 63.14 111.65 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.492 HG23 ' O ' ' D' ' 114' ' ' ILE . 97.3 t -63.45 -48.69 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.277 -0.638 . . . . 74.34 109.277 173.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 83.1 p -71.91 -28.62 63.61 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.791 -0.641 . . . . 65.31 110.985 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -69.97 -36.47 75.23 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.798 0.839 . . . . 64.2 109.948 173.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.9 2.15 87.88 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.923 0.764 . . . . 43.01 112.138 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.1 p 61.17 29.0 18.56 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.836 2.054 . . . . 65.13 114.0 173.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.438 ' HB2' HG13 ' D' ' 118' ' ' VAL . 97.8 m-85 -86.36 154.62 57.04 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.776 -0.824 . . . . 70.2 108.776 168.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -53.0 136.84 61.68 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.838 2.358 . . . . 72.41 112.693 175.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -52.85 128.98 28.71 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 124.289 0.993 . . . . 73.41 112.249 -174.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 56.9 tp -109.51 99.64 8.82 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.363 -0.835 . . . . 72.23 109.142 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -99.96 97.34 8.23 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.596 -0.89 . . . . 75.43 108.596 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.532 ' HG ' HD11 ' H' ' 6' ' ' ILE . 1.6 tt -67.97 116.43 8.6 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.199 -1.038 . . . . 75.41 108.199 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -57.14 133.51 80.68 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 123.372 0.669 . . . . 52.03 110.025 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 23.7 Cg_exo -62.4 115.38 2.84 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.623 2.216 . . . . 61.23 111.97 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 29.1 m -107.73 111.18 34.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 108.715 -0.846 . . . . 73.05 108.715 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -84.04 107.24 16.27 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.27 -0.877 . . . . 71.31 109.392 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -62.41 -31.63 72.34 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.889 0.743 . . . . 71.33 111.737 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -57.01 -56.06 26.65 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.228 0.611 . . . . 65.0 110.82 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.485 ' HA ' ' HG2' ' D' ' 138' ' ' MET . . . -59.59 -39.26 83.58 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.805 0.842 . . . . 72.04 111.713 -177.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.82 -41.03 99.14 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.364 -0.835 . . . . 72.31 111.073 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -66.97 -31.08 71.41 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.645 0.778 . . . . 74.25 112.343 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.485 ' HG2' ' HA ' ' D' ' 135' ' ' ALA . 13.0 mmt -56.96 -37.53 71.68 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.158 0.504 . . . . 74.2 110.397 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -82.99 -40.66 19.71 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.772 -1.103 . . . . 72.42 110.423 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -60.55 -35.76 76.82 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.604 0.762 . . . . 75.23 111.994 -177.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 6.4 mp -70.54 -33.23 70.92 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.913 0.885 . . . . 74.02 111.309 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -89.42 15.03 9.87 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 120.888 0.375 . . . . 75.11 110.786 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -119.39 91.7 3.61 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.422 1.089 . . . . 52.51 108.298 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -144.23 -4.83 0.79 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.102 -0.954 . . . . 65.2 110.879 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -111.02 130.54 55.56 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.748 0.819 . . . . 31.11 109.097 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.83 -72.12 0.48 Allowed Glycine 0 C--N 1.347 1.152 0 O-C-N 123.635 0.584 . . . . 62.21 112.051 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 58.63 82.41 0.14 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.932 1.293 . . . . 74.45 110.53 -173.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.11 146.08 17.93 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.538 -0.755 . . . . 71.55 112.922 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 9.0 t -96.79 68.06 2.36 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-O 122.462 1.125 . . . . 75.33 110.875 -177.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -83.57 91.4 7.42 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.488 -0.778 . . . . 72.31 109.094 174.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.77 150.21 29.43 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.4 -0.593 . . . . 64.34 109.4 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 -143.08 91.36 2.28 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.289 -1.004 . . . . 71.32 108.289 175.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -66.64 96.46 0.39 Allowed 'General case' 0 C--N 1.347 0.469 0 CA-C-N 115.726 -0.67 . . . . 74.11 109.332 175.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -88.03 -36.93 16.71 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.744 0.817 . . . . 62.3 109.585 175.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.254 0 C-N-CA 124.021 0.928 . . . . 73.45 108.693 177.005 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 109.841 -0.429 . . . . 73.33 109.841 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.83 161.39 42.77 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.226 0.61 . . . . 65.2 110.975 175.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -118.22 172.46 7.42 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 109.031 -0.729 . . . . 65.01 109.031 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 49.7 m -142.63 126.23 16.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.259 0.624 . . . . 62.54 109.495 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 5' ' ' THR . . . . . 0.425 HG22 HG13 ' E' ' 6' ' ' ILE . 21.3 m -80.28 169.17 18.12 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.741 0.816 . . . . 72.41 108.815 171.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.425 HG13 HG22 ' E' ' 5' ' ' THR . 2.8 pp -49.95 146.26 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.171 0.988 . . . . 74.43 112.445 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.62 141.18 29.2 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 122.816 0.446 . . . . 54.52 110.043 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.421 ' HB3' HD21 ' A' ' 44' ' ' LEU . 80.2 mt -67.45 135.77 53.62 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.127 -0.694 . . . . 63.53 109.127 172.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.64 158.41 34.14 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.172 0.589 . . . . 75.44 110.891 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 88.1 mt -58.77 124.04 18.43 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.766 0.426 . . . . 71.14 109.914 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.31 109.54 2.43 Favored Pre-proline 0 CA--C 1.549 0.932 0 O-C-N 124.554 1.158 . . . . 73.53 110.668 -176.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -83.68 166.87 13.4 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.713 2.275 . . . . 72.32 111.118 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 55.9 tp 76.5 -37.52 0.29 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.42 1.488 . . . . 64.22 112.36 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 14' ' ' LEU . . . . . 0.61 HD13 ' HB1' ' A' ' 95' ' ' ALA . 80.3 mt 68.18 106.94 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.87 1.268 . . . . 61.04 110.006 -175.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 15' ' ' PHE . . . . . 0.498 ' O ' ' HD3' ' E' ' 17' ' ' PRO . 13.5 m-85 -77.01 94.39 3.98 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.374 -0.972 . . . . 62.31 108.374 -174.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 16' ' ' THR . . . . . 0.592 ' HA ' HD22 ' A' ' 98' ' ' LEU . 24.3 m -97.52 97.03 3.56 Favored Pre-proline 0 CA--C 1.557 1.23 0 O-C-N 124.069 0.856 . . . . 72.01 112.029 -169.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 17' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' E' ' 15' ' ' PHE . 25.8 Cg_endo -101.8 5.74 0.53 Allowed 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 124.217 3.278 . . . . 72.32 113.168 178.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 18' ' ' VAL . . . . . 0.506 HG21 ' HA ' ' A' ' 87' ' ' ALA . 7.6 p -148.25 135.96 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.02 0.928 . . . . 74.52 108.975 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 83.6 m 63.84 121.47 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.539 1.149 . . . . 74.12 110.897 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -60.99 94.92 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 122.785 0.434 . . . . 74.13 110.658 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -133.14 100.79 4.97 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.585 0.754 . . . . 70.02 109.721 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -76.47 -30.47 57.3 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.865 0.866 . . . . 72.25 110.94 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 24.1 m 58.17 76.23 0.48 Allowed Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 125.038 1.335 . . . . 52.45 109.74 -168.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.83 177.0 6.8 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.117 2.545 . . . . 61.53 113.736 -170.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 . . . . . 0 C--O 1.251 1.133 0 C-N-CA 124.084 0.954 . . . . 62.24 109.082 -176.352 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 47.4 ttm . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 108.764 -0.828 . . . . 61.43 108.764 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.03 141.42 31.18 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.176 -0.92 . . . . 65.34 109.007 173.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -87.41 -0.06 56.23 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.208 1.003 . . . . 74.13 110.384 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 33.4 t -117.43 156.51 27.82 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.774 1.229 . . . . 73.11 108.861 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 94.1 m -140.89 -56.08 0.5 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.011 0.524 . . . . 65.02 110.914 -175.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.485 HD11 HD23 ' B' ' 128' ' ' LEU . 13.8 tt -153.57 148.01 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.106 0.562 . . . . 65.4 110.162 -170.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -175.81 146.51 0.73 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.364 1.066 . . . . 61.51 110.018 175.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 8' ' ' LEU . . . . . 0.536 ' HB2' HG21 ' B' ' 131' ' ' VAL . 75.6 mt -77.82 153.34 32.87 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.551 0.74 . . . . 64.23 110.729 176.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.85 163.98 17.78 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.953 0.501 . . . . 73.23 109.82 171.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 10' ' ' LEU . . . . . 0.532 HD12 ' HD1' ' B' ' 133' ' ' PHE . 22.7 tp -79.11 72.23 5.64 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 109.374 -0.602 . . . . 71.1 109.374 177.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.493 HD13 ' H ' ' F' ' 15' ' ' PHE . 55.9 mt 60.31 105.6 0.03 OUTLIER Pre-proline 0 N--CA 1.485 1.308 0 C-N-CA 124.381 1.072 . . . . 65.33 111.95 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -61.33 -11.13 18.02 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 123.039 2.493 . . . . 74.52 113.715 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -129.35 -88.22 0.52 Allowed 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 107.497 -1.297 . . . . 54.31 107.497 171.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 tm? 176.45 138.44 0.06 Allowed 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 106.774 -1.565 . . . . 71.34 106.774 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 15' ' ' PHE . . . . . 0.493 ' H ' HD13 ' F' ' 11' ' ' LEU . 14.8 t80 -82.52 116.91 22.16 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.465 -0.939 . . . . 75.2 108.465 177.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 16' ' ' THR . . . . . 0.742 ' H ' HG21 ' B' ' 46' ' ' THR . 44.9 p -50.61 115.98 6.35 Favored Pre-proline 0 CA--C 1.547 0.853 0 O-C-N 124.397 1.061 . . . . 75.43 111.576 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 17' ' ' PRO . . . . . 0.493 ' HA ' HD21 ' B' ' 98' ' ' LEU . 31.0 Cg_exo -62.44 163.72 19.98 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.473 2.115 . . . . 73.2 111.431 173.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 18' ' ' VAL . . . . . 0.488 ' HB ' HD13 ' B' ' 98' ' ' LEU . 8.4 p -72.55 128.95 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.838 0.351 . . . . 70.52 110.332 177.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 21.1 p -83.29 80.75 8.98 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.3 -1.0 . . . . 75.22 108.3 173.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt 64.98 95.47 0.05 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.101 1.36 . . . . 64.32 111.961 -174.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 21' ' ' ALA . . . . . 0.475 ' HB2' HG11 ' F' ' 18' ' ' VAL . . . -65.17 -43.67 90.98 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.736 0.814 . . . . 74.0 109.72 172.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.07 130.2 44.88 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 107.427 -1.323 . . . . 74.32 107.427 173.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -65.87 123.11 84.01 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 123.151 0.581 . . . . 75.44 111.402 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -81.63 -39.09 0.19 Allowed 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.61 2.207 . . . . 71.5 112.389 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.249 1.038 0 C-N-CA 124.692 1.197 . . . . 74.43 108.317 -179.436 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtm . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 108.378 -0.971 . . . . 62.52 108.378 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -127.41 148.93 50.28 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.688 0.795 . . . . 73.45 110.484 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 60.29 74.92 0.43 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.083 1.353 . . . . 73.14 111.177 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 15.2 t -90.98 94.14 9.51 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.158 -0.928 . . . . 70.52 108.925 177.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 9.2 m -69.27 156.34 38.93 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.724 0.81 . . . . 61.32 111.247 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 6' ' ' ILE . . . . . 0.411 HD12 HG11 ' C' ' 40' ' ' VAL . 22.6 pt -54.19 118.38 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.48 1.112 . . . . 71.44 112.274 -176.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.93 153.23 42.87 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.737 0.815 . . . . 54.33 109.943 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 8' ' ' LEU . . . . . 0.494 ' H ' HG21 ' C' ' 131' ' ' VAL . 6.2 mp -76.38 143.93 40.39 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.285 0.634 . . . . 61.02 110.469 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.84 152.23 43.39 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.034 0.834 . . . . 73.04 110.683 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 10' ' ' LEU . . . . . 0.477 HD13 HD12 ' C' ' 136' ' ' LEU . 50.9 tp -57.71 159.02 5.58 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 124.39 1.056 . . . . 63.54 110.758 -177.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 11' ' ' LEU . . . . . 0.473 HD21 HD13 ' C' ' 44' ' ' LEU . 58.4 mt -107.69 82.65 1.41 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.561 0.744 . . . . 74.4 110.417 176.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 12' ' ' PRO . . . . . 0.491 ' O ' ' HB ' ' G' ' 23' ' ' THR . 71.1 Cg_endo -74.49 -23.85 14.55 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 121.549 1.5 . . . . 63.23 110.601 170.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 54.8 mt -117.68 109.14 16.28 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.389 1.076 . . . . 72.13 108.521 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.57 -177.78 3.46 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.167 0.587 . . . . 72.33 110.896 175.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -73.32 -177.5 2.6 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.297 1.039 . . . . 72.14 111.749 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 22.3 p -69.36 113.35 16.16 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.564 0.746 . . . . 72.22 110.484 175.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 17' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.23 171.2 18.75 Favored 'Trans proline' 0 CA--C 1.556 1.611 0 C-N-CA 122.804 2.336 . . . . 73.14 113.215 -175.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 18' ' ' VAL . . . . . 0.52 HG23 HD22 ' C' ' 98' ' ' LEU . 23.7 t -76.75 -80.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.253 0.621 . . . . 63.31 110.831 -174.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 3.9 m -96.26 44.06 1.07 Allowed 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 124.188 0.995 . . . . 72.42 110.142 -173.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 70.06 124.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 125.221 1.408 . . . . 73.31 113.093 174.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.16 169.21 23.75 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.469 1.108 . . . . 74.31 109.342 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 22' ' ' ARG . . . . . 0.417 ' NE ' ' HA ' ' G' ' 22' ' ' ARG . 0.2 OUTLIER -120.19 161.85 20.36 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.631 0.372 . . . . 74.41 110.528 179.203 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 23' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' G' ' 12' ' ' PRO . 17.2 p -58.12 122.45 58.58 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.708 1.203 . . . . 65.33 111.044 175.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 24' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 59.3 Cg_endo -89.69 172.51 3.9 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 123.778 2.985 . . . . 72.41 114.018 -174.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 25' ' ' GLU . . . . . 0.644 ' HG3' ' HB3' ' A' ' 150' ' ' GLU . 6.0 mm-40 . . . . . 0 C--O 1.253 1.279 0 C-N-CA 125.497 1.519 . . . . 64.0 107.737 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptt? . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 109.469 -0.567 . . . . 73.5 109.469 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -150.73 101.3 2.91 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.415 -0.957 . . . . 42.21 108.415 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -119.91 92.82 3.87 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.69 0.796 . . . . 74.34 110.483 -176.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 50.9 m -149.17 65.68 1.03 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.981 0.912 . . . . 65.44 109.261 176.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 58.0 m -153.72 -46.41 0.09 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.753 0.821 . . . . 63.31 110.157 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.579 HD12 HD21 ' D' ' 42' ' ' LEU . 10.1 tp -142.91 132.84 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 C-N-CA 123.713 0.805 . . . . 72.24 108.897 -175.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.13 -62.2 0.21 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.722 0.409 . . . . 65.22 110.979 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 8' ' ' LEU . . . . . 0.536 HD21 HD21 ' D' ' 44' ' ' LEU . 5.5 tt 71.36 109.16 0.06 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.013 1.325 . . . . 61.54 109.676 -174.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.0 144.37 38.75 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.748 -0.66 . . . . 74.25 110.923 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 64.2 tp -71.89 144.26 49.07 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 123.763 0.664 . . . . 61.32 110.294 177.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -67.41 121.15 77.6 Favored Pre-proline 0 CA--C 1.549 0.92 0 O-C-N 123.88 0.737 . . . . 72.33 109.825 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.04 -25.4 38.02 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.783 2.322 . . . . 75.34 111.662 174.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 82.9 mt -98.53 138.85 35.14 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.814 0.846 . . . . 73.32 109.107 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 6.5 mp -90.65 49.59 1.69 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.33 0.652 . . . . 70.21 110.173 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 15' ' ' PHE . . . . . 0.716 ' HB2' ' HA2' ' D' ' 99' ' ' GLY . 1.2 t80 61.78 -90.42 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.881 1.273 . . . . 74.15 111.332 171.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -162.65 154.17 15.2 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.236 1.414 . . . . 75.24 109.157 -177.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -83.08 179.33 5.24 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.655 2.237 . . . . 64.34 112.705 173.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 18' ' ' VAL . . . . . 0.657 HG23 ' HB2' ' D' ' 94' ' ' MET . 61.4 t -96.23 144.42 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 108.785 -0.82 . . . . 72.01 108.785 173.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 33.2 m 71.15 127.46 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.271 1.428 . . . . 70.34 111.472 -176.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 54.9 tptt 73.42 -5.96 1.86 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.929 1.292 . . . . 53.01 112.804 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.31 82.45 5.46 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.738 0.78 . . . . 64.52 111.297 -174.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -143.26 96.82 2.98 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.429 -1.322 . . . . 74.13 107.429 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 67.6 p -75.34 147.78 82.88 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.623 -0.717 . . . . 74.34 110.638 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -84.7 20.19 1.27 Allowed 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 123.056 2.504 . . . . 61.31 112.02 170.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 124.952 1.301 . . . . 70.13 109.213 -173.839 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.9 mtp . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 109.756 -0.461 . . . . 74.2 109.756 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.8 p -156.68 -55.57 0.08 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.881 0.872 . . . . 65.52 108.979 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -167.68 143.25 3.93 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.461 -1.245 . . . . 75.11 108.657 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -110.93 148.09 33.23 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.059 0.543 . . . . 72.43 111.229 -174.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -122.79 106.58 11.03 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.305 1.042 . . . . 71.13 108.195 173.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -60.74 114.48 3.04 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.468 -0.787 . . . . 63.23 108.927 176.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.1 m 69.62 97.79 0.06 Allowed 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.963 1.305 . . . . 73.42 109.583 -160.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -71.2 173.69 7.35 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 114.762 -1.108 . . . . 70.35 109.397 173.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 12.2 tpt -52.02 137.26 27.62 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.125 0.57 . . . . 71.32 111.464 177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.8 m -138.3 129.71 27.58 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.726 -1.213 . . . . 74.14 107.726 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.691 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 9.4 t80 -135.56 124.26 23.8 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.01 0.524 . . . . 75.2 109.668 -175.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -139.27 111.01 7.17 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.36 -0.978 . . . . 75.42 108.36 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.638 HG12 ' HD2' ' A' ' 84' ' ' PHE . 57.2 mt -82.74 120.44 34.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.421 -0.955 . . . . 71.34 108.421 173.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.43 -41.25 20.1 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 124.146 0.904 . . . . 74.52 109.011 -177.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -173.83 124.09 0.35 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 121.938 0.095 . . . . 73.44 111.061 -169.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' C' ' 130' ' ' PRO . 92.2 mt -116.87 138.54 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 C-N-CA 123.924 0.89 . . . . 62.34 109.571 175.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.519 ' HB3' HG23 ' B' ' 122' ' ' THR . 35.3 p90 -169.61 176.26 5.03 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.227 0.955 . . . . 74.32 111.217 -170.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -102.26 119.43 38.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.94 -1.027 . . . . 63.23 108.533 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.459 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 36.9 mtpt -83.04 -42.65 17.23 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.957 -0.757 . . . . 72.4 108.957 176.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 16.2 t70 -134.4 136.62 43.45 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.485 -1.234 . . . . 61.2 109.602 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.8 mt -136.13 143.16 36.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 C-N-CA 125.345 1.458 . . . . 72.42 107.118 174.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.0 t -155.09 119.37 4.68 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-O 121.166 0.507 . . . . 72.04 110.476 171.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.509 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 87.8 t80 -111.34 136.53 50.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.797 -1.557 . . . . 72.44 106.797 169.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -133.53 138.23 45.97 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.638 -0.504 . . . . 74.11 109.638 175.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.85 70.83 16.97 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 106.516 -1.661 . . . . 73.4 106.516 170.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.75 -28.14 30.86 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.539 2.159 . . . . 75.31 111.448 -175.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -101.62 20.42 16.2 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 114.896 -1.047 . . . . 73.4 109.541 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.54 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -48.32 -52.54 41.78 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 114.006 1.113 . . . . 75.1 114.006 -171.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 15.9 Cg_exo -67.16 -18.54 51.04 Favored 'Trans proline' 0 C--N 1.385 2.481 0 CA-C-N 121.748 1.66 . . . . 60.23 113.02 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -90.18 -28.19 19.06 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.407 1.083 . . . . 74.22 110.599 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.523 HG21 ' HA ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -80.55 -21.14 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 115.672 -0.694 . . . . 65.14 111.722 -166.352 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -86.05 -23.99 26.53 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.373 0.669 . . . . 71.44 111.653 -176.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -78.83 -24.26 44.53 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 110.027 -0.36 . . . . 63.12 110.027 174.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -72.48 146.87 46.56 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.794 0.837 . . . . 73.14 110.719 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -67.34 128.91 38.18 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.606 -0.724 . . . . 71.1 109.455 174.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 59.5 t-105 -79.12 89.5 4.83 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.469 0.707 . . . . 74.21 110.426 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -125.11 82.8 61.36 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 108.007 -1.109 . . . . 62.11 108.007 169.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.0 127.93 11.86 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.336 2.024 . . . . 64.54 112.395 -172.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -96.9 93.12 6.46 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 106.354 -1.721 . . . . 70.12 106.354 170.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.411 HG11 HD13 ' E' ' 6' ' ' ILE . 41.8 t -72.67 91.46 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.88 -0.785 . . . . 70.45 108.88 -177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -98.32 112.46 24.45 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.342 -1.355 . . . . 73.21 107.342 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' E' ' 8' ' ' LEU . 2.5 pp -123.2 135.02 54.11 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.229 0.538 . . . . 75.22 110.885 -171.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -115.94 145.38 42.97 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.698 -1.223 . . . . 71.32 107.698 172.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.592 HD13 ' HB3' ' E' ' 8' ' ' LEU . 1.7 pt? -135.12 123.52 23.28 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.95 -0.759 . . . . 62.54 108.95 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.613 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 24.5 t70 -118.7 139.41 51.59 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.178 0.991 . . . . 62.15 109.246 -174.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.8 p -116.59 121.65 42.35 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.946 0.898 . . . . 63.34 110.476 -170.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.77 131.85 17.29 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.774 0.829 . . . . 64.2 110.636 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.9 m -131.58 157.68 43.0 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.172 0.589 . . . . 73.24 110.482 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.3 t -148.74 123.51 9.9 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.54 0.736 . . . . 52.02 109.359 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -75.41 121.29 22.06 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.284 0.633 . . . . 73.44 110.693 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.405 HD12 HG23 ' A' ' 83' ' ' ILE . 52.9 mt -94.16 -39.37 10.6 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.775 0.83 . . . . 75.1 110.724 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.452 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -148.01 -177.56 5.8 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.878 0.871 . . . . 64.22 109.839 176.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -63.67 115.36 4.67 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.398 -0.593 . . . . 74.51 109.398 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 70.35 4.07 4.74 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 125.137 1.375 . . . . 73.3 112.929 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 99.8 t -109.77 114.84 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.115 -1.068 . . . . 72.24 108.115 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -138.63 140.9 39.08 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.568 -0.901 . . . . 72.11 108.568 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -89.79 129.92 36.12 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.753 -0.658 . . . . 62.13 109.435 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.421 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 72.8 t -100.48 126.1 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 107.663 -1.236 . . . . 53.24 107.663 172.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.6 t -120.7 125.56 74.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.662 -0.866 . . . . 63.25 108.662 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -115.25 108.01 16.02 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.153 -1.425 . . . . 50.34 107.153 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.613 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 48.3 ttt180 -83.61 99.94 10.51 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.886 -0.783 . . . . 52.33 108.886 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.9 101.77 12.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.615 -0.721 . . . . 63.24 109.199 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.0 m -97.54 113.46 25.17 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.503 0.721 . . . . 72.13 109.252 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.4 HG11 HD21 ' A' ' 126' ' ' LEU . 18.2 t -116.86 107.64 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.005 0.922 . . . . 70.34 109.097 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.9 m -109.49 129.2 55.57 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.315 -0.994 . . . . 70.4 108.315 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.81 132.71 49.81 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.115 -1.439 . . . . 72.0 107.115 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.0 m -121.32 165.76 15.03 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.199 0.6 . . . . 63.52 110.362 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.409 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 82.9 mt -131.1 43.26 3.12 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.94 -1.133 . . . . 73.24 107.94 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.68 -93.07 1.84 Allowed Glycine 0 C--N 1.339 0.709 0 CA-C-N 114.84 -1.073 . . . . 42.4 111.481 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -95.09 -26.88 15.85 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.194 0.598 . . . . 75.31 111.919 -174.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -105.75 132.63 51.64 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.196 -0.668 . . . . 62.31 109.196 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.4 m -73.44 134.99 44.1 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.732 -0.47 . . . . 71.21 109.732 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.523 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.86 -60.91 2.11 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.455 -0.793 . . . . 71.44 109.926 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.427 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 33.4 p90 -160.17 174.29 14.48 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.349 -0.841 . . . . 72.21 111.696 176.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.5 tp -127.79 142.99 51.15 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.445 -1.252 . . . . 71.41 108.482 170.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 80.5 m -143.0 97.39 3.09 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.819 1.248 . . . . 64.15 108.235 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -121.51 115.71 23.35 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.922 -0.77 . . . . 74.24 108.922 -173.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.5 t -129.51 110.63 20.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 123.805 0.842 . . . . 63.31 109.592 -173.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.623 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 28.6 mt-30 -83.69 88.17 7.06 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.14 -1.059 . . . . 64.54 108.14 169.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.51 ' HG3' HD22 ' A' ' 106' ' ' LEU . 67.5 tp60 -78.48 102.48 7.86 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.692 -1.14 . . . . 73.42 108.691 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.7 145.01 17.43 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.443 -0.663 . . . . 51.51 111.443 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.407 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.0 124.5 1.71 Allowed Glycine 0 CA--C 1.508 -0.405 0 N-CA-C 110.78 -0.928 . . . . 42.24 110.78 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.405 HG23 HD12 ' A' ' 51' ' ' LEU . 46.9 mt -81.69 115.68 24.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.864 -0.791 . . . . 73.55 108.864 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.691 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 38.7 m-85 -124.06 120.27 31.91 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.927 -0.768 . . . . 74.12 108.927 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.1 t -95.43 101.84 13.6 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.225 -1.028 . . . . 72.42 108.225 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.525 HD11 HG21 ' E' ' 18' ' ' VAL . 24.4 pt -111.63 150.05 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 122.594 0.357 . . . . 73.3 110.312 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.52 174.37 5.95 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.786 0.834 . . . . 75.51 110.524 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 107.15 -80.87 0.28 Allowed Glycine 0 C--N 1.345 1.044 0 CA-C-N 116.058 -0.519 . . . . 63.33 112.045 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.677 HD12 ' HB3' ' A' ' 93' ' ' GLN . 29.8 pt -91.72 155.86 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.185 0.594 . . . . 62.42 110.948 -175.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 46.6 mt-10 -137.28 -175.7 4.14 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.064 0.945 . . . . 65.31 111.291 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.61 -135.05 23.02 Favored Glycine 0 C--N 1.353 1.506 0 CA-C-N 115.754 -0.657 . . . . 72.01 112.434 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.3 t -67.57 -22.72 65.38 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.313 0.645 . . . . 62.11 111.277 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.677 ' HB3' HD12 ' A' ' 89' ' ' ILE . 13.4 mm-40 -70.52 -45.26 65.92 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.373 0.669 . . . . 73.45 110.375 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.482 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 15.4 tmm? -76.51 -29.79 56.94 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.816 0.446 . . . . 72.32 110.411 176.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.21 -20.92 66.66 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.939 0.496 . . . . 74.33 111.208 176.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -70.63 -47.4 60.26 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.251 0.62 . . . . 71.33 110.818 172.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.628 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 27.4 p -71.67 -43.95 65.13 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.138 0.494 . . . . 72.33 110.949 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.59 -45.35 83.57 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.545 1.138 . . . . 73.43 110.765 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.55 -16.19 47.03 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 114.745 0.658 . . . . 60.21 114.745 -170.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.93 -61.94 0.87 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 117.922 0.861 . . . . 72.13 112.18 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.628 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 88.8 t80 -69.23 -62.28 1.44 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.371 0.878 . . . . 75.22 113.371 -164.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 73.7 m -63.29 -39.3 48.9 Favored Pre-proline 0 CA--C 1.563 1.472 0 N-CA-C 113.697 0.999 . . . . 74.45 113.697 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.21 -32.8 82.55 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 121.854 1.703 . . . . 73.34 113.115 166.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -74.99 -17.98 60.44 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.028 0.531 . . . . 64.15 110.849 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -67.41 -37.46 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 109.186 -0.672 . . . . 63.11 109.186 170.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.51 HD22 ' HG3' ' A' ' 80' ' ' GLN . 77.4 mt -81.23 -17.93 47.8 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.034 0.934 . . . . 63.21 112.191 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -62.81 -47.01 88.16 Favored Pre-proline 0 CA--C 1.572 1.809 0 CA-C-O 118.158 -0.925 . . . . 73.23 113.279 -174.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.61 -37.57 46.36 Favored 'Trans proline' 0 C--N 1.393 2.883 0 C-N-CA 122.35 2.033 . . . . 75.05 112.781 176.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -66.34 -44.75 82.41 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.466 0.706 . . . . 63.31 111.559 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.22 -41.74 76.65 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.992 -0.549 . . . . 73.4 110.48 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.474 ' NH1' HD12 ' C' ' 105' ' ' ILE . 27.6 ttm180 -52.0 -47.64 64.82 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.969 0.908 . . . . 75.24 110.765 171.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -68.05 -43.96 77.5 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.044 -0.98 . . . . 75.05 111.337 -175.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 39.1 t -65.6 -30.3 71.0 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.189 0.596 . . . . 72.24 111.056 -178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.8 mt -68.69 -58.83 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.888 0.875 . . . . 53.24 109.654 172.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 50.6 m -53.15 -36.51 60.93 Favored 'General case' 0 C--N 1.361 1.094 0 C-N-CA 124.246 1.018 . . . . 63.03 112.097 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -65.24 -51.22 62.27 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.56 -0.745 . . . . 73.41 110.687 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.509 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 61.0 mtm -64.28 -37.87 89.03 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.903 0.481 . . . . 55.31 111.483 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.442 HG21 HD23 ' A' ' 126' ' ' LEU . 76.0 t -62.12 -45.05 99.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.197 0.999 . . . . 73.5 110.335 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.6 t -70.2 -35.5 73.95 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.563 -0.744 . . . . 74.12 110.76 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -69.35 -33.51 73.2 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.543 0.737 . . . . 75.25 109.739 175.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.38 14.34 51.08 Favored Glycine 0 C--N 1.351 1.371 0 CA-C-N 115.344 -0.844 . . . . 63.52 112.879 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.413 HG21 ' HE ' ' B' ' 15' ' ' ARG . 2.5 t 61.4 18.58 9.45 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 126.541 1.936 . . . . 73.22 114.078 170.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -87.46 153.01 53.04 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 123.033 0.533 . . . . 72.54 109.595 176.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -55.16 165.54 2.86 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.521 2.814 . . . . 62.33 114.301 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -59.54 121.95 12.82 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.366 -0.834 . . . . 73.52 111.512 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.442 HD23 HG21 ' A' ' 118' ' ' VAL . 60.4 tp -123.67 94.5 4.26 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.223 1.009 . . . . 74.24 109.362 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -107.79 125.84 51.91 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 107.999 -1.111 . . . . 74.54 107.999 171.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mp -72.8 139.52 47.09 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.708 -0.849 . . . . 60.32 108.708 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.683 ' HB3' ' HB2' ' E' ' 7' ' ' ALA . . . -64.5 146.21 98.19 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.213 0.605 . . . . 44.15 111.242 -177.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.09 116.21 3.58 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.717 2.278 . . . . 73.41 111.751 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.3 t -101.22 113.21 36.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.782 -1.192 . . . . 63.3 107.782 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -86.26 72.32 10.37 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.515 -0.92 . . . . 63.14 108.515 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -49.38 -48.47 46.89 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.491 0.716 . . . . 72.44 110.943 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.04 -51.81 62.87 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.908 -1.042 . . . . 72.5 111.847 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.55 -40.0 88.82 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.714 0.634 . . . . 71.54 111.548 -176.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.75 -45.96 84.24 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.749 0.82 . . . . 75.33 111.424 -177.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -72.41 -36.21 68.56 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.135 -0.484 . . . . 72.15 111.172 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 36.5 mmt -72.5 -23.89 61.09 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.266 0.226 . . . . 63.32 111.181 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.685 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 66.9 m-20 -68.05 -32.02 72.09 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.124 0.569 . . . . 71.32 110.626 171.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -78.56 -39.43 37.72 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 116.244 -0.434 . . . . 74.53 110.145 176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.49 -49.41 63.62 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.291 0.637 . . . . 74.35 112.268 -175.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -152.04 -2.6 0.28 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.214 0.45 . . . . 74.12 112.214 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.685 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 58.9 tt0 66.69 111.59 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.027 1.331 . . . . 71.23 112.41 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -60.7 -41.99 96.3 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.351 0.66 . . . . 63.43 110.109 170.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 73.83 -68.99 0.2 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.553 1.541 . . . . 74.31 111.325 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.42 -177.11 43.79 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 115.975 -0.557 . . . . 71.34 112.774 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -111.34 -62.72 1.51 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.848 0.859 . . . . 61.02 111.464 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.36 72.46 1.02 Allowed Glycine 0 C--N 1.348 1.199 0 N-CA-C 110.158 -1.177 . . . . 71.31 110.158 -167.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.753 HG21 ' HB2' ' C' ' 90' ' ' GLU . 6.5 t -64.41 161.11 17.66 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.353 1.061 . . . . 74.35 111.893 -175.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -86.55 91.52 8.59 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.869 -0.789 . . . . 42.15 108.869 174.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.36 152.85 40.52 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.431 -0.804 . . . . 75.13 109.635 172.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -104.31 -35.17 8.06 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.684 0.794 . . . . 72.43 110.247 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 64.21 68.13 0.57 Allowed 'General case' 0 C--N 1.359 1.022 0 C-N-CA 125.004 1.321 . . . . 72.21 108.82 -162.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -66.98 93.05 0.26 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.68 -1.145 . . . . 72.11 111.36 -170.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 C-N-CA 124.428 1.091 . . . . 72.5 109.442 177.925 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 111.576 0.213 . . . . 73.21 111.576 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 32.2 t -76.96 85.36 3.49 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.513 0.725 . . . . 75.13 109.745 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -99.04 103.04 14.95 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.045 -0.98 . . . . 71.54 109.274 -176.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -124.23 119.4 29.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.656 0.782 . . . . 74.13 110.135 -174.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -81.58 160.26 23.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.851 0.86 . . . . 70.14 109.893 173.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -70.73 99.29 1.68 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.201 0.6 . . . . 73.13 109.513 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 12.9 t -153.43 175.01 13.63 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.67 0.788 . . . . 62.33 110.226 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 63.82 -94.99 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.913 1.285 . . . . 65.25 109.965 -177.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.544 ' SD ' ' HB ' ' B' ' 89' ' ' ILE . 9.6 tpt 59.64 167.82 0.07 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.256 1.422 . . . . 70.13 112.889 176.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 22.7 m -136.73 123.57 21.29 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 106.37 -1.715 . . . . 54.22 106.37 165.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -151.74 129.16 11.34 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.793 -0.817 . . . . 72.14 108.793 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -155.07 131.14 10.19 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.419 -0.586 . . . . 74.02 109.419 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.515 HD13 HD11 ' B' ' 16' ' ' ILE . 25.2 mt -75.59 121.54 27.57 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 108.746 -0.835 . . . . 71.33 108.746 173.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -93.05 -37.92 11.91 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.53 -0.759 . . . . 71.02 109.234 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.413 ' HE ' HG21 ' A' ' 122' ' ' THR . 46.5 ttt180 -177.39 132.42 0.17 Allowed 'General case' 0 C--N 1.356 0.856 0 CA-C-N 115.608 -0.723 . . . . 71.41 109.64 -174.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.515 HD11 HD13 ' B' ' 13' ' ' ILE . 94.6 mt -115.21 140.05 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 108.008 -1.108 . . . . 74.32 108.008 176.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -171.17 155.78 4.49 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.805 0.812 . . . . 74.11 112.483 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.9 m -75.69 125.03 28.25 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.546 -1.206 . . . . 74.12 109.191 168.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.54 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 43.9 mtpt -96.79 -31.86 12.41 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.535 0.734 . . . . 74.44 111.065 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -153.54 140.1 18.82 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.47 -0.332 . . . . 70.4 110.557 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.496 HD11 ' SG ' ' B' ' 113' ' ' CYS . 35.4 mm -135.59 143.61 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.972 1.309 . . . . 72.45 108.577 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -150.28 109.52 3.95 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.07 -1.085 . . . . 64.22 108.07 174.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 89.4 t80 -124.48 108.81 12.52 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 108.002 -1.111 . . . . 75.22 108.002 173.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -124.16 123.56 40.56 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.458 0.703 . . . . 74.34 110.29 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.425 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -114.41 87.1 13.22 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.776 1.23 . . . . 62.45 107.932 178.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.21 -29.98 25.61 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.691 2.261 . . . . 65.31 113.224 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -108.56 18.53 20.8 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.57 0.748 . . . . 73.23 110.821 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.459 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -43.09 -59.26 3.26 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 114.938 1.458 . . . . 73.04 114.938 -164.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -62.25 -28.73 79.42 Favored 'Trans proline' 0 C--N 1.395 3.006 0 C-N-CA 122.388 2.059 . . . . 74.2 112.464 -172.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -96.23 -32.76 12.29 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.167 -0.924 . . . . 72.42 112.22 -172.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.501 HG21 ' HA ' ' B' ' 73' ' ' ALA . 6.0 p -74.17 -6.29 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 122.998 0.519 . . . . 64.3 111.675 -171.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -72.83 -14.05 61.42 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.218 0.607 . . . . 74.42 112.437 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -61.49 -18.17 57.88 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.31 0.644 . . . . 62.15 111.076 172.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.615 ' HB2' HD13 ' B' ' 68' ' ' LEU . 30.3 mmtp -95.54 88.84 5.18 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.296 1.439 . . . . 75.45 109.112 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -98.29 78.38 2.45 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.604 0.716 . . . . 71.4 111.19 -176.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -159.31 172.33 18.18 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.327 -1.306 . . . . 74.42 108.582 170.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -68.58 112.73 12.09 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 109.14 -0.689 . . . . 72.45 109.14 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.491 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 20.8 Cg_endo -61.53 163.82 17.11 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.06 2.506 . . . . 71.4 114.41 -173.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -72.73 102.34 3.32 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 107.519 -1.289 . . . . 75.45 107.519 171.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -93.86 146.2 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 114.545 -1.207 . . . . 72.5 110.179 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.787 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 56.1 mtpt -121.82 142.74 49.92 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.771 0.828 . . . . 74.03 109.49 172.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.436 HD23 HG13 ' F' ' 6' ' ' ILE . 3.2 pp -92.74 134.61 34.88 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 114.33 -1.304 . . . . 74.43 107.781 168.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.697 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 18.5 m-20 -143.74 132.78 22.88 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.143 -1.058 . . . . 61.41 108.143 177.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 86.7 mt -127.92 132.38 49.29 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.485 0.714 . . . . 55.3 109.706 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 7.5 t70 -123.16 138.59 54.62 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.891 1.277 . . . . 74.03 107.587 172.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.485 HG21 ' HA ' ' F' ' 15' ' ' PHE . 43.6 m -108.88 116.19 31.51 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 122.979 0.511 . . . . 72.14 110.083 -174.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.29 135.84 53.54 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.218 1.007 . . . . 23.25 108.42 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.9 m -142.5 161.39 38.19 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 109.527 -0.546 . . . . 72.01 109.527 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 88.6 p -160.63 136.31 8.17 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 123.627 0.579 . . . . 75.51 109.518 174.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -95.08 102.12 13.91 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.119 -1.067 . . . . 74.41 108.119 167.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 54.3 mt -65.83 -35.95 82.1 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.103 -0.953 . . . . 73.32 111.041 -175.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.49 -179.49 6.02 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.291 1.036 . . . . 61.4 109.443 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.86 122.7 16.06 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.034 -0.984 . . . . 61.31 108.726 173.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 73.95 -4.77 2.19 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 125.371 1.468 . . . . 74.11 113.155 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 56.3 t -113.6 120.7 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 108.978 -0.749 . . . . 60.52 108.978 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -129.19 169.64 14.55 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.214 -0.661 . . . . 72.53 109.214 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -140.87 125.55 17.95 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.475 0.71 . . . . 52.15 109.131 174.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 87.0 t -102.39 119.48 50.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.478 1.111 . . . . 75.02 109.073 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 34.0 t -123.83 111.49 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.732 -0.84 . . . . 75.32 108.732 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 32.3 tp -106.39 119.32 38.96 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 109.059 -0.719 . . . . 54.41 109.059 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 57.7 ttm-85 -86.3 111.76 20.76 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.688 -0.856 . . . . 71.25 108.688 174.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 46.4 t -103.26 102.39 13.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 107.353 -1.351 . . . . 73.32 107.353 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.697 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 17.6 m -101.48 132.15 47.25 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.874 -1.057 . . . . 52.02 109.024 177.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 78.1 t -125.4 112.62 31.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 124.121 0.968 . . . . 75.32 109.153 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.787 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 98.4 m -87.95 149.46 24.03 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.206 -0.906 . . . . 74.43 109.14 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.68 138.4 30.59 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.137 0.575 . . . . 73.04 109.556 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.464 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 45.0 p -146.55 131.29 17.96 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.494 -0.558 . . . . 63.33 109.494 -178.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.615 HD13 ' HB2' ' B' ' 34' ' ' LYS . 26.0 mt -113.34 113.13 24.82 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.287 1.035 . . . . 74.32 108.962 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.79 -111.32 3.41 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.05 -0.523 . . . . 54.31 112.203 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -113.59 4.87 16.32 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.558 0.743 . . . . 74.43 111.598 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -130.48 151.79 50.58 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.165 0.586 . . . . 74.15 110.699 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 73.9 m -74.24 123.39 24.44 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 122.698 0.399 . . . . 73.15 110.174 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.501 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -76.16 -59.9 2.56 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.14 -0.936 . . . . 33.2 109.085 177.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -149.62 161.75 41.56 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 121.933 0.873 . . . . 71.23 111.468 174.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 78.0 mt -125.49 114.23 18.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 105.127 -2.175 . . . . 73.12 105.127 168.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.4 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 36.3 t -115.72 142.77 46.3 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.343 -1.354 . . . . 71.23 107.343 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -160.9 125.51 3.6 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.937 -0.394 . . . . 55.22 109.937 -169.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 62.0 t -128.67 148.94 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.911 0.884 . . . . 73.14 109.805 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -117.63 111.5 19.26 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.724 -1.213 . . . . 62.41 107.724 163.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -96.95 100.78 12.28 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.797 -1.186 . . . . 43.54 107.797 171.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.02 142.12 15.9 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-N 115.232 -0.894 . . . . 74.44 110.87 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.62 125.99 3.02 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 109.786 -1.326 . . . . 42.05 109.786 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 57.9 mt -84.69 126.03 40.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 107.788 -1.19 . . . . 74.34 107.788 175.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -131.88 133.37 44.53 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.03 -0.73 . . . . 74.34 109.03 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 67.2 m -89.07 110.69 21.38 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.276 -1.009 . . . . 72.2 108.276 172.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.439 ' O ' HD12 ' B' ' 86' ' ' ILE . 2.5 pp -124.33 140.76 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.176 0.99 . . . . 72.53 110.213 -172.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.75 171.17 19.31 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.318 0.488 . . . . 72.34 112.318 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.5 -65.7 4.07 Favored Glycine 0 C--N 1.354 1.549 0 CA-C-N 115.148 -0.933 . . . . 73.51 112.946 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.544 ' HB ' ' SD ' ' B' ' 9' ' ' MET . 9.7 mm -68.55 148.86 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.94 1.296 . . . . 75.32 111.026 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -152.38 179.37 8.61 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.641 0.776 . . . . 71.55 111.257 -170.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.02 -127.81 36.18 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 115.968 -0.56 . . . . 63.53 113.374 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 16.3 m -89.28 -18.55 26.77 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.266 0.627 . . . . 62.14 110.787 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -56.34 -41.7 76.53 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 109.338 -0.615 . . . . 74.3 109.338 171.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 17.4 ptt? -81.37 -33.53 32.3 Favored 'General case' 0 C--N 1.358 0.97 0 CA-C-N 115.669 -0.696 . . . . 64.22 111.194 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.4 -36.16 66.12 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.618 0.723 . . . . 71.45 110.894 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.464 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 43.5 t-80 -69.45 -46.14 67.4 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.295 -1.32 . . . . 72.13 111.137 175.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -73.14 -31.67 64.43 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.202 0.445 . . . . 74.43 112.202 -173.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.5 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 15.5 mt -95.3 -42.8 8.34 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.859 0.864 . . . . 74.32 111.242 -172.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.61 -24.61 45.66 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.832 -0.622 . . . . 63.54 113.576 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -117.09 -49.69 2.6 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.855 0.462 . . . . 54.0 111.741 -171.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -81.97 -41.86 20.19 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.022 0.379 . . . . 74.14 112.022 -174.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 85.1 m -61.6 -48.67 89.56 Favored Pre-proline 0 CA--C 1.559 1.292 0 CA-C-O 118.425 -0.798 . . . . 50.41 111.916 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 38.0 Cg_exo -64.5 -22.93 64.97 Favored 'Trans proline' 0 C--N 1.396 3.072 0 C-N-CA 122.167 1.912 . . . . 75.35 112.887 173.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -65.46 -35.97 82.5 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.168 0.587 . . . . 74.53 110.45 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 93.3 mt -63.51 -40.77 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.437 1.095 . . . . 75.41 110.017 171.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 59.8 mt -90.26 -13.01 36.24 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 114.677 -1.147 . . . . 74.2 112.337 -170.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -60.36 -48.28 94.29 Favored Pre-proline 0 N--CA 1.488 1.437 0 CA-C-O 117.911 -1.042 . . . . 71.33 113.473 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.78 -37.99 94.51 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 121.881 1.721 . . . . 72.11 113.173 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -67.64 -47.92 68.19 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.443 0.697 . . . . 73.42 110.508 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.68 -42.35 99.58 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.472 0.709 . . . . 75.2 111.123 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -59.92 -51.44 69.69 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.192 0.997 . . . . 74.12 110.777 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -65.21 -31.32 72.43 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.821 0.701 . . . . 55.54 110.03 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.496 ' SG ' HD11 ' B' ' 21' ' ' ILE . 6.0 t -74.04 -34.58 64.14 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.016 0.526 . . . . 63.1 111.204 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.423 ' O ' HG23 ' B' ' 118' ' ' VAL . 57.0 mt -66.66 -57.33 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 109.114 -0.698 . . . . 51.13 109.114 173.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.3 m -62.1 -24.61 67.23 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.637 0.775 . . . . 70.35 111.788 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 27.1 t -64.32 -52.23 59.51 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 109.379 -0.601 . . . . 73.21 109.379 173.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.5 mmt -69.94 -32.2 70.33 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.11 0.564 . . . . 72.15 111.369 -175.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.423 HG23 ' O ' ' B' ' 114' ' ' ILE . 79.3 t -62.72 -46.19 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.858 0.863 . . . . 62.43 110.184 174.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.0 t -65.72 -35.87 81.97 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.994 -1.003 . . . . 55.52 110.829 177.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.483 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 92.5 mtt-85 -67.12 -33.02 74.56 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.687 -0.688 . . . . 74.54 110.322 178.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.98 7.37 75.18 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 123.837 0.711 . . . . 70.23 112.962 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.519 HG23 ' HB3' ' A' ' 17' ' ' TYR . 81.5 p 59.68 23.89 12.73 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 126.291 1.837 . . . . 54.21 113.596 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -86.65 159.22 52.88 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 123.739 0.816 . . . . 73.3 111.409 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -54.69 158.78 9.96 Favored 'Trans proline' 0 C--N 1.393 2.882 0 C-N-CA 123.837 3.025 . . . . 75.31 115.39 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -65.01 133.84 52.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.358 1.063 . . . . 74.44 111.703 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 58.0 tp -140.21 120.66 14.09 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.451 0.7 . . . . 72.4 109.615 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -132.13 117.44 18.31 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.341 1.056 . . . . 65.21 108.917 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 7.1 mp -83.53 150.37 26.01 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.259 0.624 . . . . 52.43 110.653 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.5 156.42 90.27 Favored Pre-proline 0 CA--C 1.557 1.246 0 CA-C-N 115.063 -0.971 . . . . 74.24 110.463 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -66.34 111.24 2.0 Allowed 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 122.679 2.253 . . . . 64.43 110.667 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 36.9 t -89.75 107.24 17.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.003 -1.11 . . . . 74.43 108.003 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 132' ' ' ASN . . . . . 0.523 ' HB3' ' HB3' ' B' ' 135' ' ' ALA . 7.8 m120 -104.13 88.67 3.06 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.869 -1.06 . . . . 64.41 109.155 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -63.91 -37.61 88.02 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.982 -0.748 . . . . 73.33 108.982 170.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.452 ' N ' ' HB1' ' B' ' 100' ' ' ALA . 6.9 p-10 -62.52 -50.91 69.5 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.745 1.218 . . . . 45.13 111.632 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' B' ' 132' ' ' ASN . . . -68.54 -34.23 75.5 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 123.405 0.682 . . . . 62.21 110.567 -178.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 55.2 tp -61.18 -47.41 86.27 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 123.71 0.631 . . . . 60.31 110.826 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -64.06 -44.85 91.17 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.587 0.554 . . . . 72.31 111.657 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 73.7 mtm -72.81 -37.04 67.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.845 0.458 . . . . 63.41 111.648 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -82.65 -4.67 58.1 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.667 0.387 . . . . 75.31 111.179 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -82.1 -27.98 32.55 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.9 -0.407 . . . . 70.5 109.9 170.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 79.5 mt -96.98 25.97 4.99 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.703 0.801 . . . . 72.21 111.702 -174.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -70.92 140.37 50.97 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.056 0.542 . . . . 74.42 111.029 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -154.71 -53.94 0.1 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.59 1.156 . . . . 71.11 108.611 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -88.08 151.75 22.51 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.833 0.853 . . . . 64.3 109.741 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -139.93 -57.49 0.56 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.279 0.632 . . . . 74.14 110.971 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 120.82 -144.72 17.05 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.745 -0.661 . . . . 74.13 111.673 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -87.66 160.33 18.18 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.666 0.786 . . . . 71.54 111.938 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -126.23 103.77 0.7 Allowed Glycine 0 C--N 1.346 1.115 0 N-CA-C 109.773 -1.331 . . . . 74.31 109.773 173.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' D' ' 90' ' ' GLU . 51.3 m -67.41 104.33 1.51 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.683 1.193 . . . . 75.3 110.402 -177.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -85.89 139.19 31.46 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.633 -0.712 . . . . 74.51 109.794 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -134.88 -174.9 3.73 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.195 0.998 . . . . 74.14 109.228 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -157.54 141.3 15.82 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.992 -0.744 . . . . 74.15 108.992 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.88 108.77 16.46 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.915 0.486 . . . . 71.22 110.344 -178.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -76.79 96.27 4.22 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.778 0.831 . . . . 60.22 110.151 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.007 0 C-N-CA 124.041 0.936 . . . . 42.01 109.632 178.467 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptm . . . . . 0 N--CA 1.484 1.25 0 N-CA-C 110.206 -0.294 . . . . 61.45 110.206 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 31.0 m -75.28 101.57 4.74 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.579 0.752 . . . . 64.3 109.657 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -101.75 -39.14 7.56 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.507 0.723 . . . . 63.24 110.689 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -81.34 -64.63 1.15 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.661 0.784 . . . . 74.03 110.159 -172.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -76.29 133.25 40.1 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.036 -0.727 . . . . 43.31 109.036 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -61.99 -56.77 15.73 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.213 1.005 . . . . 75.51 110.367 -177.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 97.6 m -155.82 117.54 3.99 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.47 0.708 . . . . 74.21 109.505 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.46 118.92 6.9 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.27 -1.382 . . . . 60.52 107.27 169.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.675 ' HE1' ' HB ' ' C' ' 86' ' ' ILE . 1.1 tpt 57.88 112.63 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 O-C-N 124.7 1.25 . . . . 51.32 111.638 -173.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 36.9 m -127.37 92.46 3.51 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.571 -0.9 . . . . 74.24 108.571 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.651 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.6 t80 -105.94 133.16 51.1 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.368 0.667 . . . . 70.45 109.672 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -152.41 129.58 11.18 Favored 'General case' 0 C--O 1.242 0.667 0 O-C-N 124.072 0.857 . . . . 73.54 109.219 173.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 86.9 mt -73.36 130.51 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 108.43 -0.952 . . . . 63.01 108.43 172.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -97.05 -42.13 8.03 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.401 0.68 . . . . 60.25 110.283 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -176.19 124.97 0.19 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.701 0.4 . . . . 73.32 110.219 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.9 mt -111.26 146.39 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 109.058 -0.719 . . . . 63.43 109.058 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -172.6 166.5 5.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.12 0.968 . . . . 65.12 109.394 -175.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 63.1 p -85.06 115.43 22.87 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.267 -0.642 . . . . 63.21 109.267 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.67 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 16.3 mmtp -64.67 -44.58 89.91 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.998 -0.741 . . . . 71.03 108.998 171.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 22.6 t70 -147.25 145.55 29.47 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 114.407 -1.27 . . . . 74.11 110.609 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.8 mt -133.55 145.13 34.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 125.891 1.676 . . . . 65.54 106.712 171.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.1 t -158.37 150.53 21.76 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.414 0.626 . . . . 72.21 109.707 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 72.1 t80 -147.07 137.6 23.58 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.307 -1.368 . . . . 71.01 107.307 173.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -141.11 135.38 30.88 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.632 -0.877 . . . . 51.14 108.632 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.03 83.42 4.68 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 107.701 -1.222 . . . . 62.42 107.701 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.52 -37.39 59.15 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.816 2.344 . . . . 64.53 112.581 -173.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -101.22 21.1 14.53 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.913 -1.04 . . . . 73.03 110.806 -173.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.467 ' HA ' HG12 ' C' ' 31' ' ' VAL . . . -48.58 -57.26 11.39 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 114.661 1.356 . . . . 73.51 114.661 -167.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.43 -42.5 54.72 Favored 'Trans proline' 0 C--N 1.386 2.516 0 CA-C-N 122.141 1.801 . . . . 54.55 112.248 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.479 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.3 t60 -70.8 -30.97 67.57 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.823 0.849 . . . . 75.31 112.695 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.648 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.5 p -79.68 -21.31 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 112.501 0.556 . . . . 74.32 112.501 -171.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -72.48 -22.94 60.98 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.489 0.552 . . . . 71.21 112.489 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 20.0 pt20 -85.41 8.5 18.7 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.447 0.299 . . . . 64.41 110.88 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.573 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -97.84 157.31 16.15 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.127 0.971 . . . . 50.43 110.281 175.722 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.0 132.39 40.14 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.708 0.803 . . . . 70.43 109.504 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.436 ' H ' ' HB3' ' C' ' 154' ' ' ASP . 35.1 t-105 -70.36 91.55 0.75 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.842 0.857 . . . . 62.15 110.701 -177.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.512 ' H ' HD22 ' C' ' 68' ' ' LEU . 8.2 tp60 -132.21 71.56 79.56 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.263 1.025 . . . . 64.41 109.112 174.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -88.5 158.04 6.54 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.744 2.296 . . . . 73.02 112.842 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -89.06 99.93 12.82 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.013 -1.477 . . . . 71.11 107.013 172.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 15.0 m -66.04 98.36 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-O 122.18 0.99 . . . . 55.44 109.508 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -129.16 103.63 7.08 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.606 -1.179 . . . . 54.12 108.617 -170.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.641 HD21 HG13 ' G' ' 6' ' ' ILE . 2.1 mm? -94.68 148.37 22.34 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.626 -0.879 . . . . 64.53 108.626 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.663 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 11.8 t70 -135.48 123.45 22.72 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.2 -1.037 . . . . 73.55 108.2 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.17 111.78 21.52 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.457 -0.942 . . . . 64.02 108.457 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.522 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 16.7 t70 -114.45 137.38 51.91 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.121 0.968 . . . . 54.24 108.472 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 81.7 p -113.17 123.66 50.75 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.743 0.417 . . . . 53.34 111.464 -164.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.62 135.83 42.44 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.807 0.843 . . . . 61.22 109.181 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.636 ' HB3' ' HB3' ' G' ' 17' ' ' PRO . 51.7 m -161.7 149.19 14.62 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.874 0.47 . . . . 55.24 111.472 -172.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 52.9 p -160.26 140.77 11.77 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.688 0.795 . . . . 74.34 110.156 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 50' ' ' GLN . . . . . 0.445 ' HA ' ' HA ' ' C' ' 56' ' ' TYR . 60.4 tt0 -74.8 123.46 25.03 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.781 -0.822 . . . . 61.15 108.781 170.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.629 HD11 HD12 ' C' ' 83' ' ' ILE . 87.9 mt -84.23 -49.82 8.44 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.169 0.587 . . . . 70.25 110.622 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.78 -169.74 3.47 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.32 0.648 . . . . 73.11 110.873 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.05 106.52 0.27 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.454 1.102 . . . . 72.42 111.06 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 70.32 -5.32 1.37 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 126.004 1.721 . . . . 62.35 112.68 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 73.8 t -96.53 118.13 42.28 Favored 'Isoleucine or valine' 0 C--N 1.347 0.483 0 C-N-CA 124.572 1.149 . . . . 74.24 108.425 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.607 ' HB2' ' HB2' ' G' ' 17' ' ' PRO . 37.1 p90 -127.96 168.78 14.79 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.046 0.939 . . . . 63.34 108.955 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -126.07 130.53 51.29 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.14 0.576 . . . . 73.04 110.427 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 76.3 t -106.61 115.77 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 107.933 -1.136 . . . . 75.32 107.933 167.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 98.2 t -109.3 131.75 59.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 107.718 -1.215 . . . . 64.41 107.718 165.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 35.5 tp -129.19 119.96 24.97 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.083 -0.71 . . . . 74.41 109.083 174.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.522 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.3 ttm180 -80.08 111.98 16.94 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.745 -1.116 . . . . 75.44 109.398 175.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 15.5 t -101.32 110.69 28.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.481 -1.303 . . . . 40.32 107.481 171.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.663 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 90.7 m -118.98 118.08 30.54 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.725 -0.843 . . . . 75.54 108.725 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.636 HG23 HD13 ' C' ' 114' ' ' ILE . 94.4 t -101.72 112.85 36.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 108.388 -0.968 . . . . 53.44 108.388 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -98.87 131.85 44.66 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.359 -0.978 . . . . 72.21 108.359 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.57 101.86 4.93 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.416 -1.328 . . . . 64.51 107.416 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 47.9 m -128.62 130.12 46.85 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.957 0.503 . . . . 64.52 109.994 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.573 HD13 ' HG2' ' C' ' 34' ' ' LYS . 12.5 mt -85.75 42.7 0.98 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 124.941 1.297 . . . . 73.53 109.774 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.87 -118.96 6.05 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 109.798 -1.321 . . . . 54.2 109.798 -167.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -89.21 -18.32 27.32 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.397 0.679 . . . . 60.33 110.072 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -74.76 91.16 2.38 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.579 1.152 . . . . 73.44 109.656 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 76.9 m -71.47 119.82 16.17 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 109.516 -0.55 . . . . 73.45 109.516 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.648 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -76.57 -54.68 6.35 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.745 -1.116 . . . . 25.51 109.154 -178.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -157.15 170.38 22.63 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-O 122.349 1.071 . . . . 75.22 112.452 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -142.7 113.55 7.53 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 105.196 -2.15 . . . . 74.22 105.196 175.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.503 ' SG ' HG23 ' C' ' 114' ' ' ILE . 47.9 t -121.92 112.49 18.37 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.162 -0.681 . . . . 70.11 109.162 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -119.28 121.2 39.09 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.724 0.81 . . . . 74.15 110.056 -172.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.427 HG11 ' HA ' ' C' ' 110' ' ' ALA . 43.7 t -125.84 112.58 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.747 -0.834 . . . . 63.23 108.747 173.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.3 mt-30 -91.15 95.98 10.35 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.003 -1.11 . . . . 71.43 108.003 173.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.491 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 63.5 tp60 -83.13 117.51 22.94 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.771 0.428 . . . . 63.42 109.871 -175.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.21 145.85 17.89 Favored Glycine 0 C--N 1.342 0.913 0 O-C-N 123.863 0.727 . . . . 70.32 111.643 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.41 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.98 116.92 0.83 Allowed Glycine 0 C--O 1.238 0.361 0 N-CA-C 111.164 -0.775 . . . . 42.4 111.164 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.629 HD12 HD11 ' C' ' 51' ' ' LEU . 10.3 mm -84.44 116.59 28.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.856 -1.164 . . . . 72.32 107.856 176.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.651 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 46.9 m-85 -128.1 146.57 50.65 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.064 -1.087 . . . . 63.41 108.064 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 85' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 70.7 p -113.1 122.06 46.41 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.311 -0.626 . . . . 64.53 109.311 170.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.675 ' HB ' ' HE1' ' C' ' 9' ' ' MET . 17.7 pt -130.35 143.93 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 122.957 0.503 . . . . 64.22 109.904 170.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.7 143.33 18.45 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.035 0.934 . . . . 61.32 108.745 171.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 130.99 -52.29 0.83 Allowed Glycine 0 C--N 1.346 1.128 0 O-C-N 123.208 0.317 . . . . 65.13 113.018 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 33.0 pt -94.48 170.38 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-N 117.325 0.563 . . . . 64.25 111.831 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.753 ' HB2' HG21 ' A' ' 149' ' ' THR . 42.5 tt0 -156.89 162.3 39.66 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.626 0.77 . . . . 71.4 110.716 -175.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.11 -132.75 15.58 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.034 -0.53 . . . . 74.11 112.686 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 92' ' ' THR . . . . . 0.418 HG23 ' HD3' ' G' ' 24' ' ' PRO . 20.4 p -69.36 -24.36 63.87 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.526 0.73 . . . . 63.25 111.769 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -65.15 -51.58 60.32 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 121.243 0.544 . . . . 73.53 110.039 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.526 ' SD ' HG11 ' G' ' 18' ' ' VAL . 46.3 ttp -64.88 -45.09 87.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.763 -1.108 . . . . 70.51 110.153 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.71 -26.03 68.47 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.062 0.945 . . . . 74.41 111.822 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -73.12 -42.72 62.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.036 0.534 . . . . 74.13 110.577 175.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 40.6 t -62.84 -60.7 3.12 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.709 0.63 . . . . 52.43 110.024 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.576 HD22 ' HD2' ' G' ' 17' ' ' PRO . 4.2 pp -71.3 -29.67 65.32 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 112.151 0.426 . . . . 74.41 112.151 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.56 11.42 56.52 Favored Glycine 0 N--CA 1.48 1.584 0 N-CA-C 115.157 0.823 . . . . 72.53 115.157 -167.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.79 -51.99 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 118.21 1.005 . . . . 42.34 110.335 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.413 ' HE2' ' CE1' ' C' ' 11' ' ' PHE . 27.3 t80 -75.93 -38.28 57.82 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 113.652 -1.613 . . . . 62.21 112.793 -169.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 83.4 m -79.28 -42.35 1.62 Allowed Pre-proline 0 CA--C 1.563 1.451 0 CA-C-O 118.553 -0.737 . . . . 45.13 112.196 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.85 -23.01 68.92 Favored 'Trans proline' 0 C--N 1.397 3.106 0 C-N-CA 122.139 1.893 . . . . 74.34 112.702 171.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -63.84 -32.37 73.86 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.793 0.837 . . . . 74.44 111.019 174.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.474 HD12 ' NH1' ' A' ' 111' ' ' ARG . 47.1 mm -67.63 -35.87 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 123.365 0.666 . . . . 75.35 110.303 175.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.41 HD21 ' HA3' ' C' ' 82' ' ' GLY . 84.3 mt -90.0 -25.16 21.0 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.177 0.991 . . . . 73.14 112.923 -170.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.423 ' N ' ' HD2' ' C' ' 108' ' ' PRO . 0.1 OUTLIER -63.55 -40.34 57.01 Favored Pre-proline 0 CA--C 1.557 1.24 0 CA-C-O 117.729 -1.129 . . . . 75.12 113.905 -171.652 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' C' ' 107' ' ' PHE . 30.0 Cg_endo -61.16 -36.82 79.0 Favored 'Trans proline' 0 C--N 1.388 2.645 0 CA-C-N 121.685 1.638 . . . . 72.4 112.314 174.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -64.29 -49.29 72.41 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.522 0.729 . . . . 72.45 110.729 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.491 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.78 -41.05 96.14 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.365 -0.834 . . . . 70.21 110.888 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -53.2 -56.15 18.73 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.659 1.183 . . . . 61.34 111.39 175.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 112' ' ' GLU . . . . . 0.441 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.8 tm-20 -66.14 -34.34 77.83 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 123.568 0.542 . . . . 74.02 110.286 -176.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 12.9 t -70.6 -27.45 64.11 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.072 0.549 . . . . 75.22 111.321 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.636 HD13 HG23 ' C' ' 64' ' ' VAL . 82.0 mt -77.66 -55.47 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.228 0.611 . . . . 75.4 110.288 173.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 18.8 m -62.49 -27.76 69.36 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.534 0.734 . . . . 71.4 110.96 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 42.6 t -62.06 -51.77 66.61 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 123.786 0.834 . . . . 73.23 109.38 169.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.625 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.03 -35.54 77.17 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.687 1.195 . . . . 64.42 112.668 178.877 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.418 HG23 ' O ' ' C' ' 114' ' ' ILE . 63.7 t -63.57 -46.7 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.71 0.804 . . . . 63.11 109.238 174.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 30.7 t -68.31 -28.55 67.27 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.859 -1.064 . . . . 63.53 111.851 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -72.77 -40.48 65.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.625 0.77 . . . . 72.52 109.316 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.34 -2.54 79.75 Favored Glycine 0 C--N 1.355 1.591 0 CA-C-N 115.42 -0.809 . . . . 71.05 112.267 171.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 24.8 p 65.44 27.66 11.74 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.783 2.033 . . . . 73.35 113.193 170.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -84.14 152.26 61.46 Favored Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 109.042 -0.725 . . . . 75.12 109.042 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -54.36 160.82 6.19 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 123.447 2.765 . . . . 74.23 114.106 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -55.38 111.16 0.81 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.715 0.806 . . . . 61.32 111.461 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 26.6 tp -116.38 86.28 2.46 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 106.116 -1.809 . . . . 74.13 106.116 167.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -104.56 125.9 51.15 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.862 -1.063 . . . . 71.31 109.587 -167.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.36 127.35 32.44 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.489 0.715 . . . . 74.21 110.238 -173.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.6 156.05 68.32 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 123.99 0.916 . . . . 62.22 111.531 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.539 ' HB3' HD12 ' A' ' 16' ' ' ILE . 19.7 Cg_endo -61.22 102.34 0.21 Allowed 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.784 2.323 . . . . 72.11 112.975 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.515 ' HB ' HD12 ' G' ' 8' ' ' LEU . 60.3 t -118.86 110.08 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 108.742 -0.836 . . . . 71.45 108.742 173.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -96.1 106.39 18.56 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.057 -1.09 . . . . 73.23 108.057 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -53.87 -41.9 68.02 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.348 0.659 . . . . 74.24 112.494 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -55.41 -51.8 65.67 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.093 0.957 . . . . 74.44 111.229 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.5 -33.18 74.57 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.517 -0.765 . . . . 64.32 111.268 177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 5.1 tt -64.88 -36.72 85.26 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.383 1.073 . . . . 65.14 110.051 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -62.09 -39.6 93.04 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 123.16 0.287 . . . . 71.13 111.453 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 83.3 mtp -78.26 -33.83 49.39 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.575 0.75 . . . . 73.03 111.413 176.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -66.03 -35.83 81.6 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.02 1.328 . . . . 63.34 110.057 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' C' ' 143' ' ' GLN . 10.9 t80 -72.82 -149.41 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 125.476 1.51 . . . . 72.23 109.55 176.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 75.3 mt 68.54 -74.31 0.08 Allowed 'General case' 0 C--N 1.361 1.107 0 C-N-CA 125.094 1.357 . . . . 70.33 110.918 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -86.46 -29.92 22.43 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.162 0.985 . . . . 64.4 111.887 -175.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 143' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' C' ' 140' ' ' TYR . 14.9 pt20 -151.93 171.45 17.77 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.089 0.556 . . . . 44.54 111.456 -176.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -151.68 101.02 2.75 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.624 -0.88 . . . . 74.11 108.624 172.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.8 163.13 13.12 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.773 0.829 . . . . 63.3 110.955 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -165.09 151.05 19.69 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.44 -1.064 . . . . 53.23 110.44 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 147' ' ' GLU . . . . . 0.609 ' HB3' ' H ' ' G' ' 5' ' ' THR . 25.6 tt0 -78.46 79.66 4.88 Favored 'General case' 0 CA--C 1.554 1.129 0 CA-C-O 121.763 0.792 . . . . 73.55 110.124 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -89.99 116.6 4.82 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 110.244 -1.143 . . . . 74.03 110.244 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 5.0 m -144.59 -54.03 0.32 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.397 -0.964 . . . . 64.51 108.397 -177.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 66.25 178.68 0.21 Allowed 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.149 -1.387 . . . . 60.44 111.324 -174.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -154.53 -60.16 0.12 Allowed 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.554 -0.906 . . . . 65.03 108.554 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 64.2 80.0 0.24 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.02 0.928 . . . . 62.12 111.731 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -178.21 135.04 0.16 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.62 1.168 . . . . 70.45 108.675 167.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 154' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' C' ' 36' ' ' TRP . 24.1 t70 -154.35 -62.26 0.13 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.873 0.869 . . . . 73.31 109.104 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 N-CA-C 109.12 -0.696 . . . . 73.34 109.12 178.548 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 22.3 mmt . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 109.76 -0.459 . . . . 72.22 109.76 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 44.1 p -126.41 98.82 5.58 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.496 0.719 . . . . 72.22 109.558 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -104.11 102.8 12.54 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.037 -1.097 . . . . 61.41 108.037 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -144.31 -58.49 0.38 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.54 0.736 . . . . 75.32 109.477 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -167.14 159.33 12.86 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.481 -0.781 . . . . 74.04 110.344 -174.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 61.0 t30 177.49 77.27 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 107.392 -1.336 . . . . 74.32 107.392 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.0 m -132.56 -10.83 3.16 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.418 0.687 . . . . 54.43 111.502 -169.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -66.15 -21.12 66.32 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.978 0.511 . . . . 74.33 110.3 175.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.545 ' HE1' ' HB2' ' D' ' 11' ' ' PHE . 1.5 tmt? -27.72 127.54 0.07 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 126.113 1.765 . . . . 63.51 113.475 165.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 32.7 m -108.44 146.38 33.2 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.758 0.823 . . . . 73.45 110.603 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.545 ' HB2' ' HE1' ' D' ' 9' ' ' MET . 29.6 t80 -147.27 119.06 8.06 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.83 -1.174 . . . . 71.21 107.83 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 12' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' D' ' 85' ' ' SER . 44.6 mt-30 -132.08 133.69 44.64 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.438 -0.949 . . . . 65.41 108.438 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.595 HG21 HD11 ' D' ' 16' ' ' ILE . 21.8 mt -84.68 129.31 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 108.51 -0.922 . . . . 63.03 108.51 173.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -97.36 -46.18 6.19 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 122.586 0.354 . . . . 74.41 111.226 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -170.15 128.87 0.89 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.6 0.593 . . . . 50.03 112.6 -173.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.595 HD11 HG21 ' D' ' 13' ' ' ILE . 2.0 mp -107.57 137.92 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.445 -1.317 . . . . 43.45 107.445 174.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -163.46 163.73 24.73 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 122.277 1.037 . . . . 74.11 110.956 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -93.8 120.89 34.66 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.629 -1.623 . . . . 72.12 108.419 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -85.3 -42.59 14.48 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.869 -1.16 . . . . 74.43 107.869 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' D' ' 79' ' ' GLN . 20.0 m-20 -136.21 144.79 45.08 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 114.755 -1.111 . . . . 74.23 110.217 176.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.625 HG21 ' HE2' ' C' ' 117' ' ' MET . 56.6 mt -140.73 149.65 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.355 1.462 . . . . 65.22 107.367 174.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.1 t -156.49 142.45 18.0 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.021 0.439 . . . . 74.25 110.849 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.1 t80 -147.63 111.59 5.11 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 106.176 -1.787 . . . . 72.15 106.176 173.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 23.8 mt-10 -123.04 108.23 12.68 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.011 -0.737 . . . . 73.14 109.011 -173.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.558 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -106.44 89.06 3.72 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 123.594 0.758 . . . . 35.14 109.076 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -80.0 -28.13 3.38 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.766 2.311 . . . . 73.11 113.209 -169.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -110.05 6.29 22.84 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.466 0.706 . . . . 62.52 110.627 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.637 ' HB3' ' HE2' ' C' ' 19' ' ' LYS . . . -29.58 -66.89 0.14 Allowed Pre-proline 0 CA--C 1.566 1.588 0 N-CA-C 116.904 2.187 . . . . 50.5 116.904 -165.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.67 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 64.6 Cg_endo -74.64 -14.57 22.04 Favored 'Trans proline' 0 C--N 1.383 2.381 0 CA-C-N 123.38 2.243 . . . . 61.25 112.847 -172.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -84.4 -39.3 19.19 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.048 1.339 . . . . 73.51 110.318 172.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.665 HG22 HD12 ' D' ' 68' ' ' LEU . 5.6 p -82.48 -22.9 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-N 116.436 -0.347 . . . . 65.4 110.98 -170.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -61.67 -24.05 66.48 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.036 0.534 . . . . 64.33 112.251 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -57.6 -30.09 65.02 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.434 1.094 . . . . 75.14 110.861 175.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -84.33 71.98 10.61 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.514 -1.221 . . . . 70.12 109.502 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.72 81.55 5.97 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.215 -0.902 . . . . 50.42 110.67 -173.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 21.6 p90 -155.75 179.18 9.44 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.833 0.853 . . . . 72.0 109.485 172.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -68.84 116.26 39.43 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.868 0.867 . . . . 63.3 110.609 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.522 ' HD3' ' HG2' ' D' ' 124' ' ' PRO . 50.9 Cg_exo -56.79 131.97 48.86 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.652 2.235 . . . . 74.12 112.379 176.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.29 111.15 3.84 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.755 -1.202 . . . . 75.24 107.755 172.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' D' ' 66' ' ' ALA . 27.7 m -108.19 137.68 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.42 0.629 . . . . 73.03 110.609 -172.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -123.76 128.21 49.23 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.115 -1.439 . . . . 72.52 107.115 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.729 HD22 ' H ' ' H' ' 8' ' ' LEU . 7.8 mp -96.84 138.5 34.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.195 0.521 . . . . 72.31 110.653 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -128.01 115.87 19.16 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.331 -1.359 . . . . 74.52 107.331 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.463 HD21 HD12 ' H' ' 8' ' ' LEU . 7.5 mp -104.47 138.2 41.21 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.356 0.662 . . . . 70.04 110.28 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.632 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.9 t70 -133.7 145.05 49.54 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.089 -1.078 . . . . 73.34 108.089 177.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.5 t -105.97 158.13 17.01 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.859 0.464 . . . . 75.02 111.298 -175.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.458 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -167.66 153.11 7.2 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.935 1.294 . . . . 71.55 108.847 173.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 76.9 p -154.0 156.71 37.9 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.555 0.742 . . . . 63.41 109.813 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 15.3 m -147.6 123.92 10.92 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.357 -0.979 . . . . 73.41 108.357 -174.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -78.46 115.39 18.13 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.789 -1.189 . . . . 73.55 107.789 167.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.529 HD12 HG23 ' D' ' 83' ' ' ILE . 26.3 mt -95.44 -27.89 15.19 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.064 -0.717 . . . . 71.13 109.064 177.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.16 -178.64 6.12 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.042 0.937 . . . . 45.35 110.132 172.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -65.67 123.7 20.43 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.549 -0.75 . . . . 72.33 109.816 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 60.45 20.37 10.06 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.25 1.02 . . . . 63.23 112.475 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.3 t -125.08 118.11 52.0 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 C-N-CA 124.205 1.002 . . . . 53.54 108.511 174.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -134.69 131.26 37.48 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.466 0.707 . . . . 62.41 109.849 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.412 ' HB2' HD11 ' D' ' 51' ' ' LEU . 31.5 tt0 -87.38 128.57 35.2 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.812 -1.086 . . . . 63.42 108.274 166.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 43.2 t -110.0 125.42 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 107.789 -1.189 . . . . 61.21 107.789 173.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 16.5 t -118.69 125.67 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.883 -0.784 . . . . 71.2 108.883 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 6.9 mp -121.8 127.46 50.62 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.545 -0.909 . . . . 72.4 108.545 171.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.632 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 18.9 ttm-85 -83.94 103.66 13.38 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.601 1.16 . . . . 74.53 108.903 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 87.0 t -90.94 115.49 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 108.501 -0.925 . . . . 43.11 108.501 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' D' ' 42' ' ' LEU . 18.7 m -125.82 128.29 47.43 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.064 0.459 . . . . 61.14 109.778 -172.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 42.7 t -118.76 101.01 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 125.541 1.537 . . . . 71.42 108.475 -175.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 32.2 m -92.46 95.23 9.53 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.023 -1.103 . . . . 74.41 108.023 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.511 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -102.66 138.64 39.29 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 115.459 -0.791 . . . . 42.4 111.113 -173.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.431 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 47.6 m -146.78 134.4 21.01 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 122.786 0.434 . . . . 60.31 110.989 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.665 HD12 HG22 ' D' ' 31' ' ' VAL . 66.2 mt -94.89 102.24 14.08 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.883 -1.154 . . . . 73.33 107.883 171.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.6 -113.82 3.83 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 116.12 -0.491 . . . . 51.14 112.363 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.73 3.66 11.11 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.108 0.563 . . . . 73.04 110.24 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -116.0 155.08 28.72 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.685 -0.857 . . . . 64.43 108.685 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 35.0 m -70.01 136.43 50.39 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 123.395 0.435 . . . . 73.23 111.293 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.452 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -89.29 -62.77 1.4 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.705 -1.22 . . . . 43.53 107.705 172.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 74' ' ' PHE . . . . . 0.414 ' HE2' ' HG2' ' D' ' 38' ' ' PRO . 52.6 p90 -158.44 154.85 27.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.558 -1.201 . . . . 61.24 110.311 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 91.5 mt -120.56 112.75 19.31 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.58 1.152 . . . . 63.45 108.002 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.529 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 2.5 m -114.25 140.14 48.83 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.299 1.039 . . . . 72.1 108.918 -174.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -153.92 119.36 5.17 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.295 -1.002 . . . . 74.01 108.295 174.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 78' ' ' VAL . . . . . 0.462 HG22 HG23 ' D' ' 21' ' ' ILE . 60.3 t -124.5 115.13 43.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.487 -0.931 . . . . 73.15 108.487 174.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.577 ' HB2' ' HB2' ' D' ' 20' ' ' ASP . 51.1 mt-30 -88.13 85.37 6.94 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.92 -1.141 . . . . 65.45 107.92 171.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -80.66 104.03 10.91 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 114.132 -1.394 . . . . 62.22 108.467 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.64 141.74 15.42 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.421 -0.672 . . . . 23.22 111.421 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.507 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -137.11 131.93 5.78 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 111.472 -0.651 . . . . 64.03 111.472 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.529 HG23 HD12 ' D' ' 51' ' ' LEU . 50.8 mt -88.02 124.17 41.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.228 -1.027 . . . . 70.13 108.228 175.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -129.59 157.88 40.83 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.684 0.794 . . . . 73.02 110.071 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.408 ' HB3' ' HB2' ' D' ' 12' ' ' GLN . 43.4 t -115.56 98.88 6.97 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.986 1.314 . . . . 73.24 107.779 -178.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.9 111.55 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.532 0.733 . . . . 71.11 109.443 -176.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -131.87 149.76 52.35 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.932 0.493 . . . . 73.55 110.457 177.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.52 19.75 63.41 Favored Glycine 0 C--N 1.346 1.104 0 O-C-N 123.788 0.68 . . . . 64.11 114.426 172.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.465 HD11 ' HE3' ' D' ' 9' ' ' MET . 10.2 mt -112.65 154.16 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 117.226 0.513 . . . . 64.01 109.996 175.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.425 ' HB2' ' HB ' ' B' ' 149' ' ' THR . 0.0 OUTLIER -147.82 -174.35 4.53 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 125.085 1.354 . . . . 74.14 110.7 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.01 -138.03 39.01 Favored Glycine 0 C--N 1.353 1.485 0 CA-C-N 115.948 -0.569 . . . . 41.33 113.622 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 28.1 p -90.05 -13.74 35.33 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.793 0.837 . . . . 74.1 111.017 174.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -31.0 72.03 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.351 1.06 . . . . 75.0 110.09 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.422 ' SD ' ' HA ' ' D' ' 90' ' ' GLU . 8.0 ptm -74.52 -21.18 59.67 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.389 0.676 . . . . 73.23 112.124 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.83 -36.13 50.46 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.704 -0.48 . . . . 71.23 109.704 169.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.482 ' CD2' ' SD ' ' D' ' 138' ' ' MET . 24.7 t-80 -64.52 -37.28 87.02 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.306 0.642 . . . . 72.4 111.31 175.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 35.9 t -59.97 -49.57 77.17 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.011 -0.54 . . . . 64.15 110.491 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 43.7 mt -85.96 -21.7 27.75 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.246 -0.888 . . . . 75.2 111.557 -175.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.23 5.09 45.04 Favored Glycine 0 N--CA 1.476 1.363 0 N-CA-C 114.551 0.58 . . . . 61.43 114.551 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.639 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -150.05 -68.14 0.2 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.534 0.334 . . . . 63.31 110.855 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -65.13 -52.29 56.13 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 112.654 0.613 . . . . 73.45 112.654 -170.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 71.8 m -61.36 -50.17 84.47 Favored Pre-proline 0 CA--C 1.563 1.444 0 CA-C-O 118.76 -0.638 . . . . 70.23 112.218 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.29 -21.44 35.69 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 121.825 1.684 . . . . 72.42 113.421 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -68.74 -27.38 65.87 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 122.911 0.484 . . . . 72.42 110.528 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.432 HD13 HD11 ' D' ' 13' ' ' ILE . 58.5 mt -72.16 -28.43 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 C-N-CA 124.082 0.953 . . . . 70.11 110.441 171.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.507 HD21 ' HA3' ' D' ' 82' ' ' GLY . 94.2 mt -86.28 -22.94 26.53 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.702 0.801 . . . . 72.21 112.563 -176.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -66.9 -35.28 8.86 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.346 1.239 . . . . 75.32 114.346 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.91 -45.28 37.02 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 121.995 1.797 . . . . 75.53 112.939 166.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -74.51 -33.77 62.87 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.748 0.819 . . . . 73.44 111.884 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.41 -53.04 58.51 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.157 0.583 . . . . 41.24 109.889 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -53.77 -51.63 62.81 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-N 114.328 -1.305 . . . . 65.14 110.829 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -62.2 -44.81 95.75 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.274 0.984 . . . . 55.25 111.53 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 36.8 t -58.58 -40.63 83.72 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 123.814 0.696 . . . . 71.3 110.651 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.473 ' O ' HG23 ' D' ' 118' ' ' VAL . 76.7 mt -68.06 -48.79 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.809 0.843 . . . . 64.41 110.381 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.408 HG23 ' HG3' ' D' ' 125' ' ' GLN . 56.5 m -58.2 -42.45 86.18 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.438 1.095 . . . . 74.33 111.519 -175.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 32.8 t -66.5 -42.81 86.82 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.089 -0.96 . . . . 74.05 110.168 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.407 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 73.8 mtm -64.75 -37.57 88.05 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.946 0.498 . . . . 62.24 111.767 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.473 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.1 t -65.96 -41.7 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.063 0.945 . . . . 73.43 110.842 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.8 p -73.31 -31.36 63.96 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 116.009 -0.541 . . . . 73.3 110.952 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' D' ' 116' ' ' SER . 72.9 mtt-85 -70.19 -33.15 71.36 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.436 0.694 . . . . 73.34 110.176 175.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.48 7.63 78.2 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-N 115.919 -0.582 . . . . 50.42 112.516 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.0 p 59.58 24.12 12.87 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 126.683 1.993 . . . . 65.12 114.073 173.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.433 ' HB2' HG13 ' D' ' 118' ' ' VAL . 97.0 m-85 -83.95 156.37 64.06 Favored Pre-proline 0 N--CA 1.479 0.983 0 N-CA-C 108.908 -0.775 . . . . 64.42 108.908 167.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.522 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 18.5 Cg_endo -60.83 139.69 86.54 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.166 1.911 . . . . 74.25 111.771 176.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.408 ' HG3' HG23 ' D' ' 115' ' ' THR . 33.0 tt0 -55.28 142.48 31.57 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.755 1.222 . . . . 64.04 112.469 -174.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 45.9 tp -127.91 98.65 5.23 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.658 0.783 . . . . 73.13 109.352 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.23 107.4 18.21 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.442 0.697 . . . . 72.01 109.333 175.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 7.4 mp -63.79 117.95 7.64 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.086 0.954 . . . . 71.32 109.789 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.79 145.05 98.95 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.478 0.711 . . . . 52.43 111.115 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.471 ' HD3' HG13 ' B' ' 13' ' ' ILE . 73.9 Cg_exo -54.53 129.23 33.77 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.824 3.016 . . . . 61.31 113.4 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 29.9 m -113.53 146.39 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.467 0.707 . . . . 74.24 110.069 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -90.11 74.94 7.13 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.977 -1.49 . . . . 74.52 106.977 169.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.463 ' HD2' ' HA ' ' D' ' 100' ' ' ALA . 24.1 t80 -63.46 -26.43 68.72 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.921 0.888 . . . . 73.52 110.818 -174.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.639 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 7.1 m-20 -60.48 -61.03 2.89 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 115.013 -0.994 . . . . 60.05 111.14 172.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.1 -29.48 70.84 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.969 0.508 . . . . 31.01 111.727 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 86.8 mt -65.55 -42.68 91.63 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 124.029 0.831 . . . . 70.33 111.349 173.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -66.23 -50.75 62.72 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.053 0.541 . . . . 74.14 109.943 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.482 ' SD ' ' CD2' ' D' ' 96' ' ' HIS . 3.2 mpp? -62.01 -29.33 70.2 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.778 0.431 . . . . 65.04 111.692 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.43 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 9.4 t30 -60.57 -42.99 97.77 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.867 0.867 . . . . 73.44 110.937 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -61.66 -39.84 92.82 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.259 -0.882 . . . . 73.31 111.269 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 mp -74.48 -38.19 62.97 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.954 -0.567 . . . . 72.14 111.506 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.43 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 10.0 pt20 -88.81 5.78 42.04 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.091 0.404 . . . . 64.43 112.091 -172.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -118.78 89.81 3.2 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.713 0.768 . . . . 71.02 109.015 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -155.98 106.67 2.45 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.138 -1.392 . . . . 65.22 107.841 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.25 128.66 52.61 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.765 0.826 . . . . 63.53 108.815 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.99 73.32 1.97 Allowed Glycine 0 C--N 1.348 1.203 0 O-C-N 123.364 0.415 . . . . 73.02 112.379 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -155.86 158.3 37.81 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.285 1.034 . . . . 73.34 108.291 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -54.46 -35.04 55.63 Favored Glycine 0 C--N 1.353 1.525 0 O-C-N 123.824 0.702 . . . . 73.14 114.781 -172.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 71.0 p -83.55 105.12 14.22 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 122.877 0.471 . . . . 73.32 110.152 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -109.44 153.05 24.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.637 0.775 . . . . 72.21 109.139 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -86.67 48.5 1.65 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.638 0.732 . . . . 75.41 109.208 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -84.2 84.37 7.64 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.479 -0.782 . . . . 73.01 109.597 -173.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -137.51 73.92 1.46 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.212 -1.033 . . . . 72.23 108.212 173.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -95.3 -166.31 1.43 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 114.603 -1.18 . . . . 72.41 110.176 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.301 0 C-N-CA 123.452 0.701 . . . . 74.34 111.32 -172.693 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 109.714 -0.476 . . . . 42.51 109.714 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -173.65 106.38 0.13 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.693 1.197 . . . . 74.41 108.258 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.59 104.24 5.07 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 107.667 -1.234 . . . . 70.21 107.667 -176.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 59.0 p -100.45 130.89 46.59 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.509 -0.922 . . . . 72.14 108.509 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 28.8 m -60.57 148.58 37.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.136 0.575 . . . . 74.55 111.026 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.411 HD13 HG11 ' A' ' 40' ' ' VAL . 2.6 pp -51.1 139.3 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 125.073 1.349 . . . . 65.32 113.039 -178.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 7' ' ' ALA . . . . . 0.683 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . . . -150.8 161.92 41.74 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.79 0.836 . . . . 72.14 110.1 -175.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.592 ' HB3' HD13 ' A' ' 44' ' ' LEU . 89.3 mt -69.65 -15.28 63.16 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.283 0.633 . . . . 62.12 112.299 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . 66.1 -160.29 0.26 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.356 1.063 . . . . 52.41 110.251 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 5.6 mp -73.25 149.17 42.99 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.396 -0.594 . . . . 73.43 109.396 175.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.582 HD23 HD12 ' A' ' 44' ' ' LEU . 85.2 mt -64.74 135.51 96.41 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 123.101 0.56 . . . . 74.14 110.163 176.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -58.57 -41.33 65.52 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.582 2.855 . . . . 70.11 113.756 -167.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 23.3 tp -135.03 31.62 3.25 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 108.7 -0.852 . . . . 73.23 108.7 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 8.3 mp 59.26 -89.06 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.561 -1.199 . . . . 42.41 110.159 -173.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -165.73 176.22 8.17 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.192 0.997 . . . . 62.43 108.907 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 39.9 p -75.45 116.39 54.38 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 123.085 0.554 . . . . 54.24 110.366 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 17' ' ' PRO . . . . . 0.519 ' HB3' ' HB3' ' E' ' 21' ' ' ALA . 61.6 Cg_exo -53.95 131.21 43.24 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.85 3.033 . . . . 52.22 114.002 -174.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 18' ' ' VAL . . . . . 0.525 HG21 HD11 ' A' ' 86' ' ' ILE . 26.0 t -73.94 -75.35 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.53 0.732 . . . . 65.11 110.55 -176.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 54.7 p -93.14 58.38 2.89 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.335 0.654 . . . . 73.32 110.793 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt 62.05 22.06 12.82 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.878 1.271 . . . . 74.43 113.304 170.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 21' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' E' ' 17' ' ' PRO . . . -55.91 -28.2 55.64 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.753 0.821 . . . . 73.32 112.71 -173.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -151.97 133.14 14.38 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.345 -0.983 . . . . 73.44 108.345 171.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 29.1 m -132.9 121.62 17.08 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 107.778 -1.193 . . . . 71.31 107.778 -173.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -50.53 -37.69 52.76 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 123.591 2.861 . . . . 60.32 114.508 -170.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 CA--C 1.548 0.9 0 N-CA-C 107.943 -1.132 . . . . 72.35 107.943 170.827 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtm . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.126 -0.324 . . . . 62.24 110.126 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' F' F ' 2' ' ' LYS . . . . . 0.518 ' HA ' ' HE2' ' F' ' 2' ' ' LYS . 10.2 mmpt? -117.96 77.36 1.14 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.575 0.75 . . . . 75.24 110.615 -173.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -129.16 105.72 8.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.084 -0.71 . . . . 74.44 109.084 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 46.1 t -74.04 -42.71 59.85 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.556 -0.747 . . . . 74.3 110.779 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 83.6 m -145.63 150.58 36.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.893 0.877 . . . . 74.34 109.63 -174.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.436 HG13 HD23 ' B' ' 42' ' ' LEU . 12.4 tt -65.34 97.65 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 CA-C-O 121.887 0.851 . . . . 74.41 109.712 173.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.39 26.1 9.06 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.092 -0.958 . . . . 74.5 110.936 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 8' ' ' LEU . . . . . 0.409 HD23 ' HB2' ' B' ' 42' ' ' LEU . 96.9 mt 61.51 168.96 0.11 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.879 1.271 . . . . 64.13 113.203 177.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.22 145.72 26.28 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.091 -0.707 . . . . 62.32 109.091 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 tt -75.4 75.41 2.48 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 108.986 -0.746 . . . . 54.34 108.986 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 82.9 mt 26.83 80.44 0.22 Allowed Pre-proline 0 N--CA 1.491 1.593 0 C-N-CA 126.653 1.981 . . . . 63.21 113.773 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.53 -41.14 74.78 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.761 2.307 . . . . 63.43 112.633 -174.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.05 -20.38 45.39 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.216 -0.902 . . . . 64.33 110.879 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 6.6 mp 59.73 -165.5 0.2 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.739 1.216 . . . . 62.13 110.638 -166.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 15' ' ' PHE . . . . . 0.485 ' HA ' HG21 ' B' ' 46' ' ' THR . 35.0 t80 -113.76 134.79 54.55 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 110.023 -0.362 . . . . 73.31 110.023 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 41.7 p -72.83 119.02 73.1 Favored Pre-proline 0 CA--C 1.557 1.22 0 N-CA-C 109.399 -0.593 . . . . 63.24 109.399 175.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.23 174.49 9.83 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.961 2.441 . . . . 73.3 113.582 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 18' ' ' VAL . . . . . 0.609 ' HB ' ' HB2' ' F' ' 21' ' ' ALA . 30.7 t -91.78 138.96 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.232 1.013 . . . . 53.34 110.174 -175.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 8.0 m -76.93 -55.85 5.11 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 109.835 -0.432 . . . . 62.44 109.835 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -98.82 77.38 2.23 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.284 -0.635 . . . . 64.13 109.284 172.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 21' ' ' ALA . . . . . 0.609 ' HB2' ' HB ' ' F' ' 18' ' ' VAL . . . -95.37 -58.02 2.24 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.1 -0.955 . . . . 63.42 108.629 170.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 7.6 ppt_? -96.95 160.57 14.27 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.499 -0.773 . . . . 72.53 109.925 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 32.3 p -80.05 144.21 58.6 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.077 0.951 . . . . 70.23 110.621 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.96 -63.17 0.07 OUTLIER 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.342 2.028 . . . . 71.34 110.952 175.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 124.499 1.12 . . . . 65.44 108.33 173.711 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 91.4 mmm . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 109.914 -0.402 . . . . 74.33 109.914 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -152.99 88.79 1.34 Allowed 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 108.905 -0.776 . . . . 71.34 108.905 -166.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -151.4 67.44 0.9 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.55 1.167 . . . . 54.2 110.35 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 69.3 m -141.51 -86.94 0.17 Allowed 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 106.457 -1.683 . . . . 70.51 106.457 164.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 5' ' ' THR . . . . . 0.609 ' H ' ' HB3' ' C' ' 147' ' ' GLU . 4.0 m 55.53 -76.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 125.472 1.509 . . . . 54.25 113.318 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 6' ' ' ILE . . . . . 0.641 HG13 HD21 ' C' ' 42' ' ' LEU . 10.1 tt -59.5 112.33 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 125.168 1.387 . . . . 75.13 111.36 -178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -122.11 147.46 46.1 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.146 0.978 . . . . 44.14 110.403 -175.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 8' ' ' LEU . . . . . 0.515 HD12 ' HB ' ' C' ' 131' ' ' VAL . 56.7 mt -90.45 125.28 35.52 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 123.706 0.802 . . . . 54.04 109.43 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.55 164.77 22.48 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 123.86 0.725 . . . . 42.52 111.188 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.72 138.37 57.11 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.407 0.683 . . . . 65.55 109.794 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 96.5 mt -56.19 114.97 8.6 Favored Pre-proline 0 CA--C 1.548 0.872 0 O-C-N 123.985 0.803 . . . . 72.44 110.706 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.49 -22.85 65.08 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.094 2.529 . . . . 71.15 112.717 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 53.7 tp -139.18 135.27 33.83 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.585 0.754 . . . . 65.01 109.666 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 93.3 mt -98.17 102.67 14.48 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.354 -0.98 . . . . 74.45 108.354 172.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 15' ' ' PHE . . . . . 0.618 ' HD1' ' HD3' ' G' ' 17' ' ' PRO . 38.3 p90 -77.1 165.3 24.78 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.797 0.839 . . . . 74.41 110.913 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -149.53 91.95 4.31 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 123.491 0.716 . . . . 64.51 109.675 173.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 17' ' ' PRO . . . . . 0.636 ' HB3' ' HB3' ' C' ' 48' ' ' SER . 59.8 Cg_endo -73.26 -11.47 24.94 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.28 2.654 . . . . 73.44 112.208 173.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 18' ' ' VAL . . . . . 0.526 HG11 ' SD ' ' C' ' 94' ' ' MET . 46.9 t -92.81 166.9 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.372 0 C-N-CA 124.202 1.001 . . . . 72.23 108.495 172.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 25.7 m -31.35 -64.81 0.14 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 126.463 1.905 . . . . 63.23 114.799 -176.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.06 131.55 1.61 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.233 0.213 . . . . 71.14 111.138 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . -102.28 116.62 33.03 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.501 0.72 . . . . 71.55 109.177 173.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 22' ' ' ARG . . . . . 0.529 ' HG2' ' H ' ' G' ' 23' ' ' THR . 20.8 ttt85 -144.77 -174.75 4.42 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.002 -0.74 . . . . 73.55 109.002 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 23' ' ' THR . . . . . 0.529 ' H ' ' HG2' ' G' ' 22' ' ' ARG . 40.6 p -48.66 121.79 10.19 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 124.007 0.923 . . . . 64.23 110.646 167.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 24' ' ' PRO . . . . . 0.418 ' HD3' HG23 ' C' ' 92' ' ' THR . 87.5 Cg_endo -74.83 170.38 20.49 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.606 2.204 . . . . 75.45 111.203 176.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--O 1.251 1.175 0 N-CA-C 108.129 -1.063 . . . . 73.03 108.129 173.187 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 109.341 -0.614 . . . . 72.14 109.341 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -160.52 89.12 0.81 Allowed 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.764 0.826 . . . . 64.41 108.877 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -95.61 137.27 34.91 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.083 -1.08 . . . . 75.35 108.083 174.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 62.3 p -79.77 72.23 6.47 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.713 0.768 . . . . 73.33 109.568 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 19.4 m -86.06 129.04 34.96 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.984 -1.007 . . . . 52.41 109.406 -177.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.445 HD11 HG23 ' D' ' 40' ' ' VAL . 2.6 pp -66.07 140.28 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 123.614 0.572 . . . . 73.54 110.294 174.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -166.55 105.24 0.62 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.944 -0.762 . . . . 71.25 108.944 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 8' ' ' LEU . . . . . 0.729 ' H ' HD22 ' D' ' 42' ' ' LEU . 3.8 mm? 64.76 -175.27 0.17 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.786 1.234 . . . . 74.01 111.535 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 9' ' ' ALA . . . . . 0.412 ' HB3' HD13 ' D' ' 44' ' ' LEU . . . -165.68 -178.73 4.99 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.156 0.982 . . . . 52.44 109.299 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 87.3 mt -88.79 148.96 23.65 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.825 -0.435 . . . . 71.24 109.825 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 96.7 mt -70.87 130.26 88.69 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-N 115.59 -0.732 . . . . 65.34 110.712 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.98 -28.85 28.55 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.903 2.402 . . . . 75.35 112.323 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 98.4 mt -121.0 160.12 24.2 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.045 0.938 . . . . 74.23 110.149 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 7.3 mp -101.07 -171.2 1.96 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.938 0.895 . . . . 74.05 109.419 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -140.98 -158.29 0.85 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.734 1.213 . . . . 72.42 108.983 -176.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 16' ' ' THR . . . . . 0.536 ' HB ' ' HB1' ' H' ' 21' ' ' ALA . 63.3 p -109.06 147.3 35.65 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 123.638 0.775 . . . . 61.25 110.232 174.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -68.26 -159.01 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.737 2.958 . . . . 62.23 114.0 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 37.7 t -99.29 113.19 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.565 0.746 . . . . 75.12 110.83 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 62.2 m 73.54 137.13 0.05 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.004 1.322 . . . . 72.13 111.169 172.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt 65.21 21.54 12.1 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 122.258 1.028 . . . . 70.02 109.421 -174.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 21' ' ' ALA . . . . . 0.536 ' HB1' ' HB ' ' H' ' 16' ' ' THR . . . -114.85 -26.25 7.87 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.817 0.847 . . . . 73.32 112.045 -169.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 22' ' ' ARG . . . . . 0.418 ' NE ' ' HA ' ' H' ' 22' ' ' ARG . 2.6 mmp_? -121.25 115.27 22.68 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.226 0.61 . . . . 71.2 110.95 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 77.5 p -82.42 138.71 44.69 Favored Pre-proline 0 CA--C 1.554 1.099 0 CA-C-N 115.29 -0.868 . . . . 44.11 109.183 172.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.53 152.26 48.41 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.334 2.023 . . . . 63.11 112.411 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--O 1.248 0.99 0 N-CA-C 108.04 -1.096 . . . . 64.21 108.04 177.39 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 109.811 -0.44 . . . . 71.33 109.811 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.8 p -106.08 128.31 53.78 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.274 0.63 . . . . 71.33 109.894 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.511 ' HG3' ' HA ' ' C' ' 140' ' ' TYR . 33.3 tt0 -66.06 122.12 16.67 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.961 0.904 . . . . 65.14 108.988 176.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.55 143.22 57.18 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.399 0.68 . . . . 64.25 110.181 -172.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -151.15 129.35 11.92 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.891 -0.781 . . . . 75.33 108.891 176.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -79.13 103.54 9.14 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.464 -0.569 . . . . 71.01 109.464 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.5 p -87.78 -8.0 56.56 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.471 0.708 . . . . 64.35 110.583 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -73.64 -47.77 37.53 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.522 1.129 . . . . 64.44 109.941 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.65 ' HB2' HG22 ' A' ' 89' ' ' ILE . 23.3 ttt -145.23 161.68 38.96 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.911 -1.04 . . . . 65.41 108.194 -174.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.4 t -138.98 144.32 38.9 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.854 -0.425 . . . . 73.4 109.854 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.685 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 4.3 t80 -116.61 133.63 55.78 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.547 0.739 . . . . 72.14 109.841 -177.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.5 tp60 -150.16 127.33 11.29 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.812 -1.181 . . . . 71.32 107.812 172.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.577 HG12 ' HD2' ' A' ' 84' ' ' PHE . 48.6 mt -94.32 126.37 46.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.827 -0.805 . . . . 73.52 108.827 176.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -77.38 -39.75 46.15 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.675 -0.491 . . . . 73.0 109.675 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -169.16 145.55 3.42 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 116.365 -0.38 . . . . 73.4 110.332 -168.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 78.1 mt -137.46 136.91 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.021 -1.103 . . . . 60.34 108.021 170.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.467 ' HB3' HG23 ' B' ' 122' ' ' THR . 39.7 p90 -167.84 176.49 6.24 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.808 0.843 . . . . 72.31 110.973 -172.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.9 p -102.74 126.78 49.98 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.307 -0.86 . . . . 54.41 108.984 177.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -90.71 -40.37 11.89 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.885 0.474 . . . . 65.1 110.122 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -141.2 139.2 33.79 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.224 -1.028 . . . . 61.43 108.224 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.432 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 63.8 mt -134.52 140.32 46.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.786 -1.19 . . . . 72.24 107.786 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.531 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 42.7 t -144.43 125.83 14.85 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.363 1.065 . . . . 72.31 108.134 177.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.497 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 85.7 t80 -135.99 115.04 12.3 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 106.667 -1.605 . . . . 65.54 106.667 170.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -120.09 126.05 49.8 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.777 -0.823 . . . . 74.52 108.777 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.47 81.61 4.21 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 107.162 -1.421 . . . . 64.1 107.162 172.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.15 -41.02 46.16 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.988 2.458 . . . . 74.42 113.415 -164.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -114.87 33.07 5.6 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 109.243 -0.651 . . . . 74.21 109.243 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.5 -49.33 34.78 Favored Pre-proline 0 N--CA 1.5 2.059 0 N-CA-C 114.464 1.283 . . . . 51.14 114.464 -177.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -64.12 -20.89 67.86 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.197 1.931 . . . . 55.53 114.088 177.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -101.37 -23.46 14.36 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.728 1.211 . . . . 65.33 111.634 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.573 HG21 ' HA ' ' A' ' 73' ' ' ALA . 2.4 p -78.74 -24.27 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.342 0.657 . . . . 73.14 112.363 -165.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -79.69 -18.63 50.86 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.549 0.74 . . . . 53.22 112.474 -172.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -88.24 -11.63 46.04 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.473 0.709 . . . . 72.42 111.0 173.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -82.21 161.85 22.59 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.644 0.778 . . . . 64.45 111.823 -174.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -72.75 120.49 18.45 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.221 -0.9 . . . . 73.44 109.755 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -76.34 86.03 3.12 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.378 0.608 . . . . 72.13 109.925 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -128.66 73.35 80.94 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 124.559 1.144 . . . . 52.54 107.996 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -86.84 138.44 5.1 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.849 2.366 . . . . 64.04 113.628 -170.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -102.03 86.2 2.83 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 106.988 -1.486 . . . . 75.52 106.988 169.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.1 m -72.8 90.73 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 123.062 1.41 . . . . 75.02 109.611 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -91.97 116.3 28.81 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 112.87 -1.968 . . . . 74.52 108.206 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.525 HD11 HG13 ' A' ' 62' ' ' VAL . 52.2 tp -104.87 129.52 53.2 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.475 0.71 . . . . 75.21 111.444 -170.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -120.73 126.33 49.9 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.348 1.059 . . . . 73.41 108.925 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.1 mt -114.67 133.87 55.52 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.739 0.816 . . . . 71.24 110.306 -173.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.604 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 18.5 t70 -127.05 138.97 53.31 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.819 0.848 . . . . 75.24 110.338 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.3 p -107.78 121.57 44.99 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.752 0.821 . . . . 63.24 110.222 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.97 128.91 25.05 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.696 0.798 . . . . 73.42 109.466 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.459 ' HB3' ' HE1' ' E' ' 15' ' ' PHE . 80.3 p -131.94 164.82 25.3 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.56 0.618 . . . . 60.23 110.432 175.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -156.96 138.96 14.44 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.616 0.766 . . . . 71.1 109.754 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -93.41 118.76 31.71 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.045 -1.094 . . . . 74.24 108.045 169.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' A' ' 57' ' ' GLU . 43.7 mt -90.95 -38.88 12.58 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.945 0.498 . . . . 63.13 110.528 -176.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.16 -176.77 6.1 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.88 0.872 . . . . 62.11 109.951 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -69.2 115.39 8.43 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.166 0.586 . . . . 52.05 109.669 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 75.94 -6.05 2.06 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 125.734 1.613 . . . . 73.15 112.469 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.9 t -100.51 112.96 34.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 108.127 -1.064 . . . . 62.23 108.127 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.44 ' CZ ' ' HA ' ' E' ' 18' ' ' VAL . 31.2 t80 -136.17 127.52 28.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.367 -0.605 . . . . 73.01 109.367 -174.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.449 ' HB2' HD11 ' A' ' 51' ' ' LEU . 36.3 tt0 -97.76 142.42 29.57 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.242 1.017 . . . . 74.51 111.159 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.43 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 56.0 t -125.59 132.47 70.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 106.767 -1.568 . . . . 60.44 106.767 173.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 62.0 t -128.11 129.48 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.32 1.048 . . . . 74.12 108.936 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -119.66 110.48 16.88 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.924 -1.139 . . . . 72.31 107.924 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.604 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 8.4 tmm_? -87.56 104.43 16.49 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.638 -0.875 . . . . 54.15 108.638 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.525 HG13 HD11 ' A' ' 42' ' ' LEU . 59.2 t -100.04 108.54 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.753 1.221 . . . . 74.43 109.195 -177.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.3 m -104.04 110.78 23.07 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.611 0.764 . . . . 63.51 110.539 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.3 t -105.08 108.89 26.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 124.157 0.983 . . . . 73.52 109.659 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.3 m -103.83 127.63 51.32 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.909 -0.774 . . . . 55.21 108.909 171.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.53 115.33 29.96 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.04 -1.096 . . . . 64.35 108.04 175.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.6 m -118.44 126.35 51.88 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.084 0.469 . . . . 72.53 110.811 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.7 mt -89.51 76.64 7.39 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 107.832 -1.173 . . . . 53.41 107.832 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.34 -83.65 0.98 Allowed Glycine 0 C--N 1.351 1.368 0 N-CA-C 111.145 -0.782 . . . . 60.33 111.145 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -119.53 -26.58 5.73 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.695 0.798 . . . . 74.15 111.161 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -88.96 110.76 21.39 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.963 0.505 . . . . 74.03 110.277 -174.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.9 m -64.23 122.59 17.0 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.917 0.389 . . . . 72.53 110.667 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.573 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -70.89 -59.86 2.56 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.028 -0.987 . . . . 65.44 110.157 175.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -153.17 174.03 14.76 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.185 -0.916 . . . . 72.13 111.658 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 64.2 tp -133.69 141.13 47.44 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.134 -1.432 . . . . 73.03 107.134 173.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 73.9 m -137.86 93.89 2.83 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.542 -0.91 . . . . 43.12 108.542 172.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 45.3 tt0 -113.1 116.26 29.59 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.696 -0.853 . . . . 73.12 108.696 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 t -135.39 115.92 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.459 0.703 . . . . 74.32 110.205 -170.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -81.98 94.2 7.1 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.071 -1.085 . . . . 70.12 108.071 169.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -82.17 99.45 9.26 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.69 -0.856 . . . . 74.04 108.69 176.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.19 146.26 20.21 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 111.192 -0.763 . . . . 53.43 111.192 176.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.22 120.81 1.14 Allowed Glycine 0 CA--C 1.5 -0.845 0 N-CA-C 110.247 -1.141 . . . . 74.24 110.247 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 21.7 mt -85.36 114.47 25.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.03 -0.73 . . . . 73.21 109.03 177.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.685 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 23.3 m-85 -119.37 119.57 34.35 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.401 -0.963 . . . . 63.33 108.401 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.4 p -86.03 101.45 12.94 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.775 -0.824 . . . . 64.11 108.775 174.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.423 ' H ' HD13 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -127.74 134.54 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.392 0.677 . . . . 73.51 110.627 -174.182 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 178.65 166.5 0.86 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.125 1.37 . . . . 72.02 110.042 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 153.82 -82.75 0.16 Allowed Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.838 -0.619 . . . . 71.32 111.853 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.65 HG22 ' HB2' ' A' ' 9' ' ' MET . 11.7 tt -97.09 -29.36 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.756 0.822 . . . . 60.15 111.358 -174.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.41 ' HA ' ' HB3' ' A' ' 94' ' ' MET . 3.7 mm-40 62.34 -156.8 0.34 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.92 1.288 . . . . 73.31 110.814 -175.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.91 -128.23 14.22 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 114.245 0.458 . . . . 72.23 114.245 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.2 p -78.34 -28.86 47.34 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.606 0.762 . . . . 64.14 112.222 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -70.54 -40.37 73.46 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.328 0.651 . . . . 64.24 109.995 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.41 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 19.1 ptt? -72.52 -31.28 65.2 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.873 -0.417 . . . . 51.21 109.873 173.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.79 -35.52 80.86 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.438 0.695 . . . . 64.05 111.106 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -67.39 -42.37 83.47 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.693 -0.685 . . . . 75.34 110.091 172.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.648 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 81.6 m -62.71 -55.71 24.24 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 123.918 0.761 . . . . 64.14 111.379 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.671 HD22 ' H ' ' E' ' 18' ' ' VAL . 4.5 pp -73.09 -36.36 66.78 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.338 0.655 . . . . 73.11 111.316 -174.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.69 -16.62 58.1 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 114.764 0.665 . . . . 61.44 114.764 -168.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.41 ' HB1' ' HB3' ' A' ' 134' ' ' ASP . . . -148.74 -54.83 0.19 Allowed 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 117.655 0.728 . . . . 74.02 112.834 -171.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.648 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 79.3 t80 -63.64 -53.19 55.26 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.319 1.047 . . . . 65.04 112.896 -169.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.5 m -72.1 -37.41 4.85 Favored Pre-proline 0 CA--C 1.563 1.453 0 C-N-CA 123.591 0.757 . . . . 74.33 112.678 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.79 -40.48 47.88 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 122.441 2.094 . . . . 70.41 113.588 160.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -70.81 -24.1 62.49 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.87 0.868 . . . . 74.11 111.527 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 51.0 mm -69.6 -36.94 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 109.387 -0.598 . . . . 72.34 109.387 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 83.3 mt -79.58 -23.68 42.57 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.752 0.821 . . . . 75.53 112.445 -177.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -58.72 -49.23 94.54 Favored Pre-proline 0 CA--C 1.571 1.764 0 N-CA-C 113.651 0.982 . . . . 72.45 113.651 -176.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -63.68 -35.74 56.37 Favored 'Trans proline' 0 C--N 1.389 2.672 0 C-N-CA 122.159 1.906 . . . . 73.51 113.484 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -75.56 -35.67 60.6 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.579 0.752 . . . . 73.14 111.937 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.8 -44.83 65.79 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.376 -0.602 . . . . 70.44 109.376 175.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.583 HH12 HD12 ' C' ' 105' ' ' ILE . 17.9 ttm180 -59.5 -33.97 72.02 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.146 0.904 . . . . 75.4 110.165 173.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -66.3 -50.53 63.34 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.864 0.866 . . . . 50.24 110.836 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 36.8 t -61.45 -37.02 82.04 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.744 0.653 . . . . 71.32 110.552 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 118' ' ' VAL . 93.5 mt -62.22 -57.28 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.774 0.83 . . . . 63.54 110.021 172.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.8 m -52.28 -39.66 60.74 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.253 1.421 . . . . 63.54 111.908 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -69.98 -51.42 32.66 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.884 -1.053 . . . . 74.21 110.392 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.435 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 36.7 mtm -64.64 -36.69 85.06 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.93 0.492 . . . . 72.22 111.918 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 114' ' ' ILE . 79.2 t -61.1 -44.94 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.506 0.722 . . . . 71.44 110.227 176.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.9 t -70.47 -34.67 72.66 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.477 -0.783 . . . . 61.42 111.454 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.535 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 93.7 mtt-85 -70.58 -32.56 69.99 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.889 0.876 . . . . 54.34 109.695 176.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.95 1.64 83.66 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-O 119.065 -0.853 . . . . 63.53 112.992 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.493 HG22 HH21 ' B' ' 15' ' ' ARG . 22.5 m 73.71 12.53 4.48 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 122.446 1.117 . . . . 71.13 111.866 173.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -84.13 148.2 52.73 Favored Pre-proline 0 CA--C 1.544 0.736 0 O-C-N 121.369 -0.832 . . . . 71.24 109.591 172.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.1 142.21 96.85 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.533 2.155 . . . . 64.15 110.91 172.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -57.27 145.2 32.74 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 124.281 0.988 . . . . 71.11 113.016 -168.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.5 tp -127.99 114.91 17.73 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.871 0.868 . . . . 60.24 109.41 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -119.69 117.65 28.83 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.534 -0.913 . . . . 74.12 108.534 175.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.9 mp -72.49 146.07 47.11 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.147 0.579 . . . . 71.22 110.232 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -62.34 136.37 95.65 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.874 0.87 . . . . 72.22 112.15 -174.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 22.5 Cg_exo -67.83 89.45 0.36 Allowed 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.941 2.427 . . . . 70.04 112.265 175.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.404 HG21 ' HB3' ' E' ' 8' ' ' LEU . 87.1 t -107.31 112.03 38.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.595 -0.891 . . . . 73.41 108.595 176.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -85.32 96.75 9.63 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 107.688 -1.227 . . . . 72.42 107.688 170.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -55.3 -37.61 67.56 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.059 0.85 . . . . 74.34 111.002 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.41 ' HB3' ' HB1' ' A' ' 100' ' ' ALA . 6.4 p-10 -67.84 -36.65 80.71 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.097 -0.956 . . . . 75.32 111.326 -177.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.41 -32.65 72.85 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.751 0.82 . . . . 63.24 111.718 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.614 ' HB2' HD21 ' E' ' 10' ' ' LEU . 91.0 mt -73.2 -41.91 63.26 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.805 -0.634 . . . . 62.14 109.527 174.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -63.53 -25.75 68.39 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.537 0.735 . . . . 74.53 111.316 172.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 13.7 mmt -69.56 -34.28 73.95 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.906 0.882 . . . . 73.44 111.324 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 88.0 m-20 -61.74 -35.44 78.1 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.503 0.721 . . . . 71.41 110.23 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -84.96 -27.84 26.24 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.096 0.958 . . . . 71.44 111.728 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 46.9 tp -62.92 -50.48 70.68 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.415 0.686 . . . . 74.24 110.267 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -174.13 5.86 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.094 -0.957 . . . . 74.33 111.253 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 28.5 tt0 63.57 90.37 0.08 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.911 1.285 . . . . 74.31 110.192 -170.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.472 ' HG2' ' N ' ' A' ' 145' ' ' ALA . 12.1 tt0 -80.14 165.98 21.92 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.153 -0.931 . . . . 75.15 110.644 -176.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.472 ' N ' ' HG2' ' A' ' 144' ' ' GLN . . . 70.91 -154.82 0.11 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.546 1.138 . . . . 61.14 111.354 168.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.39 13.89 67.2 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 111.603 -0.599 . . . . 42.12 111.603 -169.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -133.59 164.63 26.74 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 124.306 1.042 . . . . 75.21 110.044 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.519 ' HA2' HD11 ' C' ' 141' ' ' LEU . . . 159.29 81.53 0.04 OUTLIER Glycine 0 C--N 1.343 0.917 0 N-CA-C 110.781 -0.927 . . . . 64.21 110.781 178.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.7 p -121.95 134.25 54.84 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.675 0.79 . . . . 53.12 110.589 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -73.61 146.37 44.7 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.854 0.862 . . . . 64.32 110.578 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -134.47 74.37 1.53 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.277 1.031 . . . . 72.2 110.036 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 52.9 m170 -125.21 114.3 18.79 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.886 0.874 . . . . 75.52 109.912 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -161.17 138.61 9.08 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.485 0.714 . . . . 65.31 109.572 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -145.35 -53.7 0.29 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.803 0.841 . . . . 73.42 109.627 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 C-N-CA 123.592 0.757 . . . . 45.33 109.432 -177.673 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 109.941 -0.392 . . . . 74.22 109.941 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 9.1 m -65.24 -90.11 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.857 0.863 . . . . 64.31 109.39 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 48.88 41.51 18.67 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 114.65 1.352 . . . . 73.21 114.65 153.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.4 ' HG2' ' HA2' ' B' ' 88' ' ' GLY . 12.0 pt20 -139.98 111.94 7.51 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 108.713 -0.847 . . . . 74.54 108.713 173.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -76.98 142.85 39.79 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.389 0.676 . . . . 62.54 110.157 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 60.54 82.98 0.15 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.118 1.367 . . . . 73.31 110.499 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 15.1 t -147.85 172.55 13.98 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.712 -0.676 . . . . 73.44 110.545 -171.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -78.72 -18.41 54.34 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.781 0.832 . . . . 74.44 111.416 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 19.6 ptm 62.42 177.26 0.14 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 126.767 2.027 . . . . 70.03 113.63 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 99.9 m -134.79 140.05 45.59 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.831 1.252 . . . . 63.21 107.84 174.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.451 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 46.0 t80 -142.22 132.89 25.44 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.053 -0.721 . . . . 71.43 109.053 172.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -153.44 121.11 5.96 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.45 -0.945 . . . . 72.44 108.45 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 54.7 mt -68.75 120.07 15.62 Favored 'Isoleucine or valine' 0 C--N 1.348 0.528 0 N-CA-C 108.186 -1.042 . . . . 72.31 108.186 170.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -89.07 -49.84 6.52 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.711 -0.848 . . . . 72.22 108.711 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.493 HH21 HG22 ' A' ' 122' ' ' THR . 34.2 ttt85 -168.74 137.03 2.1 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.55 -0.75 . . . . 71.05 109.636 -175.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 87.1 mt -115.36 142.19 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 108.341 -0.985 . . . . 61.32 108.341 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -168.13 148.98 5.01 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 112.622 0.601 . . . . 75.11 112.622 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.579 HG21 HD11 ' B' ' 21' ' ' ILE . 39.5 m -79.69 114.14 18.39 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.268 -0.878 . . . . 63.04 108.912 172.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -84.09 -25.89 29.41 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.099 0.56 . . . . 72.35 111.375 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 16.2 t70 -163.43 149.06 11.41 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.367 0.603 . . . . 65.12 112.052 -175.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.579 HD11 HG21 ' B' ' 18' ' ' THR . 46.4 mm -137.15 142.85 36.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 126.018 1.727 . . . . 70.4 107.742 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 42.5 t -146.17 137.15 24.43 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.249 -1.019 . . . . 72.41 108.249 168.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.432 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 91.2 t80 -141.15 131.86 25.69 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.301 -1.37 . . . . 62.4 107.301 172.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 34.4 mt-10 -131.66 126.84 35.65 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.798 -1.186 . . . . 73.11 107.798 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.696 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -127.98 81.19 70.84 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 107.146 -1.428 . . . . 53.12 107.146 170.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.46 -30.53 35.94 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.884 2.389 . . . . 33.32 111.33 -177.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -103.96 2.58 32.55 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.281 -1.327 . . . . 74.45 110.86 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.696 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -32.05 -66.76 0.19 Allowed Pre-proline 0 N--CA 1.499 1.997 0 C-N-CA 126.032 1.733 . . . . 72.32 115.096 -172.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 21.7 Cg_exo -62.55 -31.05 80.12 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.899 2.399 . . . . 61.33 113.669 -164.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -96.22 -41.51 8.65 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.426 -0.807 . . . . 72.32 111.158 -174.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.17 -12.71 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 113.074 0.768 . . . . 53.14 113.074 -170.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -62.89 -18.24 62.73 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.485 0.714 . . . . 73.31 112.641 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.502 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 10.6 pt20 -55.15 -29.92 58.76 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.453 1.101 . . . . 55.44 111.499 173.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.502 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 96.5 mttt -92.38 95.31 9.59 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.7 1.2 . . . . 75.51 109.202 177.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -97.95 76.65 2.43 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 122.009 0.909 . . . . 71.22 111.494 -172.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 43.0 p90 -157.51 161.13 38.82 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.61 -0.885 . . . . 70.33 108.61 171.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -68.16 116.42 38.98 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 109.062 -0.718 . . . . 74.45 109.062 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.97 159.33 54.37 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.162 1.908 . . . . 64.43 112.656 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -64.63 113.13 3.53 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 109.195 -0.669 . . . . 72.5 109.195 174.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.23 121.64 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.881 0.848 . . . . 74.54 109.79 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.538 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 37.6 ttpt -107.04 100.55 10.03 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.578 -1.638 . . . . 63.21 106.578 175.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 pp -110.24 140.58 44.24 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.735 0.814 . . . . 61.45 110.174 -169.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -136.06 129.93 32.68 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.173 0.989 . . . . 63.32 108.915 -174.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -100.78 127.39 47.23 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.802 -1.184 . . . . 62.45 107.802 170.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.477 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 24.1 t70 -126.92 155.11 43.58 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.197 0.999 . . . . 72.22 108.731 -175.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 79.2 p -107.63 120.11 41.29 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.706 -0.679 . . . . 61.34 110.685 -172.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.79 131.18 44.52 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 107.174 -1.417 . . . . 45.34 107.174 172.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 10.7 p -145.91 168.29 21.19 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.699 0.681 . . . . 64.12 111.457 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p -152.19 138.33 18.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.115 0.966 . . . . 75.4 108.521 171.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -93.82 114.0 26.16 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.133 -0.691 . . . . 61.22 109.133 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 51.6 mt -77.58 -43.2 32.51 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.867 0.467 . . . . 63.24 110.157 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.7 -179.24 7.69 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.579 0.752 . . . . 60.35 110.501 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.11 124.38 21.97 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.301 -1.318 . . . . 70.02 109.02 172.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 70.85 6.77 5.98 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.889 1.276 . . . . 74.22 112.282 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 78.0 t -119.85 111.54 33.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.7 0 N-CA-C 107.698 -1.223 . . . . 65.31 107.698 170.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -122.13 139.84 53.26 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.54 -0.541 . . . . 70.21 109.54 -177.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.444 ' HG2' HG12 ' B' ' 83' ' ' ILE . 6.6 tm-20 -111.35 101.13 9.61 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 107.489 -1.3 . . . . 71.24 107.489 -176.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 63.4 t -96.5 119.6 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.491 1.117 . . . . 62.11 109.601 -173.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.493 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 10.6 t -114.05 123.93 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.826 0.85 . . . . 75.42 108.711 178.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.488 HD22 ' HB3' ' B' ' 103' ' ' PRO . 15.6 tp -103.93 116.26 31.94 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.094 -0.706 . . . . 65.22 109.094 171.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.477 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 41.2 ttm180 -86.04 109.73 19.01 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.438 -0.949 . . . . 73.24 108.438 174.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 46.9 t -101.6 101.26 11.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.34 -1.355 . . . . 64.14 107.34 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.6 m -97.99 128.55 44.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.505 -0.77 . . . . 70.43 109.094 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.653 HG21 HG21 ' B' ' 114' ' ' ILE . 67.5 t -121.57 131.68 72.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 124.578 1.151 . . . . 73.52 108.184 -174.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 60.3 m -120.88 145.46 47.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.873 -1.158 . . . . 74.25 107.873 171.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.52 126.34 12.68 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.643 -0.873 . . . . 74.23 108.643 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 30.8 p -133.63 128.39 35.02 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.966 0.506 . . . . 65.54 110.114 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 70.4 mt -100.79 107.06 18.52 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.014 0.926 . . . . 63.33 108.804 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.16 -129.9 10.0 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 115.877 -0.601 . . . . 70.33 112.497 -176.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -92.4 1.21 57.37 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.647 0.779 . . . . 60.35 110.766 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -121.63 162.25 21.02 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.298 0.639 . . . . 75.02 110.444 -175.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 25.9 m -71.2 145.46 49.65 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.654 0.596 . . . . 73.01 109.787 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.8 -60.2 1.57 Allowed 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.296 -1.002 . . . . 71.34 108.296 168.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -153.04 164.52 37.85 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.001 0.905 . . . . 74.3 111.255 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.529 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 31.3 mt -134.48 142.8 47.18 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 105.427 -2.064 . . . . 70.04 105.427 178.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.3 t -154.8 116.42 4.11 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.601 0.637 . . . . 71.55 109.888 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -121.33 122.86 40.79 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 107.883 -1.155 . . . . 62.24 107.883 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.2 141.76 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.73 0.812 . . . . 74.3 108.959 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.5 mt-30 -118.63 94.54 4.5 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.697 -1.223 . . . . 73.51 107.697 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -90.31 103.93 16.56 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.988 -0.745 . . . . 75.32 108.988 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.46 161.98 29.04 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 123.798 0.686 . . . . 72.1 112.101 177.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.05 125.03 1.34 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.835 -1.306 . . . . 70.24 109.835 177.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.444 HG12 ' HG2' ' B' ' 57' ' ' GLU . 28.3 mt -85.05 130.22 36.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 107.854 -1.165 . . . . 74.04 107.854 175.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -136.6 133.6 36.49 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.037 -1.098 . . . . 74.41 108.037 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 40.3 m -87.25 92.36 9.04 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.452 -0.944 . . . . 71.14 108.452 170.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -107.43 130.3 59.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-N 114.907 -1.042 . . . . 71.55 108.492 176.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.66 168.73 18.16 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.622 0.769 . . . . 74.52 109.997 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.4 ' HA2' ' HG2' ' B' ' 4' ' ' GLN . . . 85.66 -63.44 4.28 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.079 -0.964 . . . . 73.54 112.903 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.56 HG23 ' HB2' ' B' ' 93' ' ' GLN . 43.4 mm -58.83 149.1 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 N-CA-C 114.757 1.392 . . . . 65.12 114.757 -165.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -159.99 -175.76 5.29 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 125.348 1.459 . . . . 61.12 109.548 171.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.01 -111.59 3.93 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 115.423 0.929 . . . . 35.25 115.423 166.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 51.2 m -81.54 -39.03 25.27 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.706 0.802 . . . . 74.44 111.125 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.56 ' HB2' HG23 ' B' ' 89' ' ' ILE . 51.0 mt-30 -66.4 -25.19 66.66 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.306 0.642 . . . . 71.3 112.219 -169.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.456 ' SD ' ' HA ' ' F' ' 17' ' ' PRO . 22.3 ptm -67.61 -27.54 66.99 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.223 0.609 . . . . 63.31 112.107 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.64 -33.18 69.78 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.796 0.838 . . . . 64.25 110.73 175.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -84.33 -49.24 8.91 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.295 -0.866 . . . . 72.24 109.811 171.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.8 t -58.51 -65.91 0.58 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.974 0.731 . . . . 70.24 112.974 -167.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.667 HD13 ' HB2' ' F' ' 15' ' ' PHE . 0.6 OUTLIER -103.8 -2.32 26.53 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 111.727 0.269 . . . . 53.45 111.727 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.04 -17.39 37.74 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 123.197 0.311 . . . . 42.22 113.527 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.59 -55.07 0.89 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.579 0.752 . . . . 74.3 110.574 -176.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -73.51 -53.07 11.48 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.359 1.064 . . . . 71.21 112.244 -166.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.452 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 64.3 m -63.77 -46.72 82.32 Favored Pre-proline 0 CA--C 1.56 1.35 0 CA-C-O 118.864 -0.589 . . . . 55.2 111.626 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.488 ' HB3' HD22 ' B' ' 60' ' ' LEU . 31.2 Cg_exo -64.23 -28.33 64.23 Favored 'Trans proline' 0 C--N 1.39 2.762 0 C-N-CA 122.003 1.802 . . . . 51.14 114.124 173.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.611 ' HA ' ' HD2' ' B' ' 107' ' ' PHE . 47.3 t-20 -57.94 -41.23 82.34 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 123.606 0.762 . . . . 71.13 110.412 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.448 HG23 ' NH2' ' D' ' 111' ' ' ARG . 96.8 mt -60.17 -42.49 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 114.415 -1.266 . . . . 71.32 110.888 175.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 56.7 mt -85.05 -15.43 44.08 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 115.21 -0.905 . . . . 62.32 112.277 -170.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.611 ' HD2' ' HA ' ' B' ' 104' ' ' ASN . 5.1 m-85 -54.46 -53.02 64.44 Favored Pre-proline 0 N--CA 1.495 1.776 0 C-N-CA 124.139 0.976 . . . . 71.04 113.592 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.16 -30.26 46.71 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 122.292 1.995 . . . . 74.41 113.849 -177.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -70.96 -44.45 66.02 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.832 0.453 . . . . 75.4 110.243 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.22 -41.24 98.21 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.963 -0.562 . . . . 62.51 110.248 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -59.59 -54.25 48.69 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.792 0.837 . . . . 74.22 110.164 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -61.73 -33.63 74.38 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 123.714 0.634 . . . . 72.13 110.289 -174.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.535 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 4.0 t -74.55 -48.23 28.07 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 116.062 -0.517 . . . . 71.32 111.452 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.653 HG21 HG21 ' B' ' 64' ' ' VAL . 98.6 mt -57.39 -56.07 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 C-N-CA 123.39 0.676 . . . . 54.34 109.867 174.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 33.0 m -59.25 -30.96 68.66 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 124.417 1.073 . . . . 75.23 111.06 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.4 t -63.64 -47.37 81.61 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 109.288 -0.634 . . . . 71.14 109.288 171.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.0 mmt -67.05 -30.79 70.96 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.089 0.556 . . . . 72.04 111.13 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.506 HG23 ' O ' ' B' ' 114' ' ' ILE . 84.8 t -65.97 -47.31 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.152 0.981 . . . . 74.32 109.171 173.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 71.2 m -66.31 -31.33 72.06 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 114.429 -1.26 . . . . 73.13 111.517 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.519 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 90.5 mtt-85 -73.95 -32.61 63.56 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 124.014 0.926 . . . . 74.41 109.655 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.47 6.33 69.31 Favored Glycine 0 C--N 1.353 1.491 0 O-C-N 124.196 0.935 . . . . 63.44 112.506 174.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.467 HG23 ' HB3' ' A' ' 17' ' ' TYR . 80.5 p 54.92 36.09 25.94 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 125.898 1.679 . . . . 73.13 112.653 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -95.6 157.78 35.54 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.138 0.975 . . . . 73.01 110.544 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -52.99 158.9 5.89 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.607 2.871 . . . . 63.34 115.036 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -64.03 115.07 4.57 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.705 -1.134 . . . . 73.15 111.77 -172.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 55.5 tp -125.35 112.14 15.98 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.366 0.666 . . . . 64.44 109.778 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -132.55 135.54 46.01 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.914 0.886 . . . . 73.44 108.89 176.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.434 ' HA ' ' CG2' ' F' ' 6' ' ' ILE . 8.0 mp -85.71 142.82 28.73 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.112 0.565 . . . . 73.54 111.622 -174.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.99 132.91 49.43 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.064 0.946 . . . . 73.32 110.646 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.37 108.86 2.78 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 123.02 2.48 . . . . 74.52 112.754 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.423 ' H ' HD12 ' F' ' 8' ' ' LEU . 98.3 t -93.62 111.6 25.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.639 -1.245 . . . . 74.5 107.639 167.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -74.36 91.33 2.2 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.458 0.703 . . . . 72.43 109.214 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -64.21 -41.12 97.19 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.417 -0.81 . . . . 74.34 110.726 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' B' ' 138' ' ' MET . 2.9 m-20 -50.27 -52.97 31.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.205 1.002 . . . . 72.2 111.526 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.28 -40.99 98.94 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.104 0.877 . . . . 73.34 111.176 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 8.5 tt -59.83 -46.46 89.17 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.847 0.859 . . . . 74.21 110.458 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -65.38 -30.21 71.01 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.033 0.933 . . . . 75.21 111.32 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' B' ' 134' ' ' ASP . 94.5 mmm -69.86 -33.76 72.7 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.061 0.544 . . . . 73.54 111.301 177.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -74.05 -19.82 60.5 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.964 0.505 . . . . 64.41 111.186 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -76.97 -48.35 18.29 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.891 -0.781 . . . . 75.11 108.891 170.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 75.8 mt -91.66 37.07 0.95 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.52 1.128 . . . . 74.21 110.798 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.02 153.09 39.84 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.686 0.794 . . . . 73.54 112.306 -172.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -113.76 121.41 43.99 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.867 -0.79 . . . . 74.0 108.867 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -81.03 130.97 35.26 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.132 0.573 . . . . 63.53 110.146 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -99.75 164.83 11.87 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.913 0.885 . . . . 62.32 110.288 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.28 144.18 6.86 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 116.581 -0.281 . . . . 71.14 112.647 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -149.45 95.39 2.34 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.923 0.889 . . . . 64.14 109.148 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -102.92 111.51 4.0 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 115.657 -0.702 . . . . 43.22 111.538 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 42.3 p -85.77 168.37 14.38 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.311 0.645 . . . . 55.22 109.844 172.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -136.87 147.16 46.32 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.354 0.662 . . . . 72.33 109.868 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -141.42 164.04 31.3 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.74 0.816 . . . . 73.54 110.575 -176.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -170.87 163.21 7.66 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.977 1.311 . . . . 70.25 108.225 169.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -172.51 144.92 1.53 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.977 0.511 . . . . 74.14 109.797 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -62.02 149.86 39.72 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.524 0.729 . . . . 75.52 110.787 175.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.263 0 C-N-CA 123.975 0.91 . . . . 44.51 109.628 -176.224 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 1' ' ' MET . . . . . 0.481 ' SD ' ' N ' ' C' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 108.84 -0.8 . . . . 64.52 108.84 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 27.3 m -63.85 -53.44 50.63 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.519 0.727 . . . . 61.4 110.255 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -124.66 -38.14 2.42 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.262 1.025 . . . . 73.53 108.416 170.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -162.38 -56.57 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.607 -0.886 . . . . 35.01 108.607 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 67.16 -79.72 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.273 1.429 . . . . 71.22 112.261 169.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -168.96 150.87 4.66 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.771 1.229 . . . . 72.51 108.157 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 27.5 m 70.44 126.96 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.904 1.282 . . . . 73.4 110.478 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -72.01 175.11 6.19 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.363 0.665 . . . . 73.32 110.32 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.482 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 12.5 tpt 66.25 113.83 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.633 1.173 . . . . 64.04 110.672 -166.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 90.4 m -108.63 109.29 20.46 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.938 -1.504 . . . . 72.2 106.938 171.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.405 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.0 OUTLIER -117.8 133.02 56.36 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.851 0.461 . . . . 64.22 110.332 -173.827 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -150.93 132.77 15.04 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.949 0.899 . . . . 74.14 108.912 168.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 90.4 mt -73.25 127.35 35.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.399 -0.963 . . . . 72.13 108.399 170.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -95.14 -44.08 7.81 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.626 0.77 . . . . 73.44 109.58 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -176.29 134.35 0.25 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.635 0.774 . . . . 73.1 109.464 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 59.4 mt -127.25 151.88 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 118.636 0.653 . . . . 62.25 109.335 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.465 ' HB3' HG23 ' D' ' 122' ' ' THR . 21.0 p90 -176.3 168.72 2.79 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.717 0.77 . . . . 72.3 110.978 -172.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 68.8 p -87.69 115.95 25.49 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.571 -1.195 . . . . 71.42 109.489 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.446 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 26.0 mmtp -65.54 -46.91 77.72 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.252 -1.018 . . . . 75.42 108.252 167.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 18.4 t70 -134.92 142.56 46.57 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 114.207 -1.36 . . . . 62.3 109.667 -174.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.524 HG12 ' SG ' ' C' ' 113' ' ' CYS . 89.0 mt -135.78 141.17 42.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 106.466 -1.679 . . . . 53.42 106.466 167.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.5 t -159.09 150.88 20.7 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.964 -0.384 . . . . 74.22 109.964 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -155.33 106.84 2.6 Favored 'General case' 0 C--O 1.226 -0.16 0 N-CA-C 107.913 -1.143 . . . . 74.33 107.913 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -117.93 111.4 18.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.524 0.73 . . . . 63.24 109.876 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.2 92.15 10.74 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 107.157 -1.423 . . . . 73.12 107.157 170.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.46 -35.58 38.49 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.657 2.238 . . . . 72.32 112.306 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -101.92 24.73 9.56 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.455 -0.793 . . . . 75.34 110.35 -175.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.96 -62.4 1.67 Allowed Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 114.714 1.376 . . . . 72.25 114.714 -167.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.53 -32.73 48.33 Favored 'Trans proline' 0 C--N 1.383 2.387 0 CA-C-N 121.834 1.691 . . . . 72.24 112.306 -174.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.583 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 72.7 t60 -70.84 -40.45 72.37 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.53 0.732 . . . . 74.41 112.012 177.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.773 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.2 p -77.8 -21.44 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 112.081 0.4 . . . . 64.31 112.081 -170.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -63.66 -29.7 70.9 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.44 0.904 . . . . 74.23 113.44 177.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 21.1 pt20 -84.78 5.76 27.21 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 122.727 0.411 . . . . 74.43 111.114 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.724 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -95.21 156.63 16.24 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.427 1.091 . . . . 74.21 110.408 -177.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -67.86 128.78 37.77 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.155 0.982 . . . . 71.13 110.061 169.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -86.07 100.62 12.3 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.331 0.652 . . . . 74.41 111.3 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -156.69 77.35 4.18 Favored Pre-proline 0 N--CA 1.474 0.773 0 N-CA-C 107.82 -1.178 . . . . 71.15 107.82 168.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -86.65 150.03 8.71 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.377 2.051 . . . . 75.42 113.294 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -82.83 81.49 8.53 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 105.953 -1.869 . . . . 72.43 105.953 168.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -69.33 99.51 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-N 114.367 -1.288 . . . . 71.15 109.444 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -96.14 112.14 23.96 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 113.787 -1.551 . . . . 73.21 109.026 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.59 141.99 28.6 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.604 -0.517 . . . . 71.44 109.604 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.454 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 24.1 t70 -135.66 147.09 48.44 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.575 1.15 . . . . 72.14 108.367 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.61 157.13 44.48 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.082 0.553 . . . . 65.11 111.145 -173.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.608 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 17.1 t70 -140.74 144.97 35.83 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.958 0.903 . . . . 72.33 109.029 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 46' ' ' THR . . . . . 0.417 ' HB ' ' HD2' ' G' ' 15' ' ' PHE . 40.8 p -112.78 112.51 24.05 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.19 -0.67 . . . . 62.05 109.19 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.48 150.35 44.0 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.035 0.934 . . . . 75.43 108.787 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 37.7 p -165.99 157.63 13.94 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.363 0.265 . . . . 73.51 111.658 -174.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 23.4 p -166.1 127.73 1.86 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.82 0.848 . . . . 65.15 109.681 173.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -72.12 130.82 41.79 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 108.917 -0.771 . . . . 72.41 108.917 168.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.61 HD11 HD12 ' C' ' 83' ' ' ILE . 60.0 mt -97.64 -37.0 10.09 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.274 0.63 . . . . 64.31 111.264 -175.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.27 -171.39 2.38 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.003 0.521 . . . . 64.44 111.746 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -57.94 109.12 0.68 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.921 1.288 . . . . 74.12 110.081 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 69.67 -7.15 0.92 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 125.224 1.41 . . . . 74.53 112.668 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.7 t -94.0 112.32 26.65 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 N-CA-C 108.061 -1.089 . . . . 62.41 108.061 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -120.17 159.75 24.27 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.128 -0.942 . . . . 72.13 108.492 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -126.66 123.62 37.98 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.237 0.615 . . . . 54.23 110.244 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.476 HG11 ' HD3' ' C' ' 103' ' ' PRO . 89.6 t -104.66 128.19 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 107.974 -1.121 . . . . 62.05 107.974 171.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -121.23 130.98 74.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.071 -1.085 . . . . 71.13 108.071 170.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.401 HD22 ' HB2' ' C' ' 103' ' ' PRO . 29.4 tp -126.17 117.7 23.66 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.187 -1.412 . . . . 75.21 107.187 170.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.608 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 6.9 tmm_? -90.95 128.64 36.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.515 -0.766 . . . . 54.03 109.611 178.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.48 140.56 19.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.971 -1.122 . . . . 64.2 107.971 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 53.8 m -133.93 122.04 22.54 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.882 -0.785 . . . . 62.45 108.882 173.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.426 HG21 HG21 ' C' ' 114' ' ' ILE . 89.4 t -101.55 109.46 25.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 107.979 -1.119 . . . . 44.42 107.979 176.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.447 HG23 HD23 ' C' ' 75' ' ' LEU . 4.2 m -99.57 107.14 19.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.852 -1.166 . . . . 74.22 107.852 175.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.02 108.37 19.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.719 -1.586 . . . . 64.51 106.719 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.4 m -132.23 127.95 36.84 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.149 -0.686 . . . . 73.0 109.149 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.724 HD13 ' HG2' ' C' ' 34' ' ' LYS . 8.2 mt -85.13 48.99 1.65 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.907 1.283 . . . . 53.32 109.56 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.15 -113.63 4.49 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 109.747 -1.341 . . . . 35.3 109.747 -168.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.69 -19.96 17.91 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.411 0.684 . . . . 63.03 110.526 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -67.24 120.66 14.16 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.866 0.867 . . . . 72.32 108.756 169.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.7 m -84.29 125.61 32.41 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 118.764 0.711 . . . . 74.43 109.295 173.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.773 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.79 -63.54 1.28 Allowed 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.364 -0.976 . . . . 71.32 108.364 173.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -155.77 173.09 17.24 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.274 -0.875 . . . . 71.0 110.663 174.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.447 HD23 HG23 ' C' ' 65' ' ' THR . 2.3 tm? -131.03 141.17 50.19 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 105.089 -2.189 . . . . 61.31 105.089 169.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.532 ' SG ' HG23 ' C' ' 114' ' ' ILE . 47.2 t -142.99 136.94 28.96 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.559 -1.274 . . . . 52.41 107.559 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 77' ' ' GLU . . . . . 0.508 ' HG3' ' HD3' ' C' ' 61' ' ' ARG . 24.4 tt0 -146.4 120.38 9.38 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.658 0.383 . . . . 72.31 110.396 -173.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 54.6 t -129.72 115.9 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.135 0.974 . . . . 64.24 109.231 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.505 ' HG2' ' HB2' ' C' ' 61' ' ' ARG . 93.8 mt-30 -89.56 99.4 12.41 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.747 -1.205 . . . . 61.24 107.747 170.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.648 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.0 tp-100 -87.88 109.76 20.02 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.825 -0.806 . . . . 73.2 108.825 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.33 145.45 17.6 Favored Glycine 0 C--N 1.341 0.819 0 O-C-N 123.6 0.562 . . . . 74.01 111.88 176.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.82 126.14 2.67 Favored Glycine 0 CA--C 1.506 -0.487 0 N-CA-C 110.921 -0.872 . . . . 64.31 110.921 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.61 HD12 HD11 ' C' ' 51' ' ' LEU . 9.6 mm -87.27 117.83 32.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 108.383 -0.969 . . . . 64.35 108.383 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.405 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 41.7 m-85 -129.17 120.99 26.78 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.227 1.011 . . . . 71.13 109.256 -173.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 57.3 p -79.4 109.11 13.45 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.633 -0.877 . . . . 74.11 108.633 172.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 70.5 mt -119.86 130.43 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.283 1.033 . . . . 72.14 108.855 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -161.63 158.52 26.24 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.741 0.816 . . . . 74.42 110.189 -175.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.1 -57.87 1.05 Allowed Glycine 0 C--N 1.345 1.035 0 O-C-N 123.296 0.372 . . . . 61.24 113.217 174.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 37.9 pt -85.41 161.28 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 122.909 0.483 . . . . 65.33 111.398 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -152.73 -178.56 6.96 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.92 0.888 . . . . 74.14 110.465 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.85 -139.39 42.91 Favored Glycine 0 C--N 1.349 1.263 0 O-C-N 123.379 0.425 . . . . 45.24 112.845 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 92' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' C' ' 95' ' ' ALA . 40.9 p -64.34 -19.86 65.73 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.54 0.736 . . . . 73.21 111.753 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -64.76 -55.92 16.78 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.496 0.718 . . . . 41.43 110.243 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.419 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 10.6 ptp -71.97 -29.82 64.64 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 116.579 -0.282 . . . . 64.12 110.479 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 95' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' C' ' 92' ' ' THR . . . -66.47 -32.68 74.19 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.205 0.602 . . . . 72.14 111.51 178.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -77.43 -37.2 52.18 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.407 0.683 . . . . 72.32 110.069 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.568 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 28.8 t -59.61 -40.08 86.34 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.862 0.726 . . . . 72.33 110.613 175.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.435 HD11 HG23 ' G' ' 18' ' ' VAL . 67.7 mt -81.49 -40.22 23.56 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.025 0.93 . . . . 71.25 111.54 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.01 -13.68 82.94 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.414 -0.812 . . . . 41.54 114.843 -168.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.627 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -157.97 -54.71 0.07 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 117.237 0.519 . . . . 63.01 112.388 -173.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.568 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 82.4 t80 -57.5 -40.59 79.01 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.711 1.204 . . . . 64.24 113.736 -172.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 89.3 m -82.08 -44.87 1.02 Allowed Pre-proline 0 CA--C 1.561 1.388 0 CA-C-O 118.784 -0.627 . . . . 65.23 112.361 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.476 ' HD3' HG11 ' C' ' 58' ' ' VAL . 37.1 Cg_endo -68.3 -7.79 21.09 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 121.624 1.549 . . . . 74.14 114.287 170.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -68.13 -30.97 70.24 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 123.396 0.678 . . . . 40.02 110.741 168.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.583 HD12 HH12 ' A' ' 111' ' ' ARG . 41.8 mm -68.33 -40.46 82.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-N 115.416 -0.811 . . . . 65.15 109.519 173.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 61.2 mt -83.08 -26.76 30.78 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.323 -1.308 . . . . 74.12 112.166 -168.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.416 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 89.7 t80 -56.14 -53.93 58.13 Favored Pre-proline 0 CA--C 1.562 1.438 0 CA-C-O 118.07 -0.967 . . . . 70.44 112.754 -176.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 36.1 Cg_exo -59.42 -36.68 93.21 Favored 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 122.319 2.012 . . . . 72.54 113.221 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -63.73 -50.76 67.86 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.156 0.982 . . . . 72.42 111.059 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.648 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -71.21 -29.89 65.7 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.331 -0.849 . . . . 63.01 111.215 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -61.79 -47.82 83.43 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.598 1.159 . . . . 62.54 110.647 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -71.02 -33.71 70.63 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.891 0.476 . . . . 73.42 110.025 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.524 ' SG ' HG12 ' C' ' 21' ' ' ILE . 44.6 t -64.44 -37.1 86.35 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.12 0.568 . . . . 61.43 111.282 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.532 HG23 ' SG ' ' C' ' 76' ' ' CYS . 97.0 mt -71.7 -51.77 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.155 0.582 . . . . 64.0 110.352 174.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.0 m -62.4 -28.4 69.75 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.124 0.57 . . . . 63.32 111.426 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 42.5 t -64.07 -49.94 70.3 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.141 -0.688 . . . . 62.14 109.141 170.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.525 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.45 -33.57 75.85 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.286 1.035 . . . . 63.12 112.662 179.658 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.454 HG23 ' O ' ' C' ' 114' ' ' ILE . 58.3 t -62.83 -44.6 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 109.085 -0.709 . . . . 73.54 109.085 175.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 39.9 t -70.8 -31.0 67.61 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.801 -1.09 . . . . 75.03 111.93 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' C' ' 116' ' ' SER . 90.8 mtt-85 -68.97 -37.49 78.83 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.33 0.652 . . . . 74.33 109.342 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.85 6.87 79.62 Favored Glycine 0 C--N 1.353 1.521 0 O-C-N 123.967 0.792 . . . . 72.54 112.639 174.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 50.7 p 57.34 28.56 15.47 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.278 1.831 . . . . 73.33 114.294 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -83.95 144.63 45.03 Favored Pre-proline 0 N--CA 1.472 0.628 0 N-CA-C 109.059 -0.719 . . . . 73.41 109.059 172.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.81 153.31 37.68 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.67 2.247 . . . . 70.43 112.4 175.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -53.85 129.35 33.37 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.042 0.937 . . . . 72.0 113.487 -170.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 31.3 tp -131.72 84.65 2.18 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 107.054 -1.461 . . . . 72.24 107.054 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -98.16 106.1 18.35 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.462 -1.245 . . . . 72.55 108.425 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.38 138.39 58.51 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.31 0.644 . . . . 74.34 111.213 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.74 133.88 90.4 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 124.088 0.868 . . . . 73.4 110.711 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.15 107.74 1.01 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.53 2.153 . . . . 61.54 112.492 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 23.7 m -100.33 131.3 48.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 108.941 -0.762 . . . . 75.51 108.941 170.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.01 84.89 0.99 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.016 -0.538 . . . . 72.32 109.567 177.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.518 ' HA ' HD12 ' C' ' 136' ' ' LEU . 39.1 t80 -65.07 -31.67 72.99 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.227 -0.897 . . . . 73.53 111.32 -172.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.627 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 32.0 t70 -77.63 -38.45 47.88 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.747 0.419 . . . . 35.45 111.584 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.406 ' HA ' ' HB3' ' C' ' 138' ' ' MET . . . -65.23 -29.66 70.47 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.738 0.649 . . . . 72.41 111.299 176.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' C' ' 133' ' ' PHE . 74.0 mt -60.2 -42.48 95.17 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.179 0.991 . . . . 75.14 111.757 173.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 137' ' ' PHE . . . . . 0.41 ' CD1' ' HB2' ' C' ' 100' ' ' ALA . 72.2 m-85 -80.39 -24.86 39.43 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.865 0.466 . . . . 63.42 111.602 174.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.406 ' HB3' ' HA ' ' C' ' 135' ' ' ALA . 54.4 ttm -75.02 -31.7 61.42 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.673 0.789 . . . . 74.12 111.996 -175.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -70.71 -37.18 73.54 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 110.061 -0.348 . . . . 72.54 110.061 174.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.511 ' HA ' ' HG3' ' A' ' 3' ' ' GLU . 52.6 t80 -54.05 -81.88 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.685 0.794 . . . . 72.11 111.094 175.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.519 HD11 ' HA2' ' A' ' 148' ' ' GLY . 3.4 tm? -64.76 115.14 4.98 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 107.383 -1.34 . . . . 72.43 107.383 176.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.7 113.02 1.64 Allowed 'General case' 0 CA--C 1.544 0.714 0 O-C-N 124.259 0.974 . . . . 54.1 110.18 -173.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 143' ' ' GLN . . . . . 0.571 ' HG2' ' H ' ' C' ' 144' ' ' GLN . 10.2 tt0 -143.44 -176.17 4.84 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.432 1.093 . . . . 73.41 108.313 -176.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 144' ' ' GLN . . . . . 0.571 ' H ' ' HG2' ' C' ' 143' ' ' GLN . 81.1 mm-40 77.35 161.91 0.22 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.346 1.458 . . . . 74.04 112.794 174.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.06 165.28 34.28 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.811 -1.086 . . . . 51.41 110.436 -174.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -136.57 -109.27 0.95 Allowed Glycine 0 C--N 1.348 1.246 0 CA-C-N 116.073 -0.512 . . . . 70.2 112.645 -177.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 67.3 -87.82 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.645 1.178 . . . . 73.45 110.535 -173.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 158.55 150.09 5.68 Favored Glycine 0 C--N 1.358 1.8 0 N-CA-C 114.326 0.49 . . . . 75.14 114.326 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 4.5 t -166.53 177.8 6.44 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.896 1.279 . . . . 73.34 109.53 175.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -160.38 87.93 0.78 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.358 -0.979 . . . . 61.31 108.358 171.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -90.87 138.12 31.83 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.114 0.565 . . . . 73.44 110.114 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -127.09 179.95 5.16 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.012 0.925 . . . . 73.3 110.996 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 153' ' ' GLN . . . . . 0.536 ' HB3' ' HA ' ' E' ' 12' ' ' PRO . 23.1 tm0? -143.82 98.93 3.32 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 106.236 -1.764 . . . . 73.11 106.236 166.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -86.19 147.04 26.3 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.673 0.389 . . . . 75.11 110.839 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.323 0 CA-C-O 118.508 -0.758 . . . . 73.53 109.242 173.15 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 109.815 -0.439 . . . . 72.25 109.815 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 42.6 m -136.65 82.55 1.95 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.615 1.166 . . . . 61.24 108.925 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -124.93 92.78 3.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.526 -0.761 . . . . 75.03 109.718 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 48.71 100.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.128 1.371 . . . . 72.54 113.671 164.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -73.91 -90.73 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 118.671 -0.681 . . . . 74.31 110.176 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 61.7 t30 43.81 44.84 5.94 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.663 1.185 . . . . 51.44 111.497 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 14.1 p -119.75 -177.86 3.49 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 124.724 1.21 . . . . 64.11 109.987 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.562 ' HG3' ' HG3' ' D' ' 9' ' ' MET . 10.0 tp10 67.44 178.17 0.24 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.588 1.155 . . . . 52.52 110.245 -177.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.562 ' HG3' ' HG3' ' D' ' 8' ' ' GLU . 4.4 ppp? -29.47 151.12 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 126.036 1.735 . . . . 74.43 114.887 169.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 67.4 m -103.59 135.88 44.35 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.479 -0.564 . . . . 75.01 109.479 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -137.56 119.14 14.93 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.042 -1.095 . . . . 71.3 108.042 -175.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -130.88 129.84 42.79 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.315 -0.994 . . . . 63.11 108.315 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.491 HG21 HD11 ' D' ' 16' ' ' ILE . 56.1 mt -79.05 129.53 37.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.985 -0.746 . . . . 72.04 108.985 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -105.14 -28.39 11.02 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 119.037 -0.506 . . . . 72.04 111.74 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -176.82 140.41 0.33 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 118.157 0.435 . . . . 74.42 111.52 -173.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.491 HD11 HG21 ' D' ' 13' ' ' ILE . 3.0 mp -123.53 136.31 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.566 -1.272 . . . . 74.14 107.566 171.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.427 ' HE1' HG13 ' D' ' 83' ' ' ILE . 28.6 p90 -162.81 175.07 11.64 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-O 122.078 0.942 . . . . 75.33 112.231 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 18' ' ' THR . . . . . 0.406 HG21 HD11 ' D' ' 21' ' ' ILE . 70.1 p -109.71 122.51 47.65 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.049 -1.432 . . . . 64.53 108.814 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -93.17 -31.81 14.63 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.3 -0.63 . . . . 74.42 109.3 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' D' ' 79' ' ' GLN . 6.5 m-20 -142.36 131.57 23.39 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 108.315 -0.994 . . . . 63.51 108.315 177.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.525 HG21 ' HE2' ' C' ' 117' ' ' MET . 89.0 mt -128.6 150.29 34.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.505 -1.294 . . . . 73.21 107.505 172.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 22' ' ' SER . . . . . 0.442 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 47.3 t -151.69 139.39 19.76 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.258 1.023 . . . . 71.12 108.923 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 84.1 t80 -152.86 127.66 9.53 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.464 -2.05 . . . . 65.43 105.464 169.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -135.96 134.59 38.79 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.876 -1.157 . . . . 75.43 107.876 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.422 ' CB ' ' HB2' ' D' ' 28' ' ' ALA . . . -120.88 90.53 46.81 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 108.032 -1.099 . . . . 43.22 108.032 175.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.44 -41.07 12.68 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.802 2.335 . . . . 75.24 112.688 -172.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.491 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 6.5 m120 -106.03 9.81 32.38 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.658 0.783 . . . . 51.54 110.737 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.451 ' HB1' ' CE2' ' C' ' 17' ' ' TYR . . . -19.44 -70.26 0.03 OUTLIER Pre-proline 0 CA--C 1.563 1.458 0 N-CA-C 117.396 2.369 . . . . 52.2 117.396 -165.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.05 -24.03 13.15 Favored 'Trans proline' 0 C--N 1.382 2.321 0 CA-C-N 123.647 2.338 . . . . 74.4 113.969 -174.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -75.1 -41.07 59.39 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.265 1.026 . . . . 72.15 110.522 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.567 HG22 HD12 ' D' ' 68' ' ' LEU . 12.3 p -75.82 -20.22 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 115.856 -0.611 . . . . 70.25 111.243 -173.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -66.64 -20.04 65.9 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 112.699 0.629 . . . . 73.12 112.699 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -59.1 -26.17 64.44 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.769 0.828 . . . . 73.24 110.627 176.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.46 108.72 20.09 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.894 1.278 . . . . 74.25 110.17 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -105.84 88.77 2.89 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.948 0.899 . . . . 74.23 110.978 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 45.5 p90 -161.14 177.26 10.43 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.382 1.073 . . . . 74.53 108.339 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -72.85 115.52 40.91 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 108.845 -0.798 . . . . 75.44 108.845 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -60.82 130.47 33.17 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.33 2.02 . . . . 62.11 111.212 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -63.54 114.44 3.92 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.454 -0.943 . . . . 73.21 108.454 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.487 HG11 HD22 ' D' ' 126' ' ' LEU . 31.1 m -106.91 112.05 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-O 121.526 0.679 . . . . 71.02 110.094 -174.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.43 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 12.0 tmtt? -84.49 119.15 24.83 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 106.467 -1.679 . . . . 55.11 106.467 174.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.647 HD23 HD12 ' H' ' 6' ' ' ILE . 4.1 pp -95.6 150.38 20.41 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.135 0.493 . . . . 75.31 110.187 -173.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.535 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 13.0 t70 -151.29 119.66 6.4 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.023 -0.99 . . . . 74.44 108.741 -176.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.52 133.84 52.6 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.764 -0.458 . . . . 50.25 109.764 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.451 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 31.4 t70 -132.99 157.55 44.92 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.094 -1.076 . . . . 75.4 108.094 176.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 46' ' ' THR . . . . . 0.434 ' HB ' HD13 ' H' ' 11' ' ' LEU . 11.8 t -119.93 153.88 35.26 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.395 0.617 . . . . 62.45 112.106 -173.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.626 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.72 152.86 33.31 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.215 1.406 . . . . 63.13 107.885 172.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 21.1 p -164.63 152.37 11.86 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.69 0.223 . . . . 64.32 110.967 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 60.3 p -164.23 135.02 4.3 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.485 0.714 . . . . 72.42 109.756 177.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -77.71 136.47 38.18 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.851 -0.796 . . . . 71.41 108.851 172.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' D' ' 57' ' ' GLU . 40.2 mt -103.24 -35.05 8.59 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.88 0.472 . . . . 75.25 110.375 -177.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.53 -174.0 3.55 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.746 0.818 . . . . 61.45 109.954 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.23 114.92 3.73 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.232 -0.895 . . . . 64.32 110.238 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 63.87 12.2 6.58 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.788 1.235 . . . . 75.4 112.761 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 76.4 t -109.03 122.67 64.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 106.936 -1.505 . . . . 60.43 106.936 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.643 ' HB3' HD13 ' D' ' 86' ' ' ILE . 16.5 t80 -143.06 131.04 21.68 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.769 -0.456 . . . . 74.41 109.769 -173.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.42 ' HB2' HD11 ' D' ' 51' ' ' LEU . 8.1 tt0 -99.7 130.97 45.97 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.052 0.941 . . . . 73.41 109.747 177.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.1 t -119.63 127.13 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.275 -1.009 . . . . 72.34 108.275 174.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.626 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 11.5 t -112.81 135.69 51.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 124.086 0.954 . . . . 65.45 108.725 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.646 HD22 ' HB3' ' D' ' 103' ' ' PRO . 11.5 tp -125.47 116.87 22.5 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.631 -0.507 . . . . 62.01 109.631 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.451 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 17.9 ttm-85 -83.86 103.14 12.89 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.74 0.816 . . . . 72.34 109.383 175.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 62.1 t -93.27 120.24 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.279 -1.008 . . . . 64.11 108.279 170.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 12.2 m -120.66 146.94 45.9 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 122.963 0.505 . . . . 74.15 109.755 -175.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.417 HG13 ' HB ' ' D' ' 40' ' ' VAL . 53.7 t -137.48 103.88 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 125.383 1.473 . . . . 75.32 109.033 -175.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 48.1 m -94.12 96.96 9.97 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.567 -0.901 . . . . 61.1 108.567 169.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.442 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -97.96 153.07 18.61 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.694 -0.685 . . . . 70.31 109.802 -171.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.433 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.9 p -155.54 128.61 8.14 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 123.559 0.537 . . . . 44.41 112.11 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.567 HD12 HG22 ' D' ' 31' ' ' VAL . 45.7 mt -96.66 96.18 8.45 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.832 -1.173 . . . . 71.31 107.832 169.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -136.14 17.72 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.808 -0.633 . . . . 74.44 112.719 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -84.41 3.15 37.39 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.547 0.739 . . . . 65.31 111.742 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -125.01 147.84 48.75 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.998 -0.371 . . . . 70.0 109.998 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 61.8 m -65.02 135.38 55.54 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 123.825 0.703 . . . . 72.24 111.32 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.555 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -85.61 -65.36 1.02 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.387 -0.968 . . . . 51.21 108.387 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -155.14 144.11 20.83 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.605 -0.725 . . . . 62.41 110.691 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 66.3 mt -106.83 107.67 18.81 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.727 -1.212 . . . . 62.23 107.727 172.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.416 ' SG ' HG23 ' D' ' 114' ' ' ILE . 45.9 t -121.52 141.41 51.07 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.764 0.826 . . . . 65.11 109.527 -174.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 77' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 21.8 tt0 -154.8 136.68 14.54 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.138 0.575 . . . . 62.54 109.487 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 82.0 t -136.76 114.88 14.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.956 -0.757 . . . . 72.12 108.956 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.403 ' HB2' ' HB2' ' D' ' 20' ' ' ASP . 69.6 mt-30 -87.88 86.93 7.21 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 107.592 -1.262 . . . . 64.54 107.592 170.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -79.89 104.02 10.18 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 114.31 -1.313 . . . . 63.23 108.116 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -107.09 143.09 15.8 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 111.557 -0.617 . . . . 51.24 111.557 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.14 138.34 9.27 Favored Glycine 0 CA--C 1.506 -0.497 0 N-CA-C 111.643 -0.583 . . . . 74.21 111.643 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.427 HG13 ' HE1' ' D' ' 17' ' ' TYR . 74.2 mt -86.58 121.4 37.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.199 -1.408 . . . . 75.3 107.199 172.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -125.33 165.8 17.7 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.288 0.635 . . . . 72.04 109.406 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 4.6 t -112.55 105.41 13.62 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.794 -1.188 . . . . 54.35 107.794 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.67 HG21 HG21 ' H' ' 18' ' ' VAL . 3.3 mp -107.95 105.76 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 108.328 -0.99 . . . . 64.41 108.328 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.72 147.04 49.98 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.328 0.651 . . . . 73.22 110.44 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.11 13.62 76.76 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-O 119.193 -0.781 . . . . 61.02 114.91 172.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.475 HG22 ' N ' ' D' ' 90' ' ' GLU . 7.6 mt -97.57 157.88 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 118.334 1.067 . . . . 55.33 110.477 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.475 ' N ' HG22 ' D' ' 89' ' ' ILE . 1.1 pp20? -153.11 -177.81 6.54 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.446 1.098 . . . . 72.02 108.979 163.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 91' ' ' GLY . . . . . 0.462 ' H ' ' HD3' ' H' ' 22' ' ' ARG . . . 60.44 -141.96 47.94 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.532 0.587 . . . . 70.15 113.694 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 7.4 m -89.96 -9.92 46.99 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.556 1.142 . . . . 62.11 111.379 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -60.74 -28.45 68.7 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.045 0.538 . . . . 74.12 111.043 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.436 ' SD ' ' HB3' ' H' ' 21' ' ' ALA . 18.1 ptt? -70.98 -32.35 69.17 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 119.462 -0.304 . . . . 72.33 111.42 176.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.42 84.0 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 120.775 0.322 . . . . 72.45 110.146 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -65.56 -43.82 88.69 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.601 -0.727 . . . . 71.54 110.949 171.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.4 t -61.5 -49.96 74.63 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.886 0.474 . . . . 40.32 110.656 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.805 HD11 HG23 ' H' ' 18' ' ' VAL . 19.4 mt -83.19 -20.51 34.51 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.054 0.942 . . . . 63.45 111.518 -173.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.83 5.93 34.98 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 114.131 0.413 . . . . 63.14 114.131 -174.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.479 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -146.44 -66.45 0.29 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.557 0.343 . . . . 51.51 110.855 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -70.25 -52.05 25.98 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.565 0.58 . . . . 74.14 112.565 -170.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.498 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 56.8 m -58.38 -47.63 98.44 Favored Pre-proline 0 CA--C 1.562 1.42 0 C-N-CA 123.53 0.732 . . . . 73.33 111.388 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.646 ' HB3' HD22 ' D' ' 60' ' ' LEU . 51.7 Cg_exo -59.4 -39.7 74.22 Favored 'Trans proline' 0 C--N 1.397 3.115 0 C-N-CA 122.231 1.954 . . . . 62.05 113.277 169.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -59.31 -36.17 75.12 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.9 0.88 . . . . 74.43 110.697 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.2 mm -63.5 -36.92 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.514 0.726 . . . . 50.03 110.597 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 73.6 mt -84.43 -13.82 51.04 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 115.221 -0.9 . . . . 71.43 112.371 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -56.68 -50.36 88.4 Favored Pre-proline 0 N--CA 1.5 2.048 0 C-N-CA 124.072 0.949 . . . . 73.32 113.46 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.38 -41.12 81.29 Favored 'Trans proline' 0 C--N 1.392 2.826 0 C-N-CA 122.181 1.921 . . . . 63.01 112.948 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -75.88 -37.98 58.33 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.329 1.052 . . . . 62.35 112.484 -175.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.94 -43.52 71.44 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.08 0.552 . . . . 53.43 110.346 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.448 ' NH2' HG23 ' B' ' 105' ' ' ILE . 46.6 ttp180 -62.28 -47.78 82.81 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.595 -0.729 . . . . 72.43 110.438 176.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -61.28 -45.76 93.13 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.416 0.686 . . . . 73.33 110.757 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.2 t -59.46 -44.5 92.97 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.657 0.598 . . . . 73.31 111.159 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.443 ' O ' HG23 ' D' ' 118' ' ' VAL . 65.5 mt -60.05 -57.64 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.323 0.649 . . . . 73.51 110.326 174.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.9 m -53.43 -41.87 66.49 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.668 1.187 . . . . 73.01 112.673 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 45.6 t -67.19 -41.74 85.34 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.214 -0.903 . . . . 75.33 110.222 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.4 mtm -68.77 -32.49 72.26 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.903 0.481 . . . . 74.41 111.428 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.443 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.0 t -65.76 -43.52 93.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.644 0.777 . . . . 73.02 110.264 176.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.3 p -74.17 -30.36 62.21 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.589 0.356 . . . . 75.53 111.176 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 74.5 mtt-85 -71.75 -27.95 63.32 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.695 0.798 . . . . 74.44 110.373 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.93 7.89 78.42 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-N 115.8 -0.636 . . . . 70.44 112.072 171.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.465 HG23 ' HB3' ' C' ' 17' ' ' TYR . 62.3 p 59.5 15.89 4.85 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 127.015 2.126 . . . . 73.41 113.792 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -78.77 157.98 76.08 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.794 0.838 . . . . 71.11 110.462 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.63 127.34 25.52 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.085 2.523 . . . . 75.12 113.069 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -52.97 136.93 33.96 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.264 1.026 . . . . 73.11 112.048 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.487 HD22 HG11 ' D' ' 40' ' ' VAL . 57.3 tp -118.16 108.77 15.58 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.796 0.838 . . . . 72.14 109.395 -177.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -106.73 99.06 8.66 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.008 -0.738 . . . . 74.1 109.008 175.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.86 130.2 41.05 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.193 -0.669 . . . . 63.42 109.193 173.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -63.02 137.81 97.16 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.338 0.655 . . . . 63.52 110.427 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 8.3 Cg_exo -69.44 111.02 2.63 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.644 2.229 . . . . 72.44 110.905 -177.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 131' ' ' VAL . . . . . 0.472 HG11 ' HB1' ' H' ' 7' ' ' ALA . 15.9 m -108.28 117.73 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 109.226 -0.657 . . . . 45.13 109.226 -177.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -74.25 101.04 3.88 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 115.546 -0.752 . . . . 72.41 110.076 -176.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -68.57 -23.28 64.48 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.99 -1.004 . . . . 60.43 112.012 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.479 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 5.1 m-20 -62.06 -51.68 66.97 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.681 0.393 . . . . 43.24 110.92 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.54 -45.59 93.52 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.916 0.76 . . . . 71.22 111.412 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 2.1 tt -65.78 -44.49 85.62 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.443 0.697 . . . . 44.32 110.6 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -67.85 -48.35 66.41 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.575 0.75 . . . . 73.22 110.275 -175.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 21.4 ptp -67.09 -28.88 68.54 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 116.073 -0.512 . . . . 62.42 110.368 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.449 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 12.7 t30 -65.81 -37.85 87.38 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.476 0.711 . . . . 74.35 110.61 177.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -63.51 -46.49 85.82 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.579 -0.737 . . . . 72.22 109.939 175.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.2 mp -68.99 -29.23 67.39 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.968 0.907 . . . . 75.2 112.695 -177.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.449 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 9.9 pt20 -90.86 7.46 39.85 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.429 0.529 . . . . 73.05 112.429 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -117.53 62.62 0.74 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.963 0.887 . . . . 73.41 108.624 178.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -170.28 138.25 1.58 Allowed 'General case' 0 C--O 1.243 0.748 0 CA-C-N 113.748 -1.569 . . . . 74.53 108.734 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.51 100.74 2.8 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.487 -0.56 . . . . 55.51 109.487 175.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.69 97.79 0.91 Allowed Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.65 -0.705 . . . . 74.53 111.619 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.0 127.31 31.06 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.975 0.91 . . . . 72.21 108.571 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -78.47 68.97 2.87 Favored Glycine 0 C--N 1.35 1.357 0 O-C-N 123.956 0.785 . . . . 65.55 112.898 -177.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 8.9 t -75.7 166.95 22.78 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.268 1.027 . . . . 61.11 110.576 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -75.23 158.87 32.27 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.518 -0.549 . . . . 72.51 109.518 173.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -53.57 88.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.581 1.153 . . . . 61.41 111.741 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -148.87 151.86 35.45 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.272 1.429 . . . . 73.21 108.727 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 153' ' ' GLN . . . . . 0.438 ' OE1' ' HB3' ' H' ' 24' ' ' PRO . 2.7 pt20 -102.3 124.69 48.33 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.902 -0.777 . . . . 64.43 108.902 171.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -109.72 102.94 11.71 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.508 -0.923 . . . . 75.44 108.508 173.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.946 0 C-N-CA 123.871 0.868 . . . . 72.32 109.382 -179.006 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 109.134 -0.691 . . . . 53.54 109.134 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -140.28 145.23 37.01 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.145 0.978 . . . . 73.44 109.483 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -115.3 119.3 35.86 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.935 -0.765 . . . . 74.03 108.935 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 30.4 p -70.29 140.0 52.22 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.75 0.82 . . . . 73.34 111.261 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 26.1 m -142.22 134.43 27.63 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.776 0.83 . . . . 73.53 109.648 -175.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 49.8 mm 71.78 116.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 125.443 1.497 . . . . 74.34 110.964 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.1 83.19 2.01 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.614 0.766 . . . . 62.3 109.956 -177.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.404 ' HB3' HG21 ' A' ' 131' ' ' VAL . 31.5 mt -140.15 135.26 32.28 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.955 0.902 . . . . 73.53 109.933 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.59 -87.87 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.873 0.869 . . . . 74.01 109.509 178.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 10' ' ' LEU . . . . . 0.614 HD21 ' HB2' ' A' ' 136' ' ' LEU . 50.3 mt -141.85 162.4 35.58 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.487 1.115 . . . . 72.01 109.874 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 90.7 mt -88.58 139.34 29.72 Favored Pre-proline 0 CA--C 1.552 1.02 0 CA-C-N 115.386 -0.824 . . . . 71.3 109.282 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 12' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' C' ' 153' ' ' GLN . 64.1 Cg_exo -55.4 -28.13 61.89 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.894 3.062 . . . . 72.24 113.753 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 pp -142.72 159.19 42.71 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.444 1.098 . . . . 74.12 109.305 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -74.49 151.16 39.58 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.237 -0.653 . . . . 72.51 109.237 174.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 15' ' ' PHE . . . . . 0.459 ' HE1' ' HB3' ' A' ' 48' ' ' SER . 4.1 t80 -62.46 147.86 47.41 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.844 0.858 . . . . 72.13 110.075 -176.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 16' ' ' THR . . . . . 0.44 ' HA ' ' HD3' ' E' ' 17' ' ' PRO . 11.0 p -54.55 122.66 40.07 Favored Pre-proline 0 CA--C 1.562 1.435 0 C-N-CA 124.58 1.152 . . . . 65.11 111.878 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 17' ' ' PRO . . . . . 0.515 ' HA ' HD13 ' A' ' 98' ' ' LEU . 27.7 Cg_exo -63.91 153.16 77.39 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 123.808 3.005 . . . . 73.51 115.665 -167.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 18' ' ' VAL . . . . . 0.671 ' H ' HD22 ' A' ' 98' ' ' LEU . 53.4 t -64.77 -49.29 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.741 1.217 . . . . 75.21 111.079 174.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 9.9 t -140.84 -163.85 1.62 Allowed 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.032 -0.986 . . . . 55.04 108.58 -175.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -54.72 109.34 0.49 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.634 0.774 . . . . 64.13 111.751 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.24 151.65 29.4 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.584 1.154 . . . . 70.2 109.203 172.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 80.91 -38.8 0.14 Allowed 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.272 1.429 . . . . 72.25 113.32 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 59.5 m -57.62 112.15 4.36 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 124.288 1.035 . . . . 64.3 112.585 -175.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -86.67 176.46 4.69 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 123.338 2.692 . . . . 74.45 113.032 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 CA--C 1.559 1.289 0 CA-C-N 115.341 -0.845 . . . . 71.01 110.692 -179.311 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 109.466 -0.568 . . . . 71.14 109.466 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -68.98 100.39 1.21 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.61 0.764 . . . . 64.3 109.29 174.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -140.25 173.4 11.55 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.787 0.835 . . . . 72.44 110.0 -174.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 35.6 m -72.22 82.06 1.01 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.486 0.714 . . . . 71.44 110.085 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 5' ' ' THR . . . . . 0.528 HG22 HG13 ' F' ' 6' ' ' ILE . 58.0 m -90.71 122.01 33.1 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.333 -0.849 . . . . 75.34 110.148 -175.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.528 HG13 HG22 ' F' ' 5' ' ' THR . 26.7 mt 67.29 125.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.708 1.603 . . . . 74.53 110.995 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -160.27 -162.8 1.02 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.126 0.571 . . . . 71.23 110.202 -175.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 8' ' ' LEU . . . . . 0.423 HD12 ' H ' ' B' ' 131' ' ' VAL . 92.3 mt -135.93 116.23 13.57 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.463 -1.31 . . . . 73.35 107.463 170.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.04 154.11 38.13 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.038 0.535 . . . . 64.44 111.052 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 90.0 mt -59.9 133.7 56.34 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 123.735 0.647 . . . . 75.41 109.686 173.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.427 ' H ' HD12 ' F' ' 11' ' ' LEU . 4.8 mp -70.59 128.76 90.74 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 123.75 0.656 . . . . 61.32 109.27 -171.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -64.65 -25.13 61.96 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 123.22 2.613 . . . . 53.31 112.546 -174.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.62 142.1 47.95 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 106.612 -1.625 . . . . 60.41 106.612 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -102.64 37.05 2.01 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.294 -0.632 . . . . 51.43 109.294 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 15' ' ' PHE . . . . . 0.667 ' HB2' HD13 ' B' ' 98' ' ' LEU . 76.7 m-85 64.5 175.79 0.19 Allowed 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 125.282 1.433 . . . . 61.51 112.128 -176.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 16' ' ' THR . . . . . 0.624 ' HB ' ' HA ' ' F' ' 21' ' ' ALA . 28.0 m -81.35 140.99 48.94 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-O 118.398 -0.811 . . . . 74.15 110.532 -176.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 17' ' ' PRO . . . . . 0.456 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 3.3 Cg_exo -34.2 136.03 0.11 Allowed 'Trans proline' 0 C--N 1.39 2.745 0 C-N-CA 125.171 3.914 . . . . 42.24 115.988 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 96.5 t -72.25 84.66 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 122.173 0.987 . . . . 71.23 110.15 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 4.7 t -170.52 -44.59 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 113.587 -1.642 . . . . 30.04 108.076 178.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -150.19 72.89 1.13 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.385 -1.339 . . . . 64.03 107.385 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 21' ' ' ALA . . . . . 0.624 ' HA ' ' HB ' ' F' ' 16' ' ' THR . . . -84.52 103.77 13.94 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.784 -0.644 . . . . 72.3 111.636 -171.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 45.2 ttt85 -150.74 100.51 2.84 Favored 'General case' 0 C--N 1.348 0.514 0 C-N-CA 123.355 0.662 . . . . 74.02 110.152 166.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 3.0 p -77.24 153.31 82.1 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 115.022 -0.99 . . . . 73.44 109.316 166.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -49.85 98.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.289 2.66 . . . . 75.21 113.537 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 . . . . . 0 CA--C 1.548 0.892 0 N-CA-C 108.931 -0.766 . . . . 70.04 108.931 177.775 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 109.582 -0.525 . . . . 70.44 109.582 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 88.4 tttt 56.91 93.27 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.524 1.53 . . . . 71.14 112.843 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -103.69 157.23 17.21 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.184 0.594 . . . . 73.43 109.538 171.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 18.8 t -150.38 162.18 41.06 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.133 0.492 . . . . 71.11 110.988 -173.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 45.6 m -81.71 155.7 25.4 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.252 1.021 . . . . 74.34 110.54 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 pp -53.55 153.64 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.356 1.063 . . . . 62.45 113.326 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -167.71 -177.14 3.37 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.315 0.646 . . . . 43.2 111.594 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 8' ' ' LEU . . . . . 0.685 ' H ' HD23 ' G' ' 8' ' ' LEU . 1.2 pt? -93.55 122.3 35.85 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.238 1.015 . . . . 72.03 108.635 172.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.62 90.07 5.58 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.549 0.74 . . . . 71.15 110.479 -175.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 10' ' ' LEU . . . . . 0.4 HD21 ' HB3' ' C' ' 136' ' ' LEU . 82.6 mt 66.24 -175.94 0.19 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.749 1.22 . . . . 75.54 112.212 177.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -100.44 137.84 20.03 Favored Pre-proline 0 N--CA 1.474 0.726 0 N-CA-C 108.572 -0.899 . . . . 61.33 108.572 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.53 -19.51 24.68 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.513 2.142 . . . . 71.2 112.123 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 58.8 tp -152.62 138.77 18.28 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.289 1.036 . . . . 62.25 108.893 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.84 131.98 35.18 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.368 -0.975 . . . . 73.13 108.368 169.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 15' ' ' PHE . . . . . 0.417 ' HD2' ' HB ' ' C' ' 46' ' ' THR . 33.8 p90 -73.76 -173.28 1.47 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.61 0.764 . . . . 75.44 111.845 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 62.5 p -55.64 150.41 26.03 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 124.419 1.087 . . . . 63.15 112.984 -172.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 17' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -76.46 167.58 25.37 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.414 2.076 . . . . 73.25 113.078 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 18' ' ' VAL . . . . . 0.435 HG23 HD11 ' C' ' 98' ' ' LEU . 49.1 t -75.74 -39.16 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 115.579 -0.737 . . . . 42.2 109.585 172.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 19.0 m -146.64 -54.63 0.25 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.408 -0.815 . . . . 74.23 110.319 -176.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -153.33 91.64 1.52 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.729 0.411 . . . . 71.04 110.448 -167.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 179.64 77.59 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 125.244 1.418 . . . . 71.43 109.897 177.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -148.3 -69.72 0.22 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.811 -0.44 . . . . 70.41 109.811 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 14.3 m -148.44 142.74 16.61 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 108.356 -0.979 . . . . 71.43 108.356 -174.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.64 98.4 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.272 1.981 . . . . 64.52 111.032 167.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 CA--C 1.557 1.226 0 C-N-CA 123.875 0.87 . . . . 71.22 109.998 -176.079 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.385 -0.598 . . . . 64.52 109.385 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -135.45 157.4 46.98 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.189 0.596 . . . . 73.13 110.182 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -94.48 -56.7 2.71 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.418 0.687 . . . . 64.11 109.886 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 35.7 t -153.4 -36.62 0.1 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.225 -0.898 . . . . 54.02 109.615 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 30.3 m -75.0 150.34 39.01 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.869 0.868 . . . . 65.42 109.396 171.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.647 HD12 HD23 ' D' ' 42' ' ' LEU . 29.1 pt -69.21 164.03 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-O 121.196 0.522 . . . . 65.24 111.675 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 7' ' ' ALA . . . . . 0.472 ' HB1' HG11 ' D' ' 131' ' ' VAL . . . -145.79 146.42 31.18 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.449 -0.796 . . . . 74.43 109.706 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 8' ' ' LEU . . . . . 0.538 HD23 HD22 ' D' ' 42' ' ' LEU . 97.8 mt -66.31 123.76 20.84 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.251 0.62 . . . . 74.4 110.119 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.95 170.13 14.31 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.275 0.63 . . . . 70.23 110.689 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 80.6 mt -73.95 174.23 8.85 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 121.312 0.577 . . . . 73.42 111.546 -177.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.494 HD21 HD11 ' D' ' 60' ' ' LEU . 80.0 mt -76.86 126.91 85.11 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.079 0.951 . . . . 73.42 111.037 -176.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.42 -42.98 3.24 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 123.035 2.49 . . . . 63.12 111.644 177.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 mp -90.85 166.24 13.18 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.544 0.738 . . . . 73.12 109.41 175.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.76 125.65 54.34 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.184 -1.413 . . . . 74.11 107.184 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -71.58 172.07 10.28 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.038 0.935 . . . . 65.35 111.415 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 38.1 p -77.02 142.66 69.23 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 109.47 -0.567 . . . . 72.11 109.47 171.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.93 178.82 6.52 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.659 2.239 . . . . 72.2 112.32 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 18' ' ' VAL . . . . . 0.805 HG23 HD11 ' D' ' 98' ' ' LEU . 98.2 t -76.17 119.69 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.252 0.621 . . . . 72.22 109.524 175.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 6.6 m -79.03 71.59 5.51 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.887 0.851 . . . . 73.24 109.112 177.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 21.7 tptm 179.36 -52.02 0.01 OUTLIER 'General case' 0 C--O 1.242 0.7 0 CA-C-N 113.802 -1.545 . . . . 74.24 107.747 -176.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 21' ' ' ALA . . . . . 0.436 ' HB3' ' SD ' ' D' ' 94' ' ' MET . . . -72.77 122.96 22.39 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.944 -1.025 . . . . 71.11 109.526 178.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 22' ' ' ARG . . . . . 0.462 ' HD3' ' H ' ' D' ' 91' ' ' GLY . 16.7 tpt180 57.74 91.02 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.604 1.162 . . . . 73.24 111.487 -177.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 73.4 p -73.86 131.42 81.68 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 109.323 -0.621 . . . . 60.32 109.323 173.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 24' ' ' PRO . . . . . 0.438 ' HB3' ' OE1' ' D' ' 153' ' ' GLN . 70.9 Cg_exo -53.09 -47.19 28.85 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 123.032 2.488 . . . . 70.0 112.512 175.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 . . . . . 0 C--O 1.248 0.986 0 N-CA-C 107.467 -1.308 . . . . 72.42 107.467 174.752 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.7 ttp . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 109.66 -0.496 . . . . 71.41 109.66 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.2 t 60.8 27.7 17.47 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 124.485 1.114 . . . . 65.41 111.148 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.74 157.59 23.21 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.142 0.977 . . . . 72.4 110.81 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 67.38 -65.77 0.22 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.389 1.476 . . . . 71.13 109.995 -168.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.8 t30 63.46 68.02 0.62 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.421 1.088 . . . . 71.34 110.434 172.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -81.65 174.22 11.59 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.266 -0.879 . . . . 71.44 110.202 178.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.2 m 58.43 35.12 24.53 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-O 122.731 1.253 . . . . 61.23 109.008 -170.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 9' ' ' MET . 5.3 tp10 -165.75 -155.43 0.23 Allowed 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 114.17 -1.377 . . . . 63.45 107.631 -170.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.487 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -63.03 138.81 58.67 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.838 -0.801 . . . . 72.11 108.838 171.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.449 ' N ' ' SD ' ' A' ' 9' ' ' MET . 17.1 p -137.26 106.74 6.12 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.649 -0.871 . . . . 74.54 108.649 -171.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.693 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 22.0 t80 -123.15 129.59 51.64 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.739 1.215 . . . . 62.41 109.048 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -149.71 112.75 4.87 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.369 0.668 . . . . 74.53 109.299 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.645 HG12 ' HD2' ' A' ' 84' ' ' PHE . 27.5 mt -83.05 116.15 26.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.555 -0.905 . . . . 71.01 108.555 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -79.28 -36.41 39.79 Favored 'General case' 0 C--O 1.242 0.702 0 O-C-N 123.895 0.747 . . . . 61.43 110.258 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -171.9 142.74 1.53 Allowed 'General case' 0 C--N 1.355 0.844 0 CA-C-N 116.374 -0.375 . . . . 70.43 110.457 -170.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.588 HD12 ' HB3' ' C' ' 130' ' ' PRO . 76.8 mt -133.66 141.31 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 124.243 1.017 . . . . 63.21 109.083 172.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.472 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 21.1 p90 -165.56 171.9 12.63 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 124.356 1.035 . . . . 73.42 110.499 -172.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.4 p -94.61 119.46 33.31 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.484 -0.932 . . . . 63.42 108.484 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.472 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 35.2 mtpt -83.01 -36.16 25.23 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.019 0.438 . . . . 64.11 109.828 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.515 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 16.2 t70 -145.72 126.02 13.93 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.114 -0.948 . . . . 75.22 109.1 -178.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.562 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 77.4 mt -118.78 142.32 34.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.864 -1.161 . . . . 70.15 107.864 172.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.0 t -150.53 125.82 10.06 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.784 -0.821 . . . . 73.42 108.784 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.501 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 75.3 t80 -127.48 121.97 32.16 Favored 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 106.867 -1.531 . . . . 75.41 106.867 174.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -124.09 118.29 26.6 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.18 -0.674 . . . . 74.15 109.18 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.48 79.64 4.22 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 106.867 -1.531 . . . . 74.03 106.867 168.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.49 -24.58 26.19 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.539 2.159 . . . . 63.24 112.915 -166.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -114.04 23.21 13.16 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 118.16 -0.924 . . . . 64.55 109.504 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.425 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -40.96 -58.14 2.88 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 114.192 1.182 . . . . 61.31 114.192 -166.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 18.0 Cg_exo -65.72 -24.65 54.61 Favored 'Trans proline' 0 C--N 1.389 2.675 0 CA-C-N 121.83 1.689 . . . . 73.11 113.245 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -83.48 -37.57 22.95 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.3 1.04 . . . . 73.22 110.833 -176.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.735 HG21 ' HA ' ' A' ' 73' ' ' ALA . 8.0 p -76.94 -23.82 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-N 115.589 -0.732 . . . . 74.45 111.348 -168.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -68.91 -25.18 64.46 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.884 0.474 . . . . 73.1 110.877 174.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -75.5 -33.02 60.73 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.027 0.931 . . . . 74.33 110.027 175.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -70.94 168.2 17.46 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.43 1.092 . . . . 73.05 111.469 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.87 145.76 27.64 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.828 -0.623 . . . . 75.53 110.025 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.407 ' CE3' HD21 ' A' ' 68' ' ' LEU . 75.1 t-105 -93.86 88.84 5.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.265 0.626 . . . . 75.41 109.583 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -135.2 79.97 48.35 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 107.113 -1.44 . . . . 73.01 107.113 170.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -91.82 165.33 3.3 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.269 2.646 . . . . 74.42 114.889 -170.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.658 ' HB3' ' HG2' ' C' ' 1' ' ' MET . 10.5 pt-20 -129.71 126.77 39.05 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.954 -1.021 . . . . 73.13 108.7 164.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.576 HG13 HG13 ' A' ' 64' ' ' VAL . 59.8 t -86.82 105.1 14.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.259 -0.645 . . . . 74.25 109.259 174.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -80.89 123.27 28.15 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.604 -1.18 . . . . 71.4 108.488 171.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.407 ' HG ' ' HA ' ' E' ' 8' ' ' LEU . 3.1 mm? -96.39 109.32 21.87 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.374 0.669 . . . . 72.13 109.394 -177.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.689 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 15.5 m-20 -110.14 119.82 40.48 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.532 -0.914 . . . . 73.53 108.532 172.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.782 HD23 HD21 ' A' ' 60' ' ' LEU . 6.3 mp -120.84 136.8 54.82 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.056 0.455 . . . . 73.45 111.103 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -134.72 121.27 20.54 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.36 -1.348 . . . . 71.21 107.36 174.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.47 HG22 ' HG ' ' A' ' 60' ' ' LEU . 43.8 p -107.74 136.51 47.37 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.261 0.624 . . . . 72.24 110.47 -172.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.89 145.56 51.04 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.048 0.939 . . . . 64.2 109.464 -178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.5 m -131.7 152.92 50.53 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.844 0.857 . . . . 45.33 109.569 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 46.7 t -150.1 142.86 24.67 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.632 0.773 . . . . 62.32 109.678 -175.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -101.56 104.32 15.2 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.029 -1.1 . . . . 70.34 108.029 172.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.671 HD11 ' HB2' ' A' ' 57' ' ' GLU . 59.4 mt -81.52 -41.5 21.59 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.921 -0.581 . . . . 73.4 110.295 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.404 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -157.88 -174.53 4.89 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.448 -0.796 . . . . 45.33 110.474 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.8 118.24 7.45 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.693 0.797 . . . . 61.23 110.057 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.28 -6.04 0.83 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.959 1.304 . . . . 71.21 112.74 -177.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 92.0 t -104.34 113.24 40.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 N-CA-C 108.191 -1.04 . . . . 71.41 108.191 -175.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -120.66 167.26 12.64 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.796 0.838 . . . . 72.01 109.429 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.671 ' HB2' HD11 ' A' ' 51' ' ' LEU . 36.3 tt0 -129.93 128.21 41.68 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.275 1.03 . . . . 71.45 108.789 174.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.434 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 53.4 t -109.89 122.79 65.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.076 -1.083 . . . . 63.2 108.076 169.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.5 t -110.14 136.38 46.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.14 -1.059 . . . . 55.33 108.14 171.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.782 HD21 HD23 ' A' ' 44' ' ' LEU . 3.3 tt -129.98 122.1 27.82 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.575 -0.898 . . . . 72.41 108.575 175.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.5 ttm-85 -85.66 103.03 14.1 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.518 1.127 . . . . 52.34 109.471 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.7 t -94.8 102.36 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 107.532 -1.284 . . . . 72.43 107.532 171.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.689 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 23.9 m -102.1 107.86 19.09 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.888 -0.782 . . . . 70.42 108.888 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.576 HG13 HG13 ' A' ' 40' ' ' VAL . 19.2 t -104.47 112.91 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 124.976 1.31 . . . . 60.22 109.121 -176.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 3.2 m -112.56 124.91 53.58 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 108.839 -0.8 . . . . 61.4 108.839 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.0 113.26 26.58 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.577 -1.268 . . . . 72.45 107.577 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.5 m -113.95 122.49 47.11 Favored 'General case' 0 C--N 1.351 0.637 0 CA-C-N 118.478 0.581 . . . . 52.05 110.903 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.407 HD21 ' CE3' ' A' ' 36' ' ' TRP . 17.5 mt -92.91 79.88 4.64 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 125.582 1.553 . . . . 53.24 107.677 173.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.46 -101.99 1.44 Allowed Glycine 0 C--N 1.34 0.801 0 CA-C-N 115.398 -0.819 . . . . 60.34 111.433 -175.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -106.64 -1.37 22.9 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.726 0.81 . . . . 62.34 111.292 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -107.33 136.69 46.71 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.956 0.903 . . . . 73.31 110.101 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.1 m -87.45 124.39 33.38 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 118.095 0.407 . . . . 54.31 110.002 167.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.735 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -73.77 -55.1 6.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.433 1.093 . . . . 74.24 109.695 174.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -152.24 164.91 36.41 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 114.45 -1.25 . . . . 54.43 111.687 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 36.0 tp -134.36 105.83 6.79 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.205 -1.361 . . . . 65.52 107.64 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.501 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 61.7 m -108.14 98.8 8.3 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.844 0.858 . . . . 75.2 109.813 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -105.4 125.44 50.99 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.384 0.674 . . . . 72.14 109.424 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.8 t -131.0 112.61 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.252 0.621 . . . . 70.21 109.545 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 78.3 mt-30 -84.33 87.9 7.23 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.324 1.05 . . . . 64.45 108.471 171.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.477 ' HG3' HD22 ' A' ' 106' ' ' LEU . 60.4 tp60 -79.53 109.76 14.21 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.869 -1.059 . . . . 71.3 109.416 -177.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.56 146.02 18.09 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 111.481 -0.648 . . . . 74.34 111.481 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.2 124.9 2.04 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 111.387 -0.685 . . . . 61.1 111.387 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.0 mt -82.94 110.23 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.347 0.659 . . . . 73.43 109.519 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.693 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 36.3 m-85 -121.94 120.33 34.12 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.838 0.855 . . . . 74.22 108.747 -177.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.8 m -89.95 101.32 14.02 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.756 -0.831 . . . . 61.55 108.756 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.2 pt -113.52 135.39 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 123.145 0.578 . . . . 74.41 110.753 -176.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.4 -179.42 5.5 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.567 1.147 . . . . 53.23 109.506 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 102.15 -75.68 0.33 Allowed Glycine 0 C--N 1.346 1.086 0 N-CA-C 112.39 -0.284 . . . . 41.53 112.39 176.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.606 HG13 ' HB2' ' A' ' 94' ' ' MET . 28.2 pt -89.81 -178.43 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 123.413 0.685 . . . . 64.24 110.881 -175.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.503 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 23.7 tt0 -161.0 -176.64 5.61 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.054 0.941 . . . . 73.13 108.801 -178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.503 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 65.01 -152.16 51.16 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-O 119.753 -0.471 . . . . 73.2 113.023 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.602 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 14.8 t -66.26 -19.23 65.76 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.117 0.567 . . . . 64.41 111.701 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -64.14 -50.15 69.34 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.836 0.855 . . . . 75.45 109.85 176.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.606 ' HB2' HG13 ' A' ' 89' ' ' ILE . 41.7 ttm -76.78 -30.69 56.59 Favored 'General case' 0 C--N 1.36 1.058 0 CA-C-N 116.153 -0.476 . . . . 75.11 110.632 175.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.602 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -63.34 -25.66 68.4 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.362 0.665 . . . . 35.45 111.707 178.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.421 ' NE2' ' HG2' ' A' ' 138' ' ' MET . 59.5 t-80 -76.03 -38.29 57.39 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.635 -0.711 . . . . 73.32 109.722 172.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.3 t -70.82 -32.81 69.99 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.261 0.624 . . . . 74.53 111.989 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.546 HD13 ' HD2' ' E' ' 17' ' ' PRO . 4.0 pp -101.17 -20.02 15.48 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.065 0.546 . . . . 72.43 111.833 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.04 -16.03 29.16 Favored Glycine 0 N--CA 1.478 1.492 0 N-CA-C 113.694 0.238 . . . . 72.12 113.694 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.531 ' HB2' ' HD2' ' A' ' 137' ' ' PHE . . . -124.54 -62.75 1.23 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.789 0.836 . . . . 73.42 109.64 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.497 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 86.4 t80 -64.47 -60.79 2.74 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.463 1.105 . . . . 72.41 113.957 -167.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 84.7 m -65.71 -37.94 21.75 Favored Pre-proline 0 CA--C 1.566 1.593 0 N-CA-C 113.656 0.984 . . . . 72.21 113.656 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.91 -27.03 43.64 Favored 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 121.729 1.619 . . . . 75.44 112.783 167.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -77.68 -17.45 57.67 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.379 0.672 . . . . 64.42 110.473 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.1 mm -67.84 -41.53 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.89 -0.781 . . . . 72.34 108.89 169.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.477 HD22 ' HG3' ' A' ' 80' ' ' GLN . 90.4 mt -77.06 -21.32 54.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.149 0.979 . . . . 62.5 111.938 -178.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -59.9 -47.53 97.0 Favored Pre-proline 0 CA--C 1.574 1.878 0 C-N-CA 124.293 1.037 . . . . 64.24 113.578 -174.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.92 -40.6 33.95 Favored 'Trans proline' 0 C--N 1.393 2.888 0 C-N-CA 122.051 1.834 . . . . 63.21 112.97 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -65.42 -44.04 88.64 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.812 0.695 . . . . 75.53 111.314 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.35 -31.81 64.17 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.519 0.728 . . . . 52.24 110.926 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.455 HH12 HD12 ' C' ' 105' ' ' ILE . 32.2 ttm180 -62.11 -50.4 72.07 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 109.321 -0.622 . . . . 73.21 109.321 170.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -66.85 -42.94 84.88 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.269 1.028 . . . . 74.34 112.202 -171.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.3 t -60.42 -42.92 97.01 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 123.786 0.679 . . . . 73.23 109.872 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 118' ' ' VAL . 57.9 mt -64.96 -46.07 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 114.811 -1.086 . . . . 73.21 110.686 175.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.3 m -57.66 -40.82 80.2 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.956 0.902 . . . . 54.43 111.304 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 44.1 t -66.41 -44.08 83.96 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 115.258 -0.883 . . . . 71.14 110.497 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 15.9 mtp -64.02 -36.84 85.3 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.895 0.878 . . . . 74.03 111.748 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 114' ' ' ILE . 51.5 t -63.09 -52.34 60.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 124.37 1.068 . . . . 70.14 110.005 176.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.6 t -65.52 -31.31 72.31 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.677 0.791 . . . . 64.54 111.578 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 116' ' ' SER . 44.3 ttm-85 -75.23 -32.53 61.16 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.093 0.957 . . . . 72.25 109.467 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.426 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.97 17.04 38.92 Favored Glycine 0 C--N 1.355 1.607 0 CA-C-N 114.97 -1.014 . . . . 62.44 113.254 171.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.462 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.5 t 62.45 12.65 5.51 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 126.944 2.098 . . . . 74.34 113.838 174.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -79.96 146.5 63.8 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 123.409 0.684 . . . . 74.32 109.474 174.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.54 162.75 35.43 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.61 2.207 . . . . 73.23 113.095 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -54.81 129.2 36.29 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.318 1.447 . . . . 74.13 113.461 -168.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.473 HD11 HG21 ' A' ' 40' ' ' VAL . 59.5 tp -130.4 110.6 11.61 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.392 1.077 . . . . 73.31 109.67 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -125.73 117.19 22.93 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.275 1.03 . . . . 55.24 108.641 175.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.1 mp -66.83 140.75 57.83 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.493 0.717 . . . . 61.14 110.24 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -63.33 130.13 94.03 Favored Pre-proline 0 CA--C 1.552 1.034 0 O-C-N 123.778 0.673 . . . . 60.14 110.417 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 36.8 Cg_exo -64.6 113.63 2.39 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 123.168 2.579 . . . . 61.2 111.893 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.414 HG21 ' O ' ' E' ' 8' ' ' LEU . 61.7 t -99.95 114.24 37.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.612 -1.255 . . . . 73.12 107.612 177.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -74.72 81.42 2.06 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.571 0.748 . . . . 63.01 109.806 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -58.38 -49.71 76.26 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.545 -0.752 . . . . 72.44 110.169 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -56.52 -52.62 64.07 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.855 -1.066 . . . . 74.41 112.106 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.04 -43.56 91.93 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.678 0.612 . . . . 70.1 110.956 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 43.3 tp -61.18 -45.3 95.16 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.862 0.865 . . . . 65.54 111.876 -177.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.531 ' HD2' ' HB2' ' A' ' 100' ' ' ALA . 24.3 m-85 -68.94 -33.89 74.46 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.746 0.419 . . . . 74.43 110.806 176.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.421 ' HG2' ' NE2' ' A' ' 96' ' ' HIS . 11.6 mmt -69.66 -30.4 68.08 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 118.937 -0.554 . . . . 73.31 111.52 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 89.9 m-20 -58.71 -43.51 90.1 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 123.894 0.746 . . . . 70.12 110.488 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -67.28 -44.28 79.69 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.18 -0.918 . . . . 73.44 110.937 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.406 HD23 ' SD ' ' A' ' 138' ' ' MET . 59.8 tp -57.18 -47.23 81.75 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 123.967 0.792 . . . . 74.04 111.228 -174.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.423 ' H ' ' H ' ' A' ' 143' ' ' GLN . 1.0 OUTLIER -169.63 -15.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.767 0.827 . . . . 74.42 110.799 173.736 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.423 ' H ' ' H ' ' A' ' 142' ' ' GLN . 7.9 tm0? 75.72 101.91 0.07 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.318 1.847 . . . . 72.13 108.826 -171.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.402 ' OE1' ' HG3' ' A' ' 138' ' ' MET . 11.9 pt20 -84.33 154.26 23.02 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.255 0.55 . . . . 74.51 111.114 -176.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.61 -166.63 1.54 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.4 -0.818 . . . . 51.25 108.938 167.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -170.06 -80.03 0.05 OUTLIER Glycine 0 C--N 1.339 0.731 0 N-CA-C 112.031 -0.428 . . . . 35.1 112.031 177.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 63.66 -156.31 0.32 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.057 0.943 . . . . 73.13 111.017 -174.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.486 ' HA2' HD21 ' C' ' 141' ' ' LEU . . . -165.51 -148.4 5.49 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 110.334 -1.106 . . . . 73.35 110.334 176.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 59.1 m -142.18 118.11 10.57 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.855 -0.795 . . . . 73.04 108.855 168.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.527 ' HG3' HG22 ' C' ' 92' ' ' THR . 42.9 mt-10 -88.62 140.46 29.44 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.342 0.657 . . . . 74.21 109.241 173.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -122.31 164.73 17.42 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 123.749 0.819 . . . . 73.52 109.035 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -71.58 91.69 1.09 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.492 0.717 . . . . 74.13 110.929 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -111.09 101.48 10.01 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.924 -1.51 . . . . 72.43 106.924 168.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -86.25 153.29 22.11 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.589 -0.732 . . . . 73.31 109.76 174.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 N-CA-C 108.78 -0.822 . . . . 73.3 108.78 175.54 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 109.407 -0.59 . . . . 74.51 109.407 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 81.0 p -139.51 -47.5 0.46 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.619 0.768 . . . . 70.11 109.416 177.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -71.05 101.66 2.27 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.584 0.754 . . . . 74.1 110.601 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -137.03 102.85 4.97 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 107.132 -1.433 . . . . 64.41 107.132 172.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -157.74 23.94 0.27 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.865 0.866 . . . . 73.44 109.142 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -112.21 112.74 24.56 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.659 1.184 . . . . 75.12 109.44 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 17.7 p -148.33 179.63 7.64 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.804 1.242 . . . . 44.42 109.423 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -84.44 -5.7 59.31 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.801 0.84 . . . . 63.53 111.935 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.56 ' HG2' ' HB ' ' B' ' 89' ' ' ILE . 0.3 OUTLIER 67.11 165.78 0.22 Allowed 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 125.849 1.66 . . . . 62.32 112.346 -178.694 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.499 ' N ' ' SD ' ' B' ' 9' ' ' MET . 94.0 m -149.64 109.18 4.0 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.866 1.266 . . . . 71.23 108.597 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' B' ' 85' ' ' SER . 35.5 t80 -130.76 138.23 49.84 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.914 0.486 . . . . 72.01 110.326 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -154.53 140.41 18.2 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.039 0.536 . . . . 51.42 110.479 175.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.415 ' HA ' ' HD2' ' B' ' 84' ' ' PHE . 17.9 mt -76.33 108.61 9.17 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 C-N-CA 123.7 0.8 . . . . 74.12 108.956 173.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -82.86 -43.64 16.36 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.349 -0.611 . . . . 75.13 109.349 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.462 ' HE ' HG21 ' A' ' 122' ' ' THR . 45.6 ttt180 -167.78 140.45 3.21 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.985 0.514 . . . . 74.52 110.612 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 62.9 mt -118.31 141.46 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 107.752 -1.203 . . . . 55.22 107.752 173.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.449 ' HE1' HG13 ' B' ' 83' ' ' ILE . 20.7 p90 -170.2 150.89 3.74 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.024 0.44 . . . . 70.33 111.721 -173.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 86.8 m -78.99 124.65 28.46 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.982 -0.747 . . . . 53.12 108.982 171.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -94.45 -27.72 15.86 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.419 0.688 . . . . 71.54 111.449 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -164.58 149.82 9.99 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.382 0.426 . . . . 64.5 111.777 -175.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 47.0 mm -140.26 142.81 30.73 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 C-N-CA 125.808 1.643 . . . . 74.22 109.344 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.573 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 46.5 t -139.17 131.92 29.08 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.261 -1.385 . . . . 73.33 107.261 171.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.562 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.7 t80 -144.46 122.52 12.11 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.1 -1.444 . . . . 61.1 107.1 170.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 40.4 mt-10 -130.61 119.73 22.92 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.148 0.979 . . . . 63.14 108.696 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.658 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -113.25 87.18 10.63 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 107.303 -1.369 . . . . 45.22 107.303 174.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.25 -44.86 0.72 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.6 2.2 . . . . 70.35 112.448 -174.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -92.76 5.72 50.14 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.419 1.088 . . . . 70.35 110.526 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.658 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -32.28 -63.24 0.26 Allowed Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 126.002 1.721 . . . . 42.01 115.406 -171.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 32.4 Cg_exo -54.79 -48.44 21.24 Favored 'Trans proline' 0 C--N 1.402 3.364 0 C-N-CA 122.465 2.11 . . . . 71.04 113.27 -167.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -97.67 -18.02 19.12 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.361 0.874 . . . . 71.31 113.361 -171.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.49 HG22 HD12 ' B' ' 68' ' ' LEU . 7.6 p -74.15 -16.19 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 118.875 0.761 . . . . 74.34 110.639 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -58.17 -23.48 55.53 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.26 1.024 . . . . 75.32 113.569 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -61.19 -23.21 65.42 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.038 0.535 . . . . 64.22 111.407 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.449 ' HB2' HD13 ' B' ' 68' ' ' LEU . 91.2 mttt -91.47 99.47 12.4 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.066 0.947 . . . . 73.35 110.211 -177.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -100.42 80.05 2.19 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.501 -0.772 . . . . 73.22 110.363 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 42.7 p90 -155.02 171.16 20.2 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.443 1.097 . . . . 70.44 108.681 170.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -67.72 112.57 10.8 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 108.916 -0.772 . . . . 73.24 108.916 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.538 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 37.8 Cg_endo -65.74 144.08 76.48 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 121.715 1.61 . . . . 74.43 112.315 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.447 ' HB2' ' HG2' ' F' ' 2' ' ' LYS . 32.3 tt0 -59.71 113.69 2.38 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.499 1.12 . . . . 73.02 109.83 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.666 HG13 HG13 ' B' ' 64' ' ' VAL . 81.6 t -92.23 127.26 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.645 0.778 . . . . 70.35 111.262 -173.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.499 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 38.4 tttp -104.62 107.54 18.54 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.017 -1.475 . . . . 73.43 107.017 173.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.532 HD22 ' HA ' ' F' ' 8' ' ' LEU . 4.1 pp -85.97 145.59 27.06 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 109.153 -0.684 . . . . 61.35 109.153 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.537 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 5.8 m-20 -142.07 110.9 6.21 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 106.992 -1.485 . . . . 74.55 106.992 171.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -98.85 135.31 40.49 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.336 -1.357 . . . . 74.32 107.336 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -144.99 156.28 43.86 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.989 -1.115 . . . . 73.15 107.989 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 6.1 t -137.14 142.76 42.25 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.457 0.646 . . . . 55.34 110.507 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.43 145.36 35.2 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.27 -1.382 . . . . 75.33 107.27 174.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.8 p -146.39 166.45 26.32 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.853 0.297 . . . . 73.14 111.143 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.5 p -151.41 137.74 18.49 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.189 0.996 . . . . 71.43 109.103 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -92.86 110.74 22.19 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.026 -0.731 . . . . 75.34 109.026 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 22.9 mt -75.59 -46.68 30.4 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.683 0.754 . . . . 63.2 109.635 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.51 179.45 7.8 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 114.572 -1.195 . . . . 74.14 109.774 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -74.92 128.9 36.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.658 -1.155 . . . . 75.23 108.179 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 73.69 -4.77 2.16 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 125.798 1.639 . . . . 63.42 112.83 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 62.2 t -114.18 113.75 44.7 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 N-CA-C 108.253 -1.017 . . . . 64.13 108.253 172.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.638 ' HB3' HD13 ' B' ' 86' ' ' ILE . 23.1 t80 -125.44 138.25 54.01 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.663 -0.865 . . . . 74.34 108.663 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -113.76 119.75 38.45 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.388 -1.338 . . . . 74.12 107.388 -175.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.431 HG21 ' HB3' ' B' ' 102' ' ' CYS . 33.0 m -116.05 148.93 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.136 0.574 . . . . 32.01 110.37 -177.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 19.3 t -129.59 124.16 58.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 C-N-CA 123.652 0.781 . . . . 60.31 109.11 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 20.0 tp -101.83 108.95 20.6 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 109.318 -0.623 . . . . 64.42 109.318 171.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -88.36 118.47 27.99 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.386 0.674 . . . . 70.13 109.994 175.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.1 t -114.12 103.4 15.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 108.242 -1.022 . . . . 71.22 108.242 176.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 4.7 m -99.62 130.3 45.84 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.267 0.627 . . . . 64.13 109.383 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.666 HG13 HG13 ' B' ' 40' ' ' VAL . 54.3 t -128.43 102.28 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 124.271 1.029 . . . . 74.31 110.564 -176.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 31.9 m -83.71 150.01 26.11 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.279 -1.008 . . . . 62.13 108.279 165.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -138.89 147.91 42.96 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.04 0.536 . . . . 61.42 110.033 177.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 36.2 p -138.92 125.31 20.4 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.121 0.568 . . . . 71.43 110.374 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.538 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 53.2 mt -94.23 100.61 12.64 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.022 -1.473 . . . . 72.32 107.022 173.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.36 -114.27 3.95 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 115.006 -0.997 . . . . 63.2 110.833 -170.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.83 6.32 9.9 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.018 0.927 . . . . 73.14 110.676 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -114.39 152.32 31.7 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.389 0.676 . . . . 65.23 109.22 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.8 m -64.56 137.99 58.15 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 123.648 0.592 . . . . 60.51 111.15 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.535 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -93.19 -63.62 1.19 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.579 -1.267 . . . . 74.12 107.579 170.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -145.56 167.76 22.26 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 114.244 -1.343 . . . . 74.41 110.601 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 61.0 mt -130.78 140.89 50.33 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.491 -2.04 . . . . 75.32 105.491 172.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.9 t -146.92 158.54 43.95 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.639 -0.874 . . . . 73.12 108.639 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.573 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 41.7 tt0 -165.04 132.24 3.01 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.512 -0.922 . . . . 73.04 108.512 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.0 t -128.23 144.54 37.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 123.479 0.712 . . . . 73.51 109.184 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -120.57 101.05 7.49 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.951 -1.129 . . . . 71.2 107.951 169.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.472 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.5 tp-100 -90.71 102.53 15.28 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.147 -1.057 . . . . 74.54 108.147 175.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.5 158.93 27.95 Favored Glycine 0 C--O 1.245 0.79 0 CA-C-N 115.283 -0.871 . . . . 72.02 110.946 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.98 125.87 1.62 Allowed Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 111.02 -0.832 . . . . 61.35 111.02 -178.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.449 HG13 ' HE1' ' B' ' 17' ' ' TYR . 50.9 mt -85.0 125.28 40.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 106.902 -1.518 . . . . 74.11 106.902 172.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 84' ' ' PHE . . . . . 0.415 ' HD2' ' HA ' ' B' ' 13' ' ' ILE . 58.1 m-85 -134.38 154.75 51.19 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.047 -0.724 . . . . 62.22 109.047 176.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 74.0 m -91.7 104.3 16.78 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.674 -0.861 . . . . 75.42 108.674 169.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.638 HD13 ' HB3' ' B' ' 56' ' ' TYR . 3.7 mp -101.37 107.86 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 106.602 -1.629 . . . . 72.4 106.602 173.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.21 171.32 15.11 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.153 0.581 . . . . 51.43 110.632 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.657 ' HA2' ' HB ' ' F' ' 23' ' ' THR . . . 83.11 -72.54 2.83 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.364 -0.834 . . . . 60.42 111.89 -177.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.56 ' HB ' ' HG2' ' B' ' 9' ' ' MET . 1.4 mm -87.16 144.35 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.029 0.932 . . . . 65.52 111.103 -176.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.48 ' HG2' ' H ' ' B' ' 91' ' ' GLY . 14.9 tt0 -154.69 175.35 13.8 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.177 -1.374 . . . . 74.21 107.611 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.48 ' H ' ' HG2' ' B' ' 90' ' ' GLU . . . 80.24 -113.89 3.74 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-O 120.03 -0.317 . . . . 52.25 112.364 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 8.9 m -73.96 -53.52 9.9 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.259 0.624 . . . . 60.25 111.718 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -70.98 -26.54 63.19 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.252 -0.886 . . . . 65.23 112.292 -165.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.448 ' HE1' ' HG2' ' B' ' 90' ' ' GLU . 21.0 ptt? -69.46 -25.08 63.92 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 122.977 0.173 . . . . 54.03 111.115 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.66 -38.72 78.76 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.491 0.716 . . . . 44.24 110.944 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -77.95 -37.4 47.68 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.949 -1.023 . . . . 72.14 110.507 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -67.74 -25.73 65.79 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.414 0.686 . . . . 65.2 112.12 -177.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.668 HD11 HG23 ' F' ' 18' ' ' VAL . 84.3 mt -93.15 -43.92 8.61 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.184 0.594 . . . . 74.3 110.59 176.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.72 -18.42 73.06 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 115.152 0.821 . . . . 64.43 115.152 -170.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.05 -43.68 1.95 Allowed 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 117.589 0.694 . . . . 43.1 111.799 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.46 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 27.3 t80 -76.77 -52.5 9.45 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.801 -0.636 . . . . 73.03 111.427 -168.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.431 ' HB3' HG21 ' B' ' 58' ' ' VAL . 70.2 m -62.28 -44.4 88.29 Favored Pre-proline 0 CA--C 1.571 1.781 0 CA-C-O 118.269 -0.872 . . . . 73.21 112.959 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -51.68 -43.46 50.79 Favored 'Trans proline' 0 C--N 1.405 3.502 0 C-N-CA 122.832 2.355 . . . . 55.24 113.324 172.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -55.95 -33.3 64.64 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.152 0.981 . . . . 73.22 112.083 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 52.3 mt -77.57 -48.32 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.749 0.82 . . . . 73.11 110.868 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 79.2 mt -87.48 -19.89 27.33 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.661 0.784 . . . . 64.1 112.806 -167.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -64.15 -44.26 76.61 Favored Pre-proline 0 CA--C 1.563 1.479 0 CA-C-O 117.676 -1.154 . . . . 75.1 112.527 -174.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -53.14 -38.46 80.97 Favored 'Trans proline' 0 C--N 1.392 2.862 0 C-N-CA 122.553 2.169 . . . . 71.04 113.83 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.472 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 72.7 m-85 -70.81 -40.69 72.34 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.583 -0.735 . . . . 74.14 110.51 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.8 -37.03 83.75 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.741 0.416 . . . . 55.41 110.673 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -60.85 -55.76 29.19 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.156 1.383 . . . . 72.32 110.717 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -58.86 -37.97 77.7 Favored 'General case' 0 C--N 1.358 0.945 0 O-C-N 124.009 0.818 . . . . 74.43 110.555 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.434 ' O ' ' HG2' ' B' ' 117' ' ' MET . 16.8 t -67.41 -42.61 82.97 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-N 115.374 -0.83 . . . . 75.33 111.293 -175.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.97 -52.68 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 123.741 0.651 . . . . 74.32 109.541 176.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 10.7 m -60.97 -27.29 68.16 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 124.129 0.893 . . . . 62.01 111.689 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -68.52 -52.04 36.4 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 123.187 0.595 . . . . 62.53 109.67 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.434 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 33.7 mmt -59.56 -38.7 81.82 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.162 0.585 . . . . 63.53 111.063 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' B' ' 123' ' ' PHE . 71.1 t -66.24 -45.63 89.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.789 1.236 . . . . 71.24 111.034 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.7 t -67.63 -29.12 68.35 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.265 0.626 . . . . 52.31 111.107 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -73.34 -38.58 65.7 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.786 0.835 . . . . 74.44 110.042 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.58 -2.5 69.29 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 124.028 0.83 . . . . 65.54 112.5 171.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 20.1 p 63.22 28.87 15.97 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.804 2.042 . . . . 64.5 112.839 174.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.426 ' HB2' HG13 ' B' ' 118' ' ' VAL . 92.2 m-85 -86.93 154.42 55.3 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.886 0.874 . . . . 75.34 110.483 176.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -48.24 153.37 3.02 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 124.095 3.197 . . . . 74.44 115.567 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.474 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -60.63 126.71 28.42 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.557 1.543 . . . . 74.42 111.797 -175.501 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 38.9 tp -127.8 113.89 16.54 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.822 -0.626 . . . . 72.14 110.386 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -121.36 112.65 18.83 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.295 -1.002 . . . . 72.11 108.295 171.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 9.2 tt -78.31 135.23 37.47 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.497 0.719 . . . . 74.44 109.667 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.93 137.34 87.44 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.487 1.115 . . . . 65.4 112.202 -173.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.525 ' HG3' HD13 ' D' ' 16' ' ' ILE . 38.1 Cg_endo -63.8 100.07 0.28 Allowed 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 123.188 2.592 . . . . 72.32 112.647 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.416 ' HB ' ' HB1' ' F' ' 7' ' ' ALA . 2.4 p -91.22 111.2 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-N 115.509 -0.769 . . . . 62.43 109.003 173.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -80.14 100.87 8.46 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.607 0.763 . . . . 74.53 109.113 -177.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -66.38 -41.6 89.15 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.41 0.684 . . . . 74.02 110.932 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -57.59 -50.57 72.68 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.452 1.101 . . . . 62.42 111.941 -174.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.33 -24.97 64.89 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.14 0.9 . . . . 54.3 112.091 -175.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' F' ' 10' ' ' LEU . 87.9 mt -66.5 -45.39 79.73 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.226 0.61 . . . . 45.13 110.233 176.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.438 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 76.8 m-85 -68.33 -43.01 78.49 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.687 -0.688 . . . . 71.51 110.48 175.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 23.5 ttt -61.68 -38.38 87.58 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.094 0.958 . . . . 74.52 111.451 -174.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -75.55 -31.66 60.14 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.032 -0.985 . . . . 72.12 109.661 -174.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -69.03 -27.99 66.16 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.401 -0.818 . . . . 63.33 110.501 177.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 65.7 mt -87.4 36.37 0.74 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.027 0.931 . . . . 63.55 111.047 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -67.52 125.15 25.26 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.943 0.897 . . . . 54.22 111.027 -178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -130.61 131.56 45.01 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.844 0.858 . . . . 73.42 109.424 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -112.2 -52.62 2.77 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.079 0.952 . . . . 74.04 110.98 -175.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.93 125.61 27.99 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.952 0.501 . . . . 74.42 110.746 -177.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 176.88 61.79 0.06 OUTLIER Glycine 0 C--N 1.347 1.181 0 O-C-N 123.317 0.385 . . . . 65.01 112.336 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.68 164.04 34.76 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.394 1.078 . . . . 73.33 110.116 -176.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -147.28 143.09 10.87 Favored Glycine 0 C--N 1.347 1.191 0 N-CA-C 112.114 -0.394 . . . . 62.4 112.114 -175.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 28.3 p -115.2 103.89 11.3 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.179 0.992 . . . . 74.31 110.187 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -89.79 99.35 12.38 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.759 0.824 . . . . 75.31 110.171 -176.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -108.69 100.16 9.43 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.785 0.834 . . . . 71.31 109.112 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -81.2 154.52 26.62 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.129 0.49 . . . . 73.12 110.331 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -124.68 178.41 5.46 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.31 1.044 . . . . 75.1 109.846 -176.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -154.91 145.22 22.0 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.811 0.845 . . . . 74.14 109.12 173.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 C-N-CA 123.46 0.704 . . . . 63.35 109.827 179.304 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 1' ' ' MET . . . . . 0.658 ' HG2' ' HB3' ' A' ' 39' ' ' GLU . 55.9 mtt . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.327 -0.619 . . . . 75.12 109.327 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 53.0 p -146.6 157.46 43.72 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.198 0.599 . . . . 73.43 111.13 -174.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -147.58 127.48 13.56 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.028 -1.101 . . . . 73.24 108.028 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -135.49 98.81 4.04 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.725 -0.843 . . . . 72.42 108.725 -176.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -165.84 115.6 1.01 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.004 0.922 . . . . 73.34 108.551 172.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -139.87 61.76 1.53 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 122.329 1.062 . . . . 60.22 108.805 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 44.7 p -115.46 166.97 11.29 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 114.47 -1.241 . . . . 75.22 108.607 169.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -73.33 164.24 26.96 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 110.534 -0.173 . . . . 44.42 110.534 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.415 ' HB2' HG23 ' C' ' 89' ' ' ILE . 23.3 ttt 65.09 116.47 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.022 1.329 . . . . 61.21 110.524 -164.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 91.5 m -84.96 90.73 7.89 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.957 -1.127 . . . . 54.2 107.957 174.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.589 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.6 t80 -104.95 119.18 38.4 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.233 -0.894 . . . . 75.33 109.738 176.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 12' ' ' GLN . . . . . 0.552 HE22 ' HB3' ' E' ' 3' ' ' GLN . 35.5 tt0 -140.96 123.61 16.07 Favored 'General case' 0 C--O 1.245 0.824 0 N-CA-C 107.611 -1.255 . . . . 70.15 107.611 175.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 70.3 mt -71.4 122.43 23.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.213 -1.032 . . . . 75.34 108.213 171.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.537 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 20.7 mm-40 -85.11 -50.51 7.36 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 124.122 0.889 . . . . 60.22 109.018 -178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -172.41 124.19 0.48 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.951 -0.568 . . . . 70.23 110.214 -172.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 77.1 mt -112.28 143.74 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.55 -0.908 . . . . 72.3 108.55 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -174.94 166.03 3.56 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.674 0.79 . . . . 74.11 109.369 -171.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 18' ' ' THR . . . . . 0.431 HG21 ' SG ' ' C' ' 113' ' ' CYS . 71.8 p -89.64 126.0 35.46 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.278 -0.638 . . . . 61.12 109.278 177.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -74.99 -50.2 17.37 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 122.668 1.223 . . . . 72.34 107.857 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.494 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 10.3 t70 -136.0 136.86 40.65 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 112.651 -2.068 . . . . 51.2 108.969 -166.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 75.2 mt -136.28 142.15 39.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.044 -1.465 . . . . 73.34 107.044 172.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -158.46 151.35 22.44 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.312 0.577 . . . . 45.02 110.328 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -150.32 134.42 17.0 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 107.919 -1.141 . . . . 72.45 107.919 174.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -134.35 137.55 44.23 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.465 0.706 . . . . 71.25 109.659 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.36 80.96 8.24 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 106.125 -1.805 . . . . 51.31 106.125 172.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.65 -8.89 24.07 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.9 2.4 . . . . 54.21 112.878 -171.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.456 ' ND2' ' HB ' ' C' ' 31' ' ' VAL . 20.2 p-10 -124.48 20.95 8.67 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.053 1.341 . . . . 74.15 110.277 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.85 -51.14 17.91 Favored Pre-proline 0 CA--C 1.564 1.511 0 N-CA-C 114.569 1.322 . . . . 64.34 114.569 -168.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.58 -51.13 9.82 Favored 'Trans proline' 0 C--N 1.392 2.845 0 CA-C-N 121.622 1.615 . . . . 54.03 112.169 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.438 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 84.1 t60 -68.38 -29.99 68.82 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.744 0.818 . . . . 53.44 112.28 -174.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.749 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.8 p -77.43 -26.52 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 N-CA-C 112.626 0.602 . . . . 73.22 112.626 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -68.98 -17.98 64.0 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.379 0.881 . . . . 73.3 113.379 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 19.4 pt20 -94.6 8.04 43.66 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.789 0.436 . . . . 70.45 111.181 177.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.766 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -89.78 168.84 11.77 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.005 0.922 . . . . 63.12 110.372 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 35' ' ' ASP . . . . . 0.438 ' N ' ' HG3' ' C' ' 34' ' ' LYS . 31.6 t70 -74.13 130.56 40.02 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.2 0.6 . . . . 75.03 109.66 165.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -80.7 88.93 5.74 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.059 0.544 . . . . 65.34 109.873 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -143.13 77.85 15.58 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 107.971 -1.122 . . . . 74.24 107.971 172.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.515 ' HB2' HG13 ' C' ' 40' ' ' VAL . 9.2 Cg_endo -88.11 127.09 2.1 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.968 2.445 . . . . 72.24 112.37 -173.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -82.46 86.5 6.75 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.522 -1.658 . . . . 75.01 106.522 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.515 HG13 ' HB2' ' C' ' 38' ' ' PRO . 3.1 m -82.81 111.29 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 113.18 -1.827 . . . . 64.23 111.006 -173.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -106.31 115.97 31.14 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.838 0.855 . . . . 63.3 109.84 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 8.0 mp -85.66 131.18 34.39 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.302 -0.999 . . . . 60.45 108.302 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.527 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 38.6 t70 -123.63 105.7 9.94 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.814 1.246 . . . . 70.21 107.903 -170.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.508 HD22 HD13 ' G' ' 8' ' ' LEU . 32.7 tp -95.66 140.57 30.29 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.728 -0.669 . . . . 74.44 110.006 -173.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.62 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 25.9 t70 -147.14 158.06 43.81 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.853 -1.166 . . . . 71.44 107.853 173.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 73.0 p -122.53 132.25 54.23 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.159 0.584 . . . . 50.45 110.59 -174.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.25 147.43 50.22 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.072 -1.085 . . . . 72.23 108.072 173.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 72.3 p -165.55 159.09 16.33 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.597 0.237 . . . . 62.11 111.609 -174.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 65.2 p -164.15 134.79 4.28 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.536 0.734 . . . . 63.02 110.013 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -77.04 120.6 22.36 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.766 -0.827 . . . . 53.34 108.766 171.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.579 HD11 HD12 ' C' ' 83' ' ' ILE . 43.6 mt -94.14 -39.84 10.36 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.638 0.775 . . . . 55.31 110.155 -176.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.451 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -148.41 -179.19 6.77 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.852 0.861 . . . . 65.42 110.146 177.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -57.23 110.39 0.83 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.629 0.772 . . . . 65.12 109.419 173.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 65.02 1.4 1.47 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.317 1.447 . . . . 61.33 114.35 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 90.1 t -93.18 110.73 23.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 106.914 -1.513 . . . . 73.31 106.914 173.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.572 ' HB2' HG13 ' G' ' 18' ' ' VAL . 17.7 t80 -125.1 136.25 53.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.911 -0.586 . . . . 75.43 110.137 -171.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.414 ' HB2' HD11 ' C' ' 51' ' ' LEU . 29.6 tt0 -94.05 119.71 33.29 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.222 -0.899 . . . . 52.23 109.234 175.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 61.7 t -104.76 114.04 43.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.419 -1.326 . . . . 71.22 107.419 168.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 63.1 t -105.54 133.24 50.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 107.674 -1.232 . . . . 62.34 107.674 169.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 13.9 tp -116.4 108.62 16.26 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.794 -0.817 . . . . 72.54 108.794 174.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.62 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 0.4 OUTLIER -83.64 114.13 21.33 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.365 -0.976 . . . . 64.31 108.365 179.366 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 12.2 t -110.81 130.13 64.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.076 -1.083 . . . . 64.13 108.076 174.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 31.1 m -124.86 118.52 26.5 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.586 -0.894 . . . . 54.43 108.586 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.543 HG23 HD13 ' C' ' 114' ' ' ILE . 98.9 t -98.77 110.41 26.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.462 -0.94 . . . . 75.31 108.462 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.4 HG23 HD23 ' C' ' 75' ' ' LEU . 11.2 m -96.32 137.7 35.01 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.123 -1.436 . . . . 74.13 107.123 174.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.45 118.38 19.25 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.526 -1.287 . . . . 63.5 107.526 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 60.1 m -138.47 127.78 24.43 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 109.253 -0.647 . . . . 63.44 109.253 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.766 HD13 ' HG2' ' C' ' 34' ' ' LYS . 2.9 mt -83.37 15.6 2.93 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.954 1.302 . . . . 72.12 111.291 -175.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.09 -104.49 0.59 Allowed Glycine 0 C--N 1.344 1.013 0 N-CA-C 109.346 -1.502 . . . . 74.13 109.346 -173.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -88.45 -20.79 24.73 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.348 0.659 . . . . 74.22 110.073 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -89.37 122.54 32.7 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.196 0.998 . . . . 74.53 110.156 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 89.1 m -75.97 125.12 28.5 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.998 -0.742 . . . . 44.45 108.998 166.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.749 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.33 -54.12 7.61 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.173 -0.677 . . . . 74.34 109.173 173.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -164.52 166.26 20.54 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 115.56 -0.745 . . . . 64.43 111.856 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.4 HD23 HG23 ' C' ' 65' ' ' THR . 2.3 tm? -131.6 104.41 6.93 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 106.762 -1.57 . . . . 60.13 106.762 172.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.51 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.8 t -110.19 146.15 36.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.842 0.857 . . . . 71.01 108.999 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -150.58 133.98 16.36 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.003 0.521 . . . . 53.03 109.877 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.5 t -132.54 132.79 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.507 -0.923 . . . . 74.1 108.507 168.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.497 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 61.0 mt-30 -105.56 98.49 8.18 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.701 -1.222 . . . . 74.42 107.701 173.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -82.57 106.98 14.87 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.888 -0.596 . . . . 74.4 110.43 -174.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.65 145.66 21.98 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.902 -0.59 . . . . 74.23 111.69 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.11 117.2 0.8 Allowed Glycine 0 CA--C 1.509 -0.282 0 N-CA-C 110.477 -1.049 . . . . 63.53 110.477 177.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.579 HD12 HD11 ' C' ' 51' ' ' LEU . 13.1 mm -83.87 118.9 32.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.145 -1.057 . . . . 64.32 108.145 177.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.589 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 50.6 m-85 -129.17 128.36 43.23 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.146 0.978 . . . . 71.03 108.71 -176.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.1 p -83.33 115.62 22.08 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.864 -0.791 . . . . 70.21 108.864 172.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.466 ' HB ' HG21 ' G' ' 18' ' ' VAL . 4.4 mp -114.65 100.3 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 107.134 -1.432 . . . . 74.42 107.134 173.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -124.25 152.66 42.72 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.159 0.984 . . . . 63.44 109.034 176.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.41 -58.25 0.74 Allowed Glycine 0 C--N 1.345 1.04 0 CA-C-O 120.272 -0.182 . . . . 65.12 113.189 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.415 HG23 ' HB2' ' C' ' 9' ' ' MET . 29.9 pt -81.89 167.44 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 121.111 0.481 . . . . 55.41 111.413 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -150.08 -177.24 5.81 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.292 1.037 . . . . 75.52 110.019 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.71 -139.07 48.74 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 124.266 0.979 . . . . 50.2 114.618 171.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 92' ' ' THR . . . . . 0.527 HG22 ' HG3' ' A' ' 150' ' ' GLU . 68.0 p -70.58 -18.75 62.9 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.853 0.861 . . . . 73.34 111.953 -175.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -74.91 -39.14 61.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.274 0.63 . . . . 61.02 109.951 174.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 46.5 ttm -60.81 -49.09 78.89 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.177 0.591 . . . . 73.24 109.815 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.22 -29.98 70.83 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.792 0.837 . . . . 71.13 112.072 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -67.15 -40.92 86.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.215 0.606 . . . . 74.45 110.327 174.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.568 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 15.2 t -64.78 -43.72 92.32 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.529 0.518 . . . . 74.43 110.799 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.559 HD11 HG23 ' G' ' 18' ' ' VAL . 86.1 mt -74.73 -36.79 62.65 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.413 0.685 . . . . 73.02 112.19 -176.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.92 -23.89 31.49 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 114.651 0.62 . . . . 72.13 114.651 -165.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.483 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -135.99 -47.03 0.65 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.446 0.641 . . . . 73.31 111.875 -172.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.568 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 82.4 t80 -74.23 -40.78 62.18 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 125.485 1.514 . . . . 74.45 112.604 -170.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 94.5 m -76.71 -43.23 3.04 Favored Pre-proline 0 N--CA 1.487 1.382 0 CA-C-O 118.568 -0.73 . . . . 71.41 111.194 176.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -47.34 -40.06 28.13 Favored 'Trans proline' 0 C--N 1.395 3.009 0 C-N-CA 122.84 2.36 . . . . 70.44 113.376 165.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -59.02 -38.49 79.38 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 123.668 0.605 . . . . 65.44 111.276 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.455 HD12 HH12 ' A' ' 111' ' ' ARG . 36.8 mm -65.27 -44.47 94.97 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 122.822 0.449 . . . . 64.4 109.842 174.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 94.9 mt -83.82 -15.22 49.13 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.816 1.043 . . . . 75.21 113.816 -169.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -58.72 -53.43 66.43 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-O 117.614 -1.184 . . . . 74.12 112.946 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.75 -32.11 78.3 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 121.702 1.601 . . . . 71.11 112.949 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -66.71 -53.69 30.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.371 0.668 . . . . 74.53 110.626 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.49 83.81 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.703 0.801 . . . . 74.4 110.465 177.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -57.77 -57.11 14.19 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.298 1.439 . . . . 71.32 111.287 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -38.0 83.19 Favored 'General case' 0 C--N 1.366 1.296 0 O-C-N 123.716 0.635 . . . . 75.54 109.713 -177.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.431 ' SG ' HG21 ' C' ' 18' ' ' THR . 8.8 t -66.3 -30.52 70.95 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 122.833 0.453 . . . . 62.3 111.761 -176.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.543 HD13 HG23 ' C' ' 64' ' ' VAL . 91.9 mt -74.46 -55.39 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.209 0.604 . . . . 71.33 109.534 173.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 21.8 m -59.99 -27.4 66.83 Favored 'General case' 0 CA--C 1.558 1.27 0 O-C-N 123.787 0.679 . . . . 61.41 111.204 -175.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 46.7 t -63.68 -48.62 76.44 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 124.429 1.092 . . . . 43.31 109.82 174.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.647 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -66.45 -36.26 82.34 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.115 0.966 . . . . 74.5 111.686 179.129 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 76.1 t -61.75 -41.12 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.561 0.744 . . . . 74.31 109.507 172.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.0 t -74.82 -28.86 60.88 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.95 -1.023 . . . . 73.14 111.763 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' C' ' 116' ' ' SER . 80.5 mtt-85 -73.0 -38.62 66.53 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.815 -0.809 . . . . 74.22 108.815 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.27 -4.92 70.22 Favored Glycine 0 C--N 1.356 1.691 0 CA-C-N 115.375 -0.829 . . . . 61.22 112.777 171.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 19.6 p 64.91 27.67 12.75 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.673 1.989 . . . . 75.41 113.157 171.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -83.99 142.25 41.49 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 108.263 -1.014 . . . . 75.32 108.263 170.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.54 163.44 1.16 Allowed 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.65 2.9 . . . . 70.35 114.711 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -54.33 134.08 45.21 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.326 1.05 . . . . 64.34 113.112 -171.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 27.5 tp -134.93 85.96 2.22 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.51 -1.293 . . . . 74.34 107.51 174.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -96.21 115.54 27.59 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.845 -1.07 . . . . 63.2 109.067 -175.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.24 121.61 14.11 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.747 0.819 . . . . 72.43 109.069 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.61 137.9 74.06 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 123.065 0.546 . . . . 71.21 111.286 -177.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.588 ' HB3' HD12 ' A' ' 16' ' ' ILE . 9.6 Cg_endo -52.47 109.51 0.35 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.139 2.559 . . . . 63.22 114.383 175.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 10.1 m -121.19 112.02 33.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 107.784 -1.191 . . . . 74.23 107.784 165.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -74.49 94.04 2.55 Favored 'General case' 0 C--N 1.354 0.774 0 N-CA-C 108.759 -0.83 . . . . 74.32 108.759 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.415 ' HA ' HD12 ' C' ' 136' ' ' LEU . 5.4 t80 -54.91 -34.18 62.86 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.943 1.697 . . . . 72.44 111.902 -173.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.483 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 9.7 t70 -74.45 -41.45 60.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.42 1.088 . . . . 73.42 111.178 -177.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.77 -30.76 71.05 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.092 0.957 . . . . 75.01 111.324 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' C' ' 133' ' ' PHE . 97.1 mt -58.6 -37.5 75.99 Favored 'General case' 0 CA--C 1.554 1.105 0 O-C-N 124.11 0.881 . . . . 53.51 111.022 172.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -80.35 -27.17 38.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.758 0.823 . . . . 64.42 111.851 175.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 23.7 mmt -66.96 -28.25 68.12 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.271 0.628 . . . . 73.23 111.472 175.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -55.79 -35.91 66.81 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.255 1.022 . . . . 75.0 111.332 172.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -72.28 -154.95 0.03 OUTLIER 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.684 0.794 . . . . 74.32 109.679 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.486 HD21 ' HA2' ' A' ' 148' ' ' GLY . 56.3 mt 59.41 -103.59 0.17 Allowed 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 124.344 1.058 . . . . 54.31 111.098 174.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 179.68 136.88 0.11 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.133 1.373 . . . . 72.25 108.487 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -115.44 96.21 5.53 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.436 -1.32 . . . . 72.51 107.436 174.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -108.01 -6.49 16.53 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.78 0.832 . . . . 74.43 111.245 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.42 123.76 34.4 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.411 0.684 . . . . 74.22 110.324 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -170.18 129.9 1.91 Allowed Glycine 0 C--N 1.334 0.446 0 CA-C-O 119.846 -0.419 . . . . 63.22 112.174 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -167.03 118.56 0.92 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.154 0.582 . . . . 75.23 110.035 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -98.59 112.41 4.46 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 111.592 -0.603 . . . . 54.23 111.592 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 149' ' ' THR . . . . . 0.499 ' H ' ' H ' ' A' ' 92' ' ' THR . 21.1 p -71.18 93.67 1.09 Allowed 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 117.2 0.5 . . . . 72.51 109.852 171.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -72.36 -49.21 35.79 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.136 0.975 . . . . 64.34 111.009 -176.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.44 133.13 39.94 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 107.345 -1.354 . . . . 74.42 107.345 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 152' ' ' HIS . . . . . 0.405 ' HB3' HG21 ' E' ' 23' ' ' THR . 35.2 m80 -90.79 -56.87 3.02 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.893 0.477 . . . . 74.13 111.125 -174.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 58.38 79.78 0.2 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.703 0.763 . . . . 72.24 109.819 -166.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.43 83.36 6.26 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.237 -0.892 . . . . 73.14 109.933 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-N 115.053 -0.976 . . . . 63.24 108.932 175.02 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 109.333 -0.617 . . . . 55.34 109.333 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 23.1 t -159.61 175.83 12.74 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.149 0.98 . . . . 61.23 109.169 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -161.66 -149.82 0.18 Allowed 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 107.283 -1.377 . . . . 73.41 107.283 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 4' ' ' GLN . . . . . 0.664 ' HA ' ' HG3' ' D' ' 93' ' ' GLN . 51.5 mt-30 67.3 97.56 0.06 Allowed 'General case' 0 C--N 1.364 1.22 0 C-N-CA 124.567 1.147 . . . . 73.13 111.872 175.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -85.63 -61.16 1.82 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.294 0.638 . . . . 75.4 111.684 -172.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -75.78 124.36 27.16 Favored 'General case' 0 C--N 1.36 1.054 0 CA-C-O 121.055 0.455 . . . . 65.12 110.98 -175.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 9.2 t -73.33 -11.97 60.67 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.418 1.087 . . . . 64.15 111.131 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -64.78 -23.6 67.29 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.419 1.087 . . . . 60.24 111.869 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.522 ' HG3' HD11 ' D' ' 89' ' ' ILE . 7.6 ttt -32.42 124.68 0.32 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.944 1.298 . . . . 63.22 113.906 168.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 64.5 m -108.67 142.28 39.4 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.718 -0.845 . . . . 75.32 108.718 169.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' D' ' 85' ' ' SER . 25.0 t80 -158.58 119.85 3.43 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.757 -0.831 . . . . 74.34 108.757 177.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -138.86 145.24 39.73 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.759 1.224 . . . . 73.33 108.118 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 52.4 mt -91.77 127.62 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.24 -0.652 . . . . 73.11 109.24 176.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -97.53 -46.63 5.97 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 122.531 0.333 . . . . 75.15 111.061 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -167.77 127.53 1.34 Allowed 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 117.816 0.28 . . . . 75.31 111.527 -170.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.525 HD13 ' HG3' ' B' ' 130' ' ' PRO . 2.4 mp -103.82 138.05 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.358 -1.349 . . . . 74.31 107.358 167.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -163.94 149.4 10.79 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 123.813 0.695 . . . . 73.2 110.658 176.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.1 p -83.36 116.85 22.66 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.419 -0.81 . . . . 74.41 109.212 174.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -84.74 -35.87 22.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.635 -0.876 . . . . 71.01 108.635 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.619 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 12.7 t70 -143.25 129.23 19.57 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.283 -1.326 . . . . 74.31 109.129 -174.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.647 HG21 ' HE2' ' C' ' 117' ' ' MET . 62.1 mt -135.56 148.45 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.643 1.177 . . . . 71.12 108.612 174.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.6 t -147.17 142.87 27.77 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.027 0.931 . . . . 55.21 109.536 171.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 83.1 t80 -146.63 119.93 8.96 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 105.252 -2.129 . . . . 73.04 105.252 172.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.8 mt-10 -134.98 109.94 8.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.311 0.645 . . . . 73.22 109.386 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.24 90.95 5.11 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 107.734 -1.21 . . . . 73.14 107.734 175.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -73.5 -33.36 6.92 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.726 2.284 . . . . 72.4 112.554 -169.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -110.4 18.53 19.73 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.143 0.977 . . . . 74.12 109.897 -175.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -34.22 -61.01 0.45 Allowed Pre-proline 0 CA--C 1.569 1.685 0 N-CA-C 116.309 1.966 . . . . 50.43 116.309 -161.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.436 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 93.1 Cg_endo -76.36 -26.88 8.39 Favored 'Trans proline' 0 C--N 1.385 2.481 0 CA-C-N 122.996 2.106 . . . . 71.34 113.202 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -66.38 -44.36 83.31 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.507 1.123 . . . . 64.44 109.624 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' D' ' 73' ' ' ALA . 12.0 p -82.46 -16.42 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-N 115.202 -0.908 . . . . 71.41 111.446 -172.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.436 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 16.7 m-85 -64.75 -26.2 68.26 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.102 0.408 . . . . 64.51 112.102 177.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -58.27 -21.92 50.48 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.842 0.857 . . . . 71.02 111.198 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.403 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 88.3 mttt -93.73 97.5 10.49 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.931 1.292 . . . . 72.12 109.09 173.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -104.9 85.29 2.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.718 0.771 . . . . 74.42 109.324 177.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 19.1 p90 -149.25 -173.16 4.31 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.688 -1.142 . . . . 73.44 108.075 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -77.14 113.13 28.01 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.147 0.579 . . . . 64.44 110.237 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.23 130.37 39.04 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.664 2.243 . . . . 75.54 112.696 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.56 112.18 3.05 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.795 -0.817 . . . . 63.42 108.795 172.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 13.9 m -101.81 125.37 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.745 0.818 . . . . 74.31 110.91 -171.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.646 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 0.1 OUTLIER -104.82 111.92 24.84 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.68 1.192 . . . . 73.1 108.096 179.032 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.619 ' HB2' HG22 ' H' ' 6' ' ' ILE . 50.2 tp -98.45 126.22 43.91 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 122.759 0.423 . . . . 73.1 110.004 -178.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -141.25 125.72 17.7 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.78 0.832 . . . . 75.32 109.019 174.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.95 146.67 27.53 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.519 0.728 . . . . 73.22 110.418 -176.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.432 ' HA ' ' HG3' ' H' ' 12' ' ' PRO . 17.2 t70 -134.53 156.04 49.34 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.842 1.257 . . . . 71.55 108.159 171.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 46' ' ' THR . . . . . 0.4 HG22 ' HG2' ' H' ' 12' ' ' PRO . 5.9 t -127.8 151.4 49.08 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.48 0.657 . . . . 65.31 110.937 -178.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.81 152.62 36.82 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.302 -1.37 . . . . 32.42 107.302 168.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 77.6 p -172.75 153.41 2.71 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.831 0.452 . . . . 70.11 110.752 -175.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 37.2 p -169.48 159.11 8.32 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.069 0.948 . . . . 75.42 109.772 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -90.47 134.77 34.13 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.386 -0.598 . . . . 73.53 109.386 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.508 ' HB2' HG12 ' D' ' 55' ' ' VAL . 63.9 mt -99.68 -42.31 6.93 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.035 0.534 . . . . 71.3 110.7 -177.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.42 -168.94 2.73 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.334 0.653 . . . . 63.33 110.388 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.04 118.36 9.7 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.539 -0.541 . . . . 52.03 109.539 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 64.4 4.65 2.28 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.016 1.327 . . . . 74.4 112.779 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.508 HG12 ' HB2' ' D' ' 51' ' ' LEU . 79.3 t -110.67 129.27 66.12 Favored 'Isoleucine or valine' 0 C--N 1.351 0.638 0 C-N-CA 124.624 1.17 . . . . 71.31 108.6 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -145.37 172.9 12.51 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.691 -0.855 . . . . 65.13 108.691 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -132.29 145.48 51.31 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.097 -0.956 . . . . 75.12 110.12 174.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.459 HG21 ' HB3' ' D' ' 102' ' ' CYS . 15.1 m -129.32 142.12 44.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.204 1.002 . . . . 73.34 108.678 167.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.405 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 39.4 t -128.44 117.23 44.59 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 C-N-CA 124.322 1.049 . . . . 62.24 108.223 -175.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.571 HD22 ' HB2' ' D' ' 103' ' ' PRO . 60.9 tp -103.61 119.13 38.28 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.714 -0.476 . . . . 65.42 109.714 174.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -88.17 108.09 19.1 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.047 -0.723 . . . . 74.12 109.047 170.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 41.1 t -91.89 128.41 43.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.356 -1.35 . . . . 73.31 107.356 166.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.4 m -125.17 125.2 43.3 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.582 0.706 . . . . 54.14 110.807 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 48.2 t -115.59 100.76 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.034 1.734 . . . . 74.45 108.242 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.646 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 91.8 m -96.35 102.5 14.29 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.062 -1.088 . . . . 65.25 108.062 172.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.16 139.67 39.48 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.371 -0.831 . . . . 71.01 109.441 -170.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.428 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 61.3 p -147.53 126.32 12.66 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.054 0.454 . . . . 64.33 111.52 -173.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.444 HD12 HG22 ' D' ' 31' ' ' VAL . 51.4 mt -98.54 113.91 26.13 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.269 1.028 . . . . 75.02 108.479 175.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.73 -128.32 9.1 Favored Glycine 0 C--N 1.343 0.935 0 O-C-N 123.383 0.427 . . . . 72.42 113.04 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.03 18.95 20.98 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.043 0.537 . . . . 73.05 110.879 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 71' ' ' GLU . . . . . 0.403 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 11.7 pt-20 -140.32 167.41 22.2 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.261 0.624 . . . . 61.3 110.07 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 77.0 m -74.35 139.5 44.16 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.461 0.704 . . . . 71.33 110.551 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.601 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.94 -64.77 1.1 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 107.717 -1.216 . . . . 64.11 107.717 171.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -156.8 162.97 39.72 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 114.497 -1.229 . . . . 74.01 110.176 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 84.8 mt -121.44 112.27 18.33 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 124.728 1.211 . . . . 63.02 107.921 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -114.05 133.82 55.27 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.208 -1.034 . . . . 72.11 108.208 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -156.6 120.56 4.36 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.186 -0.672 . . . . 65.32 109.186 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 80.8 t -130.61 114.32 27.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.643 -0.873 . . . . 72.33 108.643 -176.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.619 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 37.5 mt-30 -88.94 87.71 7.32 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 108.489 -0.93 . . . . 73.52 108.489 170.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -80.03 104.51 10.64 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 113.745 -1.571 . . . . 74.42 108.167 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -101.98 150.98 18.38 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 111.236 -0.746 . . . . 54.34 111.236 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.31 131.13 3.94 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.738 -0.545 . . . . 63.22 111.738 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.9 mt -88.38 123.18 40.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 107.572 -1.27 . . . . 74.13 107.572 171.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -131.51 169.35 16.21 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.254 1.021 . . . . 45.14 108.942 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 25.5 m -112.65 136.03 52.68 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.058 0.943 . . . . 73.12 108.862 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.59 HG12 HD13 ' D' ' 89' ' ' ILE . 12.1 tt -145.79 137.57 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.352 -0.981 . . . . 72.54 108.352 176.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.09 127.4 1.83 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.502 0.321 . . . . 63.31 111.073 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.1 4.81 55.21 Favored Glycine 0 C--N 1.346 1.129 0 O-C-N 123.613 0.57 . . . . 74.03 113.228 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.59 HD13 HG12 ' D' ' 86' ' ' ILE . 3.3 mp -115.56 150.21 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.385 0.674 . . . . 65.54 110.208 -175.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.24 176.06 6.99 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.567 1.547 . . . . 60.33 109.004 173.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.89 -129.32 46.39 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 114.58 0.592 . . . . 75.34 114.58 175.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.8 m -71.56 -33.49 69.14 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.535 1.134 . . . . 51.34 112.225 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.664 ' HG3' ' HA ' ' D' ' 4' ' ' GLN . 50.0 tt0 -64.21 -30.37 71.44 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.823 0.849 . . . . 65.14 111.566 -177.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.623 ' HE1' ' HB2' ' H' ' 20' ' ' LYS . 48.0 mtm -62.18 -39.33 92.34 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.919 0.488 . . . . 73.12 111.473 174.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.99 -36.98 83.13 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.857 0.463 . . . . 75.4 112.08 -173.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.491 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 54.5 t-80 -81.21 -29.27 34.57 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.339 0.256 . . . . 74.53 111.576 177.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 34.5 t -70.75 -49.91 41.73 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.286 0.565 . . . . 75.11 110.832 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.768 HD13 ' HD2' ' H' ' 17' ' ' PRO . 29.4 mt -93.8 -45.0 7.85 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 124.464 1.105 . . . . 62.35 110.973 -166.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.33 -1.25 88.17 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-O 119.825 -0.431 . . . . 73.23 113.534 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -133.01 -68.46 0.59 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.475 0.637 . . . . 54.2 111.317 -178.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -70.82 -42.9 69.63 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 112.896 0.702 . . . . 70.42 112.896 -167.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.459 ' HB3' HG21 ' D' ' 58' ' ' VAL . 66.6 m -62.04 -50.29 81.29 Favored Pre-proline 0 CA--C 1.568 1.664 0 N-CA-C 112.881 0.697 . . . . 54.44 112.881 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.571 ' HB2' HD22 ' D' ' 60' ' ' LEU . 98.2 Cg_endo -77.52 -7.58 16.86 Favored 'Trans proline' 0 C--N 1.39 2.715 0 C-N-CA 122.267 1.978 . . . . 74.23 112.711 175.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -77.51 -30.57 52.99 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.765 -0.828 . . . . 61.33 108.765 171.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.1 mm -70.51 -38.22 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.518 0.727 . . . . 54.42 109.638 169.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.98 -11.35 59.58 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.488 0.715 . . . . 63.3 111.771 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 107' ' ' PHE . . . . . 0.432 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 86.5 t80 -65.97 -51.63 45.64 Favored Pre-proline 0 CA--C 1.567 1.634 0 C-N-CA 124.2 1.0 . . . . 73.12 112.605 -177.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 108' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 34.3 Cg_exo -60.64 -32.32 93.15 Favored 'Trans proline' 0 C--N 1.395 2.979 0 C-N-CA 122.128 1.885 . . . . 74.04 112.814 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -80.76 -32.07 35.67 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.865 0.866 . . . . 74.14 112.177 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.1 -46.37 81.35 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.804 -0.813 . . . . 64.05 108.804 173.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -62.23 -41.24 98.23 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 124.228 0.955 . . . . 71.42 110.839 177.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -51.68 -53.64 36.83 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.428 1.091 . . . . 65.11 111.131 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.1 t -67.74 -46.75 71.25 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.191 -0.913 . . . . 55.31 111.485 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.484 ' O ' HG23 ' D' ' 118' ' ' VAL . 84.7 mt -62.2 -57.58 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.474 0.71 . . . . 73.22 110.841 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 90.9 m -49.95 -45.75 51.61 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.32 1.013 . . . . 53.44 111.734 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.5 t -64.97 -43.31 93.05 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.083 -0.962 . . . . 73.22 110.955 -175.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.423 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 73.3 mtm -65.05 -36.35 84.07 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.79 0.436 . . . . 64.14 111.559 179.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.484 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.7 t -62.53 -44.67 99.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.789 0.835 . . . . 51.12 110.366 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.2 p -76.86 -26.25 54.03 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 116.08 -0.509 . . . . 51.54 111.38 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -72.98 -34.24 66.32 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.434 0.694 . . . . 70.5 109.892 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.35 3.17 79.12 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 115.582 -0.736 . . . . 43.23 112.393 171.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.0 p 60.39 24.38 13.92 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 126.866 2.067 . . . . 55.52 113.669 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -82.43 158.89 65.55 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 124.095 0.958 . . . . 75.41 109.585 169.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -49.64 127.49 18.73 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 123.369 2.713 . . . . 74.12 113.31 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -52.08 131.24 31.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.288 1.035 . . . . 72.32 111.27 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 45.8 tp -124.08 97.86 5.53 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.243 0.617 . . . . 74.32 110.15 -172.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -101.87 121.41 42.06 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.805 0.842 . . . . 73.12 109.664 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 tt -74.3 115.88 14.32 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 108.463 -0.94 . . . . 61.05 108.463 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.47 143.86 98.56 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.684 0.794 . . . . 61.15 111.644 -176.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.46 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 6.8 Cg_exo -70.48 121.88 8.39 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.696 2.264 . . . . 64.14 111.535 -177.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.5 m -115.24 154.14 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.008 0.923 . . . . 74.24 110.743 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -73.07 80.29 1.23 Allowed 'General case' 0 C--N 1.354 0.781 0 N-CA-C 108.536 -0.913 . . . . 75.54 108.536 173.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -57.22 -35.49 69.72 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.243 1.417 . . . . 54.21 110.626 -176.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.502 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 4.1 m-20 -62.48 -56.06 21.71 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.109 -1.405 . . . . 53.2 111.801 -177.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.59 -37.9 87.96 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.924 0.765 . . . . 64.11 111.911 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 79.6 mt -58.05 -47.44 83.14 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.347 1.029 . . . . 64.12 111.572 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -78.22 -30.3 48.78 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.058 0.543 . . . . 74.53 110.92 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 34.1 ttm -63.19 -27.99 69.74 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.33 1.052 . . . . 71.5 112.269 -174.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -63.35 -34.87 78.66 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.547 0.739 . . . . 64.3 111.475 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -60.31 -38.52 83.96 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.822 0.849 . . . . 72.41 110.746 175.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.41 -32.43 73.26 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.655 0.782 . . . . 73.45 111.128 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -84.84 -0.83 55.32 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.372 0.669 . . . . 64.34 112.112 -177.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -121.88 47.97 1.79 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.719 0.808 . . . . 53.41 109.769 -176.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -165.36 126.95 2.01 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.23 -0.441 . . . . 71.03 110.783 -175.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -113.56 100.32 8.41 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.917 0.887 . . . . 75.01 108.73 174.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.29 129.87 9.7 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.886 -0.486 . . . . 71.05 111.886 -176.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -107.51 103.5 12.84 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.372 1.069 . . . . 54.22 109.411 -175.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -98.25 59.27 0.98 Allowed Glycine 0 C--N 1.346 1.131 0 C-N-CA 122.753 0.216 . . . . 71.03 113.069 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 33.1 p -106.31 143.98 33.65 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.282 0.633 . . . . 72.34 109.975 175.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.01 134.27 52.3 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.355 0.662 . . . . 74.44 111.051 -178.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.93 -11.66 14.64 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.3 1.04 . . . . 73.45 109.645 177.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -131.99 100.45 5.07 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.564 1.146 . . . . 54.52 108.132 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.25 82.96 3.72 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.413 0.625 . . . . 70.44 110.146 173.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.07 125.33 26.59 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.592 -0.731 . . . . 71.25 109.341 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.148 0 O-C-N 124.271 0.982 . . . . 53.31 111.325 -176.15 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.019 -0.734 . . . . 74.45 109.019 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 2' ' ' LYS . . . . . 0.419 ' HG2' HG21 ' C' ' 10' ' ' THR . 47.2 mtmt 71.73 120.14 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 125.403 1.481 . . . . 64.43 110.833 -174.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 3' ' ' GLN . . . . . 0.552 ' HB3' HE22 ' C' ' 12' ' ' GLN . 5.3 tp60 -94.84 138.18 32.95 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.165 0.586 . . . . 73.21 110.099 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 35.7 p -67.11 103.64 1.24 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.883 0.873 . . . . 63.22 110.619 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 63.5 m -127.96 134.69 49.31 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.589 0.756 . . . . 71.53 110.153 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.511 HG21 ' H ' ' A' ' 40' ' ' VAL . 2.5 pp -57.93 143.79 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 124.295 1.038 . . . . 64.45 112.13 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -143.39 153.96 43.22 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.084 0.554 . . . . 52.11 110.776 -175.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.505 HD11 HD21 ' A' ' 44' ' ' LEU . 4.0 tt -79.61 133.65 36.43 Favored 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 108.659 -0.867 . . . . 54.54 108.659 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.14 174.89 9.51 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.481 0.712 . . . . 73.4 111.807 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 tt -76.94 134.25 38.97 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 107.931 -1.137 . . . . 70.24 107.931 175.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.63 110.21 3.77 Favored Pre-proline 0 N--CA 1.484 1.226 0 C-N-CA 123.862 0.865 . . . . 72.5 111.159 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.43 99.56 1.3 Allowed 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.418 2.079 . . . . 52.55 110.536 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 tt 64.81 85.69 0.14 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.024 1.33 . . . . 70.42 107.972 -169.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.11 152.15 44.26 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.555 -0.748 . . . . 73.2 110.31 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -61.59 137.0 58.22 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.588 0.755 . . . . 75.24 109.893 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 50.6 p -131.13 79.34 71.09 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.351 0.66 . . . . 70.13 112.019 -171.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 17' ' ' PRO . . . . . 0.546 ' HD2' HD13 ' A' ' 98' ' ' LEU . 73.0 Cg_endo -76.1 179.75 6.03 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.189 1.926 . . . . 65.01 111.908 165.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 18' ' ' VAL . . . . . 0.432 HG11 ' SD ' ' A' ' 94' ' ' MET . 38.0 t 55.86 88.95 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 125.014 1.326 . . . . 61.21 111.982 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m 68.25 9.86 7.48 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 124.468 1.107 . . . . 75.45 112.199 172.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp 56.36 69.75 0.71 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.801 -0.814 . . . . 74.12 108.801 -166.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.95 -31.42 50.5 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.892 0.877 . . . . 52.52 112.914 -172.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -134.04 149.67 51.18 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.465 0.706 . . . . 72.41 109.992 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 23' ' ' THR . . . . . 0.405 HG21 ' HB3' ' C' ' 152' ' ' HIS . 12.5 p -140.92 153.86 67.87 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 124.496 1.118 . . . . 70.54 109.431 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -47.36 115.36 1.34 Allowed 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.74 2.96 . . . . 63.55 114.244 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 CA--C 1.553 1.062 0 C-N-CA 125.379 1.471 . . . . 72.15 109.742 -174.688 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 78.0 mtp . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.082 -0.71 . . . . 51.45 109.082 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' F' F ' 2' ' ' LYS . . . . . 0.447 ' HG2' ' HB2' ' B' ' 39' ' ' GLU . 0.5 OUTLIER -87.69 69.15 9.62 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.557 0.743 . . . . 75.45 109.652 -179.491 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -94.82 63.72 2.82 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.151 -0.931 . . . . 73.14 109.111 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 41.0 m -122.63 124.89 44.5 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.76 0.824 . . . . 74.32 109.013 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 15.2 p -68.24 137.14 54.54 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.299 0.64 . . . . 74.52 110.668 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.6 HG12 ' HB ' ' B' ' 40' ' ' VAL . 4.2 mp -104.74 128.03 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.329 1.051 . . . . 62.43 108.995 -175.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 7' ' ' ALA . . . . . 0.416 ' HB1' ' HB ' ' B' ' 131' ' ' VAL . . . -101.36 -102.45 0.26 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.886 -1.153 . . . . 62.55 107.886 170.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 8' ' ' LEU . . . . . 0.532 ' HA ' HD22 ' B' ' 42' ' ' LEU . 4.5 tt -165.87 -85.02 0.02 OUTLIER 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.77 -1.196 . . . . 71.53 107.77 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . 167.7 170.17 0.03 OUTLIER 'General case' 0 C--O 1.243 0.748 0 C-N-CA 125.973 1.709 . . . . 61.34 108.311 -173.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 10' ' ' LEU . . . . . 0.412 ' HA ' HD13 ' B' ' 136' ' ' LEU . 5.3 tt -80.63 102.18 9.67 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.029 -1.471 . . . . 73.4 107.029 170.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 60.9 mt -61.92 137.19 95.34 Favored Pre-proline 0 CA--C 1.549 0.914 0 O-C-N 123.5 0.5 . . . . 61.1 110.508 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.3 -158.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.8 2.333 . . . . 54.55 111.522 175.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tt -80.8 84.57 6.29 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 107.251 -1.389 . . . . 75.12 107.251 173.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 14' ' ' LEU . . . . . 0.592 ' HG ' ' HD1' ' F' ' 15' ' ' PHE . 2.4 pt? -105.65 178.14 4.65 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.854 0.862 . . . . 74.04 109.48 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 15' ' ' PHE . . . . . 0.592 ' HD1' ' HG ' ' F' ' 14' ' ' LEU . 43.0 m-85 69.13 116.49 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.754 1.222 . . . . 74.23 110.134 -170.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 25.2 p -63.91 128.32 92.77 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 123.2 0.6 . . . . 63.54 111.156 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -58.49 140.76 95.93 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.593 2.862 . . . . 72.43 113.786 -175.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 18' ' ' VAL . . . . . 0.668 HG23 HD11 ' B' ' 98' ' ' LEU . 17.1 t -73.39 127.47 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.198 0.599 . . . . 65.12 109.77 -178.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 19.0 m -70.87 -26.53 63.29 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.547 0.739 . . . . 73.32 111.486 -178.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -136.78 84.8 2.09 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.522 0.677 . . . . 63.23 109.702 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 21' ' ' ALA . . . . . 0.476 ' HB2' ' HB ' ' F' ' 18' ' ' VAL . . . -116.27 9.12 14.45 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 114.43 -1.259 . . . . 70.2 110.455 172.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -74.0 147.05 43.32 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.254 0.622 . . . . 65.25 109.817 173.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 23' ' ' THR . . . . . 0.657 ' HB ' ' HA2' ' B' ' 88' ' ' GLY . 5.9 t -63.85 136.77 96.87 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 122.757 0.423 . . . . 72.52 111.315 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.84 1.72 7.33 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.177 2.585 . . . . 53.03 113.347 176.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 . . . . . 0 CA--C 1.555 1.137 0 C-N-CA 124.418 1.087 . . . . 73.11 109.114 -179.219 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 83.0 mtp . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.546 0.212 . . . . 64.25 110.598 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -75.15 121.01 21.43 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.495 -1.298 . . . . 75.33 107.495 167.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -70.17 96.85 1.13 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 109.208 -0.664 . . . . 63.44 109.208 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 49.6 m -71.1 77.7 0.68 Allowed 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.266 1.026 . . . . 51.54 109.997 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 18.1 m -138.69 139.38 38.41 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.004 -0.998 . . . . 45.15 108.392 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 6' ' ' ILE . . . . . 0.478 HG21 ' O ' ' C' ' 40' ' ' VAL . 1.5 pp -84.84 167.22 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.753 0.821 . . . . 72.33 112.153 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -165.77 -175.74 3.58 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.932 -1.031 . . . . 73.43 109.797 -175.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 8' ' ' LEU . . . . . 0.508 HD13 HD22 ' C' ' 44' ' ' LEU . 97.0 mt -104.74 164.67 11.6 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.738 0.815 . . . . 65.12 110.277 174.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.03 -173.97 4.28 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.772 0.829 . . . . 63.32 111.038 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 10.6 mp -83.83 63.68 7.64 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.308 0.643 . . . . 70.32 110.209 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 11' ' ' LEU . . . . . 0.614 HD23 HD13 ' G' ' 14' ' ' LEU . 13.7 tp 38.71 78.09 0.38 Allowed Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 126.201 1.8 . . . . 54.32 113.185 -177.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.49 2.69 7.51 Favored 'Trans proline' 0 C--N 1.367 1.515 0 C-N-CA 122.323 2.016 . . . . 64.33 112.438 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -137.96 92.09 2.64 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 107.654 -1.239 . . . . 33.31 107.654 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 14' ' ' LEU . . . . . 0.614 HD13 HD23 ' G' ' 11' ' ' LEU . 3.7 mm? -72.12 -172.1 0.84 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.263 1.025 . . . . 62.3 110.313 176.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 15' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' C' ' 98' ' ' LEU . 46.6 p90 -154.19 -178.95 7.46 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 120.842 0.354 . . . . 71.54 111.479 174.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 12.4 m -60.01 142.3 89.24 Favored Pre-proline 0 CA--C 1.567 1.614 0 C-N-CA 125.832 1.653 . . . . 73.01 111.996 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 17' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.25 172.58 15.75 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.683 2.256 . . . . 54.02 113.11 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 18' ' ' VAL . . . . . 0.572 HG13 ' HB2' ' C' ' 56' ' ' TYR . 93.8 t -63.86 -67.01 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.824 0.85 . . . . 73.0 111.045 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 85.9 m -119.5 -45.63 2.51 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.056 -0.975 . . . . 55.24 108.851 177.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -165.69 141.06 4.97 Favored 'General case' 0 C--N 1.357 0.908 0 CA-C-N 116.345 -0.389 . . . . 73.4 111.542 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . -165.34 -162.25 0.58 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.401 1.08 . . . . 53.34 109.362 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -82.43 -25.62 33.48 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.384 0.674 . . . . 73.55 111.223 -175.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 23' ' ' THR . . . . . 0.418 HG23 ' HB3' ' A' ' 150' ' ' GLU . 11.0 p -65.68 137.87 96.45 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 122.955 0.502 . . . . 74.12 109.894 173.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.36 143.95 60.06 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.409 2.073 . . . . 51.21 112.518 -174.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 . . . . . 0 CA--C 1.553 1.077 0 C-N-CA 124.349 1.06 . . . . 74.31 109.939 178.18 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mpp? . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 109.526 -0.546 . . . . 74.03 109.526 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -94.08 106.12 18.1 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.838 0.828 . . . . 53.04 109.587 172.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -76.39 97.39 4.25 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.776 -0.824 . . . . 72.32 108.776 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 49.9 m -86.57 -165.51 1.29 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.608 0.763 . . . . 73.02 111.174 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 11.3 m -65.29 163.37 15.55 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 124.272 1.029 . . . . 63.12 111.116 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.619 HG22 ' HB2' ' D' ' 42' ' ' LEU . 29.4 pt -59.23 134.24 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 C-N-CA 123.274 0.63 . . . . 74.02 111.405 175.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.49 -45.63 0.17 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.238 1.015 . . . . 74.25 109.501 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 77.54 91.23 0.07 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.671 1.589 . . . . 72.21 109.337 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.73 134.46 28.56 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.532 1.133 . . . . 63.41 109.245 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 47.4 mt 64.31 106.37 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.383 1.052 . . . . 74.35 111.559 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.441 HD13 ' CD2' ' H' ' 15' ' ' PHE . 95.3 mt -79.21 151.83 75.83 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.097 0.559 . . . . 73.13 110.805 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 12' ' ' PRO . . . . . 0.432 ' HG3' ' HA ' ' D' ' 45' ' ' ASP . 33.5 Cg_endo -60.4 93.4 0.1 OUTLIER 'Trans proline' 0 C--N 1.386 2.544 0 C-N-CA 122.942 2.428 . . . . 75.45 112.287 -175.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 13' ' ' LEU . . . . . 0.652 ' HG ' ' HG ' ' H' ' 14' ' ' LEU . 44.2 tp 65.73 -84.0 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.802 1.641 . . . . 73.35 111.849 177.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 14' ' ' LEU . . . . . 0.652 ' HG ' ' HG ' ' H' ' 13' ' ' LEU . 97.5 mt -124.91 130.52 52.52 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.797 0.839 . . . . 74.14 110.766 -173.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 15' ' ' PHE . . . . . 0.441 ' CD2' HD13 ' H' ' 11' ' ' LEU . 6.4 t80 -125.81 79.67 1.84 Allowed 'General case' 0 C--O 1.24 0.591 0 N-CA-C 106.259 -1.756 . . . . 73.25 106.259 172.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 16' ' ' THR . . . . . 0.526 HG23 HD12 ' D' ' 98' ' ' LEU . 87.1 m -157.88 112.86 1.79 Allowed Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.332 0.653 . . . . 63.32 109.61 -170.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 17' ' ' PRO . . . . . 0.768 ' HD2' HD13 ' D' ' 98' ' ' LEU . 33.8 Cg_endo -96.09 -118.7 0.0 OUTLIER 'Trans proline' 0 CA--C 1.568 2.211 0 C-N-CA 123.29 2.66 . . . . 72.32 111.302 161.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 18' ' ' VAL . . . . . 0.561 HG22 HG21 ' D' ' 86' ' ' ILE . 47.1 t 72.33 -73.69 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.377 1.767 0 C-N-CA 125.782 1.633 . . . . 64.22 111.045 174.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 19' ' ' THR . . . . . 0.583 HG23 ' HG3' ' H' ' 20' ' ' LYS . 8.8 t -162.75 -41.36 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.559 0.577 . . . . 55.42 112.559 177.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 20' ' ' LYS . . . . . 0.623 ' HB2' ' HE1' ' D' ' 94' ' ' MET . 92.9 mttt -116.97 120.24 37.79 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.449 -0.574 . . . . 74.43 109.449 -174.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -173.7 -63.86 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.384 0.674 . . . . 75.21 110.231 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.56 130.68 42.58 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.987 0.915 . . . . 75.0 109.261 -176.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 35.5 p -62.66 121.62 68.91 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 124.561 1.144 . . . . 65.4 110.756 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.74 -67.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.989 2.459 . . . . 44.52 112.795 -177.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 C--O 1.247 0.926 0 C-N-CA 123.279 0.632 . . . . 70.11 109.521 -177.971 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.5 ttm . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.329 -0.619 . . . . 72.31 109.329 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.662 ' HB3' ' SD ' ' A' ' 138' ' ' MET . 25.6 t -166.08 25.01 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.582 1.153 . . . . 72.52 108.849 174.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -82.4 -175.29 5.63 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.493 1.117 . . . . 71.42 111.075 -177.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -87.68 41.64 1.0 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.964 0.906 . . . . 71.12 111.35 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 67.7 19.97 9.61 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.037 1.335 . . . . 55.01 112.082 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -141.0 156.07 46.1 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.995 -0.743 . . . . 75.35 108.995 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.7 p -88.05 94.36 9.77 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.714 0.406 . . . . 65.33 110.437 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.522 ' HB3' HD13 ' A' ' 89' ' ' ILE . 3.0 mp0 -76.85 168.14 20.61 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.697 0.799 . . . . 74.51 110.753 171.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.651 ' HE1' HG23 ' A' ' 86' ' ' ILE . 15.0 tpt 77.88 156.8 0.17 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.037 1.335 . . . . 65.05 112.854 169.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.0 m -138.94 101.97 4.43 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 106.727 -1.582 . . . . 73.41 106.727 173.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.535 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 41.2 t80 -132.87 139.63 47.52 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.907 0.883 . . . . 63.22 110.808 -166.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -158.43 116.39 2.96 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.697 0.623 . . . . 74.21 109.872 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.617 HG12 ' HD2' ' A' ' 84' ' ' PHE . 57.7 mt -72.6 114.71 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 109.416 -0.587 . . . . 73.13 109.416 177.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -82.76 -34.58 27.07 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.003 -0.998 . . . . 72.02 109.921 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -173.18 149.34 1.79 Allowed 'General case' 0 C--N 1.36 1.031 0 O-C-N 123.714 0.634 . . . . 75.31 110.679 -171.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.567 HD12 ' HG3' ' C' ' 130' ' ' PRO . 75.0 mt -141.52 134.6 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 124.23 1.012 . . . . 62.4 108.332 174.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.48 ' HB3' HG23 ' B' ' 122' ' ' THR . 32.9 p90 -167.32 176.85 6.42 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.983 0.897 . . . . 74.52 110.97 -173.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.1 p -101.54 116.86 33.72 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.737 -1.209 . . . . 63.02 107.737 174.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 42.8 mtpt -75.78 -41.95 51.52 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.733 0.777 . . . . 72.3 109.002 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 15.9 t70 -135.73 143.35 45.29 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 113.731 -1.577 . . . . 64.24 109.72 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 92.6 mt -138.62 143.66 31.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 125.743 1.617 . . . . 73.34 106.962 176.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -153.46 138.57 17.36 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.477 -0.564 . . . . 71.13 109.477 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.457 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 93.9 t80 -143.29 120.57 11.56 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 106.852 -1.536 . . . . 74.44 106.852 176.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -120.53 148.78 43.39 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.241 -0.652 . . . . 73.21 109.241 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.87 80.27 14.02 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 106.359 -1.719 . . . . 51.03 106.359 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.3 -50.26 12.61 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 123.364 2.709 . . . . 72.34 112.841 -169.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.77 33.84 3.58 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 114.867 -1.06 . . . . 61.23 108.614 -176.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.445 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -47.65 -53.09 33.24 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 113.467 0.914 . . . . 73.25 113.467 -176.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.48 -15.41 45.15 Favored 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 121.536 1.491 . . . . 73.33 112.847 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -97.93 -31.14 12.34 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.259 1.023 . . . . 63.15 110.413 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.862 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.5 p -77.42 -16.78 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.351 0.66 . . . . 51.32 112.27 -164.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -77.76 1.1 21.17 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 122.901 0.48 . . . . 74.15 111.27 174.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -89.9 -24.66 21.29 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.665 1.186 . . . . 64.22 110.568 168.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 71' ' ' GLU . 30.8 mmmt -66.85 165.5 15.18 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.422 1.089 . . . . 52.14 112.513 -176.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -84.49 138.14 32.95 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 108.011 -1.107 . . . . 62.11 108.011 167.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 26.8 t-105 -72.62 89.37 1.31 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.902 -1.147 . . . . 73.1 107.902 173.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.475 ' H ' HD22 ' A' ' 68' ' ' LEU . 35.3 tt0 -131.1 65.35 76.46 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 125.539 1.536 . . . . 74.02 107.115 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.12 120.82 4.24 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.363 2.042 . . . . 71.55 111.996 -168.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -96.11 99.58 11.31 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.4 -1.333 . . . . 64.3 107.4 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.1 m -74.81 120.9 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-N 114.793 -1.094 . . . . 64.32 111.219 -172.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.537 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 39.7 ttmt -118.24 114.13 22.54 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.032 -1.099 . . . . 72.45 108.032 173.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.527 HD22 HG13 ' E' ' 6' ' ' ILE . 2.4 pt? -114.81 131.96 56.64 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.796 -0.816 . . . . 75.23 108.796 173.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -126.37 135.07 51.0 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.33 1.052 . . . . 70.14 108.418 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -113.38 122.75 48.31 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.284 -0.636 . . . . 73.35 109.284 -175.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.626 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 16.6 t70 -119.65 124.17 45.65 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.313 1.045 . . . . 61.01 108.221 177.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.1 p -106.74 125.96 51.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.254 0.621 . . . . 64.22 110.041 -174.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.46 152.42 50.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.03 0.932 . . . . 70.23 109.514 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.9 p -131.37 165.05 24.32 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.383 0.673 . . . . 71.42 110.359 -177.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.7 t -163.51 121.33 1.89 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.805 -0.634 . . . . 63.45 109.653 175.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -82.33 120.03 24.89 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.413 -1.328 . . . . 74.55 107.413 166.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.645 HD11 ' HB2' ' A' ' 57' ' ' GLU . 24.4 mt -93.13 -40.19 10.63 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.754 -0.832 . . . . 73.44 108.754 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.86 -175.66 4.52 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.813 1.245 . . . . 72.34 109.574 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.1 123.12 20.21 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.061 -0.718 . . . . 75.22 109.061 173.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 69.88 -4.71 1.4 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.943 1.297 . . . . 54.42 112.696 -176.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.4 t -109.68 108.93 26.6 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 N-CA-C 108.05 -1.092 . . . . 62.35 108.05 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -130.07 157.63 41.84 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.352 -0.61 . . . . 73.11 109.352 -173.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.645 ' HB2' HD11 ' A' ' 51' ' ' LEU . 38.9 tt0 -130.59 135.54 47.99 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.067 0.947 . . . . 74.24 108.898 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.6 m -121.85 136.16 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 108.041 -1.096 . . . . 51.11 108.041 165.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.4 t -122.71 127.54 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.05 0.94 . . . . 60.34 109.238 -174.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 tt -117.25 107.41 14.39 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.603 -0.888 . . . . 73.24 108.603 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.626 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 10.9 ttm180 -84.88 104.39 14.79 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.284 1.034 . . . . 53.31 109.715 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 37.3 t -96.01 103.28 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 108.598 -0.89 . . . . 75.54 108.598 174.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.9 m -97.04 108.47 21.21 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.62 0.768 . . . . 73.41 109.852 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.763 HG11 HD21 ' A' ' 126' ' ' LEU . 42.1 t -103.04 139.11 24.85 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 C-N-CA 123.974 0.909 . . . . 71.15 110.588 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 25.5 m -132.14 141.05 48.99 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.898 0.879 . . . . 74.52 108.693 175.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.04 109.66 14.37 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.861 -0.792 . . . . 72.22 108.861 174.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.9 m -108.87 127.37 53.98 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.407 0.683 . . . . 75.45 109.282 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.475 HD22 ' H ' ' A' ' 37' ' ' GLN . 15.8 mt -99.7 78.37 2.14 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.874 -1.158 . . . . 74.13 107.874 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.69 -83.39 1.14 Allowed Glycine 0 C--N 1.349 1.264 0 N-CA-C 111.502 -0.639 . . . . 61.2 111.502 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -119.98 -28.96 5.05 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.737 0.815 . . . . 72.32 111.315 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.404 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 35.7 tt0 -99.95 128.79 46.0 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.633 -0.667 . . . . 71.45 110.589 -174.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.0 m -69.66 131.36 44.48 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.85 0.86 . . . . 45.2 110.902 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.862 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -74.22 -63.2 1.28 Allowed 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.514 -0.921 . . . . 73.33 108.514 168.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -155.47 163.14 40.43 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.402 -1.272 . . . . 74.23 111.322 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.2 tp -119.02 146.0 45.4 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 113.824 -1.534 . . . . 71.22 107.522 167.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.9 m -138.89 134.37 33.16 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.836 -1.172 . . . . 62.0 107.836 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -148.16 116.39 6.51 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.171 -0.678 . . . . 64.22 109.171 174.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.8 t -124.74 126.34 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 123.733 0.813 . . . . 63.02 109.051 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.414 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 64.0 mt-30 -101.48 89.05 3.6 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.227 -1.027 . . . . 73.14 108.227 172.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.42 ' HG3' HD22 ' A' ' 106' ' ' LEU . 66.5 tp60 -76.81 98.25 4.77 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.615 -1.175 . . . . 72.03 108.48 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.51 142.95 16.36 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 111.338 -0.705 . . . . 75.52 111.338 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.428 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -140.85 126.21 3.05 Favored Glycine 0 CA--C 1.502 -0.733 0 N-CA-C 110.815 -0.914 . . . . 72.34 110.815 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.2 mt -82.47 119.01 31.18 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 108.321 -0.992 . . . . 65.23 108.321 173.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.617 ' HD2' HG12 ' A' ' 13' ' ' ILE . 24.2 m-85 -131.04 130.22 43.0 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.533 -0.914 . . . . 74.42 108.533 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 43.9 t -76.2 108.03 8.85 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.513 -0.921 . . . . 55.31 108.513 172.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.651 HG23 ' HE1' ' A' ' 9' ' ' MET . 71.7 mt -116.22 119.41 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.287 0.635 . . . . 73.12 110.332 -173.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.77 -172.12 1.54 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.935 0.894 . . . . 40.24 110.398 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.43 -49.96 0.86 Allowed Glycine 0 C--N 1.349 1.27 0 CA-C-N 116.497 -0.319 . . . . 61.2 113.121 172.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 93' ' ' GLN . 10.1 pt -133.03 -179.79 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.827 0.851 . . . . 71.24 111.266 -170.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -143.89 -179.29 6.38 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.122 0.969 . . . . 72.11 109.77 -174.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.88 -142.2 44.78 Favored Glycine 0 C--N 1.347 1.141 0 C-N-CA 123.572 0.606 . . . . 75.12 113.389 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.56 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 19.4 p -74.28 -15.86 60.96 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.661 0.784 . . . . 74.25 112.008 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.539 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.1 mp0 -66.77 -48.84 67.82 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 109.488 -0.56 . . . . 75.22 109.488 176.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 42.6 ttp -77.83 -31.82 51.86 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 116.063 -0.517 . . . . 73.04 110.438 178.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.56 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -65.23 -24.62 67.39 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.984 0.514 . . . . 62.35 111.246 176.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.494 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 22.3 t-80 -68.4 -35.15 77.25 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.573 0.749 . . . . 73.4 110.674 172.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.3 t -74.96 -52.11 11.99 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.244 -0.285 . . . . 74.42 110.735 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.421 ' HG ' ' HA ' ' A' ' 95' ' ' ALA . 4.6 pp -76.34 -20.6 57.08 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.353 0.501 . . . . 64.31 112.353 -175.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.46 2.99 20.24 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 114.971 0.749 . . . . 75.22 114.971 -173.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.583 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -142.24 -52.96 0.41 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 118.031 0.915 . . . . 64.23 111.946 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.52 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 79.4 t80 -78.36 -68.18 0.67 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 122.895 0.478 . . . . 50.43 111.776 -172.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.46 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 76.8 m -63.94 -34.09 11.27 Favored Pre-proline 0 CA--C 1.567 1.632 0 N-CA-C 114.534 1.309 . . . . 63.42 114.534 -173.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.516 ' HB3' ' HE2' ' E' ' 15' ' ' PHE . 22.6 Cg_endo -62.25 -33.31 81.38 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 121.834 1.689 . . . . 51.51 112.902 167.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.469 ' ND2' ' HA ' ' A' ' 132' ' ' ASN . 15.7 t-20 -80.18 -17.59 52.0 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.635 0.374 . . . . 73.55 110.921 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.7 mm -65.82 -39.38 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 108.92 -0.77 . . . . 75.04 108.92 168.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.428 HD21 ' HA3' ' A' ' 82' ' ' GLY . 91.6 mt -77.15 -19.97 56.14 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.704 0.802 . . . . 61.12 112.205 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -61.24 -49.31 88.65 Favored Pre-proline 0 CA--C 1.571 1.781 0 N-CA-C 113.954 1.094 . . . . 75.11 113.954 -172.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -63.76 -38.42 39.87 Favored 'Trans proline' 0 C--N 1.391 2.81 0 C-N-CA 122.071 1.847 . . . . 61.44 112.654 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -68.48 -35.56 77.7 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.782 -0.645 . . . . 74.51 110.876 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.88 -42.98 76.25 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.238 0.615 . . . . 72.24 110.489 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.538 ' NH1' HD12 ' C' ' 105' ' ' ILE . 37.6 ttm180 -54.6 -53.82 49.59 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 124.164 0.915 . . . . 74.24 109.936 174.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -66.68 -39.38 88.1 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.366 1.042 . . . . 75.2 111.821 -171.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.79 -42.04 92.53 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.539 0.524 . . . . 72.24 110.287 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.414 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.2 mt -67.09 -47.5 81.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 115.281 -0.872 . . . . 74.03 110.165 175.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.9 m -56.06 -41.74 75.55 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.742 0.817 . . . . 75.23 111.358 -177.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.2 t -69.6 -45.01 69.57 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.198 -0.91 . . . . 74.22 110.766 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.459 ' SD ' HG23 ' A' ' 21' ' ' ILE . 9.2 mtp -58.51 -44.62 89.53 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.636 0.774 . . . . 75.43 111.238 177.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 114' ' ' ILE . 77.8 t -64.32 -42.89 96.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 114.774 -1.103 . . . . 74.34 110.766 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.3 t -72.22 -32.87 67.14 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.855 -0.612 . . . . 73.43 111.071 -176.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.465 HH12 ' HG3' ' B' ' 112' ' ' GLU . 81.4 mtt-85 -72.57 -29.42 63.52 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.534 0.734 . . . . 62.35 109.322 175.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.454 ' O ' HG22 ' A' ' 122' ' ' THR . . . -83.38 10.0 60.03 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-N 115.307 -0.861 . . . . 74.41 113.222 173.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.5 t 64.09 12.7 7.2 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 126.928 2.091 . . . . 54.23 113.628 173.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -84.72 150.98 57.51 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 109.119 -0.697 . . . . 74.3 109.119 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.53 141.58 41.89 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.211 2.607 . . . . 62.32 112.855 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -53.93 132.31 41.83 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 124.035 0.834 . . . . 74.5 112.162 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.763 HD21 HG11 ' A' ' 64' ' ' VAL . 60.2 tp -123.79 102.43 7.81 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.781 -1.1 . . . . 73.02 110.176 -171.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -111.01 126.35 54.7 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.111 0.965 . . . . 63.02 109.145 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 129' ' ' ALA . 3.5 tt -67.55 143.52 56.08 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 108.155 -1.054 . . . . 75.01 108.155 172.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' E' ' 7' ' ' ALA . . . -56.81 140.42 76.04 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 123.678 0.791 . . . . 71.12 111.407 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.405 ' HA ' HH22 ' A' ' 111' ' ' ARG . 37.0 Cg_endo -65.12 95.35 0.25 Allowed 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.824 2.349 . . . . 73.22 113.015 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.31 112.49 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.156 -0.929 . . . . 74.21 109.318 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.469 ' HA ' ' ND2' ' A' ' 104' ' ' ASN . 27.5 t-20 -100.97 100.27 10.86 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.556 -1.276 . . . . 74.3 107.556 170.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.498 ' HE1' HD22 ' E' ' 8' ' ' LEU . 43.2 m-85 -55.79 -47.56 76.87 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.613 0.765 . . . . 61.43 110.917 -175.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.583 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 10.3 t70 -55.16 -37.61 67.23 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.972 -1.467 . . . . 75.44 112.748 -173.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 139' ' ' ASN . . . -61.94 -46.29 89.97 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.862 0.726 . . . . 43.35 111.28 -177.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.97 -35.43 69.52 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.271 0.628 . . . . 63.44 111.034 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -67.6 -52.4 38.98 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 119.184 -0.436 . . . . 74.4 110.889 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.662 ' SD ' ' HB3' ' A' ' 2' ' ' SER . 0.2 OUTLIER -60.93 -36.52 79.54 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 122.925 0.49 . . . . 72.52 111.426 178.33 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 135' ' ' ALA . 50.7 t-20 -54.01 -54.8 34.17 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.659 1.224 . . . . 72.24 110.891 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -84.82 -29.68 25.16 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 116.368 -0.378 . . . . 62.03 111.611 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 64.2 tp -66.95 -49.56 65.07 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.562 0.745 . . . . 51.21 111.817 -175.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -147.91 -1.39 0.58 Allowed 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 119.524 -0.274 . . . . 72.33 111.693 -170.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 73.68 127.63 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.007 1.323 . . . . 65.31 111.201 -173.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.9 102.58 0.28 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.551 1.14 . . . . 64.24 109.772 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.55 84.49 2.44 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.64 0.776 . . . . 75.51 110.955 -176.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -104.18 146.59 16.31 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 111.246 -0.742 . . . . 62.42 111.246 174.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -135.12 162.88 31.24 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.302 0.641 . . . . 71.05 110.579 -176.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.02 165.69 53.85 Favored Glycine 0 C--N 1.356 1.678 0 O-C-N 123.4 0.438 . . . . 42.02 113.533 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.8 t -103.65 153.23 20.86 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.983 0.913 . . . . 72.34 110.717 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -170.98 -156.62 0.12 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.854 1.262 . . . . 43.35 109.066 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 82.35 -57.34 0.21 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.473 1.509 . . . . 73.11 111.809 177.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 18.3 t60 58.77 68.19 0.85 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.055 0.942 . . . . 63.03 110.219 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -73.66 92.66 1.98 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.012 -0.995 . . . . 71.2 109.716 176.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -148.63 145.04 27.59 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.356 -0.838 . . . . 73.45 109.123 -173.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.23 0 C-N-CA 124.11 0.964 . . . . 61.33 110.482 -177.3 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 55.7 ttp . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 109.377 -0.601 . . . . 70.03 109.377 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 45.4 t -87.05 141.86 28.35 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.931 -1.137 . . . . 61.24 107.931 169.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -80.36 68.64 6.6 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.996 0.903 . . . . 72.33 109.113 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -137.65 142.91 41.16 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.238 1.415 . . . . 72.42 108.953 -176.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -118.01 41.82 2.81 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.182 0.993 . . . . 73.41 109.16 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -61.97 102.96 0.32 Allowed 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.302 -0.863 . . . . 73.04 110.232 -176.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 70.4 p -67.7 -17.19 64.49 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.848 0.859 . . . . 74.42 111.539 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.73 -54.6 25.05 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 123.599 0.76 . . . . 61.13 109.813 170.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 1.6 tmt? 64.41 164.92 0.14 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 125.228 1.411 . . . . 72.15 111.644 -174.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 92.7 m -162.34 138.48 7.6 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.334 1.053 . . . . 72.43 108.895 172.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' B' ' 85' ' ' SER . 0.2 OUTLIER -136.35 154.67 50.77 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.45 0.643 . . . . 72.04 109.598 157.283 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -127.71 140.86 51.8 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 114.687 -1.142 . . . . 74.44 108.239 169.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.57 HD11 HD13 ' B' ' 105' ' ' ILE . 46.7 mt -72.13 119.76 19.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 O-C-N 124.143 0.902 . . . . 70.3 108.739 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -88.54 -49.87 6.64 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.637 0.775 . . . . 71.02 109.302 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.417 ' HE ' HG21 ' A' ' 122' ' ' THR . 48.2 ttt180 -163.38 132.8 4.1 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.952 -0.567 . . . . 75.12 110.488 -176.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 94.6 mt -114.23 136.04 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 107.595 -1.261 . . . . 64.24 107.595 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -164.62 146.21 8.21 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.553 0.692 . . . . 75.1 112.432 -175.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 35.3 m -73.45 121.4 20.48 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.16 -1.382 . . . . 53.41 109.27 171.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.447 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 41.2 mtpt -98.32 -27.73 13.99 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.953 0.901 . . . . 65.12 111.393 -176.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 34.9 t70 -158.39 138.03 11.95 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.458 0.473 . . . . 75.4 110.531 -168.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.425 HD11 ' SG ' ' B' ' 113' ' ' CYS . 45.3 mm -142.07 143.16 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.919 1.288 . . . . 74.04 108.976 -177.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 10.2 m -144.57 128.44 17.37 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.313 1.445 . . . . 73.53 107.665 170.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.495 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.2 t80 -133.9 109.56 9.13 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.373 -1.714 . . . . 71.53 106.373 166.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -122.39 110.66 15.91 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.807 -0.812 . . . . 65.43 108.807 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.484 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -107.55 87.28 3.32 Favored Pre-proline 0 C--O 1.241 0.624 0 N-CA-C 107.575 -1.268 . . . . 74.21 107.575 174.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -64.97 -34.67 46.86 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.719 2.279 . . . . 60.21 112.216 -170.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -102.25 6.04 40.37 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 117.645 -1.169 . . . . 71.02 112.06 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.484 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -28.66 -66.71 0.12 Allowed Pre-proline 0 N--CA 1.511 2.618 0 N-CA-C 114.785 1.402 . . . . 71.23 114.785 -168.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.432 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 28.2 Cg_endo -63.53 -29.77 70.86 Favored 'Trans proline' 0 C--N 1.398 3.134 0 C-N-CA 122.098 1.865 . . . . 73.24 112.879 -172.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.437 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 63.1 m80 -86.78 -36.31 18.65 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.464 -0.789 . . . . 72.1 112.02 -176.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.667 HG22 HD12 ' B' ' 68' ' ' LEU . 8.5 p -74.77 -16.59 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 C-N-CA 122.903 0.481 . . . . 51.02 111.883 -171.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -62.22 -21.2 64.95 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.422 0.689 . . . . 70.13 112.712 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.458 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.7 pt20 -56.53 -32.0 64.67 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.491 0.716 . . . . 73.21 110.919 174.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.458 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 99.2 mttt -91.28 69.44 6.04 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.476 1.11 . . . . 72.2 109.159 177.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -83.0 89.02 6.85 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.244 0.545 . . . . 72.15 110.95 -174.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 28.2 p90 -156.06 175.44 13.96 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.211 1.004 . . . . 74.4 108.406 169.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -71.87 109.05 4.85 Favored Pre-proline 0 CA--C 1.554 1.106 0 N-CA-C 109.601 -0.518 . . . . 61.45 109.601 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.62 149.12 79.23 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.6 2.2 . . . . 70.24 113.143 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.71 106.59 1.53 Allowed 'General case' 0 C--N 1.352 0.701 0 N-CA-C 108.367 -0.975 . . . . 74.43 108.367 174.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -96.52 137.71 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-O 121.742 0.782 . . . . 70.4 111.362 -175.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.478 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 79.0 tttt -109.03 145.81 34.96 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.015 1.326 . . . . 44.53 108.139 168.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.481 HD22 HD23 ' F' ' 8' ' ' LEU . 1.2 pp -127.83 163.14 25.05 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.844 0.458 . . . . 75.52 110.21 170.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.54 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 32.2 t70 -157.14 154.79 29.92 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.606 0.762 . . . . 63.33 109.247 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -130.94 129.28 41.97 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.251 0.62 . . . . 74.33 109.595 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -124.81 155.69 38.99 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.702 -0.851 . . . . 75.01 108.702 173.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 60.4 p -120.49 133.87 55.35 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.253 0.549 . . . . 71.44 111.497 -170.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.11 161.28 40.54 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.528 1.131 . . . . 63.44 108.764 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 54.5 m -143.13 -175.71 4.63 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.653 0.381 . . . . 74.32 111.048 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' F' ' 24' ' ' PRO . 78.3 p -164.87 137.84 4.68 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.954 0.902 . . . . 62.22 109.58 169.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.638 ' HB2' ' HA ' ' F' ' 22' ' ' ARG . 58.7 tt0 -89.03 133.25 34.41 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 120.732 0.301 . . . . 71.33 110.704 177.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 40.6 mt -102.03 -44.31 5.51 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.846 0.858 . . . . 63.23 110.457 174.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.34 -169.65 2.54 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.197 -0.91 . . . . 42.51 109.884 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.89 117.65 8.57 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.631 -1.168 . . . . 72.3 108.818 171.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 69.07 5.29 4.99 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.374 1.07 . . . . 65.44 112.486 173.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 56.0 t -112.48 106.44 20.76 Favored 'Isoleucine or valine' 0 C--O 1.246 0.887 0 N-CA-C 107.204 -1.406 . . . . 60.15 107.204 171.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -129.28 153.9 47.36 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.178 -0.675 . . . . 53.52 109.178 -176.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -116.01 122.47 45.31 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.623 -1.251 . . . . 65.21 107.623 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 43.1 t -112.39 123.63 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.667 0.787 . . . . 75.32 109.851 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 18.9 t -103.09 125.75 57.48 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 124.306 1.042 . . . . 53.44 109.978 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.629 HD23 HD12 ' B' ' 106' ' ' LEU . 3.3 mm? -107.4 110.95 23.05 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.996 -0.742 . . . . 52.31 108.996 167.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -85.39 114.25 22.3 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.699 0.8 . . . . 64.02 109.062 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.404 ' CG1' HD11 ' B' ' 114' ' ' ILE . 96.9 t -103.34 109.45 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.569 1.148 . . . . 72.04 108.547 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 87.2 m -94.45 142.19 27.72 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.392 1.077 . . . . 73.13 108.722 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.564 HG21 HG21 ' B' ' 114' ' ' ILE . 98.7 t -136.2 131.97 49.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 124.704 1.202 . . . . 73.41 108.197 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 54.3 m -126.01 148.06 49.39 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.736 -1.209 . . . . 72.34 107.736 172.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.92 143.51 27.41 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.532 -0.544 . . . . 72.34 109.532 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.517 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 23.1 p -148.82 130.2 14.73 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 123.768 0.667 . . . . 40.41 111.07 -175.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.667 HD12 HG22 ' B' ' 31' ' ' VAL . 48.3 mt -103.04 111.2 23.43 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.721 -1.215 . . . . 75.34 107.721 173.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.55 -110.75 3.11 Favored Glycine 0 C--N 1.345 1.054 0 O-C-N 123.39 0.431 . . . . 74.04 112.046 -176.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.24 5.34 9.15 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.096 0.558 . . . . 61.33 111.028 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.84 150.04 34.15 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.426 -0.583 . . . . 74.43 109.426 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 68.2 m -70.1 119.55 14.47 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 123.507 0.505 . . . . 71.01 110.348 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.634 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -70.77 -60.71 2.09 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.244 -1.021 . . . . 54.04 108.244 174.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -157.1 166.0 34.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.39 -1.277 . . . . 72.54 111.164 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 72.7 mt -125.78 137.34 53.79 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 105.791 -1.929 . . . . 74.11 105.791 170.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 44.9 t -138.71 150.64 46.38 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.245 -1.02 . . . . 73.11 108.245 173.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -160.15 131.4 5.84 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.12 -0.696 . . . . 73.45 109.12 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.405 ' HA ' HD13 ' B' ' 21' ' ' ILE . 85.4 t -124.22 149.49 28.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.007 -0.997 . . . . 75.45 108.859 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.424 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 16.7 mt-30 -120.56 97.64 5.66 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.903 -1.147 . . . . 74.42 107.903 167.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -88.54 100.61 13.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.34 -1.356 . . . . 73.25 107.34 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.447 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -97.67 147.26 18.56 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.612 -0.995 . . . . 72.21 110.612 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.44 130.15 4.14 Favored Glycine 0 CA--C 1.507 -0.417 0 N-CA-C 110.852 -0.899 . . . . 70.45 110.852 -177.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 57.4 mt -86.06 126.48 40.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.563 -0.903 . . . . 54.45 108.563 173.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -134.87 131.14 37.0 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 107.504 -1.295 . . . . 64.13 107.504 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 70.9 m -95.06 88.59 5.28 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.34 -0.615 . . . . 70.32 109.34 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 12.4 tt -107.86 129.81 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.922 0.889 . . . . 74.02 111.724 -170.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.43 163.61 33.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.78 0.832 . . . . 61.11 110.899 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.39 -70.19 0.29 Allowed Glycine 0 C--N 1.344 0.993 0 CA-C-N 115.681 -0.691 . . . . 72.32 113.336 172.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.537 HG22 ' HB3' ' B' ' 94' ' ' MET . 11.3 mt -89.65 158.23 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.046 0.938 . . . . 73.12 111.523 -175.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -154.02 158.69 40.95 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.838 1.255 . . . . 73.51 109.173 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.94 -134.79 12.34 Favored Glycine 0 C--N 1.347 1.188 0 C-N-CA 123.352 0.501 . . . . 74.01 113.733 173.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 59.4 m -70.16 -33.18 71.45 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.276 0.63 . . . . 63.14 111.423 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -66.82 -36.14 81.69 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.54 -0.755 . . . . 64.11 111.242 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.537 ' HB3' HG22 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -81.1 -22.36 39.2 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 116.307 -0.406 . . . . 53.35 110.686 176.447 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.54 -24.92 64.09 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.106 0.479 . . . . 72.43 111.168 173.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.45 ' CD2' ' HB2' ' B' ' 134' ' ' ASP . 54.9 t-80 -77.78 -30.01 51.14 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.511 0.724 . . . . 74.5 110.661 171.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.8 t -80.14 -68.39 0.68 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.748 0.819 . . . . 70.23 112.488 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.632 ' H ' HD23 ' B' ' 98' ' ' LEU . 1.9 pt? -102.5 -7.28 22.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.853 -0.529 . . . . 74.12 111.759 -174.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.02 0.75 57.54 Favored Glycine 0 C--N 1.344 1.003 0 O-C-N 123.292 0.37 . . . . 44.04 112.452 173.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' B' ' 134' ' ' ASP . . . -149.19 -60.07 0.22 Allowed 'General case' 0 C--N 1.358 0.977 0 C-N-CA 122.77 0.428 . . . . 53.01 111.98 -176.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -70.52 -36.82 73.95 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 112.233 0.457 . . . . 74.31 112.233 -175.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.538 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 70.9 m -68.76 -44.39 31.19 Favored Pre-proline 0 N--CA 1.482 1.145 0 CA-C-O 118.545 -0.74 . . . . 74.41 110.818 177.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -45.97 -40.07 20.14 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 122.536 2.157 . . . . 74.4 113.766 162.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -68.49 -33.47 74.21 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.143 0.577 . . . . 74.42 112.504 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.57 HD13 HD11 ' B' ' 13' ' ' ILE . 67.1 mt -69.26 -46.09 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.19 0.596 . . . . 52.41 109.9 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.629 HD12 HD23 ' B' ' 60' ' ' LEU . 60.1 mt -84.03 -11.44 56.75 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.677 -1.147 . . . . 73.23 110.763 -172.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.408 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 81.4 t80 -57.65 -54.47 54.87 Favored Pre-proline 0 CA--C 1.557 1.221 0 CA-C-O 117.971 -1.014 . . . . 72.24 112.993 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 36.5 Cg_exo -62.03 -35.85 74.15 Favored 'Trans proline' 0 C--N 1.39 2.745 0 C-N-CA 121.761 1.641 . . . . 55.23 113.029 -177.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -69.02 -44.69 72.23 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.854 0.462 . . . . 73.12 110.61 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.41 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -65.47 -43.66 89.59 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.903 0.481 . . . . 51.03 110.306 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -54.64 -53.13 58.76 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.523 1.129 . . . . 65.43 110.582 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.465 ' HG3' HH12 ' A' ' 120' ' ' ARG . 13.6 tp10 -62.35 -34.36 76.5 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.872 0.869 . . . . 74.33 111.05 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.524 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.9 t -71.23 -37.82 71.99 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.27 0.228 . . . . 71.22 110.862 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.564 HG21 HG21 ' B' ' 64' ' ' VAL . 84.5 mt -67.39 -56.95 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.445 0.698 . . . . 45.42 109.182 176.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 9.9 m -62.64 -24.01 67.38 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 124.288 0.992 . . . . 65.51 111.364 -173.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 39.7 t -67.19 -49.79 63.34 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 122.968 0.507 . . . . 75.54 109.913 170.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.524 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 33.9 mmt -62.02 -39.46 92.37 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 122.877 0.471 . . . . 71.3 110.644 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 114' ' ' ILE . 84.3 t -59.52 -49.5 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.585 1.154 . . . . 71.23 110.077 176.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.8 t -63.68 -37.34 86.97 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.585 -1.189 . . . . 74.11 111.156 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -69.47 -33.47 72.95 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.476 -0.784 . . . . 64.34 110.335 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.74 5.55 74.3 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.872 0.732 . . . . 54.12 112.835 173.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 17' ' ' TYR . 74.6 p 54.9 55.82 7.34 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 126.012 1.725 . . . . 64.22 111.99 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -117.76 156.98 49.18 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 124.34 1.056 . . . . 73.05 110.509 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.83 161.86 2.91 Favored 'Trans proline' 0 C--N 1.392 2.829 0 C-N-CA 123.938 3.092 . . . . 55.33 116.139 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.537 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -65.13 121.85 15.7 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 113.911 -1.495 . . . . 75.4 111.6 -178.609 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -138.63 109.55 6.74 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 108.342 -0.984 . . . . 74.33 108.342 177.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -124.49 135.1 52.93 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.935 0.894 . . . . 73.4 109.32 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 5.9 mp -87.8 139.27 30.7 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.819 0.848 . . . . 71.33 110.102 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.48 164.72 56.41 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 124.222 1.009 . . . . 65.12 111.067 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -53.88 103.79 0.1 OUTLIER 'Trans proline' 0 C--N 1.39 2.735 0 C-N-CA 122.824 2.349 . . . . 61.44 112.892 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.531 HG21 ' H ' ' F' ' 8' ' ' LEU . 37.6 t -90.72 108.62 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.32 -0.993 . . . . 73.45 108.32 176.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.64 79.95 8.12 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.322 -0.621 . . . . 71.43 109.322 177.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -51.14 -45.36 61.62 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.516 0.726 . . . . 73.3 110.119 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.45 ' HB2' ' CD2' ' B' ' 96' ' ' HIS . 7.6 p-10 -67.19 -24.64 65.88 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 113.444 -1.707 . . . . 71.43 112.531 -176.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.26 -34.64 42.43 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 122.738 0.415 . . . . 43.45 110.642 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.459 ' HB2' HD21 ' F' ' 10' ' ' LEU . 8.8 mp -70.8 -38.63 73.36 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 109.752 -0.462 . . . . 74.11 109.752 172.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.495 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 20.6 m-85 -66.83 -32.52 73.86 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.02 -0.537 . . . . 74.3 110.835 173.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.52 -35.95 73.46 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.278 0.631 . . . . 71.44 109.688 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -73.82 -24.44 59.8 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.347 -0.842 . . . . 71.24 110.286 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -71.34 -30.22 65.93 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.945 -0.391 . . . . 74.12 109.945 171.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 47.9 mt -80.78 2.68 25.21 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.505 0.722 . . . . 63.51 110.756 174.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 83.85 -7.57 1.07 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 126.216 1.806 . . . . 64.21 112.662 169.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -101.99 -179.94 4.15 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.533 0.733 . . . . 65.11 110.475 175.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -132.26 -50.4 0.94 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.609 0.764 . . . . 70.01 109.293 169.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.2 153.01 31.04 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.029 0.531 . . . . 54.32 111.559 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.6 93.97 0.09 OUTLIER Glycine 0 C--N 1.346 1.119 0 N-CA-C 110.816 -0.913 . . . . 70.31 110.816 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -95.14 64.6 2.76 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.817 0.847 . . . . 70.2 111.051 -173.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -77.48 72.59 2.15 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.919 -0.582 . . . . 73.43 112.154 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 75.4 p -96.49 148.78 22.46 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.799 0.84 . . . . 72.44 110.05 -176.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -143.18 100.67 3.67 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.508 0.723 . . . . 75.12 109.634 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.22 105.0 17.08 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 107.379 -1.341 . . . . 74.21 107.379 175.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -111.32 121.66 45.83 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.215 1.006 . . . . 73.34 110.73 -173.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.26 99.75 2.96 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 107.007 -1.479 . . . . 74.14 107.007 164.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -81.23 119.83 24.13 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.747 0.308 . . . . 72.44 110.327 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 CA-C-N 115.407 -0.815 . . . . 52.5 110.54 179.075 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 109.63 -0.507 . . . . 71.33 109.63 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 49.5 m -76.25 125.0 28.37 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.414 0.686 . . . . 73.3 110.977 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -146.98 155.99 42.69 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 108.102 -1.073 . . . . 74.04 108.102 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -52.65 117.25 2.77 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.142 0.977 . . . . 64.0 110.043 -176.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -66.61 -41.71 87.98 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.086 0.554 . . . . 71.01 110.664 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -103.34 86.8 2.73 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.111 0.964 . . . . 75.04 108.679 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 27.9 p -90.15 106.95 18.83 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.109 0.563 . . . . 63.42 110.354 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -128.26 164.0 23.53 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.697 0.799 . . . . 63.02 109.663 174.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 3.7 tpt 64.05 111.52 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.218 1.407 . . . . 75.34 111.127 -174.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 25.0 m -114.06 79.18 1.22 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 106.709 -1.589 . . . . 71.24 106.709 171.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.584 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.8 t80 -96.13 130.89 43.05 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 115.055 -0.975 . . . . 73.42 110.565 -171.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -145.53 124.88 13.04 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.095 -1.076 . . . . 71.42 108.095 171.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 51.6 mt -73.95 102.08 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 107.774 -1.195 . . . . 74.55 107.774 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -75.59 -50.92 14.12 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.582 -0.735 . . . . 73.24 110.616 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -167.3 123.88 1.16 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 110.294 -0.261 . . . . 63.33 110.294 -176.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 63.0 mt -108.76 144.46 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 108.002 -1.11 . . . . 64.34 108.002 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.47 ' HB3' HG23 ' D' ' 122' ' ' THR . 21.8 p90 -176.36 172.38 2.27 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.383 0.673 . . . . 64.55 110.11 -174.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.9 p -98.02 122.42 41.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.742 -0.663 . . . . 70.33 109.363 175.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.432 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 18.3 mmtp -70.04 -46.77 64.34 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 107.765 -1.198 . . . . 72.44 107.765 168.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 17.5 t70 -134.51 141.18 46.64 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 113.438 -1.71 . . . . 41.14 109.743 -171.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 87.5 mt -135.81 146.13 30.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 106.082 -1.822 . . . . 71.22 106.082 169.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 22' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' C' ' 77' ' ' GLU . 35.8 t -160.79 151.18 18.01 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.535 0.683 . . . . 74.53 109.859 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 86.9 t80 -144.62 136.43 25.82 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.529 -1.656 . . . . 72.03 106.529 169.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -134.24 129.29 35.46 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.2 -0.667 . . . . 74.52 109.2 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.51 81.01 11.44 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 106.858 -1.534 . . . . 65.32 106.858 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -69.53 -21.54 34.41 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.955 2.437 . . . . 62.25 112.423 -174.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -118.51 25.91 9.95 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.479 1.111 . . . . 63.41 110.147 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.73 -52.9 22.36 Favored Pre-proline 0 CA--C 1.56 1.361 0 CA-C-O 117.818 -1.087 . . . . 71.31 113.683 -173.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.72 -43.76 47.11 Favored 'Trans proline' 0 C--N 1.399 3.212 0 C-N-CA 121.834 1.689 . . . . 72.41 112.434 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.45 ' O ' ' HG3' ' C' ' 33' ' ' GLN . 86.6 t60 -69.45 -43.68 72.78 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.275 -0.875 . . . . 75.23 112.441 -175.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.728 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.2 p -69.82 -18.45 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.324 0 N-CA-C 113.43 0.9 . . . . 75.13 113.43 -174.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -70.19 -20.71 63.1 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 113.099 0.777 . . . . 75.1 113.099 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' C' ' 30' ' ' HIS . 4.9 pp0? -92.67 8.91 37.13 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 111.992 0.367 . . . . 61.22 111.992 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.68 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -91.89 156.59 17.37 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.143 0.577 . . . . 73.44 110.685 179.204 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.35 125.14 22.89 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.171 0.988 . . . . 65.2 109.452 164.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -81.12 88.67 5.98 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.252 0.548 . . . . 60.14 110.49 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -140.28 77.91 23.84 Favored Pre-proline 0 C--O 1.243 0.738 0 N-CA-C 108.234 -1.025 . . . . 61.53 108.234 171.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -84.12 129.84 4.65 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.294 1.996 . . . . 74.11 111.551 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.75 96.49 8.19 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 104.689 -2.338 . . . . 73.32 104.689 166.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 20.8 m -88.8 121.31 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 114.643 -1.162 . . . . 71.22 111.595 -168.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.439 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 35.8 ttpt -97.26 106.48 18.82 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.832 -0.803 . . . . 74.22 108.832 174.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.674 HD21 HG13 ' G' ' 6' ' ' ILE . 2.5 mm? -87.42 121.68 30.17 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.536 -1.283 . . . . 70.52 107.536 175.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -118.5 140.07 50.45 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.086 1.354 . . . . 61.13 108.397 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.604 HD23 HD11 ' C' ' 60' ' ' LEU . 0.0 OUTLIER -137.49 132.53 33.42 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.562 0.345 . . . . 74.23 110.125 172.721 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.579 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 15.1 t70 -113.2 148.3 35.73 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.905 0.882 . . . . 74.33 108.906 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 77.0 p -112.76 112.46 23.98 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.449 0.7 . . . . 71.23 109.33 -174.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.2 139.01 48.18 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.568 0.747 . . . . 73.42 109.34 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 55.6 m -157.8 155.62 30.09 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.32 0.648 . . . . 64.41 110.846 -175.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 47.2 t -160.93 130.65 4.92 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.526 -0.761 . . . . 71.44 109.842 -174.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -76.54 122.02 24.0 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.811 -0.44 . . . . 75.32 109.811 174.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.657 HD11 HD12 ' C' ' 83' ' ' ILE . 66.7 mt -86.45 -52.66 5.45 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.539 -0.755 . . . . 74.14 110.119 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.51 -172.04 3.99 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.05 0.54 . . . . 54.11 111.723 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -56.93 103.46 0.11 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.075 1.35 . . . . 61.22 110.875 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 69.51 -1.96 2.07 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 125.907 1.683 . . . . 73.14 113.054 -177.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 75.7 t -93.35 113.7 28.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 108.33 -0.989 . . . . 74.21 108.33 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.571 ' HB3' HD13 ' C' ' 86' ' ' ILE . 50.6 t80 -131.28 126.1 34.52 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.44 -0.8 . . . . 74.03 109.199 -171.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -85.72 124.91 32.76 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.177 0.991 . . . . 63.5 110.223 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 62.9 t -111.94 115.87 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 107.958 -1.127 . . . . 72.11 107.958 171.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.9 t -113.63 129.55 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.493 0.717 . . . . 62.51 109.32 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.604 HD11 HD23 ' C' ' 44' ' ' LEU . 40.9 tp -116.42 113.34 22.73 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.804 -0.814 . . . . 72.43 108.804 173.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.579 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 22.4 ttt180 -81.49 105.74 12.89 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 108.381 -0.97 . . . . 74.31 108.381 176.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 37.3 t -99.0 119.28 46.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 107.7 -1.222 . . . . 70.4 107.7 176.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 60.5 m -130.67 119.74 22.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.757 -0.831 . . . . 61.44 108.757 -174.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.793 HG23 HD13 ' C' ' 114' ' ' ILE . 97.6 t -100.17 114.66 39.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.348 -0.982 . . . . 74.53 108.348 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.504 HG23 HD23 ' C' ' 75' ' ' LEU . 5.2 m -97.69 135.78 38.99 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.104 -1.443 . . . . 64.51 107.104 171.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.12 114.82 16.2 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.308 -1.368 . . . . 74.03 107.308 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 20.1 m -136.15 126.61 26.82 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.113 -0.699 . . . . 75.25 109.113 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.68 HD13 ' HG2' ' C' ' 34' ' ' LYS . 14.2 mt -85.59 13.97 6.28 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.694 1.198 . . . . 71.15 111.588 -176.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.0 -98.77 0.4 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 110.103 -1.199 . . . . 65.23 110.103 -175.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -90.81 -32.85 15.93 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.299 0.64 . . . . 72.25 109.365 171.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -71.8 120.21 17.06 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 114.641 -1.163 . . . . 73.11 109.666 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 62.8 m -76.18 126.13 30.43 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.562 -0.903 . . . . 72.14 108.562 167.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.728 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.87 -58.27 3.39 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.163 -1.051 . . . . 74.25 108.163 170.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -166.22 176.59 7.47 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.623 0.725 . . . . 43.55 111.941 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.504 HD23 HG23 ' C' ' 65' ' ' THR . 2.6 tm? -141.71 104.82 4.6 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 106.983 -1.488 . . . . 73.15 106.983 173.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.522 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.7 t -109.45 125.76 52.78 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.216 0.606 . . . . 75.04 109.378 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 77' ' ' GLU . . . . . 0.418 ' HB3' ' HB3' ' C' ' 22' ' ' SER . 40.7 tt0 -124.48 139.73 53.62 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.494 0.718 . . . . 73.4 109.527 -177.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.401 HG11 ' HA ' ' C' ' 110' ' ' ALA . 27.4 t -144.08 114.08 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 108.147 -1.057 . . . . 63.14 108.147 174.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 77.9 mt-30 -90.69 97.5 11.22 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.545 -0.909 . . . . 72.14 108.545 171.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.607 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.0 tp-100 -82.03 105.23 12.96 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.616 -0.513 . . . . 73.24 109.616 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.49 144.73 21.61 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 111.386 -0.686 . . . . 32.34 111.386 175.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.29 116.46 0.84 Allowed Glycine 0 CA--C 1.503 -0.675 0 N-CA-C 110.376 -1.09 . . . . 74.24 110.376 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.657 HD12 HD11 ' C' ' 51' ' ' LEU . 14.6 mm -85.24 118.22 31.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 107.81 -1.182 . . . . 64.3 107.81 177.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.584 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 46.7 m-85 -132.2 142.88 49.59 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.637 0.775 . . . . 75.04 108.975 -174.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -84.54 116.74 23.29 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.671 0.388 . . . . 72.21 109.988 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.571 HD13 ' HB3' ' C' ' 56' ' ' TYR . 3.4 mp -115.09 109.07 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 108.406 -0.961 . . . . 71.02 108.406 172.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.486 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -147.01 161.99 39.69 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.66 1.184 . . . . 73.15 108.916 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.21 -51.14 3.96 Favored Glycine 0 N--CA 1.472 1.064 0 O-C-N 123.136 0.272 . . . . 63.42 112.796 175.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 30.6 pt -91.87 158.22 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.826 0.85 . . . . 73.22 111.48 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.625 ' HA ' ' HE3' ' C' ' 94' ' ' MET . 41.8 tt0 -152.12 162.01 41.75 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.112 0.965 . . . . 70.14 109.589 173.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.67 -117.55 5.8 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.024 -0.535 . . . . 75.21 112.814 172.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 57.3 p -65.1 -37.51 87.73 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.048 0.939 . . . . 74.52 111.497 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -71.8 -42.79 66.63 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.287 0.635 . . . . 63.12 111.6 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.625 ' HE3' ' HA ' ' C' ' 90' ' ' GLU . 9.1 ptp -73.09 -33.33 65.54 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 120.99 -0.284 . . . . 72.23 110.574 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.33 -28.64 69.45 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.004 0.522 . . . . 55.23 110.706 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -70.36 -44.74 67.48 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.449 -0.796 . . . . 74.14 110.206 172.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.586 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 42.3 t -65.54 -40.74 93.24 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 123.292 0.37 . . . . 63.22 110.512 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' G' ' 15' ' ' PHE . 86.9 mt -77.27 -49.9 14.03 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.22 0.608 . . . . 72.14 111.781 -175.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 99' ' ' GLY . . . . . 0.456 ' HA3' HD22 ' G' ' 14' ' ' LEU . . . -97.96 12.38 64.03 Favored Glycine 0 N--CA 1.474 1.228 0 N-CA-C 114.898 0.719 . . . . 71.11 114.898 -166.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.684 ' HB1' ' HB2' ' C' ' 134' ' ' ASP . . . -154.67 -62.54 0.13 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 117.624 0.712 . . . . 72.13 110.974 -172.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.586 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 73.9 t80 -76.14 -39.57 54.73 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.139 1.376 . . . . 73.42 113.105 -167.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 96.7 m -77.44 -39.84 2.09 Favored Pre-proline 0 N--CA 1.486 1.328 0 CA-C-O 118.687 -0.673 . . . . 71.02 111.716 176.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -48.5 -35.15 27.99 Favored 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 122.741 2.294 . . . . 64.53 113.683 164.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -64.94 -38.51 91.2 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.762 0.425 . . . . 71.35 111.022 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.538 HD12 ' NH1' ' A' ' 111' ' ' ARG . 33.4 mm -66.99 -46.36 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 109.795 -0.446 . . . . 72.42 109.795 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.13 -20.97 29.48 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 113.547 0.943 . . . . 72.34 113.547 -168.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -58.7 -52.74 72.56 Favored Pre-proline 0 N--CA 1.488 1.449 0 CA-C-O 117.951 -1.023 . . . . 72.44 113.126 -175.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.14 -32.23 83.11 Favored 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 121.647 1.565 . . . . 64.5 113.0 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -64.91 -53.78 41.09 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.253 0.621 . . . . 63.42 110.377 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.607 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -65.96 -33.43 75.79 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.03 -0.986 . . . . 73.15 111.179 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -60.14 -53.85 52.82 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.394 1.078 . . . . 75.0 110.243 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.28 -35.85 78.48 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 110.016 -0.364 . . . . 73.13 110.016 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.417 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 10.2 t -67.06 -27.92 67.78 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.148 0.579 . . . . 61.2 111.323 -178.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.793 HD13 HG23 ' C' ' 64' ' ' VAL . 83.0 mt -76.58 -55.65 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 115.882 -0.599 . . . . 71.4 109.973 171.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 17.1 m -61.15 -27.81 68.66 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 123.389 0.676 . . . . 73.23 111.502 -173.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.4 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 41.4 t -62.42 -52.77 62.23 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 124.457 1.103 . . . . 65.44 109.093 170.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.583 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.15 -34.74 75.5 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.46 1.104 . . . . 71.34 112.381 178.352 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 88.8 t -63.38 -44.31 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 109.209 -0.663 . . . . 73.44 109.209 174.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 22.8 t -74.68 -24.04 58.73 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.988 -1.006 . . . . 74.33 111.71 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' C' ' 116' ' ' SER . 87.5 mtt-85 -74.02 -40.7 62.71 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.876 -0.787 . . . . 75.45 108.876 174.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.69 -4.35 70.42 Favored Glycine 0 C--N 1.357 1.719 0 O-C-N 123.951 0.782 . . . . 61.35 112.431 171.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 29.3 p 65.26 28.44 11.97 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.679 1.992 . . . . 73.35 112.934 170.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -83.33 145.96 49.73 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 123.364 0.666 . . . . 74.34 109.323 172.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.81 146.03 29.61 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.137 2.558 . . . . 61.11 113.139 176.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -52.62 111.1 0.59 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.396 1.078 . . . . 74.52 112.254 -172.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 47.3 tp -114.21 88.95 2.97 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.079 -1.452 . . . . 53.34 107.079 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -97.83 126.1 43.02 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.337 -0.847 . . . . 74.44 109.062 -171.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.05 126.48 31.12 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 122.888 0.475 . . . . 65.55 110.218 -172.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.11 152.81 95.66 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 124.29 1.036 . . . . 64.21 111.347 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.567 ' HG3' HD12 ' A' ' 16' ' ' ILE . 38.4 Cg_exo -57.65 117.61 4.34 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.773 2.315 . . . . 62.23 113.104 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -104.06 109.52 27.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 122.397 1.094 . . . . 75.13 108.534 169.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -101.32 76.46 1.71 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.933 -1.031 . . . . 72.45 108.566 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -51.11 -45.78 61.67 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.271 0.628 . . . . 65.34 112.311 -173.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.684 ' HB2' ' HB1' ' C' ' 100' ' ' ALA . 18.4 t0 -66.1 -46.37 77.85 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.01 0.818 . . . . 64.41 110.958 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' C' ' 139' ' ' ASN . . . -61.99 -30.7 71.12 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.172 -0.922 . . . . 73.02 111.197 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 97.1 mt -78.02 -29.36 49.45 Favored 'General case' 0 CA--C 1.55 0.963 0 O-C-N 124.43 1.081 . . . . 74.5 111.795 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -71.25 -38.6 71.92 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.014 0.435 . . . . 63.14 110.109 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 57.6 mtt -74.26 -30.8 62.29 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.448 -0.796 . . . . 64.31 110.602 175.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 139' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' C' ' 135' ' ' ALA . 66.5 t30 -65.19 -37.72 88.21 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.365 1.066 . . . . 52.4 110.33 177.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -51.34 -84.78 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.987 0 O-C-N 124.158 0.911 . . . . 72.11 111.075 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 64.5 tp 58.42 -81.85 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.794 0.838 . . . . 74.03 109.901 -171.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -174.53 -54.75 0.01 OUTLIER 'General case' 0 C--N 1.355 0.812 0 C-N-CA 124.688 1.195 . . . . 74.43 108.467 174.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -134.95 146.4 49.09 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.858 0.863 . . . . 63.23 109.979 -174.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -127.02 157.71 38.88 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.752 0.821 . . . . 63.12 110.822 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -163.56 99.64 0.91 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.633 1.173 . . . . 42.11 108.392 171.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -141.91 91.33 0.18 Allowed Glycine 0 C--N 1.352 1.439 0 CA-C-N 116.776 -0.193 . . . . 32.44 112.696 -174.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -148.01 147.96 30.19 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.379 1.072 . . . . 72.45 108.775 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 145.95 47.48 0.03 OUTLIER Glycine 0 C--N 1.342 0.871 0 N-CA-C 110.898 -0.881 . . . . 62.02 110.898 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 40.6 p -88.12 155.9 19.55 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.694 0.797 . . . . 73.21 110.824 -175.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -155.1 -170.24 3.42 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.014 0.926 . . . . 73.11 110.062 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 151' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' C' ' 152' ' ' HIS . 8.8 pt-20 -133.48 -57.73 0.89 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.604 0.762 . . . . 72.22 110.122 172.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 152' ' ' HIS . . . . . 0.421 ' H ' ' HG3' ' C' ' 151' ' ' GLU . 11.1 p-80 159.45 164.7 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 127.204 2.201 . . . . 73.41 109.222 -175.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 21.8 tm0? -141.87 118.98 11.33 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.6 -1.259 . . . . 74.42 107.6 170.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 178.47 161.54 0.65 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.185 1.394 . . . . 64.25 108.942 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.645 -0.693 . . . . 42.4 109.951 175.412 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 76.6 mtp . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 110.346 -0.242 . . . . 72.15 110.346 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 29.8 t -157.13 93.41 1.33 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.537 -1.282 . . . . 63.02 107.537 172.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -70.72 -68.24 0.45 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.503 0.721 . . . . 74.3 109.131 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -95.95 116.29 28.71 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.106 -1.442 . . . . 75.31 107.106 168.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -78.63 84.9 4.71 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.526 0.679 . . . . 53.54 110.989 -172.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -136.5 80.27 1.81 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 106.394 -1.706 . . . . 73.21 106.394 171.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 15.1 t -176.0 -30.18 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 114.501 -1.227 . . . . 62.14 109.025 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -65.4 -45.85 82.35 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.336 1.055 . . . . 74.05 110.71 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 26.9 ptm -32.66 143.35 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.393 1.477 . . . . 74.13 114.173 165.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 26.0 m -111.3 138.69 47.44 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.324 0.649 . . . . 75.11 109.41 173.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.442 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 55.1 t80 -158.09 100.82 1.73 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.791 -1.188 . . . . 73.34 107.791 -175.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -127.65 116.76 20.79 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.47 -0.937 . . . . 75.3 108.47 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.558 HD13 HG21 ' D' ' 105' ' ' ILE . 7.4 mt -81.8 124.03 38.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.693 -0.484 . . . . 72.22 109.693 -177.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -90.8 -39.24 12.48 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.649 0.78 . . . . 73.22 111.478 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -174.97 123.9 0.25 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 117.805 0.275 . . . . 40.05 111.665 -166.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -103.97 137.1 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 107.986 -1.116 . . . . 73.42 107.986 167.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -160.8 148.57 15.85 Favored 'General case' 0 C--O 1.239 0.533 0 O-C-N 124.142 0.902 . . . . 70.4 109.883 177.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 77.8 p -79.61 114.05 18.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.136 -0.938 . . . . 75.32 108.979 174.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -82.4 -28.59 31.33 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.935 -0.575 . . . . 73.53 110.439 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 30.2 t70 -156.61 140.12 15.86 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.855 -1.066 . . . . 65.3 108.24 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.583 HG21 ' HE2' ' C' ' 117' ' ' MET . 84.6 mt -139.16 150.3 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.203 1.001 . . . . 72.34 108.374 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 22' ' ' SER . . . . . 0.454 ' HB2' ' HB3' ' D' ' 77' ' ' GLU . 71.7 m -147.62 140.57 24.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.689 1.196 . . . . 55.33 109.318 172.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.514 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 83.7 t80 -141.23 123.49 15.68 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 105.233 -2.136 . . . . 70.42 105.233 165.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.6 mt-10 -139.7 108.62 6.0 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.187 -0.672 . . . . 74.33 109.187 -170.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.36 94.17 9.35 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 108.422 -0.955 . . . . 33.14 108.422 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.86 -44.36 2.84 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.696 2.264 . . . . 72.51 112.607 -170.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.482 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 7.9 m120 -96.5 11.75 33.94 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.849 0.86 . . . . 72.21 111.057 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.416 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -23.88 -68.38 0.05 OUTLIER Pre-proline 0 CA--C 1.56 1.346 0 N-CA-C 116.941 2.2 . . . . 70.2 116.941 -160.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.403 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 97.2 Cg_endo -74.21 -27.23 11.82 Favored 'Trans proline' 0 C--N 1.382 2.307 0 CA-C-N 123.334 2.226 . . . . 43.03 113.509 -176.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -66.35 -45.55 79.81 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.758 0.823 . . . . 73.23 110.376 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.644 HG21 ' HA ' ' D' ' 73' ' ' ALA . 11.7 p -76.41 -15.39 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 CA-C-N 115.355 -0.839 . . . . 60.31 112.125 -171.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.403 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 21.4 m-85 -69.11 -17.99 63.91 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 112.544 0.572 . . . . 72.22 112.544 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -61.46 -20.95 63.71 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.128 0.571 . . . . 75.2 110.982 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -99.69 90.73 4.57 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.857 1.263 . . . . 72.42 109.477 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -96.93 93.08 6.42 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.874 -0.603 . . . . 63.15 109.485 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.448 ' O ' ' HG2' ' D' ' 124' ' ' PRO . 33.1 p90 -160.88 175.86 12.07 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.61 1.164 . . . . 74.33 107.866 167.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -69.62 112.0 10.73 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 122.938 0.495 . . . . 74.21 109.687 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.92 134.55 60.91 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.15 2.567 . . . . 70.41 111.541 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.11 114.27 10.03 Favored 'General case' 0 C--N 1.348 0.524 0 N-CA-C 108.235 -1.024 . . . . 71.04 108.235 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 16.1 m -103.65 108.56 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-O 122.119 0.961 . . . . 60.31 110.997 -166.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.502 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 73.7 mmtt -87.93 128.37 35.37 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.743 -1.117 . . . . 71.34 108.337 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.51 ' H ' HD23 ' D' ' 42' ' ' LEU . 1.0 OUTLIER -96.3 118.89 33.77 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.711 0.767 . . . . 72.15 110.03 -174.393 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.712 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.9 m-20 -110.33 125.69 53.44 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.539 -1.282 . . . . 73.53 107.539 174.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 93.3 mt -122.79 130.77 53.3 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.112 0.565 . . . . 74.25 109.692 -175.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.588 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 11.4 t70 -131.73 146.5 52.2 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.154 0.982 . . . . 74.12 108.368 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 42.8 p -119.67 143.73 47.57 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.507 0.723 . . . . 74.11 110.622 -171.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.75 155.68 33.52 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.331 0.653 . . . . 72.11 109.793 175.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 17.7 p -150.2 160.22 43.85 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.901 0.48 . . . . 52.34 110.576 -175.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 2.9 m -152.07 119.65 6.06 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.92 -0.77 . . . . 63.44 108.92 175.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -66.95 116.51 7.87 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.737 -1.209 . . . . 51.14 107.737 163.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.475 HD12 HG23 ' D' ' 83' ' ' ILE . 29.8 mt -95.04 -35.12 12.07 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.296 -0.631 . . . . 42.3 109.296 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.56 -173.12 4.24 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.217 -0.901 . . . . 70.5 110.208 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -68.33 123.57 21.12 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.875 -1.057 . . . . 73.53 110.225 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 65.1 m-20 62.25 17.75 9.57 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.699 1.2 . . . . 71.41 112.194 -175.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.6 t -119.44 119.67 61.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.813 -0.81 . . . . 61.45 108.813 174.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.543 ' HD2' ' HB ' ' D' ' 86' ' ' ILE . 78.3 m-85 -134.52 129.06 34.53 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.521 -0.918 . . . . 74.12 108.521 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -92.98 127.53 38.53 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.97 0.908 . . . . 74.44 109.335 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.4 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 73.8 t -103.54 112.44 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.856 -1.165 . . . . 62.53 107.856 173.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.421 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 47.5 t -103.68 132.2 50.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 108.094 -1.076 . . . . 64.34 108.094 174.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 53.6 tp -128.54 121.78 29.58 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.722 0.296 . . . . 75.11 110.208 175.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.588 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 20.6 ttm-85 -84.82 98.72 10.45 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.056 0.942 . . . . 74.44 109.404 173.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 93.6 t -90.79 114.49 28.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.31 -0.996 . . . . 45.01 108.31 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.712 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 28.6 m -122.65 133.33 54.52 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.45 0.643 . . . . 72.03 109.666 -174.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 t -119.63 101.87 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.863 1.665 . . . . 72.41 108.787 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.502 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 59.1 m -92.4 99.79 12.48 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.271 -0.877 . . . . 54.15 108.801 175.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.31 142.21 36.36 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.135 -0.939 . . . . 71.33 109.7 -169.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 70.1 m -142.93 137.45 29.46 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.222 0.534 . . . . 53.13 111.673 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.53 HD12 HG22 ' D' ' 31' ' ' VAL . 55.8 mt -105.53 104.59 14.34 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.629 1.172 . . . . 61.42 108.536 172.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.22 -123.94 6.35 Favored Glycine 0 C--N 1.342 0.896 0 CA-C-N 115.797 -0.638 . . . . 74.52 112.514 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.61 5.87 34.06 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.168 0.587 . . . . 73.55 111.081 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -120.49 157.01 30.31 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.327 0.651 . . . . 74.45 109.81 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 63.7 m -71.34 136.45 47.84 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.628 0.58 . . . . 71.53 110.731 178.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.644 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -84.45 -64.08 1.22 Allowed 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.329 -0.989 . . . . 61.25 108.329 174.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -157.09 167.5 30.24 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.685 -1.143 . . . . 72.41 110.162 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.484 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 83.3 mt -126.42 110.92 13.86 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 106.435 -1.691 . . . . 73.41 106.435 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.56 ' SG ' HG12 ' D' ' 114' ' ' ILE . 42.4 t -114.26 138.1 50.93 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.575 -1.269 . . . . 71.42 107.575 -178.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 77' ' ' GLU . . . . . 0.454 ' HB3' ' HB2' ' D' ' 22' ' ' SER . 43.6 tt0 -155.36 122.58 5.51 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 110.033 -0.358 . . . . 74.22 110.033 -175.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 50.8 t -129.73 114.69 31.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 123.24 0.616 . . . . 75.31 109.368 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.448 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 22.2 mt-30 -86.51 83.65 7.59 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.096 -1.075 . . . . 65.32 108.096 168.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -79.88 98.21 7.02 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 113.346 -1.752 . . . . 74.33 108.145 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -93.71 144.12 16.91 Favored Glycine 0 C--N 1.341 0.85 0 N-CA-C 111.4 -0.68 . . . . 74.12 111.4 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.6 131.33 5.45 Favored Glycine 0 C--N 1.331 0.259 0 N-CA-C 111.162 -0.775 . . . . 73.53 111.162 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.475 HG23 HD12 ' D' ' 51' ' ' LEU . 61.3 mt -88.04 120.23 36.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 107.923 -1.14 . . . . 65.24 107.923 175.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.4 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 61.7 m-85 -128.54 126.22 39.93 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.676 0.791 . . . . 71.41 108.97 -175.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.1 m -79.37 99.53 7.19 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.599 -0.889 . . . . 75.44 108.599 172.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.543 ' HB ' ' HD2' ' D' ' 56' ' ' TYR . 17.9 mm -108.98 111.58 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.705 0.802 . . . . 73.33 109.571 -174.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.518 ' HB2' ' HB3' ' D' ' 54' ' ' ASP . . . -138.04 147.72 44.39 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.955 0.502 . . . . 73.32 110.705 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.56 10.34 84.68 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 114.724 0.65 . . . . 71.11 114.724 171.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.543 ' HB ' HG21 ' H' ' 18' ' ' VAL . 8.9 mt -106.46 128.02 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 117.433 0.617 . . . . 54.43 109.744 -175.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -148.51 159.69 43.81 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.562 1.145 . . . . 72.53 109.957 -169.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 91' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' D' ' 94' ' ' MET . . . 68.1 -132.24 28.23 Favored Glycine 0 C--N 1.349 1.292 0 O-C-N 124.08 0.863 . . . . 52.54 113.428 173.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 18.7 m -61.75 -37.38 84.05 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.654 0.782 . . . . 71.31 111.098 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -65.77 -34.11 77.41 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.033 -0.985 . . . . 65.32 110.701 -174.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.569 ' HB2' HG23 ' H' ' 18' ' ' VAL . 10.6 ptm -75.21 -36.0 61.43 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.168 0.587 . . . . 74.42 111.424 -174.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.65 -31.37 63.46 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.484 -0.78 . . . . 63.31 110.362 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -80.0 -31.73 39.69 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.372 -0.831 . . . . 73.5 111.076 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.0 t -69.59 -53.16 20.19 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.664 0.386 . . . . 54.4 110.702 -175.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.51 ' HB3' ' CD1' ' H' ' 15' ' ' PHE . 10.3 mp -86.82 -22.61 25.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.414 0.286 . . . . 73.34 111.198 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.29 -24.82 56.29 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-O 119.729 -0.484 . . . . 72.5 113.904 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.17 -50.97 0.65 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.494 0.553 . . . . 62.11 112.494 -171.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -73.86 -43.73 57.69 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.834 0.679 . . . . 73.44 112.834 -169.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.442 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 69.0 m -72.76 -44.2 8.81 Favored Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 123.462 0.705 . . . . 73.41 111.822 -176.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.32 -25.14 64.34 Favored 'Trans proline' 0 C--N 1.395 3.017 0 C-N-CA 121.76 1.64 . . . . 71.42 112.681 170.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 104' ' ' ASN . . . . . 0.516 ' HA ' ' HD2' ' D' ' 107' ' ' PHE . 45.7 t-20 -62.43 -39.89 94.77 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.424 0.689 . . . . 71.23 110.094 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.558 HG21 HD13 ' D' ' 13' ' ' ILE . 48.6 mm -58.85 -38.41 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.62 0.768 . . . . 63.02 110.564 174.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 86.4 mt -83.14 -19.73 36.11 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.114 -0.948 . . . . 63.53 112.442 -170.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 107' ' ' PHE . . . . . 0.516 ' HD2' ' HA ' ' D' ' 104' ' ' ASN . 27.5 m-85 -63.05 -43.79 82.82 Favored Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 114.086 1.143 . . . . 62.51 114.086 -177.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -52.18 -46.14 34.62 Favored 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 122.328 2.019 . . . . 74.55 113.393 172.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -72.86 -36.44 67.42 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.456 -0.793 . . . . 74.23 111.686 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.14 78.67 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.589 0.555 . . . . 71.12 109.639 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -55.58 -50.21 70.69 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 124.953 1.408 . . . . 74.31 110.634 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -65.01 -46.67 80.44 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.728 0.642 . . . . 73.5 111.608 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -57.7 -41.8 82.44 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.578 0.549 . . . . 61.13 110.53 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.56 HG12 ' SG ' ' D' ' 76' ' ' CYS . 81.5 mt -60.93 -56.78 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 115.046 -0.979 . . . . 64.13 110.478 172.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 47.6 m -54.4 -40.77 68.53 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.677 1.191 . . . . 71.45 111.753 -172.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 32.3 t -67.09 -45.32 77.6 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.034 -0.985 . . . . 70.25 110.567 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.8 mtm -67.31 -34.5 77.51 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.852 0.461 . . . . 64.35 111.734 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' D' ' 114' ' ' ILE . 77.3 t -62.08 -45.01 99.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.586 0.754 . . . . 45.13 109.903 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.5 p -75.71 -26.58 57.66 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.901 -0.59 . . . . 73.54 111.401 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.417 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 84.3 mtt-85 -72.46 -31.22 65.25 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.374 0.669 . . . . 74.44 110.132 175.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.49 10.75 68.25 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 123.739 0.65 . . . . 34.54 112.139 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.47 HG23 ' HB3' ' C' ' 17' ' ' TYR . 24.3 p 58.63 22.3 9.7 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 126.877 2.071 . . . . 74.11 114.09 174.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -83.96 157.22 63.48 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.846 0.858 . . . . 70.01 110.04 171.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.448 ' HG2' ' O ' ' D' ' 36' ' ' TRP . 77.9 Cg_exo -54.96 134.0 61.12 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.347 2.698 . . . . 64.24 113.835 176.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -55.95 132.1 48.93 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.801 1.241 . . . . 73.53 112.071 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 61.4 tp -110.27 101.88 10.59 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.571 0.748 . . . . 65.14 110.09 -177.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -103.89 104.02 13.96 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.582 -0.896 . . . . 72.41 108.582 175.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 tt -70.9 125.68 27.5 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 108.483 -0.932 . . . . 73.43 108.483 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.91 157.07 81.76 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.173 0.989 . . . . 52.23 112.09 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.508 ' HD3' HG13 ' B' ' 13' ' ' ILE . 54.3 Cg_exo -56.52 103.52 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.046 2.498 . . . . 73.15 112.785 174.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 13.6 m -112.24 133.11 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.052 0.941 . . . . 64.34 109.84 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -94.47 110.5 22.28 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.737 -0.838 . . . . 70.41 108.737 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.469 ' HZ ' ' HG ' ' H' ' 11' ' ' LEU . 1.9 t80 -82.8 -37.54 24.36 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.605 0.762 . . . . 65.31 109.938 -176.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -62.18 -54.0 47.24 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.516 -1.22 . . . . 74.35 111.699 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.73 -40.62 93.06 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.287 0.635 . . . . 73.33 111.059 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 55.7 tp -52.2 -43.88 64.44 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.479 1.112 . . . . 52.34 111.352 176.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -73.4 -48.22 35.67 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.658 -0.701 . . . . 61.54 111.364 175.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 78.0 mtm -65.37 -23.99 67.12 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.308 0.643 . . . . 71.14 112.166 -171.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -56.81 -48.53 77.77 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.179 0.591 . . . . 64.54 110.238 173.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -65.61 -37.77 87.54 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.982 0.913 . . . . 72.21 111.421 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.8 mp -60.48 -30.08 69.47 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.243 0.617 . . . . 71.33 111.528 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -90.07 9.29 28.71 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.77 0.828 . . . . 62.41 112.253 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -119.86 74.16 1.01 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.837 -0.801 . . . . 73.25 108.837 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -159.07 -24.03 0.07 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.161 -0.927 . . . . 74.35 111.324 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.71 169.56 10.4 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.21 0.604 . . . . 42.15 111.821 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.85 101.72 2.07 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.588 -0.733 . . . . 75.44 112.607 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.63 150.55 42.93 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.747 0.819 . . . . 74.21 110.125 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.96 -47.48 88.48 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.761 0.663 . . . . 71.15 113.457 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 61.4 p -75.17 175.0 8.69 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.198 0.599 . . . . 64.3 110.754 176.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -72.88 86.63 1.28 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.207 0.527 . . . . 62.1 109.828 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -61.6 96.84 0.06 Allowed 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.304 -0.862 . . . . 71.53 110.901 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -70.84 85.76 0.68 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.753 -0.832 . . . . 71.52 108.753 171.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -82.41 154.16 25.34 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.012 -0.995 . . . . 75.32 109.59 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.4 91.4 0.55 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.503 0.721 . . . . 63.22 110.647 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.152 0 C-N-CA 124.213 1.005 . . . . 61.51 108.972 -179.81 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 53.4 mtt . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 109.311 -0.626 . . . . 71.34 109.311 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -110.85 177.5 4.65 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.868 0.867 . . . . 75.44 110.704 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -157.63 154.57 28.63 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.341 0.657 . . . . 72.32 110.033 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 66.2 m -140.57 156.68 46.22 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.595 0.758 . . . . 72.25 110.724 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 19.3 m -141.44 178.27 7.55 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 124.768 1.227 . . . . 43.44 108.412 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.527 HG13 HD22 ' A' ' 42' ' ' LEU . 9.0 tt -55.46 89.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 124.07 0.948 . . . . 60.23 110.843 173.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 7' ' ' ALA . . . . . 0.446 ' HA ' ' HB3' ' A' ' 129' ' ' ALA . . . -97.95 147.54 24.38 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.686 0.794 . . . . 53.24 111.293 -174.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.498 HD22 ' HE1' ' A' ' 133' ' ' PHE . 2.5 tt -102.7 114.53 28.86 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 107.678 -1.23 . . . . 74.4 107.678 174.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.12 50.78 2.05 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.785 0.834 . . . . 71.1 111.293 -173.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 81.7 mt 64.6 169.6 0.18 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.636 1.175 . . . . 62.53 111.304 -173.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.538 ' HB2' HD23 ' E' ' 14' ' ' LEU . 89.2 mt -81.42 125.99 77.44 Favored Pre-proline 0 CA--C 1.551 1.002 0 CA-C-O 119.058 -0.496 . . . . 75.33 110.708 -175.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.93 -29.28 87.74 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 123.502 2.802 . . . . 63.21 112.535 176.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 60.1 tp -132.17 129.85 40.32 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.189 -1.411 . . . . 74.3 107.189 169.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 14' ' ' LEU . . . . . 0.538 HD23 ' HB2' ' E' ' 11' ' ' LEU . 73.1 mt -85.39 43.69 1.04 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.394 0.678 . . . . 75.12 110.407 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 15' ' ' PHE . . . . . 0.516 ' HE2' ' HB3' ' A' ' 103' ' ' PRO . 82.3 m-85 62.28 -174.11 0.14 Allowed 'General case' 0 C--N 1.362 1.116 0 C-N-CA 124.285 1.034 . . . . 51.31 111.389 -171.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 70.3 p -94.97 144.69 28.24 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.016 0.526 . . . . 74.14 109.799 176.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 17' ' ' PRO . . . . . 0.463 ' HB3' ' H ' ' E' ' 21' ' ' ALA . 57.7 Cg_exo -45.63 108.21 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 123.544 2.83 . . . . 73.53 112.979 166.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 18' ' ' VAL . . . . . 0.515 HG11 HG21 ' A' ' 86' ' ' ILE . 15.0 p -67.07 -39.81 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.58 0.752 . . . . 63.34 111.322 -176.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 11.8 m -105.36 -73.29 0.68 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.384 -0.969 . . . . 74.11 108.384 173.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -167.27 41.95 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 109.932 -0.396 . . . . 60.1 109.932 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 21' ' ' ALA . . . . . 0.463 ' H ' ' HB3' ' E' ' 17' ' ' PRO . . . -67.84 76.32 0.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.825 0.85 . . . . 74.21 111.984 -175.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -168.72 -2.23 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.893 1.277 . . . . 63.11 109.802 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 92.7 m -46.39 122.15 6.57 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 125.055 1.342 . . . . 62.21 112.019 174.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.12 106.33 0.25 Allowed 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 123.201 2.601 . . . . 72.23 112.377 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 C--O 1.253 1.26 0 C-N-CA 124.296 1.038 . . . . 75.1 109.433 -179.383 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' F' F ' 1' ' ' MET . . . . . 0.467 ' SD ' HG13 ' F' ' 6' ' ' ILE . 54.0 mtm . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.182 -0.673 . . . . 71.04 109.182 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -111.14 -76.97 0.59 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.745 0.418 . . . . 73.13 110.391 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -104.2 2.58 31.91 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.486 0.714 . . . . 70.24 111.09 -173.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 50.5 m -99.64 118.51 36.33 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.453 0.701 . . . . 64.11 110.116 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 74.5 m -69.11 141.44 54.68 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.09 -1.078 . . . . 75.21 108.09 167.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.617 ' H ' HD12 ' F' ' 6' ' ' ILE . 3.0 mp -64.14 -64.35 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 109.238 -0.653 . . . . 63.34 109.238 -174.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . 65.74 139.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 125.292 1.437 . . . . 74.34 112.367 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 8' ' ' LEU . . . . . 0.531 ' H ' HG21 ' B' ' 131' ' ' VAL . 47.0 mt -58.4 133.22 55.56 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.774 0.321 . . . . 74.12 110.592 175.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.83 169.78 16.07 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.843 -0.617 . . . . 73.31 110.578 176.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 10' ' ' LEU . . . . . 0.459 HD21 ' HB2' ' B' ' 136' ' ' LEU . 89.1 mt -70.65 151.08 45.34 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.249 -0.649 . . . . 71.42 109.249 172.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 71.4 mt -57.95 107.3 0.89 Allowed Pre-proline 0 CA--C 1.557 1.237 0 O-C-N 124.24 0.963 . . . . 75.21 110.674 -177.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -64.77 -44.73 9.86 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 123.113 2.542 . . . . 75.43 110.604 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 mp -97.78 108.31 21.0 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 107.63 -1.248 . . . . 72.42 107.63 169.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.32 116.24 26.39 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 106.694 -1.595 . . . . 71.55 106.694 173.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -61.69 170.83 1.79 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.854 0.861 . . . . 70.15 112.816 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 9.4 p -65.89 148.3 98.36 Favored Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 124.069 0.948 . . . . 75.02 111.29 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -49.26 161.04 0.71 Allowed 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 123.857 3.038 . . . . 62.33 114.596 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 79.3 t -46.14 -45.09 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 C-N-CA 125.072 1.349 . . . . 75.11 113.284 -172.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 50.4 m -73.18 -36.69 66.62 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.676 0.79 . . . . 61.2 111.22 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -88.86 -4.82 58.37 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.007 0.923 . . . . 75.05 111.665 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.55 8.64 11.24 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.64 1.176 . . . . 74.42 110.664 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 22' ' ' ARG . . . . . 0.638 ' HA ' ' HB2' ' B' ' 50' ' ' GLN . 13.5 ptm180 -61.31 -14.64 28.33 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.848 1.259 . . . . 71.12 113.076 172.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 2.8 t -49.84 113.65 3.55 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 124.256 1.022 . . . . 71.35 111.048 173.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 24' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' B' ' 49' ' ' SER . 19.2 Cg_endo -92.37 -168.73 0.23 Allowed 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.221 2.614 . . . . 65.54 113.997 -173.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 C--O 1.256 1.431 0 C-N-CA 124.321 1.048 . . . . 71.54 109.137 174.599 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.842 -0.429 . . . . 74.22 109.842 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -159.38 -42.95 0.05 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.48 0.312 . . . . 75.2 110.894 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -143.08 114.09 7.71 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.966 0.507 . . . . 62.14 109.67 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 26.2 m -85.74 -9.47 57.08 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.545 0.738 . . . . 61.03 111.108 173.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 37.8 m 65.28 -79.94 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.668 1.587 . . . . 75.15 111.441 -178.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 6' ' ' ILE . . . . . 0.674 HG13 HD21 ' C' ' 42' ' ' LEU . 19.3 tt -158.0 131.63 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.388 0.675 . . . . 71.22 109.759 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.09 136.62 13.21 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.046 0.939 . . . . 64.03 108.942 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.55 140.75 31.2 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.772 -0.825 . . . . 73.22 108.772 177.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.61 126.84 29.29 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.875 0.87 . . . . 70.54 111.878 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 4.3 tt -65.28 132.53 49.29 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.235 1.014 . . . . 75.03 108.442 175.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 11' ' ' LEU . . . . . 0.449 HD22 ' O ' ' G' ' 13' ' ' LEU . 13.0 mt -60.39 111.3 3.81 Favored Pre-proline 0 N--CA 1.482 1.162 0 O-C-N 124.137 0.898 . . . . 74.32 112.285 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -88.09 -8.61 5.64 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.672 2.248 . . . . 75.5 111.692 172.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 13' ' ' LEU . . . . . 0.449 ' O ' HD22 ' G' ' 11' ' ' LEU . 1.7 tt -148.85 123.47 9.8 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 106.582 -1.636 . . . . 74.52 106.582 -178.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 14' ' ' LEU . . . . . 0.456 HD22 ' HA3' ' C' ' 99' ' ' GLY . 83.1 mt -75.17 -179.22 4.27 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.23 0.612 . . . . 74.32 111.639 -177.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 15' ' ' PHE . . . . . 0.451 ' HB2' ' HB3' ' C' ' 98' ' ' LEU . 7.6 m-85 -69.24 164.36 22.9 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.392 0.677 . . . . 62.23 110.818 174.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -66.85 136.26 94.45 Favored Pre-proline 0 CA--C 1.556 1.201 0 CA-C-N 115.479 -0.782 . . . . 71.53 109.959 173.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 17' ' ' PRO . . . . . 0.544 ' HB3' ' HB3' ' G' ' 21' ' ' ALA . 36.4 Cg_endo -62.34 166.33 13.27 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.552 2.835 . . . . 64.01 114.163 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 18' ' ' VAL . . . . . 0.414 HG23 HD11 ' C' ' 98' ' ' LEU . 39.9 t -90.15 -69.01 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.716 0.806 . . . . 74.52 109.042 176.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 66.8 p -96.55 -149.94 0.33 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.712 0.805 . . . . 74.21 108.941 176.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -80.81 68.21 6.98 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-O 121.436 0.636 . . . . 62.53 111.007 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 21' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' G' ' 17' ' ' PRO . . . -99.01 18.77 16.48 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.34 -0.615 . . . . 75.14 109.34 170.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 31.2 ptt85 -134.24 129.39 35.6 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 125.111 1.364 . . . . 71.33 108.887 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 28.7 m 61.45 84.31 0.2 Allowed Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 124.389 1.076 . . . . 63.25 111.588 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.1 -15.18 18.52 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.967 2.445 . . . . 74.23 113.08 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 . . . . . 0 C--O 1.256 1.396 0 C-N-CA 124.163 0.985 . . . . 55.23 108.983 -177.432 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 73.9 mtm . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 110.26 -0.274 . . . . 74.44 110.26 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 59.8 mttm 64.95 21.21 12.28 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.874 1.27 . . . . 72.52 112.218 173.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -83.99 95.07 8.43 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.326 1.051 . . . . 74.43 109.785 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 10.5 p -94.26 -59.36 1.97 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.913 0.885 . . . . 61.51 111.006 -175.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 5' ' ' THR . . . . . 0.437 ' HB ' ' H ' ' H' ' 6' ' ' ILE . 3.6 p -115.22 -142.82 0.38 Allowed 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.868 0.867 . . . . 73.53 109.957 177.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.606 ' H ' HD12 ' H' ' 6' ' ' ILE . 4.4 mp -55.37 108.21 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.411 0 C-N-CA 124.533 1.133 . . . . 72.11 111.039 -172.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.99 133.71 41.31 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.49 0.716 . . . . 72.32 109.27 175.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 97.5 mt -77.03 147.12 36.94 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.257 0.623 . . . . 72.13 110.904 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.99 160.88 14.09 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.365 0.666 . . . . 54.3 110.208 175.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 8.5 mp -68.62 120.12 14.13 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 109.093 -0.706 . . . . 65.13 109.093 173.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.469 ' HG ' ' HZ ' ' D' ' 133' ' ' PHE . 96.0 mt -58.21 146.99 68.37 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 123.392 0.677 . . . . 71.22 110.962 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.19 118.8 5.7 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.799 2.333 . . . . 70.35 110.497 176.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 22.9 tp 60.8 18.8 9.0 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.242 1.017 . . . . 71.41 111.237 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 mp 60.52 -83.81 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.86 1.264 . . . . 71.52 110.517 -171.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 15' ' ' PHE . . . . . 0.51 ' CD1' ' HB3' ' D' ' 98' ' ' LEU . 18.4 t80 -167.14 164.73 15.72 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.431 -0.951 . . . . 70.05 108.431 -176.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 60.4 p -62.31 139.04 96.36 Favored Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 122.828 0.451 . . . . 73.21 110.219 174.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.59 163.74 33.83 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.483 2.122 . . . . 75.32 111.709 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 18' ' ' VAL . . . . . 0.569 HG23 ' HB2' ' D' ' 94' ' ' MET . 96.4 t -51.66 -54.91 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 123.941 0.896 . . . . 74.42 110.959 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 89.2 m -56.62 107.0 0.34 Allowed 'General case' 0 CA--C 1.546 0.818 0 O-C-N 124.292 0.995 . . . . 54.1 110.84 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt 63.26 44.84 5.35 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.937 1.295 . . . . 73.44 111.329 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.88 82.5 0.07 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.047 0.539 . . . . 64.44 110.635 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? 52.29 86.13 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.48 1.512 . . . . 74.21 112.556 -174.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 58.8 p -56.31 145.82 55.62 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 123.962 0.905 . . . . 64.34 111.363 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -64.33 132.0 32.11 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.68 2.253 . . . . 74.25 111.876 -174.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 C--O 1.253 1.285 0 C-N-CA 123.923 0.889 . . . . 60.51 110.876 -176.853 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.8 mtt . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 108.287 -1.005 . . . . 54.2 108.287 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.2 m -73.9 100.81 3.6 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 123.777 0.831 . . . . 73.11 110.638 -174.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.22 174.73 13.89 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.872 0.869 . . . . 73.42 110.013 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 70.46 15.68 7.2 Favored 'General case' 0 C--N 1.362 1.152 0 C-N-CA 125.248 1.419 . . . . 72.05 112.191 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -83.93 117.98 23.7 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.19 -0.67 . . . . 64.41 109.19 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -57.41 97.24 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.258 1.423 . . . . 62.53 112.78 -172.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.1 m 54.57 35.23 23.03 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 125.03 1.332 . . . . 63.13 111.091 175.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -80.48 0.79 32.06 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.712 -0.676 . . . . 73.14 111.186 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.75 ' HB3' HG12 ' A' ' 89' ' ' ILE . 25.4 ptm -74.08 175.94 6.99 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.313 0.578 . . . . 74.14 110.002 169.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.5 p -136.58 143.34 43.55 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.879 -0.786 . . . . 74.51 108.879 -173.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.51 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 24.6 t80 -128.54 125.67 38.78 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.433 -0.951 . . . . 72.3 108.433 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -155.14 102.11 2.28 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.193 -0.669 . . . . 74.41 109.193 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.699 HG12 ' HD2' ' A' ' 84' ' ' PHE . 27.5 mt -72.52 120.39 20.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 109.134 -0.691 . . . . 43.35 109.134 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -85.58 -40.87 15.8 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 123.741 0.651 . . . . 71.54 110.001 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.433 ' HB3' HD12 ' A' ' 83' ' ' ILE . 19.9 ttt180 -173.44 120.89 0.34 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.387 -0.37 . . . . 65.05 110.402 -166.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.551 HD12 ' HG3' ' C' ' 130' ' ' PRO . 62.9 mt -114.0 134.47 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 108.78 -0.822 . . . . 72.42 108.78 173.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.522 ' HB3' HG23 ' B' ' 122' ' ' THR . 31.0 p90 -166.32 165.74 17.1 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 124.216 0.947 . . . . 74.32 110.848 -173.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.7 p -89.13 116.94 27.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.978 -1.01 . . . . 75.24 109.088 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.405 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.3 mtpt -85.58 -32.56 22.04 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.939 0.4 . . . . 71.32 109.996 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.663 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 9.9 t70 -142.85 136.41 28.7 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.018 -0.992 . . . . 51.0 109.289 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.0 mt -137.3 146.54 27.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 107.393 -1.336 . . . . 52.15 107.393 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.9 t -155.44 131.7 10.24 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.235 0.614 . . . . 74.5 109.829 172.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.541 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.3 t80 -130.44 141.84 50.52 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.181 -1.414 . . . . 74.12 107.181 171.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -139.48 139.99 37.14 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.021 0.929 . . . . 74.01 108.506 175.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.451 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -124.09 82.81 56.28 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 106.256 -1.757 . . . . 41.43 106.256 171.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.54 -42.01 29.14 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 123.058 2.505 . . . . 74.45 112.706 -166.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -111.41 25.14 12.0 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 118.13 -0.938 . . . . 72.54 109.654 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.493 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -37.03 -62.8 0.52 Allowed Pre-proline 0 N--CA 1.497 1.924 0 C-N-CA 124.433 1.093 . . . . 54.3 113.915 -166.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 12.7 Cg_exo -67.87 -24.53 39.98 Favored 'Trans proline' 0 C--N 1.394 2.935 0 C-N-CA 122.175 1.917 . . . . 62.52 112.712 -173.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -78.03 -47.21 18.93 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.88 0.872 . . . . 74.21 109.784 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.685 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.2 p -79.8 -12.15 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-N 114.645 -1.162 . . . . 63.35 112.654 -163.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -66.81 -27.39 67.52 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.047 0.451 . . . . 71.22 110.623 171.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -78.33 -18.04 55.72 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.284 1.034 . . . . 45.24 111.276 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -80.06 151.08 30.1 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.642 0.777 . . . . 73.22 111.01 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.05 138.82 58.64 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.268 -0.878 . . . . 74.43 110.142 174.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -79.88 83.65 5.77 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.395 0.617 . . . . 72.14 109.837 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -131.62 73.74 78.9 Favored Pre-proline 0 C--O 1.244 0.801 0 N-CA-C 108.039 -1.097 . . . . 72.43 108.039 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -84.4 159.26 12.83 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.269 1.979 . . . . 61.55 111.87 -176.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -111.16 106.4 15.41 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.375 -1.713 . . . . 74.15 106.375 166.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.499 HG11 HD12 ' E' ' 6' ' ' ILE . 53.7 t -66.48 92.25 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 108.557 -0.905 . . . . 65.01 108.557 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -100.32 112.49 24.83 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.612 -1.625 . . . . 71.14 106.612 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.43 HD21 ' O ' ' E' ' 7' ' ' ALA . 0.7 OUTLIER -132.05 150.53 52.13 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.326 0.584 . . . . 55.21 112.318 -174.438 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -136.06 113.08 10.39 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.483 -1.235 . . . . 45.41 108.262 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 mp -98.08 124.18 42.48 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 108.697 -0.853 . . . . 71.54 108.697 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.59 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 11.3 t70 -121.76 149.47 43.24 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.778 1.231 . . . . 74.14 109.953 -171.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.4 m -110.54 132.83 53.85 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.926 0.89 . . . . 72.03 109.917 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.664 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -134.52 151.96 51.47 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.723 1.209 . . . . 71.02 108.46 174.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 p -135.55 173.29 11.88 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.911 0.708 . . . . 53.13 112.911 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 37.7 t -168.58 143.9 3.47 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.456 1.502 . . . . 74.22 108.218 174.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -113.23 109.15 18.29 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.176 -1.046 . . . . 74.41 108.176 170.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 53.5 mt -80.81 -39.1 27.24 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.069 -0.514 . . . . 72.45 110.735 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -155.48 -175.92 5.68 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.431 0.693 . . . . 51.32 110.636 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.65 119.74 12.26 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.984 -0.747 . . . . 73.41 108.984 172.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 71.2 -1.68 2.64 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.723 1.209 . . . . 73.25 112.545 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 48.7 t -107.36 114.17 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.463 -0.94 . . . . 60.53 108.463 177.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -122.3 159.61 27.04 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.58 0.752 . . . . 75.43 109.286 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 12.6 tt0 -130.29 124.84 33.31 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.384 -1.339 . . . . 65.1 107.384 170.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.6 m -119.91 138.22 51.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.486 -0.931 . . . . 70.33 108.486 174.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.664 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 59.5 t -118.83 136.97 54.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.488 1.115 . . . . 61.22 109.117 -175.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tt -114.59 106.81 14.69 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.623 -1.251 . . . . 63.22 107.623 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.713 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 36.9 ttp180 -87.22 102.07 14.12 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.563 -0.532 . . . . 73.32 109.563 176.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.71 107.24 19.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 107.864 -1.162 . . . . 70.2 107.864 172.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.4 m -94.62 143.22 26.61 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 107.789 -1.189 . . . . 65.32 107.789 173.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.9 t -141.07 138.97 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.138 1.375 . . . . 73.41 108.405 -173.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.2 m -138.65 138.92 38.27 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.859 -0.793 . . . . 75.31 108.859 175.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.01 104.5 14.19 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 107.143 -1.429 . . . . 63.42 107.143 169.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -108.91 127.8 54.37 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.762 -0.459 . . . . 75.51 109.762 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.3 mt -99.06 75.8 2.06 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 106.86 -1.533 . . . . 63.43 106.86 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.95 -83.43 1.17 Allowed Glycine 0 C--N 1.346 1.105 0 N-CA-C 111.942 -0.463 . . . . 72.31 111.942 -175.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -119.03 -29.97 5.13 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.019 0.528 . . . . 70.33 110.883 175.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -88.68 113.68 24.51 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.107 0.563 . . . . 74.43 109.83 -173.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.3 m -73.37 133.23 43.74 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-O 121.06 0.457 . . . . 74.12 110.884 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.685 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -77.27 -58.97 2.98 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.915 1.286 . . . . 63.23 109.479 176.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.435 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 35.3 p90 -148.24 164.52 33.73 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.959 -1.019 . . . . 61.22 111.185 174.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.9 tp -123.52 142.11 51.34 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.336 1.454 . . . . 74.22 108.186 173.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.3 m -138.07 138.28 38.6 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 124.42 1.088 . . . . 43.1 108.781 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -148.93 120.12 7.79 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.069 -0.715 . . . . 72.12 109.069 173.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 85.9 t -128.51 128.01 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 123.411 0.684 . . . . 51.12 109.611 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.713 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 47.0 mt-30 -95.56 95.01 8.09 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.695 -0.854 . . . . 72.22 108.695 165.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.434 ' HG3' HD22 ' A' ' 106' ' ' LEU . 64.1 tp60 -78.51 99.74 6.61 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.927 -0.768 . . . . 73.5 108.927 176.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.62 154.25 29.46 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.764 -0.653 . . . . 71.34 111.557 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.89 124.98 1.44 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.232 -0.747 . . . . 55.3 111.232 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' A' ' 15' ' ' ARG . 48.8 mt -85.69 119.6 34.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.553 -0.906 . . . . 64.41 108.553 174.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.699 ' HD2' HG12 ' A' ' 13' ' ' ILE . 17.4 m-85 -129.9 120.26 24.61 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.386 -1.338 . . . . 65.43 107.386 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.7 t -75.44 96.37 3.43 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.848 -1.167 . . . . 71.23 107.848 174.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -127.94 130.85 69.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 123.95 0.9 . . . . 71.21 109.292 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 166.38 -177.78 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 126.581 1.952 . . . . 73.53 108.199 172.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 125.05 -52.24 0.81 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 110.873 -0.891 . . . . 74.34 110.873 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.75 HG12 ' HB3' ' A' ' 9' ' ' MET . 11.3 pt -131.27 168.67 23.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 C-N-CA 123.987 0.915 . . . . 75.13 109.064 174.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -125.15 -154.73 0.64 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.018 1.327 . . . . 74.11 109.607 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.61 -155.5 52.21 Favored Glycine 0 C--N 1.356 1.685 0 C-N-CA 122.841 0.258 . . . . 75.44 113.296 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.1 p -66.54 -25.9 66.88 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.095 0.958 . . . . 54.33 111.432 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -57.88 -58.65 7.45 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.785 1.234 . . . . 72.42 110.681 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 12.7 tmm? -70.14 -35.75 74.28 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.907 -1.042 . . . . 61.52 110.422 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.1 -36.82 75.8 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.325 0.65 . . . . 42.41 111.912 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.487 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 62.8 t-80 -79.57 -36.03 38.84 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.519 0.327 . . . . 64.12 111.086 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 101' ' ' TYR . 44.7 t -69.14 -50.42 48.02 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.394 0.616 . . . . 54.42 111.069 -177.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -83.27 -39.31 21.03 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.089 0.955 . . . . 62.14 110.667 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.45 -14.17 57.44 Favored Glycine 0 N--CA 1.473 1.114 0 N-CA-C 114.73 0.652 . . . . 64.15 114.73 -171.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.68 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -123.56 -53.53 1.79 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 117.928 0.864 . . . . 51.42 111.207 -176.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.51 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 68.8 t80 -70.94 -50.55 33.39 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-N 115.231 -0.895 . . . . 74.34 111.98 -176.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.425 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 92.1 m -72.05 -32.57 2.08 Favored Pre-proline 0 CA--C 1.576 1.973 0 N-CA-C 115.69 1.737 . . . . 75.51 115.69 -174.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 29.9 Cg_endo -64.43 -32.55 60.06 Favored 'Trans proline' 0 C--N 1.392 2.818 0 CA-C-N 122.343 1.872 . . . . 71.51 112.039 169.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -65.95 -24.26 66.77 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.565 0.746 . . . . 61.41 110.763 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.4 mm -70.53 -50.79 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.479 0.712 . . . . 75.13 110.304 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.434 HD22 ' HG3' ' A' ' 80' ' ' GLN . 84.5 mt -74.1 -23.77 59.37 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.007 0.743 . . . . 74.14 113.007 -176.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -58.94 -49.91 90.8 Favored Pre-proline 0 CA--C 1.573 1.86 0 N-CA-C 113.883 1.068 . . . . 74.13 113.883 -173.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.86 -32.94 54.61 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 122.176 1.917 . . . . 74.23 113.202 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -67.06 -42.52 84.59 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.938 0.495 . . . . 63.05 110.816 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.43 -42.01 98.68 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.401 -0.818 . . . . 73.54 110.343 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.43 ' NH1' HG23 ' C' ' 105' ' ' ILE . 39.3 ttm180 -56.46 -52.09 65.99 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 124.267 0.98 . . . . 65.51 110.183 175.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -63.93 -44.93 91.37 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.766 0.826 . . . . 64.45 111.073 -174.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -59.51 -34.79 73.06 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.553 0.533 . . . . 64.04 111.182 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 98.5 mt -72.74 -51.44 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 115.541 -0.754 . . . . 74.53 110.145 174.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 49.6 m -59.03 -34.48 71.94 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.218 1.007 . . . . 74.25 111.558 -174.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 34.6 t -68.45 -47.19 67.79 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.54 -0.754 . . . . 64.4 110.242 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.541 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 54.6 mtm -61.06 -40.69 94.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 123.676 0.61 . . . . 72.32 111.163 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.13 -52.82 55.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 124.283 0.989 . . . . 74.34 110.753 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.9 t -67.72 -29.42 68.66 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.412 0.685 . . . . 52.24 111.007 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 116' ' ' SER . 20.7 ttm-85 -76.79 -30.87 56.65 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.804 1.242 . . . . 71.23 108.632 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.428 ' O ' HG22 ' A' ' 122' ' ' THR . . . -86.37 13.6 57.28 Favored Glycine 0 C--N 1.355 1.634 0 CA-C-N 114.739 -1.119 . . . . 63.21 112.545 171.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.505 HG21 ' HE ' ' B' ' 15' ' ' ARG . 2.0 t 63.79 15.28 8.92 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 126.969 2.108 . . . . 32.21 114.267 171.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -81.99 149.86 63.92 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 109.478 -0.564 . . . . 72.34 109.478 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.64 165.91 4.19 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.413 2.742 . . . . 71.13 114.497 -176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.598 ' HG2' ' HG3' ' C' ' 15' ' ' ARG . 6.7 tp-100 -57.91 123.48 15.97 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.097 -0.956 . . . . 75.44 111.86 -175.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.435 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 60.5 tp -120.56 106.89 12.21 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.455 1.102 . . . . 71.4 108.817 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.416 HD21 ' HA ' ' C' ' 15' ' ' ARG . 18.3 m-80 -100.65 115.12 29.46 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.822 -0.807 . . . . 65.34 108.822 175.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.51 137.73 44.62 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 108.161 -1.052 . . . . 64.42 108.161 174.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.94 146.8 57.67 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 123.864 0.866 . . . . 72.41 112.791 -174.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.459 ' HG3' HG13 ' C' ' 13' ' ' ILE . 14.1 Cg_exo -71.45 127.66 13.55 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.649 2.233 . . . . 71.35 111.541 172.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.5 p -142.93 125.49 13.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-O 121.376 0.607 . . . . 64.44 109.734 170.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -103.4 101.31 11.21 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.083 -1.08 . . . . 71.13 108.083 174.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -64.6 -30.59 71.62 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 123.743 0.652 . . . . 73.04 110.258 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.68 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 8.1 p-10 -59.67 -45.02 93.31 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.63 0.772 . . . . 73.1 110.921 176.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.03 -41.17 36.49 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.507 0.723 . . . . 61.31 111.309 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.437 ' O ' ' HB3' ' A' ' 139' ' ' ASN . 1.5 tt -70.56 -39.39 73.96 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.751 0.82 . . . . 71.43 110.865 -172.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -77.68 -33.5 53.24 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.758 0.423 . . . . 63.21 110.394 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 16.8 ptm -80.04 -19.66 47.13 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 120.78 0.324 . . . . 75.31 111.307 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 136' ' ' LEU . 21.3 t30 -60.83 -30.93 70.4 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.066 0.946 . . . . 74.42 110.612 168.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -79.82 -31.17 40.6 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 122.233 -0.292 . . . . 44.24 111.228 171.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.608 ' HG ' ' HG2' ' A' ' 142' ' ' GLN . 60.8 tp -61.97 -48.03 82.21 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.106 0.962 . . . . 73.44 111.818 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.608 ' HG2' ' HG ' ' A' ' 141' ' ' LEU . 83.4 mm-40 -143.29 19.21 1.9 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 112.248 0.462 . . . . 74.34 112.248 -170.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 60.54 96.2 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.601 1.161 . . . . 72.23 112.914 170.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 65.82 -80.74 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.327 1.451 . . . . 53.04 111.38 175.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.61 122.54 28.72 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.445 0.698 . . . . 62.55 110.507 -176.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.38 -75.93 1.25 Allowed Glycine 0 C--N 1.342 0.912 0 N-CA-C 110.244 -1.143 . . . . 54.13 110.244 170.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 64.5 153.8 0.06 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.139 1.376 . . . . 62.13 112.855 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -146.05 -119.54 1.22 Allowed Glycine 0 C--N 1.343 0.948 0 N-CA-C 110.626 -0.989 . . . . 64.31 110.626 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.3 t -162.08 110.63 1.44 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.793 0.837 . . . . 70.34 108.919 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -89.13 85.49 6.67 Favored 'General case' 0 C--N 1.348 0.509 0 N-CA-C 108.52 -0.919 . . . . 72.41 108.52 172.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -78.05 143.97 36.99 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.727 -1.124 . . . . 73.53 108.226 165.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.8 p-80 -119.56 158.51 26.19 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.579 0.351 . . . . 73.12 110.708 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -93.17 133.74 36.05 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.962 -1.125 . . . . 64.41 107.962 172.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -72.52 -66.25 0.68 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.738 0.415 . . . . 74.5 109.921 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.769 0 N-CA-C 107.89 -1.152 . . . . 74.32 107.89 176.419 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 59.2 mtt . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 108.861 -0.792 . . . . 53.22 108.861 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t -150.69 40.71 0.75 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.246 0.618 . . . . 73.41 109.627 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -77.71 82.64 4.11 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.051 -0.522 . . . . 74.44 110.39 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -139.15 101.78 4.35 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.27 -1.011 . . . . 63.14 108.27 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -90.28 74.96 6.97 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.863 0.84 . . . . 74.14 110.875 -176.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -165.31 153.96 11.92 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.184 -0.916 . . . . 73.01 109.458 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 41.6 p -75.3 94.42 3.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.933 0.493 . . . . 75.44 110.035 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -118.09 176.1 5.37 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.924 0.889 . . . . 62.51 111.081 177.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.644 ' HB3' HG12 ' B' ' 89' ' ' ILE . 18.0 ptm 59.81 170.4 0.08 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.198 2.199 . . . . 64.23 113.522 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 26.9 m -155.73 135.71 12.84 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.603 -0.726 . . . . 75.14 109.593 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -151.43 156.51 40.79 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.344 -0.613 . . . . 73.31 109.344 157.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -125.7 134.26 51.87 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 107.423 -1.325 . . . . 74.42 107.423 172.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.527 HD11 ' HG3' ' D' ' 130' ' ' PRO . 36.4 mt -70.59 116.91 12.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.553 0 N-CA-C 107.948 -1.13 . . . . 65.14 107.948 173.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -89.46 -44.63 10.02 Favored 'General case' 0 C--O 1.243 0.746 0 O-C-N 123.822 0.701 . . . . 72.4 109.49 -176.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.505 ' HE ' HG21 ' A' ' 122' ' ' THR . 40.5 ttt180 -165.4 131.05 2.59 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 116.117 -0.492 . . . . 61.33 110.981 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.4 mt -113.9 139.34 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 107.433 -1.321 . . . . 74.42 107.433 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.408 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 33.7 p90 -167.79 158.5 10.94 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.426 0.631 . . . . 74.23 111.788 -176.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.524 HG21 HD11 ' B' ' 21' ' ' ILE . 90.0 m -80.69 129.94 34.81 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.859 -1.064 . . . . 61.23 109.284 168.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.408 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 29.9 mtpt -97.47 -32.17 11.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.864 0.866 . . . . 62.52 110.084 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -152.82 138.52 17.87 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.642 -0.708 . . . . 75.13 111.037 -169.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.618 HD11 ' SG ' ' B' ' 113' ' ' CYS . 31.9 mm -134.01 146.57 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.253 1.421 . . . . 73.42 109.63 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 98.0 p -147.87 152.43 37.59 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.371 -1.286 . . . . 74.41 109.283 163.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 85.5 t80 -154.91 109.8 3.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.375 -1.343 . . . . 71.43 107.375 167.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.23 122.2 42.37 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.909 -0.775 . . . . 61.33 108.909 -175.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.942 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -118.32 82.98 19.51 Favored Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 108.807 -0.812 . . . . 74.33 108.807 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.88 -30.13 7.71 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.965 2.443 . . . . 73.4 113.008 -172.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -107.69 10.51 28.93 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 118.799 -0.619 . . . . 73.21 110.9 176.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.942 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -40.6 -61.31 1.25 Allowed Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 115.028 1.492 . . . . 52.52 115.028 -168.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 23.4 Cg_exo -61.53 -30.05 85.64 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 122.392 2.061 . . . . 52.21 112.811 -169.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -97.74 -32.04 11.94 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.606 0.762 . . . . 71.1 112.394 -175.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.436 HG22 ' HB2' ' B' ' 68' ' ' LEU . 4.3 p -72.04 -20.73 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.22 0.608 . . . . 63.15 111.365 -169.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -60.07 -22.93 63.34 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.763 0.825 . . . . 74.1 113.202 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -67.17 -16.28 64.21 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.207 0.603 . . . . 75.54 111.441 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.421 ' HD2' ' HB3' ' B' ' 68' ' ' LEU . 92.6 mttt -87.89 102.26 14.53 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.296 1.038 . . . . 73.31 109.685 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -86.8 78.32 9.1 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.732 0.813 . . . . 61.44 111.358 -174.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -161.68 161.82 29.6 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.777 -0.823 . . . . 74.3 108.777 166.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -70.92 114.86 30.49 Favored Pre-proline 0 C--O 1.246 0.904 0 N-CA-C 107.445 -1.317 . . . . 63.44 107.445 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.506 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 10.3 Cg_endo -53.47 151.19 24.6 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 123.007 2.471 . . . . 71.23 112.712 -173.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.06 104.02 0.67 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.598 -1.26 . . . . 72.14 107.598 172.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.466 HG21 HD21 ' B' ' 126' ' ' LEU . 19.7 m -100.87 155.36 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.244 -0.889 . . . . 71.13 110.449 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -136.2 131.0 34.03 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.263 1.025 . . . . 60.34 108.616 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.566 ' HB2' ' HB ' ' F' ' 6' ' ' ILE . 0.2 OUTLIER -89.9 140.64 29.42 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 107.993 -1.114 . . . . 70.32 107.993 171.214 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -151.3 112.08 4.24 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.745 -1.206 . . . . 61.45 107.745 172.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.534 HD11 ' HG ' ' F' ' 11' ' ' LEU . 2.1 pt? -101.74 156.55 17.43 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 122.635 0.374 . . . . 74.21 110.076 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.4 t70 -139.02 151.92 47.2 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.261 0.624 . . . . 73.32 110.48 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 38.9 p -109.88 126.35 53.76 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.669 1.188 . . . . 70.04 110.108 -174.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.69 144.77 20.7 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.784 0.434 . . . . 74.54 110.141 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 47.5 p -145.43 174.09 11.44 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.78 0.432 . . . . 75.11 111.012 176.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 53.8 p -154.05 138.9 17.13 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.426 -0.806 . . . . 63.35 109.538 171.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -84.74 126.02 33.04 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.048 0.539 . . . . 72.23 110.956 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 62.2 mt -93.68 -40.92 9.98 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.759 0.823 . . . . 72.45 109.63 174.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.51 175.92 13.39 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.718 -1.128 . . . . 75.44 109.338 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.03 125.21 23.25 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.766 -0.828 . . . . 74.32 108.766 172.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 73.53 -5.48 1.98 Allowed 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 125.345 1.458 . . . . 74.35 112.831 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 72.8 t -108.05 111.97 38.21 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 N-CA-C 108.936 -0.765 . . . . 72.33 108.936 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -126.02 150.55 48.02 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.859 0.838 . . . . 73.04 110.206 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -108.12 103.94 13.25 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 113.811 -1.54 . . . . 53.25 106.915 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 74.1 t -88.53 117.28 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.885 1.274 . . . . 32.02 110.638 -173.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 18.5 t -107.31 113.64 44.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 108.507 -0.923 . . . . 74.21 108.507 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.77 HD22 ' HB3' ' B' ' 103' ' ' PRO . 43.1 tp -103.61 115.74 31.06 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.036 -1.098 . . . . 61.33 108.036 169.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 10.3 ttm180 -86.61 131.64 34.11 Favored 'General case' 0 CA--C 1.526 0.025 0 N-CA-C 108.956 -0.757 . . . . 75.11 108.956 174.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.66 103.34 14.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.781 -1.192 . . . . 72.43 107.781 171.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 9.3 m -99.69 133.58 43.83 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.816 -0.809 . . . . 71.42 108.816 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.442 HG23 HD13 ' B' ' 114' ' ' ILE . 86.8 t -123.25 127.65 74.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 124.075 0.95 . . . . 62.05 108.916 175.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 80.1 m -101.54 148.87 24.7 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.296 -1.001 . . . . 43.32 108.296 169.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.8 134.82 23.91 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.13 0.572 . . . . 74.22 109.819 177.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.589 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 33.7 p -142.1 127.93 19.36 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.748 -0.66 . . . . 64.15 110.707 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.506 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 22.1 mt -95.93 105.06 17.03 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.373 -0.973 . . . . 51.23 108.373 173.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.12 -118.05 8.42 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.804 -1.089 . . . . 44.24 112.913 -173.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -107.89 18.4 21.33 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.809 0.844 . . . . 73.34 110.696 -173.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -138.64 143.51 39.29 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.496 -0.753 . . . . 73.12 109.992 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.1 m -67.21 114.71 6.16 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.172 0.589 . . . . 62.01 110.555 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.589 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -69.85 -59.24 3.05 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.101 -1.074 . . . . 53.15 108.101 178.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -156.05 167.07 31.57 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.658 -1.156 . . . . 72.13 111.527 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 99.2 mt -128.83 146.99 50.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 113.622 -1.626 . . . . 54.03 106.635 172.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 44.9 t -150.66 135.22 17.23 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.994 -1.113 . . . . 64.23 107.994 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -143.27 124.87 14.87 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 107.959 -1.126 . . . . 60.41 107.959 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 96.9 t -122.91 146.74 27.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.914 -1.143 . . . . 71.12 107.914 178.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.496 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 21.7 mt-30 -126.65 102.89 7.28 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.943 -1.132 . . . . 74.14 107.943 172.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -89.0 99.77 12.69 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.099 -1.074 . . . . 73.4 108.099 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.55 143.09 16.3 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 110.698 -0.961 . . . . 34.24 110.698 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.91 126.97 2.48 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 110.054 -1.218 . . . . 54.1 110.054 -173.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 59.2 mt -86.7 127.59 40.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 109.263 -0.643 . . . . 63.51 109.263 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -134.28 133.36 40.69 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.11 -1.07 . . . . 74.33 108.11 175.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.5 m -99.1 89.4 4.24 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.15 0.58 . . . . 72.33 109.499 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.543 HG21 HD11 ' B' ' 98' ' ' LEU . 7.1 tt -98.17 126.75 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.704 0.802 . . . . 74.25 111.92 -168.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.22 163.18 37.78 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.641 0.776 . . . . 74.11 111.061 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.12 -53.37 0.6 Allowed Glycine 0 C--N 1.35 1.321 0 CA-C-N 115.493 -0.776 . . . . 63.11 112.818 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.644 HG12 ' HB3' ' B' ' 9' ' ' MET . 9.7 mm -90.48 162.08 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 124.089 0.956 . . . . 64.5 112.607 -170.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.697 ' HB2' ' HD2' ' F' ' 22' ' ' ARG . 26.9 tt0 -150.3 162.92 39.58 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.654 0.782 . . . . 70.24 109.855 173.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.81 -135.13 12.83 Favored Glycine 0 C--N 1.348 1.247 0 C-N-CA 123.206 0.431 . . . . 65.43 113.32 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m -89.16 -17.11 29.82 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 117.073 0.436 . . . . 53.44 110.705 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -61.88 -33.6 74.49 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.315 0.646 . . . . 73.12 111.277 175.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.493 ' HB3' HG22 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -80.21 -25.85 39.44 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.462 0.305 . . . . 71.02 110.824 175.701 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.428 ' HB2' HG22 ' F' ' 16' ' ' THR . . . -66.16 -31.06 71.69 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.113 0.565 . . . . 33.25 110.042 171.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.433 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 32.4 t-80 -75.92 -39.61 55.9 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.03 0.932 . . . . 63.41 110.613 174.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 40.6 t -66.52 -52.56 44.52 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.947 0.403 . . . . 74.42 111.389 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.543 HD11 HG21 ' B' ' 86' ' ' ILE . 85.0 mt -89.06 -12.47 41.19 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.358 0.663 . . . . 52.32 111.861 -175.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.98 -6.27 34.59 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-O 119.729 -0.484 . . . . 73.41 113.978 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -135.36 -65.1 0.62 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 117.24 0.52 . . . . 60.24 110.462 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.48 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 55.2 t80 -59.36 -52.45 65.57 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.78 0.832 . . . . 72.32 112.954 -172.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.473 ' SG ' HD23 ' B' ' 98' ' ' LEU . 61.9 m -67.61 -45.27 46.05 Favored Pre-proline 0 CA--C 1.562 1.411 0 CA-C-N 115.624 -0.716 . . . . 71.33 111.565 -177.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.77 ' HB3' HD22 ' B' ' 60' ' ' LEU . 69.9 Cg_exo -51.88 -38.77 68.84 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.633 2.222 . . . . 64.24 115.161 167.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -60.64 -30.94 70.18 Favored 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 123.123 0.569 . . . . 74.11 111.94 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.425 HD13 HD11 ' B' ' 13' ' ' ILE . 75.2 mt -69.12 -40.19 80.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.909 0.884 . . . . 73.53 110.297 177.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.7 mt -87.34 -21.33 25.76 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.187 -0.915 . . . . 71.22 111.717 -170.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -53.87 -51.09 79.91 Favored Pre-proline 0 CA--C 1.562 1.435 0 C-N-CA 124.141 0.976 . . . . 73.44 113.182 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -54.25 -40.73 81.12 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 122.339 2.026 . . . . 61.31 114.208 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -70.21 -44.99 67.5 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.293 0.637 . . . . 61.21 110.82 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.57 -39.65 91.91 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.483 0.713 . . . . 75.11 111.032 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.445 HH21 ' ND2' ' B' ' 127' ' ' ASN . 33.9 ttt-85 -60.07 -56.22 24.32 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.374 1.07 . . . . 75.45 110.445 176.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -57.57 -34.69 69.48 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.074 0.95 . . . . 73.35 110.883 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.618 ' SG ' HD11 ' B' ' 21' ' ' ILE . 8.5 t -67.89 -45.85 73.28 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 122.674 0.39 . . . . 73.11 111.187 -178.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.449 ' O ' HG23 ' B' ' 118' ' ' VAL . 84.4 mt -63.4 -53.65 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.526 0.73 . . . . 52.2 109.888 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 34.2 m -57.7 -33.32 68.27 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.024 0.929 . . . . 72.34 111.817 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.464 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 41.1 t -61.83 -51.1 69.61 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 123.233 0.613 . . . . 75.22 109.795 174.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.494 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -67.16 -37.15 83.25 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.059 0.543 . . . . 74.33 111.407 -175.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.449 HG23 ' O ' ' B' ' 114' ' ' ILE . 95.0 t -59.48 -45.37 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.569 0.748 . . . . 75.52 110.116 174.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.6 t -67.42 -33.66 75.62 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.363 -1.29 . . . . 64.53 111.135 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' B' ' 116' ' ' SER . 93.2 mtt-85 -66.83 -31.61 72.34 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.449 -0.796 . . . . 73.22 110.495 177.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.21 9.36 73.12 Favored Glycine 0 C--N 1.353 1.475 0 CA-C-O 119.036 -0.869 . . . . 63.25 113.343 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.522 HG23 ' HB3' ' A' ' 17' ' ' TYR . 81.6 p 55.73 26.13 9.07 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.624 1.57 . . . . 72.1 113.274 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.431 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 56.3 m-85 -84.76 157.32 60.82 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 123.608 0.763 . . . . 74.35 110.171 176.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -54.74 158.76 10.12 Favored 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 123.274 2.649 . . . . 74.04 113.28 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -64.73 134.17 53.62 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.102 0.961 . . . . 72.14 111.36 -171.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.466 HD21 HG21 ' B' ' 40' ' ' VAL . 2.3 tm? -136.65 120.74 17.75 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.415 -0.957 . . . . 75.2 108.415 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 127' ' ' ASN . . . . . 0.445 ' ND2' HH21 ' B' ' 111' ' ' ARG . 16.3 m120 -122.29 136.26 54.87 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.033 0.933 . . . . 65.34 109.292 173.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 5.9 mp -78.92 137.77 37.79 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.785 0.834 . . . . 64.31 109.219 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.628 ' HB3' ' HB2' ' F' ' 7' ' ' ALA . . . -76.64 147.6 78.52 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.517 0.727 . . . . 61.31 110.794 -177.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.545 ' HG3' HD11 ' D' ' 16' ' ' ILE . 89.8 Cg_endo -77.12 114.66 3.83 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.887 2.392 . . . . 73.11 112.389 -175.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 m -121.86 111.36 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.341 0.656 . . . . 71.12 109.956 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -86.41 103.54 15.07 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 108.163 -1.051 . . . . 75.01 108.163 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -60.51 -38.01 82.99 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 124.12 0.888 . . . . 73.31 111.267 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -64.74 -46.29 82.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.831 0.852 . . . . 74.34 111.298 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.64 -40.0 92.06 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 123.812 0.695 . . . . 72.34 111.005 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.599 HD12 HD11 ' F' ' 10' ' ' LEU . 0.7 OUTLIER -65.89 -49.57 67.59 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.008 -0.738 . . . . 74.12 109.008 179.038 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.03 -26.26 66.68 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.636 0.774 . . . . 73.12 111.327 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 14.0 tpt -63.33 -37.57 87.77 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.576 0.75 . . . . 71.01 110.506 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -74.56 -15.95 60.83 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.69 -0.686 . . . . 74.55 111.277 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -85.95 -46.71 10.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 110.118 -0.326 . . . . 73.53 110.118 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 88.9 mt -79.38 -7.14 58.15 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.317 0.647 . . . . 51.42 112.475 -170.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -173.54 152.93 2.2 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.454 0.702 . . . . 71.5 109.238 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -79.71 -60.98 2.14 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.794 -0.817 . . . . 75.33 108.794 172.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 51.91 79.93 0.1 Allowed 'General case' 0 C--N 1.359 0.979 0 O-C-N 124.958 1.411 . . . . 73.42 110.905 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -142.51 126.64 17.45 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.98 -0.554 . . . . 75.25 111.102 -173.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -122.38 158.7 17.06 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.006 -0.838 . . . . 53.52 111.006 174.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -163.94 152.93 13.82 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.422 0.689 . . . . 74.42 109.688 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 107.6 55.65 0.62 Allowed Glycine 0 C--N 1.343 0.931 0 O-C-N 123.425 0.453 . . . . 55.54 113.122 173.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 57.7 p -91.61 123.59 35.13 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.977 0.511 . . . . 63.24 109.764 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -152.8 146.04 24.74 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.158 0.583 . . . . 70.21 111.086 -172.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -168.76 -161.18 0.32 Allowed 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 125.312 1.445 . . . . 61.44 108.697 170.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -87.6 17.03 4.91 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.538 0.94 . . . . 75.45 113.538 -171.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.3 59.87 4.11 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.406 1.483 . . . . 73.21 110.122 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -176.85 100.1 0.05 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.081 -1.418 . . . . 71.25 107.503 -176.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.216 -0.897 . . . . 72.44 109.658 -176.718 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 87.5 mtp . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 119.202 -0.428 . . . . 50.51 111.3 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 71.0 m 65.07 109.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.842 1.257 . . . . 52.54 111.791 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -136.07 96.98 3.5 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 123.39 0.676 . . . . 63.31 109.188 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -150.1 177.09 10.22 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.767 1.227 . . . . 64.3 109.441 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 70.98 -4.72 1.68 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.877 1.271 . . . . 73.24 113.657 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -77.94 79.43 4.41 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.103 -1.073 . . . . 75.34 108.103 175.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 12.5 t -176.67 171.46 2.27 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.847 1.259 . . . . 53.25 109.79 -174.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -94.45 169.65 10.05 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.024 0.93 . . . . 62.1 108.646 171.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.439 ' HE3' HG23 ' C' ' 86' ' ' ILE . 24.1 ttt 67.44 125.38 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.32 1.448 . . . . 75.0 112.45 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 53.3 m -85.98 104.3 15.48 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.438 -0.949 . . . . 74.21 108.438 170.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.566 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.5 t80 -123.75 123.28 40.15 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.152 0.581 . . . . 60.11 109.693 178.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -144.21 133.78 23.48 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.278 1.031 . . . . 72.51 108.88 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.459 HG13 ' HG3' ' A' ' 130' ' ' PRO . 41.7 mt -81.39 128.77 38.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 108.561 -0.903 . . . . 74.13 108.561 173.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.605 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.5 mm-40 -89.84 -42.61 11.16 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.875 0.87 . . . . 55.14 110.381 -176.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.598 ' HG3' ' HG2' ' A' ' 125' ' ' GLN . 33.4 ttt180 -173.98 123.2 0.33 Allowed 'General case' 0 C--N 1.355 0.823 0 O-C-N 123.522 0.514 . . . . 64.11 110.351 -171.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 98.8 mt -110.1 139.7 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 108.818 -0.808 . . . . 51.41 108.818 174.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -170.6 154.06 4.4 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.988 0.915 . . . . 73.54 109.2 -171.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.7 p -80.84 110.14 16.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.322 -0.992 . . . . 55.44 108.322 172.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.619 ' HE2' HG21 ' C' ' 59' ' ' VAL . 6.0 mmmt -67.94 -48.33 66.22 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.141 -1.059 . . . . 75.12 108.141 175.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.697 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 20.4 t70 -135.87 143.37 45.01 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.334 -1.303 . . . . 65.3 110.153 -177.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.7 mt -135.93 149.94 28.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 125.593 1.557 . . . . 75.35 107.005 175.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 37.6 t -158.95 150.6 20.71 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.331 0.653 . . . . 74.53 109.719 173.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -145.85 138.88 25.94 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 106.534 -1.654 . . . . 74.4 106.534 171.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -143.68 113.77 7.3 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.062 -0.718 . . . . 72.31 109.062 -174.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.411 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -126.84 85.1 61.56 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 107.021 -1.474 . . . . 74.25 107.021 169.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.14 -33.13 19.64 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.567 2.178 . . . . 51.25 111.176 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -95.59 11.3 33.65 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 114.625 -1.17 . . . . 74.54 110.348 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.446 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -44.98 -59.19 4.48 Favored Pre-proline 0 C--N 1.377 1.775 0 C-N-CA 124.703 1.201 . . . . 74.24 113.55 -167.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.47 ' HG3' ' HG2' ' D' ' 57' ' ' GLU . 25.1 Cg_exo -58.35 -45.74 28.96 Favored 'Trans proline' 0 C--N 1.399 3.213 0 C-N-CA 121.633 1.555 . . . . 74.22 111.869 -175.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.438 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 83.8 t60 -69.97 -36.16 75.0 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.975 -1.466 . . . . 71.04 112.322 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.642 HG21 ' HA ' ' C' ' 73' ' ' ALA . 3.4 p -78.22 -19.02 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 111.914 0.338 . . . . 65.22 111.914 -168.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -69.74 -28.96 66.23 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.008 0.523 . . . . 75.41 112.028 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 19.5 pt20 -86.39 5.68 33.75 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 122.905 0.482 . . . . 73.4 111.707 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.759 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -84.93 154.34 22.26 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.328 0.651 . . . . 73.43 110.322 177.527 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -59.96 110.77 1.26 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.032 0.533 . . . . 72.42 109.763 166.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -71.17 90.84 0.9 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.863 0.865 . . . . 72.34 110.401 -177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -142.3 74.45 20.57 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 107.553 -1.277 . . . . 62.25 107.553 172.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -90.61 143.28 3.56 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.476 2.117 . . . . 74.01 112.446 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -88.96 106.48 18.44 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.544 1.138 . . . . 75.13 108.114 172.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 43.1 t -72.22 97.37 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 108.503 -0.925 . . . . 55.1 108.503 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.59 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 87.8 tttt -93.31 129.89 39.24 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.454 -0.793 . . . . 73.45 109.002 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.49 HD13 ' HA ' ' G' ' 8' ' ' LEU . 16.0 mt -89.23 149.74 22.96 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 124.358 1.063 . . . . 75.32 110.085 -172.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.517 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 31.1 t70 -160.52 118.67 2.55 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.743 0.652 . . . . 74.25 109.532 173.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.618 HD11 HD13 ' G' ' 8' ' ' LEU . 3.3 mm? -118.78 137.58 53.28 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.928 0.891 . . . . 70.1 108.713 176.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 18.1 t70 -130.5 153.59 48.66 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.263 -1.014 . . . . 73.11 108.263 174.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 71.7 p -114.24 118.36 33.73 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.507 0.723 . . . . 74.51 109.67 -173.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.39 135.63 54.23 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 107.904 -1.147 . . . . 51.0 107.904 172.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.512 ' HB3' ' HD1' ' G' ' 15' ' ' PHE . 58.6 p -167.36 158.91 12.09 Favored 'General case' 0 C--O 1.243 0.73 0 O-C-N 123.469 0.48 . . . . 72.41 111.303 -174.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 50.8 p -166.69 138.73 3.55 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.09 0.869 . . . . 71.32 109.682 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -72.89 121.1 19.46 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.467 -0.938 . . . . 72.2 108.467 170.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.641 HD11 HD12 ' C' ' 83' ' ' ILE . 78.8 mt -85.74 -36.6 20.06 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.91 0.484 . . . . 73.03 111.187 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.509 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -160.7 -176.15 5.38 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.934 0.893 . . . . 54.35 109.957 -173.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -62.46 108.0 1.04 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.62 0.768 . . . . 72.14 109.799 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 66.91 2.02 2.51 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 125.169 1.388 . . . . 53.33 113.017 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 97.9 t -94.4 118.18 39.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.398 -1.334 . . . . 65.23 107.398 173.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -133.46 139.03 46.46 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.679 -0.489 . . . . 61.14 109.679 -172.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -102.1 128.15 48.7 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.555 0.742 . . . . 75.31 109.994 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.46 HG11 ' HD3' ' C' ' 103' ' ' PRO . 91.1 t -112.33 124.05 68.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 107.73 -1.211 . . . . 63.14 107.73 171.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.619 HG21 ' HE2' ' C' ' 19' ' ' LYS . 34.9 t -127.99 116.85 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.387 0.675 . . . . 73.04 109.223 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.544 HD22 ' HB3' ' C' ' 103' ' ' PRO . 42.0 tp -103.99 114.16 28.21 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.403 -0.962 . . . . 51.35 108.403 -176.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.514 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 20.5 ttm-85 -82.0 105.81 13.41 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.95 -1.13 . . . . 74.34 107.95 174.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 10.3 t -100.64 117.25 45.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.736 -1.209 . . . . 73.12 107.736 175.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 34.6 m -121.87 117.99 27.85 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.775 -1.195 . . . . 73.12 107.775 -176.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.518 HG23 HD13 ' C' ' 114' ' ' ILE . 42.1 t -99.24 136.94 28.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.222 -1.354 . . . . 72.04 107.978 174.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.59 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 5.1 m -123.78 140.17 53.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.841 -1.17 . . . . 64.03 107.841 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.54 117.77 19.22 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.588 -1.634 . . . . 70.12 106.588 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.3 m -138.11 126.86 23.75 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.097 0.475 . . . . 55.12 110.965 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.759 HD13 ' HG2' ' C' ' 34' ' ' LYS . 4.3 mt -85.4 53.85 2.9 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.225 1.81 . . . . 70.42 108.427 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.78 -107.76 3.16 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 109.064 -1.614 . . . . 64.35 109.064 -166.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -104.02 -25.14 13.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.61 0.764 . . . . 61.52 110.675 172.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -62.98 104.07 0.52 Allowed 'General case' 0 C--N 1.353 0.718 0 C-N-CA 123.645 0.778 . . . . 75.44 109.214 175.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 36.7 m -73.99 121.57 21.25 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.402 -0.592 . . . . 74.41 109.402 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.642 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -69.88 -62.45 1.38 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.449 -1.25 . . . . 65.11 108.362 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -153.88 173.02 16.48 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 121.784 0.802 . . . . 64.51 111.043 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -137.36 128.3 27.41 Favored 'General case' 0 C--O 1.22 -0.494 0 N-CA-C 105.577 -2.009 . . . . 53.22 105.577 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.1 t -131.15 139.1 49.73 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.98 -1.118 . . . . 75.45 107.98 176.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -145.07 127.14 15.6 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.292 0.637 . . . . 74.3 109.434 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -132.03 114.37 24.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.422 -0.955 . . . . 64.2 108.422 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.697 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 48.1 mt-30 -89.27 87.23 7.05 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.416 -1.327 . . . . 72.35 107.416 171.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -79.34 110.58 14.76 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 114.143 -1.39 . . . . 73.41 109.396 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.36 151.97 20.06 Favored Glycine 0 C--N 1.337 0.626 0 O-C-N 123.673 0.608 . . . . 63.23 112.446 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.96 127.24 2.09 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 109.947 -1.261 . . . . 73.05 109.947 176.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.641 HD12 HD11 ' C' ' 51' ' ' LEU . 14.4 mm -88.45 124.55 41.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 107.648 -1.241 . . . . 45.54 107.648 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.566 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 66.9 m-85 -131.48 123.52 28.24 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.49 0.716 . . . . 72.32 110.001 -174.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 51.1 m -75.12 109.76 8.86 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.859 -0.793 . . . . 60.14 108.859 170.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.439 HG23 ' HE3' ' C' ' 9' ' ' MET . 67.2 mt -114.13 100.72 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.978 -1.119 . . . . 42.15 107.978 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.33 141.31 29.66 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.09 0.956 . . . . 51.14 109.384 -176.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.07 -19.95 24.47 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-O 119.758 -0.468 . . . . 21.51 112.944 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 36.6 pt -121.86 164.46 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.175 0.59 . . . . 73.13 110.856 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -152.49 164.08 38.29 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.188 0.995 . . . . 74.01 109.736 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.04 -133.22 18.26 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.485 0.491 . . . . 63.51 113.045 171.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 45.8 p -63.5 -31.78 73.04 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.014 0.926 . . . . 64.41 111.428 -178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -61.26 -51.12 70.27 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.061 0.945 . . . . 74.53 110.434 176.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.503 ' SD ' ' HB ' ' G' ' 18' ' ' VAL . 56.5 ttm -66.78 -39.84 87.97 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 115.222 -0.899 . . . . 73.13 110.393 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.07 -37.14 76.38 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.253 1.021 . . . . 64.1 111.615 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -71.51 -41.04 69.75 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.443 -0.798 . . . . 72.43 110.804 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.579 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 41.4 t -58.14 -60.89 3.04 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 124.179 0.924 . . . . 61.15 111.036 -177.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.542 HD23 HG23 ' G' ' 18' ' ' VAL . 3.6 pp -69.79 -30.08 67.54 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.988 -0.551 . . . . 73.25 111.766 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 99' ' ' GLY . . . . . 0.41 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -78.51 -29.94 50.91 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-O 118.896 -0.946 . . . . 74.41 114.672 -168.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.48 -35.87 0.1 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.101 0.95 . . . . 64.51 112.357 -170.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.579 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 18.6 t80 -71.73 -35.57 70.21 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.986 1.315 . . . . 74.44 112.637 -175.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 84.9 m -82.82 -41.55 0.88 Allowed Pre-proline 0 CA--C 1.562 1.434 0 C-N-CA 123.159 0.584 . . . . 62.45 111.001 177.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.544 ' HB3' HD22 ' C' ' 60' ' ' LEU . 52.2 Cg_exo -54.72 -26.77 48.64 Favored 'Trans proline' 0 C--N 1.396 3.068 0 C-N-CA 122.713 2.275 . . . . 43.34 113.779 166.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 104' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' C' ' 101' ' ' TYR . 23.4 t-20 -55.75 -44.17 77.37 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 124.194 0.998 . . . . 75.35 110.765 172.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.43 HG23 ' NH1' ' A' ' 111' ' ' ARG . 45.0 mm -61.97 -40.07 85.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.39 -0.823 . . . . 74.31 110.063 177.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 85.7 mt -86.54 -14.38 43.15 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.161 0.984 . . . . 64.22 112.643 -171.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.434 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 88.7 t80 -55.47 -53.69 59.49 Favored Pre-proline 0 CA--C 1.564 1.486 0 C-N-CA 123.809 0.844 . . . . 70.13 112.481 -177.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.434 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 35.7 Cg_exo -63.23 -34.16 69.06 Favored 'Trans proline' 0 C--N 1.388 2.627 0 C-N-CA 122.243 1.962 . . . . 74.04 113.476 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -64.93 -49.95 68.36 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.583 0.753 . . . . 74.43 111.06 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.37 99.16 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.477 -0.783 . . . . 31.22 110.194 177.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -55.86 -51.8 66.29 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.419 1.488 . . . . 63.13 111.326 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -71.18 -32.26 68.65 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.352 0.661 . . . . 61.42 110.338 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.7 t -70.62 -32.48 69.82 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.953 0.501 . . . . 72.32 111.193 -178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.518 HD13 HG23 ' C' ' 64' ' ' VAL . 90.0 mt -71.02 -56.38 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 109.072 -0.714 . . . . 43.02 109.072 173.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 23.9 m -60.98 -28.99 69.4 Favored 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 123.574 0.75 . . . . 75.45 111.978 -175.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 43.6 t -64.4 -51.04 65.23 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.671 0.788 . . . . 74.11 109.023 171.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.561 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.37 -35.85 78.61 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.262 1.025 . . . . 71.12 112.781 178.536 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.506 HG23 ' O ' ' C' ' 114' ' ' ILE . 59.5 t -63.45 -43.61 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.332 0.653 . . . . 51.12 109.449 176.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 31.5 t -68.16 -33.37 74.34 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.25 1.02 . . . . 74.33 111.985 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' C' ' 116' ' ' SER . 88.3 mtt-85 -67.59 -36.26 80.55 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.293 0.637 . . . . 74.11 109.786 176.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.22 11.48 60.65 Favored Glycine 0 C--N 1.355 1.616 0 O-C-N 124.059 0.849 . . . . 75.34 112.656 174.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 69.4 p 57.28 23.46 8.82 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.591 1.956 . . . . 65.14 114.746 174.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -82.74 146.07 51.96 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 107.964 -1.124 . . . . 73.23 107.964 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.32 178.75 1.87 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.709 2.273 . . . . 61.13 113.096 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 16.7 mm-40 -56.21 113.02 1.38 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.703 -1.135 . . . . 74.5 113.428 -173.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 39.7 tp -109.41 87.76 2.58 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.852 -1.067 . . . . 70.44 108.241 167.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -91.66 103.89 16.43 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.966 -0.753 . . . . 54.12 108.966 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 6.9 mp -66.14 137.85 57.31 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.224 0.609 . . . . 72.42 109.573 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.58 ' HB2' ' HB ' ' G' ' 5' ' ' THR . . . -81.83 163.09 55.24 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.249 0.62 . . . . 65.33 110.404 177.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.624 ' HG2' HG21 ' A' ' 13' ' ' ILE . 43.2 Cg_exo -58.61 138.06 83.64 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.878 2.385 . . . . 75.24 113.42 174.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.5 HG21 ' HB2' ' G' ' 8' ' ' LEU . 15.7 t -130.13 115.0 31.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.884 -0.784 . . . . 72.11 108.884 175.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.637 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 2.3 m-20 -96.63 77.79 2.91 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.795 0.838 . . . . 51.21 108.9 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -62.13 -46.0 90.97 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.626 0.727 . . . . 74.14 109.999 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -69.03 -53.23 21.54 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 113.819 -1.537 . . . . 64.13 111.566 -176.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.637 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -65.84 -38.63 89.41 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 123.765 0.665 . . . . 71.42 111.711 -174.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 10.1 tt -54.66 -36.31 64.46 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.938 0.895 . . . . 61.41 112.275 -174.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -56.23 -58.4 8.11 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.643 0.589 . . . . 64.24 111.816 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -78.46 -27.35 46.39 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.433 0.693 . . . . 75.21 112.053 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -64.28 -38.69 91.95 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.833 0.853 . . . . 74.52 110.473 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -73.12 -160.61 0.08 Allowed 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 109.238 -0.652 . . . . 75.41 109.238 173.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' C' ' 143' ' ' GLN . 46.8 tp 179.68 139.29 0.12 Allowed 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.156 -1.794 . . . . 73.31 106.156 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -83.08 11.71 6.0 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.59 0.356 . . . . 73.41 111.776 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 143' ' ' GLN . . . . . 0.414 ' H ' ' HG ' ' C' ' 141' ' ' LEU . 1.0 OUTLIER -120.03 142.86 48.44 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.311 1.044 . . . . 75.23 109.91 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -99.33 118.1 35.23 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.018 0.927 . . . . 71.31 109.508 177.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -164.66 160.44 19.97 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.107 0.963 . . . . 62.14 109.925 174.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 175.28 147.62 6.35 Favored Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.424 -0.807 . . . . 54.32 111.147 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -93.73 176.87 6.19 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.542 0.737 . . . . 75.43 111.217 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -161.76 70.28 0.22 Allowed Glycine 0 CA--C 1.503 -0.684 0 N-CA-C 108.421 -1.872 . . . . 74.41 108.421 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 18.4 m -67.75 85.38 0.21 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.13 0.972 . . . . 64.24 111.324 -172.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -95.03 177.65 5.81 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.436 -1.256 . . . . 75.33 109.295 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 67.99 110.48 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.255 1.022 . . . . 63.11 110.506 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -136.8 148.64 47.3 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.133 0.573 . . . . 70.21 110.74 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -86.7 -0.24 55.92 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 123.639 0.776 . . . . 73.13 110.786 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -61.38 94.19 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.303 0.641 . . . . 51.32 110.357 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 C-N-CA 125.195 1.398 . . . . 64.02 108.169 177.776 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 109.745 -0.465 . . . . 72.35 109.745 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 11.3 m -82.84 84.82 7.24 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 109.151 -0.685 . . . . 53.22 109.151 175.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 3' ' ' GLU . . . . . 0.582 ' HA ' HD23 ' D' ' 141' ' ' LEU . 18.0 mm-40 -110.18 -178.96 3.65 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.569 0.747 . . . . 74.41 112.188 -167.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -99.08 32.4 2.7 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 114.431 -1.259 . . . . 73.33 108.121 168.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.15 156.99 20.56 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.044 1.338 . . . . 63.41 109.859 -174.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -59.84 110.35 1.15 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.178 -0.675 . . . . 75.33 109.178 171.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 5.3 m -72.08 5.3 2.81 Favored 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 124.564 1.146 . . . . 71.41 111.933 -173.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -61.53 -23.95 66.29 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.768 1.227 . . . . 61.51 111.477 171.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -30.13 140.15 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.026 1.73 . . . . 55.41 114.53 170.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 44.8 m -120.86 146.52 46.49 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 124.48 1.112 . . . . 74.43 108.764 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -151.79 103.16 2.9 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.915 -1.143 . . . . 75.11 107.915 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -121.53 142.66 49.85 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.052 -1.092 . . . . 65.43 108.052 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 15.6 mt -90.85 127.66 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 108.265 -1.013 . . . . 72.23 108.265 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -86.77 -37.25 18.04 Favored 'General case' 0 C--O 1.242 0.673 0 O-C-N 123.371 0.419 . . . . 75.21 109.912 175.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -169.22 139.91 2.29 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.436 0.46 . . . . 62.11 111.188 -171.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.545 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.6 mp -117.79 134.04 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 106.986 -1.487 . . . . 71.15 106.986 171.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.408 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 33.9 p90 -164.57 156.54 16.07 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.474 0.654 . . . . 63.13 112.269 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.0 p -81.82 117.35 22.04 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.452 -1.249 . . . . 73.23 109.03 172.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.408 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 42.0 mtpt -88.83 -23.84 22.72 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.444 0.698 . . . . 63.04 110.005 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 18.9 t70 -158.31 143.75 16.7 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 114.616 -1.175 . . . . 74.43 109.01 176.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.561 HG21 ' HE2' ' C' ' 117' ' ' MET . 70.9 mt -142.27 148.21 20.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 106.909 -1.515 . . . . 74.22 106.909 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 30.7 t -155.95 146.25 21.65 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.659 0.784 . . . . 73.32 109.013 170.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 84.6 t80 -146.4 117.61 7.85 Favored 'General case' 0 C--O 1.213 -0.837 0 N-CA-C 105.411 -2.07 . . . . 74.43 105.411 175.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -127.06 110.16 12.64 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 109.134 -0.691 . . . . 72.41 109.134 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.41 85.91 2.44 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.405 -0.961 . . . . 73.2 108.405 174.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.87 -30.53 5.89 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.084 2.523 . . . . 73.34 113.246 -169.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -103.27 6.67 38.24 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.732 0.813 . . . . 70.21 110.179 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.445 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -29.55 -67.96 0.12 Allowed Pre-proline 0 CA--C 1.562 1.422 0 C-N-CA 126.476 1.91 . . . . 65.33 116.111 -161.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -78.37 -13.69 15.02 Favored 'Trans proline' 0 C--N 1.378 2.122 0 CA-C-N 122.775 2.027 . . . . 65.23 113.782 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -80.34 -40.54 26.5 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.656 0.783 . . . . 64.32 109.589 171.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.445 HG12 ' O ' ' D' ' 28' ' ' ALA . 5.5 p -81.51 -20.02 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 116.107 -0.497 . . . . 74.01 110.938 -172.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -65.88 -20.21 66.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.215 0.606 . . . . 71.14 112.341 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -61.79 -23.3 66.12 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.639 0.776 . . . . 60.01 110.276 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -93.26 87.15 5.55 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.27 1.428 . . . . 72.22 109.979 176.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.05 86.81 7.0 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.459 0.704 . . . . 75.4 110.577 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -155.11 173.19 16.94 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.452 -0.944 . . . . 73.54 108.452 167.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -69.41 115.87 36.89 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 108.993 -0.743 . . . . 74.23 108.993 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.23 145.38 78.1 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.676 2.25 . . . . 62.42 111.69 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 37.7 mt-10 -61.59 111.86 1.99 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.662 -0.866 . . . . 72.14 108.662 169.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.764 HG13 HG13 ' D' ' 64' ' ' VAL . 91.9 t -99.48 113.67 35.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.447 -0.946 . . . . 61.15 108.447 -178.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.612 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 10.9 tmtt? -92.53 119.42 31.99 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 106.255 -1.757 . . . . 60.53 106.255 173.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 mp -96.12 137.9 34.51 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.423 -0.954 . . . . 65.52 108.423 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.518 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 8.0 t70 -142.35 148.16 37.47 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.683 -0.858 . . . . 62.41 108.683 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -127.51 147.32 50.32 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.763 0.825 . . . . 74.54 110.358 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.436 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 10.1 t70 -144.18 145.2 31.93 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 107.681 -1.229 . . . . 72.34 107.681 172.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 57.9 p -113.17 144.16 43.14 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.195 0.598 . . . . 72.44 110.336 -175.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.488 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.59 151.93 31.22 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.79 0.836 . . . . 75.35 109.284 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 79.4 p -155.88 157.14 35.85 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 120.784 0.326 . . . . 72.11 110.916 -178.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 25.4 p -152.64 119.27 5.67 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.401 1.08 . . . . 71.4 108.917 175.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -79.81 121.05 24.9 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.183 -0.673 . . . . 74.4 109.183 176.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 30.0 mt -91.26 -35.8 14.27 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.054 0.542 . . . . 63.22 109.878 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.75 176.54 12.6 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.987 -1.006 . . . . 74.15 109.707 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -65.56 123.44 19.69 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.558 -0.905 . . . . 75.25 108.558 177.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.604 ' HB3' ' O ' ' D' ' 86' ' ' ILE . 3.8 m-20 71.94 2.95 4.5 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.212 1.005 . . . . 53.52 112.654 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.4 t -114.76 119.05 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.713 0.805 . . . . 74.1 109.255 176.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -133.02 128.43 36.29 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.297 0.639 . . . . 54.03 110.503 -173.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.642 ' HB2' HG12 ' D' ' 83' ' ' ILE . 4.6 tp10 -99.69 110.49 22.9 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 106.759 -1.571 . . . . 75.32 106.759 168.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.535 HG11 HD23 ' D' ' 98' ' ' LEU . 32.7 m -120.56 147.78 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 123.696 0.798 . . . . 73.41 109.111 -174.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 12.8 t -125.48 133.47 69.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 C-N-CA 123.69 0.796 . . . . 74.53 109.898 -169.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.494 HD22 ' HB2' ' D' ' 103' ' ' PRO . 56.3 tp -109.48 110.57 21.72 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.927 -1.138 . . . . 71.11 107.927 165.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.436 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.2 ttm180 -84.72 105.05 15.22 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.539 -0.912 . . . . 74.33 108.539 173.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 79.2 t -91.08 128.97 42.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.932 -1.136 . . . . 73.41 107.932 170.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 27.0 m -125.27 138.06 54.09 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.121 0.568 . . . . 73.35 109.522 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.764 HG13 HG13 ' D' ' 40' ' ' VAL . 24.4 t -129.16 101.04 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 124.945 1.298 . . . . 71.54 108.436 -174.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.612 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 36.8 m -95.49 93.86 7.44 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.377 -0.971 . . . . 73.02 108.377 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -95.99 144.19 26.5 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.263 0.625 . . . . 75.52 110.15 -174.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.471 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 64.7 p -145.82 129.29 16.93 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 123.683 0.614 . . . . 64.44 112.145 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.402 HD12 HG22 ' D' ' 31' ' ' VAL . 22.5 mt -99.1 112.9 24.92 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.871 0.868 . . . . 73.33 108.852 173.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.84 -111.01 3.18 Favored Glycine 0 C--N 1.345 1.074 0 N-CA-C 111.842 -0.503 . . . . 44.44 111.842 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.25 6.19 9.12 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.975 0.91 . . . . 73.12 110.526 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -121.15 165.9 14.71 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.466 0.706 . . . . 74.42 109.788 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.6 m -70.62 129.94 40.5 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.59 0.756 . . . . 74.23 111.924 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.471 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -84.36 -69.4 0.65 Allowed 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.817 -1.179 . . . . 42.43 107.817 170.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -151.07 158.75 44.47 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.74 -0.664 . . . . 72.23 110.803 175.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 74.3 mt -121.46 108.19 13.35 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.372 -1.344 . . . . 72.22 107.372 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.493 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.6 t -123.9 107.9 11.86 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.225 0.61 . . . . 72.14 109.506 -169.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -131.15 123.44 28.56 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.756 0.822 . . . . 75.21 109.072 -173.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.41 119.8 51.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 123.578 0.751 . . . . 72.34 109.012 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.532 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.0 mt-30 -87.18 85.7 7.22 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.876 -1.157 . . . . 71.15 107.876 170.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -81.91 110.86 17.58 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.341 -1.299 . . . . 64.33 108.907 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.61 167.58 14.13 Favored Glycine 0 C--N 1.341 0.826 0 O-C-N 123.557 0.536 . . . . 70.15 112.549 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.38 129.18 1.97 Allowed Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.35 -0.7 . . . . 64.32 111.35 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.642 HG12 ' HB2' ' D' ' 57' ' ' GLU . 61.8 mt -89.0 133.41 31.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.884 -1.154 . . . . 63.25 107.884 177.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -132.74 133.99 44.18 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 122.917 0.487 . . . . 71.4 110.879 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.1 m -81.21 104.85 11.96 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.089 0.956 . . . . 54.31 109.095 165.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.604 ' O ' ' HB3' ' D' ' 54' ' ' ASP . 67.3 mt -107.17 145.04 15.1 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 C-N-CA 124.158 0.983 . . . . 64.33 108.577 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.28 157.26 15.16 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 118.325 0.511 . . . . 75.12 110.05 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.96 11.35 74.17 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.568 0.543 . . . . 62.04 114.201 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.489 HG23 ' HB3' ' D' ' 93' ' ' GLN . 11.1 mt -97.57 134.92 33.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 C-N-CA 123.25 0.62 . . . . 75.31 110.696 -175.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -157.41 172.25 18.92 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.498 1.119 . . . . 75.25 109.148 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.89 -133.46 29.34 Favored Glycine 0 CA--C 1.527 0.825 0 O-C-N 123.465 0.478 . . . . 43.03 113.208 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 57.8 p -66.73 -33.19 75.08 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.944 0.898 . . . . 70.04 111.754 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.576 ' HB2' ' HG3' ' D' ' 3' ' ' GLU . 50.2 tt0 -67.71 -22.33 65.26 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.087 -0.506 . . . . 74.34 112.178 -172.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.404 ' O ' ' HA ' ' H' ' 17' ' ' PRO . 91.0 mtp -55.26 -54.18 46.68 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.022 -0.733 . . . . 71.35 109.022 174.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.36 -47.72 54.61 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.935 -1.03 . . . . 65.11 111.263 -178.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.402 ' NE2' ' HB2' ' D' ' 137' ' ' PHE . 22.1 t-160 -76.28 -24.53 54.43 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.15 0.98 . . . . 73.44 112.685 -168.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -63.21 -51.67 65.34 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.935 -0.394 . . . . 61.41 109.935 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.535 HD23 HG11 ' D' ' 58' ' ' VAL . 4.5 mp -84.34 -25.78 28.94 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 122.761 0.424 . . . . 74.43 110.341 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.59 -5.05 72.27 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.62 -0.544 . . . . 75.34 113.925 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.65 -57.71 0.11 Allowed 'General case' 0 C--N 1.358 0.955 0 N-CA-C 112.6 0.593 . . . . 63.13 112.6 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -72.31 -50.57 26.02 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 112.792 0.664 . . . . 73.02 112.792 -166.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 35.2 m -61.64 -47.14 93.36 Favored Pre-proline 0 CA--C 1.564 1.507 0 C-N-CA 123.993 0.917 . . . . 75.44 112.974 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.494 ' HB2' HD22 ' D' ' 60' ' ' LEU . 65.8 Cg_endo -70.39 -20.48 31.81 Favored 'Trans proline' 0 C--N 1.392 2.852 0 C-N-CA 122.176 1.917 . . . . 70.03 112.659 175.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -73.65 -26.96 61.01 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.285 0.634 . . . . 75.13 110.539 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mm -65.77 -37.44 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-O 121.525 0.679 . . . . 71.33 109.876 169.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 50.9 mt -84.57 -13.13 52.63 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 114.832 -1.076 . . . . 64.14 111.423 -176.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 107' ' ' PHE . . . . . 0.415 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 85.1 t80 -61.61 -53.11 64.45 Favored Pre-proline 0 CA--C 1.567 1.605 0 C-N-CA 124.422 1.089 . . . . 65.21 113.025 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 108' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 24.5 Cg_exo -65.05 -31.44 55.17 Favored 'Trans proline' 0 C--N 1.393 2.872 0 C-N-CA 122.14 1.893 . . . . 52.22 112.923 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -76.18 -33.99 59.32 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.773 0.829 . . . . 52.43 111.772 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.46 -48.89 73.58 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.238 -0.653 . . . . 63.33 109.238 172.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -55.58 -47.18 76.88 Favored 'General case' 0 C--N 1.358 0.953 0 O-C-N 124.445 1.09 . . . . 64.12 110.454 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.76 -53.26 58.37 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.066 0.546 . . . . 74.54 110.945 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.8 t -55.64 -44.86 77.56 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 123.825 0.703 . . . . 73.41 111.24 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.493 HG23 ' SG ' ' D' ' 76' ' ' CYS . 59.3 mt -60.45 -59.9 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.987 0.915 . . . . 72.12 110.659 175.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 47.7 m -54.11 -38.61 65.58 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.694 1.198 . . . . 52.22 111.796 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.4 t -65.47 -45.61 82.99 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.236 -0.893 . . . . 64.33 110.1 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.41 ' HB2' ' HE3' ' D' ' 117' ' ' MET . 69.7 mtm -70.63 -28.12 64.58 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.861 0.465 . . . . 65.12 111.889 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' D' ' 114' ' ' ILE . 99.5 t -66.09 -45.76 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.27 0.628 . . . . 73.32 109.585 174.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.0 p -72.13 -31.06 65.65 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.843 -0.617 . . . . 55.31 110.826 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -69.27 -36.32 76.97 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.974 0.909 . . . . 72.51 109.954 175.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.76 1.2 88.68 Favored Glycine 0 C--N 1.351 1.398 0 O-C-N 123.805 0.69 . . . . 74.32 112.012 174.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.0 p 61.97 23.11 13.57 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 126.832 2.053 . . . . 64.33 113.573 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -81.66 160.04 65.14 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.849 0.86 . . . . 74.34 110.003 170.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.64 132.51 51.9 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.973 2.449 . . . . 62.13 112.737 174.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -56.34 134.86 53.87 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.163 0.985 . . . . 70.34 111.792 -175.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.402 HD13 HG21 ' D' ' 40' ' ' VAL . 53.9 tp -111.95 103.38 11.6 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.389 -0.823 . . . . 70.53 109.219 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 127' ' ' ASN . . . . . 0.432 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 86.3 m-20 -100.54 96.75 7.59 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.487 -0.931 . . . . 74.42 108.487 177.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.449 ' HA ' HG22 ' H' ' 6' ' ' ILE . 31.7 tp -67.3 120.75 14.34 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-N 115.4 -0.818 . . . . 73.11 109.885 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.8 137.44 83.05 Favored Pre-proline 0 C--N 1.354 0.792 0 O-C-N 124.348 1.03 . . . . 73.54 111.43 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.527 ' HG3' HD11 ' B' ' 13' ' ' ILE . 1.8 Cg_endo -76.58 103.38 1.74 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.902 2.401 . . . . 74.4 110.891 -172.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.38 131.45 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.923 -0.58 . . . . 34.24 109.561 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 132' ' ' ASN . . . . . 0.433 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 30.6 t30 -107.02 104.32 13.96 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 108.412 -0.958 . . . . 75.53 108.412 174.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -60.3 -42.21 95.02 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.898 0.749 . . . . 62.11 110.902 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.93 -36.76 72.96 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.942 -1.026 . . . . 65.42 111.73 -173.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.433 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -70.34 -33.21 71.22 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 124.19 0.931 . . . . 61.44 112.12 -177.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 75.5 mt -69.0 -43.19 75.33 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.307 0.643 . . . . 75.2 110.445 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.402 ' HB2' ' NE2' ' D' ' 96' ' ' HIS . 62.3 m-85 -72.0 -30.65 65.45 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.303 -0.862 . . . . 61.21 111.0 175.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 36.4 ttm -62.41 -31.37 72.05 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.404 1.082 . . . . 53.33 110.389 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -64.54 -26.33 68.37 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.871 0.868 . . . . 72.24 111.177 177.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -76.78 -39.1 52.68 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.409 0.684 . . . . 70.53 110.209 173.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.582 HD23 ' HA ' ' D' ' 3' ' ' GLU . 11.1 mp -74.38 -26.9 60.4 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.231 1.012 . . . . 75.05 112.919 -175.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -78.73 28.13 0.21 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.077 0.551 . . . . 71.35 112.32 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -117.76 55.67 0.86 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.59 1.156 . . . . 63.54 108.391 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -167.68 135.75 2.41 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.107 -1.406 . . . . 74.52 108.822 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.46 99.07 3.45 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.316 -0.624 . . . . 74.22 109.316 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.22 65.47 0.27 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 111.348 -0.701 . . . . 63.54 111.348 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.92 161.13 31.08 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.137 0.575 . . . . 64.45 110.496 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.55 86.92 0.34 Allowed Glycine 0 C--N 1.347 1.175 0 N-CA-C 111.042 -0.823 . . . . 64.12 111.042 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 15.0 t -139.29 27.37 2.33 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.833 0.853 . . . . 72.44 110.209 -175.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.42 109.08 0.55 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.674 0.79 . . . . 74.4 111.217 179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -163.51 -61.5 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 107.491 -1.299 . . . . 71.21 107.491 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -157.34 145.57 19.27 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.11 -0.95 . . . . 64.34 109.147 173.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -79.63 100.39 7.8 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.716 -0.846 . . . . 62.14 108.716 170.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.63 137.05 58.22 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.907 0.883 . . . . 72.33 110.919 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 C-N-CA 123.45 0.7 . . . . 74.42 109.77 178.489 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptt? . . . . . 0 CA--C 1.542 0.648 0 CA-C-O 121.935 0.874 . . . . 72.15 109.536 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -136.56 133.01 35.95 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.516 1.126 . . . . 63.03 108.794 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -91.94 144.46 25.44 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.467 1.107 . . . . 75.12 110.013 -177.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 47.0 t -71.07 91.46 0.9 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.531 0.732 . . . . 62.15 110.113 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 6.5 t -74.42 112.91 11.06 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.136 0.574 . . . . 75.31 110.453 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.499 HD12 HG11 ' A' ' 40' ' ' VAL . 9.2 tp -167.3 133.57 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.237 1.015 . . . . 73.11 108.801 178.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 7' ' ' ALA . . . . . 0.43 ' O ' HD21 ' A' ' 42' ' ' LEU . . . -122.8 155.69 36.05 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.893 0.877 . . . . 42.21 108.893 177.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 tt -171.0 138.01 1.25 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.344 -0.984 . . . . 72.54 108.344 174.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -135.33 149.46 49.74 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 124.133 0.973 . . . . 73.22 108.53 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 pp -69.02 163.9 23.61 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 120.865 0.364 . . . . 73.01 110.977 176.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 7.5 mp -79.53 120.52 80.57 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 123.581 0.752 . . . . 73.11 109.464 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.79 -37.93 52.37 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 123.243 2.629 . . . . 64.33 112.286 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.04 -7.26 39.69 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.059 0.543 . . . . 72.21 111.373 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 83.3 mt 66.75 15.77 10.21 Favored 'General case' 0 C--N 1.363 1.155 0 C-N-CA 125.443 1.497 . . . . 75.03 111.798 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 27.4 t80 52.83 38.64 27.21 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.486 1.114 . . . . 75.52 110.302 -175.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 16' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' E' ' 21' ' ' ALA . 36.5 p -116.21 76.71 6.86 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.296 0.638 . . . . 64.23 110.871 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 17' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -88.43 -10.93 4.41 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.224 1.949 . . . . 72.42 112.623 172.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 90.5 t -86.45 105.51 14.83 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 N-CA-C 107.875 -1.157 . . . . 62.23 107.875 176.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 4.8 m 64.47 166.7 0.16 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 124.898 1.279 . . . . 54.03 111.324 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -73.6 83.67 1.55 Allowed 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 108.825 -0.806 . . . . 75.44 108.825 171.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 21' ' ' ALA . . . . . 0.555 ' HB3' ' HB ' ' E' ' 16' ' ' THR . . . -105.68 -27.97 11.0 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.99 0.916 . . . . 63.53 112.315 -172.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -58.95 -54.13 50.59 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.596 0.758 . . . . 74.42 110.517 176.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 92.3 m -143.12 85.31 9.82 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.628 -0.878 . . . . 72.14 108.628 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.28 -35.95 81.96 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.656 2.238 . . . . 72.41 111.665 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 CA--C 1.553 1.061 0 N-CA-C 107.998 -1.112 . . . . 70.21 107.998 177.977 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtm . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.879 -0.415 . . . . 34.14 109.879 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt 61.39 179.46 0.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 114.403 1.261 . . . . 75.24 114.403 170.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -161.86 104.07 1.18 Allowed 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 114.583 -1.19 . . . . 64.21 109.553 175.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 15.7 m -92.66 103.47 15.85 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.707 -0.849 . . . . 75.2 108.707 174.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 34.3 m -97.07 126.79 42.47 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.267 0.627 . . . . 75.0 110.443 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' B' ' 42' ' ' LEU . 29.0 pt -128.83 158.93 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.672 0.789 . . . . 72.23 110.602 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 7' ' ' ALA . . . . . 0.628 ' HB2' ' HB3' ' B' ' 129' ' ' ALA . . . -164.12 172.41 13.77 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.572 -1.194 . . . . 55.22 109.833 176.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 mp -83.55 170.67 14.13 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.566 0.746 . . . . 74.34 110.06 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.38 -165.1 2.18 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.711 0.804 . . . . 73.24 109.163 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 10' ' ' LEU . . . . . 0.599 HD11 HD12 ' B' ' 136' ' ' LEU . 8.6 mp -59.33 131.08 49.91 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.698 -0.482 . . . . 70.02 109.698 177.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.534 ' HG ' HD11 ' B' ' 44' ' ' LEU . 5.2 mp -73.24 133.68 80.89 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 123.801 0.84 . . . . 65.53 109.62 -170.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -60.33 -33.36 94.48 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 123.248 2.632 . . . . 63.12 112.227 -175.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.71 133.25 50.75 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.577 -0.897 . . . . 73.5 108.577 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 90.7 mt -69.23 117.55 11.0 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.108 -1.071 . . . . 72.33 108.108 169.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -75.04 88.01 2.38 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 108.828 -0.804 . . . . 71.34 108.828 -176.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 16' ' ' THR . . . . . 0.428 HG22 ' HB2' ' B' ' 95' ' ' ALA . 77.6 p -121.53 75.89 34.88 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 123.88 0.872 . . . . 71.42 111.065 -176.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -85.35 -36.23 0.14 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.585 2.19 . . . . 64.43 113.33 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 18' ' ' VAL . . . . . 0.526 HG21 ' HB2' ' F' ' 21' ' ' ALA . 2.7 m -84.26 122.29 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.285 0.634 . . . . 75.32 109.416 177.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 98.9 m -68.56 -45.58 71.73 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.595 -0.891 . . . . 74.32 108.595 169.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -138.39 110.08 7.11 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.303 -1.369 . . . . 73.51 107.303 173.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 21' ' ' ALA . . . . . 0.526 ' HB2' HG21 ' F' ' 18' ' ' VAL . . . -82.18 63.28 6.31 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 107.851 -1.166 . . . . 65.42 107.851 169.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 22' ' ' ARG . . . . . 0.697 ' HD2' ' HB2' ' B' ' 90' ' ' GLU . 50.3 mtp180 -150.04 105.22 3.36 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 106.739 -1.578 . . . . 61.13 106.739 -173.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 9.0 t -67.35 115.21 24.06 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 122.418 0.287 . . . . 75.11 110.929 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -65.28 -48.12 3.77 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.646 2.23 . . . . 72.13 110.952 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 108.215 -1.031 . . . . 74.3 108.215 171.905 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' G' G ' 1' ' ' MET . . . . . 0.446 ' SD ' ' N ' ' G' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.349 -0.611 . . . . 63.32 109.349 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -127.95 142.46 51.24 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.699 0.799 . . . . 64.12 109.542 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -72.49 94.92 1.72 Allowed 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 108.674 -0.861 . . . . 74.0 108.674 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 26.9 p -67.28 -56.9 7.87 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.357 1.063 . . . . 71.51 112.0 -170.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 5' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' C' ' 129' ' ' ALA . 20.7 m -69.69 143.4 53.14 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 123.447 0.699 . . . . 74.13 109.325 176.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 6' ' ' ILE . . . . . 0.461 HD12 ' O ' ' G' ' 6' ' ' ILE . 2.6 pp -57.42 129.88 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.301 0.64 . . . . 74.04 111.584 -177.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 7' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' C' ' 129' ' ' ALA . . . -171.72 173.42 4.6 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.053 -0.976 . . . . 72.34 109.907 -175.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 8' ' ' LEU . . . . . 0.618 HD13 HD11 ' C' ' 44' ' ' LEU . 16.6 mt -66.34 159.5 26.64 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 124.137 0.898 . . . . 61.22 109.314 176.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.67 -80.79 0.58 Allowed 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 109.764 -0.458 . . . . 71.43 109.764 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 81.8 mt -137.04 151.3 48.77 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.096 0.958 . . . . 70.41 110.124 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 93.7 mt -69.65 133.52 88.67 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 115.598 -0.728 . . . . 71.1 109.194 174.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.46 -45.43 14.68 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.718 2.278 . . . . 65.44 111.036 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt -136.74 161.05 37.02 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.989 1.316 . . . . 71.31 108.266 174.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.06 -175.9 5.96 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.957 0.503 . . . . 74.05 110.564 176.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 15' ' ' PHE . . . . . 0.512 ' HD1' ' HB3' ' C' ' 48' ' ' SER . 46.4 m-85 -87.31 174.77 8.36 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.051 0.54 . . . . 73.42 110.287 175.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 70.7 p -77.98 153.44 80.16 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.267 0.627 . . . . 74.41 110.341 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 17' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.47 145.21 95.6 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 122.471 2.114 . . . . 74.13 112.541 174.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 18' ' ' VAL . . . . . 0.542 HG23 HD23 ' C' ' 98' ' ' LEU . 44.5 t -70.03 -51.21 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 108.326 -0.99 . . . . 63.22 108.326 172.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 32.9 p -129.68 -61.14 1.02 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.263 -0.881 . . . . 74.42 111.126 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -151.31 35.2 0.57 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.617 0.722 . . . . 71.53 109.621 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.35 -18.29 63.49 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.973 -0.558 . . . . 61.02 111.706 173.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -147.25 -64.62 0.28 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.295 1.038 . . . . 74.3 108.542 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 36.3 m -143.68 134.67 12.46 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.091 0.956 . . . . 72.05 108.639 -176.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.6 -60.88 0.48 Allowed 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.128 1.886 . . . . 72.42 111.063 171.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 CA--C 1.555 1.164 0 C-N-CA 123.739 0.816 . . . . 75.33 110.07 178.298 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 109.838 -0.43 . . . . 73.54 109.838 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -125.02 97.6 5.32 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.365 0.666 . . . . 74.54 109.783 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -81.44 98.05 8.05 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 107.541 -1.281 . . . . 72.4 107.541 172.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 32.3 t 70.12 172.13 0.31 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.729 1.212 . . . . 70.3 110.683 -172.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 90.3 m -96.46 -55.86 2.79 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.641 -0.503 . . . . 70.11 109.641 176.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.449 HG22 ' HA ' ' D' ' 128' ' ' LEU . 22.8 mm -87.43 61.94 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 109.193 -0.669 . . . . 60.41 109.193 -174.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -170.06 154.84 5.25 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.775 0.83 . . . . 71.05 109.93 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 94.2 mt -107.34 118.45 36.75 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.807 -0.812 . . . . 44.13 108.807 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.4 -88.19 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.183 0.593 . . . . 72.44 110.371 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 5.4 mp -134.3 155.96 49.29 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.866 0.867 . . . . 75.0 109.252 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.07 115.82 59.78 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 108.472 -0.936 . . . . 74.41 108.472 175.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.06 -30.82 94.31 Favored 'Trans proline' 0 C--N 1.39 2.739 0 C-N-CA 123.491 2.794 . . . . 60.2 113.074 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -120.94 119.75 33.49 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 106.521 -1.659 . . . . 74.24 106.521 170.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.77 136.62 54.49 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.96 0.504 . . . . 63.43 110.201 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -59.69 140.54 56.37 Favored 'General case' 0 CA--C 1.552 1.052 0 O-C-N 124.061 0.851 . . . . 64.32 108.968 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 16' ' ' THR . . . . . 0.763 ' HB ' ' HB1' ' H' ' 21' ' ' ALA . 21.4 p -52.05 140.2 32.22 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 125.295 1.438 . . . . 64.51 112.51 -177.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 17' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' D' ' 94' ' ' MET . 87.9 Cg_exo -50.35 178.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 124.065 3.177 . . . . 73.53 117.107 177.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.63 -85.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 115.358 -0.837 . . . . 72.2 109.865 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 11.9 t -89.81 156.33 18.57 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 109.729 -0.471 . . . . 71.24 109.729 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? 77.45 -29.75 0.17 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 125.996 1.718 . . . . 72.33 112.748 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 21' ' ' ALA . . . . . 0.763 ' HB1' ' HB ' ' H' ' 16' ' ' THR . . . -59.13 -57.86 11.19 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.182 1.393 . . . . 72.11 113.61 -166.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 22' ' ' ARG . . . . . 0.487 ' NH1' ' HA ' ' H' ' 24' ' ' PRO . 0.0 OUTLIER -84.99 30.02 0.61 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.798 0.839 . . . . 71.42 112.615 -169.636 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 10.0 t 47.75 89.51 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.573 0 C-N-CA 125.971 1.708 . . . . 74.4 111.789 -170.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 24' ' ' PRO . . . . . 0.487 ' HA ' ' NH1' ' H' ' 22' ' ' ARG . 55.2 Cg_endo -66.73 -20.8 52.31 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.834 2.356 . . . . 73.1 112.394 -178.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 CA--C 1.548 0.871 0 N-CA-C 108.679 -0.86 . . . . 63.25 108.679 176.313 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 109.217 -0.66 . . . . 72.34 109.217 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.1 t 65.09 172.08 0.21 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.369 1.068 . . . . 60.02 111.333 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 57.05 31.83 20.62 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.47 1.108 . . . . 70.41 112.129 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -76.63 -5.94 49.95 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.95 0.9 . . . . 74.02 111.643 -173.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -90.75 102.78 15.53 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.103 0.961 . . . . 70.22 110.692 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -151.13 16.6 0.74 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 121.752 0.787 . . . . 73.32 110.157 174.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.7 p -94.6 -29.84 14.66 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.775 0.798 . . . . 44.21 110.043 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -89.28 -167.18 1.79 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.16 0.984 . . . . 45.13 110.501 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.459 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 95.1 mmm 73.95 138.74 0.06 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.894 1.678 . . . . 43.03 111.759 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.8 m -147.36 136.5 22.39 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.943 1.297 . . . . 50.32 107.985 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.668 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 15.6 t80 -134.27 123.26 23.93 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.037 0.535 . . . . 73.35 109.89 -175.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -138.19 117.28 12.56 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.753 0.821 . . . . 75.41 108.943 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.632 HG12 ' HD2' ' A' ' 84' ' ' PHE . 53.8 mt -89.92 125.08 42.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 108.871 -0.788 . . . . 72.23 108.871 176.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -85.94 -41.16 15.15 Favored 'General case' 0 C--O 1.242 0.66 0 O-C-N 123.847 0.717 . . . . 71.45 110.159 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -167.9 136.7 2.47 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.874 -0.417 . . . . 63.14 109.874 -167.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.47 HD11 HD13 ' A' ' 13' ' ' ILE . 94.4 mt -130.01 129.34 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.061 -1.089 . . . . 63.23 108.061 172.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -161.52 176.77 10.7 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 124.216 0.948 . . . . 65.24 111.252 -167.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -107.28 116.22 31.56 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 114.944 -1.025 . . . . 64.35 108.836 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.501 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 34.5 mtpt -82.11 -26.44 33.58 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 110.012 -0.366 . . . . 70.1 110.012 177.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 18.3 t70 -152.78 136.65 16.24 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.218 -0.901 . . . . 72.24 109.72 174.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.447 HG23 ' SD ' ' A' ' 117' ' ' MET . 83.6 mt -129.18 137.48 56.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 106.285 -1.746 . . . . 73.55 106.285 172.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.6 t -152.03 110.63 3.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.419 0.628 . . . . 75.25 110.226 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.512 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 92.3 t80 -110.38 137.34 48.22 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 107.313 -1.366 . . . . 74.22 107.313 173.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -135.16 140.92 45.76 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.701 -1.222 . . . . 74.12 107.701 171.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.407 ' CB ' ' HB2' ' A' ' 28' ' ' ALA . . . -122.9 80.78 50.01 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 105.891 -1.892 . . . . 71.43 105.891 168.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.2 -31.42 89.9 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.076 2.517 . . . . 74.2 112.746 -167.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -118.44 31.69 6.54 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 118.597 -0.716 . . . . 73.23 109.66 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.415 ' HB3' ' HZ1' ' B' ' 19' ' ' LYS . . . -42.41 -54.47 7.91 Favored Pre-proline 0 CA--C 1.573 1.84 0 N-CA-C 114.84 1.422 . . . . 74.41 114.84 -170.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HD3' ' HZ1' ' B' ' 19' ' ' LYS . 14.1 Cg_exo -64.13 -31.4 64.89 Favored 'Trans proline' 0 C--N 1.395 3.004 0 CA-C-N 121.652 1.626 . . . . 52.1 112.572 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -80.17 -39.16 29.86 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.863 -1.062 . . . . 62.13 110.51 -175.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.658 HG21 ' HA ' ' A' ' 73' ' ' ALA . 5.2 p -78.52 -22.23 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 CA-C-N 114.821 -1.081 . . . . 73.1 112.714 -161.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -70.91 -21.1 62.41 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.906 0.482 . . . . 72.44 110.754 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -86.46 -18.34 31.94 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.517 1.127 . . . . 65.11 110.519 176.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.4 tmtp? -78.13 146.67 34.99 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.142 0.977 . . . . 71.23 109.734 -175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.07 138.88 58.67 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.816 0.846 . . . . 65.24 110.524 173.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -93.01 82.99 4.64 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.868 0.842 . . . . 72.32 110.6 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -130.87 83.44 61.3 Favored Pre-proline 0 C--O 1.239 0.539 0 N-CA-C 107.017 -1.475 . . . . 60.03 107.017 165.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -85.97 156.6 10.02 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 122.214 1.943 . . . . 71.43 111.959 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -109.66 93.72 4.65 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 105.036 -2.209 . . . . 74.33 105.036 165.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.651 ' HB ' HG21 ' E' ' 6' ' ' ILE . 48.1 t -78.5 92.04 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 122.072 0.939 . . . . 74.44 108.695 -177.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.446 ' HE2' ' HB2' ' A' ' 67' ' ' SER . 62.3 mttm -82.98 113.3 20.47 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.596 -1.638 . . . . 62.32 108.98 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 pp -105.73 128.36 53.64 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.008 0.523 . . . . 71.45 110.625 -174.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.538 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.6 m-20 -114.28 139.2 49.61 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.405 1.082 . . . . 70.32 109.029 177.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' E' ' 8' ' ' LEU . 94.1 mt -124.61 119.54 29.34 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.601 0.76 . . . . 74.22 109.513 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 21.8 t70 -120.24 130.31 54.45 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.617 -0.882 . . . . 71.31 108.617 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.3 p -106.98 132.21 53.18 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.878 0.871 . . . . 52.05 110.254 -173.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.18 129.52 10.56 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.049 0.54 . . . . 74.44 110.308 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.2 m -130.82 152.92 49.64 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.223 0.609 . . . . 72.43 110.324 174.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.6 t -149.96 126.71 11.02 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.578 0.751 . . . . 75.33 109.084 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -78.47 132.55 37.31 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.857 0.463 . . . . 72.32 110.927 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.3 mt -101.32 -31.01 11.17 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.441 1.096 . . . . 60.22 111.059 -174.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.581 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -163.63 173.76 12.56 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.489 1.116 . . . . 52.22 109.712 -175.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -56.67 116.47 3.15 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.023 0.529 . . . . 50.32 110.204 171.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 70.49 -10.6 0.68 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 126.215 1.806 . . . . 74.24 113.259 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 21.6 t -100.7 117.68 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.075 -1.083 . . . . 53.1 108.075 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -142.35 170.33 15.9 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.14 -0.689 . . . . 72.54 109.14 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -120.08 132.99 55.64 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 123.521 0.729 . . . . 73.4 110.021 -175.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.446 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 93.7 t -104.39 126.82 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.008 -1.108 . . . . 73.04 108.008 169.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.99 125.81 74.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 108.269 -1.012 . . . . 74.3 108.269 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.19 110.88 18.11 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.722 -1.214 . . . . 70.11 107.722 176.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.577 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 36.8 ttm180 -81.95 100.26 9.57 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.572 -1.27 . . . . 74.54 107.572 174.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.9 t -98.86 102.46 13.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.679 -1.23 . . . . 71.24 107.679 176.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.538 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 26.5 m -96.91 135.88 38.27 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.444 -0.576 . . . . 73.53 109.444 178.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.542 HG11 HD21 ' A' ' 126' ' ' LEU . 17.9 t -126.73 107.68 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.628 1.171 . . . . 45.43 108.392 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 25.9 m -102.94 134.33 46.54 Favored 'General case' 0 C--O 1.208 -1.083 0 N-CA-C 107.707 -1.22 . . . . 54.44 107.707 173.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.71 105.28 12.56 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 107.699 -1.223 . . . . 75.5 107.699 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 50.2 m -108.72 124.29 50.33 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.304 0.574 . . . . 74.04 110.952 -177.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.1 mt -91.04 54.82 2.72 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.889 1.276 . . . . 64.41 108.399 178.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.47 -114.56 4.73 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 110.36 -1.096 . . . . 71.01 110.36 -166.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -91.93 -26.68 18.32 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.007 0.523 . . . . 70.2 110.864 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -86.73 108.8 18.84 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.206 0.602 . . . . 72.11 109.595 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 53.9 m -72.63 124.87 26.16 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.688 0.395 . . . . 70.33 110.625 176.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.658 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -62.26 -58.09 9.0 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.49 1.116 . . . . 54.12 111.183 174.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -155.83 164.54 38.4 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.816 -1.083 . . . . 74.1 111.779 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.5 tp -123.46 138.51 54.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.605 1.162 . . . . 71.53 108.158 173.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.418 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 76.6 m -142.51 96.57 2.97 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.838 0.855 . . . . 72.11 109.555 -178.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -108.29 130.43 55.18 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.788 -0.819 . . . . 70.2 108.788 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.1 t -132.15 112.43 19.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 109.238 -0.653 . . . . 63.31 109.238 173.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -84.55 84.83 7.53 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.048 -1.093 . . . . 64.43 108.048 172.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.53 ' HG3' HD22 ' A' ' 106' ' ' LEU . 61.1 tp60 -76.85 102.97 6.55 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.183 -0.917 . . . . 71.21 108.795 -177.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.21 144.92 17.42 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.041 -0.823 . . . . 73.35 111.041 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.44 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -150.86 123.13 1.47 Allowed Glycine 0 CA--C 1.504 -0.615 0 N-CA-C 110.779 -0.928 . . . . 74.43 110.779 -176.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.5 mt -81.22 122.24 36.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 108.973 -0.751 . . . . 72.53 108.973 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.668 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 25.1 m-85 -134.12 137.53 44.61 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.859 -0.793 . . . . 73.14 108.859 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.3 m -102.44 96.79 7.16 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.006 -0.738 . . . . 64.21 109.006 173.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.647 HD11 ' SG ' ' A' ' 102' ' ' CYS . 62.8 mt -96.79 119.99 45.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 108.355 -0.98 . . . . 74.23 108.355 176.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.38 132.43 12.57 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.229 0.611 . . . . 41.21 109.972 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.701 ' HA2' ' HA3' ' C' ' 146' ' ' GLY . . . 170.01 -76.57 0.1 Allowed Glycine 0 C--N 1.339 0.711 0 N-CA-C 112.105 -0.398 . . . . 51.35 112.105 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.8 tp -150.07 150.08 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.419 0.688 . . . . 71.42 109.654 -171.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -91.94 -169.55 2.3 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.127 1.371 . . . . 73.42 111.971 -167.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.5 -135.11 23.25 Favored Glycine 0 C--N 1.355 1.584 0 CA-C-N 115.072 -0.967 . . . . 74.55 112.579 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.9 t -67.96 -22.83 65.01 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.851 0.86 . . . . 71.31 111.922 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -70.37 -53.57 16.03 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.148 0.579 . . . . 65.42 111.072 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 9.5 ptp -69.16 -30.53 68.78 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 121.018 -0.273 . . . . 74.21 111.204 173.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.98 -38.22 90.28 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.667 0.787 . . . . 74.31 111.545 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -67.83 -39.67 83.84 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.559 1.144 . . . . 60.25 110.582 175.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 18.7 t -72.58 -35.64 67.97 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 116.383 -0.371 . . . . 42.32 111.8 -175.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 pp -83.49 -29.95 27.56 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.932 0.493 . . . . 71.21 111.409 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.66 ' HA3' ' HB3' ' E' ' 14' ' ' LEU . . . -106.25 3.98 37.9 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 114.6 0.6 . . . . 73.35 114.6 -168.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.63 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -146.62 -53.41 0.24 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.832 0.316 . . . . 72.15 111.674 -176.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.435 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 66.4 t80 -73.09 -65.92 0.74 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 123.445 0.465 . . . . 73.1 112.084 -171.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.647 ' SG ' HD11 ' A' ' 86' ' ' ILE . 92.3 m -68.13 -32.91 4.37 Favored Pre-proline 0 CA--C 1.566 1.56 0 N-CA-C 115.135 1.532 . . . . 61.04 115.135 -172.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 25.9 Cg_endo -63.24 -32.04 73.73 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 121.824 1.683 . . . . 75.04 112.554 166.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -76.5 -21.44 55.79 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.997 0.519 . . . . 73.24 110.715 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 42.1 mm -67.46 -36.38 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 109.501 -0.555 . . . . 70.43 109.501 170.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.53 HD22 ' HG3' ' A' ' 80' ' ' GLN . 94.7 mt -79.77 -17.52 53.22 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.426 0.69 . . . . 62.14 112.211 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -61.43 -48.79 89.88 Favored Pre-proline 0 CA--C 1.57 1.715 0 CA-C-O 117.933 -1.032 . . . . 75.3 113.546 -175.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.31 -34.1 45.82 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 121.954 1.769 . . . . 51.01 112.909 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -72.67 -40.15 66.54 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.312 0.645 . . . . 45.45 111.382 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.62 -39.45 70.42 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.994 0.518 . . . . 43.44 110.449 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.521 HH12 HD12 ' C' ' 105' ' ' ILE . 30.6 ttm180 -54.35 -51.69 63.98 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 124.173 0.921 . . . . 75.11 109.829 173.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -65.75 -42.06 91.37 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.38 1.05 . . . . 71.2 111.558 -175.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 46.2 t -61.51 -42.85 99.43 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.837 0.711 . . . . 70.54 110.329 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.06 -48.1 87.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 O-C-N 124.108 0.88 . . . . 51.34 110.407 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 35.8 m -56.65 -38.55 72.31 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.913 0.885 . . . . 73.54 111.377 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.1 t -68.69 -46.22 69.63 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.435 -0.802 . . . . 63.22 110.353 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.447 ' SD ' HG23 ' A' ' 21' ' ' ILE . 27.1 mtp -59.0 -42.57 90.37 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.884 0.874 . . . . 62.31 111.406 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.547 HG21 HD23 ' A' ' 126' ' ' LEU . 68.9 t -65.72 -44.05 93.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 124.652 1.181 . . . . 73.24 110.71 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 37.5 t -71.43 -31.13 66.85 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.239 0.616 . . . . 51.13 110.935 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.451 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 90.8 mtt-85 -73.98 -32.14 63.3 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.758 0.823 . . . . 72.5 109.512 175.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.41 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.74 12.15 57.55 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 115.453 -0.794 . . . . 63.25 112.823 172.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.487 HG21 ' HE ' ' B' ' 15' ' ' ARG . 2.8 t 60.94 15.02 5.7 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 127.234 2.214 . . . . 71.43 114.385 171.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.458 ' HB2' HG13 ' A' ' 118' ' ' VAL . 74.7 m-85 -78.57 155.08 78.82 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 109.019 -0.734 . . . . 74.31 109.019 175.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.68 174.43 2.25 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.636 2.224 . . . . 63.44 113.488 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.1 116.34 1.96 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.2 1.4 . . . . 75.31 111.853 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.547 HD23 HG21 ' A' ' 118' ' ' VAL . 56.9 tp -127.94 106.08 8.85 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.549 0.74 . . . . 63.33 109.152 176.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -130.7 128.33 40.65 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.729 1.212 . . . . 71.5 109.042 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.66 144.92 55.27 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 123.429 0.455 . . . . 53.4 110.079 174.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' E' ' 5' ' ' THR . . . -65.17 157.12 78.64 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 124.303 1.041 . . . . 72.3 111.491 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.607 ' HD3' HG13 ' C' ' 13' ' ' ILE . 64.7 Cg_endo -70.37 99.33 0.8 Allowed 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.547 2.165 . . . . 53.54 111.981 176.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.42 HG21 ' H ' ' E' ' 8' ' ' LEU . 23.4 t -103.97 112.94 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.793 -0.817 . . . . 73.52 108.793 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.534 ' HB3' ' HB3' ' A' ' 135' ' ' ALA . 1.5 m-20 -95.27 84.12 3.99 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 108.686 -0.857 . . . . 74.31 108.686 177.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -61.57 -54.31 44.75 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 123.333 0.396 . . . . 74.41 110.006 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.63 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 14.7 t70 -63.5 -42.79 98.49 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.593 -1.185 . . . . 64.32 111.231 -173.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 132' ' ' ASN . . . -69.36 -19.5 63.85 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.125 -0.943 . . . . 73.43 112.121 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.646 HD23 HD21 ' E' ' 10' ' ' LEU . 40.0 tp -80.38 -41.39 24.74 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.601 0.36 . . . . 73.15 110.301 173.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -67.42 -30.33 70.05 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.692 0.397 . . . . 71.54 110.891 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 97.1 mmm -78.83 -38.23 38.57 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.314 0.646 . . . . 73.12 110.723 175.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 143' ' ' GLN . 2.8 t-20 -57.32 -36.61 71.33 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.286 1.035 . . . . 73.31 110.65 174.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -80.92 -31.84 34.9 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.684 -1.144 . . . . 75.44 110.753 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 28.4 tp -67.27 -53.05 33.41 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.21 0.604 . . . . 54.21 111.81 -173.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 172.82 -18.16 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 124.391 1.076 . . . . 55.33 109.534 -178.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 139' ' ' ASN . 62.5 tt0 -80.77 155.99 26.42 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 109.676 -0.49 . . . . 75.31 109.676 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -155.55 120.06 4.68 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.254 -1.387 . . . . 73.44 107.254 175.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 63.85 100.56 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.336 1.023 . . . . 54.14 110.889 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -53.86 98.38 0.04 OUTLIER Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.979 -0.555 . . . . 63.14 111.856 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -69.47 137.19 52.41 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.298 -1.001 . . . . 71.35 108.298 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -77.19 -162.88 17.21 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-O 121.753 0.64 . . . . 62.22 113.994 -172.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.502 ' H ' HD11 ' G' ' 13' ' ' LEU . 14.5 m -140.76 172.36 12.81 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 108.038 -1.097 . . . . 75.43 108.038 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -129.74 149.28 51.56 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.964 -1.495 . . . . 71.2 106.964 167.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.432 ' HB3' ' HE1' ' C' ' 137' ' ' PHE . 0.1 OUTLIER -128.78 155.17 45.57 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.499 0.666 . . . . 73.35 111.219 -170.572 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -162.38 116.46 1.79 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.164 -1.38 . . . . 74.23 108.13 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -103.63 172.83 6.59 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.854 0.862 . . . . 55.13 111.003 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -126.38 132.49 51.54 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.477 1.111 . . . . 75.44 109.218 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 C-N-CA 123.531 0.732 . . . . 73.04 109.475 179.076 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 120.65 0.262 . . . . 72.43 110.753 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 45.1 t -164.81 134.07 3.61 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.91 -1.144 . . . . 35.45 107.91 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -85.4 71.04 10.86 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.445 0.64 . . . . 73.42 109.564 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 18.7 tm0? -167.55 135.66 2.46 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 114.478 -1.237 . . . . 55.34 108.663 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -132.48 135.25 45.9 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.871 -1.159 . . . . 73.23 107.871 171.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -80.87 50.26 1.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.793 0.837 . . . . 63.35 110.861 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.1 t -67.05 -35.32 79.6 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.088 0.955 . . . . 75.22 111.018 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -83.46 145.52 28.9 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.97 -0.752 . . . . 71.4 108.97 173.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.541 ' SD ' ' N ' ' B' ' 10' ' ' THR . 1.0 OUTLIER 66.48 163.32 0.17 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 125.736 1.615 . . . . 72.52 110.339 -167.169 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.541 ' N ' ' SD ' ' B' ' 9' ' ' MET . 54.6 m -167.08 130.66 1.85 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.801 0.84 . . . . 71.31 109.685 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' B' ' 85' ' ' SER 0.283 0.5 OUTLIER -155.25 155.85 34.54 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.561 0.696 . . . . 71.14 111.204 143.406 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -127.03 128.38 46.24 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 106.424 -1.695 . . . . 75.35 106.424 172.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.491 HD11 HD13 ' B' ' 105' ' ' ILE . 27.8 mt -68.52 121.34 17.61 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 N-CA-C 108.784 -0.821 . . . . 72.12 108.784 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -90.29 -40.62 12.03 Favored 'General case' 0 C--O 1.243 0.761 0 O-C-N 124.233 0.958 . . . . 74.02 109.583 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.493 ' HA ' ' ND2' ' D' ' 127' ' ' ASN . 28.3 ttt180 -167.56 133.77 2.12 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 116.396 -0.366 . . . . 53.01 111.022 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.426 HD11 HD13 ' B' ' 13' ' ' ILE . 86.1 mt -115.56 135.97 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 107.48 -1.304 . . . . 73.34 107.48 173.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.401 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 42.3 p90 -168.73 170.69 9.18 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.98 0.895 . . . . 73.15 113.052 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.421 HG21 HD11 ' B' ' 21' ' ' ILE . 86.9 m -96.42 118.03 32.1 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.828 -1.533 . . . . 65.14 108.743 174.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.415 ' HZ1' ' HB3' ' A' ' 28' ' ' ALA . 24.8 mtpp -79.8 -28.99 40.19 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.985 0.514 . . . . 73.32 110.543 176.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -162.7 149.93 13.37 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.218 0.533 . . . . 73.24 112.045 -171.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 28.3 mm -137.89 144.88 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 126.216 1.806 . . . . 65.31 108.612 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 46.2 t -147.64 126.66 12.83 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.965 -1.016 . . . . 71.42 108.786 169.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 85.3 t80 -138.81 109.82 6.8 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 107.529 -1.286 . . . . 73.41 107.529 171.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -119.09 115.47 24.34 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.922 0.889 . . . . 74.52 108.724 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.95 86.35 1.91 Allowed Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 107.091 -1.448 . . . . 40.52 107.091 169.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.88 -45.23 8.6 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.567 2.178 . . . . 72.13 112.131 -169.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -100.59 18.05 20.2 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.674 0.79 . . . . 73.11 110.748 -176.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.501 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -31.12 -68.67 0.13 Allowed Pre-proline 0 N--CA 1.504 2.242 0 N-CA-C 115.419 1.637 . . . . 54.14 115.419 -166.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 54.8 Cg_endo -70.37 -13.48 33.19 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 122.336 2.024 . . . . 65.31 113.078 -171.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -92.2 -45.7 8.12 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.544 0.738 . . . . 73.31 110.258 177.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.564 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.0 p -69.57 -17.62 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 112.295 0.48 . . . . 73.03 112.295 -171.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -62.92 -18.8 63.55 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.013 0.525 . . . . 54.33 112.383 173.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -65.98 -20.96 66.37 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.609 0.764 . . . . 65.13 110.817 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -103.99 71.27 1.03 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.835 1.254 . . . . 73.15 108.743 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -82.75 91.95 7.12 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.178 -0.919 . . . . 73.44 111.727 -173.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -158.64 -175.18 5.16 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.136 0.974 . . . . 73.2 109.52 170.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -72.74 111.59 11.84 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 123.663 0.785 . . . . 75.11 110.145 176.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.46 153.77 75.67 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.336 2.024 . . . . 72.44 112.216 178.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -69.31 113.93 7.09 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.56 -0.745 . . . . 71.24 109.16 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 12.8 t -86.46 121.35 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 122.991 0.517 . . . . 63.55 109.899 -173.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -115.86 128.63 55.96 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 107.244 -1.391 . . . . 70.5 107.244 172.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.745 HD21 ' HA ' ' F' ' 6' ' ' ILE . 0.2 OUTLIER -131.19 148.76 52.75 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.134 0.573 . . . . 73.21 109.763 174.867 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -153.2 129.82 10.77 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.066 0.946 . . . . 65.25 108.713 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 85.7 mt -99.47 150.91 21.71 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.691 0.797 . . . . 61.04 110.04 -176.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.0 t70 -137.14 139.68 41.35 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.777 -0.823 . . . . 62.41 108.777 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.8 p -109.8 124.23 50.93 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.392 0.677 . . . . 71.15 110.808 -175.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -131.94 135.36 46.54 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.42 1.088 . . . . 74.33 108.965 176.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 16.2 m -144.35 161.77 38.15 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.76 0.424 . . . . 52.21 111.385 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 53.9 p -160.55 143.39 13.17 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.328 -0.851 . . . . 72.01 109.769 174.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.412 ' NE2' ' HB2' ' F' ' 20' ' ' LYS . 41.0 tp60 -80.29 107.08 12.8 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 107.821 -1.178 . . . . 72.4 107.821 172.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.622 HD11 ' HB2' ' B' ' 57' ' ' GLU . 40.2 mt -77.09 -42.08 39.6 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.275 0.559 . . . . 74.53 110.295 -174.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.22 -166.06 1.85 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.248 1.019 . . . . 75.43 109.827 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' F' ' 25' ' ' GLU . 8.1 p-10 -69.96 131.39 44.33 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.251 0.62 . . . . 61.23 109.764 175.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 64.75 -10.4 0.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 125.727 1.611 . . . . 72.35 112.343 -171.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' B' ' 51' ' ' LEU . 91.1 t -110.7 121.82 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 O-C-N 121.502 -0.749 . . . . 72.13 109.468 -165.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -133.58 -176.48 4.17 Favored 'General case' 0 C--O 1.247 0.973 0 N-CA-C 107.796 -1.187 . . . . 65.13 107.796 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.622 ' HB2' HD11 ' B' ' 51' ' ' LEU . 35.4 tt0 -139.19 129.24 25.15 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.391 0.276 . . . . 62.33 110.608 -177.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 82.8 t -97.11 117.99 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.433 -0.951 . . . . 72.24 108.433 170.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 41.2 t -116.79 110.58 31.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.963 -1.125 . . . . 64.05 107.963 174.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 30.3 tp -107.28 107.85 18.98 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.337 -0.986 . . . . 64.23 108.337 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.552 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 45.9 ttt180 -84.74 114.44 22.05 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.52 -0.918 . . . . 73.43 108.52 176.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.6 t -102.69 105.07 17.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.968 -1.123 . . . . 71.35 107.968 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 33.1 m -95.45 138.37 33.23 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.511 -0.922 . . . . 73.53 108.511 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.55 133.26 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.563 0.745 . . . . 73.42 109.612 177.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.2 m -119.39 145.3 46.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.396 1.078 . . . . 60.31 108.421 169.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.57 129.34 26.49 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.849 -0.797 . . . . 74.54 108.849 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 30.9 p -123.11 127.83 49.25 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.587 0.755 . . . . 62.51 110.638 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.512 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 44.6 mt -102.63 109.39 20.99 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.061 0.944 . . . . 75.11 109.176 172.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.81 -110.56 3.55 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 114.958 -1.019 . . . . 53.51 113.398 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -105.08 4.02 31.04 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.007 0.923 . . . . 72.55 111.708 -174.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -139.53 164.79 28.97 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.743 0.417 . . . . 70.35 110.863 -176.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 63.3 m -79.07 125.6 29.61 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.479 0.712 . . . . 73.3 110.719 -177.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.564 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -70.55 -63.2 1.14 Allowed 'General case' 0 C--O 1.24 0.559 0 O-C-N 123.966 0.792 . . . . 71.45 109.16 171.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -155.08 164.54 38.72 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.462 -1.245 . . . . 72.25 111.724 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 55.4 mt -126.13 111.36 14.56 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 105.545 -2.02 . . . . 63.34 105.545 173.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.477 ' SG ' HG23 ' B' ' 114' ' ' ILE . 31.5 t -119.12 140.18 50.56 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.733 -0.84 . . . . 73.52 108.733 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -160.02 136.2 8.74 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.101 0.477 . . . . 70.24 110.045 -170.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' B' ' 113' ' ' CYS . 88.7 t -132.94 151.6 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.746 1.219 . . . . 71.14 108.248 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.542 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 17.3 mt-30 -124.52 98.85 5.91 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.795 -1.187 . . . . 64.42 107.795 170.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.443 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 7.8 tp-100 -88.76 99.86 12.69 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.645 -0.872 . . . . 74.3 108.645 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.84 141.51 15.62 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.303 -1.119 . . . . 64.4 110.303 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.12 127.08 3.13 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 110.673 -0.971 . . . . 60.44 110.673 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 55.3 mt -89.78 127.41 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.788 0.835 . . . . 64.42 109.084 176.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -135.56 135.06 40.02 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.129 -1.434 . . . . 75.2 107.129 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 67.6 m -99.45 89.92 4.34 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.403 0.547 . . . . 63.24 110.864 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.538 HG21 HG21 ' F' ' 18' ' ' VAL . 12.7 tt -95.54 141.43 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.221 1.008 . . . . 44.42 111.607 -172.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.16 166.73 32.42 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.604 0.761 . . . . 71.21 110.436 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.96 -51.55 1.3 Allowed Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.742 -0.663 . . . . 71.11 112.54 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 17.4 mm -90.71 152.82 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.483 0.713 . . . . 75.13 112.315 -174.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.418 ' HA ' ' HE2' ' B' ' 94' ' ' MET . 40.1 tt0 -157.07 157.52 34.74 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 114.628 -1.169 . . . . 74.54 110.056 176.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.11 -135.0 12.59 Favored Glycine 0 C--N 1.353 1.503 0 C-N-CA 123.264 0.459 . . . . 64.33 113.191 170.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m -82.97 -18.32 40.35 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.212 0.605 . . . . 62.13 110.587 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -57.06 -38.74 73.71 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.887 0.875 . . . . 64.44 111.203 173.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.418 ' HE2' ' HA ' ' B' ' 90' ' ' GLU . 17.1 ptp -78.57 -25.37 45.31 Favored 'General case' 0 C--O 1.208 -1.107 0 CA-C-O 119.112 -0.471 . . . . 72.14 111.412 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.63 -34.67 67.5 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 122.963 0.505 . . . . 72.45 111.967 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -75.27 -47.3 28.62 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.815 0.846 . . . . 53.43 111.184 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.11 -49.62 71.47 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.248 0.619 . . . . 64.43 111.415 -175.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.531 HD11 HG23 ' F' ' 18' ' ' VAL . 60.4 mt -72.51 -27.99 62.6 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.27 -0.877 . . . . 75.12 111.321 -176.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.7 -0.26 64.56 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-O 119.688 -0.507 . . . . 70.24 113.88 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.5 -62.73 0.46 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 117.384 0.592 . . . . 65.11 111.643 -176.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.451 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 33.7 t80 -64.6 -46.36 82.98 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.986 0.914 . . . . 72.25 111.646 -171.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 39.9 m -73.58 -46.66 7.33 Favored Pre-proline 0 CA--C 1.567 1.624 0 N-CA-C 113.128 0.788 . . . . 64.04 113.128 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -69.12 -21.64 36.16 Favored 'Trans proline' 0 C--N 1.395 2.994 0 C-N-CA 122.022 1.815 . . . . 70.11 113.264 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -57.62 -36.34 71.67 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 124.112 0.965 . . . . 64.11 111.118 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.491 HD13 HD11 ' B' ' 13' ' ' ILE . 68.9 mt -68.74 -43.14 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.666 1.186 . . . . 75.22 110.945 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 78.4 mt -82.94 -22.39 33.82 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.858 -1.065 . . . . 60.33 111.923 -172.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -55.54 -51.34 80.88 Favored Pre-proline 0 CA--C 1.562 1.433 0 CA-C-O 117.655 -1.164 . . . . 73.12 113.062 -175.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.14 -38.47 94.84 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 122.257 1.972 . . . . 65.13 113.744 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -69.41 -48.88 59.68 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.183 0.593 . . . . 74.15 110.747 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -62.93 -39.87 95.91 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.066 0.546 . . . . 64.43 111.194 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -59.38 -53.97 52.13 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.064 1.346 . . . . 71.4 111.146 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -68.19 -31.63 71.29 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.533 0.733 . . . . 43.15 110.032 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.492 ' O ' ' HG2' ' B' ' 117' ' ' MET . 12.6 t -68.16 -33.67 74.9 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.984 0.514 . . . . 74.31 111.188 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.477 HG23 ' SG ' ' B' ' 76' ' ' CYS . 78.9 mt -68.14 -52.23 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.162 0.585 . . . . 62.22 109.764 172.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.4 m -59.19 -30.44 68.21 Favored 'General case' 0 CA--C 1.553 1.074 0 O-C-N 123.971 0.794 . . . . 74.3 111.666 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 37.3 t -64.38 -50.77 66.37 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 123.498 0.719 . . . . 71.23 109.976 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.4 mmt -69.27 -32.48 71.69 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 123.615 0.572 . . . . 74.45 111.223 -174.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 114' ' ' ILE . 89.4 t -61.95 -47.44 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.653 0.781 . . . . 72.54 110.307 173.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 34.6 t -62.14 -37.3 84.65 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.81 -1.087 . . . . 73.44 110.799 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.424 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 93.1 mtt-85 -67.68 -32.3 72.87 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 115.435 -0.802 . . . . 74.11 110.612 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.76 4.7 84.36 Favored Glycine 0 C--N 1.349 1.302 0 O-C-N 123.717 0.636 . . . . 50.14 112.905 174.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 68.2 p 57.96 33.97 23.77 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 126.113 1.765 . . . . 74.32 113.204 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -93.99 163.8 22.55 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 123.99 0.916 . . . . 72.15 110.726 177.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.09 170.4 1.12 Allowed 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.537 2.825 . . . . 65.43 115.198 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -64.05 114.36 4.1 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.41 1.084 . . . . 72.14 110.903 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.94 84.72 2.24 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.157 -1.053 . . . . 54.3 108.157 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -108.81 118.53 37.02 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.629 0.772 . . . . 64.5 109.073 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.606 HD21 HD13 ' B' ' 42' ' ' LEU . 0.3 OUTLIER -70.85 133.03 46.14 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.505 0.722 . . . . 71.13 109.23 -177.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.76 144.04 98.38 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.428 0.691 . . . . 73.02 111.773 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.18 92.58 0.65 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.9 2.4 . . . . 73.15 112.686 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' F' ' 8' ' ' LEU . 48.3 t -98.13 110.11 25.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.434 -0.95 . . . . 74.43 108.434 172.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -89.87 114.09 25.8 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.026 -0.731 . . . . 73.03 109.026 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -60.88 -43.16 98.82 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.521 0.728 . . . . 73.51 111.0 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -57.74 -49.7 75.68 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 114.837 -1.074 . . . . 65.24 112.734 -173.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.33 74.82 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.277 0.985 . . . . 74.21 112.801 -171.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 mp -77.43 -37.42 51.72 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.863 -0.608 . . . . 74.32 110.181 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -68.18 -28.7 67.5 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.457 0.303 . . . . 65.31 111.611 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 84.4 mtp -60.33 -39.91 88.76 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.323 0.649 . . . . 73.23 111.147 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -85.69 -24.54 26.95 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.655 -1.157 . . . . 72.43 110.169 -170.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -71.7 -33.52 68.85 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.978 0.418 . . . . 74.32 110.151 173.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 80.7 mt -92.61 27.38 2.33 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.52 0.728 . . . . 64.01 110.95 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -63.55 138.75 58.63 Favored 'General case' 0 C--N 1.358 0.954 0 C-N-CA 123.195 0.598 . . . . 73.51 111.122 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -175.19 122.59 0.22 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.123 1.369 . . . . 71.2 107.45 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -91.56 128.08 37.26 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.809 0.444 . . . . 74.23 110.563 -176.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.95 178.23 5.18 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.096 0.559 . . . . 53.43 109.652 170.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -149.17 152.91 24.84 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.453 -0.659 . . . . 73.43 111.453 178.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 147' ' ' GLU . . . . . 0.587 ' HA ' ' HA ' ' D' ' 147' ' ' GLU . 41.1 mt-10 -88.47 173.54 8.63 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.784 0.802 . . . . 71.3 111.038 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 166.69 -173.43 42.05 Favored Glycine 0 C--O 1.239 0.466 0 CA-C-N 114.293 -1.321 . . . . 73.52 109.99 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 31.2 p 64.18 156.51 0.07 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.773 1.629 . . . . 63.53 113.196 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -173.85 133.74 0.45 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 106.156 -1.794 . . . . 74.03 106.156 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -136.94 99.89 4.14 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.789 0.328 . . . . 74.53 110.676 -175.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -91.95 160.06 15.45 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.37 0.668 . . . . 75.45 109.496 164.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -165.83 140.07 4.57 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.487 1.115 . . . . 71.21 108.681 174.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -137.12 2.38 2.55 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.483 0.713 . . . . 75.42 110.302 175.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.959 0 C-N-CA 124.087 0.955 . . . . 64.01 109.235 178.699 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 86.0 mtp . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 109.976 -0.379 . . . . 74.13 109.976 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 71.9 p -114.0 127.38 55.93 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.345 0.658 . . . . 53.33 109.743 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -82.2 173.69 11.88 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.276 0.63 . . . . 65.51 110.63 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -64.84 119.08 9.97 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.309 0.644 . . . . 71.33 109.785 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -65.36 -75.95 0.08 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.252 1.021 . . . . 74.44 110.378 -176.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -174.63 117.3 0.2 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 107.591 -1.262 . . . . 73.14 107.591 175.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.471 HG22 ' HB2' ' A' ' 136' ' ' LEU . 46.7 p -101.66 158.15 16.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.559 0.744 . . . . 74.44 109.665 177.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -62.38 145.79 53.01 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.18 0.592 . . . . 71.12 109.89 167.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.75 133.99 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.917 1.287 . . . . 64.45 111.412 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 35.6 m -127.37 94.93 4.12 Favored 'General case' 0 C--O 1.244 0.768 0 O-C-N 121.644 -0.66 . . . . 72.43 109.91 175.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' C' ' 85' ' ' SER . 0.2 OUTLIER -123.76 165.22 17.66 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 115.901 -0.591 . . . . 75.43 109.5 162.486 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -134.74 128.28 32.61 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 107.84 -1.17 . . . . 75.01 107.84 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.607 HG13 ' HD3' ' A' ' 130' ' ' PRO . 63.0 mt -65.75 118.27 8.17 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 N-CA-C 107.987 -1.116 . . . . 62.41 107.987 173.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -93.82 -36.82 12.07 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 123.981 0.801 . . . . 71.33 108.959 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -178.51 123.28 0.1 Allowed 'General case' 0 C--N 1.361 1.075 0 O-C-N 123.68 0.612 . . . . 61.21 110.766 -172.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.2 mt -109.85 137.91 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.838 1.255 . . . . 71.11 108.923 172.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.497 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 21.1 p90 -174.34 166.77 4.04 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.862 0.865 . . . . 74.31 109.972 -172.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.2 p -91.72 126.33 36.77 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.174 0.589 . . . . 51.23 109.532 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.497 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 14.9 mmtp -74.5 -50.07 19.68 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 107.759 -1.2 . . . . 72.12 107.759 168.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 19.8 t70 -136.08 141.98 44.28 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 113.627 -1.624 . . . . 73.33 109.883 -168.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.582 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 88.7 mt -138.37 145.51 28.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 106.604 -1.628 . . . . 73.51 106.604 175.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 22' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' C' ' 77' ' ' GLU . 42.2 t -154.9 150.11 27.09 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.763 0.825 . . . . 72.22 109.295 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 88.9 t80 -156.86 117.03 3.54 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 107.568 -1.271 . . . . 75.41 107.568 173.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -120.53 111.66 17.96 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.127 0.571 . . . . 73.42 110.146 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.97 82.96 43.68 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.379 1.072 . . . . 71.22 108.274 168.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -69.39 -31.39 22.26 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.588 2.192 . . . . 74.44 110.687 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -96.11 13.82 25.93 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.156 -1.384 . . . . 74.54 110.583 -175.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.99 -56.67 14.26 Favored Pre-proline 0 CA--C 1.566 1.59 0 N-CA-C 113.97 1.1 . . . . 64.4 113.97 -170.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -60.35 -41.41 50.13 Favored 'Trans proline' 0 C--N 1.395 3.014 0 C-N-CA 122.002 1.801 . . . . 71.22 112.075 -177.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -70.24 -38.1 75.1 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.447 -1.251 . . . . 73.43 112.298 -175.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.727 HG21 ' HA ' ' C' ' 73' ' ' ALA . 12.4 p -77.91 -23.02 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 112.471 0.545 . . . . 64.44 112.471 -173.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -64.77 -22.89 67.08 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.081 0.4 . . . . 73.41 112.081 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -103.98 29.51 5.83 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.952 0.901 . . . . 74.53 110.808 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.556 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -114.11 163.35 15.3 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.787 0.835 . . . . 73.23 109.533 173.412 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.52 120.87 11.36 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.621 0.768 . . . . 71.1 109.937 168.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -85.97 90.44 8.09 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.877 0.471 . . . . 75.54 111.133 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -150.25 76.97 8.39 Favored Pre-proline 0 N--CA 1.483 1.208 0 C-N-CA 124.913 1.285 . . . . 74.54 108.216 169.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -84.04 160.57 13.64 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.27 1.98 . . . . 74.32 112.609 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -87.1 119.47 27.35 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 106.207 -1.775 . . . . 65.23 106.207 168.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.578 HG11 HD11 ' C' ' 126' ' ' LEU . 34.9 m -91.36 97.19 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 122.469 1.128 . . . . 60.01 109.47 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.554 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 3.7 ttmp? -96.78 100.32 11.86 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 114.541 -1.208 . . . . 61.42 107.988 177.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 pp -87.93 149.53 24.01 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 109.358 -0.608 . . . . 63.02 109.358 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.482 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 33.6 t70 -149.0 114.17 5.49 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.276 0.63 . . . . 71.21 109.951 -173.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.543 HD21 HD11 ' G' ' 8' ' ' LEU . 9.1 mp -105.26 147.83 27.65 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.226 0.536 . . . . 71.44 110.519 177.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.496 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 5.7 t70 -136.36 151.06 49.15 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.334 1.454 . . . . 41.42 107.821 175.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 30.4 p -113.48 112.23 23.26 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.601 -0.518 . . . . 73.41 109.601 -177.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.11 151.62 37.19 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.349 1.06 . . . . 65.52 109.074 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.0 p -166.11 173.59 10.14 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.167 0.432 . . . . 73.32 112.167 -173.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 45.3 t -166.7 146.65 5.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.276 1.031 . . . . 72.52 109.286 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -88.38 118.61 28.12 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.891 -0.781 . . . . 65.03 108.891 170.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.618 HD11 HD12 ' C' ' 83' ' ' ILE . 65.4 mt -89.09 -38.98 13.95 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.352 0.661 . . . . 64.53 110.55 -177.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.53 -174.85 4.18 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.117 -0.947 . . . . 71.33 110.746 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -61.4 104.66 0.43 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 114.317 -1.311 . . . . 73.32 110.001 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 70.9 -2.71 2.22 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 125.894 1.677 . . . . 74.53 113.79 -175.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 71.2 t -93.71 115.61 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 107.748 -1.204 . . . . 54.11 107.748 175.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -133.35 136.99 45.7 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.718 0.771 . . . . 63.44 110.191 -170.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -86.98 113.13 22.48 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.664 1.586 . . . . 74.33 109.211 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 91.2 t -104.47 113.83 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 108.007 -1.109 . . . . 62.32 108.007 174.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -121.57 136.18 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 109.233 -0.655 . . . . 72.23 109.233 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.456 HD22 ' HB3' ' C' ' 103' ' ' PRO . 34.5 tp -120.44 115.96 24.52 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.596 -0.89 . . . . 53.2 108.596 175.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.496 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 15.3 ttm-85 -81.77 130.09 34.95 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.398 -0.964 . . . . 63.3 108.398 173.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.469 ' HB ' HD11 ' C' ' 114' ' ' ILE . 4.2 t -119.02 132.23 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 106.839 -1.541 . . . . 74.15 106.839 171.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.482 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 16.1 m -133.36 116.75 16.47 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.014 -0.736 . . . . 63.21 109.014 -177.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.632 HG21 HG21 ' C' ' 114' ' ' ILE . 62.7 t -105.31 114.71 45.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 123.835 0.854 . . . . 74.21 109.464 -175.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.554 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 18.5 m -101.79 139.11 37.87 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.559 -0.904 . . . . 64.11 108.559 172.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.46 114.58 13.03 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.887 -1.153 . . . . 74.34 107.887 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 31.4 m -137.0 130.42 31.41 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.104 0.478 . . . . 55.01 111.295 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.556 HD13 ' HG2' ' C' ' 34' ' ' LYS . 11.6 mt -86.32 46.88 1.39 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.795 1.238 . . . . 74.4 109.72 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.88 -109.67 3.56 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 110.699 -0.96 . . . . 75.14 110.699 -174.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -89.6 -23.93 21.82 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.467 0.707 . . . . 53.2 110.241 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -72.54 122.64 21.67 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 123.798 0.839 . . . . 72.23 110.005 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.0 m -82.94 128.04 34.09 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.976 -0.75 . . . . 74.04 108.976 168.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.727 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -80.52 -55.27 4.98 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 123.789 0.68 . . . . 73.3 109.525 172.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -162.6 175.65 11.18 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.116 0.96 . . . . 75.02 111.575 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.424 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -137.53 147.36 45.11 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 105.997 -1.853 . . . . 64.14 105.997 171.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.424 ' N ' HD13 ' C' ' 75' ' ' LEU . 41.9 t -147.78 153.26 38.99 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.588 -0.893 . . . . 71.34 108.588 176.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 77' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' C' ' 22' ' ' SER . 34.6 tt0 -158.1 133.25 8.66 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 122.847 0.459 . . . . 75.21 110.243 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.488 HG11 ' HA ' ' C' ' 110' ' ' ALA . 49.1 t -137.52 114.43 12.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.481 1.112 . . . . 65.24 108.547 177.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.486 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 58.4 mt-30 -95.85 94.17 7.49 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.693 -0.854 . . . . 75.15 108.693 174.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.51 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.5 tp-100 -82.27 111.01 17.96 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.454 -0.794 . . . . 74.52 109.693 -176.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.46 148.08 18.86 Favored Glycine 0 C--N 1.335 0.522 0 O-C-N 123.827 0.705 . . . . 51.44 112.079 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.05 118.57 0.97 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.096 -1.201 . . . . 72.31 110.096 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.618 HD12 HD11 ' C' ' 51' ' ' LEU . 15.0 mm -84.42 128.13 39.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.617 -0.883 . . . . 55.34 108.617 176.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.466 ' HB2' HD11 ' C' ' 86' ' ' ILE . 26.5 m-85 -136.42 149.13 48.12 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.883 -1.154 . . . . 74.25 107.883 176.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 85' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 19.4 p -102.61 109.75 21.46 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 108.949 -0.759 . . . . 62.22 108.949 174.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.466 HD11 ' HB2' ' C' ' 84' ' ' PHE . 4.4 mp -108.58 122.08 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.107 0.563 . . . . 75.04 109.95 -167.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.56 167.58 27.62 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 114.538 -1.21 . . . . 51.04 109.651 175.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.46 -60.67 0.36 Allowed Glycine 0 C--N 1.344 0.973 0 CA-C-N 116.104 -0.498 . . . . 71.45 113.088 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 41.0 pt -113.33 167.55 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.202 0.525 . . . . 75.2 111.294 -176.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -149.18 -177.49 5.85 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.975 -1.011 . . . . 71.34 110.106 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.36 -139.99 42.56 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.68 -0.691 . . . . 44.04 114.077 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 39.4 p -68.99 -27.52 65.78 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.91 0.884 . . . . 64.34 111.33 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -61.48 -45.28 94.9 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.302 0.641 . . . . 74.15 110.157 175.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.554 ' HE1' ' H ' ' G' ' 18' ' ' VAL . 9.8 ptm -77.32 -21.8 52.9 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-O 119.221 -0.419 . . . . 62.33 111.068 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.32 -36.72 82.05 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.193 0.52 . . . . 65.22 109.947 172.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.55 ' HA ' HD12 ' G' ' 13' ' ' LEU . 46.3 t-80 -60.9 -33.26 72.86 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.783 0.833 . . . . 73.33 110.744 173.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -77.79 -57.87 3.57 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.039 -0.528 . . . . 73.03 110.704 176.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.428 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 96.0 mt -71.18 -37.84 72.15 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.101 0.96 . . . . 62.1 113.386 -165.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.2 -11.15 34.69 Favored Glycine 0 N--CA 1.471 0.993 0 CA-C-O 120.007 -0.329 . . . . 71.34 113.871 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.482 ' HB1' ' HB2' ' C' ' 134' ' ' ASP . . . -116.82 -57.61 2.16 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 117.161 0.481 . . . . 74.41 110.742 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -76.74 -47.72 20.92 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.467 0.707 . . . . 74.14 112.506 -174.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.428 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 58.6 m -65.11 -46.57 73.25 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 123.886 0.875 . . . . 54.44 112.722 -173.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.456 ' HB3' HD22 ' C' ' 60' ' ' LEU . 14.1 Cg_exo -72.1 -15.83 28.83 Favored 'Trans proline' 0 C--N 1.392 2.858 0 C-N-CA 122.148 1.899 . . . . 74.45 112.352 176.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -74.48 -33.26 62.81 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.465 0.706 . . . . 75.35 110.083 175.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.521 HD12 HH12 ' A' ' 111' ' ' ARG . 48.0 mm -61.34 -40.74 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 115.607 -0.724 . . . . 73.13 109.279 170.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 81.4 mt -87.25 -18.9 29.17 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.852 -1.067 . . . . 65.5 112.923 -173.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -57.72 -51.6 80.55 Favored Pre-proline 0 CA--C 1.559 1.316 0 CA-C-O 117.755 -1.117 . . . . 62.24 113.5 -174.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.17 -30.73 91.97 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 122.032 1.821 . . . . 72.41 113.399 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -68.77 -49.48 58.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.248 0.619 . . . . 63.43 110.643 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -65.16 -35.85 82.39 Favored 'General case' 0 C--N 1.355 0.843 0 CA-C-N 115.759 -0.655 . . . . 74.12 110.684 177.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -58.82 -51.08 71.51 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.381 1.073 . . . . 70.01 110.746 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.74 -37.57 79.52 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.789 -0.448 . . . . 53.05 109.789 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.9 t -66.06 -31.83 72.94 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.042 0.537 . . . . 71.1 111.51 -176.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.632 HG21 HG21 ' C' ' 64' ' ' VAL . 96.7 mt -72.63 -54.98 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.358 -0.608 . . . . 73.22 109.358 173.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.9 m -60.31 -28.25 67.97 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.935 0.772 . . . . 40.45 111.278 -175.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 30.6 t -66.7 -49.83 64.8 Favored 'General case' 0 C--O 1.213 -0.844 0 N-CA-C 108.734 -0.839 . . . . 62.22 108.734 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.553 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.4 -37.31 83.0 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.454 1.102 . . . . 75.4 112.401 178.17 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.443 HG23 ' O ' ' C' ' 114' ' ' ILE . 76.4 t -63.24 -45.29 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.718 0.807 . . . . 64.35 109.044 174.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 44.5 t -70.55 -26.26 63.47 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.561 -1.2 . . . . 71.21 112.113 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -75.83 -40.56 54.66 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.632 0.773 . . . . 73.24 108.949 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.27 -0.39 61.56 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 123.903 0.752 . . . . 64.35 112.348 168.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 31.0 p 62.75 28.4 16.49 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.692 1.997 . . . . 74.5 113.415 170.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -83.57 141.24 41.72 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 107.997 -1.112 . . . . 73.2 107.997 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -50.98 156.46 4.82 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 123.682 2.922 . . . . 64.34 114.232 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -50.62 111.83 0.6 Allowed 'General case' 0 N--CA 1.481 1.094 0 O-C-N 124.473 1.108 . . . . 71.23 112.695 -171.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.578 HD11 HG11 ' C' ' 40' ' ' VAL . 31.2 tp -112.73 87.51 2.6 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.217 -1.401 . . . . 62.24 107.217 171.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -107.69 107.67 18.57 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.149 -1.056 . . . . 72.1 108.149 -172.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 30.7 tp -65.99 142.59 57.79 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.519 0.512 . . . . 62.34 111.157 -174.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.29 152.92 95.65 Favored Pre-proline 0 CA--C 1.555 1.141 0 O-C-N 124.072 0.858 . . . . 63.52 110.888 178.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.473 ' HG2' HG21 ' A' ' 13' ' ' ILE . 51.4 Cg_exo -54.77 143.84 68.58 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.965 2.443 . . . . 75.13 113.559 177.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.691 HG11 HD13 ' G' ' 8' ' ' LEU . 7.0 p -128.6 110.35 21.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-O 122.665 1.221 . . . . 72.43 109.595 173.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' C' ' 135' ' ' ALA . 2.3 m-20 -92.06 84.39 5.29 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.63 -1.989 . . . . 63.04 105.63 169.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -47.15 -44.29 21.7 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.765 0.826 . . . . 73.13 111.883 -171.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.482 ' HB2' ' HB1' ' C' ' 100' ' ' ALA . 16.1 t70 -62.92 -45.28 93.22 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.628 -1.169 . . . . 64.11 112.468 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.482 ' HB3' ' HB2' ' C' ' 132' ' ' ASN . . . -67.45 -21.08 65.56 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.257 0.623 . . . . 74.31 112.386 -175.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.26 -41.2 97.06 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.044 0.538 . . . . 73.51 110.612 169.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 137' ' ' PHE . . . . . 0.432 ' HE1' ' HB3' ' A' ' 151' ' ' GLU . 83.5 m-85 -70.15 -38.25 75.43 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.571 0.749 . . . . 73.05 111.419 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 85.8 mtp -68.11 -37.92 81.68 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.757 -0.656 . . . . 74.41 110.342 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.14 -37.01 68.9 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.985 1.314 . . . . 62.44 111.266 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -56.43 -82.26 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.353 1.061 . . . . 74.51 111.389 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -62.24 -33.14 74.02 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 113.513 0.931 . . . . 73.01 113.513 -170.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -67.23 151.61 47.22 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 120.833 0.349 . . . . 63.11 111.379 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -66.96 -53.02 35.78 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.295 -0.866 . . . . 53.51 109.25 171.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 62.26 96.39 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.676 1.191 . . . . 64.13 110.711 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.32 157.84 28.68 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.307 0.643 . . . . 54.43 110.019 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 146' ' ' GLY . . . . . 0.701 ' HA3' ' HA2' ' A' ' 88' ' ' GLY . . . 149.34 -157.09 27.11 Favored Glycine 0 C--N 1.343 0.947 0 C-N-CA 121.02 -0.61 . . . . 74.14 114.446 172.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -152.38 142.99 22.79 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.046 0.938 . . . . 71.44 109.195 -170.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.27 -119.06 4.17 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 111.011 -0.836 . . . . 73.24 111.011 172.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 149' ' ' THR . . . . . 0.411 HG21 ' HG3' ' E' ' 20' ' ' LYS . 8.3 m -162.92 156.6 20.13 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.586 0.754 . . . . 75.01 110.491 -177.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -111.23 101.78 10.25 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 108.031 -1.1 . . . . 71.1 108.031 170.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -101.48 133.44 46.12 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.812 -0.81 . . . . 60.13 108.812 169.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -70.24 95.11 0.97 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.228 0.611 . . . . 73.44 109.631 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -153.56 129.39 10.17 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.797 0.839 . . . . 43.22 109.158 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -142.85 117.96 10.09 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.191 0.596 . . . . 73.34 109.499 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.168 0 C-N-CA 123.25 0.62 . . . . 45.24 110.457 -179.07 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.1 pmm? . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 121.04 0.448 . . . . 53.32 110.642 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 17.0 t -149.79 162.02 41.11 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.699 0.8 . . . . 73.13 109.197 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -158.02 -42.37 0.06 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.408 0.283 . . . . 73.11 110.891 -174.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -69.63 96.84 0.98 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.506 0.723 . . . . 75.45 111.252 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -153.8 15.56 0.49 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.069 0.948 . . . . 64.12 111.334 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -53.02 -71.28 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.524 1.13 . . . . 74.54 111.302 -174.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 12.3 t 176.18 -170.69 0.07 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.708 1.603 . . . . 73.15 107.678 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.13 132.37 42.18 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 118.887 0.767 . . . . 71.22 109.372 174.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 28.2 ttt -33.28 129.12 0.27 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 115.16 1.541 . . . . 75.1 115.16 174.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 59.8 m -107.96 142.47 38.03 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.504 1.121 . . . . 75.24 108.307 165.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -157.38 118.74 3.66 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.486 -1.302 . . . . 74.45 107.486 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -123.87 115.29 21.07 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.255 -1.017 . . . . 71.24 108.255 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.438 HG21 HD11 ' D' ' 16' ' ' ILE . 56.7 mt -75.72 123.95 32.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.586 -0.894 . . . . 72.3 108.586 173.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -89.81 -40.14 12.65 Favored 'General case' 0 C--O 1.245 0.836 0 O-C-N 123.473 0.483 . . . . 73.32 111.239 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -175.9 128.74 0.24 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 119.645 -0.217 . . . . 73.4 110.929 -163.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.438 HD11 HG21 ' D' ' 13' ' ' ILE . 3.4 mp -112.05 140.89 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.924 -1.139 . . . . 75.23 107.924 166.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.472 ' HE1' HG13 ' D' ' 83' ' ' ILE . 26.0 p90 -161.91 168.43 22.95 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 124.257 0.973 . . . . 71.24 110.41 -177.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -99.46 120.74 40.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.595 -1.184 . . . . 73.23 109.251 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -90.29 -18.32 25.81 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.92 -0.582 . . . . 70.44 109.56 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.1 t70 -160.99 141.05 10.98 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 114.691 -1.141 . . . . 71.22 109.686 177.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.553 HG21 ' HE2' ' C' ' 117' ' ' MET . 67.0 mt -139.14 140.55 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.978 1.311 . . . . 75.23 107.475 174.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.7 t -142.49 140.04 31.73 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.089 0.955 . . . . 42.25 108.927 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.582 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 94.3 t80 -152.19 119.02 5.76 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 106.527 -1.657 . . . . 73.53 106.527 173.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 28.9 mt-10 -134.58 108.64 8.18 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.834 -0.802 . . . . 70.3 108.834 -173.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.4 92.03 9.26 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 109.007 -0.738 . . . . 74.44 109.007 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.74 -52.72 0.39 Allowed 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.044 2.496 . . . . 73.35 112.342 -172.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -94.23 13.25 23.99 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-N 114.943 -1.026 . . . . 73.33 110.32 -174.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -28.7 -61.97 0.21 Allowed Pre-proline 0 CA--C 1.566 1.591 0 N-CA-C 115.984 1.846 . . . . 74.14 115.984 -165.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.408 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 91.2 Cg_endo -78.04 -22.97 9.57 Favored 'Trans proline' 0 C--N 1.384 2.401 0 CA-C-N 122.782 2.029 . . . . 74.11 113.905 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -71.08 -41.3 70.85 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.592 1.157 . . . . 75.43 109.359 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.633 HG22 HD12 ' D' ' 68' ' ' LEU . 9.9 p -83.52 -20.69 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.614 -0.721 . . . . 72.41 111.617 -171.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.4 m-85 -61.85 -28.37 69.44 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.002 0.429 . . . . 75.12 111.71 176.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -59.4 -25.62 64.44 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.79 -1.095 . . . . 51.14 110.341 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -86.28 87.01 7.35 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.538 1.135 . . . . 74.42 109.834 170.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -84.04 93.07 8.01 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.003 -0.999 . . . . 72.42 110.944 -177.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 36.9 p90 -164.36 171.27 15.0 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.21 1.004 . . . . 64.42 109.428 167.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -60.76 113.37 7.5 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 123.792 0.837 . . . . 72.33 109.051 176.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.741 ' HD3' ' HG2' ' D' ' 124' ' ' PRO . 62.7 Cg_exo -52.93 124.03 14.52 Favored 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 122.77 2.313 . . . . 43.04 111.693 -177.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -68.02 111.63 4.54 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 124.38 1.05 . . . . 64.13 108.186 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.462 HG13 ' O ' ' D' ' 38' ' ' PRO . 16.6 m -99.86 144.66 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.973 0.892 . . . . 73.23 112.507 -165.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.503 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 17.7 tppt? -113.93 113.46 24.88 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.622 -1.621 . . . . 72.1 106.622 171.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 pp -94.87 141.06 29.08 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 108.069 -1.086 . . . . 51.42 108.069 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.599 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 32.8 t70 -145.68 138.13 25.67 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.487 0.715 . . . . 72.22 109.081 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -116.21 134.96 54.34 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.901 -0.777 . . . . 60.43 108.901 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 35.4 t70 -136.67 157.76 46.03 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 106.832 -1.544 . . . . 64.31 106.832 170.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.9 t -137.09 154.09 50.4 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.256 0.55 . . . . 73.15 111.328 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.494 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.38 165.77 32.08 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.906 1.283 . . . . 61.31 108.838 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 32.0 p -172.55 153.89 2.96 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.047 0.539 . . . . 71.44 111.649 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 33.7 p -157.2 120.33 4.06 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 114.722 -1.127 . . . . 42.54 108.554 173.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 50' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' D' ' 56' ' ' TYR . 61.7 tt0 -65.59 129.16 38.77 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.353 -0.61 . . . . 74.21 109.353 173.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 76.9 mt -94.96 -38.16 10.81 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.073 0.549 . . . . 63.53 110.971 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.89 -170.3 2.68 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.128 0.49 . . . . 63.24 111.294 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.44 118.13 7.67 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.839 -1.073 . . . . 74.1 109.739 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 67.83 -1.29 1.73 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.833 1.253 . . . . 64.24 112.794 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.56 123.91 65.83 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 N-CA-C 108.954 -0.758 . . . . 43.3 108.954 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.475 ' HA ' ' HA ' ' D' ' 50' ' ' GLN . 0.1 OUTLIER -136.13 150.05 48.92 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.959 -0.756 . . . . 72.0 108.959 177.002 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -110.55 134.38 52.44 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.504 -1.295 . . . . 61.22 107.504 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 76.9 t -127.28 131.16 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.617 1.167 . . . . 75.3 108.814 -172.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 21.7 t -121.56 131.94 71.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 123.446 0.699 . . . . 74.53 109.67 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.579 HD23 HD12 ' D' ' 106' ' ' LEU . 3.9 mm? -117.87 107.97 14.76 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.447 -0.946 . . . . 73.52 108.447 168.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.559 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 15.8 ttm-85 -82.24 101.9 10.81 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.876 0.87 . . . . 74.31 109.08 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 84.7 t -94.09 129.99 43.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.725 -0.843 . . . . 74.42 108.725 174.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 21.7 m -125.03 133.33 53.0 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.804 0.442 . . . . 73.55 110.194 -176.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 42.2 t -124.81 101.07 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.667 1.187 . . . . 64.22 108.703 175.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 93.4 m -92.99 106.45 18.41 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.881 -1.155 . . . . 74.14 107.881 170.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.61 142.37 42.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.893 -0.594 . . . . 50.12 110.011 -171.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.429 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 19.8 m -145.15 137.01 25.59 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.122 -0.49 . . . . 75.33 110.57 -175.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.633 HD12 HG22 ' D' ' 31' ' ' VAL . 21.2 mt -105.14 110.82 23.34 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.071 -1.085 . . . . 65.34 108.071 172.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.54 -130.01 17.48 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 116.229 -0.441 . . . . 43.11 113.242 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -89.6 4.19 50.18 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.348 0.659 . . . . 65.55 111.92 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -131.8 158.78 40.35 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.695 0.398 . . . . 74.23 110.518 -173.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.3 m -71.29 138.01 49.0 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.355 -0.839 . . . . 74.22 111.103 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.461 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.48 -62.24 1.52 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.946 -1.131 . . . . 60.25 107.946 173.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -156.61 159.53 38.56 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.583 -1.19 . . . . 74.34 110.556 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 85.7 mt -121.97 108.84 13.87 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.48 -1.304 . . . . 63.12 107.48 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.626 ' SG ' HG12 ' D' ' 114' ' ' ILE . 45.9 t -117.14 135.27 53.88 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.749 0.82 . . . . 75.32 109.272 -173.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -155.43 126.18 6.96 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.78 0.432 . . . . 63.42 110.033 175.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.43 118.74 46.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 123.819 0.848 . . . . 63.5 109.527 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.4 mt-30 -87.71 88.45 7.67 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.272 -1.01 . . . . 73.14 108.272 170.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -80.85 98.38 7.81 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 115.092 -0.958 . . . . 72.54 109.102 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.32 169.55 33.26 Favored Glycine 0 C--O 1.244 0.772 0 CA-C-N 115.74 -0.663 . . . . 64.01 112.33 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.63 133.33 2.86 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 112.058 -0.417 . . . . 60.2 112.058 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.472 HG13 ' HE1' ' D' ' 17' ' ' TYR . 57.7 mt -88.41 123.84 41.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 107.847 -1.168 . . . . 71.1 107.847 173.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -131.61 157.12 44.52 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.123 0.969 . . . . 35.02 109.718 -175.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 43.2 m -117.21 136.23 53.21 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.029 0.932 . . . . 73.44 110.2 175.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.412 HD12 ' O ' ' D' ' 86' ' ' ILE . 2.3 pp -130.77 141.71 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.554 1.141 . . . . 71.15 109.956 175.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.13 161.07 10.18 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.158 0.983 . . . . 71.55 108.639 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.44 21.04 79.93 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 121.426 -0.416 . . . . 54.12 113.382 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 12.7 mt -118.86 152.56 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.464 0.705 . . . . 73.53 109.933 -172.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -157.4 148.12 21.28 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.945 1.298 . . . . 64.3 110.557 175.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.57 -125.53 28.79 Favored Glycine 0 C--N 1.353 1.492 0 O-C-N 124.085 0.866 . . . . 62.53 114.9 169.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 92' ' ' THR . . . . . 0.613 HG21 HD21 ' D' ' 141' ' ' LEU . 11.2 m -72.0 -24.9 61.65 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.763 0.825 . . . . 53.43 111.803 -175.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -61.78 -29.9 70.45 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.328 0.651 . . . . 74.24 109.976 175.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 49.5 mtt -70.8 -44.09 67.33 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.918 0.887 . . . . 72.3 110.692 173.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.85 -36.83 82.36 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.379 0.672 . . . . 73.2 111.34 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -78.85 -29.97 44.91 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.116 0.566 . . . . 45.33 110.696 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 41.1 t -60.38 -51.09 70.99 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.413 0.685 . . . . 54.24 112.311 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.15 -17.07 14.43 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 115.492 -0.776 . . . . 72.31 112.258 -174.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.89 -25.62 29.02 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-O 120.119 -0.267 . . . . 72.54 112.867 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.14 -63.37 1.45 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.009 0.524 . . . . 62.3 110.935 -178.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -62.38 -53.99 46.83 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 112.744 0.646 . . . . 75.01 112.744 -169.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 59.1 m -59.04 -45.43 99.52 Favored Pre-proline 0 N--CA 1.494 1.753 0 CA-C-O 118.612 -0.709 . . . . 75.44 112.563 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -51.71 -46.64 30.68 Favored 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.639 2.226 . . . . 62.15 113.665 165.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -67.64 -15.54 63.7 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 123.376 0.67 . . . . 63.31 112.202 -178.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 35.9 mm -86.61 -49.43 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.285 0.634 . . . . 61.33 109.863 173.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.579 HD12 HD23 ' D' ' 60' ' ' LEU . 91.4 mt -79.52 -30.53 41.92 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.352 0.871 . . . . 50.33 113.352 -168.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -65.6 -39.25 31.23 Favored Pre-proline 0 N--CA 1.49 1.572 0 CA-C-O 118.174 -0.917 . . . . 73.51 113.264 -177.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -49.55 -45.97 28.78 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 122.62 2.213 . . . . 74.23 114.626 166.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -74.57 -36.16 63.06 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.063 0.545 . . . . 64.14 111.581 -177.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.16 -46.59 86.42 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.641 -0.503 . . . . 51.14 109.641 174.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -54.49 -49.59 69.77 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 124.706 1.254 . . . . 54.33 110.606 177.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -62.56 -43.63 98.34 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.797 0.686 . . . . 64.34 111.093 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.9 t -61.76 -44.0 97.76 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 123.761 0.663 . . . . 75.34 110.859 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.626 HG12 ' SG ' ' D' ' 76' ' ' CYS . 97.2 mt -60.61 -59.1 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.14 0.976 . . . . 73.21 110.217 175.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 37.0 m -52.98 -38.95 62.66 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.461 1.504 . . . . 64.22 111.551 -176.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.0 t -66.76 -47.06 73.4 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 114.889 -1.05 . . . . 53.14 110.344 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.8 mtm -67.17 -32.28 73.26 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.787 0.435 . . . . 72.5 111.763 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.5 t -61.9 -46.66 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.776 0.83 . . . . 63.34 109.887 174.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.1 p -76.89 -24.99 52.53 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.809 -0.632 . . . . 75.33 111.51 -177.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -74.02 -37.31 64.4 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.389 0.676 . . . . 73.04 109.52 175.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.8 4.39 65.6 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 115.561 -0.745 . . . . 62.44 112.27 170.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 47.8 p 59.12 23.09 11.3 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 126.947 2.099 . . . . 44.42 114.012 174.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -78.02 149.79 77.11 Favored Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 108.643 -0.873 . . . . 72.41 108.643 169.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.741 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 4.8 Cg_endo -53.42 133.82 54.8 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.675 2.25 . . . . 71.12 112.295 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -50.98 135.76 24.14 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.833 1.333 . . . . 73.13 112.654 -171.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 64.6 tp -114.77 103.06 10.59 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.881 0.872 . . . . 53.21 109.006 -177.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 127' ' ' ASN . . . . . 0.493 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 86.2 m-20 -99.51 101.29 12.48 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.829 -0.804 . . . . 74.44 108.829 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.657 HD21 ' HG ' ' H' ' 8' ' ' LEU . 3.2 tt -66.78 115.98 7.17 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 108.172 -1.047 . . . . 71.14 108.172 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.537 ' H ' HG23 ' H' ' 6' ' ' ILE . . . -65.15 140.54 97.99 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 123.515 0.726 . . . . 75.5 110.72 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.451 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 5.6 Cg_exo -72.18 151.25 54.83 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.81 2.34 . . . . 72.24 111.981 -171.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.9 m -127.8 128.19 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.637 0.775 . . . . 74.44 110.182 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -102.77 88.27 3.17 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.03 0.932 . . . . 60.22 109.57 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.405 ' HE1' ' HA ' ' H' ' 10' ' ' LEU . 78.9 m-85 -66.42 -30.88 71.33 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.21 0.604 . . . . 72.43 111.024 175.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -53.88 -43.66 69.8 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.314 1.009 . . . . 72.3 111.573 -174.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.0 -48.06 82.0 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.269 0.98 . . . . 44.41 111.368 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.461 HD22 HD21 ' H' ' 10' ' ' LEU . 7.9 mp -61.81 -36.39 80.99 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 123.792 0.682 . . . . 54.23 111.613 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -75.45 -44.08 46.13 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.134 0.574 . . . . 73.54 112.01 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 24.1 ptp -74.73 -44.99 47.02 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 111.743 0.275 . . . . 74.3 111.743 -172.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -73.58 -23.58 59.96 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.009 0.524 . . . . 75.42 111.579 -174.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -56.94 -34.48 68.05 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.864 0.865 . . . . 75.2 111.208 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.613 HD21 HG21 ' D' ' 92' ' ' THR . 10.0 mp -77.96 -32.2 51.26 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.792 0.837 . . . . 73.14 112.498 -176.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -90.66 12.28 19.51 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 112.289 0.477 . . . . 75.51 112.289 -175.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -119.94 58.57 0.9 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.604 0.762 . . . . 73.51 110.067 -176.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -147.31 -52.16 0.2 Allowed 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 115.637 -0.711 . . . . 62.13 110.734 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.77 -50.89 4.07 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.408 -0.59 . . . . 71.3 109.408 178.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.59 -123.74 2.33 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 110.809 -0.916 . . . . 71.51 110.809 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 147' ' ' GLU . . . . . 0.587 ' HA ' ' HA ' ' B' ' 147' ' ' GLU . 28.5 tt0 -163.05 129.82 3.45 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 109.172 -0.677 . . . . 74.5 109.172 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -106.95 127.78 8.99 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.032 -0.827 . . . . 63.23 111.032 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 80.4 m -71.6 118.61 14.64 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.378 0.671 . . . . 73.42 110.469 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -71.52 159.68 34.05 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.496 -0.557 . . . . 71.52 109.496 171.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -156.19 123.05 5.24 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 110.142 -0.318 . . . . 74.42 110.142 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -72.66 113.59 9.85 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.203 1.001 . . . . 74.5 110.322 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -72.49 152.29 42.0 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.638 -0.875 . . . . 74.34 108.638 170.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -154.44 147.43 24.58 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.638 -0.256 . . . . 73.44 110.499 -171.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.935 0 C-N-CA 123.852 0.861 . . . . 70.22 109.581 -178.127 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.595 -0.521 . . . . 73.33 109.595 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -165.48 149.3 8.27 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.685 1.194 . . . . 72.54 108.656 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -98.14 -89.29 0.3 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.851 0.46 . . . . 72.04 111.308 -174.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 47.2 t 52.34 83.59 0.06 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.907 0.883 . . . . 72.22 110.043 -167.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 5' ' ' THR . . . . . 0.512 HG22 ' HB2' ' A' ' 129' ' ' ALA . 33.4 m -65.39 125.8 26.25 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 116.148 -0.478 . . . . 70.21 110.944 -173.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.651 HG21 ' HB ' ' A' ' 40' ' ' VAL . 44.6 pt -60.63 120.68 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 124.729 1.212 . . . . 73.24 112.74 -169.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.05 136.9 47.56 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.11 0.564 . . . . 61.5 109.594 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.603 ' HB3' HD11 ' A' ' 44' ' ' LEU . 43.6 mt -71.78 107.48 4.6 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 123.854 0.721 . . . . 75.32 109.224 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.11 72.97 3.69 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.626 0.77 . . . . 64.14 110.534 -177.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 10' ' ' LEU . . . . . 0.646 HD21 HD23 ' A' ' 136' ' ' LEU . 93.5 mt 59.88 -175.63 0.1 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.023 1.329 . . . . 73.13 112.841 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 56.0 mt -122.76 130.37 24.65 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 124.148 0.979 . . . . 63.11 109.082 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.01 124.67 13.4 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.803 2.335 . . . . 73.01 111.871 176.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 68.65 19.68 8.5 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.021 1.329 . . . . 53.31 110.457 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 14' ' ' LEU . . . . . 0.66 ' HB3' ' HA3' ' A' ' 99' ' ' GLY . 10.3 mp 65.57 -73.1 0.07 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.754 1.222 . . . . 74.2 110.357 -173.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 15' ' ' PHE . . . . . 0.585 ' HB2' ' HA2' ' A' ' 99' ' ' GLY . 0.5 OUTLIER -166.82 174.45 8.57 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.105 -0.702 . . . . 72.23 109.105 174.322 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 14.5 p -68.71 138.32 90.72 Favored Pre-proline 0 CA--C 1.557 1.231 0 CA-C-N 115.562 -0.745 . . . . 73.34 110.371 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 17' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -61.88 149.06 91.68 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 123.282 2.655 . . . . 74.14 113.287 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 67.8 t -62.23 -60.59 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 108.837 -0.801 . . . . 64.52 108.837 173.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 8.3 p -156.31 -77.71 0.09 Allowed 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 114.257 -1.338 . . . . 72.12 109.662 -172.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 20' ' ' LYS . . . . . 0.411 ' HG3' HG21 ' C' ' 149' ' ' THR . 48.5 mtmt -105.56 31.85 4.7 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.949 0.9 . . . . 62.04 110.489 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.79 81.0 5.12 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.192 -0.67 . . . . 62.04 109.192 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -74.15 113.34 11.23 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.449 -1.25 . . . . 72.45 109.721 -177.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 62.8 p 53.97 87.9 0.13 Allowed Pre-proline 0 CA--C 1.561 1.371 0 C-N-CA 125.935 1.694 . . . . 74.12 111.546 -175.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.0 82.78 0.15 Allowed 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.519 2.812 . . . . 73.34 113.128 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 . . . . . 0 C--O 1.256 1.411 0 C-N-CA 125.591 1.556 . . . . 72.5 107.946 -178.82 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 120.516 0.198 . . . . 61.22 110.785 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 40.7 tptt -166.58 65.67 0.1 Allowed 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 107.661 -1.237 . . . . 62.24 107.661 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -61.03 -53.54 55.88 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.622 1.169 . . . . 73.24 113.033 -169.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 31.0 t -81.61 66.91 7.37 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.748 0.819 . . . . 44.33 109.992 -174.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 36.4 m -152.63 147.66 26.41 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.773 1.229 . . . . 71.02 108.55 -175.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.745 ' HA ' HD21 ' B' ' 42' ' ' LEU . 41.7 mm 72.62 91.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.008 1.323 . . . . 73.21 110.47 -178.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.76 19.97 2.74 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.338 -1.301 . . . . 75.53 111.928 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 8' ' ' LEU . . . . . 0.453 ' HB3' HG21 ' B' ' 131' ' ' VAL . 2.7 tt -78.53 85.28 4.61 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.195 -1.039 . . . . 73.0 108.195 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.36 51.87 1.02 Allowed 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.527 1.131 . . . . 73.43 109.726 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 79.8 mt 62.95 -166.38 0.23 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.546 1.138 . . . . 64.43 111.195 -177.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt -103.13 104.92 43.3 Favored Pre-proline 0 CA--C 1.554 1.117 0 N-CA-C 108.59 -0.893 . . . . 71.34 108.59 168.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -64.37 -23.02 65.73 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 123.259 2.64 . . . . 71.4 114.136 -177.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -97.31 3.38 51.21 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.564 0.745 . . . . 61.34 110.814 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 86.6 mt 60.13 -86.22 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.682 1.193 . . . . 63.33 109.98 -169.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 15' ' ' PHE . . . . . 0.422 ' CD2' ' HB3' ' B' ' 98' ' ' LEU . 9.6 t80 -177.87 160.49 1.49 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.443 0.697 . . . . 73.14 109.396 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 16' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' F' ' 17' ' ' PRO . 16.8 p -82.17 125.04 77.98 Favored Pre-proline 0 CA--C 1.562 1.43 0 C-N-CA 123.468 0.707 . . . . 71.4 110.655 177.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 17' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' F' ' 16' ' ' THR . 26.0 Cg_exo -64.9 146.79 88.64 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.678 2.919 . . . . 75.42 114.541 -174.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 18' ' ' VAL . . . . . 0.538 HG21 HG21 ' B' ' 86' ' ' ILE . 39.7 t -76.74 132.99 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 124.246 1.018 . . . . 72.12 109.665 176.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 17.3 m -74.9 -59.23 2.83 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-O 120.918 0.389 . . . . 64.04 110.06 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 20' ' ' LYS . . . . . 0.412 ' HB2' ' NE2' ' B' ' 50' ' ' GLN . 54.3 mttp -94.92 75.86 3.57 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.09 0.556 . . . . 75.13 109.789 178.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . -126.06 -1.81 7.1 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.353 1.061 . . . . 73.25 109.975 170.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -97.4 -26.02 15.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.249 0.62 . . . . 71.14 111.187 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 27.5 p -146.25 130.09 8.48 Favored Pre-proline 0 N--CA 1.482 1.158 0 C-N-CA 123.813 0.845 . . . . 74.0 111.028 -172.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -70.96 101.12 1.04 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.788 2.325 . . . . 70.22 110.893 166.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 25' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' B' ' 53' ' ' ASP . 11.6 tp10 . . . . . 0 CA--C 1.559 1.316 0 C-N-CA 123.29 0.636 . . . . 75.13 111.058 -174.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 1' ' ' MET . . . . . 0.436 ' SD ' ' N ' ' G' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 109.531 -0.544 . . . . 64.43 109.531 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -152.13 137.79 17.86 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.947 0.899 . . . . 74.25 109.176 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -66.51 101.53 0.78 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 122.985 0.514 . . . . 63.14 110.046 173.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 76.1 p -164.21 -54.49 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.038 1.335 . . . . 73.41 108.404 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 30.6 m 59.03 -83.69 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.595 1.558 . . . . 72.45 112.714 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 6' ' ' ILE . . . . . . . . . . . . . 47.9 mm -78.48 -27.52 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.243 0.617 . . . . 62.24 109.937 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.25 153.17 20.16 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.783 -0.644 . . . . 71.34 109.832 171.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 8' ' ' LEU . . . . . 0.691 HD13 HG11 ' C' ' 131' ' ' VAL . 7.2 tt -79.45 141.57 36.66 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 108.821 -0.807 . . . . 52.24 108.821 176.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.0 179.88 2.14 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.789 0.836 . . . . 62.22 112.544 -174.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 39.4 tp -74.6 94.82 2.71 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-O 121.073 0.463 . . . . 64.34 110.098 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 11' ' ' LEU . . . . . 0.471 HD22 ' HD2' ' G' ' 12' ' ' PRO . 3.5 tm? -78.63 118.08 70.28 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 107.695 -1.224 . . . . 62.32 107.695 175.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 12' ' ' PRO . . . . . 0.471 ' HD2' HD22 ' G' ' 11' ' ' LEU . 29.4 Cg_endo -61.58 125.47 16.82 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.805 2.337 . . . . 74.12 112.162 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 13' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' C' ' 96' ' ' HIS . 2.5 pt? -75.2 -10.42 59.45 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.406 0.283 . . . . 71.41 111.367 -177.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 14' ' ' LEU . . . . . 0.401 HD22 HD23 ' G' ' 13' ' ' LEU . 3.0 mm? -71.85 79.27 0.88 Allowed 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 109.188 -0.671 . . . . 71.53 109.188 172.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -91.75 162.37 14.49 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.203 -1.036 . . . . 74.24 108.203 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 39.0 p -57.67 114.62 8.76 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 124.021 0.928 . . . . 71.31 111.285 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 17' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.34 149.97 75.77 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.567 2.178 . . . . 63.34 113.43 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 18' ' ' VAL . . . . . 0.554 ' H ' ' HE1' ' C' ' 94' ' ' MET . 35.5 t -93.73 -50.38 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 114.813 -1.085 . . . . 72.42 109.163 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 69.4 p -82.79 -173.65 4.79 Favored 'General case' 0 C--O 1.248 1.015 0 CA-C-N 114.588 -1.187 . . . . 72.15 110.205 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -83.45 56.18 3.48 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-O 122.048 0.928 . . . . 72.02 110.278 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.54 -30.73 61.87 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.134 0.973 . . . . 43.23 109.66 170.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -120.74 170.33 9.55 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 114.993 -1.003 . . . . 74.22 109.49 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 4.9 t -99.11 107.58 45.0 Favored Pre-proline 0 CA--C 1.556 1.212 0 C-N-CA 123.184 0.594 . . . . 74.22 109.658 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -63.7 126.74 18.09 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.719 2.279 . . . . 64.21 110.504 173.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 . . . . . 0 CA--C 1.56 1.333 0 C-N-CA 123.336 0.654 . . . . 71.43 110.926 -173.2 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.483 1.225 0 CA-C-O 120.62 0.248 . . . . 64.3 110.67 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -76.16 132.14 39.79 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.52 0.728 . . . . 65.2 110.721 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -136.37 115.28 12.24 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.663 1.185 . . . . 74.13 108.254 172.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 29.7 p -71.36 87.2 0.84 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.27 0.628 . . . . 71.24 109.381 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 41.3 m -87.11 -43.78 12.02 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.333 -0.848 . . . . 54.43 110.593 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.537 HG23 ' H ' ' D' ' 129' ' ' ALA . 6.6 tt -157.23 -71.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 C-N-CA 123.22 0.608 . . . . 74.03 110.979 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 7' ' ' ALA . . . . . 0.506 ' H ' HG23 ' H' ' 6' ' ' ILE . . . 54.76 -158.66 0.19 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.456 1.102 . . . . 71.52 112.259 -175.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 8' ' ' LEU . . . . . 0.657 ' HG ' HD21 ' D' ' 128' ' ' LEU . 68.3 mt -141.83 179.57 6.78 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 125.099 1.36 . . . . 62.4 108.473 173.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.32 -179.18 3.98 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.014 0.925 . . . . 64.41 109.835 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 10' ' ' LEU . . . . . 0.461 HD21 HD22 ' D' ' 136' ' ' LEU . 79.8 mt -65.96 160.64 23.12 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.339 0.656 . . . . 70.14 111.299 175.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 72.3 mt -65.89 130.77 94.49 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-N 115.291 -0.868 . . . . 73.0 109.537 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -75.7 0.12 9.55 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.349 2.699 . . . . 74.32 113.331 -173.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 40.3 tp -153.43 139.85 18.66 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 107.465 -1.309 . . . . 45.44 107.465 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.78 130.7 43.81 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 107.498 -1.297 . . . . 72.25 107.498 175.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -70.6 161.89 29.89 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.762 0.825 . . . . 75.22 111.421 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 62.4 p -59.27 150.43 63.57 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.37 1.068 . . . . 74.51 111.805 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -79.97 154.34 22.68 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.535 2.157 . . . . 64.42 114.097 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 63.5 t -85.18 83.65 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 105.883 -1.895 . . . . 74.04 105.883 155.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 26.9 m 63.08 -79.77 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 124.604 1.162 . . . . 71.22 112.702 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.25 -7.77 34.66 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.169 0.988 . . . . 73.2 113.514 -170.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.19 -48.51 61.95 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.371 0.668 . . . . 53.35 112.389 -173.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.5 123.3 1.83 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.402 1.081 . . . . 71.44 108.911 176.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 42.4 p -70.83 131.57 87.49 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 109.927 -0.397 . . . . 55.34 109.927 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -56.0 -32.57 86.52 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.893 2.395 . . . . 65.54 112.196 170.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 C--O 1.248 1.002 0 N-CA-C 107.738 -1.208 . . . . 74.0 107.738 171.953 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.418 ' SD ' ' N ' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 107.923 -1.14 . . . . 75.13 107.923 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.418 ' N ' ' SD ' ' A' ' 1' ' ' MET . 19.8 m -47.22 134.4 11.17 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.933 1.293 . . . . 63.02 112.618 -174.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -68.48 91.25 0.4 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.264 0.626 . . . . 73.51 111.656 -172.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -146.2 -51.77 0.23 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.799 -1.091 . . . . 74.42 108.235 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -69.2 -53.85 17.86 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.081 -0.963 . . . . 75.11 110.239 176.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -89.54 -74.63 0.47 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.945 0.498 . . . . 71.53 110.574 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.9 m 64.51 127.61 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.879 1.272 . . . . 62.15 111.512 -169.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.434 ' HB3' ' HG2' ' C' ' 143' ' ' GLN . 39.6 tt0 -156.72 -62.77 0.1 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.145 0.578 . . . . 55.45 110.357 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.9 tpt -149.44 147.4 28.21 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.046 -0.524 . . . . 71.44 110.683 -164.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.5 m -135.06 104.61 6.0 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 106.939 -1.504 . . . . 31.55 106.939 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.663 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 35.7 t80 -133.25 138.61 46.54 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 123.98 0.912 . . . . 63.35 109.908 -171.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -152.92 132.96 13.38 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.201 1.0 . . . . 52.03 108.818 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.68 HG12 ' HD2' ' A' ' 84' ' ' PHE . 57.6 mt -93.49 121.25 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.104 -0.702 . . . . 65.13 109.104 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -85.3 -33.98 21.99 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.591 0.756 . . . . 64.25 110.328 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -171.06 142.47 1.82 Allowed 'General case' 0 C--N 1.352 0.717 0 O-C-N 123.411 0.445 . . . . 72.1 110.65 -174.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.458 HD12 ' HG3' ' C' ' 130' ' ' PRO . 78.6 mt -131.75 134.02 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 107.962 -1.125 . . . . 75.45 107.962 170.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -163.06 176.94 9.57 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 124.168 0.917 . . . . 64.32 110.838 -174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.4 p -100.06 121.52 41.52 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.178 -0.919 . . . . 72.21 109.035 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HG3' ' HA3' ' A' ' 81' ' ' GLY . 24.8 mtpt -84.28 -37.36 21.78 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.975 0.417 . . . . 74.43 109.935 178.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 24.4 t70 -143.28 135.28 26.84 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.122 -0.944 . . . . 74.53 109.288 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.485 HD13 ' SD ' ' B' ' 117' ' ' MET . 77.5 mt -128.74 140.02 50.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.217 -1.401 . . . . 72.24 107.217 175.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.9 t -151.31 110.98 4.02 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.071 0.462 . . . . 74.4 110.1 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -110.4 132.76 53.89 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.306 -1.368 . . . . 75.44 107.306 169.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -130.57 140.35 50.46 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.878 -1.156 . . . . 73.31 107.878 173.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.38 76.4 56.25 Favored Pre-proline 0 C--O 1.241 0.644 0 N-CA-C 106.208 -1.775 . . . . 71.25 106.208 169.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -62.5 -34.49 75.5 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.985 2.457 . . . . 65.15 112.794 -168.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 -109.1 22.79 15.43 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.467 -0.778 . . . . 63.01 110.224 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.583 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -42.46 -53.84 8.74 Favored Pre-proline 0 N--CA 1.499 1.998 0 N-CA-C 114.097 1.147 . . . . 75.51 114.097 -170.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -65.17 -29.24 55.92 Favored 'Trans proline' 0 C--N 1.387 2.581 0 CA-C-N 121.174 1.455 . . . . 73.15 112.641 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -82.56 -35.21 27.4 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.485 1.114 . . . . 65.25 110.843 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.692 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.3 p -78.68 -20.95 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 115.125 -0.943 . . . . 73.23 112.54 -161.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -71.85 -19.13 62.01 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-O 120.972 0.415 . . . . 72.21 111.002 176.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -77.88 -25.31 48.48 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.464 1.105 . . . . 64.23 110.695 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -76.58 149.49 36.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.805 0.842 . . . . 74.23 110.863 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.2 138.1 58.43 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 124.007 0.817 . . . . 74.42 109.303 170.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -84.01 92.0 7.75 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.713 -0.477 . . . . 72.13 109.713 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -127.53 82.89 67.42 Favored Pre-proline 0 C--O 1.243 0.755 0 N-CA-C 107.962 -1.125 . . . . 71.02 107.962 170.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.95 125.13 7.81 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.48 2.12 . . . . 75.42 112.677 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -98.87 96.62 7.99 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 106.76 -1.57 . . . . 61.32 106.76 165.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.7 t -75.55 94.51 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 115.948 -0.569 . . . . 74.33 109.662 -175.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.473 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 14.2 mptt -78.68 111.74 15.08 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 107.641 -1.244 . . . . 73.51 107.641 170.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.98 138.52 47.28 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.707 0.803 . . . . 63.14 108.925 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.543 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 21.2 t70 -141.64 140.75 33.35 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.784 1.234 . . . . 71.34 108.483 -172.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.456 HD11 HD13 ' E' ' 8' ' ' LEU . 75.4 mt -123.16 136.95 54.99 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.13 0.572 . . . . 74.22 110.453 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 18.0 t70 -134.25 147.14 50.62 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 114.781 -1.099 . . . . 71.5 108.428 175.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.1 m -106.57 131.65 53.48 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.958 0.903 . . . . 73.11 110.258 -173.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.71 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -131.53 105.41 7.54 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.795 -1.187 . . . . 54.13 107.795 169.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.543 ' HB3' ' HB3' ' E' ' 17' ' ' PRO . 24.5 m -95.93 152.01 18.9 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.246 -1.02 . . . . 53.0 108.246 176.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 31.2 t -159.25 142.59 14.59 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.121 0.568 . . . . 71.41 109.961 -176.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -112.72 130.28 56.11 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.016 -1.105 . . . . 62.34 108.016 168.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.0 mt -104.26 -38.1 7.01 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.215 0.606 . . . . 75.24 110.524 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.516 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -156.05 -170.46 3.4 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.241 0.617 . . . . 53.22 110.381 -178.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.82 113.89 3.7 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.509 1.124 . . . . 44.44 110.023 173.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 85' ' ' SER . 32.1 m-20 69.71 -2.56 1.93 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.369 1.468 . . . . 65.33 112.906 -176.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.516 ' CG2' ' HB3' ' A' ' 52' ' ' ALA . 39.3 t -95.75 113.29 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 107.574 -1.269 . . . . 62.44 107.574 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -127.29 125.87 41.64 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.943 -0.762 . . . . 72.21 108.943 -176.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 40.5 tt0 -92.94 116.83 29.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.304 -0.862 . . . . 72.34 108.947 175.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.434 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 54.1 t -100.2 118.61 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 106.368 -1.716 . . . . 72.53 106.368 174.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.71 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 29.5 t -118.46 121.19 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.732 -0.84 . . . . 62.45 108.732 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.35 113.52 26.24 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.476 -0.935 . . . . 73.04 108.476 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.506 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 50.1 ttt180 -83.01 101.75 11.3 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.326 -0.991 . . . . 64.23 108.326 174.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.07 102.46 13.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.96 -1.126 . . . . 73.23 107.96 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 28.5 m -97.34 126.03 42.32 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.036 -0.727 . . . . 73.14 109.036 178.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.54 HG11 HD21 ' A' ' 126' ' ' LEU . 75.1 t -122.54 139.92 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.345 1.058 . . . . 72.32 108.265 176.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 17.5 m -136.03 141.69 44.35 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.375 -0.972 . . . . 75.24 108.375 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.61 117.2 32.86 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.619 -1.252 . . . . 71.31 107.619 171.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.6 m -113.06 126.36 55.39 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.878 0.471 . . . . 73.12 109.905 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 mt -98.92 83.25 2.88 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.42 1.088 . . . . 72.42 108.326 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.43 -83.84 1.09 Allowed Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.902 -0.59 . . . . 62.35 112.003 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.73 -25.07 3.72 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.113 0.965 . . . . 73.24 110.188 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -95.85 133.79 39.58 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.688 0.795 . . . . 63.44 109.945 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.5 m -74.34 139.48 44.18 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 122.852 0.461 . . . . 63.12 110.545 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.692 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -82.11 -61.31 1.94 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.696 0.798 . . . . 73.21 109.067 172.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -154.63 168.5 26.58 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.597 -1.183 . . . . 64.44 111.413 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 64' ' ' VAL . 54.5 tp -122.61 139.53 53.83 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.948 1.299 . . . . 62.44 108.376 172.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 79.2 m -140.81 98.18 3.34 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.48 1.112 . . . . 63.51 110.098 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -115.94 127.99 55.4 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.556 0.742 . . . . 73.04 109.25 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.2 t -133.03 113.47 19.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 C-N-CA 123.267 0.627 . . . . 74.41 109.668 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -85.59 89.0 7.6 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.07 -0.968 . . . . 72.35 108.845 173.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.458 ' HG3' HD22 ' A' ' 106' ' ' LEU . 57.9 tp60 -80.83 107.5 13.7 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.331 -0.849 . . . . 74.21 109.298 -177.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.406 ' HA3' ' HG3' ' A' ' 19' ' ' LYS . . . -98.41 144.44 17.24 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 111.537 -0.625 . . . . 73.45 111.537 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.29 125.56 2.48 Favored Glycine 0 C--N 1.33 0.197 0 N-CA-C 111.54 -0.624 . . . . 62.2 111.54 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.1 mt -81.49 120.48 33.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.663 -0.866 . . . . 63.0 108.663 173.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.68 ' HD2' HG12 ' A' ' 13' ' ' ILE . 21.5 m-85 -136.23 120.44 17.83 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.553 -0.906 . . . . 73.33 108.553 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 66.7 m -89.84 113.27 24.83 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.456 -0.572 . . . . 71.41 109.456 171.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 pp -112.35 148.94 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.546 0.739 . . . . 75.13 109.996 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.56 -163.27 0.11 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.092 1.357 . . . . 72.42 108.926 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 121.24 -76.12 0.33 Allowed Glycine 0 C--N 1.348 1.238 0 N-CA-C 111.271 -0.732 . . . . 74.02 111.271 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.4 mt -130.11 -25.65 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.467 1.107 . . . . 73.41 109.396 175.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 61.01 -156.4 0.35 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.482 1.113 . . . . 70.23 110.654 -170.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.52 -129.47 16.85 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-O 119.451 -0.638 . . . . 33.22 112.592 177.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.4 t -71.25 -22.51 61.97 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.011 0.524 . . . . 72.11 111.559 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -67.55 -49.99 60.65 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.496 0.718 . . . . 60.11 109.738 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.49 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 24.1 ptt? -76.27 -27.89 56.84 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.014 -0.539 . . . . 70.04 110.537 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.89 -33.94 76.83 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.122 0.569 . . . . 51.31 111.228 -177.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -67.42 -35.61 79.61 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.858 -0.61 . . . . 71.4 110.582 171.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.682 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 71.5 m -71.08 -66.07 0.66 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.179 0.192 . . . . 61.43 111.215 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 94' ' ' MET . 3.4 pp -65.63 -25.4 67.35 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.455 0.702 . . . . 72.0 112.751 -175.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.81 -24.81 22.15 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-O 119.909 -0.384 . . . . 63.3 113.752 -176.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.523 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . . . -129.46 -64.66 0.88 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 117.206 0.503 . . . . 74.55 111.301 -175.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.682 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 83.3 t80 -69.29 -60.47 2.32 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.303 1.041 . . . . 73.14 112.967 -164.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.7 m -62.29 -39.01 52.77 Favored Pre-proline 0 CA--C 1.569 1.701 0 N-CA-C 114.024 1.12 . . . . 44.15 114.024 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -66.49 -28.61 45.64 Favored 'Trans proline' 0 C--N 1.389 2.679 0 CA-C-N 121.366 1.524 . . . . 74.3 112.853 166.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -79.96 -14.64 58.44 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.358 0.663 . . . . 73.22 110.477 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 35.1 mm -68.2 -39.75 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 108.472 -0.936 . . . . 73.15 108.472 168.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.458 HD22 ' HG3' ' A' ' 80' ' ' GLN . 77.2 mt -78.29 -23.66 47.1 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.135 -0.939 . . . . 73.23 112.129 -177.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -59.45 -47.41 97.99 Favored Pre-proline 0 CA--C 1.571 1.759 0 CA-C-O 117.862 -1.066 . . . . 75.54 113.502 -174.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -63.15 -37.13 53.81 Favored 'Trans proline' 0 C--N 1.392 2.857 0 C-N-CA 121.988 1.792 . . . . 71.45 113.224 176.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -72.14 -38.02 69.32 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.131 0.572 . . . . 74.24 111.097 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.52 -42.06 71.76 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.242 0.617 . . . . 51.3 110.207 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.43 ' NH1' HG23 ' C' ' 105' ' ' ILE . 25.7 ttm180 -60.58 -44.82 95.79 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.171 0.919 . . . . 74.51 109.597 175.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -65.24 -43.58 90.92 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.136 0.974 . . . . 75.24 111.687 -176.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.403 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 47.5 t -61.7 -43.49 98.76 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.959 0.787 . . . . 73.31 109.816 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' ' 118' ' ' VAL . 67.4 mt -61.69 -47.81 91.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 124.436 1.094 . . . . 53.21 110.756 174.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.3 m -59.52 -39.23 83.22 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.376 1.07 . . . . 75.44 110.816 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 42.9 t -67.64 -46.71 71.67 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 115.184 -0.916 . . . . 74.41 110.605 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 18.2 mtp -59.21 -41.59 88.95 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.969 0.908 . . . . 55.23 111.504 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.506 HG21 HD23 ' A' ' 126' ' ' LEU . 74.0 t -65.8 -51.28 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.237 1.015 . . . . 73.34 110.631 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.4 t -66.11 -27.78 68.31 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.597 -0.728 . . . . 73.23 111.091 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 116' ' ' SER . 30.2 ttm-85 -77.59 -31.61 53.14 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.302 1.041 . . . . 74.23 109.334 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.425 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.42 11.27 61.63 Favored Glycine 0 C--N 1.356 1.657 0 CA-C-N 114.673 -1.148 . . . . 54.3 112.811 170.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.503 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.3 t 64.23 15.59 9.49 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 127.045 2.138 . . . . 64.22 113.925 172.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -80.61 153.12 73.25 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.06 0.544 . . . . 64.44 109.91 178.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.8 155.14 23.49 Favored 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 123.252 2.635 . . . . 62.04 113.569 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -56.41 120.21 7.3 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.383 1.073 . . . . 61.45 112.645 -170.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.54 HD21 HG11 ' A' ' 64' ' ' VAL . 64.0 tp -121.86 106.13 10.99 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.417 1.087 . . . . 64.21 109.894 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -127.09 126.15 42.49 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.947 0.899 . . . . 62.14 108.853 169.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.8 mp -72.15 142.11 49.1 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.215 -0.661 . . . . 71.41 109.215 174.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.595 ' HB2' ' HB ' ' E' ' 5' ' ' THR . . . -64.58 150.13 94.33 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 122.82 0.448 . . . . 72.13 110.171 176.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.721 ' HG3' ' HD2' ' C' ' 11' ' ' PHE . 44.7 Cg_endo -61.33 154.14 60.62 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.718 2.279 . . . . 74.33 112.779 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' E' ' 8' ' ' LEU . 22.1 m -119.17 116.25 50.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 109.079 -0.712 . . . . 73.42 109.079 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -94.09 64.85 3.35 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.333 0.587 . . . . 71.52 109.581 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -62.85 -46.87 85.89 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.336 -0.847 . . . . 73.04 109.855 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -57.25 -37.92 73.07 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.766 1.226 . . . . 61.4 112.19 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.71 -41.2 79.4 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.78 0.675 . . . . 72.2 110.913 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.65 -37.83 79.99 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.069 0.548 . . . . 74.4 111.528 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.523 ' CD2' ' HB2' ' A' ' 100' ' ' ALA . 45.4 m-85 -75.11 -26.55 59.34 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.184 0.594 . . . . 71.02 111.307 175.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.6 tpt -70.31 -39.24 74.94 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 109.475 -0.565 . . . . 54.12 109.475 173.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.671 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 92.7 m-20 -64.83 -45.73 84.91 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-N 115.026 -0.988 . . . . 73.1 110.177 175.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -62.04 -39.86 93.76 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.856 -0.611 . . . . 73.31 110.972 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.422 ' HG ' ' HG3' ' A' ' 142' ' ' GLN . 31.8 tp -69.45 -51.22 38.2 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 123.42 0.45 . . . . 53.24 112.049 -175.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.422 ' HG3' ' HG ' ' A' ' 141' ' ' LEU . 78.5 mt-30 -149.25 -15.12 0.29 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 112.766 0.654 . . . . 52.52 112.766 -170.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.671 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 49.8 mt-30 64.54 -71.51 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.805 1.242 . . . . 60.21 111.486 -169.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 65.18 100.43 0.04 OUTLIER 'General case' 0 C--N 1.357 0.913 0 C-N-CA 125.115 1.366 . . . . 54.32 110.242 -178.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.54 99.27 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.041 0.937 . . . . 74.14 110.771 -177.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -72.44 154.95 50.95 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.255 -0.884 . . . . 71.14 113.106 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.482 ' HG2' ' H ' ' A' ' 148' ' ' GLY . 22.9 tt0 -138.76 -149.48 0.3 Allowed 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 106.476 -1.675 . . . . 64.32 106.476 -177.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.482 ' H ' ' HG2' ' A' ' 147' ' ' GLU . . . 68.62 71.58 0.95 Allowed Glycine 0 C--N 1.351 1.368 0 CA-C-N 118.791 0.723 . . . . 62.12 111.852 175.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.1 t -155.95 133.61 11.05 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 107.735 -1.209 . . . . 70.54 107.735 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -126.37 138.21 53.54 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.436 -0.579 . . . . 71.34 109.436 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -76.59 83.51 3.26 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.406 1.083 . . . . 75.54 110.269 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -154.68 144.81 21.88 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.149 0.58 . . . . 72.23 110.978 173.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -151.06 144.92 25.15 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.521 1.129 . . . . 73.3 108.119 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -146.68 155.07 42.15 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.418 0.687 . . . . 71.24 110.112 -170.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 C-N-CA 123.808 0.843 . . . . 53.21 109.63 177.949 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.416 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 110.34 -0.244 . . . . 72.45 110.34 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 38.9 t -157.93 70.76 0.58 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.588 0.708 . . . . 73.32 109.537 -176.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -93.03 86.54 5.44 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.935 0.894 . . . . 73.32 109.714 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -89.43 69.51 8.0 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.67 0.748 . . . . 73.24 109.178 171.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -84.84 79.34 9.65 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.156 -1.053 . . . . 70.45 108.156 175.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ASN . . . . . 0.49 ' HB3' HG13 ' B' ' 89' ' ' ILE . 24.8 t-20 -89.01 156.35 18.92 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.468 -0.787 . . . . 74.01 110.145 -177.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t -77.18 79.05 3.7 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.157 0.983 . . . . 72.04 111.357 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 64.76 12.97 8.1 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.788 1.235 . . . . 65.53 113.89 169.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.608 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 14.6 ptm 57.29 179.69 0.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 126.438 1.895 . . . . 71.32 114.65 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 40.5 m -133.34 144.85 49.89 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.459 1.103 . . . . 74.02 108.491 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.643 ' CZ ' HG13 ' B' ' 13' ' ' ILE . 0.3 OUTLIER -130.53 149.88 51.99 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 106.916 -1.513 . . . . 72.42 106.916 178.206 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -156.29 101.11 2.03 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 123.339 0.399 . . . . 71.42 111.605 164.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.907 HD11 HD13 ' B' ' 105' ' ' ILE . 44.6 mt -51.99 123.1 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.855 -0.794 . . . . 75.43 108.855 162.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -100.33 -45.07 5.71 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.048 0.842 . . . . 73.35 109.607 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.503 ' HE ' HG21 ' A' ' 122' ' ' THR . 47.9 ttt180 -162.92 135.58 5.54 Favored 'General case' 0 C--N 1.349 0.565 0 N-CA-C 109.259 -0.645 . . . . 75.45 109.259 -177.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.5 mt -114.89 137.17 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 107.896 -1.149 . . . . 74.24 107.896 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -167.29 158.32 11.73 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.11 0.481 . . . . 73.14 111.632 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.448 HG21 HD11 ' B' ' 21' ' ' ILE . 87.1 m -85.29 131.13 34.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.708 -0.678 . . . . 74.42 109.184 171.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.583 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 45.9 mtpt -97.76 -32.63 11.63 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.212 0.605 . . . . 72.11 110.665 177.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -151.13 138.21 19.19 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.613 0.244 . . . . 53.34 111.627 -175.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.486 ' CD1' ' SG ' ' B' ' 113' ' ' CYS . 45.6 mm -129.52 141.99 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.129 1.371 . . . . 73.03 108.914 173.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.628 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.1 t -144.46 137.43 26.94 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.052 -1.092 . . . . 32.34 108.052 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.2 t80 -154.35 121.47 5.65 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.844 -1.169 . . . . 65.21 107.844 174.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -127.81 122.09 31.83 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.7 0.8 . . . . 72.13 109.572 176.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.713 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -115.72 87.26 17.47 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.986 -1.116 . . . . 41.32 107.986 169.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -71.39 -40.44 3.06 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.431 2.088 . . . . 71.45 111.706 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.487 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 3.4 m-20 -93.98 3.21 55.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.259 1.024 . . . . 74.3 110.244 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.713 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -31.07 -65.84 0.19 Allowed Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 125.825 1.65 . . . . 63.12 114.653 -178.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 37.9 Cg_exo -55.23 -39.21 92.2 Favored 'Trans proline' 0 C--N 1.398 3.138 0 C-N-CA 122.975 2.45 . . . . 72.4 113.564 -162.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -95.51 -41.15 9.09 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 114.689 -1.141 . . . . 71.12 111.848 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.497 HG22 HD12 ' B' ' 68' ' ' LEU . 4.0 p -60.4 -19.22 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.48 0 C-N-CA 123.076 0.55 . . . . 72.13 112.4 -166.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -56.27 -28.89 60.17 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.56 1.144 . . . . 74.41 113.036 175.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -63.63 -21.93 66.63 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.923 0.889 . . . . 64.3 111.67 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -81.48 90.81 6.25 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.354 0.662 . . . . 73.25 109.664 172.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -83.94 89.08 7.17 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.402 -0.817 . . . . 55.2 110.844 -174.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 30.6 p90 -165.37 170.27 14.8 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.401 1.08 . . . . 74.12 109.713 167.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -75.52 111.34 13.75 Favored Pre-proline 0 N--CA 1.48 1.039 0 N-CA-C 109.038 -0.727 . . . . 74.41 109.038 173.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.98 165.69 13.87 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.015 2.476 . . . . 62.31 114.207 -172.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -73.58 103.91 4.35 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.478 -1.237 . . . . 64.5 108.974 175.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.444 HG21 HD13 ' B' ' 126' ' ' LEU . 61.7 t -102.46 123.08 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 115.333 -0.849 . . . . 60.54 111.08 -170.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -107.54 123.26 48.19 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.41 1.084 . . . . 73.43 108.688 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.84 126.1 51.57 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.768 -0.827 . . . . 73.11 108.768 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -122.95 128.47 50.29 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.582 1.153 . . . . 61.5 108.671 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -100.09 164.04 12.15 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.84 -0.8 . . . . 71.31 108.84 172.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.635 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.0 t70 -156.03 152.06 27.63 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.293 -0.867 . . . . 71.53 109.3 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 91.3 m -107.57 115.9 30.97 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.32 -1.309 . . . . 72.34 108.893 -171.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -137.03 119.32 15.66 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 109.045 -0.724 . . . . 62.54 109.045 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.5 p -142.97 161.83 37.09 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.939 0.496 . . . . 65.24 110.399 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -152.22 142.64 22.58 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.583 0.753 . . . . 74.24 109.836 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.466 ' HB2' ' HB3' ' F' ' 21' ' ' ALA . 51.0 tt0 -94.87 112.45 24.17 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.466 -0.568 . . . . 72.41 109.466 175.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 77.8 mt -80.69 -45.46 17.11 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.488 0.661 . . . . 72.14 109.314 175.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.38 -177.46 6.61 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.387 -1.278 . . . . 43.22 109.018 176.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.79 123.55 25.81 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.946 -1.025 . . . . 73.42 108.328 173.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 67.53 23.52 8.92 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.121 1.368 . . . . 74.25 111.26 -175.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 92.2 t -139.51 103.49 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 107.912 -1.144 . . . . 60.44 107.912 168.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -125.96 138.12 53.74 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.833 -0.803 . . . . 71.04 108.833 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -107.9 103.5 12.76 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.459 -1.312 . . . . 73.32 107.459 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.584 HG21 ' HB2' ' B' ' 98' ' ' LEU . 95.1 t -101.06 118.87 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.65 1.18 . . . . 70.13 109.426 -173.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.59 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 15.3 t -104.34 141.22 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.315 1.046 . . . . 72.25 109.427 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 18.5 tp -118.87 112.7 20.0 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 108.676 -0.861 . . . . 64.43 108.676 172.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.635 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 20.0 ttm-85 -88.47 113.28 23.89 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.581 -0.525 . . . . 72.53 109.581 175.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 39.8 t -108.19 101.24 12.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 107.356 -1.35 . . . . 71.1 107.356 171.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 16.0 m -97.09 139.97 32.29 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.634 -0.876 . . . . 73.14 108.634 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.698 HG21 HG21 ' B' ' 114' ' ' ILE . 89.7 t -128.16 136.45 60.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 124.339 1.056 . . . . 71.51 109.295 -174.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 95.5 m -124.81 148.31 48.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.121 -1.066 . . . . 33.34 108.121 172.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.71 139.15 31.0 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.92 -0.77 . . . . 74.41 108.92 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.476 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 36.1 p -140.35 128.1 21.78 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 123.716 0.635 . . . . 70.2 110.331 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.497 HD12 HG22 ' B' ' 31' ' ' VAL . 45.0 mt -99.61 103.56 15.27 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.476 -1.305 . . . . 63.51 107.476 173.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.86 -113.96 4.01 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.202 -0.759 . . . . 43.14 111.202 -174.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -121.88 6.05 9.89 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.864 0.466 . . . . 63.22 109.815 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.487 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 4.0 pm0 -113.48 150.89 32.2 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.161 0.584 . . . . 62.2 109.892 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 45.4 m -67.97 118.73 11.55 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.245 1.018 . . . . 72.12 111.095 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.488 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -73.14 -63.92 1.08 Allowed 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.622 -0.881 . . . . 72.42 108.622 173.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -147.77 167.76 23.86 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 114.726 -1.124 . . . . 74.21 110.958 175.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.2 mt -129.13 141.34 51.21 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.278 -1.749 . . . . 74.32 106.278 173.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.408 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 42.0 t -147.44 158.88 44.16 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.346 -0.983 . . . . 61.43 108.346 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.628 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 42.8 tt0 -165.95 133.27 2.79 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.577 -0.897 . . . . 72.33 108.577 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 91.4 t -128.05 142.15 44.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.131 -1.063 . . . . 70.32 108.131 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -124.51 87.87 2.8 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.568 -1.271 . . . . 73.22 107.568 174.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -81.09 102.13 10.05 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.068 -0.969 . . . . 71.21 108.666 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.43 171.71 38.59 Favored Glycine 0 C--O 1.245 0.83 0 CA-C-N 116.017 -0.538 . . . . 62.41 111.935 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.46 132.12 2.31 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 111.083 -0.807 . . . . 72.01 111.083 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 50.2 mt -84.17 125.01 40.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.491 -1.299 . . . . 70.12 107.491 171.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -130.61 129.09 42.27 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.39 -0.966 . . . . 63.04 108.39 174.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 69.2 m -93.52 88.75 6.02 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.522 0.729 . . . . 62.32 109.34 170.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 37.2 pt -103.34 146.28 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 N-CA-C 107.73 -1.211 . . . . 61.44 107.73 176.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.11 164.62 34.17 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 112.722 0.638 . . . . 42.43 112.722 -169.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.29 -71.35 1.19 Allowed Glycine 0 C--N 1.348 1.246 0 CA-C-N 114.822 -1.081 . . . . 65.34 114.579 167.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.608 ' HB ' ' HB3' ' B' ' 9' ' ' MET . 0.4 OUTLIER -89.39 171.7 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 123.876 0.87 . . . . 72.21 111.602 -166.17 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -150.82 158.53 44.26 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.059 0.544 . . . . 41.05 111.865 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.53 -135.81 12.77 Favored Glycine 0 C--N 1.355 1.617 0 C-N-CA 124.789 1.185 . . . . 53.1 112.875 172.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 11.2 m -69.15 -26.59 64.95 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.57 0.7 . . . . 65.51 110.389 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -62.47 -44.07 97.29 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.539 -1.209 . . . . 70.22 111.315 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.485 ' SD ' HD21 ' B' ' 98' ' ' LEU . 0.0 OUTLIER -80.11 -26.88 39.29 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 110.363 -0.236 . . . . 61.33 110.363 178.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.09 -13.98 60.98 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.554 0.742 . . . . 53.02 111.55 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -77.38 -34.67 54.9 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.806 0.443 . . . . 70.55 110.672 169.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.531 ' SG ' ' HD2' ' B' ' 11' ' ' PHE . 49.2 t -76.33 -67.58 0.67 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 119.161 -0.447 . . . . 74.32 111.356 -175.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.584 ' HB2' HG21 ' B' ' 58' ' ' VAL . 2.3 pt? -91.88 -12.37 33.78 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 118.255 0.48 . . . . 73.41 111.809 -175.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 99' ' ' GLY . . . . . 0.447 ' HA2' ' HD1' ' F' ' 15' ' ' PHE . . . -97.76 -24.24 12.34 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-O 119.837 -0.424 . . . . 71.24 113.489 -177.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.2 -55.83 2.03 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.994 0.518 . . . . 70.33 111.197 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.476 ' O ' HG13 ' B' ' 105' ' ' ILE . 56.5 t80 -83.39 -37.06 23.79 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.558 0.577 . . . . 74.35 112.558 -169.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.441 ' HA ' HD12 ' B' ' 105' ' ' ILE . 86.9 m -64.47 -43.58 72.06 Favored Pre-proline 0 N--CA 1.482 1.149 0 CA-C-O 118.338 -0.839 . . . . 72.54 110.364 177.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.49 -41.83 43.2 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 122.531 2.154 . . . . 53.34 113.622 163.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -66.27 -33.8 76.55 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 124.119 0.968 . . . . 72.45 111.187 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.907 HD13 HD11 ' B' ' 13' ' ' ILE . 73.5 mt -71.91 -46.1 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.682 0.793 . . . . 73.51 110.082 177.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 93.6 mt -77.39 -19.53 56.05 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 114.727 -1.124 . . . . 75.23 111.173 -175.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -59.91 -52.05 76.36 Favored Pre-proline 0 N--CA 1.483 1.205 0 CA-C-O 117.585 -1.198 . . . . 73.02 113.41 -173.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.02 -27.41 42.51 Favored 'Trans proline' 0 C--N 1.385 2.489 0 CA-C-N 121.546 1.588 . . . . 54.44 112.516 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -70.62 -43.17 69.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.856 0.463 . . . . 63.03 110.302 175.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.73 -43.66 92.66 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.553 -0.749 . . . . 53.54 110.327 176.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -60.98 -49.44 77.42 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.717 1.207 . . . . 71.42 110.506 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -63.17 -32.94 74.45 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 123.903 0.752 . . . . 74.24 109.427 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.496 ' O ' ' HG2' ' B' ' 117' ' ' MET . 17.1 t -72.79 -41.77 64.64 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 123.406 0.442 . . . . 74.22 112.128 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.698 HG21 HG21 ' B' ' 64' ' ' VAL . 84.7 mt -60.6 -57.0 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 108.792 -0.818 . . . . 72.25 108.792 176.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.2 m -61.43 -25.79 67.44 Favored 'General case' 0 CA--C 1.554 1.111 0 O-C-N 124.776 1.297 . . . . 74.02 111.053 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 43.0 t -65.95 -51.36 59.26 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 123.186 0.594 . . . . 51.43 109.641 170.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.1 mmt -68.16 -30.17 69.23 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.188 0.595 . . . . 73.32 111.613 -177.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 114' ' ' ILE . 95.5 t -66.79 -44.3 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.31 1.044 . . . . 74.12 109.08 173.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.0 t -69.07 -29.38 67.48 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.924 -1.035 . . . . 34.02 111.48 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.44 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 89.2 mtt-85 -74.85 -37.44 62.23 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.517 0.727 . . . . 71.43 109.637 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.26 -5.74 77.79 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 123.84 0.713 . . . . 63.25 112.236 170.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 33.8 p 63.55 25.96 14.57 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.608 1.963 . . . . 63.25 112.953 174.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -81.09 159.78 67.34 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 124.511 1.124 . . . . 75.32 110.495 174.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.58 165.09 6.49 Favored 'Trans proline' 0 C--N 1.39 2.714 0 C-N-CA 123.5 2.8 . . . . 75.5 114.273 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.439 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 65.5 tp60 -61.07 136.71 58.16 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.388 -1.278 . . . . 64.41 112.135 -173.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.444 HD13 HG21 ' B' ' 40' ' ' VAL . 43.0 tp -136.25 121.78 19.52 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.887 0.875 . . . . 73.34 109.443 -178.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -132.83 129.07 38.02 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.873 0.869 . . . . 55.11 109.098 175.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.21 149.9 30.3 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.576 0.75 . . . . 64.32 110.261 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -73.04 129.08 86.87 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 123.429 0.692 . . . . 72.35 111.919 -172.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 24.1 Cg_exo -65.86 98.23 0.36 Allowed 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.274 2.649 . . . . 60.03 113.216 177.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 21.1 m -109.83 135.96 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 109.018 -0.734 . . . . 72.54 109.018 171.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -90.55 100.98 13.72 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.006 -1.109 . . . . 75.24 108.006 177.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -60.78 -43.04 98.58 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.79 0.836 . . . . 75.03 110.816 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -60.72 -43.13 98.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.851 -1.068 . . . . 64.12 111.339 -176.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.73 -34.87 64.96 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.45 0.7 . . . . 75.32 111.516 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 tt -59.8 -51.79 68.24 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.96 0.904 . . . . 73.24 110.363 -176.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -77.6 -16.84 58.34 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.611 0.765 . . . . 74.21 111.931 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 46.9 ttm -75.27 -32.04 60.93 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.78 0.832 . . . . 70.31 110.865 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -74.21 -14.31 60.92 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.408 0.683 . . . . 44.12 111.168 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -71.79 -32.42 67.61 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.963 0.505 . . . . 72.42 109.771 171.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 32.7 mt -88.75 14.93 9.1 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.143 0.977 . . . . 63.43 111.562 -175.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.81 131.44 46.85 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.672 1.189 . . . . 70.12 110.6 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -142.87 126.92 17.37 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.612 0.765 . . . . 61.14 109.379 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -132.5 152.02 51.7 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.019 0.928 . . . . 73.25 109.93 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.58 132.01 7.47 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.447 0.699 . . . . 45.12 110.019 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.84 139.56 14.54 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 123.442 0.464 . . . . 73.32 112.342 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.65 129.25 40.56 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 107.404 -1.332 . . . . 73.21 107.404 177.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -91.04 -129.75 4.45 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 113.746 0.259 . . . . 54.12 113.746 -171.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 11.7 t -149.77 170.47 18.66 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.513 1.125 . . . . 51.53 109.189 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.54 153.3 43.85 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.959 0.503 . . . . 55.52 109.976 175.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -116.25 166.45 12.02 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.576 0.751 . . . . 63.24 111.15 -173.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -134.76 154.72 51.47 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 107.84 -1.17 . . . . 75.24 107.84 172.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -158.52 113.8 2.61 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.672 -0.492 . . . . 71.22 109.672 172.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -85.58 124.26 31.93 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.059 0.944 . . . . 72.42 108.781 173.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.99 0 CA-C-O 118.979 -0.534 . . . . 73.34 109.787 -179.888 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 109.824 -0.435 . . . . 65.03 109.824 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.1 p -91.62 90.64 7.67 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 108.872 -0.788 . . . . 74.25 108.872 170.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 60.8 -172.17 0.14 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 124.829 1.251 . . . . 75.33 113.313 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -138.5 132.9 31.94 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.299 1.039 . . . . 52.31 108.846 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -160.5 -71.87 0.07 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 108.41 -0.959 . . . . 60.45 108.41 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -139.57 89.41 2.32 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 106.999 -1.482 . . . . 62.11 106.999 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 29.8 p -102.3 125.27 48.95 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.841 0.856 . . . . 64.43 111.558 -171.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -132.39 161.79 32.74 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.661 1.184 . . . . 73.32 108.025 169.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.467 ' SD ' HG12 ' C' ' 89' ' ' ILE . 15.0 tpt 61.82 113.56 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.208 1.003 . . . . 74.1 112.357 177.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 12.2 m -98.26 101.71 13.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.625 0.77 . . . . 55.34 109.139 174.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.721 ' HD2' ' HG3' ' A' ' 130' ' ' PRO . 71.0 t80 -115.15 129.23 56.61 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.868 0.867 . . . . 72.44 108.674 175.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 12' ' ' GLN . . . . . 0.549 ' HB3' ' HB2' ' C' ' 85' ' ' SER . 38.9 tt0 -142.84 144.21 32.42 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.541 0.736 . . . . 74.44 109.403 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.446 HD13 HD11 ' C' ' 16' ' ' ILE . 27.6 mt -92.72 131.17 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 109.253 -0.647 . . . . 65.2 109.253 173.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.421 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 13.7 mm100 -98.96 -43.21 6.79 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.954 0.902 . . . . 74.15 109.84 176.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -172.54 137.18 0.81 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.628 -0.879 . . . . 70.12 108.628 -168.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.446 HD11 HD13 ' C' ' 13' ' ' ILE . 85.5 mt -129.64 138.17 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.236 -1.024 . . . . 73.33 108.236 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.447 ' HB3' HG23 ' D' ' 122' ' ' THR . 37.1 p90 -170.4 166.64 8.5 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.672 0.749 . . . . 73.4 111.43 -173.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -84.77 109.81 18.34 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.922 -1.035 . . . . 74.24 109.045 174.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -64.33 -44.32 91.88 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 121.994 0.902 . . . . 64.31 108.844 174.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.0 t70 -147.97 149.89 33.0 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 113.392 -1.731 . . . . 73.13 109.254 -175.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 79.5 mt -140.3 145.43 26.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 125.798 1.639 . . . . 64.24 106.725 177.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.5 t -155.72 150.21 25.97 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.609 0.719 . . . . 72.44 110.057 176.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -148.49 147.94 29.68 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.323 -1.362 . . . . 63.52 107.323 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -144.08 133.52 23.34 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.562 1.145 . . . . 73.1 108.804 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.01 78.68 4.27 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 107.117 -1.438 . . . . 73.4 107.117 171.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.44 -11.2 22.55 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.948 2.432 . . . . 60.31 112.333 -174.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -126.08 26.39 6.53 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.09 1.356 . . . . 72.41 109.791 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.83 -58.5 5.34 Favored Pre-proline 0 CA--C 1.57 1.724 0 CA-C-O 117.831 -1.08 . . . . 72.23 113.574 -172.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -59.95 -38.69 77.13 Favored 'Trans proline' 0 C--N 1.401 3.314 0 C-N-CA 122.162 1.908 . . . . 74.34 112.255 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -70.72 -39.79 73.17 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.331 -0.85 . . . . 71.34 111.831 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.701 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.5 p -78.78 -17.29 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.428 0 N-CA-C 112.224 0.453 . . . . 64.11 112.224 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -66.2 -37.21 85.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.194 -0.316 . . . . 74.53 111.538 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -85.19 13.49 6.29 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.493 0.717 . . . . 70.43 111.709 -176.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.62 169.29 9.61 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.545 1.138 . . . . 72.45 110.308 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -74.7 122.94 24.02 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.402 -0.592 . . . . 71.42 109.402 171.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -84.1 92.26 7.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.511 0.724 . . . . 73.33 110.49 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -146.95 80.96 9.26 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 106.928 -1.508 . . . . 71.54 106.928 168.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -88.22 155.35 6.86 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.597 2.198 . . . . 72.22 112.843 -176.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -86.02 99.49 11.5 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 106.548 -1.649 . . . . 62.43 106.548 166.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.427 ' HB ' HD11 ' G' ' 6' ' ' ILE . 43.9 t -74.77 96.55 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 107.826 -1.175 . . . . 73.04 107.826 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.568 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 88.4 mttt -93.81 100.74 12.88 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.209 -1.404 . . . . 74.0 107.209 178.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.569 HD13 ' HA ' ' G' ' 8' ' ' LEU . 2.0 pp -88.71 149.7 23.35 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.187 0.518 . . . . 73.01 109.794 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.645 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 26.1 t70 -144.36 144.84 31.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.306 -0.861 . . . . 51.23 108.964 -176.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.66 142.39 41.15 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.387 0.675 . . . . 74.55 109.782 174.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 25.8 t70 -137.66 146.54 43.98 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.363 1.065 . . . . 74.21 108.605 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 46' ' ' THR . . . . . 0.564 HG21 HD23 ' G' ' 11' ' ' LEU . 47.3 p -115.53 120.52 39.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.94 0.496 . . . . 75.15 111.283 -170.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.31 160.12 35.9 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.183 0.993 . . . . 74.11 109.447 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 35.4 p -164.55 166.46 20.3 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.908 0.385 . . . . 64.34 112.006 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 83.9 p -151.92 152.81 33.02 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.346 1.058 . . . . 75.22 108.993 171.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -102.22 124.08 47.18 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.498 -0.927 . . . . 74.22 108.498 172.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.524 HD11 HD12 ' C' ' 83' ' ' ILE . 51.2 mt -101.97 -32.27 10.27 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.251 0.62 . . . . 71.25 111.12 -174.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.52 -166.04 1.28 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.351 0.66 . . . . 74.21 110.686 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -63.36 115.62 4.76 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 124.005 0.816 . . . . 61.41 109.42 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 67.49 -5.25 0.79 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 125.017 1.327 . . . . 52.31 113.113 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 67.4 t -92.64 106.7 18.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.54 -1.281 . . . . 75.44 107.54 -177.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -124.64 128.65 49.19 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.521 -1.289 . . . . 61.45 107.521 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -81.36 119.31 23.52 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.001 -1.0 . . . . 72.25 108.547 172.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.467 HG13 ' HE2' ' G' ' 15' ' ' PHE . 65.5 t -96.45 120.44 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.339 -1.356 . . . . 50.41 107.339 171.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 55.7 t -115.09 132.76 63.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 108.671 -0.863 . . . . 71.23 108.671 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 29.9 tp -124.18 117.2 24.07 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.304 -0.999 . . . . 74.23 108.304 170.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 33.3 ttm180 -81.74 135.76 35.48 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.098 0.959 . . . . 70.53 108.955 172.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.502 ' HB ' HD11 ' C' ' 114' ' ' ILE . 14.9 t -122.89 130.06 74.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.258 -1.386 . . . . 63.21 107.258 169.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.645 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 18.0 m -129.65 116.62 19.11 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.534 -0.913 . . . . 74.24 108.534 -177.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.474 HG21 HG21 ' C' ' 114' ' ' ILE . 59.5 t -108.53 113.3 43.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 124.202 1.001 . . . . 61.1 108.978 -173.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 2.5 m -101.62 131.1 48.01 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.936 -0.764 . . . . 72.14 108.936 175.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.2 109.62 16.06 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.434 -1.691 . . . . 64.43 106.434 174.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 24.7 m -131.47 125.46 32.55 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 117.791 0.269 . . . . 71.23 110.358 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.7 mt -85.76 49.59 1.8 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.497 1.119 . . . . 52.42 108.96 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.62 -114.64 4.96 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 110.096 -1.202 . . . . 74.41 110.096 -169.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -91.97 -24.08 19.36 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.36 0.664 . . . . 64.41 110.17 172.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -67.72 101.91 1.12 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.19 -0.67 . . . . 65.13 109.19 176.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 90.3 m -70.78 122.62 20.2 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.617 -0.512 . . . . 72.12 109.617 175.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.701 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.47 -56.92 4.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.291 -1.003 . . . . 52.42 108.291 171.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -159.48 163.32 35.41 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.29 -0.868 . . . . 65.43 111.352 177.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -127.57 131.68 49.96 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 105.966 -1.864 . . . . 75.14 105.966 164.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.442 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.6 t -137.73 111.19 8.02 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.111 -0.7 . . . . 51.05 109.111 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 77' ' ' GLU . . . . . 0.438 ' HB2' HG23 ' C' ' 63' ' ' THR . 33.0 tt0 -119.51 116.59 26.39 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.31 0.644 . . . . 63.23 109.841 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -117.11 132.59 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 108.531 -0.914 . . . . 75.23 108.531 172.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.544 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 44.3 mt-30 -105.24 100.46 10.05 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.19 -1.041 . . . . 75.1 108.19 172.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -87.71 121.33 30.0 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.609 -0.723 . . . . 73.44 109.584 -177.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.88 146.92 18.87 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 112.042 -0.423 . . . . 41.25 112.042 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.505 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -143.12 124.58 2.36 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.435 -1.066 . . . . 75.33 110.435 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.524 HD12 HD11 ' C' ' 51' ' ' LEU . 16.6 mm -81.04 123.55 37.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.984 -1.117 . . . . 44.54 107.984 176.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -132.47 135.56 46.11 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.738 0.415 . . . . 72.23 110.646 -174.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 85' ' ' SER . . . . . 0.639 ' HB3' ' HG3' ' E' ' 2' ' ' LYS . 43.3 m -83.96 99.91 10.69 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 107.667 -1.235 . . . . 62.15 107.667 167.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 3.6 tt -120.0 117.76 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.519 1.128 . . . . 74.54 110.592 -172.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.24 169.89 16.99 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.458 1.103 . . . . 54.32 109.715 177.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 122.63 -60.5 0.57 Allowed Glycine 0 N--CA 1.472 1.094 0 N-CA-C 112.5 -0.24 . . . . 32.23 112.5 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.467 HG12 ' SD ' ' C' ' 9' ' ' MET . 23.5 pt -96.4 173.44 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.113 0.565 . . . . 64.35 111.015 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -153.47 160.39 42.54 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.833 0.853 . . . . 53.13 110.539 -172.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.04 -145.87 30.16 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.762 -0.654 . . . . 62.14 111.646 175.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 46.6 p -63.88 -17.38 63.12 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.082 0.553 . . . . 74.13 112.011 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -67.3 -51.01 57.83 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 123.403 0.681 . . . . 75.32 110.458 173.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.502 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 7.0 ptp -70.24 -37.14 74.9 Favored 'General case' 0 C--N 1.362 1.14 0 N-CA-C 109.839 -0.43 . . . . 64.33 109.839 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.67 -35.88 66.48 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.525 0.73 . . . . 73.12 110.988 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.52 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 17.5 t-80 -71.35 -39.64 71.18 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.397 1.079 . . . . 74.03 111.518 173.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -71.28 -62.0 1.56 Allowed 'General case' 0 N--CA 1.481 1.106 0 O-C-N 122.094 -0.379 . . . . 62.4 111.613 -175.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' C' ' 94' ' ' MET . 1.2 pp -71.14 -21.94 62.12 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.99 0.516 . . . . 64.44 112.34 -178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.44 4.97 62.36 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 119.594 -0.559 . . . . 52.25 113.466 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -149.98 -60.14 0.2 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 117.917 0.859 . . . . 75.01 112.348 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -66.7 -51.56 54.6 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.672 0.789 . . . . 72.43 112.087 -175.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 19.9 m -63.87 -44.77 80.14 Favored Pre-proline 0 CA--C 1.57 1.719 0 C-N-CA 123.738 0.815 . . . . 51.22 112.805 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.405 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 22.5 Cg_exo -68.1 -22.82 40.57 Favored 'Trans proline' 0 C--N 1.397 3.08 0 C-N-CA 122.298 1.999 . . . . 71.12 113.347 171.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -71.16 -32.12 68.53 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 122.974 0.51 . . . . 75.11 110.673 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.43 HG23 ' NH1' ' A' ' 111' ' ' ARG . 37.7 mm -59.33 -42.01 85.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.725 0.81 . . . . 42.43 109.884 171.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.505 HD21 ' HA3' ' C' ' 82' ' ' GLY . 93.8 mt -80.22 -21.22 43.09 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.732 -1.122 . . . . 74.14 112.595 -172.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -53.79 -50.84 81.44 Favored Pre-proline 0 CA--C 1.567 1.618 0 CA-C-O 117.555 -1.212 . . . . 74.4 113.377 -175.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.77 -33.19 96.52 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 122.145 1.897 . . . . 74.22 114.134 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -73.07 -44.46 60.57 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.077 0.551 . . . . 72.44 110.03 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.22 -40.01 88.63 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.242 -0.89 . . . . 64.3 110.261 173.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -59.09 -53.8 54.25 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.962 1.305 . . . . 71.45 110.765 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.79 -36.79 78.72 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 123.358 0.411 . . . . 70.24 109.903 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 20.3 t -65.73 -32.37 73.88 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.978 0.511 . . . . 74.32 111.495 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.502 HD11 ' HB ' ' C' ' 62' ' ' VAL . 81.5 mt -74.1 -55.8 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.187 0.595 . . . . 75.22 109.859 173.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.8 m -61.37 -27.44 68.52 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.452 0.701 . . . . 54.21 110.964 -174.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.7 t -65.65 -50.17 65.96 Favored 'General case' 0 C--O 1.214 -0.77 0 C-N-CA 123.782 0.833 . . . . 44.14 109.034 171.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.534 ' HG3' HD12 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.7 -33.06 74.33 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.218 1.007 . . . . 72.03 112.364 178.286 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.412 HG23 ' O ' ' C' ' 114' ' ' ILE . 66.4 t -67.85 -41.48 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 123.493 0.717 . . . . 63.33 109.066 174.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 39.9 t -74.07 -23.46 59.37 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.528 1.131 . . . . 41.1 111.986 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -78.12 -39.6 40.74 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.719 -0.845 . . . . 64.14 108.719 176.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.38 -0.65 62.7 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.549 -0.751 . . . . 43.13 112.347 167.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 31.4 p 62.24 29.73 17.46 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.695 1.998 . . . . 71.34 113.653 169.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -81.84 156.29 70.12 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 123.627 0.771 . . . . 72.33 108.947 169.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.439 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 25.3 Cg_endo -62.12 168.07 9.78 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.54 2.16 . . . . 62.54 112.485 173.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -59.79 110.47 1.17 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.279 -0.873 . . . . 64.22 112.17 -173.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.41 86.38 2.28 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 105.893 -1.891 . . . . 54.41 105.893 171.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -107.93 108.42 19.56 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.565 -0.902 . . . . 70.13 108.565 -173.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.432 HD23 ' N ' ' C' ' 129' ' ' ALA . 3.5 tt -73.03 144.75 47.03 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.485 0.714 . . . . 74.42 109.796 -174.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.432 ' N ' HD23 ' C' ' 128' ' ' LEU . . . -60.47 157.92 33.01 Favored Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 124.706 1.202 . . . . 62.41 112.417 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.458 ' HG3' HD12 ' A' ' 16' ' ' ILE . 43.6 Cg_exo -57.65 110.53 0.63 Allowed 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 122.735 2.29 . . . . 71.34 112.285 173.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.666 HG11 ' HB2' ' G' ' 8' ' ' LEU . 20.4 t -98.73 108.41 22.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.769 -0.826 . . . . 75.35 108.769 177.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -107.13 90.8 3.41 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 107.836 -1.172 . . . . 72.15 107.836 173.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -55.55 -41.39 73.16 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.044 0.84 . . . . 75.43 110.578 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.4 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 7.7 t70 -69.13 -48.6 62.01 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 114.328 -1.305 . . . . 64.03 111.458 -173.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.98 -44.31 55.12 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.524 -1.217 . . . . 64.14 111.591 -174.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.7 -32.67 73.81 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.66 0.784 . . . . 71.1 110.581 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -62.15 -44.13 97.3 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.432 0.693 . . . . 73.5 110.869 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 56.8 mtt -75.9 -45.66 34.15 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.564 -0.744 . . . . 61.33 110.627 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -59.09 -37.99 78.43 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.617 1.167 . . . . 73.33 111.419 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -48.86 -79.06 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.481 1.513 . . . . 74.5 111.519 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 53.4 tp -57.83 -40.69 80.64 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.615 0.766 . . . . 73.2 112.239 -177.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -78.55 -81.42 0.1 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.032 0.382 . . . . 72.21 112.032 -172.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 143' ' ' GLN . . . . . 0.434 ' HG2' ' HB3' ' A' ' 8' ' ' GLU . 2.6 mp0 -99.06 -160.22 0.79 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.891 0.876 . . . . 74.32 110.297 -173.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -139.83 137.22 34.78 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.052 0.541 . . . . 73.43 109.912 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.45 99.25 2.43 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.891 -0.781 . . . . 24.51 108.891 172.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.04 169.9 55.05 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 123.406 0.441 . . . . 71.54 113.123 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -68.91 114.82 7.56 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.497 0.719 . . . . 74.51 109.768 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.53 139.98 19.26 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 111.233 -0.747 . . . . 64.21 111.233 174.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 27.4 m -65.49 137.15 57.24 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.727 0.811 . . . . 54.22 111.167 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -108.24 123.1 48.25 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.339 -0.986 . . . . 70.23 108.339 174.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -66.76 91.56 0.2 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.077 0.951 . . . . 73.43 111.792 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -86.41 70.21 10.47 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.354 0.661 . . . . 74.05 109.647 176.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -93.91 -178.06 4.54 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.892 0.877 . . . . 64.53 111.115 -176.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -88.46 -47.91 8.0 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.318 -0.623 . . . . 74.24 109.318 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.256 0 C-N-CA 124.462 1.105 . . . . 63.15 109.641 173.208 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 109.594 -0.521 . . . . 72.12 109.594 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 17.2 t -164.58 12.6 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.746 0.818 . . . . 71.34 110.149 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.61 104.78 7.41 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.993 0.917 . . . . 72.51 110.328 -171.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -137.54 154.35 49.84 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.553 1.141 . . . . 75.24 109.135 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -155.64 168.43 27.19 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 120.991 0.424 . . . . 63.2 111.948 -175.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -78.09 139.6 39.06 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.049 -0.978 . . . . 63.32 109.785 174.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -159.51 -174.21 4.54 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.838 0.855 . . . . 62.51 109.772 -175.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -86.25 28.6 0.82 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.341 1.057 . . . . 52.14 111.927 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.465 ' HG3' HD11 ' D' ' 89' ' ' ILE . 22.9 ttt -29.39 123.57 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 126.193 1.797 . . . . 72.3 114.413 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 57.0 m -111.01 139.2 46.56 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.864 0.865 . . . . 70.22 109.449 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -157.73 96.72 1.52 Allowed 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.721 -1.214 . . . . 73.32 107.721 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -113.86 115.7 28.15 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.477 -0.935 . . . . 65.53 108.477 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.464 HG21 HD11 ' D' ' 16' ' ' ILE . 46.8 mt -71.32 123.06 24.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.913 -0.773 . . . . 61.31 108.913 177.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -93.41 -34.05 13.6 Favored 'General case' 0 C--O 1.246 0.881 0 O-C-N 123.59 0.557 . . . . 72.55 110.664 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -173.55 144.52 1.13 Allowed 'General case' 0 C--N 1.364 1.224 0 N-CA-C 112.303 0.483 . . . . 75.22 112.303 -170.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.464 HD11 HG21 ' D' ' 13' ' ' ILE . 3.6 mp -123.34 136.92 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 107.243 -1.391 . . . . 71.32 107.243 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.4 ' HE1' HG13 ' D' ' 83' ' ' ILE . 24.6 p90 -164.61 152.31 11.86 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.64 0.733 . . . . 73.42 110.649 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 56.7 p -84.2 117.47 23.52 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.532 -1.213 . . . . 72.1 108.525 174.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -85.53 -18.02 34.66 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.785 0.326 . . . . 73.2 110.21 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -166.24 140.49 4.33 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.429 1.092 . . . . 62.22 108.283 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.534 HD12 ' HG3' ' C' ' 117' ' ' MET . 77.5 mt -137.18 150.14 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 108.12 -1.067 . . . . 75.44 108.12 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.9 t -156.8 103.43 2.07 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.299 1.04 . . . . 71.01 109.298 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.539 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 80.8 t80 -109.09 122.1 46.56 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 106.366 -1.716 . . . . 73.23 106.366 171.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -130.48 110.47 11.48 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.502 -0.555 . . . . 65.23 109.502 -172.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.4 89.45 4.89 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 108.234 -1.025 . . . . 52.53 108.234 173.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.22 -38.15 3.97 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.555 2.17 . . . . 55.03 112.289 -172.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -101.7 11.24 39.15 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.899 0.88 . . . . 71.1 110.072 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -20.63 -68.03 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 116.151 1.908 . . . . 73.05 116.151 -168.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.415 ' HB3' HD11 ' C' ' 83' ' ' ILE . 43.6 Cg_endo -79.94 -18.24 10.33 Favored 'Trans proline' 0 C--N 1.379 2.167 0 CA-C-N 122.844 2.052 . . . . 34.42 114.029 -173.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -76.68 -39.79 50.95 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.511 1.124 . . . . 64.31 109.576 176.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.695 HG22 HD12 ' D' ' 68' ' ' LEU . 11.3 p -82.79 -18.01 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 CA-C-N 115.799 -0.637 . . . . 61.3 111.296 -172.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -65.86 -22.51 66.53 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 112.094 0.405 . . . . 71.55 112.094 177.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -60.31 -20.23 58.42 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.1 0.96 . . . . 73.22 111.26 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.417 ' HB2' HD13 ' D' ' 68' ' ' LEU . 93.1 mttt -95.92 102.14 13.9 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.659 1.183 . . . . 71.4 109.816 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -101.16 87.23 3.2 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.759 0.424 . . . . 74.23 110.151 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -158.66 179.79 8.78 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.176 0.991 . . . . 73.05 108.599 167.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -67.19 112.34 9.69 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 123.622 0.769 . . . . 73.25 110.441 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -56.39 141.62 89.26 Favored 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 122.736 2.291 . . . . 61.31 112.016 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 42.6 mt-10 -57.84 118.41 5.3 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.59 1.181 . . . . 73.13 111.291 -177.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 25.6 t -93.58 107.18 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 107.568 -1.271 . . . . 73.41 107.568 -172.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.442 ' HE3' ' HB3' ' D' ' 39' ' ' GLU . 31.1 mmtp -125.98 118.92 26.4 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.555 -1.276 . . . . 75.04 107.555 -177.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.91 115.55 27.62 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.203 0.601 . . . . 74.22 109.725 -174.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.627 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.3 m-20 -107.85 119.25 38.93 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.425 1.09 . . . . 75.43 108.066 172.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.44 HD23 ' HB3' ' H' ' 9' ' ' ALA . 3.4 mm? -111.58 152.88 27.08 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.754 0.421 . . . . 73.1 110.537 -175.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -157.01 152.82 27.05 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.881 -1.155 . . . . 64.52 107.881 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 57.9 p -118.78 149.21 41.88 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.871 0.468 . . . . 71.23 111.611 -170.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.54 164.03 38.42 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.426 1.09 . . . . 74.21 109.038 172.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 50.8 p -176.95 177.5 1.28 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.702 0.801 . . . . 62.32 110.03 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 50.8 p -173.02 143.83 1.2 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.164 0.986 . . . . 35.41 109.889 169.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -76.3 116.71 17.25 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.794 -1.187 . . . . 74.14 107.794 167.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.487 HD11 ' HB2' ' D' ' 57' ' ' GLU . 61.3 mt -88.94 -26.66 21.42 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.997 0.519 . . . . 50.11 110.054 -175.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -174.06 -172.98 0.76 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.692 1.197 . . . . 72.4 109.777 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -68.88 126.75 30.74 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.477 -0.783 . . . . 71.43 109.131 174.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.537 ' HA ' HG21 ' H' ' 19' ' ' THR . 9.1 m-20 69.08 -2.36 1.82 Allowed 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 124.956 1.302 . . . . 73.24 113.059 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 94.6 t -110.47 124.55 67.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.029 -1.1 . . . . 74.23 108.029 176.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.628 ' HB3' HD13 ' D' ' 86' ' ' ILE . 66.4 t80 -146.57 137.43 24.1 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.371 0.605 . . . . 72.03 110.142 -177.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.487 ' HB2' HD11 ' D' ' 51' ' ' LEU . 21.9 tt0 -104.13 137.61 41.83 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.964 1.306 . . . . 71.13 110.029 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.88 126.19 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 108.058 -1.09 . . . . 63.24 108.058 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.442 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 25.9 t -124.12 131.82 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.448 0.699 . . . . 70.22 109.388 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.438 HD23 HD12 ' D' ' 106' ' ' LEU . 3.9 mm? -123.81 122.14 37.24 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.518 -0.549 . . . . 61.51 109.518 173.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' D' ' 79' ' ' GLN . 12.5 ttm180 -83.54 106.39 15.24 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.387 -0.968 . . . . 74.34 108.387 170.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -92.02 125.95 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 107.601 -1.259 . . . . 74.41 107.601 169.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.627 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 22.1 m -123.83 133.34 53.81 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.041 -0.725 . . . . 33.54 109.041 177.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.415 HG21 HG21 ' D' ' 114' ' ' ILE . 73.1 t -114.19 101.36 12.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 107.85 -1.167 . . . . 72.11 107.85 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 78.6 m -90.58 92.43 8.85 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.568 -1.271 . . . . 65.14 107.568 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -100.98 135.93 41.64 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 114.831 -1.077 . . . . 64.42 109.964 -175.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.467 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 70.1 m -143.21 133.6 24.74 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.005 0.522 . . . . 72.5 110.699 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.695 HD12 HG22 ' D' ' 31' ' ' VAL . 77.2 mt -101.0 110.04 22.02 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.867 -1.16 . . . . 64.02 107.867 172.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.19 -114.02 3.75 Favored Glycine 0 C--N 1.344 0.981 0 O-C-N 123.237 0.336 . . . . 53.32 113.038 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.67 4.46 12.32 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.607 0.763 . . . . 74.12 110.576 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -120.68 156.11 32.44 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.567 0.747 . . . . 75.32 109.229 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 43.8 m -70.26 135.32 48.86 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 123.676 0.61 . . . . 61.3 110.545 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.655 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -85.91 -65.53 1.0 Allowed 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.062 -1.459 . . . . 62.21 107.062 172.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -157.43 148.57 21.63 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.606 -1.179 . . . . 73.02 110.342 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 60.1 mt -111.86 107.77 16.92 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 105.908 -1.886 . . . . 64.14 105.908 171.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' D' ' 114' ' ' ILE . 46.3 t -116.38 105.53 12.62 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.305 -0.998 . . . . 51.02 108.305 -171.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 77' ' ' GLU . . . . . 0.473 ' HB2' HG23 ' D' ' 63' ' ' THR . 41.8 tt0 -130.12 131.57 45.76 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.137 0.975 . . . . 64.04 108.994 -165.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.4 t -140.0 119.21 12.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 108.359 -0.978 . . . . 75.34 108.359 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.405 ' HA ' ' HA ' ' D' ' 61' ' ' ARG . 71.1 mt-30 -86.93 80.89 8.3 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 107.365 -1.346 . . . . 70.14 107.365 171.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -81.76 106.55 13.79 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 113.527 -1.669 . . . . 72.44 108.901 -172.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -110.36 158.46 14.42 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 115.844 -0.616 . . . . 74.11 112.442 -176.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.93 132.18 3.9 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.828 -0.509 . . . . 74.35 111.828 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.4 HG13 ' HE1' ' D' ' 17' ' ' TYR . 74.5 mt -89.4 130.8 38.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.229 -1.026 . . . . 74.53 108.229 174.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -133.36 166.84 21.58 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 123.512 0.508 . . . . 73.32 110.466 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.0 m -114.69 107.06 14.96 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.036 0.934 . . . . 70.24 108.526 175.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.628 HD13 ' HB3' ' D' ' 56' ' ' TYR . 4.2 mp -109.23 118.13 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 C-N-CA 123.402 0.681 . . . . 65.45 109.223 -176.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.7 139.65 16.33 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.707 0.803 . . . . 60.1 110.326 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.45 21.92 49.5 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-O 120.221 -0.21 . . . . 61.34 113.099 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.465 HD11 ' HG3' ' D' ' 9' ' ' MET . 3.6 mp -116.34 146.72 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.681 0.792 . . . . 72.43 109.035 176.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -149.69 153.85 37.62 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.411 1.084 . . . . 52.31 110.411 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 91' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' D' ' 94' ' ' MET . . . 76.98 -133.81 13.97 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 114.835 0.694 . . . . 55.41 114.835 167.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.8 m -85.68 -11.66 53.19 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.259 1.024 . . . . 75.31 110.955 -178.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -57.11 -40.32 76.8 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.314 1.046 . . . . 54.44 110.618 176.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.43 ' HG2' ' O ' ' D' ' 91' ' ' GLY . 23.5 ptt? -74.45 -27.07 60.43 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.572 -0.74 . . . . 73.55 111.72 177.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.11 -34.88 77.22 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.523 0.329 . . . . 44.22 110.608 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -79.7 -32.0 41.3 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.988 -0.551 . . . . 60.33 110.621 174.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.7 t -63.1 -51.12 67.84 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.176 0.512 . . . . 62.4 110.705 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.672 HD11 HG23 ' H' ' 18' ' ' VAL . 57.8 mt -82.03 -28.52 32.45 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.096 -0.956 . . . . 63.41 111.252 -174.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.6 11.36 72.29 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-O 119.61 -0.55 . . . . 53.45 113.519 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.82 -65.3 0.11 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 117.728 0.764 . . . . 60.02 111.84 -177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -73.82 -42.26 61.15 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 112.664 0.616 . . . . 74.2 112.664 -168.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.456 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 62.3 m -64.13 -46.48 79.92 Favored Pre-proline 0 CA--C 1.566 1.562 0 CA-C-O 118.55 -0.738 . . . . 74.41 111.904 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.456 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 31.3 Cg_exo -62.42 -28.64 78.34 Favored 'Trans proline' 0 C--N 1.4 3.263 0 C-N-CA 122.423 2.082 . . . . 75.11 113.078 169.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -69.33 -30.3 68.31 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.579 0.751 . . . . 74.54 111.063 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.5 mm -69.12 -36.47 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 121.42 0.628 . . . . 63.32 109.84 172.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.438 HD12 HD23 ' D' ' 60' ' ' LEU . 68.6 mt -86.16 -10.61 54.46 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.27 -0.877 . . . . 44.34 111.819 -176.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -66.0 -49.89 55.0 Favored Pre-proline 0 CA--C 1.565 1.558 0 CA-C-O 117.935 -1.031 . . . . 75.32 112.667 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -60.61 -32.13 93.0 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 122.272 1.981 . . . . 64.21 112.932 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -81.02 -35.24 32.14 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.382 -0.826 . . . . 73.01 112.206 -176.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.17 -52.0 61.09 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.003 -1.11 . . . . 64.21 108.003 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -49.28 -50.01 40.99 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.923 1.389 . . . . 72.13 111.84 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -67.05 -50.38 62.1 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.718 0.636 . . . . 65.33 111.254 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -58.19 -44.17 87.95 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 124.178 0.924 . . . . 41.33 110.611 -177.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.54 ' HA ' ' SG ' ' D' ' 76' ' ' CYS . 91.0 mt -58.53 -63.06 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 124.463 1.105 . . . . 74.31 110.862 173.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 92.0 m -55.04 -38.33 67.84 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.225 1.01 . . . . 71.43 112.287 -173.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 42.0 t -67.89 -42.81 80.63 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.409 -0.814 . . . . 65.52 110.172 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.2 mtm -69.11 -29.9 68.07 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.67 0.388 . . . . 75.24 111.645 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.445 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.4 t -62.45 -50.04 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 O-C-N 123.797 0.686 . . . . 74.13 109.457 174.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 81.9 p -71.12 -30.35 66.39 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.942 -0.572 . . . . 61.11 110.855 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 71.8 mtt-85 -70.16 -32.19 70.04 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.369 0.668 . . . . 61.45 109.961 174.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.84 10.72 71.42 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.825 -0.625 . . . . 53.41 112.502 174.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.447 HG23 ' HB3' ' C' ' 17' ' ' TYR . 45.5 p 56.12 30.8 17.03 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 126.444 1.898 . . . . 74.01 114.144 175.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -93.47 159.44 35.07 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 123.813 0.845 . . . . 62.31 110.188 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -51.75 125.03 15.81 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.502 2.801 . . . . 74.22 113.501 171.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -57.59 136.2 56.75 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.844 1.258 . . . . 74.33 111.664 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 59.0 tp -128.53 97.38 4.69 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.454 0.702 . . . . 73.03 109.573 -175.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -100.57 110.07 22.2 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.568 0.747 . . . . 73.11 110.058 -176.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.558 ' HA ' HD12 ' H' ' 6' ' ' ILE . 89.1 mt -71.0 115.24 9.9 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.919 0.488 . . . . 71.54 110.264 178.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.446 ' HB3' HG21 ' H' ' 6' ' ' ILE . . . -73.31 157.28 88.33 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 122.967 0.507 . . . . 64.14 110.568 176.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -51.0 110.06 0.37 Allowed 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.419 2.746 . . . . 63.44 112.959 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 29.6 m -108.78 121.13 61.37 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 108.639 -0.874 . . . . 75.14 108.639 172.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -74.73 89.32 2.27 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 108.664 -0.865 . . . . 70.3 108.664 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -69.5 -17.25 63.58 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.357 -0.838 . . . . 64.41 110.823 -177.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.68 -60.42 3.71 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.961 0.904 . . . . 75.02 110.398 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.29 -37.99 84.31 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.556 0.742 . . . . 72.11 111.512 -178.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.0 tt -58.68 -43.44 89.94 Favored 'General case' 0 CA--C 1.556 1.192 0 O-C-N 123.969 0.793 . . . . 64.44 110.556 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -74.02 -46.59 42.53 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.229 0.611 . . . . 72.31 110.775 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.46 ' O ' ' HG3' ' D' ' 142' ' ' GLN . 69.0 mtm -60.36 -33.45 72.46 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.168 0.587 . . . . 72.2 111.332 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -60.28 -35.24 75.1 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.878 0.871 . . . . 73.12 111.28 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -64.75 -39.71 94.09 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.841 0.856 . . . . 72.23 110.721 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.1 mp -68.86 -28.12 66.42 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.751 0.821 . . . . 71.44 111.185 178.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' D' ' 138' ' ' MET . 75.7 mt-30 -80.1 0.55 31.58 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 113.052 0.76 . . . . 73.12 113.052 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.19 52.73 1.02 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 122.116 0.96 . . . . 75.21 111.009 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -143.94 158.27 43.81 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.93 -1.032 . . . . 75.34 110.334 174.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -101.7 143.06 32.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.055 0.942 . . . . 75.32 109.674 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.08 72.14 2.52 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.532 0.52 . . . . 71.01 112.253 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -86.34 -46.11 10.59 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.274 1.03 . . . . 74.21 110.092 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 149.78 -139.73 7.59 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 115.529 -0.76 . . . . 71.4 111.653 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 14.0 t -158.54 167.96 28.21 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.436 1.094 . . . . 71.44 108.9 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -91.69 141.51 28.61 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.903 0.481 . . . . 62.44 110.594 177.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -132.72 97.82 4.16 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.876 -1.157 . . . . 74.43 107.876 178.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -136.32 119.2 16.27 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.647 0.779 . . . . 65.13 109.218 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -82.48 77.25 9.28 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.402 -0.962 . . . . 72.25 108.402 172.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -72.72 -45.1 60.5 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.205 0.602 . . . . 65.44 109.382 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.987 0 CA-C-N 115.04 -0.982 . . . . 72.13 108.618 168.965 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 109.519 -0.548 . . . . 62.14 109.519 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' E' E ' 2' ' ' LYS . . . . . 0.639 ' HG3' ' HB3' ' C' ' 85' ' ' SER . 4.1 mppt? 68.06 134.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.919 1.688 . . . . 52.11 112.644 -178.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 3' ' ' GLN . . . . . 0.518 ' HB2' HE22 ' C' ' 12' ' ' GLN . 20.1 mp0 -105.55 -161.39 0.8 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.142 0.977 . . . . 73.13 108.565 174.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -138.51 92.66 2.65 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.09 0.556 . . . . 72.21 109.893 174.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 5' ' ' THR . . . . . 0.595 ' HB ' ' HB2' ' A' ' 129' ' ' ALA . 29.0 m -69.7 146.17 51.77 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.104 -0.702 . . . . 72.44 109.104 171.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.426 ' O ' HD12 ' E' ' 6' ' ' ILE . 2.4 pp -54.34 140.6 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.164 0.986 . . . . 61.3 112.574 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 7' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . . . -150.68 163.4 38.64 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.758 0.823 . . . . 62.4 110.061 -177.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.514 ' HB2' HG11 ' A' ' 131' ' ' VAL . 16.4 mt -91.34 145.7 24.43 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.137 0.975 . . . . 74.4 110.137 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.36 173.33 12.44 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.456 0.702 . . . . 64.51 109.786 169.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 7.7 tt -59.42 146.72 39.04 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 109.222 -0.658 . . . . 63.31 109.222 175.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 76.2 mt -55.82 118.76 21.55 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 123.367 0.667 . . . . 51.54 110.48 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.13 -8.28 11.8 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 123.073 2.515 . . . . 71.34 113.759 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 13' ' ' LEU . . . . . 0.486 HD13 ' H ' ' E' ' 13' ' ' LEU . 0.0 OUTLIER -130.7 162.2 29.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.801 1.241 . . . . 70.21 110.102 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 78.7 mt -83.19 110.78 18.35 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.056 -0.72 . . . . 74.15 109.056 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.48 75.17 6.1 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 108.912 -0.773 . . . . 73.41 108.912 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -121.13 104.0 41.67 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.183 0.593 . . . . 72.34 111.32 -176.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 17' ' ' PRO . . . . . 0.543 ' HB3' ' HB3' ' A' ' 48' ' ' SER . 98.3 Cg_endo -82.52 -0.69 10.28 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.421 2.081 . . . . 74.31 112.634 166.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 t -101.88 140.99 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.924 0.89 . . . . 52.13 109.828 -172.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 24.2 m -68.15 126.46 29.59 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.643 0.777 . . . . 74.42 111.048 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 86.7 tttt 68.28 92.33 0.08 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.56 1.144 . . . . 74.13 112.038 169.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.66 -9.37 59.41 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.641 0.776 . . . . 73.14 112.992 -172.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -79.87 -75.97 0.23 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.851 0.46 . . . . 72.42 110.876 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 95.6 m -158.22 90.91 2.19 Favored Pre-proline 0 N--CA 1.485 1.304 0 C-N-CA 123.548 0.739 . . . . 61.24 109.884 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -69.13 128.62 16.88 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.705 2.27 . . . . 73.34 111.826 167.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 . . . . . 0 CA--C 1.552 1.051 0 C-N-CA 124.295 1.038 . . . . 63.23 108.584 175.683 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 68.7 mtm . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 109.995 -0.372 . . . . 71.41 109.995 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -144.74 144.34 31.14 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.616 -1.253 . . . . 43.15 107.616 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -83.9 55.88 3.45 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.646 0.736 . . . . 73.54 110.357 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 54.3 m -145.26 90.2 2.01 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.02 1.328 . . . . 71.55 107.92 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 9.1 p -150.73 129.24 12.18 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.16 1.384 . . . . 61.3 107.965 177.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 29.6 mm 57.67 96.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 124.517 1.127 . . . . 50.4 110.875 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -160.2 -174.76 4.69 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.026 0.53 . . . . 74.24 110.258 -173.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 10.8 mt -154.86 -58.19 0.11 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.912 1.285 . . . . 64.54 108.892 172.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . 67.59 -173.47 0.19 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.521 1.129 . . . . 75.21 111.424 -175.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 84.4 mt -85.67 154.42 21.68 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.3 0.571 . . . . 74.03 110.923 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 6.1 mp -83.34 152.41 64.37 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 114.743 -1.117 . . . . 73.14 110.089 -176.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.49 85.71 1.07 Allowed 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 122.699 2.266 . . . . 63.11 110.775 175.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 35.0 tp 69.0 155.46 0.13 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.303 1.441 . . . . 61.12 111.143 -175.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.96 177.51 6.97 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.175 0.59 . . . . 74.43 110.344 175.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 15' ' ' PHE . . . . . 0.447 ' HD1' ' HA2' ' B' ' 99' ' ' GLY . 80.3 m-85 -75.83 156.55 34.32 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.227 0.611 . . . . 75.02 111.44 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 36.0 p -58.93 151.64 54.04 Favored Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 125.18 1.392 . . . . 72.3 113.057 -172.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -53.74 140.96 66.37 Favored 'Trans proline' 0 C--N 1.391 2.802 0 C-N-CA 123.311 2.674 . . . . 72.31 113.36 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.33 -20.8 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.136 0.975 . . . . 74.43 111.453 -175.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 7.4 t -67.2 -48.1 68.91 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 122.036 -0.415 . . . . 73.31 110.381 175.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -147.63 114.86 6.23 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.048 0.939 . . . . 73.01 109.674 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 21' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' B' ' 50' ' ' GLN . . . -120.51 161.71 20.82 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.863 -1.162 . . . . 73.23 107.863 173.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 22' ' ' ARG . . . . . 0.557 ' HG3' ' H ' ' F' ' 23' ' ' THR . 7.6 ptp180 -141.47 -76.53 0.29 Allowed 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 118.009 0.368 . . . . 64.22 111.122 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 23' ' ' THR . . . . . 0.557 ' H ' ' HG3' ' F' ' 22' ' ' ARG . 6.1 t -168.59 155.15 6.92 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.737 0.815 . . . . 75.24 108.812 -176.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.36 143.55 35.2 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 121.929 1.752 . . . . 73.24 111.006 166.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 . . . . . 0 C--O 1.25 1.098 0 N-CA-C 108.31 -0.996 . . . . 74.43 108.31 176.62 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.358 -0.608 . . . . 51.32 109.358 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -75.34 80.1 2.42 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.407 0.683 . . . . 72.53 109.729 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -85.91 143.47 28.19 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.223 -0.899 . . . . 64.0 109.346 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 26.0 p -72.76 171.81 11.93 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 123.291 0.637 . . . . 73.41 110.42 175.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 28.0 m -63.66 131.19 47.18 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.416 -0.587 . . . . 70.44 109.416 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 6' ' ' ILE . . . . . 0.427 HD11 ' HB ' ' C' ' 40' ' ' VAL . 32.1 pt -56.28 135.22 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 O-C-N 124.338 1.024 . . . . 61.2 112.811 -173.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -112.61 161.17 17.11 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 124.612 1.165 . . . . 72.54 109.207 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 8' ' ' LEU . . . . . 0.666 ' HB2' HG11 ' C' ' 131' ' ' VAL . 97.3 mt -55.25 135.57 49.63 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.622 0.769 . . . . 74.21 110.802 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.8 176.3 3.12 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.115 0.966 . . . . 60.24 111.683 -176.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.4 151.24 44.62 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.294 0.637 . . . . 54.45 110.534 176.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 11' ' ' LEU . . . . . 0.564 HD23 HG21 ' C' ' 46' ' ' THR . 7.0 mp -70.08 124.73 91.27 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 123.667 0.787 . . . . 73.43 109.624 -173.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -63.92 -49.43 4.0 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 122.522 2.148 . . . . 70.53 111.318 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 51.9 tp -87.86 138.24 31.63 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.688 -0.856 . . . . 75.23 108.688 168.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.63 89.56 1.75 Allowed 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 106.728 -1.582 . . . . 75.33 106.728 170.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 15' ' ' PHE . . . . . 0.467 ' HE2' HG13 ' C' ' 58' ' ' VAL . 11.4 t80 -62.74 106.96 0.87 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.364 -1.289 . . . . 74.51 111.068 -172.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 9.8 p -145.03 81.21 10.73 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 124.256 1.022 . . . . 60.4 110.331 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 17' ' ' PRO . . . . . 0.433 ' HD2' HD13 ' C' ' 98' ' ' LEU . 56.3 Cg_endo -69.89 -16.62 37.1 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 122.585 2.19 . . . . 73.23 113.298 175.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 18' ' ' VAL . . . . . . . . . . . . . 4.6 t -115.22 112.86 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 108.429 -0.952 . . . . 72.1 108.429 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 2.7 m 66.77 167.86 0.23 Allowed 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 125.395 1.478 . . . . 74.44 112.435 173.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -80.35 65.21 5.42 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.807 0.813 . . . . 73.22 109.297 165.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.02 -31.1 70.55 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.537 -1.21 . . . . 54.4 110.435 178.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 49.3 ttt-85 -73.99 103.36 4.45 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 106.679 -1.6 . . . . 61.23 106.679 157.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 74.1 m -66.91 107.61 1.8 Allowed Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 123.434 0.694 . . . . 74.12 110.382 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -95.1 177.82 0.81 Allowed 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 123.166 2.577 . . . . 53.21 112.74 -176.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 CA--C 1.552 1.031 0 CA-C-N 115.285 -0.871 . . . . 45.53 108.892 177.901 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 110.05 -0.352 . . . . 64.22 110.05 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -140.31 120.79 14.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.652 1.181 . . . . 73.24 108.42 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 65.59 115.26 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.432 1.493 . . . . 52.11 110.237 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 17.7 m -82.47 31.52 0.4 Allowed 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 112.736 0.643 . . . . 72.04 112.736 -172.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 11.3 p -60.84 107.75 0.75 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.03 0.932 . . . . 63.52 110.999 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' D' ' 128' ' ' LEU . 27.9 mm 62.91 63.64 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 124.716 1.206 . . . . 74.54 110.151 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.48 176.35 10.11 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.579 -1.191 . . . . 74.13 109.268 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 tt -139.03 109.29 6.45 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.386 -1.339 . . . . 73.23 107.386 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 9' ' ' ALA . . . . . 0.44 ' HB3' HD23 ' D' ' 44' ' ' LEU . . . -68.96 150.31 47.85 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.124 0.57 . . . . 62.03 110.932 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 88.4 mt -57.92 141.19 50.21 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.724 0.81 . . . . 71.13 110.962 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 83.4 mt -67.69 112.48 10.53 Favored Pre-proline 0 CA--C 1.56 1.335 0 C-N-CA 123.365 0.666 . . . . 73.12 110.077 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.25 -8.73 18.79 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.84 2.36 . . . . 72.35 112.6 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 44.6 tp -133.08 150.59 52.08 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.664 1.186 . . . . 62.32 108.166 174.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 mp -112.65 144.26 42.46 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.747 -0.834 . . . . 71.32 108.747 174.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -93.04 -177.54 4.52 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.438 0.695 . . . . 74.53 110.19 176.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 81.3 p -69.28 162.91 62.62 Favored Pre-proline 0 N--CA 1.488 1.443 0 C-N-CA 123.174 0.59 . . . . 51.44 110.843 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -82.7 -172.52 1.43 Allowed 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 121.679 1.586 . . . . 63.41 112.242 173.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 18' ' ' VAL . . . . . 0.672 HG23 HD11 ' D' ' 98' ' ' LEU . 60.0 t -62.15 161.16 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 C-N-CA 124.457 1.103 . . . . 63.31 110.709 174.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 19' ' ' THR . . . . . 0.537 HG21 ' HA ' ' D' ' 54' ' ' ASP . 5.2 t -51.2 134.24 27.52 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.23 0.612 . . . . 73.15 110.612 166.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp 64.32 13.23 7.84 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.502 1.121 . . . . 70.34 113.364 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.06 59.06 5.39 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.482 0.713 . . . . 61.03 111.711 -173.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -155.96 -71.17 0.11 Allowed 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.893 1.277 . . . . 70.31 108.318 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 23.7 m 50.81 66.94 4.82 Favored Pre-proline 0 CA--C 1.561 1.403 0 O-C-N 124.561 1.163 . . . . 55.23 110.113 -171.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.91 90.02 1.29 Allowed 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.429 2.086 . . . . 64.13 111.796 -171.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 . . . . . 0 C--O 1.254 1.298 0 C-N-CA 125.26 1.424 . . . . 73.22 110.813 179.117 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 109.244 -0.65 . . . . 74.54 109.244 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.8 m -77.49 94.19 4.26 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.652 0.781 . . . . 75.1 110.702 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -166.59 -55.42 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.804 1.242 . . . . 61.13 108.558 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.539 ' HG2' ' H ' ' A' ' 5' ' ' ASN . 46.8 tt0 -87.32 -176.26 5.58 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-N 114.706 -1.134 . . . . 74.02 109.481 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.539 ' H ' ' HG2' ' A' ' 4' ' ' GLN . 66.2 t30 71.27 24.01 3.89 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.959 1.303 . . . . 74.25 110.309 -177.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -137.82 -44.23 0.53 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.229 0.612 . . . . 73.32 110.677 -175.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.481 ' HB ' ' HA3' ' C' ' 146' ' ' GLY . 7.8 m -94.48 3.55 54.99 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.878 0.871 . . . . 71.42 111.794 -172.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.66 88.61 0.36 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.43 1.092 . . . . 72.31 111.434 -171.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.515 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 27.9 ttt -163.36 161.58 24.57 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.426 -1.261 . . . . 54.33 108.357 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.6 t -139.55 129.1 24.38 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.707 -0.849 . . . . 71.44 108.707 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.595 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 19.4 t80 -137.65 120.31 16.2 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.678 -0.86 . . . . 72.12 108.678 169.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.7 tp60 -138.92 127.61 23.35 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.329 -0.989 . . . . 72.45 108.329 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.692 HG12 ' HD2' ' A' ' 84' ' ' PHE . 42.6 mt -95.06 112.97 28.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.639 -0.874 . . . . 63.54 108.639 172.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -86.09 -24.33 26.32 Favored 'General case' 0 C--O 1.243 0.722 0 O-C-N 123.386 0.429 . . . . 72.4 111.064 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -173.42 146.42 1.37 Allowed 'General case' 0 N--CA 1.48 1.068 0 O-C-N 123.213 0.321 . . . . 72.02 110.373 -173.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.548 HD12 ' HG3' ' C' ' 130' ' ' PRO . 80.9 mt -138.47 134.9 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 124.021 0.929 . . . . 75.21 108.634 171.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.462 ' HB3' HG23 ' B' ' 122' ' ' THR . 27.6 p90 -167.98 176.19 6.3 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 124.42 1.075 . . . . 73.24 111.58 -168.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.6 p -99.64 120.6 39.95 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.433 -0.951 . . . . 74.43 108.433 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.457 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 43.9 mtpt -87.64 -27.4 22.5 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.069 -0.345 . . . . 75.44 110.069 174.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.627 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.7 t70 -149.14 139.59 22.45 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.649 -0.705 . . . . 71.34 109.989 177.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.4 mt -136.62 146.12 29.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 C-N-CA 125.3 1.44 . . . . 72.22 107.242 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -153.73 136.51 15.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 123.495 0.497 . . . . 44.23 110.064 170.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.59 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 86.3 t80 -133.47 143.45 48.83 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.416 -1.328 . . . . 72.35 107.416 171.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -140.38 144.32 36.17 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 108.949 -0.76 . . . . 53.11 108.949 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.61 74.03 11.49 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 106.151 -1.796 . . . . 44.23 106.151 171.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -64.57 -34.78 51.16 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.39 2.06 . . . . 73.04 111.956 -170.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -101.42 20.52 15.79 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.982 0.913 . . . . 71.43 109.896 -175.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.431 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -45.73 -52.01 26.61 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-O 118.009 -0.996 . . . . 73.32 113.627 -171.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.462 ' HG3' ' HG3' ' B' ' 57' ' ' GLU . 48.4 Cg_exo -57.89 -33.7 97.39 Favored 'Trans proline' 0 C--N 1.39 2.723 0 C-N-CA 121.882 1.721 . . . . 65.41 113.564 176.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -82.1 -30.88 30.98 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.055 0.942 . . . . 22.21 110.687 -177.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.725 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.3 p -78.96 -22.38 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 C-N-CA 123.169 0.588 . . . . 63.21 112.518 -163.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -77.84 -25.85 49.02 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.697 0.799 . . . . 75.51 112.67 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -83.39 -12.81 56.08 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.407 0.683 . . . . 70.54 111.012 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -82.77 167.88 17.72 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.962 0.905 . . . . 74.43 111.96 -175.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.68 126.54 31.03 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.986 -1.006 . . . . 74.24 109.324 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.493 ' HD1' ' HB3' ' E' ' 2' ' ' LYS . 54.1 t-105 -75.47 85.5 2.57 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.326 0.584 . . . . 53.43 110.094 175.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.45 ' H ' HD22 ' A' ' 68' ' ' LEU . 35.4 tt0 -122.88 75.2 48.01 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.689 1.196 . . . . 74.2 108.258 173.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -83.9 135.75 6.78 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.866 2.378 . . . . 73.52 112.994 -171.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -104.9 106.47 16.98 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 106.97 -1.493 . . . . 72.04 106.97 170.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.573 HG21 ' HA ' ' E' ' 6' ' ' ILE . 15.2 m -75.78 91.49 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-O 122.031 0.92 . . . . 71.53 110.652 -175.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.7 tptt -80.52 111.81 17.28 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 107.118 -1.438 . . . . 54.43 107.118 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 pp -127.53 141.92 51.52 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.046 0.539 . . . . 71.45 110.549 -168.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -146.19 134.16 21.41 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.758 -0.83 . . . . 71.55 108.758 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.417 HD21 HD21 ' E' ' 8' ' ' LEU . 6.0 mp -103.69 118.61 37.12 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.917 -0.771 . . . . 71.23 108.917 177.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 33.0 t70 -119.55 143.9 47.36 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.758 -0.83 . . . . 73.41 108.758 177.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.1 p -106.94 147.86 29.33 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.195 0.598 . . . . 70.13 110.047 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -147.76 144.05 27.97 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.153 0.981 . . . . 73.23 108.667 176.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 64.2 m -136.54 162.39 33.24 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 118.162 0.437 . . . . 63.5 111.799 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.9 t -149.92 121.86 8.2 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.843 0.857 . . . . 71.11 109.439 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -81.24 125.8 30.75 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.632 -0.507 . . . . 63.13 109.632 175.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.419 HD12 HG23 ' A' ' 83' ' ' ILE . 27.4 mt -107.8 -26.61 10.7 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.915 0.886 . . . . 72.33 110.264 -177.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.38 179.01 6.44 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.252 -1.34 . . . . 74.12 108.672 174.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -67.12 113.02 4.75 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.977 -0.749 . . . . 61.0 108.977 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 87' ' ' ALA . 5.6 m-20 76.07 0.32 3.27 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 125.245 1.418 . . . . 64.22 112.401 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.451 HG11 ' HG3' ' C' ' 153' ' ' GLN . 61.0 t -99.52 109.46 24.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.896 0 N-CA-C 106.744 -1.576 . . . . 74.13 106.744 168.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -133.72 123.38 24.85 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.974 -1.121 . . . . 63.14 107.974 -170.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.403 ' HB2' HD11 ' A' ' 51' ' ' LEU . 14.4 tt0 -86.31 128.3 34.9 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.595 -0.891 . . . . 64.1 108.595 177.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.464 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 56.5 t -101.93 125.97 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.767 -1.197 . . . . 64.5 107.767 176.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 36.8 t -116.13 143.18 26.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 108.229 -1.026 . . . . 64.44 108.229 173.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tt -128.9 117.62 21.31 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.765 -0.828 . . . . 62.4 108.765 174.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.576 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 28.1 ttm105 -81.95 101.56 10.35 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 108.025 -1.102 . . . . 74.02 108.025 170.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.83 101.16 12.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 N-CA-C 107.132 -1.432 . . . . 71.11 107.132 171.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -96.47 126.45 41.67 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.906 -0.776 . . . . 73.02 108.906 176.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.64 HG21 HD13 ' E' ' 6' ' ' ILE . 67.4 t -128.06 139.76 51.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 125.189 1.396 . . . . 64.25 107.356 176.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 6.4 m -131.24 149.82 52.41 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.702 -1.222 . . . . 70.31 107.702 174.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.19 113.57 22.42 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.203 -1.406 . . . . 63.04 107.203 170.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.0 m -113.85 124.38 52.07 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.157 0.503 . . . . 74.14 110.064 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.45 HD22 ' H ' ' A' ' 37' ' ' GLN . 66.0 mt -90.09 65.52 6.5 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.771 1.228 . . . . 75.13 109.001 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.34 -90.79 0.73 Allowed Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.838 -0.619 . . . . 71.2 111.828 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -102.17 -27.16 13.05 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.291 0.636 . . . . 73.33 111.644 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -100.19 128.5 46.26 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 109.585 -0.524 . . . . 72.54 109.585 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.9 m -71.49 135.91 47.34 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 118.175 0.443 . . . . 55.42 109.92 172.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.725 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -80.61 -63.1 1.48 Allowed 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.448 -0.796 . . . . 53.41 109.729 173.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -156.04 174.88 14.71 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.915 -1.038 . . . . 73.02 111.635 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.411 HD12 ' O ' ' A' ' 64' ' ' VAL . 44.6 tp -134.87 137.62 43.41 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.171 1.388 . . . . 73.44 107.853 174.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 82.5 m -136.51 102.92 5.09 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.96 1.304 . . . . 72.21 109.589 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -122.05 117.17 25.69 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.77 -0.826 . . . . 63.45 108.77 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.7 t -128.96 112.08 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.552 0.741 . . . . 75.31 109.976 -174.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.627 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.8 mt-30 -85.76 91.2 8.25 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.873 -0.788 . . . . 72.41 108.873 168.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.4 ' HG3' HD22 ' A' ' 106' ' ' LEU . 67.7 tp60 -80.75 107.87 13.93 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.969 -1.014 . . . . 73.1 108.995 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.59 145.28 17.43 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.033 -0.427 . . . . 62.21 112.033 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.06 128.45 3.07 Favored Glycine 0 CA--C 1.507 -0.445 0 N-CA-C 110.942 -0.863 . . . . 74.21 110.942 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.419 HG23 HD12 ' A' ' 51' ' ' LEU . 62.0 mt -79.54 122.38 34.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.867 -0.79 . . . . 73.12 108.867 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.692 ' HD2' HG12 ' A' ' 13' ' ' ILE . 12.6 m-85 -137.54 151.69 48.66 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.744 -0.836 . . . . 74.24 108.744 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 44.3 m -121.01 106.64 11.78 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.325 0.65 . . . . 64.33 109.348 170.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.666 ' HB ' HG11 ' E' ' 18' ' ' VAL . 4.0 mp -115.26 121.05 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 108.692 -0.855 . . . . 45.44 108.692 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.407 ' HB2' ' HB3' ' A' ' 54' ' ' ASP . . . -164.2 158.59 19.21 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.746 0.819 . . . . 74.32 110.152 175.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 132.15 -37.34 2.06 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-O 119.873 -0.404 . . . . 22.32 113.921 173.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.8 mt -122.44 -52.6 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-N 117.492 0.646 . . . . 65.11 110.909 -171.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' E' ' 20' ' ' LYS . 0.5 OUTLIER 65.02 -164.17 0.25 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.638 1.175 . . . . 74.44 112.058 177.273 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.59 -140.43 33.4 Favored Glycine 0 C--N 1.352 1.469 0 O-C-N 123.277 0.361 . . . . 51.12 113.433 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.9 t -72.38 -18.65 61.72 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.459 0.704 . . . . 73.24 111.295 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.4 mm100 -74.42 -44.99 49.45 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.234 0.613 . . . . 72.13 110.468 178.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.655 ' HG2' HD23 ' A' ' 98' ' ' LEU . 52.9 ttm -72.16 -27.02 62.31 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.689 -0.485 . . . . 72.24 109.689 173.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.82 -29.06 69.91 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.871 0.468 . . . . 22.23 111.718 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -72.64 -39.28 67.31 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.965 0.506 . . . . 70.12 110.608 171.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.565 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 58.4 m -64.36 -56.21 15.9 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.224 0.61 . . . . 61.1 110.972 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.735 HD22 ' HA ' ' E' ' 17' ' ' PRO . 3.7 pp -71.62 -29.37 64.59 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.196 0.599 . . . . 62.22 111.332 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.61 -20.69 57.86 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-O 119.575 -0.569 . . . . 52.31 114.273 -173.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.08 -54.67 0.21 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.063 0.764 . . . . 74.51 113.063 -172.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.565 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 87.5 t80 -60.89 -63.48 1.28 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.524 0.73 . . . . 61.21 112.844 -171.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 78.2 m -65.63 -35.22 10.92 Favored Pre-proline 0 CA--C 1.57 1.732 0 C-N-CA 123.779 0.831 . . . . 75.55 113.073 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.2 -45.73 32.1 Favored 'Trans proline' 0 C--N 1.393 2.914 0 C-N-CA 122.777 2.318 . . . . 55.05 113.374 161.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -70.64 -17.69 62.87 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.401 0.681 . . . . 73.13 112.075 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 46.2 mm -69.71 -43.81 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 N-CA-C 109.209 -0.663 . . . . 72.13 109.209 171.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.4 HD22 ' HG3' ' A' ' 80' ' ' GLN . 89.1 mt -81.89 -23.48 36.27 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.012 0.925 . . . . 71.05 112.549 -177.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -56.22 -47.21 99.3 Favored Pre-proline 0 CA--C 1.572 1.792 0 C-N-CA 124.956 1.303 . . . . 71.52 113.953 -172.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.67 -32.76 14.25 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.119 1.879 . . . . 70.04 112.939 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -68.26 -40.68 81.83 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.058 0.543 . . . . 75.41 110.912 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.73 -39.92 80.13 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.766 -0.652 . . . . 65.22 110.507 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.4 ttm105 -54.67 -47.81 73.13 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.849 0.86 . . . . 70.2 110.912 173.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -68.94 -43.27 75.41 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.709 0.803 . . . . 70.04 111.408 -175.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 43.8 t -63.88 -29.65 70.81 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 123.607 0.567 . . . . 72.33 110.823 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 70.8 mt -68.2 -56.06 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 123.862 0.865 . . . . 71.33 110.011 169.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.2 m -56.28 -35.74 67.83 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.842 1.257 . . . . 44.31 112.339 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.4 t -64.38 -49.61 70.94 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 123.409 0.683 . . . . 51.01 110.647 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.59 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 57.9 mtm -65.9 -37.48 86.21 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.725 0.64 . . . . 60.15 111.25 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.0 t -60.07 -53.19 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.499 1.12 . . . . 72.02 110.403 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 40.2 t -69.78 -29.46 66.79 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.933 0.893 . . . . 61.22 111.49 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 52.0 ttm-85 -75.75 -28.92 58.68 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.256 1.023 . . . . 74.33 109.362 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.432 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.66 15.56 46.07 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 114.741 -1.118 . . . . 75.15 112.607 172.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.477 HG21 ' HE ' ' B' ' 15' ' ' ARG . 2.8 t 60.81 14.46 5.16 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 127.214 2.205 . . . . 74.11 113.77 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -80.08 155.07 75.1 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 123.681 0.792 . . . . 75.1 110.223 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.68 170.13 10.39 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.853 2.369 . . . . 74.44 113.15 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -63.68 127.69 32.5 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.193 -0.912 . . . . 74.45 111.55 -173.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.6 tp -121.88 103.96 9.21 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.651 1.18 . . . . 53.42 108.306 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -97.22 126.65 42.56 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.713 0.805 . . . . 72.43 108.867 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.518 ' HA ' ' HB ' ' E' ' 6' ' ' ILE . 1.2 tt -72.51 130.78 41.43 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.948 -1.13 . . . . 73.15 107.948 171.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.05 133.22 83.91 Favored Pre-proline 0 CA--C 1.548 0.893 0 O-C-N 123.575 0.547 . . . . 63.24 110.743 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -70.59 95.83 0.64 Allowed 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 122.343 2.028 . . . . 51.42 111.593 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.7 t -102.24 111.45 32.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 108.911 -0.774 . . . . 72.31 108.911 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -86.67 82.9 7.72 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.122 -1.066 . . . . 54.04 108.122 172.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -50.03 -35.1 23.56 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.498 1.119 . . . . 74.12 111.785 -176.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -53.34 -51.29 62.9 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.691 1.196 . . . . 75.11 111.356 178.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.8 -50.39 74.01 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.885 0.741 . . . . 45.3 111.821 -177.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.84 -42.94 94.51 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.599 0.759 . . . . 62.31 110.799 -175.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.505 ' HE2' HD23 ' E' ' 11' ' ' LEU . 25.7 m-85 -70.31 -27.68 64.57 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.286 0.634 . . . . 73.13 111.772 177.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 53.3 mtp -77.71 -26.22 49.93 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 119.02 -0.514 . . . . 72.42 111.571 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.606 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 25.0 m120 -66.81 -38.52 86.63 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.906 -0.405 . . . . 74.44 109.906 173.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -69.95 -39.59 75.94 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.643 -0.708 . . . . 74.44 111.031 172.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.6 tp -61.8 -49.46 76.25 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.89 0.876 . . . . 65.01 111.908 -175.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.422 ' H ' ' H ' ' A' ' 143' ' ' GLN . 64.9 tt0 -166.09 -11.41 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 O-C-N 123.557 0.536 . . . . 71.13 111.714 -171.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.606 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 75.3 mt-30 73.76 118.34 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.688 1.595 . . . . 73.43 109.733 -162.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -69.07 140.11 54.86 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.574 0.75 . . . . 65.22 112.02 -174.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.42 -54.54 0.17 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.262 1.025 . . . . 52.41 108.922 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 104.8 -113.72 4.44 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-N 115.39 -0.823 . . . . 63.24 111.552 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -155.35 -50.28 0.08 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.855 0.862 . . . . 53.25 108.765 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 101.9 98.57 2.39 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 111.018 -0.833 . . . . 74.24 111.018 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 37.3 p -68.44 93.91 0.52 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.124 0.97 . . . . 72.3 110.75 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.67 110.57 13.92 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.266 -1.013 . . . . 75.31 108.266 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -112.66 87.09 2.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.631 0.772 . . . . 71.43 109.61 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -95.37 140.72 29.85 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.42 -0.809 . . . . 63.12 109.873 175.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -138.29 115.46 11.0 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.871 0.868 . . . . 73.52 109.255 171.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -109.62 98.65 7.97 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.83 -1.174 . . . . 63.32 107.83 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 C-N-CA 123.696 0.799 . . . . 62.24 109.105 178.103 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 35.8 tpp . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 121.688 0.756 . . . . 74.01 109.389 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 26.5 m -153.58 115.68 4.33 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 124.107 0.963 . . . . 63.22 108.794 173.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -81.71 3.69 24.66 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.208 0.603 . . . . 63.54 111.05 169.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -65.24 95.1 0.17 Allowed 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.873 -0.788 . . . . 62.41 108.873 170.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -148.85 144.16 26.75 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.91 0.884 . . . . 73.21 108.686 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -169.65 174.33 5.87 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 108.661 -0.866 . . . . 62.12 108.661 -173.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 11.3 m 72.1 171.91 0.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.4 1.08 . . . . 74.41 111.029 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -82.59 58.19 4.09 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.562 0.745 . . . . 74.12 109.314 172.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.589 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 25.3 ptm 44.62 -166.52 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 126.981 2.112 . . . . 60.32 115.473 174.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 90.2 m -134.78 132.35 38.6 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 106.559 -1.645 . . . . 73.55 106.559 162.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.452 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 37.9 t80 -124.13 137.65 54.53 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.738 -0.838 . . . . 75.44 108.738 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -153.28 132.94 13.05 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.399 -0.593 . . . . 72.31 109.399 176.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.409 HD13 HD11 ' B' ' 16' ' ' ILE . 32.5 mt -83.32 120.39 34.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 108.438 -0.949 . . . . 62.32 108.438 173.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -88.28 -46.1 9.5 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.539 -0.541 . . . . 62.34 109.539 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.477 ' HE ' HG21 ' A' ' 122' ' ' THR . 49.2 ttt180 -167.67 137.74 2.77 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.704 0.402 . . . . 71.54 110.167 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.409 HD11 HD13 ' B' ' 13' ' ' ILE . 74.1 mt -114.79 142.32 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.407 -0.961 . . . . 75.2 108.407 175.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -169.77 158.53 7.52 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-O 121.682 0.753 . . . . 62.44 112.499 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.402 ' H ' ' HA2' ' A' ' 121' ' ' GLY . 88.4 m -86.71 129.58 34.81 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.007 -0.997 . . . . 51.12 109.188 170.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.456 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 41.1 mtpt -97.72 -29.22 13.51 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.796 0.838 . . . . 73.12 110.343 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -159.97 141.12 12.43 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.56 0.219 . . . . 73.13 111.334 -170.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 45.7 mm -135.53 146.13 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.291 1.437 . . . . 75.42 109.07 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.603 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 42.4 t -148.21 138.31 22.58 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.851 1.261 . . . . 71.33 107.965 173.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.1 t80 -153.57 109.38 3.27 Favored 'General case' 0 C--O 1.215 -0.755 0 N-CA-C 106.783 -1.562 . . . . 71.51 106.783 170.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -118.53 113.48 21.36 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.33 -1.359 . . . . 73.15 107.33 176.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.431 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -105.14 86.64 1.64 Allowed Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 106.975 -1.491 . . . . 53.34 106.975 172.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.37 -37.5 13.45 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.902 2.401 . . . . 70.1 112.502 -166.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -108.45 21.84 16.76 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.598 0.759 . . . . 71.11 110.069 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.431 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -39.36 -62.25 0.84 Allowed Pre-proline 0 N--CA 1.497 1.908 0 N-CA-C 114.792 1.404 . . . . 74.1 114.792 -166.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.457 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 46.8 Cg_endo -67.89 -27.54 36.93 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 121.823 1.682 . . . . 73.23 112.631 -174.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.405 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 26.3 m80 -75.38 -48.45 22.87 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 115.36 -0.837 . . . . 75.04 110.896 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' B' ' 68' ' ' LEU . 9.1 p -76.06 -0.49 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.365 0 C-N-CA 123.868 0.867 . . . . 64.41 112.353 -167.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -75.7 -13.38 60.31 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.985 -0.447 . . . . 72.02 112.155 173.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 10.2 pt20 -63.36 -16.97 62.03 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.756 0.822 . . . . 73.32 111.183 171.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.461 ' HB2' HD13 ' B' ' 68' ' ' LEU . 33.1 mmtp -93.72 89.87 6.36 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.058 1.343 . . . . 75.34 110.148 -176.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -89.17 84.5 6.53 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.988 0.515 . . . . 62.44 111.08 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 46.7 p90 -168.11 173.05 8.24 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.332 1.053 . . . . 71.01 109.497 169.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -65.17 116.77 33.37 Favored Pre-proline 0 N--CA 1.478 0.937 0 N-CA-C 108.602 -0.888 . . . . 62.04 108.602 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.404 ' O ' HG13 ' B' ' 40' ' ' VAL . 33.9 Cg_endo -60.06 154.15 53.19 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 121.995 1.797 . . . . 74.22 111.881 -175.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 30.3 tt0 -57.23 104.5 0.17 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.014 -0.736 . . . . 65.52 109.014 175.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.438 ' HB ' HD12 ' F' ' 6' ' ' ILE . 26.2 m -85.2 139.08 17.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-N 114.924 -1.035 . . . . 63.32 110.565 -172.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.502 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 34.3 ttmt -150.5 107.13 3.51 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.723 -0.843 . . . . 74.23 108.723 -175.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.483 HD23 HG12 ' F' ' 6' ' ' ILE . 0.1 OUTLIER -85.43 141.14 30.17 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 107.672 -1.233 . . . . 62.03 107.672 176.391 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -143.51 142.04 30.99 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.459 1.103 . . . . 73.22 108.417 174.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.809 HD21 HD23 ' F' ' 8' ' ' LEU . 5.4 mp -123.92 167.31 14.3 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.539 0.685 . . . . 74.32 110.991 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.599 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.0 t70 -149.65 148.55 29.43 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 113.879 -1.51 . . . . 74.44 109.002 175.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 3.4 t -108.27 127.02 53.49 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.236 1.015 . . . . 74.4 108.938 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -158.4 136.85 10.97 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.202 0.601 . . . . 72.3 110.216 -175.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.4 p -146.57 -179.63 6.9 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.264 0.625 . . . . 63.21 111.155 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 65.1 p -152.51 136.38 16.3 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.174 -1.047 . . . . 63.32 108.174 164.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -89.94 118.68 29.69 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.18 -0.674 . . . . 64.25 109.18 175.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 17.8 mt -84.19 -48.59 9.65 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.596 -0.891 . . . . 75.41 108.596 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.43 179.29 8.26 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.317 -1.31 . . . . 74.01 109.793 175.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.71 130.71 43.11 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.506 -1.224 . . . . 63.11 107.933 172.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 71.12 -5.37 1.55 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 125.145 1.378 . . . . 72.41 112.843 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 86.6 t -119.29 102.52 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.933 0.893 . . . . 61.12 108.714 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -121.68 139.76 53.15 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.447 0.699 . . . . 73.54 109.616 -173.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.462 ' HG3' ' HG3' ' A' ' 29' ' ' PRO . 8.9 tm-20 -106.5 107.48 18.52 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 107.645 -1.243 . . . . 73.43 107.645 -178.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 85.6 t -94.53 126.21 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.163 1.385 . . . . 74.14 110.295 -175.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 13.6 t -112.9 145.88 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.755 -0.831 . . . . 74.41 108.755 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.435 HD11 HD23 ' B' ' 44' ' ' LEU . 41.9 tp -129.44 112.02 13.37 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 108.026 -1.101 . . . . 65.32 108.026 168.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.599 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 11.4 ttm180 -88.56 110.4 20.86 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.923 -0.769 . . . . 72.13 108.923 173.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 24.9 t -105.36 102.77 14.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 107.189 -1.412 . . . . 72.51 107.189 177.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 25.4 m -99.54 134.0 43.05 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.939 -0.763 . . . . 64.2 108.939 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.438 HG23 HD13 ' B' ' 114' ' ' ILE . 40.6 t -120.28 126.16 74.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 123.53 0.732 . . . . 64.42 109.734 174.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 78.6 m -103.54 143.56 32.57 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.964 0.906 . . . . 74.35 109.476 171.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -146.82 135.94 22.55 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.703 0.801 . . . . 73.11 109.648 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.558 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 38.0 p -141.81 134.28 28.17 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 123.373 0.669 . . . . 75.55 110.16 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.461 HD13 ' HB2' ' B' ' 34' ' ' LYS . 26.2 mt -108.85 100.87 10.03 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 123.78 0.832 . . . . 71.21 109.647 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.83 -119.58 6.97 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.505 -0.77 . . . . 74.21 113.385 176.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -95.21 18.12 12.93 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.394 0.677 . . . . 74.53 112.21 -173.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -152.74 155.16 36.67 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.928 0.491 . . . . 73.0 110.562 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 96.7 m -73.12 132.38 43.22 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 116.05 -0.523 . . . . 70.32 110.045 174.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.558 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -82.83 -62.23 1.66 Allowed 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.29 -1.004 . . . . 64.25 108.29 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -158.61 160.31 36.41 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 114.882 -1.053 . . . . 71.2 111.658 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 79.6 mt -128.59 113.06 14.97 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.577 -1.638 . . . . 55.43 106.577 173.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.1 t -115.63 153.37 31.4 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.47 -0.937 . . . . 71.12 108.47 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.603 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.8 tt0 -162.03 126.77 3.34 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.286 -0.635 . . . . 74.24 109.286 -175.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 95.9 t -126.3 145.52 33.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 124.095 0.958 . . . . 74.52 108.773 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -123.47 98.75 5.99 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.199 -1.037 . . . . 70.12 108.199 173.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.484 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 8.1 tp-100 -91.82 101.09 13.68 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.29 -1.004 . . . . 74.41 108.29 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.74 162.7 30.42 Favored Glycine 0 C--O 1.242 0.61 0 N-CA-C 110.9 -0.88 . . . . 73.2 110.9 174.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.74 126.31 1.51 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.821 -0.911 . . . . 35.1 110.821 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 61.0 mt -84.16 129.46 37.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 107.757 -1.201 . . . . 64.41 107.757 174.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -133.04 168.97 17.53 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.498 0.719 . . . . 75.05 109.244 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 73.7 m -126.64 109.53 12.2 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.574 0.75 . . . . 72.21 109.207 170.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -118.74 126.16 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.7 1.2 . . . . 75.33 108.306 -175.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.4 ' HA ' ' HB1' ' F' ' 21' ' ' ALA . . . -157.47 142.97 17.25 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.718 0.407 . . . . 71.22 111.219 -174.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 107.27 -34.44 5.68 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.274 0.359 . . . . 73.12 113.145 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.589 ' HB ' ' HB3' ' B' ' 9' ' ' MET . 0.6 OUTLIER -94.08 160.48 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.751 0.82 . . . . 61.34 110.121 172.668 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -161.26 160.8 30.32 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.065 0.546 . . . . 74.11 111.207 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.73 -128.68 9.14 Favored Glycine 0 C--N 1.353 1.505 0 C-N-CA 123.818 0.723 . . . . 72.43 112.641 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 35.9 m -65.34 -31.2 72.2 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.654 0.782 . . . . 74.22 110.636 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -69.91 -37.92 76.12 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.259 -0.882 . . . . 75.42 111.01 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.412 ' SD ' ' HB ' ' F' ' 18' ' ' VAL . 0.0 OUTLIER -80.35 -28.8 38.0 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.952 -0.388 . . . . 61.24 109.952 177.197 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.6 -31.86 73.16 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.775 0.83 . . . . 61.14 110.546 172.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -81.92 -37.93 26.06 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.662 1.185 . . . . 71.01 110.466 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.8 t -64.73 -46.64 81.41 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.861 0.464 . . . . 53.24 110.918 -175.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 5.5 mp -96.26 -9.51 30.13 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.72 0.408 . . . . 71.31 111.281 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.98 -15.36 33.7 Favored Glycine 0 N--CA 1.476 1.313 0 N-CA-C 114.008 0.363 . . . . 64.41 114.008 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.56 -61.71 0.89 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.467 0.707 . . . . 70.24 109.856 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -67.03 -55.11 15.77 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.409 0.684 . . . . 73.22 112.59 -168.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.483 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 83.1 m -61.46 -49.95 85.09 Favored Pre-proline 0 CA--C 1.559 1.307 0 CA-C-O 118.362 -0.828 . . . . 64.24 111.78 -177.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 37.7 Cg_exo -61.9 -25.89 78.51 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 122.318 2.012 . . . . 74.32 113.442 174.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -77.02 -25.61 52.82 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.499 0.72 . . . . 75.43 110.927 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.409 HG23 ' NH2' ' D' ' 111' ' ' ARG . 65.2 mt -68.74 -42.86 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.635 0.774 . . . . 64.4 109.529 169.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' B' ' 102' ' ' CYS . 53.6 mt -82.03 -18.76 42.13 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.412 -1.267 . . . . 72.44 111.311 -174.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -57.64 -52.01 77.48 Favored Pre-proline 0 CA--C 1.559 1.306 0 CA-C-O 117.121 -1.419 . . . . 74.41 112.708 -177.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -53.61 -37.86 83.59 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 122.727 2.285 . . . . 64.43 114.477 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -70.34 -44.38 68.28 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.072 0.549 . . . . 73.02 109.871 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -67.18 -32.43 73.51 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 115.351 -0.84 . . . . 62.33 111.591 177.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.414 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 45.3 ttt-85 -70.3 -51.11 32.78 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.985 1.314 . . . . 72.45 109.967 -176.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -35.79 78.52 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 124.324 1.015 . . . . 61.23 108.957 176.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.487 ' O ' ' HG2' ' B' ' 117' ' ' MET . 19.1 t -65.31 -47.71 75.6 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 123.687 0.617 . . . . 41.23 112.432 -177.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.516 ' O ' HG23 ' B' ' 118' ' ' VAL . 75.5 mt -60.33 -54.72 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 108.924 -0.769 . . . . 74.03 108.924 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 45.2 m -58.27 -30.04 66.27 Favored 'General case' 0 CA--C 1.555 1.146 0 O-C-N 124.583 1.177 . . . . 45.22 111.661 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 48.0 t -69.66 -46.15 66.78 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 123.431 0.693 . . . . 73.44 109.194 176.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.561 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 9.4 mmt -70.13 -32.92 71.17 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 123.482 0.489 . . . . 63.2 110.886 -177.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.516 HG23 ' O ' ' B' ' 114' ' ' ILE . 99.4 t -59.96 -47.5 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 124.302 1.041 . . . . 74.51 109.317 171.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.0 t -70.47 -29.73 66.36 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 113.755 -1.566 . . . . 74.23 111.672 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.561 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 92.3 mtt-85 -70.05 -37.01 75.42 Favored 'General case' 0 C--O 1.214 -0.774 0 C-N-CA 123.346 0.658 . . . . 71.12 109.339 176.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.93 8.82 55.85 Favored Glycine 0 C--N 1.353 1.5 0 O-C-N 124.167 0.917 . . . . 71.12 112.863 173.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.462 HG23 ' HB3' ' A' ' 17' ' ' TYR . 76.9 p 55.38 25.32 7.49 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 126.395 1.878 . . . . 74.53 113.62 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -78.39 155.03 79.31 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 123.888 0.875 . . . . 75.34 111.118 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -46.88 143.96 8.77 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.873 3.049 . . . . 74.02 113.707 176.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -58.6 116.19 3.52 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.174 0.99 . . . . 75.14 111.679 -172.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 41.8 tp -121.25 105.08 10.23 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.328 0.651 . . . . 72.44 110.19 -176.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -105.17 126.37 52.01 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 108.913 -0.773 . . . . 50.33 108.913 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.414 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 49.3 mt -74.33 137.85 43.11 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 109.508 -0.552 . . . . 61.34 109.508 175.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' F' ' 7' ' ' ALA . . . -85.78 136.83 36.29 Favored Pre-proline 0 N--CA 1.479 1.013 0 CA-C-O 119.282 -0.39 . . . . 62.31 110.077 176.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.664 ' HG3' HD13 ' D' ' 16' ' ' ILE . 69.9 Cg_endo -73.94 141.42 30.01 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.334 2.023 . . . . 54.31 111.978 178.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 27.5 m -128.75 131.38 68.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.567 -0.901 . . . . 73.1 108.567 172.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -73.67 95.86 2.4 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.469 -0.567 . . . . 54.2 109.469 174.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.473 ' HZ ' HD22 ' F' ' 8' ' ' LEU . 45.3 m-85 -61.93 -43.59 98.54 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.671 -0.863 . . . . 65.22 108.671 171.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -55.06 -62.66 1.51 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 113.603 -1.635 . . . . 55.44 111.704 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.22 -37.08 71.69 Favored 'General case' 0 C--N 1.363 1.159 0 O-C-N 123.979 0.799 . . . . 52.22 112.341 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -58.83 -52.25 66.53 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.074 0.95 . . . . 63.44 110.125 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -70.81 -22.62 62.33 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 116.144 -0.48 . . . . 65.01 111.687 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 99.7 mtp -69.32 -36.2 76.72 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 122.874 0.47 . . . . 71.53 110.833 175.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.546 ' HA ' ' HG2' ' B' ' 142' ' ' GLN . 21.3 m-80 -73.05 -16.77 61.48 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.868 0.467 . . . . 74.33 111.067 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -75.3 -34.82 61.31 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.054 0.542 . . . . 73.33 110.131 171.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 64.8 mt -98.01 -7.9 28.99 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 113.002 0.742 . . . . 75.45 113.002 -171.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 142' ' ' GLN . . . . . 0.546 ' HG2' ' HA ' ' B' ' 139' ' ' ASN . 12.2 pt20 -113.86 166.01 12.0 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.832 0.453 . . . . 75.24 110.754 -176.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -149.55 155.6 40.59 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.784 0.834 . . . . 73.04 109.651 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -114.8 92.75 4.05 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.829 -0.804 . . . . 34.34 108.829 173.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.05 99.7 11.43 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.768 0.827 . . . . 74.24 110.461 -175.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -103.52 109.76 3.51 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 111.019 -0.832 . . . . 72.13 111.019 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -117.29 123.91 47.71 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.124 0.97 . . . . 74.42 110.011 -175.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -93.62 145.84 17.83 Favored Glycine 0 C--N 1.352 1.417 0 CA-C-O 120.129 -0.261 . . . . 72.43 113.044 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 38.2 p -84.59 154.13 22.78 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.797 0.839 . . . . 65.41 110.865 176.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -73.13 146.23 45.84 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.535 0.734 . . . . 71.22 110.047 177.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -142.23 73.59 1.42 Allowed 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.906 0.882 . . . . 63.31 109.28 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -71.32 113.77 8.7 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 109.806 -0.442 . . . . 53.41 109.806 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -85.78 148.33 25.89 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.864 -0.607 . . . . 74.33 109.667 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -127.06 104.74 8.15 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.45 -0.944 . . . . 75.23 108.45 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.85 0 C-N-CA 123.359 0.664 . . . . 72.21 109.614 -179.447 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 109.081 -0.711 . . . . 61.5 109.081 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 22.5 m 64.41 56.58 1.26 Allowed 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.395 1.078 . . . . 45.35 111.395 177.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -64.1 177.92 0.74 Allowed 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 114.539 -1.21 . . . . 72.13 110.668 173.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -61.1 104.14 0.35 Allowed 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.322 -0.621 . . . . 73.23 109.322 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -59.85 -44.46 94.11 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.997 0.919 . . . . 72.41 110.87 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -106.93 61.18 0.63 Allowed 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.087 -1.079 . . . . 73.32 108.087 174.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -66.41 -22.87 66.23 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 114.723 -1.126 . . . . 73.23 112.082 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.735 ' HG2' ' HG3' ' C' ' 9' ' ' MET . 49.1 tt0 -131.58 136.7 48.0 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.824 0.85 . . . . 73.21 109.539 -176.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.735 ' HG3' ' HG2' ' C' ' 8' ' ' GLU . 86.2 mtp 66.03 158.25 0.11 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.029 1.332 . . . . 65.43 114.521 172.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 93.6 m -96.45 80.15 3.13 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 106.61 -1.626 . . . . 74.21 106.61 154.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.475 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.7 t80 -111.47 130.92 55.56 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.127 -0.942 . . . . 61.41 109.907 -175.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -152.58 137.35 17.03 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.077 -1.453 . . . . 71.32 107.077 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 64.7 mt -79.81 116.42 23.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 108.332 -0.988 . . . . 64.01 108.332 173.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.456 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 9.8 mm100 -80.35 -39.0 29.38 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.214 -0.903 . . . . 62.04 109.72 -173.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -179.8 124.33 0.08 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.983 0.513 . . . . 73.21 109.968 -172.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 91.8 mt -109.61 141.21 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 108.848 -0.797 . . . . 64.32 108.848 173.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.448 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 23.5 p90 -174.79 163.97 3.47 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 123.91 0.756 . . . . 74.34 110.236 -173.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.3 p -90.06 125.74 35.52 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.383 0.673 . . . . 64.43 109.369 173.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.448 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 25.8 mmtp -71.07 -49.45 44.43 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 107.887 -1.153 . . . . 74.4 107.887 168.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.718 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 7.9 t70 -139.44 140.77 37.41 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 113.124 -1.853 . . . . 74.22 109.711 -165.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.506 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 73.8 mt -139.18 147.03 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.899 -1.519 . . . . 72.13 106.899 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.9 t -158.95 151.76 21.99 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.418 0.687 . . . . 73.44 109.871 176.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.413 ' CE1' ' HA3' ' C' ' 121' ' ' GLY . 79.0 t80 -153.93 110.68 3.36 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 107.813 -1.18 . . . . 64.44 107.813 173.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -120.61 110.27 16.23 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.516 0.726 . . . . 53.22 109.557 -173.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.24 87.09 22.73 Favored Pre-proline 0 C--O 1.24 0.6 0 N-CA-C 107.253 -1.388 . . . . 62.03 107.253 170.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.05 -37.2 26.79 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.509 2.139 . . . . 65.02 111.992 -176.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -103.97 28.76 6.41 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.512 0.725 . . . . 63.14 109.999 -175.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.501 ' HA ' HG12 ' C' ' 31' ' ' VAL . . . -47.94 -53.8 29.32 Favored Pre-proline 0 CA--C 1.561 1.372 0 N-CA-C 114.322 1.23 . . . . 75.14 114.322 -169.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.78 -49.61 14.1 Favored 'Trans proline' 0 C--N 1.389 2.702 0 CA-C-N 121.747 1.66 . . . . 74.04 112.788 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.475 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 83.2 t60 -69.82 -28.18 65.48 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.859 -0.609 . . . . 61.52 112.087 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.817 HG21 ' HA ' ' C' ' 73' ' ' ALA . 3.7 p -80.93 -13.8 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 O-C-N 121.27 -0.894 . . . . 75.1 112.123 -177.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -81.75 -14.97 55.76 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 112.694 0.627 . . . . 63.13 112.694 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 18.9 pt20 -92.11 9.25 34.25 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.658 0.383 . . . . 74.24 110.559 171.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.07 145.72 28.38 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.517 0.727 . . . . 73.03 110.439 -174.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -71.21 129.94 40.18 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.2 -0.667 . . . . 72.04 109.2 174.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -76.82 84.92 3.41 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.509 0.724 . . . . 72.4 110.292 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -134.14 63.36 61.37 Favored Pre-proline 0 N--CA 1.478 0.967 0 C-N-CA 124.014 0.926 . . . . 70.34 109.351 173.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.42 ' HG2' HG13 ' C' ' 40' ' ' VAL . 92.5 Cg_endo -88.49 159.72 6.6 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.196 1.93 . . . . 73.4 112.855 -172.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -86.44 86.69 7.34 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.011 -1.477 . . . . 74.03 107.011 161.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.42 HG13 ' HG2' ' C' ' 38' ' ' PRO . 15.9 m -65.99 115.03 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 114.411 -1.268 . . . . 73.12 108.593 172.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -127.43 112.35 14.88 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.613 0.765 . . . . 63.53 109.117 -174.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.53 127.68 34.91 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.846 -0.798 . . . . 74.14 108.846 174.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -120.16 135.47 54.96 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.976 1.31 . . . . 74.22 107.91 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.614 HD13 ' HB3' ' G' ' 8' ' ' LEU . 1.8 pt? -122.05 125.81 47.07 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.561 0.696 . . . . 71.52 110.627 -177.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.615 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 2.0 t70 -113.78 143.13 45.15 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.575 -1.268 . . . . 73.02 107.575 171.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 62.1 p -112.4 122.38 47.55 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.325 0.65 . . . . 54.34 109.673 -172.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.647 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -115.02 139.85 49.52 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.696 -0.853 . . . . 53.44 108.696 173.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 15.8 m -141.44 143.18 33.75 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.492 0.717 . . . . 72.23 109.677 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 48.3 t -165.8 128.67 2.08 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.082 0.553 . . . . 73.3 109.775 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -82.3 115.67 21.46 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.064 -1.458 . . . . 74.4 107.064 168.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.496 HD11 HD12 ' C' ' 83' ' ' ILE . 31.4 mt -84.94 -33.85 22.59 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.554 0.741 . . . . 73.34 110.438 -173.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.96 -175.73 5.52 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.45 -1.25 . . . . 34.41 109.681 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -65.98 121.45 15.14 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.927 -1.033 . . . . 73.44 108.968 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 69.75 -5.64 1.18 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.348 1.459 . . . . 65.21 113.288 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 93.1 t -110.8 100.48 10.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 123.652 0.781 . . . . 73.13 109.028 -175.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -105.26 166.25 10.54 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.335 -0.848 . . . . 73.44 109.373 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.471 ' HB2' HD11 ' C' ' 51' ' ' LEU . 37.5 tt0 -127.3 129.66 48.09 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 114.673 -1.149 . . . . 73.43 108.986 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 m -120.56 114.81 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.372 -0.973 . . . . 74.34 108.372 168.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.647 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 57.6 t -111.23 130.92 63.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 123.823 0.849 . . . . 75.41 108.717 176.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mp -112.79 116.59 30.31 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.114 -0.698 . . . . 71.15 109.114 176.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.615 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 19.1 ttm-85 -82.18 106.91 14.46 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.164 -1.05 . . . . 65.32 108.164 171.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 26.4 t -99.12 111.37 28.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.548 -1.279 . . . . 64.22 107.548 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 25.9 m -120.45 121.61 38.9 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.917 -0.772 . . . . 54.4 108.917 -172.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.436 HG21 HG21 ' C' ' 114' ' ' ILE . 74.5 t -98.87 114.58 37.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.905 -0.776 . . . . 73.03 108.905 176.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.5 m -101.1 110.25 22.25 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.586 -0.894 . . . . 62.42 108.586 165.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.01 110.56 21.87 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 105.951 -1.87 . . . . 63.15 105.951 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -132.23 126.62 33.93 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.162 0.506 . . . . 73.15 110.782 -177.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 14.1 mt -86.55 40.44 0.89 Allowed 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 125.741 1.616 . . . . 72.05 110.341 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.24 -101.37 2.14 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 111.467 -0.653 . . . . 63.42 111.467 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -88.33 -30.84 19.28 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.186 0.594 . . . . 52.1 109.847 175.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -79.37 121.28 24.94 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.704 0.802 . . . . 54.24 109.585 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.3 m -82.48 126.7 32.54 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.488 -0.93 . . . . 70.41 108.488 167.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.817 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -69.58 -64.4 0.89 Allowed 'General case' 0 C--O 1.238 0.499 0 O-C-N 124.136 0.897 . . . . 75.32 108.792 175.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -155.35 163.13 40.53 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.804 0.811 . . . . 75.4 111.111 173.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -124.16 102.82 7.91 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 105.719 -1.956 . . . . 71.43 105.719 171.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.421 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.1 t -106.76 151.11 25.58 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 107.742 -1.207 . . . . 54.22 107.742 178.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -158.06 135.89 10.6 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 120.608 0.242 . . . . 72.23 110.489 -173.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' C' ' 110' ' ' ALA . 42.6 t -142.25 114.51 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.52 1.128 . . . . 54.2 108.579 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.718 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 47.1 mt-30 -89.22 91.95 8.98 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.473 -0.936 . . . . 71.25 108.473 169.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.476 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 10.2 tp-100 -80.87 114.61 19.87 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.49 -0.777 . . . . 54.42 109.422 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.86 144.43 16.05 Favored Glycine 0 C--N 1.336 0.538 0 O-C-N 123.808 0.692 . . . . 64.24 111.499 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.427 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -141.76 123.02 2.14 Favored Glycine 0 CA--C 1.5 -0.848 0 N-CA-C 109.657 -1.377 . . . . 74.24 109.657 175.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.496 HD12 HD11 ' C' ' 51' ' ' LEU . 14.1 mm -85.81 123.67 39.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.436 -0.949 . . . . 74.34 108.436 176.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.475 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 59.7 m-85 -130.69 134.15 46.69 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.905 -0.776 . . . . 72.33 108.905 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 20.6 p -89.81 140.71 29.33 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 109.528 -0.545 . . . . 74.12 109.528 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 18.1 tt -137.79 139.08 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.815 0.846 . . . . 52.43 109.14 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -164.25 164.25 22.51 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.387 0.675 . . . . 42.43 109.374 171.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.92 -59.71 2.79 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-N 116.188 -0.46 . . . . 75.34 112.646 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 35.4 pt -91.49 156.26 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.078 0.551 . . . . 73.44 111.204 -173.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -148.78 -176.68 5.43 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.124 0.97 . . . . 72.23 109.385 -177.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.13 -126.42 40.49 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 114.369 0.508 . . . . 32.51 114.369 176.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 38.6 p -79.12 -19.34 51.36 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.617 0.767 . . . . 73.55 111.635 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -62.27 -49.28 76.3 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.784 0.834 . . . . 63.02 109.593 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.418 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 24.3 ptt? -76.15 -28.19 57.31 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 114.665 -1.152 . . . . 74.52 111.006 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.75 -34.17 74.04 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.284 0.633 . . . . 75.21 111.104 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -63.09 -45.1 93.66 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.242 -0.89 . . . . 73.31 110.865 171.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.573 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 47.6 t -66.96 -62.67 1.32 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.763 -0.653 . . . . 65.55 111.084 -174.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.518 HD13 ' H ' ' G' ' 16' ' ' THR . 4.2 pp -71.71 -21.57 61.75 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.234 0.614 . . . . 64.13 112.647 -174.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.05 6.67 43.46 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-O 119.445 -0.642 . . . . 73.12 114.312 -173.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -160.37 -59.4 0.06 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.027 0.913 . . . . 73.52 111.686 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.573 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 15.9 t80 -70.89 -36.25 72.66 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 125.385 1.474 . . . . 74.24 113.0 -167.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.509 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 85.3 m -83.31 -44.06 0.84 Allowed Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 123.249 0.62 . . . . 61.31 111.527 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -53.57 -29.99 52.75 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 122.304 2.003 . . . . 74.43 113.34 165.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -60.07 -36.16 76.74 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.5 1.12 . . . . 71.22 111.1 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 35.1 mm -62.92 -36.18 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 CA-C-N 115.257 -0.883 . . . . 55.2 110.245 175.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.427 HD21 ' HA3' ' C' ' 82' ' ' GLY . 81.1 mt -89.73 -21.24 22.78 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.286 1.217 . . . . 75.11 114.286 -166.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.531 ' HE1' HD22 ' G' ' 8' ' ' LEU . 34.6 m-85 -55.77 -48.16 97.17 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 113.989 1.107 . . . . 71.31 113.989 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.31 -35.39 84.57 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 122.231 1.954 . . . . 73.52 113.272 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -66.78 -48.78 67.96 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.576 0.751 . . . . 74.42 110.79 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.476 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -66.51 -39.92 88.92 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-N 115.898 -0.592 . . . . 72.13 110.859 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -56.73 -52.36 65.3 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.369 1.043 . . . . 71.31 110.42 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -67.95 -35.52 78.54 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.706 0.629 . . . . 74.54 110.141 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.5 t -70.31 -27.52 64.45 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.955 0.502 . . . . 64.54 111.097 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.436 HG21 HG21 ' C' ' 64' ' ' VAL . 85.6 mt -75.64 -55.41 11.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 109.6 -0.518 . . . . 65.33 109.6 172.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.2 m -66.57 -27.78 68.0 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.955 0.902 . . . . 74.5 111.335 -170.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 46.1 t -63.33 -49.43 73.97 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.655 0.782 . . . . 75.21 109.243 169.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.535 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.86 -34.74 78.61 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.255 1.022 . . . . 73.11 112.214 178.588 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.42 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.8 t -62.55 -46.41 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.556 0.743 . . . . 73.21 109.114 175.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 30.9 t -66.03 -34.72 78.73 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.194 -1.366 . . . . 61.52 111.6 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -68.2 -31.71 71.43 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.503 0.721 . . . . 74.13 110.054 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 121' ' ' GLY . . . . . 0.413 ' HA3' ' CE1' ' C' ' 23' ' ' PHE . . . -90.55 10.42 74.63 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.694 0.621 . . . . 73.43 112.839 173.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.491 HG23 ' HB3' ' D' ' 17' ' ' TYR . 62.6 p 56.71 29.27 15.54 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 126.016 1.726 . . . . 75.55 113.941 175.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -88.17 151.73 49.44 Favored Pre-proline 0 N--CA 1.483 1.181 0 C-N-CA 123.357 0.663 . . . . 64.32 109.475 173.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.56 162.98 11.44 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 123.283 2.655 . . . . 75.41 113.98 175.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -52.73 137.53 31.11 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.836 1.254 . . . . 64.24 113.236 -175.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 35.9 tp -150.43 101.53 2.97 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.122 -0.945 . . . . 71.25 109.094 173.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -108.35 133.22 52.85 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.015 0.926 . . . . 60.01 110.142 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.39 138.66 58.6 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.037 0.935 . . . . 73.04 111.705 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.653 ' HB3' ' HB2' ' G' ' 7' ' ' ALA . . . -70.75 147.03 94.15 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.091 0.956 . . . . 53.11 110.559 175.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.548 ' HG3' HD12 ' A' ' 16' ' ' ILE . 10.8 Cg_exo -68.26 93.79 0.41 Allowed 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.468 2.112 . . . . 74.45 111.762 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 p -98.56 110.12 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-O 121.304 0.574 . . . . 74.11 109.649 176.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -113.96 104.03 11.75 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 106.879 -1.526 . . . . 73.51 106.879 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.404 ' CE2' ' HZ ' ' C' ' 107' ' ' PHE . 55.4 m-85 -55.41 -44.35 76.11 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.106 0.879 . . . . 63.1 112.575 -167.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -70.89 -30.65 67.07 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 123.241 0.338 . . . . 70.52 111.352 -176.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.94 -36.52 84.65 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 123.305 0.378 . . . . 62.23 110.316 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 27.7 tp -75.69 -26.9 58.01 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.78 -0.645 . . . . 73.03 110.602 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -74.65 -31.0 61.82 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.067 0.547 . . . . 71.3 111.567 175.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 66.1 mtt -76.34 -40.37 51.46 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.202 0.601 . . . . 45.05 109.75 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -61.97 -37.48 84.93 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.815 1.246 . . . . 61.54 110.56 173.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -69.09 -83.53 0.03 OUTLIER 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.309 1.044 . . . . 71.21 110.04 174.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 tm? 68.67 -71.89 0.11 Allowed 'General case' 0 C--N 1.363 1.177 0 C-N-CA 125.394 1.477 . . . . 75.42 109.055 -172.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -162.45 -69.66 0.05 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.126 -1.065 . . . . 74.41 108.126 174.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -149.88 74.01 1.19 Allowed 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.52 -1.289 . . . . 75.41 107.52 174.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -78.79 82.51 5.0 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 114.746 -1.115 . . . . 70.24 109.653 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.96 137.32 38.97 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.986 -1.006 . . . . 64.14 111.73 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 146' ' ' GLY . . . . . 0.481 ' HA3' ' HB ' ' A' ' 7' ' ' THR . . . -169.61 -162.77 22.48 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 115.679 -0.691 . . . . 44.44 112.014 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -113.53 133.62 55.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.931 0.892 . . . . 74.43 109.523 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -108.5 102.88 1.77 Allowed Glycine 0 C--N 1.343 0.966 0 N-CA-C 111.184 -0.766 . . . . 54.21 111.184 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 26.9 m -65.45 97.05 0.27 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.011 0.924 . . . . 73.32 110.987 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -82.85 154.26 24.75 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.766 0.827 . . . . 74.31 110.375 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -174.82 155.05 2.03 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.608 0.763 . . . . 75.21 109.571 177.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -90.52 148.68 22.57 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.517 0.727 . . . . 44.11 110.224 175.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 153' ' ' GLN . . . . . 0.451 ' HG3' HG11 ' A' ' 55' ' ' VAL . 2.0 mp0 -103.0 135.38 44.8 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.609 1.163 . . . . 74.54 108.363 173.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -72.57 -30.17 64.17 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 109.783 -0.451 . . . . 75.54 109.783 168.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.246 0 O-C-N 124.961 1.413 . . . . 75.5 109.247 -172.938 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 120.434 0.159 . . . . 61.3 110.731 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 21.6 m -135.96 82.73 1.96 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.404 0.682 . . . . 62.14 109.338 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -114.58 94.45 4.79 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.602 0.761 . . . . 55.1 109.465 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 4' ' ' GLN . . . . . 0.539 ' HB2' ' HB2' ' D' ' 93' ' ' GLN . 25.1 mp0 -105.36 116.53 32.1 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.873 0.869 . . . . 71.45 108.787 177.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -100.44 122.25 42.88 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.147 -0.686 . . . . 62.31 109.147 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -154.68 109.3 3.01 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 109.661 -0.496 . . . . 64.35 109.661 -175.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 25.3 m -99.61 -29.21 12.82 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.874 0.87 . . . . 62.12 111.036 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.11 -18.45 60.84 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.678 0.791 . . . . 75.32 111.155 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.533 ' HG2' HG12 ' D' ' 89' ' ' ILE . 1.5 tmt? -28.76 127.19 0.09 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.956 2.102 . . . . 74.42 112.598 162.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 29.9 m -106.28 142.73 35.47 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 123.613 0.765 . . . . 71.22 110.204 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -155.85 98.85 1.94 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.608 -1.256 . . . . 75.23 107.608 -177.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 12' ' ' GLN . . . . . 0.51 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 49.6 mt-30 -113.46 118.85 35.65 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.74 -0.837 . . . . 74.41 108.74 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.489 HG21 ' HG2' ' B' ' 130' ' ' PRO . 38.0 mt -67.7 123.82 21.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 122.673 0.389 . . . . 64.12 110.14 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -96.92 -45.43 6.62 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 123.467 0.479 . . . . 71.51 110.358 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -167.55 131.36 1.77 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 119.417 -0.325 . . . . 74.14 110.908 -169.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.664 HD13 ' HG3' ' B' ' 130' ' ' PRO . 3.1 mp -115.28 138.28 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 107.7 -1.222 . . . . 60.04 107.7 169.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.491 ' HB3' HG23 ' C' ' 122' ' ' THR . 41.8 p90 -165.79 176.27 8.08 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 124.293 0.995 . . . . 71.44 111.142 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 18' ' ' THR . . . . . 0.406 HG21 HD11 ' D' ' 21' ' ' ILE . 80.4 p -106.71 122.95 47.38 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.573 -1.194 . . . . 72.2 109.356 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.425 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 32.8 mtpt -94.23 -24.41 17.48 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.675 -0.693 . . . . 64.34 109.753 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.6 t70 -152.52 133.28 13.98 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 114.527 -1.215 . . . . 51.44 108.632 176.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.535 HG21 ' HE2' ' C' ' 117' ' ' MET . 80.6 mt -131.07 147.59 33.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.155 -1.424 . . . . 71.13 107.155 172.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 22' ' ' SER . . . . . 0.54 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 34.6 t -150.49 140.36 21.87 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.789 1.236 . . . . 74.1 107.936 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.506 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.5 t80 -152.84 125.92 8.53 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 105.706 -1.961 . . . . 73.32 105.706 171.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 37.0 mt-10 -137.34 111.63 8.52 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.129 0.572 . . . . 70.13 109.644 -175.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.25 85.38 10.43 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 108.396 -0.965 . . . . 64.12 108.396 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.09 -21.12 12.38 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 122.844 2.362 . . . . 74.11 112.697 -173.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -102.64 0.84 33.83 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.786 0.834 . . . . 75.34 110.675 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -28.66 -64.88 0.16 Allowed Pre-proline 0 CA--C 1.565 1.529 0 N-CA-C 116.392 1.997 . . . . 71.32 116.392 -158.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.46 -22.41 10.83 Favored 'Trans proline' 0 C--N 1.383 2.391 0 CA-C-N 123.091 2.14 . . . . 65.01 113.907 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -69.05 -42.67 75.97 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.266 1.027 . . . . 54.42 109.75 174.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.2 p -83.17 -19.88 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 CA-C-N 115.829 -0.623 . . . . 71.43 111.404 -172.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -63.36 -26.49 68.78 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 112.454 0.539 . . . . 75.21 112.454 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -58.69 -20.59 49.86 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.627 0.771 . . . . 72.23 110.784 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.44 ' NZ ' ' HB3' ' D' ' 71' ' ' GLU . 92.2 mttt -90.52 87.39 6.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.277 1.031 . . . . 54.34 108.63 166.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -97.17 82.13 3.14 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.383 0.611 . . . . 74.14 110.15 -173.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 38.9 p90 -156.94 -174.21 4.82 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.736 1.214 . . . . 75.42 108.691 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -69.13 114.46 23.63 Favored Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 123.976 0.91 . . . . 72.33 111.108 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.59 127.99 18.25 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.553 2.169 . . . . 74.52 111.847 171.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -75.66 134.99 40.45 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.304 -0.628 . . . . 74.33 109.304 177.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.578 HG13 HG13 ' D' ' 64' ' ' VAL . 74.1 t -102.23 132.81 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.889 0.876 . . . . 65.03 111.306 -174.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.459 ' HB2' ' OG1' ' D' ' 65' ' ' THR . 74.6 mmtt -98.2 130.38 44.94 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.915 -1.143 . . . . 72.53 107.915 168.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' H' ' 6' ' ' ILE . 3.0 tm? -96.69 126.08 41.6 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.544 0.738 . . . . 74.3 109.403 -175.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.808 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 22.4 m-20 -127.66 142.85 51.23 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.136 0.974 . . . . 72.21 108.402 171.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 89.9 mt -129.69 143.26 50.74 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.588 0.755 . . . . 53.43 109.998 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 9.9 t70 -141.36 144.76 34.72 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.209 1.004 . . . . 54.42 108.53 175.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 35.9 p -104.26 143.53 32.83 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.532 0.733 . . . . 52.24 111.327 -173.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.656 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.92 141.74 22.83 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.898 0.879 . . . . 70.11 108.771 171.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.1 p -166.42 154.27 10.07 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.92 0.488 . . . . 61.11 109.795 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 60.2 p -164.04 142.56 7.45 Favored 'General case' 0 C--O 1.24 0.558 0 O-C-N 123.877 0.736 . . . . 64.43 110.224 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -76.36 126.02 30.24 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.104 -0.702 . . . . 54.11 109.104 168.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 73.9 mt -97.45 -30.73 12.74 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.25 0.62 . . . . 64.12 110.55 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.23 -175.06 2.81 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.693 0.797 . . . . 71.54 110.53 177.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -61.9 116.44 4.87 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.821 -1.081 . . . . 73.22 110.087 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 64.41 9.86 5.29 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.926 1.29 . . . . 63.32 112.48 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.7 t -109.73 114.98 48.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 108.157 -1.053 . . . . 73.34 108.157 173.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.483 ' HB2' HD12 ' D' ' 86' ' ' ILE . 72.7 m-85 -134.69 133.08 39.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.509 -0.923 . . . . 73.53 108.509 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -104.55 136.86 43.31 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.844 0.858 . . . . 72.43 109.322 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 38.2 t -121.69 129.21 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 107.737 -1.209 . . . . 64.13 107.737 174.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.656 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 20.4 t -121.56 132.07 71.59 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 C-N-CA 124.221 1.008 . . . . 71.04 108.674 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.59 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 3.9 mm? -119.09 120.2 36.47 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.305 0.642 . . . . 75.32 109.767 176.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.577 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 18.9 ttm-85 -88.67 101.25 13.8 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.404 -0.816 . . . . 71.14 108.82 173.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 55.1 t -90.99 126.37 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 107.574 -1.269 . . . . 52.25 107.574 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.808 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 9.3 m -122.57 125.7 46.23 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.761 0.791 . . . . 71.34 109.983 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.578 HG13 HG13 ' D' ' 40' ' ' VAL . 25.3 t -111.09 99.43 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.959 1.704 . . . . 72.44 108.137 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.47 HG22 HD22 ' D' ' 75' ' ' LEU . 1.8 p -99.64 94.98 6.66 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 107.887 -1.153 . . . . 73.31 107.887 174.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.23 155.62 16.66 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.935 -1.03 . . . . 42.52 111.141 -170.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.49 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.5 p -153.58 132.45 12.41 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.713 -0.676 . . . . 64.11 111.932 -176.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.521 HD12 HG22 ' D' ' 31' ' ' VAL . 24.9 mt -93.74 99.18 11.63 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 124.893 1.277 . . . . 50.14 108.856 172.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.37 -119.86 7.4 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.129 -0.941 . . . . 74.22 112.015 -174.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.77 5.4 49.22 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.428 1.091 . . . . 60.51 111.241 -177.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 71' ' ' GLU . . . . . 0.44 ' HB3' ' NZ ' ' D' ' 34' ' ' LYS . 5.5 tp10 -129.08 139.72 51.88 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.063 0.945 . . . . 63.41 109.513 -169.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.4 m -61.55 128.59 37.02 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.809 0.843 . . . . 73.25 111.471 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.527 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -83.95 -70.42 0.57 Allowed 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.838 -1.171 . . . . 73.24 107.838 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -146.33 166.74 25.41 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.623 -1.171 . . . . 70.1 109.025 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.47 HD22 HG22 ' D' ' 65' ' ' THR . 48.2 mt -116.24 151.17 36.3 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 105.842 -1.91 . . . . 72.34 105.842 171.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.48 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 50.3 t -157.1 140.23 15.44 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.247 -1.02 . . . . 71.42 108.247 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 77' ' ' GLU . . . . . 0.54 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 36.7 tt0 -156.75 131.11 8.61 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 122.853 0.461 . . . . 72.52 109.839 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -136.81 118.55 19.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 123.337 0.655 . . . . 65.13 109.742 -177.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.513 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.2 mt-30 -86.41 87.13 7.37 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.811 -1.181 . . . . 74.23 107.811 166.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 80' ' ' GLN . . . . . 0.442 ' O ' HD13 ' D' ' 106' ' ' LEU . 8.5 tp-100 -79.9 105.2 11.01 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.279 -1.328 . . . . 70.23 107.698 176.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -110.45 143.69 16.96 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.854 -0.498 . . . . 74.22 111.854 -177.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.49 131.43 5.51 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 111.371 -0.691 . . . . 63.32 111.371 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 60.4 mt -89.32 128.42 41.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 C-N-CA 124.497 1.119 . . . . 74.32 107.985 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -136.79 145.66 44.8 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.883 0.373 . . . . 73.42 110.876 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.51 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 16.6 m -78.04 99.47 6.11 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.274 -1.009 . . . . 63.13 108.274 166.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.483 HD12 ' HB2' ' D' ' 56' ' ' TYR . 66.1 mt -107.22 108.6 25.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 123.867 0.867 . . . . 72.05 108.845 -175.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.52 163.77 34.67 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.545 1.138 . . . . 64.41 109.786 -175.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.71 20.82 79.82 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.693 -0.685 . . . . 72.24 114.373 173.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.533 HG12 ' HG2' ' D' ' 9' ' ' MET . 6.0 mt -104.6 156.88 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 117.374 0.587 . . . . 70.53 110.386 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -140.22 147.62 40.3 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.431 1.092 . . . . 70.21 111.118 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.84 -136.11 48.93 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 115.216 0.847 . . . . 43.42 115.216 169.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 16.0 m -85.67 -9.17 57.63 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.911 0.885 . . . . 62.22 111.554 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.539 ' HB2' ' HB2' ' D' ' 4' ' ' GLN . 0.0 OUTLIER -53.05 -31.1 39.62 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.673 -0.862 . . . . 45.03 108.673 166.147 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.46 ' HB3' ' H ' ' H' ' 18' ' ' VAL . 51.9 mtt -57.32 -55.24 37.31 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.975 0.91 . . . . 73.34 111.357 172.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 95' ' ' ALA . . . . . 0.469 ' HB1' HD22 ' H' ' 14' ' ' LEU . . . -63.3 -29.66 70.94 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.417 0.687 . . . . 65.15 111.516 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -72.4 -40.71 66.98 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.06 0.944 . . . . 63.15 111.139 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.0 t -64.18 -49.56 71.57 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.364 0.666 . . . . 62.51 109.916 -176.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 34.0 mt -75.53 -26.94 58.46 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.275 -1.329 . . . . 74.32 110.914 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.01 -2.5 58.2 Favored Glycine 0 C--N 1.352 1.461 0 CA-C-O 119.368 -0.685 . . . . 63.25 114.399 -176.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.71 -58.98 0.57 Allowed 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 117.905 0.853 . . . . 51.25 111.338 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -71.11 -38.22 72.34 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 111.841 0.311 . . . . 61.31 111.841 -170.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 62.2 m -72.8 -47.98 8.61 Favored Pre-proline 0 CA--C 1.559 1.316 0 CA-C-O 118.576 -0.726 . . . . 63.34 111.776 -177.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.59 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 17.1 Cg_endo -61.5 -22.59 74.88 Favored 'Trans proline' 0 C--N 1.401 3.31 0 C-N-CA 122.27 1.98 . . . . 74.42 112.875 170.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -66.96 -37.46 84.31 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.223 0.609 . . . . 73.25 110.266 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 48.9 mm -71.08 -39.14 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.501 0.72 . . . . 65.11 110.333 175.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.442 HD13 ' O ' ' D' ' 80' ' ' GLN . 86.7 mt -79.28 -18.64 52.29 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.33 -0.85 . . . . 64.1 111.876 -177.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -61.21 -50.1 85.4 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-O 117.87 -1.062 . . . . 72.22 113.487 -175.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.78 -38.99 93.74 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 122.116 1.877 . . . . 42.24 112.667 178.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -78.17 -36.96 46.9 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.087 0.955 . . . . 60.41 112.26 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.79 73.84 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.046 0.539 . . . . 75.35 109.952 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.584 HH12 ' HG3' ' D' ' 130' ' ' PRO . 40.1 ttp180 -57.27 -51.48 69.17 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 124.164 0.915 . . . . 75.13 110.097 174.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -62.54 -43.82 97.87 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.719 0.807 . . . . 73.23 111.729 -174.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.8 t -58.78 -45.51 89.67 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.809 0.693 . . . . 62.51 110.779 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.463 ' O ' HG23 ' D' ' 118' ' ' VAL . 97.5 mt -62.55 -55.14 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.883 -1.053 . . . . 72.4 110.586 174.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 43.5 m -53.24 -40.06 64.29 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.849 1.26 . . . . 71.1 111.449 -174.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.4 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.0 t -66.36 -45.15 81.09 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.729 -1.123 . . . . 65.01 110.439 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.1 mtm -70.01 -28.54 65.58 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.781 0.432 . . . . 64.51 112.08 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.463 HG23 ' O ' ' D' ' 114' ' ' ILE . 96.0 t -64.85 -44.86 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.395 0.678 . . . . 74.55 109.633 174.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.8 p -77.3 -25.42 51.26 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 115.444 -0.798 . . . . 73.44 111.007 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' D' ' 116' ' ' SER . 91.0 mtt-85 -72.69 -35.22 67.59 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.438 0.695 . . . . 62.51 109.538 173.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.48 -0.14 86.42 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 115.644 -0.707 . . . . 64.42 112.122 171.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 42.6 p 62.97 22.02 13.22 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.938 2.095 . . . . 62.03 113.972 174.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -82.23 152.07 67.26 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 123.545 0.738 . . . . 75.42 109.286 169.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -49.59 132.2 29.91 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.372 2.715 . . . . 74.24 113.934 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -51.43 141.02 16.4 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.651 1.58 . . . . 63.25 113.002 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 62.5 tp -114.48 109.58 18.51 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.224 1.01 . . . . 74.5 109.577 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -113.62 97.14 6.25 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.645 -0.872 . . . . 75.41 108.645 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 20.1 tp -70.85 126.59 29.99 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 110.008 -0.367 . . . . 55.41 110.008 177.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -62.09 130.26 92.67 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.079 0.952 . . . . 72.11 110.676 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.584 ' HG3' HH12 ' D' ' 111' ' ' ARG . 2.4 Cg_endo -79.74 106.02 1.91 Allowed 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.657 2.238 . . . . 62.33 110.181 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 35.9 m -107.01 149.44 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 109.281 -0.637 . . . . 73.1 109.281 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -80.29 75.34 7.11 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.613 0.721 . . . . 71.21 109.181 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.416 ' HD2' ' HB2' ' H' ' 9' ' ' ALA . 37.6 p90 -73.62 -24.42 60.02 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.855 0.862 . . . . 71.14 110.95 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' D' ' 138' ' ' MET . 4.3 m-20 -51.77 -50.63 60.31 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.648 1.579 . . . . 63.21 111.868 176.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.0 -45.26 94.38 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.601 0.76 . . . . 31.34 111.663 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 51.7 tp -63.7 -34.96 79.04 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.379 0.671 . . . . 54.33 110.817 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -70.82 -30.05 66.38 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.684 0.793 . . . . 51.3 110.789 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.441 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 45.1 mtt -62.85 -30.69 71.69 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.573 0.749 . . . . 74.22 111.102 176.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -77.85 -20.05 53.77 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.993 0.917 . . . . 54.12 111.738 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -62.97 -37.2 86.14 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.87 0.868 . . . . 62.13 110.399 174.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.9 mp -65.43 -30.67 71.5 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.026 0.931 . . . . 70.35 110.648 175.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -86.14 0.76 52.82 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.104 -0.953 . . . . 74.4 112.101 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -135.16 47.39 2.34 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.578 0.704 . . . . 73.0 109.65 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -151.57 127.64 10.43 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.091 -0.958 . . . . 74.11 109.249 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.56 -23.35 62.59 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.506 0.722 . . . . 61.33 111.612 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 75.88 18.4 79.58 Favored Glycine 0 C--N 1.351 1.404 0 CA-C-N 115.992 -0.549 . . . . 35.12 112.119 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -89.04 171.53 9.78 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.805 0.842 . . . . 74.45 109.948 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 147.5 116.55 0.93 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 111.314 -0.714 . . . . 53.33 111.314 177.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 7.7 t -64.34 135.86 56.58 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 123.194 0.598 . . . . 43.14 110.632 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -87.26 71.89 9.95 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.852 0.834 . . . . 53.43 108.802 175.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -146.63 135.93 22.77 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.01 -1.45 . . . . 53.23 107.964 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -159.05 82.89 0.79 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.416 -0.957 . . . . 75.35 108.416 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -70.85 -41.08 71.92 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.992 -1.003 . . . . 73.35 110.518 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -74.26 136.85 42.69 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.501 0.72 . . . . 65.53 110.096 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 N-CA-C 108.394 -0.965 . . . . 51.15 108.394 179.655 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' E' E ' 1' ' ' MET . . . . . 0.422 ' SD ' ' N ' ' E' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 110.117 -0.327 . . . . 75.15 110.117 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 2' ' ' LYS . . . . . 0.493 ' HB3' ' HD1' ' A' ' 36' ' ' TRP . 37.9 ttmt -75.57 135.81 40.55 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.572 0.749 . . . . 73.34 110.337 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -73.84 149.13 41.79 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.163 -0.68 . . . . 73.1 109.163 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 22.4 p -136.99 155.05 50.2 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.85 0.86 . . . . 61.02 109.69 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 13.2 t -139.57 158.63 43.8 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.63 0.372 . . . . 73.35 110.989 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.64 HD13 HG21 ' A' ' 64' ' ' VAL . 18.6 mt -109.33 87.31 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.447 1.099 . . . . 75.44 109.041 -176.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.86 91.39 1.51 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.285 0.564 . . . . 70.01 110.643 -176.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.417 HD21 HD21 ' A' ' 44' ' ' LEU . 8.7 tt -89.8 147.17 23.96 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.754 1.221 . . . . 73.45 109.804 -175.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -101.02 -84.33 0.44 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.577 0.751 . . . . 62.21 111.244 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 27.7 mt -154.1 -170.56 3.59 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 124.404 1.082 . . . . 54.52 111.077 -176.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.505 HD23 ' HE2' ' A' ' 137' ' ' PHE . 3.6 mm? -74.21 158.94 84.9 Favored Pre-proline 0 CA--C 1.562 1.412 0 C-N-CA 124.22 1.008 . . . . 55.42 109.483 171.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.83 -24.48 79.2 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.971 2.447 . . . . 73.11 113.283 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 tt -162.27 -75.66 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 107.41 -1.329 . . . . 73.14 107.41 175.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 86.2 mt -130.61 -160.34 1.03 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.001 1.32 . . . . 64.14 108.715 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -125.8 159.72 31.68 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 107.925 -1.139 . . . . 72.23 107.925 175.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 43.8 m -59.1 133.36 87.54 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 123.928 0.891 . . . . 64.04 111.044 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 17' ' ' PRO . . . . . 0.735 ' HA ' HD22 ' A' ' 98' ' ' LEU . 39.2 Cg_endo -64.43 147.26 90.58 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.714 2.276 . . . . 63.24 113.174 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 18' ' ' VAL . . . . . 0.682 HG23 ' HB3' ' A' ' 98' ' ' LEU . 85.7 t -74.76 -76.19 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 123.252 0.621 . . . . 64.43 109.341 175.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 19' ' ' THR . . . . . 0.598 HG22 HG12 ' E' ' 18' ' ' VAL . 5.0 t -156.02 124.96 6.04 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.86 0.464 . . . . 73.54 110.036 -178.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 20' ' ' LYS . . . . . 0.437 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 50.3 tptt 76.1 -36.14 0.27 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.178 1.391 . . . . 72.12 112.739 173.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.82 93.11 0.05 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.967 0.907 . . . . 60.15 111.223 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 55.9 ttt85 -95.07 133.1 39.24 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.328 1.051 . . . . 73.32 109.145 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 13.7 t -63.39 143.29 97.83 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-O 118.11 -0.947 . . . . 63.44 109.288 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -36.52 120.6 0.25 Allowed 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 124.326 3.35 . . . . 72.33 114.136 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 . . . . . 0 C--O 1.251 1.157 0 O-C-N 124.264 0.978 . . . . 53.22 111.395 -173.073 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 110.161 -0.311 . . . . 75.15 110.161 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 68.38 6.86 5.6 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.424 1.49 . . . . 75.22 112.986 174.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 62.69 -69.79 0.06 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.657 1.583 . . . . 74.42 111.83 -175.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 19.5 t 64.54 80.73 0.22 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.64 1.176 . . . . 61.43 110.744 173.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 89.9 m -80.94 120.16 24.4 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.915 0.886 . . . . 73.1 109.784 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.483 HG12 HD23 ' B' ' 42' ' ' LEU . 19.2 tt -75.38 133.12 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 122.815 0.446 . . . . 73.32 111.003 -178.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 7' ' ' ALA . . . . . 0.573 ' HB2' ' HB3' ' B' ' 129' ' ' ALA . . . -163.02 172.24 15.28 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.655 0.782 . . . . 62.43 110.467 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 8' ' ' LEU . . . . . 0.809 HD23 HD21 ' B' ' 44' ' ' LEU . 4.2 mp -95.7 -177.05 3.92 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.251 1.021 . . . . 51.2 108.626 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -154.42 -169.89 3.37 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.527 0.331 . . . . 63.13 111.545 -173.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 10' ' ' LEU . . . . . 0.411 ' O ' ' HD3' ' F' ' 12' ' ' PRO . 6.3 tt -56.96 130.03 44.23 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.377 1.071 . . . . 75.1 108.147 170.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 82.5 mt -102.78 99.47 13.69 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.384 0.674 . . . . 72.41 109.986 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 12' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' F' ' 10' ' ' LEU . 13.9 Cg_exo -70.43 -16.84 34.8 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 122.685 2.257 . . . . 71.33 111.561 175.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 88.1 mt -58.09 -34.66 70.41 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 124.064 0.946 . . . . 61.45 110.993 175.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 90.0 mt 61.19 -171.38 0.15 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.686 1.194 . . . . 71.32 111.474 -176.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -167.1 92.94 0.43 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.081 -1.081 . . . . 74.21 108.081 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 68.2 p -129.95 73.63 81.25 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 123.791 0.837 . . . . 74.33 110.534 -177.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -94.75 9.2 1.94 Allowed 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.696 2.264 . . . . 74.42 112.382 176.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 18' ' ' VAL . . . . . 0.461 HG12 ' H ' ' F' ' 20' ' ' LYS . 33.6 t -93.49 -88.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.56 0 C-N-CA 123.061 0.544 . . . . 72.15 110.732 -171.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 9.0 m 67.8 -5.38 0.83 Allowed 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 124.791 1.237 . . . . 74.43 112.504 -176.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 20' ' ' LYS . . . . . 0.461 ' H ' HG12 ' F' ' 18' ' ' VAL . 48.7 pttt -159.75 77.66 0.68 Allowed 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.881 0.872 . . . . 62.42 110.276 -177.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 21' ' ' ALA . . . . . 0.4 ' HB1' ' HA ' ' B' ' 87' ' ' ALA . . . -117.52 99.12 6.77 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 107.799 -1.185 . . . . 71.13 107.799 168.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 22' ' ' ARG . . . . . 0.491 ' HG3' ' HD3' ' F' ' 24' ' ' PRO . 22.5 ptt180 -109.88 -179.03 3.68 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.926 0.891 . . . . 64.42 111.315 -167.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 85.1 m -138.19 99.68 8.88 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 106.577 -1.638 . . . . 72.54 106.577 164.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 24' ' ' PRO . . . . . 0.491 ' HD3' ' HG3' ' F' ' 22' ' ' ARG . 71.9 Cg_endo -76.7 67.13 7.38 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.781 2.321 . . . . 73.23 111.746 178.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 . . . . . 0 C--O 1.246 0.906 0 N-CA-C 107.231 -1.396 . . . . 61.51 107.231 -177.838 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 20.2 mmt . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 109.128 -0.693 . . . . 42.03 109.128 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt 69.0 26.38 5.68 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.301 1.441 . . . . 72.43 112.759 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -77.64 88.95 3.93 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.207 0.527 . . . . 74.42 110.16 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 17.5 m -85.06 -5.95 59.33 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.646 -0.706 . . . . 74.22 110.326 170.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 5' ' ' THR . . . . . 0.485 HG22 ' HB2' ' C' ' 129' ' ' ALA . 2.9 m -61.11 104.68 0.4 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.833 1.253 . . . . 61.43 110.025 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 pp -70.83 157.07 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 123.278 0.631 . . . . 61.42 112.351 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 7' ' ' ALA . . . . . 0.653 ' HB2' ' HB3' ' C' ' 129' ' ' ALA . . . -166.78 -165.48 0.74 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.063 0.945 . . . . 71.45 109.68 -176.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 8' ' ' LEU . . . . . 0.614 ' HB3' HD13 ' C' ' 44' ' ' LEU . 6.7 mp -69.78 -35.71 75.11 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.623 0.769 . . . . 71.14 110.817 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . 63.78 -77.44 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.461 1.504 . . . . 71.34 113.279 174.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 97.2 mt -124.51 148.4 47.76 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.413 1.085 . . . . 71.12 109.978 -176.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 11' ' ' LEU . . . . . 0.401 HD23 HD12 ' C' ' 44' ' ' LEU . 60.1 mt -82.37 122.5 79.12 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 123.218 0.607 . . . . 72.04 109.788 173.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.04 1.67 9.05 Favored 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 122.294 1.996 . . . . 74.52 113.098 171.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 52.4 tp -157.08 133.01 9.51 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.363 0.665 . . . . 61.31 109.629 173.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 93.7 mt -82.19 127.48 33.2 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.273 -1.01 . . . . 71.12 108.273 172.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -57.95 -58.75 7.03 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.845 0.858 . . . . 70.31 111.775 -175.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 16' ' ' THR . . . . . 0.518 ' H ' HD13 ' C' ' 98' ' ' LEU . 81.1 p 41.59 53.41 7.29 Favored Pre-proline 0 CA--C 1.57 1.742 0 C-N-CA 125.905 1.682 . . . . 73.2 114.615 177.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 17' ' ' PRO . . . . . 0.411 ' HD2' HG23 ' G' ' 18' ' ' VAL . 37.4 Cg_endo -96.59 26.44 0.24 Allowed 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 123.088 2.525 . . . . 75.32 112.176 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 18' ' ' VAL . . . . . 0.411 HG23 ' HD2' ' G' ' 17' ' ' PRO . 38.2 t -117.78 -75.81 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 123.963 0.905 . . . . 71.4 108.814 -177.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 16.2 p -139.75 -165.33 1.86 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.745 1.218 . . . . 71.44 109.453 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.28 122.66 26.61 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.194 0.597 . . . . 74.51 109.71 175.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.7 2.98 31.02 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.589 0.755 . . . . 75.02 112.747 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -140.89 142.52 34.46 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.429 0.692 . . . . 72.43 109.484 176.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 37.6 p -90.56 133.7 32.26 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 108.09 -1.078 . . . . 74.1 108.09 167.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -47.32 -61.15 0.65 Allowed 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.153 2.569 . . . . 74.43 112.888 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 108.157 -1.053 . . . . 71.53 108.157 176.289 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 110.082 -0.34 . . . . 60.23 110.082 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.07 102.04 5.53 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.749 -0.834 . . . . 61.35 108.749 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -73.53 88.31 1.64 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.698 0.799 . . . . 71.24 109.307 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 20.2 m -80.73 99.98 8.5 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.164 -0.925 . . . . 75.52 110.783 -174.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 63.1 m -156.35 -58.68 0.09 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.763 1.225 . . . . 74.32 107.717 172.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.562 ' HA ' ' HB2' ' D' ' 42' ' ' LEU . 9.4 tt -149.14 102.43 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 CA-C-N 114.522 -1.217 . . . . 70.4 107.877 175.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 7' ' ' ALA . . . . . 0.487 ' H ' ' HG ' ' D' ' 42' ' ' LEU . . . -108.74 174.53 5.83 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.281 1.033 . . . . 72.41 112.561 -167.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 94.4 mt -129.06 167.0 18.16 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.148 1.379 . . . . 61.31 108.734 173.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 9' ' ' ALA . . . . . 0.416 ' HB2' ' HD2' ' D' ' 133' ' ' PHE . . . 63.12 -168.32 0.2 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.436 1.094 . . . . 73.41 111.148 -173.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 82.5 mt 61.82 24.31 14.45 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.071 0.948 . . . . 72.31 111.257 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.531 HD22 HD11 ' D' ' 60' ' ' LEU . 2.0 pp -69.99 146.45 95.14 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 124.711 1.204 . . . . 74.12 110.83 -176.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -28.82 96.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.395 3.018 1 C-N-CA 125.707 4.272 . . . . 74.32 116.164 -173.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 57.53 -94.47 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.778 1.631 . . . . 74.34 109.93 -178.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 14' ' ' LEU . . . . . 0.469 HD22 ' HB1' ' D' ' 95' ' ' ALA . 67.2 mt -155.73 161.54 40.69 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.815 1.646 . . . . 71.32 108.029 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -82.67 6.05 19.17 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 118.629 -0.7 . . . . 71.41 112.084 174.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 47.4 m 72.2 138.62 0.06 OUTLIER Pre-proline 0 CA--C 1.565 1.53 0 C-N-CA 124.613 1.165 . . . . 73.21 110.881 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.33 148.84 24.46 Favored 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 122.623 2.215 . . . . 74.55 112.808 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 18' ' ' VAL . . . . . 0.46 ' H ' ' HB3' ' D' ' 94' ' ' MET . 76.3 t -61.66 -29.88 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 125.191 1.396 . . . . 64.23 111.892 -176.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 17.2 m -59.35 -37.53 78.11 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.742 0.817 . . . . 72.52 111.194 172.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -107.11 4.3 26.72 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.787 1.235 . . . . 74.51 111.98 -175.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.53 74.71 6.18 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.825 0.821 . . . . 71.24 110.318 -176.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 41.2 ttp85 -169.61 129.96 1.04 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.287 1.435 . . . . 75.15 107.241 -175.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 14.1 m 55.97 62.73 6.67 Favored Pre-proline 0 CA--C 1.57 1.74 0 C-N-CA 124.087 0.955 . . . . 75.01 110.886 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -89.38 12.33 2.69 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 122.929 2.419 . . . . 73.22 113.244 -176.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 . . . . . 0 CA--C 1.55 0.971 0 C-N-CA 123.474 0.709 . . . . 71.55 109.151 177.399 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.9 mtm . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 109.976 -0.379 . . . . 75.43 109.976 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.6 t -141.13 100.76 3.88 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.996 0.918 . . . . 63.34 108.907 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -120.12 35.97 4.69 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 108.573 -0.899 . . . . 63.02 108.573 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 65.03 175.48 0.2 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.753 1.221 . . . . 63.41 111.402 -173.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.567 ' HA ' ' HB3' ' C' ' 145' ' ' ALA . 61.0 t30 -144.37 91.69 2.22 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.426 0.631 . . . . 71.34 111.113 -175.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -126.79 99.04 5.59 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 106.608 -1.627 . . . . 71.11 106.608 164.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.0 p -72.6 -62.9 1.28 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.589 -0.732 . . . . 62.5 110.663 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -141.0 -63.81 0.46 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.946 0.898 . . . . 72.33 108.708 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.442 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 15.0 tpt -91.42 147.81 22.76 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.887 0.875 . . . . 62.15 108.86 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -141.82 145.56 34.85 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.845 0.858 . . . . 71.14 110.31 -174.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.699 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 8.4 t80 -137.99 134.86 35.37 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.668 0.787 . . . . 70.34 110.917 -168.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -147.16 108.84 4.35 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.788 0.835 . . . . 73.11 109.412 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.61 HG12 ' HD2' ' A' ' 84' ' ' PHE . 66.7 mt -78.61 124.04 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 109.494 -0.558 . . . . 62.21 109.494 176.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -84.69 -40.05 17.83 Favored 'General case' 0 C--O 1.241 0.639 0 O-C-N 124.192 0.933 . . . . 62.53 110.667 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.417 ' HB3' HD12 ' A' ' 83' ' ' ILE . 23.7 ttt180 -173.35 137.41 0.66 Allowed 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.526 0.516 . . . . 61.34 110.179 -172.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.436 HD11 HD13 ' A' ' 13' ' ' ILE . 83.5 mt -126.2 138.81 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.321 -0.992 . . . . 73.42 108.321 174.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.481 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 21.1 p90 -168.25 168.85 11.26 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.627 0.727 . . . . 73.04 111.599 -173.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -94.52 120.37 34.64 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.104 -0.953 . . . . 60.31 109.143 176.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 38.2 mtpt -91.34 -30.24 16.67 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.891 0.376 . . . . 74.35 110.635 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 18.8 t70 -148.34 134.39 19.23 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.229 -0.896 . . . . 73.24 109.141 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.411 HG23 ' SD ' ' A' ' 117' ' ' MET . 60.0 mt -132.17 139.31 50.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.061 -1.459 . . . . 60.33 107.061 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.1 t -146.49 122.15 10.49 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.693 -0.854 . . . . 61.4 108.693 173.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.468 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 93.5 t80 -126.0 129.56 49.45 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.699 -1.593 . . . . 73.34 106.699 171.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -139.74 119.31 13.12 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.676 -0.861 . . . . 74.33 108.676 -178.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.38 83.53 8.58 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 106.987 -1.486 . . . . 63.54 106.987 173.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.93 -30.24 67.22 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.916 2.41 . . . . 75.12 112.637 -167.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -117.47 26.45 9.72 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 124.145 0.978 . . . . 72.13 109.45 -174.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.565 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -45.62 -56.34 10.14 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 114.116 1.154 . . . . 74.34 114.116 -169.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 22.3 Cg_exo -64.16 -19.9 66.57 Favored 'Trans proline' 0 C--N 1.385 2.486 0 CA-C-N 121.62 1.614 . . . . 65.53 113.392 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -90.15 -38.19 13.67 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.235 1.014 . . . . 72.25 110.551 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.578 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.1 p -77.13 -21.19 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 115.246 -0.888 . . . . 70.45 112.185 -159.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -71.45 -24.62 62.05 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.013 -0.54 . . . . 74.34 110.841 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -76.0 -27.53 57.44 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.108 0.963 . . . . 74.13 110.297 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -71.18 148.9 46.86 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.081 0.952 . . . . 72.11 110.866 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.15 124.55 23.4 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.117 0.967 . . . . 71.53 109.333 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -82.04 79.4 8.56 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.704 0.764 . . . . 64.3 110.826 -176.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -132.53 77.15 70.43 Favored Pre-proline 0 C--O 1.245 0.846 0 N-CA-C 106.584 -1.635 . . . . 72.51 106.584 169.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -85.41 154.57 10.67 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 121.986 1.79 . . . . 60.11 112.848 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -94.99 83.79 4.01 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 105.355 -2.091 . . . . 75.44 105.355 161.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.598 HG21 HD11 ' A' ' 126' ' ' LEU . 2.8 p -76.48 92.17 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-O 122.575 1.179 . . . . 74.04 108.15 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -87.01 115.33 24.32 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.214 -1.357 . . . . 71.43 109.363 -175.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.575 HD23 HD22 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -95.45 151.75 19.02 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.44 0.638 . . . . 74.24 110.282 177.24 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.607 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 13.4 t70 -145.38 150.57 36.8 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.603 -1.258 . . . . 73.42 107.603 -177.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.69 HD13 HD13 ' E' ' 8' ' ' LEU . 2.4 pt? -136.96 130.63 31.83 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.091 0.472 . . . . 70.13 110.44 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 13.7 t70 -122.94 151.08 42.14 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.46 1.104 . . . . 65.14 109.71 -178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.0 p -106.71 127.71 53.6 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.379 -0.828 . . . . 71.31 110.923 -172.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.659 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -134.97 137.48 43.09 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.817 0.847 . . . . 54.32 109.019 172.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.0 p -132.12 163.08 29.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.941 0.496 . . . . 73.33 110.756 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.555 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 35.4 t -161.44 153.11 19.15 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.971 0.908 . . . . 64.32 109.82 176.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -113.58 120.18 40.04 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.433 -0.951 . . . . 75.31 108.433 167.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 52.8 mt -94.35 -32.15 13.72 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.988 0.515 . . . . 72.31 110.265 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.464 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -164.45 -177.11 4.69 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.372 1.069 . . . . 53.11 109.344 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -71.94 130.53 41.21 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.224 -0.658 . . . . 74.42 109.224 174.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 85' ' ' SER . 35.7 m-20 66.15 -2.08 1.04 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.495 1.118 . . . . 73.11 112.657 -174.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 65.5 t -116.45 107.61 22.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.637 0 N-CA-C 108.53 -0.915 . . . . 65.35 108.53 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -126.31 155.89 41.28 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.871 -0.789 . . . . 72.15 108.871 -174.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 35.5 tt0 -117.93 122.75 44.09 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 123.255 0.622 . . . . 73.44 109.424 175.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.2 t -105.48 122.35 58.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 107.017 -1.475 . . . . 63.22 107.017 170.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 47.5 t -114.98 129.44 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.453 -0.943 . . . . 62.53 108.453 176.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.493 HD21 ' HB2' ' A' ' 44' ' ' LEU . 1.4 tt -119.8 112.44 19.24 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.978 -0.749 . . . . 73.33 108.978 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 18.8 ttt180 -86.94 100.64 12.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.18 0.992 . . . . 71.34 109.354 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.8 t -95.46 104.74 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 109.117 -0.697 . . . . 74.32 109.117 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 25.5 m -96.08 106.79 19.01 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.6 0.76 . . . . 64.14 109.515 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.8 t -105.19 108.54 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.876 0.871 . . . . 64.34 109.818 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.2 m -102.23 142.96 32.64 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.827 -1.175 . . . . 71.53 107.827 174.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.01 120.64 35.99 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.334 -1.358 . . . . 62.02 107.334 170.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.2 m -117.64 124.36 48.4 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.736 -0.468 . . . . 72.13 109.736 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.534 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 94.0 mt -88.67 85.53 6.82 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.118 -1.067 . . . . 63.44 108.118 173.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.1 -93.87 1.44 Allowed Glycine 0 C--N 1.343 0.951 0 CA-C-N 114.845 -1.071 . . . . 74.21 111.276 -175.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -119.24 -20.54 7.91 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.503 0.721 . . . . 70.24 110.795 176.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.91 134.15 35.09 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.473 0.709 . . . . 73.15 109.364 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.1 m -73.41 126.62 30.6 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.298 0.499 . . . . 74.41 110.269 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.578 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.35 -58.77 3.08 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.628 0.771 . . . . 52.21 109.543 172.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.431 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 26.2 p90 -158.79 176.08 12.8 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.76 -1.109 . . . . 60.02 111.064 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.1 tp -138.06 142.44 40.29 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.904 1.282 . . . . 74.23 108.144 173.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.468 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 59.6 m -142.43 95.44 2.79 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.001 -1.111 . . . . 74.35 108.001 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -112.41 115.95 29.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.64 0.776 . . . . 75.21 108.937 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.5 t -126.96 117.4 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.637 0.775 . . . . 73.23 110.068 -176.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 75.5 mt-30 -84.61 96.1 9.08 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.246 -1.02 . . . . 73.15 108.246 168.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.413 ' HG3' HD22 ' A' ' 106' ' ' LEU . 67.9 tp60 -82.79 103.6 12.4 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.009 -0.737 . . . . 75.32 109.009 177.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.81 146.08 20.4 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.33 -0.708 . . . . 34.5 111.33 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.445 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.23 121.02 1.16 Allowed Glycine 0 CA--C 1.505 -0.59 0 N-CA-C 111.031 -0.827 . . . . 42.42 111.031 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.417 HD12 ' HB3' ' A' ' 15' ' ' ARG . 34.7 mt -83.03 120.43 34.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 108.814 -0.809 . . . . 73.31 108.814 173.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.699 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 26.6 m-85 -130.1 124.29 32.42 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 109.358 -0.608 . . . . 74.12 109.358 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 73.9 m -86.6 98.34 11.04 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.535 -0.542 . . . . 61.35 109.535 168.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 28.6 pt -108.99 131.2 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 115.187 -0.915 . . . . 72.25 109.286 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.68 167.1 29.18 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.682 0.793 . . . . 63.14 109.852 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 133.35 -76.49 0.4 Allowed Glycine 0 C--N 1.338 0.673 0 N-CA-C 111.406 -0.677 . . . . 71.55 111.406 174.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.9 mm -125.23 124.22 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 109.062 -0.718 . . . . 71.15 109.062 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.509 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 1.7 mp0 -89.54 -166.27 1.55 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.803 0.841 . . . . 74.31 110.243 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.93 -143.42 34.88 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-O 119.708 -0.496 . . . . 64.42 112.331 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.8 p -66.15 -22.63 66.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.538 0.735 . . . . 72.4 112.577 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -70.64 -49.87 42.87 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.419 0.688 . . . . 71.33 109.776 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.509 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 47.3 ttp -63.69 -34.36 77.68 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.798 -0.637 . . . . 74.31 111.037 173.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.92 80.06 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.291 0.637 . . . . 61.23 111.105 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -69.11 -35.36 76.35 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.471 -0.786 . . . . 75.54 110.975 174.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 78.8 m -69.37 -63.51 1.05 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 122.865 0.466 . . . . 64.23 111.201 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.545 HD22 ' HD2' ' E' ' 17' ' ' PRO . 3.4 pp -73.94 -14.05 60.99 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.03 0.532 . . . . 75.34 112.429 -177.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.45 -12.85 29.84 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-O 119.528 -0.595 . . . . 74.41 114.193 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.469 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . . . -141.43 -57.9 0.49 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 117.773 0.786 . . . . 61.11 112.044 -178.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.401 ' HE2' ' CD1' ' A' ' 11' ' ' PHE . 62.6 t80 -63.59 -58.74 6.0 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.294 1.038 . . . . 72.13 112.191 -169.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.2 m -70.86 -35.79 4.65 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 113.189 0.811 . . . . 62.01 113.189 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.87 -41.72 54.4 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 122.447 2.098 . . . . 74.53 113.497 162.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.48 -23.54 61.83 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.895 0.878 . . . . 73.13 110.5 -176.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -67.03 -39.77 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 123.094 0.558 . . . . 74.52 110.027 173.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.445 HD21 ' HA3' ' A' ' 82' ' ' GLY . 93.9 mt -76.48 -26.71 55.64 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.663 0.785 . . . . 41.04 112.507 -175.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -63.89 -44.12 77.95 Favored Pre-proline 0 CA--C 1.564 1.483 0 N-CA-C 114.003 1.112 . . . . 62.52 114.003 -171.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.33 -33.85 79.08 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 121.88 1.72 . . . . 75.12 113.205 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -75.66 -37.92 59.23 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.463 0.705 . . . . 75.51 111.929 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.58 -39.19 70.72 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.842 -0.429 . . . . 55.34 109.842 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.508 ' NH1' HD12 ' C' ' 105' ' ' ILE . 33.4 ttm180 -61.96 -38.28 87.91 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 124.06 0.85 . . . . 72.34 109.62 172.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.515 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 2.9 tm-20 -65.95 -48.34 71.65 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.854 0.862 . . . . 72.33 111.071 -177.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 34.4 t -60.31 -44.77 95.12 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 124.273 0.983 . . . . 71.11 110.231 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 82.9 mt -66.47 -43.5 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.909 0.883 . . . . 64.33 111.149 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.1 m -59.81 -40.37 88.19 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.816 0.846 . . . . 52.34 110.606 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.7 t -72.22 -43.69 64.04 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.219 -0.901 . . . . 64.25 110.696 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.411 ' SD ' HG23 ' A' ' 21' ' ' ILE . 18.8 mtp -60.35 -40.28 90.19 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.466 0.706 . . . . 73.31 111.661 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.529 HG13 ' HB2' ' A' ' 123' ' ' PHE . 48.6 t -66.99 -45.07 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.98 0.912 . . . . 70.25 110.848 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.6 p -71.7 -30.81 66.08 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 120.73 0.3 . . . . 45.44 111.003 -176.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -70.05 -33.73 72.32 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.655 0.782 . . . . 73.14 109.591 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.7 11.97 43.72 Favored Glycine 0 C--N 1.356 1.653 0 O-C-N 123.88 0.738 . . . . 75.41 113.053 173.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.54 HG21 ' HE ' ' B' ' 15' ' ' ARG . 3.4 t 61.56 18.18 9.24 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 127.348 2.259 . . . . 74.32 113.819 172.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.529 ' HB2' HG13 ' A' ' 118' ' ' VAL . 90.3 m-85 -84.84 147.44 48.53 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 107.296 -1.372 . . . . 75.1 107.296 170.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.47 171.85 7.51 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.236 1.957 . . . . 75.15 112.156 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.574 ' HG2' ' H ' ' C' ' 16' ' ' ILE . 67.3 tp60 -53.31 124.45 14.71 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.035 0.934 . . . . 75.23 112.065 -172.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.598 HD11 HG21 ' A' ' 40' ' ' VAL . 57.4 tp -116.9 118.3 32.09 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.39 -0.823 . . . . 72.1 108.945 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -123.65 115.77 21.99 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.755 0.822 . . . . 75.53 111.182 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.575 HD22 HD23 ' A' ' 42' ' ' LEU . 71.1 mt -74.4 121.98 22.26 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.789 -0.819 . . . . 72.42 108.789 167.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.564 ' HB3' ' HB2' ' E' ' 7' ' ' ALA . . . -66.17 130.21 94.28 Favored Pre-proline 0 CA--C 1.555 1.159 0 N-CA-C 110.106 -0.331 . . . . 71.31 110.106 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.56 119.35 6.36 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.785 2.324 . . . . 70.05 111.872 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.709 HG11 ' HB2' ' E' ' 8' ' ' LEU . 4.2 p -101.97 125.24 56.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 114.97 -1.013 . . . . 50.12 109.982 -176.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -102.66 98.09 8.18 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.616 -0.883 . . . . 73.51 108.616 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -66.71 -28.18 68.23 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.309 0.644 . . . . 73.4 110.366 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -54.36 -37.84 65.41 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.792 1.637 . . . . 63.42 112.41 -175.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.78 -41.17 96.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.47 0.708 . . . . 52.12 110.881 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.456 HD22 ' HB2' ' E' ' 10' ' ' LEU . 6.5 mp -74.44 -25.88 59.71 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.607 0.763 . . . . 71.21 110.628 -178.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 9.0 m-85 -63.91 -54.12 39.67 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.542 0.737 . . . . 72.11 110.591 173.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 31.5 mmt -68.16 -33.24 74.11 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.089 0.556 . . . . 74.12 110.807 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -66.22 -40.28 90.18 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.411 -0.813 . . . . 63.22 111.597 175.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -75.55 -37.68 59.82 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 120.745 0.307 . . . . 75.23 110.552 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.55 -48.7 59.45 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.715 0.806 . . . . 75.05 112.068 -174.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -150.46 6.84 0.57 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 111.856 0.317 . . . . 72.14 111.856 -171.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 71.47 164.95 0.29 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 125.263 1.425 . . . . 75.03 112.167 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -166.51 161.2 15.99 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.516 0.726 . . . . 73.14 110.363 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.49 140.36 46.36 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.875 -0.602 . . . . 71.2 109.777 169.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -134.0 37.03 2.02 Favored Glycine 0 CA--C 1.504 -0.635 0 N-CA-C 111.29 -0.724 . . . . 55.4 111.29 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -109.51 -171.57 1.87 Allowed 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.722 0.809 . . . . 72.2 110.792 -175.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' C' ' 88' ' ' GLY . . . 167.54 97.47 0.11 Allowed Glycine 0 C--N 1.342 0.914 0 N-CA-C 110.628 -0.989 . . . . 70.22 110.628 175.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.9 m -86.83 48.71 1.68 Allowed 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 122.002 0.906 . . . . 52.31 109.376 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -87.21 145.04 26.55 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 124.258 1.023 . . . . 61.1 109.324 -175.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.51 137.47 57.43 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.842 0.714 . . . . 45.23 111.678 -174.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -114.03 168.92 9.4 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.187 0.995 . . . . 61.22 108.574 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.07 147.56 31.4 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.601 -0.518 . . . . 73.23 109.601 173.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -52.86 -47.73 67.57 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.373 1.069 . . . . 41.5 110.973 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.187 0 O-C-N 124.993 1.433 . . . . 61.5 110.718 175.514 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 20.2 mmt . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 108.951 -0.759 . . . . 65.24 108.951 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.2 p -171.17 -179.91 2.83 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.654 1.182 . . . . 75.45 109.033 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -103.25 98.41 8.34 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.355 0.662 . . . . 71.42 109.6 -178.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -79.38 137.56 37.34 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.372 0.669 . . . . 72.34 111.266 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -83.84 115.65 22.36 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.714 -1.217 . . . . 73.25 107.714 173.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -76.62 80.91 3.28 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 122.121 0.962 . . . . 72.21 110.313 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -141.0 160.93 39.03 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 114.044 -1.435 . . . . 71.45 109.062 -178.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 74.72 -63.37 0.42 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.852 1.661 . . . . 73.33 111.927 176.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 26.0 ttt 66.68 165.29 0.2 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.872 1.669 . . . . 63.41 111.962 -176.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 86.0 m -141.94 126.79 18.17 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 105.921 -1.881 . . . . 64.54 105.921 167.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -143.28 140.47 30.63 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.202 0.456 . . . . 74.3 110.337 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -150.39 139.53 21.15 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.552 0.741 . . . . 51.32 109.401 173.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 25.7 mt -82.8 124.81 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.194 -1.039 . . . . 65.43 108.194 169.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -93.81 -38.12 11.41 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.074 -0.713 . . . . 64.23 109.074 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.54 ' HE ' HG21 ' A' ' 122' ' ' THR . 32.4 ttt180 -169.9 151.64 4.19 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.252 0.621 . . . . 73.31 110.218 -177.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.7 mt -132.95 140.97 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.364 -1.347 . . . . 72.51 107.364 174.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -169.72 157.23 6.84 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.61 0.719 . . . . 74.53 112.515 -175.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 87.6 m -82.08 127.5 33.18 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.682 -1.144 . . . . 60.11 108.561 170.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.565 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 40.4 mtpt -98.39 -35.77 10.19 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.452 0.701 . . . . 54.44 110.39 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.547 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 13.1 t70 -150.81 137.72 19.1 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.72 -0.673 . . . . 71.53 110.954 -167.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.424 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.5 mm -137.92 143.83 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.088 1.355 . . . . 70.23 108.461 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 44.2 t -149.44 114.99 5.57 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.525 -1.287 . . . . 70.13 107.525 174.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -132.38 110.81 10.82 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.235 -1.024 . . . . 72.31 108.235 173.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -117.48 137.51 52.49 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.527 0.731 . . . . 64.41 109.363 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.893 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -117.24 84.3 17.23 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 106.489 -1.671 . . . . 72.31 106.489 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -63.83 -48.35 5.51 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.829 2.352 . . . . 43.0 112.275 -167.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -104.62 20.13 19.16 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.392 -0.822 . . . . 74.43 110.828 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.893 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -43.78 -59.51 3.46 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 115.56 1.689 . . . . 72.13 115.56 -168.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.466 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 38.2 Cg_exo -58.75 -31.04 94.23 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 122.657 2.238 . . . . 61.11 113.121 -170.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -96.8 -37.19 10.37 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.173 -0.921 . . . . 74.31 111.6 -176.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.486 HG22 HD12 ' B' ' 68' ' ' LEU . 4.0 p -65.45 -20.3 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 123.214 0.606 . . . . 72.12 111.352 -172.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -61.94 -18.47 60.45 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.102 0.961 . . . . 73.52 113.421 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -62.82 -30.78 71.75 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.261 0.553 . . . . 61.42 110.205 176.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -87.71 80.77 7.83 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.45 1.1 . . . . 73.04 109.709 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -84.38 90.42 7.58 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.186 0.517 . . . . 72.11 110.143 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 27.5 p90 -158.73 172.38 18.36 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.711 1.204 . . . . 74.4 108.298 167.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -75.59 110.45 10.63 Favored Pre-proline 0 N--CA 1.477 0.895 0 N-CA-C 109.263 -0.643 . . . . 74.11 109.263 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.14 159.7 51.96 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.23 1.953 . . . . 72.21 112.653 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.44 112.19 3.01 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.685 0.615 . . . . 70.33 109.353 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.455 ' HB ' HG21 ' F' ' 6' ' ' ILE . 48.0 t -85.94 119.95 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.587 -0.894 . . . . 64.15 108.587 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.54 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 24.3 mtpp -119.45 98.56 6.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.332 -1.358 . . . . 71.24 107.332 177.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.449 HD22 HD23 ' F' ' 8' ' ' LEU . 2.2 pp -94.3 158.07 15.75 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.808 -0.633 . . . . 73.03 110.457 -176.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -162.8 119.44 1.91 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.468 -0.567 . . . . 61.31 109.468 -175.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.819 HD21 HD13 ' F' ' 8' ' ' LEU . 5.2 mp -100.61 143.83 30.31 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.766 0.426 . . . . 72.22 110.1 -178.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -125.2 151.21 46.15 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.128 0.971 . . . . 74.23 109.409 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.1 p -109.02 133.78 52.54 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.338 0.655 . . . . 54.0 110.919 -170.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.627 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -148.65 148.83 30.54 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.617 0.767 . . . . 52.12 109.243 170.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.503 ' HB2' ' HB ' ' F' ' 16' ' ' THR . 49.8 m -146.76 177.21 9.27 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.455 0.702 . . . . 71.11 109.951 172.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 1.4 m -151.55 138.63 19.16 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.681 0.792 . . . . 74.23 108.934 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -92.33 108.99 20.37 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.381 -1.34 . . . . 72.12 107.381 165.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.426 HD11 ' HB2' ' B' ' 57' ' ' GLU . 21.7 mt -83.77 -56.08 3.9 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.131 0.491 . . . . 63.22 109.797 -176.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.09 -170.22 2.74 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.197 -0.91 . . . . 53.51 109.257 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.45 109.94 4.47 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 114.75 -1.114 . . . . 55.34 109.542 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 70.45 2.63 4.14 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 125.081 1.352 . . . . 71.41 113.232 -177.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 78.3 t -105.74 123.08 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 108.435 -0.95 . . . . 72.35 108.435 173.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.429 ' HE2' ' HB3' ' B' ' 98' ' ' LEU . 4.9 p90 -133.37 175.35 9.49 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.142 0.977 . . . . 64.3 108.739 -176.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.426 ' HB2' HD11 ' B' ' 51' ' ' LEU . 12.0 tm-20 -145.4 116.0 7.66 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.806 -0.813 . . . . 71.32 108.806 -175.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 60.2 t -97.91 132.3 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.188 0.595 . . . . 53.2 109.989 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.627 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 20.7 t -115.96 119.06 60.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 124.339 1.056 . . . . 65.34 108.931 176.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.592 HD13 ' HZ ' ' F' ' 15' ' ' PHE . 50.5 tp -106.49 112.44 25.44 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.428 -0.582 . . . . 61.15 109.428 170.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.532 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 31.2 ttm180 -85.52 132.43 34.2 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.708 -0.849 . . . . 73.44 108.708 170.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 17.5 t -126.22 120.96 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 107.819 -1.178 . . . . 60.0 107.819 172.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 9.0 m -114.08 152.54 30.91 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.702 0.801 . . . . 70.4 109.265 -176.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.472 HG21 HG21 ' B' ' 114' ' ' ILE . 97.2 t -139.6 103.62 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.682 1.193 . . . . 53.41 108.559 -175.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 97.4 m -83.08 140.24 32.77 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.29 -1.004 . . . . 62.31 108.29 162.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.03 137.49 23.57 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.092 -0.707 . . . . 74.23 109.092 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.497 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 36.8 p -144.06 128.73 18.2 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 123.614 0.571 . . . . 65.14 111.584 -174.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.486 HD12 HG22 ' B' ' 31' ' ' VAL . 61.2 mt -95.91 101.41 13.09 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.97 -1.122 . . . . 65.34 107.97 174.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.0 -112.69 3.5 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 116.049 -0.523 . . . . 64.12 112.546 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.71 21.47 11.48 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.034 0.934 . . . . 63.32 111.285 -176.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -137.96 151.63 48.13 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.05 0.54 . . . . 74.24 110.007 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 86.9 m -72.11 118.11 14.58 Favored 'General case' 0 C--O 1.241 0.629 0 O-C-N 123.391 0.432 . . . . 75.1 110.777 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.497 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -71.59 -62.25 1.48 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.228 -0.896 . . . . 75.11 108.738 172.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -152.08 164.73 36.66 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.079 0.942 . . . . 75.35 112.214 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 91.0 mt -132.69 114.02 13.68 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 106.043 -1.836 . . . . 75.42 106.043 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.403 ' SG ' HG23 ' B' ' 114' ' ' ILE . 46.7 t -116.36 151.28 36.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.568 -0.901 . . . . 62.51 108.568 178.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -163.42 126.84 2.73 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.42 -0.585 . . . . 75.24 109.42 -175.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 64.4 t -123.63 153.84 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 123.698 0.799 . . . . 74.13 109.117 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.547 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 20.9 mt-30 -127.91 103.54 7.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.235 -1.024 . . . . 65.21 108.235 166.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -91.21 102.29 15.01 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.979 -0.748 . . . . 52.14 108.979 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.439 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.19 164.39 28.39 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.522 -0.763 . . . . 75.53 111.666 174.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.77 127.75 1.72 Allowed Glycine 0 CA--C 1.504 -0.638 0 N-CA-C 111.413 -0.675 . . . . 55.11 111.413 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 66.4 mt -84.21 127.93 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.056 -1.09 . . . . 74.13 108.056 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -134.29 164.12 28.11 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.404 1.082 . . . . 75.34 109.136 -176.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.6 m -132.26 133.32 43.97 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.624 0.769 . . . . 55.01 109.454 175.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.593 HG21 HG21 ' F' ' 18' ' ' VAL . 9.5 tt -135.53 146.36 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.837 0.855 . . . . 75.42 109.045 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.99 152.45 33.55 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.319 0.248 . . . . 73.12 110.433 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.91 -32.9 5.53 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.581 -0.736 . . . . 44.14 112.563 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 46.6 mm -92.89 153.34 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.183 0.993 . . . . 74.44 111.756 -175.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.06 -172.0 3.28 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.664 1.186 . . . . 72.13 110.342 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.21 -133.44 52.35 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 114.935 0.734 . . . . 73.23 114.935 175.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.6 m -65.66 -37.75 87.39 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.545 0.738 . . . . 70.21 111.231 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -75.46 -20.82 58.58 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.513 -0.767 . . . . 75.2 110.741 -172.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' F' ' 21' ' ' ALA . 57.3 ttm -64.87 -45.11 87.37 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.425 -0.583 . . . . 75.5 109.425 168.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.02 -30.67 71.67 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.958 0.903 . . . . 52.2 111.168 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -69.94 -35.84 74.83 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.827 0.851 . . . . 75.55 110.995 176.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.434 ' SG ' HD12 ' B' ' 86' ' ' ILE . 42.0 t -69.11 -66.52 0.57 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.024 0.53 . . . . 63.43 110.952 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.683 HD21 ' HA ' ' F' ' 17' ' ' PRO . 1.2 pp -76.67 -5.88 49.77 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 112.731 0.641 . . . . 71.11 112.731 -176.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.97 -36.9 8.1 Favored Glycine 0 C--N 1.336 0.535 0 O-C-N 123.452 0.47 . . . . 72.02 113.391 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.84 -52.45 1.33 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.898 0.479 . . . . 73.21 111.569 -169.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -64.46 -46.52 82.74 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.307 1.043 . . . . 73.15 111.66 -174.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.439 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 84.2 m -75.36 -46.55 4.44 Favored Pre-proline 0 CA--C 1.563 1.467 0 N-CA-C 112.74 0.644 . . . . 61.14 112.74 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.517 ' HB3' HD22 ' B' ' 60' ' ' LEU . 53.8 Cg_exo -59.72 -25.29 78.66 Favored 'Trans proline' 0 C--N 1.388 2.612 0 C-N-CA 122.294 1.996 . . . . 75.44 113.887 171.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -62.17 -40.73 97.02 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.442 0.697 . . . . 62.44 110.397 174.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.416 ' HA ' ' NH2' ' D' ' 111' ' ' ARG . 73.9 mt -63.59 -43.67 98.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 CA-C-N 114.795 -1.093 . . . . 74.52 110.253 177.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 78.9 mt -81.98 -19.93 39.56 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.303 -1.317 . . . . 74.12 112.332 -171.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.424 ' CE1' HD11 ' F' ' 8' ' ' LEU . 60.4 t80 -54.13 -53.25 60.76 Favored Pre-proline 0 CA--C 1.563 1.447 0 N-CA-C 113.945 1.091 . . . . 74.33 113.945 -174.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.98 -33.5 95.55 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.164 1.91 . . . . 73.45 113.711 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -71.74 -45.92 60.19 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.889 -0.596 . . . . 71.34 110.428 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.91 91.0 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.034 0.534 . . . . 61.31 110.563 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.0 ttt-85 -62.28 -51.67 66.76 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.24 1.416 . . . . 71.55 110.872 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.5 -32.72 72.9 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.356 0.663 . . . . 73.02 109.878 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.514 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.3 t -69.93 -35.93 74.93 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 122.653 0.381 . . . . 64.53 111.291 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.472 HG21 HG21 ' B' ' 64' ' ' VAL . 71.6 mt -64.25 -55.25 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 108.66 -0.867 . . . . 72.42 108.66 172.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 37.9 m -57.83 -31.51 66.7 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 124.374 1.047 . . . . 72.02 111.367 -175.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.1 t -62.65 -53.66 51.18 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 123.318 0.647 . . . . 70.55 109.533 175.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.514 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.3 mmt -65.92 -35.38 80.48 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.375 0.67 . . . . 61.24 111.582 -174.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 85.2 t -64.23 -43.23 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.665 0.786 . . . . 73.32 110.154 175.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 39.7 t -70.08 -28.38 65.38 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.227 -0.897 . . . . 74.15 111.334 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.494 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 89.0 mtt-85 -71.06 -39.19 72.38 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.644 0.777 . . . . 74.31 110.205 176.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.98 -0.88 71.12 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.852 0.72 . . . . 72.13 112.643 172.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 19.0 p 63.76 31.88 13.96 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.561 1.945 . . . . 53.51 112.363 173.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -90.64 160.49 38.69 Favored Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 124.545 1.138 . . . . 71.21 110.407 176.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -50.77 159.64 2.22 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 123.969 3.113 . . . . 71.35 115.874 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -64.08 112.55 3.04 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.868 -1.06 . . . . 72.21 111.42 -173.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 50.6 tp -111.1 122.46 47.94 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.524 0.73 . . . . 63.44 109.271 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -132.8 122.5 24.58 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.303 -0.999 . . . . 73.3 108.303 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 93.3 mt -68.86 145.49 53.66 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.578 0.351 . . . . 72.14 110.816 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.18 142.13 40.79 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.225 0.61 . . . . 74.32 110.463 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.31 116.12 3.42 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.356 2.704 . . . . 64.33 111.844 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.416 HG21 ' HB2' ' F' ' 8' ' ' LEU . 35.2 m -124.55 140.34 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.179 0.592 . . . . 70.2 109.688 175.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -111.52 98.2 7.28 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.942 -0.762 . . . . 75.44 108.942 174.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -56.76 -34.99 68.12 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.87 0.868 . . . . 75.35 110.545 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -61.76 -48.98 78.26 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 113.67 -1.604 . . . . 64.22 111.764 -172.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.17 -37.16 84.2 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.617 0.767 . . . . 61.21 112.2 -176.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.462 HD23 ' HG ' ' F' ' 10' ' ' LEU . 9.8 mp -67.44 -43.48 81.06 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.704 -0.68 . . . . 73.51 110.178 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.444 ' HZ ' ' HA ' ' F' ' 12' ' ' PRO . 29.5 m-85 -80.66 -14.77 57.86 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.005 0.743 . . . . 74.35 113.005 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 89.2 mtp -68.05 -39.85 82.96 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.323 0.582 . . . . 65.13 109.442 169.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -93.81 -12.21 29.55 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.91 -1.041 . . . . 74.21 110.764 -173.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -67.79 -29.56 68.78 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 109.377 -0.601 . . . . 74.41 109.377 169.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 56.9 mt -96.85 29.63 2.97 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.342 1.057 . . . . 72.44 110.419 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -73.95 95.28 2.46 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.185 0.517 . . . . 74.13 110.337 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -136.25 137.42 40.76 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.205 1.002 . . . . 72.0 108.621 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -111.45 177.04 4.78 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.345 0.658 . . . . 74.31 110.705 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.12 -174.38 3.74 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.411 0.684 . . . . 71.33 111.04 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -159.21 153.08 24.17 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.771 -0.532 . . . . 65.11 111.771 178.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -78.36 131.97 37.2 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.486 0.714 . . . . 64.31 110.715 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -76.19 154.61 44.78 Favored Glycine 0 C--N 1.346 1.084 0 O-C-N 123.745 0.653 . . . . 72.21 113.612 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 44.9 m -75.61 136.83 40.48 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.127 0.971 . . . . 64.13 110.601 177.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -67.34 133.44 49.64 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 123.513 0.508 . . . . 75.22 111.105 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -106.38 163.67 12.66 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.157 0.983 . . . . 75.44 110.877 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -151.39 169.04 22.96 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.588 0.755 . . . . 75.33 110.708 -178.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.03 -176.51 6.23 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.457 0.703 . . . . 74.31 111.582 176.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -147.06 139.24 24.58 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.185 0.994 . . . . 74.13 108.352 176.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.135 0 N-CA-C 109.038 -0.727 . . . . 73.2 109.038 176.009 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mpp? . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.573 -0.529 . . . . 51.23 109.573 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -137.78 104.85 5.41 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.724 0.81 . . . . 63.43 109.083 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -74.74 111.23 9.73 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.73 -0.841 . . . . 74.43 108.73 175.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -65.1 -73.21 0.13 Allowed 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.031 0.832 . . . . 71.54 111.659 -170.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -150.67 35.81 0.63 Allowed 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 122.516 1.15 . . . . 72.45 108.526 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -103.93 -19.72 14.13 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.181 -1.372 . . . . 75.45 110.201 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -85.51 104.28 15.14 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.194 0.998 . . . . 75.52 108.882 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -77.15 152.58 34.8 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.693 -0.685 . . . . 73.45 109.576 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.457 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 0.0 OUTLIER 68.12 140.27 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.929 1.292 . . . . 65.23 112.418 178.672 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.413 ' N ' ' SD ' ' C' ' 9' ' ' MET . 44.3 m -119.47 86.32 2.53 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.104 0.962 . . . . 70.44 108.83 176.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.706 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 23.3 t80 -101.83 139.96 36.77 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.26 -0.882 . . . . 60.15 108.828 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -152.55 132.81 13.6 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.883 -0.784 . . . . 75.01 108.883 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.407 HD13 HD11 ' C' ' 16' ' ' ILE . 16.7 mt -87.65 131.58 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.83 -0.804 . . . . 55.25 108.83 174.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -92.94 -48.61 6.44 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.558 0.743 . . . . 70.15 110.325 177.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -173.92 130.42 0.4 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 115.963 -0.562 . . . . 72.41 109.778 -168.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.574 ' H ' ' HG2' ' A' ' 125' ' ' GLN . 61.3 mt -123.2 147.76 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.962 -0.755 . . . . 73.15 108.962 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.504 ' HB3' HG23 ' D' ' 122' ' ' THR . 20.5 p90 -175.33 157.39 2.18 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.515 0.674 . . . . 72.21 110.076 -173.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.0 p -77.99 123.9 27.37 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.767 -1.106 . . . . 73.2 108.712 172.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -70.35 -49.19 51.85 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 107.479 -1.304 . . . . 63.0 107.479 167.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 11.4 t70 -136.68 136.92 39.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 112.874 -1.966 . . . . 55.21 109.203 -166.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.431 HG12 ' SG ' ' C' ' 113' ' ' CYS . 75.3 mt -134.63 142.59 40.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.663 -1.606 . . . . 60.24 106.663 171.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.4 t -156.2 150.47 25.51 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.89 -0.411 . . . . 73.3 109.89 175.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -152.26 116.69 5.01 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.446 1.098 . . . . 64.23 108.043 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -120.72 129.44 53.65 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.642 0.777 . . . . 74.21 109.757 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.38 82.7 33.79 Favored Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 107.25 -1.389 . . . . 74.22 107.25 170.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.92 -14.01 23.96 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.953 2.435 . . . . 72.12 112.06 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -110.79 17.21 20.82 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.138 0.975 . . . . 72.23 109.881 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.439 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -49.28 -56.53 15.57 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 114.514 1.302 . . . . 52.21 114.514 -167.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.439 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 35.1 Cg_exo -61.84 -38.9 55.95 Favored 'Trans proline' 0 C--N 1.385 2.474 0 CA-C-N 121.824 1.687 . . . . 73.53 112.39 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -69.5 -34.92 75.0 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.684 -1.144 . . . . 71.12 112.308 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.718 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.4 p -82.75 -16.68 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 N-CA-C 112.724 0.639 . . . . 60.34 112.724 -176.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -78.37 -16.9 57.19 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.257 0.466 . . . . 55.31 112.257 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -94.07 36.77 1.11 Allowed 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.344 0.592 . . . . 71.11 109.906 172.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.79 167.21 16.09 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.27 1.028 . . . . 74.25 110.663 -178.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -89.97 132.19 35.47 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.804 0.842 . . . . 75.25 109.95 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 50.9 t-105 -81.97 90.51 6.49 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.192 0.52 . . . . 74.32 112.053 -173.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -143.55 77.95 14.9 Favored Pre-proline 0 CA--C 1.559 1.296 0 C-N-CA 124.496 1.119 . . . . 74.4 108.744 171.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -92.74 145.93 2.56 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.967 2.445 . . . . 53.53 114.623 -176.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.75 97.71 10.76 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 107.496 -1.298 . . . . 62.43 107.496 166.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' C' ' 65' ' ' THR . 9.6 m -83.85 100.29 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.745 0.783 . . . . 62.2 111.135 -176.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -92.57 109.09 20.49 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.628 0.771 . . . . 74.34 109.552 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.475 HD22 HD23 ' G' ' 8' ' ' LEU . 2.2 pp -86.0 163.02 18.22 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.781 -0.645 . . . . 62.23 111.196 -177.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.522 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 31.2 t70 -150.48 112.57 4.59 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.918 -0.771 . . . . 60.33 108.918 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' C' ' 61' ' ' ARG . 5.7 mp -113.51 112.87 24.31 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.035 -0.728 . . . . 74.35 109.035 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -116.87 152.63 34.08 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.098 0.959 . . . . 74.33 109.369 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 33.7 p -112.42 126.93 55.83 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.329 0.652 . . . . 75.02 111.028 -169.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.47 141.31 39.44 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.434 1.094 . . . . 64.2 108.534 174.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 36.0 p -165.73 164.96 18.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.337 0.255 . . . . 70.11 111.258 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 67.8 p -167.07 138.0 3.14 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.856 0.862 . . . . 73.15 109.511 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 50' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' C' ' 56' ' ' TYR . 51.8 tt0 -78.7 117.76 20.15 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.742 -0.836 . . . . 75.31 108.742 174.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.533 HD11 HD12 ' C' ' 83' ' ' ILE . 33.3 mt -84.75 -39.91 17.9 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.981 0.912 . . . . 71.23 110.982 -171.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.405 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -152.88 -170.49 3.64 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.654 -0.703 . . . . 62.21 110.943 -175.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -59.05 107.51 0.55 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.315 1.046 . . . . 71.12 110.716 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 63.12 6.82 2.46 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.288 1.035 . . . . 52.02 112.677 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 91.9 t -103.68 113.19 39.85 Favored 'Isoleucine or valine' 0 C--N 1.345 0.38 0 N-CA-C 107.584 -1.265 . . . . 74.11 107.584 177.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' C' ' 50' ' ' GLN . 50.9 t80 -131.39 135.09 46.91 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.062 0.945 . . . . 74.41 108.8 -173.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.51 ' HB2' HD11 ' C' ' 51' ' ' LEU . 39.3 tt0 -92.43 136.95 32.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.785 -1.098 . . . . 72.22 110.377 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 86.3 t -119.35 115.36 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.312 -1.366 . . . . 74.32 107.312 173.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.3 122.1 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 109.208 -0.664 . . . . 65.41 109.208 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 tp -116.55 125.57 52.07 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.656 -0.868 . . . . 62.33 108.656 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 29.8 ttm180 -79.06 130.96 36.07 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.749 -1.204 . . . . 72.1 107.749 172.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 23.5 t -124.02 111.37 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.13 -1.433 . . . . 72.33 107.13 172.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 63.9 m -121.43 139.89 52.87 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.446 -0.946 . . . . 53.24 108.446 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 85.6 t -131.42 111.6 19.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 108.184 -1.043 . . . . 73.12 108.184 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' C' ' 40' ' ' VAL . 3.2 m -98.5 132.81 43.63 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 107.567 -1.271 . . . . 64.45 107.567 173.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.76 121.47 37.33 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.47 -0.937 . . . . 72.14 108.47 -177.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 47.1 m -136.17 126.08 25.86 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.04 0.447 . . . . 65.13 111.061 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 14.1 mt -86.06 57.92 4.76 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.135 1.374 . . . . 75.23 109.076 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.08 -92.64 1.07 Allowed Glycine 0 C--N 1.343 0.938 0 N-CA-C 110.245 -1.142 . . . . 60.53 110.245 -175.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -126.6 2.01 6.84 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.895 0.878 . . . . 73.35 110.064 172.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -82.02 114.26 20.46 Favored 'General case' 0 C--N 1.347 0.481 0 N-CA-C 108.151 -1.055 . . . . 64.3 108.151 169.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.2 m -79.02 120.49 23.67 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 119.281 0.946 . . . . 63.31 109.146 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.718 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -79.81 -58.71 3.04 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.885 -1.052 . . . . 65.33 109.006 178.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -159.09 174.85 14.27 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 122.017 0.913 . . . . 72.43 112.321 -178.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.434 HD23 HG23 ' C' ' 65' ' ' THR . 2.4 tm? -138.61 142.57 39.13 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 105.37 -2.085 . . . . 61.23 105.37 170.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 48.1 t -150.29 112.84 4.71 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.586 -0.524 . . . . 74.22 109.586 176.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -118.01 130.9 56.46 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.568 0.747 . . . . 73.31 109.545 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.44 HG11 ' HA ' ' C' ' 110' ' ' ALA . 55.6 t -131.19 113.23 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.195 0.998 . . . . 71.43 108.542 175.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -91.03 95.17 9.97 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.885 -1.154 . . . . 74.31 107.885 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.538 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.3 tp-100 -86.08 115.42 23.66 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.158 0.583 . . . . 61.12 110.098 -176.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.69 146.88 18.07 Favored Glycine 0 C--N 1.338 0.652 0 O-C-N 123.489 0.493 . . . . 34.54 112.344 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.415 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -144.51 119.18 1.23 Allowed Glycine 0 C--O 1.237 0.308 0 N-CA-C 110.698 -0.961 . . . . 72.11 110.698 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.533 HD12 HD11 ' C' ' 51' ' ' LEU . 16.4 mm -83.86 123.75 39.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.595 -0.891 . . . . 62.34 108.595 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -132.31 123.85 27.67 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.98 0.512 . . . . 65.1 110.851 -173.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 58.7 m -80.19 105.27 11.33 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.394 -0.965 . . . . 51.03 108.394 166.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.51 HD13 ' H ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -116.0 139.2 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.052 -0.721 . . . . 72.22 109.052 -179.563 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.63 170.2 16.01 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.351 0.661 . . . . 50.23 110.247 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 88' ' ' GLY . . . . . 0.466 ' O ' ' HA3' ' A' ' 148' ' ' GLY . . . 93.81 -30.02 7.94 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-O 119.625 -0.542 . . . . 54.33 113.823 172.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 47.4 pt -123.7 151.31 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 118.001 0.901 . . . . 73.31 110.333 176.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -147.75 157.9 43.76 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.921 0.889 . . . . 64.25 109.774 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.58 -148.19 21.77 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 119.167 -0.796 . . . . 74.54 111.878 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 92' ' ' THR . . . . . 0.442 ' H ' ' HD3' ' G' ' 24' ' ' PRO . 9.8 t -56.77 -26.56 57.81 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.394 0.677 . . . . 75.43 111.681 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -55.33 -59.12 5.24 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.225 1.41 . . . . 63.1 110.423 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 32.9 ttp -77.78 -22.47 50.11 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.358 -0.837 . . . . 74.33 111.425 -177.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.92 -35.08 79.49 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.261 0.624 . . . . 74.02 110.706 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -73.82 -31.67 63.34 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.396 -0.82 . . . . 73.02 110.617 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -66.47 -60.93 2.29 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.314 0.246 . . . . 71.55 110.716 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 pp -66.5 -29.96 70.18 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.192 0.597 . . . . 61.31 111.585 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.92 12.4 59.12 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-O 119.251 -0.749 . . . . 74.32 114.475 -173.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.41 -55.38 0.06 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.269 1.035 . . . . 63.53 112.045 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -71.23 -35.67 71.55 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.76 0.824 . . . . 52.22 111.555 -172.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.706 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 60.7 m -76.19 -50.91 2.83 Favored Pre-proline 0 CA--C 1.564 1.5 0 C-N-CA 123.603 0.761 . . . . 73.1 112.249 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.58 -13.54 35.27 Favored 'Trans proline' 0 C--N 1.398 3.138 0 C-N-CA 122.03 1.82 . . . . 75.41 112.959 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -60.89 -37.41 82.12 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.999 0.919 . . . . 75.14 110.154 171.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.508 HD12 ' NH1' ' A' ' 111' ' ' ARG . 37.9 mm -70.02 -36.06 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.229 -0.896 . . . . 63.54 111.19 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.415 HD21 ' HA3' ' C' ' 82' ' ' GLY . 53.6 mt -91.94 -24.59 19.22 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.862 -1.063 . . . . 72.32 111.985 -166.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -57.25 -52.64 72.71 Favored Pre-proline 0 CA--C 1.557 1.241 0 CA-C-O 117.99 -1.005 . . . . 75.33 112.733 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.515 ' HB2' ' HG3' ' A' ' 112' ' ' GLU . 42.0 Cg_endo -63.45 -27.3 70.58 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 121.683 1.589 . . . . 73.45 112.788 -177.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.427 ' CD1' HG21 ' C' ' 16' ' ' ILE . 3.2 m-30 -71.17 -50.4 33.67 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.801 0.84 . . . . 65.11 110.435 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.538 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -63.56 -35.34 80.17 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.303 -0.862 . . . . 73.43 110.914 176.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -60.02 -50.71 72.66 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.349 1.459 . . . . 73.44 111.587 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.7 -37.94 87.86 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 123.552 0.533 . . . . 73.45 109.696 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.431 ' SG ' HG12 ' C' ' 21' ' ' ILE . 42.4 t -63.9 -34.84 78.85 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.338 0.655 . . . . 41.22 111.766 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.473 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 68.0 mt -71.04 -52.19 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.127 0.571 . . . . 73.33 110.414 174.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 35.1 m -62.74 -30.02 71.12 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.25 0.62 . . . . 72.23 111.438 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.1 t -65.97 -48.71 70.36 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.899 -0.778 . . . . 60.24 108.899 174.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.558 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.11 -37.83 81.18 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.673 1.189 . . . . 71.31 112.32 178.496 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.415 HG23 ' O ' ' C' ' 114' ' ' ILE . 93.8 t -65.68 -42.94 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.365 0.666 . . . . 63.22 110.1 177.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.0 t -70.16 -29.1 65.92 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.38 -0.827 . . . . 73.24 111.714 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -69.92 -34.61 73.7 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.324 0.65 . . . . 73.53 109.3 175.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.46 11.27 64.08 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.713 0.633 . . . . 50.52 113.108 174.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.421 HG23 ' HB3' ' D' ' 17' ' ' TYR . 73.0 p 56.23 24.33 8.02 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 126.276 1.83 . . . . 71.44 114.23 176.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -84.77 140.53 37.85 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.057 -1.09 . . . . 63.23 108.057 169.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.48 168.84 2.67 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 123.028 2.485 . . . . 64.32 114.273 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -50.69 118.71 3.27 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.79 1.236 . . . . 62.04 113.594 -171.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.04 86.57 2.45 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 106.947 -1.501 . . . . 53.34 106.947 174.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -106.08 118.82 37.61 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.642 -0.873 . . . . 73.14 108.642 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.93 133.19 47.87 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.502 0.721 . . . . 44.35 109.459 -177.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.09 152.25 96.25 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 123.355 0.662 . . . . 73.3 112.486 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.63 106.28 0.42 Allowed 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.076 2.518 . . . . 54.04 112.712 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.12 109.73 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 108.568 -0.901 . . . . 64.35 108.568 171.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.425 ' HB2' ' HB3' ' C' ' 135' ' ' ALA . 3.9 m-20 -81.71 110.83 17.41 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.837 1.255 . . . . 72.32 109.996 175.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -49.83 -45.06 49.77 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.428 0.691 . . . . 73.23 111.345 174.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -56.27 -53.82 52.66 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.743 1.217 . . . . 73.02 112.051 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' C' ' 132' ' ' ASN . . . -72.18 -25.49 61.7 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 123.431 0.692 . . . . 73.1 111.335 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 36.0 tp -69.16 -39.79 78.56 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.701 0.8 . . . . 73.24 110.697 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -65.15 -32.52 74.25 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.546 0.338 . . . . 75.04 110.27 173.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 56.3 ttp -72.13 -31.74 66.29 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.683 0.793 . . . . 63.54 110.8 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -68.03 -49.65 60.17 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.472 -0.566 . . . . 61.12 109.472 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -72.74 -104.49 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.995 0.918 . . . . 75.21 111.225 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 54.4 tp 51.88 -80.84 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.009 1.324 . . . . 73.31 111.489 -172.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -150.39 98.89 2.72 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 106.602 -1.629 . . . . 42.11 106.602 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -75.98 86.27 2.9 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.544 0.687 . . . . 75.21 110.528 -175.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -136.31 79.21 1.75 Allowed 'General case' 0 C--O 1.244 0.778 0 CA-C-N 114.551 -1.204 . . . . 74.43 107.768 177.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 145' ' ' ALA . . . . . 0.567 ' HB3' ' HA ' ' A' ' 5' ' ' ASN . . . -164.38 -170.97 2.21 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 114.409 -1.269 . . . . 71.24 109.16 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.46 -170.68 28.46 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 121.184 0.324 . . . . 64.1 113.767 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -112.42 146.86 37.64 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.588 0.755 . . . . 75.24 109.732 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -126.18 107.42 0.93 Allowed Glycine 0 C--N 1.342 0.88 0 CA-C-N 115.917 -0.583 . . . . 72.41 111.835 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 43.1 p -126.79 93.54 3.8 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.6 0.76 . . . . 54.1 109.252 174.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.27 131.91 42.51 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.107 0.563 . . . . 65.32 109.729 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -68.81 108.95 3.64 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.102 0.561 . . . . 43.13 109.795 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -101.59 144.15 30.69 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 116.088 -0.505 . . . . 73.35 110.587 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -81.82 107.96 14.97 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.586 -0.894 . . . . 74.43 108.586 173.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -91.73 157.83 16.71 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.899 0.48 . . . . 61.44 110.201 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.922 0 C-N-CA 123.612 0.765 . . . . 72.51 110.087 178.52 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.718 -0.475 . . . . 73.43 109.718 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' D' D ' 2' ' ' SER . . . . . 0.445 ' O ' ' HA3' ' D' ' 91' ' ' GLY . 33.3 p -147.2 65.86 1.15 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.912 0.885 . . . . 71.15 109.023 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.69 112.13 2.38 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.81 -0.811 . . . . 72.22 108.81 172.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 4' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' D' ' 90' ' ' GLU . 18.1 mm-40 -120.23 143.99 47.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.561 -0.745 . . . . 72.31 109.058 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -127.66 42.45 3.32 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.016 0.926 . . . . 74.32 109.489 -177.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -60.64 104.89 0.38 Allowed 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.156 -0.929 . . . . 63.23 109.437 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 58.9 p -64.82 -58.64 5.67 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.34 1.456 . . . . 71.1 113.595 -164.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -86.72 32.73 0.65 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.389 0.676 . . . . 74.32 112.382 -169.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 11.7 ptp -33.17 148.8 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 124.63 1.172 . . . . 73.02 113.7 163.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 49.3 m -103.56 139.9 38.25 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.468 -0.938 . . . . 44.12 108.468 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -150.35 108.7 3.78 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.976 -1.12 . . . . 74.14 107.976 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 12' ' ' GLN . . . . . 0.617 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 43.5 mt-30 -126.46 118.51 25.1 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.194 -1.039 . . . . 75.21 108.194 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.469 HG21 HD11 ' D' ' 16' ' ' ILE . 19.8 mt -86.76 125.98 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 109.26 -0.644 . . . . 75.53 109.26 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -98.23 -29.06 13.42 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.411 0.684 . . . . 71.12 111.41 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -173.05 131.49 0.5 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 111.934 0.346 . . . . 74.34 111.934 -167.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.469 HD11 HG21 ' D' ' 13' ' ' ILE . 1.8 mp -112.74 136.02 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 107.366 -1.346 . . . . 72.34 107.366 167.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.441 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 40.5 p90 -164.64 175.84 9.42 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.779 0.8 . . . . 72.45 112.234 178.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.4 p -110.64 127.69 55.37 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.703 -1.135 . . . . 74.34 109.408 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.441 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 37.9 mtpt -100.38 -18.1 16.91 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.611 0.764 . . . . 72.53 110.134 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.657 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 11.4 t70 -159.27 133.51 7.68 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.575 1.15 . . . . 75.21 108.207 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.558 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.5 mt -136.27 146.52 28.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 106.704 -1.591 . . . . 74.44 106.704 173.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 22' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 23.0 t -152.61 143.82 23.19 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.142 0.577 . . . . 42.3 109.767 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.3 t80 -151.41 125.87 9.46 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 105.806 -1.924 . . . . 73.42 105.806 175.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -140.65 111.48 6.99 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.243 0.617 . . . . 71.42 109.807 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.56 92.0 9.43 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 108.508 -0.923 . . . . 64.13 108.508 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.82 -30.77 2.73 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.921 2.414 . . . . 64.44 113.559 -171.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -102.62 9.07 39.56 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.092 0.957 . . . . 64.01 111.081 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.512 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -30.63 -65.59 0.19 Allowed Pre-proline 0 CA--C 1.556 1.211 0 N-CA-C 117.272 2.323 . . . . 75.15 117.272 -160.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.09 -29.05 8.49 Favored 'Trans proline' 0 C--N 1.378 2.102 0 CA-C-N 123.173 2.169 . . . . 53.43 113.751 -171.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -85.72 -21.63 28.19 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.598 0.237 . . . . 71.15 110.508 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.512 HG12 ' O ' ' D' ' 28' ' ' ALA . 9.7 p -82.7 -15.72 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 116.037 -0.528 . . . . 53.5 110.827 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -69.69 -22.18 63.44 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 112.5 0.556 . . . . 70.44 112.5 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -57.81 -29.28 64.78 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.637 0.732 . . . . 51.21 109.6 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -88.11 71.13 9.32 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.073 -1.421 . . . . 71.14 109.328 173.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -88.65 84.54 6.73 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.293 0.568 . . . . 61.02 109.753 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.475 ' O ' ' HG2' ' D' ' 124' ' ' PRO . 8.9 p90 -147.49 178.48 8.4 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.379 1.071 . . . . 64.22 108.578 171.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -61.12 111.94 5.01 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 123.098 0.559 . . . . 60.42 109.903 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.11 127.63 24.83 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 121.914 1.743 . . . . 73.02 111.139 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.72 112.71 2.97 Favored 'General case' 0 C--N 1.347 0.469 0 N-CA-C 108.57 -0.9 . . . . 74.23 108.57 173.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 4.5 m -108.56 143.07 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 114.751 -1.113 . . . . 65.34 110.704 -169.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.54 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 13.9 tmtt? -125.46 122.33 36.34 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.224 -1.398 . . . . 72.43 107.224 177.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.58 HD23 ' HA ' ' H' ' 6' ' ' ILE . 4.5 pp -95.75 146.48 24.5 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 121.267 0.556 . . . . 74.2 110.037 -177.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -147.41 132.02 17.81 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.139 -1.059 . . . . 52.44 108.139 175.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -110.29 144.11 39.49 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.066 -0.716 . . . . 75.4 109.066 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.3 t70 -132.11 146.37 52.0 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.146 -1.057 . . . . 73.43 108.146 174.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 46' ' ' THR . . . . . 0.563 HG21 ' H ' ' H' ' 15' ' ' PHE . 94.5 m -105.52 144.23 32.57 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.436 0.694 . . . . 73.42 111.158 -173.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.679 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.72 154.58 35.52 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.823 0.849 . . . . 75.21 109.373 170.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 21.6 p -168.59 159.99 10.51 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.699 0.8 . . . . 61.23 109.503 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 51.9 p -160.73 140.53 10.96 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.402 0.681 . . . . 64.35 109.847 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -87.76 124.79 33.97 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.807 -0.442 . . . . 74.23 109.807 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 35.9 mt -95.58 -36.45 11.26 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.015 0.526 . . . . 62.43 110.165 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.85 178.7 9.81 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.303 1.041 . . . . 43.21 109.489 174.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -64.69 119.01 9.75 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.816 -0.809 . . . . 72.43 108.816 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 72.19 9.08 5.94 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 124.316 1.046 . . . . 75.12 111.723 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 90.1 t -118.45 115.1 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.21 -1.034 . . . . 73.52 108.21 171.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.467 ' HB2' HD11 ' D' ' 86' ' ' ILE . 69.8 m-85 -133.47 130.02 38.01 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.349 -0.612 . . . . 70.33 109.349 -175.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -92.58 124.7 36.8 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.619 -1.252 . . . . 73.42 107.619 174.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 84.6 t -119.98 132.49 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.336 1.054 . . . . 63.5 108.529 -169.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.679 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 14.7 t -125.0 136.73 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.263 0.625 . . . . 72.23 109.886 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.437 HD22 ' HB3' ' D' ' 103' ' ' PRO . 57.2 tp -125.72 118.79 26.35 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.408 -0.96 . . . . 70.54 108.408 167.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.491 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 16.9 ttm-85 -85.88 111.96 20.7 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.619 0.768 . . . . 73.11 109.497 176.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 45.8 t -91.85 128.65 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.521 -0.918 . . . . 74.21 108.521 170.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 9.9 m -122.67 134.82 54.47 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.337 -0.616 . . . . 72.43 109.337 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 57.3 t -127.18 101.53 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 125.86 1.664 . . . . 71.52 107.978 -173.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 21.4 m -92.25 94.34 9.12 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.744 -0.836 . . . . 53.42 108.744 176.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.5 141.39 30.63 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.99 -0.55 . . . . 73.44 110.377 -175.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.401 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 66.0 p -147.73 128.88 14.64 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.0 -0.546 . . . . 75.43 110.296 -178.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.445 HD12 HG22 ' D' ' 31' ' ' VAL . 43.5 mt -93.46 108.83 20.45 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.965 -1.124 . . . . 72.22 107.965 175.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.91 -115.88 4.33 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.381 -0.827 . . . . 60.43 111.193 -171.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.29 6.15 10.71 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.731 0.812 . . . . 53.1 110.511 -174.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -121.59 152.83 38.83 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.905 0.882 . . . . 63.25 109.343 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 35.1 m -64.33 132.13 49.27 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.161 0.505 . . . . 73.21 111.512 -176.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.401 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -89.36 -60.44 1.95 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.492 -1.299 . . . . 63.11 107.492 174.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -157.19 159.38 37.67 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.332 -1.304 . . . . 71.23 110.135 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 86.8 mt -124.31 114.26 19.32 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 107.506 -1.294 . . . . 71.45 107.506 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.438 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 1.2 m -114.12 135.47 53.99 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.061 -1.089 . . . . 52.04 108.061 -175.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 77' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 37.5 tt0 -156.18 121.05 4.66 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.624 -0.51 . . . . 75.4 109.624 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.5 t -135.12 116.93 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.025 0.53 . . . . 61.42 109.578 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.657 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 13.9 mt-30 -85.43 91.15 8.13 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.001 -1.111 . . . . 73.35 108.001 166.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -81.61 109.43 16.04 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.103 -1.073 . . . . 62.04 108.103 174.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.94 166.43 14.09 Favored Glycine 0 C--O 1.244 0.745 0 O-C-N 123.72 0.638 . . . . 43.35 111.993 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.89 136.49 4.2 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 112.054 -0.418 . . . . 52.2 112.054 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.8 mt -89.68 122.21 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.536 0.734 . . . . 75.54 109.102 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -130.87 125.48 33.67 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.727 0.811 . . . . 71.13 109.421 -175.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.617 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 45.5 m -89.91 96.74 10.82 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.828 0.851 . . . . 64.24 109.264 173.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.632 ' HB ' HD12 ' D' ' 89' ' ' ILE . 0.2 OUTLIER -110.79 114.92 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 123.588 0.755 . . . . 74.44 110.712 -178.118 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.41 162.47 25.5 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.783 0.833 . . . . 52.54 109.552 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.04 20.34 78.9 Favored Glycine 0 C--N 1.347 1.151 0 C-N-CA 121.783 -0.246 . . . . 63.33 112.74 178.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.632 HD12 ' HB ' ' D' ' 86' ' ' ILE . 55.8 mt -116.36 136.62 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.776 0.83 . . . . 73.23 109.137 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' D' ' 4' ' ' GLN . 9.2 pt-20 -151.05 152.36 33.34 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.433 0.693 . . . . 70.44 110.935 -170.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 91' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' D' ' 2' ' ' SER . . . 67.92 -138.9 33.76 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 115.409 -0.814 . . . . 72.32 115.006 176.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 32.1 m -62.74 -25.58 68.26 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.118 0.967 . . . . 74.12 111.557 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -62.11 -26.61 68.39 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.53 0.732 . . . . 64.54 111.073 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.401 ' HB3' ' N ' ' H' ' 18' ' ' VAL . 69.5 mtm -68.7 -46.56 68.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.804 0.841 . . . . 71.33 111.227 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.04 -30.13 68.43 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.31 -0.859 . . . . 63.45 110.69 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.404 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 25.2 t-80 -77.42 -27.15 52.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.414 0.685 . . . . 73.3 110.98 177.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.8 t -72.1 -52.95 14.36 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.398 0.618 . . . . 73.24 110.278 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 24.2 mt -86.47 -19.36 29.68 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 114.62 -1.173 . . . . 73.05 110.704 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.91 3.4 57.21 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-O 119.35 -0.694 . . . . 63.14 114.16 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.475 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -144.75 -65.9 0.34 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.105 0.952 . . . . 70.44 111.566 -178.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -69.9 -45.95 66.48 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 112.373 0.508 . . . . 70.02 112.373 -173.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 84.0 m -62.94 -45.35 87.01 Favored Pre-proline 0 CA--C 1.569 1.686 0 CA-C-O 118.782 -0.627 . . . . 75.44 112.218 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.437 ' HB3' HD22 ' D' ' 60' ' ' LEU . 51.5 Cg_exo -59.03 -27.66 85.65 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 122.786 2.324 . . . . 32.22 114.201 169.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -70.87 -26.51 63.29 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 122.854 0.462 . . . . 60.12 111.419 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 43.8 mm -72.02 -35.61 54.42 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-O 121.415 0.626 . . . . 63.14 109.465 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 86.0 mt -84.3 -23.3 30.36 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.058 -0.974 . . . . 63.43 112.114 -175.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 94.0 t80 -58.99 -49.1 95.16 Favored Pre-proline 0 CA--C 1.562 1.407 0 N-CA-C 113.662 0.986 . . . . 74.25 113.662 -174.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.06 -37.48 95.64 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 121.851 1.701 . . . . 44.52 113.116 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -75.9 -37.66 58.56 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.499 -0.773 . . . . 73.41 111.529 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.62 -41.39 96.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.081 0.552 . . . . 74.33 110.086 177.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.416 ' NH2' ' HA ' ' B' ' 105' ' ' ILE . 36.9 ttp180 -58.44 -53.42 58.53 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 124.214 0.946 . . . . 72.32 110.394 174.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.24 -43.26 96.25 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.187 0.929 . . . . 74.15 111.46 -174.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.8 t -59.58 -45.73 91.01 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.637 0.586 . . . . 63.43 111.081 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.466 ' O ' HG23 ' D' ' 118' ' ' VAL . 91.7 mt -64.35 -55.72 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 115.741 -0.663 . . . . 74.0 110.415 177.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 57.6 m -52.79 -40.36 63.14 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.693 1.197 . . . . 65.34 111.753 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.5 t -69.42 -42.39 75.08 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.33 -0.85 . . . . 63.54 110.075 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.8 mtm -64.85 -34.34 78.14 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.906 0.482 . . . . 55.21 111.482 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.466 HG23 ' O ' ' D' ' 114' ' ' ILE . 93.6 t -63.68 -47.8 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.538 0.735 . . . . 70.51 110.002 176.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.2 p -71.78 -27.33 62.88 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.918 -0.583 . . . . 61.22 110.93 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 74.7 mtt-85 -73.67 -29.29 62.22 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.462 0.705 . . . . 64.32 109.834 173.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.85 3.78 85.88 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 119.523 -0.598 . . . . 32.05 112.723 174.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.504 HG23 ' HB3' ' C' ' 17' ' ' TYR . 44.7 p 60.19 24.98 14.33 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 126.401 1.88 . . . . 73.22 113.733 177.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -89.09 156.43 49.03 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.282 0.633 . . . . 71.11 109.764 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.475 ' HG2' ' O ' ' D' ' 36' ' ' TRP . 71.5 Cg_exo -49.23 123.54 10.27 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.368 2.712 . . . . 64.15 113.338 171.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -53.87 141.17 28.2 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.749 1.22 . . . . 72.12 112.205 -177.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -121.3 116.97 25.85 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.493 -1.299 . . . . 70.44 107.493 -177.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -112.25 103.5 11.64 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.389 0.676 . . . . 52.44 109.513 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.1 116.22 10.2 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.049 0.539 . . . . 73.25 110.558 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.49 143.46 97.86 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.232 0.613 . . . . 62.42 110.28 175.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.72 123.17 13.17 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.082 2.521 . . . . 74.31 112.832 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 98.6 t -107.71 112.86 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.634 0.774 . . . . 53.34 108.941 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 132' ' ' ASN . . . . . 0.504 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 44.9 t30 -81.71 89.02 6.24 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.089 -1.078 . . . . 72.32 108.089 172.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.487 ' HZ ' HD22 ' H' ' 11' ' ' LEU . 0.9 OUTLIER -64.82 -22.97 67.1 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.874 -1.057 . . . . 63.43 111.011 -176.495 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.475 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 7.8 m-20 -61.3 -48.52 81.01 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.33 0.652 . . . . 74.51 111.185 172.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.504 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -62.49 -43.68 98.23 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.457 0.703 . . . . 72.31 111.559 -176.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 84.7 mt -57.79 -36.21 71.87 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.154 0.909 . . . . 64.44 111.485 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -81.77 -37.01 27.85 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.731 0.812 . . . . 55.41 111.657 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.454 ' HA ' ' HB2' ' D' ' 141' ' ' LEU . 75.8 mtm -70.06 -15.2 62.96 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.816 0.446 . . . . 63.03 110.887 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -62.72 -43.52 98.59 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.501 0.72 . . . . 53.02 110.757 169.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -65.15 -42.02 94.19 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.185 0.594 . . . . 72.43 110.13 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.454 ' HB2' ' HA ' ' D' ' 138' ' ' MET . 10.9 mp -62.2 -36.07 80.79 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.114 0.566 . . . . 65.5 111.545 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -90.71 36.32 0.9 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.504 0.668 . . . . 61.21 111.823 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -117.72 79.24 1.33 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 107.79 -1.189 . . . . 44.33 107.79 173.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -166.7 134.85 2.72 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.488 -1.233 . . . . 72.35 107.996 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 145' ' ' ALA . . . . . 0.514 ' H ' HG22 ' D' ' 149' ' ' THR . . . -159.72 15.77 0.15 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.738 0.815 . . . . 50.11 110.447 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 69.01 -86.12 0.22 Allowed Glycine 0 C--N 1.351 1.414 0 N-CA-C 112.17 -0.372 . . . . 45.23 112.17 -172.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.27 154.33 17.58 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.447 0.699 . . . . 74.24 110.126 176.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.02 -76.85 1.02 Allowed Glycine 0 C--N 1.352 1.459 0 O-C-N 123.532 0.52 . . . . 55.51 112.466 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 149' ' ' THR . . . . . 0.514 HG22 ' H ' ' D' ' 145' ' ' ALA . 60.1 p 60.72 -75.66 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.757 2.023 . . . . 65.13 113.474 174.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -151.34 -161.34 1.31 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.669 1.188 . . . . 72.31 108.598 -175.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.94 -173.83 4.94 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.684 0.394 . . . . 71.01 110.941 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -70.71 107.32 3.89 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.993 -0.549 . . . . 73.33 110.158 173.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -86.66 140.52 29.73 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.517 -0.549 . . . . 62.43 109.517 174.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -70.49 85.35 0.61 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.471 0.708 . . . . 63.34 109.655 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 C-N-CA 124.093 0.957 . . . . 73.3 109.245 -177.281 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' E' E ' 1' ' ' MET . . . . . 0.401 ' SD ' ' N ' ' E' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.111 -0.7 . . . . 41.02 109.111 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -140.46 129.87 23.94 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.619 0.768 . . . . 74.2 109.904 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -115.66 115.13 25.85 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.699 -1.223 . . . . 71.41 107.699 174.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -112.92 158.97 19.56 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.057 0.543 . . . . 63.51 111.12 -175.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 36.8 m -139.31 152.44 47.22 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.052 0.941 . . . . 61.54 109.129 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.441 HD13 HG13 ' A' ' 40' ' ' VAL . 38.0 pt -59.92 145.55 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 123.813 0.845 . . . . 71.2 112.583 176.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 7' ' ' ALA . . . . . 0.564 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . . . -154.99 158.52 39.3 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.972 0.909 . . . . 75.23 109.565 175.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.709 ' HB2' HG11 ' A' ' 131' ' ' VAL . 78.9 mt -80.05 174.41 11.62 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.859 0.464 . . . . 74.45 110.129 177.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.04 176.66 7.45 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.641 0.776 . . . . 44.44 109.348 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 10' ' ' LEU . . . . . 0.456 ' HB2' HD22 ' A' ' 136' ' ' LEU . 55.2 tp -61.54 129.89 43.33 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.897 0.479 . . . . 64.32 110.202 178.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.719 ' HB2' HD23 ' E' ' 14' ' ' LEU . 4.4 mp -68.35 119.69 69.78 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 108.837 -0.801 . . . . 73.43 108.837 -178.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -82.64 34.66 0.55 Allowed 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.854 2.369 . . . . 64.24 112.187 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 tt -158.83 -44.6 0.06 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.909 -1.145 . . . . 75.2 107.909 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 14' ' ' LEU . . . . . 0.719 HD23 ' HB2' ' E' ' 11' ' ' LEU . 58.2 mt 66.14 -167.77 0.21 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.549 1.14 . . . . 74.02 110.876 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 15' ' ' PHE . . . . . 0.509 ' HB3' ' HD3' ' E' ' 17' ' ' PRO . 83.4 m-85 -101.32 158.91 15.7 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.336 0.654 . . . . 74.24 110.418 174.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 16.7 p -143.43 62.3 11.09 Favored Pre-proline 0 CA--C 1.568 1.635 0 C-N-CA 123.913 0.885 . . . . 65.01 110.623 172.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 17' ' ' PRO . . . . . 0.545 ' HD2' HD22 ' A' ' 98' ' ' LEU . 74.6 Cg_endo -77.32 -27.84 6.19 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 122.205 1.936 . . . . 72.34 112.462 176.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 19.2 t -103.14 -29.62 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 123.501 0.72 . . . . 61.43 110.347 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 9.1 m 65.79 167.36 0.2 Allowed 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 124.705 1.202 . . . . 72.4 110.728 -172.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 50.7 tptt 68.83 20.34 8.06 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.234 1.016 . . . . 75.53 109.68 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.36 -75.34 0.27 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.723 -1.126 . . . . 71.23 109.382 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.97 -85.58 0.29 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 107.879 -1.156 . . . . 62.04 107.879 177.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 20.3 m 51.8 103.48 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 125.146 1.378 . . . . 52.13 112.821 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.64 -74.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.079 1.853 . . . . 61.54 110.693 175.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 . . . . . 0 C--O 1.248 0.984 0 N-CA-C 107.79 -1.189 . . . . 73.44 107.79 173.885 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 109.693 -0.484 . . . . 75.23 109.693 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -146.48 -91.83 0.09 Allowed 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 108.681 -0.859 . . . . 64.11 108.681 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -124.92 -57.57 1.52 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.202 -1.036 . . . . 72.54 108.202 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -86.98 51.9 2.37 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.259 -0.882 . . . . 74.42 110.017 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 37.6 m -65.39 -58.99 4.51 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 123.829 0.852 . . . . 62.41 109.551 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.494 HG13 ' H ' ' F' ' 7' ' ' ALA . 4.8 pt -145.44 -60.13 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 114.1 -1.409 . . . . 61.32 108.311 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 7' ' ' ALA . . . . . 0.494 ' H ' HG13 ' F' ' 6' ' ' ILE . . . 59.31 158.68 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.313 1.445 . . . . 52.33 113.054 -176.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 8' ' ' LEU . . . . . 0.819 HD13 HD21 ' B' ' 44' ' ' LEU . 60.4 mt -85.25 21.31 1.73 Allowed 'General case' 0 N--CA 1.482 1.146 0 O-C-N 121.878 -0.514 . . . . 75.12 112.164 -176.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . 66.98 -76.01 0.05 Allowed 'General case' 0 C--N 1.362 1.152 0 C-N-CA 126.011 1.724 . . . . 72.4 111.926 176.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 10' ' ' LEU . . . . . 0.462 ' HG ' HD23 ' B' ' 136' ' ' LEU . 7.0 tt -156.27 -56.1 0.09 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.311 -1.366 . . . . 74.54 107.311 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 2.7 tm? 63.36 103.76 0.03 OUTLIER Pre-proline 0 C--N 1.361 1.1 0 C-N-CA 125.226 1.41 . . . . 70.45 110.436 -173.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 12' ' ' PRO . . . . . 0.444 ' HA ' ' HZ ' ' B' ' 137' ' ' PHE . 20.9 Cg_exo -67.21 121.72 8.9 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.398 2.065 . . . . 63.54 110.645 170.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 pp -76.59 80.95 3.26 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-O 122.332 1.063 . . . . 71.25 111.955 -175.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 37.7 mt -100.77 30.55 3.95 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.671 -0.695 . . . . 75.33 110.957 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 15' ' ' PHE . . . . . 0.592 ' HZ ' HD13 ' B' ' 60' ' ' LEU . 70.4 m-85 -70.0 143.32 52.61 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.902 0.881 . . . . 75.11 110.03 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 16' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' B' ' 48' ' ' SER . 32.3 m -70.6 130.48 88.86 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.021 0.528 . . . . 75.34 110.259 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 17' ' ' PRO . . . . . 0.683 ' HA ' HD21 ' B' ' 98' ' ' LEU . 52.2 Cg_endo -64.96 167.74 15.24 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 123.308 2.672 . . . . 74.12 114.314 -177.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 18' ' ' VAL . . . . . 0.593 HG21 HG21 ' B' ' 86' ' ' ILE . 29.5 t -60.23 -44.29 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 114.678 -1.147 . . . . 71.42 109.394 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 8.8 t -162.94 121.32 2.06 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 114.722 -1.127 . . . . 74.41 109.499 168.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 56.1 tptt 60.39 -81.88 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.881 1.673 . . . . 72.0 112.913 174.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 21' ' ' ALA . . . . . 0.546 ' HB2' ' SD ' ' B' ' 94' ' ' MET . . . 52.67 -78.28 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.195 1.398 . . . . 74.42 112.225 -178.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -146.37 -30.12 0.38 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.435 1.094 . . . . 74.34 109.753 166.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 27.9 m 61.56 92.81 0.06 OUTLIER Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 125.083 1.353 . . . . 75.42 111.335 -175.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.92 105.01 0.89 Allowed 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.525 2.15 . . . . 71.45 111.32 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 . . . . . 0 C--O 1.258 1.52 0 C-N-CA 124.095 0.958 . . . . 54.02 109.516 178.631 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtt . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 109.354 -0.61 . . . . 73.21 109.354 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -81.82 66.94 7.61 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.246 0.619 . . . . 75.11 109.826 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -83.36 97.13 8.77 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.15 0.5 . . . . 75.14 109.684 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 40.8 m -132.24 164.55 26.14 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.478 1.111 . . . . 65.31 108.582 174.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 22.7 m -60.57 -59.81 4.8 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.937 -0.394 . . . . 75.23 109.937 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 6' ' ' ILE . . . . . . . . . . . . . 13.1 pt -147.97 156.93 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.888 0.875 . . . . 64.43 110.3 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.77 139.11 24.86 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.067 -0.97 . . . . 73.34 108.484 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 8' ' ' LEU . . . . . 0.475 HD23 HD22 ' C' ' 42' ' ' LEU . 53.0 mt -70.59 148.39 48.19 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.321 0.388 . . . . 64.42 110.135 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.48 163.2 27.3 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.83 0.452 . . . . 74.14 111.164 176.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -86.33 39.58 0.83 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 123.349 0.66 . . . . 75.51 110.364 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 11' ' ' LEU . . . . . 0.45 ' HB2' HD23 ' G' ' 14' ' ' LEU . 71.4 mt 55.62 95.15 0.05 OUTLIER Pre-proline 0 C--N 1.368 1.395 0 C-N-CA 125.56 1.544 . . . . 71.53 111.672 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -55.26 -56.25 2.48 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 123.833 3.022 . . . . 73.33 113.932 -166.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 40.1 tp -93.22 -16.4 24.85 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.996 0.518 . . . . 72.33 110.983 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 14' ' ' LEU . . . . . 0.45 HD23 ' HB2' ' G' ' 11' ' ' LEU . 59.1 mt 68.06 167.4 0.26 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.901 1.28 . . . . 72.41 111.059 -171.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -84.78 142.15 30.01 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.138 -0.69 . . . . 74.43 109.138 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 41.6 p -66.82 124.89 89.75 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 123.633 0.773 . . . . 71.33 111.715 -172.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 17' ' ' PRO . . . . . 0.469 ' HB3' ' H ' ' G' ' 21' ' ' ALA . 98.3 Cg_exo -48.16 123.51 8.96 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 123.726 2.95 . . . . 52.53 114.189 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 18' ' ' VAL . . . . . . . . . . . . . 54.3 t -54.19 -55.23 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 124.183 0.993 . . . . 61.35 109.833 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 3.4 t -154.92 101.97 2.31 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.246 -1.343 . . . . 75.5 108.379 171.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 20' ' ' LYS . . . . . 0.487 ' HB3' ' HZ3' ' G' ' 20' ' ' LYS . 5.7 ttpm? 55.05 33.65 20.79 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 125.06 1.344 . . . . 71.32 112.354 175.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 21' ' ' ALA . . . . . 0.469 ' H ' ' HB3' ' G' ' 17' ' ' PRO . . . -75.54 81.14 2.56 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.14 0.576 . . . . 74.33 110.944 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -162.32 -52.94 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.838 1.255 . . . . 63.53 109.746 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 23.0 p -136.54 107.37 9.22 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 123.953 0.901 . . . . 64.55 109.99 -174.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 24' ' ' PRO . . . . . 0.442 ' HD3' ' H ' ' C' ' 92' ' ' THR . 95.2 Cg_endo -94.77 78.54 0.16 Allowed 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.703 2.936 . . . . 74.04 112.108 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 CA--C 1.554 1.101 0 C-N-CA 123.748 0.819 . . . . 60.0 110.109 -176.458 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 N-CA-C 109.948 -0.39 . . . . 72.42 109.948 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -131.94 159.13 39.58 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.658 0.783 . . . . 72.4 110.386 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -68.34 -34.8 76.74 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.533 -0.758 . . . . 74.21 109.435 167.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 24.3 m -83.12 85.2 7.23 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.033 -0.985 . . . . 71.44 109.469 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 61.8 m -138.38 155.51 48.45 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.666 1.187 . . . . 43.0 108.101 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.58 ' HA ' HD23 ' D' ' 42' ' ' LEU . 16.0 tt -74.21 82.34 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 CA-C-O 123.49 1.614 . . . . 71.52 110.121 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.01 28.03 0.94 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 113.928 -1.487 . . . . 55.12 109.341 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 8' ' ' LEU . . . . . 0.407 ' H ' HD22 ' D' ' 42' ' ' LEU . 5.5 tt 61.2 112.98 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.037 1.335 . . . . 74.51 110.277 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.62 -87.32 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 122.604 0.361 . . . . 54.14 111.061 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 tt -170.32 126.59 0.79 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.734 -0.839 . . . . 73.11 108.734 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.494 ' HB3' HD23 ' H' ' 14' ' ' LEU . 10.6 mp -96.01 128.32 37.66 Favored Pre-proline 0 N--CA 1.483 1.197 0 N-CA-C 108.9 -0.778 . . . . 64.33 108.9 172.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -42.27 -65.16 0.2 Allowed 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 123.85 3.033 . . . . 62.52 113.415 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 37.6 mt -149.69 -63.37 0.22 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.422 1.089 . . . . 75.22 108.234 168.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 14' ' ' LEU . . . . . 0.494 HD23 ' HB3' ' H' ' 11' ' ' LEU . 3.8 mm? 58.95 -170.45 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.22 0.608 . . . . 74.23 111.219 -177.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 15' ' ' PHE . . . . . 0.563 ' H ' HG21 ' D' ' 46' ' ' THR . 80.9 m-85 64.47 -178.46 0.17 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.429 1.091 . . . . 74.51 112.711 176.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 16' ' ' THR . . . . . 0.407 ' HB ' ' HB1' ' H' ' 21' ' ' ALA . 43.0 p -117.3 158.02 45.7 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-N 115.271 -0.877 . . . . 72.41 109.995 -177.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.71 -152.02 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.994 0 C-N-CA 122.796 2.33 . . . . 74.04 112.639 174.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 18' ' ' VAL . . . . . 0.401 ' N ' ' HB3' ' D' ' 94' ' ' MET . 49.9 t -128.38 154.62 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.461 -1.311 . . . . 72.22 107.461 175.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 84.1 m 66.39 95.1 0.06 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.645 1.178 . . . . 62.13 109.417 -165.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt 53.05 67.59 0.97 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.676 1.191 . . . . 71.12 111.185 -172.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 21' ' ' ALA . . . . . 0.407 ' HB1' ' HB ' ' H' ' 16' ' ' THR . . . -75.46 -61.44 1.91 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.015 -0.993 . . . . 71.42 111.135 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -58.04 4.74 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.573 -0.899 . . . . 74.53 108.573 -175.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 18.4 m 48.07 74.03 0.89 Allowed Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 124.671 1.188 . . . . 71.12 111.808 -176.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -80.69 -5.99 13.33 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.084 2.523 . . . . 74.13 113.136 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 CA--C 1.556 1.176 0 C-N-CA 124.009 0.924 . . . . 61.45 109.675 -177.686 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 109.932 -0.396 . . . . 73.42 109.932 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.0 t -63.15 133.04 53.73 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.863 0.865 . . . . 72.21 110.559 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.05 41.72 1.08 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.885 0.874 . . . . 72.3 111.241 -174.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -64.7 94.59 0.13 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.566 0.746 . . . . 70.43 110.305 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -113.4 165.07 12.81 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.823 -1.081 . . . . 72.44 108.937 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 67.39 86.49 0.13 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.571 1.149 . . . . 64.53 110.036 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.8 p -125.55 -49.98 1.64 Allowed 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.373 1.069 . . . . 72.45 109.075 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -94.49 179.98 5.09 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.969 -1.014 . . . . 74.22 110.606 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.3 ttt 73.81 155.92 0.17 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 125.16 1.384 . . . . 64.32 111.574 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 56.2 m -137.16 101.36 4.52 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.621 -1.251 . . . . 61.53 107.621 175.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.585 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 20.5 t80 -98.92 127.53 44.86 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.314 -1.312 . . . . 70.41 109.296 -176.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -146.72 115.02 6.66 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.912 -0.773 . . . . 74.33 108.912 176.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.677 HG12 ' HD2' ' A' ' 84' ' ' PHE . 32.8 mt -84.38 115.33 26.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.79 -0.818 . . . . 70.42 108.79 176.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -75.77 -33.56 60.2 Favored 'General case' 0 C--O 1.242 0.684 0 O-C-N 123.687 0.617 . . . . 71.05 110.816 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -171.51 148.04 2.46 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.329 0.393 . . . . 61.32 110.912 -170.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.47 HD12 ' HB3' ' C' ' 130' ' ' PRO . 87.6 mt -138.68 133.84 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 107.983 -1.117 . . . . 71.5 107.983 172.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.425 ' HB3' HG23 ' B' ' 122' ' ' THR . 19.7 p90 -164.32 157.38 17.57 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.147 0.979 . . . . 75.44 110.701 -171.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -84.42 113.18 20.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.888 -1.051 . . . . 62.44 108.636 177.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 32.7 mtpt -82.27 -31.86 29.88 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.844 0.354 . . . . 61.42 110.287 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.8 t70 -137.45 137.94 39.26 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.392 -0.822 . . . . 74.13 109.634 171.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.415 HD13 ' SD ' ' B' ' 117' ' ' MET . 64.5 mt -127.23 139.98 50.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 C-N-CA 124.973 1.309 . . . . 62.25 107.535 171.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.9 t -150.45 128.17 11.64 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 123.822 0.701 . . . . 40.34 109.56 173.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.45 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 83.2 t80 -129.89 121.85 27.49 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 106.849 -1.537 . . . . 74.1 106.849 172.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 47.2 mt-10 -127.05 112.78 15.61 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.929 0.492 . . . . 62.3 110.0 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.5 81.77 4.33 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 107.287 -1.375 . . . . 70.41 107.287 169.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.43 -16.38 19.31 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.728 2.285 . . . . 62.3 112.599 -171.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -113.01 12.84 19.35 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.381 1.072 . . . . 71.22 110.567 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -41.35 -59.33 2.37 Favored Pre-proline 0 C--N 1.37 1.468 0 CA-C-O 117.337 -1.316 . . . . 72.43 114.38 -165.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 44.8 Cg_exo -53.72 -45.23 42.59 Favored 'Trans proline' 0 C--N 1.39 2.737 0 C-N-CA 121.934 1.756 . . . . 73.3 113.881 -174.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -97.75 -14.12 21.02 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.105 0.78 . . . . 72.43 113.105 -170.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.801 HG21 ' HA ' ' A' ' 73' ' ' ALA . 8.0 p -75.46 -22.21 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-N 118.288 0.495 . . . . 53.23 111.341 -175.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -65.85 -22.24 66.52 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.23 0.612 . . . . 73.52 111.124 173.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -80.68 -19.53 44.98 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.143 0.977 . . . . 75.54 111.079 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.431 ' NZ ' ' HB2' ' A' ' 71' ' ' GLU . 31.8 mmtp -81.62 155.02 25.85 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.707 0.803 . . . . 61.41 111.453 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.59 132.37 49.61 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.094 0.958 . . . . 63.32 110.296 174.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -81.59 85.68 6.5 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.012 0.525 . . . . 74.2 110.196 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -121.82 82.25 42.23 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 107.509 -1.293 . . . . 73.43 107.509 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -75.14 115.18 4.19 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 122.435 2.09 . . . . 72.24 111.948 -172.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -91.95 96.53 10.43 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.091 -1.818 . . . . 71.4 106.091 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.597 HG11 HG12 ' E' ' 6' ' ' ILE . 15.9 m -66.5 90.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.615 0 CA-C-O 122.69 1.233 . . . . 74.52 110.3 -175.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 54.2 tptt -96.85 110.69 23.13 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.541 -1.651 . . . . 74.54 106.541 175.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.565 HD23 ' H ' ' A' ' 42' ' ' LEU . 2.0 pt? -110.37 147.14 34.56 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.875 -0.417 . . . . 71.13 109.875 -172.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.565 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 13.5 t70 -130.91 129.11 41.81 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.295 -1.372 . . . . 74.44 107.295 177.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.467 ' H ' HD23 ' A' ' 44' ' ' LEU . 2.2 pt? -126.57 129.52 48.73 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.108 0.563 . . . . 72.02 109.564 -174.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -152.33 163.06 40.24 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.184 0.994 . . . . 52.44 108.852 -177.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.2 m -147.39 144.11 28.46 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.429 0.692 . . . . 71.22 110.804 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.52 122.22 25.77 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.171 -1.418 . . . . 65.44 107.171 173.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.674 ' HB2' ' HB3' ' E' ' 17' ' ' PRO . 66.5 p -131.52 153.5 49.75 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.727 0.299 . . . . 63.33 110.851 -173.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.8 t -155.74 146.83 22.43 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.744 0.818 . . . . 72.52 109.966 -173.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -76.53 141.26 41.27 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.905 -0.776 . . . . 74.35 108.905 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 57' ' ' GLU . 69.0 mt -113.73 -39.54 4.0 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.095 0.958 . . . . 73.43 109.605 176.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -155.96 -170.48 3.41 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.242 0.617 . . . . 72.23 110.296 -177.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -60.9 108.33 0.85 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.564 0.746 . . . . 73.34 110.059 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 65.01 7.13 3.82 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.69 1.196 . . . . 73.01 112.79 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 85.3 t -98.93 116.32 41.66 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 N-CA-C 107.239 -1.393 . . . . 71.31 107.239 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.606 ' HB3' ' HB2' ' E' ' 17' ' ' PRO . 67.5 m-85 -131.81 128.67 39.22 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.173 0.989 . . . . 75.1 109.391 -172.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.473 ' HB2' HD11 ' A' ' 51' ' ' LEU . 38.3 tt0 -87.33 131.42 34.27 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.588 0.755 . . . . 73.4 109.743 172.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.463 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 98.3 t -118.77 116.18 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.156 -1.053 . . . . 53.24 108.156 171.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.56 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 35.6 t -101.31 117.76 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 109.044 -0.724 . . . . 63.42 109.044 175.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.39 113.77 26.68 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.252 -0.647 . . . . 70.34 109.252 -176.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -82.6 101.99 11.14 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.668 -0.864 . . . . 72.41 108.668 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.6 t -100.14 102.6 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 107.404 -1.332 . . . . 63.42 107.404 170.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 37.2 m -106.59 135.92 47.27 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.935 0.894 . . . . 53.32 109.715 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.706 HG11 HD21 ' A' ' 126' ' ' LEU . 40.5 t -130.98 126.6 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.765 1.226 . . . . 54.14 108.753 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 10.8 m -112.44 135.33 53.27 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.545 -0.909 . . . . 71.55 108.545 174.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.92 105.63 14.87 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.364 -1.346 . . . . 65.11 107.364 170.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.7 m -107.1 133.81 51.15 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.903 -1.147 . . . . 71.14 107.903 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.7 mt -103.48 47.87 0.87 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.413 -0.958 . . . . 72.25 108.413 -176.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.18 -84.44 1.35 Allowed Glycine 0 C--N 1.342 0.881 0 N-CA-C 110.848 -0.901 . . . . 74.12 110.848 -170.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -90.69 -31.41 16.6 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.615 0.766 . . . . 73.41 111.588 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.431 ' HB2' ' NZ ' ' A' ' 34' ' ' LYS . 3.8 tp10 -115.9 112.69 22.27 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 116.282 -0.417 . . . . 63.11 110.294 -162.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.2 m -70.73 119.57 15.08 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.881 -0.414 . . . . 74.25 109.881 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.801 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -70.01 -58.56 3.69 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 114.951 -1.022 . . . . 61.21 109.52 175.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -155.68 171.57 19.77 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.141 -0.936 . . . . 72.1 112.528 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 28.0 tp -141.31 107.63 5.26 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 113.701 -1.59 . . . . 72.41 107.754 175.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.0 m -106.39 101.68 11.14 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.373 1.069 . . . . 52.44 110.556 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -116.43 117.3 29.55 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.918 0.887 . . . . 73.23 109.292 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.0 t -131.07 110.45 18.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 123.818 0.847 . . . . 74.3 109.326 -174.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 69.9 mt-30 -85.92 88.52 7.58 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.811 -0.811 . . . . 63.35 108.811 171.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -80.46 100.47 8.53 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.347 -0.842 . . . . 63.53 109.537 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.29 144.94 19.45 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 111.678 -0.569 . . . . 64.42 111.678 176.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.404 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -145.98 127.48 2.8 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.408 -0.677 . . . . 53.31 111.408 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.3 mt -85.2 124.75 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.629 0.772 . . . . 74.03 108.946 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.677 ' HD2' HG12 ' A' ' 13' ' ' ILE . 12.5 m-85 -133.41 159.87 39.04 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.111 0.564 . . . . 73.02 109.557 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.0 p -111.24 114.18 27.19 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.063 -0.718 . . . . 62.52 109.063 170.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.593 HG12 HD23 ' A' ' 98' ' ' LEU . 4.1 mp -109.73 117.57 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 107.754 -1.202 . . . . 73.43 107.754 175.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.54 137.15 7.73 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.905 0.882 . . . . 73.22 109.225 -174.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 140.55 -74.51 0.36 Allowed Glycine 0 C--N 1.341 0.845 0 O-C-N 123.392 0.433 . . . . 75.21 112.068 176.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.2 tt -149.84 144.16 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 122.749 0.42 . . . . 65.41 110.855 -170.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.491 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 5.6 mp0 -104.3 -152.97 0.47 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.796 1.238 . . . . 74.0 109.539 -176.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.38 -140.51 29.63 Favored Glycine 0 C--N 1.355 1.614 0 CA-C-O 119.923 -0.376 . . . . 73.21 112.812 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.5 p -67.6 -26.04 66.07 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.775 0.83 . . . . 41.1 111.832 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -68.07 -51.73 43.25 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.038 0.935 . . . . 74.32 110.373 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.491 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 53.5 ttp -70.82 -25.75 62.99 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 122.315 0.246 . . . . 74.32 111.317 176.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.07 -30.47 71.0 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 120.909 0.385 . . . . 75.54 110.682 175.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.454 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 58.9 t-80 -83.76 -37.16 22.98 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.774 -0.648 . . . . 71.12 111.071 176.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 74.3 m -77.75 -64.29 1.19 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 122.724 0.41 . . . . 52.2 111.104 -177.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.593 HD23 HG12 ' A' ' 86' ' ' ILE . 3.2 tm? -72.92 -39.75 66.05 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.883 0.873 . . . . 71.35 110.867 -175.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.82 0.44 76.56 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-O 119.378 -0.679 . . . . 45.01 114.672 -171.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.481 ' HB1' ' HB3' ' A' ' 134' ' ' ASP . . . -146.55 -50.61 0.21 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.113 0.957 . . . . 54.03 112.43 -172.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.478 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 65.1 t80 -76.21 -49.99 15.71 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.556 0.743 . . . . 72.44 111.994 -174.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.408 ' HA ' HG12 ' A' ' 105' ' ' ILE . 77.2 m -68.47 -34.27 5.49 Favored Pre-proline 0 CA--C 1.568 1.667 0 N-CA-C 113.435 0.902 . . . . 65.43 113.435 -178.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -50.93 -44.36 42.3 Favored 'Trans proline' 0 C--N 1.396 3.065 0 C-N-CA 122.68 2.254 . . . . 60.23 112.954 162.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -70.2 -22.41 62.93 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 114.846 -1.07 . . . . 73.42 111.614 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.408 HG12 ' HA ' ' A' ' 102' ' ' CYS . 44.1 mm -70.31 -43.93 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 123.299 0.64 . . . . 71.04 110.714 177.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.404 HD21 ' HA3' ' A' ' 82' ' ' GLY . 88.9 mt -76.31 -19.31 58.38 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.804 -0.634 . . . . 75.31 111.596 -176.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -64.33 -48.33 76.08 Favored Pre-proline 0 CA--C 1.568 1.657 0 N-CA-C 114.153 1.168 . . . . 61.04 114.153 -172.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.28 -34.48 67.29 Favored 'Trans proline' 0 C--N 1.388 2.649 0 CA-C-N 122.035 1.763 . . . . 51.52 112.754 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -69.2 -45.17 70.56 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.607 0.763 . . . . 73.32 111.435 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.2 -37.83 78.29 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.963 -0.562 . . . . 74.24 110.716 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.457 HH12 HD12 ' C' ' 105' ' ' ILE . 24.4 ttm180 -60.68 -45.6 93.55 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 124.004 0.815 . . . . 54.31 109.641 174.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -66.14 -44.56 83.82 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.651 0.78 . . . . 75.54 111.5 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -60.21 -42.21 94.65 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.532 0.52 . . . . 73.45 110.107 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 118' ' ' VAL . 59.0 mt -59.53 -52.56 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 124.082 0.953 . . . . 65.55 110.5 172.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.426 HG21 ' HE2' ' C' ' 109' ' ' TYR . 94.9 m -54.58 -46.7 73.78 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.472 1.109 . . . . 73.45 111.969 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 44.3 t -70.41 -34.53 72.63 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.331 -0.849 . . . . 71.14 111.22 -176.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.45 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 9.3 mtp -67.44 -40.53 85.44 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.318 0.647 . . . . 75.31 110.863 175.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 114' ' ' ILE . 51.4 t -62.92 -51.1 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.695 1.198 . . . . 74.5 110.799 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.4 p -68.35 -29.24 67.92 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.356 0.662 . . . . 73.42 111.373 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' A' ' 116' ' ' SER . 18.5 ttm-85 -74.31 -30.28 61.99 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.207 1.003 . . . . 74.41 110.042 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.444 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.93 11.6 59.6 Favored Glycine 0 C--N 1.353 1.522 0 CA-C-N 115.23 -0.895 . . . . 63.21 112.603 172.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.489 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.0 OUTLIER 66.17 11.59 7.95 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 127.025 2.13 . . . . 62.23 113.148 175.532 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -78.64 148.99 74.07 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 123.263 0.625 . . . . 74.41 109.722 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.02 158.81 41.56 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.622 2.215 . . . . 73.32 112.34 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.417 ' OE1' HG23 ' A' ' 115' ' ' THR . 6.1 tp-100 -58.77 132.56 54.25 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.546 1.138 . . . . 61.21 112.829 -167.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.706 HD21 HG11 ' A' ' 64' ' ' VAL . 51.9 tp -129.31 110.74 12.19 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.986 1.314 . . . . 65.43 109.726 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -129.8 121.16 26.25 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.65 0.78 . . . . 62.34 108.957 172.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.461 HD11 HG21 ' A' ' 64' ' ' VAL . 6.4 mp -71.83 147.0 47.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.615 0.366 . . . . 73.31 110.649 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.76 140.47 96.33 Favored Pre-proline 0 CA--C 1.554 1.124 0 O-C-N 123.771 0.669 . . . . 71.3 110.86 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.401 ' HD3' HG13 ' C' ' 13' ' ' ILE . 30.8 Cg_endo -62.31 133.21 42.21 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 123.265 2.643 . . . . 52.34 112.125 177.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 m -127.1 113.95 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 121.666 0.746 . . . . 65.33 110.391 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -87.88 96.89 10.65 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.242 -1.022 . . . . 75.11 108.242 168.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -57.12 -40.27 76.78 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 123.879 0.737 . . . . 72.42 110.474 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.481 ' HB3' ' HB1' ' A' ' 100' ' ' ALA . 11.9 p-10 -62.67 -41.75 99.24 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.299 -1.319 . . . . 60.34 112.28 -177.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.8 88.83 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.069 0.548 . . . . 71.03 110.905 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.657 ' HB2' HD21 ' E' ' 10' ' ' LEU . 85.8 mt -74.1 -29.31 61.78 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.807 -0.633 . . . . 61.52 110.984 178.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -71.4 -31.75 67.63 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.029 0.532 . . . . 63.25 110.544 173.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 33.6 mmt -71.97 -38.03 69.81 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.103 0.561 . . . . 72.44 110.309 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -62.11 -44.5 96.51 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 123.841 0.713 . . . . 73.23 109.744 175.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -65.45 -41.39 93.47 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.081 0.952 . . . . 71.11 110.983 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.8 tp -67.74 -14.58 63.07 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.118 0.967 . . . . 72.32 112.232 -174.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -146.33 30.45 1.03 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.466 0.651 . . . . 73.01 110.003 -176.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -64.4 94.12 0.11 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.777 1.231 . . . . 62.01 111.655 -176.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -137.19 110.63 7.96 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.912 0.885 . . . . 74.42 109.384 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 66.84 -75.69 0.06 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.374 1.47 . . . . 71.31 111.843 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.85 62.85 2.87 Favored Glycine 0 C--N 1.344 1.01 0 N-CA-C 111.268 -0.733 . . . . 22.54 111.268 -174.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -74.44 -28.93 61.27 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.457 1.103 . . . . 73.44 112.525 -170.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -79.5 70.81 2.78 Favored Glycine 0 C--N 1.347 1.192 0 O-C-N 123.248 0.342 . . . . 54.13 112.653 -177.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.1 t -144.33 153.91 42.48 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.769 0.827 . . . . 65.44 110.7 -174.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -77.78 144.78 36.85 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.363 0.665 . . . . 72.33 110.371 177.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -83.99 144.62 29.01 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.168 0.987 . . . . 70.23 110.804 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -92.43 153.15 19.31 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.264 1.026 . . . . 73.33 109.57 176.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -93.38 -37.44 11.99 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.204 0.602 . . . . 71.22 110.502 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -117.9 147.4 43.14 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.489 1.116 . . . . 73.23 109.622 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 C-N-CA 123.685 0.794 . . . . 74.23 109.43 176.743 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.478 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 108.835 -0.802 . . . . 73.35 108.835 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 69.6 p -161.28 -174.4 4.3 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.85 0.86 . . . . 73.42 110.219 174.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -136.57 124.56 22.83 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.452 -0.944 . . . . 73.03 108.452 173.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -92.96 -67.27 0.87 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.572 0.749 . . . . 62.44 109.161 -176.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 168.73 -30.9 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.968 1.707 . . . . 75.23 107.359 -174.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.53 64.93 0.57 Allowed 'General case' 0 C--N 1.364 1.201 0 C-N-CA 124.97 1.308 . . . . 62.15 111.118 172.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.6 p -135.38 161.94 34.01 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.596 -1.183 . . . . 63.41 110.366 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 63.32 -77.69 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.889 1.676 . . . . 75.11 111.96 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 1.9 tmt? 66.01 161.01 0.14 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.824 1.65 . . . . 74.05 111.766 -176.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 87.6 m -169.03 139.58 2.32 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 125.078 1.351 . . . . 75.23 107.936 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.35 157.37 45.65 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.413 0.625 . . . . 72.42 110.105 157.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -124.56 131.45 53.48 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 107.185 -1.413 . . . . 74.03 107.185 175.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.449 HD13 HD11 ' B' ' 16' ' ' ILE . 59.7 mt -67.87 117.32 9.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.215 -1.032 . . . . 74.4 108.215 174.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' GLN . . . . . 0.434 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 11.5 mm-40 -86.9 -37.89 17.24 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 124.038 0.836 . . . . 74.25 108.745 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.489 ' HE ' HG21 ' A' ' 122' ' ' THR . 42.4 ttt180 -175.27 137.61 0.4 Allowed 'General case' 0 C--N 1.355 0.828 0 CA-C-N 115.4 -0.818 . . . . 74.33 109.606 -176.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.449 HD11 HD13 ' B' ' 13' ' ' ILE . 94.2 mt -115.49 141.51 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 107.273 -1.38 . . . . 63.53 107.273 173.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -165.88 146.41 6.66 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.989 0.423 . . . . 70.2 111.484 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.594 HG21 HD11 ' B' ' 21' ' ' ILE . 96.2 m -75.97 123.48 25.81 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.382 -0.826 . . . . 71.24 109.049 169.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.457 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 23.0 mtpp -89.17 -38.84 13.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.817 -0.629 . . . . 74.01 109.965 178.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 14.6 t70 -153.21 142.44 21.49 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.174 0.435 . . . . 63.44 112.174 -169.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.594 HD11 HG21 ' B' ' 18' ' ' THR . 38.2 mm -134.79 146.34 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.029 1.332 . . . . 74.22 108.775 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.52 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 47.7 t -147.9 140.51 24.59 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.905 -1.146 . . . . 50.33 107.905 175.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.411 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 92.1 t80 -157.65 114.15 2.9 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.893 -1.151 . . . . 64.34 107.893 173.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -121.98 112.45 18.29 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.298 -0.63 . . . . 73.52 109.298 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.53 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -108.6 86.81 3.82 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 107.429 -1.323 . . . . 61.33 107.429 172.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.37 -40.79 2.83 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.331 2.021 . . . . 65.21 112.013 -176.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -92.44 9.29 34.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.805 0.842 . . . . 63.4 111.367 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.53 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -40.4 -66.04 0.4 Allowed Pre-proline 0 CA--C 1.57 1.722 0 C-N-CA 125.225 1.41 . . . . 74.0 114.58 -170.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.05 -34.99 94.12 Favored 'Trans proline' 0 C--N 1.399 3.202 0 C-N-CA 122.915 2.41 . . . . 73.33 113.536 -167.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -95.25 -28.85 14.81 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.545 -0.752 . . . . 71.42 111.972 -174.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.447 HG21 ' HA ' ' B' ' 73' ' ' ALA . 4.5 p -74.81 -12.44 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-N 118.271 0.487 . . . . 64.15 111.351 -176.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -68.82 -14.51 63.08 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.294 0.85 . . . . 73.22 113.294 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -64.49 -27.07 68.72 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.096 0.474 . . . . 74.44 110.148 172.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -87.75 84.01 7.1 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.647 1.179 . . . . 62.33 110.134 -177.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -93.27 87.56 5.69 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.377 -0.829 . . . . 73.15 109.873 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -160.23 177.03 11.06 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.298 1.039 . . . . 74.12 108.739 171.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -69.83 111.77 10.14 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 109.502 -0.555 . . . . 71.33 109.502 176.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -67.04 157.46 61.61 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.317 2.012 . . . . 63.25 111.89 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 24.9 tt0 -66.23 103.54 1.01 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.16 -1.052 . . . . 71.23 108.16 169.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -86.94 141.59 14.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.579 -0.896 . . . . 63.01 108.579 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -147.05 99.43 3.17 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 108.27 -1.011 . . . . 55.12 108.27 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.19 165.66 12.29 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.213 0.53 . . . . 70.51 111.097 -177.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -159.79 136.61 9.27 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.534 1.133 . . . . 65.22 108.206 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.524 HD11 HD13 ' F' ' 8' ' ' LEU . 95.5 mt -99.85 158.26 15.93 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.631 -0.507 . . . . 73.54 109.631 175.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.502 ' HB3' ' HD3' ' B' ' 61' ' ' ARG . 23.0 t70 -145.74 151.85 38.63 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 124.427 1.091 . . . . 72.34 108.163 170.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 46.1 p -107.59 106.26 16.54 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.473 0.709 . . . . 73.23 109.554 -174.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.39 135.81 53.54 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.726 -1.213 . . . . 62.12 107.726 176.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.3 p -148.13 167.54 24.76 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.321 0.581 . . . . 74.22 112.33 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.5 p -153.89 155.66 36.12 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.277 -1.329 . . . . 64.25 108.378 167.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -121.16 119.76 33.28 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.002 -0.74 . . . . 62.41 109.002 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 61.8 mt -84.18 -34.82 23.9 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.335 0.654 . . . . 74.12 111.341 -173.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.51 -175.73 4.35 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.49 -0.777 . . . . 42.34 110.119 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -76.03 119.12 19.54 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.539 -0.755 . . . . 61.23 109.207 178.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 71.45 13.5 6.49 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.099 1.76 . . . . 62.31 111.292 -176.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 99.0 t -122.41 113.19 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 108.114 -1.069 . . . . 65.22 108.114 170.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -118.75 171.52 8.15 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.255 -0.646 . . . . 64.54 109.255 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -141.68 102.79 4.25 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 107.306 -1.368 . . . . 62.24 107.306 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 92.9 t -95.23 135.67 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.219 1.007 . . . . 74.45 110.302 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 22.2 t -128.94 116.39 40.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 124.027 0.931 . . . . 73.42 109.38 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' B' ' 103' ' ' PRO . 43.5 tp -95.44 109.41 21.6 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.9 -0.778 . . . . 74.52 108.9 172.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.632 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 59.5 ttt180 -92.34 108.55 20.04 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.465 0.706 . . . . 73.45 109.43 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 38.5 t -106.24 102.49 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.316 1.046 . . . . 54.04 108.99 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 7.9 m -98.2 135.93 39.13 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.436 0.694 . . . . 74.45 109.353 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.522 HG21 HG21 ' B' ' 114' ' ' ILE . 85.8 t -126.9 139.25 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.181 0.993 . . . . 62.11 110.414 -175.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.6 m -124.78 149.44 47.36 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.524 1.13 . . . . 74.14 108.093 172.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.79 142.09 26.24 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 122.927 0.491 . . . . 64.32 110.249 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.558 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 75.8 p -141.06 128.62 21.38 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 123.477 0.485 . . . . 75.04 111.03 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 29.7 mt -100.21 118.85 37.38 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.152 0.981 . . . . 73.2 109.052 175.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.6 -112.34 4.82 Favored Glycine 0 CA--C 1.526 0.726 0 O-C-N 123.932 0.77 . . . . 75.4 112.296 -175.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -115.37 3.05 14.09 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.273 0.629 . . . . 61.35 111.192 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -120.4 159.24 25.49 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.952 0.501 . . . . 75.05 110.69 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 58.6 m -68.94 120.78 15.36 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.618 0.767 . . . . 61.2 110.129 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.558 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -77.61 -61.17 2.08 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.259 -1.015 . . . . 61.23 108.259 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -156.34 164.57 38.14 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.628 -1.169 . . . . 75.44 111.427 177.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 45.5 mt -122.49 153.53 39.04 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 106.093 -1.818 . . . . 72.1 106.093 173.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.439 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 49.5 t -157.92 159.67 36.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.393 -0.595 . . . . 74.11 109.393 -179.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.8 tt0 -165.39 135.32 3.59 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.147 -1.056 . . . . 53.45 108.147 174.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 44.9 t -132.92 145.7 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 108.536 -0.912 . . . . 75.21 108.536 174.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.632 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 61.5 mt-30 -126.06 100.34 6.3 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.601 -0.888 . . . . 73.01 108.601 177.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.431 ' HG3' HD22 ' B' ' 106' ' ' LEU . 8.9 tp-100 -90.43 114.83 27.06 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.18 -0.674 . . . . 75.24 109.18 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.457 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -104.93 167.9 15.48 Favored Glycine 0 C--O 1.242 0.641 0 O-C-N 123.851 0.719 . . . . 43.2 111.652 177.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.29 134.41 3.14 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.992 -0.843 . . . . 73.21 110.992 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.434 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 45.0 mt -86.43 126.19 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 108.549 -0.908 . . . . 75.15 108.549 173.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -135.96 139.34 43.15 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 106.883 -1.525 . . . . 63.45 106.883 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 67.8 m -108.73 91.17 3.53 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.499 0.59 . . . . 62.5 111.531 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 mp -97.6 130.92 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.772 0.829 . . . . 73.5 110.509 -171.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.79 165.57 27.13 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.737 0.815 . . . . 44.44 110.304 173.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.04 -56.9 0.65 Allowed Glycine 0 C--N 1.347 1.192 0 CA-C-N 116.161 -0.472 . . . . 41.54 112.133 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 30.8 mm -87.93 161.83 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.774 0.83 . . . . 75.11 109.798 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -167.89 149.72 5.46 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.859 0.864 . . . . 75.5 110.339 166.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.47 -136.83 12.95 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.907 0.765 . . . . 74.31 112.625 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.2 m -81.86 -23.02 36.61 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 117.256 0.528 . . . . 72.0 111.253 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -68.1 -28.22 67.16 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.934 0.493 . . . . 74.44 109.885 169.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 12.4 ttm -79.16 -28.77 42.78 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.215 0.606 . . . . 63.25 111.081 175.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.677 ' HB1' ' HB3' ' F' ' 14' ' ' LEU . . . -58.61 -26.76 64.02 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.15 0.58 . . . . 75.21 111.093 174.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -71.42 -51.33 24.53 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.331 1.053 . . . . 73.43 110.606 172.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 39.2 t -59.66 -45.83 90.86 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.375 0.67 . . . . 63.51 112.418 -175.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.616 HD11 HG23 ' F' ' 18' ' ' VAL . 72.9 mt -87.5 -17.63 31.69 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.388 0.675 . . . . 74.11 111.551 -176.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.7 3.88 32.38 Favored Glycine 0 C--N 1.35 1.325 0 O-C-N 123.244 0.34 . . . . 70.25 113.79 -175.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.53 -58.22 0.53 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.019 0.527 . . . . 74.03 110.4 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -73.64 -48.66 30.81 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.772 0.67 . . . . 74.21 112.378 -169.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.433 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 84.2 m -66.04 -46.92 63.81 Favored Pre-proline 0 CA--C 1.566 1.595 0 CA-C-O 118.699 -0.667 . . . . 63.12 111.322 177.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.433 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 85.5 Cg_exo -55.21 -33.1 83.26 Favored 'Trans proline' 0 C--N 1.402 3.356 0 C-N-CA 122.819 2.346 . . . . 65.22 114.094 168.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -63.13 -40.25 97.05 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.943 0.897 . . . . 64.13 110.25 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 84.2 mt -68.52 -47.53 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 115.121 -0.945 . . . . 74.04 110.45 175.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.431 HD22 ' HG3' ' B' ' 80' ' ' GLN . 96.0 mt -79.08 -4.44 50.28 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.358 -0.837 . . . . 63.12 111.968 -173.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.07 -61.73 7.34 Favored Pre-proline 0 N--CA 1.478 0.958 0 CA-C-O 117.914 -1.041 . . . . 75.54 112.617 -177.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.77 -25.81 68.17 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 121.842 1.694 . . . . 74.53 112.976 -172.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -71.4 -49.59 40.39 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.812 0.845 . . . . 74.23 110.709 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.74 -42.18 97.91 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.47 0.708 . . . . 64.52 110.866 175.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 75.2 ttt-85 -59.17 -59.89 4.73 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.93 1.692 . . . . 74.14 111.512 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -64.01 -25.29 68.06 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.147 0.979 . . . . 72.05 110.845 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.545 ' SG ' HD12 ' B' ' 21' ' ' ILE . 17.5 t -70.38 -46.87 63.19 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 122.293 -0.254 . . . . 71.11 111.604 178.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.522 HG21 HG21 ' B' ' 64' ' ' VAL . 97.8 mt -59.61 -49.98 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.491 0.716 . . . . 72.32 110.004 173.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 14.2 m -60.32 -28.54 68.21 Favored 'General case' 0 CA--C 1.556 1.198 0 O-C-N 123.853 0.721 . . . . 75.44 111.796 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -66.78 -46.86 73.96 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.497 0.719 . . . . 64.41 110.319 173.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.9 mmt -71.44 -30.28 65.85 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.979 0.512 . . . . 74.1 111.26 -175.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 114' ' ' ILE . 73.5 t -61.23 -47.31 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.537 1.135 . . . . 74.22 109.761 170.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 40.8 t -65.35 -36.79 85.09 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.011 -0.995 . . . . 70.12 111.59 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -71.75 -32.44 67.71 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.694 0.798 . . . . 75.51 110.513 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.19 5.89 81.45 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 123.942 0.776 . . . . 65.43 112.665 174.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.425 HG23 ' HB3' ' A' ' 17' ' ' TYR . 54.7 p 56.7 55.79 6.05 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 125.766 1.626 . . . . 62.22 112.658 176.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -119.95 158.39 50.24 Favored Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 124.585 1.154 . . . . 70.43 110.873 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.93 164.83 5.66 Favored 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 123.845 3.03 . . . . 52.33 115.527 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.512 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -65.19 129.84 41.16 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.653 1.181 . . . . 74.51 112.056 -176.706 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -139.01 119.21 13.56 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.914 -0.773 . . . . 71.42 108.914 174.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -116.45 135.33 53.93 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.233 1.013 . . . . 73.45 109.416 173.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 54.5 tp -78.78 149.18 32.7 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.274 0.63 . . . . 71.21 109.861 175.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.35 148.75 86.28 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 123.192 0.597 . . . . 72.53 110.857 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.492 ' HG3' HD11 ' D' ' 16' ' ' ILE . 72.7 Cg_endo -71.15 88.6 0.7 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.118 2.545 . . . . 63.33 111.391 176.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.58 110.45 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 109.416 -0.587 . . . . 64.13 109.416 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -101.58 93.14 5.21 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 107.529 -1.286 . . . . 64.04 107.529 176.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -62.17 -35.95 80.38 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.461 0.476 . . . . 75.51 110.687 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' B' ' 138' ' ' MET . 10.2 m-20 -53.68 -52.49 59.85 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.652 0.781 . . . . 71.31 110.335 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.13 -40.64 90.45 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 124.899 1.374 . . . . 62.25 111.478 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 59.9 tp -62.65 -47.56 83.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.331 0.652 . . . . 41.11 111.234 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.402 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 56.5 m-85 -62.16 -34.62 76.75 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.189 0.596 . . . . 62.3 111.293 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' B' ' 134' ' ' ASP . 22.2 mmt -59.41 -34.15 72.11 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.779 0.432 . . . . 72.33 111.941 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -79.98 -26.21 40.02 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.723 0.409 . . . . 75.32 111.274 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -73.18 -50.38 22.9 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 120.757 0.313 . . . . 72.54 110.952 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 2.7 pp -117.03 30.33 7.39 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.107 0.563 . . . . 53.41 110.878 -168.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -55.34 122.24 10.7 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.172 0.989 . . . . 70.13 111.332 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -115.67 111.51 20.72 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.642 -0.873 . . . . 72.24 108.642 177.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -138.76 128.4 24.76 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.216 -0.661 . . . . 65.12 109.216 176.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -166.39 -179.99 5.28 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.249 1.02 . . . . 61.21 109.582 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 177.09 -111.27 0.33 Allowed Glycine 0 C--N 1.341 0.807 0 N-CA-C 111.279 -0.728 . . . . 75.42 111.279 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -92.05 87.18 6.06 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.556 0.743 . . . . 61.42 109.63 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -98.54 -170.41 31.65 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 115.856 -0.611 . . . . 13.44 111.87 173.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 4.5 t -162.82 88.21 0.61 Allowed 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.783 0.801 . . . . 62.21 110.621 177.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -94.29 144.13 25.8 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.607 0.763 . . . . 74.44 109.597 173.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.47 131.76 34.45 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 106.997 -1.483 . . . . 71.23 106.997 173.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 -73.51 135.52 44.03 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.606 0.362 . . . . 63.14 110.462 -175.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -133.42 157.78 44.71 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.104 0.962 . . . . 53.41 108.562 174.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -153.77 174.08 15.01 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.435 0.294 . . . . 64.1 110.734 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 C-N-CA 123.686 0.794 . . . . 64.44 110.484 -179.338 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 109.577 -0.527 . . . . 73.51 109.577 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 48.5 m -143.04 24.16 1.83 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.084 0.954 . . . . 42.41 109.77 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -65.62 108.92 2.21 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.222 1.009 . . . . 53.5 110.459 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -119.99 110.34 16.57 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.005 0.922 . . . . 73.22 108.621 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -74.38 87.66 2.04 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.956 -0.565 . . . . 72.04 110.32 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -64.26 -21.22 66.51 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.043 0.937 . . . . 70.11 110.358 174.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 74.1 p -55.93 -47.19 77.99 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.619 1.168 . . . . 71.32 110.633 174.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -82.57 77.54 9.32 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.548 -0.751 . . . . 74.33 109.01 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.629 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 0.1 OUTLIER 65.49 116.66 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.045 1.338 . . . . 74.23 111.138 -177.247 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 49.7 m -85.12 90.94 7.99 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.212 0.605 . . . . 75.5 109.489 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.629 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 1.1 t80 -111.13 123.22 49.77 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.58 -0.896 . . . . 74.54 108.58 174.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -137.68 120.89 16.84 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.83 -0.804 . . . . 75.23 108.83 173.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.465 HD13 HD11 ' C' ' 16' ' ' ILE . 32.9 mt -69.59 123.76 23.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.68 -0.859 . . . . 73.43 108.68 172.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -87.57 -49.18 7.35 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.518 -0.764 . . . . 71.51 109.564 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -174.41 125.76 0.32 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.754 -0.657 . . . . 75.35 109.728 -169.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.465 HD11 HD13 ' C' ' 13' ' ' ILE . 77.2 mt -116.12 138.42 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.315 -0.995 . . . . 73.4 108.315 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.575 ' HB3' HG23 ' D' ' 122' ' ' THR . 26.5 p90 -175.28 165.45 3.32 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-O 121.484 0.659 . . . . 75.23 110.864 -172.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -86.25 125.07 33.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.501 -0.772 . . . . 71.44 109.389 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.458 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 20.6 mmtp -74.02 -48.47 29.86 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 106.895 -1.52 . . . . 52.23 106.895 167.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 24.4 t70 -134.99 146.56 49.18 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 113.64 -1.618 . . . . 62.33 110.403 -172.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 78.1 mt -140.64 146.04 24.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.088 -1.819 . . . . 71.51 106.088 175.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 31.2 t -160.54 150.32 17.65 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.18 0.514 . . . . 73.43 110.403 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 82.4 t80 -157.18 118.8 3.73 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.042 -1.096 . . . . 63.23 108.042 174.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 24' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' D' ' 19' ' ' LYS . 34.1 mt-10 -126.66 130.35 50.25 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.816 0.446 . . . . 74.41 110.204 169.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' C' ' 28' ' ' ALA . . . -109.57 92.99 12.96 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 107.263 -1.384 . . . . 63.21 107.263 172.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -59.4 -36.18 94.61 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.621 2.881 . . . . 70.4 114.11 -171.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -114.96 29.93 7.7 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.375 0.67 . . . . 40.52 110.245 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.495 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -43.79 -63.79 0.96 Allowed Pre-proline 0 CA--C 1.567 1.597 0 N-CA-C 114.51 1.3 . . . . 74.01 114.51 -164.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -62.67 -40.52 36.72 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 121.918 1.746 . . . . 63.22 112.708 -175.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -69.49 -33.11 72.38 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.075 0.95 . . . . 72.42 112.213 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.646 HG21 ' HA ' ' C' ' 73' ' ' ALA . 3.9 p -81.59 -23.1 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 122.761 0.424 . . . . 63.14 111.857 -177.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -65.45 -28.75 69.44 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.181 0.438 . . . . 74.41 112.181 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -90.23 32.13 0.95 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.696 0.798 . . . . 72.0 110.839 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.7 162.63 24.6 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.248 0.619 . . . . 74.52 111.21 -173.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.19 129.56 38.31 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.302 1.041 . . . . 75.43 110.89 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 49.2 t-105 -87.4 85.11 7.11 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.698 0.799 . . . . 60.41 111.943 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -138.28 76.42 37.9 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 123.976 0.911 . . . . 74.34 108.804 166.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -81.69 156.76 18.59 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.606 2.204 . . . . 73.43 112.533 -176.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 39' ' ' GLU . . . . . 0.557 ' HB3' ' HE2' ' C' ' 41' ' ' LYS . 2.6 mp0 -85.36 93.61 8.76 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 106.255 -1.758 . . . . 75.53 106.255 164.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 13.7 m -67.28 95.56 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-O 122.184 0.993 . . . . 62.4 109.302 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.748 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 75.3 mmtt -95.54 100.74 12.44 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.259 -1.015 . . . . 61.53 108.259 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.516 HD22 HD23 ' G' ' 8' ' ' LEU . 2.5 pp -88.11 137.28 32.47 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.624 -1.171 . . . . 65.33 108.57 -178.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -146.79 107.71 4.17 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.78 -0.822 . . . . 73.03 108.78 -175.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.578 ' H ' HD23 ' C' ' 44' ' ' LEU . 2.0 pt? -119.99 122.86 42.1 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.761 0.791 . . . . 65.52 109.417 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.779 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 22.2 t70 -113.17 157.3 21.85 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 125.168 1.387 . . . . 62.24 109.208 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 74.9 p -113.64 122.27 46.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.2 1.0 . . . . 71.22 109.909 -174.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.59 136.44 41.06 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.578 -0.897 . . . . 71.45 108.578 175.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 25.8 p -164.09 151.65 12.29 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.779 0.431 . . . . 73.52 110.227 -175.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 73.1 p -153.75 154.14 33.49 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.507 0.723 . . . . 75.42 109.713 -175.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -89.3 128.93 35.92 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.529 -0.545 . . . . 73.31 109.529 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.673 HD11 HD12 ' C' ' 83' ' ' ILE . 65.1 mt -96.33 -42.87 7.94 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.638 0.775 . . . . 55.21 111.008 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.86 -166.03 1.51 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.181 -0.918 . . . . 73.2 110.449 -176.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.89 103.77 1.54 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.185 0.994 . . . . 73.2 109.758 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 71.13 -1.67 2.63 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.638 1.575 . . . . 71.13 113.162 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.3 t -91.64 96.3 6.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 106.917 -1.512 . . . . 52.33 106.917 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -110.1 126.69 54.3 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.11 -0.95 . . . . 75.41 110.58 -173.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -83.66 127.79 34.04 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.058 0.943 . . . . 75.01 109.521 175.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 99.1 t -119.28 115.87 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 107.696 -1.224 . . . . 75.2 107.696 170.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 77.5 t -116.38 122.35 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.481 0.712 . . . . 75.14 109.571 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 49.8 tp -106.06 106.8 17.48 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.07 -0.715 . . . . 71.43 109.07 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.779 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 3.1 tmt_? -82.79 108.23 15.99 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.884 -1.154 . . . . 75.51 107.884 177.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.43 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.7 t -106.89 133.64 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.27 -1.011 . . . . 62.23 108.27 176.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 17.7 m -134.19 118.24 17.41 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.033 -0.729 . . . . 60.34 109.033 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 88.7 t -109.75 120.93 61.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.881 -1.054 . . . . 63.41 108.743 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.748 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 6.9 m -107.85 144.3 35.24 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.981 -0.748 . . . . 73.43 108.981 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.9 112.98 10.41 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.499 -0.926 . . . . 52.22 108.499 176.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 51.3 m -133.16 127.39 33.74 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.281 -0.637 . . . . 65.2 109.281 174.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 36.2 mt -84.78 54.98 3.25 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.766 1.226 . . . . 73.22 108.75 176.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.66 -115.8 5.36 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 109.541 -1.424 . . . . 63.25 109.541 -170.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -92.12 -25.7 18.61 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.023 0.929 . . . . 61.1 109.663 170.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -63.48 94.89 0.09 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.178 1.391 . . . . 65.13 110.101 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 30.7 m -75.37 121.48 22.32 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 120.869 0.366 . . . . 75.04 110.56 -174.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.646 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.93 -58.4 3.31 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.999 -1.0 . . . . 70.3 108.604 173.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -163.63 175.58 10.48 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.349 1.071 . . . . 75.05 112.65 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -141.8 141.02 33.15 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 105.046 -2.205 . . . . 75.11 105.046 170.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.483 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.4 t -147.8 134.74 20.21 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.85 -0.796 . . . . 72.05 108.85 -176.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -142.3 117.35 10.01 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.651 0.38 . . . . 64.12 110.499 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 83.3 t -119.1 122.32 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.828 -0.804 . . . . 72.22 108.828 171.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.446 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 57.4 mt-30 -98.46 89.78 4.55 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 107.782 -1.192 . . . . 75.41 107.782 177.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 69.9 tp60 -78.82 108.95 12.64 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.08 -0.964 . . . . 73.22 110.051 -175.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.35 154.66 25.38 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-O 121.51 0.505 . . . . 71.41 111.855 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.522 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -153.42 117.58 0.81 Allowed Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 109.56 -1.416 . . . . 71.11 109.56 176.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.673 HD12 HD11 ' C' ' 51' ' ' LEU . 16.4 mm -85.61 118.51 32.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.018 -1.104 . . . . 65.13 108.018 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.4 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 34.6 m-85 -130.61 129.77 43.14 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.924 0.889 . . . . 72.34 109.256 -171.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 68.6 m -84.31 118.13 24.01 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 109.141 -0.689 . . . . 55.42 109.141 170.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 3.8 mp -114.57 114.01 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 107.656 -1.238 . . . . 64.32 107.656 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.51 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -147.85 162.06 40.03 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.626 0.77 . . . . 70.13 110.259 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.36 -25.61 14.55 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.694 -0.684 . . . . 30.14 113.723 175.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.434 HG13 ' HB3' ' C' ' 94' ' ' MET . 46.3 pt -120.46 162.18 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.675 0.79 . . . . 43.51 110.039 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -147.44 -177.21 5.57 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.768 0.827 . . . . 73.13 109.634 -177.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.0 -136.38 42.05 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 114.569 0.588 . . . . 71.25 114.569 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 92' ' ' THR . . . . . 0.415 ' HA ' ' HB3' ' C' ' 95' ' ' ALA . 34.8 p -65.18 -22.25 66.88 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.535 1.134 . . . . 64.44 112.802 -178.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -60.59 -55.99 26.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.414 0.685 . . . . 70.04 110.045 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.434 ' HB3' HG13 ' C' ' 89' ' ' ILE . 27.7 ptt? -80.79 -20.92 41.51 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.93 -0.577 . . . . 73.13 111.663 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 95' ' ' ALA . . . . . 0.415 ' HB3' ' HA ' ' C' ' 92' ' ' THR . . . -64.5 -35.1 79.85 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.315 0.579 . . . . 72.05 110.742 171.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -74.35 -37.11 63.62 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.324 -0.853 . . . . 72.34 110.386 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.47 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 41.6 t -58.35 -55.97 28.13 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.079 0.862 . . . . 62.1 110.552 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.626 HD23 HG23 ' G' ' 18' ' ' VAL . 4.0 pp -70.46 -28.3 64.9 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.94 0.496 . . . . 51.34 111.852 179.035 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.79 -30.04 60.25 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 114.428 0.531 . . . . 75.23 114.428 -171.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.59 -43.2 0.22 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 117.121 0.461 . . . . 72.01 111.878 -173.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.47 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 70.0 t80 -73.85 -35.73 64.81 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 124.822 1.249 . . . . 72.22 113.095 -170.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.416 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 85.8 m -82.09 -43.7 1.02 Allowed Pre-proline 0 N--CA 1.486 1.333 0 CA-C-O 118.759 -0.639 . . . . 74.24 112.477 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.1 -22.94 61.25 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 121.796 1.664 . . . . 71.03 112.115 171.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 104' ' ' ASN . . . . . 0.495 ' HA ' ' HD2' ' C' ' 107' ' ' PHE . 25.0 t-20 -56.36 -41.28 75.91 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.906 0.883 . . . . 71.2 111.002 175.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.457 HD12 HH12 ' A' ' 111' ' ' ARG . 44.0 mm -59.88 -42.08 88.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 115.156 -0.929 . . . . 73.2 109.802 175.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.522 HD21 ' HA3' ' C' ' 82' ' ' GLY . 96.6 mt -82.34 -20.61 36.97 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.077 -0.965 . . . . 73.03 113.484 -169.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.495 ' HD2' ' HA ' ' C' ' 104' ' ' ASN . 16.5 m-85 -55.56 -49.25 93.71 Favored Pre-proline 0 N--CA 1.496 1.837 0 CA-C-O 118.008 -0.996 . . . . 75.01 113.43 -177.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -58.0 -39.81 82.97 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 122.274 1.983 . . . . 62.4 113.999 178.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.426 ' HE2' HG21 ' A' ' 115' ' ' THR . 68.5 m-85 -68.11 -48.32 65.77 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.411 0.685 . . . . 72.42 110.757 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.61 -42.06 91.76 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.128 -0.942 . . . . 63.51 110.466 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -54.59 -57.98 9.3 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.405 1.065 . . . . 72.34 110.819 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -68.02 -30.94 70.29 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.48 0.488 . . . . 71.14 111.09 -173.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 12.5 t -72.31 -32.9 66.96 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.661 0.384 . . . . 61.32 111.289 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.483 HG23 ' SG ' ' C' ' 76' ' ' CYS . 96.9 mt -73.03 -48.1 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.565 0.746 . . . . 72.14 109.706 173.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 27.1 m -67.55 -30.22 69.81 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.409 0.684 . . . . 70.12 111.413 -174.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 43.5 t -66.0 -44.82 83.69 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.708 -0.849 . . . . 74.1 108.708 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.797 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.06 -38.32 90.71 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.383 1.073 . . . . 74.34 112.474 177.763 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' C' ' 123' ' ' PHE . 79.0 t -65.52 -39.92 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.718 0.807 . . . . 65.53 109.983 174.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.5 t -72.11 -30.99 65.62 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.143 -0.935 . . . . 72.25 111.282 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 73.2 mtt-85 -71.79 -34.1 69.13 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.826 0.851 . . . . 62.5 109.181 175.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.33 6.4 72.49 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 123.985 0.803 . . . . 63.12 112.958 173.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.2 p 61.11 26.81 16.68 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.425 1.89 . . . . 70.12 114.393 171.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.424 ' HB2' HG13 ' C' ' 118' ' ' VAL . 96.5 m-85 -88.15 150.44 47.28 Favored Pre-proline 0 N--CA 1.474 0.765 0 N-CA-C 109.619 -0.511 . . . . 71.5 109.619 173.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.64 143.11 22.85 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.471 2.781 . . . . 54.51 113.762 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -58.08 114.97 2.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.41 1.084 . . . . 72.54 112.262 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 53.9 tp -117.08 103.83 10.63 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.025 0.93 . . . . 73.04 108.915 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -95.35 130.36 42.16 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.838 0.855 . . . . 72.23 109.18 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 tt -74.57 128.21 35.0 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 108.302 -0.999 . . . . 71.51 108.302 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.11 147.3 93.49 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.556 0.742 . . . . 74.3 111.72 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.47 ' HB3' HD12 ' A' ' 16' ' ' ILE . 11.6 Cg_endo -57.89 95.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.821 2.347 . . . . 63.2 112.981 171.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.622 HG21 ' H ' ' G' ' 8' ' ' LEU . 47.4 t -101.59 108.8 24.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.778 -1.194 . . . . 62.24 107.778 172.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -90.7 88.01 6.92 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.588 -0.893 . . . . 54.43 108.588 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -54.71 -44.71 73.69 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.663 0.785 . . . . 71.54 111.757 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -59.6 -45.61 91.42 Favored 'General case' 0 CA--C 1.549 0.915 0 O-C-N 124.954 1.408 . . . . 53.24 110.131 -177.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.47 -24.81 57.0 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.459 -1.246 . . . . 75.34 111.909 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.661 ' HA ' ' HB3' ' C' ' 139' ' ' ASN . 7.4 mp -81.34 -20.67 40.2 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.805 0.842 . . . . 71.24 111.375 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -71.55 -40.77 69.79 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 109.416 -0.587 . . . . 74.12 109.416 167.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 60.3 mtt -67.38 -40.15 85.69 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.402 -0.817 . . . . 75.11 110.516 174.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 139' ' ' ASN . . . . . 0.661 ' HB3' ' HA ' ' C' ' 136' ' ' LEU . 5.1 t30 -65.25 -37.15 86.31 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.596 -1.184 . . . . 74.35 110.28 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -64.61 -87.18 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.078 -0.712 . . . . 72.53 109.078 173.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 47.4 tp 32.22 -88.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.94 1.696 . . . . 74.44 113.234 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -147.73 67.71 1.11 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.644 1.577 . . . . 72.31 107.648 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 143' ' ' GLN . . . . . 0.519 ' HB3' ' O ' ' C' ' 139' ' ' ASN . 11.1 pt20 -66.67 93.56 0.26 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.694 0.797 . . . . 73.3 112.357 -175.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -93.29 -37.58 11.96 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.307 -0.861 . . . . 73.13 108.909 165.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 61.99 -179.69 0.13 Allowed 'General case' 0 C--N 1.362 1.133 0 C-N-CA 125.252 1.421 . . . . 52.54 113.4 175.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -145.7 108.81 0.48 Allowed Glycine 0 C--N 1.343 0.955 0 N-CA-C 110.226 -1.149 . . . . 41.22 110.226 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -75.9 97.68 4.02 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.481 0.712 . . . . 70.25 110.53 -175.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -103.46 -138.5 9.87 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-O 119.416 -0.658 . . . . 35.34 111.642 175.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 48.0 m 53.92 69.79 0.67 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.604 1.162 . . . . 53.11 111.79 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -128.69 -72.82 0.59 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.071 -1.085 . . . . 74.05 108.071 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 66.53 -69.67 0.12 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.139 1.376 . . . . 65.12 111.044 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -134.48 -177.52 4.64 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.059 1.344 . . . . 74.34 109.082 175.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -88.08 -28.15 21.5 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 109.395 -0.595 . . . . 75.23 109.395 168.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -156.73 107.24 2.34 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 107.721 -1.215 . . . . 73.31 107.721 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 C-N-CA 123.861 0.864 . . . . 62.5 110.714 -173.17 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 121.075 0.464 . . . . 41.24 110.007 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' D' D ' 2' ' ' SER . . . . . 0.417 ' HB3' ' HG3' ' D' ' 93' ' ' GLN . 70.4 m -149.43 26.37 0.85 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.838 1.255 . . . . 71.43 109.525 176.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -69.51 82.52 0.4 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.981 0.912 . . . . 64.11 111.259 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -152.07 43.94 0.72 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.865 1.666 . . . . 72.05 106.963 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -50.26 126.75 15.56 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.949 0.9 . . . . 51.34 112.641 -165.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -115.44 129.7 56.65 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.047 -0.979 . . . . 73.34 108.51 -174.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -94.71 -22.31 18.2 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.358 0.663 . . . . 61.22 111.235 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -101.43 -16.85 16.72 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.626 0.77 . . . . 72.2 111.964 -172.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.538 ' SD ' HG13 ' D' ' 89' ' ' ILE . 12.5 tpt -30.78 129.01 0.13 Allowed 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 125.728 1.611 . . . . 60.43 114.554 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 89.5 m -104.8 135.28 46.46 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.047 0.939 . . . . 72.44 109.314 175.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -153.88 91.52 1.47 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.896 -1.52 . . . . 54.12 106.896 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -119.11 116.36 26.19 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.94 -0.763 . . . . 70.24 108.94 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.496 HD13 HG21 ' D' ' 105' ' ' ILE . 8.7 mt -74.32 116.43 16.85 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 N-CA-C 108.898 -0.779 . . . . 72.55 108.898 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 14' ' ' GLN . . . . . 0.607 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 6.9 mm-40 -81.68 -44.94 16.44 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.555 0.742 . . . . 74.31 110.492 -176.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -171.26 143.67 1.91 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.425 -0.352 . . . . 72.13 111.373 -170.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.492 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.4 mp -117.8 132.66 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 107.223 -1.399 . . . . 74.42 107.223 173.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -161.39 141.49 10.69 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.43 0.633 . . . . 74.45 111.056 177.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 77.0 p -77.36 110.96 12.53 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.004 -0.998 . . . . 71.41 109.265 175.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' C' ' 24' ' ' GLU . 36.9 mtpt -85.53 -23.46 27.69 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.565 -0.289 . . . . 75.41 110.481 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.799 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 4.5 t70 -143.19 139.72 30.43 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.333 1.053 . . . . 61.43 108.84 173.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.797 HG21 ' HE2' ' C' ' 117' ' ' MET . 94.4 mt -139.0 146.88 25.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 106.909 -1.515 . . . . 74.21 106.909 169.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.0 t -159.87 110.26 1.89 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.347 0.659 . . . . 44.54 110.062 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.456 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 94.0 t80 -109.54 131.41 55.09 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 106.106 -1.812 . . . . 72.03 106.106 168.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.474 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 39.0 mt-10 -138.61 119.77 14.6 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.97 0.508 . . . . 73.34 109.974 -172.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -135.36 83.71 37.11 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 108.833 -0.803 . . . . 70.2 108.833 178.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.75 -33.74 7.76 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.834 2.356 . . . . 72.33 112.237 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -89.22 -3.09 58.68 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.422 1.089 . . . . 74.4 111.89 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.453 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -32.39 -61.99 0.31 Allowed Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 116.795 2.146 . . . . 71.51 116.795 -164.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.409 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 89.3 Cg_endo -76.34 -27.54 7.83 Favored 'Trans proline' 0 C--N 1.376 2.023 0 CA-C-N 122.708 2.003 . . . . 63.23 114.262 -172.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -86.86 -21.4 26.4 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 117.931 0.332 . . . . 64.23 110.838 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.453 HG12 ' O ' ' D' ' 28' ' ' ALA . 9.9 p -82.58 -16.19 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 122.794 0.437 . . . . 64.04 110.041 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.409 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.5 m-85 -68.04 -20.11 64.96 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.46 0.304 . . . . 65.54 111.648 175.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -56.01 -32.12 63.68 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.276 0.56 . . . . 73.13 110.057 171.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -85.99 85.57 7.37 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.831 1.252 . . . . 61.41 109.32 174.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -93.74 78.21 4.25 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.416 0.626 . . . . 73.1 110.418 -176.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -149.73 -178.03 6.22 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.49 -0.777 . . . . 65.15 109.612 170.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -76.42 110.96 12.91 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.65 0.78 . . . . 72.12 109.627 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.542 ' HB3' ' HG ' ' D' ' 68' ' ' LEU . 18.5 Cg_endo -63.22 147.44 93.94 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.472 2.114 . . . . 50.24 112.408 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -64.55 119.34 10.27 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.979 0.799 . . . . 72.23 108.954 172.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.693 HG13 HG13 ' D' ' 64' ' ' VAL . 99.5 t -96.54 131.04 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.856 -0.794 . . . . 63.14 108.856 -176.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.661 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 43.4 mtpt -106.33 157.36 17.67 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.807 0.843 . . . . 73.24 109.31 169.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.46 113.43 16.82 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 106.664 -1.606 . . . . 74.1 106.664 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.723 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 7.5 m-20 -117.71 144.22 45.47 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.992 -1.004 . . . . 64.44 108.912 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.33 154.72 33.11 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.023 0.529 . . . . 71.43 110.18 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 30.1 t70 -153.11 140.29 19.42 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.819 -1.178 . . . . 71.05 107.819 167.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 87.7 m -104.54 143.82 32.52 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.674 0.79 . . . . 65.12 110.454 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -154.14 152.76 30.78 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.014 0.925 . . . . 34.14 109.377 171.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 67.0 p -169.04 154.21 5.98 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.441 0.696 . . . . 63.22 110.256 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 82.9 p -156.02 156.06 33.78 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.291 0.637 . . . . 75.44 109.524 171.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -96.13 118.2 32.24 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.185 -1.043 . . . . 75.44 108.185 173.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.1 mt -92.85 -27.43 17.14 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.933 0.493 . . . . 74.32 110.757 -174.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.509 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -163.87 -178.68 5.82 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.264 1.025 . . . . 41.54 110.157 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.95 107.88 4.92 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.24 -0.891 . . . . 74.53 110.038 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 68.51 21.55 8.08 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.424 1.49 . . . . 75.34 111.367 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 42.3 t -124.11 115.31 44.5 Favored 'Isoleucine or valine' 0 C--N 1.35 0.599 0 N-CA-C 107.535 -1.283 . . . . 63.25 107.535 170.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -124.38 170.41 10.86 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.338 0.655 . . . . 73.3 109.489 -171.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.524 ' HB2' HD11 ' D' ' 51' ' ' LEU . 26.4 tt0 -130.31 117.99 20.61 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.649 -0.705 . . . . 75.34 109.397 178.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 88.0 t -100.99 117.38 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.424 1.09 . . . . 74.32 108.291 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 24.4 t -119.14 117.45 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.552 -0.907 . . . . 75.33 108.552 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.01 122.24 44.62 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.885 -0.783 . . . . 73.31 108.885 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.533 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 49.6 ttm-85 -87.26 101.87 13.94 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.226 -0.657 . . . . 74.22 109.226 175.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 83.2 t -90.72 114.73 28.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.203 -1.036 . . . . 75.14 108.203 174.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.723 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 28.0 m -116.02 139.62 50.09 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.277 0.561 . . . . 62.2 109.543 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.693 HG13 HG13 ' D' ' 40' ' ' VAL . 7.7 t -125.25 100.26 6.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 124.381 1.072 . . . . 73.41 108.136 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.661 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 58.2 m -93.39 93.75 8.33 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.185 -1.042 . . . . 73.13 108.185 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.72 141.2 29.48 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.026 -0.988 . . . . 45.34 109.487 -176.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.523 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 55.7 m -143.76 126.12 15.73 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.656 0.597 . . . . 75.14 111.105 -177.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.542 ' HG ' ' HB3' ' D' ' 38' ' ' PRO . 26.0 mt -93.75 115.6 28.03 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.348 1.059 . . . . 61.0 108.392 172.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.84 -137.73 32.46 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.402 -0.679 . . . . 65.41 111.402 -171.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -90.88 4.35 52.08 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.212 0.605 . . . . 70.21 111.84 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -118.72 160.2 22.29 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.61 0.364 . . . . 75.43 110.279 -177.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 48.7 m -68.34 133.18 48.33 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 123.753 0.658 . . . . 74.23 111.312 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.523 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.51 -68.13 0.78 Allowed 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.519 -1.289 . . . . 75.42 107.519 171.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -151.24 159.51 44.33 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 115.641 -0.709 . . . . 72.32 110.874 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.474 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 31.6 mt -117.7 110.12 17.47 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 105.778 -1.934 . . . . 73.13 105.778 173.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.486 ' SG ' HG23 ' D' ' 114' ' ' ILE . 14.8 t -119.69 112.17 18.95 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.818 -0.808 . . . . 63.35 108.818 -172.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -139.91 141.1 36.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.574 0.75 . . . . 55.45 109.891 -162.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 91.6 t -147.45 121.44 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.126 0.97 . . . . 71.34 109.228 -177.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.799 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.4 mt-30 -86.56 91.19 8.49 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 107.802 -1.184 . . . . 64.45 107.802 161.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 80' ' ' GLN . . . . . 0.411 ' O ' HD13 ' D' ' 106' ' ' LEU . 31.8 tp60 -80.38 98.63 7.57 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.392 -1.336 . . . . 75.4 107.392 175.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.16 147.43 18.59 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.628 -0.989 . . . . 72.03 110.628 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.7 133.71 4.81 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.0 -0.84 . . . . 60.41 111.0 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.607 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 25.6 mt -89.17 131.2 37.07 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 108.053 -1.092 . . . . 71.51 108.053 174.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -134.74 124.12 24.72 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.407 -0.59 . . . . 71.03 109.407 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 37.8 m -82.86 97.39 8.63 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.683 -0.858 . . . . 73.13 108.683 169.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.52 143.51 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.599 -0.519 . . . . 73.3 109.599 -177.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.82 142.33 9.03 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.954 0.502 . . . . 51.44 110.437 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.56 -22.72 14.57 Favored Glycine 0 C--N 1.345 1.035 0 O-C-N 123.658 0.599 . . . . 74.54 113.175 174.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.538 HG13 ' SD ' ' D' ' 9' ' ' MET . 63.7 mt -100.07 146.91 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 117.414 0.607 . . . . 51.33 110.16 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -160.3 176.15 12.03 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.576 1.151 . . . . 75.53 110.041 -178.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 91' ' ' GLY . . . . . 0.401 ' O ' ' HG2' ' D' ' 94' ' ' MET . . . 74.61 -130.74 12.2 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 115.366 -0.834 . . . . 70.2 113.743 174.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 72.8 p -79.57 -24.59 41.99 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.15 0.58 . . . . 73.14 111.027 -177.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.417 ' HG3' ' HB3' ' D' ' 2' ' ' SER . 31.3 tt0 -70.06 -38.39 75.75 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.948 -0.569 . . . . 73.13 109.938 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' D' ' 91' ' ' GLY . 25.5 ptt? -72.33 -27.25 62.3 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 116.49 -0.323 . . . . 73.4 110.682 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.9 -40.95 90.52 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 120.964 0.411 . . . . 75.15 111.293 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.558 ' HE2' ' HB3' ' D' ' 134' ' ' ASP . 10.6 t-80 -78.66 -37.28 42.3 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.526 0.73 . . . . 75.43 111.206 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 50.0 t -61.29 -41.05 96.31 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.233 0.539 . . . . 75.12 111.275 -176.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 23.6 mt -92.47 -31.92 15.08 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.238 -0.892 . . . . 64.42 110.707 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 99' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' H' ' 15' ' ' PHE . . . -91.15 4.83 81.28 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.719 -0.673 . . . . 71.13 113.823 -178.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -156.81 -57.47 0.09 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 117.867 0.834 . . . . 63.53 112.384 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -66.36 -37.06 84.46 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 112.796 0.665 . . . . 73.43 112.796 -169.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 73.5 m -74.84 -48.2 4.8 Favored Pre-proline 0 CA--C 1.566 1.574 0 CA-C-O 118.689 -0.672 . . . . 54.21 111.824 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.42 -13.76 38.35 Favored 'Trans proline' 0 C--N 1.4 3.274 0 C-N-CA 121.766 1.644 . . . . 71.4 113.404 170.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -65.86 -39.35 90.67 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.601 0.76 . . . . 73.24 109.914 173.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.496 HG21 HD13 ' D' ' 13' ' ' ILE . 49.3 mm -66.02 -39.18 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 115.361 -0.836 . . . . 71.45 110.45 175.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.411 HD13 ' O ' ' D' ' 80' ' ' GLN . 87.7 mt -80.49 -10.47 59.74 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 115.068 -0.969 . . . . 72.1 111.761 -174.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -65.25 -47.57 70.7 Favored Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 124.403 1.081 . . . . 73.44 113.103 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 108' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 72.7 Cg_exo -53.88 -45.46 40.86 Favored 'Trans proline' 0 C--N 1.39 2.758 0 C-N-CA 122.378 2.052 . . . . 74.22 113.378 173.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -69.68 -36.43 75.99 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.481 -0.781 . . . . 73.14 111.855 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.16 -47.35 80.18 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.891 0.476 . . . . 41.54 109.819 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -59.09 -49.48 77.73 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 114.59 -1.186 . . . . 65.3 111.146 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -64.64 -45.57 86.24 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 123.671 0.607 . . . . 74.13 111.277 -175.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.7 t -59.58 -42.17 91.91 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 123.662 0.601 . . . . 52.25 110.666 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.486 HG23 ' SG ' ' D' ' 76' ' ' CYS . 69.9 mt -59.99 -57.96 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.856 0.863 . . . . 71.24 110.779 172.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.454 HG23 ' HG3' ' D' ' 125' ' ' GLN . 97.4 m -53.54 -41.97 66.98 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 124.765 1.226 . . . . 52.23 111.841 -174.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 45.2 t -66.94 -42.54 85.12 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.76 -1.109 . . . . 73.51 110.268 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.6 mtm -68.14 -31.71 71.47 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.909 0.484 . . . . 73.25 111.716 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.468 HG23 ' O ' ' D' ' 114' ' ' ILE . 84.8 t -62.0 -47.11 94.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.327 0.651 . . . . 63.33 109.835 174.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.7 p -74.41 -24.98 59.19 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.642 -0.708 . . . . 62.55 111.235 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -70.54 -34.69 72.54 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.635 0.774 . . . . 75.31 109.896 174.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.46 9.44 73.37 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 123.889 0.743 . . . . 71.41 112.592 175.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.575 HG23 ' HB3' ' C' ' 17' ' ' TYR . 64.0 p 59.27 19.62 7.75 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 126.383 1.873 . . . . 64.02 113.883 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -84.16 154.38 63.49 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.429 0.692 . . . . 73.45 109.443 171.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -56.32 131.51 46.21 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.195 2.596 . . . . 73.34 112.513 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.454 ' HG3' HG23 ' D' ' 115' ' ' THR . 32.9 tt0 -50.75 137.55 20.06 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.747 1.219 . . . . 72.2 111.827 -177.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -128.96 101.7 6.18 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.724 -0.843 . . . . 73.05 108.724 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -100.65 121.04 40.97 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.775 0.83 . . . . 74.4 108.984 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 6.7 mp -73.65 119.26 17.63 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 109.198 -0.667 . . . . 64.22 109.198 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.44 148.58 79.95 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 123.771 0.829 . . . . 70.44 112.012 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -68.94 98.77 0.62 Allowed 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.871 2.381 . . . . 74.32 111.462 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 35.4 m -110.79 142.63 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.398 0.679 . . . . 52.31 111.027 -177.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -99.86 81.91 2.51 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.626 -1.249 . . . . 71.1 107.626 169.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -71.19 -16.7 62.53 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 114.943 -1.026 . . . . 72.02 111.345 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.558 ' HB3' ' HE2' ' D' ' 96' ' ' HIS . 3.9 m-20 -48.72 -53.32 19.39 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.229 1.412 . . . . 72.33 111.937 173.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.42 -32.74 74.26 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.497 0.719 . . . . 23.22 111.883 -176.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 37.7 tp -77.14 -32.16 56.18 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.453 -0.794 . . . . 65.35 110.591 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -64.67 -30.9 71.93 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.008 0.923 . . . . 75.25 110.709 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 12.6 mmt -56.7 -36.09 69.24 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.155 0.582 . . . . 73.13 110.455 176.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -63.75 -33.11 74.93 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.468 1.107 . . . . 74.04 111.735 -176.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 140' ' ' TYR . . . . . 0.532 ' HB2' HD22 ' H' ' 10' ' ' LEU . 78.2 t80 -71.71 -33.33 68.66 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.477 0.711 . . . . 73.2 110.746 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.8 mp -84.63 -30.28 25.04 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.657 0.783 . . . . 70.54 112.708 -177.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -82.17 23.33 0.73 Allowed 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 113.641 0.978 . . . . 65.24 113.641 -165.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -117.37 61.26 0.75 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.73 1.252 . . . . 72.01 109.446 -172.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -140.56 102.41 4.31 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.692 -1.14 . . . . 74.55 108.363 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.86 155.77 47.84 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 124.448 1.099 . . . . 70.11 109.499 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 100.26 61.3 0.82 Allowed Glycine 0 C--N 1.347 1.189 0 O-C-N 123.376 0.423 . . . . 73.52 112.228 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -64.56 145.54 55.99 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.633 0.773 . . . . 74.3 110.708 175.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 85.75 -64.94 4.02 Favored Glycine 0 C--N 1.348 1.215 0 C-N-CA 123.303 0.477 . . . . 40.34 113.125 173.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 4.3 m -77.18 -24.69 51.39 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.31 0.644 . . . . 74.32 110.767 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 66.29 41.28 3.43 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.302 1.441 . . . . 75.42 111.489 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -76.53 78.78 3.22 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.377 0.608 . . . . 64.3 110.516 177.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -152.24 -64.43 0.17 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.06 0.944 . . . . 70.24 109.132 176.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -169.36 120.77 0.72 Allowed 'General case' 0 C--N 1.355 0.838 0 C-N-CA 122.822 0.449 . . . . 63.14 110.626 -176.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -85.13 141.98 29.82 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.615 0.766 . . . . 72.13 109.208 171.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.302 0 C-N-CA 124.481 1.112 . . . . 40.0 111.565 179.919 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.486 1.345 0 N-CA-C 111.026 0.009 . . . . 72.41 111.026 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -71.18 128.1 34.79 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.074 0.55 . . . . 71.51 110.388 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -101.45 165.74 11.1 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.751 0.82 . . . . 72.42 111.847 -170.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 30.9 m -118.39 150.15 40.02 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.075 -1.083 . . . . 70.31 108.075 165.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 5' ' ' THR . . . . . 0.517 HG22 HG13 ' E' ' 6' ' ' ILE . 28.9 m -139.48 119.93 13.98 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.311 -0.625 . . . . 70.12 109.311 -176.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.597 HG12 HG11 ' A' ' 40' ' ' VAL . 40.9 mt 72.29 143.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.798 1.639 . . . . 75.22 111.319 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.96 161.94 34.66 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.735 0.814 . . . . 74.32 110.235 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 3.6 tt -144.05 120.54 11.02 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 106.699 -1.593 . . . . 74.55 106.699 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.13 166.75 22.84 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.692 0.797 . . . . 74.43 111.777 -177.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 10' ' ' LEU . . . . . 0.657 HD21 ' HB2' ' A' ' 136' ' ' LEU . 86.2 mt -61.76 156.65 19.83 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.309 0.644 . . . . 73.43 110.974 171.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 47.1 mt -72.8 119.92 78.01 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-N 115.286 -0.87 . . . . 72.44 109.811 -177.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.47 -32.66 88.68 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.09 2.526 . . . . 75.51 111.851 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.22 122.31 19.1 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 106.817 -1.549 . . . . 75.53 106.817 175.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 7.2 mp -70.97 160.53 32.74 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.339 0.656 . . . . 73.44 110.692 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -75.84 150.03 37.73 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.939 -0.573 . . . . 74.0 109.726 -174.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 7.3 t -141.0 51.89 2.68 Favored Pre-proline 0 CA--C 1.571 1.751 0 N-CA-C 113.371 0.878 . . . . 74.44 113.371 -174.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 17' ' ' PRO . . . . . 0.674 ' HB3' ' HB2' ' A' ' 48' ' ' SER . 75.8 Cg_endo -76.24 -33.07 3.65 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 121.601 1.534 . . . . 72.41 112.035 170.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 23.6 t -79.7 94.77 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.872 0.869 . . . . 71.21 109.456 -171.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 63.4 p 52.99 -80.7 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.689 1.596 . . . . 61.33 111.378 -173.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 20' ' ' LYS . . . . . 0.411 ' NZ ' ' HB2' ' E' ' 20' ' ' LYS . 4.5 ttmp? -168.77 118.49 0.72 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.196 -1.039 . . . . 70.45 108.196 175.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.5 76.11 2.55 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.811 0.844 . . . . 51.22 110.39 178.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -163.91 122.98 1.97 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.326 -1.306 . . . . 61.03 108.38 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 4.6 t -111.67 100.15 47.22 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 108.012 -1.107 . . . . 75.12 108.012 171.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.87 -43.3 38.3 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.61 2.207 . . . . 62.42 111.887 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 . . . . . 0 C--O 1.25 1.129 0 N-CA-C 107.996 -1.113 . . . . 73.42 107.996 175.874 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 110.362 -0.236 . . . . 60.43 110.362 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 88.4 tttt 73.16 136.54 0.05 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.153 1.381 . . . . 73.14 111.859 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -144.18 133.93 23.73 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.971 0.909 . . . . 71.22 108.819 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 19.0 p -141.51 99.6 3.59 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.174 0.99 . . . . 64.43 109.359 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 32.6 m -79.22 -44.48 21.75 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.236 0.614 . . . . 71.31 109.889 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 19.0 pt -134.54 -166.94 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.908 0.883 . . . . 70.54 109.724 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . 69.81 167.95 0.29 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.579 1.151 . . . . 52.1 111.692 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 8' ' ' LEU . . . . . 0.524 HD13 HD11 ' B' ' 44' ' ' LEU . 71.7 mt -137.16 163.1 31.66 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.862 0.865 . . . . 62.03 109.793 -174.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -127.93 -61.51 1.11 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.726 0.81 . . . . 73.31 109.437 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 96.1 mt -139.77 163.68 31.96 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.137 0.975 . . . . 62.1 109.972 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 7.6 mp -84.76 155.85 61.61 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 123.548 0.739 . . . . 65.12 109.348 172.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.09 91.35 0.38 Allowed 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.624 2.216 . . . . 42.23 110.088 174.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 13' ' ' LEU . . . . . 0.477 HD13 ' N ' ' F' ' 14' ' ' LEU . 1.4 tm? 71.84 146.25 0.07 Allowed 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 125.221 1.408 . . . . 62.13 109.555 -172.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 14' ' ' LEU . . . . . 0.677 ' HB3' ' HB1' ' B' ' 95' ' ' ALA . 6.2 mp -61.75 140.79 58.18 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.771 0.828 . . . . 63.11 110.808 -178.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -65.74 144.74 56.7 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.826 0.85 . . . . 75.11 110.875 -170.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 25.2 p -59.87 121.41 58.02 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 124.426 1.091 . . . . 74.43 111.97 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 17' ' ' PRO . . . . . 0.496 ' HA ' HD12 ' B' ' 98' ' ' LEU . 33.4 Cg_exo -63.54 159.29 41.29 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.461 2.774 . . . . 55.23 114.043 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 18' ' ' VAL . . . . . 0.811 ' HB ' ' HB2' ' F' ' 21' ' ' ALA . 15.8 t -71.19 114.39 9.27 Favored 'Isoleucine or valine' 0 C--N 1.355 0.809 0 N-CA-C 107.616 -1.253 . . . . 72.53 107.616 172.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 42.1 m -71.18 116.68 11.76 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.126 0.57 . . . . 73.13 109.831 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt 82.3 23.82 0.2 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.806 1.642 . . . . 74.11 111.052 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 21' ' ' ALA . . . . . 0.811 ' HB2' ' HB ' ' F' ' 18' ' ' VAL . . . -67.12 101.52 0.9 Allowed 'General case' 0 C--N 1.359 0.982 0 C-N-CA 123.292 0.637 . . . . 63.51 109.451 174.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 45.5 ttm180 -143.9 143.17 31.15 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.296 -0.411 . . . . 63.22 110.852 -166.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 23' ' ' THR . . . . . 0.411 ' HA ' ' HD2' ' F' ' 24' ' ' PRO . 3.8 t -99.96 103.67 23.83 Favored Pre-proline 0 CA--C 1.558 1.255 0 CA-C-N 115.301 -0.863 . . . . 72.2 108.71 172.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 24' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' F' ' 23' ' ' THR . 10.6 Cg_endo -54.59 -35.67 87.0 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 123.194 2.596 . . . . 75.3 113.002 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 . . . . . 0 CA--C 1.552 1.042 0 N-CA-C 108.77 -0.826 . . . . 74.12 108.77 172.975 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 109.295 -0.631 . . . . 51.42 109.295 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.34 142.01 33.47 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.84 0.856 . . . . 74.13 109.3 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -153.01 136.59 15.98 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.06 0.544 . . . . 71.51 109.807 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 42.1 m -139.63 127.87 22.58 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.792 0.837 . . . . 75.31 109.12 176.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 5' ' ' THR . . . . . 0.51 HG22 ' H ' ' G' ' 6' ' ' ILE . 3.2 m -77.0 -179.84 5.77 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 124.123 0.969 . . . . 63.41 109.673 178.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 6' ' ' ILE . . . . . 0.51 ' H ' HG22 ' G' ' 5' ' ' THR . 39.3 pt -52.59 138.25 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 124.45 1.1 . . . . 61.44 112.668 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -122.33 137.39 54.87 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.359 0.663 . . . . 52.41 110.215 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 8' ' ' LEU . . . . . 0.622 ' H ' HG21 ' C' ' 131' ' ' VAL . 87.2 mt -85.98 151.25 23.89 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.368 0.667 . . . . 75.43 110.447 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.28 130.57 36.39 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.322 0.649 . . . . 71.13 109.712 174.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 9.7 mp -60.1 144.39 49.8 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.173 0.989 . . . . 71.42 110.728 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 75.8 mt -69.14 109.32 4.17 Favored Pre-proline 0 CA--C 1.552 1.049 0 O-C-N 124.427 1.079 . . . . 72.42 111.047 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.81 -40.55 0.39 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.938 2.425 . . . . 75.2 111.004 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 5.3 mp -72.79 -39.8 66.42 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.167 -0.924 . . . . 72.42 110.09 -177.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 88.3 mt 61.43 172.61 0.11 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.387 1.075 . . . . 61.23 111.503 -173.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -76.86 161.84 28.11 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.982 -0.377 . . . . 75.24 109.982 172.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 41.7 p -73.99 150.78 88.22 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.093 0.557 . . . . 61.1 110.171 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 17' ' ' PRO . . . . . 0.573 ' HB3' ' HB3' ' G' ' 21' ' ' ALA . 85.6 Cg_exo -50.11 148.54 13.42 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.748 2.965 . . . . 65.42 114.252 174.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 18' ' ' VAL . . . . . 0.626 HG23 HD23 ' C' ' 98' ' ' LEU . 99.0 t -62.27 -59.15 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 109.111 -0.7 . . . . 52.51 109.111 174.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 11.8 p -139.82 -74.38 0.36 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.422 1.089 . . . . 73.04 109.314 175.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -120.64 79.36 1.48 Allowed 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.764 -0.828 . . . . 70.25 108.764 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 21' ' ' ALA . . . . . 0.573 ' HB3' ' HB3' ' G' ' 17' ' ' PRO . . . -129.78 5.24 5.03 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.503 -0.771 . . . . 60.54 112.062 -175.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -91.18 71.94 6.26 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.556 0.742 . . . . 74.32 109.738 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 33.9 m -147.06 66.55 10.39 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 108.995 -0.743 . . . . 63.31 108.995 170.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.34 134.82 8.0 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.571 2.181 . . . . 62.51 111.292 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 . . . . . 0 CA--C 1.562 1.42 0 C-N-CA 123.338 0.655 . . . . 74.21 111.17 -176.506 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 109.383 -0.599 . . . . 71.21 109.383 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -157.81 141.33 15.48 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.653 0.781 . . . . 72.41 109.316 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -119.57 120.94 38.19 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.384 0.674 . . . . 73.31 109.784 -176.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 42.5 m -144.74 119.88 10.11 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.917 0.887 . . . . 74.43 109.208 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 91.7 m -148.82 -70.81 0.21 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.962 0.505 . . . . 74.02 110.388 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 6' ' ' ILE . . . . . . . . . . . . . 12.6 tt -147.09 143.87 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.993 -0.442 . . . . 73.41 109.954 -173.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . 68.93 161.59 0.2 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.152 1.381 . . . . 44.01 112.139 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 74.9 mt -69.73 147.89 49.91 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.882 -0.599 . . . . 72.43 110.383 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.84 -73.1 0.37 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.372 0.669 . . . . 35.13 110.113 -177.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 10' ' ' LEU . . . . . 0.532 HD22 ' HB2' ' D' ' 140' ' ' TYR . 78.7 mt -130.86 142.83 50.4 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.199 1.0 . . . . 74.04 109.734 177.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' H' ' 12' ' ' PRO . 7.6 mp -92.92 124.06 59.52 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 108.434 -0.95 . . . . 65.3 108.434 173.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 12' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' H' ' 11' ' ' LEU . 24.6 Cg_exo -64.35 -16.41 54.91 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.424 2.749 . . . . 71.54 113.555 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 54.9 tp -133.29 148.95 51.94 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.849 0.86 . . . . 52.42 108.954 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 87.6 mt -69.01 97.55 0.88 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.316 0.646 . . . . 70.51 110.088 177.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 15' ' ' PHE . . . . . 0.425 ' HB3' ' HA2' ' D' ' 99' ' ' GLY . 0.9 OUTLIER -76.05 91.19 3.08 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 107.927 -1.138 . . . . 73.42 107.927 174.677 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 21.0 m -143.65 84.2 10.1 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 123.391 0.677 . . . . 72.51 110.35 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -78.28 -152.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.928 2.419 . . . . 62.02 111.486 162.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 95.8 t 75.81 141.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 124.826 1.25 . . . . 72.22 111.797 174.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 15.2 m 65.17 46.96 2.56 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.008 0.923 . . . . 72.41 109.289 -175.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 58.5 mttp 76.51 -13.68 0.89 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.726 1.61 . . . . 75.41 112.283 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.06 136.07 54.65 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 108.276 -1.009 . . . . 74.22 108.276 166.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -177.34 172.08 1.91 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.269 1.028 . . . . 74.41 109.406 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 20.1 p -91.44 103.09 6.81 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 108.653 -0.869 . . . . 73.42 108.653 168.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.96 172.05 13.51 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.917 2.411 . . . . 72.2 112.25 -177.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 CA--C 1.556 1.185 0 C-N-CA 123.839 0.856 . . . . 75.11 110.179 179.494 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.6 ttm . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 110.012 -0.366 . . . . 75.42 110.012 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.1 m -147.87 21.95 1.12 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.873 1.269 . . . . 65.05 109.447 176.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 6' ' ' ASN . 8.1 mp0 -85.13 143.04 29.08 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.205 0.602 . . . . 70.12 110.352 -173.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -71.52 119.71 16.07 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 107.397 -1.335 . . . . 73.34 107.397 169.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.9 t30 75.38 3.05 3.96 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 125.529 1.532 . . . . 75.42 111.783 -174.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.482 ' HA ' ' HB2' ' A' ' 3' ' ' GLU . 14.9 m120 60.31 -98.29 0.08 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.421 1.489 . . . . 52.31 112.18 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 p -151.86 86.66 1.32 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.267 1.027 . . . . 74.51 109.451 -173.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -122.78 3.68 9.48 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.352 0.661 . . . . 74.11 110.793 171.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 38.7 ttm -72.31 152.57 42.03 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.42 0.628 . . . . 63.33 111.143 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 t -137.61 140.64 41.04 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.33 -1.359 . . . . 73.2 107.33 170.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.722 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 33.4 t80 -136.68 127.75 27.81 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.028 0.531 . . . . 74.22 109.637 -175.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -148.5 127.71 12.93 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.21 -1.033 . . . . 54.21 108.21 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.643 HG12 ' HD2' ' A' ' 84' ' ' PHE . 53.7 mt -85.36 122.9 38.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 108.575 -0.898 . . . . 71.33 108.575 174.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -85.02 -41.47 15.77 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.899 -0.778 . . . . 72.41 108.899 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -173.34 128.83 0.44 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 111.453 0.168 . . . . 73.24 111.453 -167.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.4 HD12 ' CG ' ' C' ' 130' ' ' PRO . 91.8 mt -123.17 132.9 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 124.141 0.976 . . . . 51.23 109.219 176.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.475 ' HB3' HG23 ' B' ' 122' ' ' THR . 30.0 p90 -167.12 154.2 8.74 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.853 0.861 . . . . 73.53 111.119 -169.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.4 p -75.28 126.08 30.28 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.713 -0.676 . . . . 73.31 109.466 170.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.401 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 39.8 mtpt -93.48 -21.21 19.61 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.75 -0.463 . . . . 61.02 109.75 173.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.497 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 25.0 t70 -153.3 138.49 17.41 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.051 -0.977 . . . . 74.1 110.045 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.2 mt -133.28 144.29 36.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 C-N-CA 124.989 1.316 . . . . 55.24 108.09 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.609 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 42.8 t -147.64 126.37 12.61 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.889 -0.782 . . . . 74.33 108.889 170.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 84.9 t80 -131.3 117.44 18.95 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 106.289 -1.745 . . . . 71.01 106.289 170.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -125.5 120.02 29.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.134 0.425 . . . . 74.42 109.93 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.1 80.65 15.43 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 106.93 -1.507 . . . . 74.32 106.93 171.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.35 -35.54 39.62 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 122.578 2.185 . . . . 71.14 111.488 -174.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -106.01 25.51 10.85 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.922 -1.035 . . . . 63.12 109.457 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.457 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -49.11 -50.83 61.04 Favored Pre-proline 0 CA--C 1.561 1.393 0 N-CA-C 113.471 0.915 . . . . 71.24 113.471 -177.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.22 -21.35 67.4 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 121.647 1.565 . . . . 72.35 113.441 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -91.53 -35.11 14.48 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.105 0.962 . . . . 61.02 110.657 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.8 p -75.35 -25.03 17.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.564 -0.743 . . . . 64.54 112.569 -163.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -73.35 -17.69 61.26 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.325 0.65 . . . . 74.03 110.874 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -85.65 -32.1 22.18 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.483 1.113 . . . . 74.23 110.134 174.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -68.92 157.88 35.74 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.75 0.82 . . . . 53.21 111.349 -175.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -70.87 131.67 44.12 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.385 0.674 . . . . 73.44 109.386 171.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -84.11 88.3 7.18 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.487 0.661 . . . . 73.15 110.189 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -120.98 81.17 34.92 Favored Pre-proline 0 C--O 1.245 0.829 0 N-CA-C 107.977 -1.12 . . . . 64.3 107.977 169.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.59 112.11 3.39 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 121.972 1.781 . . . . 70.0 112.015 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -94.58 88.84 5.57 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 105.826 -1.916 . . . . 75.1 105.826 167.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.4 m -77.55 114.85 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 113.985 -1.461 . . . . 74.03 111.228 -172.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.437 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 87.0 tttt -87.29 130.98 34.39 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.286 -0.87 . . . . 70.05 109.085 173.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.609 ' HB3' HD11 ' E' ' 6' ' ' ILE . 4.5 pp -103.35 148.84 25.38 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.992 -0.744 . . . . 71.44 108.992 173.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.501 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 21.3 t70 -147.56 133.54 19.19 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.134 -0.691 . . . . 43.13 109.134 172.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' E' ' 8' ' ' LEU . 96.6 mt -126.38 128.87 47.72 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.033 0.933 . . . . 73.03 109.805 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -140.15 156.98 46.31 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.253 -0.647 . . . . 74.22 109.253 171.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.3 p -115.36 152.96 31.86 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.467 0.707 . . . . 73.41 110.804 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -145.57 111.85 5.73 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.179 -1.045 . . . . 74.34 108.179 173.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -89.85 152.47 21.25 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.109 0.563 . . . . 75.2 109.7 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.2 t -157.54 142.12 16.48 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.557 0.743 . . . . 74.41 109.851 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -112.76 134.66 54.17 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.706 -0.85 . . . . 71.22 108.706 171.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.594 HD11 ' HB2' ' A' ' 57' ' ' GLU . 27.0 mt -112.59 -28.86 7.67 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.303 0.641 . . . . 64.34 110.528 -174.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.44 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -160.63 179.64 8.4 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.163 0.985 . . . . 34.14 109.058 175.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.49 120.84 13.59 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.898 -0.778 . . . . 75.24 108.898 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 72.59 -1.88 2.83 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.92 1.288 . . . . 62.15 112.272 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.44 ' CG2' ' HB3' ' A' ' 52' ' ' ALA . 57.8 t -101.16 112.0 32.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 107.9 -1.148 . . . . 74.25 107.9 176.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -115.84 156.37 26.22 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 123.653 0.781 . . . . 75.22 108.996 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.594 ' HB2' HD11 ' A' ' 51' ' ' LEU . 48.3 tt0 -128.18 120.72 27.85 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.387 -0.968 . . . . 73.32 108.387 177.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.1 t -99.45 112.68 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.583 -1.636 . . . . 54.24 106.583 174.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 49.2 t -102.55 127.37 56.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 107.633 -1.247 . . . . 45.11 107.633 170.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.24 117.03 28.44 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.289 -1.004 . . . . 73.34 108.289 177.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.515 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 57.6 mtt180 -84.92 100.95 11.96 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.064 0.945 . . . . 70.35 108.81 176.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.8 t -103.43 103.29 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.613 -0.884 . . . . 61.22 108.613 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 26.0 m -109.3 109.32 20.19 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.224 0.61 . . . . 71.53 109.78 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.584 HG11 HD21 ' A' ' 126' ' ' LEU . 2.6 t -105.97 133.36 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.944 1.298 . . . . 71.53 109.537 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 41.7 m -120.47 143.14 48.68 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.538 -0.912 . . . . 72.31 108.538 173.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.14 109.58 18.64 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.612 -1.255 . . . . 74.14 107.612 168.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.2 m -111.79 127.39 55.79 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.773 -0.825 . . . . 61.24 108.773 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.6 mt -89.63 49.21 1.7 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.265 1.026 . . . . 72.22 109.314 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.28 -92.0 1.37 Allowed Glycine 0 CA--C 1.529 0.906 0 N-CA-C 111.766 -0.534 . . . . 64.33 111.766 -173.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -88.68 -30.53 19.06 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.027 0.531 . . . . 53.34 112.011 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -113.36 126.78 55.74 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 109.779 -0.452 . . . . 75.34 109.779 -175.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.4 m -71.12 126.06 28.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.839 0.456 . . . . 63.52 109.81 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.528 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -71.87 -57.44 4.33 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.677 0.791 . . . . 72.53 109.923 176.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -157.33 174.94 14.67 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.599 -1.182 . . . . 64.45 111.249 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 tp -132.42 143.55 49.88 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 113.878 -1.51 . . . . 75.14 108.123 175.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 76.1 m -137.65 129.21 28.26 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.968 1.307 . . . . 71.5 107.878 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 39.7 tt0 -147.73 116.33 6.68 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.489 -0.93 . . . . 72.42 108.489 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.4 t -133.08 110.8 15.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 123.364 0.665 . . . . 74.23 109.743 -173.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.515 ' HG2' ' HG2' ' A' ' 61' ' ' ARG . 18.6 mt-30 -86.4 85.94 7.33 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.092 -1.077 . . . . 71.23 108.092 172.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.456 ' HG3' HD22 ' A' ' 106' ' ' LEU . 9.1 tp-100 -77.61 101.02 6.36 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.27 -0.877 . . . . 75.14 108.907 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.98 146.26 20.35 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.694 -0.962 . . . . 71.24 110.694 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.508 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -149.88 122.51 1.43 Allowed Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 111.399 -0.68 . . . . 74.53 111.399 -176.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 24.6 mt -82.84 116.88 27.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 109.079 -0.711 . . . . 75.32 109.079 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.722 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 14.6 m-85 -133.14 120.56 21.38 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.507 -1.294 . . . . 74.13 107.507 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.0 m -85.17 99.47 11.1 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.854 -0.795 . . . . 51.31 108.854 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.5 pt -123.84 118.56 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 123.909 0.884 . . . . 74.54 110.67 -172.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.41 167.06 5.72 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.551 1.14 . . . . 75.51 109.625 178.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 150.79 2.58 0.24 Allowed Glycine 0 N--CA 1.477 1.388 0 O-C-N 123.564 0.54 . . . . 74.31 114.093 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 89' ' ' ILE . 3.6 mp 61.5 29.21 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.747 0 CA-C-O 122.952 1.358 . . . . 72.44 109.571 177.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 94' ' ' MET . 2.6 tp10 -73.32 -24.49 60.39 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 114.788 -1.096 . . . . 75.44 111.696 -171.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.428 ' O ' ' HB1' ' E' ' 21' ' ' ALA . . . 72.42 -111.62 3.65 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-N 116.057 -0.52 . . . . 71.42 113.618 172.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.6 p -62.52 -35.3 78.96 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.845 0.858 . . . . 72.23 111.59 -176.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -74.77 -34.53 62.47 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.887 0.875 . . . . 63.11 111.046 173.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.508 ' HG2' HD23 ' A' ' 98' ' ' LEU . 53.2 ttp -60.34 -30.37 69.48 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 122.527 0.331 . . . . 75.54 111.127 172.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.37 -33.1 74.08 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.68 0.792 . . . . 73.12 111.532 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.522 ' HE1' ' HB2' ' A' ' 134' ' ' ASP . 71.6 t60 -63.24 -37.87 88.92 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.036 0.534 . . . . 74.03 110.749 174.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 22.2 t -74.66 -54.55 7.2 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.442 0.297 . . . . 74.02 111.09 -175.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.508 HD23 ' HG2' ' A' ' 94' ' ' MET . 4.6 pp -75.42 -30.64 60.11 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.352 0.661 . . . . 74.45 112.347 -172.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.92 3.94 25.75 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.368 -0.684 . . . . 64.33 114.386 -170.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.687 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -147.73 -51.9 0.19 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 118.089 0.945 . . . . 70.31 112.612 -175.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.519 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 91.4 t80 -78.74 -61.7 1.93 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.509 0.723 . . . . 72.35 112.327 -170.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.41 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 71.2 m -65.12 -36.78 16.85 Favored Pre-proline 0 CA--C 1.564 1.495 0 N-CA-C 113.627 0.973 . . . . 61.4 113.627 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 18.0 Cg_endo -61.3 -32.36 89.82 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 121.905 1.737 . . . . 73.14 113.603 165.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -74.31 -21.85 59.53 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 122.988 0.515 . . . . 71.21 110.563 177.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 23.2 mm -65.63 -38.86 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.215 0.606 . . . . 73.24 109.411 170.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.508 HD21 ' HA3' ' A' ' 82' ' ' GLY . 86.4 mt -74.33 -23.55 59.07 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.901 0.881 . . . . 74.2 112.438 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.465 ' HE2' ' HA ' ' A' ' 130' ' ' PRO . 54.7 t80 -61.17 -47.59 94.28 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-O 118.209 -0.9 . . . . 60.21 113.268 -174.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -60.76 -34.86 91.14 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.225 1.95 . . . . 74.43 113.479 174.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -75.41 -37.51 60.44 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.365 0.666 . . . . 74.44 112.03 -178.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.28 -35.95 63.76 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.813 0.445 . . . . 55.4 109.909 177.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.647 ' NH1' HG23 ' C' ' 105' ' ' ILE . 27.3 ttm105 -63.73 -39.99 95.65 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 108.67 -0.863 . . . . 75.51 108.67 172.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.43 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 3.3 tm-20 -64.52 -48.16 76.16 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.131 0.972 . . . . 75.13 111.461 -177.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 36.0 t -60.68 -43.2 98.0 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 123.906 0.754 . . . . 74.14 110.16 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 72.4 mt -65.08 -44.31 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.353 0.661 . . . . 71.24 110.511 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.9 m -57.83 -41.75 82.94 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.564 1.145 . . . . 75.42 110.793 -177.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.3 t -77.71 -42.84 33.03 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.209 -0.905 . . . . 63.55 111.056 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 9.8 mtp -56.91 -46.85 81.7 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 123.84 0.856 . . . . 53.23 111.621 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.6 t -64.06 -41.9 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.567 1.147 . . . . 75.53 110.949 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.687 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 38.2 t -67.33 -35.11 78.75 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.769 -0.65 . . . . 52.44 111.165 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -74.46 -28.31 60.97 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.814 0.846 . . . . 74.51 110.141 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.9 6.79 64.94 Favored Glycine 0 C--N 1.354 1.53 0 O-C-N 123.899 0.75 . . . . 41.23 112.508 171.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.498 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.7 t 62.64 19.49 11.37 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 127.108 2.163 . . . . 43.43 113.299 172.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -81.95 161.78 59.52 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 109.174 -0.676 . . . . 61.44 109.174 175.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -53.53 115.13 2.11 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.343 2.029 . . . . 71.01 110.286 169.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.687 ' HG3' ' HB2' ' A' ' 119' ' ' SER . 29.2 tt0 -55.37 131.54 46.01 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 124.289 0.993 . . . . 72.13 111.24 -166.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.584 HD21 HG11 ' A' ' 64' ' ' VAL . 55.7 tp -107.08 106.73 17.38 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.425 -0.807 . . . . 71.21 110.605 -162.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -121.64 107.66 12.64 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.556 1.142 . . . . 71.24 108.582 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.451 ' O ' HD12 ' C' ' 13' ' ' ILE . 7.5 mp -72.75 145.88 46.78 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.826 0.45 . . . . 71.32 110.52 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.49 149.18 92.57 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 123.975 0.91 . . . . 61.42 111.145 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.628 ' HD3' HG13 ' C' ' 13' ' ' ILE . 44.0 Cg_endo -66.16 131.07 25.75 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 123.014 2.476 . . . . 33.32 112.194 -178.09 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.2 t -113.32 112.98 42.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.735 -1.209 . . . . 74.25 107.735 173.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -81.1 86.69 6.12 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.036 -0.727 . . . . 61.1 109.036 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -62.51 -39.84 94.81 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.9 -0.591 . . . . 65.11 109.925 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.687 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 8.9 p-10 -57.27 -29.27 63.71 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.225 1.01 . . . . 71.3 112.472 177.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -89.94 -60.39 1.95 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.22 0.608 . . . . 71.34 110.924 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.4 mp -69.45 -38.26 77.7 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.947 0.899 . . . . 63.42 113.158 -168.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -68.37 -43.2 77.9 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.517 0.675 . . . . 63.33 109.678 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 95.9 mmm -76.99 -22.7 52.74 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 114.915 -1.039 . . . . 74.43 111.184 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -64.37 -42.19 96.32 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.54 0.736 . . . . 73.24 109.466 174.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -65.25 -39.05 92.15 Favored 'General case' 0 CA--C 1.551 1.01 0 O-C-N 124.146 0.904 . . . . 61.24 110.573 176.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 21.2 tp -67.61 -7.0 22.86 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.868 1.267 . . . . 72.44 112.434 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -142.11 19.38 2.1 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.335 0.654 . . . . 75.21 109.324 -178.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -81.41 82.51 7.21 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.809 0.814 . . . . 74.13 109.224 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -159.87 14.34 0.14 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.542 -1.208 . . . . 74.42 110.728 -173.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 61.83 91.46 0.06 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.707 1.203 . . . . 73.53 110.768 -172.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.0 -128.98 2.29 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.652 -0.704 . . . . 75.21 111.44 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -160.11 163.24 33.96 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 117.228 0.514 . . . . 71.41 110.811 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -85.3 -177.71 50.68 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.396 -0.82 . . . . 73.01 113.194 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.7 t -131.91 168.24 18.22 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.125 0.97 . . . . 62.44 108.97 176.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -89.69 40.75 1.01 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.297 0.639 . . . . 65.11 110.208 177.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 59.69 -80.07 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.714 1.606 . . . . 74.45 111.745 -177.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 -152.04 149.67 29.1 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.901 0.88 . . . . 54.32 109.699 -177.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -82.45 135.39 35.15 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.322 0.649 . . . . 70.54 109.354 168.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -91.94 85.97 5.72 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.713 -0.847 . . . . 72.11 108.713 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.096 0 C-N-CA 123.875 0.87 . . . . 74.14 109.659 177.358 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 120.512 0.196 . . . . 71.21 111.174 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 32.7 t -88.54 75.3 8.36 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.602 0.715 . . . . 74.52 111.299 -173.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -128.68 91.55 3.25 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.207 -1.034 . . . . 74.54 108.207 171.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -76.5 -96.06 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.564 -0.743 . . . . 74.52 109.52 -175.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 179.99 160.05 0.84 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.184 0.594 . . . . 74.45 110.785 -176.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' B' ' 89' ' ' ILE . 18.5 t-20 -171.48 143.88 1.85 Allowed 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 107.992 -1.114 . . . . 73.05 107.992 167.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 59.6 p -117.59 -1.57 11.63 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.771 0.828 . . . . 75.41 111.08 -176.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -101.81 -81.21 0.49 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.81 0.844 . . . . 75.35 111.171 -173.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.559 ' HB2' ' HB ' ' B' ' 89' ' ' ILE . 16.8 ttt 60.27 164.45 0.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.436 1.494 . . . . 64.33 112.415 -170.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 85.3 m -159.24 143.35 15.16 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 124.171 0.988 . . . . 54.41 108.573 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -145.97 156.86 43.79 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.652 0.739 . . . . 72.41 110.448 158.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -125.26 130.59 52.35 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 106.257 -1.757 . . . . 75.42 106.257 172.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.566 HD11 HD13 ' B' ' 105' ' ' ILE . 34.0 mt -67.09 112.68 2.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 108.567 -0.901 . . . . 70.21 108.567 176.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' GLN . . . . . 0.448 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 16.9 mm-40 -80.15 -49.65 11.39 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.015 -0.993 . . . . 75.4 109.179 -178.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.498 ' HE ' HG21 ' A' ' 122' ' ' THR . 42.6 ttt180 -167.07 139.54 3.44 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.67 -0.695 . . . . 74.25 110.244 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.5 mt -114.86 141.56 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 107.424 -1.325 . . . . 74.0 107.424 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -167.78 153.43 7.26 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.689 0.757 . . . . 64.42 112.362 -176.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.6 m -80.54 122.93 27.65 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.822 -1.081 . . . . 73.45 108.707 168.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.459 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 38.0 mtpt -91.4 -41.89 10.62 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.015 0.526 . . . . 72.23 109.669 176.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 24.5 t70 -142.59 139.03 31.19 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.845 -0.616 . . . . 75.32 111.18 -168.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.415 HD11 ' SG ' ' B' ' 113' ' ' CYS . 48.8 mm -133.15 137.97 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.198 1.399 . . . . 70.43 108.174 173.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.535 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 42.8 t -144.75 117.46 8.68 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.338 -1.356 . . . . 73.51 107.338 -177.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.497 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 84.3 t80 -140.07 116.54 10.71 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.76 -1.2 . . . . 72.33 107.76 176.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -124.46 113.84 18.66 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.667 0.787 . . . . 74.1 109.34 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.728 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -108.24 85.45 2.74 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 107.989 -1.115 . . . . 53.43 107.989 170.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -73.38 -23.34 17.66 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.776 2.318 . . . . 64.35 112.667 -171.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -114.99 5.46 15.02 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.169 0.988 . . . . 70.22 110.936 -173.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.728 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -43.71 -61.63 1.84 Allowed Pre-proline 0 N--CA 1.492 1.643 0 C-N-CA 125.638 1.575 . . . . 73.21 114.382 -167.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.401 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 29.0 Cg_endo -61.86 -24.99 77.84 Favored 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 122.56 2.174 . . . . 72.33 113.245 -171.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -96.04 -33.08 12.25 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.652 0.781 . . . . 74.34 111.496 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.429 HG22 HD12 ' B' ' 68' ' ' LEU . 2.8 p -74.44 -16.03 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 122.601 0.361 . . . . 64.31 110.571 -175.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -67.88 -7.98 32.64 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.63 0.772 . . . . 71.12 112.838 176.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -67.54 -13.29 61.92 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 122.444 0.297 . . . . 72.03 110.902 171.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -105.55 110.42 22.74 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.445 1.498 . . . . 64.24 109.346 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -107.53 79.71 1.32 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.452 0.701 . . . . 64.13 110.93 -170.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 43.0 p90 -156.93 175.75 13.67 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.584 0.754 . . . . 73.54 109.217 171.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -77.37 113.13 28.64 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.197 -1.038 . . . . 75.55 108.197 173.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.28 148.53 88.6 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.171 1.914 . . . . 74.51 111.925 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -66.53 122.43 17.55 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.727 -0.842 . . . . 74.15 108.727 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.489 HG13 HG13 ' B' ' 64' ' ' VAL . 57.7 t -111.23 131.35 62.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 124.042 0.937 . . . . 63.24 111.021 -171.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -106.02 135.23 47.85 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.942 -1.133 . . . . 53.25 107.942 169.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 pp -109.24 154.83 21.86 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.06 0.944 . . . . 74.55 109.542 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -159.81 150.45 19.05 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.566 0.746 . . . . 74.34 109.273 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.475 HD13 HD11 ' B' ' 60' ' ' LEU . 62.4 mt -123.94 152.27 42.65 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.388 0.675 . . . . 65.41 110.197 175.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 11.4 t70 -138.5 142.6 39.35 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.635 1.174 . . . . 75.22 107.925 173.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 39.4 p -109.94 111.92 23.62 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.428 0.691 . . . . 73.32 109.959 -176.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.464 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -116.71 149.08 40.43 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.179 0.992 . . . . 75.11 108.379 176.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 46.5 p -145.45 162.14 38.05 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.292 0.479 . . . . 63.31 112.292 -174.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.8 p -153.55 136.2 15.22 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 114.691 -1.14 . . . . 70.44 108.532 164.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -93.86 110.18 21.85 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.157 -1.053 . . . . 63.32 108.157 173.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 63.6 mt -78.01 -39.81 41.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.189 0.596 . . . . 72.04 111.2 -174.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.47 -167.5 1.6 Allowed 'General case' 0 C--O 1.242 0.705 0 CA-C-N 115.184 -0.916 . . . . 60.42 110.167 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -71.71 120.22 16.99 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.985 -1.007 . . . . 71.05 109.083 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 70.35 -4.77 1.5 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.989 1.316 . . . . 74.55 112.362 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 85.3 t -104.88 115.29 46.48 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 N-CA-C 107.504 -1.295 . . . . 62.45 107.504 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -129.46 154.94 46.48 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.587 -0.894 . . . . 72.22 108.587 -175.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -126.25 111.36 14.48 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.341 -0.985 . . . . 72.24 108.341 -174.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 88.0 t -100.81 119.26 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.215 1.406 . . . . 61.22 110.134 -173.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 20.1 t -109.43 114.21 46.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 109.01 -0.737 . . . . 71.43 109.01 178.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.475 HD11 HD13 ' B' ' 44' ' ' LEU . 35.3 tp -99.51 111.38 23.74 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.804 -0.813 . . . . 61.04 108.804 169.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.535 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 33.7 ttm180 -86.09 127.21 34.64 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.824 -0.806 . . . . 72.41 108.824 170.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 36.2 t -113.98 103.92 16.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.579 -1.267 . . . . 74.03 107.579 172.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 9.6 m -98.1 136.27 38.57 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.166 0.586 . . . . 53.4 109.644 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.523 HG21 HG21 ' B' ' 114' ' ' ILE . 69.4 t -125.57 135.89 62.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.862 1.265 . . . . 73.33 109.584 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 95.5 m -117.5 148.86 41.46 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.934 -1.135 . . . . 63.03 107.934 167.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.37 147.0 29.84 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.036 0.534 . . . . 60.44 109.96 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.516 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 15.6 p -147.98 128.13 13.76 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.64 -0.709 . . . . 63.41 111.055 -175.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.429 HD12 HG22 ' B' ' 31' ' ' VAL . 53.1 mt -92.55 100.46 12.99 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 106.904 -1.517 . . . . 73.11 106.904 173.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.36 -139.01 26.06 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 111.345 -0.702 . . . . 44.11 111.345 -172.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -92.89 23.01 4.43 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.356 0.662 . . . . 62.42 110.138 175.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -118.93 138.95 52.42 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.276 1.03 . . . . 74.43 108.963 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 55.5 m -69.62 119.74 14.32 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.75 -0.463 . . . . 75.24 109.75 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.516 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -78.16 -62.61 1.62 Allowed 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.246 -1.02 . . . . 63.33 108.246 176.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -157.79 163.04 38.46 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.851 -1.068 . . . . 63.3 111.282 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 23.9 mt -123.34 127.37 48.41 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 105.977 -1.86 . . . . 73.33 105.977 172.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -128.74 155.35 45.24 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.323 -0.621 . . . . 73.13 109.323 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.535 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 37.2 tt0 -166.06 129.98 2.16 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.194 -0.669 . . . . 73.05 109.194 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.0 t -128.1 151.33 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.925 0.89 . . . . 71.22 108.708 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -125.37 108.93 12.17 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.681 -0.859 . . . . 61.45 108.681 168.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.44 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 7.5 tp-100 -92.81 100.41 12.9 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.43 -0.952 . . . . 73.41 108.43 174.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.459 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.09 145.32 17.62 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.895 -0.882 . . . . 73.43 110.895 176.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.13 127.7 2.48 Favored Glycine 0 CA--C 1.506 -0.518 0 N-CA-C 110.55 -1.02 . . . . 55.43 110.55 -174.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.448 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 27.8 mt -85.0 119.48 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 108.238 -1.023 . . . . 73.24 108.238 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -126.39 132.18 51.59 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 107.133 -1.432 . . . . 73.32 107.133 175.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 70.1 m -88.98 87.76 7.34 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.344 0.52 . . . . 63.25 109.861 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.409 HG12 HD21 ' B' ' 98' ' ' LEU . 2.6 pp -96.67 131.24 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.092 0.957 . . . . 55.21 109.959 -171.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.21 160.5 37.23 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.737 0.415 . . . . 40.01 111.359 173.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.47 -69.31 0.21 Allowed Glycine 0 C--N 1.343 0.949 0 CA-C-N 115.537 -0.756 . . . . 74.1 112.802 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.559 ' HB ' ' HB2' ' B' ' 9' ' ' MET . 0.1 OUTLIER -78.82 154.58 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.248 0.619 . . . . 74.41 110.759 -173.746 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' F' ' 21' ' ' ALA . 15.7 pt-20 -154.41 -175.1 5.24 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.706 -0.679 . . . . 72.04 111.717 -164.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.62 -113.52 5.94 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 115.127 -0.942 . . . . 72.41 112.53 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 77.7 m -88.21 -31.33 19.14 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.535 0.734 . . . . 53.12 110.773 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -65.96 -30.98 71.63 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 116.165 -0.47 . . . . 62.31 111.338 -171.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -68.42 -33.38 74.12 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.091 0.472 . . . . 74.55 110.686 174.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.02 -25.79 61.09 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.864 0.866 . . . . 52.14 110.927 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.445 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 35.7 t-80 -77.97 -40.18 40.11 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.698 0.799 . . . . 73.33 110.786 174.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.1 t -68.22 -57.62 5.72 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.848 0.356 . . . . 74.3 110.599 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.409 HD21 HG12 ' B' ' 86' ' ' ILE . 6.3 mp -81.43 -8.34 59.72 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 116.384 -0.371 . . . . 70.34 111.638 -177.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.97 4.06 31.88 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 119.763 -0.465 . . . . 71.51 114.037 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.447 ' HB1' ' N ' ' B' ' 134' ' ' ASP . . . -151.91 -49.07 0.11 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 117.157 0.479 . . . . 64.4 111.937 -175.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.424 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 54.0 t80 -78.58 -50.86 10.8 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.942 -0.572 . . . . 73.22 111.148 -173.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.427 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 70.3 m -64.24 -46.3 79.14 Favored Pre-proline 0 CA--C 1.568 1.657 0 C-N-CA 123.434 0.694 . . . . 54.12 111.307 177.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 56.6 Cg_exo -49.94 -36.93 45.38 Favored 'Trans proline' 0 C--N 1.404 3.473 0 C-N-CA 123.163 2.575 . . . . 50.32 114.996 168.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -63.62 -40.12 96.1 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 122.883 0.473 . . . . 74.44 110.381 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.566 HD13 HD11 ' B' ' 13' ' ' ILE . 64.7 mt -66.11 -42.66 91.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.515 0.726 . . . . 70.05 110.595 178.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 85.2 mt -82.68 -19.2 38.57 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.498 -0.774 . . . . 63.24 112.166 -174.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -57.85 -53.86 61.41 Favored Pre-proline 0 CA--C 1.561 1.367 0 CA-C-O 117.877 -1.058 . . . . 63.31 112.974 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -58.39 -33.42 97.81 Favored 'Trans proline' 0 C--N 1.392 2.854 0 C-N-CA 122.43 2.087 . . . . 72.42 114.209 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -71.02 -51.33 26.02 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.984 0.514 . . . . 74.43 110.46 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.44 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -58.07 -37.74 75.04 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.442 -0.799 . . . . 62.31 110.932 176.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -59.73 -57.02 14.73 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.747 1.619 . . . . 73.42 110.696 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -64.83 -29.8 70.78 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.706 0.803 . . . . 74.41 110.413 -178.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.524 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.2 t -70.3 -43.38 70.52 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 122.957 0.503 . . . . 74.01 110.909 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.523 HG21 HG21 ' B' ' 64' ' ' VAL . 83.6 mt -60.88 -53.15 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.287 -0.634 . . . . 75.31 109.287 175.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.4 m -55.12 -34.87 64.09 Favored 'General case' 0 CA--C 1.551 0.996 0 O-C-N 124.563 1.164 . . . . 74.11 111.744 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 42.7 t -65.85 -51.23 60.57 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 115.39 -0.823 . . . . 71.33 110.197 175.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.6 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 15.1 mmt -67.82 -30.5 69.92 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.355 0.662 . . . . 75.45 111.797 -174.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.94 -44.73 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.392 1.077 . . . . 75.04 109.969 174.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 27.7 t -70.1 -25.49 63.53 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.224 -0.898 . . . . 73.22 110.543 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.6 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 89.8 mtt-85 -70.38 -30.48 67.4 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.804 -0.443 . . . . 75.32 109.804 174.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.46 12.65 54.95 Favored Glycine 0 C--N 1.355 1.62 0 O-C-N 123.549 0.531 . . . . 64.11 112.644 170.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 17' ' ' TYR . 38.1 p 54.15 24.68 5.05 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 126.464 1.906 . . . . 72.23 113.992 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -83.86 156.76 64.23 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 123.318 0.647 . . . . 73.42 110.673 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -64.41 178.28 1.72 Allowed 'Trans proline' 0 C--N 1.389 2.668 0 C-N-CA 123.429 2.753 . . . . 73.22 114.072 -177.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.649 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 6.6 tp-100 -65.16 125.9 26.42 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.443 -1.253 . . . . 53.13 112.27 -169.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -135.52 114.41 12.05 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 108.89 -0.781 . . . . 74.42 108.89 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -130.46 135.04 47.56 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.319 1.047 . . . . 72.14 108.209 171.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 tt -87.78 142.52 27.76 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.787 0.835 . . . . 64.43 109.143 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.403 ' HB3' ' HA ' ' F' ' 7' ' ' ALA . . . -71.24 152.47 94.44 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 123.327 0.651 . . . . 41.01 110.995 176.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.52 139.79 60.27 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.89 2.393 . . . . 71.42 111.372 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.56 110.34 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.786 0.803 . . . . 74.32 109.56 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 132' ' ' ASN . . . . . 0.459 ' HB3' ' HB3' ' B' ' 135' ' ' ALA . 6.5 m120 -92.0 83.97 5.25 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.249 -0.887 . . . . 73.12 109.27 175.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -58.79 -42.41 88.99 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.766 -0.827 . . . . 73.4 108.766 172.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.447 ' N ' ' HB1' ' B' ' 100' ' ' ALA . 6.4 p-10 -57.6 -53.83 53.68 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 113.909 -1.496 . . . . 75.13 112.264 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' B' ' 132' ' ' ASN . . . -65.71 -37.19 85.74 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.568 0.747 . . . . 61.15 112.122 -175.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.21 -46.99 63.4 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.329 0.652 . . . . 74.11 111.264 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -72.47 -23.07 60.99 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.828 0.451 . . . . 55.21 111.304 178.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -70.27 -38.57 75.13 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.391 0.676 . . . . 74.24 109.491 175.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -76.43 -14.48 60.06 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.922 -1.036 . . . . 72.45 111.278 -172.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -64.78 -30.91 71.94 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.93 0.892 . . . . 72.14 111.142 173.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 62.4 mt -82.42 8.87 10.31 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.565 0.746 . . . . 71.11 112.207 -174.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.33 111.16 10.31 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.33 -0.989 . . . . 52.43 108.33 175.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -128.6 160.41 32.49 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.017 0.927 . . . . 74.34 110.23 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -167.18 152.24 7.31 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.083 0.953 . . . . 65.52 109.167 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -142.64 146.55 34.6 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.692 0.797 . . . . 50.54 109.893 177.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.94 -157.51 31.91 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 123.665 0.603 . . . . 61.55 113.149 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -161.89 128.09 3.68 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.49 0.716 . . . . 54.43 109.223 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -148.98 128.6 2.82 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 110.668 -0.973 . . . . 63.33 110.668 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 79.6 p -117.35 103.97 10.67 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.124 0.569 . . . . 70.35 110.131 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -94.29 126.84 39.79 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 107.935 -1.135 . . . . 72.1 107.935 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -141.33 143.73 34.19 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.337 0.655 . . . . 64.31 110.372 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -154.5 138.75 16.61 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.536 1.134 . . . . 65.34 108.655 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -80.56 73.91 7.48 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.749 0.785 . . . . 51.1 111.019 -176.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -77.61 96.91 4.92 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.089 -0.708 . . . . 75.13 109.089 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.9 0 C-N-CA 124.495 1.118 . . . . 51.32 108.369 -179.482 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 86.0 mtp . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.822 -0.436 . . . . 75.0 109.822 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 48.0 m -124.24 -64.52 1.12 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.81 -0.811 . . . . 74.25 108.81 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 71.06 -56.2 0.63 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.742 1.617 . . . . 71.12 111.339 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 14.1 tp60 -65.86 153.76 41.07 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 124.496 1.119 . . . . 75.11 109.728 169.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 13.7 m120 73.83 170.31 0.3 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 125.194 1.398 . . . . 44.31 111.13 -172.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 4.1 t30 62.48 41.86 9.36 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.52 1.128 . . . . 73.51 109.651 -173.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 17.7 m -62.98 -46.51 87.34 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.411 -1.268 . . . . 75.3 110.959 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -75.29 122.98 24.53 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.468 -0.787 . . . . 71.41 109.053 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.498 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 0.0 OUTLIER 64.9 114.16 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.937 1.295 . . . . 70.1 110.96 -176.412 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 30.0 m -98.75 109.17 21.97 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.703 -0.851 . . . . 72.1 108.703 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.498 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 0.3 OUTLIER -120.15 123.6 43.72 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.83 -0.804 . . . . 51.4 108.83 -177.453 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -138.31 118.08 13.19 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.248 -1.019 . . . . 60.51 108.248 174.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.628 HG13 ' HD3' ' A' ' 130' ' ' PRO . 75.8 mt -67.95 122.4 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.844 -0.798 . . . . 71.53 108.844 173.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -86.13 -45.63 11.18 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 124.079 0.862 . . . . 72.11 109.481 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -179.4 124.79 0.08 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.293 -0.867 . . . . 74.42 109.414 -170.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.487 HD11 HD13 ' C' ' 13' ' ' ILE . 30.1 mt -116.28 150.55 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 108.06 -1.089 . . . . 72.52 108.06 173.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.438 ' HE2' ' HD2' ' C' ' 19' ' ' LYS . 22.8 p90 -174.49 171.54 3.32 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.057 0.943 . . . . 72.13 109.765 -173.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -90.85 118.31 30.16 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.612 -0.884 . . . . 64.13 108.612 174.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.683 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 10.0 mmmm -69.64 -45.78 67.68 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 122.102 0.953 . . . . 65.35 108.469 171.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.668 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 12.0 t70 -146.0 147.16 31.37 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 113.71 -1.587 . . . . 73.21 109.771 -169.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 63.5 mt -142.9 150.48 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.459 1.503 . . . . 71.25 107.456 177.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -160.57 151.91 19.29 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.389 0.614 . . . . 65.15 110.428 175.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -153.78 109.18 3.19 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.975 -1.12 . . . . 71.51 107.975 171.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -117.09 110.42 18.18 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.214 0.605 . . . . 73.1 110.028 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.56 87.39 25.62 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 106.619 -1.623 . . . . 54.31 106.619 167.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.42 -29.92 19.97 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.37 2.046 . . . . 74.03 111.531 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -91.93 12.57 21.25 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.568 1.147 . . . . 64.55 111.112 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.54 -58.59 12.28 Favored Pre-proline 0 CA--C 1.562 1.442 0 N-CA-C 114.031 1.123 . . . . 74.2 114.031 -166.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -57.85 -39.9 83.08 Favored 'Trans proline' 0 C--N 1.397 3.09 0 C-N-CA 122.182 1.921 . . . . 72.55 112.414 -174.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.415 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.3 t60 -69.38 -45.75 68.58 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.449 -1.25 . . . . 74.51 111.688 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.69 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.9 p -73.72 -20.89 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 N-CA-C 113.131 0.789 . . . . 64.11 113.131 -165.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -62.15 -25.61 67.85 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 113.99 1.107 . . . . 73.44 113.99 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 20.1 pt20 -98.07 16.89 19.76 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.508 0.723 . . . . 55.52 111.259 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.818 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -94.59 157.13 16.12 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.94 0.896 . . . . 71.33 109.461 173.104 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -67.13 123.24 19.71 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.295 0.638 . . . . 72.41 109.508 166.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -79.14 99.02 6.79 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.765 0.826 . . . . 73.53 110.434 -175.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -151.69 71.31 8.12 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 108.468 -0.938 . . . . 74.24 108.468 176.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -87.41 153.46 7.88 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.916 2.411 . . . . 44.53 112.21 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -89.94 112.33 23.68 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.551 -1.278 . . . . 74.12 107.551 168.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 40.2 t -72.74 102.3 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 109.147 -0.686 . . . . 51.44 109.147 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.512 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 54.0 mmtt -93.24 113.11 25.23 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.193 0.997 . . . . 74.41 109.33 175.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.428 HD23 HD23 ' G' ' 8' ' ' LEU . 4.2 mp -96.43 123.96 40.27 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.07 -1.085 . . . . 71.52 108.07 176.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -131.87 106.87 8.35 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.971 0.909 . . . . 72.52 109.004 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.426 HD21 HD22 ' G' ' 8' ' ' LEU . 5.9 mp -108.35 123.17 48.4 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.258 -0.645 . . . . 74.04 109.258 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.455 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 15.5 t70 -112.58 147.79 35.9 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.132 1.373 . . . . 72.33 107.941 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 57.5 p -114.45 126.32 54.83 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.099 0.56 . . . . 75.32 110.904 -170.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.33 151.95 51.9 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.424 1.089 . . . . 53.31 108.494 175.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 6.4 p -163.29 163.43 25.3 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.73 0.412 . . . . 71.45 110.015 -176.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 25.8 t -165.55 133.66 3.08 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.996 0.518 . . . . 70.42 110.25 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -82.24 139.02 34.48 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.038 0.535 . . . . 53.43 109.563 173.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.599 HD11 HD12 ' C' ' 83' ' ' ILE . 84.1 mt -110.46 -41.8 4.26 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.486 0.714 . . . . 62.13 110.039 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.4 -174.36 4.91 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.56 -0.746 . . . . 71.12 110.642 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -68.93 126.22 29.11 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.747 -1.115 . . . . 73.53 108.488 172.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 67.28 6.52 4.89 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.737 1.215 . . . . 73.33 112.561 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 80.9 t -122.5 115.3 45.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 108.171 -1.048 . . . . 63.24 108.171 177.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -137.25 130.13 30.46 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.515 -0.766 . . . . 72.13 109.282 -173.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -92.35 127.26 37.77 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.214 -0.903 . . . . 74.51 109.605 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.477 HG23 HD11 ' C' ' 106' ' ' LEU . 26.9 m -111.87 136.99 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 108.141 -1.059 . . . . 75.33 108.141 166.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -126.66 121.23 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.436 1.094 . . . . 55.31 108.928 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.468 HD22 ' HB3' ' C' ' 103' ' ' PRO . 47.9 tp -111.95 113.8 26.33 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.4 -0.592 . . . . 74.44 109.4 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.455 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 34.5 ttm180 -82.92 107.69 15.71 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 108.856 -0.794 . . . . 72.53 108.856 173.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.445 ' HB ' HD11 ' C' ' 114' ' ' ILE . 6.6 t -99.5 121.34 50.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.053 -1.092 . . . . 71.23 108.053 171.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 72.0 m -112.7 128.21 56.34 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.404 -1.332 . . . . 60.32 107.404 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.544 HG23 HD13 ' C' ' 114' ' ' ILE . 99.5 t -116.03 115.18 48.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.626 -0.879 . . . . 70.03 108.626 172.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 4.4 m -100.78 139.27 36.7 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.73 -0.841 . . . . 71.44 108.73 175.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.33 113.1 15.18 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.577 -1.268 . . . . 75.43 107.577 176.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -136.18 131.44 34.64 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.032 -0.729 . . . . 74.55 109.032 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.818 HD13 ' HG2' ' C' ' 34' ' ' LYS . 3.5 mt -87.13 35.93 0.72 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.575 1.55 . . . . 73.14 110.037 -177.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.02 -117.31 4.9 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 109.682 -1.367 . . . . 74.32 109.682 -164.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -89.93 -20.43 23.36 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.611 0.764 . . . . 71.21 111.221 176.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -78.5 103.2 8.29 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.788 -0.819 . . . . 75.3 108.788 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 37.2 m -72.76 123.49 23.43 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.485 -0.561 . . . . 61.14 109.485 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.69 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.43 -56.03 5.1 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.422 -0.808 . . . . 72.13 109.017 174.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -159.66 168.18 26.63 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 122.223 1.011 . . . . 74.55 112.146 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -130.01 130.75 45.37 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 105.386 -2.079 . . . . 73.04 105.386 167.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.431 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 44.6 t -128.75 138.23 52.0 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.228 -1.397 . . . . 65.41 107.228 174.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.16 118.77 5.29 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.979 -0.378 . . . . 71.13 109.979 -172.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' C' ' 61' ' ' ARG . 95.6 t -128.74 136.85 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.564 0.746 . . . . 75.53 109.105 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.668 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 26.4 mt-30 -109.33 97.17 6.81 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.55 -0.908 . . . . 63.4 108.55 169.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -84.85 116.91 23.57 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.351 -0.84 . . . . 54.42 109.136 178.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.6 145.79 16.87 Favored Glycine 0 C--N 1.343 0.921 0 N-CA-C 111.742 -0.543 . . . . 72.32 111.742 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.39 121.3 1.75 Allowed Glycine 0 CA--C 1.507 -0.433 0 N-CA-C 111.751 -0.54 . . . . 34.15 111.751 -176.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.599 HD12 HD11 ' C' ' 51' ' ' LEU . 9.5 mm -82.55 118.94 31.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 108.054 -1.091 . . . . 61.15 108.054 174.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -133.71 123.79 25.56 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.393 0.677 . . . . 64.31 109.987 -172.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 70.2 m -71.17 108.17 4.55 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.787 -0.82 . . . . 43.05 108.787 167.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 78.2 mt -117.7 119.74 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.462 1.105 . . . . 73.14 108.412 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.15 168.28 26.46 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.53 0.732 . . . . 61.31 110.442 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.72 -33.78 5.97 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 116.26 -0.427 . . . . 74.44 113.936 170.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 40.2 pt -117.67 163.4 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.493 0.717 . . . . 55.44 110.957 -176.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -146.15 158.04 43.86 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.511 0.724 . . . . 75.15 110.696 -175.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.08 -129.72 15.64 Favored Glycine 0 C--N 1.349 1.258 0 CA-C-N 115.784 -0.644 . . . . 73.33 113.48 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 75.5 p -66.02 -26.79 67.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.685 0.794 . . . . 73.31 111.534 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -62.49 -54.12 44.7 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.959 0.504 . . . . 55.14 110.028 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.504 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 7.6 ptt? -76.79 -23.79 52.86 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.896 -0.593 . . . . 64.45 111.099 -176.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.48 -37.18 77.14 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.377 0.608 . . . . 60.22 110.364 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -67.78 -33.21 74.39 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.643 -1.162 . . . . 72.54 110.442 173.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.564 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 43.9 t -68.86 -60.59 2.27 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.802 -0.635 . . . . 64.41 110.682 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.593 HD23 HG23 ' G' ' 18' ' ' VAL . 3.7 pp -69.42 -28.3 66.03 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.44 0.696 . . . . 72.33 112.411 -174.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 99' ' ' GLY . . . . . 0.416 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -94.57 -3.9 62.5 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-O 119.558 -0.579 . . . . 64.34 114.21 -172.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.58 -62.15 0.13 Allowed 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 117.496 0.648 . . . . 74.11 112.639 -172.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.564 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 54.7 t80 -66.41 -37.92 86.3 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 124.391 1.076 . . . . 64.23 113.106 -170.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 29.7 m -80.72 -42.64 1.26 Allowed Pre-proline 0 CA--C 1.564 1.511 0 C-N-CA 123.561 0.745 . . . . 63.31 111.034 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.468 ' HB3' HD22 ' C' ' 60' ' ' LEU . 89.0 Cg_exo -54.13 -24.21 32.36 Favored 'Trans proline' 0 C--N 1.398 3.151 0 C-N-CA 122.995 2.464 . . . . 72.55 114.617 166.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -67.77 -24.72 65.37 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.399 0.68 . . . . 73.21 111.792 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.647 HG23 ' NH1' ' A' ' 111' ' ' ARG . 31.7 mm -77.3 -35.17 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 109.24 -0.652 . . . . 64.2 109.24 173.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.477 HD11 HG23 ' C' ' 58' ' ' VAL . 82.0 mt -79.41 -24.9 42.24 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.671 -1.15 . . . . 72.32 111.818 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -57.11 -55.27 45.81 Favored Pre-proline 0 CA--C 1.557 1.226 0 CA-C-O 118.198 -0.906 . . . . 75.13 113.09 -173.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.43 ' HB2' ' HG3' ' A' ' 112' ' ' GLU . 57.5 Cg_endo -66.57 -23.33 49.93 Favored 'Trans proline' 0 C--N 1.387 2.6 0 CA-C-N 121.174 1.455 . . . . 63.1 112.342 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -75.51 -49.31 19.11 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.13 0.972 . . . . 74.42 110.15 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.68 -38.24 84.29 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.149 0.98 . . . . 43.43 110.07 174.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -58.48 -53.07 62.42 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.253 1.421 . . . . 73.04 110.753 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.47 -32.61 73.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 123.694 0.622 . . . . 73.42 110.278 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.6 t -68.8 -34.41 75.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.001 0.52 . . . . 75.02 111.006 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.544 HD13 HG23 ' C' ' 64' ' ' VAL . 95.5 mt -73.33 -51.93 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.666 0.786 . . . . 74.32 109.84 175.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.0 m -64.56 -28.9 69.96 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.844 0.858 . . . . 64.32 111.426 -175.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.3 t -67.77 -48.62 65.85 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.238 -0.653 . . . . 64.41 109.238 172.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.589 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.1 -38.66 87.09 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.512 1.125 . . . . 74.44 112.836 -179.838 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' C' ' 123' ' ' PHE . 82.2 t -62.12 -45.38 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.769 0.828 . . . . 62.44 109.668 175.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 44.8 t -68.2 -32.47 72.71 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.239 -0.891 . . . . 74.43 111.947 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -68.88 -31.61 70.66 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.537 0.735 . . . . 75.13 109.703 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.82 10.79 73.83 Favored Glycine 0 C--N 1.355 1.607 0 O-C-N 123.969 0.793 . . . . 73.22 112.998 173.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.507 HG23 ' HB3' ' D' ' 17' ' ' TYR . 43.2 p 60.19 29.48 19.04 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 126.151 1.78 . . . . 61.44 114.257 173.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.402 ' HB2' HG13 ' C' ' 118' ' ' VAL . 96.8 m-85 -96.03 147.0 32.31 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.494 -0.928 . . . . 75.21 108.494 171.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.649 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 80.6 Cg_exo -49.44 141.06 26.33 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.712 2.941 . . . . 75.51 114.421 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -55.49 113.81 1.58 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.175 0.99 . . . . 73.23 111.354 -177.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 41.6 tp -107.78 92.81 4.22 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.601 -0.889 . . . . 73.53 108.601 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -93.03 114.71 27.33 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.197 -0.911 . . . . 45.05 108.976 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 tt -73.09 135.89 44.84 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.922 0.889 . . . . 75.4 110.252 -171.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.41 148.76 90.95 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 123.666 0.786 . . . . 63.3 111.997 -175.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.526 ' HG2' HG21 ' A' ' 13' ' ' ILE . 6.6 Cg_exo -70.86 116.57 4.73 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.145 2.563 . . . . 72.11 112.49 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.663 HG21 ' H ' ' G' ' 8' ' ' LEU . 90.5 t -126.96 110.58 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.784 -0.821 . . . . 75.15 108.784 173.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' C' ' 136' ' ' LEU . 12.9 m120 -71.97 104.69 3.61 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.281 1.032 . . . . 63.21 109.726 174.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -62.75 -44.63 95.71 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.283 0.563 . . . . 64.42 110.052 172.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -59.71 -43.82 93.98 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.372 -1.285 . . . . 72.52 111.184 -174.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.82 -48.77 35.11 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.521 -0.763 . . . . 71.41 110.302 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' C' ' 132' ' ' ASN . 5.7 tt -48.89 -59.94 3.17 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 124.537 1.135 . . . . 74.14 112.168 -171.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -58.23 -42.93 87.4 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 123.739 0.65 . . . . 73.4 112.127 -174.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 90.7 mtp -78.41 -32.59 48.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.877 0.471 . . . . 53.33 111.93 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -71.6 -35.35 70.48 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.503 0.721 . . . . 70.02 111.578 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -69.19 -151.71 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 124.387 1.075 . . . . 75.54 111.498 -171.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 77.2 mt 70.32 -69.87 0.16 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.691 1.196 . . . . 63.3 110.13 -174.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -80.07 87.33 5.45 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.736 -0.838 . . . . 73.32 108.736 170.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -74.95 103.72 5.27 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.427 0.691 . . . . 72.14 110.851 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -149.01 16.22 0.95 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.158 0.983 . . . . 74.45 108.733 170.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -78.31 92.84 4.57 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.695 0.798 . . . . 61.33 110.323 -176.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -177.92 -143.35 5.03 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 115.678 -0.692 . . . . 71.41 112.137 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 65.9 -168.09 0.21 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.1 1.36 . . . . 72.33 111.943 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 178.61 179.72 48.52 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 111.854 -0.499 . . . . 73.43 111.854 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 18.7 m -123.43 123.26 40.26 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 108.191 -1.04 . . . . 73.31 108.191 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -163.48 132.29 3.89 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 107.939 -1.134 . . . . 72.22 107.939 174.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -83.9 -74.09 0.39 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.891 0.876 . . . . 63.53 111.145 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -175.08 37.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.921 0.889 . . . . 74.24 110.116 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -69.19 136.68 52.43 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.546 0.738 . . . . 73.22 111.372 -175.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -166.16 -38.53 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.226 0.611 . . . . 73.34 110.932 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 C-N-CA 123.78 0.832 . . . . 72.33 109.413 -177.017 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' D' D ' 1' ' ' MET . . . . . 0.519 ' SD ' ' N ' ' D' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 108.298 -1.001 . . . . 75.55 108.298 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 60.2 p -80.15 169.85 17.25 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.361 0.664 . . . . 74.11 109.712 169.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 54.94 51.32 13.77 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.44 1.114 . . . . 74.31 110.102 -175.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 4' ' ' GLN . . . . . 0.45 ' HA ' ' HG3' ' D' ' 90' ' ' GLU . 4.1 pt20 -81.97 -14.6 55.81 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 113.79 -1.55 . . . . 74.03 112.668 -172.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 5' ' ' ASN . . . . . 0.661 HD21 ' HB2' ' D' ' 8' ' ' GLU . 44.0 t-20 75.15 122.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 125.698 1.599 . . . . 64.02 111.063 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -132.89 15.44 4.29 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.999 0.92 . . . . 74.04 110.738 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 62.1 m -133.27 -57.15 0.91 Allowed 'General case' 0 N--CA 1.482 1.141 0 O-C-N 122.104 -0.373 . . . . 63.03 111.239 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.661 ' HB2' HD21 ' D' ' 5' ' ' ASN . 1.8 mp0 -77.32 -28.7 53.27 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.135 0.174 . . . . 71.1 110.709 -177.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.478 ' HE3' HD11 ' D' ' 89' ' ' ILE . 1.2 tmt? -30.23 125.55 0.16 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 126.121 1.768 . . . . 73.4 113.005 174.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 87.8 m -110.59 144.43 39.48 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.57 0.748 . . . . 74.3 110.929 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.497 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 31.3 t80 -159.12 89.13 0.91 Allowed 'General case' 0 C--O 1.238 0.45 0 N-CA-C 107.051 -1.463 . . . . 72.23 107.051 171.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -113.96 116.38 29.14 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.018 -1.104 . . . . 74.15 108.018 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.499 HG21 HD11 ' D' ' 16' ' ' ILE . 54.3 mt -72.09 122.95 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 109.588 -0.523 . . . . 70.04 109.588 -178.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -85.61 -42.91 13.92 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.994 0.809 . . . . 72.43 111.189 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -170.97 135.12 1.0 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 111.81 0.3 . . . . 73.43 111.81 -163.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.499 HD11 HG21 ' D' ' 13' ' ' ILE . 2.7 mp -115.76 134.58 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.609 -1.256 . . . . 73.01 107.609 170.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.507 ' HB3' HG23 ' C' ' 122' ' ' THR . 32.9 p90 -166.42 169.57 13.81 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 122.18 0.991 . . . . 71.21 111.394 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.5 p -103.03 120.33 40.46 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 113.567 -1.651 . . . . 72.52 108.534 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -89.96 -31.02 17.43 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.088 -0.708 . . . . 65.34 109.088 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -140.4 134.73 31.24 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 114.385 -1.28 . . . . 54.31 108.343 173.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.589 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.7 mt -128.18 145.08 35.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.021 -1.474 . . . . 63.13 107.021 168.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 30.9 t -147.25 140.89 25.61 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.9 0.88 . . . . 70.3 108.834 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.523 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.1 t80 -146.48 136.22 23.21 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 105.89 -1.892 . . . . 64.01 105.89 168.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.535 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 43.8 mt-10 -138.52 152.37 48.18 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.338 -1.356 . . . . 74.14 107.338 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.77 84.33 7.05 Favored Pre-proline 0 C--O 1.239 0.535 0 N-CA-C 107.307 -1.368 . . . . 72.3 107.307 172.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -66.57 -36.91 23.96 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.0 2.467 . . . . 65.32 113.025 -170.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.478 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 52.6 m-20 -101.35 6.84 42.85 Favored 'General case' 0 C--O 1.211 -0.973 0 CA-C-O 118.542 -0.742 . . . . 64.01 110.747 -177.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.683 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -26.08 -65.09 0.11 Allowed Pre-proline 0 N--CA 1.496 1.85 0 N-CA-C 116.621 2.082 . . . . 73.43 116.621 -162.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -78.85 -21.97 9.23 Favored 'Trans proline' 0 C--N 1.382 2.314 0 CA-C-N 122.878 2.063 . . . . 72.53 113.842 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -73.74 -37.16 65.16 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.88 1.272 . . . . 75.51 110.37 175.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.557 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.5 p -84.13 -18.93 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.066 0.546 . . . . 65.01 111.531 -174.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -65.45 -15.83 63.02 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 112.529 0.566 . . . . 73.04 112.529 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -58.65 -33.43 70.07 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.55 0.69 . . . . 53.14 110.03 173.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -89.28 93.39 9.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.126 -1.397 . . . . 73.54 109.373 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -102.43 91.64 4.34 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.17 0.509 . . . . 63.11 109.981 -177.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 35.6 p90 -158.28 174.0 15.82 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.949 1.3 . . . . 72.4 108.009 169.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -65.43 112.91 9.6 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-O 118.938 -0.553 . . . . 42.33 109.565 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -59.07 141.24 97.99 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.582 2.188 . . . . 53.02 112.713 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -59.42 118.19 5.71 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.607 0.763 . . . . 73.42 109.959 172.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.615 ' HB ' HG23 ' H' ' 5' ' ' THR . 59.0 t -97.21 106.94 19.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 123.219 0.608 . . . . 73.03 109.426 -175.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -95.69 127.92 42.12 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.097 -0.956 . . . . 71.12 108.648 173.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.458 ' HG ' ' H ' ' H' ' 7' ' ' ALA . 3.2 mm? -97.51 146.08 25.59 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.139 0.576 . . . . 71.54 109.602 -178.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -149.54 116.76 6.05 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.226 -1.027 . . . . 63.41 108.226 177.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.513 HD22 ' H ' ' H' ' 9' ' ' ALA . 6.6 mp -108.05 140.12 41.69 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.722 0.409 . . . . 70.12 110.926 -173.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.2 t70 -136.88 151.82 49.52 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.56 1.144 . . . . 51.44 108.595 173.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 46' ' ' THR . . . . . 0.466 ' HB ' HD22 ' H' ' 11' ' ' LEU . 13.0 t -116.85 150.3 38.64 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.149 0.579 . . . . 73.12 110.839 -172.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.593 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.05 155.09 28.67 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.991 0.917 . . . . 63.54 109.229 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 13.4 p -167.09 162.12 15.16 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.697 0.399 . . . . 63.02 111.323 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 3.0 m -153.38 144.8 23.2 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.243 1.017 . . . . 61.12 108.669 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -97.92 116.49 30.23 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.152 -1.055 . . . . 60.23 108.152 165.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 24.6 mt -95.51 -40.58 9.38 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.044 0.538 . . . . 54.23 110.455 -172.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.584 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -146.11 -176.56 5.2 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.077 -0.965 . . . . 72.34 109.908 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -68.4 105.92 2.34 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.387 0.675 . . . . 73.31 109.652 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 62.85 18.55 10.85 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.759 1.224 . . . . 74.41 112.128 -177.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.584 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 57.3 t -109.23 104.83 17.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 107.353 -1.351 . . . . 52.3 107.353 171.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -119.6 131.33 55.46 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.96 -1.473 . . . . 71.2 109.686 -164.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -98.58 132.23 44.15 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.947 -0.57 . . . . 75.15 109.868 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 75.4 t -115.46 118.86 60.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 107.582 -1.266 . . . . 61.13 107.582 175.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 24.9 t -117.96 129.53 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.574 0.75 . . . . 71.12 109.276 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -122.74 129.47 51.8 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 110.328 -0.249 . . . . 74.11 110.328 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.606 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 14.3 ttm-85 -86.44 100.05 12.07 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.82 -0.807 . . . . 74.41 108.82 172.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 99.1 t -90.41 116.84 32.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.048 -1.093 . . . . 55.13 108.048 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 17.6 m -123.34 126.29 46.57 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.339 0.59 . . . . 71.43 109.671 -172.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.538 HG13 HG13 ' D' ' 40' ' ' VAL . 40.6 t -117.33 100.36 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.742 1.617 . . . . 50.22 107.977 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 60.7 m -93.53 94.26 8.55 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.832 -1.076 . . . . 71.0 108.157 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.16 143.77 28.33 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.712 -0.677 . . . . 65.22 110.456 -174.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.481 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 54.2 p -144.6 135.35 24.78 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 115.735 -0.666 . . . . 63.01 110.429 -177.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.465 HD12 HG22 ' D' ' 31' ' ' VAL . 39.0 mt -98.24 100.0 11.26 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.642 0.777 . . . . 74.44 109.052 172.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.01 -115.06 4.53 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.025 -0.989 . . . . 71.22 112.487 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -102.69 5.64 39.12 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.715 0.806 . . . . 54.34 112.15 -176.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -131.7 155.79 47.03 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.81 -0.441 . . . . 73.41 109.81 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 71.8 m -65.67 136.17 55.95 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 123.784 0.677 . . . . 73.51 110.977 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.557 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.6 -64.07 1.19 Allowed 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.577 -1.268 . . . . 74.41 107.577 174.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -155.94 152.14 27.86 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.382 -1.281 . . . . 73.33 110.194 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.535 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 78.3 mt -118.5 111.91 19.24 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.319 -0.993 . . . . 72.12 108.319 177.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.538 ' SG ' HG12 ' D' ' 114' ' ' ILE . 44.8 t -116.06 138.79 50.92 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.765 -0.828 . . . . 71.25 108.765 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -155.31 122.32 5.45 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.579 0.352 . . . . 73.3 110.258 -178.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.17 123.89 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.153 0.581 . . . . 72.32 109.957 -175.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -87.3 88.41 7.68 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.17 -1.048 . . . . 63.22 108.17 165.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -80.41 99.76 8.13 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.646 -1.242 . . . . 74.21 107.646 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.63 142.38 15.8 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.448 -0.661 . . . . 33.22 111.448 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.446 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -136.7 131.96 5.85 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.19 -0.764 . . . . 64.45 111.19 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 43.8 mt -90.77 124.78 43.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 108.088 -1.079 . . . . 54.31 108.088 176.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -132.99 123.65 26.27 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.762 0.825 . . . . 74.43 109.483 -174.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.9 m -84.25 97.76 9.59 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.97 -0.752 . . . . 64.31 108.97 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.582 HD11 HD12 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -120.66 130.81 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.771 0.828 . . . . 75.23 109.724 -174.073 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.26 164.91 36.44 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.785 0.834 . . . . 73.45 110.76 -176.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.67 -10.55 71.67 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.725 -0.671 . . . . 53.24 114.15 173.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.582 HD12 HD11 ' D' ' 86' ' ' ILE . 34.4 mt -94.5 145.08 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.63 0.772 . . . . 71.21 109.81 -174.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.45 ' HG3' ' HA ' ' D' ' 4' ' ' GLN . 0.0 OUTLIER -132.7 166.48 22.1 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.666 0.786 . . . . 65.34 110.62 178.728 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.65 -136.6 41.71 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 114.951 -1.022 . . . . 74.14 114.902 169.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 16.4 m -77.47 -18.33 57.23 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.361 1.065 . . . . 72.11 111.565 -173.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.406 ' OE1' ' HB2' ' D' ' 4' ' ' GLN . 51.3 tt0 -66.16 -24.84 66.73 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.826 0.45 . . . . 52.34 110.723 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 63.3 mtt -60.02 -43.91 94.97 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.967 0.507 . . . . 71.43 110.167 173.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.55 -26.41 67.12 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.399 -0.819 . . . . 73.24 111.53 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -85.26 -34.52 21.94 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.251 0.62 . . . . 71.21 111.111 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 97' ' ' CYS . . . . . 0.564 ' SG ' HG13 ' D' ' 86' ' ' ILE . 42.6 t -72.43 -52.44 15.92 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.265 0.555 . . . . 70.23 109.747 -175.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 26.2 mt -80.95 -29.57 35.4 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.523 -1.217 . . . . 73.41 110.24 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 99' ' ' GLY . . . . . 0.675 ' HA2' ' HE1' ' H' ' 15' ' ' PHE . . . -93.4 -17.89 40.89 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 114.968 0.747 . . . . 35.52 114.968 -171.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.561 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -132.65 -50.22 0.91 Allowed 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 117.788 0.794 . . . . 70.44 111.602 -174.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -73.94 -42.24 60.85 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 122.809 0.444 . . . . 74.2 112.043 -174.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.497 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 69.4 m -67.77 -47.31 44.28 Favored Pre-proline 0 CA--C 1.567 1.609 0 C-N-CA 123.161 0.585 . . . . 54.22 111.76 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 51.4 Cg_exo -59.75 -28.57 87.6 Favored 'Trans proline' 0 C--N 1.401 3.327 0 C-N-CA 122.597 2.198 . . . . 62.31 113.385 170.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -64.25 -40.93 97.02 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.95 0.9 . . . . 74.45 110.05 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 48.0 mm -61.73 -42.19 93.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 123.447 0.699 . . . . 74.33 110.193 173.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.446 HD21 ' HA3' ' D' ' 82' ' ' GLY . 96.1 mt -82.99 -13.37 56.09 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.975 -1.011 . . . . 61.41 112.49 -172.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -64.65 -48.15 74.35 Favored Pre-proline 0 N--CA 1.49 1.546 0 C-N-CA 123.929 0.892 . . . . 74.33 112.775 -176.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.52 -36.89 96.82 Favored 'Trans proline' 0 C--N 1.391 2.791 0 C-N-CA 122.201 1.934 . . . . 72.33 113.164 175.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -73.98 -36.08 64.53 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.893 0.877 . . . . 72.45 112.135 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.47 -49.65 72.79 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.209 -0.664 . . . . 61.53 109.209 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -55.1 -48.53 73.46 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 124.933 1.396 . . . . 72.03 110.781 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -61.81 -50.97 70.17 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 123.794 0.684 . . . . 73.11 111.365 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 38.9 t -55.43 -45.58 76.78 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 123.944 0.777 . . . . 53.14 111.039 -177.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.538 HG12 ' SG ' ' D' ' 76' ' ' CYS . 98.8 mt -59.31 -58.2 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.366 1.066 . . . . 70.01 110.817 174.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 60.7 m -54.19 -43.24 70.53 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.596 1.158 . . . . 64.21 112.16 -173.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -66.75 -40.32 88.25 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.026 -0.988 . . . . 45.31 110.045 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.1 mtm -70.28 -29.79 66.64 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.947 0.499 . . . . 73.51 111.616 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.467 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.0 t -64.99 -45.42 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.503 0.721 . . . . 75.13 110.178 175.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -74.33 -30.14 61.91 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.838 -0.619 . . . . 63.22 111.067 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 59.0 mtt-85 -69.83 -34.11 73.22 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.529 0.731 . . . . 75.21 109.867 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.12 -0.82 90.04 Favored Glycine 0 C--N 1.355 1.628 0 O-C-N 123.65 0.594 . . . . 62.5 112.388 173.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.1 p 64.21 23.18 13.06 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 126.952 2.101 . . . . 64.32 113.698 174.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -85.27 155.41 60.18 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.537 0.735 . . . . 74.22 110.055 171.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -53.2 125.63 19.0 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.182 2.588 . . . . 65.43 112.643 173.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -50.93 142.77 11.24 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.38 1.472 . . . . 75.43 112.864 -174.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.481 HD13 HG21 ' D' ' 40' ' ' VAL . 43.4 tp -114.35 125.07 53.45 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.613 0.765 . . . . 72.43 109.183 177.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -119.88 100.22 7.1 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.519 -0.919 . . . . 74.22 108.519 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.507 HD23 HD12 ' H' ' 6' ' ' ILE . 76.4 mt -61.55 114.84 3.48 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.289 -0.634 . . . . 73.41 109.289 174.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.479 ' H ' HG21 ' H' ' 6' ' ' ILE . . . -57.02 145.22 65.92 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 124.19 0.996 . . . . 72.42 111.979 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.424 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 39.3 Cg_endo -72.33 97.2 0.84 Allowed 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 122.131 1.887 . . . . 61.22 110.343 177.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 19.7 m -108.84 142.83 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 114.567 -1.197 . . . . 54.45 109.513 -175.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -76.66 96.48 4.19 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.243 0.617 . . . . 73.23 110.165 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -63.94 -40.06 95.58 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.961 -1.018 . . . . 74.13 109.663 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.561 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 7.1 m-20 -55.12 -45.34 75.54 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.325 1.05 . . . . 73.33 112.621 -176.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.94 -47.07 55.0 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.762 0.425 . . . . 73.52 111.412 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.99 -48.92 77.29 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.915 0.76 . . . . 62.14 110.112 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.598 ' HE1' ' H ' ' H' ' 11' ' ' LEU . 30.4 t80 -73.84 -28.01 61.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.648 0.779 . . . . 74.15 111.741 -177.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' D' ' 134' ' ' ASP . 28.7 ttm -60.67 -17.24 46.5 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.694 0.797 . . . . 64.44 111.604 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -66.24 -33.28 75.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.833 0.853 . . . . 63.02 110.997 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -71.47 -31.78 67.54 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.513 0.725 . . . . 74.51 110.918 175.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 mp -82.63 -31.54 28.75 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.733 0.813 . . . . 72.05 112.942 -176.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -75.05 4.43 6.73 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 112.991 0.737 . . . . 75.11 112.991 -173.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -121.46 44.94 2.41 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.977 0.911 . . . . 75.51 108.983 175.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -141.72 126.64 18.24 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.673 0.789 . . . . 73.1 108.948 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.75 -36.69 62.61 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.08 0.552 . . . . 70.45 110.068 172.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 107.73 -51.4 0.72 Allowed Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.079 -0.964 . . . . 74.13 111.11 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -81.87 175.59 10.28 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.562 0.745 . . . . 74.44 110.786 175.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 153.73 -139.33 6.78 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 110.844 -0.902 . . . . 75.14 110.844 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 88.3 m -132.56 117.82 18.45 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.828 -0.805 . . . . 60.25 108.828 173.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -133.44 160.2 38.1 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.796 0.838 . . . . 62.35 110.116 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -156.4 89.29 1.11 Allowed 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.105 -1.443 . . . . 51.31 107.105 170.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -88.38 127.9 35.5 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.322 0.649 . . . . 73.42 110.15 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -65.22 94.95 0.17 Allowed 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.735 1.272 . . . . 63.44 109.774 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.04 154.98 40.23 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.148 0.579 . . . . 75.51 110.265 176.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.249 0 CA-C-O 119.059 -0.496 . . . . 54.21 110.42 -178.079 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 61.3 mtt . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 120.83 0.347 . . . . 72.32 111.259 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.84 155.06 43.99 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.715 0.806 . . . . 72.43 108.968 169.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -122.92 90.53 3.31 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.589 0.756 . . . . 63.21 109.41 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 30.8 m -72.97 102.87 3.59 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.693 0.797 . . . . 60.24 109.42 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 26.6 m -57.74 -63.55 1.2 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.05 0.94 . . . . 72.43 111.741 -172.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.609 HD11 ' HB3' ' A' ' 42' ' ' LEU . 7.2 tt -162.88 -74.41 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 C-N-CA 123.246 0.618 . . . . 63.52 110.238 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 7' ' ' ALA . . . . . 0.576 ' H ' HG23 ' E' ' 6' ' ' ILE . . . 63.32 127.05 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 125.313 1.445 . . . . 63.04 113.289 -177.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.55 ' HB3' HD11 ' A' ' 44' ' ' LEU . 80.5 mt -73.74 161.29 30.39 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.748 0.819 . . . . 63.43 110.749 175.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.63 170.13 8.17 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.685 0.794 . . . . 70.44 110.901 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 91.2 mt -76.42 151.21 36.6 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.981 -0.554 . . . . 54.12 110.162 174.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 11' ' ' LEU . . . . . 0.609 HD12 ' HB2' ' E' ' 13' ' ' LEU . 1.1 pt? -137.2 140.28 30.56 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.69 0.796 . . . . 74.35 109.751 -174.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.73 -6.34 18.06 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.153 2.568 . . . . 64.12 112.578 175.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 13' ' ' LEU . . . . . 0.609 ' HB2' HD12 ' E' ' 11' ' ' LEU . 85.0 mt -72.41 108.2 5.38 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.604 0.762 . . . . 72.42 110.097 178.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 14' ' ' LEU . . . . . 0.443 ' HB2' ' HG3' ' E' ' 17' ' ' PRO . 83.2 mt -71.19 116.61 11.7 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.88 -0.785 . . . . 34.33 108.88 174.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -58.28 -45.33 88.12 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.433 1.093 . . . . 75.44 111.698 -170.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 92.1 m -146.99 104.82 3.86 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 107.653 -1.24 . . . . 44.42 107.653 164.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 17' ' ' PRO . . . . . 0.443 ' HG3' ' HB2' ' E' ' 14' ' ' LEU . 6.0 Cg_exo -75.43 79.12 2.84 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 123.053 2.502 . . . . 70.01 111.875 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.2 102.64 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 107.833 -1.173 . . . . 74.11 107.833 173.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 7.3 m 67.65 7.03 5.37 Favored 'General case' 0 CA--C 1.57 1.743 0 C-N-CA 124.972 1.309 . . . . 62.14 111.849 -178.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 56.9 mttp 49.17 57.56 6.34 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.726 1.21 . . . . 73.42 110.805 -169.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 21' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 91' ' ' GLY . . . -52.42 -46.73 66.48 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.878 0.871 . . . . 33.31 110.985 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 22' ' ' ARG . . . . . 0.418 ' HA ' ' HE ' ' E' ' 22' ' ' ARG . 0.9 OUTLIER -92.67 94.15 8.86 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.299 -0.864 . . . . 72.31 108.975 168.806 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 14.6 t -85.61 156.07 59.0 Favored Pre-proline 0 CA--C 1.558 1.268 0 N-CA-C 108.902 -0.777 . . . . 72.42 108.902 172.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -65.29 66.09 0.33 Allowed 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.755 2.303 . . . . 72.43 113.245 168.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 . . . . . 0 CA--C 1.552 1.051 0 N-CA-C 105.859 -1.904 . . . . 74.45 105.859 -178.879 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 109.571 -0.529 . . . . 73.2 109.571 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -178.94 123.19 0.09 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.275 1.03 . . . . 64.22 108.869 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -107.58 -79.39 0.58 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.567 0.747 . . . . 64.52 109.477 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 22.7 m 60.36 -172.81 0.13 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.482 1.113 . . . . 75.32 112.251 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 47.5 m -146.22 142.05 28.0 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.499 0.72 . . . . 71.23 109.378 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 44.4 pt -66.37 128.82 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.887 0.875 . . . . 52.23 110.796 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 7' ' ' ALA . . . . . 0.403 ' HA ' ' HB3' ' B' ' 129' ' ' ALA . . . -103.77 144.41 31.51 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.47 0.708 . . . . 74.34 110.175 -178.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 8' ' ' LEU . . . . . 0.447 HD11 HD21 ' B' ' 44' ' ' LEU . 1.1 tt -83.84 135.68 34.42 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.363 0.665 . . . . 74.43 109.359 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.37 157.01 29.22 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.56 0.744 . . . . 63.12 111.056 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 95.5 mt -71.26 148.25 47.38 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.341 0.656 . . . . 71.34 111.1 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.456 HD21 ' HB2' ' B' ' 44' ' ' LEU . 96.0 mt -79.8 112.82 32.68 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.746 0.819 . . . . 75.1 110.042 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -72.28 -21.88 22.73 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.139 2.559 . . . . 73.5 111.615 176.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.04 124.81 52.91 Favored 'General case' 0 C--N 1.347 0.465 0 N-CA-C 107.591 -1.263 . . . . 73.34 107.591 170.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 92.3 mt -73.09 -174.81 1.63 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.26 0.624 . . . . 72.24 110.74 174.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -74.53 163.24 27.98 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.661 0.384 . . . . 62.51 110.94 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 23.9 m -51.06 120.83 14.6 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.397 1.079 . . . . 72.02 110.951 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.38 111.41 0.71 Allowed 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.077 2.518 . . . . 71.34 111.728 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.06 -51.62 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.037 0.935 . . . . 74.23 110.385 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 54.9 p 70.58 -43.3 0.55 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 127.226 2.21 . . . . 72.24 112.963 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -87.92 79.32 8.09 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.553 -1.277 . . . . 74.43 107.553 169.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 21' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' B' ' 90' ' ' GLU . . . -157.7 88.75 0.99 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.451 -0.795 . . . . 61.15 109.029 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -169.4 135.76 1.64 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.793 1.237 . . . . 74.5 108.217 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 17.5 p -106.6 93.82 9.15 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 123.448 0.699 . . . . 71.22 110.251 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.93 -173.53 1.8 Allowed 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.749 2.299 . . . . 75.21 111.639 175.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 . . . . . 0 CA--C 1.555 1.161 0 C-N-CA 124.397 1.079 . . . . 72.1 111.205 -178.692 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 42.0 ttm . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 109.667 -0.494 . . . . 73.41 109.667 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -145.1 130.54 18.75 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.415 -0.957 . . . . 75.04 108.415 174.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -78.13 154.39 31.28 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.154 0.582 . . . . 72.0 111.778 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 30.5 p -122.78 110.23 15.2 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.999 -1.111 . . . . 74.51 107.999 168.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 5.4 t -62.31 -39.05 91.74 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.934 0.894 . . . . 63.32 112.102 -177.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 6' ' ' ILE . . . . . . . . . . . . . 63.4 mt -116.58 135.08 58.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.778 0.831 . . . . 64.21 108.817 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.62 132.29 23.95 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.728 0.811 . . . . 62.43 109.85 177.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 8' ' ' LEU . . . . . 0.663 ' H ' HG21 ' C' ' 131' ' ' VAL . 88.1 mt -72.79 141.42 48.07 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.268 1.027 . . . . 74.14 110.555 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.42 132.68 45.14 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.627 0.771 . . . . 51.02 110.569 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 8.5 mp -59.01 118.95 6.39 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 108.592 -0.892 . . . . 70.13 108.592 171.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 90.0 mt -56.69 111.04 2.81 Favored Pre-proline 0 CA--C 1.554 1.115 0 O-C-N 124.577 1.173 . . . . 63.41 111.75 -174.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -65.14 -29.35 56.15 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 123.059 2.506 . . . . 62.0 111.64 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 61.1 tp -125.41 129.4 49.79 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 106.927 -1.509 . . . . 75.24 106.927 171.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.03 -175.11 5.42 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.753 -0.462 . . . . 72.2 109.753 171.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 15' ' ' PHE . . . . . 0.415 ' HB2' HD13 ' C' ' 98' ' ' LEU . 10.7 m-85 -79.0 154.8 29.22 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.302 -0.629 . . . . 75.44 109.302 176.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 76.2 p -75.47 150.23 84.57 Favored Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 122.93 0.492 . . . . 63.13 110.716 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 17' ' ' PRO . . . . . 0.633 ' HB3' ' H ' ' G' ' 21' ' ' ALA . 70.9 Cg_exo -52.18 143.56 41.72 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.777 2.985 . . . . 75.44 115.137 -177.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 18' ' ' VAL . . . . . 0.593 HG23 HD23 ' C' ' 98' ' ' LEU . 46.9 t -70.08 -68.02 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 108.401 -0.963 . . . . 61.3 108.401 168.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 19' ' ' THR . . . . . 0.47 ' H ' ' HE1' ' C' ' 94' ' ' MET . 17.0 p -99.4 -89.44 0.32 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.266 1.027 . . . . 72.33 109.421 170.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -137.31 85.71 2.14 Favored 'General case' 0 C--N 1.366 1.322 0 CA-C-N 118.671 0.669 . . . . 72.32 110.844 -175.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 21' ' ' ALA . . . . . 0.633 ' H ' ' HB3' ' G' ' 17' ' ' PRO . . . -92.95 -7.4 46.09 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.992 0.517 . . . . 73.5 109.933 171.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -89.2 124.16 34.1 Favored 'General case' 0 C--N 1.35 0.615 0 C-N-CA 123.29 0.636 . . . . 74.11 110.62 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 6.3 t -77.62 137.63 63.0 Favored Pre-proline 0 CA--C 1.551 1.012 0 CA-C-N 115.237 -0.892 . . . . 63.34 109.91 169.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -62.18 -26.13 77.54 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.732 2.288 . . . . 61.24 112.527 172.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 CA--C 1.563 1.458 0 C-N-CA 124.963 1.305 . . . . 72.41 110.304 176.655 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 110.665 -0.124 . . . . 75.31 110.665 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -156.52 110.82 2.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.507 0.723 . . . . 71.25 109.154 171.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -78.14 178.74 7.33 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.872 0.869 . . . . 72.22 110.711 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 27.1 m 73.04 133.4 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.969 1.307 . . . . 71.42 110.948 -173.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 5' ' ' THR . . . . . 0.615 HG23 ' HB ' ' D' ' 40' ' ' VAL . 32.1 m -75.55 132.48 40.73 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.4 0.68 . . . . 45.11 109.752 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.507 HD12 HD23 ' D' ' 128' ' ' LEU . 15.0 mm 58.05 84.03 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 C-N-CA 125.15 1.38 . . . . 74.53 110.068 -172.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 7' ' ' ALA . . . . . 0.458 ' H ' ' HG ' ' D' ' 42' ' ' LEU . . . -150.53 165.8 32.14 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.641 0.376 . . . . 53.24 111.683 -169.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 80.3 mt -131.94 153.44 50.29 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.273 1.029 . . . . 75.51 110.255 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 9' ' ' ALA . . . . . 0.513 ' H ' HD22 ' D' ' 44' ' ' LEU . . . -125.5 154.0 42.75 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.982 0.913 . . . . 73.43 109.998 178.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 91.4 mt -70.43 140.4 52.01 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.602 0.761 . . . . 61.55 109.871 175.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.598 ' H ' ' HE1' ' D' ' 137' ' ' PHE . 36.8 mt -86.78 104.99 6.79 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 108.109 -1.071 . . . . 74.11 108.109 177.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.24 -30.25 31.19 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.144 2.563 . . . . 64.15 113.908 -169.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -93.85 -7.39 43.41 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.144 0.578 . . . . 71.13 110.976 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 62.2 tp 57.3 -105.5 0.27 Allowed 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.526 0.73 . . . . 74.04 109.952 -175.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 15' ' ' PHE . . . . . 0.675 ' HE1' ' HA2' ' D' ' 99' ' ' GLY . 84.5 m-85 -166.34 -166.85 0.93 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.36 1.864 . . . . 74.41 106.378 -172.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 28.7 p -100.22 107.1 45.85 Favored Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 108.474 -0.936 . . . . 72.44 108.474 163.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -53.18 165.41 1.39 Allowed 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.735 2.29 . . . . 64.35 113.482 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 18' ' ' VAL . . . . . 0.681 ' HA ' ' HB3' ' H' ' 21' ' ' ALA . 7.3 t -72.65 -0.67 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 CA-C-N 115.627 -0.715 . . . . 73.33 111.222 -173.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 34.0 m -66.11 -52.95 43.9 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.934 0.894 . . . . 53.0 111.075 177.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -86.17 -28.41 23.95 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.619 0.768 . . . . 74.53 110.527 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 21' ' ' ALA . . . . . 0.681 ' HB3' ' HA ' ' H' ' 18' ' ' VAL . . . -65.76 -30.96 71.69 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.835 0.709 . . . . 72.41 110.78 177.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 22' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' H' ' 18' ' ' VAL . 0.0 OUTLIER -63.67 87.71 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.989 -1.115 . . . . 63.14 107.989 174.454 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 6.3 t -112.19 131.15 22.67 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 123.954 0.902 . . . . 75.14 109.742 -175.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.5 -28.63 38.3 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.635 2.223 . . . . 73.11 111.768 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 CA--C 1.553 1.075 0 C-N-CA 124.233 1.013 . . . . 41.11 109.055 177.17 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.57 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.8 t80 . . . . . 0 CA--C 1.538 0.504 0 N-CA-C 109.63 -0.508 . . . . 65.0 109.63 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -147.78 120.35 8.54 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.048 -1.093 . . . . 64.52 108.048 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.49 HD13 HD11 ' A' ' 16' ' ' ILE . 20.2 mt -85.85 120.56 36.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 109.374 -0.602 . . . . 65.32 109.374 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.28 -41.91 19.54 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.463 -0.94 . . . . 73.53 108.463 178.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -169.03 148.91 4.17 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 116.183 -0.462 . . . . 73.42 111.116 -170.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.49 HD11 HD13 ' A' ' 13' ' ' ILE . 69.0 mt -137.65 130.35 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 124.61 1.164 . . . . 63.52 108.151 175.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.456 ' HB3' HG23 ' B' ' 122' ' ' THR . 28.2 p90 -167.83 154.52 7.92 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.61 0.719 . . . . 70.31 111.605 -174.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.1 p -83.9 122.35 28.6 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.467 -1.242 . . . . 55.41 109.111 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -94.59 -14.93 24.5 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.161 0.584 . . . . 74.24 110.638 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 18.0 t0 -158.6 139.55 12.97 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.9 -1.148 . . . . 73.3 107.9 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.408 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 59.2 mt -141.16 141.9 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 106.977 -1.49 . . . . 74.21 106.977 177.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.9 t -157.06 116.48 3.4 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.821 0.343 . . . . 41.24 110.259 177.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.591 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 81.6 t80 -110.86 139.82 45.86 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 107.206 -1.405 . . . . 72.23 107.206 170.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 49.1 mt-10 -141.68 109.69 5.82 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 123.321 0.648 . . . . 75.02 109.35 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.429 ' CB ' ' HB2' ' A' ' 28' ' ' ALA . . . -103.05 88.56 1.59 Allowed Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.064 -1.828 . . . . 51.13 106.064 165.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -66.92 -34.05 31.07 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.722 2.281 . . . . 64.31 112.097 -169.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -112.82 26.37 10.58 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 114.959 -1.019 . . . . 73.52 109.311 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.467 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -44.62 -53.91 13.89 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 113.972 1.101 . . . . 51.11 113.972 -169.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.76 -28.47 86.52 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 121.971 1.781 . . . . 63.14 112.824 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.474 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.2 m-70 -89.34 -31.19 17.92 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.439 1.096 . . . . 70.42 110.269 -176.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.564 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.0 p -73.26 -17.82 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.065 0.546 . . . . 60.35 112.186 -162.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -82.6 -23.71 34.25 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.255 0.622 . . . . 64.44 111.203 -176.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 28.9 pt20 -91.21 -11.86 37.04 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.253 0.621 . . . . 53.51 110.556 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 13.5 mmmm -76.75 168.43 20.1 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.491 0.716 . . . . 73.44 111.842 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.64 117.0 10.69 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.743 -0.836 . . . . 74.51 108.743 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.416 ' CE3' HD21 ' A' ' 68' ' ' LEU . 58.1 t-105 -83.54 85.21 7.29 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.378 0.608 . . . . 65.42 109.766 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.407 ' H ' HD22 ' A' ' 68' ' ' LEU . 6.8 tp-100 -127.82 81.38 70.4 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 107.889 -1.152 . . . . 64.51 107.889 171.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -72.94 108.2 2.53 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.532 2.154 . . . . 75.03 112.514 -174.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -95.43 90.49 5.8 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.911 -1.514 . . . . 62.51 106.911 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 65' ' ' THR . 60.3 t -88.13 113.46 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 CA-C-N 115.021 -0.991 . . . . 71.02 111.044 -171.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.425 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 80.7 tttt -79.82 136.86 36.81 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.346 1.058 . . . . 75.11 110.104 172.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.4 125.37 53.17 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.976 -1.12 . . . . 75.44 107.976 175.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.593 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 22.8 t70 -135.57 126.24 27.17 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.379 -0.6 . . . . 72.12 109.379 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -107.94 133.27 52.52 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.368 0.667 . . . . 75.31 110.278 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 11.7 t70 -124.18 146.29 48.78 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.382 1.073 . . . . 71.4 108.372 173.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 79.3 m -119.8 139.87 51.66 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.701 0.8 . . . . 71.32 110.073 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.671 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -132.53 131.59 41.73 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.922 0.889 . . . . 44.05 109.286 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.2 m -102.58 151.88 21.82 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.629 0.772 . . . . 64.34 109.946 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.6 t -162.96 127.95 3.12 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.084 -0.709 . . . . 63.34 109.084 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -112.84 119.15 36.99 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.337 -0.986 . . . . 70.24 108.337 171.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.4 mt -96.17 -30.18 13.64 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.216 0.606 . . . . 64.13 111.405 -174.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.22 -175.47 3.98 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.293 0.637 . . . . 55.55 110.469 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.51 117.79 7.24 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.326 -0.852 . . . . 74.41 108.776 171.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 71.93 -5.03 1.8 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.541 1.136 . . . . 62.14 112.93 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.0 t -99.22 106.02 18.3 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 N-CA-C 107.544 -1.28 . . . . 64.43 107.544 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -124.02 125.01 43.81 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.97 -1.122 . . . . 74.15 107.97 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -102.09 114.16 28.05 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.636 -0.876 . . . . 64.3 108.636 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.9 m -102.92 136.1 37.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.702 -1.221 . . . . 62.15 107.702 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 60.7 t -124.93 138.97 52.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 108.751 -0.833 . . . . 74.32 108.751 -174.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -128.19 112.84 14.96 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.593 -0.891 . . . . 62.23 108.593 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.564 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 19.5 ttt180 -93.23 102.44 14.73 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.029 0.932 . . . . 52.41 109.122 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -94.09 127.76 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.49 0.716 . . . . 74.0 109.444 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 13.9 m -113.31 130.45 56.26 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.836 0.855 . . . . 64.14 109.584 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.7 t -126.65 106.69 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.162 1.385 . . . . 55.51 107.851 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 23.5 m -104.61 134.4 47.85 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 107.762 -1.199 . . . . 75.33 107.762 175.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.52 127.29 55.18 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.835 -1.172 . . . . 23.43 107.835 174.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -126.94 126.33 43.06 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.302 0.641 . . . . 62.33 110.023 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.53 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 30.9 mt -86.91 78.02 9.11 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.394 1.078 . . . . 52.11 108.363 173.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.58 -84.6 0.87 Allowed Glycine 0 C--N 1.342 0.911 0 CA-C-N 115.229 -0.896 . . . . 74.0 111.443 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -115.27 -28.48 6.89 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.143 0.977 . . . . 71.33 110.621 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -87.94 132.59 34.17 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.289 -0.634 . . . . 74.03 109.289 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.2 m -72.8 123.42 23.31 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.745 0.702 . . . . 71.25 110.307 175.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.564 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -72.21 -57.35 4.31 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.52 -0.764 . . . . 40.32 109.633 174.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.437 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 35.7 p90 -162.58 176.96 9.85 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.612 -1.177 . . . . 54.22 111.093 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 58.6 tp -139.77 142.22 36.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.397 1.479 . . . . 65.53 107.31 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.452 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 76.0 m -145.5 106.96 4.21 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.114 0.965 . . . . 72.01 108.654 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -130.33 122.23 27.52 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.402 0.681 . . . . 73.12 109.492 -174.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 t -132.14 114.44 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.209 1.004 . . . . 53.32 109.685 -172.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 7.1 tt0 -84.56 90.12 7.59 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.359 -0.978 . . . . 51.14 108.359 173.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.537 ' HG3' HD22 ' A' ' 106' ' ' LEU . 6.8 tp-100 -85.13 104.13 14.74 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.288 -0.634 . . . . 75.32 109.288 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.61 153.39 21.61 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 111.485 -0.646 . . . . 62.03 111.485 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.438 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -155.8 122.0 1.16 Allowed Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 111.262 -0.735 . . . . 63.34 111.262 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.4 mt -83.04 116.15 26.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 N-CA-C 108.962 -0.755 . . . . 64.23 108.962 176.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.57 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 38.0 m-85 -127.19 120.82 29.68 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.267 0.627 . . . . 74.53 109.941 -175.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.8 m -81.1 102.02 9.98 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.434 -0.95 . . . . 71.32 108.434 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.3 pt . . . . . 0 CA--C 1.543 0.704 0 C-N-CA 123.87 0.868 . . . . 62.11 109.991 -175.378 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.945 0.402 . . . . 42.13 110.99 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.553 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 41.6 t-80 -68.79 -24.91 64.47 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.772 0.829 . . . . 73.05 110.584 173.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 69.1 m -75.77 -64.95 0.97 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.565 0.346 . . . . 72.33 110.675 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.53 HD12 ' N ' ' A' ' 99' ' ' GLY . 3.4 pp -71.1 -32.27 68.84 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.149 0.98 . . . . 74.42 112.687 -170.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.53 ' N ' HD12 ' A' ' 98' ' ' LEU . . . -105.54 3.22 39.59 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-O 119.688 -0.506 . . . . 73.03 113.597 -171.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -136.93 -60.5 0.69 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.525 0.663 . . . . 70.42 112.072 -177.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.4 ' O ' HG12 ' A' ' 105' ' ' ILE . 0.0 OUTLIER -79.13 -34.82 42.98 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 112.166 0.432 . . . . 72.14 112.166 -174.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 70.9 m -64.55 -43.56 71.43 Favored Pre-proline 0 N--CA 1.491 1.611 0 CA-C-N 115.627 -0.715 . . . . 54.4 112.416 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -48.53 -45.09 28.36 Favored 'Trans proline' 0 C--N 1.391 2.811 0 C-N-CA 122.829 2.353 . . . . 63.32 113.322 163.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -64.52 -21.57 66.72 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.652 0.781 . . . . 72.24 112.03 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 101' ' ' TYR . 45.8 mm -74.85 -48.95 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 109.667 -0.494 . . . . 62.02 109.667 174.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.537 HD22 ' HG3' ' A' ' 80' ' ' GLN . 88.4 mt -75.94 -27.05 57.44 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.401 -0.818 . . . . 71.11 112.276 -174.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.514 ' HZ ' HD22 ' A' ' 128' ' ' LEU . 31.7 t80 -63.44 -43.76 79.95 Favored Pre-proline 0 CA--C 1.564 1.504 0 N-CA-C 113.817 1.043 . . . . 71.23 113.817 -169.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.63 -40.11 82.59 Favored 'Trans proline' 0 C--N 1.387 2.578 0 C-N-CA 122.207 1.938 . . . . 75.33 112.887 173.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -69.69 -40.98 76.02 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.497 0.719 . . . . 73.21 111.415 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.0 -36.04 74.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.425 0.69 . . . . 74.13 110.29 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.552 ' NH1' HD12 ' C' ' 105' ' ' ILE . 37.3 ttm180 -57.8 -55.78 30.44 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.093 0.871 . . . . 71.02 109.6 172.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -63.98 -41.06 97.65 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.024 -0.989 . . . . 75.34 111.73 -173.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 39.0 t -66.45 -30.94 71.41 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.798 0.439 . . . . 72.33 111.167 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 60.7 mt -72.85 -50.99 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.831 0.853 . . . . 62.21 109.857 172.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 63.7 m -57.99 -34.04 69.55 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.667 1.187 . . . . 72.45 111.509 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.8 t -67.35 -46.35 73.64 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 115.439 -0.801 . . . . 73.31 109.8 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.591 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 42.6 mtm -67.49 -36.15 80.53 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.876 0.47 . . . . 72.11 111.483 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.417 HG13 ' HB2' ' A' ' 123' ' ' PHE . 72.2 t -61.59 -46.85 95.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.369 0.668 . . . . 72.23 110.075 174.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 41.2 t -67.56 -36.35 80.77 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 115.428 -0.805 . . . . 53.03 111.118 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -72.96 -29.38 63.03 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.686 0.794 . . . . 75.14 109.891 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.55 10.51 61.64 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.869 0.73 . . . . 50.54 112.198 173.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.486 HG21 ' HE ' ' B' ' 15' ' ' ARG . 2.1 t 62.17 20.18 11.49 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.84 2.056 . . . . 64.42 113.266 170.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.417 ' HB2' HG13 ' A' ' 118' ' ' VAL . 87.3 m-85 -84.28 154.89 63.4 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 122.956 0.503 . . . . 72.21 109.65 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -53.16 159.63 5.42 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.461 2.774 . . . . 75.15 113.97 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.477 HE21 HG21 ' D' ' 122' ' ' THR . 6.5 tp-100 -62.03 125.53 24.18 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.627 -0.715 . . . . 43.24 111.435 -174.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.437 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 54.9 tp -130.27 113.11 14.0 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.779 1.231 . . . . 71.34 109.407 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -129.22 123.28 31.58 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.364 0.666 . . . . 73.21 109.562 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.514 HD22 ' HZ ' ' A' ' 107' ' ' PHE . 4.2 tt -73.8 127.85 33.92 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 108.333 -0.988 . . . . 64.3 108.333 175.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.51 137.26 96.44 Favored Pre-proline 0 CA--C 1.564 1.49 0 C-N-CA 123.067 0.547 . . . . 74.41 112.051 -174.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.471 ' HG2' ' CE1' ' C' ' 11' ' ' PHE . 36.8 Cg_exo -63.95 127.32 19.17 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.974 3.116 . . . . 54.31 113.429 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.5 t -117.47 114.78 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.04 0.936 . . . . 63.15 108.738 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -83.42 88.31 6.98 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.039 -0.726 . . . . 74.21 109.039 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 . . . . . 0 N--CA 1.478 0.927 0 CA-C-N 115.279 -0.873 . . . . 52.53 110.506 -179.873 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.498 ' SD ' ' N ' ' B' ' 10' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.557 1.216 0 CA-C-O 121.349 0.595 . . . . 74.21 110.777 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 99.9 m -157.87 125.26 5.14 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 106.187 -1.783 . . . . 74.21 106.187 170.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -138.53 125.33 21.0 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.181 -0.674 . . . . 73.41 109.181 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.482 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -148.3 137.7 22.09 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.315 -0.624 . . . . 74.43 109.315 174.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 48.6 mt -85.4 122.6 38.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.608 -0.886 . . . . 74.32 108.608 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . 0.514 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 12.4 mm100 -89.83 -43.51 10.59 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.677 0.791 . . . . 73.32 109.999 -175.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.486 ' HE ' HG21 ' A' ' 122' ' ' THR . 44.2 ttt180 -178.96 130.63 0.11 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.298 -0.631 . . . . 74.13 109.298 -173.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 77.4 mt -116.73 137.08 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 108.31 -0.996 . . . . 75.25 108.31 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -162.99 145.27 10.3 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.455 0.645 . . . . 75.12 111.182 -170.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.3 m -73.68 117.9 16.0 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.471 -1.24 . . . . 35.15 108.091 170.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.495 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 45.1 mtpt -92.78 -25.01 18.36 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.795 0.838 . . . . 63.3 111.354 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -163.45 147.35 10.6 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.528 0.518 . . . . 74.2 109.851 -172.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.437 HD11 ' SG ' ' B' ' 113' ' ' CYS . 28.4 mm -141.81 145.28 24.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 125.35 1.46 . . . . 72.32 108.427 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 44.2 t -144.01 141.08 29.93 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.727 -1.124 . . . . 72.14 108.387 167.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 81.5 t80 -147.75 126.69 12.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.279 -1.749 . . . . 74.51 106.279 171.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -135.3 116.6 14.55 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.147 -1.057 . . . . 63.43 108.147 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.574 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -106.35 86.48 2.13 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 107.593 -1.262 . . . . 64.54 107.593 174.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.12 -50.35 2.15 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.89 2.393 . . . . 52.5 111.946 -168.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -96.78 15.53 21.74 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.484 0.713 . . . . 72.35 111.191 -175.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.574 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -40.36 -65.06 0.48 Allowed Pre-proline 0 N--CA 1.491 1.602 0 C-N-CA 125.242 1.417 . . . . 53.14 114.575 -165.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.17 -25.54 72.68 Favored 'Trans proline' 0 C--N 1.392 2.821 0 C-N-CA 122.262 1.975 . . . . 62.11 113.92 -169.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -94.37 -41.66 9.3 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.138 0.575 . . . . 71.35 111.182 -175.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.89 -12.69 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 123.573 0.749 . . . . 73.32 111.685 -172.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -62.66 -14.3 41.94 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.569 0.748 . . . . 71.03 112.86 174.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.546 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.0 pt20 -60.79 -29.0 69.17 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.663 0.785 . . . . 73.33 110.98 172.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.546 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 96.3 mttt -93.66 108.46 20.19 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.91 1.284 . . . . 74.31 109.959 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -114.97 105.94 13.57 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.074 0.549 . . . . 73.12 110.427 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 21.6 p90 -165.82 -166.04 0.89 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.911 1.284 . . . . 74.33 108.121 169.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 -82.15 103.62 2.46 Favored Pre-proline 0 N--CA 1.477 0.914 0 N-CA-C 108.403 -0.962 . . . . 64.13 108.403 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.69 144.18 87.19 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.769 2.312 . . . . 61.45 113.126 -173.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.472 ' HB2' ' HB2' ' B' ' 67' ' ' SER . 5.6 mp0 -55.42 103.36 0.09 Allowed 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.677 1.591 . . . . 70.32 110.311 172.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.435 HG22 HD21 ' B' ' 126' ' ' LEU . 20.3 t -85.62 155.18 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 115.182 -0.917 . . . . 71.13 109.118 -174.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.6 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 50.2 tttm -151.45 101.14 2.79 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.177 -1.786 . . . . 72.23 106.177 166.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.4 HD23 ' N ' ' B' ' 43' ' ' ASP . 7.8 tt -87.1 144.15 26.99 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.029 -1.471 . . . . 65.23 107.029 172.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.422 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 8.8 t70 -140.28 116.48 10.55 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 106.315 -1.735 . . . . 72.34 106.315 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 15.2 tp -98.13 127.89 44.33 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.182 -1.044 . . . . 73.11 108.182 -173.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -130.18 156.13 45.1 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.013 0.925 . . . . 64.34 109.136 -172.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 49.0 p -106.88 139.02 41.96 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.06 0.544 . . . . 60.21 111.131 -171.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.38 128.46 12.74 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 106.836 -1.542 . . . . 74.2 106.836 172.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.8 m -144.79 163.79 32.99 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.308 0.243 . . . . 71.11 111.16 -173.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 80.8 p -165.76 137.13 3.84 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.006 0.816 . . . . 63.15 110.049 167.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -94.72 108.82 20.82 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.093 -1.077 . . . . 71.14 108.093 171.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 35.3 mt -70.45 -53.49 16.16 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 121.643 0.735 . . . . 74.22 109.789 -175.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.89 -170.31 2.83 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.276 -1.329 . . . . 64.33 108.431 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -86.7 145.58 26.62 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.818 -1.179 . . . . 64.42 107.818 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 67.3 -2.44 1.25 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.815 1.246 . . . . 64.02 112.132 -172.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 45.9 t -126.45 116.75 46.3 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 C-N-CA 124.791 1.237 . . . . 74.4 108.0 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -127.11 139.25 53.11 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.019 -1.104 . . . . 74.02 108.019 175.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -105.51 105.65 15.78 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.628 -1.249 . . . . 74.53 107.628 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 75.1 t -94.94 124.35 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 124.938 1.295 . . . . 55.42 109.8 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.441 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 6.5 t -112.97 146.81 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.251 -1.018 . . . . 60.42 108.251 172.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 20.6 tp -125.4 111.41 15.1 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.258 -1.016 . . . . 65.03 108.258 169.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -87.83 112.23 22.24 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.13 -0.693 . . . . 72.35 109.13 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 60.9 t -104.69 104.02 16.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.7 -1.136 . . . . 73.23 108.049 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.422 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 27.0 m -94.92 136.38 35.3 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.114 -1.069 . . . . 55.31 108.114 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.518 HG21 HD13 ' B' ' 114' ' ' ILE . 95.0 t -127.85 130.7 70.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 124.096 0.958 . . . . 40.42 109.246 -175.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.6 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 53.5 m -121.53 139.65 53.22 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.899 -1.519 . . . . 64.01 106.899 168.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.05 136.72 30.48 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.668 -1.234 . . . . 63.25 107.668 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.501 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 3.7 m -139.08 145.5 39.59 Favored 'General case' 0 C--O 1.215 -0.726 0 N-CA-C 109.455 -0.572 . . . . 71.43 109.455 -168.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 42.6 mt -113.26 108.48 17.32 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.605 0.716 . . . . 72.15 109.487 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.12 -110.7 3.62 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 114.082 -1.417 . . . . 44.25 113.361 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.72 2.12 35.31 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.268 1.027 . . . . 74.34 110.489 -170.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -133.19 158.23 43.38 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.523 0.729 . . . . 72.1 109.701 -175.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 97.0 m -75.31 137.8 41.39 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.168 0.509 . . . . 72.4 110.081 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.501 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -93.35 -61.33 1.58 Allowed 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.458 1.103 . . . . 61.21 108.281 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -151.99 167.74 27.45 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 114.688 -1.142 . . . . 71.21 110.742 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 70.5 mt -133.87 138.0 45.33 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 106.008 -1.849 . . . . 73.12 106.008 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 47.1 t -138.4 159.17 42.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.869 -1.16 . . . . 74.42 107.869 175.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.466 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 40.5 tt0 -165.77 134.15 3.09 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.985 -0.746 . . . . 73.02 108.985 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.91 145.32 35.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.577 -0.897 . . . . 61.43 108.577 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -121.13 93.99 4.2 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.108 -1.071 . . . . 64.3 108.108 171.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.456 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -87.88 102.44 14.71 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.725 -0.843 . . . . 74.41 108.725 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.495 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.94 156.58 23.02 Favored Glycine 0 N--CA 1.449 -0.492 0 O-C-N 123.965 0.79 . . . . 54.23 111.305 175.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.96 126.35 1.66 Allowed Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 109.99 -1.244 . . . . 73.33 109.99 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.514 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 27.1 mt -85.67 130.1 36.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.626 -1.25 . . . . 62.35 107.626 176.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -133.83 134.23 42.55 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.36 -0.978 . . . . 74.3 108.36 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 74.1 m -92.99 110.43 21.9 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.101 -0.703 . . . . 54.51 109.101 172.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.574 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -124.81 132.71 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.623 1.169 . . . . 74.44 109.122 -178.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.3 172.29 18.75 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.209 0.604 . . . . 53.03 110.741 -172.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.42 -63.6 4.31 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.932 0.77 . . . . 62.35 112.408 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.593 HG22 ' HB3' ' B' ' 94' ' ' MET . 2.5 mm -68.8 157.84 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.474 1.11 . . . . 75.55 112.224 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -160.06 153.5 22.29 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 115.118 -0.947 . . . . 74.21 110.777 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.76 -136.81 13.36 Favored Glycine 0 C--N 1.351 1.413 0 C-N-CA 124.297 0.951 . . . . 61.22 112.933 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 19.5 m -67.14 -27.68 67.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.542 0.737 . . . . 75.24 110.94 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.432 ' HB2' HG23 ' B' ' 89' ' ' ILE . 42.8 mt-30 -63.99 -39.77 94.86 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.689 -1.141 . . . . 74.32 110.965 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.593 ' HB3' HG22 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -88.17 -25.81 22.75 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.565 0.346 . . . . 72.34 110.82 177.379 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.65 -34.2 73.95 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.149 0.58 . . . . 60.44 110.954 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -78.86 -37.57 40.02 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.655 0.782 . . . . 64.02 111.034 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.5 t -62.71 -43.2 99.4 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.201 0.601 . . . . 44.53 111.49 -175.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.412 HD11 HG13 ' B' ' 86' ' ' ILE . 6.6 mp -90.58 -23.33 20.89 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.874 0.47 . . . . 72.34 111.112 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.06 -17.62 66.86 Favored Glycine 0 C--N 1.346 1.104 0 N-CA-C 114.358 0.503 . . . . 73.44 114.358 -174.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.19 -55.56 0.59 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.068 0.547 . . . . 71.33 110.97 -177.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -66.75 -53.31 34.59 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.436 0.902 . . . . 75.43 113.436 -166.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.516 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 76.0 m -60.13 -50.08 87.88 Favored Pre-proline 0 CA--C 1.564 1.504 0 CA-C-O 118.561 -0.733 . . . . 53.22 111.493 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.516 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 47.7 Cg_exo -60.33 -29.37 88.7 Favored 'Trans proline' 0 C--N 1.401 3.296 0 C-N-CA 122.4 2.067 . . . . 73.1 113.384 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -71.15 -30.99 67.16 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.578 0.751 . . . . 62.13 110.928 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.423 HG23 ' NH2' ' D' ' 111' ' ' ARG . 53.1 mt -66.87 -37.87 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 109.568 -0.53 . . . . 45.0 109.568 171.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 54.8 mt -84.18 -18.82 35.41 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.026 0.93 . . . . 62.03 112.1 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.421 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 85.7 t80 -57.86 -50.34 88.66 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-O 118.088 -0.958 . . . . 73.52 112.338 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.421 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 51.5 Cg_exo -57.89 -38.02 94.01 Favored 'Trans proline' 0 C--N 1.394 2.929 0 C-N-CA 122.401 2.067 . . . . 74.43 113.798 177.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.456 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 38.8 m-85 -68.12 -43.29 78.73 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.281 0.632 . . . . 74.03 110.576 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.449 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -64.8 -40.61 95.51 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.285 0.634 . . . . 73.24 110.427 175.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.497 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 37.9 ttt180 -57.41 -49.57 75.8 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.542 1.537 . . . . 75.11 111.402 -176.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.428 ' HG3' ' NH2' ' C' ' 120' ' ' ARG . 2.1 tm-20 -68.79 -34.6 75.83 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 123.84 0.712 . . . . 55.33 110.033 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.476 ' O ' ' HG2' ' B' ' 117' ' ' MET . 9.3 t -67.27 -33.63 75.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.99 0.516 . . . . 54.41 111.268 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.518 HD13 HG21 ' B' ' 64' ' ' VAL . 73.7 mt -67.69 -56.04 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 108.91 -0.774 . . . . 41.12 108.91 174.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.1 m -59.84 -26.54 65.89 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 124.336 1.023 . . . . 63.1 111.396 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 29.4 t -64.78 -50.55 66.33 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.273 0.629 . . . . 72.35 109.614 174.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.0 mmt -70.44 -31.21 68.3 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.08 0.552 . . . . 73.52 111.005 -176.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.49 HG23 ' O ' ' B' ' 114' ' ' ILE . 57.7 t -60.57 -47.77 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.487 0.715 . . . . 55.02 109.414 171.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 21.0 t -65.08 -34.62 78.85 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.546 -1.206 . . . . 75.41 111.191 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.423 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 92.6 mtt-85 -70.81 -31.95 68.86 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.986 -1.006 . . . . 75.42 110.384 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.56 5.66 76.96 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.944 0.778 . . . . 52.45 112.656 174.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.456 HG23 ' HB3' ' A' ' 17' ' ' TYR . 80.6 p 54.42 29.95 11.93 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 126.0 1.72 . . . . 62.25 113.015 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -91.02 159.87 38.97 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.264 0.625 . . . . 74.14 111.317 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -48.93 158.11 1.39 Allowed 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 123.732 2.955 . . . . 62.03 114.76 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -57.9 114.6 2.39 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.978 -1.01 . . . . 73.52 111.236 -176.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.435 HD21 HG22 ' B' ' 40' ' ' VAL . 0.3 OUTLIER -121.58 101.87 7.88 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.867 -1.16 . . . . 62.13 107.867 -178.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -119.23 133.99 55.45 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.726 0.811 . . . . 71.43 109.224 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.497 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 6.6 mp -75.42 144.97 41.92 Favored 'General case' 0 C--O 1.242 0.668 0 O-C-N 123.655 0.597 . . . . 71.23 109.956 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -70.76 134.14 86.18 Favored Pre-proline 0 CA--C 1.549 0.911 0 O-C-N 123.816 0.697 . . . . 50.53 111.093 -177.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 7.0 Cg_exo -72.47 104.81 1.77 Allowed 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.886 2.391 . . . . 71.42 111.692 176.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 34.1 m -110.99 139.95 32.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 123.327 0.651 . . . . 63.33 109.63 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -92.08 90.61 7.44 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 106.414 -1.699 . . . . 61.31 106.414 169.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -67.09 -32.0 72.86 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.946 -1.025 . . . . 63.33 111.289 -171.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 . . . . . 0 N--CA 1.471 0.607 0 C-N-CA 123.941 0.896 . . . . 54.42 111.484 175.586 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.652 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.3 t80 . . . . . 0 C--O 1.236 0.356 0 CA-C-O 121.138 0.494 . . . . 72.03 110.406 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . 0.423 HE21 HE22 ' C' ' 14' ' ' GLN . 23.6 tt0 -155.31 126.43 7.15 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.839 -1.171 . . . . 74.24 107.839 175.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 88.4 mt -73.32 120.05 21.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.291 -1.003 . . . . 71.42 108.291 172.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.62 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 23.9 mm-40 -82.54 -42.64 18.11 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.208 -0.905 . . . . 71.11 109.6 -177.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -179.27 134.02 0.12 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.284 0.633 . . . . 75.32 110.345 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.8 mt -117.68 145.95 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.867 0.867 . . . . 74.44 108.855 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -174.65 158.02 2.65 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.276 0.631 . . . . 74.3 110.729 -174.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . 0.558 HG22 HE22 ' C' ' 80' ' ' GLN . 63.7 p -83.39 114.69 21.61 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.381 -0.97 . . . . 71.2 108.381 173.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -77.05 -47.06 21.62 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.736 -0.838 . . . . 74.12 108.736 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.662 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.0 t70 -133.97 137.84 45.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.336 -1.302 . . . . 64.54 109.572 -174.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 71.8 mt -136.81 144.52 32.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.021 -1.474 . . . . 72.03 107.021 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.1 t -161.82 150.66 15.61 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.976 0.417 . . . . 71.11 110.798 174.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -152.36 121.25 6.57 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 114.797 -1.092 . . . . 61.03 108.143 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -122.63 122.27 38.41 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.921 0.888 . . . . 74.11 110.451 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.09 83.01 34.71 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 107.73 -1.211 . . . . 65.4 107.73 168.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.43 -13.61 20.48 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.558 2.172 . . . . 74.55 111.764 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -103.01 14.59 31.58 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.9 1.28 . . . . 74.11 109.862 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.402 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -48.16 -53.52 32.76 Favored Pre-proline 0 C--N 1.37 1.48 0 C-N-CA 124.64 1.176 . . . . 73.01 113.55 -170.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 52.5 Cg_exo -54.59 -50.6 12.82 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 121.871 1.714 . . . . 72.12 112.828 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -68.57 -35.46 77.41 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.911 -1.041 . . . . 63.22 112.173 -172.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.728 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.0 p -78.59 -24.97 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 N-CA-C 113.182 0.808 . . . . 61.15 113.182 -172.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -67.13 -28.36 68.07 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.528 0.566 . . . . 75.14 112.528 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -86.92 5.16 38.44 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.128 0.571 . . . . 73.43 111.773 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.777 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -88.76 150.16 23.09 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.483 0.713 . . . . 73.31 110.369 178.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.25 124.07 19.88 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.292 0.637 . . . . 74.1 109.755 167.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -78.71 97.62 5.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.365 0.666 . . . . 74.32 111.211 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -153.6 78.16 5.69 Favored Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 108.605 -0.887 . . . . 71.2 108.605 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -90.45 149.66 4.36 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.013 2.475 . . . . 61.42 113.856 -176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -88.23 102.86 15.24 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 114.028 -1.442 . . . . 75.43 107.365 167.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -81.23 101.71 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.933 -0.576 . . . . 72.21 109.764 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.481 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 11.0 tmtt? -92.38 109.94 21.34 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.23 -1.396 . . . . 72.21 107.23 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 pp -85.14 161.69 19.54 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.585 -0.524 . . . . 73.42 109.585 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.612 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 12.5 t70 -147.19 134.41 20.55 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.674 -1.232 . . . . 65.43 107.674 171.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -128.79 111.24 12.9 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.104 -1.443 . . . . 74.13 107.104 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 21.6 t70 -123.54 152.68 41.55 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.022 0.929 . . . . 71.31 109.124 -177.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 52.5 p -117.92 134.48 54.91 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.519 0.728 . . . . 63.24 111.458 -169.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.53 160.19 42.45 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.377 0.671 . . . . 51.21 110.471 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 72.8 m -160.03 170.93 20.27 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.422 0.689 . . . . 74.52 111.242 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 95.8 p -153.98 140.74 19.06 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.964 0.906 . . . . 62.32 108.934 166.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -86.43 121.43 28.97 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.2 -1.037 . . . . 64.1 108.2 173.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.601 HD11 HD12 ' C' ' 83' ' ' ILE . 53.6 mt -99.22 -30.38 12.29 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.472 0.709 . . . . 73.31 109.923 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.81 -174.39 2.72 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.453 1.101 . . . . 61.02 109.604 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -71.24 125.0 25.79 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.334 -0.987 . . . . 70.43 108.334 171.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 69.37 3.67 4.26 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.876 1.27 . . . . 74.32 113.204 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 96.3 t -117.69 110.64 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 107.892 -1.151 . . . . 44.42 107.892 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -134.34 137.57 44.26 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.537 0.735 . . . . 75.12 109.573 -173.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -86.69 120.93 28.52 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.949 -1.023 . . . . 65.44 109.748 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 55.2 t -96.7 115.39 36.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.818 -1.179 . . . . 64.31 107.818 168.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 64.0 t -112.93 136.26 49.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 N-CA-C 107.603 -1.258 . . . . 72.52 107.603 171.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.719 HD22 ' HB2' ' C' ' 103' ' ' PRO . 11.6 tp -126.73 118.36 24.56 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.619 -0.882 . . . . 70.33 108.619 172.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 14.2 ttm180 -81.79 115.66 21.11 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.567 -0.742 . . . . 71.44 109.212 176.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 24.9 t -110.5 116.56 52.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.537 -1.283 . . . . 45.23 107.537 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.612 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 17.9 m -128.86 115.52 18.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.424 0.63 . . . . 63.14 109.348 -174.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 84.4 t -108.07 116.04 50.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 124.817 1.247 . . . . 74.14 109.364 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 4.1 m -100.53 145.91 27.74 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.838 -1.171 . . . . 54.53 107.838 171.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.85 119.74 18.48 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.347 -1.353 . . . . 62.31 107.347 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -133.04 125.52 29.85 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.945 0.339 . . . . 51.25 110.361 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.777 HD13 ' HG2' ' C' ' 34' ' ' LYS . 9.0 mt -86.44 41.04 0.92 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.661 1.184 . . . . 54.03 109.776 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.2 -114.2 4.54 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 110.138 -1.185 . . . . 71.22 110.138 -169.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.29 -28.12 21.27 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.346 0.658 . . . . 70.51 109.928 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.94 118.05 9.19 Favored 'General case' 0 C--N 1.345 0.402 0 N-CA-C 108.923 -0.769 . . . . 64.33 108.923 171.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 29.4 m -81.19 121.92 26.75 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 108.06 -1.089 . . . . 64.3 108.06 167.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.728 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.5 -58.14 3.61 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.41 -0.959 . . . . 64.33 108.41 177.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -162.69 170.73 17.95 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 114.95 -1.023 . . . . 74.43 111.708 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.434 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -127.6 146.39 50.55 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 106.002 -1.851 . . . . 72.21 106.002 166.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.434 ' N ' HD13 ' C' ' 75' ' ' LEU . 46.2 t -147.31 130.17 16.19 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.984 -1.117 . . . . 65.23 107.984 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -136.33 117.84 14.82 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.428 -0.582 . . . . 72.34 109.428 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 77.4 t -120.03 122.4 68.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.45 -0.945 . . . . 70.44 108.45 170.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.662 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.3 mt-30 -103.42 94.25 5.39 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 108.023 -1.102 . . . . 70.44 108.023 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.558 HE22 HG22 ' C' ' 18' ' ' THR . 9.4 tp-100 -80.07 114.81 19.25 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.963 -1.017 . . . . 65.1 109.655 -176.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.22 146.12 18.14 Favored Glycine 0 C--N 1.34 0.779 0 O-C-N 123.826 0.704 . . . . 70.34 111.423 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.449 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.54 119.66 0.95 Allowed Glycine 0 CA--C 1.503 -0.697 0 N-CA-C 110.554 -1.019 . . . . 75.21 110.554 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.62 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 8.4 mm -85.37 126.74 40.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 108.287 -1.005 . . . . 73.42 108.287 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.652 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 69.7 m-85 -132.23 147.39 52.41 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.365 0.666 . . . . 63.32 109.883 -176.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 45.4 m -87.49 123.66 32.64 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.935 0.894 . . . . 62.2 109.352 171.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.52 HG12 HD21 ' C' ' 98' ' ' LEU . 4.4 mp -121.72 121.03 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 109.675 -0.491 . . . . 74.24 109.675 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.28 167.89 21.29 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.235 1.014 . . . . 53.22 109.903 173.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.67 -60.8 1.2 Allowed Glycine 0 N--CA 1.471 1.026 0 C-N-CA 123.137 0.399 . . . . 74.23 112.661 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 pt -96.06 150.9 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.658 0.783 . . . . 74.4 110.393 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -147.61 146.77 29.49 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.69 0.796 . . . . 75.42 109.555 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.36 -139.18 14.65 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 111.671 -0.571 . . . . 74.45 111.671 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 10.3 p -68.23 -21.35 64.85 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 113.477 0.917 . . . . 64.45 113.477 -174.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.23 -40.72 43.94 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 109.337 -0.616 . . . . 51.41 109.337 177.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.511 ' SD ' HD12 ' C' ' 98' ' ' LEU . 14.3 tmm? -65.48 -36.16 83.04 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.274 -0.876 . . . . 62.43 110.136 172.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.68 -34.72 77.48 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.995 0.918 . . . . 40.52 111.412 176.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -65.65 -40.99 93.08 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.697 -0.683 . . . . 73.01 110.224 173.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.495 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 43.0 t -63.34 -45.25 92.12 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.598 0.561 . . . . 73.53 110.412 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.52 HD21 HG12 ' C' ' 86' ' ' ILE . 75.2 mt -80.98 -51.99 7.92 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.135 0.574 . . . . 72.5 112.397 -175.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.75 11.12 65.17 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 115.081 0.792 . . . . 60.11 115.081 -169.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.35 -61.82 0.14 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.425 0.631 . . . . 51.4 110.813 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.495 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 35.0 t80 -75.2 -37.15 61.3 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 125.502 1.521 . . . . 63.54 113.735 -165.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 91.7 m -77.84 -44.12 2.38 Favored Pre-proline 0 N--CA 1.486 1.344 0 C-N-CA 123.252 0.621 . . . . 73.43 112.033 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.719 ' HB2' HD22 ' C' ' 60' ' ' LEU . 78.6 Cg_endo -75.57 -9.48 19.99 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 121.849 1.699 . . . . 73.05 112.344 172.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -68.08 -37.41 81.21 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.751 -0.833 . . . . 72.05 108.751 168.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.552 HD12 ' NH1' ' A' ' 111' ' ' ARG . 39.8 mm -59.38 -43.41 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 115.455 -0.793 . . . . 70.25 109.366 171.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.449 HD21 ' HA3' ' C' ' 82' ' ' GLY . 82.0 mt -81.92 -16.02 51.96 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.307 1.043 . . . . 75.21 112.913 -173.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -55.03 -53.93 55.88 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-O 118.257 -0.878 . . . . 74.3 112.63 -175.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.13 -30.62 65.36 Favored 'Trans proline' 0 C--N 1.388 2.635 0 C-N-CA 121.951 1.767 . . . . 64.11 113.508 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -67.57 -49.85 61.19 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.297 0.639 . . . . 54.35 110.539 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.18 -42.79 95.76 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.196 -0.911 . . . . 73.2 110.276 176.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -58.81 -52.66 64.76 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.173 1.389 . . . . 70.43 111.359 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -66.84 -37.1 83.83 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.738 0.649 . . . . 72.24 110.052 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 35.2 t -67.7 -32.62 73.39 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.332 0.395 . . . . 63.15 111.59 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 83.9 mt -72.54 -52.99 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.127 0.571 . . . . 65.55 110.23 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 12.3 m -65.01 -29.31 70.22 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.176 0.59 . . . . 72.13 111.321 -175.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 40.6 t -65.72 -49.7 67.52 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.077 -0.712 . . . . 64.45 109.077 173.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.689 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.75 -37.29 78.59 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.157 0.983 . . . . 72.2 112.39 179.257 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 83.0 t -60.74 -48.26 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.226 0.61 . . . . 75.24 110.035 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 26.5 t -72.39 -22.24 61.16 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 115.325 -0.852 . . . . 74.05 111.581 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.428 ' NH2' ' HG3' ' B' ' 112' ' ' GLU . 89.2 mtt-85 -73.93 -35.0 64.54 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.856 0.862 . . . . 72.35 109.705 174.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.05 7.65 70.16 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 115.457 -0.792 . . . . 75.41 112.086 171.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 64.7 p 60.02 26.68 16.01 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.415 1.886 . . . . 72.13 113.412 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -88.65 144.95 34.17 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 108.202 -1.036 . . . . 63.33 108.202 171.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -54.63 154.25 21.01 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 123.121 2.548 . . . . 71.12 113.505 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -54.68 124.33 16.04 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.901 1.28 . . . . 52.03 113.43 -171.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 40.1 tp -127.22 90.47 3.14 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.41 -0.959 . . . . 72.21 108.41 176.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -92.31 131.24 37.67 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.067 0.947 . . . . 63.12 109.545 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.72 134.16 46.07 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.172 0.589 . . . . 64.51 109.512 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.33 151.07 77.75 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 123.291 0.636 . . . . 61.01 110.978 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.74 110.67 2.39 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.892 2.395 . . . . 60.21 112.141 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.38 111.61 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.256 0.622 . . . . 60.42 109.595 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -85.41 89.68 7.75 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.716 0.806 . . . . 73.24 110.438 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -59.63 -38.09 80.39 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 109.663 -0.495 . . . . 71.13 109.663 169.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 N--CA 1.472 0.636 0 C-N-CA 125.259 1.424 . . . . 75.2 111.362 179.013 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 65.1 m . . . . . 0 C--O 1.241 0.639 0 N-CA-C 108.071 -1.085 . . . . 72.23 108.071 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.751 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 20.8 t80 -164.79 90.63 0.53 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.673 -1.232 . . . . 63.41 107.673 -177.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -113.05 116.28 29.67 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.13 -1.433 . . . . 71.52 107.13 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.482 HG21 HD11 ' D' ' 16' ' ' ILE . 18.2 mt -68.75 123.26 21.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 109.331 -0.618 . . . . 61.34 109.331 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.529 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 21.0 mm-40 -83.01 -46.46 12.83 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 123.795 0.684 . . . . 53.02 109.687 175.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.409 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 27.7 ttt180 -178.5 141.08 0.21 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 116.603 -0.271 . . . . 75.2 111.706 -164.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.482 HD11 HG21 ' D' ' 13' ' ' ILE . 3.7 mp -122.97 142.0 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.464 -1.31 . . . . 63.12 107.464 172.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.409 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 26.3 p90 -165.46 174.48 9.95 Favored 'General case' 0 C--O 1.238 0.496 0 O-C-N 124.062 0.851 . . . . 72.51 111.187 -175.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 62.3 p -108.71 119.56 39.9 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 114.557 -1.202 . . . . 71.21 109.642 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -92.42 -19.13 22.37 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.378 0.671 . . . . 71.3 110.165 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.606 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 15.9 t70 -158.09 133.27 8.68 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.774 -1.103 . . . . 65.2 108.699 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.689 HG21 ' HE2' ' C' ' 117' ' ' MET . 68.8 mt -131.94 147.78 32.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 107.083 -1.451 . . . . 61.43 107.083 173.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -156.24 144.74 20.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 123.741 0.651 . . . . 54.31 110.114 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 87.4 t80 -148.17 122.05 9.36 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 105.346 -2.094 . . . . 63.24 105.346 173.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -133.38 110.8 10.27 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.061 0.544 . . . . 74.21 109.806 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.32 88.13 12.34 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 107.772 -1.195 . . . . 54.34 107.772 175.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -74.2 -39.85 1.47 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.907 2.405 . . . . 64.5 112.06 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -92.34 5.11 51.8 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.749 -1.114 . . . . 72.43 111.021 -176.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.506 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -30.04 -67.8 0.13 Allowed Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 116.459 2.022 . . . . 63.01 116.459 -164.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.42 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 93.5 Cg_endo -75.07 -23.91 13.22 Favored 'Trans proline' 0 C--N 1.374 1.909 0 CA-C-N 122.831 2.047 . . . . 73.33 113.119 -173.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -73.12 -39.21 65.93 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.932 0.893 . . . . 43.52 109.57 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.506 HG12 ' O ' ' D' ' 28' ' ' ALA . 4.8 p -83.03 -16.11 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-N 115.817 -0.628 . . . . 74.51 110.442 -173.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.42 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.1 m-85 -69.02 -22.82 64.04 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.524 0.33 . . . . 61.33 111.77 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -57.51 -27.04 62.22 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.587 0.755 . . . . 75.45 109.976 172.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -88.43 70.74 9.04 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.818 1.247 . . . . 65.23 109.198 172.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -79.71 87.64 5.22 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.72 -0.673 . . . . 73.4 109.714 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 18.6 p90 -163.29 174.82 11.56 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.337 1.055 . . . . 74.41 109.112 172.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.551 HE21 ' HD2' ' D' ' 38' ' ' PRO . 28.5 tp60 -68.45 115.98 35.37 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.62 0.768 . . . . 74.11 109.565 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.551 ' HD2' HE21 ' D' ' 37' ' ' GLN . 27.0 Cg_exo -63.18 151.87 82.59 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.709 2.273 . . . . 62.43 112.616 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -73.24 113.09 9.92 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.359 -1.349 . . . . 74.55 107.359 172.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.71 HG21 ' HG ' ' D' ' 126' ' ' LEU . 98.8 t -105.93 137.98 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 123.879 0.871 . . . . 73.25 109.739 -172.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -128.32 126.72 41.33 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.616 1.166 . . . . 62.34 108.131 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.49 HD22 HD23 ' D' ' 128' ' ' LEU . 45.2 tp -96.99 144.07 27.24 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.07 -0.715 . . . . 63.13 109.07 176.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.535 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 7.5 t70 -144.14 153.82 42.53 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.538 0.735 . . . . 75.32 109.081 176.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.6 mt -133.23 146.41 51.44 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.417 0.687 . . . . 74.11 111.108 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.653 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 5.8 t70 -135.58 155.18 50.88 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.919 1.287 . . . . 75.3 108.215 169.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 97.7 m -101.39 140.48 35.63 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.94 0.896 . . . . 71.0 108.812 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -166.91 142.56 4.29 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.222 -1.029 . . . . 53.01 108.222 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.8 p -176.36 162.44 2.38 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.941 0.496 . . . . 72.4 110.425 -176.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 77.5 p -153.77 150.16 28.2 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.647 0.379 . . . . 75.54 110.936 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -88.14 119.61 28.7 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.72 -0.844 . . . . 73.12 108.72 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' D' ' 57' ' ' GLU . 23.2 mt -94.72 -31.81 13.62 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.793 0.437 . . . . 73.13 111.161 -175.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -161.27 -175.72 5.0 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.739 0.816 . . . . 74.33 110.602 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.07 109.83 3.16 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.771 -1.104 . . . . 75.44 109.389 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 66.89 6.91 4.93 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.588 1.155 . . . . 64.2 112.677 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 64.1 t -110.91 120.55 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 107.427 -1.323 . . . . 73.25 107.427 175.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -140.85 131.7 25.91 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 122.917 0.487 . . . . 73.41 110.008 -165.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.456 ' HB2' HD11 ' D' ' 51' ' ' LEU . 15.9 tt0 -92.72 135.0 34.49 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.793 0.837 . . . . 73.11 110.5 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 98.0 t -117.5 128.75 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.163 1.385 . . . . 72.52 108.39 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 29.1 t -125.58 130.93 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.408 0.683 . . . . 64.2 109.594 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.495 HD23 HD12 ' D' ' 106' ' ' LEU . 4.6 mm? -117.81 121.09 39.87 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.087 -0.708 . . . . 45.33 109.087 172.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.653 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 41.2 ttm-85 -83.2 96.4 8.43 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.513 -1.291 . . . . 61.2 107.513 172.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.487 HG13 HD11 ' D' ' 42' ' ' LEU . 88.3 t -90.34 128.16 42.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.009 -1.108 . . . . 71.31 108.009 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 29.8 m -125.68 139.63 53.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.878 -0.416 . . . . 60.44 109.878 -176.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.688 HG13 HG13 ' D' ' 40' ' ' VAL . 17.8 t -128.61 102.01 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.441 1.096 . . . . 74.51 108.556 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 17.6 m -93.31 112.53 24.48 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.478 -0.934 . . . . 72.34 108.478 173.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.07 141.16 48.49 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.657 0.783 . . . . 62.11 109.186 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.435 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 59.8 p -148.8 127.02 12.12 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 123.52 0.513 . . . . 74.41 111.236 -177.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 28.8 mt -94.16 115.51 27.81 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 124.423 1.089 . . . . 73.22 109.076 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.65 -111.75 3.58 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 111.495 -0.642 . . . . 72.43 111.495 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.97 12.14 10.4 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.702 0.801 . . . . 72.05 110.863 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -131.56 165.21 24.13 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.849 0.459 . . . . 73.5 109.965 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -65.63 131.25 45.88 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.762 0.825 . . . . 71.25 111.961 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.435 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -90.97 -68.38 0.79 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.83 -1.174 . . . . 51.24 107.83 171.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -151.17 153.55 35.18 Favored 'General case' 0 C--N 1.353 0.72 0 CA-C-N 115.757 -0.656 . . . . 71.32 111.003 175.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 46.5 mt -118.97 110.56 17.27 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 106.773 -1.566 . . . . 54.44 106.773 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . . . . . . . . . 45.9 t -126.11 105.93 9.22 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 122.943 0.497 . . . . 54.24 109.972 -170.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -122.73 128.99 51.25 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.442 0.697 . . . . 70.43 109.701 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 25.6 t -126.96 121.19 57.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 123.419 0.688 . . . . 74.42 109.696 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.606 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.7 mt-30 -87.35 87.36 7.4 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.149 -1.056 . . . . 53.23 108.149 167.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -81.85 110.6 17.3 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.01 -1.45 . . . . 73.42 108.719 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.79 153.23 17.23 Favored Glycine 0 C--N 1.341 0.859 0 O-C-N 123.545 0.528 . . . . 73.13 111.842 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.8 130.87 2.88 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 111.578 -0.609 . . . . 73.51 111.578 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 22.2 mt -89.4 136.41 23.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 C-N-CA 123.801 0.84 . . . . 75.31 108.949 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -137.85 128.49 26.72 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.351 0.661 . . . . 74.23 110.26 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.1 m -78.78 98.36 6.26 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.638 0.775 . . . . 33.32 109.287 168.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 10.2 pt -115.37 139.66 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.397 1.079 . . . . 72.3 110.302 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.65 167.91 20.56 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.877 0.471 . . . . 60.31 111.048 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.56 17.35 79.98 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.954 -0.566 . . . . 65.02 113.308 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 8.4 mt -110.99 147.05 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.081 0.952 . . . . 73.21 108.832 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.42 165.31 27.13 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.687 0.795 . . . . 73.04 110.127 177.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.99 -142.17 46.62 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.168 0.917 . . . . 30.12 115.073 173.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 20.3 m -76.33 -16.25 59.8 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.93 0.892 . . . . 74.13 111.694 -172.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -68.1 -22.36 64.91 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.617 0.367 . . . . 54.44 110.764 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 92.1 mtp -64.02 -35.68 81.51 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.365 0.666 . . . . 54.1 110.432 172.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.71 -26.36 57.45 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.472 -0.786 . . . . 72.32 110.92 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -74.97 -40.35 60.78 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.812 0.445 . . . . 74.45 110.804 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -56.29 -46.79 79.61 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.422 0.689 . . . . 71.13 110.033 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 47.7 mt -87.23 -20.33 27.07 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.627 -1.169 . . . . 63.41 111.566 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.35 1.89 56.12 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-O 119.489 -0.617 . . . . 44.3 114.04 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.12 -67.82 0.28 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 117.585 0.692 . . . . 43.33 111.713 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -71.51 -38.43 71.12 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.716 0.636 . . . . 75.22 112.716 -170.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.751 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 76.3 m -68.23 -49.66 32.67 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 118.706 -0.664 . . . . 63.33 111.556 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -58.7 -29.44 89.49 Favored 'Trans proline' 0 C--N 1.401 3.308 0 C-N-CA 122.63 2.22 . . . . 51.14 113.139 170.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -63.36 -35.67 81.17 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.681 0.793 . . . . 54.23 110.575 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.8 mm -68.91 -38.09 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.626 0.77 . . . . 74.54 110.351 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.495 HD12 HD23 ' D' ' 60' ' ' LEU . 87.7 mt -81.75 -21.7 37.71 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.534 0.734 . . . . 73.13 112.576 -172.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -62.44 -46.71 89.83 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-O 118.425 -0.798 . . . . 62.11 113.121 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.14 -39.15 93.04 Favored 'Trans proline' 0 C--N 1.391 2.768 0 C-N-CA 122.348 2.032 . . . . 70.23 113.262 174.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -73.97 -36.85 64.62 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.582 0.753 . . . . 65.54 111.707 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.81 -49.25 71.4 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.661 -0.496 . . . . 54.34 109.661 176.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.423 ' NH2' HG23 ' B' ' 105' ' ' ILE . 38.9 ttp180 -58.78 -45.68 89.27 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 124.432 1.082 . . . . 74.13 110.312 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -61.08 -52.73 63.67 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.841 0.713 . . . . 65.23 110.881 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.6 t -56.42 -44.61 80.53 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 123.882 0.738 . . . . 65.42 110.925 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.498 ' O ' HG23 ' D' ' 118' ' ' VAL . 67.8 mt -61.39 -55.67 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.198 0.999 . . . . 70.12 110.69 175.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.403 HG23 ' HG3' ' D' ' 125' ' ' GLN . 92.5 m -58.77 -36.19 73.99 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.141 0.976 . . . . 64.54 111.501 -173.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 40.8 t -67.87 -43.69 78.82 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.375 -0.83 . . . . 74.32 109.794 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.6 mtm -70.02 -27.56 64.77 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.761 0.424 . . . . 71.43 111.841 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.498 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.3 t -64.52 -49.31 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.303 0.641 . . . . 61.21 109.509 174.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.6 p -69.04 -32.51 72.06 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.797 -0.638 . . . . 53.13 110.899 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.4 mtt-85 -68.39 -37.61 80.53 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.924 0.89 . . . . 71.34 110.246 174.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.91 0.97 87.81 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 115.738 -0.664 . . . . 63.11 112.259 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.477 HG21 HE21 ' A' ' 125' ' ' GLN . 30.7 p 63.07 26.79 15.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.7 2.0 . . . . 74.15 113.104 172.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -87.44 152.63 52.57 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 109.239 -0.652 . . . . 74.33 109.239 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.94 124.51 15.68 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.931 2.421 . . . . 54.12 112.341 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.403 ' HG3' HG23 ' D' ' 115' ' ' THR . 35.2 tt0 -55.42 146.7 19.12 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.633 1.173 . . . . 70.01 112.251 -174.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.71 ' HG ' HG21 ' D' ' 40' ' ' VAL . 3.2 tm? -143.58 117.14 9.17 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.138 -1.06 . . . . 73.24 108.138 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -109.9 118.88 37.65 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.415 -0.958 . . . . 74.1 108.415 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.49 HD23 HD22 ' D' ' 42' ' ' LEU . 6.5 mp -66.73 128.17 35.26 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.781 0.833 . . . . 72.22 110.428 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -67.97 133.74 91.94 Favored Pre-proline 0 CA--C 1.552 1.026 0 O-C-N 123.842 0.714 . . . . 63.42 110.931 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 14.8 Cg_exo -68.83 130.38 20.4 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.902 2.401 . . . . 72.42 112.373 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.479 1.003 0 C-N-CA 123.909 0.884 . . . . 73.43 109.897 177.443 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.736 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 2.9 t80 . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 109.478 -0.564 . . . . 74.44 109.478 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -145.48 114.59 7.01 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.477 -0.935 . . . . 74.14 108.477 176.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.612 HG12 ' HD2' ' A' ' 84' ' ' PHE . 47.7 mt -90.29 129.62 40.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.649 -0.871 . . . . 74.4 108.649 174.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -87.88 -41.79 12.97 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.818 -0.628 . . . . 73.21 110.133 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -175.93 129.46 0.24 Allowed 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.18 0.3 . . . . 65.12 111.197 -170.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.46 HD11 HD13 ' A' ' 13' ' ' ILE . 97.3 mt -121.61 139.9 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 123.653 0.781 . . . . 75.33 108.985 177.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.514 ' HB3' HG23 ' B' ' 122' ' ' THR . 35.0 p90 -169.92 177.18 4.46 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.02 0.928 . . . . 74.42 110.597 -169.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.0 p -102.33 121.19 41.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.284 -1.006 . . . . 64.41 108.284 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 33.8 mtpt -83.15 -44.08 15.48 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.639 -0.875 . . . . 72.31 108.639 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 21.9 t70 -135.59 134.8 39.72 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.19 -1.368 . . . . 51.33 108.921 -175.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.421 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 80.9 mt -135.14 142.44 39.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.148 -1.427 . . . . 73.25 107.148 178.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -154.17 115.16 4.04 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.095 0.474 . . . . 64.25 110.535 172.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.636 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 75.4 t80 -110.22 138.91 45.95 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 106.838 -1.542 . . . . 64.51 106.838 170.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -138.3 140.62 39.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.227 -1.027 . . . . 74.32 108.227 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.88 78.61 35.44 Favored Pre-proline 0 C--O 1.238 0.48 0 N-CA-C 107.314 -1.365 . . . . 53.42 107.314 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.93 -28.1 36.12 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.968 2.445 . . . . 71.13 112.293 -170.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -114.49 28.8 8.48 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.945 0.898 . . . . 70.11 109.591 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.472 ' HB3' ' HZ2' ' B' ' 19' ' ' LYS . . . -47.29 -52.38 35.97 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.03 0.932 . . . . 72.35 113.422 -178.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HG3' ' HZ1' ' B' ' 19' ' ' LYS . 15.1 Cg_exo -63.74 -21.74 69.68 Favored 'Trans proline' 0 C--N 1.39 2.751 0 CA-C-N 121.413 1.541 . . . . 61.2 112.751 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.446 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 4.6 m-70 -94.9 -32.93 13.0 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 124.123 0.969 . . . . 63.41 110.788 -174.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.492 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.5 p -76.32 -16.87 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 112.724 0.639 . . . . 73.45 112.724 -163.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -77.72 -32.58 52.96 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.027 0.531 . . . . 74.15 112.0 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -75.91 -18.62 59.31 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.821 0.449 . . . . 71.21 110.721 174.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 14.5 mmmm -75.29 148.02 39.72 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.61 0.764 . . . . 64.13 111.749 -175.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.06 127.64 32.91 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 124.238 0.961 . . . . 61.42 109.424 171.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -78.98 86.06 4.87 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.529 0.68 . . . . 72.34 110.358 -177.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -136.53 78.59 43.57 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.014 1.325 . . . . 72.14 107.907 176.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -86.45 171.4 7.48 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.448 2.099 . . . . 64.53 113.61 -174.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -115.96 101.08 8.44 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 107.095 -1.446 . . . . 72.42 107.095 170.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -77.59 93.94 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.935 0.874 . . . . 65.44 111.081 -172.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.545 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 8.4 mtpm? -82.63 114.28 20.9 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.196 -1.038 . . . . 74.02 108.196 173.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 63' ' ' THR . 0.5 OUTLIER -123.83 107.94 11.94 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.711 0.767 . . . . 74.12 109.847 -174.715 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.449 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.2 m-20 -114.01 136.61 52.72 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.61 -1.177 . . . . 74.13 109.42 -174.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.15 142.17 46.57 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.437 -0.949 . . . . 60.33 108.437 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.682 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 5.9 t70 -147.11 127.6 14.09 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.537 -0.542 . . . . 74.25 109.537 -169.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 64.1 p -105.78 126.96 52.78 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.455 0.702 . . . . 52.45 110.886 -168.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.571 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -133.03 141.84 48.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.726 0.81 . . . . 53.45 109.438 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.3 m -132.61 154.98 49.52 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.378 0.671 . . . . 70.21 110.668 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.6 t -153.78 139.59 18.07 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.595 0.758 . . . . 62.05 109.565 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -96.67 120.53 37.17 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.879 -0.785 . . . . 64.22 108.879 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.723 HD11 ' HB2' ' A' ' 57' ' ' GLU . 25.8 mt -107.27 -35.81 6.71 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.553 0.741 . . . . 75.23 110.336 -172.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.544 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -156.71 -176.88 6.22 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.368 1.067 . . . . 71.14 109.687 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -71.75 116.12 11.75 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.68 0.792 . . . . 71.14 109.956 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 70.12 0.22 3.04 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.79 1.236 . . . . 71.04 112.235 -176.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 58.9 t -111.26 112.43 40.5 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 108.247 -1.02 . . . . 73.34 108.247 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -124.84 173.32 8.68 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.438 1.095 . . . . 71.43 108.972 -173.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.723 ' HB2' HD11 ' A' ' 51' ' ' LEU . 41.3 tt0 -127.17 127.79 45.09 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.195 0.598 . . . . 74.14 109.513 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.428 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 84.3 t -105.44 122.56 58.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.761 -1.2 . . . . 65.2 107.761 170.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 46.1 t -116.78 138.57 46.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 N-CA-C 108.139 -1.06 . . . . 72.31 108.139 174.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.8 tp -127.31 118.08 23.5 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.26 -0.644 . . . . 72.23 109.26 174.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.682 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 16.9 ttm-85 -85.18 102.37 13.25 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.448 -0.945 . . . . 63.23 108.448 173.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.5 t -95.1 108.68 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.559 -0.904 . . . . 72.25 108.559 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 26.8 m -95.46 124.77 39.66 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.623 0.769 . . . . 34.45 108.993 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.9 t -124.74 107.41 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.197 -1.038 . . . . 62.4 108.197 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 18.3 m -108.12 136.16 48.27 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.515 -0.92 . . . . 63.11 108.515 175.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.12 110.99 20.36 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.29 -1.374 . . . . 72.43 107.29 172.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.9 m -115.31 124.33 51.03 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.598 0.359 . . . . 73.3 110.09 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.4 mt -90.64 84.71 5.93 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.285 -1.006 . . . . 62.34 108.285 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.86 -83.44 0.93 Allowed Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.85 -0.5 . . . . 53.43 111.85 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -125.01 -29.16 3.37 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.861 0.864 . . . . 72.23 109.203 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -77.93 109.94 12.41 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.284 -0.636 . . . . 71.33 109.284 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.8 m -69.53 122.9 19.96 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 110.234 -0.284 . . . . 72.02 110.234 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.492 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -69.03 -61.25 1.87 Allowed 'General case' 0 C--O 1.24 0.596 0 O-C-N 123.843 0.714 . . . . 51.15 110.271 176.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.437 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 26.8 p90 -160.41 172.83 16.58 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.076 -0.965 . . . . 74.32 111.966 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.2 tp -131.41 138.23 49.0 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.984 -1.462 . . . . 62.13 107.497 173.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.429 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 86.1 m -139.12 97.66 3.35 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.28 -1.007 . . . . 73.14 108.28 176.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -120.09 117.23 27.43 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.281 -1.007 . . . . 71.52 108.281 -175.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.0 t -129.31 113.54 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 123.932 0.893 . . . . 42.31 109.867 -170.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.485 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 70.5 mt-30 -84.44 89.01 7.32 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 108.322 -0.992 . . . . 63.32 108.322 170.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.522 ' HG3' HD22 ' A' ' 106' ' ' LEU . 9.5 tp-100 -77.0 103.08 6.73 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.002 -0.999 . . . . 75.53 109.079 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.71 145.83 19.0 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.978 -0.555 . . . . 74.55 111.811 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.416 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.19 123.16 1.46 Allowed Glycine 0 CA--C 1.503 -0.7 0 N-CA-C 110.731 -0.948 . . . . 64.24 110.731 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.446 HG23 HD12 ' A' ' 51' ' ' LEU . 55.5 mt -83.46 121.02 35.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.865 -0.791 . . . . 64.23 108.865 176.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.736 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 23.5 m-85 -134.26 130.13 36.65 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.337 0.655 . . . . 70.23 109.675 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.9 t -99.61 113.93 26.65 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.612 -0.884 . . . . 61.13 108.612 173.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.556 1.176 0 C-N-CA 123.96 0.904 . . . . 62.15 110.787 -175.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 121.166 0.508 . . . . 73.44 110.314 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -68.31 -44.43 75.45 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.219 1.008 . . . . 72.5 110.352 174.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.642 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 83.4 m -64.22 -44.78 90.85 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.369 0.667 . . . . 71.2 111.555 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.59 -50.86 11.67 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.668 0.787 . . . . 65.54 111.735 -173.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.4 5.08 67.42 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-O 119.186 -0.786 . . . . 72.55 114.759 -169.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.72 -51.8 0.15 Allowed 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.582 1.191 . . . . 52.22 113.48 -175.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.642 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 88.0 t80 -75.59 -49.23 19.17 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.826 0.851 . . . . 71.31 112.248 -168.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 99.3 m -69.65 -36.26 6.56 Favored Pre-proline 0 CA--C 1.563 1.478 0 CA-C-O 118.897 -0.573 . . . . 75.3 112.256 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -48.63 -42.43 35.98 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 122.504 2.136 . . . . 63.32 113.839 160.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 101' ' ' TYR . 84.0 m-20 -64.15 -34.44 78.08 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 123.537 0.735 . . . . 72.1 111.553 176.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.6 mm -66.02 -40.39 87.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 N-CA-C 109.587 -0.523 . . . . 74.13 109.587 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.522 HD22 ' HG3' ' A' ' 80' ' ' GLN . 96.5 mt -79.0 -22.44 45.52 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.755 0.822 . . . . 41.42 112.254 -178.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -58.14 -48.83 96.36 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 113.914 1.079 . . . . 62.5 113.914 -172.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -63.1 -39.83 37.11 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 122.111 1.874 . . . . 63.34 112.812 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -69.3 -40.75 77.51 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.298 0.639 . . . . 74.02 111.281 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.23 -40.63 70.97 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.071 0.548 . . . . 43.43 110.367 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.472 HH12 HD12 ' C' ' 105' ' ' ILE . 23.7 ttm180 -49.91 -51.99 36.57 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.01 0.924 . . . . 71.03 110.205 171.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -71.48 -37.54 71.3 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.006 -0.997 . . . . 54.31 111.64 -173.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.8 t -66.06 -32.66 74.25 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 121.061 0.457 . . . . 62.23 110.916 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 93.0 mt -69.18 -54.51 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 115.255 -0.884 . . . . 65.32 109.432 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.466 HG21 ' HE2' ' C' ' 109' ' ' TYR . 95.2 m -51.79 -40.6 60.66 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.994 1.317 . . . . 64.03 112.278 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.9 t -64.12 -47.6 79.36 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 115.249 -0.887 . . . . 73.34 110.656 -177.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.636 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 39.6 mtm -67.84 -36.07 79.69 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.807 0.692 . . . . 74.12 111.373 -178.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.9 -51.47 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 123.677 0.791 . . . . 74.14 110.254 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.5 t -69.46 -29.45 67.13 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.43 -0.804 . . . . 43.13 111.5 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.0 ttm-85 -77.93 -28.82 49.73 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.988 0.915 . . . . 71.51 109.2 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.425 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.96 12.65 59.33 Favored Glycine 0 C--N 1.351 1.411 0 CA-C-N 114.933 -1.03 . . . . 63.23 112.648 170.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.521 HG21 ' HE ' ' B' ' 15' ' ' ARG . 2.0 t 60.66 18.51 8.54 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 126.89 2.076 . . . . 70.35 113.523 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -77.93 158.39 77.79 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 123.938 0.895 . . . . 73.34 110.951 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.46 143.38 77.86 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.831 2.354 . . . . 64.32 112.995 173.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.414 HE21 HG21 ' D' ' 122' ' ' THR . 5.4 tp-100 -53.73 127.74 26.9 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.674 1.19 . . . . 72.13 112.183 -175.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.437 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 43.5 tp -126.92 101.37 6.55 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.048 0.939 . . . . 64.4 109.45 -177.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.429 ' ND2' ' H ' ' C' ' 16' ' ' ILE . 91.4 m-20 -123.34 102.11 7.73 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.605 -0.887 . . . . 53.21 108.605 175.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.62 144.62 56.29 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.985 0.514 . . . . 70.0 109.687 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.41 151.25 97.34 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 123.833 0.853 . . . . 41.33 111.845 -173.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.489 ' HD3' HG13 ' C' ' 13' ' ' ILE . 52.1 Cg_endo -68.97 114.63 3.64 Favored 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 123.094 2.53 . . . . 73.24 113.111 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.1 m -111.61 112.68 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 108.184 -1.043 . . . . 63.44 108.184 165.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -81.61 93.61 6.76 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.63 -1.248 . . . . 70.4 107.63 175.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 . . . . . 0 N--CA 1.481 1.096 0 C-N-CA 124.242 1.017 . . . . 60.4 111.634 -175.415 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 121.225 0.536 . . . . 74.23 110.262 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 61.6 m -133.27 129.35 37.51 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.285 -1.376 . . . . 73.31 107.285 168.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.525 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 42.7 t80 -129.35 126.61 39.3 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.799 -1.185 . . . . 75.04 107.799 175.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.527 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -144.53 126.43 15.36 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.271 -0.64 . . . . 73.34 109.271 178.337 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 27.9 mt -74.8 121.51 26.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.562 -0.903 . . . . 74.3 108.562 172.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -92.06 -50.06 5.88 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.248 -0.649 . . . . 70.52 109.248 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.521 ' HE ' HG21 ' A' ' 122' ' ' THR . 45.8 ttt180 -166.52 131.16 2.14 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.727 -0.67 . . . . 70.02 110.209 -175.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 75.6 mt -114.68 137.18 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 108.029 -1.1 . . . . 73.3 108.029 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.406 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 39.2 p90 -169.87 161.79 9.12 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.442 0.639 . . . . 75.21 111.5 -176.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.525 HG21 HD11 ' B' ' 21' ' ' ILE . 42.7 m -83.17 130.63 35.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.771 -1.104 . . . . 73.33 109.249 170.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.472 ' HZ2' ' HB3' ' A' ' 28' ' ' ALA . 24.0 mtpp -96.51 -34.22 11.56 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.261 0.625 . . . . 55.11 109.851 176.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -147.72 145.45 28.86 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.084 0.469 . . . . 73.14 111.177 -173.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.578 HD11 ' SG ' ' B' ' 113' ' ' CYS . 40.3 mm -136.35 146.5 28.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 126.047 1.739 . . . . 72.3 108.708 177.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.502 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 36.7 t -150.9 133.32 15.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.558 -1.201 . . . . 71.03 108.324 171.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 74.0 t80 -141.07 135.99 31.54 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.098 -1.445 . . . . 75.1 107.098 172.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -141.51 128.48 20.68 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.218 1.007 . . . . 75.12 108.666 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -130.17 80.95 69.8 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 107.018 -1.475 . . . . 63.51 107.018 174.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.82 -26.73 31.96 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.142 2.561 . . . . 72.01 113.152 -171.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 74.9 m-20 -115.11 18.73 16.13 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.674 0.79 . . . . 73.54 110.047 -177.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.501 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -45.86 -59.17 5.02 Favored Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 125.06 1.344 . . . . 74.52 114.129 -170.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.413 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 23.8 Cg_exo -61.43 -28.49 83.89 Favored 'Trans proline' 0 C--N 1.393 2.89 0 C-N-CA 122.233 1.955 . . . . 74.3 113.346 -169.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.437 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 78.1 m80 -93.96 -38.21 11.29 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.702 -0.681 . . . . 72.23 111.404 -175.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.502 HG22 HD12 ' B' ' 68' ' ' LEU . 4.5 p -67.88 -16.74 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.129 0.572 . . . . 62.1 111.757 -173.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -65.11 -21.03 66.74 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.222 0.823 . . . . 74.23 113.222 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 10.3 pt20 -68.28 -15.27 63.5 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.308 0.643 . . . . 61.02 111.179 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.41 ' HB2' HD13 ' B' ' 68' ' ' LEU . 89.6 mttt -95.27 105.71 17.68 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.597 1.159 . . . . 64.44 109.791 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -110.72 93.08 4.31 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.09 0.556 . . . . 72.53 109.829 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 39.7 p90 -162.65 179.7 7.52 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.716 1.206 . . . . 75.5 108.411 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -69.05 114.71 25.26 Favored Pre-proline 0 N--CA 1.477 0.915 0 N-CA-C 109.578 -0.527 . . . . 73.53 109.578 177.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.485 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 43.2 Cg_endo -65.72 139.11 56.4 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 121.901 1.734 . . . . 63.52 111.027 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -66.45 103.68 1.09 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.561 -0.903 . . . . 73.15 108.561 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.565 HG11 HD21 ' B' ' 126' ' ' LEU . 31.2 m -99.83 160.82 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 115.41 -0.813 . . . . 62.24 111.815 -172.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -145.04 133.59 22.01 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.67 -1.15 . . . . 65.34 108.524 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 pp -86.7 164.98 16.44 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 123.038 0.535 . . . . 74.23 110.15 175.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.595 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 17.5 t70 -164.72 126.31 2.15 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.072 -0.967 . . . . 75.13 108.545 175.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.431 HD23 HD21 ' B' ' 60' ' ' LEU . 5.5 mp -123.04 134.15 54.3 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.576 0.75 . . . . 70.21 109.073 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.669 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 10.9 t70 -131.32 133.65 45.55 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.845 0.858 . . . . 63.22 108.758 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 17.9 p -106.37 102.02 11.45 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.244 0.618 . . . . 64.32 109.678 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.474 ' O ' ' HB ' ' B' ' 59' ' ' VAL . . . -119.85 114.21 21.75 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 107.111 -1.44 . . . . 65.22 107.111 174.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 52.6 m -144.77 161.06 40.17 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.385 -0.598 . . . . 72.21 109.385 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 76.1 p -164.73 150.17 9.95 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.906 0.482 . . . . 71.01 110.445 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -82.24 129.5 34.86 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.205 0.602 . . . . 71.25 109.65 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' B' ' 57' ' ' GLU . 20.7 mt -91.07 -49.97 6.11 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.796 0.839 . . . . 71.2 109.971 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.03 -173.49 4.18 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.193 -0.912 . . . . 61.42 110.224 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -65.65 120.73 13.48 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.947 -1.024 . . . . 75.42 109.313 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 68.17 9.2 7.05 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.115 1.366 . . . . 64.11 111.773 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -120.92 109.36 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.048 0.939 . . . . 74.12 109.21 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -119.48 149.04 42.54 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.505 1.122 . . . . 73.52 108.443 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.448 ' HB2' HD11 ' B' ' 51' ' ' LEU . 40.3 tt0 -118.76 122.08 41.58 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.925 0.49 . . . . 73.54 109.78 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 61.9 t -100.93 118.91 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 108.375 -0.972 . . . . 65.41 108.375 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' B' ' 47' ' ' ALA . 21.4 t -118.67 130.82 72.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 107.646 -1.242 . . . . 65.55 107.646 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.431 HD21 HD23 ' B' ' 44' ' ' LEU . 14.2 tp -123.32 124.59 43.31 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 110.128 -0.323 . . . . 65.34 110.128 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.669 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 39.0 ttm180 -87.31 113.5 23.08 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.864 0.865 . . . . 43.13 109.001 173.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 43.1 t -104.88 101.32 12.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.475 -1.306 . . . . 70.03 107.475 173.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.595 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 18.1 m -103.06 132.36 49.38 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.569 0.748 . . . . 75.54 109.065 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 89.6 t -123.24 127.02 74.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 124.773 1.229 . . . . 73.02 108.825 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.1 m -103.98 148.08 26.62 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.822 -0.807 . . . . 65.01 108.822 169.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.485 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -148.53 140.14 23.6 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.544 0.738 . . . . 72.32 109.563 176.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.504 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 35.3 p -143.98 137.7 27.91 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 123.635 0.584 . . . . 73.23 110.826 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.502 HD12 HG22 ' B' ' 31' ' ' VAL . 67.4 mt -110.52 110.82 21.69 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.043 -1.095 . . . . 63.41 108.043 174.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.55 -129.93 10.29 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 123.245 0.34 . . . . 44.24 113.056 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -96.61 16.44 18.86 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.683 0.793 . . . . 61.0 111.919 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.459 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.2 pt-20 -142.06 152.81 43.69 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.699 0.399 . . . . 72.33 110.952 -175.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 58.2 m -64.94 132.65 49.9 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 123.636 0.585 . . . . 43.2 110.136 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.504 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -85.44 -66.64 0.88 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.14 -1.43 . . . . 74.31 107.14 171.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -149.21 159.55 44.15 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 122.01 0.91 . . . . 74.12 112.178 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 71.3 mt -131.45 113.1 13.3 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 105.946 -1.872 . . . . 74.31 105.946 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.576 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 48.3 t -118.9 147.83 43.57 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.739 -0.837 . . . . 74.03 108.739 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.502 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 40.0 tt0 -155.9 128.67 7.91 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.92 -0.77 . . . . 72.3 108.92 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 96.1 t -130.36 145.83 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.789 0.836 . . . . 52.24 108.947 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -122.29 101.21 7.38 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.23 -1.026 . . . . 65.22 108.23 172.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -91.25 104.62 17.14 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.079 -0.711 . . . . 74.11 109.079 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.5 142.91 16.27 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.507 -0.769 . . . . 70.44 111.643 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.42 124.0 2.92 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 109.875 -1.29 . . . . 74.43 109.875 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 53.1 mt -86.26 128.61 39.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.957 -1.127 . . . . 71.44 107.957 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -137.44 134.91 36.38 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.816 0.847 . . . . 74.41 109.001 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 74.3 m -91.11 108.34 19.81 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.597 -0.52 . . . . 72.14 109.597 171.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.674 HD13 HD21 ' B' ' 98' ' ' LEU . 48.4 pt -121.9 143.67 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.41 1.084 . . . . 72.33 110.586 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.8 152.04 22.64 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.185 0.594 . . . . 73.25 110.771 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.95 -69.59 0.23 Allowed Glycine 0 C--N 1.347 1.18 0 O-C-N 123.429 0.455 . . . . 44.22 112.869 170.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.402 HG22 ' HB2' ' B' ' 94' ' ' MET . 18.5 mt -75.07 152.75 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.394 0.678 . . . . 73.1 110.947 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -155.81 -175.04 5.22 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 124.118 0.967 . . . . 71.31 108.92 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.67 -135.07 26.46 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 123.364 0.507 . . . . 62.11 114.152 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 31.6 m -71.25 -36.51 71.8 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.58 0.752 . . . . 72.41 111.832 -174.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -60.91 -38.22 84.99 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.766 -0.652 . . . . 64.33 110.361 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.402 ' HB2' HG22 ' B' ' 89' ' ' ILE . 42.0 ttp -80.03 -28.07 39.39 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.561 -0.745 . . . . 72.21 110.569 177.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.4 -31.89 72.94 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.106 0.562 . . . . 74.25 110.708 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -75.58 -39.01 58.69 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.232 0.613 . . . . 65.1 110.573 173.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.1 t -64.12 -64.52 0.86 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.083 0.553 . . . . 64.14 110.912 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.674 HD21 HD13 ' B' ' 86' ' ' ILE . 65.9 mt -72.47 -30.74 64.82 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.122 0.569 . . . . 65.01 111.968 -176.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.74 -10.44 72.8 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 119.717 -0.491 . . . . 61.34 114.208 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.688 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -142.35 -58.58 0.45 Allowed 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 117.433 0.616 . . . . 54.34 111.948 -175.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -60.51 -49.22 78.43 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.168 0.987 . . . . 63.33 112.385 -176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.525 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 64.1 m -67.65 -50.3 36.02 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-O 118.484 -0.77 . . . . 63.13 112.579 -175.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.428 ' HB2' HD22 ' B' ' 60' ' ' LEU . 74.0 Cg_endo -72.17 -12.62 28.03 Favored 'Trans proline' 0 C--N 1.385 2.473 0 CA-C-N 121.248 1.481 . . . . 73.0 112.84 177.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' B' ' 100' ' ' ALA . 0.2 OUTLIER -73.99 -33.49 63.84 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.071 0.548 . . . . 64.22 109.548 173.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.484 HG23 ' NH2' ' D' ' 111' ' ' ARG . 97.7 mt -60.76 -42.24 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 124.031 0.932 . . . . 64.3 109.738 170.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.8 mt -87.34 -14.5 40.61 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.413 -1.267 . . . . 61.52 111.396 -171.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -54.39 -51.82 74.74 Favored Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 124.321 1.048 . . . . 73.22 112.7 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' B' ' 105' ' ' ILE . 83.1 Cg_exo -52.46 -40.15 72.33 Favored 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 122.866 2.378 . . . . 63.4 114.791 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -75.07 -41.31 59.18 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.927 -0.579 . . . . 74.5 110.51 -175.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.86 -40.27 96.16 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.196 0.598 . . . . 71.41 110.43 174.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -57.11 -59.59 4.86 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.468 1.507 . . . . 73.35 110.564 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.82 -37.74 74.35 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 124.124 0.89 . . . . 72.14 110.759 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.578 ' SG ' HD11 ' B' ' 21' ' ' ILE . 19.0 t -68.61 -40.65 80.3 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.336 -0.847 . . . . 53.0 111.593 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.576 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 63.6 mt -62.18 -50.77 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.233 -0.654 . . . . 70.02 109.233 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.402 HG21 ' OG ' ' C' ' 119' ' ' SER . 4.6 m -61.99 -29.6 70.37 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 124.133 0.896 . . . . 64.13 111.431 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -66.4 -50.42 63.51 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 109.487 -0.56 . . . . 73.31 109.487 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . . . . . . . . . 35.5 mmt -62.44 -41.69 98.91 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 123.699 0.624 . . . . 63.11 110.876 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 114' ' ' ILE . 70.0 t -61.78 -48.12 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 124.209 1.004 . . . . 63.52 110.857 177.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 26.0 t -67.48 -30.36 70.04 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.58 -0.736 . . . . 73.21 110.792 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -69.92 -31.31 69.01 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.992 0.517 . . . . 71.1 110.12 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.76 9.66 55.07 Favored Glycine 0 C--N 1.353 1.521 0 O-C-N 123.883 0.739 . . . . 64.21 112.314 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.514 HG23 ' HB3' ' A' ' 17' ' ' TYR . 82.8 p 60.5 22.18 11.88 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 126.825 2.05 . . . . 62.55 113.627 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -84.63 161.93 52.13 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 123.476 0.71 . . . . 75.04 111.062 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -61.9 174.58 2.3 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 123.057 2.505 . . . . 72.22 113.875 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.567 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -62.42 115.13 3.95 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.312 -1.313 . . . . 50.04 111.343 -175.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.565 HD21 HG11 ' B' ' 40' ' ' VAL . 1.6 tm? -131.92 96.08 3.84 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.361 -0.977 . . . . 73.15 108.361 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -123.1 137.01 55.03 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.475 1.11 . . . . 73.13 108.773 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 6.9 mp -70.67 138.01 50.31 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.749 0.655 . . . . 52.51 110.524 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.77 151.26 89.29 Favored Pre-proline 0 CA--C 1.553 1.077 0 O-C-N 124.331 1.019 . . . . 74.31 112.173 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.83 92.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.533 2.822 . . . . 72.41 112.636 173.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 16.1 m -115.09 112.37 39.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 115.673 -0.694 . . . . 73.55 109.194 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -82.57 94.11 7.44 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 107.498 -1.297 . . . . 75.22 107.498 173.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -68.7 -29.9 68.44 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.317 -1.311 . . . . 74.4 110.638 -172.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . 0.688 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 17.5 t70 . . . . . 0 C--N 1.35 0.589 0 C-N-CA 124.048 0.939 . . . . 74.34 110.898 172.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.474 ' CD1' ' HE2' ' C' ' 101' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 121.254 0.55 . . . . 74.23 110.161 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -148.74 126.24 11.65 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.152 -1.425 . . . . 42.02 107.152 173.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.489 HG13 ' HD3' ' A' ' 130' ' ' PRO . 65.2 mt -78.35 123.48 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 109.336 -0.616 . . . . 60.3 109.336 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -86.03 -43.11 13.39 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.331 -0.849 . . . . 74.21 110.315 -177.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -178.79 124.92 0.1 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.554 0.534 . . . . 63.41 110.23 -174.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.429 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 97.0 mt -114.03 143.64 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 108.263 -1.014 . . . . 73.03 108.263 175.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.468 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 31.3 p90 -174.82 172.7 2.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.34 1.056 . . . . 74.34 109.411 -170.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 66.6 p -96.94 126.06 41.81 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.844 0.458 . . . . 70.42 110.085 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.468 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 27.6 mmtp -76.37 -49.08 17.72 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.196 -1.038 . . . . 74.53 108.196 169.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 11.7 t70 -135.38 147.45 49.05 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 113.858 -1.519 . . . . 54.52 109.473 -170.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.5 mt -144.09 145.75 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 106.542 -1.651 . . . . 71.11 106.542 172.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -160.16 152.12 20.28 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.294 0.568 . . . . 61.35 110.397 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 70.0 t80 -149.87 136.59 19.3 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.356 -1.35 . . . . 74.41 107.356 175.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -138.96 127.83 23.58 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.346 0.658 . . . . 65.25 109.92 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.77 80.36 5.59 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 107.336 -1.357 . . . . 74.43 107.336 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.44 -35.53 38.84 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.749 2.299 . . . . 72.32 112.094 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -92.29 21.9 4.88 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.547 -1.206 . . . . 71.32 111.217 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.59 -49.44 45.83 Favored Pre-proline 0 CA--C 1.564 1.506 0 N-CA-C 113.849 1.055 . . . . 72.42 113.849 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.41 -44.23 34.54 Favored 'Trans proline' 0 C--N 1.388 2.614 0 CA-C-N 121.584 1.601 . . . . 72.24 112.652 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.421 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 86.4 t60 -69.34 -32.53 71.68 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.072 -0.967 . . . . 64.32 112.56 -175.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.759 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.9 p -78.68 -25.1 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 N-CA-C 112.695 0.628 . . . . 72.22 112.695 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -71.44 -16.02 62.36 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 112.811 0.671 . . . . 72.53 112.811 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 14.0 pt20 -94.9 19.17 10.62 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.282 0.633 . . . . 64.23 110.837 175.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.67 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -109.88 159.66 17.04 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.859 0.864 . . . . 75.15 110.576 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -82.11 131.04 35.24 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.118 0.967 . . . . 63.44 108.982 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -77.05 82.86 3.56 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.261 1.024 . . . . 72.33 112.341 -170.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -126.33 69.84 68.98 Favored Pre-proline 0 N--CA 1.484 1.235 0 C-N-CA 124.087 0.955 . . . . 60.24 109.865 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -88.96 135.06 2.72 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.864 2.376 . . . . 74.11 112.529 -173.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -86.44 115.79 24.17 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 106.902 -1.518 . . . . 64.21 106.902 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.2 t -79.49 100.2 3.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 108.911 -0.774 . . . . 75.42 108.911 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.629 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 4.3 mptp? -90.1 99.63 12.61 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.362 -1.718 . . . . 74.21 106.362 170.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 pp -95.52 145.01 25.52 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.867 -0.79 . . . . 74.24 108.867 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.434 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 23.0 t70 -142.86 145.29 32.99 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.845 -0.798 . . . . 64.13 108.845 -177.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -121.06 113.65 20.35 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.699 0.8 . . . . 71.2 109.312 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -113.59 163.03 15.48 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.267 1.427 . . . . 40.25 107.831 171.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.4 t -144.58 153.83 42.21 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.32 0.581 . . . . 72.41 111.27 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.91 152.17 41.78 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.039 1.336 . . . . 73.41 107.707 172.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.9 p -167.33 167.54 13.92 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 120.996 0.427 . . . . 73.42 111.454 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 69.9 p -161.21 153.61 20.28 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.063 -0.971 . . . . 70.23 109.011 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -88.54 124.11 33.71 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.26 -1.015 . . . . 72.04 108.26 168.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.559 HD11 HD12 ' C' ' 83' ' ' ILE . 64.9 mt -92.74 -38.67 11.68 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.521 0.728 . . . . 71.31 110.755 -176.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -157.07 178.03 10.82 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.515 0.726 . . . . 53.32 110.7 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -60.65 117.93 5.95 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.401 0.68 . . . . 75.15 109.811 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 70.01 -6.71 1.05 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 125.827 1.651 . . . . 63.52 113.596 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 57.6 t -97.55 111.67 27.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.932 -1.136 . . . . 65.2 107.932 177.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -127.78 134.89 49.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.299 -0.63 . . . . 72.41 109.299 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -92.24 126.89 37.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.895 -1.048 . . . . 64.42 109.679 177.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 72.9 t -116.4 116.05 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 107.739 -1.208 . . . . 74.02 107.739 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 38.9 t -116.01 132.57 65.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 108.746 -0.835 . . . . 74.32 108.746 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 54.3 tp -116.72 112.85 21.78 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.504 -0.924 . . . . 70.33 108.504 175.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.573 ' HB2' ' HG2' ' C' ' 79' ' ' GLN . 50.4 ttm-85 -91.62 111.02 22.36 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.882 -0.784 . . . . 73.42 108.882 173.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.557 ' HB ' HD11 ' C' ' 114' ' ' ILE . 20.8 t -99.33 129.16 50.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 N-CA-C 107.785 -1.191 . . . . 73.23 107.785 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 16.5 m -123.05 118.97 28.97 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.114 -0.698 . . . . 72.54 109.114 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 65.4 t -113.55 108.62 25.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-N 114.571 -1.195 . . . . 74.52 108.749 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.629 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 16.5 m -98.25 140.41 32.59 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.873 -1.158 . . . . 64.42 107.873 171.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.48 121.24 28.45 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.169 -1.419 . . . . 45.0 107.169 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 51.0 m -132.43 126.34 32.85 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.941 0.337 . . . . 74.05 110.68 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.67 HD13 ' HG2' ' C' ' 34' ' ' LYS . 10.3 mt -85.49 42.83 0.98 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.562 1.145 . . . . 63.22 109.7 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.03 -113.67 4.51 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 111.108 -0.797 . . . . 54.12 111.108 -172.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.83 -18.6 28.94 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.535 0.734 . . . . 64.43 110.044 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -80.04 120.75 24.63 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.392 1.077 . . . . 73.43 109.145 172.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 99.0 m -78.93 123.01 26.84 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.476 -0.935 . . . . 44.32 108.476 164.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.759 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.16 -56.72 5.51 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.649 0.593 . . . . 70.24 109.614 175.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -158.47 168.94 25.6 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.927 0.87 . . . . 71.44 111.392 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -128.08 141.53 51.47 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 105.859 -1.904 . . . . 72.21 105.859 166.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.485 ' SG ' HG23 ' C' ' 114' ' ' ILE . 37.3 t -145.36 136.85 25.18 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.427 -1.323 . . . . 74.01 107.427 177.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . 0.402 ' HG2' HH11 ' C' ' 61' ' ' ARG . 39.1 tt0 -156.24 121.14 4.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.532 0.206 . . . . 74.51 110.465 -168.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 84.7 t -132.59 135.56 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.644 0.778 . . . . 71.12 109.671 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.573 ' HG2' ' HB2' ' C' ' 61' ' ' ARG . 20.7 mt-30 -96.89 108.19 20.84 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.657 -0.868 . . . . 64.43 108.657 164.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -90.62 104.24 16.85 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.638 -0.875 . . . . 71.02 108.638 172.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.75 145.55 22.76 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.511 -0.768 . . . . 62.5 111.475 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.2 115.48 0.72 Allowed Glycine 0 CA--C 1.504 -0.656 0 N-CA-C 110.157 -1.177 . . . . 51.23 110.157 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.559 HD12 HD11 ' C' ' 51' ' ' LEU . 15.8 mm -83.76 121.74 36.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.886 -1.153 . . . . 60.53 107.886 175.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -129.04 119.35 24.07 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.851 -0.796 . . . . 71.45 108.851 -174.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 57.3 p -77.35 107.71 9.96 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.264 -1.013 . . . . 75.3 108.264 170.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 6.7 tt -116.25 131.91 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.831 1.252 . . . . 74.44 108.997 -177.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.02 171.03 20.8 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.913 0.885 . . . . 63.33 110.087 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.73 -58.44 3.71 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 112.228 -0.349 . . . . 65.21 112.228 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 36.2 pt -84.76 158.61 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.276 0.631 . . . . 74.24 110.669 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -149.9 164.71 34.68 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.839 0.855 . . . . 74.35 109.363 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.79 -125.31 30.4 Favored Glycine 0 C--N 1.346 1.094 0 C-N-CA 123.197 0.427 . . . . 72.31 113.69 171.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 45.5 p -56.43 -34.75 67.1 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.841 1.256 . . . . 75.02 112.531 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -73.47 -38.57 65.38 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.763 0.425 . . . . 70.53 111.592 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.434 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 47.3 mtt -62.15 -49.03 77.47 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.496 -0.557 . . . . 74.51 109.496 171.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.66 -35.88 71.14 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.787 0.835 . . . . 74.24 111.286 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -64.41 -46.55 82.79 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.292 1.037 . . . . 61.42 110.739 173.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.558 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 24.2 t -64.06 -42.02 97.16 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.497 -0.774 . . . . 54.42 111.465 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' C' ' 94' ' ' MET . 70.9 mt -85.37 -36.7 20.57 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.567 0.747 . . . . 71.21 111.706 -170.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.95 11.52 58.95 Favored Glycine 0 N--CA 1.474 1.168 0 CA-C-N 116.206 -0.452 . . . . 45.25 114.009 -171.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.43 -60.07 0.14 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.54 0.686 . . . . 70.04 110.616 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.558 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 83.1 t80 -75.79 -35.45 60.07 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 125.138 1.375 . . . . 74.22 113.49 -168.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 91.3 m -79.07 -41.68 1.64 Allowed Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 123.169 0.588 . . . . 75.32 111.49 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.58 -33.37 30.71 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 122.626 2.217 . . . . 64.12 113.705 166.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -66.02 -39.69 90.44 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.633 0.773 . . . . 62.5 111.399 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.472 HD12 HH12 ' A' ' 111' ' ' ARG . 50.6 mm -67.03 -42.64 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.127 0.571 . . . . 63.12 110.062 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 87.8 mt -88.36 -10.21 50.14 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.826 0.851 . . . . 51.33 112.209 -174.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -58.04 -55.29 46.76 Favored Pre-proline 0 N--CA 1.481 1.092 0 CA-C-O 117.892 -1.051 . . . . 72.32 112.493 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.14 -35.56 74.64 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 121.99 1.794 . . . . 74.32 113.158 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.466 ' HE2' HG21 ' A' ' 115' ' ' THR . 91.6 m-85 -64.33 -54.43 33.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.485 0.714 . . . . 54.2 110.659 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.01 -39.13 91.23 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 114.803 -1.09 . . . . 71.21 110.501 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -56.0 -51.43 67.79 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.11 1.364 . . . . 72.05 110.453 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.49 -38.18 77.54 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 123.508 0.505 . . . . 75.24 109.802 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.1 t -64.41 -32.85 74.64 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 122.971 0.508 . . . . 73.22 111.639 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.557 HD11 ' HB ' ' C' ' 62' ' ' VAL . 97.4 mt -73.42 -56.14 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.832 0.853 . . . . 70.22 109.33 175.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 15.0 m -61.88 -27.25 68.67 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.936 0.895 . . . . 73.1 111.688 -175.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.451 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 47.6 t -68.03 -47.47 68.33 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.984 0.914 . . . . 71.32 109.71 174.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.548 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.82 -36.77 84.27 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.849 0.86 . . . . 73.44 111.596 178.052 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.5 t -63.35 -39.46 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.377 0.671 . . . . 72.43 110.011 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.402 ' OG ' HG21 ' B' ' 115' ' ' THR . 32.6 t -73.06 -29.52 63.03 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.845 0.858 . . . . 53.03 112.061 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' C' ' 116' ' ' SER . 85.4 mtt-85 -71.66 -39.48 70.29 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.014 -0.735 . . . . 75.01 109.014 176.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.18 2.55 60.98 Favored Glycine 0 C--N 1.36 1.874 0 O-C-N 124.103 0.877 . . . . 75.12 112.61 172.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.2 p 61.81 26.35 15.98 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.89 2.076 . . . . 71.41 113.545 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -83.37 146.91 51.81 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 109.066 -0.716 . . . . 71.11 109.066 170.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.526 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 80.1 Cg_exo -49.86 138.21 34.43 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 123.329 2.686 . . . . 64.34 112.688 173.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.582 ' HA ' HE21 ' C' ' 125' ' ' GLN . 0.0 OUTLIER -60.11 111.36 1.48 Allowed 'General case' 0 C--N 1.354 0.761 0 O-C-N 123.955 0.784 . . . . 55.2 110.609 -176.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -105.88 88.05 2.72 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 104.587 -2.375 . . . . 74.03 104.587 174.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -92.34 126.19 37.32 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.261 -0.881 . . . . 71.14 109.046 -171.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.49 136.08 51.0 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 124.128 0.892 . . . . 70.33 109.881 -173.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.06 157.82 83.43 Favored Pre-proline 0 CA--C 1.551 0.996 0 O-C-N 124.148 0.905 . . . . 73.12 111.395 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.439 ' HB3' HD12 ' A' ' 16' ' ' ILE . 55.5 Cg_exo -54.03 110.33 0.49 Allowed 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 123.03 2.487 . . . . 65.42 113.485 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.23 109.86 30.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.26 -0.644 . . . . 72.12 109.26 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -107.8 91.93 3.86 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 105.866 -1.901 . . . . 60.03 105.866 169.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -53.63 -43.27 68.58 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 124.319 1.012 . . . . 65.13 111.586 -172.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 42.1 t0 . . . . . 0 C--O 1.241 0.647 0 CA-C-N 114.928 -1.033 . . . . 72.4 111.205 -179.232 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 96.1 m . . . . . 0 C--O 1.24 0.605 0 CA-C-O 121.029 0.442 . . . . 74.34 110.047 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.632 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 62.6 t80 -154.66 93.09 1.54 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 107.433 -1.321 . . . . 73.32 107.433 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -120.5 115.34 23.26 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.441 -0.948 . . . . 70.02 108.441 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.578 HD13 HG21 ' D' ' 105' ' ' ILE . 11.2 mt -74.0 134.31 29.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 109.952 -0.388 . . . . 53.21 109.952 -175.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -93.83 -46.42 7.21 Favored 'General case' 0 C--O 1.241 0.656 0 O-C-N 123.426 0.454 . . . . 72.14 110.675 175.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -167.18 142.7 4.13 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.66 0.615 . . . . 61.24 112.66 -165.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.439 HG21 ' CG ' ' D' ' 109' ' ' TYR . 3.0 mp -122.56 135.94 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.791 1.236 . . . . 75.55 107.725 171.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.414 ' HE1' HG13 ' D' ' 83' ' ' ILE . 25.2 p90 -163.63 157.14 19.0 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.671 0.789 . . . . 72.34 110.737 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.3 p -91.36 114.69 27.29 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.209 -0.905 . . . . 51.45 108.859 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -78.71 -44.88 22.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.354 -0.98 . . . . 74.15 108.354 175.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 14.1 t70 -135.62 139.38 43.75 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.374 -1.284 . . . . 74.04 109.577 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.548 HG21 ' HE2' ' C' ' 117' ' ' MET . 67.4 mt -138.06 151.23 25.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 124.968 1.307 . . . . 63.13 107.895 174.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -152.23 145.8 24.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.358 1.063 . . . . 75.01 108.986 172.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.523 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 84.9 t80 -152.27 133.41 14.31 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 105.584 -2.006 . . . . 73.3 105.584 173.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -141.79 139.56 32.81 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.353 -0.98 . . . . 72.43 108.353 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.89 89.78 20.31 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 107.646 -1.242 . . . . 71.53 107.646 176.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.2 -32.31 5.26 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 123.022 2.481 . . . . 73.44 113.935 -170.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -103.53 17.32 24.35 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.191 0.596 . . . . 54.35 110.32 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -38.76 -65.81 0.36 Allowed Pre-proline 0 CA--C 1.562 1.416 0 N-CA-C 115.235 1.568 . . . . 73.01 115.235 -159.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.53 -23.87 22.88 Favored 'Trans proline' 0 C--N 1.389 2.688 0 CA-C-N 121.849 1.696 . . . . 74.44 113.337 -173.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.474 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 4.7 t-160 -79.4 -39.01 33.51 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.11 0.964 . . . . 73.4 110.808 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -80.67 -18.68 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 122.537 0.335 . . . . 63.23 110.752 -170.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -62.54 -23.39 66.96 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.346 0.659 . . . . 74.02 112.623 173.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.474 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 55.1 mt-30 -60.33 -23.09 63.96 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.574 0.749 . . . . 72.52 110.603 175.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -92.54 82.14 4.84 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.151 1.381 . . . . 71.11 109.657 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.19 84.31 7.72 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.231 0.613 . . . . 74.32 110.353 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.2 p90 -156.82 -178.97 7.76 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.35 0.66 . . . . 74.53 109.343 170.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -66.76 109.84 4.05 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.457 1.103 . . . . 71.25 110.455 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.75 137.68 64.83 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.259 1.973 . . . . 75.44 111.415 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -63.21 108.58 1.31 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.709 -0.849 . . . . 63.25 108.709 172.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.557 HG13 HG13 ' D' ' 64' ' ' VAL . 87.6 t -99.13 148.81 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.034 -1.098 . . . . 62.51 108.034 -175.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.552 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 34.6 ttpt -129.83 138.91 51.26 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.663 -0.866 . . . . 65.53 108.663 169.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 53.7 tp -109.05 112.2 24.26 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.277 -1.008 . . . . 73.34 108.277 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.606 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 71.9 m-20 -111.37 120.95 43.92 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.316 1.046 . . . . 41.21 108.412 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -100.36 128.01 46.53 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.846 -0.428 . . . . 54.3 109.846 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 9.1 t70 -133.1 157.79 44.41 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 105.75 -1.945 . . . . 61.03 105.75 172.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.3 t -146.96 161.11 41.45 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.144 0.497 . . . . 70.11 111.761 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -163.01 169.41 19.63 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.187 1.395 . . . . 71.51 108.771 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 19.1 p -176.82 -179.75 0.99 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 112.454 0.538 . . . . 65.21 112.454 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 52.2 p -164.77 147.52 8.52 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.624 1.17 . . . . 60.2 109.245 172.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -82.42 119.22 23.9 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.275 -1.009 . . . . 72.04 108.275 171.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' D' ' 57' ' ' GLU . 21.1 mt -89.82 -31.3 17.44 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.779 0.432 . . . . 74.34 110.718 -173.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -162.73 178.33 8.57 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.22 1.008 . . . . 55.2 109.696 177.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -73.59 129.36 37.8 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.808 -0.812 . . . . 74.35 108.808 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 69.65 10.59 7.66 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.983 1.313 . . . . 72.41 111.311 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 87.7 t -132.67 118.23 33.65 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 124.034 0.934 . . . . 71.15 108.978 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -140.91 131.25 25.09 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.77 -0.826 . . . . 73.24 108.77 -174.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.416 ' HB2' HD11 ' D' ' 51' ' ' LEU . 31.2 tt0 -91.27 143.57 26.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.669 -1.15 . . . . 75.11 109.941 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.485 HG22 ' HE1' ' D' ' 84' ' ' PHE . 3.9 m -121.49 139.48 48.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 107.887 -1.153 . . . . 51.02 107.887 167.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 23.7 t -127.94 124.51 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 108.328 -0.99 . . . . 52.21 108.328 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.585 HD23 HD12 ' D' ' 106' ' ' LEU . 3.9 mm? -118.23 114.07 22.46 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.358 0.663 . . . . 74.45 109.497 -176.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.519 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 22.0 ttm-85 -86.22 99.62 11.68 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.67 0.788 . . . . 64.04 109.609 176.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 85.7 t -91.2 115.04 29.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 108.357 -0.979 . . . . 61.33 108.357 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 9.1 m -115.46 129.09 56.44 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.358 0.599 . . . . 74.44 109.701 -175.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.557 HG13 HG13 ' D' ' 40' ' ' VAL . 24.5 t -118.13 101.56 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.005 1.722 . . . . 75.44 108.693 -177.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 51.5 m -95.57 93.92 7.45 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.467 -0.938 . . . . 75.12 108.467 176.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.38 143.62 27.94 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.373 0.669 . . . . 72.11 110.163 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.44 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 13.7 m -149.3 124.39 10.07 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 123.027 0.531 . . . . 72.03 110.914 -174.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 17.9 mt -94.86 104.76 16.65 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.076 -0.712 . . . . 53.24 109.076 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.24 -120.87 5.26 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.832 -0.622 . . . . 70.44 111.948 -176.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.09 2.28 29.25 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.389 0.676 . . . . 71.35 111.296 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -124.11 163.45 21.47 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.315 0.646 . . . . 74.21 109.863 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 16.0 m -68.6 137.42 54.25 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 123.772 0.67 . . . . 71.14 111.503 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.44 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -92.43 -65.41 1.0 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.408 -1.33 . . . . 61.52 107.408 170.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -155.98 143.71 19.56 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 115.787 -0.642 . . . . 74.5 110.619 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 59.6 mt -106.74 109.97 22.02 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.264 -1.013 . . . . 73.01 108.264 173.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . . . . . . . . . 40.7 t -115.4 143.83 44.7 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.304 -0.998 . . . . 65.31 108.304 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -156.77 127.72 6.8 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.931 0.492 . . . . 65.22 109.895 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -132.41 119.18 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 122.972 0.509 . . . . 65.51 109.879 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.576 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.5 mt-30 -88.79 88.74 7.71 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.848 -0.797 . . . . 71.03 108.848 168.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -80.24 106.44 12.25 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.308 -1.315 . . . . 75.2 108.501 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.32 147.89 16.62 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.408 -0.677 . . . . 64.42 111.408 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.28 136.99 6.57 Favored Glycine 0 C--N 1.331 0.284 0 N-CA-C 111.539 -0.625 . . . . 42.31 111.539 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.414 HG13 ' HE1' ' D' ' 17' ' ' TYR . 54.1 mt -91.04 126.47 43.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 C-N-CA 123.728 0.811 . . . . 74.1 108.884 174.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.485 ' HE1' HG22 ' D' ' 58' ' ' VAL . 64.9 m-85 -131.79 131.77 43.2 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.765 0.426 . . . . 74.11 110.321 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 15.3 m -84.5 103.96 14.09 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.519 0.727 . . . . 74.21 109.242 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.607 HD13 HD21 ' D' ' 98' ' ' LEU . 37.7 pt -114.13 127.08 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.869 0.867 . . . . 72.35 110.024 -177.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.74 148.92 29.13 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.598 0.359 . . . . 71.54 110.641 -174.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.17 15.99 76.82 Favored Glycine 0 C--N 1.345 1.077 0 O-C-N 123.391 0.432 . . . . 62.41 113.271 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.441 HD12 ' HB ' ' D' ' 86' ' ' ILE . 41.3 mt -97.19 148.65 5.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 109.268 -0.641 . . . . 72.21 109.268 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -162.02 178.48 8.8 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.394 1.078 . . . . 63.4 109.963 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.29 -144.43 44.41 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 115.286 -0.87 . . . . 74.53 113.747 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 2.8 p -82.62 -10.64 58.86 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.599 0.76 . . . . 73.21 111.751 176.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -27.63 68.5 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 109.458 -0.571 . . . . 74.41 109.458 174.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 40.9 mtt -54.03 -43.42 70.14 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.195 0.598 . . . . 74.53 110.913 171.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.05 -46.18 62.48 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.696 -1.138 . . . . 32.23 110.939 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -64.32 -37.26 86.88 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.996 0.519 . . . . 65.11 111.702 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 47.9 t -62.03 -48.51 79.97 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.794 0.684 . . . . 53.34 110.553 -174.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.607 HD21 HD13 ' D' ' 86' ' ' ILE . 66.1 mt -98.1 -24.8 15.17 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.359 -0.837 . . . . 63.1 112.163 -169.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.04 -3.75 56.78 Favored Glycine 0 N--CA 1.47 0.925 0 CA-C-O 119.83 -0.428 . . . . 73.52 113.705 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.77 -55.35 0.33 Allowed 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.317 0.558 . . . . 71.02 111.74 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -72.81 -42.77 63.52 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 112.492 0.552 . . . . 74.41 112.492 -168.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.632 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 60.2 m -70.49 -45.66 18.77 Favored Pre-proline 0 CA--C 1.562 1.439 0 CA-C-O 119.07 -0.49 . . . . 71.02 110.881 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.477 ' HG3' HD21 ' D' ' 60' ' ' LEU . 72.7 Cg_exo -53.51 -33.78 69.41 Favored 'Trans proline' 0 C--N 1.394 2.922 0 C-N-CA 122.587 2.191 . . . . 73.5 113.922 168.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -64.98 -40.2 94.61 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.577 0.751 . . . . 74.42 110.078 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.578 HG21 HD13 ' D' ' 13' ' ' ILE . 49.3 mm -60.02 -42.83 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 115.913 -0.585 . . . . 65.11 109.726 173.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.585 HD12 HD23 ' D' ' 60' ' ' LEU . 83.9 mt -80.19 -15.31 57.32 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.004 -0.998 . . . . 61.13 112.558 -172.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -62.7 -48.82 85.05 Favored Pre-proline 0 CA--C 1.563 1.457 0 N-CA-C 113.207 0.817 . . . . 61.51 113.207 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -56.35 -35.56 96.18 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 122.097 1.865 . . . . 72.32 112.955 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . 0.439 ' CG ' HG21 ' D' ' 16' ' ' ILE . 98.5 m-85 -78.61 -29.66 46.12 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.017 0.927 . . . . 74.41 111.978 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.34 -48.03 68.71 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.735 -0.839 . . . . 62.51 108.735 174.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.484 ' NH2' HG23 ' B' ' 105' ' ' ILE . 45.4 ttp180 -65.08 -33.54 76.28 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.376 -1.283 . . . . 74.11 110.489 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -54.48 -58.52 7.13 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.067 0.947 . . . . 75.31 110.632 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.15 -45.13 89.84 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.693 -1.14 . . . . 73.04 111.271 -174.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.452 ' O ' HG23 ' D' ' 118' ' ' VAL . 79.8 mt -59.79 -62.06 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.576 0.75 . . . . 71.41 110.87 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.445 HG23 ' HG3' ' D' ' 125' ' ' GLN . 57.9 m -52.82 -38.38 61.22 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.347 1.059 . . . . 72.11 111.97 -175.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.0 t -66.73 -46.6 74.93 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.244 -0.889 . . . . 44.2 110.767 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.5 mtm -67.61 -30.02 69.5 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.782 0.433 . . . . 55.44 111.613 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.452 HG23 ' O ' ' D' ' 114' ' ' ILE . 91.2 t -63.62 -49.99 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 O-C-N 123.786 0.679 . . . . 71.23 109.819 174.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.8 p -69.06 -31.52 70.34 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 116.139 -0.482 . . . . 55.11 110.97 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 77.6 mtt-85 -69.79 -35.51 74.92 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.87 0.868 . . . . 73.54 110.384 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.59 2.62 85.26 Favored Glycine 0 C--N 1.351 1.376 0 O-C-N 123.733 0.646 . . . . 15.23 112.347 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.414 HG21 HE21 ' A' ' 125' ' ' GLN . 22.8 p 57.17 35.76 26.64 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.629 1.971 . . . . 72.42 113.384 176.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -94.7 159.41 33.53 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.267 1.027 . . . . 75.52 110.035 172.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.84 123.2 12.49 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.009 2.473 . . . . 65.32 112.774 170.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.445 ' HG3' HG23 ' D' ' 115' ' ' THR . 34.2 tt0 -53.47 142.73 21.31 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.148 1.379 . . . . 64.34 112.583 -176.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 66.4 tp -125.81 106.27 9.56 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.768 0.827 . . . . 74.52 109.735 -174.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -116.53 95.92 5.27 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.651 0.78 . . . . 73.11 109.517 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 6.2 mp -66.71 116.93 8.17 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.981 -0.748 . . . . 74.22 108.981 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -58.09 143.86 77.43 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 123.746 0.818 . . . . 71.43 110.626 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 6.0 Cg_exo -74.26 107.82 2.53 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.625 2.216 . . . . 61.11 110.524 -174.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.474 0.763 0 C-N-CA 123.254 0.622 . . . . 64.01 110.185 -174.388 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.722 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 4.8 t80 . . . . . 0 C--O 1.238 0.465 0 N-CA-C 108.283 -1.006 . . . . 74.11 108.283 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -152.1 108.44 3.43 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 123.744 0.653 . . . . 72.24 109.501 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.595 HD12 ' HB2' ' C' ' 130' ' ' PRO . 34.5 mt -76.96 125.73 37.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 109.664 -0.495 . . . . 70.0 109.664 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -86.29 -40.32 15.62 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 124.284 0.99 . . . . 72.14 110.113 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -175.38 121.75 0.2 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.489 0.316 . . . . 73.32 110.579 -174.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.6 mt -108.85 135.05 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.79 -0.818 . . . . 71.21 108.79 172.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -164.74 159.4 18.65 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 123.827 0.705 . . . . 74.34 111.784 -172.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.5 p -81.53 115.87 21.04 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.241 -0.89 . . . . 63.31 109.447 173.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -82.19 -25.92 33.83 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.43 -0.581 . . . . 65.32 109.43 174.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.4 t70 -148.38 142.29 25.8 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.167 -0.924 . . . . 74.54 109.676 176.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.557 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 69.1 mt -137.55 142.69 35.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 126.042 1.737 . . . . 64.34 106.617 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.0 t -155.0 135.73 13.58 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.186 0.594 . . . . 64.52 109.465 172.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -135.72 144.68 46.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.252 -1.388 . . . . 71.33 107.252 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -137.18 151.87 49.26 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.803 -0.814 . . . . 74.22 108.803 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.99 79.04 12.17 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 106.937 -1.505 . . . . 73.24 106.937 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.77 -33.93 42.1 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.844 2.363 . . . . 73.33 113.098 -167.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -107.62 24.68 12.52 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.752 0.821 . . . . 74.1 110.281 -176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.613 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -40.88 -62.94 0.86 Allowed Pre-proline 0 CA--C 1.574 1.902 0 CA-C-O 117.547 -1.216 . . . . 65.31 114.245 -167.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 39.1 Cg_exo -59.09 -29.78 91.48 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 122.4 2.067 . . . . 72.1 114.059 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -78.84 -41.54 29.79 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.692 0.797 . . . . 74.23 110.396 -177.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.664 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.2 p -77.36 -20.26 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.714 -1.13 . . . . 45.22 111.784 -161.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -70.97 -22.87 62.14 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.557 0.743 . . . . 71.0 110.923 175.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -83.84 -36.41 23.48 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.503 1.121 . . . . 73.31 109.676 175.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.521 ' HD2' HD13 ' A' ' 68' ' ' LEU . 2.9 tmtp? -67.3 146.98 53.57 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.456 1.502 . . . . 72.44 110.532 -173.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.446 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 7.9 m-20 -58.3 124.99 21.35 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.445 1.098 . . . . 72.01 111.266 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 50.9 t-105 -79.26 82.29 5.43 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.412 0.625 . . . . 74.01 109.733 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -123.24 80.6 52.39 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 108.093 -1.077 . . . . 73.34 108.093 176.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -83.55 124.4 3.58 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.489 2.126 . . . . 60.03 113.718 -168.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -95.9 92.09 6.34 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 106.76 -1.571 . . . . 75.3 106.76 167.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 65' ' ' THR . 16.0 m -79.81 112.41 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 113.911 -1.495 . . . . 55.22 110.965 -172.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 26.3 ttpp -95.56 112.61 24.3 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.71 -1.219 . . . . 74.45 107.71 171.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mp -98.47 107.4 19.85 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.092 -1.077 . . . . 71.45 108.092 -177.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.754 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 3.3 m-20 -104.02 135.34 45.72 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.691 -0.855 . . . . 63.3 108.691 -174.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 pp -137.3 145.35 43.34 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.35 0.66 . . . . 73.4 110.001 177.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.636 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 33.0 t70 -141.66 155.02 45.72 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 123.287 0.635 . . . . 70.31 109.937 -175.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.7 p -105.54 122.78 46.72 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.401 1.081 . . . . 60.24 110.413 -174.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.87 119.93 14.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.806 0.842 . . . . 71.44 109.032 175.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.9 t -131.91 153.28 50.42 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 122.967 0.507 . . . . 73.03 109.789 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.7 t -160.49 143.68 13.45 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.509 0.724 . . . . 51.01 110.318 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -97.18 117.74 32.06 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.618 -0.882 . . . . 74.35 108.618 173.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 58.4 mt -85.61 -40.7 15.95 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.066 0.546 . . . . 75.03 109.857 177.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.453 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -153.59 176.44 12.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.285 -0.87 . . . . 72.32 110.379 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -69.05 122.8 19.46 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.505 -0.924 . . . . 44.42 108.505 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 74.92 -2.86 2.74 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.616 1.566 . . . . 72.14 112.115 -174.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 60.8 t -111.63 105.38 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.092 0.957 . . . . 72.41 108.698 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -124.95 127.61 47.32 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.967 0.907 . . . . 54.02 109.407 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -102.29 120.9 41.24 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.911 0.884 . . . . 73.11 109.958 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.446 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 43.2 t -102.3 129.17 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.038 -1.468 . . . . 71.4 107.038 171.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.0 t -122.5 120.05 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 108.55 -0.907 . . . . 73.34 108.55 174.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.467 HD22 HG22 ' A' ' 62' ' ' VAL . 1.0 OUTLIER -104.98 112.94 26.25 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.845 -1.168 . . . . 75.34 107.845 177.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.636 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 68.3 ttt180 -83.07 97.47 8.79 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.061 -1.459 . . . . 72.01 107.061 175.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.467 HG22 HD22 ' A' ' 60' ' ' LEU . 42.7 t -97.81 135.1 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 107.695 -1.224 . . . . 34.1 107.695 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.754 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 30.9 m -137.64 141.5 41.2 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.515 -0.55 . . . . 74.01 109.515 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 20.7 t -129.31 108.37 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 125.172 1.389 . . . . 44.21 107.337 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.536 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 29.3 m -102.25 138.06 39.69 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.999 -1.111 . . . . 75.23 107.999 175.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.5 106.05 10.28 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.661 -1.237 . . . . 71.21 107.661 173.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 59.0 m -111.13 123.31 49.94 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.836 -0.431 . . . . 71.3 109.836 177.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.521 HD13 ' HD2' ' A' ' 34' ' ' LYS . 12.8 mt -90.54 73.71 6.83 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 107.295 -1.372 . . . . 51.24 107.295 176.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.15 -122.83 6.19 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 110.851 -0.9 . . . . 42.43 110.851 -171.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -86.87 -24.98 24.71 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.661 0.785 . . . . 73.45 109.005 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -77.92 132.7 38.02 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.369 1.068 . . . . 73.11 109.772 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 70.1 m -89.25 133.23 34.54 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.238 0.472 . . . . 72.31 110.753 173.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.664 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.67 -62.61 1.52 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.803 0.841 . . . . 61.34 109.836 170.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -153.34 173.7 15.28 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.188 -0.914 . . . . 62.52 111.472 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.9 tp -133.59 139.95 46.84 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.731 -1.122 . . . . 65.01 108.479 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.401 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 71.4 m -134.69 97.48 3.79 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.917 0.887 . . . . 74.21 110.294 176.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -113.71 118.8 35.33 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.178 0.591 . . . . 63.5 109.738 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.2 t -128.15 113.64 31.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 124.142 0.977 . . . . 71.1 109.282 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.545 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 71.6 mt-30 -84.66 90.05 7.61 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.276 -1.009 . . . . 74.14 108.276 171.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -79.41 102.97 9.01 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.198 -0.91 . . . . 73.21 109.231 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.12 158.47 31.67 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 111.329 -0.708 . . . . 62.32 111.329 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.35 121.14 1.02 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.93 -0.868 . . . . 55.4 110.93 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.9 mt -81.65 120.87 34.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 108.117 -1.068 . . . . 63.13 108.117 171.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.722 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 46.1 m-85 -128.77 119.12 23.97 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.922 -0.77 . . . . 72.31 108.922 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.7 t -84.77 96.22 9.2 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.628 -0.879 . . . . 62.53 108.628 174.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.6 pt . . . . . 0 C--O 1.242 0.669 0 C-N-CA 124.518 1.127 . . . . 64.35 109.425 -177.425 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 120.567 0.223 . . . . 74.54 110.646 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -82.95 -35.04 26.33 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.274 0.63 . . . . 75.42 110.685 172.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 81.7 m -63.51 -47.66 80.79 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.129 0.572 . . . . 72.24 111.322 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.84 -25.06 32.99 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.551 0.741 . . . . 62.03 109.59 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.45 -21.26 45.14 Favored Glycine 0 C--N 1.353 1.502 0 N-CA-C 115.263 0.865 . . . . 73.12 115.263 -170.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.83 -53.85 0.23 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 117.89 0.845 . . . . 60.33 111.837 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -57.7 -60.21 4.03 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 114.352 -1.294 . . . . 72.05 112.509 -171.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.6 m -74.5 -36.28 2.48 Favored Pre-proline 0 CA--C 1.568 1.661 0 N-CA-C 113.144 0.794 . . . . 74.34 113.144 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -50.83 -38.23 56.88 Favored 'Trans proline' 0 C--N 1.397 3.095 0 C-N-CA 122.767 2.311 . . . . 73.51 113.966 164.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -66.03 -38.87 89.51 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.711 0.804 . . . . 72.51 109.983 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.6 mm -58.84 -34.77 53.29 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 C-N-CA 123.784 0.833 . . . . 71.32 111.145 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 88.5 mt -76.27 -28.99 57.27 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.999 0.92 . . . . 72.34 112.665 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.568 ' HZ ' HD22 ' A' ' 128' ' ' LEU . 36.1 t80 -62.35 -44.28 87.61 Favored Pre-proline 0 CA--C 1.569 1.701 0 CA-C-O 117.806 -1.092 . . . . 55.22 113.811 -171.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.56 -31.79 87.47 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.339 2.026 . . . . 54.24 113.52 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -78.19 -35.34 48.76 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.421 0.688 . . . . 74.23 112.028 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.45 -36.58 71.28 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.641 -0.503 . . . . 71.1 109.641 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.644 HH12 HD12 ' C' ' 105' ' ' ILE . 31.9 ttm180 -60.68 -43.77 97.3 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.557 1.143 . . . . 75.22 110.366 172.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -53.99 -54.31 40.86 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.555 1.142 . . . . 75.3 111.207 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 117' ' ' MET . 48.5 t -66.81 -45.85 77.04 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.586 -1.188 . . . . 54.14 111.297 -174.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.456 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 61.6 mt -60.15 -51.89 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.749 0.82 . . . . 71.02 111.123 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.559 HG21 ' HE2' ' C' ' 109' ' ' TYR . 67.6 m -54.6 -44.19 72.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.884 0.874 . . . . 54.3 111.555 177.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 44.8 t -63.57 -41.5 98.38 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.651 -0.704 . . . . 73.4 111.166 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 113' ' ' CYS . 27.0 mtm -69.86 -37.81 76.22 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.94 0.496 . . . . 54.42 111.65 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.92 -50.62 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.38 0.672 . . . . 73.42 109.839 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.1 t -66.22 -31.35 72.13 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 114.801 -1.09 . . . . 63.33 111.192 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 116' ' ' SER . 33.9 ttm-85 -77.5 -31.73 53.74 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.181 0.992 . . . . 62.12 109.404 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.441 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.8 12.15 57.78 Favored Glycine 0 C--N 1.355 1.595 0 CA-C-N 114.804 -1.089 . . . . 51.51 112.508 172.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.441 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.2 t 68.47 13.33 8.96 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 126.964 2.106 . . . . 50.03 113.852 169.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -81.76 155.44 70.72 Favored Pre-proline 0 CA--C 1.555 1.147 0 N-CA-C 108.705 -0.85 . . . . 74.11 108.705 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.04 163.76 13.54 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 122.892 2.395 . . . . 74.31 112.928 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -57.3 124.26 18.26 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 123.802 0.689 . . . . 70.35 111.315 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 66.0 tp -130.06 106.38 8.59 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.695 1.198 . . . . 65.23 109.098 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -119.15 117.34 28.41 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.163 0.985 . . . . 53.5 108.861 176.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.568 HD22 ' HZ ' ' A' ' 107' ' ' PHE . 2.4 tt -70.99 116.61 11.48 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 108.031 -1.1 . . . . 72.11 108.031 178.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.54 145.45 97.29 Favored Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 123.893 0.877 . . . . 73.25 111.021 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.472 ' HD3' HG13 ' C' ' 13' ' ' ILE . 84.6 Cg_endo -75.96 158.69 38.33 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.203 1.935 . . . . 64.32 112.694 -174.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.8 m -128.2 116.16 41.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 114.461 -1.245 . . . . 65.05 108.427 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -72.94 82.69 1.22 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.359 0.664 . . . . 61.32 109.749 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 121.404 0.621 . . . . 73.21 109.528 177.234 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' B' ' 10' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 120.866 0.365 . . . . 52.44 110.813 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.619 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 94.0 m -145.49 114.81 7.11 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.28 -0.888 . . . . 64.25 108.99 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.613 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 51.5 t80 -131.39 132.69 44.59 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 122.957 0.503 . . . . 74.11 110.258 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.48 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -160.21 141.31 12.25 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.159 0.584 . . . . 75.51 110.285 174.28 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 23.2 mt -82.82 123.76 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.792 -0.818 . . . . 71.12 108.792 172.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -89.71 -49.91 6.37 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.438 -0.578 . . . . 71.12 109.438 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.419 ' HE ' HG21 ' A' ' 122' ' ' THR . 42.2 ttt180 -166.23 135.8 3.21 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.816 -0.629 . . . . 72.5 110.021 -175.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.7 mt -115.22 141.47 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 107.547 -1.279 . . . . 62.02 107.547 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -166.36 147.94 6.59 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.935 0.874 . . . . 72.11 112.369 -173.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.8 m -79.58 122.0 25.96 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.142 -1.39 . . . . 53.43 108.387 172.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.411 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 41.9 mtpt -97.33 -19.09 18.75 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.482 0.713 . . . . 73.23 111.138 -177.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -167.71 142.83 3.81 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.831 0.707 . . . . 71.33 110.377 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 38.7 mm -131.63 142.87 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.79 1.236 . . . . 75.32 108.736 172.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 44.3 t -143.78 110.27 5.5 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.414 1.086 . . . . 71.23 108.159 174.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.557 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 92.0 t80 -128.77 109.98 11.77 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.986 -1.116 . . . . 73.12 107.986 172.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -118.75 127.25 53.37 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.893 -0.781 . . . . 73.45 108.893 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.476 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -112.53 86.4 8.32 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 107.769 -1.197 . . . . 64.5 107.769 176.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -65.94 -43.08 9.94 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.87 2.38 . . . . 64.12 112.648 -168.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -104.26 16.78 25.46 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.098 0.959 . . . . 71.35 110.579 -175.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.476 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -38.73 -64.8 0.44 Allowed Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 115.007 1.484 . . . . 61.5 115.007 -162.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.29 -26.05 49.18 Favored 'Trans proline' 0 C--N 1.389 2.682 0 C-N-CA 121.992 1.794 . . . . 61.21 113.451 -170.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -97.5 -23.24 16.13 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.351 0.661 . . . . 53.4 112.736 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.535 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.3 p -80.58 -18.87 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 117.869 0.304 . . . . 75.24 111.08 -176.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -61.51 -27.58 68.7 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.792 0.837 . . . . 62.0 113.249 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -57.3 -23.25 47.31 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.452 0.701 . . . . 73.13 112.159 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -89.52 89.0 7.65 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.41 1.084 . . . . 71.34 109.974 -176.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.49 87.65 6.21 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.447 -0.797 . . . . 61.42 110.949 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -163.19 173.23 13.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.343 1.057 . . . . 74.44 108.722 167.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -71.83 117.08 54.62 Favored Pre-proline 0 N--CA 1.474 0.739 0 N-CA-C 109.192 -0.67 . . . . 63.51 109.192 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.19 153.82 71.65 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.279 1.986 . . . . 54.43 112.626 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.05 120.42 10.82 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 107.756 -1.201 . . . . 73.5 107.756 170.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 m -116.51 123.03 71.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.435 -0.802 . . . . 74.12 110.219 -167.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.587 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 77.2 tttt -106.98 121.31 44.2 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.66 1.184 . . . . 61.44 107.835 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.795 HD22 HD11 ' B' ' 128' ' ' LEU . 46.5 tp -96.89 137.39 36.04 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.655 -0.869 . . . . 64.25 108.655 169.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -144.01 152.54 41.17 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.22 1.008 . . . . 73.12 109.034 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 27.7 tp -128.7 157.29 41.79 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.688 0.795 . . . . 73.52 109.102 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.402 ' HB3' ' HD3' ' B' ' 61' ' ' ARG . 29.0 t70 -145.28 140.4 27.77 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.654 -0.869 . . . . 54.52 108.654 170.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 54.7 p -108.84 113.87 27.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.914 0.886 . . . . 52.51 109.401 -172.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.61 132.05 36.62 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.242 1.017 . . . . 62.41 108.692 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 59.6 p -147.55 178.87 8.1 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.009 0.433 . . . . 63.44 111.464 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.7 p -160.35 137.94 9.6 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.675 1.19 . . . . 41.34 108.91 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -88.63 128.16 35.58 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.209 -0.663 . . . . 73.0 109.209 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 78.2 mt -91.38 -40.09 11.64 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.106 0.563 . . . . 54.33 110.552 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.55 -172.49 2.93 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.332 0.586 . . . . 64.35 110.801 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.75 128.66 37.31 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.358 -1.292 . . . . 74.55 108.289 172.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.562 ' HB3' ' HB2' ' B' ' 87' ' ' ALA . 9.9 m-20 64.81 3.28 1.98 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.367 1.067 . . . . 75.2 113.31 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 91.6 t -120.45 120.19 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.879 0.872 . . . . 72.25 109.226 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.636 ' HB2' HD11 ' B' ' 86' ' ' ILE . 0.4 OUTLIER -129.21 154.54 46.67 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.931 -0.766 . . . . 64.03 108.931 178.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -125.44 108.1 11.31 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.418 -1.697 . . . . 73.23 106.418 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 31.2 m -109.42 139.43 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 122.964 0.506 . . . . 72.23 110.386 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.518 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 31.7 t -120.86 111.8 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.475 1.11 . . . . 42.43 109.128 -176.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.606 HD13 ' HB3' ' B' ' 103' ' ' PRO . 14.5 tp -94.38 100.07 12.16 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.702 -0.851 . . . . 62.32 108.702 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.497 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 70.2 ttt180 -88.62 106.8 18.55 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.161 0.584 . . . . 74.42 109.867 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.81 106.07 19.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.087 -1.079 . . . . 60.42 108.087 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 27.9 m -109.33 138.41 45.73 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.641 0.776 . . . . 72.34 109.895 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 88.4 t -134.33 134.18 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.33 1.052 . . . . 75.43 109.502 -175.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.587 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 62.8 m -109.78 149.2 30.15 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.869 0.868 . . . . 72.01 109.56 170.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.18 137.22 38.92 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.777 0.831 . . . . 44.33 109.176 177.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 11.0 m -137.4 124.31 21.36 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.292 0.637 . . . . 74.23 110.898 -175.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.466 HD12 HG22 ' B' ' 31' ' ' VAL . 47.0 mt -104.34 113.85 27.69 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.992 -0.744 . . . . 72.55 108.992 176.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.09 -110.57 3.31 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 114.987 -1.006 . . . . 33.52 111.859 -172.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -117.33 5.33 12.59 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.945 0.898 . . . . 73.14 109.943 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -125.52 164.65 20.05 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.884 0.474 . . . . 55.31 110.59 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 62.1 m -79.92 122.91 27.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.652 0.781 . . . . 70.42 110.641 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.535 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -70.83 -63.63 1.06 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.311 0.645 . . . . 71.3 109.358 172.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -150.7 167.73 26.48 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 115.066 -0.97 . . . . 72.23 111.977 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 65.4 mt -129.98 113.57 14.74 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.141 -1.8 . . . . 72.21 106.141 175.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.475 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 30.2 t -123.01 130.45 52.82 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 109.518 -0.549 . . . . 74.22 109.518 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -149.55 131.88 15.58 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.757 -0.831 . . . . 73.03 108.757 -170.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' B' ' 113' ' ' CYS . 66.1 t -129.81 144.29 38.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 123.946 0.899 . . . . 74.24 109.005 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.497 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 20.6 mt-30 -118.61 93.61 4.17 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.165 -1.05 . . . . 73.01 108.165 172.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -91.82 100.75 13.38 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.891 -0.595 . . . . 74.12 109.495 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.2 164.06 30.68 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 115.813 -0.63 . . . . 43.23 111.75 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.8 129.48 1.98 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 112.083 -0.407 . . . . 44.4 112.083 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 38.4 mt -85.42 126.85 40.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 108.214 -1.032 . . . . 74.41 108.214 171.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -133.5 144.22 49.27 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.479 0.712 . . . . 71.52 109.723 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 31.5 m -90.41 113.98 26.01 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.179 0.992 . . . . 54.11 108.837 170.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.636 HD11 ' HB2' ' B' ' 56' ' ' TYR . 0.2 OUTLIER -128.09 125.1 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.055 0.942 . . . . 71.14 109.024 178.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.619 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.32 172.96 17.58 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.153 0.427 . . . . 54.33 112.153 -175.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.49 -54.68 3.84 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.525 -0.761 . . . . 75.4 112.056 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 32.5 mm -91.25 157.2 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 124.22 1.008 . . . . 70.13 110.601 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.528 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 30.8 tt0 -161.5 153.66 19.75 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.755 0.822 . . . . 73.35 109.619 173.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 102.6 -136.0 12.58 Favored Glycine 0 C--N 1.352 1.453 0 C-N-CA 123.711 0.672 . . . . 73.35 112.917 -175.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 63.5 m -71.95 -43.24 65.55 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 117.421 0.611 . . . . 72.33 111.552 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -58.51 -32.25 68.64 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.508 0.723 . . . . 71.41 110.555 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.528 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 7.2 tpt -72.1 -44.78 62.69 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.246 -0.888 . . . . 75.15 110.426 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.33 -23.18 67.3 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.011 -0.995 . . . . 71.22 111.424 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.533 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 58.1 t-80 -82.82 -20.75 35.08 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.337 1.055 . . . . 64.44 110.874 174.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.7 t -86.11 -67.25 0.82 Allowed 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.993 -0.442 . . . . 63.13 111.314 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.689 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 1.7 pt? -83.94 -14.73 50.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.551 -0.718 . . . . 72.11 111.809 -174.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.83 1.65 55.42 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.376 0.422 . . . . 65.41 113.855 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -143.43 -59.7 0.41 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.438 0.695 . . . . 73.4 109.833 -176.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -71.63 -48.58 46.96 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.215 0.606 . . . . 63.14 112.494 -173.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.689 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 59.2 m -64.35 -43.14 71.4 Favored Pre-proline 0 CA--C 1.56 1.345 0 N-CA-C 112.872 0.693 . . . . 64.33 112.872 -175.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.606 ' HB3' HD13 ' B' ' 60' ' ' LEU . 51.8 Cg_exo -60.12 -30.65 91.88 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 122.191 1.927 . . . . 73.14 113.384 172.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -65.79 -26.89 67.9 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 122.945 0.498 . . . . 63.21 111.641 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 74.2 mt -71.25 -43.71 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.515 0.726 . . . . 74.43 109.49 173.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 99.1 mt -74.13 -23.53 59.3 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.011 -0.995 . . . . 73.14 112.087 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -57.42 -51.9 78.29 Favored Pre-proline 0 CA--C 1.563 1.466 0 CA-C-O 117.696 -1.145 . . . . 71.14 113.42 -173.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.22 -32.04 94.9 Favored 'Trans proline' 0 C--N 1.392 2.854 0 C-N-CA 122.314 2.009 . . . . 54.41 113.7 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.416 ' HE2' HG21 ' D' ' 115' ' ' THR . 33.7 m-85 -72.57 -40.27 66.76 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.552 0.741 . . . . 50.53 110.229 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.79 -37.87 87.48 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.305 0.642 . . . . 61.21 110.491 173.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.412 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 56.8 ttt-85 -69.4 -50.33 46.89 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.415 1.486 . . . . 72.34 111.223 -171.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.55 -37.4 87.17 Favored 'General case' 0 N--CA 1.484 1.225 0 O-C-N 123.898 0.749 . . . . 73.35 109.286 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.473 ' O ' ' HG2' ' B' ' 117' ' ' MET . 28.8 t -64.07 -40.73 96.9 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.371 0.669 . . . . 62.31 112.003 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.477 ' O ' HG23 ' B' ' 118' ' ' VAL . 70.9 mt -61.05 -56.48 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.692 -0.485 . . . . 75.43 109.692 175.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.8 m -61.77 -26.86 68.35 Favored 'General case' 0 CA--C 1.557 1.216 0 O-C-N 123.752 0.658 . . . . 75.45 111.586 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.8 t -71.66 -43.25 66.4 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.726 0.81 . . . . 72.43 110.078 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.6 mmt -71.11 -31.92 68.37 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.538 0.335 . . . . 61.13 110.528 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.477 HG23 ' O ' ' B' ' 114' ' ' ILE . 99.1 t -62.7 -43.22 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 124.068 0.947 . . . . 65.33 109.914 170.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 64.0 m -65.89 -36.42 83.37 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.24 -0.891 . . . . 44.5 111.764 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' B' ' 116' ' ' SER . 68.8 mtt-85 -68.53 -38.16 80.62 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.521 -0.763 . . . . 65.23 109.554 176.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.72 -0.29 79.94 Favored Glycine 0 C--N 1.354 1.571 0 O-C-N 124.026 0.829 . . . . 70.14 113.264 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 73.0 p 61.17 16.52 7.28 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 126.343 1.857 . . . . 51.14 113.831 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -77.09 160.06 76.91 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 123.496 0.718 . . . . 64.14 111.493 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -47.14 146.21 6.73 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 123.748 2.965 . . . . 72.31 114.724 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -58.86 122.59 13.98 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.558 1.143 . . . . 74.24 111.095 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 52.8 tp -138.98 99.26 3.72 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.208 0.603 . . . . 65.33 109.851 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -99.12 131.51 45.1 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.739 0.816 . . . . 71.53 108.886 172.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.795 HD11 HD22 ' B' ' 42' ' ' LEU . 25.6 tp -81.99 152.43 26.7 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.23 0.612 . . . . 65.51 112.067 -174.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.54 146.22 83.31 Favored Pre-proline 0 N--CA 1.482 1.126 0 C-N-CA 123.835 0.854 . . . . 63.4 111.644 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -70.82 119.18 6.13 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.158 2.572 . . . . 53.1 111.15 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 26.7 m -107.5 110.88 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.892 0.853 . . . . 73.33 108.912 174.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -110.42 88.8 2.85 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.19 -1.041 . . . . 74.02 108.19 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -61.33 -34.21 74.88 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.636 -0.711 . . . . 73.02 110.73 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 N--CA 1.472 0.625 0 C-N-CA 124.563 1.145 . . . . 64.45 111.255 -177.248 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.701 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 14.7 t80 . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 108.125 -1.065 . . . . 61.14 108.125 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -136.46 119.26 16.19 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.014 -0.736 . . . . 71.34 109.014 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.472 HG13 ' HD3' ' A' ' 130' ' ' PRO . 35.5 mt -73.13 128.02 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.936 -0.764 . . . . 60.43 108.936 175.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -92.65 -48.23 6.7 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.149 -0.685 . . . . 53.53 109.149 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -173.22 134.44 0.54 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.92 -0.77 . . . . 75.33 108.92 -169.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 94.5 mt -126.27 142.23 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 108.017 -1.105 . . . . 54.41 108.017 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.554 ' HB3' HG23 ' D' ' 122' ' ' THR . 26.6 p90 -173.68 167.3 4.51 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 123.942 0.776 . . . . 65.35 110.488 -174.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -86.57 119.07 26.43 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.84 -1.073 . . . . 65.31 109.062 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.7 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 10.8 mmmm -70.44 -45.8 65.12 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.999 -1.112 . . . . 53.43 107.999 169.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.606 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 5.1 t70 -139.53 147.83 41.77 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 113.776 -1.556 . . . . 75.55 110.258 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.4 mt -137.94 149.08 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.977 1.711 . . . . 60.25 107.24 174.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.4 t -162.04 150.3 14.91 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.427 0.632 . . . . 71.43 110.614 172.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 91.6 t80 -143.65 146.18 33.04 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 107.029 -1.471 . . . . 53.31 107.029 170.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -149.35 115.87 5.86 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.28 1.032 . . . . 64.25 109.011 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.05 92.01 12.21 Favored Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 105.649 -1.982 . . . . 71.04 105.649 165.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -57.25 -49.93 12.55 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.277 2.652 . . . . 65.23 112.513 -171.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -106.73 39.16 1.9 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.504 0.722 . . . . 64.35 109.488 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.545 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -37.86 -58.56 1.35 Allowed Pre-proline 0 CA--C 1.571 1.75 0 N-CA-C 115.183 1.549 . . . . 62.14 115.183 -171.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.419 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 20.3 Cg_exo -60.56 -43.29 33.93 Favored 'Trans proline' 0 C--N 1.387 2.6 0 CA-C-N 122.198 1.821 . . . . 65.51 112.418 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -69.13 -32.44 71.81 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.14 -0.937 . . . . 75.21 112.258 -175.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.724 HG21 ' HA ' ' C' ' 73' ' ' ALA . 12.4 p -79.38 -27.47 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 122.528 0.331 . . . . 62.44 111.769 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -66.69 -23.08 66.08 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 112.114 0.413 . . . . 75.52 112.114 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -95.55 15.58 19.43 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.392 0.677 . . . . 63.43 111.841 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.792 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -91.52 160.83 15.23 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.369 0.668 . . . . 70.13 110.451 177.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -69.01 130.26 42.28 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.833 0.853 . . . . 71.35 108.784 162.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -84.55 102.34 12.79 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.913 0.485 . . . . 75.31 110.607 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -155.37 77.4 4.85 Favored Pre-proline 0 N--CA 1.476 0.83 0 N-CA-C 108.674 -0.861 . . . . 71.13 108.674 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -88.31 148.65 6.52 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.71 2.273 . . . . 71.31 113.819 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -86.52 99.34 11.61 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 107.013 -1.477 . . . . 70.43 107.013 159.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 t -78.54 101.04 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 108.591 -0.892 . . . . 75.45 108.591 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.556 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 62.3 mttm -99.26 105.38 17.4 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.899 -0.778 . . . . 72.11 108.899 -176.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.406 HD13 HD21 ' C' ' 128' ' ' LEU . 42.5 tp -83.64 130.02 34.97 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 109.134 -0.691 . . . . 54.3 109.134 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -129.19 139.74 51.77 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.326 1.45 . . . . 73.44 108.284 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.33 147.59 50.25 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.844 0.458 . . . . 62.23 110.702 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 1.5 t70 -130.09 147.49 51.84 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.117 1.367 . . . . 71.22 108.693 173.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 87.9 m -111.51 114.17 27.08 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.709 0.804 . . . . 73.04 109.643 -174.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -118.36 139.9 50.66 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.29 1.036 . . . . 52.21 108.317 173.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.47 ' HB2' ' OH ' ' C' ' 56' ' ' TYR . 64.8 p -154.26 143.76 21.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.172 -0.33 . . . . 73.53 111.179 -172.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 27.8 p -159.0 128.01 5.4 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 123.923 0.764 . . . . 73.11 109.808 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -80.1 138.27 36.92 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.974 -0.75 . . . . 73.51 108.974 173.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.566 HD11 HD12 ' C' ' 83' ' ' ILE . 49.1 mt -105.48 -38.9 6.3 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.004 0.522 . . . . 73.32 110.712 -176.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.69 -170.55 2.79 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.379 0.672 . . . . 71.31 110.957 -177.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -70.39 112.25 6.56 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.261 -0.881 . . . . 62.2 109.785 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 71.24 -1.42 2.74 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 125.396 1.479 . . . . 73.13 112.944 -175.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.476 HG12 ' HB2' ' C' ' 51' ' ' LEU . 66.2 t -102.31 120.02 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.096 -0.705 . . . . 74.23 109.096 175.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . 0.47 ' OH ' ' HB2' ' C' ' 48' ' ' SER . 51.0 t80 -138.62 132.07 30.39 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.104 -1.073 . . . . 70.35 108.104 -174.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.501 ' HB2' HD11 ' C' ' 51' ' ' LEU . 39.9 tt0 -94.48 117.67 30.48 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.384 -0.825 . . . . 71.12 109.045 173.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 35.7 m -96.65 130.14 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.625 -1.25 . . . . 70.23 107.625 168.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 61.9 t -124.02 125.34 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.85 -1.167 . . . . 63.43 107.85 172.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 tp -125.9 116.41 21.47 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.013 -1.106 . . . . 73.24 108.013 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.506 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.7 ttm180 -79.12 122.25 26.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.772 -1.103 . . . . 75.14 109.036 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 11.4 t -100.81 129.06 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.019 -1.474 . . . . 72.23 107.019 171.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 62.8 m -131.95 110.53 10.83 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.089 -1.078 . . . . 75.11 108.089 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 85.1 t -101.75 112.33 34.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.578 -1.192 . . . . 62.22 108.231 -175.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.556 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 20.7 m -97.92 141.15 31.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.014 -1.106 . . . . 73.31 108.014 173.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.33 107.5 6.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 106.233 -1.766 . . . . 55.21 106.233 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 46.2 m -127.16 146.34 50.43 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.611 -0.514 . . . . 70.41 109.611 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.792 HD13 ' HG2' ' C' ' 34' ' ' LYS . 13.1 mt -110.41 35.59 3.39 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.661 1.584 . . . . 65.23 108.2 -173.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.88 -109.68 2.99 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 110.096 -1.202 . . . . 72.12 110.096 -169.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.93 -30.01 18.13 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.869 0.868 . . . . 73.13 110.314 176.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -73.52 103.07 4.02 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.726 0.81 . . . . 74.2 109.77 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 92.6 m -73.26 118.87 16.73 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.544 -0.91 . . . . 75.23 108.544 170.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.724 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -67.68 -57.75 5.85 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 124.464 1.102 . . . . 51.34 109.11 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -156.89 171.65 20.05 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.663 -1.153 . . . . 63.34 111.656 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -139.44 140.02 37.21 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 104.839 -2.282 . . . . 74.44 104.839 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.484 ' SG ' HG23 ' C' ' 114' ' ' ILE . 38.3 t -147.54 112.43 5.42 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.964 -0.754 . . . . 72.21 108.964 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -121.8 116.46 24.5 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.708 0.803 . . . . 75.52 110.147 -171.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 55.5 t -125.06 115.45 44.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.955 0.902 . . . . 73.41 109.357 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.606 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.1 mt-30 -90.96 97.85 11.43 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.807 -0.812 . . . . 73.25 108.807 173.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.671 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.1 tp-100 -86.98 117.32 25.62 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.339 0.655 . . . . 73.21 109.766 -177.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.3 146.35 18.23 Favored Glycine 0 C--N 1.342 0.909 0 O-C-N 123.813 0.695 . . . . 71.42 111.831 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.411 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -143.4 116.35 0.99 Allowed Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.754 -0.538 . . . . 43.5 111.754 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.566 HD12 HD11 ' C' ' 51' ' ' LEU . 7.7 mm -82.97 122.16 37.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 107.945 -1.131 . . . . 64.02 107.945 174.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.413 ' HD2' ' HA ' ' C' ' 13' ' ' ILE . 54.7 m-85 -138.26 132.16 31.3 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.426 0.691 . . . . 74.24 109.956 -176.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 21.8 p -95.22 103.97 15.85 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 108.17 -1.048 . . . . 72.14 108.17 169.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.525 HD13 ' H ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -124.15 137.04 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 124.144 0.977 . . . . 74.4 111.459 -171.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.67 173.38 11.96 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.352 1.061 . . . . 73.41 110.934 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 116.89 -49.03 0.88 Allowed Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.941 -0.572 . . . . 63.21 111.74 172.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 30.0 pt -92.31 170.17 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.488 0.715 . . . . 71.12 110.284 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -146.17 148.47 32.58 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.975 0.51 . . . . 73.24 111.226 -168.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.51 -133.32 23.46 Favored Glycine 0 C--N 1.35 1.33 0 O-C-N 123.745 0.653 . . . . 74.3 114.222 172.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.4 p -66.69 -18.55 65.43 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.111 0.964 . . . . 73.2 112.229 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -68.35 -43.22 77.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.196 0.598 . . . . 70.11 110.144 172.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 15.5 ttt -76.72 -31.57 57.25 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.601 -0.727 . . . . 74.53 110.55 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.19 -40.23 90.27 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.373 0.669 . . . . 63.21 110.558 172.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -59.56 -41.75 90.87 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.473 1.109 . . . . 74.5 111.006 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 50.4 t -63.79 -54.27 37.73 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.539 0.524 . . . . 64.33 110.223 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.03 -36.36 83.31 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.332 0.653 . . . . 72.24 112.036 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.6 11.28 66.7 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.497 -0.613 . . . . 73.01 114.304 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.65 -58.02 0.1 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 117.555 0.677 . . . . 43.11 111.999 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -74.51 -48.4 27.37 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.662 0.385 . . . . 63.24 112.002 -172.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.701 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 41.9 m -60.51 -47.2 96.88 Favored Pre-proline 0 CA--C 1.563 1.458 0 C-N-CA 123.97 0.908 . . . . 75.44 112.11 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.87 -12.07 19.87 Favored 'Trans proline' 0 C--N 1.395 3.024 0 C-N-CA 122.026 1.818 . . . . 64.52 113.608 172.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . 0.506 ' HA ' ' CD2' ' C' ' 107' ' ' PHE . 59.7 t30 -71.76 -32.66 67.93 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.434 0.635 . . . . 73.13 109.914 173.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.644 HD12 HH12 ' A' ' 111' ' ' ARG . 30.0 mm -65.54 -30.84 51.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 115.143 -0.935 . . . . 73.33 109.822 170.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.411 HD21 ' HA3' ' C' ' 82' ' ' GLY . 65.5 mt -88.14 -22.64 23.97 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.887 0.875 . . . . 71.14 113.208 -175.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . 0.506 ' CD2' ' HA ' ' C' ' 104' ' ' ASN . 11.8 m-85 -55.38 -48.36 96.48 Favored Pre-proline 0 N--CA 1.49 1.536 0 CA-C-O 117.242 -1.361 . . . . 75.12 113.218 -177.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -54.46 -39.53 87.43 Favored 'Trans proline' 0 C--N 1.39 2.75 0 C-N-CA 122.881 2.387 . . . . 73.41 114.461 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.559 ' HE2' HG21 ' A' ' 115' ' ' THR . 73.9 m-85 -70.04 -49.33 52.34 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.214 0.605 . . . . 72.34 110.901 -176.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.671 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -67.75 -31.97 72.25 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 115.615 -0.72 . . . . 73.42 111.081 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 26.6 ttt-85 -59.21 -54.19 49.76 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.675 1.19 . . . . 71.14 110.328 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -69.33 -29.05 66.79 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.767 0.667 . . . . 64.41 110.425 -177.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 42.7 t -70.22 -38.39 75.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.186 0.594 . . . . 71.3 110.813 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.484 HG23 ' SG ' ' C' ' 76' ' ' CYS . 87.3 mt -69.54 -49.09 62.24 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.157 0 C-N-CA 123.259 0.624 . . . . 65.33 109.742 174.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 90.5 m -63.25 -33.08 74.72 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.012 0.925 . . . . 75.25 110.977 -175.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 41.8 t -64.62 -46.67 81.6 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 115.349 -0.841 . . . . 74.31 109.092 172.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.49 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.98 -36.43 84.38 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.895 1.278 . . . . 62.4 112.929 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' C' ' 114' ' ' ILE . 97.4 t -65.56 -44.54 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.093 0.957 . . . . 72.14 108.774 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 30.6 t -66.13 -33.62 76.19 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.162 -1.381 . . . . 61.32 111.496 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -70.94 -32.2 69.01 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.648 0.779 . . . . 72.13 109.453 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.3 9.06 76.73 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 123.717 0.636 . . . . 75.03 112.947 174.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 46.0 p 58.19 30.62 19.67 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 126.143 1.777 . . . . 74.15 114.016 174.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -93.02 147.27 33.54 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 108.81 -0.811 . . . . 74.33 108.81 172.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.34 159.76 5.63 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 123.386 2.724 . . . . 62.01 113.742 174.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -47.39 125.59 8.36 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.797 1.239 . . . . 65.31 112.934 -176.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.81 91.25 3.31 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.327 -1.36 . . . . 75.42 107.327 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -116.62 122.18 43.86 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.407 1.083 . . . . 63.12 108.168 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.406 HD21 HD13 ' C' ' 42' ' ' LEU . 6.7 mp -69.11 145.94 52.97 Favored 'General case' 0 C--O 1.245 0.832 0 O-C-N 123.406 0.441 . . . . 61.13 110.479 177.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . 0.44 ' HA ' ' HD3' ' C' ' 130' ' ' PRO . . . -72.8 136.22 80.33 Favored Pre-proline 0 CA--C 1.552 1.041 0 O-C-N 124.107 0.879 . . . . 73.01 110.013 177.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.595 ' HB2' HD12 ' A' ' 13' ' ' ILE . 11.1 Cg_exo -69.22 100.7 0.77 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 123.173 2.582 . . . . 52.15 113.725 -170.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.0 t -101.04 108.62 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 108.051 -1.092 . . . . 65.51 108.051 170.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -81.41 92.61 6.46 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 107.091 -1.448 . . . . 71.5 107.091 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -65.43 -35.91 82.33 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.057 0.943 . . . . 71.42 112.642 -161.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.479 1.014 0 C-N-CA 123.516 0.727 . . . . 73.55 111.589 177.899 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 CA--C 1.54 0.571 0 CA-C-O 120.655 0.264 . . . . 72.53 110.579 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.581 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 57.6 t80 -154.14 99.85 2.27 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.703 1.201 . . . . 75.22 107.837 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -117.48 115.43 25.15 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.024 -0.732 . . . . 74.44 109.024 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.442 HG21 HD11 ' D' ' 16' ' ' ILE . 28.5 mt -75.23 121.64 27.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.23 -1.026 . . . . 71.32 108.23 176.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -96.45 -26.94 15.12 Favored 'General case' 0 C--O 1.245 0.819 0 O-C-N 123.417 0.448 . . . . 75.12 111.347 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -171.72 136.04 0.91 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 117.705 0.23 . . . . 55.34 111.364 -168.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.455 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.9 mp -120.5 133.4 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 107.107 -1.442 . . . . 54.25 107.107 174.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -160.6 173.03 16.11 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 122.582 1.182 . . . . 75.42 112.53 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -111.38 120.42 42.14 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 113.613 -1.631 . . . . 61.33 108.136 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.545 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 42.6 mtpt -87.93 -24.07 23.72 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.275 0.56 . . . . 61.41 109.552 176.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 10.3 t70 -154.57 143.3 20.82 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.124 -1.398 . . . . 64.21 109.138 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.498 HG23 HG22 ' D' ' 78' ' ' VAL . 47.1 mt -139.96 150.28 21.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 106.539 -1.652 . . . . 75.25 106.539 173.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -157.56 144.84 18.42 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.571 0.701 . . . . 73.5 110.739 169.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.489 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.2 t80 -140.17 128.64 22.76 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 105.872 -1.899 . . . . 72.32 105.872 173.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.592 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.7 mt-10 -136.89 123.44 20.93 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.441 -0.948 . . . . 75.43 108.441 -176.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.06 86.62 57.64 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 107.605 -1.257 . . . . 63.44 107.605 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.67 -36.78 10.41 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 122.676 2.25 . . . . 75.43 112.431 -175.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -96.95 16.76 18.54 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.867 0.867 . . . . 74.54 110.43 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.7 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -43.66 -64.93 0.65 Allowed Pre-proline 0 CA--C 1.561 1.386 0 N-CA-C 115.336 1.606 . . . . 74.14 115.336 -162.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.69 -12.77 22.24 Favored 'Trans proline' 0 C--N 1.386 2.542 0 CA-C-N 122.626 1.973 . . . . 63.11 113.348 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -84.58 -40.83 17.07 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.119 1.368 . . . . 72.44 110.856 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.481 HG22 HD12 ' D' ' 68' ' ' LEU . 9.9 p -83.72 -17.21 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.123 0 CA-C-N 115.886 -0.597 . . . . 64.31 111.446 -170.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -62.42 -17.62 59.72 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 113.025 0.75 . . . . 74.11 113.025 173.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -65.02 -11.95 44.95 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.369 0.668 . . . . 73.32 110.951 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.4 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 87.2 mttt -109.79 92.13 3.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.303 1.441 . . . . 53.42 109.194 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -90.9 92.5 8.8 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.844 0.457 . . . . 51.42 109.873 177.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 30.7 p90 -162.31 176.87 10.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.69 0.796 . . . . 73.13 109.448 168.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -69.9 114.34 24.3 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 123.689 0.796 . . . . 55.42 110.342 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.539 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 16.4 Cg_exo -68.08 134.98 33.34 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 123.104 2.536 . . . . 72.44 111.096 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.68 122.25 16.83 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.262 0.625 . . . . 73.35 110.033 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 35.8 t -97.87 114.93 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.631 0.773 . . . . 72.3 110.894 -168.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -104.39 152.63 22.06 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.186 -1.413 . . . . 73.03 107.186 166.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 pp -140.34 156.07 46.57 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.025 0.53 . . . . 73.42 110.967 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -150.35 152.61 34.68 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.777 0.831 . . . . 72.35 108.89 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 87.9 mt -126.92 146.92 50.13 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.483 0.713 . . . . 73.5 110.838 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.56 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 7.2 t70 -136.84 140.82 42.7 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.738 1.215 . . . . 51.54 108.19 172.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 58.0 m -102.03 142.91 32.57 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.401 0.68 . . . . 53.21 109.655 -173.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.628 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -155.04 155.25 33.78 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.08 0.952 . . . . 62.02 109.032 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 77.3 p -174.62 178.44 1.92 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.007 0.432 . . . . 71.15 111.272 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 73.0 p -168.77 146.58 3.92 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.491 -1.231 . . . . 72.51 108.935 174.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -82.66 128.54 34.44 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.879 -0.786 . . . . 73.24 108.879 171.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.627 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.5 mt -101.28 -34.5 9.62 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.024 0.53 . . . . 44.33 110.18 -175.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.54 -175.89 3.72 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.318 1.047 . . . . 62.13 110.131 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.7 114.51 7.98 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.642 -1.163 . . . . 65.13 109.306 173.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 68.46 18.77 8.95 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.151 1.381 . . . . 73.0 112.461 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 94.7 t -124.16 124.69 69.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 C-N-CA 124.927 1.291 . . . . 75.44 107.609 168.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -144.66 137.72 26.82 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.625 -0.509 . . . . 74.51 109.625 -176.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.627 ' HB2' HD11 ' D' ' 51' ' ' LEU . 27.3 tt0 -91.9 133.53 35.59 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.645 -0.707 . . . . 64.12 109.972 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 78.4 t -111.86 118.28 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.678 -1.23 . . . . 72.15 107.678 172.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.628 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 14.7 t -114.61 131.77 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.21 -1.033 . . . . 62.04 108.21 173.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.416 HD12 ' O ' ' D' ' 45' ' ' ASP . 18.8 tp -130.69 123.5 29.48 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.229 -0.656 . . . . 61.25 109.229 174.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.56 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 14.1 ttm180 -83.53 104.77 13.93 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.702 -0.851 . . . . 71.52 108.702 176.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 70.4 t -89.12 129.39 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 107.979 -1.119 . . . . 53.35 107.979 173.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 20.7 m -121.75 142.6 50.03 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.289 -0.634 . . . . 72.33 109.289 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 69.5 t -139.44 100.45 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 126.04 1.736 . . . . 55.13 107.307 -174.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 62.5 m -99.69 112.33 24.57 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.757 -0.831 . . . . 73.53 108.757 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -115.42 141.05 48.57 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.586 0.754 . . . . 61.1 109.972 -173.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 14.4 p -147.7 128.79 14.59 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 123.526 0.516 . . . . 60.53 111.906 -174.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.481 HD12 HG22 ' D' ' 31' ' ' VAL . 41.2 mt -96.93 114.81 26.46 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 124.758 1.223 . . . . 62.34 108.661 175.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.86 -121.09 8.38 Favored Glycine 0 C--N 1.341 0.858 0 O-C-N 123.737 0.648 . . . . 64.44 112.106 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.07 5.59 22.23 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.177 0.591 . . . . 75.43 111.444 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.4 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 10.9 pt-20 -122.37 162.62 21.24 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.22 0.608 . . . . 65.35 109.727 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 58.8 m -69.65 132.67 46.54 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.457 0.703 . . . . 65.04 111.284 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.482 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -84.95 -68.93 0.69 Allowed 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.414 -1.328 . . . . 62.4 107.414 172.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . 0.456 ' HZ ' HD22 ' D' ' 126' ' ' LEU . 51.5 p90 -149.83 167.28 27.0 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.654 -1.157 . . . . 75.32 110.657 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.592 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 77.5 mt -134.49 112.42 10.9 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.794 1.238 . . . . 70.41 108.269 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.537 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 10.6 m -114.81 133.32 56.04 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.189 0.996 . . . . 73.51 108.782 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -152.62 118.42 5.4 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.196 -1.409 . . . . 63.14 107.196 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . 0.498 HG22 HG23 ' D' ' 21' ' ' ILE . 80.0 t -130.09 122.17 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.989 0.916 . . . . 74.32 108.777 -175.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.611 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.9 mt-30 -88.61 87.49 7.28 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.376 -0.972 . . . . 74.41 108.376 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -80.46 110.9 16.36 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.115 -1.402 . . . . 72.13 108.569 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.36 144.55 18.34 Favored Glycine 0 N--CA 1.469 0.887 0 N-CA-C 111.471 -0.651 . . . . 72.21 111.471 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.61 138.3 8.04 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 117.038 0.419 . . . . 71.53 112.199 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.6 mt -88.39 122.86 40.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 108.203 -1.036 . . . . 74.32 108.203 173.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -128.64 156.02 44.07 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.389 0.675 . . . . 71.0 109.253 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 48.8 m -115.36 102.12 9.55 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.424 -0.954 . . . . 71.24 108.424 175.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 3.6 mp -108.05 130.49 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 108.812 -0.81 . . . . 73.2 108.812 -176.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.81 166.9 28.09 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.868 0.867 . . . . 40.42 110.385 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.44 21.71 74.61 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.452 -0.795 . . . . 64.11 114.094 173.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.421 HG22 ' N ' ' D' ' 90' ' ' GLU . 17.5 mt -125.22 157.29 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.458 0.703 . . . . 74.22 110.47 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.421 ' N ' HG22 ' D' ' 89' ' ' ILE . 29.6 mt-10 -135.0 151.84 51.19 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.844 1.257 . . . . 65.42 110.213 172.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.58 -145.79 41.0 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 116.05 1.18 . . . . 72.31 116.05 168.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 4.3 p -74.51 -10.42 59.54 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.208 1.003 . . . . 74.12 111.711 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -30.86 71.56 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.808 0.843 . . . . 72.43 109.426 172.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 56.9 ttm -77.73 -39.04 45.73 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.883 0.473 . . . . 75.24 109.818 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.69 -31.49 68.27 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.238 0.542 . . . . 75.22 111.008 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -70.82 -48.9 51.57 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.471 1.108 . . . . 73.22 110.572 174.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 50.9 t -59.67 -46.29 89.48 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.047 0.539 . . . . 60.21 110.867 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.486 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 7.3 mp -83.89 -18.99 35.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.337 0.655 . . . . 62.42 111.96 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.38 -1.74 60.63 Favored Glycine 0 N--CA 1.476 1.314 0 CA-C-O 119.992 -0.338 . . . . 60.31 113.564 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' D' ' 104' ' ' ASN . . . -140.34 -65.22 0.46 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.887 0.475 . . . . 51.3 110.967 -176.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -73.93 -40.12 63.33 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.828 0.677 . . . . 73.05 112.828 -170.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.581 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 51.5 m -69.45 -45.91 27.05 Favored Pre-proline 0 CA--C 1.559 1.3 0 CA-C-O 118.881 -0.581 . . . . 75.23 112.213 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.52 -18.93 28.94 Favored 'Trans proline' 0 C--N 1.393 2.892 0 C-N-CA 121.66 1.573 . . . . 70.14 112.412 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . 0.454 ' HA ' ' HD2' ' D' ' 107' ' ' PHE . 35.4 t-20 -64.19 -31.12 72.2 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.463 0.705 . . . . 74.03 109.992 175.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.4 mm -68.24 -33.44 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.566 0.746 . . . . 73.51 110.277 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 79.5 mt -81.35 -25.66 36.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.666 0.786 . . . . 73.43 112.664 -173.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . 0.454 ' HD2' ' HA ' ' D' ' 104' ' ' ASN . 41.0 m-85 -64.06 -42.71 71.03 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 114.255 1.206 . . . . 71.13 114.255 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.27 -39.81 85.12 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 122.409 2.073 . . . . 63.52 113.329 172.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -80.59 -32.25 36.55 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.758 0.823 . . . . 73.11 112.045 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.3 -53.03 50.01 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.836 -0.801 . . . . 73.43 108.836 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.42 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 37.4 ttp180 -55.07 -46.9 75.45 Favored 'General case' 0 C--O 1.211 -0.937 0 O-C-N 124.61 1.194 . . . . 72.02 111.313 177.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -64.69 -45.63 85.79 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.217 0.607 . . . . 71.32 111.086 -175.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.408 ' O ' ' HG3' ' D' ' 117' ' ' MET . 44.7 t -57.72 -45.97 85.06 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.413 0.685 . . . . 61.43 110.456 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.537 HD13 HG21 ' D' ' 64' ' ' VAL . 93.4 mt -62.79 -52.18 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.755 -1.111 . . . . 63.31 111.101 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.416 HG21 ' HE2' ' B' ' 109' ' ' TYR . 96.8 m -56.13 -41.03 74.69 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.891 1.277 . . . . 60.22 111.119 -177.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 30.6 t -66.72 -43.45 84.23 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.621 -1.172 . . . . 61.24 109.818 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.432 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 74.4 mtm -65.7 -33.03 74.93 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.088 0.555 . . . . 72.4 111.874 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.513 HG23 ' O ' ' D' ' 114' ' ' ILE . 76.4 t -64.68 -45.71 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.432 1.093 . . . . 60.24 109.945 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 82.5 p -75.58 -28.36 58.92 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 115.503 -0.771 . . . . 54.45 111.053 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' D' ' 116' ' ' SER . 78.0 mtt-85 -72.63 -29.11 63.19 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.374 0.67 . . . . 72.04 109.805 174.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.63 9.64 75.17 Favored Glycine 0 C--N 1.353 1.494 0 O-C-N 123.849 0.718 . . . . 75.34 112.29 173.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.554 HG23 ' HB3' ' C' ' 17' ' ' TYR . 44.8 p 60.06 20.01 9.19 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 126.533 1.933 . . . . 54.42 114.476 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -82.19 155.24 69.72 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.418 0.687 . . . . 74.45 109.66 171.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.01 132.4 49.27 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.642 2.228 . . . . 44.14 111.221 174.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -49.76 130.47 21.2 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.195 1.398 . . . . 72.14 112.499 -174.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.456 HD22 ' HZ ' ' D' ' 74' ' ' PHE . 17.8 tp -117.51 96.44 5.4 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.908 0.483 . . . . 74.3 109.783 -172.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -99.9 104.45 16.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.579 0.752 . . . . 72.33 109.245 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.42 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 6.6 mp -69.92 115.39 9.09 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.293 0.637 . . . . 63.42 109.813 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.73 126.93 86.37 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 122.898 0.479 . . . . 50.44 110.196 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -73.35 133.25 18.93 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.504 2.136 . . . . 63.44 111.855 -171.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 89.3 t . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 108.473 -0.936 . . . . 74.25 108.473 179.349 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.567 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 25.5 t80 . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 109.274 -0.639 . . . . 73.51 109.274 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -144.67 112.9 6.48 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.991 0.916 . . . . 71.44 109.05 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.648 HG12 ' HD2' ' A' ' 84' ' ' PHE . 43.0 mt -77.88 115.06 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 109.702 -0.481 . . . . 64.44 109.702 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -73.39 -27.96 61.75 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 123.801 0.688 . . . . 52.52 111.1 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.2 ttt85 -177.57 149.01 0.6 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 123.265 0.353 . . . . 72.51 111.448 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.48 HD12 ' HB3' ' C' ' 130' ' ' PRO . 91.6 mt -137.23 130.63 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.239 -1.022 . . . . 71.51 108.239 168.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.496 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 35.1 p90 -166.14 157.63 13.62 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 124.19 0.931 . . . . 74.3 110.484 -168.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.3 p -83.28 109.82 17.58 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.773 -1.103 . . . . 75.44 108.375 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 35.3 mtpt -75.05 -38.3 61.43 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.083 -0.71 . . . . 62.22 109.083 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.525 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 31.4 t70 -140.33 136.48 33.25 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 113.93 -1.486 . . . . 70.15 109.617 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.4 mt -130.23 144.73 37.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 125.406 1.482 . . . . 65.23 107.043 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.498 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 48.3 t -148.82 130.28 14.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.815 -0.809 . . . . 74.23 108.815 174.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -134.72 142.08 46.67 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.375 -1.343 . . . . 74.2 107.375 173.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -141.45 151.16 43.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.446 -0.946 . . . . 74.22 108.446 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.52 81.22 17.66 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 106.905 -1.517 . . . . 74.45 106.905 171.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.16 -46.39 33.91 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.589 2.859 . . . . 71.01 114.303 -166.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.18 37.56 3.97 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.549 -0.908 . . . . 74.53 108.549 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.599 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -40.18 -57.26 2.92 Favored Pre-proline 0 CA--C 1.569 1.686 0 N-CA-C 114.274 1.212 . . . . 51.34 114.274 -172.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.599 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 27.9 Cg_exo -62.17 -29.69 81.05 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.042 1.828 . . . . 74.25 114.006 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -83.0 -32.64 26.84 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.689 0.796 . . . . 75.24 111.347 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.702 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.2 p -77.52 -22.31 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.542 0.737 . . . . 53.32 111.265 -166.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -71.47 -22.38 61.82 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.708 -0.678 . . . . 74.13 110.773 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -80.83 -21.61 40.67 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.284 1.033 . . . . 70.1 110.633 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -82.03 170.8 15.13 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.149 0.98 . . . . 62.1 111.568 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -88.3 131.54 34.75 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.687 0.795 . . . . 75.02 110.044 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.454 ' CE3' HD21 ' A' ' 68' ' ' LEU . 66.4 t-105 -84.47 85.53 7.39 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 121.582 0.706 . . . . 72.32 111.058 -176.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -135.16 80.63 46.76 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 107.225 -1.398 . . . . 54.23 107.225 167.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -82.01 154.24 17.09 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.666 2.244 . . . . 73.12 112.658 -173.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -102.41 85.85 2.7 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.782 -1.562 . . . . 72.34 106.782 170.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 65' ' ' THR . 55.7 t -78.89 97.26 2.33 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 CA-C-N 115.54 -0.755 . . . . 75.52 109.965 -173.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.495 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 56.8 mtpt -79.39 124.18 28.19 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.127 -0.942 . . . . 74.04 109.196 174.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -97.71 108.37 21.07 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 105.922 -1.881 . . . . 52.41 105.922 169.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.782 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 15.0 m-20 -104.5 117.68 34.75 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.628 -0.878 . . . . 52.22 108.628 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -97.53 122.41 40.56 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.892 0.877 . . . . 64.35 109.512 -171.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -136.22 139.36 42.7 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.296 0.638 . . . . 75.05 109.404 172.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.1 p -111.98 136.94 50.66 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.661 0.784 . . . . 74.31 110.239 -175.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.08 110.82 5.64 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 108.341 -0.985 . . . . 62.04 108.341 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 p -132.0 152.04 51.38 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.947 -0.471 . . . . 73.54 109.931 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -152.36 132.38 13.42 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.155 0.582 . . . . 62.31 110.982 -170.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -75.11 126.05 30.21 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 108.936 -0.764 . . . . 75.45 108.936 172.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.411 HD12 HG23 ' A' ' 83' ' ' ILE . 76.1 mt -97.99 -33.24 11.27 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.723 0.409 . . . . 63.01 110.387 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.4 -176.15 5.44 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.178 0.991 . . . . 53.41 110.014 176.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.61 124.2 21.27 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 108.631 -0.877 . . . . 64.22 108.631 169.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 65.04 11.79 7.4 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.465 1.106 . . . . 62.41 112.62 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.405 HG12 ' HB2' ' A' ' 51' ' ' LEU . 61.2 t -123.06 122.59 65.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 107.938 -1.134 . . . . 62.54 107.938 174.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -140.06 169.01 18.49 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.103 -0.702 . . . . 73.11 109.103 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -129.92 127.31 39.87 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.197 -0.91 . . . . 74.51 108.807 176.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.558 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 91.9 t -102.52 120.91 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.509 -1.293 . . . . 61.42 107.509 168.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.499 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 25.9 t -107.76 131.24 58.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 107.408 -1.331 . . . . 74.14 107.408 168.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 tt -119.24 107.49 13.48 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.627 -0.879 . . . . 64.4 108.627 176.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -84.47 102.09 12.55 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.373 1.069 . . . . 72.11 109.366 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.4 t -98.41 102.51 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 108.196 -1.038 . . . . 72.03 108.196 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.782 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 33.2 m -94.82 108.02 20.04 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.976 -1.12 . . . . 75.51 107.976 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.3 t -103.22 110.23 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.218 0.607 . . . . 73.24 109.698 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 11.6 m -100.56 141.18 33.78 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.304 -0.998 . . . . 72.31 108.304 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.89 119.21 20.85 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.239 -1.023 . . . . 64.3 108.239 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.3 m -130.02 126.9 38.82 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.451 0.469 . . . . 72.14 110.724 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.454 HD21 ' CE3' ' A' ' 36' ' ' TRP . 29.6 mt -87.4 80.86 8.01 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 124.722 1.209 . . . . 74.44 109.163 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.5 -84.05 0.87 Allowed Glycine 0 C--N 1.34 0.782 0 CA-C-N 116.168 -0.469 . . . . 71.32 112.038 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -112.63 -27.9 8.02 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.368 0.667 . . . . 74.43 111.403 177.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -95.86 122.47 38.69 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 122.062 -0.399 . . . . 74.03 111.154 -173.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.3 m -65.77 126.8 29.61 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.06 0.457 . . . . 71.41 110.283 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.702 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -78.8 -56.77 4.15 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 114.975 -1.012 . . . . 72.24 109.531 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -159.45 172.71 17.4 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.601 -1.181 . . . . 63.3 111.257 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.9 tp -131.54 139.37 49.23 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 107.5 -1.296 . . . . 75.21 107.5 167.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 59.3 m -138.31 95.47 3.01 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.827 -0.805 . . . . 75.14 108.827 175.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 33.9 tt0 -105.61 121.16 43.4 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.407 0.683 . . . . 74.21 109.293 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.2 t -129.59 112.47 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.158 0.504 . . . . 72.24 110.008 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -84.78 88.82 7.41 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.43 -0.952 . . . . 72.42 108.43 172.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -80.01 96.91 6.58 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.452 -0.794 . . . . 74.23 109.407 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.9 151.25 24.8 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 115.944 -0.571 . . . . 23.51 112.085 177.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.413 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -152.77 122.01 1.24 Allowed Glycine 0 CA--C 1.504 -0.631 0 N-CA-C 111.006 -0.837 . . . . 72.43 111.006 176.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.411 HG23 HD12 ' A' ' 51' ' ' LEU . 46.4 mt -82.1 122.97 37.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 108.188 -1.042 . . . . 71.35 108.188 173.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.648 ' HD2' HG12 ' A' ' 13' ' ' ILE . 22.6 m-85 -124.96 147.98 48.63 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 109.109 -0.7 . . . . 75.03 109.109 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.2 m -113.98 122.77 47.94 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.476 -0.935 . . . . 51.51 108.476 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.549 0.921 0 N-CA-C 108.555 -0.906 . . . . 71.44 108.555 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.804 0.335 . . . . 74.11 110.921 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -67.49 -27.71 67.24 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.918 -0.583 . . . . 71.34 110.732 172.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.519 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 58.3 m -76.78 -63.91 1.24 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 122.71 0.404 . . . . 54.1 110.404 177.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.21 -30.65 71.15 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.978 0.911 . . . . 75.13 112.28 -171.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.42 -1.28 40.75 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-O 119.115 -0.825 . . . . 64.1 114.389 -172.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.86 -59.82 0.23 Allowed 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.985 1.106 . . . . 72.52 113.985 -173.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.519 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 80.1 t80 -74.15 -55.33 6.2 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.167 0.587 . . . . 72.12 111.491 -169.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 79.3 m -65.58 -36.24 14.02 Favored Pre-proline 0 CA--C 1.567 1.632 0 N-CA-C 113.084 0.772 . . . . 74.34 113.084 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.02 -46.65 27.13 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 122.68 2.253 . . . . 70.43 113.735 160.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -69.44 -27.68 65.46 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.546 0.739 . . . . 74.12 110.432 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.62 -38.59 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 C-N-CA 123.382 0.673 . . . . 64.1 110.22 173.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.413 HD21 ' HA3' ' A' ' 82' ' ' GLY . 70.2 mt -76.8 -22.96 52.9 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.616 0.766 . . . . 75.44 112.36 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -61.12 -45.67 95.95 Favored Pre-proline 0 CA--C 1.567 1.607 0 N-CA-C 114.387 1.254 . . . . 73.2 114.387 -171.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -62.6 -34.79 73.55 Favored 'Trans proline' 0 C--N 1.384 2.435 0 CA-C-N 121.676 1.634 . . . . 73.11 113.038 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -70.37 -43.59 69.82 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.229 0.612 . . . . 72.22 111.078 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.11 -36.7 80.19 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.991 -0.55 . . . . 71.03 110.484 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.515 ' NH1' HD12 ' C' ' 105' ' ' ILE . 28.7 ttm180 -54.58 -56.78 15.38 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.859 0.863 . . . . 70.13 109.903 172.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.09 -43.39 95.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.956 0.902 . . . . 73.52 111.768 -174.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 38.2 t -59.51 -42.56 92.49 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.785 0.678 . . . . 43.04 110.613 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.3 mt -68.24 -47.61 77.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 115.497 -0.774 . . . . 72.41 110.328 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 60.2 m -55.49 -41.42 72.99 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.96 0.904 . . . . 63.14 111.527 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.0 t -70.79 -44.61 66.28 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 114.994 -1.003 . . . . 53.32 110.381 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 21.1 mtp -61.6 -41.47 97.49 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.543 0.737 . . . . 71.34 111.727 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.16 -45.87 97.73 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 123.931 0.892 . . . . 71.54 110.503 175.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 26.0 t -72.28 -30.17 64.57 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.706 -0.679 . . . . 55.11 111.764 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -74.77 -28.62 60.83 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.334 0.653 . . . . 71.31 109.572 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.3 15.83 37.58 Favored Glycine 0 C--N 1.352 1.444 0 O-C-N 123.831 0.707 . . . . 62.15 113.04 172.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.434 HG21 ' HE ' ' B' ' 15' ' ' ARG . 3.0 t 59.94 12.56 3.16 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 127.054 2.142 . . . . 71.31 113.685 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -79.8 147.44 66.61 Favored Pre-proline 0 C--O 1.244 0.781 0 C-N-CA 123.25 0.62 . . . . 62.51 109.502 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.03 141.47 98.34 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.651 2.234 . . . . 60.54 111.748 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -56.28 143.11 35.2 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.029 1.122 . . . . 75.0 114.029 -168.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.1 tp -129.14 113.79 15.53 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.451 1.1 . . . . 61.03 109.195 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -112.75 126.2 55.15 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.381 0.672 . . . . 72.55 109.823 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.13 134.93 46.03 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.389 -0.597 . . . . 74.54 109.389 172.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.62 143.22 84.67 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 122.666 0.386 . . . . 54.12 110.879 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -61.11 126.85 20.49 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.537 2.825 . . . . 70.42 112.558 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.3 m -129.61 113.56 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 123.641 0.777 . . . . 72.34 109.825 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -95.91 89.58 5.29 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.285 0.634 . . . . 73.43 109.597 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 . . . . . 0 N--CA 1.471 0.611 0 CA-C-N 115.349 -0.842 . . . . 73.53 110.362 176.206 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.645 ' HB3' HG12 ' B' ' 89' ' ' ILE . 5.5 ppp? . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 113.614 0.968 . . . . 71.41 113.614 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 93.8 m -134.03 107.1 7.57 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.897 -0.779 . . . . 71.33 108.897 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.536 ' HB2' ' SD ' ' B' ' 9' ' ' MET . 41.4 t80 -123.53 142.95 50.51 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.536 -0.756 . . . . 70.21 110.057 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.462 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -160.04 140.79 12.09 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.677 0.611 . . . . 72.45 109.61 174.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.539 HD13 HD11 ' B' ' 16' ' ' ILE . 42.8 mt -79.69 125.99 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 108.693 -0.854 . . . . 62.55 108.693 170.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -98.14 -37.31 9.77 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.394 0.678 . . . . 63.43 109.22 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.434 ' HE ' HG21 ' A' ' 122' ' ' THR . 45.4 ttt180 -174.19 144.32 0.95 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.479 -0.782 . . . . 74.11 109.037 -176.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.539 HD11 HD13 ' B' ' 13' ' ' ILE . 96.5 mt -128.23 142.45 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.55 -1.278 . . . . 64.12 107.55 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -168.63 148.91 4.53 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.664 0.745 . . . . 73.52 112.712 -174.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.5 m -73.72 124.87 26.84 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.147 -1.388 . . . . 74.12 108.945 167.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.452 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 37.6 mtpt -98.41 -21.51 16.54 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.635 0.774 . . . . 70.32 110.863 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -165.56 138.64 4.38 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.761 0.663 . . . . 64.23 110.706 -167.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.478 HD12 HG22 ' B' ' 78' ' ' VAL . 48.5 mm -132.96 143.87 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.076 0.951 . . . . 65.11 110.191 174.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.638 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 75.6 m -134.24 136.47 43.66 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 125.911 1.684 . . . . 52.24 107.199 169.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.4 t80 -151.48 114.83 4.8 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.474 -1.306 . . . . 63.31 107.474 165.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -119.31 155.83 31.12 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.379 -0.971 . . . . 63.32 108.379 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.451 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -144.52 86.06 8.27 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 107.766 -1.198 . . . . 64.01 107.766 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.24 -45.79 21.43 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.593 2.862 . . . . 63.11 113.86 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -104.0 24.59 11.12 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.186 0.594 . . . . 72.15 110.849 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.451 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -42.24 -62.73 1.09 Allowed Pre-proline 0 N--CA 1.485 1.283 0 N-CA-C 115.202 1.556 . . . . 74.52 115.202 -165.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 51.9 Cg_exo -53.44 -43.23 59.26 Favored 'Trans proline' 0 C--N 1.39 2.751 0 C-N-CA 122.072 1.848 . . . . 44.41 113.878 -168.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -97.12 -22.43 16.77 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.285 0.846 . . . . 74.45 113.285 -171.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.64 -17.56 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 118.452 0.569 . . . . 52.25 112.06 -173.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -70.48 -15.61 62.82 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 113.305 0.854 . . . . 72.32 113.305 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -61.6 -27.19 68.47 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.152 0.501 . . . . 63.43 109.765 173.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -86.92 80.34 8.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.336 1.054 . . . . 73.23 110.067 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -91.47 90.41 7.64 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.923 -0.581 . . . . 73.0 109.493 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -161.51 -175.64 4.89 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.723 1.209 . . . . 63.23 108.549 172.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -81.32 109.63 14.94 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 122.951 0.501 . . . . 74.51 110.109 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.68 160.22 50.54 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.442 2.095 . . . . 70.52 113.109 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -66.17 112.64 4.03 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.269 0.628 . . . . 65.54 109.63 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 51.5 t -88.86 134.66 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.803 0.841 . . . . 61.41 109.747 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -140.87 118.0 11.26 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 106.532 -1.655 . . . . 64.0 106.532 175.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 pp -114.34 166.58 11.52 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.01 0.433 . . . . 65.4 111.771 -176.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.534 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 14.2 m-20 -147.31 155.87 42.41 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.412 1.085 . . . . 73.41 109.206 174.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -120.98 146.58 46.52 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.31 -0.996 . . . . 62.41 108.31 172.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.602 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 7.4 t70 -137.91 138.19 38.78 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.856 0.862 . . . . 73.14 108.935 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 36.7 p -109.64 127.77 54.77 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.301 0.64 . . . . 72.31 111.166 -175.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.49 142.78 29.53 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.018 0.927 . . . . 74.41 108.622 174.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 35.2 p -144.53 163.62 33.32 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 122.705 0.402 . . . . 73.41 110.855 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 79.6 p -151.1 138.41 19.39 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.875 0.87 . . . . 72.33 109.018 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -96.83 134.06 40.62 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.23 -0.656 . . . . 61.3 109.23 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 46.7 mt -101.12 -39.92 7.44 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.196 0.598 . . . . 70.2 110.64 -175.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.73 -173.98 4.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.388 -0.824 . . . . 53.15 110.449 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.12 121.68 19.68 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.009 -0.996 . . . . 71.41 108.864 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 75.51 -7.5 1.77 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 126.246 1.818 . . . . 71.53 112.584 -175.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 96.1 t -110.87 112.28 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.279 -0.637 . . . . 50.32 109.279 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -119.6 -179.77 3.98 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.572 -0.899 . . . . 72.04 108.572 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -144.05 107.01 4.48 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.988 -1.115 . . . . 73.54 107.988 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 74.1 t -96.83 128.55 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.233 1.013 . . . . 63.33 110.212 -175.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.492 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 12.7 t -118.37 126.28 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.86 0.864 . . . . 72.22 109.563 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.712 HD22 ' HB3' ' B' ' 103' ' ' PRO . 52.2 tp -112.85 115.5 28.56 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.482 -0.933 . . . . 73.44 108.482 164.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.602 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 17.2 ttt180 -92.47 118.22 30.74 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.884 -0.784 . . . . 41.44 108.884 175.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.74 121.21 54.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.361 -0.977 . . . . 71.24 108.361 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.534 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 22.6 m -104.82 143.78 32.67 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.881 -0.785 . . . . 71.54 108.881 177.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 95.0 t -136.29 136.22 49.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 123.785 0.834 . . . . 75.33 108.854 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.8 m -125.86 143.75 50.94 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.609 1.163 . . . . 73.23 108.068 172.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.68 139.2 23.81 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.083 -0.71 . . . . 63.24 109.083 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.54 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 33.2 p -140.37 128.16 21.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.887 -0.597 . . . . 54.51 110.192 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 61.6 mt -96.89 105.42 17.56 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.027 -1.101 . . . . 73.41 108.027 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.26 -111.85 3.52 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 115.663 -0.699 . . . . 75.44 111.644 -173.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -121.76 3.99 10.04 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.781 0.832 . . . . 71.13 110.328 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -113.56 139.02 49.34 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.46 -0.571 . . . . 74.53 109.46 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 94.4 m -67.52 113.41 5.33 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.319 0.581 . . . . 64.42 109.97 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.54 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -70.44 -62.03 1.54 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.258 -1.337 . . . . 75.02 108.331 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -150.22 155.04 39.0 Favored 'General case' 0 C--N 1.347 0.491 0 N-CA-C 112.853 0.686 . . . . 74.25 112.853 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 64.8 mt -123.27 110.94 15.84 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.076 -1.453 . . . . 75.44 107.076 171.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.41 ' SG ' HG23 ' B' ' 114' ' ' ILE . 37.8 t -118.46 139.23 51.74 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 108.809 -0.811 . . . . 75.41 108.809 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.638 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 39.6 tt0 -156.72 131.9 9.15 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.589 -0.522 . . . . 72.12 109.589 -172.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.478 HG22 HD12 ' B' ' 21' ' ' ILE . 98.3 t -128.15 147.91 32.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 123.715 0.806 . . . . 72.33 109.183 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -110.92 103.72 12.25 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.305 -1.368 . . . . 63.12 107.305 165.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.479 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 7.8 tp-100 -92.96 98.99 11.71 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.387 -1.338 . . . . 73.22 107.387 173.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -96.01 171.31 28.42 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.732 -1.122 . . . . 63.33 110.662 173.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.51 137.11 4.18 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 111.275 -0.73 . . . . 32.11 111.275 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 45.4 mt -84.18 127.14 40.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 107.596 -1.261 . . . . 73.14 107.596 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -136.49 142.69 43.54 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.956 0.902 . . . . 75.31 109.159 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 27.3 m -89.13 113.46 24.63 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.03 -1.1 . . . . 45.34 108.03 168.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.494 HD13 ' SG ' ' B' ' 97' ' ' CYS . 0.4 OUTLIER -130.27 107.83 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.329 1.052 . . . . 70.21 108.322 -176.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' B' ' 9' ' ' MET . . . -156.65 171.89 19.54 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.54 1.136 . . . . 75.41 110.286 -177.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.75 -57.18 1.13 Allowed Glycine 0 C--N 1.346 1.094 0 N-CA-C 112.444 -0.262 . . . . 53.42 112.444 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.645 HG12 ' HB3' ' B' ' 9' ' ' MET . 4.2 mm -83.01 156.31 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.216 0.607 . . . . 74.25 110.394 175.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -152.34 -173.31 4.51 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.195 -0.912 . . . . 74.22 110.665 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.71 -120.46 8.15 Favored Glycine 0 C--N 1.351 1.392 0 CA-C-N 115.607 -0.724 . . . . 54.42 113.289 170.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.8 m -83.48 -37.48 23.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.513 0.673 . . . . 75.15 110.643 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -72.61 -23.17 60.9 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.96 -1.018 . . . . 70.4 111.462 -167.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -71.46 -29.8 65.28 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.028 0.531 . . . . 72.0 111.09 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.64 -37.47 78.78 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.481 0.712 . . . . 70.45 110.692 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -75.15 -30.63 60.81 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.355 -0.839 . . . . 62.53 111.321 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.494 ' SG ' HD13 ' B' ' 86' ' ' ILE . 46.1 t -69.41 -66.7 0.55 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 122.296 0.238 . . . . 73.32 111.544 -174.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.471 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.0 pt? -88.32 -3.59 58.82 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.263 -0.898 . . . . 72.31 111.393 -178.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.79 -4.47 59.0 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-O 119.824 -0.431 . . . . 65.52 114.114 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.646 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -148.46 -50.0 0.16 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 117.576 0.688 . . . . 75.33 111.493 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.504 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 46.3 t80 -67.84 -47.83 67.88 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.148 0.579 . . . . 73.04 111.617 -175.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.489 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 59.2 m -66.46 -48.18 56.52 Favored Pre-proline 0 N--CA 1.488 1.468 0 CA-C-O 119.056 -0.497 . . . . 61.11 112.208 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.712 ' HB3' HD22 ' B' ' 60' ' ' LEU . 72.3 Cg_exo -55.77 -29.98 74.13 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.293 1.996 . . . . 64.33 114.283 170.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -66.68 -37.09 84.03 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.686 0.795 . . . . 74.13 110.618 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.28 -42.76 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 123.544 0.738 . . . . 75.04 110.169 175.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.416 HD22 ' HG3' ' B' ' 80' ' ' GLN . 78.7 mt -78.88 -17.21 55.97 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.298 -1.319 . . . . 72.24 111.728 -174.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.431 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 71.9 t80 -56.92 -53.91 60.01 Favored Pre-proline 0 CA--C 1.563 1.464 0 C-N-CA 124.365 1.066 . . . . 70.13 113.372 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 35.5 Cg_exo -63.27 -32.8 72.89 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 121.796 1.664 . . . . 74.21 113.292 -178.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -70.98 -44.01 66.87 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.441 0.697 . . . . 65.45 110.815 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -65.97 -36.79 84.29 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.677 0.391 . . . . 73.1 110.344 175.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -55.5 -56.36 21.09 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 124.311 1.007 . . . . 72.02 110.682 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -60.68 -40.24 91.43 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 123.633 0.583 . . . . 61.34 110.501 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.561 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.8 t -66.37 -38.87 88.54 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 123.505 0.503 . . . . 73.05 111.226 -175.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.41 HG23 ' SG ' ' B' ' 76' ' ' CYS . 97.2 mt -64.71 -52.21 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 123.132 0.573 . . . . 74.05 109.765 174.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 32.3 m -60.72 -32.48 71.74 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.784 0.834 . . . . 44.23 111.493 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.465 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.2 m -65.29 -46.58 79.86 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.852 0.461 . . . . 74.01 110.691 175.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.561 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -69.13 -34.4 74.96 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 123.229 0.331 . . . . 73.11 111.099 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.53 -40.91 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.607 0.763 . . . . 72.55 110.437 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -67.32 -37.04 82.68 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 114.95 -1.023 . . . . 50.11 111.561 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.48 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 85.6 mtt-85 -66.99 -36.38 82.03 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.314 -0.857 . . . . 74.3 109.368 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -83.62 11.65 55.33 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 124.278 0.986 . . . . 71.14 113.496 174.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 50.4 p 56.84 19.58 4.58 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 125.839 1.656 . . . . 62.2 114.648 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -78.9 166.64 40.9 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 123.63 0.772 . . . . 74.25 112.063 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.96 160.14 8.34 Favored 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 123.199 2.599 . . . . 64.33 114.059 171.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.492 HE21 ' ND2' ' B' ' 127' ' ' ASN . 66.7 tp60 -65.37 139.27 58.55 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.527 -0.761 . . . . 53.34 112.443 -173.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 51.5 tp -142.07 119.89 11.92 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.583 0.753 . . . . 73.45 109.667 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.492 ' ND2' HE21 ' B' ' 125' ' ' GLN . 54.2 m-80 -127.51 135.48 50.42 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.117 0.967 . . . . 70.01 108.581 173.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 tt -78.5 124.26 27.94 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 108.743 -0.836 . . . . 74.35 108.743 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.28 141.94 98.23 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.982 0.913 . . . . 71.42 111.993 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.402 ' HG3' HD13 ' D' ' 16' ' ' ILE . 16.4 Cg_exo -65.67 92.76 0.25 Allowed 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.627 2.218 . . . . 54.21 112.709 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.08 120.4 46.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 108.374 -0.973 . . . . 63.54 108.374 172.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -74.44 85.33 2.01 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 108.176 -1.046 . . . . 64.0 108.176 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -69.15 -34.63 75.29 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.109 -1.405 . . . . 72.31 110.765 -173.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . 0.646 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 19.0 t70 . . . . . 0 CA--C 1.536 0.423 0 CA-C-N 114.118 -1.401 . . . . 64.33 110.785 175.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.421 ' CE1' ' HE2' ' C' ' 101' ' ' TYR . 1.1 t80 . . . . . 0 C--O 1.238 0.471 0 N-CA-C 108.512 -0.921 . . . . 74.43 108.512 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -143.49 128.93 19.01 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 108.886 -0.783 . . . . 74.21 108.886 171.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 37.8 mt -79.5 118.64 27.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.693 -0.855 . . . . 73.03 108.693 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.495 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 18.1 mm-40 -89.99 -33.07 16.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.996 -1.002 . . . . 45.21 109.635 -175.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -177.96 149.47 0.57 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.676 0.79 . . . . 54.34 109.353 -175.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 93.8 mt -137.25 140.25 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 107.965 -1.124 . . . . 65.04 107.965 174.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.415 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 21.1 p90 -171.04 167.37 7.23 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 120.796 0.331 . . . . 75.45 111.342 -171.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.5 p -95.69 127.97 42.17 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 109.456 -0.572 . . . . 72.42 109.456 175.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.415 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 16.7 mmtp -79.24 -50.13 11.42 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 122.597 1.189 . . . . 71.35 108.391 172.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 16.6 t70 -139.15 144.37 38.59 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 112.597 -2.092 . . . . 75.12 108.468 -167.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.408 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 81.4 mt -138.38 149.35 24.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 106.767 -1.568 . . . . 51.53 106.767 175.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 43.2 t -157.24 150.32 23.67 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.34 0.656 . . . . 65.44 109.412 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.403 ' CE1' ' HA3' ' C' ' 121' ' ' GLY . 86.4 t80 -152.31 134.48 15.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.55 -1.278 . . . . 71.35 107.55 173.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . 0.436 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 42.2 mt-10 -133.89 110.85 10.01 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.484 0.713 . . . . 74.31 109.696 -176.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.02 79.11 73.66 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 106.979 -1.489 . . . . 63.14 106.979 163.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.19 -21.52 31.39 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.688 2.259 . . . . 70.11 111.947 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.467 ' ND2' ' HB ' ' C' ' 31' ' ' VAL . 22.9 p-10 -102.38 22.12 13.95 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.586 1.155 . . . . 64.11 110.735 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.59 -58.39 4.51 Favored Pre-proline 0 CA--C 1.562 1.405 0 N-CA-C 114.738 1.385 . . . . 50.23 114.738 -169.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -63.2 -35.64 62.41 Favored 'Trans proline' 0 C--N 1.38 2.236 0 CA-C-N 121.889 1.71 . . . . 75.43 112.169 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -69.82 -37.26 76.17 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.193 0.997 . . . . 73.35 112.247 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.722 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.0 p -80.43 -16.69 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 N-CA-C 113.109 0.781 . . . . 54.44 113.109 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-30 -73.47 -23.14 60.04 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.735 -0.603 . . . . 72.24 111.983 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -90.02 17.93 6.36 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.123 0.569 . . . . 74.54 111.764 175.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -109.45 146.84 33.85 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.922 0.889 . . . . 61.22 110.535 -172.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.51 131.41 49.04 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.679 0.792 . . . . 62.12 110.647 173.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -79.48 89.32 5.04 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.467 0.707 . . . . 70.23 110.421 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' C' ' 68' ' ' LEU . 18.7 tt0 -138.42 67.08 45.11 Favored Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 124.062 0.945 . . . . 70.31 109.297 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -90.27 140.4 3.22 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.824 2.349 . . . . 64.44 113.316 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -88.74 101.21 13.79 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.832 -1.173 . . . . 73.04 107.832 166.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.56 97.84 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.779 -0.823 . . . . 54.05 108.779 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.53 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 94.0 mttt -97.97 105.11 17.2 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 114.562 -1.199 . . . . 55.21 108.338 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.499 HD11 HD21 ' C' ' 128' ' ' LEU . 2.8 mm? -85.61 139.68 31.22 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.997 -0.742 . . . . 71.32 108.997 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -141.86 106.69 4.9 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.47 -1.307 . . . . 64.23 107.47 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 8.1 mp -109.02 148.28 31.02 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.256 0.551 . . . . 51.52 110.176 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.538 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 14.1 t70 -130.48 145.22 51.8 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.923 1.289 . . . . 74.12 108.896 -174.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 61.7 p -116.71 112.83 21.76 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.984 0.914 . . . . 55.21 110.432 -167.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.26 143.18 39.95 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.102 0.561 . . . . 72.53 110.945 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 22.1 p -160.72 155.61 24.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.245 0.618 . . . . 73.13 110.657 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 90.1 p -143.96 154.07 42.92 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.489 0.715 . . . . 64.52 110.157 -175.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -84.89 123.23 30.25 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.954 0.502 . . . . 73.42 110.29 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.638 HD11 HD12 ' C' ' 83' ' ' ILE . 25.4 mt -100.23 -41.86 6.91 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.946 -0.761 . . . . 54.23 108.946 172.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.35 -172.68 4.31 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.304 1.041 . . . . 74.13 109.611 177.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.75 117.1 11.83 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.225 -0.898 . . . . 65.51 109.498 173.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 71.95 -5.91 1.6 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.937 1.295 . . . . 64.13 112.78 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 92.2 t -105.9 107.6 23.04 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.396 -0.964 . . . . 74.44 108.396 174.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -127.41 141.3 51.72 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.715 0.806 . . . . 75.34 109.131 -175.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.456 ' HB2' HD11 ' C' ' 51' ' ' LEU . 16.9 tt0 -83.2 111.52 19.01 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.103 -1.408 . . . . 72.23 108.826 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 92.0 t -97.03 119.46 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 108.789 -0.819 . . . . 51.33 108.789 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 33.3 t -123.75 118.21 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.517 0.727 . . . . 70.34 110.477 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 50.0 tp -105.34 110.81 23.31 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.269 -1.011 . . . . 73.02 108.269 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.538 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 0.3 OUTLIER -91.91 107.09 18.96 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.417 -0.586 . . . . 72.21 109.417 178.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.08 131.63 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.3 -1.0 . . . . 61.35 108.3 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 26.7 m -127.77 117.82 22.6 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.919 -0.771 . . . . 61.21 108.919 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.56 HG21 HG21 ' C' ' 114' ' ' ILE . 61.1 t -102.27 114.58 42.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 115.106 -0.952 . . . . 62.15 109.139 -177.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 27.8 m -98.01 137.11 37.3 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.008 -1.108 . . . . 74.03 108.008 170.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.18 109.5 6.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.235 -1.394 . . . . 64.3 107.235 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 62.6 m -131.38 128.63 40.0 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.013 0.435 . . . . 54.34 110.531 -176.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' C' ' 37' ' ' GLN . 10.4 mt -85.51 42.6 0.97 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.303 1.441 . . . . 74.44 110.916 -174.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.48 -89.54 0.54 Allowed Glycine 0 C--N 1.348 1.208 0 N-CA-C 110.898 -0.881 . . . . 72.42 110.898 -173.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.9 -25.58 5.8 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.247 1.019 . . . . 61.55 109.544 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -76.37 120.98 22.35 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.107 1.363 . . . . 75.11 109.157 169.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 85.1 m -75.4 126.71 31.57 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.761 0.71 . . . . 34.14 109.422 171.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.722 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.31 -58.91 3.23 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.13 -0.692 . . . . 63.0 109.13 173.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . 0.451 ' HZ ' ' HG ' ' C' ' 126' ' ' LEU . 34.8 p90 -159.36 169.86 23.07 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.601 -1.181 . . . . 55.21 111.19 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.436 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.0 tm? -130.03 145.99 51.69 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 105.381 -2.081 . . . . 70.43 105.381 169.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.421 ' N ' HD13 ' C' ' 75' ' ' LEU . 46.2 t -144.74 148.91 34.7 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.929 -1.138 . . . . 61.34 107.929 176.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -158.36 124.76 4.71 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 120.695 0.283 . . . . 72.21 110.628 -173.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 90.0 t -133.97 134.11 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.939 0.896 . . . . 70.34 109.139 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -101.31 93.37 5.39 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.354 -0.98 . . . . 63.11 108.354 170.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -81.53 101.49 9.98 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.393 -0.595 . . . . 71.11 109.393 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.16 169.43 45.93 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 115.797 -0.638 . . . . 63.42 112.472 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.51 126.9 1.08 Allowed Glycine 0 C--O 1.237 0.3 0 N-CA-C 111.452 -0.659 . . . . 64.42 111.452 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.638 HD12 HD11 ' C' ' 51' ' ' LEU . 10.7 mm -85.12 121.28 36.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 108.82 -0.808 . . . . 42.43 108.82 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -131.96 139.91 48.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.371 0.669 . . . . 70.52 109.317 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 16.9 p -92.39 114.51 27.08 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 109.19 -0.67 . . . . 70.53 109.19 170.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.39 104.55 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.405 -0.961 . . . . 72.31 108.405 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.01 165.89 25.94 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.845 0.858 . . . . 44.53 110.197 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.9 -59.72 2.07 Favored Glycine 0 C--N 1.344 1.004 0 O-C-N 123.242 0.339 . . . . 74.52 113.351 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 30.5 pt -81.09 162.65 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 122.923 0.489 . . . . 74.44 110.086 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -147.82 174.24 12.03 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.844 0.458 . . . . 72.04 111.191 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.11 -132.41 50.76 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.909 0.756 . . . . 43.14 114.022 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.0 p -64.17 -21.93 66.75 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.788 0.835 . . . . 64.13 112.259 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -65.29 -54.51 28.12 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.507 0.723 . . . . 73.13 110.629 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 10.2 ptp -72.17 -28.16 63.05 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 116.208 -0.451 . . . . 74.14 110.746 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.9 -32.83 74.56 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.226 0.611 . . . . 72.03 110.912 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -79.36 -32.08 43.12 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.592 -0.731 . . . . 71.51 110.795 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -59.84 -48.15 82.85 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.393 0.677 . . . . 74.03 111.29 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.24 -20.07 24.6 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.595 0.358 . . . . 75.32 111.633 176.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.49 -29.68 39.18 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 115.064 0.786 . . . . 30.32 115.064 -172.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.88 -39.6 0.3 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.835 0.826 . . . . 63.02 111.265 -172.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.421 ' HE2' ' CE1' ' C' ' 11' ' ' PHE . 67.3 t80 -74.28 -41.03 61.89 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 113.792 -1.549 . . . . 75.34 112.801 -174.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 90.4 m -76.53 -39.45 2.44 Favored Pre-proline 0 N--CA 1.486 1.325 0 CA-C-O 118.959 -0.544 . . . . 75.42 111.938 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -45.55 -35.76 12.92 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.739 2.292 . . . . 75.44 114.652 163.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -66.13 -40.3 90.53 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.237 0.615 . . . . 74.42 110.205 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.515 HD12 ' NH1' ' A' ' 111' ' ' ARG . 45.5 mm -64.81 -40.56 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.142 0.577 . . . . 75.04 110.159 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 91.6 mt -89.06 -8.09 54.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.905 0.882 . . . . 74.31 112.244 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -59.77 -52.21 75.39 Favored Pre-proline 0 N--CA 1.484 1.257 0 C-N-CA 123.883 0.873 . . . . 72.01 113.165 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.41 -30.14 36.84 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 121.614 1.542 . . . . 75.41 112.969 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -70.46 -48.77 54.26 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.184 0.594 . . . . 75.45 110.624 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.25 -41.67 93.7 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.154 -0.93 . . . . 70.11 109.969 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -55.8 -52.22 64.74 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.261 0.976 . . . . 75.2 110.996 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -67.47 -30.12 69.74 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.035 0.534 . . . . 70.4 110.641 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.2 t -74.34 -32.22 62.72 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.071 0.549 . . . . 72.1 111.179 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.56 HG21 HG21 ' C' ' 64' ' ' VAL . 96.1 mt -75.71 -51.64 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.208 0.603 . . . . 75.32 109.995 176.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 12.1 m -63.96 -31.17 72.26 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 123.347 0.659 . . . . 73.42 110.893 -173.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 40.2 t -58.08 -55.25 37.33 Favored 'General case' 0 C--N 1.351 0.63 0 CA-C-N 115.494 -0.775 . . . . 73.2 109.302 169.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.443 ' HG3' HD12 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.43 -36.57 76.15 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.746 1.218 . . . . 70.44 113.138 -179.304 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.45 HG23 ' O ' ' C' ' 114' ' ' ILE . 91.4 t -62.9 -49.46 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.312 0.645 . . . . 74.25 109.798 176.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 42.7 t -71.83 -25.75 62.1 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.03 -0.986 . . . . 45.32 111.656 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 -70.24 -40.56 74.39 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.362 0.665 . . . . 72.34 109.463 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . 0.403 ' HA3' ' CE1' ' C' ' 23' ' ' PHE . . . -82.14 8.18 61.47 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.871 0.732 . . . . 74.52 112.915 173.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 82.7 p 54.9 63.7 2.05 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.975 1.71 . . . . 75.35 113.087 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -120.94 155.86 57.2 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 124.321 1.048 . . . . 75.3 108.41 169.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -55.76 161.63 7.83 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.335 2.69 . . . . 73.43 113.891 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -55.1 113.14 1.25 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.424 -0.807 . . . . 61.21 112.406 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.451 ' HG ' ' HZ ' ' C' ' 74' ' ' PHE . 2.4 tm? -117.75 90.16 3.27 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.534 -1.284 . . . . 72.2 107.534 -175.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -114.38 132.66 56.14 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.719 0.807 . . . . 71.01 108.995 176.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.499 HD21 HD11 ' C' ' 42' ' ' LEU . 96.2 mt -69.75 144.28 52.78 Favored 'General case' 0 C--O 1.246 0.871 0 O-C-N 123.682 0.614 . . . . 73.34 111.113 176.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.79 148.52 98.19 Favored Pre-proline 0 C--N 1.351 0.669 0 O-C-N 124.006 0.816 . . . . 55.13 109.849 172.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.491 ' HB2' HD12 ' A' ' 13' ' ' ILE . 31.1 Cg_exo -61.64 87.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.51 2.14 . . . . 64.43 113.199 177.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 95.0 t -104.41 107.71 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.371 -0.831 . . . . 72.04 108.923 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -83.46 106.55 15.3 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.076 -1.083 . . . . 63.11 108.076 171.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -48.44 -38.54 20.05 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.843 1.34 . . . . 70.2 113.035 -174.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t70 . . . . . 0 N--CA 1.485 1.289 0 C-N-CA 123.587 0.755 . . . . 61.41 111.25 177.541 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 36.2 m . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 107.349 -1.352 . . . . 74.31 107.349 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -162.76 89.51 0.66 Allowed 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.798 -0.815 . . . . 71.12 108.798 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -113.81 114.98 27.04 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.568 -1.271 . . . . 72.31 107.568 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mt -82.11 115.97 25.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 108.347 -0.983 . . . . 65.25 108.347 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -75.62 -44.2 44.07 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 123.27 0.356 . . . . 74.44 111.224 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.409 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 22.0 ttt180 -166.87 136.4 2.95 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.072 0.397 . . . . 64.15 112.072 -162.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.402 HD13 ' HG3' ' B' ' 130' ' ' PRO . 1.8 mp -115.31 137.5 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 107.92 -1.141 . . . . 73.04 107.92 171.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.409 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 30.6 p90 -159.74 172.24 18.07 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.201 1.001 . . . . 73.14 112.209 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.9 p -113.69 121.91 45.54 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.179 -1.373 . . . . 74.13 108.751 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -90.7 -22.15 21.27 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.048 -0.524 . . . . 53.22 109.75 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -156.85 128.82 7.26 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 114.719 -1.128 . . . . 74.25 108.325 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.443 HD12 ' HG3' ' C' ' 117' ' ' MET . 12.2 mt -128.68 150.47 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 107.866 -1.161 . . . . 73.3 107.866 174.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -154.79 146.16 23.0 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.837 0.827 . . . . 72.34 110.555 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 88.4 t80 -146.15 141.32 27.38 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 105.894 -1.891 . . . . 73.2 105.894 171.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.512 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.1 mt-10 -142.11 143.48 33.06 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.355 -0.979 . . . . 72.14 108.355 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.4 88.08 5.85 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 107.912 -1.144 . . . . 71.44 107.912 173.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.86 -17.4 13.9 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.975 2.45 . . . . 73.15 113.37 -176.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -113.84 12.88 18.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.436 1.095 . . . . 72.33 110.941 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.449 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -38.18 -67.55 0.25 Allowed Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 126.957 2.103 . . . . 54.43 116.492 -160.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.453 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 74.2 Cg_endo -71.86 -26.79 18.54 Favored 'Trans proline' 0 C--N 1.382 2.3 0 CA-C-N 123.22 2.186 . . . . 75.24 114.368 -171.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -86.45 -25.03 25.42 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 117.755 0.252 . . . . 73.42 110.568 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.638 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.5 p -82.14 -16.0 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 122.78 0.432 . . . . 74.25 111.013 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.453 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.3 m-85 -65.24 -22.83 66.92 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.105 0.409 . . . . 73.51 112.105 177.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -65.14 -15.03 61.96 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.036 0.935 . . . . 64.43 111.385 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -94.9 86.53 4.7 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.057 0.943 . . . . 75.34 110.064 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -87.47 90.86 8.53 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.701 -0.681 . . . . 74.43 109.785 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 42.3 p90 -164.76 175.72 9.43 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.022 0.929 . . . . 72.33 109.197 167.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -73.16 111.56 12.1 Favored Pre-proline 0 N--CA 1.474 0.762 0 N-CA-C 109.178 -0.675 . . . . 45.25 109.178 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -62.77 151.52 83.5 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.574 2.182 . . . . 73.44 111.771 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 56.6 mm-40 -62.77 111.67 2.21 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.018 -1.104 . . . . 65.23 108.018 169.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.771 HG13 HG13 ' D' ' 64' ' ' VAL . 57.8 t -104.68 105.19 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.687 0.795 . . . . 73.44 108.92 -175.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -86.72 129.14 34.99 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.69 -0.856 . . . . 74.4 108.69 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -97.68 110.66 23.18 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.696 -1.224 . . . . 70.4 107.696 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.516 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 10.3 t70 -116.31 130.13 56.62 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.081 -1.451 . . . . 60.31 107.081 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.6 mt -122.29 140.27 52.83 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.142 0.496 . . . . 60.11 111.104 -171.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.55 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 11.7 t70 -136.49 139.48 42.34 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.851 1.26 . . . . 63.2 108.112 174.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 45.4 p -104.03 144.75 31.12 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.361 0.664 . . . . 54.44 110.316 -174.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.413 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -160.7 157.32 26.85 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.46 0.704 . . . . 70.14 110.07 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 32.7 p -175.84 167.96 3.06 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.244 0.545 . . . . 71.34 112.178 -178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 62.5 p -156.63 126.65 6.41 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.002 -0.999 . . . . 75.21 108.471 169.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -74.24 121.09 20.73 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.422 -0.584 . . . . 74.04 109.422 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 46.8 mt -90.09 -25.5 20.72 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.273 0.629 . . . . 74.31 110.86 -172.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -172.53 -173.54 1.05 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.028 1.331 . . . . 63.02 109.56 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.87 120.49 12.65 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.886 -0.413 . . . . 73.51 109.886 176.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 69.57 -2.88 1.79 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.964 1.305 . . . . 65.53 112.595 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 97.4 t -110.92 120.06 60.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.432 -1.321 . . . . 74.24 107.432 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -150.36 142.39 23.97 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.385 0.612 . . . . 63.13 109.742 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -88.66 122.69 32.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.166 -1.379 . . . . 73.44 109.3 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 96.0 t -100.48 119.17 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 107.879 -1.156 . . . . 71.11 107.879 173.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.413 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 38.7 t -106.84 131.33 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.316 -0.994 . . . . 55.31 108.316 173.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 15.8 tp -128.58 120.1 26.03 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 109.307 -0.627 . . . . 72.13 109.307 174.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.55 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 28.3 ttm-85 -82.62 99.09 9.35 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.555 -0.906 . . . . 72.11 108.555 177.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 77.1 t -91.25 117.55 34.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.987 -1.116 . . . . 73.21 107.987 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 28.7 m -117.01 135.38 53.74 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.478 -0.564 . . . . 74.13 109.478 -176.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.771 HG13 HG13 ' D' ' 40' ' ' VAL . 41.2 t -128.23 101.21 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.927 1.291 . . . . 74.52 108.684 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 92.8 m -93.04 116.74 29.33 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 107.878 -1.156 . . . . 73.12 107.878 172.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -106.02 133.96 49.9 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.604 -0.517 . . . . 72.21 109.604 -177.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 18.2 m -128.22 123.04 33.24 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.534 -0.543 . . . . 63.44 109.534 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 31.0 mt -108.9 113.22 25.94 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.693 -1.225 . . . . 73.01 107.693 173.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.78 -133.64 21.22 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 123.467 0.479 . . . . 31.3 112.871 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.76 6.82 39.89 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.718 0.807 . . . . 75.11 111.663 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -140.83 174.93 10.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.153 0.502 . . . . 55.45 111.482 -172.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 32.7 m -73.72 135.44 43.64 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.484 1.114 . . . . 73.22 111.322 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.638 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -86.35 -65.27 1.03 Allowed 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.024 -0.732 . . . . 60.33 109.024 168.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -150.36 151.98 33.69 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.593 -1.185 . . . . 75.15 110.894 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 60.9 mt -110.86 109.84 20.19 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.883 -1.155 . . . . 74.04 107.883 171.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.468 ' SG ' HG23 ' D' ' 114' ' ' ILE . 48.1 t -116.9 142.14 47.32 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.607 0.763 . . . . 72.4 109.191 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -157.01 142.68 17.61 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.0 0.52 . . . . 75.15 109.793 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 77.7 t -138.89 139.33 40.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 108.173 -1.047 . . . . 73.05 108.173 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -110.58 87.1 2.45 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 107.3 -1.37 . . . . 75.34 107.3 173.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -80.1 99.53 7.77 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.258 -1.337 . . . . 63.41 109.398 -171.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.29 142.78 16.14 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 110.88 -0.888 . . . . 61.43 110.88 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.11 132.71 4.19 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 111.657 -0.577 . . . . 45.04 111.657 -177.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 60.2 mt -87.94 120.39 36.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 109.236 -0.653 . . . . 33.31 109.236 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -121.15 133.14 55.19 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.179 0.591 . . . . 73.1 109.929 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.9 m -111.37 92.99 4.25 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.747 -0.834 . . . . 54.33 108.747 175.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.47 HD11 HD12 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -123.19 142.71 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.103 0.961 . . . . 75.21 108.622 -176.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.99 160.62 39.52 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 122.967 0.507 . . . . 44.25 111.342 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.62 21.07 52.52 Favored Glycine 0 C--N 1.34 0.759 0 CA-C-N 114.572 -1.195 . . . . 75.44 114.414 171.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.47 HD12 HD11 ' D' ' 86' ' ' ILE . 33.2 mt -134.04 127.88 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 117.287 0.543 . . . . 75.34 109.665 176.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -140.96 171.85 13.49 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.942 0.897 . . . . 62.34 111.097 -171.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.97 -118.77 13.93 Favored Glycine 0 C--N 1.354 1.565 0 CA-C-N 114.944 -1.025 . . . . 63.55 114.861 172.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 20.4 m -86.94 -28.18 22.88 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.343 0.657 . . . . 54.03 111.046 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -68.36 -34.06 75.4 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.78 -0.646 . . . . 54.51 111.025 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -23.3 62.8 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 116.039 -0.528 . . . . 74.12 111.164 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.26 -26.95 68.68 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.86 0.464 . . . . 73.35 110.926 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -78.62 -40.73 33.52 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.843 0.857 . . . . 65.44 111.396 174.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -65.51 -43.97 88.41 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.907 0.483 . . . . 65.2 110.585 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 8.7 mp -67.54 -53.17 30.73 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.365 1.066 . . . . 55.12 109.981 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.81 -3.63 68.5 Favored Glycine 0 C--N 1.342 0.887 0 N-CA-C 115.057 0.783 . . . . 74.41 115.057 -171.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.13 -65.57 0.27 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.046 0.923 . . . . 65.35 112.906 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -61.91 -58.76 6.7 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.955 0.724 . . . . 73.31 112.955 -162.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 75.3 m -63.54 -44.79 82.41 Favored Pre-proline 0 CA--C 1.567 1.626 0 N-CA-C 113.923 1.083 . . . . 74.22 113.923 -175.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.73 -25.49 39.82 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 121.7 1.6 . . . . 73.53 113.132 172.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . 0.565 ' HA ' ' HD2' ' D' ' 107' ' ' PHE . 2.4 t-20 -69.47 -28.7 66.31 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.845 0.458 . . . . 62.13 110.75 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 51.6 mm -65.07 -35.27 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.402 0.681 . . . . 50.42 110.109 171.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.95 -19.04 48.89 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.587 -0.733 . . . . 71.1 112.619 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . 0.565 ' HD2' ' HA ' ' D' ' 104' ' ' ASN . 27.9 m-85 -60.9 -44.36 94.51 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 113.724 1.009 . . . . 71.1 113.724 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -51.14 -44.99 39.38 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 122.519 2.146 . . . . 73.32 114.329 170.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -77.16 -31.66 55.69 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.376 0.67 . . . . 75.13 111.897 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.14 -48.95 71.74 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.075 -0.713 . . . . 52.41 109.075 175.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -54.61 -47.15 73.76 Favored 'General case' 0 C--N 1.352 0.682 0 O-C-N 124.855 1.347 . . . . 74.32 110.937 177.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.35 -46.81 87.0 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.399 0.679 . . . . 72.4 111.311 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 36.4 t -62.05 -42.78 99.54 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.407 0.442 . . . . 71.24 111.238 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.468 HG23 ' SG ' ' D' ' 76' ' ' CYS . 96.9 mt -61.31 -58.3 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.119 0.967 . . . . 61.01 111.114 175.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 89.4 m -55.92 -40.77 73.56 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.569 1.148 . . . . 63.23 112.068 -173.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 44.7 t -65.04 -42.16 94.54 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.573 -0.739 . . . . 75.54 110.707 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.1 mtm -68.46 -31.69 71.17 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.811 0.444 . . . . 73.33 111.452 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.43 HG23 ' O ' ' D' ' 114' ' ' ILE . 73.6 t -63.43 -44.65 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 123.525 0.73 . . . . 64.3 110.373 174.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.7 p -77.77 -25.83 49.37 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.056 -0.52 . . . . 74.14 111.572 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -71.64 -36.27 70.67 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.316 0.647 . . . . 53.23 109.6 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.95 0.24 73.13 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.36 -0.837 . . . . 70.13 112.509 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.6 p 61.37 25.29 15.27 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.642 1.977 . . . . 72.22 113.405 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -80.37 164.13 53.53 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.266 1.027 . . . . 62.43 109.717 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.4 129.82 29.64 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.109 1.873 . . . . 72.55 111.423 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -51.32 123.64 10.09 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.402 1.081 . . . . 62.45 111.577 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -116.41 96.73 5.66 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.98 -1.118 . . . . 41.2 107.98 -174.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -98.66 117.89 34.14 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.897 -0.779 . . . . 74.31 108.897 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 6.4 mp -73.97 113.47 11.18 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 109.686 -0.487 . . . . 73.53 109.686 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -54.51 134.62 62.96 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 124.154 0.982 . . . . 74.21 110.953 176.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.504 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 2.8 Cg_exo -72.94 144.64 38.73 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.875 2.383 . . . . 73.24 111.756 -171.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--O 1.24 0.589 0 C-N-CA 123.643 0.777 . . . . 74.11 109.357 -177.358 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.589 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 26.6 t80 . . . . . 0 C--O 1.235 0.338 0 N-CA-C 109.334 -0.617 . . . . 74.13 109.334 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -143.33 119.58 10.84 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.701 0.8 . . . . 71.4 108.859 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.622 HG12 ' HD2' ' A' ' 84' ' ' PHE . 49.5 mt -80.2 124.6 38.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.513 -0.551 . . . . 74.52 109.513 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.23 -42.28 13.92 Favored 'General case' 0 C--O 1.245 0.848 0 O-C-N 123.993 0.808 . . . . 73.14 109.36 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -173.43 122.36 0.36 Allowed 'General case' 0 N--CA 1.483 1.185 0 O-C-N 123.081 0.238 . . . . 73.44 111.477 -168.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.416 HD11 HD13 ' A' ' 13' ' ' ILE . 94.8 mt -113.79 138.53 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.99 0.916 . . . . 65.33 109.26 175.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HB3' HG23 ' B' ' 122' ' ' THR . 32.3 p90 -167.3 166.69 14.54 Favored 'General case' 0 C--N 1.347 0.496 0 O-C-N 123.902 0.751 . . . . 72.31 111.511 -173.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -89.24 127.29 35.75 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.116 -0.698 . . . . 74.51 109.116 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.402 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 33.6 mtpt -96.52 -21.88 17.43 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 120.913 0.387 . . . . 61.52 109.958 176.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.739 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.0 t70 -152.16 141.27 21.29 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 114.7 -1.136 . . . . 75.01 109.588 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 82.6 mt -141.51 138.29 32.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 106.556 -1.646 . . . . 73.43 106.556 175.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.5 t -144.66 128.32 17.17 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.55 -0.907 . . . . 72.35 108.55 174.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.519 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 87.4 t80 -138.48 124.84 20.49 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.164 -1.421 . . . . 72.24 107.164 175.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -125.59 142.68 51.38 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.915 -0.772 . . . . 64.22 108.915 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.33 71.53 39.15 Favored Pre-proline 0 C--O 1.243 0.755 0 N-CA-C 105.83 -1.915 . . . . 72.44 105.83 168.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.53 -15.16 34.18 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.39 2.06 . . . . 73.22 112.181 -170.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -117.18 21.6 13.07 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 118.169 -0.92 . . . . 73.0 109.495 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.413 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -45.37 -59.17 4.72 Favored Pre-proline 0 N--CA 1.495 1.804 0 CA-C-O 117.998 -1.001 . . . . 61.12 113.329 -171.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -72.16 -9.44 24.46 Favored 'Trans proline' 0 C--N 1.381 2.288 0 CA-C-N 121.629 1.617 . . . . 64.43 112.783 -176.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -90.31 -39.46 12.71 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.858 0.863 . . . . 75.44 110.251 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.859 HG21 ' HA ' ' A' ' 73' ' ' ALA . 6.5 p -79.21 -23.17 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 114.906 -1.043 . . . . 73.31 112.059 -162.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -67.48 -21.12 65.53 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.094 0.558 . . . . 74.22 110.928 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -74.46 -39.23 62.66 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.141 0.976 . . . . 74.13 110.307 173.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.511 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 3.3 tmtp? -69.01 143.35 54.37 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.71 1.204 . . . . 72.01 110.374 -169.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.511 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 12.9 m-20 -57.82 121.5 10.62 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.098 0.959 . . . . 74.14 110.843 175.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -77.7 90.66 4.0 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.191 0.597 . . . . 73.21 110.691 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.403 ' H ' HD22 ' A' ' 68' ' ' LEU . 40.6 tt0 -125.81 82.05 64.7 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 107.582 -1.266 . . . . 74.4 107.582 168.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.0 118.86 4.52 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.327 2.018 . . . . 52.12 112.836 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -95.79 94.67 7.8 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.512 -1.292 . . . . 71.55 107.512 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.433 HG13 HG13 ' A' ' 64' ' ' VAL . 44.0 t -67.7 101.21 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 114.622 -1.172 . . . . 75.23 109.594 -177.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.23 115.76 19.96 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.535 1.134 . . . . 74.43 109.221 175.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -96.8 134.99 39.39 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.123 -0.695 . . . . 74.42 109.123 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.628 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 27.5 t70 -145.07 107.53 4.4 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.31 -0.996 . . . . 55.31 108.31 172.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.64 132.3 48.84 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.957 -0.757 . . . . 74.53 108.957 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.667 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 16.2 t70 -129.72 132.54 46.65 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.876 -0.787 . . . . 75.52 108.876 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.4 p -108.01 137.72 45.52 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.815 0.846 . . . . 61.53 110.158 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.57 139.28 18.84 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.745 0.818 . . . . 73.43 110.066 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.7 m -132.53 156.03 47.55 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.844 0.457 . . . . 73.13 110.472 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.3 t -148.8 118.12 6.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.149 0.979 . . . . 74.34 108.739 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 46.5 tt0 -76.93 122.53 25.0 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.95 -0.759 . . . . 64.13 108.95 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 57' ' ' GLU . 75.7 mt -95.11 -31.72 13.43 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.528 0.731 . . . . 43.04 111.774 -172.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.52 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -155.8 -179.45 8.13 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.454 0.701 . . . . 73.34 110.008 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -65.88 117.7 8.63 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.901 -0.777 . . . . 64.24 108.901 172.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 65.96 18.24 11.01 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.828 1.251 . . . . 71.42 112.083 -178.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 58.4 t -126.22 121.94 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 108.391 -0.966 . . . . 64.34 108.391 174.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -129.02 172.29 11.53 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.259 0.552 . . . . 72.54 109.584 174.049 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.407 ' HB2' HD11 ' A' ' 51' ' ' LEU . 35.7 tt0 -127.55 132.5 49.87 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.135 -0.938 . . . . 71.23 108.62 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.547 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 77.0 t -107.28 119.8 57.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 107.474 -1.306 . . . . 61.45 107.474 173.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.2 t -115.74 129.35 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 108.813 -0.81 . . . . 73.33 108.813 174.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tt -128.21 116.58 20.11 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.582 -0.896 . . . . 70.35 108.582 -176.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.667 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 15.6 ttm180 -84.34 106.06 15.66 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.43 1.092 . . . . 71.33 109.433 176.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.6 t -98.74 101.38 12.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 107.581 -1.266 . . . . 65.02 107.581 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 21.1 m -98.28 107.08 19.46 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.622 0.769 . . . . 71.53 109.076 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.433 HG13 HG13 ' A' ' 40' ' ' VAL . 8.2 t -113.38 109.1 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.231 1.012 . . . . 71.12 109.456 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -104.09 130.88 51.82 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 108.044 -1.095 . . . . 74.14 108.044 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.1 109.95 21.79 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.006 -1.479 . . . . 74.51 107.006 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.7 m -114.06 125.13 53.63 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.135 0.493 . . . . 41.12 110.019 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.403 HD22 ' H ' ' A' ' 37' ' ' GLN . 25.9 mt -93.36 76.14 4.51 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 107.896 -1.149 . . . . 71.45 107.896 176.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.38 -84.67 0.95 Allowed Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.414 -0.674 . . . . 64.23 111.414 -175.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -123.46 -25.28 4.42 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.29 1.036 . . . . 74.22 110.124 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -79.05 107.72 12.01 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.511 0.724 . . . . 73.11 109.98 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.5 m -66.14 130.68 44.08 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.113 0.483 . . . . 73.43 110.386 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.859 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -81.89 -58.96 2.75 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.16 -0.927 . . . . 53.14 109.179 175.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -154.99 169.01 25.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 114.396 -1.275 . . . . 75.33 110.945 176.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 23.8 tp -128.13 132.0 48.96 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.857 -1.535 . . . . 73.22 106.857 169.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.422 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 65.3 m -132.96 95.72 3.62 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.606 -0.887 . . . . 42.22 108.606 176.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -111.92 114.63 27.66 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.49 -0.929 . . . . 74.34 108.49 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -124.67 131.98 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 109.435 -0.579 . . . . 64.03 109.435 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.739 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 51.3 mt-30 -103.61 99.09 8.88 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.411 -0.588 . . . . 55.43 109.411 170.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -85.22 114.36 22.27 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.917 -1.038 . . . . 73.04 109.527 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.12 146.71 17.51 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.816 -0.514 . . . . 71.1 111.816 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.579 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -143.29 123.33 2.07 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 112.079 -0.408 . . . . 63.42 112.079 176.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.2 mt -81.98 124.29 38.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.752 -0.833 . . . . 73.12 108.752 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.622 ' HD2' HG12 ' A' ' 13' ' ' ILE . 18.9 m-85 -135.08 135.73 41.45 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.085 -0.709 . . . . 75.03 109.085 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.8 t -99.82 116.02 30.91 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.777 -0.823 . . . . 64.23 108.777 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.581 HD13 ' H ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.95 0 C-N-CA 124.639 1.176 . . . . 74.0 110.155 -173.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.619 0.247 . . . . 62.12 111.227 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -68.98 -31.86 71.02 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 116.044 -0.525 . . . . 73.15 110.634 173.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 42.0 t -68.65 -55.22 12.21 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.891 0.477 . . . . 54.44 110.742 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 pp -76.39 -16.7 59.66 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.42 0.526 . . . . 71.4 112.42 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.48 -7.24 46.06 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-O 119.465 -0.631 . . . . 64.43 114.57 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -144.01 -61.96 0.39 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 117.594 0.697 . . . . 53.44 110.891 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.426 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 70.7 t80 -62.08 -66.06 0.6 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.468 1.107 . . . . 65.14 113.581 -169.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.4 m -64.37 -38.24 31.69 Favored Pre-proline 0 CA--C 1.566 1.594 0 N-CA-C 113.741 1.015 . . . . 74.12 113.741 -175.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -65.3 -27.1 55.79 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 121.672 1.581 . . . . 73.43 113.769 167.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 37.6 t-20 -72.41 -28.53 63.04 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 122.952 0.501 . . . . 72.4 109.744 176.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.505 HG21 ' CD1' ' A' ' 13' ' ' ILE . 49.2 mm -61.92 -40.41 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.457 0.703 . . . . 54.51 109.716 171.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.579 HD21 ' HA3' ' A' ' 82' ' ' GLY . 95.5 mt -77.41 -25.38 50.71 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.386 -0.825 . . . . 71.32 112.239 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -57.2 -45.06 99.96 Favored Pre-proline 0 CA--C 1.57 1.742 0 N-CA-C 113.683 0.994 . . . . 72.41 113.683 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -60.48 -31.63 92.71 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.245 1.963 . . . . 74.43 113.368 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -77.04 -35.63 56.73 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.297 0.639 . . . . 74.21 111.786 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.66 -38.81 84.3 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.478 -0.564 . . . . 62.41 109.478 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.469 HH12 HD12 ' C' ' 105' ' ' ILE . 37.7 ttm180 -64.35 -42.3 96.3 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.675 -1.148 . . . . 74.13 110.549 173.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -53.1 -51.68 61.07 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.142 0.977 . . . . 73.31 110.75 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 30.3 t -66.77 -47.82 71.0 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.569 -1.196 . . . . 61.21 111.173 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.84 -54.69 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.426 0.69 . . . . 62.45 111.041 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.0 m -55.91 -38.62 70.49 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.945 0.898 . . . . 54.25 111.723 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.0 t -65.69 -45.54 82.42 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.03 -0.532 . . . . 71.52 110.221 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.6 mtp -63.03 -39.92 96.18 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.009 0.924 . . . . 72.33 111.927 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.7 t -61.9 -45.65 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.935 0.894 . . . . 60.42 110.501 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.9 t -67.24 -37.89 84.3 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.242 -0.89 . . . . 62.02 111.415 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.498 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 83.6 mtt-85 -70.79 -27.72 64.11 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.34 0.656 . . . . 73.33 110.455 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.55 14.18 47.99 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-O 119.227 -0.763 . . . . 64.51 113.278 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.4 t 58.31 16.47 4.05 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 127.059 2.144 . . . . 72.43 113.47 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -82.53 150.83 64.1 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.471 0.708 . . . . 73.11 110.363 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -55.39 153.6 27.48 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.248 2.632 . . . . 74.12 113.548 174.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.406 HE21 HG21 ' D' ' 122' ' ' THR . 6.0 tp-100 -59.97 132.2 53.21 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.327 1.051 . . . . 73.14 112.552 -171.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.1 tp -131.64 110.42 10.91 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.575 1.15 . . . . 61.24 109.432 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -127.13 114.71 18.08 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 108.401 -0.963 . . . . 73.13 108.401 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.2 mp -67.17 148.85 51.27 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.82 0.448 . . . . 64.12 110.983 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -68.83 128.66 92.78 Favored Pre-proline 0 CA--C 1.551 0.997 0 O-C-N 123.955 0.785 . . . . 71.51 110.256 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.442 ' HG2' ' CE2' ' C' ' 11' ' ' PHE . 10.4 Cg_exo -74.68 111.9 3.43 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 122.955 2.436 . . . . 71.32 112.178 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.4 m -102.29 116.87 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.314 0.645 . . . . 42.01 109.601 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -76.05 91.07 3.07 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 115.543 -0.753 . . . . 74.04 109.469 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 . . . . . 0 N--CA 1.476 0.854 0 C-N-CA 124.279 1.032 . . . . 62.41 110.673 -179.435 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 26.8 ptm . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 115.969 1.841 . . . . 75.31 115.969 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 56.6 m -143.64 123.07 13.13 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 107.232 -1.396 . . . . 74.25 107.232 166.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -131.37 139.36 49.47 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.874 0.87 . . . . 72.42 108.888 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.553 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -155.82 128.98 8.13 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 109.81 -0.441 . . . . 64.33 109.81 174.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.545 HD11 HD13 ' B' ' 105' ' ' ILE . 18.8 mt -77.92 121.5 30.78 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 N-CA-C 108.272 -1.011 . . . . 73.15 108.272 173.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -100.35 -32.77 10.68 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 123.754 0.659 . . . . 70.24 110.056 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -172.37 143.58 1.44 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.959 0.504 . . . . 74.54 109.974 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 84.6 mt -128.34 137.54 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 107.953 -1.128 . . . . 64.5 107.953 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -163.37 160.75 23.95 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-O 121.591 0.71 . . . . 72.21 112.287 -175.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.508 HG21 HD11 ' B' ' 21' ' ' ILE . 91.7 m -92.49 126.98 37.81 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.0 -1.0 . . . . 73.31 108.309 168.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -91.83 -25.51 18.95 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.353 0.661 . . . . 63.54 111.002 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -158.94 135.49 9.34 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 120.679 0.276 . . . . 71.2 111.713 -172.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 44.4 mm -125.74 141.4 45.61 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 C-N-CA 124.809 1.244 . . . . 63.0 109.585 173.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.531 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 46.5 t -138.01 141.76 40.4 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 107.686 -1.228 . . . . 64.32 107.686 175.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -159.28 134.55 8.33 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.66 -1.237 . . . . 61.13 107.66 169.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -137.36 157.84 45.72 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.027 0.931 . . . . 73.32 108.644 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.505 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -143.12 82.03 12.22 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 106.917 -1.512 . . . . 73.11 106.917 172.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.95 -25.32 27.84 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 123.042 2.495 . . . . 62.43 113.53 -169.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -112.75 14.27 19.92 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.663 0.785 . . . . 72.52 110.706 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.508 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -40.78 -62.93 0.85 Allowed Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 115.122 1.527 . . . . 52.44 115.122 -163.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 23.1 Cg_exo -61.3 -33.52 89.41 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 122.252 1.968 . . . . 71.12 112.793 -171.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -95.88 -20.5 18.74 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.358 -0.837 . . . . 61.1 112.633 -173.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.44 HG21 ' HA ' ' B' ' 73' ' ' ALA . 5.0 p -82.34 -11.5 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-N 118.459 0.572 . . . . 73.52 110.749 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -70.12 -14.94 62.88 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 112.879 0.696 . . . . 74.14 112.879 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -68.27 -12.54 61.19 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.046 0.538 . . . . 73.43 111.209 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -104.31 105.81 16.08 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.647 1.179 . . . . 64.42 109.29 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -111.01 92.47 4.06 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.743 -0.836 . . . . 51.44 108.743 175.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 8.1 p90 -159.27 -175.69 5.38 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.91 0.884 . . . . 73.14 109.262 170.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -68.4 110.27 5.49 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 123.899 0.88 . . . . 72.35 110.494 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -67.62 137.28 41.93 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 121.069 1.179 . . . . 74.42 111.334 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.83 110.13 3.18 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 109.09 -0.707 . . . . 75.15 109.09 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 59.3 t -94.5 123.73 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 123.858 0.863 . . . . 70.14 110.692 -174.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -103.45 102.03 11.94 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 106.76 -1.57 . . . . 74.14 106.76 169.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 pp -97.21 148.08 23.45 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.918 -0.583 . . . . 72.1 109.597 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -135.93 154.26 51.17 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.838 1.255 . . . . 55.3 108.056 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 21.1 tp -133.44 126.48 31.28 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.663 -0.865 . . . . 72.4 108.663 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -127.45 147.45 50.3 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.663 1.185 . . . . 75.11 109.972 -172.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 76.0 p -121.9 117.48 26.58 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.056 0.942 . . . . 62.31 110.486 -172.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.13 142.11 44.2 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.906 0.882 . . . . 43.41 108.657 174.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 52.4 p -148.44 176.06 10.61 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.196 0.443 . . . . 73.1 112.196 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 74.9 p -155.79 153.12 29.33 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.299 1.04 . . . . 61.43 109.006 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -102.27 121.52 42.42 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.889 -0.782 . . . . 61.33 108.889 170.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' B' ' 57' ' ' GLU . 18.7 mt -85.21 -50.48 7.35 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.747 0.819 . . . . 71.25 109.764 -173.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.78 -176.1 4.64 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.69 -1.141 . . . . 73.05 109.225 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -59.69 110.49 1.15 Allowed 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.025 0.828 . . . . 70.13 109.32 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 64.11 20.21 12.09 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.278 1.031 . . . . 70.22 112.653 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 79.7 t -116.61 112.93 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 106.868 -1.53 . . . . 64.15 106.868 168.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -129.17 137.02 50.92 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.518 -0.919 . . . . 75.21 108.518 -169.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.473 ' HB2' HD11 ' B' ' 51' ' ' LEU . 4.1 tt0 -101.02 124.82 47.33 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.207 -1.035 . . . . 73.33 108.207 174.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 18.5 m -109.26 134.77 50.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.515 -0.92 . . . . 75.51 108.515 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.78 134.32 54.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.529 -0.915 . . . . 72.11 108.529 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 24.8 tp -115.12 101.18 8.74 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 109.18 -0.674 . . . . 71.21 109.18 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -87.48 117.5 26.31 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 123.014 0.526 . . . . 74.1 109.617 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 18.9 t -107.37 122.0 61.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 107.616 -1.253 . . . . 72.04 107.616 171.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.6 m -114.39 138.01 51.09 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.481 -0.562 . . . . 45.31 109.481 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.669 HG21 HG21 ' B' ' 114' ' ' ILE . 71.0 t -129.2 125.2 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.204 1.002 . . . . 73.35 109.81 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 65.3 m -116.04 146.3 42.29 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.299 -1.371 . . . . 63.15 107.299 162.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.55 139.53 35.03 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.285 -1.006 . . . . 62.22 108.285 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.559 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 34.3 p -140.5 136.22 32.71 Favored 'General case' 0 C--O 1.226 -0.183 0 O-C-N 123.413 0.445 . . . . 65.42 110.667 -175.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 92.5 mt -109.51 109.38 20.17 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.799 -1.186 . . . . 73.35 107.799 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.23 -137.7 20.17 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.78 -0.645 . . . . 72.02 112.271 -173.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -94.57 14.13 21.89 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.18 0.992 . . . . 73.51 110.818 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -132.17 152.14 51.43 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.345 0.658 . . . . 71.51 110.558 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 64.8 m -75.15 125.65 29.39 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.448 0.699 . . . . 41.01 111.224 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.559 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -78.59 -59.17 2.89 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 114.897 -1.047 . . . . 70.23 108.683 176.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -153.25 160.82 42.84 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 115.179 -0.918 . . . . 65.44 112.483 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 59.5 mt -118.84 154.21 33.26 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.496 1.519 . . . . 72.21 107.812 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.405 ' SG ' HG23 ' B' ' 114' ' ' ILE . 42.2 t -161.06 157.5 26.23 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.371 0.668 . . . . 72.0 109.23 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.531 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 34.8 tt0 -166.02 130.77 2.29 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.044 -0.724 . . . . 74.24 109.044 175.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 96.7 t -123.66 143.65 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 108.707 -0.849 . . . . 72.32 108.707 173.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -124.8 96.33 4.84 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.563 -0.903 . . . . 74.0 108.563 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.419 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 8.5 tp-100 -85.72 100.07 11.75 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.568 -0.53 . . . . 74.45 109.568 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.15 144.66 17.19 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 111.357 -0.697 . . . . 60.15 111.357 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.49 131.81 4.35 Favored Glycine 0 C--O 1.236 0.274 0 N-CA-C 111.704 -0.558 . . . . 72.21 111.704 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.7 mt -84.63 126.95 40.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 N-CA-C 108.375 -0.972 . . . . 63.52 108.375 172.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -138.62 149.42 45.19 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.199 -0.667 . . . . 74.41 109.199 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 70.4 m -92.38 120.87 33.32 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.783 -0.821 . . . . 75.31 108.783 170.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.446 HD13 ' SG ' ' B' ' 97' ' ' CYS . 3.9 tp -120.71 118.83 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.438 1.095 . . . . 53.14 109.584 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.56 167.08 30.7 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.196 0.598 . . . . 72.23 109.981 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.14 -67.8 3.07 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.36 -0.382 . . . . 71.11 112.83 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mm -82.25 141.78 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.233 0.613 . . . . 54.54 110.813 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.441 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 11.3 pt-20 -153.09 -175.28 5.26 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.114 0.965 . . . . 65.51 109.803 -173.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.87 -133.74 37.43 Favored Glycine 0 C--N 1.354 1.582 0 C-N-CA 123.471 0.557 . . . . 51.04 113.396 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 55.4 m -66.0 -37.52 86.16 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.952 0.901 . . . . 50.23 110.614 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -67.79 -23.22 65.18 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 115.614 -0.721 . . . . 71.34 111.436 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.441 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 22.5 ttp -65.25 -29.49 70.28 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.966 0.906 . . . . 71.4 111.599 175.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.18 -29.99 71.08 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.764 0.826 . . . . 54.22 111.491 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.493 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 45.6 t-80 -69.42 -30.15 68.03 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.444 0.698 . . . . 63.4 111.427 175.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.446 ' SG ' HD13 ' B' ' 86' ' ' ILE . 44.6 t -79.62 -56.42 4.31 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.458 0.303 . . . . 64.42 111.134 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mp -81.61 -35.6 29.9 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.926 0.491 . . . . 64.35 112.27 -172.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.18 3.87 82.56 Favored Glycine 0 N--CA 1.47 0.961 0 CA-C-O 119.676 -0.514 . . . . 72.52 113.69 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -148.8 -66.88 0.23 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.531 0.567 . . . . 53.42 112.531 -172.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -60.51 -47.9 84.1 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.272 1.029 . . . . 73.2 111.945 -171.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 67.4 m -70.15 -45.5 21.43 Favored Pre-proline 0 CA--C 1.567 1.631 0 CA-C-O 118.339 -0.839 . . . . 62.11 112.241 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -48.07 -40.43 33.81 Favored 'Trans proline' 0 C--N 1.4 3.271 0 C-N-CA 123.137 2.558 . . . . 71.34 114.389 167.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -62.66 -26.06 68.45 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 112.295 0.48 . . . . 71.31 112.295 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.545 HD13 HD11 ' B' ' 13' ' ' ILE . 57.6 mt -84.53 -45.87 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.452 0.701 . . . . 51.12 110.663 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 99.2 mt -82.03 -21.69 36.83 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.329 0.652 . . . . 74.34 112.461 -170.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -57.3 -50.74 86.43 Favored Pre-proline 0 N--CA 1.489 1.497 0 CA-C-O 117.654 -1.165 . . . . 70.22 113.329 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.54 -40.57 83.14 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 122.343 2.029 . . . . 75.34 114.105 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -67.69 -47.98 67.87 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.193 0.597 . . . . 70.31 110.366 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -63.9 -35.59 81.14 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.466 -0.788 . . . . 63.51 111.292 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -59.05 -58.2 9.72 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.366 1.067 . . . . 74.02 110.399 177.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -62.7 -33.03 74.26 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 123.924 0.765 . . . . 74.33 110.178 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.514 ' SG ' HD11 ' B' ' 21' ' ' ILE . 2.0 t -69.64 -38.59 77.21 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 122.902 0.481 . . . . 63.01 111.735 -176.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.669 HG21 HG21 ' B' ' 64' ' ' VAL . 89.4 mt -65.29 -56.02 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.879 -0.786 . . . . 75.01 108.879 172.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 9.7 m -59.43 -27.74 66.31 Favored 'General case' 0 CA--C 1.554 1.101 0 O-C-N 124.579 1.174 . . . . 65.31 111.619 -174.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.5 t -65.55 -48.67 71.62 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 123.682 0.793 . . . . 64.51 109.847 175.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.2 mmt -70.59 -33.96 71.64 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.236 0.614 . . . . 74.31 110.83 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.438 HG23 ' O ' ' B' ' 114' ' ' ILE . 97.8 t -58.12 -45.23 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 124.046 0.938 . . . . 72.44 109.803 172.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 22.6 t -71.8 -30.14 65.2 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.161 -1.381 . . . . 74.22 111.421 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' B' ' 116' ' ' SER . 82.1 mtt-85 -68.76 -31.97 71.39 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.145 -0.48 . . . . 72.02 109.871 175.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.5 6.85 67.01 Favored Glycine 0 C--N 1.355 1.609 0 O-C-N 123.837 0.71 . . . . 73.43 113.116 173.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.49 HG23 ' HB3' ' A' ' 17' ' ' TYR . 59.6 p 59.83 25.84 14.96 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 126.244 1.818 . . . . 73.03 113.166 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -88.39 160.59 44.89 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 123.805 0.842 . . . . 75.41 111.204 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.49 164.65 5.3 Favored 'Trans proline' 0 C--N 1.39 2.759 0 C-N-CA 123.454 2.77 . . . . 65.51 114.834 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.549 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -64.59 132.15 49.0 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.241 1.016 . . . . 75.45 111.302 -178.76 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 49.6 tp -137.9 114.56 10.51 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.134 0.573 . . . . 70.22 109.825 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -128.82 129.5 45.7 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.65 0.78 . . . . 72.11 109.173 174.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mp -82.41 145.42 29.88 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 123.578 0.751 . . . . 63.32 109.225 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.73 133.25 95.02 Favored Pre-proline 0 CA--C 1.554 1.101 0 O-C-N 123.664 0.603 . . . . 71.42 110.929 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.431 ' HG3' HD13 ' D' ' 16' ' ' ILE . 29.4 Cg_endo -63.32 100.23 0.26 Allowed 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.898 2.398 . . . . 62.34 111.859 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 48.8 t -90.42 109.52 20.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 108.58 -0.896 . . . . 74.22 108.58 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -89.86 90.36 8.15 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 107.949 -1.13 . . . . 71.22 107.949 176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -58.55 -35.54 72.49 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.127 -0.942 . . . . 71.34 110.355 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 t70 . . . . . 0 N--CA 1.472 0.634 0 C-N-CA 124.531 1.132 . . . . 63.14 111.097 -174.365 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.442 ' CE2' ' HG2' ' A' ' 130' ' ' PRO . 50.6 t80 . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 108.817 -0.809 . . . . 73.22 108.817 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -150.61 140.1 21.5 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.632 -0.507 . . . . 74.22 109.632 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.413 HG12 ' HE2' ' C' ' 84' ' ' PHE . 43.5 mt -83.38 127.14 40.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.828 -0.804 . . . . 75.12 108.828 173.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.472 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 23.5 mm-40 -92.34 -40.0 11.16 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 123.666 0.604 . . . . 74.14 109.639 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -176.74 124.66 0.16 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.378 0.671 . . . . 75.41 109.812 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.5 mt -110.23 148.22 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 108.454 -0.943 . . . . 74.21 108.454 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -173.61 160.02 3.69 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.046 0.938 . . . . 73.23 109.235 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . 0.628 HG22 HE22 ' C' ' 80' ' ' GLN . 76.8 p -81.18 107.78 14.27 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.199 -0.667 . . . . 71.11 109.199 176.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt -65.27 -47.72 75.71 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.822 0.82 . . . . 71.22 109.262 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.3 t70 -143.33 144.54 32.13 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.114 -1.403 . . . . 73.41 109.513 -174.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.3 mt -139.13 147.12 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.229 1.411 . . . . 73.21 107.335 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -157.25 150.8 24.12 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.32 0.648 . . . . 42.33 110.008 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -151.91 149.03 28.49 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.713 -1.217 . . . . 52.13 107.713 171.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -147.5 149.55 32.86 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.112 1.365 . . . . 62.41 107.617 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.8 84.72 3.73 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 107.316 -1.364 . . . . 71.34 107.316 169.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.65 -38.3 73.08 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.228 2.619 . . . . 73.41 113.139 -173.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -107.18 19.71 20.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.812 0.845 . . . . 53.21 110.999 -172.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.467 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -45.94 -58.33 6.47 Favored Pre-proline 0 CA--C 1.562 1.426 0 CA-C-O 117.355 -1.307 . . . . 52.41 114.259 -170.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 49.5 Cg_exo -54.55 -47.46 26.7 Favored 'Trans proline' 0 C--N 1.389 2.694 0 C-N-CA 122.106 1.871 . . . . 71.51 112.255 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.516 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.9 t60 -71.38 -32.9 69.01 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.11 -0.95 . . . . 70.2 112.843 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.694 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.8 p -77.3 -24.02 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 112.541 0.571 . . . . 72.45 112.541 -169.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -63.44 -26.19 68.62 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.085 0.772 . . . . 71.04 113.085 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 10.4 pt20 -87.53 6.6 33.43 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.017 0.527 . . . . 74.14 111.521 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.719 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -88.38 154.89 20.03 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.937 0.895 . . . . 75.35 110.509 179.246 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -66.13 128.2 35.17 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.509 -0.768 . . . . 73.5 109.067 165.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -78.69 90.18 4.59 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.388 0.675 . . . . 74.24 110.796 -174.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -132.96 76.99 69.35 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 124.275 1.03 . . . . 75.4 108.927 174.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -85.83 123.43 2.43 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.521 2.147 . . . . 61.51 112.295 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -83.26 83.68 7.77 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 106.788 -1.56 . . . . 64.11 106.788 167.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 5.6 p -71.83 116.24 13.36 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 CA-C-N 114.081 -1.418 . . . . 54.14 110.787 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -108.24 102.51 11.63 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.298 -1.001 . . . . 73.0 108.298 173.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.65 137.44 32.33 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.305 -0.628 . . . . 70.32 109.305 176.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.433 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 16.0 t70 -119.59 147.72 44.17 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.384 1.074 . . . . 73.52 108.141 -177.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 16.3 tp -130.0 112.5 13.54 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.148 0.499 . . . . 74.2 110.01 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.613 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 13.5 t70 -113.73 154.08 27.93 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.156 1.382 . . . . 75.55 109.153 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 34.0 p -135.32 132.12 37.29 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.489 0.716 . . . . 60.12 110.48 -173.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.46 154.7 48.45 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.918 0.887 . . . . 73.42 109.288 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 48.3 p -160.99 146.68 14.47 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.799 0.333 . . . . 64.04 111.811 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 68.1 p -150.11 133.38 16.37 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.064 0.946 . . . . 74.23 109.154 174.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -76.98 120.82 22.63 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.315 0.646 . . . . 74.01 109.897 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.531 HD11 HD12 ' C' ' 83' ' ' ILE . 26.2 mt -94.1 -30.25 14.76 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.154 0.582 . . . . 53.52 110.517 -177.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.33 -178.92 6.99 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.299 1.04 . . . . 70.12 109.882 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.25 113.05 2.95 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.731 -0.668 . . . . 74.14 109.978 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . 0.439 ' HA ' ' HE1' ' C' ' 56' ' ' TYR . 3.6 m-20 63.26 18.63 11.13 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.536 1.134 . . . . 72.5 112.503 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 83.9 t -115.4 114.47 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.131 -1.063 . . . . 65.25 108.131 170.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . 0.439 ' HE1' ' HA ' ' C' ' 54' ' ' ASP . 83.4 m-85 -126.64 134.29 50.78 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.921 0.888 . . . . 64.34 109.018 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.529 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.2 tt0 -84.58 114.3 21.88 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.082 -1.081 . . . . 71.14 108.082 170.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.9 t -95.93 124.22 48.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 107.693 -1.225 . . . . 74.45 107.693 173.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 94.9 t -117.66 133.27 64.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 107.759 -1.2 . . . . 74.24 107.759 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.487 HD13 ' HB3' ' C' ' 103' ' ' PRO . 23.7 tp -127.8 105.76 8.66 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.691 -0.855 . . . . 71.01 108.691 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.613 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 9.2 ttm180 -82.89 122.61 28.47 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.34 -0.615 . . . . 75.15 109.34 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.418 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.2 t -113.83 127.78 71.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.031 -1.1 . . . . 73.42 108.031 171.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 31.5 m -123.5 110.12 14.68 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.017 0.527 . . . . 73.3 109.607 -177.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.495 HG23 HD13 ' C' ' 114' ' ' ILE . 69.3 t -99.72 108.43 22.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 108.883 -0.784 . . . . 71.12 108.883 -177.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.446 HG23 HD23 ' C' ' 75' ' ' LEU . 3.8 m -99.5 126.32 45.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.982 -0.748 . . . . 53.11 108.982 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.38 106.69 13.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.307 -0.997 . . . . 63.32 108.307 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 22.1 m -127.02 129.46 48.1 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.814 -0.81 . . . . 71.33 108.814 175.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.719 HD13 ' HG2' ' C' ' 34' ' ' LYS . 8.1 mt -85.09 32.64 0.54 Allowed 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 125.109 1.364 . . . . 51.5 110.78 -178.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.81 -108.83 2.36 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 110.728 -0.949 . . . . 75.25 110.728 -171.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.71 -23.06 23.06 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.393 0.677 . . . . 73.34 109.943 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.13 115.83 22.07 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 123.993 0.917 . . . . 70.13 109.48 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 79.3 m -84.39 123.84 30.66 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 118.756 0.707 . . . . 74.12 109.164 169.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.694 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -77.38 -57.32 3.89 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.007 -0.997 . . . . 72.22 109.281 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -157.86 172.48 18.39 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 122.103 0.954 . . . . 72.34 111.639 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.446 HD23 HG23 ' C' ' 65' ' ' THR . 2.4 tm? -135.18 128.36 31.87 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 105.611 -1.996 . . . . 75.03 105.611 170.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.46 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 44.4 t -128.26 143.5 51.03 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.134 -1.061 . . . . 52.21 108.134 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.48 123.29 5.18 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.206 0.316 . . . . 71.11 110.367 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 61.8 t -134.12 125.25 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.457 0.703 . . . . 72.44 109.526 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.604 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 25.8 mt-30 -96.02 98.48 10.41 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.926 -1.138 . . . . 72.23 107.926 172.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.628 HE22 HG22 ' C' ' 18' ' ' THR . 10.0 tp-100 -84.25 121.48 27.56 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.053 -0.522 . . . . 55.01 110.153 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.9 147.23 16.7 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 112.168 -0.373 . . . . 63.53 112.168 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.406 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.75 125.14 1.98 Allowed Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.169 -1.173 . . . . 72.04 110.169 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.531 HD12 HD11 ' C' ' 51' ' ' LEU . 13.1 mm -80.63 127.62 39.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 107.554 -1.276 . . . . 74.52 107.554 174.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.413 ' HE2' HG12 ' C' ' 13' ' ' ILE . 64.6 m-85 -134.42 142.28 47.08 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.976 0.417 . . . . 72.31 110.667 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 11.5 p -96.28 107.61 19.99 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 108.246 -1.02 . . . . 51.55 108.246 168.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 69.9 mt -115.36 116.47 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.368 1.067 . . . . 73.45 109.245 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.08 172.38 18.51 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.749 0.82 . . . . 63.22 111.181 -171.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.46 -59.2 0.94 Allowed Glycine 0 C--N 1.349 1.264 0 CA-C-N 116.302 -0.408 . . . . 71.12 113.308 170.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 38.1 pt -94.36 -177.24 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.634 0.774 . . . . 74.22 110.172 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -164.49 155.12 14.78 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 122.974 0.51 . . . . 62.34 110.93 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.04 -130.78 11.69 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 119.25 -0.75 . . . . 65.31 113.845 171.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 21.5 m -55.72 -40.29 72.23 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.5 1.12 . . . . 73.41 111.577 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -56.25 -48.21 77.0 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.404 -1.271 . . . . 73.14 109.817 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.504 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 56.2 ttm -80.33 -27.16 38.41 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 114.822 -1.081 . . . . 73.24 111.234 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.25 81.9 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.53 0.732 . . . . 62.14 111.359 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.549 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 57.8 t-80 -70.75 -28.54 64.77 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.189 -0.914 . . . . 75.03 111.157 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 50.3 t -77.43 -55.33 5.48 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 122.229 -0.294 . . . . 73.24 111.222 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' C' ' 94' ' ' MET . 1.0 OUTLIER -78.09 -22.78 48.45 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 112.968 0.729 . . . . 72.43 112.968 -173.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . 0.439 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -97.59 0.62 59.69 Favored Glycine 0 C--N 1.346 1.089 0 O-C-N 123.403 0.44 . . . . 74.35 112.871 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -140.62 -69.18 0.4 Allowed 'General case' 0 C--N 1.347 0.485 0 C-N-CA 123.344 0.658 . . . . 72.14 110.455 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -65.24 -51.85 58.28 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.496 0.924 . . . . 74.2 113.496 -168.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.459 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 19.9 m -61.63 -47.05 93.61 Favored Pre-proline 0 CA--C 1.564 1.506 0 CA-C-O 118.845 -0.598 . . . . 74.3 112.363 -173.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.487 ' HB3' HD13 ' C' ' 60' ' ' LEU . 21.7 Cg_exo -68.91 -26.11 32.0 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 121.997 1.798 . . . . 71.12 112.971 172.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -72.49 -25.43 61.41 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.447 0.699 . . . . 73.24 110.719 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.469 HD12 HH12 ' A' ' 111' ' ' ARG . 28.7 mm -66.02 -35.27 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.036 0.534 . . . . 74.21 109.586 169.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.406 HD21 ' HA3' ' C' ' 82' ' ' GLY . 84.3 mt -87.18 -17.68 32.11 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.048 0.939 . . . . 75.22 112.452 -176.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -54.39 -50.77 83.15 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 117.534 -1.222 . . . . 73.35 112.863 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -55.24 -36.75 94.12 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.75 2.3 . . . . 73.13 114.594 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -75.46 -44.16 45.65 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.808 0.443 . . . . 72.51 110.55 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.31 -45.74 90.48 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.453 -0.794 . . . . 73.51 109.662 174.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 41.2 ttt-85 -54.26 -51.49 64.39 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.497 1.519 . . . . 71.53 111.506 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.85 -35.58 74.84 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.319 0.648 . . . . 74.44 110.421 -176.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.6 t -71.75 -31.62 66.85 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.005 0.522 . . . . 74.14 110.901 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.495 HD13 HG23 ' C' ' 64' ' ' VAL . 89.4 mt -70.89 -53.47 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.451 0.7 . . . . 73.11 109.661 174.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.9 m -64.35 -28.79 69.94 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.366 0.667 . . . . 64.22 111.249 -176.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.1 t -65.2 -48.63 72.71 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 109.061 -0.718 . . . . 70.33 109.061 173.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.525 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.86 -36.68 84.08 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.508 1.123 . . . . 71.23 112.354 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.426 HG23 ' O ' ' C' ' 114' ' ' ILE . 97.2 t -67.89 -40.89 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.436 0.694 . . . . 74.01 110.094 176.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 48.4 t -70.18 -29.66 66.59 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.162 -0.926 . . . . 75.35 111.371 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.412 ' HD2' ' SD ' ' C' ' 117' ' ' MET . 86.5 mtt-85 -72.26 -32.18 66.44 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.622 0.769 . . . . 74.32 109.598 176.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.17 5.96 69.67 Favored Glycine 0 C--N 1.354 1.564 0 O-C-N 124.014 0.821 . . . . 65.43 112.91 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.497 HG23 ' HB3' ' D' ' 17' ' ' TYR . 76.7 p 57.73 28.3 15.65 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 126.273 1.829 . . . . 73.42 113.278 178.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -88.16 155.38 52.12 Favored Pre-proline 0 CA--C 1.555 1.153 0 N-CA-C 109.213 -0.662 . . . . 75.3 109.213 171.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.39 142.66 29.19 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 123.166 2.577 . . . . 70.3 113.382 172.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.476 ' HA ' HE21 ' C' ' 125' ' ' GLN . 0.0 OUTLIER -59.98 112.27 1.81 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.694 0.798 . . . . 73.31 111.411 -176.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 48.8 tp -113.38 93.08 4.23 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.469 -0.937 . . . . 42.53 108.469 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -91.48 127.84 37.08 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.364 -0.976 . . . . 74.32 108.364 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 89.0 mt -69.54 134.47 48.88 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 123.375 0.422 . . . . 72.33 110.18 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.09 158.73 76.94 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 123.822 0.849 . . . . 74.52 110.751 -178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.467 ' HG3' HG21 ' A' ' 13' ' ' ILE . 23.5 Cg_endo -56.85 112.0 0.97 Allowed 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.918 2.412 . . . . 73.35 112.666 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 p -96.97 107.49 19.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 107.507 -1.294 . . . . 62.33 107.507 170.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -90.86 82.83 5.65 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.812 -1.085 . . . . 72.05 109.121 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -58.61 -44.83 90.06 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.223 0.535 . . . . 64.44 109.566 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 . . . . . 0 N--CA 1.468 0.457 0 CA-C-N 114.453 -1.249 . . . . 62.13 112.127 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 85.4 m . . . . . 0 C--O 1.241 0.62 0 N-CA-C 108.469 -0.937 . . . . 75.43 108.469 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -154.81 108.25 2.86 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.99 -1.115 . . . . 72.14 107.99 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -122.42 119.78 32.0 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.84 -0.8 . . . . 62.21 108.84 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 65.7 mt -68.09 135.52 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 109.872 -0.418 . . . . 74.1 109.872 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.558 HE22 HG13 ' D' ' 55' ' ' VAL . 51.6 mt-30 -101.41 -39.54 7.51 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.069 0.547 . . . . 74.43 111.405 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 15.4 ttt180 -172.03 135.8 0.83 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.706 0.23 . . . . 71.14 111.374 -169.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.431 HD13 ' HG3' ' B' ' 130' ' ' PRO . 3.4 mp -120.6 135.51 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 107.59 -1.263 . . . . 71.05 107.59 167.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.497 ' HB3' HG23 ' C' ' 122' ' ' THR . 37.1 p90 -163.53 168.78 19.66 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.941 0.877 . . . . 70.23 111.301 177.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.2 p -99.15 128.33 45.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.316 -1.311 . . . . 74.52 109.082 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.457 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 39.0 mtpt -104.66 -15.14 15.36 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.025 0.53 . . . . 70.2 110.384 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.729 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 28.3 t70 -158.62 132.66 7.8 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.484 -1.235 . . . . 62.52 108.157 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.525 HG21 ' HE2' ' C' ' 117' ' ' MET . 57.4 mt -138.8 148.14 24.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.545 -1.279 . . . . 73.51 107.545 176.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 27.2 t -154.13 145.42 22.96 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.416 0.686 . . . . 64.2 109.818 173.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.1 t80 -149.97 122.02 8.26 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 105.55 -2.018 . . . . 75.31 105.55 172.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 26.6 mt-10 -130.4 111.54 12.42 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.96 -0.756 . . . . 64.13 108.96 -173.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -116.69 86.22 18.46 Favored Pre-proline 0 C--O 1.241 0.615 0 N-CA-C 108.683 -0.858 . . . . 73.23 108.683 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.77 -39.89 2.24 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.36 2.04 . . . . 71.31 111.727 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -86.72 -3.34 59.03 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.812 1.245 . . . . 74.25 111.31 -176.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.515 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -23.74 -67.95 0.05 OUTLIER Pre-proline 0 C--N 1.361 1.096 0 C-N-CA 127.465 2.306 . . . . 75.43 116.737 -165.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.459 ' HB3' HD11 ' C' ' 83' ' ' ILE . 86.2 Cg_endo -73.64 -29.74 10.44 Favored 'Trans proline' 0 C--N 1.375 1.951 0 CA-C-N 123.133 2.155 . . . . 74.0 113.582 -168.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -87.36 -22.52 25.01 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.623 0.249 . . . . 74.1 110.672 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.515 HG12 ' O ' ' D' ' 28' ' ' ALA . 10.0 p -81.75 -18.1 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 122.866 0.466 . . . . 74.41 110.482 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -65.62 -18.77 65.57 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 112.562 0.578 . . . . 75.22 112.562 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -64.58 -12.35 44.2 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.131 0.972 . . . . 74.14 111.602 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -102.62 106.83 17.57 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.167 1.387 . . . . 71.44 110.463 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -102.96 83.81 2.28 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.998 0.919 . . . . 74.11 110.158 -176.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -158.28 175.65 13.47 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.698 0.799 . . . . 72.22 109.171 169.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -66.5 111.95 8.12 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 123.412 0.685 . . . . 64.44 110.101 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.428 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 73.9 Cg_exo -56.12 119.44 6.62 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.004 2.469 . . . . 55.2 111.649 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -60.56 113.74 2.6 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.561 1.145 . . . . 64.53 110.419 -176.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 71.7 t -97.18 126.1 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.339 0.656 . . . . 74.22 111.226 -169.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.629 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 17.0 tppt? -101.72 110.52 22.52 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.312 -1.736 . . . . 70.42 106.312 166.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.52 114.06 25.69 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.287 -1.005 . . . . 74.01 108.287 -172.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.73 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 11.7 m-20 -107.21 150.06 27.04 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.389 1.075 . . . . 73.35 109.451 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 94.4 mt -129.5 151.02 50.58 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.571 0.748 . . . . 55.42 110.476 -176.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 33.6 t70 -156.88 136.06 11.98 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.795 -1.187 . . . . 54.34 107.795 174.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 41.1 p -107.23 144.43 34.03 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.01 0.524 . . . . 71.43 110.987 -171.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.611 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.44 156.43 41.44 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.931 0.893 . . . . 71.2 109.303 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 10.5 p -172.18 155.78 3.74 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.025 0.53 . . . . 45.32 111.129 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 56.0 p -151.93 123.12 7.68 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.343 -0.844 . . . . 73.34 109.045 175.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -76.64 123.36 26.01 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.956 -0.757 . . . . 64.21 108.956 173.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 35.8 mt -90.01 -31.02 17.38 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.293 0.568 . . . . 64.22 109.997 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -164.5 171.91 13.99 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.304 1.441 . . . . 72.35 108.397 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -68.08 127.25 32.2 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.299 -0.876 . . . . 74.4 108.978 171.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 75.63 -2.85 2.7 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 125.926 1.69 . . . . 74.42 112.494 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.558 HG13 HE22 ' D' ' 14' ' ' GLN . 64.1 t -117.06 115.7 49.73 Favored 'Isoleucine or valine' 0 C--N 1.354 0.783 0 N-CA-C 108.099 -1.075 . . . . 60.35 108.099 172.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -144.38 169.12 18.54 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.516 -0.549 . . . . 73.21 109.516 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -130.04 132.36 46.18 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.105 -0.952 . . . . 61.22 109.568 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 64.2 t -105.94 124.75 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.464 -1.31 . . . . 63.22 107.464 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 20.9 t -114.84 130.02 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.457 -1.312 . . . . 74.44 107.457 172.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' D' ' 103' ' ' PRO . 15.4 tp -125.93 120.55 30.7 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.847 -0.797 . . . . 63.51 108.847 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.565 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 55.3 ttm-85 -83.99 102.78 12.72 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.157 -0.683 . . . . 75.41 109.157 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 71.7 t -91.15 126.86 43.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 107.862 -1.162 . . . . 73.35 107.862 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.73 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 26.8 m -124.14 126.62 46.49 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.486 0.66 . . . . 74.53 110.101 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 53.4 t -111.36 98.69 7.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 124.853 1.261 . . . . 65.41 107.781 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.629 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 31.0 m -95.98 90.04 5.43 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.335 -1.357 . . . . 71.2 107.335 177.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -97.93 148.18 23.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.458 -0.792 . . . . 32.24 110.576 -170.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.48 ' HA ' ' N ' ' D' ' 73' ' ' ALA . 54.8 m -145.34 135.5 23.88 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.259 0.466 . . . . 73.53 112.259 -174.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.467 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 82.0 mt -108.35 105.73 15.54 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.714 0.806 . . . . 54.33 109.151 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.47 -135.68 14.45 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.301 0.376 . . . . 64.43 113.653 175.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.29 5.74 25.6 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.32 0.648 . . . . 74.11 111.616 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -136.93 173.2 11.96 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.243 0.617 . . . . 72.34 110.797 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 37.7 m -66.34 153.08 43.62 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.976 1.31 . . . . 73.23 111.574 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.48 ' N ' ' HA ' ' D' ' 67' ' ' SER . . . -101.67 -65.51 0.97 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.378 -1.341 . . . . 54.13 107.378 168.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -155.21 146.86 23.17 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.478 -1.237 . . . . 74.23 110.246 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.499 HD22 HG23 ' D' ' 65' ' ' THR . 31.7 mt -104.57 111.12 23.69 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.468 -1.308 . . . . 74.12 107.468 172.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.561 ' SG ' HG12 ' D' ' 114' ' ' ILE . 35.0 t -117.26 137.64 52.26 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.621 -0.881 . . . . 73.31 108.621 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -154.86 121.42 5.38 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.646 -0.502 . . . . 74.44 109.646 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 65.4 t -129.47 124.0 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.392 0.677 . . . . 74.11 109.492 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.729 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 22.0 mt-30 -86.95 93.99 9.48 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 107.947 -1.131 . . . . 65.24 107.947 164.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -83.35 105.19 14.1 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.266 -1.013 . . . . 71.23 108.266 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -98.39 150.2 19.32 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-N 116.0 -0.545 . . . . 34.2 112.019 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.497 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -152.78 129.63 2.8 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.76 -0.257 . . . . 41.34 112.511 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.5 mt -91.2 126.89 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 108.211 -1.033 . . . . 61.32 108.211 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -130.68 153.81 48.58 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.639 0.776 . . . . 62.51 110.747 -174.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.3 m -106.71 138.21 43.31 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.504 1.121 . . . . 75.02 108.5 173.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.766 HG12 HD13 ' D' ' 89' ' ' ILE . 8.8 tt -146.4 144.2 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 108.849 -0.797 . . . . 74.11 108.849 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.47 146.62 8.62 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.18 0.592 . . . . 45.53 110.219 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.94 10.4 57.58 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.278 0.361 . . . . 70.32 113.122 -177.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.766 HD13 HG12 ' D' ' 86' ' ' ILE . 3.4 mp -123.65 151.06 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.018 0.927 . . . . 51.42 109.569 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.55 178.36 9.96 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.087 1.355 . . . . 73.23 109.737 174.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.09 -134.0 31.43 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 114.481 0.552 . . . . 64.21 114.481 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 34.6 p -88.88 -12.84 40.66 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.064 0.946 . . . . 74.23 112.419 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -61.7 -40.57 95.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.179 0.592 . . . . 73.31 110.559 177.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -75.61 -20.26 58.68 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.624 -0.716 . . . . 62.31 112.2 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.24 -38.57 91.51 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.935 0.494 . . . . 72.42 110.677 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -78.01 -29.44 49.55 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.397 -0.82 . . . . 72.05 111.056 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . 0.427 ' SG ' HD12 ' D' ' 86' ' ' ILE . 44.3 t -68.5 -52.85 27.66 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 122.895 0.122 . . . . 75.14 111.085 -175.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.2 -22.06 42.27 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 110.612 -0.144 . . . . 74.42 110.612 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.29 -3.52 81.9 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-O 119.697 -0.502 . . . . 73.11 114.079 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.39 -58.76 0.13 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 117.479 0.64 . . . . 62.33 111.774 -177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -66.07 -47.96 72.57 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 112.658 0.614 . . . . 71.43 112.658 -170.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.421 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 44.6 m -67.85 -44.88 42.78 Favored Pre-proline 0 CA--C 1.565 1.523 0 CA-C-O 118.819 -0.61 . . . . 72.11 112.36 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.681 ' HB3' HD22 ' D' ' 60' ' ' LEU . 50.8 Cg_exo -59.12 -28.81 88.81 Favored 'Trans proline' 0 C--N 1.39 2.75 0 C-N-CA 122.54 2.16 . . . . 72.41 113.618 168.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -69.67 -33.57 72.76 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.507 0.723 . . . . 60.3 110.347 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.9 mm -67.33 -33.27 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-O 121.334 0.588 . . . . 74.04 110.212 174.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.497 HD21 ' HA3' ' D' ' 82' ' ' GLY . 65.4 mt -85.22 -15.97 41.83 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.885 0.874 . . . . 73.52 111.883 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -61.38 -48.51 90.84 Favored Pre-proline 0 CA--C 1.567 1.622 0 CA-C-O 118.002 -0.999 . . . . 62.13 113.262 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -59.92 -31.37 93.61 Favored 'Trans proline' 0 C--N 1.388 2.646 0 C-N-CA 122.093 1.862 . . . . 71.5 112.923 177.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -82.24 -32.04 29.92 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.727 0.811 . . . . 74.24 111.803 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.08 -48.1 72.08 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.847 -0.797 . . . . 55.33 108.847 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.449 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 34.4 ttp180 -55.39 -49.61 71.88 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 124.405 1.066 . . . . 73.44 111.141 176.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -64.68 -50.31 67.51 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 123.898 0.749 . . . . 74.41 111.144 -174.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 44.8 t -57.85 -44.39 86.52 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 124.005 0.816 . . . . 71.14 110.801 -178.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.561 HG12 ' SG ' ' D' ' 76' ' ' CYS . 91.4 mt -63.56 -55.34 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.727 0.811 . . . . 73.43 111.119 175.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 77.1 m -57.37 -39.91 77.04 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.146 0.979 . . . . 73.41 111.217 -174.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 86.5 p -66.7 -41.83 87.38 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.402 -0.817 . . . . 74.41 109.533 -177.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 65.3 mtm -69.97 -28.89 65.91 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.151 0.58 . . . . 72.14 111.734 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.487 HG23 ' O ' ' D' ' 114' ' ' ILE . 88.3 t -63.23 -49.18 84.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.23 0.612 . . . . 74.43 109.391 172.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.1 p -73.61 -26.1 60.63 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.867 -0.606 . . . . 63.3 111.039 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' D' ' 116' ' ' SER . 74.1 mtt-85 -71.94 -37.79 69.93 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.492 0.717 . . . . 62.41 109.246 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.78 4.86 77.77 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 115.362 -0.835 . . . . 50.12 112.448 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.406 HG21 HE21 ' A' ' 125' ' ' GLN . 22.4 p 58.7 30.67 20.26 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 126.683 1.993 . . . . 60.35 113.703 173.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -84.75 159.62 57.53 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 123.988 0.915 . . . . 74.24 109.883 171.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.35 126.13 21.32 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.693 2.262 . . . . 73.52 112.136 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -64.51 124.72 22.57 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.889 0.876 . . . . 73.2 111.652 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 7.0 tt -124.59 115.08 20.24 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.125 -1.435 . . . . 73.02 107.125 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -99.59 121.62 41.46 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.907 0.883 . . . . 73.12 108.653 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.449 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 7.3 mp -68.77 113.63 6.39 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 109.897 -0.409 . . . . 75.23 109.897 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -64.7 140.06 97.93 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.017 0.527 . . . . 72.31 110.432 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 9.3 Cg_exo -66.53 126.57 15.72 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.106 1.871 . . . . 74.03 110.708 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.484 1.225 0 C-N-CA 123.27 0.628 . . . . 75.42 110.725 -174.356 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.602 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 48.1 t80 . . . . . 0 C--O 1.237 0.406 0 N-CA-C 110.18 -0.304 . . . . 74.43 110.18 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -160.48 129.34 4.82 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.873 0.869 . . . . 72.54 109.372 173.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.567 ' CD1' HG21 ' A' ' 105' ' ' ILE . 58.2 mt -94.14 122.11 45.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.809 -0.811 . . . . 64.22 108.809 172.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -90.98 -31.15 16.44 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.278 0.361 . . . . 74.42 110.759 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.49 ' HB3' HD12 ' A' ' 83' ' ' ILE . 39.8 ttt180 -167.0 122.19 1.09 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 111.99 0.367 . . . . 72.55 111.99 -169.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.433 HD11 HD13 ' A' ' 13' ' ' ILE . 73.7 mt -115.02 137.14 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 123.842 0.857 . . . . 74.53 109.24 173.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HB3' HG23 ' B' ' 122' ' ' THR . 26.9 p90 -163.01 174.94 11.66 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 123.791 0.836 . . . . 73.11 111.069 -174.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -106.89 118.74 37.49 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.95 -0.759 . . . . 61.11 108.95 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -86.76 -25.75 24.52 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.857 -0.423 . . . . 64.22 109.857 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.696 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 26.3 t70 -145.91 135.39 23.1 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.604 -0.726 . . . . 62.4 109.703 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.7 mt -139.06 140.52 38.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 C-N-CA 125.477 1.511 . . . . 74.21 107.187 176.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -150.35 124.96 9.67 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.235 0.614 . . . . 73.22 109.381 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.428 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 88.1 t80 -124.08 136.6 54.35 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.052 -1.462 . . . . 74.42 107.052 168.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -137.29 135.95 37.58 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.895 0.478 . . . . 64.31 110.069 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.09 74.41 49.7 Favored Pre-proline 0 C--O 1.242 0.696 0 N-CA-C 106.6 -1.63 . . . . 72.55 106.6 167.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.58 -32.09 39.66 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.118 1.878 . . . . 74.51 110.906 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -96.98 19.59 12.53 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.226 -0.897 . . . . 73.14 110.685 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.455 ' HB3' ' HZ1' ' B' ' 19' ' ' LYS . . . -50.31 -45.94 83.51 Favored Pre-proline 0 CA--C 1.567 1.614 0 N-CA-C 114.469 1.285 . . . . 62.12 114.469 -172.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -66.37 -19.51 55.56 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 121.767 1.644 . . . . 33.04 113.479 175.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.45 ' HA ' HE21 ' A' ' 33' ' ' GLN . 5.0 m-70 -97.15 -26.07 15.09 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.01 0.924 . . . . 72.31 111.564 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.585 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.1 p -79.61 -30.26 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 N-CA-C 113.459 0.911 . . . . 74.31 113.459 -158.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -81.75 -23.9 36.4 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.813 0.445 . . . . 73.14 111.189 -171.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.45 HE21 ' HA ' ' A' ' 30' ' ' HIS . 28.9 pt20 -79.91 -11.6 59.79 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.474 0.71 . . . . 74.21 111.038 176.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -81.47 162.3 23.32 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.872 0.469 . . . . 64.05 111.417 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -68.9 126.52 30.04 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.259 -0.882 . . . . 73.22 108.967 173.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 44.3 t-105 -76.4 81.92 3.13 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.762 0.791 . . . . 72.41 109.862 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -130.94 76.19 77.42 Favored Pre-proline 0 C--O 1.246 0.876 0 N-CA-C 107.512 -1.292 . . . . 71.44 107.512 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -85.48 140.22 7.21 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.295 1.997 . . . . 72.23 112.226 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -97.06 101.74 13.37 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.411 -1.329 . . . . 71.12 107.411 169.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 65' ' ' THR . 19.3 t -85.88 93.78 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.846 -0.798 . . . . 74.25 108.846 -176.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -86.12 115.34 23.63 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.531 1.132 . . . . 75.11 109.424 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -97.9 107.81 20.38 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.02 -0.733 . . . . 65.34 109.02 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.55 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 18.1 t70 -106.9 121.75 45.04 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.275 1.03 . . . . 61.24 108.552 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 mp -103.67 145.96 29.29 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.98 -0.378 . . . . 72.11 109.98 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.636 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 23.1 t70 -148.76 159.65 43.94 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.067 0.947 . . . . 53.01 108.847 177.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.6 m -135.44 136.85 41.68 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.571 0.749 . . . . 70.41 110.41 -178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.85 144.07 49.95 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.734 1.214 . . . . 74.51 108.279 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.0 p -132.9 167.22 20.62 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.716 0.406 . . . . 72.34 111.478 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.0 t -166.67 122.51 1.19 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.336 -0.847 . . . . 70.01 109.952 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -77.29 110.93 12.41 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 107.871 -1.159 . . . . 65.25 107.871 168.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 57' ' ' GLU . 31.3 mt -84.94 -36.68 21.25 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.177 0.591 . . . . 65.14 110.75 -173.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.66 -174.47 4.23 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.848 0.859 . . . . 73.33 110.035 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -65.53 119.08 10.44 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.381 -0.6 . . . . 73.0 109.381 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 85' ' ' SER . 35.8 m-20 68.22 2.17 3.14 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.91 1.284 . . . . 74.11 113.015 -177.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.5 t -105.91 111.22 34.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 108.214 -1.032 . . . . 54.12 108.214 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -131.53 137.33 48.45 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.845 -0.798 . . . . 70.25 108.845 -174.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.454 ' HB2' HD11 ' A' ' 51' ' ' LEU . 40.5 tt0 -108.7 118.25 36.3 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.879 -1.055 . . . . 62.4 109.786 -176.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.5 t -103.43 123.74 57.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.043 -1.466 . . . . 74.34 107.043 170.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.8 131.25 70.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 107.817 -1.179 . . . . 62.41 107.817 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 tt -121.8 115.08 22.01 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.179 -1.045 . . . . 71.41 108.179 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.636 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 35.9 ttp180 -85.45 109.49 18.5 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.831 0.852 . . . . 75.34 109.93 175.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.4 t -99.48 102.77 13.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.537 -1.283 . . . . 75.15 107.537 170.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 39.8 m -94.84 108.86 20.89 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.985 0.914 . . . . 75.54 108.907 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.7 t -103.78 110.15 29.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.264 -0.88 . . . . 74.4 109.142 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 21.6 m -102.11 134.74 44.88 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.963 -1.125 . . . . 50.21 107.963 171.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.68 117.22 19.99 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.963 -1.495 . . . . 72.42 106.963 174.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 54.0 m -128.0 132.7 49.14 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.943 0.497 . . . . 71.33 110.97 -175.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.7 mt -90.85 48.01 1.48 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.484 1.114 . . . . 65.43 108.805 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.42 -90.41 0.93 Allowed Glycine 0 C--N 1.351 1.376 0 CA-C-N 114.993 -1.003 . . . . 74.5 112.552 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -87.83 -22.87 24.23 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.785 0.834 . . . . 71.41 111.034 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -118.55 98.82 6.44 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.857 -1.164 . . . . 73.14 107.857 -172.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 93.1 m -59.08 129.19 40.94 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 118.44 0.563 . . . . 53.42 110.597 177.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.585 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -70.18 -60.62 2.17 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.241 -0.891 . . . . 72.15 109.643 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -161.19 164.19 30.65 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 114.863 -1.062 . . . . 73.32 110.99 177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.1 tp -128.62 108.9 10.88 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.502 -0.925 . . . . 73.22 108.502 171.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.403 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 73.9 m -106.48 96.61 6.58 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.59 0.756 . . . . 74.53 109.824 174.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -111.04 115.27 29.18 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.866 -0.79 . . . . 60.11 108.866 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -124.11 132.04 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.048 0.539 . . . . 33.41 109.563 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.696 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.8 mt-30 -98.72 95.59 7.34 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.262 0.625 . . . . 71.53 109.521 168.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -80.41 105.16 11.46 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.807 -1.088 . . . . 70.14 109.03 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.7 150.92 20.59 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.908 -0.587 . . . . 42.24 111.821 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.53 147.49 18.6 Favored Glycine 0 C--O 1.237 0.284 0 N-CA-C 111.529 -0.628 . . . . 32.44 111.529 174.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 15' ' ' ARG . 64.1 mt -104.13 112.23 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.06 -1.089 . . . . 71.33 108.06 176.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.602 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 5.1 m-85 -123.16 154.83 38.14 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.258 1.023 . . . . 74.34 108.294 -176.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 87.9 p -109.04 116.04 31.22 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.742 -0.836 . . . . 71.24 108.742 172.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 N--CA 1.486 1.365 0 N-CA-C 109.279 -0.637 . . . . 62.42 109.279 178.741 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 120.522 0.201 . . . . 41.22 111.501 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -89.51 -47.49 7.95 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.41 0.684 . . . . 74.34 111.324 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 22.0 p -62.36 -42.86 99.74 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.228 0.537 . . . . 55.32 110.372 -174.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -88.02 -41.4 13.13 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.985 -1.007 . . . . 71.22 109.984 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.94 0.09 89.08 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-O 119.443 -0.643 . . . . 71.42 114.647 -171.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.22 -51.83 0.14 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 117.939 0.869 . . . . 73.43 112.464 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.469 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 85.6 t80 -69.86 -58.64 3.64 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.712 0.634 . . . . 74.0 112.712 -170.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.409 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 71.7 m -62.59 -40.49 65.24 Favored Pre-proline 0 CA--C 1.563 1.471 0 N-CA-C 113.651 0.982 . . . . 55.3 113.651 -175.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 34.8 Cg_endo -65.23 -27.84 56.04 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 121.941 1.761 . . . . 71.4 113.166 169.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -75.29 -23.36 57.36 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 122.843 0.457 . . . . 72.34 110.696 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.567 HG21 ' CD1' ' A' ' 13' ' ' ILE . 46.9 mm -62.35 -40.86 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.338 0.655 . . . . 64.32 109.751 170.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 80.1 mt -74.19 -21.56 59.77 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.935 -1.029 . . . . 61.42 111.607 -177.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -60.51 -49.17 91.29 Favored Pre-proline 0 CA--C 1.565 1.536 0 N-CA-C 113.982 1.104 . . . . 71.32 113.982 -172.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.29 -34.17 88.26 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 121.941 1.761 . . . . 73.24 112.829 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -70.13 -41.25 74.17 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.362 0.665 . . . . 72.25 111.455 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.32 -44.02 89.15 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.661 -0.699 . . . . 74.32 109.764 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.528 ' NH1' HD12 ' C' ' 105' ' ' ILE . 30.6 ttm180 -52.6 -48.66 66.15 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.639 1.175 . . . . 74.13 110.64 174.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.07 -49.71 66.69 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.446 0.698 . . . . 75.51 111.33 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 33.1 t -61.54 -26.43 67.93 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.473 0.709 . . . . 73.21 111.495 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 81.1 mt -77.81 -57.3 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 123.84 0.856 . . . . 65.32 110.117 174.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.5 m -55.59 -34.74 65.1 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.823 0.849 . . . . 62.25 111.89 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.0 t -63.73 -49.99 70.88 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.318 -0.856 . . . . 72.24 110.058 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 30.4 mtm -66.5 -37.51 85.23 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.103 0.561 . . . . 71.33 111.229 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.0 t -57.07 -47.98 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 124.02 0.825 . . . . 75.13 110.048 175.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 29.3 t -73.45 -28.89 62.2 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 115.039 -0.982 . . . . 62.05 111.438 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -72.83 -28.64 62.66 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.207 0.603 . . . . 73.22 109.872 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.13 4.67 75.21 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 123.659 0.599 . . . . 64.33 112.918 172.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.57 HG23 HH21 ' B' ' 15' ' ' ARG . 0.6 OUTLIER 65.72 16.33 10.45 Favored 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 126.515 1.926 . . . . 72.11 112.347 177.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -79.16 152.93 76.95 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 123.575 0.75 . . . . 61.33 109.666 172.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.98 134.31 63.72 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.474 2.116 . . . . 74.42 111.14 171.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -56.65 158.08 4.85 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.557 0.743 . . . . 72.42 112.416 -173.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.0 tp -135.85 93.73 2.97 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.28 -0.873 . . . . 75.52 109.333 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -98.12 99.14 10.38 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.986 -1.116 . . . . 71.51 107.986 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 19.0 tp -59.26 136.7 58.04 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.294 -0.867 . . . . 61.3 110.346 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.04 145.14 81.16 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 124.284 1.033 . . . . 72.31 112.147 -175.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.06 123.34 11.75 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.204 2.603 . . . . 52.25 111.759 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 77.1 t -116.02 115.94 50.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 108.96 -0.755 . . . . 74.3 108.96 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -73.26 74.69 1.32 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.88 0.872 . . . . 71.54 108.654 173.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 24.9 t80 . . . . . 0 N--CA 1.473 0.714 0 C-N-CA 125.037 1.335 . . . . 72.25 111.903 -163.318 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.507 ' HB3' HG13 ' B' ' 89' ' ' ILE . 4.2 ppp? . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 113.218 0.822 . . . . 63.22 113.218 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 93.8 m -133.57 113.59 12.61 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.134 0.574 . . . . 64.31 109.504 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -123.61 143.68 50.08 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.102 0.961 . . . . 75.45 109.342 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -162.88 141.43 8.48 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.38 0.672 . . . . 73.54 110.268 169.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.513 HD13 HD11 ' B' ' 16' ' ' ILE . 49.2 mt -68.68 129.39 33.23 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 109.014 -0.735 . . . . 75.12 109.014 171.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -97.95 -42.27 7.61 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.209 0.604 . . . . 64.32 109.537 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.57 HH21 HG23 ' A' ' 122' ' ' THR . 21.7 ttt85 -168.48 144.89 3.77 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.79 -0.641 . . . . 54.03 109.457 -174.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.513 HD11 HD13 ' B' ' 13' ' ' ILE . 96.4 mt -128.73 144.65 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 107.56 -1.274 . . . . 74.44 107.56 175.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -171.12 156.03 4.62 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.182 0.515 . . . . 65.11 111.462 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 95.2 m -85.2 126.28 33.53 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.634 -0.712 . . . . 55.42 109.244 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.455 ' HZ1' ' HB3' ' A' ' 28' ' ' ALA . 33.4 mttp -86.49 -48.36 8.47 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.27 0.628 . . . . 71.33 110.61 172.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -144.96 136.91 25.74 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 110.115 -0.328 . . . . 74.32 110.115 -165.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 44.7 mm -131.69 142.41 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.389 1.076 . . . . 74.13 109.309 176.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.687 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 69.3 m -138.84 136.67 35.85 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.83 1.252 . . . . 60.21 108.439 177.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' B' ' 75' ' ' LEU . 75.7 t80 -149.91 107.46 3.65 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 107.858 -1.164 . . . . 54.23 107.858 165.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -121.79 112.12 17.97 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.096 0.959 . . . . 74.24 108.945 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.484 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -113.53 87.6 12.0 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.688 1.195 . . . . 64.11 108.231 174.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.9 -41.93 12.72 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.867 2.378 . . . . 71.03 111.837 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.464 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 2.5 m-20 -90.87 3.49 54.36 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.874 -1.057 . . . . 72.32 111.345 -175.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.484 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -37.06 -60.51 0.8 Allowed Pre-proline 0 N--CA 1.49 1.552 0 C-N-CA 125.668 1.587 . . . . 71.34 114.973 -164.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.7 -31.63 58.55 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 122.474 2.116 . . . . 53.32 113.278 -173.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -88.62 -38.08 15.12 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.06 0.544 . . . . 71.44 111.103 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.695 HG22 HD12 ' B' ' 68' ' ' LEU . 8.9 p -69.5 -19.15 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 123.339 0.656 . . . . 75.14 111.486 -174.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -58.74 -20.66 51.24 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 113.372 0.879 . . . . 72.21 113.372 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.48 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.1 pt20 -59.82 -31.97 70.21 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.462 0.705 . . . . 72.44 111.33 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.48 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 99.8 mttt -87.91 95.95 10.3 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.878 0.871 . . . . 64.3 109.944 -176.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -91.07 87.52 6.61 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.783 -0.644 . . . . 65.21 110.597 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -163.17 -179.22 6.5 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.886 0.874 . . . . 74.23 109.726 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -77.81 108.36 7.18 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.589 0.755 . . . . 73.12 109.812 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.4 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 37.7 Cg_endo -64.77 142.1 74.91 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.433 2.089 . . . . 70.51 113.109 -176.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -68.79 119.95 13.97 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.77 0.828 . . . . 73.31 109.395 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 24.4 m -106.98 161.31 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 123.727 0.811 . . . . 72.13 112.173 -169.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.523 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 55.9 tttm -135.5 109.66 8.31 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.387 1.075 . . . . 72.53 108.794 175.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mp -90.15 138.06 31.83 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.015 -0.735 . . . . 73.21 109.015 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.559 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 7.2 t70 -149.79 158.26 43.99 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 107.838 -1.171 . . . . 62.02 107.838 -176.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.4 ' HB2' HD11 ' B' ' 60' ' ' LEU . 2.4 pt? -140.52 158.97 43.2 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.034 0.445 . . . . 54.35 110.478 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 28.9 t70 -146.86 155.58 42.44 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.881 0.872 . . . . 73.3 108.903 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 58.6 m -108.45 137.35 46.57 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.699 0.8 . . . . 72.44 110.854 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.675 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -142.8 146.31 34.09 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.739 -1.208 . . . . 52.42 107.739 166.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.4 p -142.74 168.63 19.27 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.23 0.612 . . . . 62.43 109.935 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . 0.573 ' HB2' ' HB3' ' B' ' 57' ' ' GLU . 2.3 m -150.65 151.93 33.23 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.149 -1.056 . . . . 74.1 108.149 170.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -115.57 106.59 14.1 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.23 -1.396 . . . . 73.2 107.23 168.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' B' ' 57' ' ' GLU . 21.1 mt -87.53 -38.12 16.3 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.477 0.711 . . . . 64.24 109.771 -173.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.8 -171.24 3.59 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.521 -1.218 . . . . 72.14 109.416 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -69.59 125.59 27.17 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.091 -0.959 . . . . 72.4 108.445 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 68.92 -2.09 1.86 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.771 1.229 . . . . 73.25 112.811 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 88.9 t -107.1 105.25 18.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 108.818 -0.808 . . . . 63.34 108.818 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.584 ' HB2' HD11 ' B' ' 86' ' ' ILE . 1.2 m-85 -116.36 141.65 47.88 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.524 1.129 . . . . 74.31 108.902 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.573 ' HB3' ' HB2' ' B' ' 49' ' ' SER . 6.7 tm-20 -113.8 97.0 6.14 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.39 -1.337 . . . . 74.45 107.39 -176.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 46.4 t -92.32 128.09 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.964 0.905 . . . . 64.22 109.765 -174.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.675 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 17.6 t -120.64 118.18 55.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 C-N-CA 124.105 0.962 . . . . 74.42 108.761 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.424 ' HB2' ' HB3' ' B' ' 103' ' ' PRO . 43.9 tp -102.88 127.63 50.0 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.986 -0.746 . . . . 65.23 108.986 170.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.445 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 12.7 ttm180 -86.25 135.91 33.38 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.876 -0.787 . . . . 71.02 108.876 169.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.451 ' CG1' HD11 ' B' ' 114' ' ' ILE . 93.9 t -122.32 103.48 13.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 106.958 -1.497 . . . . 71.34 106.958 175.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 52.9 m -95.43 135.99 36.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.918 0.887 . . . . 72.03 108.74 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.599 HG21 HG21 ' B' ' 114' ' ' ILE . 98.3 t -132.44 117.65 32.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.854 -1.165 . . . . 74.43 107.854 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 32.2 m -105.53 149.97 25.77 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.89 -1.152 . . . . 54.22 107.89 170.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.79 145.12 29.81 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.09 -0.707 . . . . 45.23 109.09 176.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.501 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 54.3 p -150.39 128.45 11.88 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 123.865 0.728 . . . . 71.31 110.517 -176.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.695 HD12 HG22 ' B' ' 31' ' ' VAL . 71.1 mt -93.51 98.25 11.06 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 107.281 -1.377 . . . . 54.2 107.281 172.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.97 -129.02 12.41 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 114.91 -1.041 . . . . 74.44 113.568 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -86.72 4.05 42.32 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.469 0.708 . . . . 72.43 112.063 -173.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.464 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 13.2 pt-20 -129.63 152.91 48.63 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.927 0.491 . . . . 75.15 110.213 -177.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 85.6 m -72.33 132.87 44.58 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.327 0.651 . . . . 75.23 110.277 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.536 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -86.44 -62.73 1.45 Allowed 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.851 -1.166 . . . . 53.14 107.851 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -156.01 160.73 40.29 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 115.141 -0.936 . . . . 74.24 111.783 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 23.2 mt -124.74 114.75 19.69 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 106.321 -1.733 . . . . 64.21 106.321 174.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.464 ' SG ' HG23 ' B' ' 114' ' ' ILE . 35.2 t -119.41 146.18 45.59 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.876 -0.787 . . . . 72.22 108.876 175.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.687 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 42.9 tt0 -158.45 134.61 9.22 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.345 -0.613 . . . . 72.4 109.345 -175.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 91.5 t -129.75 142.81 42.92 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 C-N-CA 123.726 0.81 . . . . 71.11 109.107 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -124.28 96.97 5.12 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 107.651 -1.24 . . . . 71.44 107.651 172.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -89.32 107.67 19.19 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.198 -1.038 . . . . 73.55 108.198 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.99 143.56 17.12 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.187 -0.765 . . . . 74.33 111.187 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.8 126.9 2.47 Favored Glycine 0 CA--C 1.51 -0.273 0 N-CA-C 112.04 -0.424 . . . . 60.14 112.04 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 38.9 mt -85.92 128.19 39.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.37 -0.974 . . . . 71.31 108.37 173.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -137.46 147.94 45.69 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.242 0.617 . . . . 73.32 110.039 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 62.8 m -97.41 125.6 42.14 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.118 -0.697 . . . . 70.21 109.118 170.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.584 HD11 ' HB2' ' B' ' 56' ' ' TYR . 1.8 pt -138.26 118.13 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 125.049 1.34 . . . . 72.13 108.993 -174.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' B' ' 9' ' ' MET . . . -152.25 168.04 26.65 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.237 0.615 . . . . 73.51 111.055 -173.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.27 -71.0 1.43 Allowed Glycine 0 C--N 1.348 1.225 0 O-C-N 123.496 0.497 . . . . 64.22 112.673 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.685 HG22 ' HB2' ' B' ' 94' ' ' MET . 10.7 mt -75.02 157.61 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.716 0.807 . . . . 74.41 110.651 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.598 ' HG2' ' H ' ' B' ' 91' ' ' GLY . 11.7 tt0 -151.96 -176.48 5.66 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.93 0.892 . . . . 73.21 108.667 173.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.598 ' H ' ' HG2' ' B' ' 90' ' ' GLU . . . 75.51 -136.27 19.81 Favored Glycine 0 C--N 1.345 1.053 0 C-N-CA 123.139 0.399 . . . . 52.33 113.187 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 44.0 m -70.17 -41.64 73.53 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.569 0.748 . . . . 70.02 111.352 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -60.14 -35.53 75.5 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.941 -1.027 . . . . 61.14 111.052 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.685 ' HB2' HG22 ' B' ' 89' ' ' ILE . 9.9 tmm? -85.14 -31.26 23.38 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.129 0.971 . . . . 74.15 111.52 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.61 -27.58 67.86 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.4 0.619 . . . . 72.42 110.324 170.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -79.64 -29.33 40.93 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.111 1.365 . . . . 53.22 111.646 173.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -63.22 -51.71 65.16 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.873 0.469 . . . . 65.32 111.746 -175.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 pp -89.62 -13.33 37.37 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 117.853 0.297 . . . . 54.42 110.99 171.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.95 3.12 85.94 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-O 119.479 -0.623 . . . . 73.0 114.099 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.69 -54.92 0.09 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.231 0.612 . . . . 62.34 110.724 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -72.88 -49.72 28.2 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.366 0.876 . . . . 73.03 113.366 -165.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.484 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 62.7 m -59.7 -47.81 96.7 Favored Pre-proline 0 CA--C 1.565 1.526 0 CA-C-O 119.189 -0.434 . . . . 44.13 111.907 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 23.9 Cg_exo -67.14 -24.97 43.95 Favored 'Trans proline' 0 C--N 1.393 2.879 0 C-N-CA 122.263 1.975 . . . . 71.53 113.599 173.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -63.96 -37.5 87.65 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.365 0.666 . . . . 75.35 110.213 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.413 HG23 ' NH2' ' D' ' 111' ' ' ARG . 68.4 mt -65.54 -39.12 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 115.671 -0.695 . . . . 72.55 110.485 175.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.24 -17.26 52.76 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.24 -0.891 . . . . 62.12 111.735 -175.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -58.99 -49.51 92.98 Favored Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 124.789 1.236 . . . . 73.32 113.556 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -60.79 -39.4 62.92 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 122.262 1.974 . . . . 71.43 113.019 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -64.38 -33.73 76.54 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.487 -0.779 . . . . 71.11 110.491 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.494 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -72.35 -42.16 65.64 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 115.857 -0.611 . . . . 62.23 110.341 174.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -53.36 -55.52 24.21 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.218 1.007 . . . . 71.42 111.527 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.419 ' HG3' ' NH2' ' C' ' 120' ' ' ARG . 2.1 tm-20 -64.03 -34.77 78.76 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.802 0.689 . . . . 44.35 110.106 -177.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.512 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.2 t -73.5 -27.59 61.45 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.734 0.414 . . . . 72.53 111.7 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.599 HG21 HG21 ' B' ' 64' ' ' VAL . 73.0 mt -71.11 -58.62 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 108.578 -0.897 . . . . 74.54 108.578 173.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 4.8 m -65.0 -23.08 67.11 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.906 -1.043 . . . . 73.24 111.441 -173.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 37.7 t -61.52 -49.87 74.96 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.302 0.641 . . . . 73.42 109.454 171.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.2 mmt -71.53 -34.14 69.78 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.415 0.686 . . . . 73.32 110.82 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 114' ' ' ILE . 87.5 t -59.76 -46.1 93.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.709 0.804 . . . . 61.43 109.85 172.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -64.56 -36.67 84.98 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.724 -1.125 . . . . 71.23 110.834 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.483 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 93.5 mtt-85 -65.46 -32.84 74.67 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.247 0.619 . . . . 74.11 110.125 177.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.64 8.71 70.97 Favored Glycine 0 C--N 1.353 1.495 0 O-C-N 123.639 0.587 . . . . 71.33 113.146 174.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.49 HG23 ' HB3' ' A' ' 17' ' ' TYR . 75.7 p 57.47 26.92 13.23 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 126.235 1.814 . . . . 42.34 113.5 177.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -88.08 158.21 50.1 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 123.519 0.728 . . . . 64.35 111.02 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -58.04 157.63 24.32 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 123.403 2.735 . . . . 73.32 114.338 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.591 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -65.33 123.19 18.95 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.482 -1.235 . . . . 64.33 112.186 -177.231 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -138.43 115.3 10.78 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 108.388 -0.967 . . . . 71.44 108.388 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -110.9 136.06 50.49 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.874 0.87 . . . . 74.22 109.819 176.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.417 HD12 ' H ' ' B' ' 129' ' ' ALA . 10.0 tp -86.78 135.52 33.33 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.334 0.653 . . . . 73.21 110.739 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . 0.417 ' H ' HD12 ' B' ' 128' ' ' LEU . . . -68.05 147.0 98.42 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.733 1.213 . . . . 74.23 111.779 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.489 ' HG2' HD13 ' D' ' 16' ' ' ILE . 7.1 Cg_exo -70.06 104.16 1.32 Allowed 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.75 2.3 . . . . 72.04 111.994 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 10.8 m -92.84 108.16 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 122.092 0.948 . . . . 64.41 109.601 173.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.54 83.89 3.87 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.949 -1.023 . . . . 75.04 108.423 172.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -52.67 -46.74 67.33 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.608 -0.723 . . . . 71.33 109.633 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 C--N 1.344 0.35 0 CA-C-N 113.411 -1.722 . . . . 64.34 112.458 179.658 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.533 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.6 t80 . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 110.276 -0.268 . . . . 63.11 110.276 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -150.85 131.17 13.66 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.536 0.735 . . . . 63.21 109.384 171.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 78.9 mt -74.99 124.06 31.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 108.445 -0.946 . . . . 70.14 108.445 172.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.44 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 81.9 mm-40 -93.74 -39.53 10.71 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.301 0.64 . . . . 71.31 110.915 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -177.19 127.01 0.15 Allowed 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.228 0.33 . . . . 71.35 110.714 -175.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 84.1 mt -114.69 133.42 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.51 0.724 . . . . 74.23 109.473 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.514 ' HE2' ' HD3' ' C' ' 19' ' ' LYS . 23.6 p90 -170.54 172.43 5.95 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-O 121.43 0.633 . . . . 74.21 110.53 -171.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.8 p -97.08 121.65 39.2 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.417 -0.811 . . . . 72.31 109.1 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.514 ' HD3' ' HE2' ' C' ' 17' ' ' TYR . 29.9 mmtp -68.98 -46.69 67.44 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.35 1.072 . . . . 74.05 108.186 167.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 13.1 t70 -141.76 138.36 32.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 112.989 -1.914 . . . . 72.43 109.041 -167.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.563 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.2 mt -134.38 152.59 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 107.258 -1.386 . . . . 61.3 107.258 174.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -160.4 152.87 20.78 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.395 0.617 . . . . 71.11 110.843 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -149.01 135.43 19.39 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.572 -1.27 . . . . 65.04 107.572 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -140.82 110.38 6.36 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.743 0.817 . . . . 75.44 109.313 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.54 85.67 56.04 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 105.371 -2.085 . . . . 64.44 105.371 165.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.82 -17.99 41.75 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 122.866 2.378 . . . . 74.45 112.397 -175.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -112.88 19.27 17.47 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.956 1.302 . . . . 74.25 110.289 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.02 -56.88 6.89 Favored Pre-proline 0 N--CA 1.489 1.475 0 N-CA-C 114.297 1.221 . . . . 62.01 114.297 -170.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.456 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 38.0 Cg_endo -62.02 -35.72 74.95 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.103 1.869 . . . . 75.22 112.582 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -68.34 -50.57 52.35 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.171 0.588 . . . . 74.11 110.972 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.704 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.0 p -69.46 -23.65 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 N-CA-C 112.772 0.656 . . . . 74.2 112.772 -169.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -62.74 -33.16 74.56 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.52 0.563 . . . . 71.25 112.52 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -88.36 15.68 7.43 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.759 0.424 . . . . 63.0 112.099 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.726 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -95.56 158.68 15.35 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.915 0.886 . . . . 72.35 109.993 175.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -70.18 129.5 39.56 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 109.047 -0.723 . . . . 75.52 109.047 170.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 55.6 t-105 -78.44 80.41 4.83 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.429 0.692 . . . . 72.44 110.44 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -129.14 74.05 81.34 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 108.279 -1.008 . . . . 75.42 108.279 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -95.92 176.51 0.79 Allowed 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.068 2.512 . . . . 75.04 112.688 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' C' ' 67' ' ' SER . 0.9 OUTLIER -117.82 120.2 37.21 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.417 -1.698 . . . . 75.24 106.417 169.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.68 97.42 5.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.257 -1.016 . . . . 75.42 108.257 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.506 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 10.1 tmtt? -91.6 108.67 20.07 Favored 'General case' 0 CA--C 1.527 0.081 0 N-CA-C 106.851 -1.537 . . . . 63.34 106.851 175.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 mp -86.53 136.38 33.1 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.695 -0.854 . . . . 74.51 108.695 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.58 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 23.4 t70 -123.04 137.95 54.81 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 124.993 1.317 . . . . 72.23 107.948 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.53 HD21 HD11 ' C' ' 60' ' ' LEU . 6.1 tt -135.48 139.9 44.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.585 -1.265 . . . . 73.4 107.585 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.499 ' N ' HD23 ' C' ' 44' ' ' LEU . 29.9 t70 -143.41 152.64 41.8 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.523 0.729 . . . . 61.23 109.36 170.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 72.4 p -115.48 112.28 22.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.84 0.856 . . . . 75.11 109.486 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.91 157.18 20.96 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.662 -0.866 . . . . 61.2 108.662 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 31.4 p -164.86 169.63 16.36 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.449 0.537 . . . . 64.34 112.449 -170.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 41.9 t -170.12 129.31 0.91 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.232 1.013 . . . . 61.35 109.345 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -77.67 115.5 17.47 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.597 -1.26 . . . . 70.45 107.597 166.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.685 HD11 HD12 ' C' ' 83' ' ' ILE . 62.9 mt -89.48 -36.3 15.48 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.175 0.59 . . . . 74.11 110.805 -175.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.33 -168.68 0.84 Allowed 'General case' 0 CA--C 1.54 0.585 0 O-C-N 124.139 0.9 . . . . 54.3 111.15 -174.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -66.53 114.12 5.26 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.671 1.188 . . . . 74.21 110.084 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 65.82 -3.03 0.79 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 125.234 1.413 . . . . 72.34 113.227 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.418 HG12 ' HB2' ' C' ' 51' ' ' LEU . 78.9 t -98.7 107.17 19.95 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.429 -0.952 . . . . 55.01 108.429 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . 0.443 ' HB3' HD13 ' C' ' 86' ' ' ILE . 49.2 t80 -122.12 137.12 54.94 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.809 -0.632 . . . . 72.23 110.064 -176.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -94.65 119.53 33.44 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.117 0.967 . . . . 75.11 109.735 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.09 117.5 55.17 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.137 -1.06 . . . . 75.14 108.137 174.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.07 136.04 56.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 108.366 -0.976 . . . . 72.01 108.366 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.53 HD11 HD21 ' C' ' 44' ' ' LEU . 16.2 tp -121.58 114.26 20.94 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 109.189 -0.671 . . . . 61.54 109.189 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 13.3 ttm180 -82.08 108.46 15.57 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.626 -0.879 . . . . 75.25 108.626 172.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 22.2 t -103.93 123.28 57.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.093 -1.447 . . . . 72.45 107.093 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.58 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 86.0 m -136.92 119.56 16.05 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 123.194 0.598 . . . . 61.22 109.448 -173.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 54.3 t -103.95 113.47 40.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 123.608 0.763 . . . . 63.21 109.135 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 4.9 m -99.4 134.94 41.53 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.674 -1.232 . . . . 74.45 107.674 171.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.01 120.28 25.74 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.791 -1.559 . . . . 71.33 106.791 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 57.0 m -135.52 130.37 34.49 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.081 0.467 . . . . 75.23 110.938 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.726 HD13 ' HG2' ' C' ' 34' ' ' LYS . 8.6 mt -84.67 46.62 1.27 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.93 1.292 . . . . 71.44 109.246 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.41 -119.72 6.48 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 109.46 -1.456 . . . . 62.12 109.46 -165.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -91.17 -19.49 23.01 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.235 0.614 . . . . 74.31 110.198 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -70.62 84.67 0.63 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.747 0.819 . . . . 63.14 108.962 174.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 62.4 m -62.42 121.6 13.65 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 110.291 -0.263 . . . . 74.21 110.291 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.704 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -67.92 -61.76 1.72 Allowed 'General case' 0 C--O 1.235 0.342 0 O-C-N 124.069 0.856 . . . . 54.14 108.739 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -155.06 172.76 17.59 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-O 122.211 1.005 . . . . 71.03 111.196 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.42 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.3 tm? -130.74 144.21 51.28 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 105.043 -2.206 . . . . 61.33 105.043 169.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.438 ' SG ' HG23 ' C' ' 114' ' ' ILE . 51.2 t -151.52 135.31 16.4 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.649 -0.871 . . . . 63.34 108.649 177.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -139.66 138.79 36.38 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.081 0.552 . . . . 74.41 109.928 -174.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.403 HG21 ' HB3' ' C' ' 113' ' ' CYS . 48.2 t -141.91 113.46 3.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.959 -1.126 . . . . 72.1 107.959 176.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -91.07 88.31 6.93 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.235 -1.024 . . . . 72.41 108.235 172.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -78.76 101.15 7.43 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.007 -0.997 . . . . 73.34 108.996 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.25 143.4 17.99 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 111.614 -0.594 . . . . 43.21 111.614 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.56 116.47 0.99 Allowed Glycine 0 CA--C 1.499 -0.949 0 N-CA-C 109.968 -1.253 . . . . 72.23 109.968 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.685 HD12 HD11 ' C' ' 51' ' ' LEU . 12.6 mm -81.63 120.44 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.736 -1.209 . . . . 74.22 107.736 177.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.533 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 54.7 m-85 -130.9 134.74 47.05 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.453 -0.943 . . . . 61.44 108.453 -177.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 49.3 m -80.24 117.42 21.0 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.949 -0.76 . . . . 64.21 108.949 170.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.443 HD13 ' HB3' ' C' ' 56' ' ' TYR . 4.1 mp -115.43 118.07 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.051 -1.092 . . . . 73.23 108.051 173.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.03 162.77 34.42 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.745 0.818 . . . . 74.34 109.86 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.12 -63.24 3.47 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.335 -0.848 . . . . 41.42 112.496 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 28.5 pt -90.03 145.86 6.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-O 120.876 0.37 . . . . 60.13 110.675 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -146.32 150.47 35.8 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.319 -0.855 . . . . 65.22 109.088 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.49 -135.89 13.02 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-O 119.721 -0.488 . . . . 41.31 112.262 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 15.5 m -67.24 -35.11 78.87 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.819 0.848 . . . . 53.11 111.412 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -56.72 -48.66 77.26 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.728 1.211 . . . . 44.43 109.682 176.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 2.7 ttp -66.62 -43.83 83.71 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 113.305 -1.77 . . . . 71.44 110.998 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.21 69.82 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.719 0.808 . . . . 55.31 111.68 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -67.09 -41.89 85.55 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.754 0.822 . . . . 73.2 110.621 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 30.1 t -63.95 -53.16 54.66 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.832 -0.622 . . . . 72.13 109.86 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 80.3 mt -70.14 -28.54 65.44 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.828 0.851 . . . . 72.43 112.695 -175.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.43 12.76 33.29 Favored Glycine 0 N--CA 1.475 1.27 0 N-CA-C 114.322 0.489 . . . . 71.24 114.322 -167.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' C' ' 133' ' ' PHE . . . -155.89 -60.08 0.1 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.787 0.803 . . . . 64.22 110.8 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.404 ' CE2' ' CE1' ' C' ' 11' ' ' PHE . 53.5 t80 -75.28 -38.2 60.54 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-N 113.607 -1.633 . . . . 74.44 112.324 -170.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 79.0 m -83.14 -43.8 0.86 Allowed Pre-proline 0 CA--C 1.565 1.528 0 C-N-CA 123.883 0.873 . . . . 61.31 112.699 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.417 ' HB3' HD13 ' C' ' 60' ' ' LEU . 32.7 Cg_exo -64.86 -20.94 64.7 Favored 'Trans proline' 0 C--N 1.394 2.938 0 C-N-CA 122.325 2.016 . . . . 74.11 112.312 173.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -67.5 -33.83 75.89 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.661 0.784 . . . . 75.01 110.512 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.528 HD12 ' NH1' ' A' ' 111' ' ' ARG . 44.0 mm -65.19 -35.56 75.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-N 115.67 -0.696 . . . . 62.24 109.752 174.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 82.7 mt -89.62 -22.35 22.36 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.201 1.001 . . . . 51.42 112.449 -174.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -54.92 -51.13 81.94 Favored Pre-proline 0 CA--C 1.559 1.297 0 N-CA-C 113.299 0.852 . . . . 74.43 113.299 -174.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -64.23 -34.45 56.28 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.083 1.855 . . . . 34.53 112.871 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -66.32 -44.81 82.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.185 0.594 . . . . 64.12 110.854 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.17 -38.6 88.46 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.527 -0.761 . . . . 73.34 110.661 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -57.64 -53.82 53.84 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.454 1.101 . . . . 72.31 110.594 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.27 -32.58 74.08 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.59 0.556 . . . . 52.42 110.463 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.403 ' HB3' HG21 ' C' ' 78' ' ' VAL . 8.0 t -73.1 -33.12 65.39 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 122.939 0.495 . . . . 74.43 111.257 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.438 HG23 ' SG ' ' C' ' 76' ' ' CYS . 57.3 mt -71.57 -52.88 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.039 0.536 . . . . 64.13 109.758 174.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.4 m -65.98 -27.05 67.85 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.424 0.689 . . . . 75.31 111.009 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -62.6 -49.4 75.36 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 109.279 -0.637 . . . . 53.42 109.279 169.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.679 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.8 -36.4 81.01 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.208 1.003 . . . . 71.2 112.546 178.222 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.1 -44.35 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.407 0.683 . . . . 72.12 109.343 173.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.457 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 22.7 t -73.27 -25.06 60.54 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.121 -0.945 . . . . 65.3 111.565 -177.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.419 ' NH2' ' HG3' ' B' ' 112' ' ' GLU . 78.3 mtt-85 -75.02 -41.66 58.87 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.567 0.747 . . . . 71.34 108.995 176.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.12 1.6 68.93 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 124.254 0.971 . . . . 61.2 112.364 172.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 22.3 p 60.96 29.84 19.26 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.632 1.973 . . . . 54.44 113.523 170.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -83.65 148.44 54.83 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 123.457 0.703 . . . . 63.12 110.193 173.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -52.83 139.35 59.72 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.351 2.701 . . . . 73.22 113.341 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.419 HE21 ' NE2' ' B' ' 125' ' ' GLN . 73.1 mm-40 -56.88 112.95 1.47 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.615 1.166 . . . . 53.24 112.353 -175.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.38 100.9 7.58 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.291 -1.744 . . . . 71.53 106.291 174.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -99.09 131.4 45.16 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.284 0.634 . . . . 65.32 110.318 -172.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.94 142.04 38.62 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.542 0.737 . . . . 73.14 110.041 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.46 162.05 74.15 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.055 0.942 . . . . 72.2 111.58 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.33 109.34 0.97 Allowed 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.385 2.057 . . . . 55.3 111.972 173.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.24 106.85 19.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 108.006 -1.109 . . . . 74.44 108.006 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -101.81 91.6 4.46 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.725 -1.583 . . . . 72.44 106.725 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . 0.487 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 45.8 m-85 -58.09 -37.79 75.18 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.597 0.713 . . . . 73.33 109.534 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 2.6 t70 . . . . . 0 C--N 1.347 0.486 0 CA-C-N 113.789 -1.55 . . . . 72.23 111.059 -177.575 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 55.7 m . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 109.926 -0.398 . . . . 73.13 109.926 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -159.04 113.88 2.47 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.203 -1.036 . . . . 74.02 108.203 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . 0.465 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 49.3 mt-30 -133.33 135.91 45.07 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.865 0.866 . . . . 54.31 108.895 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 16.6 mt -92.47 120.21 41.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 109.48 -0.563 . . . . 73.12 109.48 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -91.61 -47.21 7.52 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.284 0.365 . . . . 62.41 111.404 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -166.6 123.41 1.27 Allowed 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 111.434 0.161 . . . . 71.1 111.434 -168.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.489 HD13 ' HG2' ' B' ' 130' ' ' PRO . 1.7 mp -103.73 137.54 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 108.462 -0.94 . . . . 75.51 108.462 170.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.467 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 22.7 p90 -162.05 168.76 22.15 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 124.16 0.912 . . . . 70.22 110.861 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.1 p -96.98 122.66 40.21 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.405 -0.961 . . . . 74.11 108.405 171.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.467 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 34.4 mtpt -85.13 -40.17 17.06 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.986 -0.746 . . . . 74.42 108.986 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.515 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.8 t70 -140.62 141.26 35.13 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 113.978 -1.464 . . . . 71.04 108.99 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.679 HG21 ' HE2' ' C' ' 117' ' ' MET . 94.0 mt -135.44 147.75 28.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.695 1.198 . . . . 75.11 107.922 174.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -147.32 143.4 28.02 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.416 1.086 . . . . 74.42 108.523 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.563 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.9 t80 -149.47 132.24 15.99 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.577 -1.638 . . . . 70.13 106.577 171.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 46.5 mt-10 -135.68 151.16 49.92 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.716 -1.216 . . . . 62.42 107.716 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.66 91.59 5.27 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 108.332 -0.988 . . . . 62.55 108.332 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.78 -50.9 3.52 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.398 2.732 . . . . 53.53 113.551 -171.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.494 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 18.6 m-20 -99.86 14.1 31.54 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.832 0.853 . . . . 64.01 110.071 -171.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.484 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -28.48 -68.72 0.1 OUTLIER Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 126.826 2.05 . . . . 61.13 115.82 -163.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.29 -19.67 19.47 Favored 'Trans proline' 0 C--N 1.382 2.322 0 CA-C-N 123.162 2.165 . . . . 71.14 114.05 -173.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -79.11 -43.01 24.94 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.848 0.859 . . . . 74.5 109.944 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' D' ' 27' ' ' ASN . 10.0 p -75.01 -15.33 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-N 115.613 -0.721 . . . . 62.2 110.744 -172.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -70.56 -17.71 62.92 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 112.281 0.474 . . . . 72.13 112.281 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -64.36 -11.21 30.23 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.372 0.669 . . . . 74.3 110.879 173.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -105.55 97.17 7.04 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.014 1.726 . . . . 73.41 109.438 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -104.91 89.72 3.24 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.547 0.739 . . . . 71.34 109.329 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -162.43 171.88 16.43 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.141 0.976 . . . . 71.43 109.124 171.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.468 HE21 ' HD2' ' D' ' 38' ' ' PRO . 28.7 tp60 -63.56 110.75 4.03 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 123.26 0.624 . . . . 63.21 109.634 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.468 ' HD2' HE21 ' D' ' 37' ' ' GLN . 21.5 Cg_exo -64.73 143.92 82.16 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.629 2.219 . . . . 70.24 112.325 -176.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -71.48 116.02 11.33 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.442 0.697 . . . . 72.5 109.166 173.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.589 HG13 HG13 ' D' ' 64' ' ' VAL . 78.5 t -115.45 130.28 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.611 0.764 . . . . 74.41 110.963 -169.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.566 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 16.6 tptm -106.11 134.74 48.76 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.656 1.183 . . . . 74.25 108.579 173.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -110.17 114.81 28.6 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.611 0.764 . . . . 64.45 109.741 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.49 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 3.7 m-20 -108.87 113.64 26.72 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.993 0.917 . . . . 51.31 108.532 174.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 8.7 mp -101.29 132.05 47.01 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.182 -0.673 . . . . 52.5 109.182 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 25.0 t70 -132.48 150.11 52.21 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.027 0.931 . . . . 73.44 108.749 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 52.2 m -105.83 144.04 33.13 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.07 0.948 . . . . 71.31 110.955 -171.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.433 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.65 161.38 39.89 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.86 1.264 . . . . 54.4 108.994 171.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.3 p -175.71 166.63 3.16 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.127 0.571 . . . . 42.25 111.349 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 80.3 p -161.96 143.3 10.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.528 0.731 . . . . 54.54 110.044 172.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -78.91 121.47 24.91 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.628 -0.878 . . . . 71.33 108.628 171.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 76.3 mt -99.84 -29.03 12.83 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.809 0.444 . . . . 71.42 111.318 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.26 -175.43 4.84 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.483 0.659 . . . . 74.5 111.135 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -62.62 122.49 15.97 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.1 -1.409 . . . . 43.13 109.479 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 60.09 16.29 5.82 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.786 0.834 . . . . 63.12 112.592 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 81.8 t -119.6 125.74 74.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 C-N-CA 123.806 0.843 . . . . 71.24 108.756 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -135.09 130.85 36.18 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.874 -0.603 . . . . 64.14 109.598 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -91.23 139.81 30.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.317 -0.856 . . . . 74.14 109.579 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 62.5 t -120.8 126.12 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 107.777 -1.194 . . . . 51.05 107.777 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 21.5 t -125.07 129.28 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.463 0.705 . . . . 75.54 109.363 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.569 HD23 HD12 ' D' ' 106' ' ' LEU . 3.6 mm? -121.7 120.58 35.1 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.031 0.532 . . . . 65.43 110.218 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 32.9 ttm-85 -87.93 102.98 15.24 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.152 -0.931 . . . . 70.14 108.978 172.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.6 t -91.6 126.3 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 107.72 -1.215 . . . . 75.11 107.72 169.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 8.5 m -121.02 131.76 54.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.474 -0.565 . . . . 35.44 109.474 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.589 HG13 HG13 ' D' ' 40' ' ' VAL . 35.3 t -116.4 102.35 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 124.73 1.212 . . . . 71.5 108.856 -173.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.566 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 9.4 m -94.04 91.68 6.97 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.947 -1.131 . . . . 75.21 107.947 173.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.87 150.0 20.91 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.59 -0.732 . . . . 64.04 109.405 -175.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.419 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 67.9 m -149.35 128.95 13.13 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.222 0.534 . . . . 55.11 112.294 -173.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 34.9 mt -110.73 134.55 52.38 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.048 1.339 . . . . 72.25 109.184 174.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.03 -111.85 3.68 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 112.203 -0.359 . . . . 74.45 112.203 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.81 4.47 8.79 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.733 0.813 . . . . 74.52 110.174 178.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -125.22 173.76 8.56 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.688 0.795 . . . . 51.42 110.065 -174.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 82.3 m -72.7 139.58 47.32 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.208 0.528 . . . . 61.24 110.558 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.459 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.7 -67.85 0.8 Allowed 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.012 0.925 . . . . 72.51 108.57 173.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -152.38 160.9 43.24 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.857 -0.611 . . . . 55.45 110.653 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.407 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 68.5 mt -122.84 110.95 16.08 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.739 -1.208 . . . . 72.44 107.739 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.478 ' SG ' HG23 ' D' ' 114' ' ' ILE . 46.0 t -123.73 115.09 20.83 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.124 0.57 . . . . 52.44 109.906 -173.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -130.83 122.83 27.79 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.534 0.734 . . . . 73.33 109.855 -171.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.14 119.21 48.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 C-N-CA 123.259 0.624 . . . . 71.34 109.676 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.4 mt-30 -89.65 87.8 7.16 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.214 -0.662 . . . . 72.44 109.214 170.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.21 109.89 15.1 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.742 -1.117 . . . . 63.12 108.826 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.3 143.83 16.92 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 111.524 -0.63 . . . . 72.55 111.524 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.92 134.41 6.57 Favored Glycine 0 CA--C 1.509 -0.287 0 N-CA-C 110.933 -0.867 . . . . 52.32 110.933 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 48.3 mt -89.0 121.96 39.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 108.251 -1.018 . . . . 74.44 108.251 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -131.13 127.8 38.83 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.202 0.314 . . . . 63.12 110.366 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.465 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 21.2 m -75.96 104.82 6.68 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.064 -0.717 . . . . 71.24 109.064 170.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.465 HD11 HD12 ' D' ' 89' ' ' ILE . 16.4 tt -126.6 133.23 69.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-O 121.38 0.609 . . . . 74.34 111.077 -174.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.49 168.38 26.34 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.244 1.017 . . . . 45.22 109.601 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.07 13.37 81.12 Favored Glycine 0 N--CA 1.473 1.114 0 N-CA-C 114.289 0.476 . . . . 74.33 114.289 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.465 HD12 HD11 ' D' ' 86' ' ' ILE . 37.1 mt -113.49 139.34 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.433 1.093 . . . . 74.41 109.175 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.455 ' HA ' ' HE3' ' D' ' 94' ' ' MET . 8.7 pt-20 -153.77 158.22 40.61 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.51 0.506 . . . . 73.24 112.205 -171.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.56 -137.34 23.37 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.097 -0.956 . . . . 25.44 112.445 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 40.9 p -69.68 -20.6 63.56 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.581 0.753 . . . . 42.01 111.342 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.401 ' NE2' HG12 ' D' ' 89' ' ' ILE . 46.1 tt0 -60.11 -32.53 71.08 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.953 0.901 . . . . 74.11 111.262 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.455 ' HE3' ' HA ' ' D' ' 90' ' ' GLU . 54.4 mtt -62.49 -47.61 83.22 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.38 0.672 . . . . 74.42 110.717 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.51 94.04 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.039 -0.982 . . . . 42.14 110.471 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -66.81 -43.71 83.12 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.214 0.606 . . . . 72.41 111.785 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 39.5 t -63.13 -51.04 68.08 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.326 0.584 . . . . 61.51 110.463 -172.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.401 HD21 HD13 ' D' ' 86' ' ' ILE . 73.9 mt -85.91 -21.24 28.06 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.23 -0.895 . . . . 64.54 111.448 -175.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.39 8.62 55.31 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 119.628 -0.54 . . . . 51.43 114.03 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.92 -54.29 0.09 Allowed 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 117.28 0.54 . . . . 74.45 111.586 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -70.13 -51.1 34.12 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.662 0.385 . . . . 72.32 111.871 -173.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 30.6 m -67.15 -42.16 38.73 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 123.175 0.59 . . . . 40.12 111.904 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -53.72 -35.35 78.04 Favored 'Trans proline' 0 C--N 1.393 2.888 0 C-N-CA 122.667 2.244 . . . . 72.1 113.346 166.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -68.8 -32.92 72.99 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.514 0.726 . . . . 65.15 110.319 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 50.2 mm -67.5 -40.23 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 121.394 0.616 . . . . 75.11 110.146 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.569 HD12 HD23 ' D' ' 60' ' ' LEU . 95.6 mt -84.05 -15.52 47.19 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.274 -0.875 . . . . 63.51 112.064 -176.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . 0.402 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 83.3 t80 -61.68 -50.08 83.61 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 124.437 1.095 . . . . 63.4 112.945 -175.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 38.1 Cg_exo -59.72 -34.6 96.05 Favored 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 122.144 1.896 . . . . 52.33 112.945 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -78.34 -37.22 45.0 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.562 0.745 . . . . 64.21 112.211 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.0 -46.35 78.29 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.426 -0.583 . . . . 75.5 109.426 176.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.413 ' NH2' HG23 ' B' ' 105' ' ' ILE . 46.7 ttp180 -57.37 -47.74 80.86 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 124.41 1.068 . . . . 71.34 110.921 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -60.42 -49.88 75.8 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.808 0.843 . . . . 64.15 111.185 -177.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -56.2 -41.8 76.18 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 123.882 0.739 . . . . 42.12 111.101 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.478 HG23 ' SG ' ' D' ' 76' ' ' CYS . 98.0 mt -63.46 -56.44 17.06 Favored 'Isoleucine or valine' 0 C--N 1.349 0.568 0 CA-C-N 115.17 -0.923 . . . . 71.53 110.202 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -55.14 -36.82 66.18 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.438 1.095 . . . . 74.22 111.739 -173.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 37.2 t -66.97 -43.94 81.76 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.403 -0.817 . . . . 73.51 110.553 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 78.2 mtm -70.64 -25.88 63.22 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.74 0.416 . . . . 72.1 111.956 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.2 t -65.73 -43.79 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.274 0.63 . . . . 61.21 109.638 174.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.7 p -77.03 -27.44 54.49 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.998 -0.546 . . . . 54.22 111.142 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' D' ' 116' ' ' SER . 89.9 mtt-85 -73.02 -35.83 66.85 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.416 0.686 . . . . 65.01 109.866 174.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.4 -2.34 89.32 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.547 -0.751 . . . . 74.25 112.024 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.7 p 65.9 20.44 11.36 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 127.054 2.142 . . . . 63.24 113.657 172.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -79.16 155.0 77.38 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.418 0.687 . . . . 65.44 110.129 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.58 133.71 54.91 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.078 2.519 . . . . 64.32 112.548 172.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -54.41 140.75 32.9 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.416 1.086 . . . . 73.23 112.644 -172.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 62.4 tp -121.2 110.07 15.73 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.165 0.986 . . . . 71.04 109.141 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -111.21 104.96 13.51 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.812 -0.81 . . . . 64.25 108.812 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 tt -70.53 114.21 8.41 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 107.609 -1.256 . . . . 55.44 107.609 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.65 138.32 88.37 Favored Pre-proline 0 N--CA 1.475 0.823 0 CA-C-O 119.609 -0.234 . . . . 61.24 110.408 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -73.62 141.15 30.63 Favored 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 122.457 2.105 . . . . 72.1 111.693 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.241 0.635 0 C-N-CA 123.88 0.872 . . . . 74.24 108.961 -177.836 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.3 t80 . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 109.172 -0.677 . . . . 63.44 109.172 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -153.29 130.96 11.53 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.47 -1.308 . . . . 55.02 107.47 169.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.497 HD12 ' HB2' ' C' ' 130' ' ' PRO . 14.5 mt -80.71 114.76 22.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.778 -0.823 . . . . 74.05 108.778 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -72.55 -39.34 67.55 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 123.891 0.745 . . . . 72.22 110.055 -177.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -177.52 120.93 0.11 Allowed 'General case' 0 C--N 1.366 1.309 0 N-CA-C 111.74 0.274 . . . . 73.3 111.74 -172.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 78.6 mt -106.32 135.0 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.023 -0.732 . . . . 74.13 109.023 173.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.438 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 20.0 p90 -162.52 147.61 12.29 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 124.11 0.881 . . . . 65.32 109.968 -176.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.0 p -75.59 119.15 19.25 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.242 -0.651 . . . . 70.54 109.242 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.2 mtpt -83.22 -32.11 26.67 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.418 -0.586 . . . . 73.53 109.418 176.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 25.0 t70 -144.23 139.54 28.74 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.207 -0.906 . . . . 65.45 110.354 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.6 mt -133.22 145.61 33.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.941 1.296 . . . . 74.15 108.182 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.577 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 48.1 t -149.73 124.83 10.04 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.458 -0.792 . . . . 72.23 109.295 173.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.507 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 86.4 t80 -129.49 111.28 12.6 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 106.62 -1.622 . . . . 71.23 106.62 169.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -121.51 110.41 16.0 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.513 -0.551 . . . . 73.51 109.513 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.32 84.26 0.87 Allowed Pre-proline 0 C--O 1.241 0.654 0 N-CA-C 107.156 -1.424 . . . . 51.25 107.156 168.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.34 -19.3 29.17 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.161 1.908 . . . . 63.43 112.589 -168.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -120.26 22.76 11.24 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.933 0.893 . . . . 74.22 109.77 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.461 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -45.38 -55.04 12.78 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 113.969 1.1 . . . . 60.14 113.969 -170.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 23.2 Cg_exo -64.98 -16.95 57.93 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 121.989 1.792 . . . . 64.51 114.119 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -100.94 -26.01 13.88 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.305 1.042 . . . . 73.31 110.933 -176.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.81 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.5 p -80.78 -25.18 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 115.839 -0.619 . . . . 63.51 112.584 -166.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -71.08 -26.76 63.2 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.882 0.473 . . . . 72.32 110.779 -175.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -85.28 -13.77 48.7 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.534 0.733 . . . . 75.11 111.527 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.501 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 2.0 tmtp? -81.63 132.84 35.31 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.387 -0.968 . . . . 72.31 108.387 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.501 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 12.5 m-20 -52.51 132.35 35.05 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.663 1.185 . . . . 52.43 112.314 178.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.41 ' CE3' HD21 ' A' ' 68' ' ' LEU . 55.3 t-105 -78.57 89.17 4.5 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.374 0.607 . . . . 71.42 110.334 -175.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.488 ' H ' HD22 ' A' ' 68' ' ' LEU . 35.9 tt0 -120.21 78.49 26.18 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.905 1.282 . . . . 74.52 108.465 171.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.6 111.7 2.84 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.307 2.005 . . . . 71.23 113.239 -171.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -95.86 99.11 10.95 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 107.5 -1.296 . . . . 72.44 107.5 173.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.573 HG13 HG13 ' A' ' 64' ' ' VAL . 57.7 t -90.64 100.21 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 123.57 0.748 . . . . 52.02 110.5 -169.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -84.53 114.77 22.2 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.621 0.768 . . . . 60.54 109.754 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mp -104.67 108.35 19.76 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.918 -0.771 . . . . 73.32 108.918 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.542 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 10.7 t70 -102.35 124.49 48.02 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.949 1.3 . . . . 63.32 108.04 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.446 HD23 HD21 ' A' ' 60' ' ' LEU . 6.8 mp -111.77 125.81 54.4 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.901 0.382 . . . . 75.03 110.533 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 4.2 t70 -119.32 136.17 54.37 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.577 1.151 . . . . 71.04 108.716 175.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 46.9 p -107.75 136.44 47.48 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.243 0.617 . . . . 71.05 110.43 -174.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.618 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -139.13 137.09 35.81 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.575 0.75 . . . . 53.51 109.454 177.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.4 p -133.62 152.8 51.97 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.516 0.726 . . . . 74.45 110.381 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.9 t -161.07 127.38 3.93 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.049 0.54 . . . . 64.04 110.014 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -88.13 105.27 17.4 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.25 -1.019 . . . . 75.42 108.25 171.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.4 mt -79.33 -36.41 39.53 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.039 0.535 . . . . 73.51 111.541 -171.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.05 -174.13 3.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.475 0.71 . . . . 70.13 110.297 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -67.55 118.84 11.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.109 0.564 . . . . 72.34 109.534 171.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 67.69 13.16 9.17 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.819 1.248 . . . . 64.03 111.825 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.25 109.48 24.37 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 N-CA-C 107.864 -1.162 . . . . 72.34 107.864 175.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -129.58 155.49 45.72 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.272 -1.01 . . . . 74.43 108.272 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -129.6 124.59 34.15 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.089 0.556 . . . . 72.45 110.864 -174.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.421 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 85.3 t -109.07 113.42 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.317 -1.364 . . . . 60.33 107.317 166.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 40.3 t -103.55 135.05 42.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.554 -0.906 . . . . 74.12 108.554 171.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.446 HD21 HD23 ' A' ' 44' ' ' LEU . 2.6 tt -129.0 119.12 23.72 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.385 -0.598 . . . . 73.1 109.385 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 12.1 ttm180 -84.84 110.33 18.75 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.251 1.02 . . . . 72.44 109.63 175.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.8 t -100.47 101.33 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 107.719 -1.215 . . . . 65.31 107.719 170.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 20.9 m -99.46 104.23 16.05 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.686 0.794 . . . . 72.41 109.029 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.724 HG11 HD21 ' A' ' 126' ' ' LEU . 14.1 t -104.9 119.63 54.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 123.754 0.822 . . . . 72.13 109.966 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.5 m -112.29 123.88 51.24 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.586 -0.894 . . . . 62.04 108.586 177.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.51 110.5 22.46 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 106.603 -1.629 . . . . 74.31 106.603 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.8 m -109.87 124.9 52.15 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.195 -0.669 . . . . 44.24 109.195 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.488 HD22 ' H ' ' A' ' 37' ' ' GLN . 40.2 mt -88.99 75.76 7.94 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.193 -1.41 . . . . 62.21 107.193 176.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.49 -88.75 0.72 Allowed Glycine 0 C--N 1.345 1.043 0 CA-C-N 114.949 -1.023 . . . . 52.13 110.991 -173.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -120.85 -4.93 9.65 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.501 0.721 . . . . 70.21 111.499 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -101.9 103.6 14.28 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.652 -0.499 . . . . 74.13 109.652 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.0 m -60.52 121.15 11.41 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.139 0.495 . . . . 61.11 110.976 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.81 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -69.55 -58.29 4.13 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.959 -1.019 . . . . 51.21 109.999 175.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -158.65 174.6 14.8 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.353 -1.294 . . . . 72.42 111.16 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.9 tp -132.11 142.6 49.56 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 113.778 -1.556 . . . . 72.24 107.636 173.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 75.1 m -142.7 94.96 2.71 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.293 0.637 . . . . 63.31 109.546 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 39.0 tt0 -115.07 115.62 27.11 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.549 -0.908 . . . . 52.1 108.549 -175.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.73 109.12 18.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.781 -0.822 . . . . 74.44 108.781 -175.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 76.0 mt-30 -85.58 84.09 7.71 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.117 -1.068 . . . . 73.13 108.117 173.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -76.48 99.4 4.9 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.508 -1.224 . . . . 72.51 108.949 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.99 144.82 22.11 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 110.298 -1.121 . . . . 60.44 110.298 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.468 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -144.78 120.92 1.47 Allowed Glycine 0 CA--C 1.5 -0.865 0 N-CA-C 110.382 -1.087 . . . . 63.43 110.382 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.0 mt -88.84 123.24 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 108.529 -0.915 . . . . 75.3 108.529 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.421 ' HE1' ' HB ' ' A' ' 58' ' ' VAL . 90.1 m-85 -121.44 119.87 33.32 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.49 -1.3 . . . . 72.35 107.49 -177.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.7 m -84.78 88.5 7.39 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.199 0.6 . . . . 64.44 109.504 173.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.426 HD13 ' H ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.119 0 CA-C-N 115.581 -0.736 . . . . 61.11 110.04 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 121.046 0.451 . . . . 70.2 111.308 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -72.24 -36.58 69.13 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.234 1.014 . . . . 70.12 110.704 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 81.9 m -66.39 -60.99 2.24 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.768 -0.456 . . . . 72.22 109.768 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 69.5 mt -60.24 -40.32 89.84 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.241 1.016 . . . . 65.12 112.061 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.66 -28.13 30.32 Favored Glycine 0 C--N 1.342 0.866 0 O-C-N 123.753 0.658 . . . . 71.42 114.128 -172.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.71 -59.71 1.2 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.982 0.734 . . . . 73.23 112.982 -171.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -73.55 -56.83 4.51 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.597 0.359 . . . . 73.55 111.86 -166.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 66.6 m -55.33 -41.09 88.92 Favored Pre-proline 0 CA--C 1.571 1.785 0 CA-C-O 118.308 -0.853 . . . . 62.13 112.855 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -49.33 -51.39 10.76 Favored 'Trans proline' 0 C--N 1.399 3.224 0 C-N-CA 122.728 2.286 . . . . 73.01 113.207 164.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.5 HD21 ' N ' ' A' ' 133' ' ' PHE . 95.0 m-20 -71.98 -15.4 62.06 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.748 0.819 . . . . 64.25 112.445 -177.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.457 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 30.3 mm -80.72 -45.1 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.259 0.623 . . . . 74.33 109.494 172.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.468 HD21 ' HA3' ' A' ' 82' ' ' GLY . 90.0 mt -74.66 -22.98 58.59 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.06 -0.518 . . . . 51.44 111.053 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -61.96 -46.0 91.96 Favored Pre-proline 0 CA--C 1.559 1.319 0 CA-C-O 117.499 -1.238 . . . . 73.52 113.002 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 34.5 Cg_exo -60.35 -35.37 91.48 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 121.837 1.692 . . . . 71.34 113.926 174.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -78.34 -35.82 47.07 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 122.899 0.479 . . . . 71.12 111.093 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.57 -37.91 68.07 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.2 0.6 . . . . 72.11 109.76 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.579 ' NH1' HG23 ' C' ' 105' ' ' ILE . 26.3 ttm180 -63.51 -39.95 95.77 Favored 'General case' 0 C--O 1.209 -1.05 0 C-N-CA 124.061 0.945 . . . . 72.51 109.309 173.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -63.39 -48.3 78.42 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.992 0.917 . . . . 73.11 111.038 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 32.9 t -60.58 -41.32 94.44 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 124.385 1.053 . . . . 74.43 110.04 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 69.1 mt -65.25 -46.77 89.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 123.579 0.752 . . . . 72.0 110.83 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 55.3 m -59.44 -39.22 82.86 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.449 1.1 . . . . 75.41 110.424 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.8 t -75.03 -47.19 30.23 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.893 -1.049 . . . . 64.22 110.476 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 13.7 mtp -57.44 -45.15 85.02 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.606 0.763 . . . . 75.45 111.948 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.2 t -63.61 -43.66 98.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 124.468 1.107 . . . . 74.43 110.878 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.0 t -70.83 -31.65 68.44 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.215 0.606 . . . . 72.52 111.463 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -73.8 -30.14 62.56 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.287 0.635 . . . . 74.24 109.726 176.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.38 -0.52 78.68 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.286 -0.87 . . . . 63.33 113.41 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.499 HG22 HH21 ' B' ' 15' ' ' ARG . 17.2 m 73.42 15.59 4.2 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-O 122.574 1.178 . . . . 64.55 111.425 173.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -86.27 154.82 57.4 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-N 115.588 -0.733 . . . . 63.4 110.221 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.25 129.7 34.79 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.772 2.315 . . . . 75.12 111.851 171.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -51.76 129.56 26.62 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 124.289 0.993 . . . . 75.53 112.268 -172.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.724 HD21 HG11 ' A' ' 64' ' ' VAL . 56.1 tp -109.47 97.99 7.46 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.229 -0.896 . . . . 55.14 110.177 -174.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -103.28 112.28 25.07 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.432 0.693 . . . . 64.5 109.401 174.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.0 mp -72.43 117.73 14.45 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.103 -1.073 . . . . 60.1 108.103 172.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.24 145.02 94.36 Favored Pre-proline 0 CA--C 1.56 1.354 0 CA-C-N 117.925 0.33 . . . . 73.1 110.716 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.45 ' HD3' HG13 ' C' ' 13' ' ' ILE . 13.7 Cg_exo -69.44 110.67 2.54 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.743 2.296 . . . . 71.22 112.084 -170.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.2 m -99.49 115.25 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 108.676 -0.861 . . . . 63.02 108.676 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -90.75 98.81 12.0 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.643 -0.873 . . . . 70.44 108.643 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.5 ' N ' HD21 ' A' ' 104' ' ' ASN . 72.7 m-85 . . . . . 0 CA--C 1.542 0.651 0 O-C-N 123.445 0.465 . . . . 74.31 110.278 170.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.42 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 26.2 ttt . . . . . 0 CA--C 1.561 1.398 0 CA-C-O 121.517 0.675 . . . . 74.11 111.942 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m -143.35 133.57 24.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.446 -1.316 . . . . 73.01 107.446 166.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -141.22 137.67 32.75 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.396 -0.594 . . . . 71.54 109.396 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.528 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -158.75 129.0 5.92 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.026 0.93 . . . . 62.33 108.753 173.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.449 HD11 HD13 ' B' ' 105' ' ' ILE . 15.8 mt -75.05 119.06 21.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.629 0 N-CA-C 108.001 -1.111 . . . . 71.11 108.001 169.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -96.3 -42.58 8.09 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 123.537 0.523 . . . . 63.44 110.199 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.499 HH21 HG22 ' A' ' 122' ' ' THR . 23.0 ttt85 -165.64 133.13 2.91 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.9 -0.591 . . . . 72.32 109.739 -175.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 71.8 mt -116.66 143.05 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 107.622 -1.251 . . . . 74.3 107.622 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -166.91 155.68 10.28 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.528 0.68 . . . . 74.32 112.129 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 89.1 m -84.27 120.46 26.26 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.771 -1.104 . . . . 52.32 108.361 170.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.543 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 33.1 mtpt -87.83 -33.74 18.48 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.031 0.532 . . . . 74.11 110.383 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 19.7 t70 -157.62 144.49 18.11 Favored 'General case' 0 C--N 1.347 0.48 0 N-CA-C 112.707 0.632 . . . . 73.4 112.707 -170.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 45.3 mm -137.51 142.14 37.55 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 C-N-CA 125.648 1.579 . . . . 62.4 108.472 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.3 t -147.21 127.22 13.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.924 -1.139 . . . . 63.44 107.924 173.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 90.7 t80 -139.57 110.91 7.02 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.435 -0.95 . . . . 75.32 108.435 175.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -118.04 115.44 24.87 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.351 1.061 . . . . 73.54 108.534 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.406 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.7 87.91 3.13 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.032 -1.099 . . . . 54.02 108.032 174.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.54 -44.52 4.41 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.649 2.232 . . . . 61.22 112.562 -170.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -97.29 16.48 19.83 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.936 0.894 . . . . 74.34 110.666 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.406 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -38.31 -59.92 1.15 Allowed Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 115.303 1.594 . . . . 75.24 115.303 -168.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -66.61 -26.44 46.45 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 122.039 1.826 . . . . 72.32 112.89 -170.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -93.96 -41.21 9.71 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 115.022 -0.99 . . . . 72.41 111.176 -172.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.6 p -71.18 -12.47 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.344 0.658 . . . . 54.24 111.837 -170.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -66.25 -12.56 57.01 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.584 0.754 . . . . 65.51 112.716 174.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -65.21 -16.41 63.5 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.321 0.648 . . . . 73.01 111.427 174.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -107.53 111.62 23.98 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.023 1.329 . . . . 72.0 111.09 -176.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -107.53 95.16 5.5 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.309 0.644 . . . . 71.53 110.935 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 39.3 p90 -169.27 175.45 5.61 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.7 1.2 . . . . 63.15 108.78 167.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -73.79 107.89 4.11 Favored Pre-proline 0 CA--C 1.555 1.142 0 N-CA-C 109.891 -0.411 . . . . 73.14 109.891 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.485 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 30.5 Cg_endo -64.71 149.73 89.27 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.663 2.242 . . . . 74.32 113.565 -173.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -63.09 114.87 3.99 Favored 'General case' 0 C--N 1.359 1.006 0 O-C-N 124.087 0.867 . . . . 75.3 110.052 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.563 HG13 HG13 ' B' ' 64' ' ' VAL . 88.3 t -92.57 144.09 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 123.983 0.913 . . . . 72.21 111.29 -172.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.512 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 23.6 ttpp -128.82 116.43 19.44 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.845 -1.539 . . . . 74.31 106.845 168.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.555 ' H ' HD23 ' B' ' 42' ' ' LEU . 1.6 pt? -84.11 149.07 26.45 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.146 -0.687 . . . . 75.25 109.146 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.756 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 6.9 m-20 -139.52 110.0 6.62 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.16 -1.422 . . . . 74.21 107.16 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 84.0 mt -104.46 127.12 52.09 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.502 -0.925 . . . . 74.54 108.502 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 14.5 t70 -133.11 143.92 49.61 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.801 0.84 . . . . 64.2 109.409 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 81.3 p -109.98 126.17 53.65 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.755 0.822 . . . . 63.14 110.246 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.06 148.91 52.2 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.837 0.855 . . . . 73.33 109.355 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.9 p -144.48 164.39 31.0 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.703 0.631 . . . . 73.25 112.703 -174.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 69.7 p -155.13 146.74 23.17 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.152 -0.931 . . . . 73.51 109.552 166.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -97.62 128.89 44.67 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.95 -0.759 . . . . 70.35 108.95 174.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.9 mt -97.58 -54.15 3.21 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.315 0.578 . . . . 73.55 110.238 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.38 -168.15 2.98 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.065 -0.971 . . . . 72.32 110.051 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -67.43 103.23 1.26 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.651 -1.158 . . . . 74.44 110.602 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 67.12 15.23 10.03 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.136 1.375 . . . . 64.13 112.414 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 68.0 t -105.74 105.71 19.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 107.52 -1.289 . . . . 72.31 107.52 172.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.648 ' HB2' HD11 ' B' ' 86' ' ' ILE . 6.1 t80 -110.53 165.87 11.46 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.339 -0.846 . . . . 63.23 109.003 -172.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -136.23 114.08 11.21 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.966 -1.124 . . . . 72.03 107.966 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 95.8 t -104.09 118.43 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.829 1.252 . . . . 62.51 110.443 -171.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 13.3 t -109.76 122.55 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 109.496 -0.557 . . . . 72.42 109.496 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.523 HD22 ' HB2' ' B' ' 103' ' ' PRO . 51.8 tp -106.3 110.28 22.46 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.76 -0.83 . . . . 72.45 108.76 170.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.514 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 22.1 ttm-85 -85.94 109.38 18.71 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.223 -0.658 . . . . 71.24 109.223 173.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 30.7 t -106.26 101.86 13.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 108.143 -1.058 . . . . 75.31 108.143 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.756 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 10.4 m -102.32 128.76 48.74 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.747 -0.834 . . . . 42.14 108.747 175.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.563 HG13 HG13 ' B' ' 40' ' ' VAL . 61.3 t -119.91 108.16 22.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 123.85 0.86 . . . . 61.42 109.289 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 96.4 m -82.34 144.66 30.42 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.409 -0.96 . . . . 70.33 108.409 169.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.15 144.56 29.08 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 122.952 0.501 . . . . 73.04 109.928 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.442 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 36.1 p -147.65 127.13 13.19 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.501 0.501 . . . . 74.32 111.127 -175.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.507 HD12 HG22 ' B' ' 31' ' ' VAL . 72.7 mt -94.66 110.16 22.02 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.234 -1.025 . . . . 51.15 108.234 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.41 -112.86 3.67 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 115.477 -0.783 . . . . 62.45 111.771 -176.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -120.96 9.46 10.61 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.435 0.694 . . . . 74.3 110.421 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -123.19 155.15 37.65 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.47 0.708 . . . . 61.1 109.66 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 29.6 m -68.98 133.71 48.53 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.961 0.41 . . . . 63.45 109.984 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.514 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -87.98 -63.58 1.28 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.713 -1.217 . . . . 73.24 107.713 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -150.8 161.31 42.91 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.439 -1.255 . . . . 72.43 110.857 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 85.7 mt -125.73 113.28 17.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.564 -2.013 . . . . 61.53 105.564 172.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.8 t -116.66 151.37 36.45 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.5 -0.926 . . . . 72.3 108.5 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.425 ' HB2' HG23 ' B' ' 63' ' ' THR . 42.8 tt0 -161.14 133.18 5.82 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.055 0.455 . . . . 60.25 109.812 -175.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 93.3 t -134.12 149.0 29.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 124.697 1.199 . . . . 74.31 108.261 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.459 HE21 ' HB3' ' B' ' 20' ' ' ASP . 25.6 mt-30 -125.25 107.01 10.3 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.121 -1.066 . . . . 73.14 108.121 169.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.401 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.8 tp-100 -96.5 101.22 12.81 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.656 -0.868 . . . . 74.11 108.656 178.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.543 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -95.09 144.39 17.17 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.366 -0.834 . . . . 63.52 111.275 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.59 126.84 3.13 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.427 -0.669 . . . . 74.13 111.427 -176.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 70.2 mt -83.96 127.43 39.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.795 -0.817 . . . . 74.21 108.795 174.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -137.85 135.77 36.51 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.936 -0.764 . . . . 73.43 108.936 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.8 m -89.24 98.32 11.7 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.693 -0.855 . . . . 72.3 108.693 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.648 HD11 ' HB2' ' B' ' 56' ' ' TYR . 1.7 pp -111.48 129.53 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.93 0.892 . . . . 62.51 110.702 -175.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.65 167.31 22.86 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.153 0.581 . . . . 73.41 109.815 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 88.28 -59.42 4.14 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 114.017 0.367 . . . . 42.42 114.017 172.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 15.4 mm -78.85 138.21 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 123.632 0.773 . . . . 71.53 110.067 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -157.24 174.65 15.14 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 115.846 -0.615 . . . . 63.1 111.928 -163.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.11 -127.83 44.82 Favored Glycine 0 C--N 1.354 1.562 0 C-N-CA 123.418 0.532 . . . . 34.42 113.78 -177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 51.8 m -66.29 -30.87 71.37 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.983 0.913 . . . . 74.03 110.94 175.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -65.79 -45.3 82.94 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.707 -0.679 . . . . 71.13 110.544 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -71.17 -24.83 62.32 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.534 0.334 . . . . 73.33 111.425 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.82 -45.15 95.08 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 123.664 0.603 . . . . 43.42 109.875 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -64.66 -40.77 96.0 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.233 0.613 . . . . 71.41 111.307 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.4 t -62.14 -44.57 96.32 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.766 0.427 . . . . 65.43 111.648 -176.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 9.2 mp -92.75 -16.86 24.91 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.046 0.539 . . . . 73.34 111.708 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.11 2.87 47.61 Favored Glycine 0 N--CA 1.474 1.211 0 CA-C-O 120.052 -0.304 . . . . 64.32 113.643 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' B' ' 104' ' ' ASN . . . -145.07 -57.36 0.34 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.22 0.608 . . . . 74.01 110.57 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -74.02 -51.81 14.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.997 0.519 . . . . 75.44 112.293 -171.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 72.0 m -60.8 -49.23 90.35 Favored Pre-proline 0 CA--C 1.565 1.536 0 CA-C-O 118.59 -0.719 . . . . 65.11 112.44 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.523 ' HB2' HD22 ' B' ' 60' ' ' LEU . 71.5 Cg_endo -71.56 -16.7 30.41 Favored 'Trans proline' 0 C--N 1.393 2.87 0 C-N-CA 122.08 1.853 . . . . 75.21 113.319 176.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' B' ' 100' ' ' ALA . 51.4 t-20 -65.64 -41.21 92.89 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 123.469 0.708 . . . . 63.22 109.594 174.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.449 HD13 HD11 ' B' ' 13' ' ' ILE . 73.7 mt -60.54 -45.36 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.538 1.135 . . . . 73.13 110.741 175.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 49.5 mt -84.01 -13.22 53.81 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.224 -1.353 . . . . 74.34 111.612 -170.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -57.24 -55.74 41.13 Favored Pre-proline 0 CA--C 1.561 1.366 0 CA-C-O 117.946 -1.026 . . . . 70.43 113.549 -176.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -64.85 -27.1 59.26 Favored 'Trans proline' 0 C--N 1.383 2.368 0 CA-C-N 121.338 1.514 . . . . 62.14 113.186 -174.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.401 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.0 m-85 -68.69 -48.45 63.85 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.839 0.456 . . . . 74.52 109.888 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.59 90.12 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.449 -0.796 . . . . 62.4 110.745 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 45.2 ttt-85 -62.45 -49.03 77.04 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.757 1.223 . . . . 72.32 111.376 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -65.88 -36.85 84.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 123.711 0.632 . . . . 75.54 109.791 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.513 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.5 t -70.96 -33.8 70.82 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.892 -0.595 . . . . 61.15 111.369 -178.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.471 ' O ' HG23 ' B' ' 118' ' ' VAL . 55.6 mt -64.48 -54.64 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 109.17 -0.678 . . . . 73.51 109.17 173.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 4.3 m -63.72 -23.41 67.36 Favored 'General case' 0 CA--C 1.555 1.168 0 O-C-N 123.85 0.719 . . . . 71.02 111.353 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.434 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.0 t -67.25 -49.02 66.0 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 123.075 0.55 . . . . 73.23 109.812 172.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.513 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.4 mmt -68.68 -31.83 71.22 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.804 0.442 . . . . 73.22 111.042 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.471 HG23 ' O ' ' B' ' 114' ' ' ILE . 90.9 t -64.17 -42.67 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.837 0.855 . . . . 72.35 109.962 172.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.6 t -67.18 -31.39 71.75 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.924 -1.034 . . . . 63.41 111.336 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.438 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 81.7 mtt-85 -73.45 -38.11 65.6 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.26 0.624 . . . . 61.4 110.061 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.95 -3.94 75.98 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 123.729 0.643 . . . . 75.13 112.609 169.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 34.3 p 63.46 24.08 13.96 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 126.426 1.89 . . . . 72.24 113.129 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -77.77 160.58 74.05 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 124.533 1.133 . . . . 74.32 111.36 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -51.95 162.29 1.92 Allowed 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 123.677 2.918 . . . . 74.44 115.049 173.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.674 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 56.3 tp60 -60.24 128.81 38.6 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.287 1.035 . . . . 74.13 111.574 -173.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.436 HD21 HG21 ' B' ' 40' ' ' VAL . 1.4 tm? -146.4 99.79 3.27 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.647 -0.871 . . . . 74.34 108.647 -174.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -131.53 132.2 43.98 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.722 0.809 . . . . 72.35 109.505 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.98 150.41 45.69 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.332 0.653 . . . . 73.33 112.383 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.0 153.19 69.47 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 124.114 0.966 . . . . 70.34 111.702 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.407 ' HB2' HD12 ' D' ' 13' ' ' ILE . 57.8 Cg_endo -68.03 116.72 4.47 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.112 2.541 . . . . 74.14 112.406 176.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 72.3 t -127.79 111.44 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.89 -0.781 . . . . 71.11 108.89 173.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -80.27 94.27 6.06 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 107.688 -1.227 . . . . 73.15 107.688 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -56.69 -41.55 77.53 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.136 0.974 . . . . 53.22 111.487 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 . . . . . 0 C--O 1.239 0.504 0 C-N-CA 124.324 1.049 . . . . 74.03 112.034 -176.56 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.52 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 42.0 t80 . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 109.691 -0.485 . . . . 75.42 109.691 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -159.72 134.31 7.77 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.082 0.953 . . . . 73.14 108.581 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.45 HG13 ' HD3' ' A' ' 130' ' ' PRO . 74.9 mt -72.8 120.46 21.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.492 -0.929 . . . . 65.55 108.492 168.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -89.86 -45.48 9.22 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.698 -0.683 . . . . 75.11 109.36 175.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -176.47 141.31 0.4 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.005 -0.998 . . . . 73.01 108.481 -168.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.401 HG21 ' CD1' ' C' ' 109' ' ' TYR . 56.0 mt -137.01 144.96 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 108.993 -0.743 . . . . 74.44 108.993 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.466 ' HB3' HG23 ' D' ' 122' ' ' THR . 22.3 p90 -174.89 159.94 2.79 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.576 0.703 . . . . 72.13 110.077 -173.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . 0.46 HG21 ' SG ' ' C' ' 113' ' ' CYS . 81.0 p -78.91 119.36 21.97 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.911 -1.04 . . . . 65.35 108.988 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -69.44 -46.43 66.77 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 107.133 -1.432 . . . . 51.03 107.133 168.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.2 t70 -135.04 143.05 46.52 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 113.016 -1.902 . . . . 53.12 109.748 -171.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 70.4 mt -136.8 150.44 26.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 105.928 -1.878 . . . . 73.4 105.928 170.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -163.86 151.16 12.24 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.333 0.587 . . . . 72.03 110.012 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -146.21 124.45 12.23 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.183 -1.414 . . . . 61.31 107.183 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -126.98 110.43 12.97 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.086 -0.709 . . . . 72.43 109.086 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.38 84.65 29.39 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 107.292 -1.373 . . . . 50.03 107.292 167.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.41 -37.03 24.73 Favored 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 122.331 2.02 . . . . 72.24 111.011 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -95.83 22.69 7.03 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.044 -0.98 . . . . 71.03 110.64 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.71 -54.45 27.1 Favored Pre-proline 0 CA--C 1.564 1.518 0 N-CA-C 114.127 1.158 . . . . 32.1 114.127 -172.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.54 -40.48 47.04 Favored 'Trans proline' 0 C--N 1.39 2.726 0 CA-C-N 121.797 1.677 . . . . 60.43 111.961 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -70.69 -31.83 68.86 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.659 -1.155 . . . . 74.4 112.563 -175.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.65 HG21 ' HA ' ' C' ' 73' ' ' ALA . 11.7 p -81.46 -26.0 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 112.756 0.65 . . . . 70.54 112.756 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -67.6 -24.58 65.51 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 120.793 0.33 . . . . 74.15 111.71 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -90.49 25.5 2.26 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.789 0.836 . . . . 53.21 110.95 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.539 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -121.32 157.83 29.54 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.603 0.761 . . . . 62.33 110.485 178.547 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -70.19 131.91 44.96 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.956 0.902 . . . . 72.21 110.134 170.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -84.5 88.13 7.29 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.344 0.658 . . . . 72.24 110.779 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -132.48 78.97 66.36 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 108.021 -1.103 . . . . 72.43 108.021 171.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' C' ' 67' ' ' SER . 3.2 Cg_exo -78.54 126.71 7.64 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.574 2.183 . . . . 65.25 113.919 -172.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -85.05 91.6 8.14 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 106.249 -1.76 . . . . 74.15 106.249 160.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 28.6 m -80.15 142.69 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 114.345 -1.298 . . . . 62.44 111.262 -173.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.525 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 45.5 mmtm -124.52 103.1 7.97 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.597 -0.89 . . . . 54.45 108.597 172.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' C' ' 42' ' ' LEU . 2.2 pp -86.83 151.5 23.29 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.158 -0.682 . . . . 73.34 109.158 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -144.73 138.75 27.43 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.021 -0.733 . . . . 65.01 109.021 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 mp -125.35 114.97 19.59 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.254 -1.017 . . . . 75.33 108.254 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.592 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 11.3 t70 -111.98 144.5 41.23 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.945 0.898 . . . . 74.31 109.045 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -113.28 113.07 24.77 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.489 -0.778 . . . . 74.11 110.613 -169.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.77 141.56 50.37 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.833 0.853 . . . . 70.15 109.362 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 35.2 p -165.84 158.62 15.2 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.626 0.37 . . . . 75.24 111.832 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -161.46 148.93 14.88 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.646 0.779 . . . . 62.43 110.464 -174.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -92.23 126.7 37.42 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.35 -0.611 . . . . 63.25 109.35 172.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.669 HD11 HD12 ' C' ' 83' ' ' ILE . 74.9 mt -89.21 -54.0 4.31 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.563 0.745 . . . . 62.21 111.137 -176.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.91 -166.88 2.46 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.738 -0.665 . . . . 70.14 110.564 -174.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -57.35 103.57 0.13 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.476 1.111 . . . . 71.24 110.401 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 64.14 7.05 3.21 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.05 1.34 . . . . 65.5 113.033 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 88.1 t -97.12 113.92 32.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 107.665 -1.235 . . . . 74.05 107.665 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -118.44 159.85 22.75 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.343 -0.844 . . . . 74.05 109.119 -175.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -126.28 122.68 36.19 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.048 0.939 . . . . 74.22 109.156 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 87.4 t -109.59 125.33 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 107.738 -1.208 . . . . 63.23 107.738 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 66.2 t -124.05 125.67 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 109.083 -0.71 . . . . 43.35 109.083 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.526 HD22 ' HB2' ' C' ' 103' ' ' PRO . 33.4 tp -112.69 116.58 30.36 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 109.229 -0.656 . . . . 63.44 109.229 175.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.592 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 16.7 ttm-85 -82.09 109.31 16.3 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.446 -0.797 . . . . 73.22 109.005 174.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 36.4 t -103.56 119.17 51.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.033 -1.099 . . . . 55.11 108.033 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 27.3 m -125.41 121.49 34.02 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.228 -0.656 . . . . 51.31 109.228 -175.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.664 HG23 HD13 ' C' ' 114' ' ' ILE . 68.4 t -105.82 115.51 47.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 123.767 0.827 . . . . 60.22 109.019 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 3.7 m -98.48 139.45 34.2 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.359 -1.349 . . . . 60.11 107.359 169.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.94 122.96 31.33 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.072 -1.085 . . . . 43.52 108.072 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' C' ' 38' ' ' PRO . 54.1 m -132.54 156.28 47.12 Favored 'General case' 0 C--O 1.213 -0.851 0 C-N-CA 123.393 0.677 . . . . 62.4 109.181 175.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.539 HD13 ' HG2' ' C' ' 34' ' ' LYS . 39.0 mt -119.07 38.76 3.73 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.439 -1.319 . . . . 75.43 107.439 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.82 -99.59 1.65 Allowed Glycine 0 C--N 1.347 1.178 0 CA-C-N 114.606 -1.179 . . . . 73.35 110.469 -170.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -90.33 -30.8 17.23 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.343 0.657 . . . . 72.41 110.438 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -73.22 116.1 13.36 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.87 0.868 . . . . 74.52 110.654 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.1 m -76.85 118.35 19.36 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.376 -0.972 . . . . 73.44 108.376 168.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.65 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.88 -53.02 9.82 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.953 0.783 . . . . 53.24 109.02 176.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -165.96 173.39 10.5 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-N 115.509 -0.769 . . . . 72.55 112.392 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.505 HD23 HG23 ' C' ' 65' ' ' THR . 2.4 tm? -140.94 102.45 4.27 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 105.836 -1.913 . . . . 74.01 105.836 172.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.474 ' SG ' HG23 ' C' ' 114' ' ' ILE . 46.4 t -109.97 112.0 23.74 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.194 -0.669 . . . . 74.54 109.194 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -118.23 127.57 53.87 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.064 0.546 . . . . 70.15 110.162 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 73.2 t -124.33 138.49 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 108.714 -0.847 . . . . 72.24 108.714 170.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.576 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 47.9 mt-30 -113.1 95.17 5.25 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.714 -0.847 . . . . 64.52 108.714 172.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -81.8 106.93 14.12 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.385 -0.825 . . . . 73.42 109.405 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.52 149.13 20.4 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.539 -0.625 . . . . 72.12 111.539 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.18 117.05 0.92 Allowed Glycine 0 CA--C 1.506 -0.482 0 N-CA-C 111.012 -0.835 . . . . 71.04 111.012 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.669 HD12 HD11 ' C' ' 51' ' ' LEU . 12.5 mm -81.92 125.99 39.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 108.395 -0.965 . . . . 75.34 108.395 175.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.416 ' HD2' ' HA ' ' C' ' 13' ' ' ILE . 48.2 m-85 -138.77 142.02 38.8 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.277 -0.638 . . . . 74.33 109.277 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 60.7 m -70.76 115.56 10.05 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.354 -1.35 . . . . 54.51 107.354 164.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 69.8 mt -133.64 110.99 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 109.122 -0.696 . . . . 65.31 109.122 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.55 167.52 19.26 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.91 0.884 . . . . 72.13 110.591 177.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.43 -40.44 2.54 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 116.349 -0.387 . . . . 72.31 113.299 171.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 23.6 pt -101.78 174.77 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.237 0.615 . . . . 71.31 111.038 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -150.31 153.69 36.55 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 111.999 0.37 . . . . 74.31 111.999 -175.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.54 -115.92 8.59 Favored Glycine 0 C--N 1.353 1.486 0 N-CA-C 114.844 0.698 . . . . 54.43 114.844 169.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 75.5 p -74.49 -29.53 61.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.331 0.652 . . . . 72.1 110.986 -175.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -60.43 -48.26 82.53 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.695 -0.854 . . . . 74.34 108.695 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.473 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 51.8 ttm -69.71 -33.81 73.02 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.868 -1.514 . . . . 70.02 110.9 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.26 88.15 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.388 0.675 . . . . 65.22 111.66 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -71.2 -32.57 69.01 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.222 -0.445 . . . . 63.35 110.454 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.9 t -67.96 -61.57 1.8 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 122.628 0.371 . . . . 64.43 111.056 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' C' ' 94' ' ' MET . 2.5 pp -70.24 -25.61 63.46 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.069 0.396 . . . . 64.24 112.069 -178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.95 -17.22 44.76 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 114.584 0.593 . . . . 62.53 114.584 -172.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.73 -53.19 0.87 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 117.466 0.633 . . . . 72.15 111.231 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -72.6 -46.65 53.13 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.615 0.766 . . . . 74.03 112.622 -168.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.52 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 33.7 m -73.35 -46.94 7.74 Favored Pre-proline 0 CA--C 1.569 1.683 0 N-CA-C 113.123 0.786 . . . . 65.42 113.123 -175.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.526 ' HB2' HD22 ' C' ' 60' ' ' LEU . 87.7 Cg_endo -75.87 -10.37 19.81 Favored 'Trans proline' 0 C--N 1.387 2.557 0 C-N-CA 122.094 1.863 . . . . 71.42 112.762 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.66 -32.73 74.53 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.487 0.715 . . . . 62.54 110.314 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.579 HG23 ' NH1' ' A' ' 111' ' ' ARG . 14.6 mm -70.74 -36.5 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.208 -0.905 . . . . 73.44 110.067 177.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 43.8 mt -85.86 -22.52 27.5 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.719 -1.128 . . . . 73.33 111.677 -172.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -58.72 -52.94 71.18 Favored Pre-proline 0 CA--C 1.56 1.352 0 CA-C-O 118.198 -0.906 . . . . 75.22 112.795 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -65.65 -32.02 48.54 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 121.54 1.493 . . . . 75.31 112.382 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.401 ' CD1' HG21 ' C' ' 16' ' ' ILE . 2.6 m-30 -67.23 -45.47 76.68 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.859 0.863 . . . . 72.12 110.025 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.7 -37.87 87.64 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.236 1.014 . . . . 65.35 110.735 176.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -60.8 -49.08 78.91 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.6 1.16 . . . . 72.5 110.794 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -69.98 -34.07 72.89 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.119 0.568 . . . . 73.5 110.058 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.46 ' SG ' HG21 ' C' ' 18' ' ' THR . 21.4 t -69.26 -31.29 69.73 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.936 0.494 . . . . 40.43 111.502 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.664 HD13 HG23 ' C' ' 64' ' ' VAL . 86.3 mt -73.53 -55.31 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.081 0.553 . . . . 73.21 109.662 173.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 17.1 m -63.87 -27.6 69.27 Favored 'General case' 0 CA--C 1.553 1.074 0 O-C-N 123.653 0.596 . . . . 71.3 111.374 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 36.6 t -62.02 -50.86 70.36 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.232 -0.655 . . . . 70.11 109.232 171.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.552 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.64 -36.07 79.72 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.318 1.047 . . . . 75.42 112.409 178.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.73 -45.23 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.38 0.672 . . . . 72.55 109.821 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 31.0 t -70.6 -25.35 63.01 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 114.907 -1.042 . . . . 71.4 111.809 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' C' ' 116' ' ' SER . 87.2 mtt-85 -74.18 -40.65 62.37 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.35 0.66 . . . . 71.22 109.417 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.72 -0.12 62.88 Favored Glycine 0 C--N 1.354 1.553 0 CA-C-N 115.617 -0.72 . . . . 34.24 112.575 169.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 25.3 p 62.64 30.89 16.97 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 126.787 2.035 . . . . 74.24 113.378 170.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -83.92 148.91 55.19 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 109.044 -0.725 . . . . 74.3 109.044 170.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.674 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 86.3 Cg_exo -51.41 146.91 23.59 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 123.422 2.748 . . . . 75.23 114.2 176.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -58.81 112.11 1.52 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.985 -1.007 . . . . 75.34 112.358 -173.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 42.8 tp -112.83 86.3 2.34 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.373 -0.973 . . . . 75.33 108.373 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -94.2 106.44 18.41 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.224 -0.898 . . . . 74.4 108.816 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 56.9 tp -65.47 144.98 56.69 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.133 0.573 . . . . 44.21 111.525 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.07 143.94 92.09 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 124.03 0.932 . . . . 63.44 110.882 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.497 ' HB2' HD12 ' A' ' 13' ' ' ILE . 5.6 Cg_exo -71.4 127.42 13.29 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.77 2.314 . . . . 42.15 112.237 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -119.18 111.8 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.722 0.809 . . . . 74.44 109.401 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -80.69 97.52 7.3 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.481 0.712 . . . . 44.31 110.448 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -65.07 -41.8 94.75 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.241 -0.652 . . . . 75.45 109.241 170.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 20.4 t70 . . . . . 0 CA--C 1.538 0.494 0 CA-C-N 114.163 -1.381 . . . . 42.45 112.112 177.18 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 30.8 m . . . . . 0 C--O 1.241 0.636 0 N-CA-C 108.542 -0.911 . . . . 51.43 108.542 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -157.66 114.63 2.96 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.858 -0.793 . . . . 63.24 108.858 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -134.06 126.18 29.59 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.038 -1.097 . . . . 75.42 108.038 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.566 HD13 HG21 ' D' ' 105' ' ' ILE . 10.4 mt -78.23 127.76 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.165 -0.68 . . . . 63.31 109.165 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -87.37 -41.61 13.48 Favored 'General case' 0 C--O 1.24 0.583 0 O-C-N 123.704 0.627 . . . . 42.5 110.001 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 -175.17 142.83 0.65 Allowed 'General case' 0 N--CA 1.484 1.273 0 O-C-N 123.173 0.296 . . . . 61.1 111.676 -172.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.502 HD11 HG21 ' D' ' 13' ' ' ILE . 3.4 mp -117.14 136.45 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.303 -1.369 . . . . 72.04 107.303 168.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.457 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 24.5 p90 -163.87 147.39 9.94 Favored 'General case' 0 C--O 1.242 0.659 0 O-C-N 123.871 0.732 . . . . 74.5 110.236 176.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 78.4 p -77.97 106.75 10.04 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.351 -0.84 . . . . 71.25 108.887 173.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.457 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 37.6 mtpt -73.19 -30.57 63.62 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.466 0.65 . . . . 74.44 109.994 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.424 ' HB3' ' HB3' ' D' ' 79' ' ' GLN . 10.6 t70 -152.42 141.46 21.26 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.012 -1.449 . . . . 75.12 108.934 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.552 HG21 ' HE2' ' C' ' 117' ' ' MET . 79.7 mt -141.71 147.76 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.598 -1.26 . . . . 75.35 107.598 175.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 41.5 t -149.46 128.49 12.69 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 123.799 0.839 . . . . 71.13 109.149 170.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.538 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.6 t80 -128.34 135.58 49.77 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.129 -1.804 . . . . 64.12 106.129 169.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 44.0 mt-10 -141.78 150.15 41.35 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 124.288 1.035 . . . . 63.45 108.432 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.96 87.22 5.47 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 107.699 -1.223 . . . . 55.2 107.699 173.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.74 -27.93 17.57 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.701 2.267 . . . . 63.14 112.823 -173.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -107.82 7.21 28.1 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.001 0.921 . . . . 72.22 110.53 -176.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.419 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -29.95 -64.64 0.19 Allowed Pre-proline 0 CA--C 1.559 1.312 0 N-CA-C 116.74 2.126 . . . . 72.33 116.74 -165.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.424 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 88.7 Cg_endo -76.14 -26.4 9.2 Favored 'Trans proline' 0 C--N 1.381 2.239 0 CA-C-N 122.897 2.07 . . . . 74.23 113.382 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -70.92 -36.14 72.54 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.839 1.256 . . . . 73.41 109.75 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.7 p -84.86 -12.63 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 CA-C-N 115.708 -0.678 . . . . 75.13 111.741 -176.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.424 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.8 m-85 -72.37 -12.22 61.03 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 112.445 0.535 . . . . 72.13 112.445 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -58.13 -23.48 55.21 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.673 0.749 . . . . 62.45 110.066 169.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.443 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 79.3 mttt -104.37 102.61 12.28 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.664 1.586 . . . . 64.34 108.987 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -111.82 90.72 3.42 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.482 0.313 . . . . 74.14 110.442 -175.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 38.3 p90 -164.36 174.35 11.16 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.65 1.18 . . . . 72.42 108.763 172.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.46 HE21 ' HB2' ' D' ' 124' ' ' PRO . 2.2 mp0 -59.08 110.47 2.69 Favored Pre-proline 0 N--CA 1.486 1.328 0 CA-C-O 119.079 -0.486 . . . . 73.44 109.831 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.523 ' HD3' ' HG2' ' D' ' 124' ' ' PRO . 24.5 Cg_exo -63.17 136.74 57.54 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.368 2.045 . . . . 73.04 110.706 -177.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -62.05 107.77 0.93 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.356 -0.979 . . . . 72.03 108.356 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 6.9 m -103.56 121.29 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-N 115.165 -0.925 . . . . 44.11 110.092 -171.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -101.44 119.45 38.78 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 106.313 -1.736 . . . . 75.34 106.313 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 pp -94.66 143.1 26.71 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.193 -0.669 . . . . 63.32 109.193 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.52 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 17.0 t70 -139.38 146.82 40.67 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.411 -0.959 . . . . 72.45 108.411 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -116.33 143.56 45.39 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.126 0.57 . . . . 62.12 110.841 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.6 t70 -139.05 134.37 32.89 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.354 -1.293 . . . . 42.43 107.731 169.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 22.4 p -103.7 148.27 26.25 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.203 0.601 . . . . 54.14 110.407 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.43 160.9 41.88 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.394 1.078 . . . . 75.23 109.115 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 46.4 p -174.62 167.88 3.78 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.013 0.525 . . . . 61.23 111.275 -175.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.9 p -166.51 147.56 6.27 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.394 -0.821 . . . . 63.5 110.375 174.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -89.23 118.27 28.8 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.602 -0.888 . . . . 74.52 108.602 170.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 44.1 mt -98.69 -27.28 14.05 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.176 0.59 . . . . 61.41 110.878 -173.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -158.8 -178.53 7.32 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.021 0.928 . . . . 73.15 110.121 174.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.09 111.31 2.85 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.102 -0.954 . . . . 65.31 109.844 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 65.72 9.06 5.67 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.763 1.225 . . . . 65.15 113.252 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 83.2 t -108.07 114.15 45.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 107.468 -1.308 . . . . 73.11 107.468 172.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -134.72 131.3 37.47 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.871 -1.059 . . . . 73.43 109.497 -165.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -93.28 129.22 39.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.157 -0.929 . . . . 72.55 110.12 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 78.3 t -109.36 118.96 57.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.209 -1.034 . . . . 71.03 108.209 172.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.46 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 35.7 t -113.78 133.09 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 108.523 -0.918 . . . . 64.32 108.523 177.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 26.4 tp -129.56 120.33 25.14 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.921 -0.4 . . . . 64.15 109.921 171.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.564 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 19.5 ttm-85 -84.54 111.82 19.85 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.952 0.901 . . . . 74.53 109.849 175.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.569 HG21 ' HB1' ' D' ' 110' ' ' ALA . 40.6 t -91.78 122.32 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 108.262 -1.014 . . . . 71.44 108.262 173.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 46.4 m -112.45 143.59 43.32 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.451 -0.574 . . . . 75.01 109.451 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 88.5 t -132.29 101.94 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.663 1.185 . . . . 54.14 108.34 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 19.8 m -93.58 94.92 8.9 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.154 -1.424 . . . . 50.4 107.154 169.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.08 147.47 24.0 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.063 0.545 . . . . 72.3 110.338 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.475 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 63.8 p -150.15 133.72 16.62 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-O 121.068 0.461 . . . . 43.02 111.621 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.7 mt -106.86 114.48 28.59 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.447 -1.316 . . . . 74.13 107.447 171.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.33 -140.96 31.68 Favored Glycine 0 C--N 1.343 0.939 0 O-C-N 123.373 0.42 . . . . 64.35 112.562 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -83.13 3.45 30.66 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.19 0.596 . . . . 71.13 112.302 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.443 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 12.2 pt-20 -131.04 166.0 21.99 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.879 0.472 . . . . 74.44 110.75 -174.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.7 m -72.73 136.93 45.63 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.386 -0.824 . . . . 63.23 110.963 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.551 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.68 -69.55 0.68 Allowed 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.588 -1.264 . . . . 71.42 107.588 174.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . 0.511 ' HE2' ' HG2' ' D' ' 38' ' ' PRO . 52.1 p90 -149.58 150.26 31.97 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-N 115.313 -0.858 . . . . 70.32 110.685 177.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 45.4 mt -106.44 107.2 18.09 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.458 -1.312 . . . . 54.32 107.458 170.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.446 ' SG ' HG23 ' D' ' 114' ' ' ILE . 36.8 t -116.54 140.03 49.83 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.905 0.882 . . . . 72.34 108.967 -176.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -157.98 141.64 15.51 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.995 0.518 . . . . 72.02 109.948 -174.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -140.82 116.29 6.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.138 -1.06 . . . . 50.45 108.138 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' D' ' 61' ' ' ARG . 5.9 tt0 -87.41 81.06 7.95 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.37 -1.344 . . . . 70.55 107.37 171.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -80.09 105.18 11.18 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.353 -1.294 . . . . 73.21 108.761 -173.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -104.3 148.32 16.76 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.72 -0.673 . . . . 73.42 111.661 -178.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.408 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -144.93 131.43 4.28 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.057 -0.817 . . . . 44.11 111.057 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 45.1 mt -88.86 133.3 31.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 108.239 -1.022 . . . . 73.55 108.239 174.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.421 ' HB2' HD11 ' D' ' 86' ' ' ILE . 55.5 m-85 -130.87 159.24 37.97 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.943 0.497 . . . . 54.0 109.87 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 3.9 t -115.27 101.09 8.62 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.248 -1.019 . . . . 53.22 108.248 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.421 HD11 ' HB2' ' D' ' 84' ' ' PHE . 4.1 mp -108.92 109.84 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 109.25 -0.648 . . . . 71.44 109.25 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.34 154.34 45.09 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.398 0.679 . . . . 72.51 109.798 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.92 21.35 65.96 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-O 119.811 -0.439 . . . . 64.41 113.941 175.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.411 HG22 ' N ' ' D' ' 90' ' ' GLU . 10.9 mt -131.97 158.35 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 117.384 0.592 . . . . 63.44 110.255 178.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.411 ' N ' HG22 ' D' ' 89' ' ' ILE . 2.9 pp20? -159.44 -175.97 5.51 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.265 1.026 . . . . 70.51 110.056 171.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.46 -141.07 46.67 Favored Glycine 0 N--CA 1.473 1.132 0 N-CA-C 114.839 0.696 . . . . 73.45 114.839 174.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 41.5 p -78.81 -13.98 59.51 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.083 0.953 . . . . 51.22 112.037 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -47.01 70.79 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.556 0.742 . . . . 61.14 109.685 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 13.5 ptp -68.78 -34.62 75.86 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 110.271 -0.27 . . . . 62.43 110.271 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.45 -26.93 68.77 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.975 0.51 . . . . 60.53 111.461 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -73.03 -51.81 16.77 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.079 0.552 . . . . 74.13 110.579 171.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.7 t -56.64 -43.78 80.62 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 124.074 0.859 . . . . 32.13 111.411 -174.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 16.3 mt -78.3 -30.21 48.25 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.734 -1.121 . . . . 72.4 110.737 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.79 14.58 64.98 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 116.002 -0.545 . . . . 72.3 113.19 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.02 -79.27 0.1 Allowed 'General case' 0 C--N 1.353 0.742 0 C-N-CA 122.929 0.492 . . . . 74.12 111.235 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -65.41 -41.15 93.9 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.101 0.778 . . . . 73.12 113.101 -166.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 81.5 m -64.56 -48.96 73.18 Favored Pre-proline 0 CA--C 1.564 1.494 0 CA-C-O 118.726 -0.654 . . . . 63.51 112.595 -175.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.14 -22.73 34.52 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 121.717 1.611 . . . . 64.52 112.754 170.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.75 -25.88 66.71 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 122.539 0.336 . . . . 75.33 111.237 175.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.566 HG21 HD13 ' D' ' 13' ' ' ILE . 43.3 mm -67.99 -39.55 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.346 0.658 . . . . 72.45 109.983 170.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.408 HD21 ' HA3' ' D' ' 82' ' ' GLY . 79.4 mt -79.5 -17.68 53.58 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 115.155 -0.929 . . . . 72.43 111.941 -171.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -64.69 -45.07 75.61 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 114.214 1.19 . . . . 71.14 114.214 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -54.11 -43.88 54.37 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.065 1.843 . . . . 64.4 112.902 173.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -73.52 -34.01 65.03 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.239 -0.892 . . . . 63.52 111.911 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . 0.569 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -65.02 -49.61 69.49 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.458 -0.571 . . . . 70.15 109.458 177.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.8 ttp180 -54.54 -53.43 54.55 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 124.827 1.33 . . . . 65.41 110.801 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -60.16 -46.29 90.17 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.421 1.075 . . . . 64.11 111.378 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 39.6 t -62.12 -41.66 98.46 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.724 0.64 . . . . 63.15 110.935 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.448 ' O ' HG23 ' D' ' 118' ' ' VAL . 82.3 mt -60.48 -58.05 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.674 0.79 . . . . 60.44 110.508 173.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 40.6 m -54.7 -39.23 67.96 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.148 1.379 . . . . 75.45 111.537 -173.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 24.7 t -68.23 -43.45 77.91 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.953 -1.022 . . . . 74.33 110.506 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.8 mtm -68.6 -32.98 73.26 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 122.646 0.378 . . . . 74.42 111.715 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.448 HG23 ' O ' ' D' ' 114' ' ' ILE . 90.6 t -63.57 -45.48 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.548 0.739 . . . . 73.4 109.859 176.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.6 p -74.52 -29.91 61.59 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.877 -0.602 . . . . 64.33 111.281 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -72.24 -27.85 62.77 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.2 0.6 . . . . 74.03 110.138 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.26 8.29 74.74 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 123.621 0.575 . . . . 62.54 112.587 172.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.466 HG23 ' HB3' ' C' ' 17' ' ' TYR . 80.7 p 55.3 22.64 4.96 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 126.669 1.988 . . . . 73.14 114.105 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -82.96 151.18 63.33 Favored Pre-proline 0 CA--C 1.552 1.04 0 N-CA-C 108.717 -0.846 . . . . 73.24 108.717 168.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.523 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 17.7 Cg_endo -57.74 138.99 88.8 Favored 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.737 2.292 . . . . 75.31 112.872 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -53.03 134.33 38.14 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.58 1.152 . . . . 74.01 112.375 -175.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.83 104.76 9.8 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.526 -1.287 . . . . 74.25 107.526 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -99.58 109.4 21.91 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.605 0.762 . . . . 74.15 109.211 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.432 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 6.5 mp -70.38 119.06 14.0 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.135 0.574 . . . . 65.55 109.548 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.98 137.19 95.43 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.05 0.54 . . . . 74.24 110.774 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.72 130.77 6.92 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.269 1.979 . . . . 72.03 112.108 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.478 0.931 0 C-N-CA 122.879 0.472 . . . . 54.22 110.902 177.066 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.697 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.5 t80 . . . . . 0 C--O 1.238 0.476 0 N-CA-C 109.289 -0.634 . . . . 75.42 109.289 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.491 ' HG3' ' NE2' ' A' ' 14' ' ' GLN . 26.7 tp60 -155.65 97.41 1.85 Allowed 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.29 -1.004 . . . . 64.21 108.29 177.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.451 HG12 ' HD2' ' A' ' 84' ' ' PHE . 29.5 mt -68.21 120.47 15.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 108.729 -0.841 . . . . 74.34 108.729 176.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.491 ' NE2' ' HG3' ' A' ' 12' ' ' GLN . 27.8 mm-40 -81.8 -40.19 22.94 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 123.832 0.707 . . . . 73.23 109.994 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -175.66 122.67 0.2 Allowed 'General case' 0 C--N 1.359 0.994 0 O-C-N 123.426 0.454 . . . . 74.05 111.352 -171.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.434 HD12 ' HG3' ' C' ' 130' ' ' PRO . 88.8 mt -106.96 136.16 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.603 -0.888 . . . . 63.11 108.603 169.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.4 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 24.0 p90 -164.13 166.19 21.49 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.189 0.996 . . . . 62.24 110.597 -174.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.5 p -96.61 119.12 34.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.534 -0.757 . . . . 73.24 109.012 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 36.1 mtpt -87.09 -30.14 21.35 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.166 -0.679 . . . . 72.25 109.166 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 16.7 t70 -144.83 137.13 26.13 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.189 -0.914 . . . . 75.35 109.276 177.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.9 mt -133.69 142.97 40.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 106.384 -1.71 . . . . 75.23 106.384 174.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.6 t -150.26 135.36 17.83 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.624 -0.51 . . . . 63.22 109.624 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.57 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 87.9 t80 -136.79 137.67 40.05 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.421 -1.696 . . . . 75.13 106.421 172.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -137.75 141.45 40.97 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 108.521 -0.918 . . . . 74.53 108.521 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.68 75.27 31.77 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 106.549 -1.649 . . . . 74.44 106.549 171.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.36 -42.84 31.74 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.284 2.656 . . . . 52.55 112.76 -171.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.463 ' ND2' ' HG3' ' A' ' 71' ' ' GLU . 11.2 m-20 -101.64 22.76 12.25 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 118.35 -0.834 . . . . 63.51 109.913 -178.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.443 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -42.61 -58.31 3.87 Favored Pre-proline 0 N--CA 1.497 1.906 0 N-CA-C 113.867 1.062 . . . . 74.52 113.867 -170.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 14.4 Cg_exo -65.66 -24.76 54.92 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 121.7 1.6 . . . . 60.31 112.778 -174.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -81.26 -43.33 19.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.114 -0.948 . . . . 72.43 109.91 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.796 HG21 ' HA ' ' A' ' 73' ' ' ALA . 5.2 p -76.32 -14.01 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 115.039 -0.982 . . . . 70.15 112.505 -162.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -69.62 -12.14 61.4 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.871 0.468 . . . . 65.51 111.68 173.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -83.34 -25.59 31.31 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.389 1.076 . . . . 71.51 110.823 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.412 ' NZ ' ' HB3' ' A' ' 71' ' ' GLU . 23.3 mmtp -68.14 149.61 49.37 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.658 0.783 . . . . 73.21 111.808 -177.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -71.13 131.96 44.35 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.301 -1.0 . . . . 70.33 108.301 171.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -77.77 82.01 4.18 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.798 0.809 . . . . 73.22 110.608 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -128.8 81.23 71.21 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 106.938 -1.504 . . . . 73.44 106.938 168.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -82.98 145.59 12.53 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.65 2.233 . . . . 61.22 112.318 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -97.83 89.83 4.73 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 105.823 -1.917 . . . . 63.45 105.823 168.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.526 HG13 HG13 ' A' ' 64' ' ' VAL . 96.6 t -72.16 92.42 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.425 -0.954 . . . . 75.41 108.425 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -87.58 115.47 25.03 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.591 -1.186 . . . . 72.52 108.285 174.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.7 pp -95.41 130.59 42.16 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.788 -1.19 . . . . 65.03 107.788 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.605 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.1 m-20 -120.21 105.71 11.23 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 107.796 -1.187 . . . . 74.23 107.796 176.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.7 mp -98.22 146.7 25.36 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.789 -0.819 . . . . 71.23 108.789 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.592 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 24.9 t70 -145.81 148.27 32.74 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 109.491 -0.559 . . . . 74.24 109.491 177.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 49.1 p -106.44 125.99 51.69 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.556 -0.747 . . . . 63.11 110.247 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -132.91 133.37 43.16 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.035 0.934 . . . . 62.43 108.733 176.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.9 m -133.66 159.26 41.05 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.235 0.614 . . . . 63.34 110.96 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.3 t -158.22 147.77 19.65 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.856 0.863 . . . . 72.12 109.184 174.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -106.81 119.09 38.4 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.118 -1.067 . . . . 63.02 108.118 172.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 50.3 mt -93.09 -37.72 11.99 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.163 0.585 . . . . 72.32 111.087 -173.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.79 -171.98 3.31 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.718 0.807 . . . . 61.44 110.3 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -63.59 119.45 9.87 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.553 0.741 . . . . 75.13 109.633 170.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 70.74 -7.19 1.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.773 1.229 . . . . 64.32 112.598 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.62 110.72 28.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 N-CA-C 107.965 -1.124 . . . . 63.52 107.965 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -134.1 128.48 34.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.363 -0.835 . . . . 74.53 109.28 -170.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -96.12 127.58 42.25 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.853 0.861 . . . . 72.43 110.921 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.442 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 68.0 t -107.44 124.58 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 107.106 -1.442 . . . . 74.41 107.106 168.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.479 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 44.0 t -119.62 124.57 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.367 -0.975 . . . . 70.34 108.367 172.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.415 HD22 HG22 ' A' ' 62' ' ' VAL . 1.8 tt -115.85 115.47 26.31 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.774 -1.195 . . . . 74.14 107.774 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.592 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 49.2 ttt180 -84.11 99.72 10.66 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.897 -1.149 . . . . 71.01 107.897 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.415 HG22 HD22 ' A' ' 60' ' ' LEU . 49.9 t -97.96 101.67 12.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.027 -1.101 . . . . 70.01 108.027 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.605 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 21.9 m -102.6 143.7 31.95 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.891 -0.781 . . . . 74.41 108.891 175.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.555 HG11 HD21 ' A' ' 126' ' ' LEU . 24.7 t -136.87 137.55 46.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 125.445 1.498 . . . . 72.11 107.201 173.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.4 m -132.29 127.15 35.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.719 -0.845 . . . . 71.54 108.719 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.62 104.26 14.28 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 107.949 -1.13 . . . . 72.41 107.949 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 50.5 m -108.0 126.86 53.21 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.572 0.349 . . . . 65.32 110.464 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.2 mt -103.94 83.11 2.06 Favored 'General case' 0 C--O 1.249 1.065 0 C-N-CA 124.052 0.941 . . . . 74.13 108.535 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.13 -84.79 1.13 Allowed Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.282 -0.872 . . . . 75.53 111.715 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.38 -26.2 3.36 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.925 0.89 . . . . 54.33 110.045 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.463 ' HG3' ' ND2' ' A' ' 27' ' ' ASN . 45.5 tt0 -94.17 112.65 24.47 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.784 0.834 . . . . 75.4 109.643 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 94.0 m -73.25 135.37 44.49 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.018 0.437 . . . . 54.34 110.441 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.796 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -72.61 -61.99 1.61 Allowed 'General case' 0 C--O 1.243 0.75 0 CA-C-N 114.679 -1.146 . . . . 70.43 110.078 176.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -156.23 174.85 14.78 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 114.806 -1.088 . . . . 74.43 112.124 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.3 tp -133.67 135.46 44.12 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.778 1.631 . . . . 62.22 107.647 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 79.2 m -134.96 105.41 6.37 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.042 0.937 . . . . 71.05 109.632 178.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -126.54 115.91 20.26 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.257 1.023 . . . . 62.42 109.141 -174.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.4 t -129.74 114.52 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.277 0.631 . . . . 71.31 109.487 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.564 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 75.6 mt-30 -85.0 88.14 7.43 Favored 'General case' 0 C--O 1.249 1.048 0 N-CA-C 108.334 -0.987 . . . . 62.44 108.334 170.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.402 ' HG3' HD22 ' A' ' 106' ' ' LEU . 8.4 tp-100 -77.34 104.96 8.15 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 114.849 -1.069 . . . . 72.41 109.16 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.98 147.35 20.94 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 111.325 -0.71 . . . . 62.14 111.325 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.522 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -152.05 120.77 1.11 Allowed Glycine 0 CA--C 1.499 -0.93 0 N-CA-C 110.78 -0.928 . . . . 73.54 110.78 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.1 mt -83.61 121.49 36.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 108.308 -0.997 . . . . 73.32 108.308 173.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.697 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 33.0 m-85 -129.67 137.49 50.65 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.66 -0.867 . . . . 74.22 108.66 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.1 t -103.69 98.33 8.22 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.995 -0.743 . . . . 61.44 108.995 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.478 0.928 0 C-N-CA 124.626 1.17 . . . . 63.42 109.315 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 121.088 0.471 . . . . 62.25 110.934 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -68.53 -39.47 81.16 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.033 0.933 . . . . 71.0 109.888 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.559 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 43.7 t -69.34 -52.92 22.55 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 123.732 0.645 . . . . 51.12 111.429 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 pp -77.5 -20.96 53.48 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.893 0.477 . . . . 72.13 111.782 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.57 -16.11 23.13 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 115.223 0.849 . . . . 63.33 115.223 -170.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.02 -43.83 0.14 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.616 0.708 . . . . 45.12 112.727 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.559 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 67.9 t80 -67.9 -68.97 0.35 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.815 0.846 . . . . 75.1 111.301 -170.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 76.0 m -65.56 -35.85 12.93 Favored Pre-proline 0 CA--C 1.568 1.641 0 C-N-CA 123.573 0.749 . . . . 64.11 112.781 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -47.56 -48.56 15.25 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 122.774 2.316 . . . . 74.21 114.383 162.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.45 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 29.7 t-20 -69.72 -24.35 63.55 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.089 0.555 . . . . 72.25 110.516 -177.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 38.8 mm -63.39 -39.46 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.218 0.532 . . . . 72.23 110.567 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.522 HD21 ' HA3' ' A' ' 82' ' ' GLY . 91.2 mt -78.63 -24.94 44.99 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.617 0.767 . . . . 72.11 112.056 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -60.65 -47.38 96.18 Favored Pre-proline 0 CA--C 1.565 1.557 0 N-CA-C 114.256 1.206 . . . . 75.21 114.256 -171.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 104' ' ' ASN . 37.0 Cg_exo -62.61 -32.48 79.27 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.034 1.823 . . . . 73.24 113.121 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -77.37 -38.29 50.41 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.685 0.794 . . . . 74.22 111.002 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.11 -37.25 75.32 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.146 0.578 . . . . 74.31 110.046 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.426 ' NH1' HD12 ' C' ' 105' ' ' ILE . 24.1 ttm180 -60.63 -50.64 72.71 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.215 1.006 . . . . 74.22 109.732 174.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.1 -42.86 88.71 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.81 0.693 . . . . 61.34 110.646 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 43.5 t -62.65 -32.76 73.86 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.813 0.445 . . . . 64.14 110.666 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.512 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 32.3 mt -67.55 -55.76 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 123.518 0.727 . . . . 74.3 109.932 170.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.539 HG21 ' HE2' ' C' ' 109' ' ' TYR . 87.8 m -55.22 -38.38 68.36 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.016 1.326 . . . . 75.2 111.894 -175.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.504 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 47.5 t -63.29 -50.03 71.71 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.479 -0.782 . . . . 63.12 110.07 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.57 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 50.9 mtm -63.67 -38.25 90.4 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.373 0.669 . . . . 71.33 111.578 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.9 t -64.18 -53.17 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.807 0.843 . . . . 75.14 110.62 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.2 t -67.52 -31.41 71.51 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.613 -0.722 . . . . 73.04 110.839 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 116' ' ' SER . 24.9 ttm-85 -72.13 -32.77 67.24 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.489 1.116 . . . . 74.41 108.46 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.425 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.82 14.25 53.11 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-N 114.561 -1.2 . . . . 60.05 113.47 173.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.548 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.3 t 63.38 12.28 6.15 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 126.471 1.908 . . . . 73.23 114.178 172.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -83.16 148.51 56.48 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 108.562 -0.903 . . . . 63.25 108.562 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.15 163.11 10.42 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.215 2.61 . . . . 73.54 113.205 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -57.04 122.46 12.39 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.32 -0.855 . . . . 71.41 112.367 -171.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.555 HD21 HG11 ' A' ' 64' ' ' VAL . 52.0 tp -121.95 106.77 11.53 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.588 1.155 . . . . 62.31 109.022 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -130.14 121.09 25.63 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.996 0.918 . . . . 73.05 108.945 176.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.5 mt -68.25 143.72 55.16 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.797 0.439 . . . . 73.41 109.895 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.41 136.86 91.0 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.123 0.569 . . . . 35.32 110.384 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.423 ' HG2' ' CE2' ' C' ' 11' ' ' PHE . 2.7 Cg_endo -79.29 92.12 1.15 Allowed 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.84 2.36 . . . . 74.2 110.609 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.2 t -101.64 113.39 37.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.338 -0.986 . . . . 63.13 108.338 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -69.73 100.05 1.44 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.804 -0.813 . . . . 71.11 108.804 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 . . . . . 0 N--CA 1.485 1.286 0 C-N-CA 123.968 0.907 . . . . 72.53 111.017 -178.24 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 57.6 ttm . . . . . 0 CA--C 1.561 1.396 0 CA-C-O 121.962 0.887 . . . . 75.03 111.336 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 96.6 m -150.1 118.34 6.39 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 106.163 -1.791 . . . . 75.45 106.163 171.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.438 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 58.9 t80 -127.17 144.59 51.0 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.342 -0.614 . . . . 72.22 109.342 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.529 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -155.52 136.44 13.64 Favored 'General case' 0 C--O 1.243 0.715 0 O-C-N 123.671 0.607 . . . . 72.14 110.064 173.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.563 HD13 HD11 ' B' ' 16' ' ' ILE . 58.4 mt -76.75 125.4 36.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.492 0 N-CA-C 108.456 -0.942 . . . . 71.24 108.456 169.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -92.17 -49.86 5.97 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.833 -0.803 . . . . 72.53 108.833 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.548 ' HE ' HG21 ' A' ' 122' ' ' THR . 42.9 ttt180 -164.5 134.04 3.81 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.685 -0.689 . . . . 52.12 110.217 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.563 HD11 HD13 ' B' ' 13' ' ' ILE . 76.1 mt -115.24 140.42 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 124.042 0.937 . . . . 72.21 108.603 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -169.18 152.1 4.91 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 112.707 0.632 . . . . 75.15 112.707 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 82.5 m -76.76 125.45 29.3 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.968 -1.015 . . . . 72.23 109.008 169.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.412 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 40.3 mtpt -97.87 -31.83 12.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.099 0.56 . . . . 71.42 111.482 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.45 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 10.9 t70 -155.66 136.62 13.65 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.275 -0.421 . . . . 72.22 109.992 -168.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.474 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.7 mm -135.15 142.36 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.69 1.196 . . . . 75.11 108.68 177.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.8 t -149.34 108.17 3.86 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.803 -1.184 . . . . 63.34 107.803 173.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -122.56 118.89 29.29 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 107.644 -1.243 . . . . 64.44 107.644 172.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -118.91 153.03 35.23 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.13 0.972 . . . . 75.42 108.697 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.513 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -142.37 80.32 14.86 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 106.32 -1.733 . . . . 63.05 106.32 173.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.49 -31.0 42.93 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.059 2.506 . . . . 72.23 113.095 -168.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -108.94 14.78 23.91 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.188 0.595 . . . . 71.14 110.828 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.513 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -42.51 -64.34 0.73 Allowed Pre-proline 0 N--CA 1.492 1.661 0 N-CA-C 114.959 1.466 . . . . 62.31 114.959 -166.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.403 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 34.6 Cg_endo -63.3 -30.62 73.69 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.215 1.943 . . . . 73.4 113.702 -168.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -94.24 -28.68 15.48 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.744 0.418 . . . . 72.25 111.401 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.533 HG22 HD12 ' B' ' 68' ' ' LEU . 2.8 p -73.04 -20.12 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 122.594 0.357 . . . . 71.23 110.464 -176.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -65.43 -14.78 61.68 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.903 0.881 . . . . 75.11 113.104 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -68.05 -19.21 64.87 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.818 0.447 . . . . 74.35 110.701 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -90.6 106.34 18.44 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.451 1.101 . . . . 73.23 109.932 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -93.93 83.87 4.44 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.313 0.645 . . . . 64.35 110.626 -174.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -169.03 173.52 6.84 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.231 1.013 . . . . 75.33 109.854 170.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -85.16 121.54 73.99 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 109.14 -0.689 . . . . 75.44 109.14 176.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.12 165.53 31.07 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.772 2.315 . . . . 75.24 113.863 -175.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 10.1 tp10 -69.76 126.33 29.41 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.388 -0.824 . . . . 75.14 109.483 176.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.7 140.54 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.394 0.616 . . . . 65.22 111.16 -171.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.608 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 63.2 mttp -126.91 143.73 51.19 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.432 1.093 . . . . 63.23 109.696 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -114.07 132.5 56.0 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.924 0.89 . . . . 74.33 108.634 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -151.2 109.29 3.72 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 108.23 -1.026 . . . . 71.44 108.23 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' B' ' 62' ' ' VAL . 9.9 mp -102.41 157.03 17.2 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.471 -0.566 . . . . 64.3 109.471 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -139.28 153.9 47.86 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 108.445 -0.946 . . . . 75.53 108.445 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 74.3 p -107.66 118.39 36.61 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.362 -0.835 . . . . 74.25 108.929 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.427 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -126.87 136.37 52.24 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.552 -1.277 . . . . 32.22 107.552 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 59.7 p -143.25 163.04 34.05 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-O 120.628 0.251 . . . . 73.44 111.132 -174.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 74.9 p -153.28 137.03 16.09 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.739 0.816 . . . . 74.03 109.499 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -94.62 111.47 23.23 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.529 -1.286 . . . . 74.31 107.529 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.5 mt -81.15 -53.55 6.28 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.041 0.448 . . . . 65.2 110.809 -176.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -145.01 -177.09 5.36 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.123 -0.944 . . . . 75.14 109.517 -175.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.43 109.74 1.45 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.349 0.66 . . . . 71.21 110.011 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 69.15 4.88 4.79 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 125.011 1.324 . . . . 55.2 113.347 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 98.4 t -104.77 117.54 50.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.615 -1.254 . . . . 60.04 107.615 172.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -123.16 177.26 5.63 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 121.352 0.596 . . . . 75.41 109.822 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -142.66 102.64 4.09 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.446 -1.316 . . . . 51.1 107.446 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 65.5 t -89.43 121.25 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.626 1.171 . . . . 75.03 109.739 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.501 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.6 t -109.2 109.57 28.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 C-N-CA 123.529 0.732 . . . . 54.23 109.26 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 35.6 tp -93.31 109.42 20.96 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.306 -0.627 . . . . 74.41 109.306 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -86.83 117.99 25.92 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 108.614 -0.884 . . . . 74.22 108.614 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.441 ' HA ' ' HG ' ' B' ' 44' ' ' LEU . 14.3 t -112.19 116.82 53.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 108.392 -0.966 . . . . 72.53 108.392 172.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.8 m -112.36 138.45 49.06 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.827 0.822 . . . . 72.31 109.404 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.725 HG21 HG21 ' B' ' 114' ' ' ILE . 54.4 t -127.19 131.41 70.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 125.644 1.578 . . . . 64.21 108.284 -174.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.608 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 89.2 m -117.95 146.19 44.16 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.31 -0.626 . . . . 62.12 109.31 173.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.94 139.34 23.62 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.602 0.761 . . . . 43.41 110.085 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.594 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 17.7 p -147.49 127.21 13.4 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.486 0.492 . . . . 61.35 111.619 -176.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.533 HD12 HG22 ' B' ' 31' ' ' VAL . 54.7 mt -98.32 107.39 19.84 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 107.812 -1.181 . . . . 75.41 107.812 174.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.98 -131.53 12.54 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 120.024 -0.32 . . . . 72.34 112.572 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -99.01 17.47 19.62 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.592 0.757 . . . . 73.02 111.687 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -138.84 154.24 48.42 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.424 0.689 . . . . 73.52 109.9 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 49.5 m -77.94 123.32 26.65 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.908 0.385 . . . . 72.23 111.061 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.594 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -74.4 -60.77 2.12 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.322 -0.992 . . . . 61.42 108.322 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -155.85 156.92 35.53 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 115.252 -0.885 . . . . 74.52 112.328 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 79.7 mt -125.68 119.87 29.17 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 125.74 1.616 . . . . 65.32 106.973 175.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.511 ' SG ' HG23 ' B' ' 114' ' ' ILE . 49.3 t -118.28 150.39 39.54 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.709 -0.848 . . . . 42.23 108.709 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -159.88 126.43 4.38 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.419 -0.956 . . . . 74.31 108.419 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 86.9 t -122.69 145.94 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.325 -0.852 . . . . 74.14 109.146 176.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.45 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 18.1 mt-30 -120.65 97.1 5.4 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.271 -1.011 . . . . 74.24 108.271 169.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -87.07 101.53 13.55 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.8 -0.815 . . . . 63.55 108.8 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.08 164.08 33.55 Favored Glycine 0 C--O 1.246 0.848 0 O-C-N 123.903 0.752 . . . . 61.22 111.862 177.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.39 126.07 1.44 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.867 -0.493 . . . . 73.42 111.867 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 59.9 mt -84.61 130.02 36.71 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 108.31 -0.996 . . . . 75.44 108.31 172.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -139.22 156.5 47.05 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.147 0.579 . . . . 71.0 109.473 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 69.1 m -121.27 133.07 55.13 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.999 0.92 . . . . 71.25 109.126 175.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 12.4 tt -130.56 148.96 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.526 0.73 . . . . 74.43 110.576 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.25 175.07 14.48 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.909 0.884 . . . . 73.43 109.621 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.51 -56.29 4.72 Favored Glycine 0 N--CA 1.473 1.128 0 C-N-CA 123.128 0.394 . . . . 72.53 112.586 175.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.539 HG22 ' HB3' ' B' ' 94' ' ' MET . 7.4 mm -90.9 153.02 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.04 0.936 . . . . 75.0 110.93 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -147.21 -178.6 6.31 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.757 1.223 . . . . 70.25 109.104 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.31 -134.42 22.86 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 115.548 -0.751 . . . . 61.3 113.973 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 54.1 m -75.38 -33.64 61.03 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.559 0.744 . . . . 72.5 111.944 -177.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -60.78 -33.04 72.37 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.369 0.668 . . . . 72.03 111.854 -175.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.539 ' HB3' HG22 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -86.12 -24.62 26.16 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.695 0.398 . . . . 72.15 111.816 176.215 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.75 -32.26 73.71 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.033 0.533 . . . . 70.1 110.817 172.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -76.42 -36.08 58.19 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.554 -0.748 . . . . 61.44 110.966 172.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.0 t -60.67 -52.4 65.28 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.016 0.527 . . . . 51.45 111.354 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.52 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 0.5 OUTLIER -80.52 -13.53 59.01 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.251 0.463 . . . . 51.11 112.251 175.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.23 1.44 62.63 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-O 119.608 -0.551 . . . . 63.42 113.784 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.47 -53.38 0.11 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 117.482 0.641 . . . . 73.13 110.957 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -70.73 -50.33 37.32 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.174 0.59 . . . . 73.23 112.559 -172.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 61.2 m -60.79 -47.26 96.29 Favored Pre-proline 0 CA--C 1.563 1.452 0 CA-C-O 118.811 -0.614 . . . . 72.51 111.626 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.49 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 48.4 Cg_exo -60.8 -32.7 93.14 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 122.432 2.088 . . . . 70.34 114.106 171.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -61.01 -38.09 84.86 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.828 0.851 . . . . 61.12 110.202 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.414 HG23 ' NH2' ' D' ' 111' ' ' ARG . 74.8 mt -62.47 -40.79 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 114.976 -1.011 . . . . 72.03 110.606 174.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 56.3 mt -86.4 -13.12 47.27 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.975 -1.011 . . . . 72.3 111.765 -171.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -55.31 -52.29 72.73 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 124.019 0.928 . . . . 75.11 112.915 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -59.76 -37.0 89.75 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.324 2.016 . . . . 72.33 114.088 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -67.83 -44.57 76.89 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.03 0.532 . . . . 73.45 110.635 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.98 -36.42 83.26 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.726 -0.67 . . . . 65.43 110.822 176.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -61.96 -50.5 71.86 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.967 1.307 . . . . 60.15 110.256 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -68.73 -33.61 74.22 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 115.309 -0.86 . . . . 73.14 109.704 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.474 ' SG ' HD11 ' B' ' 21' ' ' ILE . 13.5 t -66.55 -44.47 82.26 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.934 0.494 . . . . 72.31 111.77 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.725 HG21 HG21 ' B' ' 64' ' ' VAL . 95.2 mt -60.05 -53.5 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 108.894 -0.78 . . . . 64.24 108.894 175.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 38.5 m -57.02 -36.05 69.98 Favored 'General case' 0 CA--C 1.553 1.064 0 O-C-N 124.371 1.045 . . . . 51.35 111.602 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.2 t -62.74 -47.21 84.56 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 123.526 0.73 . . . . 53.54 109.749 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 9.7 mmt -70.38 -35.8 73.73 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.006 0.523 . . . . 74.14 111.172 -176.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' B' ' 114' ' ' ILE . 97.0 t -60.24 -43.92 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.763 0.825 . . . . 65.45 109.801 172.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.2 t -65.34 -33.0 74.94 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.646 -1.161 . . . . 71.43 111.355 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' B' ' 116' ' ' SER . 83.0 mtt-85 -71.04 -36.21 72.27 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.536 -0.756 . . . . 70.54 110.187 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.95 -3.65 81.21 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 123.752 0.658 . . . . 72.11 112.316 172.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 23.6 p 62.82 35.01 14.01 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.446 1.899 . . . . 64.24 112.428 173.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -93.69 164.45 20.83 Favored Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 124.103 0.961 . . . . 73.34 110.67 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.04 166.15 1.04 Allowed 'Trans proline' 0 C--N 1.393 2.869 0 C-N-CA 123.663 2.909 . . . . 63.4 115.524 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -63.54 121.4 13.77 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 115.375 -0.83 . . . . 65.31 111.127 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 18.6 tp -129.2 98.43 4.9 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.046 -0.524 . . . . 73.41 109.922 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -124.38 121.26 34.45 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.863 0.865 . . . . 75.43 109.591 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mp -64.88 149.25 49.89 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.949 0.5 . . . . 72.55 111.117 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.9 150.99 73.05 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.452 0.701 . . . . 54.23 110.023 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -67.64 129.45 19.99 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 123.031 2.487 . . . . 34.55 112.395 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 26.0 m -131.95 128.4 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.46 0.704 . . . . 52.11 109.257 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -109.13 102.13 11.12 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 107.252 -1.388 . . . . 73.23 107.252 173.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -60.93 -47.73 85.09 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.17 0.918 . . . . 73.43 110.102 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 C--O 1.221 -0.445 0 CA-C-N 114.283 -1.326 . . . . 62.12 112.014 -174.215 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.599 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 33.8 t80 . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 108.093 -1.077 . . . . 72.43 108.093 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -155.16 136.55 14.1 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.887 -0.412 . . . . 71.41 109.887 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.492 HG12 ' HE2' ' C' ' 84' ' ' PHE . 56.4 mt -79.2 128.54 38.47 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 N-CA-C 109.036 -0.728 . . . . 43.43 109.036 171.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -101.0 -34.99 9.53 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.598 0.759 . . . . 62.12 110.073 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -176.63 139.29 0.31 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.167 0.587 . . . . 73.14 109.74 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.422 HD11 HD13 ' C' ' 13' ' ' ILE . 95.0 mt -129.89 142.58 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 108.187 -1.042 . . . . 71.32 108.187 175.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.421 ' HE1' HG12 ' C' ' 83' ' ' ILE . 32.9 p90 -172.47 167.02 5.66 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.162 0.985 . . . . 72.4 109.334 -169.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -91.76 114.2 26.68 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 122.893 0.477 . . . . 72.31 109.912 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.693 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 21.8 mmtp -65.44 -42.58 92.26 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 109.362 -0.607 . . . . 64.45 109.362 168.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.7 t70 -145.53 146.8 31.57 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.932 -1.031 . . . . 73.35 110.391 -174.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.541 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.1 mt -141.72 147.48 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.819 1.648 . . . . 74.33 106.813 174.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.0 t -160.46 151.47 18.95 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.225 0.61 . . . . 72.24 110.174 176.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -155.52 112.21 3.2 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 124.384 1.074 . . . . 74.12 108.104 174.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -122.77 132.15 54.1 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.407 0.683 . . . . 71.34 110.477 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.61 86.35 4.67 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 107.634 -1.247 . . . . 74.43 107.634 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.43 -40.81 29.26 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.088 2.525 . . . . 75.44 112.03 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -91.53 18.16 7.72 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 113.902 -1.499 . . . . 64.32 111.625 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.99 -56.32 6.42 Favored Pre-proline 0 N--CA 1.486 1.354 0 N-CA-C 114.029 1.122 . . . . 63.43 114.029 -171.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -60.99 -40.35 53.0 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 121.76 1.64 . . . . 64.24 112.415 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -68.75 -38.03 79.83 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.16 0.984 . . . . 75.33 112.493 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.662 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.6 p -79.04 -13.98 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 C-N-CA 123.329 0.652 . . . . 62.02 111.903 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -75.3 -17.67 60.22 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 112.521 0.563 . . . . 73.43 112.521 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -103.22 36.23 2.31 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.16 0.505 . . . . 70.01 110.208 175.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.435 ' HG2' HD13 ' C' ' 68' ' ' LEU . 1.0 OUTLIER -119.35 149.45 41.8 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.005 0.522 . . . . 72.42 111.358 -174.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -59.17 101.97 0.11 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.237 1.015 . . . . 72.21 109.802 176.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -79.07 101.76 8.03 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.153 0.502 . . . . 75.34 111.528 -171.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -163.04 76.65 1.86 Allowed Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 107.876 -1.157 . . . . 74.32 107.876 167.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -88.0 153.41 7.11 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.776 2.317 . . . . 62.32 113.316 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -87.6 109.04 19.36 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.079 -0.964 . . . . 55.31 108.927 167.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.468 HG23 HG13 ' C' ' 64' ' ' VAL . 2.7 p -72.02 100.35 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-O 121.85 0.833 . . . . 74.03 109.825 173.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -92.28 98.83 11.75 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.835 -1.172 . . . . 71.42 107.835 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 pp -103.19 154.12 19.65 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.661 0.384 . . . . 73.21 110.145 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -143.88 140.44 29.77 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.355 -0.609 . . . . 72.55 109.355 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -118.85 111.96 19.07 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.0 -0.741 . . . . 73.31 109.0 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.49 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 5.8 t70 -112.24 150.85 30.33 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.732 1.213 . . . . 63.23 108.513 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 76.8 p -116.48 138.07 51.67 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.506 0.723 . . . . 63.45 111.259 -170.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.34 150.19 38.81 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.253 1.021 . . . . 74.14 109.105 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 11.7 p -165.49 158.16 15.55 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.425 0.528 . . . . 51.05 112.425 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 67.7 p -160.2 143.93 14.05 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.277 1.031 . . . . 61.45 109.559 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -80.95 131.13 35.31 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.166 -0.679 . . . . 64.45 109.166 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' C' ' 57' ' ' GLU . 29.1 mt -107.57 -32.98 7.46 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.259 0.624 . . . . 72.03 110.846 -176.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.17 -174.53 4.76 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.459 0.704 . . . . 64.22 110.68 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -66.15 130.31 42.8 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.943 -1.026 . . . . 73.54 109.166 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 64.86 -6.89 0.29 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.836 1.255 . . . . 74.32 113.274 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 71.0 t -108.87 119.6 58.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 C-N-CA 123.259 0.623 . . . . 63.22 110.432 -167.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . 0.525 ' HB2' HD11 ' C' ' 86' ' ' ILE . 13.6 m-85 -119.99 143.58 47.97 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.72 -1.127 . . . . 74.52 108.864 171.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.629 ' HB2' HD11 ' C' ' 51' ' ' LEU . 24.2 tt0 -83.56 110.24 18.07 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.396 -1.729 . . . . 75.41 107.862 167.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 78.6 t -96.9 112.17 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.033 -1.469 . . . . 63.22 107.033 172.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.466 HG23 ' HG2' ' C' ' 57' ' ' GLU . 90.3 t -113.04 134.05 56.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 107.983 -1.117 . . . . 74.21 107.983 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.444 HD22 ' HB2' ' C' ' 103' ' ' PRO . 26.8 tp -127.61 119.96 27.08 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.037 -0.727 . . . . 72.25 109.037 175.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.49 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.7 ttm180 -81.21 123.68 28.66 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 124.211 0.945 . . . . 72.22 109.45 173.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.1 114.94 48.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.699 -1.222 . . . . 63.1 107.699 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 36.0 m -114.63 142.82 45.96 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.426 -0.953 . . . . 74.12 108.426 -175.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.468 HG13 HG23 ' C' ' 40' ' ' VAL . 53.5 t -136.25 110.0 9.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.717 1.207 . . . . 62.11 107.894 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.502 HG23 HD23 ' C' ' 75' ' ' LEU . 3.7 m -107.0 107.2 18.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.059 -1.46 . . . . 73.3 107.059 172.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.88 122.34 40.88 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.989 -1.485 . . . . 50.01 106.989 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 44.5 m -132.87 127.35 34.24 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.889 0.376 . . . . 32.44 111.115 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.435 HD13 ' HG2' ' C' ' 34' ' ' LYS . 10.2 mt -86.02 43.76 1.07 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.385 1.474 . . . . 71.22 109.787 174.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.49 -113.51 4.61 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 109.748 -1.341 . . . . 74.41 109.748 -171.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -90.01 -28.83 18.82 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.192 0.597 . . . . 72.45 110.2 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -72.38 102.29 3.12 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.714 -0.847 . . . . 73.31 108.714 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 30.1 m -68.99 123.85 22.13 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.294 -0.632 . . . . 71.11 109.294 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.662 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -66.08 -64.46 0.85 Allowed 'General case' 0 C--O 1.239 0.51 0 O-C-N 123.99 0.806 . . . . 74.52 108.908 177.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -154.61 171.85 18.8 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.47 -0.786 . . . . 73.32 110.632 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.502 HD23 HG23 ' C' ' 65' ' ' THR . 2.6 tm? -127.53 144.36 51.07 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.372 -1.714 . . . . 71.53 106.372 172.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.461 ' SG ' HG23 ' C' ' 114' ' ' ILE . 38.3 t -152.73 145.4 24.26 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.309 -0.997 . . . . 74.41 108.309 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -159.24 126.28 4.7 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.383 0.273 . . . . 74.3 110.531 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.501 HG11 ' HA ' ' C' ' 110' ' ' ALA . 54.9 t -133.93 113.26 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.296 1.039 . . . . 71.01 109.154 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.507 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 27.8 mt-30 -90.55 95.92 10.4 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.611 -0.885 . . . . 62.43 108.611 172.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.582 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.0 tp-100 -79.61 108.39 13.12 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.32 -0.854 . . . . 71.23 109.58 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.09 145.39 21.43 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.711 -0.677 . . . . 71.33 111.681 175.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.87 114.81 0.71 Allowed Glycine 0 CA--C 1.507 -0.467 0 N-CA-C 110.279 -1.128 . . . . 71.15 110.279 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.433 HD12 ' CD1' ' C' ' 51' ' ' LEU . 19.0 mm -82.66 123.32 38.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 N-CA-C 108.259 -1.015 . . . . 72.45 108.259 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.492 ' HE2' HG12 ' C' ' 13' ' ' ILE . 58.4 m-85 -132.64 138.8 47.48 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.164 0.586 . . . . 71.05 109.842 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 41.2 p -94.05 100.98 13.0 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.128 -1.064 . . . . 71.32 108.128 167.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.572 HD13 ' H ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -116.83 128.79 74.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 C-N-CA 123.752 0.821 . . . . 64.02 109.766 -178.133 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.73 165.98 29.53 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.418 -0.81 . . . . 74.24 110.641 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.08 -59.97 0.36 Allowed Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.85 -0.614 . . . . 71.31 112.838 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 23.7 pt -90.91 172.71 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.634 0.774 . . . . 75.43 111.813 -170.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -157.4 151.23 24.32 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.204 0.602 . . . . 75.23 111.012 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.29 -132.34 11.06 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.915 -0.584 . . . . 53.51 112.529 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 42.6 p -65.76 -27.05 68.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.744 0.818 . . . . 72.51 111.495 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -58.91 -52.37 66.04 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.972 0.909 . . . . 74.23 109.629 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 50.8 ttm -67.88 -39.63 83.67 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 114.655 -1.157 . . . . 64.44 110.109 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.86 88.88 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.109 0.963 . . . . 71.04 111.856 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -70.16 -43.46 70.8 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.977 -0.556 . . . . 63.34 110.793 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.59 -41.87 95.59 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.233 0.613 . . . . 73.31 111.013 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 64.4 mt -84.15 -37.48 21.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.641 0.777 . . . . 74.51 111.457 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.35 10.11 75.39 Favored Glycine 0 N--CA 1.476 1.335 0 N-CA-C 114.212 0.445 . . . . 41.22 114.212 -172.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' C' ' 104' ' ' ASN . . . -153.62 -59.6 0.13 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.083 0.553 . . . . 62.14 110.513 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -72.77 -42.3 64.13 Favored 'General case' 0 CA--C 1.556 1.188 0 N-CA-C 113.013 0.746 . . . . 71.32 113.013 -166.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.599 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 60.3 m -67.25 -49.91 41.96 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 123.112 0.565 . . . . 60.13 111.944 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.444 ' HB2' HD22 ' C' ' 60' ' ' LEU . 70.1 Cg_endo -71.73 -23.71 22.38 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 121.722 1.615 . . . . 72.51 112.799 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . 0.497 ' HA ' ' HD2' ' C' ' 107' ' ' PHE . 46.6 t-20 -56.22 -39.98 73.36 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 123.952 0.901 . . . . 74.1 110.153 176.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.426 HD12 ' NH1' ' A' ' 111' ' ' ARG . 34.8 mm -60.16 -41.1 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 114.382 -1.281 . . . . 65.33 111.12 175.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 68.1 mt -87.07 -19.62 28.33 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.444 0.698 . . . . 73.34 112.689 -168.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . 0.497 ' HD2' ' HA ' ' C' ' 104' ' ' ASN . 28.1 m-85 -55.47 -53.23 64.54 Favored Pre-proline 0 N--CA 1.489 1.509 0 CA-C-O 118.081 -0.961 . . . . 75.33 112.832 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -54.76 -40.19 85.94 Favored 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 122.857 2.372 . . . . 75.12 114.658 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.539 ' HE2' HG21 ' A' ' 115' ' ' THR . 39.7 m-85 -66.62 -50.1 64.1 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.56 0.744 . . . . 74.23 110.77 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.582 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.75 -35.33 80.74 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.016 -0.993 . . . . 64.34 111.041 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -61.27 -48.28 82.15 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.159 1.384 . . . . 71.25 110.638 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.73 -35.94 77.77 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 123.515 0.51 . . . . 63.22 109.73 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.4 t -67.99 -33.2 74.18 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.376 0.67 . . . . 72.12 111.151 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.461 HG23 ' SG ' ' C' ' 76' ' ' CYS . 78.1 mt -72.53 -54.35 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 109.545 -0.539 . . . . 60.53 109.545 174.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 22.6 m -62.37 -28.38 69.73 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 122.909 0.484 . . . . 64.31 111.25 -175.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.6 t -65.27 -49.03 71.11 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.996 -0.742 . . . . 52.2 108.996 171.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.668 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.03 -38.16 85.13 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.602 1.161 . . . . 64.52 112.264 178.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.458 HG23 ' O ' ' C' ' 114' ' ' ILE . 68.0 t -59.39 -47.19 91.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 108.765 -0.828 . . . . 74.23 108.765 175.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 37.9 t -74.64 -23.29 58.65 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.572 -1.195 . . . . 73.33 112.272 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.422 ' HD2' ' SD ' ' C' ' 117' ' ' MET . 90.2 mtt-85 -74.43 -39.06 62.83 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.015 -0.735 . . . . 73.34 109.015 175.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.11 0.96 82.19 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 124.168 0.917 . . . . 64.53 112.172 170.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.9 p 60.87 30.7 19.81 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.687 1.995 . . . . 61.15 113.602 171.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -83.29 143.8 45.63 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 108.242 -1.022 . . . . 64.43 108.242 170.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -51.27 152.16 11.75 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.211 2.608 . . . . 55.31 113.45 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -54.17 125.98 21.15 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.575 0.954 . . . . 71.1 113.575 -170.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 21.7 tp -122.84 86.09 2.53 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 107.682 -1.229 . . . . 73.11 107.682 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -95.7 115.9 28.1 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.387 -0.824 . . . . 72.5 108.994 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.11 129.01 37.12 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.334 0.654 . . . . 73.24 110.155 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.58 145.14 74.83 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 122.633 0.373 . . . . 65.34 110.932 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.434 ' HG3' HD12 ' A' ' 16' ' ' ILE . 71.4 Cg_endo -72.92 144.76 39.04 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.272 2.648 . . . . 73.41 113.369 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 18.5 m -137.91 134.76 45.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.213 1.005 . . . . 73.33 108.65 171.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . 0.596 HD21 ' HE1' ' A' ' 11' ' ' PHE . 3.4 m-20 -81.71 90.24 6.33 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 118.694 -0.669 . . . . 62.21 109.644 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -54.64 -44.66 73.4 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 118.363 0.529 . . . . 51.24 112.084 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 N--CA 1.478 0.929 0 C-N-CA 124.366 1.066 . . . . 65.3 111.582 178.797 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 86.6 m . . . . . 0 C--O 1.241 0.611 0 N-CA-C 108.528 -0.916 . . . . 74.42 108.528 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -163.16 105.4 1.01 Allowed 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.524 -0.917 . . . . 72.4 108.524 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -128.37 127.63 42.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.069 -1.086 . . . . 74.0 108.069 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.528 HG21 HD11 ' D' ' 16' ' ' ILE . 10.8 mt -86.82 131.42 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 109.001 -0.74 . . . . 73.32 109.001 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -98.48 -35.28 10.31 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.325 0.65 . . . . 71.14 110.931 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -167.21 142.03 3.94 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.857 0.688 . . . . 70.24 112.857 -171.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.528 HD11 HG21 ' D' ' 13' ' ' ILE . 3.4 mp -119.65 134.87 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 106.798 -1.556 . . . . 74.42 106.798 170.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.431 ' HE1' HG13 ' D' ' 83' ' ' ILE . 31.9 p90 -164.97 165.49 20.15 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.77 0.795 . . . . 72.32 110.744 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.2 p -102.68 124.11 47.62 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.461 -1.245 . . . . 72.42 108.636 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -89.78 -42.51 11.25 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.75 -0.833 . . . . 74.41 108.75 175.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -130.9 138.13 49.65 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.433 -0.803 . . . . 75.02 109.354 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.668 HG21 ' HE2' ' C' ' 117' ' ' MET . 61.0 mt -138.1 151.45 25.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 107.259 -1.385 . . . . 64.54 107.259 172.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 46.9 t -157.89 146.04 18.85 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.466 1.106 . . . . 71.11 108.734 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.541 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.0 t80 -149.45 133.44 17.11 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 105.771 -1.937 . . . . 75.23 105.771 169.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.8 mt-10 -132.6 149.64 52.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.487 -0.931 . . . . 73.01 108.487 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.669 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -145.64 77.36 12.47 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 107.355 -1.35 . . . . 62.34 107.355 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -67.16 -39.54 13.2 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.709 2.273 . . . . 53.32 112.464 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -98.31 5.8 47.95 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 118.526 -0.749 . . . . 53.41 110.817 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.669 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -29.22 -63.2 0.2 Allowed Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 117.091 2.256 . . . . 72.1 117.091 -166.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.693 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 42.5 Cg_endo -82.36 -15.0 9.08 Favored 'Trans proline' 0 C--N 1.379 2.175 0 CA-C-N 122.827 2.045 . . . . 62.21 113.838 -174.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -77.07 -41.68 41.34 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.493 1.117 . . . . 74.02 109.332 173.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.8 p -83.64 -11.03 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 C-N-CA 124.294 1.038 . . . . 64.0 111.173 -175.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.403 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 12.0 m-85 -69.77 -19.06 63.53 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 112.112 0.412 . . . . 70.12 112.112 174.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -59.67 -25.74 64.97 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.408 0.623 . . . . 74.11 110.229 169.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -100.08 90.78 4.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.966 1.306 . . . . 64.54 109.355 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -105.34 93.01 4.45 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.371 -0.603 . . . . 74.24 109.371 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -156.43 175.06 14.52 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.074 0.949 . . . . 74.51 108.74 169.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.441 HE21 ' HD2' ' D' ' 38' ' ' PRO . 19.4 tp60 -67.25 106.98 1.39 Allowed Pre-proline 0 CA--C 1.554 1.099 0 CA-C-O 118.855 -0.593 . . . . 71.44 109.408 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.509 ' HB3' ' HG ' ' D' ' 68' ' ' LEU . 30.5 Cg_endo -69.16 148.7 69.55 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.169 1.913 . . . . 54.14 112.716 -172.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -69.62 113.31 6.78 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 108.443 -0.947 . . . . 74.5 108.443 172.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.493 HG13 HG13 ' D' ' 64' ' ' VAL . 88.3 t -104.52 122.76 57.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 123.184 0.594 . . . . 71.2 109.632 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -94.36 128.47 40.9 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.803 -1.184 . . . . 74.53 107.803 170.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.4 ' H ' ' HG ' ' D' ' 42' ' ' LEU . 3.2 pp -95.87 146.76 24.31 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.816 0.846 . . . . 74.01 109.468 -171.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.568 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 12.5 t70 -149.66 131.49 15.1 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.272 -1.01 . . . . 54.42 108.272 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -124.82 138.84 54.25 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.847 0.459 . . . . 74.31 109.94 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -133.03 155.8 48.52 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.723 1.209 . . . . 74.42 108.48 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 3.1 m -106.07 152.04 23.9 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.097 0.559 . . . . 51.12 111.62 -167.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.751 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -155.12 142.51 19.54 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.783 -0.821 . . . . 43.11 108.783 169.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.4 p -165.47 152.32 10.25 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 123.193 0.597 . . . . 75.11 109.682 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.2 p -158.91 143.62 15.82 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.112 0.565 . . . . 71.34 109.836 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -77.04 121.73 23.94 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.264 -0.643 . . . . 74.43 109.264 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.55 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.3 mt -94.91 -26.42 16.15 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.171 0.588 . . . . 72.23 109.812 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.56 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -170.35 -179.73 3.14 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.712 1.605 . . . . 52.53 109.082 175.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -76.0 123.95 26.58 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.014 -1.106 . . . . 62.34 108.014 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 73.79 -3.12 2.58 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 125.597 1.559 . . . . 65.22 112.269 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 78.3 t -117.53 118.04 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 108.302 -0.999 . . . . 73.24 108.302 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -135.03 172.26 13.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.041 0.448 . . . . 55.13 109.904 -174.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.55 ' HB2' HD11 ' D' ' 51' ' ' LEU . 24.7 tt0 -125.1 126.29 45.09 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.113 0.965 . . . . 72.44 108.714 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.83 115.88 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 107.569 -1.271 . . . . 60.34 107.569 175.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.751 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 26.2 t -117.96 134.68 60.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 123.866 0.866 . . . . 54.1 108.944 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 7.8 mp -121.5 130.73 53.73 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.968 0.413 . . . . 72.33 110.1 171.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -85.47 106.18 16.63 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.809 -1.087 . . . . 63.3 109.071 173.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 94.9 t -91.46 116.19 32.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 108.248 -1.019 . . . . 52.33 108.248 171.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 72.5 m -114.64 142.16 46.83 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 108.816 -0.809 . . . . 70.45 108.816 -176.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.493 HG13 HG13 ' D' ' 40' ' ' VAL . 58.7 t -132.16 102.93 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 125.099 1.36 . . . . 74.33 108.333 -173.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 42.2 m -95.83 91.51 6.08 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.571 -1.27 . . . . 74.22 107.571 168.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.2 143.47 26.59 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.898 -0.779 . . . . 73.22 108.898 -175.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.473 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 41.1 m -143.17 127.36 17.57 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.481 0.488 . . . . 73.52 111.175 -176.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.509 ' HG ' ' HB3' ' D' ' 38' ' ' PRO . 21.7 mt -97.12 105.57 17.75 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.029 -1.101 . . . . 61.12 108.029 173.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.64 -114.12 4.95 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.377 -0.829 . . . . 64.44 111.973 -177.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.48 4.7 30.85 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 112.957 0.725 . . . . 74.24 112.957 -172.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -136.24 161.7 35.02 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.496 0.319 . . . . 73.14 110.469 -175.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 70.9 m -62.74 125.17 23.04 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 124.208 0.942 . . . . 71.23 111.45 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.473 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -78.56 -70.84 0.47 Allowed 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.788 -1.096 . . . . 74.22 108.188 170.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -149.34 146.78 27.69 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.493 -0.776 . . . . 65.33 110.382 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.447 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 72.4 mt -111.69 108.24 17.62 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.96 -1.126 . . . . 73.34 107.96 174.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.5 ' SG ' HG23 ' D' ' 114' ' ' ILE . 43.7 t -116.97 146.7 42.85 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.253 -0.647 . . . . 73.14 109.253 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 19.8 tt0 -153.55 133.13 12.95 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.449 0.699 . . . . 74.14 109.66 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 45.3 t -138.82 116.95 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.081 -0.711 . . . . 71.31 109.081 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -87.83 88.63 7.71 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 108.07 -1.085 . . . . 72.32 108.07 169.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -80.86 114.51 19.79 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.413 -1.267 . . . . 73.21 108.471 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.29 144.5 18.09 Favored Glycine 0 C--N 1.337 0.594 0 O-C-N 123.465 0.478 . . . . 72.53 112.441 -176.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.68 137.83 9.47 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 111.221 -0.752 . . . . 74.41 111.221 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.431 HG13 ' HE1' ' D' ' 17' ' ' TYR . 72.8 mt -88.71 120.45 37.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.66 -1.237 . . . . 74.45 107.66 173.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -128.72 122.07 29.87 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.863 0.865 . . . . 70.32 109.244 -175.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 31.9 m -85.04 93.99 8.73 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.206 -1.035 . . . . 65.04 108.206 169.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 11.7 tt -123.31 131.55 72.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 123.91 0.884 . . . . 73.23 109.161 -173.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.7 166.63 32.83 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.371 0.668 . . . . 64.34 110.902 -173.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.35 17.09 76.94 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.619 -0.718 . . . . 63.33 113.683 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 6.7 mt -125.61 154.13 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.059 0.543 . . . . 74.23 109.861 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.555 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 0.0 OUTLIER -159.51 -174.06 4.47 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 123.934 0.893 . . . . 75.44 110.184 174.268 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.61 -142.29 45.28 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.492 0.495 . . . . 51.21 113.425 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 51.6 m -76.84 -28.31 55.45 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.606 0.762 . . . . 73.4 111.692 -176.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -60.11 -44.17 95.07 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.84 0.456 . . . . 75.23 111.298 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.555 ' SD ' ' HA ' ' D' ' 90' ' ' GLU . 25.6 ptt? -72.38 -30.63 64.85 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 123.111 0.257 . . . . 60.44 111.477 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.76 -36.14 82.72 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.316 0.579 . . . . 73.43 110.24 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -85.86 -18.2 33.47 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.774 -0.648 . . . . 74.4 110.653 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 47.3 t -70.52 -51.07 31.33 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.536 0.684 . . . . 70.15 109.487 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 30.0 mt -77.32 -18.95 57.04 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.87 -1.059 . . . . 61.52 110.545 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.06 15.46 51.33 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 115.764 -0.653 . . . . 74.42 113.815 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.47 -65.8 0.08 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 117.235 0.517 . . . . 51.34 111.911 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -64.21 -53.47 48.74 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.68 0.792 . . . . 73.24 112.681 -169.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 21.7 m -63.67 -43.83 78.52 Favored Pre-proline 0 CA--C 1.565 1.541 0 C-N-CA 123.819 0.847 . . . . 73.34 111.798 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -52.76 -39.05 78.16 Favored 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 122.759 2.306 . . . . 74.45 113.996 166.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -64.54 -28.58 69.75 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.525 0.73 . . . . 73.24 111.682 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.2 mm -69.78 -42.17 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-O 121.491 0.662 . . . . 71.32 109.761 173.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 93.8 mt -82.62 -12.65 57.52 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.819 -1.082 . . . . 65.22 111.887 -177.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . 0.4 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 83.7 t80 -60.83 -52.73 70.34 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.489 1.116 . . . . 73.41 113.184 -176.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 39.6 Cg_exo -61.47 -35.48 82.38 Favored 'Trans proline' 0 C--N 1.385 2.482 0 C-N-CA 121.863 1.708 . . . . 63.44 112.384 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -71.29 -43.98 66.09 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.311 1.045 . . . . 65.44 111.991 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.72 -42.17 86.75 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.416 0.686 . . . . 30.23 110.127 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.414 ' NH2' HG23 ' B' ' 105' ' ' ILE . 38.8 ttp180 -57.34 -54.61 44.88 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 124.199 0.937 . . . . 73.14 110.08 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -59.04 -46.03 89.26 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.199 0.937 . . . . 73.52 111.198 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.7 t -58.05 -43.31 86.82 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 123.749 0.656 . . . . 74.35 111.041 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.5 HG23 ' SG ' ' D' ' 76' ' ' CYS . 74.1 mt -65.21 -55.45 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 123.565 0.541 . . . . 63.42 109.994 175.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 62.8 m -51.17 -44.0 61.4 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.927 1.291 . . . . 62.23 111.736 -173.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 35.9 t -65.67 -43.11 90.31 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 114.683 -1.144 . . . . 61.42 109.958 -178.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 79.3 mtm -67.86 -32.94 73.8 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.116 0.566 . . . . 61.33 111.866 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.436 HG23 ' O ' ' D' ' 114' ' ' ILE . 85.5 t -65.13 -44.19 95.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.469 0.708 . . . . 53.15 109.744 176.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 80.9 p -74.6 -28.46 60.91 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.952 -0.567 . . . . 52.14 111.153 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' D' ' 116' ' ' SER . 82.5 mtt-85 -70.88 -32.89 70.01 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.663 0.785 . . . . 70.34 109.973 174.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.73 5.69 77.46 Favored Glycine 0 C--N 1.353 1.49 0 O-C-N 123.902 0.751 . . . . 42.53 112.068 171.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.2 p 55.78 24.05 6.96 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 127.27 2.228 . . . . 73.24 113.982 176.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -79.59 155.17 76.23 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.571 0.748 . . . . 71.22 109.663 170.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -48.57 126.32 14.07 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.531 2.82 . . . . 74.44 112.327 172.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -51.92 132.39 32.06 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.617 1.167 . . . . 73.21 112.223 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 5.8 tt -108.07 101.77 10.98 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.611 -1.255 . . . . 75.23 107.611 -177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -100.95 102.89 14.0 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.299 -1.001 . . . . 74.2 108.299 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 tt -69.16 115.21 8.18 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 107.794 -1.187 . . . . 72.3 107.794 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.76 139.31 97.1 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 123.201 0.6 . . . . 62.14 110.756 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -58.72 106.26 0.27 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.007 2.471 . . . . 70.54 111.682 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 17.4 m . . . . . 0 C--O 1.241 0.64 0 CA-C-N 115.203 -0.908 . . . . 74.23 109.678 -177.002 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.649 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 16.4 t80 . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 108.491 -0.929 . . . . 74.42 108.491 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -137.7 121.85 18.0 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.552 -0.907 . . . . 75.22 108.552 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.67 HG12 ' HD2' ' A' ' 84' ' ' PHE . 58.8 mt -93.94 123.01 45.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.416 -0.957 . . . . 71.12 108.416 174.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -84.32 -40.85 17.44 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 123.493 0.496 . . . . 74.01 110.158 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -169.61 134.98 1.47 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 116.389 -0.369 . . . . 73.22 110.692 -168.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 85.8 mt -125.39 129.85 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 123.708 0.803 . . . . 70.2 109.218 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -162.24 148.06 13.01 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 124.222 0.951 . . . . 74.51 110.715 -167.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.7 p -75.05 129.04 36.93 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 109.407 -0.59 . . . . 61.33 109.407 173.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.492 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 39.3 mtpt -97.99 -27.82 14.07 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.6 0.36 . . . . 72.11 110.399 176.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 13.6 t70 -141.98 138.47 31.92 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.382 -0.599 . . . . 61.34 109.382 171.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.425 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 60.4 mt -130.5 140.64 48.3 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 N-CA-C 107.087 -1.449 . . . . 41.04 107.087 172.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.0 t -150.58 128.2 11.55 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.036 0.534 . . . . 71.1 110.19 175.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.422 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 75.9 t80 -130.48 142.46 50.49 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.416 -1.327 . . . . 64.14 107.416 171.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -141.92 139.36 32.52 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.495 -0.928 . . . . 70.4 108.495 171.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.429 ' CB ' ' HB2' ' A' ' 28' ' ' ALA . . . -118.09 86.49 26.36 Favored Pre-proline 0 C--O 1.241 0.615 0 N-CA-C 106.118 -1.808 . . . . 54.43 106.118 169.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -53.41 -42.69 63.59 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.578 2.852 . . . . 65.21 113.774 -168.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.32 37.46 4.25 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.22 -0.659 . . . . 72.11 109.22 -177.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -41.75 -60.89 1.68 Allowed Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 113.74 1.015 . . . . 72.13 113.74 -169.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 23.4 Cg_exo -63.19 -27.07 72.52 Favored 'Trans proline' 0 C--N 1.385 2.496 0 CA-C-N 121.786 1.673 . . . . 51.43 112.776 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -84.69 -32.15 23.73 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.225 1.01 . . . . 63.44 111.311 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.731 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.8 p -79.08 -23.66 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.595 -0.729 . . . . 53.25 111.642 -168.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -72.39 -12.04 60.95 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.171 0.588 . . . . 71.31 111.51 176.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -81.63 -29.79 33.1 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.123 0.969 . . . . 54.3 110.156 173.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -74.46 153.83 38.99 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.178 0.991 . . . . 73.41 111.288 -174.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.78 136.81 45.52 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.594 -0.73 . . . . 75.23 109.259 170.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.416 ' CE3' HD21 ' A' ' 68' ' ' LEU . 62.1 t-105 -80.21 85.09 5.79 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.365 0.666 . . . . 73.44 110.45 -175.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.4 ' H ' HD22 ' A' ' 68' ' ' LEU . 6.5 tp60 -125.24 79.21 66.45 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.209 1.004 . . . . 70.23 108.5 170.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -89.97 140.79 3.5 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.694 2.263 . . . . 74.13 113.364 -173.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -99.43 90.75 4.63 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 107.805 -1.183 . . . . 72.34 107.805 167.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -70.52 92.36 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 122.477 1.132 . . . . 74.04 109.609 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -79.66 147.68 31.9 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 113.971 -1.468 . . . . 43.42 109.224 172.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 pp -133.64 131.77 39.97 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.535 0.734 . . . . 64.54 110.219 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.589 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 32.8 m-20 -115.89 135.76 53.69 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.294 -1.002 . . . . 70.52 108.294 175.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.8 mp -104.58 121.92 44.51 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.92 0.888 . . . . 73.05 109.176 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -141.99 144.59 33.76 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.884 -0.784 . . . . 65.03 108.884 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.7 m -146.69 140.26 25.81 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.066 0.547 . . . . 75.44 110.14 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.25 152.38 51.37 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.987 1.315 . . . . 54.21 108.603 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.6 p -132.01 160.61 35.35 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.15 0.58 . . . . 63.44 109.867 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -149.78 119.41 6.99 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.946 -0.761 . . . . 62.22 108.946 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -84.91 111.5 19.72 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.486 -0.561 . . . . 63.34 109.486 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.3 mt -85.36 -29.95 24.05 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.555 0.742 . . . . 73.41 111.25 -175.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.598 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -164.61 -171.58 2.37 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.254 1.022 . . . . 65.2 110.142 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.14 100.75 0.63 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.31 0.644 . . . . 64.11 109.545 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 70.05 8.08 6.51 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.002 1.321 . . . . 73.44 112.613 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 57.2 t -100.27 118.37 46.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 106.303 -1.739 . . . . 74.41 106.303 166.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -142.46 173.58 11.41 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.321 0.581 . . . . 61.44 110.283 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -127.65 131.68 49.82 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.262 -1.335 . . . . 74.32 108.878 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.49 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 84.5 t -106.01 135.8 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.731 -1.211 . . . . 75.25 107.731 166.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.439 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 39.8 t -123.95 129.67 74.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.863 -1.532 . . . . 71.41 106.863 174.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tt -124.98 117.91 25.08 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.051 -0.722 . . . . 74.43 109.051 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.584 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 21.3 ttp180 -89.59 111.04 21.86 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.884 -1.053 . . . . 62.52 109.661 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.411 HG11 HD11 ' A' ' 128' ' ' LEU . 43.9 t -100.36 110.87 28.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.979 -1.119 . . . . 74.34 107.979 172.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.589 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 26.3 m -97.75 108.92 21.73 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.677 -0.49 . . . . 73.34 109.677 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.4 t -103.68 108.38 24.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.405 1.082 . . . . 75.53 109.065 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.5 m -102.86 137.05 41.58 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.929 -1.137 . . . . 72.23 107.929 171.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.51 118.91 25.87 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 107.457 -1.312 . . . . 55.45 107.457 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -130.87 132.04 44.92 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.746 0.654 . . . . 70.03 111.092 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.416 HD21 ' CE3' ' A' ' 36' ' ' TRP . 15.6 mt -87.92 75.09 8.87 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.613 -1.254 . . . . 72.01 107.613 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.0 -115.69 4.07 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 114.953 -1.021 . . . . 62.2 110.737 -170.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -90.37 -19.63 23.76 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.722 0.809 . . . . 75.24 111.355 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -94.37 119.0 32.46 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.073 0.549 . . . . 74.51 109.993 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.8 m -72.58 121.89 20.45 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.311 0.382 . . . . 74.35 110.859 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.731 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -68.67 -56.27 8.71 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.763 -0.653 . . . . 75.21 109.697 176.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.465 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 42.7 p90 -156.26 175.55 13.84 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.018 -0.992 . . . . 73.45 111.371 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.6 tp -138.52 140.47 39.14 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.056 -1.429 . . . . 64.42 107.268 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 90.1 m -144.26 95.87 2.79 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.834 0.854 . . . . 65.31 108.819 -177.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -116.07 115.27 25.79 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.499 -0.926 . . . . 73.31 108.499 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.4 t -127.91 118.03 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.398 0.679 . . . . 74.24 110.244 -175.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.584 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 78.2 mt-30 -86.31 92.3 8.76 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 108.825 -0.805 . . . . 50.04 108.825 169.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -82.67 112.5 19.59 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.979 -0.748 . . . . 70.43 108.979 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -102.66 166.49 16.96 Favored Glycine 0 C--N 1.335 0.519 0 O-C-N 123.206 0.316 . . . . 64.24 112.855 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.58 131.7 2.3 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.793 -0.523 . . . . 75.42 111.793 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.1 mt -81.33 124.58 39.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 123.316 0.646 . . . . 75.52 109.369 174.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.67 ' HD2' HG12 ' A' ' 13' ' ' ILE . 10.0 m-85 -130.58 118.39 20.96 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.296 -1.001 . . . . 74.43 108.296 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.9 p -96.89 93.33 6.58 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.634 -0.876 . . . . 61.15 108.634 173.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.535 ' HB ' ' HD2' ' A' ' 11' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.475 0.792 0 C-N-CA 124.033 0.933 . . . . 64.21 109.79 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.902 0 CA-C-O 121.202 0.525 . . . . 75.24 111.068 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -68.3 -30.24 69.19 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.426 1.09 . . . . 74.13 111.156 176.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.456 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 48.7 t -68.76 -57.78 5.14 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.202 0.525 . . . . 40.24 110.21 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 pp -76.04 -19.91 58.22 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.566 -0.743 . . . . 75.5 112.093 -177.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.17 -4.49 53.71 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-O 119.519 -0.601 . . . . 63.22 114.225 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.34 -61.37 0.22 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 117.709 0.755 . . . . 74.4 112.155 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.487 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 91.2 t80 -59.92 -61.96 2.22 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 113.21 0.819 . . . . 74.03 113.21 -168.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 73.7 m -64.3 -38.16 31.54 Favored Pre-proline 0 CA--C 1.565 1.543 0 N-CA-C 112.829 0.677 . . . . 72.24 112.829 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.24 -46.12 23.85 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.528 2.152 . . . . 73.31 113.529 161.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.697 HD21 ' HB2' ' A' ' 133' ' ' PHE . 87.7 m-20 -75.88 -12.91 60.25 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.873 0.869 . . . . 71.53 112.224 -177.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.0 mm -70.59 -41.07 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 109.199 -0.667 . . . . 75.44 109.199 169.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 83.7 mt -82.33 -22.62 35.51 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.147 0.979 . . . . 74.15 111.919 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -57.49 -48.91 96.47 Favored Pre-proline 0 CA--C 1.569 1.702 0 N-CA-C 114.245 1.202 . . . . 65.35 114.245 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -63.79 -36.03 53.5 Favored 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 122.001 1.8 . . . . 64.33 112.582 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -69.18 -42.73 75.45 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.526 0.73 . . . . 62.31 111.383 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.88 -37.68 82.08 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.355 0.662 . . . . 52.24 109.995 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.471 ' NH1' HG23 ' C' ' 105' ' ' ILE . 28.0 ttm180 -54.02 -55.18 29.73 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.804 0.842 . . . . 54.2 110.279 171.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -67.49 -40.36 85.23 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.175 0.99 . . . . 74.43 111.736 -172.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.6 t -63.4 -36.6 84.25 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.366 0.416 . . . . 73.42 110.69 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.417 ' O ' HG23 ' A' ' 118' ' ' VAL . 60.0 mt -68.6 -49.58 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 115.461 -0.79 . . . . 74.21 110.039 174.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.6 m -56.32 -37.47 69.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.289 1.035 . . . . 73.42 111.496 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.9 t -62.23 -48.8 78.35 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 115.647 -0.706 . . . . 70.44 110.261 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.422 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 36.2 mtm -67.48 -36.27 80.8 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.158 0.583 . . . . 73.52 111.569 -176.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.5 t -62.88 -53.72 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 O-C-N 123.739 0.649 . . . . 60.35 110.278 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 38.7 t -66.51 -30.17 70.44 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.339 -0.846 . . . . 61.2 110.812 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.438 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 52.4 ttm-85 -77.43 -28.78 52.69 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.475 1.11 . . . . 72.41 109.343 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.417 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.72 9.6 67.84 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 115.283 -0.871 . . . . 55.23 112.23 171.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.559 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.1 t 67.83 13.5 9.21 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 127.166 2.186 . . . . 63.31 113.568 170.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -81.47 148.56 62.85 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 108.23 -1.026 . . . . 75.44 108.23 172.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -59.31 164.29 10.97 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.922 2.415 . . . . 61.2 113.371 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -54.51 120.25 6.39 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.009 0.923 . . . . 64.22 112.189 -173.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.465 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 62.2 tp -115.19 103.32 10.73 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.378 1.071 . . . . 64.21 108.563 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -99.12 111.16 23.62 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 107.537 -1.283 . . . . 74.04 107.537 177.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.411 HD11 HG11 ' A' ' 62' ' ' VAL . 2.2 tt -64.96 121.51 14.84 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.396 -0.964 . . . . 61.3 108.396 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.45 139.14 97.65 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 122.722 0.409 . . . . 51.41 111.363 -175.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.21 132.58 10.39 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 123.044 2.496 . . . . 62.2 112.199 -175.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.7 t -112.1 114.73 47.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.605 -1.258 . . . . 73.13 107.605 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -82.25 65.93 7.61 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 123.599 0.562 . . . . 75.53 110.345 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.697 ' HB2' HD21 ' A' ' 104' ' ' ASN . 80.4 m-85 . . . . . 0 C--N 1.366 1.301 0 C-N-CA 123.865 0.866 . . . . 72.41 110.789 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.672 ' HB2' ' HB ' ' B' ' 89' ' ' ILE . 12.6 ttt . . . . . 0 CA--C 1.555 1.16 0 CA-C-O 121.646 0.736 . . . . 72.32 111.592 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 87.5 m -139.79 136.18 33.8 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.138 -1.06 . . . . 63.53 108.138 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.579 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 86.0 t80 -126.31 145.16 50.54 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.858 0.863 . . . . 71.34 109.254 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.473 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -157.32 139.29 14.31 Favored 'General case' 0 C--N 1.346 0.441 0 O-C-N 123.501 0.5 . . . . 74.43 109.806 170.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.465 HD13 HD11 ' B' ' 16' ' ' ILE . 26.2 mt -79.8 126.32 39.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.846 -0.798 . . . . 71.34 108.846 172.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -94.45 -51.09 4.92 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.763 -0.458 . . . . 73.11 109.763 175.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.559 ' HE ' HG21 ' A' ' 122' ' ' THR . 33.7 ttt180 -162.67 139.87 7.94 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.547 -0.297 . . . . 64.45 110.758 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.465 HD11 HD13 ' B' ' 13' ' ' ILE . 98.1 mt -120.56 134.68 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 107.672 -1.233 . . . . 73.23 107.672 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -168.47 158.0 9.28 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.302 0.572 . . . . 75.32 111.949 -171.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 85.3 m -89.41 129.6 35.9 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.14 -0.936 . . . . 72.41 109.559 173.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.401 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.4 mtpt -100.37 -20.33 15.88 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.558 0.743 . . . . 75.42 111.412 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -167.52 144.22 4.31 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.52 0.513 . . . . 62.23 111.583 -173.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 43.0 mm -138.42 147.09 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.996 1.319 . . . . 74.35 109.468 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.568 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.2 t -146.01 136.14 23.71 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.638 1.175 . . . . 72.44 108.467 170.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.4 t80 -150.51 108.14 3.66 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 107.749 -1.204 . . . . 65.35 107.749 170.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -120.18 113.94 21.19 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.154 0.982 . . . . 75.24 109.013 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.42 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.55 87.94 3.06 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 108.269 -1.011 . . . . 71.25 108.269 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -66.57 -45.25 5.07 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.182 2.588 . . . . 72.35 113.043 -168.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.423 HD22 ' HB2' ' B' ' 71' ' ' GLU . 81.0 m-20 -103.36 23.56 12.32 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.661 0.785 . . . . 75.33 110.494 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.492 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -40.86 -62.15 1.07 Allowed Pre-proline 0 N--CA 1.49 1.548 0 C-N-CA 124.749 1.219 . . . . 60.35 113.981 -168.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.55 -23.64 76.84 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.468 2.112 . . . . 43.43 113.5 -173.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -94.28 -39.86 10.28 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.386 0.674 . . . . 71.32 111.954 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' B' ' 73' ' ' ALA . 8.7 p -69.71 -15.89 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 122.996 0.518 . . . . 60.15 112.072 -171.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -68.3 -11.98 60.32 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.561 0.744 . . . . 53.22 112.766 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.6 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.9 pt20 -58.16 -28.82 65.07 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.401 0.62 . . . . 71.34 109.962 172.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.6 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 88.7 mttt -95.94 92.91 6.72 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.253 1.421 . . . . 72.01 109.504 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -95.09 87.92 5.05 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.31 -0.405 . . . . 72.51 110.084 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -165.71 178.18 6.78 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.126 0.97 . . . . 74.42 108.994 170.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -70.9 112.12 12.2 Favored Pre-proline 0 CA--C 1.562 1.412 0 C-N-CA 123.277 0.631 . . . . 62.34 111.302 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.55 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 18.1 Cg_endo -62.66 143.76 92.97 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.278 1.985 . . . . 65.23 112.421 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.84 108.71 4.08 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.985 -0.746 . . . . 73.24 108.985 176.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 30.8 m -93.93 147.53 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.231 -0.895 . . . . 73.34 112.592 -172.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.47 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 61.7 mtpt -125.51 100.94 6.7 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.003 1.321 . . . . 73.44 108.29 174.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pp -96.58 155.6 16.7 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.626 -0.715 . . . . 73.53 111.443 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -150.28 150.92 32.17 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.326 1.05 . . . . 74.34 109.205 -175.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 90.5 mt -125.48 127.29 46.25 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.191 0.996 . . . . 63.25 108.615 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.556 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 25.1 t70 -124.21 146.26 48.82 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.016 0.526 . . . . 70.32 110.455 -171.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 90.7 m -110.41 122.76 48.49 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.944 -1.026 . . . . 72.31 110.983 -176.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.36 122.58 11.52 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 107.061 -1.459 . . . . 54.15 107.061 169.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 36.1 p -145.82 163.16 35.89 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.795 0.27 . . . . 52.33 110.804 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 52.5 p -151.99 141.53 21.69 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.83 0.852 . . . . 71.5 109.35 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -84.22 129.82 34.86 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.196 -0.668 . . . . 71.14 109.196 175.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 50.9 mt -92.22 -44.37 8.81 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.03 0.532 . . . . 74.23 110.312 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.85 -171.86 3.58 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.052 0.941 . . . . 24.41 109.569 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -68.3 129.32 39.58 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.455 -0.793 . . . . 73.15 109.157 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 68.57 -4.67 1.09 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.489 1.515 . . . . 74.44 113.085 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 82.4 t -113.76 117.61 55.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 108.642 -0.873 . . . . 64.5 108.642 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -135.12 140.84 45.77 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.155 -0.683 . . . . 74.54 109.155 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -114.07 114.31 25.93 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.204 -1.035 . . . . 71.25 108.204 -174.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 34.3 m -108.22 136.73 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.616 0.766 . . . . 71.24 110.431 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 19.5 t -120.92 121.65 65.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 108.393 -0.966 . . . . 72.52 108.393 177.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.33 108.86 20.61 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 106.84 -1.541 . . . . 74.43 106.84 170.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.623 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 26.9 ttp180 -86.9 118.73 26.48 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.036 -0.728 . . . . 72.31 109.036 173.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 16.6 t -103.92 121.16 55.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.71 -1.218 . . . . 60.31 107.71 174.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 23.8 m -120.26 124.96 46.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.111 -0.7 . . . . 65.24 109.111 -178.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 97.9 t -123.9 113.53 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 124.216 1.006 . . . . 75.23 109.101 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 67.3 m -84.84 149.38 25.74 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.354 -0.98 . . . . 74.42 108.354 166.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.43 140.77 30.57 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.334 0.653 . . . . 64.24 109.663 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.542 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 21.0 p -145.71 130.05 17.69 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.17 0.51 . . . . 61.14 111.383 -176.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.55 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 28.6 mt -104.59 128.09 52.5 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.323 1.049 . . . . 73.4 109.004 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.99 -111.37 4.09 Favored Glycine 0 C--N 1.344 0.981 0 O-C-N 123.733 0.646 . . . . 63.14 112.196 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -118.46 10.79 12.78 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.575 0.75 . . . . 73.23 111.55 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.423 ' HB2' HD22 ' B' ' 27' ' ' ASN . 13.4 pt-20 -129.7 159.31 36.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.732 0.413 . . . . 61.23 110.759 -175.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.1 m -73.19 121.19 19.89 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 116.043 -0.526 . . . . 60.11 110.317 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.558 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -76.48 -61.68 1.88 Allowed 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.049 -1.093 . . . . 63.35 108.049 177.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -157.52 165.11 36.5 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.953 -1.022 . . . . 73.11 111.9 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 46.1 mt -125.6 112.0 15.65 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 106.043 -1.836 . . . . 62.24 106.043 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.419 ' SG ' HG23 ' B' ' 114' ' ' ILE . 34.8 t -117.15 148.93 41.15 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.665 -0.865 . . . . 75.13 108.665 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 41.9 tt0 -163.88 132.42 3.7 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.167 0.587 . . . . 73.22 109.531 -173.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 98.8 t -132.86 147.04 31.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 123.757 0.823 . . . . 74.23 109.186 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.623 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 19.1 mt-30 -118.41 103.96 10.27 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.601 -0.889 . . . . 64.11 108.601 169.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -94.62 100.52 12.45 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.195 -1.039 . . . . 61.45 108.195 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.401 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -90.12 153.42 22.9 Favored Glycine 0 C--O 1.242 0.606 0 CA-C-N 114.998 -1.001 . . . . 72.45 111.159 175.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.8 126.25 1.85 Allowed Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 111.316 -0.714 . . . . 72.34 111.316 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 48.3 mt -85.49 128.21 39.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 107.546 -1.279 . . . . 71.24 107.546 170.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -138.61 149.95 45.77 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.129 -0.693 . . . . 64.43 109.129 176.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 69.8 m -94.52 100.33 12.33 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.464 -0.939 . . . . 73.32 108.464 170.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 1.8 pp -116.1 110.77 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.358 -0.979 . . . . 64.33 108.358 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.32 170.13 21.71 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.33 0.652 . . . . 74.41 110.886 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.84 -65.63 0.25 Allowed Glycine 0 C--N 1.346 1.138 0 CA-C-O 119.672 -0.516 . . . . 74.34 113.151 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' B' ' 9' ' ' MET . 3.4 tt -82.55 170.07 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 117.597 0.698 . . . . 74.54 110.037 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -152.62 160.74 43.17 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.028 0.931 . . . . 75.33 109.172 -167.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.83 -134.47 11.7 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 110.947 -0.861 . . . . 65.41 110.947 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' B' ' 95' ' ' ALA . 12.4 m -93.47 -18.32 22.45 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 117.247 0.523 . . . . 73.43 110.575 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.39 -26.04 60.82 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.695 -0.628 . . . . 52.0 111.108 -174.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -64.84 -31.76 73.15 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 119.485 -0.293 . . . . 74.53 110.439 171.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' B' ' 92' ' ' THR . . . -59.81 -38.73 82.77 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.665 0.786 . . . . 72.51 111.135 176.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -65.34 -39.21 92.1 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.404 -0.817 . . . . 74.11 111.359 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 40.2 t -66.56 -41.46 88.58 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.626 0.602 . . . . 72.15 112.626 -173.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.574 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.0 pt? -101.35 -14.31 17.66 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 117.862 0.301 . . . . 63.13 111.664 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.32 -21.43 24.81 Favored Glycine 0 C--N 1.352 1.425 0 N-CA-C 114.3 0.48 . . . . 73.23 114.3 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.23 -54.12 1.7 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.487 0.715 . . . . 72.24 110.159 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -69.69 -52.74 23.0 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.299 0.64 . . . . 73.41 112.288 -171.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.579 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 69.0 m -59.11 -49.02 95.29 Favored Pre-proline 0 CA--C 1.565 1.555 0 CA-C-O 119.04 -0.505 . . . . 74.21 112.143 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 39.1 Cg_exo -63.54 -27.73 69.95 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 122.217 1.944 . . . . 75.22 113.835 173.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -63.54 -37.68 88.25 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.032 0.533 . . . . 53.42 109.771 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.455 HD13 HD11 ' B' ' 13' ' ' ILE . 72.1 mt -65.48 -42.43 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.781 0.832 . . . . 65.43 110.2 175.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 91.9 mt -76.96 -20.36 56.21 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.949 -1.023 . . . . 75.42 111.833 -175.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -54.03 -55.79 32.57 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 124.136 0.974 . . . . 72.25 113.151 -176.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -59.34 -31.38 94.88 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.085 1.857 . . . . 74.41 113.737 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -69.73 -46.31 66.2 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.395 0.678 . . . . 73.33 110.503 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.2 -38.66 88.5 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.582 0.753 . . . . 43.23 110.992 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -61.88 -53.37 56.79 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.092 1.357 . . . . 74.04 110.778 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.01 -33.38 75.92 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.524 -0.762 . . . . 74.33 109.716 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.485 ' O ' ' HG2' ' B' ' 117' ' ' MET . 38.0 t -64.6 -44.52 90.37 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 123.51 0.506 . . . . 74.0 111.715 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.494 ' O ' HG23 ' B' ' 118' ' ' VAL . 72.9 mt -59.59 -55.01 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 109.12 -0.696 . . . . 62.24 109.12 175.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.1 m -62.26 -28.1 69.48 Favored 'General case' 0 CA--C 1.552 1.044 0 O-C-N 123.633 0.583 . . . . 55.31 112.122 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.7 t -64.5 -48.04 76.66 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.258 -0.645 . . . . 43.42 109.258 175.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.8 mmt -70.75 -33.86 71.26 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.053 0.541 . . . . 71.44 110.663 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.494 HG23 ' O ' ' B' ' 114' ' ' ILE . 97.2 t -61.51 -43.4 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.536 0.734 . . . . 73.21 110.067 173.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.8 t -64.56 -37.59 88.08 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.058 -0.974 . . . . 72.23 110.806 178.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' B' ' 116' ' ' SER . 89.7 mtt-85 -66.58 -32.87 74.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.601 -0.727 . . . . 62.32 110.411 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.6 12.21 59.68 Favored Glycine 0 C--N 1.349 1.29 0 O-C-N 123.933 0.771 . . . . 64.41 113.013 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 76.4 p 53.08 27.95 6.31 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 126.161 1.784 . . . . 73.43 113.324 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -86.69 155.37 56.21 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.417 0.687 . . . . 74.43 110.292 177.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.0 176.45 2.47 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.112 2.541 . . . . 65.02 113.784 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.639 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 0.0 OUTLIER -62.93 124.71 21.77 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.878 -1.056 . . . . 73.3 111.8 -173.091 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -144.05 102.92 3.95 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.218 -1.031 . . . . 54.51 108.218 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -119.05 135.08 54.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.02 0.928 . . . . 72.33 108.987 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.39 145.32 52.97 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.127 0.571 . . . . 62.51 110.589 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.3 150.92 65.12 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 122.94 0.496 . . . . 73.4 110.992 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.444 ' CG ' HD13 ' D' ' 16' ' ' ILE . 33.0 Cg_exo -61.54 108.35 0.6 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.149 2.566 . . . . 72.13 111.893 175.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 66.1 t -112.33 111.04 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.573 -0.899 . . . . 63.32 108.573 176.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -96.88 93.04 6.42 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.258 -1.016 . . . . 71.12 108.258 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -61.48 -40.63 95.23 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.89 0.876 . . . . 74.41 110.301 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 . . . . . 0 N--CA 1.47 0.567 0 C-N-CA 124.914 1.286 . . . . 71.53 111.677 -178.836 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.668 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 4.2 t80 . . . . . 0 C--O 1.236 0.385 0 CA-C-O 120.922 0.392 . . . . 75.54 110.383 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -148.19 121.8 9.19 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.86 -1.163 . . . . 61.4 107.86 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.403 HG12 ' CD2' ' C' ' 84' ' ' PHE . 69.2 mt -73.15 124.43 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 109.491 -0.559 . . . . 65.44 109.491 178.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.411 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 19.1 mm-40 -88.8 -47.87 7.9 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.102 -0.954 . . . . 74.04 109.636 -175.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -170.04 133.6 1.18 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.797 0.439 . . . . 73.35 110.529 -173.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 83.8 mt -116.11 146.28 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 108.007 -1.109 . . . . 62.41 108.007 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -174.9 169.19 3.48 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.366 0.666 . . . . 72.15 110.08 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . 0.452 HG22 HE22 ' C' ' 80' ' ' GLN . 66.7 p -92.09 115.77 28.36 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.347 0.659 . . . . 71.54 109.364 176.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.639 ' HE2' ' HB3' ' D' ' 28' ' ' ALA . 23.1 mmtp -66.22 -47.62 73.24 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.615 0.721 . . . . 72.14 109.705 172.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 14.1 t70 -144.41 148.79 35.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.132 -1.394 . . . . 64.11 110.147 -175.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.499 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.7 mt -142.28 145.57 23.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.121 -1.437 . . . . 74.5 107.121 176.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 42.8 t -157.46 151.7 24.79 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.26 0.624 . . . . 64.21 110.676 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 86.1 t80 -148.5 146.12 28.21 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.674 -1.232 . . . . 63.54 107.674 170.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -145.71 132.04 19.58 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.815 0.846 . . . . 72.32 109.763 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.41 77.9 4.73 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 106.192 -1.781 . . . . 60.32 106.192 172.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -62.97 -37.65 52.16 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.902 2.402 . . . . 73.11 111.877 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -95.62 21.4 8.36 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.371 -1.286 . . . . 75.31 111.154 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.81 -53.67 9.66 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 113.744 1.016 . . . . 53.34 113.744 -173.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.68 -41.55 38.29 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 121.844 1.696 . . . . 71.53 112.4 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -69.52 -32.88 71.98 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.544 0.738 . . . . 75.13 112.197 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.756 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.1 p -78.14 -27.78 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 N-CA-C 112.359 0.503 . . . . 72.33 112.359 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -64.24 -28.31 69.65 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.466 0.543 . . . . 72.53 112.466 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -87.69 17.67 4.55 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.019 0.528 . . . . 72.21 111.409 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.541 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -109.8 158.25 18.34 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.944 0.898 . . . . 72.34 109.85 178.569 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -65.4 128.09 34.45 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.551 -0.537 . . . . 74.14 109.551 169.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -81.0 89.35 5.92 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.69 -0.686 . . . . 71.12 110.292 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . 0.401 ' H ' HD22 ' C' ' 68' ' ' LEU . 20.4 tp60 -142.07 79.58 16.08 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.598 0.759 . . . . 64.34 109.131 171.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -89.21 178.23 2.64 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 122.553 2.169 . . . . 72.15 112.704 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -109.84 117.46 33.9 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.416 -1.327 . . . . 74.35 107.416 166.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.5 t -80.29 96.45 2.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 107.613 -1.254 . . . . 50.51 107.613 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.405 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 3.1 tppp? -105.66 100.2 9.77 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.284 -1.006 . . . . 71.34 108.284 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.42 HD23 HD21 ' C' ' 128' ' ' LEU . 1.0 OUTLIER -91.36 158.55 16.47 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.107 -0.952 . . . . 72.11 110.069 -177.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.443 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 27.7 t70 -152.95 148.27 26.92 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.609 0.764 . . . . 74.31 109.012 -177.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.403 HD23 ' N ' ' C' ' 45' ' ' ASP . 9.7 tt -128.5 147.19 50.67 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.839 -0.8 . . . . 53.42 108.839 -176.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 25.6 t0 -146.36 147.11 30.97 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.592 -1.262 . . . . 72.04 107.592 173.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 18.5 p -114.84 112.3 22.54 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.459 0.704 . . . . 74.32 109.931 -173.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.22 151.75 27.89 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.463 1.105 . . . . 72.53 108.87 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 69.9 m -162.13 158.1 24.21 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.763 0.425 . . . . 55.52 111.787 -174.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 88.1 p -157.29 144.43 18.51 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.08 0.952 . . . . 53.53 109.121 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -87.83 126.19 34.88 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.767 -0.457 . . . . 70.25 109.767 176.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.703 HD11 HD12 ' C' ' 83' ' ' ILE . 71.6 mt -96.75 -43.92 7.31 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.548 -0.751 . . . . 74.32 110.109 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -156.35 -171.51 3.73 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.593 -0.73 . . . . 53.05 110.91 -176.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -66.64 108.22 2.39 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.115 -0.948 . . . . 71.42 110.038 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 70.94 -6.45 1.28 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.92 1.288 . . . . 75.15 112.772 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 42.2 t -92.2 97.06 6.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 107.011 -1.477 . . . . 71.32 107.011 173.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -120.93 124.92 46.11 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.244 -1.343 . . . . 54.41 107.985 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -83.5 125.42 31.73 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.169 -0.923 . . . . 43.1 109.778 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 6.0 m -112.09 127.09 69.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 108.026 -1.102 . . . . 72.44 108.026 171.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.578 HG12 ' HG2' ' C' ' 79' ' ' GLN . 21.9 t -121.29 134.97 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.799 -1.186 . . . . 54.21 107.799 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 13.1 tp -116.07 108.33 16.06 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.604 -0.517 . . . . 55.14 109.604 -175.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.48 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 7.3 tmm_? -84.39 105.84 15.54 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.882 -0.784 . . . . 74.44 108.882 177.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.477 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.6 t -100.32 136.31 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.585 -0.894 . . . . 63.34 108.585 175.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 51.4 m -122.94 141.67 51.66 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.239 -1.022 . . . . 64.11 108.239 173.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 75.4 t -132.85 110.05 15.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 107.75 -1.204 . . . . 72.3 107.75 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 4.5 m -99.01 144.21 28.42 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.146 -1.057 . . . . 71.53 108.146 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.71 119.41 17.16 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.443 -0.947 . . . . 41.3 108.443 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 51.6 m -136.91 132.8 34.97 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.696 0.622 . . . . 54.44 110.251 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.541 HD13 ' HG2' ' C' ' 34' ' ' LYS . 11.3 mt -85.22 47.96 1.5 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.133 1.373 . . . . 75.44 109.224 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.93 -109.56 3.53 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 110.256 -1.138 . . . . 73.14 110.256 -171.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -89.94 -32.15 16.95 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.988 0.515 . . . . 73.14 109.729 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -66.01 111.75 3.51 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.284 0.634 . . . . 53.43 109.374 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 26.4 m -79.66 125.65 29.91 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.306 -0.628 . . . . 75.42 109.306 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.756 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -81.98 -55.18 4.75 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.408 0.683 . . . . 63.04 109.837 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -157.59 166.81 31.89 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.704 0.764 . . . . 70.52 111.988 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -135.47 122.49 21.37 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 105.866 -1.901 . . . . 74.15 105.866 170.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.414 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 46.2 t -127.48 134.58 49.81 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.121 -1.066 . . . . 54.21 108.121 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -148.6 125.17 11.04 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.258 0.348 . . . . 70.35 110.644 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.6 t -131.51 134.4 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 124.107 0.963 . . . . 70.21 108.927 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.578 ' HG2' HG12 ' C' ' 59' ' ' VAL . 5.4 tt0 -112.52 90.82 3.45 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.606 -1.627 . . . . 74.44 106.606 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.452 HE22 HG22 ' C' ' 18' ' ' THR . 9.8 tp-100 -83.19 111.86 19.32 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.061 0.544 . . . . 75.42 110.437 -171.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.41 146.57 18.24 Favored Glycine 0 C--N 1.337 0.63 0 O-C-N 123.491 0.494 . . . . 74.2 112.492 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.99 118.07 0.92 Allowed Glycine 0 C--O 1.243 0.697 0 N-CA-C 110.987 -0.845 . . . . 54.43 110.987 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.703 HD12 HD11 ' C' ' 51' ' ' LEU . 12.9 mm -81.98 116.93 27.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 108.556 -0.905 . . . . 74.33 108.556 174.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.668 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 54.8 m-85 -130.92 144.27 51.35 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.955 -0.757 . . . . 73.13 108.955 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 13.1 p -91.16 118.76 30.71 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 108.915 -0.772 . . . . 71.31 108.915 170.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.478 HG21 HD23 ' C' ' 98' ' ' LEU . 4.4 mp -113.68 101.37 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.944 0.898 . . . . 61.11 108.621 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.19 170.45 16.7 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.109 0.963 . . . . 72.52 110.037 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.76 -49.35 2.55 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 116.341 -0.39 . . . . 64.41 112.141 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 33.8 pt -118.67 159.73 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.707 0.803 . . . . 71.11 110.252 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -147.67 -178.15 6.1 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.776 0.83 . . . . 53.02 109.907 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.98 -142.9 45.68 Favored Glycine 0 C--N 1.351 1.373 0 O-C-N 123.222 0.326 . . . . 70.35 112.94 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 1.2 m -68.82 -23.78 64.31 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.983 0.513 . . . . 74.22 110.699 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -57.74 -57.15 14.03 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 124.118 0.967 . . . . 70.44 109.891 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.466 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 22.3 ptt? -69.8 -30.27 67.77 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.146 -0.479 . . . . 64.1 110.766 178.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.04 -30.65 69.33 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.133 0.573 . . . . 33.15 111.181 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.476 ' NE2' ' HB2' ' C' ' 134' ' ' ASP . 32.3 t-80 -62.5 -46.02 90.33 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.263 -0.88 . . . . 64.11 110.862 170.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.553 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 31.4 t -69.21 -64.57 0.85 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.05 0.219 . . . . 74.34 111.072 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.478 HD23 HG21 ' C' ' 86' ' ' ILE . 3.7 pp -67.6 -31.47 71.54 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 113.146 0.795 . . . . 74.24 113.146 -173.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . 0.419 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -102.8 6.99 52.56 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 114.63 0.612 . . . . 43.32 114.63 -171.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -151.12 -60.83 0.18 Allowed 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.365 0.603 . . . . 75.45 110.824 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.553 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 5.0 t80 -74.81 -34.3 62.34 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 125.011 1.324 . . . . 74.51 112.757 -171.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.416 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 80.1 m -78.39 -43.81 2.07 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 123.356 0.662 . . . . 61.23 111.057 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 51.7 Cg_exo -60.92 -27.14 84.34 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 121.943 1.762 . . . . 71.14 112.403 166.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -64.92 -34.93 79.58 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 123.313 0.645 . . . . 62.11 110.696 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.471 HG23 ' NH1' ' A' ' 111' ' ' ARG . 45.6 mm -60.46 -38.33 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 121.326 0.584 . . . . 64.41 109.49 172.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 79.5 mt -89.12 -13.71 37.9 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.549 1.14 . . . . 63.32 112.655 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -57.43 -49.83 91.61 Favored Pre-proline 0 N--CA 1.485 1.281 0 CA-C-O 118.126 -0.94 . . . . 72.34 112.87 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.96 -35.18 78.64 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.179 1.919 . . . . 71.24 113.07 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -66.02 -50.75 63.13 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.517 0.727 . . . . 70.43 111.367 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.63 -42.83 99.82 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.747 -0.66 . . . . 71.34 109.901 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -54.85 -53.22 58.23 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.124 1.37 . . . . 75.22 111.052 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -69.09 -36.56 77.72 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.945 0.778 . . . . 74.2 110.283 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.0 t -68.78 -34.54 75.73 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.929 0.491 . . . . 53.2 111.049 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.477 HD11 ' HB ' ' C' ' 62' ' ' VAL . 87.5 mt -69.62 -53.61 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.349 0.66 . . . . 61.44 109.611 175.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 16.8 m -64.56 -29.16 70.18 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.269 0.628 . . . . 75.42 111.28 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.3 t -64.29 -49.94 69.83 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.063 -0.717 . . . . 63.23 109.063 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.733 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.54 -37.92 82.79 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.325 1.05 . . . . 74.2 112.179 178.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 69.9 t -66.84 -40.41 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 123.274 0.63 . . . . 73.02 110.137 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 20.9 t -74.09 -23.25 59.3 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.714 0.805 . . . . 74.05 111.576 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 86.3 mtt-85 -76.2 -38.88 55.94 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.706 0.803 . . . . 74.11 108.86 174.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.02 -1.18 67.39 Favored Glycine 0 C--N 1.355 1.627 0 O-C-N 123.974 0.797 . . . . 34.2 112.256 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.7 p 64.64 23.41 12.8 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.926 2.09 . . . . 73.1 113.14 171.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -81.75 143.28 50.21 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 108.209 -1.034 . . . . 62.51 108.209 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.639 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 66.6 Cg_exo -45.23 145.21 3.69 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 123.645 2.896 . . . . 60.04 114.826 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -53.96 114.38 1.56 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.592 1.157 . . . . 71.14 112.593 -175.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 36.8 tp -109.52 94.09 4.85 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.139 -0.937 . . . . 74.15 109.224 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -94.45 115.54 27.73 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.213 0.605 . . . . 62.55 109.709 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.479 HD13 ' H ' ' C' ' 129' ' ' ALA . 0.2 OUTLIER -72.13 149.03 45.12 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.644 0.778 . . . . 73.52 109.781 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . 0.479 ' H ' HD13 ' C' ' 128' ' ' LEU . . . -80.54 156.32 73.33 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.471 0.709 . . . . 52.32 111.194 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.429 ' HG3' HG21 ' A' ' 13' ' ' ILE . 28.7 Cg_endo -61.69 137.39 68.34 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 123.117 2.544 . . . . 63.04 112.274 172.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 15.7 t -128.75 110.27 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 108.948 -0.76 . . . . 63.0 108.948 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -100.17 91.43 4.75 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.771 0.828 . . . . 73.13 109.336 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -65.84 -40.56 91.86 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.163 -0.68 . . . . 53.42 109.163 171.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . 0.476 ' HB2' ' NE2' ' C' ' 96' ' ' HIS . 7.0 p-10 . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 125.538 1.535 . . . . 70.4 112.35 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 24.3 m . . . . . 0 C--O 1.24 0.555 0 N-CA-C 109.171 -0.677 . . . . 72.34 109.171 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -158.73 97.88 1.47 Allowed 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.625 -1.25 . . . . 70.02 107.625 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -117.02 120.56 38.74 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.367 0.667 . . . . 75.52 109.263 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 19.4 mt -78.0 115.16 19.58 Favored 'Isoleucine or valine' 0 C--N 1.345 0.412 0 N-CA-C 108.968 -0.753 . . . . 45.12 108.968 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -90.7 -44.61 9.38 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 122.857 0.463 . . . . 73.22 111.721 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.435 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 40.8 ttt180 -173.85 126.11 0.37 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 112.049 0.388 . . . . 74.44 112.049 -171.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.444 HD13 ' CG ' ' B' ' 130' ' ' PRO . 2.2 mp -104.17 141.57 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.421 -0.955 . . . . 74.52 108.421 170.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.435 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 22.4 p90 -162.72 151.4 14.66 Favored 'General case' 0 C--O 1.238 0.487 0 O-C-N 124.221 0.95 . . . . 74.13 110.571 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.7 p -83.88 120.32 25.93 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.281 -0.872 . . . . 71.31 108.856 172.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -91.33 -17.34 26.05 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.7 0.4 . . . . 72.1 110.525 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.721 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 17.5 t70 -162.7 134.98 5.46 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.641 -0.874 . . . . 73.44 108.641 -174.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.733 HG21 ' HE2' ' C' ' 117' ' ' MET . 88.1 mt -139.28 151.77 23.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 C-N-CA 124.337 1.055 . . . . 70.41 108.321 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 26.6 t -152.02 145.44 24.81 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 124.402 1.081 . . . . 72.23 109.628 175.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.499 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.7 t80 -151.55 122.46 7.58 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 105.703 -1.962 . . . . 75.44 105.703 169.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -136.51 111.43 8.86 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.821 -0.807 . . . . 74.23 108.821 -176.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.85 91.21 4.09 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.249 -1.019 . . . . 74.41 108.249 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.09 -34.5 10.18 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.968 2.445 . . . . 64.53 113.003 -169.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -112.22 10.81 20.16 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 118.556 -0.735 . . . . 73.13 110.711 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.639 ' HB3' ' HE2' ' C' ' 19' ' ' LYS . . . -18.4 -72.77 0.02 OUTLIER Pre-proline 0 CA--C 1.565 1.556 0 N-CA-C 116.455 2.02 . . . . 72.0 116.455 -168.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 44.1 Cg_endo -80.29 -13.48 12.4 Favored 'Trans proline' 0 C--N 1.377 2.072 0 CA-C-N 123.903 2.43 . . . . 74.21 114.041 -172.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -77.51 -39.79 45.02 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.573 1.149 . . . . 53.4 109.136 172.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.557 HG22 HD12 ' D' ' 68' ' ' LEU . 4.8 p -84.12 -20.53 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.461 -0.791 . . . . 73.31 111.647 -175.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.404 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 21.1 m-85 -66.04 -25.16 66.92 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 120.669 0.271 . . . . 74.41 111.455 177.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -60.07 -26.34 66.09 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.25 -0.886 . . . . 73.01 110.183 175.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -90.94 76.54 6.24 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.972 1.309 . . . . 70.13 109.647 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -85.35 92.11 8.37 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.947 -0.569 . . . . 74.32 111.132 -176.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -155.25 177.84 10.89 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.881 0.873 . . . . 74.2 108.979 166.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -66.43 110.5 4.89 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.8 0.84 . . . . 73.52 109.272 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -59.48 120.51 8.38 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.954 2.436 . . . . 54.22 111.631 -175.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -69.58 115.03 8.36 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.763 0.664 . . . . 71.52 109.489 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.414 HG13 HG13 ' D' ' 64' ' ' VAL . 58.3 t -105.91 137.48 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.003 0.921 . . . . 74.04 111.105 -169.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -109.04 142.08 40.24 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.358 -1.349 . . . . 73.13 107.358 166.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -103.28 148.86 25.32 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.283 -0.636 . . . . 71.3 109.283 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -149.56 130.11 13.96 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.111 -1.07 . . . . 75.23 108.111 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.461 HD23 HD11 ' D' ' 60' ' ' LEU . 5.4 mp -119.51 146.85 45.08 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.251 0.548 . . . . 73.1 110.325 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 16.2 t70 -132.42 144.17 50.31 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.388 1.075 . . . . 75.32 108.236 175.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 57.2 m -104.21 143.15 33.33 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.864 0.866 . . . . 73.15 109.689 -175.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.579 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.51 142.08 17.68 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.98 0.912 . . . . 64.35 108.983 178.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 25.4 p -162.73 158.41 22.93 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 122.911 0.484 . . . . 45.43 110.132 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 81.4 p -151.82 144.28 24.14 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.799 -0.815 . . . . 63.23 108.799 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -87.3 117.8 26.3 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.096 -0.705 . . . . 72.35 109.096 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' D' ' 57' ' ' GLU . 26.1 mt -91.09 -24.3 20.05 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.721 -0.672 . . . . 60.14 110.204 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -172.79 178.55 2.59 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.529 1.131 . . . . 72.44 109.284 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -75.3 135.44 40.91 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.484 -0.932 . . . . 74.24 108.484 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 69.05 2.18 3.49 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.65 1.18 . . . . 73.34 113.024 -171.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 68.9 t -124.13 131.24 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.251 0.621 . . . . 71.41 109.817 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -134.66 153.97 51.74 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 123.189 0.595 . . . . 73.12 110.922 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.54 ' HB2' HD11 ' D' ' 51' ' ' LEU . 14.3 tt0 -110.83 120.3 41.95 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.3 -1.318 . . . . 72.52 107.851 165.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' D' ' 102' ' ' CYS . 33.2 m -106.89 132.45 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 108.485 -0.931 . . . . 61.21 108.485 173.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 38.7 t -125.89 125.49 68.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 N-CA-C 108.934 -0.765 . . . . 60.32 108.934 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.629 HD22 ' HB3' ' D' ' 103' ' ' PRO . 52.0 tp -115.91 117.49 30.33 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.2 -0.667 . . . . 72.43 109.2 177.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 46.4 ttm-85 -87.34 101.52 13.64 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.948 -0.76 . . . . 74.13 108.948 176.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 99.4 t -91.53 121.31 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.975 -0.75 . . . . 74.24 108.975 174.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.6 m -120.11 142.78 48.59 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.454 0.645 . . . . 74.11 109.789 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.414 HG13 HG13 ' D' ' 40' ' ' VAL . 25.4 t -130.59 102.37 6.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 126.134 1.774 . . . . 71.31 107.606 -171.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 21.2 m -95.2 97.61 10.02 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.487 -0.931 . . . . 74.13 108.487 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.4 147.02 27.23 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.114 -0.948 . . . . 71.23 108.994 -172.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.457 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.0 p -149.75 138.06 20.59 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 123.535 0.522 . . . . 75.33 111.6 -177.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.557 HD12 HG22 ' D' ' 31' ' ' VAL . 26.1 mt -115.8 111.66 20.83 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.444 -1.253 . . . . 62.22 107.619 171.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.3 -134.72 21.56 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 116.477 -0.328 . . . . 71.44 113.084 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -86.15 2.89 45.09 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.344 0.658 . . . . 75.0 112.571 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -131.57 160.55 34.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.875 0.47 . . . . 64.41 110.064 -171.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 62.5 m -69.39 136.07 51.16 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.265 -0.879 . . . . 73.41 110.492 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.524 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -84.08 -65.8 0.97 Allowed 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.664 -1.235 . . . . 71.5 107.664 174.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -152.43 158.96 43.37 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.154 -0.93 . . . . 71.23 110.458 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 69.5 mt -122.82 108.26 12.81 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.621 -1.622 . . . . 61.34 106.621 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.421 ' SG ' HG23 ' D' ' 114' ' ' ILE . 52.8 t -117.48 138.16 52.05 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.924 -0.769 . . . . 61.14 108.924 -175.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 38.2 tt0 -152.98 133.73 13.88 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.785 -0.45 . . . . 74.12 109.785 -175.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 54.0 t -139.96 119.3 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.395 0.678 . . . . 74.33 109.678 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.721 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 14.5 mt-30 -86.58 89.94 8.08 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 108.366 -0.975 . . . . 73.13 108.366 165.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . 0.446 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.7 tp-100 -83.01 104.91 13.57 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.937 -1.134 . . . . 75.42 107.937 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -103.92 162.09 15.55 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 111.934 -0.466 . . . . 32.01 111.934 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.0 133.75 3.51 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 112.117 -0.393 . . . . 64.04 112.117 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.402 HG23 HD12 ' D' ' 51' ' ' LEU . 39.0 mt -88.79 128.12 41.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 108.558 -0.905 . . . . 61.11 108.558 174.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.462 ' HB2' HD11 ' D' ' 86' ' ' ILE . 79.8 m-85 -133.97 157.07 46.98 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.888 1.275 . . . . 73.54 108.624 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.8 m -114.63 99.15 7.31 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.802 0.841 . . . . 71.13 108.913 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.462 HD11 ' HB2' ' D' ' 84' ' ' PHE . 2.8 mp -109.66 126.73 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.463 0.705 . . . . 74.44 109.637 -173.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.24 165.04 33.1 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.932 0.893 . . . . 72.13 109.702 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.93 20.97 79.2 Favored Glycine 0 C--N 1.346 1.115 0 N-CA-C 114.413 0.525 . . . . 71.15 114.413 173.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.518 HG23 HE21 ' D' ' 93' ' ' GLN . 7.3 mt -129.21 157.26 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.32 0.648 . . . . 73.44 109.443 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.81 -174.5 4.8 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.481 0.712 . . . . 65.34 111.01 175.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.98 -141.45 39.8 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.26 -0.882 . . . . 25.13 114.274 173.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 15.6 m -90.22 -13.56 35.22 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.234 0.613 . . . . 42.55 110.095 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.518 HE21 HG23 ' D' ' 89' ' ' ILE . 29.7 tt0 -63.0 -37.69 88.21 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.953 0.901 . . . . 73.43 110.806 177.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -73.04 -33.13 65.51 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.879 0.472 . . . . 71.12 111.614 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.97 -33.67 74.08 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.778 0.431 . . . . 34.44 110.364 174.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -74.18 -32.45 63.08 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.557 0.743 . . . . 65.03 110.612 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.1 t -63.18 -50.66 69.47 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.395 0.617 . . . . 75.11 110.242 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.406 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 47.5 mt -83.04 -21.08 33.91 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.893 -1.048 . . . . 52.14 111.26 -176.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.32 -16.95 59.72 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.612 0.57 . . . . 61.52 114.289 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.2 -64.09 0.7 Allowed 'General case' 0 C--O 1.239 0.515 0 C-N-CA 122.685 0.394 . . . . 74.11 111.799 -172.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -63.53 -44.58 93.81 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 112.485 0.55 . . . . 62.53 112.485 -172.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.511 ' HB3' HG21 ' D' ' 58' ' ' VAL . 56.7 m -66.91 -47.3 53.98 Favored Pre-proline 0 CA--C 1.57 1.723 0 CA-C-O 118.943 -0.551 . . . . 70.24 112.105 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.629 ' HB3' HD22 ' D' ' 60' ' ' LEU . 72.2 Cg_exo -56.8 -29.66 81.89 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 122.427 2.084 . . . . 71.32 113.932 168.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -68.59 -26.0 65.16 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.109 0.564 . . . . 75.55 111.81 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 30.3 mm -71.91 -39.22 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 121.243 0.544 . . . . 73.03 109.648 171.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.495 HD11 HG23 ' D' ' 58' ' ' VAL . 79.1 mt -80.08 -25.57 40.0 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.216 -0.902 . . . . 53.33 111.938 -175.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -59.5 -48.33 95.91 Favored Pre-proline 0 CA--C 1.562 1.409 0 N-CA-C 113.517 0.932 . . . . 73.44 113.517 -174.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.57 -40.05 83.5 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.079 1.853 . . . . 62.34 112.956 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -71.56 -38.63 70.94 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.837 0.855 . . . . 72.13 111.803 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.15 -47.27 74.6 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.281 0.632 . . . . 71.12 109.953 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -58.07 -46.93 84.62 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.154 0.909 . . . . 72.44 110.409 176.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -59.84 -49.67 76.81 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 123.923 0.764 . . . . 71.15 110.364 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.4 t -57.55 -45.33 85.26 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.74 0.65 . . . . 72.55 111.097 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.492 ' O ' HG23 ' D' ' 118' ' ' VAL . 94.4 mt -59.59 -58.09 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.688 0.795 . . . . 63.02 110.17 175.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 90.0 m -55.59 -39.59 70.93 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.254 1.022 . . . . 52.32 111.88 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 37.8 t -66.32 -41.7 89.27 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.321 -0.854 . . . . 64.24 109.754 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.402 ' HB2' ' HE3' ' D' ' 117' ' ' MET . 75.0 mtm -71.45 -28.37 63.92 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.937 0.495 . . . . 63.14 111.65 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.492 HG23 ' O ' ' D' ' 114' ' ' ILE . 97.3 t -63.45 -48.69 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.277 -0.638 . . . . 74.34 109.277 173.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 83.1 p -71.91 -28.62 63.61 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.791 -0.641 . . . . 65.31 110.985 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -69.97 -36.47 75.23 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.798 0.839 . . . . 64.2 109.948 173.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.9 2.15 87.88 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.923 0.764 . . . . 43.01 112.138 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.1 p 61.17 29.0 18.56 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.836 2.054 . . . . 65.13 114.0 173.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.438 ' HB2' HG13 ' D' ' 118' ' ' VAL . 97.8 m-85 -86.36 154.62 57.04 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.776 -0.824 . . . . 70.2 108.776 168.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -53.0 136.84 61.68 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.838 2.358 . . . . 72.41 112.693 175.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -52.85 128.98 28.71 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 124.289 0.993 . . . . 73.41 112.249 -174.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 56.9 tp -109.51 99.64 8.82 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.363 -0.835 . . . . 72.23 109.142 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -99.96 97.34 8.23 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.596 -0.89 . . . . 75.43 108.596 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.6 tt -67.97 116.43 8.6 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.199 -1.038 . . . . 75.41 108.199 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -57.14 133.51 80.68 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 123.372 0.669 . . . . 52.03 110.025 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 23.7 Cg_exo -62.4 115.38 2.84 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.623 2.216 . . . . 61.23 111.97 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 108.715 -0.846 . . . . 73.05 108.715 -179.174 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.691 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 9.4 t80 . . . . . 0 C--O 1.235 0.294 0 N-CA-C 109.668 -0.493 . . . . 75.2 109.668 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -139.27 111.01 7.17 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.36 -0.978 . . . . 75.42 108.36 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.638 HG12 ' HD2' ' A' ' 84' ' ' PHE . 57.2 mt -82.74 120.44 34.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.421 -0.955 . . . . 71.34 108.421 173.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.43 -41.25 20.1 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 124.146 0.904 . . . . 74.52 109.011 -177.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -173.83 124.09 0.35 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 121.938 0.095 . . . . 73.44 111.061 -169.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' C' ' 130' ' ' PRO . 92.2 mt -116.87 138.54 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 C-N-CA 123.924 0.89 . . . . 62.34 109.571 175.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.519 ' HB3' HG23 ' B' ' 122' ' ' THR . 35.3 p90 -169.61 176.26 5.03 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.227 0.955 . . . . 74.32 111.217 -170.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -102.26 119.43 38.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.94 -1.027 . . . . 63.23 108.533 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.459 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 36.9 mtpt -83.04 -42.65 17.23 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.957 -0.757 . . . . 72.4 108.957 176.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 16.2 t70 -134.4 136.62 43.45 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.485 -1.234 . . . . 61.2 109.602 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.8 mt -136.13 143.16 36.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 C-N-CA 125.345 1.458 . . . . 72.42 107.118 174.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.0 t -155.09 119.37 4.68 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-O 121.166 0.507 . . . . 72.04 110.476 171.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.509 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 87.8 t80 -111.34 136.53 50.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.797 -1.557 . . . . 72.44 106.797 169.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -133.53 138.23 45.97 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.638 -0.504 . . . . 74.11 109.638 175.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.85 70.83 16.97 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 106.516 -1.661 . . . . 73.4 106.516 170.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.75 -28.14 30.86 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.539 2.159 . . . . 75.31 111.448 -175.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -101.62 20.42 16.2 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 114.896 -1.047 . . . . 73.4 109.541 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.54 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -48.32 -52.54 41.78 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 114.006 1.113 . . . . 75.1 114.006 -171.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 15.9 Cg_exo -67.16 -18.54 51.04 Favored 'Trans proline' 0 C--N 1.385 2.481 0 CA-C-N 121.748 1.66 . . . . 60.23 113.02 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -90.18 -28.19 19.06 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.407 1.083 . . . . 74.22 110.599 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.523 HG21 ' HA ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -80.55 -21.14 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 115.672 -0.694 . . . . 65.14 111.722 -166.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -86.05 -23.99 26.53 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.373 0.669 . . . . 71.44 111.653 -176.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -78.83 -24.26 44.53 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 110.027 -0.36 . . . . 63.12 110.027 174.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -72.48 146.87 46.56 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.794 0.837 . . . . 73.14 110.719 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -67.34 128.91 38.18 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.606 -0.724 . . . . 71.1 109.455 174.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 59.5 t-105 -79.12 89.5 4.83 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.469 0.707 . . . . 74.21 110.426 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -125.11 82.8 61.36 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 108.007 -1.109 . . . . 62.11 108.007 169.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.0 127.93 11.86 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.336 2.024 . . . . 64.54 112.395 -172.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -96.9 93.12 6.46 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 106.354 -1.721 . . . . 70.12 106.354 170.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.8 t -72.67 91.46 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.88 -0.785 . . . . 70.45 108.88 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -98.32 112.46 24.45 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.342 -1.355 . . . . 73.21 107.342 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 pp -123.2 135.02 54.11 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.229 0.538 . . . . 75.22 110.885 -171.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -115.94 145.38 42.97 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.698 -1.223 . . . . 71.32 107.698 172.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.12 123.52 23.28 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.95 -0.759 . . . . 62.54 108.95 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.613 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 24.5 t70 -118.7 139.41 51.59 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.178 0.991 . . . . 62.15 109.246 -174.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.8 p -116.59 121.65 42.35 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.946 0.898 . . . . 63.34 110.476 -170.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.77 131.85 17.29 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.774 0.829 . . . . 64.2 110.636 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.9 m -131.58 157.68 43.0 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.172 0.589 . . . . 73.24 110.482 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.3 t -148.74 123.51 9.9 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.54 0.736 . . . . 52.02 109.359 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -75.41 121.29 22.06 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.284 0.633 . . . . 73.44 110.693 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.405 HD12 HG23 ' A' ' 83' ' ' ILE . 52.9 mt -94.16 -39.37 10.6 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.775 0.83 . . . . 75.1 110.724 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.452 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -148.01 -177.56 5.8 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.878 0.871 . . . . 64.22 109.839 176.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -63.67 115.36 4.67 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.398 -0.593 . . . . 74.51 109.398 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 70.35 4.07 4.74 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 125.137 1.375 . . . . 73.3 112.929 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 99.8 t -109.77 114.84 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.115 -1.068 . . . . 72.24 108.115 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -138.63 140.9 39.08 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.568 -0.901 . . . . 72.11 108.568 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -89.79 129.92 36.12 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.753 -0.658 . . . . 62.13 109.435 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.421 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 72.8 t -100.48 126.1 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 107.663 -1.236 . . . . 53.24 107.663 172.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.6 t -120.7 125.56 74.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.662 -0.866 . . . . 63.25 108.662 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -115.25 108.01 16.02 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.153 -1.425 . . . . 50.34 107.153 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.613 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 48.3 ttt180 -83.61 99.94 10.51 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.886 -0.783 . . . . 52.33 108.886 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.9 101.77 12.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.615 -0.721 . . . . 63.24 109.199 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.0 m -97.54 113.46 25.17 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.503 0.721 . . . . 72.13 109.252 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.4 HG11 HD21 ' A' ' 126' ' ' LEU . 18.2 t -116.86 107.64 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.005 0.922 . . . . 70.34 109.097 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.9 m -109.49 129.2 55.57 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.315 -0.994 . . . . 70.4 108.315 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.81 132.71 49.81 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.115 -1.439 . . . . 72.0 107.115 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.0 m -121.32 165.76 15.03 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.199 0.6 . . . . 63.52 110.362 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.409 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 82.9 mt -131.1 43.26 3.12 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.94 -1.133 . . . . 73.24 107.94 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.68 -93.07 1.84 Allowed Glycine 0 C--N 1.339 0.709 0 CA-C-N 114.84 -1.073 . . . . 42.4 111.481 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -95.09 -26.88 15.85 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.194 0.598 . . . . 75.31 111.919 -174.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -105.75 132.63 51.64 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.196 -0.668 . . . . 62.31 109.196 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.4 m -73.44 134.99 44.1 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.732 -0.47 . . . . 71.21 109.732 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.523 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.86 -60.91 2.11 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.455 -0.793 . . . . 71.44 109.926 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.427 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 33.4 p90 -160.17 174.29 14.48 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.349 -0.841 . . . . 72.21 111.696 176.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.5 tp -127.79 142.99 51.15 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.445 -1.252 . . . . 71.41 108.482 170.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 80.5 m -143.0 97.39 3.09 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.819 1.248 . . . . 64.15 108.235 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -121.51 115.71 23.35 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.922 -0.77 . . . . 74.24 108.922 -173.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.5 t -129.51 110.63 20.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 123.805 0.842 . . . . 63.31 109.592 -173.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.623 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 28.6 mt-30 -83.69 88.17 7.06 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.14 -1.059 . . . . 64.54 108.14 169.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.51 ' HG3' HD22 ' A' ' 106' ' ' LEU . 9.4 tp-100 -78.48 102.48 7.86 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.692 -1.14 . . . . 73.42 108.691 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.7 145.01 17.43 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.443 -0.663 . . . . 51.51 111.443 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.407 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.0 124.5 1.71 Allowed Glycine 0 CA--C 1.508 -0.405 0 N-CA-C 110.78 -0.928 . . . . 42.24 110.78 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.405 HG23 HD12 ' A' ' 51' ' ' LEU . 46.9 mt -81.69 115.68 24.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.864 -0.791 . . . . 73.55 108.864 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.691 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 38.7 m-85 -124.06 120.27 31.91 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.927 -0.768 . . . . 74.12 108.927 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.1 t -95.43 101.84 13.6 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.225 -1.028 . . . . 72.42 108.225 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.4 pt . . . . . 0 N--CA 1.478 0.966 0 C-N-CA 122.594 0.357 . . . . 73.3 110.312 178.907 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.483 0.183 . . . . 74.33 111.208 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -70.63 -47.4 60.26 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.251 0.62 . . . . 71.33 110.818 172.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.628 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 27.4 p -71.67 -43.95 65.13 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.138 0.494 . . . . 72.33 110.949 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.59 -45.35 83.57 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.545 1.138 . . . . 73.43 110.765 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.55 -16.19 47.03 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 114.745 0.658 . . . . 60.21 114.745 -170.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.93 -61.94 0.87 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 117.922 0.861 . . . . 72.13 112.18 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.628 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 88.8 t80 -69.23 -62.28 1.44 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.371 0.878 . . . . 75.22 113.371 -164.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 73.7 m -63.29 -39.3 48.9 Favored Pre-proline 0 CA--C 1.563 1.472 0 N-CA-C 113.697 0.999 . . . . 74.45 113.697 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.21 -32.8 82.55 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 121.854 1.703 . . . . 73.34 113.115 166.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -74.99 -17.98 60.44 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.028 0.531 . . . . 64.15 110.849 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -67.41 -37.46 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 109.186 -0.672 . . . . 63.11 109.186 170.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.51 HD22 ' HG3' ' A' ' 80' ' ' GLN . 77.4 mt -81.23 -17.93 47.8 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.034 0.934 . . . . 63.21 112.191 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -62.81 -47.01 88.16 Favored Pre-proline 0 CA--C 1.572 1.809 0 CA-C-O 118.158 -0.925 . . . . 73.23 113.279 -174.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.61 -37.57 46.36 Favored 'Trans proline' 0 C--N 1.393 2.883 0 C-N-CA 122.35 2.033 . . . . 75.05 112.781 176.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -66.34 -44.75 82.41 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.466 0.706 . . . . 63.31 111.559 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.22 -41.74 76.65 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.992 -0.549 . . . . 73.4 110.48 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.474 ' NH1' HD12 ' C' ' 105' ' ' ILE . 27.6 ttm180 -52.0 -47.64 64.82 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.969 0.908 . . . . 75.24 110.765 171.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -68.05 -43.96 77.5 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.044 -0.98 . . . . 75.05 111.337 -175.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 39.1 t -65.6 -30.3 71.0 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.189 0.596 . . . . 72.24 111.056 -178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.8 mt -68.69 -58.83 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.888 0.875 . . . . 53.24 109.654 172.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 50.6 m -53.15 -36.51 60.93 Favored 'General case' 0 C--N 1.361 1.094 0 C-N-CA 124.246 1.018 . . . . 63.03 112.097 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -65.24 -51.22 62.27 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.56 -0.745 . . . . 73.41 110.687 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.509 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 61.0 mtm -64.28 -37.87 89.03 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.903 0.481 . . . . 55.31 111.483 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.442 HG21 HD23 ' A' ' 126' ' ' LEU . 76.0 t -62.12 -45.05 99.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.197 0.999 . . . . 73.5 110.335 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.6 t -70.2 -35.5 73.95 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.563 -0.744 . . . . 74.12 110.76 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -69.35 -33.51 73.2 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.543 0.737 . . . . 75.25 109.739 175.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.38 14.34 51.08 Favored Glycine 0 C--N 1.351 1.371 0 CA-C-N 115.344 -0.844 . . . . 63.52 112.879 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.413 HG21 ' HE ' ' B' ' 15' ' ' ARG . 2.5 t 61.4 18.58 9.45 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 126.541 1.936 . . . . 73.22 114.078 170.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -87.46 153.01 53.04 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 123.033 0.533 . . . . 72.54 109.595 176.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -55.16 165.54 2.86 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.521 2.814 . . . . 62.33 114.301 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -59.54 121.95 12.82 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.366 -0.834 . . . . 73.52 111.512 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.442 HD23 HG21 ' A' ' 118' ' ' VAL . 60.4 tp -123.67 94.5 4.26 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.223 1.009 . . . . 74.24 109.362 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -107.79 125.84 51.91 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 107.999 -1.111 . . . . 74.54 107.999 171.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mp -72.8 139.52 47.09 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.708 -0.849 . . . . 60.32 108.708 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.5 146.21 98.19 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.213 0.605 . . . . 44.15 111.242 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.09 116.21 3.58 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.717 2.278 . . . . 73.41 111.751 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.3 t -101.22 113.21 36.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.782 -1.192 . . . . 63.3 107.782 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -86.26 72.32 10.37 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.515 -0.92 . . . . 63.14 108.515 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 . . . . . 0 N--CA 1.482 1.157 0 C-N-CA 123.491 0.716 . . . . 72.44 110.943 -178.479 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.544 ' SD ' ' HB ' ' B' ' 89' ' ' ILE . 9.6 tpt . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 121.851 0.834 . . . . 70.13 112.889 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 22.7 m -136.73 123.57 21.29 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 106.37 -1.715 . . . . 54.22 106.37 165.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -151.74 129.16 11.34 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.793 -0.817 . . . . 72.14 108.793 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.521 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -155.07 131.14 10.19 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.419 -0.586 . . . . 74.02 109.419 175.273 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.515 HD13 HD11 ' B' ' 16' ' ' ILE . 25.2 mt -75.59 121.54 27.57 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 108.746 -0.835 . . . . 71.33 108.746 173.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -93.05 -37.92 11.91 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.53 -0.759 . . . . 71.02 109.234 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.413 ' HE ' HG21 ' A' ' 122' ' ' THR . 46.5 ttt180 -177.39 132.42 0.17 Allowed 'General case' 0 C--N 1.356 0.856 0 CA-C-N 115.608 -0.723 . . . . 71.41 109.64 -174.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.515 HD11 HD13 ' B' ' 13' ' ' ILE . 94.6 mt -115.21 140.05 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 108.008 -1.108 . . . . 74.32 108.008 176.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -171.17 155.78 4.49 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.805 0.812 . . . . 74.11 112.483 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.9 m -75.69 125.03 28.25 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.546 -1.206 . . . . 74.12 109.191 168.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.54 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 43.9 mtpt -96.79 -31.86 12.41 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.535 0.734 . . . . 74.44 111.065 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -153.54 140.1 18.82 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.47 -0.332 . . . . 70.4 110.557 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.496 HD11 ' SG ' ' B' ' 113' ' ' CYS . 35.4 mm -135.59 143.61 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.972 1.309 . . . . 72.45 108.577 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -150.28 109.52 3.95 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.07 -1.085 . . . . 64.22 108.07 174.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 89.4 t80 -124.48 108.81 12.52 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 108.002 -1.111 . . . . 75.22 108.002 173.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -124.16 123.56 40.56 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.458 0.703 . . . . 74.34 110.29 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.425 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -114.41 87.1 13.22 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.776 1.23 . . . . 62.45 107.932 178.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.21 -29.98 25.61 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.691 2.261 . . . . 65.31 113.224 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -108.56 18.53 20.8 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.57 0.748 . . . . 73.23 110.821 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.459 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -43.09 -59.26 3.26 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 114.938 1.458 . . . . 73.04 114.938 -164.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -62.25 -28.73 79.42 Favored 'Trans proline' 0 C--N 1.395 3.006 0 C-N-CA 122.388 2.059 . . . . 74.2 112.464 -172.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -96.23 -32.76 12.29 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.167 -0.924 . . . . 72.42 112.22 -172.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.501 HG21 ' HA ' ' B' ' 73' ' ' ALA . 6.0 p -74.17 -6.29 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 122.998 0.519 . . . . 64.3 111.675 -171.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -72.83 -14.05 61.42 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.218 0.607 . . . . 74.42 112.437 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -61.49 -18.17 57.88 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.31 0.644 . . . . 62.15 111.076 172.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.615 ' HB2' HD13 ' B' ' 68' ' ' LEU . 30.3 mmtp -95.54 88.84 5.18 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.296 1.439 . . . . 75.45 109.112 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -98.29 78.38 2.45 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.604 0.716 . . . . 71.4 111.19 -176.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -159.31 172.33 18.18 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.327 -1.306 . . . . 74.42 108.582 170.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -68.58 112.73 12.09 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 109.14 -0.689 . . . . 72.45 109.14 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.491 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 20.8 Cg_endo -61.53 163.82 17.11 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.06 2.506 . . . . 71.4 114.41 -173.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -72.73 102.34 3.32 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 107.519 -1.289 . . . . 75.45 107.519 171.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -93.86 146.2 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 114.545 -1.207 . . . . 72.5 110.179 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.787 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 56.1 mtpt -121.82 142.74 49.92 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.771 0.828 . . . . 74.03 109.49 172.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.42 ' H ' ' HG ' ' B' ' 42' ' ' LEU . 3.2 pp -92.74 134.61 34.88 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 114.33 -1.304 . . . . 74.43 107.781 168.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.697 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 18.5 m-20 -143.74 132.78 22.88 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.143 -1.058 . . . . 61.41 108.143 177.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 86.7 mt -127.92 132.38 49.29 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.485 0.714 . . . . 55.3 109.706 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 7.5 t70 -123.16 138.59 54.62 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.891 1.277 . . . . 74.03 107.587 172.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 43.6 m -108.88 116.19 31.51 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 122.979 0.511 . . . . 72.14 110.083 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.29 135.84 53.54 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.218 1.007 . . . . 23.25 108.42 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.9 m -142.5 161.39 38.19 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 109.527 -0.546 . . . . 72.01 109.527 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 88.6 p -160.63 136.31 8.17 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 123.627 0.579 . . . . 75.51 109.518 174.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -95.08 102.12 13.91 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.119 -1.067 . . . . 74.41 108.119 167.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 54.3 mt -65.83 -35.95 82.1 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.103 -0.953 . . . . 73.32 111.041 -175.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.49 -179.49 6.02 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.291 1.036 . . . . 61.4 109.443 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.86 122.7 16.06 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.034 -0.984 . . . . 61.31 108.726 173.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 73.95 -4.77 2.19 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 125.371 1.468 . . . . 74.11 113.155 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 56.3 t -113.6 120.7 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 108.978 -0.749 . . . . 60.52 108.978 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -129.19 169.64 14.55 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.214 -0.661 . . . . 72.53 109.214 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -140.87 125.55 17.95 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.475 0.71 . . . . 52.15 109.131 174.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 87.0 t -102.39 119.48 50.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.478 1.111 . . . . 75.02 109.073 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 34.0 t -123.83 111.49 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.732 -0.84 . . . . 75.32 108.732 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 32.3 tp -106.39 119.32 38.96 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 109.059 -0.719 . . . . 54.41 109.059 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 57.7 ttm-85 -86.3 111.76 20.76 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.688 -0.856 . . . . 71.25 108.688 174.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 46.4 t -103.26 102.39 13.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 107.353 -1.351 . . . . 73.32 107.353 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.697 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 17.6 m -101.48 132.15 47.25 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.874 -1.057 . . . . 52.02 109.024 177.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 78.1 t -125.4 112.62 31.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 124.121 0.968 . . . . 75.32 109.153 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.787 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 98.4 m -87.95 149.46 24.03 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.206 -0.906 . . . . 74.43 109.14 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.68 138.4 30.59 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.137 0.575 . . . . 73.04 109.556 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.464 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 45.0 p -146.55 131.29 17.96 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.494 -0.558 . . . . 63.33 109.494 -178.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.615 HD13 ' HB2' ' B' ' 34' ' ' LYS . 26.0 mt -113.34 113.13 24.82 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.287 1.035 . . . . 74.32 108.962 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.79 -111.32 3.41 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.05 -0.523 . . . . 54.31 112.203 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -113.59 4.87 16.32 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.558 0.743 . . . . 74.43 111.598 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -130.48 151.79 50.58 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.165 0.586 . . . . 74.15 110.699 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 73.9 m -74.24 123.39 24.44 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 122.698 0.399 . . . . 73.15 110.174 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.501 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -76.16 -59.9 2.56 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.14 -0.936 . . . . 33.2 109.085 177.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -149.62 161.75 41.56 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 121.933 0.873 . . . . 71.23 111.468 174.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 78.0 mt -125.49 114.23 18.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 105.127 -2.175 . . . . 73.12 105.127 168.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.4 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 36.3 t -115.72 142.77 46.3 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.343 -1.354 . . . . 71.23 107.343 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -160.9 125.51 3.6 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.937 -0.394 . . . . 55.22 109.937 -169.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 62.0 t -128.67 148.94 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.911 0.884 . . . . 73.14 109.805 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -117.63 111.5 19.26 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.724 -1.213 . . . . 62.41 107.724 163.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -96.95 100.78 12.28 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.797 -1.186 . . . . 43.54 107.797 171.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.02 142.12 15.9 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-N 115.232 -0.894 . . . . 74.44 110.87 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.62 125.99 3.02 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 109.786 -1.326 . . . . 42.05 109.786 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 57.9 mt -84.69 126.03 40.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 107.788 -1.19 . . . . 74.34 107.788 175.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -131.88 133.37 44.53 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.03 -0.73 . . . . 74.34 109.03 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 67.2 m -89.07 110.69 21.38 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.276 -1.009 . . . . 72.2 108.276 172.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.439 ' O ' HD12 ' B' ' 86' ' ' ILE . 2.5 pp -124.33 140.76 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.176 0.99 . . . . 72.53 110.213 -172.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.75 171.17 19.31 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.318 0.488 . . . . 72.34 112.318 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.5 -65.7 4.07 Favored Glycine 0 C--N 1.354 1.549 0 CA-C-N 115.148 -0.933 . . . . 73.51 112.946 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.544 ' HB ' ' SD ' ' B' ' 9' ' ' MET . 9.7 mm -68.55 148.86 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.94 1.296 . . . . 75.32 111.026 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -152.38 179.37 8.61 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.641 0.776 . . . . 71.55 111.257 -170.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.02 -127.81 36.18 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 115.968 -0.56 . . . . 63.53 113.374 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 16.3 m -89.28 -18.55 26.77 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.266 0.627 . . . . 62.14 110.787 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -56.34 -41.7 76.53 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 109.338 -0.615 . . . . 74.3 109.338 171.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 17.4 ptt? -81.37 -33.53 32.3 Favored 'General case' 0 C--N 1.358 0.97 0 CA-C-N 115.669 -0.696 . . . . 64.22 111.194 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.4 -36.16 66.12 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.618 0.723 . . . . 71.45 110.894 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.464 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 43.5 t-80 -69.45 -46.14 67.4 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.295 -1.32 . . . . 72.13 111.137 175.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -73.14 -31.67 64.43 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.202 0.445 . . . . 74.43 112.202 -173.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.5 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 15.5 mt -95.3 -42.8 8.34 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.859 0.864 . . . . 74.32 111.242 -172.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.61 -24.61 45.66 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.832 -0.622 . . . . 63.54 113.576 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -117.09 -49.69 2.6 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.855 0.462 . . . . 54.0 111.741 -171.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -81.97 -41.86 20.19 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.022 0.379 . . . . 74.14 112.022 -174.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 85.1 m -61.6 -48.67 89.56 Favored Pre-proline 0 CA--C 1.559 1.292 0 CA-C-O 118.425 -0.798 . . . . 50.41 111.916 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 38.0 Cg_exo -64.5 -22.93 64.97 Favored 'Trans proline' 0 C--N 1.396 3.072 0 C-N-CA 122.167 1.912 . . . . 75.35 112.887 173.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -65.46 -35.97 82.5 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.168 0.587 . . . . 74.53 110.45 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 93.3 mt -63.51 -40.77 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.437 1.095 . . . . 75.41 110.017 171.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 59.8 mt -90.26 -13.01 36.24 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 114.677 -1.147 . . . . 74.2 112.337 -170.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -60.36 -48.28 94.29 Favored Pre-proline 0 N--CA 1.488 1.437 0 CA-C-O 117.911 -1.042 . . . . 71.33 113.473 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.78 -37.99 94.51 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 121.881 1.721 . . . . 72.11 113.173 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -67.64 -47.92 68.19 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.443 0.697 . . . . 73.42 110.508 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.68 -42.35 99.58 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.472 0.709 . . . . 75.2 111.123 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -59.92 -51.44 69.69 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.192 0.997 . . . . 74.12 110.777 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -65.21 -31.32 72.43 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.821 0.701 . . . . 55.54 110.03 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.496 ' SG ' HD11 ' B' ' 21' ' ' ILE . 6.0 t -74.04 -34.58 64.14 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.016 0.526 . . . . 63.1 111.204 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.423 ' O ' HG23 ' B' ' 118' ' ' VAL . 57.0 mt -66.66 -57.33 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 109.114 -0.698 . . . . 51.13 109.114 173.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.3 m -62.1 -24.61 67.23 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.637 0.775 . . . . 70.35 111.788 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 27.1 t -64.32 -52.23 59.51 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 109.379 -0.601 . . . . 73.21 109.379 173.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.5 mmt -69.94 -32.2 70.33 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.11 0.564 . . . . 72.15 111.369 -175.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.423 HG23 ' O ' ' B' ' 114' ' ' ILE . 79.3 t -62.72 -46.19 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.858 0.863 . . . . 62.43 110.184 174.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.0 t -65.72 -35.87 81.97 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.994 -1.003 . . . . 55.52 110.829 177.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.483 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 92.5 mtt-85 -67.12 -33.02 74.56 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.687 -0.688 . . . . 74.54 110.322 178.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.98 7.37 75.18 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 123.837 0.711 . . . . 70.23 112.962 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.519 HG23 ' HB3' ' A' ' 17' ' ' TYR . 81.5 p 59.68 23.89 12.73 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 126.291 1.837 . . . . 54.21 113.596 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -86.65 159.22 52.88 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 123.739 0.816 . . . . 73.3 111.409 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -54.69 158.78 9.96 Favored 'Trans proline' 0 C--N 1.393 2.882 0 C-N-CA 123.837 3.025 . . . . 75.31 115.39 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -65.01 133.84 52.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.358 1.063 . . . . 74.44 111.703 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 58.0 tp -140.21 120.66 14.09 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.451 0.7 . . . . 72.4 109.615 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -132.13 117.44 18.31 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.341 1.056 . . . . 65.21 108.917 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 7.1 mp -83.53 150.37 26.01 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.259 0.624 . . . . 52.43 110.653 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.5 156.42 90.27 Favored Pre-proline 0 CA--C 1.557 1.246 0 CA-C-N 115.063 -0.971 . . . . 74.24 110.463 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -66.34 111.24 2.0 Allowed 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 122.679 2.253 . . . . 64.43 110.667 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 36.9 t -89.75 107.24 17.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.003 -1.11 . . . . 74.43 108.003 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -104.13 88.67 3.06 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.869 -1.06 . . . . 64.41 109.155 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -63.91 -37.61 88.02 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.982 -0.748 . . . . 73.33 108.982 170.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . 0.452 ' N ' ' HB1' ' B' ' 100' ' ' ALA . 6.9 p-10 . . . . . 0 C--O 1.24 0.59 0 C-N-CA 124.745 1.218 . . . . 45.13 111.632 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.651 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.6 t80 . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 109.672 -0.492 . . . . 70.45 109.672 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -152.41 129.58 11.18 Favored 'General case' 0 C--O 1.242 0.667 0 O-C-N 124.072 0.857 . . . . 73.54 109.219 173.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 86.9 mt -73.36 130.51 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 108.43 -0.952 . . . . 63.01 108.43 172.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -97.05 -42.13 8.03 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.401 0.68 . . . . 60.25 110.283 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -176.19 124.97 0.19 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.701 0.4 . . . . 73.32 110.219 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.9 mt -111.26 146.39 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 109.058 -0.719 . . . . 63.43 109.058 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -172.6 166.5 5.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.12 0.968 . . . . 65.12 109.394 -175.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . 0.416 HG22 HE22 ' C' ' 80' ' ' GLN . 63.1 p -85.06 115.43 22.87 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.267 -0.642 . . . . 63.21 109.267 173.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.67 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 16.3 mmtp -64.67 -44.58 89.91 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.998 -0.741 . . . . 71.03 108.998 171.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 22.6 t70 -147.25 145.55 29.47 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 114.407 -1.27 . . . . 74.11 110.609 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.8 mt -133.55 145.13 34.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 125.891 1.676 . . . . 65.54 106.712 171.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.1 t -158.37 150.53 21.76 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.414 0.626 . . . . 72.21 109.707 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 72.1 t80 -147.07 137.6 23.58 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.307 -1.368 . . . . 71.01 107.307 173.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -141.11 135.38 30.88 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.632 -0.877 . . . . 51.14 108.632 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.03 83.42 4.68 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 107.701 -1.222 . . . . 62.42 107.701 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.52 -37.39 59.15 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.816 2.344 . . . . 64.53 112.581 -173.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -101.22 21.1 14.53 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.913 -1.04 . . . . 73.03 110.806 -173.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.467 ' HA ' HG12 ' C' ' 31' ' ' VAL . . . -48.58 -57.26 11.39 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 114.661 1.356 . . . . 73.51 114.661 -167.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.43 -42.5 54.72 Favored 'Trans proline' 0 C--N 1.386 2.516 0 CA-C-N 122.141 1.801 . . . . 54.55 112.248 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.479 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.3 t60 -70.8 -30.97 67.57 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.823 0.849 . . . . 75.31 112.695 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.648 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.5 p -79.68 -21.31 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 112.501 0.556 . . . . 74.32 112.501 -171.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -72.48 -22.94 60.98 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.489 0.552 . . . . 71.21 112.489 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 20.0 pt20 -85.41 8.5 18.7 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.447 0.299 . . . . 64.41 110.88 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.573 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -97.84 157.31 16.15 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.127 0.971 . . . . 50.43 110.281 175.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.0 132.39 40.14 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.708 0.803 . . . . 70.43 109.504 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 35.1 t-105 -70.36 91.55 0.75 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.842 0.857 . . . . 62.15 110.701 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . 0.614 ' HA ' HE21 ' C' ' 37' ' ' GLN . 0.0 OUTLIER -132.21 71.56 79.56 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.263 1.025 . . . . 64.41 109.112 174.673 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -88.5 158.04 6.54 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.744 2.296 . . . . 73.02 112.842 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -89.06 99.93 12.82 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.013 -1.477 . . . . 71.11 107.013 172.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 15.0 m -66.04 98.36 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-O 122.18 0.99 . . . . 55.44 109.508 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -129.16 103.63 7.08 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.606 -1.179 . . . . 54.12 108.617 -170.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -94.68 148.37 22.34 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.626 -0.879 . . . . 64.53 108.626 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.663 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 11.8 t70 -135.48 123.45 22.72 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.2 -1.037 . . . . 73.55 108.2 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.17 111.78 21.52 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.457 -0.942 . . . . 64.02 108.457 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.522 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 16.7 t70 -114.45 137.38 51.91 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.121 0.968 . . . . 54.24 108.472 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 81.7 p -113.17 123.66 50.75 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.743 0.417 . . . . 53.34 111.464 -164.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.62 135.83 42.44 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.807 0.843 . . . . 61.22 109.181 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 51.7 m -161.7 149.19 14.62 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.874 0.47 . . . . 55.24 111.472 -172.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 52.9 p -160.26 140.77 11.77 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.688 0.795 . . . . 74.34 110.156 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . 0.445 ' HA ' ' HA ' ' C' ' 56' ' ' TYR . 60.4 tt0 -74.8 123.46 25.03 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.781 -0.822 . . . . 61.15 108.781 170.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.629 HD11 HD12 ' C' ' 83' ' ' ILE . 87.9 mt -84.23 -49.82 8.44 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.169 0.587 . . . . 70.25 110.622 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.78 -169.74 3.47 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.32 0.648 . . . . 73.11 110.873 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.05 106.52 0.27 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.454 1.102 . . . . 72.42 111.06 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 70.32 -5.32 1.37 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 126.004 1.721 . . . . 62.35 112.68 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 73.8 t -96.53 118.13 42.28 Favored 'Isoleucine or valine' 0 C--N 1.347 0.483 0 C-N-CA 124.572 1.149 . . . . 74.24 108.425 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . 0.494 ' CE1' HG12 ' C' ' 86' ' ' ILE . 37.1 p90 -127.96 168.78 14.79 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.046 0.939 . . . . 63.34 108.955 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -126.07 130.53 51.29 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.14 0.576 . . . . 73.04 110.427 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 76.3 t -106.61 115.77 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 107.933 -1.136 . . . . 75.32 107.933 167.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 98.2 t -109.3 131.75 59.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 107.718 -1.215 . . . . 64.41 107.718 165.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 35.5 tp -129.19 119.96 24.97 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.083 -0.71 . . . . 74.41 109.083 174.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.522 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.3 ttm180 -80.08 111.98 16.94 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.745 -1.116 . . . . 75.44 109.398 175.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 15.5 t -101.32 110.69 28.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.481 -1.303 . . . . 40.32 107.481 171.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.663 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 90.7 m -118.98 118.08 30.54 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.725 -0.843 . . . . 75.54 108.725 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.636 HG23 HD13 ' C' ' 114' ' ' ILE . 94.4 t -101.72 112.85 36.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 108.388 -0.968 . . . . 53.44 108.388 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -98.87 131.85 44.66 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.359 -0.978 . . . . 72.21 108.359 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.57 101.86 4.93 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.416 -1.328 . . . . 64.51 107.416 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 47.9 m -128.62 130.12 46.85 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.957 0.503 . . . . 64.52 109.994 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.573 HD13 ' HG2' ' C' ' 34' ' ' LYS . 12.5 mt -85.75 42.7 0.98 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 124.941 1.297 . . . . 73.53 109.774 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.87 -118.96 6.05 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 109.798 -1.321 . . . . 54.2 109.798 -167.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -89.21 -18.32 27.32 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.397 0.679 . . . . 60.33 110.072 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -74.76 91.16 2.38 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.579 1.152 . . . . 73.44 109.656 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 76.9 m -71.47 119.82 16.17 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 109.516 -0.55 . . . . 73.45 109.516 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.648 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -76.57 -54.68 6.35 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.745 -1.116 . . . . 25.51 109.154 -178.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -157.15 170.38 22.63 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-O 122.349 1.071 . . . . 75.22 112.452 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -142.7 113.55 7.53 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 105.196 -2.15 . . . . 74.22 105.196 175.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.503 ' SG ' HG23 ' C' ' 114' ' ' ILE . 47.9 t -121.92 112.49 18.37 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.162 -0.681 . . . . 70.11 109.162 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -119.28 121.2 39.09 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.724 0.81 . . . . 74.15 110.056 -172.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.427 HG11 ' HA ' ' C' ' 110' ' ' ALA . 43.7 t -125.84 112.58 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.747 -0.834 . . . . 63.23 108.747 173.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.3 mt-30 -91.15 95.98 10.35 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.003 -1.11 . . . . 71.43 108.003 173.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.491 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.9 tp-100 -83.13 117.51 22.94 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.771 0.428 . . . . 63.42 109.871 -175.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.21 145.85 17.89 Favored Glycine 0 C--N 1.342 0.913 0 O-C-N 123.863 0.727 . . . . 70.32 111.643 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.41 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.98 116.92 0.83 Allowed Glycine 0 C--O 1.238 0.361 0 N-CA-C 111.164 -0.775 . . . . 42.4 111.164 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.629 HD12 HD11 ' C' ' 51' ' ' LEU . 10.3 mm -84.44 116.59 28.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.856 -1.164 . . . . 72.32 107.856 176.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.651 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 46.9 m-85 -128.1 146.57 50.65 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.064 -1.087 . . . . 63.41 108.064 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 70.7 p -113.1 122.06 46.41 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.311 -0.626 . . . . 64.53 109.311 170.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.494 HG12 ' CE1' ' C' ' 56' ' ' TYR . 17.7 pt -130.35 143.93 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 122.957 0.503 . . . . 64.22 109.904 170.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.7 143.33 18.45 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.035 0.934 . . . . 61.32 108.745 171.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 130.99 -52.29 0.83 Allowed Glycine 0 C--N 1.346 1.128 0 O-C-N 123.208 0.317 . . . . 65.13 113.018 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 33.0 pt -94.48 170.38 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-N 117.325 0.563 . . . . 64.25 111.831 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -156.89 162.3 39.66 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.626 0.77 . . . . 71.4 110.716 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.11 -132.75 15.58 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.034 -0.53 . . . . 74.11 112.686 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 20.4 p -69.36 -24.36 63.87 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.526 0.73 . . . . 63.25 111.769 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -65.15 -51.58 60.32 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 121.243 0.544 . . . . 73.53 110.039 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 46.3 ttp -64.88 -45.09 87.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.763 -1.108 . . . . 70.51 110.153 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.71 -26.03 68.47 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.062 0.945 . . . . 74.41 111.822 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -73.12 -42.72 62.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.036 0.534 . . . . 74.13 110.577 175.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 40.6 t -62.84 -60.7 3.12 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.709 0.63 . . . . 52.43 110.024 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.3 -29.67 65.32 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 112.151 0.426 . . . . 74.41 112.151 -177.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.56 11.42 56.52 Favored Glycine 0 N--CA 1.48 1.584 0 N-CA-C 115.157 0.823 . . . . 72.53 115.157 -167.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.79 -51.99 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 118.21 1.005 . . . . 42.34 110.335 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.413 ' HE2' ' CE1' ' C' ' 11' ' ' PHE . 27.3 t80 -75.93 -38.28 57.82 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 113.652 -1.613 . . . . 62.21 112.793 -169.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 83.4 m -79.28 -42.35 1.62 Allowed Pre-proline 0 CA--C 1.563 1.451 0 CA-C-O 118.553 -0.737 . . . . 45.13 112.196 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.85 -23.01 68.92 Favored 'Trans proline' 0 C--N 1.397 3.106 0 C-N-CA 122.139 1.893 . . . . 74.34 112.702 171.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -63.84 -32.37 73.86 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.793 0.837 . . . . 74.44 111.019 174.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.474 HD12 ' NH1' ' A' ' 111' ' ' ARG . 47.1 mm -67.63 -35.87 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 123.365 0.666 . . . . 75.35 110.303 175.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.41 HD21 ' HA3' ' C' ' 82' ' ' GLY . 84.3 mt -90.0 -25.16 21.0 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.177 0.991 . . . . 73.14 112.923 -170.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . 0.423 ' N ' ' HD2' ' C' ' 108' ' ' PRO . 0.1 OUTLIER -63.55 -40.34 57.01 Favored Pre-proline 0 CA--C 1.557 1.24 0 CA-C-O 117.729 -1.129 . . . . 75.12 113.905 -171.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' C' ' 107' ' ' PHE . 30.0 Cg_endo -61.16 -36.82 79.0 Favored 'Trans proline' 0 C--N 1.388 2.645 0 CA-C-N 121.685 1.638 . . . . 72.4 112.314 174.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -64.29 -49.29 72.41 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.522 0.729 . . . . 72.45 110.729 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.491 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.78 -41.05 96.14 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.365 -0.834 . . . . 70.21 110.888 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -53.2 -56.15 18.73 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.659 1.183 . . . . 61.34 111.39 175.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . 0.441 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.8 tm-20 -66.14 -34.34 77.83 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 123.568 0.542 . . . . 74.02 110.286 -176.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 12.9 t -70.6 -27.45 64.11 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.072 0.549 . . . . 75.22 111.321 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.636 HD13 HG23 ' C' ' 64' ' ' VAL . 82.0 mt -77.66 -55.47 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.228 0.611 . . . . 75.4 110.288 173.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 18.8 m -62.49 -27.76 69.36 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.534 0.734 . . . . 71.4 110.96 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 42.6 t -62.06 -51.77 66.61 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 123.786 0.834 . . . . 73.23 109.38 169.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.625 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.03 -35.54 77.17 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.687 1.195 . . . . 64.42 112.668 178.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.418 HG23 ' O ' ' C' ' 114' ' ' ILE . 63.7 t -63.57 -46.7 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.71 0.804 . . . . 63.11 109.238 174.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 30.7 t -68.31 -28.55 67.27 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.859 -1.064 . . . . 63.53 111.851 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -72.77 -40.48 65.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.625 0.77 . . . . 72.52 109.316 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.34 -2.54 79.75 Favored Glycine 0 C--N 1.355 1.591 0 CA-C-N 115.42 -0.809 . . . . 71.05 112.267 171.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 24.8 p 65.44 27.66 11.74 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.783 2.033 . . . . 73.35 113.193 170.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -84.14 152.26 61.46 Favored Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 109.042 -0.725 . . . . 75.12 109.042 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -54.36 160.82 6.19 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 123.447 2.765 . . . . 74.23 114.106 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -55.38 111.16 0.81 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.715 0.806 . . . . 61.32 111.461 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 26.6 tp -116.38 86.28 2.46 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 106.116 -1.809 . . . . 74.13 106.116 167.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -104.56 125.9 51.15 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.862 -1.063 . . . . 71.31 109.587 -167.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.36 127.35 32.44 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.489 0.715 . . . . 74.21 110.238 -173.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.6 156.05 68.32 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 123.99 0.916 . . . . 62.22 111.531 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.539 ' HB3' HD12 ' A' ' 16' ' ' ILE . 19.7 Cg_endo -61.22 102.34 0.21 Allowed 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.784 2.323 . . . . 72.11 112.975 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 60.3 t -118.86 110.08 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 108.742 -0.836 . . . . 71.45 108.742 173.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -96.1 106.39 18.56 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.057 -1.09 . . . . 73.23 108.057 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -53.87 -41.9 68.02 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.348 0.659 . . . . 74.24 112.494 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 10.6 t70 . . . . . 0 CA--C 1.547 0.845 0 C-N-CA 124.093 0.957 . . . . 74.44 111.229 176.991 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 C--O 1.238 0.489 0 CA-C-O 120.996 0.427 . . . . 73.45 110.603 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -147.27 119.06 8.06 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.83 -1.174 . . . . 71.21 107.83 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' D' ' 85' ' ' SER . 44.6 mt-30 -132.08 133.69 44.64 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.438 -0.949 . . . . 65.41 108.438 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.595 HG21 HD11 ' D' ' 16' ' ' ILE . 21.8 mt -84.68 129.31 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 108.51 -0.922 . . . . 63.03 108.51 173.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.669 HE21 ' HB2' ' D' ' 85' ' ' SER . 80.1 mt-30 -97.36 -46.18 6.19 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 122.586 0.354 . . . . 74.41 111.226 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -170.15 128.87 0.89 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.6 0.593 . . . . 50.03 112.6 -173.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.595 HD11 HG21 ' D' ' 13' ' ' ILE . 2.0 mp -107.57 137.92 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.445 -1.317 . . . . 43.45 107.445 174.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -163.46 163.73 24.73 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 122.277 1.037 . . . . 74.11 110.956 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -93.8 120.89 34.66 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.629 -1.623 . . . . 72.12 108.419 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -85.3 -42.59 14.48 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.869 -1.16 . . . . 74.43 107.869 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' D' ' 79' ' ' GLN . 20.0 m-20 -136.21 144.79 45.08 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 114.755 -1.111 . . . . 74.23 110.217 176.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.625 HG21 ' HE2' ' C' ' 117' ' ' MET . 56.6 mt -140.73 149.65 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.355 1.462 . . . . 65.22 107.367 174.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.1 t -156.49 142.45 18.0 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.021 0.439 . . . . 74.25 110.849 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.1 t80 -147.63 111.59 5.11 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 106.176 -1.787 . . . . 72.15 106.176 173.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 23.8 mt-10 -123.04 108.23 12.68 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.011 -0.737 . . . . 73.14 109.011 -173.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.558 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -106.44 89.06 3.72 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 123.594 0.758 . . . . 35.14 109.076 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -80.0 -28.13 3.38 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.766 2.311 . . . . 73.11 113.209 -169.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -110.05 6.29 22.84 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.466 0.706 . . . . 62.52 110.627 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.637 ' HB3' ' HE2' ' C' ' 19' ' ' LYS . . . -29.58 -66.89 0.14 Allowed Pre-proline 0 CA--C 1.566 1.588 0 N-CA-C 116.904 2.187 . . . . 50.5 116.904 -165.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.67 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 64.6 Cg_endo -74.64 -14.57 22.04 Favored 'Trans proline' 0 C--N 1.383 2.381 0 CA-C-N 123.38 2.243 . . . . 61.25 112.847 -172.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -84.4 -39.3 19.19 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.048 1.339 . . . . 73.51 110.318 172.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.665 HG22 HD12 ' D' ' 68' ' ' LEU . 5.6 p -82.48 -22.9 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-N 116.436 -0.347 . . . . 65.4 110.98 -170.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -61.67 -24.05 66.48 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.036 0.534 . . . . 64.33 112.251 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -57.6 -30.09 65.02 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.434 1.094 . . . . 75.14 110.861 175.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -84.33 71.98 10.61 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.514 -1.221 . . . . 70.12 109.502 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.72 81.55 5.97 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.215 -0.902 . . . . 50.42 110.67 -173.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 21.6 p90 -155.75 179.18 9.44 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.833 0.853 . . . . 72.0 109.485 172.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.591 HE21 ' HD2' ' D' ' 38' ' ' PRO . 25.1 tp60 -68.84 116.26 39.43 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.868 0.867 . . . . 63.3 110.609 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.591 ' HD2' HE21 ' D' ' 37' ' ' GLN . 50.9 Cg_exo -56.79 131.97 48.86 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.652 2.235 . . . . 74.12 112.379 176.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.29 111.15 3.84 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.755 -1.202 . . . . 75.24 107.755 172.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' D' ' 66' ' ' ALA . 27.7 m -108.19 137.68 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.42 0.629 . . . . 73.03 110.609 -172.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -123.76 128.21 49.23 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.115 -1.439 . . . . 72.52 107.115 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' D' ' 63' ' ' THR . 7.8 mp -96.84 138.5 34.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.195 0.521 . . . . 72.31 110.653 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -128.01 115.87 19.16 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.331 -1.359 . . . . 74.52 107.331 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 mp -104.47 138.2 41.21 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.356 0.662 . . . . 70.04 110.28 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.632 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.9 t70 -133.7 145.05 49.54 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.089 -1.078 . . . . 73.34 108.089 177.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.5 t -105.97 158.13 17.01 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.859 0.464 . . . . 75.02 111.298 -175.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.458 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -167.66 153.11 7.2 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.935 1.294 . . . . 71.55 108.847 173.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 76.9 p -154.0 156.71 37.9 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.555 0.742 . . . . 63.41 109.813 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 15.3 m -147.6 123.92 10.92 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.357 -0.979 . . . . 73.41 108.357 -174.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -78.46 115.39 18.13 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.789 -1.189 . . . . 73.55 107.789 167.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.529 HD12 HG23 ' D' ' 83' ' ' ILE . 26.3 mt -95.44 -27.89 15.19 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.064 -0.717 . . . . 71.13 109.064 177.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.16 -178.64 6.12 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.042 0.937 . . . . 45.35 110.132 172.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -65.67 123.7 20.43 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.549 -0.75 . . . . 72.33 109.816 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 60.45 20.37 10.06 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.25 1.02 . . . . 63.23 112.475 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.3 t -125.08 118.11 52.0 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 C-N-CA 124.205 1.002 . . . . 53.54 108.511 174.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -134.69 131.26 37.48 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.466 0.707 . . . . 62.41 109.849 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.412 ' HB2' HD11 ' D' ' 51' ' ' LEU . 31.5 tt0 -87.38 128.57 35.2 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.812 -1.086 . . . . 63.42 108.274 166.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 43.2 t -110.0 125.42 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 107.789 -1.189 . . . . 61.21 107.789 173.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 16.5 t -118.69 125.67 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.883 -0.784 . . . . 71.2 108.883 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 6.9 mp -121.8 127.46 50.62 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.545 -0.909 . . . . 72.4 108.545 171.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.632 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 18.9 ttm-85 -83.94 103.66 13.38 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.601 1.16 . . . . 74.53 108.903 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 87.0 t -90.94 115.49 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 108.501 -0.925 . . . . 43.11 108.501 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' D' ' 42' ' ' LEU . 18.7 m -125.82 128.29 47.43 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.064 0.459 . . . . 61.14 109.778 -172.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 42.7 t -118.76 101.01 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 125.541 1.537 . . . . 71.42 108.475 -175.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 32.2 m -92.46 95.23 9.53 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.023 -1.103 . . . . 74.41 108.023 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.511 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -102.66 138.64 39.29 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 115.459 -0.791 . . . . 42.4 111.113 -173.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.431 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 47.6 m -146.78 134.4 21.01 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 122.786 0.434 . . . . 60.31 110.989 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.665 HD12 HG22 ' D' ' 31' ' ' VAL . 66.2 mt -94.89 102.24 14.08 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.883 -1.154 . . . . 73.33 107.883 171.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.6 -113.82 3.83 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 116.12 -0.491 . . . . 51.14 112.363 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.73 3.66 11.11 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.108 0.563 . . . . 73.04 110.24 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -116.0 155.08 28.72 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.685 -0.857 . . . . 64.43 108.685 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 35.0 m -70.01 136.43 50.39 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 123.395 0.435 . . . . 73.23 111.293 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.452 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -89.29 -62.77 1.4 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.705 -1.22 . . . . 43.53 107.705 172.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . 0.414 ' HE2' ' HG2' ' D' ' 38' ' ' PRO . 52.6 p90 -158.44 154.85 27.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.558 -1.201 . . . . 61.24 110.311 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 91.5 mt -120.56 112.75 19.31 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.58 1.152 . . . . 63.45 108.002 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.529 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 2.5 m -114.25 140.14 48.83 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.299 1.039 . . . . 72.1 108.918 -174.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -153.92 119.36 5.17 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.295 -1.002 . . . . 74.01 108.295 174.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . 0.462 HG22 HG23 ' D' ' 21' ' ' ILE . 60.3 t -124.5 115.13 43.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.487 -0.931 . . . . 73.15 108.487 174.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.577 ' HB2' ' HB2' ' D' ' 20' ' ' ASP . 51.1 mt-30 -88.13 85.37 6.94 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.92 -1.141 . . . . 65.45 107.92 171.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -80.66 104.03 10.91 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 114.132 -1.394 . . . . 62.22 108.467 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.64 141.74 15.42 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.421 -0.672 . . . . 23.22 111.421 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.507 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -137.11 131.93 5.78 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 111.472 -0.651 . . . . 64.03 111.472 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.529 HG23 HD12 ' D' ' 51' ' ' LEU . 50.8 mt -88.02 124.17 41.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.228 -1.027 . . . . 70.13 108.228 175.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -129.59 157.88 40.83 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.684 0.794 . . . . 73.02 110.071 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.669 ' HB2' HE21 ' D' ' 14' ' ' GLN . 43.4 t -115.56 98.88 6.97 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.986 1.314 . . . . 73.24 107.779 -178.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.9 111.55 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.532 0.733 . . . . 71.11 109.443 -176.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -131.87 149.76 52.35 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.932 0.493 . . . . 73.55 110.457 177.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.52 19.75 63.41 Favored Glycine 0 C--N 1.346 1.104 0 O-C-N 123.788 0.68 . . . . 64.11 114.426 172.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 10.2 mt -112.65 154.16 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 117.226 0.513 . . . . 64.01 109.996 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.422 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 0.0 OUTLIER -147.82 -174.35 4.53 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 125.085 1.354 . . . . 74.14 110.7 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.01 -138.03 39.01 Favored Glycine 0 C--N 1.353 1.485 0 CA-C-N 115.948 -0.569 . . . . 41.33 113.622 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 28.1 p -90.05 -13.74 35.33 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.793 0.837 . . . . 74.1 111.017 174.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -31.0 72.03 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.351 1.06 . . . . 75.0 110.09 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.422 ' SD ' ' HA ' ' D' ' 90' ' ' GLU . 8.0 ptm -74.52 -21.18 59.67 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.389 0.676 . . . . 73.23 112.124 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.83 -36.13 50.46 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.704 -0.48 . . . . 71.23 109.704 169.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -64.52 -37.28 87.02 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.306 0.642 . . . . 72.4 111.31 175.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 35.9 t -59.97 -49.57 77.17 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.011 -0.54 . . . . 64.15 110.491 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 43.7 mt -85.96 -21.7 27.75 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.246 -0.888 . . . . 75.2 111.557 -175.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.23 5.09 45.04 Favored Glycine 0 N--CA 1.476 1.363 0 N-CA-C 114.551 0.58 . . . . 61.43 114.551 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.05 -68.14 0.2 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.534 0.334 . . . . 63.31 110.855 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -65.13 -52.29 56.13 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 112.654 0.613 . . . . 73.45 112.654 -170.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 71.8 m -61.36 -50.17 84.47 Favored Pre-proline 0 CA--C 1.563 1.444 0 CA-C-O 118.76 -0.638 . . . . 70.23 112.218 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.29 -21.44 35.69 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 121.825 1.684 . . . . 72.42 113.421 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -68.74 -27.38 65.87 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 122.911 0.484 . . . . 72.42 110.528 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.432 HD13 HD11 ' D' ' 13' ' ' ILE . 58.5 mt -72.16 -28.43 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 C-N-CA 124.082 0.953 . . . . 70.11 110.441 171.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.507 HD21 ' HA3' ' D' ' 82' ' ' GLY . 94.2 mt -86.28 -22.94 26.53 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.702 0.801 . . . . 72.21 112.563 -176.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -66.9 -35.28 8.86 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.346 1.239 . . . . 75.32 114.346 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.91 -45.28 37.02 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 121.995 1.797 . . . . 75.53 112.939 166.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -74.51 -33.77 62.87 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.748 0.819 . . . . 73.44 111.884 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.41 -53.04 58.51 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.157 0.583 . . . . 41.24 109.889 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -53.77 -51.63 62.81 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-N 114.328 -1.305 . . . . 65.14 110.829 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -62.2 -44.81 95.75 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.274 0.984 . . . . 55.25 111.53 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 36.8 t -58.58 -40.63 83.72 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 123.814 0.696 . . . . 71.3 110.651 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.473 ' O ' HG23 ' D' ' 118' ' ' VAL . 76.7 mt -68.06 -48.79 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.809 0.843 . . . . 64.41 110.381 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.408 HG23 ' HG3' ' D' ' 125' ' ' GLN . 56.5 m -58.2 -42.45 86.18 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.438 1.095 . . . . 74.33 111.519 -175.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 32.8 t -66.5 -42.81 86.82 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.089 -0.96 . . . . 74.05 110.168 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.407 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 73.8 mtm -64.75 -37.57 88.05 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.946 0.498 . . . . 62.24 111.767 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.473 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.1 t -65.96 -41.7 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.063 0.945 . . . . 73.43 110.842 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.8 p -73.31 -31.36 63.96 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 116.009 -0.541 . . . . 73.3 110.952 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' D' ' 116' ' ' SER . 72.9 mtt-85 -70.19 -33.15 71.36 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.436 0.694 . . . . 73.34 110.176 175.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.48 7.63 78.2 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-N 115.919 -0.582 . . . . 50.42 112.516 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.0 p 59.58 24.12 12.87 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 126.683 1.993 . . . . 65.12 114.073 173.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.433 ' HB2' HG13 ' D' ' 118' ' ' VAL . 97.0 m-85 -83.95 156.37 64.06 Favored Pre-proline 0 N--CA 1.479 0.983 0 N-CA-C 108.908 -0.775 . . . . 64.42 108.908 167.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.522 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 18.5 Cg_endo -60.83 139.69 86.54 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.166 1.911 . . . . 74.25 111.771 176.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.408 ' HG3' HG23 ' D' ' 115' ' ' THR . 33.0 tt0 -55.28 142.48 31.57 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.755 1.222 . . . . 64.04 112.469 -174.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 45.9 tp -127.91 98.65 5.23 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.658 0.783 . . . . 73.13 109.352 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.23 107.4 18.21 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.442 0.697 . . . . 72.01 109.333 175.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 7.4 mp -63.79 117.95 7.64 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.086 0.954 . . . . 71.32 109.789 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.79 145.05 98.95 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.478 0.711 . . . . 52.43 111.115 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.471 ' HD3' HG13 ' B' ' 13' ' ' ILE . 73.9 Cg_exo -54.53 129.23 33.77 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.824 3.016 . . . . 61.31 113.4 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.474 0.754 0 C-N-CA 123.467 0.707 . . . . 74.24 110.069 177.738 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.685 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 4.3 t80 . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 109.841 -0.429 . . . . 72.14 109.841 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.5 tp60 -150.16 127.33 11.29 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.812 -1.181 . . . . 71.32 107.812 172.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.577 HG12 ' HD2' ' A' ' 84' ' ' PHE . 48.6 mt -94.32 126.37 46.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.827 -0.805 . . . . 73.52 108.827 176.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -77.38 -39.75 46.15 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.675 -0.491 . . . . 73.0 109.675 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -169.16 145.55 3.42 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 116.365 -0.38 . . . . 73.4 110.332 -168.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 78.1 mt -137.46 136.91 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.021 -1.103 . . . . 60.34 108.021 170.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.467 ' HB3' HG23 ' B' ' 122' ' ' THR . 39.7 p90 -167.84 176.49 6.24 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.808 0.843 . . . . 72.31 110.973 -172.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.9 p -102.74 126.78 49.98 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.307 -0.86 . . . . 54.41 108.984 177.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -90.71 -40.37 11.89 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.885 0.474 . . . . 65.1 110.122 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -141.2 139.2 33.79 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.224 -1.028 . . . . 61.43 108.224 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.432 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 63.8 mt -134.52 140.32 46.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.786 -1.19 . . . . 72.24 107.786 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.531 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 42.7 t -144.43 125.83 14.85 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.363 1.065 . . . . 72.31 108.134 177.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.497 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 85.7 t80 -135.99 115.04 12.3 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 106.667 -1.605 . . . . 65.54 106.667 170.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -120.09 126.05 49.8 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.777 -0.823 . . . . 74.52 108.777 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.47 81.61 4.21 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 107.162 -1.421 . . . . 64.1 107.162 172.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.15 -41.02 46.16 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.988 2.458 . . . . 74.42 113.415 -164.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -114.87 33.07 5.6 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 109.243 -0.651 . . . . 74.21 109.243 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.5 -49.33 34.78 Favored Pre-proline 0 N--CA 1.5 2.059 0 N-CA-C 114.464 1.283 . . . . 51.14 114.464 -177.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -64.12 -20.89 67.86 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.197 1.931 . . . . 55.53 114.088 177.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -101.37 -23.46 14.36 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.728 1.211 . . . . 65.33 111.634 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.573 HG21 ' HA ' ' A' ' 73' ' ' ALA . 2.4 p -78.74 -24.27 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.342 0.657 . . . . 73.14 112.363 -165.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -79.69 -18.63 50.86 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.549 0.74 . . . . 53.22 112.474 -172.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -88.24 -11.63 46.04 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.473 0.709 . . . . 72.42 111.0 173.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -82.21 161.85 22.59 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.644 0.778 . . . . 64.45 111.823 -174.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -72.75 120.49 18.45 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.221 -0.9 . . . . 73.44 109.755 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -76.34 86.03 3.12 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.378 0.608 . . . . 72.13 109.925 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -128.66 73.35 80.94 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 124.559 1.144 . . . . 52.54 107.996 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -86.84 138.44 5.1 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.849 2.366 . . . . 64.04 113.628 -170.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -102.03 86.2 2.83 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 106.988 -1.486 . . . . 75.52 106.988 169.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.1 m -72.8 90.73 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 123.062 1.41 . . . . 75.02 109.611 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -91.97 116.3 28.81 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 112.87 -1.968 . . . . 74.52 108.206 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.525 HD11 HG13 ' A' ' 62' ' ' VAL . 52.2 tp -104.87 129.52 53.2 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.475 0.71 . . . . 75.21 111.444 -170.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -120.73 126.33 49.9 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.348 1.059 . . . . 73.41 108.925 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.1 mt -114.67 133.87 55.52 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.739 0.816 . . . . 71.24 110.306 -173.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.604 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 18.5 t70 -127.05 138.97 53.31 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.819 0.848 . . . . 75.24 110.338 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.3 p -107.78 121.57 44.99 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.752 0.821 . . . . 63.24 110.222 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.97 128.91 25.05 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.696 0.798 . . . . 73.42 109.466 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.3 p -131.94 164.82 25.3 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.56 0.618 . . . . 60.23 110.432 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -156.96 138.96 14.44 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.616 0.766 . . . . 71.1 109.754 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -93.41 118.76 31.71 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.045 -1.094 . . . . 74.24 108.045 169.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' A' ' 57' ' ' GLU . 43.7 mt -90.95 -38.88 12.58 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.945 0.498 . . . . 63.13 110.528 -176.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.16 -176.77 6.1 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.88 0.872 . . . . 62.11 109.951 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -69.2 115.39 8.43 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.166 0.586 . . . . 52.05 109.669 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 75.94 -6.05 2.06 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 125.734 1.613 . . . . 73.15 112.469 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.9 t -100.51 112.96 34.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 108.127 -1.064 . . . . 62.23 108.127 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -136.17 127.52 28.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.367 -0.605 . . . . 73.01 109.367 -174.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.449 ' HB2' HD11 ' A' ' 51' ' ' LEU . 36.3 tt0 -97.76 142.42 29.57 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.242 1.017 . . . . 74.51 111.159 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.43 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 56.0 t -125.59 132.47 70.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 106.767 -1.568 . . . . 60.44 106.767 173.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 62.0 t -128.11 129.48 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.32 1.048 . . . . 74.12 108.936 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -119.66 110.48 16.88 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.924 -1.139 . . . . 72.31 107.924 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.604 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 8.4 tmm_? -87.56 104.43 16.49 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.638 -0.875 . . . . 54.15 108.638 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.525 HG13 HD11 ' A' ' 42' ' ' LEU . 59.2 t -100.04 108.54 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.753 1.221 . . . . 74.43 109.195 -177.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.3 m -104.04 110.78 23.07 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.611 0.764 . . . . 63.51 110.539 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.3 t -105.08 108.89 26.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 124.157 0.983 . . . . 73.52 109.659 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.3 m -103.83 127.63 51.32 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.909 -0.774 . . . . 55.21 108.909 171.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.53 115.33 29.96 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.04 -1.096 . . . . 64.35 108.04 175.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.6 m -118.44 126.35 51.88 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.084 0.469 . . . . 72.53 110.811 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.7 mt -89.51 76.64 7.39 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 107.832 -1.173 . . . . 53.41 107.832 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.34 -83.65 0.98 Allowed Glycine 0 C--N 1.351 1.368 0 N-CA-C 111.145 -0.782 . . . . 60.33 111.145 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -119.53 -26.58 5.73 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.695 0.798 . . . . 74.15 111.161 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -88.96 110.76 21.39 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.963 0.505 . . . . 74.03 110.277 -174.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.9 m -64.23 122.59 17.0 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.917 0.389 . . . . 72.53 110.667 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.573 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -70.89 -59.86 2.56 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.028 -0.987 . . . . 65.44 110.157 175.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -153.17 174.03 14.76 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.185 -0.916 . . . . 72.13 111.658 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 64.2 tp -133.69 141.13 47.44 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.134 -1.432 . . . . 73.03 107.134 173.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 73.9 m -137.86 93.89 2.83 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.542 -0.91 . . . . 43.12 108.542 172.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 45.3 tt0 -113.1 116.26 29.59 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.696 -0.853 . . . . 73.12 108.696 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 t -135.39 115.92 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.459 0.703 . . . . 74.32 110.205 -170.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -81.98 94.2 7.1 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.071 -1.085 . . . . 70.12 108.071 169.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -82.17 99.45 9.26 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.69 -0.856 . . . . 74.04 108.69 176.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.19 146.26 20.21 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 111.192 -0.763 . . . . 53.43 111.192 176.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.22 120.81 1.14 Allowed Glycine 0 CA--C 1.5 -0.845 0 N-CA-C 110.247 -1.141 . . . . 74.24 110.247 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 21.7 mt -85.36 114.47 25.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.03 -0.73 . . . . 73.21 109.03 177.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.685 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 23.3 m-85 -119.37 119.57 34.35 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.401 -0.963 . . . . 63.33 108.401 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.4 p -86.03 101.45 12.94 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.775 -0.824 . . . . 64.11 108.775 174.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.423 ' H ' HD13 ' A' ' 86' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 C-N-CA 123.392 0.677 . . . . 73.51 110.627 -174.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.811 0.338 . . . . 64.05 111.106 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -67.39 -42.37 83.47 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.693 -0.685 . . . . 75.34 110.091 172.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.648 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 81.6 m -62.71 -55.71 24.24 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 123.918 0.761 . . . . 64.14 111.379 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -73.09 -36.36 66.78 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.338 0.655 . . . . 73.11 111.316 -174.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.69 -16.62 58.1 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 114.764 0.665 . . . . 61.44 114.764 -168.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.74 -54.83 0.19 Allowed 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 117.655 0.728 . . . . 74.02 112.834 -171.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.648 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 79.3 t80 -63.64 -53.19 55.26 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.319 1.047 . . . . 65.04 112.896 -169.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.5 m -72.1 -37.41 4.85 Favored Pre-proline 0 CA--C 1.563 1.453 0 C-N-CA 123.591 0.757 . . . . 74.33 112.678 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.79 -40.48 47.88 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 122.441 2.094 . . . . 70.41 113.588 160.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -70.81 -24.1 62.49 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.87 0.868 . . . . 74.11 111.527 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 51.0 mm -69.6 -36.94 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 109.387 -0.598 . . . . 72.34 109.387 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 83.3 mt -79.58 -23.68 42.57 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.752 0.821 . . . . 75.53 112.445 -177.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -58.72 -49.23 94.54 Favored Pre-proline 0 CA--C 1.571 1.764 0 N-CA-C 113.651 0.982 . . . . 72.45 113.651 -176.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -63.68 -35.74 56.37 Favored 'Trans proline' 0 C--N 1.389 2.672 0 C-N-CA 122.159 1.906 . . . . 73.51 113.484 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -75.56 -35.67 60.6 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.579 0.752 . . . . 73.14 111.937 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.8 -44.83 65.79 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.376 -0.602 . . . . 70.44 109.376 175.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.583 HH12 HD12 ' C' ' 105' ' ' ILE . 17.9 ttm180 -59.5 -33.97 72.02 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.146 0.904 . . . . 75.4 110.165 173.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -66.3 -50.53 63.34 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.864 0.866 . . . . 50.24 110.836 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 36.8 t -61.45 -37.02 82.04 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.744 0.653 . . . . 71.32 110.552 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 118' ' ' VAL . 93.5 mt -62.22 -57.28 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.774 0.83 . . . . 63.54 110.021 172.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.8 m -52.28 -39.66 60.74 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.253 1.421 . . . . 63.54 111.908 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -69.98 -51.42 32.66 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.884 -1.053 . . . . 74.21 110.392 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.435 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 36.7 mtm -64.64 -36.69 85.06 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.93 0.492 . . . . 72.22 111.918 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 114' ' ' ILE . 79.2 t -61.1 -44.94 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.506 0.722 . . . . 71.44 110.227 176.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.9 t -70.47 -34.67 72.66 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.477 -0.783 . . . . 61.42 111.454 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.535 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 93.7 mtt-85 -70.58 -32.56 69.99 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.889 0.876 . . . . 54.34 109.695 176.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.95 1.64 83.66 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-O 119.065 -0.853 . . . . 63.53 112.992 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.493 HG22 HH21 ' B' ' 15' ' ' ARG . 22.5 m 73.71 12.53 4.48 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 122.446 1.117 . . . . 71.13 111.866 173.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -84.13 148.2 52.73 Favored Pre-proline 0 CA--C 1.544 0.736 0 O-C-N 121.369 -0.832 . . . . 71.24 109.591 172.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.1 142.21 96.85 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.533 2.155 . . . . 64.15 110.91 172.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -57.27 145.2 32.74 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 124.281 0.988 . . . . 71.11 113.016 -168.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.5 tp -127.99 114.91 17.73 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.871 0.868 . . . . 60.24 109.41 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -119.69 117.65 28.83 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.534 -0.913 . . . . 74.12 108.534 175.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.9 mp -72.49 146.07 47.11 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.147 0.579 . . . . 71.22 110.232 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -62.34 136.37 95.65 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.874 0.87 . . . . 72.22 112.15 -174.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 22.5 Cg_exo -67.83 89.45 0.36 Allowed 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.941 2.427 . . . . 70.04 112.265 175.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 87.1 t -107.31 112.03 38.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.595 -0.891 . . . . 73.41 108.595 176.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -85.32 96.75 9.63 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 107.688 -1.227 . . . . 72.42 107.688 170.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 . . . . . 0 N--CA 1.479 0.993 0 O-C-N 124.059 0.85 . . . . 74.34 111.002 -179.493 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 19.6 ptm . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 113.63 0.974 . . . . 70.03 113.63 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 99.9 m -134.79 140.05 45.59 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.831 1.252 . . . . 63.21 107.84 174.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.451 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 46.0 t80 -142.22 132.89 25.44 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.053 -0.721 . . . . 71.43 109.053 172.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.535 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -153.44 121.11 5.96 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.45 -0.945 . . . . 72.44 108.45 174.086 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 54.7 mt -68.75 120.07 15.62 Favored 'Isoleucine or valine' 0 C--N 1.348 0.528 0 N-CA-C 108.186 -1.042 . . . . 72.31 108.186 170.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -89.07 -49.84 6.52 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.711 -0.848 . . . . 72.22 108.711 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.493 HH21 HG22 ' A' ' 122' ' ' THR . 34.2 ttt85 -168.74 137.03 2.1 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.55 -0.75 . . . . 71.05 109.636 -175.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 87.1 mt -115.36 142.19 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 108.341 -0.985 . . . . 61.32 108.341 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -168.13 148.98 5.01 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 112.622 0.601 . . . . 75.11 112.622 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.579 HG21 HD11 ' B' ' 21' ' ' ILE . 39.5 m -79.69 114.14 18.39 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.268 -0.878 . . . . 63.04 108.912 172.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -84.09 -25.89 29.41 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.099 0.56 . . . . 72.35 111.375 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 16.2 t70 -163.43 149.06 11.41 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.367 0.603 . . . . 65.12 112.052 -175.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.579 HD11 HG21 ' B' ' 18' ' ' THR . 46.4 mm -137.15 142.85 36.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 126.018 1.727 . . . . 70.4 107.742 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 42.5 t -146.17 137.15 24.43 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.249 -1.019 . . . . 72.41 108.249 168.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.432 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 91.2 t80 -141.15 131.86 25.69 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.301 -1.37 . . . . 62.4 107.301 172.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 34.4 mt-10 -131.66 126.84 35.65 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.798 -1.186 . . . . 73.11 107.798 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.696 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -127.98 81.19 70.84 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 107.146 -1.428 . . . . 53.12 107.146 170.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.46 -30.53 35.94 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.884 2.389 . . . . 33.32 111.33 -177.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -103.96 2.58 32.55 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.281 -1.327 . . . . 74.45 110.86 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.696 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -32.05 -66.76 0.19 Allowed Pre-proline 0 N--CA 1.499 1.997 0 C-N-CA 126.032 1.733 . . . . 72.32 115.096 -172.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 21.7 Cg_exo -62.55 -31.05 80.12 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.899 2.399 . . . . 61.33 113.669 -164.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -96.22 -41.51 8.65 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.426 -0.807 . . . . 72.32 111.158 -174.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.17 -12.71 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 113.074 0.768 . . . . 53.14 113.074 -170.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -62.89 -18.24 62.73 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.485 0.714 . . . . 73.31 112.641 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.502 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 10.6 pt20 -55.15 -29.92 58.76 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.453 1.101 . . . . 55.44 111.499 173.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.502 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 96.5 mttt -92.38 95.31 9.59 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.7 1.2 . . . . 75.51 109.202 177.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -97.95 76.65 2.43 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 122.009 0.909 . . . . 71.22 111.494 -172.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 43.0 p90 -157.51 161.13 38.82 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.61 -0.885 . . . . 70.33 108.61 171.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -68.16 116.42 38.98 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 109.062 -0.718 . . . . 74.45 109.062 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.97 159.33 54.37 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.162 1.908 . . . . 64.43 112.656 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -64.63 113.13 3.53 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 109.195 -0.669 . . . . 72.5 109.195 174.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.23 121.64 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.881 0.848 . . . . 74.54 109.79 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.538 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 37.6 ttpt -107.04 100.55 10.03 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.578 -1.638 . . . . 63.21 106.578 175.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 pp -110.24 140.58 44.24 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.735 0.814 . . . . 61.45 110.174 -169.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -136.06 129.93 32.68 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.173 0.989 . . . . 63.32 108.915 -174.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -100.78 127.39 47.23 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.802 -1.184 . . . . 62.45 107.802 170.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.477 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 24.1 t70 -126.92 155.11 43.58 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.197 0.999 . . . . 72.22 108.731 -175.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 79.2 p -107.63 120.11 41.29 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.706 -0.679 . . . . 61.34 110.685 -172.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.79 131.18 44.52 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 107.174 -1.417 . . . . 45.34 107.174 172.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 10.7 p -145.91 168.29 21.19 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.699 0.681 . . . . 64.12 111.457 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p -152.19 138.33 18.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.115 0.966 . . . . 75.4 108.521 171.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -93.82 114.0 26.16 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.133 -0.691 . . . . 61.22 109.133 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 51.6 mt -77.58 -43.2 32.51 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.867 0.467 . . . . 63.24 110.157 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.7 -179.24 7.69 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.579 0.752 . . . . 60.35 110.501 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.11 124.38 21.97 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.301 -1.318 . . . . 70.02 109.02 172.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 70.85 6.77 5.98 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.889 1.276 . . . . 74.22 112.282 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 78.0 t -119.85 111.54 33.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.7 0 N-CA-C 107.698 -1.223 . . . . 65.31 107.698 170.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -122.13 139.84 53.26 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.54 -0.541 . . . . 70.21 109.54 -177.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.444 ' HG2' HG12 ' B' ' 83' ' ' ILE . 6.6 tm-20 -111.35 101.13 9.61 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 107.489 -1.3 . . . . 71.24 107.489 -176.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 63.4 t -96.5 119.6 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.491 1.117 . . . . 62.11 109.601 -173.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.493 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 10.6 t -114.05 123.93 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.826 0.85 . . . . 75.42 108.711 178.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.488 HD22 ' HB3' ' B' ' 103' ' ' PRO . 15.6 tp -103.93 116.26 31.94 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.094 -0.706 . . . . 65.22 109.094 171.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.477 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 41.2 ttm180 -86.04 109.73 19.01 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.438 -0.949 . . . . 73.24 108.438 174.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 46.9 t -101.6 101.26 11.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.34 -1.355 . . . . 64.14 107.34 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.6 m -97.99 128.55 44.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.505 -0.77 . . . . 70.43 109.094 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.653 HG21 HG21 ' B' ' 114' ' ' ILE . 67.5 t -121.57 131.68 72.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 124.578 1.151 . . . . 73.52 108.184 -174.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 60.3 m -120.88 145.46 47.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.873 -1.158 . . . . 74.25 107.873 171.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.52 126.34 12.68 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.643 -0.873 . . . . 74.23 108.643 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 30.8 p -133.63 128.39 35.02 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.966 0.506 . . . . 65.54 110.114 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 70.4 mt -100.79 107.06 18.52 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.014 0.926 . . . . 63.33 108.804 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.16 -129.9 10.0 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 115.877 -0.601 . . . . 70.33 112.497 -176.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -92.4 1.21 57.37 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.647 0.779 . . . . 60.35 110.766 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -121.63 162.25 21.02 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.298 0.639 . . . . 75.02 110.444 -175.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 25.9 m -71.2 145.46 49.65 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.654 0.596 . . . . 73.01 109.787 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.8 -60.2 1.57 Allowed 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.296 -1.002 . . . . 71.34 108.296 168.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -153.04 164.52 37.85 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.001 0.905 . . . . 74.3 111.255 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.529 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 31.3 mt -134.48 142.8 47.18 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 105.427 -2.064 . . . . 70.04 105.427 178.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.3 t -154.8 116.42 4.11 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.601 0.637 . . . . 71.55 109.888 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -121.33 122.86 40.79 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 107.883 -1.155 . . . . 62.24 107.883 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.2 141.76 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.73 0.812 . . . . 74.3 108.959 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.5 mt-30 -118.63 94.54 4.5 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.697 -1.223 . . . . 73.51 107.697 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -90.31 103.93 16.56 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.988 -0.745 . . . . 75.32 108.988 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.46 161.98 29.04 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 123.798 0.686 . . . . 72.1 112.101 177.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.05 125.03 1.34 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.835 -1.306 . . . . 70.24 109.835 177.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.444 HG12 ' HG2' ' B' ' 57' ' ' GLU . 28.3 mt -85.05 130.22 36.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 107.854 -1.165 . . . . 74.04 107.854 175.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -136.6 133.6 36.49 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.037 -1.098 . . . . 74.41 108.037 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 40.3 m -87.25 92.36 9.04 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.452 -0.944 . . . . 71.14 108.452 170.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -107.43 130.3 59.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-N 114.907 -1.042 . . . . 71.55 108.492 176.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.66 168.73 18.16 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.622 0.769 . . . . 74.52 109.997 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.66 -63.44 4.28 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.079 -0.964 . . . . 73.54 112.903 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.56 HG23 ' HB2' ' B' ' 93' ' ' GLN . 43.4 mm -58.83 149.1 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 N-CA-C 114.757 1.392 . . . . 65.12 114.757 -165.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -159.99 -175.76 5.29 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 125.348 1.459 . . . . 61.12 109.548 171.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.01 -111.59 3.93 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 115.423 0.929 . . . . 35.25 115.423 166.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 51.2 m -81.54 -39.03 25.27 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.706 0.802 . . . . 74.44 111.125 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.56 ' HB2' HG23 ' B' ' 89' ' ' ILE . 51.0 mt-30 -66.4 -25.19 66.66 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.306 0.642 . . . . 71.3 112.219 -169.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 22.3 ptm -67.61 -27.54 66.99 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.223 0.609 . . . . 63.31 112.107 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.64 -33.18 69.78 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.796 0.838 . . . . 64.25 110.73 175.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -84.33 -49.24 8.91 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.295 -0.866 . . . . 72.24 109.811 171.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.8 t -58.51 -65.91 0.58 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.974 0.731 . . . . 70.24 112.974 -167.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.8 -2.32 26.53 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 111.727 0.269 . . . . 53.45 111.727 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.04 -17.39 37.74 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 123.197 0.311 . . . . 42.22 113.527 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.59 -55.07 0.89 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.579 0.752 . . . . 74.3 110.574 -176.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -73.51 -53.07 11.48 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.359 1.064 . . . . 71.21 112.244 -166.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.452 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 64.3 m -63.77 -46.72 82.32 Favored Pre-proline 0 CA--C 1.56 1.35 0 CA-C-O 118.864 -0.589 . . . . 55.2 111.626 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.488 ' HB3' HD22 ' B' ' 60' ' ' LEU . 31.2 Cg_exo -64.23 -28.33 64.23 Favored 'Trans proline' 0 C--N 1.39 2.762 0 C-N-CA 122.003 1.802 . . . . 51.14 114.124 173.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.611 ' HA ' ' HD2' ' B' ' 107' ' ' PHE . 47.3 t-20 -57.94 -41.23 82.34 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 123.606 0.762 . . . . 71.13 110.412 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.448 HG23 ' NH2' ' D' ' 111' ' ' ARG . 96.8 mt -60.17 -42.49 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 114.415 -1.266 . . . . 71.32 110.888 175.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 56.7 mt -85.05 -15.43 44.08 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 115.21 -0.905 . . . . 62.32 112.277 -170.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.611 ' HD2' ' HA ' ' B' ' 104' ' ' ASN . 5.1 m-85 -54.46 -53.02 64.44 Favored Pre-proline 0 N--CA 1.495 1.776 0 C-N-CA 124.139 0.976 . . . . 71.04 113.592 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.16 -30.26 46.71 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 122.292 1.995 . . . . 74.41 113.849 -177.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -70.96 -44.45 66.02 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.832 0.453 . . . . 75.4 110.243 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.22 -41.24 98.21 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.963 -0.562 . . . . 62.51 110.248 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -59.59 -54.25 48.69 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.792 0.837 . . . . 74.22 110.164 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -61.73 -33.63 74.38 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 123.714 0.634 . . . . 72.13 110.289 -174.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.535 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 4.0 t -74.55 -48.23 28.07 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 116.062 -0.517 . . . . 71.32 111.452 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.653 HG21 HG21 ' B' ' 64' ' ' VAL . 98.6 mt -57.39 -56.07 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 C-N-CA 123.39 0.676 . . . . 54.34 109.867 174.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 33.0 m -59.25 -30.96 68.66 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 124.417 1.073 . . . . 75.23 111.06 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.4 t -63.64 -47.37 81.61 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 109.288 -0.634 . . . . 71.14 109.288 171.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.0 mmt -67.05 -30.79 70.96 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.089 0.556 . . . . 72.04 111.13 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.506 HG23 ' O ' ' B' ' 114' ' ' ILE . 84.8 t -65.97 -47.31 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.152 0.981 . . . . 74.32 109.171 173.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 71.2 m -66.31 -31.33 72.06 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 114.429 -1.26 . . . . 73.13 111.517 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.519 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 90.5 mtt-85 -73.95 -32.61 63.56 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 124.014 0.926 . . . . 74.41 109.655 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.47 6.33 69.31 Favored Glycine 0 C--N 1.353 1.491 0 O-C-N 124.196 0.935 . . . . 63.44 112.506 174.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.467 HG23 ' HB3' ' A' ' 17' ' ' TYR . 80.5 p 54.92 36.09 25.94 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 125.898 1.679 . . . . 73.13 112.653 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -95.6 157.78 35.54 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.138 0.975 . . . . 73.01 110.544 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -52.99 158.9 5.89 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.607 2.871 . . . . 63.34 115.036 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -64.03 115.07 4.57 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.705 -1.134 . . . . 73.15 111.77 -172.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 55.5 tp -125.35 112.14 15.98 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.366 0.666 . . . . 64.44 109.778 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -132.55 135.54 46.01 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.914 0.886 . . . . 73.44 108.89 176.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 8.0 mp -85.71 142.82 28.73 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.112 0.565 . . . . 73.54 111.622 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.99 132.91 49.43 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.064 0.946 . . . . 73.32 110.646 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.37 108.86 2.78 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 123.02 2.48 . . . . 74.52 112.754 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 98.3 t -93.62 111.6 25.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.639 -1.245 . . . . 74.5 107.639 167.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -74.36 91.33 2.2 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.458 0.703 . . . . 72.43 109.214 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -64.21 -41.12 97.19 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.417 -0.81 . . . . 74.34 110.726 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 N--CA 1.475 0.787 0 C-N-CA 124.205 1.002 . . . . 72.2 111.526 178.876 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.405 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.473 0.688 0 CA-C-O 120.622 0.249 . . . . 64.22 110.332 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -150.93 132.77 15.04 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.949 0.899 . . . . 74.14 108.912 168.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 90.4 mt -73.25 127.35 35.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.399 -0.963 . . . . 72.13 108.399 170.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -95.14 -44.08 7.81 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.626 0.77 . . . . 73.44 109.58 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -176.29 134.35 0.25 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.635 0.774 . . . . 73.1 109.464 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 59.4 mt -127.25 151.88 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 118.636 0.653 . . . . 62.25 109.335 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.465 ' HB3' HG23 ' D' ' 122' ' ' THR . 21.0 p90 -176.3 168.72 2.79 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.717 0.77 . . . . 72.3 110.978 -172.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 68.8 p -87.69 115.95 25.49 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.571 -1.195 . . . . 71.42 109.489 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.446 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 26.0 mmtp -65.54 -46.91 77.72 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.252 -1.018 . . . . 75.42 108.252 167.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 18.4 t70 -134.92 142.56 46.57 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 114.207 -1.36 . . . . 62.3 109.667 -174.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.524 HG12 ' SG ' ' C' ' 113' ' ' CYS . 89.0 mt -135.78 141.17 42.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 106.466 -1.679 . . . . 53.42 106.466 167.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.5 t -159.09 150.88 20.7 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.964 -0.384 . . . . 74.22 109.964 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -155.33 106.84 2.6 Favored 'General case' 0 C--O 1.226 -0.16 0 N-CA-C 107.913 -1.143 . . . . 74.33 107.913 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -117.93 111.4 18.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.524 0.73 . . . . 63.24 109.876 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.2 92.15 10.74 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 107.157 -1.423 . . . . 73.12 107.157 170.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.46 -35.58 38.49 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.657 2.238 . . . . 72.32 112.306 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -101.92 24.73 9.56 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.455 -0.793 . . . . 75.34 110.35 -175.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.96 -62.4 1.67 Allowed Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 114.714 1.376 . . . . 72.25 114.714 -167.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.53 -32.73 48.33 Favored 'Trans proline' 0 C--N 1.383 2.387 0 CA-C-N 121.834 1.691 . . . . 72.24 112.306 -174.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.583 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 72.7 t60 -70.84 -40.45 72.37 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.53 0.732 . . . . 74.41 112.012 177.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.773 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.2 p -77.8 -21.44 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 112.081 0.4 . . . . 64.31 112.081 -170.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -63.66 -29.7 70.9 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.44 0.904 . . . . 74.23 113.44 177.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 21.1 pt20 -84.78 5.76 27.21 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 122.727 0.411 . . . . 74.43 111.114 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.724 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -95.21 156.63 16.24 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.427 1.091 . . . . 74.21 110.408 -177.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -67.86 128.78 37.77 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.155 0.982 . . . . 71.13 110.061 169.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -86.07 100.62 12.3 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.331 0.652 . . . . 74.41 111.3 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -156.69 77.35 4.18 Favored Pre-proline 0 N--CA 1.474 0.773 0 N-CA-C 107.82 -1.178 . . . . 71.15 107.82 168.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -86.65 150.03 8.71 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.377 2.051 . . . . 75.42 113.294 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -82.83 81.49 8.53 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 105.953 -1.869 . . . . 72.43 105.953 168.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -69.33 99.51 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-N 114.367 -1.288 . . . . 71.15 109.444 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -96.14 112.14 23.96 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 113.787 -1.551 . . . . 73.21 109.026 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.59 141.99 28.6 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.604 -0.517 . . . . 71.44 109.604 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.454 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 24.1 t70 -135.66 147.09 48.44 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.575 1.15 . . . . 72.14 108.367 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.61 157.13 44.48 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.082 0.553 . . . . 65.11 111.145 -173.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.608 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 17.1 t70 -140.74 144.97 35.83 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.958 0.903 . . . . 72.33 109.029 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -112.78 112.51 24.05 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.19 -0.67 . . . . 62.05 109.19 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.48 150.35 44.0 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.035 0.934 . . . . 75.43 108.787 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 37.7 p -165.99 157.63 13.94 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.363 0.265 . . . . 73.51 111.658 -174.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 23.4 p -166.1 127.73 1.86 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.82 0.848 . . . . 65.15 109.681 173.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -72.12 130.82 41.79 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 108.917 -0.771 . . . . 72.41 108.917 168.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.61 HD11 HD12 ' C' ' 83' ' ' ILE . 60.0 mt -97.64 -37.0 10.09 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.274 0.63 . . . . 64.31 111.264 -175.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.27 -171.39 2.38 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.003 0.521 . . . . 64.44 111.746 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -57.94 109.12 0.68 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.921 1.288 . . . . 74.12 110.081 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 69.67 -7.15 0.92 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 125.224 1.41 . . . . 74.53 112.668 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.7 t -94.0 112.32 26.65 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 N-CA-C 108.061 -1.089 . . . . 62.41 108.061 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -120.17 159.75 24.27 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.128 -0.942 . . . . 72.13 108.492 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -126.66 123.62 37.98 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.237 0.615 . . . . 54.23 110.244 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.476 HG11 ' HD3' ' C' ' 103' ' ' PRO . 89.6 t -104.66 128.19 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 107.974 -1.121 . . . . 62.05 107.974 171.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -121.23 130.98 74.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.071 -1.085 . . . . 71.13 108.071 170.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.401 HD22 ' HB2' ' C' ' 103' ' ' PRO . 29.4 tp -126.17 117.7 23.66 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.187 -1.412 . . . . 75.21 107.187 170.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.608 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 6.9 tmm_? -90.95 128.64 36.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.515 -0.766 . . . . 54.03 109.611 178.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.48 140.56 19.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.971 -1.122 . . . . 64.2 107.971 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 53.8 m -133.93 122.04 22.54 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.882 -0.785 . . . . 62.45 108.882 173.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.426 HG21 HG21 ' C' ' 114' ' ' ILE . 89.4 t -101.55 109.46 25.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 107.979 -1.119 . . . . 44.42 107.979 176.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.447 HG23 HD23 ' C' ' 75' ' ' LEU . 4.2 m -99.57 107.14 19.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.852 -1.166 . . . . 74.22 107.852 175.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.02 108.37 19.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.719 -1.586 . . . . 64.51 106.719 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.4 m -132.23 127.95 36.84 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.149 -0.686 . . . . 73.0 109.149 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.724 HD13 ' HG2' ' C' ' 34' ' ' LYS . 8.2 mt -85.13 48.99 1.65 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.907 1.283 . . . . 53.32 109.56 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.15 -113.63 4.49 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 109.747 -1.341 . . . . 35.3 109.747 -168.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.69 -19.96 17.91 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.411 0.684 . . . . 63.03 110.526 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -67.24 120.66 14.16 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.866 0.867 . . . . 72.32 108.756 169.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.7 m -84.29 125.61 32.41 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 118.764 0.711 . . . . 74.43 109.295 173.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.773 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.79 -63.54 1.28 Allowed 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.364 -0.976 . . . . 71.32 108.364 173.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -155.77 173.09 17.24 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.274 -0.875 . . . . 71.0 110.663 174.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.447 HD23 HG23 ' C' ' 65' ' ' THR . 2.3 tm? -131.03 141.17 50.19 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 105.089 -2.189 . . . . 61.31 105.089 169.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.532 ' SG ' HG23 ' C' ' 114' ' ' ILE . 47.2 t -142.99 136.94 28.96 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.559 -1.274 . . . . 52.41 107.559 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . 0.508 ' HG3' ' HD3' ' C' ' 61' ' ' ARG . 24.4 tt0 -146.4 120.38 9.38 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.658 0.383 . . . . 72.31 110.396 -173.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 54.6 t -129.72 115.9 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.135 0.974 . . . . 64.24 109.231 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.505 ' HG2' ' HB2' ' C' ' 61' ' ' ARG . 22.6 mt-30 -89.56 99.4 12.41 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.747 -1.205 . . . . 61.24 107.747 170.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.648 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.0 tp-100 -87.88 109.76 20.02 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.825 -0.806 . . . . 73.2 108.825 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.33 145.45 17.6 Favored Glycine 0 C--N 1.341 0.819 0 O-C-N 123.6 0.562 . . . . 74.01 111.88 176.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.82 126.14 2.67 Favored Glycine 0 CA--C 1.506 -0.487 0 N-CA-C 110.921 -0.872 . . . . 64.31 110.921 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.61 HD12 HD11 ' C' ' 51' ' ' LEU . 9.6 mm -87.27 117.83 32.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 108.383 -0.969 . . . . 64.35 108.383 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.405 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 41.7 m-85 -129.17 120.99 26.78 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.227 1.011 . . . . 71.13 109.256 -173.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 57.3 p -79.4 109.11 13.45 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.633 -0.877 . . . . 74.11 108.633 172.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 70.5 mt -119.86 130.43 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.283 1.033 . . . . 72.14 108.855 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.63 158.52 26.24 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.741 0.816 . . . . 74.42 110.189 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.1 -57.87 1.05 Allowed Glycine 0 C--N 1.345 1.035 0 O-C-N 123.296 0.372 . . . . 61.24 113.217 174.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 37.9 pt -85.41 161.28 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 122.909 0.483 . . . . 65.33 111.398 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -152.73 -178.56 6.96 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.92 0.888 . . . . 74.14 110.465 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.85 -139.39 42.91 Favored Glycine 0 C--N 1.349 1.263 0 O-C-N 123.379 0.425 . . . . 45.24 112.845 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' C' ' 95' ' ' ALA . 40.9 p -64.34 -19.86 65.73 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.54 0.736 . . . . 73.21 111.753 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -64.76 -55.92 16.78 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.496 0.718 . . . . 41.43 110.243 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.419 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 10.6 ptp -71.97 -29.82 64.64 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 116.579 -0.282 . . . . 64.12 110.479 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' C' ' 92' ' ' THR . . . -66.47 -32.68 74.19 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.205 0.602 . . . . 72.14 111.51 178.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -77.43 -37.2 52.18 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.407 0.683 . . . . 72.32 110.069 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.568 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 28.8 t -59.61 -40.08 86.34 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.862 0.726 . . . . 72.33 110.613 175.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' C' ' 94' ' ' MET . 67.7 mt -81.49 -40.22 23.56 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.025 0.93 . . . . 71.25 111.54 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.01 -13.68 82.94 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.414 -0.812 . . . . 41.54 114.843 -168.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.627 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -157.97 -54.71 0.07 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 117.237 0.519 . . . . 63.01 112.388 -173.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.568 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 82.4 t80 -57.5 -40.59 79.01 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.711 1.204 . . . . 64.24 113.736 -172.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 89.3 m -82.08 -44.87 1.02 Allowed Pre-proline 0 CA--C 1.561 1.388 0 CA-C-O 118.784 -0.627 . . . . 65.23 112.361 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.476 ' HD3' HG11 ' C' ' 58' ' ' VAL . 37.1 Cg_endo -68.3 -7.79 21.09 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 121.624 1.549 . . . . 74.14 114.287 170.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . 0.612 HD21 ' HB3' ' C' ' 133' ' ' PHE . 0.9 OUTLIER -68.13 -30.97 70.24 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 123.396 0.678 . . . . 40.02 110.741 168.023 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.583 HD12 HH12 ' A' ' 111' ' ' ARG . 41.8 mm -68.33 -40.46 82.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-N 115.416 -0.811 . . . . 65.15 109.519 173.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 61.2 mt -83.08 -26.76 30.78 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.323 -1.308 . . . . 74.12 112.166 -168.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . 0.416 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 89.7 t80 -56.14 -53.93 58.13 Favored Pre-proline 0 CA--C 1.562 1.438 0 CA-C-O 118.07 -0.967 . . . . 70.44 112.754 -176.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 36.1 Cg_exo -59.42 -36.68 93.21 Favored 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 122.319 2.012 . . . . 72.54 113.221 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -63.73 -50.76 67.86 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.156 0.982 . . . . 72.42 111.059 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.648 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -71.21 -29.89 65.7 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.331 -0.849 . . . . 63.01 111.215 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -61.79 -47.82 83.43 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.598 1.159 . . . . 62.54 110.647 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -71.02 -33.71 70.63 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.891 0.476 . . . . 73.42 110.025 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.524 ' SG ' HG12 ' C' ' 21' ' ' ILE . 44.6 t -64.44 -37.1 86.35 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.12 0.568 . . . . 61.43 111.282 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.532 HG23 ' SG ' ' C' ' 76' ' ' CYS . 97.0 mt -71.7 -51.77 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.155 0.582 . . . . 64.0 110.352 174.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.0 m -62.4 -28.4 69.75 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.124 0.57 . . . . 63.32 111.426 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 42.5 t -64.07 -49.94 70.3 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.141 -0.688 . . . . 62.14 109.141 170.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.525 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.45 -33.57 75.85 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.286 1.035 . . . . 63.12 112.662 179.658 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.454 HG23 ' O ' ' C' ' 114' ' ' ILE . 58.3 t -62.83 -44.6 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 109.085 -0.709 . . . . 73.54 109.085 175.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 39.9 t -70.8 -31.0 67.61 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.801 -1.09 . . . . 75.03 111.93 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' C' ' 116' ' ' SER . 90.8 mtt-85 -68.97 -37.49 78.83 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.33 0.652 . . . . 74.33 109.342 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.85 6.87 79.62 Favored Glycine 0 C--N 1.353 1.521 0 O-C-N 123.967 0.792 . . . . 72.54 112.639 174.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 50.7 p 57.34 28.56 15.47 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.278 1.831 . . . . 73.33 114.294 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -83.95 144.63 45.03 Favored Pre-proline 0 N--CA 1.472 0.628 0 N-CA-C 109.059 -0.719 . . . . 73.41 109.059 172.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.81 153.31 37.68 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.67 2.247 . . . . 70.43 112.4 175.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -53.85 129.35 33.37 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.042 0.937 . . . . 72.0 113.487 -170.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 31.3 tp -131.72 84.65 2.18 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 107.054 -1.461 . . . . 72.24 107.054 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -98.16 106.1 18.35 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.462 -1.245 . . . . 72.55 108.425 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.38 138.39 58.51 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.31 0.644 . . . . 74.34 111.213 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.74 133.88 90.4 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 124.088 0.868 . . . . 73.4 110.711 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.15 107.74 1.01 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.53 2.153 . . . . 61.54 112.492 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 23.7 m -100.33 131.3 48.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 108.941 -0.762 . . . . 75.51 108.941 170.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . 0.461 HD21 ' HE1' ' A' ' 11' ' ' PHE . 3.3 m-20 -72.01 84.89 0.99 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.016 -0.538 . . . . 72.32 109.567 177.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . 0.612 ' HB3' HD21 ' C' ' 104' ' ' ASN . 39.1 t80 -65.07 -31.67 72.99 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.227 -0.897 . . . . 73.53 111.32 -172.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . 0.627 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 32.0 t70 . . . . . 0 N--CA 1.481 1.123 0 C-N-CA 122.747 0.419 . . . . 35.45 111.584 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 67.4 m . . . . . 0 C--O 1.242 0.668 0 N-CA-C 109.479 -0.564 . . . . 75.01 109.479 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -137.56 119.14 14.93 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.042 -1.095 . . . . 71.3 108.042 -175.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -130.88 129.84 42.79 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.315 -0.994 . . . . 63.11 108.315 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.491 HG21 HD11 ' D' ' 16' ' ' ILE . 56.1 mt -79.05 129.53 37.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.985 -0.746 . . . . 72.04 108.985 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -105.14 -28.39 11.02 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 119.037 -0.506 . . . . 72.04 111.74 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -176.82 140.41 0.33 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 118.157 0.435 . . . . 74.42 111.52 -173.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.491 HD11 HG21 ' D' ' 13' ' ' ILE . 3.0 mp -123.53 136.31 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.566 -1.272 . . . . 74.14 107.566 171.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.427 ' HE1' HG13 ' D' ' 83' ' ' ILE . 28.6 p90 -162.81 175.07 11.64 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-O 122.078 0.942 . . . . 75.33 112.231 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . 0.406 HG21 HD11 ' D' ' 21' ' ' ILE . 70.1 p -109.71 122.51 47.65 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.049 -1.432 . . . . 64.53 108.814 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -93.17 -31.81 14.63 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.3 -0.63 . . . . 74.42 109.3 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' D' ' 79' ' ' GLN . 6.5 m-20 -142.36 131.57 23.39 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 108.315 -0.994 . . . . 63.51 108.315 177.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.525 HG21 ' HE2' ' C' ' 117' ' ' MET . 89.0 mt -128.6 150.29 34.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.505 -1.294 . . . . 73.21 107.505 172.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . 0.442 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 47.3 t -151.69 139.39 19.76 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.258 1.023 . . . . 71.12 108.923 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 84.1 t80 -152.86 127.66 9.53 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.464 -2.05 . . . . 65.43 105.464 169.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -135.96 134.59 38.79 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.876 -1.157 . . . . 75.43 107.876 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.422 ' CB ' ' HB2' ' D' ' 28' ' ' ALA . . . -120.88 90.53 46.81 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 108.032 -1.099 . . . . 43.22 108.032 175.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.44 -41.07 12.68 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.802 2.335 . . . . 75.24 112.688 -172.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.491 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 27.7 m-20 -106.03 9.81 32.38 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.658 0.783 . . . . 51.54 110.737 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.451 ' HB1' ' CE2' ' C' ' 17' ' ' TYR . . . -19.44 -70.26 0.03 OUTLIER Pre-proline 0 CA--C 1.563 1.458 0 N-CA-C 117.396 2.369 . . . . 52.2 117.396 -165.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.05 -24.03 13.15 Favored 'Trans proline' 0 C--N 1.382 2.321 0 CA-C-N 123.647 2.338 . . . . 74.4 113.969 -174.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -75.1 -41.07 59.39 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.265 1.026 . . . . 72.15 110.522 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.567 HG22 HD12 ' D' ' 68' ' ' LEU . 12.3 p -75.82 -20.22 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 115.856 -0.611 . . . . 70.25 111.243 -173.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -66.64 -20.04 65.9 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 112.699 0.629 . . . . 73.12 112.699 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -59.1 -26.17 64.44 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.769 0.828 . . . . 73.24 110.627 176.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.46 108.72 20.09 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.894 1.278 . . . . 74.25 110.17 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -105.84 88.77 2.89 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.948 0.899 . . . . 74.23 110.978 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 45.5 p90 -161.14 177.26 10.43 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.382 1.073 . . . . 74.53 108.339 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -72.85 115.52 40.91 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 108.845 -0.798 . . . . 75.44 108.845 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -60.82 130.47 33.17 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.33 2.02 . . . . 62.11 111.212 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -63.54 114.44 3.92 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.454 -0.943 . . . . 73.21 108.454 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.487 HG11 HD22 ' D' ' 126' ' ' LEU . 31.1 m -106.91 112.05 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-O 121.526 0.679 . . . . 71.02 110.094 -174.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.43 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 12.0 tmtt? -84.49 119.15 24.83 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 106.467 -1.679 . . . . 55.11 106.467 174.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 pp -95.6 150.38 20.41 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.135 0.493 . . . . 75.31 110.187 -173.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.535 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 13.0 t70 -151.29 119.66 6.4 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.023 -0.99 . . . . 74.44 108.741 -176.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.52 133.84 52.6 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.764 -0.458 . . . . 50.25 109.764 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.451 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 31.4 t70 -132.99 157.55 44.92 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.094 -1.076 . . . . 75.4 108.094 176.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -119.93 153.88 35.26 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.395 0.617 . . . . 62.45 112.106 -173.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.626 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.72 152.86 33.31 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.215 1.406 . . . . 63.13 107.885 172.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 21.1 p -164.63 152.37 11.86 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.69 0.223 . . . . 64.32 110.967 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 60.3 p -164.23 135.02 4.3 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.485 0.714 . . . . 72.42 109.756 177.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -77.71 136.47 38.18 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.851 -0.796 . . . . 71.41 108.851 172.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' D' ' 57' ' ' GLU . 40.2 mt -103.24 -35.05 8.59 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.88 0.472 . . . . 75.25 110.375 -177.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.53 -174.0 3.55 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.746 0.818 . . . . 61.45 109.954 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.23 114.92 3.73 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.232 -0.895 . . . . 64.32 110.238 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 63.87 12.2 6.58 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.788 1.235 . . . . 75.4 112.761 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 76.4 t -109.03 122.67 64.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 106.936 -1.505 . . . . 60.43 106.936 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.643 ' HB3' HD13 ' D' ' 86' ' ' ILE . 16.5 t80 -143.06 131.04 21.68 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.769 -0.456 . . . . 74.41 109.769 -173.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.42 ' HB2' HD11 ' D' ' 51' ' ' LEU . 8.1 tt0 -99.7 130.97 45.97 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.052 0.941 . . . . 73.41 109.747 177.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.1 t -119.63 127.13 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.275 -1.009 . . . . 72.34 108.275 174.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.626 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 11.5 t -112.81 135.69 51.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 124.086 0.954 . . . . 65.45 108.725 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.646 HD22 ' HB3' ' D' ' 103' ' ' PRO . 11.5 tp -125.47 116.87 22.5 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.631 -0.507 . . . . 62.01 109.631 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.451 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 17.9 ttm-85 -83.86 103.14 12.89 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.74 0.816 . . . . 72.34 109.383 175.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 62.1 t -93.27 120.24 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.279 -1.008 . . . . 64.11 108.279 170.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 12.2 m -120.66 146.94 45.9 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 122.963 0.505 . . . . 74.15 109.755 -175.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.417 HG13 ' HB ' ' D' ' 40' ' ' VAL . 53.7 t -137.48 103.88 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 125.383 1.473 . . . . 75.32 109.033 -175.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 48.1 m -94.12 96.96 9.97 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.567 -0.901 . . . . 61.1 108.567 169.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.442 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -97.96 153.07 18.61 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.694 -0.685 . . . . 70.31 109.802 -171.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.433 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.9 p -155.54 128.61 8.14 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 123.559 0.537 . . . . 44.41 112.11 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.567 HD12 HG22 ' D' ' 31' ' ' VAL . 45.7 mt -96.66 96.18 8.45 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.832 -1.173 . . . . 71.31 107.832 169.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -136.14 17.72 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.808 -0.633 . . . . 74.44 112.719 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -84.41 3.15 37.39 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.547 0.739 . . . . 65.31 111.742 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -125.01 147.84 48.75 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.998 -0.371 . . . . 70.0 109.998 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 61.8 m -65.02 135.38 55.54 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 123.825 0.703 . . . . 72.24 111.32 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.555 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -85.61 -65.36 1.02 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.387 -0.968 . . . . 51.21 108.387 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -155.14 144.11 20.83 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.605 -0.725 . . . . 62.41 110.691 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 66.3 mt -106.83 107.67 18.81 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.727 -1.212 . . . . 62.23 107.727 172.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.416 ' SG ' HG23 ' D' ' 114' ' ' ILE . 45.9 t -121.52 141.41 51.07 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.764 0.826 . . . . 65.11 109.527 -174.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 21.8 tt0 -154.8 136.68 14.54 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.138 0.575 . . . . 62.54 109.487 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 82.0 t -136.76 114.88 14.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.956 -0.757 . . . . 72.12 108.956 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.403 ' HB2' ' HB2' ' D' ' 20' ' ' ASP . 69.6 mt-30 -87.88 86.93 7.21 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 107.592 -1.262 . . . . 64.54 107.592 170.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -79.89 104.02 10.18 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 114.31 -1.313 . . . . 63.23 108.116 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -107.09 143.09 15.8 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 111.557 -0.617 . . . . 51.24 111.557 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.14 138.34 9.27 Favored Glycine 0 CA--C 1.506 -0.497 0 N-CA-C 111.643 -0.583 . . . . 74.21 111.643 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.427 HG13 ' HE1' ' D' ' 17' ' ' TYR . 74.2 mt -86.58 121.4 37.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.199 -1.408 . . . . 75.3 107.199 172.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -125.33 165.8 17.7 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.288 0.635 . . . . 72.04 109.406 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 4.6 t -112.55 105.41 13.62 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.794 -1.188 . . . . 54.35 107.794 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.643 HD13 ' HB3' ' D' ' 56' ' ' TYR . 3.3 mp -107.95 105.76 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 108.328 -0.99 . . . . 64.41 108.328 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.72 147.04 49.98 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.328 0.651 . . . . 73.22 110.44 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.11 13.62 76.76 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-O 119.193 -0.781 . . . . 61.02 114.91 172.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.475 HG22 ' N ' ' D' ' 90' ' ' GLU . 7.6 mt -97.57 157.88 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 118.334 1.067 . . . . 55.33 110.477 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.475 ' N ' HG22 ' D' ' 89' ' ' ILE . 1.1 pp20? -153.11 -177.81 6.54 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.446 1.098 . . . . 72.02 108.979 163.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.44 -141.96 47.94 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.532 0.587 . . . . 70.15 113.694 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 7.4 m -89.96 -9.92 46.99 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.556 1.142 . . . . 62.11 111.379 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.74 -28.45 68.7 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.045 0.538 . . . . 74.12 111.043 -176.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 18.1 ptt? -70.98 -32.35 69.17 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 119.462 -0.304 . . . . 72.33 111.42 176.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.42 84.0 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 120.775 0.322 . . . . 72.45 110.146 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -65.56 -43.82 88.69 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.601 -0.727 . . . . 71.54 110.949 171.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.4 t -61.5 -49.96 74.63 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.886 0.474 . . . . 40.32 110.656 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 19.4 mt -83.19 -20.51 34.51 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.054 0.942 . . . . 63.45 111.518 -173.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.83 5.93 34.98 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 114.131 0.413 . . . . 63.14 114.131 -174.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.44 -66.45 0.29 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.557 0.343 . . . . 51.51 110.855 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -70.25 -52.05 25.98 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.565 0.58 . . . . 74.14 112.565 -170.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.498 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 56.8 m -58.38 -47.63 98.44 Favored Pre-proline 0 CA--C 1.562 1.42 0 C-N-CA 123.53 0.732 . . . . 73.33 111.388 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.646 ' HB3' HD22 ' D' ' 60' ' ' LEU . 51.7 Cg_exo -59.4 -39.7 74.22 Favored 'Trans proline' 0 C--N 1.397 3.115 0 C-N-CA 122.231 1.954 . . . . 62.05 113.277 169.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -59.31 -36.17 75.12 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.9 0.88 . . . . 74.43 110.697 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.2 mm -63.5 -36.92 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.514 0.726 . . . . 50.03 110.597 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 73.6 mt -84.43 -13.82 51.04 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 115.221 -0.9 . . . . 71.43 112.371 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -56.68 -50.36 88.4 Favored Pre-proline 0 N--CA 1.5 2.048 0 C-N-CA 124.072 0.949 . . . . 73.32 113.46 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.38 -41.12 81.29 Favored 'Trans proline' 0 C--N 1.392 2.826 0 C-N-CA 122.181 1.921 . . . . 63.01 112.948 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -75.88 -37.98 58.33 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.329 1.052 . . . . 62.35 112.484 -175.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.94 -43.52 71.44 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.08 0.552 . . . . 53.43 110.346 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.448 ' NH2' HG23 ' B' ' 105' ' ' ILE . 46.6 ttp180 -62.28 -47.78 82.81 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.595 -0.729 . . . . 72.43 110.438 176.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -61.28 -45.76 93.13 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.416 0.686 . . . . 73.33 110.757 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.2 t -59.46 -44.5 92.97 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.657 0.598 . . . . 73.31 111.159 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.443 ' O ' HG23 ' D' ' 118' ' ' VAL . 65.5 mt -60.05 -57.64 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.323 0.649 . . . . 73.51 110.326 174.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.9 m -53.43 -41.87 66.49 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.668 1.187 . . . . 73.01 112.673 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 45.6 t -67.19 -41.74 85.34 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.214 -0.903 . . . . 75.33 110.222 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.4 mtm -68.77 -32.49 72.26 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.903 0.481 . . . . 74.41 111.428 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.443 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.0 t -65.76 -43.52 93.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.644 0.777 . . . . 73.02 110.264 176.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.3 p -74.17 -30.36 62.21 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.589 0.356 . . . . 75.53 111.176 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 74.5 mtt-85 -71.75 -27.95 63.32 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.695 0.798 . . . . 74.44 110.373 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.93 7.89 78.42 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-N 115.8 -0.636 . . . . 70.44 112.072 171.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.465 HG23 ' HB3' ' C' ' 17' ' ' TYR . 62.3 p 59.5 15.89 4.85 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 127.015 2.126 . . . . 73.41 113.792 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -78.77 157.98 76.08 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.794 0.838 . . . . 71.11 110.462 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.63 127.34 25.52 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.085 2.523 . . . . 75.12 113.069 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -52.97 136.93 33.96 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.264 1.026 . . . . 73.11 112.048 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.487 HD22 HG11 ' D' ' 40' ' ' VAL . 57.3 tp -118.16 108.77 15.58 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.796 0.838 . . . . 72.14 109.395 -177.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -106.73 99.06 8.66 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.008 -0.738 . . . . 74.1 109.008 175.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.86 130.2 41.05 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.193 -0.669 . . . . 63.42 109.193 173.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -63.02 137.81 97.16 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.338 0.655 . . . . 63.52 110.427 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 8.3 Cg_exo -69.44 111.02 2.63 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.644 2.229 . . . . 72.44 110.905 -177.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 109.226 -0.657 . . . . 45.13 109.226 -177.103 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.693 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 22.0 t80 . . . . . 0 C--O 1.238 0.494 0 N-CA-C 109.048 -0.723 . . . . 62.41 109.048 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -149.71 112.75 4.87 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.369 0.668 . . . . 74.53 109.299 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.645 HG12 ' HD2' ' A' ' 84' ' ' PHE . 27.5 mt -83.05 116.15 26.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.555 -0.905 . . . . 71.01 108.555 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -79.28 -36.41 39.79 Favored 'General case' 0 C--O 1.242 0.702 0 O-C-N 123.895 0.747 . . . . 61.43 110.258 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -171.9 142.74 1.53 Allowed 'General case' 0 C--N 1.355 0.844 0 CA-C-N 116.374 -0.375 . . . . 70.43 110.457 -170.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.588 HD12 ' HB3' ' C' ' 130' ' ' PRO . 76.8 mt -133.66 141.31 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 124.243 1.017 . . . . 63.21 109.083 172.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.472 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 21.1 p90 -165.56 171.9 12.63 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 124.356 1.035 . . . . 73.42 110.499 -172.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.4 p -94.61 119.46 33.31 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.484 -0.932 . . . . 63.42 108.484 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.472 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 35.2 mtpt -83.01 -36.16 25.23 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.019 0.438 . . . . 64.11 109.828 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.515 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 16.2 t70 -145.72 126.02 13.93 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.114 -0.948 . . . . 75.22 109.1 -178.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.562 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 77.4 mt -118.78 142.32 34.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.864 -1.161 . . . . 70.15 107.864 172.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.0 t -150.53 125.82 10.06 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.784 -0.821 . . . . 73.42 108.784 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.501 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 75.3 t80 -127.48 121.97 32.16 Favored 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 106.867 -1.531 . . . . 75.41 106.867 174.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -124.09 118.29 26.6 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.18 -0.674 . . . . 74.15 109.18 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.48 79.64 4.22 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 106.867 -1.531 . . . . 74.03 106.867 168.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.49 -24.58 26.19 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.539 2.159 . . . . 63.24 112.915 -166.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -114.04 23.21 13.16 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 118.16 -0.924 . . . . 64.55 109.504 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.425 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -40.96 -58.14 2.88 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 114.192 1.182 . . . . 61.31 114.192 -166.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 18.0 Cg_exo -65.72 -24.65 54.61 Favored 'Trans proline' 0 C--N 1.389 2.675 0 CA-C-N 121.83 1.689 . . . . 73.11 113.245 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -83.48 -37.57 22.95 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.3 1.04 . . . . 73.22 110.833 -176.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.735 HG21 ' HA ' ' A' ' 73' ' ' ALA . 8.0 p -76.94 -23.82 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-N 115.589 -0.732 . . . . 74.45 111.348 -168.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -68.91 -25.18 64.46 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.884 0.474 . . . . 73.1 110.877 174.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -75.5 -33.02 60.73 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.027 0.931 . . . . 74.33 110.027 175.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -70.94 168.2 17.46 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.43 1.092 . . . . 73.05 111.469 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.87 145.76 27.64 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.828 -0.623 . . . . 75.53 110.025 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.407 ' CE3' HD21 ' A' ' 68' ' ' LEU . 75.1 t-105 -93.86 88.84 5.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.265 0.626 . . . . 75.41 109.583 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -135.2 79.97 48.35 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 107.113 -1.44 . . . . 73.01 107.113 170.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -91.82 165.33 3.3 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.269 2.646 . . . . 74.42 114.889 -170.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.71 126.77 39.05 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.954 -1.021 . . . . 73.13 108.7 164.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.576 HG13 HG13 ' A' ' 64' ' ' VAL . 59.8 t -86.82 105.1 14.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.259 -0.645 . . . . 74.25 109.259 174.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -80.89 123.27 28.15 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.604 -1.18 . . . . 71.4 108.488 171.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -96.39 109.32 21.87 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.374 0.669 . . . . 72.13 109.394 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.689 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 15.5 m-20 -110.14 119.82 40.48 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.532 -0.914 . . . . 73.53 108.532 172.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.782 HD23 HD21 ' A' ' 60' ' ' LEU . 6.3 mp -120.84 136.8 54.82 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.056 0.455 . . . . 73.45 111.103 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -134.72 121.27 20.54 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.36 -1.348 . . . . 71.21 107.36 174.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.47 HG22 ' HG ' ' A' ' 60' ' ' LEU . 43.8 p -107.74 136.51 47.37 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.261 0.624 . . . . 72.24 110.47 -172.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.89 145.56 51.04 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.048 0.939 . . . . 64.2 109.464 -178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.5 m -131.7 152.92 50.53 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.844 0.857 . . . . 45.33 109.569 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 46.7 t -150.1 142.86 24.67 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.632 0.773 . . . . 62.32 109.678 -175.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -101.56 104.32 15.2 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.029 -1.1 . . . . 70.34 108.029 172.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.671 HD11 ' HB2' ' A' ' 57' ' ' GLU . 59.4 mt -81.52 -41.5 21.59 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.921 -0.581 . . . . 73.4 110.295 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.404 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -157.88 -174.53 4.89 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.448 -0.796 . . . . 45.33 110.474 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.8 118.24 7.45 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.693 0.797 . . . . 61.23 110.057 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.28 -6.04 0.83 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.959 1.304 . . . . 71.21 112.74 -177.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 92.0 t -104.34 113.24 40.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 N-CA-C 108.191 -1.04 . . . . 71.41 108.191 -175.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -120.66 167.26 12.64 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.796 0.838 . . . . 72.01 109.429 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.671 ' HB2' HD11 ' A' ' 51' ' ' LEU . 36.3 tt0 -129.93 128.21 41.68 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.275 1.03 . . . . 71.45 108.789 174.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.434 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 53.4 t -109.89 122.79 65.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.076 -1.083 . . . . 63.2 108.076 169.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.5 t -110.14 136.38 46.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.14 -1.059 . . . . 55.33 108.14 171.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.782 HD21 HD23 ' A' ' 44' ' ' LEU . 3.3 tt -129.98 122.1 27.82 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.575 -0.898 . . . . 72.41 108.575 175.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.5 ttm-85 -85.66 103.03 14.1 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.518 1.127 . . . . 52.34 109.471 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.7 t -94.8 102.36 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 107.532 -1.284 . . . . 72.43 107.532 171.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.689 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 23.9 m -102.1 107.86 19.09 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.888 -0.782 . . . . 70.42 108.888 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.576 HG13 HG13 ' A' ' 40' ' ' VAL . 19.2 t -104.47 112.91 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 124.976 1.31 . . . . 60.22 109.121 -176.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 3.2 m -112.56 124.91 53.58 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 108.839 -0.8 . . . . 61.4 108.839 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.0 113.26 26.58 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.577 -1.268 . . . . 72.45 107.577 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.5 m -113.95 122.49 47.11 Favored 'General case' 0 C--N 1.351 0.637 0 CA-C-N 118.478 0.581 . . . . 52.05 110.903 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.407 HD21 ' CE3' ' A' ' 36' ' ' TRP . 17.5 mt -92.91 79.88 4.64 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 125.582 1.553 . . . . 53.24 107.677 173.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.46 -101.99 1.44 Allowed Glycine 0 C--N 1.34 0.801 0 CA-C-N 115.398 -0.819 . . . . 60.34 111.433 -175.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -106.64 -1.37 22.9 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.726 0.81 . . . . 62.34 111.292 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -107.33 136.69 46.71 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.956 0.903 . . . . 73.31 110.101 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.1 m -87.45 124.39 33.38 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 118.095 0.407 . . . . 54.31 110.002 167.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.735 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -73.77 -55.1 6.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.433 1.093 . . . . 74.24 109.695 174.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -152.24 164.91 36.41 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 114.45 -1.25 . . . . 54.43 111.687 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 36.0 tp -134.36 105.83 6.79 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.205 -1.361 . . . . 65.52 107.64 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.501 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 61.7 m -108.14 98.8 8.3 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.844 0.858 . . . . 75.2 109.813 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -105.4 125.44 50.99 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.384 0.674 . . . . 72.14 109.424 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.8 t -131.0 112.61 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.252 0.621 . . . . 70.21 109.545 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 78.3 mt-30 -84.33 87.9 7.23 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.324 1.05 . . . . 64.45 108.471 171.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.477 ' HG3' HD22 ' A' ' 106' ' ' LEU . 8.3 tp-100 -79.53 109.76 14.21 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.869 -1.059 . . . . 71.3 109.416 -177.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.56 146.02 18.09 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 111.481 -0.648 . . . . 74.34 111.481 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.2 124.9 2.04 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 111.387 -0.685 . . . . 61.1 111.387 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.0 mt -82.94 110.23 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.347 0.659 . . . . 73.43 109.519 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.693 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 36.3 m-85 -121.94 120.33 34.12 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.838 0.855 . . . . 74.22 108.747 -177.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.8 m -89.95 101.32 14.02 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.756 -0.831 . . . . 61.55 108.756 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.2 pt . . . . . 0 N--CA 1.484 1.248 0 C-N-CA 123.145 0.578 . . . . 74.41 110.753 -176.214 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.652 0.263 . . . . 35.45 111.707 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -76.03 -38.29 57.39 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.635 -0.711 . . . . 73.32 109.722 172.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.3 t -70.82 -32.81 69.99 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.261 0.624 . . . . 74.53 111.989 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 pp -101.17 -20.02 15.48 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.065 0.546 . . . . 72.43 111.833 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.04 -16.03 29.16 Favored Glycine 0 N--CA 1.478 1.492 0 N-CA-C 113.694 0.238 . . . . 72.12 113.694 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.54 -62.75 1.23 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.789 0.836 . . . . 73.42 109.64 179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.497 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 86.4 t80 -64.47 -60.79 2.74 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.463 1.105 . . . . 72.41 113.957 -167.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 84.7 m -65.71 -37.94 21.75 Favored Pre-proline 0 CA--C 1.566 1.593 0 N-CA-C 113.656 0.984 . . . . 72.21 113.656 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.91 -27.03 43.64 Favored 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 121.729 1.619 . . . . 75.44 112.783 167.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -77.68 -17.45 57.67 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.379 0.672 . . . . 64.42 110.473 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.1 mm -67.84 -41.53 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.89 -0.781 . . . . 72.34 108.89 169.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.477 HD22 ' HG3' ' A' ' 80' ' ' GLN . 90.4 mt -77.06 -21.32 54.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.149 0.979 . . . . 62.5 111.938 -178.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -59.9 -47.53 97.0 Favored Pre-proline 0 CA--C 1.574 1.878 0 C-N-CA 124.293 1.037 . . . . 64.24 113.578 -174.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.92 -40.6 33.95 Favored 'Trans proline' 0 C--N 1.393 2.888 0 C-N-CA 122.051 1.834 . . . . 63.21 112.97 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -65.42 -44.04 88.64 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.812 0.695 . . . . 75.53 111.314 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.35 -31.81 64.17 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.519 0.728 . . . . 52.24 110.926 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.455 HH12 HD12 ' C' ' 105' ' ' ILE . 32.2 ttm180 -62.11 -50.4 72.07 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 109.321 -0.622 . . . . 73.21 109.321 170.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -66.85 -42.94 84.88 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.269 1.028 . . . . 74.34 112.202 -171.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.3 t -60.42 -42.92 97.01 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 123.786 0.679 . . . . 73.23 109.872 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 118' ' ' VAL . 57.9 mt -64.96 -46.07 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 114.811 -1.086 . . . . 73.21 110.686 175.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.3 m -57.66 -40.82 80.2 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.956 0.902 . . . . 54.43 111.304 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 44.1 t -66.41 -44.08 83.96 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 115.258 -0.883 . . . . 71.14 110.497 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 15.9 mtp -64.02 -36.84 85.3 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.895 0.878 . . . . 74.03 111.748 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 114' ' ' ILE . 51.5 t -63.09 -52.34 60.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 124.37 1.068 . . . . 70.14 110.005 176.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.6 t -65.52 -31.31 72.31 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.677 0.791 . . . . 64.54 111.578 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 116' ' ' SER . 44.3 ttm-85 -75.23 -32.53 61.16 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.093 0.957 . . . . 72.25 109.467 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.426 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.97 17.04 38.92 Favored Glycine 0 C--N 1.355 1.607 0 CA-C-N 114.97 -1.014 . . . . 62.44 113.254 171.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.462 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.5 t 62.45 12.65 5.51 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 126.944 2.098 . . . . 74.34 113.838 174.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -79.96 146.5 63.8 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 123.409 0.684 . . . . 74.32 109.474 174.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.54 162.75 35.43 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.61 2.207 . . . . 73.23 113.095 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -54.81 129.2 36.29 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.318 1.447 . . . . 74.13 113.461 -168.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.473 HD11 HG21 ' A' ' 40' ' ' VAL . 59.5 tp -130.4 110.6 11.61 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.392 1.077 . . . . 73.31 109.67 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -125.73 117.19 22.93 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.275 1.03 . . . . 55.24 108.641 175.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.1 mp -66.83 140.75 57.83 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.493 0.717 . . . . 61.14 110.24 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -63.33 130.13 94.03 Favored Pre-proline 0 CA--C 1.552 1.034 0 O-C-N 123.778 0.673 . . . . 60.14 110.417 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 36.8 Cg_exo -64.6 113.63 2.39 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 123.168 2.579 . . . . 61.2 111.893 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.7 t -99.95 114.24 37.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.612 -1.255 . . . . 73.12 107.612 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -74.72 81.42 2.06 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.571 0.748 . . . . 63.01 109.806 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 . . . . . 0 N--CA 1.478 0.949 0 CA-C-N 115.545 -0.752 . . . . 72.44 110.169 179.731 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.56 ' HG2' ' HB ' ' B' ' 89' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 112.346 0.499 . . . . 62.32 112.346 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.499 ' N ' ' SD ' ' B' ' 9' ' ' MET . 94.0 m -149.64 109.18 4.0 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.866 1.266 . . . . 71.23 108.597 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' B' ' 85' ' ' SER . 35.5 t80 -130.76 138.23 49.84 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.914 0.486 . . . . 72.01 110.326 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -154.53 140.41 18.2 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.039 0.536 . . . . 51.42 110.479 175.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.415 ' HA ' ' HD2' ' B' ' 84' ' ' PHE . 17.9 mt -76.33 108.61 9.17 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 C-N-CA 123.7 0.8 . . . . 74.12 108.956 173.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -82.86 -43.64 16.36 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.349 -0.611 . . . . 75.13 109.349 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.462 ' HE ' HG21 ' A' ' 122' ' ' THR . 45.6 ttt180 -167.78 140.45 3.21 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.985 0.514 . . . . 74.52 110.612 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 62.9 mt -118.31 141.46 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 107.752 -1.203 . . . . 55.22 107.752 173.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.449 ' HE1' HG13 ' B' ' 83' ' ' ILE . 20.7 p90 -170.2 150.89 3.74 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.024 0.44 . . . . 70.33 111.721 -173.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 86.8 m -78.99 124.65 28.46 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.982 -0.747 . . . . 53.12 108.982 171.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -94.45 -27.72 15.86 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.419 0.688 . . . . 71.54 111.449 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -164.58 149.82 9.99 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.382 0.426 . . . . 64.5 111.777 -175.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 47.0 mm -140.26 142.81 30.73 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 C-N-CA 125.808 1.643 . . . . 74.22 109.344 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.573 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 46.5 t -139.17 131.92 29.08 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.261 -1.385 . . . . 73.33 107.261 171.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.562 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.7 t80 -144.46 122.52 12.11 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.1 -1.444 . . . . 61.1 107.1 170.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 40.4 mt-10 -130.61 119.73 22.92 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.148 0.979 . . . . 63.14 108.696 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.658 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -113.25 87.18 10.63 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 107.303 -1.369 . . . . 45.22 107.303 174.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.25 -44.86 0.72 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.6 2.2 . . . . 70.35 112.448 -174.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -92.76 5.72 50.14 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.419 1.088 . . . . 70.35 110.526 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.658 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -32.28 -63.24 0.26 Allowed Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 126.002 1.721 . . . . 42.01 115.406 -171.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 32.4 Cg_exo -54.79 -48.44 21.24 Favored 'Trans proline' 0 C--N 1.402 3.364 0 C-N-CA 122.465 2.11 . . . . 71.04 113.27 -167.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -97.67 -18.02 19.12 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.361 0.874 . . . . 71.31 113.361 -171.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.49 HG22 HD12 ' B' ' 68' ' ' LEU . 7.6 p -74.15 -16.19 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 118.875 0.761 . . . . 74.34 110.639 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -58.17 -23.48 55.53 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.26 1.024 . . . . 75.32 113.569 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -61.19 -23.21 65.42 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.038 0.535 . . . . 64.22 111.407 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.449 ' HB2' HD13 ' B' ' 68' ' ' LEU . 91.2 mttt -91.47 99.47 12.4 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.066 0.947 . . . . 73.35 110.211 -177.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -100.42 80.05 2.19 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.501 -0.772 . . . . 73.22 110.363 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 42.7 p90 -155.02 171.16 20.2 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.443 1.097 . . . . 70.44 108.681 170.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -67.72 112.57 10.8 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 108.916 -0.772 . . . . 73.24 108.916 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.538 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 37.8 Cg_endo -65.74 144.08 76.48 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 121.715 1.61 . . . . 74.43 112.315 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -59.71 113.69 2.38 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.499 1.12 . . . . 73.02 109.83 177.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.666 HG13 HG13 ' B' ' 64' ' ' VAL . 81.6 t -92.23 127.26 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.645 0.778 . . . . 70.35 111.262 -173.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.499 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 38.4 tttp -104.62 107.54 18.54 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.017 -1.475 . . . . 73.43 107.017 173.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 pp -85.97 145.59 27.06 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 109.153 -0.684 . . . . 61.35 109.153 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.537 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 5.8 m-20 -142.07 110.9 6.21 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 106.992 -1.485 . . . . 74.55 106.992 171.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -98.85 135.31 40.49 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.336 -1.357 . . . . 74.32 107.336 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -144.99 156.28 43.86 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.989 -1.115 . . . . 73.15 107.989 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 6.1 t -137.14 142.76 42.25 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.457 0.646 . . . . 55.34 110.507 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.43 145.36 35.2 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.27 -1.382 . . . . 75.33 107.27 174.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.8 p -146.39 166.45 26.32 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.853 0.297 . . . . 73.14 111.143 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.5 p -151.41 137.74 18.49 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.189 0.996 . . . . 71.43 109.103 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -92.86 110.74 22.19 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.026 -0.731 . . . . 75.34 109.026 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 22.9 mt -75.59 -46.68 30.4 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.683 0.754 . . . . 63.2 109.635 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.51 179.45 7.8 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 114.572 -1.195 . . . . 74.14 109.774 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -74.92 128.9 36.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.658 -1.155 . . . . 75.23 108.179 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 73.69 -4.77 2.16 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 125.798 1.639 . . . . 63.42 112.83 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 62.2 t -114.18 113.75 44.7 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 N-CA-C 108.253 -1.017 . . . . 64.13 108.253 172.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.638 ' HB3' HD13 ' B' ' 86' ' ' ILE . 23.1 t80 -125.44 138.25 54.01 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.663 -0.865 . . . . 74.34 108.663 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -113.76 119.75 38.45 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.388 -1.338 . . . . 74.12 107.388 -175.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.431 HG21 ' HB3' ' B' ' 102' ' ' CYS . 33.0 m -116.05 148.93 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.136 0.574 . . . . 32.01 110.37 -177.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 19.3 t -129.59 124.16 58.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 C-N-CA 123.652 0.781 . . . . 60.31 109.11 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 20.0 tp -101.83 108.95 20.6 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 109.318 -0.623 . . . . 64.42 109.318 171.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -88.36 118.47 27.99 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.386 0.674 . . . . 70.13 109.994 175.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.1 t -114.12 103.4 15.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 108.242 -1.022 . . . . 71.22 108.242 176.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 4.7 m -99.62 130.3 45.84 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.267 0.627 . . . . 64.13 109.383 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.666 HG13 HG13 ' B' ' 40' ' ' VAL . 54.3 t -128.43 102.28 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 124.271 1.029 . . . . 74.31 110.564 -176.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 31.9 m -83.71 150.01 26.11 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.279 -1.008 . . . . 62.13 108.279 165.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -138.89 147.91 42.96 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.04 0.536 . . . . 61.42 110.033 177.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 36.2 p -138.92 125.31 20.4 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.121 0.568 . . . . 71.43 110.374 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.538 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 53.2 mt -94.23 100.61 12.64 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.022 -1.473 . . . . 72.32 107.022 173.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.36 -114.27 3.95 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 115.006 -0.997 . . . . 63.2 110.833 -170.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.83 6.32 9.9 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.018 0.927 . . . . 73.14 110.676 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -114.39 152.32 31.7 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.389 0.676 . . . . 65.23 109.22 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.8 m -64.56 137.99 58.15 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 123.648 0.592 . . . . 60.51 111.15 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.535 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -93.19 -63.62 1.19 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.579 -1.267 . . . . 74.12 107.579 170.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -145.56 167.76 22.26 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 114.244 -1.343 . . . . 74.41 110.601 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 61.0 mt -130.78 140.89 50.33 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.491 -2.04 . . . . 75.32 105.491 172.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.9 t -146.92 158.54 43.95 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.639 -0.874 . . . . 73.12 108.639 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.573 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 41.7 tt0 -165.04 132.24 3.01 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.512 -0.922 . . . . 73.04 108.512 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.0 t -128.23 144.54 37.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 123.479 0.712 . . . . 73.51 109.184 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -120.57 101.05 7.49 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.951 -1.129 . . . . 71.2 107.951 169.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.472 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.5 tp-100 -90.71 102.53 15.28 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.147 -1.057 . . . . 74.54 108.147 175.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.5 158.93 27.95 Favored Glycine 0 C--O 1.245 0.79 0 CA-C-N 115.283 -0.871 . . . . 72.02 110.946 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.98 125.87 1.62 Allowed Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 111.02 -0.832 . . . . 61.35 111.02 -178.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.449 HG13 ' HE1' ' B' ' 17' ' ' TYR . 50.9 mt -85.0 125.28 40.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 106.902 -1.518 . . . . 74.11 106.902 172.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . 0.415 ' HD2' ' HA ' ' B' ' 13' ' ' ILE . 58.1 m-85 -134.38 154.75 51.19 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.047 -0.724 . . . . 62.22 109.047 176.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 74.0 m -91.7 104.3 16.78 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.674 -0.861 . . . . 75.42 108.674 169.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.638 HD13 ' HB3' ' B' ' 56' ' ' TYR . 3.7 mp -101.37 107.86 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 106.602 -1.629 . . . . 72.4 106.602 173.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.21 171.32 15.11 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.153 0.581 . . . . 51.43 110.632 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.11 -72.54 2.83 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.364 -0.834 . . . . 60.42 111.89 -177.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.56 ' HB ' ' HG2' ' B' ' 9' ' ' MET . 1.4 mm -87.16 144.35 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.029 0.932 . . . . 65.52 111.103 -176.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.48 ' HG2' ' H ' ' B' ' 91' ' ' GLY . 14.9 tt0 -154.69 175.35 13.8 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.177 -1.374 . . . . 74.21 107.611 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.48 ' H ' ' HG2' ' B' ' 90' ' ' GLU . . . 80.24 -113.89 3.74 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-O 120.03 -0.317 . . . . 52.25 112.364 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 8.9 m -73.96 -53.52 9.9 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.259 0.624 . . . . 60.25 111.718 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -70.98 -26.54 63.19 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.252 -0.886 . . . . 65.23 112.292 -165.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 21.0 ptt? -69.46 -25.08 63.92 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 122.977 0.173 . . . . 54.03 111.115 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.66 -38.72 78.76 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.491 0.716 . . . . 44.24 110.944 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -77.95 -37.4 47.68 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.949 -1.023 . . . . 72.14 110.507 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -67.74 -25.73 65.79 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.414 0.686 . . . . 65.2 112.12 -177.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 84.3 mt -93.15 -43.92 8.61 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.184 0.594 . . . . 74.3 110.59 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.72 -18.42 73.06 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 115.152 0.821 . . . . 64.43 115.152 -170.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.05 -43.68 1.95 Allowed 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 117.589 0.694 . . . . 43.1 111.799 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.46 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 27.3 t80 -76.77 -52.5 9.45 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.801 -0.636 . . . . 73.03 111.427 -168.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.431 ' HB3' HG21 ' B' ' 58' ' ' VAL . 70.2 m -62.28 -44.4 88.29 Favored Pre-proline 0 CA--C 1.571 1.781 0 CA-C-O 118.269 -0.872 . . . . 73.21 112.959 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -51.68 -43.46 50.79 Favored 'Trans proline' 0 C--N 1.405 3.502 0 C-N-CA 122.832 2.355 . . . . 55.24 113.324 172.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -55.95 -33.3 64.64 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.152 0.981 . . . . 73.22 112.083 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 52.3 mt -77.57 -48.32 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.749 0.82 . . . . 73.11 110.868 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 79.2 mt -87.48 -19.89 27.33 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.661 0.784 . . . . 64.1 112.806 -167.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -64.15 -44.26 76.61 Favored Pre-proline 0 CA--C 1.563 1.479 0 CA-C-O 117.676 -1.154 . . . . 75.1 112.527 -174.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -53.14 -38.46 80.97 Favored 'Trans proline' 0 C--N 1.392 2.862 0 C-N-CA 122.553 2.169 . . . . 71.04 113.83 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.472 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 72.7 m-85 -70.81 -40.69 72.34 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.583 -0.735 . . . . 74.14 110.51 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.8 -37.03 83.75 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.741 0.416 . . . . 55.41 110.673 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -60.85 -55.76 29.19 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.156 1.383 . . . . 72.32 110.717 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -58.86 -37.97 77.7 Favored 'General case' 0 C--N 1.358 0.945 0 O-C-N 124.009 0.818 . . . . 74.43 110.555 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.434 ' O ' ' HG2' ' B' ' 117' ' ' MET . 16.8 t -67.41 -42.61 82.97 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-N 115.374 -0.83 . . . . 75.33 111.293 -175.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.97 -52.68 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 123.741 0.651 . . . . 74.32 109.541 176.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 10.7 m -60.97 -27.29 68.16 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 124.129 0.893 . . . . 62.01 111.689 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -68.52 -52.04 36.4 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 123.187 0.595 . . . . 62.53 109.67 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.434 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 33.7 mmt -59.56 -38.7 81.82 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.162 0.585 . . . . 63.53 111.063 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' B' ' 123' ' ' PHE . 71.1 t -66.24 -45.63 89.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.789 1.236 . . . . 71.24 111.034 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.7 t -67.63 -29.12 68.35 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.265 0.626 . . . . 52.31 111.107 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -73.34 -38.58 65.7 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.786 0.835 . . . . 74.44 110.042 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.58 -2.5 69.29 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 124.028 0.83 . . . . 65.54 112.5 171.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 20.1 p 63.22 28.87 15.97 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.804 2.042 . . . . 64.5 112.839 174.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.426 ' HB2' HG13 ' B' ' 118' ' ' VAL . 92.2 m-85 -86.93 154.42 55.3 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.886 0.874 . . . . 75.34 110.483 176.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -48.24 153.37 3.02 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 124.095 3.197 . . . . 74.44 115.567 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.474 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -60.63 126.71 28.42 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.557 1.543 . . . . 74.42 111.797 -175.501 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 38.9 tp -127.8 113.89 16.54 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.822 -0.626 . . . . 72.14 110.386 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -121.36 112.65 18.83 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.295 -1.002 . . . . 72.11 108.295 171.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 9.2 tt -78.31 135.23 37.47 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.497 0.719 . . . . 74.44 109.667 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.93 137.34 87.44 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.487 1.115 . . . . 65.4 112.202 -173.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.525 ' HG3' HD13 ' D' ' 16' ' ' ILE . 38.1 Cg_endo -63.8 100.07 0.28 Allowed 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 123.188 2.592 . . . . 72.32 112.647 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 p -91.22 111.2 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-N 115.509 -0.769 . . . . 62.43 109.003 173.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -80.14 100.87 8.46 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.607 0.763 . . . . 74.53 109.113 -177.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -66.38 -41.6 89.15 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.41 0.684 . . . . 74.02 110.932 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 26.2 t70 . . . . . 0 N--CA 1.474 0.745 0 C-N-CA 124.452 1.101 . . . . 62.42 111.941 -174.5 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.589 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.6 t80 . . . . . 0 C--O 1.239 0.532 0 N-CA-C 109.738 -0.467 . . . . 75.33 109.738 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -140.96 123.61 16.07 Favored 'General case' 0 C--O 1.245 0.824 0 N-CA-C 107.611 -1.255 . . . . 70.15 107.611 175.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 70.3 mt -71.4 122.43 23.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.213 -1.032 . . . . 75.34 108.213 171.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.537 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 20.7 mm-40 -85.11 -50.51 7.36 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 124.122 0.889 . . . . 60.22 109.018 -178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -172.41 124.19 0.48 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.951 -0.568 . . . . 70.23 110.214 -172.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 77.1 mt -112.28 143.74 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.55 -0.908 . . . . 72.3 108.55 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -174.94 166.03 3.56 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.674 0.79 . . . . 74.11 109.369 -171.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . 0.493 HG22 HE22 ' C' ' 80' ' ' GLN . 71.8 p -89.64 126.0 35.46 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.278 -0.638 . . . . 61.12 109.278 177.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -74.99 -50.2 17.37 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 122.668 1.223 . . . . 72.34 107.857 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.494 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 10.3 t70 -136.0 136.86 40.65 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 112.651 -2.068 . . . . 51.2 108.969 -166.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 75.2 mt -136.28 142.15 39.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.044 -1.465 . . . . 73.34 107.044 172.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -158.46 151.35 22.44 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.312 0.577 . . . . 45.02 110.328 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -150.32 134.42 17.0 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 107.919 -1.141 . . . . 72.45 107.919 174.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -134.35 137.55 44.23 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.465 0.706 . . . . 71.25 109.659 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.36 80.96 8.24 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 106.125 -1.805 . . . . 51.31 106.125 172.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.65 -8.89 24.07 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.9 2.4 . . . . 54.21 112.878 -171.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.456 ' ND2' ' HB ' ' C' ' 31' ' ' VAL . 20.2 p-10 -124.48 20.95 8.67 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.053 1.341 . . . . 74.15 110.277 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.85 -51.14 17.91 Favored Pre-proline 0 CA--C 1.564 1.511 0 N-CA-C 114.569 1.322 . . . . 64.34 114.569 -168.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.58 -51.13 9.82 Favored 'Trans proline' 0 C--N 1.392 2.845 0 CA-C-N 121.622 1.615 . . . . 54.03 112.169 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.438 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 84.1 t60 -68.38 -29.99 68.82 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.744 0.818 . . . . 53.44 112.28 -174.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.749 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.8 p -77.43 -26.52 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 N-CA-C 112.626 0.602 . . . . 73.22 112.626 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -68.98 -17.98 64.0 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.379 0.881 . . . . 73.3 113.379 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 19.4 pt20 -94.6 8.04 43.66 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.789 0.436 . . . . 70.45 111.181 177.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.766 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -89.78 168.84 11.77 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.005 0.922 . . . . 63.12 110.372 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . 0.438 ' N ' ' HG3' ' C' ' 34' ' ' LYS . 31.6 t70 -74.13 130.56 40.02 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.2 0.6 . . . . 75.03 109.66 165.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -80.7 88.93 5.74 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.059 0.544 . . . . 65.34 109.873 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -143.13 77.85 15.58 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 107.971 -1.122 . . . . 74.24 107.971 172.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . 0.515 ' HB2' HG13 ' C' ' 40' ' ' VAL . 9.2 Cg_endo -88.11 127.09 2.1 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.968 2.445 . . . . 72.24 112.37 -173.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -82.46 86.5 6.75 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.522 -1.658 . . . . 75.01 106.522 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.515 HG13 ' HB2' ' C' ' 38' ' ' PRO . 3.1 m -82.81 111.29 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 113.18 -1.827 . . . . 64.23 111.006 -173.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -106.31 115.97 31.14 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.838 0.855 . . . . 63.3 109.84 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 8.0 mp -85.66 131.18 34.39 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.302 -0.999 . . . . 60.45 108.302 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.527 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 38.6 t70 -123.63 105.7 9.94 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.814 1.246 . . . . 70.21 107.903 -170.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 32.7 tp -95.66 140.57 30.29 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.728 -0.669 . . . . 74.44 110.006 -173.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.62 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 25.9 t70 -147.14 158.06 43.81 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.853 -1.166 . . . . 71.44 107.853 173.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 73.0 p -122.53 132.25 54.23 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.159 0.584 . . . . 50.45 110.59 -174.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.25 147.43 50.22 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.072 -1.085 . . . . 72.23 108.072 173.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 72.3 p -165.55 159.09 16.33 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.597 0.237 . . . . 62.11 111.609 -174.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 65.2 p -164.15 134.79 4.28 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.536 0.734 . . . . 63.02 110.013 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -77.04 120.6 22.36 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.766 -0.827 . . . . 53.34 108.766 171.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.579 HD11 HD12 ' C' ' 83' ' ' ILE . 43.6 mt -94.14 -39.84 10.36 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.638 0.775 . . . . 55.31 110.155 -176.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.451 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -148.41 -179.19 6.77 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.852 0.861 . . . . 65.42 110.146 177.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -57.23 110.39 0.83 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.629 0.772 . . . . 65.12 109.419 173.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 65.02 1.4 1.47 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.317 1.447 . . . . 61.33 114.35 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 90.1 t -93.18 110.73 23.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 106.914 -1.513 . . . . 73.31 106.914 173.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -125.1 136.25 53.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.911 -0.586 . . . . 75.43 110.137 -171.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.414 ' HB2' HD11 ' C' ' 51' ' ' LEU . 29.6 tt0 -94.05 119.71 33.29 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.222 -0.899 . . . . 52.23 109.234 175.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 61.7 t -104.76 114.04 43.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.419 -1.326 . . . . 71.22 107.419 168.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 63.1 t -105.54 133.24 50.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 107.674 -1.232 . . . . 62.34 107.674 169.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 13.9 tp -116.4 108.62 16.26 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.794 -0.817 . . . . 72.54 108.794 174.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.62 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 0.4 OUTLIER -83.64 114.13 21.33 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.365 -0.976 . . . . 64.31 108.365 179.366 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 12.2 t -110.81 130.13 64.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.076 -1.083 . . . . 64.13 108.076 174.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 31.1 m -124.86 118.52 26.5 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.586 -0.894 . . . . 54.43 108.586 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.543 HG23 HD13 ' C' ' 114' ' ' ILE . 98.9 t -98.77 110.41 26.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.462 -0.94 . . . . 75.31 108.462 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.4 HG23 HD23 ' C' ' 75' ' ' LEU . 11.2 m -96.32 137.7 35.01 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.123 -1.436 . . . . 74.13 107.123 174.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.45 118.38 19.25 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.526 -1.287 . . . . 63.5 107.526 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 60.1 m -138.47 127.78 24.43 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 109.253 -0.647 . . . . 63.44 109.253 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.766 HD13 ' HG2' ' C' ' 34' ' ' LYS . 2.9 mt -83.37 15.6 2.93 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.954 1.302 . . . . 72.12 111.291 -175.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.09 -104.49 0.59 Allowed Glycine 0 C--N 1.344 1.013 0 N-CA-C 109.346 -1.502 . . . . 74.13 109.346 -173.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -88.45 -20.79 24.73 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.348 0.659 . . . . 74.22 110.073 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -89.37 122.54 32.7 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.196 0.998 . . . . 74.53 110.156 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 89.1 m -75.97 125.12 28.5 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.998 -0.742 . . . . 44.45 108.998 166.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.749 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.33 -54.12 7.61 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.173 -0.677 . . . . 74.34 109.173 173.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -164.52 166.26 20.54 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 115.56 -0.745 . . . . 64.43 111.856 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.4 HD23 HG23 ' C' ' 65' ' ' THR . 2.3 tm? -131.6 104.41 6.93 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 106.762 -1.57 . . . . 60.13 106.762 172.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.51 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.8 t -110.19 146.15 36.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.842 0.857 . . . . 71.01 108.999 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -150.58 133.98 16.36 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.003 0.521 . . . . 53.03 109.877 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.5 t -132.54 132.79 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.507 -0.923 . . . . 74.1 108.507 168.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.497 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 61.0 mt-30 -105.56 98.49 8.18 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.701 -1.222 . . . . 74.42 107.701 173.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.493 HE22 HG22 ' C' ' 18' ' ' THR . 9.9 tp-100 -82.57 106.98 14.87 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.888 -0.596 . . . . 74.4 110.43 -174.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.65 145.66 21.98 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.902 -0.59 . . . . 74.23 111.69 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.11 117.2 0.8 Allowed Glycine 0 CA--C 1.509 -0.282 0 N-CA-C 110.477 -1.049 . . . . 63.53 110.477 177.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.579 HD12 HD11 ' C' ' 51' ' ' LEU . 13.1 mm -83.87 118.9 32.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.145 -1.057 . . . . 64.32 108.145 177.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.589 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 50.6 m-85 -129.17 128.36 43.23 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.146 0.978 . . . . 71.03 108.71 -176.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.1 p -83.33 115.62 22.08 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.864 -0.791 . . . . 70.21 108.864 172.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 4.4 mp -114.65 100.3 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 107.134 -1.432 . . . . 74.42 107.134 173.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -124.25 152.66 42.72 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.159 0.984 . . . . 63.44 109.034 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.41 -58.25 0.74 Allowed Glycine 0 C--N 1.345 1.04 0 CA-C-O 120.272 -0.182 . . . . 65.12 113.189 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 29.9 pt -81.89 167.44 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 121.111 0.481 . . . . 55.41 111.413 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -150.08 -177.24 5.81 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.292 1.037 . . . . 75.52 110.019 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.71 -139.07 48.74 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 124.266 0.979 . . . . 50.2 114.618 171.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 68.0 p -70.58 -18.75 62.9 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.853 0.861 . . . . 73.34 111.953 -175.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -74.91 -39.14 61.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.274 0.63 . . . . 61.02 109.951 174.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 46.5 ttm -60.81 -49.09 78.89 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.177 0.591 . . . . 73.24 109.815 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.22 -29.98 70.83 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.792 0.837 . . . . 71.13 112.072 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -67.15 -40.92 86.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.215 0.606 . . . . 74.45 110.327 174.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.568 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 15.2 t -64.78 -43.72 92.32 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.529 0.518 . . . . 74.43 110.799 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 86.1 mt -74.73 -36.79 62.65 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.413 0.685 . . . . 73.02 112.19 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.92 -23.89 31.49 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 114.651 0.62 . . . . 72.13 114.651 -165.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.483 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -135.99 -47.03 0.65 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.446 0.641 . . . . 73.31 111.875 -172.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.568 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 82.4 t80 -74.23 -40.78 62.18 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 125.485 1.514 . . . . 74.45 112.604 -170.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 94.5 m -76.71 -43.23 3.04 Favored Pre-proline 0 N--CA 1.487 1.382 0 CA-C-O 118.568 -0.73 . . . . 71.41 111.194 176.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -47.34 -40.06 28.13 Favored 'Trans proline' 0 C--N 1.395 3.009 0 C-N-CA 122.84 2.36 . . . . 70.44 113.376 165.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -59.02 -38.49 79.38 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 123.668 0.605 . . . . 65.44 111.276 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.455 HD12 HH12 ' A' ' 111' ' ' ARG . 36.8 mm -65.27 -44.47 94.97 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 122.822 0.449 . . . . 64.4 109.842 174.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 94.9 mt -83.82 -15.22 49.13 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.816 1.043 . . . . 75.21 113.816 -169.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -58.72 -53.43 66.43 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-O 117.614 -1.184 . . . . 74.12 112.946 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.75 -32.11 78.3 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 121.702 1.601 . . . . 71.11 112.949 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -66.71 -53.69 30.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.371 0.668 . . . . 74.53 110.626 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.49 83.81 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.703 0.801 . . . . 74.4 110.465 177.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -57.77 -57.11 14.19 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.298 1.439 . . . . 71.32 111.287 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -38.0 83.19 Favored 'General case' 0 C--N 1.366 1.296 0 O-C-N 123.716 0.635 . . . . 75.54 109.713 -177.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.431 ' SG ' HG21 ' C' ' 18' ' ' THR . 8.8 t -66.3 -30.52 70.95 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 122.833 0.453 . . . . 62.3 111.761 -176.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.543 HD13 HG23 ' C' ' 64' ' ' VAL . 91.9 mt -74.46 -55.39 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.209 0.604 . . . . 71.33 109.534 173.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 21.8 m -59.99 -27.4 66.83 Favored 'General case' 0 CA--C 1.558 1.27 0 O-C-N 123.787 0.679 . . . . 61.41 111.204 -175.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 46.7 t -63.68 -48.62 76.44 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 124.429 1.092 . . . . 43.31 109.82 174.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.647 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -66.45 -36.26 82.34 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.115 0.966 . . . . 74.5 111.686 179.129 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 76.1 t -61.75 -41.12 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.561 0.744 . . . . 74.31 109.507 172.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.0 t -74.82 -28.86 60.88 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.95 -1.023 . . . . 73.14 111.763 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' C' ' 116' ' ' SER . 80.5 mtt-85 -73.0 -38.62 66.53 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.815 -0.809 . . . . 74.22 108.815 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.27 -4.92 70.22 Favored Glycine 0 C--N 1.356 1.691 0 CA-C-N 115.375 -0.829 . . . . 61.22 112.777 171.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 19.6 p 64.91 27.67 12.75 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.673 1.989 . . . . 75.41 113.157 171.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -83.99 142.25 41.49 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 108.263 -1.014 . . . . 75.32 108.263 170.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.54 163.44 1.16 Allowed 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.65 2.9 . . . . 70.35 114.711 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -54.33 134.08 45.21 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.326 1.05 . . . . 64.34 113.112 -171.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 27.5 tp -134.93 85.96 2.22 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.51 -1.293 . . . . 74.34 107.51 174.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -96.21 115.54 27.59 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.845 -1.07 . . . . 63.2 109.067 -175.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.24 121.61 14.11 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.747 0.819 . . . . 72.43 109.069 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.61 137.9 74.06 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 123.065 0.546 . . . . 71.21 111.286 -177.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.588 ' HB3' HD12 ' A' ' 16' ' ' ILE . 9.6 Cg_endo -52.47 109.51 0.35 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.139 2.559 . . . . 63.22 114.383 175.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 10.1 m -121.19 112.02 33.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 107.784 -1.191 . . . . 74.23 107.784 165.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -74.49 94.04 2.55 Favored 'General case' 0 C--N 1.354 0.774 0 N-CA-C 108.759 -0.83 . . . . 74.32 108.759 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -54.91 -34.18 62.86 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.943 1.697 . . . . 72.44 111.902 -173.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . 0.483 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 9.7 t70 . . . . . 0 CA--C 1.54 0.592 0 C-N-CA 124.42 1.088 . . . . 73.42 111.178 -177.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 64.5 m . . . . . 0 C--O 1.242 0.701 0 N-CA-C 108.718 -0.845 . . . . 75.32 108.718 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' D' ' 85' ' ' SER . 25.0 t80 -158.58 119.85 3.43 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.757 -0.831 . . . . 74.34 108.757 177.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -138.86 145.24 39.73 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.759 1.224 . . . . 73.33 108.118 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 52.4 mt -91.77 127.62 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.24 -0.652 . . . . 73.11 109.24 176.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.425 HE22 HG13 ' D' ' 55' ' ' VAL . 51.1 mt-30 -97.53 -46.63 5.97 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 122.531 0.333 . . . . 75.15 111.061 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -167.77 127.53 1.34 Allowed 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 117.816 0.28 . . . . 75.31 111.527 -170.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.525 HD13 ' HG3' ' B' ' 130' ' ' PRO . 2.4 mp -103.82 138.05 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.358 -1.349 . . . . 74.31 107.358 167.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -163.94 149.4 10.79 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 123.813 0.695 . . . . 73.2 110.658 176.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.1 p -83.36 116.85 22.66 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.419 -0.81 . . . . 74.41 109.212 174.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -84.74 -35.87 22.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.635 -0.876 . . . . 71.01 108.635 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.619 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 12.7 t70 -143.25 129.23 19.57 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.283 -1.326 . . . . 74.31 109.129 -174.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.647 HG21 ' HE2' ' C' ' 117' ' ' MET . 62.1 mt -135.56 148.45 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.643 1.177 . . . . 71.12 108.612 174.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.6 t -147.17 142.87 27.77 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.027 0.931 . . . . 55.21 109.536 171.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 83.1 t80 -146.63 119.93 8.96 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 105.252 -2.129 . . . . 73.04 105.252 172.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.8 mt-10 -134.98 109.94 8.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.311 0.645 . . . . 73.22 109.386 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.24 90.95 5.11 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 107.734 -1.21 . . . . 73.14 107.734 175.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -73.5 -33.36 6.92 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.726 2.284 . . . . 72.4 112.554 -169.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -110.4 18.53 19.73 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.143 0.977 . . . . 74.12 109.897 -175.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -34.22 -61.01 0.45 Allowed Pre-proline 0 CA--C 1.569 1.685 0 N-CA-C 116.309 1.966 . . . . 50.43 116.309 -161.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.436 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 93.1 Cg_endo -76.36 -26.88 8.39 Favored 'Trans proline' 0 C--N 1.385 2.481 0 CA-C-N 122.996 2.106 . . . . 71.34 113.202 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -66.38 -44.36 83.31 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.507 1.123 . . . . 64.44 109.624 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' D' ' 73' ' ' ALA . 12.0 p -82.46 -16.42 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-N 115.202 -0.908 . . . . 71.41 111.446 -172.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.436 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 16.7 m-85 -64.75 -26.2 68.26 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.102 0.408 . . . . 64.51 112.102 177.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -58.27 -21.92 50.48 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.842 0.857 . . . . 71.02 111.198 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.403 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 88.3 mttt -93.73 97.5 10.49 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.931 1.292 . . . . 72.12 109.09 173.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -104.9 85.29 2.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.718 0.771 . . . . 74.42 109.324 177.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 19.1 p90 -149.25 -173.16 4.31 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.688 -1.142 . . . . 73.44 108.075 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -77.14 113.13 28.01 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.147 0.579 . . . . 64.44 110.237 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.23 130.37 39.04 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.664 2.243 . . . . 75.54 112.696 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.56 112.18 3.05 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.795 -0.817 . . . . 63.42 108.795 172.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 13.9 m -101.81 125.37 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.745 0.818 . . . . 74.31 110.91 -171.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.646 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 0.1 OUTLIER -104.82 111.92 24.84 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.68 1.192 . . . . 73.1 108.096 179.032 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 50.2 tp -98.45 126.22 43.91 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 122.759 0.423 . . . . 73.1 110.004 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -141.25 125.72 17.7 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.78 0.832 . . . . 75.32 109.019 174.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.95 146.67 27.53 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.519 0.728 . . . . 73.22 110.418 -176.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -134.53 156.04 49.34 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.842 1.257 . . . . 71.55 108.159 171.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 5.9 t -127.8 151.4 49.08 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.48 0.657 . . . . 65.31 110.937 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.81 152.62 36.82 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.302 -1.37 . . . . 32.42 107.302 168.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 77.6 p -172.75 153.41 2.71 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.831 0.452 . . . . 70.11 110.752 -175.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 37.2 p -169.48 159.11 8.32 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.069 0.948 . . . . 75.42 109.772 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -90.47 134.77 34.13 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.386 -0.598 . . . . 73.53 109.386 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.508 ' HB2' HG12 ' D' ' 55' ' ' VAL . 63.9 mt -99.68 -42.31 6.93 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.035 0.534 . . . . 71.3 110.7 -177.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.42 -168.94 2.73 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.334 0.653 . . . . 63.33 110.388 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.04 118.36 9.7 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.539 -0.541 . . . . 52.03 109.539 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 64.4 4.65 2.28 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.016 1.327 . . . . 74.4 112.779 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.508 HG12 ' HB2' ' D' ' 51' ' ' LEU . 79.3 t -110.67 129.27 66.12 Favored 'Isoleucine or valine' 0 C--N 1.351 0.638 0 C-N-CA 124.624 1.17 . . . . 71.31 108.6 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -145.37 172.9 12.51 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.691 -0.855 . . . . 65.13 108.691 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -132.29 145.48 51.31 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.097 -0.956 . . . . 75.12 110.12 174.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.459 HG21 ' HB3' ' D' ' 102' ' ' CYS . 15.1 m -129.32 142.12 44.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.204 1.002 . . . . 73.34 108.678 167.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.405 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 39.4 t -128.44 117.23 44.59 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 C-N-CA 124.322 1.049 . . . . 62.24 108.223 -175.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.571 HD22 ' HB2' ' D' ' 103' ' ' PRO . 60.9 tp -103.61 119.13 38.28 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.714 -0.476 . . . . 65.42 109.714 174.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -88.17 108.09 19.1 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.047 -0.723 . . . . 74.12 109.047 170.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 41.1 t -91.89 128.41 43.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.356 -1.35 . . . . 73.31 107.356 166.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.4 m -125.17 125.2 43.3 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.582 0.706 . . . . 54.14 110.807 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 48.2 t -115.59 100.76 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.034 1.734 . . . . 74.45 108.242 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.646 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 91.8 m -96.35 102.5 14.29 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.062 -1.088 . . . . 65.25 108.062 172.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.16 139.67 39.48 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.371 -0.831 . . . . 71.01 109.441 -170.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.428 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 61.3 p -147.53 126.32 12.66 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.054 0.454 . . . . 64.33 111.52 -173.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.444 HD12 HG22 ' D' ' 31' ' ' VAL . 51.4 mt -98.54 113.91 26.13 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.269 1.028 . . . . 75.02 108.479 175.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.73 -128.32 9.1 Favored Glycine 0 C--N 1.343 0.935 0 O-C-N 123.383 0.427 . . . . 72.42 113.04 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.03 18.95 20.98 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.043 0.537 . . . . 73.05 110.879 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.403 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 11.7 pt-20 -140.32 167.41 22.2 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.261 0.624 . . . . 61.3 110.07 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 77.0 m -74.35 139.5 44.16 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.461 0.704 . . . . 71.33 110.551 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.601 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.94 -64.77 1.1 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 107.717 -1.216 . . . . 64.11 107.717 171.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -156.8 162.97 39.72 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 114.497 -1.229 . . . . 74.01 110.176 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 84.8 mt -121.44 112.27 18.33 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 124.728 1.211 . . . . 63.02 107.921 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -114.05 133.82 55.27 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.208 -1.034 . . . . 72.11 108.208 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -156.6 120.56 4.36 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.186 -0.672 . . . . 65.32 109.186 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 80.8 t -130.61 114.32 27.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.643 -0.873 . . . . 72.33 108.643 -176.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.619 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 37.5 mt-30 -88.94 87.71 7.32 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 108.489 -0.93 . . . . 73.52 108.489 170.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -80.03 104.51 10.64 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 113.745 -1.571 . . . . 74.42 108.167 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -101.98 150.98 18.38 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 111.236 -0.746 . . . . 54.34 111.236 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.31 131.13 3.94 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.738 -0.545 . . . . 63.22 111.738 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.9 mt -88.38 123.18 40.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 107.572 -1.27 . . . . 74.13 107.572 171.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -131.51 169.35 16.21 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.254 1.021 . . . . 45.14 108.942 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 25.5 m -112.65 136.03 52.68 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.058 0.943 . . . . 73.12 108.862 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.59 HG12 HD13 ' D' ' 89' ' ' ILE . 12.1 tt -145.79 137.57 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.352 -0.981 . . . . 72.54 108.352 176.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.09 127.4 1.83 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.502 0.321 . . . . 63.31 111.073 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.1 4.81 55.21 Favored Glycine 0 C--N 1.346 1.129 0 O-C-N 123.613 0.57 . . . . 74.03 113.228 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.59 HD13 HG12 ' D' ' 86' ' ' ILE . 3.3 mp -115.56 150.21 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.385 0.674 . . . . 65.54 110.208 -175.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.24 176.06 6.99 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.567 1.547 . . . . 60.33 109.004 173.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.89 -129.32 46.39 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 114.58 0.592 . . . . 75.34 114.58 175.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.8 m -71.56 -33.49 69.14 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.535 1.134 . . . . 51.34 112.225 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -64.21 -30.37 71.44 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.823 0.849 . . . . 65.14 111.566 -177.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 48.0 mtm -62.18 -39.33 92.34 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.919 0.488 . . . . 73.12 111.473 174.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.99 -36.98 83.13 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.857 0.463 . . . . 75.4 112.08 -173.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . 0.491 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 54.5 t-80 -81.21 -29.27 34.57 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.339 0.256 . . . . 74.53 111.576 177.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 34.5 t -70.75 -49.91 41.73 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.286 0.565 . . . . 75.11 110.832 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 29.4 mt -93.8 -45.0 7.85 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 124.464 1.105 . . . . 62.35 110.973 -166.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.33 -1.25 88.17 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-O 119.825 -0.431 . . . . 73.23 113.534 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -133.01 -68.46 0.59 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.475 0.637 . . . . 54.2 111.317 -178.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -70.82 -42.9 69.63 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 112.896 0.702 . . . . 70.42 112.896 -167.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.459 ' HB3' HG21 ' D' ' 58' ' ' VAL . 66.6 m -62.04 -50.29 81.29 Favored Pre-proline 0 CA--C 1.568 1.664 0 N-CA-C 112.881 0.697 . . . . 54.44 112.881 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.571 ' HB2' HD22 ' D' ' 60' ' ' LEU . 98.2 Cg_endo -77.52 -7.58 16.86 Favored 'Trans proline' 0 C--N 1.39 2.715 0 C-N-CA 122.267 1.978 . . . . 74.23 112.711 175.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -77.51 -30.57 52.99 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.765 -0.828 . . . . 61.33 108.765 171.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.1 mm -70.51 -38.22 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.518 0.727 . . . . 54.42 109.638 169.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.98 -11.35 59.58 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.488 0.715 . . . . 63.3 111.771 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . 0.432 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 86.5 t80 -65.97 -51.63 45.64 Favored Pre-proline 0 CA--C 1.567 1.634 0 C-N-CA 124.2 1.0 . . . . 73.12 112.605 -177.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 34.3 Cg_exo -60.64 -32.32 93.15 Favored 'Trans proline' 0 C--N 1.395 2.979 0 C-N-CA 122.128 1.885 . . . . 74.04 112.814 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -80.76 -32.07 35.67 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.865 0.866 . . . . 74.14 112.177 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.1 -46.37 81.35 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.804 -0.813 . . . . 64.05 108.804 173.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -62.23 -41.24 98.23 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 124.228 0.955 . . . . 71.42 110.839 177.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -51.68 -53.64 36.83 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.428 1.091 . . . . 65.11 111.131 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.1 t -67.74 -46.75 71.25 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.191 -0.913 . . . . 55.31 111.485 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.484 ' O ' HG23 ' D' ' 118' ' ' VAL . 84.7 mt -62.2 -57.58 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.474 0.71 . . . . 73.22 110.841 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 90.9 m -49.95 -45.75 51.61 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.32 1.013 . . . . 53.44 111.734 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.5 t -64.97 -43.31 93.05 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.083 -0.962 . . . . 73.22 110.955 -175.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.423 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 73.3 mtm -65.05 -36.35 84.07 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.79 0.436 . . . . 64.14 111.559 179.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.484 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.7 t -62.53 -44.67 99.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.789 0.835 . . . . 51.12 110.366 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.2 p -76.86 -26.25 54.03 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 116.08 -0.509 . . . . 51.54 111.38 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -72.98 -34.24 66.32 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.434 0.694 . . . . 70.5 109.892 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.35 3.17 79.12 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 115.582 -0.736 . . . . 43.23 112.393 171.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.0 p 60.39 24.38 13.92 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 126.866 2.067 . . . . 55.52 113.669 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -82.43 158.89 65.55 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 124.095 0.958 . . . . 75.41 109.585 169.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -49.64 127.49 18.73 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 123.369 2.713 . . . . 74.12 113.31 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -52.08 131.24 31.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.288 1.035 . . . . 72.32 111.27 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 45.8 tp -124.08 97.86 5.53 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.243 0.617 . . . . 74.32 110.15 -172.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -101.87 121.41 42.06 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.805 0.842 . . . . 73.12 109.664 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 tt -74.3 115.88 14.32 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 108.463 -0.94 . . . . 61.05 108.463 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.47 143.86 98.56 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.684 0.794 . . . . 61.15 111.644 -176.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.46 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 6.8 Cg_exo -70.48 121.88 8.39 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.696 2.264 . . . . 64.14 111.535 -177.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 N--CA 1.482 1.165 0 C-N-CA 124.008 0.923 . . . . 74.24 110.743 -178.747 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.535 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 41.2 t80 . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.287 0.089 . . . . 63.22 110.808 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -158.43 116.39 2.96 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.697 0.623 . . . . 74.21 109.872 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.617 HG12 ' HD2' ' A' ' 84' ' ' PHE . 57.7 mt -72.6 114.71 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 109.416 -0.587 . . . . 73.13 109.416 177.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -82.76 -34.58 27.07 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.003 -0.998 . . . . 72.02 109.921 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -173.18 149.34 1.79 Allowed 'General case' 0 C--N 1.36 1.031 0 O-C-N 123.714 0.634 . . . . 75.31 110.679 -171.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.567 HD12 ' HG3' ' C' ' 130' ' ' PRO . 75.0 mt -141.52 134.6 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 124.23 1.012 . . . . 62.4 108.332 174.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.48 ' HB3' HG23 ' B' ' 122' ' ' THR . 32.9 p90 -167.32 176.85 6.42 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.983 0.897 . . . . 74.52 110.97 -173.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.1 p -101.54 116.86 33.72 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.737 -1.209 . . . . 63.02 107.737 174.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 42.8 mtpt -75.78 -41.95 51.52 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.733 0.777 . . . . 72.3 109.002 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 15.9 t70 -135.73 143.35 45.29 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 113.731 -1.577 . . . . 64.24 109.72 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 92.6 mt -138.62 143.66 31.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 125.743 1.617 . . . . 73.34 106.962 176.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -153.46 138.57 17.36 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.477 -0.564 . . . . 71.13 109.477 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.457 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 93.9 t80 -143.29 120.57 11.56 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 106.852 -1.536 . . . . 74.44 106.852 176.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -120.53 148.78 43.39 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.241 -0.652 . . . . 73.21 109.241 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.87 80.27 14.02 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 106.359 -1.719 . . . . 51.03 106.359 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.3 -50.26 12.61 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 123.364 2.709 . . . . 72.34 112.841 -169.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.77 33.84 3.58 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 114.867 -1.06 . . . . 61.23 108.614 -176.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.445 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -47.65 -53.09 33.24 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 113.467 0.914 . . . . 73.25 113.467 -176.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.48 -15.41 45.15 Favored 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 121.536 1.491 . . . . 73.33 112.847 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -97.93 -31.14 12.34 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.259 1.023 . . . . 63.15 110.413 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.862 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.5 p -77.42 -16.78 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.351 0.66 . . . . 51.32 112.27 -164.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -77.76 1.1 21.17 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 122.901 0.48 . . . . 74.15 111.27 174.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -89.9 -24.66 21.29 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.665 1.186 . . . . 64.22 110.568 168.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 71' ' ' GLU . 30.8 mmmt -66.85 165.5 15.18 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.422 1.089 . . . . 52.14 112.513 -176.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -84.49 138.14 32.95 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 108.011 -1.107 . . . . 62.11 108.011 167.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 26.8 t-105 -72.62 89.37 1.31 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.902 -1.147 . . . . 73.1 107.902 173.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.475 ' H ' HD22 ' A' ' 68' ' ' LEU . 35.3 tt0 -131.1 65.35 76.46 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 125.539 1.536 . . . . 74.02 107.115 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.12 120.82 4.24 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.363 2.042 . . . . 71.55 111.996 -168.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -96.11 99.58 11.31 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.4 -1.333 . . . . 64.3 107.4 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.1 m -74.81 120.9 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-N 114.793 -1.094 . . . . 64.32 111.219 -172.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.537 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 39.7 ttmt -118.24 114.13 22.54 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.032 -1.099 . . . . 72.45 108.032 173.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.468 HD23 ' H ' ' A' ' 42' ' ' LEU . 2.4 pt? -114.81 131.96 56.64 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.796 -0.816 . . . . 75.23 108.796 173.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -126.37 135.07 51.0 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.33 1.052 . . . . 70.14 108.418 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -113.38 122.75 48.31 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.284 -0.636 . . . . 73.35 109.284 -175.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.626 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 16.6 t70 -119.65 124.17 45.65 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.313 1.045 . . . . 61.01 108.221 177.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.1 p -106.74 125.96 51.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.254 0.621 . . . . 64.22 110.041 -174.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.46 152.42 50.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.03 0.932 . . . . 70.23 109.514 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.9 p -131.37 165.05 24.32 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.383 0.673 . . . . 71.42 110.359 -177.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.7 t -163.51 121.33 1.89 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.805 -0.634 . . . . 63.45 109.653 175.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -82.33 120.03 24.89 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.413 -1.328 . . . . 74.55 107.413 166.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.645 HD11 ' HB2' ' A' ' 57' ' ' GLU . 24.4 mt -93.13 -40.19 10.63 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.754 -0.832 . . . . 73.44 108.754 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.86 -175.66 4.52 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.813 1.245 . . . . 72.34 109.574 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.1 123.12 20.21 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.061 -0.718 . . . . 75.22 109.061 173.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 69.88 -4.71 1.4 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.943 1.297 . . . . 54.42 112.696 -176.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.4 t -109.68 108.93 26.6 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 N-CA-C 108.05 -1.092 . . . . 62.35 108.05 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -130.07 157.63 41.84 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.352 -0.61 . . . . 73.11 109.352 -173.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.645 ' HB2' HD11 ' A' ' 51' ' ' LEU . 38.9 tt0 -130.59 135.54 47.99 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.067 0.947 . . . . 74.24 108.898 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.6 m -121.85 136.16 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 108.041 -1.096 . . . . 51.11 108.041 165.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.4 t -122.71 127.54 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.05 0.94 . . . . 60.34 109.238 -174.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 tt -117.25 107.41 14.39 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.603 -0.888 . . . . 73.24 108.603 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.626 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 10.9 ttm180 -84.88 104.39 14.79 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.284 1.034 . . . . 53.31 109.715 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 37.3 t -96.01 103.28 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 108.598 -0.89 . . . . 75.54 108.598 174.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.9 m -97.04 108.47 21.21 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.62 0.768 . . . . 73.41 109.852 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.763 HG11 HD21 ' A' ' 126' ' ' LEU . 42.1 t -103.04 139.11 24.85 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 C-N-CA 123.974 0.909 . . . . 71.15 110.588 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 25.5 m -132.14 141.05 48.99 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.898 0.879 . . . . 74.52 108.693 175.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.04 109.66 14.37 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.861 -0.792 . . . . 72.22 108.861 174.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.9 m -108.87 127.37 53.98 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.407 0.683 . . . . 75.45 109.282 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.475 HD22 ' H ' ' A' ' 37' ' ' GLN . 15.8 mt -99.7 78.37 2.14 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.874 -1.158 . . . . 74.13 107.874 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.69 -83.39 1.14 Allowed Glycine 0 C--N 1.349 1.264 0 N-CA-C 111.502 -0.639 . . . . 61.2 111.502 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -119.98 -28.96 5.05 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.737 0.815 . . . . 72.32 111.315 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.404 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 35.7 tt0 -99.95 128.79 46.0 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.633 -0.667 . . . . 71.45 110.589 -174.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.0 m -69.66 131.36 44.48 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.85 0.86 . . . . 45.2 110.902 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.862 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -74.22 -63.2 1.28 Allowed 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.514 -0.921 . . . . 73.33 108.514 168.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -155.47 163.14 40.43 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.402 -1.272 . . . . 74.23 111.322 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.2 tp -119.02 146.0 45.4 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 113.824 -1.534 . . . . 71.22 107.522 167.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.9 m -138.89 134.37 33.16 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.836 -1.172 . . . . 62.0 107.836 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -148.16 116.39 6.51 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.171 -0.678 . . . . 64.22 109.171 174.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.8 t -124.74 126.34 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 123.733 0.813 . . . . 63.02 109.051 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.414 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 64.0 mt-30 -101.48 89.05 3.6 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.227 -1.027 . . . . 73.14 108.227 172.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.42 ' HG3' HD22 ' A' ' 106' ' ' LEU . 9.3 tp-100 -76.81 98.25 4.77 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.615 -1.175 . . . . 72.03 108.48 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.51 142.95 16.36 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 111.338 -0.705 . . . . 75.52 111.338 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.428 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -140.85 126.21 3.05 Favored Glycine 0 CA--C 1.502 -0.733 0 N-CA-C 110.815 -0.914 . . . . 72.34 110.815 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.2 mt -82.47 119.01 31.18 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 108.321 -0.992 . . . . 65.23 108.321 173.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.617 ' HD2' HG12 ' A' ' 13' ' ' ILE . 24.2 m-85 -131.04 130.22 43.0 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.533 -0.914 . . . . 74.42 108.533 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 43.9 t -76.2 108.03 8.85 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.513 -0.921 . . . . 55.31 108.513 172.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.7 mt . . . . . 0 N--CA 1.481 1.095 0 C-N-CA 123.287 0.635 . . . . 73.12 110.332 -173.603 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.421 ' HA ' ' HG ' ' A' ' 98' ' ' LEU . . . . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 120.591 0.234 . . . . 62.35 111.246 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.494 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 22.3 t-80 -68.4 -35.15 77.25 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.573 0.749 . . . . 73.4 110.674 172.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.3 t -74.96 -52.11 11.99 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.244 -0.285 . . . . 74.42 110.735 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.421 ' HG ' ' HA ' ' A' ' 95' ' ' ALA . 4.6 pp -76.34 -20.6 57.08 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.353 0.501 . . . . 64.31 112.353 -175.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.46 2.99 20.24 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 114.971 0.749 . . . . 75.22 114.971 -173.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -142.24 -52.96 0.41 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 118.031 0.915 . . . . 64.23 111.946 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.52 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 79.4 t80 -78.36 -68.18 0.67 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 122.895 0.478 . . . . 50.43 111.776 -172.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.46 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 76.8 m -63.94 -34.09 11.27 Favored Pre-proline 0 CA--C 1.567 1.632 0 N-CA-C 114.534 1.309 . . . . 63.42 114.534 -173.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 22.6 Cg_endo -62.25 -33.31 81.38 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 121.834 1.689 . . . . 51.51 112.902 167.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.469 ' ND2' ' HA ' ' A' ' 132' ' ' ASN . 15.7 t-20 -80.18 -17.59 52.0 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.635 0.374 . . . . 73.55 110.921 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.7 mm -65.82 -39.38 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 108.92 -0.77 . . . . 75.04 108.92 168.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.428 HD21 ' HA3' ' A' ' 82' ' ' GLY . 91.6 mt -77.15 -19.97 56.14 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.704 0.802 . . . . 61.12 112.205 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -61.24 -49.31 88.65 Favored Pre-proline 0 CA--C 1.571 1.781 0 N-CA-C 113.954 1.094 . . . . 75.11 113.954 -172.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -63.76 -38.42 39.87 Favored 'Trans proline' 0 C--N 1.391 2.81 0 C-N-CA 122.071 1.847 . . . . 61.44 112.654 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -68.48 -35.56 77.7 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.782 -0.645 . . . . 74.51 110.876 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.88 -42.98 76.25 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.238 0.615 . . . . 72.24 110.489 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.538 ' NH1' HD12 ' C' ' 105' ' ' ILE . 37.6 ttm180 -54.6 -53.82 49.59 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 124.164 0.915 . . . . 74.24 109.936 174.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -66.68 -39.38 88.1 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.366 1.042 . . . . 75.2 111.821 -171.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.79 -42.04 92.53 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.539 0.524 . . . . 72.24 110.287 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.414 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.2 mt -67.09 -47.5 81.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 115.281 -0.872 . . . . 74.03 110.165 175.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.9 m -56.06 -41.74 75.55 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.742 0.817 . . . . 75.23 111.358 -177.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.2 t -69.6 -45.01 69.57 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.198 -0.91 . . . . 74.22 110.766 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.459 ' SD ' HG23 ' A' ' 21' ' ' ILE . 9.2 mtp -58.51 -44.62 89.53 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.636 0.774 . . . . 75.43 111.238 177.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 114' ' ' ILE . 77.8 t -64.32 -42.89 96.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 114.774 -1.103 . . . . 74.34 110.766 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.3 t -72.22 -32.87 67.14 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.855 -0.612 . . . . 73.43 111.071 -176.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.465 HH12 ' HG3' ' B' ' 112' ' ' GLU . 81.4 mtt-85 -72.57 -29.42 63.52 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.534 0.734 . . . . 62.35 109.322 175.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.454 ' O ' HG22 ' A' ' 122' ' ' THR . . . -83.38 10.0 60.03 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-N 115.307 -0.861 . . . . 74.41 113.222 173.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.5 t 64.09 12.7 7.2 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 126.928 2.091 . . . . 54.23 113.628 173.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -84.72 150.98 57.51 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 109.119 -0.697 . . . . 74.3 109.119 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.53 141.58 41.89 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.211 2.607 . . . . 62.32 112.855 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -53.93 132.31 41.83 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 124.035 0.834 . . . . 74.5 112.162 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.763 HD21 HG11 ' A' ' 64' ' ' VAL . 60.2 tp -123.79 102.43 7.81 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.781 -1.1 . . . . 73.02 110.176 -171.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -111.01 126.35 54.7 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.111 0.965 . . . . 63.02 109.145 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 129' ' ' ALA . 3.5 tt -67.55 143.52 56.08 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 108.155 -1.054 . . . . 75.01 108.155 172.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.407 ' N ' HD23 ' A' ' 128' ' ' LEU . . . -56.81 140.42 76.04 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 123.678 0.791 . . . . 71.12 111.407 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.405 ' HA ' HH22 ' A' ' 111' ' ' ARG . 37.0 Cg_endo -65.12 95.35 0.25 Allowed 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.824 2.349 . . . . 73.22 113.015 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.31 112.49 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.156 -0.929 . . . . 74.21 109.318 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.469 ' HA ' ' ND2' ' A' ' 104' ' ' ASN . 27.5 t-20 -100.97 100.27 10.86 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.556 -1.276 . . . . 74.3 107.556 170.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 . . . . . 0 N--CA 1.483 1.205 0 C-N-CA 123.613 0.765 . . . . 61.43 110.917 -175.492 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 1.6 tmt? . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 111.644 0.239 . . . . 72.15 111.644 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 92.7 m -162.34 138.48 7.6 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.334 1.053 . . . . 72.43 108.895 172.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' B' ' 85' ' ' SER . 0.2 OUTLIER -136.35 154.67 50.77 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.45 0.643 . . . . 72.04 109.598 157.283 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -127.71 140.86 51.8 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 114.687 -1.142 . . . . 74.44 108.239 169.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.57 HD11 HD13 ' B' ' 105' ' ' ILE . 46.7 mt -72.13 119.76 19.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 O-C-N 124.143 0.902 . . . . 70.3 108.739 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -88.54 -49.87 6.64 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.637 0.775 . . . . 71.02 109.302 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.417 ' HE ' HG21 ' A' ' 122' ' ' THR . 48.2 ttt180 -163.38 132.8 4.1 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.952 -0.567 . . . . 75.12 110.488 -176.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 94.6 mt -114.23 136.04 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 107.595 -1.261 . . . . 64.24 107.595 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -164.62 146.21 8.21 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.553 0.692 . . . . 75.1 112.432 -175.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 35.3 m -73.45 121.4 20.48 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.16 -1.382 . . . . 53.41 109.27 171.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.447 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 41.2 mtpt -98.32 -27.73 13.99 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.953 0.901 . . . . 65.12 111.393 -176.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 34.9 t70 -158.39 138.03 11.95 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.458 0.473 . . . . 75.4 110.531 -168.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.425 HD11 ' SG ' ' B' ' 113' ' ' CYS . 45.3 mm -142.07 143.16 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.919 1.288 . . . . 74.04 108.976 -177.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 10.2 m -144.57 128.44 17.37 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.313 1.445 . . . . 73.53 107.665 170.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.495 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.2 t80 -133.9 109.56 9.13 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.373 -1.714 . . . . 71.53 106.373 166.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -122.39 110.66 15.91 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.807 -0.812 . . . . 65.43 108.807 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.484 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -107.55 87.28 3.32 Favored Pre-proline 0 C--O 1.241 0.624 0 N-CA-C 107.575 -1.268 . . . . 74.21 107.575 174.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -64.97 -34.67 46.86 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.719 2.279 . . . . 60.21 112.216 -170.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -102.25 6.04 40.37 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 117.645 -1.169 . . . . 71.02 112.06 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.484 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -28.66 -66.71 0.12 Allowed Pre-proline 0 N--CA 1.511 2.618 0 N-CA-C 114.785 1.402 . . . . 71.23 114.785 -168.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.432 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 28.2 Cg_endo -63.53 -29.77 70.86 Favored 'Trans proline' 0 C--N 1.398 3.134 0 C-N-CA 122.098 1.865 . . . . 73.24 112.879 -172.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.437 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 63.1 m80 -86.78 -36.31 18.65 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.464 -0.789 . . . . 72.1 112.02 -176.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.667 HG22 HD12 ' B' ' 68' ' ' LEU . 8.5 p -74.77 -16.59 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 C-N-CA 122.903 0.481 . . . . 51.02 111.883 -171.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -62.22 -21.2 64.95 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.422 0.689 . . . . 70.13 112.712 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.458 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.7 pt20 -56.53 -32.0 64.67 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.491 0.716 . . . . 73.21 110.919 174.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.458 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 99.2 mttt -91.28 69.44 6.04 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.476 1.11 . . . . 72.2 109.159 177.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -83.0 89.02 6.85 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.244 0.545 . . . . 72.15 110.95 -174.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 28.2 p90 -156.06 175.44 13.96 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.211 1.004 . . . . 74.4 108.406 169.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -71.87 109.05 4.85 Favored Pre-proline 0 CA--C 1.554 1.106 0 N-CA-C 109.601 -0.518 . . . . 61.45 109.601 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.62 149.12 79.23 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.6 2.2 . . . . 70.24 113.143 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.71 106.59 1.53 Allowed 'General case' 0 C--N 1.352 0.701 0 N-CA-C 108.367 -0.975 . . . . 74.43 108.367 174.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -96.52 137.71 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-O 121.742 0.782 . . . . 70.4 111.362 -175.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.478 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 79.0 tttt -109.03 145.81 34.96 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.015 1.326 . . . . 44.53 108.139 168.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 pp -127.83 163.14 25.05 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.844 0.458 . . . . 75.52 110.21 170.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.54 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 32.2 t70 -157.14 154.79 29.92 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.606 0.762 . . . . 63.33 109.247 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -130.94 129.28 41.97 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.251 0.62 . . . . 74.33 109.595 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -124.81 155.69 38.99 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.702 -0.851 . . . . 75.01 108.702 173.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 60.4 p -120.49 133.87 55.35 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.253 0.549 . . . . 71.44 111.497 -170.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.11 161.28 40.54 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.528 1.131 . . . . 63.44 108.764 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 54.5 m -143.13 -175.71 4.63 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.653 0.381 . . . . 74.32 111.048 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.3 p -164.87 137.84 4.68 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.954 0.902 . . . . 62.22 109.58 169.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -89.03 133.25 34.41 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 120.732 0.301 . . . . 71.33 110.704 177.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 40.6 mt -102.03 -44.31 5.51 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.846 0.858 . . . . 63.23 110.457 174.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.34 -169.65 2.54 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.197 -0.91 . . . . 42.51 109.884 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.89 117.65 8.57 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.631 -1.168 . . . . 72.3 108.818 171.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 69.07 5.29 4.99 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.374 1.07 . . . . 65.44 112.486 173.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 56.0 t -112.48 106.44 20.76 Favored 'Isoleucine or valine' 0 C--O 1.246 0.887 0 N-CA-C 107.204 -1.406 . . . . 60.15 107.204 171.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -129.28 153.9 47.36 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.178 -0.675 . . . . 53.52 109.178 -176.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -116.01 122.47 45.31 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.623 -1.251 . . . . 65.21 107.623 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 43.1 t -112.39 123.63 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.667 0.787 . . . . 75.32 109.851 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 18.9 t -103.09 125.75 57.48 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 124.306 1.042 . . . . 53.44 109.978 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.629 HD23 HD12 ' B' ' 106' ' ' LEU . 3.3 mm? -107.4 110.95 23.05 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.996 -0.742 . . . . 52.31 108.996 167.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -85.39 114.25 22.3 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.699 0.8 . . . . 64.02 109.062 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.404 ' CG1' HD11 ' B' ' 114' ' ' ILE . 96.9 t -103.34 109.45 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.569 1.148 . . . . 72.04 108.547 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 87.2 m -94.45 142.19 27.72 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.392 1.077 . . . . 73.13 108.722 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.564 HG21 HG21 ' B' ' 114' ' ' ILE . 98.7 t -136.2 131.97 49.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 124.704 1.202 . . . . 73.41 108.197 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 54.3 m -126.01 148.06 49.39 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.736 -1.209 . . . . 72.34 107.736 172.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.92 143.51 27.41 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.532 -0.544 . . . . 72.34 109.532 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.517 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 23.1 p -148.82 130.2 14.73 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 123.768 0.667 . . . . 40.41 111.07 -175.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.667 HD12 HG22 ' B' ' 31' ' ' VAL . 48.3 mt -103.04 111.2 23.43 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.721 -1.215 . . . . 75.34 107.721 173.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.55 -110.75 3.11 Favored Glycine 0 C--N 1.345 1.054 0 O-C-N 123.39 0.431 . . . . 74.04 112.046 -176.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.24 5.34 9.15 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.096 0.558 . . . . 61.33 111.028 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.84 150.04 34.15 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.426 -0.583 . . . . 74.43 109.426 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 68.2 m -70.1 119.55 14.47 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 123.507 0.505 . . . . 71.01 110.348 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.634 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -70.77 -60.71 2.09 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.244 -1.021 . . . . 54.04 108.244 174.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -157.1 166.0 34.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.39 -1.277 . . . . 72.54 111.164 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 72.7 mt -125.78 137.34 53.79 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 105.791 -1.929 . . . . 74.11 105.791 170.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 44.9 t -138.71 150.64 46.38 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.245 -1.02 . . . . 73.11 108.245 173.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -160.15 131.4 5.84 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.12 -0.696 . . . . 73.45 109.12 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.405 ' HA ' HD13 ' B' ' 21' ' ' ILE . 85.4 t -124.22 149.49 28.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.007 -0.997 . . . . 75.45 108.859 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.424 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 16.7 mt-30 -120.56 97.64 5.66 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.903 -1.147 . . . . 74.42 107.903 167.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -88.54 100.61 13.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.34 -1.356 . . . . 73.25 107.34 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.447 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -97.67 147.26 18.56 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.612 -0.995 . . . . 72.21 110.612 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.44 130.15 4.14 Favored Glycine 0 CA--C 1.507 -0.417 0 N-CA-C 110.852 -0.899 . . . . 70.45 110.852 -177.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 57.4 mt -86.06 126.48 40.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.563 -0.903 . . . . 54.45 108.563 173.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -134.87 131.14 37.0 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 107.504 -1.295 . . . . 64.13 107.504 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 70.9 m -95.06 88.59 5.28 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.34 -0.615 . . . . 70.32 109.34 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 12.4 tt -107.86 129.81 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.922 0.889 . . . . 74.02 111.724 -170.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.43 163.61 33.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.78 0.832 . . . . 61.11 110.899 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.39 -70.19 0.29 Allowed Glycine 0 C--N 1.344 0.993 0 CA-C-N 115.681 -0.691 . . . . 72.32 113.336 172.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.537 HG22 ' HB3' ' B' ' 94' ' ' MET . 11.3 mt -89.65 158.23 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.046 0.938 . . . . 73.12 111.523 -175.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -154.02 158.69 40.95 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.838 1.255 . . . . 73.51 109.173 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.94 -134.79 12.34 Favored Glycine 0 C--N 1.347 1.188 0 C-N-CA 123.352 0.501 . . . . 74.01 113.733 173.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 59.4 m -70.16 -33.18 71.45 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.276 0.63 . . . . 63.14 111.423 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -66.82 -36.14 81.69 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.54 -0.755 . . . . 64.11 111.242 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.537 ' HB3' HG22 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -81.1 -22.36 39.2 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 116.307 -0.406 . . . . 53.35 110.686 176.447 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.54 -24.92 64.09 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.106 0.479 . . . . 72.43 111.168 173.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.45 ' CD2' ' HB2' ' B' ' 134' ' ' ASP . 54.9 t-80 -77.78 -30.01 51.14 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.511 0.724 . . . . 74.5 110.661 171.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.8 t -80.14 -68.39 0.68 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.748 0.819 . . . . 70.23 112.488 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.632 ' H ' HD23 ' B' ' 98' ' ' LEU . 1.9 pt? -102.5 -7.28 22.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.853 -0.529 . . . . 74.12 111.759 -174.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.02 0.75 57.54 Favored Glycine 0 C--N 1.344 1.003 0 O-C-N 123.292 0.37 . . . . 44.04 112.452 173.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' B' ' 134' ' ' ASP . . . -149.19 -60.07 0.22 Allowed 'General case' 0 C--N 1.358 0.977 0 C-N-CA 122.77 0.428 . . . . 53.01 111.98 -176.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -70.52 -36.82 73.95 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 112.233 0.457 . . . . 74.31 112.233 -175.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.538 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 70.9 m -68.76 -44.39 31.19 Favored Pre-proline 0 N--CA 1.482 1.145 0 CA-C-O 118.545 -0.74 . . . . 74.41 110.818 177.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -45.97 -40.07 20.14 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 122.536 2.157 . . . . 74.4 113.766 162.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -68.49 -33.47 74.21 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.143 0.577 . . . . 74.42 112.504 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.57 HD13 HD11 ' B' ' 13' ' ' ILE . 67.1 mt -69.26 -46.09 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.19 0.596 . . . . 52.41 109.9 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.629 HD12 HD23 ' B' ' 60' ' ' LEU . 60.1 mt -84.03 -11.44 56.75 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.677 -1.147 . . . . 73.23 110.763 -172.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.408 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 81.4 t80 -57.65 -54.47 54.87 Favored Pre-proline 0 CA--C 1.557 1.221 0 CA-C-O 117.971 -1.014 . . . . 72.24 112.993 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 36.5 Cg_exo -62.03 -35.85 74.15 Favored 'Trans proline' 0 C--N 1.39 2.745 0 C-N-CA 121.761 1.641 . . . . 55.23 113.029 -177.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -69.02 -44.69 72.23 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.854 0.462 . . . . 73.12 110.61 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.41 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -65.47 -43.66 89.59 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.903 0.481 . . . . 51.03 110.306 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -54.64 -53.13 58.76 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.523 1.129 . . . . 65.43 110.582 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.465 ' HG3' HH12 ' A' ' 120' ' ' ARG . 13.6 tp10 -62.35 -34.36 76.5 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.872 0.869 . . . . 74.33 111.05 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.524 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.9 t -71.23 -37.82 71.99 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.27 0.228 . . . . 71.22 110.862 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.564 HG21 HG21 ' B' ' 64' ' ' VAL . 84.5 mt -67.39 -56.95 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.445 0.698 . . . . 45.42 109.182 176.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 9.9 m -62.64 -24.01 67.38 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 124.288 0.992 . . . . 65.51 111.364 -173.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 39.7 t -67.19 -49.79 63.34 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 122.968 0.507 . . . . 75.54 109.913 170.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.524 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 33.9 mmt -62.02 -39.46 92.37 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 122.877 0.471 . . . . 71.3 110.644 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 114' ' ' ILE . 84.3 t -59.52 -49.5 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.585 1.154 . . . . 71.23 110.077 176.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.8 t -63.68 -37.34 86.97 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.585 -1.189 . . . . 74.11 111.156 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -69.47 -33.47 72.95 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.476 -0.784 . . . . 64.34 110.335 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.74 5.55 74.3 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.872 0.732 . . . . 54.12 112.835 173.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 17' ' ' TYR . 74.6 p 54.9 55.82 7.34 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 126.012 1.725 . . . . 64.22 111.99 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -117.76 156.98 49.18 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 124.34 1.056 . . . . 73.05 110.509 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.83 161.86 2.91 Favored 'Trans proline' 0 C--N 1.392 2.829 0 C-N-CA 123.938 3.092 . . . . 55.33 116.139 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.537 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -65.13 121.85 15.7 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 113.911 -1.495 . . . . 75.4 111.6 -178.609 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -138.63 109.55 6.74 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 108.342 -0.984 . . . . 74.33 108.342 177.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -124.49 135.1 52.93 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.935 0.894 . . . . 73.4 109.32 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 5.9 mp -87.8 139.27 30.7 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.819 0.848 . . . . 71.33 110.102 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.48 164.72 56.41 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 124.222 1.009 . . . . 65.12 111.067 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -53.88 103.79 0.1 OUTLIER 'Trans proline' 0 C--N 1.39 2.735 0 C-N-CA 122.824 2.349 . . . . 61.44 112.892 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 37.6 t -90.72 108.62 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.32 -0.993 . . . . 73.45 108.32 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.64 79.95 8.12 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.322 -0.621 . . . . 71.43 109.322 177.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -51.14 -45.36 61.62 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.516 0.726 . . . . 73.3 110.119 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . 0.45 ' HB2' ' CD2' ' B' ' 96' ' ' HIS . 7.6 p-10 . . . . . 0 C--O 1.222 -0.348 0 CA-C-N 113.444 -1.707 . . . . 71.43 112.531 -176.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.584 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.8 t80 . . . . . 0 C--O 1.236 0.362 0 CA-C-O 120.852 0.358 . . . . 73.42 110.565 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -145.53 124.88 13.04 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.095 -1.076 . . . . 71.42 108.095 171.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 51.6 mt -73.95 102.08 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 107.774 -1.195 . . . . 74.55 107.774 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -75.59 -50.92 14.12 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.582 -0.735 . . . . 73.24 110.616 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -167.3 123.88 1.16 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 110.294 -0.261 . . . . 63.33 110.294 -176.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 63.0 mt -108.76 144.46 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 108.002 -1.11 . . . . 64.34 108.002 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.47 ' HB3' HG23 ' D' ' 122' ' ' THR . 21.8 p90 -176.36 172.38 2.27 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.383 0.673 . . . . 64.55 110.11 -174.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.9 p -98.02 122.42 41.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.742 -0.663 . . . . 70.33 109.363 175.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.432 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 18.3 mmtp -70.04 -46.77 64.34 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 107.765 -1.198 . . . . 72.44 107.765 168.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 17.5 t70 -134.51 141.18 46.64 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 113.438 -1.71 . . . . 41.14 109.743 -171.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 87.5 mt -135.81 146.13 30.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 106.082 -1.822 . . . . 71.22 106.082 169.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' C' ' 77' ' ' GLU . 35.8 t -160.79 151.18 18.01 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.535 0.683 . . . . 74.53 109.859 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 86.9 t80 -144.62 136.43 25.82 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.529 -1.656 . . . . 72.03 106.529 169.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -134.24 129.29 35.46 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.2 -0.667 . . . . 74.52 109.2 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.51 81.01 11.44 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 106.858 -1.534 . . . . 65.32 106.858 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -69.53 -21.54 34.41 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.955 2.437 . . . . 62.25 112.423 -174.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -118.51 25.91 9.95 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.479 1.111 . . . . 63.41 110.147 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.73 -52.9 22.36 Favored Pre-proline 0 CA--C 1.56 1.361 0 CA-C-O 117.818 -1.087 . . . . 71.31 113.683 -173.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.72 -43.76 47.11 Favored 'Trans proline' 0 C--N 1.399 3.212 0 C-N-CA 121.834 1.689 . . . . 72.41 112.434 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.45 ' O ' ' HG3' ' C' ' 33' ' ' GLN . 86.6 t60 -69.45 -43.68 72.78 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.275 -0.875 . . . . 75.23 112.441 -175.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.728 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.2 p -69.82 -18.45 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.324 0 N-CA-C 113.43 0.9 . . . . 75.13 113.43 -174.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -70.19 -20.71 63.1 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 113.099 0.777 . . . . 75.1 113.099 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' C' ' 30' ' ' HIS . 4.9 pp0? -92.67 8.91 37.13 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 111.992 0.367 . . . . 61.22 111.992 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.68 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -91.89 156.59 17.37 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.143 0.577 . . . . 73.44 110.685 179.204 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.35 125.14 22.89 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.171 0.988 . . . . 65.2 109.452 164.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -81.12 88.67 5.98 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.252 0.548 . . . . 60.14 110.49 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -140.28 77.91 23.84 Favored Pre-proline 0 C--O 1.243 0.738 0 N-CA-C 108.234 -1.025 . . . . 61.53 108.234 171.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -84.12 129.84 4.65 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.294 1.996 . . . . 74.11 111.551 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.75 96.49 8.19 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 104.689 -2.338 . . . . 73.32 104.689 166.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 20.8 m -88.8 121.31 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 114.643 -1.162 . . . . 71.22 111.595 -168.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.439 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 35.8 ttpt -97.26 106.48 18.82 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.832 -0.803 . . . . 74.22 108.832 174.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -87.42 121.68 30.17 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.536 -1.283 . . . . 70.52 107.536 175.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -118.5 140.07 50.45 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.086 1.354 . . . . 61.13 108.397 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.604 HD23 HD11 ' C' ' 60' ' ' LEU . 0.0 OUTLIER -137.49 132.53 33.42 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.562 0.345 . . . . 74.23 110.125 172.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.579 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 15.1 t70 -113.2 148.3 35.73 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.905 0.882 . . . . 74.33 108.906 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 77.0 p -112.76 112.46 23.98 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.449 0.7 . . . . 71.23 109.33 -174.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.2 139.01 48.18 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.568 0.747 . . . . 73.42 109.34 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 55.6 m -157.8 155.62 30.09 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.32 0.648 . . . . 64.41 110.846 -175.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 47.2 t -160.93 130.65 4.92 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.526 -0.761 . . . . 71.44 109.842 -174.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -76.54 122.02 24.0 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.811 -0.44 . . . . 75.32 109.811 174.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.657 HD11 HD12 ' C' ' 83' ' ' ILE . 66.7 mt -86.45 -52.66 5.45 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.539 -0.755 . . . . 74.14 110.119 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.51 -172.04 3.99 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.05 0.54 . . . . 54.11 111.723 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -56.93 103.46 0.11 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.075 1.35 . . . . 61.22 110.875 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 69.51 -1.96 2.07 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 125.907 1.683 . . . . 73.14 113.054 -177.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 75.7 t -93.35 113.7 28.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 108.33 -0.989 . . . . 74.21 108.33 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . 0.571 ' HB3' HD13 ' C' ' 86' ' ' ILE . 50.6 t80 -131.28 126.1 34.52 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.44 -0.8 . . . . 74.03 109.199 -171.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -85.72 124.91 32.76 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.177 0.991 . . . . 63.5 110.223 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 62.9 t -111.94 115.87 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 107.958 -1.127 . . . . 72.11 107.958 171.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.9 t -113.63 129.55 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.493 0.717 . . . . 62.51 109.32 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.604 HD11 HD23 ' C' ' 44' ' ' LEU . 40.9 tp -116.42 113.34 22.73 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.804 -0.814 . . . . 72.43 108.804 173.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.579 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 22.4 ttt180 -81.49 105.74 12.89 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 108.381 -0.97 . . . . 74.31 108.381 176.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 37.3 t -99.0 119.28 46.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 107.7 -1.222 . . . . 70.4 107.7 176.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 60.5 m -130.67 119.74 22.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.757 -0.831 . . . . 61.44 108.757 -174.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.793 HG23 HD13 ' C' ' 114' ' ' ILE . 97.6 t -100.17 114.66 39.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.348 -0.982 . . . . 74.53 108.348 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.504 HG23 HD23 ' C' ' 75' ' ' LEU . 5.2 m -97.69 135.78 38.99 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.104 -1.443 . . . . 64.51 107.104 171.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.12 114.82 16.2 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.308 -1.368 . . . . 74.03 107.308 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 20.1 m -136.15 126.61 26.82 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.113 -0.699 . . . . 75.25 109.113 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.68 HD13 ' HG2' ' C' ' 34' ' ' LYS . 14.2 mt -85.59 13.97 6.28 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.694 1.198 . . . . 71.15 111.588 -176.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.0 -98.77 0.4 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 110.103 -1.199 . . . . 65.23 110.103 -175.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -90.81 -32.85 15.93 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.299 0.64 . . . . 72.25 109.365 171.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -71.8 120.21 17.06 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 114.641 -1.163 . . . . 73.11 109.666 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 62.8 m -76.18 126.13 30.43 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.562 -0.903 . . . . 72.14 108.562 167.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.728 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.87 -58.27 3.39 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.163 -1.051 . . . . 74.25 108.163 170.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -166.22 176.59 7.47 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.623 0.725 . . . . 43.55 111.941 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.504 HD23 HG23 ' C' ' 65' ' ' THR . 2.6 tm? -141.71 104.82 4.6 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 106.983 -1.488 . . . . 73.15 106.983 173.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.522 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.7 t -109.45 125.76 52.78 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.216 0.606 . . . . 75.04 109.378 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . 0.418 ' HB3' ' HB3' ' C' ' 22' ' ' SER . 40.7 tt0 -124.48 139.73 53.62 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.494 0.718 . . . . 73.4 109.527 -177.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.401 HG11 ' HA ' ' C' ' 110' ' ' ALA . 27.4 t -144.08 114.08 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 108.147 -1.057 . . . . 63.14 108.147 174.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 77.9 mt-30 -90.69 97.5 11.22 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.545 -0.909 . . . . 72.14 108.545 171.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.607 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.0 tp-100 -82.03 105.23 12.96 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.616 -0.513 . . . . 73.24 109.616 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.49 144.73 21.61 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 111.386 -0.686 . . . . 32.34 111.386 175.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.29 116.46 0.84 Allowed Glycine 0 CA--C 1.503 -0.675 0 N-CA-C 110.376 -1.09 . . . . 74.24 110.376 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.657 HD12 HD11 ' C' ' 51' ' ' LEU . 14.6 mm -85.24 118.22 31.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 107.81 -1.182 . . . . 64.3 107.81 177.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.584 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 46.7 m-85 -132.2 142.88 49.59 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.637 0.775 . . . . 75.04 108.975 -174.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -84.54 116.74 23.29 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.671 0.388 . . . . 72.21 109.988 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.571 HD13 ' HB3' ' C' ' 56' ' ' TYR . 3.4 mp -115.09 109.07 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 108.406 -0.961 . . . . 71.02 108.406 172.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.01 161.99 39.69 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.66 1.184 . . . . 73.15 108.916 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.21 -51.14 3.96 Favored Glycine 0 N--CA 1.472 1.064 0 O-C-N 123.136 0.272 . . . . 63.42 112.796 175.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 30.6 pt -91.87 158.22 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.826 0.85 . . . . 73.22 111.48 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -152.12 162.01 41.75 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.112 0.965 . . . . 70.14 109.589 173.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.67 -117.55 5.8 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.024 -0.535 . . . . 75.21 112.814 172.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 57.3 p -65.1 -37.51 87.73 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.048 0.939 . . . . 74.52 111.497 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -71.8 -42.79 66.63 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.287 0.635 . . . . 63.12 111.6 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.417 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 9.1 ptp -73.09 -33.33 65.54 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 120.99 -0.284 . . . . 72.23 110.574 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.33 -28.64 69.45 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.004 0.522 . . . . 55.23 110.706 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -70.36 -44.74 67.48 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.449 -0.796 . . . . 74.14 110.206 172.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.586 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 42.3 t -65.54 -40.74 93.24 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 123.292 0.37 . . . . 63.22 110.512 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' C' ' 94' ' ' MET . 86.9 mt -77.27 -49.9 14.03 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.22 0.608 . . . . 72.14 111.781 -175.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.96 12.38 64.03 Favored Glycine 0 N--CA 1.474 1.228 0 N-CA-C 114.898 0.719 . . . . 71.11 114.898 -166.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.684 ' HB1' ' HB2' ' C' ' 134' ' ' ASP . . . -154.67 -62.54 0.13 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 117.624 0.712 . . . . 72.13 110.974 -172.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.586 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 73.9 t80 -76.14 -39.57 54.73 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.139 1.376 . . . . 73.42 113.105 -167.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 96.7 m -77.44 -39.84 2.09 Favored Pre-proline 0 N--CA 1.486 1.328 0 CA-C-O 118.687 -0.673 . . . . 71.02 111.716 176.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -48.5 -35.15 27.99 Favored 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 122.741 2.294 . . . . 64.53 113.683 164.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -38.51 91.2 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.762 0.425 . . . . 71.35 111.022 175.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.538 HD12 ' NH1' ' A' ' 111' ' ' ARG . 33.4 mm -66.99 -46.36 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 109.795 -0.446 . . . . 72.42 109.795 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.13 -20.97 29.48 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 113.547 0.943 . . . . 72.34 113.547 -168.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -58.7 -52.74 72.56 Favored Pre-proline 0 N--CA 1.488 1.449 0 CA-C-O 117.951 -1.023 . . . . 72.44 113.126 -175.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.14 -32.23 83.11 Favored 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 121.647 1.565 . . . . 64.5 113.0 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -64.91 -53.78 41.09 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.253 0.621 . . . . 63.42 110.377 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.607 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -65.96 -33.43 75.79 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.03 -0.986 . . . . 73.15 111.179 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -60.14 -53.85 52.82 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.394 1.078 . . . . 75.0 110.243 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.28 -35.85 78.48 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 110.016 -0.364 . . . . 73.13 110.016 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.417 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 10.2 t -67.06 -27.92 67.78 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.148 0.579 . . . . 61.2 111.323 -178.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.793 HD13 HG23 ' C' ' 64' ' ' VAL . 83.0 mt -76.58 -55.65 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 115.882 -0.599 . . . . 71.4 109.973 171.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 17.1 m -61.15 -27.81 68.66 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 123.389 0.676 . . . . 73.23 111.502 -173.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.4 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 41.4 t -62.42 -52.77 62.23 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 124.457 1.103 . . . . 65.44 109.093 170.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.583 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.15 -34.74 75.5 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.46 1.104 . . . . 71.34 112.381 178.352 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 88.8 t -63.38 -44.31 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 109.209 -0.663 . . . . 73.44 109.209 174.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 22.8 t -74.68 -24.04 58.73 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.988 -1.006 . . . . 74.33 111.71 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' C' ' 116' ' ' SER . 87.5 mtt-85 -74.02 -40.7 62.71 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.876 -0.787 . . . . 75.45 108.876 174.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.69 -4.35 70.42 Favored Glycine 0 C--N 1.357 1.719 0 O-C-N 123.951 0.782 . . . . 61.35 112.431 171.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 29.3 p 65.26 28.44 11.97 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.679 1.992 . . . . 73.35 112.934 170.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -83.33 145.96 49.73 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 123.364 0.666 . . . . 74.34 109.323 172.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.81 146.03 29.61 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.137 2.558 . . . . 61.11 113.139 176.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -52.62 111.1 0.59 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.396 1.078 . . . . 74.52 112.254 -172.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 47.3 tp -114.21 88.95 2.97 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.079 -1.452 . . . . 53.34 107.079 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -97.83 126.1 43.02 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.337 -0.847 . . . . 74.44 109.062 -171.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.05 126.48 31.12 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 122.888 0.475 . . . . 65.55 110.218 -172.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.11 152.81 95.66 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 124.29 1.036 . . . . 64.21 111.347 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.567 ' HG3' HD12 ' A' ' 16' ' ' ILE . 38.4 Cg_exo -57.65 117.61 4.34 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.773 2.315 . . . . 62.23 113.104 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -104.06 109.52 27.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 122.397 1.094 . . . . 75.13 108.534 169.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -101.32 76.46 1.71 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.933 -1.031 . . . . 72.45 108.566 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -51.11 -45.78 61.67 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.271 0.628 . . . . 65.34 112.311 -173.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . 0.684 ' HB2' ' HB1' ' C' ' 100' ' ' ALA . 18.4 t0 . . . . . 0 N--CA 1.482 1.155 0 O-C-N 124.01 0.818 . . . . 64.41 110.958 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 109.41 -0.589 . . . . 75.11 109.41 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.442 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 55.1 t80 -158.09 100.82 1.73 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.791 -1.188 . . . . 73.34 107.791 -175.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -127.65 116.76 20.79 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.47 -0.937 . . . . 75.3 108.47 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.558 HD13 HG21 ' D' ' 105' ' ' ILE . 7.4 mt -81.8 124.03 38.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.693 -0.484 . . . . 72.22 109.693 -177.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -90.8 -39.24 12.48 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.649 0.78 . . . . 73.22 111.478 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -174.97 123.9 0.25 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 117.805 0.275 . . . . 40.05 111.665 -166.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -103.97 137.1 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 107.986 -1.116 . . . . 73.42 107.986 167.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -160.8 148.57 15.85 Favored 'General case' 0 C--O 1.239 0.533 0 O-C-N 124.142 0.902 . . . . 70.4 109.883 177.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 77.8 p -79.61 114.05 18.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.136 -0.938 . . . . 75.32 108.979 174.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -82.4 -28.59 31.33 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.935 -0.575 . . . . 73.53 110.439 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.53 ' HB3' HE21 ' D' ' 79' ' ' GLN . 30.2 t70 -156.61 140.12 15.86 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.855 -1.066 . . . . 65.3 108.24 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.583 HG21 ' HE2' ' C' ' 117' ' ' MET . 84.6 mt -139.16 150.3 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.203 1.001 . . . . 72.34 108.374 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . 0.454 ' HB2' ' HB3' ' D' ' 77' ' ' GLU . 71.7 m -147.62 140.57 24.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.689 1.196 . . . . 55.33 109.318 172.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.514 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 83.7 t80 -141.23 123.49 15.68 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 105.233 -2.136 . . . . 70.42 105.233 165.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.6 mt-10 -139.7 108.62 6.0 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.187 -0.672 . . . . 74.33 109.187 -170.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.36 94.17 9.35 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 108.422 -0.955 . . . . 33.14 108.422 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.86 -44.36 2.84 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.696 2.264 . . . . 72.51 112.607 -170.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.482 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 36.0 m-20 -96.5 11.75 33.94 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.849 0.86 . . . . 72.21 111.057 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.416 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -23.88 -68.38 0.05 OUTLIER Pre-proline 0 CA--C 1.56 1.346 0 N-CA-C 116.941 2.2 . . . . 70.2 116.941 -160.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.403 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 97.2 Cg_endo -74.21 -27.23 11.82 Favored 'Trans proline' 0 C--N 1.382 2.307 0 CA-C-N 123.334 2.226 . . . . 43.03 113.509 -176.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -66.35 -45.55 79.81 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.758 0.823 . . . . 73.23 110.376 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.644 HG21 ' HA ' ' D' ' 73' ' ' ALA . 11.7 p -76.41 -15.39 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 CA-C-N 115.355 -0.839 . . . . 60.31 112.125 -171.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.403 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 21.4 m-85 -69.11 -17.99 63.91 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 112.544 0.572 . . . . 72.22 112.544 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -61.46 -20.95 63.71 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.128 0.571 . . . . 75.2 110.982 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -99.69 90.73 4.57 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.857 1.263 . . . . 72.42 109.477 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -96.93 93.08 6.42 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.874 -0.603 . . . . 63.15 109.485 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.448 ' O ' ' HG2' ' D' ' 124' ' ' PRO . 33.1 p90 -160.88 175.86 12.07 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.61 1.164 . . . . 74.33 107.866 167.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -69.62 112.0 10.73 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 122.938 0.495 . . . . 74.21 109.687 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.92 134.55 60.91 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.15 2.567 . . . . 70.41 111.541 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.11 114.27 10.03 Favored 'General case' 0 C--N 1.348 0.524 0 N-CA-C 108.235 -1.024 . . . . 71.04 108.235 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 16.1 m -103.65 108.56 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-O 122.119 0.961 . . . . 60.31 110.997 -166.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.502 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 73.7 mmtt -87.93 128.37 35.37 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.743 -1.117 . . . . 71.34 108.337 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.51 ' H ' HD23 ' D' ' 42' ' ' LEU . 1.0 OUTLIER -96.3 118.89 33.77 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.711 0.767 . . . . 72.15 110.03 -174.393 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.712 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.9 m-20 -110.33 125.69 53.44 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.539 -1.282 . . . . 73.53 107.539 174.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 93.3 mt -122.79 130.77 53.3 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.112 0.565 . . . . 74.25 109.692 -175.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.588 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 11.4 t70 -131.73 146.5 52.2 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.154 0.982 . . . . 74.12 108.368 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 42.8 p -119.67 143.73 47.57 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.507 0.723 . . . . 74.11 110.622 -171.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.75 155.68 33.52 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.331 0.653 . . . . 72.11 109.793 175.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 17.7 p -150.2 160.22 43.85 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.901 0.48 . . . . 52.34 110.576 -175.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 2.9 m -152.07 119.65 6.06 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.92 -0.77 . . . . 63.44 108.92 175.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -66.95 116.51 7.87 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.737 -1.209 . . . . 51.14 107.737 163.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.475 HD12 HG23 ' D' ' 83' ' ' ILE . 29.8 mt -95.04 -35.12 12.07 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.296 -0.631 . . . . 42.3 109.296 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.56 -173.12 4.24 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.217 -0.901 . . . . 70.5 110.208 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -68.33 123.57 21.12 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.875 -1.057 . . . . 73.53 110.225 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 65.1 m-20 62.25 17.75 9.57 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.699 1.2 . . . . 71.41 112.194 -175.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.6 t -119.44 119.67 61.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.813 -0.81 . . . . 61.45 108.813 174.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.543 ' HD2' ' HB ' ' D' ' 86' ' ' ILE . 78.3 m-85 -134.52 129.06 34.53 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.521 -0.918 . . . . 74.12 108.521 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -92.98 127.53 38.53 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.97 0.908 . . . . 74.44 109.335 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.4 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 73.8 t -103.54 112.44 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.856 -1.165 . . . . 62.53 107.856 173.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.421 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 47.5 t -103.68 132.2 50.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 108.094 -1.076 . . . . 64.34 108.094 174.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 53.6 tp -128.54 121.78 29.58 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.722 0.296 . . . . 75.11 110.208 175.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.588 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 20.6 ttm-85 -84.82 98.72 10.45 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.056 0.942 . . . . 74.44 109.404 173.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 93.6 t -90.79 114.49 28.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.31 -0.996 . . . . 45.01 108.31 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.712 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 28.6 m -122.65 133.33 54.52 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.45 0.643 . . . . 72.03 109.666 -174.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 t -119.63 101.87 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.863 1.665 . . . . 72.41 108.787 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.502 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 59.1 m -92.4 99.79 12.48 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.271 -0.877 . . . . 54.15 108.801 175.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.31 142.21 36.36 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.135 -0.939 . . . . 71.33 109.7 -169.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 70.1 m -142.93 137.45 29.46 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.222 0.534 . . . . 53.13 111.673 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.53 HD12 HG22 ' D' ' 31' ' ' VAL . 55.8 mt -105.53 104.59 14.34 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.629 1.172 . . . . 61.42 108.536 172.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.22 -123.94 6.35 Favored Glycine 0 C--N 1.342 0.896 0 CA-C-N 115.797 -0.638 . . . . 74.52 112.514 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.61 5.87 34.06 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.168 0.587 . . . . 73.55 111.081 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -120.49 157.01 30.31 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.327 0.651 . . . . 74.45 109.81 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 63.7 m -71.34 136.45 47.84 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.628 0.58 . . . . 71.53 110.731 178.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.644 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -84.45 -64.08 1.22 Allowed 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.329 -0.989 . . . . 61.25 108.329 174.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -157.09 167.5 30.24 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.685 -1.143 . . . . 72.41 110.162 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.484 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 83.3 mt -126.42 110.92 13.86 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 106.435 -1.691 . . . . 73.41 106.435 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.56 ' SG ' HG12 ' D' ' 114' ' ' ILE . 42.4 t -114.26 138.1 50.93 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.575 -1.269 . . . . 71.42 107.575 -178.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . 0.454 ' HB3' ' HB2' ' D' ' 22' ' ' SER . 43.6 tt0 -155.36 122.58 5.51 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 110.033 -0.358 . . . . 74.22 110.033 -175.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 50.8 t -129.73 114.69 31.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 123.24 0.616 . . . . 75.31 109.368 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.53 HE21 ' HB3' ' D' ' 20' ' ' ASP . 5.0 mt-30 -86.51 83.65 7.59 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.096 -1.075 . . . . 65.32 108.096 168.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -79.88 98.21 7.02 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 113.346 -1.752 . . . . 74.33 108.145 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -93.71 144.12 16.91 Favored Glycine 0 C--N 1.341 0.85 0 N-CA-C 111.4 -0.68 . . . . 74.12 111.4 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.6 131.33 5.45 Favored Glycine 0 C--N 1.331 0.259 0 N-CA-C 111.162 -0.775 . . . . 73.53 111.162 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.475 HG23 HD12 ' D' ' 51' ' ' LEU . 61.3 mt -88.04 120.23 36.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 107.923 -1.14 . . . . 65.24 107.923 175.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.4 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 61.7 m-85 -128.54 126.22 39.93 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.676 0.791 . . . . 71.41 108.97 -175.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.1 m -79.37 99.53 7.19 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.599 -0.889 . . . . 75.44 108.599 172.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.543 ' HB ' ' HD2' ' D' ' 56' ' ' TYR . 17.9 mm -108.98 111.58 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.705 0.802 . . . . 73.33 109.571 -174.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.518 ' HB2' ' HB3' ' D' ' 54' ' ' ASP . . . -138.04 147.72 44.39 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.955 0.502 . . . . 73.32 110.705 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.56 10.34 84.68 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 114.724 0.65 . . . . 71.11 114.724 171.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.522 HD12 HG23 ' D' ' 86' ' ' ILE . 8.9 mt -106.46 128.02 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 117.433 0.617 . . . . 54.43 109.744 -175.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -148.51 159.69 43.81 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.562 1.145 . . . . 72.53 109.957 -169.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' D' ' 94' ' ' MET . . . 68.1 -132.24 28.23 Favored Glycine 0 C--N 1.349 1.292 0 O-C-N 124.08 0.863 . . . . 52.54 113.428 173.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 18.7 m -61.75 -37.38 84.05 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.654 0.782 . . . . 71.31 111.098 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -65.77 -34.11 77.41 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.033 -0.985 . . . . 65.32 110.701 -174.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' D' ' 91' ' ' GLY . 10.6 ptm -75.21 -36.0 61.43 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.168 0.587 . . . . 74.42 111.424 -174.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.65 -31.37 63.46 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.484 -0.78 . . . . 63.31 110.362 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -80.0 -31.73 39.69 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.372 -0.831 . . . . 73.5 111.076 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.0 t -69.59 -53.16 20.19 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.664 0.386 . . . . 54.4 110.702 -175.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 10.3 mp -86.82 -22.61 25.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.414 0.286 . . . . 73.34 111.198 -178.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.29 -24.82 56.29 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-O 119.729 -0.484 . . . . 72.5 113.904 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.17 -50.97 0.65 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.494 0.553 . . . . 62.11 112.494 -171.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -73.86 -43.73 57.69 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.834 0.679 . . . . 73.44 112.834 -169.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.442 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 69.0 m -72.76 -44.2 8.81 Favored Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 123.462 0.705 . . . . 73.41 111.822 -176.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.32 -25.14 64.34 Favored 'Trans proline' 0 C--N 1.395 3.017 0 C-N-CA 121.76 1.64 . . . . 71.42 112.681 170.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . 0.516 ' HA ' ' HD2' ' D' ' 107' ' ' PHE . 45.7 t-20 -62.43 -39.89 94.77 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.424 0.689 . . . . 71.23 110.094 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.558 HG21 HD13 ' D' ' 13' ' ' ILE . 48.6 mm -58.85 -38.41 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.62 0.768 . . . . 63.02 110.564 174.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 86.4 mt -83.14 -19.73 36.11 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.114 -0.948 . . . . 63.53 112.442 -170.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . 0.516 ' HD2' ' HA ' ' D' ' 104' ' ' ASN . 27.5 m-85 -63.05 -43.79 82.82 Favored Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 114.086 1.143 . . . . 62.51 114.086 -177.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -52.18 -46.14 34.62 Favored 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 122.328 2.019 . . . . 74.55 113.393 172.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -72.86 -36.44 67.42 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.456 -0.793 . . . . 74.23 111.686 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.14 78.67 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.589 0.555 . . . . 71.12 109.639 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -55.58 -50.21 70.69 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 124.953 1.408 . . . . 74.31 110.634 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -65.01 -46.67 80.44 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.728 0.642 . . . . 73.5 111.608 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -57.7 -41.8 82.44 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.578 0.549 . . . . 61.13 110.53 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.56 HG12 ' SG ' ' D' ' 76' ' ' CYS . 81.5 mt -60.93 -56.78 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 115.046 -0.979 . . . . 64.13 110.478 172.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 47.6 m -54.4 -40.77 68.53 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.677 1.191 . . . . 71.45 111.753 -172.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 32.3 t -67.09 -45.32 77.6 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.034 -0.985 . . . . 70.25 110.567 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.8 mtm -67.31 -34.5 77.51 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.852 0.461 . . . . 64.35 111.734 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' D' ' 114' ' ' ILE . 77.3 t -62.08 -45.01 99.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.586 0.754 . . . . 45.13 109.903 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.5 p -75.71 -26.58 57.66 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.901 -0.59 . . . . 73.54 111.401 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.417 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 84.3 mtt-85 -72.46 -31.22 65.25 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.374 0.669 . . . . 74.44 110.132 175.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.49 10.75 68.25 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 123.739 0.65 . . . . 34.54 112.139 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.47 HG23 ' HB3' ' C' ' 17' ' ' TYR . 24.3 p 58.63 22.3 9.7 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 126.877 2.071 . . . . 74.11 114.09 174.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -83.96 157.22 63.48 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.846 0.858 . . . . 70.01 110.04 171.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.448 ' HG2' ' O ' ' D' ' 36' ' ' TRP . 77.9 Cg_exo -54.96 134.0 61.12 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.347 2.698 . . . . 64.24 113.835 176.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -55.95 132.1 48.93 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.801 1.241 . . . . 73.53 112.071 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 61.4 tp -110.27 101.88 10.59 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.571 0.748 . . . . 65.14 110.09 -177.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -103.89 104.02 13.96 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.582 -0.896 . . . . 72.41 108.582 175.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 tt -70.9 125.68 27.5 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 108.483 -0.932 . . . . 73.43 108.483 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.91 157.07 81.76 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.173 0.989 . . . . 52.23 112.09 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.508 ' HD3' HG13 ' B' ' 13' ' ' ILE . 54.3 Cg_exo -56.52 103.52 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.046 2.498 . . . . 73.15 112.785 174.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 124.052 0.941 . . . . 64.34 109.84 -179.428 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.51 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 24.6 t80 . . . . . 0 C--O 1.236 0.389 0 N-CA-C 108.433 -0.951 . . . . 72.3 108.433 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -155.14 102.11 2.28 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.193 -0.669 . . . . 74.41 109.193 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.699 HG12 ' HD2' ' A' ' 84' ' ' PHE . 27.5 mt -72.52 120.39 20.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 109.134 -0.691 . . . . 43.35 109.134 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -85.58 -40.87 15.8 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 123.741 0.651 . . . . 71.54 110.001 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.433 ' HB3' HD12 ' A' ' 83' ' ' ILE . 19.9 ttt180 -173.44 120.89 0.34 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.387 -0.37 . . . . 65.05 110.402 -166.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.551 HD12 ' HG3' ' C' ' 130' ' ' PRO . 62.9 mt -114.0 134.47 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 108.78 -0.822 . . . . 72.42 108.78 173.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.522 ' HB3' HG23 ' B' ' 122' ' ' THR . 31.0 p90 -166.32 165.74 17.1 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 124.216 0.947 . . . . 74.32 110.848 -173.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.7 p -89.13 116.94 27.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.978 -1.01 . . . . 75.24 109.088 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.405 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.3 mtpt -85.58 -32.56 22.04 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.939 0.4 . . . . 71.32 109.996 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.663 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 9.9 t70 -142.85 136.41 28.7 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.018 -0.992 . . . . 51.0 109.289 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.0 mt -137.3 146.54 27.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 107.393 -1.336 . . . . 52.15 107.393 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.9 t -155.44 131.7 10.24 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.235 0.614 . . . . 74.5 109.829 172.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.541 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.3 t80 -130.44 141.84 50.52 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.181 -1.414 . . . . 74.12 107.181 171.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -139.48 139.99 37.14 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.021 0.929 . . . . 74.01 108.506 175.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.451 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -124.09 82.81 56.28 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 106.256 -1.757 . . . . 41.43 106.256 171.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.54 -42.01 29.14 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 123.058 2.505 . . . . 74.45 112.706 -166.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -111.41 25.14 12.0 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 118.13 -0.938 . . . . 72.54 109.654 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.493 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -37.03 -62.8 0.52 Allowed Pre-proline 0 N--CA 1.497 1.924 0 C-N-CA 124.433 1.093 . . . . 54.3 113.915 -166.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 12.7 Cg_exo -67.87 -24.53 39.98 Favored 'Trans proline' 0 C--N 1.394 2.935 0 C-N-CA 122.175 1.917 . . . . 62.52 112.712 -173.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -78.03 -47.21 18.93 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.88 0.872 . . . . 74.21 109.784 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.685 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.2 p -79.8 -12.15 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-N 114.645 -1.162 . . . . 63.35 112.654 -163.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -66.81 -27.39 67.52 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.047 0.451 . . . . 71.22 110.623 171.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -78.33 -18.04 55.72 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.284 1.034 . . . . 45.24 111.276 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -80.06 151.08 30.1 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.642 0.777 . . . . 73.22 111.01 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.05 138.82 58.64 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.268 -0.878 . . . . 74.43 110.142 174.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -79.88 83.65 5.77 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.395 0.617 . . . . 72.14 109.837 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -131.62 73.74 78.9 Favored Pre-proline 0 C--O 1.244 0.801 0 N-CA-C 108.039 -1.097 . . . . 72.43 108.039 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -84.4 159.26 12.83 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.269 1.979 . . . . 61.55 111.87 -176.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -111.16 106.4 15.41 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.375 -1.713 . . . . 74.15 106.375 166.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.7 t -66.48 92.25 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 108.557 -0.905 . . . . 65.01 108.557 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -100.32 112.49 24.83 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.612 -1.625 . . . . 71.14 106.612 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.05 150.53 52.13 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.326 0.584 . . . . 55.21 112.318 -174.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -136.06 113.08 10.39 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.483 -1.235 . . . . 45.41 108.262 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 mp -98.08 124.18 42.48 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 108.697 -0.853 . . . . 71.54 108.697 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.59 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 11.3 t70 -121.76 149.47 43.24 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.778 1.231 . . . . 74.14 109.953 -171.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.4 m -110.54 132.83 53.85 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.926 0.89 . . . . 72.03 109.917 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.664 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -134.52 151.96 51.47 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.723 1.209 . . . . 71.02 108.46 174.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 p -135.55 173.29 11.88 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.911 0.708 . . . . 53.13 112.911 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 37.7 t -168.58 143.9 3.47 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.456 1.502 . . . . 74.22 108.218 174.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -113.23 109.15 18.29 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.176 -1.046 . . . . 74.41 108.176 170.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 53.5 mt -80.81 -39.1 27.24 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.069 -0.514 . . . . 72.45 110.735 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -155.48 -175.92 5.68 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.431 0.693 . . . . 51.32 110.636 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.65 119.74 12.26 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.984 -0.747 . . . . 73.41 108.984 172.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 71.2 -1.68 2.64 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.723 1.209 . . . . 73.25 112.545 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 48.7 t -107.36 114.17 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.463 -0.94 . . . . 60.53 108.463 177.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -122.3 159.61 27.04 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.58 0.752 . . . . 75.43 109.286 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 12.6 tt0 -130.29 124.84 33.31 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.384 -1.339 . . . . 65.1 107.384 170.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.6 m -119.91 138.22 51.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.486 -0.931 . . . . 70.33 108.486 174.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.664 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 59.5 t -118.83 136.97 54.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.488 1.115 . . . . 61.22 109.117 -175.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tt -114.59 106.81 14.69 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.623 -1.251 . . . . 63.22 107.623 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.713 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 36.9 ttp180 -87.22 102.07 14.12 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.563 -0.532 . . . . 73.32 109.563 176.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.71 107.24 19.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 107.864 -1.162 . . . . 70.2 107.864 172.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.4 m -94.62 143.22 26.61 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 107.789 -1.189 . . . . 65.32 107.789 173.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.9 t -141.07 138.97 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.138 1.375 . . . . 73.41 108.405 -173.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.2 m -138.65 138.92 38.27 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.859 -0.793 . . . . 75.31 108.859 175.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.01 104.5 14.19 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 107.143 -1.429 . . . . 63.42 107.143 169.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -108.91 127.8 54.37 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.762 -0.459 . . . . 75.51 109.762 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.3 mt -99.06 75.8 2.06 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 106.86 -1.533 . . . . 63.43 106.86 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.95 -83.43 1.17 Allowed Glycine 0 C--N 1.346 1.105 0 N-CA-C 111.942 -0.463 . . . . 72.31 111.942 -175.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -119.03 -29.97 5.13 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.019 0.528 . . . . 70.33 110.883 175.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -88.68 113.68 24.51 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.107 0.563 . . . . 74.43 109.83 -173.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.3 m -73.37 133.23 43.74 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-O 121.06 0.457 . . . . 74.12 110.884 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.685 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -77.27 -58.97 2.98 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.915 1.286 . . . . 63.23 109.479 176.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.435 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 35.3 p90 -148.24 164.52 33.73 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.959 -1.019 . . . . 61.22 111.185 174.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.9 tp -123.52 142.11 51.34 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.336 1.454 . . . . 74.22 108.186 173.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.3 m -138.07 138.28 38.6 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 124.42 1.088 . . . . 43.1 108.781 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -148.93 120.12 7.79 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.069 -0.715 . . . . 72.12 109.069 173.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 85.9 t -128.51 128.01 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 123.411 0.684 . . . . 51.12 109.611 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.713 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 47.0 mt-30 -95.56 95.01 8.09 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.695 -0.854 . . . . 72.22 108.695 165.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.434 ' HG3' HD22 ' A' ' 106' ' ' LEU . 9.3 tp-100 -78.51 99.74 6.61 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.927 -0.768 . . . . 73.5 108.927 176.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.62 154.25 29.46 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.764 -0.653 . . . . 71.34 111.557 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.89 124.98 1.44 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.232 -0.747 . . . . 55.3 111.232 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' A' ' 15' ' ' ARG . 48.8 mt -85.69 119.6 34.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.553 -0.906 . . . . 64.41 108.553 174.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.699 ' HD2' HG12 ' A' ' 13' ' ' ILE . 17.4 m-85 -129.9 120.26 24.61 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.386 -1.338 . . . . 65.43 107.386 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.7 t -75.44 96.37 3.43 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.848 -1.167 . . . . 71.23 107.848 174.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 CA--C 1.542 0.649 0 C-N-CA 123.95 0.9 . . . . 71.21 109.292 -178.622 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 111.912 0.338 . . . . 42.41 111.912 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.487 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 62.8 t-80 -79.57 -36.03 38.84 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.519 0.327 . . . . 64.12 111.086 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 101' ' ' TYR . 44.7 t -69.14 -50.42 48.02 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.394 0.616 . . . . 54.42 111.069 -177.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -83.27 -39.31 21.03 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.089 0.955 . . . . 62.14 110.667 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.45 -14.17 57.44 Favored Glycine 0 N--CA 1.473 1.114 0 N-CA-C 114.73 0.652 . . . . 64.15 114.73 -171.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -123.56 -53.53 1.79 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 117.928 0.864 . . . . 51.42 111.207 -176.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.51 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 68.8 t80 -70.94 -50.55 33.39 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-N 115.231 -0.895 . . . . 74.34 111.98 -176.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.425 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 92.1 m -72.05 -32.57 2.08 Favored Pre-proline 0 CA--C 1.576 1.973 0 N-CA-C 115.69 1.737 . . . . 75.51 115.69 -174.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 29.9 Cg_endo -64.43 -32.55 60.06 Favored 'Trans proline' 0 C--N 1.392 2.818 0 CA-C-N 122.343 1.872 . . . . 71.51 112.039 169.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -65.95 -24.26 66.77 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.565 0.746 . . . . 61.41 110.763 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.4 mm -70.53 -50.79 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.479 0.712 . . . . 75.13 110.304 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.434 HD22 ' HG3' ' A' ' 80' ' ' GLN . 84.5 mt -74.1 -23.77 59.37 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.007 0.743 . . . . 74.14 113.007 -176.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -58.94 -49.91 90.8 Favored Pre-proline 0 CA--C 1.573 1.86 0 N-CA-C 113.883 1.068 . . . . 74.13 113.883 -173.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.86 -32.94 54.61 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 122.176 1.917 . . . . 74.23 113.202 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -67.06 -42.52 84.59 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.938 0.495 . . . . 63.05 110.816 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.43 -42.01 98.68 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.401 -0.818 . . . . 73.54 110.343 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.43 ' NH1' HG23 ' C' ' 105' ' ' ILE . 39.3 ttm180 -56.46 -52.09 65.99 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 124.267 0.98 . . . . 65.51 110.183 175.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -63.93 -44.93 91.37 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.766 0.826 . . . . 64.45 111.073 -174.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -59.51 -34.79 73.06 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.553 0.533 . . . . 64.04 111.182 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 98.5 mt -72.74 -51.44 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 115.541 -0.754 . . . . 74.53 110.145 174.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 49.6 m -59.03 -34.48 71.94 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.218 1.007 . . . . 74.25 111.558 -174.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 34.6 t -68.45 -47.19 67.79 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.54 -0.754 . . . . 64.4 110.242 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.541 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 54.6 mtm -61.06 -40.69 94.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 123.676 0.61 . . . . 72.32 111.163 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.13 -52.82 55.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 124.283 0.989 . . . . 74.34 110.753 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.9 t -67.72 -29.42 68.66 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.412 0.685 . . . . 52.24 111.007 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 116' ' ' SER . 20.7 ttm-85 -76.79 -30.87 56.65 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.804 1.242 . . . . 71.23 108.632 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.428 ' O ' HG22 ' A' ' 122' ' ' THR . . . -86.37 13.6 57.28 Favored Glycine 0 C--N 1.355 1.634 0 CA-C-N 114.739 -1.119 . . . . 63.21 112.545 171.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.505 HG21 ' HE ' ' B' ' 15' ' ' ARG . 2.0 t 63.79 15.28 8.92 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 126.969 2.108 . . . . 32.21 114.267 171.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -81.99 149.86 63.92 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 109.478 -0.564 . . . . 72.34 109.478 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.64 165.91 4.19 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.413 2.742 . . . . 71.13 114.497 -176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.598 ' HG2' ' HG3' ' C' ' 15' ' ' ARG . 6.7 tp-100 -57.91 123.48 15.97 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.097 -0.956 . . . . 75.44 111.86 -175.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.435 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 60.5 tp -120.56 106.89 12.21 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.455 1.102 . . . . 71.4 108.817 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.416 HD21 ' HA ' ' C' ' 15' ' ' ARG . 18.3 m-80 -100.65 115.12 29.46 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.822 -0.807 . . . . 65.34 108.822 175.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.51 137.73 44.62 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 108.161 -1.052 . . . . 64.42 108.161 174.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.94 146.8 57.67 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 123.864 0.866 . . . . 72.41 112.791 -174.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.459 ' HG3' HG13 ' C' ' 13' ' ' ILE . 14.1 Cg_exo -71.45 127.66 13.55 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.649 2.233 . . . . 71.35 111.541 172.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.5 p -142.93 125.49 13.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-O 121.376 0.607 . . . . 64.44 109.734 170.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -103.4 101.31 11.21 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.083 -1.08 . . . . 71.13 108.083 174.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 . . . . . 0 CA--C 1.544 0.722 0 O-C-N 123.743 0.652 . . . . 73.04 110.258 -179.378 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.644 ' HB3' HG12 ' B' ' 89' ' ' ILE . 18.0 ptm . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 113.522 0.934 . . . . 64.23 113.522 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 26.9 m -155.73 135.71 12.84 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.603 -0.726 . . . . 75.14 109.593 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -151.43 156.51 40.79 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.344 -0.613 . . . . 73.31 109.344 157.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.589 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -125.7 134.26 51.87 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 107.423 -1.325 . . . . 74.42 107.423 172.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.527 HD11 ' HG3' ' D' ' 130' ' ' PRO . 36.4 mt -70.59 116.91 12.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.553 0 N-CA-C 107.948 -1.13 . . . . 65.14 107.948 173.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -89.46 -44.63 10.02 Favored 'General case' 0 C--O 1.243 0.746 0 O-C-N 123.822 0.701 . . . . 72.4 109.49 -176.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.505 ' HE ' HG21 ' A' ' 122' ' ' THR . 40.5 ttt180 -165.4 131.05 2.59 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 116.117 -0.492 . . . . 61.33 110.981 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.4 mt -113.9 139.34 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 107.433 -1.321 . . . . 74.42 107.433 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.408 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 33.7 p90 -167.79 158.5 10.94 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.426 0.631 . . . . 74.23 111.788 -176.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.524 HG21 HD11 ' B' ' 21' ' ' ILE . 90.0 m -80.69 129.94 34.81 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.859 -1.064 . . . . 61.23 109.284 168.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.408 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 29.9 mtpt -97.47 -32.17 11.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.864 0.866 . . . . 62.52 110.084 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -152.82 138.52 17.87 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.642 -0.708 . . . . 75.13 111.037 -169.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.618 HD11 ' SG ' ' B' ' 113' ' ' CYS . 31.9 mm -134.01 146.57 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.253 1.421 . . . . 73.42 109.63 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 98.0 p -147.87 152.43 37.59 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.371 -1.286 . . . . 74.41 109.283 163.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 85.5 t80 -154.91 109.8 3.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.375 -1.343 . . . . 71.43 107.375 167.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.23 122.2 42.37 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.909 -0.775 . . . . 61.33 108.909 -175.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.942 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -118.32 82.98 19.51 Favored Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 108.807 -0.812 . . . . 74.33 108.807 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.88 -30.13 7.71 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.965 2.443 . . . . 73.4 113.008 -172.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -107.69 10.51 28.93 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 118.799 -0.619 . . . . 73.21 110.9 176.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.942 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -40.6 -61.31 1.25 Allowed Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 115.028 1.492 . . . . 52.52 115.028 -168.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 23.4 Cg_exo -61.53 -30.05 85.64 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 122.392 2.061 . . . . 52.21 112.811 -169.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -97.74 -32.04 11.94 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.606 0.762 . . . . 71.1 112.394 -175.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.436 HG22 ' HB2' ' B' ' 68' ' ' LEU . 4.3 p -72.04 -20.73 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.22 0.608 . . . . 63.15 111.365 -169.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -60.07 -22.93 63.34 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.763 0.825 . . . . 74.1 113.202 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -67.17 -16.28 64.21 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.207 0.603 . . . . 75.54 111.441 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.421 ' HD2' ' HB3' ' B' ' 68' ' ' LEU . 92.6 mttt -87.89 102.26 14.53 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.296 1.038 . . . . 73.31 109.685 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -86.8 78.32 9.1 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.732 0.813 . . . . 61.44 111.358 -174.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -161.68 161.82 29.6 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.777 -0.823 . . . . 74.3 108.777 166.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -70.92 114.86 30.49 Favored Pre-proline 0 C--O 1.246 0.904 0 N-CA-C 107.445 -1.317 . . . . 63.44 107.445 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.506 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 10.3 Cg_endo -53.47 151.19 24.6 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 123.007 2.471 . . . . 71.23 112.712 -173.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.06 104.02 0.67 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.598 -1.26 . . . . 72.14 107.598 172.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.466 HG21 HD21 ' B' ' 126' ' ' LEU . 19.7 m -100.87 155.36 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.244 -0.889 . . . . 71.13 110.449 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -136.2 131.0 34.03 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.263 1.025 . . . . 60.34 108.616 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.9 140.64 29.42 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 107.993 -1.114 . . . . 70.32 107.993 171.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -151.3 112.08 4.24 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.745 -1.206 . . . . 61.45 107.745 172.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -101.74 156.55 17.43 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 122.635 0.374 . . . . 74.21 110.076 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.4 t70 -139.02 151.92 47.2 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.261 0.624 . . . . 73.32 110.48 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 38.9 p -109.88 126.35 53.76 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.669 1.188 . . . . 70.04 110.108 -174.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.69 144.77 20.7 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.784 0.434 . . . . 74.54 110.141 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 47.5 p -145.43 174.09 11.44 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.78 0.432 . . . . 75.11 111.012 176.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 53.8 p -154.05 138.9 17.13 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.426 -0.806 . . . . 63.35 109.538 171.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -84.74 126.02 33.04 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.048 0.539 . . . . 72.23 110.956 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 62.2 mt -93.68 -40.92 9.98 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.759 0.823 . . . . 72.45 109.63 174.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.51 175.92 13.39 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.718 -1.128 . . . . 75.44 109.338 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.03 125.21 23.25 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.766 -0.828 . . . . 74.32 108.766 172.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 73.53 -5.48 1.98 Allowed 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 125.345 1.458 . . . . 74.35 112.831 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 72.8 t -108.05 111.97 38.21 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 N-CA-C 108.936 -0.765 . . . . 72.33 108.936 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -126.02 150.55 48.02 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.859 0.838 . . . . 73.04 110.206 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -108.12 103.94 13.25 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 113.811 -1.54 . . . . 53.25 106.915 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 74.1 t -88.53 117.28 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.885 1.274 . . . . 32.02 110.638 -173.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 18.5 t -107.31 113.64 44.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 108.507 -0.923 . . . . 74.21 108.507 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.77 HD22 ' HB3' ' B' ' 103' ' ' PRO . 43.1 tp -103.61 115.74 31.06 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.036 -1.098 . . . . 61.33 108.036 169.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 10.3 ttm180 -86.61 131.64 34.11 Favored 'General case' 0 CA--C 1.526 0.025 0 N-CA-C 108.956 -0.757 . . . . 75.11 108.956 174.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.66 103.34 14.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.781 -1.192 . . . . 72.43 107.781 171.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 9.3 m -99.69 133.58 43.83 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.816 -0.809 . . . . 71.42 108.816 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.442 HG23 HD13 ' B' ' 114' ' ' ILE . 86.8 t -123.25 127.65 74.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 124.075 0.95 . . . . 62.05 108.916 175.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 80.1 m -101.54 148.87 24.7 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.296 -1.001 . . . . 43.32 108.296 169.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.8 134.82 23.91 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.13 0.572 . . . . 74.22 109.819 177.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.589 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 33.7 p -142.1 127.93 19.36 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.748 -0.66 . . . . 64.15 110.707 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.506 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 22.1 mt -95.93 105.06 17.03 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.373 -0.973 . . . . 51.23 108.373 173.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.12 -118.05 8.42 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.804 -1.089 . . . . 44.24 112.913 -173.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -107.89 18.4 21.33 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.809 0.844 . . . . 73.34 110.696 -173.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -138.64 143.51 39.29 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.496 -0.753 . . . . 73.12 109.992 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.1 m -67.21 114.71 6.16 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.172 0.589 . . . . 62.01 110.555 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.589 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -69.85 -59.24 3.05 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.101 -1.074 . . . . 53.15 108.101 178.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -156.05 167.07 31.57 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.658 -1.156 . . . . 72.13 111.527 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 99.2 mt -128.83 146.99 50.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 113.622 -1.626 . . . . 54.03 106.635 172.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 44.9 t -150.66 135.22 17.23 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.994 -1.113 . . . . 64.23 107.994 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -143.27 124.87 14.87 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 107.959 -1.126 . . . . 60.41 107.959 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 96.9 t -122.91 146.74 27.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.914 -1.143 . . . . 71.12 107.914 178.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.496 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 21.7 mt-30 -126.65 102.89 7.28 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.943 -1.132 . . . . 74.14 107.943 172.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -89.0 99.77 12.69 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.099 -1.074 . . . . 73.4 108.099 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.55 143.09 16.3 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 110.698 -0.961 . . . . 34.24 110.698 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.91 126.97 2.48 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 110.054 -1.218 . . . . 54.1 110.054 -173.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 59.2 mt -86.7 127.59 40.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 109.263 -0.643 . . . . 63.51 109.263 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -134.28 133.36 40.69 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.11 -1.07 . . . . 74.33 108.11 175.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.5 m -99.1 89.4 4.24 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.15 0.58 . . . . 72.33 109.499 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.543 HG21 HD11 ' B' ' 98' ' ' LEU . 7.1 tt -98.17 126.75 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.704 0.802 . . . . 74.25 111.92 -168.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.22 163.18 37.78 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.641 0.776 . . . . 74.11 111.061 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.12 -53.37 0.6 Allowed Glycine 0 C--N 1.35 1.321 0 CA-C-N 115.493 -0.776 . . . . 63.11 112.818 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.644 HG12 ' HB3' ' B' ' 9' ' ' MET . 9.7 mm -90.48 162.08 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 124.089 0.956 . . . . 64.5 112.607 -170.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -150.3 162.92 39.58 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.654 0.782 . . . . 70.24 109.855 173.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.81 -135.13 12.83 Favored Glycine 0 C--N 1.348 1.247 0 C-N-CA 123.206 0.431 . . . . 65.43 113.32 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m -89.16 -17.11 29.82 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 117.073 0.436 . . . . 53.44 110.705 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -61.88 -33.6 74.49 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.315 0.646 . . . . 73.12 111.277 175.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.493 ' HB3' HG22 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -80.21 -25.85 39.44 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.462 0.305 . . . . 71.02 110.824 175.701 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.16 -31.06 71.69 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.113 0.565 . . . . 33.25 110.042 171.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.433 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 32.4 t-80 -75.92 -39.61 55.9 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.03 0.932 . . . . 63.41 110.613 174.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 40.6 t -66.52 -52.56 44.52 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.947 0.403 . . . . 74.42 111.389 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.543 HD11 HG21 ' B' ' 86' ' ' ILE . 85.0 mt -89.06 -12.47 41.19 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.358 0.663 . . . . 52.32 111.861 -175.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.98 -6.27 34.59 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-O 119.729 -0.484 . . . . 73.41 113.978 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -135.36 -65.1 0.62 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 117.24 0.52 . . . . 60.24 110.462 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.48 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 55.2 t80 -59.36 -52.45 65.57 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.78 0.832 . . . . 72.32 112.954 -172.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.473 ' SG ' HD23 ' B' ' 98' ' ' LEU . 61.9 m -67.61 -45.27 46.05 Favored Pre-proline 0 CA--C 1.562 1.411 0 CA-C-N 115.624 -0.716 . . . . 71.33 111.565 -177.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.77 ' HB3' HD22 ' B' ' 60' ' ' LEU . 69.9 Cg_exo -51.88 -38.77 68.84 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.633 2.222 . . . . 64.24 115.161 167.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -60.64 -30.94 70.18 Favored 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 123.123 0.569 . . . . 74.11 111.94 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.425 HD13 HD11 ' B' ' 13' ' ' ILE . 75.2 mt -69.12 -40.19 80.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.909 0.884 . . . . 73.53 110.297 177.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.7 mt -87.34 -21.33 25.76 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.187 -0.915 . . . . 71.22 111.717 -170.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -53.87 -51.09 79.91 Favored Pre-proline 0 CA--C 1.562 1.435 0 C-N-CA 124.141 0.976 . . . . 73.44 113.182 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -54.25 -40.73 81.12 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 122.339 2.026 . . . . 61.31 114.208 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -70.21 -44.99 67.5 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.293 0.637 . . . . 61.21 110.82 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.57 -39.65 91.91 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.483 0.713 . . . . 75.11 111.032 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttt-85 -60.07 -56.22 24.32 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.374 1.07 . . . . 75.45 110.445 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -57.57 -34.69 69.48 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.074 0.95 . . . . 73.35 110.883 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.618 ' SG ' HD11 ' B' ' 21' ' ' ILE . 8.5 t -67.89 -45.85 73.28 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 122.674 0.39 . . . . 73.11 111.187 -178.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.449 ' O ' HG23 ' B' ' 118' ' ' VAL . 84.4 mt -63.4 -53.65 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.526 0.73 . . . . 52.2 109.888 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 34.2 m -57.7 -33.32 68.27 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.024 0.929 . . . . 72.34 111.817 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.464 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 41.1 t -61.83 -51.1 69.61 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 123.233 0.613 . . . . 75.22 109.795 174.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.494 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -67.16 -37.15 83.25 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.059 0.543 . . . . 74.33 111.407 -175.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.449 HG23 ' O ' ' B' ' 114' ' ' ILE . 95.0 t -59.48 -45.37 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.569 0.748 . . . . 75.52 110.116 174.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.6 t -67.42 -33.66 75.62 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.363 -1.29 . . . . 64.53 111.135 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' B' ' 116' ' ' SER . 93.2 mtt-85 -66.83 -31.61 72.34 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.449 -0.796 . . . . 73.22 110.495 177.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.21 9.36 73.12 Favored Glycine 0 C--N 1.353 1.475 0 CA-C-O 119.036 -0.869 . . . . 63.25 113.343 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.522 HG23 ' HB3' ' A' ' 17' ' ' TYR . 81.6 p 55.73 26.13 9.07 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.624 1.57 . . . . 72.1 113.274 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.431 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 56.3 m-85 -84.76 157.32 60.82 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 123.608 0.763 . . . . 74.35 110.171 176.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -54.74 158.76 10.12 Favored 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 123.274 2.649 . . . . 74.04 113.28 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.501 HE21 ' ND2' ' B' ' 127' ' ' ASN . 66.7 tp60 -64.73 134.17 53.62 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.102 0.961 . . . . 72.14 111.36 -171.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.466 HD21 HG21 ' B' ' 40' ' ' VAL . 2.3 tm? -136.65 120.74 17.75 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.415 -0.957 . . . . 75.2 108.415 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.501 ' ND2' HE21 ' B' ' 125' ' ' GLN . 45.3 m-80 -122.29 136.26 54.87 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.033 0.933 . . . . 65.34 109.292 173.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 5.9 mp -78.92 137.77 37.79 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.785 0.834 . . . . 64.31 109.219 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.64 147.6 78.52 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.517 0.727 . . . . 61.31 110.794 -177.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.545 ' HG3' HD11 ' D' ' 16' ' ' ILE . 89.8 Cg_endo -77.12 114.66 3.83 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.887 2.392 . . . . 73.11 112.389 -175.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 m -121.86 111.36 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.341 0.656 . . . . 71.12 109.956 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -86.41 103.54 15.07 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 108.163 -1.051 . . . . 75.01 108.163 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -60.51 -38.01 82.99 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 124.12 0.888 . . . . 73.31 111.267 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 123.831 0.852 . . . . 74.34 111.298 -178.592 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.566 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.5 t80 . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 121.235 0.54 . . . . 60.11 109.693 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -144.21 133.78 23.48 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.278 1.031 . . . . 72.51 108.88 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.459 HG13 ' HG3' ' A' ' 130' ' ' PRO . 41.7 mt -81.39 128.77 38.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 108.561 -0.903 . . . . 74.13 108.561 173.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.605 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.5 mm-40 -89.84 -42.61 11.16 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.875 0.87 . . . . 55.14 110.381 -176.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.598 ' HG3' ' HG2' ' A' ' 125' ' ' GLN . 33.4 ttt180 -173.98 123.2 0.33 Allowed 'General case' 0 C--N 1.355 0.823 0 O-C-N 123.522 0.514 . . . . 64.11 110.351 -171.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 98.8 mt -110.1 139.7 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 108.818 -0.808 . . . . 51.41 108.818 174.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -170.6 154.06 4.4 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.988 0.915 . . . . 73.54 109.2 -171.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . 0.444 HG22 ' NE2' ' C' ' 80' ' ' GLN . 82.7 p -80.84 110.14 16.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.322 -0.992 . . . . 55.44 108.322 172.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.619 ' HE2' HG21 ' C' ' 59' ' ' VAL . 6.0 mmmt -67.94 -48.33 66.22 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.141 -1.059 . . . . 75.12 108.141 175.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.697 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 20.4 t70 -135.87 143.37 45.01 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.334 -1.303 . . . . 65.3 110.153 -177.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.7 mt -135.93 149.94 28.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 125.593 1.557 . . . . 75.35 107.005 175.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 37.6 t -158.95 150.6 20.71 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.331 0.653 . . . . 74.53 109.719 173.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -145.85 138.88 25.94 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 106.534 -1.654 . . . . 74.4 106.534 171.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -143.68 113.77 7.3 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.062 -0.718 . . . . 72.31 109.062 -174.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.411 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -126.84 85.1 61.56 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 107.021 -1.474 . . . . 74.25 107.021 169.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.14 -33.13 19.64 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.567 2.178 . . . . 51.25 111.176 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -95.59 11.3 33.65 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 114.625 -1.17 . . . . 74.54 110.348 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.446 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -44.98 -59.19 4.48 Favored Pre-proline 0 C--N 1.377 1.775 0 C-N-CA 124.703 1.201 . . . . 74.24 113.55 -167.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.47 ' HG3' ' HG2' ' D' ' 57' ' ' GLU . 25.1 Cg_exo -58.35 -45.74 28.96 Favored 'Trans proline' 0 C--N 1.399 3.213 0 C-N-CA 121.633 1.555 . . . . 74.22 111.869 -175.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.438 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 83.8 t60 -69.97 -36.16 75.0 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.975 -1.466 . . . . 71.04 112.322 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.642 HG21 ' HA ' ' C' ' 73' ' ' ALA . 3.4 p -78.22 -19.02 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 111.914 0.338 . . . . 65.22 111.914 -168.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -69.74 -28.96 66.23 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.008 0.523 . . . . 75.41 112.028 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 19.5 pt20 -86.39 5.68 33.75 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 122.905 0.482 . . . . 73.4 111.707 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.759 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -84.93 154.34 22.26 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.328 0.651 . . . . 73.43 110.322 177.527 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -59.96 110.77 1.26 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.032 0.533 . . . . 72.42 109.763 166.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -71.17 90.84 0.9 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.863 0.865 . . . . 72.34 110.401 -177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -142.3 74.45 20.57 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 107.553 -1.277 . . . . 62.25 107.553 172.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -90.61 143.28 3.56 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.476 2.117 . . . . 74.01 112.446 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -88.96 106.48 18.44 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.544 1.138 . . . . 75.13 108.114 172.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 43.1 t -72.22 97.37 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 108.503 -0.925 . . . . 55.1 108.503 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.59 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 87.8 tttt -93.31 129.89 39.24 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.454 -0.793 . . . . 73.45 109.002 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 16.0 mt -89.23 149.74 22.96 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 124.358 1.063 . . . . 75.32 110.085 -172.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.517 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 31.1 t70 -160.52 118.67 2.55 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.743 0.652 . . . . 74.25 109.532 173.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -118.78 137.58 53.28 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.928 0.891 . . . . 70.1 108.713 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 18.1 t70 -130.5 153.59 48.66 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.263 -1.014 . . . . 73.11 108.263 174.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 71.7 p -114.24 118.36 33.73 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.507 0.723 . . . . 74.51 109.67 -173.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.39 135.63 54.23 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 107.904 -1.147 . . . . 51.0 107.904 172.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.6 p -167.36 158.91 12.09 Favored 'General case' 0 C--O 1.243 0.73 0 O-C-N 123.469 0.48 . . . . 72.41 111.303 -174.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 50.8 p -166.69 138.73 3.55 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.09 0.869 . . . . 71.32 109.682 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -72.89 121.1 19.46 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.467 -0.938 . . . . 72.2 108.467 170.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.641 HD11 HD12 ' C' ' 83' ' ' ILE . 78.8 mt -85.74 -36.6 20.06 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.91 0.484 . . . . 73.03 111.187 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.509 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -160.7 -176.15 5.38 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.934 0.893 . . . . 54.35 109.957 -173.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -62.46 108.0 1.04 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.62 0.768 . . . . 72.14 109.799 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 66.91 2.02 2.51 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 125.169 1.388 . . . . 53.33 113.017 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 97.9 t -94.4 118.18 39.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.398 -1.334 . . . . 65.23 107.398 173.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -133.46 139.03 46.46 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.679 -0.489 . . . . 61.14 109.679 -172.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -102.1 128.15 48.7 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.555 0.742 . . . . 75.31 109.994 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.46 HG11 ' HD3' ' C' ' 103' ' ' PRO . 91.1 t -112.33 124.05 68.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 107.73 -1.211 . . . . 63.14 107.73 171.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.619 HG21 ' HE2' ' C' ' 19' ' ' LYS . 34.9 t -127.99 116.85 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.387 0.675 . . . . 73.04 109.223 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.544 HD22 ' HB3' ' C' ' 103' ' ' PRO . 42.0 tp -103.99 114.16 28.21 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.403 -0.962 . . . . 51.35 108.403 -176.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.514 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 20.5 ttm-85 -82.0 105.81 13.41 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.95 -1.13 . . . . 74.34 107.95 174.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 10.3 t -100.64 117.25 45.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.736 -1.209 . . . . 73.12 107.736 175.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 34.6 m -121.87 117.99 27.85 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.775 -1.195 . . . . 73.12 107.775 -176.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.518 HG23 HD13 ' C' ' 114' ' ' ILE . 42.1 t -99.24 136.94 28.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.222 -1.354 . . . . 72.04 107.978 174.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.59 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 5.1 m -123.78 140.17 53.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.841 -1.17 . . . . 64.03 107.841 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.54 117.77 19.22 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.588 -1.634 . . . . 70.12 106.588 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.3 m -138.11 126.86 23.75 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.097 0.475 . . . . 55.12 110.965 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.759 HD13 ' HG2' ' C' ' 34' ' ' LYS . 4.3 mt -85.4 53.85 2.9 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.225 1.81 . . . . 70.42 108.427 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.78 -107.76 3.16 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 109.064 -1.614 . . . . 64.35 109.064 -166.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -104.02 -25.14 13.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.61 0.764 . . . . 61.52 110.675 172.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -62.98 104.07 0.52 Allowed 'General case' 0 C--N 1.353 0.718 0 C-N-CA 123.645 0.778 . . . . 75.44 109.214 175.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 36.7 m -73.99 121.57 21.25 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.402 -0.592 . . . . 74.41 109.402 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.642 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -69.88 -62.45 1.38 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.449 -1.25 . . . . 65.11 108.362 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -153.88 173.02 16.48 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 121.784 0.802 . . . . 64.51 111.043 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -137.36 128.3 27.41 Favored 'General case' 0 C--O 1.22 -0.494 0 N-CA-C 105.577 -2.009 . . . . 53.22 105.577 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.1 t -131.15 139.1 49.73 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.98 -1.118 . . . . 75.45 107.98 176.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -145.07 127.14 15.6 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.292 0.637 . . . . 74.3 109.434 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -132.03 114.37 24.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.422 -0.955 . . . . 64.2 108.422 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.697 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 48.1 mt-30 -89.27 87.23 7.05 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.416 -1.327 . . . . 72.35 107.416 171.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.444 ' NE2' HG22 ' C' ' 18' ' ' THR . 9.6 tp-100 -79.34 110.58 14.76 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 114.143 -1.39 . . . . 73.41 109.396 -177.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.36 151.97 20.06 Favored Glycine 0 C--N 1.337 0.626 0 O-C-N 123.673 0.608 . . . . 63.23 112.446 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.96 127.24 2.09 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 109.947 -1.261 . . . . 73.05 109.947 176.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.641 HD12 HD11 ' C' ' 51' ' ' LEU . 14.4 mm -88.45 124.55 41.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 107.648 -1.241 . . . . 45.54 107.648 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.566 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 66.9 m-85 -131.48 123.52 28.24 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.49 0.716 . . . . 72.32 110.001 -174.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 51.1 m -75.12 109.76 8.86 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.859 -0.793 . . . . 60.14 108.859 170.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 67.2 mt -114.13 100.72 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.978 -1.119 . . . . 42.15 107.978 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.33 141.31 29.66 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.09 0.956 . . . . 51.14 109.384 -176.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.07 -19.95 24.47 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-O 119.758 -0.468 . . . . 21.51 112.944 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 36.6 pt -121.86 164.46 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.175 0.59 . . . . 73.13 110.856 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -152.49 164.08 38.29 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.188 0.995 . . . . 74.01 109.736 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.04 -133.22 18.26 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.485 0.491 . . . . 63.51 113.045 171.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 45.8 p -63.5 -31.78 73.04 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.014 0.926 . . . . 64.41 111.428 -178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -61.26 -51.12 70.27 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.061 0.945 . . . . 74.53 110.434 176.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.421 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 56.5 ttm -66.78 -39.84 87.97 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 115.222 -0.899 . . . . 73.13 110.393 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.07 -37.14 76.38 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.253 1.021 . . . . 64.1 111.615 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -71.51 -41.04 69.75 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.443 -0.798 . . . . 72.43 110.804 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.579 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 41.4 t -58.14 -60.89 3.04 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 124.179 0.924 . . . . 61.15 111.036 -177.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.6 pp -69.79 -30.08 67.54 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.988 -0.551 . . . . 73.25 111.766 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . 0.41 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -78.51 -29.94 50.91 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-O 118.896 -0.946 . . . . 74.41 114.672 -168.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.48 -35.87 0.1 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.101 0.95 . . . . 64.51 112.357 -170.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.579 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 18.6 t80 -71.73 -35.57 70.21 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.986 1.315 . . . . 74.44 112.637 -175.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 84.9 m -82.82 -41.55 0.88 Allowed Pre-proline 0 CA--C 1.562 1.434 0 C-N-CA 123.159 0.584 . . . . 62.45 111.001 177.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.544 ' HB3' HD22 ' C' ' 60' ' ' LEU . 52.2 Cg_exo -54.72 -26.77 48.64 Favored 'Trans proline' 0 C--N 1.396 3.068 0 C-N-CA 122.713 2.275 . . . . 43.34 113.779 166.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' C' ' 101' ' ' TYR . 23.4 t-20 -55.75 -44.17 77.37 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 124.194 0.998 . . . . 75.35 110.765 172.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.43 HG23 ' NH1' ' A' ' 111' ' ' ARG . 45.0 mm -61.97 -40.07 85.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.39 -0.823 . . . . 74.31 110.063 177.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 85.7 mt -86.54 -14.38 43.15 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.161 0.984 . . . . 64.22 112.643 -171.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . 0.434 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 88.7 t80 -55.47 -53.69 59.49 Favored Pre-proline 0 CA--C 1.564 1.486 0 C-N-CA 123.809 0.844 . . . . 70.13 112.481 -177.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.434 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 35.7 Cg_exo -63.23 -34.16 69.06 Favored 'Trans proline' 0 C--N 1.388 2.627 0 C-N-CA 122.243 1.962 . . . . 74.04 113.476 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -64.93 -49.95 68.36 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.583 0.753 . . . . 74.43 111.06 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.37 99.16 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.477 -0.783 . . . . 31.22 110.194 177.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -55.86 -51.8 66.29 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.419 1.488 . . . . 63.13 111.326 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -71.18 -32.26 68.65 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.352 0.661 . . . . 61.42 110.338 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.7 t -70.62 -32.48 69.82 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.953 0.501 . . . . 72.32 111.193 -178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.518 HD13 HG23 ' C' ' 64' ' ' VAL . 90.0 mt -71.02 -56.38 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 109.072 -0.714 . . . . 43.02 109.072 173.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 23.9 m -60.98 -28.99 69.4 Favored 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 123.574 0.75 . . . . 75.45 111.978 -175.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 43.6 t -64.4 -51.04 65.23 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.671 0.788 . . . . 74.11 109.023 171.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.561 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.37 -35.85 78.61 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.262 1.025 . . . . 71.12 112.781 178.536 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.506 HG23 ' O ' ' C' ' 114' ' ' ILE . 59.5 t -63.45 -43.61 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.332 0.653 . . . . 51.12 109.449 176.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 31.5 t -68.16 -33.37 74.34 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.25 1.02 . . . . 74.33 111.985 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' C' ' 116' ' ' SER . 88.3 mtt-85 -67.59 -36.26 80.55 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.293 0.637 . . . . 74.11 109.786 176.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.22 11.48 60.65 Favored Glycine 0 C--N 1.355 1.616 0 O-C-N 124.059 0.849 . . . . 75.34 112.656 174.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 69.4 p 57.28 23.46 8.82 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.591 1.956 . . . . 65.14 114.746 174.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -82.74 146.07 51.96 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 107.964 -1.124 . . . . 73.23 107.964 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.32 178.75 1.87 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.709 2.273 . . . . 61.13 113.096 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 16.7 mm-40 -56.21 113.02 1.38 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.703 -1.135 . . . . 74.5 113.428 -173.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 39.7 tp -109.41 87.76 2.58 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.852 -1.067 . . . . 70.44 108.241 167.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -91.66 103.89 16.43 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.966 -0.753 . . . . 54.12 108.966 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 6.9 mp -66.14 137.85 57.31 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.224 0.609 . . . . 72.42 109.573 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.83 163.09 55.24 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.249 0.62 . . . . 65.33 110.404 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.624 ' HG2' HG21 ' A' ' 13' ' ' ILE . 43.2 Cg_exo -58.61 138.06 83.64 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.878 2.385 . . . . 75.24 113.42 174.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 15.7 t -130.13 115.0 31.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.884 -0.784 . . . . 72.11 108.884 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -96.63 77.79 2.91 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.795 0.838 . . . . 51.21 108.9 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -62.13 -46.0 90.97 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.626 0.727 . . . . 74.14 109.999 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 . . . . . 0 C--O 1.237 0.406 0 CA-C-N 113.819 -1.537 . . . . 64.13 111.566 -176.483 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 44.8 m . . . . . 0 C--O 1.243 0.743 0 N-CA-C 108.764 -0.828 . . . . 74.43 108.764 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -151.79 103.16 2.9 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.915 -1.143 . . . . 75.11 107.915 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -121.53 142.66 49.85 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.052 -1.092 . . . . 65.43 108.052 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 15.6 mt -90.85 127.66 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 108.265 -1.013 . . . . 72.23 108.265 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -86.77 -37.25 18.04 Favored 'General case' 0 C--O 1.242 0.673 0 O-C-N 123.371 0.419 . . . . 75.21 109.912 175.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -169.22 139.91 2.29 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.436 0.46 . . . . 62.11 111.188 -171.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.545 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.6 mp -117.79 134.04 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 106.986 -1.487 . . . . 71.15 106.986 171.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.408 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 33.9 p90 -164.57 156.54 16.07 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.474 0.654 . . . . 63.13 112.269 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.0 p -81.82 117.35 22.04 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.452 -1.249 . . . . 73.23 109.03 172.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.408 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 42.0 mtpt -88.83 -23.84 22.72 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.444 0.698 . . . . 63.04 110.005 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 18.9 t70 -158.31 143.75 16.7 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 114.616 -1.175 . . . . 74.43 109.01 176.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.561 HG21 ' HE2' ' C' ' 117' ' ' MET . 70.9 mt -142.27 148.21 20.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 106.909 -1.515 . . . . 74.22 106.909 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 30.7 t -155.95 146.25 21.65 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.659 0.784 . . . . 73.32 109.013 170.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 84.6 t80 -146.4 117.61 7.85 Favored 'General case' 0 C--O 1.213 -0.837 0 N-CA-C 105.411 -2.07 . . . . 74.43 105.411 175.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -127.06 110.16 12.64 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 109.134 -0.691 . . . . 72.41 109.134 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.41 85.91 2.44 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.405 -0.961 . . . . 73.2 108.405 174.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.87 -30.53 5.89 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.084 2.523 . . . . 73.34 113.246 -169.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -103.27 6.67 38.24 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.732 0.813 . . . . 70.21 110.179 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.445 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -29.55 -67.96 0.12 Allowed Pre-proline 0 CA--C 1.562 1.422 0 C-N-CA 126.476 1.91 . . . . 65.33 116.111 -161.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -78.37 -13.69 15.02 Favored 'Trans proline' 0 C--N 1.378 2.122 0 CA-C-N 122.775 2.027 . . . . 65.23 113.782 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -80.34 -40.54 26.5 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.656 0.783 . . . . 64.32 109.589 171.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.445 HG12 ' O ' ' D' ' 28' ' ' ALA . 5.5 p -81.51 -20.02 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 116.107 -0.497 . . . . 74.01 110.938 -172.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -65.88 -20.21 66.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.215 0.606 . . . . 71.14 112.341 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -61.79 -23.3 66.12 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.639 0.776 . . . . 60.01 110.276 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -93.26 87.15 5.55 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.27 1.428 . . . . 72.22 109.979 176.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.05 86.81 7.0 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.459 0.704 . . . . 75.4 110.577 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -155.11 173.19 16.94 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.452 -0.944 . . . . 73.54 108.452 167.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -69.41 115.87 36.89 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 108.993 -0.743 . . . . 74.23 108.993 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.23 145.38 78.1 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.676 2.25 . . . . 62.42 111.69 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 37.7 mt-10 -61.59 111.86 1.99 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.662 -0.866 . . . . 72.14 108.662 169.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.764 HG13 HG13 ' D' ' 64' ' ' VAL . 91.9 t -99.48 113.67 35.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.447 -0.946 . . . . 61.15 108.447 -178.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.612 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 10.9 tmtt? -92.53 119.42 31.99 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 106.255 -1.757 . . . . 60.53 106.255 173.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 mp -96.12 137.9 34.51 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.423 -0.954 . . . . 65.52 108.423 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.518 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 8.0 t70 -142.35 148.16 37.47 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.683 -0.858 . . . . 62.41 108.683 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -127.51 147.32 50.32 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.763 0.825 . . . . 74.54 110.358 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.436 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 10.1 t70 -144.18 145.2 31.93 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 107.681 -1.229 . . . . 72.34 107.681 172.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 57.9 p -113.17 144.16 43.14 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.195 0.598 . . . . 72.44 110.336 -175.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.488 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.59 151.93 31.22 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.79 0.836 . . . . 75.35 109.284 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 79.4 p -155.88 157.14 35.85 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 120.784 0.326 . . . . 72.11 110.916 -178.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 25.4 p -152.64 119.27 5.67 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.401 1.08 . . . . 71.4 108.917 175.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -79.81 121.05 24.9 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.183 -0.673 . . . . 74.4 109.183 176.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 30.0 mt -91.26 -35.8 14.27 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.054 0.542 . . . . 63.22 109.878 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.75 176.54 12.6 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.987 -1.006 . . . . 74.15 109.707 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -65.56 123.44 19.69 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.558 -0.905 . . . . 75.25 108.558 177.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . 0.604 ' HB3' ' O ' ' D' ' 86' ' ' ILE . 3.8 m-20 71.94 2.95 4.5 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.212 1.005 . . . . 53.52 112.654 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.4 t -114.76 119.05 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.713 0.805 . . . . 74.1 109.255 176.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -133.02 128.43 36.29 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.297 0.639 . . . . 54.03 110.503 -173.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.642 ' HB2' HG12 ' D' ' 83' ' ' ILE . 4.6 tp10 -99.69 110.49 22.9 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 106.759 -1.571 . . . . 75.32 106.759 168.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.535 HG11 HD23 ' D' ' 98' ' ' LEU . 32.7 m -120.56 147.78 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 123.696 0.798 . . . . 73.41 109.111 -174.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 12.8 t -125.48 133.47 69.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 C-N-CA 123.69 0.796 . . . . 74.53 109.898 -169.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.494 HD22 ' HB2' ' D' ' 103' ' ' PRO . 56.3 tp -109.48 110.57 21.72 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.927 -1.138 . . . . 71.11 107.927 165.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.436 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.2 ttm180 -84.72 105.05 15.22 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.539 -0.912 . . . . 74.33 108.539 173.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 79.2 t -91.08 128.97 42.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.932 -1.136 . . . . 73.41 107.932 170.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 27.0 m -125.27 138.06 54.09 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.121 0.568 . . . . 73.35 109.522 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.764 HG13 HG13 ' D' ' 40' ' ' VAL . 24.4 t -129.16 101.04 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 124.945 1.298 . . . . 71.54 108.436 -174.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.612 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 36.8 m -95.49 93.86 7.44 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.377 -0.971 . . . . 73.02 108.377 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -95.99 144.19 26.5 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.263 0.625 . . . . 75.52 110.15 -174.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.471 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 64.7 p -145.82 129.29 16.93 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 123.683 0.614 . . . . 64.44 112.145 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.402 HD12 HG22 ' D' ' 31' ' ' VAL . 22.5 mt -99.1 112.9 24.92 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.871 0.868 . . . . 73.33 108.852 173.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.84 -111.01 3.18 Favored Glycine 0 C--N 1.345 1.074 0 N-CA-C 111.842 -0.503 . . . . 44.44 111.842 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.25 6.19 9.12 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.975 0.91 . . . . 73.12 110.526 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -121.15 165.9 14.71 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.466 0.706 . . . . 74.42 109.788 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.6 m -70.62 129.94 40.5 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.59 0.756 . . . . 74.23 111.924 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.471 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -84.36 -69.4 0.65 Allowed 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.817 -1.179 . . . . 42.43 107.817 170.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -151.07 158.75 44.47 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.74 -0.664 . . . . 72.23 110.803 175.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 74.3 mt -121.46 108.19 13.35 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.372 -1.344 . . . . 72.22 107.372 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.493 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.6 t -123.9 107.9 11.86 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.225 0.61 . . . . 72.14 109.506 -169.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -131.15 123.44 28.56 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.756 0.822 . . . . 75.21 109.072 -173.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.41 119.8 51.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 123.578 0.751 . . . . 72.34 109.012 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.532 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.0 mt-30 -87.18 85.7 7.22 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.876 -1.157 . . . . 71.15 107.876 170.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -81.91 110.86 17.58 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.341 -1.299 . . . . 64.33 108.907 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.61 167.58 14.13 Favored Glycine 0 C--N 1.341 0.826 0 O-C-N 123.557 0.536 . . . . 70.15 112.549 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.38 129.18 1.97 Allowed Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.35 -0.7 . . . . 64.32 111.35 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.642 HG12 ' HB2' ' D' ' 57' ' ' GLU . 61.8 mt -89.0 133.41 31.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.884 -1.154 . . . . 63.25 107.884 177.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -132.74 133.99 44.18 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 122.917 0.487 . . . . 71.4 110.879 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.1 m -81.21 104.85 11.96 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.089 0.956 . . . . 54.31 109.095 165.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.604 ' O ' ' HB3' ' D' ' 54' ' ' ASP . 67.3 mt -107.17 145.04 15.1 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 C-N-CA 124.158 0.983 . . . . 64.33 108.577 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.28 157.26 15.16 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 118.325 0.511 . . . . 75.12 110.05 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.96 11.35 74.17 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.568 0.543 . . . . 62.04 114.201 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.489 HG23 ' HB3' ' D' ' 93' ' ' GLN . 11.1 mt -97.57 134.92 33.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 C-N-CA 123.25 0.62 . . . . 75.31 110.696 -175.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -157.41 172.25 18.92 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.498 1.119 . . . . 75.25 109.148 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.89 -133.46 29.34 Favored Glycine 0 CA--C 1.527 0.825 0 O-C-N 123.465 0.478 . . . . 43.03 113.208 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 57.8 p -66.73 -33.19 75.08 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.944 0.898 . . . . 70.04 111.754 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.489 ' HB3' HG23 ' D' ' 89' ' ' ILE . 8.4 tt0 -67.71 -22.33 65.26 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.087 -0.506 . . . . 74.34 112.178 -172.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 91.0 mtp -55.26 -54.18 46.68 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.022 -0.733 . . . . 71.35 109.022 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.36 -47.72 54.61 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.935 -1.03 . . . . 65.11 111.263 -178.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -76.28 -24.53 54.43 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.15 0.98 . . . . 73.44 112.685 -168.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -63.21 -51.67 65.34 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.935 -0.394 . . . . 61.41 109.935 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.535 HD23 HG11 ' D' ' 58' ' ' VAL . 4.5 mp -84.34 -25.78 28.94 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 122.761 0.424 . . . . 74.43 110.341 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.59 -5.05 72.27 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.62 -0.544 . . . . 75.34 113.925 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.65 -57.71 0.11 Allowed 'General case' 0 C--N 1.358 0.955 0 N-CA-C 112.6 0.593 . . . . 63.13 112.6 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -72.31 -50.57 26.02 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 112.792 0.664 . . . . 73.02 112.792 -166.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 35.2 m -61.64 -47.14 93.36 Favored Pre-proline 0 CA--C 1.564 1.507 0 C-N-CA 123.993 0.917 . . . . 75.44 112.974 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.494 ' HB2' HD22 ' D' ' 60' ' ' LEU . 65.8 Cg_endo -70.39 -20.48 31.81 Favored 'Trans proline' 0 C--N 1.392 2.852 0 C-N-CA 122.176 1.917 . . . . 70.03 112.659 175.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -73.65 -26.96 61.01 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.285 0.634 . . . . 75.13 110.539 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mm -65.77 -37.44 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-O 121.525 0.679 . . . . 71.33 109.876 169.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 50.9 mt -84.57 -13.13 52.63 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 114.832 -1.076 . . . . 64.14 111.423 -176.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . 0.415 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 85.1 t80 -61.61 -53.11 64.45 Favored Pre-proline 0 CA--C 1.567 1.605 0 C-N-CA 124.422 1.089 . . . . 65.21 113.025 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 24.5 Cg_exo -65.05 -31.44 55.17 Favored 'Trans proline' 0 C--N 1.393 2.872 0 C-N-CA 122.14 1.893 . . . . 52.22 112.923 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -76.18 -33.99 59.32 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.773 0.829 . . . . 52.43 111.772 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.46 -48.89 73.58 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.238 -0.653 . . . . 63.33 109.238 172.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -55.58 -47.18 76.88 Favored 'General case' 0 C--N 1.358 0.953 0 O-C-N 124.445 1.09 . . . . 64.12 110.454 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.76 -53.26 58.37 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.066 0.546 . . . . 74.54 110.945 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.8 t -55.64 -44.86 77.56 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 123.825 0.703 . . . . 73.41 111.24 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.493 HG23 ' SG ' ' D' ' 76' ' ' CYS . 59.3 mt -60.45 -59.9 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.987 0.915 . . . . 72.12 110.659 175.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 47.7 m -54.11 -38.61 65.58 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.694 1.198 . . . . 52.22 111.796 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.4 t -65.47 -45.61 82.99 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.236 -0.893 . . . . 64.33 110.1 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.41 ' HB2' ' HE3' ' D' ' 117' ' ' MET . 69.7 mtm -70.63 -28.12 64.58 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.861 0.465 . . . . 65.12 111.889 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' D' ' 114' ' ' ILE . 99.5 t -66.09 -45.76 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.27 0.628 . . . . 73.32 109.585 174.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.0 p -72.13 -31.06 65.65 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.843 -0.617 . . . . 55.31 110.826 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -69.27 -36.32 76.97 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.974 0.909 . . . . 72.51 109.954 175.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.76 1.2 88.68 Favored Glycine 0 C--N 1.351 1.398 0 O-C-N 123.805 0.69 . . . . 74.32 112.012 174.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.0 p 61.97 23.11 13.57 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 126.832 2.053 . . . . 64.33 113.573 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -81.66 160.04 65.14 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.849 0.86 . . . . 74.34 110.003 170.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.64 132.51 51.9 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.973 2.449 . . . . 62.13 112.737 174.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -56.34 134.86 53.87 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.163 0.985 . . . . 70.34 111.792 -175.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.402 HD13 HG21 ' D' ' 40' ' ' VAL . 53.9 tp -111.95 103.38 11.6 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.389 -0.823 . . . . 70.53 109.219 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . 0.432 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 86.3 m-20 -100.54 96.75 7.59 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.487 -0.931 . . . . 74.42 108.487 177.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 31.7 tp -67.3 120.75 14.34 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-N 115.4 -0.818 . . . . 73.11 109.885 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.8 137.44 83.05 Favored Pre-proline 0 C--N 1.354 0.792 0 O-C-N 124.348 1.03 . . . . 73.54 111.43 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.527 ' HG3' HD11 ' B' ' 13' ' ' ILE . 1.8 Cg_endo -76.58 103.38 1.74 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.902 2.401 . . . . 74.4 110.891 -172.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 CA--C 1.539 0.523 0 CA-C-N 115.923 -0.58 . . . . 34.24 109.561 179.742 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.668 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 15.6 t80 . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 109.89 -0.411 . . . . 73.35 109.89 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -138.19 117.28 12.56 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.753 0.821 . . . . 75.41 108.943 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.632 HG12 ' HD2' ' A' ' 84' ' ' PHE . 53.8 mt -89.92 125.08 42.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 108.871 -0.788 . . . . 72.23 108.871 176.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -85.94 -41.16 15.15 Favored 'General case' 0 C--O 1.242 0.66 0 O-C-N 123.847 0.717 . . . . 71.45 110.159 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -167.9 136.7 2.47 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.874 -0.417 . . . . 63.14 109.874 -167.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.47 HD11 HD13 ' A' ' 13' ' ' ILE . 94.4 mt -130.01 129.34 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.061 -1.089 . . . . 63.23 108.061 172.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -161.52 176.77 10.7 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 124.216 0.948 . . . . 65.24 111.252 -167.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -107.28 116.22 31.56 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 114.944 -1.025 . . . . 64.35 108.836 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.501 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 34.5 mtpt -82.11 -26.44 33.58 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 110.012 -0.366 . . . . 70.1 110.012 177.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 18.3 t70 -152.78 136.65 16.24 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.218 -0.901 . . . . 72.24 109.72 174.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.447 HG23 ' SD ' ' A' ' 117' ' ' MET . 83.6 mt -129.18 137.48 56.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 106.285 -1.746 . . . . 73.55 106.285 172.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.6 t -152.03 110.63 3.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.419 0.628 . . . . 75.25 110.226 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.512 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 92.3 t80 -110.38 137.34 48.22 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 107.313 -1.366 . . . . 74.22 107.313 173.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -135.16 140.92 45.76 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.701 -1.222 . . . . 74.12 107.701 171.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.407 ' CB ' ' HB2' ' A' ' 28' ' ' ALA . . . -122.9 80.78 50.01 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 105.891 -1.892 . . . . 71.43 105.891 168.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.2 -31.42 89.9 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.076 2.517 . . . . 74.2 112.746 -167.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -118.44 31.69 6.54 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 118.597 -0.716 . . . . 73.23 109.66 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.415 ' HB3' ' HZ1' ' B' ' 19' ' ' LYS . . . -42.41 -54.47 7.91 Favored Pre-proline 0 CA--C 1.573 1.84 0 N-CA-C 114.84 1.422 . . . . 74.41 114.84 -170.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HD3' ' HZ1' ' B' ' 19' ' ' LYS . 14.1 Cg_exo -64.13 -31.4 64.89 Favored 'Trans proline' 0 C--N 1.395 3.004 0 CA-C-N 121.652 1.626 . . . . 52.1 112.572 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -80.17 -39.16 29.86 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.863 -1.062 . . . . 62.13 110.51 -175.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.658 HG21 ' HA ' ' A' ' 73' ' ' ALA . 5.2 p -78.52 -22.23 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 CA-C-N 114.821 -1.081 . . . . 73.1 112.714 -161.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -70.91 -21.1 62.41 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.906 0.482 . . . . 72.44 110.754 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -86.46 -18.34 31.94 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.517 1.127 . . . . 65.11 110.519 176.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.4 tmtp? -78.13 146.67 34.99 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.142 0.977 . . . . 71.23 109.734 -175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.07 138.88 58.67 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.816 0.846 . . . . 65.24 110.524 173.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -93.01 82.99 4.64 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.868 0.842 . . . . 72.32 110.6 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -130.87 83.44 61.3 Favored Pre-proline 0 C--O 1.239 0.539 0 N-CA-C 107.017 -1.475 . . . . 60.03 107.017 165.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -85.97 156.6 10.02 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 122.214 1.943 . . . . 71.43 111.959 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -109.66 93.72 4.65 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 105.036 -2.209 . . . . 74.33 105.036 165.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 65' ' ' THR . 48.1 t -78.5 92.04 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 122.072 0.939 . . . . 74.44 108.695 -177.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.446 ' HE2' ' HB2' ' A' ' 67' ' ' SER . 62.3 mttm -82.98 113.3 20.47 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.596 -1.638 . . . . 62.32 108.98 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 pp -105.73 128.36 53.64 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.008 0.523 . . . . 71.45 110.625 -174.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.538 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.6 m-20 -114.28 139.2 49.61 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.405 1.082 . . . . 70.32 109.029 177.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.1 mt -124.61 119.54 29.34 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.601 0.76 . . . . 74.22 109.513 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 21.8 t70 -120.24 130.31 54.45 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.617 -0.882 . . . . 71.31 108.617 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.3 p -106.98 132.21 53.18 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.878 0.871 . . . . 52.05 110.254 -173.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.18 129.52 10.56 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.049 0.54 . . . . 74.44 110.308 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.2 m -130.82 152.92 49.64 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.223 0.609 . . . . 72.43 110.324 174.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.6 t -149.96 126.71 11.02 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.578 0.751 . . . . 75.33 109.084 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -78.47 132.55 37.31 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.857 0.463 . . . . 72.32 110.927 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.3 mt -101.32 -31.01 11.17 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.441 1.096 . . . . 60.22 111.059 -174.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.581 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -163.63 173.76 12.56 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.489 1.116 . . . . 52.22 109.712 -175.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -56.67 116.47 3.15 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.023 0.529 . . . . 50.32 110.204 171.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 70.49 -10.6 0.68 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 126.215 1.806 . . . . 74.24 113.259 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 21.6 t -100.7 117.68 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.075 -1.083 . . . . 53.1 108.075 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -142.35 170.33 15.9 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.14 -0.689 . . . . 72.54 109.14 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -120.08 132.99 55.64 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 123.521 0.729 . . . . 73.4 110.021 -175.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.446 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 93.7 t -104.39 126.82 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.008 -1.108 . . . . 73.04 108.008 169.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.99 125.81 74.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 108.269 -1.012 . . . . 74.3 108.269 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.19 110.88 18.11 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.722 -1.214 . . . . 70.11 107.722 176.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.577 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 36.8 ttm180 -81.95 100.26 9.57 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.572 -1.27 . . . . 74.54 107.572 174.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.9 t -98.86 102.46 13.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.679 -1.23 . . . . 71.24 107.679 176.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.538 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 26.5 m -96.91 135.88 38.27 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.444 -0.576 . . . . 73.53 109.444 178.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.542 HG11 HD21 ' A' ' 126' ' ' LEU . 17.9 t -126.73 107.68 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.628 1.171 . . . . 45.43 108.392 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 25.9 m -102.94 134.33 46.54 Favored 'General case' 0 C--O 1.208 -1.083 0 N-CA-C 107.707 -1.22 . . . . 54.44 107.707 173.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.71 105.28 12.56 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 107.699 -1.223 . . . . 75.5 107.699 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 50.2 m -108.72 124.29 50.33 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.304 0.574 . . . . 74.04 110.952 -177.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.1 mt -91.04 54.82 2.72 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.889 1.276 . . . . 64.41 108.399 178.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.47 -114.56 4.73 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 110.36 -1.096 . . . . 71.01 110.36 -166.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -91.93 -26.68 18.32 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.007 0.523 . . . . 70.2 110.864 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -86.73 108.8 18.84 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.206 0.602 . . . . 72.11 109.595 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 53.9 m -72.63 124.87 26.16 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.688 0.395 . . . . 70.33 110.625 176.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.658 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -62.26 -58.09 9.0 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.49 1.116 . . . . 54.12 111.183 174.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -155.83 164.54 38.4 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.816 -1.083 . . . . 74.1 111.779 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.5 tp -123.46 138.51 54.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.605 1.162 . . . . 71.53 108.158 173.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.418 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 76.6 m -142.51 96.57 2.97 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.838 0.855 . . . . 72.11 109.555 -178.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -108.29 130.43 55.18 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.788 -0.819 . . . . 70.2 108.788 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.1 t -132.15 112.43 19.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 109.238 -0.653 . . . . 63.31 109.238 173.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.5 ' NE2' HH21 ' A' ' 61' ' ' ARG . 69.6 mt-30 -84.55 84.83 7.53 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.048 -1.093 . . . . 64.43 108.048 172.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.53 ' HG3' HD22 ' A' ' 106' ' ' LEU . 8.4 tp-100 -76.85 102.97 6.55 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.183 -0.917 . . . . 71.21 108.795 -177.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.21 144.92 17.42 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.041 -0.823 . . . . 73.35 111.041 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.44 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -150.86 123.13 1.47 Allowed Glycine 0 CA--C 1.504 -0.615 0 N-CA-C 110.779 -0.928 . . . . 74.43 110.779 -176.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.5 mt -81.22 122.24 36.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 108.973 -0.751 . . . . 72.53 108.973 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.668 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 25.1 m-85 -134.12 137.53 44.61 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.859 -0.793 . . . . 73.14 108.859 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.3 m -102.44 96.79 7.16 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.006 -0.738 . . . . 64.21 109.006 173.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.647 HD11 ' SG ' ' A' ' 102' ' ' CYS . 62.8 mt . . . . . 0 C--O 1.241 0.648 0 N-CA-C 108.355 -0.98 . . . . 74.23 108.355 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.454 0.645 . . . . 74.31 111.545 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -67.83 -39.67 83.84 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.559 1.144 . . . . 60.25 110.582 175.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 18.7 t -72.58 -35.64 67.97 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 116.383 -0.371 . . . . 42.32 111.8 -175.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 pp -83.49 -29.95 27.56 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.932 0.493 . . . . 71.21 111.409 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.25 3.98 37.9 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 114.6 0.6 . . . . 73.35 114.6 -168.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.62 -53.41 0.24 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.832 0.316 . . . . 72.15 111.674 -176.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.435 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 66.4 t80 -73.09 -65.92 0.74 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 123.445 0.465 . . . . 73.1 112.084 -171.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.647 ' SG ' HD11 ' A' ' 86' ' ' ILE . 92.3 m -68.13 -32.91 4.37 Favored Pre-proline 0 CA--C 1.566 1.56 0 N-CA-C 115.135 1.532 . . . . 61.04 115.135 -172.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 25.9 Cg_endo -63.24 -32.04 73.73 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 121.824 1.683 . . . . 75.04 112.554 166.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.471 HD22 ' HD2' ' A' ' 133' ' ' PHE . 29.3 t-20 -76.5 -21.44 55.79 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.997 0.519 . . . . 73.24 110.715 176.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 42.1 mm -67.46 -36.38 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 109.501 -0.555 . . . . 70.43 109.501 170.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.53 HD22 ' HG3' ' A' ' 80' ' ' GLN . 94.7 mt -79.77 -17.52 53.22 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.426 0.69 . . . . 62.14 112.211 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -61.43 -48.79 89.88 Favored Pre-proline 0 CA--C 1.57 1.715 0 CA-C-O 117.933 -1.032 . . . . 75.3 113.546 -175.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.31 -34.1 45.82 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 121.954 1.769 . . . . 51.01 112.909 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -72.67 -40.15 66.54 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.312 0.645 . . . . 45.45 111.382 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.62 -39.45 70.42 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.994 0.518 . . . . 43.44 110.449 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.521 HH12 HD12 ' C' ' 105' ' ' ILE . 30.6 ttm180 -54.35 -51.69 63.98 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 124.173 0.921 . . . . 75.11 109.829 173.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -65.75 -42.06 91.37 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.38 1.05 . . . . 71.2 111.558 -175.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 46.2 t -61.51 -42.85 99.43 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.837 0.711 . . . . 70.54 110.329 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.06 -48.1 87.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 O-C-N 124.108 0.88 . . . . 51.34 110.407 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 35.8 m -56.65 -38.55 72.31 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.913 0.885 . . . . 73.54 111.377 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.1 t -68.69 -46.22 69.63 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.435 -0.802 . . . . 63.22 110.353 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.447 ' SD ' HG23 ' A' ' 21' ' ' ILE . 27.1 mtp -59.0 -42.57 90.37 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.884 0.874 . . . . 62.31 111.406 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.547 HG21 HD23 ' A' ' 126' ' ' LEU . 68.9 t -65.72 -44.05 93.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 124.652 1.181 . . . . 73.24 110.71 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 37.5 t -71.43 -31.13 66.85 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.239 0.616 . . . . 51.13 110.935 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.451 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 90.8 mtt-85 -73.98 -32.14 63.3 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.758 0.823 . . . . 72.5 109.512 175.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.41 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.74 12.15 57.55 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 115.453 -0.794 . . . . 63.25 112.823 172.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.487 HG21 ' HE ' ' B' ' 15' ' ' ARG . 2.8 t 60.94 15.02 5.7 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 127.234 2.214 . . . . 71.43 114.385 171.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.458 ' HB2' HG13 ' A' ' 118' ' ' VAL . 74.7 m-85 -78.57 155.08 78.82 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 109.019 -0.734 . . . . 74.31 109.019 175.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.68 174.43 2.25 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.636 2.224 . . . . 63.44 113.488 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.1 116.34 1.96 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.2 1.4 . . . . 75.31 111.853 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.547 HD23 HG21 ' A' ' 118' ' ' VAL . 56.9 tp -127.94 106.08 8.85 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.549 0.74 . . . . 63.33 109.152 176.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -130.7 128.33 40.65 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.729 1.212 . . . . 71.5 109.042 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.66 144.92 55.27 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 123.429 0.455 . . . . 53.4 110.079 174.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.17 157.12 78.64 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 124.303 1.041 . . . . 72.3 111.491 -178.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.607 ' HD3' HG13 ' C' ' 13' ' ' ILE . 64.7 Cg_endo -70.37 99.33 0.8 Allowed 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.547 2.165 . . . . 53.54 111.981 176.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.4 t -103.97 112.94 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.793 -0.817 . . . . 73.52 108.793 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -95.27 84.12 3.99 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 108.686 -0.857 . . . . 74.31 108.686 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.471 ' HD2' HD22 ' A' ' 104' ' ' ASN . 92.5 m-85 . . . . . 0 N--CA 1.483 1.213 0 O-C-N 123.333 0.396 . . . . 74.41 110.006 -178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.541 ' SD ' ' N ' ' B' ' 10' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 110.339 -0.245 . . . . 72.52 110.339 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.541 ' N ' ' SD ' ' B' ' 9' ' ' MET . 54.6 m -167.08 130.66 1.85 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.801 0.84 . . . . 71.31 109.685 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' B' ' 85' ' ' SER 0.283 0.5 OUTLIER -155.25 155.85 34.54 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.561 0.696 . . . . 71.14 111.204 143.406 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.739 HE22 ' HB2' ' D' ' 129' ' ' ALA . 25.4 tp60 -127.03 128.38 46.24 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 106.424 -1.695 . . . . 75.35 106.424 172.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.491 HD11 HD13 ' B' ' 105' ' ' ILE . 27.8 mt -68.52 121.34 17.61 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 N-CA-C 108.784 -0.821 . . . . 72.12 108.784 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -90.29 -40.62 12.03 Favored 'General case' 0 C--O 1.243 0.761 0 O-C-N 124.233 0.958 . . . . 74.02 109.583 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.493 ' HA ' ' ND2' ' D' ' 127' ' ' ASN . 28.3 ttt180 -167.56 133.77 2.12 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 116.396 -0.366 . . . . 53.01 111.022 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.426 HD11 HD13 ' B' ' 13' ' ' ILE . 86.1 mt -115.56 135.97 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 107.48 -1.304 . . . . 73.34 107.48 173.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.401 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 42.3 p90 -168.73 170.69 9.18 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.98 0.895 . . . . 73.15 113.052 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.421 HG21 HD11 ' B' ' 21' ' ' ILE . 86.9 m -96.42 118.03 32.1 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.828 -1.533 . . . . 65.14 108.743 174.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.415 ' HZ1' ' HB3' ' A' ' 28' ' ' ALA . 24.8 mtpp -79.8 -28.99 40.19 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.985 0.514 . . . . 73.32 110.543 176.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -162.7 149.93 13.37 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.218 0.533 . . . . 73.24 112.045 -171.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 28.3 mm -137.89 144.88 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 126.216 1.806 . . . . 65.31 108.612 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 46.2 t -147.64 126.66 12.83 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.965 -1.016 . . . . 71.42 108.786 169.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 85.3 t80 -138.81 109.82 6.8 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 107.529 -1.286 . . . . 73.41 107.529 171.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -119.09 115.47 24.34 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.922 0.889 . . . . 74.52 108.724 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.95 86.35 1.91 Allowed Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 107.091 -1.448 . . . . 40.52 107.091 169.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.88 -45.23 8.6 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.567 2.178 . . . . 72.13 112.131 -169.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 49.4 m-20 -100.59 18.05 20.2 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.674 0.79 . . . . 73.11 110.748 -176.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.501 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -31.12 -68.67 0.13 Allowed Pre-proline 0 N--CA 1.504 2.242 0 N-CA-C 115.419 1.637 . . . . 54.14 115.419 -166.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 54.8 Cg_endo -70.37 -13.48 33.19 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 122.336 2.024 . . . . 65.31 113.078 -171.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -92.2 -45.7 8.12 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.544 0.738 . . . . 73.31 110.258 177.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.564 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.0 p -69.57 -17.62 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 112.295 0.48 . . . . 73.03 112.295 -171.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -62.92 -18.8 63.55 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.013 0.525 . . . . 54.33 112.383 173.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -65.98 -20.96 66.37 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.609 0.764 . . . . 65.13 110.817 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -103.99 71.27 1.03 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.835 1.254 . . . . 73.15 108.743 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -82.75 91.95 7.12 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.178 -0.919 . . . . 73.44 111.727 -173.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -158.64 -175.18 5.16 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.136 0.974 . . . . 73.2 109.52 170.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -72.74 111.59 11.84 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 123.663 0.785 . . . . 75.11 110.145 176.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.46 153.77 75.67 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.336 2.024 . . . . 72.44 112.216 178.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -69.31 113.93 7.09 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.56 -0.745 . . . . 71.24 109.16 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 12.8 t -86.46 121.35 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 122.991 0.517 . . . . 63.55 109.899 -173.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -115.86 128.63 55.96 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 107.244 -1.391 . . . . 70.5 107.244 172.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.606 HD13 HD21 ' B' ' 128' ' ' LEU . 0.2 OUTLIER -131.19 148.76 52.75 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.134 0.573 . . . . 73.21 109.763 174.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -153.2 129.82 10.77 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.066 0.946 . . . . 65.25 108.713 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 85.7 mt -99.47 150.91 21.71 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.691 0.797 . . . . 61.04 110.04 -176.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.0 t70 -137.14 139.68 41.35 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.777 -0.823 . . . . 62.41 108.777 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.8 p -109.8 124.23 50.93 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.392 0.677 . . . . 71.15 110.808 -175.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -131.94 135.36 46.54 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.42 1.088 . . . . 74.33 108.965 176.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 16.2 m -144.35 161.77 38.15 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.76 0.424 . . . . 52.21 111.385 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 53.9 p -160.55 143.39 13.17 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.328 -0.851 . . . . 72.01 109.769 174.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -80.29 107.08 12.8 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 107.821 -1.178 . . . . 72.4 107.821 172.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.622 HD11 ' HB2' ' B' ' 57' ' ' GLU . 40.2 mt -77.09 -42.08 39.6 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.275 0.559 . . . . 74.53 110.295 -174.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.22 -166.06 1.85 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.248 1.019 . . . . 75.43 109.827 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -69.96 131.39 44.33 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.251 0.62 . . . . 61.23 109.764 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 64.75 -10.4 0.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 125.727 1.611 . . . . 72.35 112.343 -171.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' B' ' 51' ' ' LEU . 91.1 t -110.7 121.82 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 O-C-N 121.502 -0.749 . . . . 72.13 109.468 -165.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -133.58 -176.48 4.17 Favored 'General case' 0 C--O 1.247 0.973 0 N-CA-C 107.796 -1.187 . . . . 65.13 107.796 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.622 ' HB2' HD11 ' B' ' 51' ' ' LEU . 35.4 tt0 -139.19 129.24 25.15 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.391 0.276 . . . . 62.33 110.608 -177.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 82.8 t -97.11 117.99 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.433 -0.951 . . . . 72.24 108.433 170.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 41.2 t -116.79 110.58 31.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.963 -1.125 . . . . 64.05 107.963 174.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 30.3 tp -107.28 107.85 18.98 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.337 -0.986 . . . . 64.23 108.337 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.552 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 45.9 ttt180 -84.74 114.44 22.05 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.52 -0.918 . . . . 73.43 108.52 176.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.6 t -102.69 105.07 17.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.968 -1.123 . . . . 71.35 107.968 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 33.1 m -95.45 138.37 33.23 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.511 -0.922 . . . . 73.53 108.511 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.55 133.26 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.563 0.745 . . . . 73.42 109.612 177.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.2 m -119.39 145.3 46.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.396 1.078 . . . . 60.31 108.421 169.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.57 129.34 26.49 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.849 -0.797 . . . . 74.54 108.849 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 30.9 p -123.11 127.83 49.25 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.587 0.755 . . . . 62.51 110.638 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.512 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 44.6 mt -102.63 109.39 20.99 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.061 0.944 . . . . 75.11 109.176 172.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.81 -110.56 3.55 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 114.958 -1.019 . . . . 53.51 113.398 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -105.08 4.02 31.04 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.007 0.923 . . . . 72.55 111.708 -174.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -139.53 164.79 28.97 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.743 0.417 . . . . 70.35 110.863 -176.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 63.3 m -79.07 125.6 29.61 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.479 0.712 . . . . 73.3 110.719 -177.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.564 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -70.55 -63.2 1.14 Allowed 'General case' 0 C--O 1.24 0.559 0 O-C-N 123.966 0.792 . . . . 71.45 109.16 171.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -155.08 164.54 38.72 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.462 -1.245 . . . . 72.25 111.724 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 55.4 mt -126.13 111.36 14.56 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 105.545 -2.02 . . . . 63.34 105.545 173.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.477 ' SG ' HG23 ' B' ' 114' ' ' ILE . 31.5 t -119.12 140.18 50.56 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.733 -0.84 . . . . 73.52 108.733 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -160.02 136.2 8.74 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.101 0.477 . . . . 70.24 110.045 -170.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' B' ' 113' ' ' CYS . 88.7 t -132.94 151.6 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.746 1.219 . . . . 71.14 108.248 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.542 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 17.3 mt-30 -124.52 98.85 5.91 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.795 -1.187 . . . . 64.42 107.795 170.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.443 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 7.8 tp-100 -88.76 99.86 12.69 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.645 -0.872 . . . . 74.3 108.645 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.84 141.51 15.62 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.303 -1.119 . . . . 64.4 110.303 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.12 127.08 3.13 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 110.673 -0.971 . . . . 60.44 110.673 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 55.3 mt -89.78 127.41 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.788 0.835 . . . . 64.42 109.084 176.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -135.56 135.06 40.02 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.129 -1.434 . . . . 75.2 107.129 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 67.6 m -99.45 89.92 4.34 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.403 0.547 . . . . 63.24 110.864 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' B' ' 10' ' ' THR . 12.7 tt -95.54 141.43 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.221 1.008 . . . . 44.42 111.607 -172.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.16 166.73 32.42 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.604 0.761 . . . . 71.21 110.436 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.96 -51.55 1.3 Allowed Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.742 -0.663 . . . . 71.11 112.54 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 17.4 mm -90.71 152.82 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.483 0.713 . . . . 75.13 112.315 -174.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -157.07 157.52 34.74 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 114.628 -1.169 . . . . 74.54 110.056 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.11 -135.0 12.59 Favored Glycine 0 C--N 1.353 1.503 0 C-N-CA 123.264 0.459 . . . . 64.33 113.191 170.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m -82.97 -18.32 40.35 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.212 0.605 . . . . 62.13 110.587 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -57.06 -38.74 73.71 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.887 0.875 . . . . 64.44 111.203 173.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 17.1 ptp -78.57 -25.37 45.31 Favored 'General case' 0 C--O 1.208 -1.107 0 CA-C-O 119.112 -0.471 . . . . 72.14 111.412 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.63 -34.67 67.5 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 122.963 0.505 . . . . 72.45 111.967 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -75.27 -47.3 28.62 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.815 0.846 . . . . 53.43 111.184 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.11 -49.62 71.47 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.248 0.619 . . . . 64.43 111.415 -175.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 60.4 mt -72.51 -27.99 62.6 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.27 -0.877 . . . . 75.12 111.321 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.7 -0.26 64.56 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-O 119.688 -0.507 . . . . 70.24 113.88 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.5 -62.73 0.46 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 117.384 0.592 . . . . 65.11 111.643 -176.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.451 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 33.7 t80 -64.6 -46.36 82.98 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.986 0.914 . . . . 72.25 111.646 -171.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 39.9 m -73.58 -46.66 7.33 Favored Pre-proline 0 CA--C 1.567 1.624 0 N-CA-C 113.128 0.788 . . . . 64.04 113.128 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -69.12 -21.64 36.16 Favored 'Trans proline' 0 C--N 1.395 2.994 0 C-N-CA 122.022 1.815 . . . . 70.11 113.264 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -57.62 -36.34 71.67 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 124.112 0.965 . . . . 64.11 111.118 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.491 HD13 HD11 ' B' ' 13' ' ' ILE . 68.9 mt -68.74 -43.14 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.666 1.186 . . . . 75.22 110.945 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 78.4 mt -82.94 -22.39 33.82 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.858 -1.065 . . . . 60.33 111.923 -172.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -55.54 -51.34 80.88 Favored Pre-proline 0 CA--C 1.562 1.433 0 CA-C-O 117.655 -1.164 . . . . 73.12 113.062 -175.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.14 -38.47 94.84 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 122.257 1.972 . . . . 65.13 113.744 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -69.41 -48.88 59.68 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.183 0.593 . . . . 74.15 110.747 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -62.93 -39.87 95.91 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.066 0.546 . . . . 64.43 111.194 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -59.38 -53.97 52.13 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.064 1.346 . . . . 71.4 111.146 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -68.19 -31.63 71.29 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.533 0.733 . . . . 43.15 110.032 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.492 ' O ' ' HG2' ' B' ' 117' ' ' MET . 12.6 t -68.16 -33.67 74.9 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.984 0.514 . . . . 74.31 111.188 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.477 HG23 ' SG ' ' B' ' 76' ' ' CYS . 78.9 mt -68.14 -52.23 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.162 0.585 . . . . 62.22 109.764 172.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.4 m -59.19 -30.44 68.21 Favored 'General case' 0 CA--C 1.553 1.074 0 O-C-N 123.971 0.794 . . . . 74.3 111.666 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 37.3 t -64.38 -50.77 66.37 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 123.498 0.719 . . . . 71.23 109.976 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.4 mmt -69.27 -32.48 71.69 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 123.615 0.572 . . . . 74.45 111.223 -174.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 114' ' ' ILE . 89.4 t -61.95 -47.44 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.653 0.781 . . . . 72.54 110.307 173.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 34.6 t -62.14 -37.3 84.65 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.81 -1.087 . . . . 73.44 110.799 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.424 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 93.1 mtt-85 -67.68 -32.3 72.87 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 115.435 -0.802 . . . . 74.11 110.612 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.76 4.7 84.36 Favored Glycine 0 C--N 1.349 1.302 0 O-C-N 123.717 0.636 . . . . 50.14 112.905 174.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 68.2 p 57.96 33.97 23.77 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 126.113 1.765 . . . . 74.32 113.204 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -93.99 163.8 22.55 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 123.99 0.916 . . . . 72.15 110.726 177.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.09 170.4 1.12 Allowed 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.537 2.825 . . . . 65.43 115.198 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -64.05 114.36 4.1 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.41 1.084 . . . . 72.14 110.903 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.94 84.72 2.24 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.157 -1.053 . . . . 54.3 108.157 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -108.81 118.53 37.02 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.629 0.772 . . . . 64.5 109.073 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.606 HD21 HD13 ' B' ' 42' ' ' LEU . 0.3 OUTLIER -70.85 133.03 46.14 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.505 0.722 . . . . 71.13 109.23 -177.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.76 144.04 98.38 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.428 0.691 . . . . 73.02 111.773 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.18 92.58 0.65 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.9 2.4 . . . . 73.15 112.686 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 48.3 t -98.13 110.11 25.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.434 -0.95 . . . . 74.43 108.434 172.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -89.87 114.09 25.8 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.026 -0.731 . . . . 73.03 109.026 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -60.88 -43.16 98.82 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.521 0.728 . . . . 73.51 111.0 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 N--CA 1.478 0.956 0 CA-C-N 114.837 -1.074 . . . . 65.24 112.734 -173.472 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' C' ' 85' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.472 0.673 0 CA-C-O 121.313 0.578 . . . . 75.43 109.5 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -134.74 128.28 32.61 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 107.84 -1.17 . . . . 75.01 107.84 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.607 HG13 ' HD3' ' A' ' 130' ' ' PRO . 63.0 mt -65.75 118.27 8.17 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 N-CA-C 107.987 -1.116 . . . . 62.41 107.987 173.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.549 ' HA ' HE21 ' C' ' 14' ' ' GLN . 0.0 OUTLIER -93.82 -36.82 12.07 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 123.981 0.801 . . . . 71.33 108.959 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -178.51 123.28 0.1 Allowed 'General case' 0 C--N 1.361 1.075 0 O-C-N 123.68 0.612 . . . . 61.21 110.766 -172.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.2 mt -109.85 137.91 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.838 1.255 . . . . 71.11 108.923 172.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.497 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 21.1 p90 -174.34 166.77 4.04 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.862 0.865 . . . . 74.31 109.972 -172.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.2 p -91.72 126.33 36.77 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.174 0.589 . . . . 51.23 109.532 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.497 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 14.9 mmtp -74.5 -50.07 19.68 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 107.759 -1.2 . . . . 72.12 107.759 168.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 19.8 t70 -136.08 141.98 44.28 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 113.627 -1.624 . . . . 73.33 109.883 -168.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.582 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 88.7 mt -138.37 145.51 28.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 106.604 -1.628 . . . . 73.51 106.604 175.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' C' ' 77' ' ' GLU . 42.2 t -154.9 150.11 27.09 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.763 0.825 . . . . 72.22 109.295 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 88.9 t80 -156.86 117.03 3.54 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 107.568 -1.271 . . . . 75.41 107.568 173.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -120.53 111.66 17.96 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.127 0.571 . . . . 73.42 110.146 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.97 82.96 43.68 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.379 1.072 . . . . 71.22 108.274 168.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -69.39 -31.39 22.26 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.588 2.192 . . . . 74.44 110.687 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -96.11 13.82 25.93 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.156 -1.384 . . . . 74.54 110.583 -175.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.99 -56.67 14.26 Favored Pre-proline 0 CA--C 1.566 1.59 0 N-CA-C 113.97 1.1 . . . . 64.4 113.97 -170.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -60.35 -41.41 50.13 Favored 'Trans proline' 0 C--N 1.395 3.014 0 C-N-CA 122.002 1.801 . . . . 71.22 112.075 -177.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -70.24 -38.1 75.1 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.447 -1.251 . . . . 73.43 112.298 -175.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.727 HG21 ' HA ' ' C' ' 73' ' ' ALA . 12.4 p -77.91 -23.02 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 112.471 0.545 . . . . 64.44 112.471 -173.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -64.77 -22.89 67.08 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.081 0.4 . . . . 73.41 112.081 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -103.98 29.51 5.83 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.952 0.901 . . . . 74.53 110.808 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.556 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -114.11 163.35 15.3 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.787 0.835 . . . . 73.23 109.533 173.412 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.52 120.87 11.36 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.621 0.768 . . . . 71.1 109.937 168.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -85.97 90.44 8.09 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.877 0.471 . . . . 75.54 111.133 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -150.25 76.97 8.39 Favored Pre-proline 0 N--CA 1.483 1.208 0 C-N-CA 124.913 1.285 . . . . 74.54 108.216 169.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -84.04 160.57 13.64 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.27 1.98 . . . . 74.32 112.609 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -87.1 119.47 27.35 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 106.207 -1.775 . . . . 65.23 106.207 168.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.578 HG11 HD11 ' C' ' 126' ' ' LEU . 34.9 m -91.36 97.19 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 122.469 1.128 . . . . 60.01 109.47 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.554 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 3.7 ttmp? -96.78 100.32 11.86 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 114.541 -1.208 . . . . 61.42 107.988 177.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 pp -87.93 149.53 24.01 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 109.358 -0.608 . . . . 63.02 109.358 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.482 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 33.6 t70 -149.0 114.17 5.49 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.276 0.63 . . . . 71.21 109.951 -173.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 9.1 mp -105.26 147.83 27.65 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.226 0.536 . . . . 71.44 110.519 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.496 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 5.7 t70 -136.36 151.06 49.15 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.334 1.454 . . . . 41.42 107.821 175.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 30.4 p -113.48 112.23 23.26 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.601 -0.518 . . . . 73.41 109.601 -177.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.11 151.62 37.19 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.349 1.06 . . . . 65.52 109.074 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.0 p -166.11 173.59 10.14 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.167 0.432 . . . . 73.32 112.167 -173.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 45.3 t -166.7 146.65 5.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.276 1.031 . . . . 72.52 109.286 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -88.38 118.61 28.12 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.891 -0.781 . . . . 65.03 108.891 170.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.618 HD11 HD12 ' C' ' 83' ' ' ILE . 65.4 mt -89.09 -38.98 13.95 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.352 0.661 . . . . 64.53 110.55 -177.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.53 -174.85 4.18 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.117 -0.947 . . . . 71.33 110.746 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -61.4 104.66 0.43 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 114.317 -1.311 . . . . 73.32 110.001 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 70.9 -2.71 2.22 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 125.894 1.677 . . . . 74.53 113.79 -175.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 71.2 t -93.71 115.61 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 107.748 -1.204 . . . . 54.11 107.748 175.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -133.35 136.99 45.7 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.718 0.771 . . . . 63.44 110.191 -170.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -86.98 113.13 22.48 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.664 1.586 . . . . 74.33 109.211 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 91.2 t -104.47 113.83 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 108.007 -1.109 . . . . 62.32 108.007 174.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -121.57 136.18 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 109.233 -0.655 . . . . 72.23 109.233 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.456 HD22 ' HB3' ' C' ' 103' ' ' PRO . 34.5 tp -120.44 115.96 24.52 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.596 -0.89 . . . . 53.2 108.596 175.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.496 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 15.3 ttm-85 -81.77 130.09 34.95 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.398 -0.964 . . . . 63.3 108.398 173.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.469 ' HB ' HD11 ' C' ' 114' ' ' ILE . 4.2 t -119.02 132.23 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 106.839 -1.541 . . . . 74.15 106.839 171.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.482 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 16.1 m -133.36 116.75 16.47 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.014 -0.736 . . . . 63.21 109.014 -177.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.632 HG21 HG21 ' C' ' 114' ' ' ILE . 62.7 t -105.31 114.71 45.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 123.835 0.854 . . . . 74.21 109.464 -175.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.554 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 18.5 m -101.79 139.11 37.87 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.559 -0.904 . . . . 64.11 108.559 172.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.46 114.58 13.03 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.887 -1.153 . . . . 74.34 107.887 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 31.4 m -137.0 130.42 31.41 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.104 0.478 . . . . 55.01 111.295 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.556 HD13 ' HG2' ' C' ' 34' ' ' LYS . 11.6 mt -86.32 46.88 1.39 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.795 1.238 . . . . 74.4 109.72 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.88 -109.67 3.56 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 110.699 -0.96 . . . . 75.14 110.699 -174.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -89.6 -23.93 21.82 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.467 0.707 . . . . 53.2 110.241 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -72.54 122.64 21.67 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 123.798 0.839 . . . . 72.23 110.005 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.0 m -82.94 128.04 34.09 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.976 -0.75 . . . . 74.04 108.976 168.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.727 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -80.52 -55.27 4.98 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 123.789 0.68 . . . . 73.3 109.525 172.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -162.6 175.65 11.18 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.116 0.96 . . . . 75.02 111.575 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.424 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -137.53 147.36 45.11 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 105.997 -1.853 . . . . 64.14 105.997 171.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.424 ' N ' HD13 ' C' ' 75' ' ' LEU . 41.9 t -147.78 153.26 38.99 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.588 -0.893 . . . . 71.34 108.588 176.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' C' ' 22' ' ' SER . 34.6 tt0 -158.1 133.25 8.66 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 122.847 0.459 . . . . 75.21 110.243 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.488 HG11 ' HA ' ' C' ' 110' ' ' ALA . 49.1 t -137.52 114.43 12.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.481 1.112 . . . . 65.24 108.547 177.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.486 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 58.4 mt-30 -95.85 94.17 7.49 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.693 -0.854 . . . . 75.15 108.693 174.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.51 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.5 tp-100 -82.27 111.01 17.96 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.454 -0.794 . . . . 74.52 109.693 -176.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.46 148.08 18.86 Favored Glycine 0 C--N 1.335 0.522 0 O-C-N 123.827 0.705 . . . . 51.44 112.079 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.05 118.57 0.97 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.096 -1.201 . . . . 72.31 110.096 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.618 HD12 HD11 ' C' ' 51' ' ' LEU . 15.0 mm -84.42 128.13 39.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.617 -0.883 . . . . 55.34 108.617 176.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.466 ' HB2' HD11 ' C' ' 86' ' ' ILE . 26.5 m-85 -136.42 149.13 48.12 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.883 -1.154 . . . . 74.25 107.883 176.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 19.4 p -102.61 109.75 21.46 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 108.949 -0.759 . . . . 62.22 108.949 174.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.466 HD11 ' HB2' ' C' ' 84' ' ' PHE . 4.4 mp -108.58 122.08 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.107 0.563 . . . . 75.04 109.95 -167.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.56 167.58 27.62 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 114.538 -1.21 . . . . 51.04 109.651 175.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.46 -60.67 0.36 Allowed Glycine 0 C--N 1.344 0.973 0 CA-C-N 116.104 -0.498 . . . . 71.45 113.088 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 41.0 pt -113.33 167.55 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.202 0.525 . . . . 75.2 111.294 -176.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -149.18 -177.49 5.85 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.975 -1.011 . . . . 71.34 110.106 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.36 -139.99 42.56 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.68 -0.691 . . . . 44.04 114.077 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 39.4 p -68.99 -27.52 65.78 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.91 0.884 . . . . 64.34 111.33 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -61.48 -45.28 94.9 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.302 0.641 . . . . 74.15 110.157 175.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 9.8 ptm -77.32 -21.8 52.9 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-O 119.221 -0.419 . . . . 62.33 111.068 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.32 -36.72 82.05 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.193 0.52 . . . . 65.22 109.947 172.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.481 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 46.3 t-80 -60.9 -33.26 72.86 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.783 0.833 . . . . 73.33 110.744 173.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -77.79 -57.87 3.57 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.039 -0.528 . . . . 73.03 110.704 176.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.428 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 96.0 mt -71.18 -37.84 72.15 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.101 0.96 . . . . 62.1 113.386 -165.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.2 -11.15 34.69 Favored Glycine 0 N--CA 1.471 0.993 0 CA-C-O 120.007 -0.329 . . . . 71.34 113.871 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.482 ' HB1' ' HB2' ' C' ' 134' ' ' ASP . . . -116.82 -57.61 2.16 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 117.161 0.481 . . . . 74.41 110.742 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -76.74 -47.72 20.92 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.467 0.707 . . . . 74.14 112.506 -174.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.428 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 58.6 m -65.11 -46.57 73.25 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 123.886 0.875 . . . . 54.44 112.722 -173.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.456 ' HB3' HD22 ' C' ' 60' ' ' LEU . 14.1 Cg_exo -72.1 -15.83 28.83 Favored 'Trans proline' 0 C--N 1.392 2.858 0 C-N-CA 122.148 1.899 . . . . 74.45 112.352 176.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -74.48 -33.26 62.81 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.465 0.706 . . . . 75.35 110.083 175.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.521 HD12 HH12 ' A' ' 111' ' ' ARG . 48.0 mm -61.34 -40.74 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 115.607 -0.724 . . . . 73.13 109.279 170.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 81.4 mt -87.25 -18.9 29.17 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.852 -1.067 . . . . 65.5 112.923 -173.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -57.72 -51.6 80.55 Favored Pre-proline 0 CA--C 1.559 1.316 0 CA-C-O 117.755 -1.117 . . . . 62.24 113.5 -174.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.17 -30.73 91.97 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 122.032 1.821 . . . . 72.41 113.399 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -68.77 -49.48 58.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.248 0.619 . . . . 63.43 110.643 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -65.16 -35.85 82.39 Favored 'General case' 0 C--N 1.355 0.843 0 CA-C-N 115.759 -0.655 . . . . 74.12 110.684 177.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -58.82 -51.08 71.51 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.381 1.073 . . . . 70.01 110.746 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.74 -37.57 79.52 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.789 -0.448 . . . . 53.05 109.789 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.9 t -66.06 -31.83 72.94 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.042 0.537 . . . . 71.1 111.51 -176.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.632 HG21 HG21 ' C' ' 64' ' ' VAL . 96.7 mt -72.63 -54.98 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.358 -0.608 . . . . 73.22 109.358 173.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.9 m -60.31 -28.25 67.97 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.935 0.772 . . . . 40.45 111.278 -175.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 30.6 t -66.7 -49.83 64.8 Favored 'General case' 0 C--O 1.213 -0.844 0 N-CA-C 108.734 -0.839 . . . . 62.22 108.734 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.553 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.4 -37.31 83.0 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.454 1.102 . . . . 75.4 112.401 178.17 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.443 HG23 ' O ' ' C' ' 114' ' ' ILE . 76.4 t -63.24 -45.29 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.718 0.807 . . . . 64.35 109.044 174.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 44.5 t -70.55 -26.26 63.47 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.561 -1.2 . . . . 71.21 112.113 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -75.83 -40.56 54.66 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.632 0.773 . . . . 73.24 108.949 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.27 -0.39 61.56 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 123.903 0.752 . . . . 64.35 112.348 168.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 31.0 p 62.75 28.4 16.49 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.692 1.997 . . . . 74.5 113.415 170.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -83.57 141.24 41.72 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 107.997 -1.112 . . . . 73.2 107.997 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -50.98 156.46 4.82 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 123.682 2.922 . . . . 64.34 114.232 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -50.62 111.83 0.6 Allowed 'General case' 0 N--CA 1.481 1.094 0 O-C-N 124.473 1.108 . . . . 71.23 112.695 -171.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.578 HD11 HG11 ' C' ' 40' ' ' VAL . 31.2 tp -112.73 87.51 2.6 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.217 -1.401 . . . . 62.24 107.217 171.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -107.69 107.67 18.57 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.149 -1.056 . . . . 72.1 108.149 -172.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 30.7 tp -65.99 142.59 57.79 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.519 0.512 . . . . 62.34 111.157 -174.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.29 152.92 95.65 Favored Pre-proline 0 CA--C 1.555 1.141 0 O-C-N 124.072 0.858 . . . . 63.52 110.888 178.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.473 ' HG2' HG21 ' A' ' 13' ' ' ILE . 51.4 Cg_exo -54.77 143.84 68.58 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.965 2.443 . . . . 75.13 113.559 177.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.0 p -128.6 110.35 21.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-O 122.665 1.221 . . . . 72.43 109.595 173.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -92.06 84.39 5.29 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.63 -1.989 . . . . 63.04 105.63 169.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -47.15 -44.29 21.7 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.765 0.826 . . . . 73.13 111.883 -171.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . 0.482 ' HB2' ' HB1' ' C' ' 100' ' ' ALA . 16.1 t70 . . . . . 0 N--CA 1.476 0.841 0 CA-C-N 114.628 -1.169 . . . . 64.11 112.468 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 59.8 m . . . . . 0 C--O 1.242 0.693 0 N-CA-C 108.307 -0.997 . . . . 75.24 108.307 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -157.38 118.74 3.66 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.486 -1.302 . . . . 74.45 107.486 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -123.87 115.29 21.07 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.255 -1.017 . . . . 71.24 108.255 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.438 HG21 HD11 ' D' ' 16' ' ' ILE . 56.7 mt -75.72 123.95 32.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.586 -0.894 . . . . 72.3 108.586 173.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -89.81 -40.14 12.65 Favored 'General case' 0 C--O 1.245 0.836 0 O-C-N 123.473 0.483 . . . . 73.32 111.239 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -175.9 128.74 0.24 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 119.645 -0.217 . . . . 73.4 110.929 -163.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.438 HD11 HG21 ' D' ' 13' ' ' ILE . 3.4 mp -112.05 140.89 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.924 -1.139 . . . . 75.23 107.924 166.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.472 ' HE1' HG13 ' D' ' 83' ' ' ILE . 26.0 p90 -161.91 168.43 22.95 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 124.257 0.973 . . . . 71.24 110.41 -177.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -99.46 120.74 40.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.595 -1.184 . . . . 73.23 109.251 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -90.29 -18.32 25.81 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.92 -0.582 . . . . 70.44 109.56 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.1 t70 -160.99 141.05 10.98 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 114.691 -1.141 . . . . 71.22 109.686 177.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.553 HG21 ' HE2' ' C' ' 117' ' ' MET . 67.0 mt -139.14 140.55 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.978 1.311 . . . . 75.23 107.475 174.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.7 t -142.49 140.04 31.73 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.089 0.955 . . . . 42.25 108.927 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.582 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 94.3 t80 -152.19 119.02 5.76 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 106.527 -1.657 . . . . 73.53 106.527 173.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 28.9 mt-10 -134.58 108.64 8.18 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.834 -0.802 . . . . 70.3 108.834 -173.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.4 92.03 9.26 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 109.007 -0.738 . . . . 74.44 109.007 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.74 -52.72 0.39 Allowed 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.044 2.496 . . . . 73.35 112.342 -172.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -94.23 13.25 23.99 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-N 114.943 -1.026 . . . . 73.33 110.32 -174.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -28.7 -61.97 0.21 Allowed Pre-proline 0 CA--C 1.566 1.591 0 N-CA-C 115.984 1.846 . . . . 74.14 115.984 -165.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.408 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 91.2 Cg_endo -78.04 -22.97 9.57 Favored 'Trans proline' 0 C--N 1.384 2.401 0 CA-C-N 122.782 2.029 . . . . 74.11 113.905 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -71.08 -41.3 70.85 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.592 1.157 . . . . 75.43 109.359 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.633 HG22 HD12 ' D' ' 68' ' ' LEU . 9.9 p -83.52 -20.69 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.614 -0.721 . . . . 72.41 111.617 -171.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.4 m-85 -61.85 -28.37 69.44 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.002 0.429 . . . . 75.12 111.71 176.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -59.4 -25.62 64.44 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.79 -1.095 . . . . 51.14 110.341 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -86.28 87.01 7.35 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.538 1.135 . . . . 74.42 109.834 170.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -84.04 93.07 8.01 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.003 -0.999 . . . . 72.42 110.944 -177.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 36.9 p90 -164.36 171.27 15.0 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.21 1.004 . . . . 64.42 109.428 167.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.606 HE21 ' HD2' ' D' ' 38' ' ' PRO . 27.7 tp60 -60.76 113.37 7.5 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 123.792 0.837 . . . . 72.33 109.051 176.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.741 ' HD3' ' HG2' ' D' ' 124' ' ' PRO . 62.7 Cg_exo -52.93 124.03 14.52 Favored 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 122.77 2.313 . . . . 43.04 111.693 -177.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -68.02 111.63 4.54 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 124.38 1.05 . . . . 64.13 108.186 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.462 HG13 ' O ' ' D' ' 38' ' ' PRO . 16.6 m -99.86 144.66 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.973 0.892 . . . . 73.23 112.507 -165.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.503 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 17.7 tppt? -113.93 113.46 24.88 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.622 -1.621 . . . . 72.1 106.622 171.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 pp -94.87 141.06 29.08 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 108.069 -1.086 . . . . 51.42 108.069 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.599 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 32.8 t70 -145.68 138.13 25.67 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.487 0.715 . . . . 72.22 109.081 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -116.21 134.96 54.34 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.901 -0.777 . . . . 60.43 108.901 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 35.4 t70 -136.67 157.76 46.03 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 106.832 -1.544 . . . . 64.31 106.832 170.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.9 t -137.09 154.09 50.4 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.256 0.55 . . . . 73.15 111.328 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.494 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.38 165.77 32.08 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.906 1.283 . . . . 61.31 108.838 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 32.0 p -172.55 153.89 2.96 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.047 0.539 . . . . 71.44 111.649 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 33.7 p -157.2 120.33 4.06 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 114.722 -1.127 . . . . 42.54 108.554 173.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' D' ' 56' ' ' TYR . 61.7 tt0 -65.59 129.16 38.77 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.353 -0.61 . . . . 74.21 109.353 173.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 76.9 mt -94.96 -38.16 10.81 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.073 0.549 . . . . 63.53 110.971 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.89 -170.3 2.68 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.128 0.49 . . . . 63.24 111.294 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.44 118.13 7.67 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.839 -1.073 . . . . 74.1 109.739 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 67.83 -1.29 1.73 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.833 1.253 . . . . 64.24 112.794 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.56 123.91 65.83 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 N-CA-C 108.954 -0.758 . . . . 43.3 108.954 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.475 ' HA ' ' HA ' ' D' ' 50' ' ' GLN . 0.1 OUTLIER -136.13 150.05 48.92 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.959 -0.756 . . . . 72.0 108.959 177.002 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -110.55 134.38 52.44 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.504 -1.295 . . . . 61.22 107.504 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 76.9 t -127.28 131.16 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.617 1.167 . . . . 75.3 108.814 -172.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 21.7 t -121.56 131.94 71.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 123.446 0.699 . . . . 74.53 109.67 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.579 HD23 HD12 ' D' ' 106' ' ' LEU . 3.9 mm? -117.87 107.97 14.76 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.447 -0.946 . . . . 73.52 108.447 168.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.559 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 15.8 ttm-85 -82.24 101.9 10.81 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.876 0.87 . . . . 74.31 109.08 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 84.7 t -94.09 129.99 43.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.725 -0.843 . . . . 74.42 108.725 174.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 21.7 m -125.03 133.33 53.0 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.804 0.442 . . . . 73.55 110.194 -176.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 42.2 t -124.81 101.07 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.667 1.187 . . . . 64.22 108.703 175.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 93.4 m -92.99 106.45 18.41 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.881 -1.155 . . . . 74.14 107.881 170.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.61 142.37 42.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.893 -0.594 . . . . 50.12 110.011 -171.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.429 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 19.8 m -145.15 137.01 25.59 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.122 -0.49 . . . . 75.33 110.57 -175.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.633 HD12 HG22 ' D' ' 31' ' ' VAL . 21.2 mt -105.14 110.82 23.34 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.071 -1.085 . . . . 65.34 108.071 172.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.54 -130.01 17.48 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 116.229 -0.441 . . . . 43.11 113.242 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -89.6 4.19 50.18 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.348 0.659 . . . . 65.55 111.92 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -131.8 158.78 40.35 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.695 0.398 . . . . 74.23 110.518 -173.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.3 m -71.29 138.01 49.0 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.355 -0.839 . . . . 74.22 111.103 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.461 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.48 -62.24 1.52 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.946 -1.131 . . . . 60.25 107.946 173.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -156.61 159.53 38.56 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.583 -1.19 . . . . 74.34 110.556 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 85.7 mt -121.97 108.84 13.87 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.48 -1.304 . . . . 63.12 107.48 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.626 ' SG ' HG12 ' D' ' 114' ' ' ILE . 45.9 t -117.14 135.27 53.88 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.749 0.82 . . . . 75.32 109.272 -173.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -155.43 126.18 6.96 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.78 0.432 . . . . 63.42 110.033 175.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.43 118.74 46.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 123.819 0.848 . . . . 63.5 109.527 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.4 mt-30 -87.71 88.45 7.67 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.272 -1.01 . . . . 73.14 108.272 170.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -80.85 98.38 7.81 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 115.092 -0.958 . . . . 72.54 109.102 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.32 169.55 33.26 Favored Glycine 0 C--O 1.244 0.772 0 CA-C-N 115.74 -0.663 . . . . 64.01 112.33 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.63 133.33 2.86 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 112.058 -0.417 . . . . 60.2 112.058 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.472 HG13 ' HE1' ' D' ' 17' ' ' TYR . 57.7 mt -88.41 123.84 41.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 107.847 -1.168 . . . . 71.1 107.847 173.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -131.61 157.12 44.52 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.123 0.969 . . . . 35.02 109.718 -175.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 43.2 m -117.21 136.23 53.21 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.029 0.932 . . . . 73.44 110.2 175.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.412 HD12 ' O ' ' D' ' 86' ' ' ILE . 2.3 pp -130.77 141.71 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.554 1.141 . . . . 71.15 109.956 175.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.13 161.07 10.18 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.158 0.983 . . . . 71.55 108.639 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.44 21.04 79.93 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 121.426 -0.416 . . . . 54.12 113.382 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.512 HG23 HE21 ' D' ' 93' ' ' GLN . 12.7 mt -118.86 152.56 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.464 0.705 . . . . 73.53 109.933 -172.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -157.4 148.12 21.28 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.945 1.298 . . . . 64.3 110.557 175.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.57 -125.53 28.79 Favored Glycine 0 C--N 1.353 1.492 0 O-C-N 124.085 0.866 . . . . 62.53 114.9 169.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.2 m -72.0 -24.9 61.65 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.763 0.825 . . . . 53.43 111.803 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.512 HE21 HG23 ' D' ' 89' ' ' ILE . 25.6 tt0 -61.78 -29.9 70.45 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.328 0.651 . . . . 74.24 109.976 175.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 49.5 mtt -70.8 -44.09 67.33 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.918 0.887 . . . . 72.3 110.692 173.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.85 -36.83 82.36 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.379 0.672 . . . . 73.2 111.34 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -78.85 -29.97 44.91 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.116 0.566 . . . . 45.33 110.696 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 41.1 t -60.38 -51.09 70.99 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.413 0.685 . . . . 54.24 112.311 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.15 -17.07 14.43 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 115.492 -0.776 . . . . 72.31 112.258 -174.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.89 -25.62 29.02 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-O 120.119 -0.267 . . . . 72.54 112.867 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.14 -63.37 1.45 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.009 0.524 . . . . 62.3 110.935 -178.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -62.38 -53.99 46.83 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 112.744 0.646 . . . . 75.01 112.744 -169.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 59.1 m -59.04 -45.43 99.52 Favored Pre-proline 0 N--CA 1.494 1.753 0 CA-C-O 118.612 -0.709 . . . . 75.44 112.563 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -51.71 -46.64 30.68 Favored 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.639 2.226 . . . . 62.15 113.665 165.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -67.64 -15.54 63.7 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 123.376 0.67 . . . . 63.31 112.202 -178.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 35.9 mm -86.61 -49.43 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.285 0.634 . . . . 61.33 109.863 173.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.579 HD12 HD23 ' D' ' 60' ' ' LEU . 91.4 mt -79.52 -30.53 41.92 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.352 0.871 . . . . 50.33 113.352 -168.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -65.6 -39.25 31.23 Favored Pre-proline 0 N--CA 1.49 1.572 0 CA-C-O 118.174 -0.917 . . . . 73.51 113.264 -177.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -49.55 -45.97 28.78 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 122.62 2.213 . . . . 74.23 114.626 166.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -74.57 -36.16 63.06 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.063 0.545 . . . . 64.14 111.581 -177.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.16 -46.59 86.42 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.641 -0.503 . . . . 51.14 109.641 174.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -54.49 -49.59 69.77 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 124.706 1.254 . . . . 54.33 110.606 177.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -62.56 -43.63 98.34 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.797 0.686 . . . . 64.34 111.093 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.9 t -61.76 -44.0 97.76 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 123.761 0.663 . . . . 75.34 110.859 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.626 HG12 ' SG ' ' D' ' 76' ' ' CYS . 97.2 mt -60.61 -59.1 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.14 0.976 . . . . 73.21 110.217 175.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 37.0 m -52.98 -38.95 62.66 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.461 1.504 . . . . 64.22 111.551 -176.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.0 t -66.76 -47.06 73.4 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 114.889 -1.05 . . . . 53.14 110.344 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.8 mtm -67.17 -32.28 73.26 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.787 0.435 . . . . 72.5 111.763 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.5 t -61.9 -46.66 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.776 0.83 . . . . 63.34 109.887 174.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.1 p -76.89 -24.99 52.53 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.809 -0.632 . . . . 75.33 111.51 -177.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -74.02 -37.31 64.4 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.389 0.676 . . . . 73.04 109.52 175.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.8 4.39 65.6 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 115.561 -0.745 . . . . 62.44 112.27 170.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 47.8 p 59.12 23.09 11.3 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 126.947 2.099 . . . . 44.42 114.012 174.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -78.02 149.79 77.11 Favored Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 108.643 -0.873 . . . . 72.41 108.643 169.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.741 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 4.8 Cg_endo -53.42 133.82 54.8 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.675 2.25 . . . . 71.12 112.295 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -50.98 135.76 24.14 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.833 1.333 . . . . 73.13 112.654 -171.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 64.6 tp -114.77 103.06 10.59 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.881 0.872 . . . . 53.21 109.006 -177.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . 0.493 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 86.2 m-20 -99.51 101.29 12.48 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.829 -0.804 . . . . 74.44 108.829 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 tt -66.78 115.98 7.17 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 108.172 -1.047 . . . . 71.14 108.172 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.739 ' HB2' HE22 ' B' ' 12' ' ' GLN . . . -65.15 140.54 97.99 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 123.515 0.726 . . . . 75.5 110.72 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.451 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 5.6 Cg_exo -72.18 151.25 54.83 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.81 2.34 . . . . 72.24 111.981 -171.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 123.637 0.775 . . . . 74.44 110.182 -178.796 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.663 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 35.7 t80 . . . . . 0 C--O 1.239 0.525 0 N-CA-C 109.908 -0.404 . . . . 63.35 109.908 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -152.92 132.96 13.38 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.201 1.0 . . . . 52.03 108.818 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.68 HG12 ' HD2' ' A' ' 84' ' ' PHE . 57.6 mt -93.49 121.25 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.104 -0.702 . . . . 65.13 109.104 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -85.3 -33.98 21.99 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.591 0.756 . . . . 64.25 110.328 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -171.06 142.47 1.82 Allowed 'General case' 0 C--N 1.352 0.717 0 O-C-N 123.411 0.445 . . . . 72.1 110.65 -174.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.458 HD12 ' HG3' ' C' ' 130' ' ' PRO . 78.6 mt -131.75 134.02 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 107.962 -1.125 . . . . 75.45 107.962 170.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -163.06 176.94 9.57 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 124.168 0.917 . . . . 64.32 110.838 -174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.4 p -100.06 121.52 41.52 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.178 -0.919 . . . . 72.21 109.035 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HG3' ' HA3' ' A' ' 81' ' ' GLY . 24.8 mtpt -84.28 -37.36 21.78 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.975 0.417 . . . . 74.43 109.935 178.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 24.4 t70 -143.28 135.28 26.84 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.122 -0.944 . . . . 74.53 109.288 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.485 HD13 ' SD ' ' B' ' 117' ' ' MET . 77.5 mt -128.74 140.02 50.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.217 -1.401 . . . . 72.24 107.217 175.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.9 t -151.31 110.98 4.02 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.071 0.462 . . . . 74.4 110.1 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -110.4 132.76 53.89 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.306 -1.368 . . . . 75.44 107.306 169.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -130.57 140.35 50.46 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.878 -1.156 . . . . 73.31 107.878 173.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.38 76.4 56.25 Favored Pre-proline 0 C--O 1.241 0.644 0 N-CA-C 106.208 -1.775 . . . . 71.25 106.208 169.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -62.5 -34.49 75.5 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.985 2.457 . . . . 65.15 112.794 -168.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 -109.1 22.79 15.43 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.467 -0.778 . . . . 63.01 110.224 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.583 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -42.46 -53.84 8.74 Favored Pre-proline 0 N--CA 1.499 1.998 0 N-CA-C 114.097 1.147 . . . . 75.51 114.097 -170.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -65.17 -29.24 55.92 Favored 'Trans proline' 0 C--N 1.387 2.581 0 CA-C-N 121.174 1.455 . . . . 73.15 112.641 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -82.56 -35.21 27.4 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.485 1.114 . . . . 65.25 110.843 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.692 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.3 p -78.68 -20.95 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 115.125 -0.943 . . . . 73.23 112.54 -161.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -71.85 -19.13 62.01 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-O 120.972 0.415 . . . . 72.21 111.002 176.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -77.88 -25.31 48.48 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.464 1.105 . . . . 64.23 110.695 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -76.58 149.49 36.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.805 0.842 . . . . 74.23 110.863 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.2 138.1 58.43 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 124.007 0.817 . . . . 74.42 109.303 170.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -84.01 92.0 7.75 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.713 -0.477 . . . . 72.13 109.713 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -127.53 82.89 67.42 Favored Pre-proline 0 C--O 1.243 0.755 0 N-CA-C 107.962 -1.125 . . . . 71.02 107.962 170.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.95 125.13 7.81 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.48 2.12 . . . . 75.42 112.677 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -98.87 96.62 7.99 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 106.76 -1.57 . . . . 61.32 106.76 165.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.7 t -75.55 94.51 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 115.948 -0.569 . . . . 74.33 109.662 -175.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.473 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 14.2 mptt -78.68 111.74 15.08 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 107.641 -1.244 . . . . 73.51 107.641 170.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.98 138.52 47.28 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.707 0.803 . . . . 63.14 108.925 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.543 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 21.2 t70 -141.64 140.75 33.35 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.784 1.234 . . . . 71.34 108.483 -172.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.4 mt -123.16 136.95 54.99 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.13 0.572 . . . . 74.22 110.453 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 18.0 t70 -134.25 147.14 50.62 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 114.781 -1.099 . . . . 71.5 108.428 175.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.1 m -106.57 131.65 53.48 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.958 0.903 . . . . 73.11 110.258 -173.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.71 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -131.53 105.41 7.54 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.795 -1.187 . . . . 54.13 107.795 169.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 24.5 m -95.93 152.01 18.9 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.246 -1.02 . . . . 53.0 108.246 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 31.2 t -159.25 142.59 14.59 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.121 0.568 . . . . 71.41 109.961 -176.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -112.72 130.28 56.11 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.016 -1.105 . . . . 62.34 108.016 168.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.0 mt -104.26 -38.1 7.01 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.215 0.606 . . . . 75.24 110.524 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.516 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -156.05 -170.46 3.4 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.241 0.617 . . . . 53.22 110.381 -178.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.82 113.89 3.7 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.509 1.124 . . . . 44.44 110.023 173.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 85' ' ' SER . 32.1 m-20 69.71 -2.56 1.93 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.369 1.468 . . . . 65.33 112.906 -176.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.516 ' CG2' ' HB3' ' A' ' 52' ' ' ALA . 39.3 t -95.75 113.29 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 107.574 -1.269 . . . . 62.44 107.574 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -127.29 125.87 41.64 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.943 -0.762 . . . . 72.21 108.943 -176.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 40.5 tt0 -92.94 116.83 29.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.304 -0.862 . . . . 72.34 108.947 175.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.434 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 54.1 t -100.2 118.61 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 106.368 -1.716 . . . . 72.53 106.368 174.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.71 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 29.5 t -118.46 121.19 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.732 -0.84 . . . . 62.45 108.732 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.35 113.52 26.24 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.476 -0.935 . . . . 73.04 108.476 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.506 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 50.1 ttt180 -83.01 101.75 11.3 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.326 -0.991 . . . . 64.23 108.326 174.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.07 102.46 13.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.96 -1.126 . . . . 73.23 107.96 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 28.5 m -97.34 126.03 42.32 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.036 -0.727 . . . . 73.14 109.036 178.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.54 HG11 HD21 ' A' ' 126' ' ' LEU . 75.1 t -122.54 139.92 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.345 1.058 . . . . 72.32 108.265 176.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 17.5 m -136.03 141.69 44.35 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.375 -0.972 . . . . 75.24 108.375 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.61 117.2 32.86 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.619 -1.252 . . . . 71.31 107.619 171.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.6 m -113.06 126.36 55.39 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.878 0.471 . . . . 73.12 109.905 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 mt -98.92 83.25 2.88 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.42 1.088 . . . . 72.42 108.326 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.43 -83.84 1.09 Allowed Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.902 -0.59 . . . . 62.35 112.003 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.73 -25.07 3.72 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.113 0.965 . . . . 73.24 110.188 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -95.85 133.79 39.58 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.688 0.795 . . . . 63.44 109.945 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.5 m -74.34 139.48 44.18 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 122.852 0.461 . . . . 63.12 110.545 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.692 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -82.11 -61.31 1.94 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.696 0.798 . . . . 73.21 109.067 172.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -154.63 168.5 26.58 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.597 -1.183 . . . . 64.44 111.413 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 64' ' ' VAL . 54.5 tp -122.61 139.53 53.83 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.948 1.299 . . . . 62.44 108.376 172.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 79.2 m -140.81 98.18 3.34 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.48 1.112 . . . . 63.51 110.098 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -115.94 127.99 55.4 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.556 0.742 . . . . 73.04 109.25 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.2 t -133.03 113.47 19.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 C-N-CA 123.267 0.627 . . . . 74.41 109.668 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -85.59 89.0 7.6 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.07 -0.968 . . . . 72.35 108.845 173.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.458 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.9 tp-100 -80.83 107.5 13.7 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.331 -0.849 . . . . 74.21 109.298 -177.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.406 ' HA3' ' HG3' ' A' ' 19' ' ' LYS . . . -98.41 144.44 17.24 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 111.537 -0.625 . . . . 73.45 111.537 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.29 125.56 2.48 Favored Glycine 0 C--N 1.33 0.197 0 N-CA-C 111.54 -0.624 . . . . 62.2 111.54 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.1 mt -81.49 120.48 33.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.663 -0.866 . . . . 63.0 108.663 173.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.68 ' HD2' HG12 ' A' ' 13' ' ' ILE . 21.5 m-85 -136.23 120.44 17.83 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.553 -0.906 . . . . 73.33 108.553 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 66.7 m -89.84 113.27 24.83 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.456 -0.572 . . . . 71.41 109.456 171.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.477 0.909 0 C-N-CA 123.546 0.739 . . . . 75.13 109.996 -179.799 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.599 0.238 . . . . 51.31 111.228 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -67.42 -35.61 79.61 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.858 -0.61 . . . . 71.4 110.582 171.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.682 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 71.5 m -71.08 -66.07 0.66 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.179 0.192 . . . . 61.43 111.215 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.63 -25.4 67.35 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.455 0.702 . . . . 72.0 112.751 -175.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.81 -24.81 22.15 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-O 119.909 -0.384 . . . . 63.3 113.752 -176.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.46 -64.66 0.88 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 117.206 0.503 . . . . 74.55 111.301 -175.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.682 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 83.3 t80 -69.29 -60.47 2.32 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.303 1.041 . . . . 73.14 112.967 -164.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.7 m -62.29 -39.01 52.77 Favored Pre-proline 0 CA--C 1.569 1.701 0 N-CA-C 114.024 1.12 . . . . 44.15 114.024 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -66.49 -28.61 45.64 Favored 'Trans proline' 0 C--N 1.389 2.679 0 CA-C-N 121.366 1.524 . . . . 74.3 112.853 166.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -79.96 -14.64 58.44 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.358 0.663 . . . . 73.22 110.477 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 35.1 mm -68.2 -39.75 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 108.472 -0.936 . . . . 73.15 108.472 168.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.458 HD22 ' HG3' ' A' ' 80' ' ' GLN . 77.2 mt -78.29 -23.66 47.1 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.135 -0.939 . . . . 73.23 112.129 -177.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -59.45 -47.41 97.99 Favored Pre-proline 0 CA--C 1.571 1.759 0 CA-C-O 117.862 -1.066 . . . . 75.54 113.502 -174.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -63.15 -37.13 53.81 Favored 'Trans proline' 0 C--N 1.392 2.857 0 C-N-CA 121.988 1.792 . . . . 71.45 113.224 176.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -72.14 -38.02 69.32 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.131 0.572 . . . . 74.24 111.097 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.52 -42.06 71.76 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.242 0.617 . . . . 51.3 110.207 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.43 ' NH1' HG23 ' C' ' 105' ' ' ILE . 25.7 ttm180 -60.58 -44.82 95.79 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.171 0.919 . . . . 74.51 109.597 175.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -65.24 -43.58 90.92 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.136 0.974 . . . . 75.24 111.687 -176.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.403 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 47.5 t -61.7 -43.49 98.76 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.959 0.787 . . . . 73.31 109.816 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' ' 118' ' ' VAL . 67.4 mt -61.69 -47.81 91.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 124.436 1.094 . . . . 53.21 110.756 174.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.3 m -59.52 -39.23 83.22 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.376 1.07 . . . . 75.44 110.816 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 42.9 t -67.64 -46.71 71.67 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 115.184 -0.916 . . . . 74.41 110.605 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 18.2 mtp -59.21 -41.59 88.95 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.969 0.908 . . . . 55.23 111.504 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.506 HG21 HD23 ' A' ' 126' ' ' LEU . 74.0 t -65.8 -51.28 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.237 1.015 . . . . 73.34 110.631 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.4 t -66.11 -27.78 68.31 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.597 -0.728 . . . . 73.23 111.091 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 116' ' ' SER . 30.2 ttm-85 -77.59 -31.61 53.14 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.302 1.041 . . . . 74.23 109.334 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.425 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.42 11.27 61.63 Favored Glycine 0 C--N 1.356 1.657 0 CA-C-N 114.673 -1.148 . . . . 54.3 112.811 170.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.503 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.3 t 64.23 15.59 9.49 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 127.045 2.138 . . . . 64.22 113.925 172.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -80.61 153.12 73.25 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.06 0.544 . . . . 64.44 109.91 178.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.8 155.14 23.49 Favored 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 123.252 2.635 . . . . 62.04 113.569 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -56.41 120.21 7.3 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.383 1.073 . . . . 61.45 112.645 -170.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.54 HD21 HG11 ' A' ' 64' ' ' VAL . 64.0 tp -121.86 106.13 10.99 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.417 1.087 . . . . 64.21 109.894 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -127.09 126.15 42.49 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.947 0.899 . . . . 62.14 108.853 169.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.8 mp -72.15 142.11 49.1 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.215 -0.661 . . . . 71.41 109.215 174.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.58 150.13 94.33 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 122.82 0.448 . . . . 72.13 110.171 176.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.721 ' HG3' ' HD2' ' C' ' 11' ' ' PHE . 44.7 Cg_endo -61.33 154.14 60.62 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.718 2.279 . . . . 74.33 112.779 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.1 m -119.17 116.25 50.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 109.079 -0.712 . . . . 73.42 109.079 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -94.09 64.85 3.35 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.333 0.587 . . . . 71.52 109.581 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 . . . . . 0 N--CA 1.474 0.751 0 CA-C-N 115.336 -0.847 . . . . 73.04 109.855 176.292 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.608 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 14.6 ptm . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 114.65 1.352 . . . . 71.32 114.65 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 40.5 m -133.34 144.85 49.89 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.459 1.103 . . . . 74.02 108.491 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.643 ' CZ ' HG13 ' B' ' 13' ' ' ILE . 0.3 OUTLIER -130.53 149.88 51.99 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 106.916 -1.513 . . . . 72.42 106.916 178.206 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.498 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -156.29 101.11 2.03 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 123.339 0.399 . . . . 71.42 111.605 164.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.907 HD11 HD13 ' B' ' 105' ' ' ILE . 44.6 mt -51.99 123.1 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.855 -0.794 . . . . 75.43 108.855 162.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -100.33 -45.07 5.71 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.048 0.842 . . . . 73.35 109.607 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.503 ' HE ' HG21 ' A' ' 122' ' ' THR . 47.9 ttt180 -162.92 135.58 5.54 Favored 'General case' 0 C--N 1.349 0.565 0 N-CA-C 109.259 -0.645 . . . . 75.45 109.259 -177.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.5 mt -114.89 137.17 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 107.896 -1.149 . . . . 74.24 107.896 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -167.29 158.32 11.73 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.11 0.481 . . . . 73.14 111.632 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.448 HG21 HD11 ' B' ' 21' ' ' ILE . 87.1 m -85.29 131.13 34.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.708 -0.678 . . . . 74.42 109.184 171.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.583 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 45.9 mtpt -97.76 -32.63 11.63 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.212 0.605 . . . . 72.11 110.665 177.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -151.13 138.21 19.19 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.613 0.244 . . . . 53.34 111.627 -175.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.486 ' CD1' ' SG ' ' B' ' 113' ' ' CYS . 45.6 mm -129.52 141.99 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.129 1.371 . . . . 73.03 108.914 173.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.628 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.1 t -144.46 137.43 26.94 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.052 -1.092 . . . . 32.34 108.052 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.2 t80 -154.35 121.47 5.65 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.844 -1.169 . . . . 65.21 107.844 174.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -127.81 122.09 31.83 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.7 0.8 . . . . 72.13 109.572 176.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.713 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -115.72 87.26 17.47 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.986 -1.116 . . . . 41.32 107.986 169.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -71.39 -40.44 3.06 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.431 2.088 . . . . 71.45 111.706 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.487 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 3.4 m-20 -93.98 3.21 55.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.259 1.024 . . . . 74.3 110.244 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.713 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -31.07 -65.84 0.19 Allowed Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 125.825 1.65 . . . . 63.12 114.653 -178.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 37.9 Cg_exo -55.23 -39.21 92.2 Favored 'Trans proline' 0 C--N 1.398 3.138 0 C-N-CA 122.975 2.45 . . . . 72.4 113.564 -162.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -95.51 -41.15 9.09 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 114.689 -1.141 . . . . 71.12 111.848 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.497 HG22 HD12 ' B' ' 68' ' ' LEU . 4.0 p -60.4 -19.22 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.48 0 C-N-CA 123.076 0.55 . . . . 72.13 112.4 -166.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -56.27 -28.89 60.17 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.56 1.144 . . . . 74.41 113.036 175.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -63.63 -21.93 66.63 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.923 0.889 . . . . 64.3 111.67 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -81.48 90.81 6.25 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.354 0.662 . . . . 73.25 109.664 172.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -83.94 89.08 7.17 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.402 -0.817 . . . . 55.2 110.844 -174.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 30.6 p90 -165.37 170.27 14.8 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.401 1.08 . . . . 74.12 109.713 167.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -75.52 111.34 13.75 Favored Pre-proline 0 N--CA 1.48 1.039 0 N-CA-C 109.038 -0.727 . . . . 74.41 109.038 173.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.98 165.69 13.87 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.015 2.476 . . . . 62.31 114.207 -172.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -73.58 103.91 4.35 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.478 -1.237 . . . . 64.5 108.974 175.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.444 HG21 HD13 ' B' ' 126' ' ' LEU . 61.7 t -102.46 123.08 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 115.333 -0.849 . . . . 60.54 111.08 -170.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -107.54 123.26 48.19 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.41 1.084 . . . . 73.43 108.688 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.84 126.1 51.57 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.768 -0.827 . . . . 73.11 108.768 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -122.95 128.47 50.29 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.582 1.153 . . . . 61.5 108.671 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -100.09 164.04 12.15 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.84 -0.8 . . . . 71.31 108.84 172.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.635 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.0 t70 -156.03 152.06 27.63 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.293 -0.867 . . . . 71.53 109.3 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 91.3 m -107.57 115.9 30.97 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.32 -1.309 . . . . 72.34 108.893 -171.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -137.03 119.32 15.66 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 109.045 -0.724 . . . . 62.54 109.045 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.5 p -142.97 161.83 37.09 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.939 0.496 . . . . 65.24 110.399 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -152.22 142.64 22.58 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.583 0.753 . . . . 74.24 109.836 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -94.87 112.45 24.17 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.466 -0.568 . . . . 72.41 109.466 175.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 77.8 mt -80.69 -45.46 17.11 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.488 0.661 . . . . 72.14 109.314 175.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.38 -177.46 6.61 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.387 -1.278 . . . . 43.22 109.018 176.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.79 123.55 25.81 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.946 -1.025 . . . . 73.42 108.328 173.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 67.53 23.52 8.92 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.121 1.368 . . . . 74.25 111.26 -175.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 92.2 t -139.51 103.49 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 107.912 -1.144 . . . . 60.44 107.912 168.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -125.96 138.12 53.74 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.833 -0.803 . . . . 71.04 108.833 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -107.9 103.5 12.76 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.459 -1.312 . . . . 73.32 107.459 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.584 HG21 ' HB2' ' B' ' 98' ' ' LEU . 95.1 t -101.06 118.87 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.65 1.18 . . . . 70.13 109.426 -173.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.59 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 15.3 t -104.34 141.22 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.315 1.046 . . . . 72.25 109.427 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 18.5 tp -118.87 112.7 20.0 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 108.676 -0.861 . . . . 64.43 108.676 172.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.635 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 20.0 ttm-85 -88.47 113.28 23.89 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.581 -0.525 . . . . 72.53 109.581 175.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 39.8 t -108.19 101.24 12.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 107.356 -1.35 . . . . 71.1 107.356 171.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 16.0 m -97.09 139.97 32.29 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.634 -0.876 . . . . 73.14 108.634 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.698 HG21 HG21 ' B' ' 114' ' ' ILE . 89.7 t -128.16 136.45 60.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 124.339 1.056 . . . . 71.51 109.295 -174.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 95.5 m -124.81 148.31 48.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.121 -1.066 . . . . 33.34 108.121 172.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.71 139.15 31.0 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.92 -0.77 . . . . 74.41 108.92 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.476 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 36.1 p -140.35 128.1 21.78 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 123.716 0.635 . . . . 70.2 110.331 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.497 HD12 HG22 ' B' ' 31' ' ' VAL . 45.0 mt -99.61 103.56 15.27 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.476 -1.305 . . . . 63.51 107.476 173.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.86 -113.96 4.01 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.202 -0.759 . . . . 43.14 111.202 -174.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -121.88 6.05 9.89 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.864 0.466 . . . . 63.22 109.815 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.487 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 4.0 pm0 -113.48 150.89 32.2 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.161 0.584 . . . . 62.2 109.892 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 45.4 m -67.97 118.73 11.55 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.245 1.018 . . . . 72.12 111.095 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.488 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -73.14 -63.92 1.08 Allowed 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.622 -0.881 . . . . 72.42 108.622 173.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -147.77 167.76 23.86 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 114.726 -1.124 . . . . 74.21 110.958 175.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.2 mt -129.13 141.34 51.21 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.278 -1.749 . . . . 74.32 106.278 173.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.408 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 42.0 t -147.44 158.88 44.16 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.346 -0.983 . . . . 61.43 108.346 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.628 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 42.8 tt0 -165.95 133.27 2.79 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.577 -0.897 . . . . 72.33 108.577 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 91.4 t -128.05 142.15 44.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.131 -1.063 . . . . 70.32 108.131 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -124.51 87.87 2.8 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.568 -1.271 . . . . 73.22 107.568 174.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -81.09 102.13 10.05 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.068 -0.969 . . . . 71.21 108.666 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.43 171.71 38.59 Favored Glycine 0 C--O 1.245 0.83 0 CA-C-N 116.017 -0.538 . . . . 62.41 111.935 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.46 132.12 2.31 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 111.083 -0.807 . . . . 72.01 111.083 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 50.2 mt -84.17 125.01 40.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.491 -1.299 . . . . 70.12 107.491 171.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -130.61 129.09 42.27 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.39 -0.966 . . . . 63.04 108.39 174.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 69.2 m -93.52 88.75 6.02 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.522 0.729 . . . . 62.32 109.34 170.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 37.2 pt -103.34 146.28 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 N-CA-C 107.73 -1.211 . . . . 61.44 107.73 176.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.11 164.62 34.17 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 112.722 0.638 . . . . 42.43 112.722 -169.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.29 -71.35 1.19 Allowed Glycine 0 C--N 1.348 1.246 0 CA-C-N 114.822 -1.081 . . . . 65.34 114.579 167.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.608 ' HB ' ' HB3' ' B' ' 9' ' ' MET . 0.4 OUTLIER -89.39 171.7 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 123.876 0.87 . . . . 72.21 111.602 -166.17 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -150.82 158.53 44.26 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.059 0.544 . . . . 41.05 111.865 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.53 -135.81 12.77 Favored Glycine 0 C--N 1.355 1.617 0 C-N-CA 124.789 1.185 . . . . 53.1 112.875 172.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 11.2 m -69.15 -26.59 64.95 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.57 0.7 . . . . 65.51 110.389 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.431 ' NE2' HG12 ' B' ' 89' ' ' ILE . 23.1 mt-30 -62.47 -44.07 97.29 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.539 -1.209 . . . . 70.22 111.315 177.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.485 ' SD ' HD21 ' B' ' 98' ' ' LEU . 0.0 OUTLIER -80.11 -26.88 39.29 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 110.363 -0.236 . . . . 61.33 110.363 178.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.09 -13.98 60.98 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.554 0.742 . . . . 53.02 111.55 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -77.38 -34.67 54.9 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.806 0.443 . . . . 70.55 110.672 169.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.531 ' SG ' ' HD2' ' B' ' 11' ' ' PHE . 49.2 t -76.33 -67.58 0.67 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 119.161 -0.447 . . . . 74.32 111.356 -175.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.584 ' HB2' HG21 ' B' ' 58' ' ' VAL . 2.3 pt? -91.88 -12.37 33.78 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 118.255 0.48 . . . . 73.41 111.809 -175.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.76 -24.24 12.34 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-O 119.837 -0.424 . . . . 71.24 113.489 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.2 -55.83 2.03 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.994 0.518 . . . . 70.33 111.197 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.476 ' O ' HG13 ' B' ' 105' ' ' ILE . 56.5 t80 -83.39 -37.06 23.79 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.558 0.577 . . . . 74.35 112.558 -169.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.441 ' HA ' HD12 ' B' ' 105' ' ' ILE . 86.9 m -64.47 -43.58 72.06 Favored Pre-proline 0 N--CA 1.482 1.149 0 CA-C-O 118.338 -0.839 . . . . 72.54 110.364 177.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.49 -41.83 43.2 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 122.531 2.154 . . . . 53.34 113.622 163.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -66.27 -33.8 76.55 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 124.119 0.968 . . . . 72.45 111.187 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.907 HD13 HD11 ' B' ' 13' ' ' ILE . 73.5 mt -71.91 -46.1 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.682 0.793 . . . . 73.51 110.082 177.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 93.6 mt -77.39 -19.53 56.05 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 114.727 -1.124 . . . . 75.23 111.173 -175.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -59.91 -52.05 76.36 Favored Pre-proline 0 N--CA 1.483 1.205 0 CA-C-O 117.585 -1.198 . . . . 73.02 113.41 -173.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.02 -27.41 42.51 Favored 'Trans proline' 0 C--N 1.385 2.489 0 CA-C-N 121.546 1.588 . . . . 54.44 112.516 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -70.62 -43.17 69.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.856 0.463 . . . . 63.03 110.302 175.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.73 -43.66 92.66 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.553 -0.749 . . . . 53.54 110.327 176.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -60.98 -49.44 77.42 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.717 1.207 . . . . 71.42 110.506 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -63.17 -32.94 74.45 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 123.903 0.752 . . . . 74.24 109.427 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.496 ' O ' ' HG2' ' B' ' 117' ' ' MET . 17.1 t -72.79 -41.77 64.64 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 123.406 0.442 . . . . 74.22 112.128 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.698 HG21 HG21 ' B' ' 64' ' ' VAL . 84.7 mt -60.6 -57.0 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 108.792 -0.818 . . . . 72.25 108.792 176.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.2 m -61.43 -25.79 67.44 Favored 'General case' 0 CA--C 1.554 1.111 0 O-C-N 124.776 1.297 . . . . 74.02 111.053 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 43.0 t -65.95 -51.36 59.26 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 123.186 0.594 . . . . 51.43 109.641 170.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.1 mmt -68.16 -30.17 69.23 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.188 0.595 . . . . 73.32 111.613 -177.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 114' ' ' ILE . 95.5 t -66.79 -44.3 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.31 1.044 . . . . 74.12 109.08 173.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.0 t -69.07 -29.38 67.48 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.924 -1.035 . . . . 34.02 111.48 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.44 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 89.2 mtt-85 -74.85 -37.44 62.23 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.517 0.727 . . . . 71.43 109.637 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.26 -5.74 77.79 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 123.84 0.713 . . . . 63.25 112.236 170.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 33.8 p 63.55 25.96 14.57 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.608 1.963 . . . . 63.25 112.953 174.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -81.09 159.78 67.34 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 124.511 1.124 . . . . 75.32 110.495 174.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.58 165.09 6.49 Favored 'Trans proline' 0 C--N 1.39 2.714 0 C-N-CA 123.5 2.8 . . . . 75.5 114.273 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.439 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 65.5 tp60 -61.07 136.71 58.16 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.388 -1.278 . . . . 64.41 112.135 -173.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.444 HD13 HG21 ' B' ' 40' ' ' VAL . 43.0 tp -136.25 121.78 19.52 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.887 0.875 . . . . 73.34 109.443 -178.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -132.83 129.07 38.02 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.873 0.869 . . . . 55.11 109.098 175.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.21 149.9 30.3 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.576 0.75 . . . . 64.32 110.261 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -73.04 129.08 86.87 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 123.429 0.692 . . . . 72.35 111.919 -172.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 24.1 Cg_exo -65.86 98.23 0.36 Allowed 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.274 2.649 . . . . 60.03 113.216 177.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 21.1 m -109.83 135.96 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 109.018 -0.734 . . . . 72.54 109.018 171.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -90.55 100.98 13.72 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.006 -1.109 . . . . 75.24 108.006 177.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -60.78 -43.04 98.58 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.79 0.836 . . . . 75.03 110.816 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 . . . . . 0 CA--C 1.539 0.524 0 CA-C-N 114.851 -1.068 . . . . 64.12 111.339 -176.942 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.721 ' HD2' ' HG3' ' A' ' 130' ' ' PRO . 71.0 t80 . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 108.674 -0.861 . . . . 72.44 108.674 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . 0.549 ' HB3' ' HB2' ' C' ' 85' ' ' SER . 38.9 tt0 -142.84 144.21 32.42 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.541 0.736 . . . . 74.44 109.403 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.446 HD13 HD11 ' C' ' 16' ' ' ILE . 27.6 mt -92.72 131.17 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 109.253 -0.647 . . . . 65.2 109.253 173.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.421 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.4 mm-40 -98.96 -43.21 6.79 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.954 0.902 . . . . 74.15 109.84 176.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -172.54 137.18 0.81 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.628 -0.879 . . . . 70.12 108.628 -168.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.446 HD11 HD13 ' C' ' 13' ' ' ILE . 85.5 mt -129.64 138.17 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.236 -1.024 . . . . 73.33 108.236 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.447 ' HB3' HG23 ' D' ' 122' ' ' THR . 37.1 p90 -170.4 166.64 8.5 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.672 0.749 . . . . 73.4 111.43 -173.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -84.77 109.81 18.34 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.922 -1.035 . . . . 74.24 109.045 174.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -64.33 -44.32 91.88 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 121.994 0.902 . . . . 64.31 108.844 174.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.0 t70 -147.97 149.89 33.0 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 113.392 -1.731 . . . . 73.13 109.254 -175.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 79.5 mt -140.3 145.43 26.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 125.798 1.639 . . . . 64.24 106.725 177.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.5 t -155.72 150.21 25.97 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.609 0.719 . . . . 72.44 110.057 176.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -148.49 147.94 29.68 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.323 -1.362 . . . . 63.52 107.323 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -144.08 133.52 23.34 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.562 1.145 . . . . 73.1 108.804 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.01 78.68 4.27 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 107.117 -1.438 . . . . 73.4 107.117 171.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.44 -11.2 22.55 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.948 2.432 . . . . 60.31 112.333 -174.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -126.08 26.39 6.53 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.09 1.356 . . . . 72.41 109.791 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.83 -58.5 5.34 Favored Pre-proline 0 CA--C 1.57 1.724 0 CA-C-O 117.831 -1.08 . . . . 72.23 113.574 -172.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -59.95 -38.69 77.13 Favored 'Trans proline' 0 C--N 1.401 3.314 0 C-N-CA 122.162 1.908 . . . . 74.34 112.255 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -70.72 -39.79 73.17 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.331 -0.85 . . . . 71.34 111.831 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.701 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.5 p -78.78 -17.29 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.428 0 N-CA-C 112.224 0.453 . . . . 64.11 112.224 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -66.2 -37.21 85.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.194 -0.316 . . . . 74.53 111.538 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -85.19 13.49 6.29 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.493 0.717 . . . . 70.43 111.709 -176.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.62 169.29 9.61 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.545 1.138 . . . . 72.45 110.308 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -74.7 122.94 24.02 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.402 -0.592 . . . . 71.42 109.402 171.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -84.1 92.26 7.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.511 0.724 . . . . 73.33 110.49 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -146.95 80.96 9.26 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 106.928 -1.508 . . . . 71.54 106.928 168.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -88.22 155.35 6.86 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.597 2.198 . . . . 72.22 112.843 -176.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -86.02 99.49 11.5 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 106.548 -1.649 . . . . 62.43 106.548 166.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 43.9 t -74.77 96.55 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 107.826 -1.175 . . . . 73.04 107.826 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.568 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 88.4 mttt -93.81 100.74 12.88 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.209 -1.404 . . . . 74.0 107.209 178.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 pp -88.71 149.7 23.35 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.187 0.518 . . . . 73.01 109.794 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.645 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 26.1 t70 -144.36 144.84 31.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.306 -0.861 . . . . 51.23 108.964 -176.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.66 142.39 41.15 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.387 0.675 . . . . 74.55 109.782 174.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 25.8 t70 -137.66 146.54 43.98 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.363 1.065 . . . . 74.21 108.605 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 47.3 p -115.53 120.52 39.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.94 0.496 . . . . 75.15 111.283 -170.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.31 160.12 35.9 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.183 0.993 . . . . 74.11 109.447 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 35.4 p -164.55 166.46 20.3 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.908 0.385 . . . . 64.34 112.006 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 83.9 p -151.92 152.81 33.02 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.346 1.058 . . . . 75.22 108.993 171.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -102.22 124.08 47.18 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.498 -0.927 . . . . 74.22 108.498 172.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.524 HD11 HD12 ' C' ' 83' ' ' ILE . 51.2 mt -101.97 -32.27 10.27 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.251 0.62 . . . . 71.25 111.12 -174.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.52 -166.04 1.28 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.351 0.66 . . . . 74.21 110.686 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -63.36 115.62 4.76 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 124.005 0.816 . . . . 61.41 109.42 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 67.49 -5.25 0.79 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 125.017 1.327 . . . . 52.31 113.113 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 67.4 t -92.64 106.7 18.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.54 -1.281 . . . . 75.44 107.54 -177.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -124.64 128.65 49.19 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.521 -1.289 . . . . 61.45 107.521 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -81.36 119.31 23.52 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.001 -1.0 . . . . 72.25 108.547 172.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 65.5 t -96.45 120.44 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.339 -1.356 . . . . 50.41 107.339 171.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 55.7 t -115.09 132.76 63.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 108.671 -0.863 . . . . 71.23 108.671 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 29.9 tp -124.18 117.2 24.07 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.304 -0.999 . . . . 74.23 108.304 170.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 33.3 ttm180 -81.74 135.76 35.48 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.098 0.959 . . . . 70.53 108.955 172.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.502 ' HB ' HD11 ' C' ' 114' ' ' ILE . 14.9 t -122.89 130.06 74.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.258 -1.386 . . . . 63.21 107.258 169.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.645 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 18.0 m -129.65 116.62 19.11 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.534 -0.913 . . . . 74.24 108.534 -177.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.474 HG21 HG21 ' C' ' 114' ' ' ILE . 59.5 t -108.53 113.3 43.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 124.202 1.001 . . . . 61.1 108.978 -173.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 2.5 m -101.62 131.1 48.01 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.936 -0.764 . . . . 72.14 108.936 175.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.2 109.62 16.06 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.434 -1.691 . . . . 64.43 106.434 174.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 24.7 m -131.47 125.46 32.55 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 117.791 0.269 . . . . 71.23 110.358 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.7 mt -85.76 49.59 1.8 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.497 1.119 . . . . 52.42 108.96 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.62 -114.64 4.96 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 110.096 -1.202 . . . . 74.41 110.096 -169.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -91.97 -24.08 19.36 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.36 0.664 . . . . 64.41 110.17 172.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -67.72 101.91 1.12 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.19 -0.67 . . . . 65.13 109.19 176.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 90.3 m -70.78 122.62 20.2 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.617 -0.512 . . . . 72.12 109.617 175.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.701 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.47 -56.92 4.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.291 -1.003 . . . . 52.42 108.291 171.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -159.48 163.32 35.41 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.29 -0.868 . . . . 65.43 111.352 177.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -127.57 131.68 49.96 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 105.966 -1.864 . . . . 75.14 105.966 164.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.442 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.6 t -137.73 111.19 8.02 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.111 -0.7 . . . . 51.05 109.111 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . 0.438 ' HB2' HG23 ' C' ' 63' ' ' THR . 33.0 tt0 -119.51 116.59 26.39 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.31 0.644 . . . . 63.23 109.841 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -117.11 132.59 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 108.531 -0.914 . . . . 75.23 108.531 172.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.544 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 44.3 mt-30 -105.24 100.46 10.05 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.19 -1.041 . . . . 75.1 108.19 172.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -87.71 121.33 30.0 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.609 -0.723 . . . . 73.44 109.584 -177.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.88 146.92 18.87 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 112.042 -0.423 . . . . 41.25 112.042 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.505 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -143.12 124.58 2.36 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.435 -1.066 . . . . 75.33 110.435 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.524 HD12 HD11 ' C' ' 51' ' ' LEU . 16.6 mm -81.04 123.55 37.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.984 -1.117 . . . . 44.54 107.984 176.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -132.47 135.56 46.11 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.738 0.415 . . . . 72.23 110.646 -174.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . 0.549 ' HB2' ' HB3' ' C' ' 12' ' ' GLN . 43.3 m -83.96 99.91 10.69 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 107.667 -1.235 . . . . 62.15 107.667 167.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 3.6 tt -120.0 117.76 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.519 1.128 . . . . 74.54 110.592 -172.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.24 169.89 16.99 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.458 1.103 . . . . 54.32 109.715 177.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 122.63 -60.5 0.57 Allowed Glycine 0 N--CA 1.472 1.094 0 N-CA-C 112.5 -0.24 . . . . 32.23 112.5 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 23.5 pt -96.4 173.44 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.113 0.565 . . . . 64.35 111.015 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -153.47 160.39 42.54 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.833 0.853 . . . . 53.13 110.539 -172.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.04 -145.87 30.16 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.762 -0.654 . . . . 62.14 111.646 175.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 46.6 p -63.88 -17.38 63.12 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.082 0.553 . . . . 74.13 112.011 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -67.3 -51.01 57.83 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 123.403 0.681 . . . . 75.32 110.458 173.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.502 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 7.0 ptp -70.24 -37.14 74.9 Favored 'General case' 0 C--N 1.362 1.14 0 N-CA-C 109.839 -0.43 . . . . 64.33 109.839 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.67 -35.88 66.48 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.525 0.73 . . . . 73.12 110.988 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.52 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 17.5 t-80 -71.35 -39.64 71.18 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.397 1.079 . . . . 74.03 111.518 173.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -71.28 -62.0 1.56 Allowed 'General case' 0 N--CA 1.481 1.106 0 O-C-N 122.094 -0.379 . . . . 62.4 111.613 -175.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' C' ' 94' ' ' MET . 1.2 pp -71.14 -21.94 62.12 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.99 0.516 . . . . 64.44 112.34 -178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.44 4.97 62.36 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 119.594 -0.559 . . . . 52.25 113.466 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -149.98 -60.14 0.2 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 117.917 0.859 . . . . 75.01 112.348 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -66.7 -51.56 54.6 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.672 0.789 . . . . 72.43 112.087 -175.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 19.9 m -63.87 -44.77 80.14 Favored Pre-proline 0 CA--C 1.57 1.719 0 C-N-CA 123.738 0.815 . . . . 51.22 112.805 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.405 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 22.5 Cg_exo -68.1 -22.82 40.57 Favored 'Trans proline' 0 C--N 1.397 3.08 0 C-N-CA 122.298 1.999 . . . . 71.12 113.347 171.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -71.16 -32.12 68.53 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 122.974 0.51 . . . . 75.11 110.673 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.43 HG23 ' NH1' ' A' ' 111' ' ' ARG . 37.7 mm -59.33 -42.01 85.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.725 0.81 . . . . 42.43 109.884 171.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.505 HD21 ' HA3' ' C' ' 82' ' ' GLY . 93.8 mt -80.22 -21.22 43.09 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.732 -1.122 . . . . 74.14 112.595 -172.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -53.79 -50.84 81.44 Favored Pre-proline 0 CA--C 1.567 1.618 0 CA-C-O 117.555 -1.212 . . . . 74.4 113.377 -175.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.77 -33.19 96.52 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 122.145 1.897 . . . . 74.22 114.134 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -73.07 -44.46 60.57 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.077 0.551 . . . . 72.44 110.03 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.22 -40.01 88.63 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.242 -0.89 . . . . 64.3 110.261 173.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -59.09 -53.8 54.25 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.962 1.305 . . . . 71.45 110.765 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.79 -36.79 78.72 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 123.358 0.411 . . . . 70.24 109.903 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 20.3 t -65.73 -32.37 73.88 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.978 0.511 . . . . 74.32 111.495 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.502 HD11 ' HB ' ' C' ' 62' ' ' VAL . 81.5 mt -74.1 -55.8 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.187 0.595 . . . . 75.22 109.859 173.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.8 m -61.37 -27.44 68.52 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.452 0.701 . . . . 54.21 110.964 -174.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.7 t -65.65 -50.17 65.96 Favored 'General case' 0 C--O 1.214 -0.77 0 C-N-CA 123.782 0.833 . . . . 44.14 109.034 171.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.534 ' HG3' HD12 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.7 -33.06 74.33 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.218 1.007 . . . . 72.03 112.364 178.286 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.412 HG23 ' O ' ' C' ' 114' ' ' ILE . 66.4 t -67.85 -41.48 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 123.493 0.717 . . . . 63.33 109.066 174.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 39.9 t -74.07 -23.46 59.37 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.528 1.131 . . . . 41.1 111.986 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -78.12 -39.6 40.74 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.719 -0.845 . . . . 64.14 108.719 176.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.38 -0.65 62.7 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.549 -0.751 . . . . 43.13 112.347 167.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 31.4 p 62.24 29.73 17.46 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.695 1.998 . . . . 71.34 113.653 169.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -81.84 156.29 70.12 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 123.627 0.771 . . . . 72.33 108.947 169.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.439 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 25.3 Cg_endo -62.12 168.07 9.78 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.54 2.16 . . . . 62.54 112.485 173.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -59.79 110.47 1.17 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.279 -0.873 . . . . 64.22 112.17 -173.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.41 86.38 2.28 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 105.893 -1.891 . . . . 54.41 105.893 171.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -107.93 108.42 19.56 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.565 -0.902 . . . . 70.13 108.565 -173.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.432 HD23 ' N ' ' C' ' 129' ' ' ALA . 3.5 tt -73.03 144.75 47.03 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.485 0.714 . . . . 74.42 109.796 -174.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . 0.432 ' N ' HD23 ' C' ' 128' ' ' LEU . . . -60.47 157.92 33.01 Favored Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 124.706 1.202 . . . . 62.41 112.417 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.458 ' HG3' HD12 ' A' ' 16' ' ' ILE . 43.6 Cg_exo -57.65 110.53 0.63 Allowed 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 122.735 2.29 . . . . 71.34 112.285 173.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 20.4 t -98.73 108.41 22.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.769 -0.826 . . . . 75.35 108.769 177.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -107.13 90.8 3.41 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 107.836 -1.172 . . . . 72.15 107.836 173.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -55.55 -41.39 73.16 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.044 0.84 . . . . 75.43 110.578 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . 0.4 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 7.7 t70 . . . . . 0 C--O 1.242 0.67 0 CA-C-N 114.328 -1.305 . . . . 64.03 111.458 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 57.0 m . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 109.449 -0.574 . . . . 70.22 109.449 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -157.73 96.72 1.52 Allowed 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.721 -1.214 . . . . 73.32 107.721 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -113.86 115.7 28.15 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.477 -0.935 . . . . 65.53 108.477 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.464 HG21 HD11 ' D' ' 16' ' ' ILE . 46.8 mt -71.32 123.06 24.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.913 -0.773 . . . . 61.31 108.913 177.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.441 HE22 HG13 ' D' ' 55' ' ' VAL . 51.7 mt-30 -93.41 -34.05 13.6 Favored 'General case' 0 C--O 1.246 0.881 0 O-C-N 123.59 0.557 . . . . 72.55 110.664 178.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -173.55 144.52 1.13 Allowed 'General case' 0 C--N 1.364 1.224 0 N-CA-C 112.303 0.483 . . . . 75.22 112.303 -170.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.464 HD11 HG21 ' D' ' 13' ' ' ILE . 3.6 mp -123.34 136.92 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 107.243 -1.391 . . . . 71.32 107.243 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.4 ' HE1' HG13 ' D' ' 83' ' ' ILE . 24.6 p90 -164.61 152.31 11.86 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.64 0.733 . . . . 73.42 110.649 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 56.7 p -84.2 117.47 23.52 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.532 -1.213 . . . . 72.1 108.525 174.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -85.53 -18.02 34.66 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.785 0.326 . . . . 73.2 110.21 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -166.24 140.49 4.33 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.429 1.092 . . . . 62.22 108.283 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.534 HD12 ' HG3' ' C' ' 117' ' ' MET . 77.5 mt -137.18 150.14 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 108.12 -1.067 . . . . 75.44 108.12 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.9 t -156.8 103.43 2.07 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.299 1.04 . . . . 71.01 109.298 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.539 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 80.8 t80 -109.09 122.1 46.56 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 106.366 -1.716 . . . . 73.23 106.366 171.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -130.48 110.47 11.48 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.502 -0.555 . . . . 65.23 109.502 -172.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.4 89.45 4.89 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 108.234 -1.025 . . . . 52.53 108.234 173.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.22 -38.15 3.97 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.555 2.17 . . . . 55.03 112.289 -172.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 58.2 m-20 -101.7 11.24 39.15 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.899 0.88 . . . . 71.1 110.072 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -20.63 -68.03 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 116.151 1.908 . . . . 73.05 116.151 -168.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.415 ' HB3' HD11 ' C' ' 83' ' ' ILE . 43.6 Cg_endo -79.94 -18.24 10.33 Favored 'Trans proline' 0 C--N 1.379 2.167 0 CA-C-N 122.844 2.052 . . . . 34.42 114.029 -173.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.459 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 7.7 t-160 -76.68 -39.79 50.95 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.511 1.124 . . . . 64.31 109.576 176.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.695 HG22 HD12 ' D' ' 68' ' ' LEU . 11.3 p -82.79 -18.01 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 CA-C-N 115.799 -0.637 . . . . 61.3 111.296 -172.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -65.86 -22.51 66.53 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 112.094 0.405 . . . . 71.55 112.094 177.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.459 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 58.8 mt-30 -60.31 -20.23 58.42 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.1 0.96 . . . . 73.22 111.26 177.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.417 ' HB2' HD13 ' D' ' 68' ' ' LEU . 93.1 mttt -95.92 102.14 13.9 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.659 1.183 . . . . 71.4 109.816 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -101.16 87.23 3.2 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.759 0.424 . . . . 74.23 110.151 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -158.66 179.79 8.78 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.176 0.991 . . . . 73.05 108.599 167.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -67.19 112.34 9.69 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 123.622 0.769 . . . . 73.25 110.441 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -56.39 141.62 89.26 Favored 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 122.736 2.291 . . . . 61.31 112.016 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 42.6 mt-10 -57.84 118.41 5.3 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.59 1.181 . . . . 73.13 111.291 -177.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 25.6 t -93.58 107.18 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 107.568 -1.271 . . . . 73.41 107.568 -172.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.442 ' HE3' ' HB3' ' D' ' 39' ' ' GLU . 31.1 mmtp -125.98 118.92 26.4 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.555 -1.276 . . . . 75.04 107.555 -177.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.91 115.55 27.62 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.203 0.601 . . . . 74.22 109.725 -174.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.627 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.3 m-20 -107.85 119.25 38.93 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.425 1.09 . . . . 75.43 108.066 172.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.58 152.88 27.08 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.754 0.421 . . . . 73.1 110.537 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -157.01 152.82 27.05 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.881 -1.155 . . . . 64.52 107.881 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 57.9 p -118.78 149.21 41.88 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.871 0.468 . . . . 71.23 111.611 -170.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.54 164.03 38.42 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.426 1.09 . . . . 74.21 109.038 172.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 50.8 p -176.95 177.5 1.28 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.702 0.801 . . . . 62.32 110.03 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 50.8 p -173.02 143.83 1.2 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.164 0.986 . . . . 35.41 109.889 169.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -76.3 116.71 17.25 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.794 -1.187 . . . . 74.14 107.794 167.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.487 HD11 ' HB2' ' D' ' 57' ' ' GLU . 61.3 mt -88.94 -26.66 21.42 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.997 0.519 . . . . 50.11 110.054 -175.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -174.06 -172.98 0.76 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.692 1.197 . . . . 72.4 109.777 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -68.88 126.75 30.74 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.477 -0.783 . . . . 71.43 109.131 174.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 69.08 -2.36 1.82 Allowed 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 124.956 1.302 . . . . 73.24 113.059 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.441 HG13 HE22 ' D' ' 14' ' ' GLN . 94.6 t -110.47 124.55 67.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.029 -1.1 . . . . 74.23 108.029 176.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.628 ' HB3' HD13 ' D' ' 86' ' ' ILE . 66.4 t80 -146.57 137.43 24.1 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.371 0.605 . . . . 72.03 110.142 -177.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.487 ' HB2' HD11 ' D' ' 51' ' ' LEU . 21.9 tt0 -104.13 137.61 41.83 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.964 1.306 . . . . 71.13 110.029 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.88 126.19 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 108.058 -1.09 . . . . 63.24 108.058 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.442 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 25.9 t -124.12 131.82 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.448 0.699 . . . . 70.22 109.388 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.438 HD23 HD12 ' D' ' 106' ' ' LEU . 3.9 mm? -123.81 122.14 37.24 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.518 -0.549 . . . . 61.51 109.518 173.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' D' ' 79' ' ' GLN . 12.5 ttm180 -83.54 106.39 15.24 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.387 -0.968 . . . . 74.34 108.387 170.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -92.02 125.95 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 107.601 -1.259 . . . . 74.41 107.601 169.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.627 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 22.1 m -123.83 133.34 53.81 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.041 -0.725 . . . . 33.54 109.041 177.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.415 HG21 HG21 ' D' ' 114' ' ' ILE . 73.1 t -114.19 101.36 12.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 107.85 -1.167 . . . . 72.11 107.85 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 78.6 m -90.58 92.43 8.85 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.568 -1.271 . . . . 65.14 107.568 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -100.98 135.93 41.64 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 114.831 -1.077 . . . . 64.42 109.964 -175.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.467 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 70.1 m -143.21 133.6 24.74 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.005 0.522 . . . . 72.5 110.699 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.695 HD12 HG22 ' D' ' 31' ' ' VAL . 77.2 mt -101.0 110.04 22.02 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.867 -1.16 . . . . 64.02 107.867 172.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.19 -114.02 3.75 Favored Glycine 0 C--N 1.344 0.981 0 O-C-N 123.237 0.336 . . . . 53.32 113.038 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.67 4.46 12.32 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.607 0.763 . . . . 74.12 110.576 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.459 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 12.7 pt-20 -120.68 156.11 32.44 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.567 0.747 . . . . 75.32 109.229 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 43.8 m -70.26 135.32 48.86 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 123.676 0.61 . . . . 61.3 110.545 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.655 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -85.91 -65.53 1.0 Allowed 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.062 -1.459 . . . . 62.21 107.062 172.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -157.43 148.57 21.63 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.606 -1.179 . . . . 73.02 110.342 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 60.1 mt -111.86 107.77 16.92 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 105.908 -1.886 . . . . 64.14 105.908 171.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' D' ' 114' ' ' ILE . 46.3 t -116.38 105.53 12.62 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.305 -0.998 . . . . 51.02 108.305 -171.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . 0.473 ' HB2' HG23 ' D' ' 63' ' ' THR . 41.8 tt0 -130.12 131.57 45.76 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.137 0.975 . . . . 64.04 108.994 -165.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.4 t -140.0 119.21 12.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 108.359 -0.978 . . . . 75.34 108.359 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.405 ' HA ' ' HA ' ' D' ' 61' ' ' ARG . 71.1 mt-30 -86.93 80.89 8.3 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 107.365 -1.346 . . . . 70.14 107.365 171.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -81.76 106.55 13.79 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 113.527 -1.669 . . . . 72.44 108.901 -172.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -110.36 158.46 14.42 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 115.844 -0.616 . . . . 74.11 112.442 -176.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.93 132.18 3.9 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.828 -0.509 . . . . 74.35 111.828 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.4 HG13 ' HE1' ' D' ' 17' ' ' TYR . 74.5 mt -89.4 130.8 38.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.229 -1.026 . . . . 74.53 108.229 174.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -133.36 166.84 21.58 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 123.512 0.508 . . . . 73.32 110.466 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.0 m -114.69 107.06 14.96 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.036 0.934 . . . . 70.24 108.526 175.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.628 HD13 ' HB3' ' D' ' 56' ' ' TYR . 4.2 mp -109.23 118.13 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 C-N-CA 123.402 0.681 . . . . 65.45 109.223 -176.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.7 139.65 16.33 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.707 0.803 . . . . 60.1 110.326 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.45 21.92 49.5 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-O 120.221 -0.21 . . . . 61.34 113.099 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.462 HD13 HG23 ' D' ' 86' ' ' ILE . 3.6 mp -116.34 146.72 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.681 0.792 . . . . 72.43 109.035 176.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -149.69 153.85 37.62 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.411 1.084 . . . . 52.31 110.411 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' D' ' 94' ' ' MET . . . 76.98 -133.81 13.97 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 114.835 0.694 . . . . 55.41 114.835 167.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.8 m -85.68 -11.66 53.19 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.259 1.024 . . . . 75.31 110.955 -178.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -57.11 -40.32 76.8 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.314 1.046 . . . . 54.44 110.618 176.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.43 ' HG2' ' O ' ' D' ' 91' ' ' GLY . 23.5 ptt? -74.45 -27.07 60.43 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.572 -0.74 . . . . 73.55 111.72 177.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.11 -34.88 77.22 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.523 0.329 . . . . 44.22 110.608 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -79.7 -32.0 41.3 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.988 -0.551 . . . . 60.33 110.621 174.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.7 t -63.1 -51.12 67.84 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.176 0.512 . . . . 62.4 110.705 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 57.8 mt -82.03 -28.52 32.45 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.096 -0.956 . . . . 63.41 111.252 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.6 11.36 72.29 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-O 119.61 -0.55 . . . . 53.45 113.519 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.82 -65.3 0.11 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 117.728 0.764 . . . . 60.02 111.84 -177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -73.82 -42.26 61.15 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 112.664 0.616 . . . . 74.2 112.664 -168.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.456 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 62.3 m -64.13 -46.48 79.92 Favored Pre-proline 0 CA--C 1.566 1.562 0 CA-C-O 118.55 -0.738 . . . . 74.41 111.904 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.456 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 31.3 Cg_exo -62.42 -28.64 78.34 Favored 'Trans proline' 0 C--N 1.4 3.263 0 C-N-CA 122.423 2.082 . . . . 75.11 113.078 169.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -69.33 -30.3 68.31 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.579 0.751 . . . . 74.54 111.063 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.5 mm -69.12 -36.47 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 121.42 0.628 . . . . 63.32 109.84 172.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.438 HD12 HD23 ' D' ' 60' ' ' LEU . 68.6 mt -86.16 -10.61 54.46 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.27 -0.877 . . . . 44.34 111.819 -176.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -66.0 -49.89 55.0 Favored Pre-proline 0 CA--C 1.565 1.558 0 CA-C-O 117.935 -1.031 . . . . 75.32 112.667 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -60.61 -32.13 93.0 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 122.272 1.981 . . . . 64.21 112.932 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -81.02 -35.24 32.14 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.382 -0.826 . . . . 73.01 112.206 -176.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.17 -52.0 61.09 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.003 -1.11 . . . . 64.21 108.003 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -49.28 -50.01 40.99 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.923 1.389 . . . . 72.13 111.84 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -67.05 -50.38 62.1 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.718 0.636 . . . . 65.33 111.254 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -58.19 -44.17 87.95 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 124.178 0.924 . . . . 41.33 110.611 -177.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.54 ' HA ' ' SG ' ' D' ' 76' ' ' CYS . 91.0 mt -58.53 -63.06 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 124.463 1.105 . . . . 74.31 110.862 173.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 92.0 m -55.04 -38.33 67.84 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.225 1.01 . . . . 71.43 112.287 -173.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 42.0 t -67.89 -42.81 80.63 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.409 -0.814 . . . . 65.52 110.172 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.2 mtm -69.11 -29.9 68.07 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.67 0.388 . . . . 75.24 111.645 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.445 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.4 t -62.45 -50.04 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 O-C-N 123.797 0.686 . . . . 74.13 109.457 174.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 81.9 p -71.12 -30.35 66.39 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.942 -0.572 . . . . 61.11 110.855 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 71.8 mtt-85 -70.16 -32.19 70.04 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.369 0.668 . . . . 61.45 109.961 174.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.84 10.72 71.42 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.825 -0.625 . . . . 53.41 112.502 174.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.447 HG23 ' HB3' ' C' ' 17' ' ' TYR . 45.5 p 56.12 30.8 17.03 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 126.444 1.898 . . . . 74.01 114.144 175.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -93.47 159.44 35.07 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 123.813 0.845 . . . . 62.31 110.188 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -51.75 125.03 15.81 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.502 2.801 . . . . 74.22 113.501 171.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -57.59 136.2 56.75 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.844 1.258 . . . . 74.33 111.664 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 59.0 tp -128.53 97.38 4.69 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.454 0.702 . . . . 73.03 109.573 -175.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -100.57 110.07 22.2 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.568 0.747 . . . . 73.11 110.058 -176.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 89.1 mt -71.0 115.24 9.9 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.919 0.488 . . . . 71.54 110.264 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.31 157.28 88.33 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 122.967 0.507 . . . . 64.14 110.568 176.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -51.0 110.06 0.37 Allowed 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.419 2.746 . . . . 63.44 112.959 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 C--O 1.244 0.809 0 N-CA-C 108.639 -0.874 . . . . 75.14 108.639 172.128 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.595 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 19.4 t80 . . . . . 0 C--O 1.235 0.335 0 N-CA-C 108.678 -0.86 . . . . 72.12 108.678 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.7 tp60 -138.92 127.61 23.35 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.329 -0.989 . . . . 72.45 108.329 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.692 HG12 ' HD2' ' A' ' 84' ' ' PHE . 42.6 mt -95.06 112.97 28.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.639 -0.874 . . . . 63.54 108.639 172.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -86.09 -24.33 26.32 Favored 'General case' 0 C--O 1.243 0.722 0 O-C-N 123.386 0.429 . . . . 72.4 111.064 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -173.42 146.42 1.37 Allowed 'General case' 0 N--CA 1.48 1.068 0 O-C-N 123.213 0.321 . . . . 72.02 110.373 -173.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.548 HD12 ' HG3' ' C' ' 130' ' ' PRO . 80.9 mt -138.47 134.9 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 124.021 0.929 . . . . 75.21 108.634 171.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.462 ' HB3' HG23 ' B' ' 122' ' ' THR . 27.6 p90 -167.98 176.19 6.3 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 124.42 1.075 . . . . 73.24 111.58 -168.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.6 p -99.64 120.6 39.95 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.433 -0.951 . . . . 74.43 108.433 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.457 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 43.9 mtpt -87.64 -27.4 22.5 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.069 -0.345 . . . . 75.44 110.069 174.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.627 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.7 t70 -149.14 139.59 22.45 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.649 -0.705 . . . . 71.34 109.989 177.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.4 mt -136.62 146.12 29.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 C-N-CA 125.3 1.44 . . . . 72.22 107.242 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -153.73 136.51 15.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 123.495 0.497 . . . . 44.23 110.064 170.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.59 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 86.3 t80 -133.47 143.45 48.83 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.416 -1.328 . . . . 72.35 107.416 171.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -140.38 144.32 36.17 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 108.949 -0.76 . . . . 53.11 108.949 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.61 74.03 11.49 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 106.151 -1.796 . . . . 44.23 106.151 171.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -64.57 -34.78 51.16 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.39 2.06 . . . . 73.04 111.956 -170.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -101.42 20.52 15.79 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.982 0.913 . . . . 71.43 109.896 -175.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.431 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -45.73 -52.01 26.61 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-O 118.009 -0.996 . . . . 73.32 113.627 -171.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.462 ' HG3' ' HG3' ' B' ' 57' ' ' GLU . 48.4 Cg_exo -57.89 -33.7 97.39 Favored 'Trans proline' 0 C--N 1.39 2.723 0 C-N-CA 121.882 1.721 . . . . 65.41 113.564 176.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -82.1 -30.88 30.98 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.055 0.942 . . . . 22.21 110.687 -177.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.725 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.3 p -78.96 -22.38 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 C-N-CA 123.169 0.588 . . . . 63.21 112.518 -163.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -77.84 -25.85 49.02 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.697 0.799 . . . . 75.51 112.67 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -83.39 -12.81 56.08 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.407 0.683 . . . . 70.54 111.012 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -82.77 167.88 17.72 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.962 0.905 . . . . 74.43 111.96 -175.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.68 126.54 31.03 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.986 -1.006 . . . . 74.24 109.324 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.416 ' CE3' HD21 ' A' ' 68' ' ' LEU . 54.1 t-105 -75.47 85.5 2.57 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.326 0.584 . . . . 53.43 110.094 175.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.45 ' H ' HD22 ' A' ' 68' ' ' LEU . 35.4 tt0 -122.88 75.2 48.01 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.689 1.196 . . . . 74.2 108.258 173.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -83.9 135.75 6.78 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.866 2.378 . . . . 73.52 112.994 -171.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -104.9 106.47 16.98 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 106.97 -1.493 . . . . 72.04 106.97 170.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 65' ' ' THR . 15.2 m -75.78 91.49 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-O 122.031 0.92 . . . . 71.53 110.652 -175.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.7 tptt -80.52 111.81 17.28 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 107.118 -1.438 . . . . 54.43 107.118 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 pp -127.53 141.92 51.52 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.046 0.539 . . . . 71.45 110.549 -168.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -146.19 134.16 21.41 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.758 -0.83 . . . . 71.55 108.758 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -103.69 118.61 37.12 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.917 -0.771 . . . . 71.23 108.917 177.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 33.0 t70 -119.55 143.9 47.36 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.758 -0.83 . . . . 73.41 108.758 177.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.1 p -106.94 147.86 29.33 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.195 0.598 . . . . 70.13 110.047 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -147.76 144.05 27.97 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.153 0.981 . . . . 73.23 108.667 176.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 64.2 m -136.54 162.39 33.24 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 118.162 0.437 . . . . 63.5 111.799 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.9 t -149.92 121.86 8.2 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.843 0.857 . . . . 71.11 109.439 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -81.24 125.8 30.75 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.632 -0.507 . . . . 63.13 109.632 175.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.419 HD12 HG23 ' A' ' 83' ' ' ILE . 27.4 mt -107.8 -26.61 10.7 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.915 0.886 . . . . 72.33 110.264 -177.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.38 179.01 6.44 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.252 -1.34 . . . . 74.12 108.672 174.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -67.12 113.02 4.75 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.977 -0.749 . . . . 61.0 108.977 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 76.07 0.32 3.27 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 125.245 1.418 . . . . 64.22 112.401 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.52 109.46 24.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.896 0 N-CA-C 106.744 -1.576 . . . . 74.13 106.744 168.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -133.72 123.38 24.85 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.974 -1.121 . . . . 63.14 107.974 -170.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.403 ' HB2' HD11 ' A' ' 51' ' ' LEU . 14.4 tt0 -86.31 128.3 34.9 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.595 -0.891 . . . . 64.1 108.595 177.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.464 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 56.5 t -101.93 125.97 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.767 -1.197 . . . . 64.5 107.767 176.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 36.8 t -116.13 143.18 26.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 108.229 -1.026 . . . . 64.44 108.229 173.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tt -128.9 117.62 21.31 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.765 -0.828 . . . . 62.4 108.765 174.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.576 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 28.1 ttm105 -81.95 101.56 10.35 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 108.025 -1.102 . . . . 74.02 108.025 170.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.83 101.16 12.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 N-CA-C 107.132 -1.432 . . . . 71.11 107.132 171.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -96.47 126.45 41.67 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.906 -0.776 . . . . 73.02 108.906 176.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.411 ' O ' HD12 ' A' ' 75' ' ' LEU . 67.4 t -128.06 139.76 51.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 125.189 1.396 . . . . 64.25 107.356 176.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 6.4 m -131.24 149.82 52.41 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.702 -1.222 . . . . 70.31 107.702 174.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.19 113.57 22.42 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.203 -1.406 . . . . 63.04 107.203 170.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.0 m -113.85 124.38 52.07 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.157 0.503 . . . . 74.14 110.064 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.45 HD22 ' H ' ' A' ' 37' ' ' GLN . 66.0 mt -90.09 65.52 6.5 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.771 1.228 . . . . 75.13 109.001 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.34 -90.79 0.73 Allowed Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.838 -0.619 . . . . 71.2 111.828 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -102.17 -27.16 13.05 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.291 0.636 . . . . 73.33 111.644 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -100.19 128.5 46.26 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 109.585 -0.524 . . . . 72.54 109.585 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.9 m -71.49 135.91 47.34 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 118.175 0.443 . . . . 55.42 109.92 172.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.725 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -80.61 -63.1 1.48 Allowed 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.448 -0.796 . . . . 53.41 109.729 173.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -156.04 174.88 14.71 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.915 -1.038 . . . . 73.02 111.635 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.411 HD12 ' O ' ' A' ' 64' ' ' VAL . 44.6 tp -134.87 137.62 43.41 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.171 1.388 . . . . 73.44 107.853 174.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 82.5 m -136.51 102.92 5.09 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.96 1.304 . . . . 72.21 109.589 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -122.05 117.17 25.69 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.77 -0.826 . . . . 63.45 108.77 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.7 t -128.96 112.08 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.552 0.741 . . . . 75.31 109.976 -174.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.627 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.8 mt-30 -85.76 91.2 8.25 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.873 -0.788 . . . . 72.41 108.873 168.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.4 ' HG3' HD22 ' A' ' 106' ' ' LEU . 9.1 tp-100 -80.75 107.87 13.93 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.969 -1.014 . . . . 73.1 108.995 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.59 145.28 17.43 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.033 -0.427 . . . . 62.21 112.033 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.06 128.45 3.07 Favored Glycine 0 CA--C 1.507 -0.445 0 N-CA-C 110.942 -0.863 . . . . 74.21 110.942 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.419 HG23 HD12 ' A' ' 51' ' ' LEU . 62.0 mt -79.54 122.38 34.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.867 -0.79 . . . . 73.12 108.867 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.692 ' HD2' HG12 ' A' ' 13' ' ' ILE . 12.6 m-85 -137.54 151.69 48.66 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.744 -0.836 . . . . 74.24 108.744 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 44.3 m -121.01 106.64 11.78 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.325 0.65 . . . . 64.33 109.348 170.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 108.692 -0.855 . . . . 45.44 108.692 178.592 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 111.718 0.266 . . . . 22.23 111.718 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -72.64 -39.28 67.31 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.965 0.506 . . . . 70.12 110.608 171.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.565 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 58.4 m -64.36 -56.21 15.9 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.224 0.61 . . . . 61.1 110.972 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 pp -71.62 -29.37 64.59 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.196 0.599 . . . . 62.22 111.332 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.61 -20.69 57.86 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-O 119.575 -0.569 . . . . 52.31 114.273 -173.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.08 -54.67 0.21 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.063 0.764 . . . . 74.51 113.063 -172.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.565 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 87.5 t80 -60.89 -63.48 1.28 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.524 0.73 . . . . 61.21 112.844 -171.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 78.2 m -65.63 -35.22 10.92 Favored Pre-proline 0 CA--C 1.57 1.732 0 C-N-CA 123.779 0.831 . . . . 75.55 113.073 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.2 -45.73 32.1 Favored 'Trans proline' 0 C--N 1.393 2.914 0 C-N-CA 122.777 2.318 . . . . 55.05 113.374 161.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -70.64 -17.69 62.87 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.401 0.681 . . . . 73.13 112.075 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 46.2 mm -69.71 -43.81 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 N-CA-C 109.209 -0.663 . . . . 72.13 109.209 171.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.4 HD22 ' HG3' ' A' ' 80' ' ' GLN . 89.1 mt -81.89 -23.48 36.27 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.012 0.925 . . . . 71.05 112.549 -177.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -56.22 -47.21 99.3 Favored Pre-proline 0 CA--C 1.572 1.792 0 C-N-CA 124.956 1.303 . . . . 71.52 113.953 -172.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.67 -32.76 14.25 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.119 1.879 . . . . 70.04 112.939 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -68.26 -40.68 81.83 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.058 0.543 . . . . 75.41 110.912 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.73 -39.92 80.13 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.766 -0.652 . . . . 65.22 110.507 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.4 ttm105 -54.67 -47.81 73.13 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.849 0.86 . . . . 70.2 110.912 173.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -68.94 -43.27 75.41 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.709 0.803 . . . . 70.04 111.408 -175.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 43.8 t -63.88 -29.65 70.81 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 123.607 0.567 . . . . 72.33 110.823 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 70.8 mt -68.2 -56.06 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 123.862 0.865 . . . . 71.33 110.011 169.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.2 m -56.28 -35.74 67.83 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.842 1.257 . . . . 44.31 112.339 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.4 t -64.38 -49.61 70.94 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 123.409 0.683 . . . . 51.01 110.647 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.59 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 57.9 mtm -65.9 -37.48 86.21 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.725 0.64 . . . . 60.15 111.25 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.0 t -60.07 -53.19 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.499 1.12 . . . . 72.02 110.403 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 40.2 t -69.78 -29.46 66.79 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.933 0.893 . . . . 61.22 111.49 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 52.0 ttm-85 -75.75 -28.92 58.68 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.256 1.023 . . . . 74.33 109.362 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.432 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.66 15.56 46.07 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 114.741 -1.118 . . . . 75.15 112.607 172.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.477 HG21 ' HE ' ' B' ' 15' ' ' ARG . 2.8 t 60.81 14.46 5.16 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 127.214 2.205 . . . . 74.11 113.77 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -80.08 155.07 75.1 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 123.681 0.792 . . . . 75.1 110.223 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.68 170.13 10.39 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.853 2.369 . . . . 74.44 113.15 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -63.68 127.69 32.5 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.193 -0.912 . . . . 74.45 111.55 -173.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.6 tp -121.88 103.96 9.21 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.651 1.18 . . . . 53.42 108.306 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -97.22 126.65 42.56 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.713 0.805 . . . . 72.43 108.867 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 tt -72.51 130.78 41.43 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.948 -1.13 . . . . 73.15 107.948 171.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.05 133.22 83.91 Favored Pre-proline 0 CA--C 1.548 0.893 0 O-C-N 123.575 0.547 . . . . 63.24 110.743 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -70.59 95.83 0.64 Allowed 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 122.343 2.028 . . . . 51.42 111.593 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.7 t -102.24 111.45 32.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 108.911 -0.774 . . . . 72.31 108.911 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -86.67 82.9 7.72 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.122 -1.066 . . . . 54.04 108.122 172.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 . . . . . 0 N--CA 1.489 1.488 0 C-N-CA 124.498 1.119 . . . . 74.12 111.785 -176.966 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.589 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 25.3 ptm . . . . . 0 N--CA 1.486 1.351 0 N-CA-C 115.473 1.657 . . . . 60.32 115.473 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 90.2 m -134.78 132.35 38.6 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 106.559 -1.645 . . . . 73.55 106.559 162.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.452 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 37.9 t80 -124.13 137.65 54.53 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.738 -0.838 . . . . 75.44 108.738 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.405 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -153.28 132.94 13.05 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.399 -0.593 . . . . 72.31 109.399 176.378 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.409 HD13 HD11 ' B' ' 16' ' ' ILE . 32.5 mt -83.32 120.39 34.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 108.438 -0.949 . . . . 62.32 108.438 173.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -88.28 -46.1 9.5 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.539 -0.541 . . . . 62.34 109.539 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.477 ' HE ' HG21 ' A' ' 122' ' ' THR . 49.2 ttt180 -167.67 137.74 2.77 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.704 0.402 . . . . 71.54 110.167 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.409 HD11 HD13 ' B' ' 13' ' ' ILE . 74.1 mt -114.79 142.32 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.407 -0.961 . . . . 75.2 108.407 175.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -169.77 158.53 7.52 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-O 121.682 0.753 . . . . 62.44 112.499 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.402 ' H ' ' HA2' ' A' ' 121' ' ' GLY . 88.4 m -86.71 129.58 34.81 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.007 -0.997 . . . . 51.12 109.188 170.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.456 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 41.1 mtpt -97.72 -29.22 13.51 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.796 0.838 . . . . 73.12 110.343 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -159.97 141.12 12.43 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.56 0.219 . . . . 73.13 111.334 -170.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 45.7 mm -135.53 146.13 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.291 1.437 . . . . 75.42 109.07 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.603 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 42.4 t -148.21 138.31 22.58 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.851 1.261 . . . . 71.33 107.965 173.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.1 t80 -153.57 109.38 3.27 Favored 'General case' 0 C--O 1.215 -0.755 0 N-CA-C 106.783 -1.562 . . . . 71.51 106.783 170.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -118.53 113.48 21.36 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.33 -1.359 . . . . 73.15 107.33 176.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.431 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -105.14 86.64 1.64 Allowed Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 106.975 -1.491 . . . . 53.34 106.975 172.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.37 -37.5 13.45 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.902 2.401 . . . . 70.1 112.502 -166.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -108.45 21.84 16.76 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.598 0.759 . . . . 71.11 110.069 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.431 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -39.36 -62.25 0.84 Allowed Pre-proline 0 N--CA 1.497 1.908 0 N-CA-C 114.792 1.404 . . . . 74.1 114.792 -166.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.457 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 46.8 Cg_endo -67.89 -27.54 36.93 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 121.823 1.682 . . . . 73.23 112.631 -174.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.405 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 26.3 m80 -75.38 -48.45 22.87 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 115.36 -0.837 . . . . 75.04 110.896 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' B' ' 68' ' ' LEU . 9.1 p -76.06 -0.49 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.365 0 C-N-CA 123.868 0.867 . . . . 64.41 112.353 -167.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -75.7 -13.38 60.31 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.985 -0.447 . . . . 72.02 112.155 173.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 10.2 pt20 -63.36 -16.97 62.03 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.756 0.822 . . . . 73.32 111.183 171.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.461 ' HB2' HD13 ' B' ' 68' ' ' LEU . 33.1 mmtp -93.72 89.87 6.36 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.058 1.343 . . . . 75.34 110.148 -176.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -89.17 84.5 6.53 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.988 0.515 . . . . 62.44 111.08 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 46.7 p90 -168.11 173.05 8.24 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.332 1.053 . . . . 71.01 109.497 169.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -65.17 116.77 33.37 Favored Pre-proline 0 N--CA 1.478 0.937 0 N-CA-C 108.602 -0.888 . . . . 62.04 108.602 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.404 ' O ' HG13 ' B' ' 40' ' ' VAL . 33.9 Cg_endo -60.06 154.15 53.19 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 121.995 1.797 . . . . 74.22 111.881 -175.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 30.3 tt0 -57.23 104.5 0.17 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.014 -0.736 . . . . 65.52 109.014 175.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.404 HG13 ' O ' ' B' ' 38' ' ' PRO . 26.2 m -85.2 139.08 17.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-N 114.924 -1.035 . . . . 63.32 110.565 -172.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.502 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 34.3 ttmt -150.5 107.13 3.51 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.723 -0.843 . . . . 74.23 108.723 -175.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.43 141.14 30.17 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 107.672 -1.233 . . . . 62.03 107.672 176.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -143.51 142.04 30.99 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.459 1.103 . . . . 73.22 108.417 174.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.435 HD23 HD11 ' B' ' 60' ' ' LEU . 5.4 mp -123.92 167.31 14.3 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.539 0.685 . . . . 74.32 110.991 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.599 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.0 t70 -149.65 148.55 29.43 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 113.879 -1.51 . . . . 74.44 109.002 175.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 3.4 t -108.27 127.02 53.49 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.236 1.015 . . . . 74.4 108.938 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -158.4 136.85 10.97 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.202 0.601 . . . . 72.3 110.216 -175.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.4 p -146.57 -179.63 6.9 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.264 0.625 . . . . 63.21 111.155 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 65.1 p -152.51 136.38 16.3 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.174 -1.047 . . . . 63.32 108.174 164.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -89.94 118.68 29.69 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.18 -0.674 . . . . 64.25 109.18 175.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 17.8 mt -84.19 -48.59 9.65 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.596 -0.891 . . . . 75.41 108.596 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.43 179.29 8.26 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.317 -1.31 . . . . 74.01 109.793 175.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.71 130.71 43.11 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.506 -1.224 . . . . 63.11 107.933 172.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 71.12 -5.37 1.55 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 125.145 1.378 . . . . 72.41 112.843 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 86.6 t -119.29 102.52 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.933 0.893 . . . . 61.12 108.714 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -121.68 139.76 53.15 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.447 0.699 . . . . 73.54 109.616 -173.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.462 ' HG3' ' HG3' ' A' ' 29' ' ' PRO . 8.9 tm-20 -106.5 107.48 18.52 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 107.645 -1.243 . . . . 73.43 107.645 -178.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 85.6 t -94.53 126.21 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.163 1.385 . . . . 74.14 110.295 -175.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 13.6 t -112.9 145.88 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.755 -0.831 . . . . 74.41 108.755 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.435 HD11 HD23 ' B' ' 44' ' ' LEU . 41.9 tp -129.44 112.02 13.37 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 108.026 -1.101 . . . . 65.32 108.026 168.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.599 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 11.4 ttm180 -88.56 110.4 20.86 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.923 -0.769 . . . . 72.13 108.923 173.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 24.9 t -105.36 102.77 14.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 107.189 -1.412 . . . . 72.51 107.189 177.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 25.4 m -99.54 134.0 43.05 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.939 -0.763 . . . . 64.2 108.939 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.438 HG23 HD13 ' B' ' 114' ' ' ILE . 40.6 t -120.28 126.16 74.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 123.53 0.732 . . . . 64.42 109.734 174.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 78.6 m -103.54 143.56 32.57 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.964 0.906 . . . . 74.35 109.476 171.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -146.82 135.94 22.55 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.703 0.801 . . . . 73.11 109.648 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.558 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 38.0 p -141.81 134.28 28.17 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 123.373 0.669 . . . . 75.55 110.16 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.461 HD13 ' HB2' ' B' ' 34' ' ' LYS . 26.2 mt -108.85 100.87 10.03 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 123.78 0.832 . . . . 71.21 109.647 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.83 -119.58 6.97 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.505 -0.77 . . . . 74.21 113.385 176.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -95.21 18.12 12.93 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.394 0.677 . . . . 74.53 112.21 -173.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -152.74 155.16 36.67 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.928 0.491 . . . . 73.0 110.562 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 96.7 m -73.12 132.38 43.22 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 116.05 -0.523 . . . . 70.32 110.045 174.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.558 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -82.83 -62.23 1.66 Allowed 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.29 -1.004 . . . . 64.25 108.29 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -158.61 160.31 36.41 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 114.882 -1.053 . . . . 71.2 111.658 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 79.6 mt -128.59 113.06 14.97 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.577 -1.638 . . . . 55.43 106.577 173.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.1 t -115.63 153.37 31.4 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.47 -0.937 . . . . 71.12 108.47 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.603 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.8 tt0 -162.03 126.77 3.34 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.286 -0.635 . . . . 74.24 109.286 -175.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 95.9 t -126.3 145.52 33.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 124.095 0.958 . . . . 74.52 108.773 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -123.47 98.75 5.99 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.199 -1.037 . . . . 70.12 108.199 173.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.484 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 8.1 tp-100 -91.82 101.09 13.68 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.29 -1.004 . . . . 74.41 108.29 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.74 162.7 30.42 Favored Glycine 0 C--O 1.242 0.61 0 N-CA-C 110.9 -0.88 . . . . 73.2 110.9 174.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.74 126.31 1.51 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.821 -0.911 . . . . 35.1 110.821 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 61.0 mt -84.16 129.46 37.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 107.757 -1.201 . . . . 64.41 107.757 174.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -133.04 168.97 17.53 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.498 0.719 . . . . 75.05 109.244 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 73.7 m -126.64 109.53 12.2 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.574 0.75 . . . . 72.21 109.207 170.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -118.74 126.16 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.7 1.2 . . . . 75.33 108.306 -175.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.47 142.97 17.25 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.718 0.407 . . . . 71.22 111.219 -174.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 107.27 -34.44 5.68 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.274 0.359 . . . . 73.12 113.145 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.589 ' HB ' ' HB3' ' B' ' 9' ' ' MET . 0.6 OUTLIER -94.08 160.48 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.751 0.82 . . . . 61.34 110.121 172.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -161.26 160.8 30.32 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.065 0.546 . . . . 74.11 111.207 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.73 -128.68 9.14 Favored Glycine 0 C--N 1.353 1.505 0 C-N-CA 123.818 0.723 . . . . 72.43 112.641 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 35.9 m -65.34 -31.2 72.2 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.654 0.782 . . . . 74.22 110.636 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -69.91 -37.92 76.12 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.259 -0.882 . . . . 75.42 111.01 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -28.8 38.0 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.952 -0.388 . . . . 61.24 109.952 177.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.6 -31.86 73.16 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.775 0.83 . . . . 61.14 110.546 172.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -81.92 -37.93 26.06 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.662 1.185 . . . . 71.01 110.466 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.8 t -64.73 -46.64 81.41 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.861 0.464 . . . . 53.24 110.918 -175.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 5.5 mp -96.26 -9.51 30.13 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.72 0.408 . . . . 71.31 111.281 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.98 -15.36 33.7 Favored Glycine 0 N--CA 1.476 1.313 0 N-CA-C 114.008 0.363 . . . . 64.41 114.008 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.56 -61.71 0.89 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.467 0.707 . . . . 70.24 109.856 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -67.03 -55.11 15.77 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.409 0.684 . . . . 73.22 112.59 -168.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.483 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 83.1 m -61.46 -49.95 85.09 Favored Pre-proline 0 CA--C 1.559 1.307 0 CA-C-O 118.362 -0.828 . . . . 64.24 111.78 -177.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 37.7 Cg_exo -61.9 -25.89 78.51 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 122.318 2.012 . . . . 74.32 113.442 174.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -77.02 -25.61 52.82 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.499 0.72 . . . . 75.43 110.927 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.409 HG23 ' NH2' ' D' ' 111' ' ' ARG . 65.2 mt -68.74 -42.86 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.635 0.774 . . . . 64.4 109.529 169.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' B' ' 102' ' ' CYS . 53.6 mt -82.03 -18.76 42.13 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.412 -1.267 . . . . 72.44 111.311 -174.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -57.64 -52.01 77.48 Favored Pre-proline 0 CA--C 1.559 1.306 0 CA-C-O 117.121 -1.419 . . . . 74.41 112.708 -177.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -53.61 -37.86 83.59 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 122.727 2.285 . . . . 64.43 114.477 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -70.34 -44.38 68.28 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.072 0.549 . . . . 73.02 109.871 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -67.18 -32.43 73.51 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 115.351 -0.84 . . . . 62.33 111.591 177.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.414 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 45.3 ttt-85 -70.3 -51.11 32.78 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.985 1.314 . . . . 72.45 109.967 -176.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -35.79 78.52 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 124.324 1.015 . . . . 61.23 108.957 176.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.487 ' O ' ' HG2' ' B' ' 117' ' ' MET . 19.1 t -65.31 -47.71 75.6 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 123.687 0.617 . . . . 41.23 112.432 -177.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.516 ' O ' HG23 ' B' ' 118' ' ' VAL . 75.5 mt -60.33 -54.72 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 108.924 -0.769 . . . . 74.03 108.924 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 45.2 m -58.27 -30.04 66.27 Favored 'General case' 0 CA--C 1.555 1.146 0 O-C-N 124.583 1.177 . . . . 45.22 111.661 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 48.0 t -69.66 -46.15 66.78 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 123.431 0.693 . . . . 73.44 109.194 176.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.561 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 9.4 mmt -70.13 -32.92 71.17 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 123.482 0.489 . . . . 63.2 110.886 -177.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.516 HG23 ' O ' ' B' ' 114' ' ' ILE . 99.4 t -59.96 -47.5 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 124.302 1.041 . . . . 74.51 109.317 171.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.0 t -70.47 -29.73 66.36 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 113.755 -1.566 . . . . 74.23 111.672 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.561 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 92.3 mtt-85 -70.05 -37.01 75.42 Favored 'General case' 0 C--O 1.214 -0.774 0 C-N-CA 123.346 0.658 . . . . 71.12 109.339 176.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.93 8.82 55.85 Favored Glycine 0 C--N 1.353 1.5 0 O-C-N 124.167 0.917 . . . . 71.12 112.863 173.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.462 HG23 ' HB3' ' A' ' 17' ' ' TYR . 76.9 p 55.38 25.32 7.49 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 126.395 1.878 . . . . 74.53 113.62 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -78.39 155.03 79.31 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 123.888 0.875 . . . . 75.34 111.118 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -46.88 143.96 8.77 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.873 3.049 . . . . 74.02 113.707 176.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -58.6 116.19 3.52 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.174 0.99 . . . . 75.14 111.679 -172.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 41.8 tp -121.25 105.08 10.23 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.328 0.651 . . . . 72.44 110.19 -176.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -105.17 126.37 52.01 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 108.913 -0.773 . . . . 50.33 108.913 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.414 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 49.3 mt -74.33 137.85 43.11 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 109.508 -0.552 . . . . 61.34 109.508 175.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.78 136.83 36.29 Favored Pre-proline 0 N--CA 1.479 1.013 0 CA-C-O 119.282 -0.39 . . . . 62.31 110.077 176.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.664 ' HG3' HD13 ' D' ' 16' ' ' ILE . 69.9 Cg_endo -73.94 141.42 30.01 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.334 2.023 . . . . 54.31 111.978 178.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 27.5 m -128.75 131.38 68.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.567 -0.901 . . . . 73.1 108.567 172.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -73.67 95.86 2.4 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.469 -0.567 . . . . 54.2 109.469 174.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -61.93 -43.59 98.54 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.671 -0.863 . . . . 65.22 108.671 171.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 . . . . . 0 CA--C 1.537 0.462 0 CA-C-N 113.603 -1.635 . . . . 55.44 111.704 -179.619 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.475 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.7 t80 . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 121.311 0.577 . . . . 61.41 109.907 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -152.58 137.35 17.03 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.077 -1.453 . . . . 71.32 107.077 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 64.7 mt -79.81 116.42 23.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 108.332 -0.988 . . . . 64.01 108.332 173.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.456 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 22.2 mm-40 -80.35 -39.0 29.38 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.214 -0.903 . . . . 62.04 109.72 -173.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -179.8 124.33 0.08 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.983 0.513 . . . . 73.21 109.968 -172.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 91.8 mt -109.61 141.21 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 108.848 -0.797 . . . . 64.32 108.848 173.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.448 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 23.5 p90 -174.79 163.97 3.47 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 123.91 0.756 . . . . 74.34 110.236 -173.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.3 p -90.06 125.74 35.52 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.383 0.673 . . . . 64.43 109.369 173.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.448 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 25.8 mmtp -71.07 -49.45 44.43 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 107.887 -1.153 . . . . 74.4 107.887 168.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.718 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 7.9 t70 -139.44 140.77 37.41 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 113.124 -1.853 . . . . 74.22 109.711 -165.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.506 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 73.8 mt -139.18 147.03 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.899 -1.519 . . . . 72.13 106.899 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.9 t -158.95 151.76 21.99 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.418 0.687 . . . . 73.44 109.871 176.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.413 ' CE1' ' HA3' ' C' ' 121' ' ' GLY . 79.0 t80 -153.93 110.68 3.36 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 107.813 -1.18 . . . . 64.44 107.813 173.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -120.61 110.27 16.23 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.516 0.726 . . . . 53.22 109.557 -173.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.24 87.09 22.73 Favored Pre-proline 0 C--O 1.24 0.6 0 N-CA-C 107.253 -1.388 . . . . 62.03 107.253 170.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.05 -37.2 26.79 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.509 2.139 . . . . 65.02 111.992 -176.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -103.97 28.76 6.41 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.512 0.725 . . . . 63.14 109.999 -175.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.501 ' HA ' HG12 ' C' ' 31' ' ' VAL . . . -47.94 -53.8 29.32 Favored Pre-proline 0 CA--C 1.561 1.372 0 N-CA-C 114.322 1.23 . . . . 75.14 114.322 -169.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.78 -49.61 14.1 Favored 'Trans proline' 0 C--N 1.389 2.702 0 CA-C-N 121.747 1.66 . . . . 74.04 112.788 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.475 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 83.2 t60 -69.82 -28.18 65.48 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.859 -0.609 . . . . 61.52 112.087 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.817 HG21 ' HA ' ' C' ' 73' ' ' ALA . 3.7 p -80.93 -13.8 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 O-C-N 121.27 -0.894 . . . . 75.1 112.123 -177.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -81.75 -14.97 55.76 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 112.694 0.627 . . . . 63.13 112.694 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 18.9 pt20 -92.11 9.25 34.25 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.658 0.383 . . . . 74.24 110.559 171.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.07 145.72 28.38 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.517 0.727 . . . . 73.03 110.439 -174.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -71.21 129.94 40.18 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.2 -0.667 . . . . 72.04 109.2 174.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -76.82 84.92 3.41 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.509 0.724 . . . . 72.4 110.292 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -134.14 63.36 61.37 Favored Pre-proline 0 N--CA 1.478 0.967 0 C-N-CA 124.014 0.926 . . . . 70.34 109.351 173.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . 0.42 ' HG2' HG13 ' C' ' 40' ' ' VAL . 92.5 Cg_endo -88.49 159.72 6.6 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.196 1.93 . . . . 73.4 112.855 -172.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -86.44 86.69 7.34 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.011 -1.477 . . . . 74.03 107.011 161.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.42 HG13 ' HG2' ' C' ' 38' ' ' PRO . 15.9 m -65.99 115.03 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 114.411 -1.268 . . . . 73.12 108.593 172.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -127.43 112.35 14.88 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.613 0.765 . . . . 63.53 109.117 -174.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.53 127.68 34.91 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.846 -0.798 . . . . 74.14 108.846 174.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -120.16 135.47 54.96 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.976 1.31 . . . . 74.22 107.91 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.47 ' H ' HD23 ' C' ' 44' ' ' LEU . 1.8 pt? -122.05 125.81 47.07 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.561 0.696 . . . . 71.52 110.627 -177.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.615 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 2.0 t70 -113.78 143.13 45.15 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.575 -1.268 . . . . 73.02 107.575 171.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 62.1 p -112.4 122.38 47.55 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.325 0.65 . . . . 54.34 109.673 -172.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.647 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -115.02 139.85 49.52 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.696 -0.853 . . . . 53.44 108.696 173.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 15.8 m -141.44 143.18 33.75 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.492 0.717 . . . . 72.23 109.677 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 48.3 t -165.8 128.67 2.08 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.082 0.553 . . . . 73.3 109.775 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -82.3 115.67 21.46 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.064 -1.458 . . . . 74.4 107.064 168.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.496 HD11 HD12 ' C' ' 83' ' ' ILE . 31.4 mt -84.94 -33.85 22.59 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.554 0.741 . . . . 73.34 110.438 -173.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.96 -175.73 5.52 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.45 -1.25 . . . . 34.41 109.681 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -65.98 121.45 15.14 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.927 -1.033 . . . . 73.44 108.968 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 69.75 -5.64 1.18 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.348 1.459 . . . . 65.21 113.288 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 93.1 t -110.8 100.48 10.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 123.652 0.781 . . . . 73.13 109.028 -175.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -105.26 166.25 10.54 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.335 -0.848 . . . . 73.44 109.373 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.471 ' HB2' HD11 ' C' ' 51' ' ' LEU . 37.5 tt0 -127.3 129.66 48.09 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 114.673 -1.149 . . . . 73.43 108.986 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 m -120.56 114.81 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.372 -0.973 . . . . 74.34 108.372 168.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.647 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 57.6 t -111.23 130.92 63.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 123.823 0.849 . . . . 75.41 108.717 176.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mp -112.79 116.59 30.31 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.114 -0.698 . . . . 71.15 109.114 176.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.615 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 19.1 ttm-85 -82.18 106.91 14.46 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.164 -1.05 . . . . 65.32 108.164 171.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 26.4 t -99.12 111.37 28.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.548 -1.279 . . . . 64.22 107.548 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 25.9 m -120.45 121.61 38.9 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.917 -0.772 . . . . 54.4 108.917 -172.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.436 HG21 HG21 ' C' ' 114' ' ' ILE . 74.5 t -98.87 114.58 37.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.905 -0.776 . . . . 73.03 108.905 176.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.5 m -101.1 110.25 22.25 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.586 -0.894 . . . . 62.42 108.586 165.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.01 110.56 21.87 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 105.951 -1.87 . . . . 63.15 105.951 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -132.23 126.62 33.93 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.162 0.506 . . . . 73.15 110.782 -177.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 14.1 mt -86.55 40.44 0.89 Allowed 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 125.741 1.616 . . . . 72.05 110.341 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.24 -101.37 2.14 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 111.467 -0.653 . . . . 63.42 111.467 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -88.33 -30.84 19.28 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.186 0.594 . . . . 52.1 109.847 175.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -79.37 121.28 24.94 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.704 0.802 . . . . 54.24 109.585 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.3 m -82.48 126.7 32.54 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.488 -0.93 . . . . 70.41 108.488 167.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.817 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -69.58 -64.4 0.89 Allowed 'General case' 0 C--O 1.238 0.499 0 O-C-N 124.136 0.897 . . . . 75.32 108.792 175.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -155.35 163.13 40.53 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.804 0.811 . . . . 75.4 111.111 173.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -124.16 102.82 7.91 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 105.719 -1.956 . . . . 71.43 105.719 171.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.421 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.1 t -106.76 151.11 25.58 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 107.742 -1.207 . . . . 54.22 107.742 178.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -158.06 135.89 10.6 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 120.608 0.242 . . . . 72.23 110.489 -173.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' C' ' 110' ' ' ALA . 42.6 t -142.25 114.51 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.52 1.128 . . . . 54.2 108.579 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.718 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 47.1 mt-30 -89.22 91.95 8.98 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.473 -0.936 . . . . 71.25 108.473 169.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.476 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 10.2 tp-100 -80.87 114.61 19.87 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.49 -0.777 . . . . 54.42 109.422 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.86 144.43 16.05 Favored Glycine 0 C--N 1.336 0.538 0 O-C-N 123.808 0.692 . . . . 64.24 111.499 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.427 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -141.76 123.02 2.14 Favored Glycine 0 CA--C 1.5 -0.848 0 N-CA-C 109.657 -1.377 . . . . 74.24 109.657 175.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.496 HD12 HD11 ' C' ' 51' ' ' LEU . 14.1 mm -85.81 123.67 39.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.436 -0.949 . . . . 74.34 108.436 176.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.475 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 59.7 m-85 -130.69 134.15 46.69 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.905 -0.776 . . . . 72.33 108.905 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 20.6 p -89.81 140.71 29.33 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 109.528 -0.545 . . . . 74.12 109.528 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 18.1 tt -137.79 139.08 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.815 0.846 . . . . 52.43 109.14 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.25 164.25 22.51 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.387 0.675 . . . . 42.43 109.374 171.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.92 -59.71 2.79 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-N 116.188 -0.46 . . . . 75.34 112.646 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 35.4 pt -91.49 156.26 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.078 0.551 . . . . 73.44 111.204 -173.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -148.78 -176.68 5.43 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.124 0.97 . . . . 72.23 109.385 -177.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.13 -126.42 40.49 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 114.369 0.508 . . . . 32.51 114.369 176.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 38.6 p -79.12 -19.34 51.36 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.617 0.767 . . . . 73.55 111.635 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -62.27 -49.28 76.3 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.784 0.834 . . . . 63.02 109.593 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.418 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 24.3 ptt? -76.15 -28.19 57.31 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 114.665 -1.152 . . . . 74.52 111.006 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.75 -34.17 74.04 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.284 0.633 . . . . 75.21 111.104 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -63.09 -45.1 93.66 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.242 -0.89 . . . . 73.31 110.865 171.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.573 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 47.6 t -66.96 -62.67 1.32 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.763 -0.653 . . . . 65.55 111.084 -174.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' C' ' 94' ' ' MET . 4.2 pp -71.71 -21.57 61.75 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.234 0.614 . . . . 64.13 112.647 -174.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.05 6.67 43.46 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-O 119.445 -0.642 . . . . 73.12 114.312 -173.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -160.37 -59.4 0.06 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.027 0.913 . . . . 73.52 111.686 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.573 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 15.9 t80 -70.89 -36.25 72.66 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 125.385 1.474 . . . . 74.24 113.0 -167.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.509 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 85.3 m -83.31 -44.06 0.84 Allowed Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 123.249 0.62 . . . . 61.31 111.527 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -53.57 -29.99 52.75 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 122.304 2.003 . . . . 74.43 113.34 165.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -60.07 -36.16 76.74 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.5 1.12 . . . . 71.22 111.1 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 35.1 mm -62.92 -36.18 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 CA-C-N 115.257 -0.883 . . . . 55.2 110.245 175.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.427 HD21 ' HA3' ' C' ' 82' ' ' GLY . 81.1 mt -89.73 -21.24 22.78 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.286 1.217 . . . . 75.11 114.286 -166.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . 0.404 ' HZ ' ' CE2' ' C' ' 133' ' ' PHE . 34.6 m-85 -55.77 -48.16 97.17 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 113.989 1.107 . . . . 71.31 113.989 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.31 -35.39 84.57 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 122.231 1.954 . . . . 73.52 113.272 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -66.78 -48.78 67.96 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.576 0.751 . . . . 74.42 110.79 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.476 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -66.51 -39.92 88.92 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-N 115.898 -0.592 . . . . 72.13 110.859 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -56.73 -52.36 65.3 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.369 1.043 . . . . 71.31 110.42 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -67.95 -35.52 78.54 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.706 0.629 . . . . 74.54 110.141 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.5 t -70.31 -27.52 64.45 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.955 0.502 . . . . 64.54 111.097 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.436 HG21 HG21 ' C' ' 64' ' ' VAL . 85.6 mt -75.64 -55.41 11.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 109.6 -0.518 . . . . 65.33 109.6 172.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.2 m -66.57 -27.78 68.0 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.955 0.902 . . . . 74.5 111.335 -170.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 46.1 t -63.33 -49.43 73.97 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.655 0.782 . . . . 75.21 109.243 169.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.535 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.86 -34.74 78.61 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.255 1.022 . . . . 73.11 112.214 178.588 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.42 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.8 t -62.55 -46.41 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.556 0.743 . . . . 73.21 109.114 175.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 30.9 t -66.03 -34.72 78.73 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.194 -1.366 . . . . 61.52 111.6 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -68.2 -31.71 71.43 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.503 0.721 . . . . 74.13 110.054 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . 0.413 ' HA3' ' CE1' ' C' ' 23' ' ' PHE . . . -90.55 10.42 74.63 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.694 0.621 . . . . 73.43 112.839 173.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.491 HG23 ' HB3' ' D' ' 17' ' ' TYR . 62.6 p 56.71 29.27 15.54 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 126.016 1.726 . . . . 75.55 113.941 175.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -88.17 151.73 49.44 Favored Pre-proline 0 N--CA 1.483 1.181 0 C-N-CA 123.357 0.663 . . . . 64.32 109.475 173.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.56 162.98 11.44 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 123.283 2.655 . . . . 75.41 113.98 175.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -52.73 137.53 31.11 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.836 1.254 . . . . 64.24 113.236 -175.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 35.9 tp -150.43 101.53 2.97 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.122 -0.945 . . . . 71.25 109.094 173.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -108.35 133.22 52.85 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.015 0.926 . . . . 60.01 110.142 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.39 138.66 58.6 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.037 0.935 . . . . 73.04 111.705 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.75 147.03 94.15 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.091 0.956 . . . . 53.11 110.559 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.548 ' HG3' HD12 ' A' ' 16' ' ' ILE . 10.8 Cg_exo -68.26 93.79 0.41 Allowed 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.468 2.112 . . . . 74.45 111.762 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 p -98.56 110.12 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-O 121.304 0.574 . . . . 74.11 109.649 176.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -113.96 104.03 11.75 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 106.879 -1.526 . . . . 73.51 106.879 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . 0.404 ' CE2' ' HZ ' ' C' ' 107' ' ' PHE . 55.4 m-85 -55.41 -44.35 76.11 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.106 0.879 . . . . 63.1 112.575 -167.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 N--CA 1.479 0.998 0 O-C-N 123.241 0.338 . . . . 70.52 111.352 -176.578 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 29.9 m . . . . . 0 C--O 1.242 0.683 0 CA-C-O 120.967 0.413 . . . . 71.22 110.204 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -155.85 98.85 1.94 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.608 -1.256 . . . . 75.23 107.608 -177.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . 0.51 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 49.6 mt-30 -113.46 118.85 35.65 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.74 -0.837 . . . . 74.41 108.74 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.489 HG21 ' HG2' ' B' ' 130' ' ' PRO . 38.0 mt -67.7 123.82 21.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 122.673 0.389 . . . . 64.12 110.14 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.429 HE22 HG22 ' D' ' 55' ' ' VAL . 68.5 mt-30 -96.92 -45.43 6.62 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 123.467 0.479 . . . . 71.51 110.358 176.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -167.55 131.36 1.77 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 119.417 -0.325 . . . . 74.14 110.908 -169.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.664 HD13 ' HG3' ' B' ' 130' ' ' PRO . 3.1 mp -115.28 138.28 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 107.7 -1.222 . . . . 60.04 107.7 169.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.491 ' HB3' HG23 ' C' ' 122' ' ' THR . 41.8 p90 -165.79 176.27 8.08 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 124.293 0.995 . . . . 71.44 111.142 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . 0.406 HG21 HD11 ' D' ' 21' ' ' ILE . 80.4 p -106.71 122.95 47.38 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.573 -1.194 . . . . 72.2 109.356 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.425 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 32.8 mtpt -94.23 -24.41 17.48 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.675 -0.693 . . . . 64.34 109.753 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.6 t70 -152.52 133.28 13.98 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 114.527 -1.215 . . . . 51.44 108.632 176.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.535 HG21 ' HE2' ' C' ' 117' ' ' MET . 80.6 mt -131.07 147.59 33.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.155 -1.424 . . . . 71.13 107.155 172.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . 0.54 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 34.6 t -150.49 140.36 21.87 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.789 1.236 . . . . 74.1 107.936 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.506 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.5 t80 -152.84 125.92 8.53 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 105.706 -1.961 . . . . 73.32 105.706 171.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 37.0 mt-10 -137.34 111.63 8.52 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.129 0.572 . . . . 70.13 109.644 -175.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.25 85.38 10.43 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 108.396 -0.965 . . . . 64.12 108.396 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.09 -21.12 12.38 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 122.844 2.362 . . . . 74.11 112.697 -173.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -102.64 0.84 33.83 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.786 0.834 . . . . 75.34 110.675 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -28.66 -64.88 0.16 Allowed Pre-proline 0 CA--C 1.565 1.529 0 N-CA-C 116.392 1.997 . . . . 71.32 116.392 -158.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.46 -22.41 10.83 Favored 'Trans proline' 0 C--N 1.383 2.391 0 CA-C-N 123.091 2.14 . . . . 65.01 113.907 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -69.05 -42.67 75.97 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.266 1.027 . . . . 54.42 109.75 174.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.2 p -83.17 -19.88 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 CA-C-N 115.829 -0.623 . . . . 71.43 111.404 -172.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -63.36 -26.49 68.78 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 112.454 0.539 . . . . 75.21 112.454 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -58.69 -20.59 49.86 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.627 0.771 . . . . 72.23 110.784 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.44 ' NZ ' ' HB3' ' D' ' 71' ' ' GLU . 92.2 mttt -90.52 87.39 6.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.277 1.031 . . . . 54.34 108.63 166.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -97.17 82.13 3.14 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.383 0.611 . . . . 74.14 110.15 -173.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 38.9 p90 -156.94 -174.21 4.82 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.736 1.214 . . . . 75.42 108.691 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.13 114.46 23.63 Favored Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 123.976 0.91 . . . . 72.33 111.108 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.59 127.99 18.25 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.553 2.169 . . . . 74.52 111.847 171.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -75.66 134.99 40.45 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.304 -0.628 . . . . 74.33 109.304 177.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.578 HG13 HG13 ' D' ' 64' ' ' VAL . 74.1 t -102.23 132.81 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.889 0.876 . . . . 65.03 111.306 -174.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.459 ' HB2' ' OG1' ' D' ' 65' ' ' THR . 74.6 mmtt -98.2 130.38 44.94 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.915 -1.143 . . . . 72.53 107.915 168.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -96.69 126.08 41.6 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.544 0.738 . . . . 74.3 109.403 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.808 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 22.4 m-20 -127.66 142.85 51.23 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.136 0.974 . . . . 72.21 108.402 171.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 89.9 mt -129.69 143.26 50.74 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.588 0.755 . . . . 53.43 109.998 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 9.9 t70 -141.36 144.76 34.72 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.209 1.004 . . . . 54.42 108.53 175.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 35.9 p -104.26 143.53 32.83 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.532 0.733 . . . . 52.24 111.327 -173.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.656 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.92 141.74 22.83 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.898 0.879 . . . . 70.11 108.771 171.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.1 p -166.42 154.27 10.07 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.92 0.488 . . . . 61.11 109.795 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 60.2 p -164.04 142.56 7.45 Favored 'General case' 0 C--O 1.24 0.558 0 O-C-N 123.877 0.736 . . . . 64.43 110.224 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -76.36 126.02 30.24 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.104 -0.702 . . . . 54.11 109.104 168.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 73.9 mt -97.45 -30.73 12.74 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.25 0.62 . . . . 64.12 110.55 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.23 -175.06 2.81 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.693 0.797 . . . . 71.54 110.53 177.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -61.9 116.44 4.87 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.821 -1.081 . . . . 73.22 110.087 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 64.41 9.86 5.29 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.926 1.29 . . . . 63.32 112.48 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.429 HG22 HE22 ' D' ' 14' ' ' GLN . 93.7 t -109.73 114.98 48.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 108.157 -1.053 . . . . 73.34 108.157 173.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.483 ' HB2' HD12 ' D' ' 86' ' ' ILE . 72.7 m-85 -134.69 133.08 39.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.509 -0.923 . . . . 73.53 108.509 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -104.55 136.86 43.31 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.844 0.858 . . . . 72.43 109.322 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 38.2 t -121.69 129.21 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 107.737 -1.209 . . . . 64.13 107.737 174.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.656 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 20.4 t -121.56 132.07 71.59 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 C-N-CA 124.221 1.008 . . . . 71.04 108.674 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.59 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 3.9 mm? -119.09 120.2 36.47 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.305 0.642 . . . . 75.32 109.767 176.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.577 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 18.9 ttm-85 -88.67 101.25 13.8 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.404 -0.816 . . . . 71.14 108.82 173.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 55.1 t -90.99 126.37 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 107.574 -1.269 . . . . 52.25 107.574 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.808 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 9.3 m -122.57 125.7 46.23 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.761 0.791 . . . . 71.34 109.983 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.578 HG13 HG13 ' D' ' 40' ' ' VAL . 25.3 t -111.09 99.43 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.959 1.704 . . . . 72.44 108.137 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.47 HG22 HD22 ' D' ' 75' ' ' LEU . 1.8 p -99.64 94.98 6.66 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 107.887 -1.153 . . . . 73.31 107.887 174.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.23 155.62 16.66 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.935 -1.03 . . . . 42.52 111.141 -170.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.49 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.5 p -153.58 132.45 12.41 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.713 -0.676 . . . . 64.11 111.932 -176.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.521 HD12 HG22 ' D' ' 31' ' ' VAL . 24.9 mt -93.74 99.18 11.63 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 124.893 1.277 . . . . 50.14 108.856 172.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.37 -119.86 7.4 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.129 -0.941 . . . . 74.22 112.015 -174.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.77 5.4 49.22 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.428 1.091 . . . . 60.51 111.241 -177.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.44 ' HB3' ' NZ ' ' D' ' 34' ' ' LYS . 5.5 tp10 -129.08 139.72 51.88 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.063 0.945 . . . . 63.41 109.513 -169.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.4 m -61.55 128.59 37.02 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.809 0.843 . . . . 73.25 111.471 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.527 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -83.95 -70.42 0.57 Allowed 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.838 -1.171 . . . . 73.24 107.838 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -146.33 166.74 25.41 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.623 -1.171 . . . . 70.1 109.025 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.47 HD22 HG22 ' D' ' 65' ' ' THR . 48.2 mt -116.24 151.17 36.3 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 105.842 -1.91 . . . . 72.34 105.842 171.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.48 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 50.3 t -157.1 140.23 15.44 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.247 -1.02 . . . . 71.42 108.247 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . 0.54 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 36.7 tt0 -156.75 131.11 8.61 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 122.853 0.461 . . . . 72.52 109.839 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -136.81 118.55 19.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 123.337 0.655 . . . . 65.13 109.742 -177.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.513 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.2 mt-30 -86.41 87.13 7.37 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.811 -1.181 . . . . 74.23 107.811 166.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . 0.442 ' O ' HD13 ' D' ' 106' ' ' LEU . 8.5 tp-100 -79.9 105.2 11.01 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.279 -1.328 . . . . 70.23 107.698 176.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -110.45 143.69 16.96 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.854 -0.498 . . . . 74.22 111.854 -177.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.49 131.43 5.51 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 111.371 -0.691 . . . . 63.32 111.371 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 60.4 mt -89.32 128.42 41.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 C-N-CA 124.497 1.119 . . . . 74.32 107.985 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -136.79 145.66 44.8 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.883 0.373 . . . . 73.42 110.876 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.51 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 16.6 m -78.04 99.47 6.11 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.274 -1.009 . . . . 63.13 108.274 166.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.483 HD12 ' HB2' ' D' ' 56' ' ' TYR . 66.1 mt -107.22 108.6 25.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 123.867 0.867 . . . . 72.05 108.845 -175.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.52 163.77 34.67 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.545 1.138 . . . . 64.41 109.786 -175.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.71 20.82 79.82 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.693 -0.685 . . . . 72.24 114.373 173.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.405 HG23 ' NE2' ' D' ' 93' ' ' GLN . 6.0 mt -104.6 156.88 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 117.374 0.587 . . . . 70.53 110.386 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -140.22 147.62 40.3 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.431 1.092 . . . . 70.21 111.118 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.84 -136.11 48.93 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 115.216 0.847 . . . . 43.42 115.216 169.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 16.0 m -85.67 -9.17 57.63 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.911 0.885 . . . . 62.22 111.554 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.405 ' NE2' HG23 ' D' ' 89' ' ' ILE . 0.1 OUTLIER -53.05 -31.1 39.62 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.673 -0.862 . . . . 45.03 108.673 166.147 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 51.9 mtt -57.32 -55.24 37.31 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.975 0.91 . . . . 73.34 111.357 172.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.3 -29.66 70.94 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.417 0.687 . . . . 65.15 111.516 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -72.4 -40.71 66.98 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.06 0.944 . . . . 63.15 111.139 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.0 t -64.18 -49.56 71.57 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.364 0.666 . . . . 62.51 109.916 -176.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 34.0 mt -75.53 -26.94 58.46 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.275 -1.329 . . . . 74.32 110.914 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.01 -2.5 58.2 Favored Glycine 0 C--N 1.352 1.461 0 CA-C-O 119.368 -0.685 . . . . 63.25 114.399 -176.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.71 -58.98 0.57 Allowed 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 117.905 0.853 . . . . 51.25 111.338 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -71.11 -38.22 72.34 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 111.841 0.311 . . . . 61.31 111.841 -170.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 62.2 m -72.8 -47.98 8.61 Favored Pre-proline 0 CA--C 1.559 1.316 0 CA-C-O 118.576 -0.726 . . . . 63.34 111.776 -177.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.59 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 17.1 Cg_endo -61.5 -22.59 74.88 Favored 'Trans proline' 0 C--N 1.401 3.31 0 C-N-CA 122.27 1.98 . . . . 74.42 112.875 170.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -66.96 -37.46 84.31 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.223 0.609 . . . . 73.25 110.266 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 48.9 mm -71.08 -39.14 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.501 0.72 . . . . 65.11 110.333 175.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.442 HD13 ' O ' ' D' ' 80' ' ' GLN . 86.7 mt -79.28 -18.64 52.29 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.33 -0.85 . . . . 64.1 111.876 -177.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -61.21 -50.1 85.4 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-O 117.87 -1.062 . . . . 72.22 113.487 -175.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.78 -38.99 93.74 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 122.116 1.877 . . . . 42.24 112.667 178.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -78.17 -36.96 46.9 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.087 0.955 . . . . 60.41 112.26 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.79 73.84 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.046 0.539 . . . . 75.35 109.952 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.584 HH12 ' HG3' ' D' ' 130' ' ' PRO . 40.1 ttp180 -57.27 -51.48 69.17 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 124.164 0.915 . . . . 75.13 110.097 174.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -62.54 -43.82 97.87 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.719 0.807 . . . . 73.23 111.729 -174.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.8 t -58.78 -45.51 89.67 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.809 0.693 . . . . 62.51 110.779 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.463 ' O ' HG23 ' D' ' 118' ' ' VAL . 97.5 mt -62.55 -55.14 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.883 -1.053 . . . . 72.4 110.586 174.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 43.5 m -53.24 -40.06 64.29 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.849 1.26 . . . . 71.1 111.449 -174.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.4 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.0 t -66.36 -45.15 81.09 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.729 -1.123 . . . . 65.01 110.439 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.1 mtm -70.01 -28.54 65.58 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.781 0.432 . . . . 64.51 112.08 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.463 HG23 ' O ' ' D' ' 114' ' ' ILE . 96.0 t -64.85 -44.86 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.395 0.678 . . . . 74.55 109.633 174.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.8 p -77.3 -25.42 51.26 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 115.444 -0.798 . . . . 73.44 111.007 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' D' ' 116' ' ' SER . 91.0 mtt-85 -72.69 -35.22 67.59 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.438 0.695 . . . . 62.51 109.538 173.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.48 -0.14 86.42 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 115.644 -0.707 . . . . 64.42 112.122 171.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 42.6 p 62.97 22.02 13.22 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.938 2.095 . . . . 62.03 113.972 174.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -82.23 152.07 67.26 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 123.545 0.738 . . . . 75.42 109.286 169.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -49.59 132.2 29.91 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.372 2.715 . . . . 74.24 113.934 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -51.43 141.02 16.4 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.651 1.58 . . . . 63.25 113.002 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 62.5 tp -114.48 109.58 18.51 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.224 1.01 . . . . 74.5 109.577 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -113.62 97.14 6.25 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.645 -0.872 . . . . 75.41 108.645 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 20.1 tp -70.85 126.59 29.99 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 110.008 -0.367 . . . . 55.41 110.008 177.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -62.09 130.26 92.67 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.079 0.952 . . . . 72.11 110.676 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.584 ' HG3' HH12 ' D' ' 111' ' ' ARG . 2.4 Cg_endo -79.74 106.02 1.91 Allowed 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.657 2.238 . . . . 62.33 110.181 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 109.281 -0.637 . . . . 73.1 109.281 -178.783 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.699 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 8.4 t80 . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 120.26 0.076 . . . . 70.34 110.917 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -147.16 108.84 4.35 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.788 0.835 . . . . 73.11 109.412 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.61 HG12 ' HD2' ' A' ' 84' ' ' PHE . 66.7 mt -78.61 124.04 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 109.494 -0.558 . . . . 62.21 109.494 176.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -84.69 -40.05 17.83 Favored 'General case' 0 C--O 1.241 0.639 0 O-C-N 124.192 0.933 . . . . 62.53 110.667 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.417 ' HB3' HD12 ' A' ' 83' ' ' ILE . 23.7 ttt180 -173.35 137.41 0.66 Allowed 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.526 0.516 . . . . 61.34 110.179 -172.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.436 HD11 HD13 ' A' ' 13' ' ' ILE . 83.5 mt -126.2 138.81 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.321 -0.992 . . . . 73.42 108.321 174.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.481 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 21.1 p90 -168.25 168.85 11.26 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.627 0.727 . . . . 73.04 111.599 -173.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -94.52 120.37 34.64 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.104 -0.953 . . . . 60.31 109.143 176.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 38.2 mtpt -91.34 -30.24 16.67 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.891 0.376 . . . . 74.35 110.635 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 18.8 t70 -148.34 134.39 19.23 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.229 -0.896 . . . . 73.24 109.141 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.411 HG23 ' SD ' ' A' ' 117' ' ' MET . 60.0 mt -132.17 139.31 50.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.061 -1.459 . . . . 60.33 107.061 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.1 t -146.49 122.15 10.49 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.693 -0.854 . . . . 61.4 108.693 173.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.468 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 93.5 t80 -126.0 129.56 49.45 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.699 -1.593 . . . . 73.34 106.699 171.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -139.74 119.31 13.12 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.676 -0.861 . . . . 74.33 108.676 -178.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.38 83.53 8.58 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 106.987 -1.486 . . . . 63.54 106.987 173.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.93 -30.24 67.22 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.916 2.41 . . . . 75.12 112.637 -167.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -117.47 26.45 9.72 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 124.145 0.978 . . . . 72.13 109.45 -174.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.565 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -45.62 -56.34 10.14 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 114.116 1.154 . . . . 74.34 114.116 -169.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 22.3 Cg_exo -64.16 -19.9 66.57 Favored 'Trans proline' 0 C--N 1.385 2.486 0 CA-C-N 121.62 1.614 . . . . 65.53 113.392 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -90.15 -38.19 13.67 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.235 1.014 . . . . 72.25 110.551 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.578 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.1 p -77.13 -21.19 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 115.246 -0.888 . . . . 70.45 112.185 -159.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -71.45 -24.62 62.05 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.013 -0.54 . . . . 74.34 110.841 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -76.0 -27.53 57.44 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.108 0.963 . . . . 74.13 110.297 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -71.18 148.9 46.86 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.081 0.952 . . . . 72.11 110.866 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.15 124.55 23.4 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.117 0.967 . . . . 71.53 109.333 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -82.04 79.4 8.56 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.704 0.764 . . . . 64.3 110.826 -176.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -132.53 77.15 70.43 Favored Pre-proline 0 C--O 1.245 0.846 0 N-CA-C 106.584 -1.635 . . . . 72.51 106.584 169.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -85.41 154.57 10.67 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 121.986 1.79 . . . . 60.11 112.848 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -94.99 83.79 4.01 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 105.355 -2.091 . . . . 75.44 105.355 161.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.598 HG21 HD11 ' A' ' 126' ' ' LEU . 2.8 p -76.48 92.17 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-O 122.575 1.179 . . . . 74.04 108.15 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -87.01 115.33 24.32 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.214 -1.357 . . . . 71.43 109.363 -175.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.575 HD23 HD22 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -95.45 151.75 19.02 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.44 0.638 . . . . 74.24 110.282 177.24 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.607 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 13.4 t70 -145.38 150.57 36.8 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.603 -1.258 . . . . 73.42 107.603 -177.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.493 ' HB2' HD21 ' A' ' 60' ' ' LEU . 2.4 pt? -136.96 130.63 31.83 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.091 0.472 . . . . 70.13 110.44 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 13.7 t70 -122.94 151.08 42.14 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.46 1.104 . . . . 65.14 109.71 -178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.0 p -106.71 127.71 53.6 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.379 -0.828 . . . . 71.31 110.923 -172.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.659 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -134.97 137.48 43.09 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.817 0.847 . . . . 54.32 109.019 172.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.0 p -132.12 163.08 29.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.941 0.496 . . . . 73.33 110.756 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.555 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 35.4 t -161.44 153.11 19.15 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.971 0.908 . . . . 64.32 109.82 176.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -113.58 120.18 40.04 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.433 -0.951 . . . . 75.31 108.433 167.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 52.8 mt -94.35 -32.15 13.72 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.988 0.515 . . . . 72.31 110.265 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.464 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -164.45 -177.11 4.69 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.372 1.069 . . . . 53.11 109.344 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -71.94 130.53 41.21 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.224 -0.658 . . . . 74.42 109.224 174.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 85' ' ' SER . 35.7 m-20 66.15 -2.08 1.04 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.495 1.118 . . . . 73.11 112.657 -174.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 65.5 t -116.45 107.61 22.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.637 0 N-CA-C 108.53 -0.915 . . . . 65.35 108.53 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -126.31 155.89 41.28 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.871 -0.789 . . . . 72.15 108.871 -174.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 35.5 tt0 -117.93 122.75 44.09 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 123.255 0.622 . . . . 73.44 109.424 175.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.2 t -105.48 122.35 58.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 107.017 -1.475 . . . . 63.22 107.017 170.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 47.5 t -114.98 129.44 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.453 -0.943 . . . . 62.53 108.453 176.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.493 HD21 ' HB2' ' A' ' 44' ' ' LEU . 1.4 tt -119.8 112.44 19.24 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.978 -0.749 . . . . 73.33 108.978 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 18.8 ttt180 -86.94 100.64 12.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.18 0.992 . . . . 71.34 109.354 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.8 t -95.46 104.74 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 109.117 -0.697 . . . . 74.32 109.117 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 25.5 m -96.08 106.79 19.01 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.6 0.76 . . . . 64.14 109.515 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.8 t -105.19 108.54 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.876 0.871 . . . . 64.34 109.818 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.2 m -102.23 142.96 32.64 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.827 -1.175 . . . . 71.53 107.827 174.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.01 120.64 35.99 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.334 -1.358 . . . . 62.02 107.334 170.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.2 m -117.64 124.36 48.4 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.736 -0.468 . . . . 72.13 109.736 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.534 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 94.0 mt -88.67 85.53 6.82 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.118 -1.067 . . . . 63.44 108.118 173.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.1 -93.87 1.44 Allowed Glycine 0 C--N 1.343 0.951 0 CA-C-N 114.845 -1.071 . . . . 74.21 111.276 -175.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -119.24 -20.54 7.91 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.503 0.721 . . . . 70.24 110.795 176.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.91 134.15 35.09 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.473 0.709 . . . . 73.15 109.364 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.1 m -73.41 126.62 30.6 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.298 0.499 . . . . 74.41 110.269 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.578 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.35 -58.77 3.08 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.628 0.771 . . . . 52.21 109.543 172.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.431 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 26.2 p90 -158.79 176.08 12.8 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.76 -1.109 . . . . 60.02 111.064 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.1 tp -138.06 142.44 40.29 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.904 1.282 . . . . 74.23 108.144 173.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.468 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 59.6 m -142.43 95.44 2.79 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.001 -1.111 . . . . 74.35 108.001 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -112.41 115.95 29.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.64 0.776 . . . . 75.21 108.937 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.5 t -126.96 117.4 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.637 0.775 . . . . 73.23 110.068 -176.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 75.5 mt-30 -84.61 96.1 9.08 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.246 -1.02 . . . . 73.15 108.246 168.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.413 ' HG3' HD22 ' A' ' 106' ' ' LEU . 9.5 tp-100 -82.79 103.6 12.4 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.009 -0.737 . . . . 75.32 109.009 177.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.81 146.08 20.4 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.33 -0.708 . . . . 34.5 111.33 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.445 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.23 121.02 1.16 Allowed Glycine 0 CA--C 1.505 -0.59 0 N-CA-C 111.031 -0.827 . . . . 42.42 111.031 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.417 HD12 ' HB3' ' A' ' 15' ' ' ARG . 34.7 mt -83.03 120.43 34.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 108.814 -0.809 . . . . 73.31 108.814 173.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.699 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 26.6 m-85 -130.1 124.29 32.42 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 109.358 -0.608 . . . . 74.12 109.358 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 73.9 m -86.6 98.34 11.04 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.535 -0.542 . . . . 61.35 109.535 168.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 28.6 pt . . . . . 0 N--CA 1.473 0.687 0 CA-C-N 115.187 -0.915 . . . . 72.25 109.286 177.911 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.865 0.364 . . . . 61.23 111.105 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -69.11 -35.36 76.35 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.471 -0.786 . . . . 75.54 110.975 174.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 78.8 m -69.37 -63.51 1.05 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 122.865 0.466 . . . . 64.23 111.201 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 pp -73.94 -14.05 60.99 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.03 0.532 . . . . 75.34 112.429 -177.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.45 -12.85 29.84 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-O 119.528 -0.595 . . . . 74.41 114.193 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.43 -57.9 0.49 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 117.773 0.786 . . . . 61.11 112.044 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.401 ' HE2' ' CD1' ' A' ' 11' ' ' PHE . 62.6 t80 -63.59 -58.74 6.0 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.294 1.038 . . . . 72.13 112.191 -169.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.2 m -70.86 -35.79 4.65 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 113.189 0.811 . . . . 62.01 113.189 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.87 -41.72 54.4 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 122.447 2.098 . . . . 74.53 113.497 162.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -71.48 -23.54 61.83 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.895 0.878 . . . . 73.13 110.5 -176.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -67.03 -39.77 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 123.094 0.558 . . . . 74.52 110.027 173.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.445 HD21 ' HA3' ' A' ' 82' ' ' GLY . 93.9 mt -76.48 -26.71 55.64 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.663 0.785 . . . . 41.04 112.507 -175.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -63.89 -44.12 77.95 Favored Pre-proline 0 CA--C 1.564 1.483 0 N-CA-C 114.003 1.112 . . . . 62.52 114.003 -171.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.33 -33.85 79.08 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 121.88 1.72 . . . . 75.12 113.205 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -75.66 -37.92 59.23 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.463 0.705 . . . . 75.51 111.929 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.58 -39.19 70.72 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.842 -0.429 . . . . 55.34 109.842 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.508 ' NH1' HD12 ' C' ' 105' ' ' ILE . 33.4 ttm180 -61.96 -38.28 87.91 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 124.06 0.85 . . . . 72.34 109.62 172.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.515 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 2.9 tm-20 -65.95 -48.34 71.65 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.854 0.862 . . . . 72.33 111.071 -177.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 34.4 t -60.31 -44.77 95.12 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 124.273 0.983 . . . . 71.11 110.231 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 82.9 mt -66.47 -43.5 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.909 0.883 . . . . 64.33 111.149 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.1 m -59.81 -40.37 88.19 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.816 0.846 . . . . 52.34 110.606 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.7 t -72.22 -43.69 64.04 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.219 -0.901 . . . . 64.25 110.696 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.411 ' SD ' HG23 ' A' ' 21' ' ' ILE . 18.8 mtp -60.35 -40.28 90.19 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.466 0.706 . . . . 73.31 111.661 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.529 HG13 ' HB2' ' A' ' 123' ' ' PHE . 48.6 t -66.99 -45.07 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.98 0.912 . . . . 70.25 110.848 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.6 p -71.7 -30.81 66.08 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 120.73 0.3 . . . . 45.44 111.003 -176.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -70.05 -33.73 72.32 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.655 0.782 . . . . 73.14 109.591 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.7 11.97 43.72 Favored Glycine 0 C--N 1.356 1.653 0 O-C-N 123.88 0.738 . . . . 75.41 113.053 173.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.54 HG21 ' HE ' ' B' ' 15' ' ' ARG . 3.4 t 61.56 18.18 9.24 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 127.348 2.259 . . . . 74.32 113.819 172.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.529 ' HB2' HG13 ' A' ' 118' ' ' VAL . 90.3 m-85 -84.84 147.44 48.53 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 107.296 -1.372 . . . . 75.1 107.296 170.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.47 171.85 7.51 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.236 1.957 . . . . 75.15 112.156 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.574 ' HG2' ' H ' ' C' ' 16' ' ' ILE . 9.0 tp-100 -53.31 124.45 14.71 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.035 0.934 . . . . 75.23 112.065 -172.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.598 HD11 HG21 ' A' ' 40' ' ' VAL . 57.4 tp -116.9 118.3 32.09 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.39 -0.823 . . . . 72.1 108.945 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.467 ' ND2' HD12 ' C' ' 16' ' ' ILE . 15.4 m120 -123.65 115.77 21.99 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.755 0.822 . . . . 75.53 111.182 -174.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.575 HD22 HD23 ' A' ' 42' ' ' LEU . 71.1 mt -74.4 121.98 22.26 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.789 -0.819 . . . . 72.42 108.789 167.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.17 130.21 94.28 Favored Pre-proline 0 CA--C 1.555 1.159 0 N-CA-C 110.106 -0.331 . . . . 71.31 110.106 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.56 119.35 6.36 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.785 2.324 . . . . 70.05 111.872 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.2 p -101.97 125.24 56.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 114.97 -1.013 . . . . 50.12 109.982 -176.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -102.66 98.09 8.18 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.616 -0.883 . . . . 73.51 108.616 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 123.309 0.644 . . . . 73.4 110.366 178.4 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 122.029 0.919 . . . . 63.41 111.962 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 86.0 m -141.94 126.79 18.17 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 105.921 -1.881 . . . . 64.54 105.921 167.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -143.28 140.47 30.63 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.202 0.456 . . . . 74.3 110.337 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.527 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -150.39 139.53 21.15 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.552 0.741 . . . . 51.32 109.401 173.059 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 25.7 mt -82.8 124.81 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.194 -1.039 . . . . 65.43 108.194 169.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -93.81 -38.12 11.41 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.074 -0.713 . . . . 64.23 109.074 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.54 ' HE ' HG21 ' A' ' 122' ' ' THR . 32.4 ttt180 -169.9 151.64 4.19 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.252 0.621 . . . . 73.31 110.218 -177.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.464 HD12 HD22 ' D' ' 127' ' ' ASN . 81.7 mt -132.95 140.97 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.364 -1.347 . . . . 72.51 107.364 174.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -169.72 157.23 6.84 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.61 0.719 . . . . 74.53 112.515 -175.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 87.6 m -82.08 127.5 33.18 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.682 -1.144 . . . . 60.11 108.561 170.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.565 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 40.4 mtpt -98.39 -35.77 10.19 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.452 0.701 . . . . 54.44 110.39 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.547 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 13.1 t70 -150.81 137.72 19.1 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.72 -0.673 . . . . 71.53 110.954 -167.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.424 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.5 mm -137.92 143.83 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.088 1.355 . . . . 70.23 108.461 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 44.2 t -149.44 114.99 5.57 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.525 -1.287 . . . . 70.13 107.525 174.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -132.38 110.81 10.82 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.235 -1.024 . . . . 72.31 108.235 173.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -117.48 137.51 52.49 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.527 0.731 . . . . 64.41 109.363 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.893 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -117.24 84.3 17.23 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 106.489 -1.671 . . . . 72.31 106.489 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -63.83 -48.35 5.51 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.829 2.352 . . . . 43.0 112.275 -167.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -104.62 20.13 19.16 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.392 -0.822 . . . . 74.43 110.828 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.893 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -43.78 -59.51 3.46 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 115.56 1.689 . . . . 72.13 115.56 -168.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.466 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 38.2 Cg_exo -58.75 -31.04 94.23 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 122.657 2.238 . . . . 61.11 113.121 -170.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -96.8 -37.19 10.37 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.173 -0.921 . . . . 74.31 111.6 -176.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.486 HG22 HD12 ' B' ' 68' ' ' LEU . 4.0 p -65.45 -20.3 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 123.214 0.606 . . . . 72.12 111.352 -172.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -61.94 -18.47 60.45 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.102 0.961 . . . . 73.52 113.421 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -62.82 -30.78 71.75 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.261 0.553 . . . . 61.42 110.205 176.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -87.71 80.77 7.83 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.45 1.1 . . . . 73.04 109.709 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -84.38 90.42 7.58 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.186 0.517 . . . . 72.11 110.143 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 27.5 p90 -158.73 172.38 18.36 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.711 1.204 . . . . 74.4 108.298 167.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -75.59 110.45 10.63 Favored Pre-proline 0 N--CA 1.477 0.895 0 N-CA-C 109.263 -0.643 . . . . 74.11 109.263 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.14 159.7 51.96 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.23 1.953 . . . . 72.21 112.653 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.44 112.19 3.01 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.685 0.615 . . . . 70.33 109.353 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 48.0 t -85.94 119.95 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.587 -0.894 . . . . 64.15 108.587 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.54 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 24.3 mtpp -119.45 98.56 6.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.332 -1.358 . . . . 71.24 107.332 177.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 pp -94.3 158.07 15.75 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.808 -0.633 . . . . 73.03 110.457 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -162.8 119.44 1.91 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.468 -0.567 . . . . 61.31 109.468 -175.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.582 HD23 HD11 ' B' ' 60' ' ' LEU . 5.2 mp -100.61 143.83 30.31 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.766 0.426 . . . . 72.22 110.1 -178.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -125.2 151.21 46.15 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.128 0.971 . . . . 74.23 109.409 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.1 p -109.02 133.78 52.54 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.338 0.655 . . . . 54.0 110.919 -170.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.627 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -148.65 148.83 30.54 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.617 0.767 . . . . 52.12 109.243 170.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.8 m -146.76 177.21 9.27 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.455 0.702 . . . . 71.11 109.951 172.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 1.4 m -151.55 138.63 19.16 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.681 0.792 . . . . 74.23 108.934 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -92.33 108.99 20.37 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.381 -1.34 . . . . 72.12 107.381 165.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.426 HD11 ' HB2' ' B' ' 57' ' ' GLU . 21.7 mt -83.77 -56.08 3.9 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.131 0.491 . . . . 63.22 109.797 -176.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.09 -170.22 2.74 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.197 -0.91 . . . . 53.51 109.257 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.45 109.94 4.47 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 114.75 -1.114 . . . . 55.34 109.542 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 70.45 2.63 4.14 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 125.081 1.352 . . . . 71.41 113.232 -177.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 78.3 t -105.74 123.08 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 108.435 -0.95 . . . . 72.35 108.435 173.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.429 ' HE2' ' HB3' ' B' ' 98' ' ' LEU . 4.9 p90 -133.37 175.35 9.49 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.142 0.977 . . . . 64.3 108.739 -176.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.426 ' HB2' HD11 ' B' ' 51' ' ' LEU . 12.0 tm-20 -145.4 116.0 7.66 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.806 -0.813 . . . . 71.32 108.806 -175.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 60.2 t -97.91 132.3 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.188 0.595 . . . . 53.2 109.989 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.627 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 20.7 t -115.96 119.06 60.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 124.339 1.056 . . . . 65.34 108.931 176.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.582 HD11 HD23 ' B' ' 44' ' ' LEU . 50.5 tp -106.49 112.44 25.44 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.428 -0.582 . . . . 61.15 109.428 170.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.532 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 31.2 ttm180 -85.52 132.43 34.2 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.708 -0.849 . . . . 73.44 108.708 170.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 17.5 t -126.22 120.96 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 107.819 -1.178 . . . . 60.0 107.819 172.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 9.0 m -114.08 152.54 30.91 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.702 0.801 . . . . 70.4 109.265 -176.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.472 HG21 HG21 ' B' ' 114' ' ' ILE . 97.2 t -139.6 103.62 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.682 1.193 . . . . 53.41 108.559 -175.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 97.4 m -83.08 140.24 32.77 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.29 -1.004 . . . . 62.31 108.29 162.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.03 137.49 23.57 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.092 -0.707 . . . . 74.23 109.092 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.497 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 36.8 p -144.06 128.73 18.2 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 123.614 0.571 . . . . 65.14 111.584 -174.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.486 HD12 HG22 ' B' ' 31' ' ' VAL . 61.2 mt -95.91 101.41 13.09 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.97 -1.122 . . . . 65.34 107.97 174.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.0 -112.69 3.5 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 116.049 -0.523 . . . . 64.12 112.546 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.71 21.47 11.48 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.034 0.934 . . . . 63.32 111.285 -176.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -137.96 151.63 48.13 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.05 0.54 . . . . 74.24 110.007 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 86.9 m -72.11 118.11 14.58 Favored 'General case' 0 C--O 1.241 0.629 0 O-C-N 123.391 0.432 . . . . 75.1 110.777 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.497 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -71.59 -62.25 1.48 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.228 -0.896 . . . . 75.11 108.738 172.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -152.08 164.73 36.66 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.079 0.942 . . . . 75.35 112.214 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 91.0 mt -132.69 114.02 13.68 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 106.043 -1.836 . . . . 75.42 106.043 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.403 ' SG ' HG23 ' B' ' 114' ' ' ILE . 46.7 t -116.36 151.28 36.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.568 -0.901 . . . . 62.51 108.568 178.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -163.42 126.84 2.73 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.42 -0.585 . . . . 75.24 109.42 -175.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 64.4 t -123.63 153.84 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 123.698 0.799 . . . . 74.13 109.117 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.547 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 20.9 mt-30 -127.91 103.54 7.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.235 -1.024 . . . . 65.21 108.235 166.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -91.21 102.29 15.01 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.979 -0.748 . . . . 52.14 108.979 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.439 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.19 164.39 28.39 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.522 -0.763 . . . . 75.53 111.666 174.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.77 127.75 1.72 Allowed Glycine 0 CA--C 1.504 -0.638 0 N-CA-C 111.413 -0.675 . . . . 55.11 111.413 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 66.4 mt -84.21 127.93 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.056 -1.09 . . . . 74.13 108.056 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -134.29 164.12 28.11 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.404 1.082 . . . . 75.34 109.136 -176.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.6 m -132.26 133.32 43.97 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.624 0.769 . . . . 55.01 109.454 175.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' B' ' 10' ' ' THR . 9.5 tt -135.53 146.36 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.837 0.855 . . . . 75.42 109.045 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.99 152.45 33.55 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.319 0.248 . . . . 73.12 110.433 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.91 -32.9 5.53 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.581 -0.736 . . . . 44.14 112.563 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 46.6 mm -92.89 153.34 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.183 0.993 . . . . 74.44 111.756 -175.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.06 -172.0 3.28 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.664 1.186 . . . . 72.13 110.342 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.21 -133.44 52.35 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 114.935 0.734 . . . . 73.23 114.935 175.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.6 m -65.66 -37.75 87.39 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.545 0.738 . . . . 70.21 111.231 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -75.46 -20.82 58.58 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.513 -0.767 . . . . 75.2 110.741 -172.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 57.3 ttm -64.87 -45.11 87.37 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.425 -0.583 . . . . 75.5 109.425 168.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.02 -30.67 71.67 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.958 0.903 . . . . 52.2 111.168 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -69.94 -35.84 74.83 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.827 0.851 . . . . 75.55 110.995 176.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.434 ' SG ' HD12 ' B' ' 86' ' ' ILE . 42.0 t -69.11 -66.52 0.57 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.024 0.53 . . . . 63.43 110.952 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.429 ' HB3' ' HE2' ' B' ' 56' ' ' TYR . 1.2 pp -76.67 -5.88 49.77 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 112.731 0.641 . . . . 71.11 112.731 -176.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.97 -36.9 8.1 Favored Glycine 0 C--N 1.336 0.535 0 O-C-N 123.452 0.47 . . . . 72.02 113.391 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.84 -52.45 1.33 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.898 0.479 . . . . 73.21 111.569 -169.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -64.46 -46.52 82.74 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.307 1.043 . . . . 73.15 111.66 -174.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.439 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 84.2 m -75.36 -46.55 4.44 Favored Pre-proline 0 CA--C 1.563 1.467 0 N-CA-C 112.74 0.644 . . . . 61.14 112.74 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.517 ' HB3' HD22 ' B' ' 60' ' ' LEU . 53.8 Cg_exo -59.72 -25.29 78.66 Favored 'Trans proline' 0 C--N 1.388 2.612 0 C-N-CA 122.294 1.996 . . . . 75.44 113.887 171.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -62.17 -40.73 97.02 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.442 0.697 . . . . 62.44 110.397 174.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.416 ' HA ' ' NH2' ' D' ' 111' ' ' ARG . 73.9 mt -63.59 -43.67 98.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 CA-C-N 114.795 -1.093 . . . . 74.52 110.253 177.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 78.9 mt -81.98 -19.93 39.56 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.303 -1.317 . . . . 74.12 112.332 -171.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -54.13 -53.25 60.76 Favored Pre-proline 0 CA--C 1.563 1.447 0 N-CA-C 113.945 1.091 . . . . 74.33 113.945 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.98 -33.5 95.55 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.164 1.91 . . . . 73.45 113.711 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -71.74 -45.92 60.19 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.889 -0.596 . . . . 71.34 110.428 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.91 91.0 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.034 0.534 . . . . 61.31 110.563 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.0 ttt-85 -62.28 -51.67 66.76 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.24 1.416 . . . . 71.55 110.872 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.5 -32.72 72.9 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.356 0.663 . . . . 73.02 109.878 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.514 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.3 t -69.93 -35.93 74.93 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 122.653 0.381 . . . . 64.53 111.291 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.472 HG21 HG21 ' B' ' 64' ' ' VAL . 71.6 mt -64.25 -55.25 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 108.66 -0.867 . . . . 72.42 108.66 172.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 37.9 m -57.83 -31.51 66.7 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 124.374 1.047 . . . . 72.02 111.367 -175.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.1 t -62.65 -53.66 51.18 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 123.318 0.647 . . . . 70.55 109.533 175.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.514 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.3 mmt -65.92 -35.38 80.48 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.375 0.67 . . . . 61.24 111.582 -174.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 85.2 t -64.23 -43.23 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.665 0.786 . . . . 73.32 110.154 175.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 39.7 t -70.08 -28.38 65.38 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.227 -0.897 . . . . 74.15 111.334 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.494 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 89.0 mtt-85 -71.06 -39.19 72.38 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.644 0.777 . . . . 74.31 110.205 176.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.98 -0.88 71.12 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.852 0.72 . . . . 72.13 112.643 172.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 19.0 p 63.76 31.88 13.96 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.561 1.945 . . . . 53.51 112.363 173.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -90.64 160.49 38.69 Favored Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 124.545 1.138 . . . . 71.21 110.407 176.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -50.77 159.64 2.22 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 123.969 3.113 . . . . 71.35 115.874 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -64.08 112.55 3.04 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.868 -1.06 . . . . 72.21 111.42 -173.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 50.6 tp -111.1 122.46 47.94 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.524 0.73 . . . . 63.44 109.271 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -132.8 122.5 24.58 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.303 -0.999 . . . . 73.3 108.303 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 93.3 mt -68.86 145.49 53.66 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.578 0.351 . . . . 72.14 110.816 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.18 142.13 40.79 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.225 0.61 . . . . 74.32 110.463 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.31 116.12 3.42 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.356 2.704 . . . . 64.33 111.844 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 35.2 m -124.55 140.34 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.179 0.592 . . . . 70.2 109.688 175.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -111.52 98.2 7.28 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.942 -0.762 . . . . 75.44 108.942 174.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -56.76 -34.99 68.12 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.87 0.868 . . . . 75.35 110.545 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 t70 . . . . . 0 CA--C 1.536 0.442 0 CA-C-N 113.67 -1.604 . . . . 64.22 111.764 -172.207 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.706 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 23.3 t80 . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 108.828 -0.804 . . . . 60.15 108.828 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -152.55 132.81 13.6 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.883 -0.784 . . . . 75.01 108.883 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.407 HD13 HD11 ' C' ' 16' ' ' ILE . 16.7 mt -87.65 131.58 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.83 -0.804 . . . . 55.25 108.83 174.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -92.94 -48.61 6.44 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.558 0.743 . . . . 70.15 110.325 177.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -173.92 130.42 0.4 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 115.963 -0.562 . . . . 72.41 109.778 -168.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.574 ' H ' ' HG2' ' A' ' 125' ' ' GLN . 61.3 mt -123.2 147.76 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.962 -0.755 . . . . 73.15 108.962 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.504 ' HB3' HG23 ' D' ' 122' ' ' THR . 20.5 p90 -175.33 157.39 2.18 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.515 0.674 . . . . 72.21 110.076 -173.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.0 p -77.99 123.9 27.37 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.767 -1.106 . . . . 73.2 108.712 172.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -70.35 -49.19 51.85 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 107.479 -1.304 . . . . 63.0 107.479 167.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 11.4 t70 -136.68 136.92 39.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 112.874 -1.966 . . . . 55.21 109.203 -166.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.431 HG12 ' SG ' ' C' ' 113' ' ' CYS . 75.3 mt -134.63 142.59 40.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.663 -1.606 . . . . 60.24 106.663 171.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.4 t -156.2 150.47 25.51 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.89 -0.411 . . . . 73.3 109.89 175.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -152.26 116.69 5.01 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.446 1.098 . . . . 64.23 108.043 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -120.72 129.44 53.65 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.642 0.777 . . . . 74.21 109.757 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.38 82.7 33.79 Favored Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 107.25 -1.389 . . . . 74.22 107.25 170.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.92 -14.01 23.96 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.953 2.435 . . . . 72.12 112.06 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -110.79 17.21 20.82 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.138 0.975 . . . . 72.23 109.881 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.439 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -49.28 -56.53 15.57 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 114.514 1.302 . . . . 52.21 114.514 -167.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.439 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 35.1 Cg_exo -61.84 -38.9 55.95 Favored 'Trans proline' 0 C--N 1.385 2.474 0 CA-C-N 121.824 1.687 . . . . 73.53 112.39 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -69.5 -34.92 75.0 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.684 -1.144 . . . . 71.12 112.308 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.718 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.4 p -82.75 -16.68 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 N-CA-C 112.724 0.639 . . . . 60.34 112.724 -176.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -78.37 -16.9 57.19 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.257 0.466 . . . . 55.31 112.257 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -94.07 36.77 1.11 Allowed 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.344 0.592 . . . . 71.11 109.906 172.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.79 167.21 16.09 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.27 1.028 . . . . 74.25 110.663 -178.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -89.97 132.19 35.47 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.804 0.842 . . . . 75.25 109.95 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 50.9 t-105 -81.97 90.51 6.49 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.192 0.52 . . . . 74.32 112.053 -173.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -143.55 77.95 14.9 Favored Pre-proline 0 CA--C 1.559 1.296 0 C-N-CA 124.496 1.119 . . . . 74.4 108.744 171.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -92.74 145.93 2.56 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.967 2.445 . . . . 53.53 114.623 -176.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.75 97.71 10.76 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 107.496 -1.298 . . . . 62.43 107.496 166.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' C' ' 65' ' ' THR . 9.6 m -83.85 100.29 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.745 0.783 . . . . 62.2 111.135 -176.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -92.57 109.09 20.49 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.628 0.771 . . . . 74.34 109.552 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 pp -86.0 163.02 18.22 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.781 -0.645 . . . . 62.23 111.196 -177.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.522 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 31.2 t70 -150.48 112.57 4.59 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.918 -0.771 . . . . 60.33 108.918 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' C' ' 61' ' ' ARG . 5.7 mp -113.51 112.87 24.31 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.035 -0.728 . . . . 74.35 109.035 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -116.87 152.63 34.08 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.098 0.959 . . . . 74.33 109.369 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 33.7 p -112.42 126.93 55.83 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.329 0.652 . . . . 75.02 111.028 -169.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.47 141.31 39.44 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.434 1.094 . . . . 64.2 108.534 174.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 36.0 p -165.73 164.96 18.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.337 0.255 . . . . 70.11 111.258 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 67.8 p -167.07 138.0 3.14 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.856 0.862 . . . . 73.15 109.511 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' C' ' 56' ' ' TYR . 51.8 tt0 -78.7 117.76 20.15 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.742 -0.836 . . . . 75.31 108.742 174.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.533 HD11 HD12 ' C' ' 83' ' ' ILE . 33.3 mt -84.75 -39.91 17.9 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.981 0.912 . . . . 71.23 110.982 -171.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.405 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -152.88 -170.49 3.64 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.654 -0.703 . . . . 62.21 110.943 -175.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -59.05 107.51 0.55 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.315 1.046 . . . . 71.12 110.716 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 63.12 6.82 2.46 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.288 1.035 . . . . 52.02 112.677 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 91.9 t -103.68 113.19 39.85 Favored 'Isoleucine or valine' 0 C--N 1.345 0.38 0 N-CA-C 107.584 -1.265 . . . . 74.11 107.584 177.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' C' ' 50' ' ' GLN . 50.9 t80 -131.39 135.09 46.91 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.062 0.945 . . . . 74.41 108.8 -173.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.51 ' HB2' HD11 ' C' ' 51' ' ' LEU . 39.3 tt0 -92.43 136.95 32.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.785 -1.098 . . . . 72.22 110.377 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 86.3 t -119.35 115.36 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.312 -1.366 . . . . 74.32 107.312 173.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.3 122.1 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 109.208 -0.664 . . . . 65.41 109.208 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 tp -116.55 125.57 52.07 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.656 -0.868 . . . . 62.33 108.656 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 29.8 ttm180 -79.06 130.96 36.07 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.749 -1.204 . . . . 72.1 107.749 172.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 23.5 t -124.02 111.37 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.13 -1.433 . . . . 72.33 107.13 172.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 63.9 m -121.43 139.89 52.87 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.446 -0.946 . . . . 53.24 108.446 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 85.6 t -131.42 111.6 19.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 108.184 -1.043 . . . . 73.12 108.184 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' C' ' 40' ' ' VAL . 3.2 m -98.5 132.81 43.63 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 107.567 -1.271 . . . . 64.45 107.567 173.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.76 121.47 37.33 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.47 -0.937 . . . . 72.14 108.47 -177.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 47.1 m -136.17 126.08 25.86 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.04 0.447 . . . . 65.13 111.061 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 14.1 mt -86.06 57.92 4.76 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.135 1.374 . . . . 75.23 109.076 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.08 -92.64 1.07 Allowed Glycine 0 C--N 1.343 0.938 0 N-CA-C 110.245 -1.142 . . . . 60.53 110.245 -175.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -126.6 2.01 6.84 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.895 0.878 . . . . 73.35 110.064 172.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -82.02 114.26 20.46 Favored 'General case' 0 C--N 1.347 0.481 0 N-CA-C 108.151 -1.055 . . . . 64.3 108.151 169.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.2 m -79.02 120.49 23.67 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 119.281 0.946 . . . . 63.31 109.146 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.718 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -79.81 -58.71 3.04 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.885 -1.052 . . . . 65.33 109.006 178.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -159.09 174.85 14.27 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 122.017 0.913 . . . . 72.43 112.321 -178.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.434 HD23 HG23 ' C' ' 65' ' ' THR . 2.4 tm? -138.61 142.57 39.13 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 105.37 -2.085 . . . . 61.23 105.37 170.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 48.1 t -150.29 112.84 4.71 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.586 -0.524 . . . . 74.22 109.586 176.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -118.01 130.9 56.46 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.568 0.747 . . . . 73.31 109.545 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.44 HG11 ' HA ' ' C' ' 110' ' ' ALA . 55.6 t -131.19 113.23 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.195 0.998 . . . . 71.43 108.542 175.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -91.03 95.17 9.97 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.885 -1.154 . . . . 74.31 107.885 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.538 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.3 tp-100 -86.08 115.42 23.66 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.158 0.583 . . . . 61.12 110.098 -176.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.69 146.88 18.07 Favored Glycine 0 C--N 1.338 0.652 0 O-C-N 123.489 0.493 . . . . 34.54 112.344 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.415 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -144.51 119.18 1.23 Allowed Glycine 0 C--O 1.237 0.308 0 N-CA-C 110.698 -0.961 . . . . 72.11 110.698 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.533 HD12 HD11 ' C' ' 51' ' ' LEU . 16.4 mm -83.86 123.75 39.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.595 -0.891 . . . . 62.34 108.595 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -132.31 123.85 27.67 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.98 0.512 . . . . 65.1 110.851 -173.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 58.7 m -80.19 105.27 11.33 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.394 -0.965 . . . . 51.03 108.394 166.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.51 HD13 ' H ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -116.0 139.2 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.052 -0.721 . . . . 72.22 109.052 -179.563 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.63 170.2 16.01 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.351 0.661 . . . . 50.23 110.247 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.81 -30.02 7.94 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-O 119.625 -0.542 . . . . 54.33 113.823 172.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 47.4 pt -123.7 151.31 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 118.001 0.901 . . . . 73.31 110.333 176.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -147.75 157.9 43.76 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.921 0.889 . . . . 64.25 109.774 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.58 -148.19 21.77 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 119.167 -0.796 . . . . 74.54 111.878 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 9.8 t -56.77 -26.56 57.81 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.394 0.677 . . . . 75.43 111.681 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -55.33 -59.12 5.24 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.225 1.41 . . . . 63.1 110.423 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 32.9 ttp -77.78 -22.47 50.11 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.358 -0.837 . . . . 74.33 111.425 -177.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.92 -35.08 79.49 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.261 0.624 . . . . 74.02 110.706 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -73.82 -31.67 63.34 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.396 -0.82 . . . . 73.02 110.617 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -66.47 -60.93 2.29 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.314 0.246 . . . . 71.55 110.716 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 pp -66.5 -29.96 70.18 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.192 0.597 . . . . 61.31 111.585 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.92 12.4 59.12 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-O 119.251 -0.749 . . . . 74.32 114.475 -173.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.41 -55.38 0.06 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.269 1.035 . . . . 63.53 112.045 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -71.23 -35.67 71.55 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.76 0.824 . . . . 52.22 111.555 -172.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.706 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 60.7 m -76.19 -50.91 2.83 Favored Pre-proline 0 CA--C 1.564 1.5 0 C-N-CA 123.603 0.761 . . . . 73.1 112.249 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.58 -13.54 35.27 Favored 'Trans proline' 0 C--N 1.398 3.138 0 C-N-CA 122.03 1.82 . . . . 75.41 112.959 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -60.89 -37.41 82.12 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.999 0.919 . . . . 75.14 110.154 171.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.508 HD12 ' NH1' ' A' ' 111' ' ' ARG . 37.9 mm -70.02 -36.06 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.229 -0.896 . . . . 63.54 111.19 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.415 HD21 ' HA3' ' C' ' 82' ' ' GLY . 53.6 mt -91.94 -24.59 19.22 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.862 -1.063 . . . . 72.32 111.985 -166.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -57.25 -52.64 72.71 Favored Pre-proline 0 CA--C 1.557 1.241 0 CA-C-O 117.99 -1.005 . . . . 75.33 112.733 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.515 ' HB2' ' HG3' ' A' ' 112' ' ' GLU . 42.0 Cg_endo -63.45 -27.3 70.58 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 121.683 1.589 . . . . 73.45 112.788 -177.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.427 ' CD1' HG21 ' C' ' 16' ' ' ILE . 3.2 m-30 -71.17 -50.4 33.67 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.801 0.84 . . . . 65.11 110.435 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.538 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -63.56 -35.34 80.17 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.303 -0.862 . . . . 73.43 110.914 176.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -60.02 -50.71 72.66 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.349 1.459 . . . . 73.44 111.587 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.7 -37.94 87.86 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 123.552 0.533 . . . . 73.45 109.696 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.431 ' SG ' HG12 ' C' ' 21' ' ' ILE . 42.4 t -63.9 -34.84 78.85 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.338 0.655 . . . . 41.22 111.766 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.473 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 68.0 mt -71.04 -52.19 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.127 0.571 . . . . 73.33 110.414 174.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 35.1 m -62.74 -30.02 71.12 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.25 0.62 . . . . 72.23 111.438 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.1 t -65.97 -48.71 70.36 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.899 -0.778 . . . . 60.24 108.899 174.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.558 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.11 -37.83 81.18 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.673 1.189 . . . . 71.31 112.32 178.496 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.415 HG23 ' O ' ' C' ' 114' ' ' ILE . 93.8 t -65.68 -42.94 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.365 0.666 . . . . 63.22 110.1 177.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.0 t -70.16 -29.1 65.92 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.38 -0.827 . . . . 73.24 111.714 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -69.92 -34.61 73.7 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.324 0.65 . . . . 73.53 109.3 175.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.46 11.27 64.08 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.713 0.633 . . . . 50.52 113.108 174.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.421 HG23 ' HB3' ' D' ' 17' ' ' TYR . 73.0 p 56.23 24.33 8.02 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 126.276 1.83 . . . . 71.44 114.23 176.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -84.77 140.53 37.85 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.057 -1.09 . . . . 63.23 108.057 169.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.48 168.84 2.67 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 123.028 2.485 . . . . 64.32 114.273 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -50.69 118.71 3.27 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.79 1.236 . . . . 62.04 113.594 -171.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.04 86.57 2.45 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 106.947 -1.501 . . . . 53.34 106.947 174.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -106.08 118.82 37.61 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.642 -0.873 . . . . 73.14 108.642 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.93 133.19 47.87 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.502 0.721 . . . . 44.35 109.459 -177.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.09 152.25 96.25 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 123.355 0.662 . . . . 73.3 112.486 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.63 106.28 0.42 Allowed 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.076 2.518 . . . . 54.04 112.712 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.12 109.73 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 108.568 -0.901 . . . . 64.35 108.568 171.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -81.71 110.83 17.41 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.837 1.255 . . . . 72.32 109.996 175.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -49.83 -45.06 49.77 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.428 0.691 . . . . 73.23 111.345 174.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 N--CA 1.477 0.888 0 C-N-CA 124.743 1.217 . . . . 73.02 112.051 178.112 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 49.3 m . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 108.468 -0.938 . . . . 44.12 108.468 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -150.35 108.7 3.78 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.976 -1.12 . . . . 74.14 107.976 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . 0.617 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 43.5 mt-30 -126.46 118.51 25.1 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.194 -1.039 . . . . 75.21 108.194 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.469 HG21 HD11 ' D' ' 16' ' ' ILE . 19.8 mt -86.76 125.98 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 109.26 -0.644 . . . . 75.53 109.26 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -98.23 -29.06 13.42 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.411 0.684 . . . . 71.12 111.41 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -173.05 131.49 0.5 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 111.934 0.346 . . . . 74.34 111.934 -167.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.469 HD11 HG21 ' D' ' 13' ' ' ILE . 1.8 mp -112.74 136.02 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 107.366 -1.346 . . . . 72.34 107.366 167.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.441 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 40.5 p90 -164.64 175.84 9.42 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.779 0.8 . . . . 72.45 112.234 178.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.4 p -110.64 127.69 55.37 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.703 -1.135 . . . . 74.34 109.408 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.441 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 37.9 mtpt -100.38 -18.1 16.91 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.611 0.764 . . . . 72.53 110.134 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.657 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 11.4 t70 -159.27 133.51 7.68 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.575 1.15 . . . . 75.21 108.207 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.558 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.5 mt -136.27 146.52 28.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 106.704 -1.591 . . . . 74.44 106.704 173.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 23.0 t -152.61 143.82 23.19 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.142 0.577 . . . . 42.3 109.767 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.3 t80 -151.41 125.87 9.46 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 105.806 -1.924 . . . . 73.42 105.806 175.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -140.65 111.48 6.99 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.243 0.617 . . . . 71.42 109.807 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.56 92.0 9.43 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 108.508 -0.923 . . . . 64.13 108.508 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.82 -30.77 2.73 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.921 2.414 . . . . 64.44 113.559 -171.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -102.62 9.07 39.56 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.092 0.957 . . . . 64.01 111.081 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.512 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -30.63 -65.59 0.19 Allowed Pre-proline 0 CA--C 1.556 1.211 0 N-CA-C 117.272 2.323 . . . . 75.15 117.272 -160.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.09 -29.05 8.49 Favored 'Trans proline' 0 C--N 1.378 2.102 0 CA-C-N 123.173 2.169 . . . . 53.43 113.751 -171.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -85.72 -21.63 28.19 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.598 0.237 . . . . 71.15 110.508 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.512 HG12 ' O ' ' D' ' 28' ' ' ALA . 9.7 p -82.7 -15.72 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 116.037 -0.528 . . . . 53.5 110.827 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -69.69 -22.18 63.44 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 112.5 0.556 . . . . 70.44 112.5 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -57.81 -29.28 64.78 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.637 0.732 . . . . 51.21 109.6 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -88.11 71.13 9.32 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.073 -1.421 . . . . 71.14 109.328 173.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -88.65 84.54 6.73 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.293 0.568 . . . . 61.02 109.753 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.475 ' O ' ' HG2' ' D' ' 124' ' ' PRO . 8.9 p90 -147.49 178.48 8.4 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.379 1.071 . . . . 64.22 108.578 171.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -61.12 111.94 5.01 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 123.098 0.559 . . . . 60.42 109.903 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.11 127.63 24.83 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 121.914 1.743 . . . . 73.02 111.139 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.72 112.71 2.97 Favored 'General case' 0 C--N 1.347 0.469 0 N-CA-C 108.57 -0.9 . . . . 74.23 108.57 173.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 4.5 m -108.56 143.07 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 114.751 -1.113 . . . . 65.34 110.704 -169.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.54 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 13.9 tmtt? -125.46 122.33 36.34 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.224 -1.398 . . . . 72.43 107.224 177.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 pp -95.75 146.48 24.5 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 121.267 0.556 . . . . 74.2 110.037 -177.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -147.41 132.02 17.81 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.139 -1.059 . . . . 52.44 108.139 175.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -110.29 144.11 39.49 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.066 -0.716 . . . . 75.4 109.066 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.3 t70 -132.11 146.37 52.0 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.146 -1.057 . . . . 73.43 108.146 174.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 94.5 m -105.52 144.23 32.57 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.436 0.694 . . . . 73.42 111.158 -173.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.679 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.72 154.58 35.52 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.823 0.849 . . . . 75.21 109.373 170.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 21.6 p -168.59 159.99 10.51 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.699 0.8 . . . . 61.23 109.503 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 51.9 p -160.73 140.53 10.96 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.402 0.681 . . . . 64.35 109.847 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -87.76 124.79 33.97 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.807 -0.442 . . . . 74.23 109.807 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 35.9 mt -95.58 -36.45 11.26 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.015 0.526 . . . . 62.43 110.165 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.85 178.7 9.81 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.303 1.041 . . . . 43.21 109.489 174.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -64.69 119.01 9.75 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.816 -0.809 . . . . 72.43 108.816 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 72.19 9.08 5.94 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 124.316 1.046 . . . . 75.12 111.723 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 90.1 t -118.45 115.1 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.21 -1.034 . . . . 73.52 108.21 171.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.467 ' HB2' HD11 ' D' ' 86' ' ' ILE . 69.8 m-85 -133.47 130.02 38.01 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.349 -0.612 . . . . 70.33 109.349 -175.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -92.58 124.7 36.8 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.619 -1.252 . . . . 73.42 107.619 174.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 84.6 t -119.98 132.49 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.336 1.054 . . . . 63.5 108.529 -169.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.679 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 14.7 t -125.0 136.73 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.263 0.625 . . . . 72.23 109.886 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.437 HD22 ' HB3' ' D' ' 103' ' ' PRO . 57.2 tp -125.72 118.79 26.35 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.408 -0.96 . . . . 70.54 108.408 167.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.491 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 16.9 ttm-85 -85.88 111.96 20.7 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.619 0.768 . . . . 73.11 109.497 176.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 45.8 t -91.85 128.65 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.521 -0.918 . . . . 74.21 108.521 170.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 9.9 m -122.67 134.82 54.47 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.337 -0.616 . . . . 72.43 109.337 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 57.3 t -127.18 101.53 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 125.86 1.664 . . . . 71.52 107.978 -173.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 21.4 m -92.25 94.34 9.12 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.744 -0.836 . . . . 53.42 108.744 176.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.5 141.39 30.63 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.99 -0.55 . . . . 73.44 110.377 -175.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.401 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 66.0 p -147.73 128.88 14.64 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.0 -0.546 . . . . 75.43 110.296 -178.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.445 HD12 HG22 ' D' ' 31' ' ' VAL . 43.5 mt -93.46 108.83 20.45 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.965 -1.124 . . . . 72.22 107.965 175.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.91 -115.88 4.33 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.381 -0.827 . . . . 60.43 111.193 -171.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.29 6.15 10.71 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.731 0.812 . . . . 53.1 110.511 -174.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -121.59 152.83 38.83 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.905 0.882 . . . . 63.25 109.343 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 35.1 m -64.33 132.13 49.27 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.161 0.505 . . . . 73.21 111.512 -176.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.401 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -89.36 -60.44 1.95 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.492 -1.299 . . . . 63.11 107.492 174.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -157.19 159.38 37.67 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.332 -1.304 . . . . 71.23 110.135 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 86.8 mt -124.31 114.26 19.32 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 107.506 -1.294 . . . . 71.45 107.506 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.438 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 1.2 m -114.12 135.47 53.99 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.061 -1.089 . . . . 52.04 108.061 -175.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 37.5 tt0 -156.18 121.05 4.66 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.624 -0.51 . . . . 75.4 109.624 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.5 t -135.12 116.93 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.025 0.53 . . . . 61.42 109.578 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.657 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 13.9 mt-30 -85.43 91.15 8.13 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.001 -1.111 . . . . 73.35 108.001 166.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -81.61 109.43 16.04 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.103 -1.073 . . . . 62.04 108.103 174.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.94 166.43 14.09 Favored Glycine 0 C--O 1.244 0.745 0 O-C-N 123.72 0.638 . . . . 43.35 111.993 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.89 136.49 4.2 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 112.054 -0.418 . . . . 52.2 112.054 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.8 mt -89.68 122.21 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.536 0.734 . . . . 75.54 109.102 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -130.87 125.48 33.67 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.727 0.811 . . . . 71.13 109.421 -175.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.617 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 45.5 m -89.91 96.74 10.82 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.828 0.851 . . . . 64.24 109.264 173.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.632 ' HB ' HD12 ' D' ' 89' ' ' ILE . 0.2 OUTLIER -110.79 114.92 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 123.588 0.755 . . . . 74.44 110.712 -178.118 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.41 162.47 25.5 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.783 0.833 . . . . 52.54 109.552 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.04 20.34 78.9 Favored Glycine 0 C--N 1.347 1.151 0 C-N-CA 121.783 -0.246 . . . . 63.33 112.74 178.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.632 HD12 ' HB ' ' D' ' 86' ' ' ILE . 55.8 mt -116.36 136.62 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.776 0.83 . . . . 73.23 109.137 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -151.05 152.36 33.34 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.433 0.693 . . . . 70.44 110.935 -170.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.92 -138.9 33.76 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 115.409 -0.814 . . . . 72.32 115.006 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 32.1 m -62.74 -25.58 68.26 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.118 0.967 . . . . 74.12 111.557 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.556 HE21 HG23 ' D' ' 89' ' ' ILE . 21.5 tt0 -62.11 -26.61 68.39 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.53 0.732 . . . . 64.54 111.073 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 69.5 mtm -68.7 -46.56 68.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.804 0.841 . . . . 71.33 111.227 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.04 -30.13 68.43 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.31 -0.859 . . . . 63.45 110.69 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . 0.404 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 25.2 t-80 -77.42 -27.15 52.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.414 0.685 . . . . 73.3 110.98 177.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.8 t -72.1 -52.95 14.36 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.398 0.618 . . . . 73.24 110.278 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 24.2 mt -86.47 -19.36 29.68 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 114.62 -1.173 . . . . 73.05 110.704 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.91 3.4 57.21 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-O 119.35 -0.694 . . . . 63.14 114.16 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -144.75 -65.9 0.34 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.105 0.952 . . . . 70.44 111.566 -178.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -69.9 -45.95 66.48 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 112.373 0.508 . . . . 70.02 112.373 -173.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 84.0 m -62.94 -45.35 87.01 Favored Pre-proline 0 CA--C 1.569 1.686 0 CA-C-O 118.782 -0.627 . . . . 75.44 112.218 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.437 ' HB3' HD22 ' D' ' 60' ' ' LEU . 51.5 Cg_exo -59.03 -27.66 85.65 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 122.786 2.324 . . . . 32.22 114.201 169.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -70.87 -26.51 63.29 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 122.854 0.462 . . . . 60.12 111.419 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 43.8 mm -72.02 -35.61 54.42 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-O 121.415 0.626 . . . . 63.14 109.465 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 86.0 mt -84.3 -23.3 30.36 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.058 -0.974 . . . . 63.43 112.114 -175.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 94.0 t80 -58.99 -49.1 95.16 Favored Pre-proline 0 CA--C 1.562 1.407 0 N-CA-C 113.662 0.986 . . . . 74.25 113.662 -174.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.06 -37.48 95.64 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 121.851 1.701 . . . . 44.52 113.116 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -75.9 -37.66 58.56 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.499 -0.773 . . . . 73.41 111.529 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.62 -41.39 96.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.081 0.552 . . . . 74.33 110.086 177.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.416 ' NH2' ' HA ' ' B' ' 105' ' ' ILE . 36.9 ttp180 -58.44 -53.42 58.53 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 124.214 0.946 . . . . 72.32 110.394 174.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.24 -43.26 96.25 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.187 0.929 . . . . 74.15 111.46 -174.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.8 t -59.58 -45.73 91.01 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.637 0.586 . . . . 63.43 111.081 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.466 ' O ' HG23 ' D' ' 118' ' ' VAL . 91.7 mt -64.35 -55.72 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 115.741 -0.663 . . . . 74.0 110.415 177.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 57.6 m -52.79 -40.36 63.14 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.693 1.197 . . . . 65.34 111.753 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.5 t -69.42 -42.39 75.08 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.33 -0.85 . . . . 63.54 110.075 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.8 mtm -64.85 -34.34 78.14 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.906 0.482 . . . . 55.21 111.482 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.466 HG23 ' O ' ' D' ' 114' ' ' ILE . 93.6 t -63.68 -47.8 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.538 0.735 . . . . 70.51 110.002 176.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.2 p -71.78 -27.33 62.88 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.918 -0.583 . . . . 61.22 110.93 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 74.7 mtt-85 -73.67 -29.29 62.22 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.462 0.705 . . . . 64.32 109.834 173.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.85 3.78 85.88 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 119.523 -0.598 . . . . 32.05 112.723 174.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.504 HG23 ' HB3' ' C' ' 17' ' ' TYR . 44.7 p 60.19 24.98 14.33 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 126.401 1.88 . . . . 73.22 113.733 177.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -89.09 156.43 49.03 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.282 0.633 . . . . 71.11 109.764 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.475 ' HG2' ' O ' ' D' ' 36' ' ' TRP . 71.5 Cg_exo -49.23 123.54 10.27 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.368 2.712 . . . . 64.15 113.338 171.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -53.87 141.17 28.2 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.749 1.22 . . . . 72.12 112.205 -177.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -121.3 116.97 25.85 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.493 -1.299 . . . . 70.44 107.493 -177.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . 0.464 HD22 HD12 ' B' ' 16' ' ' ILE . 12.6 m120 -112.25 103.5 11.64 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.389 0.676 . . . . 52.44 109.513 -176.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.1 116.22 10.2 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.049 0.539 . . . . 73.25 110.558 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.49 143.46 97.86 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.232 0.613 . . . . 62.42 110.28 175.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.72 123.17 13.17 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.082 2.521 . . . . 74.31 112.832 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 98.6 t . . . . . 0 N--CA 1.465 0.316 0 C-N-CA 123.634 0.774 . . . . 53.34 108.941 -176.371 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.585 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 20.5 t80 . . . . . 0 C--O 1.237 0.396 0 N-CA-C 109.296 -0.631 . . . . 70.41 109.296 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -146.72 115.02 6.66 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.912 -0.773 . . . . 74.33 108.912 176.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.677 HG12 ' HD2' ' A' ' 84' ' ' PHE . 32.8 mt -84.38 115.33 26.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.79 -0.818 . . . . 70.42 108.79 176.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -75.77 -33.56 60.2 Favored 'General case' 0 C--O 1.242 0.684 0 O-C-N 123.687 0.617 . . . . 71.05 110.816 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -171.51 148.04 2.46 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.329 0.393 . . . . 61.32 110.912 -170.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.47 HD12 ' HB3' ' C' ' 130' ' ' PRO . 87.6 mt -138.68 133.84 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 107.983 -1.117 . . . . 71.5 107.983 172.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.425 ' HB3' HG23 ' B' ' 122' ' ' THR . 19.7 p90 -164.32 157.38 17.57 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.147 0.979 . . . . 75.44 110.701 -171.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -84.42 113.18 20.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.888 -1.051 . . . . 62.44 108.636 177.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 32.7 mtpt -82.27 -31.86 29.88 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.844 0.354 . . . . 61.42 110.287 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.8 t70 -137.45 137.94 39.26 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.392 -0.822 . . . . 74.13 109.634 171.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.415 HD13 ' SD ' ' B' ' 117' ' ' MET . 64.5 mt -127.23 139.98 50.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 C-N-CA 124.973 1.309 . . . . 62.25 107.535 171.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.9 t -150.45 128.17 11.64 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 123.822 0.701 . . . . 40.34 109.56 173.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.45 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 83.2 t80 -129.89 121.85 27.49 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 106.849 -1.537 . . . . 74.1 106.849 172.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 47.2 mt-10 -127.05 112.78 15.61 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.929 0.492 . . . . 62.3 110.0 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.5 81.77 4.33 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 107.287 -1.375 . . . . 70.41 107.287 169.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.43 -16.38 19.31 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.728 2.285 . . . . 62.3 112.599 -171.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -113.01 12.84 19.35 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.381 1.072 . . . . 71.22 110.567 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -41.35 -59.33 2.37 Favored Pre-proline 0 C--N 1.37 1.468 0 CA-C-O 117.337 -1.316 . . . . 72.43 114.38 -165.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 44.8 Cg_exo -53.72 -45.23 42.59 Favored 'Trans proline' 0 C--N 1.39 2.737 0 C-N-CA 121.934 1.756 . . . . 73.3 113.881 -174.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -97.75 -14.12 21.02 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.105 0.78 . . . . 72.43 113.105 -170.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.801 HG21 ' HA ' ' A' ' 73' ' ' ALA . 8.0 p -75.46 -22.21 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-N 118.288 0.495 . . . . 53.23 111.341 -175.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -65.85 -22.24 66.52 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.23 0.612 . . . . 73.52 111.124 173.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -80.68 -19.53 44.98 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.143 0.977 . . . . 75.54 111.079 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.431 ' NZ ' ' HB2' ' A' ' 71' ' ' GLU . 31.8 mmtp -81.62 155.02 25.85 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.707 0.803 . . . . 61.41 111.453 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.59 132.37 49.61 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.094 0.958 . . . . 63.32 110.296 174.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -81.59 85.68 6.5 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.012 0.525 . . . . 74.2 110.196 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -121.82 82.25 42.23 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 107.509 -1.293 . . . . 73.43 107.509 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -75.14 115.18 4.19 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 122.435 2.09 . . . . 72.24 111.948 -172.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -91.95 96.53 10.43 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.091 -1.818 . . . . 71.4 106.091 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 m -66.5 90.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.615 0 CA-C-O 122.69 1.233 . . . . 74.52 110.3 -175.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 54.2 tptt -96.85 110.69 23.13 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.541 -1.651 . . . . 74.54 106.541 175.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.565 HD23 ' H ' ' A' ' 42' ' ' LEU . 2.0 pt? -110.37 147.14 34.56 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.875 -0.417 . . . . 71.13 109.875 -172.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.565 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 13.5 t70 -130.91 129.11 41.81 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.295 -1.372 . . . . 74.44 107.295 177.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.467 ' H ' HD23 ' A' ' 44' ' ' LEU . 2.2 pt? -126.57 129.52 48.73 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.108 0.563 . . . . 72.02 109.564 -174.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -152.33 163.06 40.24 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.184 0.994 . . . . 52.44 108.852 -177.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.2 m -147.39 144.11 28.46 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.429 0.692 . . . . 71.22 110.804 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.52 122.22 25.77 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.171 -1.418 . . . . 65.44 107.171 173.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.5 p -131.52 153.5 49.75 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.727 0.299 . . . . 63.33 110.851 -173.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.8 t -155.74 146.83 22.43 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.744 0.818 . . . . 72.52 109.966 -173.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -76.53 141.26 41.27 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.905 -0.776 . . . . 74.35 108.905 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 57' ' ' GLU . 69.0 mt -113.73 -39.54 4.0 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.095 0.958 . . . . 73.43 109.605 176.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -155.96 -170.48 3.41 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.242 0.617 . . . . 72.23 110.296 -177.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -60.9 108.33 0.85 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.564 0.746 . . . . 73.34 110.059 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 65.01 7.13 3.82 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.69 1.196 . . . . 73.01 112.79 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 85.3 t -98.93 116.32 41.66 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 N-CA-C 107.239 -1.393 . . . . 71.31 107.239 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -131.81 128.67 39.22 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.173 0.989 . . . . 75.1 109.391 -172.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.473 ' HB2' HD11 ' A' ' 51' ' ' LEU . 38.3 tt0 -87.33 131.42 34.27 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.588 0.755 . . . . 73.4 109.743 172.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.463 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 98.3 t -118.77 116.18 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.156 -1.053 . . . . 53.24 108.156 171.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.56 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 35.6 t -101.31 117.76 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 109.044 -0.724 . . . . 63.42 109.044 175.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.39 113.77 26.68 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.252 -0.647 . . . . 70.34 109.252 -176.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -82.6 101.99 11.14 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.668 -0.864 . . . . 72.41 108.668 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.6 t -100.14 102.6 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 107.404 -1.332 . . . . 63.42 107.404 170.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 37.2 m -106.59 135.92 47.27 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.935 0.894 . . . . 53.32 109.715 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.706 HG11 HD21 ' A' ' 126' ' ' LEU . 40.5 t -130.98 126.6 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.765 1.226 . . . . 54.14 108.753 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 10.8 m -112.44 135.33 53.27 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.545 -0.909 . . . . 71.55 108.545 174.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.92 105.63 14.87 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.364 -1.346 . . . . 65.11 107.364 170.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.7 m -107.1 133.81 51.15 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.903 -1.147 . . . . 71.14 107.903 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.7 mt -103.48 47.87 0.87 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.413 -0.958 . . . . 72.25 108.413 -176.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.18 -84.44 1.35 Allowed Glycine 0 C--N 1.342 0.881 0 N-CA-C 110.848 -0.901 . . . . 74.12 110.848 -170.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -90.69 -31.41 16.6 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.615 0.766 . . . . 73.41 111.588 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.431 ' HB2' ' NZ ' ' A' ' 34' ' ' LYS . 3.8 tp10 -115.9 112.69 22.27 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 116.282 -0.417 . . . . 63.11 110.294 -162.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.2 m -70.73 119.57 15.08 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.881 -0.414 . . . . 74.25 109.881 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.801 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -70.01 -58.56 3.69 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 114.951 -1.022 . . . . 61.21 109.52 175.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -155.68 171.57 19.77 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.141 -0.936 . . . . 72.1 112.528 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 28.0 tp -141.31 107.63 5.26 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 113.701 -1.59 . . . . 72.41 107.754 175.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.0 m -106.39 101.68 11.14 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.373 1.069 . . . . 52.44 110.556 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -116.43 117.3 29.55 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.918 0.887 . . . . 73.23 109.292 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.0 t -131.07 110.45 18.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 123.818 0.847 . . . . 74.3 109.326 -174.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 69.9 mt-30 -85.92 88.52 7.58 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.811 -0.811 . . . . 63.35 108.811 171.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -80.46 100.47 8.53 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.347 -0.842 . . . . 63.53 109.537 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.29 144.94 19.45 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 111.678 -0.569 . . . . 64.42 111.678 176.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.404 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -145.98 127.48 2.8 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.408 -0.677 . . . . 53.31 111.408 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.3 mt -85.2 124.75 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.629 0.772 . . . . 74.03 108.946 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.677 ' HD2' HG12 ' A' ' 13' ' ' ILE . 12.5 m-85 -133.41 159.87 39.04 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.111 0.564 . . . . 73.02 109.557 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.0 p -111.24 114.18 27.19 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.063 -0.718 . . . . 62.52 109.063 170.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.593 HG12 HD23 ' A' ' 98' ' ' LEU . 4.1 mp . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 107.754 -1.202 . . . . 73.43 107.754 175.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.909 0.385 . . . . 75.54 110.682 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.454 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 58.9 t-80 -83.76 -37.16 22.98 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.774 -0.648 . . . . 71.12 111.071 176.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 74.3 m -77.75 -64.29 1.19 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 122.724 0.41 . . . . 52.2 111.104 -177.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.593 HD23 HG12 ' A' ' 86' ' ' ILE . 3.2 tm? -72.92 -39.75 66.05 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.883 0.873 . . . . 71.35 110.867 -175.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.82 0.44 76.56 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-O 119.378 -0.679 . . . . 45.01 114.672 -171.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -146.55 -50.61 0.21 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.113 0.957 . . . . 54.03 112.43 -172.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.478 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 65.1 t80 -76.21 -49.99 15.71 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.556 0.743 . . . . 72.44 111.994 -174.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.408 ' HA ' HG12 ' A' ' 105' ' ' ILE . 77.2 m -68.47 -34.27 5.49 Favored Pre-proline 0 CA--C 1.568 1.667 0 N-CA-C 113.435 0.902 . . . . 65.43 113.435 -178.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -50.93 -44.36 42.3 Favored 'Trans proline' 0 C--N 1.396 3.065 0 C-N-CA 122.68 2.254 . . . . 60.23 112.954 162.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -70.2 -22.41 62.93 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 114.846 -1.07 . . . . 73.42 111.614 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.408 HG12 ' HA ' ' A' ' 102' ' ' CYS . 44.1 mm -70.31 -43.93 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 123.299 0.64 . . . . 71.04 110.714 177.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.404 HD21 ' HA3' ' A' ' 82' ' ' GLY . 88.9 mt -76.31 -19.31 58.38 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.804 -0.634 . . . . 75.31 111.596 -176.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -64.33 -48.33 76.08 Favored Pre-proline 0 CA--C 1.568 1.657 0 N-CA-C 114.153 1.168 . . . . 61.04 114.153 -172.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.28 -34.48 67.29 Favored 'Trans proline' 0 C--N 1.388 2.649 0 CA-C-N 122.035 1.763 . . . . 51.52 112.754 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -69.2 -45.17 70.56 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.607 0.763 . . . . 73.32 111.435 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.2 -37.83 78.29 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.963 -0.562 . . . . 74.24 110.716 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.457 HH12 HD12 ' C' ' 105' ' ' ILE . 24.4 ttm180 -60.68 -45.6 93.55 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 124.004 0.815 . . . . 54.31 109.641 174.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -66.14 -44.56 83.82 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.651 0.78 . . . . 75.54 111.5 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -60.21 -42.21 94.65 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.532 0.52 . . . . 73.45 110.107 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 118' ' ' VAL . 59.0 mt -59.53 -52.56 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 124.082 0.953 . . . . 65.55 110.5 172.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.426 HG21 ' HE2' ' C' ' 109' ' ' TYR . 94.9 m -54.58 -46.7 73.78 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.472 1.109 . . . . 73.45 111.969 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 44.3 t -70.41 -34.53 72.63 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.331 -0.849 . . . . 71.14 111.22 -176.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.45 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 9.3 mtp -67.44 -40.53 85.44 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.318 0.647 . . . . 75.31 110.863 175.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 114' ' ' ILE . 51.4 t -62.92 -51.1 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.695 1.198 . . . . 74.5 110.799 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.4 p -68.35 -29.24 67.92 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.356 0.662 . . . . 73.42 111.373 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' A' ' 116' ' ' SER . 18.5 ttm-85 -74.31 -30.28 61.99 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.207 1.003 . . . . 74.41 110.042 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.444 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.93 11.6 59.6 Favored Glycine 0 C--N 1.353 1.522 0 CA-C-N 115.23 -0.895 . . . . 63.21 112.603 172.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.489 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.0 OUTLIER 66.17 11.59 7.95 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 127.025 2.13 . . . . 62.23 113.148 175.532 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -78.64 148.99 74.07 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 123.263 0.625 . . . . 74.41 109.722 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.02 158.81 41.56 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.622 2.215 . . . . 73.32 112.34 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.417 ' OE1' HG23 ' A' ' 115' ' ' THR . 6.1 tp-100 -58.77 132.56 54.25 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.546 1.138 . . . . 61.21 112.829 -167.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.706 HD21 HG11 ' A' ' 64' ' ' VAL . 51.9 tp -129.31 110.74 12.19 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.986 1.314 . . . . 65.43 109.726 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -129.8 121.16 26.25 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.65 0.78 . . . . 62.34 108.957 172.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.461 HD11 HG21 ' A' ' 64' ' ' VAL . 6.4 mp -71.83 147.0 47.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.615 0.366 . . . . 73.31 110.649 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.76 140.47 96.33 Favored Pre-proline 0 CA--C 1.554 1.124 0 O-C-N 123.771 0.669 . . . . 71.3 110.86 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.401 ' HD3' HG13 ' C' ' 13' ' ' ILE . 30.8 Cg_endo -62.31 133.21 42.21 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 123.265 2.643 . . . . 52.34 112.125 177.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 m -127.1 113.95 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 121.666 0.746 . . . . 65.33 110.391 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -87.88 96.89 10.65 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.242 -1.022 . . . . 75.11 108.242 168.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 . . . . . 0 N--CA 1.475 0.809 0 O-C-N 123.879 0.737 . . . . 72.42 110.474 178.703 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 1.9 tmt? . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 120.907 0.384 . . . . 74.05 111.766 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 87.6 m -169.03 139.58 2.32 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 125.078 1.351 . . . . 75.23 107.936 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.35 157.37 45.65 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.413 0.625 . . . . 72.42 110.105 157.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.538 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -124.56 131.45 53.48 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 107.185 -1.413 . . . . 74.03 107.185 175.558 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.449 HD13 HD11 ' B' ' 16' ' ' ILE . 59.7 mt -67.87 117.32 9.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.215 -1.032 . . . . 74.4 108.215 174.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . 0.434 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 11.5 mm-40 -86.9 -37.89 17.24 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 124.038 0.836 . . . . 74.25 108.745 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.489 ' HE ' HG21 ' A' ' 122' ' ' THR . 42.4 ttt180 -175.27 137.61 0.4 Allowed 'General case' 0 C--N 1.355 0.828 0 CA-C-N 115.4 -0.818 . . . . 74.33 109.606 -176.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.449 HD11 HD13 ' B' ' 13' ' ' ILE . 94.2 mt -115.49 141.51 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 107.273 -1.38 . . . . 63.53 107.273 173.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -165.88 146.41 6.66 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.989 0.423 . . . . 70.2 111.484 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.594 HG21 HD11 ' B' ' 21' ' ' ILE . 96.2 m -75.97 123.48 25.81 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.382 -0.826 . . . . 71.24 109.049 169.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.457 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 23.0 mtpp -89.17 -38.84 13.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.817 -0.629 . . . . 74.01 109.965 178.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 14.6 t70 -153.21 142.44 21.49 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.174 0.435 . . . . 63.44 112.174 -169.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.594 HD11 HG21 ' B' ' 18' ' ' THR . 38.2 mm -134.79 146.34 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.029 1.332 . . . . 74.22 108.775 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.52 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 47.7 t -147.9 140.51 24.59 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.905 -1.146 . . . . 50.33 107.905 175.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.411 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 92.1 t80 -157.65 114.15 2.9 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.893 -1.151 . . . . 64.34 107.893 173.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -121.98 112.45 18.29 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.298 -0.63 . . . . 73.52 109.298 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.53 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -108.6 86.81 3.82 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 107.429 -1.323 . . . . 61.33 107.429 172.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.37 -40.79 2.83 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.331 2.021 . . . . 65.21 112.013 -176.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -92.44 9.29 34.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.805 0.842 . . . . 63.4 111.367 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.53 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -40.4 -66.04 0.4 Allowed Pre-proline 0 CA--C 1.57 1.722 0 C-N-CA 125.225 1.41 . . . . 74.0 114.58 -170.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.05 -34.99 94.12 Favored 'Trans proline' 0 C--N 1.399 3.202 0 C-N-CA 122.915 2.41 . . . . 73.33 113.536 -167.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -95.25 -28.85 14.81 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.545 -0.752 . . . . 71.42 111.972 -174.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.447 HG21 ' HA ' ' B' ' 73' ' ' ALA . 4.5 p -74.81 -12.44 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-N 118.271 0.487 . . . . 64.15 111.351 -176.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -68.82 -14.51 63.08 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.294 0.85 . . . . 73.22 113.294 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -64.49 -27.07 68.72 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.096 0.474 . . . . 74.44 110.148 172.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -87.75 84.01 7.1 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.647 1.179 . . . . 62.33 110.134 -177.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -93.27 87.56 5.69 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.377 -0.829 . . . . 73.15 109.873 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -160.23 177.03 11.06 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.298 1.039 . . . . 74.12 108.739 171.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -69.83 111.77 10.14 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 109.502 -0.555 . . . . 71.33 109.502 176.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -67.04 157.46 61.61 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.317 2.012 . . . . 63.25 111.89 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 24.9 tt0 -66.23 103.54 1.01 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.16 -1.052 . . . . 71.23 108.16 169.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -86.94 141.59 14.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.579 -0.896 . . . . 63.01 108.579 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -147.05 99.43 3.17 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 108.27 -1.011 . . . . 55.12 108.27 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.19 165.66 12.29 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.213 0.53 . . . . 70.51 111.097 -177.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -159.79 136.61 9.27 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.534 1.133 . . . . 65.22 108.206 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 95.5 mt -99.85 158.26 15.93 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.631 -0.507 . . . . 73.54 109.631 175.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.502 ' HB3' ' HD3' ' B' ' 61' ' ' ARG . 23.0 t70 -145.74 151.85 38.63 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 124.427 1.091 . . . . 72.34 108.163 170.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 46.1 p -107.59 106.26 16.54 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.473 0.709 . . . . 73.23 109.554 -174.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.39 135.81 53.54 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.726 -1.213 . . . . 62.12 107.726 176.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.3 p -148.13 167.54 24.76 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.321 0.581 . . . . 74.22 112.33 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.5 p -153.89 155.66 36.12 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.277 -1.329 . . . . 64.25 108.378 167.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -121.16 119.76 33.28 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.002 -0.74 . . . . 62.41 109.002 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 61.8 mt -84.18 -34.82 23.9 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.335 0.654 . . . . 74.12 111.341 -173.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.51 -175.73 4.35 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.49 -0.777 . . . . 42.34 110.119 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -76.03 119.12 19.54 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.539 -0.755 . . . . 61.23 109.207 178.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 71.45 13.5 6.49 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.099 1.76 . . . . 62.31 111.292 -176.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 99.0 t -122.41 113.19 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 108.114 -1.069 . . . . 65.22 108.114 170.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -118.75 171.52 8.15 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.255 -0.646 . . . . 64.54 109.255 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -141.68 102.79 4.25 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 107.306 -1.368 . . . . 62.24 107.306 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 92.9 t -95.23 135.67 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.219 1.007 . . . . 74.45 110.302 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 22.2 t -128.94 116.39 40.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 124.027 0.931 . . . . 73.42 109.38 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' B' ' 103' ' ' PRO . 43.5 tp -95.44 109.41 21.6 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.9 -0.778 . . . . 74.52 108.9 172.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.632 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 59.5 ttt180 -92.34 108.55 20.04 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.465 0.706 . . . . 73.45 109.43 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 38.5 t -106.24 102.49 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.316 1.046 . . . . 54.04 108.99 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 7.9 m -98.2 135.93 39.13 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.436 0.694 . . . . 74.45 109.353 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.522 HG21 HG21 ' B' ' 114' ' ' ILE . 85.8 t -126.9 139.25 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.181 0.993 . . . . 62.11 110.414 -175.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.6 m -124.78 149.44 47.36 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.524 1.13 . . . . 74.14 108.093 172.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.79 142.09 26.24 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 122.927 0.491 . . . . 64.32 110.249 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.558 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 75.8 p -141.06 128.62 21.38 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 123.477 0.485 . . . . 75.04 111.03 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 29.7 mt -100.21 118.85 37.38 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.152 0.981 . . . . 73.2 109.052 175.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.6 -112.34 4.82 Favored Glycine 0 CA--C 1.526 0.726 0 O-C-N 123.932 0.77 . . . . 75.4 112.296 -175.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -115.37 3.05 14.09 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.273 0.629 . . . . 61.35 111.192 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -120.4 159.24 25.49 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.952 0.501 . . . . 75.05 110.69 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 58.6 m -68.94 120.78 15.36 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.618 0.767 . . . . 61.2 110.129 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.558 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -77.61 -61.17 2.08 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.259 -1.015 . . . . 61.23 108.259 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -156.34 164.57 38.14 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.628 -1.169 . . . . 75.44 111.427 177.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 45.5 mt -122.49 153.53 39.04 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 106.093 -1.818 . . . . 72.1 106.093 173.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.439 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 49.5 t -157.92 159.67 36.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.393 -0.595 . . . . 74.11 109.393 -179.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.8 tt0 -165.39 135.32 3.59 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.147 -1.056 . . . . 53.45 108.147 174.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 44.9 t -132.92 145.7 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 108.536 -0.912 . . . . 75.21 108.536 174.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.632 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 14.8 mt-30 -126.06 100.34 6.3 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.601 -0.888 . . . . 73.01 108.601 177.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.431 ' HG3' HD22 ' B' ' 106' ' ' LEU . 8.9 tp-100 -90.43 114.83 27.06 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.18 -0.674 . . . . 75.24 109.18 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.457 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -104.93 167.9 15.48 Favored Glycine 0 C--O 1.242 0.641 0 O-C-N 123.851 0.719 . . . . 43.2 111.652 177.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.29 134.41 3.14 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.992 -0.843 . . . . 73.21 110.992 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.434 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 45.0 mt -86.43 126.19 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 108.549 -0.908 . . . . 75.15 108.549 173.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -135.96 139.34 43.15 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 106.883 -1.525 . . . . 63.45 106.883 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 67.8 m -108.73 91.17 3.53 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.499 0.59 . . . . 62.5 111.531 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 mp -97.6 130.92 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.772 0.829 . . . . 73.5 110.509 -171.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.79 165.57 27.13 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.737 0.815 . . . . 44.44 110.304 173.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.04 -56.9 0.65 Allowed Glycine 0 C--N 1.347 1.192 0 CA-C-N 116.161 -0.472 . . . . 41.54 112.133 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 30.8 mm -87.93 161.83 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.774 0.83 . . . . 75.11 109.798 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -167.89 149.72 5.46 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.859 0.864 . . . . 75.5 110.339 166.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.47 -136.83 12.95 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.907 0.765 . . . . 74.31 112.625 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.2 m -81.86 -23.02 36.61 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 117.256 0.528 . . . . 72.0 111.253 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -68.1 -28.22 67.16 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.934 0.493 . . . . 74.44 109.885 169.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 12.4 ttm -79.16 -28.77 42.78 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.215 0.606 . . . . 63.25 111.081 175.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.61 -26.76 64.02 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.15 0.58 . . . . 75.21 111.093 174.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -71.42 -51.33 24.53 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.331 1.053 . . . . 73.43 110.606 172.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 39.2 t -59.66 -45.83 90.86 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.375 0.67 . . . . 63.51 112.418 -175.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 72.9 mt -87.5 -17.63 31.69 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.388 0.675 . . . . 74.11 111.551 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.7 3.88 32.38 Favored Glycine 0 C--N 1.35 1.325 0 O-C-N 123.244 0.34 . . . . 70.25 113.79 -175.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.53 -58.22 0.53 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.019 0.527 . . . . 74.03 110.4 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -73.64 -48.66 30.81 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.772 0.67 . . . . 74.21 112.378 -169.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.433 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 84.2 m -66.04 -46.92 63.81 Favored Pre-proline 0 CA--C 1.566 1.595 0 CA-C-O 118.699 -0.667 . . . . 63.12 111.322 177.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.433 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 85.5 Cg_exo -55.21 -33.1 83.26 Favored 'Trans proline' 0 C--N 1.402 3.356 0 C-N-CA 122.819 2.346 . . . . 65.22 114.094 168.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -63.13 -40.25 97.05 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.943 0.897 . . . . 64.13 110.25 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 84.2 mt -68.52 -47.53 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 115.121 -0.945 . . . . 74.04 110.45 175.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.431 HD22 ' HG3' ' B' ' 80' ' ' GLN . 96.0 mt -79.08 -4.44 50.28 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.358 -0.837 . . . . 63.12 111.968 -173.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.07 -61.73 7.34 Favored Pre-proline 0 N--CA 1.478 0.958 0 CA-C-O 117.914 -1.041 . . . . 75.54 112.617 -177.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.77 -25.81 68.17 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 121.842 1.694 . . . . 74.53 112.976 -172.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -71.4 -49.59 40.39 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.812 0.845 . . . . 74.23 110.709 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.74 -42.18 97.91 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.47 0.708 . . . . 64.52 110.866 175.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 75.2 ttt-85 -59.17 -59.89 4.73 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.93 1.692 . . . . 74.14 111.512 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -64.01 -25.29 68.06 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.147 0.979 . . . . 72.05 110.845 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.545 ' SG ' HD12 ' B' ' 21' ' ' ILE . 17.5 t -70.38 -46.87 63.19 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 122.293 -0.254 . . . . 71.11 111.604 178.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.522 HG21 HG21 ' B' ' 64' ' ' VAL . 97.8 mt -59.61 -49.98 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.491 0.716 . . . . 72.32 110.004 173.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 14.2 m -60.32 -28.54 68.21 Favored 'General case' 0 CA--C 1.556 1.198 0 O-C-N 123.853 0.721 . . . . 75.44 111.796 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -66.78 -46.86 73.96 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.497 0.719 . . . . 64.41 110.319 173.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.9 mmt -71.44 -30.28 65.85 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.979 0.512 . . . . 74.1 111.26 -175.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 114' ' ' ILE . 73.5 t -61.23 -47.31 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.537 1.135 . . . . 74.22 109.761 170.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 40.8 t -65.35 -36.79 85.09 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.011 -0.995 . . . . 70.12 111.59 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -71.75 -32.44 67.71 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.694 0.798 . . . . 75.51 110.513 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.19 5.89 81.45 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 123.942 0.776 . . . . 65.43 112.665 174.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.425 HG23 ' HB3' ' A' ' 17' ' ' TYR . 54.7 p 56.7 55.79 6.05 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 125.766 1.626 . . . . 62.22 112.658 176.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -119.95 158.39 50.24 Favored Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 124.585 1.154 . . . . 70.43 110.873 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.93 164.83 5.66 Favored 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 123.845 3.03 . . . . 52.33 115.527 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.512 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -65.19 129.84 41.16 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.653 1.181 . . . . 74.51 112.056 -176.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -139.01 119.21 13.56 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.914 -0.773 . . . . 71.42 108.914 174.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -116.45 135.33 53.93 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.233 1.013 . . . . 73.45 109.416 173.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 54.5 tp -78.78 149.18 32.7 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.274 0.63 . . . . 71.21 109.861 175.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.35 148.75 86.28 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 123.192 0.597 . . . . 72.53 110.857 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.492 ' HG3' HD11 ' D' ' 16' ' ' ILE . 72.7 Cg_endo -71.15 88.6 0.7 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.118 2.545 . . . . 63.33 111.391 176.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.58 110.45 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 109.416 -0.587 . . . . 64.13 109.416 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -101.58 93.14 5.21 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 107.529 -1.286 . . . . 64.04 107.529 176.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -62.17 -35.95 80.38 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.461 0.476 . . . . 75.51 110.687 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 . . . . . 0 N--CA 1.481 1.103 0 C-N-CA 123.652 0.781 . . . . 71.31 110.335 179.192 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.411 ' CD1' ' HE2' ' C' ' 101' ' ' TYR . 1.1 t80 . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 108.58 -0.896 . . . . 74.54 108.58 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -137.68 120.89 16.84 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.83 -0.804 . . . . 75.23 108.83 173.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.465 HD13 HD11 ' C' ' 16' ' ' ILE . 32.9 mt -69.59 123.76 23.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.68 -0.859 . . . . 73.43 108.68 172.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -87.57 -49.18 7.35 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.518 -0.764 . . . . 71.51 109.564 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -174.41 125.76 0.32 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.754 -0.657 . . . . 75.35 109.728 -169.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.465 HD11 HD13 ' C' ' 13' ' ' ILE . 77.2 mt -116.12 138.42 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.315 -0.995 . . . . 73.4 108.315 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.575 ' HB3' HG23 ' D' ' 122' ' ' THR . 26.5 p90 -175.28 165.45 3.32 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-O 121.484 0.659 . . . . 75.23 110.864 -172.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -86.25 125.07 33.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.501 -0.772 . . . . 71.44 109.389 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.458 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 20.6 mmtp -74.02 -48.47 29.86 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 106.895 -1.52 . . . . 52.23 106.895 167.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 24.4 t70 -134.99 146.56 49.18 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 113.64 -1.618 . . . . 62.33 110.403 -172.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 78.1 mt -140.64 146.04 24.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.088 -1.819 . . . . 71.51 106.088 175.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 31.2 t -160.54 150.32 17.65 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.18 0.514 . . . . 73.43 110.403 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 82.4 t80 -157.18 118.8 3.73 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.042 -1.096 . . . . 63.23 108.042 174.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' D' ' 19' ' ' LYS . 34.1 mt-10 -126.66 130.35 50.25 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.816 0.446 . . . . 74.41 110.204 169.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' C' ' 28' ' ' ALA . . . -109.57 92.99 12.96 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 107.263 -1.384 . . . . 63.21 107.263 172.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -59.4 -36.18 94.61 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.621 2.881 . . . . 70.4 114.11 -171.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -114.96 29.93 7.7 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.375 0.67 . . . . 40.52 110.245 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.495 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -43.79 -63.79 0.96 Allowed Pre-proline 0 CA--C 1.567 1.597 0 N-CA-C 114.51 1.3 . . . . 74.01 114.51 -164.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -62.67 -40.52 36.72 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 121.918 1.746 . . . . 63.22 112.708 -175.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -69.49 -33.11 72.38 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.075 0.95 . . . . 72.42 112.213 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.646 HG21 ' HA ' ' C' ' 73' ' ' ALA . 3.9 p -81.59 -23.1 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 122.761 0.424 . . . . 63.14 111.857 -177.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -65.45 -28.75 69.44 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.181 0.438 . . . . 74.41 112.181 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -90.23 32.13 0.95 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.696 0.798 . . . . 72.0 110.839 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.7 162.63 24.6 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.248 0.619 . . . . 74.52 111.21 -173.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.19 129.56 38.31 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.302 1.041 . . . . 75.43 110.89 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 49.2 t-105 -87.4 85.11 7.11 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.698 0.799 . . . . 60.41 111.943 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -138.28 76.42 37.9 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 123.976 0.911 . . . . 74.34 108.804 166.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -81.69 156.76 18.59 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.606 2.204 . . . . 73.43 112.533 -176.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . 0.557 ' HB3' ' HE2' ' C' ' 41' ' ' LYS . 2.6 mp0 -85.36 93.61 8.76 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 106.255 -1.758 . . . . 75.53 106.255 164.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 13.7 m -67.28 95.56 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-O 122.184 0.993 . . . . 62.4 109.302 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.748 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 75.3 mmtt -95.54 100.74 12.44 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.259 -1.015 . . . . 61.53 108.259 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 pp -88.11 137.28 32.47 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.624 -1.171 . . . . 65.33 108.57 -178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -146.79 107.71 4.17 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.78 -0.822 . . . . 73.03 108.78 -175.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.578 ' H ' HD23 ' C' ' 44' ' ' LEU . 2.0 pt? -119.99 122.86 42.1 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.761 0.791 . . . . 65.52 109.417 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.779 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 22.2 t70 -113.17 157.3 21.85 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 125.168 1.387 . . . . 62.24 109.208 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 74.9 p -113.64 122.27 46.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.2 1.0 . . . . 71.22 109.909 -174.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.59 136.44 41.06 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.578 -0.897 . . . . 71.45 108.578 175.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 25.8 p -164.09 151.65 12.29 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.779 0.431 . . . . 73.52 110.227 -175.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 73.1 p -153.75 154.14 33.49 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.507 0.723 . . . . 75.42 109.713 -175.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -89.3 128.93 35.92 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.529 -0.545 . . . . 73.31 109.529 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.673 HD11 HD12 ' C' ' 83' ' ' ILE . 65.1 mt -96.33 -42.87 7.94 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.638 0.775 . . . . 55.21 111.008 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.86 -166.03 1.51 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.181 -0.918 . . . . 73.2 110.449 -176.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.89 103.77 1.54 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.185 0.994 . . . . 73.2 109.758 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 71.13 -1.67 2.63 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.638 1.575 . . . . 71.13 113.162 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.3 t -91.64 96.3 6.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 106.917 -1.512 . . . . 52.33 106.917 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -110.1 126.69 54.3 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.11 -0.95 . . . . 75.41 110.58 -173.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -83.66 127.79 34.04 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.058 0.943 . . . . 75.01 109.521 175.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 99.1 t -119.28 115.87 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 107.696 -1.224 . . . . 75.2 107.696 170.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 77.5 t -116.38 122.35 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.481 0.712 . . . . 75.14 109.571 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 49.8 tp -106.06 106.8 17.48 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.07 -0.715 . . . . 71.43 109.07 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.779 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 3.1 tmt_? -82.79 108.23 15.99 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.884 -1.154 . . . . 75.51 107.884 177.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.43 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.7 t -106.89 133.64 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.27 -1.011 . . . . 62.23 108.27 176.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 17.7 m -134.19 118.24 17.41 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.033 -0.729 . . . . 60.34 109.033 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 88.7 t -109.75 120.93 61.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.881 -1.054 . . . . 63.41 108.743 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.748 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 6.9 m -107.85 144.3 35.24 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.981 -0.748 . . . . 73.43 108.981 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.9 112.98 10.41 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.499 -0.926 . . . . 52.22 108.499 176.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 51.3 m -133.16 127.39 33.74 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.281 -0.637 . . . . 65.2 109.281 174.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 36.2 mt -84.78 54.98 3.25 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.766 1.226 . . . . 73.22 108.75 176.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.66 -115.8 5.36 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 109.541 -1.424 . . . . 63.25 109.541 -170.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -92.12 -25.7 18.61 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.023 0.929 . . . . 61.1 109.663 170.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -63.48 94.89 0.09 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.178 1.391 . . . . 65.13 110.101 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 30.7 m -75.37 121.48 22.32 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 120.869 0.366 . . . . 75.04 110.56 -174.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.646 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.93 -58.4 3.31 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.999 -1.0 . . . . 70.3 108.604 173.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -163.63 175.58 10.48 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.349 1.071 . . . . 75.05 112.65 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -141.8 141.02 33.15 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 105.046 -2.205 . . . . 75.11 105.046 170.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.483 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.4 t -147.8 134.74 20.21 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.85 -0.796 . . . . 72.05 108.85 -176.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -142.3 117.35 10.01 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.651 0.38 . . . . 64.12 110.499 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 83.3 t -119.1 122.32 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.828 -0.804 . . . . 72.22 108.828 171.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.446 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 57.4 mt-30 -98.46 89.78 4.55 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 107.782 -1.192 . . . . 75.41 107.782 177.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -78.82 108.95 12.64 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.08 -0.964 . . . . 73.22 110.051 -175.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.35 154.66 25.38 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-O 121.51 0.505 . . . . 71.41 111.855 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.522 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -153.42 117.58 0.81 Allowed Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 109.56 -1.416 . . . . 71.11 109.56 176.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.673 HD12 HD11 ' C' ' 51' ' ' LEU . 16.4 mm -85.61 118.51 32.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.018 -1.104 . . . . 65.13 108.018 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.4 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 34.6 m-85 -130.61 129.77 43.14 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.924 0.889 . . . . 72.34 109.256 -171.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 68.6 m -84.31 118.13 24.01 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 109.141 -0.689 . . . . 55.42 109.141 170.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 3.8 mp -114.57 114.01 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 107.656 -1.238 . . . . 64.32 107.656 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.85 162.06 40.03 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.626 0.77 . . . . 70.13 110.259 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.36 -25.61 14.55 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.694 -0.684 . . . . 30.14 113.723 175.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.434 HG13 ' HB3' ' C' ' 94' ' ' MET . 46.3 pt -120.46 162.18 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.675 0.79 . . . . 43.51 110.039 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -147.44 -177.21 5.57 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.768 0.827 . . . . 73.13 109.634 -177.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.0 -136.38 42.05 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 114.569 0.588 . . . . 71.25 114.569 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . 0.415 ' HA ' ' HB3' ' C' ' 95' ' ' ALA . 34.8 p -65.18 -22.25 66.88 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.535 1.134 . . . . 64.44 112.802 -178.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -60.59 -55.99 26.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.414 0.685 . . . . 70.04 110.045 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.434 ' HB3' HG13 ' C' ' 89' ' ' ILE . 27.7 ptt? -80.79 -20.92 41.51 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.93 -0.577 . . . . 73.13 111.663 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . 0.415 ' HB3' ' HA ' ' C' ' 92' ' ' THR . . . -64.5 -35.1 79.85 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.315 0.579 . . . . 72.05 110.742 171.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -74.35 -37.11 63.62 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.324 -0.853 . . . . 72.34 110.386 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.47 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 41.6 t -58.35 -55.97 28.13 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.079 0.862 . . . . 62.1 110.552 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 pp -70.46 -28.3 64.9 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.94 0.496 . . . . 51.34 111.852 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.79 -30.04 60.25 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 114.428 0.531 . . . . 75.23 114.428 -171.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.59 -43.2 0.22 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 117.121 0.461 . . . . 72.01 111.878 -173.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.47 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 70.0 t80 -73.85 -35.73 64.81 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 124.822 1.249 . . . . 72.22 113.095 -170.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.416 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 85.8 m -82.09 -43.7 1.02 Allowed Pre-proline 0 N--CA 1.486 1.333 0 CA-C-O 118.759 -0.639 . . . . 74.24 112.477 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.1 -22.94 61.25 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 121.796 1.664 . . . . 71.03 112.115 171.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . 0.495 ' HA ' ' HD2' ' C' ' 107' ' ' PHE . 25.0 t-20 -56.36 -41.28 75.91 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.906 0.883 . . . . 71.2 111.002 175.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.457 HD12 HH12 ' A' ' 111' ' ' ARG . 44.0 mm -59.88 -42.08 88.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 115.156 -0.929 . . . . 73.2 109.802 175.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.522 HD21 ' HA3' ' C' ' 82' ' ' GLY . 96.6 mt -82.34 -20.61 36.97 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.077 -0.965 . . . . 73.03 113.484 -169.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . 0.495 ' HD2' ' HA ' ' C' ' 104' ' ' ASN . 16.5 m-85 -55.56 -49.25 93.71 Favored Pre-proline 0 N--CA 1.496 1.837 0 CA-C-O 118.008 -0.996 . . . . 75.01 113.43 -177.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -58.0 -39.81 82.97 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 122.274 1.983 . . . . 62.4 113.999 178.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.426 ' HE2' HG21 ' A' ' 115' ' ' THR . 68.5 m-85 -68.11 -48.32 65.77 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.411 0.685 . . . . 72.42 110.757 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.61 -42.06 91.76 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.128 -0.942 . . . . 63.51 110.466 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -54.59 -57.98 9.3 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.405 1.065 . . . . 72.34 110.819 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -68.02 -30.94 70.29 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.48 0.488 . . . . 71.14 111.09 -173.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 12.5 t -72.31 -32.9 66.96 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.661 0.384 . . . . 61.32 111.289 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.483 HG23 ' SG ' ' C' ' 76' ' ' CYS . 96.9 mt -73.03 -48.1 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.565 0.746 . . . . 72.14 109.706 173.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 27.1 m -67.55 -30.22 69.81 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.409 0.684 . . . . 70.12 111.413 -174.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 43.5 t -66.0 -44.82 83.69 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.708 -0.849 . . . . 74.1 108.708 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.797 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.06 -38.32 90.71 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.383 1.073 . . . . 74.34 112.474 177.763 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' C' ' 123' ' ' PHE . 79.0 t -65.52 -39.92 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.718 0.807 . . . . 65.53 109.983 174.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.5 t -72.11 -30.99 65.62 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.143 -0.935 . . . . 72.25 111.282 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 73.2 mtt-85 -71.79 -34.1 69.13 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.826 0.851 . . . . 62.5 109.181 175.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.33 6.4 72.49 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 123.985 0.803 . . . . 63.12 112.958 173.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.2 p 61.11 26.81 16.68 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.425 1.89 . . . . 70.12 114.393 171.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.424 ' HB2' HG13 ' C' ' 118' ' ' VAL . 96.5 m-85 -88.15 150.44 47.28 Favored Pre-proline 0 N--CA 1.474 0.765 0 N-CA-C 109.619 -0.511 . . . . 71.5 109.619 173.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.64 143.11 22.85 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.471 2.781 . . . . 54.51 113.762 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -58.08 114.97 2.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.41 1.084 . . . . 72.54 112.262 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 53.9 tp -117.08 103.83 10.63 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.025 0.93 . . . . 73.04 108.915 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -95.35 130.36 42.16 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.838 0.855 . . . . 72.23 109.18 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 tt -74.57 128.21 35.0 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 108.302 -0.999 . . . . 71.51 108.302 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.11 147.3 93.49 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.556 0.742 . . . . 74.3 111.72 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.47 ' HB3' HD12 ' A' ' 16' ' ' ILE . 11.6 Cg_endo -57.89 95.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.821 2.347 . . . . 63.2 112.981 171.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 47.4 t -101.59 108.8 24.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.778 -1.194 . . . . 62.24 107.778 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -90.7 88.01 6.92 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.588 -0.893 . . . . 54.43 108.588 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -54.71 -44.71 73.69 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.663 0.785 . . . . 71.54 111.757 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.5 t70 . . . . . 0 CA--C 1.549 0.915 0 O-C-N 124.954 1.408 . . . . 53.24 110.131 -177.628 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 89.5 m . . . . . 0 N--CA 1.467 0.384 0 N-CA-C 109.314 -0.625 . . . . 72.44 109.314 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -153.88 91.52 1.47 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.896 -1.52 . . . . 54.12 106.896 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -119.11 116.36 26.19 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.94 -0.763 . . . . 70.24 108.94 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.496 HD13 HG21 ' D' ' 105' ' ' ILE . 8.7 mt -74.32 116.43 16.85 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 N-CA-C 108.898 -0.779 . . . . 72.55 108.898 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.607 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 11.7 mm100 -81.68 -44.94 16.44 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.555 0.742 . . . . 74.31 110.492 -176.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -171.26 143.67 1.91 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.425 -0.352 . . . . 72.13 111.373 -170.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.492 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.4 mp -117.8 132.66 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 107.223 -1.399 . . . . 74.42 107.223 173.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -161.39 141.49 10.69 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.43 0.633 . . . . 74.45 111.056 177.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 77.0 p -77.36 110.96 12.53 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.004 -0.998 . . . . 71.41 109.265 175.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' C' ' 24' ' ' GLU . 36.9 mtpt -85.53 -23.46 27.69 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.565 -0.289 . . . . 75.41 110.481 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.799 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 4.5 t70 -143.19 139.72 30.43 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.333 1.053 . . . . 61.43 108.84 173.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.797 HG21 ' HE2' ' C' ' 117' ' ' MET . 94.4 mt -139.0 146.88 25.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 106.909 -1.515 . . . . 74.21 106.909 169.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.0 t -159.87 110.26 1.89 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.347 0.659 . . . . 44.54 110.062 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.456 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 94.0 t80 -109.54 131.41 55.09 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 106.106 -1.812 . . . . 72.03 106.106 168.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.474 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 39.0 mt-10 -138.61 119.77 14.6 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.97 0.508 . . . . 73.34 109.974 -172.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -135.36 83.71 37.11 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 108.833 -0.803 . . . . 70.2 108.833 178.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.75 -33.74 7.76 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.834 2.356 . . . . 72.33 112.237 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -89.22 -3.09 58.68 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.422 1.089 . . . . 74.4 111.89 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.453 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -32.39 -61.99 0.31 Allowed Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 116.795 2.146 . . . . 71.51 116.795 -164.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.409 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 89.3 Cg_endo -76.34 -27.54 7.83 Favored 'Trans proline' 0 C--N 1.376 2.023 0 CA-C-N 122.708 2.003 . . . . 63.23 114.262 -172.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -86.86 -21.4 26.4 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 117.931 0.332 . . . . 64.23 110.838 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.453 HG12 ' O ' ' D' ' 28' ' ' ALA . 9.9 p -82.58 -16.19 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 122.794 0.437 . . . . 64.04 110.041 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.409 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.5 m-85 -68.04 -20.11 64.96 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.46 0.304 . . . . 65.54 111.648 175.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -56.01 -32.12 63.68 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.276 0.56 . . . . 73.13 110.057 171.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -85.99 85.57 7.37 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.831 1.252 . . . . 61.41 109.32 174.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -93.74 78.21 4.25 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.416 0.626 . . . . 73.1 110.418 -176.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -149.73 -178.03 6.22 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.49 -0.777 . . . . 65.15 109.612 170.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -76.42 110.96 12.91 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.65 0.78 . . . . 72.12 109.627 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.542 ' HB3' ' HG ' ' D' ' 68' ' ' LEU . 18.5 Cg_endo -63.22 147.44 93.94 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.472 2.114 . . . . 50.24 112.408 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -64.55 119.34 10.27 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.979 0.799 . . . . 72.23 108.954 172.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.693 HG13 HG13 ' D' ' 64' ' ' VAL . 99.5 t -96.54 131.04 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.856 -0.794 . . . . 63.14 108.856 -176.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.661 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 43.4 mtpt -106.33 157.36 17.67 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.807 0.843 . . . . 73.24 109.31 169.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.46 113.43 16.82 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 106.664 -1.606 . . . . 74.1 106.664 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.723 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 7.5 m-20 -117.71 144.22 45.47 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.992 -1.004 . . . . 64.44 108.912 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.33 154.72 33.11 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.023 0.529 . . . . 71.43 110.18 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 30.1 t70 -153.11 140.29 19.42 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.819 -1.178 . . . . 71.05 107.819 167.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 87.7 m -104.54 143.82 32.52 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.674 0.79 . . . . 65.12 110.454 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -154.14 152.76 30.78 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.014 0.925 . . . . 34.14 109.377 171.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 67.0 p -169.04 154.21 5.98 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.441 0.696 . . . . 63.22 110.256 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 82.9 p -156.02 156.06 33.78 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.291 0.637 . . . . 75.44 109.524 171.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -96.13 118.2 32.24 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.185 -1.043 . . . . 75.44 108.185 173.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.1 mt -92.85 -27.43 17.14 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.933 0.493 . . . . 74.32 110.757 -174.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.509 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -163.87 -178.68 5.82 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.264 1.025 . . . . 41.54 110.157 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.95 107.88 4.92 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.24 -0.891 . . . . 74.53 110.038 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 68.51 21.55 8.08 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.424 1.49 . . . . 75.34 111.367 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 42.3 t -124.11 115.31 44.5 Favored 'Isoleucine or valine' 0 C--N 1.35 0.599 0 N-CA-C 107.535 -1.283 . . . . 63.25 107.535 170.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -124.38 170.41 10.86 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.338 0.655 . . . . 73.3 109.489 -171.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.524 ' HB2' HD11 ' D' ' 51' ' ' LEU . 26.4 tt0 -130.31 117.99 20.61 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.649 -0.705 . . . . 75.34 109.397 178.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 88.0 t -100.99 117.38 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.424 1.09 . . . . 74.32 108.291 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 24.4 t -119.14 117.45 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.552 -0.907 . . . . 75.33 108.552 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.01 122.24 44.62 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.885 -0.783 . . . . 73.31 108.885 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.533 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 49.6 ttm-85 -87.26 101.87 13.94 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.226 -0.657 . . . . 74.22 109.226 175.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 83.2 t -90.72 114.73 28.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.203 -1.036 . . . . 75.14 108.203 174.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.723 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 28.0 m -116.02 139.62 50.09 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.277 0.561 . . . . 62.2 109.543 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.693 HG13 HG13 ' D' ' 40' ' ' VAL . 7.7 t -125.25 100.26 6.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 124.381 1.072 . . . . 73.41 108.136 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.661 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 58.2 m -93.39 93.75 8.33 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.185 -1.042 . . . . 73.13 108.185 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.72 141.2 29.48 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.026 -0.988 . . . . 45.34 109.487 -176.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.523 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 55.7 m -143.76 126.12 15.73 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.656 0.597 . . . . 75.14 111.105 -177.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.542 ' HG ' ' HB3' ' D' ' 38' ' ' PRO . 26.0 mt -93.75 115.6 28.03 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.348 1.059 . . . . 61.0 108.392 172.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.84 -137.73 32.46 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.402 -0.679 . . . . 65.41 111.402 -171.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -90.88 4.35 52.08 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.212 0.605 . . . . 70.21 111.84 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -118.72 160.2 22.29 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.61 0.364 . . . . 75.43 110.279 -177.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 48.7 m -68.34 133.18 48.33 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 123.753 0.658 . . . . 74.23 111.312 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.523 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.51 -68.13 0.78 Allowed 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.519 -1.289 . . . . 75.42 107.519 171.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -151.24 159.51 44.33 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 115.641 -0.709 . . . . 72.32 110.874 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.474 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 31.6 mt -117.7 110.12 17.47 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 105.778 -1.934 . . . . 73.13 105.778 173.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.486 ' SG ' HG23 ' D' ' 114' ' ' ILE . 14.8 t -119.69 112.17 18.95 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.818 -0.808 . . . . 63.35 108.818 -172.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -139.91 141.1 36.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.574 0.75 . . . . 55.45 109.891 -162.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 91.6 t -147.45 121.44 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.126 0.97 . . . . 71.34 109.228 -177.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.799 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 15.4 mt-30 -86.56 91.19 8.49 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 107.802 -1.184 . . . . 64.45 107.802 161.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . 0.411 ' O ' HD13 ' D' ' 106' ' ' LEU . 6.7 tp-100 -80.38 98.63 7.57 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.392 -1.336 . . . . 75.4 107.392 175.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.16 147.43 18.59 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.628 -0.989 . . . . 72.03 110.628 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.7 133.71 4.81 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.0 -0.84 . . . . 60.41 111.0 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.607 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 25.6 mt -89.17 131.2 37.07 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 108.053 -1.092 . . . . 71.51 108.053 174.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -134.74 124.12 24.72 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.407 -0.59 . . . . 71.03 109.407 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 37.8 m -82.86 97.39 8.63 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.683 -0.858 . . . . 73.13 108.683 169.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.52 143.51 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.599 -0.519 . . . . 73.3 109.599 -177.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.82 142.33 9.03 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.954 0.502 . . . . 51.44 110.437 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.56 -22.72 14.57 Favored Glycine 0 C--N 1.345 1.035 0 O-C-N 123.658 0.599 . . . . 74.54 113.175 174.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 63.7 mt -100.07 146.91 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 117.414 0.607 . . . . 51.33 110.16 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -160.3 176.15 12.03 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.576 1.151 . . . . 75.53 110.041 -178.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . 0.401 ' O ' ' HG2' ' D' ' 94' ' ' MET . . . 74.61 -130.74 12.2 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 115.366 -0.834 . . . . 70.2 113.743 174.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 72.8 p -79.57 -24.59 41.99 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.15 0.58 . . . . 73.14 111.027 -177.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -70.06 -38.39 75.75 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.948 -0.569 . . . . 73.13 109.938 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' D' ' 91' ' ' GLY . 25.5 ptt? -72.33 -27.25 62.3 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 116.49 -0.323 . . . . 73.4 110.682 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.9 -40.95 90.52 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 120.964 0.411 . . . . 75.15 111.293 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -78.66 -37.28 42.3 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.526 0.73 . . . . 75.43 111.206 175.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 50.0 t -61.29 -41.05 96.31 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.233 0.539 . . . . 75.12 111.275 -176.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 23.6 mt -92.47 -31.92 15.08 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.238 -0.892 . . . . 64.42 110.707 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.15 4.83 81.28 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.719 -0.673 . . . . 71.13 113.823 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -156.81 -57.47 0.09 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 117.867 0.834 . . . . 63.53 112.384 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -66.36 -37.06 84.46 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 112.796 0.665 . . . . 73.43 112.796 -169.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 73.5 m -74.84 -48.2 4.8 Favored Pre-proline 0 CA--C 1.566 1.574 0 CA-C-O 118.689 -0.672 . . . . 54.21 111.824 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.42 -13.76 38.35 Favored 'Trans proline' 0 C--N 1.4 3.274 0 C-N-CA 121.766 1.644 . . . . 71.4 113.404 170.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -65.86 -39.35 90.67 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.601 0.76 . . . . 73.24 109.914 173.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.496 HG21 HD13 ' D' ' 13' ' ' ILE . 49.3 mm -66.02 -39.18 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 115.361 -0.836 . . . . 71.45 110.45 175.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.411 HD13 ' O ' ' D' ' 80' ' ' GLN . 87.7 mt -80.49 -10.47 59.74 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 115.068 -0.969 . . . . 72.1 111.761 -174.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -65.25 -47.57 70.7 Favored Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 124.403 1.081 . . . . 73.44 113.103 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 72.7 Cg_exo -53.88 -45.46 40.86 Favored 'Trans proline' 0 C--N 1.39 2.758 0 C-N-CA 122.378 2.052 . . . . 74.22 113.378 173.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -69.68 -36.43 75.99 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.481 -0.781 . . . . 73.14 111.855 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.16 -47.35 80.18 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.891 0.476 . . . . 41.54 109.819 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -59.09 -49.48 77.73 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 114.59 -1.186 . . . . 65.3 111.146 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -64.64 -45.57 86.24 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 123.671 0.607 . . . . 74.13 111.277 -175.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.7 t -59.58 -42.17 91.91 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 123.662 0.601 . . . . 52.25 110.666 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.486 HG23 ' SG ' ' D' ' 76' ' ' CYS . 69.9 mt -59.99 -57.96 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.856 0.863 . . . . 71.24 110.779 172.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.454 HG23 ' HG3' ' D' ' 125' ' ' GLN . 97.4 m -53.54 -41.97 66.98 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 124.765 1.226 . . . . 52.23 111.841 -174.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 45.2 t -66.94 -42.54 85.12 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.76 -1.109 . . . . 73.51 110.268 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.6 mtm -68.14 -31.71 71.47 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.909 0.484 . . . . 73.25 111.716 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.468 HG23 ' O ' ' D' ' 114' ' ' ILE . 84.8 t -62.0 -47.11 94.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.327 0.651 . . . . 63.33 109.835 174.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.7 p -74.41 -24.98 59.19 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.642 -0.708 . . . . 62.55 111.235 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -70.54 -34.69 72.54 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.635 0.774 . . . . 75.31 109.896 174.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.46 9.44 73.37 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 123.889 0.743 . . . . 71.41 112.592 175.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.575 HG23 ' HB3' ' C' ' 17' ' ' TYR . 64.0 p 59.27 19.62 7.75 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 126.383 1.873 . . . . 64.02 113.883 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -84.16 154.38 63.49 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.429 0.692 . . . . 73.45 109.443 171.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -56.32 131.51 46.21 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.195 2.596 . . . . 73.34 112.513 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.454 ' HG3' HG23 ' D' ' 115' ' ' THR . 32.9 tt0 -50.75 137.55 20.06 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.747 1.219 . . . . 72.2 111.827 -177.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -128.96 101.7 6.18 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.724 -0.843 . . . . 73.05 108.724 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -100.65 121.04 40.97 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.775 0.83 . . . . 74.4 108.984 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 6.7 mp -73.65 119.26 17.63 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 109.198 -0.667 . . . . 64.22 109.198 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.44 148.58 79.95 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 123.771 0.829 . . . . 70.44 112.012 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -68.94 98.77 0.62 Allowed 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.871 2.381 . . . . 74.32 111.462 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.48 1.062 0 C-N-CA 123.398 0.679 . . . . 52.31 111.027 -177.698 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.722 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 33.4 t80 . . . . . 0 C--O 1.235 0.317 0 N-CA-C 109.637 -0.505 . . . . 74.22 109.637 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -148.5 127.71 12.93 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.21 -1.033 . . . . 54.21 108.21 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.643 HG12 ' HD2' ' A' ' 84' ' ' PHE . 53.7 mt -85.36 122.9 38.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 108.575 -0.898 . . . . 71.33 108.575 174.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -85.02 -41.47 15.77 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.899 -0.778 . . . . 72.41 108.899 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -173.34 128.83 0.44 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 111.453 0.168 . . . . 73.24 111.453 -167.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.4 HD12 ' CG ' ' C' ' 130' ' ' PRO . 91.8 mt -123.17 132.9 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 124.141 0.976 . . . . 51.23 109.219 176.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.475 ' HB3' HG23 ' B' ' 122' ' ' THR . 30.0 p90 -167.12 154.2 8.74 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.853 0.861 . . . . 73.53 111.119 -169.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.4 p -75.28 126.08 30.28 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.713 -0.676 . . . . 73.31 109.466 170.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.401 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 39.8 mtpt -93.48 -21.21 19.61 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.75 -0.463 . . . . 61.02 109.75 173.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.497 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 25.0 t70 -153.3 138.49 17.41 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.051 -0.977 . . . . 74.1 110.045 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.2 mt -133.28 144.29 36.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 C-N-CA 124.989 1.316 . . . . 55.24 108.09 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.609 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 42.8 t -147.64 126.37 12.61 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.889 -0.782 . . . . 74.33 108.889 170.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 84.9 t80 -131.3 117.44 18.95 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 106.289 -1.745 . . . . 71.01 106.289 170.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -125.5 120.02 29.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.134 0.425 . . . . 74.42 109.93 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.1 80.65 15.43 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 106.93 -1.507 . . . . 74.32 106.93 171.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.35 -35.54 39.62 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 122.578 2.185 . . . . 71.14 111.488 -174.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -106.01 25.51 10.85 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.922 -1.035 . . . . 63.12 109.457 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.457 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -49.11 -50.83 61.04 Favored Pre-proline 0 CA--C 1.561 1.393 0 N-CA-C 113.471 0.915 . . . . 71.24 113.471 -177.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.22 -21.35 67.4 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 121.647 1.565 . . . . 72.35 113.441 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -91.53 -35.11 14.48 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.105 0.962 . . . . 61.02 110.657 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.8 p -75.35 -25.03 17.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.564 -0.743 . . . . 64.54 112.569 -163.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -73.35 -17.69 61.26 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.325 0.65 . . . . 74.03 110.874 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -85.65 -32.1 22.18 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.483 1.113 . . . . 74.23 110.134 174.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -68.92 157.88 35.74 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.75 0.82 . . . . 53.21 111.349 -175.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -70.87 131.67 44.12 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.385 0.674 . . . . 73.44 109.386 171.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -84.11 88.3 7.18 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.487 0.661 . . . . 73.15 110.189 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -120.98 81.17 34.92 Favored Pre-proline 0 C--O 1.245 0.829 0 N-CA-C 107.977 -1.12 . . . . 64.3 107.977 169.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.59 112.11 3.39 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 121.972 1.781 . . . . 70.0 112.015 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -94.58 88.84 5.57 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 105.826 -1.916 . . . . 75.1 105.826 167.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.4 m -77.55 114.85 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 113.985 -1.461 . . . . 74.03 111.228 -172.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.437 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 87.0 tttt -87.29 130.98 34.39 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.286 -0.87 . . . . 70.05 109.085 173.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 pp -103.35 148.84 25.38 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.992 -0.744 . . . . 71.44 108.992 173.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.501 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 21.3 t70 -147.56 133.54 19.19 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.134 -0.691 . . . . 43.13 109.134 172.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.6 mt -126.38 128.87 47.72 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.033 0.933 . . . . 73.03 109.805 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -140.15 156.98 46.31 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.253 -0.647 . . . . 74.22 109.253 171.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.3 p -115.36 152.96 31.86 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.467 0.707 . . . . 73.41 110.804 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -145.57 111.85 5.73 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.179 -1.045 . . . . 74.34 108.179 173.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -89.85 152.47 21.25 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.109 0.563 . . . . 75.2 109.7 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.2 t -157.54 142.12 16.48 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.557 0.743 . . . . 74.41 109.851 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -112.76 134.66 54.17 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.706 -0.85 . . . . 71.22 108.706 171.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.594 HD11 ' HB2' ' A' ' 57' ' ' GLU . 27.0 mt -112.59 -28.86 7.67 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.303 0.641 . . . . 64.34 110.528 -174.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.44 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -160.63 179.64 8.4 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.163 0.985 . . . . 34.14 109.058 175.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.49 120.84 13.59 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.898 -0.778 . . . . 75.24 108.898 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 72.59 -1.88 2.83 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.92 1.288 . . . . 62.15 112.272 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.44 ' CG2' ' HB3' ' A' ' 52' ' ' ALA . 57.8 t -101.16 112.0 32.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 107.9 -1.148 . . . . 74.25 107.9 176.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -115.84 156.37 26.22 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 123.653 0.781 . . . . 75.22 108.996 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.594 ' HB2' HD11 ' A' ' 51' ' ' LEU . 48.3 tt0 -128.18 120.72 27.85 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.387 -0.968 . . . . 73.32 108.387 177.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.1 t -99.45 112.68 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.583 -1.636 . . . . 54.24 106.583 174.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 49.2 t -102.55 127.37 56.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 107.633 -1.247 . . . . 45.11 107.633 170.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.24 117.03 28.44 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.289 -1.004 . . . . 73.34 108.289 177.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.515 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 57.6 mtt180 -84.92 100.95 11.96 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.064 0.945 . . . . 70.35 108.81 176.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.8 t -103.43 103.29 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.613 -0.884 . . . . 61.22 108.613 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 26.0 m -109.3 109.32 20.19 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.224 0.61 . . . . 71.53 109.78 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.584 HG11 HD21 ' A' ' 126' ' ' LEU . 2.6 t -105.97 133.36 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.944 1.298 . . . . 71.53 109.537 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 41.7 m -120.47 143.14 48.68 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.538 -0.912 . . . . 72.31 108.538 173.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.14 109.58 18.64 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.612 -1.255 . . . . 74.14 107.612 168.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.2 m -111.79 127.39 55.79 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.773 -0.825 . . . . 61.24 108.773 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.6 mt -89.63 49.21 1.7 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.265 1.026 . . . . 72.22 109.314 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.28 -92.0 1.37 Allowed Glycine 0 CA--C 1.529 0.906 0 N-CA-C 111.766 -0.534 . . . . 64.33 111.766 -173.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -88.68 -30.53 19.06 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.027 0.531 . . . . 53.34 112.011 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -113.36 126.78 55.74 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 109.779 -0.452 . . . . 75.34 109.779 -175.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.4 m -71.12 126.06 28.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.839 0.456 . . . . 63.52 109.81 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.528 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -71.87 -57.44 4.33 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.677 0.791 . . . . 72.53 109.923 176.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -157.33 174.94 14.67 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.599 -1.182 . . . . 64.45 111.249 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 tp -132.42 143.55 49.88 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 113.878 -1.51 . . . . 75.14 108.123 175.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 76.1 m -137.65 129.21 28.26 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.968 1.307 . . . . 71.5 107.878 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 39.7 tt0 -147.73 116.33 6.68 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.489 -0.93 . . . . 72.42 108.489 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.4 t -133.08 110.8 15.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 123.364 0.665 . . . . 74.23 109.743 -173.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.515 ' HG2' ' HG2' ' A' ' 61' ' ' ARG . 18.6 mt-30 -86.4 85.94 7.33 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.092 -1.077 . . . . 71.23 108.092 172.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.456 ' HG3' HD22 ' A' ' 106' ' ' LEU . 9.1 tp-100 -77.61 101.02 6.36 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.27 -0.877 . . . . 75.14 108.907 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.98 146.26 20.35 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.694 -0.962 . . . . 71.24 110.694 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.508 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -149.88 122.51 1.43 Allowed Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 111.399 -0.68 . . . . 74.53 111.399 -176.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 24.6 mt -82.84 116.88 27.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 109.079 -0.711 . . . . 75.32 109.079 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.722 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 14.6 m-85 -133.14 120.56 21.38 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.507 -1.294 . . . . 74.13 107.507 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.0 m -85.17 99.47 11.1 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.854 -0.795 . . . . 51.31 108.854 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.5 pt . . . . . 0 CA--C 1.547 0.862 0 C-N-CA 123.909 0.884 . . . . 74.54 110.67 -172.372 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 111.532 0.197 . . . . 73.12 111.532 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -63.24 -37.87 88.92 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.036 0.534 . . . . 74.03 110.749 174.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 22.2 t -74.66 -54.55 7.2 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.442 0.297 . . . . 74.02 111.09 -175.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 pp -75.42 -30.64 60.11 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.352 0.661 . . . . 74.45 112.347 -172.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.92 3.94 25.75 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.368 -0.684 . . . . 64.33 114.386 -170.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.73 -51.9 0.19 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 118.089 0.945 . . . . 70.31 112.612 -175.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.519 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 91.4 t80 -78.74 -61.7 1.93 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.509 0.723 . . . . 72.35 112.327 -170.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.41 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 71.2 m -65.12 -36.78 16.85 Favored Pre-proline 0 CA--C 1.564 1.495 0 N-CA-C 113.627 0.973 . . . . 61.4 113.627 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 18.0 Cg_endo -61.3 -32.36 89.82 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 121.905 1.737 . . . . 73.14 113.603 165.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -74.31 -21.85 59.53 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 122.988 0.515 . . . . 71.21 110.563 177.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 23.2 mm -65.63 -38.86 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.215 0.606 . . . . 73.24 109.411 170.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.508 HD21 ' HA3' ' A' ' 82' ' ' GLY . 86.4 mt -74.33 -23.55 59.07 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.901 0.881 . . . . 74.2 112.438 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.465 ' HE2' ' HA ' ' A' ' 130' ' ' PRO . 54.7 t80 -61.17 -47.59 94.28 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-O 118.209 -0.9 . . . . 60.21 113.268 -174.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -60.76 -34.86 91.14 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.225 1.95 . . . . 74.43 113.479 174.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -75.41 -37.51 60.44 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.365 0.666 . . . . 74.44 112.03 -178.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.28 -35.95 63.76 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.813 0.445 . . . . 55.4 109.909 177.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.647 ' NH1' HG23 ' C' ' 105' ' ' ILE . 27.3 ttm105 -63.73 -39.99 95.65 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 108.67 -0.863 . . . . 75.51 108.67 172.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.43 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 3.3 tm-20 -64.52 -48.16 76.16 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.131 0.972 . . . . 75.13 111.461 -177.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 36.0 t -60.68 -43.2 98.0 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 123.906 0.754 . . . . 74.14 110.16 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 72.4 mt -65.08 -44.31 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.353 0.661 . . . . 71.24 110.511 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.9 m -57.83 -41.75 82.94 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.564 1.145 . . . . 75.42 110.793 -177.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.3 t -77.71 -42.84 33.03 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.209 -0.905 . . . . 63.55 111.056 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 9.8 mtp -56.91 -46.85 81.7 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 123.84 0.856 . . . . 53.23 111.621 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.6 t -64.06 -41.9 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.567 1.147 . . . . 75.53 110.949 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.687 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 38.2 t -67.33 -35.11 78.75 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.769 -0.65 . . . . 52.44 111.165 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -74.46 -28.31 60.97 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.814 0.846 . . . . 74.51 110.141 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.9 6.79 64.94 Favored Glycine 0 C--N 1.354 1.53 0 O-C-N 123.899 0.75 . . . . 41.23 112.508 171.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.498 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.7 t 62.64 19.49 11.37 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 127.108 2.163 . . . . 43.43 113.299 172.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -81.95 161.78 59.52 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 109.174 -0.676 . . . . 61.44 109.174 175.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -53.53 115.13 2.11 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.343 2.029 . . . . 71.01 110.286 169.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.687 ' HG3' ' HB2' ' A' ' 119' ' ' SER . 4.0 tt0 -55.37 131.54 46.01 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 124.289 0.993 . . . . 72.13 111.24 -166.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.584 HD21 HG11 ' A' ' 64' ' ' VAL . 55.7 tp -107.08 106.73 17.38 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.425 -0.807 . . . . 71.21 110.605 -162.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -121.64 107.66 12.64 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.556 1.142 . . . . 71.24 108.582 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.451 ' O ' HD12 ' C' ' 13' ' ' ILE . 7.5 mp -72.75 145.88 46.78 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.826 0.45 . . . . 71.32 110.52 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.49 149.18 92.57 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 123.975 0.91 . . . . 61.42 111.145 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.628 ' HD3' HG13 ' C' ' 13' ' ' ILE . 44.0 Cg_endo -66.16 131.07 25.75 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 123.014 2.476 . . . . 33.32 112.194 -178.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.2 t -113.32 112.98 42.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.735 -1.209 . . . . 74.25 107.735 173.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -81.1 86.69 6.12 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.036 -0.727 . . . . 61.1 109.036 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 . . . . . 0 N--CA 1.475 0.793 0 CA-C-N 115.9 -0.591 . . . . 65.11 109.925 177.941 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.559 ' HB2' ' HB ' ' B' ' 89' ' ' ILE . 16.8 ttt . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.384 0.611 . . . . 64.33 112.415 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 85.3 m -159.24 143.35 15.16 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 124.171 0.988 . . . . 54.41 108.573 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -145.97 156.86 43.79 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.652 0.739 . . . . 72.41 110.448 158.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -125.26 130.59 52.35 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 106.257 -1.757 . . . . 75.42 106.257 172.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.566 HD11 HD13 ' B' ' 105' ' ' ILE . 34.0 mt -67.09 112.68 2.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 108.567 -0.901 . . . . 70.21 108.567 176.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . 0.448 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 16.9 mm-40 -80.15 -49.65 11.39 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.015 -0.993 . . . . 75.4 109.179 -178.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.498 ' HE ' HG21 ' A' ' 122' ' ' THR . 42.6 ttt180 -167.07 139.54 3.44 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.67 -0.695 . . . . 74.25 110.244 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.5 mt -114.86 141.56 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 107.424 -1.325 . . . . 74.0 107.424 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -167.78 153.43 7.26 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.689 0.757 . . . . 64.42 112.362 -176.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.6 m -80.54 122.93 27.65 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.822 -1.081 . . . . 73.45 108.707 168.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.459 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 38.0 mtpt -91.4 -41.89 10.62 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.015 0.526 . . . . 72.23 109.669 176.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 24.5 t70 -142.59 139.03 31.19 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.845 -0.616 . . . . 75.32 111.18 -168.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.415 HD11 ' SG ' ' B' ' 113' ' ' CYS . 48.8 mm -133.15 137.97 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.198 1.399 . . . . 70.43 108.174 173.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.535 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 42.8 t -144.75 117.46 8.68 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.338 -1.356 . . . . 73.51 107.338 -177.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.497 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 84.3 t80 -140.07 116.54 10.71 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.76 -1.2 . . . . 72.33 107.76 176.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -124.46 113.84 18.66 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.667 0.787 . . . . 74.1 109.34 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.728 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -108.24 85.45 2.74 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 107.989 -1.115 . . . . 53.43 107.989 170.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -73.38 -23.34 17.66 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.776 2.318 . . . . 64.35 112.667 -171.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -114.99 5.46 15.02 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.169 0.988 . . . . 70.22 110.936 -173.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.728 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -43.71 -61.63 1.84 Allowed Pre-proline 0 N--CA 1.492 1.643 0 C-N-CA 125.638 1.575 . . . . 73.21 114.382 -167.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.401 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 29.0 Cg_endo -61.86 -24.99 77.84 Favored 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 122.56 2.174 . . . . 72.33 113.245 -171.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -96.04 -33.08 12.25 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.652 0.781 . . . . 74.34 111.496 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.429 HG22 HD12 ' B' ' 68' ' ' LEU . 2.8 p -74.44 -16.03 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 122.601 0.361 . . . . 64.31 110.571 -175.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -67.88 -7.98 32.64 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.63 0.772 . . . . 71.12 112.838 176.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -67.54 -13.29 61.92 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 122.444 0.297 . . . . 72.03 110.902 171.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -105.55 110.42 22.74 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.445 1.498 . . . . 64.24 109.346 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -107.53 79.71 1.32 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.452 0.701 . . . . 64.13 110.93 -170.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 43.0 p90 -156.93 175.75 13.67 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.584 0.754 . . . . 73.54 109.217 171.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -77.37 113.13 28.64 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.197 -1.038 . . . . 75.55 108.197 173.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.28 148.53 88.6 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.171 1.914 . . . . 74.51 111.925 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -66.53 122.43 17.55 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.727 -0.842 . . . . 74.15 108.727 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.489 HG13 HG13 ' B' ' 64' ' ' VAL . 57.7 t -111.23 131.35 62.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 124.042 0.937 . . . . 63.24 111.021 -171.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -106.02 135.23 47.85 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.942 -1.133 . . . . 53.25 107.942 169.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 pp -109.24 154.83 21.86 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.06 0.944 . . . . 74.55 109.542 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -159.81 150.45 19.05 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.566 0.746 . . . . 74.34 109.273 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.475 HD13 HD11 ' B' ' 60' ' ' LEU . 62.4 mt -123.94 152.27 42.65 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.388 0.675 . . . . 65.41 110.197 175.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 11.4 t70 -138.5 142.6 39.35 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.635 1.174 . . . . 75.22 107.925 173.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 39.4 p -109.94 111.92 23.62 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.428 0.691 . . . . 73.32 109.959 -176.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.464 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -116.71 149.08 40.43 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.179 0.992 . . . . 75.11 108.379 176.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 46.5 p -145.45 162.14 38.05 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.292 0.479 . . . . 63.31 112.292 -174.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.8 p -153.55 136.2 15.22 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 114.691 -1.14 . . . . 70.44 108.532 164.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -93.86 110.18 21.85 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.157 -1.053 . . . . 63.32 108.157 173.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 63.6 mt -78.01 -39.81 41.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.189 0.596 . . . . 72.04 111.2 -174.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.47 -167.5 1.6 Allowed 'General case' 0 C--O 1.242 0.705 0 CA-C-N 115.184 -0.916 . . . . 60.42 110.167 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -71.71 120.22 16.99 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.985 -1.007 . . . . 71.05 109.083 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 70.35 -4.77 1.5 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.989 1.316 . . . . 74.55 112.362 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 85.3 t -104.88 115.29 46.48 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 N-CA-C 107.504 -1.295 . . . . 62.45 107.504 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -129.46 154.94 46.48 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.587 -0.894 . . . . 72.22 108.587 -175.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -126.25 111.36 14.48 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.341 -0.985 . . . . 72.24 108.341 -174.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 88.0 t -100.81 119.26 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.215 1.406 . . . . 61.22 110.134 -173.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 20.1 t -109.43 114.21 46.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 109.01 -0.737 . . . . 71.43 109.01 178.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.475 HD11 HD13 ' B' ' 44' ' ' LEU . 35.3 tp -99.51 111.38 23.74 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.804 -0.813 . . . . 61.04 108.804 169.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.535 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 33.7 ttm180 -86.09 127.21 34.64 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.824 -0.806 . . . . 72.41 108.824 170.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 36.2 t -113.98 103.92 16.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.579 -1.267 . . . . 74.03 107.579 172.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 9.6 m -98.1 136.27 38.57 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.166 0.586 . . . . 53.4 109.644 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.523 HG21 HG21 ' B' ' 114' ' ' ILE . 69.4 t -125.57 135.89 62.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.862 1.265 . . . . 73.33 109.584 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 95.5 m -117.5 148.86 41.46 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.934 -1.135 . . . . 63.03 107.934 167.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.37 147.0 29.84 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.036 0.534 . . . . 60.44 109.96 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.516 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 15.6 p -147.98 128.13 13.76 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.64 -0.709 . . . . 63.41 111.055 -175.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.429 HD12 HG22 ' B' ' 31' ' ' VAL . 53.1 mt -92.55 100.46 12.99 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 106.904 -1.517 . . . . 73.11 106.904 173.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.36 -139.01 26.06 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 111.345 -0.702 . . . . 44.11 111.345 -172.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -92.89 23.01 4.43 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.356 0.662 . . . . 62.42 110.138 175.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -118.93 138.95 52.42 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.276 1.03 . . . . 74.43 108.963 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 55.5 m -69.62 119.74 14.32 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.75 -0.463 . . . . 75.24 109.75 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.516 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -78.16 -62.61 1.62 Allowed 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.246 -1.02 . . . . 63.33 108.246 176.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -157.79 163.04 38.46 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.851 -1.068 . . . . 63.3 111.282 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 23.9 mt -123.34 127.37 48.41 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 105.977 -1.86 . . . . 73.33 105.977 172.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -128.74 155.35 45.24 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.323 -0.621 . . . . 73.13 109.323 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.535 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 37.2 tt0 -166.06 129.98 2.16 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.194 -0.669 . . . . 73.05 109.194 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.0 t -128.1 151.33 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.925 0.89 . . . . 71.22 108.708 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -125.37 108.93 12.17 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.681 -0.859 . . . . 61.45 108.681 168.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.44 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 7.5 tp-100 -92.81 100.41 12.9 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.43 -0.952 . . . . 73.41 108.43 174.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.459 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.09 145.32 17.62 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.895 -0.882 . . . . 73.43 110.895 176.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.13 127.7 2.48 Favored Glycine 0 CA--C 1.506 -0.518 0 N-CA-C 110.55 -1.02 . . . . 55.43 110.55 -174.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.448 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 27.8 mt -85.0 119.48 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 108.238 -1.023 . . . . 73.24 108.238 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -126.39 132.18 51.59 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 107.133 -1.432 . . . . 73.32 107.133 175.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 70.1 m -88.98 87.76 7.34 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.344 0.52 . . . . 63.25 109.861 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.409 HG12 HD21 ' B' ' 98' ' ' LEU . 2.6 pp -96.67 131.24 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.092 0.957 . . . . 55.21 109.959 -171.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.21 160.5 37.23 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.737 0.415 . . . . 40.01 111.359 173.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.47 -69.31 0.21 Allowed Glycine 0 C--N 1.343 0.949 0 CA-C-N 115.537 -0.756 . . . . 74.1 112.802 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.559 ' HB ' ' HB2' ' B' ' 9' ' ' MET . 0.1 OUTLIER -78.82 154.58 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.248 0.619 . . . . 74.41 110.759 -173.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -154.41 -175.1 5.24 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.706 -0.679 . . . . 72.04 111.717 -164.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.62 -113.52 5.94 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 115.127 -0.942 . . . . 72.41 112.53 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 77.7 m -88.21 -31.33 19.14 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.535 0.734 . . . . 53.12 110.773 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -65.96 -30.98 71.63 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 116.165 -0.47 . . . . 62.31 111.338 -171.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -68.42 -33.38 74.12 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.091 0.472 . . . . 74.55 110.686 174.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.02 -25.79 61.09 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.864 0.866 . . . . 52.14 110.927 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.445 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 35.7 t-80 -77.97 -40.18 40.11 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.698 0.799 . . . . 73.33 110.786 174.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.1 t -68.22 -57.62 5.72 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.848 0.356 . . . . 74.3 110.599 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.409 HD21 HG12 ' B' ' 86' ' ' ILE . 6.3 mp -81.43 -8.34 59.72 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 116.384 -0.371 . . . . 70.34 111.638 -177.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.97 4.06 31.88 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 119.763 -0.465 . . . . 71.51 114.037 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.447 ' HB1' ' N ' ' B' ' 134' ' ' ASP . . . -151.91 -49.07 0.11 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 117.157 0.479 . . . . 64.4 111.937 -175.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.424 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 54.0 t80 -78.58 -50.86 10.8 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.942 -0.572 . . . . 73.22 111.148 -173.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.427 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 70.3 m -64.24 -46.3 79.14 Favored Pre-proline 0 CA--C 1.568 1.657 0 C-N-CA 123.434 0.694 . . . . 54.12 111.307 177.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 56.6 Cg_exo -49.94 -36.93 45.38 Favored 'Trans proline' 0 C--N 1.404 3.473 0 C-N-CA 123.163 2.575 . . . . 50.32 114.996 168.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -63.62 -40.12 96.1 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 122.883 0.473 . . . . 74.44 110.381 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.566 HD13 HD11 ' B' ' 13' ' ' ILE . 64.7 mt -66.11 -42.66 91.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.515 0.726 . . . . 70.05 110.595 178.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 85.2 mt -82.68 -19.2 38.57 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.498 -0.774 . . . . 63.24 112.166 -174.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -57.85 -53.86 61.41 Favored Pre-proline 0 CA--C 1.561 1.367 0 CA-C-O 117.877 -1.058 . . . . 63.31 112.974 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -58.39 -33.42 97.81 Favored 'Trans proline' 0 C--N 1.392 2.854 0 C-N-CA 122.43 2.087 . . . . 72.42 114.209 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -71.02 -51.33 26.02 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.984 0.514 . . . . 74.43 110.46 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.44 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -58.07 -37.74 75.04 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.442 -0.799 . . . . 62.31 110.932 176.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -59.73 -57.02 14.73 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.747 1.619 . . . . 73.42 110.696 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -64.83 -29.8 70.78 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.706 0.803 . . . . 74.41 110.413 -178.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.524 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.2 t -70.3 -43.38 70.52 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 122.957 0.503 . . . . 74.01 110.909 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.523 HG21 HG21 ' B' ' 64' ' ' VAL . 83.6 mt -60.88 -53.15 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.287 -0.634 . . . . 75.31 109.287 175.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.4 m -55.12 -34.87 64.09 Favored 'General case' 0 CA--C 1.551 0.996 0 O-C-N 124.563 1.164 . . . . 74.11 111.744 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 42.7 t -65.85 -51.23 60.57 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 115.39 -0.823 . . . . 71.33 110.197 175.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.6 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 15.1 mmt -67.82 -30.5 69.92 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.355 0.662 . . . . 75.45 111.797 -174.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.94 -44.73 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.392 1.077 . . . . 75.04 109.969 174.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 27.7 t -70.1 -25.49 63.53 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.224 -0.898 . . . . 73.22 110.543 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.6 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 89.8 mtt-85 -70.38 -30.48 67.4 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.804 -0.443 . . . . 75.32 109.804 174.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.46 12.65 54.95 Favored Glycine 0 C--N 1.355 1.62 0 O-C-N 123.549 0.531 . . . . 64.11 112.644 170.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 17' ' ' TYR . 38.1 p 54.15 24.68 5.05 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 126.464 1.906 . . . . 72.23 113.992 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -83.86 156.76 64.23 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 123.318 0.647 . . . . 73.42 110.673 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -64.41 178.28 1.72 Allowed 'Trans proline' 0 C--N 1.389 2.668 0 C-N-CA 123.429 2.753 . . . . 73.22 114.072 -177.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.649 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 23.2 tp60 -65.16 125.9 26.42 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.443 -1.253 . . . . 53.13 112.27 -169.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -135.52 114.41 12.05 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 108.89 -0.781 . . . . 74.42 108.89 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -130.46 135.04 47.56 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.319 1.047 . . . . 72.14 108.209 171.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 tt -87.78 142.52 27.76 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.787 0.835 . . . . 64.43 109.143 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.24 152.47 94.44 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 123.327 0.651 . . . . 41.01 110.995 176.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.52 139.79 60.27 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.89 2.393 . . . . 71.42 111.372 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.56 110.34 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.786 0.803 . . . . 74.32 109.56 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -92.0 83.97 5.25 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.249 -0.887 . . . . 73.12 109.27 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -58.79 -42.41 88.99 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.766 -0.827 . . . . 73.4 108.766 172.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . 0.447 ' N ' ' HB1' ' B' ' 100' ' ' ALA . 6.4 p-10 . . . . . 0 CA--C 1.538 0.511 0 CA-C-N 113.909 -1.496 . . . . 75.13 112.264 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.456 ' CD1' ' HE2' ' C' ' 101' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 108.83 -0.804 . . . . 51.4 108.83 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -138.31 118.08 13.19 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.248 -1.019 . . . . 60.51 108.248 174.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.628 HG13 ' HD3' ' A' ' 130' ' ' PRO . 75.8 mt -67.95 122.4 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.844 -0.798 . . . . 71.53 108.844 173.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -86.13 -45.63 11.18 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 124.079 0.862 . . . . 72.11 109.481 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -179.4 124.79 0.08 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.293 -0.867 . . . . 74.42 109.414 -170.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.487 HD11 HD13 ' C' ' 13' ' ' ILE . 30.1 mt -116.28 150.55 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 108.06 -1.089 . . . . 72.52 108.06 173.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.438 ' HE2' ' HD2' ' C' ' 19' ' ' LYS . 22.8 p90 -174.49 171.54 3.32 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.057 0.943 . . . . 72.13 109.765 -173.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -90.85 118.31 30.16 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.612 -0.884 . . . . 64.13 108.612 174.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.683 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 10.0 mmmm -69.64 -45.78 67.68 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 122.102 0.953 . . . . 65.35 108.469 171.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.668 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 12.0 t70 -146.0 147.16 31.37 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 113.71 -1.587 . . . . 73.21 109.771 -169.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 63.5 mt -142.9 150.48 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.459 1.503 . . . . 71.25 107.456 177.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -160.57 151.91 19.29 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.389 0.614 . . . . 65.15 110.428 175.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -153.78 109.18 3.19 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.975 -1.12 . . . . 71.51 107.975 171.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -117.09 110.42 18.18 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.214 0.605 . . . . 73.1 110.028 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.56 87.39 25.62 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 106.619 -1.623 . . . . 54.31 106.619 167.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.42 -29.92 19.97 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.37 2.046 . . . . 74.03 111.531 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -91.93 12.57 21.25 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.568 1.147 . . . . 64.55 111.112 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.54 -58.59 12.28 Favored Pre-proline 0 CA--C 1.562 1.442 0 N-CA-C 114.031 1.123 . . . . 74.2 114.031 -166.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -57.85 -39.9 83.08 Favored 'Trans proline' 0 C--N 1.397 3.09 0 C-N-CA 122.182 1.921 . . . . 72.55 112.414 -174.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.415 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.3 t60 -69.38 -45.75 68.58 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.449 -1.25 . . . . 74.51 111.688 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.69 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.9 p -73.72 -20.89 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 N-CA-C 113.131 0.789 . . . . 64.11 113.131 -165.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -62.15 -25.61 67.85 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 113.99 1.107 . . . . 73.44 113.99 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 20.1 pt20 -98.07 16.89 19.76 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.508 0.723 . . . . 55.52 111.259 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.818 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -94.59 157.13 16.12 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.94 0.896 . . . . 71.33 109.461 173.104 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -67.13 123.24 19.71 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.295 0.638 . . . . 72.41 109.508 166.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -79.14 99.02 6.79 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.765 0.826 . . . . 73.53 110.434 -175.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -151.69 71.31 8.12 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 108.468 -0.938 . . . . 74.24 108.468 176.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -87.41 153.46 7.88 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.916 2.411 . . . . 44.53 112.21 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -89.94 112.33 23.68 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.551 -1.278 . . . . 74.12 107.551 168.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 40.2 t -72.74 102.3 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 109.147 -0.686 . . . . 51.44 109.147 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.512 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 54.0 mmtt -93.24 113.11 25.23 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.193 0.997 . . . . 74.41 109.33 175.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 mp -96.43 123.96 40.27 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.07 -1.085 . . . . 71.52 108.07 176.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -131.87 106.87 8.35 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.971 0.909 . . . . 72.52 109.004 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.35 123.17 48.4 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.258 -0.645 . . . . 74.04 109.258 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.455 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 15.5 t70 -112.58 147.79 35.9 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.132 1.373 . . . . 72.33 107.941 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 57.5 p -114.45 126.32 54.83 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.099 0.56 . . . . 75.32 110.904 -170.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.33 151.95 51.9 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.424 1.089 . . . . 53.31 108.494 175.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 6.4 p -163.29 163.43 25.3 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.73 0.412 . . . . 71.45 110.015 -176.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 25.8 t -165.55 133.66 3.08 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.996 0.518 . . . . 70.42 110.25 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -82.24 139.02 34.48 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.038 0.535 . . . . 53.43 109.563 173.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.599 HD11 HD12 ' C' ' 83' ' ' ILE . 84.1 mt -110.46 -41.8 4.26 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.486 0.714 . . . . 62.13 110.039 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.4 -174.36 4.91 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.56 -0.746 . . . . 71.12 110.642 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -68.93 126.22 29.11 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.747 -1.115 . . . . 73.53 108.488 172.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 67.28 6.52 4.89 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.737 1.215 . . . . 73.33 112.561 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 80.9 t -122.5 115.3 45.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 108.171 -1.048 . . . . 63.24 108.171 177.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -137.25 130.13 30.46 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.515 -0.766 . . . . 72.13 109.282 -173.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -92.35 127.26 37.77 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.214 -0.903 . . . . 74.51 109.605 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.477 HG23 HD11 ' C' ' 106' ' ' LEU . 26.9 m -111.87 136.99 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 108.141 -1.059 . . . . 75.33 108.141 166.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -126.66 121.23 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.436 1.094 . . . . 55.31 108.928 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.468 HD22 ' HB3' ' C' ' 103' ' ' PRO . 47.9 tp -111.95 113.8 26.33 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.4 -0.592 . . . . 74.44 109.4 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.455 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 34.5 ttm180 -82.92 107.69 15.71 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 108.856 -0.794 . . . . 72.53 108.856 173.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.445 ' HB ' HD11 ' C' ' 114' ' ' ILE . 6.6 t -99.5 121.34 50.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.053 -1.092 . . . . 71.23 108.053 171.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 72.0 m -112.7 128.21 56.34 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.404 -1.332 . . . . 60.32 107.404 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.544 HG23 HD13 ' C' ' 114' ' ' ILE . 99.5 t -116.03 115.18 48.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.626 -0.879 . . . . 70.03 108.626 172.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 4.4 m -100.78 139.27 36.7 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.73 -0.841 . . . . 71.44 108.73 175.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.33 113.1 15.18 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.577 -1.268 . . . . 75.43 107.577 176.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -136.18 131.44 34.64 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.032 -0.729 . . . . 74.55 109.032 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.818 HD13 ' HG2' ' C' ' 34' ' ' LYS . 3.5 mt -87.13 35.93 0.72 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.575 1.55 . . . . 73.14 110.037 -177.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.02 -117.31 4.9 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 109.682 -1.367 . . . . 74.32 109.682 -164.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -89.93 -20.43 23.36 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.611 0.764 . . . . 71.21 111.221 176.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -78.5 103.2 8.29 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.788 -0.819 . . . . 75.3 108.788 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 37.2 m -72.76 123.49 23.43 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.485 -0.561 . . . . 61.14 109.485 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.69 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.43 -56.03 5.1 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.422 -0.808 . . . . 72.13 109.017 174.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -159.66 168.18 26.63 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 122.223 1.011 . . . . 74.55 112.146 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -130.01 130.75 45.37 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 105.386 -2.079 . . . . 73.04 105.386 167.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.431 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 44.6 t -128.75 138.23 52.0 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.228 -1.397 . . . . 65.41 107.228 174.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.16 118.77 5.29 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.979 -0.378 . . . . 71.13 109.979 -172.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' C' ' 61' ' ' ARG . 95.6 t -128.74 136.85 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.564 0.746 . . . . 75.53 109.105 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.668 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 26.4 mt-30 -109.33 97.17 6.81 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.55 -0.908 . . . . 63.4 108.55 169.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -84.85 116.91 23.57 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.351 -0.84 . . . . 54.42 109.136 178.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.6 145.79 16.87 Favored Glycine 0 C--N 1.343 0.921 0 N-CA-C 111.742 -0.543 . . . . 72.32 111.742 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.39 121.3 1.75 Allowed Glycine 0 CA--C 1.507 -0.433 0 N-CA-C 111.751 -0.54 . . . . 34.15 111.751 -176.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.599 HD12 HD11 ' C' ' 51' ' ' LEU . 9.5 mm -82.55 118.94 31.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 108.054 -1.091 . . . . 61.15 108.054 174.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -133.71 123.79 25.56 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.393 0.677 . . . . 64.31 109.987 -172.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 70.2 m -71.17 108.17 4.55 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.787 -0.82 . . . . 43.05 108.787 167.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 78.2 mt -117.7 119.74 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.462 1.105 . . . . 73.14 108.412 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.15 168.28 26.46 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.53 0.732 . . . . 61.31 110.442 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.72 -33.78 5.97 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 116.26 -0.427 . . . . 74.44 113.936 170.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 40.2 pt -117.67 163.4 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.493 0.717 . . . . 55.44 110.957 -176.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -146.15 158.04 43.86 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.511 0.724 . . . . 75.15 110.696 -175.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.08 -129.72 15.64 Favored Glycine 0 C--N 1.349 1.258 0 CA-C-N 115.784 -0.644 . . . . 73.33 113.48 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 75.5 p -66.02 -26.79 67.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.685 0.794 . . . . 73.31 111.534 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -62.49 -54.12 44.7 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.959 0.504 . . . . 55.14 110.028 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.504 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 7.6 ptt? -76.79 -23.79 52.86 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.896 -0.593 . . . . 64.45 111.099 -176.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.48 -37.18 77.14 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.377 0.608 . . . . 60.22 110.364 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -67.78 -33.21 74.39 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.643 -1.162 . . . . 72.54 110.442 173.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.564 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 43.9 t -68.86 -60.59 2.27 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.802 -0.635 . . . . 64.41 110.682 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.7 pp -69.42 -28.3 66.03 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.44 0.696 . . . . 72.33 112.411 -174.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . 0.416 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -94.57 -3.9 62.5 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-O 119.558 -0.579 . . . . 64.34 114.21 -172.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.58 -62.15 0.13 Allowed 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 117.496 0.648 . . . . 74.11 112.639 -172.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.564 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 54.7 t80 -66.41 -37.92 86.3 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 124.391 1.076 . . . . 64.23 113.106 -170.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 29.7 m -80.72 -42.64 1.26 Allowed Pre-proline 0 CA--C 1.564 1.511 0 C-N-CA 123.561 0.745 . . . . 63.31 111.034 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.468 ' HB3' HD22 ' C' ' 60' ' ' LEU . 89.0 Cg_exo -54.13 -24.21 32.36 Favored 'Trans proline' 0 C--N 1.398 3.151 0 C-N-CA 122.995 2.464 . . . . 72.55 114.617 166.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -67.77 -24.72 65.37 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.399 0.68 . . . . 73.21 111.792 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.647 HG23 ' NH1' ' A' ' 111' ' ' ARG . 31.7 mm -77.3 -35.17 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 109.24 -0.652 . . . . 64.2 109.24 173.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.477 HD11 HG23 ' C' ' 58' ' ' VAL . 82.0 mt -79.41 -24.9 42.24 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.671 -1.15 . . . . 72.32 111.818 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -57.11 -55.27 45.81 Favored Pre-proline 0 CA--C 1.557 1.226 0 CA-C-O 118.198 -0.906 . . . . 75.13 113.09 -173.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.43 ' HB2' ' HG3' ' A' ' 112' ' ' GLU . 57.5 Cg_endo -66.57 -23.33 49.93 Favored 'Trans proline' 0 C--N 1.387 2.6 0 CA-C-N 121.174 1.455 . . . . 63.1 112.342 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -75.51 -49.31 19.11 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.13 0.972 . . . . 74.42 110.15 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.68 -38.24 84.29 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.149 0.98 . . . . 43.43 110.07 174.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -58.48 -53.07 62.42 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.253 1.421 . . . . 73.04 110.753 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.47 -32.61 73.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 123.694 0.622 . . . . 73.42 110.278 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.6 t -68.8 -34.41 75.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.001 0.52 . . . . 75.02 111.006 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.544 HD13 HG23 ' C' ' 64' ' ' VAL . 95.5 mt -73.33 -51.93 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.666 0.786 . . . . 74.32 109.84 175.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.0 m -64.56 -28.9 69.96 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.844 0.858 . . . . 64.32 111.426 -175.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.3 t -67.77 -48.62 65.85 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.238 -0.653 . . . . 64.41 109.238 172.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.589 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.1 -38.66 87.09 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.512 1.125 . . . . 74.44 112.836 -179.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' C' ' 123' ' ' PHE . 82.2 t -62.12 -45.38 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.769 0.828 . . . . 62.44 109.668 175.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 44.8 t -68.2 -32.47 72.71 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.239 -0.891 . . . . 74.43 111.947 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -68.88 -31.61 70.66 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.537 0.735 . . . . 75.13 109.703 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.82 10.79 73.83 Favored Glycine 0 C--N 1.355 1.607 0 O-C-N 123.969 0.793 . . . . 73.22 112.998 173.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.507 HG23 ' HB3' ' D' ' 17' ' ' TYR . 43.2 p 60.19 29.48 19.04 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 126.151 1.78 . . . . 61.44 114.257 173.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.402 ' HB2' HG13 ' C' ' 118' ' ' VAL . 96.8 m-85 -96.03 147.0 32.31 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.494 -0.928 . . . . 75.21 108.494 171.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.649 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 80.6 Cg_exo -49.44 141.06 26.33 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.712 2.941 . . . . 75.51 114.421 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.524 ' HA ' HE21 ' C' ' 125' ' ' GLN . 0.0 OUTLIER -55.49 113.81 1.58 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.175 0.99 . . . . 73.23 111.354 -177.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 41.6 tp -107.78 92.81 4.22 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.601 -0.889 . . . . 73.53 108.601 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -93.03 114.71 27.33 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.197 -0.911 . . . . 45.05 108.976 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 tt -73.09 135.89 44.84 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.922 0.889 . . . . 75.4 110.252 -171.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.41 148.76 90.95 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 123.666 0.786 . . . . 63.3 111.997 -175.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.526 ' HG2' HG21 ' A' ' 13' ' ' ILE . 6.6 Cg_exo -70.86 116.57 4.73 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.145 2.563 . . . . 72.11 112.49 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 90.5 t -126.96 110.58 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.784 -0.821 . . . . 75.15 108.784 173.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -71.97 104.69 3.61 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.281 1.032 . . . . 63.21 109.726 174.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -62.75 -44.63 95.71 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.283 0.563 . . . . 64.42 110.052 172.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 . . . . . 0 CA--C 1.54 0.577 0 CA-C-N 114.372 -1.285 . . . . 72.52 111.184 -174.476 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 87.8 m . . . . . 0 C--O 1.237 0.438 0 CA-C-O 120.613 0.244 . . . . 74.3 110.929 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.497 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 31.3 t80 -159.12 89.13 0.91 Allowed 'General case' 0 C--O 1.238 0.45 0 N-CA-C 107.051 -1.463 . . . . 72.23 107.051 171.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -113.96 116.38 29.14 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.018 -1.104 . . . . 74.15 108.018 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.499 HG21 HD11 ' D' ' 16' ' ' ILE . 54.3 mt -72.09 122.95 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 109.588 -0.523 . . . . 70.04 109.588 -178.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -85.61 -42.91 13.92 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.994 0.809 . . . . 72.43 111.189 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -170.97 135.12 1.0 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 111.81 0.3 . . . . 73.43 111.81 -163.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.499 HD11 HG21 ' D' ' 13' ' ' ILE . 2.7 mp -115.76 134.58 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.609 -1.256 . . . . 73.01 107.609 170.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.507 ' HB3' HG23 ' C' ' 122' ' ' THR . 32.9 p90 -166.42 169.57 13.81 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 122.18 0.991 . . . . 71.21 111.394 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.5 p -103.03 120.33 40.46 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 113.567 -1.651 . . . . 72.52 108.534 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -89.96 -31.02 17.43 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.088 -0.708 . . . . 65.34 109.088 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -140.4 134.73 31.24 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 114.385 -1.28 . . . . 54.31 108.343 173.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.589 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.7 mt -128.18 145.08 35.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.021 -1.474 . . . . 63.13 107.021 168.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 30.9 t -147.25 140.89 25.61 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.9 0.88 . . . . 70.3 108.834 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.523 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.1 t80 -146.48 136.22 23.21 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 105.89 -1.892 . . . . 64.01 105.89 168.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.535 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 43.8 mt-10 -138.52 152.37 48.18 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.338 -1.356 . . . . 74.14 107.338 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.77 84.33 7.05 Favored Pre-proline 0 C--O 1.239 0.535 0 N-CA-C 107.307 -1.368 . . . . 72.3 107.307 172.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -66.57 -36.91 23.96 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.0 2.467 . . . . 65.32 113.025 -170.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.478 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 52.6 m-20 -101.35 6.84 42.85 Favored 'General case' 0 C--O 1.211 -0.973 0 CA-C-O 118.542 -0.742 . . . . 64.01 110.747 -177.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.683 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -26.08 -65.09 0.11 Allowed Pre-proline 0 N--CA 1.496 1.85 0 N-CA-C 116.621 2.082 . . . . 73.43 116.621 -162.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -78.85 -21.97 9.23 Favored 'Trans proline' 0 C--N 1.382 2.314 0 CA-C-N 122.878 2.063 . . . . 72.53 113.842 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -73.74 -37.16 65.16 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.88 1.272 . . . . 75.51 110.37 175.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.557 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.5 p -84.13 -18.93 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.066 0.546 . . . . 65.01 111.531 -174.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -65.45 -15.83 63.02 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 112.529 0.566 . . . . 73.04 112.529 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -58.65 -33.43 70.07 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.55 0.69 . . . . 53.14 110.03 173.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -89.28 93.39 9.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.126 -1.397 . . . . 73.54 109.373 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -102.43 91.64 4.34 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.17 0.509 . . . . 63.11 109.981 -177.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 35.6 p90 -158.28 174.0 15.82 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.949 1.3 . . . . 72.4 108.009 169.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.435 HE21 ' HD2' ' D' ' 38' ' ' PRO . 31.0 tp60 -65.43 112.91 9.6 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-O 118.938 -0.553 . . . . 42.33 109.565 178.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.435 ' HD2' HE21 ' D' ' 37' ' ' GLN . 49.9 Cg_exo -59.07 141.24 97.99 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.582 2.188 . . . . 53.02 112.713 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -59.42 118.19 5.71 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.607 0.763 . . . . 73.42 109.959 172.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.538 HG13 HG13 ' D' ' 64' ' ' VAL . 59.0 t -97.21 106.94 19.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 123.219 0.608 . . . . 73.03 109.426 -175.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -95.69 127.92 42.12 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.097 -0.956 . . . . 71.12 108.648 173.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -97.51 146.08 25.59 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.139 0.576 . . . . 71.54 109.602 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -149.54 116.76 6.05 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.226 -1.027 . . . . 63.41 108.226 177.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.05 140.12 41.69 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.722 0.409 . . . . 70.12 110.926 -173.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.2 t70 -136.88 151.82 49.52 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.56 1.144 . . . . 51.44 108.595 173.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.0 t -116.85 150.3 38.64 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.149 0.579 . . . . 73.12 110.839 -172.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.593 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.05 155.09 28.67 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.991 0.917 . . . . 63.54 109.229 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 13.4 p -167.09 162.12 15.16 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.697 0.399 . . . . 63.02 111.323 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 3.0 m -153.38 144.8 23.2 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.243 1.017 . . . . 61.12 108.669 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -97.92 116.49 30.23 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.152 -1.055 . . . . 60.23 108.152 165.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 24.6 mt -95.51 -40.58 9.38 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.044 0.538 . . . . 54.23 110.455 -172.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.584 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -146.11 -176.56 5.2 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.077 -0.965 . . . . 72.34 109.908 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -68.4 105.92 2.34 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.387 0.675 . . . . 73.31 109.652 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 62.85 18.55 10.85 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.759 1.224 . . . . 74.41 112.128 -177.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.584 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 57.3 t -109.23 104.83 17.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 107.353 -1.351 . . . . 52.3 107.353 171.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -119.6 131.33 55.46 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.96 -1.473 . . . . 71.2 109.686 -164.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -98.58 132.23 44.15 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.947 -0.57 . . . . 75.15 109.868 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 75.4 t -115.46 118.86 60.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 107.582 -1.266 . . . . 61.13 107.582 175.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 24.9 t -117.96 129.53 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.574 0.75 . . . . 71.12 109.276 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -122.74 129.47 51.8 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 110.328 -0.249 . . . . 74.11 110.328 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.606 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 14.3 ttm-85 -86.44 100.05 12.07 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.82 -0.807 . . . . 74.41 108.82 172.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 99.1 t -90.41 116.84 32.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.048 -1.093 . . . . 55.13 108.048 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 17.6 m -123.34 126.29 46.57 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.339 0.59 . . . . 71.43 109.671 -172.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.538 HG13 HG13 ' D' ' 40' ' ' VAL . 40.6 t -117.33 100.36 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.742 1.617 . . . . 50.22 107.977 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 60.7 m -93.53 94.26 8.55 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.832 -1.076 . . . . 71.0 108.157 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.16 143.77 28.33 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.712 -0.677 . . . . 65.22 110.456 -174.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.481 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 54.2 p -144.6 135.35 24.78 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 115.735 -0.666 . . . . 63.01 110.429 -177.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.465 HD12 HG22 ' D' ' 31' ' ' VAL . 39.0 mt -98.24 100.0 11.26 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.642 0.777 . . . . 74.44 109.052 172.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.01 -115.06 4.53 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.025 -0.989 . . . . 71.22 112.487 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -102.69 5.64 39.12 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.715 0.806 . . . . 54.34 112.15 -176.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -131.7 155.79 47.03 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.81 -0.441 . . . . 73.41 109.81 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 71.8 m -65.67 136.17 55.95 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 123.784 0.677 . . . . 73.51 110.977 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.557 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.6 -64.07 1.19 Allowed 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.577 -1.268 . . . . 74.41 107.577 174.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -155.94 152.14 27.86 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.382 -1.281 . . . . 73.33 110.194 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.535 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 78.3 mt -118.5 111.91 19.24 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.319 -0.993 . . . . 72.12 108.319 177.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.538 ' SG ' HG12 ' D' ' 114' ' ' ILE . 44.8 t -116.06 138.79 50.92 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.765 -0.828 . . . . 71.25 108.765 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -155.31 122.32 5.45 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.579 0.352 . . . . 73.3 110.258 -178.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.17 123.89 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.153 0.581 . . . . 72.32 109.957 -175.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -87.3 88.41 7.68 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.17 -1.048 . . . . 63.22 108.17 165.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -80.41 99.76 8.13 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.646 -1.242 . . . . 74.21 107.646 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.63 142.38 15.8 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.448 -0.661 . . . . 33.22 111.448 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.446 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -136.7 131.96 5.85 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.19 -0.764 . . . . 64.45 111.19 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 43.8 mt -90.77 124.78 43.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 108.088 -1.079 . . . . 54.31 108.088 176.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -132.99 123.65 26.27 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.762 0.825 . . . . 74.43 109.483 -174.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.9 m -84.25 97.76 9.59 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.97 -0.752 . . . . 64.31 108.97 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.582 HD11 HD12 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -120.66 130.81 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.771 0.828 . . . . 75.23 109.724 -174.073 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.26 164.91 36.44 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.785 0.834 . . . . 73.45 110.76 -176.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.67 -10.55 71.67 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.725 -0.671 . . . . 53.24 114.15 173.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.582 HD12 HD11 ' D' ' 86' ' ' ILE . 34.4 mt -94.5 145.08 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.63 0.772 . . . . 71.21 109.81 -174.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.7 166.48 22.1 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.666 0.786 . . . . 65.34 110.62 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.65 -136.6 41.71 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 114.951 -1.022 . . . . 74.14 114.902 169.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 16.4 m -77.47 -18.33 57.23 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.361 1.065 . . . . 72.11 111.565 -173.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -66.16 -24.84 66.73 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.826 0.45 . . . . 52.34 110.723 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 63.3 mtt -60.02 -43.91 94.97 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.967 0.507 . . . . 71.43 110.167 173.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.55 -26.41 67.12 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.399 -0.819 . . . . 73.24 111.53 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -85.26 -34.52 21.94 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.251 0.62 . . . . 71.21 111.111 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . 0.564 ' SG ' HG13 ' D' ' 86' ' ' ILE . 42.6 t -72.43 -52.44 15.92 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.265 0.555 . . . . 70.23 109.747 -175.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 26.2 mt -80.95 -29.57 35.4 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.523 -1.217 . . . . 73.41 110.24 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.4 -17.89 40.89 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 114.968 0.747 . . . . 35.52 114.968 -171.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.65 -50.22 0.91 Allowed 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 117.788 0.794 . . . . 70.44 111.602 -174.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -73.94 -42.24 60.85 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 122.809 0.444 . . . . 74.2 112.043 -174.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.497 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 69.4 m -67.77 -47.31 44.28 Favored Pre-proline 0 CA--C 1.567 1.609 0 C-N-CA 123.161 0.585 . . . . 54.22 111.76 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 51.4 Cg_exo -59.75 -28.57 87.6 Favored 'Trans proline' 0 C--N 1.401 3.327 0 C-N-CA 122.597 2.198 . . . . 62.31 113.385 170.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -64.25 -40.93 97.02 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.95 0.9 . . . . 74.45 110.05 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 48.0 mm -61.73 -42.19 93.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 123.447 0.699 . . . . 74.33 110.193 173.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.446 HD21 ' HA3' ' D' ' 82' ' ' GLY . 96.1 mt -82.99 -13.37 56.09 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.975 -1.011 . . . . 61.41 112.49 -172.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -64.65 -48.15 74.35 Favored Pre-proline 0 N--CA 1.49 1.546 0 C-N-CA 123.929 0.892 . . . . 74.33 112.775 -176.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.52 -36.89 96.82 Favored 'Trans proline' 0 C--N 1.391 2.791 0 C-N-CA 122.201 1.934 . . . . 72.33 113.164 175.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -73.98 -36.08 64.53 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.893 0.877 . . . . 72.45 112.135 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.47 -49.65 72.79 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.209 -0.664 . . . . 61.53 109.209 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -55.1 -48.53 73.46 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 124.933 1.396 . . . . 72.03 110.781 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -61.81 -50.97 70.17 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 123.794 0.684 . . . . 73.11 111.365 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 38.9 t -55.43 -45.58 76.78 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 123.944 0.777 . . . . 53.14 111.039 -177.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.538 HG12 ' SG ' ' D' ' 76' ' ' CYS . 98.8 mt -59.31 -58.2 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.366 1.066 . . . . 70.01 110.817 174.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 60.7 m -54.19 -43.24 70.53 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.596 1.158 . . . . 64.21 112.16 -173.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -66.75 -40.32 88.25 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.026 -0.988 . . . . 45.31 110.045 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.1 mtm -70.28 -29.79 66.64 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.947 0.499 . . . . 73.51 111.616 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.467 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.0 t -64.99 -45.42 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.503 0.721 . . . . 75.13 110.178 175.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -74.33 -30.14 61.91 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.838 -0.619 . . . . 63.22 111.067 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 59.0 mtt-85 -69.83 -34.11 73.22 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.529 0.731 . . . . 75.21 109.867 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.12 -0.82 90.04 Favored Glycine 0 C--N 1.355 1.628 0 O-C-N 123.65 0.594 . . . . 62.5 112.388 173.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.1 p 64.21 23.18 13.06 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 126.952 2.101 . . . . 64.32 113.698 174.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -85.27 155.41 60.18 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.537 0.735 . . . . 74.22 110.055 171.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -53.2 125.63 19.0 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.182 2.588 . . . . 65.43 112.643 173.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -50.93 142.77 11.24 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.38 1.472 . . . . 75.43 112.864 -174.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.481 HD13 HG21 ' D' ' 40' ' ' VAL . 43.4 tp -114.35 125.07 53.45 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.613 0.765 . . . . 72.43 109.183 177.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -119.88 100.22 7.1 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.519 -0.919 . . . . 74.22 108.519 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 76.4 mt -61.55 114.84 3.48 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.289 -0.634 . . . . 73.41 109.289 174.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.02 145.22 65.92 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 124.19 0.996 . . . . 72.42 111.979 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.424 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 39.3 Cg_endo -72.33 97.2 0.84 Allowed 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 122.131 1.887 . . . . 61.22 110.343 177.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.47 0.569 0 CA-C-N 114.567 -1.197 . . . . 54.45 109.513 -175.934 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 119.335 -0.364 . . . . 73.23 111.923 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.0 m 53.02 66.92 1.09 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.195 0.998 . . . . 75.14 111.108 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.604 ' HG3' ' HG3' ' A' ' 4' ' ' GLN . 9.6 pt-20 -74.21 -32.2 62.94 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.633 -1.167 . . . . 71.22 111.48 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.604 ' HG3' ' HG3' ' A' ' 3' ' ' GLU . 40.2 mt-30 -96.48 144.88 26.17 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.672 0.789 . . . . 75.51 109.851 -176.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.402 ' OD1' ' HG2' ' C' ' 143' ' ' GLN . 4.5 p30 -67.85 130.93 44.49 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.289 -1.004 . . . . 74.14 108.289 173.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.579 ' HA ' ' HG3' ' C' ' 143' ' ' GLN . 28.6 t-20 -172.13 -42.81 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.605 0.565 . . . . 62.25 110.101 -176.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 m 69.12 72.06 0.26 Allowed 'General case' 0 CA--C 1.546 0.789 0 O-C-N 124.48 1.112 . . . . 64.4 109.023 -171.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -75.2 -50.75 15.21 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.715 -1.13 . . . . 72.3 109.639 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.4 ' SD ' ' N ' ' A' ' 10' ' ' THR . 0.1 OUTLIER -68.3 144.98 54.63 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.034 -0.985 . . . . 73.5 109.105 176.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.4 ' N ' ' SD ' ' A' ' 9' ' ' MET . 76.5 m -138.75 143.41 39.01 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.218 0.532 . . . . 75.04 110.776 -170.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.57 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.8 t80 -131.81 137.98 48.34 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.875 -1.057 . . . . 65.0 109.63 -172.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -147.78 120.35 8.54 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.048 -1.093 . . . . 64.52 108.048 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.49 HD13 HD11 ' A' ' 16' ' ' ILE . 20.2 mt -85.85 120.56 36.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 109.374 -0.602 . . . . 65.32 109.374 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.28 -41.91 19.54 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.463 -0.94 . . . . 73.53 108.463 178.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -169.03 148.91 4.17 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 116.183 -0.462 . . . . 73.42 111.116 -170.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.49 HD11 HD13 ' A' ' 13' ' ' ILE . 69.0 mt -137.65 130.35 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 124.61 1.164 . . . . 63.52 108.151 175.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.456 ' HB3' HG23 ' B' ' 122' ' ' THR . 28.2 p90 -167.83 154.52 7.92 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.61 0.719 . . . . 70.31 111.605 -174.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.1 p -83.9 122.35 28.6 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.467 -1.242 . . . . 55.41 109.111 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -94.59 -14.93 24.5 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.161 0.584 . . . . 74.24 110.638 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 18.0 t0 -158.6 139.55 12.97 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.9 -1.148 . . . . 73.3 107.9 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.408 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 59.2 mt -141.16 141.9 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 106.977 -1.49 . . . . 74.21 106.977 177.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.9 t -157.06 116.48 3.4 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.821 0.343 . . . . 41.24 110.259 177.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.591 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 81.6 t80 -110.86 139.82 45.86 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 107.206 -1.405 . . . . 72.23 107.206 170.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 49.1 mt-10 -141.68 109.69 5.82 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 123.321 0.648 . . . . 75.02 109.35 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.429 ' CB ' ' HB2' ' A' ' 28' ' ' ALA . . . -103.05 88.56 1.59 Allowed Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.064 -1.828 . . . . 51.13 106.064 165.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -66.92 -34.05 31.07 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.722 2.281 . . . . 64.31 112.097 -169.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -112.82 26.37 10.58 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 114.959 -1.019 . . . . 73.52 109.311 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.467 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -44.62 -53.91 13.89 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 113.972 1.101 . . . . 51.11 113.972 -169.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.76 -28.47 86.52 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 121.971 1.781 . . . . 63.14 112.824 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.474 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.2 m-70 -89.34 -31.19 17.92 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.439 1.096 . . . . 70.42 110.269 -176.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.564 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.0 p -73.26 -17.82 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.065 0.546 . . . . 60.35 112.186 -162.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -82.6 -23.71 34.25 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.255 0.622 . . . . 64.44 111.203 -176.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 28.9 pt20 -91.21 -11.86 37.04 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.253 0.621 . . . . 53.51 110.556 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 13.5 mmmm -76.75 168.43 20.1 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.491 0.716 . . . . 73.44 111.842 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.64 117.0 10.69 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.743 -0.836 . . . . 74.51 108.743 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.416 ' CE3' HD21 ' A' ' 68' ' ' LEU . 58.1 t-105 -83.54 85.21 7.29 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.378 0.608 . . . . 65.42 109.766 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.407 ' H ' HD22 ' A' ' 68' ' ' LEU . 6.8 tp-100 -127.82 81.38 70.4 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 107.889 -1.152 . . . . 64.51 107.889 171.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -72.94 108.2 2.53 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.532 2.154 . . . . 75.03 112.514 -174.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -95.43 90.49 5.8 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.911 -1.514 . . . . 62.51 106.911 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 65' ' ' THR . 60.3 t -88.13 113.46 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 CA-C-N 115.021 -0.991 . . . . 71.02 111.044 -171.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.425 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 80.7 tttt -79.82 136.86 36.81 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.346 1.058 . . . . 75.11 110.104 172.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.46 HD21 HG12 ' E' ' 6' ' ' ILE . 0.6 OUTLIER -110.4 125.37 53.17 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.976 -1.12 . . . . 75.44 107.976 175.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.593 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 22.8 t70 -135.57 126.24 27.17 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.379 -0.6 . . . . 72.12 109.379 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.613 HD21 HD22 ' E' ' 8' ' ' LEU . 2.5 mm? -107.94 133.27 52.52 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.368 0.667 . . . . 75.31 110.278 -177.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 11.7 t70 -124.18 146.29 48.78 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.382 1.073 . . . . 71.4 108.372 173.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 79.3 m -119.8 139.87 51.66 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.701 0.8 . . . . 71.32 110.073 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.671 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -132.53 131.59 41.73 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.922 0.889 . . . . 44.05 109.286 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.2 m -102.58 151.88 21.82 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.629 0.772 . . . . 64.34 109.946 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.6 t -162.96 127.95 3.12 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.084 -0.709 . . . . 63.34 109.084 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -112.84 119.15 36.99 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.337 -0.986 . . . . 70.24 108.337 171.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.4 mt -96.17 -30.18 13.64 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.216 0.606 . . . . 64.13 111.405 -174.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.22 -175.47 3.98 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.293 0.637 . . . . 55.55 110.469 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.51 117.79 7.24 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.326 -0.852 . . . . 74.41 108.776 171.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 71.93 -5.03 1.8 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.541 1.136 . . . . 62.14 112.93 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.0 t -99.22 106.02 18.3 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 N-CA-C 107.544 -1.28 . . . . 64.43 107.544 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -124.02 125.01 43.81 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.97 -1.122 . . . . 74.15 107.97 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -102.09 114.16 28.05 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.636 -0.876 . . . . 64.3 108.636 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.9 m -102.92 136.1 37.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.702 -1.221 . . . . 62.15 107.702 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 60.7 t -124.93 138.97 52.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 108.751 -0.833 . . . . 74.32 108.751 -174.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -128.19 112.84 14.96 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.593 -0.891 . . . . 62.23 108.593 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.564 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 19.5 ttt180 -93.23 102.44 14.73 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.029 0.932 . . . . 52.41 109.122 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -94.09 127.76 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.49 0.716 . . . . 74.0 109.444 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 13.9 m -113.31 130.45 56.26 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.836 0.855 . . . . 64.14 109.584 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.7 t -126.65 106.69 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.162 1.385 . . . . 55.51 107.851 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 23.5 m -104.61 134.4 47.85 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 107.762 -1.199 . . . . 75.33 107.762 175.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.52 127.29 55.18 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.835 -1.172 . . . . 23.43 107.835 174.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -126.94 126.33 43.06 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.302 0.641 . . . . 62.33 110.023 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.53 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 30.9 mt -86.91 78.02 9.11 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.394 1.078 . . . . 52.11 108.363 173.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.58 -84.6 0.87 Allowed Glycine 0 C--N 1.342 0.911 0 CA-C-N 115.229 -0.896 . . . . 74.0 111.443 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -115.27 -28.48 6.89 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.143 0.977 . . . . 71.33 110.621 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -87.94 132.59 34.17 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.289 -0.634 . . . . 74.03 109.289 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.2 m -72.8 123.42 23.31 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.745 0.702 . . . . 71.25 110.307 175.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.564 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -72.21 -57.35 4.31 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.52 -0.764 . . . . 40.32 109.633 174.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.437 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 35.7 p90 -162.58 176.96 9.85 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.612 -1.177 . . . . 54.22 111.093 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 58.6 tp -139.77 142.22 36.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.397 1.479 . . . . 65.53 107.31 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.452 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 76.0 m -145.5 106.96 4.21 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.114 0.965 . . . . 72.01 108.654 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -130.33 122.23 27.52 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.402 0.681 . . . . 73.12 109.492 -174.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 t -132.14 114.44 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.209 1.004 . . . . 53.32 109.685 -172.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 7.1 tt0 -84.56 90.12 7.59 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.359 -0.978 . . . . 51.14 108.359 173.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.537 ' HG3' HD22 ' A' ' 106' ' ' LEU . 6.8 tp-100 -85.13 104.13 14.74 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.288 -0.634 . . . . 75.32 109.288 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.61 153.39 21.61 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 111.485 -0.646 . . . . 62.03 111.485 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.438 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -155.8 122.0 1.16 Allowed Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 111.262 -0.735 . . . . 63.34 111.262 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.4 mt -83.04 116.15 26.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 N-CA-C 108.962 -0.755 . . . . 64.23 108.962 176.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.57 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 38.0 m-85 -127.19 120.82 29.68 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.267 0.627 . . . . 74.53 109.941 -175.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.8 m -81.1 102.02 9.98 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.434 -0.95 . . . . 71.32 108.434 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.3 pt -126.23 121.38 59.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.87 0.868 . . . . 62.11 109.991 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.46 169.3 8.98 Favored 'General case' 0 C--O 1.247 0.927 0 C-N-CA 124.654 1.181 . . . . 51.32 109.42 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.35 97.13 0.35 Allowed Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.383 -1.087 . . . . 71.45 110.383 -172.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.7 mm 88.05 108.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.185 1.394 . . . . 75.22 109.996 170.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -105.26 -163.6 0.96 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.976 1.311 . . . . 75.52 111.031 -166.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.82 -148.87 40.57 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 116.004 -0.544 . . . . 60.11 112.949 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.461 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 17.8 p -62.22 -25.29 67.73 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.268 1.027 . . . . 74.03 111.963 177.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -61.73 -53.93 49.36 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.28 1.032 . . . . 74.31 109.428 176.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.476 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 46.3 ttp -71.82 -27.71 63.1 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.321 -0.854 . . . . 70.21 111.228 175.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.461 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -66.67 -34.21 77.35 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.868 0.467 . . . . 42.13 110.99 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.553 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 41.6 t-80 -68.79 -24.91 64.47 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.772 0.829 . . . . 73.05 110.584 173.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 69.1 m -75.77 -64.95 0.97 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.565 0.346 . . . . 72.33 110.675 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.53 HD12 ' N ' ' A' ' 99' ' ' GLY . 3.4 pp -71.1 -32.27 68.84 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.149 0.98 . . . . 74.42 112.687 -170.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.53 ' N ' HD12 ' A' ' 98' ' ' LEU . . . -105.54 3.22 39.59 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-O 119.688 -0.506 . . . . 73.03 113.597 -171.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.565 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -136.93 -60.5 0.69 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.525 0.663 . . . . 70.42 112.072 -177.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.4 ' O ' HG12 ' A' ' 105' ' ' ILE . 0.0 OUTLIER -79.13 -34.82 42.98 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 112.166 0.432 . . . . 72.14 112.166 -174.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 70.9 m -64.55 -43.56 71.43 Favored Pre-proline 0 N--CA 1.491 1.611 0 CA-C-N 115.627 -0.715 . . . . 54.4 112.416 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -48.53 -45.09 28.36 Favored 'Trans proline' 0 C--N 1.391 2.811 0 C-N-CA 122.829 2.353 . . . . 63.32 113.322 163.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -64.52 -21.57 66.72 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.652 0.781 . . . . 72.24 112.03 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 101' ' ' TYR . 45.8 mm -74.85 -48.95 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 109.667 -0.494 . . . . 62.02 109.667 174.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.537 HD22 ' HG3' ' A' ' 80' ' ' GLN . 88.4 mt -75.94 -27.05 57.44 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.401 -0.818 . . . . 71.11 112.276 -174.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.514 ' HZ ' HD22 ' A' ' 128' ' ' LEU . 31.7 t80 -63.44 -43.76 79.95 Favored Pre-proline 0 CA--C 1.564 1.504 0 N-CA-C 113.817 1.043 . . . . 71.23 113.817 -169.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.63 -40.11 82.59 Favored 'Trans proline' 0 C--N 1.387 2.578 0 C-N-CA 122.207 1.938 . . . . 75.33 112.887 173.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -69.69 -40.98 76.02 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.497 0.719 . . . . 73.21 111.415 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.0 -36.04 74.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.425 0.69 . . . . 74.13 110.29 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.552 ' NH1' HD12 ' C' ' 105' ' ' ILE . 37.3 ttm180 -57.8 -55.78 30.44 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.093 0.871 . . . . 71.02 109.6 172.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -63.98 -41.06 97.65 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.024 -0.989 . . . . 75.34 111.73 -173.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 39.0 t -66.45 -30.94 71.41 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.798 0.439 . . . . 72.33 111.167 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 60.7 mt -72.85 -50.99 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.831 0.853 . . . . 62.21 109.857 172.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 63.7 m -57.99 -34.04 69.55 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.667 1.187 . . . . 72.45 111.509 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.8 t -67.35 -46.35 73.64 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 115.439 -0.801 . . . . 73.31 109.8 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.591 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 42.6 mtm -67.49 -36.15 80.53 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.876 0.47 . . . . 72.11 111.483 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.417 HG13 ' HB2' ' A' ' 123' ' ' PHE . 72.2 t -61.59 -46.85 95.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.369 0.668 . . . . 72.23 110.075 174.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 41.2 t -67.56 -36.35 80.77 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 115.428 -0.805 . . . . 53.03 111.118 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -72.96 -29.38 63.03 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.686 0.794 . . . . 75.14 109.891 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.55 10.51 61.64 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.869 0.73 . . . . 50.54 112.198 173.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.486 HG21 ' HE ' ' B' ' 15' ' ' ARG . 2.1 t 62.17 20.18 11.49 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.84 2.056 . . . . 64.42 113.266 170.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.417 ' HB2' HG13 ' A' ' 118' ' ' VAL . 87.3 m-85 -84.28 154.89 63.4 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 122.956 0.503 . . . . 72.21 109.65 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -53.16 159.63 5.42 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.461 2.774 . . . . 75.15 113.97 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.477 HE21 HG21 ' D' ' 122' ' ' THR . 6.5 tp-100 -62.03 125.53 24.18 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.627 -0.715 . . . . 43.24 111.435 -174.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.437 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 54.9 tp -130.27 113.11 14.0 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.779 1.231 . . . . 71.34 109.407 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -129.22 123.28 31.58 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.364 0.666 . . . . 73.21 109.562 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.514 HD22 ' HZ ' ' A' ' 107' ' ' PHE . 4.2 tt -73.8 127.85 33.92 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 108.333 -0.988 . . . . 64.3 108.333 175.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.593 ' HB3' ' HB2' ' E' ' 7' ' ' ALA . . . -65.51 137.26 96.44 Favored Pre-proline 0 CA--C 1.564 1.49 0 C-N-CA 123.067 0.547 . . . . 74.41 112.051 -174.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.471 ' HG2' ' CE1' ' C' ' 11' ' ' PHE . 36.8 Cg_exo -63.95 127.32 19.17 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.974 3.116 . . . . 54.31 113.429 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.5 t -117.47 114.78 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.04 0.936 . . . . 63.15 108.738 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -83.42 88.31 6.98 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.039 -0.726 . . . . 74.21 109.039 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -63.09 -44.22 96.33 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.279 -0.873 . . . . 52.53 110.506 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.565 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 18.6 p-10 -58.09 -41.82 84.31 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.165 1.386 . . . . 65.23 113.201 -170.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.12 96.61 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.246 0.618 . . . . 64.31 111.15 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.52 ' HB2' HD21 ' E' ' 10' ' ' LEU . 87.7 mt -76.38 -15.18 60.01 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.744 -0.662 . . . . 73.14 111.64 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -84.41 -26.52 28.26 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.63 0.372 . . . . 74.14 110.781 169.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 99.4 mmm -69.87 -28.75 65.91 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 110.019 -0.363 . . . . 64.14 110.019 170.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -59.18 -34.62 72.34 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.835 1.254 . . . . 75.34 110.576 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -94.29 -29.07 15.24 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.602 0.761 . . . . 74.4 111.89 177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 40.2 tp -63.54 -49.4 73.64 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.405 0.282 . . . . 74.0 110.675 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -164.5 27.1 0.07 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.521 0.729 . . . . 73.31 111.289 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 67.83 164.52 0.22 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.82 1.248 . . . . 73.43 112.483 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -100.2 101.6 12.67 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.44 0.696 . . . . 53.14 110.201 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.01 169.81 14.23 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.168 0.987 . . . . 75.41 109.498 173.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 100.63 60.71 0.81 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.16 -0.776 . . . . 70.03 111.16 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -75.85 100.64 4.85 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.196 -0.668 . . . . 73.25 109.196 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -90.11 146.0 18.46 Favored Glycine 0 C--N 1.338 0.662 0 N-CA-C 110.921 -0.872 . . . . 60.2 110.921 172.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.5 p -151.38 66.97 0.89 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.06 0.944 . . . . 74.32 108.681 174.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -78.08 87.34 4.21 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.949 -1.13 . . . . 73.11 107.949 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -92.36 157.76 16.45 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.236 1.015 . . . . 73.34 111.122 -170.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -147.0 90.27 1.88 Allowed 'General case' 0 C--O 1.241 0.605 0 C-N-CA 124.276 1.03 . . . . 70.33 108.482 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -75.42 101.84 4.95 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.48 -0.933 . . . . 63.11 108.48 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -174.51 153.88 1.96 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.389 1.076 . . . . 74.1 109.079 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 C-N-CA 124.024 0.93 . . . . 74.54 108.657 177.22 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 110.855 -0.054 . . . . 71.1 110.855 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.5 p -162.86 85.83 0.54 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.535 0.734 . . . . 75.44 109.578 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.65 132.91 35.31 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 108.199 -1.038 . . . . 61.42 108.199 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -74.77 77.69 2.08 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.191 0.596 . . . . 72.14 110.596 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -158.09 159.19 36.01 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.631 -1.248 . . . . 61.11 107.631 -175.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -66.5 89.28 0.14 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.036 0.534 . . . . 71.4 110.159 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -73.49 126.04 29.3 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.286 -0.87 . . . . 75.44 110.693 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 61.47 -84.13 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.22 1.408 . . . . 72.44 111.773 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.498 ' SD ' ' N ' ' B' ' 10' ' ' THR . 0.0 OUTLIER 63.49 166.84 0.14 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 125.603 1.561 . . . . 74.21 110.777 -173.329 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 99.9 m -157.87 125.26 5.14 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 106.187 -1.783 . . . . 74.21 106.187 170.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -138.53 125.33 21.0 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.181 -0.674 . . . . 73.41 109.181 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.482 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -148.3 137.7 22.09 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.315 -0.624 . . . . 74.43 109.315 174.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 48.6 mt -85.4 122.6 38.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.608 -0.886 . . . . 74.32 108.608 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . 0.514 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 12.4 mm100 -89.83 -43.51 10.59 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.677 0.791 . . . . 73.32 109.999 -175.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.486 ' HE ' HG21 ' A' ' 122' ' ' THR . 44.2 ttt180 -178.96 130.63 0.11 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.298 -0.631 . . . . 74.13 109.298 -173.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 77.4 mt -116.73 137.08 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 108.31 -0.996 . . . . 75.25 108.31 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -162.99 145.27 10.3 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.455 0.645 . . . . 75.12 111.182 -170.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.3 m -73.68 117.9 16.0 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.471 -1.24 . . . . 35.15 108.091 170.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.495 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 45.1 mtpt -92.78 -25.01 18.36 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.795 0.838 . . . . 63.3 111.354 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -163.45 147.35 10.6 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.528 0.518 . . . . 74.2 109.851 -172.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.437 HD11 ' SG ' ' B' ' 113' ' ' CYS . 28.4 mm -141.81 145.28 24.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 125.35 1.46 . . . . 72.32 108.427 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 44.2 t -144.01 141.08 29.93 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.727 -1.124 . . . . 72.14 108.387 167.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 81.5 t80 -147.75 126.69 12.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.279 -1.749 . . . . 74.51 106.279 171.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -135.3 116.6 14.55 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.147 -1.057 . . . . 63.43 108.147 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.574 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -106.35 86.48 2.13 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 107.593 -1.262 . . . . 64.54 107.593 174.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.12 -50.35 2.15 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.89 2.393 . . . . 52.5 111.946 -168.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -96.78 15.53 21.74 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.484 0.713 . . . . 72.35 111.191 -175.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.574 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -40.36 -65.06 0.48 Allowed Pre-proline 0 N--CA 1.491 1.602 0 C-N-CA 125.242 1.417 . . . . 53.14 114.575 -165.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.17 -25.54 72.68 Favored 'Trans proline' 0 C--N 1.392 2.821 0 C-N-CA 122.262 1.975 . . . . 62.11 113.92 -169.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -94.37 -41.66 9.3 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.138 0.575 . . . . 71.35 111.182 -175.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.89 -12.69 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 123.573 0.749 . . . . 73.32 111.685 -172.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -62.66 -14.3 41.94 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.569 0.748 . . . . 71.03 112.86 174.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.546 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.0 pt20 -60.79 -29.0 69.17 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.663 0.785 . . . . 73.33 110.98 172.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.546 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 96.3 mttt -93.66 108.46 20.19 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.91 1.284 . . . . 74.31 109.959 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -114.97 105.94 13.57 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.074 0.549 . . . . 73.12 110.427 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 21.6 p90 -165.82 -166.04 0.89 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.911 1.284 . . . . 74.33 108.121 169.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 -82.15 103.62 2.46 Favored Pre-proline 0 N--CA 1.477 0.914 0 N-CA-C 108.403 -0.962 . . . . 64.13 108.403 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.69 144.18 87.19 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.769 2.312 . . . . 61.45 113.126 -173.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.532 ' HB3' ' HA ' ' F' ' 3' ' ' GLN . 5.6 mp0 -55.42 103.36 0.09 Allowed 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.677 1.591 . . . . 70.32 110.311 172.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.435 HG22 HD21 ' B' ' 126' ' ' LEU . 20.3 t -85.62 155.18 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 115.182 -0.917 . . . . 71.13 109.118 -174.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.6 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 50.2 tttm -151.45 101.14 2.79 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.177 -1.786 . . . . 72.23 106.177 166.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.4 HD23 ' N ' ' B' ' 43' ' ' ASP . 7.8 tt -87.1 144.15 26.99 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.029 -1.471 . . . . 65.23 107.029 172.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.422 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 8.8 t70 -140.28 116.48 10.55 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 106.315 -1.735 . . . . 72.34 106.315 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 15.2 tp -98.13 127.89 44.33 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.182 -1.044 . . . . 73.11 108.182 -173.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -130.18 156.13 45.1 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.013 0.925 . . . . 64.34 109.136 -172.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 49.0 p -106.88 139.02 41.96 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.06 0.544 . . . . 60.21 111.131 -171.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.38 128.46 12.74 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 106.836 -1.542 . . . . 74.2 106.836 172.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.8 m -144.79 163.79 32.99 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.308 0.243 . . . . 71.11 111.16 -173.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 80.8 p -165.76 137.13 3.84 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.006 0.816 . . . . 63.15 110.049 167.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -94.72 108.82 20.82 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.093 -1.077 . . . . 71.14 108.093 171.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 35.3 mt -70.45 -53.49 16.16 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 121.643 0.735 . . . . 74.22 109.789 -175.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.89 -170.31 2.83 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.276 -1.329 . . . . 64.33 108.431 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -86.7 145.58 26.62 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.818 -1.179 . . . . 64.42 107.818 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 67.3 -2.44 1.25 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.815 1.246 . . . . 64.02 112.132 -172.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 45.9 t -126.45 116.75 46.3 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 C-N-CA 124.791 1.237 . . . . 74.4 108.0 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -127.11 139.25 53.11 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.019 -1.104 . . . . 74.02 108.019 175.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -105.51 105.65 15.78 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.628 -1.249 . . . . 74.53 107.628 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 75.1 t -94.94 124.35 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 124.938 1.295 . . . . 55.42 109.8 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.441 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 6.5 t -112.97 146.81 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.251 -1.018 . . . . 60.42 108.251 172.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 20.6 tp -125.4 111.41 15.1 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.258 -1.016 . . . . 65.03 108.258 169.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -87.83 112.23 22.24 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.13 -0.693 . . . . 72.35 109.13 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 60.9 t -104.69 104.02 16.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.7 -1.136 . . . . 73.23 108.049 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.422 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 27.0 m -94.92 136.38 35.3 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.114 -1.069 . . . . 55.31 108.114 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.518 HG21 HD13 ' B' ' 114' ' ' ILE . 95.0 t -127.85 130.7 70.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 124.096 0.958 . . . . 40.42 109.246 -175.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.6 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 53.5 m -121.53 139.65 53.22 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.899 -1.519 . . . . 64.01 106.899 168.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.05 136.72 30.48 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.668 -1.234 . . . . 63.25 107.668 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.501 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 3.7 m -139.08 145.5 39.59 Favored 'General case' 0 C--O 1.215 -0.726 0 N-CA-C 109.455 -0.572 . . . . 71.43 109.455 -168.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 42.6 mt -113.26 108.48 17.32 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.605 0.716 . . . . 72.15 109.487 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.12 -110.7 3.62 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 114.082 -1.417 . . . . 44.25 113.361 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.72 2.12 35.31 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.268 1.027 . . . . 74.34 110.489 -170.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -133.19 158.23 43.38 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.523 0.729 . . . . 72.1 109.701 -175.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 97.0 m -75.31 137.8 41.39 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.168 0.509 . . . . 72.4 110.081 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.501 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -93.35 -61.33 1.58 Allowed 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.458 1.103 . . . . 61.21 108.281 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -151.99 167.74 27.45 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 114.688 -1.142 . . . . 71.21 110.742 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 70.5 mt -133.87 138.0 45.33 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 106.008 -1.849 . . . . 73.12 106.008 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 47.1 t -138.4 159.17 42.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.869 -1.16 . . . . 74.42 107.869 175.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.466 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 40.5 tt0 -165.77 134.15 3.09 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.985 -0.746 . . . . 73.02 108.985 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.91 145.32 35.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.577 -0.897 . . . . 61.43 108.577 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -121.13 93.99 4.2 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.108 -1.071 . . . . 64.3 108.108 171.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.456 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -87.88 102.44 14.71 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.725 -0.843 . . . . 74.41 108.725 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.495 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.94 156.58 23.02 Favored Glycine 0 N--CA 1.449 -0.492 0 O-C-N 123.965 0.79 . . . . 54.23 111.305 175.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.96 126.35 1.66 Allowed Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 109.99 -1.244 . . . . 73.33 109.99 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.514 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 27.1 mt -85.67 130.1 36.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.626 -1.25 . . . . 62.35 107.626 176.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -133.83 134.23 42.55 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.36 -0.978 . . . . 74.3 108.36 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 74.1 m -92.99 110.43 21.9 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.101 -0.703 . . . . 54.51 109.101 172.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.574 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -124.81 132.71 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.623 1.169 . . . . 74.44 109.122 -178.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.3 172.29 18.75 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.209 0.604 . . . . 53.03 110.741 -172.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.42 -63.6 4.31 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.932 0.77 . . . . 62.35 112.408 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.593 HG22 ' HB3' ' B' ' 94' ' ' MET . 2.5 mm -68.8 157.84 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.474 1.11 . . . . 75.55 112.224 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.525 ' HB3' HH21 ' F' ' 22' ' ' ARG . 17.2 tp10 -160.06 153.5 22.29 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 115.118 -0.947 . . . . 74.21 110.777 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.76 -136.81 13.36 Favored Glycine 0 C--N 1.351 1.413 0 C-N-CA 124.297 0.951 . . . . 61.22 112.933 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 19.5 m -67.14 -27.68 67.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.542 0.737 . . . . 75.24 110.94 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.432 ' HB2' HG23 ' B' ' 89' ' ' ILE . 42.8 mt-30 -63.99 -39.77 94.86 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.689 -1.141 . . . . 74.32 110.965 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.593 ' HB3' HG22 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -88.17 -25.81 22.75 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.565 0.346 . . . . 72.34 110.82 177.379 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.65 -34.2 73.95 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.149 0.58 . . . . 60.44 110.954 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -78.86 -37.57 40.02 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.655 0.782 . . . . 64.02 111.034 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.5 t -62.71 -43.2 99.4 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.201 0.601 . . . . 44.53 111.49 -175.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.412 HD11 HG13 ' B' ' 86' ' ' ILE . 6.6 mp -90.58 -23.33 20.89 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.874 0.47 . . . . 72.34 111.112 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.06 -17.62 66.86 Favored Glycine 0 C--N 1.346 1.104 0 N-CA-C 114.358 0.503 . . . . 73.44 114.358 -174.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.19 -55.56 0.59 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.068 0.547 . . . . 71.33 110.97 -177.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -66.75 -53.31 34.59 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.436 0.902 . . . . 75.43 113.436 -166.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.516 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 76.0 m -60.13 -50.08 87.88 Favored Pre-proline 0 CA--C 1.564 1.504 0 CA-C-O 118.561 -0.733 . . . . 53.22 111.493 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.516 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 47.7 Cg_exo -60.33 -29.37 88.7 Favored 'Trans proline' 0 C--N 1.401 3.296 0 C-N-CA 122.4 2.067 . . . . 73.1 113.384 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -71.15 -30.99 67.16 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.578 0.751 . . . . 62.13 110.928 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.423 HG23 ' NH2' ' D' ' 111' ' ' ARG . 53.1 mt -66.87 -37.87 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 109.568 -0.53 . . . . 45.0 109.568 171.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 54.8 mt -84.18 -18.82 35.41 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.026 0.93 . . . . 62.03 112.1 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.421 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 85.7 t80 -57.86 -50.34 88.66 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-O 118.088 -0.958 . . . . 73.52 112.338 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.421 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 51.5 Cg_exo -57.89 -38.02 94.01 Favored 'Trans proline' 0 C--N 1.394 2.929 0 C-N-CA 122.401 2.067 . . . . 74.43 113.798 177.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.456 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 38.8 m-85 -68.12 -43.29 78.73 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.281 0.632 . . . . 74.03 110.576 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.449 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -64.8 -40.61 95.51 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.285 0.634 . . . . 73.24 110.427 175.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.497 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 37.9 ttt180 -57.41 -49.57 75.8 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.542 1.537 . . . . 75.11 111.402 -176.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.428 ' HG3' ' NH2' ' C' ' 120' ' ' ARG . 2.1 tm-20 -68.79 -34.6 75.83 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 123.84 0.712 . . . . 55.33 110.033 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.476 ' O ' ' HG2' ' B' ' 117' ' ' MET . 9.3 t -67.27 -33.63 75.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.99 0.516 . . . . 54.41 111.268 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.518 HD13 HG21 ' B' ' 64' ' ' VAL . 73.7 mt -67.69 -56.04 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 108.91 -0.774 . . . . 41.12 108.91 174.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.1 m -59.84 -26.54 65.89 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 124.336 1.023 . . . . 63.1 111.396 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 29.4 t -64.78 -50.55 66.33 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.273 0.629 . . . . 72.35 109.614 174.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.0 mmt -70.44 -31.21 68.3 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.08 0.552 . . . . 73.52 111.005 -176.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.49 HG23 ' O ' ' B' ' 114' ' ' ILE . 57.7 t -60.57 -47.77 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.487 0.715 . . . . 55.02 109.414 171.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 21.0 t -65.08 -34.62 78.85 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.546 -1.206 . . . . 75.41 111.191 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.423 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 92.6 mtt-85 -70.81 -31.95 68.86 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.986 -1.006 . . . . 75.42 110.384 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.56 5.66 76.96 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.944 0.778 . . . . 52.45 112.656 174.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.456 HG23 ' HB3' ' A' ' 17' ' ' TYR . 80.6 p 54.42 29.95 11.93 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 126.0 1.72 . . . . 62.25 113.015 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -91.02 159.87 38.97 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.264 0.625 . . . . 74.14 111.317 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -48.93 158.11 1.39 Allowed 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 123.732 2.955 . . . . 62.03 114.76 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -57.9 114.6 2.39 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.978 -1.01 . . . . 73.52 111.236 -176.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.435 HD21 HG22 ' B' ' 40' ' ' VAL . 0.3 OUTLIER -121.58 101.87 7.88 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.867 -1.16 . . . . 62.13 107.867 -178.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -119.23 133.99 55.45 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.726 0.811 . . . . 71.43 109.224 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.535 ' HA ' HD12 ' F' ' 6' ' ' ILE . 6.6 mp -75.42 144.97 41.92 Favored 'General case' 0 C--O 1.242 0.668 0 O-C-N 123.655 0.597 . . . . 71.23 109.956 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -70.76 134.14 86.18 Favored Pre-proline 0 CA--C 1.549 0.911 0 O-C-N 123.816 0.697 . . . . 50.53 111.093 -177.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 7.0 Cg_exo -72.47 104.81 1.77 Allowed 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.886 2.391 . . . . 71.42 111.692 176.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.525 HG21 ' HG ' ' F' ' 8' ' ' LEU . 34.1 m -110.99 139.95 32.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 123.327 0.651 . . . . 63.33 109.63 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -92.08 90.61 7.44 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 106.414 -1.699 . . . . 61.31 106.414 169.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -67.09 -32.0 72.86 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.946 -1.025 . . . . 63.33 111.289 -171.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -65.72 -37.76 87.3 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.941 0.896 . . . . 54.42 111.484 175.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' B' ' 138' ' ' MET . . . -63.48 -32.34 73.76 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.587 0.755 . . . . 71.52 111.668 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.435 ' HB3' HD11 ' F' ' 10' ' ' LEU . 89.5 mt -60.33 -35.2 75.09 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.779 0.832 . . . . 75.12 111.587 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -83.87 -39.07 20.34 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.362 0.665 . . . . 71.14 110.638 174.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.493 ' HB3' ' HA ' ' B' ' 135' ' ' ALA . 1.8 tmt? -62.12 -36.27 81.26 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.243 1.017 . . . . 62.01 111.968 -174.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.2 -24.31 59.34 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.267 0.627 . . . . 55.35 110.502 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -75.68 -35.42 60.36 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 122.681 0.392 . . . . 73.53 110.031 175.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 83.4 mt -87.51 -3.57 58.99 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 112.594 0.59 . . . . 65.24 112.594 -172.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . 0.49 HE22 ' HB3' ' D' ' 5' ' ' ASN . 57.3 tt0 -116.12 137.71 51.89 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.668 0.387 . . . . 72.02 110.609 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -73.1 118.14 15.68 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.457 -0.942 . . . . 64.33 108.457 167.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -74.76 124.53 26.96 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 122.897 0.479 . . . . 75.11 109.733 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -148.36 145.79 28.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.551 0.74 . . . . 73.25 109.533 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -141.89 -164.86 10.22 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.682 -0.567 . . . . 60.14 111.682 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.48 -167.98 1.91 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.527 0.731 . . . . 65.13 109.633 176.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.53 145.86 12.59 Favored Glycine 0 C--N 1.342 0.877 0 C-N-CA 121.727 -0.273 . . . . 71.22 112.523 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 21.2 m -67.87 136.22 53.73 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.384 0.674 . . . . 73.31 110.071 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -120.92 140.6 51.62 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.017 0.927 . . . . 71.42 110.035 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -142.8 172.27 12.92 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.701 0.8 . . . . 74.24 110.614 -176.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -154.43 140.41 18.3 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.648 0.779 . . . . 72.41 109.097 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -154.72 129.72 9.5 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.796 0.839 . . . . 42.34 109.017 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -126.26 110.54 13.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.199 0.999 . . . . 73.53 108.818 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 C-N-CA 123.551 0.74 . . . . 63.24 109.557 176.846 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tmm? . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 108.359 -0.978 . . . . 53.21 108.359 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 20.2 p -171.47 9.14 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.892 1.677 . . . . 72.3 109.69 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -80.61 149.89 29.7 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 124.349 1.059 . . . . 71.1 109.906 -169.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -89.24 -68.74 0.75 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.057 0.943 . . . . 70.14 108.467 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 63.4 t30 64.1 143.98 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.514 1.526 . . . . 75.11 113.05 173.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -81.69 159.48 23.92 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.849 0.459 . . . . 45.23 109.777 175.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 29.0 m -97.02 -72.34 0.64 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.786 -0.82 . . . . 63.44 108.786 173.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 49.28 -93.03 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.882 1.273 . . . . 62.04 110.87 -171.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.445 ' HG3' ' HB2' ' C' ' 11' ' ' PHE . 15.6 tpt 33.28 111.03 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 126.991 2.116 . . . . 74.12 115.141 174.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.597 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 19.9 m -86.24 92.91 8.92 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.975 -1.12 . . . . 75.51 107.975 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.652 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.3 t80 -121.31 135.66 55.07 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.959 -1.018 . . . . 72.03 110.406 -173.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.423 HE21 HE22 ' C' ' 14' ' ' GLN . 23.6 tt0 -155.31 126.43 7.15 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.839 -1.171 . . . . 74.24 107.839 175.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 88.4 mt -73.32 120.05 21.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.291 -1.003 . . . . 71.42 108.291 172.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.62 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 23.9 mm-40 -82.54 -42.64 18.11 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.208 -0.905 . . . . 71.11 109.6 -177.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -179.27 134.02 0.12 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.284 0.633 . . . . 75.32 110.345 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.8 mt -117.68 145.95 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.867 0.867 . . . . 74.44 108.855 175.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -174.65 158.02 2.65 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.276 0.631 . . . . 74.3 110.729 -174.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . 0.558 HG22 HE22 ' C' ' 80' ' ' GLN . 63.7 p -83.39 114.69 21.61 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.381 -0.97 . . . . 71.2 108.381 173.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -77.05 -47.06 21.62 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.736 -0.838 . . . . 74.12 108.736 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.662 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.0 t70 -133.97 137.84 45.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.336 -1.302 . . . . 64.54 109.572 -174.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 71.8 mt -136.81 144.52 32.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.021 -1.474 . . . . 72.03 107.021 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.1 t -161.82 150.66 15.61 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.976 0.417 . . . . 71.11 110.798 174.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -152.36 121.25 6.57 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 114.797 -1.092 . . . . 61.03 108.143 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -122.63 122.27 38.41 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.921 0.888 . . . . 74.11 110.451 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.09 83.01 34.71 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 107.73 -1.211 . . . . 65.4 107.73 168.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.43 -13.61 20.48 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.558 2.172 . . . . 74.55 111.764 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -103.01 14.59 31.58 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.9 1.28 . . . . 74.11 109.862 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.402 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -48.16 -53.52 32.76 Favored Pre-proline 0 C--N 1.37 1.48 0 C-N-CA 124.64 1.176 . . . . 73.01 113.55 -170.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 52.5 Cg_exo -54.59 -50.6 12.82 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 121.871 1.714 . . . . 72.12 112.828 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -68.57 -35.46 77.41 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.911 -1.041 . . . . 63.22 112.173 -172.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.728 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.0 p -78.59 -24.97 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 N-CA-C 113.182 0.808 . . . . 61.15 113.182 -172.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -67.13 -28.36 68.07 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.528 0.566 . . . . 75.14 112.528 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -86.92 5.16 38.44 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.128 0.571 . . . . 73.43 111.773 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.777 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -88.76 150.16 23.09 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.483 0.713 . . . . 73.31 110.369 178.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.25 124.07 19.88 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.292 0.637 . . . . 74.1 109.755 167.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -78.71 97.62 5.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.365 0.666 . . . . 74.32 111.211 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -153.6 78.16 5.69 Favored Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 108.605 -0.887 . . . . 71.2 108.605 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -90.45 149.66 4.36 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.013 2.475 . . . . 61.42 113.856 -176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -88.23 102.86 15.24 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 114.028 -1.442 . . . . 75.43 107.365 167.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -81.23 101.71 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.933 -0.576 . . . . 72.21 109.764 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.481 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 11.0 tmtt? -92.38 109.94 21.34 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.23 -1.396 . . . . 72.21 107.23 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.643 HD23 ' HB ' ' G' ' 6' ' ' ILE . 4.1 pp -85.14 161.69 19.54 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.585 -0.524 . . . . 73.42 109.585 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.612 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 12.5 t70 -147.19 134.41 20.55 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.674 -1.232 . . . . 65.43 107.674 171.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.557 HD12 HD21 ' G' ' 11' ' ' LEU . 1.7 tm? -128.79 111.24 12.9 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.104 -1.443 . . . . 74.13 107.104 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 21.6 t70 -123.54 152.68 41.55 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.022 0.929 . . . . 71.31 109.124 -177.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . 0.504 ' HB ' ' CD1' ' G' ' 15' ' ' PHE . 52.5 p -117.92 134.48 54.91 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.519 0.728 . . . . 63.24 111.458 -169.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.53 160.19 42.45 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.377 0.671 . . . . 51.21 110.471 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 72.8 m -160.03 170.93 20.27 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.422 0.689 . . . . 74.52 111.242 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 95.8 p -153.98 140.74 19.06 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.964 0.906 . . . . 62.32 108.934 166.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -86.43 121.43 28.97 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.2 -1.037 . . . . 64.1 108.2 173.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.601 HD11 HD12 ' C' ' 83' ' ' ILE . 53.6 mt -99.22 -30.38 12.29 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.472 0.709 . . . . 73.31 109.923 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.81 -174.39 2.72 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.453 1.101 . . . . 61.02 109.604 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -71.24 125.0 25.79 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.334 -0.987 . . . . 70.43 108.334 171.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 69.37 3.67 4.26 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.876 1.27 . . . . 74.32 113.204 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 96.3 t -117.69 110.64 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 107.892 -1.151 . . . . 44.42 107.892 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -134.34 137.57 44.26 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.537 0.735 . . . . 75.12 109.573 -173.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -86.69 120.93 28.52 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.949 -1.023 . . . . 65.44 109.748 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 55.2 t -96.7 115.39 36.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.818 -1.179 . . . . 64.31 107.818 168.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 64.0 t -112.93 136.26 49.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 N-CA-C 107.603 -1.258 . . . . 72.52 107.603 171.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.719 HD22 ' HB2' ' C' ' 103' ' ' PRO . 11.6 tp -126.73 118.36 24.56 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.619 -0.882 . . . . 70.33 108.619 172.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 14.2 ttm180 -81.79 115.66 21.11 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.567 -0.742 . . . . 71.44 109.212 176.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 24.9 t -110.5 116.56 52.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.537 -1.283 . . . . 45.23 107.537 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.612 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 17.9 m -128.86 115.52 18.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.424 0.63 . . . . 63.14 109.348 -174.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 84.4 t -108.07 116.04 50.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 124.817 1.247 . . . . 74.14 109.364 -177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 4.1 m -100.53 145.91 27.74 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.838 -1.171 . . . . 54.53 107.838 171.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.85 119.74 18.48 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.347 -1.353 . . . . 62.31 107.347 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -133.04 125.52 29.85 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.945 0.339 . . . . 51.25 110.361 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.777 HD13 ' HG2' ' C' ' 34' ' ' LYS . 9.0 mt -86.44 41.04 0.92 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.661 1.184 . . . . 54.03 109.776 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.2 -114.2 4.54 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 110.138 -1.185 . . . . 71.22 110.138 -169.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.29 -28.12 21.27 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.346 0.658 . . . . 70.51 109.928 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.94 118.05 9.19 Favored 'General case' 0 C--N 1.345 0.402 0 N-CA-C 108.923 -0.769 . . . . 64.33 108.923 171.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 29.4 m -81.19 121.92 26.75 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 108.06 -1.089 . . . . 64.3 108.06 167.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.728 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.5 -58.14 3.61 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.41 -0.959 . . . . 64.33 108.41 177.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -162.69 170.73 17.95 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 114.95 -1.023 . . . . 74.43 111.708 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.434 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -127.6 146.39 50.55 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 106.002 -1.851 . . . . 72.21 106.002 166.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.434 ' N ' HD13 ' C' ' 75' ' ' LEU . 46.2 t -147.31 130.17 16.19 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.984 -1.117 . . . . 65.23 107.984 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -136.33 117.84 14.82 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.428 -0.582 . . . . 72.34 109.428 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 77.4 t -120.03 122.4 68.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.45 -0.945 . . . . 70.44 108.45 170.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.662 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.3 mt-30 -103.42 94.25 5.39 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 108.023 -1.102 . . . . 70.44 108.023 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.558 HE22 HG22 ' C' ' 18' ' ' THR . 9.4 tp-100 -80.07 114.81 19.25 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.963 -1.017 . . . . 65.1 109.655 -176.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.22 146.12 18.14 Favored Glycine 0 C--N 1.34 0.779 0 O-C-N 123.826 0.704 . . . . 70.34 111.423 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.449 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.54 119.66 0.95 Allowed Glycine 0 CA--C 1.503 -0.697 0 N-CA-C 110.554 -1.019 . . . . 75.21 110.554 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.62 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 8.4 mm -85.37 126.74 40.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 108.287 -1.005 . . . . 73.42 108.287 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.652 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 69.7 m-85 -132.23 147.39 52.41 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.365 0.666 . . . . 63.32 109.883 -176.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 45.4 m -87.49 123.66 32.64 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.935 0.894 . . . . 62.2 109.352 171.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.52 HG12 HD21 ' C' ' 98' ' ' LEU . 4.4 mp -121.72 121.03 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 109.675 -0.491 . . . . 74.24 109.675 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.597 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -163.28 167.89 21.29 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.235 1.014 . . . . 53.22 109.903 173.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.67 -60.8 1.2 Allowed Glycine 0 N--CA 1.471 1.026 0 C-N-CA 123.137 0.399 . . . . 74.23 112.661 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 pt -96.06 150.9 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.658 0.783 . . . . 74.4 110.393 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -147.61 146.77 29.49 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.69 0.796 . . . . 75.42 109.555 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.36 -139.18 14.65 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 111.671 -0.571 . . . . 74.45 111.671 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 10.3 p -68.23 -21.35 64.85 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 113.477 0.917 . . . . 64.45 113.477 -174.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.23 -40.72 43.94 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 109.337 -0.616 . . . . 51.41 109.337 177.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.511 ' SD ' HD12 ' C' ' 98' ' ' LEU . 14.3 tmm? -65.48 -36.16 83.04 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.274 -0.876 . . . . 62.43 110.136 172.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' G' ' 21' ' ' ALA . . . -67.68 -34.72 77.48 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.995 0.918 . . . . 40.52 111.412 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -65.65 -40.99 93.08 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.697 -0.683 . . . . 73.01 110.224 173.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.495 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 43.0 t -63.34 -45.25 92.12 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.598 0.561 . . . . 73.53 110.412 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.68 HD13 ' HD2' ' G' ' 17' ' ' PRO . 75.2 mt -80.98 -51.99 7.92 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.135 0.574 . . . . 72.5 112.397 -175.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.75 11.12 65.17 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 115.081 0.792 . . . . 60.11 115.081 -169.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.35 -61.82 0.14 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.425 0.631 . . . . 51.4 110.813 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.495 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 35.0 t80 -75.2 -37.15 61.3 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 125.502 1.521 . . . . 63.54 113.735 -165.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 91.7 m -77.84 -44.12 2.38 Favored Pre-proline 0 N--CA 1.486 1.344 0 C-N-CA 123.252 0.621 . . . . 73.43 112.033 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.719 ' HB2' HD22 ' C' ' 60' ' ' LEU . 78.6 Cg_endo -75.57 -9.48 19.99 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 121.849 1.699 . . . . 73.05 112.344 172.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -68.08 -37.41 81.21 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.751 -0.833 . . . . 72.05 108.751 168.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.552 HD12 ' NH1' ' A' ' 111' ' ' ARG . 39.8 mm -59.38 -43.41 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 115.455 -0.793 . . . . 70.25 109.366 171.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.449 HD21 ' HA3' ' C' ' 82' ' ' GLY . 82.0 mt -81.92 -16.02 51.96 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.307 1.043 . . . . 75.21 112.913 -173.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -55.03 -53.93 55.88 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-O 118.257 -0.878 . . . . 74.3 112.63 -175.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.13 -30.62 65.36 Favored 'Trans proline' 0 C--N 1.388 2.635 0 C-N-CA 121.951 1.767 . . . . 64.11 113.508 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -67.57 -49.85 61.19 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.297 0.639 . . . . 54.35 110.539 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.18 -42.79 95.76 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.196 -0.911 . . . . 73.2 110.276 176.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -58.81 -52.66 64.76 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.173 1.389 . . . . 70.43 111.359 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -66.84 -37.1 83.83 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.738 0.649 . . . . 72.24 110.052 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 35.2 t -67.7 -32.62 73.39 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.332 0.395 . . . . 63.15 111.59 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 83.9 mt -72.54 -52.99 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.127 0.571 . . . . 65.55 110.23 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 12.3 m -65.01 -29.31 70.22 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.176 0.59 . . . . 72.13 111.321 -175.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 40.6 t -65.72 -49.7 67.52 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.077 -0.712 . . . . 64.45 109.077 173.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.689 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.75 -37.29 78.59 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.157 0.983 . . . . 72.2 112.39 179.257 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 83.0 t -60.74 -48.26 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.226 0.61 . . . . 75.24 110.035 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 26.5 t -72.39 -22.24 61.16 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 115.325 -0.852 . . . . 74.05 111.581 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.428 ' NH2' ' HG3' ' B' ' 112' ' ' GLU . 89.2 mtt-85 -73.93 -35.0 64.54 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.856 0.862 . . . . 72.35 109.705 174.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.05 7.65 70.16 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 115.457 -0.792 . . . . 75.41 112.086 171.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 64.7 p 60.02 26.68 16.01 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.415 1.886 . . . . 72.13 113.412 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -88.65 144.95 34.17 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 108.202 -1.036 . . . . 63.33 108.202 171.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -54.63 154.25 21.01 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 123.121 2.548 . . . . 71.12 113.505 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -54.68 124.33 16.04 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.901 1.28 . . . . 52.03 113.43 -171.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 40.1 tp -127.22 90.47 3.14 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.41 -0.959 . . . . 72.21 108.41 176.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -92.31 131.24 37.67 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.067 0.947 . . . . 63.12 109.545 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.72 134.16 46.07 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.172 0.589 . . . . 64.51 109.512 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.33 151.07 77.75 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 123.291 0.636 . . . . 61.01 110.978 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.74 110.67 2.39 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.892 2.395 . . . . 60.21 112.141 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.597 HG21 ' H ' ' G' ' 8' ' ' LEU . 39.6 t -105.38 111.61 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.256 0.622 . . . . 60.42 109.595 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -85.41 89.68 7.75 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.716 0.806 . . . . 73.24 110.438 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -59.63 -38.09 80.39 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 109.663 -0.495 . . . . 71.13 109.663 169.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.09 -51.21 67.09 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.259 1.424 . . . . 75.2 111.362 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.55 -30.84 67.68 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.869 0.868 . . . . 64.51 111.237 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.411 ' HA ' ' ND2' ' C' ' 139' ' ' ASN . 96.0 mt -67.65 -32.89 73.89 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.628 -0.715 . . . . 71.31 111.538 173.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -78.07 -25.38 47.65 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.996 0.518 . . . . 73.55 110.944 173.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 66.9 mtt -67.32 -27.95 67.59 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.755 0.422 . . . . 71.42 110.353 172.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . 0.411 ' ND2' ' HA ' ' C' ' 136' ' ' LEU . 95.0 m-20 -59.62 -44.59 93.4 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 123.448 0.699 . . . . 73.12 112.279 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -72.29 -165.74 0.21 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 119.154 0.888 . . . . 61.23 110.498 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 37.5 tp 64.53 -17.43 0.08 Allowed 'General case' 0 CA--C 1.577 1.986 0 C-N-CA 124.615 1.166 . . . . 63.24 114.004 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -156.53 -174.41 4.92 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.891 0.876 . . . . 70.14 110.44 -167.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . 0.579 ' HG3' ' HA ' ' A' ' 6' ' ' ASN . 10.5 pt20 -90.86 147.46 23.15 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.51 0.724 . . . . 55.24 109.681 174.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -122.82 112.79 18.31 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.809 -0.811 . . . . 74.53 108.809 -176.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -116.56 -176.05 2.89 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.781 0.832 . . . . 62.1 108.857 173.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -167.31 121.83 1.0 Allowed Glycine 0 C--N 1.335 0.495 0 N-CA-C 111.668 -0.573 . . . . 72.11 111.668 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -76.78 151.41 35.99 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.072 0.949 . . . . 73.44 110.115 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -95.05 166.84 26.18 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 116.455 -0.339 . . . . 34.41 112.48 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 4.5 t -66.89 114.99 6.16 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.432 0.693 . . . . 41.2 110.051 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -79.41 -27.42 41.8 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.279 1.031 . . . . 74.24 111.689 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 60.21 84.47 0.12 Allowed 'General case' 0 C--N 1.357 0.91 0 C-N-CA 124.225 1.01 . . . . 73.2 110.707 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -139.62 115.89 10.5 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 120.941 0.401 . . . . 75.23 111.38 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -131.61 135.35 46.89 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.539 1.136 . . . . 74.4 108.589 166.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -142.37 159.09 42.91 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.949 0.9 . . . . 64.0 109.438 175.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.883 0 N-CA-C 108.974 -0.75 . . . . 61.5 108.974 -177.016 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 119.88 -0.105 . . . . 72.41 111.018 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 36.9 m -144.04 170.68 15.47 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.897 0.479 . . . . 64.0 110.348 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -161.96 -174.64 4.24 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.418 1.087 . . . . 52.42 109.938 172.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -70.59 85.41 0.63 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.111 0.964 . . . . 63.43 110.688 -174.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . 0.49 ' HB3' HE22 ' B' ' 142' ' ' GLN . 52.2 t30 -85.56 85.46 7.42 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.508 -0.769 . . . . 63.22 109.046 175.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -128.23 23.19 6.03 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.238 1.015 . . . . 75.14 109.693 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.44 HG23 ' H ' ' D' ' 9' ' ' MET . 10.9 t -143.16 -170.97 3.38 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.281 1.032 . . . . 73.43 108.611 -174.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -83.12 24.84 0.75 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.571 0.749 . . . . 53.01 111.763 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.44 ' H ' HG23 ' D' ' 7' ' ' THR . 14.4 tpt -30.28 123.59 0.18 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.996 1.718 . . . . 75.11 113.331 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 65.1 m -123.95 142.26 51.31 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.071 -1.085 . . . . 72.23 108.071 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.751 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 20.8 t80 -164.79 90.63 0.53 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.673 -1.232 . . . . 63.41 107.673 -177.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -113.05 116.28 29.67 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.13 -1.433 . . . . 71.52 107.13 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.482 HG21 HD11 ' D' ' 16' ' ' ILE . 18.2 mt -68.75 123.26 21.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 109.331 -0.618 . . . . 61.34 109.331 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.529 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 21.0 mm-40 -83.01 -46.46 12.83 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 123.795 0.684 . . . . 53.02 109.687 175.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.409 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 27.7 ttt180 -178.5 141.08 0.21 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 116.603 -0.271 . . . . 75.2 111.706 -164.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.482 HD11 HG21 ' D' ' 13' ' ' ILE . 3.7 mp -122.97 142.0 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.464 -1.31 . . . . 63.12 107.464 172.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.409 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 26.3 p90 -165.46 174.48 9.95 Favored 'General case' 0 C--O 1.238 0.496 0 O-C-N 124.062 0.851 . . . . 72.51 111.187 -175.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 62.3 p -108.71 119.56 39.9 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 114.557 -1.202 . . . . 71.21 109.642 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -92.42 -19.13 22.37 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.378 0.671 . . . . 71.3 110.165 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.606 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 15.9 t70 -158.09 133.27 8.68 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.774 -1.103 . . . . 65.2 108.699 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.689 HG21 ' HE2' ' C' ' 117' ' ' MET . 68.8 mt -131.94 147.78 32.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 107.083 -1.451 . . . . 61.43 107.083 173.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -156.24 144.74 20.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 123.741 0.651 . . . . 54.31 110.114 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 87.4 t80 -148.17 122.05 9.36 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 105.346 -2.094 . . . . 63.24 105.346 173.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -133.38 110.8 10.27 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.061 0.544 . . . . 74.21 109.806 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.32 88.13 12.34 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 107.772 -1.195 . . . . 54.34 107.772 175.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -74.2 -39.85 1.47 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.907 2.405 . . . . 64.5 112.06 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -92.34 5.11 51.8 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.749 -1.114 . . . . 72.43 111.021 -176.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.506 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -30.04 -67.8 0.13 Allowed Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 116.459 2.022 . . . . 63.01 116.459 -164.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.42 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 93.5 Cg_endo -75.07 -23.91 13.22 Favored 'Trans proline' 0 C--N 1.374 1.909 0 CA-C-N 122.831 2.047 . . . . 73.33 113.119 -173.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -73.12 -39.21 65.93 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.932 0.893 . . . . 43.52 109.57 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.506 HG12 ' O ' ' D' ' 28' ' ' ALA . 4.8 p -83.03 -16.11 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-N 115.817 -0.628 . . . . 74.51 110.442 -173.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.42 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.1 m-85 -69.02 -22.82 64.04 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.524 0.33 . . . . 61.33 111.77 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -57.51 -27.04 62.22 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.587 0.755 . . . . 75.45 109.976 172.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -88.43 70.74 9.04 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.818 1.247 . . . . 65.23 109.198 172.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -79.71 87.64 5.22 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.72 -0.673 . . . . 73.4 109.714 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 18.6 p90 -163.29 174.82 11.56 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.337 1.055 . . . . 74.41 109.112 172.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.551 HE21 ' HD2' ' D' ' 38' ' ' PRO . 28.5 tp60 -68.45 115.98 35.37 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.62 0.768 . . . . 74.11 109.565 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.551 ' HD2' HE21 ' D' ' 37' ' ' GLN . 27.0 Cg_exo -63.18 151.87 82.59 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.709 2.273 . . . . 62.43 112.616 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -73.24 113.09 9.92 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.359 -1.349 . . . . 74.55 107.359 172.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.71 HG21 ' HG ' ' D' ' 126' ' ' LEU . 98.8 t -105.93 137.98 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 123.879 0.871 . . . . 73.25 109.739 -172.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -128.32 126.72 41.33 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.616 1.166 . . . . 62.34 108.131 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.49 HD22 HD23 ' D' ' 128' ' ' LEU . 45.2 tp -96.99 144.07 27.24 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.07 -0.715 . . . . 63.13 109.07 176.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.535 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 7.5 t70 -144.14 153.82 42.53 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.538 0.735 . . . . 75.32 109.081 176.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.6 mt -133.23 146.41 51.44 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.417 0.687 . . . . 74.11 111.108 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.653 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 5.8 t70 -135.58 155.18 50.88 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.919 1.287 . . . . 75.3 108.215 169.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . 0.433 HG23 ' CD1' ' H' ' 15' ' ' PHE . 97.7 m -101.39 140.48 35.63 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.94 0.896 . . . . 71.0 108.812 -176.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' D' ' 152' ' ' HIS . . . -166.91 142.56 4.29 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.222 -1.029 . . . . 53.01 108.222 175.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.8 p -176.36 162.44 2.38 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.941 0.496 . . . . 72.4 110.425 -176.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 77.5 p -153.77 150.16 28.2 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.647 0.379 . . . . 75.54 110.936 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -88.14 119.61 28.7 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.72 -0.844 . . . . 73.12 108.72 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' D' ' 57' ' ' GLU . 23.2 mt -94.72 -31.81 13.62 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.793 0.437 . . . . 73.13 111.161 -175.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -161.27 -175.72 5.0 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.739 0.816 . . . . 74.33 110.602 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.07 109.83 3.16 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.771 -1.104 . . . . 75.44 109.389 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 66.89 6.91 4.93 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.588 1.155 . . . . 64.2 112.677 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 64.1 t -110.91 120.55 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 107.427 -1.323 . . . . 73.25 107.427 175.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -140.85 131.7 25.91 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 122.917 0.487 . . . . 73.41 110.008 -165.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.456 ' HB2' HD11 ' D' ' 51' ' ' LEU . 15.9 tt0 -92.72 135.0 34.49 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.793 0.837 . . . . 73.11 110.5 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 98.0 t -117.5 128.75 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.163 1.385 . . . . 72.52 108.39 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 29.1 t -125.58 130.93 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.408 0.683 . . . . 64.2 109.594 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.495 HD23 HD12 ' D' ' 106' ' ' LEU . 4.6 mm? -117.81 121.09 39.87 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.087 -0.708 . . . . 45.33 109.087 172.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.653 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 41.2 ttm-85 -83.2 96.4 8.43 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.513 -1.291 . . . . 61.2 107.513 172.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.487 HG13 HD11 ' D' ' 42' ' ' LEU . 88.3 t -90.34 128.16 42.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.009 -1.108 . . . . 71.31 108.009 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 29.8 m -125.68 139.63 53.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.878 -0.416 . . . . 60.44 109.878 -176.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.688 HG13 HG13 ' D' ' 40' ' ' VAL . 17.8 t -128.61 102.01 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.441 1.096 . . . . 74.51 108.556 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 17.6 m -93.31 112.53 24.48 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.478 -0.934 . . . . 72.34 108.478 173.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.07 141.16 48.49 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.657 0.783 . . . . 62.11 109.186 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.435 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 59.8 p -148.8 127.02 12.12 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 123.52 0.513 . . . . 74.41 111.236 -177.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 28.8 mt -94.16 115.51 27.81 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 124.423 1.089 . . . . 73.22 109.076 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.65 -111.75 3.58 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 111.495 -0.642 . . . . 72.43 111.495 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.97 12.14 10.4 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.702 0.801 . . . . 72.05 110.863 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -131.56 165.21 24.13 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.849 0.459 . . . . 73.5 109.965 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -65.63 131.25 45.88 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.762 0.825 . . . . 71.25 111.961 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.435 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -90.97 -68.38 0.79 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.83 -1.174 . . . . 51.24 107.83 171.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -151.17 153.55 35.18 Favored 'General case' 0 C--N 1.353 0.72 0 CA-C-N 115.757 -0.656 . . . . 71.32 111.003 175.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 46.5 mt -118.97 110.56 17.27 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 106.773 -1.566 . . . . 54.44 106.773 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . . . . . . . . . 45.9 t -126.11 105.93 9.22 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 122.943 0.497 . . . . 54.24 109.972 -170.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -122.73 128.99 51.25 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.442 0.697 . . . . 70.43 109.701 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 25.6 t -126.96 121.19 57.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 123.419 0.688 . . . . 74.42 109.696 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.606 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.7 mt-30 -87.35 87.36 7.4 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.149 -1.056 . . . . 53.23 108.149 167.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -81.85 110.6 17.3 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.01 -1.45 . . . . 73.42 108.719 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.79 153.23 17.23 Favored Glycine 0 C--N 1.341 0.859 0 O-C-N 123.545 0.528 . . . . 73.13 111.842 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.8 130.87 2.88 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 111.578 -0.609 . . . . 73.51 111.578 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 22.2 mt -89.4 136.41 23.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 C-N-CA 123.801 0.84 . . . . 75.31 108.949 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -137.85 128.49 26.72 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.351 0.661 . . . . 74.23 110.26 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.1 m -78.78 98.36 6.26 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.638 0.775 . . . . 33.32 109.287 168.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 10.2 pt -115.37 139.66 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.397 1.079 . . . . 72.3 110.302 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.65 167.91 20.56 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.877 0.471 . . . . 60.31 111.048 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.56 17.35 79.98 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.954 -0.566 . . . . 65.02 113.308 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 8.4 mt -110.99 147.05 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.081 0.952 . . . . 73.21 108.832 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.42 165.31 27.13 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.687 0.795 . . . . 73.04 110.127 177.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.99 -142.17 46.62 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.168 0.917 . . . . 30.12 115.073 173.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 20.3 m -76.33 -16.25 59.8 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.93 0.892 . . . . 74.13 111.694 -172.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -68.1 -22.36 64.91 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.617 0.367 . . . . 54.44 110.764 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 92.1 mtp -64.02 -35.68 81.51 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.365 0.666 . . . . 54.1 110.432 172.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.71 -26.36 57.45 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.472 -0.786 . . . . 72.32 110.92 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -74.97 -40.35 60.78 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.812 0.445 . . . . 74.45 110.804 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -56.29 -46.79 79.61 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.422 0.689 . . . . 71.13 110.033 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 47.7 mt -87.23 -20.33 27.07 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.627 -1.169 . . . . 63.41 111.566 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.35 1.89 56.12 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-O 119.489 -0.617 . . . . 44.3 114.04 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.464 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -146.12 -67.82 0.28 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 117.585 0.692 . . . . 43.33 111.713 -178.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -71.51 -38.43 71.12 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.716 0.636 . . . . 75.22 112.716 -170.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.751 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 76.3 m -68.23 -49.66 32.67 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 118.706 -0.664 . . . . 63.33 111.556 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -58.7 -29.44 89.49 Favored 'Trans proline' 0 C--N 1.401 3.308 0 C-N-CA 122.63 2.22 . . . . 51.14 113.139 170.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -63.36 -35.67 81.17 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.681 0.793 . . . . 54.23 110.575 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.8 mm -68.91 -38.09 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.626 0.77 . . . . 74.54 110.351 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.495 HD12 HD23 ' D' ' 60' ' ' LEU . 87.7 mt -81.75 -21.7 37.71 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.534 0.734 . . . . 73.13 112.576 -172.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -62.44 -46.71 89.83 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-O 118.425 -0.798 . . . . 62.11 113.121 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.14 -39.15 93.04 Favored 'Trans proline' 0 C--N 1.391 2.768 0 C-N-CA 122.348 2.032 . . . . 70.23 113.262 174.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -73.97 -36.85 64.62 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.582 0.753 . . . . 65.54 111.707 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.81 -49.25 71.4 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.661 -0.496 . . . . 54.34 109.661 176.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.423 ' NH2' HG23 ' B' ' 105' ' ' ILE . 38.9 ttp180 -58.78 -45.68 89.27 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 124.432 1.082 . . . . 74.13 110.312 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -61.08 -52.73 63.67 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.841 0.713 . . . . 65.23 110.881 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.6 t -56.42 -44.61 80.53 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 123.882 0.738 . . . . 65.42 110.925 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.498 ' O ' HG23 ' D' ' 118' ' ' VAL . 67.8 mt -61.39 -55.67 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.198 0.999 . . . . 70.12 110.69 175.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.403 HG23 ' HG3' ' D' ' 125' ' ' GLN . 92.5 m -58.77 -36.19 73.99 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.141 0.976 . . . . 64.54 111.501 -173.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 40.8 t -67.87 -43.69 78.82 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.375 -0.83 . . . . 74.32 109.794 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.6 mtm -70.02 -27.56 64.77 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.761 0.424 . . . . 71.43 111.841 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.498 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.3 t -64.52 -49.31 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.303 0.641 . . . . 61.21 109.509 174.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.6 p -69.04 -32.51 72.06 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.797 -0.638 . . . . 53.13 110.899 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.4 mtt-85 -68.39 -37.61 80.53 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.924 0.89 . . . . 71.34 110.246 174.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.91 0.97 87.81 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 115.738 -0.664 . . . . 63.11 112.259 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.477 HG21 HE21 ' A' ' 125' ' ' GLN . 30.7 p 63.07 26.79 15.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.7 2.0 . . . . 74.15 113.104 172.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -87.44 152.63 52.57 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 109.239 -0.652 . . . . 74.33 109.239 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.94 124.51 15.68 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.931 2.421 . . . . 54.12 112.341 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.403 ' HG3' HG23 ' D' ' 115' ' ' THR . 35.2 tt0 -55.42 146.7 19.12 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.633 1.173 . . . . 70.01 112.251 -174.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.71 ' HG ' HG21 ' D' ' 40' ' ' VAL . 3.2 tm? -143.58 117.14 9.17 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.138 -1.06 . . . . 73.24 108.138 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -109.9 118.88 37.65 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.415 -0.958 . . . . 74.1 108.415 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.546 ' HA ' HD12 ' H' ' 6' ' ' ILE . 6.5 mp -66.73 128.17 35.26 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.781 0.833 . . . . 72.22 110.428 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -67.97 133.74 91.94 Favored Pre-proline 0 CA--C 1.552 1.026 0 O-C-N 123.842 0.714 . . . . 63.42 110.931 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 14.8 Cg_exo -68.83 130.38 20.4 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.902 2.401 . . . . 72.42 112.373 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 29.4 m -116.25 142.0 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.909 0.884 . . . . 73.43 109.897 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -92.97 72.34 4.73 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 122.11 0.957 . . . . 75.25 108.597 173.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.424 ' HD1' ' H ' ' D' ' 133' ' ' PHE . 4.8 p90 -73.31 -23.48 60.27 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.353 -1.294 . . . . 72.23 110.645 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' D' ' 138' ' ' MET . 2.8 m-20 -48.42 -51.29 27.44 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.724 1.209 . . . . 75.34 111.046 174.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.22 -46.61 86.18 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 124.279 0.987 . . . . 75.51 111.248 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 49.3 tp -57.9 -40.29 79.96 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.17 0.918 . . . . 75.13 111.156 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.506 ' O ' HD13 ' D' ' 141' ' ' LEU . 14.2 m-85 -60.29 -47.94 83.85 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 115.554 -0.748 . . . . 72.11 110.826 173.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 41.6 mtt -58.55 -48.65 80.18 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 123.272 0.358 . . . . 74.42 110.748 -175.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -54.15 -40.48 67.47 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 124.308 1.005 . . . . 73.44 111.558 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -76.75 -43.66 36.23 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.972 -0.558 . . . . 74.31 111.162 -177.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.506 HD13 ' O ' ' D' ' 137' ' ' PHE . 5.2 mp -65.18 -42.51 93.55 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.33 1.052 . . . . 72.12 111.688 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -75.44 -1.57 24.67 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.759 -0.655 . . . . 70.51 111.864 -172.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -128.94 43.62 3.11 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 123.481 0.713 . . . . 73.11 109.485 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -177.0 153.46 1.0 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.109 0.964 . . . . 64.34 110.513 171.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.74 8.35 45.05 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.366 0.667 . . . . 73.33 110.506 171.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.3 79.16 0.79 Allowed Glycine 0 C--N 1.353 1.481 0 C-N-CA 123.489 0.566 . . . . 61.42 112.642 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -88.9 85.05 6.65 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.153 0.981 . . . . 71.1 108.439 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -93.85 162.49 25.27 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.519 -0.764 . . . . 35.22 111.945 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 9.5 t -164.58 153.26 12.76 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.576 0.75 . . . . 74.31 110.433 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -113.18 143.15 44.88 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.097 0.559 . . . . 74.22 109.495 174.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -92.52 99.25 12.01 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 106.643 -1.614 . . . . 73.44 106.643 173.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . 0.438 ' O ' ' HA ' ' D' ' 47' ' ' ALA . 58.1 t-80 -146.15 114.75 6.8 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.375 -0.972 . . . . 52.22 108.375 -175.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -130.2 21.02 5.29 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.138 0.575 . . . . 73.43 111.733 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.19 88.47 0.62 Allowed 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 109.291 -0.633 . . . . 64.13 109.291 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.503 0 C-N-CA 124.645 1.178 . . . . 74.14 109.397 -177.606 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 110.062 -0.348 . . . . 70.13 110.062 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -141.79 154.41 45.2 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.752 0.821 . . . . 72.34 110.11 173.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -134.12 177.79 7.47 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.124 0.97 . . . . 72.01 109.447 173.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 41.9 p -143.83 136.73 27.4 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.127 0.571 . . . . 74.34 109.94 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 92.0 m -75.28 152.92 38.19 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.541 0.736 . . . . 74.2 109.536 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.46 HG12 HD21 ' A' ' 42' ' ' LEU . 11.7 tt -52.14 132.99 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 C-N-CA 125.374 1.47 . . . . 62.33 112.766 -176.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 7' ' ' ALA . . . . . 0.593 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . . . -147.97 162.5 39.21 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.016 0.926 . . . . 74.21 110.522 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.613 HD22 HD21 ' A' ' 44' ' ' LEU . 76.6 mt -81.61 -179.72 7.49 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.599 0.76 . . . . 75.2 110.848 174.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -135.84 175.1 9.9 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.333 1.053 . . . . 74.13 108.758 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . 0.52 HD21 ' HB2' ' A' ' 136' ' ' LEU . 90.0 mt -56.11 129.93 42.02 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.193 0.597 . . . . 72.21 110.639 177.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' E' ' 12' ' ' PRO . 72.4 mt -62.71 109.1 2.05 Favored Pre-proline 0 CA--C 1.549 0.937 0 O-C-N 124.335 1.022 . . . . 71.22 109.303 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 12' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' E' ' 11' ' ' LEU . 6.0 Cg_exo -77.96 68.03 7.89 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 123.786 2.991 . . . . 72.14 111.85 -172.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 6.3 tt -175.91 -49.69 0.01 OUTLIER 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.421 -1.326 . . . . 65.24 107.421 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 61.6 tp 60.03 89.38 0.07 Allowed 'General case' 0 C--N 1.36 1.062 0 O-C-N 124.622 1.201 . . . . 74.15 109.042 -170.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -68.59 136.35 52.9 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.924 -0.58 . . . . 74.1 110.582 -172.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 16' ' ' THR . . . . . 0.474 HG22 HD11 ' A' ' 98' ' ' LEU . 7.5 p -132.86 81.77 57.31 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.176 0.991 . . . . 75.43 109.266 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 17' ' ' PRO . . . . . 0.524 ' HD2' HD13 ' A' ' 98' ' ' LEU . 84.1 Cg_endo -78.87 -23.84 7.63 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.946 2.431 . . . . 71.53 112.999 -176.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 65.4 t -82.8 143.94 11.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 123.64 0.776 . . . . 71.31 109.319 -176.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 35.0 p -68.21 151.54 46.81 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.867 0.867 . . . . 63.55 110.577 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? 68.13 16.14 9.43 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.707 1.203 . . . . 73.24 112.714 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.9 51.29 1.94 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.187 0.595 . . . . 53.12 110.083 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -60.37 128.49 36.95 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.195 0.998 . . . . 73.13 110.59 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 24.4 p -116.44 82.83 12.54 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.14 0.576 . . . . 64.21 110.359 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.92 105.16 2.03 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.579 2.186 . . . . 44.31 111.612 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 . . . . . 0 C--O 1.251 1.163 0 C-N-CA 123.682 0.793 . . . . 62.11 109.368 176.312 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 58.1 mtm . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 109.801 -0.444 . . . . 71.24 109.801 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.37 -56.52 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.635 -0.876 . . . . 72.41 108.635 176.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 3' ' ' GLN . . . . . 0.532 ' HA ' ' HB3' ' B' ' 39' ' ' GLU . 34.9 tt0 81.07 106.61 0.07 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.7 1.6 . . . . 71.13 110.745 -172.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 32.3 t -166.43 -175.03 3.06 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.917 1.287 . . . . 73.11 108.227 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 25.1 m -139.9 107.55 5.62 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.686 -0.857 . . . . 70.42 108.686 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.584 HG22 ' H ' ' F' ' 7' ' ' ALA . 7.3 mm 57.48 -149.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 124.829 1.251 . . . . 75.33 108.5 -176.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 7' ' ' ALA . . . . . 0.584 ' H ' HG22 ' F' ' 6' ' ' ILE . . . -169.4 -92.0 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.63 1.105 . . . . 53.15 109.685 174.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . 0.525 ' HG ' HG21 ' B' ' 131' ' ' VAL . 4.1 mm? 57.02 108.67 0.01 OUTLIER 'General case' 0 C--N 1.363 1.183 0 C-N-CA 124.974 1.309 . . . . 64.11 112.425 -174.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.82 142.41 50.69 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.983 0.913 . . . . 64.14 108.757 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 10' ' ' LEU . . . . . 0.435 HD11 ' HB3' ' B' ' 136' ' ' LEU . 6.3 mp -61.65 117.05 5.29 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.832 -1.173 . . . . 63.1 107.832 174.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 8.6 mp -47.07 108.84 0.93 Allowed Pre-proline 0 CA--C 1.557 1.226 0 O-C-N 125.002 1.439 . . . . 72.2 111.461 -172.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.4 -28.72 26.65 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 122.806 2.337 . . . . 63.25 112.028 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 7.3 mp -82.15 -8.05 59.64 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.993 0.917 . . . . 75.0 109.966 173.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 94.5 mt 61.61 -168.58 0.18 Allowed 'General case' 0 C--N 1.359 0.99 0 C-N-CA 124.77 1.228 . . . . 63.12 110.177 -168.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -112.28 139.84 47.49 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.335 -0.987 . . . . 65.15 108.335 174.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 25.7 p -66.63 108.62 2.5 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.524 0.73 . . . . 64.43 109.092 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 17' ' ' PRO . . . . . 0.506 ' HB2' ' SD ' ' B' ' 94' ' ' MET . 33.4 Cg_endo -86.14 -169.92 0.62 Allowed 'Trans proline' 0 C--N 1.364 1.381 0 C-N-CA 122.84 2.36 . . . . 73.43 112.309 -170.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.04 135.96 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.44 -0.578 . . . . 70.22 109.44 177.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 35.4 m -79.22 104.2 9.68 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.125 -1.065 . . . . 71.23 108.125 170.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 93.7 mttt 56.07 79.68 0.16 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.363 1.065 . . . . 63.2 111.359 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.71 52.85 2.0 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.697 0.799 . . . . 73.14 110.485 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . 0.525 HH21 ' HB3' ' B' ' 90' ' ' GLU . 97.9 mtt180 -143.41 -59.45 0.41 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.945 0.898 . . . . 63.53 109.777 -176.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 23' ' ' THR . . . . . 0.401 ' HA ' ' HD2' ' F' ' 24' ' ' PRO . 52.6 p -117.36 113.24 38.96 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.167 0.587 . . . . 65.14 110.55 -173.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 24' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' F' ' 23' ' ' THR . 18.0 Cg_endo -61.72 82.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 122.969 2.446 . . . . 71.32 111.909 165.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 . . . . . 0 C--O 1.254 1.314 0 C-N-CA 123.853 0.861 . . . . 74.1 108.74 -176.748 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 109.951 -0.389 . . . . 72.53 109.951 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -128.13 117.76 22.17 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.175 -0.676 . . . . 62.42 109.175 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -88.74 61.86 6.19 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 122.015 0.912 . . . . 73.33 108.859 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 52.0 m -152.0 157.15 41.31 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.335 -0.848 . . . . 72.11 109.559 -175.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 25.5 m -63.08 111.23 2.1 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.946 0.779 . . . . 70.22 109.812 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . 0.643 ' HB ' HD23 ' C' ' 42' ' ' LEU 0.278 38.8 pt 51.91 -73.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 127.087 2.155 . . . . 75.03 114.309 178.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 7' ' ' ALA . . . . . 0.534 ' H ' HG13 ' G' ' 6' ' ' ILE . . . 67.72 123.63 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.219 1.408 . . . . 50.51 112.657 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 8' ' ' LEU . . . . . 0.597 ' H ' HG21 ' C' ' 131' ' ' VAL . 29.3 mt -71.99 174.83 6.5 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.213 1.005 . . . . 62.24 110.803 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.52 169.65 11.67 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.822 0.849 . . . . 70.13 110.14 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 45.0 mt -68.78 162.67 25.81 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.624 0.726 . . . . 64.43 111.091 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 11' ' ' LEU . . . . . 0.557 HD21 HD12 ' C' ' 44' ' ' LEU . 34.8 mt -97.35 137.31 21.14 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 114.359 -1.291 . . . . 63.22 109.38 -175.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.86 -46.77 24.17 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 123.258 2.638 . . . . 61.44 111.485 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mp -96.88 142.15 29.21 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 106.906 -1.516 . . . . 73.52 106.906 168.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 mp -75.06 8.82 2.3 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.977 0.732 . . . . 52.44 112.977 -171.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . 0.504 ' CD1' ' HB ' ' C' ' 46' ' ' THR . 93.8 t80 58.62 92.0 0.04 OUTLIER 'General case' 0 C--N 1.36 1.065 0 C-N-CA 124.559 1.144 . . . . 75.24 110.511 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 16' ' ' THR . . . . . 0.616 HG21 ' HB3' ' G' ' 21' ' ' ALA . 7.3 p -141.42 87.36 10.48 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 122.562 0.345 . . . . 75.11 111.54 -175.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 17' ' ' PRO . . . . . 0.68 ' HD2' HD13 ' C' ' 98' ' ' LEU . 57.1 Cg_endo -71.74 -20.85 25.88 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.742 2.294 . . . . 71.5 113.208 172.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 18' ' ' VAL . . . . . 0.408 HG21 HG21 ' C' ' 86' ' ' ILE . 93.6 t -65.4 -64.41 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.067 0.547 . . . . 64.42 110.727 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 31.7 p -122.48 -98.12 0.44 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.953 -1.129 . . . . 72.34 107.953 171.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 82.3 tttt 176.5 84.73 0.01 OUTLIER 'General case' 0 C--N 1.352 0.687 0 N-CA-C 107.647 -1.242 . . . . 64.3 107.647 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . 0.616 ' HB3' HG21 ' G' ' 16' ' ' THR . . . -91.57 119.27 31.34 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 122.925 0.49 . . . . 62.14 110.051 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 22' ' ' ARG . . . . . 0.422 ' HG2' ' N ' ' G' ' 23' ' ' THR . 66.7 ttt-85 -172.28 173.9 4.08 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.427 1.491 . . . . 73.54 107.503 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 23' ' ' THR . . . . . 0.422 ' N ' ' HG2' ' G' ' 22' ' ' ARG . 39.2 p -70.71 144.73 91.37 Favored Pre-proline 0 CA--C 1.556 1.182 0 N-CA-C 109.091 -0.707 . . . . 64.21 109.091 164.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.8 -0.63 8.68 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.755 2.303 . . . . 72.0 113.215 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 CA--C 1.555 1.147 0 C-N-CA 124.62 1.168 . . . . 64.54 108.675 -178.984 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 74.0 mtp . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 121.212 0.53 . . . . 62.23 110.298 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -127.68 69.11 1.31 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 106.141 -1.8 . . . . 63.53 106.141 167.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -57.54 -38.22 74.36 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 114.038 -1.437 . . . . 71.3 111.58 -170.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 16.1 m 61.69 -163.38 0.26 Allowed 'General case' 0 C--N 1.353 0.721 0 CA-C-N 114.793 -1.094 . . . . 71.24 110.342 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 98.5 m -63.76 -58.26 7.39 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 109.591 -0.522 . . . . 70.32 109.591 168.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' D' ' 128' ' ' LEU . 6.8 pt -149.03 84.69 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 124.293 1.037 . . . . 43.32 109.814 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -154.86 141.73 19.13 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.188 0.595 . . . . 41.21 110.668 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 8' ' ' LEU . . . . . 0.441 HD23 HD21 ' D' ' 42' ' ' LEU . 57.8 mt -75.65 -57.72 3.71 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.05 -0.722 . . . . 71.31 109.05 177.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . 64.74 -74.19 0.05 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.645 1.578 . . . . 64.22 112.525 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tt -152.69 134.61 14.76 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.63 -1.248 . . . . 72.31 107.63 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.24 152.78 95.76 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 124.083 0.953 . . . . 75.24 111.204 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.71 -28.02 86.33 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.187 2.591 . . . . 74.33 112.852 -176.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 13' ' ' LEU . . . . . 0.461 HD13 ' N ' ' H' ' 14' ' ' LEU . 2.6 tm? -152.17 150.47 29.88 Favored 'General case' 0 C--O 1.245 0.867 0 N-CA-C 106.293 -1.743 . . . . 71.32 106.293 176.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . 0.461 ' N ' HD13 ' H' ' 13' ' ' LEU . 94.9 mt -54.29 120.29 6.34 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.331 -0.618 . . . . 64.43 109.331 176.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . 0.433 ' CD1' HG23 ' D' ' 46' ' ' THR . 32.9 t80 -49.03 -89.23 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.156 0 O-C-N 125.133 1.52 . . . . 53.3 112.314 -164.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 21.3 p -156.89 155.03 27.81 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 124.281 1.032 . . . . 73.32 109.194 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 17' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' H' ' 21' ' ' ALA . 53.1 Cg_endo -90.49 168.1 4.12 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 122.881 2.387 . . . . 75.12 109.733 163.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 t -81.09 -9.31 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 121.84 -0.537 . . . . 74.25 109.825 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -56.69 -68.64 0.2 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.543 1.537 . . . . 53.03 112.152 -170.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -122.49 -64.6 1.18 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.033 -1.099 . . . . 74.45 108.033 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' H' ' 17' ' ' PRO . . . 64.96 14.92 9.65 Favored 'General case' 0 C--N 1.362 1.111 0 CA-C-N 114.338 -1.301 . . . . 72.34 112.76 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -163.89 159.94 21.55 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 123.972 0.909 . . . . 75.43 109.366 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 23' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' H' ' 24' ' ' PRO . 64.0 p -62.9 128.77 92.53 Favored Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 108.873 -0.788 . . . . 70.15 108.873 165.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 24' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' H' ' 23' ' ' THR . 21.7 Cg_exo -65.2 -3.26 7.05 Favored 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 123.407 2.738 . . . . 74.32 115.671 -165.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 CA--C 1.55 0.943 0 C-N-CA 123.709 0.804 . . . . 70.03 109.7 -177.761 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 mmt . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 110.134 -0.321 . . . . 73.41 110.134 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 m 63.79 -77.69 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.792 1.237 . . . . 62.42 109.507 -168.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -86.83 166.12 15.44 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.197 0.999 . . . . 75.22 111.174 173.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.465 HE22 ' HB3' ' A' ' 142' ' ' GLN . 28.5 pt20 -147.91 -3.93 0.5 Allowed 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 114.505 -1.225 . . . . 71.14 109.875 171.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -114.55 160.87 18.77 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.963 1.305 . . . . 75.42 109.32 -175.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -125.86 -85.75 0.62 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.377 0.671 . . . . 72.54 110.163 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.8 m -158.56 109.08 2.08 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.175 0.59 . . . . 74.31 110.319 -173.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.475 ' HG3' HD12 ' A' ' 89' ' ' ILE . 53.7 mm-40 -137.57 163.13 31.95 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.639 1.175 . . . . 73.05 109.578 175.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.7 ttm 69.95 172.67 0.3 Allowed 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.803 1.241 . . . . 61.42 110.666 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.7 m -136.59 113.45 10.36 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.013 -1.106 . . . . 75.44 108.013 175.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.736 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 2.9 t80 -96.45 134.89 39.07 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.969 -1.014 . . . . 74.44 109.478 -174.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -145.48 114.59 7.01 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.477 -0.935 . . . . 74.14 108.477 176.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.612 HG12 ' HD2' ' A' ' 84' ' ' PHE . 47.7 mt -90.29 129.62 40.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.649 -0.871 . . . . 74.4 108.649 174.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -87.88 -41.79 12.97 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.818 -0.628 . . . . 73.21 110.133 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -175.93 129.46 0.24 Allowed 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.18 0.3 . . . . 65.12 111.197 -170.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.46 HD11 HD13 ' A' ' 13' ' ' ILE . 97.3 mt -121.61 139.9 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 123.653 0.781 . . . . 75.33 108.985 177.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.514 ' HB3' HG23 ' B' ' 122' ' ' THR . 35.0 p90 -169.92 177.18 4.46 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.02 0.928 . . . . 74.42 110.597 -169.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.0 p -102.33 121.19 41.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.284 -1.006 . . . . 64.41 108.284 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 33.8 mtpt -83.15 -44.08 15.48 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.639 -0.875 . . . . 72.31 108.639 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 21.9 t70 -135.59 134.8 39.72 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.19 -1.368 . . . . 51.33 108.921 -175.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.421 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 80.9 mt -135.14 142.44 39.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.148 -1.427 . . . . 73.25 107.148 178.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -154.17 115.16 4.04 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.095 0.474 . . . . 64.25 110.535 172.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.636 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 75.4 t80 -110.22 138.91 45.95 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 106.838 -1.542 . . . . 64.51 106.838 170.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -138.3 140.62 39.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.227 -1.027 . . . . 74.32 108.227 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.88 78.61 35.44 Favored Pre-proline 0 C--O 1.238 0.48 0 N-CA-C 107.314 -1.365 . . . . 53.42 107.314 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.93 -28.1 36.12 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.968 2.445 . . . . 71.13 112.293 -170.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -114.49 28.8 8.48 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.945 0.898 . . . . 70.11 109.591 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.472 ' HB3' ' HZ2' ' B' ' 19' ' ' LYS . . . -47.29 -52.38 35.97 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.03 0.932 . . . . 72.35 113.422 -178.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HG3' ' HZ1' ' B' ' 19' ' ' LYS . 15.1 Cg_exo -63.74 -21.74 69.68 Favored 'Trans proline' 0 C--N 1.39 2.751 0 CA-C-N 121.413 1.541 . . . . 61.2 112.751 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.446 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 4.6 m-70 -94.9 -32.93 13.0 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 124.123 0.969 . . . . 63.41 110.788 -174.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.492 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.5 p -76.32 -16.87 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 112.724 0.639 . . . . 73.45 112.724 -163.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -77.72 -32.58 52.96 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.027 0.531 . . . . 74.15 112.0 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -75.91 -18.62 59.31 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.821 0.449 . . . . 71.21 110.721 174.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 14.5 mmmm -75.29 148.02 39.72 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.61 0.764 . . . . 64.13 111.749 -175.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.06 127.64 32.91 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 124.238 0.961 . . . . 61.42 109.424 171.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -78.98 86.06 4.87 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.529 0.68 . . . . 72.34 110.358 -177.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -136.53 78.59 43.57 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.014 1.325 . . . . 72.14 107.907 176.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -86.45 171.4 7.48 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.448 2.099 . . . . 64.53 113.61 -174.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -115.96 101.08 8.44 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 107.095 -1.446 . . . . 72.42 107.095 170.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -77.59 93.94 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.935 0.874 . . . . 65.44 111.081 -172.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.545 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 8.4 mtpm? -82.63 114.28 20.9 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.196 -1.038 . . . . 74.02 108.196 173.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.538 HD13 ' H ' ' E' ' 9' ' ' ALA . 0.5 OUTLIER -123.83 107.94 11.94 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.711 0.767 . . . . 74.12 109.847 -174.715 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.449 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.2 m-20 -114.01 136.61 52.72 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.61 -1.177 . . . . 74.13 109.42 -174.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.15 142.17 46.57 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.437 -0.949 . . . . 60.33 108.437 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.682 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 5.9 t70 -147.11 127.6 14.09 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.537 -0.542 . . . . 74.25 109.537 -169.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 64.1 p -105.78 126.96 52.78 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.455 0.702 . . . . 52.45 110.886 -168.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.571 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -133.03 141.84 48.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.726 0.81 . . . . 53.45 109.438 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.3 m -132.61 154.98 49.52 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.378 0.671 . . . . 70.21 110.668 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.6 t -153.78 139.59 18.07 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.595 0.758 . . . . 62.05 109.565 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -96.67 120.53 37.17 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.879 -0.785 . . . . 64.22 108.879 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.723 HD11 ' HB2' ' A' ' 57' ' ' GLU . 25.8 mt -107.27 -35.81 6.71 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.553 0.741 . . . . 75.23 110.336 -172.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.544 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -156.71 -176.88 6.22 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.368 1.067 . . . . 71.14 109.687 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -71.75 116.12 11.75 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.68 0.792 . . . . 71.14 109.956 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 70.12 0.22 3.04 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.79 1.236 . . . . 71.04 112.235 -176.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 58.9 t -111.26 112.43 40.5 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 108.247 -1.02 . . . . 73.34 108.247 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -124.84 173.32 8.68 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.438 1.095 . . . . 71.43 108.972 -173.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.723 ' HB2' HD11 ' A' ' 51' ' ' LEU . 41.3 tt0 -127.17 127.79 45.09 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.195 0.598 . . . . 74.14 109.513 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.428 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 84.3 t -105.44 122.56 58.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.761 -1.2 . . . . 65.2 107.761 170.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 46.1 t -116.78 138.57 46.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 N-CA-C 108.139 -1.06 . . . . 72.31 108.139 174.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.8 tp -127.31 118.08 23.5 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.26 -0.644 . . . . 72.23 109.26 174.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.682 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 16.9 ttm-85 -85.18 102.37 13.25 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.448 -0.945 . . . . 63.23 108.448 173.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.5 t -95.1 108.68 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 108.559 -0.904 . . . . 72.25 108.559 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 26.8 m -95.46 124.77 39.66 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.623 0.769 . . . . 34.45 108.993 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.9 t -124.74 107.41 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.197 -1.038 . . . . 62.4 108.197 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 18.3 m -108.12 136.16 48.27 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.515 -0.92 . . . . 63.11 108.515 175.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.12 110.99 20.36 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.29 -1.374 . . . . 72.43 107.29 172.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.9 m -115.31 124.33 51.03 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.598 0.359 . . . . 73.3 110.09 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.4 mt -90.64 84.71 5.93 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.285 -1.006 . . . . 62.34 108.285 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.86 -83.44 0.93 Allowed Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.85 -0.5 . . . . 53.43 111.85 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -125.01 -29.16 3.37 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.861 0.864 . . . . 72.23 109.203 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -77.93 109.94 12.41 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.284 -0.636 . . . . 71.33 109.284 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.8 m -69.53 122.9 19.96 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 110.234 -0.284 . . . . 72.02 110.234 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.492 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -69.03 -61.25 1.87 Allowed 'General case' 0 C--O 1.24 0.596 0 O-C-N 123.843 0.714 . . . . 51.15 110.271 176.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.437 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 26.8 p90 -160.41 172.83 16.58 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.076 -0.965 . . . . 74.32 111.966 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.2 tp -131.41 138.23 49.0 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.984 -1.462 . . . . 62.13 107.497 173.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.429 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 86.1 m -139.12 97.66 3.35 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.28 -1.007 . . . . 73.14 108.28 176.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -120.09 117.23 27.43 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.281 -1.007 . . . . 71.52 108.281 -175.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.0 t -129.31 113.54 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 123.932 0.893 . . . . 42.31 109.867 -170.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.485 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 70.5 mt-30 -84.44 89.01 7.32 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 108.322 -0.992 . . . . 63.32 108.322 170.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.522 ' HG3' HD22 ' A' ' 106' ' ' LEU . 9.5 tp-100 -77.0 103.08 6.73 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.002 -0.999 . . . . 75.53 109.079 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.71 145.83 19.0 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.978 -0.555 . . . . 74.55 111.811 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.416 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.19 123.16 1.46 Allowed Glycine 0 CA--C 1.503 -0.7 0 N-CA-C 110.731 -0.948 . . . . 64.24 110.731 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.446 HG23 HD12 ' A' ' 51' ' ' LEU . 55.5 mt -83.46 121.02 35.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.865 -0.791 . . . . 64.23 108.865 176.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.736 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 23.5 m-85 -134.26 130.13 36.65 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.337 0.655 . . . . 70.23 109.675 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.9 t -99.61 113.93 26.65 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.612 -0.884 . . . . 61.13 108.612 173.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -139.21 120.36 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 C-N-CA 123.96 0.904 . . . . 62.15 110.787 -175.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.54 160.11 10.7 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.202 1.001 . . . . 64.1 110.301 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 145.17 -85.04 0.18 Allowed Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.467 -0.788 . . . . 34.54 112.407 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.475 HD12 ' HG3' ' A' ' 8' ' ' GLU . 9.0 tt -80.98 -40.49 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 112.514 0.561 . . . . 64.42 112.514 -168.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 67.58 -166.68 0.2 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.078 0.951 . . . . 73.51 110.946 -172.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.34 -135.77 22.78 Favored Glycine 0 C--N 1.353 1.477 0 C-N-CA 122.915 0.293 . . . . 72.01 113.694 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.5 p -68.76 -37.56 79.44 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.172 0.989 . . . . 32.24 111.759 -174.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -63.19 -42.7 99.39 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.82 0.848 . . . . 73.14 111.534 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 18.6 ttt -77.18 -34.78 56.27 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 116.6 -0.273 . . . . 73.43 110.522 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.47 -35.13 79.42 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.156 0.582 . . . . 73.44 110.314 172.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.557 ' NE2' ' HB2' ' A' ' 134' ' ' ASP . 26.9 t-80 -68.31 -44.43 75.45 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.219 1.008 . . . . 72.5 110.352 174.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.642 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 83.4 m -64.22 -44.78 90.85 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.369 0.667 . . . . 71.2 111.555 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.59 -50.86 11.67 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.668 0.787 . . . . 65.54 111.735 -173.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.4 5.08 67.42 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-O 119.186 -0.786 . . . . 72.55 114.759 -169.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.497 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -149.72 -51.8 0.15 Allowed 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.582 1.191 . . . . 52.22 113.48 -175.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.642 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 88.0 t80 -75.59 -49.23 19.17 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.826 0.851 . . . . 71.31 112.248 -168.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 99.3 m -69.65 -36.26 6.56 Favored Pre-proline 0 CA--C 1.563 1.478 0 CA-C-O 118.897 -0.573 . . . . 75.3 112.256 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -48.63 -42.43 35.98 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 122.504 2.136 . . . . 63.32 113.839 160.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.611 HD21 ' H ' ' A' ' 134' ' ' ASP . 84.0 m-20 -64.15 -34.44 78.08 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 123.537 0.735 . . . . 72.1 111.553 176.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.6 mm -66.02 -40.39 87.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 N-CA-C 109.587 -0.523 . . . . 74.13 109.587 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.522 HD22 ' HG3' ' A' ' 80' ' ' GLN . 96.5 mt -79.0 -22.44 45.52 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.755 0.822 . . . . 41.42 112.254 -178.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -58.14 -48.83 96.36 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 113.914 1.079 . . . . 62.5 113.914 -172.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -63.1 -39.83 37.11 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 122.111 1.874 . . . . 63.34 112.812 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -69.3 -40.75 77.51 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.298 0.639 . . . . 74.02 111.281 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.23 -40.63 70.97 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.071 0.548 . . . . 43.43 110.367 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.472 HH12 HD12 ' C' ' 105' ' ' ILE . 23.7 ttm180 -49.91 -51.99 36.57 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.01 0.924 . . . . 71.03 110.205 171.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -71.48 -37.54 71.3 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.006 -0.997 . . . . 54.31 111.64 -173.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.8 t -66.06 -32.66 74.25 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 121.061 0.457 . . . . 62.23 110.916 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 93.0 mt -69.18 -54.51 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 115.255 -0.884 . . . . 65.32 109.432 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.466 HG21 ' HE2' ' C' ' 109' ' ' TYR . 95.2 m -51.79 -40.6 60.66 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.994 1.317 . . . . 64.03 112.278 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.9 t -64.12 -47.6 79.36 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 115.249 -0.887 . . . . 73.34 110.656 -177.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.636 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 39.6 mtm -67.84 -36.07 79.69 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.807 0.692 . . . . 74.12 111.373 -178.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.9 -51.47 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 123.677 0.791 . . . . 74.14 110.254 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.5 t -69.46 -29.45 67.13 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.43 -0.804 . . . . 43.13 111.5 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.0 ttm-85 -77.93 -28.82 49.73 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.988 0.915 . . . . 71.51 109.2 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.425 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.96 12.65 59.33 Favored Glycine 0 C--N 1.351 1.411 0 CA-C-N 114.933 -1.03 . . . . 63.23 112.648 170.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.521 HG21 ' HE ' ' B' ' 15' ' ' ARG . 2.0 t 60.66 18.51 8.54 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 126.89 2.076 . . . . 70.35 113.523 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -77.93 158.39 77.79 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 123.938 0.895 . . . . 73.34 110.951 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.46 143.38 77.86 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.831 2.354 . . . . 64.32 112.995 173.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.414 HE21 HG21 ' D' ' 122' ' ' THR . 5.4 tp-100 -53.73 127.74 26.9 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.674 1.19 . . . . 72.13 112.183 -175.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.437 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 43.5 tp -126.92 101.37 6.55 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.048 0.939 . . . . 64.4 109.45 -177.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.429 ' ND2' ' H ' ' C' ' 16' ' ' ILE . 91.4 m-20 -123.34 102.11 7.73 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.605 -0.887 . . . . 53.21 108.605 175.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.62 144.62 56.29 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.985 0.514 . . . . 70.0 109.687 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' E' ' 7' ' ' ALA . . . -68.41 151.25 97.34 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 123.833 0.853 . . . . 41.33 111.845 -173.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.489 ' HD3' HG13 ' C' ' 13' ' ' ILE . 52.1 Cg_endo -68.97 114.63 3.64 Favored 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 123.094 2.53 . . . . 73.24 113.111 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.1 m -111.61 112.68 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 108.184 -1.043 . . . . 63.44 108.184 165.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -81.61 93.61 6.76 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.63 -1.248 . . . . 70.4 107.63 175.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 137' ' ' PHE . 79.9 m-85 -49.52 -37.72 27.83 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.242 1.017 . . . . 60.4 111.634 -175.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.611 ' H ' HD21 ' A' ' 104' ' ' ASN . 5.4 p-10 -75.49 -39.54 58.43 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.784 0.834 . . . . 74.2 111.855 -172.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.27 -42.06 93.58 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.523 0.729 . . . . 63.11 111.008 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.21 -26.17 47.35 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.322 -0.854 . . . . 53.42 110.565 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 133' ' ' PHE . 9.5 t80 -75.06 -38.5 61.35 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.165 0.586 . . . . 74.13 109.565 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.569 ' HB3' ' HB3' ' A' ' 144' ' ' GLN . 34.6 mmt -76.12 -27.23 57.01 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.397 0.679 . . . . 75.33 110.272 177.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -63.78 -44.98 91.78 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.832 0.853 . . . . 73.54 109.053 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -65.15 -37.7 88.23 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.356 0.662 . . . . 74.34 110.757 172.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 138' ' ' MET . 0.2 OUTLIER -64.8 -50.68 65.77 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.105 0.962 . . . . 73.45 110.465 -171.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.465 ' HB3' HE22 ' A' ' 4' ' ' GLN . 6.2 tp-100 -166.39 28.65 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.791 -0.641 . . . . 71.32 110.391 -170.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 56.5 33.29 22.3 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.155 0.982 . . . . 74.14 111.73 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.569 ' HB3' ' HB3' ' A' ' 138' ' ' MET . 0.6 OUTLIER -80.62 91.09 5.78 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.283 -1.377 . . . . 73.44 107.283 173.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -175.38 168.34 3.29 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.758 1.223 . . . . 30.14 109.62 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 109.82 128.28 5.51 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 116.11 -0.495 . . . . 71.53 112.077 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -118.74 175.73 5.6 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.304 1.041 . . . . 72.53 109.03 171.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 152.4 76.81 0.02 OUTLIER Glycine 0 C--N 1.345 1.071 0 C-N-CA 121.757 -0.259 . . . . 64.02 113.088 174.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.42 ' H ' ' NE2' ' C' ' 93' ' ' GLN . 65.4 p -105.3 116.7 32.39 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.937 -0.764 . . . . 53.14 108.937 170.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -100.39 103.54 14.93 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.097 0.959 . . . . 65.3 108.497 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -122.03 116.41 24.23 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.727 0.811 . . . . 73.31 109.721 -175.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -128.43 120.4 26.83 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.903 0.881 . . . . 75.51 109.431 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.503 ' H ' ' HD3' ' G' ' 20' ' ' LYS . 16.6 mm100 -126.67 98.83 5.54 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.6 -1.259 . . . . 72.3 107.6 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -63.14 121.8 14.53 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.455 0.702 . . . . 74.41 110.864 -175.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 O-C-N 124.112 0.882 . . . . 64.41 110.468 178.616 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.912 0.387 . . . . 74.21 110.353 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 41.0 t -131.03 127.19 37.76 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.43 1.092 . . . . 71.01 109.216 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -117.78 28.62 8.31 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.788 0.835 . . . . 75.2 109.736 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -59.28 132.83 55.19 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.553 0.741 . . . . 64.33 110.121 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -58.7 100.35 0.06 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.746 0.818 . . . . 71.43 110.864 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -69.19 146.65 52.23 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.495 -0.775 . . . . 75.45 109.692 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.7 t -105.2 175.5 5.47 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.149 0.98 . . . . 75.03 110.323 -176.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 74.97 -61.41 0.49 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 126.118 1.767 . . . . 73.2 112.033 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 25.2 ttt 66.18 175.79 0.23 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.396 1.078 . . . . 74.23 110.262 -174.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 61.6 m -133.27 129.35 37.51 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.285 -1.376 . . . . 73.31 107.285 168.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.525 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 42.7 t80 -129.35 126.61 39.3 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.799 -1.185 . . . . 75.04 107.799 175.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.527 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -144.53 126.43 15.36 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.271 -0.64 . . . . 73.34 109.271 178.337 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 27.9 mt -74.8 121.51 26.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.562 -0.903 . . . . 74.3 108.562 172.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -92.06 -50.06 5.88 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.248 -0.649 . . . . 70.52 109.248 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.521 ' HE ' HG21 ' A' ' 122' ' ' THR . 45.8 ttt180 -166.52 131.16 2.14 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.727 -0.67 . . . . 70.02 110.209 -175.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 75.6 mt -114.68 137.18 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 108.029 -1.1 . . . . 73.3 108.029 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.406 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 39.2 p90 -169.87 161.79 9.12 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.442 0.639 . . . . 75.21 111.5 -176.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.525 HG21 HD11 ' B' ' 21' ' ' ILE . 42.7 m -83.17 130.63 35.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.771 -1.104 . . . . 73.33 109.249 170.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.472 ' HZ2' ' HB3' ' A' ' 28' ' ' ALA . 24.0 mtpp -96.51 -34.22 11.56 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.261 0.625 . . . . 55.11 109.851 176.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -147.72 145.45 28.86 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.084 0.469 . . . . 73.14 111.177 -173.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.578 HD11 ' SG ' ' B' ' 113' ' ' CYS . 40.3 mm -136.35 146.5 28.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 126.047 1.739 . . . . 72.3 108.708 177.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.502 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 36.7 t -150.9 133.32 15.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.558 -1.201 . . . . 71.03 108.324 171.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 74.0 t80 -141.07 135.99 31.54 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.098 -1.445 . . . . 75.1 107.098 172.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -141.51 128.48 20.68 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.218 1.007 . . . . 75.12 108.666 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -130.17 80.95 69.8 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 107.018 -1.475 . . . . 63.51 107.018 174.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.82 -26.73 31.96 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.142 2.561 . . . . 72.01 113.152 -171.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 74.9 m-20 -115.11 18.73 16.13 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.674 0.79 . . . . 73.54 110.047 -177.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.501 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -45.86 -59.17 5.02 Favored Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 125.06 1.344 . . . . 74.52 114.129 -170.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.413 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 23.8 Cg_exo -61.43 -28.49 83.89 Favored 'Trans proline' 0 C--N 1.393 2.89 0 C-N-CA 122.233 1.955 . . . . 74.3 113.346 -169.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.437 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 78.1 m80 -93.96 -38.21 11.29 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.702 -0.681 . . . . 72.23 111.404 -175.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.502 HG22 HD12 ' B' ' 68' ' ' LEU . 4.5 p -67.88 -16.74 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.129 0.572 . . . . 62.1 111.757 -173.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -65.11 -21.03 66.74 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.222 0.823 . . . . 74.23 113.222 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 10.3 pt20 -68.28 -15.27 63.5 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.308 0.643 . . . . 61.02 111.179 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.41 ' HB2' HD13 ' B' ' 68' ' ' LEU . 89.6 mttt -95.27 105.71 17.68 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.597 1.159 . . . . 64.44 109.791 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -110.72 93.08 4.31 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.09 0.556 . . . . 72.53 109.829 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 39.7 p90 -162.65 179.7 7.52 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.716 1.206 . . . . 75.5 108.411 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -69.05 114.71 25.26 Favored Pre-proline 0 N--CA 1.477 0.915 0 N-CA-C 109.578 -0.527 . . . . 73.53 109.578 177.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.485 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 43.2 Cg_endo -65.72 139.11 56.4 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 121.901 1.734 . . . . 63.52 111.027 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -66.45 103.68 1.09 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.561 -0.903 . . . . 73.15 108.561 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.565 HG11 HD21 ' B' ' 126' ' ' LEU . 31.2 m -99.83 160.82 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 115.41 -0.813 . . . . 62.24 111.815 -172.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -145.04 133.59 22.01 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.67 -1.15 . . . . 65.34 108.524 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 pp -86.7 164.98 16.44 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 123.038 0.535 . . . . 74.23 110.15 175.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.595 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 17.5 t70 -164.72 126.31 2.15 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.072 -0.967 . . . . 75.13 108.545 175.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.431 HD23 HD21 ' B' ' 60' ' ' LEU . 5.5 mp -123.04 134.15 54.3 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.576 0.75 . . . . 70.21 109.073 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.669 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 10.9 t70 -131.32 133.65 45.55 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.845 0.858 . . . . 63.22 108.758 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' F' ' 15' ' ' PHE . 17.9 p -106.37 102.02 11.45 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.244 0.618 . . . . 64.32 109.678 -175.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.474 ' O ' ' HB ' ' B' ' 59' ' ' VAL . . . -119.85 114.21 21.75 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 107.111 -1.44 . . . . 65.22 107.111 174.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 52.6 m -144.77 161.06 40.17 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.385 -0.598 . . . . 72.21 109.385 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 76.1 p -164.73 150.17 9.95 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.906 0.482 . . . . 71.01 110.445 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -82.24 129.5 34.86 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.205 0.602 . . . . 71.25 109.65 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' B' ' 57' ' ' GLU . 20.7 mt -91.07 -49.97 6.11 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.796 0.839 . . . . 71.2 109.971 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.03 -173.49 4.18 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.193 -0.912 . . . . 61.42 110.224 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -65.65 120.73 13.48 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.947 -1.024 . . . . 75.42 109.313 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 68.17 9.2 7.05 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.115 1.366 . . . . 64.11 111.773 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -120.92 109.36 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.048 0.939 . . . . 74.12 109.21 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -119.48 149.04 42.54 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.505 1.122 . . . . 73.52 108.443 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.448 ' HB2' HD11 ' B' ' 51' ' ' LEU . 40.3 tt0 -118.76 122.08 41.58 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.925 0.49 . . . . 73.54 109.78 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 61.9 t -100.93 118.91 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 108.375 -0.972 . . . . 65.41 108.375 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' B' ' 47' ' ' ALA . 21.4 t -118.67 130.82 72.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 107.646 -1.242 . . . . 65.55 107.646 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.431 HD21 HD23 ' B' ' 44' ' ' LEU . 14.2 tp -123.32 124.59 43.31 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 110.128 -0.323 . . . . 65.34 110.128 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.669 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 39.0 ttm180 -87.31 113.5 23.08 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.864 0.865 . . . . 43.13 109.001 173.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 43.1 t -104.88 101.32 12.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.475 -1.306 . . . . 70.03 107.475 173.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.595 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 18.1 m -103.06 132.36 49.38 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.569 0.748 . . . . 75.54 109.065 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 89.6 t -123.24 127.02 74.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 124.773 1.229 . . . . 73.02 108.825 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.1 m -103.98 148.08 26.62 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.822 -0.807 . . . . 65.01 108.822 169.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.485 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -148.53 140.14 23.6 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.544 0.738 . . . . 72.32 109.563 176.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.504 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 35.3 p -143.98 137.7 27.91 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 123.635 0.584 . . . . 73.23 110.826 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.502 HD12 HG22 ' B' ' 31' ' ' VAL . 67.4 mt -110.52 110.82 21.69 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.043 -1.095 . . . . 63.41 108.043 174.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.55 -129.93 10.29 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 123.245 0.34 . . . . 44.24 113.056 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -96.61 16.44 18.86 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.683 0.793 . . . . 61.0 111.919 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.459 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.2 pt-20 -142.06 152.81 43.69 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.699 0.399 . . . . 72.33 110.952 -175.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 58.2 m -64.94 132.65 49.9 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 123.636 0.585 . . . . 43.2 110.136 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.504 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -85.44 -66.64 0.88 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.14 -1.43 . . . . 74.31 107.14 171.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -149.21 159.55 44.15 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 122.01 0.91 . . . . 74.12 112.178 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 71.3 mt -131.45 113.1 13.3 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 105.946 -1.872 . . . . 74.31 105.946 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.576 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 48.3 t -118.9 147.83 43.57 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.739 -0.837 . . . . 74.03 108.739 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.502 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 40.0 tt0 -155.9 128.67 7.91 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.92 -0.77 . . . . 72.3 108.92 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 96.1 t -130.36 145.83 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.789 0.836 . . . . 52.24 108.947 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -122.29 101.21 7.38 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.23 -1.026 . . . . 65.22 108.23 172.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -91.25 104.62 17.14 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.079 -0.711 . . . . 74.11 109.079 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.5 142.91 16.27 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.507 -0.769 . . . . 70.44 111.643 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.42 124.0 2.92 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 109.875 -1.29 . . . . 74.43 109.875 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 53.1 mt -86.26 128.61 39.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.957 -1.127 . . . . 71.44 107.957 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -137.44 134.91 36.38 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.816 0.847 . . . . 74.41 109.001 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 74.3 m -91.11 108.34 19.81 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.597 -0.52 . . . . 72.14 109.597 171.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.674 HD13 HD21 ' B' ' 98' ' ' LEU . 48.4 pt -121.9 143.67 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.41 1.084 . . . . 72.33 110.586 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.8 152.04 22.64 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.185 0.594 . . . . 73.25 110.771 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.95 -69.59 0.23 Allowed Glycine 0 C--N 1.347 1.18 0 O-C-N 123.429 0.455 . . . . 44.22 112.869 170.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.402 HG22 ' HB2' ' B' ' 94' ' ' MET . 18.5 mt -75.07 152.75 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.394 0.678 . . . . 73.1 110.947 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -155.81 -175.04 5.22 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 124.118 0.967 . . . . 71.31 108.92 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.67 -135.07 26.46 Favored Glycine 0 N--CA 1.47 0.925 0 C-N-CA 123.364 0.507 . . . . 62.11 114.152 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 31.6 m -71.25 -36.51 71.8 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.58 0.752 . . . . 72.41 111.832 -174.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -60.91 -38.22 84.99 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.766 -0.652 . . . . 64.33 110.361 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.402 ' HB2' HG22 ' B' ' 89' ' ' ILE . 42.0 ttp -80.03 -28.07 39.39 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.561 -0.745 . . . . 72.21 110.569 177.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.4 -31.89 72.94 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.106 0.562 . . . . 74.25 110.708 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -75.58 -39.01 58.69 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.232 0.613 . . . . 65.1 110.573 173.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.1 t -64.12 -64.52 0.86 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.083 0.553 . . . . 64.14 110.912 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.674 HD21 HD13 ' B' ' 86' ' ' ILE . 65.9 mt -72.47 -30.74 64.82 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.122 0.569 . . . . 65.01 111.968 -176.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.74 -10.44 72.8 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 119.717 -0.491 . . . . 61.34 114.208 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.688 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -142.35 -58.58 0.45 Allowed 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 117.433 0.616 . . . . 54.34 111.948 -175.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -60.51 -49.22 78.43 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.168 0.987 . . . . 63.33 112.385 -176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.525 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 64.1 m -67.65 -50.3 36.02 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-O 118.484 -0.77 . . . . 63.13 112.579 -175.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.428 ' HB2' HD22 ' B' ' 60' ' ' LEU . 74.0 Cg_endo -72.17 -12.62 28.03 Favored 'Trans proline' 0 C--N 1.385 2.473 0 CA-C-N 121.248 1.481 . . . . 73.0 112.84 177.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' B' ' 100' ' ' ALA . 0.2 OUTLIER -73.99 -33.49 63.84 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.071 0.548 . . . . 64.22 109.548 173.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.484 HG23 ' NH2' ' D' ' 111' ' ' ARG . 97.7 mt -60.76 -42.24 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 124.031 0.932 . . . . 64.3 109.738 170.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.8 mt -87.34 -14.5 40.61 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.413 -1.267 . . . . 61.52 111.396 -171.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -54.39 -51.82 74.74 Favored Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 124.321 1.048 . . . . 73.22 112.7 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' B' ' 105' ' ' ILE . 83.1 Cg_exo -52.46 -40.15 72.33 Favored 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 122.866 2.378 . . . . 63.4 114.791 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -75.07 -41.31 59.18 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.927 -0.579 . . . . 74.5 110.51 -175.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.86 -40.27 96.16 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.196 0.598 . . . . 71.41 110.43 174.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -57.11 -59.59 4.86 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.468 1.507 . . . . 73.35 110.564 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.82 -37.74 74.35 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 124.124 0.89 . . . . 72.14 110.759 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.578 ' SG ' HD11 ' B' ' 21' ' ' ILE . 19.0 t -68.61 -40.65 80.3 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.336 -0.847 . . . . 53.0 111.593 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.576 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 63.6 mt -62.18 -50.77 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.233 -0.654 . . . . 70.02 109.233 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.402 HG21 ' OG ' ' C' ' 119' ' ' SER . 4.6 m -61.99 -29.6 70.37 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 124.133 0.896 . . . . 64.13 111.431 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -66.4 -50.42 63.51 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 109.487 -0.56 . . . . 73.31 109.487 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . . . . . . . . . 35.5 mmt -62.44 -41.69 98.91 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 123.699 0.624 . . . . 63.11 110.876 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 114' ' ' ILE . 70.0 t -61.78 -48.12 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 124.209 1.004 . . . . 63.52 110.857 177.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 26.0 t -67.48 -30.36 70.04 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.58 -0.736 . . . . 73.21 110.792 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -69.92 -31.31 69.01 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.992 0.517 . . . . 71.1 110.12 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.76 9.66 55.07 Favored Glycine 0 C--N 1.353 1.521 0 O-C-N 123.883 0.739 . . . . 64.21 112.314 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.514 HG23 ' HB3' ' A' ' 17' ' ' TYR . 82.8 p 60.5 22.18 11.88 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 126.825 2.05 . . . . 62.55 113.627 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -84.63 161.93 52.13 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 123.476 0.71 . . . . 75.04 111.062 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -61.9 174.58 2.3 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 123.057 2.505 . . . . 72.22 113.875 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.567 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -62.42 115.13 3.95 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.312 -1.313 . . . . 50.04 111.343 -175.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.565 HD21 HG11 ' B' ' 40' ' ' VAL . 1.6 tm? -131.92 96.08 3.84 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.361 -0.977 . . . . 73.15 108.361 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -123.1 137.01 55.03 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.475 1.11 . . . . 73.13 108.773 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 6.9 mp -70.67 138.01 50.31 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.749 0.655 . . . . 52.51 110.524 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.77 151.26 89.29 Favored Pre-proline 0 CA--C 1.553 1.077 0 O-C-N 124.331 1.019 . . . . 74.31 112.173 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.83 92.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.533 2.822 . . . . 72.41 112.636 173.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 16.1 m -115.09 112.37 39.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 115.673 -0.694 . . . . 73.55 109.194 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.442 ' ND2' ' HB2' ' B' ' 135' ' ' ALA . 49.2 t30 -82.57 94.11 7.44 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 107.498 -1.297 . . . . 75.22 107.498 173.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -68.7 -29.9 68.44 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.317 -1.311 . . . . 74.4 110.638 -172.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.688 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 17.5 t70 -58.34 -45.34 88.34 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.048 0.939 . . . . 74.34 110.898 172.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' B' ' 138' ' ' MET . . . -66.51 -32.31 73.59 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.885 0.741 . . . . 70.22 111.481 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 48.6 tp -58.88 -37.06 75.7 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.468 0.707 . . . . 75.41 110.836 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.423 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 38.5 m-85 -91.06 -27.51 18.56 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.641 -0.709 . . . . 75.22 111.57 175.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.464 ' HB3' ' HA ' ' B' ' 135' ' ' ALA . 1.5 tmt? -68.15 -35.74 78.57 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.195 0.598 . . . . 71.34 111.247 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.457 ' HA ' ' NE2' ' B' ' 142' ' ' GLN . 64.3 m-80 -74.68 -16.26 60.77 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.65 0.38 . . . . 74.0 111.184 178.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -77.13 -33.3 56.78 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.623 0.369 . . . . 65.44 110.353 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 67.2 mt -77.88 -6.2 53.48 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.8 0.667 . . . . 70.33 112.8 -172.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . 0.457 ' NE2' ' HA ' ' B' ' 139' ' ' ASN . 3.2 pp0? -152.38 176.21 11.88 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.115 0.566 . . . . 71.31 110.705 177.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -131.78 161.34 33.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.237 1.015 . . . . 63.55 108.755 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -66.32 140.49 58.11 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.186 0.595 . . . . 75.12 111.101 -176.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.16 169.04 25.43 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.152 0.981 . . . . 75.32 110.215 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.77 110.27 0.34 Allowed Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.53 -0.628 . . . . 64.1 111.53 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.81 -21.89 34.35 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.587 0.755 . . . . 64.33 111.034 173.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.83 -179.79 44.38 Favored Glycine 0 C--N 1.351 1.362 0 N-CA-C 113.987 0.355 . . . . 63.4 113.987 170.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 11.7 t -156.79 35.37 0.3 Allowed 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.028 0.931 . . . . 73.35 109.991 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -77.83 151.27 34.02 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 115.463 -0.79 . . . . 71.41 110.291 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.47 172.23 7.1 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.219 0.608 . . . . 74.41 110.972 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -147.49 61.53 1.15 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.286 1.034 . . . . 74.45 108.214 170.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -74.08 148.26 42.04 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.324 -0.853 . . . . 61.23 110.209 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -70.39 96.41 1.14 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.76 0.791 . . . . 74.11 109.315 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 CA-C-N 115.016 -0.993 . . . . 73.42 110.053 -176.917 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 48.8 tpp . . . . . 0 N--CA 1.473 0.675 0 N-CA-C 109.699 -0.482 . . . . 73.25 109.699 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 32.5 t -159.85 154.02 23.47 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.517 0.727 . . . . 71.25 109.728 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -159.72 117.11 2.63 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.985 -0.746 . . . . 73.51 108.985 170.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -146.09 -71.03 0.25 Allowed 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.201 -1.407 . . . . 44.15 107.201 166.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 60.43 178.08 0.1 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.253 1.021 . . . . 74.43 110.725 -176.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 40.5 t30 66.32 154.25 0.08 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.788 0.835 . . . . 74.33 110.758 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 5.6 m 56.43 32.74 21.23 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-O 122.076 0.941 . . . . 73.14 109.982 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -81.87 46.34 0.98 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.474 1.11 . . . . 61.14 110.933 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.657 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 0.0 OUTLIER 63.13 112.87 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.068 1.747 . . . . 71.14 110.731 -172.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 72.6 m -87.6 93.19 9.36 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.924 -1.139 . . . . 52.33 107.924 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.657 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 0.9 OUTLIER -123.02 129.55 51.65 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.643 -0.708 . . . . 74.23 110.161 -173.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -148.74 126.24 11.65 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.152 -1.425 . . . . 42.02 107.152 173.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.489 HG13 ' HD3' ' A' ' 130' ' ' PRO . 65.2 mt -78.35 123.48 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 109.336 -0.616 . . . . 60.3 109.336 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -86.03 -43.11 13.39 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.331 -0.849 . . . . 74.21 110.315 -177.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -178.79 124.92 0.1 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.554 0.534 . . . . 63.41 110.23 -174.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.429 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 97.0 mt -114.03 143.64 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 108.263 -1.014 . . . . 73.03 108.263 175.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.468 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 31.3 p90 -174.82 172.7 2.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.34 1.056 . . . . 74.34 109.411 -170.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 66.6 p -96.94 126.06 41.81 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.844 0.458 . . . . 70.42 110.085 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.468 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 27.6 mmtp -76.37 -49.08 17.72 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.196 -1.038 . . . . 74.53 108.196 169.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 11.7 t70 -135.38 147.45 49.05 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 113.858 -1.519 . . . . 54.52 109.473 -170.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.5 mt -144.09 145.75 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 106.542 -1.651 . . . . 71.11 106.542 172.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -160.16 152.12 20.28 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.294 0.568 . . . . 61.35 110.397 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 70.0 t80 -149.87 136.59 19.3 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.356 -1.35 . . . . 74.41 107.356 175.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -138.96 127.83 23.58 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.346 0.658 . . . . 65.25 109.92 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.77 80.36 5.59 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 107.336 -1.357 . . . . 74.43 107.336 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.44 -35.53 38.84 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.749 2.299 . . . . 72.32 112.094 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -92.29 21.9 4.88 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.547 -1.206 . . . . 71.32 111.217 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.59 -49.44 45.83 Favored Pre-proline 0 CA--C 1.564 1.506 0 N-CA-C 113.849 1.055 . . . . 72.42 113.849 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.41 -44.23 34.54 Favored 'Trans proline' 0 C--N 1.388 2.614 0 CA-C-N 121.584 1.601 . . . . 72.24 112.652 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.421 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 86.4 t60 -69.34 -32.53 71.68 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.072 -0.967 . . . . 64.32 112.56 -175.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.759 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.9 p -78.68 -25.1 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 N-CA-C 112.695 0.628 . . . . 72.22 112.695 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -71.44 -16.02 62.36 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 112.811 0.671 . . . . 72.53 112.811 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 14.0 pt20 -94.9 19.17 10.62 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.282 0.633 . . . . 64.23 110.837 175.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.67 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -109.88 159.66 17.04 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.859 0.864 . . . . 75.15 110.576 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -82.11 131.04 35.24 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.118 0.967 . . . . 63.44 108.982 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -77.05 82.86 3.56 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.261 1.024 . . . . 72.33 112.341 -170.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -126.33 69.84 68.98 Favored Pre-proline 0 N--CA 1.484 1.235 0 C-N-CA 124.087 0.955 . . . . 60.24 109.865 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -88.96 135.06 2.72 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.864 2.376 . . . . 74.11 112.529 -173.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -86.44 115.79 24.17 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 106.902 -1.518 . . . . 64.21 106.902 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.2 t -79.49 100.2 3.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 108.911 -0.774 . . . . 75.42 108.911 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.629 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 4.3 mptp? -90.1 99.63 12.61 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.362 -1.718 . . . . 74.21 106.362 170.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 pp -95.52 145.01 25.52 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.867 -0.79 . . . . 74.24 108.867 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.434 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 23.0 t70 -142.86 145.29 32.99 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.845 -0.798 . . . . 64.13 108.845 -177.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.56 HD11 HD13 ' G' ' 8' ' ' LEU . 3.1 mm? -121.06 113.65 20.35 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.699 0.8 . . . . 71.2 109.312 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -113.59 163.03 15.48 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.267 1.427 . . . . 40.25 107.831 171.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.4 t -144.58 153.83 42.21 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.32 0.581 . . . . 72.41 111.27 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.91 152.17 41.78 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.039 1.336 . . . . 73.41 107.707 172.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.9 p -167.33 167.54 13.92 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 120.996 0.427 . . . . 73.42 111.454 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 69.9 p -161.21 153.61 20.28 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.063 -0.971 . . . . 70.23 109.011 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -88.54 124.11 33.71 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.26 -1.015 . . . . 72.04 108.26 168.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.559 HD11 HD12 ' C' ' 83' ' ' ILE . 64.9 mt -92.74 -38.67 11.68 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.521 0.728 . . . . 71.31 110.755 -176.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -157.07 178.03 10.82 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.515 0.726 . . . . 53.32 110.7 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -60.65 117.93 5.95 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.401 0.68 . . . . 75.15 109.811 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 70.01 -6.71 1.05 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 125.827 1.651 . . . . 63.52 113.596 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 57.6 t -97.55 111.67 27.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.932 -1.136 . . . . 65.2 107.932 177.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -127.78 134.89 49.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.299 -0.63 . . . . 72.41 109.299 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -92.24 126.89 37.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.895 -1.048 . . . . 64.42 109.679 177.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 72.9 t -116.4 116.05 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 107.739 -1.208 . . . . 74.02 107.739 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 38.9 t -116.01 132.57 65.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 108.746 -0.835 . . . . 74.32 108.746 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 54.3 tp -116.72 112.85 21.78 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.504 -0.924 . . . . 70.33 108.504 175.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.573 ' HB2' ' HG2' ' C' ' 79' ' ' GLN . 50.4 ttm-85 -91.62 111.02 22.36 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.882 -0.784 . . . . 73.42 108.882 173.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.557 ' HB ' HD11 ' C' ' 114' ' ' ILE . 20.8 t -99.33 129.16 50.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 N-CA-C 107.785 -1.191 . . . . 73.23 107.785 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 16.5 m -123.05 118.97 28.97 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.114 -0.698 . . . . 72.54 109.114 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 65.4 t -113.55 108.62 25.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-N 114.571 -1.195 . . . . 74.52 108.749 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.629 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 16.5 m -98.25 140.41 32.59 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.873 -1.158 . . . . 64.42 107.873 171.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.48 121.24 28.45 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.169 -1.419 . . . . 45.0 107.169 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 51.0 m -132.43 126.34 32.85 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.941 0.337 . . . . 74.05 110.68 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.67 HD13 ' HG2' ' C' ' 34' ' ' LYS . 10.3 mt -85.49 42.83 0.98 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.562 1.145 . . . . 63.22 109.7 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.03 -113.67 4.51 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 111.108 -0.797 . . . . 54.12 111.108 -172.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.83 -18.6 28.94 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.535 0.734 . . . . 64.43 110.044 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -80.04 120.75 24.63 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.392 1.077 . . . . 73.43 109.145 172.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 99.0 m -78.93 123.01 26.84 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.476 -0.935 . . . . 44.32 108.476 164.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.759 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.16 -56.72 5.51 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.649 0.593 . . . . 70.24 109.614 175.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -158.47 168.94 25.6 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.927 0.87 . . . . 71.44 111.392 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -128.08 141.53 51.47 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 105.859 -1.904 . . . . 72.21 105.859 166.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.485 ' SG ' HG23 ' C' ' 114' ' ' ILE . 37.3 t -145.36 136.85 25.18 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.427 -1.323 . . . . 74.01 107.427 177.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . 0.402 ' HG2' HH11 ' C' ' 61' ' ' ARG . 39.1 tt0 -156.24 121.14 4.66 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.532 0.206 . . . . 74.51 110.465 -168.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 84.7 t -132.59 135.56 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.644 0.778 . . . . 71.12 109.671 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.573 ' HG2' ' HB2' ' C' ' 61' ' ' ARG . 20.7 mt-30 -96.89 108.19 20.84 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.657 -0.868 . . . . 64.43 108.657 164.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -90.62 104.24 16.85 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.638 -0.875 . . . . 71.02 108.638 172.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.75 145.55 22.76 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.511 -0.768 . . . . 62.5 111.475 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.2 115.48 0.72 Allowed Glycine 0 CA--C 1.504 -0.656 0 N-CA-C 110.157 -1.177 . . . . 51.23 110.157 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.559 HD12 HD11 ' C' ' 51' ' ' LEU . 15.8 mm -83.76 121.74 36.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.886 -1.153 . . . . 60.53 107.886 175.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -129.04 119.35 24.07 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.851 -0.796 . . . . 71.45 108.851 -174.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 57.3 p -77.35 107.71 9.96 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.264 -1.013 . . . . 75.3 108.264 170.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.509 HD13 HG21 ' G' ' 18' ' ' VAL . 6.7 tt -116.25 131.91 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.831 1.252 . . . . 74.44 108.997 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.02 171.03 20.8 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.913 0.885 . . . . 63.33 110.087 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.73 -58.44 3.71 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 112.228 -0.349 . . . . 65.21 112.228 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.589 HD13 ' HG2' ' C' ' 9' ' ' MET . 36.2 pt -84.76 158.61 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.276 0.631 . . . . 74.24 110.669 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -149.9 164.71 34.68 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.839 0.855 . . . . 74.35 109.363 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' G' ' 21' ' ' ALA . . . 64.79 -125.31 30.4 Favored Glycine 0 C--N 1.346 1.094 0 C-N-CA 123.197 0.427 . . . . 72.31 113.69 171.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 45.5 p -56.43 -34.75 67.1 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.841 1.256 . . . . 75.02 112.531 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.42 ' NE2' ' H ' ' A' ' 149' ' ' THR . 26.3 mt-30 -73.47 -38.57 65.38 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.763 0.425 . . . . 70.53 111.592 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.545 ' SD ' ' HB ' ' G' ' 18' ' ' VAL . 47.3 mtt -62.15 -49.03 77.47 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.496 -0.557 . . . . 74.51 109.496 171.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.66 -35.88 71.14 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.787 0.835 . . . . 74.24 111.286 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -64.41 -46.55 82.79 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.292 1.037 . . . . 61.42 110.739 173.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.558 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 24.2 t -64.06 -42.02 97.16 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.497 -0.774 . . . . 54.42 111.465 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.68 HD11 HG23 ' G' ' 18' ' ' VAL . 70.9 mt -85.37 -36.7 20.57 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.567 0.747 . . . . 71.21 111.706 -170.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.95 11.52 58.95 Favored Glycine 0 N--CA 1.474 1.168 0 CA-C-N 116.206 -0.452 . . . . 45.25 114.009 -171.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.43 -60.07 0.14 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.54 0.686 . . . . 70.04 110.616 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.558 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 83.1 t80 -75.79 -35.45 60.07 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 125.138 1.375 . . . . 74.22 113.49 -168.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 91.3 m -79.07 -41.68 1.64 Allowed Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 123.169 0.588 . . . . 75.32 111.49 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.58 -33.37 30.71 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 122.626 2.217 . . . . 64.12 113.705 166.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -66.02 -39.69 90.44 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.633 0.773 . . . . 62.5 111.399 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.472 HD12 HH12 ' A' ' 111' ' ' ARG . 50.6 mm -67.03 -42.64 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.127 0.571 . . . . 63.12 110.062 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 87.8 mt -88.36 -10.21 50.14 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.826 0.851 . . . . 51.33 112.209 -174.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -58.04 -55.29 46.76 Favored Pre-proline 0 N--CA 1.481 1.092 0 CA-C-O 117.892 -1.051 . . . . 72.32 112.493 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.14 -35.56 74.64 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 121.99 1.794 . . . . 74.32 113.158 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.466 ' HE2' HG21 ' A' ' 115' ' ' THR . 91.6 m-85 -64.33 -54.43 33.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.485 0.714 . . . . 54.2 110.659 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.01 -39.13 91.23 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 114.803 -1.09 . . . . 71.21 110.501 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -56.0 -51.43 67.79 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.11 1.364 . . . . 72.05 110.453 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.49 -38.18 77.54 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 123.508 0.505 . . . . 75.24 109.802 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.1 t -64.41 -32.85 74.64 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 122.971 0.508 . . . . 73.22 111.639 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.557 HD11 ' HB ' ' C' ' 62' ' ' VAL . 97.4 mt -73.42 -56.14 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.832 0.853 . . . . 70.22 109.33 175.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 15.0 m -61.88 -27.25 68.67 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.936 0.895 . . . . 73.1 111.688 -175.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.451 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 47.6 t -68.03 -47.47 68.33 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.984 0.914 . . . . 71.32 109.71 174.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.548 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.82 -36.77 84.27 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.849 0.86 . . . . 73.44 111.596 178.052 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.5 t -63.35 -39.46 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.377 0.671 . . . . 72.43 110.011 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.402 ' OG ' HG21 ' B' ' 115' ' ' THR . 32.6 t -73.06 -29.52 63.03 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.845 0.858 . . . . 53.03 112.061 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' C' ' 116' ' ' SER . 85.4 mtt-85 -71.66 -39.48 70.29 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.014 -0.735 . . . . 75.01 109.014 176.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.18 2.55 60.98 Favored Glycine 0 C--N 1.36 1.874 0 O-C-N 124.103 0.877 . . . . 75.12 112.61 172.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.2 p 61.81 26.35 15.98 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.89 2.076 . . . . 71.41 113.545 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -83.37 146.91 51.81 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 109.066 -0.716 . . . . 71.11 109.066 170.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.526 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 80.1 Cg_exo -49.86 138.21 34.43 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 123.329 2.686 . . . . 64.34 112.688 173.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.582 ' HA ' HE21 ' C' ' 125' ' ' GLN . 0.0 OUTLIER -60.11 111.36 1.48 Allowed 'General case' 0 C--N 1.354 0.761 0 O-C-N 123.955 0.784 . . . . 55.2 110.609 -176.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -105.88 88.05 2.72 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 104.587 -2.375 . . . . 74.03 104.587 174.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -92.34 126.19 37.32 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.261 -0.881 . . . . 71.14 109.046 -171.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.49 136.08 51.0 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 124.128 0.892 . . . . 70.33 109.881 -173.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.06 157.82 83.43 Favored Pre-proline 0 CA--C 1.551 0.996 0 O-C-N 124.148 0.905 . . . . 73.12 111.395 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.439 ' HB3' HD12 ' A' ' 16' ' ' ILE . 55.5 Cg_exo -54.03 110.33 0.49 Allowed 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 123.03 2.487 . . . . 65.42 113.485 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.606 HG11 ' HB2' ' G' ' 8' ' ' LEU . 40.9 t -112.23 109.86 30.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.26 -0.644 . . . . 72.12 109.26 175.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -107.8 91.93 3.86 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 105.866 -1.901 . . . . 60.03 105.866 169.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -53.63 -43.27 68.58 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 124.319 1.012 . . . . 65.13 111.586 -172.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -60.75 -47.2 87.38 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 114.928 -1.033 . . . . 72.4 111.205 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.19 -22.19 63.91 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.119 -0.946 . . . . 64.23 111.74 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.83 -38.36 90.72 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.902 0.481 . . . . 74.01 110.849 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -66.88 -39.75 87.58 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 116.043 -0.526 . . . . 75.01 110.519 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 61.4 mtt -73.43 -30.98 63.57 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.947 0.899 . . . . 61.14 111.848 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -73.63 -38.0 65.17 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.598 0.759 . . . . 71.01 111.026 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -57.76 -86.28 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.133 0 O-C-N 124.344 1.027 . . . . 74.34 112.511 -170.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 9.2 mp 61.99 -74.35 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.519 1.127 . . . . 72.22 110.86 -171.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -158.68 -74.9 0.08 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.566 -0.902 . . . . 62.3 108.566 174.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -171.07 171.22 5.88 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.419 1.088 . . . . 64.24 108.491 -175.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 73.07 119.23 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.131 1.372 . . . . 62.23 111.355 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -153.31 -52.52 0.1 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.312 0.645 . . . . 71.52 110.0 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 110.53 -166.39 12.38 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.945 -0.57 . . . . 73.0 112.408 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.09 -154.26 0.54 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.565 1.146 . . . . 74.54 109.771 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.96 37.57 2.35 Favored Glycine 0 C--N 1.354 1.578 0 N-CA-C 114.922 0.729 . . . . 73.12 114.922 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 17.4 m 61.47 79.37 0.25 Allowed 'General case' 0 C--N 1.362 1.15 0 C-N-CA 125.108 1.363 . . . . 71.41 111.005 171.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 68.37 -75.63 0.06 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.814 1.246 . . . . 74.31 109.269 -171.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -178.71 -104.89 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.205 1.402 . . . . 73.13 107.692 172.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -162.1 -68.82 0.05 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.227 1.411 . . . . 71.22 108.223 -174.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 70.88 -4.29 1.77 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.624 1.57 . . . . 74.24 113.047 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -90.01 154.92 19.45 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.231 0.612 . . . . 73.41 110.461 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.182 0 C-N-CA 124.89 1.276 . . . . 71.42 108.296 172.769 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 108.94 -0.763 . . . . 74.21 108.94 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 55.5 p -162.8 75.66 0.42 Allowed 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.75 0.786 . . . . 63.42 109.982 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -88.5 67.65 8.59 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.08 0.943 . . . . 73.15 108.974 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -160.66 134.57 7.02 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 106.677 -1.601 . . . . 64.45 106.677 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 64.57 -164.14 0.25 Allowed 'General case' 0 CA--C 1.566 1.576 0 O-C-N 123.909 0.756 . . . . 62.22 109.472 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -57.39 106.44 0.33 Allowed 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 118.918 0.781 . . . . 72.41 110.113 170.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 39.8 p -71.25 -9.16 57.65 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.252 1.021 . . . . 65.21 111.984 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.66 -25.23 68.12 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.287 1.035 . . . . 53.24 111.169 173.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.505 ' HB2' HG12 ' D' ' 89' ' ' ILE . 14.6 ptm -30.42 140.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 125.38 1.472 . . . . 73.45 114.053 173.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 96.1 m -105.92 143.01 34.67 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.475 1.11 . . . . 74.34 110.047 -175.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.632 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 62.6 t80 -154.66 93.09 1.54 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 107.433 -1.321 . . . . 73.32 107.433 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -120.5 115.34 23.26 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.441 -0.948 . . . . 70.02 108.441 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.578 HD13 HG21 ' D' ' 105' ' ' ILE . 11.2 mt -74.0 134.31 29.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 109.952 -0.388 . . . . 53.21 109.952 -175.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -93.83 -46.42 7.21 Favored 'General case' 0 C--O 1.241 0.656 0 O-C-N 123.426 0.454 . . . . 72.14 110.675 175.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -167.18 142.7 4.13 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.66 0.615 . . . . 61.24 112.66 -165.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.439 HG21 ' CG ' ' D' ' 109' ' ' TYR . 3.0 mp -122.56 135.94 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.791 1.236 . . . . 75.55 107.725 171.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.414 ' HE1' HG13 ' D' ' 83' ' ' ILE . 25.2 p90 -163.63 157.14 19.0 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.671 0.789 . . . . 72.34 110.737 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.3 p -91.36 114.69 27.29 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.209 -0.905 . . . . 51.45 108.859 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -78.71 -44.88 22.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.354 -0.98 . . . . 74.15 108.354 175.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 14.1 t70 -135.62 139.38 43.75 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.374 -1.284 . . . . 74.04 109.577 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.548 HG21 ' HE2' ' C' ' 117' ' ' MET . 67.4 mt -138.06 151.23 25.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 124.968 1.307 . . . . 63.13 107.895 174.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -152.23 145.8 24.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.358 1.063 . . . . 75.01 108.986 172.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.523 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 84.9 t80 -152.27 133.41 14.31 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 105.584 -2.006 . . . . 73.3 105.584 173.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -141.79 139.56 32.81 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.353 -0.98 . . . . 72.43 108.353 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.89 89.78 20.31 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 107.646 -1.242 . . . . 71.53 107.646 176.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.2 -32.31 5.26 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 123.022 2.481 . . . . 73.44 113.935 -170.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -103.53 17.32 24.35 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.191 0.596 . . . . 54.35 110.32 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -38.76 -65.81 0.36 Allowed Pre-proline 0 CA--C 1.562 1.416 0 N-CA-C 115.235 1.568 . . . . 73.01 115.235 -159.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.53 -23.87 22.88 Favored 'Trans proline' 0 C--N 1.389 2.688 0 CA-C-N 121.849 1.696 . . . . 74.44 113.337 -173.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.474 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 4.7 t-160 -79.4 -39.01 33.51 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.11 0.964 . . . . 73.4 110.808 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -80.67 -18.68 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 122.537 0.335 . . . . 63.23 110.752 -170.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -62.54 -23.39 66.96 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.346 0.659 . . . . 74.02 112.623 173.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.474 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 55.1 mt-30 -60.33 -23.09 63.96 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.574 0.749 . . . . 72.52 110.603 175.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -92.54 82.14 4.84 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.151 1.381 . . . . 71.11 109.657 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.19 84.31 7.72 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.231 0.613 . . . . 74.32 110.353 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.2 p90 -156.82 -178.97 7.76 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.35 0.66 . . . . 74.53 109.343 170.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -66.76 109.84 4.05 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.457 1.103 . . . . 71.25 110.455 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.75 137.68 64.83 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.259 1.973 . . . . 75.44 111.415 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -63.21 108.58 1.31 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.709 -0.849 . . . . 63.25 108.709 172.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.557 HG13 HG13 ' D' ' 64' ' ' VAL . 87.6 t -99.13 148.81 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.034 -1.098 . . . . 62.51 108.034 -175.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.552 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 34.6 ttpt -129.83 138.91 51.26 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.663 -0.866 . . . . 65.53 108.663 169.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.658 HD21 HD23 ' H' ' 8' ' ' LEU . 53.7 tp -109.05 112.2 24.26 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.277 -1.008 . . . . 73.34 108.277 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.606 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 71.9 m-20 -111.37 120.95 43.92 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.316 1.046 . . . . 41.21 108.412 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.417 HD22 ' O ' ' H' ' 10' ' ' LEU . 5.2 mp -100.36 128.01 46.53 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.846 -0.428 . . . . 54.3 109.846 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 9.1 t70 -133.1 157.79 44.41 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 105.75 -1.945 . . . . 61.03 105.75 172.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.3 t -146.96 161.11 41.45 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.144 0.497 . . . . 70.11 111.761 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -163.01 169.41 19.63 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.187 1.395 . . . . 71.51 108.771 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 19.1 p -176.82 -179.75 0.99 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 112.454 0.538 . . . . 65.21 112.454 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 52.2 p -164.77 147.52 8.52 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.624 1.17 . . . . 60.2 109.245 172.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -82.42 119.22 23.9 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.275 -1.009 . . . . 72.04 108.275 171.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' D' ' 57' ' ' GLU . 21.1 mt -89.82 -31.3 17.44 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.779 0.432 . . . . 74.34 110.718 -173.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -162.73 178.33 8.57 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.22 1.008 . . . . 55.2 109.696 177.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -73.59 129.36 37.8 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.808 -0.812 . . . . 74.35 108.808 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 69.65 10.59 7.66 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.983 1.313 . . . . 72.41 111.311 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 87.7 t -132.67 118.23 33.65 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 124.034 0.934 . . . . 71.15 108.978 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -140.91 131.25 25.09 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.77 -0.826 . . . . 73.24 108.77 -174.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.416 ' HB2' HD11 ' D' ' 51' ' ' LEU . 31.2 tt0 -91.27 143.57 26.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.669 -1.15 . . . . 75.11 109.941 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.485 HG22 ' HE1' ' D' ' 84' ' ' PHE . 3.9 m -121.49 139.48 48.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 107.887 -1.153 . . . . 51.02 107.887 167.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 23.7 t -127.94 124.51 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 108.328 -0.99 . . . . 52.21 108.328 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.585 HD23 HD12 ' D' ' 106' ' ' LEU . 3.9 mm? -118.23 114.07 22.46 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.358 0.663 . . . . 74.45 109.497 -176.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.519 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 22.0 ttm-85 -86.22 99.62 11.68 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.67 0.788 . . . . 64.04 109.609 176.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 85.7 t -91.2 115.04 29.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 108.357 -0.979 . . . . 61.33 108.357 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 9.1 m -115.46 129.09 56.44 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.358 0.599 . . . . 74.44 109.701 -175.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.557 HG13 HG13 ' D' ' 40' ' ' VAL . 24.5 t -118.13 101.56 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.005 1.722 . . . . 75.44 108.693 -177.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 51.5 m -95.57 93.92 7.45 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.467 -0.938 . . . . 75.12 108.467 176.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.38 143.62 27.94 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.373 0.669 . . . . 72.11 110.163 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.44 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 13.7 m -149.3 124.39 10.07 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 123.027 0.531 . . . . 72.03 110.914 -174.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 17.9 mt -94.86 104.76 16.65 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.076 -0.712 . . . . 53.24 109.076 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.24 -120.87 5.26 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.832 -0.622 . . . . 70.44 111.948 -176.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.09 2.28 29.25 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.389 0.676 . . . . 71.35 111.296 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -124.11 163.45 21.47 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.315 0.646 . . . . 74.21 109.863 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 16.0 m -68.6 137.42 54.25 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 123.772 0.67 . . . . 71.14 111.503 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.44 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -92.43 -65.41 1.0 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.408 -1.33 . . . . 61.52 107.408 170.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -155.98 143.71 19.56 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 115.787 -0.642 . . . . 74.5 110.619 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 59.6 mt -106.74 109.97 22.02 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.264 -1.013 . . . . 73.01 108.264 173.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . . . . . . . . . 40.7 t -115.4 143.83 44.7 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.304 -0.998 . . . . 65.31 108.304 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -156.77 127.72 6.8 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.931 0.492 . . . . 65.22 109.895 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -132.41 119.18 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 122.972 0.509 . . . . 65.51 109.879 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.576 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.5 mt-30 -88.79 88.74 7.71 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.848 -0.797 . . . . 71.03 108.848 168.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -80.24 106.44 12.25 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.308 -1.315 . . . . 75.2 108.501 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.32 147.89 16.62 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.408 -0.677 . . . . 64.42 111.408 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.28 136.99 6.57 Favored Glycine 0 C--N 1.331 0.284 0 N-CA-C 111.539 -0.625 . . . . 42.31 111.539 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.414 HG13 ' HE1' ' D' ' 17' ' ' TYR . 54.1 mt -91.04 126.47 43.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 C-N-CA 123.728 0.811 . . . . 74.1 108.884 174.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.485 ' HE1' HG22 ' D' ' 58' ' ' VAL . 64.9 m-85 -131.79 131.77 43.2 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.765 0.426 . . . . 74.11 110.321 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 15.3 m -84.5 103.96 14.09 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.519 0.727 . . . . 74.21 109.242 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.607 HD13 HD21 ' D' ' 98' ' ' LEU . 37.7 pt -114.13 127.08 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.869 0.867 . . . . 72.35 110.024 -177.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.74 148.92 29.13 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.598 0.359 . . . . 71.54 110.641 -174.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.17 15.99 76.82 Favored Glycine 0 C--N 1.345 1.077 0 O-C-N 123.391 0.432 . . . . 62.41 113.271 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.505 HG12 ' HB2' ' D' ' 9' ' ' MET . 41.3 mt -97.19 148.65 5.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 109.268 -0.641 . . . . 72.21 109.268 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -162.02 178.48 8.8 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.394 1.078 . . . . 63.4 109.963 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.29 -144.43 44.41 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 115.286 -0.87 . . . . 74.53 113.747 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 2.8 p -82.62 -10.64 58.86 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.599 0.76 . . . . 73.21 111.751 176.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -27.63 68.5 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 109.458 -0.571 . . . . 74.41 109.458 174.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.474 ' HB3' ' H ' ' H' ' 18' ' ' VAL . 40.9 mtt -54.03 -43.42 70.14 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.195 0.598 . . . . 74.53 110.913 171.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.05 -46.18 62.48 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.696 -1.138 . . . . 32.23 110.939 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -64.32 -37.26 86.88 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.996 0.519 . . . . 65.11 111.702 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 47.9 t -62.03 -48.51 79.97 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.794 0.684 . . . . 53.34 110.553 -174.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.607 HD21 HD13 ' D' ' 86' ' ' ILE . 66.1 mt -98.1 -24.8 15.17 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.359 -0.837 . . . . 63.1 112.163 -169.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.04 -3.75 56.78 Favored Glycine 0 N--CA 1.47 0.925 0 CA-C-O 119.83 -0.428 . . . . 73.52 113.705 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.77 -55.35 0.33 Allowed 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.317 0.558 . . . . 71.02 111.74 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -72.81 -42.77 63.52 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 112.492 0.552 . . . . 74.41 112.492 -168.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.632 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 60.2 m -70.49 -45.66 18.77 Favored Pre-proline 0 CA--C 1.562 1.439 0 CA-C-O 119.07 -0.49 . . . . 71.02 110.881 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.477 ' HG3' HD21 ' D' ' 60' ' ' LEU . 72.7 Cg_exo -53.51 -33.78 69.41 Favored 'Trans proline' 0 C--N 1.394 2.922 0 C-N-CA 122.587 2.191 . . . . 73.5 113.922 168.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -64.98 -40.2 94.61 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.577 0.751 . . . . 74.42 110.078 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.578 HG21 HD13 ' D' ' 13' ' ' ILE . 49.3 mm -60.02 -42.83 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 115.913 -0.585 . . . . 65.11 109.726 173.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.585 HD12 HD23 ' D' ' 60' ' ' LEU . 83.9 mt -80.19 -15.31 57.32 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.004 -0.998 . . . . 61.13 112.558 -172.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -62.7 -48.82 85.05 Favored Pre-proline 0 CA--C 1.563 1.457 0 N-CA-C 113.207 0.817 . . . . 61.51 113.207 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -56.35 -35.56 96.18 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 122.097 1.865 . . . . 72.32 112.955 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . 0.439 ' CG ' HG21 ' D' ' 16' ' ' ILE . 98.5 m-85 -78.61 -29.66 46.12 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.017 0.927 . . . . 74.41 111.978 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.34 -48.03 68.71 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.735 -0.839 . . . . 62.51 108.735 174.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.484 ' NH2' HG23 ' B' ' 105' ' ' ILE . 45.4 ttp180 -65.08 -33.54 76.28 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.376 -1.283 . . . . 74.11 110.489 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -54.48 -58.52 7.13 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.067 0.947 . . . . 75.31 110.632 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.15 -45.13 89.84 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.693 -1.14 . . . . 73.04 111.271 -174.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.452 ' O ' HG23 ' D' ' 118' ' ' VAL . 79.8 mt -59.79 -62.06 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.576 0.75 . . . . 71.41 110.87 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.445 HG23 ' HG3' ' D' ' 125' ' ' GLN . 57.9 m -52.82 -38.38 61.22 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.347 1.059 . . . . 72.11 111.97 -175.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.0 t -66.73 -46.6 74.93 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.244 -0.889 . . . . 44.2 110.767 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.5 mtm -67.61 -30.02 69.5 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.782 0.433 . . . . 55.44 111.613 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.452 HG23 ' O ' ' D' ' 114' ' ' ILE . 91.2 t -63.62 -49.99 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 O-C-N 123.786 0.679 . . . . 71.23 109.819 174.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.8 p -69.06 -31.52 70.34 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 116.139 -0.482 . . . . 55.11 110.97 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 77.6 mtt-85 -69.79 -35.51 74.92 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.87 0.868 . . . . 73.54 110.384 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.59 2.62 85.26 Favored Glycine 0 C--N 1.351 1.376 0 O-C-N 123.733 0.646 . . . . 15.23 112.347 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.414 HG21 HE21 ' A' ' 125' ' ' GLN . 22.8 p 57.17 35.76 26.64 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.629 1.971 . . . . 72.42 113.384 176.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -94.7 159.41 33.53 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.267 1.027 . . . . 75.52 110.035 172.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.84 123.2 12.49 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.009 2.473 . . . . 65.32 112.774 170.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.445 ' HG3' HG23 ' D' ' 115' ' ' THR . 34.2 tt0 -53.47 142.73 21.31 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.148 1.379 . . . . 64.34 112.583 -176.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 66.4 tp -125.81 106.27 9.56 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.768 0.827 . . . . 74.52 109.735 -174.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -116.53 95.92 5.27 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.651 0.78 . . . . 73.11 109.517 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.45 ' HA ' HD12 ' H' ' 6' ' ' ILE . 6.2 mp -66.71 116.93 8.17 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.981 -0.748 . . . . 74.22 108.981 175.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -58.09 143.86 77.43 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 123.746 0.818 . . . . 71.43 110.626 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 6.0 Cg_exo -74.26 107.82 2.53 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.625 2.216 . . . . 61.11 110.524 -174.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . 0.643 HG21 ' HA ' ' H' ' 7' ' ' ALA . 27.7 m -107.47 140.3 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.254 0.622 . . . . 64.01 110.185 -174.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -83.99 79.42 9.5 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.865 0.84 . . . . 74.55 109.116 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -76.17 -18.74 58.96 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.785 -1.098 . . . . 74.12 110.962 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' D' ' 138' ' ' MET . 1.7 m-20 -50.77 -47.73 59.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.519 1.128 . . . . 71.1 111.412 171.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.67 -44.12 97.56 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.802 0.841 . . . . 53.21 111.82 -176.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 53.6 tp -63.26 -36.21 82.91 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.538 -0.755 . . . . 74.12 110.715 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.428 ' O ' HD13 ' D' ' 141' ' ' LEU . 38.4 t80 -72.73 -32.29 65.59 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.294 -0.866 . . . . 65.34 110.278 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.46 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 39.9 mtt -67.45 -29.45 68.91 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.578 0.751 . . . . 73.32 110.701 176.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -59.04 -29.59 67.4 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.604 0.761 . . . . 72.25 110.824 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -86.31 -32.65 20.92 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.743 0.817 . . . . 74.3 110.302 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.428 HD13 ' O ' ' D' ' 137' ' ' PHE . 7.7 mp -83.54 -25.97 30.54 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.651 1.18 . . . . 72.25 113.594 -175.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -65.98 2.84 0.96 Allowed 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 114.913 1.449 . . . . 71.51 114.913 -167.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.23 40.74 2.78 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.057 -0.72 . . . . 72.55 109.057 -174.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 174.51 146.12 0.06 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-N 113.464 -1.698 . . . . 70.43 107.663 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -142.56 -77.38 0.25 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.189 -1.412 . . . . 71.42 107.189 172.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 72.38 56.63 6.06 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 116.094 -0.503 . . . . 75.54 113.158 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -67.83 120.87 14.85 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.678 -0.49 . . . . 72.43 109.678 173.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.81 88.95 0.46 Allowed Glycine 0 C--N 1.345 1.051 0 N-CA-C 110.547 -1.021 . . . . 73.1 110.547 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 41.4 p -73.98 74.87 1.69 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.813 0.845 . . . . 73.23 110.532 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.81 137.99 31.87 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 114.919 -1.037 . . . . 63.13 108.304 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.48 134.53 53.6 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 107.964 -1.124 . . . . 75.33 107.964 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -57.82 -32.7 67.84 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.859 0.864 . . . . 73.2 112.686 -171.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 53.53 73.42 0.37 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.73 1.212 . . . . 72.42 110.809 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -81.22 153.86 26.94 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.248 -0.887 . . . . 60.0 110.213 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.235 0 C-N-CA 123.618 0.767 . . . . 42.13 108.933 -176.677 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 61.9 mtt . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 109.7 -0.481 . . . . 73.05 109.7 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -167.69 150.26 5.83 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.972 0.909 . . . . 55.54 109.247 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.64 101.08 5.16 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.007 -1.108 . . . . 75.11 108.007 177.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 42.8 t -69.9 95.55 0.93 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 109.316 -0.624 . . . . 71.24 109.316 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 11.6 t -71.55 -17.24 62.32 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.046 -0.979 . . . . 60.13 111.56 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 10.1 pt -89.96 90.55 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 123.939 0.896 . . . . 74.35 110.922 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 7' ' ' ALA . . . . . 0.525 ' HA ' ' HB3' ' A' ' 129' ' ' ALA . . . -110.4 -39.8 4.84 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.058 0.943 . . . . 70.22 109.95 176.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 tt 77.0 130.65 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.982 1.713 . . . . 71.31 110.591 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 9' ' ' ALA . . . . . 0.538 ' H ' HD13 ' A' ' 42' ' ' LEU . . . -84.14 159.13 21.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.724 0.81 . . . . 72.33 111.112 -175.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 8.7 mp -71.8 172.16 10.34 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.64 0.376 . . . . 72.13 110.163 172.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 78.7 mt -54.57 112.23 3.76 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.437 0.695 . . . . 70.32 110.799 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.76 -19.14 18.76 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.999 2.466 . . . . 74.0 111.602 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 4.2 mp -114.8 159.12 20.99 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.249 1.02 . . . . 62.24 109.491 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 95.7 mt -82.11 141.03 33.47 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.98 0.512 . . . . 73.11 109.871 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -80.8 134.37 35.78 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.557 -0.534 . . . . 71.24 109.557 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 12.4 p -64.7 114.71 15.61 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 123.959 0.903 . . . . 73.32 110.126 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 17' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.91 -179.27 5.24 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.714 2.276 . . . . 54.32 112.788 -171.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 55.8 t -86.94 141.87 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 123.51 0.724 . . . . 61.33 109.185 173.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 38.4 p -70.75 75.7 0.61 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.006 0.922 . . . . 53.1 109.691 173.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? 176.93 -47.19 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.142 1.377 . . . . 64.22 108.177 -171.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.55 115.64 5.38 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 114.921 -1.036 . . . . 72.11 111.276 -175.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -76.6 164.2 26.15 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.627 -0.508 . . . . 74.42 109.627 169.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 81.8 p -63.36 151.12 88.1 Favored Pre-proline 0 CA--C 1.553 1.081 0 CA-C-N 115.405 -0.816 . . . . 61.34 111.757 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -61.36 93.88 0.11 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.635 2.223 . . . . 71.42 112.363 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 C--O 1.25 1.126 0 C-N-CA 124.589 1.155 . . . . 64.3 107.969 174.966 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 18.4 ptt? . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 110.369 -0.234 . . . . 70.21 110.369 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -74.46 106.45 6.07 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.562 0.745 . . . . 75.21 109.839 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -158.74 158.63 34.01 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.972 0.909 . . . . 72.01 109.962 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 34.0 m -103.52 11.07 36.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.808 0.843 . . . . 64.23 110.006 169.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 32.8 m 63.83 -78.13 0.03 OUTLIER 'General case' 0 C--N 1.36 1.061 0 C-N-CA 125.307 1.443 . . . . 75.24 109.945 -170.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 8.2 tt -175.67 -54.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 125.393 1.477 . . . . 71.34 108.826 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . 62.89 -167.46 0.21 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.003 1.321 . . . . 72.42 111.959 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 69.4 mt -123.89 -179.44 4.4 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.965 0.906 . . . . 71.52 109.337 169.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.4 177.05 9.77 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.245 1.018 . . . . 71.23 109.318 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 83.7 mt -62.08 156.71 20.74 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.894 0.478 . . . . 73.24 110.925 175.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.413 HD22 HD11 ' B' ' 60' ' ' LEU . 0.3 OUTLIER -126.91 89.29 52.43 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 123.939 0.896 . . . . 65.35 109.406 -178.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.58 44.86 1.77 Allowed 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 123.853 3.036 . . . . 70.02 112.557 -176.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.09 -50.9 2.94 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 108.539 -0.912 . . . . 73.01 108.539 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 85.1 mt 66.42 -175.36 0.19 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.326 1.451 . . . . 73.23 111.832 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . 0.499 ' HD2' ' HB ' ' B' ' 46' ' ' THR . 2.8 p90 -146.97 -178.76 6.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.756 0.822 . . . . 52.43 110.286 -173.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 53.6 p -68.4 130.89 91.95 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 123.931 0.892 . . . . 65.12 112.33 -173.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.72 136.88 76.77 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.737 2.291 . . . . 72.22 111.46 169.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . 0.406 HG21 HD11 ' B' ' 86' ' ' ILE . 13.8 t -76.84 116.91 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 109.622 -0.511 . . . . 73.12 109.622 -172.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 38.9 m -63.07 -47.1 84.38 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.007 0.923 . . . . 74.22 111.022 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -103.04 60.12 0.77 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 122.104 0.954 . . . . 71.33 109.877 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.16 -21.59 1.84 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.531 -1.213 . . . . 74.54 108.964 166.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -55.08 137.39 46.65 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 125.057 1.343 . . . . 70.3 110.221 171.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 23' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' F' ' 24' ' ' PRO . 6.7 t -65.21 120.25 65.84 Favored Pre-proline 0 CA--C 1.554 1.097 0 N-CA-C 109.366 -0.605 . . . . 75.22 109.366 173.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 24' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' F' ' 23' ' ' THR . 3.8 Cg_exo -79.29 9.26 3.46 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.686 2.258 . . . . 75.01 112.902 -174.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 C--O 1.251 1.161 0 C-N-CA 125.014 1.326 . . . . 71.13 111.43 179.208 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' G' G ' 1' ' ' MET . . . . . 0.43 ' SD ' ' N ' ' G' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 121.801 0.81 . . . . 54.44 111.2 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -116.21 76.76 1.04 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 107.99 -1.115 . . . . 65.02 107.99 170.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -138.47 25.27 2.65 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.342 1.057 . . . . 73.42 109.055 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 77.4 p -65.45 148.71 51.25 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.057 0.543 . . . . 75.4 109.9 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 7.5 m -59.49 122.86 15.07 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.76 0.824 . . . . 61.1 111.045 -173.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . . . . . . . . . 2.9 pp -67.44 140.26 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.304 0.642 . . . . 54.35 111.082 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 7' ' ' ALA . . . . . 0.413 ' HB1' HG22 ' C' ' 131' ' ' VAL . . . -156.23 152.85 28.29 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.642 0.777 . . . . 61.3 109.529 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 8' ' ' LEU . . . . . 0.606 ' HB2' HG11 ' C' ' 131' ' ' VAL . 48.2 mt -62.16 135.51 57.53 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.497 0.719 . . . . 74.5 109.905 177.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.21 -175.38 4.12 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.457 0.703 . . . . 61.23 111.71 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.86 158.97 29.25 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.548 0.739 . . . . 53.44 109.042 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 11' ' ' LEU . . . . . 0.4 HD21 ' HG ' ' C' ' 44' ' ' LEU . 88.9 mt -106.26 97.83 17.4 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 123.027 0.531 . . . . 45.01 110.9 -176.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.01 -13.77 13.93 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 122.58 2.187 . . . . 73.44 111.499 168.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.94 -36.87 83.21 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.0 0.92 . . . . 61.14 109.623 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 86.9 mt 63.53 -159.01 0.31 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.888 1.275 . . . . 74.14 111.248 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -146.34 153.6 40.71 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-O 120.899 0.381 . . . . 71.21 110.317 -174.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 22.0 p -66.33 164.85 27.2 Favored Pre-proline 0 CA--C 1.563 1.449 0 C-N-CA 126.173 1.789 . . . . 35.23 112.423 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 17' ' ' PRO . . . . . 0.658 ' HA ' ' HB3' ' G' ' 21' ' ' ALA . 67.3 Cg_endo -82.55 150.82 14.95 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.537 2.158 . . . . 72.51 114.607 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 18' ' ' VAL . . . . . 0.68 HG23 HD11 ' C' ' 98' ' ' LEU . 55.0 t -76.53 -44.85 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 108.427 -0.953 . . . . 65.14 108.427 164.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 28.8 m -132.41 -67.06 0.67 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.06 -0.973 . . . . 73.25 109.746 174.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 20' ' ' LYS . . . . . 0.577 ' HA ' ' HE3' ' G' ' 20' ' ' LYS . 0.3 OUTLIER -138.32 23.57 2.75 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.151 0.581 . . . . 71.04 110.716 -171.454 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . 0.658 ' HB3' ' HA ' ' G' ' 17' ' ' PRO . . . -60.6 -29.67 69.36 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.726 0.81 . . . . 64.53 113.051 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 22' ' ' ARG . . . . . 0.541 ' H ' ' HB3' ' G' ' 17' ' ' PRO . 0.1 OUTLIER -92.51 60.82 3.63 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.486 -0.931 . . . . 74.31 108.486 -179.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 70.1 m -54.17 101.58 0.27 Allowed Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 126.012 1.725 . . . . 71.42 112.093 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 24' ' ' PRO . . . . . 0.451 ' HD2' ' HG3' ' A' ' 153' ' ' GLN . 78.2 Cg_endo -75.43 160.24 38.94 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.632 2.222 . . . . 71.23 112.318 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 C--O 1.251 1.183 0 C-N-CA 123.968 0.907 . . . . 54.35 109.292 179.727 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.254 0 N-CA-C 108.773 -0.825 . . . . 71.44 108.773 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -171.22 131.09 0.76 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.864 0.865 . . . . 70.33 109.924 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -37.32 72.37 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.058 0.543 . . . . 53.4 111.662 -177.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 48.7 p -93.84 96.51 9.79 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 108.258 -1.016 . . . . 74.51 108.258 170.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 76.0 p -68.61 -29.12 67.56 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.521 1.128 . . . . 45.34 113.031 -170.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' D' ' 128' ' ' LEU . 29.0 mm -85.31 72.26 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 109.41 -0.589 . . . . 74.22 109.41 -177.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 7' ' ' ALA . . . . . 0.643 ' HA ' HG21 ' D' ' 131' ' ' VAL . . . -176.01 116.18 0.13 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.987 0.915 . . . . 62.55 110.191 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 8' ' ' LEU . . . . . 0.658 HD23 HD21 ' D' ' 42' ' ' LEU . 81.7 mt -75.73 74.27 2.7 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 109.193 -0.669 . . . . 65.32 109.193 171.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.5 100.41 11.88 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.177 0.591 . . . . 72.53 110.8 -173.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 10' ' ' LEU . . . . . 0.417 ' O ' HD22 ' D' ' 44' ' ' LEU . 82.2 mt 65.86 174.32 0.23 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.871 1.268 . . . . 74.3 111.917 176.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -154.29 149.86 21.22 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 109.008 -0.738 . . . . 72.25 109.008 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -45.34 126.39 8.23 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 124.253 3.302 . . . . 62.14 114.698 -174.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 49.3 tp 63.25 -91.95 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.352 1.461 . . . . 71.12 110.668 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' H' ' 14' ' ' LEU . 0.4 OUTLIER -167.05 28.43 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 106.632 -1.618 . . . . 73.12 106.632 -179.04 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 67.9 t80 58.41 -98.86 0.09 Allowed 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 114.819 -1.082 . . . . 74.45 109.694 -170.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 87.5 m -174.59 122.77 0.37 Allowed Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 126.055 1.742 . . . . 73.14 106.947 -175.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.26 169.07 19.1 Favored 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 122.487 2.125 . . . . 74.43 112.048 172.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . 0.513 HG22 HD12 ' D' ' 86' ' ' ILE . 44.7 t -62.3 -45.33 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 108.78 -0.822 . . . . 70.41 108.78 173.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 23.6 m 65.48 -71.96 0.08 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.974 1.71 . . . . 71.05 112.186 174.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -147.93 16.43 1.09 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.069 0.547 . . . . 72.45 110.611 -176.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.4 75.27 1.4 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.853 0.861 . . . . 64.45 111.219 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . 0.543 ' HG3' HG23 ' H' ' 23' ' ' THR . 20.3 ptt85 -174.95 -34.15 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.513 1.125 . . . . 74.1 110.267 -175.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 23' ' ' THR . . . . . 0.543 HG23 ' HG3' ' H' ' 22' ' ' ARG . 41.4 p -110.51 126.83 28.05 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.78 0.832 . . . . 55.33 109.519 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.71 135.06 61.44 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.438 2.759 . . . . 62.32 112.73 -171.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 . . . . . 0 CA--C 1.56 1.333 0 C-N-CA 123.579 0.751 . . . . 71.03 111.083 -177.607 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 111.774 0.287 . . . . 71.51 111.774 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.72 ' HA ' ' HB2' ' A' ' 151' ' ' GLU . 32.3 p -137.59 74.23 1.47 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.827 0.822 . . . . 60.44 109.901 -175.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -102.07 74.37 1.44 Allowed 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.261 -0.881 . . . . 71.42 109.776 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -83.43 129.53 34.99 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.519 -0.764 . . . . 72.43 109.413 174.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -71.62 -59.68 2.63 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.741 -0.837 . . . . 73.34 108.741 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -178.51 149.48 0.5 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.373 1.469 . . . . 43.45 108.241 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.2 p -86.46 126.47 34.43 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 109.292 -0.633 . . . . 73.43 109.292 172.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -71.4 149.76 45.65 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.581 -0.896 . . . . 74.34 108.581 169.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.6 tmt? 74.46 155.08 0.16 Allowed 'General case' 0 N--CA 1.485 1.316 0 O-C-N 124.407 1.067 . . . . 74.23 109.587 -174.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.4 m -138.28 120.62 15.91 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.595 -0.69 . . . . 54.25 110.089 -177.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.722 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 4.8 t80 -115.55 133.59 55.89 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.732 1.213 . . . . 74.11 108.283 177.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -152.1 108.44 3.43 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 123.744 0.653 . . . . 72.24 109.501 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.595 HD12 ' HB2' ' C' ' 130' ' ' PRO . 34.5 mt -76.96 125.73 37.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 109.664 -0.495 . . . . 70.0 109.664 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -86.29 -40.32 15.62 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 124.284 0.99 . . . . 72.14 110.113 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -175.38 121.75 0.2 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.489 0.316 . . . . 73.32 110.579 -174.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.6 mt -108.85 135.05 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.79 -0.818 . . . . 71.21 108.79 172.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -164.74 159.4 18.65 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 123.827 0.705 . . . . 74.34 111.784 -172.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.5 p -81.53 115.87 21.04 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.241 -0.89 . . . . 63.31 109.447 173.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -82.19 -25.92 33.83 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.43 -0.581 . . . . 65.32 109.43 174.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.4 t70 -148.38 142.29 25.8 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.167 -0.924 . . . . 74.54 109.676 176.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.557 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 69.1 mt -137.55 142.69 35.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 126.042 1.737 . . . . 64.34 106.617 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.0 t -155.0 135.73 13.58 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.186 0.594 . . . . 64.52 109.465 172.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -135.72 144.68 46.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.252 -1.388 . . . . 71.33 107.252 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -137.18 151.87 49.26 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.803 -0.814 . . . . 74.22 108.803 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.99 79.04 12.17 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 106.937 -1.505 . . . . 73.24 106.937 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.77 -33.93 42.1 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.844 2.363 . . . . 73.33 113.098 -167.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -107.62 24.68 12.52 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.752 0.821 . . . . 74.1 110.281 -176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.613 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -40.88 -62.94 0.86 Allowed Pre-proline 0 CA--C 1.574 1.902 0 CA-C-O 117.547 -1.216 . . . . 65.31 114.245 -167.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 39.1 Cg_exo -59.09 -29.78 91.48 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 122.4 2.067 . . . . 72.1 114.059 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -78.84 -41.54 29.79 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.692 0.797 . . . . 74.23 110.396 -177.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.664 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.2 p -77.36 -20.26 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.714 -1.13 . . . . 45.22 111.784 -161.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -70.97 -22.87 62.14 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.557 0.743 . . . . 71.0 110.923 175.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -83.84 -36.41 23.48 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.503 1.121 . . . . 73.31 109.676 175.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.521 ' HD2' HD13 ' A' ' 68' ' ' LEU . 2.9 tmtp? -67.3 146.98 53.57 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.456 1.502 . . . . 72.44 110.532 -173.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.446 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 7.9 m-20 -58.3 124.99 21.35 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.445 1.098 . . . . 72.01 111.266 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 50.9 t-105 -79.26 82.29 5.43 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.412 0.625 . . . . 74.01 109.733 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -123.24 80.6 52.39 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 108.093 -1.077 . . . . 73.34 108.093 176.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -83.55 124.4 3.58 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.489 2.126 . . . . 60.03 113.718 -168.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -95.9 92.09 6.34 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 106.76 -1.571 . . . . 75.3 106.76 167.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.682 HG21 HG21 ' E' ' 6' ' ' ILE . 16.0 m -79.81 112.41 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 113.911 -1.495 . . . . 55.22 110.965 -172.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 26.3 ttpp -95.56 112.61 24.3 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.71 -1.219 . . . . 74.45 107.71 171.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mp -98.47 107.4 19.85 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.092 -1.077 . . . . 71.45 108.092 -177.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.754 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 3.3 m-20 -104.02 135.34 45.72 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.691 -0.855 . . . . 63.3 108.691 -174.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.441 HD23 HD22 ' E' ' 8' ' ' LEU . 1.2 pp -137.3 145.35 43.34 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.35 0.66 . . . . 73.4 110.001 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.636 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 33.0 t70 -141.66 155.02 45.72 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 123.287 0.635 . . . . 70.31 109.937 -175.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.7 p -105.54 122.78 46.72 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.401 1.081 . . . . 60.24 110.413 -174.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.87 119.93 14.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.806 0.842 . . . . 71.44 109.032 175.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.9 t -131.91 153.28 50.42 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 122.967 0.507 . . . . 73.03 109.789 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' E' ' 22' ' ' ARG . 31.7 t -160.49 143.68 13.45 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.509 0.724 . . . . 51.01 110.318 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.506 ' HB2' ' O ' ' E' ' 20' ' ' LYS . 54.5 tt0 -97.18 117.74 32.06 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.618 -0.882 . . . . 74.35 108.618 173.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 58.4 mt -85.61 -40.7 15.95 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.066 0.546 . . . . 75.03 109.857 177.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.453 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -153.59 176.44 12.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.285 -0.87 . . . . 72.32 110.379 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -69.05 122.8 19.46 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.505 -0.924 . . . . 44.42 108.505 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 74.92 -2.86 2.74 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.616 1.566 . . . . 72.14 112.115 -174.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 60.8 t -111.63 105.38 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.092 0.957 . . . . 72.41 108.698 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -124.95 127.61 47.32 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.967 0.907 . . . . 54.02 109.407 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -102.29 120.9 41.24 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.911 0.884 . . . . 73.11 109.958 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.446 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 43.2 t -102.3 129.17 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.038 -1.468 . . . . 71.4 107.038 171.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.0 t -122.5 120.05 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 108.55 -0.907 . . . . 73.34 108.55 174.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.467 HD22 HG22 ' A' ' 62' ' ' VAL . 1.0 OUTLIER -104.98 112.94 26.25 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.845 -1.168 . . . . 75.34 107.845 177.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.636 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 68.3 ttt180 -83.07 97.47 8.79 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.061 -1.459 . . . . 72.01 107.061 175.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.467 HG22 HD22 ' A' ' 60' ' ' LEU . 42.7 t -97.81 135.1 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 107.695 -1.224 . . . . 34.1 107.695 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.754 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 30.9 m -137.64 141.5 41.2 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.515 -0.55 . . . . 74.01 109.515 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 20.7 t -129.31 108.37 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 125.172 1.389 . . . . 44.21 107.337 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.536 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 29.3 m -102.25 138.06 39.69 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.999 -1.111 . . . . 75.23 107.999 175.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.5 106.05 10.28 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.661 -1.237 . . . . 71.21 107.661 173.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 59.0 m -111.13 123.31 49.94 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.836 -0.431 . . . . 71.3 109.836 177.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.521 HD13 ' HD2' ' A' ' 34' ' ' LYS . 12.8 mt -90.54 73.71 6.83 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 107.295 -1.372 . . . . 51.24 107.295 176.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.15 -122.83 6.19 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 110.851 -0.9 . . . . 42.43 110.851 -171.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -86.87 -24.98 24.71 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.661 0.785 . . . . 73.45 109.005 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -77.92 132.7 38.02 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.369 1.068 . . . . 73.11 109.772 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 70.1 m -89.25 133.23 34.54 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.238 0.472 . . . . 72.31 110.753 173.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.664 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.67 -62.61 1.52 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.803 0.841 . . . . 61.34 109.836 170.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -153.34 173.7 15.28 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.188 -0.914 . . . . 62.52 111.472 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.9 tp -133.59 139.95 46.84 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.731 -1.122 . . . . 65.01 108.479 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.401 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 71.4 m -134.69 97.48 3.79 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.917 0.887 . . . . 74.21 110.294 176.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -113.71 118.8 35.33 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.178 0.591 . . . . 63.5 109.738 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.2 t -128.15 113.64 31.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 124.142 0.977 . . . . 71.1 109.282 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.545 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 71.6 mt-30 -84.66 90.05 7.61 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.276 -1.009 . . . . 74.14 108.276 171.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -79.41 102.97 9.01 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.198 -0.91 . . . . 73.21 109.231 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.12 158.47 31.67 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 111.329 -0.708 . . . . 62.32 111.329 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.35 121.14 1.02 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.93 -0.868 . . . . 55.4 110.93 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.9 mt -81.65 120.87 34.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 108.117 -1.068 . . . . 63.13 108.117 171.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.722 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 46.1 m-85 -128.77 119.12 23.97 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.922 -0.77 . . . . 72.31 108.922 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.7 t -84.77 96.22 9.2 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.628 -0.879 . . . . 62.53 108.628 174.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.6 pt -112.58 135.66 51.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 124.518 1.127 . . . . 64.35 109.425 -177.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.34 165.64 34.25 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.444 0.697 . . . . 71.05 110.798 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.26 41.43 79.12 Favored Glycine 0 C--N 1.347 1.178 0 O-C-N 123.965 0.79 . . . . 70.3 111.908 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.552 HD12 HG21 ' E' ' 18' ' ' VAL . 14.9 pt -139.18 131.32 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 124.501 1.12 . . . . 64.52 110.165 -174.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -142.38 159.0 43.1 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.931 0.892 . . . . 72.45 110.209 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.2 -125.28 39.15 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 115.447 0.939 . . . . 64.23 115.447 170.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -78.73 -25.39 44.57 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.013 0.925 . . . . 60.13 111.001 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.24 -42.29 93.51 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.174 0.99 . . . . 73.52 109.216 178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -78.63 -28.72 45.62 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 116.069 -0.514 . . . . 30.21 111.175 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.92 -25.04 65.28 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.225 0.61 . . . . 74.54 110.646 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -82.95 -35.04 26.33 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.274 0.63 . . . . 75.42 110.685 172.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 81.7 m -63.51 -47.66 80.79 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.129 0.572 . . . . 72.24 111.322 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.43 HD23 HG22 ' E' ' 18' ' ' VAL . 0.2 OUTLIER -82.84 -25.06 32.99 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.551 0.741 . . . . 62.03 109.59 177.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.45 -21.26 45.14 Favored Glycine 0 C--N 1.353 1.502 0 N-CA-C 115.263 0.865 . . . . 73.12 115.263 -170.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.83 -53.85 0.23 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 117.89 0.845 . . . . 60.33 111.837 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -57.7 -60.21 4.03 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 114.352 -1.294 . . . . 72.05 112.509 -171.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.6 m -74.5 -36.28 2.48 Favored Pre-proline 0 CA--C 1.568 1.661 0 N-CA-C 113.144 0.794 . . . . 74.34 113.144 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -50.83 -38.23 56.88 Favored 'Trans proline' 0 C--N 1.397 3.095 0 C-N-CA 122.767 2.311 . . . . 73.51 113.966 164.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -66.03 -38.87 89.51 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.711 0.804 . . . . 72.51 109.983 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.6 mm -58.84 -34.77 53.29 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 C-N-CA 123.784 0.833 . . . . 71.32 111.145 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 88.5 mt -76.27 -28.99 57.27 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.999 0.92 . . . . 72.34 112.665 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.568 ' HZ ' HD22 ' A' ' 128' ' ' LEU . 36.1 t80 -62.35 -44.28 87.61 Favored Pre-proline 0 CA--C 1.569 1.701 0 CA-C-O 117.806 -1.092 . . . . 55.22 113.811 -171.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.56 -31.79 87.47 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.339 2.026 . . . . 54.24 113.52 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -78.19 -35.34 48.76 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.421 0.688 . . . . 74.23 112.028 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.45 -36.58 71.28 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.641 -0.503 . . . . 71.1 109.641 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.644 HH12 HD12 ' C' ' 105' ' ' ILE . 31.9 ttm180 -60.68 -43.77 97.3 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.557 1.143 . . . . 75.22 110.366 172.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -53.99 -54.31 40.86 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.555 1.142 . . . . 75.3 111.207 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 117' ' ' MET . 48.5 t -66.81 -45.85 77.04 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.586 -1.188 . . . . 54.14 111.297 -174.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.456 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 61.6 mt -60.15 -51.89 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.749 0.82 . . . . 71.02 111.123 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.559 HG21 ' HE2' ' C' ' 109' ' ' TYR . 67.6 m -54.6 -44.19 72.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.884 0.874 . . . . 54.3 111.555 177.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 44.8 t -63.57 -41.5 98.38 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.651 -0.704 . . . . 73.4 111.166 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 113' ' ' CYS . 27.0 mtm -69.86 -37.81 76.22 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.94 0.496 . . . . 54.42 111.65 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.92 -50.62 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.38 0.672 . . . . 73.42 109.839 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.1 t -66.22 -31.35 72.13 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 114.801 -1.09 . . . . 63.33 111.192 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 116' ' ' SER . 33.9 ttm-85 -77.5 -31.73 53.74 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.181 0.992 . . . . 62.12 109.404 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.441 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.8 12.15 57.78 Favored Glycine 0 C--N 1.355 1.595 0 CA-C-N 114.804 -1.089 . . . . 51.51 112.508 172.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.441 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.2 t 68.47 13.33 8.96 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 126.964 2.106 . . . . 50.03 113.852 169.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -81.76 155.44 70.72 Favored Pre-proline 0 CA--C 1.555 1.147 0 N-CA-C 108.705 -0.85 . . . . 74.11 108.705 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.04 163.76 13.54 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 122.892 2.395 . . . . 74.31 112.928 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -57.3 124.26 18.26 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 123.802 0.689 . . . . 70.35 111.315 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 66.0 tp -130.06 106.38 8.59 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.695 1.198 . . . . 65.23 109.098 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -119.15 117.34 28.41 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.163 0.985 . . . . 53.5 108.861 176.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.568 HD22 ' HZ ' ' A' ' 107' ' ' PHE . 2.4 tt -70.99 116.61 11.48 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 108.031 -1.1 . . . . 72.11 108.031 178.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.54 145.45 97.29 Favored Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 123.893 0.877 . . . . 73.25 111.021 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.472 ' HD3' HG13 ' C' ' 13' ' ' ILE . 84.6 Cg_endo -75.96 158.69 38.33 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.203 1.935 . . . . 64.32 112.694 -174.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.413 HG13 ' HB1' ' E' ' 7' ' ' ALA . 1.8 m -128.2 116.16 41.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 114.461 -1.245 . . . . 65.05 108.427 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.511 ' HB3' ' HB3' ' A' ' 135' ' ' ALA . 75.6 m-20 -72.94 82.69 1.22 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.359 0.664 . . . . 61.32 109.749 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -62.0 -53.33 57.03 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.404 0.621 . . . . 73.21 109.528 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.61 -42.92 81.61 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 113.661 -1.609 . . . . 62.42 111.005 -169.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.511 ' HB3' ' HB3' ' A' ' 132' ' ' ASN . . . -63.2 -46.03 88.94 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 123.894 0.746 . . . . 71.45 110.634 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.408 HD22 ' HG ' ' E' ' 10' ' ' LEU . 6.4 tt -62.49 -41.32 98.72 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.738 0.815 . . . . 63.5 109.896 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -63.19 -37.03 85.62 Favored 'General case' 0 C--O 1.211 -0.941 0 O-C-N 123.733 0.646 . . . . 74.44 111.269 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.1 mmt -72.47 -39.47 67.7 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 118.013 0.37 . . . . 73.14 111.22 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -69.29 -19.22 63.9 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 122.885 0.474 . . . . 71.1 111.328 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -90.99 -46.62 8.04 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.064 0.459 . . . . 74.23 110.351 176.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.7 tp -69.67 -43.88 71.62 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.621 1.168 . . . . 61.34 112.468 -170.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -158.45 39.14 0.24 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.238 -0.437 . . . . 71.13 110.36 -163.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -42.92 77.83 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 124.586 1.154 . . . . 75.43 113.31 170.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -174.37 117.63 0.22 Allowed 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.891 1.276 . . . . 73.41 108.18 -173.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -126.48 129.68 49.14 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.801 0.84 . . . . 62.21 109.831 -177.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.44 -42.5 14.32 Favored Glycine 0 C--N 1.344 0.989 0 N-CA-C 110.539 -1.024 . . . . 43.14 110.539 169.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -155.59 172.59 18.02 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.384 0.674 . . . . 75.14 110.984 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -146.28 18.1 1.71 Allowed Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.643 -0.708 . . . . 54.41 112.526 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.47 110.96 10.28 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 123.217 0.607 . . . . 64.31 110.864 177.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.18 148.45 28.46 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.313 1.045 . . . . 72.44 110.213 176.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.72 ' HB2' ' HA ' ' A' ' 2' ' ' SER . 8.5 pt-20 -87.1 74.88 9.54 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 121.884 0.85 . . . . 74.42 110.23 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -67.29 116.02 7.61 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.167 -0.924 . . . . 64.44 110.417 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -86.86 169.44 12.54 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.723 0.809 . . . . 72.42 110.945 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -143.92 153.14 41.99 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.633 -1.247 . . . . 71.21 107.633 170.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' G' ' 12' ' ' PRO . . . . . . . . 0 C--O 1.247 0.951 0 N-CA-C 109.11 -0.7 . . . . 73.14 109.11 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.497 ' HB3' ' NE2' ' B' ' 4' ' ' GLN . 54.7 mtt . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 121.22 0.533 . . . . 71.41 109.939 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 54.9 p -105.13 -4.68 21.56 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.834 0.854 . . . . 72.21 110.959 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.67 114.88 17.91 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.678 1.191 . . . . 64.23 107.789 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.497 ' NE2' ' HB3' ' B' ' 1' ' ' MET . 84.8 mm-40 -122.86 130.61 53.08 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.207 0.603 . . . . 64.34 110.592 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -88.22 -176.18 5.3 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.219 1.008 . . . . 73.22 109.564 170.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -151.4 138.49 19.18 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.737 -0.838 . . . . 74.25 108.737 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -142.21 16.86 2.07 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 122.903 0.481 . . . . 54.01 111.294 -173.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -147.97 60.95 1.12 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.522 0.729 . . . . 74.02 110.634 -173.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' B' ' 10' ' ' THR . 0.9 OUTLIER 66.01 165.92 0.19 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 125.067 1.347 . . . . 52.44 110.813 -174.309 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.619 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 94.0 m -145.49 114.81 7.11 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.28 -0.888 . . . . 64.25 108.99 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.613 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 51.5 t80 -131.39 132.69 44.59 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 122.957 0.503 . . . . 74.11 110.258 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.48 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -160.21 141.31 12.25 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.159 0.584 . . . . 75.51 110.285 174.28 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 23.2 mt -82.82 123.76 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.792 -0.818 . . . . 71.12 108.792 172.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -89.71 -49.91 6.37 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.438 -0.578 . . . . 71.12 109.438 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.419 ' HE ' HG21 ' A' ' 122' ' ' THR . 42.2 ttt180 -166.23 135.8 3.21 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.816 -0.629 . . . . 72.5 110.021 -175.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.7 mt -115.22 141.47 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 107.547 -1.279 . . . . 62.02 107.547 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -166.36 147.94 6.59 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.935 0.874 . . . . 72.11 112.369 -173.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.8 m -79.58 122.0 25.96 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.142 -1.39 . . . . 53.43 108.387 172.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.411 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 41.9 mtpt -97.33 -19.09 18.75 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.482 0.713 . . . . 73.23 111.138 -177.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -167.71 142.83 3.81 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.831 0.707 . . . . 71.33 110.377 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 38.7 mm -131.63 142.87 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.79 1.236 . . . . 75.32 108.736 172.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 44.3 t -143.78 110.27 5.5 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.414 1.086 . . . . 71.23 108.159 174.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.557 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 92.0 t80 -128.77 109.98 11.77 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.986 -1.116 . . . . 73.12 107.986 172.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -118.75 127.25 53.37 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.893 -0.781 . . . . 73.45 108.893 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.476 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -112.53 86.4 8.32 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 107.769 -1.197 . . . . 64.5 107.769 176.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -65.94 -43.08 9.94 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.87 2.38 . . . . 64.12 112.648 -168.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -104.26 16.78 25.46 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.098 0.959 . . . . 71.35 110.579 -175.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.476 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -38.73 -64.8 0.44 Allowed Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 115.007 1.484 . . . . 61.5 115.007 -162.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.29 -26.05 49.18 Favored 'Trans proline' 0 C--N 1.389 2.682 0 C-N-CA 121.992 1.794 . . . . 61.21 113.451 -170.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -97.5 -23.24 16.13 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.351 0.661 . . . . 53.4 112.736 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.535 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.3 p -80.58 -18.87 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 117.869 0.304 . . . . 75.24 111.08 -176.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -61.51 -27.58 68.7 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.792 0.837 . . . . 62.0 113.249 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -57.3 -23.25 47.31 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.452 0.701 . . . . 73.13 112.159 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -89.52 89.0 7.65 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.41 1.084 . . . . 71.34 109.974 -176.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.49 87.65 6.21 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.447 -0.797 . . . . 61.42 110.949 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -163.19 173.23 13.69 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.343 1.057 . . . . 74.44 108.722 167.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -71.83 117.08 54.62 Favored Pre-proline 0 N--CA 1.474 0.739 0 N-CA-C 109.192 -0.67 . . . . 63.51 109.192 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.19 153.82 71.65 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.279 1.986 . . . . 54.43 112.626 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.05 120.42 10.82 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 107.756 -1.201 . . . . 73.5 107.756 170.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 m -116.51 123.03 71.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.435 -0.802 . . . . 74.12 110.219 -167.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.587 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 77.2 tttt -106.98 121.31 44.2 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.66 1.184 . . . . 61.44 107.835 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.795 HD22 HD11 ' B' ' 128' ' ' LEU . 46.5 tp -96.89 137.39 36.04 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.655 -0.869 . . . . 64.25 108.655 169.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -144.01 152.54 41.17 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.22 1.008 . . . . 73.12 109.034 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.613 HD22 HD13 ' F' ' 8' ' ' LEU . 27.7 tp -128.7 157.29 41.79 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.688 0.795 . . . . 73.52 109.102 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.402 ' HB3' ' HD3' ' B' ' 61' ' ' ARG . 29.0 t70 -145.28 140.4 27.77 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.654 -0.869 . . . . 54.52 108.654 170.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 54.7 p -108.84 113.87 27.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.914 0.886 . . . . 52.51 109.401 -172.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.61 132.05 36.62 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.242 1.017 . . . . 62.41 108.692 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.513 ' HB3' ' HE2' ' F' ' 15' ' ' PHE . 59.6 p -147.55 178.87 8.1 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.009 0.433 . . . . 63.44 111.464 174.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.7 p -160.35 137.94 9.6 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.675 1.19 . . . . 41.34 108.91 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -88.63 128.16 35.58 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.209 -0.663 . . . . 73.0 109.209 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 78.2 mt -91.38 -40.09 11.64 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.106 0.563 . . . . 54.33 110.552 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.55 -172.49 2.93 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.332 0.586 . . . . 64.35 110.801 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.75 128.66 37.31 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.358 -1.292 . . . . 74.55 108.289 172.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.562 ' HB3' ' HB2' ' B' ' 87' ' ' ALA . 9.9 m-20 64.81 3.28 1.98 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.367 1.067 . . . . 75.2 113.31 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 91.6 t -120.45 120.19 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.879 0.872 . . . . 72.25 109.226 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.636 ' HB2' HD11 ' B' ' 86' ' ' ILE . 0.4 OUTLIER -129.21 154.54 46.67 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.931 -0.766 . . . . 64.03 108.931 178.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -125.44 108.1 11.31 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.418 -1.697 . . . . 73.23 106.418 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 31.2 m -109.42 139.43 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 122.964 0.506 . . . . 72.23 110.386 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.518 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 31.7 t -120.86 111.8 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.475 1.11 . . . . 42.43 109.128 -176.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.606 HD13 ' HB3' ' B' ' 103' ' ' PRO . 14.5 tp -94.38 100.07 12.16 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.702 -0.851 . . . . 62.32 108.702 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.497 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 70.2 ttt180 -88.62 106.8 18.55 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.161 0.584 . . . . 74.42 109.867 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.81 106.07 19.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.087 -1.079 . . . . 60.42 108.087 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 27.9 m -109.33 138.41 45.73 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.641 0.776 . . . . 72.34 109.895 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 88.4 t -134.33 134.18 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.33 1.052 . . . . 75.43 109.502 -175.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.587 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 62.8 m -109.78 149.2 30.15 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.869 0.868 . . . . 72.01 109.56 170.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.18 137.22 38.92 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.777 0.831 . . . . 44.33 109.176 177.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 11.0 m -137.4 124.31 21.36 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.292 0.637 . . . . 74.23 110.898 -175.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.466 HD12 HG22 ' B' ' 31' ' ' VAL . 47.0 mt -104.34 113.85 27.69 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.992 -0.744 . . . . 72.55 108.992 176.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.09 -110.57 3.31 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 114.987 -1.006 . . . . 33.52 111.859 -172.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -117.33 5.33 12.59 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.945 0.898 . . . . 73.14 109.943 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -125.52 164.65 20.05 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.884 0.474 . . . . 55.31 110.59 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 62.1 m -79.92 122.91 27.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.652 0.781 . . . . 70.42 110.641 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.535 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -70.83 -63.63 1.06 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.311 0.645 . . . . 71.3 109.358 172.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -150.7 167.73 26.48 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 115.066 -0.97 . . . . 72.23 111.977 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 65.4 mt -129.98 113.57 14.74 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.141 -1.8 . . . . 72.21 106.141 175.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.475 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 30.2 t -123.01 130.45 52.82 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 109.518 -0.549 . . . . 74.22 109.518 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -149.55 131.88 15.58 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.757 -0.831 . . . . 73.03 108.757 -170.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' B' ' 113' ' ' CYS . 66.1 t -129.81 144.29 38.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 123.946 0.899 . . . . 74.24 109.005 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.497 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 20.6 mt-30 -118.61 93.61 4.17 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.165 -1.05 . . . . 73.01 108.165 172.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -91.82 100.75 13.38 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.891 -0.595 . . . . 74.12 109.495 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.2 164.06 30.68 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 115.813 -0.63 . . . . 43.23 111.75 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.8 129.48 1.98 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 112.083 -0.407 . . . . 44.4 112.083 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 38.4 mt -85.42 126.85 40.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 108.214 -1.032 . . . . 74.41 108.214 171.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -133.5 144.22 49.27 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.479 0.712 . . . . 71.52 109.723 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 31.5 m -90.41 113.98 26.01 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.179 0.992 . . . . 54.11 108.837 170.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.636 HD11 ' HB2' ' B' ' 56' ' ' TYR . 0.2 OUTLIER -128.09 125.1 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.055 0.942 . . . . 71.14 109.024 178.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.619 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.32 172.96 17.58 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.153 0.427 . . . . 54.33 112.153 -175.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.49 -54.68 3.84 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.525 -0.761 . . . . 75.4 112.056 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 32.5 mm -91.25 157.2 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 124.22 1.008 . . . . 70.13 110.601 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.528 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 30.8 tt0 -161.5 153.66 19.75 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.755 0.822 . . . . 73.35 109.619 173.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 102.6 -136.0 12.58 Favored Glycine 0 C--N 1.352 1.453 0 C-N-CA 123.711 0.672 . . . . 73.35 112.917 -175.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 63.5 m -71.95 -43.24 65.55 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 117.421 0.611 . . . . 72.33 111.552 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -58.51 -32.25 68.64 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.508 0.723 . . . . 71.41 110.555 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.528 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 7.2 tpt -72.1 -44.78 62.69 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.246 -0.888 . . . . 75.15 110.426 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.693 ' HB1' ' HB3' ' F' ' 14' ' ' LEU . . . -63.33 -23.18 67.3 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.011 -0.995 . . . . 71.22 111.424 176.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.533 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 58.1 t-80 -82.82 -20.75 35.08 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.337 1.055 . . . . 64.44 110.874 174.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.7 t -86.11 -67.25 0.82 Allowed 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.993 -0.442 . . . . 63.13 111.314 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.689 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 1.7 pt? -83.94 -14.73 50.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.551 -0.718 . . . . 72.11 111.809 -174.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.83 1.65 55.42 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.376 0.422 . . . . 65.41 113.855 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -143.43 -59.7 0.41 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.438 0.695 . . . . 73.4 109.833 -176.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -71.63 -48.58 46.96 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.215 0.606 . . . . 63.14 112.494 -173.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.689 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 59.2 m -64.35 -43.14 71.4 Favored Pre-proline 0 CA--C 1.56 1.345 0 N-CA-C 112.872 0.693 . . . . 64.33 112.872 -175.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.606 ' HB3' HD13 ' B' ' 60' ' ' LEU . 51.8 Cg_exo -60.12 -30.65 91.88 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 122.191 1.927 . . . . 73.14 113.384 172.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -65.79 -26.89 67.9 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 122.945 0.498 . . . . 63.21 111.641 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 74.2 mt -71.25 -43.71 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.515 0.726 . . . . 74.43 109.49 173.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 99.1 mt -74.13 -23.53 59.3 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.011 -0.995 . . . . 73.14 112.087 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -57.42 -51.9 78.29 Favored Pre-proline 0 CA--C 1.563 1.466 0 CA-C-O 117.696 -1.145 . . . . 71.14 113.42 -173.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.22 -32.04 94.9 Favored 'Trans proline' 0 C--N 1.392 2.854 0 C-N-CA 122.314 2.009 . . . . 54.41 113.7 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.416 ' HE2' HG21 ' D' ' 115' ' ' THR . 33.7 m-85 -72.57 -40.27 66.76 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.552 0.741 . . . . 50.53 110.229 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.79 -37.87 87.48 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.305 0.642 . . . . 61.21 110.491 173.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.412 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 56.8 ttt-85 -69.4 -50.33 46.89 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.415 1.486 . . . . 72.34 111.223 -171.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.55 -37.4 87.17 Favored 'General case' 0 N--CA 1.484 1.225 0 O-C-N 123.898 0.749 . . . . 73.35 109.286 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.473 ' O ' ' HG2' ' B' ' 117' ' ' MET . 28.8 t -64.07 -40.73 96.9 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.371 0.669 . . . . 62.31 112.003 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.477 ' O ' HG23 ' B' ' 118' ' ' VAL . 70.9 mt -61.05 -56.48 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.692 -0.485 . . . . 75.43 109.692 175.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.8 m -61.77 -26.86 68.35 Favored 'General case' 0 CA--C 1.557 1.216 0 O-C-N 123.752 0.658 . . . . 75.45 111.586 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.8 t -71.66 -43.25 66.4 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.726 0.81 . . . . 72.43 110.078 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.6 mmt -71.11 -31.92 68.37 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.538 0.335 . . . . 61.13 110.528 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.477 HG23 ' O ' ' B' ' 114' ' ' ILE . 99.1 t -62.7 -43.22 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 124.068 0.947 . . . . 65.33 109.914 170.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 64.0 m -65.89 -36.42 83.37 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.24 -0.891 . . . . 44.5 111.764 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' B' ' 116' ' ' SER . 68.8 mtt-85 -68.53 -38.16 80.62 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.521 -0.763 . . . . 65.23 109.554 176.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.72 -0.29 79.94 Favored Glycine 0 C--N 1.354 1.571 0 O-C-N 124.026 0.829 . . . . 70.14 113.264 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 73.0 p 61.17 16.52 7.28 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 126.343 1.857 . . . . 51.14 113.831 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -77.09 160.06 76.91 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 123.496 0.718 . . . . 64.14 111.493 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -47.14 146.21 6.73 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 123.748 2.965 . . . . 72.31 114.724 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -58.86 122.59 13.98 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.558 1.143 . . . . 74.24 111.095 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 52.8 tp -138.98 99.26 3.72 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.208 0.603 . . . . 65.33 109.851 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -99.12 131.51 45.1 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.739 0.816 . . . . 71.53 108.886 172.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.795 HD11 HD22 ' B' ' 42' ' ' LEU . 25.6 tp -81.99 152.43 26.7 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.23 0.612 . . . . 65.51 112.067 -174.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.54 146.22 83.31 Favored Pre-proline 0 N--CA 1.482 1.126 0 C-N-CA 123.835 0.854 . . . . 63.4 111.644 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -70.82 119.18 6.13 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.158 2.572 . . . . 53.1 111.15 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.662 HG21 HD12 ' F' ' 8' ' ' LEU . 26.7 m -107.5 110.88 33.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.892 0.853 . . . . 73.33 108.912 174.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -110.42 88.8 2.85 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.19 -1.041 . . . . 74.02 108.19 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -61.33 -34.21 74.88 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.636 -0.711 . . . . 73.02 110.73 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.74 -54.11 46.97 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.563 1.145 . . . . 64.45 111.255 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.95 -22.65 65.93 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.367 -0.833 . . . . 61.32 111.541 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.51 -53.68 13.06 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 109.125 -0.695 . . . . 74.51 109.125 175.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -69.37 -15.85 63.4 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.108 0.563 . . . . 74.03 111.869 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -63.19 -29.54 70.86 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.105 0.962 . . . . 72.32 111.028 174.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -72.88 -24.8 60.9 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.162 0.585 . . . . 63.14 110.908 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -70.47 -29.2 65.69 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.19 0.596 . . . . 75.43 110.017 173.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 59.0 mt -107.09 19.6 20.2 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.09 0.956 . . . . 71.43 111.039 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -70.28 138.56 51.68 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.523 0.729 . . . . 75.43 111.749 -174.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -115.01 -178.48 3.37 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.521 1.128 . . . . 71.53 111.38 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -105.84 134.85 48.3 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.011 0.924 . . . . 73.3 109.518 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -169.26 -146.21 0.06 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.273 1.429 . . . . 75.3 108.01 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . 0.444 ' HA2' ' H ' ' D' ' 3' ' ' GLU . . . 73.85 37.33 51.16 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-N 117.926 0.33 . . . . 72.52 113.923 171.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -81.03 96.22 7.06 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.258 -1.016 . . . . 72.42 108.258 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -107.47 142.64 15.83 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 116.364 -0.38 . . . . 64.34 112.18 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 22.6 p -132.26 139.56 48.3 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.916 0.886 . . . . 70.0 110.236 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.83 -175.14 2.66 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.632 0.773 . . . . 74.13 110.573 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -144.67 157.94 43.99 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.61 0.764 . . . . 63.41 109.446 172.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -128.68 29.29 5.28 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.515 1.126 . . . . 71.31 108.87 -173.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -60.44 114.25 2.85 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.869 0.867 . . . . 72.13 110.826 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -146.97 89.15 1.79 Allowed 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.666 -0.864 . . . . 71.21 108.666 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.168 0 CA-C-N 115.565 -0.743 . . . . 64.51 109.792 178.181 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.645 0 N-CA-C 106.777 -1.564 . . . . 73.41 106.777 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 44.9 m -71.97 -76.12 0.12 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.066 0.854 . . . . 73.52 111.208 -173.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -172.87 -75.56 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.453 -0.573 . . . . 61.14 109.453 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -139.22 150.08 45.1 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.28 1.032 . . . . 62.13 108.429 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -70.89 95.26 1.14 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.071 0.548 . . . . 74.43 109.933 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -75.66 140.35 42.49 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.027 -1.101 . . . . 72.3 108.027 172.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 19.5 p -62.38 97.39 0.09 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.757 0.823 . . . . 50.23 111.491 -176.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 68.9 104.95 0.06 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.864 1.666 . . . . 73.14 110.825 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.407 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 0.0 OUTLIER 66.62 114.03 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 126.017 1.727 . . . . 62.51 111.869 179.076 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 42.6 m -98.28 97.53 8.91 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.034 0.934 . . . . 51.35 109.165 173.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.701 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 14.7 t80 -106.98 125.34 50.88 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.125 -1.065 . . . . 61.14 108.125 176.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -136.46 119.26 16.19 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.014 -0.736 . . . . 71.34 109.014 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.472 HG13 ' HD3' ' A' ' 130' ' ' PRO . 35.5 mt -73.13 128.02 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.936 -0.764 . . . . 60.43 108.936 175.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -92.65 -48.23 6.7 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.149 -0.685 . . . . 53.53 109.149 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -173.22 134.44 0.54 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.92 -0.77 . . . . 75.33 108.92 -169.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 94.5 mt -126.27 142.23 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 108.017 -1.105 . . . . 54.41 108.017 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.554 ' HB3' HG23 ' D' ' 122' ' ' THR . 26.6 p90 -173.68 167.3 4.51 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 123.942 0.776 . . . . 65.35 110.488 -174.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -86.57 119.07 26.43 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.84 -1.073 . . . . 65.31 109.062 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.7 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 10.8 mmmm -70.44 -45.8 65.12 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.999 -1.112 . . . . 53.43 107.999 169.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.606 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 5.1 t70 -139.53 147.83 41.77 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 113.776 -1.556 . . . . 75.55 110.258 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.4 mt -137.94 149.08 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.977 1.711 . . . . 60.25 107.24 174.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.4 t -162.04 150.3 14.91 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.427 0.632 . . . . 71.43 110.614 172.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 91.6 t80 -143.65 146.18 33.04 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 107.029 -1.471 . . . . 53.31 107.029 170.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -149.35 115.87 5.86 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.28 1.032 . . . . 64.25 109.011 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.05 92.01 12.21 Favored Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 105.649 -1.982 . . . . 71.04 105.649 165.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -57.25 -49.93 12.55 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.277 2.652 . . . . 65.23 112.513 -171.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -106.73 39.16 1.9 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.504 0.722 . . . . 64.35 109.488 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.545 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -37.86 -58.56 1.35 Allowed Pre-proline 0 CA--C 1.571 1.75 0 N-CA-C 115.183 1.549 . . . . 62.14 115.183 -171.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.419 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 20.3 Cg_exo -60.56 -43.29 33.93 Favored 'Trans proline' 0 C--N 1.387 2.6 0 CA-C-N 122.198 1.821 . . . . 65.51 112.418 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -69.13 -32.44 71.81 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.14 -0.937 . . . . 75.21 112.258 -175.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.724 HG21 ' HA ' ' C' ' 73' ' ' ALA . 12.4 p -79.38 -27.47 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 122.528 0.331 . . . . 62.44 111.769 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -66.69 -23.08 66.08 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 112.114 0.413 . . . . 75.52 112.114 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -95.55 15.58 19.43 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.392 0.677 . . . . 63.43 111.841 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.792 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -91.52 160.83 15.23 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.369 0.668 . . . . 70.13 110.451 177.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -69.01 130.26 42.28 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.833 0.853 . . . . 71.35 108.784 162.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -84.55 102.34 12.79 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.913 0.485 . . . . 75.31 110.607 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -155.37 77.4 4.85 Favored Pre-proline 0 N--CA 1.476 0.83 0 N-CA-C 108.674 -0.861 . . . . 71.13 108.674 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -88.31 148.65 6.52 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.71 2.273 . . . . 71.31 113.819 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -86.52 99.34 11.61 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 107.013 -1.477 . . . . 70.43 107.013 159.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.513 ' HB ' HG21 ' G' ' 6' ' ' ILE . 35.3 t -78.54 101.04 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 108.591 -0.892 . . . . 75.45 108.591 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.556 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 62.3 mttm -99.26 105.38 17.4 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.899 -0.778 . . . . 72.11 108.899 -176.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.406 HD13 HD21 ' C' ' 128' ' ' LEU . 42.5 tp -83.64 130.02 34.97 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 109.134 -0.691 . . . . 54.3 109.134 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -129.19 139.74 51.77 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.326 1.45 . . . . 73.44 108.284 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.33 147.59 50.25 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.844 0.458 . . . . 62.23 110.702 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 1.5 t70 -130.09 147.49 51.84 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.117 1.367 . . . . 71.22 108.693 173.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 87.9 m -111.51 114.17 27.08 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.709 0.804 . . . . 73.04 109.643 -174.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -118.36 139.9 50.66 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.29 1.036 . . . . 52.21 108.317 173.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.47 ' HB2' ' OH ' ' C' ' 56' ' ' TYR . 64.8 p -154.26 143.76 21.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.172 -0.33 . . . . 73.53 111.179 -172.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 27.8 p -159.0 128.01 5.4 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 123.923 0.764 . . . . 73.11 109.808 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -80.1 138.27 36.92 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.974 -0.75 . . . . 73.51 108.974 173.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.566 HD11 HD12 ' C' ' 83' ' ' ILE . 49.1 mt -105.48 -38.9 6.3 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.004 0.522 . . . . 73.32 110.712 -176.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.69 -170.55 2.79 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.379 0.672 . . . . 71.31 110.957 -177.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -70.39 112.25 6.56 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.261 -0.881 . . . . 62.2 109.785 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 71.24 -1.42 2.74 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 125.396 1.479 . . . . 73.13 112.944 -175.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.559 HG21 ' HA ' ' E' ' 1' ' ' MET . 66.2 t -102.31 120.02 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.096 -0.705 . . . . 74.23 109.096 175.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.47 ' OH ' ' HB2' ' C' ' 48' ' ' SER . 51.0 t80 -138.62 132.07 30.39 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.104 -1.073 . . . . 70.35 108.104 -174.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.501 ' HB2' HD11 ' C' ' 51' ' ' LEU . 39.9 tt0 -94.48 117.67 30.48 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.384 -0.825 . . . . 71.12 109.045 173.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 35.7 m -96.65 130.14 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.625 -1.25 . . . . 70.23 107.625 168.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 61.9 t -124.02 125.34 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.85 -1.167 . . . . 63.43 107.85 172.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 tp -125.9 116.41 21.47 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.013 -1.106 . . . . 73.24 108.013 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.506 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.7 ttm180 -79.12 122.25 26.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.772 -1.103 . . . . 75.14 109.036 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 11.4 t -100.81 129.06 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.019 -1.474 . . . . 72.23 107.019 171.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 62.8 m -131.95 110.53 10.83 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.089 -1.078 . . . . 75.11 108.089 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 85.1 t -101.75 112.33 34.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.578 -1.192 . . . . 62.22 108.231 -175.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.556 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 20.7 m -97.92 141.15 31.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.014 -1.106 . . . . 73.31 108.014 173.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.33 107.5 6.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 106.233 -1.766 . . . . 55.21 106.233 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 46.2 m -127.16 146.34 50.43 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.611 -0.514 . . . . 70.41 109.611 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.792 HD13 ' HG2' ' C' ' 34' ' ' LYS . 13.1 mt -110.41 35.59 3.39 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.661 1.584 . . . . 65.23 108.2 -173.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.88 -109.68 2.99 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 110.096 -1.202 . . . . 72.12 110.096 -169.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.93 -30.01 18.13 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.869 0.868 . . . . 73.13 110.314 176.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -73.52 103.07 4.02 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.726 0.81 . . . . 74.2 109.77 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 92.6 m -73.26 118.87 16.73 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.544 -0.91 . . . . 75.23 108.544 170.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.724 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -67.68 -57.75 5.85 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 124.464 1.102 . . . . 51.34 109.11 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -156.89 171.65 20.05 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.663 -1.153 . . . . 63.34 111.656 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -139.44 140.02 37.21 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 104.839 -2.282 . . . . 74.44 104.839 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.484 ' SG ' HG23 ' C' ' 114' ' ' ILE . 38.3 t -147.54 112.43 5.42 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.964 -0.754 . . . . 72.21 108.964 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -121.8 116.46 24.5 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.708 0.803 . . . . 75.52 110.147 -171.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 55.5 t -125.06 115.45 44.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.955 0.902 . . . . 73.41 109.357 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.606 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.1 mt-30 -90.96 97.85 11.43 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.807 -0.812 . . . . 73.25 108.807 173.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.671 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.1 tp-100 -86.98 117.32 25.62 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.339 0.655 . . . . 73.21 109.766 -177.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.3 146.35 18.23 Favored Glycine 0 C--N 1.342 0.909 0 O-C-N 123.813 0.695 . . . . 71.42 111.831 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.411 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -143.4 116.35 0.99 Allowed Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.754 -0.538 . . . . 43.5 111.754 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.566 HD12 HD11 ' C' ' 51' ' ' LEU . 7.7 mm -82.97 122.16 37.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 107.945 -1.131 . . . . 64.02 107.945 174.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.413 ' HD2' ' HA ' ' C' ' 13' ' ' ILE . 54.7 m-85 -138.26 132.16 31.3 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.426 0.691 . . . . 74.24 109.956 -176.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 21.8 p -95.22 103.97 15.85 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 108.17 -1.048 . . . . 72.14 108.17 169.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.525 HD13 ' H ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -124.15 137.04 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 124.144 0.977 . . . . 74.4 111.459 -171.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.67 173.38 11.96 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.352 1.061 . . . . 73.41 110.934 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 116.89 -49.03 0.88 Allowed Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.941 -0.572 . . . . 63.21 111.74 172.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 30.0 pt -92.31 170.17 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.488 0.715 . . . . 71.12 110.284 177.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -146.17 148.47 32.58 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.975 0.51 . . . . 73.24 111.226 -168.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.51 -133.32 23.46 Favored Glycine 0 C--N 1.35 1.33 0 O-C-N 123.745 0.653 . . . . 74.3 114.222 172.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.4 p -66.69 -18.55 65.43 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.111 0.964 . . . . 73.2 112.229 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -68.35 -43.22 77.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.196 0.598 . . . . 70.11 110.144 172.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 15.5 ttt -76.72 -31.57 57.25 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.601 -0.727 . . . . 74.53 110.55 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.19 -40.23 90.27 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.373 0.669 . . . . 63.21 110.558 172.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -59.56 -41.75 90.87 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.473 1.109 . . . . 74.5 111.006 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 50.4 t -63.79 -54.27 37.73 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.539 0.524 . . . . 64.33 110.223 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.534 HD11 HG23 ' G' ' 18' ' ' VAL . 90.0 mt -63.03 -36.36 83.31 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.332 0.653 . . . . 72.24 112.036 -177.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.6 11.28 66.7 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.497 -0.613 . . . . 73.01 114.304 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.65 -58.02 0.1 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 117.555 0.677 . . . . 43.11 111.999 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -74.51 -48.4 27.37 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.662 0.385 . . . . 63.24 112.002 -172.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.701 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 41.9 m -60.51 -47.2 96.88 Favored Pre-proline 0 CA--C 1.563 1.458 0 C-N-CA 123.97 0.908 . . . . 75.44 112.11 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.87 -12.07 19.87 Favored 'Trans proline' 0 C--N 1.395 3.024 0 C-N-CA 122.026 1.818 . . . . 64.52 113.608 172.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . 0.506 ' HA ' ' CD2' ' C' ' 107' ' ' PHE . 59.7 t30 -71.76 -32.66 67.93 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.434 0.635 . . . . 73.13 109.914 173.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.644 HD12 HH12 ' A' ' 111' ' ' ARG . 30.0 mm -65.54 -30.84 51.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-N 115.143 -0.935 . . . . 73.33 109.822 170.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.411 HD21 ' HA3' ' C' ' 82' ' ' GLY . 65.5 mt -88.14 -22.64 23.97 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.887 0.875 . . . . 71.14 113.208 -175.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.506 ' CD2' ' HA ' ' C' ' 104' ' ' ASN . 11.8 m-85 -55.38 -48.36 96.48 Favored Pre-proline 0 N--CA 1.49 1.536 0 CA-C-O 117.242 -1.361 . . . . 75.12 113.218 -177.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -54.46 -39.53 87.43 Favored 'Trans proline' 0 C--N 1.39 2.75 0 C-N-CA 122.881 2.387 . . . . 73.41 114.461 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.559 ' HE2' HG21 ' A' ' 115' ' ' THR . 73.9 m-85 -70.04 -49.33 52.34 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.214 0.605 . . . . 72.34 110.901 -176.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.671 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -67.75 -31.97 72.25 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 115.615 -0.72 . . . . 73.42 111.081 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 26.6 ttt-85 -59.21 -54.19 49.76 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.675 1.19 . . . . 71.14 110.328 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -69.33 -29.05 66.79 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.767 0.667 . . . . 64.41 110.425 -177.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 42.7 t -70.22 -38.39 75.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.186 0.594 . . . . 71.3 110.813 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.484 HG23 ' SG ' ' C' ' 76' ' ' CYS . 87.3 mt -69.54 -49.09 62.24 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.157 0 C-N-CA 123.259 0.624 . . . . 65.33 109.742 174.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 90.5 m -63.25 -33.08 74.72 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.012 0.925 . . . . 75.25 110.977 -175.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 41.8 t -64.62 -46.67 81.6 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 115.349 -0.841 . . . . 74.31 109.092 172.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.49 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.98 -36.43 84.38 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.895 1.278 . . . . 62.4 112.929 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' C' ' 114' ' ' ILE . 97.4 t -65.56 -44.54 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.093 0.957 . . . . 72.14 108.774 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 30.6 t -66.13 -33.62 76.19 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.162 -1.381 . . . . 61.32 111.496 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -70.94 -32.2 69.01 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.648 0.779 . . . . 72.13 109.453 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.3 9.06 76.73 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 123.717 0.636 . . . . 75.03 112.947 174.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 46.0 p 58.19 30.62 19.67 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 126.143 1.777 . . . . 74.15 114.016 174.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -93.02 147.27 33.54 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 108.81 -0.811 . . . . 74.33 108.81 172.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.34 159.76 5.63 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 123.386 2.724 . . . . 62.01 113.742 174.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -47.39 125.59 8.36 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.797 1.239 . . . . 65.31 112.934 -176.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.81 91.25 3.31 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.327 -1.36 . . . . 75.42 107.327 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -116.62 122.18 43.86 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.407 1.083 . . . . 63.12 108.168 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.406 HD21 HD13 ' C' ' 42' ' ' LEU . 6.7 mp -69.11 145.94 52.97 Favored 'General case' 0 C--O 1.245 0.832 0 O-C-N 123.406 0.441 . . . . 61.13 110.479 177.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.44 ' HA ' ' HD3' ' C' ' 130' ' ' PRO . . . -72.8 136.22 80.33 Favored Pre-proline 0 CA--C 1.552 1.041 0 O-C-N 124.107 0.879 . . . . 73.01 110.013 177.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.595 ' HB2' HD12 ' A' ' 13' ' ' ILE . 11.1 Cg_exo -69.22 100.7 0.77 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 123.173 2.582 . . . . 52.15 113.725 -170.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.0 t -101.04 108.62 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 108.051 -1.092 . . . . 65.51 108.051 170.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.404 HD22 ' H ' ' C' ' 135' ' ' ALA . 1.9 t30 -81.41 92.61 6.46 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 107.091 -1.448 . . . . 71.5 107.091 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -65.43 -35.91 82.33 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.057 0.943 . . . . 71.42 112.642 -161.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -70.1 -41.1 74.46 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.516 0.727 . . . . 73.55 111.589 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.404 ' H ' HD22 ' C' ' 132' ' ' ASN . . . -62.66 -33.36 74.9 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.883 0.739 . . . . 54.21 111.181 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 7.7 tt -54.14 -47.45 71.9 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.957 0.903 . . . . 71.41 110.477 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -80.8 -26.25 37.28 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.438 0.695 . . . . 71.23 111.816 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -77.38 -36.59 53.36 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.719 0.808 . . . . 65.23 111.414 -175.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -55.14 -35.52 64.79 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.053 0.941 . . . . 73.22 111.685 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -59.65 -86.14 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.367 0 O-C-N 123.891 0.745 . . . . 73.44 110.349 172.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 50.7 tp 57.64 -81.5 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.216 1.406 . . . . 65.12 112.759 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -163.28 -172.93 3.16 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.408 1.083 . . . . 62.22 109.914 -172.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -94.39 -27.05 16.26 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.592 0.757 . . . . 60.24 111.746 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -55.41 116.9 3.12 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 124.543 1.137 . . . . 64.42 112.165 -170.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.41 150.71 30.76 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.29 1.036 . . . . 44.03 109.825 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.5 174.05 37.56 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 111.188 -0.765 . . . . 74.42 111.188 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -103.12 156.88 17.39 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.572 0.749 . . . . 74.42 111.452 -172.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -163.49 78.36 0.15 Allowed Glycine 0 C--N 1.342 0.872 0 N-CA-C 110.791 -0.924 . . . . 74.04 110.791 -175.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 8.8 t -156.74 134.82 11.16 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.34 0.656 . . . . 44.1 110.111 -177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -166.8 113.58 0.81 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.395 1.078 . . . . 73.52 108.365 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -147.34 160.78 42.14 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.489 0.716 . . . . 73.32 110.651 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -158.43 -81.29 0.06 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.141 0.976 . . . . 64.32 108.424 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 173.36 127.79 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.799 1.64 . . . . 74.11 107.082 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.67 -51.93 65.29 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.995 0.518 . . . . 52.12 109.711 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 1.398 0 C-N-CA 124.667 1.187 . . . . 64.43 110.962 179.768 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptt? . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.517 -0.549 . . . . 73.11 109.517 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 20.9 p 173.33 102.6 0.01 OUTLIER 'General case' 0 C--N 1.363 1.159 0 C-N-CA 124.629 1.172 . . . . 74.25 110.063 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . 0.475 ' HB2' ' SD ' ' D' ' 138' ' ' MET . 1.2 pm0 -148.53 -179.36 6.9 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.914 0.885 . . . . 64.44 110.913 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -66.42 147.66 52.98 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 112.457 0.54 . . . . 74.3 112.457 -174.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -153.81 153.85 32.91 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.466 1.106 . . . . 61.25 109.369 -175.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -63.64 97.68 0.16 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.462 0.705 . . . . 71.23 109.494 173.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.406 HG22 ' H ' ' D' ' 9' ' ' MET . 34.2 m -142.35 160.95 39.25 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.966 0.906 . . . . 72.3 109.842 -174.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.49 -4.72 6.27 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.992 1.317 . . . . 73.2 112.963 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.406 ' H ' HG22 ' D' ' 7' ' ' THR . 1.1 tmt? -28.58 125.36 0.1 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 126.585 1.954 . . . . 71.34 113.27 170.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 28.7 m -112.81 146.71 38.37 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.642 0.777 . . . . 72.53 110.579 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.581 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 57.6 t80 -154.14 99.85 2.27 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.703 1.201 . . . . 75.22 107.837 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -117.48 115.43 25.15 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.024 -0.732 . . . . 74.44 109.024 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.442 HG21 HD11 ' D' ' 16' ' ' ILE . 28.5 mt -75.23 121.64 27.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.23 -1.026 . . . . 71.32 108.23 176.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -96.45 -26.94 15.12 Favored 'General case' 0 C--O 1.245 0.819 0 O-C-N 123.417 0.448 . . . . 75.12 111.347 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -171.72 136.04 0.91 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 117.705 0.23 . . . . 55.34 111.364 -168.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.455 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.9 mp -120.5 133.4 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 107.107 -1.442 . . . . 54.25 107.107 174.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -160.6 173.03 16.11 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 122.582 1.182 . . . . 75.42 112.53 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -111.38 120.42 42.14 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 113.613 -1.631 . . . . 61.33 108.136 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.545 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 42.6 mtpt -87.93 -24.07 23.72 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.275 0.56 . . . . 61.41 109.552 176.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 10.3 t70 -154.57 143.3 20.82 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.124 -1.398 . . . . 64.21 109.138 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.498 HG23 HG22 ' D' ' 78' ' ' VAL . 47.1 mt -139.96 150.28 21.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 106.539 -1.652 . . . . 75.25 106.539 173.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -157.56 144.84 18.42 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.571 0.701 . . . . 73.5 110.739 169.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.489 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.2 t80 -140.17 128.64 22.76 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 105.872 -1.899 . . . . 72.32 105.872 173.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.592 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.7 mt-10 -136.89 123.44 20.93 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.441 -0.948 . . . . 75.43 108.441 -176.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.06 86.62 57.64 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 107.605 -1.257 . . . . 63.44 107.605 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.67 -36.78 10.41 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 122.676 2.25 . . . . 75.43 112.431 -175.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -96.95 16.76 18.54 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.867 0.867 . . . . 74.54 110.43 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.7 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -43.66 -64.93 0.65 Allowed Pre-proline 0 CA--C 1.561 1.386 0 N-CA-C 115.336 1.606 . . . . 74.14 115.336 -162.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.69 -12.77 22.24 Favored 'Trans proline' 0 C--N 1.386 2.542 0 CA-C-N 122.626 1.973 . . . . 63.11 113.348 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -84.58 -40.83 17.07 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.119 1.368 . . . . 72.44 110.856 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.481 HG22 HD12 ' D' ' 68' ' ' LEU . 9.9 p -83.72 -17.21 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.123 0 CA-C-N 115.886 -0.597 . . . . 64.31 111.446 -170.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -62.42 -17.62 59.72 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 113.025 0.75 . . . . 74.11 113.025 173.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -65.02 -11.95 44.95 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.369 0.668 . . . . 73.32 110.951 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.4 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 87.2 mttt -109.79 92.13 3.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.303 1.441 . . . . 53.42 109.194 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -90.9 92.5 8.8 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.844 0.457 . . . . 51.42 109.873 177.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 30.7 p90 -162.31 176.87 10.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.69 0.796 . . . . 73.13 109.448 168.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -69.9 114.34 24.3 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 123.689 0.796 . . . . 55.42 110.342 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.539 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 16.4 Cg_exo -68.08 134.98 33.34 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 123.104 2.536 . . . . 72.44 111.096 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.68 122.25 16.83 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.262 0.625 . . . . 73.35 110.033 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 35.8 t -97.87 114.93 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.631 0.773 . . . . 72.3 110.894 -168.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -104.39 152.63 22.06 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.186 -1.413 . . . . 73.03 107.186 166.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 pp -140.34 156.07 46.57 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.025 0.53 . . . . 73.42 110.967 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -150.35 152.61 34.68 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.777 0.831 . . . . 72.35 108.89 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 87.9 mt -126.92 146.92 50.13 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.483 0.713 . . . . 73.5 110.838 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.56 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 7.2 t70 -136.84 140.82 42.7 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.738 1.215 . . . . 51.54 108.19 172.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 58.0 m -102.03 142.91 32.57 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.401 0.68 . . . . 53.21 109.655 -173.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.628 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -155.04 155.25 33.78 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.08 0.952 . . . . 62.02 109.032 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 77.3 p -174.62 178.44 1.92 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.007 0.432 . . . . 71.15 111.272 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 73.0 p -168.77 146.58 3.92 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.491 -1.231 . . . . 72.51 108.935 174.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -82.66 128.54 34.44 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.879 -0.786 . . . . 73.24 108.879 171.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.627 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.5 mt -101.28 -34.5 9.62 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.024 0.53 . . . . 44.33 110.18 -175.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.54 -175.89 3.72 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.318 1.047 . . . . 62.13 110.131 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.7 114.51 7.98 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.642 -1.163 . . . . 65.13 109.306 173.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 68.46 18.77 8.95 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.151 1.381 . . . . 73.0 112.461 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 94.7 t -124.16 124.69 69.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 C-N-CA 124.927 1.291 . . . . 75.44 107.609 168.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.691 ' HB2' HG13 ' H' ' 18' ' ' VAL . 21.3 t80 -144.66 137.72 26.82 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.625 -0.509 . . . . 74.51 109.625 -176.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.627 ' HB2' HD11 ' D' ' 51' ' ' LEU . 27.3 tt0 -91.9 133.53 35.59 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.645 -0.707 . . . . 64.12 109.972 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 78.4 t -111.86 118.28 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.678 -1.23 . . . . 72.15 107.678 172.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.628 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 14.7 t -114.61 131.77 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.21 -1.033 . . . . 62.04 108.21 173.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.416 HD12 ' O ' ' D' ' 45' ' ' ASP . 18.8 tp -130.69 123.5 29.48 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.229 -0.656 . . . . 61.25 109.229 174.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.56 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 14.1 ttm180 -83.53 104.77 13.93 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.702 -0.851 . . . . 71.52 108.702 176.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 70.4 t -89.12 129.39 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 107.979 -1.119 . . . . 53.35 107.979 173.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 20.7 m -121.75 142.6 50.03 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.289 -0.634 . . . . 72.33 109.289 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 69.5 t -139.44 100.45 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 126.04 1.736 . . . . 55.13 107.307 -174.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 62.5 m -99.69 112.33 24.57 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.757 -0.831 . . . . 73.53 108.757 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -115.42 141.05 48.57 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.586 0.754 . . . . 61.1 109.972 -173.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 14.4 p -147.7 128.79 14.59 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 123.526 0.516 . . . . 60.53 111.906 -174.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.481 HD12 HG22 ' D' ' 31' ' ' VAL . 41.2 mt -96.93 114.81 26.46 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 124.758 1.223 . . . . 62.34 108.661 175.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.86 -121.09 8.38 Favored Glycine 0 C--N 1.341 0.858 0 O-C-N 123.737 0.648 . . . . 64.44 112.106 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.07 5.59 22.23 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.177 0.591 . . . . 75.43 111.444 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.4 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 10.9 pt-20 -122.37 162.62 21.24 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.22 0.608 . . . . 65.35 109.727 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 58.8 m -69.65 132.67 46.54 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.457 0.703 . . . . 65.04 111.284 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.482 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -84.95 -68.93 0.69 Allowed 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.414 -1.328 . . . . 62.4 107.414 172.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . 0.456 ' HZ ' HD22 ' D' ' 126' ' ' LEU . 51.5 p90 -149.83 167.28 27.0 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.654 -1.157 . . . . 75.32 110.657 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.592 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 77.5 mt -134.49 112.42 10.9 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.794 1.238 . . . . 70.41 108.269 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.537 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 10.6 m -114.81 133.32 56.04 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.189 0.996 . . . . 73.51 108.782 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -152.62 118.42 5.4 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.196 -1.409 . . . . 63.14 107.196 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . 0.498 HG22 HG23 ' D' ' 21' ' ' ILE . 80.0 t -130.09 122.17 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.989 0.916 . . . . 74.32 108.777 -175.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.611 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.9 mt-30 -88.61 87.49 7.28 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.376 -0.972 . . . . 74.41 108.376 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -80.46 110.9 16.36 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.115 -1.402 . . . . 72.13 108.569 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.36 144.55 18.34 Favored Glycine 0 N--CA 1.469 0.887 0 N-CA-C 111.471 -0.651 . . . . 72.21 111.471 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.61 138.3 8.04 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 117.038 0.419 . . . . 71.53 112.199 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.6 mt -88.39 122.86 40.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 108.203 -1.036 . . . . 74.32 108.203 173.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -128.64 156.02 44.07 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.389 0.675 . . . . 71.0 109.253 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 48.8 m -115.36 102.12 9.55 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.424 -0.954 . . . . 71.24 108.424 175.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.742 ' HB ' HG21 ' H' ' 18' ' ' VAL . 3.6 mp -108.05 130.49 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 108.812 -0.81 . . . . 73.2 108.812 -176.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.81 166.9 28.09 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.868 0.867 . . . . 40.42 110.385 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.44 21.71 74.61 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.452 -0.795 . . . . 64.11 114.094 173.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.421 HG22 ' N ' ' D' ' 90' ' ' GLU . 17.5 mt -125.22 157.29 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.458 0.703 . . . . 74.22 110.47 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.421 ' N ' HG22 ' D' ' 89' ' ' ILE . 29.6 mt-10 -135.0 151.84 51.19 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.844 1.257 . . . . 65.42 110.213 172.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . 0.43 ' O ' ' HB1' ' H' ' 21' ' ' ALA . . . 70.58 -145.79 41.0 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 116.05 1.18 . . . . 72.31 116.05 168.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 4.3 p -74.51 -10.42 59.54 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.208 1.003 . . . . 74.12 111.711 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -30.86 71.56 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.808 0.843 . . . . 72.43 109.426 172.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.462 ' SD ' ' HB2' ' H' ' 21' ' ' ALA . 56.9 ttm -77.73 -39.04 45.73 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.883 0.473 . . . . 75.24 109.818 174.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' H' ' 14' ' ' LEU . . . -58.69 -31.49 68.27 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.238 0.542 . . . . 75.22 111.008 171.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -70.82 -48.9 51.57 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.471 1.108 . . . . 73.22 110.572 174.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 50.9 t -59.67 -46.29 89.48 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.047 0.539 . . . . 60.21 110.867 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.486 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 7.3 mp -83.89 -18.99 35.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.337 0.655 . . . . 62.42 111.96 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.38 -1.74 60.63 Favored Glycine 0 N--CA 1.476 1.314 0 CA-C-O 119.992 -0.338 . . . . 60.31 113.564 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.525 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -140.34 -65.22 0.46 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.887 0.475 . . . . 51.3 110.967 -176.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -73.93 -40.12 63.33 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.828 0.677 . . . . 73.05 112.828 -170.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.581 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 51.5 m -69.45 -45.91 27.05 Favored Pre-proline 0 CA--C 1.559 1.3 0 CA-C-O 118.881 -0.581 . . . . 75.23 112.213 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.52 -18.93 28.94 Favored 'Trans proline' 0 C--N 1.393 2.892 0 C-N-CA 121.66 1.573 . . . . 70.14 112.412 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . 0.454 ' HA ' ' HD2' ' D' ' 107' ' ' PHE . 35.4 t-20 -64.19 -31.12 72.2 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.463 0.705 . . . . 74.03 109.992 175.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.4 mm -68.24 -33.44 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.566 0.746 . . . . 73.51 110.277 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 79.5 mt -81.35 -25.66 36.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.666 0.786 . . . . 73.43 112.664 -173.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . 0.454 ' HD2' ' HA ' ' D' ' 104' ' ' ASN . 41.0 m-85 -64.06 -42.71 71.03 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 114.255 1.206 . . . . 71.13 114.255 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.27 -39.81 85.12 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 122.409 2.073 . . . . 63.52 113.329 172.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -80.59 -32.25 36.55 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.758 0.823 . . . . 73.11 112.045 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.3 -53.03 50.01 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.836 -0.801 . . . . 73.43 108.836 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.42 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 37.4 ttp180 -55.07 -46.9 75.45 Favored 'General case' 0 C--O 1.211 -0.937 0 O-C-N 124.61 1.194 . . . . 72.02 111.313 177.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -64.69 -45.63 85.79 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.217 0.607 . . . . 71.32 111.086 -175.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.408 ' O ' ' HG3' ' D' ' 117' ' ' MET . 44.7 t -57.72 -45.97 85.06 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.413 0.685 . . . . 61.43 110.456 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.537 HD13 HG21 ' D' ' 64' ' ' VAL . 93.4 mt -62.79 -52.18 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.755 -1.111 . . . . 63.31 111.101 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.416 HG21 ' HE2' ' B' ' 109' ' ' TYR . 96.8 m -56.13 -41.03 74.69 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.891 1.277 . . . . 60.22 111.119 -177.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 30.6 t -66.72 -43.45 84.23 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.621 -1.172 . . . . 61.24 109.818 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.432 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 74.4 mtm -65.7 -33.03 74.93 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.088 0.555 . . . . 72.4 111.874 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.513 HG23 ' O ' ' D' ' 114' ' ' ILE . 76.4 t -64.68 -45.71 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.432 1.093 . . . . 60.24 109.945 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 82.5 p -75.58 -28.36 58.92 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 115.503 -0.771 . . . . 54.45 111.053 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' D' ' 116' ' ' SER . 78.0 mtt-85 -72.63 -29.11 63.19 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.374 0.67 . . . . 72.04 109.805 174.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.63 9.64 75.17 Favored Glycine 0 C--N 1.353 1.494 0 O-C-N 123.849 0.718 . . . . 75.34 112.29 173.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.554 HG23 ' HB3' ' C' ' 17' ' ' TYR . 44.8 p 60.06 20.01 9.19 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 126.533 1.933 . . . . 54.42 114.476 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -82.19 155.24 69.72 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.418 0.687 . . . . 74.45 109.66 171.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.01 132.4 49.27 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.642 2.228 . . . . 44.14 111.221 174.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -49.76 130.47 21.2 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.195 1.398 . . . . 72.14 112.499 -174.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.456 HD22 ' HZ ' ' D' ' 74' ' ' PHE . 17.8 tp -117.51 96.44 5.4 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.908 0.483 . . . . 74.3 109.783 -172.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -99.9 104.45 16.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.579 0.752 . . . . 72.33 109.245 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.42 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 6.6 mp -69.92 115.39 9.09 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.293 0.637 . . . . 63.42 109.813 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.73 126.93 86.37 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 122.898 0.479 . . . . 50.44 110.196 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -73.35 133.25 18.93 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.504 2.136 . . . . 63.44 111.855 -171.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 89.3 t -108.9 136.14 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.473 -0.936 . . . . 74.25 108.473 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -77.91 87.69 4.1 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.252 -0.647 . . . . 72.4 109.252 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -58.84 -30.52 67.74 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.088 -0.96 . . . . 71.33 112.272 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.525 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 2.2 t70 -60.4 -46.17 90.97 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.261 0.976 . . . . 62.33 110.203 -174.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.24 -48.27 71.05 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.599 0.76 . . . . 73.53 111.954 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 10.0 mp -66.25 -35.22 79.85 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.755 -0.657 . . . . 70.45 111.519 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.468 ' HZ ' ' HA ' ' H' ' 14' ' ' LEU . 12.8 t80 -74.44 -43.86 54.33 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.254 0.622 . . . . 71.23 109.53 -177.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.475 ' SD ' ' HB2' ' D' ' 3' ' ' GLU . 74.3 mtm -57.71 -40.58 79.88 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.668 0.387 . . . . 73.11 110.292 175.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -59.07 -35.02 72.66 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 123.918 0.761 . . . . 74.24 111.621 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -71.0 -49.99 39.06 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.118 0.567 . . . . 73.22 110.755 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.436 HD13 ' O ' ' D' ' 137' ' ' PHE . 10.5 mp -66.83 -33.73 76.25 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.857 0.863 . . . . 74.11 112.438 -172.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -76.09 9.75 2.32 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.309 0.643 . . . . 73.11 112.25 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -118.28 89.26 3.09 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.419 -0.956 . . . . 74.35 108.419 176.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -163.69 148.95 10.91 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.376 1.07 . . . . 64.4 109.087 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.29 135.4 8.91 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.756 0.822 . . . . 72.54 109.227 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.23 -60.89 4.77 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 110.854 -0.898 . . . . 24.5 110.854 -174.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.71 127.88 34.39 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.213 1.005 . . . . 62.5 110.554 171.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -98.74 -110.54 3.03 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 109.825 -1.31 . . . . 72.12 109.825 172.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 4.9 t -166.91 118.88 0.94 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.075 0.95 . . . . 74.23 108.887 175.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . 0.65 ' HB2' ' HG3' ' H' ' 24' ' ' PRO . 6.6 mm-40 -63.06 132.73 52.9 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.696 1.198 . . . . 74.22 113.183 -173.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -142.67 116.06 9.04 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.104 -1.073 . . . . 74.44 108.104 167.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -124.92 46.91 2.23 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.142 -1.058 . . . . 65.44 108.142 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -70.42 -38.32 74.58 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 113.457 -1.701 . . . . 75.51 110.811 -176.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -75.53 -29.48 59.47 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.512 -0.767 . . . . 73.52 110.388 176.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.36 0 C-N-CA 124.83 1.252 . . . . 74.44 111.34 179.044 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . 0.559 ' HA ' HG21 ' C' ' 55' ' ' VAL . 67.1 mtm . . . . . 0 N--CA 1.477 0.908 0 CA-C-O 120.704 0.287 . . . . 75.35 110.303 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.82 93.82 9.71 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.812 -0.81 . . . . 65.24 108.812 172.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -88.8 -26.76 21.53 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 116.148 -0.478 . . . . 55.33 110.689 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 44.9 m 62.44 91.09 0.07 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.105 0.962 . . . . 42.14 111.021 -173.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 62.0 p -111.95 176.35 5.05 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.879 0.472 . . . . 63.03 110.353 174.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.682 HG21 HG21 ' A' ' 40' ' ' VAL . 41.9 pt -102.73 135.56 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 123.496 0.718 . . . . 63.41 111.219 -169.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 7' ' ' ALA . . . . . 0.413 ' HB1' HG13 ' A' ' 131' ' ' VAL . . . -127.17 162.88 25.1 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.79 0.836 . . . . 61.4 109.773 178.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.441 HD22 HD23 ' A' ' 44' ' ' LEU . 93.3 mt -67.9 -90.69 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 122.691 0.397 . . . . 71.43 110.437 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . 166.3 -170.93 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.129 1.772 . . . . 64.25 108.331 -173.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . 0.408 ' HG ' HD22 ' A' ' 136' ' ' LEU . 3.3 tm? -96.38 135.56 38.07 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.304 -1.369 . . . . 62.35 107.304 167.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt -71.51 111.09 9.02 Favored Pre-proline 0 N--CA 1.483 1.218 0 C-N-CA 123.128 0.571 . . . . 64.32 110.368 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.99 -12.58 17.68 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 122.904 2.403 . . . . 52.32 111.869 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 70.6 mt -117.83 140.27 49.93 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.647 1.179 . . . . 71.54 108.494 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 97.9 mt -73.66 157.07 37.27 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.762 0.425 . . . . 64.2 110.116 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -91.38 27.48 1.94 Allowed 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.756 0.822 . . . . 74.11 109.826 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 36.7 m 68.15 123.65 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.45 0 C-N-CA 125.254 1.422 . . . . 75.55 110.597 -170.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 17' ' ' PRO . . . . . 0.444 ' HB2' HG22 ' E' ' 19' ' ' THR . 24.2 Cg_exo -65.54 177.62 2.63 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.877 2.384 . . . . 74.24 113.309 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 18' ' ' VAL . . . . . 0.552 HG21 HD12 ' A' ' 89' ' ' ILE . 22.2 t -81.64 13.29 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 123.845 0.858 . . . . 73.2 111.032 -175.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . 0.444 HG22 ' HB2' ' E' ' 17' ' ' PRO . 4.6 t -74.43 78.92 1.9 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.69 0.796 . . . . 71.45 109.815 172.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 20' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 96.4 mttt 70.6 -59.24 0.53 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.813 1.645 . . . . 70.21 111.578 -173.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 69.95 -4.22 1.54 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.204 1.002 . . . . 73.31 113.134 172.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 22' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 49' ' ' SER . 45.5 ttt180 -82.83 80.83 8.79 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 107.913 -1.143 . . . . 73.24 107.913 177.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 9.5 t -159.13 135.73 6.57 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-N 115.395 -0.821 . . . . 74.45 110.956 -173.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -66.12 -34.46 37.08 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.691 2.26 . . . . 72.03 112.233 169.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 . . . . . 0 C--O 1.249 1.066 0 N-CA-C 108.215 -1.032 . . . . 72.54 108.215 176.958 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 109.962 -0.384 . . . . 61.45 109.962 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -116.56 177.15 4.8 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 107.981 -1.118 . . . . 72.35 107.981 173.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -77.1 157.34 31.1 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 108.631 -0.877 . . . . 53.1 108.631 162.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 81.1 p -54.7 -41.37 70.18 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.802 0.841 . . . . 52.44 112.066 -173.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 30.5 m -151.6 125.99 9.41 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.137 0.975 . . . . 71.03 108.486 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.509 HD12 ' HB2' ' B' ' 42' ' ' LEU . 33.9 pt -78.12 137.56 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 122.775 0.43 . . . . 65.32 111.18 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -152.69 150.4 29.41 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.595 0.758 . . . . 74.33 110.381 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . 0.662 HD12 HG21 ' B' ' 131' ' ' VAL . 94.4 mt -68.6 143.78 54.74 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.064 0.946 . . . . 71.21 110.199 174.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.67 -74.11 0.18 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.797 0.839 . . . . 54.42 111.666 -172.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 8.5 tt -179.2 149.52 0.41 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.154 -1.054 . . . . 72.12 108.154 -170.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.488 HD21 HD23 ' B' ' 44' ' ' LEU . 91.1 mt -104.83 91.18 4.05 Favored Pre-proline 0 N--CA 1.486 1.344 0 C-N-CA 123.61 0.764 . . . . 72.54 110.476 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.34 -17.47 18.79 Favored 'Trans proline' 0 C--N 1.388 2.615 0 C-N-CA 122.43 2.087 . . . . 74.24 111.596 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 55.9 mt -68.73 -19.32 64.34 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 124.236 1.015 . . . . 60.55 110.621 170.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . 0.693 ' HB3' ' HB1' ' B' ' 95' ' ' ALA . 84.7 mt 61.53 30.47 18.75 Favored 'General case' 0 C--N 1.367 1.35 0 C-N-CA 124.484 1.114 . . . . 74.14 109.97 -173.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . 0.513 ' HE2' ' HB3' ' B' ' 48' ' ' SER . 26.2 t80 59.66 -87.27 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 125.609 1.564 . . . . 62.41 109.728 -174.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 6.6 p -154.3 113.15 2.46 Favored Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 125.0 1.32 . . . . 32.11 108.537 173.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.57 141.53 46.29 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 121.938 1.759 . . . . 73.15 110.552 168.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . 0.593 HG12 ' H ' ' F' ' 20' ' ' LYS . 8.2 t -68.92 138.73 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 110.007 -0.368 . . . . 75.23 110.007 -175.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 6.3 m -65.28 -34.3 78.01 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.482 0.713 . . . . 75.43 110.488 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 20' ' ' LYS . . . . . 0.593 ' H ' HG12 ' F' ' 18' ' ' VAL . 0.1 OUTLIER -156.52 102.72 2.08 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.916 1.286 . . . . 74.23 110.326 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . -124.97 40.43 3.75 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 122.129 0.966 . . . . 73.13 109.011 174.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -163.97 164.73 23.1 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-N 114.512 -1.222 . . . . 74.31 109.028 175.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 49.6 p -61.6 147.73 87.96 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.876 0.871 . . . . 75.45 110.739 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.78 -27.77 73.13 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.165 2.576 . . . . 74.02 112.179 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 124.52 1.128 . . . . 72.11 109.214 171.082 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 110.197 -0.297 . . . . 73.35 110.197 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -162.47 -39.73 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.435 1.094 . . . . 71.41 109.253 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 52.82 13.37 0.34 Allowed 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 125.822 1.649 . . . . 74.33 115.227 166.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 4' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' G' ' 7' ' ' ALA . 15.6 m -80.94 154.39 27.02 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.199 0.6 . . . . 70.22 109.986 -177.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 5.2 t -54.91 -33.01 61.66 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.122 0.889 . . . . 50.52 111.399 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . 0.513 HG21 ' HB ' ' C' ' 40' ' ' VAL . 21.3 pt -130.3 -47.15 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.477 0.711 . . . . 74.2 111.089 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 7' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' G' ' 4' ' ' SER . . . 59.9 -160.18 0.29 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.239 1.016 . . . . 70.4 112.454 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.0 135.58 54.55 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 107.74 -1.207 . . . . 75.32 107.74 171.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.29 139.47 32.29 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.481 0.712 . . . . 61.14 110.308 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 89.8 mt -61.82 126.04 25.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.702 0.801 . . . . 75.12 110.822 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 95.2 mt -67.9 133.45 92.11 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 123.293 0.637 . . . . 63.43 111.064 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 12' ' ' PRO . . . . . 0.425 ' HB3' ' HB3' ' A' ' 155' ' ' ALA . 60.8 Cg_endo -70.72 -23.88 25.89 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.967 2.445 . . . . 72.03 112.552 174.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 52.5 tp -150.48 137.69 19.45 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.14 0.976 . . . . 72.22 108.718 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 73.2 mt -95.16 -178.53 4.5 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.516 0.726 . . . . 63.51 110.16 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . 0.421 ' HB2' ' HB3' ' C' ' 98' ' ' LEU . 5.8 m-85 -71.0 152.58 43.43 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.299 0.639 . . . . 72.12 110.498 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 59.9 p -73.7 138.89 77.06 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 123.329 0.651 . . . . 61.21 110.867 -174.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 17' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -52.53 134.5 52.87 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.751 2.967 . . . . 31.44 114.553 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 18' ' ' VAL . . . . . 0.534 HG23 HD11 ' C' ' 98' ' ' LEU . 22.1 t -66.03 128.92 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.521 0.728 . . . . 72.41 110.291 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 94.2 m 68.34 -72.0 0.1 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.813 1.245 . . . . 74.23 111.32 176.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 20' ' ' LYS . . . . . 0.486 ' HD3' ' HG2' ' G' ' 25' ' ' GLU . 4.1 ttmp? -169.63 37.73 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 108.306 -0.998 . . . . 74.24 108.306 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.95 75.53 0.21 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 122.126 0.965 . . . . 64.41 111.379 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -164.56 -71.03 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.331 -1.359 . . . . 71.51 107.331 -169.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -168.33 139.8 2.26 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 125.067 1.347 . . . . 61.42 108.6 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -60.97 141.72 95.34 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.743 2.296 . . . . 72.15 112.31 172.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 25' ' ' GLU . . . . . 0.486 ' HG2' ' HD3' ' G' ' 20' ' ' LYS . 6.7 pt-20 . . . . . 0 CA--C 1.554 1.122 0 C-N-CA 124.376 1.071 . . . . 73.31 109.13 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 49.0 ttm . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 109.901 -0.407 . . . . 74.42 109.901 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.56 82.25 7.39 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.324 0.65 . . . . 75.22 110.55 -171.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.43 28.34 0.24 Allowed 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 114.654 -1.157 . . . . 72.4 108.342 171.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 26.2 m -89.46 123.12 33.3 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.71 0.804 . . . . 72.01 109.69 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 16.4 m -60.34 -32.02 70.86 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.955 0.902 . . . . 42.15 111.081 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . . . . . . . . . 14.2 tt -138.95 129.11 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 123.946 0.898 . . . . 73.22 109.209 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -168.44 -156.15 0.17 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.199 1.0 . . . . 71.44 109.408 -175.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 78.9 mt -136.97 142.47 42.6 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.867 1.267 . . . . 71.31 108.848 173.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -99.9 144.55 28.82 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.395 0.678 . . . . 54.5 111.069 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 35.7 tp -69.11 155.42 40.4 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.716 0.806 . . . . 74.02 111.461 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 mp -86.19 128.13 58.83 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 123.385 0.674 . . . . 61.53 109.228 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.67 -31.71 8.33 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.623 2.216 . . . . 64.3 113.316 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -97.91 135.68 39.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.884 0.873 . . . . 74.12 109.241 -173.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . 0.477 ' HB3' ' HB1' ' D' ' 95' ' ' ALA . 8.2 mp -76.64 125.46 29.29 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.431 0.692 . . . . 74.5 109.861 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -65.45 146.2 55.18 Favored 'General case' 0 CA--C 1.551 1.018 0 O-C-N 124.159 0.912 . . . . 65.03 110.774 -171.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 19.5 p -62.43 147.47 91.88 Favored Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 124.808 1.243 . . . . 72.5 112.233 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 17' ' ' PRO . . . . . 0.737 ' HB3' ' HB3' ' H' ' 21' ' ' ALA . 55.9 Cg_endo -67.04 169.12 15.64 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.256 2.637 . . . . 74.23 113.815 -177.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . 0.742 HG21 ' HB ' ' D' ' 86' ' ' ILE . 45.6 t -81.06 -74.76 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.002 0.921 . . . . 55.21 110.121 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 46.1 m -111.92 -58.82 2.07 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.432 -0.951 . . . . 75.13 108.432 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -141.63 123.52 15.32 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 115.436 -0.802 . . . . 75.24 109.697 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . 0.737 ' HB3' ' HB3' ' H' ' 17' ' ' PRO . . . -163.08 138.72 6.83 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.526 1.13 . . . . 53.2 108.092 171.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . 0.633 ' HD2' ' H ' ' H' ' 22' ' ' ARG . 0.1 OUTLIER -69.5 87.22 0.46 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.97 0.908 . . . . 75.21 108.558 177.159 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 90.9 m -151.01 93.36 3.68 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 124.376 1.07 . . . . 64.41 108.459 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 24' ' ' PRO . . . . . 0.65 ' HG3' ' HB2' ' D' ' 150' ' ' GLU . 32.6 Cg_endo -87.68 166.59 7.45 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 123.109 2.539 . . . . 74.03 111.814 174.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 C--O 1.253 1.278 0 N-CA-C 108.643 -0.873 . . . . 71.32 108.643 176.95 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 mtt . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 121.533 0.682 . . . . 74.2 109.411 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.4 p -90.77 -57.79 2.7 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.122 -0.945 . . . . 64.51 109.795 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -129.59 47.17 2.53 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 107.887 -1.153 . . . . 71.24 107.887 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 68.61 133.74 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 113.404 -1.726 . . . . 75.45 112.39 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -76.38 79.56 3.12 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.45 -0.944 . . . . 73.55 108.45 172.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -90.89 123.96 34.82 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.932 -0.766 . . . . 61.54 108.932 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.9 p -75.84 75.05 2.78 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.897 0.879 . . . . 74.22 110.388 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -85.64 -59.27 2.36 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.922 0.889 . . . . 74.34 109.793 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -155.88 142.19 18.44 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.204 -1.036 . . . . 63.4 108.204 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 91.0 m -140.44 143.72 35.72 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.468 0.707 . . . . 73.04 110.253 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.567 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 25.5 t80 -136.52 124.33 22.58 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.004 0.922 . . . . 73.51 109.274 177.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -144.67 112.9 6.48 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.991 0.916 . . . . 71.44 109.05 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.648 HG12 ' HD2' ' A' ' 84' ' ' PHE . 43.0 mt -77.88 115.06 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 109.702 -0.481 . . . . 64.44 109.702 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -73.39 -27.96 61.75 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 123.801 0.688 . . . . 52.52 111.1 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.2 ttt85 -177.57 149.01 0.6 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 123.265 0.353 . . . . 72.51 111.448 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.48 HD12 ' HB3' ' C' ' 130' ' ' PRO . 91.6 mt -137.23 130.63 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.239 -1.022 . . . . 71.51 108.239 168.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.496 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 35.1 p90 -166.14 157.63 13.62 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 124.19 0.931 . . . . 74.3 110.484 -168.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.3 p -83.28 109.82 17.58 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.773 -1.103 . . . . 75.44 108.375 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 35.3 mtpt -75.05 -38.3 61.43 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.083 -0.71 . . . . 62.22 109.083 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.525 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 31.4 t70 -140.33 136.48 33.25 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 113.93 -1.486 . . . . 70.15 109.617 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.4 mt -130.23 144.73 37.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 125.406 1.482 . . . . 65.23 107.043 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.498 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 48.3 t -148.82 130.28 14.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.815 -0.809 . . . . 74.23 108.815 174.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -134.72 142.08 46.67 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.375 -1.343 . . . . 74.2 107.375 173.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -141.45 151.16 43.15 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.446 -0.946 . . . . 74.22 108.446 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.52 81.22 17.66 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 106.905 -1.517 . . . . 74.45 106.905 171.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.16 -46.39 33.91 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.589 2.859 . . . . 71.01 114.303 -166.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.18 37.56 3.97 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.549 -0.908 . . . . 74.53 108.549 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.599 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -40.18 -57.26 2.92 Favored Pre-proline 0 CA--C 1.569 1.686 0 N-CA-C 114.274 1.212 . . . . 51.34 114.274 -172.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.599 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 27.9 Cg_exo -62.17 -29.69 81.05 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.042 1.828 . . . . 74.25 114.006 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -83.0 -32.64 26.84 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.689 0.796 . . . . 75.24 111.347 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.702 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.2 p -77.52 -22.31 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.542 0.737 . . . . 53.32 111.265 -166.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -71.47 -22.38 61.82 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.708 -0.678 . . . . 74.13 110.773 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -80.83 -21.61 40.67 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.284 1.033 . . . . 70.1 110.633 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -82.03 170.8 15.13 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.149 0.98 . . . . 62.1 111.568 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -88.3 131.54 34.75 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.687 0.795 . . . . 75.02 110.044 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.454 ' CE3' HD21 ' A' ' 68' ' ' LEU . 66.4 t-105 -84.47 85.53 7.39 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 121.582 0.706 . . . . 72.32 111.058 -176.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -135.16 80.63 46.76 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 107.225 -1.398 . . . . 54.23 107.225 167.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -82.01 154.24 17.09 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.666 2.244 . . . . 73.12 112.658 -173.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -102.41 85.85 2.7 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.782 -1.562 . . . . 72.34 106.782 170.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.682 ' HB ' HG21 ' E' ' 6' ' ' ILE . 55.7 t -78.89 97.26 2.33 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 CA-C-N 115.54 -0.755 . . . . 75.52 109.965 -173.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.495 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 56.8 mtpt -79.39 124.18 28.19 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.127 -0.942 . . . . 74.04 109.196 174.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.737 HD21 ' HB ' ' E' ' 6' ' ' ILE . 1.9 mm? -97.71 108.37 21.07 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 105.922 -1.881 . . . . 52.41 105.922 169.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.782 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 15.0 m-20 -104.5 117.68 34.75 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.628 -0.878 . . . . 52.22 108.628 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.409 HD11 ' HB2' ' E' ' 8' ' ' LEU . 5.2 mp -97.53 122.41 40.56 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.892 0.877 . . . . 64.35 109.512 -171.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -136.22 139.36 42.7 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.296 0.638 . . . . 75.05 109.404 172.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.1 p -111.98 136.94 50.66 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.661 0.784 . . . . 74.31 110.239 -175.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.08 110.82 5.64 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 108.341 -0.985 . . . . 62.04 108.341 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 p -132.0 152.04 51.38 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.947 -0.471 . . . . 73.54 109.931 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -152.36 132.38 13.42 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.155 0.582 . . . . 62.31 110.982 -170.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -75.11 126.05 30.21 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 108.936 -0.764 . . . . 75.45 108.936 172.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.411 HD12 HG23 ' A' ' 83' ' ' ILE . 76.1 mt -97.99 -33.24 11.27 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.723 0.409 . . . . 63.01 110.387 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.4 -176.15 5.44 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.178 0.991 . . . . 53.41 110.014 176.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.61 124.2 21.27 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 108.631 -0.877 . . . . 64.22 108.631 169.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 65.04 11.79 7.4 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.465 1.106 . . . . 62.41 112.62 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.405 HG12 ' HB2' ' A' ' 51' ' ' LEU . 61.2 t -123.06 122.59 65.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 107.938 -1.134 . . . . 62.54 107.938 174.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -140.06 169.01 18.49 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.103 -0.702 . . . . 73.11 109.103 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -129.92 127.31 39.87 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.197 -0.91 . . . . 74.51 108.807 176.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.558 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 91.9 t -102.52 120.91 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.509 -1.293 . . . . 61.42 107.509 168.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.499 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 25.9 t -107.76 131.24 58.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 107.408 -1.331 . . . . 74.14 107.408 168.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 tt -119.24 107.49 13.48 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.627 -0.879 . . . . 64.4 108.627 176.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -84.47 102.09 12.55 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.373 1.069 . . . . 72.11 109.366 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.4 t -98.41 102.51 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 108.196 -1.038 . . . . 72.03 108.196 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.782 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 33.2 m -94.82 108.02 20.04 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.976 -1.12 . . . . 75.51 107.976 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.3 t -103.22 110.23 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.218 0.607 . . . . 73.24 109.698 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 11.6 m -100.56 141.18 33.78 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.304 -0.998 . . . . 72.31 108.304 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.89 119.21 20.85 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.239 -1.023 . . . . 64.3 108.239 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.3 m -130.02 126.9 38.82 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.451 0.469 . . . . 72.14 110.724 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.454 HD21 ' CE3' ' A' ' 36' ' ' TRP . 29.6 mt -87.4 80.86 8.01 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 124.722 1.209 . . . . 74.44 109.163 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.5 -84.05 0.87 Allowed Glycine 0 C--N 1.34 0.782 0 CA-C-N 116.168 -0.469 . . . . 71.32 112.038 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -112.63 -27.9 8.02 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.368 0.667 . . . . 74.43 111.403 177.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -95.86 122.47 38.69 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 122.062 -0.399 . . . . 74.03 111.154 -173.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.3 m -65.77 126.8 29.61 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.06 0.457 . . . . 71.41 110.283 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.702 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -78.8 -56.77 4.15 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 114.975 -1.012 . . . . 72.24 109.531 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -159.45 172.71 17.4 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.601 -1.181 . . . . 63.3 111.257 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.9 tp -131.54 139.37 49.23 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 107.5 -1.296 . . . . 75.21 107.5 167.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 59.3 m -138.31 95.47 3.01 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.827 -0.805 . . . . 75.14 108.827 175.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 33.9 tt0 -105.61 121.16 43.4 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.407 0.683 . . . . 74.21 109.293 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.2 t -129.59 112.47 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.158 0.504 . . . . 72.24 110.008 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -84.78 88.82 7.41 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.43 -0.952 . . . . 72.42 108.43 172.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -80.01 96.91 6.58 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.452 -0.794 . . . . 74.23 109.407 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.9 151.25 24.8 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 115.944 -0.571 . . . . 23.51 112.085 177.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.413 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -152.77 122.01 1.24 Allowed Glycine 0 CA--C 1.504 -0.631 0 N-CA-C 111.006 -0.837 . . . . 72.43 111.006 176.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.411 HG23 HD12 ' A' ' 51' ' ' LEU . 46.4 mt -82.1 122.97 37.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 108.188 -1.042 . . . . 71.35 108.188 173.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.648 ' HD2' HG12 ' A' ' 13' ' ' ILE . 22.6 m-85 -124.96 147.98 48.63 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 109.109 -0.7 . . . . 75.03 109.109 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.2 m -113.98 122.77 47.94 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.476 -0.935 . . . . 51.51 108.476 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 10' ' ' THR . 0.1 OUTLIER -135.8 125.97 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 N-CA-C 108.555 -0.906 . . . . 71.44 108.555 178.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.72 135.74 22.48 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.474 0.71 . . . . 63.14 110.347 -176.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.95 -62.29 0.34 Allowed Glycine 0 C--N 1.352 1.444 0 N-CA-C 114.038 0.375 . . . . 45.33 114.038 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 48.7 mm -120.88 -40.69 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 112.144 0.424 . . . . 73.12 112.144 -167.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.413 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 31.8 mt-10 64.54 -163.7 0.26 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.227 1.011 . . . . 72.22 111.229 -166.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.37 -137.82 26.77 Favored Glycine 0 C--N 1.356 1.681 0 CA-C-O 119.672 -0.515 . . . . 32.12 113.393 175.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.509 HG23 ' HD2' ' E' ' 24' ' ' PRO . 27.8 p -72.42 -26.48 61.87 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.8 0.84 . . . . 62.45 111.727 -177.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -59.64 -52.44 65.52 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.782 0.833 . . . . 73.21 110.159 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.413 ' SD ' ' HA ' ' A' ' 90' ' ' GLU . 14.0 ptt? -83.29 -16.05 47.77 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.84 -0.618 . . . . 74.11 111.508 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.57 -32.48 73.27 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 118.093 0.406 . . . . 74.11 110.921 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.454 ' NE2' ' HB2' ' A' ' 134' ' ' ASP . 45.3 t-80 -67.49 -27.71 67.24 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.918 -0.583 . . . . 71.34 110.732 172.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.519 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 58.3 m -76.78 -63.91 1.24 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 122.71 0.404 . . . . 54.1 110.404 177.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.21 -30.65 71.15 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.978 0.911 . . . . 75.13 112.28 -171.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.42 -1.28 40.75 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-O 119.115 -0.825 . . . . 64.1 114.389 -172.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.426 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.86 -59.82 0.23 Allowed 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.985 1.106 . . . . 72.52 113.985 -173.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.519 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 80.1 t80 -74.15 -55.33 6.2 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.167 0.587 . . . . 72.12 111.491 -169.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 79.3 m -65.58 -36.24 14.02 Favored Pre-proline 0 CA--C 1.567 1.632 0 N-CA-C 113.084 0.772 . . . . 74.34 113.084 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.02 -46.65 27.13 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 122.68 2.253 . . . . 70.43 113.735 160.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -69.44 -27.68 65.46 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.546 0.739 . . . . 74.12 110.432 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.62 -38.59 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 C-N-CA 123.382 0.673 . . . . 64.1 110.22 173.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.413 HD21 ' HA3' ' A' ' 82' ' ' GLY . 70.2 mt -76.8 -22.96 52.9 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.616 0.766 . . . . 75.44 112.36 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -61.12 -45.67 95.95 Favored Pre-proline 0 CA--C 1.567 1.607 0 N-CA-C 114.387 1.254 . . . . 73.2 114.387 -171.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -62.6 -34.79 73.55 Favored 'Trans proline' 0 C--N 1.384 2.435 0 CA-C-N 121.676 1.634 . . . . 73.11 113.038 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -70.37 -43.59 69.82 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.229 0.612 . . . . 72.22 111.078 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.11 -36.7 80.19 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.991 -0.55 . . . . 71.03 110.484 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.515 ' NH1' HD12 ' C' ' 105' ' ' ILE . 28.7 ttm180 -54.58 -56.78 15.38 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.859 0.863 . . . . 70.13 109.903 172.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.09 -43.39 95.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.956 0.902 . . . . 73.52 111.768 -174.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 38.2 t -59.51 -42.56 92.49 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.785 0.678 . . . . 43.04 110.613 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.3 mt -68.24 -47.61 77.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 115.497 -0.774 . . . . 72.41 110.328 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 60.2 m -55.49 -41.42 72.99 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.96 0.904 . . . . 63.14 111.527 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.0 t -70.79 -44.61 66.28 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 114.994 -1.003 . . . . 53.32 110.381 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 21.1 mtp -61.6 -41.47 97.49 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.543 0.737 . . . . 71.34 111.727 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.16 -45.87 97.73 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 123.931 0.892 . . . . 71.54 110.503 175.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 26.0 t -72.28 -30.17 64.57 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.706 -0.679 . . . . 55.11 111.764 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -74.77 -28.62 60.83 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.334 0.653 . . . . 71.31 109.572 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.3 15.83 37.58 Favored Glycine 0 C--N 1.352 1.444 0 O-C-N 123.831 0.707 . . . . 62.15 113.04 172.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.434 HG21 ' HE ' ' B' ' 15' ' ' ARG . 3.0 t 59.94 12.56 3.16 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 127.054 2.142 . . . . 71.31 113.685 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -79.8 147.44 66.61 Favored Pre-proline 0 C--O 1.244 0.781 0 C-N-CA 123.25 0.62 . . . . 62.51 109.502 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.03 141.47 98.34 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.651 2.234 . . . . 60.54 111.748 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -56.28 143.11 35.2 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.029 1.122 . . . . 75.0 114.029 -168.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.1 tp -129.14 113.79 15.53 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.451 1.1 . . . . 61.03 109.195 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -112.75 126.2 55.15 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.381 0.672 . . . . 72.55 109.823 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.13 134.93 46.03 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.389 -0.597 . . . . 74.54 109.389 172.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.62 143.22 84.67 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 122.666 0.386 . . . . 54.12 110.879 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -61.11 126.85 20.49 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.537 2.825 . . . . 70.42 112.558 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.3 m -129.61 113.56 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 123.641 0.777 . . . . 72.34 109.825 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -95.91 89.58 5.29 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.285 0.634 . . . . 73.43 109.597 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -63.48 -36.11 82.69 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.349 -0.842 . . . . 73.53 110.362 176.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.454 ' HB2' ' NE2' ' A' ' 96' ' ' HIS . 8.6 p-10 -56.82 -42.7 80.05 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.654 1.182 . . . . 75.31 112.139 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.72 -42.3 97.94 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.569 0.543 . . . . 65.31 110.965 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 75.1 mt -65.28 -44.5 87.8 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.323 -0.853 . . . . 74.25 110.955 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -65.23 -30.89 71.82 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.337 0.655 . . . . 71.31 112.024 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 30.1 mmt -70.18 -33.96 72.39 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.391 0.276 . . . . 73.34 110.969 176.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 87.5 m-20 -68.62 -20.92 64.5 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.677 0.791 . . . . 64.2 111.529 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -95.55 -38.37 10.45 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.124 0.57 . . . . 63.34 111.733 175.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 57.2 tp -68.87 -46.47 68.38 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.233 0.613 . . . . 53.51 112.017 -174.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -147.07 0.21 0.72 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.767 0.427 . . . . 70.35 110.581 -172.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 1.8 mp0 63.63 164.74 0.13 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.628 1.171 . . . . 63.14 110.929 -171.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -73.36 93.9 1.99 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.604 0.716 . . . . 75.43 109.361 174.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.95 163.6 32.98 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 114.489 -1.232 . . . . 64.13 109.084 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 150.25 158.39 8.19 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.993 -0.548 . . . . 73.51 112.04 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -134.74 -73.78 0.47 Allowed 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.526 -0.916 . . . . 72.35 108.526 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 62.44 66.38 2.63 Favored Glycine 0 C--N 1.351 1.386 0 O-C-N 123.542 0.527 . . . . 55.41 113.299 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.2 p -106.01 -73.25 0.69 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.27 0.628 . . . . 62.24 109.826 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 55.83 23.09 6.11 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.083 0.953 . . . . 73.33 111.532 -175.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -92.98 149.02 21.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.032 1.333 . . . . 74.02 108.026 -173.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 83.2 t60 70.35 97.28 0.07 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.446 1.098 . . . . 55.53 109.919 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -141.29 92.22 2.46 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.683 -1.228 . . . . 72.52 107.683 177.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -133.95 173.1 11.93 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.599 0.76 . . . . 65.13 110.509 -167.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 C-N-CA 123.739 0.815 . . . . 72.13 109.201 179.422 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 109.848 -0.427 . . . . 74.11 109.848 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 17.6 m -97.68 -77.07 0.51 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.741 -0.836 . . . . 75.42 108.741 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -174.15 134.25 0.43 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.6 0.76 . . . . 72.52 109.311 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -87.01 24.12 1.6 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.813 0.845 . . . . 64.14 112.07 -177.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -70.59 124.91 25.37 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.349 1.06 . . . . 72.15 110.48 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 64.7 t30 68.67 144.44 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 125.939 1.696 . . . . 74.43 111.395 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t -134.03 120.24 19.99 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.421 0.629 . . . . 74.44 111.343 -173.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -142.95 -45.61 0.3 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.763 1.225 . . . . 74.3 108.046 168.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.645 ' HB3' HG12 ' B' ' 89' ' ' ILE . 5.5 ppp? 51.58 -171.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 126.485 1.914 . . . . 71.41 113.614 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 93.8 m -134.03 107.1 7.57 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.897 -0.779 . . . . 71.33 108.897 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.536 ' HB2' ' SD ' ' B' ' 9' ' ' MET . 41.4 t80 -123.53 142.95 50.51 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.536 -0.756 . . . . 70.21 110.057 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.462 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -160.04 140.79 12.09 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.677 0.611 . . . . 72.45 109.61 174.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.539 HD13 HD11 ' B' ' 16' ' ' ILE . 42.8 mt -79.69 125.99 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 108.693 -0.854 . . . . 62.55 108.693 170.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -98.14 -37.31 9.77 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.394 0.678 . . . . 63.43 109.22 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.434 ' HE ' HG21 ' A' ' 122' ' ' THR . 45.4 ttt180 -174.19 144.32 0.95 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.479 -0.782 . . . . 74.11 109.037 -176.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.539 HD11 HD13 ' B' ' 13' ' ' ILE . 96.5 mt -128.23 142.45 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.55 -1.278 . . . . 64.12 107.55 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -168.63 148.91 4.53 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.664 0.745 . . . . 73.52 112.712 -174.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.5 m -73.72 124.87 26.84 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.147 -1.388 . . . . 74.12 108.945 167.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.452 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 37.6 mtpt -98.41 -21.51 16.54 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.635 0.774 . . . . 70.32 110.863 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -165.56 138.64 4.38 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.761 0.663 . . . . 64.23 110.706 -167.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.478 HD12 HG22 ' B' ' 78' ' ' VAL . 48.5 mm -132.96 143.87 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.076 0.951 . . . . 65.11 110.191 174.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.638 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 75.6 m -134.24 136.47 43.66 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 125.911 1.684 . . . . 52.24 107.199 169.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.4 t80 -151.48 114.83 4.8 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.474 -1.306 . . . . 63.31 107.474 165.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -119.31 155.83 31.12 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.379 -0.971 . . . . 63.32 108.379 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.451 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -144.52 86.06 8.27 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 107.766 -1.198 . . . . 64.01 107.766 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.24 -45.79 21.43 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.593 2.862 . . . . 63.11 113.86 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -104.0 24.59 11.12 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.186 0.594 . . . . 72.15 110.849 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.451 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -42.24 -62.73 1.09 Allowed Pre-proline 0 N--CA 1.485 1.283 0 N-CA-C 115.202 1.556 . . . . 74.52 115.202 -165.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 51.9 Cg_exo -53.44 -43.23 59.26 Favored 'Trans proline' 0 C--N 1.39 2.751 0 C-N-CA 122.072 1.848 . . . . 44.41 113.878 -168.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -97.12 -22.43 16.77 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.285 0.846 . . . . 74.45 113.285 -171.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.64 -17.56 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 118.452 0.569 . . . . 52.25 112.06 -173.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -70.48 -15.61 62.82 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 113.305 0.854 . . . . 72.32 113.305 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -61.6 -27.19 68.47 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.152 0.501 . . . . 63.43 109.765 173.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -86.92 80.34 8.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.336 1.054 . . . . 73.23 110.067 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -91.47 90.41 7.64 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.923 -0.581 . . . . 73.0 109.493 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -161.51 -175.64 4.89 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.723 1.209 . . . . 63.23 108.549 172.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -81.32 109.63 14.94 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 122.951 0.501 . . . . 74.51 110.109 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.68 160.22 50.54 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.442 2.095 . . . . 70.52 113.109 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -66.17 112.64 4.03 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.269 0.628 . . . . 65.54 109.63 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 51.5 t -88.86 134.66 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.803 0.841 . . . . 61.41 109.747 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -140.87 118.0 11.26 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 106.532 -1.655 . . . . 64.0 106.532 175.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 pp -114.34 166.58 11.52 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.01 0.433 . . . . 65.4 111.771 -176.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.534 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 14.2 m-20 -147.31 155.87 42.41 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.412 1.085 . . . . 73.41 109.206 174.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -120.98 146.58 46.52 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.31 -0.996 . . . . 62.41 108.31 172.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.602 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 7.4 t70 -137.91 138.19 38.78 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.856 0.862 . . . . 73.14 108.935 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 36.7 p -109.64 127.77 54.77 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.301 0.64 . . . . 72.31 111.166 -175.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.49 142.78 29.53 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.018 0.927 . . . . 74.41 108.622 174.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 35.2 p -144.53 163.62 33.32 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 122.705 0.402 . . . . 73.41 110.855 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 79.6 p -151.1 138.41 19.39 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.875 0.87 . . . . 72.33 109.018 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -96.83 134.06 40.62 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.23 -0.656 . . . . 61.3 109.23 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 46.7 mt -101.12 -39.92 7.44 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.196 0.598 . . . . 70.2 110.64 -175.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.73 -173.98 4.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.388 -0.824 . . . . 53.15 110.449 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.12 121.68 19.68 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.009 -0.996 . . . . 71.41 108.864 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 75.51 -7.5 1.77 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 126.246 1.818 . . . . 71.53 112.584 -175.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 96.1 t -110.87 112.28 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.279 -0.637 . . . . 50.32 109.279 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -119.6 -179.77 3.98 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.572 -0.899 . . . . 72.04 108.572 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -144.05 107.01 4.48 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.988 -1.115 . . . . 73.54 107.988 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 74.1 t -96.83 128.55 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.233 1.013 . . . . 63.33 110.212 -175.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.492 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 12.7 t -118.37 126.28 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.86 0.864 . . . . 72.22 109.563 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.712 HD22 ' HB3' ' B' ' 103' ' ' PRO . 52.2 tp -112.85 115.5 28.56 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.482 -0.933 . . . . 73.44 108.482 164.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.602 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 17.2 ttt180 -92.47 118.22 30.74 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.884 -0.784 . . . . 41.44 108.884 175.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.74 121.21 54.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.361 -0.977 . . . . 71.24 108.361 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.534 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 22.6 m -104.82 143.78 32.67 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.881 -0.785 . . . . 71.54 108.881 177.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 95.0 t -136.29 136.22 49.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 123.785 0.834 . . . . 75.33 108.854 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.8 m -125.86 143.75 50.94 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.609 1.163 . . . . 73.23 108.068 172.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.68 139.2 23.81 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.083 -0.71 . . . . 63.24 109.083 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.54 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 33.2 p -140.37 128.16 21.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.887 -0.597 . . . . 54.51 110.192 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 61.6 mt -96.89 105.42 17.56 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.027 -1.101 . . . . 73.41 108.027 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.26 -111.85 3.52 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 115.663 -0.699 . . . . 75.44 111.644 -173.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -121.76 3.99 10.04 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.781 0.832 . . . . 71.13 110.328 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -113.56 139.02 49.34 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.46 -0.571 . . . . 74.53 109.46 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 94.4 m -67.52 113.41 5.33 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.319 0.581 . . . . 64.42 109.97 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.54 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -70.44 -62.03 1.54 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.258 -1.337 . . . . 75.02 108.331 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -150.22 155.04 39.0 Favored 'General case' 0 C--N 1.347 0.491 0 N-CA-C 112.853 0.686 . . . . 74.25 112.853 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 64.8 mt -123.27 110.94 15.84 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.076 -1.453 . . . . 75.44 107.076 171.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.41 ' SG ' HG23 ' B' ' 114' ' ' ILE . 37.8 t -118.46 139.23 51.74 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 108.809 -0.811 . . . . 75.41 108.809 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.638 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 39.6 tt0 -156.72 131.9 9.15 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.589 -0.522 . . . . 72.12 109.589 -172.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.478 HG22 HD12 ' B' ' 21' ' ' ILE . 98.3 t -128.15 147.91 32.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 123.715 0.806 . . . . 72.33 109.183 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -110.92 103.72 12.25 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.305 -1.368 . . . . 63.12 107.305 165.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.479 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 7.8 tp-100 -92.96 98.99 11.71 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.387 -1.338 . . . . 73.22 107.387 173.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -96.01 171.31 28.42 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.732 -1.122 . . . . 63.33 110.662 173.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.51 137.11 4.18 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 111.275 -0.73 . . . . 32.11 111.275 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 45.4 mt -84.18 127.14 40.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 107.596 -1.261 . . . . 73.14 107.596 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -136.49 142.69 43.54 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.956 0.902 . . . . 75.31 109.159 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 27.3 m -89.13 113.46 24.63 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.03 -1.1 . . . . 45.34 108.03 168.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.494 HD13 ' SG ' ' B' ' 97' ' ' CYS . 0.4 OUTLIER -130.27 107.83 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.329 1.052 . . . . 70.21 108.322 -176.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' B' ' 9' ' ' MET . . . -156.65 171.89 19.54 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.54 1.136 . . . . 75.41 110.286 -177.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.75 -57.18 1.13 Allowed Glycine 0 C--N 1.346 1.094 0 N-CA-C 112.444 -0.262 . . . . 53.42 112.444 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.645 HG12 ' HB3' ' B' ' 9' ' ' MET . 4.2 mm -83.01 156.31 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.216 0.607 . . . . 74.25 110.394 175.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -152.34 -173.31 4.51 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.195 -0.912 . . . . 74.22 110.665 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.71 -120.46 8.15 Favored Glycine 0 C--N 1.351 1.392 0 CA-C-N 115.607 -0.724 . . . . 54.42 113.289 170.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.8 m -83.48 -37.48 23.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.513 0.673 . . . . 75.15 110.643 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -72.61 -23.17 60.9 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.96 -1.018 . . . . 70.4 111.462 -167.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -71.46 -29.8 65.28 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.028 0.531 . . . . 72.0 111.09 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.64 -37.47 78.78 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.481 0.712 . . . . 70.45 110.692 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -75.15 -30.63 60.81 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.355 -0.839 . . . . 62.53 111.321 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.494 ' SG ' HD13 ' B' ' 86' ' ' ILE . 46.1 t -69.41 -66.7 0.55 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 122.296 0.238 . . . . 73.32 111.544 -174.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.56 HD11 ' HD2' ' F' ' 17' ' ' PRO . 2.0 pt? -88.32 -3.59 58.82 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.263 -0.898 . . . . 72.31 111.393 -178.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.79 -4.47 59.0 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-O 119.824 -0.431 . . . . 65.52 114.114 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.646 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -148.46 -50.0 0.16 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 117.576 0.688 . . . . 75.33 111.493 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.504 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 46.3 t80 -67.84 -47.83 67.88 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.148 0.579 . . . . 73.04 111.617 -175.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.489 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 59.2 m -66.46 -48.18 56.52 Favored Pre-proline 0 N--CA 1.488 1.468 0 CA-C-O 119.056 -0.497 . . . . 61.11 112.208 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.712 ' HB3' HD22 ' B' ' 60' ' ' LEU . 72.3 Cg_exo -55.77 -29.98 74.13 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.293 1.996 . . . . 64.33 114.283 170.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -66.68 -37.09 84.03 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.686 0.795 . . . . 74.13 110.618 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.28 -42.76 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 123.544 0.738 . . . . 75.04 110.169 175.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.416 HD22 ' HG3' ' B' ' 80' ' ' GLN . 78.7 mt -78.88 -17.21 55.97 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.298 -1.319 . . . . 72.24 111.728 -174.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.431 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 71.9 t80 -56.92 -53.91 60.01 Favored Pre-proline 0 CA--C 1.563 1.464 0 C-N-CA 124.365 1.066 . . . . 70.13 113.372 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 35.5 Cg_exo -63.27 -32.8 72.89 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 121.796 1.664 . . . . 74.21 113.292 -178.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -70.98 -44.01 66.87 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.441 0.697 . . . . 65.45 110.815 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -65.97 -36.79 84.29 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.677 0.391 . . . . 73.1 110.344 175.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -55.5 -56.36 21.09 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 124.311 1.007 . . . . 72.02 110.682 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -60.68 -40.24 91.43 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 123.633 0.583 . . . . 61.34 110.501 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.561 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.8 t -66.37 -38.87 88.54 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 123.505 0.503 . . . . 73.05 111.226 -175.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.41 HG23 ' SG ' ' B' ' 76' ' ' CYS . 97.2 mt -64.71 -52.21 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 123.132 0.573 . . . . 74.05 109.765 174.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 32.3 m -60.72 -32.48 71.74 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.784 0.834 . . . . 44.23 111.493 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.465 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.2 m -65.29 -46.58 79.86 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.852 0.461 . . . . 74.01 110.691 175.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.561 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -69.13 -34.4 74.96 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 123.229 0.331 . . . . 73.11 111.099 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.53 -40.91 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.607 0.763 . . . . 72.55 110.437 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -67.32 -37.04 82.68 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 114.95 -1.023 . . . . 50.11 111.561 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.48 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 85.6 mtt-85 -66.99 -36.38 82.03 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.314 -0.857 . . . . 74.3 109.368 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -83.62 11.65 55.33 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 124.278 0.986 . . . . 71.14 113.496 174.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 50.4 p 56.84 19.58 4.58 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 125.839 1.656 . . . . 62.2 114.648 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -78.9 166.64 40.9 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 123.63 0.772 . . . . 74.25 112.063 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.96 160.14 8.34 Favored 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 123.199 2.599 . . . . 64.33 114.059 171.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.492 HE21 ' ND2' ' B' ' 127' ' ' ASN . 66.7 tp60 -65.37 139.27 58.55 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.527 -0.761 . . . . 53.34 112.443 -173.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 51.5 tp -142.07 119.89 11.92 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.583 0.753 . . . . 73.45 109.667 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.492 ' ND2' HE21 ' B' ' 125' ' ' GLN . 54.2 m-80 -127.51 135.48 50.42 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.117 0.967 . . . . 70.01 108.581 173.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.658 ' HA ' HD11 ' F' ' 6' ' ' ILE . 1.3 tt -78.5 124.26 27.94 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 108.743 -0.836 . . . . 74.35 108.743 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.28 141.94 98.23 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.982 0.913 . . . . 71.42 111.993 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.402 ' HG3' HD13 ' D' ' 16' ' ' ILE . 16.4 Cg_exo -65.67 92.76 0.25 Allowed 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.627 2.218 . . . . 54.21 112.709 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.419 HG21 ' HA ' ' F' ' 7' ' ' ALA . 60.6 t -97.08 120.4 46.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 108.374 -0.973 . . . . 63.54 108.374 172.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -74.44 85.33 2.01 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 108.176 -1.046 . . . . 64.0 108.176 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.436 ' HZ ' ' HG ' ' F' ' 11' ' ' LEU . 12.9 t80 -69.15 -34.63 75.29 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.109 -1.405 . . . . 72.31 110.765 -173.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.646 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 19.0 t70 -58.94 -49.18 78.79 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.118 -1.401 . . . . 64.33 110.785 175.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.82 -38.29 86.16 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.497 0.719 . . . . 73.4 111.898 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.3 tt -62.63 -50.64 70.4 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.688 0.795 . . . . 72.11 109.663 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -71.26 -33.91 70.24 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.106 -0.952 . . . . 74.12 111.113 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 13.9 tmm? -64.46 -37.04 86.16 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.494 0.718 . . . . 72.2 110.188 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -74.13 -24.89 59.5 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.791 -1.095 . . . . 72.43 110.926 -171.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -62.46 -35.92 80.84 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.743 -0.662 . . . . 63.44 111.041 176.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 pp -120.75 18.96 11.88 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.545 0.738 . . . . 63.01 111.965 -173.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -71.59 -29.45 64.71 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 112.628 0.603 . . . . 73.43 112.628 -173.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -55.57 103.0 0.08 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.488 0.715 . . . . 72.44 111.87 -174.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -135.78 144.71 45.93 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.909 0.884 . . . . 62.21 109.873 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -111.52 144.99 39.86 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.878 0.871 . . . . 72.1 111.029 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.57 120.97 6.45 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 111.045 -0.822 . . . . 72.23 111.045 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -90.76 -173.99 3.91 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.586 0.754 . . . . 65.23 111.951 -174.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.91 -178.3 29.97 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.443 -0.799 . . . . 62.43 111.776 173.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 96.7 m -133.03 127.36 33.91 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.046 0.938 . . . . 74.44 109.545 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -91.88 127.79 37.48 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.9 -0.778 . . . . 74.23 108.9 171.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -99.46 171.6 7.85 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.899 0.879 . . . . 75.22 109.95 174.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -144.69 163.03 35.22 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.363 0.665 . . . . 62.02 110.154 -176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -72.17 157.43 37.76 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 120.883 0.373 . . . . 54.34 111.316 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -161.14 124.16 3.22 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.471 0.708 . . . . 75.34 109.314 177.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.077 0 C-N-CA 123.679 0.791 . . . . 37.92 110.392 178.151 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 109.342 -0.614 . . . . 62.24 109.342 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 41.1 t -84.96 63.61 8.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.904 0.882 . . . . 73.0 108.774 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -173.61 146.87 1.36 Allowed 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.532 1.133 . . . . 61.02 109.32 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . 0.436 HE22 HE22 ' C' ' 12' ' ' GLN . 35.5 tt0 -170.84 -47.75 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.229 1.012 . . . . 65.03 108.702 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 9.8 t30 66.79 98.26 0.05 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.067 1.347 . . . . 74.42 111.726 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -123.66 116.68 23.48 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.994 0.918 . . . . 72.1 108.78 174.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 40.0 p -110.09 112.39 24.34 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.675 0.79 . . . . 62.4 109.365 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 68.95 129.74 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.356 1.462 . . . . 73.24 110.646 -172.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.624 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 0.0 OUTLIER 64.74 113.08 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.883 1.273 . . . . 71.43 110.596 -174.835 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 93.4 m -97.55 102.41 14.17 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.789 -0.819 . . . . 71.13 108.789 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.624 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 1.1 t80 -112.87 128.71 56.53 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.512 -0.921 . . . . 74.43 108.512 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.436 HE22 HE22 ' C' ' 4' ' ' GLN . 7.5 tp-100 -143.49 128.93 19.01 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 108.886 -0.783 . . . . 74.21 108.886 171.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 37.8 mt -79.5 118.64 27.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.693 -0.855 . . . . 73.03 108.693 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.495 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 18.1 mm-40 -89.99 -33.07 16.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.996 -1.002 . . . . 45.21 109.635 -175.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -177.96 149.47 0.57 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.676 0.79 . . . . 54.34 109.353 -175.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 93.8 mt -137.25 140.25 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 107.965 -1.124 . . . . 65.04 107.965 174.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.415 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 21.1 p90 -171.04 167.37 7.23 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 120.796 0.331 . . . . 75.45 111.342 -171.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.5 p -95.69 127.97 42.17 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 109.456 -0.572 . . . . 72.42 109.456 175.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.415 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 16.7 mmtp -79.24 -50.13 11.42 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 122.597 1.189 . . . . 71.35 108.391 172.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 16.6 t70 -139.15 144.37 38.59 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 112.597 -2.092 . . . . 75.12 108.468 -167.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.408 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 81.4 mt -138.38 149.35 24.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 106.767 -1.568 . . . . 51.53 106.767 175.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 43.2 t -157.24 150.32 23.67 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.34 0.656 . . . . 65.44 109.412 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.403 ' CE1' ' HA3' ' C' ' 121' ' ' GLY . 86.4 t80 -152.31 134.48 15.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.55 -1.278 . . . . 71.35 107.55 173.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . 0.436 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 42.2 mt-10 -133.89 110.85 10.01 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.484 0.713 . . . . 74.31 109.696 -176.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.02 79.11 73.66 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 106.979 -1.489 . . . . 63.14 106.979 163.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.19 -21.52 31.39 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.688 2.259 . . . . 70.11 111.947 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.467 ' ND2' ' HB ' ' C' ' 31' ' ' VAL . 22.9 p-10 -102.38 22.12 13.95 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.586 1.155 . . . . 64.11 110.735 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.59 -58.39 4.51 Favored Pre-proline 0 CA--C 1.562 1.405 0 N-CA-C 114.738 1.385 . . . . 50.23 114.738 -169.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -63.2 -35.64 62.41 Favored 'Trans proline' 0 C--N 1.38 2.236 0 CA-C-N 121.889 1.71 . . . . 75.43 112.169 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -69.82 -37.26 76.17 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.193 0.997 . . . . 73.35 112.247 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.722 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.0 p -80.43 -16.69 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 N-CA-C 113.109 0.781 . . . . 54.44 113.109 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-30 -73.47 -23.14 60.04 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.735 -0.603 . . . . 72.24 111.983 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -90.02 17.93 6.36 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.123 0.569 . . . . 74.54 111.764 175.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -109.45 146.84 33.85 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.922 0.889 . . . . 61.22 110.535 -172.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.51 131.41 49.04 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.679 0.792 . . . . 62.12 110.647 173.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -79.48 89.32 5.04 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.467 0.707 . . . . 70.23 110.421 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' C' ' 68' ' ' LEU . 18.7 tt0 -138.42 67.08 45.11 Favored Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 124.062 0.945 . . . . 70.31 109.297 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -90.27 140.4 3.22 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.824 2.349 . . . . 64.44 113.316 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -88.74 101.21 13.79 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.832 -1.173 . . . . 73.04 107.832 166.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.517 HG11 HD12 ' G' ' 6' ' ' ILE . 38.6 t -78.56 97.84 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.779 -0.823 . . . . 54.05 108.779 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.53 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 94.0 mttt -97.97 105.11 17.2 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 114.562 -1.199 . . . . 55.21 108.338 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.499 HD11 HD21 ' C' ' 128' ' ' LEU . 2.8 mm? -85.61 139.68 31.22 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.997 -0.742 . . . . 71.32 108.997 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -141.86 106.69 4.9 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.47 -1.307 . . . . 64.23 107.47 -176.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 8.1 mp -109.02 148.28 31.02 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.256 0.551 . . . . 51.52 110.176 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.538 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 14.1 t70 -130.48 145.22 51.8 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.923 1.289 . . . . 74.12 108.896 -174.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 61.7 p -116.71 112.83 21.76 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.984 0.914 . . . . 55.21 110.432 -167.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.26 143.18 39.95 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.102 0.561 . . . . 72.53 110.945 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 22.1 p -160.72 155.61 24.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.245 0.618 . . . . 73.13 110.657 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 90.1 p -143.96 154.07 42.92 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.489 0.715 . . . . 64.52 110.157 -175.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -84.89 123.23 30.25 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.954 0.502 . . . . 73.42 110.29 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.638 HD11 HD12 ' C' ' 83' ' ' ILE . 25.4 mt -100.23 -41.86 6.91 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.946 -0.761 . . . . 54.23 108.946 172.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.35 -172.68 4.31 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.304 1.041 . . . . 74.13 109.611 177.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.75 117.1 11.83 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.225 -0.898 . . . . 65.51 109.498 173.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 71.95 -5.91 1.6 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.937 1.295 . . . . 64.13 112.78 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 92.2 t -105.9 107.6 23.04 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.396 -0.964 . . . . 74.44 108.396 174.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.485 ' CD1' HG23 ' G' ' 18' ' ' VAL . 7.4 m-85 -127.41 141.3 51.72 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.715 0.806 . . . . 75.34 109.131 -175.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.456 ' HB2' HD11 ' C' ' 51' ' ' LEU . 16.9 tt0 -83.2 111.52 19.01 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.103 -1.408 . . . . 72.23 108.826 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 92.0 t -97.03 119.46 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 108.789 -0.819 . . . . 51.33 108.789 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 33.3 t -123.75 118.21 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.517 0.727 . . . . 70.34 110.477 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 50.0 tp -105.34 110.81 23.31 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.269 -1.011 . . . . 73.02 108.269 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.538 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 0.3 OUTLIER -91.91 107.09 18.96 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.417 -0.586 . . . . 72.21 109.417 178.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.08 131.63 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.3 -1.0 . . . . 61.35 108.3 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 26.7 m -127.77 117.82 22.6 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.919 -0.771 . . . . 61.21 108.919 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.56 HG21 HG21 ' C' ' 114' ' ' ILE . 61.1 t -102.27 114.58 42.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 115.106 -0.952 . . . . 62.15 109.139 -177.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 27.8 m -98.01 137.11 37.3 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.008 -1.108 . . . . 74.03 108.008 170.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.18 109.5 6.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.235 -1.394 . . . . 64.3 107.235 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 62.6 m -131.38 128.63 40.0 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.013 0.435 . . . . 54.34 110.531 -176.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' C' ' 37' ' ' GLN . 10.4 mt -85.51 42.6 0.97 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.303 1.441 . . . . 74.44 110.916 -174.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.48 -89.54 0.54 Allowed Glycine 0 C--N 1.348 1.208 0 N-CA-C 110.898 -0.881 . . . . 72.42 110.898 -173.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.9 -25.58 5.8 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.247 1.019 . . . . 61.55 109.544 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -76.37 120.98 22.35 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.107 1.363 . . . . 75.11 109.157 169.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 85.1 m -75.4 126.71 31.57 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.761 0.71 . . . . 34.14 109.422 171.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.722 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.31 -58.91 3.23 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.13 -0.692 . . . . 63.0 109.13 173.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . 0.451 ' HZ ' ' HG ' ' C' ' 126' ' ' LEU . 34.8 p90 -159.36 169.86 23.07 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.601 -1.181 . . . . 55.21 111.19 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.436 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.0 tm? -130.03 145.99 51.69 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 105.381 -2.081 . . . . 70.43 105.381 169.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.421 ' N ' HD13 ' C' ' 75' ' ' LEU . 46.2 t -144.74 148.91 34.7 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.929 -1.138 . . . . 61.34 107.929 176.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -158.36 124.76 4.71 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 120.695 0.283 . . . . 72.21 110.628 -173.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 90.0 t -133.97 134.11 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.939 0.896 . . . . 70.34 109.139 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -101.31 93.37 5.39 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.354 -0.98 . . . . 63.11 108.354 170.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -81.53 101.49 9.98 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.393 -0.595 . . . . 71.11 109.393 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.16 169.43 45.93 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 115.797 -0.638 . . . . 63.42 112.472 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.51 126.9 1.08 Allowed Glycine 0 C--O 1.237 0.3 0 N-CA-C 111.452 -0.659 . . . . 64.42 111.452 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.638 HD12 HD11 ' C' ' 51' ' ' LEU . 10.7 mm -85.12 121.28 36.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 108.82 -0.808 . . . . 42.43 108.82 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -131.96 139.91 48.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.371 0.669 . . . . 70.52 109.317 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 16.9 p -92.39 114.51 27.08 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 109.19 -0.67 . . . . 70.53 109.19 170.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.39 104.55 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.405 -0.961 . . . . 72.31 108.405 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.01 165.89 25.94 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.845 0.858 . . . . 44.53 110.197 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.9 -59.72 2.07 Favored Glycine 0 C--N 1.344 1.004 0 O-C-N 123.242 0.339 . . . . 74.52 113.351 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 30.5 pt -81.09 162.65 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 122.923 0.489 . . . . 74.44 110.086 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -147.82 174.24 12.03 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.844 0.458 . . . . 72.04 111.191 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.11 -132.41 50.76 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.909 0.756 . . . . 43.14 114.022 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.0 p -64.17 -21.93 66.75 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.788 0.835 . . . . 64.13 112.259 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -65.29 -54.51 28.12 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.507 0.723 . . . . 73.13 110.629 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.506 ' SD ' HG13 ' G' ' 18' ' ' VAL . 10.2 ptp -72.17 -28.16 63.05 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 116.208 -0.451 . . . . 74.14 110.746 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . 0.432 ' HB2' ' HB1' ' G' ' 21' ' ' ALA . . . -65.9 -32.83 74.56 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.226 0.611 . . . . 72.03 110.912 173.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -79.36 -32.08 43.12 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.592 -0.731 . . . . 71.51 110.795 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -59.84 -48.15 82.85 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.393 0.677 . . . . 74.03 111.29 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.611 HD13 ' HB2' ' G' ' 15' ' ' PHE . 1.0 OUTLIER -89.24 -20.07 24.6 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.595 0.358 . . . . 75.32 111.633 176.126 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.49 -29.68 39.18 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 115.064 0.786 . . . . 30.32 115.064 -172.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.88 -39.6 0.3 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.835 0.826 . . . . 63.02 111.265 -172.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.421 ' HE2' ' CE1' ' C' ' 11' ' ' PHE . 67.3 t80 -74.28 -41.03 61.89 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 113.792 -1.549 . . . . 75.34 112.801 -174.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 90.4 m -76.53 -39.45 2.44 Favored Pre-proline 0 N--CA 1.486 1.325 0 CA-C-O 118.959 -0.544 . . . . 75.42 111.938 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -45.55 -35.76 12.92 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.739 2.292 . . . . 75.44 114.652 163.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -66.13 -40.3 90.53 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.237 0.615 . . . . 74.42 110.205 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.515 HD12 ' NH1' ' A' ' 111' ' ' ARG . 45.5 mm -64.81 -40.56 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.142 0.577 . . . . 75.04 110.159 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 91.6 mt -89.06 -8.09 54.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.905 0.882 . . . . 74.31 112.244 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -59.77 -52.21 75.39 Favored Pre-proline 0 N--CA 1.484 1.257 0 C-N-CA 123.883 0.873 . . . . 72.01 113.165 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.41 -30.14 36.84 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 121.614 1.542 . . . . 75.41 112.969 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -70.46 -48.77 54.26 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.184 0.594 . . . . 75.45 110.624 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.25 -41.67 93.7 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.154 -0.93 . . . . 70.11 109.969 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -55.8 -52.22 64.74 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.261 0.976 . . . . 75.2 110.996 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -67.47 -30.12 69.74 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.035 0.534 . . . . 70.4 110.641 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.2 t -74.34 -32.22 62.72 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.071 0.549 . . . . 72.1 111.179 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.56 HG21 HG21 ' C' ' 64' ' ' VAL . 96.1 mt -75.71 -51.64 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.208 0.603 . . . . 75.32 109.995 176.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 12.1 m -63.96 -31.17 72.26 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 123.347 0.659 . . . . 73.42 110.893 -173.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 40.2 t -58.08 -55.25 37.33 Favored 'General case' 0 C--N 1.351 0.63 0 CA-C-N 115.494 -0.775 . . . . 73.2 109.302 169.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.443 ' HG3' HD12 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.43 -36.57 76.15 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.746 1.218 . . . . 70.44 113.138 -179.304 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.45 HG23 ' O ' ' C' ' 114' ' ' ILE . 91.4 t -62.9 -49.46 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.312 0.645 . . . . 74.25 109.798 176.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 42.7 t -71.83 -25.75 62.1 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.03 -0.986 . . . . 45.32 111.656 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 -70.24 -40.56 74.39 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.362 0.665 . . . . 72.34 109.463 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . 0.403 ' HA3' ' CE1' ' C' ' 23' ' ' PHE . . . -82.14 8.18 61.47 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.871 0.732 . . . . 74.52 112.915 173.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 82.7 p 54.9 63.7 2.05 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.975 1.71 . . . . 75.35 113.087 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -120.94 155.86 57.2 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 124.321 1.048 . . . . 75.3 108.41 169.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -55.76 161.63 7.83 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.335 2.69 . . . . 73.43 113.891 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -55.1 113.14 1.25 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.424 -0.807 . . . . 61.21 112.406 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.451 ' HG ' ' HZ ' ' C' ' 74' ' ' PHE . 2.4 tm? -117.75 90.16 3.27 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.534 -1.284 . . . . 72.2 107.534 -175.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -114.38 132.66 56.14 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.719 0.807 . . . . 71.01 108.995 176.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.499 HD21 HD11 ' C' ' 42' ' ' LEU . 96.2 mt -69.75 144.28 52.78 Favored 'General case' 0 C--O 1.246 0.871 0 O-C-N 123.682 0.614 . . . . 73.34 111.113 176.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.79 148.52 98.19 Favored Pre-proline 0 C--N 1.351 0.669 0 O-C-N 124.006 0.816 . . . . 55.13 109.849 172.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.491 ' HB2' HD12 ' A' ' 13' ' ' ILE . 31.1 Cg_exo -61.64 87.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.51 2.14 . . . . 64.43 113.199 177.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 95.0 t -104.41 107.71 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.371 -0.831 . . . . 72.04 108.923 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -83.46 106.55 15.3 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.076 -1.083 . . . . 63.11 108.076 171.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -48.44 -38.54 20.05 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 124.843 1.34 . . . . 70.2 113.035 -174.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.04 -59.22 4.01 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.587 0.755 . . . . 61.41 111.25 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.63 -23.59 67.44 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.867 -0.606 . . . . 71.14 112.077 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 55.0 tp -63.41 -34.15 77.1 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.907 0.883 . . . . 71.43 110.766 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -64.1 -40.16 95.61 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.776 0.43 . . . . 75.43 111.053 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 84.9 mtp -77.49 -43.34 32.51 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.519 0.728 . . . . 74.53 111.367 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -64.18 -36.04 82.76 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.088 0.955 . . . . 65.2 111.078 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -67.65 -84.85 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 108.039 -1.097 . . . . 71.14 108.039 172.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 1.2 tm? 14.77 -79.91 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 127.851 2.46 . . . . 63.21 114.639 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.63 -56.02 5.27 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.931 0.892 . . . . 73.41 110.34 -171.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -145.32 125.61 13.87 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.754 0.821 . . . . 62.33 109.557 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -116.85 162.12 18.23 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.034 0.534 . . . . 71.11 111.748 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 178.73 170.75 0.83 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.724 1.61 . . . . 75.43 108.465 171.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -151.15 -90.76 0.08 OUTLIER Glycine 0 C--N 1.345 1.066 0 CA-C-O 119.961 -0.355 . . . . 44.13 112.782 -176.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 62.39 -179.86 0.13 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.639 1.176 . . . . 62.45 112.177 -174.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.62 -130.24 5.45 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-O 119.605 -0.553 . . . . 75.01 113.422 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 53.2 m 72.38 93.52 0.08 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.402 1.481 . . . . 63.45 110.907 -172.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -80.31 137.22 36.56 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.478 -0.783 . . . . 70.5 109.068 168.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -73.86 -57.32 4.06 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.7 0.8 . . . . 44.41 110.06 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 33.5 m170 70.56 -59.23 0.53 Allowed 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 125.515 1.526 . . . . 70.43 113.112 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -136.67 165.75 25.17 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.009 0.924 . . . . 72.24 109.543 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -60.16 -62.69 1.68 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.227 1.011 . . . . 74.52 111.135 174.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 107.665 -1.235 . . . . 62.33 107.665 177.228 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . 0.422 ' SD ' ' N ' ' D' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 121.47 0.652 . . . . 73.45 109.703 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 19.7 m -76.14 169.18 18.69 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.719 0.808 . . . . 75.32 112.691 -173.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -158.03 134.26 9.43 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.297 1.039 . . . . 73.24 108.695 172.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . 0.569 HE22 ' HB2' ' D' ' 90' ' ' GLU . 0.6 OUTLIER -147.75 139.6 24.05 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.161 0.505 . . . . 74.1 111.862 -172.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -98.4 23.61 8.25 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 122.156 0.979 . . . . 54.41 108.463 167.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -70.27 143.01 52.23 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.621 1.169 . . . . 70.22 111.016 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -79.4 22.44 0.44 Allowed 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 123.243 0.617 . . . . 70.32 112.564 -172.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -66.6 -17.65 64.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.394 0.677 . . . . 61.34 111.229 165.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 3.8 tpt -30.94 123.67 0.21 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.839 1.656 . . . . 74.23 113.811 172.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 36.2 m -144.45 150.45 37.66 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.349 -1.352 . . . . 74.31 107.349 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -162.76 89.51 0.66 Allowed 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.798 -0.815 . . . . 71.12 108.798 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -113.81 114.98 27.04 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.568 -1.271 . . . . 72.31 107.568 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mt -82.11 115.97 25.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 108.347 -0.983 . . . . 65.25 108.347 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -75.62 -44.2 44.07 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 123.27 0.356 . . . . 74.44 111.224 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.409 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 22.0 ttt180 -166.87 136.4 2.95 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.072 0.397 . . . . 64.15 112.072 -162.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.402 HD13 ' HG3' ' B' ' 130' ' ' PRO . 1.8 mp -115.31 137.5 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 107.92 -1.141 . . . . 73.04 107.92 171.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.409 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 30.6 p90 -159.74 172.24 18.07 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.201 1.001 . . . . 73.14 112.209 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.9 p -113.69 121.91 45.54 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.179 -1.373 . . . . 74.13 108.751 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -90.7 -22.15 21.27 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.048 -0.524 . . . . 53.22 109.75 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -156.85 128.82 7.26 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 114.719 -1.128 . . . . 74.25 108.325 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.443 HD12 ' HG3' ' C' ' 117' ' ' MET . 12.2 mt -128.68 150.47 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 107.866 -1.161 . . . . 73.3 107.866 174.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -154.79 146.16 23.0 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.837 0.827 . . . . 72.34 110.555 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 88.4 t80 -146.15 141.32 27.38 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 105.894 -1.891 . . . . 73.2 105.894 171.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.512 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.1 mt-10 -142.11 143.48 33.06 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.355 -0.979 . . . . 72.14 108.355 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.4 88.08 5.85 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 107.912 -1.144 . . . . 71.44 107.912 173.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.86 -17.4 13.9 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.975 2.45 . . . . 73.15 113.37 -176.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -113.84 12.88 18.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.436 1.095 . . . . 72.33 110.941 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.449 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -38.18 -67.55 0.25 Allowed Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 126.957 2.103 . . . . 54.43 116.492 -160.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.453 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 74.2 Cg_endo -71.86 -26.79 18.54 Favored 'Trans proline' 0 C--N 1.382 2.3 0 CA-C-N 123.22 2.186 . . . . 75.24 114.368 -171.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -86.45 -25.03 25.42 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 117.755 0.252 . . . . 73.42 110.568 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.638 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.5 p -82.14 -16.0 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 122.78 0.432 . . . . 74.25 111.013 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.453 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.3 m-85 -65.24 -22.83 66.92 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.105 0.409 . . . . 73.51 112.105 177.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -65.14 -15.03 61.96 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.036 0.935 . . . . 64.43 111.385 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -94.9 86.53 4.7 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.057 0.943 . . . . 75.34 110.064 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -87.47 90.86 8.53 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.701 -0.681 . . . . 74.43 109.785 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 42.3 p90 -164.76 175.72 9.43 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.022 0.929 . . . . 72.33 109.197 167.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -73.16 111.56 12.1 Favored Pre-proline 0 N--CA 1.474 0.762 0 N-CA-C 109.178 -0.675 . . . . 45.25 109.178 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -62.77 151.52 83.5 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.574 2.182 . . . . 73.44 111.771 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 56.6 mm-40 -62.77 111.67 2.21 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.018 -1.104 . . . . 65.23 108.018 169.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.771 HG13 HG13 ' D' ' 64' ' ' VAL . 57.8 t -104.68 105.19 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.687 0.795 . . . . 73.44 108.92 -175.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -86.72 129.14 34.99 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.69 -0.856 . . . . 74.4 108.69 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -97.68 110.66 23.18 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.696 -1.224 . . . . 70.4 107.696 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.516 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 10.3 t70 -116.31 130.13 56.62 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.081 -1.451 . . . . 60.31 107.081 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.6 mt -122.29 140.27 52.83 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.142 0.496 . . . . 60.11 111.104 -171.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.55 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 11.7 t70 -136.49 139.48 42.34 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.851 1.26 . . . . 63.2 108.112 174.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 45.4 p -104.03 144.75 31.12 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.361 0.664 . . . . 54.44 110.316 -174.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.413 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -160.7 157.32 26.85 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.46 0.704 . . . . 70.14 110.07 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 32.7 p -175.84 167.96 3.06 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.244 0.545 . . . . 71.34 112.178 -178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 62.5 p -156.63 126.65 6.41 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.002 -0.999 . . . . 75.21 108.471 169.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -74.24 121.09 20.73 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.422 -0.584 . . . . 74.04 109.422 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 46.8 mt -90.09 -25.5 20.72 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.273 0.629 . . . . 74.31 110.86 -172.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -172.53 -173.54 1.05 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.028 1.331 . . . . 63.02 109.56 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.87 120.49 12.65 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.886 -0.413 . . . . 73.51 109.886 176.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 69.57 -2.88 1.79 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.964 1.305 . . . . 65.53 112.595 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 97.4 t -110.92 120.06 60.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.432 -1.321 . . . . 74.24 107.432 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -150.36 142.39 23.97 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.385 0.612 . . . . 63.13 109.742 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -88.66 122.69 32.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.166 -1.379 . . . . 73.44 109.3 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 96.0 t -100.48 119.17 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 107.879 -1.156 . . . . 71.11 107.879 173.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.413 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 38.7 t -106.84 131.33 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.316 -0.994 . . . . 55.31 108.316 173.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.424 HD13 ' HZ ' ' H' ' 15' ' ' PHE . 15.8 tp -128.58 120.1 26.03 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 109.307 -0.627 . . . . 72.13 109.307 174.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.55 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 28.3 ttm-85 -82.62 99.09 9.35 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.555 -0.906 . . . . 72.11 108.555 177.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 77.1 t -91.25 117.55 34.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.987 -1.116 . . . . 73.21 107.987 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 28.7 m -117.01 135.38 53.74 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.478 -0.564 . . . . 74.13 109.478 -176.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.771 HG13 HG13 ' D' ' 40' ' ' VAL . 41.2 t -128.23 101.21 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.927 1.291 . . . . 74.52 108.684 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 92.8 m -93.04 116.74 29.33 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 107.878 -1.156 . . . . 73.12 107.878 172.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -106.02 133.96 49.9 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.604 -0.517 . . . . 72.21 109.604 -177.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 18.2 m -128.22 123.04 33.24 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.534 -0.543 . . . . 63.44 109.534 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 31.0 mt -108.9 113.22 25.94 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.693 -1.225 . . . . 73.01 107.693 173.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.78 -133.64 21.22 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 123.467 0.479 . . . . 31.3 112.871 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.76 6.82 39.89 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.718 0.807 . . . . 75.11 111.663 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -140.83 174.93 10.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.153 0.502 . . . . 55.45 111.482 -172.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 32.7 m -73.72 135.44 43.64 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.484 1.114 . . . . 73.22 111.322 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.638 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -86.35 -65.27 1.03 Allowed 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.024 -0.732 . . . . 60.33 109.024 168.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -150.36 151.98 33.69 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.593 -1.185 . . . . 75.15 110.894 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 60.9 mt -110.86 109.84 20.19 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.883 -1.155 . . . . 74.04 107.883 171.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.468 ' SG ' HG23 ' D' ' 114' ' ' ILE . 48.1 t -116.9 142.14 47.32 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.607 0.763 . . . . 72.4 109.191 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -157.01 142.68 17.61 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.0 0.52 . . . . 75.15 109.793 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 77.7 t -138.89 139.33 40.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 108.173 -1.047 . . . . 73.05 108.173 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -110.58 87.1 2.45 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 107.3 -1.37 . . . . 75.34 107.3 173.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -80.1 99.53 7.77 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.258 -1.337 . . . . 63.41 109.398 -171.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.29 142.78 16.14 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 110.88 -0.888 . . . . 61.43 110.88 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.11 132.71 4.19 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 111.657 -0.577 . . . . 45.04 111.657 -177.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 60.2 mt -87.94 120.39 36.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 109.236 -0.653 . . . . 33.31 109.236 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -121.15 133.14 55.19 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.179 0.591 . . . . 73.1 109.929 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.9 m -111.37 92.99 4.25 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.747 -0.834 . . . . 54.33 108.747 175.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.76 HG23 HG21 ' H' ' 18' ' ' VAL . 0.0 OUTLIER -123.19 142.71 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.103 0.961 . . . . 75.21 108.622 -176.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.99 160.62 39.52 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 122.967 0.507 . . . . 44.25 111.342 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.62 21.07 52.52 Favored Glycine 0 C--N 1.34 0.759 0 CA-C-N 114.572 -1.195 . . . . 75.44 114.414 171.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.47 HD12 HD11 ' D' ' 86' ' ' ILE . 33.2 mt -134.04 127.88 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 117.287 0.543 . . . . 75.34 109.665 176.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.569 ' HB2' HE22 ' D' ' 4' ' ' GLN . 38.1 mt-10 -140.96 171.85 13.49 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.942 0.897 . . . . 62.34 111.097 -171.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.97 -118.77 13.93 Favored Glycine 0 C--N 1.354 1.565 0 CA-C-N 114.944 -1.025 . . . . 63.55 114.861 172.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 20.4 m -86.94 -28.18 22.88 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.343 0.657 . . . . 54.03 111.046 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -68.36 -34.06 75.4 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.78 -0.646 . . . . 54.51 111.025 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.516 ' HG2' ' HB1' ' H' ' 21' ' ' ALA . 0.0 OUTLIER -70.33 -23.3 62.8 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 116.039 -0.528 . . . . 74.12 111.164 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.26 -26.95 68.68 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.86 0.464 . . . . 73.35 110.926 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -78.62 -40.73 33.52 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.843 0.857 . . . . 65.44 111.396 174.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -65.51 -43.97 88.41 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.907 0.483 . . . . 65.2 110.585 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.445 HD21 ' HA ' ' H' ' 17' ' ' PRO . 8.7 mp -67.54 -53.17 30.73 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.365 1.066 . . . . 55.12 109.981 173.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.81 -3.63 68.5 Favored Glycine 0 C--N 1.342 0.887 0 N-CA-C 115.057 0.783 . . . . 74.41 115.057 -171.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.64 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -147.13 -65.57 0.27 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.046 0.923 . . . . 65.35 112.906 -177.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -61.91 -58.76 6.7 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.955 0.724 . . . . 73.31 112.955 -162.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 75.3 m -63.54 -44.79 82.41 Favored Pre-proline 0 CA--C 1.567 1.626 0 N-CA-C 113.923 1.083 . . . . 74.22 113.923 -175.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.73 -25.49 39.82 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 121.7 1.6 . . . . 73.53 113.132 172.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . 0.565 ' HA ' ' HD2' ' D' ' 107' ' ' PHE . 2.4 t-20 -69.47 -28.7 66.31 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.845 0.458 . . . . 62.13 110.75 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 51.6 mm -65.07 -35.27 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.402 0.681 . . . . 50.42 110.109 171.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.95 -19.04 48.89 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.587 -0.733 . . . . 71.1 112.619 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . 0.565 ' HD2' ' HA ' ' D' ' 104' ' ' ASN . 27.9 m-85 -60.9 -44.36 94.51 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 113.724 1.009 . . . . 71.1 113.724 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -51.14 -44.99 39.38 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 122.519 2.146 . . . . 73.32 114.329 170.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -77.16 -31.66 55.69 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.376 0.67 . . . . 75.13 111.897 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.14 -48.95 71.74 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.075 -0.713 . . . . 52.41 109.075 175.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -54.61 -47.15 73.76 Favored 'General case' 0 C--N 1.352 0.682 0 O-C-N 124.855 1.347 . . . . 74.32 110.937 177.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.35 -46.81 87.0 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.399 0.679 . . . . 72.4 111.311 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 36.4 t -62.05 -42.78 99.54 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.407 0.442 . . . . 71.24 111.238 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.468 HG23 ' SG ' ' D' ' 76' ' ' CYS . 96.9 mt -61.31 -58.3 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.119 0.967 . . . . 61.01 111.114 175.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 89.4 m -55.92 -40.77 73.56 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.569 1.148 . . . . 63.23 112.068 -173.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 44.7 t -65.04 -42.16 94.54 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.573 -0.739 . . . . 75.54 110.707 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.1 mtm -68.46 -31.69 71.17 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.811 0.444 . . . . 73.33 111.452 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.43 HG23 ' O ' ' D' ' 114' ' ' ILE . 73.6 t -63.43 -44.65 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 123.525 0.73 . . . . 64.3 110.373 174.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.7 p -77.77 -25.83 49.37 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.056 -0.52 . . . . 74.14 111.572 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -71.64 -36.27 70.67 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.316 0.647 . . . . 53.23 109.6 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.95 0.24 73.13 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.36 -0.837 . . . . 70.13 112.509 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.6 p 61.37 25.29 15.27 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.642 1.977 . . . . 72.22 113.405 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -80.37 164.13 53.53 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.266 1.027 . . . . 62.43 109.717 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.4 129.82 29.64 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.109 1.873 . . . . 72.55 111.423 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -51.32 123.64 10.09 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.402 1.081 . . . . 62.45 111.577 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -116.41 96.73 5.66 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.98 -1.118 . . . . 41.2 107.98 -174.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -98.66 117.89 34.14 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.897 -0.779 . . . . 74.31 108.897 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.597 ' HA ' HD11 ' H' ' 6' ' ' ILE . 6.4 mp -73.97 113.47 11.18 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 109.686 -0.487 . . . . 73.53 109.686 176.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -54.51 134.62 62.96 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 124.154 0.982 . . . . 74.21 110.953 176.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.504 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 2.8 Cg_exo -72.94 144.64 38.73 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.875 2.383 . . . . 73.24 111.756 -171.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.55 131.95 54.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 123.643 0.777 . . . . 74.11 109.357 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -81.54 82.68 7.24 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.076 -1.083 . . . . 72.23 108.076 174.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -71.03 -21.37 62.28 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.414 -1.266 . . . . 74.01 110.732 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.64 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 15.5 t70 -54.58 -52.72 61.26 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.567 1.147 . . . . 65.21 110.841 172.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.488 ' HA ' ' SD ' ' D' ' 138' ' ' MET . . . -65.26 -37.06 86.04 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.663 0.785 . . . . 71.14 112.37 -179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.92 -42.43 98.12 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.229 0.612 . . . . 64.11 112.075 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -75.17 -26.87 59.41 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.632 -0.713 . . . . 72.42 111.211 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.488 ' SD ' ' HA ' ' D' ' 135' ' ' ALA . 61.5 mtt -54.56 -33.77 60.73 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.199 0.6 . . . . 72.4 111.67 176.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -64.98 -28.54 69.58 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.781 0.833 . . . . 64.45 111.977 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -66.46 -38.07 86.53 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.45 0.7 . . . . 73.1 110.408 172.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.4 -27.6 62.46 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.028 0.531 . . . . 65.34 110.935 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -74.99 -0.79 19.96 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.901 0.48 . . . . 70.2 111.303 173.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -129.35 44.16 3.02 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.206 -1.035 . . . . 72.2 108.206 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -173.97 114.62 0.21 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.173 0.989 . . . . 75.11 108.8 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -153.25 -177.1 6.11 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.445 0.698 . . . . 62.21 110.697 -176.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 58.49 -136.32 51.16 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-N 115.583 -0.735 . . . . 71.02 112.972 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -86.85 73.59 9.94 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.383 0.673 . . . . 74.41 109.405 175.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -106.23 59.15 0.41 Allowed Glycine 0 C--N 1.351 1.408 0 N-CA-C 109.947 -1.261 . . . . 45.03 109.947 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 6.1 m -73.61 82.54 1.53 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.719 0.807 . . . . 71.12 110.279 -177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -100.87 93.42 5.52 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.665 0.745 . . . . 62.31 109.282 174.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -102.89 -164.49 1.09 Allowed 'General case' 0 C--O 1.244 0.766 0 CA-C-N 114.351 -1.295 . . . . 74.3 109.215 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -71.97 86.5 1.01 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.008 0.432 . . . . 64.34 110.151 173.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -64.54 111.05 2.53 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.271 -0.64 . . . . 71.23 109.271 172.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -85.42 80.73 9.01 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.367 0.603 . . . . 72.25 110.361 -171.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.268 0 N-CA-C 107.915 -1.143 . . . . 71.05 107.915 175.288 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 109.83 -0.433 . . . . 51.21 109.83 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -105.86 172.68 6.67 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.998 0.919 . . . . 75.1 110.404 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -158.11 149.0 20.8 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.343 0.657 . . . . 75.34 109.759 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 40.7 m -144.11 103.74 4.04 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.195 0.998 . . . . 44.25 108.569 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 28.8 m -65.33 -76.61 0.07 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.212 0.605 . . . . 73.41 109.946 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.737 ' HB ' HD21 ' A' ' 42' ' ' LEU . 1.6 pp -157.78 156.03 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.28 1.032 . . . . 61.52 109.119 171.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -161.25 172.24 17.01 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.135 0.574 . . . . 40.54 110.527 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.563 ' H ' HD23 ' E' ' 8' ' ' LEU . 1.3 pt? -122.96 152.38 40.91 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.133 0.973 . . . . 51.54 109.855 -175.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.78 -174.98 4.2 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.761 0.824 . . . . 71.4 112.046 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 30.0 tp -77.72 17.93 0.51 Allowed 'General case' 0 CA--C 1.568 1.648 0 C-N-CA 124.442 1.097 . . . . 74.41 112.037 -173.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 7.3 mp 70.45 142.18 0.09 OUTLIER Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 125.295 1.438 . . . . 52.31 111.229 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.39 -20.53 20.85 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.242 1.961 . . . . 74.25 112.096 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 pp -154.22 170.36 21.43 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.202 1.001 . . . . 74.22 110.229 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 84.4 mt -104.37 179.64 4.21 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.155 0.582 . . . . 43.52 111.101 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -86.99 154.28 20.9 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.359 1.064 . . . . 65.11 109.038 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 64.2 p -65.87 146.65 98.99 Favored Pre-proline 0 CA--C 1.557 1.216 0 C-N-CA 123.471 0.708 . . . . 74.34 110.917 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 17' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -51.08 150.69 13.24 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.644 2.896 . . . . 74.03 114.483 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 99.2 t -54.79 -41.92 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 124.137 0.975 . . . . 73.31 110.907 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 5.8 t -155.32 -39.73 0.09 Allowed 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.998 -1.001 . . . . 72.31 110.678 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -150.12 -59.93 0.2 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.895 0.478 . . . . 75.25 110.424 -176.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 57.23 69.73 0.72 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.514 1.126 . . . . 63.4 111.248 -174.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -70.42 107.85 4.0 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.449 -0.945 . . . . 74.52 108.449 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 33.0 m -54.58 116.1 10.15 Favored Pre-proline 0 CA--C 1.552 1.05 0 O-C-N 124.509 1.131 . . . . 71.54 110.399 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 24' ' ' PRO . . . . . 0.509 ' HD2' HG23 ' A' ' 92' ' ' THR . 95.1 Cg_endo -86.73 -151.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.708 2.272 . . . . 53.3 110.671 174.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.12 0 N-CA-C 106.338 -1.727 . . . . 71.34 106.338 172.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 70.6 mtp . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.555 0.217 . . . . 63.55 110.662 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -101.14 -156.78 0.57 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.766 1.226 . . . . 73.04 107.911 168.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -62.9 -52.78 61.76 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.265 0.555 . . . . 74.11 109.523 173.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 37.9 m -110.28 110.64 21.54 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.295 1.038 . . . . 53.11 109.691 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 59.5 m -148.02 -40.63 0.17 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.272 0.629 . . . . 63.23 110.185 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' B' ' 128' ' ' LEU . 14.7 tt -139.84 90.93 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-O 122.26 1.029 . . . . 74.4 110.164 -176.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 7' ' ' ALA . . . . . 0.419 ' HA ' HG21 ' B' ' 131' ' ' VAL . . . -157.34 143.51 17.8 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.943 -1.026 . . . . 70.13 110.04 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 20.8 mt -76.59 87.86 3.29 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 109.726 -0.472 . . . . 55.45 109.726 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.52 77.14 10.08 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.15 0.58 . . . . 63.12 110.363 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 97.4 mt 60.4 -170.32 0.15 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.349 1.06 . . . . 75.52 112.678 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.436 ' HG ' ' HZ ' ' B' ' 133' ' ' PHE . 98.8 mt -113.95 151.37 44.75 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.16 0.984 . . . . 74.22 109.683 177.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -59.34 -49.41 10.79 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 122.964 2.443 . . . . 75.24 111.636 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.7 153.91 23.61 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.764 0.826 . . . . 62.42 108.865 172.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -69.73 109.34 4.33 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 107.349 -1.352 . . . . 74.15 107.349 175.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -78.56 79.25 4.99 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.696 0.76 . . . . 73.44 109.41 -172.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 7.3 t -134.56 68.33 72.26 Favored Pre-proline 0 CA--C 1.556 1.183 0 CA-C-N 114.668 -1.151 . . . . 74.44 109.157 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 17' ' ' PRO . . . . . 0.56 ' HD2' HD11 ' B' ' 98' ' ' LEU . 32.8 Cg_exo -62.35 -38.68 51.95 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.369 2.046 . . . . 73.23 111.809 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -49.77 -23.96 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 125.218 1.407 . . . . 71.24 113.12 -172.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 24.2 m -49.52 -48.25 48.32 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.514 1.126 . . . . 72.35 112.237 175.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -115.06 -20.17 10.58 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.454 0.702 . . . . 71.21 110.884 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.4 87.5 0.45 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.46 0.704 . . . . 74.13 111.372 -172.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -158.69 97.49 1.45 Allowed 'General case' 0 C--O 1.237 0.413 0 N-CA-C 106.791 -1.559 . . . . 73.23 106.791 167.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 9.3 t -64.55 141.84 98.33 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 115.958 -0.564 . . . . 72.11 110.793 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.63 165.45 11.53 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.333 2.022 . . . . 75.21 112.155 169.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 CA--C 1.562 1.416 0 C-N-CA 123.492 0.717 . . . . 71.1 111.282 175.952 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' G' G ' 1' ' ' MET . . . . . 0.42 ' SD ' ' N ' ' G' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 110.032 -0.358 . . . . 75.34 110.032 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -139.63 118.72 12.65 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.738 -1.208 . . . . 75.22 107.738 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -140.07 138.79 35.63 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.67 0.788 . . . . 74.44 109.603 -174.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 34.7 m -65.21 -37.36 87.04 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.694 0.797 . . . . 74.41 110.987 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -79.91 152.52 29.55 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.03 -0.986 . . . . 43.42 109.748 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . 0.517 HD12 HG11 ' C' ' 40' ' ' VAL . 27.3 pt -63.73 131.42 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.028 0.931 . . . . 72.12 112.011 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.84 -179.03 5.17 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.153 0.581 . . . . 74.15 111.993 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 8' ' ' LEU . . . . . 0.409 HD23 ' N ' ' G' ' 9' ' ' ALA . 3.8 tt -136.56 137.56 40.35 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 107.442 -1.318 . . . . 72.32 107.442 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 9' ' ' ALA . . . . . 0.409 ' N ' HD23 ' G' ' 8' ' ' LEU . . . -76.11 -179.84 5.22 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.779 0.832 . . . . 25.15 112.47 -177.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 59.1 mt -75.43 164.29 26.54 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.489 0.716 . . . . 71.42 110.708 175.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 89.4 mt -86.97 129.93 50.28 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 109.023 -0.732 . . . . 75.22 109.023 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.86 -45.47 10.62 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.885 2.39 . . . . 62.13 112.25 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 95.6 mt -134.99 175.89 9.16 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.633 1.173 . . . . 75.35 108.79 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 83.6 mt -103.13 -178.04 3.55 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.106 0.562 . . . . 73.5 109.667 173.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . 0.611 ' HB2' HD13 ' C' ' 98' ' ' LEU . 2.2 m-85 -78.11 171.37 15.12 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.463 0.705 . . . . 73.24 110.774 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 12.4 m -66.81 128.41 93.85 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-O 118.511 -0.757 . . . . 72.43 109.387 174.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 17' ' ' PRO . . . . . 0.496 ' HB3' ' HB3' ' G' ' 21' ' ' ALA . 41.6 Cg_exo -43.69 142.32 3.4 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.962 3.108 . . . . 74.53 114.587 174.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 18' ' ' VAL . . . . . 0.53 HG13 ' H ' ' G' ' 19' ' ' THR . 2.2 p -74.17 -91.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 CA-C-O 119.083 -0.484 . . . . 64.53 109.926 176.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 19' ' ' THR . . . . . 0.53 ' H ' HG13 ' G' ' 18' ' ' VAL . 8.4 m -86.58 -52.5 5.52 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.603 1.092 . . . . 74.31 110.486 -174.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -162.83 105.85 1.06 Allowed 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 116.084 -0.507 . . . . 62.25 110.248 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' G' ' 17' ' ' PRO . . . -140.15 16.08 2.43 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.526 0.73 . . . . 74.02 110.751 176.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -83.32 160.94 21.57 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.541 0.736 . . . . 74.42 110.333 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 86.5 m 56.98 81.93 0.25 Allowed Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 124.106 0.962 . . . . 74.14 111.35 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -64.73 -67.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 121.759 1.639 . . . . 51.4 109.501 167.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.338 1.455 . . . . 74.53 107.95 166.481 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 12.3 tpt . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 109.275 -0.639 . . . . 60.22 109.275 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -85.68 -174.25 5.05 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.582 0.753 . . . . 74.14 109.89 172.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -82.09 64.2 6.66 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.639 1.209 . . . . 74.24 109.486 169.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 50.2 m -83.17 62.26 6.54 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 114.489 -1.232 . . . . 74.31 109.451 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 43.6 m -163.8 99.22 0.88 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 106.004 -1.85 . . . . 73.45 106.004 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.597 HD11 ' HA ' ' D' ' 128' ' ' LEU . 3.1 mp 62.17 98.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 124.3 1.04 . . . . 63.22 110.119 -174.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.35 96.1 3.41 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.629 0.772 . . . . 72.41 110.185 -174.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.41 121.12 42.14 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.211 1.004 . . . . 71.13 109.51 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.75 29.17 6.63 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.91 0.884 . . . . 75.34 110.273 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 9.7 mp 66.09 176.08 0.22 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 125.114 1.366 . . . . 51.32 111.174 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.37 123.45 39.54 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 123.256 0.622 . . . . 65.2 110.593 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.26 129.55 18.33 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.796 2.331 . . . . 71.14 110.636 168.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 64.21 179.88 0.17 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.715 1.206 . . . . 71.1 111.448 -172.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 88.3 mt -122.64 173.09 7.93 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.242 1.017 . . . . 73.35 109.701 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . 0.424 ' HZ ' HD13 ' D' ' 60' ' ' LEU . 76.6 m-85 -89.45 -168.83 2.27 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.333 0.653 . . . . 62.2 109.734 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 21.4 p -68.62 131.17 91.52 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.047 0.539 . . . . 73.13 110.411 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 17' ' ' PRO . . . . . 0.445 ' HA ' HD21 ' D' ' 98' ' ' LEU . 53.4 Cg_endo -65.59 146.45 84.57 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 123.061 2.507 . . . . 71.43 113.461 -171.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . 0.76 HG21 HG23 ' D' ' 86' ' ' ILE . 8.3 p -110.4 151.65 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.438 0.695 . . . . 73.01 110.267 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 3.4 m 58.07 29.8 18.34 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.326 1.05 . . . . 73.21 110.226 -176.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 72.16 -48.97 0.69 Allowed 'General case' 0 C--N 1.369 1.435 0 C-N-CA 126.04 1.736 . . . . 72.42 111.439 -175.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . 0.516 ' HB1' ' HG2' ' D' ' 94' ' ' MET . . . 75.07 -75.94 0.07 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.854 1.262 . . . . 75.41 113.299 163.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -41.1 80.91 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.178 0.591 . . . . 75.33 109.469 -178.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 31.6 p -108.57 92.46 10.17 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.667 1.187 . . . . 75.32 109.204 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.29 -177.76 0.71 Allowed 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.853 2.369 . . . . 64.31 113.607 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 . . . . . 0 C--O 1.256 1.406 0 C-N-CA 124.143 0.977 . . . . 75.33 110.888 -179.217 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 ppp? . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 110.431 -0.211 . . . . 71.42 110.431 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -138.58 143.69 39.49 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.232 0.613 . . . . 70.41 111.289 -170.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -83.15 98.02 9.12 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.314 0.646 . . . . 64.35 109.303 170.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -78.96 68.04 4.81 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.981 0.512 . . . . 44.01 110.474 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -133.0 112.02 11.49 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.048 -0.723 . . . . 72.35 109.048 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.414 ' HB2' HG22 ' A' ' 89' ' ' ILE . 15.2 m120 -71.71 173.96 7.44 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.59 -0.732 . . . . 73.22 110.217 173.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.568 ' HB ' ' HA2' ' A' ' 88' ' ' GLY . 81.7 m -73.69 156.2 38.18 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.601 -0.727 . . . . 72.24 110.029 176.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.29 130.99 46.0 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.583 -0.525 . . . . 74.12 109.583 172.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.464 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -64.58 138.75 58.58 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.603 0.564 . . . . 74.42 109.662 -176.118 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.9 m -137.91 130.79 29.97 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 108.529 -0.915 . . . . 43.45 108.529 -170.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.589 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 26.6 t80 -136.4 124.28 22.68 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.422 0.689 . . . . 74.13 109.334 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -143.33 119.58 10.84 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.701 0.8 . . . . 71.4 108.859 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.622 HG12 ' HD2' ' A' ' 84' ' ' PHE . 49.5 mt -80.2 124.6 38.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.513 -0.551 . . . . 74.52 109.513 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.23 -42.28 13.92 Favored 'General case' 0 C--O 1.245 0.848 0 O-C-N 123.993 0.808 . . . . 73.14 109.36 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -173.43 122.36 0.36 Allowed 'General case' 0 N--CA 1.483 1.185 0 O-C-N 123.081 0.238 . . . . 73.44 111.477 -168.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.416 HD11 HD13 ' A' ' 13' ' ' ILE . 94.8 mt -113.79 138.53 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.99 0.916 . . . . 65.33 109.26 175.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HB3' HG23 ' B' ' 122' ' ' THR . 32.3 p90 -167.3 166.69 14.54 Favored 'General case' 0 C--N 1.347 0.496 0 O-C-N 123.902 0.751 . . . . 72.31 111.511 -173.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -89.24 127.29 35.75 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.116 -0.698 . . . . 74.51 109.116 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.402 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 33.6 mtpt -96.52 -21.88 17.43 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 120.913 0.387 . . . . 61.52 109.958 176.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.739 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.0 t70 -152.16 141.27 21.29 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 114.7 -1.136 . . . . 75.01 109.588 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 82.6 mt -141.51 138.29 32.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 106.556 -1.646 . . . . 73.43 106.556 175.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.5 t -144.66 128.32 17.17 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.55 -0.907 . . . . 72.35 108.55 174.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.519 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 87.4 t80 -138.48 124.84 20.49 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.164 -1.421 . . . . 72.24 107.164 175.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -125.59 142.68 51.38 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.915 -0.772 . . . . 64.22 108.915 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.33 71.53 39.15 Favored Pre-proline 0 C--O 1.243 0.755 0 N-CA-C 105.83 -1.915 . . . . 72.44 105.83 168.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.53 -15.16 34.18 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.39 2.06 . . . . 73.22 112.181 -170.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -117.18 21.6 13.07 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 118.169 -0.92 . . . . 73.0 109.495 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.413 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -45.37 -59.17 4.72 Favored Pre-proline 0 N--CA 1.495 1.804 0 CA-C-O 117.998 -1.001 . . . . 61.12 113.329 -171.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -72.16 -9.44 24.46 Favored 'Trans proline' 0 C--N 1.381 2.288 0 CA-C-N 121.629 1.617 . . . . 64.43 112.783 -176.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -90.31 -39.46 12.71 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.858 0.863 . . . . 75.44 110.251 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.859 HG21 ' HA ' ' A' ' 73' ' ' ALA . 6.5 p -79.21 -23.17 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 114.906 -1.043 . . . . 73.31 112.059 -162.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -67.48 -21.12 65.53 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.094 0.558 . . . . 74.22 110.928 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -74.46 -39.23 62.66 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.141 0.976 . . . . 74.13 110.307 173.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.511 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 3.3 tmtp? -69.01 143.35 54.37 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.71 1.204 . . . . 72.01 110.374 -169.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.511 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 12.9 m-20 -57.82 121.5 10.62 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.098 0.959 . . . . 74.14 110.843 175.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -77.7 90.66 4.0 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.191 0.597 . . . . 73.21 110.691 -177.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.403 ' H ' HD22 ' A' ' 68' ' ' LEU . 40.6 tt0 -125.81 82.05 64.7 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 107.582 -1.266 . . . . 74.4 107.582 168.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.0 118.86 4.52 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.327 2.018 . . . . 52.12 112.836 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -95.79 94.67 7.8 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.512 -1.292 . . . . 71.55 107.512 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.433 HG13 HG13 ' A' ' 64' ' ' VAL . 44.0 t -67.7 101.21 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 114.622 -1.172 . . . . 75.23 109.594 -177.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.23 115.76 19.96 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.535 1.134 . . . . 74.43 109.221 175.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -96.8 134.99 39.39 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.123 -0.695 . . . . 74.42 109.123 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.628 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 27.5 t70 -145.07 107.53 4.4 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.31 -0.996 . . . . 55.31 108.31 172.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.64 132.3 48.84 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.957 -0.757 . . . . 74.53 108.957 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.667 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 16.2 t70 -129.72 132.54 46.65 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.876 -0.787 . . . . 75.52 108.876 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.4 p -108.01 137.72 45.52 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.815 0.846 . . . . 61.53 110.158 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.57 139.28 18.84 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.745 0.818 . . . . 73.43 110.066 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.685 ' HB2' HG22 ' E' ' 16' ' ' THR . 56.7 m -132.53 156.03 47.55 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.844 0.457 . . . . 73.13 110.472 173.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.3 t -148.8 118.12 6.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.149 0.979 . . . . 74.34 108.739 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 46.5 tt0 -76.93 122.53 25.0 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.95 -0.759 . . . . 64.13 108.95 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 57' ' ' GLU . 75.7 mt -95.11 -31.72 13.43 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.528 0.731 . . . . 43.04 111.774 -172.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.52 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -155.8 -179.45 8.13 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.454 0.701 . . . . 73.34 110.008 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -65.88 117.7 8.63 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.901 -0.777 . . . . 64.24 108.901 172.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 65.96 18.24 11.01 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.828 1.251 . . . . 71.42 112.083 -178.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 58.4 t -126.22 121.94 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 108.391 -0.966 . . . . 64.34 108.391 174.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -129.02 172.29 11.53 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.259 0.552 . . . . 72.54 109.584 174.049 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.407 ' HB2' HD11 ' A' ' 51' ' ' LEU . 35.7 tt0 -127.55 132.5 49.87 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.135 -0.938 . . . . 71.23 108.62 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.547 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 77.0 t -107.28 119.8 57.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 107.474 -1.306 . . . . 61.45 107.474 173.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.2 t -115.74 129.35 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 108.813 -0.81 . . . . 73.33 108.813 174.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tt -128.21 116.58 20.11 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.582 -0.896 . . . . 70.35 108.582 -176.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.667 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 15.6 ttm180 -84.34 106.06 15.66 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.43 1.092 . . . . 71.33 109.433 176.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.6 t -98.74 101.38 12.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 107.581 -1.266 . . . . 65.02 107.581 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 21.1 m -98.28 107.08 19.46 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.622 0.769 . . . . 71.53 109.076 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.433 HG13 HG13 ' A' ' 40' ' ' VAL . 8.2 t -113.38 109.1 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.231 1.012 . . . . 71.12 109.456 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -104.09 130.88 51.82 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 108.044 -1.095 . . . . 74.14 108.044 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.1 109.95 21.79 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.006 -1.479 . . . . 74.51 107.006 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.7 m -114.06 125.13 53.63 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.135 0.493 . . . . 41.12 110.019 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.403 HD22 ' H ' ' A' ' 37' ' ' GLN . 25.9 mt -93.36 76.14 4.51 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 107.896 -1.149 . . . . 71.45 107.896 176.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.38 -84.67 0.95 Allowed Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.414 -0.674 . . . . 64.23 111.414 -175.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -123.46 -25.28 4.42 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.29 1.036 . . . . 74.22 110.124 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -79.05 107.72 12.01 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.511 0.724 . . . . 73.11 109.98 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.5 m -66.14 130.68 44.08 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.113 0.483 . . . . 73.43 110.386 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.859 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -81.89 -58.96 2.75 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.16 -0.927 . . . . 53.14 109.179 175.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -154.99 169.01 25.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 114.396 -1.275 . . . . 75.33 110.945 176.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 23.8 tp -128.13 132.0 48.96 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.857 -1.535 . . . . 73.22 106.857 169.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.422 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 65.3 m -132.96 95.72 3.62 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.606 -0.887 . . . . 42.22 108.606 176.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -111.92 114.63 27.66 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.49 -0.929 . . . . 74.34 108.49 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -124.67 131.98 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 109.435 -0.579 . . . . 64.03 109.435 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.739 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 51.3 mt-30 -103.61 99.09 8.88 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.411 -0.588 . . . . 55.43 109.411 170.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -85.22 114.36 22.27 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.917 -1.038 . . . . 73.04 109.527 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.12 146.71 17.51 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.816 -0.514 . . . . 71.1 111.816 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.579 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -143.29 123.33 2.07 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 112.079 -0.408 . . . . 63.42 112.079 176.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.2 mt -81.98 124.29 38.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.752 -0.833 . . . . 73.12 108.752 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.622 ' HD2' HG12 ' A' ' 13' ' ' ILE . 18.9 m-85 -135.08 135.73 41.45 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.085 -0.709 . . . . 75.03 109.085 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.8 t -99.82 116.02 30.91 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.777 -0.823 . . . . 64.23 108.777 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.7 HD11 HG21 ' E' ' 18' ' ' VAL . 0.1 OUTLIER -130.48 150.66 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.639 1.176 . . . . 74.0 110.155 -173.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -177.47 -178.08 0.73 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.025 0.93 . . . . 54.01 110.083 173.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.568 ' HA2' ' HB ' ' A' ' 7' ' ' THR . . . 117.41 -83.96 0.36 Allowed Glycine 0 C--N 1.339 0.721 0 O-C-N 123.73 0.644 . . . . 73.3 112.117 175.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 94' ' ' MET . 26.6 pt -120.01 139.61 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.952 0.901 . . . . 71.41 108.998 -175.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -115.38 -165.24 1.01 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.725 0.81 . . . . 64.4 111.101 -171.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.632 ' HA3' HG23 ' E' ' 23' ' ' THR . . . 72.5 -140.59 29.6 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-O 119.577 -0.569 . . . . 73.11 112.712 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -62.62 -26.5 68.65 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.724 0.81 . . . . 70.33 112.031 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -68.63 -47.47 66.53 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.924 0.89 . . . . 62.33 110.724 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 89' ' ' ILE . 55.8 ttm -80.38 -24.35 39.81 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.86 0.464 . . . . 74.41 111.145 176.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.42 -32.24 73.5 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.034 0.534 . . . . 62.12 111.227 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -68.98 -31.86 71.02 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 116.044 -0.525 . . . . 73.15 110.634 173.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 42.0 t -68.65 -55.22 12.21 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.891 0.477 . . . . 54.44 110.742 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 pp -76.39 -16.7 59.66 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.42 0.526 . . . . 71.4 112.42 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.48 -7.24 46.06 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-O 119.465 -0.631 . . . . 64.43 114.57 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -144.01 -61.96 0.39 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 117.594 0.697 . . . . 53.44 110.891 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.426 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 70.7 t80 -62.08 -66.06 0.6 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.468 1.107 . . . . 65.14 113.581 -169.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.4 m -64.37 -38.24 31.69 Favored Pre-proline 0 CA--C 1.566 1.594 0 N-CA-C 113.741 1.015 . . . . 74.12 113.741 -175.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -65.3 -27.1 55.79 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 121.672 1.581 . . . . 73.43 113.769 167.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 37.6 t-20 -72.41 -28.53 63.04 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 122.952 0.501 . . . . 72.4 109.744 176.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.505 HG21 ' CD1' ' A' ' 13' ' ' ILE . 49.2 mm -61.92 -40.41 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.457 0.703 . . . . 54.51 109.716 171.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.579 HD21 ' HA3' ' A' ' 82' ' ' GLY . 95.5 mt -77.41 -25.38 50.71 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.386 -0.825 . . . . 71.32 112.239 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -57.2 -45.06 99.96 Favored Pre-proline 0 CA--C 1.57 1.742 0 N-CA-C 113.683 0.994 . . . . 72.41 113.683 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -60.48 -31.63 92.71 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.245 1.963 . . . . 74.43 113.368 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -77.04 -35.63 56.73 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.297 0.639 . . . . 74.21 111.786 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.66 -38.81 84.3 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.478 -0.564 . . . . 62.41 109.478 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.469 HH12 HD12 ' C' ' 105' ' ' ILE . 37.7 ttm180 -64.35 -42.3 96.3 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.675 -1.148 . . . . 74.13 110.549 173.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -53.1 -51.68 61.07 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.142 0.977 . . . . 73.31 110.75 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 30.3 t -66.77 -47.82 71.0 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.569 -1.196 . . . . 61.21 111.173 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.84 -54.69 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.426 0.69 . . . . 62.45 111.041 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.0 m -55.91 -38.62 70.49 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.945 0.898 . . . . 54.25 111.723 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.0 t -65.69 -45.54 82.42 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.03 -0.532 . . . . 71.52 110.221 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.6 mtp -63.03 -39.92 96.18 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.009 0.924 . . . . 72.33 111.927 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.7 t -61.9 -45.65 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.935 0.894 . . . . 60.42 110.501 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.9 t -67.24 -37.89 84.3 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.242 -0.89 . . . . 62.02 111.415 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.498 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 83.6 mtt-85 -70.79 -27.72 64.11 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.34 0.656 . . . . 73.33 110.455 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.55 14.18 47.99 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-O 119.227 -0.763 . . . . 64.51 113.278 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.4 t 58.31 16.47 4.05 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 127.059 2.144 . . . . 72.43 113.47 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -82.53 150.83 64.1 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.471 0.708 . . . . 73.11 110.363 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -55.39 153.6 27.48 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.248 2.632 . . . . 74.12 113.548 174.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.406 HE21 HG21 ' D' ' 122' ' ' THR . 6.0 tp-100 -59.97 132.2 53.21 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.327 1.051 . . . . 73.14 112.552 -171.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.1 tp -131.64 110.42 10.91 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.575 1.15 . . . . 61.24 109.432 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -127.13 114.71 18.08 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 108.401 -0.963 . . . . 73.13 108.401 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.421 ' HA ' HG21 ' E' ' 6' ' ' ILE . 8.2 mp -67.17 148.85 51.27 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.82 0.448 . . . . 64.12 110.983 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -68.83 128.66 92.78 Favored Pre-proline 0 CA--C 1.551 0.997 0 O-C-N 123.955 0.785 . . . . 71.51 110.256 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.442 ' HG2' ' CE2' ' C' ' 11' ' ' PHE . 10.4 Cg_exo -74.68 111.9 3.43 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 122.955 2.436 . . . . 71.32 112.178 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.4 m -102.29 116.87 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.314 0.645 . . . . 42.01 109.601 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -76.05 91.07 3.07 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 115.543 -0.753 . . . . 74.04 109.469 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -53.59 -47.78 69.82 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.279 1.032 . . . . 62.41 110.673 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -51.31 -52.06 48.7 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.285 -1.325 . . . . 71.21 112.442 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.51 97.04 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.365 1.041 . . . . 42.43 111.445 -177.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.412 HD22 HD11 ' E' ' 10' ' ' LEU . 5.4 tt -66.92 -43.79 82.38 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 124.137 0.898 . . . . 74.35 110.398 -174.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -66.44 -36.35 82.57 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.884 0.474 . . . . 71.13 111.438 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.427 ' HA ' ' HB3' ' A' ' 141' ' ' LEU . 78.1 mtp -74.11 -20.02 60.4 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.472 0.545 . . . . 63.12 112.472 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.637 ' HA ' ' HB2' ' A' ' 143' ' ' GLN . 94.1 m-20 -60.13 -46.38 89.82 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.989 0.515 . . . . 74.2 110.447 172.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -74.15 -29.74 61.94 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.58 0.352 . . . . 73.1 111.15 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 138' ' ' MET . 58.8 tp -64.39 -47.94 77.32 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.549 0.74 . . . . 71.5 111.457 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -163.08 -15.51 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 114.364 1.246 . . . . 71.32 114.364 -174.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.637 ' HB2' ' HA ' ' A' ' 139' ' ' ASN . 36.9 mt-30 -86.46 151.07 23.82 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 119.126 0.875 . . . . 74.23 111.102 -174.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -162.96 -71.74 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.673 0.389 . . . . 75.54 110.074 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.05 73.58 9.08 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.357 0.663 . . . . 63.25 109.451 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.2 78.4 1.73 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.08 -0.964 . . . . 71.22 111.167 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.89 147.52 29.68 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.864 -0.791 . . . . 73.53 108.864 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -174.51 145.15 7.86 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.616 -0.594 . . . . 62.43 111.616 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.2 p -142.25 168.58 19.41 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.249 1.02 . . . . 61.01 109.76 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -154.38 141.15 19.08 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 122.486 0.315 . . . . 74.24 111.568 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -80.92 87.41 5.96 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.188 -1.041 . . . . 73.53 108.188 171.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.508 ' HB2' ' HA ' ' G' ' 20' ' ' LYS . 15.1 p-80 -78.94 102.42 8.27 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 114.487 -1.233 . . . . 63.24 111.541 -174.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -135.69 92.72 2.86 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.288 -1.005 . . . . 74.55 108.288 171.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -79.12 160.25 27.12 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.543 -0.753 . . . . 73.0 110.209 -176.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 C-N-CA 123.901 0.881 . . . . 75.13 109.609 -175.749 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mmt . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.613 -0.514 . . . . 75.01 109.613 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 42.7 m -142.53 96.24 2.91 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.61 -1.256 . . . . 60.34 107.61 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -109.42 144.0 38.24 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.194 0.598 . . . . 74.53 111.078 -168.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -129.95 12.71 5.72 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.708 0.803 . . . . 64.11 112.587 -173.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 43.5 p30 -68.4 -16.68 64.0 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 113.276 0.843 . . . . 74.33 113.276 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.409 HD21 ' NE2' ' D' ' 4' ' ' GLN . 60.5 m-80 -58.99 121.2 10.63 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.068 0.547 . . . . 61.33 110.064 177.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 10.3 t -71.12 131.82 44.14 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.022 0.826 . . . . 72.14 110.942 -172.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -102.8 -87.52 0.41 Allowed 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 107.552 -1.277 . . . . 73.32 107.552 169.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 26.8 ptm 40.9 -171.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 126.448 1.899 . . . . 75.31 115.969 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 56.6 m -143.64 123.07 13.13 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 107.232 -1.396 . . . . 74.25 107.232 166.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -131.37 139.36 49.47 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.874 0.87 . . . . 72.42 108.888 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.553 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -155.82 128.98 8.13 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 109.81 -0.441 . . . . 64.33 109.81 174.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.545 HD11 HD13 ' B' ' 105' ' ' ILE . 18.8 mt -77.92 121.5 30.78 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 N-CA-C 108.272 -1.011 . . . . 73.15 108.272 173.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -100.35 -32.77 10.68 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 123.754 0.659 . . . . 70.24 110.056 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -172.37 143.58 1.44 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.959 0.504 . . . . 74.54 109.974 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 84.6 mt -128.34 137.54 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 107.953 -1.128 . . . . 64.5 107.953 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -163.37 160.75 23.95 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-O 121.591 0.71 . . . . 72.21 112.287 -175.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.508 HG21 HD11 ' B' ' 21' ' ' ILE . 91.7 m -92.49 126.98 37.81 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.0 -1.0 . . . . 73.31 108.309 168.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -91.83 -25.51 18.95 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.353 0.661 . . . . 63.54 111.002 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -158.94 135.49 9.34 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 120.679 0.276 . . . . 71.2 111.713 -172.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 44.4 mm -125.74 141.4 45.61 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 C-N-CA 124.809 1.244 . . . . 63.0 109.585 173.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.531 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 46.5 t -138.01 141.76 40.4 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 107.686 -1.228 . . . . 64.32 107.686 175.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -159.28 134.55 8.33 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.66 -1.237 . . . . 61.13 107.66 169.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -137.36 157.84 45.72 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.027 0.931 . . . . 73.32 108.644 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.505 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -143.12 82.03 12.22 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 106.917 -1.512 . . . . 73.11 106.917 172.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.95 -25.32 27.84 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 123.042 2.495 . . . . 62.43 113.53 -169.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -112.75 14.27 19.92 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.663 0.785 . . . . 72.52 110.706 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.508 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -40.78 -62.93 0.85 Allowed Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 115.122 1.527 . . . . 52.44 115.122 -163.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 23.1 Cg_exo -61.3 -33.52 89.41 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 122.252 1.968 . . . . 71.12 112.793 -171.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -95.88 -20.5 18.74 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.358 -0.837 . . . . 61.1 112.633 -173.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.44 HG21 ' HA ' ' B' ' 73' ' ' ALA . 5.0 p -82.34 -11.5 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-N 118.459 0.572 . . . . 73.52 110.749 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -70.12 -14.94 62.88 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 112.879 0.696 . . . . 74.14 112.879 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -68.27 -12.54 61.19 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.046 0.538 . . . . 73.43 111.209 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -104.31 105.81 16.08 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.647 1.179 . . . . 64.42 109.29 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -111.01 92.47 4.06 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.743 -0.836 . . . . 51.44 108.743 175.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 8.1 p90 -159.27 -175.69 5.38 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.91 0.884 . . . . 73.14 109.262 170.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -68.4 110.27 5.49 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 123.899 0.88 . . . . 72.35 110.494 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -67.62 137.28 41.93 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 121.069 1.179 . . . . 74.42 111.334 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.83 110.13 3.18 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 109.09 -0.707 . . . . 75.15 109.09 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.426 ' HB ' HG21 ' F' ' 6' ' ' ILE . 59.3 t -94.5 123.73 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 123.858 0.863 . . . . 70.14 110.692 -174.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -103.45 102.03 11.94 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 106.76 -1.57 . . . . 74.14 106.76 169.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 pp -97.21 148.08 23.45 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.918 -0.583 . . . . 72.1 109.597 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -135.93 154.26 51.17 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.838 1.255 . . . . 55.3 108.056 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 21.1 tp -133.44 126.48 31.28 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.663 -0.865 . . . . 72.4 108.663 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -127.45 147.45 50.3 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.663 1.185 . . . . 75.11 109.972 -172.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 76.0 p -121.9 117.48 26.58 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.056 0.942 . . . . 62.31 110.486 -172.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.13 142.11 44.2 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.906 0.882 . . . . 43.41 108.657 174.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 52.4 p -148.44 176.06 10.61 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.196 0.443 . . . . 73.1 112.196 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 74.9 p -155.79 153.12 29.33 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.299 1.04 . . . . 61.43 109.006 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -102.27 121.52 42.42 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.889 -0.782 . . . . 61.33 108.889 170.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' B' ' 57' ' ' GLU . 18.7 mt -85.21 -50.48 7.35 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.747 0.819 . . . . 71.25 109.764 -173.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.78 -176.1 4.64 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.69 -1.141 . . . . 73.05 109.225 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -59.69 110.49 1.15 Allowed 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.025 0.828 . . . . 70.13 109.32 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 64.11 20.21 12.09 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.278 1.031 . . . . 70.22 112.653 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 79.7 t -116.61 112.93 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 106.868 -1.53 . . . . 64.15 106.868 168.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -129.17 137.02 50.92 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.518 -0.919 . . . . 75.21 108.518 -169.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.473 ' HB2' HD11 ' B' ' 51' ' ' LEU . 4.1 tt0 -101.02 124.82 47.33 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.207 -1.035 . . . . 73.33 108.207 174.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 18.5 m -109.26 134.77 50.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.515 -0.92 . . . . 75.51 108.515 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 20.9 t -111.78 134.32 54.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.529 -0.915 . . . . 72.11 108.529 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 24.8 tp -115.12 101.18 8.74 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 109.18 -0.674 . . . . 71.21 109.18 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -87.48 117.5 26.31 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 123.014 0.526 . . . . 74.1 109.617 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.493 HG13 HD21 ' F' ' 8' ' ' LEU . 18.9 t -107.37 122.0 61.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 107.616 -1.253 . . . . 72.04 107.616 171.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.6 m -114.39 138.01 51.09 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.481 -0.562 . . . . 45.31 109.481 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.669 HG21 HG21 ' B' ' 114' ' ' ILE . 71.0 t -129.2 125.2 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.204 1.002 . . . . 73.35 109.81 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 65.3 m -116.04 146.3 42.29 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.299 -1.371 . . . . 63.15 107.299 162.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.55 139.53 35.03 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.285 -1.006 . . . . 62.22 108.285 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.559 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 34.3 p -140.5 136.22 32.71 Favored 'General case' 0 C--O 1.226 -0.183 0 O-C-N 123.413 0.445 . . . . 65.42 110.667 -175.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 92.5 mt -109.51 109.38 20.17 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.799 -1.186 . . . . 73.35 107.799 175.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.23 -137.7 20.17 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.78 -0.645 . . . . 72.02 112.271 -173.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -94.57 14.13 21.89 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.18 0.992 . . . . 73.51 110.818 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -132.17 152.14 51.43 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.345 0.658 . . . . 71.51 110.558 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 64.8 m -75.15 125.65 29.39 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.448 0.699 . . . . 41.01 111.224 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.559 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -78.59 -59.17 2.89 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 114.897 -1.047 . . . . 70.23 108.683 176.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -153.25 160.82 42.84 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 115.179 -0.918 . . . . 65.44 112.483 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 59.5 mt -118.84 154.21 33.26 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.496 1.519 . . . . 72.21 107.812 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.405 ' SG ' HG23 ' B' ' 114' ' ' ILE . 42.2 t -161.06 157.5 26.23 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.371 0.668 . . . . 72.0 109.23 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.531 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 34.8 tt0 -166.02 130.77 2.29 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.044 -0.724 . . . . 74.24 109.044 175.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 96.7 t -123.66 143.65 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 108.707 -0.849 . . . . 72.32 108.707 173.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -124.8 96.33 4.84 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.563 -0.903 . . . . 74.0 108.563 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.419 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 8.5 tp-100 -85.72 100.07 11.75 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.568 -0.53 . . . . 74.45 109.568 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.15 144.66 17.19 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 111.357 -0.697 . . . . 60.15 111.357 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.49 131.81 4.35 Favored Glycine 0 C--O 1.236 0.274 0 N-CA-C 111.704 -0.558 . . . . 72.21 111.704 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.7 mt -84.63 126.95 40.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 N-CA-C 108.375 -0.972 . . . . 63.52 108.375 172.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -138.62 149.42 45.19 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.199 -0.667 . . . . 74.41 109.199 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 70.4 m -92.38 120.87 33.32 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.783 -0.821 . . . . 75.31 108.783 170.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.534 HG12 HG21 ' F' ' 18' ' ' VAL . 3.9 tp -120.71 118.83 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.438 1.095 . . . . 53.14 109.584 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.56 167.08 30.7 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.196 0.598 . . . . 72.23 109.981 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.14 -67.8 3.07 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.36 -0.382 . . . . 71.11 112.83 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mm -82.25 141.78 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.233 0.613 . . . . 54.54 110.813 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.441 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 11.3 pt-20 -153.09 -175.28 5.26 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.114 0.965 . . . . 65.51 109.803 -173.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.87 -133.74 37.43 Favored Glycine 0 C--N 1.354 1.582 0 C-N-CA 123.471 0.557 . . . . 51.04 113.396 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 55.4 m -66.0 -37.52 86.16 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.952 0.901 . . . . 50.23 110.614 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -67.79 -23.22 65.18 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 115.614 -0.721 . . . . 71.34 111.436 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.441 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 22.5 ttp -65.25 -29.49 70.28 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.966 0.906 . . . . 71.4 111.599 175.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.509 ' HB1' ' HB3' ' F' ' 14' ' ' LEU . . . -64.18 -29.99 71.08 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.764 0.826 . . . . 54.22 111.491 175.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.493 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 45.6 t-80 -69.42 -30.15 68.03 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.444 0.698 . . . . 63.4 111.427 175.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.446 ' SG ' HD13 ' B' ' 86' ' ' ILE . 44.6 t -79.62 -56.42 4.31 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.458 0.303 . . . . 64.42 111.134 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mp -81.61 -35.6 29.9 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.926 0.491 . . . . 64.35 112.27 -172.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.18 3.87 82.56 Favored Glycine 0 N--CA 1.47 0.961 0 CA-C-O 119.676 -0.514 . . . . 72.52 113.69 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -148.8 -66.88 0.23 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.531 0.567 . . . . 53.42 112.531 -172.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -60.51 -47.9 84.1 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.272 1.029 . . . . 73.2 111.945 -171.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 67.4 m -70.15 -45.5 21.43 Favored Pre-proline 0 CA--C 1.567 1.631 0 CA-C-O 118.339 -0.839 . . . . 62.11 112.241 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -48.07 -40.43 33.81 Favored 'Trans proline' 0 C--N 1.4 3.271 0 C-N-CA 123.137 2.558 . . . . 71.34 114.389 167.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -62.66 -26.06 68.45 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 112.295 0.48 . . . . 71.31 112.295 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.545 HD13 HD11 ' B' ' 13' ' ' ILE . 57.6 mt -84.53 -45.87 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.452 0.701 . . . . 51.12 110.663 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 99.2 mt -82.03 -21.69 36.83 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.329 0.652 . . . . 74.34 112.461 -170.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -57.3 -50.74 86.43 Favored Pre-proline 0 N--CA 1.489 1.497 0 CA-C-O 117.654 -1.165 . . . . 70.22 113.329 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.54 -40.57 83.14 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 122.343 2.029 . . . . 75.34 114.105 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -67.69 -47.98 67.87 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.193 0.597 . . . . 70.31 110.366 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -63.9 -35.59 81.14 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.466 -0.788 . . . . 63.51 111.292 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -59.05 -58.2 9.72 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.366 1.067 . . . . 74.02 110.399 177.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -62.7 -33.03 74.26 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 123.924 0.765 . . . . 74.33 110.178 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.514 ' SG ' HD11 ' B' ' 21' ' ' ILE . 2.0 t -69.64 -38.59 77.21 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 122.902 0.481 . . . . 63.01 111.735 -176.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.669 HG21 HG21 ' B' ' 64' ' ' VAL . 89.4 mt -65.29 -56.02 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.879 -0.786 . . . . 75.01 108.879 172.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 9.7 m -59.43 -27.74 66.31 Favored 'General case' 0 CA--C 1.554 1.101 0 O-C-N 124.579 1.174 . . . . 65.31 111.619 -174.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.5 t -65.55 -48.67 71.62 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 123.682 0.793 . . . . 64.51 109.847 175.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.2 mmt -70.59 -33.96 71.64 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.236 0.614 . . . . 74.31 110.83 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.438 HG23 ' O ' ' B' ' 114' ' ' ILE . 97.8 t -58.12 -45.23 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 124.046 0.938 . . . . 72.44 109.803 172.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 22.6 t -71.8 -30.14 65.2 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.161 -1.381 . . . . 74.22 111.421 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' B' ' 116' ' ' SER . 82.1 mtt-85 -68.76 -31.97 71.39 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.145 -0.48 . . . . 72.02 109.871 175.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.5 6.85 67.01 Favored Glycine 0 C--N 1.355 1.609 0 O-C-N 123.837 0.71 . . . . 73.43 113.116 173.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.49 HG23 ' HB3' ' A' ' 17' ' ' TYR . 59.6 p 59.83 25.84 14.96 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 126.244 1.818 . . . . 73.03 113.166 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -88.39 160.59 44.89 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 123.805 0.842 . . . . 75.41 111.204 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.49 164.65 5.3 Favored 'Trans proline' 0 C--N 1.39 2.759 0 C-N-CA 123.454 2.77 . . . . 65.51 114.834 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.549 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -64.59 132.15 49.0 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.241 1.016 . . . . 75.45 111.302 -178.76 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 49.6 tp -137.9 114.56 10.51 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.134 0.573 . . . . 70.22 109.825 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -128.82 129.5 45.7 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.65 0.78 . . . . 72.11 109.173 174.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mp -82.41 145.42 29.88 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 123.578 0.751 . . . . 63.32 109.225 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' F' ' 7' ' ' ALA . . . -65.73 133.25 95.02 Favored Pre-proline 0 CA--C 1.554 1.101 0 O-C-N 123.664 0.603 . . . . 71.42 110.929 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.431 ' HG3' HD13 ' D' ' 16' ' ' ILE . 29.4 Cg_endo -63.32 100.23 0.26 Allowed 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.898 2.398 . . . . 62.34 111.859 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 48.8 t -90.42 109.52 20.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 108.58 -0.896 . . . . 74.22 108.58 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -89.86 90.36 8.15 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 107.949 -1.13 . . . . 71.22 107.949 176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -58.55 -35.54 72.49 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.127 -0.942 . . . . 71.34 110.355 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -66.97 -42.21 85.52 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.531 1.132 . . . . 63.14 111.097 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.62 -38.34 90.68 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.978 0.799 . . . . 63.55 111.076 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -66.02 -50.49 64.03 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 123.746 0.654 . . . . 62.45 109.529 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -61.12 -40.23 92.97 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 123.588 0.555 . . . . 73.4 111.06 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 38.2 mtt -63.56 -40.2 96.38 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 123.386 0.429 . . . . 72.25 111.093 177.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -84.01 -25.92 29.55 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 120.931 0.396 . . . . 72.43 110.82 -171.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -70.93 -35.56 72.28 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.729 -0.669 . . . . 74.55 109.851 176.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 66.0 mt -93.84 -5.71 47.48 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.638 -0.71 . . . . 65.14 111.097 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . 0.765 ' HG3' ' HB3' ' D' ' 6' ' ' ASN . 0.0 OUTLIER -147.05 98.78 3.08 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.818 0.818 . . . . 65.3 110.511 -176.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -141.13 149.28 41.33 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 125.052 1.341 . . . . 72.35 107.81 174.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -154.07 128.39 9.12 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.585 -0.524 . . . . 73.3 109.585 -176.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.31 121.19 19.02 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 124.108 0.88 . . . . 72.45 110.983 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -151.8 -157.84 8.11 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.922 -0.581 . . . . 73.54 111.88 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . 0.549 ' HB3' HG23 ' B' ' 149' ' ' THR . 4.9 mp0 -71.3 115.2 10.17 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.526 0.73 . . . . 63.32 111.513 -173.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -79.79 69.47 3.05 Favored Glycine 0 C--N 1.347 1.17 0 N-CA-C 110.889 -0.884 . . . . 31.22 110.889 170.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.549 HG23 ' HB3' ' B' ' 147' ' ' GLU . 10.8 p -82.95 67.38 9.01 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.808 0.843 . . . . 74.43 111.313 -174.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -85.14 18.23 2.66 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.883 0.873 . . . . 70.44 110.655 173.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.02 156.29 25.13 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 124.526 1.13 . . . . 73.43 110.052 171.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -134.46 93.64 3.09 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.51 -0.922 . . . . 63.12 108.51 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -78.75 65.78 4.08 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 122.517 1.151 . . . . 62.42 109.727 172.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.3 176.83 7.05 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.515 -1.22 . . . . 60.32 110.997 -174.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 C-N-CA 123.664 0.785 . . . . 74.33 109.176 -179.513 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . 0.461 ' SD ' ' N ' ' C' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.924 0.393 . . . . 75.24 110.449 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m -131.86 148.18 52.53 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.974 0.91 . . . . 62.54 108.904 174.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -71.66 139.37 49.23 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.127 0.489 . . . . 61.35 110.461 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . 0.434 ' HG2' ' HA ' ' A' ' 143' ' ' GLN . 71.6 mt-30 -102.69 98.7 8.69 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.418 1.087 . . . . 65.31 109.715 -168.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -78.07 151.3 33.5 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.828 0.851 . . . . 71.42 110.725 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . 0.459 ' HB3' ' NE2' ' C' ' 93' ' ' GLN . 45.4 t-20 -73.63 93.45 2.06 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.865 -0.791 . . . . 71.23 108.865 174.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.434 HG21 HE22 ' A' ' 143' ' ' GLN . 14.8 t -105.93 21.44 17.31 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 114.677 -1.147 . . . . 72.14 110.136 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -57.44 -74.23 0.06 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.088 0.955 . . . . 65.43 108.969 -178.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.669 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 0.0 OUTLIER 63.36 115.26 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 124.872 1.269 . . . . 71.0 113.124 167.348 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 45.0 m -98.32 98.48 9.72 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.683 0.793 . . . . 72.14 109.285 171.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.669 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 50.6 t80 -121.53 130.77 53.74 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.817 -0.809 . . . . 73.22 108.817 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -150.61 140.1 21.5 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.632 -0.507 . . . . 74.22 109.632 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.413 HG12 ' HE2' ' C' ' 84' ' ' PHE . 43.5 mt -83.38 127.14 40.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.828 -0.804 . . . . 75.12 108.828 173.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.472 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 23.5 mm-40 -92.34 -40.0 11.16 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 123.666 0.604 . . . . 74.14 109.639 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -176.74 124.66 0.16 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.378 0.671 . . . . 75.41 109.812 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.5 mt -110.23 148.22 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 108.454 -0.943 . . . . 74.21 108.454 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -173.61 160.02 3.69 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.046 0.938 . . . . 73.23 109.235 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . 0.628 HG22 HE22 ' C' ' 80' ' ' GLN . 76.8 p -81.18 107.78 14.27 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.199 -0.667 . . . . 71.11 109.199 176.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt -65.27 -47.72 75.71 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.822 0.82 . . . . 71.22 109.262 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.3 t70 -143.33 144.54 32.13 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.114 -1.403 . . . . 73.41 109.513 -174.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.3 mt -139.13 147.12 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.229 1.411 . . . . 73.21 107.335 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -157.25 150.8 24.12 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.32 0.648 . . . . 42.33 110.008 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -151.91 149.03 28.49 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.713 -1.217 . . . . 52.13 107.713 171.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -147.5 149.55 32.86 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.112 1.365 . . . . 62.41 107.617 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.8 84.72 3.73 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 107.316 -1.364 . . . . 71.34 107.316 169.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.65 -38.3 73.08 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.228 2.619 . . . . 73.41 113.139 -173.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -107.18 19.71 20.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.812 0.845 . . . . 53.21 110.999 -172.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.467 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -45.94 -58.33 6.47 Favored Pre-proline 0 CA--C 1.562 1.426 0 CA-C-O 117.355 -1.307 . . . . 52.41 114.259 -170.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 49.5 Cg_exo -54.55 -47.46 26.7 Favored 'Trans proline' 0 C--N 1.389 2.694 0 C-N-CA 122.106 1.871 . . . . 71.51 112.255 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.516 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.9 t60 -71.38 -32.9 69.01 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.11 -0.95 . . . . 70.2 112.843 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.694 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.8 p -77.3 -24.02 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 112.541 0.571 . . . . 72.45 112.541 -169.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -63.44 -26.19 68.62 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.085 0.772 . . . . 71.04 113.085 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 10.4 pt20 -87.53 6.6 33.43 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.017 0.527 . . . . 74.14 111.521 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.719 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -88.38 154.89 20.03 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.937 0.895 . . . . 75.35 110.509 179.246 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -66.13 128.2 35.17 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.509 -0.768 . . . . 73.5 109.067 165.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -78.69 90.18 4.59 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.388 0.675 . . . . 74.24 110.796 -174.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -132.96 76.99 69.35 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 124.275 1.03 . . . . 75.4 108.927 174.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -85.83 123.43 2.43 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.521 2.147 . . . . 61.51 112.295 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -83.26 83.68 7.77 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 106.788 -1.56 . . . . 64.11 106.788 167.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 5.6 p -71.83 116.24 13.36 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 CA-C-N 114.081 -1.418 . . . . 54.14 110.787 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -108.24 102.51 11.63 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.298 -1.001 . . . . 73.0 108.298 173.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.65 137.44 32.33 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.305 -0.628 . . . . 70.32 109.305 176.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.433 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 16.0 t70 -119.59 147.72 44.17 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.384 1.074 . . . . 73.52 108.141 -177.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.536 HD13 HD13 ' G' ' 8' ' ' LEU . 16.3 tp -130.0 112.5 13.54 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.148 0.499 . . . . 74.2 110.01 -177.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.613 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 13.5 t70 -113.73 154.08 27.93 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.156 1.382 . . . . 75.55 109.153 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 34.0 p -135.32 132.12 37.29 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.489 0.716 . . . . 60.12 110.48 -173.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.46 154.7 48.45 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.918 0.887 . . . . 73.42 109.288 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 48.3 p -160.99 146.68 14.47 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.799 0.333 . . . . 64.04 111.811 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 68.1 p -150.11 133.38 16.37 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.064 0.946 . . . . 74.23 109.154 174.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -76.98 120.82 22.63 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.315 0.646 . . . . 74.01 109.897 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.531 HD11 HD12 ' C' ' 83' ' ' ILE . 26.2 mt -94.1 -30.25 14.76 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.154 0.582 . . . . 53.52 110.517 -177.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.33 -178.92 6.99 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.299 1.04 . . . . 70.12 109.882 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.25 113.05 2.95 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.731 -0.668 . . . . 74.14 109.978 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . 0.439 ' HA ' ' HE1' ' C' ' 56' ' ' TYR . 3.6 m-20 63.26 18.63 11.13 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.536 1.134 . . . . 72.5 112.503 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 83.9 t -115.4 114.47 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.131 -1.063 . . . . 65.25 108.131 170.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.439 ' HE1' ' HA ' ' C' ' 54' ' ' ASP . 83.4 m-85 -126.64 134.29 50.78 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.921 0.888 . . . . 64.34 109.018 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.529 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.2 tt0 -84.58 114.3 21.88 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.082 -1.081 . . . . 71.14 108.082 170.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.467 HG13 ' HE2' ' G' ' 15' ' ' PHE . 98.9 t -95.93 124.22 48.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 107.693 -1.225 . . . . 74.45 107.693 173.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 94.9 t -117.66 133.27 64.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 107.759 -1.2 . . . . 74.24 107.759 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.487 HD13 ' HB3' ' C' ' 103' ' ' PRO . 23.7 tp -127.8 105.76 8.66 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.691 -0.855 . . . . 71.01 108.691 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.613 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 9.2 ttm180 -82.89 122.61 28.47 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.34 -0.615 . . . . 75.15 109.34 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.418 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.2 t -113.83 127.78 71.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.031 -1.1 . . . . 73.42 108.031 171.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 31.5 m -123.5 110.12 14.68 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.017 0.527 . . . . 73.3 109.607 -177.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.495 HG23 HD13 ' C' ' 114' ' ' ILE . 69.3 t -99.72 108.43 22.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 108.883 -0.784 . . . . 71.12 108.883 -177.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.446 HG23 HD23 ' C' ' 75' ' ' LEU . 3.8 m -99.5 126.32 45.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.982 -0.748 . . . . 53.11 108.982 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.38 106.69 13.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.307 -0.997 . . . . 63.32 108.307 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 22.1 m -127.02 129.46 48.1 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.814 -0.81 . . . . 71.33 108.814 175.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.719 HD13 ' HG2' ' C' ' 34' ' ' LYS . 8.1 mt -85.09 32.64 0.54 Allowed 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 125.109 1.364 . . . . 51.5 110.78 -178.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.81 -108.83 2.36 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 110.728 -0.949 . . . . 75.25 110.728 -171.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.71 -23.06 23.06 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.393 0.677 . . . . 73.34 109.943 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.13 115.83 22.07 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 123.993 0.917 . . . . 70.13 109.48 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 79.3 m -84.39 123.84 30.66 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 118.756 0.707 . . . . 74.12 109.164 169.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.694 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -77.38 -57.32 3.89 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.007 -0.997 . . . . 72.22 109.281 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -157.86 172.48 18.39 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 122.103 0.954 . . . . 72.34 111.639 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.446 HD23 HG23 ' C' ' 65' ' ' THR . 2.4 tm? -135.18 128.36 31.87 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 105.611 -1.996 . . . . 75.03 105.611 170.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.46 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 44.4 t -128.26 143.5 51.03 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.134 -1.061 . . . . 52.21 108.134 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.48 123.29 5.18 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.206 0.316 . . . . 71.11 110.367 -174.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 61.8 t -134.12 125.25 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.457 0.703 . . . . 72.44 109.526 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.604 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 25.8 mt-30 -96.02 98.48 10.41 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.926 -1.138 . . . . 72.23 107.926 172.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.628 HE22 HG22 ' C' ' 18' ' ' THR . 10.0 tp-100 -84.25 121.48 27.56 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.053 -0.522 . . . . 55.01 110.153 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.9 147.23 16.7 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 112.168 -0.373 . . . . 63.53 112.168 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.406 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.75 125.14 1.98 Allowed Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.169 -1.173 . . . . 72.04 110.169 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.531 HD12 HD11 ' C' ' 51' ' ' LEU . 13.1 mm -80.63 127.62 39.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 107.554 -1.276 . . . . 74.52 107.554 174.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.413 ' HE2' HG12 ' C' ' 13' ' ' ILE . 64.6 m-85 -134.42 142.28 47.08 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.976 0.417 . . . . 72.31 110.667 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 11.5 p -96.28 107.61 19.99 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 108.246 -1.02 . . . . 51.55 108.246 168.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.456 HG23 ' HE1' ' C' ' 9' ' ' MET . 69.9 mt -115.36 116.47 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.368 1.067 . . . . 73.45 109.245 -176.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.08 172.38 18.51 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.749 0.82 . . . . 63.22 111.181 -171.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.46 -59.2 0.94 Allowed Glycine 0 C--N 1.349 1.264 0 CA-C-N 116.302 -0.408 . . . . 71.12 113.308 170.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.418 ' CD1' ' HG2' ' C' ' 9' ' ' MET . 38.1 pt -94.36 -177.24 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.634 0.774 . . . . 74.22 110.172 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -164.49 155.12 14.78 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 122.974 0.51 . . . . 62.34 110.93 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.52 ' H ' ' HA ' ' G' ' 21' ' ' ALA . . . 75.04 -130.78 11.69 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 119.25 -0.75 . . . . 65.31 113.845 171.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 21.5 m -55.72 -40.29 72.23 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.5 1.12 . . . . 73.41 111.577 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.459 ' NE2' ' HB3' ' C' ' 6' ' ' ASN . 14.0 mt-30 -56.25 -48.21 77.0 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.404 -1.271 . . . . 73.14 109.817 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.564 ' SD ' ' HB2' ' G' ' 21' ' ' ALA . 56.2 ttm -80.33 -27.16 38.41 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 114.822 -1.081 . . . . 73.24 111.234 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.25 81.9 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.53 0.732 . . . . 62.14 111.359 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.549 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 57.8 t-80 -70.75 -28.54 64.77 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.189 -0.914 . . . . 75.03 111.157 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 50.3 t -77.43 -55.33 5.48 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 122.229 -0.294 . . . . 73.24 111.222 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' C' ' 94' ' ' MET . 1.0 OUTLIER -78.09 -22.78 48.45 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 112.968 0.729 . . . . 72.43 112.968 -173.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . 0.439 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -97.59 0.62 59.69 Favored Glycine 0 C--N 1.346 1.089 0 O-C-N 123.403 0.44 . . . . 74.35 112.871 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -140.62 -69.18 0.4 Allowed 'General case' 0 C--N 1.347 0.485 0 C-N-CA 123.344 0.658 . . . . 72.14 110.455 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -65.24 -51.85 58.28 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.496 0.924 . . . . 74.2 113.496 -168.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.459 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 19.9 m -61.63 -47.05 93.61 Favored Pre-proline 0 CA--C 1.564 1.506 0 CA-C-O 118.845 -0.598 . . . . 74.3 112.363 -173.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.487 ' HB3' HD13 ' C' ' 60' ' ' LEU . 21.7 Cg_exo -68.91 -26.11 32.0 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 121.997 1.798 . . . . 71.12 112.971 172.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -72.49 -25.43 61.41 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.447 0.699 . . . . 73.24 110.719 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.469 HD12 HH12 ' A' ' 111' ' ' ARG . 28.7 mm -66.02 -35.27 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.036 0.534 . . . . 74.21 109.586 169.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.406 HD21 ' HA3' ' C' ' 82' ' ' GLY . 84.3 mt -87.18 -17.68 32.11 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.048 0.939 . . . . 75.22 112.452 -176.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -54.39 -50.77 83.15 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 117.534 -1.222 . . . . 73.35 112.863 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -55.24 -36.75 94.12 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.75 2.3 . . . . 73.13 114.594 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -75.46 -44.16 45.65 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.808 0.443 . . . . 72.51 110.55 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.31 -45.74 90.48 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.453 -0.794 . . . . 73.51 109.662 174.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 41.2 ttt-85 -54.26 -51.49 64.39 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.497 1.519 . . . . 71.53 111.506 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.85 -35.58 74.84 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.319 0.648 . . . . 74.44 110.421 -176.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.6 t -71.75 -31.62 66.85 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.005 0.522 . . . . 74.14 110.901 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.495 HD13 HG23 ' C' ' 64' ' ' VAL . 89.4 mt -70.89 -53.47 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.451 0.7 . . . . 73.11 109.661 174.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.9 m -64.35 -28.79 69.94 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.366 0.667 . . . . 64.22 111.249 -176.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.1 t -65.2 -48.63 72.71 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 109.061 -0.718 . . . . 70.33 109.061 173.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.525 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.86 -36.68 84.08 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.508 1.123 . . . . 71.23 112.354 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.426 HG23 ' O ' ' C' ' 114' ' ' ILE . 97.2 t -67.89 -40.89 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.436 0.694 . . . . 74.01 110.094 176.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 48.4 t -70.18 -29.66 66.59 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.162 -0.926 . . . . 75.35 111.371 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.412 ' HD2' ' SD ' ' C' ' 117' ' ' MET . 86.5 mtt-85 -72.26 -32.18 66.44 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.622 0.769 . . . . 74.32 109.598 176.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.17 5.96 69.67 Favored Glycine 0 C--N 1.354 1.564 0 O-C-N 124.014 0.821 . . . . 65.43 112.91 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.497 HG23 ' HB3' ' D' ' 17' ' ' TYR . 76.7 p 57.73 28.3 15.65 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 126.273 1.829 . . . . 73.42 113.278 178.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -88.16 155.38 52.12 Favored Pre-proline 0 CA--C 1.555 1.153 0 N-CA-C 109.213 -0.662 . . . . 75.3 109.213 171.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.39 142.66 29.19 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 123.166 2.577 . . . . 70.3 113.382 172.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.476 ' HA ' HE21 ' C' ' 125' ' ' GLN . 0.0 OUTLIER -59.98 112.27 1.81 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.694 0.798 . . . . 73.31 111.411 -176.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 48.8 tp -113.38 93.08 4.23 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.469 -0.937 . . . . 42.53 108.469 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -91.48 127.84 37.08 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.364 -0.976 . . . . 74.32 108.364 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 89.0 mt -69.54 134.47 48.88 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 123.375 0.422 . . . . 72.33 110.18 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' G' ' 6' ' ' ILE . . . -78.09 158.73 76.94 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 123.822 0.849 . . . . 74.52 110.751 -178.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.467 ' HG3' HG21 ' A' ' 13' ' ' ILE . 23.5 Cg_endo -56.85 112.0 0.97 Allowed 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.918 2.412 . . . . 73.35 112.666 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 p -96.97 107.49 19.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 107.507 -1.294 . . . . 62.33 107.507 170.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -90.86 82.83 5.65 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.812 -1.085 . . . . 72.05 109.121 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -58.61 -44.83 90.06 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.223 0.535 . . . . 64.44 109.566 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -58.23 -46.86 85.16 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.453 -1.249 . . . . 62.13 112.127 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.75 -41.34 87.94 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.885 0.74 . . . . 53.1 111.406 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.42 HD12 HD21 ' G' ' 10' ' ' LEU . 95.4 mt -68.78 -45.05 72.33 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.559 0.344 . . . . 74.12 110.777 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -68.05 -21.63 65.0 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.8 0.44 . . . . 73.32 111.855 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 49.2 ttm -70.44 -35.33 73.3 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.873 0.869 . . . . 70.11 110.633 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -69.31 -43.65 73.33 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.821 0.449 . . . . 72.34 110.089 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -72.07 -154.6 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.728 0.811 . . . . 75.5 112.077 175.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 20.6 tp 71.23 -70.6 0.15 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.431 1.492 . . . . 60.03 110.961 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -120.23 89.19 3.08 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.541 -0.911 . . . . 75.25 108.541 166.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -71.76 -18.71 62.1 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.565 0.746 . . . . 74.44 110.567 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -66.62 -26.2 66.96 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.315 0.646 . . . . 74.12 110.615 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 68.9 -177.34 0.21 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.764 1.226 . . . . 54.54 111.295 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -173.44 55.82 0.15 Allowed Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.445 -0.662 . . . . 73.11 111.445 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -74.76 -90.66 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.879 0.872 . . . . 72.32 109.628 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 51.93 20.34 6.2 Favored Glycine 0 C--N 1.361 1.941 0 N-CA-C 115.446 0.938 . . . . 74.33 115.446 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 88.8 m -123.16 102.17 7.81 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.823 0.849 . . . . 54.11 110.35 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -163.24 124.45 2.4 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.115 -1.439 . . . . 71.11 107.115 172.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -153.17 91.27 1.5 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.926 -0.768 . . . . 72.53 108.926 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -137.52 109.28 7.07 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.089 0.956 . . . . 74.52 108.572 173.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -94.12 -76.23 0.49 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.82 0.848 . . . . 74.01 109.888 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -179.42 -65.04 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.9 1.28 . . . . 72.43 108.894 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.904 0 N-CA-C 108.307 -0.997 . . . . 54.32 108.307 -175.228 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 76.3 mtp . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 121.128 0.49 . . . . 54.44 109.997 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 40.7 p -163.54 85.39 0.49 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.239 -1.393 . . . . 65.5 107.239 -172.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -142.65 82.86 1.79 Allowed 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.874 0.845 . . . . 73.2 109.156 -177.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . 0.409 ' NE2' HD21 ' B' ' 6' ' ' ASN . 90.0 mt-30 -127.73 154.95 44.75 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.092 0.957 . . . . 72.12 110.142 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -145.84 107.37 4.24 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.583 0.753 . . . . 65.23 109.598 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . 0.765 ' HB3' ' HG3' ' B' ' 142' ' ' GLN . 2.8 p30 -144.95 93.16 2.36 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.959 0.903 . . . . 70.21 109.931 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.53 HG23 ' HB3' ' D' ' 9' ' ' MET . 2.1 t -164.54 168.45 18.28 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.961 -1.018 . . . . 72.02 110.01 -173.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -68.36 -27.47 66.28 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.735 1.214 . . . . 71.14 110.614 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.715 ' HG3' HD11 ' D' ' 89' ' ' ILE . 16.9 ttt -24.12 125.69 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 127.11 2.164 . . . . 73.0 116.196 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 85.4 m -104.81 142.63 34.39 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.469 -0.937 . . . . 75.43 108.469 168.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -154.81 108.25 2.86 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.99 -1.115 . . . . 72.14 107.99 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -122.42 119.78 32.0 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.84 -0.8 . . . . 62.21 108.84 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 65.7 mt -68.09 135.52 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 109.872 -0.418 . . . . 74.1 109.872 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.558 HE22 HG13 ' D' ' 55' ' ' VAL . 51.6 mt-30 -101.41 -39.54 7.51 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.069 0.547 . . . . 74.43 111.405 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 15.4 ttt180 -172.03 135.8 0.83 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.706 0.23 . . . . 71.14 111.374 -169.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.431 HD13 ' HG3' ' B' ' 130' ' ' PRO . 3.4 mp -120.6 135.51 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 107.59 -1.263 . . . . 71.05 107.59 167.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.497 ' HB3' HG23 ' C' ' 122' ' ' THR . 37.1 p90 -163.53 168.78 19.66 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.941 0.877 . . . . 70.23 111.301 177.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.2 p -99.15 128.33 45.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.316 -1.311 . . . . 74.52 109.082 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.457 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 39.0 mtpt -104.66 -15.14 15.36 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.025 0.53 . . . . 70.2 110.384 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.729 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 28.3 t70 -158.62 132.66 7.8 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.484 -1.235 . . . . 62.52 108.157 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.525 HG21 ' HE2' ' C' ' 117' ' ' MET . 57.4 mt -138.8 148.14 24.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.545 -1.279 . . . . 73.51 107.545 176.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 27.2 t -154.13 145.42 22.96 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.416 0.686 . . . . 64.2 109.818 173.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.1 t80 -149.97 122.02 8.26 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 105.55 -2.018 . . . . 75.31 105.55 172.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 26.6 mt-10 -130.4 111.54 12.42 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.96 -0.756 . . . . 64.13 108.96 -173.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -116.69 86.22 18.46 Favored Pre-proline 0 C--O 1.241 0.615 0 N-CA-C 108.683 -0.858 . . . . 73.23 108.683 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.77 -39.89 2.24 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.36 2.04 . . . . 71.31 111.727 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -86.72 -3.34 59.03 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.812 1.245 . . . . 74.25 111.31 -176.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.515 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -23.74 -67.95 0.05 OUTLIER Pre-proline 0 C--N 1.361 1.096 0 C-N-CA 127.465 2.306 . . . . 75.43 116.737 -165.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.459 ' HB3' HD11 ' C' ' 83' ' ' ILE . 86.2 Cg_endo -73.64 -29.74 10.44 Favored 'Trans proline' 0 C--N 1.375 1.951 0 CA-C-N 123.133 2.155 . . . . 74.0 113.582 -168.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -87.36 -22.52 25.01 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.623 0.249 . . . . 74.1 110.672 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.515 HG12 ' O ' ' D' ' 28' ' ' ALA . 10.0 p -81.75 -18.1 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 122.866 0.466 . . . . 74.41 110.482 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -65.62 -18.77 65.57 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 112.562 0.578 . . . . 75.22 112.562 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -64.58 -12.35 44.2 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.131 0.972 . . . . 74.14 111.602 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -102.62 106.83 17.57 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.167 1.387 . . . . 71.44 110.463 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -102.96 83.81 2.28 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.998 0.919 . . . . 74.11 110.158 -176.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -158.28 175.65 13.47 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.698 0.799 . . . . 72.22 109.171 169.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -66.5 111.95 8.12 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 123.412 0.685 . . . . 64.44 110.101 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.428 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 73.9 Cg_exo -56.12 119.44 6.62 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.004 2.469 . . . . 55.2 111.649 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -60.56 113.74 2.6 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.561 1.145 . . . . 64.53 110.419 -176.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 71.7 t -97.18 126.1 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.339 0.656 . . . . 74.22 111.226 -169.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.629 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 17.0 tppt? -101.72 110.52 22.52 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.312 -1.736 . . . . 70.42 106.312 166.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.52 114.06 25.69 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.287 -1.005 . . . . 74.01 108.287 -172.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.73 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 11.7 m-20 -107.21 150.06 27.04 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.389 1.075 . . . . 73.35 109.451 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.414 HD21 HD23 ' H' ' 8' ' ' LEU . 94.4 mt -129.5 151.02 50.58 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.571 0.748 . . . . 55.42 110.476 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 33.6 t70 -156.88 136.06 11.98 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.795 -1.187 . . . . 54.34 107.795 174.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 41.1 p -107.23 144.43 34.03 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.01 0.524 . . . . 71.43 110.987 -171.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.611 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.44 156.43 41.44 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.931 0.893 . . . . 71.2 109.303 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.484 ' HB3' ' HE2' ' H' ' 15' ' ' PHE . 10.5 p -172.18 155.78 3.74 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.025 0.53 . . . . 45.32 111.129 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 56.0 p -151.93 123.12 7.68 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.343 -0.844 . . . . 73.34 109.045 175.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -76.64 123.36 26.01 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.956 -0.757 . . . . 64.21 108.956 173.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 35.8 mt -90.01 -31.02 17.38 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.293 0.568 . . . . 64.22 109.997 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -164.5 171.91 13.99 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.304 1.441 . . . . 72.35 108.397 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -68.08 127.25 32.2 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.299 -0.876 . . . . 74.4 108.978 171.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 75.63 -2.85 2.7 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 125.926 1.69 . . . . 74.42 112.494 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.558 HG13 HE22 ' D' ' 14' ' ' GLN . 64.1 t -117.06 115.7 49.73 Favored 'Isoleucine or valine' 0 C--N 1.354 0.783 0 N-CA-C 108.099 -1.075 . . . . 60.35 108.099 172.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -144.38 169.12 18.54 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.516 -0.549 . . . . 73.21 109.516 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -130.04 132.36 46.18 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.105 -0.952 . . . . 61.22 109.568 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 64.2 t -105.94 124.75 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.464 -1.31 . . . . 63.22 107.464 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 20.9 t -114.84 130.02 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.457 -1.312 . . . . 74.44 107.457 172.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' D' ' 103' ' ' PRO . 15.4 tp -125.93 120.55 30.7 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.847 -0.797 . . . . 63.51 108.847 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.565 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 55.3 ttm-85 -83.99 102.78 12.72 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.157 -0.683 . . . . 75.41 109.157 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 71.7 t -91.15 126.86 43.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 107.862 -1.162 . . . . 73.35 107.862 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.73 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 26.8 m -124.14 126.62 46.49 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.486 0.66 . . . . 74.53 110.101 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 53.4 t -111.36 98.69 7.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 124.853 1.261 . . . . 65.41 107.781 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.629 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 31.0 m -95.98 90.04 5.43 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.335 -1.357 . . . . 71.2 107.335 177.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -97.93 148.18 23.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.458 -0.792 . . . . 32.24 110.576 -170.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.48 ' HA ' ' N ' ' D' ' 73' ' ' ALA . 54.8 m -145.34 135.5 23.88 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.259 0.466 . . . . 73.53 112.259 -174.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.467 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 82.0 mt -108.35 105.73 15.54 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.714 0.806 . . . . 54.33 109.151 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.47 -135.68 14.45 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.301 0.376 . . . . 64.43 113.653 175.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.29 5.74 25.6 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.32 0.648 . . . . 74.11 111.616 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -136.93 173.2 11.96 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.243 0.617 . . . . 72.34 110.797 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 37.7 m -66.34 153.08 43.62 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.976 1.31 . . . . 73.23 111.574 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.48 ' N ' ' HA ' ' D' ' 67' ' ' SER . . . -101.67 -65.51 0.97 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.378 -1.341 . . . . 54.13 107.378 168.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -155.21 146.86 23.17 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.478 -1.237 . . . . 74.23 110.246 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.499 HD22 HG23 ' D' ' 65' ' ' THR . 31.7 mt -104.57 111.12 23.69 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.468 -1.308 . . . . 74.12 107.468 172.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.561 ' SG ' HG12 ' D' ' 114' ' ' ILE . 35.0 t -117.26 137.64 52.26 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.621 -0.881 . . . . 73.31 108.621 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -154.86 121.42 5.38 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.646 -0.502 . . . . 74.44 109.646 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 65.4 t -129.47 124.0 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.392 0.677 . . . . 74.11 109.492 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.729 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 22.0 mt-30 -86.95 93.99 9.48 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 107.947 -1.131 . . . . 65.24 107.947 164.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -83.35 105.19 14.1 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.266 -1.013 . . . . 71.23 108.266 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -98.39 150.2 19.32 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-N 116.0 -0.545 . . . . 34.2 112.019 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.497 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -152.78 129.63 2.8 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.76 -0.257 . . . . 41.34 112.511 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.5 mt -91.2 126.89 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 108.211 -1.033 . . . . 61.32 108.211 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -130.68 153.81 48.58 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.639 0.776 . . . . 62.51 110.747 -174.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.3 m -106.71 138.21 43.31 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.504 1.121 . . . . 75.02 108.5 173.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.766 HG12 HD13 ' D' ' 89' ' ' ILE . 8.8 tt -146.4 144.2 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 108.849 -0.797 . . . . 74.11 108.849 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.47 146.62 8.62 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.18 0.592 . . . . 45.53 110.219 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.94 10.4 57.58 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.278 0.361 . . . . 70.32 113.122 -177.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.766 HD13 HG12 ' D' ' 86' ' ' ILE . 3.4 mp -123.65 151.06 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.018 0.927 . . . . 51.42 109.569 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.55 178.36 9.96 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.087 1.355 . . . . 73.23 109.737 174.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.09 -134.0 31.43 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 114.481 0.552 . . . . 64.21 114.481 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 34.6 p -88.88 -12.84 40.66 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.064 0.946 . . . . 74.23 112.419 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -61.7 -40.57 95.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.179 0.592 . . . . 73.31 110.559 177.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.611 ' HB2' HG23 ' H' ' 18' ' ' VAL . 26.4 ptt? -75.61 -20.26 58.68 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.624 -0.716 . . . . 62.31 112.2 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.24 -38.57 91.51 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.935 0.494 . . . . 72.42 110.677 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -78.01 -29.44 49.55 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.397 -0.82 . . . . 72.05 111.056 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . 0.427 ' SG ' HD12 ' D' ' 86' ' ' ILE . 44.3 t -68.5 -52.85 27.66 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 122.895 0.122 . . . . 75.14 111.085 -175.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.2 -22.06 42.27 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 110.612 -0.144 . . . . 74.42 110.612 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.29 -3.52 81.9 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-O 119.697 -0.502 . . . . 73.11 114.079 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.39 -58.76 0.13 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 117.479 0.64 . . . . 62.33 111.774 -177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -66.07 -47.96 72.57 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 112.658 0.614 . . . . 71.43 112.658 -170.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.421 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 44.6 m -67.85 -44.88 42.78 Favored Pre-proline 0 CA--C 1.565 1.523 0 CA-C-O 118.819 -0.61 . . . . 72.11 112.36 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.681 ' HB3' HD22 ' D' ' 60' ' ' LEU . 50.8 Cg_exo -59.12 -28.81 88.81 Favored 'Trans proline' 0 C--N 1.39 2.75 0 C-N-CA 122.54 2.16 . . . . 72.41 113.618 168.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -69.67 -33.57 72.76 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.507 0.723 . . . . 60.3 110.347 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.9 mm -67.33 -33.27 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-O 121.334 0.588 . . . . 74.04 110.212 174.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.497 HD21 ' HA3' ' D' ' 82' ' ' GLY . 65.4 mt -85.22 -15.97 41.83 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.885 0.874 . . . . 73.52 111.883 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -61.38 -48.51 90.84 Favored Pre-proline 0 CA--C 1.567 1.622 0 CA-C-O 118.002 -0.999 . . . . 62.13 113.262 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -59.92 -31.37 93.61 Favored 'Trans proline' 0 C--N 1.388 2.646 0 C-N-CA 122.093 1.862 . . . . 71.5 112.923 177.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -82.24 -32.04 29.92 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.727 0.811 . . . . 74.24 111.803 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.08 -48.1 72.08 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.847 -0.797 . . . . 55.33 108.847 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.449 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 34.4 ttp180 -55.39 -49.61 71.88 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 124.405 1.066 . . . . 73.44 111.141 176.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -64.68 -50.31 67.51 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 123.898 0.749 . . . . 74.41 111.144 -174.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 44.8 t -57.85 -44.39 86.52 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 124.005 0.816 . . . . 71.14 110.801 -178.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.561 HG12 ' SG ' ' D' ' 76' ' ' CYS . 91.4 mt -63.56 -55.34 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.727 0.811 . . . . 73.43 111.119 175.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 77.1 m -57.37 -39.91 77.04 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.146 0.979 . . . . 73.41 111.217 -174.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 86.5 p -66.7 -41.83 87.38 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.402 -0.817 . . . . 74.41 109.533 -177.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 65.3 mtm -69.97 -28.89 65.91 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.151 0.58 . . . . 72.14 111.734 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.487 HG23 ' O ' ' D' ' 114' ' ' ILE . 88.3 t -63.23 -49.18 84.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.23 0.612 . . . . 74.43 109.391 172.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.1 p -73.61 -26.1 60.63 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.867 -0.606 . . . . 63.3 111.039 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' D' ' 116' ' ' SER . 74.1 mtt-85 -71.94 -37.79 69.93 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.492 0.717 . . . . 62.41 109.246 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.78 4.86 77.77 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 115.362 -0.835 . . . . 50.12 112.448 173.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.406 HG21 HE21 ' A' ' 125' ' ' GLN . 22.4 p 58.7 30.67 20.26 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 126.683 1.993 . . . . 60.35 113.703 173.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -84.75 159.62 57.53 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 123.988 0.915 . . . . 74.24 109.883 171.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.35 126.13 21.32 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.693 2.262 . . . . 73.52 112.136 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -64.51 124.72 22.57 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.889 0.876 . . . . 73.2 111.652 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 7.0 tt -124.59 115.08 20.24 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.125 -1.435 . . . . 73.02 107.125 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -99.59 121.62 41.46 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.907 0.883 . . . . 73.12 108.653 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.69 ' HA ' HD11 ' H' ' 6' ' ' ILE . 7.3 mp -68.77 113.63 6.39 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 109.897 -0.409 . . . . 75.23 109.897 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -64.7 140.06 97.93 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.017 0.527 . . . . 72.31 110.432 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 9.3 Cg_exo -66.53 126.57 15.72 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.106 1.871 . . . . 74.03 110.708 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.6 m -107.85 146.71 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 C-N-CA 123.27 0.628 . . . . 75.42 110.725 -174.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -97.33 68.7 2.21 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.916 0.865 . . . . 63.41 109.207 -176.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -87.91 -26.6 22.64 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.191 -0.913 . . . . 52.4 111.485 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' D' ' 138' ' ' MET . 1.2 m-20 -52.69 -44.4 66.23 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.292 0.637 . . . . 71.14 110.779 169.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.07 -43.94 97.76 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 124.222 0.951 . . . . 75.22 111.772 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.84 -45.16 93.91 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.572 0.749 . . . . 73.22 111.161 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.429 ' O ' HD13 ' D' ' 141' ' ' LEU . 32.2 m-85 -69.32 -30.78 68.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.671 0.788 . . . . 63.11 111.695 175.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' D' ' 134' ' ' ASP . 21.1 ttm -68.72 -42.92 76.99 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.41 0.684 . . . . 73.23 109.617 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -70.13 -24.92 63.26 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.165 -0.925 . . . . 73.21 111.2 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . 0.616 ' HA ' HE21 ' D' ' 143' ' ' GLN . 71.2 t80 -68.27 -50.03 56.55 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.981 0.513 . . . . 73.31 110.736 178.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.429 HD13 ' O ' ' D' ' 137' ' ' PHE . 9.0 mp -63.56 -32.26 73.67 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.612 0.765 . . . . 63.43 112.6 -176.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -89.99 31.77 0.95 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.075 0.55 . . . . 75.01 112.389 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.616 HE21 ' HA ' ' D' ' 140' ' ' TYR . 48.3 mt-30 -119.77 58.4 0.89 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.727 -0.842 . . . . 71.01 108.727 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -142.49 143.81 32.72 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.087 0.955 . . . . 70.11 108.879 -176.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.7 157.06 35.48 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.661 0.384 . . . . 72.24 110.386 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.63 50.59 4.27 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 112.149 -0.38 . . . . 73.13 112.149 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -150.16 141.84 23.61 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.537 1.135 . . . . 74.25 108.627 -176.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.81 71.36 2.88 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 111.673 -0.571 . . . . 72.03 111.673 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 47.4 p -58.13 142.25 47.75 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.188 0.995 . . . . 74.45 110.656 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -60.78 98.53 0.07 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.187 0.595 . . . . 72.32 110.536 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -72.49 123.77 23.83 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.372 -0.973 . . . . 74.4 108.372 173.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 -78.89 117.51 20.04 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.315 0.579 . . . . 73.2 110.984 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -88.02 66.76 8.74 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.01 0.924 . . . . 74.23 108.783 173.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -75.33 159.13 31.82 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.861 -1.063 . . . . 73.53 110.933 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.965 0 N-CA-C 108.942 -0.762 . . . . 40.04 108.942 178.959 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptp . . . . . 0 N--CA 1.478 0.963 0 CA-C-O 121.616 0.722 . . . . 70.2 110.013 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -154.01 108.15 3.02 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.901 -0.778 . . . . 75.14 108.901 174.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -92.35 103.47 15.91 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.695 -0.854 . . . . 61.45 108.695 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 23.0 t -134.59 93.86 3.11 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.753 -0.832 . . . . 74.24 108.753 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 48.6 p -113.99 144.28 43.35 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.112 0.965 . . . . 75.45 109.327 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.421 HG21 ' HA ' ' A' ' 128' ' ' LEU . 79.9 mt 69.99 133.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 124.784 1.233 . . . . 72.42 111.433 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.47 141.01 29.28 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.492 0.717 . . . . 42.14 109.803 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 16.2 mt -157.06 160.68 39.16 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.41 1.084 . . . . 70.45 108.954 173.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -158.01 -77.91 0.08 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.376 0.67 . . . . 65.43 109.796 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . 0.412 HD11 HD22 ' A' ' 136' ' ' LEU . 96.6 mt -136.96 175.92 9.18 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.779 0.831 . . . . 62.34 110.864 -174.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 86.9 mt -86.8 145.87 39.82 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 115.016 -0.993 . . . . 52.11 109.63 174.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -61.98 -46.43 13.28 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.507 2.138 . . . . 63.2 111.341 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -121.97 154.97 36.49 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.883 0.873 . . . . 75.45 108.718 172.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 82.5 mt -89.09 35.67 0.8 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.474 0.709 . . . . 61.23 110.338 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 60.64 -166.58 0.2 Allowed 'General case' 0 C--N 1.359 0.991 0 C-N-CA 124.231 1.012 . . . . 72.14 111.227 -174.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 16' ' ' THR . . . . . 0.685 HG22 ' HB2' ' A' ' 48' ' ' SER . 6.8 t -106.85 145.65 31.51 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 109.368 -0.605 . . . . 72.4 109.368 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 17' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.8 135.43 67.69 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.547 2.165 . . . . 73.22 112.664 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 18' ' ' VAL . . . . . 0.7 HG21 HD11 ' A' ' 86' ' ' ILE . 5.2 p -66.51 -44.84 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.437 0.695 . . . . 70.34 111.177 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 23.2 p -138.0 49.76 1.94 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.211 1.005 . . . . 73.21 110.097 -174.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 59.7 tttm 62.86 25.75 15.23 Favored 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 123.799 0.839 . . . . 74.35 110.147 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.98 87.55 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.785 1.234 . . . . 63.33 112.755 -172.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -147.34 125.4 12.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.019 1.328 . . . . 73.12 108.619 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . 0.632 HG23 ' HA3' ' A' ' 91' ' ' GLY . 3.5 p -97.28 142.32 24.37 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 123.274 0.63 . . . . 65.43 110.329 175.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -48.59 111.74 0.51 Allowed 'Trans proline' 0 C--N 1.39 2.763 0 C-N-CA 123.587 2.858 . . . . 72.41 113.27 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--O 1.253 1.244 0 C-N-CA 124.269 1.028 . . . . 45.23 111.549 -175.718 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 110.259 -0.274 . . . . 52.1 110.259 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -81.21 152.92 27.45 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.266 0.627 . . . . 74.34 110.375 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -77.86 167.42 21.54 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.181 0.593 . . . . 61.32 110.105 168.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 26.7 m 59.15 36.58 24.02 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.813 0.845 . . . . 42.34 111.323 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 22.2 m -53.59 -58.42 7.22 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.843 1.257 . . . . 63.12 112.166 -175.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.426 HG21 ' HB ' ' B' ' 40' ' ' VAL . 1.9 pp -137.23 135.5 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.22 1.008 . . . . 32.21 109.069 176.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 7' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' B' ' 129' ' ' ALA . . . -166.81 149.09 6.36 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.393 1.077 . . . . 62.31 109.097 -176.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . 0.493 HD21 HG13 ' B' ' 62' ' ' VAL . 92.4 mt -65.28 129.02 38.22 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.672 0.389 . . . . 73.12 111.122 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.99 147.93 52.56 Favored 'General case' 0 C--O 1.243 0.731 0 O-C-N 123.756 0.66 . . . . 74.35 110.849 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 6.9 tt -60.92 133.24 55.9 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.884 0.874 . . . . 51.11 108.667 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 86.8 mt -66.02 106.53 1.12 Allowed Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.492 0.717 . . . . 71.51 111.589 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.26 -17.27 10.47 Favored 'Trans proline' 0 C--N 1.383 2.35 0 C-N-CA 122.377 2.051 . . . . 75.12 111.589 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 73.0 mt -78.41 -24.74 46.06 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 124.539 1.136 . . . . 75.23 110.379 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . 0.509 ' HB3' ' HB1' ' B' ' 95' ' ' ALA . 90.3 mt 64.82 16.8 10.68 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.95 1.3 . . . . 75.45 111.653 -174.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 21.1 t80 68.94 145.54 0.05 Allowed 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 125.965 1.706 . . . . 74.25 111.369 -177.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 8.2 p -62.66 119.1 47.76 Favored Pre-proline 0 CA--C 1.559 1.296 0 C-N-CA 123.706 0.802 . . . . 74.05 110.976 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.03 165.69 30.76 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.201 2.601 . . . . 73.22 114.1 -167.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . 0.534 HG21 HG12 ' B' ' 86' ' ' ILE . 39.6 t -77.62 140.27 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.607 0.763 . . . . 72.13 109.267 176.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 38.3 m -62.43 -34.77 77.42 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.115 0.566 . . . . 42.33 111.057 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 20' ' ' LYS . . . . . 0.454 ' H ' HG12 ' F' ' 18' ' ' VAL . 99.4 mttt -114.05 -81.66 0.6 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.905 0.482 . . . . 63.45 110.426 175.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . 0.463 ' HB2' ' HB ' ' F' ' 18' ' ' VAL . . . 65.69 30.25 10.4 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 122.093 0.949 . . . . 64.42 110.479 -170.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 22.9 ptt85 -162.96 108.49 1.14 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.73 1.612 . . . . 71.52 108.412 -176.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 15.5 p -63.77 153.07 85.08 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.471 0.708 . . . . 74.0 111.79 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.6 -13.84 32.14 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.058 2.506 . . . . 74.43 112.715 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 CA--C 1.561 1.366 0 C-N-CA 125.523 1.529 . . . . 71.05 108.922 178.582 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ptt? . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 110.175 -0.306 . . . . 73.21 110.175 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -111.78 133.7 53.83 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.051 0.94 . . . . 74.11 109.367 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 55.41 70.47 0.63 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.328 1.051 . . . . 50.43 110.656 -170.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 22.8 p -112.17 -78.54 0.58 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.735 0.814 . . . . 51.13 110.224 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 7.6 m -108.3 163.11 13.48 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.622 0.769 . . . . 74.4 109.635 -175.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . 0.438 ' O ' ' HB3' ' C' ' 129' ' ' ALA . 49.2 pt -64.64 141.82 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.537 0.735 . . . . 64.44 111.571 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -163.33 156.74 19.29 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.584 0.753 . . . . 74.51 109.617 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 8' ' ' LEU . . . . . 0.536 HD13 HD13 ' C' ' 44' ' ' LEU . 83.7 mt -72.23 152.4 42.23 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.478 0.711 . . . . 73.24 111.056 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.74 144.38 37.28 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.027 -0.533 . . . . 45.14 110.361 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 10' ' ' LEU . . . . . 0.42 HD21 HD12 ' C' ' 136' ' ' LEU . 96.5 mt -62.05 134.49 56.68 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.289 0.636 . . . . 64.54 109.816 173.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.9 101.73 0.29 Allowed Pre-proline 0 CA--C 1.558 1.261 0 O-C-N 124.298 0.999 . . . . 71.53 110.776 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.25 -36.02 7.71 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.094 2.529 . . . . 73.04 112.292 -169.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 5.4 mp -73.21 -12.13 60.76 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.194 0.998 . . . . 62.3 111.174 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 84.6 mt 63.12 81.56 0.2 Allowed 'General case' 0 C--N 1.36 1.046 0 C-N-CA 124.77 1.228 . . . . 74.32 109.651 -174.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . 0.467 ' HE2' HG13 ' C' ' 58' ' ' VAL . 28.9 t80 -59.17 104.08 0.22 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.781 -0.645 . . . . 74.23 110.217 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 16' ' ' THR . . . . . 0.416 ' HA ' HD13 ' C' ' 98' ' ' LEU . 36.4 m -113.23 87.02 10.32 Favored Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 124.403 1.081 . . . . 73.44 109.796 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 17' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.36 -35.77 13.16 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 123.296 2.664 . . . . 61.24 113.035 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 18' ' ' VAL . . . . . 0.496 HG11 ' SD ' ' C' ' 94' ' ' MET . 61.5 t -84.72 135.82 24.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 115.782 -0.644 . . . . 64.44 110.695 -172.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 80.4 p -67.52 142.68 56.49 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 123.978 0.799 . . . . 72.02 110.375 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 20' ' ' LYS . . . . . 0.508 ' HA ' ' HB2' ' A' ' 152' ' ' HIS . 9.4 mtmp? 77.55 -8.77 1.62 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.982 1.713 . . . . 60.32 113.232 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . 0.564 ' HB2' ' SD ' ' C' ' 94' ' ' MET . . . -80.18 2.01 25.96 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.145 0.578 . . . . 72.44 111.849 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -62.88 124.14 20.29 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 123.695 0.798 . . . . 71.42 110.704 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -120.61 149.8 51.03 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.64 1.176 . . . . 74.14 109.084 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.65 141.4 90.88 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.248 1.965 . . . . 73.35 111.744 171.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 CA--C 1.553 1.093 0 C-N-CA 123.328 0.651 . . . . 63.43 109.446 175.365 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' H' H ' 1' ' ' MET . . . . . 0.517 ' SD ' ' HG2' ' H' ' 3' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 120.529 0.204 . . . . 73.25 110.556 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -154.0 98.73 2.19 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.541 -1.281 . . . . 75.41 107.541 172.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 3' ' ' GLN . . . . . 0.614 ' HA ' HE21 ' H' ' 3' ' ' GLN . 0.0 OUTLIER -80.81 88.31 5.83 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.435 0.694 . . . . 73.22 110.04 -177.712 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 19.9 m -64.62 92.71 0.09 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.16 0.984 . . . . 75.42 110.551 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 9.9 t -140.28 142.96 35.68 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.366 0.666 . . . . 51.11 110.129 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.69 HD11 ' HA ' ' D' ' 128' ' ' LEU . 9.4 tp -160.53 127.97 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.814 -0.63 . . . . 71.41 109.379 173.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . 58.89 -100.15 0.11 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.575 1.15 . . . . 65.05 112.604 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 8' ' ' LEU . . . . . 0.414 HD23 HD21 ' D' ' 44' ' ' LEU . 2.4 pp -157.28 173.88 16.29 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 122.054 -0.404 . . . . 72.51 111.388 -171.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.91 -71.47 0.27 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.707 0.803 . . . . 62.4 109.15 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 6.4 mp -127.66 146.04 50.68 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.654 0.782 . . . . 73.31 109.522 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.07 140.52 31.58 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.065 0.946 . . . . 74.11 109.429 177.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.36 172.54 16.13 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 122.816 2.344 . . . . 72.14 112.919 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tm? 67.27 -74.78 0.07 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.729 1.612 . . . . 72.14 109.08 -173.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 16.2 tp 69.28 160.85 0.2 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.13 1.372 . . . . 73.02 111.721 174.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . 0.484 ' HE2' ' HB3' ' D' ' 48' ' ' SER . 22.1 m-85 -77.49 153.34 33.57 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.317 0.647 . . . . 74.11 110.081 176.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 28.9 m -137.88 -56.78 0.02 OUTLIER Pre-proline 0 CA--C 1.572 1.801 0 N-CA-C 113.208 0.818 . . . . 65.51 113.208 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -95.18 169.34 1.47 Allowed 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 122.327 2.018 . . . . 43.15 114.49 -175.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' D' ' 94' ' ' MET . 11.8 t -106.61 -57.36 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.437 1.095 . . . . 75.13 108.324 166.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 8.4 t -75.7 128.34 34.99 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.175 -0.921 . . . . 64.01 109.578 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt 61.38 27.92 17.45 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.38 1.472 . . . . 71.52 111.189 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.57 120.1 14.83 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.943 0.897 . . . . 65.43 111.157 -175.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 70.02 -75.12 0.08 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.846 1.659 . . . . 70.45 110.29 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 5.4 m 58.26 72.41 0.87 Allowed Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 124.724 1.21 . . . . 74.41 109.978 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.86 103.46 0.72 Allowed 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 123.073 2.515 . . . . 65.13 112.009 -172.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.553 1.07 0 N-CA-C 108.027 -1.101 . . . . 73.3 108.027 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.2 ttp . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.265 0.079 . . . . 54.43 110.927 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 m -70.64 84.56 0.63 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.728 0.775 . . . . 54.14 111.672 -172.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -104.98 87.17 2.58 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.252 1.021 . . . . 75.52 108.932 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.14 -178.45 4.32 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.639 0.776 . . . . 74.23 111.177 -172.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.6 t30 65.98 -74.12 0.06 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.667 1.587 . . . . 64.2 112.42 170.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -117.62 87.81 2.78 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.398 1.479 . . . . 74.24 109.37 -176.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.6 p -98.79 -54.63 2.95 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.51 0.724 . . . . 74.12 110.153 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -84.37 88.21 7.25 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 123.354 0.661 . . . . 75.34 109.483 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.56 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.9 OUTLIER 70.86 157.9 0.18 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.764 1.226 . . . . 74.53 110.894 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.442 ' N ' ' SD ' ' A' ' 9' ' ' MET . 5.7 t -145.78 134.49 22.27 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 123.054 0.542 . . . . 71.33 110.329 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.602 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 48.1 t80 -137.27 135.68 37.38 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.728 -0.669 . . . . 74.43 110.18 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -160.48 129.34 4.82 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.873 0.869 . . . . 72.54 109.372 173.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.567 ' CD1' HG21 ' A' ' 105' ' ' ILE . 58.2 mt -94.14 122.11 45.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.809 -0.811 . . . . 64.22 108.809 172.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -90.98 -31.15 16.44 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.278 0.361 . . . . 74.42 110.759 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.49 ' HB3' HD12 ' A' ' 83' ' ' ILE . 39.8 ttt180 -167.0 122.19 1.09 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 111.99 0.367 . . . . 72.55 111.99 -169.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.433 HD11 HD13 ' A' ' 13' ' ' ILE . 73.7 mt -115.02 137.14 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 C-N-CA 123.842 0.857 . . . . 74.53 109.24 173.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HB3' HG23 ' B' ' 122' ' ' THR . 26.9 p90 -163.01 174.94 11.66 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 123.791 0.836 . . . . 73.11 111.069 -174.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -106.89 118.74 37.49 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.95 -0.759 . . . . 61.11 108.95 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -86.76 -25.75 24.52 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.857 -0.423 . . . . 64.22 109.857 176.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.696 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 26.3 t70 -145.91 135.39 23.1 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.604 -0.726 . . . . 62.4 109.703 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.7 mt -139.06 140.52 38.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 C-N-CA 125.477 1.511 . . . . 74.21 107.187 176.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -150.35 124.96 9.67 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.235 0.614 . . . . 73.22 109.381 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.428 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 88.1 t80 -124.08 136.6 54.35 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.052 -1.462 . . . . 74.42 107.052 168.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -137.29 135.95 37.58 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.895 0.478 . . . . 64.31 110.069 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.09 74.41 49.7 Favored Pre-proline 0 C--O 1.242 0.696 0 N-CA-C 106.6 -1.63 . . . . 72.55 106.6 167.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.58 -32.09 39.66 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.118 1.878 . . . . 74.51 110.906 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -96.98 19.59 12.53 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.226 -0.897 . . . . 73.14 110.685 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.455 ' HB3' ' HZ1' ' B' ' 19' ' ' LYS . . . -50.31 -45.94 83.51 Favored Pre-proline 0 CA--C 1.567 1.614 0 N-CA-C 114.469 1.285 . . . . 62.12 114.469 -172.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -66.37 -19.51 55.56 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 121.767 1.644 . . . . 33.04 113.479 175.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.45 ' HA ' HE21 ' A' ' 33' ' ' GLN . 5.0 m-70 -97.15 -26.07 15.09 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.01 0.924 . . . . 72.31 111.564 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.585 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.1 p -79.61 -30.26 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 N-CA-C 113.459 0.911 . . . . 74.31 113.459 -158.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -81.75 -23.9 36.4 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.813 0.445 . . . . 73.14 111.189 -171.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.45 HE21 ' HA ' ' A' ' 30' ' ' HIS . 28.9 pt20 -79.91 -11.6 59.79 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.474 0.71 . . . . 74.21 111.038 176.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -81.47 162.3 23.32 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.872 0.469 . . . . 64.05 111.417 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -68.9 126.52 30.04 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.259 -0.882 . . . . 73.22 108.967 173.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 44.3 t-105 -76.4 81.92 3.13 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.762 0.791 . . . . 72.41 109.862 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -130.94 76.19 77.42 Favored Pre-proline 0 C--O 1.246 0.876 0 N-CA-C 107.512 -1.292 . . . . 71.44 107.512 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -85.48 140.22 7.21 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.295 1.997 . . . . 72.23 112.226 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -97.06 101.74 13.37 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.411 -1.329 . . . . 71.12 107.411 169.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 65' ' ' THR . 19.3 t -85.88 93.78 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.846 -0.798 . . . . 74.25 108.846 -176.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -86.12 115.34 23.63 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.531 1.132 . . . . 75.11 109.424 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.459 HD21 HG23 ' E' ' 6' ' ' ILE . 1.9 mm? -97.9 107.81 20.38 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.02 -0.733 . . . . 65.34 109.02 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.55 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 18.1 t70 -106.9 121.75 45.04 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.275 1.03 . . . . 61.24 108.552 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.468 HD21 HD22 ' E' ' 8' ' ' LEU . 6.5 mp -103.67 145.96 29.29 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.98 -0.378 . . . . 72.11 109.98 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.636 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 23.1 t70 -148.76 159.65 43.94 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.067 0.947 . . . . 53.01 108.847 177.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.6 m -135.44 136.85 41.68 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.571 0.749 . . . . 70.41 110.41 -178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.85 144.07 49.95 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.734 1.214 . . . . 74.51 108.279 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.0 p -132.9 167.22 20.62 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.716 0.406 . . . . 72.34 111.478 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.0 t -166.67 122.51 1.19 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.336 -0.847 . . . . 70.01 109.952 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -77.29 110.93 12.41 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 107.871 -1.159 . . . . 65.25 107.871 168.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 57' ' ' GLU . 31.3 mt -84.94 -36.68 21.25 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.177 0.591 . . . . 65.14 110.75 -173.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.66 -174.47 4.23 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.848 0.859 . . . . 73.33 110.035 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -65.53 119.08 10.44 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.381 -0.6 . . . . 73.0 109.381 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 85' ' ' SER . 35.8 m-20 68.22 2.17 3.14 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.91 1.284 . . . . 74.11 113.015 -177.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.5 t -105.91 111.22 34.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 108.214 -1.032 . . . . 54.12 108.214 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -131.53 137.33 48.45 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.845 -0.798 . . . . 70.25 108.845 -174.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.454 ' HB2' HD11 ' A' ' 51' ' ' LEU . 40.5 tt0 -108.7 118.25 36.3 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.879 -1.055 . . . . 62.4 109.786 -176.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.5 t -103.43 123.74 57.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.043 -1.466 . . . . 74.34 107.043 170.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.8 131.25 70.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 107.817 -1.179 . . . . 62.41 107.817 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 tt -121.8 115.08 22.01 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.179 -1.045 . . . . 71.41 108.179 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.636 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 35.9 ttp180 -85.45 109.49 18.5 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.831 0.852 . . . . 75.34 109.93 175.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.4 t -99.48 102.77 13.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.537 -1.283 . . . . 75.15 107.537 170.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 39.8 m -94.84 108.86 20.89 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.985 0.914 . . . . 75.54 108.907 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.7 t -103.78 110.15 29.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.264 -0.88 . . . . 74.4 109.142 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 21.6 m -102.11 134.74 44.88 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.963 -1.125 . . . . 50.21 107.963 171.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.68 117.22 19.99 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.963 -1.495 . . . . 72.42 106.963 174.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 54.0 m -128.0 132.7 49.14 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.943 0.497 . . . . 71.33 110.97 -175.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.7 mt -90.85 48.01 1.48 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.484 1.114 . . . . 65.43 108.805 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.42 -90.41 0.93 Allowed Glycine 0 C--N 1.351 1.376 0 CA-C-N 114.993 -1.003 . . . . 74.5 112.552 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -87.83 -22.87 24.23 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.785 0.834 . . . . 71.41 111.034 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -118.55 98.82 6.44 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.857 -1.164 . . . . 73.14 107.857 -172.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 93.1 m -59.08 129.19 40.94 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 118.44 0.563 . . . . 53.42 110.597 177.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.585 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -70.18 -60.62 2.17 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.241 -0.891 . . . . 72.15 109.643 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -161.19 164.19 30.65 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 114.863 -1.062 . . . . 73.32 110.99 177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.1 tp -128.62 108.9 10.88 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.502 -0.925 . . . . 73.22 108.502 171.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.403 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 73.9 m -106.48 96.61 6.58 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.59 0.756 . . . . 74.53 109.824 174.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -111.04 115.27 29.18 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.866 -0.79 . . . . 60.11 108.866 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -124.11 132.04 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.048 0.539 . . . . 33.41 109.563 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.696 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.8 mt-30 -98.72 95.59 7.34 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.262 0.625 . . . . 71.53 109.521 168.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -80.41 105.16 11.46 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.807 -1.088 . . . . 70.14 109.03 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.7 150.92 20.59 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.908 -0.587 . . . . 42.24 111.821 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.53 147.49 18.6 Favored Glycine 0 C--O 1.237 0.284 0 N-CA-C 111.529 -0.628 . . . . 32.44 111.529 174.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 15' ' ' ARG . 64.1 mt -104.13 112.23 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.06 -1.089 . . . . 71.33 108.06 176.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.602 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 5.1 m-85 -123.16 154.83 38.14 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.258 1.023 . . . . 74.34 108.294 -176.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 87.9 p -109.04 116.04 31.22 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.742 -0.836 . . . . 71.24 108.742 172.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.47 122.0 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 109.279 -0.637 . . . . 62.42 109.279 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.96 166.47 7.52 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.315 1.046 . . . . 53.34 110.005 173.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 122.07 -81.01 0.34 Allowed Glycine 0 C--N 1.34 0.78 0 O-C-N 123.657 0.598 . . . . 73.34 111.623 174.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.9 mm -117.18 132.88 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.262 -0.644 . . . . 75.23 109.262 -173.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -94.57 -144.91 0.25 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.832 0.853 . . . . 70.43 109.519 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.607 ' HA2' ' HB2' ' E' ' 22' ' ' ARG . . . 72.48 -148.86 42.78 Favored Glycine 0 C--N 1.354 1.561 0 N-CA-C 112.24 -0.344 . . . . 74.12 112.24 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.5 p -71.14 -18.19 62.52 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.732 0.813 . . . . 63.31 111.653 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -72.33 -55.27 7.4 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 123.142 0.577 . . . . 75.02 110.485 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.637 ' HA ' ' SG ' ' A' ' 97' ' ' CYS . 58.0 ttm -65.62 -31.7 72.87 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.801 0.273 . . . . 72.35 110.705 176.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.96 -26.96 67.08 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.152 0.581 . . . . 41.22 111.501 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.402 ' NE2' ' HB2' ' A' ' 134' ' ' ASP . 34.1 t-80 -89.51 -47.49 7.95 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.41 0.684 . . . . 74.34 111.324 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.637 ' SG ' ' HA ' ' A' ' 94' ' ' MET . 22.0 p -62.36 -42.86 99.74 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.228 0.537 . . . . 55.32 110.372 -174.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.526 ' HG ' HG23 ' E' ' 18' ' ' VAL . 3.2 tm? -88.02 -41.4 13.13 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.985 -1.007 . . . . 71.22 109.984 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.94 0.09 89.08 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-O 119.443 -0.643 . . . . 71.42 114.647 -171.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.22 -51.83 0.14 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 117.939 0.869 . . . . 73.43 112.464 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.469 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 85.6 t80 -69.86 -58.64 3.64 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.712 0.634 . . . . 74.0 112.712 -170.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.409 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 71.7 m -62.59 -40.49 65.24 Favored Pre-proline 0 CA--C 1.563 1.471 0 N-CA-C 113.651 0.982 . . . . 55.3 113.651 -175.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 34.8 Cg_endo -65.23 -27.84 56.04 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 121.941 1.761 . . . . 71.4 113.166 169.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -75.29 -23.36 57.36 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 122.843 0.457 . . . . 72.34 110.696 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.567 HG21 ' CD1' ' A' ' 13' ' ' ILE . 46.9 mm -62.35 -40.86 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.338 0.655 . . . . 64.32 109.751 170.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 80.1 mt -74.19 -21.56 59.77 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.935 -1.029 . . . . 61.42 111.607 -177.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -60.51 -49.17 91.29 Favored Pre-proline 0 CA--C 1.565 1.536 0 N-CA-C 113.982 1.104 . . . . 71.32 113.982 -172.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.29 -34.17 88.26 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 121.941 1.761 . . . . 73.24 112.829 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -70.13 -41.25 74.17 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.362 0.665 . . . . 72.25 111.455 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.32 -44.02 89.15 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.661 -0.699 . . . . 74.32 109.764 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.528 ' NH1' HD12 ' C' ' 105' ' ' ILE . 30.6 ttm180 -52.6 -48.66 66.15 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.639 1.175 . . . . 74.13 110.64 174.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.07 -49.71 66.69 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.446 0.698 . . . . 75.51 111.33 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 33.1 t -61.54 -26.43 67.93 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.473 0.709 . . . . 73.21 111.495 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 81.1 mt -77.81 -57.3 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 123.84 0.856 . . . . 65.32 110.117 174.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.5 m -55.59 -34.74 65.1 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.823 0.849 . . . . 62.25 111.89 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.0 t -63.73 -49.99 70.88 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.318 -0.856 . . . . 72.24 110.058 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 30.4 mtm -66.5 -37.51 85.23 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.103 0.561 . . . . 71.33 111.229 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.0 t -57.07 -47.98 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 124.02 0.825 . . . . 75.13 110.048 175.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 29.3 t -73.45 -28.89 62.2 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 115.039 -0.982 . . . . 62.05 111.438 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -72.83 -28.64 62.66 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.207 0.603 . . . . 73.22 109.872 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.13 4.67 75.21 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 123.659 0.599 . . . . 64.33 112.918 172.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.57 HG23 HH21 ' B' ' 15' ' ' ARG . 0.6 OUTLIER 65.72 16.33 10.45 Favored 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 126.515 1.926 . . . . 72.11 112.347 177.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -79.16 152.93 76.95 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 123.575 0.75 . . . . 61.33 109.666 172.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.98 134.31 63.72 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.474 2.116 . . . . 74.42 111.14 171.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -56.65 158.08 4.85 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.557 0.743 . . . . 72.42 112.416 -173.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.0 tp -135.85 93.73 2.97 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.28 -0.873 . . . . 75.52 109.333 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -98.12 99.14 10.38 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.986 -1.116 . . . . 71.51 107.986 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.687 HD13 HG22 ' E' ' 6' ' ' ILE . 19.0 tp -59.26 136.7 58.04 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.294 -0.867 . . . . 61.3 110.346 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.04 145.14 81.16 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 124.284 1.033 . . . . 72.31 112.147 -175.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.06 123.34 11.75 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.204 2.603 . . . . 52.25 111.759 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 77.1 t -116.02 115.94 50.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 108.96 -0.755 . . . . 74.3 108.96 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.473 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 2.8 m-20 -73.26 74.69 1.32 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.88 0.872 . . . . 71.54 108.654 173.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -58.69 -52.02 67.47 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.037 1.335 . . . . 72.25 111.903 -163.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.402 ' HB2' ' NE2' ' A' ' 96' ' ' HIS . 5.2 p-10 -69.95 -32.63 70.98 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.98 -1.009 . . . . 61.01 111.29 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.485 ' HA ' ' HB2' ' A' ' 138' ' ' MET . . . -67.65 -33.76 75.6 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.086 0.954 . . . . 52.1 111.935 -175.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 132' ' ' ASN . 77.5 mt -64.35 -38.69 91.92 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.362 0.665 . . . . 74.33 110.272 177.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -75.12 -33.56 61.6 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.409 -0.814 . . . . 64.54 110.597 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.485 ' HB2' ' HA ' ' A' ' 135' ' ' ALA . 7.6 mmt -66.83 -25.9 66.66 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.164 0.986 . . . . 62.03 112.008 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -64.49 -27.74 69.18 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.422 0.689 . . . . 74.55 111.303 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -95.06 -34.87 12.15 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.831 0.452 . . . . 75.21 110.359 172.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.454 HD23 ' SD ' ' A' ' 138' ' ' MET . 11.7 tp -64.91 -46.23 82.58 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.189 0.996 . . . . 73.32 110.948 -170.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.86 -0.28 0.82 Allowed 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.1 -0.5 . . . . 74.42 111.356 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 64.73 100.51 0.04 OUTLIER 'General case' 0 C--N 1.36 1.025 0 C-N-CA 124.541 1.136 . . . . 72.32 111.531 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -75.23 129.21 37.08 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 110.072 -0.344 . . . . 75.23 110.072 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.2 -17.96 38.18 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.364 0.666 . . . . 71.13 110.771 172.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 84.24 176.93 51.26 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 115.497 -0.774 . . . . 42.43 112.094 -173.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -155.68 96.38 1.75 Allowed 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.232 -1.025 . . . . 53.2 108.232 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -178.06 163.37 31.5 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.17 -0.923 . . . . 62.02 112.98 -176.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.5 p -93.08 165.36 12.88 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.933 0.893 . . . . 65.14 109.962 175.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.44 ' O ' ' HA2' ' C' ' 88' ' ' GLY . 33.0 tt0 -81.17 -59.48 2.63 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.275 -0.639 . . . . 64.32 109.275 172.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.42 ' HB3' HE21 ' A' ' 153' ' ' GLN . 49.1 mm-40 54.5 170.03 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.217 1.407 . . . . 43.31 114.426 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -149.58 100.71 3.02 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 113.623 -1.626 . . . . 72.23 106.675 171.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.42 HE21 ' HB3' ' A' ' 151' ' ' GLU . 33.5 mm-40 -83.64 66.7 9.13 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.778 0.431 . . . . 72.5 110.274 -177.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -71.73 78.92 0.84 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.751 -0.833 . . . . 71.13 108.751 174.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.966 0 C-N-CA 124.173 0.989 . . . . 72.31 108.613 -177.026 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.737 0.303 . . . . 63.22 110.786 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 28.6 p -104.03 121.24 42.77 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.759 0.824 . . . . 54.44 109.357 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.43 -169.48 1.85 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.761 0.824 . . . . 64.41 110.727 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -72.49 115.17 11.43 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.469 0.708 . . . . 74.0 110.94 -176.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 10.9 t30 174.07 121.18 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.974 1.709 . . . . 75.45 108.444 168.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -154.26 134.52 13.29 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.255 0.622 . . . . 60.12 109.819 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 13.1 t -61.63 172.79 1.13 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.429 1.092 . . . . 52.12 112.18 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' B' ' 9' ' ' MET . 42.4 tt0 79.6 -59.66 0.35 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.686 1.594 . . . . 73.34 110.437 -174.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.507 ' HB3' HG13 ' B' ' 89' ' ' ILE . 4.2 ppp? 57.5 178.97 0.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 126.293 1.837 . . . . 63.22 113.218 176.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 93.8 m -133.57 113.59 12.61 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.134 0.574 . . . . 64.31 109.504 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -123.61 143.68 50.08 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.102 0.961 . . . . 75.45 109.342 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -162.88 141.43 8.48 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.38 0.672 . . . . 73.54 110.268 169.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.513 HD13 HD11 ' B' ' 16' ' ' ILE . 49.2 mt -68.68 129.39 33.23 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 109.014 -0.735 . . . . 75.12 109.014 171.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -97.95 -42.27 7.61 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.209 0.604 . . . . 64.32 109.537 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.57 HH21 HG23 ' A' ' 122' ' ' THR . 21.7 ttt85 -168.48 144.89 3.77 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.79 -0.641 . . . . 54.03 109.457 -174.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.513 HD11 HD13 ' B' ' 13' ' ' ILE . 96.4 mt -128.73 144.65 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 107.56 -1.274 . . . . 74.44 107.56 175.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -171.12 156.03 4.62 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.182 0.515 . . . . 65.11 111.462 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 95.2 m -85.2 126.28 33.53 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.634 -0.712 . . . . 55.42 109.244 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.455 ' HZ1' ' HB3' ' A' ' 28' ' ' ALA . 33.4 mttp -86.49 -48.36 8.47 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.27 0.628 . . . . 71.33 110.61 172.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -144.96 136.91 25.74 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 110.115 -0.328 . . . . 74.32 110.115 -165.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 44.7 mm -131.69 142.41 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.389 1.076 . . . . 74.13 109.309 176.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.687 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 69.3 m -138.84 136.67 35.85 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.83 1.252 . . . . 60.21 108.439 177.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' B' ' 75' ' ' LEU . 75.7 t80 -149.91 107.46 3.65 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 107.858 -1.164 . . . . 54.23 107.858 165.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -121.79 112.12 17.97 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.096 0.959 . . . . 74.24 108.945 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.484 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -113.53 87.6 12.0 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.688 1.195 . . . . 64.11 108.231 174.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.9 -41.93 12.72 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.867 2.378 . . . . 71.03 111.837 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.464 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 2.5 m-20 -90.87 3.49 54.36 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.874 -1.057 . . . . 72.32 111.345 -175.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.484 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -37.06 -60.51 0.8 Allowed Pre-proline 0 N--CA 1.49 1.552 0 C-N-CA 125.668 1.587 . . . . 71.34 114.973 -164.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.7 -31.63 58.55 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 122.474 2.116 . . . . 53.32 113.278 -173.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -88.62 -38.08 15.12 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.06 0.544 . . . . 71.44 111.103 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.695 HG22 HD12 ' B' ' 68' ' ' LEU . 8.9 p -69.5 -19.15 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 123.339 0.656 . . . . 75.14 111.486 -174.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -58.74 -20.66 51.24 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 113.372 0.879 . . . . 72.21 113.372 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.48 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.1 pt20 -59.82 -31.97 70.21 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.462 0.705 . . . . 72.44 111.33 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.48 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 99.8 mttt -87.91 95.95 10.3 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.878 0.871 . . . . 64.3 109.944 -176.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -91.07 87.52 6.61 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.783 -0.644 . . . . 65.21 110.597 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -163.17 -179.22 6.5 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.886 0.874 . . . . 74.23 109.726 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -77.81 108.36 7.18 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.589 0.755 . . . . 73.12 109.812 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.4 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 37.7 Cg_endo -64.77 142.1 74.91 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.433 2.089 . . . . 70.51 113.109 -176.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -68.79 119.95 13.97 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.77 0.828 . . . . 73.31 109.395 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.462 HG21 HG12 ' F' ' 6' ' ' ILE . 24.4 m -106.98 161.31 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 123.727 0.811 . . . . 72.13 112.173 -169.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.523 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 55.9 tttm -135.5 109.66 8.31 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.387 1.075 . . . . 72.53 108.794 175.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.425 HD21 HD13 ' F' ' 6' ' ' ILE . 5.3 mp -90.15 138.06 31.83 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.015 -0.735 . . . . 73.21 109.015 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.559 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 7.2 t70 -149.79 158.26 43.99 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 107.838 -1.171 . . . . 62.02 107.838 -176.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.4 ' HB2' HD11 ' B' ' 60' ' ' LEU . 2.4 pt? -140.52 158.97 43.2 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.034 0.445 . . . . 54.35 110.478 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 28.9 t70 -146.86 155.58 42.44 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.881 0.872 . . . . 73.3 108.903 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 58.6 m -108.45 137.35 46.57 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.699 0.8 . . . . 72.44 110.854 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.675 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -142.8 146.31 34.09 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.739 -1.208 . . . . 52.42 107.739 166.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.4 p -142.74 168.63 19.27 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.23 0.612 . . . . 62.43 109.935 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . 0.573 ' HB2' ' HB3' ' B' ' 57' ' ' GLU . 2.3 m -150.65 151.93 33.23 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.149 -1.056 . . . . 74.1 108.149 170.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -115.57 106.59 14.1 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.23 -1.396 . . . . 73.2 107.23 168.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' B' ' 57' ' ' GLU . 21.1 mt -87.53 -38.12 16.3 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.477 0.711 . . . . 64.24 109.771 -173.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.8 -171.24 3.59 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.521 -1.218 . . . . 72.14 109.416 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -69.59 125.59 27.17 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.091 -0.959 . . . . 72.4 108.445 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 68.92 -2.09 1.86 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.771 1.229 . . . . 73.25 112.811 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 88.9 t -107.1 105.25 18.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 108.818 -0.808 . . . . 63.34 108.818 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.584 ' HB2' HD11 ' B' ' 86' ' ' ILE . 1.2 m-85 -116.36 141.65 47.88 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.524 1.129 . . . . 74.31 108.902 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.573 ' HB3' ' HB2' ' B' ' 49' ' ' SER . 6.7 tm-20 -113.8 97.0 6.14 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.39 -1.337 . . . . 74.45 107.39 -176.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 46.4 t -92.32 128.09 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.964 0.905 . . . . 64.22 109.765 -174.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.675 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 17.6 t -120.64 118.18 55.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 C-N-CA 124.105 0.962 . . . . 74.42 108.761 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.424 ' HB2' ' HB3' ' B' ' 103' ' ' PRO . 43.9 tp -102.88 127.63 50.0 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.986 -0.746 . . . . 65.23 108.986 170.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.445 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 12.7 ttm180 -86.25 135.91 33.38 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.876 -0.787 . . . . 71.02 108.876 169.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.451 ' CG1' HD11 ' B' ' 114' ' ' ILE . 93.9 t -122.32 103.48 13.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 106.958 -1.497 . . . . 71.34 106.958 175.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 52.9 m -95.43 135.99 36.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.918 0.887 . . . . 72.03 108.74 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.599 HG21 HG21 ' B' ' 114' ' ' ILE . 98.3 t -132.44 117.65 32.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.854 -1.165 . . . . 74.43 107.854 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 32.2 m -105.53 149.97 25.77 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.89 -1.152 . . . . 54.22 107.89 170.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.79 145.12 29.81 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.09 -0.707 . . . . 45.23 109.09 176.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.501 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 54.3 p -150.39 128.45 11.88 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 123.865 0.728 . . . . 71.31 110.517 -176.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.695 HD12 HG22 ' B' ' 31' ' ' VAL . 71.1 mt -93.51 98.25 11.06 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 107.281 -1.377 . . . . 54.2 107.281 172.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.97 -129.02 12.41 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 114.91 -1.041 . . . . 74.44 113.568 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -86.72 4.05 42.32 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.469 0.708 . . . . 72.43 112.063 -173.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.464 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 13.2 pt-20 -129.63 152.91 48.63 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.927 0.491 . . . . 75.15 110.213 -177.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 85.6 m -72.33 132.87 44.58 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.327 0.651 . . . . 75.23 110.277 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.536 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -86.44 -62.73 1.45 Allowed 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.851 -1.166 . . . . 53.14 107.851 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -156.01 160.73 40.29 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 115.141 -0.936 . . . . 74.24 111.783 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 23.2 mt -124.74 114.75 19.69 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 106.321 -1.733 . . . . 64.21 106.321 174.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.464 ' SG ' HG23 ' B' ' 114' ' ' ILE . 35.2 t -119.41 146.18 45.59 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.876 -0.787 . . . . 72.22 108.876 175.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.687 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 42.9 tt0 -158.45 134.61 9.22 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.345 -0.613 . . . . 72.4 109.345 -175.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 91.5 t -129.75 142.81 42.92 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 C-N-CA 123.726 0.81 . . . . 71.11 109.107 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -124.28 96.97 5.12 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 107.651 -1.24 . . . . 71.44 107.651 172.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -89.32 107.67 19.19 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.198 -1.038 . . . . 73.55 108.198 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.99 143.56 17.12 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.187 -0.765 . . . . 74.33 111.187 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.8 126.9 2.47 Favored Glycine 0 CA--C 1.51 -0.273 0 N-CA-C 112.04 -0.424 . . . . 60.14 112.04 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 38.9 mt -85.92 128.19 39.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.37 -0.974 . . . . 71.31 108.37 173.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -137.46 147.94 45.69 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.242 0.617 . . . . 73.32 110.039 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 62.8 m -97.41 125.6 42.14 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.118 -0.697 . . . . 70.21 109.118 170.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.584 HD11 ' HB2' ' B' ' 56' ' ' TYR . 1.8 pt -138.26 118.13 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 125.049 1.34 . . . . 72.13 108.993 -174.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' B' ' 9' ' ' MET . . . -152.25 168.04 26.65 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.237 0.615 . . . . 73.51 111.055 -173.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.27 -71.0 1.43 Allowed Glycine 0 C--N 1.348 1.225 0 O-C-N 123.496 0.497 . . . . 64.22 112.673 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.685 HG22 ' HB2' ' B' ' 94' ' ' MET . 10.7 mt -75.02 157.61 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.716 0.807 . . . . 74.41 110.651 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.598 ' HG2' ' H ' ' B' ' 91' ' ' GLY . 11.7 tt0 -151.96 -176.48 5.66 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.93 0.892 . . . . 73.21 108.667 173.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.598 ' H ' ' HG2' ' B' ' 90' ' ' GLU . . . 75.51 -136.27 19.81 Favored Glycine 0 C--N 1.345 1.053 0 C-N-CA 123.139 0.399 . . . . 52.33 113.187 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 44.0 m -70.17 -41.64 73.53 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.569 0.748 . . . . 70.02 111.352 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -60.14 -35.53 75.5 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.941 -1.027 . . . . 61.14 111.052 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.685 ' HB2' HG22 ' B' ' 89' ' ' ILE . 9.9 tmm? -85.14 -31.26 23.38 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.129 0.971 . . . . 74.15 111.52 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.61 -27.58 67.86 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.4 0.619 . . . . 72.42 110.324 170.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.43 ' HA ' HD22 ' F' ' 14' ' ' LEU . 18.7 t-80 -79.64 -29.33 40.93 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.111 1.365 . . . . 53.22 111.646 173.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -63.22 -51.71 65.16 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.873 0.469 . . . . 65.32 111.746 -175.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.498 HD23 HG22 ' F' ' 18' ' ' VAL . 1.6 pp -89.62 -13.33 37.37 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 117.853 0.297 . . . . 54.42 110.99 171.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.95 3.12 85.94 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-O 119.479 -0.623 . . . . 73.0 114.099 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.69 -54.92 0.09 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.231 0.612 . . . . 62.34 110.724 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -72.88 -49.72 28.2 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.366 0.876 . . . . 73.03 113.366 -165.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.484 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 62.7 m -59.7 -47.81 96.7 Favored Pre-proline 0 CA--C 1.565 1.526 0 CA-C-O 119.189 -0.434 . . . . 44.13 111.907 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 23.9 Cg_exo -67.14 -24.97 43.95 Favored 'Trans proline' 0 C--N 1.393 2.879 0 C-N-CA 122.263 1.975 . . . . 71.53 113.599 173.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -63.96 -37.5 87.65 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.365 0.666 . . . . 75.35 110.213 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.413 HG23 ' NH2' ' D' ' 111' ' ' ARG . 68.4 mt -65.54 -39.12 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 115.671 -0.695 . . . . 72.55 110.485 175.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.24 -17.26 52.76 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.24 -0.891 . . . . 62.12 111.735 -175.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -58.99 -49.51 92.98 Favored Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 124.789 1.236 . . . . 73.32 113.556 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -60.79 -39.4 62.92 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 122.262 1.974 . . . . 71.43 113.019 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -64.38 -33.73 76.54 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.487 -0.779 . . . . 71.11 110.491 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.494 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -72.35 -42.16 65.64 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 115.857 -0.611 . . . . 62.23 110.341 174.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -53.36 -55.52 24.21 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.218 1.007 . . . . 71.42 111.527 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.419 ' HG3' ' NH2' ' C' ' 120' ' ' ARG . 2.1 tm-20 -64.03 -34.77 78.76 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.802 0.689 . . . . 44.35 110.106 -177.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.512 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.2 t -73.5 -27.59 61.45 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.734 0.414 . . . . 72.53 111.7 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.599 HG21 HG21 ' B' ' 64' ' ' VAL . 73.0 mt -71.11 -58.62 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 108.578 -0.897 . . . . 74.54 108.578 173.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 4.8 m -65.0 -23.08 67.11 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.906 -1.043 . . . . 73.24 111.441 -173.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 37.7 t -61.52 -49.87 74.96 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.302 0.641 . . . . 73.42 109.454 171.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.2 mmt -71.53 -34.14 69.78 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.415 0.686 . . . . 73.32 110.82 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 114' ' ' ILE . 87.5 t -59.76 -46.1 93.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.709 0.804 . . . . 61.43 109.85 172.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -64.56 -36.67 84.98 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.724 -1.125 . . . . 71.23 110.834 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.483 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 93.5 mtt-85 -65.46 -32.84 74.67 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.247 0.619 . . . . 74.11 110.125 177.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.64 8.71 70.97 Favored Glycine 0 C--N 1.353 1.495 0 O-C-N 123.639 0.587 . . . . 71.33 113.146 174.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.49 HG23 ' HB3' ' A' ' 17' ' ' TYR . 75.7 p 57.47 26.92 13.23 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 126.235 1.814 . . . . 42.34 113.5 177.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -88.08 158.21 50.1 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 123.519 0.728 . . . . 64.35 111.02 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -58.04 157.63 24.32 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 123.403 2.735 . . . . 73.32 114.338 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.591 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -65.33 123.19 18.95 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.482 -1.235 . . . . 64.33 112.186 -177.231 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.539 HD11 HD11 ' F' ' 6' ' ' ILE . 2.3 tm? -138.43 115.3 10.78 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 108.388 -0.967 . . . . 71.44 108.388 176.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -110.9 136.06 50.49 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.874 0.87 . . . . 74.22 109.819 176.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.417 HD12 ' H ' ' B' ' 129' ' ' ALA . 10.0 tp -86.78 135.52 33.33 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.334 0.653 . . . . 73.21 110.739 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.417 ' H ' HD12 ' B' ' 128' ' ' LEU . . . -68.05 147.0 98.42 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.733 1.213 . . . . 74.23 111.779 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.489 ' HG2' HD13 ' D' ' 16' ' ' ILE . 7.1 Cg_exo -70.06 104.16 1.32 Allowed 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.75 2.3 . . . . 72.04 111.994 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.403 HG11 ' H ' ' F' ' 8' ' ' LEU . 10.8 m -92.84 108.16 19.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 122.092 0.948 . . . . 64.41 109.601 173.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.54 83.89 3.87 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.949 -1.023 . . . . 75.04 108.423 172.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -52.67 -46.74 67.33 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.608 -0.723 . . . . 71.33 109.633 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -55.11 -41.87 72.2 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 113.411 -1.722 . . . . 64.34 112.458 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.1 -42.58 84.33 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 123.665 0.603 . . . . 72.23 110.755 -171.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.421 ' HB2' HD21 ' F' ' 10' ' ' LEU . 9.4 mp -74.31 -24.67 59.26 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.572 0.349 . . . . 74.32 111.38 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -69.56 -37.6 77.07 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 110.006 -0.368 . . . . 75.2 110.006 170.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 95.8 mmm -69.19 -35.9 76.73 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.314 0.645 . . . . 64.11 110.708 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -76.4 -21.52 55.92 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 116.127 -0.488 . . . . 74.11 110.999 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -69.07 -26.42 64.94 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.24 0.543 . . . . 75.14 109.718 172.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 51.4 mt -94.54 34.77 1.27 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.906 0.883 . . . . 64.4 110.101 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.42 133.69 55.39 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.686 0.795 . . . . 74.12 110.506 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -116.25 144.52 44.11 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.027 0.931 . . . . 54.52 110.021 -176.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -76.86 146.31 37.8 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.213 1.005 . . . . 73.2 111.185 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.85 139.0 32.21 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.077 0.551 . . . . 73.11 110.596 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.61 75.22 0.36 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 111.866 -0.494 . . . . 65.14 111.866 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -101.88 141.26 35.0 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.568 0.747 . . . . 52.53 110.196 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -158.84 140.07 6.66 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 116.293 -0.412 . . . . 53.13 112.24 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 11.5 t -156.86 148.46 22.47 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.371 0.669 . . . . 65.41 110.054 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -121.66 121.82 38.2 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.471 0.708 . . . . 52.01 110.506 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -110.19 122.91 48.75 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.267 1.027 . . . . 71.43 108.363 168.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -149.63 116.45 5.92 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.734 0.414 . . . . 63.23 110.771 -175.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -112.92 142.08 46.0 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.243 -1.021 . . . . 75.23 108.243 169.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -106.17 162.88 13.25 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.152 0.581 . . . . 71.11 110.16 176.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 C-N-CA 124.132 0.973 . . . . 62.44 108.759 178.378 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tpt . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 110.441 -0.207 . . . . 64.21 110.441 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 49.8 m 57.84 -153.31 0.38 Allowed 'General case' 0 N--CA 1.483 1.192 0 O-C-N 124.002 0.814 . . . . 73.25 110.641 -174.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . 0.454 ' HG2' ' H ' ' C' ' 4' ' ' GLN . 19.5 tt0 61.97 -146.12 0.41 Allowed 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 118.444 -0.789 . . . . 74.25 108.953 175.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . 0.512 ' HA ' HE21 ' C' ' 4' ' ' GLN . 0.0 OUTLIER 72.24 -65.91 0.33 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.897 1.279 . . . . 73.0 111.702 171.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -75.5 89.92 2.71 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.689 0.757 . . . . 61.23 110.397 176.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -109.16 4.0 22.46 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 114.81 -1.086 . . . . 73.13 108.527 166.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 31.8 m -73.52 -59.41 2.73 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 124.088 0.955 . . . . 75.53 111.031 -171.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.06 117.88 6.66 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.844 -0.799 . . . . 70.34 108.844 -176.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.401 ' SD ' ' N ' ' C' ' 10' ' ' THR . 0.0 OUTLIER 64.49 142.6 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 125.331 1.452 . . . . 74.13 112.26 177.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.732 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 40.5 m -129.1 109.88 11.56 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.991 -0.744 . . . . 61.4 108.991 174.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.533 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.6 t80 -124.58 134.03 53.09 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.412 0.685 . . . . 63.11 110.276 -176.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -150.85 131.17 13.66 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.536 0.735 . . . . 63.21 109.384 171.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 78.9 mt -74.99 124.06 31.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 108.445 -0.946 . . . . 70.14 108.445 172.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.44 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 81.9 mm-40 -93.74 -39.53 10.71 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.301 0.64 . . . . 71.31 110.915 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -177.19 127.01 0.15 Allowed 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.228 0.33 . . . . 71.35 110.714 -175.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 84.1 mt -114.69 133.42 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.51 0.724 . . . . 74.23 109.473 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.514 ' HE2' ' HD3' ' C' ' 19' ' ' LYS . 23.6 p90 -170.54 172.43 5.95 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-O 121.43 0.633 . . . . 74.21 110.53 -171.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.8 p -97.08 121.65 39.2 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.417 -0.811 . . . . 72.31 109.1 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.514 ' HD3' ' HE2' ' C' ' 17' ' ' TYR . 29.9 mmtp -68.98 -46.69 67.44 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.35 1.072 . . . . 74.05 108.186 167.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 13.1 t70 -141.76 138.36 32.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 112.989 -1.914 . . . . 72.43 109.041 -167.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.563 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.2 mt -134.38 152.59 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 107.258 -1.386 . . . . 61.3 107.258 174.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -160.4 152.87 20.78 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.395 0.617 . . . . 71.11 110.843 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -149.01 135.43 19.39 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.572 -1.27 . . . . 65.04 107.572 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -140.82 110.38 6.36 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.743 0.817 . . . . 75.44 109.313 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.54 85.67 56.04 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 105.371 -2.085 . . . . 64.44 105.371 165.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.82 -17.99 41.75 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 122.866 2.378 . . . . 74.45 112.397 -175.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -112.88 19.27 17.47 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.956 1.302 . . . . 74.25 110.289 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.02 -56.88 6.89 Favored Pre-proline 0 N--CA 1.489 1.475 0 N-CA-C 114.297 1.221 . . . . 62.01 114.297 -170.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.456 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 38.0 Cg_endo -62.02 -35.72 74.95 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.103 1.869 . . . . 75.22 112.582 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -68.34 -50.57 52.35 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.171 0.588 . . . . 74.11 110.972 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.704 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.0 p -69.46 -23.65 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 N-CA-C 112.772 0.656 . . . . 74.2 112.772 -169.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -62.74 -33.16 74.56 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.52 0.563 . . . . 71.25 112.52 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -88.36 15.68 7.43 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.759 0.424 . . . . 63.0 112.099 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.726 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -95.56 158.68 15.35 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.915 0.886 . . . . 72.35 109.993 175.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -70.18 129.5 39.56 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 109.047 -0.723 . . . . 75.52 109.047 170.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 55.6 t-105 -78.44 80.41 4.83 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.429 0.692 . . . . 72.44 110.44 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -129.14 74.05 81.34 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 108.279 -1.008 . . . . 75.42 108.279 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -95.92 176.51 0.79 Allowed 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.068 2.512 . . . . 75.04 112.688 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' C' ' 67' ' ' SER . 0.9 OUTLIER -117.82 120.2 37.21 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.417 -1.698 . . . . 75.24 106.417 169.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.68 97.42 5.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.257 -1.016 . . . . 75.42 108.257 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.506 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 10.1 tmtt? -91.6 108.67 20.07 Favored 'General case' 0 CA--C 1.527 0.081 0 N-CA-C 106.851 -1.537 . . . . 63.34 106.851 175.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.487 HD11 ' HB ' ' G' ' 6' ' ' ILE . 4.4 mp -86.53 136.38 33.1 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.695 -0.854 . . . . 74.51 108.695 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.58 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 23.4 t70 -123.04 137.95 54.81 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 124.993 1.317 . . . . 72.23 107.948 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.53 HD21 HD11 ' C' ' 60' ' ' LEU . 6.1 tt -135.48 139.9 44.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.585 -1.265 . . . . 73.4 107.585 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.499 ' N ' HD23 ' C' ' 44' ' ' LEU . 29.9 t70 -143.41 152.64 41.8 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.523 0.729 . . . . 61.23 109.36 170.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 72.4 p -115.48 112.28 22.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.84 0.856 . . . . 75.11 109.486 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.91 157.18 20.96 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.662 -0.866 . . . . 61.2 108.662 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 31.4 p -164.86 169.63 16.36 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.449 0.537 . . . . 64.34 112.449 -170.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 41.9 t -170.12 129.31 0.91 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.232 1.013 . . . . 61.35 109.345 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -77.67 115.5 17.47 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.597 -1.26 . . . . 70.45 107.597 166.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.685 HD11 HD12 ' C' ' 83' ' ' ILE . 62.9 mt -89.48 -36.3 15.48 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.175 0.59 . . . . 74.11 110.805 -175.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.33 -168.68 0.84 Allowed 'General case' 0 CA--C 1.54 0.585 0 O-C-N 124.139 0.9 . . . . 54.3 111.15 -174.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -66.53 114.12 5.26 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.671 1.188 . . . . 74.21 110.084 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 65.82 -3.03 0.79 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 125.234 1.413 . . . . 72.34 113.227 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.418 HG12 ' HB2' ' C' ' 51' ' ' LEU . 78.9 t -98.7 107.17 19.95 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.429 -0.952 . . . . 55.01 108.429 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.443 ' HB3' HD13 ' C' ' 86' ' ' ILE . 49.2 t80 -122.12 137.12 54.94 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.809 -0.632 . . . . 72.23 110.064 -176.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -94.65 119.53 33.44 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.117 0.967 . . . . 75.11 109.735 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.09 117.5 55.17 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.137 -1.06 . . . . 75.14 108.137 174.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.07 136.04 56.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 108.366 -0.976 . . . . 72.01 108.366 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.53 HD11 HD21 ' C' ' 44' ' ' LEU . 16.2 tp -121.58 114.26 20.94 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 109.189 -0.671 . . . . 61.54 109.189 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 13.3 ttm180 -82.08 108.46 15.57 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.626 -0.879 . . . . 75.25 108.626 172.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 22.2 t -103.93 123.28 57.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.093 -1.447 . . . . 72.45 107.093 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.58 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 86.0 m -136.92 119.56 16.05 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 123.194 0.598 . . . . 61.22 109.448 -173.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 54.3 t -103.95 113.47 40.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 123.608 0.763 . . . . 63.21 109.135 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 4.9 m -99.4 134.94 41.53 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.674 -1.232 . . . . 74.45 107.674 171.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.01 120.28 25.74 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.791 -1.559 . . . . 71.33 106.791 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 57.0 m -135.52 130.37 34.49 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.081 0.467 . . . . 75.23 110.938 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.726 HD13 ' HG2' ' C' ' 34' ' ' LYS . 8.6 mt -84.67 46.62 1.27 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.93 1.292 . . . . 71.44 109.246 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.41 -119.72 6.48 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 109.46 -1.456 . . . . 62.12 109.46 -165.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -91.17 -19.49 23.01 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.235 0.614 . . . . 74.31 110.198 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -70.62 84.67 0.63 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.747 0.819 . . . . 63.14 108.962 174.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 62.4 m -62.42 121.6 13.65 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 110.291 -0.263 . . . . 74.21 110.291 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.704 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -67.92 -61.76 1.72 Allowed 'General case' 0 C--O 1.235 0.342 0 O-C-N 124.069 0.856 . . . . 54.14 108.739 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -155.06 172.76 17.59 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-O 122.211 1.005 . . . . 71.03 111.196 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.42 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.3 tm? -130.74 144.21 51.28 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 105.043 -2.206 . . . . 61.33 105.043 169.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.438 ' SG ' HG23 ' C' ' 114' ' ' ILE . 51.2 t -151.52 135.31 16.4 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.649 -0.871 . . . . 63.34 108.649 177.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -139.66 138.79 36.38 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.081 0.552 . . . . 74.41 109.928 -174.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.403 HG21 ' HB3' ' C' ' 113' ' ' CYS . 48.2 t -141.91 113.46 3.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.959 -1.126 . . . . 72.1 107.959 176.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -91.07 88.31 6.93 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.235 -1.024 . . . . 72.41 108.235 172.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -78.76 101.15 7.43 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.007 -0.997 . . . . 73.34 108.996 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.25 143.4 17.99 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 111.614 -0.594 . . . . 43.21 111.614 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.56 116.47 0.99 Allowed Glycine 0 CA--C 1.499 -0.949 0 N-CA-C 109.968 -1.253 . . . . 72.23 109.968 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.685 HD12 HD11 ' C' ' 51' ' ' LEU . 12.6 mm -81.63 120.44 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.736 -1.209 . . . . 74.22 107.736 177.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.533 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 54.7 m-85 -130.9 134.74 47.05 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.453 -0.943 . . . . 61.44 108.453 -177.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 49.3 m -80.24 117.42 21.0 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.949 -0.76 . . . . 64.21 108.949 170.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.443 HD13 ' HB3' ' C' ' 56' ' ' TYR . 4.1 mp -115.43 118.07 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.051 -1.092 . . . . 73.23 108.051 173.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.732 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -140.03 162.77 34.42 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.745 0.818 . . . . 74.34 109.86 176.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 150' ' ' GLU . . . 89.12 -63.24 3.47 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.335 -0.848 . . . . 41.42 112.496 176.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 28.5 pt -90.03 145.86 6.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-O 120.876 0.37 . . . . 60.13 110.675 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -146.32 150.47 35.8 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.319 -0.855 . . . . 65.22 109.088 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.49 -135.89 13.02 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-O 119.721 -0.488 . . . . 41.31 112.262 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 15.5 m -67.24 -35.11 78.87 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.819 0.848 . . . . 53.11 111.412 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -56.72 -48.66 77.26 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.728 1.211 . . . . 44.43 109.682 176.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.574 ' HE1' ' HA ' ' G' ' 17' ' ' PRO . 2.7 ttp -66.62 -43.83 83.71 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 113.305 -1.77 . . . . 71.44 110.998 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.21 69.82 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.719 0.808 . . . . 55.31 111.68 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -67.09 -41.89 85.55 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.754 0.822 . . . . 73.2 110.621 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 30.1 t -63.95 -53.16 54.66 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.832 -0.622 . . . . 72.13 109.86 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.729 HD11 HG23 ' G' ' 18' ' ' VAL . 80.3 mt -70.14 -28.54 65.44 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.828 0.851 . . . . 72.43 112.695 -175.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.43 12.76 33.29 Favored Glycine 0 N--CA 1.475 1.27 0 N-CA-C 114.322 0.489 . . . . 71.24 114.322 -167.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' C' ' 133' ' ' PHE . . . -155.89 -60.08 0.1 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.787 0.803 . . . . 64.22 110.8 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.404 ' CE2' ' CE1' ' C' ' 11' ' ' PHE . 53.5 t80 -75.28 -38.2 60.54 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-N 113.607 -1.633 . . . . 74.44 112.324 -170.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 79.0 m -83.14 -43.8 0.86 Allowed Pre-proline 0 CA--C 1.565 1.528 0 C-N-CA 123.883 0.873 . . . . 61.31 112.699 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.417 ' HB3' HD13 ' C' ' 60' ' ' LEU . 32.7 Cg_exo -64.86 -20.94 64.7 Favored 'Trans proline' 0 C--N 1.394 2.938 0 C-N-CA 122.325 2.016 . . . . 74.11 112.312 173.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -67.5 -33.83 75.89 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.661 0.784 . . . . 75.01 110.512 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.528 HD12 ' NH1' ' A' ' 111' ' ' ARG . 44.0 mm -65.19 -35.56 75.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-N 115.67 -0.696 . . . . 62.24 109.752 174.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 82.7 mt -89.62 -22.35 22.36 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.201 1.001 . . . . 51.42 112.449 -174.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -54.92 -51.13 81.94 Favored Pre-proline 0 CA--C 1.559 1.297 0 N-CA-C 113.299 0.852 . . . . 74.43 113.299 -174.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -64.23 -34.45 56.28 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.083 1.855 . . . . 34.53 112.871 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -66.32 -44.81 82.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.185 0.594 . . . . 64.12 110.854 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.17 -38.6 88.46 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.527 -0.761 . . . . 73.34 110.661 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -57.64 -53.82 53.84 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.454 1.101 . . . . 72.31 110.594 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.27 -32.58 74.08 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.59 0.556 . . . . 52.42 110.463 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.403 ' HB3' HG21 ' C' ' 78' ' ' VAL . 8.0 t -73.1 -33.12 65.39 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 122.939 0.495 . . . . 74.43 111.257 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.438 HG23 ' SG ' ' C' ' 76' ' ' CYS . 57.3 mt -71.57 -52.88 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.039 0.536 . . . . 64.13 109.758 174.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.4 m -65.98 -27.05 67.85 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.424 0.689 . . . . 75.31 111.009 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -62.6 -49.4 75.36 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 109.279 -0.637 . . . . 53.42 109.279 169.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.679 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.8 -36.4 81.01 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.208 1.003 . . . . 71.2 112.546 178.222 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.1 -44.35 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.407 0.683 . . . . 72.12 109.343 173.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.457 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 22.7 t -73.27 -25.06 60.54 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.121 -0.945 . . . . 65.3 111.565 -177.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.419 ' NH2' ' HG3' ' B' ' 112' ' ' GLU . 78.3 mtt-85 -75.02 -41.66 58.87 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.567 0.747 . . . . 71.34 108.995 176.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.12 1.6 68.93 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 124.254 0.971 . . . . 61.2 112.364 172.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 22.3 p 60.96 29.84 19.26 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.632 1.973 . . . . 54.44 113.523 170.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -83.65 148.44 54.83 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 123.457 0.703 . . . . 63.12 110.193 173.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -52.83 139.35 59.72 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.351 2.701 . . . . 73.22 113.341 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.419 HE21 ' NE2' ' B' ' 125' ' ' GLN . 73.1 mm-40 -56.88 112.95 1.47 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.615 1.166 . . . . 53.24 112.353 -175.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.38 100.9 7.58 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.291 -1.744 . . . . 71.53 106.291 174.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -99.09 131.4 45.16 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.284 0.634 . . . . 65.32 110.318 -172.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.94 142.04 38.62 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.542 0.737 . . . . 73.14 110.041 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.704 ' HB2' ' HB ' ' G' ' 5' ' ' THR . . . -75.46 162.05 74.15 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.055 0.942 . . . . 72.2 111.58 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.33 109.34 0.97 Allowed 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.385 2.057 . . . . 55.3 111.972 173.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.666 HG11 ' HB2' ' G' ' 8' ' ' LEU . 21.6 t -98.24 106.85 19.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 108.006 -1.109 . . . . 74.44 108.006 174.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -101.81 91.6 4.46 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.725 -1.583 . . . . 72.44 106.725 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.487 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 45.8 m-85 -58.09 -37.79 75.18 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.597 0.713 . . . . 73.33 109.534 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -67.01 -30.76 70.95 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 113.789 -1.55 . . . . 72.23 111.059 -177.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.68 -23.23 64.37 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.369 0.667 . . . . 31.1 111.459 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 8.5 mp -80.22 -26.66 39.01 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.999 0.52 . . . . 40.35 110.37 173.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -78.52 -28.05 46.12 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.754 0.422 . . . . 73.15 110.523 172.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 67.1 mtt -77.01 -30.34 55.83 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.827 0.851 . . . . 75.23 110.04 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -66.71 -38.53 86.91 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.139 0.976 . . . . 63.3 109.665 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -68.2 -84.11 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 115.16 -0.927 . . . . 75.42 108.765 172.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 19.5 tp 63.89 -175.07 0.16 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.227 1.011 . . . . 72.5 110.844 172.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.409 HE22 ' HB3' ' C' ' 144' ' ' GLN . 0.1 OUTLIER -94.3 144.7 25.31 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 107.582 -1.266 . . . . 73.03 107.582 169.332 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.39 -53.44 44.87 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.221 1.008 . . . . 71.02 111.373 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.409 ' HB3' HE22 ' C' ' 142' ' ' GLN . 63.9 tt0 -74.74 95.27 2.85 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 109.407 -0.59 . . . . 63.52 109.407 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.27 131.25 6.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.583 1.153 . . . . 61.31 109.006 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.7 137.75 4.74 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 111.971 -0.452 . . . . 53.35 111.971 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -92.28 124.11 36.1 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.946 0.898 . . . . 73.13 110.261 -177.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -163.58 128.77 1.89 Allowed Glycine 0 C--N 1.345 1.034 0 N-CA-C 111.29 -0.724 . . . . 51.42 111.29 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 2.5 m -139.13 97.45 3.3 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.211 0.505 . . . . 64.22 109.74 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -86.96 -4.27 59.16 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.199 0.6 . . . . 73.14 110.662 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -82.17 133.16 35.25 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.824 -0.806 . . . . 64.14 108.824 168.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -137.54 149.09 46.47 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.826 0.45 . . . . 71.11 111.391 -171.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -155.8 126.35 6.8 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.109 0.964 . . . . 74.3 109.227 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -115.41 108.18 16.17 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.0 -0.741 . . . . 74.12 109.0 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 C-N-CA 123.702 0.801 . . . . 63.02 108.924 179.464 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 109.213 -0.662 . . . . 54.55 109.213 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 49.6 p 46.19 45.3 12.79 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.195 1.398 . . . . 73.43 111.412 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -70.93 132.53 45.35 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 114.522 -1.217 . . . . 64.15 111.822 -171.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . 0.585 ' HG3' ' HG3' ' D' ' 93' ' ' GLN . 42.4 tt0 -137.74 135.34 36.29 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.846 1.258 . . . . 73.11 108.848 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -79.88 74.8 6.61 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 107.848 -1.167 . . . . 74.54 107.848 174.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -88.44 70.51 9.02 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.97 0.89 . . . . 63.01 110.089 -172.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 13.1 t -162.41 166.96 24.4 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 113.904 -1.498 . . . . 45.2 108.769 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 59.04 -96.26 0.06 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 117.771 -1.109 . . . . 74.2 110.435 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 5.2 ppp? 22.16 171.96 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 118.766 2.876 . . . . 74.14 118.766 -174.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 55.7 m -140.73 142.06 34.84 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 120.91 -1.119 . . . . 73.13 109.926 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -159.04 113.88 2.47 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.203 -1.036 . . . . 74.02 108.203 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . 0.465 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 49.3 mt-30 -133.33 135.91 45.07 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.865 0.866 . . . . 54.31 108.895 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 16.6 mt -92.47 120.21 41.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 109.48 -0.563 . . . . 73.12 109.48 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -91.61 -47.21 7.52 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.284 0.365 . . . . 62.41 111.404 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -166.6 123.41 1.27 Allowed 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 111.434 0.161 . . . . 71.1 111.434 -168.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.489 HD13 ' HG2' ' B' ' 130' ' ' PRO . 1.7 mp -103.73 137.54 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 108.462 -0.94 . . . . 75.51 108.462 170.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.467 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 22.7 p90 -162.05 168.76 22.15 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 124.16 0.912 . . . . 70.22 110.861 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.1 p -96.98 122.66 40.21 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.405 -0.961 . . . . 74.11 108.405 171.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.467 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 34.4 mtpt -85.13 -40.17 17.06 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.986 -0.746 . . . . 74.42 108.986 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.515 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.8 t70 -140.62 141.26 35.13 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 113.978 -1.464 . . . . 71.04 108.99 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.679 HG21 ' HE2' ' C' ' 117' ' ' MET . 94.0 mt -135.44 147.75 28.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.695 1.198 . . . . 75.11 107.922 174.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -147.32 143.4 28.02 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.416 1.086 . . . . 74.42 108.523 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.563 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.9 t80 -149.47 132.24 15.99 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.577 -1.638 . . . . 70.13 106.577 171.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 46.5 mt-10 -135.68 151.16 49.92 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.716 -1.216 . . . . 62.42 107.716 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.66 91.59 5.27 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 108.332 -0.988 . . . . 62.55 108.332 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.78 -50.9 3.52 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.398 2.732 . . . . 53.53 113.551 -171.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.494 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 18.6 m-20 -99.86 14.1 31.54 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.832 0.853 . . . . 64.01 110.071 -171.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.484 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -28.48 -68.72 0.1 OUTLIER Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 126.826 2.05 . . . . 61.13 115.82 -163.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.29 -19.67 19.47 Favored 'Trans proline' 0 C--N 1.382 2.322 0 CA-C-N 123.162 2.165 . . . . 71.14 114.05 -173.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -79.11 -43.01 24.94 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.848 0.859 . . . . 74.5 109.944 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' D' ' 27' ' ' ASN . 10.0 p -75.01 -15.33 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-N 115.613 -0.721 . . . . 62.2 110.744 -172.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -70.56 -17.71 62.92 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 112.281 0.474 . . . . 72.13 112.281 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -64.36 -11.21 30.23 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.372 0.669 . . . . 74.3 110.879 173.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -105.55 97.17 7.04 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.014 1.726 . . . . 73.41 109.438 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -104.91 89.72 3.24 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.547 0.739 . . . . 71.34 109.329 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -162.43 171.88 16.43 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.141 0.976 . . . . 71.43 109.124 171.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.468 HE21 ' HD2' ' D' ' 38' ' ' PRO . 28.7 tp60 -63.56 110.75 4.03 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 123.26 0.624 . . . . 63.21 109.634 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.468 ' HD2' HE21 ' D' ' 37' ' ' GLN . 21.5 Cg_exo -64.73 143.92 82.16 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.629 2.219 . . . . 70.24 112.325 -176.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -71.48 116.02 11.33 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.442 0.697 . . . . 72.5 109.166 173.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.589 HG13 HG13 ' D' ' 64' ' ' VAL . 78.5 t -115.45 130.28 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.611 0.764 . . . . 74.41 110.963 -169.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.566 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 16.6 tptm -106.11 134.74 48.76 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.656 1.183 . . . . 74.25 108.579 173.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -110.17 114.81 28.6 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.611 0.764 . . . . 64.45 109.741 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.49 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 3.7 m-20 -108.87 113.64 26.72 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.993 0.917 . . . . 51.31 108.532 174.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.64 HD13 ' H ' ' H' ' 9' ' ' ALA . 8.7 mp -101.29 132.05 47.01 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.182 -0.673 . . . . 52.5 109.182 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 25.0 t70 -132.48 150.11 52.21 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.027 0.931 . . . . 73.44 108.749 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 52.2 m -105.83 144.04 33.13 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.07 0.948 . . . . 71.31 110.955 -171.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.433 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.65 161.38 39.89 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.86 1.264 . . . . 54.4 108.994 171.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.3 p -175.71 166.63 3.16 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.127 0.571 . . . . 42.25 111.349 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 80.3 p -161.96 143.3 10.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.528 0.731 . . . . 54.54 110.044 172.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -78.91 121.47 24.91 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.628 -0.878 . . . . 71.33 108.628 171.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 76.3 mt -99.84 -29.03 12.83 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.809 0.444 . . . . 71.42 111.318 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.26 -175.43 4.84 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.483 0.659 . . . . 74.5 111.135 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -62.62 122.49 15.97 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.1 -1.409 . . . . 43.13 109.479 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 60.09 16.29 5.82 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.786 0.834 . . . . 63.12 112.592 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 81.8 t -119.6 125.74 74.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 C-N-CA 123.806 0.843 . . . . 71.24 108.756 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -135.09 130.85 36.18 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.874 -0.603 . . . . 64.14 109.598 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -91.23 139.81 30.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.317 -0.856 . . . . 74.14 109.579 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 62.5 t -120.8 126.12 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 107.777 -1.194 . . . . 51.05 107.777 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 21.5 t -125.07 129.28 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.463 0.705 . . . . 75.54 109.363 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.569 HD23 HD12 ' D' ' 106' ' ' LEU . 3.6 mm? -121.7 120.58 35.1 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.031 0.532 . . . . 65.43 110.218 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 32.9 ttm-85 -87.93 102.98 15.24 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.152 -0.931 . . . . 70.14 108.978 172.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.6 t -91.6 126.3 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 107.72 -1.215 . . . . 75.11 107.72 169.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 8.5 m -121.02 131.76 54.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.474 -0.565 . . . . 35.44 109.474 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.589 HG13 HG13 ' D' ' 40' ' ' VAL . 35.3 t -116.4 102.35 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 124.73 1.212 . . . . 71.5 108.856 -173.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.566 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 9.4 m -94.04 91.68 6.97 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.947 -1.131 . . . . 75.21 107.947 173.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.87 150.0 20.91 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.59 -0.732 . . . . 64.04 109.405 -175.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.419 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 67.9 m -149.35 128.95 13.13 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.222 0.534 . . . . 55.11 112.294 -173.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 34.9 mt -110.73 134.55 52.38 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.048 1.339 . . . . 72.25 109.184 174.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.03 -111.85 3.68 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 112.203 -0.359 . . . . 74.45 112.203 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.81 4.47 8.79 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.733 0.813 . . . . 74.52 110.174 178.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -125.22 173.76 8.56 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.688 0.795 . . . . 51.42 110.065 -174.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 82.3 m -72.7 139.58 47.32 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.208 0.528 . . . . 61.24 110.558 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.459 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.7 -67.85 0.8 Allowed 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.012 0.925 . . . . 72.51 108.57 173.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -152.38 160.9 43.24 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.857 -0.611 . . . . 55.45 110.653 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.407 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 68.5 mt -122.84 110.95 16.08 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.739 -1.208 . . . . 72.44 107.739 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.478 ' SG ' HG23 ' D' ' 114' ' ' ILE . 46.0 t -123.73 115.09 20.83 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.124 0.57 . . . . 52.44 109.906 -173.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -130.83 122.83 27.79 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.534 0.734 . . . . 73.33 109.855 -171.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.14 119.21 48.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 C-N-CA 123.259 0.624 . . . . 71.34 109.676 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.4 mt-30 -89.65 87.8 7.16 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.214 -0.662 . . . . 72.44 109.214 170.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.21 109.89 15.1 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.742 -1.117 . . . . 63.12 108.826 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.3 143.83 16.92 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 111.524 -0.63 . . . . 72.55 111.524 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.92 134.41 6.57 Favored Glycine 0 CA--C 1.509 -0.287 0 N-CA-C 110.933 -0.867 . . . . 52.32 110.933 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 48.3 mt -89.0 121.96 39.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 108.251 -1.018 . . . . 74.44 108.251 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -131.13 127.8 38.83 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.202 0.314 . . . . 63.12 110.366 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.465 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 21.2 m -75.96 104.82 6.68 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.064 -0.717 . . . . 71.24 109.064 170.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.465 HD11 HD12 ' D' ' 89' ' ' ILE . 16.4 tt -126.6 133.23 69.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-O 121.38 0.609 . . . . 74.34 111.077 -174.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.49 168.38 26.34 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.244 1.017 . . . . 45.22 109.601 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.07 13.37 81.12 Favored Glycine 0 N--CA 1.473 1.114 0 N-CA-C 114.289 0.476 . . . . 74.33 114.289 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.465 HD12 HD11 ' D' ' 86' ' ' ILE . 37.1 mt -113.49 139.34 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.433 1.093 . . . . 74.41 109.175 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.748 ' HA ' ' HE3' ' D' ' 94' ' ' MET . 8.7 pt-20 -153.77 158.22 40.61 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.51 0.506 . . . . 73.24 112.205 -171.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.56 -137.34 23.37 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.097 -0.956 . . . . 25.44 112.445 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . 0.457 ' HB ' HD23 ' D' ' 141' ' ' LEU . 40.9 p -69.68 -20.6 63.56 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.581 0.753 . . . . 42.01 111.342 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.585 ' HG3' ' HG3' ' D' ' 4' ' ' GLN . 46.1 tt0 -60.11 -32.53 71.08 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.953 0.901 . . . . 74.11 111.262 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.748 ' HE3' ' HA ' ' D' ' 90' ' ' GLU . 54.4 mtt -62.49 -47.61 83.22 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.38 0.672 . . . . 74.42 110.717 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.51 94.04 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.039 -0.982 . . . . 42.14 110.471 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -66.81 -43.71 83.12 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.214 0.606 . . . . 72.41 111.785 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 39.5 t -63.13 -51.04 68.08 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.326 0.584 . . . . 61.51 110.463 -172.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.557 HD11 HG22 ' H' ' 18' ' ' VAL . 73.9 mt -85.91 -21.24 28.06 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.23 -0.895 . . . . 64.54 111.448 -175.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.39 8.62 55.31 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 119.628 -0.54 . . . . 51.43 114.03 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.458 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -154.92 -54.29 0.09 Allowed 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 117.28 0.54 . . . . 74.45 111.586 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -70.13 -51.1 34.12 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.662 0.385 . . . . 72.32 111.871 -173.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 30.6 m -67.15 -42.16 38.73 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 123.175 0.59 . . . . 40.12 111.904 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -53.72 -35.35 78.04 Favored 'Trans proline' 0 C--N 1.393 2.888 0 C-N-CA 122.667 2.244 . . . . 72.1 113.346 166.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -68.8 -32.92 72.99 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.514 0.726 . . . . 65.15 110.319 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 50.2 mm -67.5 -40.23 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 121.394 0.616 . . . . 75.11 110.146 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.569 HD12 HD23 ' D' ' 60' ' ' LEU . 95.6 mt -84.05 -15.52 47.19 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.274 -0.875 . . . . 63.51 112.064 -176.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . 0.402 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 83.3 t80 -61.68 -50.08 83.61 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 124.437 1.095 . . . . 63.4 112.945 -175.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 38.1 Cg_exo -59.72 -34.6 96.05 Favored 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 122.144 1.896 . . . . 52.33 112.945 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -78.34 -37.22 45.0 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.562 0.745 . . . . 64.21 112.211 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.0 -46.35 78.29 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.426 -0.583 . . . . 75.5 109.426 176.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.413 ' NH2' HG23 ' B' ' 105' ' ' ILE . 46.7 ttp180 -57.37 -47.74 80.86 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 124.41 1.068 . . . . 71.34 110.921 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -60.42 -49.88 75.8 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.808 0.843 . . . . 64.15 111.185 -177.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -56.2 -41.8 76.18 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 123.882 0.739 . . . . 42.12 111.101 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.478 HG23 ' SG ' ' D' ' 76' ' ' CYS . 98.0 mt -63.46 -56.44 17.06 Favored 'Isoleucine or valine' 0 C--N 1.349 0.568 0 CA-C-N 115.17 -0.923 . . . . 71.53 110.202 176.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -55.14 -36.82 66.18 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.438 1.095 . . . . 74.22 111.739 -173.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 37.2 t -66.97 -43.94 81.76 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.403 -0.817 . . . . 73.51 110.553 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 78.2 mtm -70.64 -25.88 63.22 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.74 0.416 . . . . 72.1 111.956 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.2 t -65.73 -43.79 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 123.274 0.63 . . . . 61.21 109.638 174.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.7 p -77.03 -27.44 54.49 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.998 -0.546 . . . . 54.22 111.142 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' D' ' 116' ' ' SER . 89.9 mtt-85 -73.02 -35.83 66.85 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.416 0.686 . . . . 65.01 109.866 174.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.4 -2.34 89.32 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.547 -0.751 . . . . 74.25 112.024 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.7 p 65.9 20.44 11.36 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 127.054 2.142 . . . . 63.24 113.657 172.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -79.16 155.0 77.38 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.418 0.687 . . . . 65.44 110.129 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.58 133.71 54.91 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.078 2.519 . . . . 64.32 112.548 172.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -54.41 140.75 32.9 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.416 1.086 . . . . 73.23 112.644 -172.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 62.4 tp -121.2 110.07 15.73 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.165 0.986 . . . . 71.04 109.141 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -111.21 104.96 13.51 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.812 -0.81 . . . . 64.25 108.812 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 tt -70.53 114.21 8.41 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 107.609 -1.256 . . . . 55.44 107.609 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.65 138.32 88.37 Favored Pre-proline 0 N--CA 1.475 0.823 0 CA-C-O 119.609 -0.234 . . . . 61.24 110.408 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -73.62 141.15 30.63 Favored 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 122.457 2.105 . . . . 72.1 111.693 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.74 147.73 24.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 C-N-CA 123.88 0.872 . . . . 74.24 108.961 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . 0.466 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 60.0 t30 -75.42 82.54 2.5 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.657 -0.868 . . . . 64.12 108.657 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -71.41 -25.86 62.52 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.586 -1.188 . . . . 74.24 110.106 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.458 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 3.8 m-20 -54.55 -43.53 72.09 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 114.818 -1.083 . . . . 74.24 111.146 172.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.466 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -61.66 -45.68 93.01 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.842 0.857 . . . . 73.22 111.303 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 7.6 tt -63.02 -42.48 99.8 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.014 -0.993 . . . . 51.24 110.048 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -72.89 -44.51 61.21 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.566 -0.743 . . . . 65.24 110.941 -174.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 70.2 mtm -64.17 -24.83 67.83 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.162 0.585 . . . . 53.51 111.934 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.451 ' HA ' HE21 ' D' ' 142' ' ' GLN . 59.5 t30 -60.42 -39.76 88.6 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.769 0.668 . . . . 74.33 110.711 176.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -64.94 -43.14 93.72 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.295 0.638 . . . . 74.24 110.663 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.457 HD23 ' HB ' ' D' ' 92' ' ' THR . 9.0 mp -66.48 -29.27 69.35 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.312 -0.858 . . . . 62.22 111.992 -175.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.451 HE21 ' HA ' ' D' ' 139' ' ' ASN . 28.2 pt20 -89.93 18.44 5.73 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.088 0.403 . . . . 72.43 112.088 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -121.06 77.07 1.27 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.285 0.564 . . . . 64.35 110.001 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.54 116.37 1.74 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.627 -1.249 . . . . 74.11 107.627 171.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.09 83.25 3.59 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.131 0.491 . . . . 53.34 109.693 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.5 -176.08 38.53 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 115.462 -0.79 . . . . 60.32 112.373 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.69 156.89 46.1 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.895 0.878 . . . . 75.54 109.732 -176.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 85.03 -30.74 3.86 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 116.229 -0.441 . . . . 23.43 113.453 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 63.9 p 51.72 -159.44 0.1 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.622 1.569 . . . . 63.54 111.797 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -162.94 135.22 5.36 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 110.013 -0.366 . . . . 75.23 110.013 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -86.93 64.6 8.57 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 108.136 -1.061 . . . . 73.55 108.136 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -70.67 104.24 2.78 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.61 -0.723 . . . . 45.44 110.491 -171.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -98.34 154.24 17.97 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.202 1.001 . . . . 60.41 110.247 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -145.97 19.65 1.44 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.274 -0.875 . . . . 63.54 109.06 169.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 C-N-CA 124.756 1.222 . . . . 61.41 108.606 176.481 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 58.6 mtt . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.228 -0.656 . . . . 64.01 109.228 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 2' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' C' ' 14' ' ' GLN . 52.7 mtpt -129.53 105.62 8.2 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.631 0.772 . . . . 71.34 110.747 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -105.51 101.79 11.29 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.177 -1.416 . . . . 73.14 107.177 168.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 37.2 t -68.03 147.92 51.72 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.698 0.761 . . . . 63.14 112.675 -171.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 5' ' ' THR . . . . . 0.504 ' H ' HD12 ' E' ' 6' ' ' ILE . 7.0 t -130.55 8.0 4.93 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 114.197 -1.365 . . . . 74.23 109.442 176.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.687 HG22 HD13 ' A' ' 128' ' ' LEU . 2.7 mp -114.14 119.0 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.76 0.824 . . . . 75.1 108.983 -173.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.51 159.73 37.51 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.126 0.57 . . . . 50.42 111.31 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.468 HD22 HD21 ' A' ' 44' ' ' LEU . 64.7 mt -73.37 151.0 41.37 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.944 0.498 . . . . 74.45 111.066 175.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.76 126.21 41.76 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.443 -0.947 . . . . 25.25 108.443 171.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 mp -63.73 127.42 31.28 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.582 0.753 . . . . 72.15 110.15 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 7.8 mp -76.9 126.66 85.38 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.011 0.524 . . . . 63.35 109.876 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.31 -21.77 30.46 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.717 2.278 . . . . 72.04 112.246 176.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 90.2 mt -114.9 157.95 22.64 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.99 0.916 . . . . 64.31 109.677 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 93.1 mt -90.82 175.13 7.11 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.143 0.577 . . . . 71.43 110.337 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -80.26 160.09 25.66 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.61 0.764 . . . . 73.41 110.265 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 16' ' ' THR . . . . . 0.413 ' O ' HD11 ' A' ' 98' ' ' LEU . 34.1 p -66.62 126.01 91.53 Favored Pre-proline 0 CA--C 1.557 1.216 0 C-N-CA 123.842 0.857 . . . . 60.34 112.159 -171.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 17' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.71 163.53 21.32 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 123.816 3.011 . . . . 73.42 114.156 -171.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 18' ' ' VAL . . . . . 0.526 HG23 ' HG ' ' A' ' 98' ' ' LEU . 58.2 t -102.6 -80.48 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 114.9 -1.045 . . . . 63.22 110.883 -175.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 2.6 m -82.5 -45.48 14.66 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 115.585 -0.734 . . . . 61.53 109.058 -174.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -164.31 -70.9 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.494 -1.23 . . . . 54.23 109.327 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 63.56 159.78 0.09 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.557 1.143 . . . . 63.22 112.134 -171.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 22' ' ' ARG . . . . . 0.607 ' HB2' ' HA2' ' A' ' 91' ' ' GLY . 2.7 mmp_? -134.09 111.1 10.07 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.214 -0.662 . . . . 74.4 109.214 174.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 4.4 t -130.93 100.22 17.54 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.398 1.079 . . . . 73.24 108.32 173.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.93 -22.35 68.41 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 123.074 2.516 . . . . 63.53 112.318 172.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.256 1.427 0 C-N-CA 124.505 1.122 . . . . 74.33 109.076 174.351 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.969 -0.382 . . . . 74.35 109.969 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -161.91 -44.62 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.292 1.037 . . . . 75.42 109.501 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 52.14 82.53 0.07 Allowed 'General case' 0 C--N 1.356 0.879 0 C-N-CA 124.958 1.303 . . . . 72.22 111.248 -173.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 31.5 p -65.82 94.49 0.22 Allowed 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.873 -0.788 . . . . 62.41 108.873 173.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 20.5 m -64.96 97.5 0.24 Allowed 'General case' 0 C--N 1.349 0.576 0 CA-C-N 115.304 -0.862 . . . . 54.53 110.188 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.539 HD11 HD11 ' B' ' 126' ' ' LEU . 2.4 pp -72.37 156.72 6.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 CA-C-N 114.743 -1.117 . . . . 73.12 111.348 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -154.75 177.9 10.73 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.342 -0.845 . . . . 42.03 109.571 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . 0.403 ' H ' HG11 ' B' ' 131' ' ' VAL . 98.7 mt -90.29 163.2 14.85 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.983 0.513 . . . . 73.52 109.763 173.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.77 173.49 8.13 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.548 0.739 . . . . 51.13 111.367 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 10' ' ' LEU . . . . . 0.421 HD21 ' HB2' ' B' ' 136' ' ' LEU . 0.4 OUTLIER -84.5 12.96 6.03 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.985 0.514 . . . . 71.42 110.446 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 82.1 mt 61.42 90.08 0.1 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.118 0.967 . . . . 64.41 110.039 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -65.67 -9.34 22.35 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.844 2.362 . . . . 74.45 113.244 -174.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.7 143.36 23.63 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.355 -0.98 . . . . 62.44 108.355 175.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' B' ' 96' ' ' HIS . 88.6 mt -69.76 159.09 34.2 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.349 0.659 . . . . 71.12 110.31 173.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -75.96 -86.63 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.01 0.524 . . . . 73.04 112.065 -168.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 16' ' ' THR . . . . . 0.415 ' O ' HD11 ' B' ' 98' ' ' LEU . 21.9 p -145.05 149.29 41.64 Favored Pre-proline 0 N--CA 1.486 1.359 0 C-N-CA 123.086 0.554 . . . . 73.21 110.994 -172.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 17' ' ' PRO . . . . . 0.546 ' HB2' HG22 ' F' ' 19' ' ' THR . 88.2 Cg_endo -82.76 114.89 2.38 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.69 2.26 . . . . 73.04 113.2 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . 0.498 HG22 HD23 ' B' ' 98' ' ' LEU . 88.3 t -48.07 -32.43 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 125.626 1.571 . . . . 74.53 113.387 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 19' ' ' THR . . . . . 0.546 HG22 ' HB2' ' F' ' 17' ' ' PRO . 13.5 t -49.79 -35.86 24.16 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 124.306 1.043 . . . . 72.44 112.136 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -174.49 79.54 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.73 1.212 . . . . 74.22 107.989 177.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.07 -71.7 0.7 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.455 0.702 . . . . 75.44 110.225 -175.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . 0.405 ' HG2' ' HA ' ' B' ' 49' ' ' SER . 3.3 tpm_? -69.67 -45.24 68.79 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 115.781 -0.645 . . . . 71.33 110.565 -176.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 21.1 m 65.46 106.38 0.03 OUTLIER Pre-proline 0 CA--C 1.56 1.34 0 O-C-N 124.752 1.283 . . . . 74.43 110.295 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.14 83.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.332 2.688 . . . . 55.42 113.638 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 CA--C 1.55 0.961 0 C-N-CA 124.146 0.979 . . . . 75.53 108.96 177.722 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 109.33 -0.618 . . . . 73.11 109.33 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -88.89 -85.22 0.2 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.525 -0.546 . . . . 71.22 109.525 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -90.75 89.86 7.69 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.096 -0.705 . . . . 74.21 109.096 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 15.0 m -69.75 139.86 53.38 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.942 -0.572 . . . . 54.41 109.954 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 5' ' ' THR . . . . . 0.704 ' HB ' ' HB2' ' C' ' 129' ' ' ALA . 8.9 p -66.95 109.38 2.93 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.196 0.599 . . . . 74.31 110.353 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . 0.487 ' HB ' HD11 ' C' ' 42' ' ' LEU . 0.2 OUTLIER -60.92 145.78 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.475 1.51 . . . . 54.1 112.772 -173.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.85 154.4 46.17 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.167 0.587 . . . . 61.15 110.785 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 8' ' ' LEU . . . . . 0.666 ' HB2' HG11 ' C' ' 131' ' ' VAL . 56.2 mt -75.0 157.85 34.22 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.396 1.079 . . . . 72.4 110.345 177.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.99 159.34 26.29 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.542 0.737 . . . . 74.14 111.165 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 40.8 tp -73.55 147.4 43.97 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.071 0.549 . . . . 72.22 109.838 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 90.4 mt -86.17 110.76 33.57 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.729 0.812 . . . . 72.22 110.399 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.04 -34.94 27.26 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 123.127 2.551 . . . . 72.34 112.661 -175.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 35.4 tp -90.28 -5.41 56.33 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.707 -0.679 . . . . 63.23 110.525 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 7.7 mp 65.71 -77.02 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.734 1.213 . . . . 61.31 109.239 -169.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -166.33 168.47 15.02 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.253 0.621 . . . . 71.42 109.417 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 35.1 p -71.44 155.01 93.22 Favored Pre-proline 0 CA--C 1.561 1.393 0 C-N-CA 124.379 1.071 . . . . 74.4 111.418 176.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 17' ' ' PRO . . . . . 0.677 ' HB3' ' HB3' ' G' ' 21' ' ' ALA . 45.6 Cg_endo -65.67 150.52 86.23 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 123.375 2.717 . . . . 73.42 114.098 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 18' ' ' VAL . . . . . 0.729 HG23 HD11 ' C' ' 98' ' ' LEU . 46.2 t -77.22 -55.57 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 109.207 -0.664 . . . . 55.34 109.207 169.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 19' ' ' THR . . . . . 0.537 HG22 ' HG3' ' G' ' 20' ' ' LYS . 21.7 m -137.01 -62.94 0.62 Allowed 'General case' 0 CA--C 1.553 1.074 0 O-C-N 123.211 0.319 . . . . 62.03 111.434 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 20' ' ' LYS . . . . . 0.537 ' HG3' HG22 ' G' ' 19' ' ' THR . 91.1 mttt -125.94 20.6 7.64 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.6 0.76 . . . . 63.51 112.298 -167.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . 0.677 ' HB3' ' HB3' ' G' ' 17' ' ' PRO . . . -65.47 103.74 0.88 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 120.806 0.336 . . . . 62.12 111.613 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -155.66 162.39 40.6 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 115.215 -0.902 . . . . 65.4 109.718 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 32.1 p -116.53 83.79 14.03 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 108.47 -0.937 . . . . 71.44 108.47 172.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -93.29 179.96 0.98 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.49 2.793 . . . . 71.34 113.628 -172.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 . . . . . 0 CA--C 1.551 1.002 0 C-N-CA 123.496 0.718 . . . . 71.2 109.945 176.962 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptm . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.148 -0.315 . . . . 72.32 110.148 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' H' H ' 2' ' ' LYS . . . . . 0.638 ' HE3' ' HA ' ' H' ' 5' ' ' THR . 58.0 tptt -73.93 94.33 2.31 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.121 0.569 . . . . 73.44 110.443 -176.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -113.94 -35.81 4.99 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.047 0.939 . . . . 75.42 109.518 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 16.6 m -82.27 69.07 8.93 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.429 0.692 . . . . 65.21 109.563 175.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 5' ' ' THR . . . . . 0.638 ' HA ' ' HE3' ' H' ' 2' ' ' LYS . 9.9 m -83.31 -23.27 32.65 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.463 -0.79 . . . . 63.42 110.094 176.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . . . . . . . . . 10.7 tp -152.19 137.56 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.018 -1.104 . . . . 71.21 108.018 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.84 144.2 18.91 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.439 0.296 . . . . 62.54 110.817 -176.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -89.85 170.1 10.69 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.272 0.629 . . . . 71.3 110.58 175.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 9' ' ' ALA . . . . . 0.64 ' H ' HD13 ' D' ' 44' ' ' LEU . . . -111.17 148.39 32.86 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.871 -1.059 . . . . 54.01 108.549 170.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 10' ' ' LEU . . . . . 0.403 HD23 ' N ' ' H' ' 11' ' ' LEU . 2.3 tt -66.87 147.5 53.16 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.162 -1.051 . . . . 70.41 108.162 177.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.403 ' N ' HD23 ' H' ' 10' ' ' LEU . 75.7 mt -65.64 137.1 96.22 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-O 119.425 -0.321 . . . . 73.02 110.402 175.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.99 103.17 0.28 Allowed 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.785 2.324 . . . . 44.5 111.371 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 91.7 mt 67.99 -179.19 0.22 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.064 1.346 . . . . 73.24 111.503 -173.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.88 148.48 48.96 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.472 0.309 . . . . 73.32 110.426 174.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -72.61 149.41 43.96 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 109.049 -0.723 . . . . 72.03 109.049 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 16' ' ' THR . . . . . 0.456 ' HA ' ' HD3' ' H' ' 17' ' ' PRO . 40.7 p -57.54 116.71 14.85 Favored Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 124.755 1.222 . . . . 63.13 111.1 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 17' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' H' ' 16' ' ' THR . 34.3 Cg_exo -62.53 164.85 16.93 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.565 2.843 . . . . 72.12 115.095 -172.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . 0.557 HG22 HD11 ' D' ' 98' ' ' LEU . 12.1 t -81.23 1.75 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.63 0 C-N-CA 124.131 0.972 . . . . 73.43 110.669 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 6.6 m -54.48 -44.42 72.62 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.267 1.027 . . . . 71.43 113.517 -168.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -97.2 -19.31 18.7 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.621 0.368 . . . . 52.31 111.505 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.17 97.13 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.261 0.624 . . . . 75.44 109.703 176.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.08 107.13 8.09 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.361 -1.291 . . . . 71.34 107.763 176.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 23' ' ' THR . . . . . 0.426 ' HA ' ' HD3' ' H' ' 24' ' ' PRO . 5.7 t -157.86 140.52 10.61 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 123.064 0.545 . . . . 74.42 110.079 -174.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 24' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' H' ' 23' ' ' THR . 15.1 Cg_exo -71.48 -18.88 29.14 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 123.218 2.612 . . . . 60.41 113.36 176.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 CA--C 1.553 1.082 0 C-N-CA 124.543 1.137 . . . . 64.3 109.532 -172.075 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 110.384 -0.228 . . . . 73.14 110.384 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m -68.75 102.51 1.54 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.3 0.64 . . . . 54.54 111.443 -176.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -129.04 110.49 12.09 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.097 -1.075 . . . . 72.12 108.097 171.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -67.71 -22.33 65.26 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.814 0.846 . . . . 61.05 111.937 -176.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -65.11 102.06 0.59 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.882 0.473 . . . . 71.43 110.478 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -94.46 105.62 17.59 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.253 -1.017 . . . . 72.45 108.253 173.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.5 t -100.52 -13.96 18.43 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.201 0.6 . . . . 74.22 110.624 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -104.76 122.99 46.87 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.034 -0.728 . . . . 52.11 109.034 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.53 173.39 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 125.065 1.346 . . . . 53.32 112.29 178.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 49.7 p -137.3 108.5 6.81 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 106.481 -1.674 . . . . 74.33 106.481 171.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -131.48 123.76 28.75 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.172 -0.677 . . . . 63.44 109.172 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -153.29 130.96 11.53 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.47 -1.308 . . . . 55.02 107.47 169.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.497 HD12 ' HB2' ' C' ' 130' ' ' PRO . 14.5 mt -80.71 114.76 22.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.778 -0.823 . . . . 74.05 108.778 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -72.55 -39.34 67.55 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 123.891 0.745 . . . . 72.22 110.055 -177.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -177.52 120.93 0.11 Allowed 'General case' 0 C--N 1.366 1.309 0 N-CA-C 111.74 0.274 . . . . 73.3 111.74 -172.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 78.6 mt -106.32 135.0 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.023 -0.732 . . . . 74.13 109.023 173.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.438 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 20.0 p90 -162.52 147.61 12.29 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 124.11 0.881 . . . . 65.32 109.968 -176.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.0 p -75.59 119.15 19.25 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.242 -0.651 . . . . 70.54 109.242 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.2 mtpt -83.22 -32.11 26.67 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.418 -0.586 . . . . 73.53 109.418 176.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 25.0 t70 -144.23 139.54 28.74 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.207 -0.906 . . . . 65.45 110.354 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.6 mt -133.22 145.61 33.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.941 1.296 . . . . 74.15 108.182 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.577 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 48.1 t -149.73 124.83 10.04 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.458 -0.792 . . . . 72.23 109.295 173.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.507 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 86.4 t80 -129.49 111.28 12.6 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 106.62 -1.622 . . . . 71.23 106.62 169.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -121.51 110.41 16.0 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.513 -0.551 . . . . 73.51 109.513 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.32 84.26 0.87 Allowed Pre-proline 0 C--O 1.241 0.654 0 N-CA-C 107.156 -1.424 . . . . 51.25 107.156 168.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.34 -19.3 29.17 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.161 1.908 . . . . 63.43 112.589 -168.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -120.26 22.76 11.24 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.933 0.893 . . . . 74.22 109.77 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.461 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -45.38 -55.04 12.78 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 113.969 1.1 . . . . 60.14 113.969 -170.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 23.2 Cg_exo -64.98 -16.95 57.93 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 121.989 1.792 . . . . 64.51 114.119 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -100.94 -26.01 13.88 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.305 1.042 . . . . 73.31 110.933 -176.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.81 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.5 p -80.78 -25.18 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 115.839 -0.619 . . . . 63.51 112.584 -166.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -71.08 -26.76 63.2 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.882 0.473 . . . . 72.32 110.779 -175.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -85.28 -13.77 48.7 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.534 0.733 . . . . 75.11 111.527 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.501 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 2.0 tmtp? -81.63 132.84 35.31 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.387 -0.968 . . . . 72.31 108.387 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.501 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 12.5 m-20 -52.51 132.35 35.05 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.663 1.185 . . . . 52.43 112.314 178.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.41 ' CE3' HD21 ' A' ' 68' ' ' LEU . 55.3 t-105 -78.57 89.17 4.5 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.374 0.607 . . . . 71.42 110.334 -175.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.488 ' H ' HD22 ' A' ' 68' ' ' LEU . 35.9 tt0 -120.21 78.49 26.18 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.905 1.282 . . . . 74.52 108.465 171.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.6 111.7 2.84 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.307 2.005 . . . . 71.23 113.239 -171.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -95.86 99.11 10.95 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 107.5 -1.296 . . . . 72.44 107.5 173.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.573 HG13 HG13 ' A' ' 64' ' ' VAL . 57.7 t -90.64 100.21 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 123.57 0.748 . . . . 52.02 110.5 -169.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -84.53 114.77 22.2 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.621 0.768 . . . . 60.54 109.754 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mp -104.67 108.35 19.76 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.918 -0.771 . . . . 73.32 108.918 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.542 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 10.7 t70 -102.35 124.49 48.02 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.949 1.3 . . . . 63.32 108.04 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.842 HD21 HD11 ' E' ' 8' ' ' LEU . 6.8 mp -111.77 125.81 54.4 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.901 0.382 . . . . 75.03 110.533 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 4.2 t70 -119.32 136.17 54.37 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.577 1.151 . . . . 71.04 108.716 175.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 46.9 p -107.75 136.44 47.48 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.243 0.617 . . . . 71.05 110.43 -174.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.618 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -139.13 137.09 35.81 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.575 0.75 . . . . 53.51 109.454 177.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.4 p -133.62 152.8 51.97 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.516 0.726 . . . . 74.45 110.381 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.9 t -161.07 127.38 3.93 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.049 0.54 . . . . 64.04 110.014 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -88.13 105.27 17.4 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.25 -1.019 . . . . 75.42 108.25 171.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.4 mt -79.33 -36.41 39.53 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.039 0.535 . . . . 73.51 111.541 -171.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.05 -174.13 3.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.475 0.71 . . . . 70.13 110.297 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -67.55 118.84 11.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.109 0.564 . . . . 72.34 109.534 171.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 67.69 13.16 9.17 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.819 1.248 . . . . 64.03 111.825 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.25 109.48 24.37 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 N-CA-C 107.864 -1.162 . . . . 72.34 107.864 175.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -129.58 155.49 45.72 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.272 -1.01 . . . . 74.43 108.272 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -129.6 124.59 34.15 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.089 0.556 . . . . 72.45 110.864 -174.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.421 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 85.3 t -109.07 113.42 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.317 -1.364 . . . . 60.33 107.317 166.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.618 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 40.3 t -103.55 135.05 42.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.554 -0.906 . . . . 74.12 108.554 171.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.446 HD21 HD23 ' A' ' 44' ' ' LEU . 2.6 tt -129.0 119.12 23.72 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.385 -0.598 . . . . 73.1 109.385 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 12.1 ttm180 -84.84 110.33 18.75 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.251 1.02 . . . . 72.44 109.63 175.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.8 t -100.47 101.33 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 107.719 -1.215 . . . . 65.31 107.719 170.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 20.9 m -99.46 104.23 16.05 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.686 0.794 . . . . 72.41 109.029 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.724 HG11 HD21 ' A' ' 126' ' ' LEU . 14.1 t -104.9 119.63 54.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 123.754 0.822 . . . . 72.13 109.966 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.5 m -112.29 123.88 51.24 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.586 -0.894 . . . . 62.04 108.586 177.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.51 110.5 22.46 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 106.603 -1.629 . . . . 74.31 106.603 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.8 m -109.87 124.9 52.15 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.195 -0.669 . . . . 44.24 109.195 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.488 HD22 ' H ' ' A' ' 37' ' ' GLN . 40.2 mt -88.99 75.76 7.94 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.193 -1.41 . . . . 62.21 107.193 176.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.49 -88.75 0.72 Allowed Glycine 0 C--N 1.345 1.043 0 CA-C-N 114.949 -1.023 . . . . 52.13 110.991 -173.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -120.85 -4.93 9.65 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.501 0.721 . . . . 70.21 111.499 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -101.9 103.6 14.28 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.652 -0.499 . . . . 74.13 109.652 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.0 m -60.52 121.15 11.41 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.139 0.495 . . . . 61.11 110.976 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.81 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -69.55 -58.29 4.13 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.959 -1.019 . . . . 51.21 109.999 175.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -158.65 174.6 14.8 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.353 -1.294 . . . . 72.42 111.16 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.9 tp -132.11 142.6 49.56 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 113.778 -1.556 . . . . 72.24 107.636 173.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 75.1 m -142.7 94.96 2.71 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.293 0.637 . . . . 63.31 109.546 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 39.0 tt0 -115.07 115.62 27.11 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.549 -0.908 . . . . 52.1 108.549 -175.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.73 109.12 18.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.781 -0.822 . . . . 74.44 108.781 -175.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 76.0 mt-30 -85.58 84.09 7.71 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.117 -1.068 . . . . 73.13 108.117 173.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -76.48 99.4 4.9 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.508 -1.224 . . . . 72.51 108.949 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.99 144.82 22.11 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 110.298 -1.121 . . . . 60.44 110.298 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.468 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -144.78 120.92 1.47 Allowed Glycine 0 CA--C 1.5 -0.865 0 N-CA-C 110.382 -1.087 . . . . 63.43 110.382 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.0 mt -88.84 123.24 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 108.529 -0.915 . . . . 75.3 108.529 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.421 ' HE1' ' HB ' ' A' ' 58' ' ' VAL . 90.1 m-85 -121.44 119.87 33.32 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.49 -1.3 . . . . 72.35 107.49 -177.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.7 m -84.78 88.5 7.39 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.199 0.6 . . . . 64.44 109.504 173.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.426 HD13 ' H ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -123.18 141.4 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 115.581 -0.736 . . . . 61.11 110.04 178.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.23 23.81 0.07 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.554 0.742 . . . . 70.33 110.663 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.77 -71.34 0.93 Allowed Glycine 0 C--N 1.348 1.228 0 CA-C-N 116.193 -0.458 . . . . 54.23 112.262 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 pp -158.94 173.4 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.501 1.12 . . . . 70.44 111.02 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.503 ' HG3' ' H ' ' A' ' 91' ' ' GLY . 6.3 tp10 -114.66 -159.14 0.69 Allowed 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 125.982 1.713 . . . . 65.34 106.74 -175.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.503 ' H ' ' HG3' ' A' ' 90' ' ' GLU . . . 75.68 -141.96 28.2 Favored Glycine 0 N--CA 1.468 0.831 0 CA-C-O 119.575 -0.569 . . . . 53.55 112.697 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.9 p -58.35 -42.9 87.95 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.525 0.73 . . . . 74.43 112.761 -174.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -73.1 -43.84 61.2 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 118.887 -0.577 . . . . 72.54 112.383 -172.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.572 ' SD ' ' HB ' ' E' ' 18' ' ' VAL . 58.0 ttm -67.13 -38.82 86.21 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 118.899 0.772 . . . . 75.15 110.809 174.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.42 -31.08 72.14 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 122.853 0.461 . . . . 70.2 111.308 175.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -72.24 -36.58 69.13 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.234 1.014 . . . . 70.12 110.704 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 81.9 m -66.39 -60.99 2.24 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.768 -0.456 . . . . 72.22 109.768 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.688 HD11 HG23 ' E' ' 18' ' ' VAL . 69.5 mt -60.24 -40.32 89.84 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.241 1.016 . . . . 65.12 112.061 -177.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.66 -28.13 30.32 Favored Glycine 0 C--N 1.342 0.866 0 O-C-N 123.753 0.658 . . . . 71.42 114.128 -172.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.71 -59.71 1.2 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.982 0.734 . . . . 73.23 112.982 -171.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -73.55 -56.83 4.51 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.597 0.359 . . . . 73.55 111.86 -166.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 66.6 m -55.33 -41.09 88.92 Favored Pre-proline 0 CA--C 1.571 1.785 0 CA-C-O 118.308 -0.853 . . . . 62.13 112.855 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -49.33 -51.39 10.76 Favored 'Trans proline' 0 C--N 1.399 3.224 0 C-N-CA 122.728 2.286 . . . . 73.01 113.207 164.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.5 HD21 ' N ' ' A' ' 133' ' ' PHE . 95.0 m-20 -71.98 -15.4 62.06 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.748 0.819 . . . . 64.25 112.445 -177.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.457 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 30.3 mm -80.72 -45.1 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.259 0.623 . . . . 74.33 109.494 172.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.468 HD21 ' HA3' ' A' ' 82' ' ' GLY . 90.0 mt -74.66 -22.98 58.59 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.06 -0.518 . . . . 51.44 111.053 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -61.96 -46.0 91.96 Favored Pre-proline 0 CA--C 1.559 1.319 0 CA-C-O 117.499 -1.238 . . . . 73.52 113.002 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 34.5 Cg_exo -60.35 -35.37 91.48 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 121.837 1.692 . . . . 71.34 113.926 174.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -78.34 -35.82 47.07 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 122.899 0.479 . . . . 71.12 111.093 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.57 -37.91 68.07 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.2 0.6 . . . . 72.11 109.76 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.579 ' NH1' HG23 ' C' ' 105' ' ' ILE . 26.3 ttm180 -63.51 -39.95 95.77 Favored 'General case' 0 C--O 1.209 -1.05 0 C-N-CA 124.061 0.945 . . . . 72.51 109.309 173.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -63.39 -48.3 78.42 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.992 0.917 . . . . 73.11 111.038 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 32.9 t -60.58 -41.32 94.44 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 124.385 1.053 . . . . 74.43 110.04 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 69.1 mt -65.25 -46.77 89.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 123.579 0.752 . . . . 72.0 110.83 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 55.3 m -59.44 -39.22 82.86 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.449 1.1 . . . . 75.41 110.424 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.8 t -75.03 -47.19 30.23 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.893 -1.049 . . . . 64.22 110.476 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 13.7 mtp -57.44 -45.15 85.02 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.606 0.763 . . . . 75.45 111.948 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.2 t -63.61 -43.66 98.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 124.468 1.107 . . . . 74.43 110.878 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.0 t -70.83 -31.65 68.44 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.215 0.606 . . . . 72.52 111.463 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -73.8 -30.14 62.56 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.287 0.635 . . . . 74.24 109.726 176.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.38 -0.52 78.68 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.286 -0.87 . . . . 63.33 113.41 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.499 HG22 HH21 ' B' ' 15' ' ' ARG . 17.2 m 73.42 15.59 4.2 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-O 122.574 1.178 . . . . 64.55 111.425 173.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -86.27 154.82 57.4 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-N 115.588 -0.733 . . . . 63.4 110.221 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.25 129.7 34.79 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.772 2.315 . . . . 75.12 111.851 171.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -51.76 129.56 26.62 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 124.289 0.993 . . . . 75.53 112.268 -172.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.724 HD21 HG11 ' A' ' 64' ' ' VAL . 56.1 tp -109.47 97.99 7.46 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.229 -0.896 . . . . 55.14 110.177 -174.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -103.28 112.28 25.07 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.432 0.693 . . . . 64.5 109.401 174.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.0 mp -72.43 117.73 14.45 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.103 -1.073 . . . . 60.1 108.103 172.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' E' ' 7' ' ' ALA . . . -62.24 145.02 94.36 Favored Pre-proline 0 CA--C 1.56 1.354 0 CA-C-N 117.925 0.33 . . . . 73.1 110.716 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.45 ' HD3' HG13 ' C' ' 13' ' ' ILE . 13.7 Cg_exo -69.44 110.67 2.54 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.743 2.296 . . . . 71.22 112.084 -170.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.43 HG21 ' HB3' ' E' ' 8' ' ' LEU . 15.2 m -99.49 115.25 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 108.676 -0.861 . . . . 63.02 108.676 175.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -90.75 98.81 12.0 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.643 -0.873 . . . . 70.44 108.643 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.5 ' N ' HD21 ' A' ' 104' ' ' ASN . 72.7 m-85 -55.58 -34.56 64.92 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 123.445 0.465 . . . . 74.31 110.278 170.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.36 -51.55 19.24 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.864 0.866 . . . . 73.31 111.957 170.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.51 -50.08 74.22 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.315 0.646 . . . . 61.32 111.768 -173.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.08 -40.95 74.7 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.798 0.439 . . . . 72.25 110.932 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -74.96 -27.64 60.26 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.128 0.571 . . . . 74.44 111.533 -174.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 30.1 mmt -79.91 -37.03 35.53 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.542 0.337 . . . . 73.05 110.186 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -59.92 -41.69 92.31 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 123.713 0.633 . . . . 73.25 110.356 173.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -65.15 -47.12 78.16 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.722 -0.672 . . . . 73.15 110.926 173.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.431 HD23 ' HG3' ' C' ' 144' ' ' GLN . 26.3 tp -58.04 -43.2 86.68 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.001 0.813 . . . . 75.13 111.566 -170.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.693 ' HB3' HE22 ' C' ' 144' ' ' GLN . 33.0 tt0 -173.93 -17.72 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 O-C-N 123.859 0.724 . . . . 62.1 111.304 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.413 ' H ' ' H ' ' A' ' 142' ' ' GLN . 14.5 tm0? 67.15 122.42 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.956 1.702 . . . . 72.42 110.554 -176.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -106.63 138.54 42.61 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.226 0.61 . . . . 73.43 110.009 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -148.22 133.83 18.79 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.381 0.672 . . . . 74.1 109.794 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.93 -163.34 9.69 Favored Glycine 0 C--N 1.349 1.266 0 O-C-N 123.445 0.466 . . . . 52.34 112.226 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -71.24 141.17 50.6 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.738 0.415 . . . . 73.03 111.292 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -96.75 -174.19 35.05 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.369 -0.693 . . . . 72.31 111.369 171.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.736 HG21 ' HA3' ' C' ' 91' ' ' GLY . 6.1 m -99.81 127.55 45.96 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.681 -0.488 . . . . 71.3 109.681 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -97.58 149.83 21.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.936 0.494 . . . . 74.54 110.261 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.566 ' HG2' HG22 ' G' ' 23' ' ' THR . 0.3 OUTLIER -138.45 168.74 19.12 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 107.738 -1.208 . . . . 64.21 107.738 176.066 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.413 ' HE1' ' HG2' ' G' ' 24' ' ' PRO . 54.1 m80 -62.5 89.65 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.845 0.858 . . . . 72.42 109.658 172.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -90.62 136.73 32.87 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.188 0.995 . . . . 73.31 109.776 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -98.37 143.98 28.25 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.391 -0.596 . . . . 64.52 109.391 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 C-N-CA 123.895 0.878 . . . . 74.14 109.109 -178.647 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.896 0.379 . . . . 75.34 110.936 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 27.1 p -111.06 128.15 55.78 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.391 -0.966 . . . . 73.3 108.391 169.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -74.45 91.59 2.27 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.58 0.705 . . . . 74.41 110.129 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -90.28 109.7 20.78 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.785 -1.098 . . . . 72.15 109.774 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -68.47 -39.13 81.51 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.423 0.63 . . . . 63.45 109.328 170.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -127.08 120.96 30.19 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.92 -1.511 . . . . 74.12 106.92 169.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 58.0 p -78.35 -29.0 47.27 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.546 0.738 . . . . 73.41 111.494 -174.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 69.07 -2.31 1.83 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.989 1.316 . . . . 72.22 112.984 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.42 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 26.2 ttt 64.07 168.18 0.16 Allowed 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 125.25 1.42 . . . . 74.11 111.942 -170.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m -143.35 133.57 24.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.446 -1.316 . . . . 73.01 107.446 166.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -141.22 137.67 32.75 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.396 -0.594 . . . . 71.54 109.396 175.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.528 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -158.75 129.0 5.92 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.026 0.93 . . . . 62.33 108.753 173.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.449 HD11 HD13 ' B' ' 105' ' ' ILE . 15.8 mt -75.05 119.06 21.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.629 0 N-CA-C 108.001 -1.111 . . . . 71.11 108.001 169.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -96.3 -42.58 8.09 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 123.537 0.523 . . . . 63.44 110.199 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.499 HH21 HG22 ' A' ' 122' ' ' THR . 23.0 ttt85 -165.64 133.13 2.91 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.9 -0.591 . . . . 72.32 109.739 -175.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 71.8 mt -116.66 143.05 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 107.622 -1.251 . . . . 74.3 107.622 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -166.91 155.68 10.28 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.528 0.68 . . . . 74.32 112.129 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 89.1 m -84.27 120.46 26.26 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.771 -1.104 . . . . 52.32 108.361 170.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.543 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 33.1 mtpt -87.83 -33.74 18.48 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.031 0.532 . . . . 74.11 110.383 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 19.7 t70 -157.62 144.49 18.11 Favored 'General case' 0 C--N 1.347 0.48 0 N-CA-C 112.707 0.632 . . . . 73.4 112.707 -170.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 45.3 mm -137.51 142.14 37.55 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 C-N-CA 125.648 1.579 . . . . 62.4 108.472 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.3 t -147.21 127.22 13.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.924 -1.139 . . . . 63.44 107.924 173.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 90.7 t80 -139.57 110.91 7.02 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.435 -0.95 . . . . 75.32 108.435 175.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -118.04 115.44 24.87 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.351 1.061 . . . . 73.54 108.534 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.406 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.7 87.91 3.13 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.032 -1.099 . . . . 54.02 108.032 174.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.54 -44.52 4.41 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.649 2.232 . . . . 61.22 112.562 -170.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -97.29 16.48 19.83 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.936 0.894 . . . . 74.34 110.666 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.406 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -38.31 -59.92 1.15 Allowed Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 115.303 1.594 . . . . 75.24 115.303 -168.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -66.61 -26.44 46.45 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 122.039 1.826 . . . . 72.32 112.89 -170.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -93.96 -41.21 9.71 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 115.022 -0.99 . . . . 72.41 111.176 -172.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.6 p -71.18 -12.47 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.344 0.658 . . . . 54.24 111.837 -170.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -66.25 -12.56 57.01 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.584 0.754 . . . . 65.51 112.716 174.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -65.21 -16.41 63.5 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.321 0.648 . . . . 73.01 111.427 174.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -107.53 111.62 23.98 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.023 1.329 . . . . 72.0 111.09 -176.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -107.53 95.16 5.5 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.309 0.644 . . . . 71.53 110.935 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 39.3 p90 -169.27 175.45 5.61 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.7 1.2 . . . . 63.15 108.78 167.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -73.79 107.89 4.11 Favored Pre-proline 0 CA--C 1.555 1.142 0 N-CA-C 109.891 -0.411 . . . . 73.14 109.891 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.485 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 30.5 Cg_endo -64.71 149.73 89.27 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.663 2.242 . . . . 74.32 113.565 -173.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.621 ' HA ' HG23 ' F' ' 5' ' ' THR . 32.7 tt0 -63.09 114.87 3.99 Favored 'General case' 0 C--N 1.359 1.006 0 O-C-N 124.087 0.867 . . . . 75.3 110.052 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.563 HG13 HG13 ' B' ' 64' ' ' VAL . 88.3 t -92.57 144.09 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 123.983 0.913 . . . . 72.21 111.29 -172.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.512 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 23.6 ttpp -128.82 116.43 19.44 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.845 -1.539 . . . . 74.31 106.845 168.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.62 HD13 ' HA ' ' F' ' 8' ' ' LEU . 1.6 pt? -84.11 149.07 26.45 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.146 -0.687 . . . . 75.25 109.146 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.756 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 6.9 m-20 -139.52 110.0 6.62 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.16 -1.422 . . . . 74.21 107.16 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 84.0 mt -104.46 127.12 52.09 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.502 -0.925 . . . . 74.54 108.502 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 14.5 t70 -133.11 143.92 49.61 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.801 0.84 . . . . 64.2 109.409 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 81.3 p -109.98 126.17 53.65 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.755 0.822 . . . . 63.14 110.246 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.06 148.91 52.2 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.837 0.855 . . . . 73.33 109.355 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.9 p -144.48 164.39 31.0 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.703 0.631 . . . . 73.25 112.703 -174.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 69.7 p -155.13 146.74 23.17 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.152 -0.931 . . . . 73.51 109.552 166.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -97.62 128.89 44.67 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.95 -0.759 . . . . 70.35 108.95 174.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.9 mt -97.58 -54.15 3.21 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.315 0.578 . . . . 73.55 110.238 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.38 -168.15 2.98 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.065 -0.971 . . . . 72.32 110.051 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -67.43 103.23 1.26 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.651 -1.158 . . . . 74.44 110.602 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 67.12 15.23 10.03 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.136 1.375 . . . . 64.13 112.414 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 68.0 t -105.74 105.71 19.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 107.52 -1.289 . . . . 72.31 107.52 172.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.648 ' HB2' HD11 ' B' ' 86' ' ' ILE . 6.1 t80 -110.53 165.87 11.46 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.339 -0.846 . . . . 63.23 109.003 -172.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -136.23 114.08 11.21 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.966 -1.124 . . . . 72.03 107.966 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 95.8 t -104.09 118.43 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.829 1.252 . . . . 62.51 110.443 -171.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 13.3 t -109.76 122.55 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 109.496 -0.557 . . . . 72.42 109.496 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.523 HD22 ' HB2' ' B' ' 103' ' ' PRO . 51.8 tp -106.3 110.28 22.46 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.76 -0.83 . . . . 72.45 108.76 170.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.514 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 22.1 ttm-85 -85.94 109.38 18.71 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.223 -0.658 . . . . 71.24 109.223 173.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 30.7 t -106.26 101.86 13.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 108.143 -1.058 . . . . 75.31 108.143 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.756 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 10.4 m -102.32 128.76 48.74 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.747 -0.834 . . . . 42.14 108.747 175.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.563 HG13 HG13 ' B' ' 40' ' ' VAL . 61.3 t -119.91 108.16 22.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 123.85 0.86 . . . . 61.42 109.289 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 96.4 m -82.34 144.66 30.42 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.409 -0.96 . . . . 70.33 108.409 169.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.15 144.56 29.08 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 122.952 0.501 . . . . 73.04 109.928 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.442 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 36.1 p -147.65 127.13 13.19 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.501 0.501 . . . . 74.32 111.127 -175.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.507 HD12 HG22 ' B' ' 31' ' ' VAL . 72.7 mt -94.66 110.16 22.02 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.234 -1.025 . . . . 51.15 108.234 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.41 -112.86 3.67 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 115.477 -0.783 . . . . 62.45 111.771 -176.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -120.96 9.46 10.61 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.435 0.694 . . . . 74.3 110.421 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -123.19 155.15 37.65 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.47 0.708 . . . . 61.1 109.66 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 29.6 m -68.98 133.71 48.53 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.961 0.41 . . . . 63.45 109.984 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.514 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -87.98 -63.58 1.28 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.713 -1.217 . . . . 73.24 107.713 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -150.8 161.31 42.91 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.439 -1.255 . . . . 72.43 110.857 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 85.7 mt -125.73 113.28 17.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.564 -2.013 . . . . 61.53 105.564 172.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.8 t -116.66 151.37 36.45 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.5 -0.926 . . . . 72.3 108.5 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.425 ' HB2' HG23 ' B' ' 63' ' ' THR . 42.8 tt0 -161.14 133.18 5.82 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.055 0.455 . . . . 60.25 109.812 -175.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 93.3 t -134.12 149.0 29.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 124.697 1.199 . . . . 74.31 108.261 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.459 HE21 ' HB3' ' B' ' 20' ' ' ASP . 25.6 mt-30 -125.25 107.01 10.3 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.121 -1.066 . . . . 73.14 108.121 169.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.401 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.8 tp-100 -96.5 101.22 12.81 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.656 -0.868 . . . . 74.11 108.656 178.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.543 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -95.09 144.39 17.17 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.366 -0.834 . . . . 63.52 111.275 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.59 126.84 3.13 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.427 -0.669 . . . . 74.13 111.427 -176.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 70.2 mt -83.96 127.43 39.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.795 -0.817 . . . . 74.21 108.795 174.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -137.85 135.77 36.51 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.936 -0.764 . . . . 73.43 108.936 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.8 m -89.24 98.32 11.7 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.693 -0.855 . . . . 72.3 108.693 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.648 HD11 ' HB2' ' B' ' 56' ' ' TYR . 1.7 pp -111.48 129.53 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.93 0.892 . . . . 62.51 110.702 -175.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.65 167.31 22.86 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.153 0.581 . . . . 73.41 109.815 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 88.28 -59.42 4.14 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 114.017 0.367 . . . . 42.42 114.017 172.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 15.4 mm -78.85 138.21 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 123.632 0.773 . . . . 71.53 110.067 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -157.24 174.65 15.14 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 115.846 -0.615 . . . . 63.1 111.928 -163.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.11 -127.83 44.82 Favored Glycine 0 C--N 1.354 1.562 0 C-N-CA 123.418 0.532 . . . . 34.42 113.78 -177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 51.8 m -66.29 -30.87 71.37 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.983 0.913 . . . . 74.03 110.94 175.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -65.79 -45.3 82.94 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.707 -0.679 . . . . 71.13 110.544 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -71.17 -24.83 62.32 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.534 0.334 . . . . 73.33 111.425 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.82 -45.15 95.08 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 123.664 0.603 . . . . 43.42 109.875 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -64.66 -40.77 96.0 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.233 0.613 . . . . 71.41 111.307 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.4 t -62.14 -44.57 96.32 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.766 0.427 . . . . 65.43 111.648 -176.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.435 ' HB3' ' CD2' ' F' ' 15' ' ' PHE . 9.2 mp -92.75 -16.86 24.91 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.046 0.539 . . . . 73.34 111.708 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.11 2.87 47.61 Favored Glycine 0 N--CA 1.474 1.211 0 CA-C-O 120.052 -0.304 . . . . 64.32 113.643 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' B' ' 104' ' ' ASN . . . -145.07 -57.36 0.34 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.22 0.608 . . . . 74.01 110.57 -178.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -74.02 -51.81 14.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.997 0.519 . . . . 75.44 112.293 -171.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 72.0 m -60.8 -49.23 90.35 Favored Pre-proline 0 CA--C 1.565 1.536 0 CA-C-O 118.59 -0.719 . . . . 65.11 112.44 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.523 ' HB2' HD22 ' B' ' 60' ' ' LEU . 71.5 Cg_endo -71.56 -16.7 30.41 Favored 'Trans proline' 0 C--N 1.393 2.87 0 C-N-CA 122.08 1.853 . . . . 75.21 113.319 176.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' B' ' 100' ' ' ALA . 51.4 t-20 -65.64 -41.21 92.89 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 123.469 0.708 . . . . 63.22 109.594 174.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.449 HD13 HD11 ' B' ' 13' ' ' ILE . 73.7 mt -60.54 -45.36 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.538 1.135 . . . . 73.13 110.741 175.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 49.5 mt -84.01 -13.22 53.81 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.224 -1.353 . . . . 74.34 111.612 -170.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -57.24 -55.74 41.13 Favored Pre-proline 0 CA--C 1.561 1.366 0 CA-C-O 117.946 -1.026 . . . . 70.43 113.549 -176.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -64.85 -27.1 59.26 Favored 'Trans proline' 0 C--N 1.383 2.368 0 CA-C-N 121.338 1.514 . . . . 62.14 113.186 -174.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.401 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.0 m-85 -68.69 -48.45 63.85 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.839 0.456 . . . . 74.52 109.888 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.59 90.12 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.449 -0.796 . . . . 62.4 110.745 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 45.2 ttt-85 -62.45 -49.03 77.04 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.757 1.223 . . . . 72.32 111.376 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -65.88 -36.85 84.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 123.711 0.632 . . . . 75.54 109.791 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.513 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.5 t -70.96 -33.8 70.82 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.892 -0.595 . . . . 61.15 111.369 -178.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.471 ' O ' HG23 ' B' ' 118' ' ' VAL . 55.6 mt -64.48 -54.64 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 109.17 -0.678 . . . . 73.51 109.17 173.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 4.3 m -63.72 -23.41 67.36 Favored 'General case' 0 CA--C 1.555 1.168 0 O-C-N 123.85 0.719 . . . . 71.02 111.353 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.434 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.0 t -67.25 -49.02 66.0 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 123.075 0.55 . . . . 73.23 109.812 172.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.513 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.4 mmt -68.68 -31.83 71.22 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.804 0.442 . . . . 73.22 111.042 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.471 HG23 ' O ' ' B' ' 114' ' ' ILE . 90.9 t -64.17 -42.67 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.837 0.855 . . . . 72.35 109.962 172.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.6 t -67.18 -31.39 71.75 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.924 -1.034 . . . . 63.41 111.336 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.438 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 81.7 mtt-85 -73.45 -38.11 65.6 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.26 0.624 . . . . 61.4 110.061 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.95 -3.94 75.98 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 123.729 0.643 . . . . 75.13 112.609 169.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 34.3 p 63.46 24.08 13.96 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 126.426 1.89 . . . . 72.24 113.129 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -77.77 160.58 74.05 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 124.533 1.133 . . . . 74.32 111.36 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -51.95 162.29 1.92 Allowed 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 123.677 2.918 . . . . 74.44 115.049 173.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.674 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 56.3 tp60 -60.24 128.81 38.6 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.287 1.035 . . . . 74.13 111.574 -173.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.436 HD21 HG21 ' B' ' 40' ' ' VAL . 1.4 tm? -146.4 99.79 3.27 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.647 -0.871 . . . . 74.34 108.647 -174.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -131.53 132.2 43.98 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.722 0.809 . . . . 72.35 109.505 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.594 HD23 HD11 ' F' ' 6' ' ' ILE . 96.1 mt -70.98 150.41 45.69 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.332 0.653 . . . . 73.33 112.383 -175.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.0 153.19 69.47 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 124.114 0.966 . . . . 70.34 111.702 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.407 ' HB2' HD12 ' D' ' 13' ' ' ILE . 57.8 Cg_endo -68.03 116.72 4.47 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.112 2.541 . . . . 74.14 112.406 176.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.613 HG21 ' HB2' ' F' ' 8' ' ' LEU . 72.3 t -127.79 111.44 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.89 -0.781 . . . . 71.11 108.89 173.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -80.27 94.27 6.06 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 107.688 -1.227 . . . . 73.15 107.688 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -56.69 -41.55 77.53 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.136 0.974 . . . . 53.22 111.487 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -64.09 -46.13 85.62 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.324 1.049 . . . . 74.03 112.034 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.68 -27.22 67.48 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.805 0.69 . . . . 50.02 112.2 -175.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 88.2 mt -60.44 -46.51 89.77 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.246 0.618 . . . . 65.51 110.636 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -80.47 -27.39 37.87 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.367 -0.833 . . . . 74.54 111.077 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 25.9 ttt -70.8 -39.47 73.08 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.085 0.554 . . . . 74.23 111.206 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -75.49 -17.25 60.17 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.937 0.495 . . . . 54.1 110.874 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -72.39 -40.08 67.51 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.769 -0.456 . . . . 74.41 109.769 172.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 51.2 mt -86.42 -8.1 57.9 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.799 -0.637 . . . . 73.31 111.275 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -109.11 147.41 32.48 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.787 0.835 . . . . 74.22 109.68 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -142.4 147.52 36.33 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.847 0.859 . . . . 73.43 109.554 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -170.8 152.85 3.79 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.025 0.93 . . . . 73.21 109.844 174.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -164.18 -164.87 0.9 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.325 1.05 . . . . 64.22 109.314 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 126.44 129.05 3.24 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 112.328 -0.309 . . . . 34.11 112.328 173.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -150.35 100.54 2.89 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 107.792 -1.188 . . . . 70.25 107.792 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -69.48 82.15 0.28 Allowed Glycine 0 C--N 1.348 1.22 0 N-CA-C 111.0 -0.84 . . . . 74.14 111.0 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 16.0 p -65.76 88.2 0.1 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.921 0.888 . . . . 64.3 110.738 -177.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.01 137.97 39.31 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.504 -1.225 . . . . 74.43 110.352 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -131.08 146.64 52.44 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.434 -0.95 . . . . 73.21 108.434 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -134.81 118.87 17.48 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.057 -0.519 . . . . 71.14 109.991 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -144.52 134.5 23.95 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.013 0.925 . . . . 73.35 109.111 175.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -165.54 153.32 10.92 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.741 0.816 . . . . 70.54 109.317 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.777 0 N-CA-C 108.583 -0.895 . . . . 63.3 108.583 175.02 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 108.667 -0.864 . . . . 73.12 108.667 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 31.0 m 66.83 169.4 0.24 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.06 1.344 . . . . 73.14 112.189 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -80.13 -43.42 21.69 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.988 -0.745 . . . . 73.3 108.988 170.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -76.83 91.34 3.52 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.296 -0.865 . . . . 65.41 109.49 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -71.16 -54.36 11.28 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.184 -1.043 . . . . 74.02 108.184 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -170.58 133.78 1.04 Allowed 'General case' 0 C--N 1.351 0.659 0 CA-C-N 115.114 -0.948 . . . . 75.41 109.637 167.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 44.1 m -88.79 -52.39 5.15 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 107.351 -1.352 . . . . 72.11 107.351 167.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -137.4 147.22 45.28 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.446 -1.252 . . . . 73.54 108.288 167.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.633 ' HE1' HG23 ' C' ' 86' ' ' ILE . 13.4 tpt 65.61 122.97 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.149 1.38 . . . . 71.12 113.064 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 20.2 m -111.51 99.68 8.4 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.237 -1.023 . . . . 71.0 108.237 173.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.52 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 42.0 t80 -111.62 140.04 46.56 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.011 0.524 . . . . 75.42 109.691 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -159.72 134.31 7.77 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.082 0.953 . . . . 73.14 108.581 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.45 HG13 ' HD3' ' A' ' 130' ' ' PRO . 74.9 mt -72.8 120.46 21.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.492 -0.929 . . . . 65.55 108.492 168.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -89.86 -45.48 9.22 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.698 -0.683 . . . . 75.11 109.36 175.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -176.47 141.31 0.4 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.005 -0.998 . . . . 73.01 108.481 -168.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.401 HG21 ' CD1' ' C' ' 109' ' ' TYR . 56.0 mt -137.01 144.96 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 108.993 -0.743 . . . . 74.44 108.993 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.466 ' HB3' HG23 ' D' ' 122' ' ' THR . 22.3 p90 -174.89 159.94 2.79 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.576 0.703 . . . . 72.13 110.077 -173.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . 0.46 HG21 ' SG ' ' C' ' 113' ' ' CYS . 81.0 p -78.91 119.36 21.97 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.911 -1.04 . . . . 65.35 108.988 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -69.44 -46.43 66.77 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 107.133 -1.432 . . . . 51.03 107.133 168.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.2 t70 -135.04 143.05 46.52 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 113.016 -1.902 . . . . 53.12 109.748 -171.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 70.4 mt -136.8 150.44 26.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 105.928 -1.878 . . . . 73.4 105.928 170.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -163.86 151.16 12.24 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.333 0.587 . . . . 72.03 110.012 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -146.21 124.45 12.23 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.183 -1.414 . . . . 61.31 107.183 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -126.98 110.43 12.97 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.086 -0.709 . . . . 72.43 109.086 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.38 84.65 29.39 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 107.292 -1.373 . . . . 50.03 107.292 167.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.41 -37.03 24.73 Favored 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 122.331 2.02 . . . . 72.24 111.011 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -95.83 22.69 7.03 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.044 -0.98 . . . . 71.03 110.64 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.71 -54.45 27.1 Favored Pre-proline 0 CA--C 1.564 1.518 0 N-CA-C 114.127 1.158 . . . . 32.1 114.127 -172.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.54 -40.48 47.04 Favored 'Trans proline' 0 C--N 1.39 2.726 0 CA-C-N 121.797 1.677 . . . . 60.43 111.961 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -70.69 -31.83 68.86 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.659 -1.155 . . . . 74.4 112.563 -175.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.65 HG21 ' HA ' ' C' ' 73' ' ' ALA . 11.7 p -81.46 -26.0 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 112.756 0.65 . . . . 70.54 112.756 -177.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -67.6 -24.58 65.51 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 120.793 0.33 . . . . 74.15 111.71 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -90.49 25.5 2.26 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.789 0.836 . . . . 53.21 110.95 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.539 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -121.32 157.83 29.54 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.603 0.761 . . . . 62.33 110.485 178.547 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -70.19 131.91 44.96 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.956 0.902 . . . . 72.21 110.134 170.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -84.5 88.13 7.29 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.344 0.658 . . . . 72.24 110.779 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -132.48 78.97 66.36 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 108.021 -1.103 . . . . 72.43 108.021 171.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' C' ' 67' ' ' SER . 3.2 Cg_exo -78.54 126.71 7.64 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.574 2.183 . . . . 65.25 113.919 -172.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -85.05 91.6 8.14 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 106.249 -1.76 . . . . 74.15 106.249 160.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 28.6 m -80.15 142.69 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 114.345 -1.298 . . . . 62.44 111.262 -173.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.525 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 45.5 mmtm -124.52 103.1 7.97 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.597 -0.89 . . . . 54.45 108.597 172.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.482 HD22 HD23 ' G' ' 8' ' ' LEU . 2.2 pp -86.83 151.5 23.29 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.158 -0.682 . . . . 73.34 109.158 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -144.73 138.75 27.43 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.021 -0.733 . . . . 65.01 109.021 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.492 HD11 HD22 ' G' ' 8' ' ' LEU . 2.4 mp -125.35 114.97 19.59 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.254 -1.017 . . . . 75.33 108.254 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.592 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 11.3 t70 -111.98 144.5 41.23 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.945 0.898 . . . . 74.31 109.045 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -113.28 113.07 24.77 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.489 -0.778 . . . . 74.11 110.613 -169.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.77 141.56 50.37 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.833 0.853 . . . . 70.15 109.362 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 35.2 p -165.84 158.62 15.2 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.626 0.37 . . . . 75.24 111.832 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -161.46 148.93 14.88 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.646 0.779 . . . . 62.43 110.464 -174.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -92.23 126.7 37.42 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.35 -0.611 . . . . 63.25 109.35 172.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.669 HD11 HD12 ' C' ' 83' ' ' ILE . 74.9 mt -89.21 -54.0 4.31 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.563 0.745 . . . . 62.21 111.137 -176.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.91 -166.88 2.46 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.738 -0.665 . . . . 70.14 110.564 -174.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -57.35 103.57 0.13 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.476 1.111 . . . . 71.24 110.401 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 64.14 7.05 3.21 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.05 1.34 . . . . 65.5 113.033 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 88.1 t -97.12 113.92 32.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 107.665 -1.235 . . . . 74.05 107.665 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -118.44 159.85 22.75 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.343 -0.844 . . . . 74.05 109.119 -175.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -126.28 122.68 36.19 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.048 0.939 . . . . 74.22 109.156 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 87.4 t -109.59 125.33 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 107.738 -1.208 . . . . 63.23 107.738 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 66.2 t -124.05 125.67 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 109.083 -0.71 . . . . 43.35 109.083 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.526 HD22 ' HB2' ' C' ' 103' ' ' PRO . 33.4 tp -112.69 116.58 30.36 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 109.229 -0.656 . . . . 63.44 109.229 175.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.592 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 16.7 ttm-85 -82.09 109.31 16.3 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.446 -0.797 . . . . 73.22 109.005 174.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 36.4 t -103.56 119.17 51.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.033 -1.099 . . . . 55.11 108.033 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 27.3 m -125.41 121.49 34.02 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.228 -0.656 . . . . 51.31 109.228 -175.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.664 HG23 HD13 ' C' ' 114' ' ' ILE . 68.4 t -105.82 115.51 47.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 123.767 0.827 . . . . 60.22 109.019 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 3.7 m -98.48 139.45 34.2 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.359 -1.349 . . . . 60.11 107.359 169.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.94 122.96 31.33 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.072 -1.085 . . . . 43.52 108.072 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' C' ' 38' ' ' PRO . 54.1 m -132.54 156.28 47.12 Favored 'General case' 0 C--O 1.213 -0.851 0 C-N-CA 123.393 0.677 . . . . 62.4 109.181 175.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.539 HD13 ' HG2' ' C' ' 34' ' ' LYS . 39.0 mt -119.07 38.76 3.73 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.439 -1.319 . . . . 75.43 107.439 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.82 -99.59 1.65 Allowed Glycine 0 C--N 1.347 1.178 0 CA-C-N 114.606 -1.179 . . . . 73.35 110.469 -170.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -90.33 -30.8 17.23 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.343 0.657 . . . . 72.41 110.438 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -73.22 116.1 13.36 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.87 0.868 . . . . 74.52 110.654 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.1 m -76.85 118.35 19.36 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.376 -0.972 . . . . 73.44 108.376 168.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.65 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.88 -53.02 9.82 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.953 0.783 . . . . 53.24 109.02 176.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -165.96 173.39 10.5 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-N 115.509 -0.769 . . . . 72.55 112.392 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.505 HD23 HG23 ' C' ' 65' ' ' THR . 2.4 tm? -140.94 102.45 4.27 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 105.836 -1.913 . . . . 74.01 105.836 172.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.474 ' SG ' HG23 ' C' ' 114' ' ' ILE . 46.4 t -109.97 112.0 23.74 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.194 -0.669 . . . . 74.54 109.194 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -118.23 127.57 53.87 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.064 0.546 . . . . 70.15 110.162 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 73.2 t -124.33 138.49 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 108.714 -0.847 . . . . 72.24 108.714 170.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.576 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 47.9 mt-30 -113.1 95.17 5.25 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.714 -0.847 . . . . 64.52 108.714 172.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -81.8 106.93 14.12 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.385 -0.825 . . . . 73.42 109.405 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.52 149.13 20.4 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.539 -0.625 . . . . 72.12 111.539 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.18 117.05 0.92 Allowed Glycine 0 CA--C 1.506 -0.482 0 N-CA-C 111.012 -0.835 . . . . 71.04 111.012 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.669 HD12 HD11 ' C' ' 51' ' ' LEU . 12.5 mm -81.92 125.99 39.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 108.395 -0.965 . . . . 75.34 108.395 175.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.416 ' HD2' ' HA ' ' C' ' 13' ' ' ILE . 48.2 m-85 -138.77 142.02 38.8 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.277 -0.638 . . . . 74.33 109.277 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 60.7 m -70.76 115.56 10.05 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.354 -1.35 . . . . 54.51 107.354 164.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.633 HG23 ' HE1' ' C' ' 9' ' ' MET . 69.8 mt -133.64 110.99 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 109.122 -0.696 . . . . 65.31 109.122 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.55 167.52 19.26 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.91 0.884 . . . . 72.13 110.591 177.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.43 -40.44 2.54 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 116.349 -0.387 . . . . 72.31 113.299 171.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 23.6 pt -101.78 174.77 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.237 0.615 . . . . 71.31 111.038 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -150.31 153.69 36.55 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 111.999 0.37 . . . . 74.31 111.999 -175.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.736 ' HA3' HG21 ' A' ' 149' ' ' THR . . . 63.54 -115.92 8.59 Favored Glycine 0 C--N 1.353 1.486 0 N-CA-C 114.844 0.698 . . . . 54.43 114.844 169.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 75.5 p -74.49 -29.53 61.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.331 0.652 . . . . 72.1 110.986 -175.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -60.43 -48.26 82.53 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.695 -0.854 . . . . 74.34 108.695 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.576 ' SD ' ' HB ' ' G' ' 18' ' ' VAL . 51.8 ttm -69.71 -33.81 73.02 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 113.868 -1.514 . . . . 70.02 110.9 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.26 88.15 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.388 0.675 . . . . 65.22 111.66 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -71.2 -32.57 69.01 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.222 -0.445 . . . . 63.35 110.454 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.9 t -67.96 -61.57 1.8 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 122.628 0.371 . . . . 64.43 111.056 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.549 HD23 HG23 ' G' ' 18' ' ' VAL . 2.5 pp -70.24 -25.61 63.46 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 112.069 0.396 . . . . 64.24 112.069 -178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.95 -17.22 44.76 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 114.584 0.593 . . . . 62.53 114.584 -172.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.73 -53.19 0.87 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 117.466 0.633 . . . . 72.15 111.231 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -72.6 -46.65 53.13 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.615 0.766 . . . . 74.03 112.622 -168.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.52 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 33.7 m -73.35 -46.94 7.74 Favored Pre-proline 0 CA--C 1.569 1.683 0 N-CA-C 113.123 0.786 . . . . 65.42 113.123 -175.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.526 ' HB2' HD22 ' C' ' 60' ' ' LEU . 87.7 Cg_endo -75.87 -10.37 19.81 Favored 'Trans proline' 0 C--N 1.387 2.557 0 C-N-CA 122.094 1.863 . . . . 71.42 112.762 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.66 -32.73 74.53 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.487 0.715 . . . . 62.54 110.314 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.579 HG23 ' NH1' ' A' ' 111' ' ' ARG . 14.6 mm -70.74 -36.5 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.208 -0.905 . . . . 73.44 110.067 177.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 43.8 mt -85.86 -22.52 27.5 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.719 -1.128 . . . . 73.33 111.677 -172.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -58.72 -52.94 71.18 Favored Pre-proline 0 CA--C 1.56 1.352 0 CA-C-O 118.198 -0.906 . . . . 75.22 112.795 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -65.65 -32.02 48.54 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 121.54 1.493 . . . . 75.31 112.382 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.401 ' CD1' HG21 ' C' ' 16' ' ' ILE . 2.6 m-30 -67.23 -45.47 76.68 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.859 0.863 . . . . 72.12 110.025 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.7 -37.87 87.64 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.236 1.014 . . . . 65.35 110.735 176.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -60.8 -49.08 78.91 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.6 1.16 . . . . 72.5 110.794 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -69.98 -34.07 72.89 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.119 0.568 . . . . 73.5 110.058 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.46 ' SG ' HG21 ' C' ' 18' ' ' THR . 21.4 t -69.26 -31.29 69.73 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.936 0.494 . . . . 40.43 111.502 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.664 HD13 HG23 ' C' ' 64' ' ' VAL . 86.3 mt -73.53 -55.31 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.081 0.553 . . . . 73.21 109.662 173.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 17.1 m -63.87 -27.6 69.27 Favored 'General case' 0 CA--C 1.553 1.074 0 O-C-N 123.653 0.596 . . . . 71.3 111.374 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 36.6 t -62.02 -50.86 70.36 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.232 -0.655 . . . . 70.11 109.232 171.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.552 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.64 -36.07 79.72 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.318 1.047 . . . . 75.42 112.409 178.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.73 -45.23 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.38 0.672 . . . . 72.55 109.821 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 31.0 t -70.6 -25.35 63.01 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 114.907 -1.042 . . . . 71.4 111.809 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' C' ' 116' ' ' SER . 87.2 mtt-85 -74.18 -40.65 62.37 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.35 0.66 . . . . 71.22 109.417 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.72 -0.12 62.88 Favored Glycine 0 C--N 1.354 1.553 0 CA-C-N 115.617 -0.72 . . . . 34.24 112.575 169.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 25.3 p 62.64 30.89 16.97 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 126.787 2.035 . . . . 74.24 113.378 170.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -83.92 148.91 55.19 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 109.044 -0.725 . . . . 74.3 109.044 170.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.674 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 86.3 Cg_exo -51.41 146.91 23.59 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 123.422 2.748 . . . . 75.23 114.2 176.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -58.81 112.11 1.52 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.985 -1.007 . . . . 75.34 112.358 -173.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 42.8 tp -112.83 86.3 2.34 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.373 -0.973 . . . . 75.33 108.373 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -94.2 106.44 18.41 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.224 -0.898 . . . . 74.4 108.816 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 56.9 tp -65.47 144.98 56.69 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.133 0.573 . . . . 44.21 111.525 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.07 143.94 92.09 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 124.03 0.932 . . . . 63.44 110.882 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.497 ' HB2' HD12 ' A' ' 13' ' ' ILE . 5.6 Cg_exo -71.4 127.42 13.29 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.77 2.314 . . . . 42.15 112.237 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.79 HG21 ' H ' ' G' ' 8' ' ' LEU . 61.6 t -119.18 111.8 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.722 0.809 . . . . 74.44 109.401 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -80.69 97.52 7.3 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.481 0.712 . . . . 44.31 110.448 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -65.07 -41.8 94.75 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.241 -0.652 . . . . 75.45 109.241 170.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -53.34 -52.38 59.4 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.163 -1.381 . . . . 42.45 112.112 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.84 -31.0 68.1 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 123.854 0.722 . . . . 71.42 112.563 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 89.7 mt -70.05 -41.64 73.92 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.513 0.725 . . . . 71.14 110.658 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -80.79 -15.69 55.74 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.184 0.594 . . . . 64.25 111.795 175.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.406 ' O ' ' HB3' ' C' ' 142' ' ' GLN . 24.4 ttt -78.48 -44.82 23.56 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.805 0.842 . . . . 63.51 111.059 -175.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -60.4 -33.41 72.44 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 120.819 0.343 . . . . 63.52 110.296 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -61.89 -83.53 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.884 0.874 . . . . 73.53 111.642 170.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 84.8 mt -92.37 49.62 1.52 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.529 0.732 . . . . 73.11 112.441 -168.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.406 ' HB3' ' O ' ' C' ' 138' ' ' MET . 0.9 OUTLIER -158.21 129.83 6.71 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 109.041 -0.726 . . . . 63.34 109.041 171.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -146.92 86.94 1.66 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.498 -1.297 . . . . 54.24 107.498 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.693 HE22 ' HB3' ' A' ' 142' ' ' GLN . 22.1 tp60 -135.45 -24.52 1.37 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.173 0.589 . . . . 62.23 111.245 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.63 86.9 0.21 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 120.994 0.426 . . . . 64.13 110.44 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.92 87.01 0.07 OUTLIER Glycine 0 C--N 1.343 0.928 0 CA-C-N 115.484 -0.78 . . . . 73.21 111.814 -175.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -151.76 -98.8 0.06 Allowed 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 107.151 -1.426 . . . . 65.31 107.151 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 82.52 43.14 8.03 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 116.414 1.325 . . . . 62.34 116.414 166.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 17.4 p -78.52 -49.43 13.38 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.479 -0.934 . . . . 72.31 108.479 163.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . 0.498 ' HA ' ' HB3' ' E' ' 24' ' ' PRO . 30.3 tt0 52.33 90.7 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.671 1.588 . . . . 72.22 112.876 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . 0.544 ' HG3' ' H ' ' C' ' 152' ' ' HIS . 5.5 pt-20 -69.74 -67.94 0.45 Allowed 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 123.822 0.849 . . . . 71.4 112.26 -178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . 0.544 ' H ' ' HG3' ' C' ' 151' ' ' GLU . 15.9 t60 179.24 146.8 0.19 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.436 1.094 . . . . 71.12 108.812 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' E' ' 22' ' ' ARG . 0.0 OUTLIER -79.72 108.31 13.18 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 109.036 -0.727 . . . . 63.25 109.036 174.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -125.8 152.17 45.79 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.113 0.565 . . . . 75.3 110.242 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.184 0 C-N-CA 124.073 0.949 . . . . 62.51 108.974 175.089 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . 0.438 ' HB2' ' HA3' ' D' ' 146' ' ' GLY . 1.8 mpt? . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.741 0.305 . . . . 53.1 110.485 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 63.8 p -82.21 175.06 10.61 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.034 0.534 . . . . 53.1 110.186 169.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -81.91 -34.12 30.09 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.784 0.434 . . . . 74.32 110.713 176.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . 0.445 ' HA ' ' HA2' ' D' ' 148' ' ' GLY . 35.3 tt0 -163.94 -79.85 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.123 0.969 . . . . 73.15 108.644 170.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 55.35 37.83 29.46 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.051 0.94 . . . . 74.33 112.464 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . 0.414 ' H ' ' HG2' ' D' ' 4' ' ' GLN . 15.0 m120 -78.76 80.64 5.11 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.446 -0.946 . . . . 62.51 108.446 169.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 29.0 m -149.59 142.89 25.18 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.005 -1.452 . . . . 62.4 107.633 -177.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -75.73 87.69 2.78 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.526 0.33 . . . . 61.33 110.121 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.581 ' HG3' HD11 ' D' ' 89' ' ' ILE . 23.1 ttt -31.79 125.73 0.25 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 125.089 1.356 . . . . 65.32 113.686 170.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 30.8 m -107.66 137.9 44.86 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.542 -0.911 . . . . 51.43 108.542 169.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -157.66 114.63 2.96 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.858 -0.793 . . . . 63.24 108.858 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -134.06 126.18 29.59 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.038 -1.097 . . . . 75.42 108.038 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.566 HD13 HG21 ' D' ' 105' ' ' ILE . 10.4 mt -78.23 127.76 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.165 -0.68 . . . . 63.31 109.165 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -87.37 -41.61 13.48 Favored 'General case' 0 C--O 1.24 0.583 0 O-C-N 123.704 0.627 . . . . 42.5 110.001 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 -175.17 142.83 0.65 Allowed 'General case' 0 N--CA 1.484 1.273 0 O-C-N 123.173 0.296 . . . . 61.1 111.676 -172.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.502 HD11 HG21 ' D' ' 13' ' ' ILE . 3.4 mp -117.14 136.45 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.303 -1.369 . . . . 72.04 107.303 168.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.457 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 24.5 p90 -163.87 147.39 9.94 Favored 'General case' 0 C--O 1.242 0.659 0 O-C-N 123.871 0.732 . . . . 74.5 110.236 176.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 78.4 p -77.97 106.75 10.04 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.351 -0.84 . . . . 71.25 108.887 173.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.457 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 37.6 mtpt -73.19 -30.57 63.62 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.466 0.65 . . . . 74.44 109.994 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.424 ' HB3' ' HB3' ' D' ' 79' ' ' GLN . 10.6 t70 -152.42 141.46 21.26 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.012 -1.449 . . . . 75.12 108.934 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.552 HG21 ' HE2' ' C' ' 117' ' ' MET . 79.7 mt -141.71 147.76 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.598 -1.26 . . . . 75.35 107.598 175.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 41.5 t -149.46 128.49 12.69 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 123.799 0.839 . . . . 71.13 109.149 170.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.538 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.6 t80 -128.34 135.58 49.77 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.129 -1.804 . . . . 64.12 106.129 169.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 44.0 mt-10 -141.78 150.15 41.35 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 124.288 1.035 . . . . 63.45 108.432 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.96 87.22 5.47 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 107.699 -1.223 . . . . 55.2 107.699 173.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.74 -27.93 17.57 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.701 2.267 . . . . 63.14 112.823 -173.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -107.82 7.21 28.1 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.001 0.921 . . . . 72.22 110.53 -176.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.419 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -29.95 -64.64 0.19 Allowed Pre-proline 0 CA--C 1.559 1.312 0 N-CA-C 116.74 2.126 . . . . 72.33 116.74 -165.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.424 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 88.7 Cg_endo -76.14 -26.4 9.2 Favored 'Trans proline' 0 C--N 1.381 2.239 0 CA-C-N 122.897 2.07 . . . . 74.23 113.382 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -70.92 -36.14 72.54 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.839 1.256 . . . . 73.41 109.75 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.7 p -84.86 -12.63 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 CA-C-N 115.708 -0.678 . . . . 75.13 111.741 -176.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.424 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.8 m-85 -72.37 -12.22 61.03 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 112.445 0.535 . . . . 72.13 112.445 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -58.13 -23.48 55.21 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.673 0.749 . . . . 62.45 110.066 169.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.443 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 79.3 mttt -104.37 102.61 12.28 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.664 1.586 . . . . 64.34 108.987 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -111.82 90.72 3.42 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.482 0.313 . . . . 74.14 110.442 -175.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 38.3 p90 -164.36 174.35 11.16 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.65 1.18 . . . . 72.42 108.763 172.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.46 HE21 ' HB2' ' D' ' 124' ' ' PRO . 2.2 mp0 -59.08 110.47 2.69 Favored Pre-proline 0 N--CA 1.486 1.328 0 CA-C-O 119.079 -0.486 . . . . 73.44 109.831 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.523 ' HD3' ' HG2' ' D' ' 124' ' ' PRO . 24.5 Cg_exo -63.17 136.74 57.54 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.368 2.045 . . . . 73.04 110.706 -177.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -62.05 107.77 0.93 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.356 -0.979 . . . . 72.03 108.356 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 6.9 m -103.56 121.29 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-N 115.165 -0.925 . . . . 44.11 110.092 -171.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -101.44 119.45 38.78 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 106.313 -1.736 . . . . 75.34 106.313 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.605 HD23 HG13 ' H' ' 6' ' ' ILE . 4.4 pp -94.66 143.1 26.71 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.193 -0.669 . . . . 63.32 109.193 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.52 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 17.0 t70 -139.38 146.82 40.67 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.411 -0.959 . . . . 72.45 108.411 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -116.33 143.56 45.39 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.126 0.57 . . . . 62.12 110.841 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.6 t70 -139.05 134.37 32.89 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.354 -1.293 . . . . 42.43 107.731 169.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 22.4 p -103.7 148.27 26.25 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.203 0.601 . . . . 54.14 110.407 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.43 160.9 41.88 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.394 1.078 . . . . 75.23 109.115 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 46.4 p -174.62 167.88 3.78 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.013 0.525 . . . . 61.23 111.275 -175.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.9 p -166.51 147.56 6.27 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.394 -0.821 . . . . 63.5 110.375 174.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -89.23 118.27 28.8 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.602 -0.888 . . . . 74.52 108.602 170.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 44.1 mt -98.69 -27.28 14.05 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.176 0.59 . . . . 61.41 110.878 -173.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -158.8 -178.53 7.32 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.021 0.928 . . . . 73.15 110.121 174.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.09 111.31 2.85 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.102 -0.954 . . . . 65.31 109.844 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 65.72 9.06 5.67 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.763 1.225 . . . . 65.15 113.252 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 83.2 t -108.07 114.15 45.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 107.468 -1.308 . . . . 73.11 107.468 172.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.553 ' HB2' HG13 ' H' ' 18' ' ' VAL . 36.0 t80 -134.72 131.3 37.47 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.871 -1.059 . . . . 73.43 109.497 -165.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -93.28 129.22 39.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.157 -0.929 . . . . 72.55 110.12 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 78.3 t -109.36 118.96 57.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.209 -1.034 . . . . 71.03 108.209 172.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.46 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 35.7 t -113.78 133.09 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 108.523 -0.918 . . . . 64.32 108.523 177.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 26.4 tp -129.56 120.33 25.14 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.921 -0.4 . . . . 64.15 109.921 171.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.564 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 19.5 ttm-85 -84.54 111.82 19.85 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.952 0.901 . . . . 74.53 109.849 175.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.569 HG21 ' HB1' ' D' ' 110' ' ' ALA . 40.6 t -91.78 122.32 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 108.262 -1.014 . . . . 71.44 108.262 173.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 46.4 m -112.45 143.59 43.32 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.451 -0.574 . . . . 75.01 109.451 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 88.5 t -132.29 101.94 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.663 1.185 . . . . 54.14 108.34 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 19.8 m -93.58 94.92 8.9 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.154 -1.424 . . . . 50.4 107.154 169.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.08 147.47 24.0 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.063 0.545 . . . . 72.3 110.338 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.475 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 63.8 p -150.15 133.72 16.62 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-O 121.068 0.461 . . . . 43.02 111.621 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.7 mt -106.86 114.48 28.59 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.447 -1.316 . . . . 74.13 107.447 171.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.33 -140.96 31.68 Favored Glycine 0 C--N 1.343 0.939 0 O-C-N 123.373 0.42 . . . . 64.35 112.562 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -83.13 3.45 30.66 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.19 0.596 . . . . 71.13 112.302 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.443 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 12.2 pt-20 -131.04 166.0 21.99 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.879 0.472 . . . . 74.44 110.75 -174.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.7 m -72.73 136.93 45.63 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.386 -0.824 . . . . 63.23 110.963 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.551 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.68 -69.55 0.68 Allowed 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.588 -1.264 . . . . 71.42 107.588 174.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . 0.511 ' HE2' ' HG2' ' D' ' 38' ' ' PRO . 52.1 p90 -149.58 150.26 31.97 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-N 115.313 -0.858 . . . . 70.32 110.685 177.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 45.4 mt -106.44 107.2 18.09 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.458 -1.312 . . . . 54.32 107.458 170.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.446 ' SG ' HG23 ' D' ' 114' ' ' ILE . 36.8 t -116.54 140.03 49.83 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.905 0.882 . . . . 72.34 108.967 -176.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -157.98 141.64 15.51 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.995 0.518 . . . . 72.02 109.948 -174.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -140.82 116.29 6.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.138 -1.06 . . . . 50.45 108.138 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' D' ' 61' ' ' ARG . 5.9 tt0 -87.41 81.06 7.95 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.37 -1.344 . . . . 70.55 107.37 171.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -80.09 105.18 11.18 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.353 -1.294 . . . . 73.21 108.761 -173.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -104.3 148.32 16.76 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.72 -0.673 . . . . 73.42 111.661 -178.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.408 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -144.93 131.43 4.28 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.057 -0.817 . . . . 44.11 111.057 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 45.1 mt -88.86 133.3 31.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 108.239 -1.022 . . . . 73.55 108.239 174.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.421 ' HB2' HD11 ' D' ' 86' ' ' ILE . 55.5 m-85 -130.87 159.24 37.97 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.943 0.497 . . . . 54.0 109.87 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 3.9 t -115.27 101.09 8.62 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.248 -1.019 . . . . 53.22 108.248 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.421 HD11 ' HB2' ' D' ' 84' ' ' PHE . 4.1 mp -108.92 109.84 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 109.25 -0.648 . . . . 71.44 109.25 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.34 154.34 45.09 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.398 0.679 . . . . 72.51 109.798 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.92 21.35 65.96 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-O 119.811 -0.439 . . . . 64.41 113.941 175.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.581 HD11 ' HG3' ' D' ' 9' ' ' MET . 10.9 mt -131.97 158.35 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 117.384 0.592 . . . . 63.44 110.255 178.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.411 ' N ' HG22 ' D' ' 89' ' ' ILE . 2.9 pp20? -159.44 -175.97 5.51 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.265 1.026 . . . . 70.51 110.056 171.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . 0.428 ' H ' ' HA ' ' H' ' 21' ' ' ALA . . . 62.46 -141.07 46.67 Favored Glycine 0 N--CA 1.473 1.132 0 N-CA-C 114.839 0.696 . . . . 73.45 114.839 174.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 41.5 p -78.81 -13.98 59.51 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.083 0.953 . . . . 51.22 112.037 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -47.01 70.79 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.556 0.742 . . . . 61.14 109.685 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.576 ' SD ' ' HB2' ' H' ' 21' ' ' ALA . 13.5 ptp -68.78 -34.62 75.86 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 110.271 -0.27 . . . . 62.43 110.271 176.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.45 -26.93 68.77 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.975 0.51 . . . . 60.53 111.461 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -73.03 -51.81 16.77 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.079 0.552 . . . . 74.13 110.579 171.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.7 t -56.64 -43.78 80.62 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 124.074 0.859 . . . . 32.13 111.411 -174.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.698 HD11 HG23 ' H' ' 18' ' ' VAL . 16.3 mt -78.3 -30.21 48.25 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.734 -1.121 . . . . 72.4 110.737 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.79 14.58 64.98 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 116.002 -0.545 . . . . 72.3 113.19 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.547 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -153.02 -79.27 0.1 Allowed 'General case' 0 C--N 1.353 0.742 0 C-N-CA 122.929 0.492 . . . . 74.12 111.235 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -65.41 -41.15 93.9 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.101 0.778 . . . . 73.12 113.101 -166.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 81.5 m -64.56 -48.96 73.18 Favored Pre-proline 0 CA--C 1.564 1.494 0 CA-C-O 118.726 -0.654 . . . . 63.51 112.595 -175.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.14 -22.73 34.52 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 121.717 1.611 . . . . 64.52 112.754 170.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . 0.469 HD21 ' HB3' ' D' ' 133' ' ' PHE . 0.9 OUTLIER -66.75 -25.88 66.71 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 122.539 0.336 . . . . 75.33 111.237 175.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.566 HG21 HD13 ' D' ' 13' ' ' ILE . 43.3 mm -67.99 -39.55 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.346 0.658 . . . . 72.45 109.983 170.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.408 HD21 ' HA3' ' D' ' 82' ' ' GLY . 79.4 mt -79.5 -17.68 53.58 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 115.155 -0.929 . . . . 72.43 111.941 -171.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -64.69 -45.07 75.61 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 114.214 1.19 . . . . 71.14 114.214 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -54.11 -43.88 54.37 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.065 1.843 . . . . 64.4 112.902 173.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -73.52 -34.01 65.03 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.239 -0.892 . . . . 63.52 111.911 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . 0.569 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -65.02 -49.61 69.49 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.458 -0.571 . . . . 70.15 109.458 177.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.8 ttp180 -54.54 -53.43 54.55 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 124.827 1.33 . . . . 65.41 110.801 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -60.16 -46.29 90.17 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.421 1.075 . . . . 64.11 111.378 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 39.6 t -62.12 -41.66 98.46 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.724 0.64 . . . . 63.15 110.935 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.448 ' O ' HG23 ' D' ' 118' ' ' VAL . 82.3 mt -60.48 -58.05 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.674 0.79 . . . . 60.44 110.508 173.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 40.6 m -54.7 -39.23 67.96 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.148 1.379 . . . . 75.45 111.537 -173.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 24.7 t -68.23 -43.45 77.91 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.953 -1.022 . . . . 74.33 110.506 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.8 mtm -68.6 -32.98 73.26 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 122.646 0.378 . . . . 74.42 111.715 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.448 HG23 ' O ' ' D' ' 114' ' ' ILE . 90.6 t -63.57 -45.48 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.548 0.739 . . . . 73.4 109.859 176.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.6 p -74.52 -29.91 61.59 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.877 -0.602 . . . . 64.33 111.281 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 68.7 mtt-85 -72.24 -27.85 62.77 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.2 0.6 . . . . 74.03 110.138 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.26 8.29 74.74 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 123.621 0.575 . . . . 62.54 112.587 172.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.466 HG23 ' HB3' ' C' ' 17' ' ' TYR . 80.7 p 55.3 22.64 4.96 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 126.669 1.988 . . . . 73.14 114.105 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -82.96 151.18 63.33 Favored Pre-proline 0 CA--C 1.552 1.04 0 N-CA-C 108.717 -0.846 . . . . 73.24 108.717 168.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.523 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 17.7 Cg_endo -57.74 138.99 88.8 Favored 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.737 2.292 . . . . 75.31 112.872 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -53.03 134.33 38.14 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.58 1.152 . . . . 74.01 112.375 -175.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.83 104.76 9.8 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.526 -1.287 . . . . 74.25 107.526 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -99.58 109.4 21.91 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.605 0.762 . . . . 74.15 109.211 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.714 ' HA ' HG23 ' H' ' 6' ' ' ILE . 6.5 mp -70.38 119.06 14.0 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.135 0.574 . . . . 65.55 109.548 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.98 137.19 95.43 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.05 0.54 . . . . 74.24 110.774 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.72 130.77 6.92 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.269 1.979 . . . . 72.03 112.108 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 17.6 m -117.43 136.35 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 122.879 0.472 . . . . 54.22 110.902 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -86.92 77.32 9.25 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 107.023 -1.473 . . . . 63.11 107.023 163.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.469 ' HB3' HD21 ' D' ' 104' ' ' ASN . 44.8 t80 -68.34 -26.18 65.47 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 115.026 -0.988 . . . . 44.31 109.925 -176.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.547 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 14.4 t70 -55.98 -43.08 77.24 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 124.154 0.909 . . . . 71.31 111.548 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.59 -45.78 64.68 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.809 0.444 . . . . 71.54 111.696 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.4 tt -58.87 -35.46 73.01 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.511 0.724 . . . . 65.51 110.112 176.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -80.74 -29.57 36.27 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.982 0.913 . . . . 75.41 110.92 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.411 ' O ' ' HG3' ' D' ' 142' ' ' GLN . 59.4 mtm -60.54 -42.19 96.01 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 119.109 -0.472 . . . . 51.33 110.295 174.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -47.91 -49.05 31.22 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 124.414 1.071 . . . . 75.05 111.442 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -56.14 -45.67 79.52 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.008 0.923 . . . . 53.1 111.863 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mp -68.61 -29.98 68.62 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.215 0.606 . . . . 71.14 111.988 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' D' ' 138' ' ' MET . 13.4 mt-30 -83.8 2.06 39.95 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.526 0.73 . . . . 75.51 111.28 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -121.35 48.48 1.66 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.509 1.123 . . . . 52.03 108.132 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -142.53 -174.16 4.06 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.448 1.099 . . . . 70.44 109.78 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.62 165.54 12.47 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.318 0.647 . . . . 73.21 109.533 167.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' D' ' 1' ' ' MET . . . 135.56 176.65 14.47 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 111.9 -0.48 . . . . 70.54 111.9 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -160.62 -173.02 3.75 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.225 0.61 . . . . 72.54 110.731 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' D' ' 4' ' ' GLN . . . -176.0 79.1 0.07 OUTLIER Glycine 0 C--N 1.338 0.641 0 N-CA-C 110.352 -1.099 . . . . 51.54 110.352 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 5.9 t -65.38 91.41 0.11 Allowed 'General case' 0 CA--C 1.551 1.013 0 CA-C-O 121.976 0.893 . . . . 64.24 110.357 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.44 100.32 2.67 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-N 114.549 -1.205 . . . . 73.24 108.215 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . 0.524 ' HB3' HE22 ' D' ' 153' ' ' GLN . 42.7 mt-10 -115.03 163.24 15.88 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.121 -0.945 . . . . 74.11 109.446 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 36.7 p-80 -166.05 79.36 0.27 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.751 0.821 . . . . 74.23 109.537 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . 0.524 HE22 ' HB3' ' D' ' 151' ' ' GLU . 24.8 mp0 -70.3 162.31 28.75 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 115.631 -0.713 . . . . 74.12 109.8 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -135.65 75.78 1.58 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 109.735 -0.468 . . . . 33.1 109.735 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.017 0 C-N-CA 123.62 0.768 . . . . 72.11 109.883 -178.79 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 110.135 -0.32 . . . . 74.44 110.135 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 95.7 mttt 62.81 93.46 0.05 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.545 1.138 . . . . 64.43 112.177 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -119.26 89.67 3.18 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.416 -1.328 . . . . 75.24 107.416 168.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 50.9 m -145.38 106.1 4.12 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.195 0.998 . . . . 72.32 109.439 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 21.4 m -90.09 160.83 16.1 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.705 0.802 . . . . 61.41 109.783 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.35 160.24 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-O 121.14 0.495 . . . . 75.11 111.129 170.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 7' ' ' ALA . . . . . 0.54 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . . . -152.65 -62.26 0.16 Allowed 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.674 -0.694 . . . . 73.42 110.023 -171.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.842 HD11 HD21 ' A' ' 44' ' ' LEU . 3.3 tt 170.69 148.07 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.067 1.747 . . . . 55.25 106.349 -176.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 9' ' ' ALA . . . . . 0.428 ' N ' HD23 ' E' ' 8' ' ' LEU . . . -77.73 -83.59 0.08 Allowed 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 109.862 -0.421 . . . . 54.1 109.862 175.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 6.9 mt -172.45 -176.57 1.58 Allowed 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 125.058 1.343 . . . . 65.31 109.727 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 81.9 mt -112.91 133.07 22.05 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 124.178 0.991 . . . . 72.2 109.433 172.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.2 -5.67 17.31 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.582 2.188 . . . . 75.33 113.297 176.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -146.82 171.43 15.19 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.699 0.8 . . . . 55.2 109.792 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . 0.586 HD12 ' HB ' ' E' ' 23' ' ' THR . 75.1 mt -75.68 -84.15 0.06 Allowed 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 109.65 -0.5 . . . . 72.03 109.65 173.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 35.3 t80 177.63 161.18 0.51 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.713 1.205 . . . . 75.01 108.147 -176.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 17.7 p -73.47 128.41 87.29 Favored Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 123.061 0.545 . . . . 62.32 111.23 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 17' ' ' PRO . . . . . 0.42 ' HB3' ' HB3' ' E' ' 21' ' ' ALA . 59.4 Cg_endo -66.96 155.28 71.51 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.602 2.868 . . . . 70.03 113.927 -173.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 18' ' ' VAL . . . . . 0.688 HG23 HD11 ' A' ' 98' ' ' LEU . 43.9 t -77.16 -71.98 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.945 0 N-CA-C 109.058 -0.719 . . . . 44.42 109.058 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 33.8 m -76.45 -74.94 0.21 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.618 0.767 . . . . 73.11 111.193 -169.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -164.84 25.59 0.06 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.515 0.931 . . . . 73.54 113.515 -171.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' E' ' 17' ' ' PRO . . . -71.77 172.34 9.98 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 117.998 0.363 . . . . 54.13 110.426 168.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 22' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' C' ' 153' ' ' GLN . 0.1 OUTLIER -119.15 -17.22 8.99 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 108.881 -0.785 . . . . 72.42 108.881 173.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . 0.586 ' HB ' HD12 ' E' ' 14' ' ' LEU . 60.1 p 60.89 121.96 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.622 0 C-N-CA 126.744 2.018 . . . . 71.35 112.69 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 24' ' ' PRO . . . . . 0.498 ' HB3' ' HA ' ' C' ' 150' ' ' GLU . 73.7 Cg_endo -77.81 93.73 1.08 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.381 2.054 . . . . 64.12 111.94 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 CA--C 1.562 1.415 0 C-N-CA 125.015 1.326 . . . . 70.31 110.437 -178.97 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . 0.426 ' SD ' ' N ' ' F' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 108.882 -0.784 . . . . 71.44 108.882 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 2' ' ' LYS . . . . . 0.416 ' N ' ' HE3' ' F' ' 2' ' ' LYS . 0.0 OUTLIER 63.03 103.33 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.958 1.303 . . . . 64.11 110.903 -173.029 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -60.88 -27.8 68.41 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.44 0.696 . . . . 74.21 111.225 174.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 42.4 m -118.27 50.87 1.12 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.895 0.878 . . . . 74.12 109.612 174.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 5' ' ' THR . . . . . 0.621 HG23 ' HA ' ' B' ' 39' ' ' GLU . 24.4 m -48.25 -48.04 35.58 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.531 0.732 . . . . 54.42 110.532 171.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.594 HD11 HD23 ' B' ' 128' ' ' LEU . 11.8 tt -120.83 125.56 74.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 114.655 -1.157 . . . . 74.35 108.925 174.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -160.46 166.22 29.6 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.026 0.93 . . . . 53.24 109.247 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . 0.62 ' HA ' HD13 ' B' ' 42' ' ' LEU . 91.9 mt -121.58 146.39 47.01 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.214 0.606 . . . . 70.31 110.006 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -118.29 178.19 4.53 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.13 0.972 . . . . 51.1 109.509 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 8.0 mp -71.35 151.54 44.04 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 108.877 -0.786 . . . . 72.24 108.877 172.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 7.5 mp -69.22 117.16 49.46 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 122.923 0.489 . . . . 75.34 109.967 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.62 -37.21 95.5 Favored 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 123.486 2.791 . . . . 60.02 112.546 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 61.0 tp -112.78 121.87 45.98 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.153 -1.054 . . . . 73.53 108.153 166.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . 0.464 HD13 ' N ' ' F' ' 15' ' ' PHE . 2.2 tm? -69.72 142.24 53.34 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 108.051 -1.092 . . . . 64.32 108.051 172.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . 0.464 ' N ' HD13 ' F' ' 14' ' ' LEU . 45.9 t80 -58.26 152.0 18.25 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.788 0.835 . . . . 74.25 112.089 -174.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 40.8 p -62.18 128.83 91.56 Favored Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 124.16 0.984 . . . . 73.11 111.909 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.71 164.34 11.73 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 123.052 2.502 . . . . 22.43 113.205 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . 0.568 HG12 ' H ' ' F' ' 20' ' ' LYS . 16.2 t -76.51 149.83 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 122.683 0.393 . . . . 65.3 110.298 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 20.1 m -57.81 -34.89 70.13 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.952 0.901 . . . . 73.55 111.58 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 20' ' ' LYS . . . . . 0.604 ' HA ' ' HE3' ' F' ' 20' ' ' LYS . 0.5 OUTLIER -144.32 -79.15 0.2 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 122.913 0.485 . . . . 74.14 111.096 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . 0.458 ' HB2' HG11 ' F' ' 18' ' ' VAL . . . 55.38 57.0 5.76 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.386 1.075 . . . . 72.45 111.46 -173.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -161.44 -88.72 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.329 -0.85 . . . . 75.04 109.938 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 22.0 p -145.67 87.28 6.95 Favored Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 123.871 0.869 . . . . 65.23 108.734 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -78.76 112.8 3.18 Favored 'Trans proline' 0 CA--C 1.555 1.545 0 C-N-CA 122.96 2.44 . . . . 72.34 111.735 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.489 1.489 0 C-N-CA 124.964 1.306 . . . . 64.24 110.771 -173.731 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.473 0.719 0 N-CA-C 109.131 -0.692 . . . . 75.0 109.131 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -77.7 106.9 9.82 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.411 -0.959 . . . . 74.14 108.411 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -146.8 138.39 24.38 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.969 -1.014 . . . . 74.23 108.683 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 45.4 t 178.78 150.4 0.27 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.562 1.145 . . . . 73.31 109.047 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 5' ' ' THR . . . . . 0.49 HG22 HD12 ' G' ' 6' ' ' ILE . 5.2 m -79.58 -86.6 0.07 Allowed 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 108.664 -0.865 . . . . 61.34 108.664 173.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . 0.49 HD12 HG22 ' G' ' 5' ' ' THR . 3.8 mp -124.38 132.09 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 106.586 -1.635 . . . . 73.4 106.586 166.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -122.43 157.5 31.77 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.133 0.573 . . . . 62.44 112.296 -172.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 8' ' ' LEU . . . . . 0.79 ' H ' HG21 ' C' ' 131' ' ' VAL . 30.8 mt -88.21 150.01 23.54 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.942 1.297 . . . . 63.31 109.919 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.29 157.07 25.24 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.243 0.617 . . . . 55.4 109.998 173.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 17.3 mt -62.4 172.32 1.58 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.383 0.611 . . . . 70.12 111.841 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 59.1 mt -118.33 85.81 26.21 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 115.517 -0.765 . . . . 61.23 109.432 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 12' ' ' PRO . . . . . 0.419 ' HD2' HD12 ' G' ' 13' ' ' LEU . 2.8 Cg_exo -76.98 -13.82 17.25 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.83 2.353 . . . . 64.33 112.267 174.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . 0.419 HD12 ' HD2' ' G' ' 12' ' ' PRO . 5.4 mp -71.38 -47.24 57.48 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.248 0.619 . . . . 74.52 110.522 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 59.55 172.61 0.08 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.73 1.212 . . . . 73.34 111.818 -169.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . 0.497 ' HB2' HD13 ' C' ' 98' ' ' LEU . 28.5 m-85 -91.02 164.32 14.0 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 109.129 -0.693 . . . . 72.22 109.129 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 73.3 p -63.84 151.88 88.13 Favored Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 123.462 0.705 . . . . 64.54 111.014 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 17' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.14 128.88 30.41 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.643 2.229 . . . . 64.2 112.788 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 18' ' ' VAL . . . . . 0.576 ' HB ' ' SD ' ' C' ' 94' ' ' MET . 61.8 t -69.52 -34.43 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.061 0.545 . . . . 63.44 109.919 174.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 19' ' ' THR . . . . . 0.471 HG22 ' HG3' ' G' ' 20' ' ' LYS . 20.5 m -133.16 -77.8 0.49 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.544 -0.753 . . . . 73.25 109.732 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 20' ' ' LYS . . . . . 0.471 ' HG3' HG22 ' G' ' 19' ' ' THR . 42.7 mtpt -137.62 20.46 2.9 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.891 0.476 . . . . 71.11 110.302 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . 0.564 ' HB2' ' SD ' ' C' ' 94' ' ' MET . . . -62.75 87.95 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.674 0.79 . . . . 62.31 111.45 -175.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -159.78 -58.94 0.06 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.336 -1.302 . . . . 75.04 107.661 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 23' ' ' THR . . . . . 0.566 HG22 ' HG2' ' A' ' 151' ' ' GLU . 66.2 p 49.9 93.97 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 125.494 1.518 . . . . 70.05 112.454 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 24' ' ' PRO . . . . . 0.413 ' HG2' ' HE1' ' A' ' 152' ' ' HIS . 19.5 Cg_endo -59.29 -32.8 97.43 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.533 2.155 . . . . 61.4 111.764 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 CA--C 1.552 1.032 0 C-N-CA 123.769 0.827 . . . . 75.43 109.009 173.769 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 109.452 -0.573 . . . . 72.42 109.452 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' H' H ' 2' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' H' ' 9' ' ' ALA . 13.2 tmtt? -162.78 85.81 0.55 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.092 -1.077 . . . . 75.51 108.092 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -104.41 17.29 24.4 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.915 0.886 . . . . 71.11 109.511 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 6.2 m -63.88 111.55 2.52 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.727 0.811 . . . . 65.31 109.921 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 9.6 m -50.88 -53.67 30.52 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.274 1.43 . . . . 74.31 112.648 -170.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.714 HG23 ' HA ' ' D' ' 128' ' ' LEU . 4.4 tt -145.98 101.14 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.202 0.601 . . . . 63.25 109.584 172.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -177.39 93.43 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.805 1.242 . . . . 62.32 109.295 174.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 82.4 mt 57.81 -165.15 0.17 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.281 1.032 . . . . 71.15 112.535 175.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 9' ' ' ALA . . . . . 0.425 ' HA ' ' HE3' ' H' ' 2' ' ' LYS . . . -150.21 -62.61 0.2 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.326 -1.361 . . . . 63.22 107.326 161.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.89 124.75 6.04 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 107.987 -1.116 . . . . 73.23 107.987 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 67.8 mt -68.05 156.94 88.57 Favored Pre-proline 0 N--CA 1.487 1.392 0 C-N-CA 123.675 0.79 . . . . 53.23 110.958 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -47.59 -51.98 8.8 Favored 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 123.612 2.875 . . . . 73.42 112.608 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 19.7 tp -170.63 -84.46 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.696 0.798 . . . . 74.33 108.881 166.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 92.1 mt -109.9 -161.95 0.78 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.96 0.904 . . . . 72.04 110.232 -173.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -141.27 158.95 43.21 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.204 -1.035 . . . . 73.33 108.204 172.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 16' ' ' THR . . . . . 0.421 ' O ' HD13 ' D' ' 98' ' ' LEU . 24.6 p -56.88 131.4 79.21 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 124.435 1.094 . . . . 75.54 112.095 -175.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.87 152.22 77.46 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.125 2.55 . . . . 60.15 113.616 -173.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . 0.698 HG23 HD11 ' D' ' 98' ' ' LEU . 88.9 t -63.28 -56.52 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.035 0.934 . . . . 64.05 110.448 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 19' ' ' THR . . . . . 0.534 HG23 HG12 ' H' ' 18' ' ' VAL . 12.4 p -144.0 -149.79 0.29 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 113.954 -1.475 . . . . 70.31 108.658 -172.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -62.69 99.12 0.14 Allowed 'General case' 0 C--N 1.36 1.056 0 CA-C-O 121.102 0.477 . . . . 74.2 111.054 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . 0.576 ' HB2' ' SD ' ' D' ' 94' ' ' MET . . . -110.4 128.38 55.55 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.86 0.864 . . . . 51.34 109.243 175.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -69.8 88.94 0.55 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.868 0.842 . . . . 72.23 110.432 174.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 9.6 t -153.56 142.58 14.63 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-N 113.98 -1.464 . . . . 71.13 108.384 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.9 89.84 0.43 Allowed 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.524 2.149 . . . . 74.53 112.344 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 CA--C 1.551 1.008 0 C-N-CA 123.742 0.817 . . . . 75.02 110.525 177.609 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.486 1.345 0 N-CA-C 109.606 -0.516 . . . . 53.44 109.606 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 p -60.44 96.29 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.153 0.981 . . . . 71.15 111.6 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -90.14 -52.74 4.8 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.804 0.842 . . . . 63.33 109.066 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -134.18 35.59 3.26 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 122.275 1.036 . . . . 71.05 109.071 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.15 80.43 9.06 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.572 0.701 . . . . 63.34 109.427 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -76.27 -49.28 17.45 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.777 -1.101 . . . . 54.5 110.418 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.9 p -70.11 -14.7 62.78 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.429 -0.805 . . . . 74.23 112.069 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -63.91 -37.09 86.12 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.465 0.706 . . . . 62.11 109.898 172.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.437 ' SD ' ' N ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -73.46 148.23 43.41 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.645 -0.872 . . . . 74.41 108.645 174.108 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.437 ' N ' ' SD ' ' A' ' 9' ' ' MET . 87.9 m -138.13 124.47 20.56 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.481 0.713 . . . . 61.41 109.308 -173.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.697 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.5 t80 -136.79 136.36 38.79 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 124.046 0.842 . . . . 75.42 109.289 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.491 ' HG3' ' NE2' ' A' ' 14' ' ' GLN . 26.7 tp60 -155.65 97.41 1.85 Allowed 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.29 -1.004 . . . . 64.21 108.29 177.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.451 HG12 ' HD2' ' A' ' 84' ' ' PHE . 29.5 mt -68.21 120.47 15.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 108.729 -0.841 . . . . 74.34 108.729 176.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.491 ' NE2' ' HG3' ' A' ' 12' ' ' GLN . 27.8 mm-40 -81.8 -40.19 22.94 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 123.832 0.707 . . . . 73.23 109.994 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -175.66 122.67 0.2 Allowed 'General case' 0 C--N 1.359 0.994 0 O-C-N 123.426 0.454 . . . . 74.05 111.352 -171.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.434 HD12 ' HG3' ' C' ' 130' ' ' PRO . 88.8 mt -106.96 136.16 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.603 -0.888 . . . . 63.11 108.603 169.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.4 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 24.0 p90 -164.13 166.19 21.49 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.189 0.996 . . . . 62.24 110.597 -174.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.5 p -96.61 119.12 34.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.534 -0.757 . . . . 73.24 109.012 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 36.1 mtpt -87.09 -30.14 21.35 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.166 -0.679 . . . . 72.25 109.166 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 16.7 t70 -144.83 137.13 26.13 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.189 -0.914 . . . . 75.35 109.276 177.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.9 mt -133.69 142.97 40.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 106.384 -1.71 . . . . 75.23 106.384 174.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.6 t -150.26 135.36 17.83 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.624 -0.51 . . . . 63.22 109.624 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.57 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 87.9 t80 -136.79 137.67 40.05 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.421 -1.696 . . . . 75.13 106.421 172.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -137.75 141.45 40.97 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 108.521 -0.918 . . . . 74.53 108.521 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.68 75.27 31.77 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 106.549 -1.649 . . . . 74.44 106.549 171.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.36 -42.84 31.74 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.284 2.656 . . . . 52.55 112.76 -171.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.463 ' ND2' ' HG3' ' A' ' 71' ' ' GLU . 11.2 m-20 -101.64 22.76 12.25 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 118.35 -0.834 . . . . 63.51 109.913 -178.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.443 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -42.61 -58.31 3.87 Favored Pre-proline 0 N--CA 1.497 1.906 0 N-CA-C 113.867 1.062 . . . . 74.52 113.867 -170.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 14.4 Cg_exo -65.66 -24.76 54.92 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 121.7 1.6 . . . . 60.31 112.778 -174.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -81.26 -43.33 19.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.114 -0.948 . . . . 72.43 109.91 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.796 HG21 ' HA ' ' A' ' 73' ' ' ALA . 5.2 p -76.32 -14.01 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-N 115.039 -0.982 . . . . 70.15 112.505 -162.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -69.62 -12.14 61.4 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.871 0.468 . . . . 65.51 111.68 173.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -83.34 -25.59 31.31 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.389 1.076 . . . . 71.51 110.823 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.412 ' NZ ' ' HB3' ' A' ' 71' ' ' GLU . 23.3 mmtp -68.14 149.61 49.37 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.658 0.783 . . . . 73.21 111.808 -177.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -71.13 131.96 44.35 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.301 -1.0 . . . . 70.33 108.301 171.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -77.77 82.01 4.18 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.798 0.809 . . . . 73.22 110.608 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -128.8 81.23 71.21 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 106.938 -1.504 . . . . 73.44 106.938 168.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -82.98 145.59 12.53 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.65 2.233 . . . . 61.22 112.318 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -97.83 89.83 4.73 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 105.823 -1.917 . . . . 63.45 105.823 168.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.526 HG13 HG13 ' A' ' 64' ' ' VAL . 96.6 t -72.16 92.42 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.425 -0.954 . . . . 75.41 108.425 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -87.58 115.47 25.03 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.591 -1.186 . . . . 72.52 108.285 174.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.7 pp -95.41 130.59 42.16 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.788 -1.19 . . . . 65.03 107.788 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.605 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.1 m-20 -120.21 105.71 11.23 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 107.796 -1.187 . . . . 74.23 107.796 176.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.7 mp -98.22 146.7 25.36 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.789 -0.819 . . . . 71.23 108.789 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.592 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 24.9 t70 -145.81 148.27 32.74 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 109.491 -0.559 . . . . 74.24 109.491 177.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 49.1 p -106.44 125.99 51.69 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.556 -0.747 . . . . 63.11 110.247 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -132.91 133.37 43.16 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.035 0.934 . . . . 62.43 108.733 176.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.9 m -133.66 159.26 41.05 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.235 0.614 . . . . 63.34 110.96 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.3 t -158.22 147.77 19.65 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.856 0.863 . . . . 72.12 109.184 174.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -106.81 119.09 38.4 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.118 -1.067 . . . . 63.02 108.118 172.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 50.3 mt -93.09 -37.72 11.99 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.163 0.585 . . . . 72.32 111.087 -173.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.79 -171.98 3.31 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.718 0.807 . . . . 61.44 110.3 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -63.59 119.45 9.87 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.553 0.741 . . . . 75.13 109.633 170.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 70.74 -7.19 1.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.773 1.229 . . . . 64.32 112.598 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.62 110.72 28.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 N-CA-C 107.965 -1.124 . . . . 63.52 107.965 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -134.1 128.48 34.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.363 -0.835 . . . . 74.53 109.28 -170.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -96.12 127.58 42.25 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.853 0.861 . . . . 72.43 110.921 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.442 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 68.0 t -107.44 124.58 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 107.106 -1.442 . . . . 74.41 107.106 168.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.479 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 44.0 t -119.62 124.57 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.367 -0.975 . . . . 70.34 108.367 172.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.415 HD22 HG22 ' A' ' 62' ' ' VAL . 1.8 tt -115.85 115.47 26.31 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.774 -1.195 . . . . 74.14 107.774 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.592 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 49.2 ttt180 -84.11 99.72 10.66 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.897 -1.149 . . . . 71.01 107.897 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.415 HG22 HD22 ' A' ' 60' ' ' LEU . 49.9 t -97.96 101.67 12.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.027 -1.101 . . . . 70.01 108.027 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.605 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 21.9 m -102.6 143.7 31.95 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.891 -0.781 . . . . 74.41 108.891 175.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.555 HG11 HD21 ' A' ' 126' ' ' LEU . 24.7 t -136.87 137.55 46.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 125.445 1.498 . . . . 72.11 107.201 173.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.4 m -132.29 127.15 35.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.719 -0.845 . . . . 71.54 108.719 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.62 104.26 14.28 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 107.949 -1.13 . . . . 72.41 107.949 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 50.5 m -108.0 126.86 53.21 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.572 0.349 . . . . 65.32 110.464 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.2 mt -103.94 83.11 2.06 Favored 'General case' 0 C--O 1.249 1.065 0 C-N-CA 124.052 0.941 . . . . 74.13 108.535 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.13 -84.79 1.13 Allowed Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.282 -0.872 . . . . 75.53 111.715 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.38 -26.2 3.36 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.925 0.89 . . . . 54.33 110.045 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.463 ' HG3' ' ND2' ' A' ' 27' ' ' ASN . 45.5 tt0 -94.17 112.65 24.47 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.784 0.834 . . . . 75.4 109.643 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 94.0 m -73.25 135.37 44.49 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.018 0.437 . . . . 54.34 110.441 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.796 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -72.61 -61.99 1.61 Allowed 'General case' 0 C--O 1.243 0.75 0 CA-C-N 114.679 -1.146 . . . . 70.43 110.078 176.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -156.23 174.85 14.78 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 114.806 -1.088 . . . . 74.43 112.124 -178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.3 tp -133.67 135.46 44.12 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.778 1.631 . . . . 62.22 107.647 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 79.2 m -134.96 105.41 6.37 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.042 0.937 . . . . 71.05 109.632 178.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -126.54 115.91 20.26 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.257 1.023 . . . . 62.42 109.141 -174.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.4 t -129.74 114.52 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.277 0.631 . . . . 71.31 109.487 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.564 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 75.6 mt-30 -85.0 88.14 7.43 Favored 'General case' 0 C--O 1.249 1.048 0 N-CA-C 108.334 -0.987 . . . . 62.44 108.334 170.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.402 ' HG3' HD22 ' A' ' 106' ' ' LEU . 8.4 tp-100 -77.34 104.96 8.15 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 114.849 -1.069 . . . . 72.41 109.16 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.98 147.35 20.94 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 111.325 -0.71 . . . . 62.14 111.325 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.522 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -152.05 120.77 1.11 Allowed Glycine 0 CA--C 1.499 -0.93 0 N-CA-C 110.78 -0.928 . . . . 73.54 110.78 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.1 mt -83.61 121.49 36.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 108.308 -0.997 . . . . 73.32 108.308 173.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.697 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 33.0 m-85 -129.67 137.49 50.65 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.66 -0.867 . . . . 74.22 108.66 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.1 t -103.69 98.33 8.22 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.995 -0.743 . . . . 61.44 108.995 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.488 HG12 HG21 ' E' ' 18' ' ' VAL . 0.2 OUTLIER -136.11 153.45 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.626 1.17 . . . . 63.42 109.315 179.172 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.31 -32.39 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.552 -0.749 . . . . 51.1 111.127 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.0 64.52 3.91 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.229 -0.441 . . . . 65.13 112.998 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.486 ' HB ' ' HA ' ' A' ' 94' ' ' MET . 4.0 pt -147.58 123.39 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.636 1.174 . . . . 74.45 108.836 -175.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -137.38 167.02 22.45 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.934 0.893 . . . . 72.5 110.299 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.02 -136.78 29.12 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.406 0.441 . . . . 75.02 112.599 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.0 t -80.32 -15.27 57.29 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.008 0.523 . . . . 55.14 110.598 174.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -67.65 -34.78 77.62 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.613 0.765 . . . . 74.32 111.011 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.486 ' HA ' ' HB ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -66.77 -41.29 87.96 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 109.845 -0.428 . . . . 74.24 109.845 176.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.86 -29.38 66.6 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.948 0.899 . . . . 62.25 110.934 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -68.53 -39.47 81.16 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.033 0.933 . . . . 71.0 109.888 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.559 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 43.7 t -69.34 -52.92 22.55 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 123.732 0.645 . . . . 51.12 111.429 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.62 HD23 HG12 ' E' ' 18' ' ' VAL . 3.7 pp -77.5 -20.96 53.48 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.893 0.477 . . . . 72.13 111.782 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.619 ' HA3' HD22 ' E' ' 14' ' ' LEU . . . -102.57 -16.11 23.13 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 115.223 0.849 . . . . 63.33 115.223 -170.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.02 -43.83 0.14 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.616 0.708 . . . . 45.12 112.727 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.559 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 67.9 t80 -67.9 -68.97 0.35 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.815 0.846 . . . . 75.1 111.301 -170.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 76.0 m -65.56 -35.85 12.93 Favored Pre-proline 0 CA--C 1.568 1.641 0 C-N-CA 123.573 0.749 . . . . 64.11 112.781 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -47.56 -48.56 15.25 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 122.774 2.316 . . . . 74.21 114.383 162.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.45 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 29.7 t-20 -69.72 -24.35 63.55 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.089 0.555 . . . . 72.25 110.516 -177.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 38.8 mm -63.39 -39.46 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.218 0.532 . . . . 72.23 110.567 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.522 HD21 ' HA3' ' A' ' 82' ' ' GLY . 91.2 mt -78.63 -24.94 44.99 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.617 0.767 . . . . 72.11 112.056 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -60.65 -47.38 96.18 Favored Pre-proline 0 CA--C 1.565 1.557 0 N-CA-C 114.256 1.206 . . . . 75.21 114.256 -171.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 104' ' ' ASN . 37.0 Cg_exo -62.61 -32.48 79.27 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.034 1.823 . . . . 73.24 113.121 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -77.37 -38.29 50.41 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.685 0.794 . . . . 74.22 111.002 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.11 -37.25 75.32 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.146 0.578 . . . . 74.31 110.046 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.426 ' NH1' HD12 ' C' ' 105' ' ' ILE . 24.1 ttm180 -60.63 -50.64 72.71 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.215 1.006 . . . . 74.22 109.732 174.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.1 -42.86 88.71 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.81 0.693 . . . . 61.34 110.646 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 43.5 t -62.65 -32.76 73.86 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.813 0.445 . . . . 64.14 110.666 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.512 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 32.3 mt -67.55 -55.76 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 123.518 0.727 . . . . 74.3 109.932 170.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.539 HG21 ' HE2' ' C' ' 109' ' ' TYR . 87.8 m -55.22 -38.38 68.36 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.016 1.326 . . . . 75.2 111.894 -175.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.504 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 47.5 t -63.29 -50.03 71.71 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.479 -0.782 . . . . 63.12 110.07 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.57 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 50.9 mtm -63.67 -38.25 90.4 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.373 0.669 . . . . 71.33 111.578 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.9 t -64.18 -53.17 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.807 0.843 . . . . 75.14 110.62 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.2 t -67.52 -31.41 71.51 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.613 -0.722 . . . . 73.04 110.839 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 116' ' ' SER . 24.9 ttm-85 -72.13 -32.77 67.24 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.489 1.116 . . . . 74.41 108.46 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.425 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.82 14.25 53.11 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-N 114.561 -1.2 . . . . 60.05 113.47 173.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.548 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.3 t 63.38 12.28 6.15 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 126.471 1.908 . . . . 73.23 114.178 172.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -83.16 148.51 56.48 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 108.562 -0.903 . . . . 63.25 108.562 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.15 163.11 10.42 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.215 2.61 . . . . 73.54 113.205 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -57.04 122.46 12.39 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.32 -0.855 . . . . 71.41 112.367 -171.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.555 HD21 HG11 ' A' ' 64' ' ' VAL . 52.0 tp -121.95 106.77 11.53 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.588 1.155 . . . . 62.31 109.022 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -130.14 121.09 25.63 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.996 0.918 . . . . 73.05 108.945 176.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.659 HD23 HD12 ' E' ' 6' ' ' ILE . 96.5 mt -68.25 143.72 55.16 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.797 0.439 . . . . 73.41 109.895 173.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.501 ' HB3' ' HA ' ' E' ' 7' ' ' ALA . . . -68.41 136.86 91.0 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.123 0.569 . . . . 35.32 110.384 178.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.423 ' HG2' ' CE2' ' C' ' 11' ' ' PHE . 2.7 Cg_endo -79.29 92.12 1.15 Allowed 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.84 2.36 . . . . 74.2 110.609 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.2 t -101.64 113.39 37.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.338 -0.986 . . . . 63.13 108.338 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -69.73 100.05 1.44 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.804 -0.813 . . . . 71.11 108.804 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -50.71 -44.76 58.19 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.968 0.907 . . . . 72.53 111.017 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -66.09 -36.91 84.44 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.171 -1.377 . . . . 45.55 112.644 -176.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.64 -40.25 96.4 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 123.623 0.577 . . . . 73.43 110.408 176.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.7 mp -71.42 -32.24 68.16 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 116.025 -0.534 . . . . 75.12 110.723 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -68.4 -28.12 66.81 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.876 0.47 . . . . 73.13 110.602 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 22.5 mmt -69.7 -33.3 72.33 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.449 0.7 . . . . 74.21 110.491 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 143' ' ' GLN . 0.9 OUTLIER -59.16 -35.57 73.77 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 123.679 0.612 . . . . 55.44 111.052 174.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -85.45 -29.69 24.12 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.726 0.811 . . . . 72.41 111.389 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.2 tp -66.04 -48.8 69.87 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.086 0.555 . . . . 72.25 110.408 -174.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -169.72 -15.45 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.785 0.661 . . . . 64.3 112.785 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' A' ' 139' ' ' ASN . 63.8 mm-40 -99.47 70.84 1.72 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.135 0.574 . . . . 71.54 110.388 -170.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -66.09 88.08 0.11 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.214 0.606 . . . . 64.42 110.586 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.64 ' HA ' HG22 ' C' ' 7' ' ' THR . . . 61.42 -163.97 0.25 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.345 1.058 . . . . 74.32 112.209 175.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 97.53 103.75 2.25 Favored Glycine 0 C--N 1.344 1.027 0 N-CA-C 111.267 -0.733 . . . . 75.04 111.267 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -165.36 140.3 5.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.04 0.936 . . . . 61.44 109.15 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -77.92 169.43 54.6 Favored Glycine 0 C--N 1.35 1.347 0 O-C-N 123.636 0.585 . . . . 50.32 111.829 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.617 ' HA ' ' HA2' ' C' ' 88' ' ' GLY . 12.7 p -135.84 148.61 48.74 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.694 0.798 . . . . 74.22 109.33 176.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.69 105.63 3.46 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 107.564 -1.273 . . . . 70.45 107.564 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.64 -27.48 68.41 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.912 0.885 . . . . 74.33 111.71 -174.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 80.0 t60 66.86 115.76 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.095 1.358 . . . . 64.44 112.94 171.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -131.05 1.1 4.24 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.923 0.489 . . . . 73.23 111.283 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -76.29 94.71 3.62 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.286 0.565 . . . . 74.03 110.536 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 N-CA-C 108.494 -0.928 . . . . 73.02 108.494 177.191 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 C--O 1.244 0.804 0 N-CA-C 110.004 -0.369 . . . . 64.02 110.004 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 67.9 m -137.67 122.34 18.63 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.177 0.991 . . . . 64.33 109.023 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -137.9 111.62 8.23 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.85 0.86 . . . . 65.22 109.114 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -148.28 115.29 6.11 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.087 -0.709 . . . . 54.1 109.087 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -85.77 162.49 18.67 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.347 0.659 . . . . 62.34 110.46 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -114.89 88.33 2.85 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.899 -1.148 . . . . 73.03 107.899 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 32.3 m -137.37 103.67 5.15 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.485 0.714 . . . . 75.41 109.191 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.23 -175.24 5.23 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 124.251 1.02 . . . . 74.52 108.788 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 57.6 ttm 66.17 166.21 0.2 Allowed 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 125.003 1.321 . . . . 75.03 111.336 -174.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 96.6 m -150.1 118.34 6.39 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 106.163 -1.791 . . . . 75.45 106.163 171.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.438 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 58.9 t80 -127.17 144.59 51.0 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.342 -0.614 . . . . 72.22 109.342 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.529 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -155.52 136.44 13.64 Favored 'General case' 0 C--O 1.243 0.715 0 O-C-N 123.671 0.607 . . . . 72.14 110.064 173.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.563 HD13 HD11 ' B' ' 16' ' ' ILE . 58.4 mt -76.75 125.4 36.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.492 0 N-CA-C 108.456 -0.942 . . . . 71.24 108.456 169.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -92.17 -49.86 5.97 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.833 -0.803 . . . . 72.53 108.833 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.548 ' HE ' HG21 ' A' ' 122' ' ' THR . 42.9 ttt180 -164.5 134.04 3.81 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.685 -0.689 . . . . 52.12 110.217 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.563 HD11 HD13 ' B' ' 13' ' ' ILE . 76.1 mt -115.24 140.42 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 124.042 0.937 . . . . 72.21 108.603 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -169.18 152.1 4.91 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 112.707 0.632 . . . . 75.15 112.707 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 82.5 m -76.76 125.45 29.3 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.968 -1.015 . . . . 72.23 109.008 169.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.412 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 40.3 mtpt -97.87 -31.83 12.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.099 0.56 . . . . 71.42 111.482 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.45 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 10.9 t70 -155.66 136.62 13.65 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.275 -0.421 . . . . 72.22 109.992 -168.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.474 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.7 mm -135.15 142.36 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.69 1.196 . . . . 75.11 108.68 177.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.8 t -149.34 108.17 3.86 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.803 -1.184 . . . . 63.34 107.803 173.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -122.56 118.89 29.29 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 107.644 -1.243 . . . . 64.44 107.644 172.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -118.91 153.03 35.23 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.13 0.972 . . . . 75.42 108.697 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.513 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -142.37 80.32 14.86 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 106.32 -1.733 . . . . 63.05 106.32 173.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.49 -31.0 42.93 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.059 2.506 . . . . 72.23 113.095 -168.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -108.94 14.78 23.91 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.188 0.595 . . . . 71.14 110.828 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.513 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -42.51 -64.34 0.73 Allowed Pre-proline 0 N--CA 1.492 1.661 0 N-CA-C 114.959 1.466 . . . . 62.31 114.959 -166.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.403 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 34.6 Cg_endo -63.3 -30.62 73.69 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.215 1.943 . . . . 73.4 113.702 -168.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -94.24 -28.68 15.48 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.744 0.418 . . . . 72.25 111.401 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.533 HG22 HD12 ' B' ' 68' ' ' LEU . 2.8 p -73.04 -20.12 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 122.594 0.357 . . . . 71.23 110.464 -176.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -65.43 -14.78 61.68 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.903 0.881 . . . . 75.11 113.104 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -68.05 -19.21 64.87 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.818 0.447 . . . . 74.35 110.701 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -90.6 106.34 18.44 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.451 1.101 . . . . 73.23 109.932 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -93.93 83.87 4.44 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.313 0.645 . . . . 64.35 110.626 -174.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -169.03 173.52 6.84 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.231 1.013 . . . . 75.33 109.854 170.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -85.16 121.54 73.99 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 109.14 -0.689 . . . . 75.44 109.14 176.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.12 165.53 31.07 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.772 2.315 . . . . 75.24 113.863 -175.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 10.1 tp10 -69.76 126.33 29.41 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.388 -0.824 . . . . 75.14 109.483 176.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.7 140.54 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.394 0.616 . . . . 65.22 111.16 -171.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.608 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 63.2 mttp -126.91 143.73 51.19 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.432 1.093 . . . . 63.23 109.696 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.718 HD21 HG13 ' F' ' 6' ' ' ILE . 3.4 mm? -114.07 132.5 56.0 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.924 0.89 . . . . 74.33 108.634 175.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -151.2 109.29 3.72 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 108.23 -1.026 . . . . 71.44 108.23 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.522 HD21 HD11 ' F' ' 8' ' ' LEU . 9.9 mp -102.41 157.03 17.2 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.471 -0.566 . . . . 64.3 109.471 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -139.28 153.9 47.86 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 108.445 -0.946 . . . . 75.53 108.445 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 74.3 p -107.66 118.39 36.61 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.362 -0.835 . . . . 74.25 108.929 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.427 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -126.87 136.37 52.24 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.552 -1.277 . . . . 32.22 107.552 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 59.7 p -143.25 163.04 34.05 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-O 120.628 0.251 . . . . 73.44 111.132 -174.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . 0.481 ' HA ' ' HB3' ' F' ' 22' ' ' ARG . 74.9 p -153.28 137.03 16.09 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.739 0.816 . . . . 74.03 109.499 173.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -94.62 111.47 23.23 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.529 -1.286 . . . . 74.31 107.529 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.5 mt -81.15 -53.55 6.28 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.041 0.448 . . . . 65.2 110.809 -176.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -145.01 -177.09 5.36 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.123 -0.944 . . . . 75.14 109.517 -175.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.43 109.74 1.45 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.349 0.66 . . . . 71.21 110.011 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 69.15 4.88 4.79 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 125.011 1.324 . . . . 55.2 113.347 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 98.4 t -104.77 117.54 50.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.615 -1.254 . . . . 60.04 107.615 172.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -123.16 177.26 5.63 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 121.352 0.596 . . . . 75.41 109.822 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -142.66 102.64 4.09 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.446 -1.316 . . . . 51.1 107.446 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 65.5 t -89.43 121.25 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.626 1.171 . . . . 75.03 109.739 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.501 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.6 t -109.2 109.57 28.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 C-N-CA 123.529 0.732 . . . . 54.23 109.26 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 35.6 tp -93.31 109.42 20.96 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.306 -0.627 . . . . 74.41 109.306 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -86.83 117.99 25.92 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 108.614 -0.884 . . . . 74.22 108.614 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.441 ' HA ' ' HG ' ' B' ' 44' ' ' LEU . 14.3 t -112.19 116.82 53.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 108.392 -0.966 . . . . 72.53 108.392 172.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.8 m -112.36 138.45 49.06 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.827 0.822 . . . . 72.31 109.404 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.725 HG21 HG21 ' B' ' 114' ' ' ILE . 54.4 t -127.19 131.41 70.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 125.644 1.578 . . . . 64.21 108.284 -174.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.608 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 89.2 m -117.95 146.19 44.16 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.31 -0.626 . . . . 62.12 109.31 173.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.94 139.34 23.62 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.602 0.761 . . . . 43.41 110.085 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.594 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 17.7 p -147.49 127.21 13.4 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.486 0.492 . . . . 61.35 111.619 -176.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.533 HD12 HG22 ' B' ' 31' ' ' VAL . 54.7 mt -98.32 107.39 19.84 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 107.812 -1.181 . . . . 75.41 107.812 174.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.98 -131.53 12.54 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 120.024 -0.32 . . . . 72.34 112.572 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -99.01 17.47 19.62 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.592 0.757 . . . . 73.02 111.687 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -138.84 154.24 48.42 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.424 0.689 . . . . 73.52 109.9 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 49.5 m -77.94 123.32 26.65 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.908 0.385 . . . . 72.23 111.061 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.594 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -74.4 -60.77 2.12 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.322 -0.992 . . . . 61.42 108.322 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -155.85 156.92 35.53 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 115.252 -0.885 . . . . 74.52 112.328 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 79.7 mt -125.68 119.87 29.17 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 125.74 1.616 . . . . 65.32 106.973 175.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.511 ' SG ' HG23 ' B' ' 114' ' ' ILE . 49.3 t -118.28 150.39 39.54 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.709 -0.848 . . . . 42.23 108.709 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -159.88 126.43 4.38 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.419 -0.956 . . . . 74.31 108.419 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 86.9 t -122.69 145.94 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.325 -0.852 . . . . 74.14 109.146 176.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.45 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 18.1 mt-30 -120.65 97.1 5.4 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.271 -1.011 . . . . 74.24 108.271 169.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -87.07 101.53 13.55 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.8 -0.815 . . . . 63.55 108.8 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.08 164.08 33.55 Favored Glycine 0 C--O 1.246 0.848 0 O-C-N 123.903 0.752 . . . . 61.22 111.862 177.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.39 126.07 1.44 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.867 -0.493 . . . . 73.42 111.867 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 59.9 mt -84.61 130.02 36.71 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 108.31 -0.996 . . . . 75.44 108.31 172.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -139.22 156.5 47.05 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.147 0.579 . . . . 71.0 109.473 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 69.1 m -121.27 133.07 55.13 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.999 0.92 . . . . 71.25 109.126 175.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.494 HG21 HG21 ' F' ' 18' ' ' VAL . 12.4 tt -130.56 148.96 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.526 0.73 . . . . 74.43 110.576 -177.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.25 175.07 14.48 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.909 0.884 . . . . 73.43 109.621 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.51 -56.29 4.72 Favored Glycine 0 N--CA 1.473 1.128 0 C-N-CA 123.128 0.394 . . . . 72.53 112.586 175.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.539 HG22 ' HB3' ' B' ' 94' ' ' MET . 7.4 mm -90.9 153.02 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.04 0.936 . . . . 75.0 110.93 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -147.21 -178.6 6.31 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.757 1.223 . . . . 70.25 109.104 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.31 -134.42 22.86 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 115.548 -0.751 . . . . 61.3 113.973 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 54.1 m -75.38 -33.64 61.03 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.559 0.744 . . . . 72.5 111.944 -177.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -60.78 -33.04 72.37 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.369 0.668 . . . . 72.03 111.854 -175.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.539 ' HB3' HG22 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -86.12 -24.62 26.16 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.695 0.398 . . . . 72.15 111.816 176.215 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.75 -32.26 73.71 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.033 0.533 . . . . 70.1 110.817 172.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -76.42 -36.08 58.19 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.554 -0.748 . . . . 61.44 110.966 172.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.0 t -60.67 -52.4 65.28 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.016 0.527 . . . . 51.45 111.354 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.52 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 0.5 OUTLIER -80.52 -13.53 59.01 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.251 0.463 . . . . 51.11 112.251 175.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.23 1.44 62.63 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-O 119.608 -0.551 . . . . 63.42 113.784 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.47 -53.38 0.11 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 117.482 0.641 . . . . 73.13 110.957 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -70.73 -50.33 37.32 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.174 0.59 . . . . 73.23 112.559 -172.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 61.2 m -60.79 -47.26 96.29 Favored Pre-proline 0 CA--C 1.563 1.452 0 CA-C-O 118.811 -0.614 . . . . 72.51 111.626 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.49 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 48.4 Cg_exo -60.8 -32.7 93.14 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 122.432 2.088 . . . . 70.34 114.106 171.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -61.01 -38.09 84.86 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.828 0.851 . . . . 61.12 110.202 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.414 HG23 ' NH2' ' D' ' 111' ' ' ARG . 74.8 mt -62.47 -40.79 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 114.976 -1.011 . . . . 72.03 110.606 174.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 56.3 mt -86.4 -13.12 47.27 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.975 -1.011 . . . . 72.3 111.765 -171.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -55.31 -52.29 72.73 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 124.019 0.928 . . . . 75.11 112.915 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -59.76 -37.0 89.75 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.324 2.016 . . . . 72.33 114.088 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -67.83 -44.57 76.89 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.03 0.532 . . . . 73.45 110.635 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.98 -36.42 83.26 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.726 -0.67 . . . . 65.43 110.822 176.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -61.96 -50.5 71.86 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.967 1.307 . . . . 60.15 110.256 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -68.73 -33.61 74.22 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 115.309 -0.86 . . . . 73.14 109.704 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.474 ' SG ' HD11 ' B' ' 21' ' ' ILE . 13.5 t -66.55 -44.47 82.26 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.934 0.494 . . . . 72.31 111.77 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.725 HG21 HG21 ' B' ' 64' ' ' VAL . 95.2 mt -60.05 -53.5 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 108.894 -0.78 . . . . 64.24 108.894 175.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 38.5 m -57.02 -36.05 69.98 Favored 'General case' 0 CA--C 1.553 1.064 0 O-C-N 124.371 1.045 . . . . 51.35 111.602 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.2 t -62.74 -47.21 84.56 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 123.526 0.73 . . . . 53.54 109.749 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 9.7 mmt -70.38 -35.8 73.73 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.006 0.523 . . . . 74.14 111.172 -176.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' B' ' 114' ' ' ILE . 97.0 t -60.24 -43.92 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.763 0.825 . . . . 65.45 109.801 172.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.2 t -65.34 -33.0 74.94 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.646 -1.161 . . . . 71.43 111.355 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' B' ' 116' ' ' SER . 83.0 mtt-85 -71.04 -36.21 72.27 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.536 -0.756 . . . . 70.54 110.187 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.95 -3.65 81.21 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 123.752 0.658 . . . . 72.11 112.316 172.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 23.6 p 62.82 35.01 14.01 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.446 1.899 . . . . 64.24 112.428 173.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -93.69 164.45 20.83 Favored Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 124.103 0.961 . . . . 73.34 110.67 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.04 166.15 1.04 Allowed 'Trans proline' 0 C--N 1.393 2.869 0 C-N-CA 123.663 2.909 . . . . 63.4 115.524 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -63.54 121.4 13.77 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 115.375 -0.83 . . . . 65.31 111.127 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 18.6 tp -129.2 98.43 4.9 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.046 -0.524 . . . . 73.41 109.922 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -124.38 121.26 34.45 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.863 0.865 . . . . 75.43 109.591 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mp -64.88 149.25 49.89 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.949 0.5 . . . . 72.55 111.117 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.9 150.99 73.05 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.452 0.701 . . . . 54.23 110.023 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -67.64 129.45 19.99 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 123.031 2.487 . . . . 34.55 112.395 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 26.0 m -131.95 128.4 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.46 0.704 . . . . 52.11 109.257 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -109.13 102.13 11.12 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 107.252 -1.388 . . . . 73.23 107.252 173.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -60.93 -47.73 85.09 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.17 0.918 . . . . 73.43 110.102 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -60.85 -40.73 93.99 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 114.283 -1.326 . . . . 62.12 112.014 -174.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.98 -40.13 79.89 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 123.906 0.754 . . . . 65.05 111.927 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.705 HD12 HD21 ' F' ' 10' ' ' LEU . 62.9 mt -76.67 -44.25 34.54 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.576 -0.738 . . . . 64.31 111.219 -176.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -70.98 -27.43 63.71 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.055 0.542 . . . . 75.2 111.756 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 10.7 tmm? -68.42 -35.0 76.99 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.509 0.724 . . . . 73.13 109.293 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -75.33 -5.82 46.71 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.763 -1.108 . . . . 71.22 111.856 -172.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -82.31 -26.83 32.7 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 122.791 0.436 . . . . 62.43 110.028 171.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 63.5 mt -104.43 13.69 31.45 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.244 1.018 . . . . 74.1 111.35 -176.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -65.98 129.58 40.27 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.05 0.54 . . . . 65.34 110.384 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -163.2 129.49 3.31 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.148 -0.686 . . . . 73.4 109.148 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -150.35 153.27 35.76 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.392 0.677 . . . . 73.5 110.137 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.18 98.7 1.31 Allowed 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.377 1.071 . . . . 32.14 108.547 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -112.5 156.95 15.26 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.698 -0.561 . . . . 73.12 111.698 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.91 142.12 37.04 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 108.805 -0.813 . . . . 54.24 108.805 178.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -139.03 103.39 0.39 Allowed Glycine 0 C--N 1.345 1.065 0 N-CA-C 111.488 -0.645 . . . . 64.21 111.488 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 14.7 t -138.57 162.08 35.46 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.657 0.783 . . . . 63.13 110.399 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -150.59 169.3 21.87 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.991 0.916 . . . . 74.32 109.639 171.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -157.84 136.47 11.28 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.553 0.741 . . . . 73.15 110.047 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -164.75 96.3 0.73 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.268 1.027 . . . . 74.14 109.171 174.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -81.23 160.83 24.19 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.386 0.675 . . . . 62.25 110.709 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -147.92 95.91 2.57 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.713 0.805 . . . . 65.1 108.875 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.19 0 C-N-CA 123.812 0.845 . . . . 44.03 109.234 -175.543 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.8 ttp . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.442 -0.577 . . . . 74.14 109.442 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 43.8 p -71.8 96.62 1.66 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.213 0.605 . . . . 74.43 110.256 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 65.17 -148.78 0.25 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.282 1.033 . . . . 75.21 111.88 169.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -77.38 174.81 10.39 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.013 0.925 . . . . 71.4 112.443 -170.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -129.55 -43.11 1.28 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.192 0.997 . . . . 73.32 110.159 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -84.07 57.27 4.1 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 122.115 0.959 . . . . 71.14 109.669 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 145' ' ' ALA . 11.8 p -142.5 83.09 1.8 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.764 1.225 . . . . 71.01 108.966 -172.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 62.59 86.47 0.11 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.579 1.151 . . . . 72.52 112.112 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 12.6 tpt 65.8 151.85 0.06 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.196 1.398 . . . . 75.03 113.367 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 53.4 m -117.46 92.76 3.93 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.884 -0.784 . . . . 73.11 108.884 170.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.599 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 33.8 t80 -113.21 136.31 52.87 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.093 -1.077 . . . . 72.43 108.093 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -155.16 136.55 14.1 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.887 -0.412 . . . . 71.41 109.887 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.492 HG12 ' HE2' ' C' ' 84' ' ' PHE . 56.4 mt -79.2 128.54 38.47 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 N-CA-C 109.036 -0.728 . . . . 43.43 109.036 171.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -101.0 -34.99 9.53 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.598 0.759 . . . . 62.12 110.073 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -176.63 139.29 0.31 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.167 0.587 . . . . 73.14 109.74 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.422 HD11 HD13 ' C' ' 13' ' ' ILE . 95.0 mt -129.89 142.58 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 108.187 -1.042 . . . . 71.32 108.187 175.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.421 ' HE1' HG12 ' C' ' 83' ' ' ILE . 32.9 p90 -172.47 167.02 5.66 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.162 0.985 . . . . 72.4 109.334 -169.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -91.76 114.2 26.68 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 122.893 0.477 . . . . 72.31 109.912 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.693 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 21.8 mmtp -65.44 -42.58 92.26 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 109.362 -0.607 . . . . 64.45 109.362 168.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.7 t70 -145.53 146.8 31.57 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.932 -1.031 . . . . 73.35 110.391 -174.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.541 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.1 mt -141.72 147.48 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.819 1.648 . . . . 74.33 106.813 174.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.0 t -160.46 151.47 18.95 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.225 0.61 . . . . 72.24 110.174 176.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -155.52 112.21 3.2 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 124.384 1.074 . . . . 74.12 108.104 174.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -122.77 132.15 54.1 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.407 0.683 . . . . 71.34 110.477 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.61 86.35 4.67 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 107.634 -1.247 . . . . 74.43 107.634 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.43 -40.81 29.26 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.088 2.525 . . . . 75.44 112.03 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -91.53 18.16 7.72 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 113.902 -1.499 . . . . 64.32 111.625 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.99 -56.32 6.42 Favored Pre-proline 0 N--CA 1.486 1.354 0 N-CA-C 114.029 1.122 . . . . 63.43 114.029 -171.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -60.99 -40.35 53.0 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 121.76 1.64 . . . . 64.24 112.415 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -68.75 -38.03 79.83 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.16 0.984 . . . . 75.33 112.493 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.662 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.6 p -79.04 -13.98 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 C-N-CA 123.329 0.652 . . . . 62.02 111.903 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -75.3 -17.67 60.22 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 112.521 0.563 . . . . 73.43 112.521 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -103.22 36.23 2.31 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.16 0.505 . . . . 70.01 110.208 175.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.435 ' HG2' HD13 ' C' ' 68' ' ' LEU . 1.0 OUTLIER -119.35 149.45 41.8 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.005 0.522 . . . . 72.42 111.358 -174.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -59.17 101.97 0.11 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.237 1.015 . . . . 72.21 109.802 176.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.602 ' HD1' ' HB3' ' C' ' 154' ' ' ASP . 75.9 t-105 -79.07 101.76 8.03 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.153 0.502 . . . . 75.34 111.528 -171.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.484 ' HB2' ' HG2' ' C' ' 153' ' ' GLN . 62.4 tt0 -163.04 76.65 1.86 Allowed Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 107.876 -1.157 . . . . 74.32 107.876 167.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -88.0 153.41 7.11 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.776 2.317 . . . . 62.32 113.316 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -87.6 109.04 19.36 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.079 -0.964 . . . . 55.31 108.927 167.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.468 HG23 HG13 ' C' ' 64' ' ' VAL . 2.7 p -72.02 100.35 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-O 121.85 0.833 . . . . 74.03 109.825 173.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -92.28 98.83 11.75 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.835 -1.172 . . . . 71.42 107.835 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 pp -103.19 154.12 19.65 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.661 0.384 . . . . 73.21 110.145 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -143.88 140.44 29.77 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.355 -0.609 . . . . 72.55 109.355 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -118.85 111.96 19.07 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.0 -0.741 . . . . 73.31 109.0 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.49 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 5.8 t70 -112.24 150.85 30.33 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.732 1.213 . . . . 63.23 108.513 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . 0.608 ' HB ' ' HD2' ' G' ' 15' ' ' PHE . 76.8 p -116.48 138.07 51.67 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.506 0.723 . . . . 63.45 111.259 -170.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.34 150.19 38.81 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.253 1.021 . . . . 74.14 109.105 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 11.7 p -165.49 158.16 15.55 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.425 0.528 . . . . 51.05 112.425 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 67.7 p -160.2 143.93 14.05 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.277 1.031 . . . . 61.45 109.559 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -80.95 131.13 35.31 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.166 -0.679 . . . . 64.45 109.166 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' C' ' 57' ' ' GLU . 29.1 mt -107.57 -32.98 7.46 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.259 0.624 . . . . 72.03 110.846 -176.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.17 -174.53 4.76 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.459 0.704 . . . . 64.22 110.68 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -66.15 130.31 42.8 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.943 -1.026 . . . . 73.54 109.166 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 64.86 -6.89 0.29 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.836 1.255 . . . . 74.32 113.274 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 71.0 t -108.87 119.6 58.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 C-N-CA 123.259 0.623 . . . . 63.22 110.432 -167.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.525 ' HB2' HD11 ' C' ' 86' ' ' ILE . 13.6 m-85 -119.99 143.58 47.97 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.72 -1.127 . . . . 74.52 108.864 171.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.629 ' HB2' HD11 ' C' ' 51' ' ' LEU . 24.2 tt0 -83.56 110.24 18.07 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.396 -1.729 . . . . 75.41 107.862 167.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 78.6 t -96.9 112.17 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.033 -1.469 . . . . 63.22 107.033 172.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.466 HG23 ' HG2' ' C' ' 57' ' ' GLU . 90.3 t -113.04 134.05 56.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 107.983 -1.117 . . . . 74.21 107.983 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.444 HD22 ' HB2' ' C' ' 103' ' ' PRO . 26.8 tp -127.61 119.96 27.08 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.037 -0.727 . . . . 72.25 109.037 175.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.49 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.7 ttm180 -81.21 123.68 28.66 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 124.211 0.945 . . . . 72.22 109.45 173.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.1 114.94 48.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.699 -1.222 . . . . 63.1 107.699 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 36.0 m -114.63 142.82 45.96 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.426 -0.953 . . . . 74.12 108.426 -175.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.468 HG13 HG23 ' C' ' 40' ' ' VAL . 53.5 t -136.25 110.0 9.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.717 1.207 . . . . 62.11 107.894 178.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.502 HG23 HD23 ' C' ' 75' ' ' LEU . 3.7 m -107.0 107.2 18.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.059 -1.46 . . . . 73.3 107.059 172.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.88 122.34 40.88 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.989 -1.485 . . . . 50.01 106.989 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 44.5 m -132.87 127.35 34.24 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.889 0.376 . . . . 32.44 111.115 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.435 HD13 ' HG2' ' C' ' 34' ' ' LYS . 10.2 mt -86.02 43.76 1.07 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.385 1.474 . . . . 71.22 109.787 174.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.49 -113.51 4.61 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 109.748 -1.341 . . . . 74.41 109.748 -171.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -90.01 -28.83 18.82 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.192 0.597 . . . . 72.45 110.2 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -72.38 102.29 3.12 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.714 -0.847 . . . . 73.31 108.714 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 30.1 m -68.99 123.85 22.13 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.294 -0.632 . . . . 71.11 109.294 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.662 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -66.08 -64.46 0.85 Allowed 'General case' 0 C--O 1.239 0.51 0 O-C-N 123.99 0.806 . . . . 74.52 108.908 177.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -154.61 171.85 18.8 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.47 -0.786 . . . . 73.32 110.632 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.502 HD23 HG23 ' C' ' 65' ' ' THR . 2.6 tm? -127.53 144.36 51.07 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.372 -1.714 . . . . 71.53 106.372 172.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.461 ' SG ' HG23 ' C' ' 114' ' ' ILE . 38.3 t -152.73 145.4 24.26 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.309 -0.997 . . . . 74.41 108.309 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -159.24 126.28 4.7 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.383 0.273 . . . . 74.3 110.531 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.501 HG11 ' HA ' ' C' ' 110' ' ' ALA . 54.9 t -133.93 113.26 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.296 1.039 . . . . 71.01 109.154 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.507 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 27.8 mt-30 -90.55 95.92 10.4 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.611 -0.885 . . . . 62.43 108.611 172.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.582 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.0 tp-100 -79.61 108.39 13.12 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.32 -0.854 . . . . 71.23 109.58 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.09 145.39 21.43 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.711 -0.677 . . . . 71.33 111.681 175.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.87 114.81 0.71 Allowed Glycine 0 CA--C 1.507 -0.467 0 N-CA-C 110.279 -1.128 . . . . 71.15 110.279 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.433 HD12 ' CD1' ' C' ' 51' ' ' LEU . 19.0 mm -82.66 123.32 38.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 N-CA-C 108.259 -1.015 . . . . 72.45 108.259 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.492 ' HE2' HG12 ' C' ' 13' ' ' ILE . 58.4 m-85 -132.64 138.8 47.48 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.164 0.586 . . . . 71.05 109.842 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 41.2 p -94.05 100.98 13.0 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.128 -1.064 . . . . 71.32 108.128 167.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.572 HD13 ' H ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -116.83 128.79 74.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 C-N-CA 123.752 0.821 . . . . 64.02 109.766 -178.133 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.73 165.98 29.53 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.418 -0.81 . . . . 74.24 110.641 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 149' ' ' THR . . . 113.08 -59.97 0.36 Allowed Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.85 -0.614 . . . . 71.31 112.838 173.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 23.7 pt -90.91 172.71 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.634 0.774 . . . . 75.43 111.813 -170.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -157.4 151.23 24.32 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.204 0.602 . . . . 75.23 111.012 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.29 -132.34 11.06 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.915 -0.584 . . . . 53.51 112.529 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 42.6 p -65.76 -27.05 68.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.744 0.818 . . . . 72.51 111.495 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -58.91 -52.37 66.04 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.972 0.909 . . . . 74.23 109.629 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.477 ' SD ' ' HB2' ' G' ' 21' ' ' ALA . 50.8 ttm -67.88 -39.63 83.67 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 114.655 -1.157 . . . . 64.44 110.109 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.86 88.88 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.109 0.963 . . . . 71.04 111.856 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -70.16 -43.46 70.8 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.977 -0.556 . . . . 63.34 110.793 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.59 -41.87 95.59 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.233 0.613 . . . . 73.31 111.013 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.584 HD13 ' HD2' ' G' ' 17' ' ' PRO . 64.4 mt -84.15 -37.48 21.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.641 0.777 . . . . 74.51 111.457 -177.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.35 10.11 75.39 Favored Glycine 0 N--CA 1.476 1.335 0 N-CA-C 114.212 0.445 . . . . 41.22 114.212 -172.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' C' ' 104' ' ' ASN . . . -153.62 -59.6 0.13 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.083 0.553 . . . . 62.14 110.513 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -72.77 -42.3 64.13 Favored 'General case' 0 CA--C 1.556 1.188 0 N-CA-C 113.013 0.746 . . . . 71.32 113.013 -166.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.599 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 60.3 m -67.25 -49.91 41.96 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 123.112 0.565 . . . . 60.13 111.944 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.444 ' HB2' HD22 ' C' ' 60' ' ' LEU . 70.1 Cg_endo -71.73 -23.71 22.38 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 121.722 1.615 . . . . 72.51 112.799 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . 0.497 ' HA ' ' HD2' ' C' ' 107' ' ' PHE . 46.6 t-20 -56.22 -39.98 73.36 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 123.952 0.901 . . . . 74.1 110.153 176.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.426 HD12 ' NH1' ' A' ' 111' ' ' ARG . 34.8 mm -60.16 -41.1 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 114.382 -1.281 . . . . 65.33 111.12 175.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 68.1 mt -87.07 -19.62 28.33 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.444 0.698 . . . . 73.34 112.689 -168.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.497 ' HD2' ' HA ' ' C' ' 104' ' ' ASN . 28.1 m-85 -55.47 -53.23 64.54 Favored Pre-proline 0 N--CA 1.489 1.509 0 CA-C-O 118.081 -0.961 . . . . 75.33 112.832 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -54.76 -40.19 85.94 Favored 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 122.857 2.372 . . . . 75.12 114.658 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.539 ' HE2' HG21 ' A' ' 115' ' ' THR . 39.7 m-85 -66.62 -50.1 64.1 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.56 0.744 . . . . 74.23 110.77 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.582 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.75 -35.33 80.74 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.016 -0.993 . . . . 64.34 111.041 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -61.27 -48.28 82.15 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.159 1.384 . . . . 71.25 110.638 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.73 -35.94 77.77 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 123.515 0.51 . . . . 63.22 109.73 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.4 t -67.99 -33.2 74.18 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.376 0.67 . . . . 72.12 111.151 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.461 HG23 ' SG ' ' C' ' 76' ' ' CYS . 78.1 mt -72.53 -54.35 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 109.545 -0.539 . . . . 60.53 109.545 174.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 22.6 m -62.37 -28.38 69.73 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 122.909 0.484 . . . . 64.31 111.25 -175.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.6 t -65.27 -49.03 71.11 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.996 -0.742 . . . . 52.2 108.996 171.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.668 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.03 -38.16 85.13 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.602 1.161 . . . . 64.52 112.264 178.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.458 HG23 ' O ' ' C' ' 114' ' ' ILE . 68.0 t -59.39 -47.19 91.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 108.765 -0.828 . . . . 74.23 108.765 175.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 37.9 t -74.64 -23.29 58.65 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.572 -1.195 . . . . 73.33 112.272 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.422 ' HD2' ' SD ' ' C' ' 117' ' ' MET . 90.2 mtt-85 -74.43 -39.06 62.83 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.015 -0.735 . . . . 73.34 109.015 175.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.11 0.96 82.19 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 124.168 0.917 . . . . 64.53 112.172 170.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.9 p 60.87 30.7 19.81 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.687 1.995 . . . . 61.15 113.602 171.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -83.29 143.8 45.63 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 108.242 -1.022 . . . . 64.43 108.242 170.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -51.27 152.16 11.75 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.211 2.608 . . . . 55.31 113.45 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -54.17 125.98 21.15 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.575 0.954 . . . . 71.1 113.575 -170.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 21.7 tp -122.84 86.09 2.53 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 107.682 -1.229 . . . . 73.11 107.682 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -95.7 115.9 28.1 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.387 -0.824 . . . . 72.5 108.994 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.541 ' HG ' HD11 ' G' ' 6' ' ' ILE . 6.1 mp -73.11 129.01 37.12 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.334 0.654 . . . . 73.24 110.155 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.58 145.14 74.83 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 122.633 0.373 . . . . 65.34 110.932 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.434 ' HG3' HD12 ' A' ' 16' ' ' ILE . 71.4 Cg_endo -72.92 144.76 39.04 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.272 2.648 . . . . 73.41 113.369 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.736 ' HB ' HD11 ' C' ' 136' ' ' LEU . 18.5 m -137.91 134.76 45.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.213 1.005 . . . . 73.33 108.65 171.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.596 HD21 ' HE1' ' A' ' 11' ' ' PHE . 3.4 m-20 -81.71 90.24 6.33 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 118.694 -0.669 . . . . 62.21 109.644 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -54.64 -44.66 73.4 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 118.363 0.529 . . . . 51.24 112.084 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -56.35 -38.55 71.55 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.366 1.066 . . . . 65.3 111.582 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.32 -28.89 21.98 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.683 0.793 . . . . 51.12 111.7 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.736 HD11 ' HB ' ' C' ' 131' ' ' VAL . 50.4 mt -62.97 -45.91 90.21 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.451 0.701 . . . . 62.34 111.362 -175.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -60.98 -29.18 69.53 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.561 0.538 . . . . 73.4 111.61 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 64.9 mtt -78.08 -59.99 2.55 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.868 0.867 . . . . 74.24 110.855 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -58.75 -35.67 73.12 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.296 1.439 . . . . 73.34 112.058 -175.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -54.99 -84.89 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.576 1.15 . . . . 60.34 109.591 175.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 55.2 tp 61.75 -78.83 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.237 1.015 . . . . 72.35 110.705 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -138.93 2.64 2.16 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 123.5 0.72 . . . . 72.3 111.164 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -118.73 149.33 41.63 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.182 0.593 . . . . 73.43 110.796 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -167.67 102.93 0.49 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 106.604 -1.628 . . . . 73.01 106.604 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.88 157.36 33.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.633 0.773 . . . . 62.14 110.37 -177.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 176.68 176.39 44.8 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.78 -0.645 . . . . 64.03 111.769 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -88.84 54.85 3.15 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.846 0.858 . . . . 75.03 109.916 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.35 81.5 0.48 Allowed Glycine 0 C--N 1.351 1.373 0 CA-C-N 114.87 -1.059 . . . . 30.53 112.89 -177.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 5.8 t -158.67 127.5 5.44 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.696 1.198 . . . . 65.41 108.231 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . 0.565 ' HG2' ' HA ' ' G' ' 2' ' ' LYS . 0.6 OUTLIER -161.54 143.17 11.49 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.588 -0.523 . . . . 64.14 109.588 -175.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -98.62 -90.9 0.28 Allowed 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.827 0.851 . . . . 64.54 110.72 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 27.3 m80 43.29 79.05 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.688 1.195 . . . . 74.02 112.802 -168.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . 0.484 ' HG2' ' HB2' ' C' ' 37' ' ' GLN . 15.8 tm0? -95.31 134.3 38.24 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 107.687 -1.227 . . . . 64.34 107.687 171.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . 0.602 ' HB3' ' HD1' ' C' ' 36' ' ' TRP . 34.8 t70 -120.55 158.46 27.27 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.995 0.918 . . . . 72.41 109.961 -176.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.089 0 C-N-CA 124.1 0.96 . . . . 62.23 111.624 -176.782 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.755 0.312 . . . . 73.42 111.056 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m -63.5 110.67 2.04 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.876 0.87 . . . . 33.52 111.231 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -101.16 177.54 4.91 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.397 0.617 . . . . 74.22 110.758 173.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -128.18 166.6 18.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.54 1.136 . . . . 73.2 109.683 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -100.98 161.92 13.26 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.126 0.571 . . . . 74.43 109.877 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -128.99 108.75 10.65 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.356 0.662 . . . . 70.21 109.327 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -88.84 12.13 16.0 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.051 0.941 . . . . 74.3 111.859 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -96.58 -60.26 1.64 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.253 0.621 . . . . 74.4 110.38 -176.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 27.9 ptm 24.17 169.52 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 119.154 3.02 . . . . 65.4 119.154 -170.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 86.6 m -129.46 143.24 50.75 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 113.805 -1.543 . . . . 74.42 108.528 170.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -163.16 105.4 1.01 Allowed 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.524 -0.917 . . . . 72.4 108.524 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -128.37 127.63 42.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.069 -1.086 . . . . 74.0 108.069 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.528 HG21 HD11 ' D' ' 16' ' ' ILE . 10.8 mt -86.82 131.42 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 109.001 -0.74 . . . . 73.32 109.001 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -98.48 -35.28 10.31 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.325 0.65 . . . . 71.14 110.931 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -167.21 142.03 3.94 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.857 0.688 . . . . 70.24 112.857 -171.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.528 HD11 HG21 ' D' ' 13' ' ' ILE . 3.4 mp -119.65 134.87 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 106.798 -1.556 . . . . 74.42 106.798 170.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.431 ' HE1' HG13 ' D' ' 83' ' ' ILE . 31.9 p90 -164.97 165.49 20.15 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.77 0.795 . . . . 72.32 110.744 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 68.2 p -102.68 124.11 47.62 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.461 -1.245 . . . . 72.42 108.636 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -89.78 -42.51 11.25 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.75 -0.833 . . . . 74.41 108.75 175.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -130.9 138.13 49.65 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.433 -0.803 . . . . 75.02 109.354 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.668 HG21 ' HE2' ' C' ' 117' ' ' MET . 61.0 mt -138.1 151.45 25.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 107.259 -1.385 . . . . 64.54 107.259 172.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 46.9 t -157.89 146.04 18.85 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.466 1.106 . . . . 71.11 108.734 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.541 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.0 t80 -149.45 133.44 17.11 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 105.771 -1.937 . . . . 75.23 105.771 169.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.8 mt-10 -132.6 149.64 52.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.487 -0.931 . . . . 73.01 108.487 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.669 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -145.64 77.36 12.47 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 107.355 -1.35 . . . . 62.34 107.355 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -67.16 -39.54 13.2 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.709 2.273 . . . . 53.32 112.464 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -98.31 5.8 47.95 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 118.526 -0.749 . . . . 53.41 110.817 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.669 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -29.22 -63.2 0.2 Allowed Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 117.091 2.256 . . . . 72.1 117.091 -166.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.693 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 42.5 Cg_endo -82.36 -15.0 9.08 Favored 'Trans proline' 0 C--N 1.379 2.175 0 CA-C-N 122.827 2.045 . . . . 62.21 113.838 -174.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -77.07 -41.68 41.34 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.493 1.117 . . . . 74.02 109.332 173.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.8 p -83.64 -11.03 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 C-N-CA 124.294 1.038 . . . . 64.0 111.173 -175.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.403 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 12.0 m-85 -69.77 -19.06 63.53 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 112.112 0.412 . . . . 70.12 112.112 174.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -59.67 -25.74 64.97 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.408 0.623 . . . . 74.11 110.229 169.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -100.08 90.78 4.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.966 1.306 . . . . 64.54 109.355 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -105.34 93.01 4.45 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.371 -0.603 . . . . 74.24 109.371 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -156.43 175.06 14.52 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.074 0.949 . . . . 74.51 108.74 169.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.441 HE21 ' HD2' ' D' ' 38' ' ' PRO . 19.4 tp60 -67.25 106.98 1.39 Allowed Pre-proline 0 CA--C 1.554 1.099 0 CA-C-O 118.855 -0.593 . . . . 71.44 109.408 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.509 ' HB3' ' HG ' ' D' ' 68' ' ' LEU . 30.5 Cg_endo -69.16 148.7 69.55 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.169 1.913 . . . . 54.14 112.716 -172.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -69.62 113.31 6.78 Favored 'General case' 0 C--N 1.349 0.58 0 N-CA-C 108.443 -0.947 . . . . 74.5 108.443 172.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.493 HG13 HG13 ' D' ' 64' ' ' VAL . 88.3 t -104.52 122.76 57.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 123.184 0.594 . . . . 71.2 109.632 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -94.36 128.47 40.9 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.803 -1.184 . . . . 74.53 107.803 170.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.4 ' H ' ' HG ' ' D' ' 42' ' ' LEU . 3.2 pp -95.87 146.76 24.31 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.816 0.846 . . . . 74.01 109.468 -171.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.568 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 12.5 t70 -149.66 131.49 15.1 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.272 -1.01 . . . . 54.42 108.272 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -124.82 138.84 54.25 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.847 0.459 . . . . 74.31 109.94 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -133.03 155.8 48.52 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.723 1.209 . . . . 74.42 108.48 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 3.1 m -106.07 152.04 23.9 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.097 0.559 . . . . 51.12 111.62 -167.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.751 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -155.12 142.51 19.54 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.783 -0.821 . . . . 43.11 108.783 169.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.4 p -165.47 152.32 10.25 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 123.193 0.597 . . . . 75.11 109.682 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.2 p -158.91 143.62 15.82 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.112 0.565 . . . . 71.34 109.836 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -77.04 121.73 23.94 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.264 -0.643 . . . . 74.43 109.264 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.55 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.3 mt -94.91 -26.42 16.15 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.171 0.588 . . . . 72.23 109.812 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.56 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -170.35 -179.73 3.14 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.712 1.605 . . . . 52.53 109.082 175.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -76.0 123.95 26.58 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.014 -1.106 . . . . 62.34 108.014 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 73.79 -3.12 2.58 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 125.597 1.559 . . . . 65.22 112.269 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 78.3 t -117.53 118.04 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 108.302 -0.999 . . . . 73.24 108.302 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -135.03 172.26 13.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.041 0.448 . . . . 55.13 109.904 -174.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.55 ' HB2' HD11 ' D' ' 51' ' ' LEU . 24.7 tt0 -125.1 126.29 45.09 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.113 0.965 . . . . 72.44 108.714 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.83 115.88 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 107.569 -1.271 . . . . 60.34 107.569 175.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.751 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 26.2 t -117.96 134.68 60.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 123.866 0.866 . . . . 54.1 108.944 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 7.8 mp -121.5 130.73 53.73 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.968 0.413 . . . . 72.33 110.1 171.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -85.47 106.18 16.63 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.809 -1.087 . . . . 63.3 109.071 173.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 94.9 t -91.46 116.19 32.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 108.248 -1.019 . . . . 52.33 108.248 171.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 72.5 m -114.64 142.16 46.83 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 108.816 -0.809 . . . . 70.45 108.816 -176.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.493 HG13 HG13 ' D' ' 40' ' ' VAL . 58.7 t -132.16 102.93 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 125.099 1.36 . . . . 74.33 108.333 -173.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 42.2 m -95.83 91.51 6.08 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.571 -1.27 . . . . 74.22 107.571 168.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.2 143.47 26.59 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.898 -0.779 . . . . 73.22 108.898 -175.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.473 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 41.1 m -143.17 127.36 17.57 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.481 0.488 . . . . 73.52 111.175 -176.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.509 ' HG ' ' HB3' ' D' ' 38' ' ' PRO . 21.7 mt -97.12 105.57 17.75 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.029 -1.101 . . . . 61.12 108.029 173.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.64 -114.12 4.95 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.377 -0.829 . . . . 64.44 111.973 -177.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.48 4.7 30.85 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 112.957 0.725 . . . . 74.24 112.957 -172.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -136.24 161.7 35.02 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.496 0.319 . . . . 73.14 110.469 -175.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 70.9 m -62.74 125.17 23.04 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 124.208 0.942 . . . . 71.23 111.45 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.473 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -78.56 -70.84 0.47 Allowed 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.788 -1.096 . . . . 74.22 108.188 170.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -149.34 146.78 27.69 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.493 -0.776 . . . . 65.33 110.382 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.447 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 72.4 mt -111.69 108.24 17.62 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.96 -1.126 . . . . 73.34 107.96 174.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.5 ' SG ' HG23 ' D' ' 114' ' ' ILE . 43.7 t -116.97 146.7 42.85 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.253 -0.647 . . . . 73.14 109.253 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 19.8 tt0 -153.55 133.13 12.95 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.449 0.699 . . . . 74.14 109.66 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 45.3 t -138.82 116.95 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.081 -0.711 . . . . 71.31 109.081 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -87.83 88.63 7.71 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 108.07 -1.085 . . . . 72.32 108.07 169.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -80.86 114.51 19.79 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.413 -1.267 . . . . 73.21 108.471 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.29 144.5 18.09 Favored Glycine 0 C--N 1.337 0.594 0 O-C-N 123.465 0.478 . . . . 72.53 112.441 -176.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.68 137.83 9.47 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 111.221 -0.752 . . . . 74.41 111.221 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.431 HG13 ' HE1' ' D' ' 17' ' ' TYR . 72.8 mt -88.71 120.45 37.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.66 -1.237 . . . . 74.45 107.66 173.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -128.72 122.07 29.87 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.863 0.865 . . . . 70.32 109.244 -175.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 31.9 m -85.04 93.99 8.73 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.206 -1.035 . . . . 65.04 108.206 169.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 11.7 tt -123.31 131.55 72.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 123.91 0.884 . . . . 73.23 109.161 -173.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.7 166.63 32.83 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.371 0.668 . . . . 64.34 110.902 -173.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.35 17.09 76.94 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.619 -0.718 . . . . 63.33 113.683 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 6.7 mt -125.61 154.13 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.059 0.543 . . . . 74.23 109.861 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.555 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 0.0 OUTLIER -159.51 -174.06 4.47 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 123.934 0.893 . . . . 75.44 110.184 174.268 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.61 -142.29 45.28 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.492 0.495 . . . . 51.21 113.425 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 51.6 m -76.84 -28.31 55.45 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.606 0.762 . . . . 73.4 111.692 -176.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -60.11 -44.17 95.07 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.84 0.456 . . . . 75.23 111.298 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.555 ' SD ' ' HA ' ' D' ' 90' ' ' GLU . 25.6 ptt? -72.38 -30.63 64.85 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 123.111 0.257 . . . . 60.44 111.477 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.76 -36.14 82.72 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.316 0.579 . . . . 73.43 110.24 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -85.86 -18.2 33.47 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.774 -0.648 . . . . 74.4 110.653 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 47.3 t -70.52 -51.07 31.33 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.536 0.684 . . . . 70.15 109.487 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 30.0 mt -77.32 -18.95 57.04 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.87 -1.059 . . . . 61.52 110.545 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.06 15.46 51.33 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 115.764 -0.653 . . . . 74.42 113.815 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.484 ' HA ' ' HD2' ' D' ' 133' ' ' PHE . . . -159.47 -65.8 0.08 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 117.235 0.517 . . . . 51.34 111.911 176.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -64.21 -53.47 48.74 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.68 0.792 . . . . 73.24 112.681 -169.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 21.7 m -63.67 -43.83 78.52 Favored Pre-proline 0 CA--C 1.565 1.541 0 C-N-CA 123.819 0.847 . . . . 73.34 111.798 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -52.76 -39.05 78.16 Favored 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 122.759 2.306 . . . . 74.45 113.996 166.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -64.54 -28.58 69.75 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.525 0.73 . . . . 73.24 111.682 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.2 mm -69.78 -42.17 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-O 121.491 0.662 . . . . 71.32 109.761 173.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 93.8 mt -82.62 -12.65 57.52 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.819 -1.082 . . . . 65.22 111.887 -177.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . 0.4 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 83.7 t80 -60.83 -52.73 70.34 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.489 1.116 . . . . 73.41 113.184 -176.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 39.6 Cg_exo -61.47 -35.48 82.38 Favored 'Trans proline' 0 C--N 1.385 2.482 0 C-N-CA 121.863 1.708 . . . . 63.44 112.384 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -71.29 -43.98 66.09 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.311 1.045 . . . . 65.44 111.991 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.72 -42.17 86.75 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.416 0.686 . . . . 30.23 110.127 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.414 ' NH2' HG23 ' B' ' 105' ' ' ILE . 38.8 ttp180 -57.34 -54.61 44.88 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 124.199 0.937 . . . . 73.14 110.08 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -59.04 -46.03 89.26 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.199 0.937 . . . . 73.52 111.198 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.7 t -58.05 -43.31 86.82 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 123.749 0.656 . . . . 74.35 111.041 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.5 HG23 ' SG ' ' D' ' 76' ' ' CYS . 74.1 mt -65.21 -55.45 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 123.565 0.541 . . . . 63.42 109.994 175.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 62.8 m -51.17 -44.0 61.4 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.927 1.291 . . . . 62.23 111.736 -173.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 35.9 t -65.67 -43.11 90.31 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 114.683 -1.144 . . . . 61.42 109.958 -178.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 79.3 mtm -67.86 -32.94 73.8 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.116 0.566 . . . . 61.33 111.866 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.436 HG23 ' O ' ' D' ' 114' ' ' ILE . 85.5 t -65.13 -44.19 95.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.469 0.708 . . . . 53.15 109.744 176.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 80.9 p -74.6 -28.46 60.91 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.952 -0.567 . . . . 52.14 111.153 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' D' ' 116' ' ' SER . 82.5 mtt-85 -70.88 -32.89 70.01 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.663 0.785 . . . . 70.34 109.973 174.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.73 5.69 77.46 Favored Glycine 0 C--N 1.353 1.49 0 O-C-N 123.902 0.751 . . . . 42.53 112.068 171.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.2 p 55.78 24.05 6.96 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 127.27 2.228 . . . . 73.24 113.982 176.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -79.59 155.17 76.23 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.571 0.748 . . . . 71.22 109.663 170.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -48.57 126.32 14.07 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.531 2.82 . . . . 74.44 112.327 172.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -51.92 132.39 32.06 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.617 1.167 . . . . 73.21 112.223 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.505 HD21 HG21 ' H' ' 6' ' ' ILE . 5.8 tt -108.07 101.77 10.98 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.611 -1.255 . . . . 75.23 107.611 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -100.95 102.89 14.0 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.299 -1.001 . . . . 74.2 108.299 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 tt -69.16 115.21 8.18 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 107.794 -1.187 . . . . 72.3 107.794 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.76 139.31 97.1 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 123.201 0.6 . . . . 62.14 110.756 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -58.72 106.26 0.27 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.007 2.471 . . . . 70.54 111.682 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 17.4 m -109.14 138.48 36.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 115.203 -0.908 . . . . 74.23 109.678 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -79.78 96.78 6.38 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.384 -0.969 . . . . 71.52 108.384 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.484 ' HD2' ' HA ' ' D' ' 100' ' ' ALA . 7.9 t80 -64.47 -23.67 67.36 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.854 0.862 . . . . 74.24 110.964 -177.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.58 -54.03 51.22 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 124.066 0.946 . . . . 73.12 110.601 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.77 -50.25 73.1 Favored 'General case' 0 C--O 1.22 -0.469 0 O-C-N 124.202 0.939 . . . . 72.13 110.065 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 94.2 mt -49.49 -43.57 45.41 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.952 0.901 . . . . 74.4 112.212 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.497 ' HA ' HD11 ' H' ' 10' ' ' LEU . 48.7 t80 -59.79 -55.19 37.32 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.137 -0.938 . . . . 72.33 110.711 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.469 ' O ' ' HA3' ' D' ' 148' ' ' GLY . 21.7 ptp -73.72 -20.43 60.53 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.819 0.448 . . . . 52.45 111.302 -177.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.99 -30.41 62.47 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.19 0.596 . . . . 72.41 111.112 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . 0.434 ' HB2' HD13 ' H' ' 10' ' ' LEU . 92.9 t80 -60.38 -45.47 93.42 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.276 0.63 . . . . 74.54 111.906 -177.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.483 HD22 ' H ' ' D' ' 141' ' ' LEU . 1.0 OUTLIER -63.27 -38.41 91.05 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.67 0.388 . . . . 65.05 110.518 -175.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.43 ' HB3' ' H ' ' D' ' 148' ' ' GLY . 10.0 pt20 -84.95 4.85 31.67 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.772 -0.649 . . . . 73.0 112.561 -174.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.456 ' NE2' ' HG2' ' D' ' 144' ' ' GLN . 1.0 OUTLIER -133.21 41.1 3.14 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.005 0.431 . . . . 64.42 110.344 168.427 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . 0.456 ' HG2' ' NE2' ' D' ' 143' ' ' GLN . 14.6 mm100 -152.23 -70.2 0.16 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.461 1.104 . . . . 73.32 109.341 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.33 117.91 3.54 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.56 -0.904 . . . . 53.05 108.56 -174.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 78.69 -154.96 40.58 Favored Glycine 0 C--N 1.341 0.85 0 O-C-N 123.544 0.527 . . . . 62.43 112.245 -176.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -127.78 160.52 31.48 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.512 0.725 . . . . 65.32 110.96 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' D' ' 138' ' ' MET . . . -82.96 134.29 12.73 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.626 -0.715 . . . . 72.12 112.532 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 25.7 m -80.88 108.65 14.73 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.245 0.618 . . . . 51.42 110.041 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.88 110.88 15.41 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.827 -1.175 . . . . 75.31 107.827 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -93.78 160.54 14.71 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.499 0.666 . . . . 65.33 111.779 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -84.39 61.43 6.61 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 114.44 -1.255 . . . . 73.15 110.621 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -61.49 -35.96 79.13 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.361 0.664 . . . . 75.2 110.595 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 29.2 t70 74.9 -64.41 0.38 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.681 1.593 . . . . 75.22 111.049 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.354 0 C-N-CA 124.294 1.038 . . . . 73.24 108.811 172.101 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 110.332 -0.248 . . . . 74.21 110.332 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -67.85 136.08 53.53 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.885 0.474 . . . . 51.14 111.144 -176.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -160.12 169.55 23.08 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.853 0.861 . . . . 71.55 109.503 174.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 16.8 p -96.0 137.97 34.31 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.028 0.531 . . . . 54.1 110.431 175.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 76.8 m -66.36 -52.87 42.44 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.637 0.775 . . . . 74.41 109.979 173.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.659 HD12 HD23 ' A' ' 128' ' ' LEU . 28.0 pt -127.52 163.29 31.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 CA-C-N 115.599 -0.728 . . . . 71.24 109.675 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 7' ' ' ALA . . . . . 0.501 ' HA ' ' HB3' ' A' ' 129' ' ' ALA . . . -151.53 -151.1 0.37 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.931 0.893 . . . . 55.13 108.669 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 90.7 mt -126.51 161.87 26.96 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.775 0.83 . . . . 64.52 111.039 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.37 131.28 44.79 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.627 -0.879 . . . . 72.3 108.627 171.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 6.6 mp -63.35 163.51 10.52 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.328 0.651 . . . . 63.3 110.251 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 75.6 mt -113.3 86.54 9.89 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 123.13 0.572 . . . . 65.01 109.493 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.61 -10.95 14.36 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.396 2.064 . . . . 71.52 111.677 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 tt -81.14 -41.6 22.19 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.824 0.849 . . . . 42.3 108.815 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . 0.619 HD22 ' HA3' ' A' ' 99' ' ' GLY . 47.7 mt 66.48 175.36 0.24 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.005 1.322 . . . . 71.12 111.3 -175.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -91.41 167.69 12.09 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.74 -0.467 . . . . 73.23 109.74 170.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 45.3 p -68.13 154.61 93.68 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-O 119.092 -0.48 . . . . 73.21 110.965 -174.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 17' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -54.8 102.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.042 2.495 . . . . 70.43 112.58 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 18' ' ' VAL . . . . . 0.62 HG12 HD23 ' A' ' 98' ' ' LEU . 1.9 p -58.14 121.32 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.629 1.171 . . . . 72.33 112.077 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 12.8 t 42.26 40.38 1.75 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.888 1.675 . . . . 55.13 112.176 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 93.9 mttt 66.8 65.69 0.45 Allowed 'General case' 0 C--N 1.366 1.32 0 CA-C-N 113.951 -1.477 . . . . 63.43 110.375 -172.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . 0.436 ' HB1' ' SD ' ' A' ' 94' ' ' MET . . . -69.49 107.79 3.51 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.142 -0.935 . . . . 72.43 109.92 178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 66.44 87.42 0.12 Allowed 'General case' 0 CA--C 1.543 0.692 0 O-C-N 124.515 1.134 . . . . 54.23 111.263 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 4.8 p -110.22 151.44 42.58 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 123.83 0.852 . . . . 74.13 110.687 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.74 -25.48 53.7 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.77 2.313 . . . . 74.55 112.237 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 C--O 1.252 1.197 0 N-CA-C 107.568 -1.271 . . . . 52.41 107.568 179.195 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 109.018 -0.734 . . . . 72.45 109.018 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -67.38 -32.97 74.24 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.595 0.758 . . . . 74.33 112.218 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -73.73 -29.85 62.49 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.849 0.46 . . . . 70.14 111.205 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -84.92 69.1 10.74 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 122.012 0.91 . . . . 73.41 110.07 175.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 64.8 m -119.95 154.73 34.03 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-N 114.536 -1.211 . . . . 74.25 107.869 173.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.718 HG13 HD21 ' B' ' 42' ' ' LEU . 10.3 tt -59.01 100.42 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.215 0 CA-C-O 121.688 0.756 . . . . 73.13 110.865 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -125.93 158.93 33.93 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.403 1.081 . . . . 70.14 109.478 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . 0.522 HD11 HD21 ' B' ' 44' ' ' LEU . 1.6 tt -100.25 127.96 46.42 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 109.14 -0.689 . . . . 74.21 109.14 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.2 45.11 1.1 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.619 0.767 . . . . 74.24 110.805 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 10' ' ' LEU . . . . . 0.705 HD21 HD12 ' B' ' 136' ' ' LEU . 94.0 mt 65.55 178.47 0.2 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.382 1.073 . . . . 64.21 112.593 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 73.4 mt -79.81 143.67 58.61 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.327 -0.851 . . . . 74.43 109.717 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -59.67 -31.64 94.59 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.1 2.534 . . . . 34.54 112.22 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 28.3 tp -165.66 164.39 19.06 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.48 1.112 . . . . 74.15 108.528 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 79.6 mt -67.38 161.9 24.17 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.335 -0.616 . . . . 65.1 109.335 170.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -70.46 -93.33 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.997 0.519 . . . . 62.31 111.11 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 2.3 p -165.38 133.55 2.47 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 124.564 1.146 . . . . 61.52 108.028 -172.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.02 150.71 77.06 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 122.789 2.326 . . . . 64.33 112.365 -174.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . 0.494 HG21 HG21 ' B' ' 86' ' ' ILE . 58.4 t -54.99 -30.48 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 C-N-CA 124.501 1.121 . . . . 73.22 113.108 -174.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 9.4 t -57.0 -30.42 64.16 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.571 0.748 . . . . 72.24 111.54 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -158.44 74.16 0.68 Allowed 'General case' 0 C--O 1.244 0.805 0 N-CA-C 107.925 -1.139 . . . . 73.21 107.925 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.57 57.0 4.08 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.63 0.729 . . . . 72.54 110.673 -177.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . 0.481 ' HB3' ' HA ' ' B' ' 49' ' ' SER . 0.0 OUTLIER -162.78 123.17 2.37 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.6 1.16 . . . . 74.31 109.289 178.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 48.5 m -167.03 -50.66 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.353 0 C-N-CA 125.707 1.603 . . . . 74.53 109.129 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.55 133.01 11.4 Favored 'Trans proline' 0 C--N 1.399 3.19 0 C-N-CA 121.697 1.598 . . . . 70.54 112.168 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 . . . . . 0 CA--C 1.55 0.972 0 C-N-CA 124.421 1.088 . . . . 75.01 108.279 -178.426 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 109.29 -0.633 . . . . 71.3 109.29 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' G' G ' 2' ' ' LYS . . . . . 0.565 ' HA ' ' HG2' ' C' ' 150' ' ' GLU . 9.8 mtmp? 74.21 82.01 0.11 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.319 1.447 . . . . 72.34 111.538 175.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -162.59 154.56 18.55 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.07 -0.968 . . . . 73.41 109.396 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 24.4 m 64.82 25.3 12.87 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.565 1.146 . . . . 75.24 112.303 174.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 2.2 m -58.2 -53.38 58.97 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.406 1.082 . . . . 73.33 110.915 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . 0.541 HD11 ' HG ' ' C' ' 128' ' ' LEU . 10.5 tt -150.28 130.97 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 113.974 -1.466 . . . . 52.21 108.352 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -167.24 154.95 9.13 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.252 0.621 . . . . 51.25 110.601 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 8' ' ' LEU . . . . . . . . . . . . . 40.9 mt -68.61 131.25 44.9 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.908 0.883 . . . . 72.45 110.602 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.96 151.67 28.39 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.104 0.562 . . . . 50.14 110.075 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 10' ' ' LEU . . . . . 0.423 HD11 HD13 ' C' ' 136' ' ' LEU . 6.6 mp -65.65 153.95 40.21 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.128 0.571 . . . . 63.14 109.665 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.95 108.99 5.21 Favored Pre-proline 0 CA--C 1.548 0.867 0 CA-C-O 118.884 -0.579 . . . . 72.25 110.056 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.42 -33.91 21.96 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 122.236 1.958 . . . . 75.11 110.572 177.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 7.4 mp -101.33 106.57 17.76 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.245 -1.391 . . . . 64.31 107.245 169.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.95 113.62 9.18 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.31 -0.626 . . . . 72.13 109.31 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . 0.608 ' HD2' ' HB ' ' C' ' 46' ' ' THR . 55.9 t80 -62.0 112.86 2.51 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 124.153 0.908 . . . . 73.35 109.347 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 9.5 t -159.22 62.32 2.04 Favored Pre-proline 0 CA--C 1.561 1.39 0 CA-C-O 121.445 0.64 . . . . 61.52 111.227 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 17' ' ' PRO . . . . . 0.584 ' HD2' HD13 ' C' ' 98' ' ' LEU . 23.8 Cg_endo -90.01 -6.89 4.65 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.11 2.54 . . . . 61.43 114.395 -172.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 18' ' ' VAL . . . . . 0.476 ' HB ' ' SD ' ' C' ' 94' ' ' MET . 89.0 t -73.89 123.38 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 110.09 -0.337 . . . . 70.13 110.09 -174.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 1.9 m 63.93 -104.18 0.12 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.914 1.285 . . . . 72.44 109.728 -176.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -150.48 38.7 0.71 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 106.688 -1.597 . . . . 74.21 106.688 176.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . 0.477 ' HB2' ' SD ' ' C' ' 94' ' ' MET . . . -61.28 87.81 0.02 OUTLIER 'General case' 0 C--N 1.362 1.128 0 C-N-CA 124.153 0.981 . . . . 73.31 111.181 -174.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -145.07 -0.67 0.88 Allowed 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 114.155 -1.384 . . . . 73.3 108.353 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 23' ' ' THR . . . . . 0.486 ' HA ' ' HD3' ' G' ' 24' ' ' PRO . 37.6 p -69.58 128.72 91.97 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.408 1.083 . . . . 53.34 110.454 -177.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 24' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' G' ' 23' ' ' THR . 16.4 Cg_exo -69.11 179.87 3.06 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 123.353 2.702 . . . . 60.13 112.904 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 C--O 1.248 1.008 0 N-CA-C 108.135 -1.061 . . . . 64.22 108.135 178.254 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 110.23 -0.285 . . . . 64.42 110.23 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 5.9 tmtm? -147.73 137.53 22.7 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 107.195 -1.409 . . . . 73.22 107.195 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -67.0 87.79 0.15 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.633 0.773 . . . . 72.33 110.266 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 32.0 t -167.94 170.44 10.57 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-N 114.487 -1.233 . . . . 70.42 108.658 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 27.4 m -79.65 158.41 27.03 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 108.653 -0.869 . . . . 72.24 108.653 173.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.505 HG21 HD21 ' D' ' 126' ' ' LEU . 14.7 tt -56.48 95.29 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 CA-C-O 122.417 1.103 . . . . 72.4 111.98 -177.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.45 13.51 4.55 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 113.937 -1.483 . . . . 60.04 109.888 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 81.0 mt 66.15 175.16 0.23 Allowed 'General case' 0 C--N 1.357 0.904 0 C-N-CA 125.015 1.326 . . . . 62.15 112.368 -176.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -163.79 -163.06 0.76 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.765 1.226 . . . . 44.14 107.953 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 10' ' ' LEU . . . . . 0.497 HD11 ' HA ' ' D' ' 137' ' ' PHE . 7.3 mp -92.71 168.12 11.43 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.821 0.819 . . . . 74.13 110.946 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' H' ' 12' ' ' PRO . 0.5 OUTLIER -111.21 137.16 20.91 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-N 114.164 -1.38 . . . . 75.43 109.293 -178.12 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 12' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' H' ' 11' ' ' LEU . 23.0 Cg_exo -66.31 -44.74 6.3 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.623 2.882 . . . . 72.51 113.157 -176.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 tt -73.02 119.53 17.4 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.2 -1.037 . . . . 54.44 108.2 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.47 118.02 20.22 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 107.578 -1.268 . . . . 63.44 107.578 176.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -58.13 171.86 0.5 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.676 1.19 . . . . 71.22 112.715 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 16' ' ' THR . . . . . 0.403 ' HB ' ' HA ' ' H' ' 21' ' ' ALA . 41.7 p -83.99 131.18 52.19 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-N 114.729 -1.123 . . . . 74.24 110.61 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.98 145.12 31.12 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.593 2.862 . . . . 71.12 113.352 -173.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 77.2 t -52.03 -28.82 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 C-N-CA 124.551 1.141 . . . . 71.51 113.519 -173.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 6.6 p -50.84 -44.99 59.48 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.221 0.608 . . . . 62.43 111.901 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -116.77 -62.18 1.62 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.922 0.889 . . . . 74.51 108.952 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . 0.403 ' HA ' ' HB ' ' H' ' 16' ' ' THR . . . 60.75 26.9 16.68 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.308 1.443 . . . . 64.44 111.919 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -112.85 149.26 33.36 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 113.958 -1.474 . . . . 61.42 108.314 174.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 26.8 p -95.65 101.09 7.2 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 123.979 0.912 . . . . 74.32 109.913 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -71.91 -28.62 16.21 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.272 1.981 . . . . 73.12 111.605 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 CA--C 1.548 0.867 0 N-CA-C 106.262 -1.755 . . . . 75.52 106.262 175.342 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 mmt . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.61 0.243 . . . . 64.12 111.009 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 m -138.91 33.09 2.18 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.906 0.483 . . . . 64.51 111.251 -164.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.488 ' HA ' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -125.17 78.91 1.75 Allowed 'General case' 0 CA--C 1.555 1.156 0 CA-C-O 122.019 0.914 . . . . 70.35 110.899 -171.265 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -148.49 66.04 1.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.47 1.108 . . . . 71.15 109.547 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 65.61 -73.93 0.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.647 1.179 . . . . 72.04 111.709 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -78.63 76.98 5.12 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 108.61 -0.885 . . . . 74.52 108.61 174.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 3' ' ' GLU . 50.5 p -88.78 -168.85 2.32 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 114.323 -1.308 . . . . 74.31 111.169 -170.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -75.84 118.17 18.35 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 107.824 -1.176 . . . . 72.41 107.824 161.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.614 ' HB2' ' HB ' ' C' ' 149' ' ' THR . 22.5 mmt -75.23 126.16 30.44 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.078 -0.712 . . . . 71.32 109.078 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t 174.78 147.15 0.07 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.935 0.894 . . . . 70.42 109.329 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.649 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 16.4 t80 -96.03 120.71 36.8 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.491 -0.929 . . . . 74.42 108.491 164.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -137.7 121.85 18.0 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.552 -0.907 . . . . 75.22 108.552 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.67 HG12 ' HD2' ' A' ' 84' ' ' PHE . 58.8 mt -93.94 123.01 45.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.416 -0.957 . . . . 71.12 108.416 174.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -84.32 -40.85 17.44 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 123.493 0.496 . . . . 74.01 110.158 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -169.61 134.98 1.47 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 116.389 -0.369 . . . . 73.22 110.692 -168.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 85.8 mt -125.39 129.85 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 123.708 0.803 . . . . 70.2 109.218 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -162.24 148.06 13.01 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 124.222 0.951 . . . . 74.51 110.715 -167.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.7 p -75.05 129.04 36.93 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 109.407 -0.59 . . . . 61.33 109.407 173.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.492 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 39.3 mtpt -97.99 -27.82 14.07 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.6 0.36 . . . . 72.11 110.399 176.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 13.6 t70 -141.98 138.47 31.92 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.382 -0.599 . . . . 61.34 109.382 171.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.425 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 60.4 mt -130.5 140.64 48.3 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 N-CA-C 107.087 -1.449 . . . . 41.04 107.087 172.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.0 t -150.58 128.2 11.55 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.036 0.534 . . . . 71.1 110.19 175.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.422 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 75.9 t80 -130.48 142.46 50.49 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.416 -1.327 . . . . 64.14 107.416 171.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -141.92 139.36 32.52 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.495 -0.928 . . . . 70.4 108.495 171.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.429 ' CB ' ' HB2' ' A' ' 28' ' ' ALA . . . -118.09 86.49 26.36 Favored Pre-proline 0 C--O 1.241 0.615 0 N-CA-C 106.118 -1.808 . . . . 54.43 106.118 169.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -53.41 -42.69 63.59 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.578 2.852 . . . . 65.21 113.774 -168.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.32 37.46 4.25 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.22 -0.659 . . . . 72.11 109.22 -177.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -41.75 -60.89 1.68 Allowed Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 113.74 1.015 . . . . 72.13 113.74 -169.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 23.4 Cg_exo -63.19 -27.07 72.52 Favored 'Trans proline' 0 C--N 1.385 2.496 0 CA-C-N 121.786 1.673 . . . . 51.43 112.776 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -84.69 -32.15 23.73 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.225 1.01 . . . . 63.44 111.311 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.731 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.8 p -79.08 -23.66 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.595 -0.729 . . . . 53.25 111.642 -168.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -72.39 -12.04 60.95 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.171 0.588 . . . . 71.31 111.51 176.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -81.63 -29.79 33.1 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.123 0.969 . . . . 54.3 110.156 173.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -74.46 153.83 38.99 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.178 0.991 . . . . 73.41 111.288 -174.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.78 136.81 45.52 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.594 -0.73 . . . . 75.23 109.259 170.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.416 ' CE3' HD21 ' A' ' 68' ' ' LEU . 62.1 t-105 -80.21 85.09 5.79 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.365 0.666 . . . . 73.44 110.45 -175.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.4 ' H ' HD22 ' A' ' 68' ' ' LEU . 6.5 tp60 -125.24 79.21 66.45 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.209 1.004 . . . . 70.23 108.5 170.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -89.97 140.79 3.5 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.694 2.263 . . . . 74.13 113.364 -173.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -99.43 90.75 4.63 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 107.805 -1.183 . . . . 72.34 107.805 167.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -70.52 92.36 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 122.477 1.132 . . . . 74.04 109.609 177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -79.66 147.68 31.9 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 113.971 -1.468 . . . . 43.42 109.224 172.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.417 HD23 HD13 ' E' ' 6' ' ' ILE . 2.2 pp -133.64 131.77 39.97 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.535 0.734 . . . . 64.54 110.219 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.589 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 32.8 m-20 -115.89 135.76 53.69 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.294 -1.002 . . . . 70.52 108.294 175.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' E' ' 8' ' ' LEU . 4.8 mp -104.58 121.92 44.51 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.92 0.888 . . . . 73.05 109.176 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -141.99 144.59 33.76 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.884 -0.784 . . . . 65.03 108.884 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.7 m -146.69 140.26 25.81 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.066 0.547 . . . . 75.44 110.14 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.25 152.38 51.37 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.987 1.315 . . . . 54.21 108.603 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.6 p -132.01 160.61 35.35 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.15 0.58 . . . . 63.44 109.867 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -149.78 119.41 6.99 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.946 -0.761 . . . . 62.22 108.946 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -84.91 111.5 19.72 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.486 -0.561 . . . . 63.34 109.486 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.3 mt -85.36 -29.95 24.05 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.555 0.742 . . . . 73.41 111.25 -175.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.598 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -164.61 -171.58 2.37 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.254 1.022 . . . . 65.2 110.142 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.14 100.75 0.63 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.31 0.644 . . . . 64.11 109.545 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 70.05 8.08 6.51 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.002 1.321 . . . . 73.44 112.613 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 57.2 t -100.27 118.37 46.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 106.303 -1.739 . . . . 74.41 106.303 166.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -142.46 173.58 11.41 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.321 0.581 . . . . 61.44 110.283 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -127.65 131.68 49.82 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.262 -1.335 . . . . 74.32 108.878 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.49 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 84.5 t -106.01 135.8 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.731 -1.211 . . . . 75.25 107.731 166.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.439 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 39.8 t -123.95 129.67 74.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.863 -1.532 . . . . 71.41 106.863 174.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tt -124.98 117.91 25.08 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.051 -0.722 . . . . 74.43 109.051 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.584 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 21.3 ttp180 -89.59 111.04 21.86 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.884 -1.053 . . . . 62.52 109.661 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.411 HG11 HD11 ' A' ' 128' ' ' LEU . 43.9 t -100.36 110.87 28.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.979 -1.119 . . . . 74.34 107.979 172.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.589 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 26.3 m -97.75 108.92 21.73 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.677 -0.49 . . . . 73.34 109.677 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.4 t -103.68 108.38 24.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.405 1.082 . . . . 75.53 109.065 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.5 m -102.86 137.05 41.58 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.929 -1.137 . . . . 72.23 107.929 171.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.51 118.91 25.87 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 107.457 -1.312 . . . . 55.45 107.457 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -130.87 132.04 44.92 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.746 0.654 . . . . 70.03 111.092 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.416 HD21 ' CE3' ' A' ' 36' ' ' TRP . 15.6 mt -87.92 75.09 8.87 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.613 -1.254 . . . . 72.01 107.613 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.0 -115.69 4.07 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 114.953 -1.021 . . . . 62.2 110.737 -170.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -90.37 -19.63 23.76 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.722 0.809 . . . . 75.24 111.355 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -94.37 119.0 32.46 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.073 0.549 . . . . 74.51 109.993 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.8 m -72.58 121.89 20.45 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.311 0.382 . . . . 74.35 110.859 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.731 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -68.67 -56.27 8.71 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.763 -0.653 . . . . 75.21 109.697 176.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.465 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 42.7 p90 -156.26 175.55 13.84 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.018 -0.992 . . . . 73.45 111.371 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.6 tp -138.52 140.47 39.14 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.056 -1.429 . . . . 64.42 107.268 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 90.1 m -144.26 95.87 2.79 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.834 0.854 . . . . 65.31 108.819 -177.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -116.07 115.27 25.79 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.499 -0.926 . . . . 73.31 108.499 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.4 t -127.91 118.03 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.398 0.679 . . . . 74.24 110.244 -175.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.584 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 78.2 mt-30 -86.31 92.3 8.76 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 108.825 -0.805 . . . . 50.04 108.825 169.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -82.67 112.5 19.59 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.979 -0.748 . . . . 70.43 108.979 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -102.66 166.49 16.96 Favored Glycine 0 C--N 1.335 0.519 0 O-C-N 123.206 0.316 . . . . 64.24 112.855 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.58 131.7 2.3 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.793 -0.523 . . . . 75.42 111.793 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.1 mt -81.33 124.58 39.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 123.316 0.646 . . . . 75.52 109.369 174.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.67 ' HD2' HG12 ' A' ' 13' ' ' ILE . 10.0 m-85 -130.58 118.39 20.96 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.296 -1.001 . . . . 74.43 108.296 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.9 p -96.89 93.33 6.58 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.634 -0.876 . . . . 61.15 108.634 173.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.535 ' HB ' ' HD2' ' A' ' 11' ' ' PHE . 1.0 OUTLIER -139.53 122.67 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.033 0.933 . . . . 64.21 109.79 -175.443 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.506 ' HA ' HG21 ' E' ' 18' ' ' VAL . . . -129.13 -13.22 4.53 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.737 1.215 . . . . 74.1 109.983 169.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.462 ' H ' HD12 ' A' ' 86' ' ' ILE . . . -88.64 70.09 2.63 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.701 -0.681 . . . . 73.33 114.315 -170.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.591 HD13 ' HB2' ' A' ' 97' ' ' CYS . 19.3 tt -166.09 144.85 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 108.641 -0.874 . . . . 72.03 108.641 175.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.51 170.31 16.23 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.392 0.677 . . . . 73.43 110.224 -166.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.517 ' O ' ' HG3' ' A' ' 94' ' ' MET . . . 69.0 -147.29 46.06 Favored Glycine 0 C--N 1.352 1.462 0 CA-C-N 115.463 -0.79 . . . . 53.45 113.575 174.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.9 p -68.79 -20.84 64.35 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.231 0.613 . . . . 64.34 111.026 173.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -67.78 -35.37 78.55 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 123.664 0.785 . . . . 64.0 112.169 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.517 ' HG3' ' O ' ' A' ' 91' ' ' GLY . 4.0 ppp? -64.79 -40.61 95.51 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 118.128 0.422 . . . . 65.25 110.199 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.61 ' HB1' HD13 ' E' ' 14' ' ' LEU . . . -69.36 -36.21 76.63 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.817 0.847 . . . . 75.24 111.068 176.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -68.3 -30.24 69.19 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.426 1.09 . . . . 74.13 111.156 176.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.591 ' HB2' HD13 ' A' ' 89' ' ' ILE . 48.7 t -68.76 -57.78 5.14 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.202 0.525 . . . . 40.24 110.21 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.592 HD22 ' HA ' ' E' ' 16' ' ' THR . 4.0 pp -76.04 -19.91 58.22 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.566 -0.743 . . . . 75.5 112.093 -177.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.17 -4.49 53.71 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-O 119.519 -0.601 . . . . 63.22 114.225 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.34 -61.37 0.22 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 117.709 0.755 . . . . 74.4 112.155 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.487 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 91.2 t80 -59.92 -61.96 2.22 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 113.21 0.819 . . . . 74.03 113.21 -168.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 73.7 m -64.3 -38.16 31.54 Favored Pre-proline 0 CA--C 1.565 1.543 0 N-CA-C 112.829 0.677 . . . . 72.24 112.829 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.24 -46.12 23.85 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.528 2.152 . . . . 73.31 113.529 161.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.697 HD21 ' HB2' ' A' ' 133' ' ' PHE . 87.7 m-20 -75.88 -12.91 60.25 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.873 0.869 . . . . 71.53 112.224 -177.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.0 mm -70.59 -41.07 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 109.199 -0.667 . . . . 75.44 109.199 169.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 83.7 mt -82.33 -22.62 35.51 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.147 0.979 . . . . 74.15 111.919 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -57.49 -48.91 96.47 Favored Pre-proline 0 CA--C 1.569 1.702 0 N-CA-C 114.245 1.202 . . . . 65.35 114.245 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -63.79 -36.03 53.5 Favored 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 122.001 1.8 . . . . 64.33 112.582 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -69.18 -42.73 75.45 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.526 0.73 . . . . 62.31 111.383 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.88 -37.68 82.08 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.355 0.662 . . . . 52.24 109.995 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.471 ' NH1' HG23 ' C' ' 105' ' ' ILE . 28.0 ttm180 -54.02 -55.18 29.73 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.804 0.842 . . . . 54.2 110.279 171.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -67.49 -40.36 85.23 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.175 0.99 . . . . 74.43 111.736 -172.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.6 t -63.4 -36.6 84.25 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.366 0.416 . . . . 73.42 110.69 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.417 ' O ' HG23 ' A' ' 118' ' ' VAL . 60.0 mt -68.6 -49.58 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 115.461 -0.79 . . . . 74.21 110.039 174.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.6 m -56.32 -37.47 69.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.289 1.035 . . . . 73.42 111.496 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.9 t -62.23 -48.8 78.35 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 115.647 -0.706 . . . . 70.44 110.261 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.422 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 36.2 mtm -67.48 -36.27 80.8 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.158 0.583 . . . . 73.52 111.569 -176.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.5 t -62.88 -53.72 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 O-C-N 123.739 0.649 . . . . 60.35 110.278 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 38.7 t -66.51 -30.17 70.44 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.339 -0.846 . . . . 61.2 110.812 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.438 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 52.4 ttm-85 -77.43 -28.78 52.69 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.475 1.11 . . . . 72.41 109.343 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.417 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.72 9.6 67.84 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 115.283 -0.871 . . . . 55.23 112.23 171.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.559 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.1 t 67.83 13.5 9.21 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 127.166 2.186 . . . . 63.31 113.568 170.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -81.47 148.56 62.85 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 108.23 -1.026 . . . . 75.44 108.23 172.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -59.31 164.29 10.97 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.922 2.415 . . . . 61.2 113.371 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -54.51 120.25 6.39 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.009 0.923 . . . . 64.22 112.189 -173.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.465 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 62.2 tp -115.19 103.32 10.73 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.378 1.071 . . . . 64.21 108.563 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -99.12 111.16 23.62 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 107.537 -1.283 . . . . 74.04 107.537 177.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.411 HD11 HG11 ' A' ' 62' ' ' VAL . 2.2 tt -64.96 121.51 14.84 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.396 -0.964 . . . . 61.3 108.396 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' E' ' 6' ' ' ILE . . . -64.45 139.14 97.65 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 122.722 0.409 . . . . 51.41 111.363 -175.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.21 132.58 10.39 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 123.044 2.496 . . . . 62.2 112.199 -175.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.7 t -112.1 114.73 47.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.605 -1.258 . . . . 73.13 107.605 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -82.25 65.93 7.61 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 123.599 0.562 . . . . 75.53 110.345 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.697 ' HB2' HD21 ' A' ' 104' ' ' ASN . 80.4 m-85 -52.6 -41.95 64.11 Favored 'General case' 0 C--N 1.366 1.301 0 C-N-CA 123.865 0.866 . . . . 72.41 110.789 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -55.35 -50.92 68.42 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 124.448 1.092 . . . . 70.21 111.187 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.46 -43.95 95.88 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.657 0.598 . . . . 64.24 111.12 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.2 mt -60.5 -48.72 80.51 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.913 0.885 . . . . 72.53 111.662 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -71.4 -35.62 71.08 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.126 0.57 . . . . 72.51 111.499 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 85.7 mtp -72.12 -22.77 61.28 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 119.079 -0.486 . . . . 64.4 111.651 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -58.75 -29.19 66.55 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 122.924 0.489 . . . . 64.23 111.259 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -84.51 -29.69 25.77 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.242 0.617 . . . . 73.21 110.738 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.2 tp -67.69 -54.97 15.18 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.462 0.705 . . . . 72.34 110.945 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 172.34 15.09 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 125.039 1.336 . . . . 63.3 110.394 -175.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 59.1 -74.18 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.672 1.189 . . . . 63.24 110.468 -163.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 70.17 137.76 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.459 1.503 . . . . 71.04 112.118 174.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -141.01 -174.62 4.05 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.987 0.915 . . . . 43.42 109.751 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -173.43 108.18 0.27 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.611 -0.995 . . . . 70.04 110.611 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -113.72 86.01 2.32 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.645 0.778 . . . . 73.04 110.875 -174.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -96.31 121.68 7.07 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 110.014 -1.235 . . . . 21.33 110.014 171.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' G' ' 24' ' ' PRO . 45.3 p -131.44 134.08 45.83 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.29 0.636 . . . . 72.22 110.386 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.644 ' HB3' ' HG3' ' G' ' 25' ' ' GLU . 9.0 tp10 -160.91 140.44 10.66 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.032 0.933 . . . . 54.21 109.995 172.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -80.33 77.9 7.05 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.445 -0.946 . . . . 74.44 108.445 171.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -106.42 104.51 14.22 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.177 -0.92 . . . . 65.04 108.694 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -89.37 135.38 33.62 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.475 -0.565 . . . . 72.24 109.475 175.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -132.04 140.67 48.97 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 107.896 -1.15 . . . . 53.5 107.896 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 N-CA-C 109.473 -0.566 . . . . 72.2 109.473 -178.105 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttm . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 109.023 -0.732 . . . . 71.4 109.023 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m -79.88 75.18 6.6 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.679 0.792 . . . . 53.41 110.432 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -88.55 96.81 10.77 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.476 -0.784 . . . . 63.14 109.285 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -155.02 133.34 11.79 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.879 0.871 . . . . 72.41 109.034 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -151.11 94.71 2.08 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 107.763 -1.199 . . . . 71.24 107.763 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -125.51 82.24 2.05 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.206 0.527 . . . . 75.54 110.808 -173.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 23.9 p -141.25 18.48 2.25 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.634 1.173 . . . . 71.45 108.458 169.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.584 ' HG2' ' H ' ' B' ' 9' ' ' MET . 12.1 tt0 -82.44 -166.97 1.41 Allowed 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 114.767 -1.106 . . . . 73.14 111.131 -166.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.672 ' HB2' ' HB ' ' B' ' 89' ' ' ILE . 12.6 ttt 67.26 168.32 0.24 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 125.71 1.604 . . . . 72.32 111.592 -176.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 87.5 m -139.79 136.18 33.8 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.138 -1.06 . . . . 63.53 108.138 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.579 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 86.0 t80 -126.31 145.16 50.54 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.858 0.863 . . . . 71.34 109.254 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.473 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -157.32 139.29 14.31 Favored 'General case' 0 C--N 1.346 0.441 0 O-C-N 123.501 0.5 . . . . 74.43 109.806 170.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.465 HD13 HD11 ' B' ' 16' ' ' ILE . 26.2 mt -79.8 126.32 39.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.846 -0.798 . . . . 71.34 108.846 172.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -94.45 -51.09 4.92 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.763 -0.458 . . . . 73.11 109.763 175.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.559 ' HE ' HG21 ' A' ' 122' ' ' THR . 33.7 ttt180 -162.67 139.87 7.94 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.547 -0.297 . . . . 64.45 110.758 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.465 HD11 HD13 ' B' ' 13' ' ' ILE . 98.1 mt -120.56 134.68 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 107.672 -1.233 . . . . 73.23 107.672 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -168.47 158.0 9.28 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.302 0.572 . . . . 75.32 111.949 -171.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 85.3 m -89.41 129.6 35.9 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.14 -0.936 . . . . 72.41 109.559 173.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.401 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.4 mtpt -100.37 -20.33 15.88 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.558 0.743 . . . . 75.42 111.412 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -167.52 144.22 4.31 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.52 0.513 . . . . 62.23 111.583 -173.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 43.0 mm -138.42 147.09 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.996 1.319 . . . . 74.35 109.468 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.568 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.2 t -146.01 136.14 23.71 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.638 1.175 . . . . 72.44 108.467 170.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.4 t80 -150.51 108.14 3.66 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 107.749 -1.204 . . . . 65.35 107.749 170.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -120.18 113.94 21.19 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.154 0.982 . . . . 75.24 109.013 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.42 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.55 87.94 3.06 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 108.269 -1.011 . . . . 71.25 108.269 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -66.57 -45.25 5.07 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.182 2.588 . . . . 72.35 113.043 -168.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.423 HD22 ' HB2' ' B' ' 71' ' ' GLU . 81.0 m-20 -103.36 23.56 12.32 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.661 0.785 . . . . 75.33 110.494 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.492 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -40.86 -62.15 1.07 Allowed Pre-proline 0 N--CA 1.49 1.548 0 C-N-CA 124.749 1.219 . . . . 60.35 113.981 -168.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.55 -23.64 76.84 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.468 2.112 . . . . 43.43 113.5 -173.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -94.28 -39.86 10.28 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.386 0.674 . . . . 71.32 111.954 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' B' ' 73' ' ' ALA . 8.7 p -69.71 -15.89 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 122.996 0.518 . . . . 60.15 112.072 -171.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -68.3 -11.98 60.32 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.561 0.744 . . . . 53.22 112.766 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.6 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.9 pt20 -58.16 -28.82 65.07 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.401 0.62 . . . . 71.34 109.962 172.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.6 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 88.7 mttt -95.94 92.91 6.72 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.253 1.421 . . . . 72.01 109.504 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -95.09 87.92 5.05 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.31 -0.405 . . . . 72.51 110.084 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -165.71 178.18 6.78 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.126 0.97 . . . . 74.42 108.994 170.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.437 HE22 HG23 ' F' ' 5' ' ' THR . 16.7 pt20 -70.9 112.12 12.2 Favored Pre-proline 0 CA--C 1.562 1.412 0 C-N-CA 123.277 0.631 . . . . 62.34 111.302 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.55 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 18.1 Cg_endo -62.66 143.76 92.97 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.278 1.985 . . . . 65.23 112.421 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.84 108.71 4.08 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.985 -0.746 . . . . 73.24 108.985 176.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 30.8 m -93.93 147.53 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.231 -0.895 . . . . 73.34 112.592 -172.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.47 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 61.7 mtpt -125.51 100.94 6.7 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.003 1.321 . . . . 73.44 108.29 174.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.519 HD22 HD23 ' F' ' 8' ' ' LEU . 1.1 pp -96.58 155.6 16.7 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.626 -0.715 . . . . 73.53 111.443 -174.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -150.28 150.92 32.17 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.326 1.05 . . . . 74.34 109.205 -175.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.5 HD21 HD13 ' F' ' 8' ' ' LEU . 90.5 mt -125.48 127.29 46.25 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.191 0.996 . . . . 63.25 108.615 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.556 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 25.1 t70 -124.21 146.26 48.82 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.016 0.526 . . . . 70.32 110.455 -171.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.742 HG21 ' H ' ' F' ' 16' ' ' THR . 90.7 m -110.41 122.76 48.49 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.944 -1.026 . . . . 72.31 110.983 -176.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.36 122.58 11.52 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 107.061 -1.459 . . . . 54.15 107.061 169.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 36.1 p -145.82 163.16 35.89 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.795 0.27 . . . . 52.33 110.804 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 52.5 p -151.99 141.53 21.69 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.83 0.852 . . . . 71.5 109.35 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -84.22 129.82 34.86 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.196 -0.668 . . . . 71.14 109.196 175.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 50.9 mt -92.22 -44.37 8.81 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.03 0.532 . . . . 74.23 110.312 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.85 -171.86 3.58 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.052 0.941 . . . . 24.41 109.569 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -68.3 129.32 39.58 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.455 -0.793 . . . . 73.15 109.157 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 68.57 -4.67 1.09 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.489 1.515 . . . . 74.44 113.085 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 82.4 t -113.76 117.61 55.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 108.642 -0.873 . . . . 64.5 108.642 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -135.12 140.84 45.77 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.155 -0.683 . . . . 74.54 109.155 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -114.07 114.31 25.93 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.204 -1.035 . . . . 71.25 108.204 -174.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.461 ' HB ' ' HZ ' ' F' ' 15' ' ' PHE . 34.3 m -108.22 136.73 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.616 0.766 . . . . 71.24 110.431 -178.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 19.5 t -120.92 121.65 65.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 108.393 -0.966 . . . . 72.52 108.393 177.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.33 108.86 20.61 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 106.84 -1.541 . . . . 74.43 106.84 170.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.623 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 26.9 ttp180 -86.9 118.73 26.48 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.036 -0.728 . . . . 72.31 109.036 173.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 16.6 t -103.92 121.16 55.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.71 -1.218 . . . . 60.31 107.71 174.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 23.8 m -120.26 124.96 46.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.111 -0.7 . . . . 65.24 109.111 -178.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 97.9 t -123.9 113.53 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 124.216 1.006 . . . . 75.23 109.101 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 67.3 m -84.84 149.38 25.74 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.354 -0.98 . . . . 74.42 108.354 166.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.43 140.77 30.57 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.334 0.653 . . . . 64.24 109.663 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.542 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 21.0 p -145.71 130.05 17.69 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.17 0.51 . . . . 61.14 111.383 -176.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.55 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 28.6 mt -104.59 128.09 52.5 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.323 1.049 . . . . 73.4 109.004 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.99 -111.37 4.09 Favored Glycine 0 C--N 1.344 0.981 0 O-C-N 123.733 0.646 . . . . 63.14 112.196 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -118.46 10.79 12.78 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.575 0.75 . . . . 73.23 111.55 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.423 ' HB2' HD22 ' B' ' 27' ' ' ASN . 13.4 pt-20 -129.7 159.31 36.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.732 0.413 . . . . 61.23 110.759 -175.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.1 m -73.19 121.19 19.89 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 116.043 -0.526 . . . . 60.11 110.317 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.558 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -76.48 -61.68 1.88 Allowed 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.049 -1.093 . . . . 63.35 108.049 177.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -157.52 165.11 36.5 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.953 -1.022 . . . . 73.11 111.9 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 46.1 mt -125.6 112.0 15.65 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 106.043 -1.836 . . . . 62.24 106.043 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.419 ' SG ' HG23 ' B' ' 114' ' ' ILE . 34.8 t -117.15 148.93 41.15 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.665 -0.865 . . . . 75.13 108.665 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 41.9 tt0 -163.88 132.42 3.7 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.167 0.587 . . . . 73.22 109.531 -173.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 98.8 t -132.86 147.04 31.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 123.757 0.823 . . . . 74.23 109.186 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.623 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 19.1 mt-30 -118.41 103.96 10.27 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.601 -0.889 . . . . 64.11 108.601 169.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -94.62 100.52 12.45 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.195 -1.039 . . . . 61.45 108.195 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.401 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -90.12 153.42 22.9 Favored Glycine 0 C--O 1.242 0.606 0 CA-C-N 114.998 -1.001 . . . . 72.45 111.159 175.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.8 126.25 1.85 Allowed Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 111.316 -0.714 . . . . 72.34 111.316 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 48.3 mt -85.49 128.21 39.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 107.546 -1.279 . . . . 71.24 107.546 170.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -138.61 149.95 45.77 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.129 -0.693 . . . . 64.43 109.129 176.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 69.8 m -94.52 100.33 12.33 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.464 -0.939 . . . . 73.32 108.464 170.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.449 ' O ' ' HB1' ' F' ' 21' ' ' ALA . 1.8 pp -116.1 110.77 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.358 -0.979 . . . . 64.33 108.358 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.32 170.13 21.71 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.33 0.652 . . . . 74.41 110.886 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.84 -65.63 0.25 Allowed Glycine 0 C--N 1.346 1.138 0 CA-C-O 119.672 -0.516 . . . . 74.34 113.151 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' B' ' 9' ' ' MET . 3.4 tt -82.55 170.07 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 117.597 0.698 . . . . 74.54 110.037 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -152.62 160.74 43.17 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.028 0.931 . . . . 75.33 109.172 -167.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.83 -134.47 11.7 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 110.947 -0.861 . . . . 65.41 110.947 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' B' ' 95' ' ' ALA . 12.4 m -93.47 -18.32 22.45 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 117.247 0.523 . . . . 73.43 110.575 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.39 -26.04 60.82 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.695 -0.628 . . . . 52.0 111.108 -174.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -64.84 -31.76 73.15 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 119.485 -0.293 . . . . 74.53 110.439 171.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' B' ' 92' ' ' THR . . . -59.81 -38.73 82.77 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.665 0.786 . . . . 72.51 111.135 176.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -65.34 -39.21 92.1 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.404 -0.817 . . . . 74.11 111.359 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 40.2 t -66.56 -41.46 88.58 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.626 0.602 . . . . 72.15 112.626 -173.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.574 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.0 pt? -101.35 -14.31 17.66 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 117.862 0.301 . . . . 63.13 111.664 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.32 -21.43 24.81 Favored Glycine 0 C--N 1.352 1.425 0 N-CA-C 114.3 0.48 . . . . 73.23 114.3 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.23 -54.12 1.7 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.487 0.715 . . . . 72.24 110.159 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -69.69 -52.74 23.0 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.299 0.64 . . . . 73.41 112.288 -171.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.579 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 69.0 m -59.11 -49.02 95.29 Favored Pre-proline 0 CA--C 1.565 1.555 0 CA-C-O 119.04 -0.505 . . . . 74.21 112.143 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 39.1 Cg_exo -63.54 -27.73 69.95 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 122.217 1.944 . . . . 75.22 113.835 173.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -63.54 -37.68 88.25 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.032 0.533 . . . . 53.42 109.771 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.455 HD13 HD11 ' B' ' 13' ' ' ILE . 72.1 mt -65.48 -42.43 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.781 0.832 . . . . 65.43 110.2 175.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 91.9 mt -76.96 -20.36 56.21 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.949 -1.023 . . . . 75.42 111.833 -175.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -54.03 -55.79 32.57 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 124.136 0.974 . . . . 72.25 113.151 -176.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -59.34 -31.38 94.88 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.085 1.857 . . . . 74.41 113.737 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -69.73 -46.31 66.2 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.395 0.678 . . . . 73.33 110.503 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.2 -38.66 88.5 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.582 0.753 . . . . 43.23 110.992 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -61.88 -53.37 56.79 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.092 1.357 . . . . 74.04 110.778 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.01 -33.38 75.92 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.524 -0.762 . . . . 74.33 109.716 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.485 ' O ' ' HG2' ' B' ' 117' ' ' MET . 38.0 t -64.6 -44.52 90.37 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 123.51 0.506 . . . . 74.0 111.715 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.494 ' O ' HG23 ' B' ' 118' ' ' VAL . 72.9 mt -59.59 -55.01 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 109.12 -0.696 . . . . 62.24 109.12 175.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.1 m -62.26 -28.1 69.48 Favored 'General case' 0 CA--C 1.552 1.044 0 O-C-N 123.633 0.583 . . . . 55.31 112.122 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.7 t -64.5 -48.04 76.66 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.258 -0.645 . . . . 43.42 109.258 175.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.8 mmt -70.75 -33.86 71.26 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.053 0.541 . . . . 71.44 110.663 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.494 HG23 ' O ' ' B' ' 114' ' ' ILE . 97.2 t -61.51 -43.4 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.536 0.734 . . . . 73.21 110.067 173.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.8 t -64.56 -37.59 88.08 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.058 -0.974 . . . . 72.23 110.806 178.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' B' ' 116' ' ' SER . 89.7 mtt-85 -66.58 -32.87 74.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.601 -0.727 . . . . 62.32 110.411 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.6 12.21 59.68 Favored Glycine 0 C--N 1.349 1.29 0 O-C-N 123.933 0.771 . . . . 64.41 113.013 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 76.4 p 53.08 27.95 6.31 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 126.161 1.784 . . . . 73.43 113.324 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -86.69 155.37 56.21 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.417 0.687 . . . . 74.43 110.292 177.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.0 176.45 2.47 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.112 2.541 . . . . 65.02 113.784 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.639 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 0.0 OUTLIER -62.93 124.71 21.77 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.878 -1.056 . . . . 73.3 111.8 -173.091 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -144.05 102.92 3.95 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.218 -1.031 . . . . 54.51 108.218 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -119.05 135.08 54.81 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.02 0.928 . . . . 72.33 108.987 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.485 HD23 HD11 ' F' ' 6' ' ' ILE . 91.8 mt -69.39 145.32 52.97 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.127 0.571 . . . . 62.51 110.589 174.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.3 150.92 65.12 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 122.94 0.496 . . . . 73.4 110.992 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.444 ' CG ' HD13 ' D' ' 16' ' ' ILE . 33.0 Cg_exo -61.54 108.35 0.6 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.149 2.566 . . . . 72.13 111.893 175.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.536 HG21 ' HB2' ' F' ' 8' ' ' LEU . 66.1 t -112.33 111.04 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.573 -0.899 . . . . 63.32 108.573 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -96.88 93.04 6.42 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.258 -1.016 . . . . 71.12 108.258 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.532 ' HD1' HD12 ' F' ' 10' ' ' LEU . 63.8 m-85 -61.48 -40.63 95.23 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.89 0.876 . . . . 74.41 110.301 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -57.61 -43.64 84.86 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.914 1.286 . . . . 71.53 111.677 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.53 -40.13 95.03 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.623 0.769 . . . . 71.0 111.072 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.454 HD22 HD22 ' F' ' 10' ' ' LEU . 4.1 tt -66.4 -42.81 87.31 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.026 0.53 . . . . 74.12 109.66 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -66.03 -30.97 71.6 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.143 0.577 . . . . 72.32 111.404 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -67.9 -37.48 81.78 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.975 0.51 . . . . 51.52 110.723 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -73.67 -23.03 59.78 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 122.656 0.382 . . . . 63.15 110.472 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -70.4 -36.62 74.17 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.905 0.482 . . . . 74.12 110.472 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 71.7 mt -89.52 4.53 48.93 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.537 0.735 . . . . 62.34 111.847 -176.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -73.26 101.09 3.29 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.01 0.524 . . . . 64.42 110.384 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -134.3 108.01 7.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.803 0.841 . . . . 74.04 108.954 176.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -170.49 110.11 0.37 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.097 -1.446 . . . . 73.34 107.097 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.56 131.44 44.78 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.173 0.589 . . . . 60.42 110.624 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.64 117.55 5.22 Favored Glycine 0 C--N 1.348 1.239 0 O-C-N 123.659 0.6 . . . . 73.12 111.658 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -111.65 140.68 46.07 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.467 0.707 . . . . 65.45 110.484 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 140.02 152.86 5.91 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.726 -0.55 . . . . 74.2 111.726 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 15.3 t -163.74 170.76 16.52 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.288 0.635 . . . . 75.11 110.718 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -143.22 163.1 33.87 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.77 0.828 . . . . 61.44 110.042 173.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -166.75 119.74 1.01 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.153 0.981 . . . . 62.34 108.739 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -129.62 101.79 6.07 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.698 0.799 . . . . 73.44 109.939 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -84.89 84.01 7.85 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 108.809 -0.811 . . . . 72.42 108.809 171.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -89.96 151.57 21.63 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.843 0.857 . . . . 72.41 110.44 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 C-N-CA 124.068 0.947 . . . . 63.51 108.988 178.844 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 58.6 ttp . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.986 -0.375 . . . . 73.33 109.986 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 49.3 m -75.03 80.87 2.21 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.291 0.636 . . . . 73.03 109.855 173.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -77.11 -75.06 0.22 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.864 -0.791 . . . . 62.14 108.864 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -104.52 89.9 3.35 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 108.322 -0.992 . . . . 70.11 108.322 171.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -142.02 147.45 36.9 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 108.093 -1.077 . . . . 75.22 108.093 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -56.14 -48.04 77.01 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.065 0.853 . . . . 71.31 109.366 174.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 17.7 m 65.51 146.39 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 O-C-N 125.083 1.489 . . . . 75.22 111.757 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -112.14 120.67 42.6 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 106.599 -1.63 . . . . 72.54 106.599 174.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.873 ' HE1' ' HA ' ' C' ' 86' ' ' ILE . 0.0 OUTLIER 65.08 120.77 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.304 0 O-C-N 124.605 1.191 . . . . 72.53 111.456 178.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 28.0 m -86.57 85.29 7.3 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.282 -1.007 . . . . 65.54 108.282 175.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.676 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 4.2 t80 -121.08 126.79 50.72 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 114.83 -1.077 . . . . 75.54 110.383 -171.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -148.19 121.8 9.19 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.86 -1.163 . . . . 61.4 107.86 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.403 HG12 ' CD2' ' C' ' 84' ' ' PHE . 69.2 mt -73.15 124.43 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 109.491 -0.559 . . . . 65.44 109.491 178.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.411 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 19.1 mm-40 -88.8 -47.87 7.9 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.102 -0.954 . . . . 74.04 109.636 -175.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -170.04 133.6 1.18 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.797 0.439 . . . . 73.35 110.529 -173.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 83.8 mt -116.11 146.28 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 108.007 -1.109 . . . . 62.41 108.007 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -174.9 169.19 3.48 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.366 0.666 . . . . 72.15 110.08 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . 0.452 HG22 HE22 ' C' ' 80' ' ' GLN . 66.7 p -92.09 115.77 28.36 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.347 0.659 . . . . 71.54 109.364 176.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.639 ' HE2' ' HB3' ' D' ' 28' ' ' ALA . 23.1 mmtp -66.22 -47.62 73.24 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.615 0.721 . . . . 72.14 109.705 172.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 14.1 t70 -144.41 148.79 35.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.132 -1.394 . . . . 64.11 110.147 -175.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.499 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.7 mt -142.28 145.57 23.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.121 -1.437 . . . . 74.5 107.121 176.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 42.8 t -157.46 151.7 24.79 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.26 0.624 . . . . 64.21 110.676 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 86.1 t80 -148.5 146.12 28.21 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.674 -1.232 . . . . 63.54 107.674 170.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -145.71 132.04 19.58 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.815 0.846 . . . . 72.32 109.763 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.41 77.9 4.73 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 106.192 -1.781 . . . . 60.32 106.192 172.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -62.97 -37.65 52.16 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.902 2.402 . . . . 73.11 111.877 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -95.62 21.4 8.36 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.371 -1.286 . . . . 75.31 111.154 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.81 -53.67 9.66 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 113.744 1.016 . . . . 53.34 113.744 -173.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.68 -41.55 38.29 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 121.844 1.696 . . . . 71.53 112.4 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -69.52 -32.88 71.98 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.544 0.738 . . . . 75.13 112.197 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.756 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.1 p -78.14 -27.78 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 N-CA-C 112.359 0.503 . . . . 72.33 112.359 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -64.24 -28.31 69.65 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.466 0.543 . . . . 72.53 112.466 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -87.69 17.67 4.55 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.019 0.528 . . . . 72.21 111.409 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.541 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -109.8 158.25 18.34 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.944 0.898 . . . . 72.34 109.85 178.569 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -65.4 128.09 34.45 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.551 -0.537 . . . . 74.14 109.551 169.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -81.0 89.35 5.92 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.69 -0.686 . . . . 71.12 110.292 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.401 ' H ' HD22 ' C' ' 68' ' ' LEU . 20.4 tp60 -142.07 79.58 16.08 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.598 0.759 . . . . 64.34 109.131 171.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -89.21 178.23 2.64 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 122.553 2.169 . . . . 72.15 112.704 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -109.84 117.46 33.9 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.416 -1.327 . . . . 74.35 107.416 166.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.411 HG11 HD12 ' G' ' 6' ' ' ILE . 46.5 t -80.29 96.45 2.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 107.613 -1.254 . . . . 50.51 107.613 174.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.405 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 3.1 tppp? -105.66 100.2 9.77 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.284 -1.006 . . . . 71.34 108.284 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.471 HD13 ' HA ' ' G' ' 8' ' ' LEU . 1.0 OUTLIER -91.36 158.55 16.47 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.107 -0.952 . . . . 72.11 110.069 -177.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.443 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 27.7 t70 -152.95 148.27 26.92 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.609 0.764 . . . . 74.31 109.012 -177.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.473 HD13 HD21 ' G' ' 11' ' ' LEU . 9.7 tt -128.5 147.19 50.67 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.839 -0.8 . . . . 53.42 108.839 -176.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 25.6 t0 -146.36 147.11 30.97 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.592 -1.262 . . . . 72.04 107.592 173.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 18.5 p -114.84 112.3 22.54 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.459 0.704 . . . . 74.32 109.931 -173.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.22 151.75 27.89 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.463 1.105 . . . . 72.53 108.87 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 69.9 m -162.13 158.1 24.21 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.763 0.425 . . . . 55.52 111.787 -174.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 88.1 p -157.29 144.43 18.51 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.08 0.952 . . . . 53.53 109.121 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -87.83 126.19 34.88 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.767 -0.457 . . . . 70.25 109.767 176.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.703 HD11 HD12 ' C' ' 83' ' ' ILE . 71.6 mt -96.75 -43.92 7.31 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.548 -0.751 . . . . 74.32 110.109 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -156.35 -171.51 3.73 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.593 -0.73 . . . . 53.05 110.91 -176.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -66.64 108.22 2.39 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.115 -0.948 . . . . 71.42 110.038 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 70.94 -6.45 1.28 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.92 1.288 . . . . 75.15 112.772 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 42.2 t -92.2 97.06 6.79 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 107.011 -1.477 . . . . 71.32 107.011 173.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -120.93 124.92 46.11 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.244 -1.343 . . . . 54.41 107.985 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -83.5 125.42 31.73 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.169 -0.923 . . . . 43.1 109.778 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 6.0 m -112.09 127.09 69.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 108.026 -1.102 . . . . 72.44 108.026 171.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.578 HG12 ' HG2' ' C' ' 79' ' ' GLN . 21.9 t -121.29 134.97 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.799 -1.186 . . . . 54.21 107.799 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 13.1 tp -116.07 108.33 16.06 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.604 -0.517 . . . . 55.14 109.604 -175.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.48 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 7.3 tmm_? -84.39 105.84 15.54 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.882 -0.784 . . . . 74.44 108.882 177.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.477 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.6 t -100.32 136.31 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.585 -0.894 . . . . 63.34 108.585 175.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 51.4 m -122.94 141.67 51.66 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.239 -1.022 . . . . 64.11 108.239 173.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 75.4 t -132.85 110.05 15.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 107.75 -1.204 . . . . 72.3 107.75 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 4.5 m -99.01 144.21 28.42 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.146 -1.057 . . . . 71.53 108.146 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.71 119.41 17.16 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.443 -0.947 . . . . 41.3 108.443 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 51.6 m -136.91 132.8 34.97 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.696 0.622 . . . . 54.44 110.251 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.541 HD13 ' HG2' ' C' ' 34' ' ' LYS . 11.3 mt -85.22 47.96 1.5 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.133 1.373 . . . . 75.44 109.224 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.93 -109.56 3.53 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 110.256 -1.138 . . . . 73.14 110.256 -171.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -89.94 -32.15 16.95 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.988 0.515 . . . . 73.14 109.729 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -66.01 111.75 3.51 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 123.284 0.634 . . . . 53.43 109.374 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 26.4 m -79.66 125.65 29.91 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.306 -0.628 . . . . 75.42 109.306 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.756 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -81.98 -55.18 4.75 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.408 0.683 . . . . 63.04 109.837 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -157.59 166.81 31.89 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.704 0.764 . . . . 70.52 111.988 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -135.47 122.49 21.37 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 105.866 -1.901 . . . . 74.15 105.866 170.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.414 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 46.2 t -127.48 134.58 49.81 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.121 -1.066 . . . . 54.21 108.121 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -148.6 125.17 11.04 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.258 0.348 . . . . 70.35 110.644 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.6 t -131.51 134.4 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 124.107 0.963 . . . . 70.21 108.927 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.578 ' HG2' HG12 ' C' ' 59' ' ' VAL . 5.4 tt0 -112.52 90.82 3.45 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.606 -1.627 . . . . 74.44 106.606 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.452 HE22 HG22 ' C' ' 18' ' ' THR . 9.8 tp-100 -83.19 111.86 19.32 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.061 0.544 . . . . 75.42 110.437 -171.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.41 146.57 18.24 Favored Glycine 0 C--N 1.337 0.63 0 O-C-N 123.491 0.494 . . . . 74.2 112.492 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.99 118.07 0.92 Allowed Glycine 0 C--O 1.243 0.697 0 N-CA-C 110.987 -0.845 . . . . 54.43 110.987 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.703 HD12 HD11 ' C' ' 51' ' ' LEU . 12.9 mm -81.98 116.93 27.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 108.556 -0.905 . . . . 74.33 108.556 174.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.668 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 54.8 m-85 -130.92 144.27 51.35 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.955 -0.757 . . . . 73.13 108.955 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 13.1 p -91.16 118.76 30.71 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 108.915 -0.772 . . . . 71.31 108.915 170.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.873 ' HA ' ' HE1' ' C' ' 9' ' ' MET . 4.4 mp -113.68 101.37 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.944 0.898 . . . . 61.11 108.621 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.474 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -146.19 170.45 16.7 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.109 0.963 . . . . 72.52 110.037 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.76 -49.35 2.55 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 116.341 -0.39 . . . . 64.41 112.141 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 33.8 pt -118.67 159.73 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.707 0.803 . . . . 71.11 110.252 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -147.67 -178.15 6.1 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.776 0.83 . . . . 53.02 109.907 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.98 -142.9 45.68 Favored Glycine 0 C--N 1.351 1.373 0 O-C-N 123.222 0.326 . . . . 70.35 112.94 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 1.2 m -68.82 -23.78 64.31 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.983 0.513 . . . . 74.22 110.699 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -57.74 -57.15 14.03 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 124.118 0.967 . . . . 70.44 109.891 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.466 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 22.3 ptt? -69.8 -30.27 67.77 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.146 -0.479 . . . . 64.1 110.766 178.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.04 -30.65 69.33 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.133 0.573 . . . . 33.15 111.181 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.476 ' NE2' ' HB2' ' C' ' 134' ' ' ASP . 32.3 t-80 -62.5 -46.02 90.33 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.263 -0.88 . . . . 64.11 110.862 170.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.553 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 31.4 t -69.21 -64.57 0.85 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.05 0.219 . . . . 74.34 111.072 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.52 HD22 HG23 ' G' ' 18' ' ' VAL . 3.7 pp -67.6 -31.47 71.54 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 113.146 0.795 . . . . 74.24 113.146 -173.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . 0.419 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -102.8 6.99 52.56 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 114.63 0.612 . . . . 43.32 114.63 -171.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -151.12 -60.83 0.18 Allowed 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.365 0.603 . . . . 75.45 110.824 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.553 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 5.0 t80 -74.81 -34.3 62.34 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 125.011 1.324 . . . . 74.51 112.757 -171.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.416 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 80.1 m -78.39 -43.81 2.07 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 123.356 0.662 . . . . 61.23 111.057 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 51.7 Cg_exo -60.92 -27.14 84.34 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 121.943 1.762 . . . . 71.14 112.403 166.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -64.92 -34.93 79.58 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 123.313 0.645 . . . . 62.11 110.696 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.471 HG23 ' NH1' ' A' ' 111' ' ' ARG . 45.6 mm -60.46 -38.33 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 121.326 0.584 . . . . 64.41 109.49 172.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 79.5 mt -89.12 -13.71 37.9 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.549 1.14 . . . . 63.32 112.655 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -57.43 -49.83 91.61 Favored Pre-proline 0 N--CA 1.485 1.281 0 CA-C-O 118.126 -0.94 . . . . 72.34 112.87 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.96 -35.18 78.64 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.179 1.919 . . . . 71.24 113.07 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -66.02 -50.75 63.13 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.517 0.727 . . . . 70.43 111.367 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.63 -42.83 99.82 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.747 -0.66 . . . . 71.34 109.901 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -54.85 -53.22 58.23 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.124 1.37 . . . . 75.22 111.052 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -69.09 -36.56 77.72 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.945 0.778 . . . . 74.2 110.283 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.0 t -68.78 -34.54 75.73 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.929 0.491 . . . . 53.2 111.049 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.477 HD11 ' HB ' ' C' ' 62' ' ' VAL . 87.5 mt -69.62 -53.61 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.349 0.66 . . . . 61.44 109.611 175.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 16.8 m -64.56 -29.16 70.18 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.269 0.628 . . . . 75.42 111.28 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.3 t -64.29 -49.94 69.83 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.063 -0.717 . . . . 63.23 109.063 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.733 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.54 -37.92 82.79 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.325 1.05 . . . . 74.2 112.179 178.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 69.9 t -66.84 -40.41 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 123.274 0.63 . . . . 73.02 110.137 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 20.9 t -74.09 -23.25 59.3 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.714 0.805 . . . . 74.05 111.576 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 86.3 mtt-85 -76.2 -38.88 55.94 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.706 0.803 . . . . 74.11 108.86 174.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.02 -1.18 67.39 Favored Glycine 0 C--N 1.355 1.627 0 O-C-N 123.974 0.797 . . . . 34.2 112.256 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.7 p 64.64 23.41 12.8 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.926 2.09 . . . . 73.1 113.14 171.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -81.75 143.28 50.21 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 108.209 -1.034 . . . . 62.51 108.209 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.639 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 66.6 Cg_exo -45.23 145.21 3.69 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 123.645 2.896 . . . . 60.04 114.826 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -53.96 114.38 1.56 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.592 1.157 . . . . 71.14 112.593 -175.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 36.8 tp -109.52 94.09 4.85 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.139 -0.937 . . . . 74.15 109.224 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -94.45 115.54 27.73 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.213 0.605 . . . . 62.55 109.709 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.479 HD13 ' H ' ' C' ' 129' ' ' ALA . 0.2 OUTLIER -72.13 149.03 45.12 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.644 0.778 . . . . 73.52 109.781 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.479 ' H ' HD13 ' C' ' 128' ' ' LEU . . . -80.54 156.32 73.33 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.471 0.709 . . . . 52.32 111.194 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.429 ' HG3' HG21 ' A' ' 13' ' ' ILE . 28.7 Cg_endo -61.69 137.39 68.34 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 123.117 2.544 . . . . 63.04 112.274 172.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.494 HG21 ' H ' ' G' ' 8' ' ' LEU . 15.7 t -128.75 110.27 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 108.948 -0.76 . . . . 63.0 108.948 176.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.416 ' O ' ' HB2' ' C' ' 136' ' ' LEU . 12.8 m120 -100.17 91.43 4.75 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.771 0.828 . . . . 73.13 109.336 175.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -65.84 -40.56 91.86 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.163 -0.68 . . . . 53.42 109.163 171.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.476 ' HB2' ' NE2' ' C' ' 96' ' ' HIS . 7.0 p-10 -55.01 -42.14 72.16 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.538 1.535 . . . . 70.4 112.35 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.46 -32.11 24.2 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.046 0.938 . . . . 71.14 110.959 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.477 HD12 HD13 ' G' ' 10' ' ' LEU . 1.5 tm? -59.73 -44.5 93.73 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.833 0.853 . . . . 72.24 110.791 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -62.95 -31.73 72.89 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.14 0.576 . . . . 73.1 111.299 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 62.7 mtt -73.16 -38.55 66.17 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.977 0.511 . . . . 60.12 110.981 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -70.75 -44.1 67.45 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.561 0.745 . . . . 72.42 110.489 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -72.2 -87.1 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.898 0.879 . . . . 74.43 110.321 175.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 46.3 tp 63.95 -72.39 0.06 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 125.108 1.363 . . . . 71.01 111.884 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -76.96 -65.07 0.99 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.836 -0.801 . . . . 64.24 108.836 172.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -179.72 161.21 0.98 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.507 1.123 . . . . 74.33 108.528 -174.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -71.06 82.19 0.69 Allowed 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.727 0.811 . . . . 62.53 110.569 174.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.15 -35.46 77.15 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.814 0.846 . . . . 74.32 111.316 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.42 71.03 1.02 Allowed Glycine 0 C--N 1.348 1.234 0 CA-C-N 115.693 -0.685 . . . . 74.43 112.271 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -72.38 144.64 48.15 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.365 0.666 . . . . 74.53 111.151 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -73.13 69.82 1.29 Allowed Glycine 0 C--N 1.345 1.038 0 N-CA-C 111.379 -0.689 . . . . 60.21 111.379 169.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . 0.614 ' HB ' ' HB2' ' A' ' 9' ' ' MET . 41.3 p -70.16 -25.8 63.63 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.609 1.163 . . . . 62.12 112.123 -172.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.69 122.15 30.18 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.299 0.639 . . . . 74.52 110.453 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -99.39 -33.75 10.57 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.192 -0.67 . . . . 63.45 109.192 167.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 56.38 82.79 0.11 Allowed 'General case' 0 C--N 1.358 0.941 0 C-N-CA 125.084 1.354 . . . . 74.33 111.53 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -75.0 132.38 41.32 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.146 -1.057 . . . . 73.11 108.146 170.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -144.33 -67.99 0.32 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.037 0.535 . . . . 70.22 110.353 -168.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.522 -0.751 . . . . 70.32 109.026 -179.891 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.972 -0.381 . . . . 73.35 109.972 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 25.7 p -69.98 85.17 0.51 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.917 0.887 . . . . 62.33 110.102 175.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -132.06 168.45 17.93 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.636 1.174 . . . . 75.41 107.833 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -53.2 104.77 0.1 Allowed 'General case' 0 C--N 1.353 0.735 0 N-CA-C 108.864 -0.791 . . . . 54.42 108.864 171.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -74.43 74.57 1.91 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 122.207 1.003 . . . . 74.22 111.822 -172.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -124.32 83.19 2.12 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 106.807 -1.553 . . . . 74.01 106.807 174.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 10.7 t -164.5 168.4 18.39 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.913 -1.04 . . . . 73.32 109.273 -175.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -104.31 85.7 2.41 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.55 -0.907 . . . . 75.23 108.55 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 17.9 ptm -31.33 141.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.407 1.483 . . . . 72.22 114.451 175.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 24.3 m -106.38 143.53 34.36 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 109.171 -0.677 . . . . 72.34 109.171 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -158.73 97.88 1.47 Allowed 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.625 -1.25 . . . . 70.02 107.625 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -117.02 120.56 38.74 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.367 0.667 . . . . 75.52 109.263 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 19.4 mt -78.0 115.16 19.58 Favored 'Isoleucine or valine' 0 C--N 1.345 0.412 0 N-CA-C 108.968 -0.753 . . . . 45.12 108.968 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -90.7 -44.61 9.38 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 122.857 0.463 . . . . 73.22 111.721 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.435 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 40.8 ttt180 -173.85 126.11 0.37 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 112.049 0.388 . . . . 74.44 112.049 -171.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.444 HD13 ' CG ' ' B' ' 130' ' ' PRO . 2.2 mp -104.17 141.57 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.421 -0.955 . . . . 74.52 108.421 170.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.435 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 22.4 p90 -162.72 151.4 14.66 Favored 'General case' 0 C--O 1.238 0.487 0 O-C-N 124.221 0.95 . . . . 74.13 110.571 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.7 p -83.88 120.32 25.93 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.281 -0.872 . . . . 71.31 108.856 172.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -91.33 -17.34 26.05 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.7 0.4 . . . . 72.1 110.525 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.721 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 17.5 t70 -162.7 134.98 5.46 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.641 -0.874 . . . . 73.44 108.641 -174.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.733 HG21 ' HE2' ' C' ' 117' ' ' MET . 88.1 mt -139.28 151.77 23.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 C-N-CA 124.337 1.055 . . . . 70.41 108.321 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 26.6 t -152.02 145.44 24.81 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 124.402 1.081 . . . . 72.23 109.628 175.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.499 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.7 t80 -151.55 122.46 7.58 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 105.703 -1.962 . . . . 75.44 105.703 169.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -136.51 111.43 8.86 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.821 -0.807 . . . . 74.23 108.821 -176.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.85 91.21 4.09 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.249 -1.019 . . . . 74.41 108.249 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.09 -34.5 10.18 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.968 2.445 . . . . 64.53 113.003 -169.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -112.22 10.81 20.16 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 118.556 -0.735 . . . . 73.13 110.711 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.639 ' HB3' ' HE2' ' C' ' 19' ' ' LYS . . . -18.4 -72.77 0.02 OUTLIER Pre-proline 0 CA--C 1.565 1.556 0 N-CA-C 116.455 2.02 . . . . 72.0 116.455 -168.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 44.1 Cg_endo -80.29 -13.48 12.4 Favored 'Trans proline' 0 C--N 1.377 2.072 0 CA-C-N 123.903 2.43 . . . . 74.21 114.041 -172.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -77.51 -39.79 45.02 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.573 1.149 . . . . 53.4 109.136 172.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.557 HG22 HD12 ' D' ' 68' ' ' LEU . 4.8 p -84.12 -20.53 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.461 -0.791 . . . . 73.31 111.647 -175.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.404 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 21.1 m-85 -66.04 -25.16 66.92 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 120.669 0.271 . . . . 74.41 111.455 177.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -60.07 -26.34 66.09 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.25 -0.886 . . . . 73.01 110.183 175.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -90.94 76.54 6.24 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.972 1.309 . . . . 70.13 109.647 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -85.35 92.11 8.37 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.947 -0.569 . . . . 74.32 111.132 -176.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -155.25 177.84 10.89 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.881 0.873 . . . . 74.2 108.979 166.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -66.43 110.5 4.89 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.8 0.84 . . . . 73.52 109.272 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -59.48 120.51 8.38 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.954 2.436 . . . . 54.22 111.631 -175.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -69.58 115.03 8.36 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.763 0.664 . . . . 71.52 109.489 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.414 HG13 HG13 ' D' ' 64' ' ' VAL . 58.3 t -105.91 137.48 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.003 0.921 . . . . 74.04 111.105 -169.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -109.04 142.08 40.24 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.358 -1.349 . . . . 73.13 107.358 166.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.579 HD21 HD12 ' H' ' 6' ' ' ILE . 3.4 mm? -103.28 148.86 25.32 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.283 -0.636 . . . . 71.3 109.283 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -149.56 130.11 13.96 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.111 -1.07 . . . . 75.23 108.111 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.536 HD21 HD21 ' H' ' 8' ' ' LEU . 5.4 mp -119.51 146.85 45.08 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.251 0.548 . . . . 73.1 110.325 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 16.2 t70 -132.42 144.17 50.31 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.388 1.075 . . . . 75.32 108.236 175.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 57.2 m -104.21 143.15 33.33 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.864 0.866 . . . . 73.15 109.689 -175.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.579 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.51 142.08 17.68 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.98 0.912 . . . . 64.35 108.983 178.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.43 ' HB3' ' HE2' ' H' ' 15' ' ' PHE . 25.4 p -162.73 158.41 22.93 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 122.911 0.484 . . . . 45.43 110.132 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 81.4 p -151.82 144.28 24.14 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.799 -0.815 . . . . 63.23 108.799 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -87.3 117.8 26.3 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.096 -0.705 . . . . 72.35 109.096 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' D' ' 57' ' ' GLU . 26.1 mt -91.09 -24.3 20.05 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.721 -0.672 . . . . 60.14 110.204 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -172.79 178.55 2.59 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.529 1.131 . . . . 72.44 109.284 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -75.3 135.44 40.91 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.484 -0.932 . . . . 74.24 108.484 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 69.05 2.18 3.49 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.65 1.18 . . . . 73.34 113.024 -171.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 68.9 t -124.13 131.24 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.251 0.621 . . . . 71.41 109.817 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -134.66 153.97 51.74 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 123.189 0.595 . . . . 73.12 110.922 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.54 ' HB2' HD11 ' D' ' 51' ' ' LEU . 14.3 tt0 -110.83 120.3 41.95 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.3 -1.318 . . . . 72.52 107.851 165.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' D' ' 102' ' ' CYS . 33.2 m -106.89 132.45 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 108.485 -0.931 . . . . 61.21 108.485 173.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 38.7 t -125.89 125.49 68.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 N-CA-C 108.934 -0.765 . . . . 60.32 108.934 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.629 HD22 ' HB3' ' D' ' 103' ' ' PRO . 52.0 tp -115.91 117.49 30.33 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.2 -0.667 . . . . 72.43 109.2 177.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 46.4 ttm-85 -87.34 101.52 13.64 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.948 -0.76 . . . . 74.13 108.948 176.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 99.4 t -91.53 121.31 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.975 -0.75 . . . . 74.24 108.975 174.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.6 m -120.11 142.78 48.59 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.454 0.645 . . . . 74.11 109.789 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.414 HG13 HG13 ' D' ' 40' ' ' VAL . 25.4 t -130.59 102.37 6.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 126.134 1.774 . . . . 71.31 107.606 -171.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 21.2 m -95.2 97.61 10.02 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.487 -0.931 . . . . 74.13 108.487 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.4 147.02 27.23 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.114 -0.948 . . . . 71.23 108.994 -172.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.457 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.0 p -149.75 138.06 20.59 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 123.535 0.522 . . . . 75.33 111.6 -177.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.557 HD12 HG22 ' D' ' 31' ' ' VAL . 26.1 mt -115.8 111.66 20.83 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.444 -1.253 . . . . 62.22 107.619 171.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.3 -134.72 21.56 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 116.477 -0.328 . . . . 71.44 113.084 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -86.15 2.89 45.09 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.344 0.658 . . . . 75.0 112.571 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -131.57 160.55 34.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.875 0.47 . . . . 64.41 110.064 -171.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 62.5 m -69.39 136.07 51.16 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.265 -0.879 . . . . 73.41 110.492 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.524 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -84.08 -65.8 0.97 Allowed 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.664 -1.235 . . . . 71.5 107.664 174.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -152.43 158.96 43.37 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.154 -0.93 . . . . 71.23 110.458 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 69.5 mt -122.82 108.26 12.81 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.621 -1.622 . . . . 61.34 106.621 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.421 ' SG ' HG23 ' D' ' 114' ' ' ILE . 52.8 t -117.48 138.16 52.05 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.924 -0.769 . . . . 61.14 108.924 -175.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 38.2 tt0 -152.98 133.73 13.88 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.785 -0.45 . . . . 74.12 109.785 -175.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 54.0 t -139.96 119.3 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.395 0.678 . . . . 74.33 109.678 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.721 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 14.5 mt-30 -86.58 89.94 8.08 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 108.366 -0.975 . . . . 73.13 108.366 165.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . 0.446 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.7 tp-100 -83.01 104.91 13.57 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.937 -1.134 . . . . 75.42 107.937 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -103.92 162.09 15.55 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 111.934 -0.466 . . . . 32.01 111.934 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.0 133.75 3.51 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 112.117 -0.393 . . . . 64.04 112.117 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.402 HG23 HD12 ' D' ' 51' ' ' LEU . 39.0 mt -88.79 128.12 41.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 108.558 -0.905 . . . . 61.11 108.558 174.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.462 ' HB2' HD11 ' D' ' 86' ' ' ILE . 79.8 m-85 -133.97 157.07 46.98 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.888 1.275 . . . . 73.54 108.624 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.8 m -114.63 99.15 7.31 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.802 0.841 . . . . 71.13 108.913 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.462 HD11 ' HB2' ' D' ' 84' ' ' PHE . 2.8 mp -109.66 126.73 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.463 0.705 . . . . 74.44 109.637 -173.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.24 165.04 33.1 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.932 0.893 . . . . 72.13 109.702 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.93 20.97 79.2 Favored Glycine 0 C--N 1.346 1.115 0 N-CA-C 114.413 0.525 . . . . 71.15 114.413 173.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.518 HG23 HE21 ' D' ' 93' ' ' GLN . 7.3 mt -129.21 157.26 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.32 0.648 . . . . 73.44 109.443 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.81 -174.5 4.8 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.481 0.712 . . . . 65.34 111.01 175.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.98 -141.45 39.8 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.26 -0.882 . . . . 25.13 114.274 173.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 15.6 m -90.22 -13.56 35.22 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.234 0.613 . . . . 42.55 110.095 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.518 HE21 HG23 ' D' ' 89' ' ' ILE . 29.7 tt0 -63.0 -37.69 88.21 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.953 0.901 . . . . 73.43 110.806 177.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.657 ' HB2' HG23 ' H' ' 18' ' ' VAL . 25.5 ptt? -73.04 -33.13 65.51 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.879 0.472 . . . . 71.12 111.614 177.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.97 -33.67 74.08 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.778 0.431 . . . . 34.44 110.364 174.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -74.18 -32.45 63.08 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.557 0.743 . . . . 65.03 110.612 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.1 t -63.18 -50.66 69.47 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.395 0.617 . . . . 75.11 110.242 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.406 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 47.5 mt -83.04 -21.08 33.91 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.893 -1.048 . . . . 52.14 111.26 -176.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . 0.716 ' HA2' ' HB2' ' H' ' 15' ' ' PHE . . . -87.32 -16.95 59.72 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.612 0.57 . . . . 61.52 114.289 -178.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.2 -64.09 0.7 Allowed 'General case' 0 C--O 1.239 0.515 0 C-N-CA 122.685 0.394 . . . . 74.11 111.799 -172.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -63.53 -44.58 93.81 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 112.485 0.55 . . . . 62.53 112.485 -172.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.511 ' HB3' HG21 ' D' ' 58' ' ' VAL . 56.7 m -66.91 -47.3 53.98 Favored Pre-proline 0 CA--C 1.57 1.723 0 CA-C-O 118.943 -0.551 . . . . 70.24 112.105 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.629 ' HB3' HD22 ' D' ' 60' ' ' LEU . 72.2 Cg_exo -56.8 -29.66 81.89 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 122.427 2.084 . . . . 71.32 113.932 168.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -68.59 -26.0 65.16 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.109 0.564 . . . . 75.55 111.81 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 30.3 mm -71.91 -39.22 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-O 121.243 0.544 . . . . 73.03 109.648 171.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.495 HD11 HG23 ' D' ' 58' ' ' VAL . 79.1 mt -80.08 -25.57 40.0 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.216 -0.902 . . . . 53.33 111.938 -175.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -59.5 -48.33 95.91 Favored Pre-proline 0 CA--C 1.562 1.409 0 N-CA-C 113.517 0.932 . . . . 73.44 113.517 -174.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.57 -40.05 83.5 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.079 1.853 . . . . 62.34 112.956 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -71.56 -38.63 70.94 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.837 0.855 . . . . 72.13 111.803 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.15 -47.27 74.6 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.281 0.632 . . . . 71.12 109.953 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -58.07 -46.93 84.62 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.154 0.909 . . . . 72.44 110.409 176.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -59.84 -49.67 76.81 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 123.923 0.764 . . . . 71.15 110.364 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.4 t -57.55 -45.33 85.26 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.74 0.65 . . . . 72.55 111.097 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.492 ' O ' HG23 ' D' ' 118' ' ' VAL . 94.4 mt -59.59 -58.09 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.688 0.795 . . . . 63.02 110.17 175.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 90.0 m -55.59 -39.59 70.93 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.254 1.022 . . . . 52.32 111.88 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 37.8 t -66.32 -41.7 89.27 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.321 -0.854 . . . . 64.24 109.754 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.402 ' HB2' ' HE3' ' D' ' 117' ' ' MET . 75.0 mtm -71.45 -28.37 63.92 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.937 0.495 . . . . 63.14 111.65 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.492 HG23 ' O ' ' D' ' 114' ' ' ILE . 97.3 t -63.45 -48.69 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.277 -0.638 . . . . 74.34 109.277 173.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 83.1 p -71.91 -28.62 63.61 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.791 -0.641 . . . . 65.31 110.985 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -69.97 -36.47 75.23 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.798 0.839 . . . . 64.2 109.948 173.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.9 2.15 87.88 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.923 0.764 . . . . 43.01 112.138 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.1 p 61.17 29.0 18.56 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.836 2.054 . . . . 65.13 114.0 173.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.438 ' HB2' HG13 ' D' ' 118' ' ' VAL . 97.8 m-85 -86.36 154.62 57.04 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.776 -0.824 . . . . 70.2 108.776 168.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -53.0 136.84 61.68 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.838 2.358 . . . . 72.41 112.693 175.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -52.85 128.98 28.71 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 124.289 0.993 . . . . 73.41 112.249 -174.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 56.9 tp -109.51 99.64 8.82 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.363 -0.835 . . . . 72.23 109.142 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -99.96 97.34 8.23 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.596 -0.89 . . . . 75.43 108.596 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.532 ' HG ' HD11 ' H' ' 6' ' ' ILE . 1.6 tt -67.97 116.43 8.6 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.199 -1.038 . . . . 75.41 108.199 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -57.14 133.51 80.68 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 123.372 0.669 . . . . 52.03 110.025 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 23.7 Cg_exo -62.4 115.38 2.84 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.623 2.216 . . . . 61.23 111.97 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 29.1 m -107.73 111.18 34.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 108.715 -0.846 . . . . 73.05 108.715 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -84.04 107.24 16.27 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.27 -0.877 . . . . 71.31 109.392 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -62.41 -31.63 72.34 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.889 0.743 . . . . 71.33 111.737 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -57.01 -56.06 26.65 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.228 0.611 . . . . 65.0 110.82 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.485 ' HA ' ' HG2' ' D' ' 138' ' ' MET . . . -59.59 -39.26 83.58 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.805 0.842 . . . . 72.04 111.713 -177.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.82 -41.03 99.14 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.364 -0.835 . . . . 72.31 111.073 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -66.97 -31.08 71.41 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.645 0.778 . . . . 74.25 112.343 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.485 ' HG2' ' HA ' ' D' ' 135' ' ' ALA . 13.0 mmt -56.96 -37.53 71.68 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.158 0.504 . . . . 74.2 110.397 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -82.99 -40.66 19.71 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.772 -1.103 . . . . 72.42 110.423 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -60.55 -35.76 76.82 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.604 0.762 . . . . 75.23 111.994 -177.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 6.4 mp -70.54 -33.23 70.92 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.913 0.885 . . . . 74.02 111.309 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -89.42 15.03 9.87 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 120.888 0.375 . . . . 75.11 110.786 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -119.39 91.7 3.61 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.422 1.089 . . . . 52.51 108.298 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -144.23 -4.83 0.79 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.102 -0.954 . . . . 65.2 110.879 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -111.02 130.54 55.56 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.748 0.819 . . . . 31.11 109.097 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.83 -72.12 0.48 Allowed Glycine 0 C--N 1.347 1.152 0 O-C-N 123.635 0.584 . . . . 62.21 112.051 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 58.63 82.41 0.14 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.932 1.293 . . . . 74.45 110.53 -173.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.11 146.08 17.93 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.538 -0.755 . . . . 71.55 112.922 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 9.0 t -96.79 68.06 2.36 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-O 122.462 1.125 . . . . 75.33 110.875 -177.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -83.57 91.4 7.42 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.488 -0.778 . . . . 72.31 109.094 174.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.77 150.21 29.43 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.4 -0.593 . . . . 64.34 109.4 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 -143.08 91.36 2.28 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.289 -1.004 . . . . 71.32 108.289 175.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -66.64 96.46 0.39 Allowed 'General case' 0 C--N 1.347 0.469 0 CA-C-N 115.726 -0.67 . . . . 74.11 109.332 175.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -88.03 -36.93 16.71 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.744 0.817 . . . . 62.3 109.585 175.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.254 0 C-N-CA 124.021 0.928 . . . . 73.45 108.693 177.005 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 109.841 -0.429 . . . . 73.33 109.841 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.83 161.39 42.77 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.226 0.61 . . . . 65.2 110.975 175.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -118.22 172.46 7.42 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 109.031 -0.729 . . . . 65.01 109.031 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 49.7 m -142.63 126.23 16.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.259 0.624 . . . . 62.54 109.495 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 5' ' ' THR . . . . . 0.425 HG22 HG13 ' E' ' 6' ' ' ILE . 21.3 m -80.28 169.17 18.12 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.741 0.816 . . . . 72.41 108.815 171.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.425 HG13 HG22 ' E' ' 5' ' ' THR . 2.8 pp -49.95 146.26 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.171 0.988 . . . . 74.43 112.445 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.62 141.18 29.2 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 122.816 0.446 . . . . 54.52 110.043 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.421 ' HB3' HD21 ' A' ' 44' ' ' LEU . 80.2 mt -67.45 135.77 53.62 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.127 -0.694 . . . . 63.53 109.127 172.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.64 158.41 34.14 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.172 0.589 . . . . 75.44 110.891 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 88.1 mt -58.77 124.04 18.43 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.766 0.426 . . . . 71.14 109.914 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.31 109.54 2.43 Favored Pre-proline 0 CA--C 1.549 0.932 0 O-C-N 124.554 1.158 . . . . 73.53 110.668 -176.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -83.68 166.87 13.4 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.713 2.275 . . . . 72.32 111.118 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 55.9 tp 76.5 -37.52 0.29 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.42 1.488 . . . . 64.22 112.36 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . 0.61 HD13 ' HB1' ' A' ' 95' ' ' ALA . 80.3 mt 68.18 106.94 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.87 1.268 . . . . 61.04 110.006 -175.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . 0.498 ' O ' ' HD3' ' E' ' 17' ' ' PRO . 13.5 m-85 -77.01 94.39 3.98 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.374 -0.972 . . . . 62.31 108.374 -174.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 16' ' ' THR . . . . . 0.592 ' HA ' HD22 ' A' ' 98' ' ' LEU . 24.3 m -97.52 97.03 3.56 Favored Pre-proline 0 CA--C 1.557 1.23 0 O-C-N 124.069 0.856 . . . . 72.01 112.029 -169.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 17' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' E' ' 15' ' ' PHE . 25.8 Cg_endo -101.8 5.74 0.53 Allowed 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 124.217 3.278 . . . . 72.32 113.168 178.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 18' ' ' VAL . . . . . 0.506 HG21 ' HA ' ' A' ' 87' ' ' ALA . 7.6 p -148.25 135.96 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.02 0.928 . . . . 74.52 108.975 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 83.6 m 63.84 121.47 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.539 1.149 . . . . 74.12 110.897 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -60.99 94.92 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 122.785 0.434 . . . . 74.13 110.658 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -133.14 100.79 4.97 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.585 0.754 . . . . 70.02 109.721 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -76.47 -30.47 57.3 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.865 0.866 . . . . 72.25 110.94 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 24.1 m 58.17 76.23 0.48 Allowed Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 125.038 1.335 . . . . 52.45 109.74 -168.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.83 177.0 6.8 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.117 2.545 . . . . 61.53 113.736 -170.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 . . . . . 0 C--O 1.251 1.133 0 C-N-CA 124.084 0.954 . . . . 62.24 109.082 -176.352 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 47.4 ttm . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 108.764 -0.828 . . . . 61.43 108.764 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.03 141.42 31.18 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.176 -0.92 . . . . 65.34 109.007 173.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -87.41 -0.06 56.23 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.208 1.003 . . . . 74.13 110.384 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 33.4 t -117.43 156.51 27.82 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.774 1.229 . . . . 73.11 108.861 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 5' ' ' THR . . . . . 0.437 HG23 HE22 ' B' ' 37' ' ' GLN . 94.1 m -140.89 -56.08 0.5 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.011 0.524 . . . . 65.02 110.914 -175.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.485 HD11 HD23 ' B' ' 128' ' ' LEU . 13.8 tt -153.57 148.01 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.106 0.562 . . . . 65.4 110.162 -170.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -175.81 146.51 0.73 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.364 1.066 . . . . 61.51 110.018 175.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . 0.536 ' HB2' HG21 ' B' ' 131' ' ' VAL . 75.6 mt -77.82 153.34 32.87 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.551 0.74 . . . . 64.23 110.729 176.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.85 163.98 17.78 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.953 0.501 . . . . 73.23 109.82 171.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 10' ' ' LEU . . . . . 0.532 HD12 ' HD1' ' B' ' 133' ' ' PHE . 22.7 tp -79.11 72.23 5.64 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 109.374 -0.602 . . . . 71.1 109.374 177.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.493 HD13 ' H ' ' F' ' 15' ' ' PHE . 55.9 mt 60.31 105.6 0.03 OUTLIER Pre-proline 0 N--CA 1.485 1.308 0 C-N-CA 124.381 1.072 . . . . 65.33 111.95 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -61.33 -11.13 18.02 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 123.039 2.493 . . . . 74.52 113.715 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -129.35 -88.22 0.52 Allowed 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 107.497 -1.297 . . . . 54.31 107.497 171.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 tm? 176.45 138.44 0.06 Allowed 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 106.774 -1.565 . . . . 71.34 106.774 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . 0.493 ' H ' HD13 ' F' ' 11' ' ' LEU . 14.8 t80 -82.52 116.91 22.16 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.465 -0.939 . . . . 75.2 108.465 177.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 16' ' ' THR . . . . . 0.742 ' H ' HG21 ' B' ' 46' ' ' THR . 44.9 p -50.61 115.98 6.35 Favored Pre-proline 0 CA--C 1.547 0.853 0 O-C-N 124.397 1.061 . . . . 75.43 111.576 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 17' ' ' PRO . . . . . 0.493 ' HA ' HD21 ' B' ' 98' ' ' LEU . 31.0 Cg_exo -62.44 163.72 19.98 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.473 2.115 . . . . 73.2 111.431 173.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . 0.488 ' HB ' HD13 ' B' ' 98' ' ' LEU . 8.4 p -72.55 128.95 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.838 0.351 . . . . 70.52 110.332 177.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 21.1 p -83.29 80.75 8.98 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.3 -1.0 . . . . 75.22 108.3 173.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt 64.98 95.47 0.05 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.101 1.36 . . . . 64.32 111.961 -174.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . 0.475 ' HB2' HG11 ' F' ' 18' ' ' VAL . . . -65.17 -43.67 90.98 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.736 0.814 . . . . 74.0 109.72 172.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.07 130.2 44.88 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 107.427 -1.323 . . . . 74.32 107.427 173.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -65.87 123.11 84.01 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 123.151 0.581 . . . . 75.44 111.402 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -81.63 -39.09 0.19 Allowed 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.61 2.207 . . . . 71.5 112.389 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.249 1.038 0 C-N-CA 124.692 1.197 . . . . 74.43 108.317 -179.436 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtm . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 108.378 -0.971 . . . . 62.52 108.378 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -127.41 148.93 50.28 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.688 0.795 . . . . 73.45 110.484 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 60.29 74.92 0.43 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.083 1.353 . . . . 73.14 111.177 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 15.2 t -90.98 94.14 9.51 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.158 -0.928 . . . . 70.52 108.925 177.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 9.2 m -69.27 156.34 38.93 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.724 0.81 . . . . 61.32 111.247 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . 0.411 HD12 HG11 ' C' ' 40' ' ' VAL . 22.6 pt -54.19 118.38 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.48 1.112 . . . . 71.44 112.274 -176.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.93 153.23 42.87 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.737 0.815 . . . . 54.33 109.943 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 8' ' ' LEU . . . . . 0.494 ' H ' HG21 ' C' ' 131' ' ' VAL . 6.2 mp -76.38 143.93 40.39 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.285 0.634 . . . . 61.02 110.469 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.84 152.23 43.39 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.034 0.834 . . . . 73.04 110.683 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 10' ' ' LEU . . . . . 0.477 HD13 HD12 ' C' ' 136' ' ' LEU . 50.9 tp -57.71 159.02 5.58 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 124.39 1.056 . . . . 63.54 110.758 -177.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 11' ' ' LEU . . . . . 0.473 HD21 HD13 ' C' ' 44' ' ' LEU . 58.4 mt -107.69 82.65 1.41 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.561 0.744 . . . . 74.4 110.417 176.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 12' ' ' PRO . . . . . 0.491 ' O ' ' HB ' ' G' ' 23' ' ' THR . 71.1 Cg_endo -74.49 -23.85 14.55 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 121.549 1.5 . . . . 63.23 110.601 170.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 54.8 mt -117.68 109.14 16.28 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.389 1.076 . . . . 72.13 108.521 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.57 -177.78 3.46 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.167 0.587 . . . . 72.33 110.896 175.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -73.32 -177.5 2.6 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.297 1.039 . . . . 72.14 111.749 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 22.3 p -69.36 113.35 16.16 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.564 0.746 . . . . 72.22 110.484 175.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 17' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.23 171.2 18.75 Favored 'Trans proline' 0 CA--C 1.556 1.611 0 C-N-CA 122.804 2.336 . . . . 73.14 113.215 -175.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 18' ' ' VAL . . . . . 0.52 HG23 HD22 ' C' ' 98' ' ' LEU . 23.7 t -76.75 -80.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.253 0.621 . . . . 63.31 110.831 -174.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 3.9 m -96.26 44.06 1.07 Allowed 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 124.188 0.995 . . . . 72.42 110.142 -173.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 70.06 124.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 125.221 1.408 . . . . 73.31 113.093 174.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.16 169.21 23.75 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.469 1.108 . . . . 74.31 109.342 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 22' ' ' ARG . . . . . 0.417 ' NE ' ' HA ' ' G' ' 22' ' ' ARG . 0.2 OUTLIER -120.19 161.85 20.36 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.631 0.372 . . . . 74.41 110.528 179.203 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 23' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' G' ' 12' ' ' PRO . 17.2 p -58.12 122.45 58.58 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.708 1.203 . . . . 65.33 111.044 175.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 24' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 149' ' ' THR . 59.3 Cg_endo -89.69 172.51 3.9 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 123.778 2.985 . . . . 72.41 114.018 -174.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 25' ' ' GLU . . . . . 0.644 ' HG3' ' HB3' ' A' ' 150' ' ' GLU . 6.0 mm-40 . . . . . 0 C--O 1.253 1.279 0 C-N-CA 125.497 1.519 . . . . 64.0 107.737 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptt? . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 109.469 -0.567 . . . . 73.5 109.469 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -150.73 101.3 2.91 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.415 -0.957 . . . . 42.21 108.415 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -119.91 92.82 3.87 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.69 0.796 . . . . 74.34 110.483 -176.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 50.9 m -149.17 65.68 1.03 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.981 0.912 . . . . 65.44 109.261 176.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 58.0 m -153.72 -46.41 0.09 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.753 0.821 . . . . 63.31 110.157 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.579 HD12 HD21 ' D' ' 42' ' ' LEU . 10.1 tp -142.91 132.84 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 C-N-CA 123.713 0.805 . . . . 72.24 108.897 -175.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.13 -62.2 0.21 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.722 0.409 . . . . 65.22 110.979 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 8' ' ' LEU . . . . . 0.536 HD21 HD21 ' D' ' 44' ' ' LEU . 5.5 tt 71.36 109.16 0.06 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.013 1.325 . . . . 61.54 109.676 -174.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.0 144.37 38.75 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.748 -0.66 . . . . 74.25 110.923 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 64.2 tp -71.89 144.26 49.07 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 123.763 0.664 . . . . 61.32 110.294 177.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -67.41 121.15 77.6 Favored Pre-proline 0 CA--C 1.549 0.92 0 O-C-N 123.88 0.737 . . . . 72.33 109.825 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.04 -25.4 38.02 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.783 2.322 . . . . 75.34 111.662 174.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 82.9 mt -98.53 138.85 35.14 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.814 0.846 . . . . 73.32 109.107 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 6.5 mp -90.65 49.59 1.69 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.33 0.652 . . . . 70.21 110.173 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . 0.716 ' HB2' ' HA2' ' D' ' 99' ' ' GLY . 1.2 t80 61.78 -90.42 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.881 1.273 . . . . 74.15 111.332 171.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -162.65 154.17 15.2 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.236 1.414 . . . . 75.24 109.157 -177.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -83.08 179.33 5.24 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.655 2.237 . . . . 64.34 112.705 173.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . 0.657 HG23 ' HB2' ' D' ' 94' ' ' MET . 61.4 t -96.23 144.42 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 108.785 -0.82 . . . . 72.01 108.785 173.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 33.2 m 71.15 127.46 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.271 1.428 . . . . 70.34 111.472 -176.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 54.9 tptt 73.42 -5.96 1.86 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.929 1.292 . . . . 53.01 112.804 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.31 82.45 5.46 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.738 0.78 . . . . 64.52 111.297 -174.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -143.26 96.82 2.98 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.429 -1.322 . . . . 74.13 107.429 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 67.6 p -75.34 147.78 82.88 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 115.623 -0.717 . . . . 74.34 110.638 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -84.7 20.19 1.27 Allowed 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 123.056 2.504 . . . . 61.31 112.02 170.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 124.952 1.301 . . . . 70.13 109.213 -173.839 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.9 mtp . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 109.756 -0.461 . . . . 74.2 109.756 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.8 p -156.68 -55.57 0.08 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.881 0.872 . . . . 65.52 108.979 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -167.68 143.25 3.93 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.461 -1.245 . . . . 75.11 108.657 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -110.93 148.09 33.23 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.059 0.543 . . . . 72.43 111.229 -174.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -122.79 106.58 11.03 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.305 1.042 . . . . 71.13 108.195 173.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -60.74 114.48 3.04 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.468 -0.787 . . . . 63.23 108.927 176.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.1 m 69.62 97.79 0.06 Allowed 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.963 1.305 . . . . 73.42 109.583 -160.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -71.2 173.69 7.35 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 114.762 -1.108 . . . . 70.35 109.397 173.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 12.2 tpt -52.02 137.26 27.62 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.125 0.57 . . . . 71.32 111.464 177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.8 m -138.3 129.71 27.58 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.726 -1.213 . . . . 74.14 107.726 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.691 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 9.4 t80 -135.56 124.26 23.8 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.01 0.524 . . . . 75.2 109.668 -175.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -139.27 111.01 7.17 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.36 -0.978 . . . . 75.42 108.36 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.638 HG12 ' HD2' ' A' ' 84' ' ' PHE . 57.2 mt -82.74 120.44 34.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.421 -0.955 . . . . 71.34 108.421 173.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.43 -41.25 20.1 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 124.146 0.904 . . . . 74.52 109.011 -177.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -173.83 124.09 0.35 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 121.938 0.095 . . . . 73.44 111.061 -169.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' C' ' 130' ' ' PRO . 92.2 mt -116.87 138.54 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 C-N-CA 123.924 0.89 . . . . 62.34 109.571 175.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.519 ' HB3' HG23 ' B' ' 122' ' ' THR . 35.3 p90 -169.61 176.26 5.03 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.227 0.955 . . . . 74.32 111.217 -170.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -102.26 119.43 38.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.94 -1.027 . . . . 63.23 108.533 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.459 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 36.9 mtpt -83.04 -42.65 17.23 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.957 -0.757 . . . . 72.4 108.957 176.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 16.2 t70 -134.4 136.62 43.45 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.485 -1.234 . . . . 61.2 109.602 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.8 mt -136.13 143.16 36.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 C-N-CA 125.345 1.458 . . . . 72.42 107.118 174.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.0 t -155.09 119.37 4.68 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-O 121.166 0.507 . . . . 72.04 110.476 171.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.509 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 87.8 t80 -111.34 136.53 50.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.797 -1.557 . . . . 72.44 106.797 169.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -133.53 138.23 45.97 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.638 -0.504 . . . . 74.11 109.638 175.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.85 70.83 16.97 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 106.516 -1.661 . . . . 73.4 106.516 170.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.75 -28.14 30.86 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.539 2.159 . . . . 75.31 111.448 -175.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -101.62 20.42 16.2 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 114.896 -1.047 . . . . 73.4 109.541 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.54 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -48.32 -52.54 41.78 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 114.006 1.113 . . . . 75.1 114.006 -171.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 15.9 Cg_exo -67.16 -18.54 51.04 Favored 'Trans proline' 0 C--N 1.385 2.481 0 CA-C-N 121.748 1.66 . . . . 60.23 113.02 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -90.18 -28.19 19.06 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.407 1.083 . . . . 74.22 110.599 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.523 HG21 ' HA ' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -80.55 -21.14 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 115.672 -0.694 . . . . 65.14 111.722 -166.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -86.05 -23.99 26.53 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.373 0.669 . . . . 71.44 111.653 -176.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -78.83 -24.26 44.53 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 110.027 -0.36 . . . . 63.12 110.027 174.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -72.48 146.87 46.56 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.794 0.837 . . . . 73.14 110.719 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -67.34 128.91 38.18 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.606 -0.724 . . . . 71.1 109.455 174.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 59.5 t-105 -79.12 89.5 4.83 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.469 0.707 . . . . 74.21 110.426 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -125.11 82.8 61.36 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 108.007 -1.109 . . . . 62.11 108.007 169.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.0 127.93 11.86 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.336 2.024 . . . . 64.54 112.395 -172.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -96.9 93.12 6.46 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 106.354 -1.721 . . . . 70.12 106.354 170.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.411 HG11 HD13 ' E' ' 6' ' ' ILE . 41.8 t -72.67 91.46 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.88 -0.785 . . . . 70.45 108.88 -177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -98.32 112.46 24.45 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.342 -1.355 . . . . 73.21 107.342 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' E' ' 8' ' ' LEU . 2.5 pp -123.2 135.02 54.11 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.229 0.538 . . . . 75.22 110.885 -171.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -115.94 145.38 42.97 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.698 -1.223 . . . . 71.32 107.698 172.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.592 HD13 ' HB3' ' E' ' 8' ' ' LEU . 1.7 pt? -135.12 123.52 23.28 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.95 -0.759 . . . . 62.54 108.95 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.613 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 24.5 t70 -118.7 139.41 51.59 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.178 0.991 . . . . 62.15 109.246 -174.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.8 p -116.59 121.65 42.35 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.946 0.898 . . . . 63.34 110.476 -170.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.77 131.85 17.29 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.774 0.829 . . . . 64.2 110.636 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.9 m -131.58 157.68 43.0 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.172 0.589 . . . . 73.24 110.482 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.3 t -148.74 123.51 9.9 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.54 0.736 . . . . 52.02 109.359 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -75.41 121.29 22.06 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.284 0.633 . . . . 73.44 110.693 -177.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.405 HD12 HG23 ' A' ' 83' ' ' ILE . 52.9 mt -94.16 -39.37 10.6 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.775 0.83 . . . . 75.1 110.724 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.452 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -148.01 -177.56 5.8 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.878 0.871 . . . . 64.22 109.839 176.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -63.67 115.36 4.67 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.398 -0.593 . . . . 74.51 109.398 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 70.35 4.07 4.74 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 125.137 1.375 . . . . 73.3 112.929 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 99.8 t -109.77 114.84 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.115 -1.068 . . . . 72.24 108.115 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -138.63 140.9 39.08 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.568 -0.901 . . . . 72.11 108.568 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -89.79 129.92 36.12 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.753 -0.658 . . . . 62.13 109.435 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.421 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 72.8 t -100.48 126.1 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 107.663 -1.236 . . . . 53.24 107.663 172.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.6 t -120.7 125.56 74.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.662 -0.866 . . . . 63.25 108.662 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -115.25 108.01 16.02 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.153 -1.425 . . . . 50.34 107.153 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.613 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 48.3 ttt180 -83.61 99.94 10.51 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.886 -0.783 . . . . 52.33 108.886 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.9 101.77 12.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.615 -0.721 . . . . 63.24 109.199 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.0 m -97.54 113.46 25.17 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.503 0.721 . . . . 72.13 109.252 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.4 HG11 HD21 ' A' ' 126' ' ' LEU . 18.2 t -116.86 107.64 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.005 0.922 . . . . 70.34 109.097 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.9 m -109.49 129.2 55.57 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.315 -0.994 . . . . 70.4 108.315 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.81 132.71 49.81 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.115 -1.439 . . . . 72.0 107.115 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.0 m -121.32 165.76 15.03 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.199 0.6 . . . . 63.52 110.362 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.409 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 82.9 mt -131.1 43.26 3.12 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.94 -1.133 . . . . 73.24 107.94 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.68 -93.07 1.84 Allowed Glycine 0 C--N 1.339 0.709 0 CA-C-N 114.84 -1.073 . . . . 42.4 111.481 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -95.09 -26.88 15.85 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.194 0.598 . . . . 75.31 111.919 -174.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -105.75 132.63 51.64 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.196 -0.668 . . . . 62.31 109.196 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.4 m -73.44 134.99 44.1 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.732 -0.47 . . . . 71.21 109.732 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.523 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.86 -60.91 2.11 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.455 -0.793 . . . . 71.44 109.926 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.427 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 33.4 p90 -160.17 174.29 14.48 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.349 -0.841 . . . . 72.21 111.696 176.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.5 tp -127.79 142.99 51.15 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.445 -1.252 . . . . 71.41 108.482 170.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 80.5 m -143.0 97.39 3.09 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.819 1.248 . . . . 64.15 108.235 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -121.51 115.71 23.35 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.922 -0.77 . . . . 74.24 108.922 -173.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.5 t -129.51 110.63 20.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 123.805 0.842 . . . . 63.31 109.592 -173.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.623 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 28.6 mt-30 -83.69 88.17 7.06 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.14 -1.059 . . . . 64.54 108.14 169.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.51 ' HG3' HD22 ' A' ' 106' ' ' LEU . 9.4 tp-100 -78.48 102.48 7.86 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.692 -1.14 . . . . 73.42 108.691 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.7 145.01 17.43 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.443 -0.663 . . . . 51.51 111.443 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.407 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.0 124.5 1.71 Allowed Glycine 0 CA--C 1.508 -0.405 0 N-CA-C 110.78 -0.928 . . . . 42.24 110.78 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.405 HG23 HD12 ' A' ' 51' ' ' LEU . 46.9 mt -81.69 115.68 24.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.864 -0.791 . . . . 73.55 108.864 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.691 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 38.7 m-85 -124.06 120.27 31.91 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.927 -0.768 . . . . 74.12 108.927 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.1 t -95.43 101.84 13.6 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.225 -1.028 . . . . 72.42 108.225 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.525 HD11 HG21 ' E' ' 18' ' ' VAL . 24.4 pt -111.63 150.05 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 122.594 0.357 . . . . 73.3 110.312 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.52 174.37 5.95 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.786 0.834 . . . . 75.51 110.524 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 107.15 -80.87 0.28 Allowed Glycine 0 C--N 1.345 1.044 0 CA-C-N 116.058 -0.519 . . . . 63.33 112.045 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.677 HD12 ' HB3' ' A' ' 93' ' ' GLN . 29.8 pt -91.72 155.86 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.185 0.594 . . . . 62.42 110.948 -175.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 46.6 mt-10 -137.28 -175.7 4.14 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.064 0.945 . . . . 65.31 111.291 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.61 -135.05 23.02 Favored Glycine 0 C--N 1.353 1.506 0 CA-C-N 115.754 -0.657 . . . . 72.01 112.434 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.3 t -67.57 -22.72 65.38 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.313 0.645 . . . . 62.11 111.277 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.677 ' HB3' HD12 ' A' ' 89' ' ' ILE . 13.4 mm-40 -70.52 -45.26 65.92 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.373 0.669 . . . . 73.45 110.375 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.482 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 15.4 tmm? -76.51 -29.79 56.94 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.816 0.446 . . . . 72.32 110.411 176.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.21 -20.92 66.66 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.939 0.496 . . . . 74.33 111.208 176.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -70.63 -47.4 60.26 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.251 0.62 . . . . 71.33 110.818 172.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.628 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 27.4 p -71.67 -43.95 65.13 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.138 0.494 . . . . 72.33 110.949 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.59 -45.35 83.57 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.545 1.138 . . . . 73.43 110.765 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.55 -16.19 47.03 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 114.745 0.658 . . . . 60.21 114.745 -170.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.93 -61.94 0.87 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 117.922 0.861 . . . . 72.13 112.18 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.628 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 88.8 t80 -69.23 -62.28 1.44 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.371 0.878 . . . . 75.22 113.371 -164.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 73.7 m -63.29 -39.3 48.9 Favored Pre-proline 0 CA--C 1.563 1.472 0 N-CA-C 113.697 0.999 . . . . 74.45 113.697 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.21 -32.8 82.55 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 121.854 1.703 . . . . 73.34 113.115 166.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -74.99 -17.98 60.44 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.028 0.531 . . . . 64.15 110.849 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -67.41 -37.46 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 109.186 -0.672 . . . . 63.11 109.186 170.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.51 HD22 ' HG3' ' A' ' 80' ' ' GLN . 77.4 mt -81.23 -17.93 47.8 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.034 0.934 . . . . 63.21 112.191 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -62.81 -47.01 88.16 Favored Pre-proline 0 CA--C 1.572 1.809 0 CA-C-O 118.158 -0.925 . . . . 73.23 113.279 -174.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.61 -37.57 46.36 Favored 'Trans proline' 0 C--N 1.393 2.883 0 C-N-CA 122.35 2.033 . . . . 75.05 112.781 176.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -66.34 -44.75 82.41 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.466 0.706 . . . . 63.31 111.559 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.22 -41.74 76.65 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.992 -0.549 . . . . 73.4 110.48 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.474 ' NH1' HD12 ' C' ' 105' ' ' ILE . 27.6 ttm180 -52.0 -47.64 64.82 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.969 0.908 . . . . 75.24 110.765 171.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -68.05 -43.96 77.5 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.044 -0.98 . . . . 75.05 111.337 -175.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 39.1 t -65.6 -30.3 71.0 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.189 0.596 . . . . 72.24 111.056 -178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.8 mt -68.69 -58.83 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.888 0.875 . . . . 53.24 109.654 172.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 50.6 m -53.15 -36.51 60.93 Favored 'General case' 0 C--N 1.361 1.094 0 C-N-CA 124.246 1.018 . . . . 63.03 112.097 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -65.24 -51.22 62.27 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.56 -0.745 . . . . 73.41 110.687 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.509 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 61.0 mtm -64.28 -37.87 89.03 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.903 0.481 . . . . 55.31 111.483 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.442 HG21 HD23 ' A' ' 126' ' ' LEU . 76.0 t -62.12 -45.05 99.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.197 0.999 . . . . 73.5 110.335 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.6 t -70.2 -35.5 73.95 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.563 -0.744 . . . . 74.12 110.76 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -69.35 -33.51 73.2 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.543 0.737 . . . . 75.25 109.739 175.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.38 14.34 51.08 Favored Glycine 0 C--N 1.351 1.371 0 CA-C-N 115.344 -0.844 . . . . 63.52 112.879 175.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.413 HG21 ' HE ' ' B' ' 15' ' ' ARG . 2.5 t 61.4 18.58 9.45 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 126.541 1.936 . . . . 73.22 114.078 170.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -87.46 153.01 53.04 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 123.033 0.533 . . . . 72.54 109.595 176.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -55.16 165.54 2.86 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.521 2.814 . . . . 62.33 114.301 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -59.54 121.95 12.82 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.366 -0.834 . . . . 73.52 111.512 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.442 HD23 HG21 ' A' ' 118' ' ' VAL . 60.4 tp -123.67 94.5 4.26 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.223 1.009 . . . . 74.24 109.362 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -107.79 125.84 51.91 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 107.999 -1.111 . . . . 74.54 107.999 171.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.5 mp -72.8 139.52 47.09 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.708 -0.849 . . . . 60.32 108.708 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.683 ' HB3' ' HB2' ' E' ' 7' ' ' ALA . . . -64.5 146.21 98.19 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.213 0.605 . . . . 44.15 111.242 -177.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.09 116.21 3.58 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.717 2.278 . . . . 73.41 111.751 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.3 t -101.22 113.21 36.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.782 -1.192 . . . . 63.3 107.782 173.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -86.26 72.32 10.37 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.515 -0.92 . . . . 63.14 108.515 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -49.38 -48.47 46.89 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.491 0.716 . . . . 72.44 110.943 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.04 -51.81 62.87 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.908 -1.042 . . . . 72.5 111.847 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.55 -40.0 88.82 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.714 0.634 . . . . 71.54 111.548 -176.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.75 -45.96 84.24 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.749 0.82 . . . . 75.33 111.424 -177.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -72.41 -36.21 68.56 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.135 -0.484 . . . . 72.15 111.172 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 36.5 mmt -72.5 -23.89 61.09 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.266 0.226 . . . . 63.32 111.181 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.685 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 66.9 m-20 -68.05 -32.02 72.09 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.124 0.569 . . . . 71.32 110.626 171.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -78.56 -39.43 37.72 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 116.244 -0.434 . . . . 74.53 110.145 176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.49 -49.41 63.62 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.291 0.637 . . . . 74.35 112.268 -175.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -152.04 -2.6 0.28 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.214 0.45 . . . . 74.12 112.214 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.685 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 8.5 tt0 66.69 111.59 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.027 1.331 . . . . 71.23 112.41 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -60.7 -41.99 96.3 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.351 0.66 . . . . 63.43 110.109 170.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 73.83 -68.99 0.2 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.553 1.541 . . . . 74.31 111.325 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.42 -177.11 43.79 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 115.975 -0.557 . . . . 71.34 112.774 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -111.34 -62.72 1.51 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.848 0.859 . . . . 61.02 111.464 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.36 72.46 1.02 Allowed Glycine 0 C--N 1.348 1.199 0 N-CA-C 110.158 -1.177 . . . . 71.31 110.158 -167.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.753 HG21 ' HB2' ' C' ' 90' ' ' GLU . 6.5 t -64.41 161.11 17.66 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.353 1.061 . . . . 74.35 111.893 -175.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -86.55 91.52 8.59 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.869 -0.789 . . . . 42.15 108.869 174.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.36 152.85 40.52 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.431 -0.804 . . . . 75.13 109.635 172.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -104.31 -35.17 8.06 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.684 0.794 . . . . 72.43 110.247 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 64.21 68.13 0.57 Allowed 'General case' 0 C--N 1.359 1.022 0 C-N-CA 125.004 1.321 . . . . 72.21 108.82 -162.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -66.98 93.05 0.26 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.68 -1.145 . . . . 72.11 111.36 -170.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 C-N-CA 124.428 1.091 . . . . 72.5 109.442 177.925 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 111.576 0.213 . . . . 73.21 111.576 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 32.2 t -76.96 85.36 3.49 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.513 0.725 . . . . 75.13 109.745 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -99.04 103.04 14.95 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.045 -0.98 . . . . 71.54 109.274 -176.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -124.23 119.4 29.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.656 0.782 . . . . 74.13 110.135 -174.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -81.58 160.26 23.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.851 0.86 . . . . 70.14 109.893 173.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -70.73 99.29 1.68 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.201 0.6 . . . . 73.13 109.513 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 12.9 t -153.43 175.01 13.63 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.67 0.788 . . . . 62.33 110.226 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 63.82 -94.99 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.913 1.285 . . . . 65.25 109.965 -177.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.544 ' SD ' ' HB ' ' B' ' 89' ' ' ILE . 9.6 tpt 59.64 167.82 0.07 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.256 1.422 . . . . 70.13 112.889 176.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 22.7 m -136.73 123.57 21.29 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 106.37 -1.715 . . . . 54.22 106.37 165.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -151.74 129.16 11.34 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.793 -0.817 . . . . 72.14 108.793 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.521 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -155.07 131.14 10.19 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.419 -0.586 . . . . 74.02 109.419 175.273 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.515 HD13 HD11 ' B' ' 16' ' ' ILE . 25.2 mt -75.59 121.54 27.57 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 108.746 -0.835 . . . . 71.33 108.746 173.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -93.05 -37.92 11.91 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.53 -0.759 . . . . 71.02 109.234 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.413 ' HE ' HG21 ' A' ' 122' ' ' THR . 46.5 ttt180 -177.39 132.42 0.17 Allowed 'General case' 0 C--N 1.356 0.856 0 CA-C-N 115.608 -0.723 . . . . 71.41 109.64 -174.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.515 HD11 HD13 ' B' ' 13' ' ' ILE . 94.6 mt -115.21 140.05 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 108.008 -1.108 . . . . 74.32 108.008 176.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -171.17 155.78 4.49 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.805 0.812 . . . . 74.11 112.483 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.9 m -75.69 125.03 28.25 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.546 -1.206 . . . . 74.12 109.191 168.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.54 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 43.9 mtpt -96.79 -31.86 12.41 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.535 0.734 . . . . 74.44 111.065 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -153.54 140.1 18.82 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.47 -0.332 . . . . 70.4 110.557 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.496 HD11 ' SG ' ' B' ' 113' ' ' CYS . 35.4 mm -135.59 143.61 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.972 1.309 . . . . 72.45 108.577 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -150.28 109.52 3.95 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.07 -1.085 . . . . 64.22 108.07 174.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 89.4 t80 -124.48 108.81 12.52 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 108.002 -1.111 . . . . 75.22 108.002 173.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -124.16 123.56 40.56 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.458 0.703 . . . . 74.34 110.29 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.425 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -114.41 87.1 13.22 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.776 1.23 . . . . 62.45 107.932 178.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.21 -29.98 25.61 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.691 2.261 . . . . 65.31 113.224 -169.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -108.56 18.53 20.8 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.57 0.748 . . . . 73.23 110.821 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.459 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -43.09 -59.26 3.26 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 114.938 1.458 . . . . 73.04 114.938 -164.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -62.25 -28.73 79.42 Favored 'Trans proline' 0 C--N 1.395 3.006 0 C-N-CA 122.388 2.059 . . . . 74.2 112.464 -172.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -96.23 -32.76 12.29 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.167 -0.924 . . . . 72.42 112.22 -172.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.501 HG21 ' HA ' ' B' ' 73' ' ' ALA . 6.0 p -74.17 -6.29 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 122.998 0.519 . . . . 64.3 111.675 -171.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -72.83 -14.05 61.42 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.218 0.607 . . . . 74.42 112.437 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -61.49 -18.17 57.88 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.31 0.644 . . . . 62.15 111.076 172.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.615 ' HB2' HD13 ' B' ' 68' ' ' LEU . 30.3 mmtp -95.54 88.84 5.18 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.296 1.439 . . . . 75.45 109.112 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -98.29 78.38 2.45 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.604 0.716 . . . . 71.4 111.19 -176.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -159.31 172.33 18.18 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.327 -1.306 . . . . 74.42 108.582 170.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -68.58 112.73 12.09 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 109.14 -0.689 . . . . 72.45 109.14 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.491 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 20.8 Cg_endo -61.53 163.82 17.11 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.06 2.506 . . . . 71.4 114.41 -173.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -72.73 102.34 3.32 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 107.519 -1.289 . . . . 75.45 107.519 171.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -93.86 146.2 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 114.545 -1.207 . . . . 72.5 110.179 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.787 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 56.1 mtpt -121.82 142.74 49.92 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.771 0.828 . . . . 74.03 109.49 172.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.436 HD23 HG13 ' F' ' 6' ' ' ILE . 3.2 pp -92.74 134.61 34.88 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 114.33 -1.304 . . . . 74.43 107.781 168.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.697 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 18.5 m-20 -143.74 132.78 22.88 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.143 -1.058 . . . . 61.41 108.143 177.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 86.7 mt -127.92 132.38 49.29 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.485 0.714 . . . . 55.3 109.706 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 7.5 t70 -123.16 138.59 54.62 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.891 1.277 . . . . 74.03 107.587 172.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.485 HG21 ' HA ' ' F' ' 15' ' ' PHE . 43.6 m -108.88 116.19 31.51 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 122.979 0.511 . . . . 72.14 110.083 -174.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.29 135.84 53.54 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.218 1.007 . . . . 23.25 108.42 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.9 m -142.5 161.39 38.19 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 109.527 -0.546 . . . . 72.01 109.527 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 88.6 p -160.63 136.31 8.17 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 123.627 0.579 . . . . 75.51 109.518 174.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -95.08 102.12 13.91 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.119 -1.067 . . . . 74.41 108.119 167.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 54.3 mt -65.83 -35.95 82.1 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.103 -0.953 . . . . 73.32 111.041 -175.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.49 -179.49 6.02 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.291 1.036 . . . . 61.4 109.443 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.86 122.7 16.06 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.034 -0.984 . . . . 61.31 108.726 173.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 73.95 -4.77 2.19 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 125.371 1.468 . . . . 74.11 113.155 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 56.3 t -113.6 120.7 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 108.978 -0.749 . . . . 60.52 108.978 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -129.19 169.64 14.55 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.214 -0.661 . . . . 72.53 109.214 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -140.87 125.55 17.95 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.475 0.71 . . . . 52.15 109.131 174.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 87.0 t -102.39 119.48 50.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.478 1.111 . . . . 75.02 109.073 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 34.0 t -123.83 111.49 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.732 -0.84 . . . . 75.32 108.732 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 32.3 tp -106.39 119.32 38.96 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 109.059 -0.719 . . . . 54.41 109.059 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 57.7 ttm-85 -86.3 111.76 20.76 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.688 -0.856 . . . . 71.25 108.688 174.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 46.4 t -103.26 102.39 13.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 107.353 -1.351 . . . . 73.32 107.353 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.697 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 17.6 m -101.48 132.15 47.25 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.874 -1.057 . . . . 52.02 109.024 177.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 78.1 t -125.4 112.62 31.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 124.121 0.968 . . . . 75.32 109.153 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.787 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 98.4 m -87.95 149.46 24.03 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.206 -0.906 . . . . 74.43 109.14 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.68 138.4 30.59 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.137 0.575 . . . . 73.04 109.556 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.464 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 45.0 p -146.55 131.29 17.96 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.494 -0.558 . . . . 63.33 109.494 -178.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.615 HD13 ' HB2' ' B' ' 34' ' ' LYS . 26.0 mt -113.34 113.13 24.82 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.287 1.035 . . . . 74.32 108.962 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.79 -111.32 3.41 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.05 -0.523 . . . . 54.31 112.203 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -113.59 4.87 16.32 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.558 0.743 . . . . 74.43 111.598 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -130.48 151.79 50.58 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.165 0.586 . . . . 74.15 110.699 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 73.9 m -74.24 123.39 24.44 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 122.698 0.399 . . . . 73.15 110.174 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.501 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -76.16 -59.9 2.56 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.14 -0.936 . . . . 33.2 109.085 177.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -149.62 161.75 41.56 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 121.933 0.873 . . . . 71.23 111.468 174.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 78.0 mt -125.49 114.23 18.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 105.127 -2.175 . . . . 73.12 105.127 168.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.4 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 36.3 t -115.72 142.77 46.3 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.343 -1.354 . . . . 71.23 107.343 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -160.9 125.51 3.6 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.937 -0.394 . . . . 55.22 109.937 -169.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 62.0 t -128.67 148.94 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.911 0.884 . . . . 73.14 109.805 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -117.63 111.5 19.26 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.724 -1.213 . . . . 62.41 107.724 163.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -96.95 100.78 12.28 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.797 -1.186 . . . . 43.54 107.797 171.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.02 142.12 15.9 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-N 115.232 -0.894 . . . . 74.44 110.87 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.62 125.99 3.02 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 109.786 -1.326 . . . . 42.05 109.786 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 57.9 mt -84.69 126.03 40.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 107.788 -1.19 . . . . 74.34 107.788 175.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -131.88 133.37 44.53 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.03 -0.73 . . . . 74.34 109.03 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 67.2 m -89.07 110.69 21.38 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.276 -1.009 . . . . 72.2 108.276 172.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.439 ' O ' HD12 ' B' ' 86' ' ' ILE . 2.5 pp -124.33 140.76 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.176 0.99 . . . . 72.53 110.213 -172.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.75 171.17 19.31 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.318 0.488 . . . . 72.34 112.318 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.5 -65.7 4.07 Favored Glycine 0 C--N 1.354 1.549 0 CA-C-N 115.148 -0.933 . . . . 73.51 112.946 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.544 ' HB ' ' SD ' ' B' ' 9' ' ' MET . 9.7 mm -68.55 148.86 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.94 1.296 . . . . 75.32 111.026 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -152.38 179.37 8.61 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.641 0.776 . . . . 71.55 111.257 -170.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.02 -127.81 36.18 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 115.968 -0.56 . . . . 63.53 113.374 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 16.3 m -89.28 -18.55 26.77 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.266 0.627 . . . . 62.14 110.787 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -56.34 -41.7 76.53 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 109.338 -0.615 . . . . 74.3 109.338 171.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 17.4 ptt? -81.37 -33.53 32.3 Favored 'General case' 0 C--N 1.358 0.97 0 CA-C-N 115.669 -0.696 . . . . 64.22 111.194 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.4 -36.16 66.12 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.618 0.723 . . . . 71.45 110.894 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.464 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 43.5 t-80 -69.45 -46.14 67.4 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.295 -1.32 . . . . 72.13 111.137 175.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -73.14 -31.67 64.43 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.202 0.445 . . . . 74.43 112.202 -173.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.5 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 15.5 mt -95.3 -42.8 8.34 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.859 0.864 . . . . 74.32 111.242 -172.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.61 -24.61 45.66 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.832 -0.622 . . . . 63.54 113.576 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -117.09 -49.69 2.6 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.855 0.462 . . . . 54.0 111.741 -171.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -81.97 -41.86 20.19 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.022 0.379 . . . . 74.14 112.022 -174.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 85.1 m -61.6 -48.67 89.56 Favored Pre-proline 0 CA--C 1.559 1.292 0 CA-C-O 118.425 -0.798 . . . . 50.41 111.916 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 38.0 Cg_exo -64.5 -22.93 64.97 Favored 'Trans proline' 0 C--N 1.396 3.072 0 C-N-CA 122.167 1.912 . . . . 75.35 112.887 173.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -65.46 -35.97 82.5 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.168 0.587 . . . . 74.53 110.45 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 93.3 mt -63.51 -40.77 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.437 1.095 . . . . 75.41 110.017 171.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 59.8 mt -90.26 -13.01 36.24 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 114.677 -1.147 . . . . 74.2 112.337 -170.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -60.36 -48.28 94.29 Favored Pre-proline 0 N--CA 1.488 1.437 0 CA-C-O 117.911 -1.042 . . . . 71.33 113.473 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.78 -37.99 94.51 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 121.881 1.721 . . . . 72.11 113.173 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -67.64 -47.92 68.19 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.443 0.697 . . . . 73.42 110.508 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.68 -42.35 99.58 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.472 0.709 . . . . 75.2 111.123 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -59.92 -51.44 69.69 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.192 0.997 . . . . 74.12 110.777 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -65.21 -31.32 72.43 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.821 0.701 . . . . 55.54 110.03 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.496 ' SG ' HD11 ' B' ' 21' ' ' ILE . 6.0 t -74.04 -34.58 64.14 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.016 0.526 . . . . 63.1 111.204 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.423 ' O ' HG23 ' B' ' 118' ' ' VAL . 57.0 mt -66.66 -57.33 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 109.114 -0.698 . . . . 51.13 109.114 173.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.3 m -62.1 -24.61 67.23 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.637 0.775 . . . . 70.35 111.788 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 27.1 t -64.32 -52.23 59.51 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 109.379 -0.601 . . . . 73.21 109.379 173.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.5 mmt -69.94 -32.2 70.33 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.11 0.564 . . . . 72.15 111.369 -175.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.423 HG23 ' O ' ' B' ' 114' ' ' ILE . 79.3 t -62.72 -46.19 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.858 0.863 . . . . 62.43 110.184 174.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.0 t -65.72 -35.87 81.97 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.994 -1.003 . . . . 55.52 110.829 177.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.483 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 92.5 mtt-85 -67.12 -33.02 74.56 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.687 -0.688 . . . . 74.54 110.322 178.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.98 7.37 75.18 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 123.837 0.711 . . . . 70.23 112.962 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.519 HG23 ' HB3' ' A' ' 17' ' ' TYR . 81.5 p 59.68 23.89 12.73 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 126.291 1.837 . . . . 54.21 113.596 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -86.65 159.22 52.88 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 123.739 0.816 . . . . 73.3 111.409 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -54.69 158.78 9.96 Favored 'Trans proline' 0 C--N 1.393 2.882 0 C-N-CA 123.837 3.025 . . . . 75.31 115.39 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -65.01 133.84 52.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.358 1.063 . . . . 74.44 111.703 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 58.0 tp -140.21 120.66 14.09 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.451 0.7 . . . . 72.4 109.615 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -132.13 117.44 18.31 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.341 1.056 . . . . 65.21 108.917 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 7.1 mp -83.53 150.37 26.01 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.259 0.624 . . . . 52.43 110.653 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.5 156.42 90.27 Favored Pre-proline 0 CA--C 1.557 1.246 0 CA-C-N 115.063 -0.971 . . . . 74.24 110.463 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -66.34 111.24 2.0 Allowed 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 122.679 2.253 . . . . 64.43 110.667 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 36.9 t -89.75 107.24 17.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.003 -1.11 . . . . 74.43 108.003 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.523 ' HB3' ' HB3' ' B' ' 135' ' ' ALA . 7.8 m120 -104.13 88.67 3.06 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.869 -1.06 . . . . 64.41 109.155 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -63.91 -37.61 88.02 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.982 -0.748 . . . . 73.33 108.982 170.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.452 ' N ' ' HB1' ' B' ' 100' ' ' ALA . 6.9 p-10 -62.52 -50.91 69.5 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.745 1.218 . . . . 45.13 111.632 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' B' ' 132' ' ' ASN . . . -68.54 -34.23 75.5 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 123.405 0.682 . . . . 62.21 110.567 -178.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 55.2 tp -61.18 -47.41 86.27 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 123.71 0.631 . . . . 60.31 110.826 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -64.06 -44.85 91.17 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.587 0.554 . . . . 72.31 111.657 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 73.7 mtm -72.81 -37.04 67.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.845 0.458 . . . . 63.41 111.648 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -82.65 -4.67 58.1 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.667 0.387 . . . . 75.31 111.179 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -82.1 -27.98 32.55 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.9 -0.407 . . . . 70.5 109.9 170.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 79.5 mt -96.98 25.97 4.99 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.703 0.801 . . . . 72.21 111.702 -174.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -70.92 140.37 50.97 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.056 0.542 . . . . 74.42 111.029 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -154.71 -53.94 0.1 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.59 1.156 . . . . 71.11 108.611 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -88.08 151.75 22.51 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.833 0.853 . . . . 64.3 109.741 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -139.93 -57.49 0.56 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.279 0.632 . . . . 74.14 110.971 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 120.82 -144.72 17.05 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.745 -0.661 . . . . 74.13 111.673 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -87.66 160.33 18.18 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.666 0.786 . . . . 71.54 111.938 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -126.23 103.77 0.7 Allowed Glycine 0 C--N 1.346 1.115 0 N-CA-C 109.773 -1.331 . . . . 74.31 109.773 173.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' D' ' 90' ' ' GLU . 51.3 m -67.41 104.33 1.51 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.683 1.193 . . . . 75.3 110.402 -177.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -85.89 139.19 31.46 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.633 -0.712 . . . . 74.51 109.794 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -134.88 -174.9 3.73 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.195 0.998 . . . . 74.14 109.228 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -157.54 141.3 15.82 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.992 -0.744 . . . . 74.15 108.992 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . 0.418 ' H ' ' NE2' ' B' ' 153' ' ' GLN . 0.7 OUTLIER -82.88 108.77 16.46 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.915 0.486 . . . . 71.22 110.344 -178.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -76.79 96.27 4.22 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.778 0.831 . . . . 60.22 110.151 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.007 0 C-N-CA 124.041 0.936 . . . . 42.01 109.632 178.467 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptm . . . . . 0 N--CA 1.484 1.25 0 N-CA-C 110.206 -0.294 . . . . 61.45 110.206 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 31.0 m -75.28 101.57 4.74 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.579 0.752 . . . . 64.3 109.657 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -101.75 -39.14 7.56 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.507 0.723 . . . . 63.24 110.689 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -81.34 -64.63 1.15 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.661 0.784 . . . . 74.03 110.159 -172.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -76.29 133.25 40.1 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.036 -0.727 . . . . 43.31 109.036 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -61.99 -56.77 15.73 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.213 1.005 . . . . 75.51 110.367 -177.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 97.6 m -155.82 117.54 3.99 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.47 0.708 . . . . 74.21 109.505 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.46 118.92 6.9 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.27 -1.382 . . . . 60.52 107.27 169.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.675 ' HE1' ' HB ' ' C' ' 86' ' ' ILE . 1.1 tpt 57.88 112.63 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 O-C-N 124.7 1.25 . . . . 51.32 111.638 -173.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 36.9 m -127.37 92.46 3.51 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.571 -0.9 . . . . 74.24 108.571 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.651 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.6 t80 -105.94 133.16 51.1 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.368 0.667 . . . . 70.45 109.672 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -152.41 129.58 11.18 Favored 'General case' 0 C--O 1.242 0.667 0 O-C-N 124.072 0.857 . . . . 73.54 109.219 173.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 86.9 mt -73.36 130.51 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 108.43 -0.952 . . . . 63.01 108.43 172.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -97.05 -42.13 8.03 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.401 0.68 . . . . 60.25 110.283 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -176.19 124.97 0.19 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.701 0.4 . . . . 73.32 110.219 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 96.9 mt -111.26 146.39 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 109.058 -0.719 . . . . 63.43 109.058 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -172.6 166.5 5.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.12 0.968 . . . . 65.12 109.394 -175.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . 0.416 HG22 HE22 ' C' ' 80' ' ' GLN . 63.1 p -85.06 115.43 22.87 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.267 -0.642 . . . . 63.21 109.267 173.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.67 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 16.3 mmtp -64.67 -44.58 89.91 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.998 -0.741 . . . . 71.03 108.998 171.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 22.6 t70 -147.25 145.55 29.47 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 114.407 -1.27 . . . . 74.11 110.609 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.8 mt -133.55 145.13 34.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 125.891 1.676 . . . . 65.54 106.712 171.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.1 t -158.37 150.53 21.76 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.414 0.626 . . . . 72.21 109.707 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 72.1 t80 -147.07 137.6 23.58 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.307 -1.368 . . . . 71.01 107.307 173.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -141.11 135.38 30.88 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.632 -0.877 . . . . 51.14 108.632 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.03 83.42 4.68 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 107.701 -1.222 . . . . 62.42 107.701 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.52 -37.39 59.15 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.816 2.344 . . . . 64.53 112.581 -173.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -101.22 21.1 14.53 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.913 -1.04 . . . . 73.03 110.806 -173.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.467 ' HA ' HG12 ' C' ' 31' ' ' VAL . . . -48.58 -57.26 11.39 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 114.661 1.356 . . . . 73.51 114.661 -167.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.43 -42.5 54.72 Favored 'Trans proline' 0 C--N 1.386 2.516 0 CA-C-N 122.141 1.801 . . . . 54.55 112.248 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.479 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.3 t60 -70.8 -30.97 67.57 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.823 0.849 . . . . 75.31 112.695 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.648 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.5 p -79.68 -21.31 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 112.501 0.556 . . . . 74.32 112.501 -171.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -72.48 -22.94 60.98 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.489 0.552 . . . . 71.21 112.489 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 20.0 pt20 -85.41 8.5 18.7 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.447 0.299 . . . . 64.41 110.88 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.573 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -97.84 157.31 16.15 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.127 0.971 . . . . 50.43 110.281 175.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.0 132.39 40.14 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.708 0.803 . . . . 70.43 109.504 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.436 ' H ' ' HB3' ' C' ' 154' ' ' ASP . 35.1 t-105 -70.36 91.55 0.75 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.842 0.857 . . . . 62.15 110.701 -177.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.614 ' HA ' HE21 ' C' ' 37' ' ' GLN . 0.0 OUTLIER -132.21 71.56 79.56 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.263 1.025 . . . . 64.41 109.112 174.673 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -88.5 158.04 6.54 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.744 2.296 . . . . 73.02 112.842 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -89.06 99.93 12.82 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.013 -1.477 . . . . 71.11 107.013 172.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 15.0 m -66.04 98.36 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-O 122.18 0.99 . . . . 55.44 109.508 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -129.16 103.63 7.08 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.606 -1.179 . . . . 54.12 108.617 -170.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.641 HD21 HG13 ' G' ' 6' ' ' ILE . 2.1 mm? -94.68 148.37 22.34 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.626 -0.879 . . . . 64.53 108.626 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.663 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 11.8 t70 -135.48 123.45 22.72 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.2 -1.037 . . . . 73.55 108.2 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.17 111.78 21.52 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.457 -0.942 . . . . 64.02 108.457 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.522 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 16.7 t70 -114.45 137.38 51.91 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.121 0.968 . . . . 54.24 108.472 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 81.7 p -113.17 123.66 50.75 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.743 0.417 . . . . 53.34 111.464 -164.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.62 135.83 42.44 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.807 0.843 . . . . 61.22 109.181 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.636 ' HB3' ' HB3' ' G' ' 17' ' ' PRO . 51.7 m -161.7 149.19 14.62 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.874 0.47 . . . . 55.24 111.472 -172.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 52.9 p -160.26 140.77 11.77 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.688 0.795 . . . . 74.34 110.156 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.445 ' HA ' ' HA ' ' C' ' 56' ' ' TYR . 60.4 tt0 -74.8 123.46 25.03 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.781 -0.822 . . . . 61.15 108.781 170.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.629 HD11 HD12 ' C' ' 83' ' ' ILE . 87.9 mt -84.23 -49.82 8.44 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.169 0.587 . . . . 70.25 110.622 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.78 -169.74 3.47 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.32 0.648 . . . . 73.11 110.873 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.05 106.52 0.27 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.454 1.102 . . . . 72.42 111.06 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 70.32 -5.32 1.37 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 126.004 1.721 . . . . 62.35 112.68 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 73.8 t -96.53 118.13 42.28 Favored 'Isoleucine or valine' 0 C--N 1.347 0.483 0 C-N-CA 124.572 1.149 . . . . 74.24 108.425 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.607 ' HB2' ' HB2' ' G' ' 17' ' ' PRO . 37.1 p90 -127.96 168.78 14.79 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.046 0.939 . . . . 63.34 108.955 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -126.07 130.53 51.29 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.14 0.576 . . . . 73.04 110.427 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 76.3 t -106.61 115.77 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 107.933 -1.136 . . . . 75.32 107.933 167.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 98.2 t -109.3 131.75 59.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 107.718 -1.215 . . . . 64.41 107.718 165.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 35.5 tp -129.19 119.96 24.97 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.083 -0.71 . . . . 74.41 109.083 174.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.522 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.3 ttm180 -80.08 111.98 16.94 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.745 -1.116 . . . . 75.44 109.398 175.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 15.5 t -101.32 110.69 28.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.481 -1.303 . . . . 40.32 107.481 171.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.663 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 90.7 m -118.98 118.08 30.54 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.725 -0.843 . . . . 75.54 108.725 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.636 HG23 HD13 ' C' ' 114' ' ' ILE . 94.4 t -101.72 112.85 36.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 108.388 -0.968 . . . . 53.44 108.388 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -98.87 131.85 44.66 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.359 -0.978 . . . . 72.21 108.359 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.57 101.86 4.93 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.416 -1.328 . . . . 64.51 107.416 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 47.9 m -128.62 130.12 46.85 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.957 0.503 . . . . 64.52 109.994 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.573 HD13 ' HG2' ' C' ' 34' ' ' LYS . 12.5 mt -85.75 42.7 0.98 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 124.941 1.297 . . . . 73.53 109.774 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.87 -118.96 6.05 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 109.798 -1.321 . . . . 54.2 109.798 -167.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -89.21 -18.32 27.32 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.397 0.679 . . . . 60.33 110.072 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -74.76 91.16 2.38 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.579 1.152 . . . . 73.44 109.656 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 76.9 m -71.47 119.82 16.17 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 109.516 -0.55 . . . . 73.45 109.516 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.648 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -76.57 -54.68 6.35 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.745 -1.116 . . . . 25.51 109.154 -178.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -157.15 170.38 22.63 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-O 122.349 1.071 . . . . 75.22 112.452 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -142.7 113.55 7.53 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 105.196 -2.15 . . . . 74.22 105.196 175.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.503 ' SG ' HG23 ' C' ' 114' ' ' ILE . 47.9 t -121.92 112.49 18.37 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.162 -0.681 . . . . 70.11 109.162 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -119.28 121.2 39.09 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.724 0.81 . . . . 74.15 110.056 -172.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.427 HG11 ' HA ' ' C' ' 110' ' ' ALA . 43.7 t -125.84 112.58 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.747 -0.834 . . . . 63.23 108.747 173.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.3 mt-30 -91.15 95.98 10.35 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.003 -1.11 . . . . 71.43 108.003 173.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.491 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.9 tp-100 -83.13 117.51 22.94 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.771 0.428 . . . . 63.42 109.871 -175.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.21 145.85 17.89 Favored Glycine 0 C--N 1.342 0.913 0 O-C-N 123.863 0.727 . . . . 70.32 111.643 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.41 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.98 116.92 0.83 Allowed Glycine 0 C--O 1.238 0.361 0 N-CA-C 111.164 -0.775 . . . . 42.4 111.164 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.629 HD12 HD11 ' C' ' 51' ' ' LEU . 10.3 mm -84.44 116.59 28.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.856 -1.164 . . . . 72.32 107.856 176.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.651 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 46.9 m-85 -128.1 146.57 50.65 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.064 -1.087 . . . . 63.41 108.064 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 70.7 p -113.1 122.06 46.41 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.311 -0.626 . . . . 64.53 109.311 170.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.675 ' HB ' ' HE1' ' C' ' 9' ' ' MET . 17.7 pt -130.35 143.93 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 122.957 0.503 . . . . 64.22 109.904 170.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.7 143.33 18.45 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.035 0.934 . . . . 61.32 108.745 171.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 130.99 -52.29 0.83 Allowed Glycine 0 C--N 1.346 1.128 0 O-C-N 123.208 0.317 . . . . 65.13 113.018 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 33.0 pt -94.48 170.38 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-N 117.325 0.563 . . . . 64.25 111.831 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.753 ' HB2' HG21 ' A' ' 149' ' ' THR . 42.5 tt0 -156.89 162.3 39.66 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.626 0.77 . . . . 71.4 110.716 -175.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.11 -132.75 15.58 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.034 -0.53 . . . . 74.11 112.686 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . 0.418 HG23 ' HD3' ' G' ' 24' ' ' PRO . 20.4 p -69.36 -24.36 63.87 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.526 0.73 . . . . 63.25 111.769 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -65.15 -51.58 60.32 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 121.243 0.544 . . . . 73.53 110.039 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.526 ' SD ' HG11 ' G' ' 18' ' ' VAL . 46.3 ttp -64.88 -45.09 87.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.763 -1.108 . . . . 70.51 110.153 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.71 -26.03 68.47 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.062 0.945 . . . . 74.41 111.822 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -73.12 -42.72 62.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.036 0.534 . . . . 74.13 110.577 175.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 40.6 t -62.84 -60.7 3.12 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.709 0.63 . . . . 52.43 110.024 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.576 HD22 ' HD2' ' G' ' 17' ' ' PRO . 4.2 pp -71.3 -29.67 65.32 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 112.151 0.426 . . . . 74.41 112.151 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.56 11.42 56.52 Favored Glycine 0 N--CA 1.48 1.584 0 N-CA-C 115.157 0.823 . . . . 72.53 115.157 -167.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.79 -51.99 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 118.21 1.005 . . . . 42.34 110.335 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.413 ' HE2' ' CE1' ' C' ' 11' ' ' PHE . 27.3 t80 -75.93 -38.28 57.82 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 113.652 -1.613 . . . . 62.21 112.793 -169.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 83.4 m -79.28 -42.35 1.62 Allowed Pre-proline 0 CA--C 1.563 1.451 0 CA-C-O 118.553 -0.737 . . . . 45.13 112.196 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.85 -23.01 68.92 Favored 'Trans proline' 0 C--N 1.397 3.106 0 C-N-CA 122.139 1.893 . . . . 74.34 112.702 171.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -63.84 -32.37 73.86 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.793 0.837 . . . . 74.44 111.019 174.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.474 HD12 ' NH1' ' A' ' 111' ' ' ARG . 47.1 mm -67.63 -35.87 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 123.365 0.666 . . . . 75.35 110.303 175.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.41 HD21 ' HA3' ' C' ' 82' ' ' GLY . 84.3 mt -90.0 -25.16 21.0 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.177 0.991 . . . . 73.14 112.923 -170.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.423 ' N ' ' HD2' ' C' ' 108' ' ' PRO . 0.1 OUTLIER -63.55 -40.34 57.01 Favored Pre-proline 0 CA--C 1.557 1.24 0 CA-C-O 117.729 -1.129 . . . . 75.12 113.905 -171.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' C' ' 107' ' ' PHE . 30.0 Cg_endo -61.16 -36.82 79.0 Favored 'Trans proline' 0 C--N 1.388 2.645 0 CA-C-N 121.685 1.638 . . . . 72.4 112.314 174.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -64.29 -49.29 72.41 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.522 0.729 . . . . 72.45 110.729 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.491 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.78 -41.05 96.14 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.365 -0.834 . . . . 70.21 110.888 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -53.2 -56.15 18.73 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.659 1.183 . . . . 61.34 111.39 175.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . 0.441 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.8 tm-20 -66.14 -34.34 77.83 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 123.568 0.542 . . . . 74.02 110.286 -176.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 12.9 t -70.6 -27.45 64.11 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.072 0.549 . . . . 75.22 111.321 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.636 HD13 HG23 ' C' ' 64' ' ' VAL . 82.0 mt -77.66 -55.47 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.228 0.611 . . . . 75.4 110.288 173.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 18.8 m -62.49 -27.76 69.36 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.534 0.734 . . . . 71.4 110.96 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 42.6 t -62.06 -51.77 66.61 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 123.786 0.834 . . . . 73.23 109.38 169.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.625 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.03 -35.54 77.17 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.687 1.195 . . . . 64.42 112.668 178.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.418 HG23 ' O ' ' C' ' 114' ' ' ILE . 63.7 t -63.57 -46.7 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.71 0.804 . . . . 63.11 109.238 174.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 30.7 t -68.31 -28.55 67.27 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.859 -1.064 . . . . 63.53 111.851 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -72.77 -40.48 65.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.625 0.77 . . . . 72.52 109.316 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.34 -2.54 79.75 Favored Glycine 0 C--N 1.355 1.591 0 CA-C-N 115.42 -0.809 . . . . 71.05 112.267 171.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 24.8 p 65.44 27.66 11.74 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.783 2.033 . . . . 73.35 113.193 170.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -84.14 152.26 61.46 Favored Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 109.042 -0.725 . . . . 75.12 109.042 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -54.36 160.82 6.19 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 123.447 2.765 . . . . 74.23 114.106 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -55.38 111.16 0.81 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.715 0.806 . . . . 61.32 111.461 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 26.6 tp -116.38 86.28 2.46 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 106.116 -1.809 . . . . 74.13 106.116 167.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -104.56 125.9 51.15 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.862 -1.063 . . . . 71.31 109.587 -167.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.36 127.35 32.44 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.489 0.715 . . . . 74.21 110.238 -173.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.6 156.05 68.32 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 123.99 0.916 . . . . 62.22 111.531 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.539 ' HB3' HD12 ' A' ' 16' ' ' ILE . 19.7 Cg_endo -61.22 102.34 0.21 Allowed 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.784 2.323 . . . . 72.11 112.975 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.515 ' HB ' HD12 ' G' ' 8' ' ' LEU . 60.3 t -118.86 110.08 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 108.742 -0.836 . . . . 71.45 108.742 173.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -96.1 106.39 18.56 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.057 -1.09 . . . . 73.23 108.057 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -53.87 -41.9 68.02 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.348 0.659 . . . . 74.24 112.494 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -55.41 -51.8 65.67 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.093 0.957 . . . . 74.44 111.229 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.5 -33.18 74.57 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.517 -0.765 . . . . 64.32 111.268 177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 5.1 tt -64.88 -36.72 85.26 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.383 1.073 . . . . 65.14 110.051 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -62.09 -39.6 93.04 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 123.16 0.287 . . . . 71.13 111.453 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 83.3 mtp -78.26 -33.83 49.39 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.575 0.75 . . . . 73.03 111.413 176.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -66.03 -35.83 81.6 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.02 1.328 . . . . 63.34 110.057 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' C' ' 143' ' ' GLN . 10.9 t80 -72.82 -149.41 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 125.476 1.51 . . . . 72.23 109.55 176.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 75.3 mt 68.54 -74.31 0.08 Allowed 'General case' 0 C--N 1.361 1.107 0 C-N-CA 125.094 1.357 . . . . 70.33 110.918 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -86.46 -29.92 22.43 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.162 0.985 . . . . 64.4 111.887 -175.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' C' ' 140' ' ' TYR . 14.9 pt20 -151.93 171.45 17.77 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.089 0.556 . . . . 44.54 111.456 -176.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -151.68 101.02 2.75 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.624 -0.88 . . . . 74.11 108.624 172.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.8 163.13 13.12 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.773 0.829 . . . . 63.3 110.955 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -165.09 151.05 19.69 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.44 -1.064 . . . . 53.23 110.44 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . 0.609 ' HB3' ' H ' ' G' ' 5' ' ' THR . 25.6 tt0 -78.46 79.66 4.88 Favored 'General case' 0 CA--C 1.554 1.129 0 CA-C-O 121.763 0.792 . . . . 73.55 110.124 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -89.99 116.6 4.82 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 110.244 -1.143 . . . . 74.03 110.244 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 5.0 m -144.59 -54.03 0.32 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.397 -0.964 . . . . 64.51 108.397 -177.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 66.25 178.68 0.21 Allowed 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.149 -1.387 . . . . 60.44 111.324 -174.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -154.53 -60.16 0.12 Allowed 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.554 -0.906 . . . . 65.03 108.554 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 64.2 80.0 0.24 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.02 0.928 . . . . 62.12 111.731 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -178.21 135.04 0.16 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.62 1.168 . . . . 70.45 108.675 167.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' C' ' 36' ' ' TRP . 24.1 t70 -154.35 -62.26 0.13 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.873 0.869 . . . . 73.31 109.104 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 N-CA-C 109.12 -0.696 . . . . 73.34 109.12 178.548 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 22.3 mmt . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 109.76 -0.459 . . . . 72.22 109.76 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 44.1 p -126.41 98.82 5.58 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.496 0.719 . . . . 72.22 109.558 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -104.11 102.8 12.54 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.037 -1.097 . . . . 61.41 108.037 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -144.31 -58.49 0.38 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.54 0.736 . . . . 75.32 109.477 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -167.14 159.33 12.86 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.481 -0.781 . . . . 74.04 110.344 -174.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 61.0 t30 177.49 77.27 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 107.392 -1.336 . . . . 74.32 107.392 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.0 m -132.56 -10.83 3.16 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.418 0.687 . . . . 54.43 111.502 -169.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -66.15 -21.12 66.32 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.978 0.511 . . . . 74.33 110.3 175.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.545 ' HE1' ' HB2' ' D' ' 11' ' ' PHE . 1.5 tmt? -27.72 127.54 0.07 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 126.113 1.765 . . . . 63.51 113.475 165.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 32.7 m -108.44 146.38 33.2 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.758 0.823 . . . . 73.45 110.603 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.545 ' HB2' ' HE1' ' D' ' 9' ' ' MET . 29.6 t80 -147.27 119.06 8.06 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.83 -1.174 . . . . 71.21 107.83 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' D' ' 85' ' ' SER . 44.6 mt-30 -132.08 133.69 44.64 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.438 -0.949 . . . . 65.41 108.438 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.595 HG21 HD11 ' D' ' 16' ' ' ILE . 21.8 mt -84.68 129.31 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 108.51 -0.922 . . . . 63.03 108.51 173.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.669 HE21 ' HB2' ' D' ' 85' ' ' SER . 80.1 mt-30 -97.36 -46.18 6.19 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 122.586 0.354 . . . . 74.41 111.226 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -170.15 128.87 0.89 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.6 0.593 . . . . 50.03 112.6 -173.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.595 HD11 HG21 ' D' ' 13' ' ' ILE . 2.0 mp -107.57 137.92 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.445 -1.317 . . . . 43.45 107.445 174.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -163.46 163.73 24.73 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 122.277 1.037 . . . . 74.11 110.956 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -93.8 120.89 34.66 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.629 -1.623 . . . . 72.12 108.419 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -85.3 -42.59 14.48 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.869 -1.16 . . . . 74.43 107.869 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' D' ' 79' ' ' GLN . 20.0 m-20 -136.21 144.79 45.08 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 114.755 -1.111 . . . . 74.23 110.217 176.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.625 HG21 ' HE2' ' C' ' 117' ' ' MET . 56.6 mt -140.73 149.65 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.355 1.462 . . . . 65.22 107.367 174.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.1 t -156.49 142.45 18.0 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.021 0.439 . . . . 74.25 110.849 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.1 t80 -147.63 111.59 5.11 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 106.176 -1.787 . . . . 72.15 106.176 173.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 23.8 mt-10 -123.04 108.23 12.68 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.011 -0.737 . . . . 73.14 109.011 -173.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.558 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -106.44 89.06 3.72 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 123.594 0.758 . . . . 35.14 109.076 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -80.0 -28.13 3.38 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.766 2.311 . . . . 73.11 113.209 -169.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -110.05 6.29 22.84 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.466 0.706 . . . . 62.52 110.627 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.637 ' HB3' ' HE2' ' C' ' 19' ' ' LYS . . . -29.58 -66.89 0.14 Allowed Pre-proline 0 CA--C 1.566 1.588 0 N-CA-C 116.904 2.187 . . . . 50.5 116.904 -165.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.67 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 64.6 Cg_endo -74.64 -14.57 22.04 Favored 'Trans proline' 0 C--N 1.383 2.381 0 CA-C-N 123.38 2.243 . . . . 61.25 112.847 -172.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -84.4 -39.3 19.19 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.048 1.339 . . . . 73.51 110.318 172.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.665 HG22 HD12 ' D' ' 68' ' ' LEU . 5.6 p -82.48 -22.9 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-N 116.436 -0.347 . . . . 65.4 110.98 -170.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -61.67 -24.05 66.48 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.036 0.534 . . . . 64.33 112.251 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -57.6 -30.09 65.02 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.434 1.094 . . . . 75.14 110.861 175.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -84.33 71.98 10.61 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.514 -1.221 . . . . 70.12 109.502 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.72 81.55 5.97 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.215 -0.902 . . . . 50.42 110.67 -173.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 21.6 p90 -155.75 179.18 9.44 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.833 0.853 . . . . 72.0 109.485 172.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.591 HE21 ' HD2' ' D' ' 38' ' ' PRO . 25.1 tp60 -68.84 116.26 39.43 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.868 0.867 . . . . 63.3 110.609 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.591 ' HD2' HE21 ' D' ' 37' ' ' GLN . 50.9 Cg_exo -56.79 131.97 48.86 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.652 2.235 . . . . 74.12 112.379 176.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.29 111.15 3.84 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.755 -1.202 . . . . 75.24 107.755 172.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' D' ' 66' ' ' ALA . 27.7 m -108.19 137.68 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.42 0.629 . . . . 73.03 110.609 -172.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -123.76 128.21 49.23 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.115 -1.439 . . . . 72.52 107.115 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.729 HD22 ' H ' ' H' ' 8' ' ' LEU . 7.8 mp -96.84 138.5 34.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.195 0.521 . . . . 72.31 110.653 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -128.01 115.87 19.16 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.331 -1.359 . . . . 74.52 107.331 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.463 HD21 HD12 ' H' ' 8' ' ' LEU . 7.5 mp -104.47 138.2 41.21 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.356 0.662 . . . . 70.04 110.28 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.632 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.9 t70 -133.7 145.05 49.54 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.089 -1.078 . . . . 73.34 108.089 177.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.5 t -105.97 158.13 17.01 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.859 0.464 . . . . 75.02 111.298 -175.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.458 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -167.66 153.11 7.2 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.935 1.294 . . . . 71.55 108.847 173.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 76.9 p -154.0 156.71 37.9 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.555 0.742 . . . . 63.41 109.813 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 15.3 m -147.6 123.92 10.92 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.357 -0.979 . . . . 73.41 108.357 -174.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -78.46 115.39 18.13 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.789 -1.189 . . . . 73.55 107.789 167.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.529 HD12 HG23 ' D' ' 83' ' ' ILE . 26.3 mt -95.44 -27.89 15.19 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.064 -0.717 . . . . 71.13 109.064 177.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.16 -178.64 6.12 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.042 0.937 . . . . 45.35 110.132 172.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -65.67 123.7 20.43 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.549 -0.75 . . . . 72.33 109.816 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 60.45 20.37 10.06 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.25 1.02 . . . . 63.23 112.475 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.3 t -125.08 118.11 52.0 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 C-N-CA 124.205 1.002 . . . . 53.54 108.511 174.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -134.69 131.26 37.48 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.466 0.707 . . . . 62.41 109.849 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.412 ' HB2' HD11 ' D' ' 51' ' ' LEU . 31.5 tt0 -87.38 128.57 35.2 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.812 -1.086 . . . . 63.42 108.274 166.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 43.2 t -110.0 125.42 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 107.789 -1.189 . . . . 61.21 107.789 173.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 16.5 t -118.69 125.67 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.883 -0.784 . . . . 71.2 108.883 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 6.9 mp -121.8 127.46 50.62 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.545 -0.909 . . . . 72.4 108.545 171.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.632 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 18.9 ttm-85 -83.94 103.66 13.38 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.601 1.16 . . . . 74.53 108.903 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 87.0 t -90.94 115.49 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 108.501 -0.925 . . . . 43.11 108.501 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' D' ' 42' ' ' LEU . 18.7 m -125.82 128.29 47.43 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.064 0.459 . . . . 61.14 109.778 -172.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 42.7 t -118.76 101.01 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 125.541 1.537 . . . . 71.42 108.475 -175.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 32.2 m -92.46 95.23 9.53 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.023 -1.103 . . . . 74.41 108.023 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.511 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -102.66 138.64 39.29 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 115.459 -0.791 . . . . 42.4 111.113 -173.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.431 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 47.6 m -146.78 134.4 21.01 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 122.786 0.434 . . . . 60.31 110.989 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.665 HD12 HG22 ' D' ' 31' ' ' VAL . 66.2 mt -94.89 102.24 14.08 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.883 -1.154 . . . . 73.33 107.883 171.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.6 -113.82 3.83 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 116.12 -0.491 . . . . 51.14 112.363 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.73 3.66 11.11 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.108 0.563 . . . . 73.04 110.24 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -116.0 155.08 28.72 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.685 -0.857 . . . . 64.43 108.685 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 35.0 m -70.01 136.43 50.39 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 123.395 0.435 . . . . 73.23 111.293 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.452 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -89.29 -62.77 1.4 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.705 -1.22 . . . . 43.53 107.705 172.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . 0.414 ' HE2' ' HG2' ' D' ' 38' ' ' PRO . 52.6 p90 -158.44 154.85 27.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.558 -1.201 . . . . 61.24 110.311 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 91.5 mt -120.56 112.75 19.31 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.58 1.152 . . . . 63.45 108.002 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.529 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 2.5 m -114.25 140.14 48.83 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.299 1.039 . . . . 72.1 108.918 -174.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -153.92 119.36 5.17 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.295 -1.002 . . . . 74.01 108.295 174.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . 0.462 HG22 HG23 ' D' ' 21' ' ' ILE . 60.3 t -124.5 115.13 43.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.487 -0.931 . . . . 73.15 108.487 174.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.577 ' HB2' ' HB2' ' D' ' 20' ' ' ASP . 51.1 mt-30 -88.13 85.37 6.94 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.92 -1.141 . . . . 65.45 107.92 171.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -80.66 104.03 10.91 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 114.132 -1.394 . . . . 62.22 108.467 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.64 141.74 15.42 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.421 -0.672 . . . . 23.22 111.421 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.507 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -137.11 131.93 5.78 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 111.472 -0.651 . . . . 64.03 111.472 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.529 HG23 HD12 ' D' ' 51' ' ' LEU . 50.8 mt -88.02 124.17 41.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.228 -1.027 . . . . 70.13 108.228 175.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -129.59 157.88 40.83 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.684 0.794 . . . . 73.02 110.071 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.669 ' HB2' HE21 ' D' ' 14' ' ' GLN . 43.4 t -115.56 98.88 6.97 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.986 1.314 . . . . 73.24 107.779 -178.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.9 111.55 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.532 0.733 . . . . 71.11 109.443 -176.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -131.87 149.76 52.35 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.932 0.493 . . . . 73.55 110.457 177.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.52 19.75 63.41 Favored Glycine 0 C--N 1.346 1.104 0 O-C-N 123.788 0.68 . . . . 64.11 114.426 172.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.465 HD11 ' HE3' ' D' ' 9' ' ' MET . 10.2 mt -112.65 154.16 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 117.226 0.513 . . . . 64.01 109.996 175.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.425 ' HB2' ' HB ' ' B' ' 149' ' ' THR . 0.0 OUTLIER -147.82 -174.35 4.53 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 125.085 1.354 . . . . 74.14 110.7 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.01 -138.03 39.01 Favored Glycine 0 C--N 1.353 1.485 0 CA-C-N 115.948 -0.569 . . . . 41.33 113.622 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 28.1 p -90.05 -13.74 35.33 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.793 0.837 . . . . 74.1 111.017 174.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -31.0 72.03 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.351 1.06 . . . . 75.0 110.09 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.422 ' SD ' ' HA ' ' D' ' 90' ' ' GLU . 8.0 ptm -74.52 -21.18 59.67 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.389 0.676 . . . . 73.23 112.124 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.83 -36.13 50.46 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.704 -0.48 . . . . 71.23 109.704 169.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.482 ' CD2' ' SD ' ' D' ' 138' ' ' MET . 24.7 t-80 -64.52 -37.28 87.02 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.306 0.642 . . . . 72.4 111.31 175.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 35.9 t -59.97 -49.57 77.17 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.011 -0.54 . . . . 64.15 110.491 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 43.7 mt -85.96 -21.7 27.75 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.246 -0.888 . . . . 75.2 111.557 -175.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.23 5.09 45.04 Favored Glycine 0 N--CA 1.476 1.363 0 N-CA-C 114.551 0.58 . . . . 61.43 114.551 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.639 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -150.05 -68.14 0.2 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.534 0.334 . . . . 63.31 110.855 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -65.13 -52.29 56.13 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 112.654 0.613 . . . . 73.45 112.654 -170.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 71.8 m -61.36 -50.17 84.47 Favored Pre-proline 0 CA--C 1.563 1.444 0 CA-C-O 118.76 -0.638 . . . . 70.23 112.218 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.29 -21.44 35.69 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 121.825 1.684 . . . . 72.42 113.421 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -68.74 -27.38 65.87 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 122.911 0.484 . . . . 72.42 110.528 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.432 HD13 HD11 ' D' ' 13' ' ' ILE . 58.5 mt -72.16 -28.43 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 C-N-CA 124.082 0.953 . . . . 70.11 110.441 171.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.507 HD21 ' HA3' ' D' ' 82' ' ' GLY . 94.2 mt -86.28 -22.94 26.53 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.702 0.801 . . . . 72.21 112.563 -176.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -66.9 -35.28 8.86 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 114.346 1.239 . . . . 75.32 114.346 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.91 -45.28 37.02 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 121.995 1.797 . . . . 75.53 112.939 166.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -74.51 -33.77 62.87 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.748 0.819 . . . . 73.44 111.884 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.41 -53.04 58.51 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.157 0.583 . . . . 41.24 109.889 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -53.77 -51.63 62.81 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-N 114.328 -1.305 . . . . 65.14 110.829 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -62.2 -44.81 95.75 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.274 0.984 . . . . 55.25 111.53 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 36.8 t -58.58 -40.63 83.72 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 123.814 0.696 . . . . 71.3 110.651 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.473 ' O ' HG23 ' D' ' 118' ' ' VAL . 76.7 mt -68.06 -48.79 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.809 0.843 . . . . 64.41 110.381 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.408 HG23 ' HG3' ' D' ' 125' ' ' GLN . 56.5 m -58.2 -42.45 86.18 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.438 1.095 . . . . 74.33 111.519 -175.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 32.8 t -66.5 -42.81 86.82 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.089 -0.96 . . . . 74.05 110.168 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.407 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 73.8 mtm -64.75 -37.57 88.05 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.946 0.498 . . . . 62.24 111.767 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.473 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.1 t -65.96 -41.7 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.063 0.945 . . . . 73.43 110.842 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.8 p -73.31 -31.36 63.96 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 116.009 -0.541 . . . . 73.3 110.952 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' D' ' 116' ' ' SER . 72.9 mtt-85 -70.19 -33.15 71.36 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.436 0.694 . . . . 73.34 110.176 175.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.48 7.63 78.2 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-N 115.919 -0.582 . . . . 50.42 112.516 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.0 p 59.58 24.12 12.87 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 126.683 1.993 . . . . 65.12 114.073 173.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.433 ' HB2' HG13 ' D' ' 118' ' ' VAL . 97.0 m-85 -83.95 156.37 64.06 Favored Pre-proline 0 N--CA 1.479 0.983 0 N-CA-C 108.908 -0.775 . . . . 64.42 108.908 167.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.522 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 18.5 Cg_endo -60.83 139.69 86.54 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.166 1.911 . . . . 74.25 111.771 176.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.408 ' HG3' HG23 ' D' ' 115' ' ' THR . 33.0 tt0 -55.28 142.48 31.57 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.755 1.222 . . . . 64.04 112.469 -174.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 45.9 tp -127.91 98.65 5.23 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.658 0.783 . . . . 73.13 109.352 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.23 107.4 18.21 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.442 0.697 . . . . 72.01 109.333 175.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 7.4 mp -63.79 117.95 7.64 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.086 0.954 . . . . 71.32 109.789 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.79 145.05 98.95 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.478 0.711 . . . . 52.43 111.115 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.471 ' HD3' HG13 ' B' ' 13' ' ' ILE . 73.9 Cg_exo -54.53 129.23 33.77 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.824 3.016 . . . . 61.31 113.4 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 29.9 m -113.53 146.39 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.467 0.707 . . . . 74.24 110.069 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -90.11 74.94 7.13 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.977 -1.49 . . . . 74.52 106.977 169.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.463 ' HD2' ' HA ' ' D' ' 100' ' ' ALA . 24.1 t80 -63.46 -26.43 68.72 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.921 0.888 . . . . 73.52 110.818 -174.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.639 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 7.1 m-20 -60.48 -61.03 2.89 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 115.013 -0.994 . . . . 60.05 111.14 172.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.1 -29.48 70.84 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.969 0.508 . . . . 31.01 111.727 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 86.8 mt -65.55 -42.68 91.63 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 124.029 0.831 . . . . 70.33 111.349 173.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -66.23 -50.75 62.72 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.053 0.541 . . . . 74.14 109.943 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.482 ' SD ' ' CD2' ' D' ' 96' ' ' HIS . 3.2 mpp? -62.01 -29.33 70.2 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.778 0.431 . . . . 65.04 111.692 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.43 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 9.4 t30 -60.57 -42.99 97.77 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.867 0.867 . . . . 73.44 110.937 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -61.66 -39.84 92.82 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.259 -0.882 . . . . 73.31 111.269 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 mp -74.48 -38.19 62.97 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.954 -0.567 . . . . 72.14 111.506 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.43 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 10.0 pt20 -88.81 5.78 42.04 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.091 0.404 . . . . 64.43 112.091 -172.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -118.78 89.81 3.2 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.713 0.768 . . . . 71.02 109.015 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -155.98 106.67 2.45 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.138 -1.392 . . . . 65.22 107.841 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.25 128.66 52.61 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.765 0.826 . . . . 63.53 108.815 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.99 73.32 1.97 Allowed Glycine 0 C--N 1.348 1.203 0 O-C-N 123.364 0.415 . . . . 73.02 112.379 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -155.86 158.3 37.81 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.285 1.034 . . . . 73.34 108.291 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -54.46 -35.04 55.63 Favored Glycine 0 C--N 1.353 1.525 0 O-C-N 123.824 0.702 . . . . 73.14 114.781 -172.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 71.0 p -83.55 105.12 14.22 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 122.877 0.471 . . . . 73.32 110.152 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -109.44 153.05 24.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.637 0.775 . . . . 72.21 109.139 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -86.67 48.5 1.65 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.638 0.732 . . . . 75.41 109.208 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -84.2 84.37 7.64 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.479 -0.782 . . . . 73.01 109.597 -173.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -137.51 73.92 1.46 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.212 -1.033 . . . . 72.23 108.212 173.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -95.3 -166.31 1.43 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 114.603 -1.18 . . . . 72.41 110.176 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.301 0 C-N-CA 123.452 0.701 . . . . 74.34 111.32 -172.693 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 109.714 -0.476 . . . . 42.51 109.714 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -173.65 106.38 0.13 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.693 1.197 . . . . 74.41 108.258 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.59 104.24 5.07 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 107.667 -1.234 . . . . 70.21 107.667 -176.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 59.0 p -100.45 130.89 46.59 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.509 -0.922 . . . . 72.14 108.509 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 28.8 m -60.57 148.58 37.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.136 0.575 . . . . 74.55 111.026 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.411 HD13 HG11 ' A' ' 40' ' ' VAL . 2.6 pp -51.1 139.3 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 125.073 1.349 . . . . 65.32 113.039 -178.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 7' ' ' ALA . . . . . 0.683 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . . . -150.8 161.92 41.74 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.79 0.836 . . . . 72.14 110.1 -175.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.592 ' HB3' HD13 ' A' ' 44' ' ' LEU . 89.3 mt -69.65 -15.28 63.16 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.283 0.633 . . . . 62.12 112.299 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . 66.1 -160.29 0.26 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.356 1.063 . . . . 52.41 110.251 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 5.6 mp -73.25 149.17 42.99 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.396 -0.594 . . . . 73.43 109.396 175.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.582 HD23 HD12 ' A' ' 44' ' ' LEU . 85.2 mt -64.74 135.51 96.41 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 123.101 0.56 . . . . 74.14 110.163 176.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -58.57 -41.33 65.52 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.582 2.855 . . . . 70.11 113.756 -167.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 23.3 tp -135.03 31.62 3.25 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 108.7 -0.852 . . . . 73.23 108.7 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 8.3 mp 59.26 -89.06 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.561 -1.199 . . . . 42.41 110.159 -173.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -165.73 176.22 8.17 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.192 0.997 . . . . 62.43 108.907 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 39.9 p -75.45 116.39 54.38 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 123.085 0.554 . . . . 54.24 110.366 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 17' ' ' PRO . . . . . 0.519 ' HB3' ' HB3' ' E' ' 21' ' ' ALA . 61.6 Cg_exo -53.95 131.21 43.24 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.85 3.033 . . . . 52.22 114.002 -174.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 18' ' ' VAL . . . . . 0.525 HG21 HD11 ' A' ' 86' ' ' ILE . 26.0 t -73.94 -75.35 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.53 0.732 . . . . 65.11 110.55 -176.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 54.7 p -93.14 58.38 2.89 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.335 0.654 . . . . 73.32 110.793 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt 62.05 22.06 12.82 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.878 1.271 . . . . 74.43 113.304 170.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' E' ' 17' ' ' PRO . . . -55.91 -28.2 55.64 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.753 0.821 . . . . 73.32 112.71 -173.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -151.97 133.14 14.38 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.345 -0.983 . . . . 73.44 108.345 171.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 29.1 m -132.9 121.62 17.08 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 107.778 -1.193 . . . . 71.31 107.778 -173.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -50.53 -37.69 52.76 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 123.591 2.861 . . . . 60.32 114.508 -170.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 CA--C 1.548 0.9 0 N-CA-C 107.943 -1.132 . . . . 72.35 107.943 170.827 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtm . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.126 -0.324 . . . . 62.24 110.126 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' F' F ' 2' ' ' LYS . . . . . 0.518 ' HA ' ' HE2' ' F' ' 2' ' ' LYS . 10.2 mmpt? -117.96 77.36 1.14 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.575 0.75 . . . . 75.24 110.615 -173.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -129.16 105.72 8.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.084 -0.71 . . . . 74.44 109.084 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 46.1 t -74.04 -42.71 59.85 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.556 -0.747 . . . . 74.3 110.779 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 83.6 m -145.63 150.58 36.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.893 0.877 . . . . 74.34 109.63 -174.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.436 HG13 HD23 ' B' ' 42' ' ' LEU . 12.4 tt -65.34 97.65 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 CA-C-O 121.887 0.851 . . . . 74.41 109.712 173.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.39 26.1 9.06 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.092 -0.958 . . . . 74.5 110.936 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . 0.409 HD23 ' HB2' ' B' ' 42' ' ' LEU . 96.9 mt 61.51 168.96 0.11 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.879 1.271 . . . . 64.13 113.203 177.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.22 145.72 26.28 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.091 -0.707 . . . . 62.32 109.091 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 tt -75.4 75.41 2.48 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 108.986 -0.746 . . . . 54.34 108.986 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 82.9 mt 26.83 80.44 0.22 Allowed Pre-proline 0 N--CA 1.491 1.593 0 C-N-CA 126.653 1.981 . . . . 63.21 113.773 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.53 -41.14 74.78 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.761 2.307 . . . . 63.43 112.633 -174.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.05 -20.38 45.39 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.216 -0.902 . . . . 64.33 110.879 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 6.6 mp 59.73 -165.5 0.2 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.739 1.216 . . . . 62.13 110.638 -166.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . 0.485 ' HA ' HG21 ' B' ' 46' ' ' THR . 35.0 t80 -113.76 134.79 54.55 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 110.023 -0.362 . . . . 73.31 110.023 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 41.7 p -72.83 119.02 73.1 Favored Pre-proline 0 CA--C 1.557 1.22 0 N-CA-C 109.399 -0.593 . . . . 63.24 109.399 175.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.23 174.49 9.83 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.961 2.441 . . . . 73.3 113.582 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . 0.609 ' HB ' ' HB2' ' F' ' 21' ' ' ALA . 30.7 t -91.78 138.96 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.232 1.013 . . . . 53.34 110.174 -175.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 8.0 m -76.93 -55.85 5.11 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 109.835 -0.432 . . . . 62.44 109.835 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -98.82 77.38 2.23 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.284 -0.635 . . . . 64.13 109.284 172.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . 0.609 ' HB2' ' HB ' ' F' ' 18' ' ' VAL . . . -95.37 -58.02 2.24 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.1 -0.955 . . . . 63.42 108.629 170.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 7.6 ppt_? -96.95 160.57 14.27 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.499 -0.773 . . . . 72.53 109.925 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 32.3 p -80.05 144.21 58.6 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.077 0.951 . . . . 70.23 110.621 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.96 -63.17 0.07 OUTLIER 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.342 2.028 . . . . 71.34 110.952 175.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 124.499 1.12 . . . . 65.44 108.33 173.711 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 91.4 mmm . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 109.914 -0.402 . . . . 74.33 109.914 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -152.99 88.79 1.34 Allowed 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 108.905 -0.776 . . . . 71.34 108.905 -166.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -151.4 67.44 0.9 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.55 1.167 . . . . 54.2 110.35 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 69.3 m -141.51 -86.94 0.17 Allowed 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 106.457 -1.683 . . . . 70.51 106.457 164.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 5' ' ' THR . . . . . 0.609 ' H ' ' HB3' ' C' ' 147' ' ' GLU . 4.0 m 55.53 -76.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 125.472 1.509 . . . . 54.25 113.318 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . 0.641 HG13 HD21 ' C' ' 42' ' ' LEU . 10.1 tt -59.5 112.33 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 125.168 1.387 . . . . 75.13 111.36 -178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -122.11 147.46 46.1 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.146 0.978 . . . . 44.14 110.403 -175.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 8' ' ' LEU . . . . . 0.515 HD12 ' HB ' ' C' ' 131' ' ' VAL . 56.7 mt -90.45 125.28 35.52 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 123.706 0.802 . . . . 54.04 109.43 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.55 164.77 22.48 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 123.86 0.725 . . . . 42.52 111.188 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.72 138.37 57.11 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.407 0.683 . . . . 65.55 109.794 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 96.5 mt -56.19 114.97 8.6 Favored Pre-proline 0 CA--C 1.548 0.872 0 O-C-N 123.985 0.803 . . . . 72.44 110.706 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.49 -22.85 65.08 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.094 2.529 . . . . 71.15 112.717 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 53.7 tp -139.18 135.27 33.83 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.585 0.754 . . . . 65.01 109.666 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 93.3 mt -98.17 102.67 14.48 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.354 -0.98 . . . . 74.45 108.354 172.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . 0.618 ' HD1' ' HD3' ' G' ' 17' ' ' PRO . 38.3 p90 -77.1 165.3 24.78 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.797 0.839 . . . . 74.41 110.913 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -149.53 91.95 4.31 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 123.491 0.716 . . . . 64.51 109.675 173.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 17' ' ' PRO . . . . . 0.636 ' HB3' ' HB3' ' C' ' 48' ' ' SER . 59.8 Cg_endo -73.26 -11.47 24.94 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.28 2.654 . . . . 73.44 112.208 173.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 18' ' ' VAL . . . . . 0.526 HG11 ' SD ' ' C' ' 94' ' ' MET . 46.9 t -92.81 166.9 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.372 0 C-N-CA 124.202 1.001 . . . . 72.23 108.495 172.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 25.7 m -31.35 -64.81 0.14 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 126.463 1.905 . . . . 63.23 114.799 -176.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.06 131.55 1.61 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.233 0.213 . . . . 71.14 111.138 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . -102.28 116.62 33.03 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.501 0.72 . . . . 71.55 109.177 173.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 22' ' ' ARG . . . . . 0.529 ' HG2' ' H ' ' G' ' 23' ' ' THR . 20.8 ttt85 -144.77 -174.75 4.42 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.002 -0.74 . . . . 73.55 109.002 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 23' ' ' THR . . . . . 0.529 ' H ' ' HG2' ' G' ' 22' ' ' ARG . 40.6 p -48.66 121.79 10.19 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 124.007 0.923 . . . . 64.23 110.646 167.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 24' ' ' PRO . . . . . 0.418 ' HD3' HG23 ' C' ' 92' ' ' THR . 87.5 Cg_endo -74.83 170.38 20.49 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.606 2.204 . . . . 75.45 111.203 176.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--O 1.251 1.175 0 N-CA-C 108.129 -1.063 . . . . 73.03 108.129 173.187 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 109.341 -0.614 . . . . 72.14 109.341 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -160.52 89.12 0.81 Allowed 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.764 0.826 . . . . 64.41 108.877 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -95.61 137.27 34.91 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.083 -1.08 . . . . 75.35 108.083 174.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 62.3 p -79.77 72.23 6.47 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.713 0.768 . . . . 73.33 109.568 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 19.4 m -86.06 129.04 34.96 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.984 -1.007 . . . . 52.41 109.406 -177.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.445 HD11 HG23 ' D' ' 40' ' ' VAL . 2.6 pp -66.07 140.28 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 123.614 0.572 . . . . 73.54 110.294 174.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -166.55 105.24 0.62 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.944 -0.762 . . . . 71.25 108.944 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 8' ' ' LEU . . . . . 0.729 ' H ' HD22 ' D' ' 42' ' ' LEU . 3.8 mm? 64.76 -175.27 0.17 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.786 1.234 . . . . 74.01 111.535 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 9' ' ' ALA . . . . . 0.412 ' HB3' HD13 ' D' ' 44' ' ' LEU . . . -165.68 -178.73 4.99 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.156 0.982 . . . . 52.44 109.299 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 87.3 mt -88.79 148.96 23.65 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.825 -0.435 . . . . 71.24 109.825 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 96.7 mt -70.87 130.26 88.69 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-N 115.59 -0.732 . . . . 65.34 110.712 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.98 -28.85 28.55 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.903 2.402 . . . . 75.35 112.323 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 98.4 mt -121.0 160.12 24.2 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.045 0.938 . . . . 74.23 110.149 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 7.3 mp -101.07 -171.2 1.96 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.938 0.895 . . . . 74.05 109.419 174.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -140.98 -158.29 0.85 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.734 1.213 . . . . 72.42 108.983 -176.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 16' ' ' THR . . . . . 0.536 ' HB ' ' HB1' ' H' ' 21' ' ' ALA . 63.3 p -109.06 147.3 35.65 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 123.638 0.775 . . . . 61.25 110.232 174.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -68.26 -159.01 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.737 2.958 . . . . 62.23 114.0 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 37.7 t -99.29 113.19 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.565 0.746 . . . . 75.12 110.83 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 62.2 m 73.54 137.13 0.05 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.004 1.322 . . . . 72.13 111.169 172.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt 65.21 21.54 12.1 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 122.258 1.028 . . . . 70.02 109.421 -174.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . 0.536 ' HB1' ' HB ' ' H' ' 16' ' ' THR . . . -114.85 -26.25 7.87 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.817 0.847 . . . . 73.32 112.045 -169.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . 0.418 ' NE ' ' HA ' ' H' ' 22' ' ' ARG . 2.6 mmp_? -121.25 115.27 22.68 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.226 0.61 . . . . 71.2 110.95 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 77.5 p -82.42 138.71 44.69 Favored Pre-proline 0 CA--C 1.554 1.099 0 CA-C-N 115.29 -0.868 . . . . 44.11 109.183 172.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.53 152.26 48.41 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.334 2.023 . . . . 63.11 112.411 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--O 1.248 0.99 0 N-CA-C 108.04 -1.096 . . . . 64.21 108.04 177.39 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 109.811 -0.44 . . . . 71.33 109.811 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.8 p -106.08 128.31 53.78 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.274 0.63 . . . . 71.33 109.894 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.511 ' HG3' ' HA ' ' C' ' 140' ' ' TYR . 33.3 tt0 -66.06 122.12 16.67 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.961 0.904 . . . . 65.14 108.988 176.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.423 HE22 ' ND2' ' A' ' 6' ' ' ASN . 20.8 tm0? -66.55 143.22 57.18 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.399 0.68 . . . . 64.25 110.181 -172.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -151.15 129.35 11.92 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.891 -0.781 . . . . 75.33 108.891 176.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.423 ' ND2' HE22 ' A' ' 4' ' ' GLN . 0.9 OUTLIER -79.13 103.54 9.14 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.464 -0.569 . . . . 71.01 109.464 179.208 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.5 p -87.78 -8.0 56.56 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.471 0.708 . . . . 64.35 110.583 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -73.64 -47.77 37.53 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.522 1.129 . . . . 64.44 109.941 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.65 ' HB2' HG22 ' A' ' 89' ' ' ILE . 23.3 ttt -145.23 161.68 38.96 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.911 -1.04 . . . . 65.41 108.194 -174.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.4 t -138.98 144.32 38.9 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.854 -0.425 . . . . 73.4 109.854 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.685 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 4.3 t80 -116.61 133.63 55.78 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.547 0.739 . . . . 72.14 109.841 -177.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.5 tp60 -150.16 127.33 11.29 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.812 -1.181 . . . . 71.32 107.812 172.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.577 HG12 ' HD2' ' A' ' 84' ' ' PHE . 48.6 mt -94.32 126.37 46.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.827 -0.805 . . . . 73.52 108.827 176.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -77.38 -39.75 46.15 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.675 -0.491 . . . . 73.0 109.675 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -169.16 145.55 3.42 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 116.365 -0.38 . . . . 73.4 110.332 -168.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 78.1 mt -137.46 136.91 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.021 -1.103 . . . . 60.34 108.021 170.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.467 ' HB3' HG23 ' B' ' 122' ' ' THR . 39.7 p90 -167.84 176.49 6.24 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.808 0.843 . . . . 72.31 110.973 -172.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.9 p -102.74 126.78 49.98 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.307 -0.86 . . . . 54.41 108.984 177.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -90.71 -40.37 11.89 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.885 0.474 . . . . 65.1 110.122 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -141.2 139.2 33.79 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.224 -1.028 . . . . 61.43 108.224 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.432 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 63.8 mt -134.52 140.32 46.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.786 -1.19 . . . . 72.24 107.786 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.531 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 42.7 t -144.43 125.83 14.85 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.363 1.065 . . . . 72.31 108.134 177.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.497 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 85.7 t80 -135.99 115.04 12.3 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 106.667 -1.605 . . . . 65.54 106.667 170.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -120.09 126.05 49.8 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.777 -0.823 . . . . 74.52 108.777 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.47 81.61 4.21 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 107.162 -1.421 . . . . 64.1 107.162 172.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.15 -41.02 46.16 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.988 2.458 . . . . 74.42 113.415 -164.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -114.87 33.07 5.6 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 109.243 -0.651 . . . . 74.21 109.243 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.5 -49.33 34.78 Favored Pre-proline 0 N--CA 1.5 2.059 0 N-CA-C 114.464 1.283 . . . . 51.14 114.464 -177.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -64.12 -20.89 67.86 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.197 1.931 . . . . 55.53 114.088 177.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -101.37 -23.46 14.36 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.728 1.211 . . . . 65.33 111.634 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.573 HG21 ' HA ' ' A' ' 73' ' ' ALA . 2.4 p -78.74 -24.27 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.342 0.657 . . . . 73.14 112.363 -165.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -79.69 -18.63 50.86 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.549 0.74 . . . . 53.22 112.474 -172.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -88.24 -11.63 46.04 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.473 0.709 . . . . 72.42 111.0 173.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -82.21 161.85 22.59 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.644 0.778 . . . . 64.45 111.823 -174.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -72.75 120.49 18.45 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.221 -0.9 . . . . 73.44 109.755 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -76.34 86.03 3.12 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.378 0.608 . . . . 72.13 109.925 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -128.66 73.35 80.94 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 124.559 1.144 . . . . 52.54 107.996 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -86.84 138.44 5.1 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.849 2.366 . . . . 64.04 113.628 -170.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -102.03 86.2 2.83 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 106.988 -1.486 . . . . 75.52 106.988 169.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.1 m -72.8 90.73 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 123.062 1.41 . . . . 75.02 109.611 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -91.97 116.3 28.81 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 112.87 -1.968 . . . . 74.52 108.206 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.525 HD11 HG13 ' A' ' 62' ' ' VAL . 52.2 tp -104.87 129.52 53.2 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.475 0.71 . . . . 75.21 111.444 -170.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -120.73 126.33 49.9 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.348 1.059 . . . . 73.41 108.925 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.1 mt -114.67 133.87 55.52 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.739 0.816 . . . . 71.24 110.306 -173.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.604 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 18.5 t70 -127.05 138.97 53.31 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.819 0.848 . . . . 75.24 110.338 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.3 p -107.78 121.57 44.99 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.752 0.821 . . . . 63.24 110.222 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.97 128.91 25.05 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.696 0.798 . . . . 73.42 109.466 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.459 ' HB3' ' HE1' ' E' ' 15' ' ' PHE . 80.3 p -131.94 164.82 25.3 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.56 0.618 . . . . 60.23 110.432 175.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -156.96 138.96 14.44 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.616 0.766 . . . . 71.1 109.754 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -93.41 118.76 31.71 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.045 -1.094 . . . . 74.24 108.045 169.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' A' ' 57' ' ' GLU . 43.7 mt -90.95 -38.88 12.58 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.945 0.498 . . . . 63.13 110.528 -176.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.16 -176.77 6.1 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.88 0.872 . . . . 62.11 109.951 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -69.2 115.39 8.43 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.166 0.586 . . . . 52.05 109.669 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 75.94 -6.05 2.06 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 125.734 1.613 . . . . 73.15 112.469 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.9 t -100.51 112.96 34.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 108.127 -1.064 . . . . 62.23 108.127 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.44 ' CZ ' ' HA ' ' E' ' 18' ' ' VAL . 31.2 t80 -136.17 127.52 28.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.367 -0.605 . . . . 73.01 109.367 -174.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.449 ' HB2' HD11 ' A' ' 51' ' ' LEU . 36.3 tt0 -97.76 142.42 29.57 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.242 1.017 . . . . 74.51 111.159 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.43 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 56.0 t -125.59 132.47 70.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 106.767 -1.568 . . . . 60.44 106.767 173.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 62.0 t -128.11 129.48 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.32 1.048 . . . . 74.12 108.936 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -119.66 110.48 16.88 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.924 -1.139 . . . . 72.31 107.924 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.604 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 8.4 tmm_? -87.56 104.43 16.49 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.638 -0.875 . . . . 54.15 108.638 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.525 HG13 HD11 ' A' ' 42' ' ' LEU . 59.2 t -100.04 108.54 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.753 1.221 . . . . 74.43 109.195 -177.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.3 m -104.04 110.78 23.07 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.611 0.764 . . . . 63.51 110.539 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.3 t -105.08 108.89 26.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 124.157 0.983 . . . . 73.52 109.659 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.3 m -103.83 127.63 51.32 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.909 -0.774 . . . . 55.21 108.909 171.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.53 115.33 29.96 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.04 -1.096 . . . . 64.35 108.04 175.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.6 m -118.44 126.35 51.88 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.084 0.469 . . . . 72.53 110.811 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.7 mt -89.51 76.64 7.39 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 107.832 -1.173 . . . . 53.41 107.832 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.34 -83.65 0.98 Allowed Glycine 0 C--N 1.351 1.368 0 N-CA-C 111.145 -0.782 . . . . 60.33 111.145 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -119.53 -26.58 5.73 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.695 0.798 . . . . 74.15 111.161 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -88.96 110.76 21.39 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.963 0.505 . . . . 74.03 110.277 -174.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.9 m -64.23 122.59 17.0 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.917 0.389 . . . . 72.53 110.667 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.573 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -70.89 -59.86 2.56 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.028 -0.987 . . . . 65.44 110.157 175.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -153.17 174.03 14.76 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.185 -0.916 . . . . 72.13 111.658 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 64.2 tp -133.69 141.13 47.44 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.134 -1.432 . . . . 73.03 107.134 173.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 73.9 m -137.86 93.89 2.83 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.542 -0.91 . . . . 43.12 108.542 172.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 45.3 tt0 -113.1 116.26 29.59 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.696 -0.853 . . . . 73.12 108.696 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 t -135.39 115.92 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.459 0.703 . . . . 74.32 110.205 -170.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -81.98 94.2 7.1 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.071 -1.085 . . . . 70.12 108.071 169.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -82.17 99.45 9.26 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.69 -0.856 . . . . 74.04 108.69 176.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.19 146.26 20.21 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 111.192 -0.763 . . . . 53.43 111.192 176.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.22 120.81 1.14 Allowed Glycine 0 CA--C 1.5 -0.845 0 N-CA-C 110.247 -1.141 . . . . 74.24 110.247 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 21.7 mt -85.36 114.47 25.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.03 -0.73 . . . . 73.21 109.03 177.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.685 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 23.3 m-85 -119.37 119.57 34.35 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.401 -0.963 . . . . 63.33 108.401 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.4 p -86.03 101.45 12.94 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.775 -0.824 . . . . 64.11 108.775 174.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.423 ' H ' HD13 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -127.74 134.54 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.392 0.677 . . . . 73.51 110.627 -174.182 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 178.65 166.5 0.86 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.125 1.37 . . . . 72.02 110.042 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 153.82 -82.75 0.16 Allowed Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.838 -0.619 . . . . 71.32 111.853 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.65 HG22 ' HB2' ' A' ' 9' ' ' MET . 11.7 tt -97.09 -29.36 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.756 0.822 . . . . 60.15 111.358 -174.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.41 ' HA ' ' HB3' ' A' ' 94' ' ' MET . 3.7 mm-40 62.34 -156.8 0.34 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.92 1.288 . . . . 73.31 110.814 -175.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.91 -128.23 14.22 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 114.245 0.458 . . . . 72.23 114.245 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.2 p -78.34 -28.86 47.34 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.606 0.762 . . . . 64.14 112.222 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -70.54 -40.37 73.46 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.328 0.651 . . . . 64.24 109.995 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.41 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 19.1 ptt? -72.52 -31.28 65.2 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.873 -0.417 . . . . 51.21 109.873 173.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.79 -35.52 80.86 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.438 0.695 . . . . 64.05 111.106 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -67.39 -42.37 83.47 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.693 -0.685 . . . . 75.34 110.091 172.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.648 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 81.6 m -62.71 -55.71 24.24 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 123.918 0.761 . . . . 64.14 111.379 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.671 HD22 ' H ' ' E' ' 18' ' ' VAL . 4.5 pp -73.09 -36.36 66.78 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.338 0.655 . . . . 73.11 111.316 -174.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.69 -16.62 58.1 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 114.764 0.665 . . . . 61.44 114.764 -168.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.41 ' HB1' ' HB3' ' A' ' 134' ' ' ASP . . . -148.74 -54.83 0.19 Allowed 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 117.655 0.728 . . . . 74.02 112.834 -171.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.648 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 79.3 t80 -63.64 -53.19 55.26 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.319 1.047 . . . . 65.04 112.896 -169.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.5 m -72.1 -37.41 4.85 Favored Pre-proline 0 CA--C 1.563 1.453 0 C-N-CA 123.591 0.757 . . . . 74.33 112.678 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.79 -40.48 47.88 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 122.441 2.094 . . . . 70.41 113.588 160.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -70.81 -24.1 62.49 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.87 0.868 . . . . 74.11 111.527 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 51.0 mm -69.6 -36.94 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 109.387 -0.598 . . . . 72.34 109.387 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 83.3 mt -79.58 -23.68 42.57 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.752 0.821 . . . . 75.53 112.445 -177.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -58.72 -49.23 94.54 Favored Pre-proline 0 CA--C 1.571 1.764 0 N-CA-C 113.651 0.982 . . . . 72.45 113.651 -176.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -63.68 -35.74 56.37 Favored 'Trans proline' 0 C--N 1.389 2.672 0 C-N-CA 122.159 1.906 . . . . 73.51 113.484 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -75.56 -35.67 60.6 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.579 0.752 . . . . 73.14 111.937 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.8 -44.83 65.79 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.376 -0.602 . . . . 70.44 109.376 175.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.583 HH12 HD12 ' C' ' 105' ' ' ILE . 17.9 ttm180 -59.5 -33.97 72.02 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.146 0.904 . . . . 75.4 110.165 173.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -66.3 -50.53 63.34 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.864 0.866 . . . . 50.24 110.836 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 36.8 t -61.45 -37.02 82.04 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.744 0.653 . . . . 71.32 110.552 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 118' ' ' VAL . 93.5 mt -62.22 -57.28 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.774 0.83 . . . . 63.54 110.021 172.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.8 m -52.28 -39.66 60.74 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.253 1.421 . . . . 63.54 111.908 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -69.98 -51.42 32.66 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.884 -1.053 . . . . 74.21 110.392 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.435 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 36.7 mtm -64.64 -36.69 85.06 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.93 0.492 . . . . 72.22 111.918 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 114' ' ' ILE . 79.2 t -61.1 -44.94 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.506 0.722 . . . . 71.44 110.227 176.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.9 t -70.47 -34.67 72.66 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.477 -0.783 . . . . 61.42 111.454 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.535 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 93.7 mtt-85 -70.58 -32.56 69.99 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.889 0.876 . . . . 54.34 109.695 176.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.95 1.64 83.66 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-O 119.065 -0.853 . . . . 63.53 112.992 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.493 HG22 HH21 ' B' ' 15' ' ' ARG . 22.5 m 73.71 12.53 4.48 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 122.446 1.117 . . . . 71.13 111.866 173.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -84.13 148.2 52.73 Favored Pre-proline 0 CA--C 1.544 0.736 0 O-C-N 121.369 -0.832 . . . . 71.24 109.591 172.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.1 142.21 96.85 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.533 2.155 . . . . 64.15 110.91 172.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -57.27 145.2 32.74 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 124.281 0.988 . . . . 71.11 113.016 -168.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.5 tp -127.99 114.91 17.73 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.871 0.868 . . . . 60.24 109.41 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -119.69 117.65 28.83 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.534 -0.913 . . . . 74.12 108.534 175.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.9 mp -72.49 146.07 47.11 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.147 0.579 . . . . 71.22 110.232 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -62.34 136.37 95.65 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.874 0.87 . . . . 72.22 112.15 -174.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 22.5 Cg_exo -67.83 89.45 0.36 Allowed 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.941 2.427 . . . . 70.04 112.265 175.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.404 HG21 ' HB3' ' E' ' 8' ' ' LEU . 87.1 t -107.31 112.03 38.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.595 -0.891 . . . . 73.41 108.595 176.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -85.32 96.75 9.63 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 107.688 -1.227 . . . . 72.42 107.688 170.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -55.3 -37.61 67.56 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.059 0.85 . . . . 74.34 111.002 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.41 ' HB3' ' HB1' ' A' ' 100' ' ' ALA . 6.4 p-10 -67.84 -36.65 80.71 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.097 -0.956 . . . . 75.32 111.326 -177.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.41 -32.65 72.85 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.751 0.82 . . . . 63.24 111.718 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.614 ' HB2' HD21 ' E' ' 10' ' ' LEU . 91.0 mt -73.2 -41.91 63.26 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.805 -0.634 . . . . 62.14 109.527 174.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -63.53 -25.75 68.39 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.537 0.735 . . . . 74.53 111.316 172.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 13.7 mmt -69.56 -34.28 73.95 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.906 0.882 . . . . 73.44 111.324 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 88.0 m-20 -61.74 -35.44 78.1 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.503 0.721 . . . . 71.41 110.23 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -84.96 -27.84 26.24 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.096 0.958 . . . . 71.44 111.728 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 46.9 tp -62.92 -50.48 70.68 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.415 0.686 . . . . 74.24 110.267 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -174.13 5.86 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.094 -0.957 . . . . 74.33 111.253 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 28.5 tt0 63.57 90.37 0.08 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.911 1.285 . . . . 74.31 110.192 -170.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.494 ' NE2' ' HA ' ' C' ' 144' ' ' GLN . 24.7 tt0 -80.14 165.98 21.92 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.153 -0.931 . . . . 75.15 110.644 -176.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.472 ' N ' ' HG2' ' A' ' 144' ' ' GLN . . . 70.91 -154.82 0.11 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.546 1.138 . . . . 61.14 111.354 168.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.39 13.89 67.2 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 111.603 -0.599 . . . . 42.12 111.603 -169.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -133.59 164.63 26.74 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 124.306 1.042 . . . . 75.21 110.044 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.519 ' HA2' HD11 ' C' ' 141' ' ' LEU . . . 159.29 81.53 0.04 OUTLIER Glycine 0 C--N 1.343 0.917 0 N-CA-C 110.781 -0.927 . . . . 64.21 110.781 178.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.7 p -121.95 134.25 54.84 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.675 0.79 . . . . 53.12 110.589 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -73.61 146.37 44.7 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.854 0.862 . . . . 64.32 110.578 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -134.47 74.37 1.53 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.277 1.031 . . . . 72.2 110.036 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 52.9 m170 -125.21 114.3 18.79 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.886 0.874 . . . . 75.52 109.912 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -161.17 138.61 9.08 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.485 0.714 . . . . 65.31 109.572 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -145.35 -53.7 0.29 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.803 0.841 . . . . 73.42 109.627 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 C-N-CA 123.592 0.757 . . . . 45.33 109.432 -177.673 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 109.941 -0.392 . . . . 74.22 109.941 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 9.1 m -65.24 -90.11 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.857 0.863 . . . . 64.31 109.39 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 48.88 41.51 18.67 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 114.65 1.352 . . . . 73.21 114.65 153.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.4 ' HG2' ' HA2' ' B' ' 88' ' ' GLY . 12.0 pt20 -139.98 111.94 7.51 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 108.713 -0.847 . . . . 74.54 108.713 173.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -76.98 142.85 39.79 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.389 0.676 . . . . 62.54 110.157 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 60.54 82.98 0.15 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.118 1.367 . . . . 73.31 110.499 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 15.1 t -147.85 172.55 13.98 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.712 -0.676 . . . . 73.44 110.545 -171.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -78.72 -18.41 54.34 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.781 0.832 . . . . 74.44 111.416 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 19.6 ptm 62.42 177.26 0.14 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 126.767 2.027 . . . . 70.03 113.63 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 99.9 m -134.79 140.05 45.59 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.831 1.252 . . . . 63.21 107.84 174.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.451 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 46.0 t80 -142.22 132.89 25.44 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.053 -0.721 . . . . 71.43 109.053 172.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.535 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -153.44 121.11 5.96 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.45 -0.945 . . . . 72.44 108.45 174.086 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 54.7 mt -68.75 120.07 15.62 Favored 'Isoleucine or valine' 0 C--N 1.348 0.528 0 N-CA-C 108.186 -1.042 . . . . 72.31 108.186 170.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -89.07 -49.84 6.52 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.711 -0.848 . . . . 72.22 108.711 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.493 HH21 HG22 ' A' ' 122' ' ' THR . 34.2 ttt85 -168.74 137.03 2.1 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.55 -0.75 . . . . 71.05 109.636 -175.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 87.1 mt -115.36 142.19 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 108.341 -0.985 . . . . 61.32 108.341 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -168.13 148.98 5.01 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 112.622 0.601 . . . . 75.11 112.622 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.579 HG21 HD11 ' B' ' 21' ' ' ILE . 39.5 m -79.69 114.14 18.39 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.268 -0.878 . . . . 63.04 108.912 172.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -84.09 -25.89 29.41 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.099 0.56 . . . . 72.35 111.375 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 16.2 t70 -163.43 149.06 11.41 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.367 0.603 . . . . 65.12 112.052 -175.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.579 HD11 HG21 ' B' ' 18' ' ' THR . 46.4 mm -137.15 142.85 36.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 126.018 1.727 . . . . 70.4 107.742 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 42.5 t -146.17 137.15 24.43 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.249 -1.019 . . . . 72.41 108.249 168.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.432 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 91.2 t80 -141.15 131.86 25.69 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.301 -1.37 . . . . 62.4 107.301 172.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 34.4 mt-10 -131.66 126.84 35.65 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.798 -1.186 . . . . 73.11 107.798 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.696 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -127.98 81.19 70.84 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 107.146 -1.428 . . . . 53.12 107.146 170.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.46 -30.53 35.94 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.884 2.389 . . . . 33.32 111.33 -177.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -103.96 2.58 32.55 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.281 -1.327 . . . . 74.45 110.86 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.696 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -32.05 -66.76 0.19 Allowed Pre-proline 0 N--CA 1.499 1.997 0 C-N-CA 126.032 1.733 . . . . 72.32 115.096 -172.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 21.7 Cg_exo -62.55 -31.05 80.12 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.899 2.399 . . . . 61.33 113.669 -164.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -96.22 -41.51 8.65 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.426 -0.807 . . . . 72.32 111.158 -174.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.17 -12.71 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 113.074 0.768 . . . . 53.14 113.074 -170.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -62.89 -18.24 62.73 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.485 0.714 . . . . 73.31 112.641 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.502 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 10.6 pt20 -55.15 -29.92 58.76 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.453 1.101 . . . . 55.44 111.499 173.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.502 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 96.5 mttt -92.38 95.31 9.59 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.7 1.2 . . . . 75.51 109.202 177.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -97.95 76.65 2.43 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 122.009 0.909 . . . . 71.22 111.494 -172.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 43.0 p90 -157.51 161.13 38.82 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.61 -0.885 . . . . 70.33 108.61 171.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -68.16 116.42 38.98 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 109.062 -0.718 . . . . 74.45 109.062 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.97 159.33 54.37 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.162 1.908 . . . . 64.43 112.656 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -64.63 113.13 3.53 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 109.195 -0.669 . . . . 72.5 109.195 174.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.23 121.64 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 121.881 0.848 . . . . 74.54 109.79 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.538 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 37.6 ttpt -107.04 100.55 10.03 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.578 -1.638 . . . . 63.21 106.578 175.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 pp -110.24 140.58 44.24 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.735 0.814 . . . . 61.45 110.174 -169.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -136.06 129.93 32.68 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.173 0.989 . . . . 63.32 108.915 -174.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -100.78 127.39 47.23 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.802 -1.184 . . . . 62.45 107.802 170.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.477 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 24.1 t70 -126.92 155.11 43.58 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.197 0.999 . . . . 72.22 108.731 -175.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 79.2 p -107.63 120.11 41.29 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.706 -0.679 . . . . 61.34 110.685 -172.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.79 131.18 44.52 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 107.174 -1.417 . . . . 45.34 107.174 172.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 10.7 p -145.91 168.29 21.19 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.699 0.681 . . . . 64.12 111.457 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p -152.19 138.33 18.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.115 0.966 . . . . 75.4 108.521 171.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -93.82 114.0 26.16 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.133 -0.691 . . . . 61.22 109.133 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 51.6 mt -77.58 -43.2 32.51 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.867 0.467 . . . . 63.24 110.157 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.7 -179.24 7.69 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.579 0.752 . . . . 60.35 110.501 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.11 124.38 21.97 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.301 -1.318 . . . . 70.02 109.02 172.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 70.85 6.77 5.98 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.889 1.276 . . . . 74.22 112.282 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 78.0 t -119.85 111.54 33.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.7 0 N-CA-C 107.698 -1.223 . . . . 65.31 107.698 170.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -122.13 139.84 53.26 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.54 -0.541 . . . . 70.21 109.54 -177.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.444 ' HG2' HG12 ' B' ' 83' ' ' ILE . 6.6 tm-20 -111.35 101.13 9.61 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 107.489 -1.3 . . . . 71.24 107.489 -176.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 63.4 t -96.5 119.6 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.491 1.117 . . . . 62.11 109.601 -173.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.493 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 10.6 t -114.05 123.93 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.826 0.85 . . . . 75.42 108.711 178.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.488 HD22 ' HB3' ' B' ' 103' ' ' PRO . 15.6 tp -103.93 116.26 31.94 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.094 -0.706 . . . . 65.22 109.094 171.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.477 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 41.2 ttm180 -86.04 109.73 19.01 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.438 -0.949 . . . . 73.24 108.438 174.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 46.9 t -101.6 101.26 11.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.34 -1.355 . . . . 64.14 107.34 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.6 m -97.99 128.55 44.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.505 -0.77 . . . . 70.43 109.094 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.653 HG21 HG21 ' B' ' 114' ' ' ILE . 67.5 t -121.57 131.68 72.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 124.578 1.151 . . . . 73.52 108.184 -174.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 60.3 m -120.88 145.46 47.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.873 -1.158 . . . . 74.25 107.873 171.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.52 126.34 12.68 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.643 -0.873 . . . . 74.23 108.643 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 30.8 p -133.63 128.39 35.02 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.966 0.506 . . . . 65.54 110.114 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 70.4 mt -100.79 107.06 18.52 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.014 0.926 . . . . 63.33 108.804 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.16 -129.9 10.0 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 115.877 -0.601 . . . . 70.33 112.497 -176.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -92.4 1.21 57.37 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.647 0.779 . . . . 60.35 110.766 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -121.63 162.25 21.02 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.298 0.639 . . . . 75.02 110.444 -175.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 25.9 m -71.2 145.46 49.65 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.654 0.596 . . . . 73.01 109.787 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.8 -60.2 1.57 Allowed 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.296 -1.002 . . . . 71.34 108.296 168.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -153.04 164.52 37.85 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.001 0.905 . . . . 74.3 111.255 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.529 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 31.3 mt -134.48 142.8 47.18 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 105.427 -2.064 . . . . 70.04 105.427 178.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.3 t -154.8 116.42 4.11 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.601 0.637 . . . . 71.55 109.888 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -121.33 122.86 40.79 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 107.883 -1.155 . . . . 62.24 107.883 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.2 141.76 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.73 0.812 . . . . 74.3 108.959 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.5 mt-30 -118.63 94.54 4.5 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.697 -1.223 . . . . 73.51 107.697 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -90.31 103.93 16.56 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.988 -0.745 . . . . 75.32 108.988 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.46 161.98 29.04 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 123.798 0.686 . . . . 72.1 112.101 177.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.05 125.03 1.34 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.835 -1.306 . . . . 70.24 109.835 177.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.444 HG12 ' HG2' ' B' ' 57' ' ' GLU . 28.3 mt -85.05 130.22 36.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 107.854 -1.165 . . . . 74.04 107.854 175.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -136.6 133.6 36.49 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.037 -1.098 . . . . 74.41 108.037 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 40.3 m -87.25 92.36 9.04 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.452 -0.944 . . . . 71.14 108.452 170.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -107.43 130.3 59.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-N 114.907 -1.042 . . . . 71.55 108.492 176.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.66 168.73 18.16 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.622 0.769 . . . . 74.52 109.997 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.4 ' HA2' ' HG2' ' B' ' 4' ' ' GLN . . . 85.66 -63.44 4.28 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.079 -0.964 . . . . 73.54 112.903 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.56 HG23 ' HB2' ' B' ' 93' ' ' GLN . 43.4 mm -58.83 149.1 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 N-CA-C 114.757 1.392 . . . . 65.12 114.757 -165.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -159.99 -175.76 5.29 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 125.348 1.459 . . . . 61.12 109.548 171.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.01 -111.59 3.93 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 115.423 0.929 . . . . 35.25 115.423 166.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 51.2 m -81.54 -39.03 25.27 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.706 0.802 . . . . 74.44 111.125 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.56 ' HB2' HG23 ' B' ' 89' ' ' ILE . 51.0 mt-30 -66.4 -25.19 66.66 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.306 0.642 . . . . 71.3 112.219 -169.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.456 ' SD ' ' HA ' ' F' ' 17' ' ' PRO . 22.3 ptm -67.61 -27.54 66.99 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.223 0.609 . . . . 63.31 112.107 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.64 -33.18 69.78 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.796 0.838 . . . . 64.25 110.73 175.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -84.33 -49.24 8.91 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.295 -0.866 . . . . 72.24 109.811 171.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.8 t -58.51 -65.91 0.58 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.974 0.731 . . . . 70.24 112.974 -167.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.667 HD13 ' HB2' ' F' ' 15' ' ' PHE . 0.6 OUTLIER -103.8 -2.32 26.53 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 111.727 0.269 . . . . 53.45 111.727 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.04 -17.39 37.74 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 123.197 0.311 . . . . 42.22 113.527 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.59 -55.07 0.89 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.579 0.752 . . . . 74.3 110.574 -176.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -73.51 -53.07 11.48 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.359 1.064 . . . . 71.21 112.244 -166.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.452 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 64.3 m -63.77 -46.72 82.32 Favored Pre-proline 0 CA--C 1.56 1.35 0 CA-C-O 118.864 -0.589 . . . . 55.2 111.626 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.488 ' HB3' HD22 ' B' ' 60' ' ' LEU . 31.2 Cg_exo -64.23 -28.33 64.23 Favored 'Trans proline' 0 C--N 1.39 2.762 0 C-N-CA 122.003 1.802 . . . . 51.14 114.124 173.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.611 ' HA ' ' HD2' ' B' ' 107' ' ' PHE . 47.3 t-20 -57.94 -41.23 82.34 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 123.606 0.762 . . . . 71.13 110.412 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.448 HG23 ' NH2' ' D' ' 111' ' ' ARG . 96.8 mt -60.17 -42.49 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 114.415 -1.266 . . . . 71.32 110.888 175.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 56.7 mt -85.05 -15.43 44.08 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 115.21 -0.905 . . . . 62.32 112.277 -170.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.611 ' HD2' ' HA ' ' B' ' 104' ' ' ASN . 5.1 m-85 -54.46 -53.02 64.44 Favored Pre-proline 0 N--CA 1.495 1.776 0 C-N-CA 124.139 0.976 . . . . 71.04 113.592 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.16 -30.26 46.71 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 122.292 1.995 . . . . 74.41 113.849 -177.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -70.96 -44.45 66.02 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.832 0.453 . . . . 75.4 110.243 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.22 -41.24 98.21 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.963 -0.562 . . . . 62.51 110.248 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -59.59 -54.25 48.69 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.792 0.837 . . . . 74.22 110.164 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -61.73 -33.63 74.38 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 123.714 0.634 . . . . 72.13 110.289 -174.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.535 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 4.0 t -74.55 -48.23 28.07 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 116.062 -0.517 . . . . 71.32 111.452 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.653 HG21 HG21 ' B' ' 64' ' ' VAL . 98.6 mt -57.39 -56.07 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 C-N-CA 123.39 0.676 . . . . 54.34 109.867 174.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 33.0 m -59.25 -30.96 68.66 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 124.417 1.073 . . . . 75.23 111.06 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.4 t -63.64 -47.37 81.61 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 109.288 -0.634 . . . . 71.14 109.288 171.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.0 mmt -67.05 -30.79 70.96 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.089 0.556 . . . . 72.04 111.13 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.506 HG23 ' O ' ' B' ' 114' ' ' ILE . 84.8 t -65.97 -47.31 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.152 0.981 . . . . 74.32 109.171 173.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 71.2 m -66.31 -31.33 72.06 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 114.429 -1.26 . . . . 73.13 111.517 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.519 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 90.5 mtt-85 -73.95 -32.61 63.56 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 124.014 0.926 . . . . 74.41 109.655 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.47 6.33 69.31 Favored Glycine 0 C--N 1.353 1.491 0 O-C-N 124.196 0.935 . . . . 63.44 112.506 174.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.467 HG23 ' HB3' ' A' ' 17' ' ' TYR . 80.5 p 54.92 36.09 25.94 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 125.898 1.679 . . . . 73.13 112.653 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -95.6 157.78 35.54 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.138 0.975 . . . . 73.01 110.544 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -52.99 158.9 5.89 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.607 2.871 . . . . 63.34 115.036 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -64.03 115.07 4.57 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.705 -1.134 . . . . 73.15 111.77 -172.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 55.5 tp -125.35 112.14 15.98 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.366 0.666 . . . . 64.44 109.778 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -132.55 135.54 46.01 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.914 0.886 . . . . 73.44 108.89 176.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.434 ' HA ' ' CG2' ' F' ' 6' ' ' ILE . 8.0 mp -85.71 142.82 28.73 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.112 0.565 . . . . 73.54 111.622 -174.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.99 132.91 49.43 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.064 0.946 . . . . 73.32 110.646 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.37 108.86 2.78 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 123.02 2.48 . . . . 74.52 112.754 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.423 ' H ' HD12 ' F' ' 8' ' ' LEU . 98.3 t -93.62 111.6 25.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.639 -1.245 . . . . 74.5 107.639 167.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -74.36 91.33 2.2 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.458 0.703 . . . . 72.43 109.214 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -64.21 -41.12 97.19 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.417 -0.81 . . . . 74.34 110.726 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' B' ' 138' ' ' MET . 2.9 m-20 -50.27 -52.97 31.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.205 1.002 . . . . 72.2 111.526 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.28 -40.99 98.94 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.104 0.877 . . . . 73.34 111.176 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 8.5 tt -59.83 -46.46 89.17 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.847 0.859 . . . . 74.21 110.458 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -65.38 -30.21 71.01 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.033 0.933 . . . . 75.21 111.32 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' B' ' 134' ' ' ASP . 94.5 mmm -69.86 -33.76 72.7 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.061 0.544 . . . . 73.54 111.301 177.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -74.05 -19.82 60.5 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.964 0.505 . . . . 64.41 111.186 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -76.97 -48.35 18.29 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.891 -0.781 . . . . 75.11 108.891 170.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 75.8 mt -91.66 37.07 0.95 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.52 1.128 . . . . 74.21 110.798 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.02 153.09 39.84 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.686 0.794 . . . . 73.54 112.306 -172.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -113.76 121.41 43.99 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.867 -0.79 . . . . 74.0 108.867 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -81.03 130.97 35.26 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.132 0.573 . . . . 63.53 110.146 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -99.75 164.83 11.87 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.913 0.885 . . . . 62.32 110.288 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.28 144.18 6.86 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 116.581 -0.281 . . . . 71.14 112.647 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -149.45 95.39 2.34 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.923 0.889 . . . . 64.14 109.148 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -102.92 111.51 4.0 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 115.657 -0.702 . . . . 43.22 111.538 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 42.3 p -85.77 168.37 14.38 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.311 0.645 . . . . 55.22 109.844 172.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -136.87 147.16 46.32 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.354 0.662 . . . . 72.33 109.868 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -141.42 164.04 31.3 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.74 0.816 . . . . 73.54 110.575 -176.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -170.87 163.21 7.66 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.977 1.311 . . . . 70.25 108.225 169.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -172.51 144.92 1.53 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.977 0.511 . . . . 74.14 109.797 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -62.02 149.86 39.72 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.524 0.729 . . . . 75.52 110.787 175.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.263 0 C-N-CA 123.975 0.91 . . . . 44.51 109.628 -176.224 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . 0.481 ' SD ' ' N ' ' C' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 108.84 -0.8 . . . . 64.52 108.84 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 27.3 m -63.85 -53.44 50.63 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.519 0.727 . . . . 61.4 110.255 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -124.66 -38.14 2.42 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.262 1.025 . . . . 73.53 108.416 170.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -162.38 -56.57 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.607 -0.886 . . . . 35.01 108.607 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 67.16 -79.72 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.273 1.429 . . . . 71.22 112.261 169.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -168.96 150.87 4.66 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.771 1.229 . . . . 72.51 108.157 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 27.5 m 70.44 126.96 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.904 1.282 . . . . 73.4 110.478 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -72.01 175.11 6.19 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.363 0.665 . . . . 73.32 110.32 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.482 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 12.5 tpt 66.25 113.83 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.633 1.173 . . . . 64.04 110.672 -166.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 90.4 m -108.63 109.29 20.46 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.938 -1.504 . . . . 72.2 106.938 171.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.405 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.0 OUTLIER -117.8 133.02 56.36 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.851 0.461 . . . . 64.22 110.332 -173.827 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -150.93 132.77 15.04 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.949 0.899 . . . . 74.14 108.912 168.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 90.4 mt -73.25 127.35 35.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.399 -0.963 . . . . 72.13 108.399 170.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -95.14 -44.08 7.81 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.626 0.77 . . . . 73.44 109.58 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -176.29 134.35 0.25 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.635 0.774 . . . . 73.1 109.464 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 59.4 mt -127.25 151.88 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 118.636 0.653 . . . . 62.25 109.335 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.465 ' HB3' HG23 ' D' ' 122' ' ' THR . 21.0 p90 -176.3 168.72 2.79 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.717 0.77 . . . . 72.3 110.978 -172.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 68.8 p -87.69 115.95 25.49 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.571 -1.195 . . . . 71.42 109.489 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.446 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 26.0 mmtp -65.54 -46.91 77.72 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.252 -1.018 . . . . 75.42 108.252 167.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 18.4 t70 -134.92 142.56 46.57 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 114.207 -1.36 . . . . 62.3 109.667 -174.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.524 HG12 ' SG ' ' C' ' 113' ' ' CYS . 89.0 mt -135.78 141.17 42.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 106.466 -1.679 . . . . 53.42 106.466 167.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.5 t -159.09 150.88 20.7 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.964 -0.384 . . . . 74.22 109.964 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -155.33 106.84 2.6 Favored 'General case' 0 C--O 1.226 -0.16 0 N-CA-C 107.913 -1.143 . . . . 74.33 107.913 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -117.93 111.4 18.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.524 0.73 . . . . 63.24 109.876 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.2 92.15 10.74 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 107.157 -1.423 . . . . 73.12 107.157 170.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.46 -35.58 38.49 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.657 2.238 . . . . 72.32 112.306 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -101.92 24.73 9.56 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.455 -0.793 . . . . 75.34 110.35 -175.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.96 -62.4 1.67 Allowed Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 114.714 1.376 . . . . 72.25 114.714 -167.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.53 -32.73 48.33 Favored 'Trans proline' 0 C--N 1.383 2.387 0 CA-C-N 121.834 1.691 . . . . 72.24 112.306 -174.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.583 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 72.7 t60 -70.84 -40.45 72.37 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.53 0.732 . . . . 74.41 112.012 177.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.773 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.2 p -77.8 -21.44 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 112.081 0.4 . . . . 64.31 112.081 -170.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -63.66 -29.7 70.9 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.44 0.904 . . . . 74.23 113.44 177.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 21.1 pt20 -84.78 5.76 27.21 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 122.727 0.411 . . . . 74.43 111.114 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.724 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -95.21 156.63 16.24 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.427 1.091 . . . . 74.21 110.408 -177.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -67.86 128.78 37.77 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.155 0.982 . . . . 71.13 110.061 169.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -86.07 100.62 12.3 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.331 0.652 . . . . 74.41 111.3 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -156.69 77.35 4.18 Favored Pre-proline 0 N--CA 1.474 0.773 0 N-CA-C 107.82 -1.178 . . . . 71.15 107.82 168.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -86.65 150.03 8.71 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.377 2.051 . . . . 75.42 113.294 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -82.83 81.49 8.53 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 105.953 -1.869 . . . . 72.43 105.953 168.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -69.33 99.51 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-N 114.367 -1.288 . . . . 71.15 109.444 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -96.14 112.14 23.96 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 113.787 -1.551 . . . . 73.21 109.026 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.59 141.99 28.6 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.604 -0.517 . . . . 71.44 109.604 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.454 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 24.1 t70 -135.66 147.09 48.44 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.575 1.15 . . . . 72.14 108.367 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.61 157.13 44.48 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.082 0.553 . . . . 65.11 111.145 -173.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.608 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 17.1 t70 -140.74 144.97 35.83 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.958 0.903 . . . . 72.33 109.029 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . 0.417 ' HB ' ' HD2' ' G' ' 15' ' ' PHE . 40.8 p -112.78 112.51 24.05 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.19 -0.67 . . . . 62.05 109.19 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.48 150.35 44.0 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.035 0.934 . . . . 75.43 108.787 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 37.7 p -165.99 157.63 13.94 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.363 0.265 . . . . 73.51 111.658 -174.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 23.4 p -166.1 127.73 1.86 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.82 0.848 . . . . 65.15 109.681 173.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -72.12 130.82 41.79 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 108.917 -0.771 . . . . 72.41 108.917 168.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.61 HD11 HD12 ' C' ' 83' ' ' ILE . 60.0 mt -97.64 -37.0 10.09 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.274 0.63 . . . . 64.31 111.264 -175.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.27 -171.39 2.38 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.003 0.521 . . . . 64.44 111.746 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -57.94 109.12 0.68 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.921 1.288 . . . . 74.12 110.081 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 69.67 -7.15 0.92 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 125.224 1.41 . . . . 74.53 112.668 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.7 t -94.0 112.32 26.65 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 N-CA-C 108.061 -1.089 . . . . 62.41 108.061 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -120.17 159.75 24.27 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.128 -0.942 . . . . 72.13 108.492 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -126.66 123.62 37.98 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.237 0.615 . . . . 54.23 110.244 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.476 HG11 ' HD3' ' C' ' 103' ' ' PRO . 89.6 t -104.66 128.19 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 107.974 -1.121 . . . . 62.05 107.974 171.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -121.23 130.98 74.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.071 -1.085 . . . . 71.13 108.071 170.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.401 HD22 ' HB2' ' C' ' 103' ' ' PRO . 29.4 tp -126.17 117.7 23.66 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.187 -1.412 . . . . 75.21 107.187 170.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.608 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 6.9 tmm_? -90.95 128.64 36.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.515 -0.766 . . . . 54.03 109.611 178.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.48 140.56 19.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.971 -1.122 . . . . 64.2 107.971 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 53.8 m -133.93 122.04 22.54 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.882 -0.785 . . . . 62.45 108.882 173.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.426 HG21 HG21 ' C' ' 114' ' ' ILE . 89.4 t -101.55 109.46 25.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 107.979 -1.119 . . . . 44.42 107.979 176.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.447 HG23 HD23 ' C' ' 75' ' ' LEU . 4.2 m -99.57 107.14 19.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.852 -1.166 . . . . 74.22 107.852 175.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.02 108.37 19.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.719 -1.586 . . . . 64.51 106.719 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.4 m -132.23 127.95 36.84 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.149 -0.686 . . . . 73.0 109.149 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.724 HD13 ' HG2' ' C' ' 34' ' ' LYS . 8.2 mt -85.13 48.99 1.65 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.907 1.283 . . . . 53.32 109.56 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.15 -113.63 4.49 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 109.747 -1.341 . . . . 35.3 109.747 -168.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.69 -19.96 17.91 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.411 0.684 . . . . 63.03 110.526 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -67.24 120.66 14.16 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.866 0.867 . . . . 72.32 108.756 169.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.7 m -84.29 125.61 32.41 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 118.764 0.711 . . . . 74.43 109.295 173.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.773 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.79 -63.54 1.28 Allowed 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.364 -0.976 . . . . 71.32 108.364 173.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -155.77 173.09 17.24 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.274 -0.875 . . . . 71.0 110.663 174.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.447 HD23 HG23 ' C' ' 65' ' ' THR . 2.3 tm? -131.03 141.17 50.19 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 105.089 -2.189 . . . . 61.31 105.089 169.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.532 ' SG ' HG23 ' C' ' 114' ' ' ILE . 47.2 t -142.99 136.94 28.96 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.559 -1.274 . . . . 52.41 107.559 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . 0.508 ' HG3' ' HD3' ' C' ' 61' ' ' ARG . 24.4 tt0 -146.4 120.38 9.38 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.658 0.383 . . . . 72.31 110.396 -173.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 54.6 t -129.72 115.9 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.135 0.974 . . . . 64.24 109.231 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.505 ' HG2' ' HB2' ' C' ' 61' ' ' ARG . 22.6 mt-30 -89.56 99.4 12.41 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.747 -1.205 . . . . 61.24 107.747 170.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.648 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.0 tp-100 -87.88 109.76 20.02 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.825 -0.806 . . . . 73.2 108.825 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.33 145.45 17.6 Favored Glycine 0 C--N 1.341 0.819 0 O-C-N 123.6 0.562 . . . . 74.01 111.88 176.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.82 126.14 2.67 Favored Glycine 0 CA--C 1.506 -0.487 0 N-CA-C 110.921 -0.872 . . . . 64.31 110.921 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.61 HD12 HD11 ' C' ' 51' ' ' LEU . 9.6 mm -87.27 117.83 32.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 108.383 -0.969 . . . . 64.35 108.383 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.405 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 41.7 m-85 -129.17 120.99 26.78 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.227 1.011 . . . . 71.13 109.256 -173.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 57.3 p -79.4 109.11 13.45 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.633 -0.877 . . . . 74.11 108.633 172.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 70.5 mt -119.86 130.43 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.283 1.033 . . . . 72.14 108.855 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -161.63 158.52 26.24 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.741 0.816 . . . . 74.42 110.189 -175.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.1 -57.87 1.05 Allowed Glycine 0 C--N 1.345 1.035 0 O-C-N 123.296 0.372 . . . . 61.24 113.217 174.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 37.9 pt -85.41 161.28 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 122.909 0.483 . . . . 65.33 111.398 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -152.73 -178.56 6.96 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.92 0.888 . . . . 74.14 110.465 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.85 -139.39 42.91 Favored Glycine 0 C--N 1.349 1.263 0 O-C-N 123.379 0.425 . . . . 45.24 112.845 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' C' ' 95' ' ' ALA . 40.9 p -64.34 -19.86 65.73 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.54 0.736 . . . . 73.21 111.753 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -64.76 -55.92 16.78 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.496 0.718 . . . . 41.43 110.243 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.419 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 10.6 ptp -71.97 -29.82 64.64 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 116.579 -0.282 . . . . 64.12 110.479 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' C' ' 92' ' ' THR . . . -66.47 -32.68 74.19 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.205 0.602 . . . . 72.14 111.51 178.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -77.43 -37.2 52.18 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.407 0.683 . . . . 72.32 110.069 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.568 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 28.8 t -59.61 -40.08 86.34 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.862 0.726 . . . . 72.33 110.613 175.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.435 HD11 HG23 ' G' ' 18' ' ' VAL . 67.7 mt -81.49 -40.22 23.56 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.025 0.93 . . . . 71.25 111.54 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.01 -13.68 82.94 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.414 -0.812 . . . . 41.54 114.843 -168.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.627 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -157.97 -54.71 0.07 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 117.237 0.519 . . . . 63.01 112.388 -173.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.568 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 82.4 t80 -57.5 -40.59 79.01 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.711 1.204 . . . . 64.24 113.736 -172.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 89.3 m -82.08 -44.87 1.02 Allowed Pre-proline 0 CA--C 1.561 1.388 0 CA-C-O 118.784 -0.627 . . . . 65.23 112.361 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.476 ' HD3' HG11 ' C' ' 58' ' ' VAL . 37.1 Cg_endo -68.3 -7.79 21.09 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 121.624 1.549 . . . . 74.14 114.287 170.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . 0.612 HD21 ' HB3' ' C' ' 133' ' ' PHE . 0.9 OUTLIER -68.13 -30.97 70.24 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 123.396 0.678 . . . . 40.02 110.741 168.023 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.583 HD12 HH12 ' A' ' 111' ' ' ARG . 41.8 mm -68.33 -40.46 82.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-N 115.416 -0.811 . . . . 65.15 109.519 173.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 61.2 mt -83.08 -26.76 30.78 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.323 -1.308 . . . . 74.12 112.166 -168.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.416 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 89.7 t80 -56.14 -53.93 58.13 Favored Pre-proline 0 CA--C 1.562 1.438 0 CA-C-O 118.07 -0.967 . . . . 70.44 112.754 -176.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 36.1 Cg_exo -59.42 -36.68 93.21 Favored 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 122.319 2.012 . . . . 72.54 113.221 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -63.73 -50.76 67.86 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.156 0.982 . . . . 72.42 111.059 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.648 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -71.21 -29.89 65.7 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.331 -0.849 . . . . 63.01 111.215 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -61.79 -47.82 83.43 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.598 1.159 . . . . 62.54 110.647 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -71.02 -33.71 70.63 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.891 0.476 . . . . 73.42 110.025 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.524 ' SG ' HG12 ' C' ' 21' ' ' ILE . 44.6 t -64.44 -37.1 86.35 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.12 0.568 . . . . 61.43 111.282 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.532 HG23 ' SG ' ' C' ' 76' ' ' CYS . 97.0 mt -71.7 -51.77 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.155 0.582 . . . . 64.0 110.352 174.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.0 m -62.4 -28.4 69.75 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.124 0.57 . . . . 63.32 111.426 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 42.5 t -64.07 -49.94 70.3 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.141 -0.688 . . . . 62.14 109.141 170.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.525 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.45 -33.57 75.85 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.286 1.035 . . . . 63.12 112.662 179.658 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.454 HG23 ' O ' ' C' ' 114' ' ' ILE . 58.3 t -62.83 -44.6 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 109.085 -0.709 . . . . 73.54 109.085 175.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 39.9 t -70.8 -31.0 67.61 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.801 -1.09 . . . . 75.03 111.93 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' C' ' 116' ' ' SER . 90.8 mtt-85 -68.97 -37.49 78.83 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.33 0.652 . . . . 74.33 109.342 176.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.85 6.87 79.62 Favored Glycine 0 C--N 1.353 1.521 0 O-C-N 123.967 0.792 . . . . 72.54 112.639 174.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 50.7 p 57.34 28.56 15.47 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.278 1.831 . . . . 73.33 114.294 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -83.95 144.63 45.03 Favored Pre-proline 0 N--CA 1.472 0.628 0 N-CA-C 109.059 -0.719 . . . . 73.41 109.059 172.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.81 153.31 37.68 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.67 2.247 . . . . 70.43 112.4 175.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -53.85 129.35 33.37 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.042 0.937 . . . . 72.0 113.487 -170.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 31.3 tp -131.72 84.65 2.18 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 107.054 -1.461 . . . . 72.24 107.054 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -98.16 106.1 18.35 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.462 -1.245 . . . . 72.55 108.425 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.38 138.39 58.51 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.31 0.644 . . . . 74.34 111.213 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.74 133.88 90.4 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 124.088 0.868 . . . . 73.4 110.711 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.15 107.74 1.01 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.53 2.153 . . . . 61.54 112.492 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 23.7 m -100.33 131.3 48.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 108.941 -0.762 . . . . 75.51 108.941 170.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.461 HD21 ' HE1' ' A' ' 11' ' ' PHE . 3.3 m-20 -72.01 84.89 0.99 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.016 -0.538 . . . . 72.32 109.567 177.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.612 ' HB3' HD21 ' C' ' 104' ' ' ASN . 39.1 t80 -65.07 -31.67 72.99 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.227 -0.897 . . . . 73.53 111.32 -172.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.627 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 32.0 t70 -77.63 -38.45 47.88 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.747 0.419 . . . . 35.45 111.584 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.406 ' HA ' ' HB3' ' C' ' 138' ' ' MET . . . -65.23 -29.66 70.47 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.738 0.649 . . . . 72.41 111.299 176.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' C' ' 133' ' ' PHE . 74.0 mt -60.2 -42.48 95.17 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.179 0.991 . . . . 75.14 111.757 173.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . 0.41 ' CD1' ' HB2' ' C' ' 100' ' ' ALA . 72.2 m-85 -80.39 -24.86 39.43 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.865 0.466 . . . . 63.42 111.602 174.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.406 ' HB3' ' HA ' ' C' ' 135' ' ' ALA . 54.4 ttm -75.02 -31.7 61.42 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.673 0.789 . . . . 74.12 111.996 -175.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -70.71 -37.18 73.54 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 110.061 -0.348 . . . . 72.54 110.061 174.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.511 ' HA ' ' HG3' ' A' ' 3' ' ' GLU . 52.6 t80 -54.05 -81.88 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.685 0.794 . . . . 72.11 111.094 175.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.519 HD11 ' HA2' ' A' ' 148' ' ' GLY . 3.4 tm? -64.76 115.14 4.98 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 107.383 -1.34 . . . . 72.43 107.383 176.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.7 113.02 1.64 Allowed 'General case' 0 CA--C 1.544 0.714 0 O-C-N 124.259 0.974 . . . . 54.1 110.18 -173.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . 0.571 ' HG2' ' H ' ' C' ' 144' ' ' GLN . 10.2 tt0 -143.44 -176.17 4.84 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.432 1.093 . . . . 73.41 108.313 -176.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.571 ' H ' ' HG2' ' C' ' 143' ' ' GLN . 81.1 mm-40 77.35 161.91 0.22 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.346 1.458 . . . . 74.04 112.794 174.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.06 165.28 34.28 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.811 -1.086 . . . . 51.41 110.436 -174.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -136.57 -109.27 0.95 Allowed Glycine 0 C--N 1.348 1.246 0 CA-C-N 116.073 -0.512 . . . . 70.2 112.645 -177.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 67.3 -87.82 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.645 1.178 . . . . 73.45 110.535 -173.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 158.55 150.09 5.68 Favored Glycine 0 C--N 1.358 1.8 0 N-CA-C 114.326 0.49 . . . . 75.14 114.326 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 4.5 t -166.53 177.8 6.44 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.896 1.279 . . . . 73.34 109.53 175.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -160.38 87.93 0.78 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.358 -0.979 . . . . 61.31 108.358 171.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -90.87 138.12 31.83 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.114 0.565 . . . . 73.44 110.114 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -127.09 179.95 5.16 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.012 0.925 . . . . 73.3 110.996 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . 0.536 ' HB3' ' HA ' ' E' ' 12' ' ' PRO . 23.1 tm0? -143.82 98.93 3.32 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 106.236 -1.764 . . . . 73.11 106.236 166.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -86.19 147.04 26.3 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.673 0.389 . . . . 75.11 110.839 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.323 0 CA-C-O 118.508 -0.758 . . . . 73.53 109.242 173.15 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 109.815 -0.439 . . . . 72.25 109.815 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 42.6 m -136.65 82.55 1.95 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.615 1.166 . . . . 61.24 108.925 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -124.93 92.78 3.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.526 -0.761 . . . . 75.03 109.718 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 48.71 100.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.128 1.371 . . . . 72.54 113.671 164.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -73.91 -90.73 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 118.671 -0.681 . . . . 74.31 110.176 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 61.7 t30 43.81 44.84 5.94 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.663 1.185 . . . . 51.44 111.497 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 14.1 p -119.75 -177.86 3.49 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 124.724 1.21 . . . . 64.11 109.987 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.562 ' HG3' ' HG3' ' D' ' 9' ' ' MET . 10.0 tp10 67.44 178.17 0.24 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.588 1.155 . . . . 52.52 110.245 -177.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.562 ' HG3' ' HG3' ' D' ' 8' ' ' GLU . 4.4 ppp? -29.47 151.12 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 126.036 1.735 . . . . 74.43 114.887 169.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 67.4 m -103.59 135.88 44.35 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.479 -0.564 . . . . 75.01 109.479 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -137.56 119.14 14.93 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.042 -1.095 . . . . 71.3 108.042 -175.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -130.88 129.84 42.79 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.315 -0.994 . . . . 63.11 108.315 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.491 HG21 HD11 ' D' ' 16' ' ' ILE . 56.1 mt -79.05 129.53 37.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.985 -0.746 . . . . 72.04 108.985 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -105.14 -28.39 11.02 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 119.037 -0.506 . . . . 72.04 111.74 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -176.82 140.41 0.33 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 118.157 0.435 . . . . 74.42 111.52 -173.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.491 HD11 HG21 ' D' ' 13' ' ' ILE . 3.0 mp -123.53 136.31 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.566 -1.272 . . . . 74.14 107.566 171.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.427 ' HE1' HG13 ' D' ' 83' ' ' ILE . 28.6 p90 -162.81 175.07 11.64 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-O 122.078 0.942 . . . . 75.33 112.231 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . 0.406 HG21 HD11 ' D' ' 21' ' ' ILE . 70.1 p -109.71 122.51 47.65 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.049 -1.432 . . . . 64.53 108.814 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -93.17 -31.81 14.63 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.3 -0.63 . . . . 74.42 109.3 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' D' ' 79' ' ' GLN . 6.5 m-20 -142.36 131.57 23.39 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 108.315 -0.994 . . . . 63.51 108.315 177.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.525 HG21 ' HE2' ' C' ' 117' ' ' MET . 89.0 mt -128.6 150.29 34.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.505 -1.294 . . . . 73.21 107.505 172.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . 0.442 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 47.3 t -151.69 139.39 19.76 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.258 1.023 . . . . 71.12 108.923 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 84.1 t80 -152.86 127.66 9.53 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.464 -2.05 . . . . 65.43 105.464 169.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -135.96 134.59 38.79 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.876 -1.157 . . . . 75.43 107.876 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.422 ' CB ' ' HB2' ' D' ' 28' ' ' ALA . . . -120.88 90.53 46.81 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 108.032 -1.099 . . . . 43.22 108.032 175.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.44 -41.07 12.68 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.802 2.335 . . . . 75.24 112.688 -172.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.491 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 27.7 m-20 -106.03 9.81 32.38 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.658 0.783 . . . . 51.54 110.737 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.451 ' HB1' ' CE2' ' C' ' 17' ' ' TYR . . . -19.44 -70.26 0.03 OUTLIER Pre-proline 0 CA--C 1.563 1.458 0 N-CA-C 117.396 2.369 . . . . 52.2 117.396 -165.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.05 -24.03 13.15 Favored 'Trans proline' 0 C--N 1.382 2.321 0 CA-C-N 123.647 2.338 . . . . 74.4 113.969 -174.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -75.1 -41.07 59.39 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.265 1.026 . . . . 72.15 110.522 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.567 HG22 HD12 ' D' ' 68' ' ' LEU . 12.3 p -75.82 -20.22 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 115.856 -0.611 . . . . 70.25 111.243 -173.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -66.64 -20.04 65.9 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 112.699 0.629 . . . . 73.12 112.699 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -59.1 -26.17 64.44 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.769 0.828 . . . . 73.24 110.627 176.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -91.46 108.72 20.09 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.894 1.278 . . . . 74.25 110.17 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -105.84 88.77 2.89 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.948 0.899 . . . . 74.23 110.978 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 45.5 p90 -161.14 177.26 10.43 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.382 1.073 . . . . 74.53 108.339 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -72.85 115.52 40.91 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 108.845 -0.798 . . . . 75.44 108.845 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -60.82 130.47 33.17 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.33 2.02 . . . . 62.11 111.212 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -63.54 114.44 3.92 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.454 -0.943 . . . . 73.21 108.454 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.487 HG11 HD22 ' D' ' 126' ' ' LEU . 31.1 m -106.91 112.05 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-O 121.526 0.679 . . . . 71.02 110.094 -174.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.43 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 12.0 tmtt? -84.49 119.15 24.83 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 106.467 -1.679 . . . . 55.11 106.467 174.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.647 HD23 HD12 ' H' ' 6' ' ' ILE . 4.1 pp -95.6 150.38 20.41 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.135 0.493 . . . . 75.31 110.187 -173.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.535 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 13.0 t70 -151.29 119.66 6.4 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.023 -0.99 . . . . 74.44 108.741 -176.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.52 133.84 52.6 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.764 -0.458 . . . . 50.25 109.764 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.451 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 31.4 t70 -132.99 157.55 44.92 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.094 -1.076 . . . . 75.4 108.094 176.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . 0.434 ' HB ' HD13 ' H' ' 11' ' ' LEU . 11.8 t -119.93 153.88 35.26 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.395 0.617 . . . . 62.45 112.106 -173.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.626 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.72 152.86 33.31 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.215 1.406 . . . . 63.13 107.885 172.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 21.1 p -164.63 152.37 11.86 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.69 0.223 . . . . 64.32 110.967 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 60.3 p -164.23 135.02 4.3 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.485 0.714 . . . . 72.42 109.756 177.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -77.71 136.47 38.18 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.851 -0.796 . . . . 71.41 108.851 172.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' D' ' 57' ' ' GLU . 40.2 mt -103.24 -35.05 8.59 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.88 0.472 . . . . 75.25 110.375 -177.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.53 -174.0 3.55 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.746 0.818 . . . . 61.45 109.954 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.23 114.92 3.73 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.232 -0.895 . . . . 64.32 110.238 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 63.87 12.2 6.58 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.788 1.235 . . . . 75.4 112.761 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 76.4 t -109.03 122.67 64.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 106.936 -1.505 . . . . 60.43 106.936 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.643 ' HB3' HD13 ' D' ' 86' ' ' ILE . 16.5 t80 -143.06 131.04 21.68 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.769 -0.456 . . . . 74.41 109.769 -173.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.42 ' HB2' HD11 ' D' ' 51' ' ' LEU . 8.1 tt0 -99.7 130.97 45.97 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.052 0.941 . . . . 73.41 109.747 177.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.1 t -119.63 127.13 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.275 -1.009 . . . . 72.34 108.275 174.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.626 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 11.5 t -112.81 135.69 51.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 124.086 0.954 . . . . 65.45 108.725 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.646 HD22 ' HB3' ' D' ' 103' ' ' PRO . 11.5 tp -125.47 116.87 22.5 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.631 -0.507 . . . . 62.01 109.631 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.451 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 17.9 ttm-85 -83.86 103.14 12.89 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.74 0.816 . . . . 72.34 109.383 175.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 62.1 t -93.27 120.24 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.279 -1.008 . . . . 64.11 108.279 170.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 12.2 m -120.66 146.94 45.9 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 122.963 0.505 . . . . 74.15 109.755 -175.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.417 HG13 ' HB ' ' D' ' 40' ' ' VAL . 53.7 t -137.48 103.88 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 125.383 1.473 . . . . 75.32 109.033 -175.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 48.1 m -94.12 96.96 9.97 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.567 -0.901 . . . . 61.1 108.567 169.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.442 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -97.96 153.07 18.61 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.694 -0.685 . . . . 70.31 109.802 -171.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.433 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.9 p -155.54 128.61 8.14 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 123.559 0.537 . . . . 44.41 112.11 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.567 HD12 HG22 ' D' ' 31' ' ' VAL . 45.7 mt -96.66 96.18 8.45 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.832 -1.173 . . . . 71.31 107.832 169.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.71 -136.14 17.72 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.808 -0.633 . . . . 74.44 112.719 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -84.41 3.15 37.39 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.547 0.739 . . . . 65.31 111.742 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -125.01 147.84 48.75 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.998 -0.371 . . . . 70.0 109.998 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 61.8 m -65.02 135.38 55.54 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 123.825 0.703 . . . . 72.24 111.32 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.555 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -85.61 -65.36 1.02 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.387 -0.968 . . . . 51.21 108.387 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -155.14 144.11 20.83 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.605 -0.725 . . . . 62.41 110.691 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 66.3 mt -106.83 107.67 18.81 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.727 -1.212 . . . . 62.23 107.727 172.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.416 ' SG ' HG23 ' D' ' 114' ' ' ILE . 45.9 t -121.52 141.41 51.07 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.764 0.826 . . . . 65.11 109.527 -174.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 21.8 tt0 -154.8 136.68 14.54 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.138 0.575 . . . . 62.54 109.487 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 82.0 t -136.76 114.88 14.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.956 -0.757 . . . . 72.12 108.956 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.403 ' HB2' ' HB2' ' D' ' 20' ' ' ASP . 69.6 mt-30 -87.88 86.93 7.21 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 107.592 -1.262 . . . . 64.54 107.592 170.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -79.89 104.02 10.18 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 114.31 -1.313 . . . . 63.23 108.116 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -107.09 143.09 15.8 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 111.557 -0.617 . . . . 51.24 111.557 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.14 138.34 9.27 Favored Glycine 0 CA--C 1.506 -0.497 0 N-CA-C 111.643 -0.583 . . . . 74.21 111.643 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.427 HG13 ' HE1' ' D' ' 17' ' ' TYR . 74.2 mt -86.58 121.4 37.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.199 -1.408 . . . . 75.3 107.199 172.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -125.33 165.8 17.7 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.288 0.635 . . . . 72.04 109.406 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 4.6 t -112.55 105.41 13.62 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.794 -1.188 . . . . 54.35 107.794 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.67 HG21 HG21 ' H' ' 18' ' ' VAL . 3.3 mp -107.95 105.76 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 108.328 -0.99 . . . . 64.41 108.328 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.72 147.04 49.98 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.328 0.651 . . . . 73.22 110.44 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.11 13.62 76.76 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-O 119.193 -0.781 . . . . 61.02 114.91 172.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.475 HG22 ' N ' ' D' ' 90' ' ' GLU . 7.6 mt -97.57 157.88 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 118.334 1.067 . . . . 55.33 110.477 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.475 ' N ' HG22 ' D' ' 89' ' ' ILE . 1.1 pp20? -153.11 -177.81 6.54 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.446 1.098 . . . . 72.02 108.979 163.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . 0.462 ' H ' ' HD3' ' H' ' 22' ' ' ARG . . . 60.44 -141.96 47.94 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.532 0.587 . . . . 70.15 113.694 -178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 7.4 m -89.96 -9.92 46.99 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.556 1.142 . . . . 62.11 111.379 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.74 -28.45 68.7 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.045 0.538 . . . . 74.12 111.043 -176.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.436 ' SD ' ' HB3' ' H' ' 21' ' ' ALA . 18.1 ptt? -70.98 -32.35 69.17 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 119.462 -0.304 . . . . 72.33 111.42 176.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.42 84.0 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 120.775 0.322 . . . . 72.45 110.146 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -65.56 -43.82 88.69 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.601 -0.727 . . . . 71.54 110.949 171.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.4 t -61.5 -49.96 74.63 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.886 0.474 . . . . 40.32 110.656 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.805 HD11 HG23 ' H' ' 18' ' ' VAL . 19.4 mt -83.19 -20.51 34.51 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.054 0.942 . . . . 63.45 111.518 -173.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.83 5.93 34.98 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 114.131 0.413 . . . . 63.14 114.131 -174.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.479 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -146.44 -66.45 0.29 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.557 0.343 . . . . 51.51 110.855 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -70.25 -52.05 25.98 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.565 0.58 . . . . 74.14 112.565 -170.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.498 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 56.8 m -58.38 -47.63 98.44 Favored Pre-proline 0 CA--C 1.562 1.42 0 C-N-CA 123.53 0.732 . . . . 73.33 111.388 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.646 ' HB3' HD22 ' D' ' 60' ' ' LEU . 51.7 Cg_exo -59.4 -39.7 74.22 Favored 'Trans proline' 0 C--N 1.397 3.115 0 C-N-CA 122.231 1.954 . . . . 62.05 113.277 169.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -59.31 -36.17 75.12 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.9 0.88 . . . . 74.43 110.697 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.2 mm -63.5 -36.92 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.514 0.726 . . . . 50.03 110.597 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 73.6 mt -84.43 -13.82 51.04 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 115.221 -0.9 . . . . 71.43 112.371 -176.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -56.68 -50.36 88.4 Favored Pre-proline 0 N--CA 1.5 2.048 0 C-N-CA 124.072 0.949 . . . . 73.32 113.46 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.38 -41.12 81.29 Favored 'Trans proline' 0 C--N 1.392 2.826 0 C-N-CA 122.181 1.921 . . . . 63.01 112.948 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -75.88 -37.98 58.33 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.329 1.052 . . . . 62.35 112.484 -175.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.94 -43.52 71.44 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.08 0.552 . . . . 53.43 110.346 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.448 ' NH2' HG23 ' B' ' 105' ' ' ILE . 46.6 ttp180 -62.28 -47.78 82.81 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.595 -0.729 . . . . 72.43 110.438 176.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -61.28 -45.76 93.13 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.416 0.686 . . . . 73.33 110.757 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.2 t -59.46 -44.5 92.97 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.657 0.598 . . . . 73.31 111.159 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.443 ' O ' HG23 ' D' ' 118' ' ' VAL . 65.5 mt -60.05 -57.64 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.323 0.649 . . . . 73.51 110.326 174.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.9 m -53.43 -41.87 66.49 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.668 1.187 . . . . 73.01 112.673 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 45.6 t -67.19 -41.74 85.34 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.214 -0.903 . . . . 75.33 110.222 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.4 mtm -68.77 -32.49 72.26 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.903 0.481 . . . . 74.41 111.428 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.443 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.0 t -65.76 -43.52 93.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.644 0.777 . . . . 73.02 110.264 176.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.3 p -74.17 -30.36 62.21 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.589 0.356 . . . . 75.53 111.176 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 74.5 mtt-85 -71.75 -27.95 63.32 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.695 0.798 . . . . 74.44 110.373 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.93 7.89 78.42 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-N 115.8 -0.636 . . . . 70.44 112.072 171.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.465 HG23 ' HB3' ' C' ' 17' ' ' TYR . 62.3 p 59.5 15.89 4.85 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 127.015 2.126 . . . . 73.41 113.792 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -78.77 157.98 76.08 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.794 0.838 . . . . 71.11 110.462 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.63 127.34 25.52 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.085 2.523 . . . . 75.12 113.069 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -52.97 136.93 33.96 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.264 1.026 . . . . 73.11 112.048 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.487 HD22 HG11 ' D' ' 40' ' ' VAL . 57.3 tp -118.16 108.77 15.58 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.796 0.838 . . . . 72.14 109.395 -177.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -106.73 99.06 8.66 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.008 -0.738 . . . . 74.1 109.008 175.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.86 130.2 41.05 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.193 -0.669 . . . . 63.42 109.193 173.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -63.02 137.81 97.16 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.338 0.655 . . . . 63.52 110.427 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 8.3 Cg_exo -69.44 111.02 2.63 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.644 2.229 . . . . 72.44 110.905 -177.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . 0.472 HG11 ' HB1' ' H' ' 7' ' ' ALA . 15.9 m -108.28 117.73 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 109.226 -0.657 . . . . 45.13 109.226 -177.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -74.25 101.04 3.88 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 115.546 -0.752 . . . . 72.41 110.076 -176.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -68.57 -23.28 64.48 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.99 -1.004 . . . . 60.43 112.012 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.479 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 5.1 m-20 -62.06 -51.68 66.97 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.681 0.393 . . . . 43.24 110.92 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.54 -45.59 93.52 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.916 0.76 . . . . 71.22 111.412 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 2.1 tt -65.78 -44.49 85.62 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.443 0.697 . . . . 44.32 110.6 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -67.85 -48.35 66.41 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.575 0.75 . . . . 73.22 110.275 -175.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 21.4 ptp -67.09 -28.88 68.54 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 116.073 -0.512 . . . . 62.42 110.368 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.449 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 12.7 t30 -65.81 -37.85 87.38 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.476 0.711 . . . . 74.35 110.61 177.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -63.51 -46.49 85.82 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.579 -0.737 . . . . 72.22 109.939 175.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.2 mp -68.99 -29.23 67.39 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.968 0.907 . . . . 75.2 112.695 -177.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.449 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 9.9 pt20 -90.86 7.46 39.85 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.429 0.529 . . . . 73.05 112.429 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -117.53 62.62 0.74 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.963 0.887 . . . . 73.41 108.624 178.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -170.28 138.25 1.58 Allowed 'General case' 0 C--O 1.243 0.748 0 CA-C-N 113.748 -1.569 . . . . 74.53 108.734 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.51 100.74 2.8 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.487 -0.56 . . . . 55.51 109.487 175.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.69 97.79 0.91 Allowed Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.65 -0.705 . . . . 74.53 111.619 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.0 127.31 31.06 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.975 0.91 . . . . 72.21 108.571 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -78.47 68.97 2.87 Favored Glycine 0 C--N 1.35 1.357 0 O-C-N 123.956 0.785 . . . . 65.55 112.898 -177.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 8.9 t -75.7 166.95 22.78 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.268 1.027 . . . . 61.11 110.576 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -75.23 158.87 32.27 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.518 -0.549 . . . . 72.51 109.518 173.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -53.57 88.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.581 1.153 . . . . 61.41 111.741 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -148.87 151.86 35.45 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.272 1.429 . . . . 73.21 108.727 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . 0.595 ' NE2' ' HB3' ' H' ' 24' ' ' PRO . 28.3 pt20 -102.3 124.69 48.33 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.902 -0.777 . . . . 64.43 108.902 171.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -109.72 102.94 11.71 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.508 -0.923 . . . . 75.44 108.508 173.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.946 0 C-N-CA 123.871 0.868 . . . . 72.32 109.382 -179.006 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 109.134 -0.691 . . . . 53.54 109.134 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -140.28 145.23 37.01 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.145 0.978 . . . . 73.44 109.483 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -115.3 119.3 35.86 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.935 -0.765 . . . . 74.03 108.935 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 30.4 p -70.29 140.0 52.22 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.75 0.82 . . . . 73.34 111.261 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 26.1 m -142.22 134.43 27.63 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.776 0.83 . . . . 73.53 109.648 -175.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 49.8 mm 71.78 116.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 125.443 1.497 . . . . 74.34 110.964 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.1 83.19 2.01 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.614 0.766 . . . . 62.3 109.956 -177.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.404 ' HB3' HG21 ' A' ' 131' ' ' VAL . 31.5 mt -140.15 135.26 32.28 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.955 0.902 . . . . 73.53 109.933 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.59 -87.87 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.873 0.869 . . . . 74.01 109.509 178.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . 0.614 HD21 ' HB2' ' A' ' 136' ' ' LEU . 50.3 mt -141.85 162.4 35.58 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.487 1.115 . . . . 72.01 109.874 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 90.7 mt -88.58 139.34 29.72 Favored Pre-proline 0 CA--C 1.552 1.02 0 CA-C-N 115.386 -0.824 . . . . 71.3 109.282 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 12' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' C' ' 153' ' ' GLN . 64.1 Cg_exo -55.4 -28.13 61.89 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.894 3.062 . . . . 72.24 113.753 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 pp -142.72 159.19 42.71 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.444 1.098 . . . . 74.12 109.305 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -74.49 151.16 39.58 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.237 -0.653 . . . . 72.51 109.237 174.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . 0.459 ' HE1' ' HB3' ' A' ' 48' ' ' SER . 4.1 t80 -62.46 147.86 47.41 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.844 0.858 . . . . 72.13 110.075 -176.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 16' ' ' THR . . . . . 0.44 ' HA ' ' HD3' ' E' ' 17' ' ' PRO . 11.0 p -54.55 122.66 40.07 Favored Pre-proline 0 CA--C 1.562 1.435 0 C-N-CA 124.58 1.152 . . . . 65.11 111.878 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 17' ' ' PRO . . . . . 0.515 ' HA ' HD13 ' A' ' 98' ' ' LEU . 27.7 Cg_exo -63.91 153.16 77.39 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 123.808 3.005 . . . . 73.51 115.665 -167.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 18' ' ' VAL . . . . . 0.671 ' H ' HD22 ' A' ' 98' ' ' LEU . 53.4 t -64.77 -49.29 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.741 1.217 . . . . 75.21 111.079 174.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 9.9 t -140.84 -163.85 1.62 Allowed 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.032 -0.986 . . . . 55.04 108.58 -175.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -54.72 109.34 0.49 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.634 0.774 . . . . 64.13 111.751 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.24 151.65 29.4 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.584 1.154 . . . . 70.2 109.203 172.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 80.91 -38.8 0.14 Allowed 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.272 1.429 . . . . 72.25 113.32 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 59.5 m -57.62 112.15 4.36 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 124.288 1.035 . . . . 64.3 112.585 -175.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -86.67 176.46 4.69 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 123.338 2.692 . . . . 74.45 113.032 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 CA--C 1.559 1.289 0 CA-C-N 115.341 -0.845 . . . . 71.01 110.692 -179.311 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 109.466 -0.568 . . . . 71.14 109.466 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -68.98 100.39 1.21 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.61 0.764 . . . . 64.3 109.29 174.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -140.25 173.4 11.55 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.787 0.835 . . . . 72.44 110.0 -174.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 35.6 m -72.22 82.06 1.01 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.486 0.714 . . . . 71.44 110.085 176.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 5' ' ' THR . . . . . 0.528 HG22 HG13 ' F' ' 6' ' ' ILE . 58.0 m -90.71 122.01 33.1 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.333 -0.849 . . . . 75.34 110.148 -175.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.528 HG13 HG22 ' F' ' 5' ' ' THR . 26.7 mt 67.29 125.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.708 1.603 . . . . 74.53 110.995 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -160.27 -162.8 1.02 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.126 0.571 . . . . 71.23 110.202 -175.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . 0.423 HD12 ' H ' ' B' ' 131' ' ' VAL . 92.3 mt -135.93 116.23 13.57 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.463 -1.31 . . . . 73.35 107.463 170.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.04 154.11 38.13 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.038 0.535 . . . . 64.44 111.052 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 90.0 mt -59.9 133.7 56.34 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 123.735 0.647 . . . . 75.41 109.686 173.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.427 ' H ' HD12 ' F' ' 11' ' ' LEU . 4.8 mp -70.59 128.76 90.74 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 123.75 0.656 . . . . 61.32 109.27 -171.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -64.65 -25.13 61.96 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 123.22 2.613 . . . . 53.31 112.546 -174.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.62 142.1 47.95 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 106.612 -1.625 . . . . 60.41 106.612 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -102.64 37.05 2.01 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.294 -0.632 . . . . 51.43 109.294 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . 0.667 ' HB2' HD13 ' B' ' 98' ' ' LEU . 76.7 m-85 64.5 175.79 0.19 Allowed 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 125.282 1.433 . . . . 61.51 112.128 -176.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 16' ' ' THR . . . . . 0.624 ' HB ' ' HA ' ' F' ' 21' ' ' ALA . 28.0 m -81.35 140.99 48.94 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-O 118.398 -0.811 . . . . 74.15 110.532 -176.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 17' ' ' PRO . . . . . 0.456 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 3.3 Cg_exo -34.2 136.03 0.11 Allowed 'Trans proline' 0 C--N 1.39 2.745 0 C-N-CA 125.171 3.914 . . . . 42.24 115.988 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 96.5 t -72.25 84.66 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 122.173 0.987 . . . . 71.23 110.15 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 4.7 t -170.52 -44.59 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 113.587 -1.642 . . . . 30.04 108.076 178.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -150.19 72.89 1.13 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.385 -1.339 . . . . 64.03 107.385 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . 0.624 ' HA ' ' HB ' ' F' ' 16' ' ' THR . . . -84.52 103.77 13.94 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.784 -0.644 . . . . 72.3 111.636 -171.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 45.2 ttt85 -150.74 100.51 2.84 Favored 'General case' 0 C--N 1.348 0.514 0 C-N-CA 123.355 0.662 . . . . 74.02 110.152 166.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 3.0 p -77.24 153.31 82.1 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 115.022 -0.99 . . . . 73.44 109.316 166.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -49.85 98.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.289 2.66 . . . . 75.21 113.537 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 . . . . . 0 CA--C 1.548 0.892 0 N-CA-C 108.931 -0.766 . . . . 70.04 108.931 177.775 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 109.582 -0.525 . . . . 70.44 109.582 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 88.4 tttt 56.91 93.27 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.524 1.53 . . . . 71.14 112.843 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -103.69 157.23 17.21 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.184 0.594 . . . . 73.43 109.538 171.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 18.8 t -150.38 162.18 41.06 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.133 0.492 . . . . 71.11 110.988 -173.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 45.6 m -81.71 155.7 25.4 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.252 1.021 . . . . 74.34 110.54 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 pp -53.55 153.64 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.356 1.063 . . . . 62.45 113.326 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -167.71 -177.14 3.37 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.315 0.646 . . . . 43.2 111.594 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 8' ' ' LEU . . . . . 0.685 ' H ' HD23 ' G' ' 8' ' ' LEU . 1.2 pt? -93.55 122.3 35.85 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.238 1.015 . . . . 72.03 108.635 172.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.62 90.07 5.58 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.549 0.74 . . . . 71.15 110.479 -175.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 10' ' ' LEU . . . . . 0.4 HD21 ' HB3' ' C' ' 136' ' ' LEU . 82.6 mt 66.24 -175.94 0.19 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.749 1.22 . . . . 75.54 112.212 177.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -100.44 137.84 20.03 Favored Pre-proline 0 N--CA 1.474 0.726 0 N-CA-C 108.572 -0.899 . . . . 61.33 108.572 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.53 -19.51 24.68 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.513 2.142 . . . . 71.2 112.123 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 58.8 tp -152.62 138.77 18.28 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.289 1.036 . . . . 62.25 108.893 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.84 131.98 35.18 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.368 -0.975 . . . . 73.13 108.368 169.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . 0.417 ' HD2' ' HB ' ' C' ' 46' ' ' THR . 33.8 p90 -73.76 -173.28 1.47 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.61 0.764 . . . . 75.44 111.845 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 62.5 p -55.64 150.41 26.03 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 124.419 1.087 . . . . 63.15 112.984 -172.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 17' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -76.46 167.58 25.37 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.414 2.076 . . . . 73.25 113.078 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 18' ' ' VAL . . . . . 0.435 HG23 HD11 ' C' ' 98' ' ' LEU . 49.1 t -75.74 -39.16 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 115.579 -0.737 . . . . 42.2 109.585 172.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 19.0 m -146.64 -54.63 0.25 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.408 -0.815 . . . . 74.23 110.319 -176.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -153.33 91.64 1.52 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.729 0.411 . . . . 71.04 110.448 -167.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 179.64 77.59 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 125.244 1.418 . . . . 71.43 109.897 177.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -148.3 -69.72 0.22 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.811 -0.44 . . . . 70.41 109.811 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 14.3 m -148.44 142.74 16.61 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 108.356 -0.979 . . . . 71.43 108.356 -174.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.64 98.4 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.272 1.981 . . . . 64.52 111.032 167.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 CA--C 1.557 1.226 0 C-N-CA 123.875 0.87 . . . . 71.22 109.998 -176.079 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.385 -0.598 . . . . 64.52 109.385 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -135.45 157.4 46.98 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.189 0.596 . . . . 73.13 110.182 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -94.48 -56.7 2.71 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.418 0.687 . . . . 64.11 109.886 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 35.7 t -153.4 -36.62 0.1 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.225 -0.898 . . . . 54.02 109.615 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 30.3 m -75.0 150.34 39.01 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.869 0.868 . . . . 65.42 109.396 171.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.647 HD12 HD23 ' D' ' 42' ' ' LEU . 29.1 pt -69.21 164.03 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-O 121.196 0.522 . . . . 65.24 111.675 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 7' ' ' ALA . . . . . 0.472 ' HB1' HG11 ' D' ' 131' ' ' VAL . . . -145.79 146.42 31.18 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.449 -0.796 . . . . 74.43 109.706 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 8' ' ' LEU . . . . . 0.538 HD23 HD22 ' D' ' 42' ' ' LEU . 97.8 mt -66.31 123.76 20.84 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.251 0.62 . . . . 74.4 110.119 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.95 170.13 14.31 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.275 0.63 . . . . 70.23 110.689 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 80.6 mt -73.95 174.23 8.85 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 121.312 0.577 . . . . 73.42 111.546 -177.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.494 HD21 HD11 ' D' ' 60' ' ' LEU . 80.0 mt -76.86 126.91 85.11 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.079 0.951 . . . . 73.42 111.037 -176.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.42 -42.98 3.24 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 123.035 2.49 . . . . 63.12 111.644 177.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 mp -90.85 166.24 13.18 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.544 0.738 . . . . 73.12 109.41 175.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.76 125.65 54.34 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.184 -1.413 . . . . 74.11 107.184 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -71.58 172.07 10.28 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.038 0.935 . . . . 65.35 111.415 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 38.1 p -77.02 142.66 69.23 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 109.47 -0.567 . . . . 72.11 109.47 171.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.93 178.82 6.52 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.659 2.239 . . . . 72.2 112.32 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . 0.805 HG23 HD11 ' D' ' 98' ' ' LEU . 98.2 t -76.17 119.69 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.252 0.621 . . . . 72.22 109.524 175.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 6.6 m -79.03 71.59 5.51 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.887 0.851 . . . . 73.24 109.112 177.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 21.7 tptm 179.36 -52.02 0.01 OUTLIER 'General case' 0 C--O 1.242 0.7 0 CA-C-N 113.802 -1.545 . . . . 74.24 107.747 -176.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . 0.436 ' HB3' ' SD ' ' D' ' 94' ' ' MET . . . -72.77 122.96 22.39 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.944 -1.025 . . . . 71.11 109.526 178.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . 0.462 ' HD3' ' H ' ' D' ' 91' ' ' GLY . 16.7 tpt180 57.74 91.02 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.604 1.162 . . . . 73.24 111.487 -177.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 73.4 p -73.86 131.42 81.68 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 109.323 -0.621 . . . . 60.32 109.323 173.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 24' ' ' PRO . . . . . 0.595 ' HB3' ' NE2' ' D' ' 153' ' ' GLN . 70.9 Cg_exo -53.09 -47.19 28.85 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 123.032 2.488 . . . . 70.0 112.512 175.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 . . . . . 0 C--O 1.248 0.986 0 N-CA-C 107.467 -1.308 . . . . 72.42 107.467 174.752 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.7 ttp . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 109.66 -0.496 . . . . 71.41 109.66 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.2 t 60.8 27.7 17.47 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 124.485 1.114 . . . . 65.41 111.148 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.74 157.59 23.21 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.142 0.977 . . . . 72.4 110.81 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 67.38 -65.77 0.22 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.389 1.476 . . . . 71.13 109.995 -168.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.8 t30 63.46 68.02 0.62 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.421 1.088 . . . . 71.34 110.434 172.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -81.65 174.22 11.59 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.266 -0.879 . . . . 71.44 110.202 178.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.2 m 58.43 35.12 24.53 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-O 122.731 1.253 . . . . 61.23 109.008 -170.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 9' ' ' MET . 5.3 tp10 -165.75 -155.43 0.23 Allowed 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 114.17 -1.377 . . . . 63.45 107.631 -170.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.487 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -63.03 138.81 58.67 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.838 -0.801 . . . . 72.11 108.838 171.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.449 ' N ' ' SD ' ' A' ' 9' ' ' MET . 17.1 p -137.26 106.74 6.12 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.649 -0.871 . . . . 74.54 108.649 -171.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.693 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 22.0 t80 -123.15 129.59 51.64 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.739 1.215 . . . . 62.41 109.048 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -149.71 112.75 4.87 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.369 0.668 . . . . 74.53 109.299 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.645 HG12 ' HD2' ' A' ' 84' ' ' PHE . 27.5 mt -83.05 116.15 26.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.555 -0.905 . . . . 71.01 108.555 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -79.28 -36.41 39.79 Favored 'General case' 0 C--O 1.242 0.702 0 O-C-N 123.895 0.747 . . . . 61.43 110.258 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -171.9 142.74 1.53 Allowed 'General case' 0 C--N 1.355 0.844 0 CA-C-N 116.374 -0.375 . . . . 70.43 110.457 -170.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.588 HD12 ' HB3' ' C' ' 130' ' ' PRO . 76.8 mt -133.66 141.31 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 124.243 1.017 . . . . 63.21 109.083 172.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.472 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 21.1 p90 -165.56 171.9 12.63 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 124.356 1.035 . . . . 73.42 110.499 -172.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.4 p -94.61 119.46 33.31 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.484 -0.932 . . . . 63.42 108.484 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.472 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 35.2 mtpt -83.01 -36.16 25.23 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.019 0.438 . . . . 64.11 109.828 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.515 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 16.2 t70 -145.72 126.02 13.93 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.114 -0.948 . . . . 75.22 109.1 -178.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.562 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 77.4 mt -118.78 142.32 34.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.864 -1.161 . . . . 70.15 107.864 172.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.0 t -150.53 125.82 10.06 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.784 -0.821 . . . . 73.42 108.784 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.501 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 75.3 t80 -127.48 121.97 32.16 Favored 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 106.867 -1.531 . . . . 75.41 106.867 174.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -124.09 118.29 26.6 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.18 -0.674 . . . . 74.15 109.18 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.48 79.64 4.22 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 106.867 -1.531 . . . . 74.03 106.867 168.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.49 -24.58 26.19 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.539 2.159 . . . . 63.24 112.915 -166.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -114.04 23.21 13.16 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 118.16 -0.924 . . . . 64.55 109.504 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.425 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -40.96 -58.14 2.88 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 114.192 1.182 . . . . 61.31 114.192 -166.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 18.0 Cg_exo -65.72 -24.65 54.61 Favored 'Trans proline' 0 C--N 1.389 2.675 0 CA-C-N 121.83 1.689 . . . . 73.11 113.245 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -83.48 -37.57 22.95 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.3 1.04 . . . . 73.22 110.833 -176.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.735 HG21 ' HA ' ' A' ' 73' ' ' ALA . 8.0 p -76.94 -23.82 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-N 115.589 -0.732 . . . . 74.45 111.348 -168.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -68.91 -25.18 64.46 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.884 0.474 . . . . 73.1 110.877 174.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -75.5 -33.02 60.73 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.027 0.931 . . . . 74.33 110.027 175.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -70.94 168.2 17.46 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.43 1.092 . . . . 73.05 111.469 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.87 145.76 27.64 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.828 -0.623 . . . . 75.53 110.025 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.407 ' CE3' HD21 ' A' ' 68' ' ' LEU . 75.1 t-105 -93.86 88.84 5.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.265 0.626 . . . . 75.41 109.583 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -135.2 79.97 48.35 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 107.113 -1.44 . . . . 73.01 107.113 170.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -91.82 165.33 3.3 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.269 2.646 . . . . 74.42 114.889 -170.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.658 ' HB3' ' HG2' ' C' ' 1' ' ' MET . 10.5 pt-20 -129.71 126.77 39.05 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.954 -1.021 . . . . 73.13 108.7 164.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.576 HG13 HG13 ' A' ' 64' ' ' VAL . 59.8 t -86.82 105.1 14.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.259 -0.645 . . . . 74.25 109.259 174.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -80.89 123.27 28.15 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.604 -1.18 . . . . 71.4 108.488 171.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.407 ' HG ' ' HA ' ' E' ' 8' ' ' LEU . 3.1 mm? -96.39 109.32 21.87 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.374 0.669 . . . . 72.13 109.394 -177.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.689 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 15.5 m-20 -110.14 119.82 40.48 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.532 -0.914 . . . . 73.53 108.532 172.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.782 HD23 HD21 ' A' ' 60' ' ' LEU . 6.3 mp -120.84 136.8 54.82 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.056 0.455 . . . . 73.45 111.103 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -134.72 121.27 20.54 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.36 -1.348 . . . . 71.21 107.36 174.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.47 HG22 ' HG ' ' A' ' 60' ' ' LEU . 43.8 p -107.74 136.51 47.37 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.261 0.624 . . . . 72.24 110.47 -172.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.89 145.56 51.04 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.048 0.939 . . . . 64.2 109.464 -178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.5 m -131.7 152.92 50.53 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.844 0.857 . . . . 45.33 109.569 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 46.7 t -150.1 142.86 24.67 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.632 0.773 . . . . 62.32 109.678 -175.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -101.56 104.32 15.2 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.029 -1.1 . . . . 70.34 108.029 172.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.671 HD11 ' HB2' ' A' ' 57' ' ' GLU . 59.4 mt -81.52 -41.5 21.59 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.921 -0.581 . . . . 73.4 110.295 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.404 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -157.88 -174.53 4.89 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.448 -0.796 . . . . 45.33 110.474 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.8 118.24 7.45 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.693 0.797 . . . . 61.23 110.057 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.28 -6.04 0.83 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.959 1.304 . . . . 71.21 112.74 -177.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 92.0 t -104.34 113.24 40.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 N-CA-C 108.191 -1.04 . . . . 71.41 108.191 -175.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -120.66 167.26 12.64 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.796 0.838 . . . . 72.01 109.429 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.671 ' HB2' HD11 ' A' ' 51' ' ' LEU . 36.3 tt0 -129.93 128.21 41.68 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.275 1.03 . . . . 71.45 108.789 174.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.434 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 53.4 t -109.89 122.79 65.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.076 -1.083 . . . . 63.2 108.076 169.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.5 t -110.14 136.38 46.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.14 -1.059 . . . . 55.33 108.14 171.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.782 HD21 HD23 ' A' ' 44' ' ' LEU . 3.3 tt -129.98 122.1 27.82 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.575 -0.898 . . . . 72.41 108.575 175.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.5 ttm-85 -85.66 103.03 14.1 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.518 1.127 . . . . 52.34 109.471 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.7 t -94.8 102.36 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 107.532 -1.284 . . . . 72.43 107.532 171.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.689 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 23.9 m -102.1 107.86 19.09 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.888 -0.782 . . . . 70.42 108.888 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.576 HG13 HG13 ' A' ' 40' ' ' VAL . 19.2 t -104.47 112.91 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 124.976 1.31 . . . . 60.22 109.121 -176.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 3.2 m -112.56 124.91 53.58 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 108.839 -0.8 . . . . 61.4 108.839 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.0 113.26 26.58 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.577 -1.268 . . . . 72.45 107.577 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.5 m -113.95 122.49 47.11 Favored 'General case' 0 C--N 1.351 0.637 0 CA-C-N 118.478 0.581 . . . . 52.05 110.903 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.407 HD21 ' CE3' ' A' ' 36' ' ' TRP . 17.5 mt -92.91 79.88 4.64 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 125.582 1.553 . . . . 53.24 107.677 173.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.46 -101.99 1.44 Allowed Glycine 0 C--N 1.34 0.801 0 CA-C-N 115.398 -0.819 . . . . 60.34 111.433 -175.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -106.64 -1.37 22.9 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.726 0.81 . . . . 62.34 111.292 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -107.33 136.69 46.71 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.956 0.903 . . . . 73.31 110.101 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.1 m -87.45 124.39 33.38 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 118.095 0.407 . . . . 54.31 110.002 167.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.735 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -73.77 -55.1 6.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.433 1.093 . . . . 74.24 109.695 174.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -152.24 164.91 36.41 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 114.45 -1.25 . . . . 54.43 111.687 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 36.0 tp -134.36 105.83 6.79 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.205 -1.361 . . . . 65.52 107.64 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.501 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 61.7 m -108.14 98.8 8.3 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.844 0.858 . . . . 75.2 109.813 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -105.4 125.44 50.99 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.384 0.674 . . . . 72.14 109.424 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.8 t -131.0 112.61 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.252 0.621 . . . . 70.21 109.545 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 78.3 mt-30 -84.33 87.9 7.23 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.324 1.05 . . . . 64.45 108.471 171.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.477 ' HG3' HD22 ' A' ' 106' ' ' LEU . 8.3 tp-100 -79.53 109.76 14.21 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.869 -1.059 . . . . 71.3 109.416 -177.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.56 146.02 18.09 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 111.481 -0.648 . . . . 74.34 111.481 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.2 124.9 2.04 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 111.387 -0.685 . . . . 61.1 111.387 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.0 mt -82.94 110.23 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.347 0.659 . . . . 73.43 109.519 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.693 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 36.3 m-85 -121.94 120.33 34.12 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.838 0.855 . . . . 74.22 108.747 -177.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.8 m -89.95 101.32 14.02 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.756 -0.831 . . . . 61.55 108.756 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.2 pt -113.52 135.39 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 123.145 0.578 . . . . 74.41 110.753 -176.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.4 -179.42 5.5 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.567 1.147 . . . . 53.23 109.506 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 102.15 -75.68 0.33 Allowed Glycine 0 C--N 1.346 1.086 0 N-CA-C 112.39 -0.284 . . . . 41.53 112.39 176.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.606 HG13 ' HB2' ' A' ' 94' ' ' MET . 28.2 pt -89.81 -178.43 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 123.413 0.685 . . . . 64.24 110.881 -175.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.503 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 23.7 tt0 -161.0 -176.64 5.61 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.054 0.941 . . . . 73.13 108.801 -178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.503 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 65.01 -152.16 51.16 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-O 119.753 -0.471 . . . . 73.2 113.023 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.602 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 14.8 t -66.26 -19.23 65.76 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.117 0.567 . . . . 64.41 111.701 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -64.14 -50.15 69.34 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.836 0.855 . . . . 75.45 109.85 176.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.606 ' HB2' HG13 ' A' ' 89' ' ' ILE . 41.7 ttm -76.78 -30.69 56.59 Favored 'General case' 0 C--N 1.36 1.058 0 CA-C-N 116.153 -0.476 . . . . 75.11 110.632 175.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.602 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -63.34 -25.66 68.4 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.362 0.665 . . . . 35.45 111.707 178.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.421 ' NE2' ' HG2' ' A' ' 138' ' ' MET . 59.5 t-80 -76.03 -38.29 57.39 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.635 -0.711 . . . . 73.32 109.722 172.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.3 t -70.82 -32.81 69.99 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.261 0.624 . . . . 74.53 111.989 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.546 HD13 ' HD2' ' E' ' 17' ' ' PRO . 4.0 pp -101.17 -20.02 15.48 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.065 0.546 . . . . 72.43 111.833 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.04 -16.03 29.16 Favored Glycine 0 N--CA 1.478 1.492 0 N-CA-C 113.694 0.238 . . . . 72.12 113.694 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.531 ' HB2' ' HD2' ' A' ' 137' ' ' PHE . . . -124.54 -62.75 1.23 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.789 0.836 . . . . 73.42 109.64 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.497 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 86.4 t80 -64.47 -60.79 2.74 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.463 1.105 . . . . 72.41 113.957 -167.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 84.7 m -65.71 -37.94 21.75 Favored Pre-proline 0 CA--C 1.566 1.593 0 N-CA-C 113.656 0.984 . . . . 72.21 113.656 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.91 -27.03 43.64 Favored 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 121.729 1.619 . . . . 75.44 112.783 167.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -77.68 -17.45 57.67 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.379 0.672 . . . . 64.42 110.473 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.1 mm -67.84 -41.53 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.89 -0.781 . . . . 72.34 108.89 169.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.477 HD22 ' HG3' ' A' ' 80' ' ' GLN . 90.4 mt -77.06 -21.32 54.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.149 0.979 . . . . 62.5 111.938 -178.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -59.9 -47.53 97.0 Favored Pre-proline 0 CA--C 1.574 1.878 0 C-N-CA 124.293 1.037 . . . . 64.24 113.578 -174.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.92 -40.6 33.95 Favored 'Trans proline' 0 C--N 1.393 2.888 0 C-N-CA 122.051 1.834 . . . . 63.21 112.97 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -65.42 -44.04 88.64 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.812 0.695 . . . . 75.53 111.314 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.35 -31.81 64.17 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.519 0.728 . . . . 52.24 110.926 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.455 HH12 HD12 ' C' ' 105' ' ' ILE . 32.2 ttm180 -62.11 -50.4 72.07 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 109.321 -0.622 . . . . 73.21 109.321 170.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -66.85 -42.94 84.88 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.269 1.028 . . . . 74.34 112.202 -171.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.3 t -60.42 -42.92 97.01 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 123.786 0.679 . . . . 73.23 109.872 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 118' ' ' VAL . 57.9 mt -64.96 -46.07 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 114.811 -1.086 . . . . 73.21 110.686 175.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.3 m -57.66 -40.82 80.2 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.956 0.902 . . . . 54.43 111.304 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 44.1 t -66.41 -44.08 83.96 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 115.258 -0.883 . . . . 71.14 110.497 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 15.9 mtp -64.02 -36.84 85.3 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.895 0.878 . . . . 74.03 111.748 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 114' ' ' ILE . 51.5 t -63.09 -52.34 60.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 124.37 1.068 . . . . 70.14 110.005 176.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.6 t -65.52 -31.31 72.31 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.677 0.791 . . . . 64.54 111.578 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 116' ' ' SER . 44.3 ttm-85 -75.23 -32.53 61.16 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.093 0.957 . . . . 72.25 109.467 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.426 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.97 17.04 38.92 Favored Glycine 0 C--N 1.355 1.607 0 CA-C-N 114.97 -1.014 . . . . 62.44 113.254 171.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.462 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.5 t 62.45 12.65 5.51 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 126.944 2.098 . . . . 74.34 113.838 174.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -79.96 146.5 63.8 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 123.409 0.684 . . . . 74.32 109.474 174.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.54 162.75 35.43 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.61 2.207 . . . . 73.23 113.095 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -54.81 129.2 36.29 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.318 1.447 . . . . 74.13 113.461 -168.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.473 HD11 HG21 ' A' ' 40' ' ' VAL . 59.5 tp -130.4 110.6 11.61 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.392 1.077 . . . . 73.31 109.67 178.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -125.73 117.19 22.93 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.275 1.03 . . . . 55.24 108.641 175.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.1 mp -66.83 140.75 57.83 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.493 0.717 . . . . 61.14 110.24 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -63.33 130.13 94.03 Favored Pre-proline 0 CA--C 1.552 1.034 0 O-C-N 123.778 0.673 . . . . 60.14 110.417 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 36.8 Cg_exo -64.6 113.63 2.39 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 123.168 2.579 . . . . 61.2 111.893 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.414 HG21 ' O ' ' E' ' 8' ' ' LEU . 61.7 t -99.95 114.24 37.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.612 -1.255 . . . . 73.12 107.612 177.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -74.72 81.42 2.06 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.571 0.748 . . . . 63.01 109.806 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -58.38 -49.71 76.26 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.545 -0.752 . . . . 72.44 110.169 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -56.52 -52.62 64.07 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.855 -1.066 . . . . 74.41 112.106 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.04 -43.56 91.93 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.678 0.612 . . . . 70.1 110.956 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 43.3 tp -61.18 -45.3 95.16 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.862 0.865 . . . . 65.54 111.876 -177.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.531 ' HD2' ' HB2' ' A' ' 100' ' ' ALA . 24.3 m-85 -68.94 -33.89 74.46 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.746 0.419 . . . . 74.43 110.806 176.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.421 ' HG2' ' NE2' ' A' ' 96' ' ' HIS . 11.6 mmt -69.66 -30.4 68.08 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 118.937 -0.554 . . . . 73.31 111.52 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 89.9 m-20 -58.71 -43.51 90.1 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 123.894 0.746 . . . . 70.12 110.488 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -67.28 -44.28 79.69 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.18 -0.918 . . . . 73.44 110.937 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.406 HD23 ' SD ' ' A' ' 138' ' ' MET . 59.8 tp -57.18 -47.23 81.75 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 123.967 0.792 . . . . 74.04 111.228 -174.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.423 ' H ' ' H ' ' A' ' 143' ' ' GLN . 1.0 OUTLIER -169.63 -15.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.767 0.827 . . . . 74.42 110.799 173.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.423 ' H ' ' H ' ' A' ' 142' ' ' GLN . 7.9 tm0? 75.72 101.91 0.07 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.318 1.847 . . . . 72.13 108.826 -171.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.402 ' OE1' ' HG3' ' A' ' 138' ' ' MET . 11.9 pt20 -84.33 154.26 23.02 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.255 0.55 . . . . 74.51 111.114 -176.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.61 -166.63 1.54 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.4 -0.818 . . . . 51.25 108.938 167.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -170.06 -80.03 0.05 OUTLIER Glycine 0 C--N 1.339 0.731 0 N-CA-C 112.031 -0.428 . . . . 35.1 112.031 177.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 63.66 -156.31 0.32 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.057 0.943 . . . . 73.13 111.017 -174.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.486 ' HA2' HD21 ' C' ' 141' ' ' LEU . . . -165.51 -148.4 5.49 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 110.334 -1.106 . . . . 73.35 110.334 176.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 59.1 m -142.18 118.11 10.57 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.855 -0.795 . . . . 73.04 108.855 168.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.527 ' HG3' HG22 ' C' ' 92' ' ' THR . 42.9 mt-10 -88.62 140.46 29.44 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.342 0.657 . . . . 74.21 109.241 173.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -122.31 164.73 17.42 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 123.749 0.819 . . . . 73.52 109.035 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -71.58 91.69 1.09 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.492 0.717 . . . . 74.13 110.929 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -111.09 101.48 10.01 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.924 -1.51 . . . . 72.43 106.924 168.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -86.25 153.29 22.11 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.589 -0.732 . . . . 73.31 109.76 174.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 N-CA-C 108.78 -0.822 . . . . 73.3 108.78 175.54 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 109.407 -0.59 . . . . 74.51 109.407 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 81.0 p -139.51 -47.5 0.46 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.619 0.768 . . . . 70.11 109.416 177.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -71.05 101.66 2.27 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.584 0.754 . . . . 74.1 110.601 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -137.03 102.85 4.97 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 107.132 -1.433 . . . . 64.41 107.132 172.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -157.74 23.94 0.27 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.865 0.866 . . . . 73.44 109.142 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -112.21 112.74 24.56 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.659 1.184 . . . . 75.12 109.44 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 17.7 p -148.33 179.63 7.64 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.804 1.242 . . . . 44.42 109.423 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -84.44 -5.7 59.31 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.801 0.84 . . . . 63.53 111.935 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.56 ' HG2' ' HB ' ' B' ' 89' ' ' ILE . 0.3 OUTLIER 67.11 165.78 0.22 Allowed 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 125.849 1.66 . . . . 62.32 112.346 -178.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.499 ' N ' ' SD ' ' B' ' 9' ' ' MET . 94.0 m -149.64 109.18 4.0 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.866 1.266 . . . . 71.23 108.597 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' B' ' 85' ' ' SER . 35.5 t80 -130.76 138.23 49.84 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.914 0.486 . . . . 72.01 110.326 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -154.53 140.41 18.2 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.039 0.536 . . . . 51.42 110.479 175.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.415 ' HA ' ' HD2' ' B' ' 84' ' ' PHE . 17.9 mt -76.33 108.61 9.17 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 C-N-CA 123.7 0.8 . . . . 74.12 108.956 173.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -82.86 -43.64 16.36 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.349 -0.611 . . . . 75.13 109.349 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.462 ' HE ' HG21 ' A' ' 122' ' ' THR . 45.6 ttt180 -167.78 140.45 3.21 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.985 0.514 . . . . 74.52 110.612 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 62.9 mt -118.31 141.46 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 107.752 -1.203 . . . . 55.22 107.752 173.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.449 ' HE1' HG13 ' B' ' 83' ' ' ILE . 20.7 p90 -170.2 150.89 3.74 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.024 0.44 . . . . 70.33 111.721 -173.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 86.8 m -78.99 124.65 28.46 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.982 -0.747 . . . . 53.12 108.982 171.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -94.45 -27.72 15.86 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.419 0.688 . . . . 71.54 111.449 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -164.58 149.82 9.99 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.382 0.426 . . . . 64.5 111.777 -175.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 47.0 mm -140.26 142.81 30.73 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 C-N-CA 125.808 1.643 . . . . 74.22 109.344 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.573 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 46.5 t -139.17 131.92 29.08 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.261 -1.385 . . . . 73.33 107.261 171.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.562 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.7 t80 -144.46 122.52 12.11 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.1 -1.444 . . . . 61.1 107.1 170.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 40.4 mt-10 -130.61 119.73 22.92 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.148 0.979 . . . . 63.14 108.696 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.658 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -113.25 87.18 10.63 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 107.303 -1.369 . . . . 45.22 107.303 174.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.25 -44.86 0.72 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.6 2.2 . . . . 70.35 112.448 -174.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -92.76 5.72 50.14 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.419 1.088 . . . . 70.35 110.526 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.658 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -32.28 -63.24 0.26 Allowed Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 126.002 1.721 . . . . 42.01 115.406 -171.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 32.4 Cg_exo -54.79 -48.44 21.24 Favored 'Trans proline' 0 C--N 1.402 3.364 0 C-N-CA 122.465 2.11 . . . . 71.04 113.27 -167.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -97.67 -18.02 19.12 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.361 0.874 . . . . 71.31 113.361 -171.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.49 HG22 HD12 ' B' ' 68' ' ' LEU . 7.6 p -74.15 -16.19 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 118.875 0.761 . . . . 74.34 110.639 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -58.17 -23.48 55.53 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.26 1.024 . . . . 75.32 113.569 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -61.19 -23.21 65.42 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.038 0.535 . . . . 64.22 111.407 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.449 ' HB2' HD13 ' B' ' 68' ' ' LEU . 91.2 mttt -91.47 99.47 12.4 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.066 0.947 . . . . 73.35 110.211 -177.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -100.42 80.05 2.19 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.501 -0.772 . . . . 73.22 110.363 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 42.7 p90 -155.02 171.16 20.2 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.443 1.097 . . . . 70.44 108.681 170.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -67.72 112.57 10.8 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 108.916 -0.772 . . . . 73.24 108.916 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.538 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 37.8 Cg_endo -65.74 144.08 76.48 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 121.715 1.61 . . . . 74.43 112.315 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.447 ' HB2' ' HG2' ' F' ' 2' ' ' LYS . 32.3 tt0 -59.71 113.69 2.38 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.499 1.12 . . . . 73.02 109.83 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.666 HG13 HG13 ' B' ' 64' ' ' VAL . 81.6 t -92.23 127.26 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.645 0.778 . . . . 70.35 111.262 -173.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.499 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 38.4 tttp -104.62 107.54 18.54 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.017 -1.475 . . . . 73.43 107.017 173.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.532 HD22 ' HA ' ' F' ' 8' ' ' LEU . 4.1 pp -85.97 145.59 27.06 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 109.153 -0.684 . . . . 61.35 109.153 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.537 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 5.8 m-20 -142.07 110.9 6.21 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 106.992 -1.485 . . . . 74.55 106.992 171.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -98.85 135.31 40.49 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.336 -1.357 . . . . 74.32 107.336 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -144.99 156.28 43.86 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.989 -1.115 . . . . 73.15 107.989 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 6.1 t -137.14 142.76 42.25 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.457 0.646 . . . . 55.34 110.507 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.43 145.36 35.2 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.27 -1.382 . . . . 75.33 107.27 174.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.8 p -146.39 166.45 26.32 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.853 0.297 . . . . 73.14 111.143 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.5 p -151.41 137.74 18.49 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.189 0.996 . . . . 71.43 109.103 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -92.86 110.74 22.19 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.026 -0.731 . . . . 75.34 109.026 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 22.9 mt -75.59 -46.68 30.4 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.683 0.754 . . . . 63.2 109.635 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.51 179.45 7.8 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 114.572 -1.195 . . . . 74.14 109.774 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -74.92 128.9 36.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.658 -1.155 . . . . 75.23 108.179 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 73.69 -4.77 2.16 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 125.798 1.639 . . . . 63.42 112.83 -175.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 62.2 t -114.18 113.75 44.7 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 N-CA-C 108.253 -1.017 . . . . 64.13 108.253 172.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.638 ' HB3' HD13 ' B' ' 86' ' ' ILE . 23.1 t80 -125.44 138.25 54.01 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.663 -0.865 . . . . 74.34 108.663 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -113.76 119.75 38.45 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.388 -1.338 . . . . 74.12 107.388 -175.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.431 HG21 ' HB3' ' B' ' 102' ' ' CYS . 33.0 m -116.05 148.93 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.136 0.574 . . . . 32.01 110.37 -177.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 19.3 t -129.59 124.16 58.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 C-N-CA 123.652 0.781 . . . . 60.31 109.11 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 20.0 tp -101.83 108.95 20.6 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 109.318 -0.623 . . . . 64.42 109.318 171.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -88.36 118.47 27.99 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.386 0.674 . . . . 70.13 109.994 175.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.1 t -114.12 103.4 15.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 108.242 -1.022 . . . . 71.22 108.242 176.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 4.7 m -99.62 130.3 45.84 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.267 0.627 . . . . 64.13 109.383 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.666 HG13 HG13 ' B' ' 40' ' ' VAL . 54.3 t -128.43 102.28 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 124.271 1.029 . . . . 74.31 110.564 -176.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 31.9 m -83.71 150.01 26.11 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.279 -1.008 . . . . 62.13 108.279 165.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -138.89 147.91 42.96 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.04 0.536 . . . . 61.42 110.033 177.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 36.2 p -138.92 125.31 20.4 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.121 0.568 . . . . 71.43 110.374 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.538 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 53.2 mt -94.23 100.61 12.64 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.022 -1.473 . . . . 72.32 107.022 173.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.36 -114.27 3.95 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 115.006 -0.997 . . . . 63.2 110.833 -170.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.83 6.32 9.9 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.018 0.927 . . . . 73.14 110.676 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -114.39 152.32 31.7 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.389 0.676 . . . . 65.23 109.22 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.8 m -64.56 137.99 58.15 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 123.648 0.592 . . . . 60.51 111.15 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.535 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -93.19 -63.62 1.19 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.579 -1.267 . . . . 74.12 107.579 170.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -145.56 167.76 22.26 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 114.244 -1.343 . . . . 74.41 110.601 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 61.0 mt -130.78 140.89 50.33 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.491 -2.04 . . . . 75.32 105.491 172.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.9 t -146.92 158.54 43.95 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.639 -0.874 . . . . 73.12 108.639 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.573 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 41.7 tt0 -165.04 132.24 3.01 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.512 -0.922 . . . . 73.04 108.512 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.0 t -128.23 144.54 37.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 123.479 0.712 . . . . 73.51 109.184 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -120.57 101.05 7.49 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.951 -1.129 . . . . 71.2 107.951 169.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.472 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.5 tp-100 -90.71 102.53 15.28 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.147 -1.057 . . . . 74.54 108.147 175.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.5 158.93 27.95 Favored Glycine 0 C--O 1.245 0.79 0 CA-C-N 115.283 -0.871 . . . . 72.02 110.946 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.98 125.87 1.62 Allowed Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 111.02 -0.832 . . . . 61.35 111.02 -178.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.449 HG13 ' HE1' ' B' ' 17' ' ' TYR . 50.9 mt -85.0 125.28 40.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 106.902 -1.518 . . . . 74.11 106.902 172.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . 0.415 ' HD2' ' HA ' ' B' ' 13' ' ' ILE . 58.1 m-85 -134.38 154.75 51.19 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.047 -0.724 . . . . 62.22 109.047 176.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 74.0 m -91.7 104.3 16.78 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.674 -0.861 . . . . 75.42 108.674 169.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.638 HD13 ' HB3' ' B' ' 56' ' ' TYR . 3.7 mp -101.37 107.86 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 106.602 -1.629 . . . . 72.4 106.602 173.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.21 171.32 15.11 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.153 0.581 . . . . 51.43 110.632 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.657 ' HA2' ' HB ' ' F' ' 23' ' ' THR . . . 83.11 -72.54 2.83 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.364 -0.834 . . . . 60.42 111.89 -177.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.56 ' HB ' ' HG2' ' B' ' 9' ' ' MET . 1.4 mm -87.16 144.35 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.029 0.932 . . . . 65.52 111.103 -176.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.48 ' HG2' ' H ' ' B' ' 91' ' ' GLY . 14.9 tt0 -154.69 175.35 13.8 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.177 -1.374 . . . . 74.21 107.611 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.48 ' H ' ' HG2' ' B' ' 90' ' ' GLU . . . 80.24 -113.89 3.74 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-O 120.03 -0.317 . . . . 52.25 112.364 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 8.9 m -73.96 -53.52 9.9 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.259 0.624 . . . . 60.25 111.718 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -70.98 -26.54 63.19 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.252 -0.886 . . . . 65.23 112.292 -165.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.448 ' HE1' ' HG2' ' B' ' 90' ' ' GLU . 21.0 ptt? -69.46 -25.08 63.92 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 122.977 0.173 . . . . 54.03 111.115 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.66 -38.72 78.76 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.491 0.716 . . . . 44.24 110.944 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -77.95 -37.4 47.68 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.949 -1.023 . . . . 72.14 110.507 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -67.74 -25.73 65.79 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.414 0.686 . . . . 65.2 112.12 -177.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.668 HD11 HG23 ' F' ' 18' ' ' VAL . 84.3 mt -93.15 -43.92 8.61 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.184 0.594 . . . . 74.3 110.59 176.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.72 -18.42 73.06 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 115.152 0.821 . . . . 64.43 115.152 -170.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.05 -43.68 1.95 Allowed 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 117.589 0.694 . . . . 43.1 111.799 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.46 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 27.3 t80 -76.77 -52.5 9.45 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.801 -0.636 . . . . 73.03 111.427 -168.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.431 ' HB3' HG21 ' B' ' 58' ' ' VAL . 70.2 m -62.28 -44.4 88.29 Favored Pre-proline 0 CA--C 1.571 1.781 0 CA-C-O 118.269 -0.872 . . . . 73.21 112.959 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -51.68 -43.46 50.79 Favored 'Trans proline' 0 C--N 1.405 3.502 0 C-N-CA 122.832 2.355 . . . . 55.24 113.324 172.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -55.95 -33.3 64.64 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.152 0.981 . . . . 73.22 112.083 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 52.3 mt -77.57 -48.32 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.749 0.82 . . . . 73.11 110.868 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 79.2 mt -87.48 -19.89 27.33 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.661 0.784 . . . . 64.1 112.806 -167.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -64.15 -44.26 76.61 Favored Pre-proline 0 CA--C 1.563 1.479 0 CA-C-O 117.676 -1.154 . . . . 75.1 112.527 -174.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -53.14 -38.46 80.97 Favored 'Trans proline' 0 C--N 1.392 2.862 0 C-N-CA 122.553 2.169 . . . . 71.04 113.83 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.472 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 72.7 m-85 -70.81 -40.69 72.34 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.583 -0.735 . . . . 74.14 110.51 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.8 -37.03 83.75 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.741 0.416 . . . . 55.41 110.673 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -60.85 -55.76 29.19 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.156 1.383 . . . . 72.32 110.717 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -58.86 -37.97 77.7 Favored 'General case' 0 C--N 1.358 0.945 0 O-C-N 124.009 0.818 . . . . 74.43 110.555 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.434 ' O ' ' HG2' ' B' ' 117' ' ' MET . 16.8 t -67.41 -42.61 82.97 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-N 115.374 -0.83 . . . . 75.33 111.293 -175.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.97 -52.68 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 123.741 0.651 . . . . 74.32 109.541 176.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 10.7 m -60.97 -27.29 68.16 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 124.129 0.893 . . . . 62.01 111.689 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -68.52 -52.04 36.4 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 123.187 0.595 . . . . 62.53 109.67 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.434 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 33.7 mmt -59.56 -38.7 81.82 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.162 0.585 . . . . 63.53 111.063 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' B' ' 123' ' ' PHE . 71.1 t -66.24 -45.63 89.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.789 1.236 . . . . 71.24 111.034 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.7 t -67.63 -29.12 68.35 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.265 0.626 . . . . 52.31 111.107 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -73.34 -38.58 65.7 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.786 0.835 . . . . 74.44 110.042 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.58 -2.5 69.29 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 124.028 0.83 . . . . 65.54 112.5 171.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 20.1 p 63.22 28.87 15.97 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.804 2.042 . . . . 64.5 112.839 174.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.426 ' HB2' HG13 ' B' ' 118' ' ' VAL . 92.2 m-85 -86.93 154.42 55.3 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.886 0.874 . . . . 75.34 110.483 176.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -48.24 153.37 3.02 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 124.095 3.197 . . . . 74.44 115.567 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.474 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -60.63 126.71 28.42 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.557 1.543 . . . . 74.42 111.797 -175.501 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 38.9 tp -127.8 113.89 16.54 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.822 -0.626 . . . . 72.14 110.386 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -121.36 112.65 18.83 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.295 -1.002 . . . . 72.11 108.295 171.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 9.2 tt -78.31 135.23 37.47 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.497 0.719 . . . . 74.44 109.667 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.93 137.34 87.44 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.487 1.115 . . . . 65.4 112.202 -173.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.525 ' HG3' HD13 ' D' ' 16' ' ' ILE . 38.1 Cg_endo -63.8 100.07 0.28 Allowed 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 123.188 2.592 . . . . 72.32 112.647 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.416 ' HB ' ' HB1' ' F' ' 7' ' ' ALA . 2.4 p -91.22 111.2 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-N 115.509 -0.769 . . . . 62.43 109.003 173.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -80.14 100.87 8.46 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.607 0.763 . . . . 74.53 109.113 -177.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -66.38 -41.6 89.15 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.41 0.684 . . . . 74.02 110.932 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -57.59 -50.57 72.68 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.452 1.101 . . . . 62.42 111.941 -174.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.33 -24.97 64.89 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.14 0.9 . . . . 54.3 112.091 -175.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' F' ' 10' ' ' LEU . 87.9 mt -66.5 -45.39 79.73 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.226 0.61 . . . . 45.13 110.233 176.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.438 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 76.8 m-85 -68.33 -43.01 78.49 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.687 -0.688 . . . . 71.51 110.48 175.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 23.5 ttt -61.68 -38.38 87.58 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.094 0.958 . . . . 74.52 111.451 -174.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -75.55 -31.66 60.14 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.032 -0.985 . . . . 72.12 109.661 -174.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -69.03 -27.99 66.16 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.401 -0.818 . . . . 63.33 110.501 177.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 65.7 mt -87.4 36.37 0.74 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.027 0.931 . . . . 63.55 111.047 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -67.52 125.15 25.26 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.943 0.897 . . . . 54.22 111.027 -178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -130.61 131.56 45.01 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.844 0.858 . . . . 73.42 109.424 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -112.2 -52.62 2.77 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.079 0.952 . . . . 74.04 110.98 -175.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.93 125.61 27.99 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.952 0.501 . . . . 74.42 110.746 -177.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 176.88 61.79 0.06 OUTLIER Glycine 0 C--N 1.347 1.181 0 O-C-N 123.317 0.385 . . . . 65.01 112.336 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.68 164.04 34.76 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.394 1.078 . . . . 73.33 110.116 -176.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -147.28 143.09 10.87 Favored Glycine 0 C--N 1.347 1.191 0 N-CA-C 112.114 -0.394 . . . . 62.4 112.114 -175.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 28.3 p -115.2 103.89 11.3 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.179 0.992 . . . . 74.31 110.187 -176.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -89.79 99.35 12.38 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.759 0.824 . . . . 75.31 110.171 -176.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -108.69 100.16 9.43 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.785 0.834 . . . . 71.31 109.112 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -81.2 154.52 26.62 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.129 0.49 . . . . 73.12 110.331 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -124.68 178.41 5.46 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.31 1.044 . . . . 75.1 109.846 -176.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -154.91 145.22 22.0 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.811 0.845 . . . . 74.14 109.12 173.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 C-N-CA 123.46 0.704 . . . . 63.35 109.827 179.304 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . 0.658 ' HG2' ' HB3' ' A' ' 39' ' ' GLU . 55.9 mtt . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.327 -0.619 . . . . 75.12 109.327 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 53.0 p -146.6 157.46 43.72 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.198 0.599 . . . . 73.43 111.13 -174.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -147.58 127.48 13.56 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.028 -1.101 . . . . 73.24 108.028 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -135.49 98.81 4.04 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.725 -0.843 . . . . 72.42 108.725 -176.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -165.84 115.6 1.01 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.004 0.922 . . . . 73.34 108.551 172.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -139.87 61.76 1.53 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 122.329 1.062 . . . . 60.22 108.805 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 44.7 p -115.46 166.97 11.29 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 114.47 -1.241 . . . . 75.22 108.607 169.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -73.33 164.24 26.96 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 110.534 -0.173 . . . . 44.42 110.534 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.415 ' HB2' HG23 ' C' ' 89' ' ' ILE . 23.3 ttt 65.09 116.47 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.022 1.329 . . . . 61.21 110.524 -164.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 91.5 m -84.96 90.73 7.89 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.957 -1.127 . . . . 54.2 107.957 174.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.589 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.6 t80 -104.95 119.18 38.4 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.233 -0.894 . . . . 75.33 109.738 176.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.552 HE22 ' HB3' ' E' ' 3' ' ' GLN . 35.5 tt0 -140.96 123.61 16.07 Favored 'General case' 0 C--O 1.245 0.824 0 N-CA-C 107.611 -1.255 . . . . 70.15 107.611 175.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 70.3 mt -71.4 122.43 23.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.213 -1.032 . . . . 75.34 108.213 171.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.537 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 20.7 mm-40 -85.11 -50.51 7.36 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 124.122 0.889 . . . . 60.22 109.018 -178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -172.41 124.19 0.48 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.951 -0.568 . . . . 70.23 110.214 -172.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 77.1 mt -112.28 143.74 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.55 -0.908 . . . . 72.3 108.55 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -174.94 166.03 3.56 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.674 0.79 . . . . 74.11 109.369 -171.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . 0.493 HG22 HE22 ' C' ' 80' ' ' GLN . 71.8 p -89.64 126.0 35.46 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.278 -0.638 . . . . 61.12 109.278 177.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -74.99 -50.2 17.37 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 122.668 1.223 . . . . 72.34 107.857 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.494 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 10.3 t70 -136.0 136.86 40.65 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 112.651 -2.068 . . . . 51.2 108.969 -166.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 75.2 mt -136.28 142.15 39.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.044 -1.465 . . . . 73.34 107.044 172.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -158.46 151.35 22.44 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.312 0.577 . . . . 45.02 110.328 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -150.32 134.42 17.0 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 107.919 -1.141 . . . . 72.45 107.919 174.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -134.35 137.55 44.23 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.465 0.706 . . . . 71.25 109.659 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.36 80.96 8.24 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 106.125 -1.805 . . . . 51.31 106.125 172.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.65 -8.89 24.07 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.9 2.4 . . . . 54.21 112.878 -171.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.456 ' ND2' ' HB ' ' C' ' 31' ' ' VAL . 20.2 p-10 -124.48 20.95 8.67 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.053 1.341 . . . . 74.15 110.277 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.85 -51.14 17.91 Favored Pre-proline 0 CA--C 1.564 1.511 0 N-CA-C 114.569 1.322 . . . . 64.34 114.569 -168.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.58 -51.13 9.82 Favored 'Trans proline' 0 C--N 1.392 2.845 0 CA-C-N 121.622 1.615 . . . . 54.03 112.169 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.438 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 84.1 t60 -68.38 -29.99 68.82 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.744 0.818 . . . . 53.44 112.28 -174.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.749 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.8 p -77.43 -26.52 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 N-CA-C 112.626 0.602 . . . . 73.22 112.626 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -68.98 -17.98 64.0 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.379 0.881 . . . . 73.3 113.379 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 19.4 pt20 -94.6 8.04 43.66 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.789 0.436 . . . . 70.45 111.181 177.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.766 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -89.78 168.84 11.77 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.005 0.922 . . . . 63.12 110.372 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . 0.438 ' N ' ' HG3' ' C' ' 34' ' ' LYS . 31.6 t70 -74.13 130.56 40.02 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.2 0.6 . . . . 75.03 109.66 165.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -80.7 88.93 5.74 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.059 0.544 . . . . 65.34 109.873 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -143.13 77.85 15.58 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 107.971 -1.122 . . . . 74.24 107.971 172.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.515 ' HB2' HG13 ' C' ' 40' ' ' VAL . 9.2 Cg_endo -88.11 127.09 2.1 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.968 2.445 . . . . 72.24 112.37 -173.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -82.46 86.5 6.75 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.522 -1.658 . . . . 75.01 106.522 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.515 HG13 ' HB2' ' C' ' 38' ' ' PRO . 3.1 m -82.81 111.29 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 113.18 -1.827 . . . . 64.23 111.006 -173.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -106.31 115.97 31.14 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.838 0.855 . . . . 63.3 109.84 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 8.0 mp -85.66 131.18 34.39 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.302 -0.999 . . . . 60.45 108.302 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.527 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 38.6 t70 -123.63 105.7 9.94 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.814 1.246 . . . . 70.21 107.903 -170.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.508 HD22 HD13 ' G' ' 8' ' ' LEU . 32.7 tp -95.66 140.57 30.29 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.728 -0.669 . . . . 74.44 110.006 -173.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.62 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 25.9 t70 -147.14 158.06 43.81 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.853 -1.166 . . . . 71.44 107.853 173.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 73.0 p -122.53 132.25 54.23 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.159 0.584 . . . . 50.45 110.59 -174.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -127.25 147.43 50.22 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.072 -1.085 . . . . 72.23 108.072 173.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 72.3 p -165.55 159.09 16.33 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.597 0.237 . . . . 62.11 111.609 -174.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 65.2 p -164.15 134.79 4.28 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.536 0.734 . . . . 63.02 110.013 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -77.04 120.6 22.36 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.766 -0.827 . . . . 53.34 108.766 171.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.579 HD11 HD12 ' C' ' 83' ' ' ILE . 43.6 mt -94.14 -39.84 10.36 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.638 0.775 . . . . 55.31 110.155 -176.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.451 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -148.41 -179.19 6.77 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.852 0.861 . . . . 65.42 110.146 177.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -57.23 110.39 0.83 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.629 0.772 . . . . 65.12 109.419 173.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 65.02 1.4 1.47 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.317 1.447 . . . . 61.33 114.35 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 90.1 t -93.18 110.73 23.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 106.914 -1.513 . . . . 73.31 106.914 173.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.572 ' HB2' HG13 ' G' ' 18' ' ' VAL . 17.7 t80 -125.1 136.25 53.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.911 -0.586 . . . . 75.43 110.137 -171.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.414 ' HB2' HD11 ' C' ' 51' ' ' LEU . 29.6 tt0 -94.05 119.71 33.29 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.222 -0.899 . . . . 52.23 109.234 175.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 61.7 t -104.76 114.04 43.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 107.419 -1.326 . . . . 71.22 107.419 168.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 63.1 t -105.54 133.24 50.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 107.674 -1.232 . . . . 62.34 107.674 169.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 13.9 tp -116.4 108.62 16.26 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.794 -0.817 . . . . 72.54 108.794 174.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.62 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 0.4 OUTLIER -83.64 114.13 21.33 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.365 -0.976 . . . . 64.31 108.365 179.366 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 12.2 t -110.81 130.13 64.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.076 -1.083 . . . . 64.13 108.076 174.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 31.1 m -124.86 118.52 26.5 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.586 -0.894 . . . . 54.43 108.586 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.543 HG23 HD13 ' C' ' 114' ' ' ILE . 98.9 t -98.77 110.41 26.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.462 -0.94 . . . . 75.31 108.462 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.4 HG23 HD23 ' C' ' 75' ' ' LEU . 11.2 m -96.32 137.7 35.01 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.123 -1.436 . . . . 74.13 107.123 174.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.45 118.38 19.25 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.526 -1.287 . . . . 63.5 107.526 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 60.1 m -138.47 127.78 24.43 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 109.253 -0.647 . . . . 63.44 109.253 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.766 HD13 ' HG2' ' C' ' 34' ' ' LYS . 2.9 mt -83.37 15.6 2.93 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.954 1.302 . . . . 72.12 111.291 -175.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.09 -104.49 0.59 Allowed Glycine 0 C--N 1.344 1.013 0 N-CA-C 109.346 -1.502 . . . . 74.13 109.346 -173.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -88.45 -20.79 24.73 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.348 0.659 . . . . 74.22 110.073 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -89.37 122.54 32.7 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.196 0.998 . . . . 74.53 110.156 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 89.1 m -75.97 125.12 28.5 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.998 -0.742 . . . . 44.45 108.998 166.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.749 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.33 -54.12 7.61 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.173 -0.677 . . . . 74.34 109.173 173.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -164.52 166.26 20.54 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 115.56 -0.745 . . . . 64.43 111.856 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.4 HD23 HG23 ' C' ' 65' ' ' THR . 2.3 tm? -131.6 104.41 6.93 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 106.762 -1.57 . . . . 60.13 106.762 172.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.51 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.8 t -110.19 146.15 36.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.842 0.857 . . . . 71.01 108.999 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -150.58 133.98 16.36 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.003 0.521 . . . . 53.03 109.877 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.5 t -132.54 132.79 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.507 -0.923 . . . . 74.1 108.507 168.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.497 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 61.0 mt-30 -105.56 98.49 8.18 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.701 -1.222 . . . . 74.42 107.701 173.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.493 HE22 HG22 ' C' ' 18' ' ' THR . 9.9 tp-100 -82.57 106.98 14.87 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.888 -0.596 . . . . 74.4 110.43 -174.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.65 145.66 21.98 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.902 -0.59 . . . . 74.23 111.69 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.11 117.2 0.8 Allowed Glycine 0 CA--C 1.509 -0.282 0 N-CA-C 110.477 -1.049 . . . . 63.53 110.477 177.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.579 HD12 HD11 ' C' ' 51' ' ' LEU . 13.1 mm -83.87 118.9 32.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.145 -1.057 . . . . 64.32 108.145 177.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.589 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 50.6 m-85 -129.17 128.36 43.23 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.146 0.978 . . . . 71.03 108.71 -176.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.1 p -83.33 115.62 22.08 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.864 -0.791 . . . . 70.21 108.864 172.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.466 ' HB ' HG21 ' G' ' 18' ' ' VAL . 4.4 mp -114.65 100.3 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 107.134 -1.432 . . . . 74.42 107.134 173.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -124.25 152.66 42.72 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.159 0.984 . . . . 63.44 109.034 176.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.41 -58.25 0.74 Allowed Glycine 0 C--N 1.345 1.04 0 CA-C-O 120.272 -0.182 . . . . 65.12 113.189 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.415 HG23 ' HB2' ' C' ' 9' ' ' MET . 29.9 pt -81.89 167.44 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 121.111 0.481 . . . . 55.41 111.413 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -150.08 -177.24 5.81 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.292 1.037 . . . . 75.52 110.019 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.71 -139.07 48.74 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 124.266 0.979 . . . . 50.2 114.618 171.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . 0.527 HG22 ' HG3' ' A' ' 150' ' ' GLU . 68.0 p -70.58 -18.75 62.9 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.853 0.861 . . . . 73.34 111.953 -175.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -74.91 -39.14 61.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.274 0.63 . . . . 61.02 109.951 174.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 46.5 ttm -60.81 -49.09 78.89 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.177 0.591 . . . . 73.24 109.815 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.22 -29.98 70.83 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.792 0.837 . . . . 71.13 112.072 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -67.15 -40.92 86.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.215 0.606 . . . . 74.45 110.327 174.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.568 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 15.2 t -64.78 -43.72 92.32 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.529 0.518 . . . . 74.43 110.799 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.559 HD11 HG23 ' G' ' 18' ' ' VAL . 86.1 mt -74.73 -36.79 62.65 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.413 0.685 . . . . 73.02 112.19 -176.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.92 -23.89 31.49 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 114.651 0.62 . . . . 72.13 114.651 -165.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.483 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -135.99 -47.03 0.65 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.446 0.641 . . . . 73.31 111.875 -172.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.568 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 82.4 t80 -74.23 -40.78 62.18 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 125.485 1.514 . . . . 74.45 112.604 -170.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 94.5 m -76.71 -43.23 3.04 Favored Pre-proline 0 N--CA 1.487 1.382 0 CA-C-O 118.568 -0.73 . . . . 71.41 111.194 176.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -47.34 -40.06 28.13 Favored 'Trans proline' 0 C--N 1.395 3.009 0 C-N-CA 122.84 2.36 . . . . 70.44 113.376 165.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -59.02 -38.49 79.38 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 123.668 0.605 . . . . 65.44 111.276 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.455 HD12 HH12 ' A' ' 111' ' ' ARG . 36.8 mm -65.27 -44.47 94.97 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 122.822 0.449 . . . . 64.4 109.842 174.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 94.9 mt -83.82 -15.22 49.13 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.816 1.043 . . . . 75.21 113.816 -169.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -58.72 -53.43 66.43 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-O 117.614 -1.184 . . . . 74.12 112.946 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.75 -32.11 78.3 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 121.702 1.601 . . . . 71.11 112.949 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -66.71 -53.69 30.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.371 0.668 . . . . 74.53 110.626 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.49 83.81 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.703 0.801 . . . . 74.4 110.465 177.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -57.77 -57.11 14.19 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.298 1.439 . . . . 71.32 111.287 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -38.0 83.19 Favored 'General case' 0 C--N 1.366 1.296 0 O-C-N 123.716 0.635 . . . . 75.54 109.713 -177.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.431 ' SG ' HG21 ' C' ' 18' ' ' THR . 8.8 t -66.3 -30.52 70.95 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 122.833 0.453 . . . . 62.3 111.761 -176.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.543 HD13 HG23 ' C' ' 64' ' ' VAL . 91.9 mt -74.46 -55.39 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.209 0.604 . . . . 71.33 109.534 173.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 21.8 m -59.99 -27.4 66.83 Favored 'General case' 0 CA--C 1.558 1.27 0 O-C-N 123.787 0.679 . . . . 61.41 111.204 -175.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 46.7 t -63.68 -48.62 76.44 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 124.429 1.092 . . . . 43.31 109.82 174.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.647 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -66.45 -36.26 82.34 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.115 0.966 . . . . 74.5 111.686 179.129 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 76.1 t -61.75 -41.12 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.561 0.744 . . . . 74.31 109.507 172.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.0 t -74.82 -28.86 60.88 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.95 -1.023 . . . . 73.14 111.763 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' C' ' 116' ' ' SER . 80.5 mtt-85 -73.0 -38.62 66.53 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.815 -0.809 . . . . 74.22 108.815 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.27 -4.92 70.22 Favored Glycine 0 C--N 1.356 1.691 0 CA-C-N 115.375 -0.829 . . . . 61.22 112.777 171.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 19.6 p 64.91 27.67 12.75 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.673 1.989 . . . . 75.41 113.157 171.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -83.99 142.25 41.49 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 108.263 -1.014 . . . . 75.32 108.263 170.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.54 163.44 1.16 Allowed 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.65 2.9 . . . . 70.35 114.711 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -54.33 134.08 45.21 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.326 1.05 . . . . 64.34 113.112 -171.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 27.5 tp -134.93 85.96 2.22 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.51 -1.293 . . . . 74.34 107.51 174.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -96.21 115.54 27.59 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.845 -1.07 . . . . 63.2 109.067 -175.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.24 121.61 14.11 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.747 0.819 . . . . 72.43 109.069 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.61 137.9 74.06 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 123.065 0.546 . . . . 71.21 111.286 -177.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.588 ' HB3' HD12 ' A' ' 16' ' ' ILE . 9.6 Cg_endo -52.47 109.51 0.35 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.139 2.559 . . . . 63.22 114.383 175.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 10.1 m -121.19 112.02 33.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 107.784 -1.191 . . . . 74.23 107.784 165.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -74.49 94.04 2.55 Favored 'General case' 0 C--N 1.354 0.774 0 N-CA-C 108.759 -0.83 . . . . 74.32 108.759 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.415 ' HA ' HD12 ' C' ' 136' ' ' LEU . 5.4 t80 -54.91 -34.18 62.86 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.943 1.697 . . . . 72.44 111.902 -173.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.483 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 9.7 t70 -74.45 -41.45 60.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.42 1.088 . . . . 73.42 111.178 -177.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.77 -30.76 71.05 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.092 0.957 . . . . 75.01 111.324 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' C' ' 133' ' ' PHE . 97.1 mt -58.6 -37.5 75.99 Favored 'General case' 0 CA--C 1.554 1.105 0 O-C-N 124.11 0.881 . . . . 53.51 111.022 172.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -80.35 -27.17 38.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.758 0.823 . . . . 64.42 111.851 175.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 23.7 mmt -66.96 -28.25 68.12 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.271 0.628 . . . . 73.23 111.472 175.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -55.79 -35.91 66.81 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.255 1.022 . . . . 75.0 111.332 172.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -72.28 -154.95 0.03 OUTLIER 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.684 0.794 . . . . 74.32 109.679 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.486 HD21 ' HA2' ' A' ' 148' ' ' GLY . 56.3 mt 59.41 -103.59 0.17 Allowed 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 124.344 1.058 . . . . 54.31 111.098 174.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 179.68 136.88 0.11 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.133 1.373 . . . . 72.25 108.487 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -115.44 96.21 5.53 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.436 -1.32 . . . . 72.51 107.436 174.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -108.01 -6.49 16.53 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.78 0.832 . . . . 74.43 111.245 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.42 123.76 34.4 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.411 0.684 . . . . 74.22 110.324 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -170.18 129.9 1.91 Allowed Glycine 0 C--N 1.334 0.446 0 CA-C-O 119.846 -0.419 . . . . 63.22 112.174 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -167.03 118.56 0.92 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.154 0.582 . . . . 75.23 110.035 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -98.59 112.41 4.46 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 111.592 -0.603 . . . . 54.23 111.592 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . 0.499 ' H ' ' H ' ' A' ' 92' ' ' THR . 21.1 p -71.18 93.67 1.09 Allowed 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 117.2 0.5 . . . . 72.51 109.852 171.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -72.36 -49.21 35.79 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.136 0.975 . . . . 64.34 111.009 -176.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.44 133.13 39.94 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 107.345 -1.354 . . . . 74.42 107.345 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . 0.405 ' HB3' HG21 ' E' ' 23' ' ' THR . 35.2 m80 -90.79 -56.87 3.02 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.893 0.477 . . . . 74.13 111.125 -174.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 58.38 79.78 0.2 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.703 0.763 . . . . 72.24 109.819 -166.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.43 83.36 6.26 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.237 -0.892 . . . . 73.14 109.933 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-N 115.053 -0.976 . . . . 63.24 108.932 175.02 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 109.333 -0.617 . . . . 55.34 109.333 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 23.1 t -159.61 175.83 12.74 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.149 0.98 . . . . 61.23 109.169 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -161.66 -149.82 0.18 Allowed 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 107.283 -1.377 . . . . 73.41 107.283 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . 0.664 ' HA ' ' HG3' ' D' ' 93' ' ' GLN . 51.5 mt-30 67.3 97.56 0.06 Allowed 'General case' 0 C--N 1.364 1.22 0 C-N-CA 124.567 1.147 . . . . 73.13 111.872 175.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -85.63 -61.16 1.82 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.294 0.638 . . . . 75.4 111.684 -172.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -75.78 124.36 27.16 Favored 'General case' 0 C--N 1.36 1.054 0 CA-C-O 121.055 0.455 . . . . 65.12 110.98 -175.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 9.2 t -73.33 -11.97 60.67 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.418 1.087 . . . . 64.15 111.131 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -64.78 -23.6 67.29 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.419 1.087 . . . . 60.24 111.869 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.522 ' HG3' HD11 ' D' ' 89' ' ' ILE . 7.6 ttt -32.42 124.68 0.32 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.944 1.298 . . . . 63.22 113.906 168.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 64.5 m -108.67 142.28 39.4 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.718 -0.845 . . . . 75.32 108.718 169.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' D' ' 85' ' ' SER . 25.0 t80 -158.58 119.85 3.43 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.757 -0.831 . . . . 74.34 108.757 177.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -138.86 145.24 39.73 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.759 1.224 . . . . 73.33 108.118 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 52.4 mt -91.77 127.62 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.24 -0.652 . . . . 73.11 109.24 176.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.425 HE22 HG13 ' D' ' 55' ' ' VAL . 51.1 mt-30 -97.53 -46.63 5.97 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 122.531 0.333 . . . . 75.15 111.061 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -167.77 127.53 1.34 Allowed 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 117.816 0.28 . . . . 75.31 111.527 -170.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.525 HD13 ' HG3' ' B' ' 130' ' ' PRO . 2.4 mp -103.82 138.05 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.358 -1.349 . . . . 74.31 107.358 167.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -163.94 149.4 10.79 Favored 'General case' 0 C--O 1.242 0.664 0 O-C-N 123.813 0.695 . . . . 73.2 110.658 176.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.1 p -83.36 116.85 22.66 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.419 -0.81 . . . . 74.41 109.212 174.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -84.74 -35.87 22.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.635 -0.876 . . . . 71.01 108.635 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.619 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 12.7 t70 -143.25 129.23 19.57 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.283 -1.326 . . . . 74.31 109.129 -174.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.647 HG21 ' HE2' ' C' ' 117' ' ' MET . 62.1 mt -135.56 148.45 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.643 1.177 . . . . 71.12 108.612 174.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.6 t -147.17 142.87 27.77 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.027 0.931 . . . . 55.21 109.536 171.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 83.1 t80 -146.63 119.93 8.96 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 105.252 -2.129 . . . . 73.04 105.252 172.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.8 mt-10 -134.98 109.94 8.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.311 0.645 . . . . 73.22 109.386 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.24 90.95 5.11 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 107.734 -1.21 . . . . 73.14 107.734 175.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -73.5 -33.36 6.92 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.726 2.284 . . . . 72.4 112.554 -169.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -110.4 18.53 19.73 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.143 0.977 . . . . 74.12 109.897 -175.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -34.22 -61.01 0.45 Allowed Pre-proline 0 CA--C 1.569 1.685 0 N-CA-C 116.309 1.966 . . . . 50.43 116.309 -161.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.436 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 93.1 Cg_endo -76.36 -26.88 8.39 Favored 'Trans proline' 0 C--N 1.385 2.481 0 CA-C-N 122.996 2.106 . . . . 71.34 113.202 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -66.38 -44.36 83.31 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.507 1.123 . . . . 64.44 109.624 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' D' ' 73' ' ' ALA . 12.0 p -82.46 -16.42 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-N 115.202 -0.908 . . . . 71.41 111.446 -172.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.436 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 16.7 m-85 -64.75 -26.2 68.26 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.102 0.408 . . . . 64.51 112.102 177.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -58.27 -21.92 50.48 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.842 0.857 . . . . 71.02 111.198 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.403 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 88.3 mttt -93.73 97.5 10.49 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.931 1.292 . . . . 72.12 109.09 173.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -104.9 85.29 2.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.718 0.771 . . . . 74.42 109.324 177.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 19.1 p90 -149.25 -173.16 4.31 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.688 -1.142 . . . . 73.44 108.075 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -77.14 113.13 28.01 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.147 0.579 . . . . 64.44 110.237 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.23 130.37 39.04 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.664 2.243 . . . . 75.54 112.696 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -64.56 112.18 3.05 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.795 -0.817 . . . . 63.42 108.795 172.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 13.9 m -101.81 125.37 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.745 0.818 . . . . 74.31 110.91 -171.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.646 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 0.1 OUTLIER -104.82 111.92 24.84 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.68 1.192 . . . . 73.1 108.096 179.032 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.619 ' HB2' HG22 ' H' ' 6' ' ' ILE . 50.2 tp -98.45 126.22 43.91 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 122.759 0.423 . . . . 73.1 110.004 -178.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -141.25 125.72 17.7 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.78 0.832 . . . . 75.32 109.019 174.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.95 146.67 27.53 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.519 0.728 . . . . 73.22 110.418 -176.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.432 ' HA ' ' HG3' ' H' ' 12' ' ' PRO . 17.2 t70 -134.53 156.04 49.34 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.842 1.257 . . . . 71.55 108.159 171.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . 0.4 HG22 ' HG2' ' H' ' 12' ' ' PRO . 5.9 t -127.8 151.4 49.08 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.48 0.657 . . . . 65.31 110.937 -178.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.81 152.62 36.82 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.302 -1.37 . . . . 32.42 107.302 168.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 77.6 p -172.75 153.41 2.71 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.831 0.452 . . . . 70.11 110.752 -175.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 37.2 p -169.48 159.11 8.32 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.069 0.948 . . . . 75.42 109.772 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -90.47 134.77 34.13 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.386 -0.598 . . . . 73.53 109.386 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.508 ' HB2' HG12 ' D' ' 55' ' ' VAL . 63.9 mt -99.68 -42.31 6.93 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.035 0.534 . . . . 71.3 110.7 -177.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.42 -168.94 2.73 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.334 0.653 . . . . 63.33 110.388 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.04 118.36 9.7 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.539 -0.541 . . . . 52.03 109.539 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 64.4 4.65 2.28 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.016 1.327 . . . . 74.4 112.779 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.508 HG12 ' HB2' ' D' ' 51' ' ' LEU . 79.3 t -110.67 129.27 66.12 Favored 'Isoleucine or valine' 0 C--N 1.351 0.638 0 C-N-CA 124.624 1.17 . . . . 71.31 108.6 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -145.37 172.9 12.51 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.691 -0.855 . . . . 65.13 108.691 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -132.29 145.48 51.31 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.097 -0.956 . . . . 75.12 110.12 174.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.459 HG21 ' HB3' ' D' ' 102' ' ' CYS . 15.1 m -129.32 142.12 44.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.204 1.002 . . . . 73.34 108.678 167.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.405 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 39.4 t -128.44 117.23 44.59 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 C-N-CA 124.322 1.049 . . . . 62.24 108.223 -175.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.571 HD22 ' HB2' ' D' ' 103' ' ' PRO . 60.9 tp -103.61 119.13 38.28 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.714 -0.476 . . . . 65.42 109.714 174.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -88.17 108.09 19.1 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.047 -0.723 . . . . 74.12 109.047 170.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 41.1 t -91.89 128.41 43.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.356 -1.35 . . . . 73.31 107.356 166.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.4 m -125.17 125.2 43.3 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.582 0.706 . . . . 54.14 110.807 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 48.2 t -115.59 100.76 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.034 1.734 . . . . 74.45 108.242 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.646 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 91.8 m -96.35 102.5 14.29 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.062 -1.088 . . . . 65.25 108.062 172.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.16 139.67 39.48 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.371 -0.831 . . . . 71.01 109.441 -170.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.428 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 61.3 p -147.53 126.32 12.66 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.054 0.454 . . . . 64.33 111.52 -173.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.444 HD12 HG22 ' D' ' 31' ' ' VAL . 51.4 mt -98.54 113.91 26.13 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.269 1.028 . . . . 75.02 108.479 175.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.73 -128.32 9.1 Favored Glycine 0 C--N 1.343 0.935 0 O-C-N 123.383 0.427 . . . . 72.42 113.04 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.03 18.95 20.98 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.043 0.537 . . . . 73.05 110.879 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.403 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 11.7 pt-20 -140.32 167.41 22.2 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.261 0.624 . . . . 61.3 110.07 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 77.0 m -74.35 139.5 44.16 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.461 0.704 . . . . 71.33 110.551 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.601 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.94 -64.77 1.1 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 107.717 -1.216 . . . . 64.11 107.717 171.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -156.8 162.97 39.72 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 114.497 -1.229 . . . . 74.01 110.176 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 84.8 mt -121.44 112.27 18.33 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 124.728 1.211 . . . . 63.02 107.921 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -114.05 133.82 55.27 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.208 -1.034 . . . . 72.11 108.208 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -156.6 120.56 4.36 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.186 -0.672 . . . . 65.32 109.186 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 80.8 t -130.61 114.32 27.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.643 -0.873 . . . . 72.33 108.643 -176.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.619 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 37.5 mt-30 -88.94 87.71 7.32 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 108.489 -0.93 . . . . 73.52 108.489 170.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -80.03 104.51 10.64 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 113.745 -1.571 . . . . 74.42 108.167 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -101.98 150.98 18.38 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 111.236 -0.746 . . . . 54.34 111.236 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.31 131.13 3.94 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.738 -0.545 . . . . 63.22 111.738 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.9 mt -88.38 123.18 40.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 107.572 -1.27 . . . . 74.13 107.572 171.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -131.51 169.35 16.21 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.254 1.021 . . . . 45.14 108.942 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 25.5 m -112.65 136.03 52.68 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.058 0.943 . . . . 73.12 108.862 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.59 HG12 HD13 ' D' ' 89' ' ' ILE . 12.1 tt -145.79 137.57 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.352 -0.981 . . . . 72.54 108.352 176.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.09 127.4 1.83 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.502 0.321 . . . . 63.31 111.073 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.1 4.81 55.21 Favored Glycine 0 C--N 1.346 1.129 0 O-C-N 123.613 0.57 . . . . 74.03 113.228 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.59 HD13 HG12 ' D' ' 86' ' ' ILE . 3.3 mp -115.56 150.21 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.385 0.674 . . . . 65.54 110.208 -175.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.24 176.06 6.99 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.567 1.547 . . . . 60.33 109.004 173.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.89 -129.32 46.39 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 114.58 0.592 . . . . 75.34 114.58 175.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.8 m -71.56 -33.49 69.14 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.535 1.134 . . . . 51.34 112.225 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.664 ' HG3' ' HA ' ' D' ' 4' ' ' GLN . 50.0 tt0 -64.21 -30.37 71.44 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.823 0.849 . . . . 65.14 111.566 -177.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.623 ' HE1' ' HB2' ' H' ' 20' ' ' LYS . 48.0 mtm -62.18 -39.33 92.34 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.919 0.488 . . . . 73.12 111.473 174.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.99 -36.98 83.13 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.857 0.463 . . . . 75.4 112.08 -173.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.491 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 54.5 t-80 -81.21 -29.27 34.57 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.339 0.256 . . . . 74.53 111.576 177.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 34.5 t -70.75 -49.91 41.73 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.286 0.565 . . . . 75.11 110.832 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.768 HD13 ' HD2' ' H' ' 17' ' ' PRO . 29.4 mt -93.8 -45.0 7.85 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 124.464 1.105 . . . . 62.35 110.973 -166.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.33 -1.25 88.17 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-O 119.825 -0.431 . . . . 73.23 113.534 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -133.01 -68.46 0.59 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.475 0.637 . . . . 54.2 111.317 -178.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -70.82 -42.9 69.63 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 112.896 0.702 . . . . 70.42 112.896 -167.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.459 ' HB3' HG21 ' D' ' 58' ' ' VAL . 66.6 m -62.04 -50.29 81.29 Favored Pre-proline 0 CA--C 1.568 1.664 0 N-CA-C 112.881 0.697 . . . . 54.44 112.881 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.571 ' HB2' HD22 ' D' ' 60' ' ' LEU . 98.2 Cg_endo -77.52 -7.58 16.86 Favored 'Trans proline' 0 C--N 1.39 2.715 0 C-N-CA 122.267 1.978 . . . . 74.23 112.711 175.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -77.51 -30.57 52.99 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.765 -0.828 . . . . 61.33 108.765 171.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.1 mm -70.51 -38.22 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.518 0.727 . . . . 54.42 109.638 169.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.98 -11.35 59.58 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.488 0.715 . . . . 63.3 111.771 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . 0.432 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 86.5 t80 -65.97 -51.63 45.64 Favored Pre-proline 0 CA--C 1.567 1.634 0 C-N-CA 124.2 1.0 . . . . 73.12 112.605 -177.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 34.3 Cg_exo -60.64 -32.32 93.15 Favored 'Trans proline' 0 C--N 1.395 2.979 0 C-N-CA 122.128 1.885 . . . . 74.04 112.814 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -80.76 -32.07 35.67 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.865 0.866 . . . . 74.14 112.177 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.1 -46.37 81.35 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.804 -0.813 . . . . 64.05 108.804 173.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -62.23 -41.24 98.23 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 124.228 0.955 . . . . 71.42 110.839 177.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -51.68 -53.64 36.83 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.428 1.091 . . . . 65.11 111.131 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.1 t -67.74 -46.75 71.25 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.191 -0.913 . . . . 55.31 111.485 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.484 ' O ' HG23 ' D' ' 118' ' ' VAL . 84.7 mt -62.2 -57.58 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.474 0.71 . . . . 73.22 110.841 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 90.9 m -49.95 -45.75 51.61 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.32 1.013 . . . . 53.44 111.734 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.5 t -64.97 -43.31 93.05 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.083 -0.962 . . . . 73.22 110.955 -175.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.423 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 73.3 mtm -65.05 -36.35 84.07 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.79 0.436 . . . . 64.14 111.559 179.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.484 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.7 t -62.53 -44.67 99.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.789 0.835 . . . . 51.12 110.366 177.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.2 p -76.86 -26.25 54.03 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 116.08 -0.509 . . . . 51.54 111.38 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -72.98 -34.24 66.32 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.434 0.694 . . . . 70.5 109.892 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.35 3.17 79.12 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 115.582 -0.736 . . . . 43.23 112.393 171.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.0 p 60.39 24.38 13.92 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 126.866 2.067 . . . . 55.52 113.669 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -82.43 158.89 65.55 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 124.095 0.958 . . . . 75.41 109.585 169.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -49.64 127.49 18.73 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 123.369 2.713 . . . . 74.12 113.31 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -52.08 131.24 31.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.288 1.035 . . . . 72.32 111.27 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 45.8 tp -124.08 97.86 5.53 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.243 0.617 . . . . 74.32 110.15 -172.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -101.87 121.41 42.06 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.805 0.842 . . . . 73.12 109.664 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 tt -74.3 115.88 14.32 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 108.463 -0.94 . . . . 61.05 108.463 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.47 143.86 98.56 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.684 0.794 . . . . 61.15 111.644 -176.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.46 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 6.8 Cg_exo -70.48 121.88 8.39 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.696 2.264 . . . . 64.14 111.535 -177.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.5 m -115.24 154.14 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.008 0.923 . . . . 74.24 110.743 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -73.07 80.29 1.23 Allowed 'General case' 0 C--N 1.354 0.781 0 N-CA-C 108.536 -0.913 . . . . 75.54 108.536 173.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -57.22 -35.49 69.72 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.243 1.417 . . . . 54.21 110.626 -176.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.502 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 4.1 m-20 -62.48 -56.06 21.71 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.109 -1.405 . . . . 53.2 111.801 -177.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.59 -37.9 87.96 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.924 0.765 . . . . 64.11 111.911 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 79.6 mt -58.05 -47.44 83.14 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.347 1.029 . . . . 64.12 111.572 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -78.22 -30.3 48.78 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.058 0.543 . . . . 74.53 110.92 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 34.1 ttm -63.19 -27.99 69.74 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.33 1.052 . . . . 71.5 112.269 -174.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -63.35 -34.87 78.66 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.547 0.739 . . . . 64.3 111.475 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -60.31 -38.52 83.96 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.822 0.849 . . . . 72.41 110.746 175.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 mp -62.41 -32.43 73.26 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.655 0.782 . . . . 73.45 111.128 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -84.84 -0.83 55.32 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.372 0.669 . . . . 64.34 112.112 -177.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -121.88 47.97 1.79 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.719 0.808 . . . . 53.41 109.769 -176.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -165.36 126.95 2.01 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.23 -0.441 . . . . 71.03 110.783 -175.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -113.56 100.32 8.41 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.917 0.887 . . . . 75.01 108.73 174.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.29 129.87 9.7 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.886 -0.486 . . . . 71.05 111.886 -176.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -107.51 103.5 12.84 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.372 1.069 . . . . 54.22 109.411 -175.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -98.25 59.27 0.98 Allowed Glycine 0 C--N 1.346 1.131 0 C-N-CA 122.753 0.216 . . . . 71.03 113.069 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 33.1 p -106.31 143.98 33.65 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.282 0.633 . . . . 72.34 109.975 175.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.01 134.27 52.3 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.355 0.662 . . . . 74.44 111.051 -178.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.93 -11.66 14.64 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.3 1.04 . . . . 73.45 109.645 177.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -131.99 100.45 5.07 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.564 1.146 . . . . 54.52 108.132 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.25 82.96 3.72 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.413 0.625 . . . . 70.44 110.146 173.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.07 125.33 26.59 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.592 -0.731 . . . . 71.25 109.341 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.148 0 O-C-N 124.271 0.982 . . . . 53.31 111.325 -176.15 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.019 -0.734 . . . . 74.45 109.019 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 2' ' ' LYS . . . . . 0.419 ' HG2' HG21 ' C' ' 10' ' ' THR . 47.2 mtmt 71.73 120.14 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 125.403 1.481 . . . . 64.43 110.833 -174.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . 0.552 ' HB3' HE22 ' C' ' 12' ' ' GLN . 5.3 tp60 -94.84 138.18 32.95 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.165 0.586 . . . . 73.21 110.099 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 35.7 p -67.11 103.64 1.24 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.883 0.873 . . . . 63.22 110.619 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 63.5 m -127.96 134.69 49.31 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.589 0.756 . . . . 71.53 110.153 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.511 HG21 ' H ' ' A' ' 40' ' ' VAL . 2.5 pp -57.93 143.79 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 124.295 1.038 . . . . 64.45 112.13 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -143.39 153.96 43.22 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.084 0.554 . . . . 52.11 110.776 -175.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.505 HD11 HD21 ' A' ' 44' ' ' LEU . 4.0 tt -79.61 133.65 36.43 Favored 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 108.659 -0.867 . . . . 54.54 108.659 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.14 174.89 9.51 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.481 0.712 . . . . 73.4 111.807 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 tt -76.94 134.25 38.97 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 107.931 -1.137 . . . . 70.24 107.931 175.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.63 110.21 3.77 Favored Pre-proline 0 N--CA 1.484 1.226 0 C-N-CA 123.862 0.865 . . . . 72.5 111.159 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.43 99.56 1.3 Allowed 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.418 2.079 . . . . 52.55 110.536 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 tt 64.81 85.69 0.14 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.024 1.33 . . . . 70.42 107.972 -169.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.11 152.15 44.26 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.555 -0.748 . . . . 73.2 110.31 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -61.59 137.0 58.22 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.588 0.755 . . . . 75.24 109.893 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 50.6 p -131.13 79.34 71.09 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.351 0.66 . . . . 70.13 112.019 -171.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 17' ' ' PRO . . . . . 0.546 ' HD2' HD13 ' A' ' 98' ' ' LEU . 73.0 Cg_endo -76.1 179.75 6.03 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.189 1.926 . . . . 65.01 111.908 165.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 18' ' ' VAL . . . . . 0.432 HG11 ' SD ' ' A' ' 94' ' ' MET . 38.0 t 55.86 88.95 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 125.014 1.326 . . . . 61.21 111.982 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m 68.25 9.86 7.48 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 124.468 1.107 . . . . 75.45 112.199 172.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp 56.36 69.75 0.71 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.801 -0.814 . . . . 74.12 108.801 -166.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.95 -31.42 50.5 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.892 0.877 . . . . 52.52 112.914 -172.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -134.04 149.67 51.18 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.465 0.706 . . . . 72.41 109.992 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . 0.405 HG21 ' HB3' ' C' ' 152' ' ' HIS . 12.5 p -140.92 153.86 67.87 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 124.496 1.118 . . . . 70.54 109.431 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -47.36 115.36 1.34 Allowed 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.74 2.96 . . . . 63.55 114.244 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 CA--C 1.553 1.062 0 C-N-CA 125.379 1.471 . . . . 72.15 109.742 -174.688 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 78.0 mtp . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.082 -0.71 . . . . 51.45 109.082 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' F' F ' 2' ' ' LYS . . . . . 0.447 ' HG2' ' HB2' ' B' ' 39' ' ' GLU . 0.5 OUTLIER -87.69 69.15 9.62 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.557 0.743 . . . . 75.45 109.652 -179.491 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -94.82 63.72 2.82 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.151 -0.931 . . . . 73.14 109.111 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 41.0 m -122.63 124.89 44.5 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.76 0.824 . . . . 74.32 109.013 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 15.2 p -68.24 137.14 54.54 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.299 0.64 . . . . 74.52 110.668 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.6 HG12 ' HB ' ' B' ' 40' ' ' VAL . 4.2 mp -104.74 128.03 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.329 1.051 . . . . 62.43 108.995 -175.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 7' ' ' ALA . . . . . 0.416 ' HB1' ' HB ' ' B' ' 131' ' ' VAL . . . -101.36 -102.45 0.26 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.886 -1.153 . . . . 62.55 107.886 170.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . 0.532 ' HA ' HD22 ' B' ' 42' ' ' LEU . 4.5 tt -165.87 -85.02 0.02 OUTLIER 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.77 -1.196 . . . . 71.53 107.77 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . 167.7 170.17 0.03 OUTLIER 'General case' 0 C--O 1.243 0.748 0 C-N-CA 125.973 1.709 . . . . 61.34 108.311 -173.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 10' ' ' LEU . . . . . 0.412 ' HA ' HD13 ' B' ' 136' ' ' LEU . 5.3 tt -80.63 102.18 9.67 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.029 -1.471 . . . . 73.4 107.029 170.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 60.9 mt -61.92 137.19 95.34 Favored Pre-proline 0 CA--C 1.549 0.914 0 O-C-N 123.5 0.5 . . . . 61.1 110.508 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.3 -158.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.8 2.333 . . . . 54.55 111.522 175.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tt -80.8 84.57 6.29 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 107.251 -1.389 . . . . 75.12 107.251 173.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . 0.592 ' HG ' ' HD1' ' F' ' 15' ' ' PHE . 2.4 pt? -105.65 178.14 4.65 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.854 0.862 . . . . 74.04 109.48 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . 0.592 ' HD1' ' HG ' ' F' ' 14' ' ' LEU . 43.0 m-85 69.13 116.49 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.754 1.222 . . . . 74.23 110.134 -170.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 25.2 p -63.91 128.32 92.77 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 123.2 0.6 . . . . 63.54 111.156 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -58.49 140.76 95.93 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.593 2.862 . . . . 72.43 113.786 -175.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . 0.668 HG23 HD11 ' B' ' 98' ' ' LEU . 17.1 t -73.39 127.47 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.198 0.599 . . . . 65.12 109.77 -178.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 19.0 m -70.87 -26.53 63.29 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.547 0.739 . . . . 73.32 111.486 -178.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -136.78 84.8 2.09 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.522 0.677 . . . . 63.23 109.702 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . 0.476 ' HB2' ' HB ' ' F' ' 18' ' ' VAL . . . -116.27 9.12 14.45 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 114.43 -1.259 . . . . 70.2 110.455 172.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -74.0 147.05 43.32 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.254 0.622 . . . . 65.25 109.817 173.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 23' ' ' THR . . . . . 0.657 ' HB ' ' HA2' ' B' ' 88' ' ' GLY . 5.9 t -63.85 136.77 96.87 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 122.757 0.423 . . . . 72.52 111.315 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.84 1.72 7.33 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.177 2.585 . . . . 53.03 113.347 176.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 . . . . . 0 CA--C 1.555 1.137 0 C-N-CA 124.418 1.087 . . . . 73.11 109.114 -179.219 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 83.0 mtp . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.546 0.212 . . . . 64.25 110.598 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -75.15 121.01 21.43 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.495 -1.298 . . . . 75.33 107.495 167.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -70.17 96.85 1.13 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 109.208 -0.664 . . . . 63.44 109.208 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 49.6 m -71.1 77.7 0.68 Allowed 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.266 1.026 . . . . 51.54 109.997 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 18.1 m -138.69 139.38 38.41 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.004 -0.998 . . . . 45.15 108.392 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . 0.478 HG21 ' O ' ' C' ' 40' ' ' VAL . 1.5 pp -84.84 167.22 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.753 0.821 . . . . 72.33 112.153 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -165.77 -175.74 3.58 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.932 -1.031 . . . . 73.43 109.797 -175.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 8' ' ' LEU . . . . . 0.508 HD13 HD22 ' C' ' 44' ' ' LEU . 97.0 mt -104.74 164.67 11.6 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.738 0.815 . . . . 65.12 110.277 174.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.03 -173.97 4.28 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.772 0.829 . . . . 63.32 111.038 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 10.6 mp -83.83 63.68 7.64 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.308 0.643 . . . . 70.32 110.209 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 11' ' ' LEU . . . . . 0.614 HD23 HD13 ' G' ' 14' ' ' LEU . 13.7 tp 38.71 78.09 0.38 Allowed Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 126.201 1.8 . . . . 54.32 113.185 -177.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.49 2.69 7.51 Favored 'Trans proline' 0 C--N 1.367 1.515 0 C-N-CA 122.323 2.016 . . . . 64.33 112.438 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -137.96 92.09 2.64 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 107.654 -1.239 . . . . 33.31 107.654 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . 0.614 HD13 HD23 ' G' ' 11' ' ' LEU . 3.7 mm? -72.12 -172.1 0.84 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.263 1.025 . . . . 62.3 110.313 176.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' C' ' 98' ' ' LEU . 46.6 p90 -154.19 -178.95 7.46 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 120.842 0.354 . . . . 71.54 111.479 174.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 12.4 m -60.01 142.3 89.24 Favored Pre-proline 0 CA--C 1.567 1.614 0 C-N-CA 125.832 1.653 . . . . 73.01 111.996 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 17' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.25 172.58 15.75 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.683 2.256 . . . . 54.02 113.11 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 18' ' ' VAL . . . . . 0.572 HG13 ' HB2' ' C' ' 56' ' ' TYR . 93.8 t -63.86 -67.01 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.824 0.85 . . . . 73.0 111.045 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 85.9 m -119.5 -45.63 2.51 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.056 -0.975 . . . . 55.24 108.851 177.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -165.69 141.06 4.97 Favored 'General case' 0 C--N 1.357 0.908 0 CA-C-N 116.345 -0.389 . . . . 73.4 111.542 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . -165.34 -162.25 0.58 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.401 1.08 . . . . 53.34 109.362 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -82.43 -25.62 33.48 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.384 0.674 . . . . 73.55 111.223 -175.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 23' ' ' THR . . . . . 0.418 HG23 ' HB3' ' A' ' 150' ' ' GLU . 11.0 p -65.68 137.87 96.45 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 122.955 0.502 . . . . 74.12 109.894 173.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.36 143.95 60.06 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.409 2.073 . . . . 51.21 112.518 -174.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 . . . . . 0 CA--C 1.553 1.077 0 C-N-CA 124.349 1.06 . . . . 74.31 109.939 178.18 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mpp? . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 109.526 -0.546 . . . . 74.03 109.526 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -94.08 106.12 18.1 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.838 0.828 . . . . 53.04 109.587 172.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -76.39 97.39 4.25 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.776 -0.824 . . . . 72.32 108.776 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 49.9 m -86.57 -165.51 1.29 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.608 0.763 . . . . 73.02 111.174 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 11.3 m -65.29 163.37 15.55 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 124.272 1.029 . . . . 63.12 111.116 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.619 HG22 ' HB2' ' D' ' 42' ' ' LEU . 29.4 pt -59.23 134.24 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 C-N-CA 123.274 0.63 . . . . 74.02 111.405 175.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.49 -45.63 0.17 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.238 1.015 . . . . 74.25 109.501 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 77.54 91.23 0.07 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.671 1.589 . . . . 72.21 109.337 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.73 134.46 28.56 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.532 1.133 . . . . 63.41 109.245 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 47.4 mt 64.31 106.37 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.383 1.052 . . . . 74.35 111.559 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.441 HD13 ' CD2' ' H' ' 15' ' ' PHE . 95.3 mt -79.21 151.83 75.83 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.097 0.559 . . . . 73.13 110.805 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 12' ' ' PRO . . . . . 0.432 ' HG3' ' HA ' ' D' ' 45' ' ' ASP . 33.5 Cg_endo -60.4 93.4 0.1 OUTLIER 'Trans proline' 0 C--N 1.386 2.544 0 C-N-CA 122.942 2.428 . . . . 75.45 112.287 -175.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 13' ' ' LEU . . . . . 0.652 ' HG ' ' HG ' ' H' ' 14' ' ' LEU . 44.2 tp 65.73 -84.0 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.802 1.641 . . . . 73.35 111.849 177.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . 0.652 ' HG ' ' HG ' ' H' ' 13' ' ' LEU . 97.5 mt -124.91 130.52 52.52 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.797 0.839 . . . . 74.14 110.766 -173.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . 0.441 ' CD2' HD13 ' H' ' 11' ' ' LEU . 6.4 t80 -125.81 79.67 1.84 Allowed 'General case' 0 C--O 1.24 0.591 0 N-CA-C 106.259 -1.756 . . . . 73.25 106.259 172.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 16' ' ' THR . . . . . 0.526 HG23 HD12 ' D' ' 98' ' ' LEU . 87.1 m -157.88 112.86 1.79 Allowed Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.332 0.653 . . . . 63.32 109.61 -170.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 17' ' ' PRO . . . . . 0.768 ' HD2' HD13 ' D' ' 98' ' ' LEU . 33.8 Cg_endo -96.09 -118.7 0.0 OUTLIER 'Trans proline' 0 CA--C 1.568 2.211 0 C-N-CA 123.29 2.66 . . . . 72.32 111.302 161.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . 0.561 HG22 HG21 ' D' ' 86' ' ' ILE . 47.1 t 72.33 -73.69 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.377 1.767 0 C-N-CA 125.782 1.633 . . . . 64.22 111.045 174.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 19' ' ' THR . . . . . 0.583 HG23 ' HG3' ' H' ' 20' ' ' LYS . 8.8 t -162.75 -41.36 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.559 0.577 . . . . 55.42 112.559 177.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 20' ' ' LYS . . . . . 0.623 ' HB2' ' HE1' ' D' ' 94' ' ' MET . 92.9 mttt -116.97 120.24 37.79 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.449 -0.574 . . . . 74.43 109.449 -174.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -173.7 -63.86 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.384 0.674 . . . . 75.21 110.231 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.56 130.68 42.58 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.987 0.915 . . . . 75.0 109.261 -176.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 35.5 p -62.66 121.62 68.91 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 124.561 1.144 . . . . 65.4 110.756 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.74 -67.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.989 2.459 . . . . 44.52 112.795 -177.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 C--O 1.247 0.926 0 C-N-CA 123.279 0.632 . . . . 70.11 109.521 -177.971 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.5 ttm . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.329 -0.619 . . . . 72.31 109.329 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.662 ' HB3' ' SD ' ' A' ' 138' ' ' MET . 25.6 t -166.08 25.01 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.582 1.153 . . . . 72.52 108.849 174.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -82.4 -175.29 5.63 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.493 1.117 . . . . 71.42 111.075 -177.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -87.68 41.64 1.0 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.964 0.906 . . . . 71.12 111.35 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 67.7 19.97 9.61 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.037 1.335 . . . . 55.01 112.082 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -141.0 156.07 46.1 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.995 -0.743 . . . . 75.35 108.995 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.7 p -88.05 94.36 9.77 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.714 0.406 . . . . 65.33 110.437 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.522 ' HB3' HD13 ' A' ' 89' ' ' ILE . 3.0 mp0 -76.85 168.14 20.61 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.697 0.799 . . . . 74.51 110.753 171.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.651 ' HE1' HG23 ' A' ' 86' ' ' ILE . 15.0 tpt 77.88 156.8 0.17 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.037 1.335 . . . . 65.05 112.854 169.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.0 m -138.94 101.97 4.43 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 106.727 -1.582 . . . . 73.41 106.727 173.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.535 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 41.2 t80 -132.87 139.63 47.52 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.907 0.883 . . . . 63.22 110.808 -166.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -158.43 116.39 2.96 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.697 0.623 . . . . 74.21 109.872 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.617 HG12 ' HD2' ' A' ' 84' ' ' PHE . 57.7 mt -72.6 114.71 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 109.416 -0.587 . . . . 73.13 109.416 177.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -82.76 -34.58 27.07 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.003 -0.998 . . . . 72.02 109.921 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -173.18 149.34 1.79 Allowed 'General case' 0 C--N 1.36 1.031 0 O-C-N 123.714 0.634 . . . . 75.31 110.679 -171.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.567 HD12 ' HG3' ' C' ' 130' ' ' PRO . 75.0 mt -141.52 134.6 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 124.23 1.012 . . . . 62.4 108.332 174.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.48 ' HB3' HG23 ' B' ' 122' ' ' THR . 32.9 p90 -167.32 176.85 6.42 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.983 0.897 . . . . 74.52 110.97 -173.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.1 p -101.54 116.86 33.72 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.737 -1.209 . . . . 63.02 107.737 174.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 42.8 mtpt -75.78 -41.95 51.52 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.733 0.777 . . . . 72.3 109.002 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 15.9 t70 -135.73 143.35 45.29 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 113.731 -1.577 . . . . 64.24 109.72 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 92.6 mt -138.62 143.66 31.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 125.743 1.617 . . . . 73.34 106.962 176.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -153.46 138.57 17.36 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.477 -0.564 . . . . 71.13 109.477 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.457 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 93.9 t80 -143.29 120.57 11.56 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 106.852 -1.536 . . . . 74.44 106.852 176.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -120.53 148.78 43.39 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.241 -0.652 . . . . 73.21 109.241 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.87 80.27 14.02 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 106.359 -1.719 . . . . 51.03 106.359 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.3 -50.26 12.61 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 123.364 2.709 . . . . 72.34 112.841 -169.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.77 33.84 3.58 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 114.867 -1.06 . . . . 61.23 108.614 -176.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.445 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -47.65 -53.09 33.24 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 113.467 0.914 . . . . 73.25 113.467 -176.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.48 -15.41 45.15 Favored 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 121.536 1.491 . . . . 73.33 112.847 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -97.93 -31.14 12.34 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.259 1.023 . . . . 63.15 110.413 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.862 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.5 p -77.42 -16.78 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.351 0.66 . . . . 51.32 112.27 -164.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -77.76 1.1 21.17 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 122.901 0.48 . . . . 74.15 111.27 174.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -89.9 -24.66 21.29 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.665 1.186 . . . . 64.22 110.568 168.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 71' ' ' GLU . 30.8 mmmt -66.85 165.5 15.18 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.422 1.089 . . . . 52.14 112.513 -176.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -84.49 138.14 32.95 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 108.011 -1.107 . . . . 62.11 108.011 167.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 26.8 t-105 -72.62 89.37 1.31 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.902 -1.147 . . . . 73.1 107.902 173.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.475 ' H ' HD22 ' A' ' 68' ' ' LEU . 35.3 tt0 -131.1 65.35 76.46 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 125.539 1.536 . . . . 74.02 107.115 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.12 120.82 4.24 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.363 2.042 . . . . 71.55 111.996 -168.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -96.11 99.58 11.31 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.4 -1.333 . . . . 64.3 107.4 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.1 m -74.81 120.9 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-N 114.793 -1.094 . . . . 64.32 111.219 -172.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.537 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 39.7 ttmt -118.24 114.13 22.54 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.032 -1.099 . . . . 72.45 108.032 173.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.527 HD22 HG13 ' E' ' 6' ' ' ILE . 2.4 pt? -114.81 131.96 56.64 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.796 -0.816 . . . . 75.23 108.796 173.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -126.37 135.07 51.0 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.33 1.052 . . . . 70.14 108.418 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -113.38 122.75 48.31 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.284 -0.636 . . . . 73.35 109.284 -175.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.626 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 16.6 t70 -119.65 124.17 45.65 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.313 1.045 . . . . 61.01 108.221 177.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.1 p -106.74 125.96 51.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.254 0.621 . . . . 64.22 110.041 -174.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.46 152.42 50.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.03 0.932 . . . . 70.23 109.514 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.9 p -131.37 165.05 24.32 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.383 0.673 . . . . 71.42 110.359 -177.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.7 t -163.51 121.33 1.89 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.805 -0.634 . . . . 63.45 109.653 175.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -82.33 120.03 24.89 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.413 -1.328 . . . . 74.55 107.413 166.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.645 HD11 ' HB2' ' A' ' 57' ' ' GLU . 24.4 mt -93.13 -40.19 10.63 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.754 -0.832 . . . . 73.44 108.754 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.86 -175.66 4.52 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.813 1.245 . . . . 72.34 109.574 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.1 123.12 20.21 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.061 -0.718 . . . . 75.22 109.061 173.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 69.88 -4.71 1.4 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.943 1.297 . . . . 54.42 112.696 -176.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.4 t -109.68 108.93 26.6 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 N-CA-C 108.05 -1.092 . . . . 62.35 108.05 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -130.07 157.63 41.84 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.352 -0.61 . . . . 73.11 109.352 -173.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.645 ' HB2' HD11 ' A' ' 51' ' ' LEU . 38.9 tt0 -130.59 135.54 47.99 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.067 0.947 . . . . 74.24 108.898 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.6 m -121.85 136.16 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 108.041 -1.096 . . . . 51.11 108.041 165.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.4 t -122.71 127.54 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.05 0.94 . . . . 60.34 109.238 -174.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 tt -117.25 107.41 14.39 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.603 -0.888 . . . . 73.24 108.603 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.626 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 10.9 ttm180 -84.88 104.39 14.79 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.284 1.034 . . . . 53.31 109.715 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 37.3 t -96.01 103.28 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 108.598 -0.89 . . . . 75.54 108.598 174.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.9 m -97.04 108.47 21.21 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.62 0.768 . . . . 73.41 109.852 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.763 HG11 HD21 ' A' ' 126' ' ' LEU . 42.1 t -103.04 139.11 24.85 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 C-N-CA 123.974 0.909 . . . . 71.15 110.588 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 25.5 m -132.14 141.05 48.99 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.898 0.879 . . . . 74.52 108.693 175.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.04 109.66 14.37 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.861 -0.792 . . . . 72.22 108.861 174.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.9 m -108.87 127.37 53.98 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.407 0.683 . . . . 75.45 109.282 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.475 HD22 ' H ' ' A' ' 37' ' ' GLN . 15.8 mt -99.7 78.37 2.14 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.874 -1.158 . . . . 74.13 107.874 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.69 -83.39 1.14 Allowed Glycine 0 C--N 1.349 1.264 0 N-CA-C 111.502 -0.639 . . . . 61.2 111.502 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -119.98 -28.96 5.05 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.737 0.815 . . . . 72.32 111.315 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.404 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 35.7 tt0 -99.95 128.79 46.0 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.633 -0.667 . . . . 71.45 110.589 -174.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.0 m -69.66 131.36 44.48 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.85 0.86 . . . . 45.2 110.902 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.862 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -74.22 -63.2 1.28 Allowed 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.514 -0.921 . . . . 73.33 108.514 168.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -155.47 163.14 40.43 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.402 -1.272 . . . . 74.23 111.322 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.2 tp -119.02 146.0 45.4 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 113.824 -1.534 . . . . 71.22 107.522 167.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.9 m -138.89 134.37 33.16 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.836 -1.172 . . . . 62.0 107.836 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -148.16 116.39 6.51 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.171 -0.678 . . . . 64.22 109.171 174.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.8 t -124.74 126.34 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 123.733 0.813 . . . . 63.02 109.051 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.414 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 64.0 mt-30 -101.48 89.05 3.6 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.227 -1.027 . . . . 73.14 108.227 172.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.42 ' HG3' HD22 ' A' ' 106' ' ' LEU . 9.3 tp-100 -76.81 98.25 4.77 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.615 -1.175 . . . . 72.03 108.48 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.51 142.95 16.36 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 111.338 -0.705 . . . . 75.52 111.338 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.428 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -140.85 126.21 3.05 Favored Glycine 0 CA--C 1.502 -0.733 0 N-CA-C 110.815 -0.914 . . . . 72.34 110.815 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.2 mt -82.47 119.01 31.18 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 108.321 -0.992 . . . . 65.23 108.321 173.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.617 ' HD2' HG12 ' A' ' 13' ' ' ILE . 24.2 m-85 -131.04 130.22 43.0 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.533 -0.914 . . . . 74.42 108.533 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 43.9 t -76.2 108.03 8.85 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.513 -0.921 . . . . 55.31 108.513 172.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.651 HG23 ' HE1' ' A' ' 9' ' ' MET . 71.7 mt -116.22 119.41 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.287 0.635 . . . . 73.12 110.332 -173.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.77 -172.12 1.54 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.935 0.894 . . . . 40.24 110.398 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.43 -49.96 0.86 Allowed Glycine 0 C--N 1.349 1.27 0 CA-C-N 116.497 -0.319 . . . . 61.2 113.121 172.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 93' ' ' GLN . 10.1 pt -133.03 -179.79 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.827 0.851 . . . . 71.24 111.266 -170.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -143.89 -179.29 6.38 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.122 0.969 . . . . 72.11 109.77 -174.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.88 -142.2 44.78 Favored Glycine 0 C--N 1.347 1.141 0 C-N-CA 123.572 0.606 . . . . 75.12 113.389 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.56 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 19.4 p -74.28 -15.86 60.96 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.661 0.784 . . . . 74.25 112.008 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.539 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.5 mp0 -66.77 -48.84 67.82 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 109.488 -0.56 . . . . 75.22 109.488 176.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 42.6 ttp -77.83 -31.82 51.86 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 116.063 -0.517 . . . . 73.04 110.438 178.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.56 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -65.23 -24.62 67.39 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.984 0.514 . . . . 62.35 111.246 176.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.494 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 22.3 t-80 -68.4 -35.15 77.25 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.573 0.749 . . . . 73.4 110.674 172.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.3 t -74.96 -52.11 11.99 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.244 -0.285 . . . . 74.42 110.735 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.421 ' HG ' ' HA ' ' A' ' 95' ' ' ALA . 4.6 pp -76.34 -20.6 57.08 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.353 0.501 . . . . 64.31 112.353 -175.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.46 2.99 20.24 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 114.971 0.749 . . . . 75.22 114.971 -173.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.583 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -142.24 -52.96 0.41 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 118.031 0.915 . . . . 64.23 111.946 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.52 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 79.4 t80 -78.36 -68.18 0.67 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 122.895 0.478 . . . . 50.43 111.776 -172.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.46 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 76.8 m -63.94 -34.09 11.27 Favored Pre-proline 0 CA--C 1.567 1.632 0 N-CA-C 114.534 1.309 . . . . 63.42 114.534 -173.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.516 ' HB3' ' HE2' ' E' ' 15' ' ' PHE . 22.6 Cg_endo -62.25 -33.31 81.38 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 121.834 1.689 . . . . 51.51 112.902 167.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.469 ' ND2' ' HA ' ' A' ' 132' ' ' ASN . 15.7 t-20 -80.18 -17.59 52.0 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.635 0.374 . . . . 73.55 110.921 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.7 mm -65.82 -39.38 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 108.92 -0.77 . . . . 75.04 108.92 168.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.428 HD21 ' HA3' ' A' ' 82' ' ' GLY . 91.6 mt -77.15 -19.97 56.14 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.704 0.802 . . . . 61.12 112.205 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -61.24 -49.31 88.65 Favored Pre-proline 0 CA--C 1.571 1.781 0 N-CA-C 113.954 1.094 . . . . 75.11 113.954 -172.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -63.76 -38.42 39.87 Favored 'Trans proline' 0 C--N 1.391 2.81 0 C-N-CA 122.071 1.847 . . . . 61.44 112.654 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -68.48 -35.56 77.7 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.782 -0.645 . . . . 74.51 110.876 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.88 -42.98 76.25 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.238 0.615 . . . . 72.24 110.489 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.538 ' NH1' HD12 ' C' ' 105' ' ' ILE . 37.6 ttm180 -54.6 -53.82 49.59 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 124.164 0.915 . . . . 74.24 109.936 174.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -66.68 -39.38 88.1 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.366 1.042 . . . . 75.2 111.821 -171.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.79 -42.04 92.53 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.539 0.524 . . . . 72.24 110.287 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.414 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.2 mt -67.09 -47.5 81.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 115.281 -0.872 . . . . 74.03 110.165 175.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.9 m -56.06 -41.74 75.55 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.742 0.817 . . . . 75.23 111.358 -177.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.2 t -69.6 -45.01 69.57 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.198 -0.91 . . . . 74.22 110.766 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.459 ' SD ' HG23 ' A' ' 21' ' ' ILE . 9.2 mtp -58.51 -44.62 89.53 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.636 0.774 . . . . 75.43 111.238 177.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 114' ' ' ILE . 77.8 t -64.32 -42.89 96.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 114.774 -1.103 . . . . 74.34 110.766 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.3 t -72.22 -32.87 67.14 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.855 -0.612 . . . . 73.43 111.071 -176.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.465 HH12 ' HG3' ' B' ' 112' ' ' GLU . 81.4 mtt-85 -72.57 -29.42 63.52 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.534 0.734 . . . . 62.35 109.322 175.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.454 ' O ' HG22 ' A' ' 122' ' ' THR . . . -83.38 10.0 60.03 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-N 115.307 -0.861 . . . . 74.41 113.222 173.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.5 t 64.09 12.7 7.2 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 126.928 2.091 . . . . 54.23 113.628 173.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -84.72 150.98 57.51 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 109.119 -0.697 . . . . 74.3 109.119 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.53 141.58 41.89 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.211 2.607 . . . . 62.32 112.855 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -53.93 132.31 41.83 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 124.035 0.834 . . . . 74.5 112.162 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.763 HD21 HG11 ' A' ' 64' ' ' VAL . 60.2 tp -123.79 102.43 7.81 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.781 -1.1 . . . . 73.02 110.176 -171.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -111.01 126.35 54.7 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.111 0.965 . . . . 63.02 109.145 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 129' ' ' ALA . 3.5 tt -67.55 143.52 56.08 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 108.155 -1.054 . . . . 75.01 108.155 172.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' E' ' 7' ' ' ALA . . . -56.81 140.42 76.04 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 123.678 0.791 . . . . 71.12 111.407 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.405 ' HA ' HH22 ' A' ' 111' ' ' ARG . 37.0 Cg_endo -65.12 95.35 0.25 Allowed 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.824 2.349 . . . . 73.22 113.015 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.31 112.49 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.156 -0.929 . . . . 74.21 109.318 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.469 ' HA ' ' ND2' ' A' ' 104' ' ' ASN . 27.5 t-20 -100.97 100.27 10.86 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.556 -1.276 . . . . 74.3 107.556 170.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.498 ' HE1' HD22 ' E' ' 8' ' ' LEU . 43.2 m-85 -55.79 -47.56 76.87 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.613 0.765 . . . . 61.43 110.917 -175.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.583 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 10.3 t70 -55.16 -37.61 67.23 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.972 -1.467 . . . . 75.44 112.748 -173.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 139' ' ' ASN . . . -61.94 -46.29 89.97 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.862 0.726 . . . . 43.35 111.28 -177.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.97 -35.43 69.52 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.271 0.628 . . . . 63.44 111.034 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -67.6 -52.4 38.98 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 119.184 -0.436 . . . . 74.4 110.889 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.662 ' SD ' ' HB3' ' A' ' 2' ' ' SER . 0.2 OUTLIER -60.93 -36.52 79.54 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 122.925 0.49 . . . . 72.52 111.426 178.33 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 135' ' ' ALA . 50.7 t-20 -54.01 -54.8 34.17 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.659 1.224 . . . . 72.24 110.891 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -84.82 -29.68 25.16 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 116.368 -0.378 . . . . 62.03 111.611 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 64.2 tp -66.95 -49.56 65.07 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.562 0.745 . . . . 51.21 111.817 -175.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -147.91 -1.39 0.58 Allowed 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 119.524 -0.274 . . . . 72.33 111.693 -170.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 73.68 127.63 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.007 1.323 . . . . 65.31 111.201 -173.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.9 102.58 0.28 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.551 1.14 . . . . 64.24 109.772 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.55 84.49 2.44 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.64 0.776 . . . . 75.51 110.955 -176.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -104.18 146.59 16.31 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 111.246 -0.742 . . . . 62.42 111.246 174.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -135.12 162.88 31.24 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.302 0.641 . . . . 71.05 110.579 -176.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.02 165.69 53.85 Favored Glycine 0 C--N 1.356 1.678 0 O-C-N 123.4 0.438 . . . . 42.02 113.533 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.8 t -103.65 153.23 20.86 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.983 0.913 . . . . 72.34 110.717 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -170.98 -156.62 0.12 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.854 1.262 . . . . 43.35 109.066 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 82.35 -57.34 0.21 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.473 1.509 . . . . 73.11 111.809 177.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 18.3 t60 58.77 68.19 0.85 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.055 0.942 . . . . 63.03 110.219 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -73.66 92.66 1.98 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.012 -0.995 . . . . 71.2 109.716 176.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -148.63 145.04 27.59 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.356 -0.838 . . . . 73.45 109.123 -173.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.23 0 C-N-CA 124.11 0.964 . . . . 61.33 110.482 -177.3 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 55.7 ttp . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 109.377 -0.601 . . . . 70.03 109.377 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 45.4 t -87.05 141.86 28.35 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.931 -1.137 . . . . 61.24 107.931 169.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -80.36 68.64 6.6 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.996 0.903 . . . . 72.33 109.113 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -137.65 142.91 41.16 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.238 1.415 . . . . 72.42 108.953 -176.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -118.01 41.82 2.81 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.182 0.993 . . . . 73.41 109.16 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -61.97 102.96 0.32 Allowed 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.302 -0.863 . . . . 73.04 110.232 -176.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 70.4 p -67.7 -17.19 64.49 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.848 0.859 . . . . 74.42 111.539 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.73 -54.6 25.05 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 123.599 0.76 . . . . 61.13 109.813 170.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 1.6 tmt? 64.41 164.92 0.14 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 125.228 1.411 . . . . 72.15 111.644 -174.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 92.7 m -162.34 138.48 7.6 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.334 1.053 . . . . 72.43 108.895 172.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' B' ' 85' ' ' SER . 0.2 OUTLIER -136.35 154.67 50.77 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.45 0.643 . . . . 72.04 109.598 157.283 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -127.71 140.86 51.8 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 114.687 -1.142 . . . . 74.44 108.239 169.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.57 HD11 HD13 ' B' ' 105' ' ' ILE . 46.7 mt -72.13 119.76 19.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 O-C-N 124.143 0.902 . . . . 70.3 108.739 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -88.54 -49.87 6.64 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.637 0.775 . . . . 71.02 109.302 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.417 ' HE ' HG21 ' A' ' 122' ' ' THR . 48.2 ttt180 -163.38 132.8 4.1 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.952 -0.567 . . . . 75.12 110.488 -176.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 94.6 mt -114.23 136.04 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 107.595 -1.261 . . . . 64.24 107.595 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -164.62 146.21 8.21 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.553 0.692 . . . . 75.1 112.432 -175.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 35.3 m -73.45 121.4 20.48 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.16 -1.382 . . . . 53.41 109.27 171.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.447 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 41.2 mtpt -98.32 -27.73 13.99 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.953 0.901 . . . . 65.12 111.393 -176.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 34.9 t70 -158.39 138.03 11.95 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.458 0.473 . . . . 75.4 110.531 -168.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.425 HD11 ' SG ' ' B' ' 113' ' ' CYS . 45.3 mm -142.07 143.16 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.919 1.288 . . . . 74.04 108.976 -177.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 10.2 m -144.57 128.44 17.37 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.313 1.445 . . . . 73.53 107.665 170.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.495 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.2 t80 -133.9 109.56 9.13 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.373 -1.714 . . . . 71.53 106.373 166.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -122.39 110.66 15.91 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.807 -0.812 . . . . 65.43 108.807 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.484 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -107.55 87.28 3.32 Favored Pre-proline 0 C--O 1.241 0.624 0 N-CA-C 107.575 -1.268 . . . . 74.21 107.575 174.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -64.97 -34.67 46.86 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.719 2.279 . . . . 60.21 112.216 -170.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -102.25 6.04 40.37 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 117.645 -1.169 . . . . 71.02 112.06 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.484 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -28.66 -66.71 0.12 Allowed Pre-proline 0 N--CA 1.511 2.618 0 N-CA-C 114.785 1.402 . . . . 71.23 114.785 -168.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.432 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 28.2 Cg_endo -63.53 -29.77 70.86 Favored 'Trans proline' 0 C--N 1.398 3.134 0 C-N-CA 122.098 1.865 . . . . 73.24 112.879 -172.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.437 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 63.1 m80 -86.78 -36.31 18.65 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.464 -0.789 . . . . 72.1 112.02 -176.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.667 HG22 HD12 ' B' ' 68' ' ' LEU . 8.5 p -74.77 -16.59 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 C-N-CA 122.903 0.481 . . . . 51.02 111.883 -171.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -62.22 -21.2 64.95 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.422 0.689 . . . . 70.13 112.712 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.458 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.7 pt20 -56.53 -32.0 64.67 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.491 0.716 . . . . 73.21 110.919 174.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.458 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 99.2 mttt -91.28 69.44 6.04 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.476 1.11 . . . . 72.2 109.159 177.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -83.0 89.02 6.85 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.244 0.545 . . . . 72.15 110.95 -174.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 28.2 p90 -156.06 175.44 13.96 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.211 1.004 . . . . 74.4 108.406 169.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -71.87 109.05 4.85 Favored Pre-proline 0 CA--C 1.554 1.106 0 N-CA-C 109.601 -0.518 . . . . 61.45 109.601 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.62 149.12 79.23 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.6 2.2 . . . . 70.24 113.143 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.71 106.59 1.53 Allowed 'General case' 0 C--N 1.352 0.701 0 N-CA-C 108.367 -0.975 . . . . 74.43 108.367 174.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -96.52 137.71 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-O 121.742 0.782 . . . . 70.4 111.362 -175.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.478 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 79.0 tttt -109.03 145.81 34.96 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.015 1.326 . . . . 44.53 108.139 168.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.481 HD22 HD23 ' F' ' 8' ' ' LEU . 1.2 pp -127.83 163.14 25.05 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.844 0.458 . . . . 75.52 110.21 170.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.54 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 32.2 t70 -157.14 154.79 29.92 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.606 0.762 . . . . 63.33 109.247 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -130.94 129.28 41.97 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.251 0.62 . . . . 74.33 109.595 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -124.81 155.69 38.99 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.702 -0.851 . . . . 75.01 108.702 173.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 60.4 p -120.49 133.87 55.35 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.253 0.549 . . . . 71.44 111.497 -170.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.11 161.28 40.54 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.528 1.131 . . . . 63.44 108.764 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 54.5 m -143.13 -175.71 4.63 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.653 0.381 . . . . 74.32 111.048 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' F' ' 24' ' ' PRO . 78.3 p -164.87 137.84 4.68 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.954 0.902 . . . . 62.22 109.58 169.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.638 ' HB2' ' HA ' ' F' ' 22' ' ' ARG . 58.7 tt0 -89.03 133.25 34.41 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 120.732 0.301 . . . . 71.33 110.704 177.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 40.6 mt -102.03 -44.31 5.51 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.846 0.858 . . . . 63.23 110.457 174.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.34 -169.65 2.54 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.197 -0.91 . . . . 42.51 109.884 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.89 117.65 8.57 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.631 -1.168 . . . . 72.3 108.818 171.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 69.07 5.29 4.99 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.374 1.07 . . . . 65.44 112.486 173.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 56.0 t -112.48 106.44 20.76 Favored 'Isoleucine or valine' 0 C--O 1.246 0.887 0 N-CA-C 107.204 -1.406 . . . . 60.15 107.204 171.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -129.28 153.9 47.36 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.178 -0.675 . . . . 53.52 109.178 -176.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -116.01 122.47 45.31 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.623 -1.251 . . . . 65.21 107.623 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 43.1 t -112.39 123.63 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.667 0.787 . . . . 75.32 109.851 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 18.9 t -103.09 125.75 57.48 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 124.306 1.042 . . . . 53.44 109.978 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.629 HD23 HD12 ' B' ' 106' ' ' LEU . 3.3 mm? -107.4 110.95 23.05 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.996 -0.742 . . . . 52.31 108.996 167.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -85.39 114.25 22.3 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.699 0.8 . . . . 64.02 109.062 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.404 ' CG1' HD11 ' B' ' 114' ' ' ILE . 96.9 t -103.34 109.45 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.569 1.148 . . . . 72.04 108.547 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 87.2 m -94.45 142.19 27.72 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.392 1.077 . . . . 73.13 108.722 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.564 HG21 HG21 ' B' ' 114' ' ' ILE . 98.7 t -136.2 131.97 49.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 124.704 1.202 . . . . 73.41 108.197 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 54.3 m -126.01 148.06 49.39 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.736 -1.209 . . . . 72.34 107.736 172.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.92 143.51 27.41 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.532 -0.544 . . . . 72.34 109.532 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.517 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 23.1 p -148.82 130.2 14.73 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 123.768 0.667 . . . . 40.41 111.07 -175.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.667 HD12 HG22 ' B' ' 31' ' ' VAL . 48.3 mt -103.04 111.2 23.43 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.721 -1.215 . . . . 75.34 107.721 173.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.55 -110.75 3.11 Favored Glycine 0 C--N 1.345 1.054 0 O-C-N 123.39 0.431 . . . . 74.04 112.046 -176.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.24 5.34 9.15 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.096 0.558 . . . . 61.33 111.028 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.84 150.04 34.15 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.426 -0.583 . . . . 74.43 109.426 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 68.2 m -70.1 119.55 14.47 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 123.507 0.505 . . . . 71.01 110.348 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.634 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -70.77 -60.71 2.09 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.244 -1.021 . . . . 54.04 108.244 174.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -157.1 166.0 34.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.39 -1.277 . . . . 72.54 111.164 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 72.7 mt -125.78 137.34 53.79 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 105.791 -1.929 . . . . 74.11 105.791 170.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 44.9 t -138.71 150.64 46.38 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.245 -1.02 . . . . 73.11 108.245 173.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -160.15 131.4 5.84 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.12 -0.696 . . . . 73.45 109.12 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.405 ' HA ' HD13 ' B' ' 21' ' ' ILE . 85.4 t -124.22 149.49 28.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.007 -0.997 . . . . 75.45 108.859 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.424 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 16.7 mt-30 -120.56 97.64 5.66 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.903 -1.147 . . . . 74.42 107.903 167.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -88.54 100.61 13.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.34 -1.356 . . . . 73.25 107.34 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.447 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -97.67 147.26 18.56 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.612 -0.995 . . . . 72.21 110.612 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.44 130.15 4.14 Favored Glycine 0 CA--C 1.507 -0.417 0 N-CA-C 110.852 -0.899 . . . . 70.45 110.852 -177.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 57.4 mt -86.06 126.48 40.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.563 -0.903 . . . . 54.45 108.563 173.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -134.87 131.14 37.0 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 107.504 -1.295 . . . . 64.13 107.504 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 70.9 m -95.06 88.59 5.28 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.34 -0.615 . . . . 70.32 109.34 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 12.4 tt -107.86 129.81 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.922 0.889 . . . . 74.02 111.724 -170.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.43 163.61 33.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.78 0.832 . . . . 61.11 110.899 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.39 -70.19 0.29 Allowed Glycine 0 C--N 1.344 0.993 0 CA-C-N 115.681 -0.691 . . . . 72.32 113.336 172.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.537 HG22 ' HB3' ' B' ' 94' ' ' MET . 11.3 mt -89.65 158.23 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.046 0.938 . . . . 73.12 111.523 -175.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -154.02 158.69 40.95 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.838 1.255 . . . . 73.51 109.173 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.94 -134.79 12.34 Favored Glycine 0 C--N 1.347 1.188 0 C-N-CA 123.352 0.501 . . . . 74.01 113.733 173.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 59.4 m -70.16 -33.18 71.45 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.276 0.63 . . . . 63.14 111.423 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -66.82 -36.14 81.69 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.54 -0.755 . . . . 64.11 111.242 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.537 ' HB3' HG22 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -81.1 -22.36 39.2 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 116.307 -0.406 . . . . 53.35 110.686 176.447 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.54 -24.92 64.09 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.106 0.479 . . . . 72.43 111.168 173.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.45 ' CD2' ' HB2' ' B' ' 134' ' ' ASP . 54.9 t-80 -77.78 -30.01 51.14 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.511 0.724 . . . . 74.5 110.661 171.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.8 t -80.14 -68.39 0.68 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.748 0.819 . . . . 70.23 112.488 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.632 ' H ' HD23 ' B' ' 98' ' ' LEU . 1.9 pt? -102.5 -7.28 22.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.853 -0.529 . . . . 74.12 111.759 -174.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.02 0.75 57.54 Favored Glycine 0 C--N 1.344 1.003 0 O-C-N 123.292 0.37 . . . . 44.04 112.452 173.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' B' ' 134' ' ' ASP . . . -149.19 -60.07 0.22 Allowed 'General case' 0 C--N 1.358 0.977 0 C-N-CA 122.77 0.428 . . . . 53.01 111.98 -176.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -70.52 -36.82 73.95 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 112.233 0.457 . . . . 74.31 112.233 -175.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.538 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 70.9 m -68.76 -44.39 31.19 Favored Pre-proline 0 N--CA 1.482 1.145 0 CA-C-O 118.545 -0.74 . . . . 74.41 110.818 177.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -45.97 -40.07 20.14 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 122.536 2.157 . . . . 74.4 113.766 162.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -68.49 -33.47 74.21 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.143 0.577 . . . . 74.42 112.504 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.57 HD13 HD11 ' B' ' 13' ' ' ILE . 67.1 mt -69.26 -46.09 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.19 0.596 . . . . 52.41 109.9 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.629 HD12 HD23 ' B' ' 60' ' ' LEU . 60.1 mt -84.03 -11.44 56.75 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.677 -1.147 . . . . 73.23 110.763 -172.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.408 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 81.4 t80 -57.65 -54.47 54.87 Favored Pre-proline 0 CA--C 1.557 1.221 0 CA-C-O 117.971 -1.014 . . . . 72.24 112.993 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 36.5 Cg_exo -62.03 -35.85 74.15 Favored 'Trans proline' 0 C--N 1.39 2.745 0 C-N-CA 121.761 1.641 . . . . 55.23 113.029 -177.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -69.02 -44.69 72.23 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.854 0.462 . . . . 73.12 110.61 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.41 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -65.47 -43.66 89.59 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.903 0.481 . . . . 51.03 110.306 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -54.64 -53.13 58.76 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.523 1.129 . . . . 65.43 110.582 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.465 ' HG3' HH12 ' A' ' 120' ' ' ARG . 13.6 tp10 -62.35 -34.36 76.5 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.872 0.869 . . . . 74.33 111.05 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.524 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.9 t -71.23 -37.82 71.99 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.27 0.228 . . . . 71.22 110.862 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.564 HG21 HG21 ' B' ' 64' ' ' VAL . 84.5 mt -67.39 -56.95 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.445 0.698 . . . . 45.42 109.182 176.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 9.9 m -62.64 -24.01 67.38 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 124.288 0.992 . . . . 65.51 111.364 -173.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 39.7 t -67.19 -49.79 63.34 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 122.968 0.507 . . . . 75.54 109.913 170.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.524 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 33.9 mmt -62.02 -39.46 92.37 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 122.877 0.471 . . . . 71.3 110.644 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 114' ' ' ILE . 84.3 t -59.52 -49.5 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.585 1.154 . . . . 71.23 110.077 176.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.8 t -63.68 -37.34 86.97 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.585 -1.189 . . . . 74.11 111.156 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -69.47 -33.47 72.95 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.476 -0.784 . . . . 64.34 110.335 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.74 5.55 74.3 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.872 0.732 . . . . 54.12 112.835 173.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 17' ' ' TYR . 74.6 p 54.9 55.82 7.34 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 126.012 1.725 . . . . 64.22 111.99 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -117.76 156.98 49.18 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 124.34 1.056 . . . . 73.05 110.509 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.83 161.86 2.91 Favored 'Trans proline' 0 C--N 1.392 2.829 0 C-N-CA 123.938 3.092 . . . . 55.33 116.139 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.537 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -65.13 121.85 15.7 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 113.911 -1.495 . . . . 75.4 111.6 -178.609 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -138.63 109.55 6.74 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 108.342 -0.984 . . . . 74.33 108.342 177.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -124.49 135.1 52.93 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.935 0.894 . . . . 73.4 109.32 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 5.9 mp -87.8 139.27 30.7 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.819 0.848 . . . . 71.33 110.102 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.48 164.72 56.41 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 124.222 1.009 . . . . 65.12 111.067 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -53.88 103.79 0.1 OUTLIER 'Trans proline' 0 C--N 1.39 2.735 0 C-N-CA 122.824 2.349 . . . . 61.44 112.892 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.531 HG21 ' H ' ' F' ' 8' ' ' LEU . 37.6 t -90.72 108.62 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.32 -0.993 . . . . 73.45 108.32 176.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.64 79.95 8.12 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.322 -0.621 . . . . 71.43 109.322 177.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -51.14 -45.36 61.62 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.516 0.726 . . . . 73.3 110.119 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.45 ' HB2' ' CD2' ' B' ' 96' ' ' HIS . 7.6 p-10 -67.19 -24.64 65.88 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 113.444 -1.707 . . . . 71.43 112.531 -176.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.26 -34.64 42.43 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 122.738 0.415 . . . . 43.45 110.642 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.459 ' HB2' HD21 ' F' ' 10' ' ' LEU . 8.8 mp -70.8 -38.63 73.36 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 109.752 -0.462 . . . . 74.11 109.752 172.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.495 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 20.6 m-85 -66.83 -32.52 73.86 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.02 -0.537 . . . . 74.3 110.835 173.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.52 -35.95 73.46 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.278 0.631 . . . . 71.44 109.688 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.82 -24.44 59.8 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.347 -0.842 . . . . 71.24 110.286 176.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -71.34 -30.22 65.93 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.945 -0.391 . . . . 74.12 109.945 171.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 47.9 mt -80.78 2.68 25.21 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.505 0.722 . . . . 63.51 110.756 174.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 83.85 -7.57 1.07 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 126.216 1.806 . . . . 64.21 112.662 169.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -101.99 -179.94 4.15 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.533 0.733 . . . . 65.11 110.475 175.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -132.26 -50.4 0.94 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.609 0.764 . . . . 70.01 109.293 169.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.2 153.01 31.04 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.029 0.531 . . . . 54.32 111.559 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.6 93.97 0.09 OUTLIER Glycine 0 C--N 1.346 1.119 0 N-CA-C 110.816 -0.913 . . . . 70.31 110.816 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -95.14 64.6 2.76 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.817 0.847 . . . . 70.2 111.051 -173.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -77.48 72.59 2.15 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.919 -0.582 . . . . 73.43 112.154 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 75.4 p -96.49 148.78 22.46 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.799 0.84 . . . . 72.44 110.05 -176.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -143.18 100.67 3.67 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.508 0.723 . . . . 75.12 109.634 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.22 105.0 17.08 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 107.379 -1.341 . . . . 74.21 107.379 175.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -111.32 121.66 45.83 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.215 1.006 . . . . 73.34 110.73 -173.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.26 99.75 2.96 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 107.007 -1.479 . . . . 74.14 107.007 164.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -81.23 119.83 24.13 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.747 0.308 . . . . 72.44 110.327 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 CA-C-N 115.407 -0.815 . . . . 52.5 110.54 179.075 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 109.63 -0.507 . . . . 71.33 109.63 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 49.5 m -76.25 125.0 28.37 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.414 0.686 . . . . 73.3 110.977 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -146.98 155.99 42.69 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 108.102 -1.073 . . . . 74.04 108.102 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -52.65 117.25 2.77 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.142 0.977 . . . . 64.0 110.043 -176.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -66.61 -41.71 87.98 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.086 0.554 . . . . 71.01 110.664 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -103.34 86.8 2.73 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.111 0.964 . . . . 75.04 108.679 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 27.9 p -90.15 106.95 18.83 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.109 0.563 . . . . 63.42 110.354 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -128.26 164.0 23.53 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.697 0.799 . . . . 63.02 109.663 174.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 3.7 tpt 64.05 111.52 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.218 1.407 . . . . 75.34 111.127 -174.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 25.0 m -114.06 79.18 1.22 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 106.709 -1.589 . . . . 71.24 106.709 171.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.584 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 1.8 t80 -96.13 130.89 43.05 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 115.055 -0.975 . . . . 73.42 110.565 -171.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -145.53 124.88 13.04 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.095 -1.076 . . . . 71.42 108.095 171.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 51.6 mt -73.95 102.08 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 107.774 -1.195 . . . . 74.55 107.774 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -75.59 -50.92 14.12 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.582 -0.735 . . . . 73.24 110.616 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -167.3 123.88 1.16 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 110.294 -0.261 . . . . 63.33 110.294 -176.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 63.0 mt -108.76 144.46 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 108.002 -1.11 . . . . 64.34 108.002 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.47 ' HB3' HG23 ' D' ' 122' ' ' THR . 21.8 p90 -176.36 172.38 2.27 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.383 0.673 . . . . 64.55 110.11 -174.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.9 p -98.02 122.42 41.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.742 -0.663 . . . . 70.33 109.363 175.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.432 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 18.3 mmtp -70.04 -46.77 64.34 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 107.765 -1.198 . . . . 72.44 107.765 168.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 17.5 t70 -134.51 141.18 46.64 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 113.438 -1.71 . . . . 41.14 109.743 -171.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 87.5 mt -135.81 146.13 30.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 106.082 -1.822 . . . . 71.22 106.082 169.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' C' ' 77' ' ' GLU . 35.8 t -160.79 151.18 18.01 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.535 0.683 . . . . 74.53 109.859 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 86.9 t80 -144.62 136.43 25.82 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.529 -1.656 . . . . 72.03 106.529 169.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -134.24 129.29 35.46 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.2 -0.667 . . . . 74.52 109.2 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.51 81.01 11.44 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 106.858 -1.534 . . . . 65.32 106.858 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -69.53 -21.54 34.41 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.955 2.437 . . . . 62.25 112.423 -174.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -118.51 25.91 9.95 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.479 1.111 . . . . 63.41 110.147 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.73 -52.9 22.36 Favored Pre-proline 0 CA--C 1.56 1.361 0 CA-C-O 117.818 -1.087 . . . . 71.31 113.683 -173.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.72 -43.76 47.11 Favored 'Trans proline' 0 C--N 1.399 3.212 0 C-N-CA 121.834 1.689 . . . . 72.41 112.434 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.45 ' O ' ' HG3' ' C' ' 33' ' ' GLN . 86.6 t60 -69.45 -43.68 72.78 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.275 -0.875 . . . . 75.23 112.441 -175.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.728 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.2 p -69.82 -18.45 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.324 0 N-CA-C 113.43 0.9 . . . . 75.13 113.43 -174.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -70.19 -20.71 63.1 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 113.099 0.777 . . . . 75.1 113.099 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' C' ' 30' ' ' HIS . 4.9 pp0? -92.67 8.91 37.13 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 111.992 0.367 . . . . 61.22 111.992 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.68 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -91.89 156.59 17.37 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.143 0.577 . . . . 73.44 110.685 179.204 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.35 125.14 22.89 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.171 0.988 . . . . 65.2 109.452 164.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -81.12 88.67 5.98 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.252 0.548 . . . . 60.14 110.49 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -140.28 77.91 23.84 Favored Pre-proline 0 C--O 1.243 0.738 0 N-CA-C 108.234 -1.025 . . . . 61.53 108.234 171.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -84.12 129.84 4.65 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.294 1.996 . . . . 74.11 111.551 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.75 96.49 8.19 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 104.689 -2.338 . . . . 73.32 104.689 166.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 20.8 m -88.8 121.31 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 114.643 -1.162 . . . . 71.22 111.595 -168.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.439 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 35.8 ttpt -97.26 106.48 18.82 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.832 -0.803 . . . . 74.22 108.832 174.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.674 HD21 HG13 ' G' ' 6' ' ' ILE . 2.5 mm? -87.42 121.68 30.17 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.536 -1.283 . . . . 70.52 107.536 175.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -118.5 140.07 50.45 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.086 1.354 . . . . 61.13 108.397 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.604 HD23 HD11 ' C' ' 60' ' ' LEU . 0.0 OUTLIER -137.49 132.53 33.42 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.562 0.345 . . . . 74.23 110.125 172.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.579 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 15.1 t70 -113.2 148.3 35.73 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.905 0.882 . . . . 74.33 108.906 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 77.0 p -112.76 112.46 23.98 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.449 0.7 . . . . 71.23 109.33 -174.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.2 139.01 48.18 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.568 0.747 . . . . 73.42 109.34 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 55.6 m -157.8 155.62 30.09 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.32 0.648 . . . . 64.41 110.846 -175.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 47.2 t -160.93 130.65 4.92 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.526 -0.761 . . . . 71.44 109.842 -174.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -76.54 122.02 24.0 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.811 -0.44 . . . . 75.32 109.811 174.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.657 HD11 HD12 ' C' ' 83' ' ' ILE . 66.7 mt -86.45 -52.66 5.45 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.539 -0.755 . . . . 74.14 110.119 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.51 -172.04 3.99 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.05 0.54 . . . . 54.11 111.723 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -56.93 103.46 0.11 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.075 1.35 . . . . 61.22 110.875 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 69.51 -1.96 2.07 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 125.907 1.683 . . . . 73.14 113.054 -177.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 75.7 t -93.35 113.7 28.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 108.33 -0.989 . . . . 74.21 108.33 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.571 ' HB3' HD13 ' C' ' 86' ' ' ILE . 50.6 t80 -131.28 126.1 34.52 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.44 -0.8 . . . . 74.03 109.199 -171.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -85.72 124.91 32.76 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.177 0.991 . . . . 63.5 110.223 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 62.9 t -111.94 115.87 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 107.958 -1.127 . . . . 72.11 107.958 171.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.9 t -113.63 129.55 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.493 0.717 . . . . 62.51 109.32 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.604 HD11 HD23 ' C' ' 44' ' ' LEU . 40.9 tp -116.42 113.34 22.73 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.804 -0.814 . . . . 72.43 108.804 173.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.579 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 22.4 ttt180 -81.49 105.74 12.89 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 108.381 -0.97 . . . . 74.31 108.381 176.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 37.3 t -99.0 119.28 46.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 107.7 -1.222 . . . . 70.4 107.7 176.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 60.5 m -130.67 119.74 22.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.757 -0.831 . . . . 61.44 108.757 -174.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.793 HG23 HD13 ' C' ' 114' ' ' ILE . 97.6 t -100.17 114.66 39.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.348 -0.982 . . . . 74.53 108.348 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.504 HG23 HD23 ' C' ' 75' ' ' LEU . 5.2 m -97.69 135.78 38.99 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.104 -1.443 . . . . 64.51 107.104 171.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.12 114.82 16.2 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.308 -1.368 . . . . 74.03 107.308 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 20.1 m -136.15 126.61 26.82 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.113 -0.699 . . . . 75.25 109.113 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.68 HD13 ' HG2' ' C' ' 34' ' ' LYS . 14.2 mt -85.59 13.97 6.28 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.694 1.198 . . . . 71.15 111.588 -176.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.0 -98.77 0.4 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 110.103 -1.199 . . . . 65.23 110.103 -175.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -90.81 -32.85 15.93 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.299 0.64 . . . . 72.25 109.365 171.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -71.8 120.21 17.06 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 114.641 -1.163 . . . . 73.11 109.666 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 62.8 m -76.18 126.13 30.43 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.562 -0.903 . . . . 72.14 108.562 167.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.728 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.87 -58.27 3.39 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.163 -1.051 . . . . 74.25 108.163 170.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -166.22 176.59 7.47 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.623 0.725 . . . . 43.55 111.941 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.504 HD23 HG23 ' C' ' 65' ' ' THR . 2.6 tm? -141.71 104.82 4.6 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 106.983 -1.488 . . . . 73.15 106.983 173.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.522 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.7 t -109.45 125.76 52.78 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.216 0.606 . . . . 75.04 109.378 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . 0.418 ' HB3' ' HB3' ' C' ' 22' ' ' SER . 40.7 tt0 -124.48 139.73 53.62 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.494 0.718 . . . . 73.4 109.527 -177.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.401 HG11 ' HA ' ' C' ' 110' ' ' ALA . 27.4 t -144.08 114.08 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 108.147 -1.057 . . . . 63.14 108.147 174.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 77.9 mt-30 -90.69 97.5 11.22 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.545 -0.909 . . . . 72.14 108.545 171.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.607 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.0 tp-100 -82.03 105.23 12.96 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.616 -0.513 . . . . 73.24 109.616 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.49 144.73 21.61 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 111.386 -0.686 . . . . 32.34 111.386 175.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.29 116.46 0.84 Allowed Glycine 0 CA--C 1.503 -0.675 0 N-CA-C 110.376 -1.09 . . . . 74.24 110.376 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.657 HD12 HD11 ' C' ' 51' ' ' LEU . 14.6 mm -85.24 118.22 31.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 107.81 -1.182 . . . . 64.3 107.81 177.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.584 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 46.7 m-85 -132.2 142.88 49.59 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.637 0.775 . . . . 75.04 108.975 -174.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -84.54 116.74 23.29 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.671 0.388 . . . . 72.21 109.988 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.571 HD13 ' HB3' ' C' ' 56' ' ' TYR . 3.4 mp -115.09 109.07 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 108.406 -0.961 . . . . 71.02 108.406 172.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.486 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -147.01 161.99 39.69 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.66 1.184 . . . . 73.15 108.916 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.21 -51.14 3.96 Favored Glycine 0 N--CA 1.472 1.064 0 O-C-N 123.136 0.272 . . . . 63.42 112.796 175.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 30.6 pt -91.87 158.22 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.826 0.85 . . . . 73.22 111.48 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.625 ' HA ' ' HE3' ' C' ' 94' ' ' MET . 41.8 tt0 -152.12 162.01 41.75 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.112 0.965 . . . . 70.14 109.589 173.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.67 -117.55 5.8 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.024 -0.535 . . . . 75.21 112.814 172.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 57.3 p -65.1 -37.51 87.73 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.048 0.939 . . . . 74.52 111.497 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -71.8 -42.79 66.63 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.287 0.635 . . . . 63.12 111.6 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.625 ' HE3' ' HA ' ' C' ' 90' ' ' GLU . 9.1 ptp -73.09 -33.33 65.54 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 120.99 -0.284 . . . . 72.23 110.574 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.33 -28.64 69.45 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.004 0.522 . . . . 55.23 110.706 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -70.36 -44.74 67.48 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.449 -0.796 . . . . 74.14 110.206 172.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.586 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 42.3 t -65.54 -40.74 93.24 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 123.292 0.37 . . . . 63.22 110.512 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' G' ' 15' ' ' PHE . 86.9 mt -77.27 -49.9 14.03 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.22 0.608 . . . . 72.14 111.781 -175.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . 0.456 ' HA3' HD22 ' G' ' 14' ' ' LEU . . . -97.96 12.38 64.03 Favored Glycine 0 N--CA 1.474 1.228 0 N-CA-C 114.898 0.719 . . . . 71.11 114.898 -166.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.684 ' HB1' ' HB2' ' C' ' 134' ' ' ASP . . . -154.67 -62.54 0.13 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 117.624 0.712 . . . . 72.13 110.974 -172.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.586 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 73.9 t80 -76.14 -39.57 54.73 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.139 1.376 . . . . 73.42 113.105 -167.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 96.7 m -77.44 -39.84 2.09 Favored Pre-proline 0 N--CA 1.486 1.328 0 CA-C-O 118.687 -0.673 . . . . 71.02 111.716 176.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -48.5 -35.15 27.99 Favored 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 122.741 2.294 . . . . 64.53 113.683 164.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -38.51 91.2 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.762 0.425 . . . . 71.35 111.022 175.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.538 HD12 ' NH1' ' A' ' 111' ' ' ARG . 33.4 mm -66.99 -46.36 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 109.795 -0.446 . . . . 72.42 109.795 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.13 -20.97 29.48 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 113.547 0.943 . . . . 72.34 113.547 -168.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -58.7 -52.74 72.56 Favored Pre-proline 0 N--CA 1.488 1.449 0 CA-C-O 117.951 -1.023 . . . . 72.44 113.126 -175.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.14 -32.23 83.11 Favored 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 121.647 1.565 . . . . 64.5 113.0 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -64.91 -53.78 41.09 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.253 0.621 . . . . 63.42 110.377 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.607 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -65.96 -33.43 75.79 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.03 -0.986 . . . . 73.15 111.179 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -60.14 -53.85 52.82 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.394 1.078 . . . . 75.0 110.243 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.28 -35.85 78.48 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 110.016 -0.364 . . . . 73.13 110.016 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.417 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 10.2 t -67.06 -27.92 67.78 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.148 0.579 . . . . 61.2 111.323 -178.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.793 HD13 HG23 ' C' ' 64' ' ' VAL . 83.0 mt -76.58 -55.65 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 115.882 -0.599 . . . . 71.4 109.973 171.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 17.1 m -61.15 -27.81 68.66 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 123.389 0.676 . . . . 73.23 111.502 -173.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.4 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 41.4 t -62.42 -52.77 62.23 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 124.457 1.103 . . . . 65.44 109.093 170.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.583 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.15 -34.74 75.5 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.46 1.104 . . . . 71.34 112.381 178.352 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 88.8 t -63.38 -44.31 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 109.209 -0.663 . . . . 73.44 109.209 174.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 22.8 t -74.68 -24.04 58.73 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.988 -1.006 . . . . 74.33 111.71 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' C' ' 116' ' ' SER . 87.5 mtt-85 -74.02 -40.7 62.71 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.876 -0.787 . . . . 75.45 108.876 174.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.69 -4.35 70.42 Favored Glycine 0 C--N 1.357 1.719 0 O-C-N 123.951 0.782 . . . . 61.35 112.431 171.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 29.3 p 65.26 28.44 11.97 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.679 1.992 . . . . 73.35 112.934 170.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -83.33 145.96 49.73 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 123.364 0.666 . . . . 74.34 109.323 172.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.81 146.03 29.61 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.137 2.558 . . . . 61.11 113.139 176.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -52.62 111.1 0.59 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.396 1.078 . . . . 74.52 112.254 -172.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 47.3 tp -114.21 88.95 2.97 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.079 -1.452 . . . . 53.34 107.079 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -97.83 126.1 43.02 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.337 -0.847 . . . . 74.44 109.062 -171.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.05 126.48 31.12 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 122.888 0.475 . . . . 65.55 110.218 -172.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.11 152.81 95.66 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 124.29 1.036 . . . . 64.21 111.347 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.567 ' HG3' HD12 ' A' ' 16' ' ' ILE . 38.4 Cg_exo -57.65 117.61 4.34 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.773 2.315 . . . . 62.23 113.104 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -104.06 109.52 27.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 122.397 1.094 . . . . 75.13 108.534 169.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -101.32 76.46 1.71 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.933 -1.031 . . . . 72.45 108.566 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -51.11 -45.78 61.67 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.271 0.628 . . . . 65.34 112.311 -173.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.684 ' HB2' ' HB1' ' C' ' 100' ' ' ALA . 18.4 t0 -66.1 -46.37 77.85 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.01 0.818 . . . . 64.41 110.958 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' C' ' 139' ' ' ASN . . . -61.99 -30.7 71.12 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.172 -0.922 . . . . 73.02 111.197 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 97.1 mt -78.02 -29.36 49.45 Favored 'General case' 0 CA--C 1.55 0.963 0 O-C-N 124.43 1.081 . . . . 74.5 111.795 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -71.25 -38.6 71.92 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.014 0.435 . . . . 63.14 110.109 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 57.6 mtt -74.26 -30.8 62.29 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.448 -0.796 . . . . 64.31 110.602 175.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' C' ' 135' ' ' ALA . 66.5 t30 -65.19 -37.72 88.21 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.365 1.066 . . . . 52.4 110.33 177.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -51.34 -84.78 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.987 0 O-C-N 124.158 0.911 . . . . 72.11 111.075 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 64.5 tp 58.42 -81.85 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.794 0.838 . . . . 74.03 109.901 -171.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -174.53 -54.75 0.01 OUTLIER 'General case' 0 C--N 1.355 0.812 0 C-N-CA 124.688 1.195 . . . . 74.43 108.467 174.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -134.95 146.4 49.09 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.858 0.863 . . . . 63.23 109.979 -174.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -127.02 157.71 38.88 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.752 0.821 . . . . 63.12 110.822 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -163.56 99.64 0.91 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.633 1.173 . . . . 42.11 108.392 171.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -141.91 91.33 0.18 Allowed Glycine 0 C--N 1.352 1.439 0 CA-C-N 116.776 -0.193 . . . . 32.44 112.696 -174.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -148.01 147.96 30.19 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.379 1.072 . . . . 72.45 108.775 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 145.95 47.48 0.03 OUTLIER Glycine 0 C--N 1.342 0.871 0 N-CA-C 110.898 -0.881 . . . . 62.02 110.898 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 40.6 p -88.12 155.9 19.55 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.694 0.797 . . . . 73.21 110.824 -175.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -155.1 -170.24 3.42 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.014 0.926 . . . . 73.11 110.062 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' C' ' 152' ' ' HIS . 8.8 pt-20 -133.48 -57.73 0.89 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.604 0.762 . . . . 72.22 110.122 172.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . 0.421 ' H ' ' HG3' ' C' ' 151' ' ' GLU . 11.1 p-80 159.45 164.7 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 127.204 2.201 . . . . 73.41 109.222 -175.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 21.8 tm0? -141.87 118.98 11.33 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.6 -1.259 . . . . 74.42 107.6 170.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 178.47 161.54 0.65 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.185 1.394 . . . . 64.25 108.942 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.645 -0.693 . . . . 42.4 109.951 175.412 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 76.6 mtp . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 110.346 -0.242 . . . . 72.15 110.346 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 29.8 t -157.13 93.41 1.33 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.537 -1.282 . . . . 63.02 107.537 172.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -70.72 -68.24 0.45 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.503 0.721 . . . . 74.3 109.131 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -95.95 116.29 28.71 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.106 -1.442 . . . . 75.31 107.106 168.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -78.63 84.9 4.71 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.526 0.679 . . . . 53.54 110.989 -172.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -136.5 80.27 1.81 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 106.394 -1.706 . . . . 73.21 106.394 171.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 15.1 t -176.0 -30.18 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 114.501 -1.227 . . . . 62.14 109.025 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -65.4 -45.85 82.35 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.336 1.055 . . . . 74.05 110.71 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 26.9 ptm -32.66 143.35 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.393 1.477 . . . . 74.13 114.173 165.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 26.0 m -111.3 138.69 47.44 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.324 0.649 . . . . 75.11 109.41 173.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.442 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 55.1 t80 -158.09 100.82 1.73 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.791 -1.188 . . . . 73.34 107.791 -175.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -127.65 116.76 20.79 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.47 -0.937 . . . . 75.3 108.47 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.558 HD13 HG21 ' D' ' 105' ' ' ILE . 7.4 mt -81.8 124.03 38.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.693 -0.484 . . . . 72.22 109.693 -177.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -90.8 -39.24 12.48 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.649 0.78 . . . . 73.22 111.478 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -174.97 123.9 0.25 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 117.805 0.275 . . . . 40.05 111.665 -166.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -103.97 137.1 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 107.986 -1.116 . . . . 73.42 107.986 167.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -160.8 148.57 15.85 Favored 'General case' 0 C--O 1.239 0.533 0 O-C-N 124.142 0.902 . . . . 70.4 109.883 177.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 77.8 p -79.61 114.05 18.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.136 -0.938 . . . . 75.32 108.979 174.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -82.4 -28.59 31.33 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.935 -0.575 . . . . 73.53 110.439 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.53 ' HB3' HE21 ' D' ' 79' ' ' GLN . 30.2 t70 -156.61 140.12 15.86 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.855 -1.066 . . . . 65.3 108.24 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.583 HG21 ' HE2' ' C' ' 117' ' ' MET . 84.6 mt -139.16 150.3 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.203 1.001 . . . . 72.34 108.374 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . 0.454 ' HB2' ' HB3' ' D' ' 77' ' ' GLU . 71.7 m -147.62 140.57 24.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.689 1.196 . . . . 55.33 109.318 172.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.514 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 83.7 t80 -141.23 123.49 15.68 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 105.233 -2.136 . . . . 70.42 105.233 165.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.6 mt-10 -139.7 108.62 6.0 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.187 -0.672 . . . . 74.33 109.187 -170.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.36 94.17 9.35 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 108.422 -0.955 . . . . 33.14 108.422 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.86 -44.36 2.84 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.696 2.264 . . . . 72.51 112.607 -170.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.482 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 36.0 m-20 -96.5 11.75 33.94 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.849 0.86 . . . . 72.21 111.057 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.416 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -23.88 -68.38 0.05 OUTLIER Pre-proline 0 CA--C 1.56 1.346 0 N-CA-C 116.941 2.2 . . . . 70.2 116.941 -160.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.403 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 97.2 Cg_endo -74.21 -27.23 11.82 Favored 'Trans proline' 0 C--N 1.382 2.307 0 CA-C-N 123.334 2.226 . . . . 43.03 113.509 -176.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -66.35 -45.55 79.81 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.758 0.823 . . . . 73.23 110.376 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.644 HG21 ' HA ' ' D' ' 73' ' ' ALA . 11.7 p -76.41 -15.39 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 CA-C-N 115.355 -0.839 . . . . 60.31 112.125 -171.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.403 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 21.4 m-85 -69.11 -17.99 63.91 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 112.544 0.572 . . . . 72.22 112.544 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -61.46 -20.95 63.71 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.128 0.571 . . . . 75.2 110.982 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -99.69 90.73 4.57 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.857 1.263 . . . . 72.42 109.477 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -96.93 93.08 6.42 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.874 -0.603 . . . . 63.15 109.485 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.448 ' O ' ' HG2' ' D' ' 124' ' ' PRO . 33.1 p90 -160.88 175.86 12.07 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.61 1.164 . . . . 74.33 107.866 167.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -69.62 112.0 10.73 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 122.938 0.495 . . . . 74.21 109.687 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.92 134.55 60.91 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.15 2.567 . . . . 70.41 111.541 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.11 114.27 10.03 Favored 'General case' 0 C--N 1.348 0.524 0 N-CA-C 108.235 -1.024 . . . . 71.04 108.235 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 16.1 m -103.65 108.56 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-O 122.119 0.961 . . . . 60.31 110.997 -166.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.502 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 73.7 mmtt -87.93 128.37 35.37 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.743 -1.117 . . . . 71.34 108.337 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.51 ' H ' HD23 ' D' ' 42' ' ' LEU . 1.0 OUTLIER -96.3 118.89 33.77 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.711 0.767 . . . . 72.15 110.03 -174.393 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.712 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.9 m-20 -110.33 125.69 53.44 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.539 -1.282 . . . . 73.53 107.539 174.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 93.3 mt -122.79 130.77 53.3 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.112 0.565 . . . . 74.25 109.692 -175.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.588 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 11.4 t70 -131.73 146.5 52.2 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.154 0.982 . . . . 74.12 108.368 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 42.8 p -119.67 143.73 47.57 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.507 0.723 . . . . 74.11 110.622 -171.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.75 155.68 33.52 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.331 0.653 . . . . 72.11 109.793 175.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 17.7 p -150.2 160.22 43.85 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.901 0.48 . . . . 52.34 110.576 -175.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 2.9 m -152.07 119.65 6.06 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.92 -0.77 . . . . 63.44 108.92 175.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -66.95 116.51 7.87 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.737 -1.209 . . . . 51.14 107.737 163.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.475 HD12 HG23 ' D' ' 83' ' ' ILE . 29.8 mt -95.04 -35.12 12.07 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.296 -0.631 . . . . 42.3 109.296 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.56 -173.12 4.24 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.217 -0.901 . . . . 70.5 110.208 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -68.33 123.57 21.12 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.875 -1.057 . . . . 73.53 110.225 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 65.1 m-20 62.25 17.75 9.57 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.699 1.2 . . . . 71.41 112.194 -175.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.6 t -119.44 119.67 61.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.813 -0.81 . . . . 61.45 108.813 174.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.543 ' HD2' ' HB ' ' D' ' 86' ' ' ILE . 78.3 m-85 -134.52 129.06 34.53 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.521 -0.918 . . . . 74.12 108.521 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -92.98 127.53 38.53 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.97 0.908 . . . . 74.44 109.335 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.4 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 73.8 t -103.54 112.44 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.856 -1.165 . . . . 62.53 107.856 173.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.421 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 47.5 t -103.68 132.2 50.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 108.094 -1.076 . . . . 64.34 108.094 174.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 53.6 tp -128.54 121.78 29.58 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.722 0.296 . . . . 75.11 110.208 175.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.588 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 20.6 ttm-85 -84.82 98.72 10.45 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.056 0.942 . . . . 74.44 109.404 173.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 93.6 t -90.79 114.49 28.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.31 -0.996 . . . . 45.01 108.31 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.712 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 28.6 m -122.65 133.33 54.52 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.45 0.643 . . . . 72.03 109.666 -174.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 21.7 t -119.63 101.87 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.863 1.665 . . . . 72.41 108.787 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.502 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 59.1 m -92.4 99.79 12.48 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.271 -0.877 . . . . 54.15 108.801 175.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.31 142.21 36.36 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.135 -0.939 . . . . 71.33 109.7 -169.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 70.1 m -142.93 137.45 29.46 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.222 0.534 . . . . 53.13 111.673 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.53 HD12 HG22 ' D' ' 31' ' ' VAL . 55.8 mt -105.53 104.59 14.34 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.629 1.172 . . . . 61.42 108.536 172.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.22 -123.94 6.35 Favored Glycine 0 C--N 1.342 0.896 0 CA-C-N 115.797 -0.638 . . . . 74.52 112.514 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.61 5.87 34.06 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.168 0.587 . . . . 73.55 111.081 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -120.49 157.01 30.31 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.327 0.651 . . . . 74.45 109.81 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 63.7 m -71.34 136.45 47.84 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.628 0.58 . . . . 71.53 110.731 178.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.644 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -84.45 -64.08 1.22 Allowed 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.329 -0.989 . . . . 61.25 108.329 174.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -157.09 167.5 30.24 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.685 -1.143 . . . . 72.41 110.162 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.484 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 83.3 mt -126.42 110.92 13.86 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 106.435 -1.691 . . . . 73.41 106.435 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.56 ' SG ' HG12 ' D' ' 114' ' ' ILE . 42.4 t -114.26 138.1 50.93 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.575 -1.269 . . . . 71.42 107.575 -178.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . 0.454 ' HB3' ' HB2' ' D' ' 22' ' ' SER . 43.6 tt0 -155.36 122.58 5.51 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 110.033 -0.358 . . . . 74.22 110.033 -175.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 50.8 t -129.73 114.69 31.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 123.24 0.616 . . . . 75.31 109.368 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.53 HE21 ' HB3' ' D' ' 20' ' ' ASP . 5.0 mt-30 -86.51 83.65 7.59 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.096 -1.075 . . . . 65.32 108.096 168.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -79.88 98.21 7.02 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 113.346 -1.752 . . . . 74.33 108.145 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -93.71 144.12 16.91 Favored Glycine 0 C--N 1.341 0.85 0 N-CA-C 111.4 -0.68 . . . . 74.12 111.4 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.6 131.33 5.45 Favored Glycine 0 C--N 1.331 0.259 0 N-CA-C 111.162 -0.775 . . . . 73.53 111.162 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.475 HG23 HD12 ' D' ' 51' ' ' LEU . 61.3 mt -88.04 120.23 36.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 107.923 -1.14 . . . . 65.24 107.923 175.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.4 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 61.7 m-85 -128.54 126.22 39.93 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.676 0.791 . . . . 71.41 108.97 -175.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.1 m -79.37 99.53 7.19 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.599 -0.889 . . . . 75.44 108.599 172.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.543 ' HB ' ' HD2' ' D' ' 56' ' ' TYR . 17.9 mm -108.98 111.58 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.705 0.802 . . . . 73.33 109.571 -174.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.518 ' HB2' ' HB3' ' D' ' 54' ' ' ASP . . . -138.04 147.72 44.39 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.955 0.502 . . . . 73.32 110.705 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.56 10.34 84.68 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 114.724 0.65 . . . . 71.11 114.724 171.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.543 ' HB ' HG21 ' H' ' 18' ' ' VAL . 8.9 mt -106.46 128.02 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 117.433 0.617 . . . . 54.43 109.744 -175.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -148.51 159.69 43.81 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.562 1.145 . . . . 72.53 109.957 -169.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' D' ' 94' ' ' MET . . . 68.1 -132.24 28.23 Favored Glycine 0 C--N 1.349 1.292 0 O-C-N 124.08 0.863 . . . . 52.54 113.428 173.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 18.7 m -61.75 -37.38 84.05 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.654 0.782 . . . . 71.31 111.098 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -65.77 -34.11 77.41 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.033 -0.985 . . . . 65.32 110.701 -174.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.569 ' HB2' HG23 ' H' ' 18' ' ' VAL . 10.6 ptm -75.21 -36.0 61.43 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.168 0.587 . . . . 74.42 111.424 -174.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.65 -31.37 63.46 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.484 -0.78 . . . . 63.31 110.362 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -80.0 -31.73 39.69 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.372 -0.831 . . . . 73.5 111.076 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.0 t -69.59 -53.16 20.19 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.664 0.386 . . . . 54.4 110.702 -175.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.51 ' HB3' ' CD1' ' H' ' 15' ' ' PHE . 10.3 mp -86.82 -22.61 25.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.414 0.286 . . . . 73.34 111.198 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.29 -24.82 56.29 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-O 119.729 -0.484 . . . . 72.5 113.904 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.17 -50.97 0.65 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.494 0.553 . . . . 62.11 112.494 -171.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -73.86 -43.73 57.69 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.834 0.679 . . . . 73.44 112.834 -169.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.442 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 69.0 m -72.76 -44.2 8.81 Favored Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 123.462 0.705 . . . . 73.41 111.822 -176.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.32 -25.14 64.34 Favored 'Trans proline' 0 C--N 1.395 3.017 0 C-N-CA 121.76 1.64 . . . . 71.42 112.681 170.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . 0.516 ' HA ' ' HD2' ' D' ' 107' ' ' PHE . 45.7 t-20 -62.43 -39.89 94.77 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.424 0.689 . . . . 71.23 110.094 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.558 HG21 HD13 ' D' ' 13' ' ' ILE . 48.6 mm -58.85 -38.41 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.62 0.768 . . . . 63.02 110.564 174.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 86.4 mt -83.14 -19.73 36.11 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.114 -0.948 . . . . 63.53 112.442 -170.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . 0.516 ' HD2' ' HA ' ' D' ' 104' ' ' ASN . 27.5 m-85 -63.05 -43.79 82.82 Favored Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 114.086 1.143 . . . . 62.51 114.086 -177.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -52.18 -46.14 34.62 Favored 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 122.328 2.019 . . . . 74.55 113.393 172.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -72.86 -36.44 67.42 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.456 -0.793 . . . . 74.23 111.686 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.14 78.67 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.589 0.555 . . . . 71.12 109.639 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -55.58 -50.21 70.69 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 124.953 1.408 . . . . 74.31 110.634 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -65.01 -46.67 80.44 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 123.728 0.642 . . . . 73.5 111.608 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -57.7 -41.8 82.44 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.578 0.549 . . . . 61.13 110.53 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.56 HG12 ' SG ' ' D' ' 76' ' ' CYS . 81.5 mt -60.93 -56.78 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 115.046 -0.979 . . . . 64.13 110.478 172.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 47.6 m -54.4 -40.77 68.53 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.677 1.191 . . . . 71.45 111.753 -172.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 32.3 t -67.09 -45.32 77.6 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.034 -0.985 . . . . 70.25 110.567 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.8 mtm -67.31 -34.5 77.51 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.852 0.461 . . . . 64.35 111.734 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' D' ' 114' ' ' ILE . 77.3 t -62.08 -45.01 99.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.586 0.754 . . . . 45.13 109.903 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.5 p -75.71 -26.58 57.66 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.901 -0.59 . . . . 73.54 111.401 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.417 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 84.3 mtt-85 -72.46 -31.22 65.25 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.374 0.669 . . . . 74.44 110.132 175.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.49 10.75 68.25 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 123.739 0.65 . . . . 34.54 112.139 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.47 HG23 ' HB3' ' C' ' 17' ' ' TYR . 24.3 p 58.63 22.3 9.7 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 126.877 2.071 . . . . 74.11 114.09 174.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -83.96 157.22 63.48 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.846 0.858 . . . . 70.01 110.04 171.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.448 ' HG2' ' O ' ' D' ' 36' ' ' TRP . 77.9 Cg_exo -54.96 134.0 61.12 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.347 2.698 . . . . 64.24 113.835 176.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -55.95 132.1 48.93 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.801 1.241 . . . . 73.53 112.071 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 61.4 tp -110.27 101.88 10.59 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.571 0.748 . . . . 65.14 110.09 -177.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -103.89 104.02 13.96 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.582 -0.896 . . . . 72.41 108.582 175.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 tt -70.9 125.68 27.5 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 108.483 -0.932 . . . . 73.43 108.483 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.91 157.07 81.76 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.173 0.989 . . . . 52.23 112.09 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.508 ' HD3' HG13 ' B' ' 13' ' ' ILE . 54.3 Cg_exo -56.52 103.52 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.046 2.498 . . . . 73.15 112.785 174.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 13.6 m -112.24 133.11 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.052 0.941 . . . . 64.34 109.84 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -94.47 110.5 22.28 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.737 -0.838 . . . . 70.41 108.737 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.469 ' HZ ' ' HG ' ' H' ' 11' ' ' LEU . 1.9 t80 -82.8 -37.54 24.36 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.605 0.762 . . . . 65.31 109.938 -176.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -62.18 -54.0 47.24 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.516 -1.22 . . . . 74.35 111.699 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.73 -40.62 93.06 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.287 0.635 . . . . 73.33 111.059 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 55.7 tp -52.2 -43.88 64.44 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.479 1.112 . . . . 52.34 111.352 176.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -73.4 -48.22 35.67 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.658 -0.701 . . . . 61.54 111.364 175.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 78.0 mtm -65.37 -23.99 67.12 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.308 0.643 . . . . 71.14 112.166 -171.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -56.81 -48.53 77.77 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.179 0.591 . . . . 64.54 110.238 173.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -65.61 -37.77 87.54 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.982 0.913 . . . . 72.21 111.421 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.8 mp -60.48 -30.08 69.47 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.243 0.617 . . . . 71.33 111.528 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -90.07 9.29 28.71 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.77 0.828 . . . . 62.41 112.253 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -119.86 74.16 1.01 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.837 -0.801 . . . . 73.25 108.837 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -159.07 -24.03 0.07 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.161 -0.927 . . . . 74.35 111.324 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.71 169.56 10.4 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.21 0.604 . . . . 42.15 111.821 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.85 101.72 2.07 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.588 -0.733 . . . . 75.44 112.607 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.63 150.55 42.93 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.747 0.819 . . . . 74.21 110.125 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.96 -47.48 88.48 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 123.761 0.663 . . . . 71.15 113.457 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 61.4 p -75.17 175.0 8.69 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.198 0.599 . . . . 64.3 110.754 176.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -72.88 86.63 1.28 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.207 0.527 . . . . 62.1 109.828 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -61.6 96.84 0.06 Allowed 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.304 -0.862 . . . . 71.53 110.901 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -70.84 85.76 0.68 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.753 -0.832 . . . . 71.52 108.753 171.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -82.41 154.16 25.34 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.012 -0.995 . . . . 75.32 109.59 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.4 91.4 0.55 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.503 0.721 . . . . 63.22 110.647 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.152 0 C-N-CA 124.213 1.005 . . . . 61.51 108.972 -179.81 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 53.4 mtt . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 109.311 -0.626 . . . . 71.34 109.311 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -110.85 177.5 4.65 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.868 0.867 . . . . 75.44 110.704 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -157.63 154.57 28.63 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.341 0.657 . . . . 72.32 110.033 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 66.2 m -140.57 156.68 46.22 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.595 0.758 . . . . 72.25 110.724 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 19.3 m -141.44 178.27 7.55 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 124.768 1.227 . . . . 43.44 108.412 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.527 HG13 HD22 ' A' ' 42' ' ' LEU . 9.0 tt -55.46 89.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 124.07 0.948 . . . . 60.23 110.843 173.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 7' ' ' ALA . . . . . 0.446 ' HA ' ' HB3' ' A' ' 129' ' ' ALA . . . -97.95 147.54 24.38 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.686 0.794 . . . . 53.24 111.293 -174.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.498 HD22 ' HE1' ' A' ' 133' ' ' PHE . 2.5 tt -102.7 114.53 28.86 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 107.678 -1.23 . . . . 74.4 107.678 174.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.12 50.78 2.05 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.785 0.834 . . . . 71.1 111.293 -173.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 81.7 mt 64.6 169.6 0.18 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.636 1.175 . . . . 62.53 111.304 -173.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.538 ' HB2' HD23 ' E' ' 14' ' ' LEU . 89.2 mt -81.42 125.99 77.44 Favored Pre-proline 0 CA--C 1.551 1.002 0 CA-C-O 119.058 -0.496 . . . . 75.33 110.708 -175.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.93 -29.28 87.74 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 123.502 2.802 . . . . 63.21 112.535 176.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 60.1 tp -132.17 129.85 40.32 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.189 -1.411 . . . . 74.3 107.189 169.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . 0.538 HD23 ' HB2' ' E' ' 11' ' ' LEU . 73.1 mt -85.39 43.69 1.04 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.394 0.678 . . . . 75.12 110.407 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . 0.516 ' HE2' ' HB3' ' A' ' 103' ' ' PRO . 82.3 m-85 62.28 -174.11 0.14 Allowed 'General case' 0 C--N 1.362 1.116 0 C-N-CA 124.285 1.034 . . . . 51.31 111.389 -171.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 70.3 p -94.97 144.69 28.24 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.016 0.526 . . . . 74.14 109.799 176.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 17' ' ' PRO . . . . . 0.463 ' HB3' ' H ' ' E' ' 21' ' ' ALA . 57.7 Cg_exo -45.63 108.21 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 123.544 2.83 . . . . 73.53 112.979 166.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 18' ' ' VAL . . . . . 0.515 HG11 HG21 ' A' ' 86' ' ' ILE . 15.0 p -67.07 -39.81 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.58 0.752 . . . . 63.34 111.322 -176.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 11.8 m -105.36 -73.29 0.68 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.384 -0.969 . . . . 74.11 108.384 173.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -167.27 41.95 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 109.932 -0.396 . . . . 60.1 109.932 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . 0.463 ' H ' ' HB3' ' E' ' 17' ' ' PRO . . . -67.84 76.32 0.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.825 0.85 . . . . 74.21 111.984 -175.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -168.72 -2.23 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.893 1.277 . . . . 63.11 109.802 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 92.7 m -46.39 122.15 6.57 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 125.055 1.342 . . . . 62.21 112.019 174.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.12 106.33 0.25 Allowed 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 123.201 2.601 . . . . 72.23 112.377 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 C--O 1.253 1.26 0 C-N-CA 124.296 1.038 . . . . 75.1 109.433 -179.383 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . 0.467 ' SD ' HG13 ' F' ' 6' ' ' ILE . 54.0 mtm . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.182 -0.673 . . . . 71.04 109.182 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -111.14 -76.97 0.59 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.745 0.418 . . . . 73.13 110.391 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -104.2 2.58 31.91 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.486 0.714 . . . . 70.24 111.09 -173.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 50.5 m -99.64 118.51 36.33 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.453 0.701 . . . . 64.11 110.116 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 74.5 m -69.11 141.44 54.68 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.09 -1.078 . . . . 75.21 108.09 167.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.617 ' H ' HD12 ' F' ' 6' ' ' ILE . 3.0 mp -64.14 -64.35 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 109.238 -0.653 . . . . 63.34 109.238 -174.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . 65.74 139.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 125.292 1.437 . . . . 74.34 112.367 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . 0.531 ' H ' HG21 ' B' ' 131' ' ' VAL . 47.0 mt -58.4 133.22 55.56 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.774 0.321 . . . . 74.12 110.592 175.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.83 169.78 16.07 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.843 -0.617 . . . . 73.31 110.578 176.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 10' ' ' LEU . . . . . 0.459 HD21 ' HB2' ' B' ' 136' ' ' LEU . 89.1 mt -70.65 151.08 45.34 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.249 -0.649 . . . . 71.42 109.249 172.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 71.4 mt -57.95 107.3 0.89 Allowed Pre-proline 0 CA--C 1.557 1.237 0 O-C-N 124.24 0.963 . . . . 75.21 110.674 -177.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -64.77 -44.73 9.86 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 123.113 2.542 . . . . 75.43 110.604 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 mp -97.78 108.31 21.0 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 107.63 -1.248 . . . . 72.42 107.63 169.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.32 116.24 26.39 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 106.694 -1.595 . . . . 71.55 106.694 173.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -61.69 170.83 1.79 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.854 0.861 . . . . 70.15 112.816 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 9.4 p -65.89 148.3 98.36 Favored Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 124.069 0.948 . . . . 75.02 111.29 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -49.26 161.04 0.71 Allowed 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 123.857 3.038 . . . . 62.33 114.596 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 79.3 t -46.14 -45.09 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 C-N-CA 125.072 1.349 . . . . 75.11 113.284 -172.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 50.4 m -73.18 -36.69 66.62 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.676 0.79 . . . . 61.2 111.22 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -88.86 -4.82 58.37 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.007 0.923 . . . . 75.05 111.665 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.55 8.64 11.24 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.64 1.176 . . . . 74.42 110.664 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . 0.638 ' HA ' ' HB2' ' B' ' 50' ' ' GLN . 13.5 ptm180 -61.31 -14.64 28.33 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.848 1.259 . . . . 71.12 113.076 172.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 2.8 t -49.84 113.65 3.55 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 124.256 1.022 . . . . 71.35 111.048 173.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 24' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' B' ' 49' ' ' SER . 19.2 Cg_endo -92.37 -168.73 0.23 Allowed 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.221 2.614 . . . . 65.54 113.997 -173.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 C--O 1.256 1.431 0 C-N-CA 124.321 1.048 . . . . 71.54 109.137 174.599 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.842 -0.429 . . . . 74.22 109.842 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -159.38 -42.95 0.05 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.48 0.312 . . . . 75.2 110.894 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -143.08 114.09 7.71 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.966 0.507 . . . . 62.14 109.67 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 26.2 m -85.74 -9.47 57.08 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.545 0.738 . . . . 61.03 111.108 173.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 37.8 m 65.28 -79.94 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.668 1.587 . . . . 75.15 111.441 -178.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . 0.674 HG13 HD21 ' C' ' 42' ' ' LEU . 19.3 tt -158.0 131.63 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.388 0.675 . . . . 71.22 109.759 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.09 136.62 13.21 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.046 0.939 . . . . 64.03 108.942 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.55 140.75 31.2 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.772 -0.825 . . . . 73.22 108.772 177.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.61 126.84 29.29 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.875 0.87 . . . . 70.54 111.878 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 4.3 tt -65.28 132.53 49.29 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.235 1.014 . . . . 75.03 108.442 175.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 11' ' ' LEU . . . . . 0.449 HD22 ' O ' ' G' ' 13' ' ' LEU . 13.0 mt -60.39 111.3 3.81 Favored Pre-proline 0 N--CA 1.482 1.162 0 O-C-N 124.137 0.898 . . . . 74.32 112.285 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -88.09 -8.61 5.64 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.672 2.248 . . . . 75.5 111.692 172.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . 0.449 ' O ' HD22 ' G' ' 11' ' ' LEU . 1.7 tt -148.85 123.47 9.8 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 106.582 -1.636 . . . . 74.52 106.582 -178.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . 0.456 HD22 ' HA3' ' C' ' 99' ' ' GLY . 83.1 mt -75.17 -179.22 4.27 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.23 0.612 . . . . 74.32 111.639 -177.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . 0.451 ' HB2' ' HB3' ' C' ' 98' ' ' LEU . 7.6 m-85 -69.24 164.36 22.9 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.392 0.677 . . . . 62.23 110.818 174.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -66.85 136.26 94.45 Favored Pre-proline 0 CA--C 1.556 1.201 0 CA-C-N 115.479 -0.782 . . . . 71.53 109.959 173.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 17' ' ' PRO . . . . . 0.544 ' HB3' ' HB3' ' G' ' 21' ' ' ALA . 36.4 Cg_endo -62.34 166.33 13.27 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 123.552 2.835 . . . . 64.01 114.163 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 18' ' ' VAL . . . . . 0.414 HG23 HD11 ' C' ' 98' ' ' LEU . 39.9 t -90.15 -69.01 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.716 0.806 . . . . 74.52 109.042 176.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 66.8 p -96.55 -149.94 0.33 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.712 0.805 . . . . 74.21 108.941 176.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -80.81 68.21 6.98 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-O 121.436 0.636 . . . . 62.53 111.007 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' G' ' 17' ' ' PRO . . . -99.01 18.77 16.48 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.34 -0.615 . . . . 75.14 109.34 170.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 31.2 ptt85 -134.24 129.39 35.6 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 125.111 1.364 . . . . 71.33 108.887 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 28.7 m 61.45 84.31 0.2 Allowed Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 124.389 1.076 . . . . 63.25 111.588 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.1 -15.18 18.52 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.967 2.445 . . . . 74.23 113.08 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 . . . . . 0 C--O 1.256 1.396 0 C-N-CA 124.163 0.985 . . . . 55.23 108.983 -177.432 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 73.9 mtm . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 110.26 -0.274 . . . . 74.44 110.26 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 59.8 mttm 64.95 21.21 12.28 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.874 1.27 . . . . 72.52 112.218 173.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -83.99 95.07 8.43 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.326 1.051 . . . . 74.43 109.785 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 10.5 p -94.26 -59.36 1.97 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.913 0.885 . . . . 61.51 111.006 -175.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 5' ' ' THR . . . . . 0.437 ' HB ' ' H ' ' H' ' 6' ' ' ILE . 3.6 p -115.22 -142.82 0.38 Allowed 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.868 0.867 . . . . 73.53 109.957 177.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.606 ' H ' HD12 ' H' ' 6' ' ' ILE . 4.4 mp -55.37 108.21 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.411 0 C-N-CA 124.533 1.133 . . . . 72.11 111.039 -172.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.99 133.71 41.31 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.49 0.716 . . . . 72.32 109.27 175.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 97.5 mt -77.03 147.12 36.94 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.257 0.623 . . . . 72.13 110.904 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.99 160.88 14.09 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.365 0.666 . . . . 54.3 110.208 175.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 8.5 mp -68.62 120.12 14.13 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 109.093 -0.706 . . . . 65.13 109.093 173.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.469 ' HG ' ' HZ ' ' D' ' 133' ' ' PHE . 96.0 mt -58.21 146.99 68.37 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 123.392 0.677 . . . . 71.22 110.962 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.19 118.8 5.7 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.799 2.333 . . . . 70.35 110.497 176.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 22.9 tp 60.8 18.8 9.0 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.242 1.017 . . . . 71.41 111.237 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 mp 60.52 -83.81 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.86 1.264 . . . . 71.52 110.517 -171.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . 0.51 ' CD1' ' HB3' ' D' ' 98' ' ' LEU . 18.4 t80 -167.14 164.73 15.72 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.431 -0.951 . . . . 70.05 108.431 -176.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 60.4 p -62.31 139.04 96.36 Favored Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 122.828 0.451 . . . . 73.21 110.219 174.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.59 163.74 33.83 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.483 2.122 . . . . 75.32 111.709 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . 0.569 HG23 ' HB2' ' D' ' 94' ' ' MET . 96.4 t -51.66 -54.91 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 123.941 0.896 . . . . 74.42 110.959 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 89.2 m -56.62 107.0 0.34 Allowed 'General case' 0 CA--C 1.546 0.818 0 O-C-N 124.292 0.995 . . . . 54.1 110.84 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt 63.26 44.84 5.35 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.937 1.295 . . . . 73.44 111.329 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.88 82.5 0.07 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.047 0.539 . . . . 64.44 110.635 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? 52.29 86.13 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.48 1.512 . . . . 74.21 112.556 -174.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 58.8 p -56.31 145.82 55.62 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 123.962 0.905 . . . . 64.34 111.363 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -64.33 132.0 32.11 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.68 2.253 . . . . 74.25 111.876 -174.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 C--O 1.253 1.285 0 C-N-CA 123.923 0.889 . . . . 60.51 110.876 -176.853 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.8 mtt . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 108.287 -1.005 . . . . 54.2 108.287 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.2 m -73.9 100.81 3.6 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 123.777 0.831 . . . . 73.11 110.638 -174.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.22 174.73 13.89 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.872 0.869 . . . . 73.42 110.013 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 70.46 15.68 7.2 Favored 'General case' 0 C--N 1.362 1.152 0 C-N-CA 125.248 1.419 . . . . 72.05 112.191 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -83.93 117.98 23.7 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.19 -0.67 . . . . 64.41 109.19 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -57.41 97.24 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.258 1.423 . . . . 62.53 112.78 -172.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.1 m 54.57 35.23 23.03 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 125.03 1.332 . . . . 63.13 111.091 175.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -80.48 0.79 32.06 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.712 -0.676 . . . . 73.14 111.186 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.75 ' HB3' HG12 ' A' ' 89' ' ' ILE . 25.4 ptm -74.08 175.94 6.99 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.313 0.578 . . . . 74.14 110.002 169.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.5 p -136.58 143.34 43.55 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.879 -0.786 . . . . 74.51 108.879 -173.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.51 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 24.6 t80 -128.54 125.67 38.78 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.433 -0.951 . . . . 72.3 108.433 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -155.14 102.11 2.28 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.193 -0.669 . . . . 74.41 109.193 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.699 HG12 ' HD2' ' A' ' 84' ' ' PHE . 27.5 mt -72.52 120.39 20.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 109.134 -0.691 . . . . 43.35 109.134 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -85.58 -40.87 15.8 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 123.741 0.651 . . . . 71.54 110.001 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.433 ' HB3' HD12 ' A' ' 83' ' ' ILE . 19.9 ttt180 -173.44 120.89 0.34 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.387 -0.37 . . . . 65.05 110.402 -166.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.551 HD12 ' HG3' ' C' ' 130' ' ' PRO . 62.9 mt -114.0 134.47 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 108.78 -0.822 . . . . 72.42 108.78 173.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.522 ' HB3' HG23 ' B' ' 122' ' ' THR . 31.0 p90 -166.32 165.74 17.1 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 124.216 0.947 . . . . 74.32 110.848 -173.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.7 p -89.13 116.94 27.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.978 -1.01 . . . . 75.24 109.088 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.405 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.3 mtpt -85.58 -32.56 22.04 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.939 0.4 . . . . 71.32 109.996 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.663 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 9.9 t70 -142.85 136.41 28.7 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.018 -0.992 . . . . 51.0 109.289 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.0 mt -137.3 146.54 27.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 107.393 -1.336 . . . . 52.15 107.393 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.9 t -155.44 131.7 10.24 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.235 0.614 . . . . 74.5 109.829 172.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.541 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.3 t80 -130.44 141.84 50.52 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.181 -1.414 . . . . 74.12 107.181 171.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -139.48 139.99 37.14 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.021 0.929 . . . . 74.01 108.506 175.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.451 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -124.09 82.81 56.28 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 106.256 -1.757 . . . . 41.43 106.256 171.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.54 -42.01 29.14 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 123.058 2.505 . . . . 74.45 112.706 -166.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -111.41 25.14 12.0 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 118.13 -0.938 . . . . 72.54 109.654 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.493 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -37.03 -62.8 0.52 Allowed Pre-proline 0 N--CA 1.497 1.924 0 C-N-CA 124.433 1.093 . . . . 54.3 113.915 -166.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 12.7 Cg_exo -67.87 -24.53 39.98 Favored 'Trans proline' 0 C--N 1.394 2.935 0 C-N-CA 122.175 1.917 . . . . 62.52 112.712 -173.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -78.03 -47.21 18.93 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.88 0.872 . . . . 74.21 109.784 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.685 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.2 p -79.8 -12.15 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-N 114.645 -1.162 . . . . 63.35 112.654 -163.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -66.81 -27.39 67.52 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.047 0.451 . . . . 71.22 110.623 171.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -78.33 -18.04 55.72 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.284 1.034 . . . . 45.24 111.276 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -80.06 151.08 30.1 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.642 0.777 . . . . 73.22 111.01 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.05 138.82 58.64 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.268 -0.878 . . . . 74.43 110.142 174.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -79.88 83.65 5.77 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.395 0.617 . . . . 72.14 109.837 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -131.62 73.74 78.9 Favored Pre-proline 0 C--O 1.244 0.801 0 N-CA-C 108.039 -1.097 . . . . 72.43 108.039 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -84.4 159.26 12.83 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.269 1.979 . . . . 61.55 111.87 -176.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -111.16 106.4 15.41 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.375 -1.713 . . . . 74.15 106.375 166.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.499 HG11 HD12 ' E' ' 6' ' ' ILE . 53.7 t -66.48 92.25 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 108.557 -0.905 . . . . 65.01 108.557 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -100.32 112.49 24.83 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.612 -1.625 . . . . 71.14 106.612 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.43 HD21 ' O ' ' E' ' 7' ' ' ALA . 0.7 OUTLIER -132.05 150.53 52.13 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.326 0.584 . . . . 55.21 112.318 -174.438 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -136.06 113.08 10.39 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.483 -1.235 . . . . 45.41 108.262 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 mp -98.08 124.18 42.48 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 108.697 -0.853 . . . . 71.54 108.697 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.59 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 11.3 t70 -121.76 149.47 43.24 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.778 1.231 . . . . 74.14 109.953 -171.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.4 m -110.54 132.83 53.85 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.926 0.89 . . . . 72.03 109.917 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.664 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -134.52 151.96 51.47 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.723 1.209 . . . . 71.02 108.46 174.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 p -135.55 173.29 11.88 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.911 0.708 . . . . 53.13 112.911 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 37.7 t -168.58 143.9 3.47 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.456 1.502 . . . . 74.22 108.218 174.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -113.23 109.15 18.29 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.176 -1.046 . . . . 74.41 108.176 170.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 53.5 mt -80.81 -39.1 27.24 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.069 -0.514 . . . . 72.45 110.735 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -155.48 -175.92 5.68 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.431 0.693 . . . . 51.32 110.636 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.65 119.74 12.26 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.984 -0.747 . . . . 73.41 108.984 172.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 71.2 -1.68 2.64 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.723 1.209 . . . . 73.25 112.545 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 48.7 t -107.36 114.17 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.463 -0.94 . . . . 60.53 108.463 177.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -122.3 159.61 27.04 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.58 0.752 . . . . 75.43 109.286 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 12.6 tt0 -130.29 124.84 33.31 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.384 -1.339 . . . . 65.1 107.384 170.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.6 m -119.91 138.22 51.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.486 -0.931 . . . . 70.33 108.486 174.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.664 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 59.5 t -118.83 136.97 54.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.488 1.115 . . . . 61.22 109.117 -175.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tt -114.59 106.81 14.69 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.623 -1.251 . . . . 63.22 107.623 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.713 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 36.9 ttp180 -87.22 102.07 14.12 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.563 -0.532 . . . . 73.32 109.563 176.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.71 107.24 19.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 107.864 -1.162 . . . . 70.2 107.864 172.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.4 m -94.62 143.22 26.61 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 107.789 -1.189 . . . . 65.32 107.789 173.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.9 t -141.07 138.97 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.138 1.375 . . . . 73.41 108.405 -173.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.2 m -138.65 138.92 38.27 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.859 -0.793 . . . . 75.31 108.859 175.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.01 104.5 14.19 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 107.143 -1.429 . . . . 63.42 107.143 169.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -108.91 127.8 54.37 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.762 -0.459 . . . . 75.51 109.762 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.3 mt -99.06 75.8 2.06 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 106.86 -1.533 . . . . 63.43 106.86 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.95 -83.43 1.17 Allowed Glycine 0 C--N 1.346 1.105 0 N-CA-C 111.942 -0.463 . . . . 72.31 111.942 -175.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -119.03 -29.97 5.13 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.019 0.528 . . . . 70.33 110.883 175.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -88.68 113.68 24.51 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.107 0.563 . . . . 74.43 109.83 -173.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.3 m -73.37 133.23 43.74 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-O 121.06 0.457 . . . . 74.12 110.884 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.685 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -77.27 -58.97 2.98 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.915 1.286 . . . . 63.23 109.479 176.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.435 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 35.3 p90 -148.24 164.52 33.73 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.959 -1.019 . . . . 61.22 111.185 174.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.9 tp -123.52 142.11 51.34 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.336 1.454 . . . . 74.22 108.186 173.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.3 m -138.07 138.28 38.6 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 124.42 1.088 . . . . 43.1 108.781 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -148.93 120.12 7.79 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.069 -0.715 . . . . 72.12 109.069 173.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 85.9 t -128.51 128.01 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 123.411 0.684 . . . . 51.12 109.611 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.713 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 47.0 mt-30 -95.56 95.01 8.09 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.695 -0.854 . . . . 72.22 108.695 165.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.434 ' HG3' HD22 ' A' ' 106' ' ' LEU . 9.3 tp-100 -78.51 99.74 6.61 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.927 -0.768 . . . . 73.5 108.927 176.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.62 154.25 29.46 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.764 -0.653 . . . . 71.34 111.557 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.89 124.98 1.44 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.232 -0.747 . . . . 55.3 111.232 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' A' ' 15' ' ' ARG . 48.8 mt -85.69 119.6 34.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.553 -0.906 . . . . 64.41 108.553 174.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.699 ' HD2' HG12 ' A' ' 13' ' ' ILE . 17.4 m-85 -129.9 120.26 24.61 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.386 -1.338 . . . . 65.43 107.386 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.7 t -75.44 96.37 3.43 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.848 -1.167 . . . . 71.23 107.848 174.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -127.94 130.85 69.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 123.95 0.9 . . . . 71.21 109.292 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 166.38 -177.78 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 126.581 1.952 . . . . 73.53 108.199 172.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 125.05 -52.24 0.81 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 110.873 -0.891 . . . . 74.34 110.873 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.75 HG12 ' HB3' ' A' ' 9' ' ' MET . 11.3 pt -131.27 168.67 23.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 C-N-CA 123.987 0.915 . . . . 75.13 109.064 174.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -125.15 -154.73 0.64 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.018 1.327 . . . . 74.11 109.607 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.61 -155.5 52.21 Favored Glycine 0 C--N 1.356 1.685 0 C-N-CA 122.841 0.258 . . . . 75.44 113.296 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.1 p -66.54 -25.9 66.88 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.095 0.958 . . . . 54.33 111.432 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -57.88 -58.65 7.45 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.785 1.234 . . . . 72.42 110.681 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 12.7 tmm? -70.14 -35.75 74.28 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.907 -1.042 . . . . 61.52 110.422 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.1 -36.82 75.8 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.325 0.65 . . . . 42.41 111.912 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.487 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 62.8 t-80 -79.57 -36.03 38.84 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.519 0.327 . . . . 64.12 111.086 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 101' ' ' TYR . 44.7 t -69.14 -50.42 48.02 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.394 0.616 . . . . 54.42 111.069 -177.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -83.27 -39.31 21.03 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.089 0.955 . . . . 62.14 110.667 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.45 -14.17 57.44 Favored Glycine 0 N--CA 1.473 1.114 0 N-CA-C 114.73 0.652 . . . . 64.15 114.73 -171.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.68 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -123.56 -53.53 1.79 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 117.928 0.864 . . . . 51.42 111.207 -176.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.51 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 68.8 t80 -70.94 -50.55 33.39 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-N 115.231 -0.895 . . . . 74.34 111.98 -176.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.425 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 92.1 m -72.05 -32.57 2.08 Favored Pre-proline 0 CA--C 1.576 1.973 0 N-CA-C 115.69 1.737 . . . . 75.51 115.69 -174.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 29.9 Cg_endo -64.43 -32.55 60.06 Favored 'Trans proline' 0 C--N 1.392 2.818 0 CA-C-N 122.343 1.872 . . . . 71.51 112.039 169.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -65.95 -24.26 66.77 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.565 0.746 . . . . 61.41 110.763 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.4 mm -70.53 -50.79 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.479 0.712 . . . . 75.13 110.304 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.434 HD22 ' HG3' ' A' ' 80' ' ' GLN . 84.5 mt -74.1 -23.77 59.37 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.007 0.743 . . . . 74.14 113.007 -176.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -58.94 -49.91 90.8 Favored Pre-proline 0 CA--C 1.573 1.86 0 N-CA-C 113.883 1.068 . . . . 74.13 113.883 -173.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.86 -32.94 54.61 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 122.176 1.917 . . . . 74.23 113.202 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -67.06 -42.52 84.59 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.938 0.495 . . . . 63.05 110.816 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.43 -42.01 98.68 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.401 -0.818 . . . . 73.54 110.343 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.43 ' NH1' HG23 ' C' ' 105' ' ' ILE . 39.3 ttm180 -56.46 -52.09 65.99 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 124.267 0.98 . . . . 65.51 110.183 175.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -63.93 -44.93 91.37 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.766 0.826 . . . . 64.45 111.073 -174.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -59.51 -34.79 73.06 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.553 0.533 . . . . 64.04 111.182 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 98.5 mt -72.74 -51.44 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 115.541 -0.754 . . . . 74.53 110.145 174.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 49.6 m -59.03 -34.48 71.94 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.218 1.007 . . . . 74.25 111.558 -174.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 34.6 t -68.45 -47.19 67.79 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.54 -0.754 . . . . 64.4 110.242 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.541 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 54.6 mtm -61.06 -40.69 94.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 123.676 0.61 . . . . 72.32 111.163 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.13 -52.82 55.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 124.283 0.989 . . . . 74.34 110.753 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.9 t -67.72 -29.42 68.66 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.412 0.685 . . . . 52.24 111.007 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 116' ' ' SER . 20.7 ttm-85 -76.79 -30.87 56.65 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.804 1.242 . . . . 71.23 108.632 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.428 ' O ' HG22 ' A' ' 122' ' ' THR . . . -86.37 13.6 57.28 Favored Glycine 0 C--N 1.355 1.634 0 CA-C-N 114.739 -1.119 . . . . 63.21 112.545 171.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.505 HG21 ' HE ' ' B' ' 15' ' ' ARG . 2.0 t 63.79 15.28 8.92 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 126.969 2.108 . . . . 32.21 114.267 171.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -81.99 149.86 63.92 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 109.478 -0.564 . . . . 72.34 109.478 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.64 165.91 4.19 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.413 2.742 . . . . 71.13 114.497 -176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.598 ' HG2' ' HG3' ' C' ' 15' ' ' ARG . 6.7 tp-100 -57.91 123.48 15.97 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.097 -0.956 . . . . 75.44 111.86 -175.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.435 HD22 ' HZ ' ' A' ' 74' ' ' PHE . 60.5 tp -120.56 106.89 12.21 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.455 1.102 . . . . 71.4 108.817 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.416 HD21 ' HA ' ' C' ' 15' ' ' ARG . 18.3 m-80 -100.65 115.12 29.46 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.822 -0.807 . . . . 65.34 108.822 175.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.51 137.73 44.62 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 108.161 -1.052 . . . . 64.42 108.161 174.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.94 146.8 57.67 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 123.864 0.866 . . . . 72.41 112.791 -174.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.459 ' HG3' HG13 ' C' ' 13' ' ' ILE . 14.1 Cg_exo -71.45 127.66 13.55 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.649 2.233 . . . . 71.35 111.541 172.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.5 p -142.93 125.49 13.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-O 121.376 0.607 . . . . 64.44 109.734 170.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -103.4 101.31 11.21 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.083 -1.08 . . . . 71.13 108.083 174.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -64.6 -30.59 71.62 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 123.743 0.652 . . . . 73.04 110.258 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.68 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 8.1 p-10 -59.67 -45.02 93.31 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.63 0.772 . . . . 73.1 110.921 176.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.03 -41.17 36.49 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.507 0.723 . . . . 61.31 111.309 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.437 ' O ' ' HB3' ' A' ' 139' ' ' ASN . 1.5 tt -70.56 -39.39 73.96 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.751 0.82 . . . . 71.43 110.865 -172.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -77.68 -33.5 53.24 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.758 0.423 . . . . 63.21 110.394 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 16.8 ptm -80.04 -19.66 47.13 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 120.78 0.324 . . . . 75.31 111.307 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 136' ' ' LEU . 21.3 t30 -60.83 -30.93 70.4 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.066 0.946 . . . . 74.42 110.612 168.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -79.82 -31.17 40.6 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 122.233 -0.292 . . . . 44.24 111.228 171.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.608 ' HG ' ' HG2' ' A' ' 142' ' ' GLN . 60.8 tp -61.97 -48.03 82.21 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.106 0.962 . . . . 73.44 111.818 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.608 ' HG2' ' HG ' ' A' ' 141' ' ' LEU . 83.4 mm-40 -143.29 19.21 1.9 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 112.248 0.462 . . . . 74.34 112.248 -170.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 60.54 96.2 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.601 1.161 . . . . 72.23 112.914 170.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 65.82 -80.74 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.327 1.451 . . . . 53.04 111.38 175.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.61 122.54 28.72 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.445 0.698 . . . . 62.55 110.507 -176.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.38 -75.93 1.25 Allowed Glycine 0 C--N 1.342 0.912 0 N-CA-C 110.244 -1.143 . . . . 54.13 110.244 170.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 64.5 153.8 0.06 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.139 1.376 . . . . 62.13 112.855 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -146.05 -119.54 1.22 Allowed Glycine 0 C--N 1.343 0.948 0 N-CA-C 110.626 -0.989 . . . . 64.31 110.626 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.3 t -162.08 110.63 1.44 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.793 0.837 . . . . 70.34 108.919 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -89.13 85.49 6.67 Favored 'General case' 0 C--N 1.348 0.509 0 N-CA-C 108.52 -0.919 . . . . 72.41 108.52 172.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -78.05 143.97 36.99 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.727 -1.124 . . . . 73.53 108.226 165.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.8 p-80 -119.56 158.51 26.19 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.579 0.351 . . . . 73.12 110.708 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -93.17 133.74 36.05 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.962 -1.125 . . . . 64.41 107.962 172.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -72.52 -66.25 0.68 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.738 0.415 . . . . 74.5 109.921 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.769 0 N-CA-C 107.89 -1.152 . . . . 74.32 107.89 176.419 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 59.2 mtt . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 108.861 -0.792 . . . . 53.22 108.861 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t -150.69 40.71 0.75 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.246 0.618 . . . . 73.41 109.627 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -77.71 82.64 4.11 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.051 -0.522 . . . . 74.44 110.39 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -139.15 101.78 4.35 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.27 -1.011 . . . . 63.14 108.27 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -90.28 74.96 6.97 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.863 0.84 . . . . 74.14 110.875 -176.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -165.31 153.96 11.92 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.184 -0.916 . . . . 73.01 109.458 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 41.6 p -75.3 94.42 3.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.933 0.493 . . . . 75.44 110.035 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -118.09 176.1 5.37 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.924 0.889 . . . . 62.51 111.081 177.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.644 ' HB3' HG12 ' B' ' 89' ' ' ILE . 18.0 ptm 59.81 170.4 0.08 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.198 2.199 . . . . 64.23 113.522 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 26.9 m -155.73 135.71 12.84 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.603 -0.726 . . . . 75.14 109.593 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -151.43 156.51 40.79 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.344 -0.613 . . . . 73.31 109.344 157.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.589 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -125.7 134.26 51.87 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 107.423 -1.325 . . . . 74.42 107.423 172.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.527 HD11 ' HG3' ' D' ' 130' ' ' PRO . 36.4 mt -70.59 116.91 12.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.553 0 N-CA-C 107.948 -1.13 . . . . 65.14 107.948 173.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -89.46 -44.63 10.02 Favored 'General case' 0 C--O 1.243 0.746 0 O-C-N 123.822 0.701 . . . . 72.4 109.49 -176.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.505 ' HE ' HG21 ' A' ' 122' ' ' THR . 40.5 ttt180 -165.4 131.05 2.59 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 116.117 -0.492 . . . . 61.33 110.981 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.4 mt -113.9 139.34 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 107.433 -1.321 . . . . 74.42 107.433 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.408 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 33.7 p90 -167.79 158.5 10.94 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.426 0.631 . . . . 74.23 111.788 -176.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.524 HG21 HD11 ' B' ' 21' ' ' ILE . 90.0 m -80.69 129.94 34.81 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.859 -1.064 . . . . 61.23 109.284 168.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.408 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 29.9 mtpt -97.47 -32.17 11.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.864 0.866 . . . . 62.52 110.084 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -152.82 138.52 17.87 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.642 -0.708 . . . . 75.13 111.037 -169.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.618 HD11 ' SG ' ' B' ' 113' ' ' CYS . 31.9 mm -134.01 146.57 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.253 1.421 . . . . 73.42 109.63 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 98.0 p -147.87 152.43 37.59 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.371 -1.286 . . . . 74.41 109.283 163.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 85.5 t80 -154.91 109.8 3.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.375 -1.343 . . . . 71.43 107.375 167.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.23 122.2 42.37 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.909 -0.775 . . . . 61.33 108.909 -175.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.942 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -118.32 82.98 19.51 Favored Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 108.807 -0.812 . . . . 74.33 108.807 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.88 -30.13 7.71 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.965 2.443 . . . . 73.4 113.008 -172.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -107.69 10.51 28.93 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 118.799 -0.619 . . . . 73.21 110.9 176.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.942 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -40.6 -61.31 1.25 Allowed Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 115.028 1.492 . . . . 52.52 115.028 -168.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 23.4 Cg_exo -61.53 -30.05 85.64 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 122.392 2.061 . . . . 52.21 112.811 -169.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -97.74 -32.04 11.94 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.606 0.762 . . . . 71.1 112.394 -175.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.436 HG22 ' HB2' ' B' ' 68' ' ' LEU . 4.3 p -72.04 -20.73 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.22 0.608 . . . . 63.15 111.365 -169.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -60.07 -22.93 63.34 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.763 0.825 . . . . 74.1 113.202 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -67.17 -16.28 64.21 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.207 0.603 . . . . 75.54 111.441 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.421 ' HD2' ' HB3' ' B' ' 68' ' ' LEU . 92.6 mttt -87.89 102.26 14.53 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.296 1.038 . . . . 73.31 109.685 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -86.8 78.32 9.1 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.732 0.813 . . . . 61.44 111.358 -174.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -161.68 161.82 29.6 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.777 -0.823 . . . . 74.3 108.777 166.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -70.92 114.86 30.49 Favored Pre-proline 0 C--O 1.246 0.904 0 N-CA-C 107.445 -1.317 . . . . 63.44 107.445 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.506 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 10.3 Cg_endo -53.47 151.19 24.6 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 123.007 2.471 . . . . 71.23 112.712 -173.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.06 104.02 0.67 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.598 -1.26 . . . . 72.14 107.598 172.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.466 HG21 HD21 ' B' ' 126' ' ' LEU . 19.7 m -100.87 155.36 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.244 -0.889 . . . . 71.13 110.449 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -136.2 131.0 34.03 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.263 1.025 . . . . 60.34 108.616 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.566 ' HB2' ' HB ' ' F' ' 6' ' ' ILE . 0.2 OUTLIER -89.9 140.64 29.42 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 107.993 -1.114 . . . . 70.32 107.993 171.214 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -151.3 112.08 4.24 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.745 -1.206 . . . . 61.45 107.745 172.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.534 HD11 ' HG ' ' F' ' 11' ' ' LEU . 2.1 pt? -101.74 156.55 17.43 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 122.635 0.374 . . . . 74.21 110.076 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.4 t70 -139.02 151.92 47.2 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.261 0.624 . . . . 73.32 110.48 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 38.9 p -109.88 126.35 53.76 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.669 1.188 . . . . 70.04 110.108 -174.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -155.69 144.77 20.7 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.784 0.434 . . . . 74.54 110.141 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 47.5 p -145.43 174.09 11.44 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.78 0.432 . . . . 75.11 111.012 176.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 53.8 p -154.05 138.9 17.13 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.426 -0.806 . . . . 63.35 109.538 171.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -84.74 126.02 33.04 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.048 0.539 . . . . 72.23 110.956 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 62.2 mt -93.68 -40.92 9.98 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.759 0.823 . . . . 72.45 109.63 174.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.51 175.92 13.39 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.718 -1.128 . . . . 75.44 109.338 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.03 125.21 23.25 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.766 -0.828 . . . . 74.32 108.766 172.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 73.53 -5.48 1.98 Allowed 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 125.345 1.458 . . . . 74.35 112.831 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 72.8 t -108.05 111.97 38.21 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 N-CA-C 108.936 -0.765 . . . . 72.33 108.936 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -126.02 150.55 48.02 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.859 0.838 . . . . 73.04 110.206 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -108.12 103.94 13.25 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 113.811 -1.54 . . . . 53.25 106.915 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 74.1 t -88.53 117.28 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.885 1.274 . . . . 32.02 110.638 -173.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 18.5 t -107.31 113.64 44.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 108.507 -0.923 . . . . 74.21 108.507 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.77 HD22 ' HB3' ' B' ' 103' ' ' PRO . 43.1 tp -103.61 115.74 31.06 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.036 -1.098 . . . . 61.33 108.036 169.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 10.3 ttm180 -86.61 131.64 34.11 Favored 'General case' 0 CA--C 1.526 0.025 0 N-CA-C 108.956 -0.757 . . . . 75.11 108.956 174.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.66 103.34 14.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.781 -1.192 . . . . 72.43 107.781 171.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 9.3 m -99.69 133.58 43.83 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.816 -0.809 . . . . 71.42 108.816 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.442 HG23 HD13 ' B' ' 114' ' ' ILE . 86.8 t -123.25 127.65 74.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 124.075 0.95 . . . . 62.05 108.916 175.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 80.1 m -101.54 148.87 24.7 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.296 -1.001 . . . . 43.32 108.296 169.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.8 134.82 23.91 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.13 0.572 . . . . 74.22 109.819 177.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.589 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 33.7 p -142.1 127.93 19.36 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.748 -0.66 . . . . 64.15 110.707 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.506 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 22.1 mt -95.93 105.06 17.03 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.373 -0.973 . . . . 51.23 108.373 173.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.12 -118.05 8.42 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.804 -1.089 . . . . 44.24 112.913 -173.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -107.89 18.4 21.33 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 123.809 0.844 . . . . 73.34 110.696 -173.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -138.64 143.51 39.29 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.496 -0.753 . . . . 73.12 109.992 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.1 m -67.21 114.71 6.16 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.172 0.589 . . . . 62.01 110.555 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.589 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -69.85 -59.24 3.05 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.101 -1.074 . . . . 53.15 108.101 178.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -156.05 167.07 31.57 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.658 -1.156 . . . . 72.13 111.527 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 99.2 mt -128.83 146.99 50.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 113.622 -1.626 . . . . 54.03 106.635 172.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 44.9 t -150.66 135.22 17.23 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.994 -1.113 . . . . 64.23 107.994 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -143.27 124.87 14.87 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 107.959 -1.126 . . . . 60.41 107.959 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 96.9 t -122.91 146.74 27.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.914 -1.143 . . . . 71.12 107.914 178.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.496 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 21.7 mt-30 -126.65 102.89 7.28 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.943 -1.132 . . . . 74.14 107.943 172.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -89.0 99.77 12.69 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.099 -1.074 . . . . 73.4 108.099 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.55 143.09 16.3 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 110.698 -0.961 . . . . 34.24 110.698 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.91 126.97 2.48 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 110.054 -1.218 . . . . 54.1 110.054 -173.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 59.2 mt -86.7 127.59 40.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 109.263 -0.643 . . . . 63.51 109.263 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -134.28 133.36 40.69 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.11 -1.07 . . . . 74.33 108.11 175.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.5 m -99.1 89.4 4.24 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.15 0.58 . . . . 72.33 109.499 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.543 HG21 HD11 ' B' ' 98' ' ' LEU . 7.1 tt -98.17 126.75 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.704 0.802 . . . . 74.25 111.92 -168.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.22 163.18 37.78 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.641 0.776 . . . . 74.11 111.061 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.12 -53.37 0.6 Allowed Glycine 0 C--N 1.35 1.321 0 CA-C-N 115.493 -0.776 . . . . 63.11 112.818 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.644 HG12 ' HB3' ' B' ' 9' ' ' MET . 9.7 mm -90.48 162.08 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 124.089 0.956 . . . . 64.5 112.607 -170.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.697 ' HB2' ' HD2' ' F' ' 22' ' ' ARG . 26.9 tt0 -150.3 162.92 39.58 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.654 0.782 . . . . 70.24 109.855 173.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.81 -135.13 12.83 Favored Glycine 0 C--N 1.348 1.247 0 C-N-CA 123.206 0.431 . . . . 65.43 113.32 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m -89.16 -17.11 29.82 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 117.073 0.436 . . . . 53.44 110.705 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -61.88 -33.6 74.49 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.315 0.646 . . . . 73.12 111.277 175.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.493 ' HB3' HG22 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -80.21 -25.85 39.44 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.462 0.305 . . . . 71.02 110.824 175.701 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.428 ' HB2' HG22 ' F' ' 16' ' ' THR . . . -66.16 -31.06 71.69 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.113 0.565 . . . . 33.25 110.042 171.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.433 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 32.4 t-80 -75.92 -39.61 55.9 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.03 0.932 . . . . 63.41 110.613 174.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 40.6 t -66.52 -52.56 44.52 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.947 0.403 . . . . 74.42 111.389 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.543 HD11 HG21 ' B' ' 86' ' ' ILE . 85.0 mt -89.06 -12.47 41.19 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.358 0.663 . . . . 52.32 111.861 -175.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.98 -6.27 34.59 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-O 119.729 -0.484 . . . . 73.41 113.978 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -135.36 -65.1 0.62 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 117.24 0.52 . . . . 60.24 110.462 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.48 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 55.2 t80 -59.36 -52.45 65.57 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.78 0.832 . . . . 72.32 112.954 -172.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.473 ' SG ' HD23 ' B' ' 98' ' ' LEU . 61.9 m -67.61 -45.27 46.05 Favored Pre-proline 0 CA--C 1.562 1.411 0 CA-C-N 115.624 -0.716 . . . . 71.33 111.565 -177.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.77 ' HB3' HD22 ' B' ' 60' ' ' LEU . 69.9 Cg_exo -51.88 -38.77 68.84 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.633 2.222 . . . . 64.24 115.161 167.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -60.64 -30.94 70.18 Favored 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 123.123 0.569 . . . . 74.11 111.94 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.425 HD13 HD11 ' B' ' 13' ' ' ILE . 75.2 mt -69.12 -40.19 80.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.909 0.884 . . . . 73.53 110.297 177.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.7 mt -87.34 -21.33 25.76 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.187 -0.915 . . . . 71.22 111.717 -170.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -53.87 -51.09 79.91 Favored Pre-proline 0 CA--C 1.562 1.435 0 C-N-CA 124.141 0.976 . . . . 73.44 113.182 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -54.25 -40.73 81.12 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 122.339 2.026 . . . . 61.31 114.208 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -70.21 -44.99 67.5 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.293 0.637 . . . . 61.21 110.82 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.57 -39.65 91.91 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.483 0.713 . . . . 75.11 111.032 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttt-85 -60.07 -56.22 24.32 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.374 1.07 . . . . 75.45 110.445 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -57.57 -34.69 69.48 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.074 0.95 . . . . 73.35 110.883 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.618 ' SG ' HD11 ' B' ' 21' ' ' ILE . 8.5 t -67.89 -45.85 73.28 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 122.674 0.39 . . . . 73.11 111.187 -178.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.449 ' O ' HG23 ' B' ' 118' ' ' VAL . 84.4 mt -63.4 -53.65 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.526 0.73 . . . . 52.2 109.888 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 34.2 m -57.7 -33.32 68.27 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.024 0.929 . . . . 72.34 111.817 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.464 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 41.1 t -61.83 -51.1 69.61 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 123.233 0.613 . . . . 75.22 109.795 174.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.494 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -67.16 -37.15 83.25 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.059 0.543 . . . . 74.33 111.407 -175.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.449 HG23 ' O ' ' B' ' 114' ' ' ILE . 95.0 t -59.48 -45.37 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.569 0.748 . . . . 75.52 110.116 174.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.6 t -67.42 -33.66 75.62 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.363 -1.29 . . . . 64.53 111.135 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' B' ' 116' ' ' SER . 93.2 mtt-85 -66.83 -31.61 72.34 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.449 -0.796 . . . . 73.22 110.495 177.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.21 9.36 73.12 Favored Glycine 0 C--N 1.353 1.475 0 CA-C-O 119.036 -0.869 . . . . 63.25 113.343 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.522 HG23 ' HB3' ' A' ' 17' ' ' TYR . 81.6 p 55.73 26.13 9.07 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.624 1.57 . . . . 72.1 113.274 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.431 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 56.3 m-85 -84.76 157.32 60.82 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 123.608 0.763 . . . . 74.35 110.171 176.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -54.74 158.76 10.12 Favored 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 123.274 2.649 . . . . 74.04 113.28 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.501 HE21 ' ND2' ' B' ' 127' ' ' ASN . 66.7 tp60 -64.73 134.17 53.62 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.102 0.961 . . . . 72.14 111.36 -171.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.466 HD21 HG21 ' B' ' 40' ' ' VAL . 2.3 tm? -136.65 120.74 17.75 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.415 -0.957 . . . . 75.2 108.415 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.501 ' ND2' HE21 ' B' ' 125' ' ' GLN . 45.3 m-80 -122.29 136.26 54.87 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.033 0.933 . . . . 65.34 109.292 173.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 5.9 mp -78.92 137.77 37.79 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.785 0.834 . . . . 64.31 109.219 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.628 ' HB3' ' HB2' ' F' ' 7' ' ' ALA . . . -76.64 147.6 78.52 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.517 0.727 . . . . 61.31 110.794 -177.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.545 ' HG3' HD11 ' D' ' 16' ' ' ILE . 89.8 Cg_endo -77.12 114.66 3.83 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.887 2.392 . . . . 73.11 112.389 -175.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 m -121.86 111.36 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.341 0.656 . . . . 71.12 109.956 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -86.41 103.54 15.07 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 108.163 -1.051 . . . . 75.01 108.163 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -60.51 -38.01 82.99 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 124.12 0.888 . . . . 73.31 111.267 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -64.74 -46.29 82.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.831 0.852 . . . . 74.34 111.298 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.64 -40.0 92.06 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 123.812 0.695 . . . . 72.34 111.005 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.599 HD12 HD11 ' F' ' 10' ' ' LEU . 0.7 OUTLIER -65.89 -49.57 67.59 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.008 -0.738 . . . . 74.12 109.008 179.038 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.03 -26.26 66.68 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.636 0.774 . . . . 73.12 111.327 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 14.0 tpt -63.33 -37.57 87.77 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.576 0.75 . . . . 71.01 110.506 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -74.56 -15.95 60.83 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.69 -0.686 . . . . 74.55 111.277 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -85.95 -46.71 10.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 110.118 -0.326 . . . . 73.53 110.118 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 88.9 mt -79.38 -7.14 58.15 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.317 0.647 . . . . 51.42 112.475 -170.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -173.54 152.93 2.2 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.454 0.702 . . . . 71.5 109.238 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -79.71 -60.98 2.14 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.794 -0.817 . . . . 75.33 108.794 172.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 51.91 79.93 0.1 Allowed 'General case' 0 C--N 1.359 0.979 0 O-C-N 124.958 1.411 . . . . 73.42 110.905 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -142.51 126.64 17.45 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.98 -0.554 . . . . 75.25 111.102 -173.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -122.38 158.7 17.06 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.006 -0.838 . . . . 53.52 111.006 174.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -163.94 152.93 13.82 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.422 0.689 . . . . 74.42 109.688 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 107.6 55.65 0.62 Allowed Glycine 0 C--N 1.343 0.931 0 O-C-N 123.425 0.453 . . . . 55.54 113.122 173.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.549 ' HA ' ' NE2' ' D' ' 153' ' ' GLN . 57.7 p -91.61 123.59 35.13 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.977 0.511 . . . . 63.24 109.764 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -152.8 146.04 24.74 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.158 0.583 . . . . 70.21 111.086 -172.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -168.76 -161.18 0.32 Allowed 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 125.312 1.445 . . . . 61.44 108.697 170.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -87.6 17.03 4.91 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.538 0.94 . . . . 75.45 113.538 -171.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.3 59.87 4.11 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.406 1.483 . . . . 73.21 110.122 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -176.85 100.1 0.05 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.081 -1.418 . . . . 71.25 107.503 -176.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.216 -0.897 . . . . 72.44 109.658 -176.718 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 87.5 mtp . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 119.202 -0.428 . . . . 50.51 111.3 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 71.0 m 65.07 109.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.842 1.257 . . . . 52.54 111.791 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -136.07 96.98 3.5 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 123.39 0.676 . . . . 63.31 109.188 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -150.1 177.09 10.22 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.767 1.227 . . . . 64.3 109.441 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 70.98 -4.72 1.68 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.877 1.271 . . . . 73.24 113.657 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -77.94 79.43 4.41 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.103 -1.073 . . . . 75.34 108.103 175.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 12.5 t -176.67 171.46 2.27 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.847 1.259 . . . . 53.25 109.79 -174.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -94.45 169.65 10.05 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.024 0.93 . . . . 62.1 108.646 171.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.439 ' HE3' HG23 ' C' ' 86' ' ' ILE . 24.1 ttt 67.44 125.38 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.32 1.448 . . . . 75.0 112.45 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 53.3 m -85.98 104.3 15.48 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.438 -0.949 . . . . 74.21 108.438 170.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.566 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.5 t80 -123.75 123.28 40.15 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.152 0.581 . . . . 60.11 109.693 178.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -144.21 133.78 23.48 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.278 1.031 . . . . 72.51 108.88 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.459 HG13 ' HG3' ' A' ' 130' ' ' PRO . 41.7 mt -81.39 128.77 38.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 108.561 -0.903 . . . . 74.13 108.561 173.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.605 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.5 mm-40 -89.84 -42.61 11.16 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.875 0.87 . . . . 55.14 110.381 -176.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.598 ' HG3' ' HG2' ' A' ' 125' ' ' GLN . 33.4 ttt180 -173.98 123.2 0.33 Allowed 'General case' 0 C--N 1.355 0.823 0 O-C-N 123.522 0.514 . . . . 64.11 110.351 -171.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 98.8 mt -110.1 139.7 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 108.818 -0.808 . . . . 51.41 108.818 174.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -170.6 154.06 4.4 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.988 0.915 . . . . 73.54 109.2 -171.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . 0.444 HG22 ' NE2' ' C' ' 80' ' ' GLN . 82.7 p -80.84 110.14 16.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.322 -0.992 . . . . 55.44 108.322 172.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.619 ' HE2' HG21 ' C' ' 59' ' ' VAL . 6.0 mmmt -67.94 -48.33 66.22 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.141 -1.059 . . . . 75.12 108.141 175.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.697 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 20.4 t70 -135.87 143.37 45.01 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.334 -1.303 . . . . 65.3 110.153 -177.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.7 mt -135.93 149.94 28.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 125.593 1.557 . . . . 75.35 107.005 175.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 37.6 t -158.95 150.6 20.71 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.331 0.653 . . . . 74.53 109.719 173.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -145.85 138.88 25.94 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 106.534 -1.654 . . . . 74.4 106.534 171.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -143.68 113.77 7.3 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.062 -0.718 . . . . 72.31 109.062 -174.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.411 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -126.84 85.1 61.56 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 107.021 -1.474 . . . . 74.25 107.021 169.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.14 -33.13 19.64 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.567 2.178 . . . . 51.25 111.176 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -95.59 11.3 33.65 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 114.625 -1.17 . . . . 74.54 110.348 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.446 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -44.98 -59.19 4.48 Favored Pre-proline 0 C--N 1.377 1.775 0 C-N-CA 124.703 1.201 . . . . 74.24 113.55 -167.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.47 ' HG3' ' HG2' ' D' ' 57' ' ' GLU . 25.1 Cg_exo -58.35 -45.74 28.96 Favored 'Trans proline' 0 C--N 1.399 3.213 0 C-N-CA 121.633 1.555 . . . . 74.22 111.869 -175.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.438 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 83.8 t60 -69.97 -36.16 75.0 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.975 -1.466 . . . . 71.04 112.322 -178.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.642 HG21 ' HA ' ' C' ' 73' ' ' ALA . 3.4 p -78.22 -19.02 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 111.914 0.338 . . . . 65.22 111.914 -168.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -69.74 -28.96 66.23 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.008 0.523 . . . . 75.41 112.028 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 19.5 pt20 -86.39 5.68 33.75 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 122.905 0.482 . . . . 73.4 111.707 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.759 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -84.93 154.34 22.26 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.328 0.651 . . . . 73.43 110.322 177.527 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -59.96 110.77 1.26 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.032 0.533 . . . . 72.42 109.763 166.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -71.17 90.84 0.9 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.863 0.865 . . . . 72.34 110.401 -177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -142.3 74.45 20.57 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 107.553 -1.277 . . . . 62.25 107.553 172.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -90.61 143.28 3.56 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.476 2.117 . . . . 74.01 112.446 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -88.96 106.48 18.44 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.544 1.138 . . . . 75.13 108.114 172.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 43.1 t -72.22 97.37 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 108.503 -0.925 . . . . 55.1 108.503 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.59 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 87.8 tttt -93.31 129.89 39.24 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.454 -0.793 . . . . 73.45 109.002 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.49 HD13 ' HA ' ' G' ' 8' ' ' LEU . 16.0 mt -89.23 149.74 22.96 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 124.358 1.063 . . . . 75.32 110.085 -172.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.517 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 31.1 t70 -160.52 118.67 2.55 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.743 0.652 . . . . 74.25 109.532 173.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.618 HD11 HD13 ' G' ' 8' ' ' LEU . 3.3 mm? -118.78 137.58 53.28 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.928 0.891 . . . . 70.1 108.713 176.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 18.1 t70 -130.5 153.59 48.66 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.263 -1.014 . . . . 73.11 108.263 174.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 71.7 p -114.24 118.36 33.73 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.507 0.723 . . . . 74.51 109.67 -173.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.39 135.63 54.23 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 107.904 -1.147 . . . . 51.0 107.904 172.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.512 ' HB3' ' HD1' ' G' ' 15' ' ' PHE . 58.6 p -167.36 158.91 12.09 Favored 'General case' 0 C--O 1.243 0.73 0 O-C-N 123.469 0.48 . . . . 72.41 111.303 -174.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 50.8 p -166.69 138.73 3.55 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.09 0.869 . . . . 71.32 109.682 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -72.89 121.1 19.46 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.467 -0.938 . . . . 72.2 108.467 170.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.641 HD11 HD12 ' C' ' 83' ' ' ILE . 78.8 mt -85.74 -36.6 20.06 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.91 0.484 . . . . 73.03 111.187 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.509 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -160.7 -176.15 5.38 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.934 0.893 . . . . 54.35 109.957 -173.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -62.46 108.0 1.04 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.62 0.768 . . . . 72.14 109.799 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 66.91 2.02 2.51 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 125.169 1.388 . . . . 53.33 113.017 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 97.9 t -94.4 118.18 39.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.398 -1.334 . . . . 65.23 107.398 173.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -133.46 139.03 46.46 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.679 -0.489 . . . . 61.14 109.679 -172.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -102.1 128.15 48.7 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.555 0.742 . . . . 75.31 109.994 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.46 HG11 ' HD3' ' C' ' 103' ' ' PRO . 91.1 t -112.33 124.05 68.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 107.73 -1.211 . . . . 63.14 107.73 171.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.619 HG21 ' HE2' ' C' ' 19' ' ' LYS . 34.9 t -127.99 116.85 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.387 0.675 . . . . 73.04 109.223 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.544 HD22 ' HB3' ' C' ' 103' ' ' PRO . 42.0 tp -103.99 114.16 28.21 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.403 -0.962 . . . . 51.35 108.403 -176.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.514 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 20.5 ttm-85 -82.0 105.81 13.41 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.95 -1.13 . . . . 74.34 107.95 174.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 10.3 t -100.64 117.25 45.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.736 -1.209 . . . . 73.12 107.736 175.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 34.6 m -121.87 117.99 27.85 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.775 -1.195 . . . . 73.12 107.775 -176.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.518 HG23 HD13 ' C' ' 114' ' ' ILE . 42.1 t -99.24 136.94 28.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.222 -1.354 . . . . 72.04 107.978 174.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.59 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 5.1 m -123.78 140.17 53.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.841 -1.17 . . . . 64.03 107.841 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.54 117.77 19.22 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.588 -1.634 . . . . 70.12 106.588 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.3 m -138.11 126.86 23.75 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.097 0.475 . . . . 55.12 110.965 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.759 HD13 ' HG2' ' C' ' 34' ' ' LYS . 4.3 mt -85.4 53.85 2.9 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.225 1.81 . . . . 70.42 108.427 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.78 -107.76 3.16 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 109.064 -1.614 . . . . 64.35 109.064 -166.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -104.02 -25.14 13.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.61 0.764 . . . . 61.52 110.675 172.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -62.98 104.07 0.52 Allowed 'General case' 0 C--N 1.353 0.718 0 C-N-CA 123.645 0.778 . . . . 75.44 109.214 175.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 36.7 m -73.99 121.57 21.25 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.402 -0.592 . . . . 74.41 109.402 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.642 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -69.88 -62.45 1.38 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.449 -1.25 . . . . 65.11 108.362 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -153.88 173.02 16.48 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 121.784 0.802 . . . . 64.51 111.043 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -137.36 128.3 27.41 Favored 'General case' 0 C--O 1.22 -0.494 0 N-CA-C 105.577 -2.009 . . . . 53.22 105.577 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.1 t -131.15 139.1 49.73 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.98 -1.118 . . . . 75.45 107.98 176.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -145.07 127.14 15.6 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.292 0.637 . . . . 74.3 109.434 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -132.03 114.37 24.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.422 -0.955 . . . . 64.2 108.422 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.697 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 48.1 mt-30 -89.27 87.23 7.05 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.416 -1.327 . . . . 72.35 107.416 171.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.444 ' NE2' HG22 ' C' ' 18' ' ' THR . 9.6 tp-100 -79.34 110.58 14.76 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 114.143 -1.39 . . . . 73.41 109.396 -177.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.36 151.97 20.06 Favored Glycine 0 C--N 1.337 0.626 0 O-C-N 123.673 0.608 . . . . 63.23 112.446 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.96 127.24 2.09 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 109.947 -1.261 . . . . 73.05 109.947 176.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.641 HD12 HD11 ' C' ' 51' ' ' LEU . 14.4 mm -88.45 124.55 41.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 107.648 -1.241 . . . . 45.54 107.648 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.566 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 66.9 m-85 -131.48 123.52 28.24 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.49 0.716 . . . . 72.32 110.001 -174.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 51.1 m -75.12 109.76 8.86 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.859 -0.793 . . . . 60.14 108.859 170.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.439 HG23 ' HE3' ' C' ' 9' ' ' MET . 67.2 mt -114.13 100.72 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 107.978 -1.119 . . . . 42.15 107.978 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.33 141.31 29.66 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.09 0.956 . . . . 51.14 109.384 -176.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.07 -19.95 24.47 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-O 119.758 -0.468 . . . . 21.51 112.944 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 36.6 pt -121.86 164.46 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.175 0.59 . . . . 73.13 110.856 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -152.49 164.08 38.29 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.188 0.995 . . . . 74.01 109.736 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.04 -133.22 18.26 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.485 0.491 . . . . 63.51 113.045 171.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 45.8 p -63.5 -31.78 73.04 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.014 0.926 . . . . 64.41 111.428 -178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -61.26 -51.12 70.27 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.061 0.945 . . . . 74.53 110.434 176.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.503 ' SD ' ' HB ' ' G' ' 18' ' ' VAL . 56.5 ttm -66.78 -39.84 87.97 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 115.222 -0.899 . . . . 73.13 110.393 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.07 -37.14 76.38 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.253 1.021 . . . . 64.1 111.615 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -71.51 -41.04 69.75 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.443 -0.798 . . . . 72.43 110.804 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.579 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 41.4 t -58.14 -60.89 3.04 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 124.179 0.924 . . . . 61.15 111.036 -177.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.542 HD23 HG23 ' G' ' 18' ' ' VAL . 3.6 pp -69.79 -30.08 67.54 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.988 -0.551 . . . . 73.25 111.766 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . 0.41 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -78.51 -29.94 50.91 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-O 118.896 -0.946 . . . . 74.41 114.672 -168.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.48 -35.87 0.1 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.101 0.95 . . . . 64.51 112.357 -170.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.579 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 18.6 t80 -71.73 -35.57 70.21 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.986 1.315 . . . . 74.44 112.637 -175.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 84.9 m -82.82 -41.55 0.88 Allowed Pre-proline 0 CA--C 1.562 1.434 0 C-N-CA 123.159 0.584 . . . . 62.45 111.001 177.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.544 ' HB3' HD22 ' C' ' 60' ' ' LEU . 52.2 Cg_exo -54.72 -26.77 48.64 Favored 'Trans proline' 0 C--N 1.396 3.068 0 C-N-CA 122.713 2.275 . . . . 43.34 113.779 166.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' C' ' 101' ' ' TYR . 23.4 t-20 -55.75 -44.17 77.37 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 124.194 0.998 . . . . 75.35 110.765 172.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.43 HG23 ' NH1' ' A' ' 111' ' ' ARG . 45.0 mm -61.97 -40.07 85.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.39 -0.823 . . . . 74.31 110.063 177.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 85.7 mt -86.54 -14.38 43.15 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.161 0.984 . . . . 64.22 112.643 -171.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.434 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 88.7 t80 -55.47 -53.69 59.49 Favored Pre-proline 0 CA--C 1.564 1.486 0 C-N-CA 123.809 0.844 . . . . 70.13 112.481 -177.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.434 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 35.7 Cg_exo -63.23 -34.16 69.06 Favored 'Trans proline' 0 C--N 1.388 2.627 0 C-N-CA 122.243 1.962 . . . . 74.04 113.476 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -64.93 -49.95 68.36 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.583 0.753 . . . . 74.43 111.06 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.37 99.16 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.477 -0.783 . . . . 31.22 110.194 177.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -55.86 -51.8 66.29 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.419 1.488 . . . . 63.13 111.326 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -71.18 -32.26 68.65 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.352 0.661 . . . . 61.42 110.338 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.7 t -70.62 -32.48 69.82 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.953 0.501 . . . . 72.32 111.193 -178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.518 HD13 HG23 ' C' ' 64' ' ' VAL . 90.0 mt -71.02 -56.38 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 109.072 -0.714 . . . . 43.02 109.072 173.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 23.9 m -60.98 -28.99 69.4 Favored 'General case' 0 CA--C 1.561 1.395 0 C-N-CA 123.574 0.75 . . . . 75.45 111.978 -175.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 43.6 t -64.4 -51.04 65.23 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.671 0.788 . . . . 74.11 109.023 171.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.561 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.37 -35.85 78.61 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.262 1.025 . . . . 71.12 112.781 178.536 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.506 HG23 ' O ' ' C' ' 114' ' ' ILE . 59.5 t -63.45 -43.61 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.332 0.653 . . . . 51.12 109.449 176.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 31.5 t -68.16 -33.37 74.34 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.25 1.02 . . . . 74.33 111.985 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' C' ' 116' ' ' SER . 88.3 mtt-85 -67.59 -36.26 80.55 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.293 0.637 . . . . 74.11 109.786 176.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.22 11.48 60.65 Favored Glycine 0 C--N 1.355 1.616 0 O-C-N 124.059 0.849 . . . . 75.34 112.656 174.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 69.4 p 57.28 23.46 8.82 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.591 1.956 . . . . 65.14 114.746 174.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -82.74 146.07 51.96 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 107.964 -1.124 . . . . 73.23 107.964 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.32 178.75 1.87 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.709 2.273 . . . . 61.13 113.096 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 16.7 mm-40 -56.21 113.02 1.38 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.703 -1.135 . . . . 74.5 113.428 -173.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 39.7 tp -109.41 87.76 2.58 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.852 -1.067 . . . . 70.44 108.241 167.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -91.66 103.89 16.43 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.966 -0.753 . . . . 54.12 108.966 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 6.9 mp -66.14 137.85 57.31 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.224 0.609 . . . . 72.42 109.573 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.58 ' HB2' ' HB ' ' G' ' 5' ' ' THR . . . -81.83 163.09 55.24 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.249 0.62 . . . . 65.33 110.404 177.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.624 ' HG2' HG21 ' A' ' 13' ' ' ILE . 43.2 Cg_exo -58.61 138.06 83.64 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.878 2.385 . . . . 75.24 113.42 174.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.5 HG21 ' HB2' ' G' ' 8' ' ' LEU . 15.7 t -130.13 115.0 31.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.884 -0.784 . . . . 72.11 108.884 175.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.637 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 2.3 m-20 -96.63 77.79 2.91 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.795 0.838 . . . . 51.21 108.9 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -62.13 -46.0 90.97 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.626 0.727 . . . . 74.14 109.999 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -69.03 -53.23 21.54 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 113.819 -1.537 . . . . 64.13 111.566 -176.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.637 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -65.84 -38.63 89.41 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 123.765 0.665 . . . . 71.42 111.711 -174.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 10.1 tt -54.66 -36.31 64.46 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.938 0.895 . . . . 61.41 112.275 -174.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -56.23 -58.4 8.11 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.643 0.589 . . . . 64.24 111.816 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -78.46 -27.35 46.39 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.433 0.693 . . . . 75.21 112.053 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -64.28 -38.69 91.95 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.833 0.853 . . . . 74.52 110.473 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -73.12 -160.61 0.08 Allowed 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 109.238 -0.652 . . . . 75.41 109.238 173.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' C' ' 143' ' ' GLN . 46.8 tp 179.68 139.29 0.12 Allowed 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.156 -1.794 . . . . 73.31 106.156 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -83.08 11.71 6.0 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.59 0.356 . . . . 73.41 111.776 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . 0.414 ' H ' ' HG ' ' C' ' 141' ' ' LEU . 1.0 OUTLIER -120.03 142.86 48.44 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.311 1.044 . . . . 75.23 109.91 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -99.33 118.1 35.23 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.018 0.927 . . . . 71.31 109.508 177.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -164.66 160.44 19.97 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.107 0.963 . . . . 62.14 109.925 174.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 175.28 147.62 6.35 Favored Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.424 -0.807 . . . . 54.32 111.147 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -93.73 176.87 6.19 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.542 0.737 . . . . 75.43 111.217 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -161.76 70.28 0.22 Allowed Glycine 0 CA--C 1.503 -0.684 0 N-CA-C 108.421 -1.872 . . . . 74.41 108.421 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 18.4 m -67.75 85.38 0.21 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.13 0.972 . . . . 64.24 111.324 -172.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -95.03 177.65 5.81 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.436 -1.256 . . . . 75.33 109.295 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 67.99 110.48 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.255 1.022 . . . . 63.11 110.506 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -136.8 148.64 47.3 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.133 0.573 . . . . 70.21 110.74 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -86.7 -0.24 55.92 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 123.639 0.776 . . . . 73.13 110.786 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -61.38 94.19 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.303 0.641 . . . . 51.32 110.357 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 C-N-CA 125.195 1.398 . . . . 64.02 108.169 177.776 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 109.745 -0.465 . . . . 72.35 109.745 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 11.3 m -82.84 84.82 7.24 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 109.151 -0.685 . . . . 53.22 109.151 175.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . 0.582 ' HA ' HD23 ' D' ' 141' ' ' LEU . 18.0 mm-40 -110.18 -178.96 3.65 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.569 0.747 . . . . 74.41 112.188 -167.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -99.08 32.4 2.7 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 114.431 -1.259 . . . . 73.33 108.121 168.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.15 156.99 20.56 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.044 1.338 . . . . 63.41 109.859 -174.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -59.84 110.35 1.15 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.178 -0.675 . . . . 75.33 109.178 171.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 5.3 m -72.08 5.3 2.81 Favored 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 124.564 1.146 . . . . 71.41 111.933 -173.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -61.53 -23.95 66.29 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.768 1.227 . . . . 61.51 111.477 171.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -30.13 140.15 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.026 1.73 . . . . 55.41 114.53 170.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 44.8 m -120.86 146.52 46.49 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 124.48 1.112 . . . . 74.43 108.764 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -151.79 103.16 2.9 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.915 -1.143 . . . . 75.11 107.915 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -121.53 142.66 49.85 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.052 -1.092 . . . . 65.43 108.052 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 15.6 mt -90.85 127.66 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 108.265 -1.013 . . . . 72.23 108.265 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -86.77 -37.25 18.04 Favored 'General case' 0 C--O 1.242 0.673 0 O-C-N 123.371 0.419 . . . . 75.21 109.912 175.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -169.22 139.91 2.29 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.436 0.46 . . . . 62.11 111.188 -171.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.545 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.6 mp -117.79 134.04 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 106.986 -1.487 . . . . 71.15 106.986 171.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.408 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 33.9 p90 -164.57 156.54 16.07 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.474 0.654 . . . . 63.13 112.269 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.0 p -81.82 117.35 22.04 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.452 -1.249 . . . . 73.23 109.03 172.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.408 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 42.0 mtpt -88.83 -23.84 22.72 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.444 0.698 . . . . 63.04 110.005 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 18.9 t70 -158.31 143.75 16.7 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 114.616 -1.175 . . . . 74.43 109.01 176.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.561 HG21 ' HE2' ' C' ' 117' ' ' MET . 70.9 mt -142.27 148.21 20.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 106.909 -1.515 . . . . 74.22 106.909 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 30.7 t -155.95 146.25 21.65 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.659 0.784 . . . . 73.32 109.013 170.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 84.6 t80 -146.4 117.61 7.85 Favored 'General case' 0 C--O 1.213 -0.837 0 N-CA-C 105.411 -2.07 . . . . 74.43 105.411 175.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -127.06 110.16 12.64 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 109.134 -0.691 . . . . 72.41 109.134 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.41 85.91 2.44 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.405 -0.961 . . . . 73.2 108.405 174.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.87 -30.53 5.89 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.084 2.523 . . . . 73.34 113.246 -169.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -103.27 6.67 38.24 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.732 0.813 . . . . 70.21 110.179 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.445 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -29.55 -67.96 0.12 Allowed Pre-proline 0 CA--C 1.562 1.422 0 C-N-CA 126.476 1.91 . . . . 65.33 116.111 -161.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -78.37 -13.69 15.02 Favored 'Trans proline' 0 C--N 1.378 2.122 0 CA-C-N 122.775 2.027 . . . . 65.23 113.782 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -80.34 -40.54 26.5 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.656 0.783 . . . . 64.32 109.589 171.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.445 HG12 ' O ' ' D' ' 28' ' ' ALA . 5.5 p -81.51 -20.02 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 116.107 -0.497 . . . . 74.01 110.938 -172.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -65.88 -20.21 66.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.215 0.606 . . . . 71.14 112.341 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -61.79 -23.3 66.12 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.639 0.776 . . . . 60.01 110.276 174.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -93.26 87.15 5.55 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.27 1.428 . . . . 72.22 109.979 176.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.05 86.81 7.0 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.459 0.704 . . . . 75.4 110.577 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -155.11 173.19 16.94 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.452 -0.944 . . . . 73.54 108.452 167.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -69.41 115.87 36.89 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 108.993 -0.743 . . . . 74.23 108.993 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.23 145.38 78.1 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.676 2.25 . . . . 62.42 111.69 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 37.7 mt-10 -61.59 111.86 1.99 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.662 -0.866 . . . . 72.14 108.662 169.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.764 HG13 HG13 ' D' ' 64' ' ' VAL . 91.9 t -99.48 113.67 35.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.447 -0.946 . . . . 61.15 108.447 -178.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.612 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 10.9 tmtt? -92.53 119.42 31.99 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 106.255 -1.757 . . . . 60.53 106.255 173.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 mp -96.12 137.9 34.51 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.423 -0.954 . . . . 65.52 108.423 -178.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.518 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 8.0 t70 -142.35 148.16 37.47 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.683 -0.858 . . . . 62.41 108.683 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -127.51 147.32 50.32 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.763 0.825 . . . . 74.54 110.358 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.436 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 10.1 t70 -144.18 145.2 31.93 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 107.681 -1.229 . . . . 72.34 107.681 172.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 57.9 p -113.17 144.16 43.14 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.195 0.598 . . . . 72.44 110.336 -175.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.488 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.59 151.93 31.22 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.79 0.836 . . . . 75.35 109.284 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 79.4 p -155.88 157.14 35.85 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 120.784 0.326 . . . . 72.11 110.916 -178.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 25.4 p -152.64 119.27 5.67 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.401 1.08 . . . . 71.4 108.917 175.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -79.81 121.05 24.9 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.183 -0.673 . . . . 74.4 109.183 176.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 30.0 mt -91.26 -35.8 14.27 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.054 0.542 . . . . 63.22 109.878 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.75 176.54 12.6 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.987 -1.006 . . . . 74.15 109.707 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -65.56 123.44 19.69 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.558 -0.905 . . . . 75.25 108.558 177.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.604 ' HB3' ' O ' ' D' ' 86' ' ' ILE . 3.8 m-20 71.94 2.95 4.5 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.212 1.005 . . . . 53.52 112.654 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.4 t -114.76 119.05 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.713 0.805 . . . . 74.1 109.255 176.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -133.02 128.43 36.29 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.297 0.639 . . . . 54.03 110.503 -173.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.642 ' HB2' HG12 ' D' ' 83' ' ' ILE . 4.6 tp10 -99.69 110.49 22.9 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 106.759 -1.571 . . . . 75.32 106.759 168.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.535 HG11 HD23 ' D' ' 98' ' ' LEU . 32.7 m -120.56 147.78 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 123.696 0.798 . . . . 73.41 109.111 -174.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 12.8 t -125.48 133.47 69.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 C-N-CA 123.69 0.796 . . . . 74.53 109.898 -169.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.494 HD22 ' HB2' ' D' ' 103' ' ' PRO . 56.3 tp -109.48 110.57 21.72 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.927 -1.138 . . . . 71.11 107.927 165.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.436 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.2 ttm180 -84.72 105.05 15.22 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.539 -0.912 . . . . 74.33 108.539 173.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 79.2 t -91.08 128.97 42.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.932 -1.136 . . . . 73.41 107.932 170.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 27.0 m -125.27 138.06 54.09 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.121 0.568 . . . . 73.35 109.522 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.764 HG13 HG13 ' D' ' 40' ' ' VAL . 24.4 t -129.16 101.04 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 124.945 1.298 . . . . 71.54 108.436 -174.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.612 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 36.8 m -95.49 93.86 7.44 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.377 -0.971 . . . . 73.02 108.377 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -95.99 144.19 26.5 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.263 0.625 . . . . 75.52 110.15 -174.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.471 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 64.7 p -145.82 129.29 16.93 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 123.683 0.614 . . . . 64.44 112.145 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.402 HD12 HG22 ' D' ' 31' ' ' VAL . 22.5 mt -99.1 112.9 24.92 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.871 0.868 . . . . 73.33 108.852 173.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.84 -111.01 3.18 Favored Glycine 0 C--N 1.345 1.074 0 N-CA-C 111.842 -0.503 . . . . 44.44 111.842 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.25 6.19 9.12 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.975 0.91 . . . . 73.12 110.526 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -121.15 165.9 14.71 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.466 0.706 . . . . 74.42 109.788 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.6 m -70.62 129.94 40.5 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.59 0.756 . . . . 74.23 111.924 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.471 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -84.36 -69.4 0.65 Allowed 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.817 -1.179 . . . . 42.43 107.817 170.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -151.07 158.75 44.47 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.74 -0.664 . . . . 72.23 110.803 175.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 74.3 mt -121.46 108.19 13.35 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.372 -1.344 . . . . 72.22 107.372 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.493 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.6 t -123.9 107.9 11.86 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.225 0.61 . . . . 72.14 109.506 -169.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -131.15 123.44 28.56 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.756 0.822 . . . . 75.21 109.072 -173.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.41 119.8 51.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 123.578 0.751 . . . . 72.34 109.012 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.532 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.0 mt-30 -87.18 85.7 7.22 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.876 -1.157 . . . . 71.15 107.876 170.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -81.91 110.86 17.58 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.341 -1.299 . . . . 64.33 108.907 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.61 167.58 14.13 Favored Glycine 0 C--N 1.341 0.826 0 O-C-N 123.557 0.536 . . . . 70.15 112.549 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.38 129.18 1.97 Allowed Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.35 -0.7 . . . . 64.32 111.35 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.642 HG12 ' HB2' ' D' ' 57' ' ' GLU . 61.8 mt -89.0 133.41 31.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.884 -1.154 . . . . 63.25 107.884 177.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -132.74 133.99 44.18 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 122.917 0.487 . . . . 71.4 110.879 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.1 m -81.21 104.85 11.96 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.089 0.956 . . . . 54.31 109.095 165.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.604 ' O ' ' HB3' ' D' ' 54' ' ' ASP . 67.3 mt -107.17 145.04 15.1 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 C-N-CA 124.158 0.983 . . . . 64.33 108.577 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.28 157.26 15.16 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 118.325 0.511 . . . . 75.12 110.05 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.96 11.35 74.17 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.568 0.543 . . . . 62.04 114.201 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.489 HG23 ' HB3' ' D' ' 93' ' ' GLN . 11.1 mt -97.57 134.92 33.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 C-N-CA 123.25 0.62 . . . . 75.31 110.696 -175.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -157.41 172.25 18.92 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.498 1.119 . . . . 75.25 109.148 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.89 -133.46 29.34 Favored Glycine 0 CA--C 1.527 0.825 0 O-C-N 123.465 0.478 . . . . 43.03 113.208 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 57.8 p -66.73 -33.19 75.08 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.944 0.898 . . . . 70.04 111.754 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.576 ' HB2' ' HG3' ' D' ' 3' ' ' GLU . 8.4 tt0 -67.71 -22.33 65.26 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.087 -0.506 . . . . 74.34 112.178 -172.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.404 ' O ' ' HA ' ' H' ' 17' ' ' PRO . 91.0 mtp -55.26 -54.18 46.68 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.022 -0.733 . . . . 71.35 109.022 174.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.36 -47.72 54.61 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.935 -1.03 . . . . 65.11 111.263 -178.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.402 ' NE2' ' HB2' ' D' ' 137' ' ' PHE . 22.1 t-160 -76.28 -24.53 54.43 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.15 0.98 . . . . 73.44 112.685 -168.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -63.21 -51.67 65.34 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.935 -0.394 . . . . 61.41 109.935 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.535 HD23 HG11 ' D' ' 58' ' ' VAL . 4.5 mp -84.34 -25.78 28.94 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 122.761 0.424 . . . . 74.43 110.341 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.59 -5.05 72.27 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.62 -0.544 . . . . 75.34 113.925 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.65 -57.71 0.11 Allowed 'General case' 0 C--N 1.358 0.955 0 N-CA-C 112.6 0.593 . . . . 63.13 112.6 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -72.31 -50.57 26.02 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 112.792 0.664 . . . . 73.02 112.792 -166.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 35.2 m -61.64 -47.14 93.36 Favored Pre-proline 0 CA--C 1.564 1.507 0 C-N-CA 123.993 0.917 . . . . 75.44 112.974 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.494 ' HB2' HD22 ' D' ' 60' ' ' LEU . 65.8 Cg_endo -70.39 -20.48 31.81 Favored 'Trans proline' 0 C--N 1.392 2.852 0 C-N-CA 122.176 1.917 . . . . 70.03 112.659 175.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -73.65 -26.96 61.01 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.285 0.634 . . . . 75.13 110.539 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mm -65.77 -37.44 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-O 121.525 0.679 . . . . 71.33 109.876 169.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 50.9 mt -84.57 -13.13 52.63 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 114.832 -1.076 . . . . 64.14 111.423 -176.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . 0.415 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 85.1 t80 -61.61 -53.11 64.45 Favored Pre-proline 0 CA--C 1.567 1.605 0 C-N-CA 124.422 1.089 . . . . 65.21 113.025 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 24.5 Cg_exo -65.05 -31.44 55.17 Favored 'Trans proline' 0 C--N 1.393 2.872 0 C-N-CA 122.14 1.893 . . . . 52.22 112.923 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -76.18 -33.99 59.32 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.773 0.829 . . . . 52.43 111.772 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.46 -48.89 73.58 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.238 -0.653 . . . . 63.33 109.238 172.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -55.58 -47.18 76.88 Favored 'General case' 0 C--N 1.358 0.953 0 O-C-N 124.445 1.09 . . . . 64.12 110.454 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.76 -53.26 58.37 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.066 0.546 . . . . 74.54 110.945 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.8 t -55.64 -44.86 77.56 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 123.825 0.703 . . . . 73.41 111.24 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.493 HG23 ' SG ' ' D' ' 76' ' ' CYS . 59.3 mt -60.45 -59.9 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.987 0.915 . . . . 72.12 110.659 175.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 47.7 m -54.11 -38.61 65.58 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.694 1.198 . . . . 52.22 111.796 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.4 t -65.47 -45.61 82.99 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.236 -0.893 . . . . 64.33 110.1 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.41 ' HB2' ' HE3' ' D' ' 117' ' ' MET . 69.7 mtm -70.63 -28.12 64.58 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.861 0.465 . . . . 65.12 111.889 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' D' ' 114' ' ' ILE . 99.5 t -66.09 -45.76 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.27 0.628 . . . . 73.32 109.585 174.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.0 p -72.13 -31.06 65.65 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.843 -0.617 . . . . 55.31 110.826 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -69.27 -36.32 76.97 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.974 0.909 . . . . 72.51 109.954 175.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.76 1.2 88.68 Favored Glycine 0 C--N 1.351 1.398 0 O-C-N 123.805 0.69 . . . . 74.32 112.012 174.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.0 p 61.97 23.11 13.57 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 126.832 2.053 . . . . 64.33 113.573 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -81.66 160.04 65.14 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.849 0.86 . . . . 74.34 110.003 170.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.64 132.51 51.9 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.973 2.449 . . . . 62.13 112.737 174.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -56.34 134.86 53.87 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.163 0.985 . . . . 70.34 111.792 -175.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.402 HD13 HG21 ' D' ' 40' ' ' VAL . 53.9 tp -111.95 103.38 11.6 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.389 -0.823 . . . . 70.53 109.219 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.432 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 86.3 m-20 -100.54 96.75 7.59 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.487 -0.931 . . . . 74.42 108.487 177.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.449 ' HA ' HG22 ' H' ' 6' ' ' ILE . 31.7 tp -67.3 120.75 14.34 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-N 115.4 -0.818 . . . . 73.11 109.885 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.8 137.44 83.05 Favored Pre-proline 0 C--N 1.354 0.792 0 O-C-N 124.348 1.03 . . . . 73.54 111.43 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.527 ' HG3' HD11 ' B' ' 13' ' ' ILE . 1.8 Cg_endo -76.58 103.38 1.74 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.902 2.401 . . . . 74.4 110.891 -172.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.38 131.45 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.923 -0.58 . . . . 34.24 109.561 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . 0.433 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 30.6 t30 -107.02 104.32 13.96 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 108.412 -0.958 . . . . 75.53 108.412 174.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -60.3 -42.21 95.02 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.898 0.749 . . . . 62.11 110.902 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.93 -36.76 72.96 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.942 -1.026 . . . . 65.42 111.73 -173.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.433 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -70.34 -33.21 71.22 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 124.19 0.931 . . . . 61.44 112.12 -177.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 75.5 mt -69.0 -43.19 75.33 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.307 0.643 . . . . 75.2 110.445 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.402 ' HB2' ' NE2' ' D' ' 96' ' ' HIS . 62.3 m-85 -72.0 -30.65 65.45 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.303 -0.862 . . . . 61.21 111.0 175.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 36.4 ttm -62.41 -31.37 72.05 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.404 1.082 . . . . 53.33 110.389 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -64.54 -26.33 68.37 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.871 0.868 . . . . 72.24 111.177 177.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -76.78 -39.1 52.68 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.409 0.684 . . . . 70.53 110.209 173.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.582 HD23 ' HA ' ' D' ' 3' ' ' GLU . 11.1 mp -74.38 -26.9 60.4 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.231 1.012 . . . . 75.05 112.919 -175.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -78.73 28.13 0.21 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.077 0.551 . . . . 71.35 112.32 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -117.76 55.67 0.86 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.59 1.156 . . . . 63.54 108.391 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -167.68 135.75 2.41 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.107 -1.406 . . . . 74.52 108.822 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.46 99.07 3.45 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.316 -0.624 . . . . 74.22 109.316 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.22 65.47 0.27 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 111.348 -0.701 . . . . 63.54 111.348 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.92 161.13 31.08 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.137 0.575 . . . . 64.45 110.496 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.55 86.92 0.34 Allowed Glycine 0 C--N 1.347 1.175 0 N-CA-C 111.042 -0.823 . . . . 64.12 111.042 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 15.0 t -139.29 27.37 2.33 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.833 0.853 . . . . 72.44 110.209 -175.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.42 109.08 0.55 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.674 0.79 . . . . 74.4 111.217 179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -163.51 -61.5 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 107.491 -1.299 . . . . 71.21 107.491 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -157.34 145.57 19.27 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.11 -0.95 . . . . 64.34 109.147 173.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . 0.549 ' NE2' ' HA ' ' B' ' 149' ' ' THR . 72.2 mt-30 -79.63 100.39 7.8 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.716 -0.846 . . . . 62.14 108.716 170.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.63 137.05 58.22 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.907 0.883 . . . . 72.33 110.919 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 C-N-CA 123.45 0.7 . . . . 74.42 109.77 178.489 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptt? . . . . . 0 CA--C 1.542 0.648 0 CA-C-O 121.935 0.874 . . . . 72.15 109.536 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -136.56 133.01 35.95 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.516 1.126 . . . . 63.03 108.794 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -91.94 144.46 25.44 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.467 1.107 . . . . 75.12 110.013 -177.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 47.0 t -71.07 91.46 0.9 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.531 0.732 . . . . 62.15 110.113 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 6.5 t -74.42 112.91 11.06 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.136 0.574 . . . . 75.31 110.453 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.499 HD12 HG11 ' A' ' 40' ' ' VAL . 9.2 tp -167.3 133.57 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.237 1.015 . . . . 73.11 108.801 178.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 7' ' ' ALA . . . . . 0.43 ' O ' HD21 ' A' ' 42' ' ' LEU . . . -122.8 155.69 36.05 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.893 0.877 . . . . 42.21 108.893 177.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 tt -171.0 138.01 1.25 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.344 -0.984 . . . . 72.54 108.344 174.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -135.33 149.46 49.74 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 124.133 0.973 . . . . 73.22 108.53 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 pp -69.02 163.9 23.61 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 120.865 0.364 . . . . 73.01 110.977 176.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 7.5 mp -79.53 120.52 80.57 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 123.581 0.752 . . . . 73.11 109.464 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.79 -37.93 52.37 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 123.243 2.629 . . . . 64.33 112.286 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.04 -7.26 39.69 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.059 0.543 . . . . 72.21 111.373 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 83.3 mt 66.75 15.77 10.21 Favored 'General case' 0 C--N 1.363 1.155 0 C-N-CA 125.443 1.497 . . . . 75.03 111.798 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 27.4 t80 52.83 38.64 27.21 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.486 1.114 . . . . 75.52 110.302 -175.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 16' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' E' ' 21' ' ' ALA . 36.5 p -116.21 76.71 6.86 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.296 0.638 . . . . 64.23 110.871 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 17' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -88.43 -10.93 4.41 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.224 1.949 . . . . 72.42 112.623 172.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 90.5 t -86.45 105.51 14.83 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 N-CA-C 107.875 -1.157 . . . . 62.23 107.875 176.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 4.8 m 64.47 166.7 0.16 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 124.898 1.279 . . . . 54.03 111.324 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -73.6 83.67 1.55 Allowed 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 108.825 -0.806 . . . . 75.44 108.825 171.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . 0.555 ' HB3' ' HB ' ' E' ' 16' ' ' THR . . . -105.68 -27.97 11.0 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.99 0.916 . . . . 63.53 112.315 -172.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -58.95 -54.13 50.59 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.596 0.758 . . . . 74.42 110.517 176.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 92.3 m -143.12 85.31 9.82 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.628 -0.878 . . . . 72.14 108.628 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -61.28 -35.95 81.96 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.656 2.238 . . . . 72.41 111.665 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 CA--C 1.553 1.061 0 N-CA-C 107.998 -1.112 . . . . 70.21 107.998 177.977 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtm . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.879 -0.415 . . . . 34.14 109.879 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt 61.39 179.46 0.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 114.403 1.261 . . . . 75.24 114.403 170.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -161.86 104.07 1.18 Allowed 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 114.583 -1.19 . . . . 64.21 109.553 175.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 15.7 m -92.66 103.47 15.85 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.707 -0.849 . . . . 75.2 108.707 174.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 34.3 m -97.07 126.79 42.47 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.267 0.627 . . . . 75.0 110.443 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' B' ' 42' ' ' LEU . 29.0 pt -128.83 158.93 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.672 0.789 . . . . 72.23 110.602 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 7' ' ' ALA . . . . . 0.628 ' HB2' ' HB3' ' B' ' 129' ' ' ALA . . . -164.12 172.41 13.77 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.572 -1.194 . . . . 55.22 109.833 176.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 mp -83.55 170.67 14.13 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.566 0.746 . . . . 74.34 110.06 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.38 -165.1 2.18 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.711 0.804 . . . . 73.24 109.163 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 10' ' ' LEU . . . . . 0.599 HD11 HD12 ' B' ' 136' ' ' LEU . 8.6 mp -59.33 131.08 49.91 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.698 -0.482 . . . . 70.02 109.698 177.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.534 ' HG ' HD11 ' B' ' 44' ' ' LEU . 5.2 mp -73.24 133.68 80.89 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 123.801 0.84 . . . . 65.53 109.62 -170.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -60.33 -33.36 94.48 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 123.248 2.632 . . . . 63.12 112.227 -175.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.71 133.25 50.75 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.577 -0.897 . . . . 73.5 108.577 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 90.7 mt -69.23 117.55 11.0 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.108 -1.071 . . . . 72.33 108.108 169.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -75.04 88.01 2.38 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 108.828 -0.804 . . . . 71.34 108.828 -176.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 16' ' ' THR . . . . . 0.428 HG22 ' HB2' ' B' ' 95' ' ' ALA . 77.6 p -121.53 75.89 34.88 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 123.88 0.872 . . . . 71.42 111.065 -176.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -85.35 -36.23 0.14 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.585 2.19 . . . . 64.43 113.33 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . 0.526 HG21 ' HB2' ' F' ' 21' ' ' ALA . 2.7 m -84.26 122.29 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.285 0.634 . . . . 75.32 109.416 177.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 98.9 m -68.56 -45.58 71.73 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.595 -0.891 . . . . 74.32 108.595 169.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -138.39 110.08 7.11 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.303 -1.369 . . . . 73.51 107.303 173.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . 0.526 ' HB2' HG21 ' F' ' 18' ' ' VAL . . . -82.18 63.28 6.31 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 107.851 -1.166 . . . . 65.42 107.851 169.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . 0.697 ' HD2' ' HB2' ' B' ' 90' ' ' GLU . 50.3 mtp180 -150.04 105.22 3.36 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 106.739 -1.578 . . . . 61.13 106.739 -173.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 9.0 t -67.35 115.21 24.06 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 122.418 0.287 . . . . 75.11 110.929 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -65.28 -48.12 3.77 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.646 2.23 . . . . 72.13 110.952 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 108.215 -1.031 . . . . 74.3 108.215 171.905 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' G' G ' 1' ' ' MET . . . . . 0.446 ' SD ' ' N ' ' G' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.349 -0.611 . . . . 63.32 109.349 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -127.95 142.46 51.24 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.699 0.799 . . . . 64.12 109.542 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -72.49 94.92 1.72 Allowed 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 108.674 -0.861 . . . . 74.0 108.674 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 26.9 p -67.28 -56.9 7.87 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.357 1.063 . . . . 71.51 112.0 -170.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 5' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' C' ' 129' ' ' ALA . 20.7 m -69.69 143.4 53.14 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 123.447 0.699 . . . . 74.13 109.325 176.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . 0.461 HD12 ' O ' ' G' ' 6' ' ' ILE . 2.6 pp -57.42 129.88 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.301 0.64 . . . . 74.04 111.584 -177.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 7' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' C' ' 129' ' ' ALA . . . -171.72 173.42 4.6 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.053 -0.976 . . . . 72.34 109.907 -175.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 8' ' ' LEU . . . . . 0.618 HD13 HD11 ' C' ' 44' ' ' LEU . 16.6 mt -66.34 159.5 26.64 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 124.137 0.898 . . . . 61.22 109.314 176.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.67 -80.79 0.58 Allowed 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 109.764 -0.458 . . . . 71.43 109.764 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 81.8 mt -137.04 151.3 48.77 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.096 0.958 . . . . 70.41 110.124 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 93.7 mt -69.65 133.52 88.67 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 115.598 -0.728 . . . . 71.1 109.194 174.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.46 -45.43 14.68 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.718 2.278 . . . . 65.44 111.036 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt -136.74 161.05 37.02 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.989 1.316 . . . . 71.31 108.266 174.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.06 -175.9 5.96 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.957 0.503 . . . . 74.05 110.564 176.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . 0.512 ' HD1' ' HB3' ' C' ' 48' ' ' SER . 46.4 m-85 -87.31 174.77 8.36 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.051 0.54 . . . . 73.42 110.287 175.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 70.7 p -77.98 153.44 80.16 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.267 0.627 . . . . 74.41 110.341 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 17' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.47 145.21 95.6 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 122.471 2.114 . . . . 74.13 112.541 174.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 18' ' ' VAL . . . . . 0.542 HG23 HD23 ' C' ' 98' ' ' LEU . 44.5 t -70.03 -51.21 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 108.326 -0.99 . . . . 63.22 108.326 172.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 32.9 p -129.68 -61.14 1.02 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.263 -0.881 . . . . 74.42 111.126 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -151.31 35.2 0.57 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.617 0.722 . . . . 71.53 109.621 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.35 -18.29 63.49 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.973 -0.558 . . . . 61.02 111.706 173.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -147.25 -64.62 0.28 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.295 1.038 . . . . 74.3 108.542 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 36.3 m -143.68 134.67 12.46 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.091 0.956 . . . . 72.05 108.639 -176.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.6 -60.88 0.48 Allowed 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.128 1.886 . . . . 72.42 111.063 171.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 CA--C 1.555 1.164 0 C-N-CA 123.739 0.816 . . . . 75.33 110.07 178.298 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 109.838 -0.43 . . . . 73.54 109.838 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -125.02 97.6 5.32 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.365 0.666 . . . . 74.54 109.783 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -81.44 98.05 8.05 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 107.541 -1.281 . . . . 72.4 107.541 172.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 32.3 t 70.12 172.13 0.31 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.729 1.212 . . . . 70.3 110.683 -172.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 90.3 m -96.46 -55.86 2.79 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.641 -0.503 . . . . 70.11 109.641 176.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.449 HG22 ' HA ' ' D' ' 128' ' ' LEU . 22.8 mm -87.43 61.94 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 109.193 -0.669 . . . . 60.41 109.193 -174.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -170.06 154.84 5.25 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.775 0.83 . . . . 71.05 109.93 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 94.2 mt -107.34 118.45 36.75 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.807 -0.812 . . . . 44.13 108.807 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.4 -88.19 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.183 0.593 . . . . 72.44 110.371 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 5.4 mp -134.3 155.96 49.29 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.866 0.867 . . . . 75.0 109.252 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.07 115.82 59.78 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 108.472 -0.936 . . . . 74.41 108.472 175.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.06 -30.82 94.31 Favored 'Trans proline' 0 C--N 1.39 2.739 0 C-N-CA 123.491 2.794 . . . . 60.2 113.074 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -120.94 119.75 33.49 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 106.521 -1.659 . . . . 74.24 106.521 170.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.77 136.62 54.49 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.96 0.504 . . . . 63.43 110.201 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -59.69 140.54 56.37 Favored 'General case' 0 CA--C 1.552 1.052 0 O-C-N 124.061 0.851 . . . . 64.32 108.968 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 16' ' ' THR . . . . . 0.763 ' HB ' ' HB1' ' H' ' 21' ' ' ALA . 21.4 p -52.05 140.2 32.22 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 125.295 1.438 . . . . 64.51 112.51 -177.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 17' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' D' ' 94' ' ' MET . 87.9 Cg_exo -50.35 178.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 124.065 3.177 . . . . 73.53 117.107 177.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.63 -85.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 115.358 -0.837 . . . . 72.2 109.865 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 11.9 t -89.81 156.33 18.57 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 109.729 -0.471 . . . . 71.24 109.729 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? 77.45 -29.75 0.17 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 125.996 1.718 . . . . 72.33 112.748 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . 0.763 ' HB1' ' HB ' ' H' ' 16' ' ' THR . . . -59.13 -57.86 11.19 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.182 1.393 . . . . 72.11 113.61 -166.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . 0.487 ' NH1' ' HA ' ' H' ' 24' ' ' PRO . 0.0 OUTLIER -84.99 30.02 0.61 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.798 0.839 . . . . 71.42 112.615 -169.636 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 10.0 t 47.75 89.51 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.573 0 C-N-CA 125.971 1.708 . . . . 74.4 111.789 -170.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 24' ' ' PRO . . . . . 0.487 ' HA ' ' NH1' ' H' ' 22' ' ' ARG . 55.2 Cg_endo -66.73 -20.8 52.31 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.834 2.356 . . . . 73.1 112.394 -178.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 CA--C 1.548 0.871 0 N-CA-C 108.679 -0.86 . . . . 63.25 108.679 176.313 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 109.217 -0.66 . . . . 72.34 109.217 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.1 t 65.09 172.08 0.21 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.369 1.068 . . . . 60.02 111.333 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 57.05 31.83 20.62 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.47 1.108 . . . . 70.41 112.129 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -76.63 -5.94 49.95 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.95 0.9 . . . . 74.02 111.643 -173.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -90.75 102.78 15.53 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.103 0.961 . . . . 70.22 110.692 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -151.13 16.6 0.74 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 121.752 0.787 . . . . 73.32 110.157 174.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.7 p -94.6 -29.84 14.66 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.775 0.798 . . . . 44.21 110.043 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -89.28 -167.18 1.79 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.16 0.984 . . . . 45.13 110.501 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.459 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 95.1 mmm 73.95 138.74 0.06 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.894 1.678 . . . . 43.03 111.759 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.8 m -147.36 136.5 22.39 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.943 1.297 . . . . 50.32 107.985 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.668 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 15.6 t80 -134.27 123.26 23.93 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.037 0.535 . . . . 73.35 109.89 -175.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -138.19 117.28 12.56 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.753 0.821 . . . . 75.41 108.943 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.632 HG12 ' HD2' ' A' ' 84' ' ' PHE . 53.8 mt -89.92 125.08 42.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 108.871 -0.788 . . . . 72.23 108.871 176.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -85.94 -41.16 15.15 Favored 'General case' 0 C--O 1.242 0.66 0 O-C-N 123.847 0.717 . . . . 71.45 110.159 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -167.9 136.7 2.47 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.874 -0.417 . . . . 63.14 109.874 -167.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.47 HD11 HD13 ' A' ' 13' ' ' ILE . 94.4 mt -130.01 129.34 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.061 -1.089 . . . . 63.23 108.061 172.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -161.52 176.77 10.7 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 124.216 0.948 . . . . 65.24 111.252 -167.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -107.28 116.22 31.56 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 114.944 -1.025 . . . . 64.35 108.836 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.501 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 34.5 mtpt -82.11 -26.44 33.58 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 110.012 -0.366 . . . . 70.1 110.012 177.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 18.3 t70 -152.78 136.65 16.24 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.218 -0.901 . . . . 72.24 109.72 174.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.447 HG23 ' SD ' ' A' ' 117' ' ' MET . 83.6 mt -129.18 137.48 56.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 106.285 -1.746 . . . . 73.55 106.285 172.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.6 t -152.03 110.63 3.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.419 0.628 . . . . 75.25 110.226 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.512 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 92.3 t80 -110.38 137.34 48.22 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 107.313 -1.366 . . . . 74.22 107.313 173.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -135.16 140.92 45.76 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.701 -1.222 . . . . 74.12 107.701 171.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.407 ' CB ' ' HB2' ' A' ' 28' ' ' ALA . . . -122.9 80.78 50.01 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 105.891 -1.892 . . . . 71.43 105.891 168.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.2 -31.42 89.9 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.076 2.517 . . . . 74.2 112.746 -167.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -118.44 31.69 6.54 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 118.597 -0.716 . . . . 73.23 109.66 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.415 ' HB3' ' HZ1' ' B' ' 19' ' ' LYS . . . -42.41 -54.47 7.91 Favored Pre-proline 0 CA--C 1.573 1.84 0 N-CA-C 114.84 1.422 . . . . 74.41 114.84 -170.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HD3' ' HZ1' ' B' ' 19' ' ' LYS . 14.1 Cg_exo -64.13 -31.4 64.89 Favored 'Trans proline' 0 C--N 1.395 3.004 0 CA-C-N 121.652 1.626 . . . . 52.1 112.572 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -80.17 -39.16 29.86 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.863 -1.062 . . . . 62.13 110.51 -175.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.658 HG21 ' HA ' ' A' ' 73' ' ' ALA . 5.2 p -78.52 -22.23 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 CA-C-N 114.821 -1.081 . . . . 73.1 112.714 -161.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -70.91 -21.1 62.41 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.906 0.482 . . . . 72.44 110.754 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -86.46 -18.34 31.94 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.517 1.127 . . . . 65.11 110.519 176.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.4 tmtp? -78.13 146.67 34.99 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.142 0.977 . . . . 71.23 109.734 -175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.07 138.88 58.67 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.816 0.846 . . . . 65.24 110.524 173.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -93.01 82.99 4.64 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.868 0.842 . . . . 72.32 110.6 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -130.87 83.44 61.3 Favored Pre-proline 0 C--O 1.239 0.539 0 N-CA-C 107.017 -1.475 . . . . 60.03 107.017 165.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -85.97 156.6 10.02 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 122.214 1.943 . . . . 71.43 111.959 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -109.66 93.72 4.65 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 105.036 -2.209 . . . . 74.33 105.036 165.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.651 ' HB ' HG21 ' E' ' 6' ' ' ILE . 48.1 t -78.5 92.04 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 122.072 0.939 . . . . 74.44 108.695 -177.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.446 ' HE2' ' HB2' ' A' ' 67' ' ' SER . 62.3 mttm -82.98 113.3 20.47 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.596 -1.638 . . . . 62.32 108.98 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 pp -105.73 128.36 53.64 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.008 0.523 . . . . 71.45 110.625 -174.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.538 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.6 m-20 -114.28 139.2 49.61 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.405 1.082 . . . . 70.32 109.029 177.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' E' ' 8' ' ' LEU . 94.1 mt -124.61 119.54 29.34 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.601 0.76 . . . . 74.22 109.513 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 21.8 t70 -120.24 130.31 54.45 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.617 -0.882 . . . . 71.31 108.617 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.3 p -106.98 132.21 53.18 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.878 0.871 . . . . 52.05 110.254 -173.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.18 129.52 10.56 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.049 0.54 . . . . 74.44 110.308 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.2 m -130.82 152.92 49.64 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.223 0.609 . . . . 72.43 110.324 174.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.6 t -149.96 126.71 11.02 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.578 0.751 . . . . 75.33 109.084 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -78.47 132.55 37.31 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.857 0.463 . . . . 72.32 110.927 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.3 mt -101.32 -31.01 11.17 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.441 1.096 . . . . 60.22 111.059 -174.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.581 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -163.63 173.76 12.56 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.489 1.116 . . . . 52.22 109.712 -175.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -56.67 116.47 3.15 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.023 0.529 . . . . 50.32 110.204 171.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 70.49 -10.6 0.68 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 126.215 1.806 . . . . 74.24 113.259 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 21.6 t -100.7 117.68 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.075 -1.083 . . . . 53.1 108.075 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -142.35 170.33 15.9 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.14 -0.689 . . . . 72.54 109.14 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -120.08 132.99 55.64 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 123.521 0.729 . . . . 73.4 110.021 -175.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.446 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 93.7 t -104.39 126.82 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.008 -1.108 . . . . 73.04 108.008 169.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.99 125.81 74.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 108.269 -1.012 . . . . 74.3 108.269 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.19 110.88 18.11 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.722 -1.214 . . . . 70.11 107.722 176.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.577 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 36.8 ttm180 -81.95 100.26 9.57 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.572 -1.27 . . . . 74.54 107.572 174.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.9 t -98.86 102.46 13.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.679 -1.23 . . . . 71.24 107.679 176.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.538 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 26.5 m -96.91 135.88 38.27 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.444 -0.576 . . . . 73.53 109.444 178.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.542 HG11 HD21 ' A' ' 126' ' ' LEU . 17.9 t -126.73 107.68 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.628 1.171 . . . . 45.43 108.392 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 25.9 m -102.94 134.33 46.54 Favored 'General case' 0 C--O 1.208 -1.083 0 N-CA-C 107.707 -1.22 . . . . 54.44 107.707 173.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.71 105.28 12.56 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 107.699 -1.223 . . . . 75.5 107.699 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 50.2 m -108.72 124.29 50.33 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.304 0.574 . . . . 74.04 110.952 -177.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.1 mt -91.04 54.82 2.72 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.889 1.276 . . . . 64.41 108.399 178.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.47 -114.56 4.73 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 110.36 -1.096 . . . . 71.01 110.36 -166.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -91.93 -26.68 18.32 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.007 0.523 . . . . 70.2 110.864 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -86.73 108.8 18.84 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.206 0.602 . . . . 72.11 109.595 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 53.9 m -72.63 124.87 26.16 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.688 0.395 . . . . 70.33 110.625 176.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.658 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -62.26 -58.09 9.0 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.49 1.116 . . . . 54.12 111.183 174.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -155.83 164.54 38.4 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.816 -1.083 . . . . 74.1 111.779 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.5 tp -123.46 138.51 54.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.605 1.162 . . . . 71.53 108.158 173.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.418 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 76.6 m -142.51 96.57 2.97 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.838 0.855 . . . . 72.11 109.555 -178.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -108.29 130.43 55.18 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.788 -0.819 . . . . 70.2 108.788 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.1 t -132.15 112.43 19.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 109.238 -0.653 . . . . 63.31 109.238 173.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.5 ' NE2' HH21 ' A' ' 61' ' ' ARG . 69.6 mt-30 -84.55 84.83 7.53 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.048 -1.093 . . . . 64.43 108.048 172.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.53 ' HG3' HD22 ' A' ' 106' ' ' LEU . 8.4 tp-100 -76.85 102.97 6.55 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.183 -0.917 . . . . 71.21 108.795 -177.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.21 144.92 17.42 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.041 -0.823 . . . . 73.35 111.041 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.44 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -150.86 123.13 1.47 Allowed Glycine 0 CA--C 1.504 -0.615 0 N-CA-C 110.779 -0.928 . . . . 74.43 110.779 -176.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.5 mt -81.22 122.24 36.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 108.973 -0.751 . . . . 72.53 108.973 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.668 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 25.1 m-85 -134.12 137.53 44.61 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.859 -0.793 . . . . 73.14 108.859 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.3 m -102.44 96.79 7.16 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.006 -0.738 . . . . 64.21 109.006 173.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.647 HD11 ' SG ' ' A' ' 102' ' ' CYS . 62.8 mt -96.79 119.99 45.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 108.355 -0.98 . . . . 74.23 108.355 176.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.38 132.43 12.57 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.229 0.611 . . . . 41.21 109.972 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.701 ' HA2' ' HA3' ' C' ' 146' ' ' GLY . . . 170.01 -76.57 0.1 Allowed Glycine 0 C--N 1.339 0.711 0 N-CA-C 112.105 -0.398 . . . . 51.35 112.105 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.8 tp -150.07 150.08 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.419 0.688 . . . . 71.42 109.654 -171.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -91.94 -169.55 2.3 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.127 1.371 . . . . 73.42 111.971 -167.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.5 -135.11 23.25 Favored Glycine 0 C--N 1.355 1.584 0 CA-C-N 115.072 -0.967 . . . . 74.55 112.579 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.9 t -67.96 -22.83 65.01 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.851 0.86 . . . . 71.31 111.922 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -70.37 -53.57 16.03 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.148 0.579 . . . . 65.42 111.072 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 9.5 ptp -69.16 -30.53 68.78 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 121.018 -0.273 . . . . 74.21 111.204 173.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.98 -38.22 90.28 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.667 0.787 . . . . 74.31 111.545 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -67.83 -39.67 83.84 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.559 1.144 . . . . 60.25 110.582 175.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 18.7 t -72.58 -35.64 67.97 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 116.383 -0.371 . . . . 42.32 111.8 -175.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 pp -83.49 -29.95 27.56 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.932 0.493 . . . . 71.21 111.409 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.66 ' HA3' ' HB3' ' E' ' 14' ' ' LEU . . . -106.25 3.98 37.9 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 114.6 0.6 . . . . 73.35 114.6 -168.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.63 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -146.62 -53.41 0.24 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.832 0.316 . . . . 72.15 111.674 -176.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.435 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 66.4 t80 -73.09 -65.92 0.74 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 123.445 0.465 . . . . 73.1 112.084 -171.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.647 ' SG ' HD11 ' A' ' 86' ' ' ILE . 92.3 m -68.13 -32.91 4.37 Favored Pre-proline 0 CA--C 1.566 1.56 0 N-CA-C 115.135 1.532 . . . . 61.04 115.135 -172.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 25.9 Cg_endo -63.24 -32.04 73.73 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 121.824 1.683 . . . . 75.04 112.554 166.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.471 HD22 ' HD2' ' A' ' 133' ' ' PHE . 29.3 t-20 -76.5 -21.44 55.79 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.997 0.519 . . . . 73.24 110.715 176.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 42.1 mm -67.46 -36.38 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 109.501 -0.555 . . . . 70.43 109.501 170.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.53 HD22 ' HG3' ' A' ' 80' ' ' GLN . 94.7 mt -79.77 -17.52 53.22 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.426 0.69 . . . . 62.14 112.211 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -61.43 -48.79 89.88 Favored Pre-proline 0 CA--C 1.57 1.715 0 CA-C-O 117.933 -1.032 . . . . 75.3 113.546 -175.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.31 -34.1 45.82 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 121.954 1.769 . . . . 51.01 112.909 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -72.67 -40.15 66.54 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.312 0.645 . . . . 45.45 111.382 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.62 -39.45 70.42 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.994 0.518 . . . . 43.44 110.449 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.521 HH12 HD12 ' C' ' 105' ' ' ILE . 30.6 ttm180 -54.35 -51.69 63.98 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 124.173 0.921 . . . . 75.11 109.829 173.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -65.75 -42.06 91.37 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.38 1.05 . . . . 71.2 111.558 -175.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 46.2 t -61.51 -42.85 99.43 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.837 0.711 . . . . 70.54 110.329 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.06 -48.1 87.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 O-C-N 124.108 0.88 . . . . 51.34 110.407 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 35.8 m -56.65 -38.55 72.31 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.913 0.885 . . . . 73.54 111.377 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.1 t -68.69 -46.22 69.63 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.435 -0.802 . . . . 63.22 110.353 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.447 ' SD ' HG23 ' A' ' 21' ' ' ILE . 27.1 mtp -59.0 -42.57 90.37 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.884 0.874 . . . . 62.31 111.406 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.547 HG21 HD23 ' A' ' 126' ' ' LEU . 68.9 t -65.72 -44.05 93.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 124.652 1.181 . . . . 73.24 110.71 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 37.5 t -71.43 -31.13 66.85 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.239 0.616 . . . . 51.13 110.935 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.451 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 90.8 mtt-85 -73.98 -32.14 63.3 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.758 0.823 . . . . 72.5 109.512 175.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.41 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.74 12.15 57.55 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 115.453 -0.794 . . . . 63.25 112.823 172.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.487 HG21 ' HE ' ' B' ' 15' ' ' ARG . 2.8 t 60.94 15.02 5.7 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 127.234 2.214 . . . . 71.43 114.385 171.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.458 ' HB2' HG13 ' A' ' 118' ' ' VAL . 74.7 m-85 -78.57 155.08 78.82 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 109.019 -0.734 . . . . 74.31 109.019 175.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.68 174.43 2.25 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.636 2.224 . . . . 63.44 113.488 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.1 116.34 1.96 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.2 1.4 . . . . 75.31 111.853 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.547 HD23 HG21 ' A' ' 118' ' ' VAL . 56.9 tp -127.94 106.08 8.85 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.549 0.74 . . . . 63.33 109.152 176.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -130.7 128.33 40.65 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.729 1.212 . . . . 71.5 109.042 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.66 144.92 55.27 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 123.429 0.455 . . . . 53.4 110.079 174.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' E' ' 5' ' ' THR . . . -65.17 157.12 78.64 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 124.303 1.041 . . . . 72.3 111.491 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.607 ' HD3' HG13 ' C' ' 13' ' ' ILE . 64.7 Cg_endo -70.37 99.33 0.8 Allowed 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.547 2.165 . . . . 53.54 111.981 176.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.42 HG21 ' H ' ' E' ' 8' ' ' LEU . 23.4 t -103.97 112.94 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.793 -0.817 . . . . 73.52 108.793 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.534 ' HB3' ' HB3' ' A' ' 135' ' ' ALA . 1.5 m-20 -95.27 84.12 3.99 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 108.686 -0.857 . . . . 74.31 108.686 177.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.471 ' HD2' HD22 ' A' ' 104' ' ' ASN . 92.5 m-85 -61.57 -54.31 44.75 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 123.333 0.396 . . . . 74.41 110.006 -178.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.63 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 14.7 t70 -63.5 -42.79 98.49 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.593 -1.185 . . . . 64.32 111.231 -173.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 132' ' ' ASN . . . -69.36 -19.5 63.85 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.125 -0.943 . . . . 73.43 112.121 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.646 HD23 HD21 ' E' ' 10' ' ' LEU . 40.0 tp -80.38 -41.39 24.74 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.601 0.36 . . . . 73.15 110.301 173.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -67.42 -30.33 70.05 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.692 0.397 . . . . 71.54 110.891 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 97.1 mmm -78.83 -38.23 38.57 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.314 0.646 . . . . 73.12 110.723 175.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 143' ' ' GLN . 39.3 t30 -57.32 -36.61 71.33 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.286 1.035 . . . . 73.31 110.65 174.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -80.92 -31.84 34.9 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.684 -1.144 . . . . 75.44 110.753 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 28.4 tp -67.27 -53.05 33.41 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.21 0.604 . . . . 54.21 111.81 -173.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 172.82 -18.16 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 124.391 1.076 . . . . 55.33 109.534 -178.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 139' ' ' ASN . 62.5 tt0 -80.77 155.99 26.42 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 109.676 -0.49 . . . . 75.31 109.676 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -155.55 120.06 4.68 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.254 -1.387 . . . . 73.44 107.254 175.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 63.85 100.56 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.336 1.023 . . . . 54.14 110.889 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -53.86 98.38 0.04 OUTLIER Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.979 -0.555 . . . . 63.14 111.856 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -69.47 137.19 52.41 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.298 -1.001 . . . . 71.35 108.298 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -77.19 -162.88 17.21 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-O 121.753 0.64 . . . . 62.22 113.994 -172.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.502 ' H ' HD11 ' G' ' 13' ' ' LEU . 14.5 m -140.76 172.36 12.81 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 108.038 -1.097 . . . . 75.43 108.038 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -129.74 149.28 51.56 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.964 -1.495 . . . . 71.2 106.964 167.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.432 ' HB3' ' HE1' ' C' ' 137' ' ' PHE . 0.1 OUTLIER -128.78 155.17 45.57 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.499 0.666 . . . . 73.35 111.219 -170.572 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -162.38 116.46 1.79 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.164 -1.38 . . . . 74.23 108.13 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -103.63 172.83 6.59 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.854 0.862 . . . . 55.13 111.003 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -126.38 132.49 51.54 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.477 1.111 . . . . 75.44 109.218 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 C-N-CA 123.531 0.732 . . . . 73.04 109.475 179.076 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 120.65 0.262 . . . . 72.43 110.753 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 45.1 t -164.81 134.07 3.61 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.91 -1.144 . . . . 35.45 107.91 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -85.4 71.04 10.86 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.445 0.64 . . . . 73.42 109.564 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 18.7 tm0? -167.55 135.66 2.46 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 114.478 -1.237 . . . . 55.34 108.663 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -132.48 135.25 45.9 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.871 -1.159 . . . . 73.23 107.871 171.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -80.87 50.26 1.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.793 0.837 . . . . 63.35 110.861 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.1 t -67.05 -35.32 79.6 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.088 0.955 . . . . 75.22 111.018 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -83.46 145.52 28.9 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.97 -0.752 . . . . 71.4 108.97 173.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.541 ' SD ' ' N ' ' B' ' 10' ' ' THR . 1.0 OUTLIER 66.48 163.32 0.17 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 125.736 1.615 . . . . 72.52 110.339 -167.169 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.541 ' N ' ' SD ' ' B' ' 9' ' ' MET . 54.6 m -167.08 130.66 1.85 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.801 0.84 . . . . 71.31 109.685 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' B' ' 85' ' ' SER 0.283 0.5 OUTLIER -155.25 155.85 34.54 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.561 0.696 . . . . 71.14 111.204 143.406 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.739 HE22 ' HB2' ' D' ' 129' ' ' ALA . 25.4 tp60 -127.03 128.38 46.24 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 106.424 -1.695 . . . . 75.35 106.424 172.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.491 HD11 HD13 ' B' ' 105' ' ' ILE . 27.8 mt -68.52 121.34 17.61 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 N-CA-C 108.784 -0.821 . . . . 72.12 108.784 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -90.29 -40.62 12.03 Favored 'General case' 0 C--O 1.243 0.761 0 O-C-N 124.233 0.958 . . . . 74.02 109.583 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.493 ' HA ' ' ND2' ' D' ' 127' ' ' ASN . 28.3 ttt180 -167.56 133.77 2.12 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 116.396 -0.366 . . . . 53.01 111.022 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.426 HD11 HD13 ' B' ' 13' ' ' ILE . 86.1 mt -115.56 135.97 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 107.48 -1.304 . . . . 73.34 107.48 173.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.401 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 42.3 p90 -168.73 170.69 9.18 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.98 0.895 . . . . 73.15 113.052 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.421 HG21 HD11 ' B' ' 21' ' ' ILE . 86.9 m -96.42 118.03 32.1 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.828 -1.533 . . . . 65.14 108.743 174.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.415 ' HZ1' ' HB3' ' A' ' 28' ' ' ALA . 24.8 mtpp -79.8 -28.99 40.19 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.985 0.514 . . . . 73.32 110.543 176.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -162.7 149.93 13.37 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.218 0.533 . . . . 73.24 112.045 -171.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 28.3 mm -137.89 144.88 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 126.216 1.806 . . . . 65.31 108.612 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 46.2 t -147.64 126.66 12.83 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.965 -1.016 . . . . 71.42 108.786 169.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 85.3 t80 -138.81 109.82 6.8 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 107.529 -1.286 . . . . 73.41 107.529 171.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -119.09 115.47 24.34 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.922 0.889 . . . . 74.52 108.724 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.95 86.35 1.91 Allowed Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 107.091 -1.448 . . . . 40.52 107.091 169.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.88 -45.23 8.6 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.567 2.178 . . . . 72.13 112.131 -169.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 49.4 m-20 -100.59 18.05 20.2 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.674 0.79 . . . . 73.11 110.748 -176.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.501 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -31.12 -68.67 0.13 Allowed Pre-proline 0 N--CA 1.504 2.242 0 N-CA-C 115.419 1.637 . . . . 54.14 115.419 -166.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 54.8 Cg_endo -70.37 -13.48 33.19 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 122.336 2.024 . . . . 65.31 113.078 -171.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -92.2 -45.7 8.12 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.544 0.738 . . . . 73.31 110.258 177.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.564 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.0 p -69.57 -17.62 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 112.295 0.48 . . . . 73.03 112.295 -171.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -62.92 -18.8 63.55 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.013 0.525 . . . . 54.33 112.383 173.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -65.98 -20.96 66.37 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.609 0.764 . . . . 65.13 110.817 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -103.99 71.27 1.03 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.835 1.254 . . . . 73.15 108.743 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -82.75 91.95 7.12 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.178 -0.919 . . . . 73.44 111.727 -173.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -158.64 -175.18 5.16 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.136 0.974 . . . . 73.2 109.52 170.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -72.74 111.59 11.84 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 123.663 0.785 . . . . 75.11 110.145 176.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.46 153.77 75.67 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.336 2.024 . . . . 72.44 112.216 178.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -69.31 113.93 7.09 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.56 -0.745 . . . . 71.24 109.16 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 12.8 t -86.46 121.35 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 122.991 0.517 . . . . 63.55 109.899 -173.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -115.86 128.63 55.96 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 107.244 -1.391 . . . . 70.5 107.244 172.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.745 HD21 ' HA ' ' F' ' 6' ' ' ILE . 0.2 OUTLIER -131.19 148.76 52.75 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.134 0.573 . . . . 73.21 109.763 174.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -153.2 129.82 10.77 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.066 0.946 . . . . 65.25 108.713 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 85.7 mt -99.47 150.91 21.71 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.691 0.797 . . . . 61.04 110.04 -176.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.0 t70 -137.14 139.68 41.35 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.777 -0.823 . . . . 62.41 108.777 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.8 p -109.8 124.23 50.93 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.392 0.677 . . . . 71.15 110.808 -175.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -131.94 135.36 46.54 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.42 1.088 . . . . 74.33 108.965 176.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 16.2 m -144.35 161.77 38.15 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.76 0.424 . . . . 52.21 111.385 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 53.9 p -160.55 143.39 13.17 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.328 -0.851 . . . . 72.01 109.769 174.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.412 ' NE2' ' HB2' ' F' ' 20' ' ' LYS . 41.0 tp60 -80.29 107.08 12.8 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 107.821 -1.178 . . . . 72.4 107.821 172.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.622 HD11 ' HB2' ' B' ' 57' ' ' GLU . 40.2 mt -77.09 -42.08 39.6 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.275 0.559 . . . . 74.53 110.295 -174.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.22 -166.06 1.85 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.248 1.019 . . . . 75.43 109.827 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' F' ' 25' ' ' GLU . 8.1 p-10 -69.96 131.39 44.33 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.251 0.62 . . . . 61.23 109.764 175.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 64.75 -10.4 0.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 125.727 1.611 . . . . 72.35 112.343 -171.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' B' ' 51' ' ' LEU . 91.1 t -110.7 121.82 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 O-C-N 121.502 -0.749 . . . . 72.13 109.468 -165.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -133.58 -176.48 4.17 Favored 'General case' 0 C--O 1.247 0.973 0 N-CA-C 107.796 -1.187 . . . . 65.13 107.796 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.622 ' HB2' HD11 ' B' ' 51' ' ' LEU . 35.4 tt0 -139.19 129.24 25.15 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.391 0.276 . . . . 62.33 110.608 -177.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 82.8 t -97.11 117.99 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.433 -0.951 . . . . 72.24 108.433 170.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 41.2 t -116.79 110.58 31.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.963 -1.125 . . . . 64.05 107.963 174.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 30.3 tp -107.28 107.85 18.98 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.337 -0.986 . . . . 64.23 108.337 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.552 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 45.9 ttt180 -84.74 114.44 22.05 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.52 -0.918 . . . . 73.43 108.52 176.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.6 t -102.69 105.07 17.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.968 -1.123 . . . . 71.35 107.968 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 33.1 m -95.45 138.37 33.23 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.511 -0.922 . . . . 73.53 108.511 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.55 133.26 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.563 0.745 . . . . 73.42 109.612 177.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.2 m -119.39 145.3 46.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.396 1.078 . . . . 60.31 108.421 169.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.57 129.34 26.49 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.849 -0.797 . . . . 74.54 108.849 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 30.9 p -123.11 127.83 49.25 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.587 0.755 . . . . 62.51 110.638 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.512 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 44.6 mt -102.63 109.39 20.99 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.061 0.944 . . . . 75.11 109.176 172.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.81 -110.56 3.55 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 114.958 -1.019 . . . . 53.51 113.398 -176.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -105.08 4.02 31.04 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.007 0.923 . . . . 72.55 111.708 -174.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -139.53 164.79 28.97 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.743 0.417 . . . . 70.35 110.863 -176.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 63.3 m -79.07 125.6 29.61 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.479 0.712 . . . . 73.3 110.719 -177.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.564 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -70.55 -63.2 1.14 Allowed 'General case' 0 C--O 1.24 0.559 0 O-C-N 123.966 0.792 . . . . 71.45 109.16 171.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -155.08 164.54 38.72 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.462 -1.245 . . . . 72.25 111.724 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 55.4 mt -126.13 111.36 14.56 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 105.545 -2.02 . . . . 63.34 105.545 173.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.477 ' SG ' HG23 ' B' ' 114' ' ' ILE . 31.5 t -119.12 140.18 50.56 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.733 -0.84 . . . . 73.52 108.733 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -160.02 136.2 8.74 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.101 0.477 . . . . 70.24 110.045 -170.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' B' ' 113' ' ' CYS . 88.7 t -132.94 151.6 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.746 1.219 . . . . 71.14 108.248 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.542 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 17.3 mt-30 -124.52 98.85 5.91 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.795 -1.187 . . . . 64.42 107.795 170.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.443 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 7.8 tp-100 -88.76 99.86 12.69 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.645 -0.872 . . . . 74.3 108.645 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.84 141.51 15.62 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.303 -1.119 . . . . 64.4 110.303 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.12 127.08 3.13 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 110.673 -0.971 . . . . 60.44 110.673 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 55.3 mt -89.78 127.41 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.788 0.835 . . . . 64.42 109.084 176.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -135.56 135.06 40.02 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.129 -1.434 . . . . 75.2 107.129 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 67.6 m -99.45 89.92 4.34 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.403 0.547 . . . . 63.24 110.864 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.538 HG21 HG21 ' F' ' 18' ' ' VAL . 12.7 tt -95.54 141.43 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.221 1.008 . . . . 44.42 111.607 -172.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.16 166.73 32.42 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.604 0.761 . . . . 71.21 110.436 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.96 -51.55 1.3 Allowed Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.742 -0.663 . . . . 71.11 112.54 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 17.4 mm -90.71 152.82 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.483 0.713 . . . . 75.13 112.315 -174.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.418 ' HA ' ' HE2' ' B' ' 94' ' ' MET . 40.1 tt0 -157.07 157.52 34.74 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 114.628 -1.169 . . . . 74.54 110.056 176.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.11 -135.0 12.59 Favored Glycine 0 C--N 1.353 1.503 0 C-N-CA 123.264 0.459 . . . . 64.33 113.191 170.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m -82.97 -18.32 40.35 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.212 0.605 . . . . 62.13 110.587 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -57.06 -38.74 73.71 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.887 0.875 . . . . 64.44 111.203 173.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.418 ' HE2' ' HA ' ' B' ' 90' ' ' GLU . 17.1 ptp -78.57 -25.37 45.31 Favored 'General case' 0 C--O 1.208 -1.107 0 CA-C-O 119.112 -0.471 . . . . 72.14 111.412 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.63 -34.67 67.5 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 122.963 0.505 . . . . 72.45 111.967 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -75.27 -47.3 28.62 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.815 0.846 . . . . 53.43 111.184 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.11 -49.62 71.47 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.248 0.619 . . . . 64.43 111.415 -175.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.531 HD11 HG23 ' F' ' 18' ' ' VAL . 60.4 mt -72.51 -27.99 62.6 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.27 -0.877 . . . . 75.12 111.321 -176.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.7 -0.26 64.56 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-O 119.688 -0.507 . . . . 70.24 113.88 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.5 -62.73 0.46 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 117.384 0.592 . . . . 65.11 111.643 -176.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.451 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 33.7 t80 -64.6 -46.36 82.98 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.986 0.914 . . . . 72.25 111.646 -171.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 39.9 m -73.58 -46.66 7.33 Favored Pre-proline 0 CA--C 1.567 1.624 0 N-CA-C 113.128 0.788 . . . . 64.04 113.128 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -69.12 -21.64 36.16 Favored 'Trans proline' 0 C--N 1.395 2.994 0 C-N-CA 122.022 1.815 . . . . 70.11 113.264 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -57.62 -36.34 71.67 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 124.112 0.965 . . . . 64.11 111.118 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.491 HD13 HD11 ' B' ' 13' ' ' ILE . 68.9 mt -68.74 -43.14 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.666 1.186 . . . . 75.22 110.945 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 78.4 mt -82.94 -22.39 33.82 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.858 -1.065 . . . . 60.33 111.923 -172.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -55.54 -51.34 80.88 Favored Pre-proline 0 CA--C 1.562 1.433 0 CA-C-O 117.655 -1.164 . . . . 73.12 113.062 -175.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.14 -38.47 94.84 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 122.257 1.972 . . . . 65.13 113.744 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -69.41 -48.88 59.68 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.183 0.593 . . . . 74.15 110.747 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -62.93 -39.87 95.91 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.066 0.546 . . . . 64.43 111.194 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -59.38 -53.97 52.13 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.064 1.346 . . . . 71.4 111.146 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -68.19 -31.63 71.29 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.533 0.733 . . . . 43.15 110.032 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.492 ' O ' ' HG2' ' B' ' 117' ' ' MET . 12.6 t -68.16 -33.67 74.9 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.984 0.514 . . . . 74.31 111.188 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.477 HG23 ' SG ' ' B' ' 76' ' ' CYS . 78.9 mt -68.14 -52.23 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.162 0.585 . . . . 62.22 109.764 172.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.4 m -59.19 -30.44 68.21 Favored 'General case' 0 CA--C 1.553 1.074 0 O-C-N 123.971 0.794 . . . . 74.3 111.666 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 37.3 t -64.38 -50.77 66.37 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 123.498 0.719 . . . . 71.23 109.976 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.4 mmt -69.27 -32.48 71.69 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 123.615 0.572 . . . . 74.45 111.223 -174.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 114' ' ' ILE . 89.4 t -61.95 -47.44 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.653 0.781 . . . . 72.54 110.307 173.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 34.6 t -62.14 -37.3 84.65 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.81 -1.087 . . . . 73.44 110.799 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.424 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 93.1 mtt-85 -67.68 -32.3 72.87 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 115.435 -0.802 . . . . 74.11 110.612 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.76 4.7 84.36 Favored Glycine 0 C--N 1.349 1.302 0 O-C-N 123.717 0.636 . . . . 50.14 112.905 174.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 68.2 p 57.96 33.97 23.77 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 126.113 1.765 . . . . 74.32 113.204 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -93.99 163.8 22.55 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 123.99 0.916 . . . . 72.15 110.726 177.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.09 170.4 1.12 Allowed 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.537 2.825 . . . . 65.43 115.198 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -64.05 114.36 4.1 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.41 1.084 . . . . 72.14 110.903 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.94 84.72 2.24 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.157 -1.053 . . . . 54.3 108.157 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -108.81 118.53 37.02 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.629 0.772 . . . . 64.5 109.073 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.606 HD21 HD13 ' B' ' 42' ' ' LEU . 0.3 OUTLIER -70.85 133.03 46.14 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.505 0.722 . . . . 71.13 109.23 -177.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.76 144.04 98.38 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.428 0.691 . . . . 73.02 111.773 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.18 92.58 0.65 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.9 2.4 . . . . 73.15 112.686 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' F' ' 8' ' ' LEU . 48.3 t -98.13 110.11 25.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.434 -0.95 . . . . 74.43 108.434 172.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -89.87 114.09 25.8 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.026 -0.731 . . . . 73.03 109.026 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -60.88 -43.16 98.82 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.521 0.728 . . . . 73.51 111.0 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -57.74 -49.7 75.68 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 114.837 -1.074 . . . . 65.24 112.734 -173.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.33 74.82 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.277 0.985 . . . . 74.21 112.801 -171.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 mp -77.43 -37.42 51.72 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.863 -0.608 . . . . 74.32 110.181 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -68.18 -28.7 67.5 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.457 0.303 . . . . 65.31 111.611 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 84.4 mtp -60.33 -39.91 88.76 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.323 0.649 . . . . 73.23 111.147 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -85.69 -24.54 26.95 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 114.655 -1.157 . . . . 72.43 110.169 -170.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -71.7 -33.52 68.85 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.978 0.418 . . . . 74.32 110.151 173.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 80.7 mt -92.61 27.38 2.33 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.52 0.728 . . . . 64.01 110.95 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -63.55 138.75 58.63 Favored 'General case' 0 C--N 1.358 0.954 0 C-N-CA 123.195 0.598 . . . . 73.51 111.122 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -175.19 122.59 0.22 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.123 1.369 . . . . 71.2 107.45 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -91.56 128.08 37.26 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.809 0.444 . . . . 74.23 110.563 -176.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.95 178.23 5.18 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.096 0.559 . . . . 53.43 109.652 170.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -149.17 152.91 24.84 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.453 -0.659 . . . . 73.43 111.453 178.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . 0.587 ' HA ' ' HA ' ' D' ' 147' ' ' GLU . 41.1 mt-10 -88.47 173.54 8.63 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.784 0.802 . . . . 71.3 111.038 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 166.69 -173.43 42.05 Favored Glycine 0 C--O 1.239 0.466 0 CA-C-N 114.293 -1.321 . . . . 73.52 109.99 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 31.2 p 64.18 156.51 0.07 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.773 1.629 . . . . 63.53 113.196 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -173.85 133.74 0.45 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 106.156 -1.794 . . . . 74.03 106.156 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -136.94 99.89 4.14 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.789 0.328 . . . . 74.53 110.676 -175.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -91.95 160.06 15.45 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.37 0.668 . . . . 75.45 109.496 164.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -165.83 140.07 4.57 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.487 1.115 . . . . 71.21 108.681 174.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -137.12 2.38 2.55 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.483 0.713 . . . . 75.42 110.302 175.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.959 0 C-N-CA 124.087 0.955 . . . . 64.01 109.235 178.699 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 86.0 mtp . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 109.976 -0.379 . . . . 74.13 109.976 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 71.9 p -114.0 127.38 55.93 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.345 0.658 . . . . 53.33 109.743 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -82.2 173.69 11.88 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.276 0.63 . . . . 65.51 110.63 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -64.84 119.08 9.97 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.309 0.644 . . . . 71.33 109.785 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -65.36 -75.95 0.08 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.252 1.021 . . . . 74.44 110.378 -176.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -174.63 117.3 0.2 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 107.591 -1.262 . . . . 73.14 107.591 175.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.471 HG22 ' HB2' ' A' ' 136' ' ' LEU . 46.7 p -101.66 158.15 16.3 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.559 0.744 . . . . 74.44 109.665 177.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -62.38 145.79 53.01 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.18 0.592 . . . . 71.12 109.89 167.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.75 133.99 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.917 1.287 . . . . 64.45 111.412 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 35.6 m -127.37 94.93 4.12 Favored 'General case' 0 C--O 1.244 0.768 0 O-C-N 121.644 -0.66 . . . . 72.43 109.91 175.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' C' ' 85' ' ' SER . 0.2 OUTLIER -123.76 165.22 17.66 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 115.901 -0.591 . . . . 75.43 109.5 162.486 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -134.74 128.28 32.61 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 107.84 -1.17 . . . . 75.01 107.84 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.607 HG13 ' HD3' ' A' ' 130' ' ' PRO . 63.0 mt -65.75 118.27 8.17 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 N-CA-C 107.987 -1.116 . . . . 62.41 107.987 173.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.549 ' HA ' HE21 ' C' ' 14' ' ' GLN . 0.0 OUTLIER -93.82 -36.82 12.07 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 123.981 0.801 . . . . 71.33 108.959 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -178.51 123.28 0.1 Allowed 'General case' 0 C--N 1.361 1.075 0 O-C-N 123.68 0.612 . . . . 61.21 110.766 -172.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.2 mt -109.85 137.91 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.838 1.255 . . . . 71.11 108.923 172.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.497 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 21.1 p90 -174.34 166.77 4.04 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.862 0.865 . . . . 74.31 109.972 -172.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.2 p -91.72 126.33 36.77 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.174 0.589 . . . . 51.23 109.532 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.497 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 14.9 mmtp -74.5 -50.07 19.68 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 107.759 -1.2 . . . . 72.12 107.759 168.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 19.8 t70 -136.08 141.98 44.28 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 113.627 -1.624 . . . . 73.33 109.883 -168.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.582 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 88.7 mt -138.37 145.51 28.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 106.604 -1.628 . . . . 73.51 106.604 175.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' C' ' 77' ' ' GLU . 42.2 t -154.9 150.11 27.09 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.763 0.825 . . . . 72.22 109.295 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 88.9 t80 -156.86 117.03 3.54 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 107.568 -1.271 . . . . 75.41 107.568 173.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -120.53 111.66 17.96 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.127 0.571 . . . . 73.42 110.146 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.97 82.96 43.68 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.379 1.072 . . . . 71.22 108.274 168.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -69.39 -31.39 22.26 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.588 2.192 . . . . 74.44 110.687 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -96.11 13.82 25.93 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.156 -1.384 . . . . 74.54 110.583 -175.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.99 -56.67 14.26 Favored Pre-proline 0 CA--C 1.566 1.59 0 N-CA-C 113.97 1.1 . . . . 64.4 113.97 -170.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -60.35 -41.41 50.13 Favored 'Trans proline' 0 C--N 1.395 3.014 0 C-N-CA 122.002 1.801 . . . . 71.22 112.075 -177.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -70.24 -38.1 75.1 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.447 -1.251 . . . . 73.43 112.298 -175.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.727 HG21 ' HA ' ' C' ' 73' ' ' ALA . 12.4 p -77.91 -23.02 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 112.471 0.545 . . . . 64.44 112.471 -173.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -64.77 -22.89 67.08 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.081 0.4 . . . . 73.41 112.081 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -103.98 29.51 5.83 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.952 0.901 . . . . 74.53 110.808 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.556 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -114.11 163.35 15.3 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.787 0.835 . . . . 73.23 109.533 173.412 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.52 120.87 11.36 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.621 0.768 . . . . 71.1 109.937 168.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -85.97 90.44 8.09 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.877 0.471 . . . . 75.54 111.133 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -150.25 76.97 8.39 Favored Pre-proline 0 N--CA 1.483 1.208 0 C-N-CA 124.913 1.285 . . . . 74.54 108.216 169.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -84.04 160.57 13.64 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.27 1.98 . . . . 74.32 112.609 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -87.1 119.47 27.35 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 106.207 -1.775 . . . . 65.23 106.207 168.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.578 HG11 HD11 ' C' ' 126' ' ' LEU . 34.9 m -91.36 97.19 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 122.469 1.128 . . . . 60.01 109.47 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.554 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 3.7 ttmp? -96.78 100.32 11.86 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 114.541 -1.208 . . . . 61.42 107.988 177.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 pp -87.93 149.53 24.01 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 109.358 -0.608 . . . . 63.02 109.358 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.482 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 33.6 t70 -149.0 114.17 5.49 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.276 0.63 . . . . 71.21 109.951 -173.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.543 HD21 HD11 ' G' ' 8' ' ' LEU . 9.1 mp -105.26 147.83 27.65 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.226 0.536 . . . . 71.44 110.519 177.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.496 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 5.7 t70 -136.36 151.06 49.15 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.334 1.454 . . . . 41.42 107.821 175.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 30.4 p -113.48 112.23 23.26 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.601 -0.518 . . . . 73.41 109.601 -177.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.11 151.62 37.19 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.349 1.06 . . . . 65.52 109.074 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.0 p -166.11 173.59 10.14 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.167 0.432 . . . . 73.32 112.167 -173.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 45.3 t -166.7 146.65 5.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.276 1.031 . . . . 72.52 109.286 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -88.38 118.61 28.12 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.891 -0.781 . . . . 65.03 108.891 170.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.618 HD11 HD12 ' C' ' 83' ' ' ILE . 65.4 mt -89.09 -38.98 13.95 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.352 0.661 . . . . 64.53 110.55 -177.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.53 -174.85 4.18 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.117 -0.947 . . . . 71.33 110.746 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -61.4 104.66 0.43 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 114.317 -1.311 . . . . 73.32 110.001 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 70.9 -2.71 2.22 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 125.894 1.677 . . . . 74.53 113.79 -175.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 71.2 t -93.71 115.61 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 107.748 -1.204 . . . . 54.11 107.748 175.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -133.35 136.99 45.7 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.718 0.771 . . . . 63.44 110.191 -170.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -86.98 113.13 22.48 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.664 1.586 . . . . 74.33 109.211 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 91.2 t -104.47 113.83 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 108.007 -1.109 . . . . 62.32 108.007 174.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -121.57 136.18 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 109.233 -0.655 . . . . 72.23 109.233 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.456 HD22 ' HB3' ' C' ' 103' ' ' PRO . 34.5 tp -120.44 115.96 24.52 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.596 -0.89 . . . . 53.2 108.596 175.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.496 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 15.3 ttm-85 -81.77 130.09 34.95 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.398 -0.964 . . . . 63.3 108.398 173.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.469 ' HB ' HD11 ' C' ' 114' ' ' ILE . 4.2 t -119.02 132.23 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 106.839 -1.541 . . . . 74.15 106.839 171.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.482 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 16.1 m -133.36 116.75 16.47 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.014 -0.736 . . . . 63.21 109.014 -177.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.632 HG21 HG21 ' C' ' 114' ' ' ILE . 62.7 t -105.31 114.71 45.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 123.835 0.854 . . . . 74.21 109.464 -175.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.554 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 18.5 m -101.79 139.11 37.87 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.559 -0.904 . . . . 64.11 108.559 172.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.46 114.58 13.03 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.887 -1.153 . . . . 74.34 107.887 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 31.4 m -137.0 130.42 31.41 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.104 0.478 . . . . 55.01 111.295 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.556 HD13 ' HG2' ' C' ' 34' ' ' LYS . 11.6 mt -86.32 46.88 1.39 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.795 1.238 . . . . 74.4 109.72 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.88 -109.67 3.56 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 110.699 -0.96 . . . . 75.14 110.699 -174.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -89.6 -23.93 21.82 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.467 0.707 . . . . 53.2 110.241 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -72.54 122.64 21.67 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 123.798 0.839 . . . . 72.23 110.005 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.0 m -82.94 128.04 34.09 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.976 -0.75 . . . . 74.04 108.976 168.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.727 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -80.52 -55.27 4.98 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 123.789 0.68 . . . . 73.3 109.525 172.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -162.6 175.65 11.18 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.116 0.96 . . . . 75.02 111.575 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.424 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -137.53 147.36 45.11 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 105.997 -1.853 . . . . 64.14 105.997 171.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.424 ' N ' HD13 ' C' ' 75' ' ' LEU . 41.9 t -147.78 153.26 38.99 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.588 -0.893 . . . . 71.34 108.588 176.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' C' ' 22' ' ' SER . 34.6 tt0 -158.1 133.25 8.66 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 122.847 0.459 . . . . 75.21 110.243 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.488 HG11 ' HA ' ' C' ' 110' ' ' ALA . 49.1 t -137.52 114.43 12.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.481 1.112 . . . . 65.24 108.547 177.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.486 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 58.4 mt-30 -95.85 94.17 7.49 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.693 -0.854 . . . . 75.15 108.693 174.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.51 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.5 tp-100 -82.27 111.01 17.96 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.454 -0.794 . . . . 74.52 109.693 -176.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.46 148.08 18.86 Favored Glycine 0 C--N 1.335 0.522 0 O-C-N 123.827 0.705 . . . . 51.44 112.079 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.05 118.57 0.97 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.096 -1.201 . . . . 72.31 110.096 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.618 HD12 HD11 ' C' ' 51' ' ' LEU . 15.0 mm -84.42 128.13 39.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.617 -0.883 . . . . 55.34 108.617 176.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.466 ' HB2' HD11 ' C' ' 86' ' ' ILE . 26.5 m-85 -136.42 149.13 48.12 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.883 -1.154 . . . . 74.25 107.883 176.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 19.4 p -102.61 109.75 21.46 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 108.949 -0.759 . . . . 62.22 108.949 174.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.466 HD11 ' HB2' ' C' ' 84' ' ' PHE . 4.4 mp -108.58 122.08 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.107 0.563 . . . . 75.04 109.95 -167.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.56 167.58 27.62 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 114.538 -1.21 . . . . 51.04 109.651 175.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.46 -60.67 0.36 Allowed Glycine 0 C--N 1.344 0.973 0 CA-C-N 116.104 -0.498 . . . . 71.45 113.088 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 41.0 pt -113.33 167.55 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.202 0.525 . . . . 75.2 111.294 -176.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -149.18 -177.49 5.85 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.975 -1.011 . . . . 71.34 110.106 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.36 -139.99 42.56 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.68 -0.691 . . . . 44.04 114.077 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 39.4 p -68.99 -27.52 65.78 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.91 0.884 . . . . 64.34 111.33 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -61.48 -45.28 94.9 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.302 0.641 . . . . 74.15 110.157 175.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.554 ' HE1' ' H ' ' G' ' 18' ' ' VAL . 9.8 ptm -77.32 -21.8 52.9 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-O 119.221 -0.419 . . . . 62.33 111.068 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.32 -36.72 82.05 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.193 0.52 . . . . 65.22 109.947 172.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.55 ' HA ' HD12 ' G' ' 13' ' ' LEU . 46.3 t-80 -60.9 -33.26 72.86 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.783 0.833 . . . . 73.33 110.744 173.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -77.79 -57.87 3.57 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.039 -0.528 . . . . 73.03 110.704 176.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.428 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 96.0 mt -71.18 -37.84 72.15 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.101 0.96 . . . . 62.1 113.386 -165.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.2 -11.15 34.69 Favored Glycine 0 N--CA 1.471 0.993 0 CA-C-O 120.007 -0.329 . . . . 71.34 113.871 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.482 ' HB1' ' HB2' ' C' ' 134' ' ' ASP . . . -116.82 -57.61 2.16 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 117.161 0.481 . . . . 74.41 110.742 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -76.74 -47.72 20.92 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.467 0.707 . . . . 74.14 112.506 -174.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.428 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 58.6 m -65.11 -46.57 73.25 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 123.886 0.875 . . . . 54.44 112.722 -173.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.456 ' HB3' HD22 ' C' ' 60' ' ' LEU . 14.1 Cg_exo -72.1 -15.83 28.83 Favored 'Trans proline' 0 C--N 1.392 2.858 0 C-N-CA 122.148 1.899 . . . . 74.45 112.352 176.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -74.48 -33.26 62.81 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.465 0.706 . . . . 75.35 110.083 175.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.521 HD12 HH12 ' A' ' 111' ' ' ARG . 48.0 mm -61.34 -40.74 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 115.607 -0.724 . . . . 73.13 109.279 170.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 81.4 mt -87.25 -18.9 29.17 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.852 -1.067 . . . . 65.5 112.923 -173.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -57.72 -51.6 80.55 Favored Pre-proline 0 CA--C 1.559 1.316 0 CA-C-O 117.755 -1.117 . . . . 62.24 113.5 -174.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.17 -30.73 91.97 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 122.032 1.821 . . . . 72.41 113.399 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -68.77 -49.48 58.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.248 0.619 . . . . 63.43 110.643 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -65.16 -35.85 82.39 Favored 'General case' 0 C--N 1.355 0.843 0 CA-C-N 115.759 -0.655 . . . . 74.12 110.684 177.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -58.82 -51.08 71.51 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.381 1.073 . . . . 70.01 110.746 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.74 -37.57 79.52 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.789 -0.448 . . . . 53.05 109.789 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.9 t -66.06 -31.83 72.94 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.042 0.537 . . . . 71.1 111.51 -176.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.632 HG21 HG21 ' C' ' 64' ' ' VAL . 96.7 mt -72.63 -54.98 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.358 -0.608 . . . . 73.22 109.358 173.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.9 m -60.31 -28.25 67.97 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.935 0.772 . . . . 40.45 111.278 -175.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 30.6 t -66.7 -49.83 64.8 Favored 'General case' 0 C--O 1.213 -0.844 0 N-CA-C 108.734 -0.839 . . . . 62.22 108.734 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.553 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.4 -37.31 83.0 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.454 1.102 . . . . 75.4 112.401 178.17 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.443 HG23 ' O ' ' C' ' 114' ' ' ILE . 76.4 t -63.24 -45.29 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.718 0.807 . . . . 64.35 109.044 174.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 44.5 t -70.55 -26.26 63.47 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.561 -1.2 . . . . 71.21 112.113 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -75.83 -40.56 54.66 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.632 0.773 . . . . 73.24 108.949 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.27 -0.39 61.56 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 123.903 0.752 . . . . 64.35 112.348 168.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 31.0 p 62.75 28.4 16.49 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.692 1.997 . . . . 74.5 113.415 170.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -83.57 141.24 41.72 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 107.997 -1.112 . . . . 73.2 107.997 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -50.98 156.46 4.82 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 123.682 2.922 . . . . 64.34 114.232 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -50.62 111.83 0.6 Allowed 'General case' 0 N--CA 1.481 1.094 0 O-C-N 124.473 1.108 . . . . 71.23 112.695 -171.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.578 HD11 HG11 ' C' ' 40' ' ' VAL . 31.2 tp -112.73 87.51 2.6 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.217 -1.401 . . . . 62.24 107.217 171.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -107.69 107.67 18.57 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.149 -1.056 . . . . 72.1 108.149 -172.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 30.7 tp -65.99 142.59 57.79 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.519 0.512 . . . . 62.34 111.157 -174.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.29 152.92 95.65 Favored Pre-proline 0 CA--C 1.555 1.141 0 O-C-N 124.072 0.858 . . . . 63.52 110.888 178.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.473 ' HG2' HG21 ' A' ' 13' ' ' ILE . 51.4 Cg_exo -54.77 143.84 68.58 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.965 2.443 . . . . 75.13 113.559 177.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.691 HG11 HD13 ' G' ' 8' ' ' LEU . 7.0 p -128.6 110.35 21.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-O 122.665 1.221 . . . . 72.43 109.595 173.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' C' ' 135' ' ' ALA . 2.3 m-20 -92.06 84.39 5.29 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.63 -1.989 . . . . 63.04 105.63 169.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -47.15 -44.29 21.7 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.765 0.826 . . . . 73.13 111.883 -171.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.482 ' HB2' ' HB1' ' C' ' 100' ' ' ALA . 16.1 t70 -62.92 -45.28 93.22 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.628 -1.169 . . . . 64.11 112.468 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.482 ' HB3' ' HB2' ' C' ' 132' ' ' ASN . . . -67.45 -21.08 65.56 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.257 0.623 . . . . 74.31 112.386 -175.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.26 -41.2 97.06 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.044 0.538 . . . . 73.51 110.612 169.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . 0.432 ' HE1' ' HB3' ' A' ' 151' ' ' GLU . 83.5 m-85 -70.15 -38.25 75.43 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.571 0.749 . . . . 73.05 111.419 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 85.8 mtp -68.11 -37.92 81.68 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.757 -0.656 . . . . 74.41 110.342 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.14 -37.01 68.9 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.985 1.314 . . . . 62.44 111.266 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -56.43 -82.26 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.353 1.061 . . . . 74.51 111.389 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -62.24 -33.14 74.02 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 113.513 0.931 . . . . 73.01 113.513 -170.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -67.23 151.61 47.22 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 120.833 0.349 . . . . 63.11 111.379 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -66.96 -53.02 35.78 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.295 -0.866 . . . . 53.51 109.25 171.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 62.26 96.39 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.676 1.191 . . . . 64.13 110.711 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.32 157.84 28.68 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.307 0.643 . . . . 54.43 110.019 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . 0.701 ' HA3' ' HA2' ' A' ' 88' ' ' GLY . . . 149.34 -157.09 27.11 Favored Glycine 0 C--N 1.343 0.947 0 C-N-CA 121.02 -0.61 . . . . 74.14 114.446 172.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -152.38 142.99 22.79 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.046 0.938 . . . . 71.44 109.195 -170.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.27 -119.06 4.17 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 111.011 -0.836 . . . . 73.24 111.011 172.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . 0.411 HG21 ' HG3' ' E' ' 20' ' ' LYS . 8.3 m -162.92 156.6 20.13 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.586 0.754 . . . . 75.01 110.491 -177.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -111.23 101.78 10.25 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 108.031 -1.1 . . . . 71.1 108.031 170.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -101.48 133.44 46.12 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.812 -0.81 . . . . 60.13 108.812 169.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -70.24 95.11 0.97 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.228 0.611 . . . . 73.44 109.631 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -153.56 129.39 10.17 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.797 0.839 . . . . 43.22 109.158 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -142.85 117.96 10.09 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.191 0.596 . . . . 73.34 109.499 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.168 0 C-N-CA 123.25 0.62 . . . . 45.24 110.457 -179.07 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.1 pmm? . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 121.04 0.448 . . . . 53.32 110.642 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 17.0 t -149.79 162.02 41.11 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.699 0.8 . . . . 73.13 109.197 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -158.02 -42.37 0.06 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.408 0.283 . . . . 73.11 110.891 -174.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -69.63 96.84 0.98 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.506 0.723 . . . . 75.45 111.252 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -153.8 15.56 0.49 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.069 0.948 . . . . 64.12 111.334 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -53.02 -71.28 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.524 1.13 . . . . 74.54 111.302 -174.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 12.3 t 176.18 -170.69 0.07 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.708 1.603 . . . . 73.15 107.678 175.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.13 132.37 42.18 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 118.887 0.767 . . . . 71.22 109.372 174.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 28.2 ttt -33.28 129.12 0.27 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 115.16 1.541 . . . . 75.1 115.16 174.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 59.8 m -107.96 142.47 38.03 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.504 1.121 . . . . 75.24 108.307 165.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -157.38 118.74 3.66 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.486 -1.302 . . . . 74.45 107.486 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -123.87 115.29 21.07 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.255 -1.017 . . . . 71.24 108.255 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.438 HG21 HD11 ' D' ' 16' ' ' ILE . 56.7 mt -75.72 123.95 32.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.586 -0.894 . . . . 72.3 108.586 173.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -89.81 -40.14 12.65 Favored 'General case' 0 C--O 1.245 0.836 0 O-C-N 123.473 0.483 . . . . 73.32 111.239 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -175.9 128.74 0.24 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 119.645 -0.217 . . . . 73.4 110.929 -163.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.438 HD11 HG21 ' D' ' 13' ' ' ILE . 3.4 mp -112.05 140.89 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.924 -1.139 . . . . 75.23 107.924 166.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.472 ' HE1' HG13 ' D' ' 83' ' ' ILE . 26.0 p90 -161.91 168.43 22.95 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 124.257 0.973 . . . . 71.24 110.41 -177.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -99.46 120.74 40.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.595 -1.184 . . . . 73.23 109.251 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -90.29 -18.32 25.81 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.92 -0.582 . . . . 70.44 109.56 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.1 t70 -160.99 141.05 10.98 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 114.691 -1.141 . . . . 71.22 109.686 177.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.553 HG21 ' HE2' ' C' ' 117' ' ' MET . 67.0 mt -139.14 140.55 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.978 1.311 . . . . 75.23 107.475 174.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.7 t -142.49 140.04 31.73 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.089 0.955 . . . . 42.25 108.927 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.582 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 94.3 t80 -152.19 119.02 5.76 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 106.527 -1.657 . . . . 73.53 106.527 173.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 28.9 mt-10 -134.58 108.64 8.18 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.834 -0.802 . . . . 70.3 108.834 -173.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.4 92.03 9.26 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 109.007 -0.738 . . . . 74.44 109.007 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.74 -52.72 0.39 Allowed 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.044 2.496 . . . . 73.35 112.342 -172.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -94.23 13.25 23.99 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-N 114.943 -1.026 . . . . 73.33 110.32 -174.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -28.7 -61.97 0.21 Allowed Pre-proline 0 CA--C 1.566 1.591 0 N-CA-C 115.984 1.846 . . . . 74.14 115.984 -165.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.408 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 91.2 Cg_endo -78.04 -22.97 9.57 Favored 'Trans proline' 0 C--N 1.384 2.401 0 CA-C-N 122.782 2.029 . . . . 74.11 113.905 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -71.08 -41.3 70.85 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.592 1.157 . . . . 75.43 109.359 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.633 HG22 HD12 ' D' ' 68' ' ' LEU . 9.9 p -83.52 -20.69 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.614 -0.721 . . . . 72.41 111.617 -171.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.4 m-85 -61.85 -28.37 69.44 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.002 0.429 . . . . 75.12 111.71 176.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -59.4 -25.62 64.44 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.79 -1.095 . . . . 51.14 110.341 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -86.28 87.01 7.35 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.538 1.135 . . . . 74.42 109.834 170.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -84.04 93.07 8.01 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.003 -0.999 . . . . 72.42 110.944 -177.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 36.9 p90 -164.36 171.27 15.0 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.21 1.004 . . . . 64.42 109.428 167.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.606 HE21 ' HD2' ' D' ' 38' ' ' PRO . 27.7 tp60 -60.76 113.37 7.5 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 123.792 0.837 . . . . 72.33 109.051 176.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.741 ' HD3' ' HG2' ' D' ' 124' ' ' PRO . 62.7 Cg_exo -52.93 124.03 14.52 Favored 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 122.77 2.313 . . . . 43.04 111.693 -177.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -68.02 111.63 4.54 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 124.38 1.05 . . . . 64.13 108.186 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.462 HG13 ' O ' ' D' ' 38' ' ' PRO . 16.6 m -99.86 144.66 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.973 0.892 . . . . 73.23 112.507 -165.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.503 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 17.7 tppt? -113.93 113.46 24.88 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.622 -1.621 . . . . 72.1 106.622 171.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 pp -94.87 141.06 29.08 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 108.069 -1.086 . . . . 51.42 108.069 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.599 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 32.8 t70 -145.68 138.13 25.67 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.487 0.715 . . . . 72.22 109.081 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -116.21 134.96 54.34 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.901 -0.777 . . . . 60.43 108.901 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 35.4 t70 -136.67 157.76 46.03 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 106.832 -1.544 . . . . 64.31 106.832 170.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.9 t -137.09 154.09 50.4 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.256 0.55 . . . . 73.15 111.328 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.494 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.38 165.77 32.08 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.906 1.283 . . . . 61.31 108.838 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 32.0 p -172.55 153.89 2.96 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.047 0.539 . . . . 71.44 111.649 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 33.7 p -157.2 120.33 4.06 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 114.722 -1.127 . . . . 42.54 108.554 173.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' D' ' 56' ' ' TYR . 61.7 tt0 -65.59 129.16 38.77 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.353 -0.61 . . . . 74.21 109.353 173.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 76.9 mt -94.96 -38.16 10.81 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.073 0.549 . . . . 63.53 110.971 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.89 -170.3 2.68 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.128 0.49 . . . . 63.24 111.294 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.44 118.13 7.67 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.839 -1.073 . . . . 74.1 109.739 176.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 67.83 -1.29 1.73 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.833 1.253 . . . . 64.24 112.794 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -109.56 123.91 65.83 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 N-CA-C 108.954 -0.758 . . . . 43.3 108.954 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.475 ' HA ' ' HA ' ' D' ' 50' ' ' GLN . 0.1 OUTLIER -136.13 150.05 48.92 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.959 -0.756 . . . . 72.0 108.959 177.002 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -110.55 134.38 52.44 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.504 -1.295 . . . . 61.22 107.504 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 76.9 t -127.28 131.16 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.617 1.167 . . . . 75.3 108.814 -172.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 21.7 t -121.56 131.94 71.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 123.446 0.699 . . . . 74.53 109.67 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.579 HD23 HD12 ' D' ' 106' ' ' LEU . 3.9 mm? -117.87 107.97 14.76 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.447 -0.946 . . . . 73.52 108.447 168.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.559 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 15.8 ttm-85 -82.24 101.9 10.81 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.876 0.87 . . . . 74.31 109.08 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 84.7 t -94.09 129.99 43.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.725 -0.843 . . . . 74.42 108.725 174.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 21.7 m -125.03 133.33 53.0 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.804 0.442 . . . . 73.55 110.194 -176.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 42.2 t -124.81 101.07 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.667 1.187 . . . . 64.22 108.703 175.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 93.4 m -92.99 106.45 18.41 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.881 -1.155 . . . . 74.14 107.881 170.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.61 142.37 42.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.893 -0.594 . . . . 50.12 110.011 -171.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.429 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 19.8 m -145.15 137.01 25.59 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.122 -0.49 . . . . 75.33 110.57 -175.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.633 HD12 HG22 ' D' ' 31' ' ' VAL . 21.2 mt -105.14 110.82 23.34 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.071 -1.085 . . . . 65.34 108.071 172.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.54 -130.01 17.48 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 116.229 -0.441 . . . . 43.11 113.242 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -89.6 4.19 50.18 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.348 0.659 . . . . 65.55 111.92 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -131.8 158.78 40.35 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.695 0.398 . . . . 74.23 110.518 -173.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.3 m -71.29 138.01 49.0 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.355 -0.839 . . . . 74.22 111.103 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.461 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.48 -62.24 1.52 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.946 -1.131 . . . . 60.25 107.946 173.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -156.61 159.53 38.56 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.583 -1.19 . . . . 74.34 110.556 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 85.7 mt -121.97 108.84 13.87 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.48 -1.304 . . . . 63.12 107.48 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.626 ' SG ' HG12 ' D' ' 114' ' ' ILE . 45.9 t -117.14 135.27 53.88 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.749 0.82 . . . . 75.32 109.272 -173.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -155.43 126.18 6.96 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.78 0.432 . . . . 63.42 110.033 175.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.43 118.74 46.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 123.819 0.848 . . . . 63.5 109.527 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.4 mt-30 -87.71 88.45 7.67 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.272 -1.01 . . . . 73.14 108.272 170.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -80.85 98.38 7.81 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 115.092 -0.958 . . . . 72.54 109.102 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.32 169.55 33.26 Favored Glycine 0 C--O 1.244 0.772 0 CA-C-N 115.74 -0.663 . . . . 64.01 112.33 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.63 133.33 2.86 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 112.058 -0.417 . . . . 60.2 112.058 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.472 HG13 ' HE1' ' D' ' 17' ' ' TYR . 57.7 mt -88.41 123.84 41.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 107.847 -1.168 . . . . 71.1 107.847 173.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -131.61 157.12 44.52 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.123 0.969 . . . . 35.02 109.718 -175.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 43.2 m -117.21 136.23 53.21 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.029 0.932 . . . . 73.44 110.2 175.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.412 HD12 ' O ' ' D' ' 86' ' ' ILE . 2.3 pp -130.77 141.71 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.554 1.141 . . . . 71.15 109.956 175.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.13 161.07 10.18 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.158 0.983 . . . . 71.55 108.639 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.44 21.04 79.93 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 121.426 -0.416 . . . . 54.12 113.382 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.512 HG23 HE21 ' D' ' 93' ' ' GLN . 12.7 mt -118.86 152.56 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.464 0.705 . . . . 73.53 109.933 -172.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -157.4 148.12 21.28 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.945 1.298 . . . . 64.3 110.557 175.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.57 -125.53 28.79 Favored Glycine 0 C--N 1.353 1.492 0 O-C-N 124.085 0.866 . . . . 62.53 114.9 169.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . 0.613 HG21 HD21 ' D' ' 141' ' ' LEU . 11.2 m -72.0 -24.9 61.65 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.763 0.825 . . . . 53.43 111.803 -175.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.512 HE21 HG23 ' D' ' 89' ' ' ILE . 25.6 tt0 -61.78 -29.9 70.45 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.328 0.651 . . . . 74.24 109.976 175.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 49.5 mtt -70.8 -44.09 67.33 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.918 0.887 . . . . 72.3 110.692 173.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.85 -36.83 82.36 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.379 0.672 . . . . 73.2 111.34 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -78.85 -29.97 44.91 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.116 0.566 . . . . 45.33 110.696 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 41.1 t -60.38 -51.09 70.99 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.413 0.685 . . . . 54.24 112.311 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.15 -17.07 14.43 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 115.492 -0.776 . . . . 72.31 112.258 -174.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.89 -25.62 29.02 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-O 120.119 -0.267 . . . . 72.54 112.867 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.14 -63.37 1.45 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.009 0.524 . . . . 62.3 110.935 -178.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -62.38 -53.99 46.83 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 112.744 0.646 . . . . 75.01 112.744 -169.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 59.1 m -59.04 -45.43 99.52 Favored Pre-proline 0 N--CA 1.494 1.753 0 CA-C-O 118.612 -0.709 . . . . 75.44 112.563 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -51.71 -46.64 30.68 Favored 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.639 2.226 . . . . 62.15 113.665 165.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -67.64 -15.54 63.7 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 123.376 0.67 . . . . 63.31 112.202 -178.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 35.9 mm -86.61 -49.43 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.285 0.634 . . . . 61.33 109.863 173.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.579 HD12 HD23 ' D' ' 60' ' ' LEU . 91.4 mt -79.52 -30.53 41.92 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.352 0.871 . . . . 50.33 113.352 -168.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -65.6 -39.25 31.23 Favored Pre-proline 0 N--CA 1.49 1.572 0 CA-C-O 118.174 -0.917 . . . . 73.51 113.264 -177.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -49.55 -45.97 28.78 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 122.62 2.213 . . . . 74.23 114.626 166.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -74.57 -36.16 63.06 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.063 0.545 . . . . 64.14 111.581 -177.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.16 -46.59 86.42 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.641 -0.503 . . . . 51.14 109.641 174.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -54.49 -49.59 69.77 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 124.706 1.254 . . . . 54.33 110.606 177.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -62.56 -43.63 98.34 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.797 0.686 . . . . 64.34 111.093 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.9 t -61.76 -44.0 97.76 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 123.761 0.663 . . . . 75.34 110.859 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.626 HG12 ' SG ' ' D' ' 76' ' ' CYS . 97.2 mt -60.61 -59.1 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.14 0.976 . . . . 73.21 110.217 175.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 37.0 m -52.98 -38.95 62.66 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.461 1.504 . . . . 64.22 111.551 -176.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.0 t -66.76 -47.06 73.4 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 114.889 -1.05 . . . . 53.14 110.344 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.8 mtm -67.17 -32.28 73.26 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.787 0.435 . . . . 72.5 111.763 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.5 t -61.9 -46.66 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.776 0.83 . . . . 63.34 109.887 174.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.1 p -76.89 -24.99 52.53 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.809 -0.632 . . . . 75.33 111.51 -177.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -74.02 -37.31 64.4 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.389 0.676 . . . . 73.04 109.52 175.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.8 4.39 65.6 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 115.561 -0.745 . . . . 62.44 112.27 170.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 47.8 p 59.12 23.09 11.3 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 126.947 2.099 . . . . 44.42 114.012 174.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -78.02 149.79 77.11 Favored Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 108.643 -0.873 . . . . 72.41 108.643 169.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.741 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 4.8 Cg_endo -53.42 133.82 54.8 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.675 2.25 . . . . 71.12 112.295 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -50.98 135.76 24.14 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.833 1.333 . . . . 73.13 112.654 -171.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 64.6 tp -114.77 103.06 10.59 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.881 0.872 . . . . 53.21 109.006 -177.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.493 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 86.2 m-20 -99.51 101.29 12.48 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.829 -0.804 . . . . 74.44 108.829 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.657 HD21 ' HG ' ' H' ' 8' ' ' LEU . 3.2 tt -66.78 115.98 7.17 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 108.172 -1.047 . . . . 71.14 108.172 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.739 ' HB2' HE22 ' B' ' 12' ' ' GLN . . . -65.15 140.54 97.99 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 123.515 0.726 . . . . 75.5 110.72 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.451 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 5.6 Cg_exo -72.18 151.25 54.83 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.81 2.34 . . . . 72.24 111.981 -171.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.9 m -127.8 128.19 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.637 0.775 . . . . 74.44 110.182 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -102.77 88.27 3.17 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.03 0.932 . . . . 60.22 109.57 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.405 ' HE1' ' HA ' ' H' ' 10' ' ' LEU . 78.9 m-85 -66.42 -30.88 71.33 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.21 0.604 . . . . 72.43 111.024 175.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -53.88 -43.66 69.8 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.314 1.009 . . . . 72.3 111.573 -174.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.0 -48.06 82.0 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.269 0.98 . . . . 44.41 111.368 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.461 HD22 HD21 ' H' ' 10' ' ' LEU . 7.9 mp -61.81 -36.39 80.99 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 123.792 0.682 . . . . 54.23 111.613 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -75.45 -44.08 46.13 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.134 0.574 . . . . 73.54 112.01 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 24.1 ptp -74.73 -44.99 47.02 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 111.743 0.275 . . . . 74.3 111.743 -172.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -73.58 -23.58 59.96 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.009 0.524 . . . . 75.42 111.579 -174.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -56.94 -34.48 68.05 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.864 0.865 . . . . 75.2 111.208 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.613 HD21 HG21 ' D' ' 92' ' ' THR . 10.0 mp -77.96 -32.2 51.26 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.792 0.837 . . . . 73.14 112.498 -176.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -90.66 12.28 19.51 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 112.289 0.477 . . . . 75.51 112.289 -175.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -119.94 58.57 0.9 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.604 0.762 . . . . 73.51 110.067 -176.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -147.31 -52.16 0.2 Allowed 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 115.637 -0.711 . . . . 62.13 110.734 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.77 -50.89 4.07 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.408 -0.59 . . . . 71.3 109.408 178.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.59 -123.74 2.33 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 110.809 -0.916 . . . . 71.51 110.809 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . 0.587 ' HA ' ' HA ' ' B' ' 147' ' ' GLU . 28.5 tt0 -163.05 129.82 3.45 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 109.172 -0.677 . . . . 74.5 109.172 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -106.95 127.78 8.99 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.032 -0.827 . . . . 63.23 111.032 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 80.4 m -71.6 118.61 14.64 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.378 0.671 . . . . 73.42 110.469 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -71.52 159.68 34.05 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.496 -0.557 . . . . 71.52 109.496 171.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -156.19 123.05 5.24 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 110.142 -0.318 . . . . 74.42 110.142 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -72.66 113.59 9.85 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.203 1.001 . . . . 74.5 110.322 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -72.49 152.29 42.0 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.638 -0.875 . . . . 74.34 108.638 170.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -154.44 147.43 24.58 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.638 -0.256 . . . . 73.44 110.499 -171.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.935 0 C-N-CA 123.852 0.861 . . . . 70.22 109.581 -178.127 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.595 -0.521 . . . . 73.33 109.595 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -165.48 149.3 8.27 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.685 1.194 . . . . 72.54 108.656 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -98.14 -89.29 0.3 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.851 0.46 . . . . 72.04 111.308 -174.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 47.2 t 52.34 83.59 0.06 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.907 0.883 . . . . 72.22 110.043 -167.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 5' ' ' THR . . . . . 0.512 HG22 ' HB2' ' A' ' 129' ' ' ALA . 33.4 m -65.39 125.8 26.25 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 116.148 -0.478 . . . . 70.21 110.944 -173.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.651 HG21 ' HB ' ' A' ' 40' ' ' VAL . 44.6 pt -60.63 120.68 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 124.729 1.212 . . . . 73.24 112.74 -169.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.05 136.9 47.56 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.11 0.564 . . . . 61.5 109.594 -178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.603 ' HB3' HD11 ' A' ' 44' ' ' LEU . 43.6 mt -71.78 107.48 4.6 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 123.854 0.721 . . . . 75.32 109.224 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.11 72.97 3.69 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.626 0.77 . . . . 64.14 110.534 -177.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . 0.646 HD21 HD23 ' A' ' 136' ' ' LEU . 93.5 mt 59.88 -175.63 0.1 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.023 1.329 . . . . 73.13 112.841 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 56.0 mt -122.76 130.37 24.65 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 124.148 0.979 . . . . 63.11 109.082 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.01 124.67 13.4 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.803 2.335 . . . . 73.01 111.871 176.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 68.65 19.68 8.5 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.021 1.329 . . . . 53.31 110.457 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . 0.66 ' HB3' ' HA3' ' A' ' 99' ' ' GLY . 10.3 mp 65.57 -73.1 0.07 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.754 1.222 . . . . 74.2 110.357 -173.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . 0.585 ' HB2' ' HA2' ' A' ' 99' ' ' GLY . 0.5 OUTLIER -166.82 174.45 8.57 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.105 -0.702 . . . . 72.23 109.105 174.322 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 14.5 p -68.71 138.32 90.72 Favored Pre-proline 0 CA--C 1.557 1.231 0 CA-C-N 115.562 -0.745 . . . . 73.34 110.371 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 17' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -61.88 149.06 91.68 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 123.282 2.655 . . . . 74.14 113.287 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 67.8 t -62.23 -60.59 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 108.837 -0.801 . . . . 64.52 108.837 173.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 8.3 p -156.31 -77.71 0.09 Allowed 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 114.257 -1.338 . . . . 72.12 109.662 -172.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 20' ' ' LYS . . . . . 0.411 ' HG3' HG21 ' C' ' 149' ' ' THR . 48.5 mtmt -105.56 31.85 4.7 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.949 0.9 . . . . 62.04 110.489 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.79 81.0 5.12 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.192 -0.67 . . . . 62.04 109.192 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -74.15 113.34 11.23 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.449 -1.25 . . . . 72.45 109.721 -177.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 62.8 p 53.97 87.9 0.13 Allowed Pre-proline 0 CA--C 1.561 1.371 0 C-N-CA 125.935 1.694 . . . . 74.12 111.546 -175.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.0 82.78 0.15 Allowed 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.519 2.812 . . . . 73.34 113.128 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 . . . . . 0 C--O 1.256 1.411 0 C-N-CA 125.591 1.556 . . . . 72.5 107.946 -178.82 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 120.516 0.198 . . . . 61.22 110.785 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 40.7 tptt -166.58 65.67 0.1 Allowed 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 107.661 -1.237 . . . . 62.24 107.661 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -61.03 -53.54 55.88 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.622 1.169 . . . . 73.24 113.033 -169.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 31.0 t -81.61 66.91 7.37 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.748 0.819 . . . . 44.33 109.992 -174.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 36.4 m -152.63 147.66 26.41 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.773 1.229 . . . . 71.02 108.55 -175.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.745 ' HA ' HD21 ' B' ' 42' ' ' LEU . 41.7 mm 72.62 91.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.008 1.323 . . . . 73.21 110.47 -178.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.76 19.97 2.74 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.338 -1.301 . . . . 75.53 111.928 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . 0.453 ' HB3' HG21 ' B' ' 131' ' ' VAL . 2.7 tt -78.53 85.28 4.61 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.195 -1.039 . . . . 73.0 108.195 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.36 51.87 1.02 Allowed 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.527 1.131 . . . . 73.43 109.726 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 79.8 mt 62.95 -166.38 0.23 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.546 1.138 . . . . 64.43 111.195 -177.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt -103.13 104.92 43.3 Favored Pre-proline 0 CA--C 1.554 1.117 0 N-CA-C 108.59 -0.893 . . . . 71.34 108.59 168.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -64.37 -23.02 65.73 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 123.259 2.64 . . . . 71.4 114.136 -177.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -97.31 3.38 51.21 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.564 0.745 . . . . 61.34 110.814 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 86.6 mt 60.13 -86.22 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.682 1.193 . . . . 63.33 109.98 -169.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . 0.422 ' CD2' ' HB3' ' B' ' 98' ' ' LEU . 9.6 t80 -177.87 160.49 1.49 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.443 0.697 . . . . 73.14 109.396 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 16' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' F' ' 17' ' ' PRO . 16.8 p -82.17 125.04 77.98 Favored Pre-proline 0 CA--C 1.562 1.43 0 C-N-CA 123.468 0.707 . . . . 71.4 110.655 177.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 17' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' F' ' 16' ' ' THR . 26.0 Cg_exo -64.9 146.79 88.64 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.678 2.919 . . . . 75.42 114.541 -174.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . 0.538 HG21 HG21 ' B' ' 86' ' ' ILE . 39.7 t -76.74 132.99 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 124.246 1.018 . . . . 72.12 109.665 176.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 17.3 m -74.9 -59.23 2.83 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-O 120.918 0.389 . . . . 64.04 110.06 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 20' ' ' LYS . . . . . 0.412 ' HB2' ' NE2' ' B' ' 50' ' ' GLN . 54.3 mttp -94.92 75.86 3.57 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.09 0.556 . . . . 75.13 109.789 178.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . -126.06 -1.81 7.1 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.353 1.061 . . . . 73.25 109.975 170.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -97.4 -26.02 15.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.249 0.62 . . . . 71.14 111.187 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 27.5 p -146.25 130.09 8.48 Favored Pre-proline 0 N--CA 1.482 1.158 0 C-N-CA 123.813 0.845 . . . . 74.0 111.028 -172.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -70.96 101.12 1.04 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.788 2.325 . . . . 70.22 110.893 166.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 25' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' B' ' 53' ' ' ASP . 11.6 tp10 . . . . . 0 CA--C 1.559 1.316 0 C-N-CA 123.29 0.636 . . . . 75.13 111.058 -174.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 1' ' ' MET . . . . . 0.436 ' SD ' ' N ' ' G' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 109.531 -0.544 . . . . 64.43 109.531 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -152.13 137.79 17.86 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.947 0.899 . . . . 74.25 109.176 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -66.51 101.53 0.78 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 122.985 0.514 . . . . 63.14 110.046 173.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 76.1 p -164.21 -54.49 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.038 1.335 . . . . 73.41 108.404 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 30.6 m 59.03 -83.69 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.595 1.558 . . . . 72.45 112.714 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . . . . . . . . . 47.9 mm -78.48 -27.52 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.243 0.617 . . . . 62.24 109.937 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.25 153.17 20.16 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.783 -0.644 . . . . 71.34 109.832 171.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 8' ' ' LEU . . . . . 0.691 HD13 HG11 ' C' ' 131' ' ' VAL . 7.2 tt -79.45 141.57 36.66 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 108.821 -0.807 . . . . 52.24 108.821 176.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.0 179.88 2.14 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.789 0.836 . . . . 62.22 112.544 -174.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 39.4 tp -74.6 94.82 2.71 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-O 121.073 0.463 . . . . 64.34 110.098 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 11' ' ' LEU . . . . . 0.471 HD22 ' HD2' ' G' ' 12' ' ' PRO . 3.5 tm? -78.63 118.08 70.28 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 107.695 -1.224 . . . . 62.32 107.695 175.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 12' ' ' PRO . . . . . 0.471 ' HD2' HD22 ' G' ' 11' ' ' LEU . 29.4 Cg_endo -61.58 125.47 16.82 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.805 2.337 . . . . 74.12 112.162 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' C' ' 96' ' ' HIS . 2.5 pt? -75.2 -10.42 59.45 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.406 0.283 . . . . 71.41 111.367 -177.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . 0.401 HD22 HD23 ' G' ' 13' ' ' LEU . 3.0 mm? -71.85 79.27 0.88 Allowed 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 109.188 -0.671 . . . . 71.53 109.188 172.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -91.75 162.37 14.49 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.203 -1.036 . . . . 74.24 108.203 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 39.0 p -57.67 114.62 8.76 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 124.021 0.928 . . . . 71.31 111.285 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 17' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.34 149.97 75.77 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.567 2.178 . . . . 63.34 113.43 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 18' ' ' VAL . . . . . 0.554 ' H ' ' HE1' ' C' ' 94' ' ' MET . 35.5 t -93.73 -50.38 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 114.813 -1.085 . . . . 72.42 109.163 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 69.4 p -82.79 -173.65 4.79 Favored 'General case' 0 C--O 1.248 1.015 0 CA-C-N 114.588 -1.187 . . . . 72.15 110.205 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -83.45 56.18 3.48 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-O 122.048 0.928 . . . . 72.02 110.278 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.54 -30.73 61.87 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.134 0.973 . . . . 43.23 109.66 170.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -120.74 170.33 9.55 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 114.993 -1.003 . . . . 74.22 109.49 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 4.9 t -99.11 107.58 45.0 Favored Pre-proline 0 CA--C 1.556 1.212 0 C-N-CA 123.184 0.594 . . . . 74.22 109.658 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -63.7 126.74 18.09 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.719 2.279 . . . . 64.21 110.504 173.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 . . . . . 0 CA--C 1.56 1.333 0 C-N-CA 123.336 0.654 . . . . 71.43 110.926 -173.2 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.483 1.225 0 CA-C-O 120.62 0.248 . . . . 64.3 110.67 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -76.16 132.14 39.79 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.52 0.728 . . . . 65.2 110.721 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -136.37 115.28 12.24 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.663 1.185 . . . . 74.13 108.254 172.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 29.7 p -71.36 87.2 0.84 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.27 0.628 . . . . 71.24 109.381 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 41.3 m -87.11 -43.78 12.02 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.333 -0.848 . . . . 54.43 110.593 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.537 HG23 ' H ' ' D' ' 129' ' ' ALA . 6.6 tt -157.23 -71.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 C-N-CA 123.22 0.608 . . . . 74.03 110.979 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 7' ' ' ALA . . . . . 0.506 ' H ' HG23 ' H' ' 6' ' ' ILE . . . 54.76 -158.66 0.19 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.456 1.102 . . . . 71.52 112.259 -175.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 8' ' ' LEU . . . . . 0.657 ' HG ' HD21 ' D' ' 128' ' ' LEU . 68.3 mt -141.83 179.57 6.78 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 125.099 1.36 . . . . 62.4 108.473 173.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.32 -179.18 3.98 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.014 0.925 . . . . 64.41 109.835 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 10' ' ' LEU . . . . . 0.461 HD21 HD22 ' D' ' 136' ' ' LEU . 79.8 mt -65.96 160.64 23.12 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.339 0.656 . . . . 70.14 111.299 175.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 72.3 mt -65.89 130.77 94.49 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-N 115.291 -0.868 . . . . 73.0 109.537 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -75.7 0.12 9.55 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.349 2.699 . . . . 74.32 113.331 -173.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 40.3 tp -153.43 139.85 18.66 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 107.465 -1.309 . . . . 45.44 107.465 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.78 130.7 43.81 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 107.498 -1.297 . . . . 72.25 107.498 175.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -70.6 161.89 29.89 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.762 0.825 . . . . 75.22 111.421 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 62.4 p -59.27 150.43 63.57 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.37 1.068 . . . . 74.51 111.805 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -79.97 154.34 22.68 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.535 2.157 . . . . 64.42 114.097 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 63.5 t -85.18 83.65 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 105.883 -1.895 . . . . 74.04 105.883 155.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 26.9 m 63.08 -79.77 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 124.604 1.162 . . . . 71.22 112.702 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.25 -7.77 34.66 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.169 0.988 . . . . 73.2 113.514 -170.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.19 -48.51 61.95 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.371 0.668 . . . . 53.35 112.389 -173.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.5 123.3 1.83 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.402 1.081 . . . . 71.44 108.911 176.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 42.4 p -70.83 131.57 87.49 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 109.927 -0.397 . . . . 55.34 109.927 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -56.0 -32.57 86.52 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.893 2.395 . . . . 65.54 112.196 170.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 C--O 1.248 1.002 0 N-CA-C 107.738 -1.208 . . . . 74.0 107.738 171.953 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.418 ' SD ' ' N ' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 107.923 -1.14 . . . . 75.13 107.923 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.418 ' N ' ' SD ' ' A' ' 1' ' ' MET . 19.8 m -47.22 134.4 11.17 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.933 1.293 . . . . 63.02 112.618 -174.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -68.48 91.25 0.4 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.264 0.626 . . . . 73.51 111.656 -172.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -146.2 -51.77 0.23 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.799 -1.091 . . . . 74.42 108.235 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -69.2 -53.85 17.86 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.081 -0.963 . . . . 75.11 110.239 176.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -89.54 -74.63 0.47 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.945 0.498 . . . . 71.53 110.574 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.9 m 64.51 127.61 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.879 1.272 . . . . 62.15 111.512 -169.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.434 ' HB3' ' HG2' ' C' ' 143' ' ' GLN . 39.6 tt0 -156.72 -62.77 0.1 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.145 0.578 . . . . 55.45 110.357 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.9 tpt -149.44 147.4 28.21 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.046 -0.524 . . . . 71.44 110.683 -164.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.5 m -135.06 104.61 6.0 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 106.939 -1.504 . . . . 31.55 106.939 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.663 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 35.7 t80 -133.25 138.61 46.54 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 123.98 0.912 . . . . 63.35 109.908 -171.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -152.92 132.96 13.38 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.201 1.0 . . . . 52.03 108.818 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.68 HG12 ' HD2' ' A' ' 84' ' ' PHE . 57.6 mt -93.49 121.25 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.104 -0.702 . . . . 65.13 109.104 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -85.3 -33.98 21.99 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.591 0.756 . . . . 64.25 110.328 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -171.06 142.47 1.82 Allowed 'General case' 0 C--N 1.352 0.717 0 O-C-N 123.411 0.445 . . . . 72.1 110.65 -174.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.458 HD12 ' HG3' ' C' ' 130' ' ' PRO . 78.6 mt -131.75 134.02 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 107.962 -1.125 . . . . 75.45 107.962 170.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -163.06 176.94 9.57 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 124.168 0.917 . . . . 64.32 110.838 -174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.4 p -100.06 121.52 41.52 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.178 -0.919 . . . . 72.21 109.035 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HG3' ' HA3' ' A' ' 81' ' ' GLY . 24.8 mtpt -84.28 -37.36 21.78 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.975 0.417 . . . . 74.43 109.935 178.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 24.4 t70 -143.28 135.28 26.84 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.122 -0.944 . . . . 74.53 109.288 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.485 HD13 ' SD ' ' B' ' 117' ' ' MET . 77.5 mt -128.74 140.02 50.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.217 -1.401 . . . . 72.24 107.217 175.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.9 t -151.31 110.98 4.02 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.071 0.462 . . . . 74.4 110.1 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -110.4 132.76 53.89 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.306 -1.368 . . . . 75.44 107.306 169.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -130.57 140.35 50.46 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.878 -1.156 . . . . 73.31 107.878 173.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.38 76.4 56.25 Favored Pre-proline 0 C--O 1.241 0.644 0 N-CA-C 106.208 -1.775 . . . . 71.25 106.208 169.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -62.5 -34.49 75.5 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.985 2.457 . . . . 65.15 112.794 -168.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 -109.1 22.79 15.43 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.467 -0.778 . . . . 63.01 110.224 -177.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.583 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -42.46 -53.84 8.74 Favored Pre-proline 0 N--CA 1.499 1.998 0 N-CA-C 114.097 1.147 . . . . 75.51 114.097 -170.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -65.17 -29.24 55.92 Favored 'Trans proline' 0 C--N 1.387 2.581 0 CA-C-N 121.174 1.455 . . . . 73.15 112.641 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -82.56 -35.21 27.4 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.485 1.114 . . . . 65.25 110.843 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.692 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.3 p -78.68 -20.95 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 115.125 -0.943 . . . . 73.23 112.54 -161.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -71.85 -19.13 62.01 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-O 120.972 0.415 . . . . 72.21 111.002 176.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -77.88 -25.31 48.48 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.464 1.105 . . . . 64.23 110.695 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -76.58 149.49 36.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.805 0.842 . . . . 74.23 110.863 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.2 138.1 58.43 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 124.007 0.817 . . . . 74.42 109.303 170.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -84.01 92.0 7.75 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.713 -0.477 . . . . 72.13 109.713 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -127.53 82.89 67.42 Favored Pre-proline 0 C--O 1.243 0.755 0 N-CA-C 107.962 -1.125 . . . . 71.02 107.962 170.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.95 125.13 7.81 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.48 2.12 . . . . 75.42 112.677 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -98.87 96.62 7.99 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 106.76 -1.57 . . . . 61.32 106.76 165.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.7 t -75.55 94.51 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 115.948 -0.569 . . . . 74.33 109.662 -175.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.473 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 14.2 mptt -78.68 111.74 15.08 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 107.641 -1.244 . . . . 73.51 107.641 170.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.98 138.52 47.28 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.707 0.803 . . . . 63.14 108.925 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.543 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 21.2 t70 -141.64 140.75 33.35 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.784 1.234 . . . . 71.34 108.483 -172.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.456 HD11 HD13 ' E' ' 8' ' ' LEU . 75.4 mt -123.16 136.95 54.99 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.13 0.572 . . . . 74.22 110.453 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 18.0 t70 -134.25 147.14 50.62 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 114.781 -1.099 . . . . 71.5 108.428 175.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.1 m -106.57 131.65 53.48 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.958 0.903 . . . . 73.11 110.258 -173.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.71 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -131.53 105.41 7.54 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.795 -1.187 . . . . 54.13 107.795 169.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.543 ' HB3' ' HB3' ' E' ' 17' ' ' PRO . 24.5 m -95.93 152.01 18.9 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.246 -1.02 . . . . 53.0 108.246 176.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 31.2 t -159.25 142.59 14.59 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.121 0.568 . . . . 71.41 109.961 -176.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -112.72 130.28 56.11 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.016 -1.105 . . . . 62.34 108.016 168.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.0 mt -104.26 -38.1 7.01 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.215 0.606 . . . . 75.24 110.524 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.516 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -156.05 -170.46 3.4 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.241 0.617 . . . . 53.22 110.381 -178.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.82 113.89 3.7 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.509 1.124 . . . . 44.44 110.023 173.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 85' ' ' SER . 32.1 m-20 69.71 -2.56 1.93 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.369 1.468 . . . . 65.33 112.906 -176.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.516 ' CG2' ' HB3' ' A' ' 52' ' ' ALA . 39.3 t -95.75 113.29 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 107.574 -1.269 . . . . 62.44 107.574 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -127.29 125.87 41.64 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.943 -0.762 . . . . 72.21 108.943 -176.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 40.5 tt0 -92.94 116.83 29.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.304 -0.862 . . . . 72.34 108.947 175.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.434 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 54.1 t -100.2 118.61 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 106.368 -1.716 . . . . 72.53 106.368 174.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.71 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 29.5 t -118.46 121.19 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.732 -0.84 . . . . 62.45 108.732 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.35 113.52 26.24 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.476 -0.935 . . . . 73.04 108.476 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.506 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 50.1 ttt180 -83.01 101.75 11.3 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.326 -0.991 . . . . 64.23 108.326 174.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.07 102.46 13.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.96 -1.126 . . . . 73.23 107.96 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 28.5 m -97.34 126.03 42.32 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.036 -0.727 . . . . 73.14 109.036 178.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.54 HG11 HD21 ' A' ' 126' ' ' LEU . 75.1 t -122.54 139.92 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.345 1.058 . . . . 72.32 108.265 176.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 17.5 m -136.03 141.69 44.35 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.375 -0.972 . . . . 75.24 108.375 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.61 117.2 32.86 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.619 -1.252 . . . . 71.31 107.619 171.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.6 m -113.06 126.36 55.39 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.878 0.471 . . . . 73.12 109.905 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 mt -98.92 83.25 2.88 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.42 1.088 . . . . 72.42 108.326 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.43 -83.84 1.09 Allowed Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.902 -0.59 . . . . 62.35 112.003 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.73 -25.07 3.72 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.113 0.965 . . . . 73.24 110.188 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -95.85 133.79 39.58 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.688 0.795 . . . . 63.44 109.945 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.5 m -74.34 139.48 44.18 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 122.852 0.461 . . . . 63.12 110.545 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.692 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -82.11 -61.31 1.94 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.696 0.798 . . . . 73.21 109.067 172.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -154.63 168.5 26.58 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.597 -1.183 . . . . 64.44 111.413 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 64' ' ' VAL . 54.5 tp -122.61 139.53 53.83 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.948 1.299 . . . . 62.44 108.376 172.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 79.2 m -140.81 98.18 3.34 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.48 1.112 . . . . 63.51 110.098 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -115.94 127.99 55.4 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.556 0.742 . . . . 73.04 109.25 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.2 t -133.03 113.47 19.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 C-N-CA 123.267 0.627 . . . . 74.41 109.668 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -85.59 89.0 7.6 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.07 -0.968 . . . . 72.35 108.845 173.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.458 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.9 tp-100 -80.83 107.5 13.7 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.331 -0.849 . . . . 74.21 109.298 -177.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.406 ' HA3' ' HG3' ' A' ' 19' ' ' LYS . . . -98.41 144.44 17.24 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 111.537 -0.625 . . . . 73.45 111.537 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.29 125.56 2.48 Favored Glycine 0 C--N 1.33 0.197 0 N-CA-C 111.54 -0.624 . . . . 62.2 111.54 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.1 mt -81.49 120.48 33.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.663 -0.866 . . . . 63.0 108.663 173.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.68 ' HD2' HG12 ' A' ' 13' ' ' ILE . 21.5 m-85 -136.23 120.44 17.83 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.553 -0.906 . . . . 73.33 108.553 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 66.7 m -89.84 113.27 24.83 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.456 -0.572 . . . . 71.41 109.456 171.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 pp -112.35 148.94 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.546 0.739 . . . . 75.13 109.996 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.56 -163.27 0.11 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.092 1.357 . . . . 72.42 108.926 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 121.24 -76.12 0.33 Allowed Glycine 0 C--N 1.348 1.238 0 N-CA-C 111.271 -0.732 . . . . 74.02 111.271 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.4 mt -130.11 -25.65 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.467 1.107 . . . . 73.41 109.396 175.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 61.01 -156.4 0.35 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.482 1.113 . . . . 70.23 110.654 -170.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.52 -129.47 16.85 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-O 119.451 -0.638 . . . . 33.22 112.592 177.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.4 t -71.25 -22.51 61.97 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.011 0.524 . . . . 72.11 111.559 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -67.55 -49.99 60.65 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.496 0.718 . . . . 60.11 109.738 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.49 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 24.1 ptt? -76.27 -27.89 56.84 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.014 -0.539 . . . . 70.04 110.537 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.89 -33.94 76.83 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.122 0.569 . . . . 51.31 111.228 -177.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -67.42 -35.61 79.61 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.858 -0.61 . . . . 71.4 110.582 171.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.682 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 71.5 m -71.08 -66.07 0.66 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.179 0.192 . . . . 61.43 111.215 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 94' ' ' MET . 3.4 pp -65.63 -25.4 67.35 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.455 0.702 . . . . 72.0 112.751 -175.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.81 -24.81 22.15 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-O 119.909 -0.384 . . . . 63.3 113.752 -176.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.523 ' HB2' ' CD2' ' A' ' 137' ' ' PHE . . . -129.46 -64.66 0.88 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 117.206 0.503 . . . . 74.55 111.301 -175.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.682 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 83.3 t80 -69.29 -60.47 2.32 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.303 1.041 . . . . 73.14 112.967 -164.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.7 m -62.29 -39.01 52.77 Favored Pre-proline 0 CA--C 1.569 1.701 0 N-CA-C 114.024 1.12 . . . . 44.15 114.024 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -66.49 -28.61 45.64 Favored 'Trans proline' 0 C--N 1.389 2.679 0 CA-C-N 121.366 1.524 . . . . 74.3 112.853 166.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -79.96 -14.64 58.44 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.358 0.663 . . . . 73.22 110.477 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 35.1 mm -68.2 -39.75 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 108.472 -0.936 . . . . 73.15 108.472 168.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.458 HD22 ' HG3' ' A' ' 80' ' ' GLN . 77.2 mt -78.29 -23.66 47.1 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.135 -0.939 . . . . 73.23 112.129 -177.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -59.45 -47.41 97.99 Favored Pre-proline 0 CA--C 1.571 1.759 0 CA-C-O 117.862 -1.066 . . . . 75.54 113.502 -174.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -63.15 -37.13 53.81 Favored 'Trans proline' 0 C--N 1.392 2.857 0 C-N-CA 121.988 1.792 . . . . 71.45 113.224 176.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -72.14 -38.02 69.32 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.131 0.572 . . . . 74.24 111.097 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.52 -42.06 71.76 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.242 0.617 . . . . 51.3 110.207 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.43 ' NH1' HG23 ' C' ' 105' ' ' ILE . 25.7 ttm180 -60.58 -44.82 95.79 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.171 0.919 . . . . 74.51 109.597 175.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -65.24 -43.58 90.92 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.136 0.974 . . . . 75.24 111.687 -176.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.403 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 47.5 t -61.7 -43.49 98.76 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.959 0.787 . . . . 73.31 109.816 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' ' 118' ' ' VAL . 67.4 mt -61.69 -47.81 91.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 124.436 1.094 . . . . 53.21 110.756 174.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.3 m -59.52 -39.23 83.22 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.376 1.07 . . . . 75.44 110.816 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 42.9 t -67.64 -46.71 71.67 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 115.184 -0.916 . . . . 74.41 110.605 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 18.2 mtp -59.21 -41.59 88.95 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.969 0.908 . . . . 55.23 111.504 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.506 HG21 HD23 ' A' ' 126' ' ' LEU . 74.0 t -65.8 -51.28 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.237 1.015 . . . . 73.34 110.631 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.4 t -66.11 -27.78 68.31 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.597 -0.728 . . . . 73.23 111.091 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 116' ' ' SER . 30.2 ttm-85 -77.59 -31.61 53.14 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.302 1.041 . . . . 74.23 109.334 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.425 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.42 11.27 61.63 Favored Glycine 0 C--N 1.356 1.657 0 CA-C-N 114.673 -1.148 . . . . 54.3 112.811 170.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.503 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.3 t 64.23 15.59 9.49 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 127.045 2.138 . . . . 64.22 113.925 172.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -80.61 153.12 73.25 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.06 0.544 . . . . 64.44 109.91 178.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.8 155.14 23.49 Favored 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 123.252 2.635 . . . . 62.04 113.569 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -56.41 120.21 7.3 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.383 1.073 . . . . 61.45 112.645 -170.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.54 HD21 HG11 ' A' ' 64' ' ' VAL . 64.0 tp -121.86 106.13 10.99 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.417 1.087 . . . . 64.21 109.894 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -127.09 126.15 42.49 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.947 0.899 . . . . 62.14 108.853 169.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.8 mp -72.15 142.11 49.1 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.215 -0.661 . . . . 71.41 109.215 174.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.595 ' HB2' ' HB ' ' E' ' 5' ' ' THR . . . -64.58 150.13 94.33 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 122.82 0.448 . . . . 72.13 110.171 176.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.721 ' HG3' ' HD2' ' C' ' 11' ' ' PHE . 44.7 Cg_endo -61.33 154.14 60.62 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.718 2.279 . . . . 74.33 112.779 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' E' ' 8' ' ' LEU . 22.1 m -119.17 116.25 50.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 109.079 -0.712 . . . . 73.42 109.079 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -94.09 64.85 3.35 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.333 0.587 . . . . 71.52 109.581 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -62.85 -46.87 85.89 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.336 -0.847 . . . . 73.04 109.855 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -57.25 -37.92 73.07 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.766 1.226 . . . . 61.4 112.19 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.71 -41.2 79.4 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.78 0.675 . . . . 72.2 110.913 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.65 -37.83 79.99 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.069 0.548 . . . . 74.4 111.528 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.523 ' CD2' ' HB2' ' A' ' 100' ' ' ALA . 45.4 m-85 -75.11 -26.55 59.34 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.184 0.594 . . . . 71.02 111.307 175.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.6 tpt -70.31 -39.24 74.94 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 109.475 -0.565 . . . . 54.12 109.475 173.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.671 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 92.7 m-20 -64.83 -45.73 84.91 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-N 115.026 -0.988 . . . . 73.1 110.177 175.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -62.04 -39.86 93.76 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.856 -0.611 . . . . 73.31 110.972 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.422 ' HG ' ' HG3' ' A' ' 142' ' ' GLN . 31.8 tp -69.45 -51.22 38.2 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 123.42 0.45 . . . . 53.24 112.049 -175.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.422 ' HG3' ' HG ' ' A' ' 141' ' ' LEU . 78.5 mt-30 -149.25 -15.12 0.29 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 112.766 0.654 . . . . 52.52 112.766 -170.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.671 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 49.8 mt-30 64.54 -71.51 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.805 1.242 . . . . 60.21 111.486 -169.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 65.18 100.43 0.04 OUTLIER 'General case' 0 C--N 1.357 0.913 0 C-N-CA 125.115 1.366 . . . . 54.32 110.242 -178.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -55.54 99.27 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.041 0.937 . . . . 74.14 110.771 -177.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -72.44 154.95 50.95 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.255 -0.884 . . . . 71.14 113.106 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.482 ' HG2' ' H ' ' A' ' 148' ' ' GLY . 22.9 tt0 -138.76 -149.48 0.3 Allowed 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 106.476 -1.675 . . . . 64.32 106.476 -177.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.482 ' H ' ' HG2' ' A' ' 147' ' ' GLU . . . 68.62 71.58 0.95 Allowed Glycine 0 C--N 1.351 1.368 0 CA-C-N 118.791 0.723 . . . . 62.12 111.852 175.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.1 t -155.95 133.61 11.05 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 107.735 -1.209 . . . . 70.54 107.735 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -126.37 138.21 53.54 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.436 -0.579 . . . . 71.34 109.436 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -76.59 83.51 3.26 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.406 1.083 . . . . 75.54 110.269 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -154.68 144.81 21.88 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.149 0.58 . . . . 72.23 110.978 173.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -151.06 144.92 25.15 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.521 1.129 . . . . 73.3 108.119 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -146.68 155.07 42.15 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.418 0.687 . . . . 71.24 110.112 -170.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.414 ' HA ' HE21 ' C' ' 50' ' ' GLN . . . . . . . . 0 C--O 1.249 1.045 0 C-N-CA 123.808 0.843 . . . . 53.21 109.63 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.416 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 110.34 -0.244 . . . . 72.45 110.34 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 38.9 t -157.93 70.76 0.58 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.588 0.708 . . . . 73.32 109.537 -176.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -93.03 86.54 5.44 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.935 0.894 . . . . 73.32 109.714 -177.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -89.43 69.51 8.0 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.67 0.748 . . . . 73.24 109.178 171.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -84.84 79.34 9.65 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.156 -1.053 . . . . 70.45 108.156 175.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.49 ' HB3' HG13 ' B' ' 89' ' ' ILE . 24.8 t-20 -89.01 156.35 18.92 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.468 -0.787 . . . . 74.01 110.145 -177.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.0 t -77.18 79.05 3.7 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.157 0.983 . . . . 72.04 111.357 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 64.76 12.97 8.1 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.788 1.235 . . . . 65.53 113.89 169.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.608 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 14.6 ptm 57.29 179.69 0.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 126.438 1.895 . . . . 71.32 114.65 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 40.5 m -133.34 144.85 49.89 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.459 1.103 . . . . 74.02 108.491 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.643 ' CZ ' HG13 ' B' ' 13' ' ' ILE . 0.3 OUTLIER -130.53 149.88 51.99 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 106.916 -1.513 . . . . 72.42 106.916 178.206 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.498 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.1 OUTLIER -156.29 101.11 2.03 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 123.339 0.399 . . . . 71.42 111.605 164.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.907 HD11 HD13 ' B' ' 105' ' ' ILE . 44.6 mt -51.99 123.1 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.855 -0.794 . . . . 75.43 108.855 162.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -100.33 -45.07 5.71 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.048 0.842 . . . . 73.35 109.607 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.503 ' HE ' HG21 ' A' ' 122' ' ' THR . 47.9 ttt180 -162.92 135.58 5.54 Favored 'General case' 0 C--N 1.349 0.565 0 N-CA-C 109.259 -0.645 . . . . 75.45 109.259 -177.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.5 mt -114.89 137.17 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 107.896 -1.149 . . . . 74.24 107.896 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -167.29 158.32 11.73 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.11 0.481 . . . . 73.14 111.632 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.448 HG21 HD11 ' B' ' 21' ' ' ILE . 87.1 m -85.29 131.13 34.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.708 -0.678 . . . . 74.42 109.184 171.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.583 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 45.9 mtpt -97.76 -32.63 11.63 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.212 0.605 . . . . 72.11 110.665 177.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -151.13 138.21 19.19 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.613 0.244 . . . . 53.34 111.627 -175.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.486 ' CD1' ' SG ' ' B' ' 113' ' ' CYS . 45.6 mm -129.52 141.99 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.129 1.371 . . . . 73.03 108.914 173.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.628 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.1 t -144.46 137.43 26.94 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.052 -1.092 . . . . 32.34 108.052 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.2 t80 -154.35 121.47 5.65 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.844 -1.169 . . . . 65.21 107.844 174.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -127.81 122.09 31.83 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.7 0.8 . . . . 72.13 109.572 176.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.713 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -115.72 87.26 17.47 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.986 -1.116 . . . . 41.32 107.986 169.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -71.39 -40.44 3.06 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.431 2.088 . . . . 71.45 111.706 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.487 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 3.4 m-20 -93.98 3.21 55.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.259 1.024 . . . . 74.3 110.244 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.713 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -31.07 -65.84 0.19 Allowed Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 125.825 1.65 . . . . 63.12 114.653 -178.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 37.9 Cg_exo -55.23 -39.21 92.2 Favored 'Trans proline' 0 C--N 1.398 3.138 0 C-N-CA 122.975 2.45 . . . . 72.4 113.564 -162.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -95.51 -41.15 9.09 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 114.689 -1.141 . . . . 71.12 111.848 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.497 HG22 HD12 ' B' ' 68' ' ' LEU . 4.0 p -60.4 -19.22 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.48 0 C-N-CA 123.076 0.55 . . . . 72.13 112.4 -166.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -56.27 -28.89 60.17 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.56 1.144 . . . . 74.41 113.036 175.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -63.63 -21.93 66.63 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.923 0.889 . . . . 64.3 111.67 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -81.48 90.81 6.25 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.354 0.662 . . . . 73.25 109.664 172.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -83.94 89.08 7.17 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.402 -0.817 . . . . 55.2 110.844 -174.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 30.6 p90 -165.37 170.27 14.8 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.401 1.08 . . . . 74.12 109.713 167.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -75.52 111.34 13.75 Favored Pre-proline 0 N--CA 1.48 1.039 0 N-CA-C 109.038 -0.727 . . . . 74.41 109.038 173.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.98 165.69 13.87 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.015 2.476 . . . . 62.31 114.207 -172.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -73.58 103.91 4.35 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.478 -1.237 . . . . 64.5 108.974 175.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.444 HG21 HD13 ' B' ' 126' ' ' LEU . 61.7 t -102.46 123.08 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 115.333 -0.849 . . . . 60.54 111.08 -170.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -107.54 123.26 48.19 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.41 1.084 . . . . 73.43 108.688 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.84 126.1 51.57 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.768 -0.827 . . . . 73.11 108.768 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -122.95 128.47 50.29 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.582 1.153 . . . . 61.5 108.671 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -100.09 164.04 12.15 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.84 -0.8 . . . . 71.31 108.84 172.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.635 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.0 t70 -156.03 152.06 27.63 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.293 -0.867 . . . . 71.53 109.3 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 91.3 m -107.57 115.9 30.97 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.32 -1.309 . . . . 72.34 108.893 -171.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -137.03 119.32 15.66 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 109.045 -0.724 . . . . 62.54 109.045 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.5 p -142.97 161.83 37.09 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.939 0.496 . . . . 65.24 110.399 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -152.22 142.64 22.58 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.583 0.753 . . . . 74.24 109.836 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.466 ' HB2' ' HB3' ' F' ' 21' ' ' ALA . 51.0 tt0 -94.87 112.45 24.17 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.466 -0.568 . . . . 72.41 109.466 175.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 77.8 mt -80.69 -45.46 17.11 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.488 0.661 . . . . 72.14 109.314 175.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.38 -177.46 6.61 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.387 -1.278 . . . . 43.22 109.018 176.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.79 123.55 25.81 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.946 -1.025 . . . . 73.42 108.328 173.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 67.53 23.52 8.92 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.121 1.368 . . . . 74.25 111.26 -175.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 92.2 t -139.51 103.49 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 107.912 -1.144 . . . . 60.44 107.912 168.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -125.96 138.12 53.74 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.833 -0.803 . . . . 71.04 108.833 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -107.9 103.5 12.76 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.459 -1.312 . . . . 73.32 107.459 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.584 HG21 ' HB2' ' B' ' 98' ' ' LEU . 95.1 t -101.06 118.87 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.65 1.18 . . . . 70.13 109.426 -173.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.59 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 15.3 t -104.34 141.22 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.315 1.046 . . . . 72.25 109.427 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 18.5 tp -118.87 112.7 20.0 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 108.676 -0.861 . . . . 64.43 108.676 172.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.635 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 20.0 ttm-85 -88.47 113.28 23.89 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.581 -0.525 . . . . 72.53 109.581 175.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 39.8 t -108.19 101.24 12.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 107.356 -1.35 . . . . 71.1 107.356 171.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 16.0 m -97.09 139.97 32.29 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.634 -0.876 . . . . 73.14 108.634 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.698 HG21 HG21 ' B' ' 114' ' ' ILE . 89.7 t -128.16 136.45 60.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 124.339 1.056 . . . . 71.51 109.295 -174.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 95.5 m -124.81 148.31 48.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.121 -1.066 . . . . 33.34 108.121 172.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.71 139.15 31.0 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.92 -0.77 . . . . 74.41 108.92 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.476 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 36.1 p -140.35 128.1 21.78 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 123.716 0.635 . . . . 70.2 110.331 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.497 HD12 HG22 ' B' ' 31' ' ' VAL . 45.0 mt -99.61 103.56 15.27 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.476 -1.305 . . . . 63.51 107.476 173.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.86 -113.96 4.01 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.202 -0.759 . . . . 43.14 111.202 -174.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -121.88 6.05 9.89 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.864 0.466 . . . . 63.22 109.815 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.487 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 4.0 pm0 -113.48 150.89 32.2 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.161 0.584 . . . . 62.2 109.892 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 45.4 m -67.97 118.73 11.55 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.245 1.018 . . . . 72.12 111.095 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.488 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -73.14 -63.92 1.08 Allowed 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.622 -0.881 . . . . 72.42 108.622 173.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -147.77 167.76 23.86 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 114.726 -1.124 . . . . 74.21 110.958 175.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.2 mt -129.13 141.34 51.21 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.278 -1.749 . . . . 74.32 106.278 173.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.408 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 42.0 t -147.44 158.88 44.16 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.346 -0.983 . . . . 61.43 108.346 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.628 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 42.8 tt0 -165.95 133.27 2.79 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.577 -0.897 . . . . 72.33 108.577 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 91.4 t -128.05 142.15 44.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.131 -1.063 . . . . 70.32 108.131 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -124.51 87.87 2.8 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.568 -1.271 . . . . 73.22 107.568 174.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -81.09 102.13 10.05 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.068 -0.969 . . . . 71.21 108.666 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.43 171.71 38.59 Favored Glycine 0 C--O 1.245 0.83 0 CA-C-N 116.017 -0.538 . . . . 62.41 111.935 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.46 132.12 2.31 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 111.083 -0.807 . . . . 72.01 111.083 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 50.2 mt -84.17 125.01 40.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.491 -1.299 . . . . 70.12 107.491 171.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -130.61 129.09 42.27 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.39 -0.966 . . . . 63.04 108.39 174.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 69.2 m -93.52 88.75 6.02 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.522 0.729 . . . . 62.32 109.34 170.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 37.2 pt -103.34 146.28 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 N-CA-C 107.73 -1.211 . . . . 61.44 107.73 176.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.11 164.62 34.17 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 112.722 0.638 . . . . 42.43 112.722 -169.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.29 -71.35 1.19 Allowed Glycine 0 C--N 1.348 1.246 0 CA-C-N 114.822 -1.081 . . . . 65.34 114.579 167.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.608 ' HB ' ' HB3' ' B' ' 9' ' ' MET . 0.4 OUTLIER -89.39 171.7 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 123.876 0.87 . . . . 72.21 111.602 -166.17 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -150.82 158.53 44.26 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.059 0.544 . . . . 41.05 111.865 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.53 -135.81 12.77 Favored Glycine 0 C--N 1.355 1.617 0 C-N-CA 124.789 1.185 . . . . 53.1 112.875 172.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 11.2 m -69.15 -26.59 64.95 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.57 0.7 . . . . 65.51 110.389 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.431 ' NE2' HG12 ' B' ' 89' ' ' ILE . 23.1 mt-30 -62.47 -44.07 97.29 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.539 -1.209 . . . . 70.22 111.315 177.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.485 ' SD ' HD21 ' B' ' 98' ' ' LEU . 0.0 OUTLIER -80.11 -26.88 39.29 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 110.363 -0.236 . . . . 61.33 110.363 178.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.09 -13.98 60.98 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.554 0.742 . . . . 53.02 111.55 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -77.38 -34.67 54.9 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.806 0.443 . . . . 70.55 110.672 169.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.531 ' SG ' ' HD2' ' B' ' 11' ' ' PHE . 49.2 t -76.33 -67.58 0.67 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 119.161 -0.447 . . . . 74.32 111.356 -175.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.584 ' HB2' HG21 ' B' ' 58' ' ' VAL . 2.3 pt? -91.88 -12.37 33.78 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 118.255 0.48 . . . . 73.41 111.809 -175.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . 0.447 ' HA2' ' HD1' ' F' ' 15' ' ' PHE . . . -97.76 -24.24 12.34 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-O 119.837 -0.424 . . . . 71.24 113.489 -177.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.2 -55.83 2.03 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.994 0.518 . . . . 70.33 111.197 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.476 ' O ' HG13 ' B' ' 105' ' ' ILE . 56.5 t80 -83.39 -37.06 23.79 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.558 0.577 . . . . 74.35 112.558 -169.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.441 ' HA ' HD12 ' B' ' 105' ' ' ILE . 86.9 m -64.47 -43.58 72.06 Favored Pre-proline 0 N--CA 1.482 1.149 0 CA-C-O 118.338 -0.839 . . . . 72.54 110.364 177.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.49 -41.83 43.2 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 122.531 2.154 . . . . 53.34 113.622 163.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -66.27 -33.8 76.55 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 124.119 0.968 . . . . 72.45 111.187 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.907 HD13 HD11 ' B' ' 13' ' ' ILE . 73.5 mt -71.91 -46.1 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.682 0.793 . . . . 73.51 110.082 177.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 93.6 mt -77.39 -19.53 56.05 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 114.727 -1.124 . . . . 75.23 111.173 -175.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -59.91 -52.05 76.36 Favored Pre-proline 0 N--CA 1.483 1.205 0 CA-C-O 117.585 -1.198 . . . . 73.02 113.41 -173.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.02 -27.41 42.51 Favored 'Trans proline' 0 C--N 1.385 2.489 0 CA-C-N 121.546 1.588 . . . . 54.44 112.516 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -70.62 -43.17 69.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.856 0.463 . . . . 63.03 110.302 175.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.73 -43.66 92.66 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.553 -0.749 . . . . 53.54 110.327 176.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -60.98 -49.44 77.42 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.717 1.207 . . . . 71.42 110.506 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -63.17 -32.94 74.45 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 123.903 0.752 . . . . 74.24 109.427 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.496 ' O ' ' HG2' ' B' ' 117' ' ' MET . 17.1 t -72.79 -41.77 64.64 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 123.406 0.442 . . . . 74.22 112.128 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.698 HG21 HG21 ' B' ' 64' ' ' VAL . 84.7 mt -60.6 -57.0 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 108.792 -0.818 . . . . 72.25 108.792 176.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.2 m -61.43 -25.79 67.44 Favored 'General case' 0 CA--C 1.554 1.111 0 O-C-N 124.776 1.297 . . . . 74.02 111.053 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 43.0 t -65.95 -51.36 59.26 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 123.186 0.594 . . . . 51.43 109.641 170.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.1 mmt -68.16 -30.17 69.23 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.188 0.595 . . . . 73.32 111.613 -177.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 114' ' ' ILE . 95.5 t -66.79 -44.3 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.31 1.044 . . . . 74.12 109.08 173.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.0 t -69.07 -29.38 67.48 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.924 -1.035 . . . . 34.02 111.48 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.44 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 89.2 mtt-85 -74.85 -37.44 62.23 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.517 0.727 . . . . 71.43 109.637 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.26 -5.74 77.79 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 123.84 0.713 . . . . 63.25 112.236 170.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 33.8 p 63.55 25.96 14.57 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.608 1.963 . . . . 63.25 112.953 174.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -81.09 159.78 67.34 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 124.511 1.124 . . . . 75.32 110.495 174.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.58 165.09 6.49 Favored 'Trans proline' 0 C--N 1.39 2.714 0 C-N-CA 123.5 2.8 . . . . 75.5 114.273 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.439 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 65.5 tp60 -61.07 136.71 58.16 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.388 -1.278 . . . . 64.41 112.135 -173.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.444 HD13 HG21 ' B' ' 40' ' ' VAL . 43.0 tp -136.25 121.78 19.52 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.887 0.875 . . . . 73.34 109.443 -178.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -132.83 129.07 38.02 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.873 0.869 . . . . 55.11 109.098 175.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.21 149.9 30.3 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.576 0.75 . . . . 64.32 110.261 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -73.04 129.08 86.87 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 123.429 0.692 . . . . 72.35 111.919 -172.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 24.1 Cg_exo -65.86 98.23 0.36 Allowed 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.274 2.649 . . . . 60.03 113.216 177.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 21.1 m -109.83 135.96 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 109.018 -0.734 . . . . 72.54 109.018 171.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -90.55 100.98 13.72 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.006 -1.109 . . . . 75.24 108.006 177.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -60.78 -43.04 98.58 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.79 0.836 . . . . 75.03 110.816 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -60.72 -43.13 98.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.851 -1.068 . . . . 64.12 111.339 -176.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.73 -34.87 64.96 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.45 0.7 . . . . 75.32 111.516 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 tt -59.8 -51.79 68.24 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.96 0.904 . . . . 73.24 110.363 -176.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -77.6 -16.84 58.34 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.611 0.765 . . . . 74.21 111.931 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 46.9 ttm -75.27 -32.04 60.93 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.78 0.832 . . . . 70.31 110.865 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -74.21 -14.31 60.92 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.408 0.683 . . . . 44.12 111.168 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -71.79 -32.42 67.61 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.963 0.505 . . . . 72.42 109.771 171.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 32.7 mt -88.75 14.93 9.1 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.143 0.977 . . . . 63.43 111.562 -175.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.81 131.44 46.85 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.672 1.189 . . . . 70.12 110.6 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -142.87 126.92 17.37 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.612 0.765 . . . . 61.14 109.379 178.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -132.5 152.02 51.7 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.019 0.928 . . . . 73.25 109.93 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.58 132.01 7.47 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.447 0.699 . . . . 45.12 110.019 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.84 139.56 14.54 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 123.442 0.464 . . . . 73.32 112.342 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.65 129.25 40.56 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 107.404 -1.332 . . . . 73.21 107.404 177.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -91.04 -129.75 4.45 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 113.746 0.259 . . . . 54.12 113.746 -171.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 11.7 t -149.77 170.47 18.66 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.513 1.125 . . . . 51.53 109.189 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.54 153.3 43.85 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.959 0.503 . . . . 55.52 109.976 175.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -116.25 166.45 12.02 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.576 0.751 . . . . 63.24 111.15 -173.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -134.76 154.72 51.47 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 107.84 -1.17 . . . . 75.24 107.84 172.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -158.52 113.8 2.61 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.672 -0.492 . . . . 71.22 109.672 172.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -85.58 124.26 31.93 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.059 0.944 . . . . 72.42 108.781 173.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.99 0 CA-C-O 118.979 -0.534 . . . . 73.34 109.787 -179.888 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 109.824 -0.435 . . . . 65.03 109.824 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.1 p -91.62 90.64 7.67 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 108.872 -0.788 . . . . 74.25 108.872 170.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 60.8 -172.17 0.14 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 124.829 1.251 . . . . 75.33 113.313 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -138.5 132.9 31.94 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.299 1.039 . . . . 52.31 108.846 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -160.5 -71.87 0.07 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 108.41 -0.959 . . . . 60.45 108.41 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -139.57 89.41 2.32 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 106.999 -1.482 . . . . 62.11 106.999 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 29.8 p -102.3 125.27 48.95 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.841 0.856 . . . . 64.43 111.558 -171.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -132.39 161.79 32.74 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.661 1.184 . . . . 73.32 108.025 169.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.467 ' SD ' HG12 ' C' ' 89' ' ' ILE . 15.0 tpt 61.82 113.56 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.208 1.003 . . . . 74.1 112.357 177.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 12.2 m -98.26 101.71 13.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.625 0.77 . . . . 55.34 109.139 174.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.721 ' HD2' ' HG3' ' A' ' 130' ' ' PRO . 71.0 t80 -115.15 129.23 56.61 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.868 0.867 . . . . 72.44 108.674 175.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.549 ' HB3' ' HB2' ' C' ' 85' ' ' SER . 38.9 tt0 -142.84 144.21 32.42 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.541 0.736 . . . . 74.44 109.403 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.446 HD13 HD11 ' C' ' 16' ' ' ILE . 27.6 mt -92.72 131.17 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 109.253 -0.647 . . . . 65.2 109.253 173.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.421 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.4 mm-40 -98.96 -43.21 6.79 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.954 0.902 . . . . 74.15 109.84 176.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -172.54 137.18 0.81 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.628 -0.879 . . . . 70.12 108.628 -168.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.446 HD11 HD13 ' C' ' 13' ' ' ILE . 85.5 mt -129.64 138.17 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.236 -1.024 . . . . 73.33 108.236 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.447 ' HB3' HG23 ' D' ' 122' ' ' THR . 37.1 p90 -170.4 166.64 8.5 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.672 0.749 . . . . 73.4 111.43 -173.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -84.77 109.81 18.34 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.922 -1.035 . . . . 74.24 109.045 174.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -64.33 -44.32 91.88 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 121.994 0.902 . . . . 64.31 108.844 174.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.0 t70 -147.97 149.89 33.0 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 113.392 -1.731 . . . . 73.13 109.254 -175.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 79.5 mt -140.3 145.43 26.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 125.798 1.639 . . . . 64.24 106.725 177.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.5 t -155.72 150.21 25.97 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.609 0.719 . . . . 72.44 110.057 176.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -148.49 147.94 29.68 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.323 -1.362 . . . . 63.52 107.323 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -144.08 133.52 23.34 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.562 1.145 . . . . 73.1 108.804 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.01 78.68 4.27 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 107.117 -1.438 . . . . 73.4 107.117 171.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.44 -11.2 22.55 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.948 2.432 . . . . 60.31 112.333 -174.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -126.08 26.39 6.53 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.09 1.356 . . . . 72.41 109.791 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.83 -58.5 5.34 Favored Pre-proline 0 CA--C 1.57 1.724 0 CA-C-O 117.831 -1.08 . . . . 72.23 113.574 -172.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -59.95 -38.69 77.13 Favored 'Trans proline' 0 C--N 1.401 3.314 0 C-N-CA 122.162 1.908 . . . . 74.34 112.255 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -70.72 -39.79 73.17 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.331 -0.85 . . . . 71.34 111.831 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.701 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.5 p -78.78 -17.29 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.428 0 N-CA-C 112.224 0.453 . . . . 64.11 112.224 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -66.2 -37.21 85.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.194 -0.316 . . . . 74.53 111.538 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -85.19 13.49 6.29 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.493 0.717 . . . . 70.43 111.709 -176.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.62 169.29 9.61 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.545 1.138 . . . . 72.45 110.308 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -74.7 122.94 24.02 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.402 -0.592 . . . . 71.42 109.402 171.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -84.1 92.26 7.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.511 0.724 . . . . 73.33 110.49 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -146.95 80.96 9.26 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 106.928 -1.508 . . . . 71.54 106.928 168.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -88.22 155.35 6.86 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.597 2.198 . . . . 72.22 112.843 -176.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -86.02 99.49 11.5 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 106.548 -1.649 . . . . 62.43 106.548 166.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.427 ' HB ' HD11 ' G' ' 6' ' ' ILE . 43.9 t -74.77 96.55 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 107.826 -1.175 . . . . 73.04 107.826 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.568 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 88.4 mttt -93.81 100.74 12.88 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.209 -1.404 . . . . 74.0 107.209 178.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.569 HD13 ' HA ' ' G' ' 8' ' ' LEU . 2.0 pp -88.71 149.7 23.35 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.187 0.518 . . . . 73.01 109.794 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.645 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 26.1 t70 -144.36 144.84 31.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.306 -0.861 . . . . 51.23 108.964 -176.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.66 142.39 41.15 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.387 0.675 . . . . 74.55 109.782 174.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 25.8 t70 -137.66 146.54 43.98 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.363 1.065 . . . . 74.21 108.605 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . 0.564 HG21 HD23 ' G' ' 11' ' ' LEU . 47.3 p -115.53 120.52 39.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.94 0.496 . . . . 75.15 111.283 -170.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.31 160.12 35.9 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.183 0.993 . . . . 74.11 109.447 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 35.4 p -164.55 166.46 20.3 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.908 0.385 . . . . 64.34 112.006 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 83.9 p -151.92 152.81 33.02 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.346 1.058 . . . . 75.22 108.993 171.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.414 HE21 ' HA ' ' A' ' 155' ' ' ALA . 54.0 tt0 -102.22 124.08 47.18 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.498 -0.927 . . . . 74.22 108.498 172.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.524 HD11 HD12 ' C' ' 83' ' ' ILE . 51.2 mt -101.97 -32.27 10.27 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.251 0.62 . . . . 71.25 111.12 -174.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.52 -166.04 1.28 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.351 0.66 . . . . 74.21 110.686 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -63.36 115.62 4.76 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 124.005 0.816 . . . . 61.41 109.42 173.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 67.49 -5.25 0.79 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 125.017 1.327 . . . . 52.31 113.113 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 67.4 t -92.64 106.7 18.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.54 -1.281 . . . . 75.44 107.54 -177.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -124.64 128.65 49.19 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.521 -1.289 . . . . 61.45 107.521 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -81.36 119.31 23.52 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.001 -1.0 . . . . 72.25 108.547 172.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.467 HG13 ' HE2' ' G' ' 15' ' ' PHE . 65.5 t -96.45 120.44 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.339 -1.356 . . . . 50.41 107.339 171.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 55.7 t -115.09 132.76 63.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 108.671 -0.863 . . . . 71.23 108.671 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 29.9 tp -124.18 117.2 24.07 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.304 -0.999 . . . . 74.23 108.304 170.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 33.3 ttm180 -81.74 135.76 35.48 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.098 0.959 . . . . 70.53 108.955 172.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.502 ' HB ' HD11 ' C' ' 114' ' ' ILE . 14.9 t -122.89 130.06 74.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.258 -1.386 . . . . 63.21 107.258 169.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.645 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 18.0 m -129.65 116.62 19.11 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.534 -0.913 . . . . 74.24 108.534 -177.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.474 HG21 HG21 ' C' ' 114' ' ' ILE . 59.5 t -108.53 113.3 43.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 124.202 1.001 . . . . 61.1 108.978 -173.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 2.5 m -101.62 131.1 48.01 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.936 -0.764 . . . . 72.14 108.936 175.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.2 109.62 16.06 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.434 -1.691 . . . . 64.43 106.434 174.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 24.7 m -131.47 125.46 32.55 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 117.791 0.269 . . . . 71.23 110.358 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.7 mt -85.76 49.59 1.8 Allowed 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.497 1.119 . . . . 52.42 108.96 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.62 -114.64 4.96 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 110.096 -1.202 . . . . 74.41 110.096 -169.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -91.97 -24.08 19.36 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.36 0.664 . . . . 64.41 110.17 172.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -67.72 101.91 1.12 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.19 -0.67 . . . . 65.13 109.19 176.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 90.3 m -70.78 122.62 20.2 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.617 -0.512 . . . . 72.12 109.617 175.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.701 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.47 -56.92 4.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.291 -1.003 . . . . 52.42 108.291 171.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -159.48 163.32 35.41 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.29 -0.868 . . . . 65.43 111.352 177.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -127.57 131.68 49.96 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 105.966 -1.864 . . . . 75.14 105.966 164.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.442 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.6 t -137.73 111.19 8.02 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.111 -0.7 . . . . 51.05 109.111 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . 0.438 ' HB2' HG23 ' C' ' 63' ' ' THR . 33.0 tt0 -119.51 116.59 26.39 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.31 0.644 . . . . 63.23 109.841 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -117.11 132.59 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 108.531 -0.914 . . . . 75.23 108.531 172.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.544 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 44.3 mt-30 -105.24 100.46 10.05 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.19 -1.041 . . . . 75.1 108.19 172.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -87.71 121.33 30.0 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.609 -0.723 . . . . 73.44 109.584 -177.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.88 146.92 18.87 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 112.042 -0.423 . . . . 41.25 112.042 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.505 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -143.12 124.58 2.36 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.435 -1.066 . . . . 75.33 110.435 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.524 HD12 HD11 ' C' ' 51' ' ' LEU . 16.6 mm -81.04 123.55 37.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.984 -1.117 . . . . 44.54 107.984 176.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -132.47 135.56 46.11 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.738 0.415 . . . . 72.23 110.646 -174.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . 0.639 ' HB3' ' HG3' ' E' ' 2' ' ' LYS . 43.3 m -83.96 99.91 10.69 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 107.667 -1.235 . . . . 62.15 107.667 167.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 3.6 tt -120.0 117.76 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.519 1.128 . . . . 74.54 110.592 -172.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.24 169.89 16.99 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.458 1.103 . . . . 54.32 109.715 177.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 122.63 -60.5 0.57 Allowed Glycine 0 N--CA 1.472 1.094 0 N-CA-C 112.5 -0.24 . . . . 32.23 112.5 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.467 HG12 ' SD ' ' C' ' 9' ' ' MET . 23.5 pt -96.4 173.44 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.113 0.565 . . . . 64.35 111.015 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -153.47 160.39 42.54 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.833 0.853 . . . . 53.13 110.539 -172.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.04 -145.87 30.16 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.762 -0.654 . . . . 62.14 111.646 175.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 46.6 p -63.88 -17.38 63.12 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.082 0.553 . . . . 74.13 112.011 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -67.3 -51.01 57.83 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 123.403 0.681 . . . . 75.32 110.458 173.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.502 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 7.0 ptp -70.24 -37.14 74.9 Favored 'General case' 0 C--N 1.362 1.14 0 N-CA-C 109.839 -0.43 . . . . 64.33 109.839 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.67 -35.88 66.48 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.525 0.73 . . . . 73.12 110.988 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.52 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 17.5 t-80 -71.35 -39.64 71.18 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.397 1.079 . . . . 74.03 111.518 173.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -71.28 -62.0 1.56 Allowed 'General case' 0 N--CA 1.481 1.106 0 O-C-N 122.094 -0.379 . . . . 62.4 111.613 -175.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' C' ' 94' ' ' MET . 1.2 pp -71.14 -21.94 62.12 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.99 0.516 . . . . 64.44 112.34 -178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.44 4.97 62.36 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 119.594 -0.559 . . . . 52.25 113.466 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -149.98 -60.14 0.2 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 117.917 0.859 . . . . 75.01 112.348 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -66.7 -51.56 54.6 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.672 0.789 . . . . 72.43 112.087 -175.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 19.9 m -63.87 -44.77 80.14 Favored Pre-proline 0 CA--C 1.57 1.719 0 C-N-CA 123.738 0.815 . . . . 51.22 112.805 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.405 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 22.5 Cg_exo -68.1 -22.82 40.57 Favored 'Trans proline' 0 C--N 1.397 3.08 0 C-N-CA 122.298 1.999 . . . . 71.12 113.347 171.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -71.16 -32.12 68.53 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 122.974 0.51 . . . . 75.11 110.673 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.43 HG23 ' NH1' ' A' ' 111' ' ' ARG . 37.7 mm -59.33 -42.01 85.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.725 0.81 . . . . 42.43 109.884 171.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.505 HD21 ' HA3' ' C' ' 82' ' ' GLY . 93.8 mt -80.22 -21.22 43.09 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.732 -1.122 . . . . 74.14 112.595 -172.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -53.79 -50.84 81.44 Favored Pre-proline 0 CA--C 1.567 1.618 0 CA-C-O 117.555 -1.212 . . . . 74.4 113.377 -175.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.77 -33.19 96.52 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 122.145 1.897 . . . . 74.22 114.134 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -73.07 -44.46 60.57 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.077 0.551 . . . . 72.44 110.03 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.22 -40.01 88.63 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.242 -0.89 . . . . 64.3 110.261 173.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -59.09 -53.8 54.25 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.962 1.305 . . . . 71.45 110.765 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.79 -36.79 78.72 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 123.358 0.411 . . . . 70.24 109.903 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 20.3 t -65.73 -32.37 73.88 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.978 0.511 . . . . 74.32 111.495 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.502 HD11 ' HB ' ' C' ' 62' ' ' VAL . 81.5 mt -74.1 -55.8 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.187 0.595 . . . . 75.22 109.859 173.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.8 m -61.37 -27.44 68.52 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.452 0.701 . . . . 54.21 110.964 -174.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.7 t -65.65 -50.17 65.96 Favored 'General case' 0 C--O 1.214 -0.77 0 C-N-CA 123.782 0.833 . . . . 44.14 109.034 171.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.534 ' HG3' HD12 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.7 -33.06 74.33 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.218 1.007 . . . . 72.03 112.364 178.286 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.412 HG23 ' O ' ' C' ' 114' ' ' ILE . 66.4 t -67.85 -41.48 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 123.493 0.717 . . . . 63.33 109.066 174.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 39.9 t -74.07 -23.46 59.37 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.528 1.131 . . . . 41.1 111.986 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -78.12 -39.6 40.74 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.719 -0.845 . . . . 64.14 108.719 176.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.38 -0.65 62.7 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.549 -0.751 . . . . 43.13 112.347 167.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 31.4 p 62.24 29.73 17.46 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.695 1.998 . . . . 71.34 113.653 169.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -81.84 156.29 70.12 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 123.627 0.771 . . . . 72.33 108.947 169.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.439 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 25.3 Cg_endo -62.12 168.07 9.78 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.54 2.16 . . . . 62.54 112.485 173.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -59.79 110.47 1.17 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.279 -0.873 . . . . 64.22 112.17 -173.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.41 86.38 2.28 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 105.893 -1.891 . . . . 54.41 105.893 171.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -107.93 108.42 19.56 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.565 -0.902 . . . . 70.13 108.565 -173.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.432 HD23 ' N ' ' C' ' 129' ' ' ALA . 3.5 tt -73.03 144.75 47.03 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.485 0.714 . . . . 74.42 109.796 -174.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.432 ' N ' HD23 ' C' ' 128' ' ' LEU . . . -60.47 157.92 33.01 Favored Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 124.706 1.202 . . . . 62.41 112.417 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.458 ' HG3' HD12 ' A' ' 16' ' ' ILE . 43.6 Cg_exo -57.65 110.53 0.63 Allowed 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 122.735 2.29 . . . . 71.34 112.285 173.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.666 HG11 ' HB2' ' G' ' 8' ' ' LEU . 20.4 t -98.73 108.41 22.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.769 -0.826 . . . . 75.35 108.769 177.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -107.13 90.8 3.41 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 107.836 -1.172 . . . . 72.15 107.836 173.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -55.55 -41.39 73.16 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.044 0.84 . . . . 75.43 110.578 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.4 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 7.7 t70 -69.13 -48.6 62.01 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 114.328 -1.305 . . . . 64.03 111.458 -173.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.98 -44.31 55.12 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.524 -1.217 . . . . 64.14 111.591 -174.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.7 -32.67 73.81 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.66 0.784 . . . . 71.1 110.581 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -62.15 -44.13 97.3 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.432 0.693 . . . . 73.5 110.869 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 56.8 mtt -75.9 -45.66 34.15 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.564 -0.744 . . . . 61.33 110.627 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -59.09 -37.99 78.43 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.617 1.167 . . . . 73.33 111.419 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -48.86 -79.06 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.481 1.513 . . . . 74.5 111.519 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 53.4 tp -57.83 -40.69 80.64 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.615 0.766 . . . . 73.2 112.239 -177.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -78.55 -81.42 0.1 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.032 0.382 . . . . 72.21 112.032 -172.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . 0.434 ' HG2' ' HB3' ' A' ' 8' ' ' GLU . 2.6 mp0 -99.06 -160.22 0.79 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.891 0.876 . . . . 74.32 110.297 -173.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -139.83 137.22 34.78 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.052 0.541 . . . . 73.43 109.912 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.45 99.25 2.43 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.891 -0.781 . . . . 24.51 108.891 172.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.04 169.9 55.05 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 123.406 0.441 . . . . 71.54 113.123 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -68.91 114.82 7.56 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.497 0.719 . . . . 74.51 109.768 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.53 139.98 19.26 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 111.233 -0.747 . . . . 64.21 111.233 174.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 27.4 m -65.49 137.15 57.24 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.727 0.811 . . . . 54.22 111.167 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -108.24 123.1 48.25 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.339 -0.986 . . . . 70.23 108.339 174.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -66.76 91.56 0.2 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.077 0.951 . . . . 73.43 111.792 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -86.41 70.21 10.47 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.354 0.661 . . . . 74.05 109.647 176.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -93.91 -178.06 4.54 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.892 0.877 . . . . 64.53 111.115 -176.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -88.46 -47.91 8.0 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.318 -0.623 . . . . 74.24 109.318 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.256 0 C-N-CA 124.462 1.105 . . . . 63.15 109.641 173.208 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 109.594 -0.521 . . . . 72.12 109.594 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 17.2 t -164.58 12.6 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.746 0.818 . . . . 71.34 110.149 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.61 104.78 7.41 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.993 0.917 . . . . 72.51 110.328 -171.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -137.54 154.35 49.84 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.553 1.141 . . . . 75.24 109.135 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -155.64 168.43 27.19 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 120.991 0.424 . . . . 63.2 111.948 -175.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -78.09 139.6 39.06 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.049 -0.978 . . . . 63.32 109.785 174.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -159.51 -174.21 4.54 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.838 0.855 . . . . 62.51 109.772 -175.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -86.25 28.6 0.82 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.341 1.057 . . . . 52.14 111.927 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.465 ' HG3' HD11 ' D' ' 89' ' ' ILE . 22.9 ttt -29.39 123.57 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 126.193 1.797 . . . . 72.3 114.413 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 57.0 m -111.01 139.2 46.56 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.864 0.865 . . . . 70.22 109.449 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -157.73 96.72 1.52 Allowed 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.721 -1.214 . . . . 73.32 107.721 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -113.86 115.7 28.15 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.477 -0.935 . . . . 65.53 108.477 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.464 HG21 HD11 ' D' ' 16' ' ' ILE . 46.8 mt -71.32 123.06 24.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.913 -0.773 . . . . 61.31 108.913 177.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.441 HE22 HG13 ' D' ' 55' ' ' VAL . 51.7 mt-30 -93.41 -34.05 13.6 Favored 'General case' 0 C--O 1.246 0.881 0 O-C-N 123.59 0.557 . . . . 72.55 110.664 178.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -173.55 144.52 1.13 Allowed 'General case' 0 C--N 1.364 1.224 0 N-CA-C 112.303 0.483 . . . . 75.22 112.303 -170.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.464 HD11 HG21 ' D' ' 13' ' ' ILE . 3.6 mp -123.34 136.92 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 107.243 -1.391 . . . . 71.32 107.243 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.4 ' HE1' HG13 ' D' ' 83' ' ' ILE . 24.6 p90 -164.61 152.31 11.86 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.64 0.733 . . . . 73.42 110.649 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 56.7 p -84.2 117.47 23.52 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.532 -1.213 . . . . 72.1 108.525 174.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -85.53 -18.02 34.66 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.785 0.326 . . . . 73.2 110.21 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -166.24 140.49 4.33 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.429 1.092 . . . . 62.22 108.283 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.534 HD12 ' HG3' ' C' ' 117' ' ' MET . 77.5 mt -137.18 150.14 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 108.12 -1.067 . . . . 75.44 108.12 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.9 t -156.8 103.43 2.07 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.299 1.04 . . . . 71.01 109.298 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.539 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 80.8 t80 -109.09 122.1 46.56 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 106.366 -1.716 . . . . 73.23 106.366 171.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -130.48 110.47 11.48 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.502 -0.555 . . . . 65.23 109.502 -172.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.4 89.45 4.89 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 108.234 -1.025 . . . . 52.53 108.234 173.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.22 -38.15 3.97 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.555 2.17 . . . . 55.03 112.289 -172.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 58.2 m-20 -101.7 11.24 39.15 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.899 0.88 . . . . 71.1 110.072 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -20.63 -68.03 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 116.151 1.908 . . . . 73.05 116.151 -168.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.415 ' HB3' HD11 ' C' ' 83' ' ' ILE . 43.6 Cg_endo -79.94 -18.24 10.33 Favored 'Trans proline' 0 C--N 1.379 2.167 0 CA-C-N 122.844 2.052 . . . . 34.42 114.029 -173.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.459 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 7.7 t-160 -76.68 -39.79 50.95 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.511 1.124 . . . . 64.31 109.576 176.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.695 HG22 HD12 ' D' ' 68' ' ' LEU . 11.3 p -82.79 -18.01 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 CA-C-N 115.799 -0.637 . . . . 61.3 111.296 -172.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -65.86 -22.51 66.53 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 112.094 0.405 . . . . 71.55 112.094 177.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.459 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 58.8 mt-30 -60.31 -20.23 58.42 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.1 0.96 . . . . 73.22 111.26 177.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.417 ' HB2' HD13 ' D' ' 68' ' ' LEU . 93.1 mttt -95.92 102.14 13.9 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.659 1.183 . . . . 71.4 109.816 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -101.16 87.23 3.2 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.759 0.424 . . . . 74.23 110.151 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -158.66 179.79 8.78 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.176 0.991 . . . . 73.05 108.599 167.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -67.19 112.34 9.69 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 123.622 0.769 . . . . 73.25 110.441 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -56.39 141.62 89.26 Favored 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 122.736 2.291 . . . . 61.31 112.016 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 42.6 mt-10 -57.84 118.41 5.3 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.59 1.181 . . . . 73.13 111.291 -177.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 25.6 t -93.58 107.18 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 107.568 -1.271 . . . . 73.41 107.568 -172.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.442 ' HE3' ' HB3' ' D' ' 39' ' ' GLU . 31.1 mmtp -125.98 118.92 26.4 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.555 -1.276 . . . . 75.04 107.555 -177.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.91 115.55 27.62 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.203 0.601 . . . . 74.22 109.725 -174.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.627 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.3 m-20 -107.85 119.25 38.93 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.425 1.09 . . . . 75.43 108.066 172.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.44 HD23 ' HB3' ' H' ' 9' ' ' ALA . 3.4 mm? -111.58 152.88 27.08 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.754 0.421 . . . . 73.1 110.537 -175.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -157.01 152.82 27.05 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 107.881 -1.155 . . . . 64.52 107.881 177.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 57.9 p -118.78 149.21 41.88 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.871 0.468 . . . . 71.23 111.611 -170.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.54 164.03 38.42 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.426 1.09 . . . . 74.21 109.038 172.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 50.8 p -176.95 177.5 1.28 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.702 0.801 . . . . 62.32 110.03 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 50.8 p -173.02 143.83 1.2 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.164 0.986 . . . . 35.41 109.889 169.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -76.3 116.71 17.25 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.794 -1.187 . . . . 74.14 107.794 167.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.487 HD11 ' HB2' ' D' ' 57' ' ' GLU . 61.3 mt -88.94 -26.66 21.42 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.997 0.519 . . . . 50.11 110.054 -175.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -174.06 -172.98 0.76 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.692 1.197 . . . . 72.4 109.777 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -68.88 126.75 30.74 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.477 -0.783 . . . . 71.43 109.131 174.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.537 ' HA ' HG21 ' H' ' 19' ' ' THR . 9.1 m-20 69.08 -2.36 1.82 Allowed 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 124.956 1.302 . . . . 73.24 113.059 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.441 HG13 HE22 ' D' ' 14' ' ' GLN . 94.6 t -110.47 124.55 67.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.029 -1.1 . . . . 74.23 108.029 176.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.628 ' HB3' HD13 ' D' ' 86' ' ' ILE . 66.4 t80 -146.57 137.43 24.1 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.371 0.605 . . . . 72.03 110.142 -177.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.487 ' HB2' HD11 ' D' ' 51' ' ' LEU . 21.9 tt0 -104.13 137.61 41.83 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.964 1.306 . . . . 71.13 110.029 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.88 126.19 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 108.058 -1.09 . . . . 63.24 108.058 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.442 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 25.9 t -124.12 131.82 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.448 0.699 . . . . 70.22 109.388 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.438 HD23 HD12 ' D' ' 106' ' ' LEU . 3.9 mm? -123.81 122.14 37.24 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.518 -0.549 . . . . 61.51 109.518 173.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' D' ' 79' ' ' GLN . 12.5 ttm180 -83.54 106.39 15.24 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.387 -0.968 . . . . 74.34 108.387 170.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -92.02 125.95 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 107.601 -1.259 . . . . 74.41 107.601 169.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.627 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 22.1 m -123.83 133.34 53.81 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.041 -0.725 . . . . 33.54 109.041 177.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.415 HG21 HG21 ' D' ' 114' ' ' ILE . 73.1 t -114.19 101.36 12.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 107.85 -1.167 . . . . 72.11 107.85 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 78.6 m -90.58 92.43 8.85 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.568 -1.271 . . . . 65.14 107.568 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -100.98 135.93 41.64 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 114.831 -1.077 . . . . 64.42 109.964 -175.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.467 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 70.1 m -143.21 133.6 24.74 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.005 0.522 . . . . 72.5 110.699 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.695 HD12 HG22 ' D' ' 31' ' ' VAL . 77.2 mt -101.0 110.04 22.02 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.867 -1.16 . . . . 64.02 107.867 172.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.19 -114.02 3.75 Favored Glycine 0 C--N 1.344 0.981 0 O-C-N 123.237 0.336 . . . . 53.32 113.038 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.67 4.46 12.32 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.607 0.763 . . . . 74.12 110.576 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.459 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 12.7 pt-20 -120.68 156.11 32.44 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.567 0.747 . . . . 75.32 109.229 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 43.8 m -70.26 135.32 48.86 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 123.676 0.61 . . . . 61.3 110.545 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.655 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -85.91 -65.53 1.0 Allowed 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.062 -1.459 . . . . 62.21 107.062 172.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -157.43 148.57 21.63 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.606 -1.179 . . . . 73.02 110.342 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 60.1 mt -111.86 107.77 16.92 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 105.908 -1.886 . . . . 64.14 105.908 171.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' D' ' 114' ' ' ILE . 46.3 t -116.38 105.53 12.62 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.305 -0.998 . . . . 51.02 108.305 -171.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . 0.473 ' HB2' HG23 ' D' ' 63' ' ' THR . 41.8 tt0 -130.12 131.57 45.76 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.137 0.975 . . . . 64.04 108.994 -165.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.4 t -140.0 119.21 12.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 108.359 -0.978 . . . . 75.34 108.359 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.405 ' HA ' ' HA ' ' D' ' 61' ' ' ARG . 71.1 mt-30 -86.93 80.89 8.3 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 107.365 -1.346 . . . . 70.14 107.365 171.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -81.76 106.55 13.79 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 113.527 -1.669 . . . . 72.44 108.901 -172.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -110.36 158.46 14.42 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 115.844 -0.616 . . . . 74.11 112.442 -176.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.93 132.18 3.9 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.828 -0.509 . . . . 74.35 111.828 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.4 HG13 ' HE1' ' D' ' 17' ' ' TYR . 74.5 mt -89.4 130.8 38.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.229 -1.026 . . . . 74.53 108.229 174.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -133.36 166.84 21.58 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 123.512 0.508 . . . . 73.32 110.466 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.0 m -114.69 107.06 14.96 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.036 0.934 . . . . 70.24 108.526 175.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.628 HD13 ' HB3' ' D' ' 56' ' ' TYR . 4.2 mp -109.23 118.13 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 C-N-CA 123.402 0.681 . . . . 65.45 109.223 -176.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.7 139.65 16.33 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.707 0.803 . . . . 60.1 110.326 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.45 21.92 49.5 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-O 120.221 -0.21 . . . . 61.34 113.099 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.465 HD11 ' HG3' ' D' ' 9' ' ' MET . 3.6 mp -116.34 146.72 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.681 0.792 . . . . 72.43 109.035 176.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -149.69 153.85 37.62 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.411 1.084 . . . . 52.31 110.411 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' D' ' 94' ' ' MET . . . 76.98 -133.81 13.97 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 114.835 0.694 . . . . 55.41 114.835 167.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.8 m -85.68 -11.66 53.19 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.259 1.024 . . . . 75.31 110.955 -178.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -57.11 -40.32 76.8 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.314 1.046 . . . . 54.44 110.618 176.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.43 ' HG2' ' O ' ' D' ' 91' ' ' GLY . 23.5 ptt? -74.45 -27.07 60.43 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.572 -0.74 . . . . 73.55 111.72 177.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.11 -34.88 77.22 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.523 0.329 . . . . 44.22 110.608 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -79.7 -32.0 41.3 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.988 -0.551 . . . . 60.33 110.621 174.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.7 t -63.1 -51.12 67.84 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.176 0.512 . . . . 62.4 110.705 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.672 HD11 HG23 ' H' ' 18' ' ' VAL . 57.8 mt -82.03 -28.52 32.45 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.096 -0.956 . . . . 63.41 111.252 -174.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.6 11.36 72.29 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-O 119.61 -0.55 . . . . 53.45 113.519 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.82 -65.3 0.11 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 117.728 0.764 . . . . 60.02 111.84 -177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -73.82 -42.26 61.15 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 112.664 0.616 . . . . 74.2 112.664 -168.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.456 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 62.3 m -64.13 -46.48 79.92 Favored Pre-proline 0 CA--C 1.566 1.562 0 CA-C-O 118.55 -0.738 . . . . 74.41 111.904 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.456 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 31.3 Cg_exo -62.42 -28.64 78.34 Favored 'Trans proline' 0 C--N 1.4 3.263 0 C-N-CA 122.423 2.082 . . . . 75.11 113.078 169.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -69.33 -30.3 68.31 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.579 0.751 . . . . 74.54 111.063 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.5 mm -69.12 -36.47 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 121.42 0.628 . . . . 63.32 109.84 172.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.438 HD12 HD23 ' D' ' 60' ' ' LEU . 68.6 mt -86.16 -10.61 54.46 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.27 -0.877 . . . . 44.34 111.819 -176.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -66.0 -49.89 55.0 Favored Pre-proline 0 CA--C 1.565 1.558 0 CA-C-O 117.935 -1.031 . . . . 75.32 112.667 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -60.61 -32.13 93.0 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 122.272 1.981 . . . . 64.21 112.932 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -81.02 -35.24 32.14 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.382 -0.826 . . . . 73.01 112.206 -176.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.17 -52.0 61.09 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.003 -1.11 . . . . 64.21 108.003 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -49.28 -50.01 40.99 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.923 1.389 . . . . 72.13 111.84 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -67.05 -50.38 62.1 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.718 0.636 . . . . 65.33 111.254 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -58.19 -44.17 87.95 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 124.178 0.924 . . . . 41.33 110.611 -177.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.54 ' HA ' ' SG ' ' D' ' 76' ' ' CYS . 91.0 mt -58.53 -63.06 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 124.463 1.105 . . . . 74.31 110.862 173.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 92.0 m -55.04 -38.33 67.84 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.225 1.01 . . . . 71.43 112.287 -173.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 42.0 t -67.89 -42.81 80.63 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.409 -0.814 . . . . 65.52 110.172 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.2 mtm -69.11 -29.9 68.07 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.67 0.388 . . . . 75.24 111.645 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.445 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.4 t -62.45 -50.04 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 O-C-N 123.797 0.686 . . . . 74.13 109.457 174.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 81.9 p -71.12 -30.35 66.39 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.942 -0.572 . . . . 61.11 110.855 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 71.8 mtt-85 -70.16 -32.19 70.04 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.369 0.668 . . . . 61.45 109.961 174.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.84 10.72 71.42 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.825 -0.625 . . . . 53.41 112.502 174.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.447 HG23 ' HB3' ' C' ' 17' ' ' TYR . 45.5 p 56.12 30.8 17.03 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 126.444 1.898 . . . . 74.01 114.144 175.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -93.47 159.44 35.07 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 123.813 0.845 . . . . 62.31 110.188 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -51.75 125.03 15.81 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.502 2.801 . . . . 74.22 113.501 171.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -57.59 136.2 56.75 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.844 1.258 . . . . 74.33 111.664 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 59.0 tp -128.53 97.38 4.69 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.454 0.702 . . . . 73.03 109.573 -175.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -100.57 110.07 22.2 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.568 0.747 . . . . 73.11 110.058 -176.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.558 ' HA ' HD12 ' H' ' 6' ' ' ILE . 89.1 mt -71.0 115.24 9.9 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.919 0.488 . . . . 71.54 110.264 178.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.446 ' HB3' HG21 ' H' ' 6' ' ' ILE . . . -73.31 157.28 88.33 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 122.967 0.507 . . . . 64.14 110.568 176.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -51.0 110.06 0.37 Allowed 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.419 2.746 . . . . 63.44 112.959 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 29.6 m -108.78 121.13 61.37 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 108.639 -0.874 . . . . 75.14 108.639 172.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -74.73 89.32 2.27 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 108.664 -0.865 . . . . 70.3 108.664 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -69.5 -17.25 63.58 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.357 -0.838 . . . . 64.41 110.823 -177.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.68 -60.42 3.71 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.961 0.904 . . . . 75.02 110.398 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.29 -37.99 84.31 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.556 0.742 . . . . 72.11 111.512 -178.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.0 tt -58.68 -43.44 89.94 Favored 'General case' 0 CA--C 1.556 1.192 0 O-C-N 123.969 0.793 . . . . 64.44 110.556 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -74.02 -46.59 42.53 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.229 0.611 . . . . 72.31 110.775 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.46 ' O ' ' HG3' ' D' ' 142' ' ' GLN . 69.0 mtm -60.36 -33.45 72.46 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.168 0.587 . . . . 72.2 111.332 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -60.28 -35.24 75.1 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.878 0.871 . . . . 73.12 111.28 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -64.75 -39.71 94.09 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.841 0.856 . . . . 72.23 110.721 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.1 mp -68.86 -28.12 66.42 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.751 0.821 . . . . 71.44 111.185 178.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' D' ' 138' ' ' MET . 75.7 mt-30 -80.1 0.55 31.58 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 113.052 0.76 . . . . 73.12 113.052 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.19 52.73 1.02 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 122.116 0.96 . . . . 75.21 111.009 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -143.94 158.27 43.81 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.93 -1.032 . . . . 75.34 110.334 174.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -101.7 143.06 32.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.055 0.942 . . . . 75.32 109.674 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.08 72.14 2.52 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.532 0.52 . . . . 71.01 112.253 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -86.34 -46.11 10.59 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.274 1.03 . . . . 74.21 110.092 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 149.78 -139.73 7.59 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 115.529 -0.76 . . . . 71.4 111.653 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 14.0 t -158.54 167.96 28.21 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.436 1.094 . . . . 71.44 108.9 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -91.69 141.51 28.61 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.903 0.481 . . . . 62.44 110.594 177.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -132.72 97.82 4.16 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.876 -1.157 . . . . 74.43 107.876 178.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -136.32 119.2 16.27 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.647 0.779 . . . . 65.13 109.218 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -82.48 77.25 9.28 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.402 -0.962 . . . . 72.25 108.402 172.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -72.72 -45.1 60.5 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.205 0.602 . . . . 65.44 109.382 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.987 0 CA-C-N 115.04 -0.982 . . . . 72.13 108.618 168.965 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 109.519 -0.548 . . . . 62.14 109.519 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' E' E ' 2' ' ' LYS . . . . . 0.639 ' HG3' ' HB3' ' C' ' 85' ' ' SER . 4.1 mppt? 68.06 134.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.919 1.688 . . . . 52.11 112.644 -178.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . 0.518 ' HB2' HE22 ' C' ' 12' ' ' GLN . 20.1 mp0 -105.55 -161.39 0.8 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.142 0.977 . . . . 73.13 108.565 174.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -138.51 92.66 2.65 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.09 0.556 . . . . 72.21 109.893 174.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 5' ' ' THR . . . . . 0.595 ' HB ' ' HB2' ' A' ' 129' ' ' ALA . 29.0 m -69.7 146.17 51.77 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.104 -0.702 . . . . 72.44 109.104 171.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.426 ' O ' HD12 ' E' ' 6' ' ' ILE . 2.4 pp -54.34 140.6 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.164 0.986 . . . . 61.3 112.574 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 7' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . . . -150.68 163.4 38.64 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.758 0.823 . . . . 62.4 110.061 -177.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.514 ' HB2' HG11 ' A' ' 131' ' ' VAL . 16.4 mt -91.34 145.7 24.43 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.137 0.975 . . . . 74.4 110.137 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.36 173.33 12.44 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.456 0.702 . . . . 64.51 109.786 169.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 7.7 tt -59.42 146.72 39.04 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 109.222 -0.658 . . . . 63.31 109.222 175.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 76.2 mt -55.82 118.76 21.55 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 123.367 0.667 . . . . 51.54 110.48 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.13 -8.28 11.8 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 123.073 2.515 . . . . 71.34 113.759 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . 0.486 HD13 ' H ' ' E' ' 13' ' ' LEU . 0.0 OUTLIER -130.7 162.2 29.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.801 1.241 . . . . 70.21 110.102 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 78.7 mt -83.19 110.78 18.35 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.056 -0.72 . . . . 74.15 109.056 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.48 75.17 6.1 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 108.912 -0.773 . . . . 73.41 108.912 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -121.13 104.0 41.67 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.183 0.593 . . . . 72.34 111.32 -176.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 17' ' ' PRO . . . . . 0.543 ' HB3' ' HB3' ' A' ' 48' ' ' SER . 98.3 Cg_endo -82.52 -0.69 10.28 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.421 2.081 . . . . 74.31 112.634 166.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 t -101.88 140.99 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.924 0.89 . . . . 52.13 109.828 -172.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 24.2 m -68.15 126.46 29.59 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.643 0.777 . . . . 74.42 111.048 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 86.7 tttt 68.28 92.33 0.08 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.56 1.144 . . . . 74.13 112.038 169.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.66 -9.37 59.41 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.641 0.776 . . . . 73.14 112.992 -172.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -79.87 -75.97 0.23 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.851 0.46 . . . . 72.42 110.876 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 95.6 m -158.22 90.91 2.19 Favored Pre-proline 0 N--CA 1.485 1.304 0 C-N-CA 123.548 0.739 . . . . 61.24 109.884 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -69.13 128.62 16.88 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.705 2.27 . . . . 73.34 111.826 167.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 . . . . . 0 CA--C 1.552 1.051 0 C-N-CA 124.295 1.038 . . . . 63.23 108.584 175.683 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 68.7 mtm . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 109.995 -0.372 . . . . 71.41 109.995 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -144.74 144.34 31.14 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.616 -1.253 . . . . 43.15 107.616 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -83.9 55.88 3.45 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.646 0.736 . . . . 73.54 110.357 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 54.3 m -145.26 90.2 2.01 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.02 1.328 . . . . 71.55 107.92 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 9.1 p -150.73 129.24 12.18 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.16 1.384 . . . . 61.3 107.965 177.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 29.6 mm 57.67 96.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 124.517 1.127 . . . . 50.4 110.875 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . -160.2 -174.76 4.69 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.026 0.53 . . . . 74.24 110.258 -173.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 10.8 mt -154.86 -58.19 0.11 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.912 1.285 . . . . 64.54 108.892 172.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . 67.59 -173.47 0.19 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.521 1.129 . . . . 75.21 111.424 -175.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 84.4 mt -85.67 154.42 21.68 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.3 0.571 . . . . 74.03 110.923 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 6.1 mp -83.34 152.41 64.37 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 114.743 -1.117 . . . . 73.14 110.089 -176.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.49 85.71 1.07 Allowed 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 122.699 2.266 . . . . 63.11 110.775 175.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 35.0 tp 69.0 155.46 0.13 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.303 1.441 . . . . 61.12 111.143 -175.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.96 177.51 6.97 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.175 0.59 . . . . 74.43 110.344 175.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . 0.447 ' HD1' ' HA2' ' B' ' 99' ' ' GLY . 80.3 m-85 -75.83 156.55 34.32 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.227 0.611 . . . . 75.02 111.44 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 36.0 p -58.93 151.64 54.04 Favored Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 125.18 1.392 . . . . 72.3 113.057 -172.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -53.74 140.96 66.37 Favored 'Trans proline' 0 C--N 1.391 2.802 0 C-N-CA 123.311 2.674 . . . . 72.31 113.36 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.33 -20.8 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.136 0.975 . . . . 74.43 111.453 -175.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 7.4 t -67.2 -48.1 68.91 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 122.036 -0.415 . . . . 73.31 110.381 175.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -147.63 114.86 6.23 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.048 0.939 . . . . 73.01 109.674 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' B' ' 50' ' ' GLN . . . -120.51 161.71 20.82 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.863 -1.162 . . . . 73.23 107.863 173.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . 0.557 ' HG3' ' H ' ' F' ' 23' ' ' THR . 7.6 ptp180 -141.47 -76.53 0.29 Allowed 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 118.009 0.368 . . . . 64.22 111.122 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 23' ' ' THR . . . . . 0.557 ' H ' ' HG3' ' F' ' 22' ' ' ARG . 6.1 t -168.59 155.15 6.92 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.737 0.815 . . . . 75.24 108.812 -176.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.36 143.55 35.2 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 121.929 1.752 . . . . 73.24 111.006 166.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 . . . . . 0 C--O 1.25 1.098 0 N-CA-C 108.31 -0.996 . . . . 74.43 108.31 176.62 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.358 -0.608 . . . . 51.32 109.358 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -75.34 80.1 2.42 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.407 0.683 . . . . 72.53 109.729 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -85.91 143.47 28.19 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.223 -0.899 . . . . 64.0 109.346 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 26.0 p -72.76 171.81 11.93 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 123.291 0.637 . . . . 73.41 110.42 175.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 28.0 m -63.66 131.19 47.18 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.416 -0.587 . . . . 70.44 109.416 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . 0.427 HD11 ' HB ' ' C' ' 40' ' ' VAL . 32.1 pt -56.28 135.22 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 O-C-N 124.338 1.024 . . . . 61.2 112.811 -173.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -112.61 161.17 17.11 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 124.612 1.165 . . . . 72.54 109.207 174.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 8' ' ' LEU . . . . . 0.666 ' HB2' HG11 ' C' ' 131' ' ' VAL . 97.3 mt -55.25 135.57 49.63 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.622 0.769 . . . . 74.21 110.802 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.8 176.3 3.12 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.115 0.966 . . . . 60.24 111.683 -176.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.4 151.24 44.62 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.294 0.637 . . . . 54.45 110.534 176.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 11' ' ' LEU . . . . . 0.564 HD23 HG21 ' C' ' 46' ' ' THR . 7.0 mp -70.08 124.73 91.27 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 123.667 0.787 . . . . 73.43 109.624 -173.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -63.92 -49.43 4.0 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 122.522 2.148 . . . . 70.53 111.318 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 51.9 tp -87.86 138.24 31.63 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.688 -0.856 . . . . 75.23 108.688 168.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.63 89.56 1.75 Allowed 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 106.728 -1.582 . . . . 75.33 106.728 170.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . 0.467 ' HE2' HG13 ' C' ' 58' ' ' VAL . 11.4 t80 -62.74 106.96 0.87 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.364 -1.289 . . . . 74.51 111.068 -172.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 9.8 p -145.03 81.21 10.73 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 124.256 1.022 . . . . 60.4 110.331 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 17' ' ' PRO . . . . . 0.433 ' HD2' HD13 ' C' ' 98' ' ' LEU . 56.3 Cg_endo -69.89 -16.62 37.1 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 122.585 2.19 . . . . 73.23 113.298 175.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 18' ' ' VAL . . . . . . . . . . . . . 4.6 t -115.22 112.86 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 108.429 -0.952 . . . . 72.1 108.429 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 2.7 m 66.77 167.86 0.23 Allowed 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 125.395 1.478 . . . . 74.44 112.435 173.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -80.35 65.21 5.42 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.807 0.813 . . . . 73.22 109.297 165.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.02 -31.1 70.55 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.537 -1.21 . . . . 54.4 110.435 178.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 49.3 ttt-85 -73.99 103.36 4.45 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 106.679 -1.6 . . . . 61.23 106.679 157.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 74.1 m -66.91 107.61 1.8 Allowed Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 123.434 0.694 . . . . 74.12 110.382 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -95.1 177.82 0.81 Allowed 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 123.166 2.577 . . . . 53.21 112.74 -176.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 CA--C 1.552 1.031 0 CA-C-N 115.285 -0.871 . . . . 45.53 108.892 177.901 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 110.05 -0.352 . . . . 64.22 110.05 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -140.31 120.79 14.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.652 1.181 . . . . 73.24 108.42 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 65.59 115.26 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.432 1.493 . . . . 52.11 110.237 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 17.7 m -82.47 31.52 0.4 Allowed 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 112.736 0.643 . . . . 72.04 112.736 -172.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 11.3 p -60.84 107.75 0.75 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.03 0.932 . . . . 63.52 110.999 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' D' ' 128' ' ' LEU . 27.9 mm 62.91 63.64 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 C-N-CA 124.716 1.206 . . . . 74.54 110.151 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.48 176.35 10.11 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.579 -1.191 . . . . 74.13 109.268 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 tt -139.03 109.29 6.45 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.386 -1.339 . . . . 73.23 107.386 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 9' ' ' ALA . . . . . 0.44 ' HB3' HD23 ' D' ' 44' ' ' LEU . . . -68.96 150.31 47.85 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.124 0.57 . . . . 62.03 110.932 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 88.4 mt -57.92 141.19 50.21 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.724 0.81 . . . . 71.13 110.962 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 83.4 mt -67.69 112.48 10.53 Favored Pre-proline 0 CA--C 1.56 1.335 0 C-N-CA 123.365 0.666 . . . . 73.12 110.077 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.25 -8.73 18.79 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.84 2.36 . . . . 72.35 112.6 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 44.6 tp -133.08 150.59 52.08 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.664 1.186 . . . . 62.32 108.166 174.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 mp -112.65 144.26 42.46 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.747 -0.834 . . . . 71.32 108.747 174.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -93.04 -177.54 4.52 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.438 0.695 . . . . 74.53 110.19 176.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 81.3 p -69.28 162.91 62.62 Favored Pre-proline 0 N--CA 1.488 1.443 0 C-N-CA 123.174 0.59 . . . . 51.44 110.843 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -82.7 -172.52 1.43 Allowed 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 121.679 1.586 . . . . 63.41 112.242 173.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . 0.672 HG23 HD11 ' D' ' 98' ' ' LEU . 60.0 t -62.15 161.16 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 C-N-CA 124.457 1.103 . . . . 63.31 110.709 174.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 19' ' ' THR . . . . . 0.537 HG21 ' HA ' ' D' ' 54' ' ' ASP . 5.2 t -51.2 134.24 27.52 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.23 0.612 . . . . 73.15 110.612 166.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp 64.32 13.23 7.84 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.502 1.121 . . . . 70.34 113.364 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.06 59.06 5.39 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.482 0.713 . . . . 61.03 111.711 -173.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -155.96 -71.17 0.11 Allowed 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.893 1.277 . . . . 70.31 108.318 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 23.7 m 50.81 66.94 4.82 Favored Pre-proline 0 CA--C 1.561 1.403 0 O-C-N 124.561 1.163 . . . . 55.23 110.113 -171.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.91 90.02 1.29 Allowed 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.429 2.086 . . . . 64.13 111.796 -171.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 . . . . . 0 C--O 1.254 1.298 0 C-N-CA 125.26 1.424 . . . . 73.22 110.813 179.117 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 109.244 -0.65 . . . . 74.54 109.244 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.8 m -77.49 94.19 4.26 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.652 0.781 . . . . 75.1 110.702 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -166.59 -55.42 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.804 1.242 . . . . 61.13 108.558 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.539 ' HG2' ' H ' ' A' ' 5' ' ' ASN . 46.8 tt0 -87.32 -176.26 5.58 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-N 114.706 -1.134 . . . . 74.02 109.481 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.539 ' H ' ' HG2' ' A' ' 4' ' ' GLN . 66.2 t30 71.27 24.01 3.89 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.959 1.303 . . . . 74.25 110.309 -177.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -137.82 -44.23 0.53 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.229 0.612 . . . . 73.32 110.677 -175.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.481 ' HB ' ' HA3' ' C' ' 146' ' ' GLY . 7.8 m -94.48 3.55 54.99 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.878 0.871 . . . . 71.42 111.794 -172.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.66 88.61 0.36 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.43 1.092 . . . . 72.31 111.434 -171.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.515 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 27.9 ttt -163.36 161.58 24.57 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.426 -1.261 . . . . 54.33 108.357 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.6 t -139.55 129.1 24.38 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.707 -0.849 . . . . 71.44 108.707 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.595 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 19.4 t80 -137.65 120.31 16.2 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.678 -0.86 . . . . 72.12 108.678 169.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.7 tp60 -138.92 127.61 23.35 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.329 -0.989 . . . . 72.45 108.329 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.692 HG12 ' HD2' ' A' ' 84' ' ' PHE . 42.6 mt -95.06 112.97 28.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.639 -0.874 . . . . 63.54 108.639 172.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -86.09 -24.33 26.32 Favored 'General case' 0 C--O 1.243 0.722 0 O-C-N 123.386 0.429 . . . . 72.4 111.064 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -173.42 146.42 1.37 Allowed 'General case' 0 N--CA 1.48 1.068 0 O-C-N 123.213 0.321 . . . . 72.02 110.373 -173.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.548 HD12 ' HG3' ' C' ' 130' ' ' PRO . 80.9 mt -138.47 134.9 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 124.021 0.929 . . . . 75.21 108.634 171.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.462 ' HB3' HG23 ' B' ' 122' ' ' THR . 27.6 p90 -167.98 176.19 6.3 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 124.42 1.075 . . . . 73.24 111.58 -168.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.6 p -99.64 120.6 39.95 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.433 -0.951 . . . . 74.43 108.433 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.457 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 43.9 mtpt -87.64 -27.4 22.5 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.069 -0.345 . . . . 75.44 110.069 174.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.627 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.7 t70 -149.14 139.59 22.45 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.649 -0.705 . . . . 71.34 109.989 177.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.4 mt -136.62 146.12 29.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 C-N-CA 125.3 1.44 . . . . 72.22 107.242 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -153.73 136.51 15.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 123.495 0.497 . . . . 44.23 110.064 170.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.59 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 86.3 t80 -133.47 143.45 48.83 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.416 -1.328 . . . . 72.35 107.416 171.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -140.38 144.32 36.17 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 108.949 -0.76 . . . . 53.11 108.949 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.61 74.03 11.49 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 106.151 -1.796 . . . . 44.23 106.151 171.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -64.57 -34.78 51.16 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.39 2.06 . . . . 73.04 111.956 -170.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -101.42 20.52 15.79 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.982 0.913 . . . . 71.43 109.896 -175.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.431 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -45.73 -52.01 26.61 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-O 118.009 -0.996 . . . . 73.32 113.627 -171.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.462 ' HG3' ' HG3' ' B' ' 57' ' ' GLU . 48.4 Cg_exo -57.89 -33.7 97.39 Favored 'Trans proline' 0 C--N 1.39 2.723 0 C-N-CA 121.882 1.721 . . . . 65.41 113.564 176.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -82.1 -30.88 30.98 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.055 0.942 . . . . 22.21 110.687 -177.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.725 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.3 p -78.96 -22.38 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 C-N-CA 123.169 0.588 . . . . 63.21 112.518 -163.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -77.84 -25.85 49.02 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.697 0.799 . . . . 75.51 112.67 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -83.39 -12.81 56.08 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.407 0.683 . . . . 70.54 111.012 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -82.77 167.88 17.72 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.962 0.905 . . . . 74.43 111.96 -175.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.68 126.54 31.03 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.986 -1.006 . . . . 74.24 109.324 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.493 ' HD1' ' HB3' ' E' ' 2' ' ' LYS . 54.1 t-105 -75.47 85.5 2.57 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.326 0.584 . . . . 53.43 110.094 175.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.45 ' H ' HD22 ' A' ' 68' ' ' LEU . 35.4 tt0 -122.88 75.2 48.01 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.689 1.196 . . . . 74.2 108.258 173.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -83.9 135.75 6.78 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.866 2.378 . . . . 73.52 112.994 -171.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -104.9 106.47 16.98 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 106.97 -1.493 . . . . 72.04 106.97 170.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.573 HG21 ' HA ' ' E' ' 6' ' ' ILE . 15.2 m -75.78 91.49 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-O 122.031 0.92 . . . . 71.53 110.652 -175.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.7 tptt -80.52 111.81 17.28 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 107.118 -1.438 . . . . 54.43 107.118 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 pp -127.53 141.92 51.52 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.046 0.539 . . . . 71.45 110.549 -168.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -146.19 134.16 21.41 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.758 -0.83 . . . . 71.55 108.758 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.417 HD21 HD21 ' E' ' 8' ' ' LEU . 6.0 mp -103.69 118.61 37.12 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.917 -0.771 . . . . 71.23 108.917 177.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 33.0 t70 -119.55 143.9 47.36 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.758 -0.83 . . . . 73.41 108.758 177.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.1 p -106.94 147.86 29.33 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.195 0.598 . . . . 70.13 110.047 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -147.76 144.05 27.97 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.153 0.981 . . . . 73.23 108.667 176.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 64.2 m -136.54 162.39 33.24 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 118.162 0.437 . . . . 63.5 111.799 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.9 t -149.92 121.86 8.2 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.843 0.857 . . . . 71.11 109.439 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -81.24 125.8 30.75 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.632 -0.507 . . . . 63.13 109.632 175.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.419 HD12 HG23 ' A' ' 83' ' ' ILE . 27.4 mt -107.8 -26.61 10.7 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.915 0.886 . . . . 72.33 110.264 -177.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.38 179.01 6.44 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.252 -1.34 . . . . 74.12 108.672 174.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -67.12 113.02 4.75 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.977 -0.749 . . . . 61.0 108.977 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 87' ' ' ALA . 5.6 m-20 76.07 0.32 3.27 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 125.245 1.418 . . . . 64.22 112.401 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.451 HG11 ' HG3' ' C' ' 153' ' ' GLN . 61.0 t -99.52 109.46 24.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.896 0 N-CA-C 106.744 -1.576 . . . . 74.13 106.744 168.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -133.72 123.38 24.85 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.974 -1.121 . . . . 63.14 107.974 -170.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.403 ' HB2' HD11 ' A' ' 51' ' ' LEU . 14.4 tt0 -86.31 128.3 34.9 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.595 -0.891 . . . . 64.1 108.595 177.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.464 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 56.5 t -101.93 125.97 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.767 -1.197 . . . . 64.5 107.767 176.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 36.8 t -116.13 143.18 26.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 108.229 -1.026 . . . . 64.44 108.229 173.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tt -128.9 117.62 21.31 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.765 -0.828 . . . . 62.4 108.765 174.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.576 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 28.1 ttm105 -81.95 101.56 10.35 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 108.025 -1.102 . . . . 74.02 108.025 170.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.83 101.16 12.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 N-CA-C 107.132 -1.432 . . . . 71.11 107.132 171.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -96.47 126.45 41.67 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.906 -0.776 . . . . 73.02 108.906 176.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.64 HG21 HD13 ' E' ' 6' ' ' ILE . 67.4 t -128.06 139.76 51.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 125.189 1.396 . . . . 64.25 107.356 176.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 6.4 m -131.24 149.82 52.41 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.702 -1.222 . . . . 70.31 107.702 174.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.19 113.57 22.42 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.203 -1.406 . . . . 63.04 107.203 170.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.0 m -113.85 124.38 52.07 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.157 0.503 . . . . 74.14 110.064 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.45 HD22 ' H ' ' A' ' 37' ' ' GLN . 66.0 mt -90.09 65.52 6.5 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.771 1.228 . . . . 75.13 109.001 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.34 -90.79 0.73 Allowed Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.838 -0.619 . . . . 71.2 111.828 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -102.17 -27.16 13.05 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.291 0.636 . . . . 73.33 111.644 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -100.19 128.5 46.26 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 109.585 -0.524 . . . . 72.54 109.585 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.9 m -71.49 135.91 47.34 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 118.175 0.443 . . . . 55.42 109.92 172.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.725 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -80.61 -63.1 1.48 Allowed 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.448 -0.796 . . . . 53.41 109.729 173.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -156.04 174.88 14.71 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.915 -1.038 . . . . 73.02 111.635 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.411 HD12 ' O ' ' A' ' 64' ' ' VAL . 44.6 tp -134.87 137.62 43.41 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.171 1.388 . . . . 73.44 107.853 174.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 82.5 m -136.51 102.92 5.09 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.96 1.304 . . . . 72.21 109.589 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -122.05 117.17 25.69 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.77 -0.826 . . . . 63.45 108.77 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.7 t -128.96 112.08 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.552 0.741 . . . . 75.31 109.976 -174.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.627 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.8 mt-30 -85.76 91.2 8.25 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.873 -0.788 . . . . 72.41 108.873 168.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.4 ' HG3' HD22 ' A' ' 106' ' ' LEU . 9.1 tp-100 -80.75 107.87 13.93 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.969 -1.014 . . . . 73.1 108.995 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.59 145.28 17.43 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.033 -0.427 . . . . 62.21 112.033 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.06 128.45 3.07 Favored Glycine 0 CA--C 1.507 -0.445 0 N-CA-C 110.942 -0.863 . . . . 74.21 110.942 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.419 HG23 HD12 ' A' ' 51' ' ' LEU . 62.0 mt -79.54 122.38 34.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.867 -0.79 . . . . 73.12 108.867 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.692 ' HD2' HG12 ' A' ' 13' ' ' ILE . 12.6 m-85 -137.54 151.69 48.66 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.744 -0.836 . . . . 74.24 108.744 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 44.3 m -121.01 106.64 11.78 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.325 0.65 . . . . 64.33 109.348 170.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.666 ' HB ' HG11 ' E' ' 18' ' ' VAL . 4.0 mp -115.26 121.05 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 108.692 -0.855 . . . . 45.44 108.692 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.407 ' HB2' ' HB3' ' A' ' 54' ' ' ASP . . . -164.2 158.59 19.21 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.746 0.819 . . . . 74.32 110.152 175.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 132.15 -37.34 2.06 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-O 119.873 -0.404 . . . . 22.32 113.921 173.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.8 mt -122.44 -52.6 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-N 117.492 0.646 . . . . 65.11 110.909 -171.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' E' ' 20' ' ' LYS . 0.5 OUTLIER 65.02 -164.17 0.25 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.638 1.175 . . . . 74.44 112.058 177.273 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.59 -140.43 33.4 Favored Glycine 0 C--N 1.352 1.469 0 O-C-N 123.277 0.361 . . . . 51.12 113.433 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.9 t -72.38 -18.65 61.72 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.459 0.704 . . . . 73.24 111.295 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.4 mm100 -74.42 -44.99 49.45 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.234 0.613 . . . . 72.13 110.468 178.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.655 ' HG2' HD23 ' A' ' 98' ' ' LEU . 52.9 ttm -72.16 -27.02 62.31 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.689 -0.485 . . . . 72.24 109.689 173.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.82 -29.06 69.91 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.871 0.468 . . . . 22.23 111.718 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -72.64 -39.28 67.31 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.965 0.506 . . . . 70.12 110.608 171.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.565 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 58.4 m -64.36 -56.21 15.9 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.224 0.61 . . . . 61.1 110.972 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.735 HD22 ' HA ' ' E' ' 17' ' ' PRO . 3.7 pp -71.62 -29.37 64.59 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.196 0.599 . . . . 62.22 111.332 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.61 -20.69 57.86 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-O 119.575 -0.569 . . . . 52.31 114.273 -173.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.08 -54.67 0.21 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.063 0.764 . . . . 74.51 113.063 -172.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.565 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 87.5 t80 -60.89 -63.48 1.28 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.524 0.73 . . . . 61.21 112.844 -171.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 78.2 m -65.63 -35.22 10.92 Favored Pre-proline 0 CA--C 1.57 1.732 0 C-N-CA 123.779 0.831 . . . . 75.55 113.073 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.2 -45.73 32.1 Favored 'Trans proline' 0 C--N 1.393 2.914 0 C-N-CA 122.777 2.318 . . . . 55.05 113.374 161.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -70.64 -17.69 62.87 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.401 0.681 . . . . 73.13 112.075 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 46.2 mm -69.71 -43.81 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 N-CA-C 109.209 -0.663 . . . . 72.13 109.209 171.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.4 HD22 ' HG3' ' A' ' 80' ' ' GLN . 89.1 mt -81.89 -23.48 36.27 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.012 0.925 . . . . 71.05 112.549 -177.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -56.22 -47.21 99.3 Favored Pre-proline 0 CA--C 1.572 1.792 0 C-N-CA 124.956 1.303 . . . . 71.52 113.953 -172.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.67 -32.76 14.25 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.119 1.879 . . . . 70.04 112.939 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -68.26 -40.68 81.83 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.058 0.543 . . . . 75.41 110.912 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.73 -39.92 80.13 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.766 -0.652 . . . . 65.22 110.507 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.4 ttm105 -54.67 -47.81 73.13 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.849 0.86 . . . . 70.2 110.912 173.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -68.94 -43.27 75.41 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.709 0.803 . . . . 70.04 111.408 -175.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 43.8 t -63.88 -29.65 70.81 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 123.607 0.567 . . . . 72.33 110.823 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 70.8 mt -68.2 -56.06 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 123.862 0.865 . . . . 71.33 110.011 169.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.2 m -56.28 -35.74 67.83 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.842 1.257 . . . . 44.31 112.339 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.4 t -64.38 -49.61 70.94 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 123.409 0.683 . . . . 51.01 110.647 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.59 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 57.9 mtm -65.9 -37.48 86.21 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.725 0.64 . . . . 60.15 111.25 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.0 t -60.07 -53.19 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.499 1.12 . . . . 72.02 110.403 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 40.2 t -69.78 -29.46 66.79 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.933 0.893 . . . . 61.22 111.49 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 52.0 ttm-85 -75.75 -28.92 58.68 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.256 1.023 . . . . 74.33 109.362 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.432 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.66 15.56 46.07 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 114.741 -1.118 . . . . 75.15 112.607 172.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.477 HG21 ' HE ' ' B' ' 15' ' ' ARG . 2.8 t 60.81 14.46 5.16 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 127.214 2.205 . . . . 74.11 113.77 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -80.08 155.07 75.1 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 123.681 0.792 . . . . 75.1 110.223 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.68 170.13 10.39 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.853 2.369 . . . . 74.44 113.15 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -63.68 127.69 32.5 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.193 -0.912 . . . . 74.45 111.55 -173.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.6 tp -121.88 103.96 9.21 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.651 1.18 . . . . 53.42 108.306 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -97.22 126.65 42.56 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.713 0.805 . . . . 72.43 108.867 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.518 ' HA ' ' HB ' ' E' ' 6' ' ' ILE . 1.2 tt -72.51 130.78 41.43 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.948 -1.13 . . . . 73.15 107.948 171.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.05 133.22 83.91 Favored Pre-proline 0 CA--C 1.548 0.893 0 O-C-N 123.575 0.547 . . . . 63.24 110.743 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -70.59 95.83 0.64 Allowed 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 122.343 2.028 . . . . 51.42 111.593 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.7 t -102.24 111.45 32.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 108.911 -0.774 . . . . 72.31 108.911 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -86.67 82.9 7.72 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.122 -1.066 . . . . 54.04 108.122 172.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -50.03 -35.1 23.56 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.498 1.119 . . . . 74.12 111.785 -176.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -53.34 -51.29 62.9 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.691 1.196 . . . . 75.11 111.356 178.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.8 -50.39 74.01 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.885 0.741 . . . . 45.3 111.821 -177.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.84 -42.94 94.51 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.599 0.759 . . . . 62.31 110.799 -175.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.505 ' HE2' HD23 ' E' ' 11' ' ' LEU . 25.7 m-85 -70.31 -27.68 64.57 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.286 0.634 . . . . 73.13 111.772 177.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 53.3 mtp -77.71 -26.22 49.93 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 119.02 -0.514 . . . . 72.42 111.571 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.606 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 65.7 m-80 -66.81 -38.52 86.63 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.906 -0.405 . . . . 74.44 109.906 173.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -69.95 -39.59 75.94 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.643 -0.708 . . . . 74.44 111.031 172.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.6 tp -61.8 -49.46 76.25 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.89 0.876 . . . . 65.01 111.908 -175.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.422 ' H ' ' H ' ' A' ' 143' ' ' GLN . 64.9 tt0 -166.09 -11.41 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 O-C-N 123.557 0.536 . . . . 71.13 111.714 -171.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.606 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 75.3 mt-30 73.76 118.34 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.688 1.595 . . . . 73.43 109.733 -162.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -69.07 140.11 54.86 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.574 0.75 . . . . 65.22 112.02 -174.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.42 -54.54 0.17 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.262 1.025 . . . . 52.41 108.922 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 104.8 -113.72 4.44 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-N 115.39 -0.823 . . . . 63.24 111.552 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -155.35 -50.28 0.08 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.855 0.862 . . . . 53.25 108.765 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 101.9 98.57 2.39 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 111.018 -0.833 . . . . 74.24 111.018 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 37.3 p -68.44 93.91 0.52 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.124 0.97 . . . . 72.3 110.75 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.67 110.57 13.92 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.266 -1.013 . . . . 75.31 108.266 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -112.66 87.09 2.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.631 0.772 . . . . 71.43 109.61 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -95.37 140.72 29.85 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.42 -0.809 . . . . 63.12 109.873 175.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -138.29 115.46 11.0 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.871 0.868 . . . . 73.52 109.255 171.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -109.62 98.65 7.97 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.83 -1.174 . . . . 63.32 107.83 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 C-N-CA 123.696 0.799 . . . . 62.24 109.105 178.103 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 35.8 tpp . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 121.688 0.756 . . . . 74.01 109.389 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 26.5 m -153.58 115.68 4.33 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 124.107 0.963 . . . . 63.22 108.794 173.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -81.71 3.69 24.66 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.208 0.603 . . . . 63.54 111.05 169.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -65.24 95.1 0.17 Allowed 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.873 -0.788 . . . . 62.41 108.873 170.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -148.85 144.16 26.75 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.91 0.884 . . . . 73.21 108.686 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -169.65 174.33 5.87 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 108.661 -0.866 . . . . 62.12 108.661 -173.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 11.3 m 72.1 171.91 0.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.4 1.08 . . . . 74.41 111.029 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -82.59 58.19 4.09 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.562 0.745 . . . . 74.12 109.314 172.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.589 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 25.3 ptm 44.62 -166.52 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 126.981 2.112 . . . . 60.32 115.473 174.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 90.2 m -134.78 132.35 38.6 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 106.559 -1.645 . . . . 73.55 106.559 162.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.452 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 37.9 t80 -124.13 137.65 54.53 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.738 -0.838 . . . . 75.44 108.738 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.405 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -153.28 132.94 13.05 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.399 -0.593 . . . . 72.31 109.399 176.378 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.409 HD13 HD11 ' B' ' 16' ' ' ILE . 32.5 mt -83.32 120.39 34.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 108.438 -0.949 . . . . 62.32 108.438 173.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -88.28 -46.1 9.5 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.539 -0.541 . . . . 62.34 109.539 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.477 ' HE ' HG21 ' A' ' 122' ' ' THR . 49.2 ttt180 -167.67 137.74 2.77 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.704 0.402 . . . . 71.54 110.167 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.409 HD11 HD13 ' B' ' 13' ' ' ILE . 74.1 mt -114.79 142.32 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.407 -0.961 . . . . 75.2 108.407 175.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -169.77 158.53 7.52 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-O 121.682 0.753 . . . . 62.44 112.499 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.402 ' H ' ' HA2' ' A' ' 121' ' ' GLY . 88.4 m -86.71 129.58 34.81 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.007 -0.997 . . . . 51.12 109.188 170.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.456 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 41.1 mtpt -97.72 -29.22 13.51 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.796 0.838 . . . . 73.12 110.343 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -159.97 141.12 12.43 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.56 0.219 . . . . 73.13 111.334 -170.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 45.7 mm -135.53 146.13 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.291 1.437 . . . . 75.42 109.07 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.603 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 42.4 t -148.21 138.31 22.58 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.851 1.261 . . . . 71.33 107.965 173.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.1 t80 -153.57 109.38 3.27 Favored 'General case' 0 C--O 1.215 -0.755 0 N-CA-C 106.783 -1.562 . . . . 71.51 106.783 170.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -118.53 113.48 21.36 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.33 -1.359 . . . . 73.15 107.33 176.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.431 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -105.14 86.64 1.64 Allowed Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 106.975 -1.491 . . . . 53.34 106.975 172.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.37 -37.5 13.45 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.902 2.401 . . . . 70.1 112.502 -166.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -108.45 21.84 16.76 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.598 0.759 . . . . 71.11 110.069 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.431 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -39.36 -62.25 0.84 Allowed Pre-proline 0 N--CA 1.497 1.908 0 N-CA-C 114.792 1.404 . . . . 74.1 114.792 -166.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.457 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 46.8 Cg_endo -67.89 -27.54 36.93 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 121.823 1.682 . . . . 73.23 112.631 -174.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.405 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 26.3 m80 -75.38 -48.45 22.87 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 115.36 -0.837 . . . . 75.04 110.896 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' B' ' 68' ' ' LEU . 9.1 p -76.06 -0.49 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.365 0 C-N-CA 123.868 0.867 . . . . 64.41 112.353 -167.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -75.7 -13.38 60.31 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.985 -0.447 . . . . 72.02 112.155 173.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 10.2 pt20 -63.36 -16.97 62.03 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.756 0.822 . . . . 73.32 111.183 171.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.461 ' HB2' HD13 ' B' ' 68' ' ' LEU . 33.1 mmtp -93.72 89.87 6.36 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.058 1.343 . . . . 75.34 110.148 -176.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -89.17 84.5 6.53 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.988 0.515 . . . . 62.44 111.08 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 46.7 p90 -168.11 173.05 8.24 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.332 1.053 . . . . 71.01 109.497 169.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -65.17 116.77 33.37 Favored Pre-proline 0 N--CA 1.478 0.937 0 N-CA-C 108.602 -0.888 . . . . 62.04 108.602 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.404 ' O ' HG13 ' B' ' 40' ' ' VAL . 33.9 Cg_endo -60.06 154.15 53.19 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 121.995 1.797 . . . . 74.22 111.881 -175.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 30.3 tt0 -57.23 104.5 0.17 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.014 -0.736 . . . . 65.52 109.014 175.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.438 ' HB ' HD12 ' F' ' 6' ' ' ILE . 26.2 m -85.2 139.08 17.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-N 114.924 -1.035 . . . . 63.32 110.565 -172.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.502 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 34.3 ttmt -150.5 107.13 3.51 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.723 -0.843 . . . . 74.23 108.723 -175.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.483 HD23 HG12 ' F' ' 6' ' ' ILE . 0.1 OUTLIER -85.43 141.14 30.17 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 107.672 -1.233 . . . . 62.03 107.672 176.391 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -143.51 142.04 30.99 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.459 1.103 . . . . 73.22 108.417 174.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.809 HD21 HD23 ' F' ' 8' ' ' LEU . 5.4 mp -123.92 167.31 14.3 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.539 0.685 . . . . 74.32 110.991 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.599 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.0 t70 -149.65 148.55 29.43 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 113.879 -1.51 . . . . 74.44 109.002 175.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 3.4 t -108.27 127.02 53.49 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.236 1.015 . . . . 74.4 108.938 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -158.4 136.85 10.97 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.202 0.601 . . . . 72.3 110.216 -175.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.4 p -146.57 -179.63 6.9 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.264 0.625 . . . . 63.21 111.155 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 65.1 p -152.51 136.38 16.3 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.174 -1.047 . . . . 63.32 108.174 164.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.75 HE22 ' HE3' ' F' ' 20' ' ' LYS . 54.0 tt0 -89.94 118.68 29.69 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.18 -0.674 . . . . 64.25 109.18 175.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 17.8 mt -84.19 -48.59 9.65 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.596 -0.891 . . . . 75.41 108.596 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.43 179.29 8.26 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.317 -1.31 . . . . 74.01 109.793 175.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.71 130.71 43.11 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.506 -1.224 . . . . 63.11 107.933 172.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 71.12 -5.37 1.55 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 125.145 1.378 . . . . 72.41 112.843 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 86.6 t -119.29 102.52 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.933 0.893 . . . . 61.12 108.714 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -121.68 139.76 53.15 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.447 0.699 . . . . 73.54 109.616 -173.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.462 ' HG3' ' HG3' ' A' ' 29' ' ' PRO . 8.9 tm-20 -106.5 107.48 18.52 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 107.645 -1.243 . . . . 73.43 107.645 -178.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 85.6 t -94.53 126.21 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.163 1.385 . . . . 74.14 110.295 -175.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 13.6 t -112.9 145.88 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.755 -0.831 . . . . 74.41 108.755 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.435 HD11 HD23 ' B' ' 44' ' ' LEU . 41.9 tp -129.44 112.02 13.37 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 108.026 -1.101 . . . . 65.32 108.026 168.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.599 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 11.4 ttm180 -88.56 110.4 20.86 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.923 -0.769 . . . . 72.13 108.923 173.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 24.9 t -105.36 102.77 14.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 107.189 -1.412 . . . . 72.51 107.189 177.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 25.4 m -99.54 134.0 43.05 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.939 -0.763 . . . . 64.2 108.939 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.438 HG23 HD13 ' B' ' 114' ' ' ILE . 40.6 t -120.28 126.16 74.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 123.53 0.732 . . . . 64.42 109.734 174.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 78.6 m -103.54 143.56 32.57 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.964 0.906 . . . . 74.35 109.476 171.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -146.82 135.94 22.55 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.703 0.801 . . . . 73.11 109.648 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.558 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 38.0 p -141.81 134.28 28.17 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 123.373 0.669 . . . . 75.55 110.16 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.461 HD13 ' HB2' ' B' ' 34' ' ' LYS . 26.2 mt -108.85 100.87 10.03 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 123.78 0.832 . . . . 71.21 109.647 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.83 -119.58 6.97 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.505 -0.77 . . . . 74.21 113.385 176.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -95.21 18.12 12.93 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.394 0.677 . . . . 74.53 112.21 -173.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -152.74 155.16 36.67 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.928 0.491 . . . . 73.0 110.562 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 96.7 m -73.12 132.38 43.22 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 116.05 -0.523 . . . . 70.32 110.045 174.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.558 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -82.83 -62.23 1.66 Allowed 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.29 -1.004 . . . . 64.25 108.29 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -158.61 160.31 36.41 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 114.882 -1.053 . . . . 71.2 111.658 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 79.6 mt -128.59 113.06 14.97 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.577 -1.638 . . . . 55.43 106.577 173.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.1 t -115.63 153.37 31.4 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.47 -0.937 . . . . 71.12 108.47 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.603 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.8 tt0 -162.03 126.77 3.34 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.286 -0.635 . . . . 74.24 109.286 -175.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 95.9 t -126.3 145.52 33.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 124.095 0.958 . . . . 74.52 108.773 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -123.47 98.75 5.99 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.199 -1.037 . . . . 70.12 108.199 173.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.484 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 8.1 tp-100 -91.82 101.09 13.68 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.29 -1.004 . . . . 74.41 108.29 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.74 162.7 30.42 Favored Glycine 0 C--O 1.242 0.61 0 N-CA-C 110.9 -0.88 . . . . 73.2 110.9 174.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.74 126.31 1.51 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.821 -0.911 . . . . 35.1 110.821 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 61.0 mt -84.16 129.46 37.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 107.757 -1.201 . . . . 64.41 107.757 174.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -133.04 168.97 17.53 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.498 0.719 . . . . 75.05 109.244 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 73.7 m -126.64 109.53 12.2 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.574 0.75 . . . . 72.21 109.207 170.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -118.74 126.16 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.7 1.2 . . . . 75.33 108.306 -175.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.4 ' HA ' ' HB1' ' F' ' 21' ' ' ALA . . . -157.47 142.97 17.25 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.718 0.407 . . . . 71.22 111.219 -174.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 107.27 -34.44 5.68 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.274 0.359 . . . . 73.12 113.145 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.589 ' HB ' ' HB3' ' B' ' 9' ' ' MET . 0.6 OUTLIER -94.08 160.48 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.751 0.82 . . . . 61.34 110.121 172.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -161.26 160.8 30.32 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.065 0.546 . . . . 74.11 111.207 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.73 -128.68 9.14 Favored Glycine 0 C--N 1.353 1.505 0 C-N-CA 123.818 0.723 . . . . 72.43 112.641 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 35.9 m -65.34 -31.2 72.2 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.654 0.782 . . . . 74.22 110.636 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -69.91 -37.92 76.12 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.259 -0.882 . . . . 75.42 111.01 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.412 ' SD ' ' HB ' ' F' ' 18' ' ' VAL . 0.0 OUTLIER -80.35 -28.8 38.0 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.952 -0.388 . . . . 61.24 109.952 177.197 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.6 -31.86 73.16 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.775 0.83 . . . . 61.14 110.546 172.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -81.92 -37.93 26.06 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.662 1.185 . . . . 71.01 110.466 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.8 t -64.73 -46.64 81.41 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.861 0.464 . . . . 53.24 110.918 -175.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 5.5 mp -96.26 -9.51 30.13 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.72 0.408 . . . . 71.31 111.281 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.98 -15.36 33.7 Favored Glycine 0 N--CA 1.476 1.313 0 N-CA-C 114.008 0.363 . . . . 64.41 114.008 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.56 -61.71 0.89 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.467 0.707 . . . . 70.24 109.856 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -67.03 -55.11 15.77 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.409 0.684 . . . . 73.22 112.59 -168.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.483 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 83.1 m -61.46 -49.95 85.09 Favored Pre-proline 0 CA--C 1.559 1.307 0 CA-C-O 118.362 -0.828 . . . . 64.24 111.78 -177.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 37.7 Cg_exo -61.9 -25.89 78.51 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 122.318 2.012 . . . . 74.32 113.442 174.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -77.02 -25.61 52.82 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.499 0.72 . . . . 75.43 110.927 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.409 HG23 ' NH2' ' D' ' 111' ' ' ARG . 65.2 mt -68.74 -42.86 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.635 0.774 . . . . 64.4 109.529 169.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' B' ' 102' ' ' CYS . 53.6 mt -82.03 -18.76 42.13 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.412 -1.267 . . . . 72.44 111.311 -174.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -57.64 -52.01 77.48 Favored Pre-proline 0 CA--C 1.559 1.306 0 CA-C-O 117.121 -1.419 . . . . 74.41 112.708 -177.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -53.61 -37.86 83.59 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 122.727 2.285 . . . . 64.43 114.477 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -70.34 -44.38 68.28 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.072 0.549 . . . . 73.02 109.871 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -67.18 -32.43 73.51 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 115.351 -0.84 . . . . 62.33 111.591 177.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.414 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 45.3 ttt-85 -70.3 -51.11 32.78 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.985 1.314 . . . . 72.45 109.967 -176.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -35.79 78.52 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 124.324 1.015 . . . . 61.23 108.957 176.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.487 ' O ' ' HG2' ' B' ' 117' ' ' MET . 19.1 t -65.31 -47.71 75.6 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 123.687 0.617 . . . . 41.23 112.432 -177.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.516 ' O ' HG23 ' B' ' 118' ' ' VAL . 75.5 mt -60.33 -54.72 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 108.924 -0.769 . . . . 74.03 108.924 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 45.2 m -58.27 -30.04 66.27 Favored 'General case' 0 CA--C 1.555 1.146 0 O-C-N 124.583 1.177 . . . . 45.22 111.661 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 48.0 t -69.66 -46.15 66.78 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 123.431 0.693 . . . . 73.44 109.194 176.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.561 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 9.4 mmt -70.13 -32.92 71.17 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 123.482 0.489 . . . . 63.2 110.886 -177.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.516 HG23 ' O ' ' B' ' 114' ' ' ILE . 99.4 t -59.96 -47.5 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 124.302 1.041 . . . . 74.51 109.317 171.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.0 t -70.47 -29.73 66.36 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 113.755 -1.566 . . . . 74.23 111.672 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.561 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 92.3 mtt-85 -70.05 -37.01 75.42 Favored 'General case' 0 C--O 1.214 -0.774 0 C-N-CA 123.346 0.658 . . . . 71.12 109.339 176.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.93 8.82 55.85 Favored Glycine 0 C--N 1.353 1.5 0 O-C-N 124.167 0.917 . . . . 71.12 112.863 173.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.462 HG23 ' HB3' ' A' ' 17' ' ' TYR . 76.9 p 55.38 25.32 7.49 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 126.395 1.878 . . . . 74.53 113.62 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -78.39 155.03 79.31 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 123.888 0.875 . . . . 75.34 111.118 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -46.88 143.96 8.77 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.873 3.049 . . . . 74.02 113.707 176.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -58.6 116.19 3.52 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.174 0.99 . . . . 75.14 111.679 -172.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 41.8 tp -121.25 105.08 10.23 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.328 0.651 . . . . 72.44 110.19 -176.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -105.17 126.37 52.01 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 108.913 -0.773 . . . . 50.33 108.913 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.414 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 49.3 mt -74.33 137.85 43.11 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 109.508 -0.552 . . . . 61.34 109.508 175.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' F' ' 7' ' ' ALA . . . -85.78 136.83 36.29 Favored Pre-proline 0 N--CA 1.479 1.013 0 CA-C-O 119.282 -0.39 . . . . 62.31 110.077 176.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.664 ' HG3' HD13 ' D' ' 16' ' ' ILE . 69.9 Cg_endo -73.94 141.42 30.01 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.334 2.023 . . . . 54.31 111.978 178.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 27.5 m -128.75 131.38 68.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.567 -0.901 . . . . 73.1 108.567 172.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -73.67 95.86 2.4 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.469 -0.567 . . . . 54.2 109.469 174.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.473 ' HZ ' HD22 ' F' ' 8' ' ' LEU . 45.3 m-85 -61.93 -43.59 98.54 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.671 -0.863 . . . . 65.22 108.671 171.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -55.06 -62.66 1.51 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 113.603 -1.635 . . . . 55.44 111.704 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.22 -37.08 71.69 Favored 'General case' 0 C--N 1.363 1.159 0 O-C-N 123.979 0.799 . . . . 52.22 112.341 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -58.83 -52.25 66.53 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.074 0.95 . . . . 63.44 110.125 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -70.81 -22.62 62.33 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 116.144 -0.48 . . . . 65.01 111.687 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 99.7 mtp -69.32 -36.2 76.72 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 122.874 0.47 . . . . 71.53 110.833 175.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.546 ' HA ' ' HG2' ' B' ' 142' ' ' GLN . 21.3 m-80 -73.05 -16.77 61.48 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.868 0.467 . . . . 74.33 111.067 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -75.3 -34.82 61.31 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.054 0.542 . . . . 73.33 110.131 171.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 64.8 mt -98.01 -7.9 28.99 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 113.002 0.742 . . . . 75.45 113.002 -171.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . 0.546 ' HG2' ' HA ' ' B' ' 139' ' ' ASN . 12.2 pt20 -113.86 166.01 12.0 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.832 0.453 . . . . 75.24 110.754 -176.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -149.55 155.6 40.59 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.784 0.834 . . . . 73.04 109.651 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -114.8 92.75 4.05 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.829 -0.804 . . . . 34.34 108.829 173.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.05 99.7 11.43 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.768 0.827 . . . . 74.24 110.461 -175.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -103.52 109.76 3.51 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 111.019 -0.832 . . . . 72.13 111.019 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -117.29 123.91 47.71 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.124 0.97 . . . . 74.42 110.011 -175.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -93.62 145.84 17.83 Favored Glycine 0 C--N 1.352 1.417 0 CA-C-O 120.129 -0.261 . . . . 72.43 113.044 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 38.2 p -84.59 154.13 22.78 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.797 0.839 . . . . 65.41 110.865 176.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -73.13 146.23 45.84 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.535 0.734 . . . . 71.22 110.047 177.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -142.23 73.59 1.42 Allowed 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.906 0.882 . . . . 63.31 109.28 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -71.32 113.77 8.7 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 109.806 -0.442 . . . . 53.41 109.806 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -85.78 148.33 25.89 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.864 -0.607 . . . . 74.33 109.667 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -127.06 104.74 8.15 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.45 -0.944 . . . . 75.23 108.45 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.85 0 C-N-CA 123.359 0.664 . . . . 72.21 109.614 -179.447 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 109.081 -0.711 . . . . 61.5 109.081 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 22.5 m 64.41 56.58 1.26 Allowed 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.395 1.078 . . . . 45.35 111.395 177.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -64.1 177.92 0.74 Allowed 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 114.539 -1.21 . . . . 72.13 110.668 173.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -61.1 104.14 0.35 Allowed 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.322 -0.621 . . . . 73.23 109.322 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -59.85 -44.46 94.11 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.997 0.919 . . . . 72.41 110.87 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -106.93 61.18 0.63 Allowed 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.087 -1.079 . . . . 73.32 108.087 174.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -66.41 -22.87 66.23 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 114.723 -1.126 . . . . 73.23 112.082 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.735 ' HG2' ' HG3' ' C' ' 9' ' ' MET . 49.1 tt0 -131.58 136.7 48.0 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.824 0.85 . . . . 73.21 109.539 -176.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.735 ' HG3' ' HG2' ' C' ' 8' ' ' GLU . 86.2 mtp 66.03 158.25 0.11 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.029 1.332 . . . . 65.43 114.521 172.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 93.6 m -96.45 80.15 3.13 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 106.61 -1.626 . . . . 74.21 106.61 154.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.475 ' HE2' ' HB3' ' C' ' 84' ' ' PHE . 2.7 t80 -111.47 130.92 55.56 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.127 -0.942 . . . . 61.41 109.907 -175.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -152.58 137.35 17.03 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.077 -1.453 . . . . 71.32 107.077 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 64.7 mt -79.81 116.42 23.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 108.332 -0.988 . . . . 64.01 108.332 173.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.456 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 22.2 mm-40 -80.35 -39.0 29.38 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.214 -0.903 . . . . 62.04 109.72 -173.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -179.8 124.33 0.08 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.983 0.513 . . . . 73.21 109.968 -172.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 91.8 mt -109.61 141.21 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 108.848 -0.797 . . . . 64.32 108.848 173.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.448 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 23.5 p90 -174.79 163.97 3.47 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 123.91 0.756 . . . . 74.34 110.236 -173.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.3 p -90.06 125.74 35.52 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.383 0.673 . . . . 64.43 109.369 173.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.448 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 25.8 mmtp -71.07 -49.45 44.43 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 107.887 -1.153 . . . . 74.4 107.887 168.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.718 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 7.9 t70 -139.44 140.77 37.41 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 113.124 -1.853 . . . . 74.22 109.711 -165.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.506 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 73.8 mt -139.18 147.03 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.899 -1.519 . . . . 72.13 106.899 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.9 t -158.95 151.76 21.99 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.418 0.687 . . . . 73.44 109.871 176.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.413 ' CE1' ' HA3' ' C' ' 121' ' ' GLY . 79.0 t80 -153.93 110.68 3.36 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 107.813 -1.18 . . . . 64.44 107.813 173.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -120.61 110.27 16.23 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.516 0.726 . . . . 53.22 109.557 -173.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.24 87.09 22.73 Favored Pre-proline 0 C--O 1.24 0.6 0 N-CA-C 107.253 -1.388 . . . . 62.03 107.253 170.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.05 -37.2 26.79 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.509 2.139 . . . . 65.02 111.992 -176.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -103.97 28.76 6.41 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.512 0.725 . . . . 63.14 109.999 -175.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.501 ' HA ' HG12 ' C' ' 31' ' ' VAL . . . -47.94 -53.8 29.32 Favored Pre-proline 0 CA--C 1.561 1.372 0 N-CA-C 114.322 1.23 . . . . 75.14 114.322 -169.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.78 -49.61 14.1 Favored 'Trans proline' 0 C--N 1.389 2.702 0 CA-C-N 121.747 1.66 . . . . 74.04 112.788 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.475 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 83.2 t60 -69.82 -28.18 65.48 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.859 -0.609 . . . . 61.52 112.087 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.817 HG21 ' HA ' ' C' ' 73' ' ' ALA . 3.7 p -80.93 -13.8 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 O-C-N 121.27 -0.894 . . . . 75.1 112.123 -177.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -81.75 -14.97 55.76 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 112.694 0.627 . . . . 63.13 112.694 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 18.9 pt20 -92.11 9.25 34.25 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.658 0.383 . . . . 74.24 110.559 171.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.07 145.72 28.38 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.517 0.727 . . . . 73.03 110.439 -174.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -71.21 129.94 40.18 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.2 -0.667 . . . . 72.04 109.2 174.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -76.82 84.92 3.41 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.509 0.724 . . . . 72.4 110.292 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -134.14 63.36 61.37 Favored Pre-proline 0 N--CA 1.478 0.967 0 C-N-CA 124.014 0.926 . . . . 70.34 109.351 173.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.42 ' HG2' HG13 ' C' ' 40' ' ' VAL . 92.5 Cg_endo -88.49 159.72 6.6 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.196 1.93 . . . . 73.4 112.855 -172.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -86.44 86.69 7.34 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.011 -1.477 . . . . 74.03 107.011 161.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.42 HG13 ' HG2' ' C' ' 38' ' ' PRO . 15.9 m -65.99 115.03 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 114.411 -1.268 . . . . 73.12 108.593 172.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -127.43 112.35 14.88 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.613 0.765 . . . . 63.53 109.117 -174.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.53 127.68 34.91 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.846 -0.798 . . . . 74.14 108.846 174.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -120.16 135.47 54.96 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.976 1.31 . . . . 74.22 107.91 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.614 HD13 ' HB3' ' G' ' 8' ' ' LEU . 1.8 pt? -122.05 125.81 47.07 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.561 0.696 . . . . 71.52 110.627 -177.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.615 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 2.0 t70 -113.78 143.13 45.15 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.575 -1.268 . . . . 73.02 107.575 171.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 62.1 p -112.4 122.38 47.55 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.325 0.65 . . . . 54.34 109.673 -172.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.647 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -115.02 139.85 49.52 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.696 -0.853 . . . . 53.44 108.696 173.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 15.8 m -141.44 143.18 33.75 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.492 0.717 . . . . 72.23 109.677 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 48.3 t -165.8 128.67 2.08 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.082 0.553 . . . . 73.3 109.775 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -82.3 115.67 21.46 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.064 -1.458 . . . . 74.4 107.064 168.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.496 HD11 HD12 ' C' ' 83' ' ' ILE . 31.4 mt -84.94 -33.85 22.59 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.554 0.741 . . . . 73.34 110.438 -173.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.96 -175.73 5.52 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.45 -1.25 . . . . 34.41 109.681 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -65.98 121.45 15.14 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.927 -1.033 . . . . 73.44 108.968 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 69.75 -5.64 1.18 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.348 1.459 . . . . 65.21 113.288 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 93.1 t -110.8 100.48 10.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 123.652 0.781 . . . . 73.13 109.028 -175.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -105.26 166.25 10.54 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.335 -0.848 . . . . 73.44 109.373 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.471 ' HB2' HD11 ' C' ' 51' ' ' LEU . 37.5 tt0 -127.3 129.66 48.09 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 114.673 -1.149 . . . . 73.43 108.986 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 m -120.56 114.81 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.372 -0.973 . . . . 74.34 108.372 168.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.647 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 57.6 t -111.23 130.92 63.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 123.823 0.849 . . . . 75.41 108.717 176.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mp -112.79 116.59 30.31 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.114 -0.698 . . . . 71.15 109.114 176.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.615 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 19.1 ttm-85 -82.18 106.91 14.46 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.164 -1.05 . . . . 65.32 108.164 171.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 26.4 t -99.12 111.37 28.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.548 -1.279 . . . . 64.22 107.548 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 25.9 m -120.45 121.61 38.9 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.917 -0.772 . . . . 54.4 108.917 -172.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.436 HG21 HG21 ' C' ' 114' ' ' ILE . 74.5 t -98.87 114.58 37.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.905 -0.776 . . . . 73.03 108.905 176.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.5 m -101.1 110.25 22.25 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.586 -0.894 . . . . 62.42 108.586 165.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.01 110.56 21.87 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 105.951 -1.87 . . . . 63.15 105.951 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -132.23 126.62 33.93 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.162 0.506 . . . . 73.15 110.782 -177.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 14.1 mt -86.55 40.44 0.89 Allowed 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 125.741 1.616 . . . . 72.05 110.341 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.24 -101.37 2.14 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 111.467 -0.653 . . . . 63.42 111.467 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -88.33 -30.84 19.28 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.186 0.594 . . . . 52.1 109.847 175.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -79.37 121.28 24.94 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.704 0.802 . . . . 54.24 109.585 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.3 m -82.48 126.7 32.54 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.488 -0.93 . . . . 70.41 108.488 167.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.817 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -69.58 -64.4 0.89 Allowed 'General case' 0 C--O 1.238 0.499 0 O-C-N 124.136 0.897 . . . . 75.32 108.792 175.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -155.35 163.13 40.53 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.804 0.811 . . . . 75.4 111.111 173.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -124.16 102.82 7.91 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 105.719 -1.956 . . . . 71.43 105.719 171.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.421 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.1 t -106.76 151.11 25.58 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 107.742 -1.207 . . . . 54.22 107.742 178.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -158.06 135.89 10.6 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 120.608 0.242 . . . . 72.23 110.489 -173.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' C' ' 110' ' ' ALA . 42.6 t -142.25 114.51 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.52 1.128 . . . . 54.2 108.579 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.718 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 47.1 mt-30 -89.22 91.95 8.98 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.473 -0.936 . . . . 71.25 108.473 169.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.476 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 10.2 tp-100 -80.87 114.61 19.87 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.49 -0.777 . . . . 54.42 109.422 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.86 144.43 16.05 Favored Glycine 0 C--N 1.336 0.538 0 O-C-N 123.808 0.692 . . . . 64.24 111.499 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.427 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -141.76 123.02 2.14 Favored Glycine 0 CA--C 1.5 -0.848 0 N-CA-C 109.657 -1.377 . . . . 74.24 109.657 175.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.496 HD12 HD11 ' C' ' 51' ' ' LEU . 14.1 mm -85.81 123.67 39.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.436 -0.949 . . . . 74.34 108.436 176.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.475 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 59.7 m-85 -130.69 134.15 46.69 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.905 -0.776 . . . . 72.33 108.905 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 20.6 p -89.81 140.71 29.33 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 109.528 -0.545 . . . . 74.12 109.528 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 18.1 tt -137.79 139.08 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.815 0.846 . . . . 52.43 109.14 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -164.25 164.25 22.51 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.387 0.675 . . . . 42.43 109.374 171.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.92 -59.71 2.79 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-N 116.188 -0.46 . . . . 75.34 112.646 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 35.4 pt -91.49 156.26 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.078 0.551 . . . . 73.44 111.204 -173.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -148.78 -176.68 5.43 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.124 0.97 . . . . 72.23 109.385 -177.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.13 -126.42 40.49 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 114.369 0.508 . . . . 32.51 114.369 176.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 38.6 p -79.12 -19.34 51.36 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.617 0.767 . . . . 73.55 111.635 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -62.27 -49.28 76.3 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.784 0.834 . . . . 63.02 109.593 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.418 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 24.3 ptt? -76.15 -28.19 57.31 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 114.665 -1.152 . . . . 74.52 111.006 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.75 -34.17 74.04 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.284 0.633 . . . . 75.21 111.104 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -63.09 -45.1 93.66 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.242 -0.89 . . . . 73.31 110.865 171.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.573 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 47.6 t -66.96 -62.67 1.32 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.763 -0.653 . . . . 65.55 111.084 -174.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.518 HD13 ' H ' ' G' ' 16' ' ' THR . 4.2 pp -71.71 -21.57 61.75 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.234 0.614 . . . . 64.13 112.647 -174.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.05 6.67 43.46 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-O 119.445 -0.642 . . . . 73.12 114.312 -173.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -160.37 -59.4 0.06 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.027 0.913 . . . . 73.52 111.686 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.573 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 15.9 t80 -70.89 -36.25 72.66 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 125.385 1.474 . . . . 74.24 113.0 -167.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.509 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 85.3 m -83.31 -44.06 0.84 Allowed Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 123.249 0.62 . . . . 61.31 111.527 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -53.57 -29.99 52.75 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 122.304 2.003 . . . . 74.43 113.34 165.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -60.07 -36.16 76.74 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.5 1.12 . . . . 71.22 111.1 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 35.1 mm -62.92 -36.18 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 CA-C-N 115.257 -0.883 . . . . 55.2 110.245 175.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.427 HD21 ' HA3' ' C' ' 82' ' ' GLY . 81.1 mt -89.73 -21.24 22.78 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.286 1.217 . . . . 75.11 114.286 -166.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.531 ' HE1' HD22 ' G' ' 8' ' ' LEU . 34.6 m-85 -55.77 -48.16 97.17 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 113.989 1.107 . . . . 71.31 113.989 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.31 -35.39 84.57 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 122.231 1.954 . . . . 73.52 113.272 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -66.78 -48.78 67.96 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.576 0.751 . . . . 74.42 110.79 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.476 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -66.51 -39.92 88.92 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-N 115.898 -0.592 . . . . 72.13 110.859 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -56.73 -52.36 65.3 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.369 1.043 . . . . 71.31 110.42 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -67.95 -35.52 78.54 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.706 0.629 . . . . 74.54 110.141 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.5 t -70.31 -27.52 64.45 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.955 0.502 . . . . 64.54 111.097 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.436 HG21 HG21 ' C' ' 64' ' ' VAL . 85.6 mt -75.64 -55.41 11.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 109.6 -0.518 . . . . 65.33 109.6 172.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.2 m -66.57 -27.78 68.0 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.955 0.902 . . . . 74.5 111.335 -170.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 46.1 t -63.33 -49.43 73.97 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.655 0.782 . . . . 75.21 109.243 169.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.535 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.86 -34.74 78.61 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.255 1.022 . . . . 73.11 112.214 178.588 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.42 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.8 t -62.55 -46.41 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.556 0.743 . . . . 73.21 109.114 175.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 30.9 t -66.03 -34.72 78.73 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.194 -1.366 . . . . 61.52 111.6 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -68.2 -31.71 71.43 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.503 0.721 . . . . 74.13 110.054 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . 0.413 ' HA3' ' CE1' ' C' ' 23' ' ' PHE . . . -90.55 10.42 74.63 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.694 0.621 . . . . 73.43 112.839 173.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.491 HG23 ' HB3' ' D' ' 17' ' ' TYR . 62.6 p 56.71 29.27 15.54 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 126.016 1.726 . . . . 75.55 113.941 175.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -88.17 151.73 49.44 Favored Pre-proline 0 N--CA 1.483 1.181 0 C-N-CA 123.357 0.663 . . . . 64.32 109.475 173.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.56 162.98 11.44 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 123.283 2.655 . . . . 75.41 113.98 175.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -52.73 137.53 31.11 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.836 1.254 . . . . 64.24 113.236 -175.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 35.9 tp -150.43 101.53 2.97 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.122 -0.945 . . . . 71.25 109.094 173.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -108.35 133.22 52.85 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.015 0.926 . . . . 60.01 110.142 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.39 138.66 58.6 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.037 0.935 . . . . 73.04 111.705 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.653 ' HB3' ' HB2' ' G' ' 7' ' ' ALA . . . -70.75 147.03 94.15 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.091 0.956 . . . . 53.11 110.559 175.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.548 ' HG3' HD12 ' A' ' 16' ' ' ILE . 10.8 Cg_exo -68.26 93.79 0.41 Allowed 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.468 2.112 . . . . 74.45 111.762 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 p -98.56 110.12 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-O 121.304 0.574 . . . . 74.11 109.649 176.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -113.96 104.03 11.75 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 106.879 -1.526 . . . . 73.51 106.879 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.404 ' CE2' ' HZ ' ' C' ' 107' ' ' PHE . 55.4 m-85 -55.41 -44.35 76.11 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 124.106 0.879 . . . . 63.1 112.575 -167.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -70.89 -30.65 67.07 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 123.241 0.338 . . . . 70.52 111.352 -176.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.94 -36.52 84.65 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 123.305 0.378 . . . . 62.23 110.316 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 27.7 tp -75.69 -26.9 58.01 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.78 -0.645 . . . . 73.03 110.602 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -74.65 -31.0 61.82 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.067 0.547 . . . . 71.3 111.567 175.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 66.1 mtt -76.34 -40.37 51.46 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.202 0.601 . . . . 45.05 109.75 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -61.97 -37.48 84.93 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.815 1.246 . . . . 61.54 110.56 173.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -69.09 -83.53 0.03 OUTLIER 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.309 1.044 . . . . 71.21 110.04 174.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 tm? 68.67 -71.89 0.11 Allowed 'General case' 0 C--N 1.363 1.177 0 C-N-CA 125.394 1.477 . . . . 75.42 109.055 -172.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -162.45 -69.66 0.05 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.126 -1.065 . . . . 74.41 108.126 174.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -149.88 74.01 1.19 Allowed 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.52 -1.289 . . . . 75.41 107.52 174.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -78.79 82.51 5.0 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 114.746 -1.115 . . . . 70.24 109.653 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.96 137.32 38.97 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.986 -1.006 . . . . 64.14 111.73 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . 0.481 ' HA3' ' HB ' ' A' ' 7' ' ' THR . . . -169.61 -162.77 22.48 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 115.679 -0.691 . . . . 44.44 112.014 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -113.53 133.62 55.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.931 0.892 . . . . 74.43 109.523 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -108.5 102.88 1.77 Allowed Glycine 0 C--N 1.343 0.966 0 N-CA-C 111.184 -0.766 . . . . 54.21 111.184 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 26.9 m -65.45 97.05 0.27 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.011 0.924 . . . . 73.32 110.987 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -82.85 154.26 24.75 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.766 0.827 . . . . 74.31 110.375 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -174.82 155.05 2.03 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.608 0.763 . . . . 75.21 109.571 177.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -90.52 148.68 22.57 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.517 0.727 . . . . 44.11 110.224 175.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . 0.451 ' HG3' HG11 ' A' ' 55' ' ' VAL . 2.0 mp0 -103.0 135.38 44.8 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.609 1.163 . . . . 74.54 108.363 173.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -72.57 -30.17 64.17 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 109.783 -0.451 . . . . 75.54 109.783 168.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.246 0 O-C-N 124.961 1.413 . . . . 75.5 109.247 -172.938 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 120.434 0.159 . . . . 61.3 110.731 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 21.6 m -135.96 82.73 1.96 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.404 0.682 . . . . 62.14 109.338 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -114.58 94.45 4.79 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.602 0.761 . . . . 55.1 109.465 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . 0.539 ' HB2' ' HB2' ' D' ' 93' ' ' GLN . 25.1 mp0 -105.36 116.53 32.1 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.873 0.869 . . . . 71.45 108.787 177.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -100.44 122.25 42.88 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.147 -0.686 . . . . 62.31 109.147 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -154.68 109.3 3.01 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 109.661 -0.496 . . . . 64.35 109.661 -175.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 25.3 m -99.61 -29.21 12.82 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.874 0.87 . . . . 62.12 111.036 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.11 -18.45 60.84 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.678 0.791 . . . . 75.32 111.155 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.533 ' HG2' HG12 ' D' ' 89' ' ' ILE . 1.5 tmt? -28.76 127.19 0.09 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.956 2.102 . . . . 74.42 112.598 162.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 29.9 m -106.28 142.73 35.47 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 123.613 0.765 . . . . 71.22 110.204 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -155.85 98.85 1.94 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.608 -1.256 . . . . 75.23 107.608 -177.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . 0.51 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 49.6 mt-30 -113.46 118.85 35.65 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.74 -0.837 . . . . 74.41 108.74 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.489 HG21 ' HG2' ' B' ' 130' ' ' PRO . 38.0 mt -67.7 123.82 21.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 122.673 0.389 . . . . 64.12 110.14 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.429 HE22 HG22 ' D' ' 55' ' ' VAL . 68.5 mt-30 -96.92 -45.43 6.62 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 123.467 0.479 . . . . 71.51 110.358 176.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -167.55 131.36 1.77 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 119.417 -0.325 . . . . 74.14 110.908 -169.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.664 HD13 ' HG3' ' B' ' 130' ' ' PRO . 3.1 mp -115.28 138.28 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 107.7 -1.222 . . . . 60.04 107.7 169.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.491 ' HB3' HG23 ' C' ' 122' ' ' THR . 41.8 p90 -165.79 176.27 8.08 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 124.293 0.995 . . . . 71.44 111.142 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . 0.406 HG21 HD11 ' D' ' 21' ' ' ILE . 80.4 p -106.71 122.95 47.38 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.573 -1.194 . . . . 72.2 109.356 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.425 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 32.8 mtpt -94.23 -24.41 17.48 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.675 -0.693 . . . . 64.34 109.753 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.6 t70 -152.52 133.28 13.98 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 114.527 -1.215 . . . . 51.44 108.632 176.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.535 HG21 ' HE2' ' C' ' 117' ' ' MET . 80.6 mt -131.07 147.59 33.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.155 -1.424 . . . . 71.13 107.155 172.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . 0.54 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 34.6 t -150.49 140.36 21.87 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.789 1.236 . . . . 74.1 107.936 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.506 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.5 t80 -152.84 125.92 8.53 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 105.706 -1.961 . . . . 73.32 105.706 171.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 37.0 mt-10 -137.34 111.63 8.52 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.129 0.572 . . . . 70.13 109.644 -175.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.25 85.38 10.43 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 108.396 -0.965 . . . . 64.12 108.396 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.09 -21.12 12.38 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 122.844 2.362 . . . . 74.11 112.697 -173.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -102.64 0.84 33.83 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.786 0.834 . . . . 75.34 110.675 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -28.66 -64.88 0.16 Allowed Pre-proline 0 CA--C 1.565 1.529 0 N-CA-C 116.392 1.997 . . . . 71.32 116.392 -158.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.46 -22.41 10.83 Favored 'Trans proline' 0 C--N 1.383 2.391 0 CA-C-N 123.091 2.14 . . . . 65.01 113.907 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -69.05 -42.67 75.97 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.266 1.027 . . . . 54.42 109.75 174.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.2 p -83.17 -19.88 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 CA-C-N 115.829 -0.623 . . . . 71.43 111.404 -172.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -63.36 -26.49 68.78 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 112.454 0.539 . . . . 75.21 112.454 177.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -58.69 -20.59 49.86 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.627 0.771 . . . . 72.23 110.784 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.44 ' NZ ' ' HB3' ' D' ' 71' ' ' GLU . 92.2 mttt -90.52 87.39 6.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.277 1.031 . . . . 54.34 108.63 166.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -97.17 82.13 3.14 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.383 0.611 . . . . 74.14 110.15 -173.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 38.9 p90 -156.94 -174.21 4.82 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.736 1.214 . . . . 75.42 108.691 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -69.13 114.46 23.63 Favored Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 123.976 0.91 . . . . 72.33 111.108 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.59 127.99 18.25 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.553 2.169 . . . . 74.52 111.847 171.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -75.66 134.99 40.45 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.304 -0.628 . . . . 74.33 109.304 177.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.578 HG13 HG13 ' D' ' 64' ' ' VAL . 74.1 t -102.23 132.81 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.889 0.876 . . . . 65.03 111.306 -174.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.459 ' HB2' ' OG1' ' D' ' 65' ' ' THR . 74.6 mmtt -98.2 130.38 44.94 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.915 -1.143 . . . . 72.53 107.915 168.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' H' ' 6' ' ' ILE . 3.0 tm? -96.69 126.08 41.6 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.544 0.738 . . . . 74.3 109.403 -175.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.808 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 22.4 m-20 -127.66 142.85 51.23 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.136 0.974 . . . . 72.21 108.402 171.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 89.9 mt -129.69 143.26 50.74 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.588 0.755 . . . . 53.43 109.998 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 9.9 t70 -141.36 144.76 34.72 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.209 1.004 . . . . 54.42 108.53 175.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 35.9 p -104.26 143.53 32.83 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.532 0.733 . . . . 52.24 111.327 -173.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.656 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.92 141.74 22.83 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.898 0.879 . . . . 70.11 108.771 171.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.1 p -166.42 154.27 10.07 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.92 0.488 . . . . 61.11 109.795 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 60.2 p -164.04 142.56 7.45 Favored 'General case' 0 C--O 1.24 0.558 0 O-C-N 123.877 0.736 . . . . 64.43 110.224 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -76.36 126.02 30.24 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.104 -0.702 . . . . 54.11 109.104 168.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 73.9 mt -97.45 -30.73 12.74 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.25 0.62 . . . . 64.12 110.55 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.23 -175.06 2.81 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.693 0.797 . . . . 71.54 110.53 177.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -61.9 116.44 4.87 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.821 -1.081 . . . . 73.22 110.087 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 64.41 9.86 5.29 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.926 1.29 . . . . 63.32 112.48 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.429 HG22 HE22 ' D' ' 14' ' ' GLN . 93.7 t -109.73 114.98 48.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 108.157 -1.053 . . . . 73.34 108.157 173.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.483 ' HB2' HD12 ' D' ' 86' ' ' ILE . 72.7 m-85 -134.69 133.08 39.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.509 -0.923 . . . . 73.53 108.509 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -104.55 136.86 43.31 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.844 0.858 . . . . 72.43 109.322 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 38.2 t -121.69 129.21 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 107.737 -1.209 . . . . 64.13 107.737 174.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.656 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 20.4 t -121.56 132.07 71.59 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 C-N-CA 124.221 1.008 . . . . 71.04 108.674 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.59 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 3.9 mm? -119.09 120.2 36.47 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.305 0.642 . . . . 75.32 109.767 176.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.577 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 18.9 ttm-85 -88.67 101.25 13.8 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.404 -0.816 . . . . 71.14 108.82 173.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 55.1 t -90.99 126.37 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 107.574 -1.269 . . . . 52.25 107.574 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.808 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 9.3 m -122.57 125.7 46.23 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.761 0.791 . . . . 71.34 109.983 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.578 HG13 HG13 ' D' ' 40' ' ' VAL . 25.3 t -111.09 99.43 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.959 1.704 . . . . 72.44 108.137 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.47 HG22 HD22 ' D' ' 75' ' ' LEU . 1.8 p -99.64 94.98 6.66 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 107.887 -1.153 . . . . 73.31 107.887 174.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.23 155.62 16.66 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.935 -1.03 . . . . 42.52 111.141 -170.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.49 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.5 p -153.58 132.45 12.41 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.713 -0.676 . . . . 64.11 111.932 -176.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.521 HD12 HG22 ' D' ' 31' ' ' VAL . 24.9 mt -93.74 99.18 11.63 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 124.893 1.277 . . . . 50.14 108.856 172.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.37 -119.86 7.4 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.129 -0.941 . . . . 74.22 112.015 -174.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.77 5.4 49.22 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.428 1.091 . . . . 60.51 111.241 -177.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.44 ' HB3' ' NZ ' ' D' ' 34' ' ' LYS . 5.5 tp10 -129.08 139.72 51.88 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.063 0.945 . . . . 63.41 109.513 -169.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.4 m -61.55 128.59 37.02 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.809 0.843 . . . . 73.25 111.471 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.527 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -83.95 -70.42 0.57 Allowed 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.838 -1.171 . . . . 73.24 107.838 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -146.33 166.74 25.41 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.623 -1.171 . . . . 70.1 109.025 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.47 HD22 HG22 ' D' ' 65' ' ' THR . 48.2 mt -116.24 151.17 36.3 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 105.842 -1.91 . . . . 72.34 105.842 171.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.48 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 50.3 t -157.1 140.23 15.44 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.247 -1.02 . . . . 71.42 108.247 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . 0.54 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 36.7 tt0 -156.75 131.11 8.61 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 122.853 0.461 . . . . 72.52 109.839 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -136.81 118.55 19.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 123.337 0.655 . . . . 65.13 109.742 -177.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.513 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.2 mt-30 -86.41 87.13 7.37 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.811 -1.181 . . . . 74.23 107.811 166.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . 0.442 ' O ' HD13 ' D' ' 106' ' ' LEU . 8.5 tp-100 -79.9 105.2 11.01 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.279 -1.328 . . . . 70.23 107.698 176.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -110.45 143.69 16.96 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.854 -0.498 . . . . 74.22 111.854 -177.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.49 131.43 5.51 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 111.371 -0.691 . . . . 63.32 111.371 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 60.4 mt -89.32 128.42 41.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 C-N-CA 124.497 1.119 . . . . 74.32 107.985 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -136.79 145.66 44.8 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.883 0.373 . . . . 73.42 110.876 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.51 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 16.6 m -78.04 99.47 6.11 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.274 -1.009 . . . . 63.13 108.274 166.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.483 HD12 ' HB2' ' D' ' 56' ' ' TYR . 66.1 mt -107.22 108.6 25.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 123.867 0.867 . . . . 72.05 108.845 -175.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.52 163.77 34.67 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.545 1.138 . . . . 64.41 109.786 -175.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.71 20.82 79.82 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.693 -0.685 . . . . 72.24 114.373 173.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.533 HG12 ' HG2' ' D' ' 9' ' ' MET . 6.0 mt -104.6 156.88 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 117.374 0.587 . . . . 70.53 110.386 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -140.22 147.62 40.3 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.431 1.092 . . . . 70.21 111.118 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.84 -136.11 48.93 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 115.216 0.847 . . . . 43.42 115.216 169.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 16.0 m -85.67 -9.17 57.63 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.911 0.885 . . . . 62.22 111.554 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.539 ' HB2' ' HB2' ' D' ' 4' ' ' GLN . 0.1 OUTLIER -53.05 -31.1 39.62 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.673 -0.862 . . . . 45.03 108.673 166.147 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.46 ' HB3' ' H ' ' H' ' 18' ' ' VAL . 51.9 mtt -57.32 -55.24 37.31 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.975 0.91 . . . . 73.34 111.357 172.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . 0.469 ' HB1' HD22 ' H' ' 14' ' ' LEU . . . -63.3 -29.66 70.94 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.417 0.687 . . . . 65.15 111.516 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -72.4 -40.71 66.98 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.06 0.944 . . . . 63.15 111.139 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.0 t -64.18 -49.56 71.57 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.364 0.666 . . . . 62.51 109.916 -176.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 34.0 mt -75.53 -26.94 58.46 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.275 -1.329 . . . . 74.32 110.914 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.01 -2.5 58.2 Favored Glycine 0 C--N 1.352 1.461 0 CA-C-O 119.368 -0.685 . . . . 63.25 114.399 -176.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.71 -58.98 0.57 Allowed 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 117.905 0.853 . . . . 51.25 111.338 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -71.11 -38.22 72.34 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 111.841 0.311 . . . . 61.31 111.841 -170.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 62.2 m -72.8 -47.98 8.61 Favored Pre-proline 0 CA--C 1.559 1.316 0 CA-C-O 118.576 -0.726 . . . . 63.34 111.776 -177.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.59 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 17.1 Cg_endo -61.5 -22.59 74.88 Favored 'Trans proline' 0 C--N 1.401 3.31 0 C-N-CA 122.27 1.98 . . . . 74.42 112.875 170.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -66.96 -37.46 84.31 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.223 0.609 . . . . 73.25 110.266 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 48.9 mm -71.08 -39.14 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.501 0.72 . . . . 65.11 110.333 175.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.442 HD13 ' O ' ' D' ' 80' ' ' GLN . 86.7 mt -79.28 -18.64 52.29 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.33 -0.85 . . . . 64.1 111.876 -177.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -61.21 -50.1 85.4 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-O 117.87 -1.062 . . . . 72.22 113.487 -175.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.78 -38.99 93.74 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 122.116 1.877 . . . . 42.24 112.667 178.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -78.17 -36.96 46.9 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.087 0.955 . . . . 60.41 112.26 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.79 73.84 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.046 0.539 . . . . 75.35 109.952 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.584 HH12 ' HG3' ' D' ' 130' ' ' PRO . 40.1 ttp180 -57.27 -51.48 69.17 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 124.164 0.915 . . . . 75.13 110.097 174.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -62.54 -43.82 97.87 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.719 0.807 . . . . 73.23 111.729 -174.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.8 t -58.78 -45.51 89.67 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.809 0.693 . . . . 62.51 110.779 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.463 ' O ' HG23 ' D' ' 118' ' ' VAL . 97.5 mt -62.55 -55.14 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.883 -1.053 . . . . 72.4 110.586 174.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 43.5 m -53.24 -40.06 64.29 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.849 1.26 . . . . 71.1 111.449 -174.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.4 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.0 t -66.36 -45.15 81.09 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.729 -1.123 . . . . 65.01 110.439 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.1 mtm -70.01 -28.54 65.58 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.781 0.432 . . . . 64.51 112.08 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.463 HG23 ' O ' ' D' ' 114' ' ' ILE . 96.0 t -64.85 -44.86 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.395 0.678 . . . . 74.55 109.633 174.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.8 p -77.3 -25.42 51.26 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 115.444 -0.798 . . . . 73.44 111.007 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' D' ' 116' ' ' SER . 91.0 mtt-85 -72.69 -35.22 67.59 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.438 0.695 . . . . 62.51 109.538 173.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.48 -0.14 86.42 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 115.644 -0.707 . . . . 64.42 112.122 171.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 42.6 p 62.97 22.02 13.22 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.938 2.095 . . . . 62.03 113.972 174.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -82.23 152.07 67.26 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 123.545 0.738 . . . . 75.42 109.286 169.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -49.59 132.2 29.91 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.372 2.715 . . . . 74.24 113.934 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -51.43 141.02 16.4 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.651 1.58 . . . . 63.25 113.002 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 62.5 tp -114.48 109.58 18.51 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.224 1.01 . . . . 74.5 109.577 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -113.62 97.14 6.25 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.645 -0.872 . . . . 75.41 108.645 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 20.1 tp -70.85 126.59 29.99 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 110.008 -0.367 . . . . 55.41 110.008 177.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -62.09 130.26 92.67 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.079 0.952 . . . . 72.11 110.676 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.584 ' HG3' HH12 ' D' ' 111' ' ' ARG . 2.4 Cg_endo -79.74 106.02 1.91 Allowed 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.657 2.238 . . . . 62.33 110.181 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 35.9 m -107.01 149.44 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 109.281 -0.637 . . . . 73.1 109.281 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -80.29 75.34 7.11 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.613 0.721 . . . . 71.21 109.181 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.416 ' HD2' ' HB2' ' H' ' 9' ' ' ALA . 37.6 p90 -73.62 -24.42 60.02 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.855 0.862 . . . . 71.14 110.95 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' D' ' 138' ' ' MET . 4.3 m-20 -51.77 -50.63 60.31 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.648 1.579 . . . . 63.21 111.868 176.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.0 -45.26 94.38 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.601 0.76 . . . . 31.34 111.663 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 51.7 tp -63.7 -34.96 79.04 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.379 0.671 . . . . 54.33 110.817 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -70.82 -30.05 66.38 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.684 0.793 . . . . 51.3 110.789 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.441 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 45.1 mtt -62.85 -30.69 71.69 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.573 0.749 . . . . 74.22 111.102 176.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -77.85 -20.05 53.77 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.993 0.917 . . . . 54.12 111.738 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -62.97 -37.2 86.14 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.87 0.868 . . . . 62.13 110.399 174.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.9 mp -65.43 -30.67 71.5 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.026 0.931 . . . . 70.35 110.648 175.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -86.14 0.76 52.82 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.104 -0.953 . . . . 74.4 112.101 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -135.16 47.39 2.34 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.578 0.704 . . . . 73.0 109.65 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -151.57 127.64 10.43 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.091 -0.958 . . . . 74.11 109.249 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.56 -23.35 62.59 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.506 0.722 . . . . 61.33 111.612 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 75.88 18.4 79.58 Favored Glycine 0 C--N 1.351 1.404 0 CA-C-N 115.992 -0.549 . . . . 35.12 112.119 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -89.04 171.53 9.78 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.805 0.842 . . . . 74.45 109.948 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 147.5 116.55 0.93 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 111.314 -0.714 . . . . 53.33 111.314 177.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 7.7 t -64.34 135.86 56.58 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 123.194 0.598 . . . . 43.14 110.632 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -87.26 71.89 9.95 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.852 0.834 . . . . 53.43 108.802 175.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -146.63 135.93 22.77 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.01 -1.45 . . . . 53.23 107.964 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -159.05 82.89 0.79 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.416 -0.957 . . . . 75.35 108.416 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -70.85 -41.08 71.92 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.992 -1.003 . . . . 73.35 110.518 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -74.26 136.85 42.69 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.501 0.72 . . . . 65.53 110.096 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 N-CA-C 108.394 -0.965 . . . . 51.15 108.394 179.655 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . 0.422 ' SD ' ' N ' ' E' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 110.117 -0.327 . . . . 75.15 110.117 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 2' ' ' LYS . . . . . 0.493 ' HB3' ' HD1' ' A' ' 36' ' ' TRP . 37.9 ttmt -75.57 135.81 40.55 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.572 0.749 . . . . 73.34 110.337 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -73.84 149.13 41.79 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.163 -0.68 . . . . 73.1 109.163 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 22.4 p -136.99 155.05 50.2 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.85 0.86 . . . . 61.02 109.69 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 13.2 t -139.57 158.63 43.8 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.63 0.372 . . . . 73.35 110.989 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.64 HD13 HG21 ' A' ' 64' ' ' VAL . 18.6 mt -109.33 87.31 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.447 1.099 . . . . 75.44 109.041 -176.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.86 91.39 1.51 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.285 0.564 . . . . 70.01 110.643 -176.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.417 HD21 HD21 ' A' ' 44' ' ' LEU . 8.7 tt -89.8 147.17 23.96 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.754 1.221 . . . . 73.45 109.804 -175.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -101.02 -84.33 0.44 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.577 0.751 . . . . 62.21 111.244 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 27.7 mt -154.1 -170.56 3.59 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 124.404 1.082 . . . . 54.52 111.077 -176.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.505 HD23 ' HE2' ' A' ' 137' ' ' PHE . 3.6 mm? -74.21 158.94 84.9 Favored Pre-proline 0 CA--C 1.562 1.412 0 C-N-CA 124.22 1.008 . . . . 55.42 109.483 171.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.83 -24.48 79.2 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.971 2.447 . . . . 73.11 113.283 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 tt -162.27 -75.66 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 107.41 -1.329 . . . . 73.14 107.41 175.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 86.2 mt -130.61 -160.34 1.03 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.001 1.32 . . . . 64.14 108.715 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -125.8 159.72 31.68 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 107.925 -1.139 . . . . 72.23 107.925 175.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 43.8 m -59.1 133.36 87.54 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 123.928 0.891 . . . . 64.04 111.044 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 17' ' ' PRO . . . . . 0.735 ' HA ' HD22 ' A' ' 98' ' ' LEU . 39.2 Cg_endo -64.43 147.26 90.58 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.714 2.276 . . . . 63.24 113.174 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 18' ' ' VAL . . . . . 0.682 HG23 ' HB3' ' A' ' 98' ' ' LEU . 85.7 t -74.76 -76.19 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 123.252 0.621 . . . . 64.43 109.341 175.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . 0.598 HG22 HG12 ' E' ' 18' ' ' VAL . 5.0 t -156.02 124.96 6.04 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.86 0.464 . . . . 73.54 110.036 -178.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 20' ' ' LYS . . . . . 0.437 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 50.3 tptt 76.1 -36.14 0.27 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.178 1.391 . . . . 72.12 112.739 173.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.82 93.11 0.05 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.967 0.907 . . . . 60.15 111.223 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 55.9 ttt85 -95.07 133.1 39.24 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.328 1.051 . . . . 73.32 109.145 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 13.7 t -63.39 143.29 97.83 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-O 118.11 -0.947 . . . . 63.44 109.288 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -36.52 120.6 0.25 Allowed 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 124.326 3.35 . . . . 72.33 114.136 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 . . . . . 0 C--O 1.251 1.157 0 O-C-N 124.264 0.978 . . . . 53.22 111.395 -173.073 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 110.161 -0.311 . . . . 75.15 110.161 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 68.38 6.86 5.6 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.424 1.49 . . . . 75.22 112.986 174.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 62.69 -69.79 0.06 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.657 1.583 . . . . 74.42 111.83 -175.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 19.5 t 64.54 80.73 0.22 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.64 1.176 . . . . 61.43 110.744 173.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 89.9 m -80.94 120.16 24.4 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.915 0.886 . . . . 73.1 109.784 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.483 HG12 HD23 ' B' ' 42' ' ' LEU . 19.2 tt -75.38 133.12 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 122.815 0.446 . . . . 73.32 111.003 -178.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 7' ' ' ALA . . . . . 0.573 ' HB2' ' HB3' ' B' ' 129' ' ' ALA . . . -163.02 172.24 15.28 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.655 0.782 . . . . 62.43 110.467 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . 0.809 HD23 HD21 ' B' ' 44' ' ' LEU . 4.2 mp -95.7 -177.05 3.92 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.251 1.021 . . . . 51.2 108.626 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -154.42 -169.89 3.37 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.527 0.331 . . . . 63.13 111.545 -173.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 10' ' ' LEU . . . . . 0.411 ' O ' ' HD3' ' F' ' 12' ' ' PRO . 6.3 tt -56.96 130.03 44.23 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.377 1.071 . . . . 75.1 108.147 170.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 82.5 mt -102.78 99.47 13.69 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.384 0.674 . . . . 72.41 109.986 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 12' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' F' ' 10' ' ' LEU . 13.9 Cg_exo -70.43 -16.84 34.8 Favored 'Trans proline' 0 C--N 1.385 2.489 0 C-N-CA 122.685 2.257 . . . . 71.33 111.561 175.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 88.1 mt -58.09 -34.66 70.41 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 124.064 0.946 . . . . 61.45 110.993 175.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 90.0 mt 61.19 -171.38 0.15 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.686 1.194 . . . . 71.32 111.474 -176.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -167.1 92.94 0.43 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.081 -1.081 . . . . 74.21 108.081 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 68.2 p -129.95 73.63 81.25 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 123.791 0.837 . . . . 74.33 110.534 -177.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -94.75 9.2 1.94 Allowed 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.696 2.264 . . . . 74.42 112.382 176.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . 0.461 HG12 ' H ' ' F' ' 20' ' ' LYS . 33.6 t -93.49 -88.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.56 0 C-N-CA 123.061 0.544 . . . . 72.15 110.732 -171.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 9.0 m 67.8 -5.38 0.83 Allowed 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 124.791 1.237 . . . . 74.43 112.504 -176.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 20' ' ' LYS . . . . . 0.75 ' HE3' HE22 ' B' ' 50' ' ' GLN . 48.7 pttt -159.75 77.66 0.68 Allowed 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.881 0.872 . . . . 62.42 110.276 -177.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . 0.4 ' HB1' ' HA ' ' B' ' 87' ' ' ALA . . . -117.52 99.12 6.77 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 107.799 -1.185 . . . . 71.13 107.799 168.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . 0.491 ' HG3' ' HD3' ' F' ' 24' ' ' PRO . 22.5 ptt180 -109.88 -179.03 3.68 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.926 0.891 . . . . 64.42 111.315 -167.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 85.1 m -138.19 99.68 8.88 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 106.577 -1.638 . . . . 72.54 106.577 164.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 24' ' ' PRO . . . . . 0.491 ' HD3' ' HG3' ' F' ' 22' ' ' ARG . 71.9 Cg_endo -76.7 67.13 7.38 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.781 2.321 . . . . 73.23 111.746 178.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 . . . . . 0 C--O 1.246 0.906 0 N-CA-C 107.231 -1.396 . . . . 61.51 107.231 -177.838 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 20.2 mmt . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 109.128 -0.693 . . . . 42.03 109.128 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt 69.0 26.38 5.68 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.301 1.441 . . . . 72.43 112.759 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -77.64 88.95 3.93 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.207 0.527 . . . . 74.42 110.16 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 17.5 m -85.06 -5.95 59.33 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.646 -0.706 . . . . 74.22 110.326 170.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 5' ' ' THR . . . . . 0.485 HG22 ' HB2' ' C' ' 129' ' ' ALA . 2.9 m -61.11 104.68 0.4 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.833 1.253 . . . . 61.43 110.025 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 pp -70.83 157.07 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 123.278 0.631 . . . . 61.42 112.351 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 7' ' ' ALA . . . . . 0.653 ' HB2' ' HB3' ' C' ' 129' ' ' ALA . . . -166.78 -165.48 0.74 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.063 0.945 . . . . 71.45 109.68 -176.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 8' ' ' LEU . . . . . 0.614 ' HB3' HD13 ' C' ' 44' ' ' LEU . 6.7 mp -69.78 -35.71 75.11 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.623 0.769 . . . . 71.14 110.817 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . 63.78 -77.44 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.461 1.504 . . . . 71.34 113.279 174.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 97.2 mt -124.51 148.4 47.76 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.413 1.085 . . . . 71.12 109.978 -176.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 11' ' ' LEU . . . . . 0.401 HD23 HD12 ' C' ' 44' ' ' LEU . 60.1 mt -82.37 122.5 79.12 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 123.218 0.607 . . . . 72.04 109.788 173.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.04 1.67 9.05 Favored 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 122.294 1.996 . . . . 74.52 113.098 171.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 52.4 tp -157.08 133.01 9.51 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.363 0.665 . . . . 61.31 109.629 173.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 93.7 mt -82.19 127.48 33.2 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.273 -1.01 . . . . 71.12 108.273 172.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -57.95 -58.75 7.03 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.845 0.858 . . . . 70.31 111.775 -175.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 16' ' ' THR . . . . . 0.518 ' H ' HD13 ' C' ' 98' ' ' LEU . 81.1 p 41.59 53.41 7.29 Favored Pre-proline 0 CA--C 1.57 1.742 0 C-N-CA 125.905 1.682 . . . . 73.2 114.615 177.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 17' ' ' PRO . . . . . 0.411 ' HD2' HG23 ' G' ' 18' ' ' VAL . 37.4 Cg_endo -96.59 26.44 0.24 Allowed 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 123.088 2.525 . . . . 75.32 112.176 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 18' ' ' VAL . . . . . 0.411 HG23 ' HD2' ' G' ' 17' ' ' PRO . 38.2 t -117.78 -75.81 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 123.963 0.905 . . . . 71.4 108.814 -177.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 16.2 p -139.75 -165.33 1.86 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.745 1.218 . . . . 71.44 109.453 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.28 122.66 26.61 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.194 0.597 . . . . 74.51 109.71 175.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.7 2.98 31.02 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.589 0.755 . . . . 75.02 112.747 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -140.89 142.52 34.46 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.429 0.692 . . . . 72.43 109.484 176.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 37.6 p -90.56 133.7 32.26 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 108.09 -1.078 . . . . 74.1 108.09 167.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -47.32 -61.15 0.65 Allowed 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.153 2.569 . . . . 74.43 112.888 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 108.157 -1.053 . . . . 71.53 108.157 176.289 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 110.082 -0.34 . . . . 60.23 110.082 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.07 102.04 5.53 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.749 -0.834 . . . . 61.35 108.749 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -73.53 88.31 1.64 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.698 0.799 . . . . 71.24 109.307 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 20.2 m -80.73 99.98 8.5 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.164 -0.925 . . . . 75.52 110.783 -174.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 63.1 m -156.35 -58.68 0.09 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.763 1.225 . . . . 74.32 107.717 172.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.562 ' HA ' ' HB2' ' D' ' 42' ' ' LEU . 9.4 tt -149.14 102.43 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 CA-C-N 114.522 -1.217 . . . . 70.4 107.877 175.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 7' ' ' ALA . . . . . 0.487 ' H ' ' HG ' ' D' ' 42' ' ' LEU . . . -108.74 174.53 5.83 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.281 1.033 . . . . 72.41 112.561 -167.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 94.4 mt -129.06 167.0 18.16 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.148 1.379 . . . . 61.31 108.734 173.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 9' ' ' ALA . . . . . 0.416 ' HB2' ' HD2' ' D' ' 133' ' ' PHE . . . 63.12 -168.32 0.2 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.436 1.094 . . . . 73.41 111.148 -173.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 82.5 mt 61.82 24.31 14.45 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.071 0.948 . . . . 72.31 111.257 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.531 HD22 HD11 ' D' ' 60' ' ' LEU . 2.0 pp -69.99 146.45 95.14 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 124.711 1.204 . . . . 74.12 110.83 -176.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -28.82 96.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.395 3.018 1 C-N-CA 125.707 4.272 . . . . 74.32 116.164 -173.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 57.53 -94.47 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.778 1.631 . . . . 74.34 109.93 -178.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . 0.469 HD22 ' HB1' ' D' ' 95' ' ' ALA . 67.2 mt -155.73 161.54 40.69 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.815 1.646 . . . . 71.32 108.029 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -82.67 6.05 19.17 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 118.629 -0.7 . . . . 71.41 112.084 174.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 47.4 m 72.2 138.62 0.06 OUTLIER Pre-proline 0 CA--C 1.565 1.53 0 C-N-CA 124.613 1.165 . . . . 73.21 110.881 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.33 148.84 24.46 Favored 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 122.623 2.215 . . . . 74.55 112.808 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . 0.46 ' H ' ' HB3' ' D' ' 94' ' ' MET . 76.3 t -61.66 -29.88 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 125.191 1.396 . . . . 64.23 111.892 -176.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 17.2 m -59.35 -37.53 78.11 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.742 0.817 . . . . 72.52 111.194 172.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -107.11 4.3 26.72 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.787 1.235 . . . . 74.51 111.98 -175.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.53 74.71 6.18 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.825 0.821 . . . . 71.24 110.318 -176.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 41.2 ttp85 -169.61 129.96 1.04 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.287 1.435 . . . . 75.15 107.241 -175.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 14.1 m 55.97 62.73 6.67 Favored Pre-proline 0 CA--C 1.57 1.74 0 C-N-CA 124.087 0.955 . . . . 75.01 110.886 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -89.38 12.33 2.69 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 122.929 2.419 . . . . 73.22 113.244 -176.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 . . . . . 0 CA--C 1.55 0.971 0 C-N-CA 123.474 0.709 . . . . 71.55 109.151 177.399 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.9 mtm . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 109.976 -0.379 . . . . 75.43 109.976 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.6 t -141.13 100.76 3.88 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.996 0.918 . . . . 63.34 108.907 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -120.12 35.97 4.69 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 108.573 -0.899 . . . . 63.02 108.573 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 65.03 175.48 0.2 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.753 1.221 . . . . 63.41 111.402 -173.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.567 ' HA ' ' HB3' ' C' ' 145' ' ' ALA . 61.0 t30 -144.37 91.69 2.22 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.426 0.631 . . . . 71.34 111.113 -175.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -126.79 99.04 5.59 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 106.608 -1.627 . . . . 71.11 106.608 164.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.0 p -72.6 -62.9 1.28 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.589 -0.732 . . . . 62.5 110.663 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -141.0 -63.81 0.46 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.946 0.898 . . . . 72.33 108.708 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.442 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 15.0 tpt -91.42 147.81 22.76 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.887 0.875 . . . . 62.15 108.86 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -141.82 145.56 34.85 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.845 0.858 . . . . 71.14 110.31 -174.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.699 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 8.4 t80 -137.99 134.86 35.37 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.668 0.787 . . . . 70.34 110.917 -168.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -147.16 108.84 4.35 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.788 0.835 . . . . 73.11 109.412 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.61 HG12 ' HD2' ' A' ' 84' ' ' PHE . 66.7 mt -78.61 124.04 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 109.494 -0.558 . . . . 62.21 109.494 176.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -84.69 -40.05 17.83 Favored 'General case' 0 C--O 1.241 0.639 0 O-C-N 124.192 0.933 . . . . 62.53 110.667 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.417 ' HB3' HD12 ' A' ' 83' ' ' ILE . 23.7 ttt180 -173.35 137.41 0.66 Allowed 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.526 0.516 . . . . 61.34 110.179 -172.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.436 HD11 HD13 ' A' ' 13' ' ' ILE . 83.5 mt -126.2 138.81 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.321 -0.992 . . . . 73.42 108.321 174.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.481 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 21.1 p90 -168.25 168.85 11.26 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.627 0.727 . . . . 73.04 111.599 -173.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -94.52 120.37 34.64 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.104 -0.953 . . . . 60.31 109.143 176.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 38.2 mtpt -91.34 -30.24 16.67 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.891 0.376 . . . . 74.35 110.635 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 18.8 t70 -148.34 134.39 19.23 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.229 -0.896 . . . . 73.24 109.141 179.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.411 HG23 ' SD ' ' A' ' 117' ' ' MET . 60.0 mt -132.17 139.31 50.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.061 -1.459 . . . . 60.33 107.061 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 45.1 t -146.49 122.15 10.49 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.693 -0.854 . . . . 61.4 108.693 173.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.468 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 93.5 t80 -126.0 129.56 49.45 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.699 -1.593 . . . . 73.34 106.699 171.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -139.74 119.31 13.12 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.676 -0.861 . . . . 74.33 108.676 -178.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.38 83.53 8.58 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 106.987 -1.486 . . . . 63.54 106.987 173.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.93 -30.24 67.22 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.916 2.41 . . . . 75.12 112.637 -167.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -117.47 26.45 9.72 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 124.145 0.978 . . . . 72.13 109.45 -174.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.565 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -45.62 -56.34 10.14 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 114.116 1.154 . . . . 74.34 114.116 -169.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 22.3 Cg_exo -64.16 -19.9 66.57 Favored 'Trans proline' 0 C--N 1.385 2.486 0 CA-C-N 121.62 1.614 . . . . 65.53 113.392 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -90.15 -38.19 13.67 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.235 1.014 . . . . 72.25 110.551 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.578 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.1 p -77.13 -21.19 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 115.246 -0.888 . . . . 70.45 112.185 -159.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -71.45 -24.62 62.05 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.013 -0.54 . . . . 74.34 110.841 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -76.0 -27.53 57.44 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.108 0.963 . . . . 74.13 110.297 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -71.18 148.9 46.86 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.081 0.952 . . . . 72.11 110.866 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.15 124.55 23.4 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.117 0.967 . . . . 71.53 109.333 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -82.04 79.4 8.56 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.704 0.764 . . . . 64.3 110.826 -176.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -132.53 77.15 70.43 Favored Pre-proline 0 C--O 1.245 0.846 0 N-CA-C 106.584 -1.635 . . . . 72.51 106.584 169.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -85.41 154.57 10.67 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 121.986 1.79 . . . . 60.11 112.848 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -94.99 83.79 4.01 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 105.355 -2.091 . . . . 75.44 105.355 161.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.598 HG21 HD11 ' A' ' 126' ' ' LEU . 2.8 p -76.48 92.17 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-O 122.575 1.179 . . . . 74.04 108.15 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -87.01 115.33 24.32 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.214 -1.357 . . . . 71.43 109.363 -175.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.575 HD23 HD22 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -95.45 151.75 19.02 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.44 0.638 . . . . 74.24 110.282 177.24 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.607 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 13.4 t70 -145.38 150.57 36.8 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.603 -1.258 . . . . 73.42 107.603 -177.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.69 HD13 HD13 ' E' ' 8' ' ' LEU . 2.4 pt? -136.96 130.63 31.83 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.091 0.472 . . . . 70.13 110.44 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 13.7 t70 -122.94 151.08 42.14 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.46 1.104 . . . . 65.14 109.71 -178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.0 p -106.71 127.71 53.6 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.379 -0.828 . . . . 71.31 110.923 -172.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.659 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -134.97 137.48 43.09 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.817 0.847 . . . . 54.32 109.019 172.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.0 p -132.12 163.08 29.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.941 0.496 . . . . 73.33 110.756 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.555 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 35.4 t -161.44 153.11 19.15 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.971 0.908 . . . . 64.32 109.82 176.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -113.58 120.18 40.04 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.433 -0.951 . . . . 75.31 108.433 167.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 52.8 mt -94.35 -32.15 13.72 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.988 0.515 . . . . 72.31 110.265 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.464 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -164.45 -177.11 4.69 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.372 1.069 . . . . 53.11 109.344 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -71.94 130.53 41.21 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.224 -0.658 . . . . 74.42 109.224 174.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 85' ' ' SER . 35.7 m-20 66.15 -2.08 1.04 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.495 1.118 . . . . 73.11 112.657 -174.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 65.5 t -116.45 107.61 22.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.637 0 N-CA-C 108.53 -0.915 . . . . 65.35 108.53 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -126.31 155.89 41.28 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.871 -0.789 . . . . 72.15 108.871 -174.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 35.5 tt0 -117.93 122.75 44.09 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 123.255 0.622 . . . . 73.44 109.424 175.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.2 t -105.48 122.35 58.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 107.017 -1.475 . . . . 63.22 107.017 170.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 47.5 t -114.98 129.44 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.453 -0.943 . . . . 62.53 108.453 176.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.493 HD21 ' HB2' ' A' ' 44' ' ' LEU . 1.4 tt -119.8 112.44 19.24 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.978 -0.749 . . . . 73.33 108.978 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 18.8 ttt180 -86.94 100.64 12.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.18 0.992 . . . . 71.34 109.354 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.8 t -95.46 104.74 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 109.117 -0.697 . . . . 74.32 109.117 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 25.5 m -96.08 106.79 19.01 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.6 0.76 . . . . 64.14 109.515 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.8 t -105.19 108.54 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.876 0.871 . . . . 64.34 109.818 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.2 m -102.23 142.96 32.64 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.827 -1.175 . . . . 71.53 107.827 174.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.01 120.64 35.99 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.334 -1.358 . . . . 62.02 107.334 170.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.2 m -117.64 124.36 48.4 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.736 -0.468 . . . . 72.13 109.736 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.534 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 94.0 mt -88.67 85.53 6.82 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.118 -1.067 . . . . 63.44 108.118 173.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.1 -93.87 1.44 Allowed Glycine 0 C--N 1.343 0.951 0 CA-C-N 114.845 -1.071 . . . . 74.21 111.276 -175.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -119.24 -20.54 7.91 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.503 0.721 . . . . 70.24 110.795 176.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.91 134.15 35.09 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.473 0.709 . . . . 73.15 109.364 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.1 m -73.41 126.62 30.6 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.298 0.499 . . . . 74.41 110.269 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.578 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.35 -58.77 3.08 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.628 0.771 . . . . 52.21 109.543 172.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.431 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 26.2 p90 -158.79 176.08 12.8 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.76 -1.109 . . . . 60.02 111.064 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.1 tp -138.06 142.44 40.29 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.904 1.282 . . . . 74.23 108.144 173.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.468 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 59.6 m -142.43 95.44 2.79 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.001 -1.111 . . . . 74.35 108.001 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -112.41 115.95 29.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.64 0.776 . . . . 75.21 108.937 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.5 t -126.96 117.4 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.637 0.775 . . . . 73.23 110.068 -176.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 75.5 mt-30 -84.61 96.1 9.08 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.246 -1.02 . . . . 73.15 108.246 168.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.413 ' HG3' HD22 ' A' ' 106' ' ' LEU . 9.5 tp-100 -82.79 103.6 12.4 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.009 -0.737 . . . . 75.32 109.009 177.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.81 146.08 20.4 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.33 -0.708 . . . . 34.5 111.33 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.445 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.23 121.02 1.16 Allowed Glycine 0 CA--C 1.505 -0.59 0 N-CA-C 111.031 -0.827 . . . . 42.42 111.031 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.417 HD12 ' HB3' ' A' ' 15' ' ' ARG . 34.7 mt -83.03 120.43 34.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 108.814 -0.809 . . . . 73.31 108.814 173.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.699 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 26.6 m-85 -130.1 124.29 32.42 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 109.358 -0.608 . . . . 74.12 109.358 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 73.9 m -86.6 98.34 11.04 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.535 -0.542 . . . . 61.35 109.535 168.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 28.6 pt -108.99 131.2 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 115.187 -0.915 . . . . 72.25 109.286 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.68 167.1 29.18 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.682 0.793 . . . . 63.14 109.852 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 133.35 -76.49 0.4 Allowed Glycine 0 C--N 1.338 0.673 0 N-CA-C 111.406 -0.677 . . . . 71.55 111.406 174.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.9 mm -125.23 124.22 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 109.062 -0.718 . . . . 71.15 109.062 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.509 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 1.7 mp0 -89.54 -166.27 1.55 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.803 0.841 . . . . 74.31 110.243 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.93 -143.42 34.88 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-O 119.708 -0.496 . . . . 64.42 112.331 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.8 p -66.15 -22.63 66.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.538 0.735 . . . . 72.4 112.577 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -70.64 -49.87 42.87 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.419 0.688 . . . . 71.33 109.776 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.509 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 47.3 ttp -63.69 -34.36 77.68 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.798 -0.637 . . . . 74.31 111.037 173.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.92 80.06 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.291 0.637 . . . . 61.23 111.105 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -69.11 -35.36 76.35 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.471 -0.786 . . . . 75.54 110.975 174.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 78.8 m -69.37 -63.51 1.05 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 122.865 0.466 . . . . 64.23 111.201 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.545 HD22 ' HD2' ' E' ' 17' ' ' PRO . 3.4 pp -73.94 -14.05 60.99 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.03 0.532 . . . . 75.34 112.429 -177.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.45 -12.85 29.84 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-O 119.528 -0.595 . . . . 74.41 114.193 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.469 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . . . -141.43 -57.9 0.49 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 117.773 0.786 . . . . 61.11 112.044 -178.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.401 ' HE2' ' CD1' ' A' ' 11' ' ' PHE . 62.6 t80 -63.59 -58.74 6.0 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.294 1.038 . . . . 72.13 112.191 -169.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.2 m -70.86 -35.79 4.65 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 113.189 0.811 . . . . 62.01 113.189 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.87 -41.72 54.4 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 122.447 2.098 . . . . 74.53 113.497 162.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -71.48 -23.54 61.83 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.895 0.878 . . . . 73.13 110.5 -176.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -67.03 -39.77 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 123.094 0.558 . . . . 74.52 110.027 173.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.445 HD21 ' HA3' ' A' ' 82' ' ' GLY . 93.9 mt -76.48 -26.71 55.64 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.663 0.785 . . . . 41.04 112.507 -175.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -63.89 -44.12 77.95 Favored Pre-proline 0 CA--C 1.564 1.483 0 N-CA-C 114.003 1.112 . . . . 62.52 114.003 -171.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.33 -33.85 79.08 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 121.88 1.72 . . . . 75.12 113.205 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -75.66 -37.92 59.23 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.463 0.705 . . . . 75.51 111.929 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.58 -39.19 70.72 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.842 -0.429 . . . . 55.34 109.842 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.508 ' NH1' HD12 ' C' ' 105' ' ' ILE . 33.4 ttm180 -61.96 -38.28 87.91 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 124.06 0.85 . . . . 72.34 109.62 172.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.515 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 2.9 tm-20 -65.95 -48.34 71.65 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.854 0.862 . . . . 72.33 111.071 -177.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 34.4 t -60.31 -44.77 95.12 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 124.273 0.983 . . . . 71.11 110.231 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 82.9 mt -66.47 -43.5 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.909 0.883 . . . . 64.33 111.149 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.1 m -59.81 -40.37 88.19 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.816 0.846 . . . . 52.34 110.606 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.7 t -72.22 -43.69 64.04 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.219 -0.901 . . . . 64.25 110.696 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.411 ' SD ' HG23 ' A' ' 21' ' ' ILE . 18.8 mtp -60.35 -40.28 90.19 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.466 0.706 . . . . 73.31 111.661 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.529 HG13 ' HB2' ' A' ' 123' ' ' PHE . 48.6 t -66.99 -45.07 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.98 0.912 . . . . 70.25 110.848 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.6 p -71.7 -30.81 66.08 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 120.73 0.3 . . . . 45.44 111.003 -176.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -70.05 -33.73 72.32 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.655 0.782 . . . . 73.14 109.591 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.7 11.97 43.72 Favored Glycine 0 C--N 1.356 1.653 0 O-C-N 123.88 0.738 . . . . 75.41 113.053 173.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.54 HG21 ' HE ' ' B' ' 15' ' ' ARG . 3.4 t 61.56 18.18 9.24 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 127.348 2.259 . . . . 74.32 113.819 172.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.529 ' HB2' HG13 ' A' ' 118' ' ' VAL . 90.3 m-85 -84.84 147.44 48.53 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 107.296 -1.372 . . . . 75.1 107.296 170.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.47 171.85 7.51 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.236 1.957 . . . . 75.15 112.156 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.574 ' HG2' ' H ' ' C' ' 16' ' ' ILE . 9.0 tp-100 -53.31 124.45 14.71 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.035 0.934 . . . . 75.23 112.065 -172.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.598 HD11 HG21 ' A' ' 40' ' ' VAL . 57.4 tp -116.9 118.3 32.09 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.39 -0.823 . . . . 72.1 108.945 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.467 ' ND2' HD12 ' C' ' 16' ' ' ILE . 15.4 m120 -123.65 115.77 21.99 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.755 0.822 . . . . 75.53 111.182 -174.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.575 HD22 HD23 ' A' ' 42' ' ' LEU . 71.1 mt -74.4 121.98 22.26 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.789 -0.819 . . . . 72.42 108.789 167.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.564 ' HB3' ' HB2' ' E' ' 7' ' ' ALA . . . -66.17 130.21 94.28 Favored Pre-proline 0 CA--C 1.555 1.159 0 N-CA-C 110.106 -0.331 . . . . 71.31 110.106 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.56 119.35 6.36 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.785 2.324 . . . . 70.05 111.872 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.709 HG11 ' HB2' ' E' ' 8' ' ' LEU . 4.2 p -101.97 125.24 56.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 114.97 -1.013 . . . . 50.12 109.982 -176.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -102.66 98.09 8.18 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.616 -0.883 . . . . 73.51 108.616 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -66.71 -28.18 68.23 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.309 0.644 . . . . 73.4 110.366 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -54.36 -37.84 65.41 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.792 1.637 . . . . 63.42 112.41 -175.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.78 -41.17 96.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.47 0.708 . . . . 52.12 110.881 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.456 HD22 ' HB2' ' E' ' 10' ' ' LEU . 6.5 mp -74.44 -25.88 59.71 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.607 0.763 . . . . 71.21 110.628 -178.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 9.0 m-85 -63.91 -54.12 39.67 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.542 0.737 . . . . 72.11 110.591 173.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 31.5 mmt -68.16 -33.24 74.11 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.089 0.556 . . . . 74.12 110.807 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -66.22 -40.28 90.18 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.411 -0.813 . . . . 63.22 111.597 175.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -75.55 -37.68 59.82 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 120.745 0.307 . . . . 75.23 110.552 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.55 -48.7 59.45 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.715 0.806 . . . . 75.05 112.068 -174.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -150.46 6.84 0.57 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 111.856 0.317 . . . . 72.14 111.856 -171.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 71.47 164.95 0.29 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 125.263 1.425 . . . . 75.03 112.167 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -166.51 161.2 15.99 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.516 0.726 . . . . 73.14 110.363 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.49 140.36 46.36 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.875 -0.602 . . . . 71.2 109.777 169.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -134.0 37.03 2.02 Favored Glycine 0 CA--C 1.504 -0.635 0 N-CA-C 111.29 -0.724 . . . . 55.4 111.29 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.505 ' HB3' HD21 ' C' ' 5' ' ' ASN . 10.1 pt-20 -109.51 -171.57 1.87 Allowed 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.722 0.809 . . . . 72.2 110.792 -175.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' C' ' 88' ' ' GLY . . . 167.54 97.47 0.11 Allowed Glycine 0 C--N 1.342 0.914 0 N-CA-C 110.628 -0.989 . . . . 70.22 110.628 175.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.9 m -86.83 48.71 1.68 Allowed 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 122.002 0.906 . . . . 52.31 109.376 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -87.21 145.04 26.55 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 124.258 1.023 . . . . 61.1 109.324 -175.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.51 137.47 57.43 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.842 0.714 . . . . 45.23 111.678 -174.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -114.03 168.92 9.4 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.187 0.995 . . . . 61.22 108.574 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.07 147.56 31.4 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.601 -0.518 . . . . 73.23 109.601 173.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -52.86 -47.73 67.57 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.373 1.069 . . . . 41.5 110.973 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.187 0 O-C-N 124.993 1.433 . . . . 61.5 110.718 175.514 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 20.2 mmt . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 108.951 -0.759 . . . . 65.24 108.951 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.2 p -171.17 -179.91 2.83 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.654 1.182 . . . . 75.45 109.033 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -103.25 98.41 8.34 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.355 0.662 . . . . 71.42 109.6 -178.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -79.38 137.56 37.34 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.372 0.669 . . . . 72.34 111.266 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -83.84 115.65 22.36 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.714 -1.217 . . . . 73.25 107.714 173.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -76.62 80.91 3.28 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 122.121 0.962 . . . . 72.21 110.313 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -141.0 160.93 39.03 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 114.044 -1.435 . . . . 71.45 109.062 -178.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 74.72 -63.37 0.42 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.852 1.661 . . . . 73.33 111.927 176.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 26.0 ttt 66.68 165.29 0.2 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.872 1.669 . . . . 63.41 111.962 -176.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 86.0 m -141.94 126.79 18.17 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 105.921 -1.881 . . . . 64.54 105.921 167.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -143.28 140.47 30.63 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.202 0.456 . . . . 74.3 110.337 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.527 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -150.39 139.53 21.15 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.552 0.741 . . . . 51.32 109.401 173.059 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 25.7 mt -82.8 124.81 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.194 -1.039 . . . . 65.43 108.194 169.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -93.81 -38.12 11.41 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.074 -0.713 . . . . 64.23 109.074 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.54 ' HE ' HG21 ' A' ' 122' ' ' THR . 32.4 ttt180 -169.9 151.64 4.19 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.252 0.621 . . . . 73.31 110.218 -177.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.464 HD12 HD22 ' D' ' 127' ' ' ASN . 81.7 mt -132.95 140.97 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.364 -1.347 . . . . 72.51 107.364 174.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -169.72 157.23 6.84 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.61 0.719 . . . . 74.53 112.515 -175.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 87.6 m -82.08 127.5 33.18 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.682 -1.144 . . . . 60.11 108.561 170.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.565 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 40.4 mtpt -98.39 -35.77 10.19 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.452 0.701 . . . . 54.44 110.39 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.547 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 13.1 t70 -150.81 137.72 19.1 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.72 -0.673 . . . . 71.53 110.954 -167.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.424 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.5 mm -137.92 143.83 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.088 1.355 . . . . 70.23 108.461 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 44.2 t -149.44 114.99 5.57 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.525 -1.287 . . . . 70.13 107.525 174.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -132.38 110.81 10.82 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.235 -1.024 . . . . 72.31 108.235 173.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -117.48 137.51 52.49 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.527 0.731 . . . . 64.41 109.363 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.893 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -117.24 84.3 17.23 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 106.489 -1.671 . . . . 72.31 106.489 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -63.83 -48.35 5.51 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.829 2.352 . . . . 43.0 112.275 -167.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -104.62 20.13 19.16 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.392 -0.822 . . . . 74.43 110.828 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.893 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -43.78 -59.51 3.46 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 115.56 1.689 . . . . 72.13 115.56 -168.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.466 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 38.2 Cg_exo -58.75 -31.04 94.23 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 122.657 2.238 . . . . 61.11 113.121 -170.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -96.8 -37.19 10.37 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.173 -0.921 . . . . 74.31 111.6 -176.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.486 HG22 HD12 ' B' ' 68' ' ' LEU . 4.0 p -65.45 -20.3 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 123.214 0.606 . . . . 72.12 111.352 -172.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -61.94 -18.47 60.45 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.102 0.961 . . . . 73.52 113.421 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -62.82 -30.78 71.75 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.261 0.553 . . . . 61.42 110.205 176.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -87.71 80.77 7.83 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.45 1.1 . . . . 73.04 109.709 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -84.38 90.42 7.58 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.186 0.517 . . . . 72.11 110.143 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 27.5 p90 -158.73 172.38 18.36 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.711 1.204 . . . . 74.4 108.298 167.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -75.59 110.45 10.63 Favored Pre-proline 0 N--CA 1.477 0.895 0 N-CA-C 109.263 -0.643 . . . . 74.11 109.263 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.14 159.7 51.96 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.23 1.953 . . . . 72.21 112.653 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.44 112.19 3.01 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.685 0.615 . . . . 70.33 109.353 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.455 ' HB ' HG21 ' F' ' 6' ' ' ILE . 48.0 t -85.94 119.95 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.587 -0.894 . . . . 64.15 108.587 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.54 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 24.3 mtpp -119.45 98.56 6.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.332 -1.358 . . . . 71.24 107.332 177.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.449 HD22 HD23 ' F' ' 8' ' ' LEU . 2.2 pp -94.3 158.07 15.75 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.808 -0.633 . . . . 73.03 110.457 -176.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -162.8 119.44 1.91 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.468 -0.567 . . . . 61.31 109.468 -175.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.819 HD21 HD13 ' F' ' 8' ' ' LEU . 5.2 mp -100.61 143.83 30.31 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.766 0.426 . . . . 72.22 110.1 -178.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -125.2 151.21 46.15 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.128 0.971 . . . . 74.23 109.409 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.1 p -109.02 133.78 52.54 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.338 0.655 . . . . 54.0 110.919 -170.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.627 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -148.65 148.83 30.54 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.617 0.767 . . . . 52.12 109.243 170.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.503 ' HB2' ' HB ' ' F' ' 16' ' ' THR . 49.8 m -146.76 177.21 9.27 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.455 0.702 . . . . 71.11 109.951 172.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 1.4 m -151.55 138.63 19.16 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.681 0.792 . . . . 74.23 108.934 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -92.33 108.99 20.37 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.381 -1.34 . . . . 72.12 107.381 165.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.426 HD11 ' HB2' ' B' ' 57' ' ' GLU . 21.7 mt -83.77 -56.08 3.9 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.131 0.491 . . . . 63.22 109.797 -176.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.09 -170.22 2.74 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.197 -0.91 . . . . 53.51 109.257 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.45 109.94 4.47 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 114.75 -1.114 . . . . 55.34 109.542 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 70.45 2.63 4.14 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 125.081 1.352 . . . . 71.41 113.232 -177.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 78.3 t -105.74 123.08 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 108.435 -0.95 . . . . 72.35 108.435 173.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.429 ' HE2' ' HB3' ' B' ' 98' ' ' LEU . 4.9 p90 -133.37 175.35 9.49 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.142 0.977 . . . . 64.3 108.739 -176.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.426 ' HB2' HD11 ' B' ' 51' ' ' LEU . 12.0 tm-20 -145.4 116.0 7.66 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.806 -0.813 . . . . 71.32 108.806 -175.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 60.2 t -97.91 132.3 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.188 0.595 . . . . 53.2 109.989 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.627 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 20.7 t -115.96 119.06 60.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 124.339 1.056 . . . . 65.34 108.931 176.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.592 HD13 ' HZ ' ' F' ' 15' ' ' PHE . 50.5 tp -106.49 112.44 25.44 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.428 -0.582 . . . . 61.15 109.428 170.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.532 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 31.2 ttm180 -85.52 132.43 34.2 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.708 -0.849 . . . . 73.44 108.708 170.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 17.5 t -126.22 120.96 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 107.819 -1.178 . . . . 60.0 107.819 172.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 9.0 m -114.08 152.54 30.91 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.702 0.801 . . . . 70.4 109.265 -176.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.472 HG21 HG21 ' B' ' 114' ' ' ILE . 97.2 t -139.6 103.62 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.682 1.193 . . . . 53.41 108.559 -175.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 97.4 m -83.08 140.24 32.77 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.29 -1.004 . . . . 62.31 108.29 162.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.03 137.49 23.57 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.092 -0.707 . . . . 74.23 109.092 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.497 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 36.8 p -144.06 128.73 18.2 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 123.614 0.571 . . . . 65.14 111.584 -174.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.486 HD12 HG22 ' B' ' 31' ' ' VAL . 61.2 mt -95.91 101.41 13.09 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.97 -1.122 . . . . 65.34 107.97 174.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.0 -112.69 3.5 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 116.049 -0.523 . . . . 64.12 112.546 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.71 21.47 11.48 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.034 0.934 . . . . 63.32 111.285 -176.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -137.96 151.63 48.13 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.05 0.54 . . . . 74.24 110.007 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 86.9 m -72.11 118.11 14.58 Favored 'General case' 0 C--O 1.241 0.629 0 O-C-N 123.391 0.432 . . . . 75.1 110.777 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.497 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -71.59 -62.25 1.48 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.228 -0.896 . . . . 75.11 108.738 172.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -152.08 164.73 36.66 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.079 0.942 . . . . 75.35 112.214 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 91.0 mt -132.69 114.02 13.68 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 106.043 -1.836 . . . . 75.42 106.043 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.403 ' SG ' HG23 ' B' ' 114' ' ' ILE . 46.7 t -116.36 151.28 36.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.568 -0.901 . . . . 62.51 108.568 178.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -163.42 126.84 2.73 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.42 -0.585 . . . . 75.24 109.42 -175.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 64.4 t -123.63 153.84 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 123.698 0.799 . . . . 74.13 109.117 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.547 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 20.9 mt-30 -127.91 103.54 7.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.235 -1.024 . . . . 65.21 108.235 166.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -91.21 102.29 15.01 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.979 -0.748 . . . . 52.14 108.979 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.439 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.19 164.39 28.39 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.522 -0.763 . . . . 75.53 111.666 174.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.77 127.75 1.72 Allowed Glycine 0 CA--C 1.504 -0.638 0 N-CA-C 111.413 -0.675 . . . . 55.11 111.413 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 66.4 mt -84.21 127.93 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.056 -1.09 . . . . 74.13 108.056 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -134.29 164.12 28.11 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.404 1.082 . . . . 75.34 109.136 -176.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.6 m -132.26 133.32 43.97 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.624 0.769 . . . . 55.01 109.454 175.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.593 HG21 HG21 ' F' ' 18' ' ' VAL . 9.5 tt -135.53 146.36 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.837 0.855 . . . . 75.42 109.045 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.99 152.45 33.55 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.319 0.248 . . . . 73.12 110.433 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.91 -32.9 5.53 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.581 -0.736 . . . . 44.14 112.563 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 46.6 mm -92.89 153.34 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.183 0.993 . . . . 74.44 111.756 -175.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.06 -172.0 3.28 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.664 1.186 . . . . 72.13 110.342 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.21 -133.44 52.35 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 114.935 0.734 . . . . 73.23 114.935 175.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.6 m -65.66 -37.75 87.39 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.545 0.738 . . . . 70.21 111.231 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -75.46 -20.82 58.58 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.513 -0.767 . . . . 75.2 110.741 -172.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' F' ' 21' ' ' ALA . 57.3 ttm -64.87 -45.11 87.37 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.425 -0.583 . . . . 75.5 109.425 168.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.02 -30.67 71.67 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.958 0.903 . . . . 52.2 111.168 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -69.94 -35.84 74.83 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.827 0.851 . . . . 75.55 110.995 176.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.434 ' SG ' HD12 ' B' ' 86' ' ' ILE . 42.0 t -69.11 -66.52 0.57 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.024 0.53 . . . . 63.43 110.952 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.683 HD21 ' HA ' ' F' ' 17' ' ' PRO . 1.2 pp -76.67 -5.88 49.77 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 112.731 0.641 . . . . 71.11 112.731 -176.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.97 -36.9 8.1 Favored Glycine 0 C--N 1.336 0.535 0 O-C-N 123.452 0.47 . . . . 72.02 113.391 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.84 -52.45 1.33 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.898 0.479 . . . . 73.21 111.569 -169.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -64.46 -46.52 82.74 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.307 1.043 . . . . 73.15 111.66 -174.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.439 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 84.2 m -75.36 -46.55 4.44 Favored Pre-proline 0 CA--C 1.563 1.467 0 N-CA-C 112.74 0.644 . . . . 61.14 112.74 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.517 ' HB3' HD22 ' B' ' 60' ' ' LEU . 53.8 Cg_exo -59.72 -25.29 78.66 Favored 'Trans proline' 0 C--N 1.388 2.612 0 C-N-CA 122.294 1.996 . . . . 75.44 113.887 171.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -62.17 -40.73 97.02 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.442 0.697 . . . . 62.44 110.397 174.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.416 ' HA ' ' NH2' ' D' ' 111' ' ' ARG . 73.9 mt -63.59 -43.67 98.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 CA-C-N 114.795 -1.093 . . . . 74.52 110.253 177.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 78.9 mt -81.98 -19.93 39.56 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.303 -1.317 . . . . 74.12 112.332 -171.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.424 ' CE1' HD11 ' F' ' 8' ' ' LEU . 60.4 t80 -54.13 -53.25 60.76 Favored Pre-proline 0 CA--C 1.563 1.447 0 N-CA-C 113.945 1.091 . . . . 74.33 113.945 -174.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.98 -33.5 95.55 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.164 1.91 . . . . 73.45 113.711 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -71.74 -45.92 60.19 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.889 -0.596 . . . . 71.34 110.428 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.91 91.0 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.034 0.534 . . . . 61.31 110.563 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.0 ttt-85 -62.28 -51.67 66.76 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.24 1.416 . . . . 71.55 110.872 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.5 -32.72 72.9 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.356 0.663 . . . . 73.02 109.878 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.514 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.3 t -69.93 -35.93 74.93 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 122.653 0.381 . . . . 64.53 111.291 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.472 HG21 HG21 ' B' ' 64' ' ' VAL . 71.6 mt -64.25 -55.25 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 108.66 -0.867 . . . . 72.42 108.66 172.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 37.9 m -57.83 -31.51 66.7 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 124.374 1.047 . . . . 72.02 111.367 -175.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.1 t -62.65 -53.66 51.18 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 123.318 0.647 . . . . 70.55 109.533 175.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.514 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.3 mmt -65.92 -35.38 80.48 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.375 0.67 . . . . 61.24 111.582 -174.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 85.2 t -64.23 -43.23 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.665 0.786 . . . . 73.32 110.154 175.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 39.7 t -70.08 -28.38 65.38 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.227 -0.897 . . . . 74.15 111.334 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.494 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 89.0 mtt-85 -71.06 -39.19 72.38 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.644 0.777 . . . . 74.31 110.205 176.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.98 -0.88 71.12 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.852 0.72 . . . . 72.13 112.643 172.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 19.0 p 63.76 31.88 13.96 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.561 1.945 . . . . 53.51 112.363 173.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -90.64 160.49 38.69 Favored Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 124.545 1.138 . . . . 71.21 110.407 176.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -50.77 159.64 2.22 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 123.969 3.113 . . . . 71.35 115.874 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -64.08 112.55 3.04 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.868 -1.06 . . . . 72.21 111.42 -173.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 50.6 tp -111.1 122.46 47.94 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.524 0.73 . . . . 63.44 109.271 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -132.8 122.5 24.58 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.303 -0.999 . . . . 73.3 108.303 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 93.3 mt -68.86 145.49 53.66 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.578 0.351 . . . . 72.14 110.816 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.18 142.13 40.79 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.225 0.61 . . . . 74.32 110.463 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.31 116.12 3.42 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.356 2.704 . . . . 64.33 111.844 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.416 HG21 ' HB2' ' F' ' 8' ' ' LEU . 35.2 m -124.55 140.34 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.179 0.592 . . . . 70.2 109.688 175.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -111.52 98.2 7.28 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.942 -0.762 . . . . 75.44 108.942 174.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -56.76 -34.99 68.12 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.87 0.868 . . . . 75.35 110.545 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -61.76 -48.98 78.26 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 113.67 -1.604 . . . . 64.22 111.764 -172.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.17 -37.16 84.2 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.617 0.767 . . . . 61.21 112.2 -176.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.462 HD23 ' HG ' ' F' ' 10' ' ' LEU . 9.8 mp -67.44 -43.48 81.06 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.704 -0.68 . . . . 73.51 110.178 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.444 ' HZ ' ' HA ' ' F' ' 12' ' ' PRO . 29.5 m-85 -80.66 -14.77 57.86 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.005 0.743 . . . . 74.35 113.005 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 89.2 mtp -68.05 -39.85 82.96 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.323 0.582 . . . . 65.13 109.442 169.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -93.81 -12.21 29.55 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.91 -1.041 . . . . 74.21 110.764 -173.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -67.79 -29.56 68.78 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 109.377 -0.601 . . . . 74.41 109.377 169.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 56.9 mt -96.85 29.63 2.97 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.342 1.057 . . . . 72.44 110.419 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -73.95 95.28 2.46 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.185 0.517 . . . . 74.13 110.337 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -136.25 137.42 40.76 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.205 1.002 . . . . 72.0 108.621 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -111.45 177.04 4.78 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.345 0.658 . . . . 74.31 110.705 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.12 -174.38 3.74 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.411 0.684 . . . . 71.33 111.04 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -159.21 153.08 24.17 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.771 -0.532 . . . . 65.11 111.771 178.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -78.36 131.97 37.2 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.486 0.714 . . . . 64.31 110.715 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -76.19 154.61 44.78 Favored Glycine 0 C--N 1.346 1.084 0 O-C-N 123.745 0.653 . . . . 72.21 113.612 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 44.9 m -75.61 136.83 40.48 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.127 0.971 . . . . 64.13 110.601 177.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -67.34 133.44 49.64 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 123.513 0.508 . . . . 75.22 111.105 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -106.38 163.67 12.66 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.157 0.983 . . . . 75.44 110.877 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -151.39 169.04 22.96 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.588 0.755 . . . . 75.33 110.708 -178.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.03 -176.51 6.23 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.457 0.703 . . . . 74.31 111.582 176.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -147.06 139.24 24.58 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.185 0.994 . . . . 74.13 108.352 176.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.135 0 N-CA-C 109.038 -0.727 . . . . 73.2 109.038 176.009 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mpp? . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.573 -0.529 . . . . 51.23 109.573 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -137.78 104.85 5.41 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.724 0.81 . . . . 63.43 109.083 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -74.74 111.23 9.73 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.73 -0.841 . . . . 74.43 108.73 175.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -65.1 -73.21 0.13 Allowed 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.031 0.832 . . . . 71.54 111.659 -170.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . 0.505 HD21 ' HB3' ' A' ' 147' ' ' GLU . 64.8 t30 -150.67 35.81 0.63 Allowed 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 122.516 1.15 . . . . 72.45 108.526 -178.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -103.93 -19.72 14.13 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.181 -1.372 . . . . 75.45 110.201 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -85.51 104.28 15.14 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.194 0.998 . . . . 75.52 108.882 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -77.15 152.58 34.8 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.693 -0.685 . . . . 73.45 109.576 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.457 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 0.0 OUTLIER 68.12 140.27 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.929 1.292 . . . . 65.23 112.418 178.672 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.413 ' N ' ' SD ' ' C' ' 9' ' ' MET . 44.3 m -119.47 86.32 2.53 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.104 0.962 . . . . 70.44 108.83 176.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.706 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 23.3 t80 -101.83 139.96 36.77 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.26 -0.882 . . . . 60.15 108.828 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -152.55 132.81 13.6 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.883 -0.784 . . . . 75.01 108.883 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.407 HD13 HD11 ' C' ' 16' ' ' ILE . 16.7 mt -87.65 131.58 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.83 -0.804 . . . . 55.25 108.83 174.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -92.94 -48.61 6.44 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.558 0.743 . . . . 70.15 110.325 177.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -173.92 130.42 0.4 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 115.963 -0.562 . . . . 72.41 109.778 -168.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.574 ' H ' ' HG2' ' A' ' 125' ' ' GLN . 61.3 mt -123.2 147.76 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.962 -0.755 . . . . 73.15 108.962 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.504 ' HB3' HG23 ' D' ' 122' ' ' THR . 20.5 p90 -175.33 157.39 2.18 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.515 0.674 . . . . 72.21 110.076 -173.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.0 p -77.99 123.9 27.37 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.767 -1.106 . . . . 73.2 108.712 172.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -70.35 -49.19 51.85 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 107.479 -1.304 . . . . 63.0 107.479 167.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 11.4 t70 -136.68 136.92 39.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 112.874 -1.966 . . . . 55.21 109.203 -166.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.431 HG12 ' SG ' ' C' ' 113' ' ' CYS . 75.3 mt -134.63 142.59 40.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.663 -1.606 . . . . 60.24 106.663 171.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.4 t -156.2 150.47 25.51 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.89 -0.411 . . . . 73.3 109.89 175.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -152.26 116.69 5.01 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.446 1.098 . . . . 64.23 108.043 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -120.72 129.44 53.65 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.642 0.777 . . . . 74.21 109.757 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.38 82.7 33.79 Favored Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 107.25 -1.389 . . . . 74.22 107.25 170.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.92 -14.01 23.96 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.953 2.435 . . . . 72.12 112.06 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -110.79 17.21 20.82 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.138 0.975 . . . . 72.23 109.881 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.439 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -49.28 -56.53 15.57 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 114.514 1.302 . . . . 52.21 114.514 -167.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.439 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 35.1 Cg_exo -61.84 -38.9 55.95 Favored 'Trans proline' 0 C--N 1.385 2.474 0 CA-C-N 121.824 1.687 . . . . 73.53 112.39 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -69.5 -34.92 75.0 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.684 -1.144 . . . . 71.12 112.308 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.718 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.4 p -82.75 -16.68 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 N-CA-C 112.724 0.639 . . . . 60.34 112.724 -176.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -78.37 -16.9 57.19 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.257 0.466 . . . . 55.31 112.257 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -94.07 36.77 1.11 Allowed 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.344 0.592 . . . . 71.11 109.906 172.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.79 167.21 16.09 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.27 1.028 . . . . 74.25 110.663 -178.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -89.97 132.19 35.47 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.804 0.842 . . . . 75.25 109.95 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 50.9 t-105 -81.97 90.51 6.49 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.192 0.52 . . . . 74.32 112.053 -173.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -143.55 77.95 14.9 Favored Pre-proline 0 CA--C 1.559 1.296 0 C-N-CA 124.496 1.119 . . . . 74.4 108.744 171.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -92.74 145.93 2.56 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.967 2.445 . . . . 53.53 114.623 -176.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.75 97.71 10.76 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 107.496 -1.298 . . . . 62.43 107.496 166.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' C' ' 65' ' ' THR . 9.6 m -83.85 100.29 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.745 0.783 . . . . 62.2 111.135 -176.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -92.57 109.09 20.49 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.628 0.771 . . . . 74.34 109.552 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.475 HD22 HD23 ' G' ' 8' ' ' LEU . 2.2 pp -86.0 163.02 18.22 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.781 -0.645 . . . . 62.23 111.196 -177.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.522 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 31.2 t70 -150.48 112.57 4.59 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.918 -0.771 . . . . 60.33 108.918 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' C' ' 61' ' ' ARG . 5.7 mp -113.51 112.87 24.31 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.035 -0.728 . . . . 74.35 109.035 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -116.87 152.63 34.08 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.098 0.959 . . . . 74.33 109.369 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 33.7 p -112.42 126.93 55.83 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.329 0.652 . . . . 75.02 111.028 -169.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.47 141.31 39.44 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.434 1.094 . . . . 64.2 108.534 174.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 36.0 p -165.73 164.96 18.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.337 0.255 . . . . 70.11 111.258 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 67.8 p -167.07 138.0 3.14 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.856 0.862 . . . . 73.15 109.511 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' C' ' 56' ' ' TYR . 51.8 tt0 -78.7 117.76 20.15 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.742 -0.836 . . . . 75.31 108.742 174.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.533 HD11 HD12 ' C' ' 83' ' ' ILE . 33.3 mt -84.75 -39.91 17.9 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.981 0.912 . . . . 71.23 110.982 -171.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.405 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -152.88 -170.49 3.64 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.654 -0.703 . . . . 62.21 110.943 -175.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -59.05 107.51 0.55 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.315 1.046 . . . . 71.12 110.716 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 63.12 6.82 2.46 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.288 1.035 . . . . 52.02 112.677 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 91.9 t -103.68 113.19 39.85 Favored 'Isoleucine or valine' 0 C--N 1.345 0.38 0 N-CA-C 107.584 -1.265 . . . . 74.11 107.584 177.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' C' ' 50' ' ' GLN . 50.9 t80 -131.39 135.09 46.91 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.062 0.945 . . . . 74.41 108.8 -173.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.51 ' HB2' HD11 ' C' ' 51' ' ' LEU . 39.3 tt0 -92.43 136.95 32.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.785 -1.098 . . . . 72.22 110.377 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 86.3 t -119.35 115.36 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.312 -1.366 . . . . 74.32 107.312 173.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.3 122.1 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 109.208 -0.664 . . . . 65.41 109.208 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 tp -116.55 125.57 52.07 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.656 -0.868 . . . . 62.33 108.656 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' C' ' 44' ' ' LEU . 29.8 ttm180 -79.06 130.96 36.07 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.749 -1.204 . . . . 72.1 107.749 172.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 23.5 t -124.02 111.37 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.13 -1.433 . . . . 72.33 107.13 172.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 63.9 m -121.43 139.89 52.87 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.446 -0.946 . . . . 53.24 108.446 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 85.6 t -131.42 111.6 19.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 108.184 -1.043 . . . . 73.12 108.184 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' C' ' 40' ' ' VAL . 3.2 m -98.5 132.81 43.63 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 107.567 -1.271 . . . . 64.45 107.567 173.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.76 121.47 37.33 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.47 -0.937 . . . . 72.14 108.47 -177.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 47.1 m -136.17 126.08 25.86 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.04 0.447 . . . . 65.13 111.061 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 14.1 mt -86.06 57.92 4.76 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.135 1.374 . . . . 75.23 109.076 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.08 -92.64 1.07 Allowed Glycine 0 C--N 1.343 0.938 0 N-CA-C 110.245 -1.142 . . . . 60.53 110.245 -175.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -126.6 2.01 6.84 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.895 0.878 . . . . 73.35 110.064 172.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -82.02 114.26 20.46 Favored 'General case' 0 C--N 1.347 0.481 0 N-CA-C 108.151 -1.055 . . . . 64.3 108.151 169.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.2 m -79.02 120.49 23.67 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 119.281 0.946 . . . . 63.31 109.146 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.718 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -79.81 -58.71 3.04 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.885 -1.052 . . . . 65.33 109.006 178.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -159.09 174.85 14.27 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 122.017 0.913 . . . . 72.43 112.321 -178.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.434 HD23 HG23 ' C' ' 65' ' ' THR . 2.4 tm? -138.61 142.57 39.13 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 105.37 -2.085 . . . . 61.23 105.37 170.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 48.1 t -150.29 112.84 4.71 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.586 -0.524 . . . . 74.22 109.586 176.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -118.01 130.9 56.46 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.568 0.747 . . . . 73.31 109.545 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.44 HG11 ' HA ' ' C' ' 110' ' ' ALA . 55.6 t -131.19 113.23 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.195 0.998 . . . . 71.43 108.542 175.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -91.03 95.17 9.97 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.885 -1.154 . . . . 74.31 107.885 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.538 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.3 tp-100 -86.08 115.42 23.66 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.158 0.583 . . . . 61.12 110.098 -176.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.69 146.88 18.07 Favored Glycine 0 C--N 1.338 0.652 0 O-C-N 123.489 0.493 . . . . 34.54 112.344 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.415 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -144.51 119.18 1.23 Allowed Glycine 0 C--O 1.237 0.308 0 N-CA-C 110.698 -0.961 . . . . 72.11 110.698 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.533 HD12 HD11 ' C' ' 51' ' ' LEU . 16.4 mm -83.86 123.75 39.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.595 -0.891 . . . . 62.34 108.595 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -132.31 123.85 27.67 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.98 0.512 . . . . 65.1 110.851 -173.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 58.7 m -80.19 105.27 11.33 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.394 -0.965 . . . . 51.03 108.394 166.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.51 HD13 ' H ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -116.0 139.2 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.052 -0.721 . . . . 72.22 109.052 -179.563 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.63 170.2 16.01 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.351 0.661 . . . . 50.23 110.247 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . 0.466 ' O ' ' HA3' ' A' ' 148' ' ' GLY . . . 93.81 -30.02 7.94 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-O 119.625 -0.542 . . . . 54.33 113.823 172.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 47.4 pt -123.7 151.31 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 118.001 0.901 . . . . 73.31 110.333 176.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -147.75 157.9 43.76 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.921 0.889 . . . . 64.25 109.774 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.58 -148.19 21.77 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 119.167 -0.796 . . . . 74.54 111.878 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . 0.442 ' H ' ' HD3' ' G' ' 24' ' ' PRO . 9.8 t -56.77 -26.56 57.81 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.394 0.677 . . . . 75.43 111.681 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -55.33 -59.12 5.24 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.225 1.41 . . . . 63.1 110.423 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 32.9 ttp -77.78 -22.47 50.11 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.358 -0.837 . . . . 74.33 111.425 -177.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.92 -35.08 79.49 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.261 0.624 . . . . 74.02 110.706 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -73.82 -31.67 63.34 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.396 -0.82 . . . . 73.02 110.617 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -66.47 -60.93 2.29 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.314 0.246 . . . . 71.55 110.716 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 pp -66.5 -29.96 70.18 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.192 0.597 . . . . 61.31 111.585 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.92 12.4 59.12 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-O 119.251 -0.749 . . . . 74.32 114.475 -173.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.41 -55.38 0.06 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.269 1.035 . . . . 63.53 112.045 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -71.23 -35.67 71.55 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.76 0.824 . . . . 52.22 111.555 -172.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.706 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 60.7 m -76.19 -50.91 2.83 Favored Pre-proline 0 CA--C 1.564 1.5 0 C-N-CA 123.603 0.761 . . . . 73.1 112.249 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.58 -13.54 35.27 Favored 'Trans proline' 0 C--N 1.398 3.138 0 C-N-CA 122.03 1.82 . . . . 75.41 112.959 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -60.89 -37.41 82.12 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.999 0.919 . . . . 75.14 110.154 171.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.508 HD12 ' NH1' ' A' ' 111' ' ' ARG . 37.9 mm -70.02 -36.06 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.229 -0.896 . . . . 63.54 111.19 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.415 HD21 ' HA3' ' C' ' 82' ' ' GLY . 53.6 mt -91.94 -24.59 19.22 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.862 -1.063 . . . . 72.32 111.985 -166.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -57.25 -52.64 72.71 Favored Pre-proline 0 CA--C 1.557 1.241 0 CA-C-O 117.99 -1.005 . . . . 75.33 112.733 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.515 ' HB2' ' HG3' ' A' ' 112' ' ' GLU . 42.0 Cg_endo -63.45 -27.3 70.58 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 121.683 1.589 . . . . 73.45 112.788 -177.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.427 ' CD1' HG21 ' C' ' 16' ' ' ILE . 3.2 m-30 -71.17 -50.4 33.67 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.801 0.84 . . . . 65.11 110.435 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.538 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -63.56 -35.34 80.17 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.303 -0.862 . . . . 73.43 110.914 176.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -60.02 -50.71 72.66 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.349 1.459 . . . . 73.44 111.587 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.7 -37.94 87.86 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 123.552 0.533 . . . . 73.45 109.696 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.431 ' SG ' HG12 ' C' ' 21' ' ' ILE . 42.4 t -63.9 -34.84 78.85 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.338 0.655 . . . . 41.22 111.766 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.473 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 68.0 mt -71.04 -52.19 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.127 0.571 . . . . 73.33 110.414 174.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 35.1 m -62.74 -30.02 71.12 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.25 0.62 . . . . 72.23 111.438 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.1 t -65.97 -48.71 70.36 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.899 -0.778 . . . . 60.24 108.899 174.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.558 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.11 -37.83 81.18 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.673 1.189 . . . . 71.31 112.32 178.496 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.415 HG23 ' O ' ' C' ' 114' ' ' ILE . 93.8 t -65.68 -42.94 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.365 0.666 . . . . 63.22 110.1 177.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.0 t -70.16 -29.1 65.92 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.38 -0.827 . . . . 73.24 111.714 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -69.92 -34.61 73.7 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.324 0.65 . . . . 73.53 109.3 175.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.46 11.27 64.08 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.713 0.633 . . . . 50.52 113.108 174.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.421 HG23 ' HB3' ' D' ' 17' ' ' TYR . 73.0 p 56.23 24.33 8.02 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 126.276 1.83 . . . . 71.44 114.23 176.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -84.77 140.53 37.85 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.057 -1.09 . . . . 63.23 108.057 169.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.48 168.84 2.67 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 123.028 2.485 . . . . 64.32 114.273 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -50.69 118.71 3.27 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.79 1.236 . . . . 62.04 113.594 -171.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.04 86.57 2.45 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 106.947 -1.501 . . . . 53.34 106.947 174.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -106.08 118.82 37.61 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.642 -0.873 . . . . 73.14 108.642 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.93 133.19 47.87 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.502 0.721 . . . . 44.35 109.459 -177.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.09 152.25 96.25 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 123.355 0.662 . . . . 73.3 112.486 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.63 106.28 0.42 Allowed 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.076 2.518 . . . . 54.04 112.712 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.12 109.73 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 108.568 -0.901 . . . . 64.35 108.568 171.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.425 ' HB2' ' HB3' ' C' ' 135' ' ' ALA . 3.9 m-20 -81.71 110.83 17.41 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.837 1.255 . . . . 72.32 109.996 175.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -49.83 -45.06 49.77 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.428 0.691 . . . . 73.23 111.345 174.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -56.27 -53.82 52.66 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.743 1.217 . . . . 73.02 112.051 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' C' ' 132' ' ' ASN . . . -72.18 -25.49 61.7 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 123.431 0.692 . . . . 73.1 111.335 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 36.0 tp -69.16 -39.79 78.56 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.701 0.8 . . . . 73.24 110.697 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -65.15 -32.52 74.25 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.546 0.338 . . . . 75.04 110.27 173.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 56.3 ttp -72.13 -31.74 66.29 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.683 0.793 . . . . 63.54 110.8 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -68.03 -49.65 60.17 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.472 -0.566 . . . . 61.12 109.472 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -72.74 -104.49 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.995 0.918 . . . . 75.21 111.225 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 54.4 tp 51.88 -80.84 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.009 1.324 . . . . 73.31 111.489 -172.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -150.39 98.89 2.72 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 106.602 -1.629 . . . . 42.11 106.602 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -75.98 86.27 2.9 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.544 0.687 . . . . 75.21 110.528 -175.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -136.31 79.21 1.75 Allowed 'General case' 0 C--O 1.244 0.778 0 CA-C-N 114.551 -1.204 . . . . 74.43 107.768 177.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . 0.567 ' HB3' ' HA ' ' A' ' 5' ' ' ASN . . . -164.38 -170.97 2.21 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 114.409 -1.269 . . . . 71.24 109.16 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.46 -170.68 28.46 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 121.184 0.324 . . . . 64.1 113.767 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -112.42 146.86 37.64 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.588 0.755 . . . . 75.24 109.732 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -126.18 107.42 0.93 Allowed Glycine 0 C--N 1.342 0.88 0 CA-C-N 115.917 -0.583 . . . . 72.41 111.835 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 43.1 p -126.79 93.54 3.8 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.6 0.76 . . . . 54.1 109.252 174.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.27 131.91 42.51 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.107 0.563 . . . . 65.32 109.729 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -68.81 108.95 3.64 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.102 0.561 . . . . 43.13 109.795 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -101.59 144.15 30.69 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 116.088 -0.505 . . . . 73.35 110.587 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -81.82 107.96 14.97 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.586 -0.894 . . . . 74.43 108.586 173.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -91.73 157.83 16.71 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.899 0.48 . . . . 61.44 110.201 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.922 0 C-N-CA 123.612 0.765 . . . . 72.51 110.087 178.52 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.718 -0.475 . . . . 73.43 109.718 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . 0.445 ' O ' ' HA3' ' D' ' 91' ' ' GLY . 33.3 p -147.2 65.86 1.15 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.912 0.885 . . . . 71.15 109.023 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.69 112.13 2.38 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.81 -0.811 . . . . 72.22 108.81 172.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' D' ' 90' ' ' GLU . 18.1 mm-40 -120.23 143.99 47.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.561 -0.745 . . . . 72.31 109.058 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -127.66 42.45 3.32 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.016 0.926 . . . . 74.32 109.489 -177.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -60.64 104.89 0.38 Allowed 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.156 -0.929 . . . . 63.23 109.437 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 58.9 p -64.82 -58.64 5.67 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.34 1.456 . . . . 71.1 113.595 -164.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -86.72 32.73 0.65 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.389 0.676 . . . . 74.32 112.382 -169.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 11.7 ptp -33.17 148.8 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 124.63 1.172 . . . . 73.02 113.7 163.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 49.3 m -103.56 139.9 38.25 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.468 -0.938 . . . . 44.12 108.468 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -150.35 108.7 3.78 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.976 -1.12 . . . . 74.14 107.976 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . 0.617 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 43.5 mt-30 -126.46 118.51 25.1 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.194 -1.039 . . . . 75.21 108.194 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.469 HG21 HD11 ' D' ' 16' ' ' ILE . 19.8 mt -86.76 125.98 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 109.26 -0.644 . . . . 75.53 109.26 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -98.23 -29.06 13.42 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.411 0.684 . . . . 71.12 111.41 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -173.05 131.49 0.5 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 111.934 0.346 . . . . 74.34 111.934 -167.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.469 HD11 HG21 ' D' ' 13' ' ' ILE . 1.8 mp -112.74 136.02 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 107.366 -1.346 . . . . 72.34 107.366 167.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.441 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 40.5 p90 -164.64 175.84 9.42 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.779 0.8 . . . . 72.45 112.234 178.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.4 p -110.64 127.69 55.37 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.703 -1.135 . . . . 74.34 109.408 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.441 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 37.9 mtpt -100.38 -18.1 16.91 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.611 0.764 . . . . 72.53 110.134 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.657 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 11.4 t70 -159.27 133.51 7.68 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.575 1.15 . . . . 75.21 108.207 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.558 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.5 mt -136.27 146.52 28.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 106.704 -1.591 . . . . 74.44 106.704 173.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 23.0 t -152.61 143.82 23.19 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.142 0.577 . . . . 42.3 109.767 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.3 t80 -151.41 125.87 9.46 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 105.806 -1.924 . . . . 73.42 105.806 175.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -140.65 111.48 6.99 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.243 0.617 . . . . 71.42 109.807 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.56 92.0 9.43 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 108.508 -0.923 . . . . 64.13 108.508 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.82 -30.77 2.73 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.921 2.414 . . . . 64.44 113.559 -171.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -102.62 9.07 39.56 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.092 0.957 . . . . 64.01 111.081 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.512 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -30.63 -65.59 0.19 Allowed Pre-proline 0 CA--C 1.556 1.211 0 N-CA-C 117.272 2.323 . . . . 75.15 117.272 -160.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.09 -29.05 8.49 Favored 'Trans proline' 0 C--N 1.378 2.102 0 CA-C-N 123.173 2.169 . . . . 53.43 113.751 -171.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -85.72 -21.63 28.19 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.598 0.237 . . . . 71.15 110.508 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.512 HG12 ' O ' ' D' ' 28' ' ' ALA . 9.7 p -82.7 -15.72 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 116.037 -0.528 . . . . 53.5 110.827 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -69.69 -22.18 63.44 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 112.5 0.556 . . . . 70.44 112.5 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -57.81 -29.28 64.78 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.637 0.732 . . . . 51.21 109.6 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -88.11 71.13 9.32 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.073 -1.421 . . . . 71.14 109.328 173.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -88.65 84.54 6.73 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.293 0.568 . . . . 61.02 109.753 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.475 ' O ' ' HG2' ' D' ' 124' ' ' PRO . 8.9 p90 -147.49 178.48 8.4 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.379 1.071 . . . . 64.22 108.578 171.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -61.12 111.94 5.01 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 123.098 0.559 . . . . 60.42 109.903 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.11 127.63 24.83 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 121.914 1.743 . . . . 73.02 111.139 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.72 112.71 2.97 Favored 'General case' 0 C--N 1.347 0.469 0 N-CA-C 108.57 -0.9 . . . . 74.23 108.57 173.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 4.5 m -108.56 143.07 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 114.751 -1.113 . . . . 65.34 110.704 -169.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.54 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 13.9 tmtt? -125.46 122.33 36.34 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.224 -1.398 . . . . 72.43 107.224 177.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.58 HD23 ' HA ' ' H' ' 6' ' ' ILE . 4.5 pp -95.75 146.48 24.5 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-O 121.267 0.556 . . . . 74.2 110.037 -177.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -147.41 132.02 17.81 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.139 -1.059 . . . . 52.44 108.139 175.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -110.29 144.11 39.49 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.066 -0.716 . . . . 75.4 109.066 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.3 t70 -132.11 146.37 52.0 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.146 -1.057 . . . . 73.43 108.146 174.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . 0.563 HG21 ' H ' ' H' ' 15' ' ' PHE . 94.5 m -105.52 144.23 32.57 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.436 0.694 . . . . 73.42 111.158 -173.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.679 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.72 154.58 35.52 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.823 0.849 . . . . 75.21 109.373 170.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 21.6 p -168.59 159.99 10.51 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.699 0.8 . . . . 61.23 109.503 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 51.9 p -160.73 140.53 10.96 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.402 0.681 . . . . 64.35 109.847 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -87.76 124.79 33.97 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.807 -0.442 . . . . 74.23 109.807 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 35.9 mt -95.58 -36.45 11.26 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.015 0.526 . . . . 62.43 110.165 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.85 178.7 9.81 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.303 1.041 . . . . 43.21 109.489 174.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -64.69 119.01 9.75 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.816 -0.809 . . . . 72.43 108.816 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 72.19 9.08 5.94 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 124.316 1.046 . . . . 75.12 111.723 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 90.1 t -118.45 115.1 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.21 -1.034 . . . . 73.52 108.21 171.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.467 ' HB2' HD11 ' D' ' 86' ' ' ILE . 69.8 m-85 -133.47 130.02 38.01 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.349 -0.612 . . . . 70.33 109.349 -175.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -92.58 124.7 36.8 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.619 -1.252 . . . . 73.42 107.619 174.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 84.6 t -119.98 132.49 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.336 1.054 . . . . 63.5 108.529 -169.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.679 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 14.7 t -125.0 136.73 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.263 0.625 . . . . 72.23 109.886 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.437 HD22 ' HB3' ' D' ' 103' ' ' PRO . 57.2 tp -125.72 118.79 26.35 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.408 -0.96 . . . . 70.54 108.408 167.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.491 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 16.9 ttm-85 -85.88 111.96 20.7 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.619 0.768 . . . . 73.11 109.497 176.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 45.8 t -91.85 128.65 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.521 -0.918 . . . . 74.21 108.521 170.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 9.9 m -122.67 134.82 54.47 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.337 -0.616 . . . . 72.43 109.337 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 57.3 t -127.18 101.53 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 125.86 1.664 . . . . 71.52 107.978 -173.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 21.4 m -92.25 94.34 9.12 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.744 -0.836 . . . . 53.42 108.744 176.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.5 141.39 30.63 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.99 -0.55 . . . . 73.44 110.377 -175.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.401 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 66.0 p -147.73 128.88 14.64 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.0 -0.546 . . . . 75.43 110.296 -178.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.445 HD12 HG22 ' D' ' 31' ' ' VAL . 43.5 mt -93.46 108.83 20.45 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.965 -1.124 . . . . 72.22 107.965 175.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.91 -115.88 4.33 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.381 -0.827 . . . . 60.43 111.193 -171.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.29 6.15 10.71 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.731 0.812 . . . . 53.1 110.511 -174.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -121.59 152.83 38.83 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.905 0.882 . . . . 63.25 109.343 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 35.1 m -64.33 132.13 49.27 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.161 0.505 . . . . 73.21 111.512 -176.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.401 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -89.36 -60.44 1.95 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.492 -1.299 . . . . 63.11 107.492 174.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -157.19 159.38 37.67 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.332 -1.304 . . . . 71.23 110.135 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 86.8 mt -124.31 114.26 19.32 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 107.506 -1.294 . . . . 71.45 107.506 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.438 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 1.2 m -114.12 135.47 53.99 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.061 -1.089 . . . . 52.04 108.061 -175.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 37.5 tt0 -156.18 121.05 4.66 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.624 -0.51 . . . . 75.4 109.624 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.5 t -135.12 116.93 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.025 0.53 . . . . 61.42 109.578 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.657 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 13.9 mt-30 -85.43 91.15 8.13 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.001 -1.111 . . . . 73.35 108.001 166.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -81.61 109.43 16.04 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.103 -1.073 . . . . 62.04 108.103 174.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.94 166.43 14.09 Favored Glycine 0 C--O 1.244 0.745 0 O-C-N 123.72 0.638 . . . . 43.35 111.993 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.89 136.49 4.2 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 112.054 -0.418 . . . . 52.2 112.054 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.8 mt -89.68 122.21 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.536 0.734 . . . . 75.54 109.102 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -130.87 125.48 33.67 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.727 0.811 . . . . 71.13 109.421 -175.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.617 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 45.5 m -89.91 96.74 10.82 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.828 0.851 . . . . 64.24 109.264 173.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.632 ' HB ' HD12 ' D' ' 89' ' ' ILE . 0.2 OUTLIER -110.79 114.92 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 123.588 0.755 . . . . 74.44 110.712 -178.118 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.41 162.47 25.5 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.783 0.833 . . . . 52.54 109.552 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.04 20.34 78.9 Favored Glycine 0 C--N 1.347 1.151 0 C-N-CA 121.783 -0.246 . . . . 63.33 112.74 178.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.632 HD12 ' HB ' ' D' ' 86' ' ' ILE . 55.8 mt -116.36 136.62 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.776 0.83 . . . . 73.23 109.137 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' D' ' 4' ' ' GLN . 9.2 pt-20 -151.05 152.36 33.34 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.433 0.693 . . . . 70.44 110.935 -170.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' D' ' 2' ' ' SER . . . 67.92 -138.9 33.76 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 115.409 -0.814 . . . . 72.32 115.006 176.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 32.1 m -62.74 -25.58 68.26 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.118 0.967 . . . . 74.12 111.557 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.556 HE21 HG23 ' D' ' 89' ' ' ILE . 21.5 tt0 -62.11 -26.61 68.39 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.53 0.732 . . . . 64.54 111.073 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.401 ' HB3' ' N ' ' H' ' 18' ' ' VAL . 69.5 mtm -68.7 -46.56 68.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.804 0.841 . . . . 71.33 111.227 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.04 -30.13 68.43 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.31 -0.859 . . . . 63.45 110.69 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.404 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 25.2 t-80 -77.42 -27.15 52.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.414 0.685 . . . . 73.3 110.98 177.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.8 t -72.1 -52.95 14.36 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.398 0.618 . . . . 73.24 110.278 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 24.2 mt -86.47 -19.36 29.68 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 114.62 -1.173 . . . . 73.05 110.704 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.91 3.4 57.21 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-O 119.35 -0.694 . . . . 63.14 114.16 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.475 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -144.75 -65.9 0.34 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.105 0.952 . . . . 70.44 111.566 -178.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -69.9 -45.95 66.48 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 112.373 0.508 . . . . 70.02 112.373 -173.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 84.0 m -62.94 -45.35 87.01 Favored Pre-proline 0 CA--C 1.569 1.686 0 CA-C-O 118.782 -0.627 . . . . 75.44 112.218 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.437 ' HB3' HD22 ' D' ' 60' ' ' LEU . 51.5 Cg_exo -59.03 -27.66 85.65 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 122.786 2.324 . . . . 32.22 114.201 169.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -70.87 -26.51 63.29 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 122.854 0.462 . . . . 60.12 111.419 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 43.8 mm -72.02 -35.61 54.42 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-O 121.415 0.626 . . . . 63.14 109.465 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 86.0 mt -84.3 -23.3 30.36 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.058 -0.974 . . . . 63.43 112.114 -175.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 94.0 t80 -58.99 -49.1 95.16 Favored Pre-proline 0 CA--C 1.562 1.407 0 N-CA-C 113.662 0.986 . . . . 74.25 113.662 -174.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.06 -37.48 95.64 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 121.851 1.701 . . . . 44.52 113.116 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -75.9 -37.66 58.56 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.499 -0.773 . . . . 73.41 111.529 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.62 -41.39 96.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.081 0.552 . . . . 74.33 110.086 177.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.416 ' NH2' ' HA ' ' B' ' 105' ' ' ILE . 36.9 ttp180 -58.44 -53.42 58.53 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 124.214 0.946 . . . . 72.32 110.394 174.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.24 -43.26 96.25 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.187 0.929 . . . . 74.15 111.46 -174.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.8 t -59.58 -45.73 91.01 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.637 0.586 . . . . 63.43 111.081 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.466 ' O ' HG23 ' D' ' 118' ' ' VAL . 91.7 mt -64.35 -55.72 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 115.741 -0.663 . . . . 74.0 110.415 177.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 57.6 m -52.79 -40.36 63.14 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.693 1.197 . . . . 65.34 111.753 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.5 t -69.42 -42.39 75.08 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.33 -0.85 . . . . 63.54 110.075 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.8 mtm -64.85 -34.34 78.14 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.906 0.482 . . . . 55.21 111.482 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.466 HG23 ' O ' ' D' ' 114' ' ' ILE . 93.6 t -63.68 -47.8 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.538 0.735 . . . . 70.51 110.002 176.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 79.2 p -71.78 -27.33 62.88 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.918 -0.583 . . . . 61.22 110.93 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 74.7 mtt-85 -73.67 -29.29 62.22 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.462 0.705 . . . . 64.32 109.834 173.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.85 3.78 85.88 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 119.523 -0.598 . . . . 32.05 112.723 174.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.504 HG23 ' HB3' ' C' ' 17' ' ' TYR . 44.7 p 60.19 24.98 14.33 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 126.401 1.88 . . . . 73.22 113.733 177.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -89.09 156.43 49.03 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.282 0.633 . . . . 71.11 109.764 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.475 ' HG2' ' O ' ' D' ' 36' ' ' TRP . 71.5 Cg_exo -49.23 123.54 10.27 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.368 2.712 . . . . 64.15 113.338 171.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -53.87 141.17 28.2 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.749 1.22 . . . . 72.12 112.205 -177.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -121.3 116.97 25.85 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.493 -1.299 . . . . 70.44 107.493 -177.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.464 HD22 HD12 ' B' ' 16' ' ' ILE . 12.6 m120 -112.25 103.5 11.64 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.389 0.676 . . . . 52.44 109.513 -176.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.1 116.22 10.2 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.049 0.539 . . . . 73.25 110.558 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.49 143.46 97.86 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.232 0.613 . . . . 62.42 110.28 175.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.72 123.17 13.17 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.082 2.521 . . . . 74.31 112.832 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 98.6 t -107.71 112.86 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.634 0.774 . . . . 53.34 108.941 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . 0.504 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 44.9 t30 -81.71 89.02 6.24 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.089 -1.078 . . . . 72.32 108.089 172.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.487 ' HZ ' HD22 ' H' ' 11' ' ' LEU . 0.9 OUTLIER -64.82 -22.97 67.1 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.874 -1.057 . . . . 63.43 111.011 -176.495 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.475 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 7.8 m-20 -61.3 -48.52 81.01 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.33 0.652 . . . . 74.51 111.185 172.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.504 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -62.49 -43.68 98.23 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.457 0.703 . . . . 72.31 111.559 -176.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 84.7 mt -57.79 -36.21 71.87 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.154 0.909 . . . . 64.44 111.485 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -81.77 -37.01 27.85 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.731 0.812 . . . . 55.41 111.657 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.454 ' HA ' ' HB2' ' D' ' 141' ' ' LEU . 75.8 mtm -70.06 -15.2 62.96 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.816 0.446 . . . . 63.03 110.887 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -62.72 -43.52 98.59 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.501 0.72 . . . . 53.02 110.757 169.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -65.15 -42.02 94.19 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.185 0.594 . . . . 72.43 110.13 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.454 ' HB2' ' HA ' ' D' ' 138' ' ' MET . 10.9 mp -62.2 -36.07 80.79 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.114 0.566 . . . . 65.5 111.545 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -90.71 36.32 0.9 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.504 0.668 . . . . 61.21 111.823 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -117.72 79.24 1.33 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 107.79 -1.189 . . . . 44.33 107.79 173.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -166.7 134.85 2.72 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.488 -1.233 . . . . 72.35 107.996 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . 0.514 ' H ' HG22 ' D' ' 149' ' ' THR . . . -159.72 15.77 0.15 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.738 0.815 . . . . 50.11 110.447 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 69.01 -86.12 0.22 Allowed Glycine 0 C--N 1.351 1.414 0 N-CA-C 112.17 -0.372 . . . . 45.23 112.17 -172.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.27 154.33 17.58 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.447 0.699 . . . . 74.24 110.126 176.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.02 -76.85 1.02 Allowed Glycine 0 C--N 1.352 1.459 0 O-C-N 123.532 0.52 . . . . 55.51 112.466 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . 0.514 HG22 ' H ' ' D' ' 145' ' ' ALA . 60.1 p 60.72 -75.66 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.757 2.023 . . . . 65.13 113.474 174.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -151.34 -161.34 1.31 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.669 1.188 . . . . 72.31 108.598 -175.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.94 -173.83 4.94 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.684 0.394 . . . . 71.01 110.941 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -70.71 107.32 3.89 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.993 -0.549 . . . . 73.33 110.158 173.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -86.66 140.52 29.73 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.517 -0.549 . . . . 62.43 109.517 174.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -70.49 85.35 0.61 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.471 0.708 . . . . 63.34 109.655 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 C-N-CA 124.093 0.957 . . . . 73.3 109.245 -177.281 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . 0.401 ' SD ' ' N ' ' E' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.111 -0.7 . . . . 41.02 109.111 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -140.46 129.87 23.94 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.619 0.768 . . . . 74.2 109.904 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -115.66 115.13 25.85 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.699 -1.223 . . . . 71.41 107.699 174.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -112.92 158.97 19.56 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.057 0.543 . . . . 63.51 111.12 -175.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 36.8 m -139.31 152.44 47.22 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.052 0.941 . . . . 61.54 109.129 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.441 HD13 HG13 ' A' ' 40' ' ' VAL . 38.0 pt -59.92 145.55 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 123.813 0.845 . . . . 71.2 112.583 176.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 7' ' ' ALA . . . . . 0.564 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . . . -154.99 158.52 39.3 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.972 0.909 . . . . 75.23 109.565 175.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.709 ' HB2' HG11 ' A' ' 131' ' ' VAL . 78.9 mt -80.05 174.41 11.62 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.859 0.464 . . . . 74.45 110.129 177.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.04 176.66 7.45 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.641 0.776 . . . . 44.44 109.348 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . 0.456 ' HB2' HD22 ' A' ' 136' ' ' LEU . 55.2 tp -61.54 129.89 43.33 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.897 0.479 . . . . 64.32 110.202 178.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.719 ' HB2' HD23 ' E' ' 14' ' ' LEU . 4.4 mp -68.35 119.69 69.78 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 108.837 -0.801 . . . . 73.43 108.837 -178.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -82.64 34.66 0.55 Allowed 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.854 2.369 . . . . 64.24 112.187 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 tt -158.83 -44.6 0.06 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.909 -1.145 . . . . 75.2 107.909 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . 0.719 HD23 ' HB2' ' E' ' 11' ' ' LEU . 58.2 mt 66.14 -167.77 0.21 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.549 1.14 . . . . 74.02 110.876 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . 0.509 ' HB3' ' HD3' ' E' ' 17' ' ' PRO . 83.4 m-85 -101.32 158.91 15.7 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.336 0.654 . . . . 74.24 110.418 174.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 16.7 p -143.43 62.3 11.09 Favored Pre-proline 0 CA--C 1.568 1.635 0 C-N-CA 123.913 0.885 . . . . 65.01 110.623 172.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 17' ' ' PRO . . . . . 0.545 ' HD2' HD22 ' A' ' 98' ' ' LEU . 74.6 Cg_endo -77.32 -27.84 6.19 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 122.205 1.936 . . . . 72.34 112.462 176.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 19.2 t -103.14 -29.62 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 123.501 0.72 . . . . 61.43 110.347 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 9.1 m 65.79 167.36 0.2 Allowed 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 124.705 1.202 . . . . 72.4 110.728 -172.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 50.7 tptt 68.83 20.34 8.06 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.234 1.016 . . . . 75.53 109.68 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.36 -75.34 0.27 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.723 -1.126 . . . . 71.23 109.382 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.97 -85.58 0.29 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 107.879 -1.156 . . . . 62.04 107.879 177.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 20.3 m 51.8 103.48 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 125.146 1.378 . . . . 52.13 112.821 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.64 -74.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.079 1.853 . . . . 61.54 110.693 175.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 . . . . . 0 C--O 1.248 0.984 0 N-CA-C 107.79 -1.189 . . . . 73.44 107.79 173.885 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 109.693 -0.484 . . . . 75.23 109.693 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -146.48 -91.83 0.09 Allowed 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 108.681 -0.859 . . . . 64.11 108.681 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -124.92 -57.57 1.52 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.202 -1.036 . . . . 72.54 108.202 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -86.98 51.9 2.37 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.259 -0.882 . . . . 74.42 110.017 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 37.6 m -65.39 -58.99 4.51 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 123.829 0.852 . . . . 62.41 109.551 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.494 HG13 ' H ' ' F' ' 7' ' ' ALA . 4.8 pt -145.44 -60.13 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 114.1 -1.409 . . . . 61.32 108.311 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 7' ' ' ALA . . . . . 0.494 ' H ' HG13 ' F' ' 6' ' ' ILE . . . 59.31 158.68 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.313 1.445 . . . . 52.33 113.054 -176.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . 0.819 HD13 HD21 ' B' ' 44' ' ' LEU . 60.4 mt -85.25 21.31 1.73 Allowed 'General case' 0 N--CA 1.482 1.146 0 O-C-N 121.878 -0.514 . . . . 75.12 112.164 -176.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . 66.98 -76.01 0.05 Allowed 'General case' 0 C--N 1.362 1.152 0 C-N-CA 126.011 1.724 . . . . 72.4 111.926 176.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 10' ' ' LEU . . . . . 0.462 ' HG ' HD23 ' B' ' 136' ' ' LEU . 7.0 tt -156.27 -56.1 0.09 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.311 -1.366 . . . . 74.54 107.311 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 2.7 tm? 63.36 103.76 0.03 OUTLIER Pre-proline 0 C--N 1.361 1.1 0 C-N-CA 125.226 1.41 . . . . 70.45 110.436 -173.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 12' ' ' PRO . . . . . 0.444 ' HA ' ' HZ ' ' B' ' 137' ' ' PHE . 20.9 Cg_exo -67.21 121.72 8.9 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.398 2.065 . . . . 63.54 110.645 170.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 pp -76.59 80.95 3.26 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-O 122.332 1.063 . . . . 71.25 111.955 -175.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 37.7 mt -100.77 30.55 3.95 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.671 -0.695 . . . . 75.33 110.957 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . 0.592 ' HZ ' HD13 ' B' ' 60' ' ' LEU . 70.4 m-85 -70.0 143.32 52.61 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.902 0.881 . . . . 75.11 110.03 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 16' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' B' ' 48' ' ' SER . 32.3 m -70.6 130.48 88.86 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.021 0.528 . . . . 75.34 110.259 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 17' ' ' PRO . . . . . 0.683 ' HA ' HD21 ' B' ' 98' ' ' LEU . 52.2 Cg_endo -64.96 167.74 15.24 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 123.308 2.672 . . . . 74.12 114.314 -177.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . 0.593 HG21 HG21 ' B' ' 86' ' ' ILE . 29.5 t -60.23 -44.29 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 114.678 -1.147 . . . . 71.42 109.394 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 8.8 t -162.94 121.32 2.06 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 114.722 -1.127 . . . . 74.41 109.499 168.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 56.1 tptt 60.39 -81.88 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.881 1.673 . . . . 72.0 112.913 174.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . 0.546 ' HB2' ' SD ' ' B' ' 94' ' ' MET . . . 52.67 -78.28 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.195 1.398 . . . . 74.42 112.225 -178.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -146.37 -30.12 0.38 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.435 1.094 . . . . 74.34 109.753 166.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 27.9 m 61.56 92.81 0.06 OUTLIER Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 125.083 1.353 . . . . 75.42 111.335 -175.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.92 105.01 0.89 Allowed 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.525 2.15 . . . . 71.45 111.32 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 . . . . . 0 C--O 1.258 1.52 0 C-N-CA 124.095 0.958 . . . . 54.02 109.516 178.631 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtt . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 109.354 -0.61 . . . . 73.21 109.354 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -81.82 66.94 7.61 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.246 0.619 . . . . 75.11 109.826 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -83.36 97.13 8.77 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.15 0.5 . . . . 75.14 109.684 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 40.8 m -132.24 164.55 26.14 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.478 1.111 . . . . 65.31 108.582 174.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 22.7 m -60.57 -59.81 4.8 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.937 -0.394 . . . . 75.23 109.937 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . . . . . . . . . 13.1 pt -147.97 156.93 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.888 0.875 . . . . 64.43 110.3 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.77 139.11 24.86 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.067 -0.97 . . . . 73.34 108.484 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 8' ' ' LEU . . . . . 0.475 HD23 HD22 ' C' ' 42' ' ' LEU . 53.0 mt -70.59 148.39 48.19 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.321 0.388 . . . . 64.42 110.135 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.48 163.2 27.3 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.83 0.452 . . . . 74.14 111.164 176.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -86.33 39.58 0.83 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 123.349 0.66 . . . . 75.51 110.364 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 11' ' ' LEU . . . . . 0.45 ' HB2' HD23 ' G' ' 14' ' ' LEU . 71.4 mt 55.62 95.15 0.05 OUTLIER Pre-proline 0 C--N 1.368 1.395 0 C-N-CA 125.56 1.544 . . . . 71.53 111.672 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -55.26 -56.25 2.48 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 123.833 3.022 . . . . 73.33 113.932 -166.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 40.1 tp -93.22 -16.4 24.85 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.996 0.518 . . . . 72.33 110.983 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . 0.45 HD23 ' HB2' ' G' ' 11' ' ' LEU . 59.1 mt 68.06 167.4 0.26 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.901 1.28 . . . . 72.41 111.059 -171.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -84.78 142.15 30.01 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.138 -0.69 . . . . 74.43 109.138 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 41.6 p -66.82 124.89 89.75 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 123.633 0.773 . . . . 71.33 111.715 -172.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 17' ' ' PRO . . . . . 0.469 ' HB3' ' H ' ' G' ' 21' ' ' ALA . 98.3 Cg_exo -48.16 123.51 8.96 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 123.726 2.95 . . . . 52.53 114.189 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 18' ' ' VAL . . . . . . . . . . . . . 54.3 t -54.19 -55.23 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 124.183 0.993 . . . . 61.35 109.833 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 3.4 t -154.92 101.97 2.31 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.246 -1.343 . . . . 75.5 108.379 171.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 20' ' ' LYS . . . . . 0.487 ' HB3' ' HZ3' ' G' ' 20' ' ' LYS . 5.7 ttpm? 55.05 33.65 20.79 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 125.06 1.344 . . . . 71.32 112.354 175.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . 0.469 ' H ' ' HB3' ' G' ' 17' ' ' PRO . . . -75.54 81.14 2.56 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.14 0.576 . . . . 74.33 110.944 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -162.32 -52.94 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.838 1.255 . . . . 63.53 109.746 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 23.0 p -136.54 107.37 9.22 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 123.953 0.901 . . . . 64.55 109.99 -174.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 24' ' ' PRO . . . . . 0.442 ' HD3' ' H ' ' C' ' 92' ' ' THR . 95.2 Cg_endo -94.77 78.54 0.16 Allowed 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.703 2.936 . . . . 74.04 112.108 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 CA--C 1.554 1.101 0 C-N-CA 123.748 0.819 . . . . 60.0 110.109 -176.458 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 N-CA-C 109.948 -0.39 . . . . 72.42 109.948 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -131.94 159.13 39.58 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.658 0.783 . . . . 72.4 110.386 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -68.34 -34.8 76.74 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.533 -0.758 . . . . 74.21 109.435 167.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 24.3 m -83.12 85.2 7.23 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.033 -0.985 . . . . 71.44 109.469 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 61.8 m -138.38 155.51 48.45 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.666 1.187 . . . . 43.0 108.101 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.58 ' HA ' HD23 ' D' ' 42' ' ' LEU . 16.0 tt -74.21 82.34 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 CA-C-O 123.49 1.614 . . . . 71.52 110.121 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.01 28.03 0.94 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 113.928 -1.487 . . . . 55.12 109.341 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 8' ' ' LEU . . . . . 0.407 ' H ' HD22 ' D' ' 42' ' ' LEU . 5.5 tt 61.2 112.98 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.037 1.335 . . . . 74.51 110.277 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.62 -87.32 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 122.604 0.361 . . . . 54.14 111.061 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 tt -170.32 126.59 0.79 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.734 -0.839 . . . . 73.11 108.734 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.494 ' HB3' HD23 ' H' ' 14' ' ' LEU . 10.6 mp -96.01 128.32 37.66 Favored Pre-proline 0 N--CA 1.483 1.197 0 N-CA-C 108.9 -0.778 . . . . 64.33 108.9 172.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -42.27 -65.16 0.2 Allowed 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 123.85 3.033 . . . . 62.52 113.415 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 37.6 mt -149.69 -63.37 0.22 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.422 1.089 . . . . 75.22 108.234 168.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . 0.494 HD23 ' HB3' ' H' ' 11' ' ' LEU . 3.8 mm? 58.95 -170.45 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.22 0.608 . . . . 74.23 111.219 -177.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . 0.563 ' H ' HG21 ' D' ' 46' ' ' THR . 80.9 m-85 64.47 -178.46 0.17 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.429 1.091 . . . . 74.51 112.711 176.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 16' ' ' THR . . . . . 0.407 ' HB ' ' HB1' ' H' ' 21' ' ' ALA . 43.0 p -117.3 158.02 45.7 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-N 115.271 -0.877 . . . . 72.41 109.995 -177.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.71 -152.02 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.994 0 C-N-CA 122.796 2.33 . . . . 74.04 112.639 174.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . 0.401 ' N ' ' HB3' ' D' ' 94' ' ' MET . 49.9 t -128.38 154.62 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.461 -1.311 . . . . 72.22 107.461 175.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 84.1 m 66.39 95.1 0.06 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.645 1.178 . . . . 62.13 109.417 -165.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt 53.05 67.59 0.97 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.676 1.191 . . . . 71.12 111.185 -172.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . 0.407 ' HB1' ' HB ' ' H' ' 16' ' ' THR . . . -75.46 -61.44 1.91 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.015 -0.993 . . . . 71.42 111.135 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -58.04 4.74 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.573 -0.899 . . . . 74.53 108.573 -175.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 18.4 m 48.07 74.03 0.89 Allowed Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 124.671 1.188 . . . . 71.12 111.808 -176.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -80.69 -5.99 13.33 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.084 2.523 . . . . 74.13 113.136 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 CA--C 1.556 1.176 0 C-N-CA 124.009 0.924 . . . . 61.45 109.675 -177.686 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 109.932 -0.396 . . . . 73.42 109.932 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.0 t -63.15 133.04 53.73 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.863 0.865 . . . . 72.21 110.559 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.05 41.72 1.08 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.885 0.874 . . . . 72.3 111.241 -174.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -64.7 94.59 0.13 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.566 0.746 . . . . 70.43 110.305 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -113.4 165.07 12.81 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.823 -1.081 . . . . 72.44 108.937 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 67.39 86.49 0.13 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.571 1.149 . . . . 64.53 110.036 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.8 p -125.55 -49.98 1.64 Allowed 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.373 1.069 . . . . 72.45 109.075 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -94.49 179.98 5.09 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.969 -1.014 . . . . 74.22 110.606 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.3 ttt 73.81 155.92 0.17 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 125.16 1.384 . . . . 64.32 111.574 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 56.2 m -137.16 101.36 4.52 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.621 -1.251 . . . . 61.53 107.621 175.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.585 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 20.5 t80 -98.92 127.53 44.86 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.314 -1.312 . . . . 70.41 109.296 -176.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -146.72 115.02 6.66 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.912 -0.773 . . . . 74.33 108.912 176.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.677 HG12 ' HD2' ' A' ' 84' ' ' PHE . 32.8 mt -84.38 115.33 26.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.79 -0.818 . . . . 70.42 108.79 176.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -75.77 -33.56 60.2 Favored 'General case' 0 C--O 1.242 0.684 0 O-C-N 123.687 0.617 . . . . 71.05 110.816 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -171.51 148.04 2.46 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.329 0.393 . . . . 61.32 110.912 -170.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.47 HD12 ' HB3' ' C' ' 130' ' ' PRO . 87.6 mt -138.68 133.84 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 107.983 -1.117 . . . . 71.5 107.983 172.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.425 ' HB3' HG23 ' B' ' 122' ' ' THR . 19.7 p90 -164.32 157.38 17.57 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.147 0.979 . . . . 75.44 110.701 -171.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -84.42 113.18 20.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.888 -1.051 . . . . 62.44 108.636 177.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 32.7 mtpt -82.27 -31.86 29.88 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.844 0.354 . . . . 61.42 110.287 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.8 t70 -137.45 137.94 39.26 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.392 -0.822 . . . . 74.13 109.634 171.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.415 HD13 ' SD ' ' B' ' 117' ' ' MET . 64.5 mt -127.23 139.98 50.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 C-N-CA 124.973 1.309 . . . . 62.25 107.535 171.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.9 t -150.45 128.17 11.64 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 123.822 0.701 . . . . 40.34 109.56 173.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.45 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 83.2 t80 -129.89 121.85 27.49 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 106.849 -1.537 . . . . 74.1 106.849 172.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 47.2 mt-10 -127.05 112.78 15.61 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.929 0.492 . . . . 62.3 110.0 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.5 81.77 4.33 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 107.287 -1.375 . . . . 70.41 107.287 169.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.43 -16.38 19.31 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.728 2.285 . . . . 62.3 112.599 -171.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -113.01 12.84 19.35 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.381 1.072 . . . . 71.22 110.567 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -41.35 -59.33 2.37 Favored Pre-proline 0 C--N 1.37 1.468 0 CA-C-O 117.337 -1.316 . . . . 72.43 114.38 -165.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 44.8 Cg_exo -53.72 -45.23 42.59 Favored 'Trans proline' 0 C--N 1.39 2.737 0 C-N-CA 121.934 1.756 . . . . 73.3 113.881 -174.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -97.75 -14.12 21.02 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.105 0.78 . . . . 72.43 113.105 -170.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.801 HG21 ' HA ' ' A' ' 73' ' ' ALA . 8.0 p -75.46 -22.21 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-N 118.288 0.495 . . . . 53.23 111.341 -175.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -65.85 -22.24 66.52 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.23 0.612 . . . . 73.52 111.124 173.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -80.68 -19.53 44.98 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.143 0.977 . . . . 75.54 111.079 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.431 ' NZ ' ' HB2' ' A' ' 71' ' ' GLU . 31.8 mmtp -81.62 155.02 25.85 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.707 0.803 . . . . 61.41 111.453 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.59 132.37 49.61 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.094 0.958 . . . . 63.32 110.296 174.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -81.59 85.68 6.5 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.012 0.525 . . . . 74.2 110.196 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -121.82 82.25 42.23 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 107.509 -1.293 . . . . 73.43 107.509 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -75.14 115.18 4.19 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 122.435 2.09 . . . . 72.24 111.948 -172.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -91.95 96.53 10.43 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.091 -1.818 . . . . 71.4 106.091 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.597 HG11 HG12 ' E' ' 6' ' ' ILE . 15.9 m -66.5 90.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.615 0 CA-C-O 122.69 1.233 . . . . 74.52 110.3 -175.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 54.2 tptt -96.85 110.69 23.13 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.541 -1.651 . . . . 74.54 106.541 175.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.565 HD23 ' H ' ' A' ' 42' ' ' LEU . 2.0 pt? -110.37 147.14 34.56 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.875 -0.417 . . . . 71.13 109.875 -172.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.565 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 13.5 t70 -130.91 129.11 41.81 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.295 -1.372 . . . . 74.44 107.295 177.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.467 ' H ' HD23 ' A' ' 44' ' ' LEU . 2.2 pt? -126.57 129.52 48.73 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.108 0.563 . . . . 72.02 109.564 -174.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -152.33 163.06 40.24 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.184 0.994 . . . . 52.44 108.852 -177.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.2 m -147.39 144.11 28.46 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.429 0.692 . . . . 71.22 110.804 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.52 122.22 25.77 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.171 -1.418 . . . . 65.44 107.171 173.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.674 ' HB2' ' HB3' ' E' ' 17' ' ' PRO . 66.5 p -131.52 153.5 49.75 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.727 0.299 . . . . 63.33 110.851 -173.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.8 t -155.74 146.83 22.43 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.744 0.818 . . . . 72.52 109.966 -173.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -76.53 141.26 41.27 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.905 -0.776 . . . . 74.35 108.905 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 57' ' ' GLU . 69.0 mt -113.73 -39.54 4.0 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.095 0.958 . . . . 73.43 109.605 176.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -155.96 -170.48 3.41 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.242 0.617 . . . . 72.23 110.296 -177.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -60.9 108.33 0.85 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.564 0.746 . . . . 73.34 110.059 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 65.01 7.13 3.82 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.69 1.196 . . . . 73.01 112.79 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 85.3 t -98.93 116.32 41.66 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 N-CA-C 107.239 -1.393 . . . . 71.31 107.239 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.606 ' HB3' ' HB2' ' E' ' 17' ' ' PRO . 67.5 m-85 -131.81 128.67 39.22 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.173 0.989 . . . . 75.1 109.391 -172.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.473 ' HB2' HD11 ' A' ' 51' ' ' LEU . 38.3 tt0 -87.33 131.42 34.27 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.588 0.755 . . . . 73.4 109.743 172.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.463 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 98.3 t -118.77 116.18 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.156 -1.053 . . . . 53.24 108.156 171.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.56 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 35.6 t -101.31 117.76 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 109.044 -0.724 . . . . 63.42 109.044 175.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.39 113.77 26.68 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.252 -0.647 . . . . 70.34 109.252 -176.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -82.6 101.99 11.14 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.668 -0.864 . . . . 72.41 108.668 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.6 t -100.14 102.6 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 107.404 -1.332 . . . . 63.42 107.404 170.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 37.2 m -106.59 135.92 47.27 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.935 0.894 . . . . 53.32 109.715 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.706 HG11 HD21 ' A' ' 126' ' ' LEU . 40.5 t -130.98 126.6 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.765 1.226 . . . . 54.14 108.753 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 10.8 m -112.44 135.33 53.27 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.545 -0.909 . . . . 71.55 108.545 174.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.92 105.63 14.87 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.364 -1.346 . . . . 65.11 107.364 170.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.7 m -107.1 133.81 51.15 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.903 -1.147 . . . . 71.14 107.903 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.7 mt -103.48 47.87 0.87 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.413 -0.958 . . . . 72.25 108.413 -176.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.18 -84.44 1.35 Allowed Glycine 0 C--N 1.342 0.881 0 N-CA-C 110.848 -0.901 . . . . 74.12 110.848 -170.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -90.69 -31.41 16.6 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.615 0.766 . . . . 73.41 111.588 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.431 ' HB2' ' NZ ' ' A' ' 34' ' ' LYS . 3.8 tp10 -115.9 112.69 22.27 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 116.282 -0.417 . . . . 63.11 110.294 -162.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.2 m -70.73 119.57 15.08 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.881 -0.414 . . . . 74.25 109.881 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.801 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -70.01 -58.56 3.69 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 114.951 -1.022 . . . . 61.21 109.52 175.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -155.68 171.57 19.77 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.141 -0.936 . . . . 72.1 112.528 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 28.0 tp -141.31 107.63 5.26 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 113.701 -1.59 . . . . 72.41 107.754 175.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.0 m -106.39 101.68 11.14 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.373 1.069 . . . . 52.44 110.556 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -116.43 117.3 29.55 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.918 0.887 . . . . 73.23 109.292 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.0 t -131.07 110.45 18.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 123.818 0.847 . . . . 74.3 109.326 -174.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 69.9 mt-30 -85.92 88.52 7.58 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.811 -0.811 . . . . 63.35 108.811 171.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -80.46 100.47 8.53 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.347 -0.842 . . . . 63.53 109.537 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.29 144.94 19.45 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 111.678 -0.569 . . . . 64.42 111.678 176.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.404 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -145.98 127.48 2.8 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.408 -0.677 . . . . 53.31 111.408 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.3 mt -85.2 124.75 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.629 0.772 . . . . 74.03 108.946 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.677 ' HD2' HG12 ' A' ' 13' ' ' ILE . 12.5 m-85 -133.41 159.87 39.04 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.111 0.564 . . . . 73.02 109.557 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.0 p -111.24 114.18 27.19 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.063 -0.718 . . . . 62.52 109.063 170.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.593 HG12 HD23 ' A' ' 98' ' ' LEU . 4.1 mp -109.73 117.57 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 107.754 -1.202 . . . . 73.43 107.754 175.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.54 137.15 7.73 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.905 0.882 . . . . 73.22 109.225 -174.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 140.55 -74.51 0.36 Allowed Glycine 0 C--N 1.341 0.845 0 O-C-N 123.392 0.433 . . . . 75.21 112.068 176.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.2 tt -149.84 144.16 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 122.749 0.42 . . . . 65.41 110.855 -170.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.491 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 5.6 mp0 -104.3 -152.97 0.47 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.796 1.238 . . . . 74.0 109.539 -176.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.38 -140.51 29.63 Favored Glycine 0 C--N 1.355 1.614 0 CA-C-O 119.923 -0.376 . . . . 73.21 112.812 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.5 p -67.6 -26.04 66.07 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.775 0.83 . . . . 41.1 111.832 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -68.07 -51.73 43.25 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.038 0.935 . . . . 74.32 110.373 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.491 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 53.5 ttp -70.82 -25.75 62.99 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 122.315 0.246 . . . . 74.32 111.317 176.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.07 -30.47 71.0 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 120.909 0.385 . . . . 75.54 110.682 175.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.454 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 58.9 t-80 -83.76 -37.16 22.98 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.774 -0.648 . . . . 71.12 111.071 176.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 74.3 m -77.75 -64.29 1.19 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 122.724 0.41 . . . . 52.2 111.104 -177.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.593 HD23 HG12 ' A' ' 86' ' ' ILE . 3.2 tm? -72.92 -39.75 66.05 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.883 0.873 . . . . 71.35 110.867 -175.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.82 0.44 76.56 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-O 119.378 -0.679 . . . . 45.01 114.672 -171.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.481 ' HB1' ' HB3' ' A' ' 134' ' ' ASP . . . -146.55 -50.61 0.21 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.113 0.957 . . . . 54.03 112.43 -172.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.478 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 65.1 t80 -76.21 -49.99 15.71 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.556 0.743 . . . . 72.44 111.994 -174.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.408 ' HA ' HG12 ' A' ' 105' ' ' ILE . 77.2 m -68.47 -34.27 5.49 Favored Pre-proline 0 CA--C 1.568 1.667 0 N-CA-C 113.435 0.902 . . . . 65.43 113.435 -178.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -50.93 -44.36 42.3 Favored 'Trans proline' 0 C--N 1.396 3.065 0 C-N-CA 122.68 2.254 . . . . 60.23 112.954 162.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -70.2 -22.41 62.93 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 114.846 -1.07 . . . . 73.42 111.614 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.408 HG12 ' HA ' ' A' ' 102' ' ' CYS . 44.1 mm -70.31 -43.93 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 123.299 0.64 . . . . 71.04 110.714 177.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.404 HD21 ' HA3' ' A' ' 82' ' ' GLY . 88.9 mt -76.31 -19.31 58.38 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.804 -0.634 . . . . 75.31 111.596 -176.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -64.33 -48.33 76.08 Favored Pre-proline 0 CA--C 1.568 1.657 0 N-CA-C 114.153 1.168 . . . . 61.04 114.153 -172.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.28 -34.48 67.29 Favored 'Trans proline' 0 C--N 1.388 2.649 0 CA-C-N 122.035 1.763 . . . . 51.52 112.754 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -69.2 -45.17 70.56 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.607 0.763 . . . . 73.32 111.435 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.2 -37.83 78.29 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.963 -0.562 . . . . 74.24 110.716 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.457 HH12 HD12 ' C' ' 105' ' ' ILE . 24.4 ttm180 -60.68 -45.6 93.55 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 124.004 0.815 . . . . 54.31 109.641 174.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -66.14 -44.56 83.82 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.651 0.78 . . . . 75.54 111.5 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -60.21 -42.21 94.65 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.532 0.52 . . . . 73.45 110.107 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 118' ' ' VAL . 59.0 mt -59.53 -52.56 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 124.082 0.953 . . . . 65.55 110.5 172.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.426 HG21 ' HE2' ' C' ' 109' ' ' TYR . 94.9 m -54.58 -46.7 73.78 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.472 1.109 . . . . 73.45 111.969 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 44.3 t -70.41 -34.53 72.63 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.331 -0.849 . . . . 71.14 111.22 -176.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.45 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 9.3 mtp -67.44 -40.53 85.44 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.318 0.647 . . . . 75.31 110.863 175.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 114' ' ' ILE . 51.4 t -62.92 -51.1 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.695 1.198 . . . . 74.5 110.799 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.4 p -68.35 -29.24 67.92 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.356 0.662 . . . . 73.42 111.373 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' A' ' 116' ' ' SER . 18.5 ttm-85 -74.31 -30.28 61.99 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.207 1.003 . . . . 74.41 110.042 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.444 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.93 11.6 59.6 Favored Glycine 0 C--N 1.353 1.522 0 CA-C-N 115.23 -0.895 . . . . 63.21 112.603 172.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.489 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.0 OUTLIER 66.17 11.59 7.95 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 127.025 2.13 . . . . 62.23 113.148 175.532 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -78.64 148.99 74.07 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 123.263 0.625 . . . . 74.41 109.722 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.02 158.81 41.56 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.622 2.215 . . . . 73.32 112.34 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.417 ' OE1' HG23 ' A' ' 115' ' ' THR . 6.1 tp-100 -58.77 132.56 54.25 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.546 1.138 . . . . 61.21 112.829 -167.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.706 HD21 HG11 ' A' ' 64' ' ' VAL . 51.9 tp -129.31 110.74 12.19 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.986 1.314 . . . . 65.43 109.726 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -129.8 121.16 26.25 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.65 0.78 . . . . 62.34 108.957 172.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.461 HD11 HG21 ' A' ' 64' ' ' VAL . 6.4 mp -71.83 147.0 47.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.615 0.366 . . . . 73.31 110.649 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.76 140.47 96.33 Favored Pre-proline 0 CA--C 1.554 1.124 0 O-C-N 123.771 0.669 . . . . 71.3 110.86 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.401 ' HD3' HG13 ' C' ' 13' ' ' ILE . 30.8 Cg_endo -62.31 133.21 42.21 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 123.265 2.643 . . . . 52.34 112.125 177.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 m -127.1 113.95 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 121.666 0.746 . . . . 65.33 110.391 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -87.88 96.89 10.65 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.242 -1.022 . . . . 75.11 108.242 168.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -57.12 -40.27 76.78 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 123.879 0.737 . . . . 72.42 110.474 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.481 ' HB3' ' HB1' ' A' ' 100' ' ' ALA . 11.9 p-10 -62.67 -41.75 99.24 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.299 -1.319 . . . . 60.34 112.28 -177.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.8 88.83 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.069 0.548 . . . . 71.03 110.905 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.657 ' HB2' HD21 ' E' ' 10' ' ' LEU . 85.8 mt -74.1 -29.31 61.78 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.807 -0.633 . . . . 61.52 110.984 178.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -71.4 -31.75 67.63 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.029 0.532 . . . . 63.25 110.544 173.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 33.6 mmt -71.97 -38.03 69.81 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.103 0.561 . . . . 72.44 110.309 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -62.11 -44.5 96.51 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 123.841 0.713 . . . . 73.23 109.744 175.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -65.45 -41.39 93.47 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.081 0.952 . . . . 71.11 110.983 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.8 tp -67.74 -14.58 63.07 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.118 0.967 . . . . 72.32 112.232 -174.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -146.33 30.45 1.03 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.466 0.651 . . . . 73.01 110.003 -176.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -64.4 94.12 0.11 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.777 1.231 . . . . 62.01 111.655 -176.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -137.19 110.63 7.96 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.912 0.885 . . . . 74.42 109.384 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 66.84 -75.69 0.06 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.374 1.47 . . . . 71.31 111.843 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.85 62.85 2.87 Favored Glycine 0 C--N 1.344 1.01 0 N-CA-C 111.268 -0.733 . . . . 22.54 111.268 -174.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -74.44 -28.93 61.27 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.457 1.103 . . . . 73.44 112.525 -170.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -79.5 70.81 2.78 Favored Glycine 0 C--N 1.347 1.192 0 O-C-N 123.248 0.342 . . . . 54.13 112.653 -177.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.1 t -144.33 153.91 42.48 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.769 0.827 . . . . 65.44 110.7 -174.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -77.78 144.78 36.85 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.363 0.665 . . . . 72.33 110.371 177.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -83.99 144.62 29.01 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.168 0.987 . . . . 70.23 110.804 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -92.43 153.15 19.31 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.264 1.026 . . . . 73.33 109.57 176.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -93.38 -37.44 11.99 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.204 0.602 . . . . 71.22 110.502 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -117.9 147.4 43.14 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.489 1.116 . . . . 73.23 109.622 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 C-N-CA 123.685 0.794 . . . . 74.23 109.43 176.743 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.478 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 108.835 -0.802 . . . . 73.35 108.835 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 69.6 p -161.28 -174.4 4.3 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.85 0.86 . . . . 73.42 110.219 174.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -136.57 124.56 22.83 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.452 -0.944 . . . . 73.03 108.452 173.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -92.96 -67.27 0.87 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.572 0.749 . . . . 62.44 109.161 -176.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 168.73 -30.9 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.968 1.707 . . . . 75.23 107.359 -174.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.53 64.93 0.57 Allowed 'General case' 0 C--N 1.364 1.201 0 C-N-CA 124.97 1.308 . . . . 62.15 111.118 172.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.6 p -135.38 161.94 34.01 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.596 -1.183 . . . . 63.41 110.366 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 63.32 -77.69 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.889 1.676 . . . . 75.11 111.96 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 1.9 tmt? 66.01 161.01 0.14 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.824 1.65 . . . . 74.05 111.766 -176.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 87.6 m -169.03 139.58 2.32 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 125.078 1.351 . . . . 75.23 107.936 177.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.35 157.37 45.65 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.413 0.625 . . . . 72.42 110.105 157.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.538 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -124.56 131.45 53.48 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 107.185 -1.413 . . . . 74.03 107.185 175.558 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.449 HD13 HD11 ' B' ' 16' ' ' ILE . 59.7 mt -67.87 117.32 9.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.215 -1.032 . . . . 74.4 108.215 174.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . 0.434 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 11.5 mm-40 -86.9 -37.89 17.24 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 124.038 0.836 . . . . 74.25 108.745 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.489 ' HE ' HG21 ' A' ' 122' ' ' THR . 42.4 ttt180 -175.27 137.61 0.4 Allowed 'General case' 0 C--N 1.355 0.828 0 CA-C-N 115.4 -0.818 . . . . 74.33 109.606 -176.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.449 HD11 HD13 ' B' ' 13' ' ' ILE . 94.2 mt -115.49 141.51 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 107.273 -1.38 . . . . 63.53 107.273 173.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -165.88 146.41 6.66 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.989 0.423 . . . . 70.2 111.484 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.594 HG21 HD11 ' B' ' 21' ' ' ILE . 96.2 m -75.97 123.48 25.81 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.382 -0.826 . . . . 71.24 109.049 169.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.457 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 23.0 mtpp -89.17 -38.84 13.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.817 -0.629 . . . . 74.01 109.965 178.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 14.6 t70 -153.21 142.44 21.49 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.174 0.435 . . . . 63.44 112.174 -169.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.594 HD11 HG21 ' B' ' 18' ' ' THR . 38.2 mm -134.79 146.34 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.029 1.332 . . . . 74.22 108.775 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.52 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 47.7 t -147.9 140.51 24.59 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.905 -1.146 . . . . 50.33 107.905 175.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.411 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 92.1 t80 -157.65 114.15 2.9 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.893 -1.151 . . . . 64.34 107.893 173.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -121.98 112.45 18.29 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.298 -0.63 . . . . 73.52 109.298 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.53 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -108.6 86.81 3.82 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 107.429 -1.323 . . . . 61.33 107.429 172.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.37 -40.79 2.83 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.331 2.021 . . . . 65.21 112.013 -176.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -92.44 9.29 34.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.805 0.842 . . . . 63.4 111.367 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.53 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -40.4 -66.04 0.4 Allowed Pre-proline 0 CA--C 1.57 1.722 0 C-N-CA 125.225 1.41 . . . . 74.0 114.58 -170.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.05 -34.99 94.12 Favored 'Trans proline' 0 C--N 1.399 3.202 0 C-N-CA 122.915 2.41 . . . . 73.33 113.536 -167.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -95.25 -28.85 14.81 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.545 -0.752 . . . . 71.42 111.972 -174.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.447 HG21 ' HA ' ' B' ' 73' ' ' ALA . 4.5 p -74.81 -12.44 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-N 118.271 0.487 . . . . 64.15 111.351 -176.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -68.82 -14.51 63.08 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.294 0.85 . . . . 73.22 113.294 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -64.49 -27.07 68.72 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.096 0.474 . . . . 74.44 110.148 172.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -87.75 84.01 7.1 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.647 1.179 . . . . 62.33 110.134 -177.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -93.27 87.56 5.69 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.377 -0.829 . . . . 73.15 109.873 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -160.23 177.03 11.06 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.298 1.039 . . . . 74.12 108.739 171.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -69.83 111.77 10.14 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 109.502 -0.555 . . . . 71.33 109.502 176.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -67.04 157.46 61.61 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.317 2.012 . . . . 63.25 111.89 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 24.9 tt0 -66.23 103.54 1.01 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.16 -1.052 . . . . 71.23 108.16 169.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -86.94 141.59 14.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.579 -0.896 . . . . 63.01 108.579 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -147.05 99.43 3.17 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 108.27 -1.011 . . . . 55.12 108.27 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.19 165.66 12.29 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.213 0.53 . . . . 70.51 111.097 -177.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -159.79 136.61 9.27 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.534 1.133 . . . . 65.22 108.206 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.524 HD11 HD13 ' F' ' 8' ' ' LEU . 95.5 mt -99.85 158.26 15.93 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.631 -0.507 . . . . 73.54 109.631 175.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.502 ' HB3' ' HD3' ' B' ' 61' ' ' ARG . 23.0 t70 -145.74 151.85 38.63 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 124.427 1.091 . . . . 72.34 108.163 170.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 46.1 p -107.59 106.26 16.54 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.473 0.709 . . . . 73.23 109.554 -174.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.39 135.81 53.54 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.726 -1.213 . . . . 62.12 107.726 176.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.3 p -148.13 167.54 24.76 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.321 0.581 . . . . 74.22 112.33 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.5 p -153.89 155.66 36.12 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.277 -1.329 . . . . 64.25 108.378 167.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -121.16 119.76 33.28 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.002 -0.74 . . . . 62.41 109.002 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 61.8 mt -84.18 -34.82 23.9 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.335 0.654 . . . . 74.12 111.341 -173.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.51 -175.73 4.35 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.49 -0.777 . . . . 42.34 110.119 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -76.03 119.12 19.54 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.539 -0.755 . . . . 61.23 109.207 178.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 71.45 13.5 6.49 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.099 1.76 . . . . 62.31 111.292 -176.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 99.0 t -122.41 113.19 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 108.114 -1.069 . . . . 65.22 108.114 170.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -118.75 171.52 8.15 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.255 -0.646 . . . . 64.54 109.255 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -141.68 102.79 4.25 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 107.306 -1.368 . . . . 62.24 107.306 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 92.9 t -95.23 135.67 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.219 1.007 . . . . 74.45 110.302 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 22.2 t -128.94 116.39 40.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 124.027 0.931 . . . . 73.42 109.38 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' B' ' 103' ' ' PRO . 43.5 tp -95.44 109.41 21.6 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.9 -0.778 . . . . 74.52 108.9 172.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.632 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 59.5 ttt180 -92.34 108.55 20.04 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.465 0.706 . . . . 73.45 109.43 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 38.5 t -106.24 102.49 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.316 1.046 . . . . 54.04 108.99 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 7.9 m -98.2 135.93 39.13 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.436 0.694 . . . . 74.45 109.353 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.522 HG21 HG21 ' B' ' 114' ' ' ILE . 85.8 t -126.9 139.25 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.181 0.993 . . . . 62.11 110.414 -175.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.6 m -124.78 149.44 47.36 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.524 1.13 . . . . 74.14 108.093 172.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.79 142.09 26.24 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 122.927 0.491 . . . . 64.32 110.249 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.558 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 75.8 p -141.06 128.62 21.38 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 123.477 0.485 . . . . 75.04 111.03 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 29.7 mt -100.21 118.85 37.38 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.152 0.981 . . . . 73.2 109.052 175.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.6 -112.34 4.82 Favored Glycine 0 CA--C 1.526 0.726 0 O-C-N 123.932 0.77 . . . . 75.4 112.296 -175.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -115.37 3.05 14.09 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.273 0.629 . . . . 61.35 111.192 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -120.4 159.24 25.49 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.952 0.501 . . . . 75.05 110.69 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 58.6 m -68.94 120.78 15.36 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.618 0.767 . . . . 61.2 110.129 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.558 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -77.61 -61.17 2.08 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.259 -1.015 . . . . 61.23 108.259 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -156.34 164.57 38.14 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.628 -1.169 . . . . 75.44 111.427 177.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 45.5 mt -122.49 153.53 39.04 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 106.093 -1.818 . . . . 72.1 106.093 173.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.439 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 49.5 t -157.92 159.67 36.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.393 -0.595 . . . . 74.11 109.393 -179.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.8 tt0 -165.39 135.32 3.59 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.147 -1.056 . . . . 53.45 108.147 174.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 44.9 t -132.92 145.7 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 108.536 -0.912 . . . . 75.21 108.536 174.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.632 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 14.8 mt-30 -126.06 100.34 6.3 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.601 -0.888 . . . . 73.01 108.601 177.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.431 ' HG3' HD22 ' B' ' 106' ' ' LEU . 8.9 tp-100 -90.43 114.83 27.06 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.18 -0.674 . . . . 75.24 109.18 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.457 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -104.93 167.9 15.48 Favored Glycine 0 C--O 1.242 0.641 0 O-C-N 123.851 0.719 . . . . 43.2 111.652 177.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.29 134.41 3.14 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.992 -0.843 . . . . 73.21 110.992 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.434 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 45.0 mt -86.43 126.19 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 108.549 -0.908 . . . . 75.15 108.549 173.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -135.96 139.34 43.15 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 106.883 -1.525 . . . . 63.45 106.883 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 67.8 m -108.73 91.17 3.53 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.499 0.59 . . . . 62.5 111.531 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 mp -97.6 130.92 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.772 0.829 . . . . 73.5 110.509 -171.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.79 165.57 27.13 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.737 0.815 . . . . 44.44 110.304 173.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.04 -56.9 0.65 Allowed Glycine 0 C--N 1.347 1.192 0 CA-C-N 116.161 -0.472 . . . . 41.54 112.133 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 30.8 mm -87.93 161.83 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.774 0.83 . . . . 75.11 109.798 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -167.89 149.72 5.46 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.859 0.864 . . . . 75.5 110.339 166.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.47 -136.83 12.95 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.907 0.765 . . . . 74.31 112.625 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.2 m -81.86 -23.02 36.61 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 117.256 0.528 . . . . 72.0 111.253 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -68.1 -28.22 67.16 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.934 0.493 . . . . 74.44 109.885 169.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 12.4 ttm -79.16 -28.77 42.78 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.215 0.606 . . . . 63.25 111.081 175.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.677 ' HB1' ' HB3' ' F' ' 14' ' ' LEU . . . -58.61 -26.76 64.02 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.15 0.58 . . . . 75.21 111.093 174.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -71.42 -51.33 24.53 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.331 1.053 . . . . 73.43 110.606 172.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 39.2 t -59.66 -45.83 90.86 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.375 0.67 . . . . 63.51 112.418 -175.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.616 HD11 HG23 ' F' ' 18' ' ' VAL . 72.9 mt -87.5 -17.63 31.69 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.388 0.675 . . . . 74.11 111.551 -176.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.7 3.88 32.38 Favored Glycine 0 C--N 1.35 1.325 0 O-C-N 123.244 0.34 . . . . 70.25 113.79 -175.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.53 -58.22 0.53 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.019 0.527 . . . . 74.03 110.4 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -73.64 -48.66 30.81 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.772 0.67 . . . . 74.21 112.378 -169.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.433 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 84.2 m -66.04 -46.92 63.81 Favored Pre-proline 0 CA--C 1.566 1.595 0 CA-C-O 118.699 -0.667 . . . . 63.12 111.322 177.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.433 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 85.5 Cg_exo -55.21 -33.1 83.26 Favored 'Trans proline' 0 C--N 1.402 3.356 0 C-N-CA 122.819 2.346 . . . . 65.22 114.094 168.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -63.13 -40.25 97.05 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.943 0.897 . . . . 64.13 110.25 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 84.2 mt -68.52 -47.53 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 115.121 -0.945 . . . . 74.04 110.45 175.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.431 HD22 ' HG3' ' B' ' 80' ' ' GLN . 96.0 mt -79.08 -4.44 50.28 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.358 -0.837 . . . . 63.12 111.968 -173.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.07 -61.73 7.34 Favored Pre-proline 0 N--CA 1.478 0.958 0 CA-C-O 117.914 -1.041 . . . . 75.54 112.617 -177.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.77 -25.81 68.17 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 121.842 1.694 . . . . 74.53 112.976 -172.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -71.4 -49.59 40.39 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.812 0.845 . . . . 74.23 110.709 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.74 -42.18 97.91 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.47 0.708 . . . . 64.52 110.866 175.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 75.2 ttt-85 -59.17 -59.89 4.73 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.93 1.692 . . . . 74.14 111.512 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -64.01 -25.29 68.06 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.147 0.979 . . . . 72.05 110.845 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.545 ' SG ' HD12 ' B' ' 21' ' ' ILE . 17.5 t -70.38 -46.87 63.19 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 122.293 -0.254 . . . . 71.11 111.604 178.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.522 HG21 HG21 ' B' ' 64' ' ' VAL . 97.8 mt -59.61 -49.98 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.491 0.716 . . . . 72.32 110.004 173.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 14.2 m -60.32 -28.54 68.21 Favored 'General case' 0 CA--C 1.556 1.198 0 O-C-N 123.853 0.721 . . . . 75.44 111.796 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -66.78 -46.86 73.96 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.497 0.719 . . . . 64.41 110.319 173.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.9 mmt -71.44 -30.28 65.85 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.979 0.512 . . . . 74.1 111.26 -175.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 114' ' ' ILE . 73.5 t -61.23 -47.31 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.537 1.135 . . . . 74.22 109.761 170.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 40.8 t -65.35 -36.79 85.09 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.011 -0.995 . . . . 70.12 111.59 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -71.75 -32.44 67.71 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.694 0.798 . . . . 75.51 110.513 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.19 5.89 81.45 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 123.942 0.776 . . . . 65.43 112.665 174.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.425 HG23 ' HB3' ' A' ' 17' ' ' TYR . 54.7 p 56.7 55.79 6.05 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 125.766 1.626 . . . . 62.22 112.658 176.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -119.95 158.39 50.24 Favored Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 124.585 1.154 . . . . 70.43 110.873 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.93 164.83 5.66 Favored 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 123.845 3.03 . . . . 52.33 115.527 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.512 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -65.19 129.84 41.16 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.653 1.181 . . . . 74.51 112.056 -176.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -139.01 119.21 13.56 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.914 -0.773 . . . . 71.42 108.914 174.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -116.45 135.33 53.93 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.233 1.013 . . . . 73.45 109.416 173.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 54.5 tp -78.78 149.18 32.7 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.274 0.63 . . . . 71.21 109.861 175.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.35 148.75 86.28 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 123.192 0.597 . . . . 72.53 110.857 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.492 ' HG3' HD11 ' D' ' 16' ' ' ILE . 72.7 Cg_endo -71.15 88.6 0.7 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.118 2.545 . . . . 63.33 111.391 176.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.58 110.45 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 109.416 -0.587 . . . . 64.13 109.416 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -101.58 93.14 5.21 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 107.529 -1.286 . . . . 64.04 107.529 176.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -62.17 -35.95 80.38 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.461 0.476 . . . . 75.51 110.687 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' B' ' 138' ' ' MET . 10.2 m-20 -53.68 -52.49 59.85 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.652 0.781 . . . . 71.31 110.335 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.13 -40.64 90.45 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 124.899 1.374 . . . . 62.25 111.478 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 59.9 tp -62.65 -47.56 83.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.331 0.652 . . . . 41.11 111.234 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.402 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 56.5 m-85 -62.16 -34.62 76.75 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.189 0.596 . . . . 62.3 111.293 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' B' ' 134' ' ' ASP . 22.2 mmt -59.41 -34.15 72.11 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.779 0.432 . . . . 72.33 111.941 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -79.98 -26.21 40.02 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.723 0.409 . . . . 75.32 111.274 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -73.18 -50.38 22.9 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 120.757 0.313 . . . . 72.54 110.952 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 2.7 pp -117.03 30.33 7.39 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.107 0.563 . . . . 53.41 110.878 -168.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -55.34 122.24 10.7 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.172 0.989 . . . . 70.13 111.332 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -115.67 111.51 20.72 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.642 -0.873 . . . . 72.24 108.642 177.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -138.76 128.4 24.76 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.216 -0.661 . . . . 65.12 109.216 176.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -166.39 -179.99 5.28 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.249 1.02 . . . . 61.21 109.582 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 177.09 -111.27 0.33 Allowed Glycine 0 C--N 1.341 0.807 0 N-CA-C 111.279 -0.728 . . . . 75.42 111.279 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -92.05 87.18 6.06 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.556 0.743 . . . . 61.42 109.63 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -98.54 -170.41 31.65 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 115.856 -0.611 . . . . 13.44 111.87 173.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 4.5 t -162.82 88.21 0.61 Allowed 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.783 0.801 . . . . 62.21 110.621 177.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -94.29 144.13 25.8 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.607 0.763 . . . . 74.44 109.597 173.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.47 131.76 34.45 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 106.997 -1.483 . . . . 71.23 106.997 173.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 -73.51 135.52 44.03 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.606 0.362 . . . . 63.14 110.462 -175.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -133.42 157.78 44.71 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.104 0.962 . . . . 53.41 108.562 174.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -153.77 174.08 15.01 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.435 0.294 . . . . 64.1 110.734 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 C-N-CA 123.686 0.794 . . . . 64.44 110.484 -179.338 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 109.577 -0.527 . . . . 73.51 109.577 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 48.5 m -143.04 24.16 1.83 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.084 0.954 . . . . 42.41 109.77 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -65.62 108.92 2.21 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.222 1.009 . . . . 53.5 110.459 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -119.99 110.34 16.57 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.005 0.922 . . . . 73.22 108.621 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -74.38 87.66 2.04 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.956 -0.565 . . . . 72.04 110.32 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -64.26 -21.22 66.51 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.043 0.937 . . . . 70.11 110.358 174.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 74.1 p -55.93 -47.19 77.99 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.619 1.168 . . . . 71.32 110.633 174.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -82.57 77.54 9.32 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.548 -0.751 . . . . 74.33 109.01 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.629 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 0.1 OUTLIER 65.49 116.66 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 125.045 1.338 . . . . 74.23 111.138 -177.247 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 49.7 m -85.12 90.94 7.99 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.212 0.605 . . . . 75.5 109.489 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.629 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 1.1 t80 -111.13 123.22 49.77 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.58 -0.896 . . . . 74.54 108.58 174.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -137.68 120.89 16.84 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.83 -0.804 . . . . 75.23 108.83 173.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.465 HD13 HD11 ' C' ' 16' ' ' ILE . 32.9 mt -69.59 123.76 23.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.68 -0.859 . . . . 73.43 108.68 172.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -87.57 -49.18 7.35 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.518 -0.764 . . . . 71.51 109.564 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -174.41 125.76 0.32 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.754 -0.657 . . . . 75.35 109.728 -169.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.465 HD11 HD13 ' C' ' 13' ' ' ILE . 77.2 mt -116.12 138.42 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.315 -0.995 . . . . 73.4 108.315 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.575 ' HB3' HG23 ' D' ' 122' ' ' THR . 26.5 p90 -175.28 165.45 3.32 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-O 121.484 0.659 . . . . 75.23 110.864 -172.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -86.25 125.07 33.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.501 -0.772 . . . . 71.44 109.389 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.458 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 20.6 mmtp -74.02 -48.47 29.86 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 106.895 -1.52 . . . . 52.23 106.895 167.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 24.4 t70 -134.99 146.56 49.18 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 113.64 -1.618 . . . . 62.33 110.403 -172.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 78.1 mt -140.64 146.04 24.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.088 -1.819 . . . . 71.51 106.088 175.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 31.2 t -160.54 150.32 17.65 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.18 0.514 . . . . 73.43 110.403 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 82.4 t80 -157.18 118.8 3.73 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.042 -1.096 . . . . 63.23 108.042 174.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' D' ' 19' ' ' LYS . 34.1 mt-10 -126.66 130.35 50.25 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.816 0.446 . . . . 74.41 110.204 169.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' C' ' 28' ' ' ALA . . . -109.57 92.99 12.96 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 107.263 -1.384 . . . . 63.21 107.263 172.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -59.4 -36.18 94.61 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.621 2.881 . . . . 70.4 114.11 -171.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -114.96 29.93 7.7 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.375 0.67 . . . . 40.52 110.245 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.495 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -43.79 -63.79 0.96 Allowed Pre-proline 0 CA--C 1.567 1.597 0 N-CA-C 114.51 1.3 . . . . 74.01 114.51 -164.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -62.67 -40.52 36.72 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 121.918 1.746 . . . . 63.22 112.708 -175.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -69.49 -33.11 72.38 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.075 0.95 . . . . 72.42 112.213 -177.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.646 HG21 ' HA ' ' C' ' 73' ' ' ALA . 3.9 p -81.59 -23.1 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 122.761 0.424 . . . . 63.14 111.857 -177.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -65.45 -28.75 69.44 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.181 0.438 . . . . 74.41 112.181 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -90.23 32.13 0.95 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.696 0.798 . . . . 72.0 110.839 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.7 162.63 24.6 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.248 0.619 . . . . 74.52 111.21 -173.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.19 129.56 38.31 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.302 1.041 . . . . 75.43 110.89 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 49.2 t-105 -87.4 85.11 7.11 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.698 0.799 . . . . 60.41 111.943 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -138.28 76.42 37.9 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 123.976 0.911 . . . . 74.34 108.804 166.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -81.69 156.76 18.59 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.606 2.204 . . . . 73.43 112.533 -176.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . 0.557 ' HB3' ' HE2' ' C' ' 41' ' ' LYS . 2.6 mp0 -85.36 93.61 8.76 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 106.255 -1.758 . . . . 75.53 106.255 164.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 13.7 m -67.28 95.56 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-O 122.184 0.993 . . . . 62.4 109.302 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.748 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 75.3 mmtt -95.54 100.74 12.44 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.259 -1.015 . . . . 61.53 108.259 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.516 HD22 HD23 ' G' ' 8' ' ' LEU . 2.5 pp -88.11 137.28 32.47 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.624 -1.171 . . . . 65.33 108.57 -178.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -146.79 107.71 4.17 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.78 -0.822 . . . . 73.03 108.78 -175.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.578 ' H ' HD23 ' C' ' 44' ' ' LEU . 2.0 pt? -119.99 122.86 42.1 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.761 0.791 . . . . 65.52 109.417 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.779 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 22.2 t70 -113.17 157.3 21.85 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 125.168 1.387 . . . . 62.24 109.208 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 74.9 p -113.64 122.27 46.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.2 1.0 . . . . 71.22 109.909 -174.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.59 136.44 41.06 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.578 -0.897 . . . . 71.45 108.578 175.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 25.8 p -164.09 151.65 12.29 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.779 0.431 . . . . 73.52 110.227 -175.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 73.1 p -153.75 154.14 33.49 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.507 0.723 . . . . 75.42 109.713 -175.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -89.3 128.93 35.92 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.529 -0.545 . . . . 73.31 109.529 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.673 HD11 HD12 ' C' ' 83' ' ' ILE . 65.1 mt -96.33 -42.87 7.94 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.638 0.775 . . . . 55.21 111.008 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.86 -166.03 1.51 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.181 -0.918 . . . . 73.2 110.449 -176.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.89 103.77 1.54 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.185 0.994 . . . . 73.2 109.758 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 71.13 -1.67 2.63 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.638 1.575 . . . . 71.13 113.162 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.3 t -91.64 96.3 6.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 106.917 -1.512 . . . . 52.33 106.917 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -110.1 126.69 54.3 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.11 -0.95 . . . . 75.41 110.58 -173.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -83.66 127.79 34.04 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.058 0.943 . . . . 75.01 109.521 175.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 99.1 t -119.28 115.87 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 107.696 -1.224 . . . . 75.2 107.696 170.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 77.5 t -116.38 122.35 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.481 0.712 . . . . 75.14 109.571 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 49.8 tp -106.06 106.8 17.48 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.07 -0.715 . . . . 71.43 109.07 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.779 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 3.1 tmt_? -82.79 108.23 15.99 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.884 -1.154 . . . . 75.51 107.884 177.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.43 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.7 t -106.89 133.64 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.27 -1.011 . . . . 62.23 108.27 176.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 17.7 m -134.19 118.24 17.41 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.033 -0.729 . . . . 60.34 109.033 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 88.7 t -109.75 120.93 61.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.881 -1.054 . . . . 63.41 108.743 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.748 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 6.9 m -107.85 144.3 35.24 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.981 -0.748 . . . . 73.43 108.981 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.9 112.98 10.41 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.499 -0.926 . . . . 52.22 108.499 176.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 51.3 m -133.16 127.39 33.74 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.281 -0.637 . . . . 65.2 109.281 174.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 36.2 mt -84.78 54.98 3.25 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.766 1.226 . . . . 73.22 108.75 176.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.66 -115.8 5.36 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 109.541 -1.424 . . . . 63.25 109.541 -170.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -92.12 -25.7 18.61 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.023 0.929 . . . . 61.1 109.663 170.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -63.48 94.89 0.09 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.178 1.391 . . . . 65.13 110.101 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 30.7 m -75.37 121.48 22.32 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 120.869 0.366 . . . . 75.04 110.56 -174.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.646 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -74.93 -58.4 3.31 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.999 -1.0 . . . . 70.3 108.604 173.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -163.63 175.58 10.48 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.349 1.071 . . . . 75.05 112.65 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -141.8 141.02 33.15 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 105.046 -2.205 . . . . 75.11 105.046 170.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.483 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.4 t -147.8 134.74 20.21 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.85 -0.796 . . . . 72.05 108.85 -176.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -142.3 117.35 10.01 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.651 0.38 . . . . 64.12 110.499 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 83.3 t -119.1 122.32 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.828 -0.804 . . . . 72.22 108.828 171.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.446 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 57.4 mt-30 -98.46 89.78 4.55 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 107.782 -1.192 . . . . 75.41 107.782 177.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -78.82 108.95 12.64 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.08 -0.964 . . . . 73.22 110.051 -175.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.35 154.66 25.38 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-O 121.51 0.505 . . . . 71.41 111.855 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.522 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -153.42 117.58 0.81 Allowed Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 109.56 -1.416 . . . . 71.11 109.56 176.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.673 HD12 HD11 ' C' ' 51' ' ' LEU . 16.4 mm -85.61 118.51 32.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.018 -1.104 . . . . 65.13 108.018 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.4 ' HB3' ' HE2' ' C' ' 11' ' ' PHE . 34.6 m-85 -130.61 129.77 43.14 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.924 0.889 . . . . 72.34 109.256 -171.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 68.6 m -84.31 118.13 24.01 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 109.141 -0.689 . . . . 55.42 109.141 170.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 3.8 mp -114.57 114.01 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 107.656 -1.238 . . . . 64.32 107.656 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.51 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -147.85 162.06 40.03 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.626 0.77 . . . . 70.13 110.259 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.36 -25.61 14.55 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.694 -0.684 . . . . 30.14 113.723 175.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.434 HG13 ' HB3' ' C' ' 94' ' ' MET . 46.3 pt -120.46 162.18 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.675 0.79 . . . . 43.51 110.039 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -147.44 -177.21 5.57 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.768 0.827 . . . . 73.13 109.634 -177.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.0 -136.38 42.05 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 114.569 0.588 . . . . 71.25 114.569 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . 0.415 ' HA ' ' HB3' ' C' ' 95' ' ' ALA . 34.8 p -65.18 -22.25 66.88 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.535 1.134 . . . . 64.44 112.802 -178.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -60.59 -55.99 26.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.414 0.685 . . . . 70.04 110.045 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.434 ' HB3' HG13 ' C' ' 89' ' ' ILE . 27.7 ptt? -80.79 -20.92 41.51 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.93 -0.577 . . . . 73.13 111.663 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . 0.415 ' HB3' ' HA ' ' C' ' 92' ' ' THR . . . -64.5 -35.1 79.85 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.315 0.579 . . . . 72.05 110.742 171.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -74.35 -37.11 63.62 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.324 -0.853 . . . . 72.34 110.386 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.47 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 41.6 t -58.35 -55.97 28.13 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.079 0.862 . . . . 62.1 110.552 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.626 HD23 HG23 ' G' ' 18' ' ' VAL . 4.0 pp -70.46 -28.3 64.9 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.94 0.496 . . . . 51.34 111.852 179.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.79 -30.04 60.25 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 114.428 0.531 . . . . 75.23 114.428 -171.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.59 -43.2 0.22 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 117.121 0.461 . . . . 72.01 111.878 -173.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.47 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 70.0 t80 -73.85 -35.73 64.81 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 124.822 1.249 . . . . 72.22 113.095 -170.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.416 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 85.8 m -82.09 -43.7 1.02 Allowed Pre-proline 0 N--CA 1.486 1.333 0 CA-C-O 118.759 -0.639 . . . . 74.24 112.477 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.1 -22.94 61.25 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 121.796 1.664 . . . . 71.03 112.115 171.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . 0.495 ' HA ' ' HD2' ' C' ' 107' ' ' PHE . 25.0 t-20 -56.36 -41.28 75.91 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.906 0.883 . . . . 71.2 111.002 175.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.457 HD12 HH12 ' A' ' 111' ' ' ARG . 44.0 mm -59.88 -42.08 88.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 115.156 -0.929 . . . . 73.2 109.802 175.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.522 HD21 ' HA3' ' C' ' 82' ' ' GLY . 96.6 mt -82.34 -20.61 36.97 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.077 -0.965 . . . . 73.03 113.484 -169.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.495 ' HD2' ' HA ' ' C' ' 104' ' ' ASN . 16.5 m-85 -55.56 -49.25 93.71 Favored Pre-proline 0 N--CA 1.496 1.837 0 CA-C-O 118.008 -0.996 . . . . 75.01 113.43 -177.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -58.0 -39.81 82.97 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 122.274 1.983 . . . . 62.4 113.999 178.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.426 ' HE2' HG21 ' A' ' 115' ' ' THR . 68.5 m-85 -68.11 -48.32 65.77 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.411 0.685 . . . . 72.42 110.757 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.61 -42.06 91.76 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.128 -0.942 . . . . 63.51 110.466 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -54.59 -57.98 9.3 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.405 1.065 . . . . 72.34 110.819 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -68.02 -30.94 70.29 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.48 0.488 . . . . 71.14 111.09 -173.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 12.5 t -72.31 -32.9 66.96 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.661 0.384 . . . . 61.32 111.289 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.483 HG23 ' SG ' ' C' ' 76' ' ' CYS . 96.9 mt -73.03 -48.1 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.565 0.746 . . . . 72.14 109.706 173.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 27.1 m -67.55 -30.22 69.81 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.409 0.684 . . . . 70.12 111.413 -174.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 43.5 t -66.0 -44.82 83.69 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.708 -0.849 . . . . 74.1 108.708 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.797 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.06 -38.32 90.71 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.383 1.073 . . . . 74.34 112.474 177.763 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' C' ' 123' ' ' PHE . 79.0 t -65.52 -39.92 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.718 0.807 . . . . 65.53 109.983 174.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.5 t -72.11 -30.99 65.62 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.143 -0.935 . . . . 72.25 111.282 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 73.2 mtt-85 -71.79 -34.1 69.13 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.826 0.851 . . . . 62.5 109.181 175.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.33 6.4 72.49 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 123.985 0.803 . . . . 63.12 112.958 173.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.2 p 61.11 26.81 16.68 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.425 1.89 . . . . 70.12 114.393 171.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.424 ' HB2' HG13 ' C' ' 118' ' ' VAL . 96.5 m-85 -88.15 150.44 47.28 Favored Pre-proline 0 N--CA 1.474 0.765 0 N-CA-C 109.619 -0.511 . . . . 71.5 109.619 173.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.64 143.11 22.85 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.471 2.781 . . . . 54.51 113.762 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -58.08 114.97 2.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.41 1.084 . . . . 72.54 112.262 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 53.9 tp -117.08 103.83 10.63 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.025 0.93 . . . . 73.04 108.915 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -95.35 130.36 42.16 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.838 0.855 . . . . 72.23 109.18 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 tt -74.57 128.21 35.0 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 108.302 -0.999 . . . . 71.51 108.302 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.11 147.3 93.49 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.556 0.742 . . . . 74.3 111.72 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.47 ' HB3' HD12 ' A' ' 16' ' ' ILE . 11.6 Cg_endo -57.89 95.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.821 2.347 . . . . 63.2 112.981 171.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.622 HG21 ' H ' ' G' ' 8' ' ' LEU . 47.4 t -101.59 108.8 24.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.778 -1.194 . . . . 62.24 107.778 172.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -90.7 88.01 6.92 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.588 -0.893 . . . . 54.43 108.588 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -54.71 -44.71 73.69 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.663 0.785 . . . . 71.54 111.757 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -59.6 -45.61 91.42 Favored 'General case' 0 CA--C 1.549 0.915 0 O-C-N 124.954 1.408 . . . . 53.24 110.131 -177.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.47 -24.81 57.0 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.459 -1.246 . . . . 75.34 111.909 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.661 ' HA ' ' HB3' ' C' ' 139' ' ' ASN . 7.4 mp -81.34 -20.67 40.2 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.805 0.842 . . . . 71.24 111.375 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -71.55 -40.77 69.79 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 109.416 -0.587 . . . . 74.12 109.416 167.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 60.3 mtt -67.38 -40.15 85.69 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.402 -0.817 . . . . 75.11 110.516 174.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . 0.661 ' HB3' ' HA ' ' C' ' 136' ' ' LEU . 5.1 t30 -65.25 -37.15 86.31 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.596 -1.184 . . . . 74.35 110.28 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -64.61 -87.18 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.078 -0.712 . . . . 72.53 109.078 173.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 47.4 tp 32.22 -88.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.94 1.696 . . . . 74.44 113.234 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -147.73 67.71 1.11 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.644 1.577 . . . . 72.31 107.648 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . 0.519 ' HB3' ' O ' ' C' ' 139' ' ' ASN . 11.1 pt20 -66.67 93.56 0.26 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.694 0.797 . . . . 73.3 112.357 -175.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -93.29 -37.58 11.96 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.307 -0.861 . . . . 73.13 108.909 165.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 61.99 -179.69 0.13 Allowed 'General case' 0 C--N 1.362 1.133 0 C-N-CA 125.252 1.421 . . . . 52.54 113.4 175.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -145.7 108.81 0.48 Allowed Glycine 0 C--N 1.343 0.955 0 N-CA-C 110.226 -1.149 . . . . 41.22 110.226 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -75.9 97.68 4.02 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.481 0.712 . . . . 70.25 110.53 -175.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -103.46 -138.5 9.87 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-O 119.416 -0.658 . . . . 35.34 111.642 175.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 48.0 m 53.92 69.79 0.67 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.604 1.162 . . . . 53.11 111.79 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -128.69 -72.82 0.59 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.071 -1.085 . . . . 74.05 108.071 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 66.53 -69.67 0.12 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.139 1.376 . . . . 65.12 111.044 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -134.48 -177.52 4.64 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.059 1.344 . . . . 74.34 109.082 175.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -88.08 -28.15 21.5 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 109.395 -0.595 . . . . 75.23 109.395 168.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -156.73 107.24 2.34 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 107.721 -1.215 . . . . 73.31 107.721 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 C-N-CA 123.861 0.864 . . . . 62.5 110.714 -173.17 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 121.075 0.464 . . . . 41.24 110.007 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . 0.417 ' HB3' ' HG3' ' D' ' 93' ' ' GLN . 70.4 m -149.43 26.37 0.85 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.838 1.255 . . . . 71.43 109.525 176.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -69.51 82.52 0.4 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.981 0.912 . . . . 64.11 111.259 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . 0.432 ' HB2' HE21 ' D' ' 93' ' ' GLN . 51.4 mt-30 -152.07 43.94 0.72 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.865 1.666 . . . . 72.05 106.963 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -50.26 126.75 15.56 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.949 0.9 . . . . 51.34 112.641 -165.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -115.44 129.7 56.65 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.047 -0.979 . . . . 73.34 108.51 -174.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -94.71 -22.31 18.2 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.358 0.663 . . . . 61.22 111.235 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -101.43 -16.85 16.72 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.626 0.77 . . . . 72.2 111.964 -172.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.538 ' SD ' HG13 ' D' ' 89' ' ' ILE . 12.5 tpt -30.78 129.01 0.13 Allowed 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 125.728 1.611 . . . . 60.43 114.554 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 89.5 m -104.8 135.28 46.46 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.047 0.939 . . . . 72.44 109.314 175.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -153.88 91.52 1.47 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.896 -1.52 . . . . 54.12 106.896 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -119.11 116.36 26.19 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.94 -0.763 . . . . 70.24 108.94 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.496 HD13 HG21 ' D' ' 105' ' ' ILE . 8.7 mt -74.32 116.43 16.85 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 N-CA-C 108.898 -0.779 . . . . 72.55 108.898 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.607 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 11.7 mm100 -81.68 -44.94 16.44 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.555 0.742 . . . . 74.31 110.492 -176.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -171.26 143.67 1.91 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.425 -0.352 . . . . 72.13 111.373 -170.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.492 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.4 mp -117.8 132.66 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 107.223 -1.399 . . . . 74.42 107.223 173.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -161.39 141.49 10.69 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.43 0.633 . . . . 74.45 111.056 177.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 77.0 p -77.36 110.96 12.53 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.004 -0.998 . . . . 71.41 109.265 175.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' C' ' 24' ' ' GLU . 36.9 mtpt -85.53 -23.46 27.69 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.565 -0.289 . . . . 75.41 110.481 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.799 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 4.5 t70 -143.19 139.72 30.43 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.333 1.053 . . . . 61.43 108.84 173.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.797 HG21 ' HE2' ' C' ' 117' ' ' MET . 94.4 mt -139.0 146.88 25.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 106.909 -1.515 . . . . 74.21 106.909 169.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.0 t -159.87 110.26 1.89 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.347 0.659 . . . . 44.54 110.062 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.456 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 94.0 t80 -109.54 131.41 55.09 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 106.106 -1.812 . . . . 72.03 106.106 168.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.474 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 39.0 mt-10 -138.61 119.77 14.6 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.97 0.508 . . . . 73.34 109.974 -172.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -135.36 83.71 37.11 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 108.833 -0.803 . . . . 70.2 108.833 178.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.75 -33.74 7.76 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.834 2.356 . . . . 72.33 112.237 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -89.22 -3.09 58.68 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.422 1.089 . . . . 74.4 111.89 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.453 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -32.39 -61.99 0.31 Allowed Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 116.795 2.146 . . . . 71.51 116.795 -164.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.409 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 89.3 Cg_endo -76.34 -27.54 7.83 Favored 'Trans proline' 0 C--N 1.376 2.023 0 CA-C-N 122.708 2.003 . . . . 63.23 114.262 -172.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -86.86 -21.4 26.4 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 117.931 0.332 . . . . 64.23 110.838 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.453 HG12 ' O ' ' D' ' 28' ' ' ALA . 9.9 p -82.58 -16.19 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 122.794 0.437 . . . . 64.04 110.041 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.409 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.5 m-85 -68.04 -20.11 64.96 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.46 0.304 . . . . 65.54 111.648 175.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -56.01 -32.12 63.68 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.276 0.56 . . . . 73.13 110.057 171.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -85.99 85.57 7.37 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.831 1.252 . . . . 61.41 109.32 174.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -93.74 78.21 4.25 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.416 0.626 . . . . 73.1 110.418 -176.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -149.73 -178.03 6.22 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.49 -0.777 . . . . 65.15 109.612 170.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -76.42 110.96 12.91 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.65 0.78 . . . . 72.12 109.627 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.542 ' HB3' ' HG ' ' D' ' 68' ' ' LEU . 18.5 Cg_endo -63.22 147.44 93.94 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.472 2.114 . . . . 50.24 112.408 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -64.55 119.34 10.27 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.979 0.799 . . . . 72.23 108.954 172.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.693 HG13 HG13 ' D' ' 64' ' ' VAL . 99.5 t -96.54 131.04 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.856 -0.794 . . . . 63.14 108.856 -176.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.661 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 43.4 mtpt -106.33 157.36 17.67 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.807 0.843 . . . . 73.24 109.31 169.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.46 113.43 16.82 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 106.664 -1.606 . . . . 74.1 106.664 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.723 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 7.5 m-20 -117.71 144.22 45.47 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.992 -1.004 . . . . 64.44 108.912 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.33 154.72 33.11 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.023 0.529 . . . . 71.43 110.18 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 30.1 t70 -153.11 140.29 19.42 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.819 -1.178 . . . . 71.05 107.819 167.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 87.7 m -104.54 143.82 32.52 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.674 0.79 . . . . 65.12 110.454 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -154.14 152.76 30.78 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.014 0.925 . . . . 34.14 109.377 171.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 67.0 p -169.04 154.21 5.98 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.441 0.696 . . . . 63.22 110.256 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 82.9 p -156.02 156.06 33.78 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.291 0.637 . . . . 75.44 109.524 171.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -96.13 118.2 32.24 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.185 -1.043 . . . . 75.44 108.185 173.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.1 mt -92.85 -27.43 17.14 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.933 0.493 . . . . 74.32 110.757 -174.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.509 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -163.87 -178.68 5.82 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.264 1.025 . . . . 41.54 110.157 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.95 107.88 4.92 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.24 -0.891 . . . . 74.53 110.038 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 68.51 21.55 8.08 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.424 1.49 . . . . 75.34 111.367 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 42.3 t -124.11 115.31 44.5 Favored 'Isoleucine or valine' 0 C--N 1.35 0.599 0 N-CA-C 107.535 -1.283 . . . . 63.25 107.535 170.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -124.38 170.41 10.86 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.338 0.655 . . . . 73.3 109.489 -171.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.524 ' HB2' HD11 ' D' ' 51' ' ' LEU . 26.4 tt0 -130.31 117.99 20.61 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.649 -0.705 . . . . 75.34 109.397 178.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 88.0 t -100.99 117.38 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.424 1.09 . . . . 74.32 108.291 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 24.4 t -119.14 117.45 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.552 -0.907 . . . . 75.33 108.552 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.01 122.24 44.62 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.885 -0.783 . . . . 73.31 108.885 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.533 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 49.6 ttm-85 -87.26 101.87 13.94 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.226 -0.657 . . . . 74.22 109.226 175.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 83.2 t -90.72 114.73 28.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.203 -1.036 . . . . 75.14 108.203 174.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.723 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 28.0 m -116.02 139.62 50.09 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.277 0.561 . . . . 62.2 109.543 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.693 HG13 HG13 ' D' ' 40' ' ' VAL . 7.7 t -125.25 100.26 6.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 124.381 1.072 . . . . 73.41 108.136 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.661 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 58.2 m -93.39 93.75 8.33 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.185 -1.042 . . . . 73.13 108.185 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.72 141.2 29.48 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.026 -0.988 . . . . 45.34 109.487 -176.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.523 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 55.7 m -143.76 126.12 15.73 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.656 0.597 . . . . 75.14 111.105 -177.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.542 ' HG ' ' HB3' ' D' ' 38' ' ' PRO . 26.0 mt -93.75 115.6 28.03 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.348 1.059 . . . . 61.0 108.392 172.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.84 -137.73 32.46 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.402 -0.679 . . . . 65.41 111.402 -171.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -90.88 4.35 52.08 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.212 0.605 . . . . 70.21 111.84 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -118.72 160.2 22.29 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.61 0.364 . . . . 75.43 110.279 -177.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 48.7 m -68.34 133.18 48.33 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 123.753 0.658 . . . . 74.23 111.312 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.523 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.51 -68.13 0.78 Allowed 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.519 -1.289 . . . . 75.42 107.519 171.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -151.24 159.51 44.33 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 115.641 -0.709 . . . . 72.32 110.874 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.474 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 31.6 mt -117.7 110.12 17.47 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 105.778 -1.934 . . . . 73.13 105.778 173.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.486 ' SG ' HG23 ' D' ' 114' ' ' ILE . 14.8 t -119.69 112.17 18.95 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.818 -0.808 . . . . 63.35 108.818 -172.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -139.91 141.1 36.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.574 0.75 . . . . 55.45 109.891 -162.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 91.6 t -147.45 121.44 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.126 0.97 . . . . 71.34 109.228 -177.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.799 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 15.4 mt-30 -86.56 91.19 8.49 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 107.802 -1.184 . . . . 64.45 107.802 161.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . 0.411 ' O ' HD13 ' D' ' 106' ' ' LEU . 6.7 tp-100 -80.38 98.63 7.57 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.392 -1.336 . . . . 75.4 107.392 175.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.16 147.43 18.59 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.628 -0.989 . . . . 72.03 110.628 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.7 133.71 4.81 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.0 -0.84 . . . . 60.41 111.0 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.607 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 25.6 mt -89.17 131.2 37.07 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 108.053 -1.092 . . . . 71.51 108.053 174.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -134.74 124.12 24.72 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.407 -0.59 . . . . 71.03 109.407 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 37.8 m -82.86 97.39 8.63 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.683 -0.858 . . . . 73.13 108.683 169.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.52 143.51 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.599 -0.519 . . . . 73.3 109.599 -177.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.82 142.33 9.03 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.954 0.502 . . . . 51.44 110.437 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 113.56 -22.72 14.57 Favored Glycine 0 C--N 1.345 1.035 0 O-C-N 123.658 0.599 . . . . 74.54 113.175 174.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.538 HG13 ' SD ' ' D' ' 9' ' ' MET . 63.7 mt -100.07 146.91 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 117.414 0.607 . . . . 51.33 110.16 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -160.3 176.15 12.03 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.576 1.151 . . . . 75.53 110.041 -178.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . 0.401 ' O ' ' HG2' ' D' ' 94' ' ' MET . . . 74.61 -130.74 12.2 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 115.366 -0.834 . . . . 70.2 113.743 174.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 72.8 p -79.57 -24.59 41.99 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.15 0.58 . . . . 73.14 111.027 -177.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.432 HE21 ' HB2' ' D' ' 4' ' ' GLN . 5.6 tt0 -70.06 -38.39 75.75 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.948 -0.569 . . . . 73.13 109.938 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' D' ' 91' ' ' GLY . 25.5 ptt? -72.33 -27.25 62.3 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 116.49 -0.323 . . . . 73.4 110.682 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.9 -40.95 90.52 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 120.964 0.411 . . . . 75.15 111.293 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.558 ' HE2' ' HB3' ' D' ' 134' ' ' ASP . 10.6 t-80 -78.66 -37.28 42.3 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.526 0.73 . . . . 75.43 111.206 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 50.0 t -61.29 -41.05 96.31 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.233 0.539 . . . . 75.12 111.275 -176.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 23.6 mt -92.47 -31.92 15.08 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.238 -0.892 . . . . 64.42 110.707 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' H' ' 15' ' ' PHE . . . -91.15 4.83 81.28 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.719 -0.673 . . . . 71.13 113.823 -178.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -156.81 -57.47 0.09 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 117.867 0.834 . . . . 63.53 112.384 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -66.36 -37.06 84.46 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 112.796 0.665 . . . . 73.43 112.796 -169.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 73.5 m -74.84 -48.2 4.8 Favored Pre-proline 0 CA--C 1.566 1.574 0 CA-C-O 118.689 -0.672 . . . . 54.21 111.824 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.42 -13.76 38.35 Favored 'Trans proline' 0 C--N 1.4 3.274 0 C-N-CA 121.766 1.644 . . . . 71.4 113.404 170.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -65.86 -39.35 90.67 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.601 0.76 . . . . 73.24 109.914 173.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.496 HG21 HD13 ' D' ' 13' ' ' ILE . 49.3 mm -66.02 -39.18 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 115.361 -0.836 . . . . 71.45 110.45 175.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.411 HD13 ' O ' ' D' ' 80' ' ' GLN . 87.7 mt -80.49 -10.47 59.74 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 115.068 -0.969 . . . . 72.1 111.761 -174.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -65.25 -47.57 70.7 Favored Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 124.403 1.081 . . . . 73.44 113.103 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 72.7 Cg_exo -53.88 -45.46 40.86 Favored 'Trans proline' 0 C--N 1.39 2.758 0 C-N-CA 122.378 2.052 . . . . 74.22 113.378 173.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -69.68 -36.43 75.99 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.481 -0.781 . . . . 73.14 111.855 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.16 -47.35 80.18 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.891 0.476 . . . . 41.54 109.819 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -59.09 -49.48 77.73 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 114.59 -1.186 . . . . 65.3 111.146 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -64.64 -45.57 86.24 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 123.671 0.607 . . . . 74.13 111.277 -175.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.7 t -59.58 -42.17 91.91 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 123.662 0.601 . . . . 52.25 110.666 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.486 HG23 ' SG ' ' D' ' 76' ' ' CYS . 69.9 mt -59.99 -57.96 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.856 0.863 . . . . 71.24 110.779 172.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.454 HG23 ' HG3' ' D' ' 125' ' ' GLN . 97.4 m -53.54 -41.97 66.98 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 124.765 1.226 . . . . 52.23 111.841 -174.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 45.2 t -66.94 -42.54 85.12 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.76 -1.109 . . . . 73.51 110.268 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.6 mtm -68.14 -31.71 71.47 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.909 0.484 . . . . 73.25 111.716 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.468 HG23 ' O ' ' D' ' 114' ' ' ILE . 84.8 t -62.0 -47.11 94.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.327 0.651 . . . . 63.33 109.835 174.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.7 p -74.41 -24.98 59.19 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.642 -0.708 . . . . 62.55 111.235 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -70.54 -34.69 72.54 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.635 0.774 . . . . 75.31 109.896 174.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.46 9.44 73.37 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 123.889 0.743 . . . . 71.41 112.592 175.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.575 HG23 ' HB3' ' C' ' 17' ' ' TYR . 64.0 p 59.27 19.62 7.75 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 126.383 1.873 . . . . 64.02 113.883 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -84.16 154.38 63.49 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.429 0.692 . . . . 73.45 109.443 171.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -56.32 131.51 46.21 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.195 2.596 . . . . 73.34 112.513 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.454 ' HG3' HG23 ' D' ' 115' ' ' THR . 32.9 tt0 -50.75 137.55 20.06 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.747 1.219 . . . . 72.2 111.827 -177.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -128.96 101.7 6.18 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.724 -0.843 . . . . 73.05 108.724 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -100.65 121.04 40.97 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.775 0.83 . . . . 74.4 108.984 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 6.7 mp -73.65 119.26 17.63 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 109.198 -0.667 . . . . 64.22 109.198 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.44 148.58 79.95 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 123.771 0.829 . . . . 70.44 112.012 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -68.94 98.77 0.62 Allowed 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.871 2.381 . . . . 74.32 111.462 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 35.4 m -110.79 142.63 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.398 0.679 . . . . 52.31 111.027 -177.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -99.86 81.91 2.51 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.626 -1.249 . . . . 71.1 107.626 169.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -71.19 -16.7 62.53 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 114.943 -1.026 . . . . 72.02 111.345 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.558 ' HB3' ' HE2' ' D' ' 96' ' ' HIS . 3.9 m-20 -48.72 -53.32 19.39 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.229 1.412 . . . . 72.33 111.937 173.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.42 -32.74 74.26 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.497 0.719 . . . . 23.22 111.883 -176.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 37.7 tp -77.14 -32.16 56.18 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.453 -0.794 . . . . 65.35 110.591 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -64.67 -30.9 71.93 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.008 0.923 . . . . 75.25 110.709 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 12.6 mmt -56.7 -36.09 69.24 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.155 0.582 . . . . 73.13 110.455 176.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.419 ' HA ' ' NE2' ' D' ' 142' ' ' GLN . 24.6 t-20 -63.75 -33.11 74.93 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.468 1.107 . . . . 74.04 111.735 -176.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . 0.532 ' HB2' HD22 ' H' ' 10' ' ' LEU . 78.2 t80 -71.71 -33.33 68.66 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.477 0.711 . . . . 73.2 110.746 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.8 mp -84.63 -30.28 25.04 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.657 0.783 . . . . 70.54 112.708 -177.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.419 ' NE2' ' HA ' ' D' ' 139' ' ' ASN . 26.2 pt20 -82.17 23.33 0.73 Allowed 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 113.641 0.978 . . . . 65.24 113.641 -165.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -117.37 61.26 0.75 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.73 1.252 . . . . 72.01 109.446 -172.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -140.56 102.41 4.31 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.692 -1.14 . . . . 74.55 108.363 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.86 155.77 47.84 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 124.448 1.099 . . . . 70.11 109.499 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 100.26 61.3 0.82 Allowed Glycine 0 C--N 1.347 1.189 0 O-C-N 123.376 0.423 . . . . 73.52 112.228 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -64.56 145.54 55.99 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.633 0.773 . . . . 74.3 110.708 175.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 85.75 -64.94 4.02 Favored Glycine 0 C--N 1.348 1.215 0 C-N-CA 123.303 0.477 . . . . 40.34 113.125 173.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 4.3 m -77.18 -24.69 51.39 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.31 0.644 . . . . 74.32 110.767 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 66.29 41.28 3.43 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.302 1.441 . . . . 75.42 111.489 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -76.53 78.78 3.22 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.377 0.608 . . . . 64.3 110.516 177.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -152.24 -64.43 0.17 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.06 0.944 . . . . 70.24 109.132 176.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -169.36 120.77 0.72 Allowed 'General case' 0 C--N 1.355 0.838 0 C-N-CA 122.822 0.449 . . . . 63.14 110.626 -176.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -85.13 141.98 29.82 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.615 0.766 . . . . 72.13 109.208 171.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.302 0 C-N-CA 124.481 1.112 . . . . 40.0 111.565 179.919 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.486 1.345 0 N-CA-C 111.026 0.009 . . . . 72.41 111.026 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -71.18 128.1 34.79 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.074 0.55 . . . . 71.51 110.388 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -101.45 165.74 11.1 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.751 0.82 . . . . 72.42 111.847 -170.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 30.9 m -118.39 150.15 40.02 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.075 -1.083 . . . . 70.31 108.075 165.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 5' ' ' THR . . . . . 0.517 HG22 HG13 ' E' ' 6' ' ' ILE . 28.9 m -139.48 119.93 13.98 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.311 -0.625 . . . . 70.12 109.311 -176.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.597 HG12 HG11 ' A' ' 40' ' ' VAL . 40.9 mt 72.29 143.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.798 1.639 . . . . 75.22 111.319 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.96 161.94 34.66 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.735 0.814 . . . . 74.32 110.235 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 3.6 tt -144.05 120.54 11.02 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 106.699 -1.593 . . . . 74.55 106.699 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.13 166.75 22.84 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.692 0.797 . . . . 74.43 111.777 -177.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . 0.657 HD21 ' HB2' ' A' ' 136' ' ' LEU . 86.2 mt -61.76 156.65 19.83 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.309 0.644 . . . . 73.43 110.974 171.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 47.1 mt -72.8 119.92 78.01 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-N 115.286 -0.87 . . . . 72.44 109.811 -177.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.47 -32.66 88.68 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.09 2.526 . . . . 75.51 111.851 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.22 122.31 19.1 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 106.817 -1.549 . . . . 75.53 106.817 175.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 7.2 mp -70.97 160.53 32.74 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.339 0.656 . . . . 73.44 110.692 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -75.84 150.03 37.73 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.939 -0.573 . . . . 74.0 109.726 -174.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 7.3 t -141.0 51.89 2.68 Favored Pre-proline 0 CA--C 1.571 1.751 0 N-CA-C 113.371 0.878 . . . . 74.44 113.371 -174.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 17' ' ' PRO . . . . . 0.674 ' HB3' ' HB2' ' A' ' 48' ' ' SER . 75.8 Cg_endo -76.24 -33.07 3.65 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 121.601 1.534 . . . . 72.41 112.035 170.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 23.6 t -79.7 94.77 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.872 0.869 . . . . 71.21 109.456 -171.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 63.4 p 52.99 -80.7 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.689 1.596 . . . . 61.33 111.378 -173.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 20' ' ' LYS . . . . . 0.411 ' NZ ' ' HB2' ' E' ' 20' ' ' LYS . 4.5 ttmp? -168.77 118.49 0.72 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.196 -1.039 . . . . 70.45 108.196 175.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.5 76.11 2.55 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.811 0.844 . . . . 51.22 110.39 178.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 22' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -163.91 122.98 1.97 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.326 -1.306 . . . . 61.03 108.38 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 4.6 t -111.67 100.15 47.22 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 108.012 -1.107 . . . . 75.12 108.012 171.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.87 -43.3 38.3 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.61 2.207 . . . . 62.42 111.887 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 . . . . . 0 C--O 1.25 1.129 0 N-CA-C 107.996 -1.113 . . . . 73.42 107.996 175.874 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 110.362 -0.236 . . . . 60.43 110.362 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 88.4 tttt 73.16 136.54 0.05 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.153 1.381 . . . . 73.14 111.859 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -144.18 133.93 23.73 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.971 0.909 . . . . 71.22 108.819 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 19.0 p -141.51 99.6 3.59 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.174 0.99 . . . . 64.43 109.359 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 32.6 m -79.22 -44.48 21.75 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.236 0.614 . . . . 71.31 109.889 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 19.0 pt -134.54 -166.94 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.908 0.883 . . . . 70.54 109.724 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 7' ' ' ALA . . . . . . . . . . . . . . . 69.81 167.95 0.29 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.579 1.151 . . . . 52.1 111.692 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . 0.524 HD13 HD11 ' B' ' 44' ' ' LEU . 71.7 mt -137.16 163.1 31.66 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.862 0.865 . . . . 62.03 109.793 -174.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -127.93 -61.51 1.11 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.726 0.81 . . . . 73.31 109.437 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 96.1 mt -139.77 163.68 31.96 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.137 0.975 . . . . 62.1 109.972 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 7.6 mp -84.76 155.85 61.61 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 123.548 0.739 . . . . 65.12 109.348 172.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.09 91.35 0.38 Allowed 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.624 2.216 . . . . 42.23 110.088 174.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 13' ' ' LEU . . . . . 0.477 HD13 ' N ' ' F' ' 14' ' ' LEU . 1.4 tm? 71.84 146.25 0.07 Allowed 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 125.221 1.408 . . . . 62.13 109.555 -172.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . 0.677 ' HB3' ' HB1' ' B' ' 95' ' ' ALA . 6.2 mp -61.75 140.79 58.18 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.771 0.828 . . . . 63.11 110.808 -178.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -65.74 144.74 56.7 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.826 0.85 . . . . 75.11 110.875 -170.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 25.2 p -59.87 121.41 58.02 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 124.426 1.091 . . . . 74.43 111.97 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 17' ' ' PRO . . . . . 0.496 ' HA ' HD12 ' B' ' 98' ' ' LEU . 33.4 Cg_exo -63.54 159.29 41.29 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.461 2.774 . . . . 55.23 114.043 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . 0.811 ' HB ' ' HB2' ' F' ' 21' ' ' ALA . 15.8 t -71.19 114.39 9.27 Favored 'Isoleucine or valine' 0 C--N 1.355 0.809 0 N-CA-C 107.616 -1.253 . . . . 72.53 107.616 172.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 42.1 m -71.18 116.68 11.76 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.126 0.57 . . . . 73.13 109.831 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt 82.3 23.82 0.2 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.806 1.642 . . . . 74.11 111.052 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . 0.811 ' HB2' ' HB ' ' F' ' 18' ' ' VAL . . . -67.12 101.52 0.9 Allowed 'General case' 0 C--N 1.359 0.982 0 C-N-CA 123.292 0.637 . . . . 63.51 109.451 174.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 45.5 ttm180 -143.9 143.17 31.15 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.296 -0.411 . . . . 63.22 110.852 -166.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 23' ' ' THR . . . . . 0.411 ' HA ' ' HD2' ' F' ' 24' ' ' PRO . 3.8 t -99.96 103.67 23.83 Favored Pre-proline 0 CA--C 1.558 1.255 0 CA-C-N 115.301 -0.863 . . . . 72.2 108.71 172.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 24' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' F' ' 23' ' ' THR . 10.6 Cg_endo -54.59 -35.67 87.0 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 123.194 2.596 . . . . 75.3 113.002 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 . . . . . 0 CA--C 1.552 1.042 0 N-CA-C 108.77 -0.826 . . . . 74.12 108.77 172.975 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 109.295 -0.631 . . . . 51.42 109.295 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.34 142.01 33.47 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.84 0.856 . . . . 74.13 109.3 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -153.01 136.59 15.98 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.06 0.544 . . . . 71.51 109.807 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 42.1 m -139.63 127.87 22.58 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.792 0.837 . . . . 75.31 109.12 176.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 5' ' ' THR . . . . . 0.51 HG22 ' H ' ' G' ' 6' ' ' ILE . 3.2 m -77.0 -179.84 5.77 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 124.123 0.969 . . . . 63.41 109.673 178.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . 0.51 ' H ' HG22 ' G' ' 5' ' ' THR . 39.3 pt -52.59 138.25 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 124.45 1.1 . . . . 61.44 112.668 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -122.33 137.39 54.87 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.359 0.663 . . . . 52.41 110.215 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 8' ' ' LEU . . . . . 0.622 ' H ' HG21 ' C' ' 131' ' ' VAL . 87.2 mt -85.98 151.25 23.89 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.368 0.667 . . . . 75.43 110.447 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.28 130.57 36.39 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.322 0.649 . . . . 71.13 109.712 174.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 9.7 mp -60.1 144.39 49.8 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.173 0.989 . . . . 71.42 110.728 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 75.8 mt -69.14 109.32 4.17 Favored Pre-proline 0 CA--C 1.552 1.049 0 O-C-N 124.427 1.079 . . . . 72.42 111.047 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.81 -40.55 0.39 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.938 2.425 . . . . 75.2 111.004 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 5.3 mp -72.79 -39.8 66.42 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.167 -0.924 . . . . 72.42 110.09 -177.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 88.3 mt 61.43 172.61 0.11 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.387 1.075 . . . . 61.23 111.503 -173.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -76.86 161.84 28.11 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.982 -0.377 . . . . 75.24 109.982 172.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 41.7 p -73.99 150.78 88.22 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.093 0.557 . . . . 61.1 110.171 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 17' ' ' PRO . . . . . 0.573 ' HB3' ' HB3' ' G' ' 21' ' ' ALA . 85.6 Cg_exo -50.11 148.54 13.42 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.748 2.965 . . . . 65.42 114.252 174.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 18' ' ' VAL . . . . . 0.626 HG23 HD23 ' C' ' 98' ' ' LEU . 99.0 t -62.27 -59.15 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 109.111 -0.7 . . . . 52.51 109.111 174.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 19' ' ' THR . . . . . . . . . . . . . 11.8 p -139.82 -74.38 0.36 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.422 1.089 . . . . 73.04 109.314 175.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -120.64 79.36 1.48 Allowed 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.764 -0.828 . . . . 70.25 108.764 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . 0.573 ' HB3' ' HB3' ' G' ' 17' ' ' PRO . . . -129.78 5.24 5.03 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.503 -0.771 . . . . 60.54 112.062 -175.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -91.18 71.94 6.26 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.556 0.742 . . . . 74.32 109.738 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 33.9 m -147.06 66.55 10.39 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 108.995 -0.743 . . . . 63.31 108.995 170.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.34 134.82 8.0 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.571 2.181 . . . . 62.51 111.292 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 . . . . . 0 CA--C 1.562 1.42 0 C-N-CA 123.338 0.655 . . . . 74.21 111.17 -176.506 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 109.383 -0.599 . . . . 71.21 109.383 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -157.81 141.33 15.48 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.653 0.781 . . . . 72.41 109.316 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -119.57 120.94 38.19 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.384 0.674 . . . . 73.31 109.784 -176.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 42.5 m -144.74 119.88 10.11 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.917 0.887 . . . . 74.43 109.208 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 5' ' ' THR . . . . . . . . . . . . . 91.7 m -148.82 -70.81 0.21 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.962 0.505 . . . . 74.02 110.388 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . . . . . . . . . 12.6 tt -147.09 143.87 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.993 -0.442 . . . . 73.41 109.954 -173.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 7' ' ' ALA . . . . . . . . . . . . . . . 68.93 161.59 0.2 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.152 1.381 . . . . 44.01 112.139 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 74.9 mt -69.73 147.89 49.91 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.882 -0.599 . . . . 72.43 110.383 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.84 -73.1 0.37 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.372 0.669 . . . . 35.13 110.113 -177.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 10' ' ' LEU . . . . . 0.532 HD22 ' HB2' ' D' ' 140' ' ' TYR . 78.7 mt -130.86 142.83 50.4 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.199 1.0 . . . . 74.04 109.734 177.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' H' ' 12' ' ' PRO . 7.6 mp -92.92 124.06 59.52 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 108.434 -0.95 . . . . 65.3 108.434 173.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 12' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' H' ' 11' ' ' LEU . 24.6 Cg_exo -64.35 -16.41 54.91 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.424 2.749 . . . . 71.54 113.555 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 54.9 tp -133.29 148.95 51.94 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.849 0.86 . . . . 52.42 108.954 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 87.6 mt -69.01 97.55 0.88 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.316 0.646 . . . . 70.51 110.088 177.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . 0.425 ' HB3' ' HA2' ' D' ' 99' ' ' GLY . 0.9 OUTLIER -76.05 91.19 3.08 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 107.927 -1.138 . . . . 73.42 107.927 174.677 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 21.0 m -143.65 84.2 10.1 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 123.391 0.677 . . . . 72.51 110.35 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -78.28 -152.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.928 2.419 . . . . 62.02 111.486 162.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 95.8 t 75.81 141.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 124.826 1.25 . . . . 72.22 111.797 174.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 15.2 m 65.17 46.96 2.56 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.008 0.923 . . . . 72.41 109.289 -175.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 58.5 mttp 76.51 -13.68 0.89 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.726 1.61 . . . . 75.41 112.283 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.06 136.07 54.65 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 108.276 -1.009 . . . . 74.22 108.276 166.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -177.34 172.08 1.91 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.269 1.028 . . . . 74.41 109.406 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 20.1 p -91.44 103.09 6.81 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 108.653 -0.869 . . . . 73.42 108.653 168.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.96 172.05 13.51 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.917 2.411 . . . . 72.2 112.25 -177.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 CA--C 1.556 1.185 0 C-N-CA 123.839 0.856 . . . . 75.11 110.179 179.494 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.6 ttm . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 110.012 -0.366 . . . . 75.42 110.012 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.1 m -147.87 21.95 1.12 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.873 1.269 . . . . 65.05 109.447 176.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 6' ' ' ASN . 8.1 mp0 -85.13 143.04 29.08 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.205 0.602 . . . . 70.12 110.352 -173.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -71.52 119.71 16.07 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 107.397 -1.335 . . . . 73.34 107.397 169.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.9 t30 75.38 3.05 3.96 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 125.529 1.532 . . . . 75.42 111.783 -174.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.482 ' HA ' ' HB2' ' A' ' 3' ' ' GLU . 14.9 m120 60.31 -98.29 0.08 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.421 1.489 . . . . 52.31 112.18 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 p -151.86 86.66 1.32 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.267 1.027 . . . . 74.51 109.451 -173.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -122.78 3.68 9.48 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.352 0.661 . . . . 74.11 110.793 171.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 38.7 ttm -72.31 152.57 42.03 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.42 0.628 . . . . 63.33 111.143 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 t -137.61 140.64 41.04 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.33 -1.359 . . . . 73.2 107.33 170.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.722 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 33.4 t80 -136.68 127.75 27.81 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.028 0.531 . . . . 74.22 109.637 -175.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -148.5 127.71 12.93 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.21 -1.033 . . . . 54.21 108.21 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.643 HG12 ' HD2' ' A' ' 84' ' ' PHE . 53.7 mt -85.36 122.9 38.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 108.575 -0.898 . . . . 71.33 108.575 174.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -85.02 -41.47 15.77 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.899 -0.778 . . . . 72.41 108.899 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -173.34 128.83 0.44 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 111.453 0.168 . . . . 73.24 111.453 -167.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.4 HD12 ' CG ' ' C' ' 130' ' ' PRO . 91.8 mt -123.17 132.9 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 124.141 0.976 . . . . 51.23 109.219 176.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.475 ' HB3' HG23 ' B' ' 122' ' ' THR . 30.0 p90 -167.12 154.2 8.74 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.853 0.861 . . . . 73.53 111.119 -169.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.4 p -75.28 126.08 30.28 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.713 -0.676 . . . . 73.31 109.466 170.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.401 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 39.8 mtpt -93.48 -21.21 19.61 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.75 -0.463 . . . . 61.02 109.75 173.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.497 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 25.0 t70 -153.3 138.49 17.41 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.051 -0.977 . . . . 74.1 110.045 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.2 mt -133.28 144.29 36.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 C-N-CA 124.989 1.316 . . . . 55.24 108.09 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.609 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 42.8 t -147.64 126.37 12.61 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.889 -0.782 . . . . 74.33 108.889 170.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 84.9 t80 -131.3 117.44 18.95 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 106.289 -1.745 . . . . 71.01 106.289 170.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -125.5 120.02 29.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.134 0.425 . . . . 74.42 109.93 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.1 80.65 15.43 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 106.93 -1.507 . . . . 74.32 106.93 171.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.35 -35.54 39.62 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 122.578 2.185 . . . . 71.14 111.488 -174.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -106.01 25.51 10.85 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.922 -1.035 . . . . 63.12 109.457 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.457 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -49.11 -50.83 61.04 Favored Pre-proline 0 CA--C 1.561 1.393 0 N-CA-C 113.471 0.915 . . . . 71.24 113.471 -177.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.22 -21.35 67.4 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 121.647 1.565 . . . . 72.35 113.441 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -91.53 -35.11 14.48 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.105 0.962 . . . . 61.02 110.657 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.8 p -75.35 -25.03 17.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.564 -0.743 . . . . 64.54 112.569 -163.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -73.35 -17.69 61.26 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.325 0.65 . . . . 74.03 110.874 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -85.65 -32.1 22.18 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.483 1.113 . . . . 74.23 110.134 174.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -68.92 157.88 35.74 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.75 0.82 . . . . 53.21 111.349 -175.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -70.87 131.67 44.12 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.385 0.674 . . . . 73.44 109.386 171.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -84.11 88.3 7.18 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.487 0.661 . . . . 73.15 110.189 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -120.98 81.17 34.92 Favored Pre-proline 0 C--O 1.245 0.829 0 N-CA-C 107.977 -1.12 . . . . 64.3 107.977 169.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.59 112.11 3.39 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 121.972 1.781 . . . . 70.0 112.015 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -94.58 88.84 5.57 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 105.826 -1.916 . . . . 75.1 105.826 167.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.4 m -77.55 114.85 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 113.985 -1.461 . . . . 74.03 111.228 -172.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.437 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 87.0 tttt -87.29 130.98 34.39 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.286 -0.87 . . . . 70.05 109.085 173.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.609 ' HB3' HD11 ' E' ' 6' ' ' ILE . 4.5 pp -103.35 148.84 25.38 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.992 -0.744 . . . . 71.44 108.992 173.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.501 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 21.3 t70 -147.56 133.54 19.19 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.134 -0.691 . . . . 43.13 109.134 172.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' E' ' 8' ' ' LEU . 96.6 mt -126.38 128.87 47.72 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.033 0.933 . . . . 73.03 109.805 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -140.15 156.98 46.31 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.253 -0.647 . . . . 74.22 109.253 171.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.3 p -115.36 152.96 31.86 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.467 0.707 . . . . 73.41 110.804 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -145.57 111.85 5.73 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.179 -1.045 . . . . 74.34 108.179 173.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -89.85 152.47 21.25 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.109 0.563 . . . . 75.2 109.7 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.2 t -157.54 142.12 16.48 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.557 0.743 . . . . 74.41 109.851 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -112.76 134.66 54.17 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.706 -0.85 . . . . 71.22 108.706 171.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.594 HD11 ' HB2' ' A' ' 57' ' ' GLU . 27.0 mt -112.59 -28.86 7.67 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.303 0.641 . . . . 64.34 110.528 -174.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.44 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -160.63 179.64 8.4 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.163 0.985 . . . . 34.14 109.058 175.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.49 120.84 13.59 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.898 -0.778 . . . . 75.24 108.898 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 72.59 -1.88 2.83 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.92 1.288 . . . . 62.15 112.272 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.44 ' CG2' ' HB3' ' A' ' 52' ' ' ALA . 57.8 t -101.16 112.0 32.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 107.9 -1.148 . . . . 74.25 107.9 176.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -115.84 156.37 26.22 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 123.653 0.781 . . . . 75.22 108.996 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.594 ' HB2' HD11 ' A' ' 51' ' ' LEU . 48.3 tt0 -128.18 120.72 27.85 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.387 -0.968 . . . . 73.32 108.387 177.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.1 t -99.45 112.68 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.583 -1.636 . . . . 54.24 106.583 174.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 49.2 t -102.55 127.37 56.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 107.633 -1.247 . . . . 45.11 107.633 170.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.24 117.03 28.44 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.289 -1.004 . . . . 73.34 108.289 177.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.515 ' HG2' ' HG2' ' A' ' 79' ' ' GLN . 57.6 mtt180 -84.92 100.95 11.96 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.064 0.945 . . . . 70.35 108.81 176.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.8 t -103.43 103.29 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.613 -0.884 . . . . 61.22 108.613 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 26.0 m -109.3 109.32 20.19 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.224 0.61 . . . . 71.53 109.78 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.584 HG11 HD21 ' A' ' 126' ' ' LEU . 2.6 t -105.97 133.36 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.944 1.298 . . . . 71.53 109.537 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 41.7 m -120.47 143.14 48.68 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.538 -0.912 . . . . 72.31 108.538 173.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.14 109.58 18.64 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.612 -1.255 . . . . 74.14 107.612 168.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.2 m -111.79 127.39 55.79 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.773 -0.825 . . . . 61.24 108.773 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.6 mt -89.63 49.21 1.7 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.265 1.026 . . . . 72.22 109.314 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.28 -92.0 1.37 Allowed Glycine 0 CA--C 1.529 0.906 0 N-CA-C 111.766 -0.534 . . . . 64.33 111.766 -173.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -88.68 -30.53 19.06 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.027 0.531 . . . . 53.34 112.011 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -113.36 126.78 55.74 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 109.779 -0.452 . . . . 75.34 109.779 -175.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.4 m -71.12 126.06 28.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.839 0.456 . . . . 63.52 109.81 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.528 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -71.87 -57.44 4.33 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.677 0.791 . . . . 72.53 109.923 176.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -157.33 174.94 14.67 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.599 -1.182 . . . . 64.45 111.249 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 tp -132.42 143.55 49.88 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 113.878 -1.51 . . . . 75.14 108.123 175.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 76.1 m -137.65 129.21 28.26 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.968 1.307 . . . . 71.5 107.878 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 39.7 tt0 -147.73 116.33 6.68 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.489 -0.93 . . . . 72.42 108.489 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.4 t -133.08 110.8 15.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 123.364 0.665 . . . . 74.23 109.743 -173.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.515 ' HG2' ' HG2' ' A' ' 61' ' ' ARG . 18.6 mt-30 -86.4 85.94 7.33 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.092 -1.077 . . . . 71.23 108.092 172.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.456 ' HG3' HD22 ' A' ' 106' ' ' LEU . 9.1 tp-100 -77.61 101.02 6.36 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.27 -0.877 . . . . 75.14 108.907 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.98 146.26 20.35 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.694 -0.962 . . . . 71.24 110.694 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.508 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -149.88 122.51 1.43 Allowed Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 111.399 -0.68 . . . . 74.53 111.399 -176.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 24.6 mt -82.84 116.88 27.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 109.079 -0.711 . . . . 75.32 109.079 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.722 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 14.6 m-85 -133.14 120.56 21.38 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.507 -1.294 . . . . 74.13 107.507 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.0 m -85.17 99.47 11.1 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.854 -0.795 . . . . 51.31 108.854 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.5 pt -123.84 118.56 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 123.909 0.884 . . . . 74.54 110.67 -172.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.41 167.06 5.72 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.551 1.14 . . . . 75.51 109.625 178.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 150.79 2.58 0.24 Allowed Glycine 0 N--CA 1.477 1.388 0 O-C-N 123.564 0.54 . . . . 74.31 114.093 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 89' ' ' ILE . 3.6 mp 61.5 29.21 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.747 0 CA-C-O 122.952 1.358 . . . . 72.44 109.571 177.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 94' ' ' MET . 2.6 tp10 -73.32 -24.49 60.39 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 114.788 -1.096 . . . . 75.44 111.696 -171.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.428 ' O ' ' HB1' ' E' ' 21' ' ' ALA . . . 72.42 -111.62 3.65 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-N 116.057 -0.52 . . . . 71.42 113.618 172.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.6 p -62.52 -35.3 78.96 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.845 0.858 . . . . 72.23 111.59 -176.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -74.77 -34.53 62.47 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.887 0.875 . . . . 63.11 111.046 173.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.508 ' HG2' HD23 ' A' ' 98' ' ' LEU . 53.2 ttp -60.34 -30.37 69.48 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 122.527 0.331 . . . . 75.54 111.127 172.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.37 -33.1 74.08 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.68 0.792 . . . . 73.12 111.532 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.522 ' HD2' ' HG3' ' A' ' 138' ' ' MET . 41.3 t-80 -63.24 -37.87 88.92 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.036 0.534 . . . . 74.03 110.749 174.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 22.2 t -74.66 -54.55 7.2 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.442 0.297 . . . . 74.02 111.09 -175.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.508 HD23 ' HG2' ' A' ' 94' ' ' MET . 4.6 pp -75.42 -30.64 60.11 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.352 0.661 . . . . 74.45 112.347 -172.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.92 3.94 25.75 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.368 -0.684 . . . . 64.33 114.386 -170.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.687 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -147.73 -51.9 0.19 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 118.089 0.945 . . . . 70.31 112.612 -175.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.519 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 91.4 t80 -78.74 -61.7 1.93 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.509 0.723 . . . . 72.35 112.327 -170.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.41 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 71.2 m -65.12 -36.78 16.85 Favored Pre-proline 0 CA--C 1.564 1.495 0 N-CA-C 113.627 0.973 . . . . 61.4 113.627 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 18.0 Cg_endo -61.3 -32.36 89.82 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 121.905 1.737 . . . . 73.14 113.603 165.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -74.31 -21.85 59.53 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 122.988 0.515 . . . . 71.21 110.563 177.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 23.2 mm -65.63 -38.86 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.215 0.606 . . . . 73.24 109.411 170.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.508 HD21 ' HA3' ' A' ' 82' ' ' GLY . 86.4 mt -74.33 -23.55 59.07 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.901 0.881 . . . . 74.2 112.438 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.465 ' HE2' ' HA ' ' A' ' 130' ' ' PRO . 54.7 t80 -61.17 -47.59 94.28 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-O 118.209 -0.9 . . . . 60.21 113.268 -174.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -60.76 -34.86 91.14 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.225 1.95 . . . . 74.43 113.479 174.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -75.41 -37.51 60.44 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.365 0.666 . . . . 74.44 112.03 -178.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.28 -35.95 63.76 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.813 0.445 . . . . 55.4 109.909 177.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.647 ' NH1' HG23 ' C' ' 105' ' ' ILE . 27.3 ttm105 -63.73 -39.99 95.65 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 108.67 -0.863 . . . . 75.51 108.67 172.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.43 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 3.3 tm-20 -64.52 -48.16 76.16 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.131 0.972 . . . . 75.13 111.461 -177.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 36.0 t -60.68 -43.2 98.0 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 123.906 0.754 . . . . 74.14 110.16 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 72.4 mt -65.08 -44.31 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.353 0.661 . . . . 71.24 110.511 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.9 m -57.83 -41.75 82.94 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.564 1.145 . . . . 75.42 110.793 -177.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.3 t -77.71 -42.84 33.03 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.209 -0.905 . . . . 63.55 111.056 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 9.8 mtp -56.91 -46.85 81.7 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 123.84 0.856 . . . . 53.23 111.621 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.6 t -64.06 -41.9 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.567 1.147 . . . . 75.53 110.949 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.687 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 38.2 t -67.33 -35.11 78.75 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.769 -0.65 . . . . 52.44 111.165 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -74.46 -28.31 60.97 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.814 0.846 . . . . 74.51 110.141 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.9 6.79 64.94 Favored Glycine 0 C--N 1.354 1.53 0 O-C-N 123.899 0.75 . . . . 41.23 112.508 171.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.498 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.7 t 62.64 19.49 11.37 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 127.108 2.163 . . . . 43.43 113.299 172.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -81.95 161.78 59.52 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 109.174 -0.676 . . . . 61.44 109.174 175.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -53.53 115.13 2.11 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.343 2.029 . . . . 71.01 110.286 169.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.687 ' HG3' ' HB2' ' A' ' 119' ' ' SER . 4.0 tt0 -55.37 131.54 46.01 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 124.289 0.993 . . . . 72.13 111.24 -166.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.584 HD21 HG11 ' A' ' 64' ' ' VAL . 55.7 tp -107.08 106.73 17.38 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.425 -0.807 . . . . 71.21 110.605 -162.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -121.64 107.66 12.64 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.556 1.142 . . . . 71.24 108.582 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.451 ' O ' HD12 ' C' ' 13' ' ' ILE . 7.5 mp -72.75 145.88 46.78 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.826 0.45 . . . . 71.32 110.52 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.49 149.18 92.57 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 123.975 0.91 . . . . 61.42 111.145 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.628 ' HD3' HG13 ' C' ' 13' ' ' ILE . 44.0 Cg_endo -66.16 131.07 25.75 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 123.014 2.476 . . . . 33.32 112.194 -178.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.2 t -113.32 112.98 42.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.735 -1.209 . . . . 74.25 107.735 173.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -81.1 86.69 6.12 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.036 -0.727 . . . . 61.1 109.036 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -62.51 -39.84 94.81 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.9 -0.591 . . . . 65.11 109.925 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.687 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 8.9 p-10 -57.27 -29.27 63.71 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.225 1.01 . . . . 71.3 112.472 177.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -89.94 -60.39 1.95 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.22 0.608 . . . . 71.34 110.924 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.4 mp -69.45 -38.26 77.7 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.947 0.899 . . . . 63.42 113.158 -168.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -68.37 -43.2 77.9 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.517 0.675 . . . . 63.33 109.678 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.522 ' HG3' ' HD2' ' A' ' 96' ' ' HIS . 95.9 mmm -76.99 -22.7 52.74 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 114.915 -1.039 . . . . 74.43 111.184 177.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -64.37 -42.19 96.32 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.54 0.736 . . . . 73.24 109.466 174.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -65.25 -39.05 92.15 Favored 'General case' 0 CA--C 1.551 1.01 0 O-C-N 124.146 0.904 . . . . 61.24 110.573 176.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 21.2 tp -67.61 -7.0 22.86 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.868 1.267 . . . . 72.44 112.434 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -142.11 19.38 2.1 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.335 0.654 . . . . 75.21 109.324 -178.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -81.41 82.51 7.21 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.809 0.814 . . . . 74.13 109.224 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -159.87 14.34 0.14 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.542 -1.208 . . . . 74.42 110.728 -173.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 61.83 91.46 0.06 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.707 1.203 . . . . 73.53 110.768 -172.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.0 -128.98 2.29 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.652 -0.704 . . . . 75.21 111.44 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -160.11 163.24 33.96 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 117.228 0.514 . . . . 71.41 110.811 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -85.3 -177.71 50.68 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.396 -0.82 . . . . 73.01 113.194 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.7 t -131.91 168.24 18.22 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.125 0.97 . . . . 62.44 108.97 176.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -89.69 40.75 1.01 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.297 0.639 . . . . 65.11 110.208 177.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 59.69 -80.07 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.714 1.606 . . . . 74.45 111.745 -177.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 -152.04 149.67 29.1 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.901 0.88 . . . . 54.32 109.699 -177.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -82.45 135.39 35.15 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.322 0.649 . . . . 70.54 109.354 168.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -91.94 85.97 5.72 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.713 -0.847 . . . . 72.11 108.713 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.096 0 C-N-CA 123.875 0.87 . . . . 74.14 109.659 177.358 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 120.512 0.196 . . . . 71.21 111.174 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 32.7 t -88.54 75.3 8.36 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.602 0.715 . . . . 74.52 111.299 -173.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -128.68 91.55 3.25 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.207 -1.034 . . . . 74.54 108.207 171.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -76.5 -96.06 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.564 -0.743 . . . . 74.52 109.52 -175.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 179.99 160.05 0.84 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.184 0.594 . . . . 74.45 110.785 -176.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' B' ' 89' ' ' ILE . 18.5 t-20 -171.48 143.88 1.85 Allowed 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 107.992 -1.114 . . . . 73.05 107.992 167.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 59.6 p -117.59 -1.57 11.63 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.771 0.828 . . . . 75.41 111.08 -176.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -101.81 -81.21 0.49 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.81 0.844 . . . . 75.35 111.171 -173.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.559 ' HB2' ' HB ' ' B' ' 89' ' ' ILE . 16.8 ttt 60.27 164.45 0.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.436 1.494 . . . . 64.33 112.415 -170.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 85.3 m -159.24 143.35 15.16 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 124.171 0.988 . . . . 54.41 108.573 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -145.97 156.86 43.79 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.652 0.739 . . . . 72.41 110.448 158.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -125.26 130.59 52.35 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 106.257 -1.757 . . . . 75.42 106.257 172.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.566 HD11 HD13 ' B' ' 105' ' ' ILE . 34.0 mt -67.09 112.68 2.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 108.567 -0.901 . . . . 70.21 108.567 176.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . 0.448 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 16.9 mm-40 -80.15 -49.65 11.39 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.015 -0.993 . . . . 75.4 109.179 -178.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.498 ' HE ' HG21 ' A' ' 122' ' ' THR . 42.6 ttt180 -167.07 139.54 3.44 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.67 -0.695 . . . . 74.25 110.244 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.5 mt -114.86 141.56 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 107.424 -1.325 . . . . 74.0 107.424 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -167.78 153.43 7.26 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.689 0.757 . . . . 64.42 112.362 -176.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.6 m -80.54 122.93 27.65 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.822 -1.081 . . . . 73.45 108.707 168.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.459 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 38.0 mtpt -91.4 -41.89 10.62 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.015 0.526 . . . . 72.23 109.669 176.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 24.5 t70 -142.59 139.03 31.19 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.845 -0.616 . . . . 75.32 111.18 -168.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.415 HD11 ' SG ' ' B' ' 113' ' ' CYS . 48.8 mm -133.15 137.97 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.198 1.399 . . . . 70.43 108.174 173.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.535 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 42.8 t -144.75 117.46 8.68 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.338 -1.356 . . . . 73.51 107.338 -177.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.497 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 84.3 t80 -140.07 116.54 10.71 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.76 -1.2 . . . . 72.33 107.76 176.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -124.46 113.84 18.66 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.667 0.787 . . . . 74.1 109.34 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.728 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -108.24 85.45 2.74 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 107.989 -1.115 . . . . 53.43 107.989 170.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -73.38 -23.34 17.66 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.776 2.318 . . . . 64.35 112.667 -171.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -114.99 5.46 15.02 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.169 0.988 . . . . 70.22 110.936 -173.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.728 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -43.71 -61.63 1.84 Allowed Pre-proline 0 N--CA 1.492 1.643 0 C-N-CA 125.638 1.575 . . . . 73.21 114.382 -167.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.401 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 29.0 Cg_endo -61.86 -24.99 77.84 Favored 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 122.56 2.174 . . . . 72.33 113.245 -171.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -96.04 -33.08 12.25 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.652 0.781 . . . . 74.34 111.496 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.429 HG22 HD12 ' B' ' 68' ' ' LEU . 2.8 p -74.44 -16.03 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 122.601 0.361 . . . . 64.31 110.571 -175.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -67.88 -7.98 32.64 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.63 0.772 . . . . 71.12 112.838 176.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -67.54 -13.29 61.92 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 122.444 0.297 . . . . 72.03 110.902 171.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -105.55 110.42 22.74 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.445 1.498 . . . . 64.24 109.346 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -107.53 79.71 1.32 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.452 0.701 . . . . 64.13 110.93 -170.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 43.0 p90 -156.93 175.75 13.67 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.584 0.754 . . . . 73.54 109.217 171.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -77.37 113.13 28.64 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.197 -1.038 . . . . 75.55 108.197 173.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.28 148.53 88.6 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.171 1.914 . . . . 74.51 111.925 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -66.53 122.43 17.55 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.727 -0.842 . . . . 74.15 108.727 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.489 HG13 HG13 ' B' ' 64' ' ' VAL . 57.7 t -111.23 131.35 62.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 124.042 0.937 . . . . 63.24 111.021 -171.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -106.02 135.23 47.85 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.942 -1.133 . . . . 53.25 107.942 169.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 pp -109.24 154.83 21.86 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.06 0.944 . . . . 74.55 109.542 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -159.81 150.45 19.05 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.566 0.746 . . . . 74.34 109.273 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.475 HD13 HD11 ' B' ' 60' ' ' LEU . 62.4 mt -123.94 152.27 42.65 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.388 0.675 . . . . 65.41 110.197 175.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 11.4 t70 -138.5 142.6 39.35 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.635 1.174 . . . . 75.22 107.925 173.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 39.4 p -109.94 111.92 23.62 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.428 0.691 . . . . 73.32 109.959 -176.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.464 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -116.71 149.08 40.43 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.179 0.992 . . . . 75.11 108.379 176.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 46.5 p -145.45 162.14 38.05 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.292 0.479 . . . . 63.31 112.292 -174.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.8 p -153.55 136.2 15.22 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 114.691 -1.14 . . . . 70.44 108.532 164.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -93.86 110.18 21.85 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.157 -1.053 . . . . 63.32 108.157 173.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 63.6 mt -78.01 -39.81 41.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.189 0.596 . . . . 72.04 111.2 -174.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.47 -167.5 1.6 Allowed 'General case' 0 C--O 1.242 0.705 0 CA-C-N 115.184 -0.916 . . . . 60.42 110.167 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -71.71 120.22 16.99 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.985 -1.007 . . . . 71.05 109.083 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 70.35 -4.77 1.5 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.989 1.316 . . . . 74.55 112.362 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 85.3 t -104.88 115.29 46.48 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 N-CA-C 107.504 -1.295 . . . . 62.45 107.504 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -129.46 154.94 46.48 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.587 -0.894 . . . . 72.22 108.587 -175.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -126.25 111.36 14.48 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.341 -0.985 . . . . 72.24 108.341 -174.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 88.0 t -100.81 119.26 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.215 1.406 . . . . 61.22 110.134 -173.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 20.1 t -109.43 114.21 46.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 109.01 -0.737 . . . . 71.43 109.01 178.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.475 HD11 HD13 ' B' ' 44' ' ' LEU . 35.3 tp -99.51 111.38 23.74 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.804 -0.813 . . . . 61.04 108.804 169.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.535 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 33.7 ttm180 -86.09 127.21 34.64 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.824 -0.806 . . . . 72.41 108.824 170.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 36.2 t -113.98 103.92 16.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.579 -1.267 . . . . 74.03 107.579 172.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 9.6 m -98.1 136.27 38.57 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.166 0.586 . . . . 53.4 109.644 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.523 HG21 HG21 ' B' ' 114' ' ' ILE . 69.4 t -125.57 135.89 62.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.862 1.265 . . . . 73.33 109.584 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 95.5 m -117.5 148.86 41.46 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.934 -1.135 . . . . 63.03 107.934 167.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.37 147.0 29.84 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.036 0.534 . . . . 60.44 109.96 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.516 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 15.6 p -147.98 128.13 13.76 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.64 -0.709 . . . . 63.41 111.055 -175.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.429 HD12 HG22 ' B' ' 31' ' ' VAL . 53.1 mt -92.55 100.46 12.99 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 106.904 -1.517 . . . . 73.11 106.904 173.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.36 -139.01 26.06 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 111.345 -0.702 . . . . 44.11 111.345 -172.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -92.89 23.01 4.43 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.356 0.662 . . . . 62.42 110.138 175.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -118.93 138.95 52.42 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.276 1.03 . . . . 74.43 108.963 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 55.5 m -69.62 119.74 14.32 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.75 -0.463 . . . . 75.24 109.75 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.516 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -78.16 -62.61 1.62 Allowed 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.246 -1.02 . . . . 63.33 108.246 176.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -157.79 163.04 38.46 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.851 -1.068 . . . . 63.3 111.282 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 23.9 mt -123.34 127.37 48.41 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 105.977 -1.86 . . . . 73.33 105.977 172.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -128.74 155.35 45.24 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.323 -0.621 . . . . 73.13 109.323 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.535 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 37.2 tt0 -166.06 129.98 2.16 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.194 -0.669 . . . . 73.05 109.194 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.0 t -128.1 151.33 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.925 0.89 . . . . 71.22 108.708 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -125.37 108.93 12.17 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.681 -0.859 . . . . 61.45 108.681 168.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.44 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 7.5 tp-100 -92.81 100.41 12.9 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.43 -0.952 . . . . 73.41 108.43 174.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.459 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.09 145.32 17.62 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.895 -0.882 . . . . 73.43 110.895 176.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.13 127.7 2.48 Favored Glycine 0 CA--C 1.506 -0.518 0 N-CA-C 110.55 -1.02 . . . . 55.43 110.55 -174.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.448 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 27.8 mt -85.0 119.48 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 108.238 -1.023 . . . . 73.24 108.238 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -126.39 132.18 51.59 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 107.133 -1.432 . . . . 73.32 107.133 175.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 70.1 m -88.98 87.76 7.34 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.344 0.52 . . . . 63.25 109.861 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.409 HG12 HD21 ' B' ' 98' ' ' LEU . 2.6 pp -96.67 131.24 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.092 0.957 . . . . 55.21 109.959 -171.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.21 160.5 37.23 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.737 0.415 . . . . 40.01 111.359 173.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.47 -69.31 0.21 Allowed Glycine 0 C--N 1.343 0.949 0 CA-C-N 115.537 -0.756 . . . . 74.1 112.802 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.559 ' HB ' ' HB2' ' B' ' 9' ' ' MET . 0.1 OUTLIER -78.82 154.58 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.248 0.619 . . . . 74.41 110.759 -173.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' F' ' 21' ' ' ALA . 15.7 pt-20 -154.41 -175.1 5.24 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.706 -0.679 . . . . 72.04 111.717 -164.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.62 -113.52 5.94 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 115.127 -0.942 . . . . 72.41 112.53 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 77.7 m -88.21 -31.33 19.14 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.535 0.734 . . . . 53.12 110.773 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -65.96 -30.98 71.63 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 116.165 -0.47 . . . . 62.31 111.338 -171.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -68.42 -33.38 74.12 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.091 0.472 . . . . 74.55 110.686 174.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.02 -25.79 61.09 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.864 0.866 . . . . 52.14 110.927 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.445 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 35.7 t-80 -77.97 -40.18 40.11 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.698 0.799 . . . . 73.33 110.786 174.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.1 t -68.22 -57.62 5.72 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.848 0.356 . . . . 74.3 110.599 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.409 HD21 HG12 ' B' ' 86' ' ' ILE . 6.3 mp -81.43 -8.34 59.72 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 116.384 -0.371 . . . . 70.34 111.638 -177.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.97 4.06 31.88 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 119.763 -0.465 . . . . 71.51 114.037 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.447 ' HB1' ' N ' ' B' ' 134' ' ' ASP . . . -151.91 -49.07 0.11 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 117.157 0.479 . . . . 64.4 111.937 -175.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.424 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 54.0 t80 -78.58 -50.86 10.8 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.942 -0.572 . . . . 73.22 111.148 -173.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.427 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 70.3 m -64.24 -46.3 79.14 Favored Pre-proline 0 CA--C 1.568 1.657 0 C-N-CA 123.434 0.694 . . . . 54.12 111.307 177.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 56.6 Cg_exo -49.94 -36.93 45.38 Favored 'Trans proline' 0 C--N 1.404 3.473 0 C-N-CA 123.163 2.575 . . . . 50.32 114.996 168.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -63.62 -40.12 96.1 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 122.883 0.473 . . . . 74.44 110.381 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.566 HD13 HD11 ' B' ' 13' ' ' ILE . 64.7 mt -66.11 -42.66 91.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.515 0.726 . . . . 70.05 110.595 178.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 85.2 mt -82.68 -19.2 38.57 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.498 -0.774 . . . . 63.24 112.166 -174.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -57.85 -53.86 61.41 Favored Pre-proline 0 CA--C 1.561 1.367 0 CA-C-O 117.877 -1.058 . . . . 63.31 112.974 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -58.39 -33.42 97.81 Favored 'Trans proline' 0 C--N 1.392 2.854 0 C-N-CA 122.43 2.087 . . . . 72.42 114.209 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -71.02 -51.33 26.02 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.984 0.514 . . . . 74.43 110.46 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.44 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -58.07 -37.74 75.04 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.442 -0.799 . . . . 62.31 110.932 176.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -59.73 -57.02 14.73 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.747 1.619 . . . . 73.42 110.696 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -64.83 -29.8 70.78 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.706 0.803 . . . . 74.41 110.413 -178.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.524 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.2 t -70.3 -43.38 70.52 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 122.957 0.503 . . . . 74.01 110.909 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.523 HG21 HG21 ' B' ' 64' ' ' VAL . 83.6 mt -60.88 -53.15 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.287 -0.634 . . . . 75.31 109.287 175.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.4 m -55.12 -34.87 64.09 Favored 'General case' 0 CA--C 1.551 0.996 0 O-C-N 124.563 1.164 . . . . 74.11 111.744 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 42.7 t -65.85 -51.23 60.57 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 115.39 -0.823 . . . . 71.33 110.197 175.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.6 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 15.1 mmt -67.82 -30.5 69.92 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.355 0.662 . . . . 75.45 111.797 -174.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.94 -44.73 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.392 1.077 . . . . 75.04 109.969 174.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 27.7 t -70.1 -25.49 63.53 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.224 -0.898 . . . . 73.22 110.543 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.6 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 89.8 mtt-85 -70.38 -30.48 67.4 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.804 -0.443 . . . . 75.32 109.804 174.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.46 12.65 54.95 Favored Glycine 0 C--N 1.355 1.62 0 O-C-N 123.549 0.531 . . . . 64.11 112.644 170.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 17' ' ' TYR . 38.1 p 54.15 24.68 5.05 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 126.464 1.906 . . . . 72.23 113.992 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -83.86 156.76 64.23 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 123.318 0.647 . . . . 73.42 110.673 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -64.41 178.28 1.72 Allowed 'Trans proline' 0 C--N 1.389 2.668 0 C-N-CA 123.429 2.753 . . . . 73.22 114.072 -177.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.649 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 23.2 tp60 -65.16 125.9 26.42 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.443 -1.253 . . . . 53.13 112.27 -169.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -135.52 114.41 12.05 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 108.89 -0.781 . . . . 74.42 108.89 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -130.46 135.04 47.56 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.319 1.047 . . . . 72.14 108.209 171.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 tt -87.78 142.52 27.76 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.787 0.835 . . . . 64.43 109.143 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.403 ' HB3' ' HA ' ' F' ' 7' ' ' ALA . . . -71.24 152.47 94.44 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 123.327 0.651 . . . . 41.01 110.995 176.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.52 139.79 60.27 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.89 2.393 . . . . 71.42 111.372 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.56 110.34 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.786 0.803 . . . . 74.32 109.56 177.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.459 ' HB3' ' HB3' ' B' ' 135' ' ' ALA . 6.5 m120 -92.0 83.97 5.25 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.249 -0.887 . . . . 73.12 109.27 175.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -58.79 -42.41 88.99 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.766 -0.827 . . . . 73.4 108.766 172.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.447 ' N ' ' HB1' ' B' ' 100' ' ' ALA . 6.4 p-10 -57.6 -53.83 53.68 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 113.909 -1.496 . . . . 75.13 112.264 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' B' ' 132' ' ' ASN . . . -65.71 -37.19 85.74 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.568 0.747 . . . . 61.15 112.122 -175.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.21 -46.99 63.4 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.329 0.652 . . . . 74.11 111.264 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -72.47 -23.07 60.99 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.828 0.451 . . . . 55.21 111.304 178.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -70.27 -38.57 75.13 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.391 0.676 . . . . 74.24 109.491 175.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -76.43 -14.48 60.06 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.922 -1.036 . . . . 72.45 111.278 -172.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -64.78 -30.91 71.94 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.93 0.892 . . . . 72.14 111.142 173.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 62.4 mt -82.42 8.87 10.31 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.565 0.746 . . . . 71.11 112.207 -174.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.33 111.16 10.31 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.33 -0.989 . . . . 52.43 108.33 175.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -128.6 160.41 32.49 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.017 0.927 . . . . 74.34 110.23 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -167.18 152.24 7.31 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.083 0.953 . . . . 65.52 109.167 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -142.64 146.55 34.6 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.692 0.797 . . . . 50.54 109.893 177.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.94 -157.51 31.91 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 123.665 0.603 . . . . 61.55 113.149 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -161.89 128.09 3.68 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.49 0.716 . . . . 54.43 109.223 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -148.98 128.6 2.82 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 110.668 -0.973 . . . . 63.33 110.668 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 79.6 p -117.35 103.97 10.67 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.124 0.569 . . . . 70.35 110.131 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -94.29 126.84 39.79 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 107.935 -1.135 . . . . 72.1 107.935 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -141.33 143.73 34.19 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.337 0.655 . . . . 64.31 110.372 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -154.5 138.75 16.61 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.536 1.134 . . . . 65.34 108.655 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -80.56 73.91 7.48 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.749 0.785 . . . . 51.1 111.019 -176.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -77.61 96.91 4.92 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.089 -0.708 . . . . 75.13 109.089 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.9 0 C-N-CA 124.495 1.118 . . . . 51.32 108.369 -179.482 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 86.0 mtp . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.822 -0.436 . . . . 75.0 109.822 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 48.0 m -124.24 -64.52 1.12 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.81 -0.811 . . . . 74.25 108.81 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 71.06 -56.2 0.63 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.742 1.617 . . . . 71.12 111.339 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 14.1 tp60 -65.86 153.76 41.07 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 124.496 1.119 . . . . 75.11 109.728 169.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 13.7 m120 73.83 170.31 0.3 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 125.194 1.398 . . . . 44.31 111.13 -172.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 4.1 t30 62.48 41.86 9.36 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.52 1.128 . . . . 73.51 109.651 -173.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 17.7 m -62.98 -46.51 87.34 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.411 -1.268 . . . . 75.3 110.959 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -75.29 122.98 24.53 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.468 -0.787 . . . . 71.41 109.053 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.498 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 0.0 OUTLIER 64.9 114.16 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.937 1.295 . . . . 70.1 110.96 -176.412 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 30.0 m -98.75 109.17 21.97 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.703 -0.851 . . . . 72.1 108.703 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.498 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 0.3 OUTLIER -120.15 123.6 43.72 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.83 -0.804 . . . . 51.4 108.83 -177.453 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -138.31 118.08 13.19 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.248 -1.019 . . . . 60.51 108.248 174.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.628 HG13 ' HD3' ' A' ' 130' ' ' PRO . 75.8 mt -67.95 122.4 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.844 -0.798 . . . . 71.53 108.844 173.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -86.13 -45.63 11.18 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 124.079 0.862 . . . . 72.11 109.481 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -179.4 124.79 0.08 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.293 -0.867 . . . . 74.42 109.414 -170.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.487 HD11 HD13 ' C' ' 13' ' ' ILE . 30.1 mt -116.28 150.55 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 108.06 -1.089 . . . . 72.52 108.06 173.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.438 ' HE2' ' HD2' ' C' ' 19' ' ' LYS . 22.8 p90 -174.49 171.54 3.32 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.057 0.943 . . . . 72.13 109.765 -173.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -90.85 118.31 30.16 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.612 -0.884 . . . . 64.13 108.612 174.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.683 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 10.0 mmmm -69.64 -45.78 67.68 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 122.102 0.953 . . . . 65.35 108.469 171.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.668 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 12.0 t70 -146.0 147.16 31.37 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 113.71 -1.587 . . . . 73.21 109.771 -169.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 63.5 mt -142.9 150.48 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.459 1.503 . . . . 71.25 107.456 177.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -160.57 151.91 19.29 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.389 0.614 . . . . 65.15 110.428 175.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -153.78 109.18 3.19 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.975 -1.12 . . . . 71.51 107.975 171.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -117.09 110.42 18.18 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.214 0.605 . . . . 73.1 110.028 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.56 87.39 25.62 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 106.619 -1.623 . . . . 54.31 106.619 167.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.42 -29.92 19.97 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.37 2.046 . . . . 74.03 111.531 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -91.93 12.57 21.25 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.568 1.147 . . . . 64.55 111.112 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.54 -58.59 12.28 Favored Pre-proline 0 CA--C 1.562 1.442 0 N-CA-C 114.031 1.123 . . . . 74.2 114.031 -166.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -57.85 -39.9 83.08 Favored 'Trans proline' 0 C--N 1.397 3.09 0 C-N-CA 122.182 1.921 . . . . 72.55 112.414 -174.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.415 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.3 t60 -69.38 -45.75 68.58 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.449 -1.25 . . . . 74.51 111.688 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.69 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.9 p -73.72 -20.89 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 N-CA-C 113.131 0.789 . . . . 64.11 113.131 -165.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -62.15 -25.61 67.85 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 113.99 1.107 . . . . 73.44 113.99 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 20.1 pt20 -98.07 16.89 19.76 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.508 0.723 . . . . 55.52 111.259 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.818 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -94.59 157.13 16.12 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.94 0.896 . . . . 71.33 109.461 173.104 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -67.13 123.24 19.71 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.295 0.638 . . . . 72.41 109.508 166.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -79.14 99.02 6.79 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.765 0.826 . . . . 73.53 110.434 -175.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -151.69 71.31 8.12 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 108.468 -0.938 . . . . 74.24 108.468 176.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -87.41 153.46 7.88 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.916 2.411 . . . . 44.53 112.21 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -89.94 112.33 23.68 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.551 -1.278 . . . . 74.12 107.551 168.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 40.2 t -72.74 102.3 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 109.147 -0.686 . . . . 51.44 109.147 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.512 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 54.0 mmtt -93.24 113.11 25.23 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.193 0.997 . . . . 74.41 109.33 175.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.428 HD23 HD23 ' G' ' 8' ' ' LEU . 4.2 mp -96.43 123.96 40.27 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.07 -1.085 . . . . 71.52 108.07 176.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -131.87 106.87 8.35 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.971 0.909 . . . . 72.52 109.004 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.426 HD21 HD22 ' G' ' 8' ' ' LEU . 5.9 mp -108.35 123.17 48.4 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.258 -0.645 . . . . 74.04 109.258 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.455 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 15.5 t70 -112.58 147.79 35.9 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.132 1.373 . . . . 72.33 107.941 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 57.5 p -114.45 126.32 54.83 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.099 0.56 . . . . 75.32 110.904 -170.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.33 151.95 51.9 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.424 1.089 . . . . 53.31 108.494 175.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 6.4 p -163.29 163.43 25.3 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.73 0.412 . . . . 71.45 110.015 -176.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 25.8 t -165.55 133.66 3.08 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.996 0.518 . . . . 70.42 110.25 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -82.24 139.02 34.48 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.038 0.535 . . . . 53.43 109.563 173.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.599 HD11 HD12 ' C' ' 83' ' ' ILE . 84.1 mt -110.46 -41.8 4.26 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.486 0.714 . . . . 62.13 110.039 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.4 -174.36 4.91 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.56 -0.746 . . . . 71.12 110.642 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -68.93 126.22 29.11 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.747 -1.115 . . . . 73.53 108.488 172.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 67.28 6.52 4.89 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.737 1.215 . . . . 73.33 112.561 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 80.9 t -122.5 115.3 45.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 108.171 -1.048 . . . . 63.24 108.171 177.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -137.25 130.13 30.46 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.515 -0.766 . . . . 72.13 109.282 -173.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -92.35 127.26 37.77 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.214 -0.903 . . . . 74.51 109.605 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.477 HG23 HD11 ' C' ' 106' ' ' LEU . 26.9 m -111.87 136.99 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 108.141 -1.059 . . . . 75.33 108.141 166.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -126.66 121.23 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.436 1.094 . . . . 55.31 108.928 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.468 HD22 ' HB3' ' C' ' 103' ' ' PRO . 47.9 tp -111.95 113.8 26.33 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.4 -0.592 . . . . 74.44 109.4 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.455 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 34.5 ttm180 -82.92 107.69 15.71 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 108.856 -0.794 . . . . 72.53 108.856 173.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.445 ' HB ' HD11 ' C' ' 114' ' ' ILE . 6.6 t -99.5 121.34 50.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.053 -1.092 . . . . 71.23 108.053 171.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 72.0 m -112.7 128.21 56.34 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.404 -1.332 . . . . 60.32 107.404 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.544 HG23 HD13 ' C' ' 114' ' ' ILE . 99.5 t -116.03 115.18 48.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.626 -0.879 . . . . 70.03 108.626 172.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 4.4 m -100.78 139.27 36.7 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.73 -0.841 . . . . 71.44 108.73 175.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.33 113.1 15.18 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.577 -1.268 . . . . 75.43 107.577 176.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -136.18 131.44 34.64 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.032 -0.729 . . . . 74.55 109.032 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.818 HD13 ' HG2' ' C' ' 34' ' ' LYS . 3.5 mt -87.13 35.93 0.72 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.575 1.55 . . . . 73.14 110.037 -177.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.02 -117.31 4.9 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 109.682 -1.367 . . . . 74.32 109.682 -164.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -89.93 -20.43 23.36 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.611 0.764 . . . . 71.21 111.221 176.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -78.5 103.2 8.29 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.788 -0.819 . . . . 75.3 108.788 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 37.2 m -72.76 123.49 23.43 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.485 -0.561 . . . . 61.14 109.485 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.69 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.43 -56.03 5.1 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.422 -0.808 . . . . 72.13 109.017 174.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -159.66 168.18 26.63 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 122.223 1.011 . . . . 74.55 112.146 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -130.01 130.75 45.37 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 105.386 -2.079 . . . . 73.04 105.386 167.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.431 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 44.6 t -128.75 138.23 52.0 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.228 -1.397 . . . . 65.41 107.228 174.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.16 118.77 5.29 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.979 -0.378 . . . . 71.13 109.979 -172.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' C' ' 61' ' ' ARG . 95.6 t -128.74 136.85 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.564 0.746 . . . . 75.53 109.105 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.668 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 26.4 mt-30 -109.33 97.17 6.81 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.55 -0.908 . . . . 63.4 108.55 169.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -84.85 116.91 23.57 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.351 -0.84 . . . . 54.42 109.136 178.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.6 145.79 16.87 Favored Glycine 0 C--N 1.343 0.921 0 N-CA-C 111.742 -0.543 . . . . 72.32 111.742 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.39 121.3 1.75 Allowed Glycine 0 CA--C 1.507 -0.433 0 N-CA-C 111.751 -0.54 . . . . 34.15 111.751 -176.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.599 HD12 HD11 ' C' ' 51' ' ' LEU . 9.5 mm -82.55 118.94 31.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 108.054 -1.091 . . . . 61.15 108.054 174.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -133.71 123.79 25.56 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.393 0.677 . . . . 64.31 109.987 -172.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 70.2 m -71.17 108.17 4.55 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.787 -0.82 . . . . 43.05 108.787 167.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 78.2 mt -117.7 119.74 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.462 1.105 . . . . 73.14 108.412 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.15 168.28 26.46 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.53 0.732 . . . . 61.31 110.442 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.72 -33.78 5.97 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 116.26 -0.427 . . . . 74.44 113.936 170.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 40.2 pt -117.67 163.4 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.493 0.717 . . . . 55.44 110.957 -176.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -146.15 158.04 43.86 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.511 0.724 . . . . 75.15 110.696 -175.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.08 -129.72 15.64 Favored Glycine 0 C--N 1.349 1.258 0 CA-C-N 115.784 -0.644 . . . . 73.33 113.48 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 75.5 p -66.02 -26.79 67.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.685 0.794 . . . . 73.31 111.534 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -62.49 -54.12 44.7 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.959 0.504 . . . . 55.14 110.028 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.504 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 7.6 ptt? -76.79 -23.79 52.86 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.896 -0.593 . . . . 64.45 111.099 -176.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.48 -37.18 77.14 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.377 0.608 . . . . 60.22 110.364 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -67.78 -33.21 74.39 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.643 -1.162 . . . . 72.54 110.442 173.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.564 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 43.9 t -68.86 -60.59 2.27 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.802 -0.635 . . . . 64.41 110.682 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.593 HD23 HG23 ' G' ' 18' ' ' VAL . 3.7 pp -69.42 -28.3 66.03 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.44 0.696 . . . . 72.33 112.411 -174.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . 0.416 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -94.57 -3.9 62.5 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-O 119.558 -0.579 . . . . 64.34 114.21 -172.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.58 -62.15 0.13 Allowed 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 117.496 0.648 . . . . 74.11 112.639 -172.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.564 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 54.7 t80 -66.41 -37.92 86.3 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 124.391 1.076 . . . . 64.23 113.106 -170.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 29.7 m -80.72 -42.64 1.26 Allowed Pre-proline 0 CA--C 1.564 1.511 0 C-N-CA 123.561 0.745 . . . . 63.31 111.034 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.468 ' HB3' HD22 ' C' ' 60' ' ' LEU . 89.0 Cg_exo -54.13 -24.21 32.36 Favored 'Trans proline' 0 C--N 1.398 3.151 0 C-N-CA 122.995 2.464 . . . . 72.55 114.617 166.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -67.77 -24.72 65.37 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.399 0.68 . . . . 73.21 111.792 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.647 HG23 ' NH1' ' A' ' 111' ' ' ARG . 31.7 mm -77.3 -35.17 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 109.24 -0.652 . . . . 64.2 109.24 173.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.477 HD11 HG23 ' C' ' 58' ' ' VAL . 82.0 mt -79.41 -24.9 42.24 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.671 -1.15 . . . . 72.32 111.818 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -57.11 -55.27 45.81 Favored Pre-proline 0 CA--C 1.557 1.226 0 CA-C-O 118.198 -0.906 . . . . 75.13 113.09 -173.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.43 ' HB2' ' HG3' ' A' ' 112' ' ' GLU . 57.5 Cg_endo -66.57 -23.33 49.93 Favored 'Trans proline' 0 C--N 1.387 2.6 0 CA-C-N 121.174 1.455 . . . . 63.1 112.342 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -75.51 -49.31 19.11 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.13 0.972 . . . . 74.42 110.15 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.68 -38.24 84.29 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.149 0.98 . . . . 43.43 110.07 174.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -58.48 -53.07 62.42 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.253 1.421 . . . . 73.04 110.753 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.47 -32.61 73.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 123.694 0.622 . . . . 73.42 110.278 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.6 t -68.8 -34.41 75.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.001 0.52 . . . . 75.02 111.006 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.544 HD13 HG23 ' C' ' 64' ' ' VAL . 95.5 mt -73.33 -51.93 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.666 0.786 . . . . 74.32 109.84 175.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.0 m -64.56 -28.9 69.96 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.844 0.858 . . . . 64.32 111.426 -175.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.3 t -67.77 -48.62 65.85 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.238 -0.653 . . . . 64.41 109.238 172.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.589 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.1 -38.66 87.09 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.512 1.125 . . . . 74.44 112.836 -179.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' C' ' 123' ' ' PHE . 82.2 t -62.12 -45.38 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.769 0.828 . . . . 62.44 109.668 175.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 44.8 t -68.2 -32.47 72.71 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.239 -0.891 . . . . 74.43 111.947 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -68.88 -31.61 70.66 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.537 0.735 . . . . 75.13 109.703 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.82 10.79 73.83 Favored Glycine 0 C--N 1.355 1.607 0 O-C-N 123.969 0.793 . . . . 73.22 112.998 173.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.507 HG23 ' HB3' ' D' ' 17' ' ' TYR . 43.2 p 60.19 29.48 19.04 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 126.151 1.78 . . . . 61.44 114.257 173.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.402 ' HB2' HG13 ' C' ' 118' ' ' VAL . 96.8 m-85 -96.03 147.0 32.31 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.494 -0.928 . . . . 75.21 108.494 171.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.649 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 80.6 Cg_exo -49.44 141.06 26.33 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.712 2.941 . . . . 75.51 114.421 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.524 ' HA ' HE21 ' C' ' 125' ' ' GLN . 0.0 OUTLIER -55.49 113.81 1.58 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.175 0.99 . . . . 73.23 111.354 -177.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 41.6 tp -107.78 92.81 4.22 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.601 -0.889 . . . . 73.53 108.601 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -93.03 114.71 27.33 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.197 -0.911 . . . . 45.05 108.976 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 tt -73.09 135.89 44.84 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.922 0.889 . . . . 75.4 110.252 -171.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.41 148.76 90.95 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 123.666 0.786 . . . . 63.3 111.997 -175.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.526 ' HG2' HG21 ' A' ' 13' ' ' ILE . 6.6 Cg_exo -70.86 116.57 4.73 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.145 2.563 . . . . 72.11 112.49 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.663 HG21 ' H ' ' G' ' 8' ' ' LEU . 90.5 t -126.96 110.58 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.784 -0.821 . . . . 75.15 108.784 173.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' C' ' 136' ' ' LEU . 12.9 m120 -71.97 104.69 3.61 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.281 1.032 . . . . 63.21 109.726 174.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -62.75 -44.63 95.71 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.283 0.563 . . . . 64.42 110.052 172.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -59.71 -43.82 93.98 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.372 -1.285 . . . . 72.52 111.184 -174.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.82 -48.77 35.11 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.521 -0.763 . . . . 71.41 110.302 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' C' ' 132' ' ' ASN . 5.7 tt -48.89 -59.94 3.17 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 124.537 1.135 . . . . 74.14 112.168 -171.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -58.23 -42.93 87.4 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 123.739 0.65 . . . . 73.4 112.127 -174.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 90.7 mtp -78.41 -32.59 48.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.877 0.471 . . . . 53.33 111.93 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -71.6 -35.35 70.48 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.503 0.721 . . . . 70.02 111.578 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -69.19 -151.71 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 124.387 1.075 . . . . 75.54 111.498 -171.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 77.2 mt 70.32 -69.87 0.16 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.691 1.196 . . . . 63.3 110.13 -174.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -80.07 87.33 5.45 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.736 -0.838 . . . . 73.32 108.736 170.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -74.95 103.72 5.27 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.427 0.691 . . . . 72.14 110.851 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -149.01 16.22 0.95 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.158 0.983 . . . . 74.45 108.733 170.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -78.31 92.84 4.57 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.695 0.798 . . . . 61.33 110.323 -176.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -177.92 -143.35 5.03 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 115.678 -0.692 . . . . 71.41 112.137 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 65.9 -168.09 0.21 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.1 1.36 . . . . 72.33 111.943 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 178.61 179.72 48.52 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 111.854 -0.499 . . . . 73.43 111.854 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 18.7 m -123.43 123.26 40.26 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 108.191 -1.04 . . . . 73.31 108.191 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -163.48 132.29 3.89 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 107.939 -1.134 . . . . 72.22 107.939 174.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -83.9 -74.09 0.39 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.891 0.876 . . . . 63.53 111.145 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -175.08 37.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.921 0.889 . . . . 74.24 110.116 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -69.19 136.68 52.43 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.546 0.738 . . . . 73.22 111.372 -175.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -166.16 -38.53 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.226 0.611 . . . . 73.34 110.932 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 C-N-CA 123.78 0.832 . . . . 72.33 109.413 -177.017 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . 0.519 ' SD ' ' N ' ' D' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 108.298 -1.001 . . . . 75.55 108.298 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 60.2 p -80.15 169.85 17.25 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.361 0.664 . . . . 74.11 109.712 169.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 54.94 51.32 13.77 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.44 1.114 . . . . 74.31 110.102 -175.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . 0.45 ' HA ' ' HG3' ' D' ' 90' ' ' GLU . 10.9 pt20 -81.97 -14.6 55.81 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 113.79 -1.55 . . . . 74.03 112.668 -172.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . 0.661 HD21 ' HB2' ' D' ' 8' ' ' GLU . 44.0 t-20 75.15 122.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 125.698 1.599 . . . . 64.02 111.063 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -132.89 15.44 4.29 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.999 0.92 . . . . 74.04 110.738 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 62.1 m -133.27 -57.15 0.91 Allowed 'General case' 0 N--CA 1.482 1.141 0 O-C-N 122.104 -0.373 . . . . 63.03 111.239 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.661 ' HB2' HD21 ' D' ' 5' ' ' ASN . 1.8 mp0 -77.32 -28.7 53.27 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.135 0.174 . . . . 71.1 110.709 -177.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.478 ' HE3' HD11 ' D' ' 89' ' ' ILE . 1.2 tmt? -30.23 125.55 0.16 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 126.121 1.768 . . . . 73.4 113.005 174.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 87.8 m -110.59 144.43 39.48 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.57 0.748 . . . . 74.3 110.929 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.497 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 31.3 t80 -159.12 89.13 0.91 Allowed 'General case' 0 C--O 1.238 0.45 0 N-CA-C 107.051 -1.463 . . . . 72.23 107.051 171.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -113.96 116.38 29.14 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.018 -1.104 . . . . 74.15 108.018 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.499 HG21 HD11 ' D' ' 16' ' ' ILE . 54.3 mt -72.09 122.95 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 109.588 -0.523 . . . . 70.04 109.588 -178.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -85.61 -42.91 13.92 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.994 0.809 . . . . 72.43 111.189 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -170.97 135.12 1.0 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 111.81 0.3 . . . . 73.43 111.81 -163.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.499 HD11 HG21 ' D' ' 13' ' ' ILE . 2.7 mp -115.76 134.58 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.609 -1.256 . . . . 73.01 107.609 170.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.507 ' HB3' HG23 ' C' ' 122' ' ' THR . 32.9 p90 -166.42 169.57 13.81 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 122.18 0.991 . . . . 71.21 111.394 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.5 p -103.03 120.33 40.46 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 113.567 -1.651 . . . . 72.52 108.534 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -89.96 -31.02 17.43 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.088 -0.708 . . . . 65.34 109.088 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -140.4 134.73 31.24 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 114.385 -1.28 . . . . 54.31 108.343 173.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.589 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.7 mt -128.18 145.08 35.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.021 -1.474 . . . . 63.13 107.021 168.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 30.9 t -147.25 140.89 25.61 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.9 0.88 . . . . 70.3 108.834 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.523 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.1 t80 -146.48 136.22 23.21 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 105.89 -1.892 . . . . 64.01 105.89 168.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.535 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 43.8 mt-10 -138.52 152.37 48.18 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.338 -1.356 . . . . 74.14 107.338 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.77 84.33 7.05 Favored Pre-proline 0 C--O 1.239 0.535 0 N-CA-C 107.307 -1.368 . . . . 72.3 107.307 172.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -66.57 -36.91 23.96 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.0 2.467 . . . . 65.32 113.025 -170.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.478 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 52.6 m-20 -101.35 6.84 42.85 Favored 'General case' 0 C--O 1.211 -0.973 0 CA-C-O 118.542 -0.742 . . . . 64.01 110.747 -177.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.683 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -26.08 -65.09 0.11 Allowed Pre-proline 0 N--CA 1.496 1.85 0 N-CA-C 116.621 2.082 . . . . 73.43 116.621 -162.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -78.85 -21.97 9.23 Favored 'Trans proline' 0 C--N 1.382 2.314 0 CA-C-N 122.878 2.063 . . . . 72.53 113.842 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -73.74 -37.16 65.16 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.88 1.272 . . . . 75.51 110.37 175.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.557 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.5 p -84.13 -18.93 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.066 0.546 . . . . 65.01 111.531 -174.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -65.45 -15.83 63.02 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 112.529 0.566 . . . . 73.04 112.529 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -58.65 -33.43 70.07 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.55 0.69 . . . . 53.14 110.03 173.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -89.28 93.39 9.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.126 -1.397 . . . . 73.54 109.373 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -102.43 91.64 4.34 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.17 0.509 . . . . 63.11 109.981 -177.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 35.6 p90 -158.28 174.0 15.82 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.949 1.3 . . . . 72.4 108.009 169.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.435 HE21 ' HD2' ' D' ' 38' ' ' PRO . 31.0 tp60 -65.43 112.91 9.6 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-O 118.938 -0.553 . . . . 42.33 109.565 178.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.435 ' HD2' HE21 ' D' ' 37' ' ' GLN . 49.9 Cg_exo -59.07 141.24 97.99 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.582 2.188 . . . . 53.02 112.713 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -59.42 118.19 5.71 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.607 0.763 . . . . 73.42 109.959 172.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.615 ' HB ' HG23 ' H' ' 5' ' ' THR . 59.0 t -97.21 106.94 19.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 123.219 0.608 . . . . 73.03 109.426 -175.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -95.69 127.92 42.12 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.097 -0.956 . . . . 71.12 108.648 173.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.458 ' HG ' ' H ' ' H' ' 7' ' ' ALA . 3.2 mm? -97.51 146.08 25.59 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.139 0.576 . . . . 71.54 109.602 -178.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -149.54 116.76 6.05 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.226 -1.027 . . . . 63.41 108.226 177.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.513 HD22 ' H ' ' H' ' 9' ' ' ALA . 6.6 mp -108.05 140.12 41.69 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.722 0.409 . . . . 70.12 110.926 -173.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.2 t70 -136.88 151.82 49.52 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.56 1.144 . . . . 51.44 108.595 173.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . 0.466 ' HB ' HD22 ' H' ' 11' ' ' LEU . 13.0 t -116.85 150.3 38.64 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.149 0.579 . . . . 73.12 110.839 -172.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.593 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.05 155.09 28.67 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.991 0.917 . . . . 63.54 109.229 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 13.4 p -167.09 162.12 15.16 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.697 0.399 . . . . 63.02 111.323 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 3.0 m -153.38 144.8 23.2 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.243 1.017 . . . . 61.12 108.669 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -97.92 116.49 30.23 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.152 -1.055 . . . . 60.23 108.152 165.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 24.6 mt -95.51 -40.58 9.38 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.044 0.538 . . . . 54.23 110.455 -172.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.584 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -146.11 -176.56 5.2 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.077 -0.965 . . . . 72.34 109.908 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -68.4 105.92 2.34 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.387 0.675 . . . . 73.31 109.652 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 62.85 18.55 10.85 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.759 1.224 . . . . 74.41 112.128 -177.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.584 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 57.3 t -109.23 104.83 17.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 107.353 -1.351 . . . . 52.3 107.353 171.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -119.6 131.33 55.46 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.96 -1.473 . . . . 71.2 109.686 -164.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -98.58 132.23 44.15 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.947 -0.57 . . . . 75.15 109.868 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 75.4 t -115.46 118.86 60.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 107.582 -1.266 . . . . 61.13 107.582 175.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 24.9 t -117.96 129.53 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.574 0.75 . . . . 71.12 109.276 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -122.74 129.47 51.8 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 110.328 -0.249 . . . . 74.11 110.328 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.606 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 14.3 ttm-85 -86.44 100.05 12.07 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.82 -0.807 . . . . 74.41 108.82 172.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 99.1 t -90.41 116.84 32.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.048 -1.093 . . . . 55.13 108.048 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 17.6 m -123.34 126.29 46.57 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.339 0.59 . . . . 71.43 109.671 -172.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.538 HG13 HG13 ' D' ' 40' ' ' VAL . 40.6 t -117.33 100.36 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.742 1.617 . . . . 50.22 107.977 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 60.7 m -93.53 94.26 8.55 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.832 -1.076 . . . . 71.0 108.157 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.16 143.77 28.33 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.712 -0.677 . . . . 65.22 110.456 -174.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.481 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 54.2 p -144.6 135.35 24.78 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 115.735 -0.666 . . . . 63.01 110.429 -177.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.465 HD12 HG22 ' D' ' 31' ' ' VAL . 39.0 mt -98.24 100.0 11.26 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.642 0.777 . . . . 74.44 109.052 172.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.01 -115.06 4.53 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.025 -0.989 . . . . 71.22 112.487 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -102.69 5.64 39.12 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.715 0.806 . . . . 54.34 112.15 -176.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -131.7 155.79 47.03 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.81 -0.441 . . . . 73.41 109.81 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 71.8 m -65.67 136.17 55.95 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 123.784 0.677 . . . . 73.51 110.977 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.557 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.6 -64.07 1.19 Allowed 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.577 -1.268 . . . . 74.41 107.577 174.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -155.94 152.14 27.86 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.382 -1.281 . . . . 73.33 110.194 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.535 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 78.3 mt -118.5 111.91 19.24 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.319 -0.993 . . . . 72.12 108.319 177.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.538 ' SG ' HG12 ' D' ' 114' ' ' ILE . 44.8 t -116.06 138.79 50.92 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.765 -0.828 . . . . 71.25 108.765 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -155.31 122.32 5.45 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.579 0.352 . . . . 73.3 110.258 -178.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.17 123.89 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.153 0.581 . . . . 72.32 109.957 -175.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -87.3 88.41 7.68 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.17 -1.048 . . . . 63.22 108.17 165.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -80.41 99.76 8.13 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.646 -1.242 . . . . 74.21 107.646 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.63 142.38 15.8 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.448 -0.661 . . . . 33.22 111.448 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.446 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -136.7 131.96 5.85 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.19 -0.764 . . . . 64.45 111.19 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 43.8 mt -90.77 124.78 43.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 108.088 -1.079 . . . . 54.31 108.088 176.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -132.99 123.65 26.27 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.762 0.825 . . . . 74.43 109.483 -174.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.9 m -84.25 97.76 9.59 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.97 -0.752 . . . . 64.31 108.97 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.582 HD11 HD12 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -120.66 130.81 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.771 0.828 . . . . 75.23 109.724 -174.073 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.26 164.91 36.44 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.785 0.834 . . . . 73.45 110.76 -176.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.67 -10.55 71.67 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.725 -0.671 . . . . 53.24 114.15 173.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.582 HD12 HD11 ' D' ' 86' ' ' ILE . 34.4 mt -94.5 145.08 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.63 0.772 . . . . 71.21 109.81 -174.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.45 ' HG3' ' HA ' ' D' ' 4' ' ' GLN . 0.0 OUTLIER -132.7 166.48 22.1 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.666 0.786 . . . . 65.34 110.62 178.728 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.65 -136.6 41.71 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 114.951 -1.022 . . . . 74.14 114.902 169.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 16.4 m -77.47 -18.33 57.23 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.361 1.065 . . . . 72.11 111.565 -173.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.406 ' OE1' ' HB2' ' D' ' 4' ' ' GLN . 51.3 tt0 -66.16 -24.84 66.73 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.826 0.45 . . . . 52.34 110.723 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 63.3 mtt -60.02 -43.91 94.97 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.967 0.507 . . . . 71.43 110.167 173.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.55 -26.41 67.12 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.399 -0.819 . . . . 73.24 111.53 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -85.26 -34.52 21.94 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.251 0.62 . . . . 71.21 111.111 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . 0.564 ' SG ' HG13 ' D' ' 86' ' ' ILE . 42.6 t -72.43 -52.44 15.92 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.265 0.555 . . . . 70.23 109.747 -175.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 26.2 mt -80.95 -29.57 35.4 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.523 -1.217 . . . . 73.41 110.24 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . 0.675 ' HA2' ' HE1' ' H' ' 15' ' ' PHE . . . -93.4 -17.89 40.89 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 114.968 0.747 . . . . 35.52 114.968 -171.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.561 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -132.65 -50.22 0.91 Allowed 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 117.788 0.794 . . . . 70.44 111.602 -174.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -73.94 -42.24 60.85 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 122.809 0.444 . . . . 74.2 112.043 -174.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.497 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 69.4 m -67.77 -47.31 44.28 Favored Pre-proline 0 CA--C 1.567 1.609 0 C-N-CA 123.161 0.585 . . . . 54.22 111.76 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 51.4 Cg_exo -59.75 -28.57 87.6 Favored 'Trans proline' 0 C--N 1.401 3.327 0 C-N-CA 122.597 2.198 . . . . 62.31 113.385 170.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -64.25 -40.93 97.02 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.95 0.9 . . . . 74.45 110.05 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 48.0 mm -61.73 -42.19 93.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 123.447 0.699 . . . . 74.33 110.193 173.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.446 HD21 ' HA3' ' D' ' 82' ' ' GLY . 96.1 mt -82.99 -13.37 56.09 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.975 -1.011 . . . . 61.41 112.49 -172.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -64.65 -48.15 74.35 Favored Pre-proline 0 N--CA 1.49 1.546 0 C-N-CA 123.929 0.892 . . . . 74.33 112.775 -176.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.52 -36.89 96.82 Favored 'Trans proline' 0 C--N 1.391 2.791 0 C-N-CA 122.201 1.934 . . . . 72.33 113.164 175.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -73.98 -36.08 64.53 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.893 0.877 . . . . 72.45 112.135 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.47 -49.65 72.79 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.209 -0.664 . . . . 61.53 109.209 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -55.1 -48.53 73.46 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 124.933 1.396 . . . . 72.03 110.781 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -61.81 -50.97 70.17 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 123.794 0.684 . . . . 73.11 111.365 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 38.9 t -55.43 -45.58 76.78 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 123.944 0.777 . . . . 53.14 111.039 -177.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.538 HG12 ' SG ' ' D' ' 76' ' ' CYS . 98.8 mt -59.31 -58.2 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.366 1.066 . . . . 70.01 110.817 174.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 60.7 m -54.19 -43.24 70.53 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.596 1.158 . . . . 64.21 112.16 -173.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -66.75 -40.32 88.25 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.026 -0.988 . . . . 45.31 110.045 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.1 mtm -70.28 -29.79 66.64 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.947 0.499 . . . . 73.51 111.616 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.467 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.0 t -64.99 -45.42 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.503 0.721 . . . . 75.13 110.178 175.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -74.33 -30.14 61.91 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.838 -0.619 . . . . 63.22 111.067 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 59.0 mtt-85 -69.83 -34.11 73.22 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.529 0.731 . . . . 75.21 109.867 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.12 -0.82 90.04 Favored Glycine 0 C--N 1.355 1.628 0 O-C-N 123.65 0.594 . . . . 62.5 112.388 173.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 31.1 p 64.21 23.18 13.06 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 126.952 2.101 . . . . 64.32 113.698 174.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -85.27 155.41 60.18 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.537 0.735 . . . . 74.22 110.055 171.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -53.2 125.63 19.0 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.182 2.588 . . . . 65.43 112.643 173.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -50.93 142.77 11.24 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.38 1.472 . . . . 75.43 112.864 -174.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.481 HD13 HG21 ' D' ' 40' ' ' VAL . 43.4 tp -114.35 125.07 53.45 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.613 0.765 . . . . 72.43 109.183 177.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -119.88 100.22 7.1 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.519 -0.919 . . . . 74.22 108.519 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.507 HD23 HD12 ' H' ' 6' ' ' ILE . 76.4 mt -61.55 114.84 3.48 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.289 -0.634 . . . . 73.41 109.289 174.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.479 ' H ' HG21 ' H' ' 6' ' ' ILE . . . -57.02 145.22 65.92 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 124.19 0.996 . . . . 72.42 111.979 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.424 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 39.3 Cg_endo -72.33 97.2 0.84 Allowed 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 122.131 1.887 . . . . 61.22 110.343 177.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 19.7 m -108.84 142.83 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 114.567 -1.197 . . . . 54.45 109.513 -175.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -76.66 96.48 4.19 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.243 0.617 . . . . 73.23 110.165 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -63.94 -40.06 95.58 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.961 -1.018 . . . . 74.13 109.663 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.561 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 7.1 m-20 -55.12 -45.34 75.54 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.325 1.05 . . . . 73.33 112.621 -176.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.94 -47.07 55.0 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.762 0.425 . . . . 73.52 111.412 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.99 -48.92 77.29 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.915 0.76 . . . . 62.14 110.112 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.598 ' HE1' ' H ' ' H' ' 11' ' ' LEU . 30.4 t80 -73.84 -28.01 61.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.648 0.779 . . . . 74.15 111.741 -177.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' D' ' 134' ' ' ASP . 28.7 ttm -60.67 -17.24 46.5 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.694 0.797 . . . . 64.44 111.604 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.424 ' HA ' ' NE2' ' D' ' 142' ' ' GLN . 66.2 t30 -66.24 -33.28 75.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.833 0.853 . . . . 63.02 110.997 174.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -71.47 -31.78 67.54 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.513 0.725 . . . . 74.51 110.918 175.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 mp -82.63 -31.54 28.75 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.733 0.813 . . . . 72.05 112.942 -176.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.424 ' NE2' ' HA ' ' D' ' 139' ' ' ASN . 10.6 pt20 -75.05 4.43 6.73 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 112.991 0.737 . . . . 75.11 112.991 -173.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -121.46 44.94 2.41 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.977 0.911 . . . . 75.51 108.983 175.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -141.72 126.64 18.24 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.673 0.789 . . . . 73.1 108.948 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.75 -36.69 62.61 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.08 0.552 . . . . 70.45 110.068 172.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 107.73 -51.4 0.72 Allowed Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.079 -0.964 . . . . 74.13 111.11 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -81.87 175.59 10.28 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.562 0.745 . . . . 74.44 110.786 175.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 153.73 -139.33 6.78 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 110.844 -0.902 . . . . 75.14 110.844 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 88.3 m -132.56 117.82 18.45 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.828 -0.805 . . . . 60.25 108.828 173.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -133.44 160.2 38.1 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.796 0.838 . . . . 62.35 110.116 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -156.4 89.29 1.11 Allowed 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.105 -1.443 . . . . 51.31 107.105 170.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -88.38 127.9 35.5 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.322 0.649 . . . . 73.42 110.15 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -65.22 94.95 0.17 Allowed 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.735 1.272 . . . . 63.44 109.774 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.04 154.98 40.23 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.148 0.579 . . . . 75.51 110.265 176.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.249 0 CA-C-O 119.059 -0.496 . . . . 54.21 110.42 -178.079 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 61.3 mtt . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 120.83 0.347 . . . . 72.32 111.259 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' E' E ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.84 155.06 43.99 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.715 0.806 . . . . 72.43 108.968 169.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 3' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -122.92 90.53 3.31 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.589 0.756 . . . . 63.21 109.41 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 4' ' ' SER . . . . . . . . . . . . . 30.8 m -72.97 102.87 3.59 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.693 0.797 . . . . 60.24 109.42 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 5' ' ' THR . . . . . . . . . . . . . 26.6 m -57.74 -63.55 1.2 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.05 0.94 . . . . 72.43 111.741 -172.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.609 HD11 ' HB3' ' A' ' 42' ' ' LEU . 7.2 tt -162.88 -74.41 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 C-N-CA 123.246 0.618 . . . . 63.52 110.238 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 7' ' ' ALA . . . . . 0.576 ' H ' HG23 ' E' ' 6' ' ' ILE . . . 63.32 127.05 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 125.313 1.445 . . . . 63.04 113.289 -177.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.55 ' HB3' HD11 ' A' ' 44' ' ' LEU . 80.5 mt -73.74 161.29 30.39 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.748 0.819 . . . . 63.43 110.749 175.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.63 170.13 8.17 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.685 0.794 . . . . 70.44 110.901 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 10' ' ' LEU . . . . . . . . . . . . . 91.2 mt -76.42 151.21 36.6 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.981 -0.554 . . . . 54.12 110.162 174.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . 0.609 HD12 ' HB2' ' E' ' 13' ' ' LEU . 1.1 pt? -137.2 140.28 30.56 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.69 0.796 . . . . 74.35 109.751 -174.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 12' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.73 -6.34 18.06 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.153 2.568 . . . . 64.12 112.578 175.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . 0.609 ' HB2' HD12 ' E' ' 11' ' ' LEU . 85.0 mt -72.41 108.2 5.38 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.604 0.762 . . . . 72.42 110.097 178.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . 0.443 ' HB2' ' HG3' ' E' ' 17' ' ' PRO . 83.2 mt -71.19 116.61 11.7 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.88 -0.785 . . . . 34.33 108.88 174.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -58.28 -45.33 88.12 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.433 1.093 . . . . 75.44 111.698 -170.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 16' ' ' THR . . . . . . . . . . . . . 92.1 m -146.99 104.82 3.86 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 107.653 -1.24 . . . . 44.42 107.653 164.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 17' ' ' PRO . . . . . 0.443 ' HG3' ' HB2' ' E' ' 14' ' ' LEU . 6.0 Cg_exo -75.43 79.12 2.84 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 123.053 2.502 . . . . 70.01 111.875 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.2 102.64 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 107.833 -1.173 . . . . 74.11 107.833 173.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 19' ' ' THR . . . . . . . . . . . . . 7.3 m 67.65 7.03 5.37 Favored 'General case' 0 CA--C 1.57 1.743 0 C-N-CA 124.972 1.309 . . . . 62.14 111.849 -178.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 20' ' ' LYS . . . . . . . . . . . . . 56.9 mttp 49.17 57.56 6.34 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.726 1.21 . . . . 73.42 110.805 -169.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 91' ' ' GLY . . . -52.42 -46.73 66.48 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.878 0.871 . . . . 33.31 110.985 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 22' ' ' ARG . . . . . 0.418 ' HA ' ' HE ' ' E' ' 22' ' ' ARG . 0.9 OUTLIER -92.67 94.15 8.86 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.299 -0.864 . . . . 72.31 108.975 168.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 14.6 t -85.61 156.07 59.0 Favored Pre-proline 0 CA--C 1.558 1.268 0 N-CA-C 108.902 -0.777 . . . . 72.42 108.902 172.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 24' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -65.29 66.09 0.33 Allowed 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.755 2.303 . . . . 72.43 113.245 168.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 . . . . . 0 CA--C 1.552 1.051 0 N-CA-C 105.859 -1.904 . . . . 74.45 105.859 -178.879 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 109.571 -0.529 . . . . 73.2 109.571 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 2' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -178.94 123.19 0.09 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.275 1.03 . . . . 64.22 108.869 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 3' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -107.58 -79.39 0.58 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.567 0.747 . . . . 64.52 109.477 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 4' ' ' SER . . . . . . . . . . . . . 22.7 m 60.36 -172.81 0.13 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.482 1.113 . . . . 75.32 112.251 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 5' ' ' THR . . . . . . . . . . . . . 47.5 m -146.22 142.05 28.0 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.499 0.72 . . . . 71.23 109.378 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 44.4 pt -66.37 128.82 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.887 0.875 . . . . 52.23 110.796 177.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 7' ' ' ALA . . . . . 0.403 ' HA ' ' HB3' ' B' ' 129' ' ' ALA . . . -103.77 144.41 31.51 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.47 0.708 . . . . 74.34 110.175 -178.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . 0.447 HD11 HD21 ' B' ' 44' ' ' LEU . 1.1 tt -83.84 135.68 34.42 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.363 0.665 . . . . 74.43 109.359 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.37 157.01 29.22 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.56 0.744 . . . . 63.12 111.056 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 10' ' ' LEU . . . . . . . . . . . . . 95.5 mt -71.26 148.25 47.38 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.341 0.656 . . . . 71.34 111.1 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.456 HD21 ' HB2' ' B' ' 44' ' ' LEU . 96.0 mt -79.8 112.82 32.68 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.746 0.819 . . . . 75.1 110.042 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 12' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -72.28 -21.88 22.73 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.139 2.559 . . . . 73.5 111.615 176.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 13' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.04 124.81 52.91 Favored 'General case' 0 C--N 1.347 0.465 0 N-CA-C 107.591 -1.263 . . . . 73.34 107.591 170.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 92.3 mt -73.09 -174.81 1.63 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.26 0.624 . . . . 72.24 110.74 174.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -74.53 163.24 27.98 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.661 0.384 . . . . 62.51 110.94 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 16' ' ' THR . . . . . . . . . . . . . 23.9 m -51.06 120.83 14.6 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.397 1.079 . . . . 72.02 110.951 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.38 111.41 0.71 Allowed 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.077 2.518 . . . . 71.34 111.728 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.06 -51.62 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.037 0.935 . . . . 74.23 110.385 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 19' ' ' THR . . . . . . . . . . . . . 54.9 p 70.58 -43.3 0.55 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 127.226 2.21 . . . . 72.24 112.963 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 20' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -87.92 79.32 8.09 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.553 -1.277 . . . . 74.43 107.553 169.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' B' ' 90' ' ' GLU . . . -157.7 88.75 0.99 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.451 -0.795 . . . . 61.15 109.029 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -169.4 135.76 1.64 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.793 1.237 . . . . 74.5 108.217 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 23' ' ' THR . . . . . . . . . . . . . 17.5 p -106.6 93.82 9.15 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 123.448 0.699 . . . . 71.22 110.251 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 24' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.93 -173.53 1.8 Allowed 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.749 2.299 . . . . 75.21 111.639 175.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 . . . . . 0 CA--C 1.555 1.161 0 C-N-CA 124.397 1.079 . . . . 72.1 111.205 -178.692 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 42.0 ttm . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 109.667 -0.494 . . . . 73.41 109.667 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' G' G ' 2' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -145.1 130.54 18.75 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.415 -0.957 . . . . 75.04 108.415 174.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 3' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -78.13 154.39 31.28 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.154 0.582 . . . . 72.0 111.778 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 4' ' ' SER . . . . . . . . . . . . . 30.5 p -122.78 110.23 15.2 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.999 -1.111 . . . . 74.51 107.999 168.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 5' ' ' THR . . . . . . . . . . . . . 5.4 t -62.31 -39.05 91.74 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.934 0.894 . . . . 63.32 112.102 -177.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . . . . . . . . . 63.4 mt -116.58 135.08 58.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.778 0.831 . . . . 64.21 108.817 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.62 132.29 23.95 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.728 0.811 . . . . 62.43 109.85 177.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 8' ' ' LEU . . . . . 0.663 ' H ' HG21 ' C' ' 131' ' ' VAL . 88.1 mt -72.79 141.42 48.07 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.268 1.027 . . . . 74.14 110.555 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.42 132.68 45.14 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.627 0.771 . . . . 51.02 110.569 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 10' ' ' LEU . . . . . . . . . . . . . 8.5 mp -59.01 118.95 6.39 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 108.592 -0.892 . . . . 70.13 108.592 171.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 90.0 mt -56.69 111.04 2.81 Favored Pre-proline 0 CA--C 1.554 1.115 0 O-C-N 124.577 1.173 . . . . 63.41 111.75 -174.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 12' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -65.14 -29.35 56.15 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 123.059 2.506 . . . . 62.0 111.64 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 61.1 tp -125.41 129.4 49.79 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 106.927 -1.509 . . . . 75.24 106.927 171.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.03 -175.11 5.42 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.753 -0.462 . . . . 72.2 109.753 171.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . 0.415 ' HB2' HD13 ' C' ' 98' ' ' LEU . 10.7 m-85 -79.0 154.8 29.22 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.302 -0.629 . . . . 75.44 109.302 176.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 16' ' ' THR . . . . . . . . . . . . . 76.2 p -75.47 150.23 84.57 Favored Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 122.93 0.492 . . . . 63.13 110.716 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 17' ' ' PRO . . . . . 0.633 ' HB3' ' H ' ' G' ' 21' ' ' ALA . 70.9 Cg_exo -52.18 143.56 41.72 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.777 2.985 . . . . 75.44 115.137 -177.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 18' ' ' VAL . . . . . 0.593 HG23 HD23 ' C' ' 98' ' ' LEU . 46.9 t -70.08 -68.02 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 108.401 -0.963 . . . . 61.3 108.401 168.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 19' ' ' THR . . . . . 0.47 ' H ' ' HE1' ' C' ' 94' ' ' MET . 17.0 p -99.4 -89.44 0.32 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.266 1.027 . . . . 72.33 109.421 170.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 20' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -137.31 85.71 2.14 Favored 'General case' 0 C--N 1.366 1.322 0 CA-C-N 118.671 0.669 . . . . 72.32 110.844 -175.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . 0.633 ' H ' ' HB3' ' G' ' 17' ' ' PRO . . . -92.95 -7.4 46.09 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.992 0.517 . . . . 73.5 109.933 171.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 22' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -89.2 124.16 34.1 Favored 'General case' 0 C--N 1.35 0.615 0 C-N-CA 123.29 0.636 . . . . 74.11 110.62 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 23' ' ' THR . . . . . . . . . . . . . 6.3 t -77.62 137.63 63.0 Favored Pre-proline 0 CA--C 1.551 1.012 0 CA-C-N 115.237 -0.892 . . . . 63.34 109.91 169.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 24' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -62.18 -26.13 77.54 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.732 2.288 . . . . 61.24 112.527 172.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 CA--C 1.563 1.458 0 C-N-CA 124.963 1.305 . . . . 72.41 110.304 176.655 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 110.665 -0.124 . . . . 75.31 110.665 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 2' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -156.52 110.82 2.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.507 0.723 . . . . 71.25 109.154 171.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 3' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -78.14 178.74 7.33 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.872 0.869 . . . . 72.22 110.711 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 4' ' ' SER . . . . . . . . . . . . . 27.1 m 73.04 133.4 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.969 1.307 . . . . 71.42 110.948 -173.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 5' ' ' THR . . . . . 0.615 HG23 ' HB ' ' D' ' 40' ' ' VAL . 32.1 m -75.55 132.48 40.73 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.4 0.68 . . . . 45.11 109.752 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.507 HD12 HD23 ' D' ' 128' ' ' LEU . 15.0 mm 58.05 84.03 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 C-N-CA 125.15 1.38 . . . . 74.53 110.068 -172.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 7' ' ' ALA . . . . . 0.458 ' H ' ' HG ' ' D' ' 42' ' ' LEU . . . -150.53 165.8 32.14 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.641 0.376 . . . . 53.24 111.683 -169.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 8' ' ' LEU . . . . . . . . . . . . . 80.3 mt -131.94 153.44 50.29 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.273 1.029 . . . . 75.51 110.255 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 9' ' ' ALA . . . . . 0.513 ' H ' HD22 ' D' ' 44' ' ' LEU . . . -125.5 154.0 42.75 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.982 0.913 . . . . 73.43 109.998 178.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 10' ' ' LEU . . . . . . . . . . . . . 91.4 mt -70.43 140.4 52.01 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.602 0.761 . . . . 61.55 109.871 175.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.598 ' H ' ' HE1' ' D' ' 137' ' ' PHE . 36.8 mt -86.78 104.99 6.79 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 108.109 -1.071 . . . . 74.11 108.109 177.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 12' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.24 -30.25 31.19 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.144 2.563 . . . . 64.15 113.908 -169.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -93.85 -7.39 43.41 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.144 0.578 . . . . 71.13 110.976 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 62.2 tp 57.3 -105.5 0.27 Allowed 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.526 0.73 . . . . 74.04 109.952 -175.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . 0.675 ' HE1' ' HA2' ' D' ' 99' ' ' GLY . 84.5 m-85 -166.34 -166.85 0.93 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.36 1.864 . . . . 74.41 106.378 -172.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 16' ' ' THR . . . . . . . . . . . . . 28.7 p -100.22 107.1 45.85 Favored Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 108.474 -0.936 . . . . 72.44 108.474 163.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 17' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -53.18 165.41 1.39 Allowed 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.735 2.29 . . . . 64.35 113.482 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . 0.681 ' HA ' ' HB3' ' H' ' 21' ' ' ALA . 7.3 t -72.65 -0.67 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 CA-C-N 115.627 -0.715 . . . . 73.33 111.222 -173.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 19' ' ' THR . . . . . . . . . . . . . 34.0 m -66.11 -52.95 43.9 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.934 0.894 . . . . 53.0 111.075 177.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 20' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -86.17 -28.41 23.95 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.619 0.768 . . . . 74.53 110.527 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . 0.681 ' HB3' ' HA ' ' H' ' 18' ' ' VAL . . . -65.76 -30.96 71.69 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.835 0.709 . . . . 72.41 110.78 177.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' H' ' 18' ' ' VAL . 0.0 OUTLIER -63.67 87.71 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.989 -1.115 . . . . 63.14 107.989 174.454 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' H' H ' 23' ' ' THR . . . . . . . . . . . . . 6.3 t -112.19 131.15 22.67 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 123.954 0.902 . . . . 75.14 109.742 -175.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 24' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.5 -28.63 38.3 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.635 2.223 . . . . 73.11 111.768 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 CA--C 1.553 1.075 0 C-N-CA 124.233 1.013 . . . . 41.11 109.055 177.17 . . . . . . . . 0 0 . 1 stop_ save_